PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Torres-Fuentes, C; Golubeva, AV; Zhdanov, AV; Wallace, S; Arboleya, S; Papkovsky, DB; El Aidy, S; Ross, P; Roy, BL; Stanton, C; Dinan, TG; Cryan, JF; Schellekens, H				Torres-Fuentes, Cristina; Golubeva, Anna V.; Zhdanov, Alexander V.; Wallace, Shauna; Arboleya, Silvia; Papkovsky, Dimitri B.; El Aidy, Sahar; Ross, Paul; Roy, Bernard L.; Stanton, Catherine; Dinan, Timothy G.; Cryan, John F.; Schellekens, Harriet			Short-chain fatty acids and microbiota metabolites attenuate ghrelin receptor signaling	FASEB JOURNAL			English	Article						GHSR-1a; SCFA; lactate; probiotics; gut bacteria	GUT-BRAIN AXIS; HORMONE SECRETAGOGUE RECEPTOR; HIGH CONSTITUTIVE ACTIVITY; ACUTE LUNG INJURY; EXPRESSION; MECHANISMS; INCREASE; MOTILITY; CELLS; DIET	The gastrointestinal microbiota is emerging as a unique and inexhaustible source for metabolites with potential to modulate G-protein coupled receptors (GPCRs). The ghrelin receptor [growth hormone secretagogue receptor (GHSR)-1a] is a GPCR expressed throughout both the gut and the brain and plays a crucial role in maintaining energy balance, metabolism, and the central modulation of food intake, motivation, reward, and mood. To date, few studies have investigated the potential of the gastrointestinal microbiota and its metabolites to modulate GPCR signaling. Here we investigate the ability of short-chain fatty acids (SCFAs), lactate, and different bacterial strains, including Bifidobacterium and Lactobacillus genera, to modulate GHSR-1a signaling. We identify, for what is to our knowledge the first time, a potent effect of microbiota-derived metabolites on GHSR-1a signaling with potential significant consequences for host metabolism and physiology. We show that SCFAs, lactate, and bacterial supernatants are able to attenuate ghrelin-mediated signaling through the GHSR-1a. We suggest a novel route of communication between the gut microbiota and the host via modulation of GHSR-1a receptor signaling. Together, this highlights the emerging therapeutic potential in the exploration of the microbiota metabolome in the specific targeting of key GPCRs, with pleiotropic actions that span both the CNS and periphery.	[Torres-Fuentes, Cristina; Golubeva, Anna V.; Wallace, Shauna; Arboleya, Silvia; El Aidy, Sahar; Ross, Paul; Stanton, Catherine; Dinan, Timothy G.; Cryan, John F.; Schellekens, Harriet] Univ Coll Cork, Alimentary Pharmabiot Ctr APC Microbiome Ireland, Cork, Ireland; [Golubeva, Anna V.; Cryan, John F.; Schellekens, Harriet] Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland; [Zhdanov, Alexander V.; Papkovsky, Dimitri B.] Univ Coll Cork, Sch Biochem & Cell Biol, Cork, Ireland; [Dinan, Timothy G.] Univ Coll Cork, Dept Psychiat & Neurobehav Sci, Cork, Ireland; [Arboleya, Silvia; Stanton, Catherine] TEAGASC, Food Res Ctr, Cork, Ireland; [Roy, Bernard L.] Cremo SA, Fribourg, Switzerland; [Torres-Fuentes, Cristina] Rovira & Virgili Univ, Tarragona, Spain; [Wallace, Shauna] MSD, Brinny, Cork, Ireland; [Arboleya, Silvia] CSIC, IPLA, Asturias, Spain; [El Aidy, Sahar] Groningen Biomol Sci & Biotechnol Inst GBB, Groningen, Netherlands	University College Cork; University College Cork; University College Cork; University College Cork; Teagasc; Universitat Rovira i Virgili; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA); University of Groningen	Schellekens, H (corresponding author), Univ Coll Cork, Alimentary Pharmabot Ctr APC Microbiome Ireland, Dept Anat & Neurosci, Western Rd,Western Gateway Bldg, Cork T12 XF62, Ireland.	h.schellekens@ucc.ie	Dinan, Timothy/ABA-8284-2020; Torres-Fuentes, Cristina/J-5551-2019; Ross, Paul/A-7584-2015; Aidy, Sahar El/J-5246-2017; Cryan, John F./A-6950-2013; Stanton, Catherine/A-9549-2015; arboleya, silvia/Q-2385-2018	Torres-Fuentes, Cristina/0000-0002-2917-6910; Ross, Paul/0000-0003-4876-8839; Aidy, Sahar El/0000-0001-8950-4392; Cryan, John F./0000-0001-5887-2723; Stanton, Catherine/0000-0002-6724-7011; Roy, L. B./0000-0003-4209-6007; arboleya, silvia/0000-0002-6155-5822; Zhdanov, Alexander/0000-0001-5787-2035; Schellekens, Harriet/0000-0002-6065-3797	Science Foundation Ireland Research Centre Grant [SFI/12/RC/2273]; Student/Faculty Interaction (SFI) Grant [12/RC/2276]; APC Microbiome Ireland industry partner Cremo SA	Science Foundation Ireland Research Centre Grant(Science Foundation Ireland); Student/Faculty Interaction (SFI) Grant; APC Microbiome Ireland industry partner Cremo SA	This study was supported by Science Foundation Ireland Research Centre Grant SFI/12/RC/2273 to the Alimentary Pharmabiotic Centre (APC) Microbiome Ireland, Student/Faculty Interaction (SFI) Grant 12/RC/2276 DBP and APC Microbiome Ireland industry partner Cremo SA. The authors declare no conflicts of interest.	Altier Christophe, 2012, Subcell Biochem, V63, P241, DOI 10.1007/978-94-007-4765-4_13; Altier C, 2011, METHODS MOL BIOL, V756, P215, DOI 10.1007/978-1-61779-160-4_11; Altindis E, 2018, P NATL ACAD SCI USA, V115, P2461, DOI 10.1073/pnas.1721117115; Araujo A, 2019, INT CONF SYST SIGNAL, P175, DOI 10.1109/IWSSIP.2019.8787250; Baldanzi G, 2002, J CELL BIOL, V159, P1029, DOI 10.1083/jcb.200207165; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Bhattarai Y, 2018, CELL HOST MICROBE, V23, P775, DOI 10.1016/j.chom.2018.05.004; Camina JP, 2004, ENDOCRINOLOGY, V145, P930, DOI 10.1210/en.2003-0974; Cani PD, 2004, BRIT J NUTR, V92, P521, DOI 10.1079/BJN20041225; Chen HW, 2019, CELL, V177, P1217, DOI 10.1016/j.cell.2019.03.036; Chen J, 2008, MED SCI MONITOR, V14, pBR141; Cherbut C, 1998, AM J PHYSIOL-GASTR L, V275, pG1415, DOI 10.1152/ajpgi.1998.275.6.G1415; Cohen LJ, 2017, NATURE, V549, P48, DOI 10.1038/nature23874; Colosimo DA, 2019, CELL HOST MICROBE, V26, P273, DOI 10.1016/j.chom.2019.07.002; Cryan JF, 2018, CELL HOST MICROBE, V23, P691, DOI 10.1016/j.chom.2018.05.020; Cummings DE, 2001, DIABETES, V50, P1714, DOI 10.2337/diabetes.50.8.1714; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Dalile B, 2019, NAT REV GASTRO HEPAT, V16, P461, DOI 10.1038/s41575-019-0157-3; Damian M, 2012, J BIOL CHEM, V287, P3630, DOI 10.1074/jbc.M111.288324; Dass NB, 2007, NEUROGASTROENT MOTIL, V19, P66, DOI 10.1111/j.1365-2982.2006.00853.x; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Dinan TG, 2017, J PHYSIOL-LONDON, V595, P489, DOI 10.1113/JP273106; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Duca FA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039748; Els S, 2010, METHOD ENZYMOL, V485, P103, DOI [10.1016/S0076-6879(10)85006-2, 10.1016/B978-0-12-381296-4.00006-3]; Frost G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4611; Garbison K. E., 2012, ASSAY GUIDANCE MANUA; Holliday ND, 2007, MOL ENDOCRINOL, V21, P3100, DOI 10.1210/me.2007-0254; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Howick K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020273; Husted AS, 2017, CELL METAB, V25, P777, DOI 10.1016/j.cmet.2017.03.008; Huuskonen J, 2004, BRIT J PHARMACOL, V141, P874, DOI 10.1038/sj.bjp.0705682; Queipo-Ortuno MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065465; Jain R, 2018, INT REV CEL MOL BIO, V338, P79, DOI 10.1016/bs.ircmb.2018.02.003; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Layden BT, 2013, TRANSL RES, V161, P131, DOI 10.1016/j.trsl.2012.10.007; Li GA, 2010, TOHOKU J EXP MED, V222, P7, DOI 10.1620/tjem.222.7; Liu Ke, 2008, Curr Chem Genomics, V1, P70, DOI 10.2174/1875397300801010070; Liu Y, 2018, INT J MOL MED, V42, P3037, DOI 10.3892/ijmm.2018.3886; Soto EJL, 2015, J GEN PHYSIOL, V146, P205, DOI 10.1085/jgp.201511383; M'Kadmi C, 2015, J BIOL CHEM, V290, P27021, DOI 10.1074/jbc.M115.659250; Muccioli G, 2011, PEPTIDES, V32, P2514, DOI 10.1016/j.peptides.2011.10.020; Muller TD, 2015, MOL METAB, V4, P437, DOI 10.1016/j.molmet.2015.03.005; Mustafa ER, 2017, J CELL SCI, V130, P3907, DOI 10.1242/jcs.207886; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Nohr MK, 2015, NEUROSCIENCE, V290, P126, DOI 10.1016/j.neuroscience.2015.01.040; Park J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156334; Pastor-Cavada E, 2016, SCI REP-UK, V6, DOI 10.1038/srep36456; Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309; Qiang XL, 2017, NPJ BIOFILMS MICROBI, V3, DOI 10.1038/s41522-017-0039-9; Ramirez VT, 2019, FASEB J, V33, P518, DOI 10.1096/fj.201800655R; Rivas PMS, 2017, HORM BEHAV, V93, P166, DOI 10.1016/j.yhbeh.2017.05.018; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Sandhu KV, 2017, TRANSL RES, V179, P223, DOI 10.1016/j.trsl.2016.10.002; Sato T, 2005, ENDOCRINOLOGY, V146, P2510, DOI 10.1210/en.2005-0174; Schellekens H, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00148; Schellekens H, 2013, J PHARM PHARMACOL, V65, P528, DOI 10.1111/jphp.12010; Schellekens H, 2012, PHARMACOL THERAPEUT, V135, P316, DOI 10.1016/j.pharmthera.2012.06.004; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Stievenard A, 2017, NEUROSCI BIOBEHAV R, V73, P255, DOI 10.1016/j.neubiorev.2016.11.021; Sun MM, 2017, J GASTROENTEROL, V52, P1, DOI 10.1007/s00535-016-1242-9; Takeshita E, 2006, J GASTROENTEROL, V41, P223, DOI 10.1007/s00535-005-1739-0; Tibes R, 2006, MOL CANCER THER, V5, P2512, DOI 10.1158/1535-7163.MCT-06-0334; Torres-Fuentes C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061605; Torres-Fuentes C, 2017, LANCET GASTROENTEROL, V2, P747, DOI 10.1016/S2468-1253(17)30147-4; Torres-Fuentes C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103118; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; van de Wouw M, 2017, J NUTR, V147, P727, DOI 10.3945/jn.116.240481; Yin Y, 2014, INT J MOL SCI, V15, P4837, DOI 10.3390/ijms15034837; Zarogoulidis P, 2014, ONCOL LETT, V8, P2367, DOI 10.3892/ol.2014.2608; Zhdanov AV, 2015, EXP CELL RES, V330, P13, DOI 10.1016/j.yexcr.2014.10.005	72	48	50	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13546	13559		10.1096/fj.201901433R	http://dx.doi.org/10.1096/fj.201901433R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31545915	Green Submitted, Bronze			2022-12-26	WOS:000507466100040
J	Tsednee, M; Castruita, M; Salome, PA; Sharma, A; Lewis, BE; Schmollinger, SR; Strenkert, D; Holbrook, K; Otegui, MS; Khatua, K; Das, S; Datta, A; Chen, S; Ramon, C; Ralle, M; Weber, PK; Stemmler, TL; Pett-Ridge, J; Hoffman, BM; Merchant, SS				Tsednee, Munkhtsetseg; Castruita, Madeli; Salome, Patrice A.; Sharma, Ajay; Lewis, Brianne E.; Schmollinger, Stefan R.; Strenkert, Daniela; Holbrook, Kristen; Otegui, Marisa S.; Khatua, Kaustav; Das, Sayani; Datta, Ankona; Chen, Si; Ramon, Christina; Ralle, Martina; Weber, Peter K.; Stemmler, Timothy L.; Pett-Ridge, Jennifer; Hoffman, Brian M.; Merchant, Sabeeha S.			Manganese co-localizes with calcium and phosphorus in Chlamydomonas acidocalcisomes and is mobilized in manganese-deficient conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						algae; antioxidant; calcium; Chlamydomonas; histidine; imaging; lysosomal acidification; lysosome; manganese; metal homeostasis; H plus -PPase; NRAMP; organelle; photosynthesis; polyphosphate	IRON-DEFICIENCY; SACCHAROMYCES-CEREVISIAE; DEINOCOCCUS-RADIODURANS; SUPEROXIDE-DISMUTASE; VACUOLAR MANGANESE; MN2+ SPECIATION; GAMMA-RADIATION; POLYPHOSPHATE; ARABIDOPSIS; STRESS	Exposing cells to excess metal concentrations well beyond the cellular quota is a powerful tool for understanding the molecular mechanisms of metal homeostasis. Such improved understanding may enable bioengineering of organisms with improved nutrition and bioremediation capacity. We report here that Chlamydomonas reinhardtii can accumulate manganese (Mn) in proportion to extracellular supply, up to 30-fold greater than its typical quota and with remarkable tolerance. As visualized by X-ray fluorescence microscopy and nanoscale secondary ion MS (nanoSIMS), Mn largely co-localizes with phosphorus (P) and calcium (Ca), consistent with the Mn-accumulating site being an acidic vacuole, known as the acidocalcisome. Vacuolar Mn stores are accessible reserves that can be mobilized in Mn-deficient conditions to support algal growth. We noted that Mn accumulation depends on cellular polyphosphate (polyP) content, indicated by 1) a consistent failure of C. reinhardtii vtc1 mutant strains, which are deficient in polyphosphate synthesis, to accumulate Mn and 2) a drastic reduction of the Mn storage capacity in P-deficient cells. Rather surprisingly, X-ray absorption spectroscopy, EPR, and electron nuclear double resonance revealed that only little Mn2+ is stably complexed with polyP, indicating that polyP is not the final Mn ligand. We propose that polyPs are a critical component of Mn accumulation in Chlamydomonas by driving Mn relocation from the cytosol to acidocalcisomes. Within these structures, polyP may, in turn, escort vacuolar Mn to a number of storage ligands, including phosphate and phytate, and other, yet unidentified, compounds.	[Tsednee, Munkhtsetseg; Castruita, Madeli; Salome, Patrice A.; Schmollinger, Stefan R.; Strenkert, Daniela; Holbrook, Kristen; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Salome, Patrice A.; Schmollinger, Stefan R.; Strenkert, Daniela; Merchant, Sabeeha S.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Sharma, Ajay; Hoffman, Brian M.] Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA; [Lewis, Brianne E.; Stemmler, Timothy L.] Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48201 USA; [Otegui, Marisa S.] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; [Otegui, Marisa S.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Khatua, Kaustav; Das, Sayani; Datta, Ankona] Tata Inst Fundamental Res, Dept Chem Sci, Mumbai 400005, Maharashtra, India; [Chen, Si] Argonne Natl Lab, Adv Photon Source, Lemont, IL 60439 USA; [Ramon, Christina; Weber, Peter K.; Pett-Ridge, Jennifer] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA 94550 USA; [Ralle, Martina] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97239 USA; [Schmollinger, Stefan R.; Strenkert, Daniela] Univ Calif Berkeley, 427 Stanley Hall QB3, Berkeley, CA 94720 USA; [Holbrook, Kristen] Amgen Inc, 1 Amgen Ctr Dr, Thousand Oaks, CA 91320 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Northwestern University; Wayne State University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Tata Institute of Fundamental Research (TIFR); United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Oregon Health & Science University; University of California System; University of California Berkeley; Amgen	Merchant, SS (corresponding author), Univ Calif Berkeley, 176 Stanley Hall QB3, Berkeley, CA 94720 USA.	sabeeha@chem.ucla.edu	, Jennifer Pett RIdge/AAE-9934-2022; , Jennifer Pett RIdge/AFF-7780-2022; Sharma, Ajay/H-2146-2018; Ralle, Martina/H-2936-2019; Lewis, Brianne/AAU-5344-2021; Weber, Peter Kilian/AAP-9517-2020	Sharma, Ajay/0000-0002-0829-6753; Weber, Peter Kilian/0000-0001-6022-6050; Strenkert, Daniela/0000-0002-3420-1332; Salome, Patrice/0000-0003-4452-9064; Lewis, Brianne/0000-0003-1584-6407; Pett-Ridge, Jennifer/0000-0002-4439-2398; Tsednee, Munkhtsetseg/0000-0002-2878-0112; Datta, Ankona/0000-0003-0821-6044; Schmollinger, Stefan/0000-0002-7487-8014; Stemmler, Timothy/0000-0002-6298-088X	DOE Office of Science [DE-AC02-06CH11357]; DOE, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources, Biomedical Technology Program; DOE [DE-AC52-07NA27344]; Office of Biological and Environmental Research [130367]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111097] Funding Source: NIH RePORTER	DOE Office of Science(United States Department of Energy (DOE)); DOE, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources, Biomedical Technology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOE(United States Department of Energy (DOE)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge use of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. We thank Janice Pennington and Julio Paez Valencia for help handling samples and with the EDX analysis. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL). SSRL is a national user facility operated by Stanford University on behalf of the United States DOE, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the DOE, Office of Biological and Environmental Research, and by the National Institutes of Health, National Center for Research Resources, Biomedical Technology Program. Work at Lawrence Livermore National Laboratory was performed under the auspices of DOE Contract DE-AC52-07NA27344. Part of the research was performed at EMSL (Ringgold ID 130367), a DOE Office of Science User Facility sponsored by the Office of Biological and Environmental Research.	Abragam A., 1970, ELECTRON PARAMAGNETI, P87; Aksoy M, 2014, PLANT CELL, V26, P4214, DOI 10.1105/tpc.114.129270; Alejandro S, 2017, PLANT CELL, V29, P3068, DOI 10.1105/tpc.17.00578; Allen MD, 2007, PLANT PHYSIOL, V143, P263, DOI 10.1104/pp.106.088609; Anbar AD, 2008, SCIENCE, V322, P1481, DOI 10.1126/science.1163100; Andreeva N, 2013, FEMS YEAST RES, V13, P463, DOI 10.1111/1567-1364.12049; Azevedo C, 2014, BIOCHEM SOC T, V42, P98, DOI 10.1042/BST20130111; Bakthavatsalam S, 2015, CHEM COMMUN, V51, P2605, DOI 10.1039/c4cc09542a; Barnese K, 2008, J AM CHEM SOC, V130, P4604, DOI 10.1021/ja710162n; Blaby-Haas CE, 2014, J BIOL CHEM, V289, P28129, DOI 10.1074/jbc.R114.592618; Cailliatte R, 2010, PLANT CELL, V22, P904, DOI 10.1105/tpc.109.073023; Castaings L, 2016, SCI REP-UK, V6, DOI 10.1038/srep37222; Chandra S., 2010, ENCY MASS SPECTROMET, P469; Cohen A, 1999, J BIOL CHEM, V274, P26885, DOI 10.1074/jbc.274.38.26885; CRAMER CL, 1984, J BIOL CHEM, V259, P5152; Culotta VC, 2005, EUKARYOT CELL, V4, P1159, DOI 10.1128/EC.4.7.1159-1165.2005; Curie C, 2000, BIOCHEM J, V347, P749, DOI 10.1042/0264-6021:3470749; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Davoust CE, 1996, J MAGN RESON SER A, V119, P38, DOI 10.1006/jmra.1996.0049; Desfougeres Y, 2016, J BIOL CHEM, V291, P22262, DOI 10.1074/jbc.M116.746784; Docampo R, 2016, CURR OPIN CELL BIOL, V41, P66, DOI 10.1016/j.ceb.2016.04.007; Eroglu S, 2017, PLANT PHYSIOL, V174, P1633, DOI 10.1104/pp.16.01646; Eroglu S, 2016, PLANT PHYSIOL, V170, P1030, DOI 10.1104/pp.15.01194; Fernando DR, 2010, NEW PHYTOL, V188, P1014, DOI 10.1111/j.1469-8137.2010.03431.x; Gerasimaite R, 2014, J CELL SCI, V127, P5093, DOI 10.1242/jcs.159772; Ghosal S, 2008, ANAL CHEM, V80, P5986, DOI 10.1021/ac8006279; Glaesener AG, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00337; Goodenough U, 2019, PROTIST, V170, P287, DOI 10.1016/j.protis.2019.05.001; Haddy A, 2007, PHOTOSYNTH RES, V92, P357, DOI 10.1007/s11120-007-9194-9; Hohner R, 2013, MOL CELL PROTEOMICS, V12, P2774, DOI 10.1074/mcp.M113.029991; Hoffman BM, 2003, ACCOUNTS CHEM RES, V36, P522, DOI 10.1021/ar0202565; Hoffman BM, 2003, P NATL ACAD SCI USA, V100, P3575, DOI 10.1073/pnas.0636464100; Hong-Hermesdorf A, 2014, NAT CHEM BIOL, V10, P1034, DOI 10.1038/nchembio.1662; Hothorn M, 2009, SCIENCE, V324, P513, DOI 10.1126/science.1168120; Hurlimann BC, 2007, MOL BIOL CELL, V18, P4438, DOI 10.1091/mbc.E07-05-0457; Imlay JA, 2014, J BIOL CHEM, V289, P28121, DOI 10.1074/jbc.R114.588814; Jensen LT, 2003, J BIOL CHEM, V278, P42036, DOI 10.1074/jbc.M307413200; Kai Y, 2003, ARCH BIOCHEM BIOPHYS, V414, P170, DOI 10.1016/S0003-9861(03)00170-X; Kim SA, 2006, SCIENCE, V314, P1295, DOI 10.1126/science.1132563; Kliebenstein DJ, 1998, PLANT PHYSIOL, V118, P637, DOI 10.1104/pp.118.2.637; Klompmaker SH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01930-5; Kropat J, 2015, P NATL ACAD SCI USA, V112, P2644, DOI 10.1073/pnas.1422492112; Kropat J, 2011, PLANT J, V66, P770, DOI 10.1111/j.1365-313X.2011.04537.x; Lander N, 2016, BIOCHEM SOC T, V44, P1, DOI 10.1042/BST20150193; Lanquar V, 2010, PLANT PHYSIOL, V152, P1986, DOI 10.1104/pp.109.150946; Long JC, 2008, PHOTOCHEM PHOTOBIOL, V84, P1395, DOI 10.1111/j.1751-1097.2008.00451.x; Lukehart, 2007, APPL PHYS METHODS IN, P513; LYTLE FW, 1988, PHYS REV B, V37, P1550, DOI 10.1103/PhysRevB.37.1550; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P1; McNaughton RL, 2010, P NATL ACAD SCI USA, V107, P15335, DOI 10.1073/pnas.1009648107; Merchant SS, 2006, BBA-MOL CELL RES, V1763, P578, DOI 10.1016/j.bbamcr.2006.04.007; Milner MJ, 2013, J EXP BOT, V64, P369, DOI 10.1093/jxb/ers315; Moseley JL, 2006, EUKARYOT CELL, V5, P26, DOI 10.1128/EC.5.1.26-44.2006; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Naumann B, 2007, PROTEOMICS, V7, P3964, DOI 10.1002/pmic.200700407; Page MD, 2012, PLANT CELL, V24, P2649, DOI 10.1105/tpc.112.098962; Peiter E, 2007, P NATL ACAD SCI USA, V104, P8532, DOI 10.1073/pnas.0609507104; Pett-Ridge Jennifer, 2012, Methods Mol Biol, V881, P375, DOI 10.1007/978-1-61779-827-6_13; Reddi AR, 2009, FREE RADICAL BIO MED, V46, P154, DOI 10.1016/j.freeradbiomed.2008.09.032; Requena L, 1999, BIOCHEM J, V343, P185, DOI 10.1042/0264-6021:3430185; Rosenfeld L, 2010, J BIOL INORG CHEM, V15, P1051, DOI 10.1007/s00775-010-0664-8; Ruiz FA, 2001, J BIOL CHEM, V276, P26114, DOI 10.1074/jbc.M102402200; Salikhov K. M., 2002, APPL MAGN RESON, V22, P319, DOI [10.1007/BF03166113, DOI 10.1007/BF03166113]; Sharma A, 2017, P NATL ACAD SCI USA, V114, pE9253, DOI 10.1073/pnas.1713608114; Sharma A, 2013, P NATL ACAD SCI USA, V110, P5945, DOI 10.1073/pnas.1303376110; Slaveykova VI, 2009, ANAL BIOANAL CHEM, V393, P583, DOI 10.1007/s00216-008-2486-x; Socha AL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00106; Somers II, 1942, PLANT PHYSIOL, V17, P582, DOI 10.1104/pp.17.4.582; SPILLER SC, 1982, PLANT PHYSIOL, V69, P107, DOI 10.1104/pp.69.1.107; Stich TA, 2007, APPL MAGN RESON, V31, P321, DOI 10.1007/BF03166263; Strenkert D, 2016, J BIOL CHEM, V291, P19118, DOI 10.1074/jbc.M116.717413; TANAKA A., 1966, Soil and Plant Food, V12, P29; Terauchi AM, 2010, PHOTOSYNTH RES, V105, P39, DOI 10.1007/s11120-010-9562-8; Thomine S, 2000, P NATL ACAD SCI USA, V97, P4991, DOI 10.1073/pnas.97.9.4991; Tottey S, 2003, P NATL ACAD SCI USA, V100, P16119, DOI 10.1073/pnas.2136793100; Vinyard DJ, 2017, ANNU REV PHYS CHEM, V68, P101, DOI 10.1146/annurev-physchem-052516-044820; Wang YR, 2018, METALLOMICS, V10, DOI 10.1039/c8mt00269j; WERST MM, 1991, J AM CHEM SOC, V113, P1533, DOI 10.1021/ja00005a011; Yu DN, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-623	79	27	28	6	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17626	17641		10.1074/jbc.RA119.009130	http://dx.doi.org/10.1074/jbc.RA119.009130			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31527081	hybrid, Green Published			2022-12-26	WOS:000503173500036
J	Garg, A; Orru, R; Ye, WX; Distler, U; Chojnacki, JE; Kohn, M; Tenzer, S; Sonnichsen, C; Wolf, E				Garg, Archit; Orru, Roberto; Ye, Weixiang; Distler, Ute; Chojnacki, Jeremy E.; Koehn, Maja; Tenzer, Stefan; Soennichsen, Carsten; Wolf, Eva			Structural and mechanistic insights into the interaction of the circadian transcription factor BMAL1 with the KIX domain of the CREB-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						circadian clock; gene regulation; structural biology; transcription regulation; chromatin modification; biophysics; brain and muscle ARNT-like protein-1 (BMAL1); circadian gene regulation; kinase inducible domain interacting (KIX) domain of CBP; protein interactions; SAXS; CREB-binding protein (CBP); transactivation domain (TAD); BMAL1 G-region; transcriptional rhythmicity	SMALL-ANGLE SCATTERING; X-RAY-SCATTERING; TRANSACTIVATION DOMAIN; SECONDARY STRUCTURE; BIOLOGICAL MACROMOLECULES; PLASMONIC NANOSENSORS; C-MYB; CBP; CLOCK; PHOSPHORYLATION	The mammalian CLOCK:BMAL1 transcription factor complex and its coactivators CREB-binding protein (CBP)/p300 and mixed-lineage leukemia 1 (MLL1) critically regulate circadian transcription and chromatin modification. Circadian oscillations are regulated by interactions of BMAL1's C-terminal transactivation domain (TAD) with the KIX domain of CBP/p300 (activating) and with the clock protein CRY1 (repressing) as well as by the BMAL1 G-region preceding the TAD. Circadian acetylation of Lys(537) within the G-region enhances repressive BMAL1-TAD-CRY1 interactions. Here, we characterized the interaction of the CBP-KIX domain with BMAL1 proteins, including the BMAL1-TAD, parts of the G-region, and Lys(537). Tethering the small compound 1?10 in the MLL-binding pocket of the CBP-KIX domain weakened BMAL1 binding, and MLL1-bound KIX did not form a ternary complex with BMAL1, indicating that the MLL-binding pocket is important for KIX-BMAL1 interactions. Small-angle X-ray scattering (SAXS) models of BMAL1 and BMAL1:KIX complexes revealed that the N-terminal BMAL1 G-region including Lys(537) forms elongated extensions emerging from the bulkier BMAL1-TAD:KIX core complex. Fitting high-resolution KIX domain structures into the SAXS-derived envelopes suggested that the G-region emerges near the MLL-binding pocket, further supporting a role of this pocket in BMAL1 binding. Additionally, mutations in the second CREB-pKID/c-Myb?binding pocket of the KIX domain moderately impacted BMAL1 binding. The BMAL1(K537Q) mutation mimicking Lys(537) acetylation, however, did not affect the KIX-binding affinity, in contrast to its enhancing effect on CRY1 binding. Our results significantly advance the mechanistic understanding of the protein interaction networks controlling CLOCK:BMAL1- and CBP-dependent gene regulation in the mammalian circadian clock.	[Garg, Archit; Wolf, Eva] Inst Mol Biol, Ackermannweg 4, D-55128 Mainz, Germany; [Garg, Archit; Orru, Roberto; Wolf, Eva] Johannes Gutenberg Univ Mainz, Inst Mol Physiol, D-55128 Mainz, Germany; [Ye, Weixiang; Soennichsen, Carsten] Johannes Gutenberg Univ Mainz, Inst Phys Chem, Duesbergweg 10-14, D-55128 Mainz, Germany; [Distler, Ute; Tenzer, Stefan] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Immunol, D-55131 Mainz, Germany; [Chojnacki, Jeremy E.; Koehn, Maja] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Koehn, Maja] Albert Ludwigs Univ Freiburg, Fac Biol, Schanzlestr 18, D-79104 Freiburg, Germany; [Koehn, Maja] Albert Ludwigs Univ Freiburg, Signalling Res Ctr BIOSS, Schanzlestr 18, D-79104 Freiburg, Germany; [Koehn, Maja] Albert Ludwigs Univ Freiburg, CIBSS, Schanzlestr 18, D-79104 Freiburg, Germany	Institute of Molecular Biology (IMB); Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; European Molecular Biology Laboratory (EMBL); University of Freiburg; University of Freiburg; University of Freiburg	Wolf, E (corresponding author), Inst Mol Biol, Ackermannweg 4, D-55128 Mainz, Germany.; Wolf, E (corresponding author), Johannes Gutenberg Univ Mainz, Inst Mol Physiol, D-55128 Mainz, Germany.	evawolf1@uni-mainz.de	Tenzer, Stefan/AAE-2180-2020; Sönnichsen, Carsten/A-5682-2009; Köhn, Maja/G-5131-2012	Tenzer, Stefan/0000-0003-3034-0017; Sönnichsen, Carsten/0000-0003-1824-7696; Köhn, Maja/0000-0001-8142-3504; Distler, Ute/0000-0002-8031-6384; Garg, Archit/0000-0002-5931-2522	International Ph.D. Programme on Gene Regulation, Epigenetics, and Genome Stability, Mainz, Germany	International Ph.D. Programme on Gene Regulation, Epigenetics, and Genome Stability, Mainz, Germany	Affiliated with and financially supported by the International Ph.D. Programme on Gene Regulation, Epigenetics, and Genome Stability, Mainz, Germany.	Aguilar-Arnal L, 2015, NAT STRUCT MOL BIOL, V22, P312, DOI 10.1038/nsmb.2990; Ahijado-Guzman R, 2017, ACS APPL MATER INTER, V9, P218, DOI 10.1021/acsami.6b14013; Ahijado-Guzman R, 2014, NANO LETT, V14, P5528, DOI 10.1021/nl501865p; Aryal RP, 2017, MOL CELL, V67, P770, DOI 10.1016/j.molcel.2017.07.017; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; Bruschweiler S, 2013, ACS CHEM BIOL, V8, P1600, DOI 10.1021/cb4002188; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Czarna A, 2013, CELL, V153, P1394, DOI 10.1016/j.cell.2013.05.011; Czarna A, 2011, J BIOL CHEM, V286, P22414, DOI 10.1074/jbc.M111.244749; De Guzman RN, 2006, J MOL BIOL, V355, P1005, DOI 10.1016/j.jmb.2005.09.059; Dyson HJ, 2016, J BIOL CHEM, V291, P6714, DOI 10.1074/jbc.R115.692020; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gau D, 2002, NEURON, V34, P245, DOI 10.1016/S0896-6273(02)00656-6; Gianni S, 2012, BIOCHEM BIOPH RES CO, V428, P205, DOI 10.1016/j.bbrc.2012.09.112; Goto NK, 2002, J BIOL CHEM, V277, P43168, DOI 10.1074/jbc.M207660200; Gustafson CL, 2017, MOL CELL, V66, P447, DOI 10.1016/j.molcel.2017.04.011; Hajizadeh NR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25355-2; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Kiyohara YB, 2006, P NATL ACAD SCI USA, V103, P10074, DOI 10.1073/pnas.0601416103; Koike N, 2012, SCIENCE, V338, P349, DOI 10.1126/science.1226339; Lee B, 2010, J BIOL RHYTHM, V25, P410, DOI 10.1177/0748730410381229; Lee CW, 2009, BIOCHEMISTRY-US, V48, P2115, DOI 10.1021/bi802055v; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Merbitz-Zahradnik T, 2015, FEBS LETT, V589, P1516, DOI 10.1016/j.febslet.2015.05.024; Panjkovich A, 2016, PHYS CHEM CHEM PHYS, V18, P5707, DOI 10.1039/c5cp04540a; Park N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138661; Parker D, 1999, MOL CELL BIOL, V19, P5601; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Paz JC, 2014, P NATL ACAD SCI USA, V111, P17116, DOI 10.1073/pnas.1420389111; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Schneidman-Duhovny D, 2016, NUCLEIC ACIDS RES, V44, pW424, DOI 10.1093/nar/gkw389; Scholz J, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-12; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Takahata S, 2000, GENES CELLS, V5, P739, DOI 10.1046/j.1365-2443.2000.00363.x; Thakur JK, 2014, NUCLEIC ACIDS RES, V42, P2112, DOI 10.1093/nar/gkt1147; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Valentini E, 2015, NUCLEIC ACIDS RES, V43, pD357, DOI 10.1093/nar/gku1047; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang F, 2012, P NATL ACAD SCI USA, V109, P6078, DOI 10.1073/pnas.1119073109; Wang NK, 2014, P NATL ACAD SCI USA, V111, P12061, DOI 10.1073/pnas.1406033111; Wang NK, 2013, J AM CHEM SOC, V135, P3363, DOI 10.1021/ja3122334; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Xu HY, 2015, NAT STRUCT MOL BIOL, V22, P476, DOI 10.1038/nsmb.3018; Ye R, 2014, GENE DEV, V28, P1989, DOI 10.1101/gad.249417.114; Ye R, 2011, J BIOL CHEM, V286, P25891, DOI 10.1074/jbc.M111.254680; Ye WX, 2018, J AM CHEM SOC, V140, P17901, DOI 10.1021/jacs.8b07759; Ye WX, 2018, NANO LETT, V18, P6633, DOI 10.1021/acs.nanolett.8b03342; Zor T, 2004, J MOL BIOL, V337, P521, DOI 10.1016/j.jmb.2004.01.038; Zor T, 2002, J BIOL CHEM, V277, P42241, DOI 10.1074/jbc.M207361200	59	6	6	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16604	16619		10.1074/jbc.RA119.009845	http://dx.doi.org/10.1074/jbc.RA119.009845			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31515273	hybrid, Green Published			2022-12-26	WOS:000501801900012
J	Xu, YQ; Mak, HY; Lukmantara, I; Li, YE; Hoehn, KL; Huang, X; Du, XM; Yang, HY				Xu, Yanqing; Mak, Hoi Yin; Lukmantara, Ivan; Li, Yang E.; Hoehn, Kyle L.; Huang, Xun; Du, Ximing; Yang, Hongyuan			CDP-DAG synthase 1 and 2 regulate lipid droplet growth through distinct mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipid droplet (LD); phospholipid; enzyme; phosphatidic acid; metabolic disease; CDP-diacylglycerol synthase (CDS); cell death-inducing DFF45-like effector C (CIDEC); Fsp27; diacylglycerol O-acyltransferase 2 (DGAT2); glycerol-3-phosphate acyltransferase 4 (GPAT4); triacylglycerol (TAG); phosphatidic acid (PA); SEIPIN	FAT-SPECIFIC PROTEIN-27; ADIPOCYTE DEVELOPMENT; SEIPIN; ER; LOCALIZATION; MITOCHONDRIA; DIMERIZATION; SYNTHETASE; DEFICIENT; EXPANSION	Lipid droplets (LDs) are evolutionarily conserved organelles that play critical roles in mammalian lipid storage and metabolism. However, the molecular mechanisms governing the biogenesis and growth of LDs remain poorly understood. Phosphatidic acid (PA) is a precursor of phospholipids and triacylglycerols and substrate of CDP-diacylglycerol (CDP-DAG) synthase 1 (CDS1) and CDS2, which catalyze the formation of CDP-DAG. Here, using siRNA-based gene knockdowns and CRISPR/Cas9-mediated gene knockouts, along with immunological, molecular, and fluorescence microscopy approaches, we examined the role of CDS1 and CDS2 in LD biogenesis and growth. Knockdown of either CDS1 or CDS2 expression resulted in the formation of giant or supersized LDs in cultured mammalian cells. Interestingly, down-regulation of cell death-inducing DFF45-like effector C (CIDEC), encoding a prominent regulator of LD growth in adipocytes, restored LD size in CDS1- but not in CDS2-deficient cells. On the other hand, reducing expression of two enzymes responsible for triacylglycerol synthesis, diacylglycerol O-acyltransferase 2 (DGAT2) and glycerol-3-phosphate acyltransferase 4 (GPAT4), rescued the LD phenotype in CDS2-deficient, but not CDS1-deficient, cells. Moreover, CDS2 deficiency, but not CDS1 deficiency, promoted the LD association of DGAT2 and GPAT4 and impaired initial LD maturation. Finally, although both CDS1 and CDS2 appeared to regulate PA levels on the LD surface, CDS2 had a stronger effect. We conclude that CDS1 and CDS2 regulate LD dynamics through distinct mechanisms.	[Xu, Yanqing; Mak, Hoi Yin; Lukmantara, Ivan; Li, Yang E.; Hoehn, Kyle L.; Du, Ximing; Yang, Hongyuan] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia; [Huang, Xun] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Mol Dev Biol, Beijing 100049, Peoples R China	University of New South Wales Sydney; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Yang, HY (corresponding author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW 2052, Australia.	h.rob.yang@unsw.edu.au	Yang, Hongyuan/AAR-1326-2020	Yang, Hongyuan/0000-0002-8482-6031; Hoehn, Kyle/0000-0002-0214-3238; Lukmantara, Ivan/0000-0001-9759-5669	National Health and Medical Research Council of Australia (NHMRC) [1141939, 1144726]; NHMRC [1058237]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council of Australia (NHMRC) Project Grants 1141939 and 1144726. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by NHMRC Senior Research Fellowship 1058237. To whom correspondence should be addressed: School of Biotechnology and Biomolecular Sciences, the University of New South Wales, Sydney, New South Wales 2052, Australia. Tel.: 61-2-93858133; Fax: 61-2-93851483; E-mail: h.rob.yang@unsw.edu.au.	Barneda D, 2017, CURR OPIN CELL BIOL, V47, P9, DOI 10.1016/j.ceb.2017.02.002; Ben M'barek K, 2017, DEV CELL, V41, P591, DOI 10.1016/j.devcel.2017.05.012; Chang CL, 2013, CELL REP, V5, P813, DOI 10.1016/j.celrep.2013.09.038; Chazotte Brad, 2011, Cold Spring Harb Protoc, V2011, P990, DOI 10.1101/pdb.prot5648; Chen ZM, 2000, J BIOL CHEM, V275, P22619, DOI 10.1074/jbc.C000207200; Choi SY, 2006, NAT CELL BIOL, V8, P1255, DOI 10.1038/ncb1487; Craveiro Sarmento Aquiles Sales, 2018, Int J Cell Biol, V2018, P5207608, DOI 10.1155/2018/5207608; Cui XYA, 2015, J CELL SCI, V128, P3398, DOI 10.1242/jcs.168583; D'Souza K, 2014, BIOCHEMISTRY-US, V53, P7358, DOI 10.1021/bi501250m; Farmer BC, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020182; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Fei WH, 2011, J LIPID RES, V52, P2136, DOI 10.1194/jlr.M017566; Fei WH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002201; Fei WH, 2011, TRENDS ENDOCRIN MET, V22, P204, DOI 10.1016/j.tem.2011.02.004; Gao MM, 2019, PROG LIPID RES, V75, DOI 10.1016/j.plipres.2019.100989; Gong JY, 2011, J CELL BIOL, V195, P953, DOI 10.1083/jcb.201104142; Grahn THM, 2014, J BIOL CHEM, V289, P12029, DOI 10.1074/jbc.M113.539890; Grippa A, 2015, J CELL BIOL, V211, P829, DOI 10.1083/jcb.201502070; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Henne WM, 2018, EMBO J, V37, DOI 10.15252/embj.201898947; Jambunathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028614; Jiang M, 2014, P NATL ACAD SCI USA, V111, P7054, DOI 10.1073/pnas.1324025111; Kassan A, 2013, J CELL BIOL, V203, P985, DOI 10.1083/jcb.201305142; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kim YJ, 2015, DEV CELL, V33, P549, DOI 10.1016/j.devcel.2015.04.028; Kim YJ, 2011, DEV CELL, V21, P813, DOI 10.1016/j.devcel.2011.09.005; Kory N, 2016, TRENDS CELL BIOL, V26, P535, DOI 10.1016/j.tcb.2016.02.007; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; KUCHLER K, 1986, J BACTERIOL, V165, P901, DOI 10.1128/jb.165.3.901-910.1986; Lai L, 2014, J BIOL CHEM, V289, P2250, DOI 10.1074/jbc.M113.523654; Langhi C, 2015, HEPATOLOGY, V61, P1227, DOI 10.1002/hep.27607; Liu K, 2009, AM J PHYSIOL-ENDOC M, V297, pE1395, DOI 10.1152/ajpendo.00188.2009; Lykidis A, 1997, J BIOL CHEM, V272, P33402, DOI 10.1074/jbc.272.52.33402; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; MOK AYP, 1993, BIOCHEM CELL BIOL, V71, P183, DOI 10.1139/o93-029; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Nagle CA, 2008, J LIPID RES, V49, P823, DOI 10.1194/jlr.M700592-JLR200; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Olzmann JA, 2019, NAT REV MOL CELL BIO, V20, P137, DOI 10.1038/s41580-018-0085-z; Pagac M, 2016, CELL REP, V17, P1546, DOI 10.1016/j.celrep.2016.10.037; Prinz WA, 2013, DEV CELL, V24, P335, DOI 10.1016/j.devcel.2013.02.004; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Qi YF, 2017, BBA-MOL CELL BIOL L, V1862, P1273, DOI 10.1016/j.bbalip.2017.06.016; Qi YF, 2016, J LIPID RES, V57, P767, DOI 10.1194/jlr.M060574; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Salo VT, 2016, EMBO J, V35, P2699, DOI 10.15252/embj.201695170; Shyu P, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180764; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wang HJ, 2016, ELIFE, V5, DOI 10.7554/eLife.16582; Wilfling F, 2014, ELIFE, V3, DOI 10.7554/eLife.01607; Wilfling F, 2013, DEV CELL, V24, P384, DOI 10.1016/j.devcel.2013.01.013; Yan RH, 2018, DEV CELL, V47, P248, DOI 10.1016/j.devcel.2018.09.010; Yang HY, 2012, CURR OPIN CELL BIOL, V24, P509, DOI 10.1016/j.ceb.2012.05.012	56	12	12	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16740	16755		10.1074/jbc.RA119.009992	http://dx.doi.org/10.1074/jbc.RA119.009992			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31548309	hybrid, Green Published			2022-12-26	WOS:000501801900022
J	Zheng, YJ; Zhao, JY; Liang, TS; Wang, P; Wang, J; Yang, DK; Liu, ZS				Zheng, Ying-Juan; Zhao, Jing-Yi; Liang, Tian-Song; Wang, Ping; Wang, Juan; Yang, Dao-Ke; Liu, Zhang-Suo			Long noncoding RNA SMAD5-AS1 acts as a microRNA-106a-5p sponge to promote epithelial mesenchymal transition in nasopharyngeal carcinoma	FASEB JOURNAL			English	Article						ceRNA; SMAD5; proliferation; migration; invasion	POOR-PROGNOSIS; CELL-PROLIFERATION; CANCER-CELLS; N-CADHERIN; METASTASIS; EXPRESSION; MIGRATION; INVASION; LNCRNA; PROGRESSION	Nasopharyngeal carcinoma (NPC) is a malignant epithelial cancer of the head and neck with high prevalence in southern China, which is accompanied by notable invasiveness and metastasis. Long noncoding RNAs (lncRNAs) participate in the progression of various cancers including NPC. Microarray-based analysis identified highly expressed IncRNA mothers against decapentaplegic homolog 5 (SMAD5)-antisense RNA 1 (AS1) related to NPC. Interestingly, it is found that SMAD5-AS1 competitively bound to microRNA (miR)-106a-5p to regulate SMAD5. Herein, the study aimed to clarify the role of SMAD5-AS1/miR-106a-5p/SMAD5 axis in the process of epithelial mesenchymal transition (EMT) in NPC. SMAD5-AS1 was highly expressed and miR-106a-5p was poorly expressed in NPC tissues and cell lines. The NPC cells were treated with a series of small interfering RNAs, mimics, or inhibitors to explore the effects of SMAD5-AS1, SMAD5, and miR-106a-5p on EMT, cell proliferation, migration, and invasion in NPC. Of note, SMAD5-AS1 silencing or miR-106a-5p overexpression reduced expression of N-cadherin, matrix metallopeptidase 9, Snail, and Vimentin while elevating E-cadherin expression, thus inhibiting EMT, cell proliferation, migration, and invasion in NPC by down-regulation of SMAD5. Moreover, SMAD5 silencing could reduce the ability of EMT induced by SMAD5-AS1 up-regulation. SMAD5-AS1 silencing or miR-106a-5p elevation inhibited tumorigenesis in nude mice. Taken together, SMAD5-AS1 silencing suppressed EMT, cell proliferation, migration, and invasion in NPC by elevating miR-106a-5p to down-regulate SMAD5, which provided a novel therapeutic target for NPC treatment.	[Zheng, Ying-Juan; Zhao, Jing-Yi; Liang, Tian-Song; Wang, Ping; Wang, Juan; Yang, Dao-Ke; Liu, Zhang-Suo] Zhengzhou Univ, Affiliated Hosp 1, Dept Radiotherapy, Zhengzhou, Peoples R China	Zhengzhou University	Yang, DK; Liu, ZS (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Radiotherapy, Zhengdong Branch, Zhengzhou 475000, Henan, Peoples R China.	dryang_yangdaoke@yeah.net; zhangsuoliu_lzs@126.com						Bo H, 2015, ONCOTARGET, V6, P20404, DOI 10.18632/oncotarget.4057; Cheng N, 2017, ONCOTARGETS THER, V10, P5843, DOI 10.2147/OTT.S151800; Cho JH, 2014, PEDIATR CARDIOL, V35, P601, DOI 10.1007/s00246-013-0826-x; Clendenon SG, 2012, DEV DYNAM, V241, P442, DOI 10.1002/dvdy.23729; Du BW, 2016, MOLECULES, V21, DOI 10.3390/molecules21070965; Fang T, 2016, MOL MED REP, V14, P1269, DOI 10.3892/mmr.2016.5363; Feng SY, 2017, CELL CYCLE, V16, P869, DOI 10.1080/15384101.2017.1308617; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; He QY, 2016, DNA CELL BIOL, V35, P506, DOI 10.1089/dna.2015.3121; He RZ, 2017, ONCOTARGET, V8, P16075, DOI 10.18632/oncotarget.14211; Hu ZY, 2015, BBA-MOL BASIS DIS, V1852, P1876, DOI 10.1016/j.bbadis.2015.06.009; Huang HP, 2015, TUMOR BIOL, V36, P4123, DOI 10.1007/s13277-015-3046-6; Lai IL, 2017, ONCOTARGET, V8, P98148, DOI 10.18632/oncotarget.21465; Lan XT, 2019, J CELL MOL MED, V23, P2351, DOI 10.1111/jcmm.13497; Lee AWM, 2011, EUR J CANCER, V47, P656, DOI 10.1016/j.ejca.2010.10.026; Li L, 2016, CANCER SCI, V107, P1215, DOI 10.1111/cas.12989; Li T, 2011, ONCOL REP, V25, P1353, DOI 10.3892/or.2011.1204; Li XJ, 2012, CARCINOGENESIS, V33, P1302, DOI 10.1093/carcin/bgs181; Liang WC, 2015, ONCOTARGET, V6, P22513, DOI 10.18632/oncotarget.4154; Liu YJ, 2017, BIOCHEM BIOPH RES CO, V491, P374, DOI 10.1016/j.bbrc.2017.07.093; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Luo WR, 2012, HISTOPATHOLOGY, V61, P237, DOI 10.1111/j.1365-2559.2012.04212.x; Nie MY, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.130690; Pan YJ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.561; Qi GY, 2016, CELL PHYSIOL BIOCHEM, V40, P589, DOI 10.1159/000452572; Qi XM, 2014, FEBS LETT, V588, P3732, DOI 10.1016/j.febslet.2014.08.021; Qu CJ, 2012, CELL CYCLE, V11, P785, DOI 10.4161/cc.11.4.19228; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Song XD, 2014, J CELL MOL MED, V18, P991, DOI 10.1111/jcmm.12243; Su ZW, 2016, ONCOL REP, V36, P72, DOI 10.3892/or.2016.4768; Sun H, 2017, ONCOL LETT, V13, P1725, DOI 10.3892/ol.2017.5645; Sun XJ, 2014, ASIAN PAC J CANCER P, V15, P4019, DOI 10.7314/APJCP.2014.15.9.4019; Wang F, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0292-4; Wang H, 2017, PANCREATOLOGY, V17, P237, DOI 10.1016/j.pan.2017.01.010; Wang QR, 2014, INT J ONCOL, V44, P858, DOI 10.3892/ijo.2013.2237; Wang T, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-160; Wang ZL, 2015, INT J CLIN EXP MED, V8, P18765; Wei FL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16720-8; Wu JH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21708-z; Wu YD, 2010, CELL ADHES MIGR, V4, P199, DOI 10.4161/cam.4.2.10943; Xiao C, 2016, EUR REV MED PHARMACO, V20, P2819; Xu J, 2017, J ECON ENTOMOL, V110, P683, DOI 10.1093/jee/tow297; Yue B, 2015, CANCER SCI, V106, P1323, DOI 10.1111/cas.12759; Zheng J, 2016, NAT GENET, V48, P747, DOI 10.1038/ng.3568; Zhi H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054867; Zou ZW, 2016, ONCOTARGET, V7, P61741, DOI 10.18632/oncotarget.11437	46	31	32	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12915	12928		10.1096/fj.201900803R	http://dx.doi.org/10.1096/fj.201900803R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31557058	Green Published, Bronze			2022-12-26	WOS:000507461600101
J	Stapledon, CJM; Tsangari, H; Solomon, LB; Campbell, DG; Hurtado, P; Krishnan, R; Atkins, GJ				Stapledon, Catherine J. M.; Tsangari, Helen; Solomon, Lucian B.; Campbell, David G.; Hurtado, Plinio; Krishnan, Ravi; Atkins, Gerald J.			Human osteocyte expression of Nerve Growth Factor: The effect of Pentosan Polysulphate Sodium (PPS) and implications for pain associated with knee osteoarthritis	PLOS ONE			English	Article							TANEZUMAB; NGF; OSTEOBLASTS; PHENOTYPE; PROMOTES; EFFICACY; KINASE; SAFETY; CELLS; TRKA	Pentosan polysulphate sodium (PPS) is a promising therapeutic agent for blocking knee pain in individuals with knee osteoarthritis (KOA). The mode of action of PPS in this context is unknown. We hypothesised that the osteocyte, being the principal cell type in the subchondral bone, was capable of expressing the pain mediator Nerve Growth Factor (NGF), and that this may be altered in the presence of PPS. We tested the expression of NGF and the response to PPS in the presence or absence of the proinflammatory cytokine tumour necrosis factor-alpha (TNF alpha), in human osteocytes. For this we differentiated human primary osteoblasts grown from subchondral bone obtained at primary knee arthroplasty for KOA to an osteocyte-like stage over 28d. We also tested NGF expression in fresh osteocytes obtained by sequential digestion from KOA bone and by immunofluorescence in KOA bone sections. We demonstrate for the first time the production and secretion of NGF/proNGF by this cell type derived from patients with KOA, implicating osteocytes in the pain response in this pathological condition and possibly others. PPS inhibited TNF alpha-induced levels of proNGF secretion and TNF alpha induced NGF mRNA expression. Together, this provides evidence that PPS may act to suppress the release of NGF in the subchondral bone to ameliorate pain associated with knee osteoarthritis.	[Stapledon, Catherine J. M.; Tsangari, Helen; Solomon, Lucian B.; Campbell, David G.; Atkins, Gerald J.] Univ Adelaide, Ctr Orthopaed & Trauma Res, Adelaide, SA, Australia; [Solomon, Lucian B.] Royal Adelaide Hosp, Orthopaed & Trauma Serv, Adelaide, SA, Australia; [Campbell, David G.] Calvary Wakefield Hosp, Wakefield Orthopaed Clin, Adelaide, SA, Australia; [Hurtado, Plinio] Royal Adelaide Hosp, Renal Unit, Adelaide, SA, Australia; [Krishnan, Ravi] Paradigm Biopharmaceut Ltd, Melbourne, Vic, Australia	University of Adelaide; Royal Adelaide Hospital; Royal Adelaide Hospital	Atkins, GJ (corresponding author), Univ Adelaide, Ctr Orthopaed & Trauma Res, Adelaide, SA, Australia.; Krishnan, R (corresponding author), Paradigm Biopharmaceut Ltd, Melbourne, Vic, Australia.	rkrishnan@paradigmbiopharma.com; Gerald.atkins@adelaide.edu.au	Campbell, David/AAM-9263-2020	Campbell, David/0000-0002-1572-9529; Atkins, Gerald/0000-0002-3123-9861; Hurtado, Plinio Reinaldo/0000-0002-0913-7797; Solomon, Lucian/0000-0001-6254-2372; Stapledon, Catherine/0000-0002-2827-2396	Paradigm Biopharmaceuticals Ltd; National Health and Medical Research Council of Australia (NHMRC) [1106029]; Australian Postgraduate Award scholarship	Paradigm Biopharmaceuticals Ltd; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award scholarship	This study was funded by a research grant from Paradigm Biopharmaceuticals Ltd (https://paradigmbiopharma.com/) and from a Project Grant awarded to GJA from the National Health and Medical Research Council of Australia (NHMRC) (Project ID1106029). CJMS was supported by an Australian Postgraduate Award scholarship. GJA is an NHMRC Senior Research Fellow. Paradigm Biopharmaceuticals Ltd provided additional funding in the form of salary to RK. The specific roles of these authors are articulated in the `author contributions' section. The funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript beyond those specifieThe authors thank the nursing and surgical staff of the Orthopaedic and Trauma Services of the Royal Adelaide Hospital and the Calvary Wakefield Hospital for the provision of patient samples.; The authors also thank Dr. Sonja Klebe (Flinders University) for the kind provision of NCI-H266 cells. This study was funded by a research grant from Paradigm Biopharmaceuticals Ltd (https://paradigmbiopharma.com/) and from a Project Grant awarded to GJA from the National Health and Medical Research Council of Australia (NHMRC) (Project ID1106029). CJMS was supported by an Australian Postgraduate Award scholarship. GJA is an NHMRC Senior Research Fellow. Paradigm Biopharmaceuticals Ltd provided additional funding in the form of salary to RK. The specific roles of these authors are articulated in the `author contributions' section. The funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript beyond those specified.	Atkins GJ, 2012, OSTEOPOROSIS INT, V23, P2067, DOI 10.1007/s00198-012-1915-z; Atkins GJ, 2009, OSTEOPOROSIS INT, V20, P653, DOI 10.1007/s00198-008-0728-6; Atkins GJ, 2011, J BONE MINER RES, V26, P1425, DOI 10.1002/jbmr.345; Atkins GJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1358, DOI 10.1152/ajpcell.00216.2009; Ayers DC, 2015, CLIN ORTHOP RELAT R, V473, P76, DOI 10.1007/s11999-014-3716-5; Bonewald LF, 2011, J BONE MINER RES, V26, P229, DOI 10.1002/jbmr.320; Bradshaw Ralph A., 2015, Advances in Biological Regulation, V58, P16, DOI 10.1016/j.jbior.2014.11.003; Bwalya EC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177144; Castaneda-Corral G, 2011, NEUROSCIENCE, V178, P196, DOI 10.1016/j.neuroscience.2011.01.039; Chevalier X, 2013, NAT REV RHEUMATOL, V9, P400, DOI 10.1038/nrrheum.2013.44; DAWES J, 1986, THROMB RES, V44, P683, DOI 10.1016/0049-3848(86)90169-6; Ekman EF, 2014, J RHEUMATOL, V41, P2249, DOI 10.3899/jrheum.131294; Ghosh P, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2935; Giusto LL, 2018, EXPERT OPIN PHARMACO, V19, P1097, DOI 10.1080/14656566.2018.1491968; Iannone F, 2002, RHEUMATOLOGY, V41, P1413, DOI 10.1093/rheumatology/41.12.1413; Kogawa M, 2013, J BONE MINER RES, V28, P2436, DOI 10.1002/jbmr.2003; Kumagai K, SODIUM PENTOSAN POLY; Kumarasinghe DD, 2012, OSTEOARTHR CARTILAGE, V20, P1357, DOI 10.1016/j.joca.2012.07.005; Lane NE, 2010, NEW ENGL J MED, V363, P1521, DOI 10.1056/NEJMoa0901510; Malerba F, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00063; Manni L, 1998, RHEUMATOL INT, V18, P97, DOI 10.1007/s002960050065; Ormsby RT, 2016, ACTA BIOMATER, V33, P242, DOI 10.1016/j.actbio.2016.01.016; Prideaux M, 2016, BONE, V88, P64, DOI 10.1016/j.bone.2016.04.017; Prideaux M, 2016, CURR OPIN PHARMACOL, V28, P24, DOI 10.1016/j.coph.2016.02.003; Rouillard AD, HARMONIZOME COLLECTI, DOI [10.1093/database/baw100, DOI 10.1093/DATABASE/BAW100]; Sampson MJ, 2017, BMC MUSCULOSKEL DIS, V18, DOI 10.1186/s12891-017-1754-3; Schnitzer TJ, 2015, ANN RHEUM DIS, V74, P1202, DOI 10.1136/annrheumdis-2013-204905; Sunaga T, 2012, J VET MED SCI, V74, P707, DOI 10.1292/jvms.11-0511; Takano S, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/5706359; Tomlinson RE, 2017, P NATL ACAD SCI USA, V114, pE3632, DOI 10.1073/pnas.1701054114; Wijenayaka AR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025900; Yang DQ, 2018, MBIO, V9, DOI 10.1128/mBio.00415-18; Zhang J, 2015, INT J CLIN EXP MED, V8, P634	33	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222602	10.1371/journal.pone.0222602	http://dx.doi.org/10.1371/journal.pone.0222602			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557169	gold, Green Published			2022-12-26	WOS:000532345500024
J	Akhloufi, H; Verhaegh, SJC; Jaspers, MWM; Melles, DC; van Der Sijs, H; Verbon, A				Akhloufi, H.; Verhaegh, S. J. C.; Jaspers, M. W. M.; Melles, D. C.; van Der Sijs, H.; Verbon, A.			A usability study to improve a clinical decision support system for the prescription of antibiotic drugs	PLOS ONE			English	Article							ANTIMICROBIAL THERAPY; POINT-PREVALENCE; ADOPTION	Objective A clinical decision support system (CDSS) for empirical antibiotic treatment has the potential to increase appropriate antibiotic use. Before using such a system on a broad scale, it needs to be tailored to the users preferred way of working. We have developed a CDSS for empirical antibiotic treatment in hospitalized adult patients. Here we determined in a usability study if the developed CDSS needed changes. Methods Four prespecified patient cases, based on real life clinical scenarios, were evaluated by 8 medical residents in the study. The "think-aloud" method was used, and sessions were recorded and analyzed afterwards. Usability was assessed by 3 evaluators using an augmented classification scheme, which combines the User Action Framework with severity rating of the usability problems and the assessment of the potential impact of these problems on the final task outcomes. Results In total 51 usability problems were identified, which could be grouped into 29 different categories. Most (n = 17/29) of the usability problems were cosmetic problems or minor problems. Eighteen (out of 29) of the usability categories could have an ordering error as a result. Classification of the problems showed that some of the problems would get a low priority based on their severity rating, but got a high priority for their impact on the task outcome. This effectively provided information to prioritize system redesign efforts. Conclusion Usability studies improve lay-out and functionality of a CDSS for empirical antibiotic treatment, even after development by a multidisciplinary system.	[Akhloufi, H.; Verhaegh, S. J. C.; Melles, D. C.; Verbon, A.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Akhloufi, H.; Verbon, A.] Erasmus MC, Dept Internal Med, Div Infect Dis, Rotterdam, Netherlands; [Jaspers, M. W. M.] Acad Med Ctr, Ctr Human Factors Engn Hlth Informat Technol HIT, Dept Med Informat, Amsterdam, Netherlands; [van Der Sijs, H.] Erasmus MC, Dept Hosp Pharm, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC	Verbon, A (corresponding author), Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.; Verbon, A (corresponding author), Erasmus MC, Dept Internal Med, Div Infect Dis, Rotterdam, Netherlands.	a.verbon@erasmusmc.nl			Netherlands Organization for Health Research and Development (ZonMW) [836021021]	Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	This work was supported by the Netherlands Organization for Health Research and Development (ZonMW) [grant number 836021021] to AV. The funding source had no involvement in study design, in the collection, analysis and interpretation of the data or in writing this report. Also there was no involvement in the decision to submit the article for publication.	Akhloufi H, 2015, EUR J CLIN MICROBIOL, V34, P1631, DOI 10.1007/s10096-015-2398-6; [Anonymous], 1994, HDB USABILITY TESTIN; Bangor A, 2008, INT J HUM-COMPUT INT, V24, P574, DOI 10.1080/10447310802205776; Beaulieu J, 2013, AM J HEALTH-SYST PH, V70, P1103, DOI 10.2146/ajhp120589; Camins BC, 2009, INFECT CONT HOSP EP, V30, P931, DOI 10.1086/605924; Diasinos N, 2015, INTERN MED J, V45, P55, DOI 10.1111/imj.12627; EVANS RS, 1994, ARCH INTERN MED, V154, P878, DOI 10.1001/archinte.154.8.878; Filice GA, 2013, INFECT CONT HOSP EP, V34, P558, DOI 10.1086/670627; Ingram PR, 2012, INTERN MED J, V42, P719, DOI 10.1111/j.1445-5994.2012.02809.x; James BC, 2001, NEW ENGL J MED, V345, P991, DOI 10.1056/NEJM200109273451311; Jaspers MWM, 2009, INT J MED INFORM, V78, P340, DOI 10.1016/j.ijmedinf.2008.10.002; Jordan P. W., 1996, USABILITY EVALUATION; Kallen MC, 2017, INFECT DIS REP, V9, P13, DOI 10.4081/idr.2017.6821; Kerremans JJ, 2008, J ANTIMICROB CHEMOTH, V61, P428, DOI 10.1093/jac/dkm497; Kerremans JJ, 2012, J CLIN MICROBIOL, V50, P2066, DOI 10.1128/JCM.06051-11; Khairat S, 2018, JMIR RES PROTOC, V7, P87, DOI 10.2196/11239; Khajouei R, 2011, J BIOMED INFORM, V44, P948, DOI 10.1016/j.jbi.2011.07.002; Leibovici L, 1997, J INTERN MED, V242, P395, DOI 10.1046/j.1365-2796.1997.00232.x; Litvin CB, 2012, INT J MED INFORM, V81, P521, DOI 10.1016/j.ijmedinf.2012.03.002; Macefield R., 2009, J USABILITY STUD, P5, DOI [10.1016/j.jclinepi.2013.08.015, DOI 10.1016/J.JCLINEPI.2013.08.015]; McCambridge J, 2014, J CLIN EPIDEMIOL, V67, P267, DOI 10.1016/j.jclinepi.2013.08.015; Mullett Charles J, 2003, AMIA Annu Symp Proc, P480; Mullett CJ, 2004, INT J MED INFORM, V73, P455, DOI 10.1016/j.ijmedinf.2004.04.002; Nielsen J., 1993, USABILITY ENG; Nielsen J., 2012, MANY TEST USERS USAB; Nielsen Jakob, 1994, HEURISTIC EVALUATION; O'Neill J, 2014, ANTIMICROBIAL RESIST; Paul M, 2006, J ANTIMICROB CHEMOTH, V58, P1238, DOI 10.1093/jac/dkl372; Phillips Ira E, 2008, AMIA Annu Symp Proc, P1093; Rawson TM, 2017, CLIN MICROBIOL INFEC, V23, P524, DOI 10.1016/j.cmi.2017.02.028; Rodrigues JF, 2012, INFECT CONT HOSP EP, V33, P435, DOI 10.1086/664923; Sauro J, 2012, QUANTIFYING THE USER EXPERIENCE: PRACTICAL STATISTICS FOR USER RESEARCH, P1; Schulz L, 2013, INFECT CONT HOSP EP, V34, P1259, DOI 10.1086/673977; Schuts EC, 2016, LANCET INFECT DIS, V16, P847, DOI 10.1016/S1473-3099(16)00065-7; Tsopra R, 2019, J AM MED INFORM ASSN, V26, P1010, DOI 10.1093/jamia/ocz057; Tsopra R, 2014, J AM MED INFORM ASSN, V21, pE107, DOI 10.1136/amiajnl-2013-002042; Vincent WR, 2009, J AM MED INFORM ASSN, V16, P47, DOI 10.1197/jamia.M2559; VIRZI RA, 1992, HUM FACTORS, V34, P457, DOI 10.1177/001872089203400407; Warner H, 1999, J AM MED INFORM ASSN, P440; Willemsen I, 2007, ANTIMICROB AGENTS CH, V51, P864, DOI 10.1128/AAC.00994-06; Yen PY, 2012, J AM MED INFORM ASSN, V19, P413, DOI 10.1136/amiajnl-2010-000020	41	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0223073	10.1371/journal.pone.0223073	http://dx.doi.org/10.1371/journal.pone.0223073			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5WE	31553785	Green Published, gold			2022-12-26	WOS:000532319200054
J	Martin-Sosa, E; Martinez-Reina, J; Mayo, J; Ojeda, J				Martin-Sosa, E.; Martinez-Reina, J.; Mayo, J.; Ojeda, J.			Influence of musculotendon geometry variability in muscle forces and hip bone-on-bone forces during walking	PLOS ONE			English	Article							JOINT; SENSITIVITY; GAIT; PREDICTIONS; LOADS	Inverse dynamics problems are usually solved in the analysis of human gait to obtain reaction forces and moments at the joints. However, these actions are not the actual forces and moments supported by the joint structure, because they do not consider the forces of the muscles acting across the joint. Therefore, to analyse bone-on bone forces it is necessary to estimate those muscle forces. Usually, this problem is addressed by means of optimization algorithms. One of the parameters required to solve this problem is the musculotendon geometry. These data are usually taken from cadavers or MRI data from several subjects, different from the analysed subject. Then, the model is scaled to the subject morphology. This procedure constitutes a source of error. The goals of this work were two. First, to perform a sensitivity analysis of the influence of muscle insertion locations on the muscle forces acting on the hip joint and on the hip joint bone-on-bone forces. Second, to compare the hip joint bone-on-bone forces during gait cycle obtained through muscle insertion locations taken from a musculoskeletal model template and a scaling procedure to those obtained from a subject-specific model using an MRI of the subject. The problem was solved using OpenSim. Results showed that anatomical variability should be analysed from two perspectives. One the one hand, throughout the gait cycle, in a global way. On the other hand, at a characteristic instant of the gait cycle. Variations of +/- 1 cm in the position of the attachment points of certain muscles caused variations of up to 14.21% in averaged deviation of the muscle forces and 58.96% in the peak force in the modified muscle and variations up to 57.23% in the averaged deviation of the muscle force and up to 117.23% in the peak force in the rest of muscles. Then, the influence of that variability on muscle activity patterns and hip bone-on-bone forces could be described more precisely. A biomechanical analysis of a subject-specific musculoskeletal model was carried out. Using MRI data, variations up to 5 cm in the location of the insertion points were introduced. These modifications showed significant differences between the baseline model and the customized model: within the range [-12%, 10%] for muscle forces and around 35% of body weight for hip bone-on-bone forces.	[Martin-Sosa, E.; Martinez-Reina, J.; Mayo, J.; Ojeda, J.] Univ Seville, Dept Ingn Mecan & Fabricac, Seville, Spain	University of Sevilla	Ojeda, J (corresponding author), Univ Seville, Dept Ingn Mecan & Fabricac, Seville, Spain.	joaquinojeda@us.es	Ojeda, Joaquín/AAA-3222-2021; Ojeda, Joaquín/I-2380-2014; Sosa, Ezequiel Martín/AAA-3224-2021	Ojeda, Joaquín/0000-0002-6894-197X; Ojeda, Joaquín/0000-0002-6894-197X; Sosa, Ezequiel Martín/0000-0002-7484-3364	Ministry of Economy, Industry and Competitiveness [DPI2016-80796-P]	Ministry of Economy, Industry and Competitiveness	The authors thank the Ministry of Economy, Industry and Competitiveness for funding the project DPI2016-80796-P.	Anderson FC, 2001, J BIOMECH, V34, P153, DOI 10.1016/S0021-9290(00)00155-X; Ardestani MM, 2016, J BIOMECH, V49, P1620, DOI 10.1016/j.jbiomech.2016.03.047; Bergmann G, 2008, CHARITE UNIVERSITAET; Bosmans L, 2015, J BIOMECH, V48, P2116, DOI 10.1016/j.jbiomech.2015.02.052; Brand R A, 1994, J Arthroplasty, V9, P45, DOI 10.1016/0883-5403(94)90136-8; BRAND RA, 1986, J BIOMECH, V19, P589, DOI 10.1016/0021-9290(86)90164-8; Carbone V, 2012, J BIOMECH, V45, P2476, DOI 10.1016/j.jbiomech.2012.06.026; Damm P, 2017, J BIOMECH, V60, P197, DOI 10.1016/j.jbiomech.2017.06.047; Daysal GA, 2007, OSTEOARTHR CARTILAGE, V15, P1446, DOI 10.1016/j.joca.2007.05.016; Delp SL, 2007, IEEE T BIO-MED ENG, V54, P1940, DOI 10.1109/TBME.2007.901024; Graham DF, 2016, J BIOMECH, V49, P2619, DOI 10.1016/j.jbiomech.2016.05.033; HINRICHSEN GJ, 1968, ANGLE ORTHOD, V38, P155; Lu T. W., 1999, GAIT POSTURE, V30, P296; Michnik R., 2012, 3 INT C INF TECHN BI, P464; Ojeda J, 2016, MULTIBODY SYST DYN, V37, P291, DOI 10.1007/s11044-016-9508-9; Ojeda J., THESIS; Quental C, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025325; Roemer K, 2010, MATH COMP MODEL DYN, V16, P391, DOI 10.1080/13873954.2010.507090; Saliba CM, 2017, J BIOMECH, V57, P125, DOI 10.1016/j.jbiomech.2017.03.005; Slater AA, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2329-7; Steele KM, 2012, GAIT POSTURE, V35, P556, DOI 10.1016/j.gaitpost.2011.11.023; Sutherland DH, 2002, GAIT POSTURE, V16, P159, DOI 10.1016/S0966-6362(02)00004-8; Thambyah A, 2005, KNEE, V12, P383, DOI 10.1016/j.knee.2004.12.005; Valente G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112625; VANDERHELM FCT, 1991, J BIOMECH, V24, P1151, DOI 10.1016/0021-9290(91)90007-A; Vaughan C., 1999, DYNAMICS HUMAN GAIT; Wang X., 2017, J HEALTHC ENG, V2017, DOI DOI 10.1155/2017/6375976; Wesseling M, 2016, COMPUT METHOD BIOMEC, V19, P1475, DOI 10.1080/10255842.2016.1154547; Winter DA., 1987, BIOMECHANICS MOTOR C	29	2	2	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222491	10.1371/journal.pone.0222491	http://dx.doi.org/10.1371/journal.pone.0222491			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553756	Green Published, gold			2022-12-26	WOS:000532319200028
J	Westbury, MV; Petersen, B; Lorenzen, ED				Westbury, Michael, V; Petersen, Bent; Lorenzen, Eline D.			Genomic analyses reveal an absence of contemporary introgressive admixture between fin whales and blue whales, despite known hybrids	PLOS ONE			English	Article							BALAENOPTERA-MUSCULUS; GENE PREDICTION; B-PHYSALUS; MODEL	Fin whales (Balaenoptera physalus) and blue whales (B. musculus) are the two largest species on Earth and are widely distributed across the world's oceans. Hybrids between these species appear to be relatively widespread and have been reported in both the North Atlantic and North Pacific; they are also relatively common, and have been proposed to occur once in every thousand fin whales. However, despite known hybridization, fin and blue whales are not sibling species. Rather, the closest living relative of fin whales are humpback whales (Megaptera novaeangliae). To improve the quality of fin whale data available for analysis, we assembled and annotated a fin whale nuclear genome using in-silico mate pair libraries and previously published short-read data. Using this assembly and genomic data from a humpback, blue, and bowhead whale, we investigated whether signatures of introgression between the fin and blue whale could be found. We find no signatures of contemporary admixture in the fin and blue whale genomes, although our analyses support ancestral gene flow between the species until 2.4-1.3 Ma. We propose the following explanations for our findings; i) fin/blue whale hybridization does not occur in the populations our samples originate from, ii) contemporary hybrids are a recent phenomenon and the genetic consequences have yet to become widespread across populations, or iii) fin/blue whale hybrids are under large negative selection, preventing them from backcrossing and contributing to the parental gene pools.	[Westbury, Michael, V; Petersen, Bent; Lorenzen, Eline D.] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen K, Denmark; [Petersen, Bent] AIMST Univ, Fac Appl Sci, Ctr Excellence Omics Driven Computat Biodiscovery, Bedong, Kedah, Malaysia	University of Copenhagen; AIMST University	Westbury, MV; Lorenzen, ED (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen K, Denmark.	m.westbury@snm.ku.dk; elinelorenzen@snm.ku.dk	Lorenzen, Eline/GRF-1592-2022	Petersen, Bent/0000-0002-2472-8317; Westbury, Michael/0000-0003-0478-3930	Villum Fonden [13151]; Independent Research Fund Denmark [8021-00218B]; Villum Fonden Young Investigator Programme [13151]	Villum Fonden(Villum Fonden); Independent Research Fund Denmark; Villum Fonden Young Investigator Programme(Villum Fonden)	This work was supported by Villum Fonden (https://veluxfoundations.dk) Young Investigator Programme, grant no 13151 and the Independent Research Fund Denmark (https://dff.dk), grant no 8021-00218B. Both awarded to EDL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Villum Fonden Young Investigator Programme, grant no 13151 and the Independent Research Fund Denmark, grant no 8021-00218B. We would like to thank Binia De Cahsan for providing the whale illustrations in Fig 1.	Aguilar A, 2018, ENCYCLOPEDIA OF MARINE MAMMALS, 3RD EDITION, P368; ARNASON U, 1991, HEREDITAS, V115, P183, DOI 10.1111/j.1601-5223.1991.tb03554.x; Arnason U, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aap9873; Berube M, 1998, MAR MAMMAL SCI, V14, P82, DOI 10.1111/j.1748-7692.1998.tb00692.x; Bushnell B., 2014, BBTOOLS SOFTWARE PAC; Cahill JA, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0138; Cipriano F, 1999, NATURE, V397, P307, DOI 10.1038/16823; Cocks AH., 1887, ZOOLOGIST, V11, P207; Grau JH, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy029; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hatch LT, 2006, MOL PHYLOGENET EVOL, V41, P12, DOI 10.1016/j.ympev.2006.05.023; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Hubley R., 2013, REPEATMASKER OPEN 40; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Keane M, 2015, CELL REP, V10, P112, DOI 10.1016/j.celrep.2014.12.008; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Nowak R.M., 1999, WALKERS MAMMALS WORL, V1; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Parra G, 2009, NUCLEIC ACIDS RES, V37, P289, DOI 10.1093/nar/gkn916; Paulino D, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0663-4; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Roman J, 2003, SCIENCE, V301, P508, DOI 10.1126/science.1084524; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Sears R, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P120; Smit A.F., 2008, REPEATMODELER OPEN 1; SPILLIAERT R, 1991, J HERED, V82, P269, DOI 10.1093/oxfordjournals.jhered.a111085; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Steeman ME, 2009, SYST BIOL, V58, P573, DOI 10.1093/sysbio/syp060; Waterhouse RM, 2018, MOL BIOL EVOL, V35, P543, DOI 10.1093/molbev/msx319; Yim HS, 2014, NAT GENET, V46, P88, DOI 10.1038/ng.2835	36	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222004	10.1371/journal.pone.0222004	http://dx.doi.org/10.1371/journal.pone.0222004			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553763	Green Published, gold			2022-12-26	WOS:000532319200009
J	Sivey, P; McAllister, R; Vally, H; Burgess, A; Kelly, AM				Sivey, Peter; McAllister, Richard; Vally, Hassan; Burgess, Anna; Kelly, Anne-Maree			Anatomy of a demand shock: Quantitative analysis of crowding in hospital emergency departments in Victoria, Australia during the 2009 influenza pandemic	PLOS ONE			English	Article							A(H1N1) INFECTION; H1N1 INFLUENZA; ACCESS BLOCK; SURVEILLANCE; IMPACT; CARE	Objective An infectious disease outbreak such as the 2009 influenza pandemic is an unexpected demand shock to hospital emergency departments (EDs). We analysed changes in key performance metrics in (EDs) in Victoria during this pandemic to assess the impact of this demand shock. Design and setting Descriptive time-series analysis and longitudinal regression analysis of data from the Victorian Emergency Minimum Dataset (VEMD) using data from the 38 EDs that submit data to the state's Department of Health and Human Services. Main outcome measures Daily number of presentations, influenza-like-illness (ILI) presentations, daily mean waiting time (time to first being seen by a doctor), daily number of patients who did-not-wait and daily number of access-blocked patients (admitted patients with length of stay > 8 hours) at a system and hospital-level. Results During the influenza pandemic, mean waiting time increased by up to 25%, access block increased by 32% and did not wait presentations increased by 69% above pre-pandemic levels. The peaks of all three crowding variables corresponded approximately to the peak in admitted ILI presentations. Longitudinal fixed-effects regression analysis estimated positive and statistically significant associations between mean waiting times, did not wait presentations and access block and ILI presentations. Conclusions This pandemic event caused excess demand leading to increased waiting times, did-not-wait patients and access block. Increases in admitted patients were more strongly associated with crowding than non-admitted patients during the pandemic period, so policies to divert or mitigate low-complexity non-admitted patients are unlikely to be effective in reducing ED crowding.	[Sivey, Peter] RMIT Univ, Sch Econ Finance & Mkt, Melbourne, Vic, Australia; [McAllister, Richard] Australian Govt, Dept Educ & Training, Canberra, ACT, Australia; [Vally, Hassan] La Trobe Univ, Dept Publ Hlth, Melbourne, Vic, Australia; [Burgess, Anna] Dept Hlth & Human Serv Victoria, Melbourne, Vic, Australia; [Kelly, Anne-Maree] Univ Melbourne, Joseph Epstein Ctr Emergency Med Res Western Hlth, Parkville, Vic, Australia; [Kelly, Anne-Maree] Univ Melbourne, Sch Med, Western Clin Sch, Parkville, Vic, Australia	Royal Melbourne Institute of Technology (RMIT); La Trobe University; University of Melbourne; University of Melbourne	Sivey, P (corresponding author), RMIT Univ, Sch Econ Finance & Mkt, Melbourne, Vic, Australia.	peter.sivey@rmit.edu.au	Vally, Hassan/AAG-1307-2022; Vally, Hassan/AFK-2936-2022	Vally, Hassan/0000-0001-5281-7459; Vally, Hassan/0000-0001-5281-7459; Sivey, Peter/0000-0002-3703-615X	La Trobe University	La Trobe University	PM and RM would also like to acknowledge funding from the La Trobe University "Building Healthy Communities" Research Focus Area. The funders played no role in the research; https://www.latrobe.edu.au/research/research-focus-areas/building-healthy-communities.	Andrew E, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5636; Baker AW, 2012, AM J INFECT CONTROL, V40, P606, DOI 10.1016/j.ajic.2011.12.009; Costello BE, 2010, ANN EMERG MED, V56, P643, DOI 10.1016/j.annemergmed.2010.03.001; Fatovich DM, 2005, EMERG MED J, V22, P351, DOI 10.1136/emj.2004.018002; Gaudette E., 2014, 2014005 CES U SO CAL; Goodacre S, 2005, EMERG MED J, V22, P93, DOI 10.1136/emj.2003.007690; Gunasekara FI, 2014, INT J EPIDEMIOL, V43, P264, DOI 10.1093/ije/dyt221; Guttmann A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2983; Harris A, 2010, EMERG MED J, V27, P508, DOI 10.1136/emj.2009.072546; Hoot NR, 2008, ANN EMERG MED, V52, P126, DOI 10.1016/j.annemergmed.2008.03.014; Jeng K, 2012, J CLIN VIROL, V54, P332, DOI 10.1016/j.jcv.2012.05.002; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Lambe S, 2003, ANN EMERG MED, V41, P35, DOI 10.1067/mem.2003.2; Lau K, 2019, HEALTH ECON, V28, P175, DOI 10.1002/hec.3834; Lindstrom SJ, 2013, INTERN MED J, V43, P1246, DOI 10.1111/imj.12275; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Lum ME, 2009, MED J AUSTRALIA, V191, P502, DOI 10.5694/j.1326-5377.2009.tb02914.x; Martin S, 2007, J HEALTH ECON, V26, P263, DOI 10.1016/j.jhealeco.2006.08.006; Moore K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-338; Nichol KL, 2006, VACCINE, V24, P6726, DOI 10.1016/j.vaccine.2006.05.064; Richardson DB, 2009, MED J AUSTRALIA, V190, P369, DOI 10.5694/j.1326-5377.2009.tb02451.x; Schull MJ, 2007, ANN EMERG MED, V49, P257, DOI 10.1016/j.annemergmed.2006.06.027; Schull MJ, 2004, ANN EMERG MED, V44, P61, DOI 10.1016/j.annemergmed.2003.12.008; Sivey P, 2018, HEALTH ECON, V27, pE30, DOI 10.1002/hec.3610; Stang AS, 2015, ACAD EMERG MED, V22, P643, DOI 10.1111/acem.12682; StataCorp, 2017, STATA STAT SOFTWARE; Sugerman D, 2011, CLIN INFECT DIS, V52, pS177, DOI 10.1093/cid/ciq035; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481	28	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222851	10.1371/journal.pone.0222851	http://dx.doi.org/10.1371/journal.pone.0222851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550288	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000532307700027
J	Zhang, HW; Lin, CW; Kok, VC; Tseng, CH; Lin, YP; Li, TC; Sung, FC; Wen, CP; Hsiung, CA; Hsu, CY				Zhang, Han-Wei; Lin, Chao-Wen; Kok, Victor C.; Tseng, Chun-Hung; Lin, Yuan-Pei; Li, Tsai-Chung; Sung, Fung-Chang; Wen, Chi Pang; Hsiung, Chao A.; Hsu, Chung Y.			Incidence of retinal vein occlusion with longterm exposure to ambient air pollution	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; NONMETHANE HYDROCARBONS; PARTICULATE MATTER; UNITED-STATES; POPULATION; DISEASE; MORTALITY	This study aimed to investigate whether long-term exposure to airborne hydrocarbons, including volatile organic compounds, increases the risk of developing retinal vein occlusion (RVO) among the population of Taiwan. A retrospective cohort study involving 855,297 people was conducted. Cox proportional hazards regression analysis fitted the multiple pollutant models for two targeted pollutants, including total hydrocarbons (THC), nonmethane hydrocarbons (NMHC) were used, and the risk of RVO was estimated. The chi-squared test and one-way analysis of variance were used to test differences in demographics and comorbidity distribution among tertiles of the targeted pollutants. Before controlling for multiple pollutants, hazard ratios for the overall population were 19.88 (95% CI: 17.56-22.50) at 0.51-ppm increases in THC and 4.33 (95% CI: 3.97-4.73) at 0.27-ppm increases in NMHC. The highest adjusted hazard ratios for different multiple pollutant models of each targeted pollutant were statistically significant (all p values were.0.05) for all patients at 29.67 (95% CI: 25.57-34.42) for THC and 16.24 (95% CI: 14.14-18.65) for NMHC. Our findings suggest that long-term exposure to THC and NMHC contribute to RVO development.	[Zhang, Han-Wei] China Med Univ, PhD Program Aging, Taichung, Taiwan; [Zhang, Han-Wei; Lin, Yuan-Pei] Natl Chiao Tung Univ, Inst Elect Control Engn, Dept Elect & Comp Engn, Hsinchu, Taiwan; [Zhang, Han-Wei; Wen, Chi Pang; Hsiung, Chao A.] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan; [Lin, Chao-Wen] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan; [Kok, Victor C.] Asia Univ Taiwan, Dis Informat Res Grp, Taichung, Taiwan; [Kok, Victor C.] Kuang Tien Gen Hosp, Dept Internal Med, Taichung, Taiwan; [Tseng, Chun-Hung] China Med Univ, China Med Univ Hosp, Dept Neurol, Taichung, Taiwan; [Tseng, Chun-Hung] China Med Univ, Sch Med, Taichung, Taiwan; [Li, Tsai-Chung] China Med Univ, Grad Inst Biostat, Coll Publ Hlth, Taichung, Taiwan; [Li, Tsai-Chung] Asia Univ, Dept Healthcare Adm, Coll Hlth Sci, Taichung, Taiwan; [Sung, Fung-Chang] China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan; [Sung, Fung-Chang] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Hsu, Chung Y.] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan	China Medical University Taiwan; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; National Taiwan University; National Taiwan University Hospital; Asia University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan	Zhang, HW (corresponding author), China Med Univ, PhD Program Aging, Taichung, Taiwan.; Zhang, HW (corresponding author), Natl Chiao Tung Univ, Inst Elect Control Engn, Dept Elect & Comp Engn, Hsinchu, Taiwan.; Zhang, HW (corresponding author), Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Taiwan.	omnizhang@nhri.org.tw	Kok, Victor C/C-1437-2013	Kok, Victor C/0000-0003-3440-8154				Adar SD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000372; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Chen RJ, 2013, NEUROLOGY, V81, P1064, DOI 10.1212/WNL.0b013e3182a4a43c; Chen YY, 2018, J OPHTHALMOL, V2018, DOI 10.1155/2018/8629429; Cheung N, 2007, J AM COLL CARDIOL, V50, P48, DOI 10.1016/j.jacc.2007.03.029; Cugati S, 2006, ARCH OPHTHALMOL-CHIC, V124, P726, DOI 10.1001/archopht.124.5.726; Deobhakta A, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/438412; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Guo SJ, 2012, ENVIRON ENG SCI, V29, P262, DOI 10.1089/ees.2010.0421; Hayreh SS, 2001, AM J OPHTHALMOL, V131, P61, DOI 10.1016/S0002-9394(00)00709-1; Ho JD, 2009, AM J OPHTHALMOL, V147, P283, DOI 10.1016/j.ajo.2008.08.006; Hwang SH, 2016, JAMA OPHTHALMOL, V134, P503, DOI 10.1001/jamaophthalmol.2016.0139; Jung CR, 2015, J ALZHEIMERS DIS, V44, P573, DOI 10.3233/JAD-140855; Knudtson MD, 2005, ARCH OPHTHALMOL-CHIC, V123, P807, DOI 10.1001/archopht.123.6.807; Laouri M, 2011, EYE, V25, P981, DOI 10.1038/eye.2011.92; Lelieveld J, 2015, NATURE, V525, P367, DOI 10.1038/nature15371; Lin YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082678; Louwies T, 2013, ENVIRON HEALTH PERSP, V121, P1011, DOI 10.1289/ehp.1205721; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Mo ZW, 2017, SCI TOTAL ENVIRON, V593, P641, DOI 10.1016/j.scitotenv.2017.03.123; Moghadamnia MT, 2017, PEERJ, V5, DOI 10.7717/peerj.3574; National Health Insurance Research Database, INTR NAT HLTH INS RE; O'Mahoney PRA, 2008, ARCH OPHTHALMOL-CHIC, V126, P692, DOI 10.1001/archopht.126.5.692; Peters A, 2009, CIRCULATION, V120, P924, DOI 10.1161/CIRCULATIONAHA.109.895524; Rogers S, 2010, OPHTHALMOLOGY, V117, P313, DOI [10.1016/j.ophtha.2009.07.017, 10.1016/j.ophtha.2010.01.060]; Sherman RE, 2016, NEW ENGL J MED, V375, P2293, DOI 10.1056/NEJMsb1609216; Song PG, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.010427; Tomasini Dawn N, 2007, Optometry, V78, P402, DOI 10.1016/j.optm.2006.12.017; Villeneuve PJ, 2002, ANN EPIDEMIOL, V12, P568, DOI 10.1016/S1047-2797(01)00292-7; Wang M, 2015, ATMOS CHEM PHYS, V15, P1489, DOI 10.5194/acp-15-1489-2015; Wong TY, 2006, INVEST OPHTH VIS SCI, V47, P2341, DOI 10.1167/iovs.05-1539; Wong TY, 2005, OPHTHALMOLOGY, V112, P540, DOI 10.1016/j.ophtha.2004.10.039; Yen YC, 2013, BRIT J OPHTHALMOL, V97, P1192, DOI 10.1136/bjophthalmol-2013-303265; Zhang RH, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00827; Zhang X, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0157-5	35	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222895	10.1371/journal.pone.0222895	http://dx.doi.org/10.1371/journal.pone.0222895			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550294	gold, Green Published, Green Submitted			2022-12-26	WOS:000532307700031
J	John, M; Duguid, S; Tomasello, M; Melis, AP				John, Maria; Duguid, Shona; Tomasello, Michael; Melis, Alicia P.			How chimpanzees (Pan troglodytes) share the spoils with collaborators and bystanders	PLOS ONE			English	Article							FOOD; HARASSMENT; BEHAVIOR	Chimpanzees hunt cooperatively in the wild, but the factors influencing food sharing after the hunt are not well understood. In an experimental study, groups of three captive chimpanzees obtained a monopolizable food resource, either via two individuals cooperating (with the third as bystander) or via one individual acting alone alongside two bystanders. The individual that obtained the resource first retained most of the food but the other two individuals attempted to obtain food from the "captor" by begging. We found the main predictor of the overall amount of food obtained by bystanders was proximity to the food at the moment it was obtained by the captor. Whether or not an individual had cooperated to obtain the food had no effect. Interestingly, however, cooperators begged more from captors than did bystanders, suggesting that they were more motivated or had a greater expectation to obtain food. These results suggest that while chimpanzee captors in cooperative hunting may not reward cooperative participation directly, cooperators may influence sharing behavior through increased begging.	[John, Maria] Dr Maria John Commun, Leipzig, Germany; [Duguid, Shona; Melis, Alicia P.] UCL, Dept Expt Psychol, London, England; [Tomasello, Michael] Duke Univ, Dept Psychol & Neurosci, Durham, NC USA	University of London; University College London; Duke University	Duguid, S (corresponding author), UCL, Dept Expt Psychol, London, England.	shona.duguid@ucl.ac.uk		Duguid, Shona/0000-0003-4844-0673	Max Planck Society; Templeton World Charity Foundation [TWCF0264]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Templeton World Charity Foundation(Templeton World Charity Foundation)	The study was funded by the Max Planck Society. S. Duguid wrote the manuscript supported by a grant awarded to A. P. Melis from the Templeton World Charity Foundation (TWCF0264).; We are very thankful to L. Ajarova, J. Rukundo, T. Mukungu, the trustees and all staff of the Chimpanzee Sanctuary and Wildlife Conservation Trust (CSWCT) (www.ngambaisland.org) for their continuous help and support. In particular, we appreciate the hard work of the animal caregivers and their support helping us to conduct the experiments. We thank also Roger Mundry for his advice and support with the statistical analyses. We also appreciate permission from the Ugandan National Council for Science and Technology and the Uganda Wildlife Authority for allowing us to conduct our research in Uganda. Shona Duguid was supported by a grant from the Templeton World Charity Foundation while writing the paper.	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baumard N, 2012, DEV PSYCHOL, V48, P492, DOI 10.1037/a0026598; BOESCH C, 1994, ANIM BEHAV, V48, P653, DOI 10.1006/anbe.1994.1285; Boesch C, 2000, CHIMPANZEES TAI FORE; Bullinger AF, 2011, ANIM BEHAV, V82, P1135, DOI 10.1016/j.anbehav.2011.08.008; Crockford C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2765; de Waal FBM, 1997, EVOL HUM BEHAV, V18, P375, DOI 10.1016/S1090-5138(97)00085-8; DEWAAL FBM, 1989, J HUM EVOL, V18, P433, DOI 10.1016/0047-2484(89)90074-2; Dobson A. J, 2002, INTRO GEN LINEAR MOD; Gilby IC, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0005; Gilby IC, 2010, J HUM EVOL, V59, P44, DOI 10.1016/j.jhevol.2010.02.006; Gilby IC, 2006, ANIM BEHAV, V71, P953, DOI 10.1016/j.anbehav.2005.09.009; Greenberg JR, 2010, ANIM BEHAV, V80, P873, DOI 10.1016/j.anbehav.2010.08.008; Gurven M, 2004, BEHAV ECOL SOCIOBIOL, V56, P366, DOI 10.1007/s00265-004-0793-6; Hamann K, 2011, NATURE, V476, P328, DOI 10.1038/nature10278; Hockings KJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000886; Liebal K, 2017, ANIM BEHAV, V133, P91, DOI 10.1016/j.anbehav.2017.09.006; McGrath MC, 2019, NAT HUM BEHAV, V3, P354, DOI 10.1038/s41562-019-0530-9; Melis AP, 2006, ANIM BEHAV, V72, P275, DOI 10.1016/j.anbehav.2005.09.018; Melis AP, 2013, J EXP CHILD PSYCHOL, V114, P364, DOI 10.1016/j.jecp.2012.08.006; Melis AP, 2011, ANIM BEHAV, V82, P485, DOI 10.1016/j.anbehav.2011.05.024; Melis AP, 2006, SCIENCE, V311, P1297, DOI 10.1126/science.1123007; Mitani JC, 1999, AM J PHYS ANTHROPOL, V109, P439, DOI 10.1002/(SICI)1096-8644(199908)109:4<439::AID-AJPA2>3.0.CO;2-3; Mitani JC, 2001, ANIM BEHAV, V61, P915, DOI 10.1006/anbe.2000.1681; Newton-Fisher NE, 2013, HDB PALEOANTHROPOLOG, VII, P1; Nissen HW, 1936, J COMP PSYCHOL, V22, P383, DOI 10.1037/h0062234; R Core Team, 2021, R LANGUAGE ENV STAT; Samuni L, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1643; Samuni L, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0142-3; Samuni L, 2017, P NATL ACAD SCI USA, V114, P268, DOI 10.1073/pnas.1616812114; Schmelz M, 2017, P NATL ACAD SCI USA, V114, P7462, DOI 10.1073/pnas.1700351114; Silk JB, 2013, ANIM BEHAV, V85, P941, DOI 10.1016/j.anbehav.2013.02.014; Warneken F, 2011, PSYCHOL SCI, V22, P267, DOI 10.1177/0956797610395392; Wittig RM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3096	36	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222795	10.1371/journal.pone.0222795	http://dx.doi.org/10.1371/journal.pone.0222795			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5QI	31545837	Green Published, gold			2022-12-26	WOS:000532303200035
J	Ni, GY; Huang, KS; Luan, Y; Cao, ZZ; Chen, S; Ma, BW; Yuan, JW; Wu, XL; Chen, GQ; Wang, TF; Li, HJ; Walton, S; Liu, F; Chen, BB; Wang, YJ; Pan, X; Liu, XS; Frazer, IH				Ni, Guoying; Huang, Kunsong; Luan, Yi; Cao, Zaizai; Chen, Shu; Ma, Bowei; Yuan, Jianwei; Wu, Xiaolian; Chen, Guoqiang; Wang, Tianfang; Li, Hejie; Walton, Shelley; Liu, Fang; Chen, Bobei; Wang, Yuejian; Pan, Xuan; Liu, Xiaosong; Frazer, Ian H.			Human papillomavirus infection among head and neck squamous cell carcinomas in southern China	PLOS ONE			English	Article							DNA EXTRACTION; EPIDEMIOLOGY; DIAGNOSIS; LESIONS; CANCER; UPDATE	Human papillomavirus (HPV) related tumours account for a significant proportion of head and neck squamous cell carcinomas (HNSCCs) in developed countries. They respond better to chemo- and radio-therapy, and have a better stage specific prognosis. To establish their prevalence in China, we assessed a series of histology confirmed HNSCCs collected in Zhejiang and Guangdong provinces by PCR for HPV DNA and by immunohistochemistry for p16 protein status. Among 303 HNSCCs, HPV DNA was detected in 26.4%, with HPV16 DNA in 71% of these. Of HNSCC located in the oropharynx, 38.55% (32/83) were HPV+ve. In this series, p16 status was a relatively poor predictor of HPV status as detected by PCR. The stage specific survival time of HPV+ HNSCCs was significantly longer than for HPV-HNSCC. HPV status should be assessed for oropharyngeal cancers in China to assist with appropriate management, and prophylaxis against HPV infection should be considered to reduce the incidence of this disease.	[Ni, Guoying; Huang, Kunsong; Ma, Bowei; Yuan, Jianwei; Pan, Xuan; Liu, Xiaosong] Guangdong Pharmaceut Univ, Clin Med Sch, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Ni, Guoying; Wang, Tianfang; Li, Hejie] Univ Sunshine Coast, Genecol Res Ctr, Maroochydore, Qld, Australia; [Luan, Yi; Chen, Shu; Wu, Xiaolian; Chen, Guoqiang; Liu, Fang; Wang, Yuejian; Liu, Xiaosong] Foshan First Peoples Hosp, Canc Res Inst, Foshan, Guangdong, Peoples R China; [Cao, Zaizai; Chen, Bobei] Wenzhou Med Univ, Affiliated Hosp 2, Wenzhou, Zhejiang, Peoples R China; [Walton, Shelley; Liu, Xiaosong] Univ Sunshine Coast, Sch Hlth & Sport Sci, Inflammat & Healing Res Cluster, Maroochydore, Qld, Australia; [Frazer, Ian H.] Univ Queensland, Fac Med, Diamantina Inst, Translat Res Inst, Woolloongabba, Qld, Australia	Guangdong Pharmaceutical University; University of the Sunshine Coast; Wenzhou Medical University; University of the Sunshine Coast; University of Queensland	Liu, XS (corresponding author), Guangdong Pharmaceut Univ, Clin Med Sch, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.; Liu, XS (corresponding author), Foshan First Peoples Hosp, Canc Res Inst, Foshan, Guangdong, Peoples R China.; Liu, XS (corresponding author), Univ Sunshine Coast, Sch Hlth & Sport Sci, Inflammat & Healing Res Cluster, Maroochydore, Qld, Australia.	xiaosongl@yahoo.com	Wang, Tianfang/L-5192-2016; Walton, Shelley/A-9767-2012	Wang, Tianfang/0000-0002-4876-7767; Walton, Shelley/0000-0002-5857-6913; Ma, Bowei/0000-0002-3035-5115	Foshan City Council Research Platform Fund [2015AG1003, FS0AA-KJ218-1301-0039]; Science and Technology Research program of Guangdong province [2016A020213001]; National Natural Science Foundation of China [81472451]	Foshan City Council Research Platform Fund; Science and Technology Research program of Guangdong province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was partly supported by the by Foshan City Council Research Platform Fund (No.: 2015AG1003, FS0AA-KJ218-1301-0039) to XSL. SC, TFW, GYN, https://kjyw.fskw.gov.cn/stmsres/; Science and Technology Research program of Guangdong province (No: 2016A020213001) to XSL.TFW, GYN, SC, http://pro.gdstc.gov.cn/egrantweb/; National Natural Science Foundation of China (No: 81472451) to XSL. TFW, GYN, SC, https://isisn.nsfc.gov.cn/egrantweb/.All the funding received during this study were external to our organization. There was no additional external funding received for this study.	Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Ceccarelli Manuela, 2018, Oncotarget, V9, P17171, DOI 10.18632/oncotarget.24660; Chor JSY, 2016, J MED VIROL, V88, P877, DOI 10.1002/jmv.24405; Gillison ML, 2015, J CLIN ONCOL, V33, P3235, DOI 10.1200/JCO.2015.61.6995; Gotz C, 2019, MOL CLIN ONCOL, V10, P17, DOI 10.3892/mco.2018.1749; Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357; Guo LW, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00619; Janecka A, 2015, ANAL BIOCHEM, V476, P8, DOI 10.1016/j.ab.2015.01.019; Kobayashi K, 2018, J CLIN MED, V7, DOI 10.3390/jcm7090241; Kounis NG, 2016, CLIN CHEM LAB MED, V54, P1545, DOI 10.1515/cclm-2016-0010; Lam EWH, 2016, CANCER EPIDEM BIOMAR, V25, P165, DOI 10.1158/1055-9965.EPI-15-0869; LeConte BA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203403; Lee LA, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002069; Leemans CR, 2018, NAT REV CANCER, V18, P269, DOI 10.1038/nrc.2018.11; Li S, 2015, ORAL ONCOL, V51, P1082, DOI 10.1016/j.oraloncology.2015.10.014; Liu J, 2018, CANCER COMMUN, V38, DOI 10.1186/s40880-018-0345-5; Marur S, 2016, MAYO CLIN PROC, V91, P386, DOI 10.1016/j.mayocp.2015.12.017; Marur S, 2010, LANCET ONCOL, V11, P781, DOI 10.1016/S1470-2045(10)70017-6; Ni GY, 2015, CELL IMMUNOL, V293, P126, DOI 10.1016/j.cellimm.2014.12.012; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pesek M, 2013, Ceska Gynekol, V78, P195; Pinatti LM, 2018, J DENT RES, V97, P691, DOI 10.1177/0022034517744213; Rabelo-Goncalves E, 2014, PATHOL RES PRACT, V210, P142, DOI 10.1016/j.prp.2013.11.003; Richards Lisa, 2010, Nat Rev Clin Oncol, V7, P481, DOI 10.1038/nrclinonc.2010.123; Smola Sigrun, 2017, Ther Adv Vaccines, V5, P69, DOI 10.1177/2051013617717914; Sun PM, 2017, J GYNECOL ONCOL, V28, DOI 10.3802/jgo.2017.28.e50; Syrjanen S, 2018, EUR J ORAL SCI, V126, P49, DOI 10.1111/eos.12538; Termine N, 2008, ANN ONCOL, V19, P1681, DOI 10.1093/annonc/mdn372; Tong FJ, 2018, CELL PHYSIOL BIOCHEM, V49, P206, DOI 10.1159/000492858; van der Sluis TC, 2015, CURR OPIN IMMUNOL, V35, P9, DOI 10.1016/j.coi.2015.05.002; Vokes EE, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv344; Wei W, 2012, ONCOL REP, V28, P1750, DOI 10.3892/or.2012.1990; Wiegand S, 2018, EUR ARCH OTO-RHINO-L, V275, P1365, DOI 10.1007/s00405-018-4954-z; Zhang YR, 2016, ONCOTARGET, V7, P62411, DOI 10.18632/oncotarget.11498	34	18	20	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0221045	10.1371/journal.pone.0221045	http://dx.doi.org/10.1371/journal.pone.0221045			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545798	Green Published, gold			2022-12-26	WOS:000532303200010
J	Wei, XY; You, L; Wang, D; Huang, H; Li, SJ; Wang, DM				Wei, Xiaoyu; You, Lv; Wang, Dan; Huang, He; Li, Shijun; Wang, Dingming			Antimicrobial resistance and molecular genotyping of Salmonella enterica serovar Enteritidis clinical isolates from Guizhou province of Southwestern China	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; ABUSE; SURVEILLANCE; PROFILES	Salmonella enterica serovar Enteritidis (S. Enteritidis) is the most common and essential serotype that causes salmonellosis in Guizhou province. This study aimed to investigate the antimicrobial resistance (AMR) and molecular genotyping of 79 S. Enteritidis clinical isolates from 2011 to 2016 in Guizhou, China. Antimicrobial resistance and minimum inhibitory concentrations (MICs) of S. Enteritidis clinical isolates were detected by micro broth dilution method against ten classes 16 antimicrobial agents, and molecular genotyping were examined by pulsed-field gel electrophoresis (PFGE) and multiple-locus variable-number tandem repeat analysis (MLVA). All (100%) isolates showed resistance to at least one antimicrobial. Resistance to nalidixic acid (98.7%) was the highest, followed by sulfamethoxazole (87.3%) and ampicillin (77.2%). The majority of isolates (92.4%) showed decreased susceptibility to ciprofloxacin. Resistance to the third and fourth-generation cephalosporins was observed. Twenty-six AMR profiles were observed, and the predominant AMR profile was ampicillin-streptomycin-sulfamethoxazole-amoxicillin/clavulanic acid-nalidixic acid. A high burden of multidrug resistance (MDR) (81.0%) was found. Seventy-nine S. Enteritidis isolates were divided into 33 different pulsotypes (PTs), and the most frequent PT was PT18. Twenty-six different MLVA types (MTs) were generated with seven VNTR loci analysis of these isolates. The dominant PTs and MTs were persistent during 2011-2016. S. Enteritidis clinical isolates showed higher genetic diversity using PFGE combined with MLVA grouped into 60 PT-MT genotypes. No correlation was observed between genotypes, AMR profiles and geographic location. These data revealed the characteristics of AMR and molecular genotyping of S. Enteritidis clinical isolates in Guizhou province. These results highlight that strengthening the AMR and molecular genotyping surveillance is essential to prevent and control salmonellosis in Guizhou. PFGE combined with MLVA should be powerful tools for the molecular genotyping of S. Enteritidis isolates.	[Wei, Xiaoyu; You, Lv; Li, Shijun] Guizhou Prov Ctr Dis Control & Prevent, Lab Bacterial Infect Dis Expt Ctr, Guiyang, Peoples R China; [Wang, Dan; Huang, He; Wang, Dingming] Guizhou Prov Ctr Dis Control & Prevent, Inst Communicable Dis Control & Prevent, Guiyang, Peoples R China		Wei, XY; Li, SJ (corresponding author), Guizhou Prov Ctr Dis Control & Prevent, Lab Bacterial Infect Dis Expt Ctr, Guiyang, Peoples R China.	weixyuse18@163.com; zjumedjun@163.com		Wei, Xiaoyu/0000-0002-9948-664X	Science and Technology Foundation Planning Project of Guizhou Province of China [Qian Ke He Basis [2017]1094]; Science and Technology Foundation of the Health Department of Guizhou Province of China [gzwjkj2016-1-003]; Program of Scientific and Technological Innovation Team of Guizhou Province [Qian Ke He Platform Talent [2018]5606]	Science and Technology Foundation Planning Project of Guizhou Province of China; Science and Technology Foundation of the Health Department of Guizhou Province of China; Program of Scientific and Technological Innovation Team of Guizhou Province	This work was funded by (to XYW) the Science and Technology Foundation Planning Project of Guizhou Province of China (Qian Ke He Basis [2017]1094), (to XYW) The Science and Technology Foundation of the Health Department of Guizhou Province of China (gzwjkj2016-1-003), and (to SJL) the Program of Scientific and Technological Innovation Team of Guizhou Province (Qian Ke He Platform Talent [2018]5606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campioni F, 2015, APMIS, V123, P422, DOI 10.1111/apm.12367; Cao Z, 2016, CHINA ANIMAL HUSBAND, V43, P1737, DOI [10.16431/j.cnki.1671-7236.2016.07.012, DOI 10.16431/J.CNKI.1671-7236.2016.07.012]; CDC. National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS), 2018, HUM IS SURV REP 2015; Chiou CS, 2015, INT J FOOD MICROBIOL, V214, P1, DOI 10.1016/j.ijfoodmicro.2015.07.016; Deng XY, 2015, J CLIN MICROBIOL, V53, P212, DOI 10.1128/JCM.02332-14; Diao BaoWei, 2013, Disease Surveillance, V28, P1021; English BK, 2010, ADV EXP MED BIOL, V659, P73, DOI 10.1007/978-1-4419-0981-7_6; Fardsanei F, 2018, J GLOB ANTIMICROB RE, V12, P220, DOI 10.1016/j.jgar.2017.10.005; Galanis E, 2006, EMERG INFECT DIS, V12, P381, DOI 10.3201/eid1203.050854; Garca V, 2019, MICROB DRUG RESIST, V25, P219, DOI 10.1089/mdr.2018.0139; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; Kang Xi-lin, 2018, Zhongguo Kangshengsu Zazhi, V43, P1073; Ke BX, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-338; Kim J, 2014, FOODBORNE PATHOG DIS, V11, P38, DOI 10.1089/fpd.2013.1579; Kozoderovic G, 2011, FOLIA MICROBIOL, V56, P66, DOI 10.1007/s12223-011-0003-7; Ktari S, 2016, APMIS, V124, P194, DOI 10.1111/apm.12484; Li J, 2011, GUIZHOU AGR SCI, V39, P132; Lin, 2012, CHINESE J FOOD HYG, V24, P387; Liu Y, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0119-3; Lou Jing, 2013, Disease Surveillance, V28, P434; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Mao X., 2011, CHIN J DIS CONTROL P, V15, P622; Muvhali M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2751-8; NAIR US, 1995, J AM VET MED ASSOC, V206, P1339; Peters T, 2017, EUROSURVEILLANCE, V22, P13, DOI 10.2807/1560-7917.ES.2017.22.9.30477; Ren H, 2016, HEILONGJIANG ANIMAL, P257; Song QF, 2018, INFECT DRUG RESIST, V11, P267, DOI 10.2147/IDR.S157460; Song QF, 2016, J FOOD SCI, V81, pM1778, DOI 10.1111/1750-3841.13339; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Utrarachkij F, 2016, J INFECT CHEMOTHER, V22, P209, DOI 10.1016/j.jiac.2015.12.011; Wang WenXia, 2011, Guizhou Agricultural Sciences, P133; Wang X, 2015, BIOESSAYS, V37, P1045, DOI 10.1002/bies.201500071; Wang Y, 2014, GUIZHOU MED J, V38, P164, DOI [10.3969/j.ISSN.1000-744X.2014.02.030, DOI 10.3969/J.ISSN.1000-744X.2014.02.030]; Wang Y, 2017, FOODBORNE PATHOG DIS, V14, P393, DOI 10.1089/fpd.2016.2237; Wang Z, 2017, INFECT CONT HOSP EP, V38, P758, DOI 10.1017/ice.2017.60; Wei XiaoYu, 2012, Modern Preventive Medicine, V39, P5351; Wei ZQ, 2019, FOODBORNE PATHOG DIS, V16, P244, DOI 10.1089/fpd.2018.2557; World Health Organization, 2010, WHO REC MAN DIARRH P; Wu Q, 2015, STUDIES TRACE ELEMEN, V32, P41; Xu L, 2018, J INFECT DEV COUNTR, V12, P573, DOI 10.3855/jidc.9733; You Lyu, 2018, Chinese Journal of Zoonoses, V34, P712; Yu JX, 2015, J INFECTION, V71, P19, DOI 10.1016/j.jinf.2015.03.001; Yuan H, 2014, B DIS CONTROL PREVEN, V29, P63, DOI [10.13215/j.cnki.jbyfkztb.1405006, DOI 10.13215/J.CNKI.JBYFKZTB.1405006]; Zhang ZK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173881; Zhou XJ, 2018, FOODBORNE PATHOG DIS, V15, P346, DOI 10.1089/fpd.2017.2387	45	2	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0221492	10.1371/journal.pone.0221492	http://dx.doi.org/10.1371/journal.pone.0221492			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31546249	gold, Green Published			2022-12-26	WOS:000532303200011
J	Chahal, KK; Li, J; Kufareva, I; Parle, M; Durden, DL; Wechsler-Reya, RJ; Chen, CC; Abagyan, R				Chahal, Kirti Kandhwal; Li, Jie; Kufareva, Irina; Parle, Milind; Durden, Donald L.; Wechsler-Reya, Robert J.; Chen, Clark C.; Abagyan, Ruben			Nilotinib, an approved leukemia drug, inhibits smoothened signaling in Hedgehog-dependent medulloblastoma	PLOS ONE			English	Article							CANCER STEM-CELLS; ACTIVITY PREDICTION; GLIOBLASTOMA CELLS; PATHWAY INHIBITOR; KINASE INHIBITOR; STRUCTURAL BASIS; IMATINIB; RESISTANCE; GROWTH; IDENTIFICATION	Dysregulation of the seven-transmembrane (7TM) receptor Smoothened (SMO) and other components of the Hedgehog (Hh) signaling pathway contributes to the development of cancers including basal cell carcinoma (BCC) and medulloblastoma (MB). However, SMO-specific antagonists produced mixed results in clinical trials, marked by limited efficacy and high rate of acquired resistance in tumors. Here we discovered that Nilotinib, an approved inhibitor of several kinases, possesses an anti-Hh activity, at clinically achievable concentrations, due to direct binding to SMO and inhibition of SMO signaling. Nilotinib was more efficacious than the SMO-specific antagonist Vismodegib in inhibiting growth of two Hh-dependent MB cell lines. It also reduced tumor growth in subcutaneous MB mouse xenograft model. These results indicate that in addition to its known activity against several tyrosine-kinase-mediated proliferative pathways, Nilotinib is a direct inhibitor of the Hh pathway. The newly discovered extension of Nilotinib's target profile holds promise for the treatment of Hh-dependent cancers.	[Chahal, Kirti Kandhwal; Kufareva, Irina; Abagyan, Ruben] Univ Calif San Diego UCSD, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Chahal, Kirti Kandhwal; Parle, Milind] GJ Univ Sci & Technol, Dept Pharmaceut Sci, Hisar, Haryana, India; [Li, Jie; Chen, Clark C.] Dept Neurosurg, Minneapolis, MN 55455 USA; [Durden, Donald L.] UCSD, Dept Pediat, Moores Canc Ctr, Sch Med, La Jolla, CA USA; [Durden, Donald L.] Rady Childrens Hosp, La Jolla, CA USA; [Wechsler-Reya, Robert J.] NCI, Tumor Initiat & Maintenance Program, Designated Canc Ctr, Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA USA	University of California System; University of California San Diego; Guru Jambheshwar University of Science & Technology; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Sanford Burnham Prebys Medical Discovery Institute	Abagyan, R (corresponding author), Univ Calif San Diego UCSD, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.; Chen, CC (corresponding author), Dept Neurosurg, Minneapolis, MN 55455 USA.	ccchen@umn.edu; ruben@ucsd.edu		Abagyan, Ruben/0000-0001-9309-2976; Chahal, Kirti Kandhwal/0000-0002-5520-4161	NIH [R01 GM071872, 1R01NS097649-01, R01 AI118985, R01 GM117424]; Doris Duke Charitable Foundation Clinical Scientist Development Award; Sontag Foundation Distinguished Scientist Award; Kimmel Scholar Award; BWF [1006774.01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R35HL135737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117424, R35GM131881, R01GM071872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS097649, R01NS102432] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation Clinical Scientist Development Award(American Heart AssociationDoris Duke Charitable Foundation (DDCF)); Sontag Foundation Distinguished Scientist Award; Kimmel Scholar Award; BWF; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The project is partially funded by NIH grant R01 GM071872 (to R.A.) and 1R01NS097649-01, the Doris Duke Charitable Foundation Clinical Scientist Development Award, The Sontag Foundation Distinguished Scientist Award, the Kimmel Scholar Award, and BWF 1006774.01 (to C.C.C.). The part of the project was also supported by NIH grant R01 AI118985 and R01 GM117424 (to I.K.).	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Abouantoun TJ, 2009, MOL CANCER THER, V8, P1137, DOI 10.1158/1535-7163.MCT-08-0889; Akare UR, 2014, BIOINFORMATION, V10, P737, DOI 10.6026/97320630010737; Au K, 2015, J NEURO-ONCOL, V122, P471, DOI 10.1007/s11060-015-1744-y; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Blagosklonny MV, 2002, LEUKEMIA, V16, P570, DOI 10.1038/sj.leu.2402409; Bozic I, 2013, ELIFE, V2, DOI 10.7554/eLife.00747; Byrne EFX, 2016, NATURE, V535, P517, DOI 10.1038/nature18934; Campbell V, 2015, STEM CELLS CLONING, V8, P27, DOI 10.2147/SCCAA.S58613; Caro I, 2010, CLIN CANCER RES, V16, P3335, DOI 10.1158/1078-0432.CCR-09-2570; Carpenter D, 1998, P NATL ACAD SCI USA, V95, P13630, DOI 10.1073/pnas.95.23.13630; Chahal KK, 2018, ANTI-CANCER DRUG, V29, P387, DOI 10.1097/CAD.0000000000000609; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen YC, 2014, FUTURE MED CHEM, V6, P1741, DOI [10.4155/fmc.14.113, 10.4155/FMC.14.113]; Chilton-Macneill S, PEDIAT DEV PATHOL OF; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Cochrane CR, 2015, CANCERS, V7, P1554, DOI 10.3390/cancers7030851; Conradt L, 2011, NEOPLASIA, V13, P1026, DOI 10.1593/neo.111016; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Eleutherakis-Papaiakovou V, 2004, ANN ONCOL, V15, P1151, DOI 10.1093/annonc/mdh300; Emmenegger BA, 2008, J CHILD NEUROL, V23, P1172, DOI 10.1177/0883073808321062; Fossati P, 2009, CANCER TREAT REV, V35, P79, DOI 10.1016/j.ctrv.2008.09.002; Gendreau SB, 2009, MOL CANCER THER, V8, DOI 10.1158/1535-7163.TARG-09-B192; Giles FJ, 2013, EUR J CLIN PHARMACOL, V69, P813, DOI 10.1007/s00228-012-1385-4; Gotschel F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065403; Gonda TJ, 2015, NAT REV CANCER, V15, P686, DOI 10.1038/nrc4018; Hantschel O, 2008, LEUKEMIA LYMPHOMA, V49, P615, DOI 10.1080/10428190801896103; Hebron ML, 2013, HUM MOL GENET, V22, P3315, DOI 10.1093/hmg/ddt192; Heikens J, 1998, EUR J CANCER, V34, P1592, DOI 10.1016/S0959-8049(98)00212-3; Higdon R, 2017, PROTEOMES, V5, DOI 10.3390/proteomes5010005; Holdhoff M, 2005, BLOOD CELL MOL DIS, V34, P181, DOI 10.1016/j.bcmd.2004.11.006; Huang HC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-234; Huang P, 2018, CELL; Huang PX, 2016, CELL, V166, P1176, DOI 10.1016/j.cell.2016.08.003; Irvine DA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25476; JACOBSEN PF, 1985, J NEUROPATH EXP NEUR, V44, P472, DOI 10.1097/00005072-198509000-00003; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Justilien V, 2015, CLIN CANCER RES, V21, P505, DOI 10.1158/1078-0432.CCR-14-0507; Kantarjian HM, 2007, BLOOD, V110, P3540, DOI 10.1182/blood-2007-03-080689; Karuppagounder SS, 2014, SCI REP-UK, V4, DOI 10.1038/srep04874; Kieran MW, 2014, NEURO-ONCOLOGY, V16, P1037, DOI 10.1093/neuonc/nou109; Kim J, 2010, CANCER CELL, V17, P388, DOI 10.1016/j.ccr.2010.02.027; Komarova NL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004423; Komarova NL, 2005, P NATL ACAD SCI USA, V102, P9714, DOI 10.1073/pnas.0501870102; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Kufareva I, 2014, STRUCTURE, V22, P1120, DOI 10.1016/j.str.2014.06.012; Kufareva I, 2012, CURR TOP MED CHEM, V12, P1869, DOI 10.2174/156802612804547335; Larsen AR, 2015, MOL CANCER THER, V14, P3, DOI 10.1158/1535-7163.MCT-14-0755-T; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee MJ, 2012, P NATL ACAD SCI USA, V109, P7859, DOI 10.1073/pnas.1114718109; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Malancona S, 2011, BIOORG MED CHEM LETT, V21, P4422, DOI 10.1016/j.bmcl.2011.06.024; Manley PW, 2005, BBA-PROTEINS PROTEOM, V1754, P3, DOI 10.1016/j.bbapap.2005.07.040; Martarelli D, 2008, CANCER CHEMOTH PHARM, V61, P809, DOI 10.1007/s00280-007-0538-0; Metcalfe C, 2011, CANCER RES, V71, P5057, DOI 10.1158/0008-5472.CAN-11-0923; Miller-Moslin K, 2009, J MED CHEM, V52, P3954, DOI 10.1021/jm900309j; Morgillo F, 2017, J MED CHEM, V60, P7447, DOI 10.1021/acs.jmedchem.7b00794; Nygren P, 2013, J CANCER RES CLIN, V139, P2133, DOI 10.1007/s00432-013-1539-5; Ogino S, 2016, EPIDEMIOLOGY, V27, P602, DOI 10.1097/EDE.0000000000000471; Pan SF, 2010, ACS MED CHEM LETT, V1, P130, DOI 10.1021/ml1000307; Parkkila S, 2009, BIOORGANIC MED CHEM, V19; Peukert S, 2009, BIOORGANIC MED CHEM, V19; Razis E, 2009, CLIN CANCER RES, V15, P6258, DOI 10.1158/1078-0432.CCR-08-1867; Reinwald M, 2014, BIOMED RES INT, V2014, P15; Rimkus TK, 2016, CANCERS, V8, DOI 10.3390/cancers8020022; Robbins DJ, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002906; Romer J, 2005, CANCER RES, V65, P4975, DOI 10.1158/0008-5472.CAN-05-0481; SCHREIBER E, 1990, NUCLEIC ACIDS RES, V18, P5495, DOI 10.1093/nar/18.18.5495; Shi D, 2019, J CHEM INF MODEL, V59, P3006, DOI 10.1021/acs.jcim.9b00031; Singh AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150836; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smoll NR, 2012, J CLIN NEUROSCI, V19, P1541, DOI 10.1016/j.jocn.2012.04.009; Soria JC, 2009, J CLIN ONCOL, V27, P1359, DOI 10.1200/JCO.2008.20.8595; Su B, 2009, BIOORG MED CHEM LETT, V19, P6733, DOI 10.1016/j.bmcl.2009.09.109; SU G, 2011, CHEM BIOL, V10, DOI DOI 10.1186/1475-2840-10-19; Therapeutic Goods Administration, 2011, AUSTR PUBL ASS REP N; Totrov M, 1997, PROTEINS, P215; Totrov M., 2001, DRUG RECEPTOR THERMO, P603; Totrov M, 2008, CHEM BIOL DRUG DES, V71, P15, DOI 10.1111/j.1747-0285.2007.00605.x; Wang C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5355; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Wang JB, 2012, BIOORGAN MED CHEM, V20, P6751, DOI 10.1016/j.bmc.2012.09.030; Weierstall U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4309; Yang B, 2012, BIOORGANIC MED CHEM, V22; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Yauch RL, 2009, SCIENCE, V326, P572, DOI 10.1126/science.1179386; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	91	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0214901	10.1371/journal.pone.0214901	http://dx.doi.org/10.1371/journal.pone.0214901			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539380	Green Published, Green Submitted, gold			2022-12-26	WOS:000532297900002
J	Itohiya, H; Matsushima, Y; Shirakawa, S; Kajiyama, S; Yashima, A; Nagano, T; Gomi, K				Itohiya, Hiroo; Matsushima, Yuji; Shirakawa, Satoshi; Kajiyama, Sohtaro; Yashima, Akihiro; Nagano, Takatoshi; Gomi, Kazuhiro			Organic resolution function and effects of platinum nanoparticles on bacteria and organic matter	PLOS ONE			English	Article							METAL NANOPARTICLES; PERIODONTAL-DISEASE; VISUALIZATION; COMBINATION; GOLD	Rapid progress has been made in terms of metal nanoparticles studied in numerous fields. Metal nanoparticles have also been used in medical research, and antibacterial properties and anticancer effects have been reported. However, the underlying mechanism responsible for these effects has not been fully elucidated. Therefore, the present study focused on platinum nanoparticles (PtNPs) and examined their antibacterial properties and functional potential for decomposing organic matter, considering potential applications in the dental field. PtNPs were allowed to react with dental-related bacteria (Streptococcus mutans; Enterococcus faecalis, caries; Porphyromonas gingivalis, and endodontic and periodontal lesions). Antibacterial properties were evaluated by measuring colony formation. In addition, PtNPs were allowed to react with albumin and lipopolysaccharides (LPSs), and the functional potential to decompose organic matter was evaluated. All evaluations were performed in vitro. Colony formation in all bacterial species was completely suppressed by PtNPs at concentrations of > 5 ppm. The addition of PtNPs at concentrations of > 10 ppm significantly increased fragmentation and decomposition. The addition of PtNPs at concentrations of >125 pico/mL to 1 EU/mL LPS resulted in significant amounts of decomposition and elimination. The results revealed that PtNPs had antibacterial effects against dental-related bacteria and proteolytic potential to decompose proteins and LPS, an inflammatory factor associated with periodontal disease. Therefore, the use and application of PtNPs in periodontal and endodontic treatment is considered promising.	[Itohiya, Hiroo; Matsushima, Yuji; Shirakawa, Satoshi; Kajiyama, Sohtaro; Yashima, Akihiro; Nagano, Takatoshi; Gomi, Kazuhiro] Tsurumi Univ, Sch Dent Med, Dept Periodontol, Tsurumi Ku, Yokohama, Kanagawa, Japan	Tsurumi University	Gomi, K (corresponding author), Tsurumi Univ, Sch Dent Med, Dept Periodontol, Tsurumi Ku, Yokohama, Kanagawa, Japan.	gomi-k@tsurumi-u.ac.jp		Gomi, Kazuhiro/0000-0003-4484-6238				BROWN RE, 1989, ANAL BIOCHEM, V180, P136, DOI 10.1016/0003-2697(89)90101-2; Chondrogianni N, 2014, MOL ASPECTS MED, V35, P1, DOI 10.1016/j.mam.2012.09.001; Chwalibog A, 2010, INT J NANOMED, V5, P1085, DOI 10.2147/IJN.S13532; Corain B, 2008, METAL NANOCLUSTERS IN CATALYSIS AND MATERIALS SCIENCE: THE ISSUE OF SIZE CONTROL, P1; Gopal J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01260; HANAZAWA S, 1985, INFECT IMMUN, V50, P262, DOI 10.1128/IAI.50.1.262-270.1985; Horie M, 2014, J TOXICOL SCI, V39, P897, DOI 10.2131/jts.39.897; Konieczny P, 2013, INT J NANOMED, V8, P3963, DOI 10.2147/IJN.S49612; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lu Z, 2013, J MATER SCI-MATER M, V24, P1465, DOI 10.1007/s10856-013-4894-5; Ma S, 2012, DENT MATER J, V31, P150, DOI 10.4012/dmj.2011-180; Mafune F, 2003, J PHYS CHEM B, V107, P4218, DOI 10.1021/jp021580k; Mao BH, 2016, NANOTOXICOLOGY, V10, P1021, DOI 10.1080/17435390.2016.1189614; Mathur A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141301; Mayer ABR, 2001, POLYM ADVAN TECHNOL, V12, P96, DOI 10.1002/1099-1581(200101/02)12:1/2<96::AID-PAT943>3.0.CO;2-G; McGuffie MJ, 2016, NANOMED-NANOTECHNOL, V12, P33, DOI 10.1016/j.nano.2015.10.002; Onizawa S, 2009, PULM PHARMACOL THER, V22, P340, DOI 10.1016/j.pupt.2008.12.015; Rai A, 2010, J MATER CHEM, V20, P6789, DOI 10.1039/c0jm00817f; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Roduner E, 2006, CHEM SOC REV, V35, P583, DOI 10.1039/b502142c; ROSENBERG B, 1965, NATURE, V205, P698, DOI 10.1038/205698a0; Sawosz E, 2010, INT J NANOMED, V5, P631, DOI 10.2147/IJN.S12361; SCHMID G, 1994, CLUSTERS COLLOIDS TH; Silvert PY, 1996, J MATER CHEM, V6, P573, DOI 10.1039/jm9960600573; Slavin YN, 2017, J NANOBIOTECHNOL, V15, DOI 10.1186/s12951-017-0308-z; SOCRANSKY SS, 1992, J PERIODONTOL, V63, P322, DOI 10.1902/jop.1992.63.4s.322; Su YL, 2015, SCI REP-UK, V5, DOI 10.1038/srep15824; Taylor E, 2011, INT J NANOMED, V6, P1463, DOI 10.2147/IJN.S22021; Toshima N, 1998, NEW J CHEM, V22, P1179, DOI 10.1039/a805753b; Veerapandian M, 2011, APPL MICROBIOL BIOT, V90, P1655, DOI 10.1007/s00253-011-3291-6; Wang LL, 2017, INT J NANOMED, V12, P1227, DOI 10.2147/IJN.S121956; Wieckowski A., 2003, CATALYSIS ELECTROCAT; Yamada M, 2015, WIRES NANOMED NANOBI, V7, P428, DOI 10.1002/wnan.1322; Yang XL, 2017, ACS NANO, V11, P5737, DOI 10.1021/acsnano.7b01240; Yhee JY, 2015, CURR PHARM DESIGN, V21, P3158, DOI 10.2174/1381612821666150531165059	35	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222634	10.1371/journal.pone.0222634	http://dx.doi.org/10.1371/journal.pone.0222634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536547	gold, Green Published, Green Submitted			2022-12-26	WOS:000532262800065
J	Ntamba, YL; Mavoko, HM; Kalabuanga, M; Fungula, B; Nsengi, PMN; Lutete, GT; da Luz, RI; Van Geertruyden, JP; Lutumba, P				Ntamba, Yves Lula; Mavoko, Hypolite Muhindo; Kalabuanga, Marion; Fungula, Blaise; Nsengi, Pierre-Michel Ntamabyaliro; Lutete, Gaston Tona; da Luz, Raquel Inocencio; Van Geertruyden, Jean-Pierre; Lutumba, Pascal			Safety and tolerability of artesunate-amodiaquine, artemether-lumefantrine and quinine plus clindamycin in the treatment of uncomplicated Plasmodium falciparum malaria in Kinshasa, the Democratic Republic of the Congo	PLOS ONE			English	Article							COMBINATION THERAPIES; PHARMACOVIGILANCE; EFFICACY; COUNTRIES	Introduction Artemisinin-based combination therapy is currently the best option for the treatment of uncomplicated malaria. Quinine is recommended as a rescue treatment. Safety information during repeated treatment with the same drug is scarce. We report safety data from the Quinact randomized clinical trial (RCT) that was designed to assess efficacy and safety of artesunate-amodiaquine (ASAQ), artemether-lumefantrine (AL) and quinine+clindamycin (QnC). Methodology Males and females aged 12 to 59 months with uncomplicated malaria were treated with ASAQ and followed up during 42 days (preRCT). Clinical failures were randomized to one of the 3 treatments and followed up for 28 days (RCT). Subsequent failures were repeatedly treated with ASAQ several times as needed (postRCT1, postRCT2 and so on) until a 28days follow up period without parasitaemia. Results Eight hundred and sixty-five, 242 and 64 patients were recruited respectively in preRCT, RCT and postRCTs. In preRCT, 433 (50.0%) patients experienced at least one drug-related adverse event (AE). The most reported AEs were anorexia (22.9%), asthenia (19.4%), and abnormal behavior (14.6%). Twenty-nine AEs (3.5%) were reported to be severe. In RCT, at least one drug-related AE was reported in 54.7%, 21.5% and 40.0% of patient randomized respectively to ASAQ, AL and QnC (p< 0.001). During postRCT1 (n = 64), postRCT 2 (n = 17) and postRCT3 (n = 7), respectively 32.8%, 35.3% and 71.4% of patients experienced at least one drug-related AE. Three serious adverse events occurred but not judged related to study medication. Conclusion The proportion of AEs did not increase over the treatment courses with ASAQ. However, continuous monitoring is important.	[Ntamba, Yves Lula; Nsengi, Pierre-Michel Ntamabyaliro; Lutete, Gaston Tona] Univ Kinshasa, Clin Pharmacol & Pharmacovigilance Unit, Kinshasa, DEM REP CONGO; [Ntamba, Yves Lula; Mavoko, Hypolite Muhindo; da Luz, Raquel Inocencio; Van Geertruyden, Jean-Pierre] Univ Antwerp, Fac Med, Global Hlth Inst, Antwerp, Belgium; [Mavoko, Hypolite Muhindo; Lutumba, Pascal] Univ Kinshasa, Dept Trop Med, Kinshasa, DEM REP CONGO; [Kalabuanga, Marion; Fungula, Blaise] Lisungi Hlth Ctr, Kinshasa, DEM REP CONGO	Universite de Kinshasa; University of Antwerp; Universite de Kinshasa	Ntamba, YL (corresponding author), Univ Kinshasa, Clin Pharmacol & Pharmacovigilance Unit, Kinshasa, DEM REP CONGO.; Ntamba, YL (corresponding author), Univ Antwerp, Fac Med, Global Hlth Inst, Antwerp, Belgium.	yveslula@yahoo.fr	Inocencio da Luz, Raquel/ABE-8206-2021; Van geertruyden, Jean-Pierre/K-6425-2014	Inocencio da Luz, Raquel/0000-0002-2870-0311; Van geertruyden, Jean-Pierre/0000-0001-5006-6364; Lula, Yves/0000-0001-9196-7150	Fonds Wetenschappelijk Onderzoek (FWO) [G.078.11]; Vlaamse Interuniversitaire Raad-Universitaire Ontwikkelings Samenwerking (VLIR-UOS) [ZRDC2012MP076]; European and Developing Countries Clinical Trials Partnership (EDCTP) [MS.2010.10800.004]; Belgian Technical Cooperation-Programme d'Etudes et d'Expertises-in the Democratic Republic of Congo (BTC) [FEE/06/12]	Fonds Wetenschappelijk Onderzoek (FWO)(FWO); Vlaamse Interuniversitaire Raad-Universitaire Ontwikkelings Samenwerking (VLIR-UOS); European and Developing Countries Clinical Trials Partnership (EDCTP); Belgian Technical Cooperation-Programme d'Etudes et d'Expertises-in the Democratic Republic of Congo (BTC)	The Quinact trial was co-funded by Fonds Wetenschappelijk Onderzoek (FWO, Grant reference G.078.11 to JPVg), Vlaamse Interuniversitaire Raad-Universitaire Ontwikkelings Samenwerking (VLIR-UOS, Grant reference ZRDC2012MP076 to JPVg, PL), European and Developing Countries Clinical Trials Partnership (EDCTP, Grant reference MS.2010.10800.004 to JPVg) and the Belgian Technical Cooperation-Programme d'Etudes et d'Expertises-in the Democratic Republic of Congo (BTC, Grant reference FEE/06/12 to PL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjuik MA, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0301-z; Andrade RJ, 2007, WORLD J GASTROENTERO, V13, P329, DOI 10.3748/wjg.v13.i3.329; [Anonymous], 2003, ASS MON ANT DRUG EFF; [Anonymous], 1999, GUIDELINES PREPARING; [Anonymous], 1996, INT C HARM TECHN REQ; Anstey NM, 2015, LANCET INFECT DIS, V15, P692, DOI 10.1016/S1473-3099(15)70024-1; Bassi PU, 2013, DRUG SAFETY, V36, P747, DOI 10.1007/s40264-013-0044-8; Bethell D, 2010, CLIN INFECT DIS, V51, pE105, DOI 10.1086/657402; Chau TTH, 1996, CLIN INFECT DIS, V23, P1274, DOI 10.1093/clinids/23.6.1274; Chinawa JM, 2013, NIGER J PAED, V40, P416; Dodoo ANO, 2014, DRUG SAFETY, V37, P433, DOI 10.1007/s40264-014-0164-9; Ekong M B, 2008, Niger J Physiol Sci, V23, P51; Falade C., 2009, MALARIA J, V8, P1; Hien TT, 1996, NEW ENGL J MED, V335, P76, DOI 10.1056/NEJM199607113350202; IFPMA, 2016, MSSODI62261900 IFPMA; Kuemmerle A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-57; Maiteki-Sebuguzi C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-106; Maketa V, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0595-5; Mavoko HM, 2017, LANCET GLOB HEALTH, V5, pE60, DOI 10.1016/S2214-109X(16)30236-4; Mavoko HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157074; Mavoko HM, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-307; Mehta U, 2007, DRUG SAFETY, V30, P899, DOI 10.2165/00002018-200730100-00008; Meyboom RHB, 1997, DRUG SAFETY, V17, P374, DOI 10.2165/00002018-199717060-00004; Ndiaye JLA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-237; NEFTEL KA, 1986, BRIT MED J, V292, P721, DOI 10.1136/bmj.292.6522.721; Ngasala BE, 2011, CLIN INFECT DIS, V52, P873, DOI 10.1093/cid/cir066; Ngouesse B, 2001, AM J TROP MED HYG, V65, P711, DOI 10.4269/ajtmh.2001.65.711; Olsson S, 2010, DRUG SAFETY, V33, P689, DOI 10.2165/11536390-000000000-00000; Pirmohamed M, 2007, BRIT MED J, V335, P462, DOI 10.1136/bmj.39323.586123.BE; PNLP, 2012, GUID TECHN PREV PRIS; Price R, 1999, AM J TROP MED HYG, V60, P547, DOI 10.4269/ajtmh.1999.60.547; Sagara I, 2012, AM J TROP MED HYG, V87, P50, DOI 10.4269/ajtmh.2012.11-0649; Sanofi-Aventis, 2014, ART AM TABL SUMM PRO; Schramm B, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-250; Sinclair D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007483.pub2; Stergachis A, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-148; Sweetman S. C., 2007, MARTINDALE COMPLETE; Talisuna AO, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-50; Thiam S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-54; WHO, 2015, WHO ADV REACT TERM W; WHO Evidence Review Group Meeting, 2016, WHO EV REV GROUP M C; World Health Organization, 2007, PRACT HDB PHARM ANT; World Health Organization, 2015, GUID TREATM MAL, Vthird; Yeka A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113311	44	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222379	10.1371/journal.pone.0222379	http://dx.doi.org/10.1371/journal.pone.0222379			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527899	Green Published, Green Submitted, gold			2022-12-26	WOS:000532231400017
J	Spenlingwimmer, T; Zipperle, J; Jafarmadar, M; Osuchowski, MF; Drechsler, S				Spenlingwimmer, Tanja; Zipperle, Johannes; Jafarmadar, Mohammad; Osuchowski, Marcin Filip; Drechsler, Susanne			Comparison of post-traumatic changes in circulating and bone marrow leukocytes between BALB/c and CD-1 mouse strains	PLOS ONE			English	Article							MULTIPLE-TRAUMA; MODEL; SUSCEPTIBILITY; POLYTRAUMA; CELLS; MICE; INFLAMMATION; ASSOCIATION; RESPONSES	This manuscript emerged from a larger third-party funded project investigating a new polytrauma model and its influence upon secondary sepsis. The present sub-study compared selected leukocyte subpopulations in the circulation and bone marrow after polytrauma in BALB/c versus CD-1 mice. Animals underwent unilateral femur fracture, splenectomy and hemorrhagic shock. We collected blood and bone marrow for flow cytometry analysis at 24h and 48h post-trauma. Circulating granulocytes (Ly6G+CD11+) increased in both strains after trauma. Only in BALB/c mice circulating CD8+ T-lymphocytes decreased within 48h by 30%. Regulatory T-cells (T-regs, CD4+CD25+CD127(low)) increased in both strains by approx. 32%. Circulating Tregs and lymphocytes (CD11b-Ly6G-MHC-2+) were always at least 1.5-fold higher in BALB/c, while the bone marrow MHC-2 expression decreased in CD-1 mice (p<0.05). Overall, immune responses to polytrauma were similar in both strains. Additionally, BALB/c expressed higher level of circulating regulatory T-cells and MHC-2-positive lymphocytes compared to CD-1 mice.	[Spenlingwimmer, Tanja; Zipperle, Johannes; Jafarmadar, Mohammad; Osuchowski, Marcin Filip; Drechsler, Susanne] AUVA Res Ctr, Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria	Ludwig Boltzmann Institute	Drechsler, S (corresponding author), AUVA Res Ctr, Ludwig Boltzmann Inst Expt & Clin Traumatol, Vienna, Austria.	susanne.drechsler@trauma.lbg.ac.at		Zipperle, Johannes/0000-0002-8222-3413; Osuchowski, Marcin/0000-0002-1321-9883; Drechsler, Susanne/0000-0002-0758-303X	FWF Austrian Science Fund [T707-B13]	FWF Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by FWF Austrian Science Fund, Grant Number T707-B13 awarded to SD (www.fwf.ac.at).The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNABA V, 1994, EUR J IMMUNOL, V24, P71, DOI 10.1002/eji.1830240112; BRETT SJ, 1982, PARASITOLOGY, V85, P85, DOI 10.1017/S0031182000054172; Bricker-Anthony C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131921; Cahill LS, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-60; Casellas J, 2011, ANIMAL, V5, P1, DOI 10.1017/S1751731110001667; Charles River International, 2011, CD 1 IGS MIC NOM CRL; Chen X, 2005, J LEUKOCYTE BIOL, V78, P114, DOI 10.1189/jlb.0604341; Chick JM, 2016, NATURE, V534, P500, DOI 10.1038/nature18270; CROCKER PR, 1987, J EXP MED, V166, P613, DOI 10.1084/jem.166.2.613; Dai HL, 2013, INJURY, V44, P1521, DOI 10.1016/j.injury.2013.03.015; Denton MD, 1999, J EXP MED, V190, P555, DOI 10.1084/jem.190.4.555; Doeing Diana C, 2003, BMC Clin Pathol, V3, P3; Drechsler S, 2018, SCI REP, V8, P1, DOI 10.1038/s41598-017-17765-5; Ehrnthaller C, 2016, EUR J MED RES, V21, DOI 10.1186/s40001-016-0236-7; European Commission, 2016, 7 REP STAT NUMB AN U; Festing MFW, 2010, TOXICOL PATHOL, V38, P681, DOI 10.1177/0192623310373776; Gentile LF, 2014, CRIT CARE MED, V42, P1406, DOI 10.1097/CCM.0000000000000222; Gentile LF, 2013, CRIT CARE MED, V41, P1075, DOI 10.1097/CCM.0b013e318275d1f9; Jensen VS, 2016, AM J TRANSL RES, V8, P3574; Johnson M., 2012, MAT METHODS, V2, DOI 10.13070; Kong LB, 1996, J AM COLL SURGEONS, V182, P17; Li P, 2017, NUCLEIC ACIDS RES, V45, pD908, DOI 10.1093/nar/gkw974; LUEKER DC, 1975, J PARASITOL, V61, P158, DOI 10.2307/3279135; MA L, 1989, J TRAUMA, V29, P1245, DOI 10.1097/00005373-198909000-00010; MacConmara MP, 2006, ANN SURG, V244, P514, DOI 10.1097/01.sla.0000239031.06906.1f; Martin MD, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01527; Matsutani T, 2005, CYTOKINE, V30, P168, DOI 10.1016/j.cyto.2004.12.019; Menges T, 1999, CRIT CARE MED, V27, P733, DOI 10.1097/00003246-199904000-00026; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mira JC, 2018, METHODS MOL BIOL, V1717, P1, DOI 10.1007/978-1-4939-7526-6_1; Morgan AP, 2016, G3-GENES GENOM GENET, V6, P263, DOI 10.1534/g3.115.022087; Nashef A, 2017, METHODS MOL BIOL, V1488, P551, DOI 10.1007/978-1-4939-6427-7_27; Ni Choileain N, 2006, J IMMUNOL, V176, P225; Osuchowski MF, 2014, SHOCK, V41, P463, DOI 10.1097/SHK.0000000000000153; Pfeifer R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148844; Rai D, 2009, J IMMUNOL, V183, P7672, DOI 10.4049/jimmunol.0902874; Rau CD, 2015, G3-GENES GENOM GENET, V5, P2021, DOI 10.1534/g3.115.020784; RICHARDSON SH, 1986, INFECT IMMUN, V54, P522, DOI 10.1128/IAI.54.2.522-528.1986; Smith CM, 2016, MBIO, V7, DOI [10.1128/mbio.01516-16, 10.1128/mBio.01516-16]; Srivastava A, 2017, GENETICS, V206, P537, DOI 10.1534/genetics.116.198838; Turnbull IR, 2016, SHOCK, V45, P555, DOI 10.1097/SHK.0000000000000538; Venet F, 2009, INTENS CARE MED, V35, P678, DOI 10.1007/s00134-008-1337-8; Vester H, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0180-y; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Winter JM, 2017, CELL SYST, V4, P31, DOI 10.1016/j.cels.2016.10.018	45	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222594	10.1371/journal.pone.0222594	http://dx.doi.org/10.1371/journal.pone.0222594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527918	Green Published, Green Submitted, gold			2022-12-26	WOS:000532231400031
J	Tlili, H; Hanen, N; Ben Arfa, A; Neffati, M; Boubakri, A; Buonocore, D; Dossena, M; Verri, M; Doria, E				Tlili, Hajer; Hanen, Najjaa; Ben Arfa, Abdelkerim; Neffati, Mohamed; Boubakri, Abdelbasset; Buonocore, Daniela; Dossena, Maurizia; Verri, Manuela; Doria, Enrico			Biochemical profile and in vitro biological activities of extracts from seven folk medicinal plants growing wild in southern Tunisia	PLOS ONE			English	Article							MARRUBIUM-VULGARE L.; ANTIOXIDANT ACTIVITY; THYMELAEA-HIRSUTA; INHIBITION; SAPONINS	Recently, much attention has been paid to the extracts obtained from plant species in order to analyse their biological activities. Due to the climate diversity in Tunisia, the traditional pharmacopoeia consists of a wide arsenal of medicinal plant species since long used in folk medicine, in foods as spices, and in aromatherapy. Although many of these species are nearly facing extinction, only a small proportion of them have been scientifically studied. Therefore, this study explores the biochemical properties of seven spontaneous plants, which were harvested in the arid Tunisian desert: Marrubium vulgare (L.), Rhus tripartita (Ucria) D.C., Thymelaea hirsute (L.) Endl., Plantago ovata (Forsk.), Herniaria fontanesii (J. Gay.), Ziziphus lotus (L.) and Hyoscyamus albus (L.). Extracts from these plants were found to contain different types of secondary metabolites (polyphenols, flavonoids, condensed tannins, crude saponins, carotenoids and alkaloids) that are involved in important biological activities. The biological activity of the extracts obtained from each Tunisian plant was assessed: first of all, leukaemia and colon cancer cell lines (K-562 and CaCo-2 respectively) were treated with different concentrations of extracts, and then the anti-proliferative activity was observed. The results showed, in particular, how the plant extract from Rhus tripartita significantly inhibits cell proliferation, especially on the K-562 tumour cell line. Subsequently, the anti-inflammatory activity was also assessed, and the results showed that Herniaria fontanesii and Marrubium vulgare possess the highest activity in the group of analysed plants. Finally, the greatest acetylcholinesterase inhibitory effect was exhibited by the extract obtained from Rhus tripartita. In conclusion, all the Tunisian plants we analysed were shown to contain a remarkable amount of different bio-active compounds, thus confirming their involvement in several biological activities. Rhus tripartita and Ziziphus lotus were shown to be particularly effective in anti-proliferative activity, while Herniaria fontanesii were shown to have the best anti-inflammatory activity.	[Tlili, Hajer; Hanen, Najjaa; Ben Arfa, Abdelkerim; Neffati, Mohamed; Boubakri, Abdelbasset] Inst Arid Reg IRA, Lab Pastoral Ecosyst & Valorisat Spontaneous Plan, Medenine, Tunisia; [Buonocore, Daniela; Dossena, Maurizia; Verri, Manuela; Doria, Enrico] Univ Pavia, Dept Biol & Biotechnol, Pavia, Italy	Institut des Regions Arides; University of Pavia	Doria, E (corresponding author), Univ Pavia, Dept Biol & Biotechnol, Pavia, Italy.	enrico.doria@unipv.it	Boubakri, Abdelbasset/AAY-8784-2020	Boubakri, Abdelbasset/0000-0001-8755-8362; Doria, Enrico/0000-0002-6805-0202; Verri, Manuela/0000-0003-3734-9540				Abdoul-Azize S, 2016, J NUTR METAB, V2016, DOI 10.1155/2016/2867470; Abdoul-Azize S, 2013, INT IMMUNOPHARMACOL, V15, P364, DOI 10.1016/j.intimp.2012.11.013; Adewusi EA, 2011, S AFR J BOT, V77, P638, DOI 10.1016/j.sajb.2010.12.009; Adzu B, 2003, ACTA TROP, V87, P245, DOI 10.1016/S0001-706X(03)00114-1; Akrout A, 2011, FOOD CHEM TOXICOL, V49, P342, DOI 10.1016/j.fct.2010.11.003; Ben Barka Z, 2016, BIOMED PHARMACOTHER, V83, P827, DOI 10.1016/j.biopha.2016.07.055; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Biradar S.R., 2013, AM J LIFE SCI, V1, P243, DOI [10.11648/j.ajls.20130106.11, DOI 10.11648/J.AJLS.20130106.11]; Borgi W, 2004, S AFRICAN J BOT, V74, P320; BORRIS RP, 1988, J ETHNOPHARMACOL, V24, P41, DOI 10.1016/0378-8741(88)90138-9; Chao HC, 2013, EXP DERMATOL, V22, P131, DOI 10.1111/exd.12089; Chatterjee P, 2012, J ADV PHARM TECHNOL, V3, P136, DOI 10.4103/2231-4040.97298; Chevallier A., 1996, ENCY MED PLANTS; CORDELL GA, 1995, PHYTOCHEMISTRY, V40, P1585, DOI 10.1016/0031-9422(95)00444-C; Cuenod A, 1954, FLORE ANAL SYNOPTIQU; Doit C, 1997, ANTIMICROB AGENTS CH, V41, P2050, DOI 10.1128/AAC.41.9.2050; El Amrani F, 2009, J MED PLANTS RES, V3, P625; El-Saltani Alghazeer Hussein, 2012, NATURAL SCI, V4, P324; El-Seedi HR, 2013, J ETHNOPHARMACOL, V145, P746, DOI 10.1016/j.jep.2012.12.007; Essawi T, 2000, J ETHNOPHARMACOL, V70, P343, DOI 10.1016/S0378-8741(99)00187-7; Essawy SS, 2014, SAUDI PHARM J, V22, P472, DOI 10.1016/j.jsps.2013.12.004; Fan FY, 2017, MOLECULES, V22, DOI 10.3390/molecules22030484; Fawole OA, 2010, J ETHNOPHARMACOL, V127, P235, DOI 10.1016/j.jep.2009.11.015; Garcia-Ayllon Maria-Salud, 2011, Front Mol Neurosci, V4, P22, DOI 10.3389/fnmol.2011.00022; Giancarlo S, 2006, NAT PROD RES, V20, P882, DOI 10.1080/14786410500520186; Haddadian K, 2014, INDIAN J TRADIT KNOW, V13, P681; Hajipoor K, 2015, IJBPAS, V4, P4016; Harrison A. P., 2006, American Journal of Pharmacology and Toxicology, V1, P26; Hernandez MF, 2010, FOOD CHEM, V120, P1076, DOI 10.1016/j.foodchem.2009.11.055; Itidel C, 2013, IND CROP PROD, V51, P171, DOI 10.1016/j.indcrop.2013.09.002; Kabbaj F.Z., 2012, PHYTOPHARMACOLOGY, V2, P243; Kaur R, 2015, INT J PHARM BIO SCI, V6, P826; Kawano M, 2007, EXP DERMATOL, V16, P977, DOI 10.1111/j.1600-0625.2007.00618.x; Khadri A, 2010, LWT-FOOD SCI TECHNOL, V43, P331, DOI 10.1016/j.lwt.2009.08.004; Kurilich AC, 1999, J AGR FOOD CHEM, V47, P1948, DOI 10.1021/jf981029d; Le Floc'h E., 1983, CONTRIBUTION ETUDE E; Le Houerou HN, 1969, ANN I NAT RECH AGR T, V42; Lodhi S, 2017, J INTERCULT ETHNOPHA, V6, P429, DOI 10.5455/jice.20170713060840; Loizzo MR, 2010, NUTR RES, V30, P823, DOI 10.1016/j.nutres.2010.09.016; Lola-Luz T, 2014, AGR FOOD SCI, V23, P28, DOI 10.23986/afsci.8832; Madland E., 2013, EXTRACTION ISOLATION; Mamta S, 2017, ASIAN J PHARM CLIN R, V10, P202; Marrif HI, 1995, J ETHNOPHARMACOL, V49, P51, DOI 10.1016/0378-8741(95)01302-4; Mbark AN, 2000, PHARMAZIE, V55, P690; Medoua GN, 2009, FOOD CHEM, V115, P260, DOI 10.1016/j.foodchem.2008.12.007; Mohammed I., 2015, J PHARMACOGN PHYTOCH, V4, P276; Moon JK, 2009, J AGR FOOD CHEM, V57, P1655, DOI 10.1021/jf803537k; Najjaa H, 2017, MED AROMATIC PLANTS, P3; Nargund L. V. G., 1993, Indian Journal of Experimental Biology, V31, P395; Ohtera A, 2013, BIOCHEM BIOPH RES CO, V440, P204, DOI 10.1016/j.bbrc.2013.09.003; Orhan IE, 2010, IND CROP PROD, V32, P566, DOI 10.1016/j.indcrop.2010.07.005; Ouelbani R, 2016, J ETHNOPHARMACOL, V194, P196, DOI 10.1016/j.jep.2016.08.016; Parveen M, 2014, NAT PROD RES, V28, P646, DOI 10.1080/14786419.2014.891201; Perk AA, 2014, CANCER CELL INT, V14, DOI 10.1186/s12935-014-0124-6; Pourmorad F, 2006, AFR J BIOTECHNOL, V5, P1142; Renault JH, 1997, PHYTOCHEMISTRY, V44, P1321, DOI 10.1016/S0031-9422(96)00721-2; Rhiouani H, 2008, J ETHNOPHARMACOL, V118, P378, DOI 10.1016/j.jep.2008.05.009; Sakat SS., 2010, INT J PHARM PHARM SC, V2, P82; Saso L, 2001, ARCH PHARM RES, V24, P150, DOI 10.1007/BF02976483; Schlemper V, 1996, PHYTOMEDICINE, V3, P211, DOI 10.1016/S0944-7113(96)80038-9; Souri E, 2008, DARU, V16, P83; Sung Bokyung, 2016, J Cancer Prev, V21, P216, DOI 10.15430/JCP.2016.21.4.216; Talukder P, 2016, J SCI FOOD AGR, V96, P232, DOI 10.1002/jsfa.7086; Trigui M, 2013, IND CROP PROD, V41, P150, DOI 10.1016/j.indcrop.2012.04.011; Wu T, 2013, FOOD CHEM, V138, P1333, DOI 10.1016/j.foodchem.2012.10.086; Zaabat N, 2011, FOOD CHEM TOXICOL, V49, P3328, DOI 10.1016/j.fct.2011.08.026; Ziyyat A, 1997, J ETHNOPHARMACOL, V58, P45, DOI 10.1016/S0378-8741(97)00077-9	67	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0213049	10.1371/journal.pone.0213049	http://dx.doi.org/10.1371/journal.pone.0213049			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527869	Green Submitted, Green Published, gold			2022-12-26	WOS:000532231400001
J	Rahman, MM; Shimizu, K; Yamauchi, M; Takase, H; Ugawa, S; Okada, A; Inoshima, Y				Rahman, Md Matiur; Shimizu, Kaori; Yamauchi, Marika; Takase, Hiroshi; Ugawa, Shinya; Okada, Ayaka; Inoshima, Yasuo			Acidification effects on isolation of extracellular vesicles from bovine milk	PLOS ONE			English	Article							EXOSOMES; MICRORNAS; PROTEINS; CELLS; RNA	Bovine milk extracellular vesicles (EVs) attract research interest as carriers of biologically active cargo including miRNA from donor to recipient cells to facilitate intercellular communication. Since toxicity of edible milk seems to be negligible, milk EVs are applicable to use for therapeutics in human medicine. Casein separation is an important step in obtaining pure EVs from milk, and recent studies reported that adding hydrochloric acid (HCI) and acetic acid (AA) to milk accelerates casein aggregation and precipitation to facilitate EV isolation and purification; however, the effects of acidification on EVs remain unclear. In this study, we evaluated the acidification effects on milk-derived EVs with that by standard ultracentrifugation (UC). We separated casein from milk by either UC method or treatment with HCI or AA, followed by evaluation of EVs in milk serum (whey) by transmission electron microcopy (TEM), spectrophotometry, and tunable resistive pulse sensing analysis to determine EVs morphology, protein concentration, and EVs size and concentration, respectively. Moreover, we used anti-CD9, -CD63, -CD81, -MFG-E8, -HSP70, and -Alix antibodies for the detection of EVs surface and internal marker proteins by western blot (WB). Morphological features of EVs were spherical shape and similar structure was observed in isolated EVs by TEM. However, some of the EVs isolated by HCI and AA had shown rough surface. Although protein concentration was higher in whey obtained by UC, EV concentration was significantly higher in whey following acid treatment. Moreover, although all of the targeted EVs-marker-proteins were detected by WB, HCI- or AA-treatments partially degraded CD9 and CD81. These findings indicated that acid treatment successfully separated casein from milk to allow efficient EV isolation and purification but resulted in partial degradation of EV-surface proteins. Our results suggest that following acid treatment, appropriate EV-surface-marker antibodies should be used for accurate assess the obtained EVs for downstream applications. This study describes the acidification effects on EVs isolated from bovine milk for the first time.	[Rahman, Md Matiur; Inoshima, Yasuo] Gifu Univ, United Grad Sch Vet Sci, Gifu, Gifu, Japan; [Rahman, Md Matiur; Shimizu, Kaori; Yamauchi, Marika; Okada, Ayaka; Inoshima, Yasuo] Gifu Univ, Cooperat Dept Vet Med, Lab Food & Environm Hyg, Gifu, Gifu, Japan; [Rahman, Md Matiur] Sylhet Agr Univ, Dept Med, Sylhet, Bangladesh; [Takase, Hiroshi] Nagoya City Univ, Grad Sch Med Sci, Core Lab, Mizuho Ku, Mizuho Cho, Nagoya, Aichi, Japan; [Ugawa, Shinya] Nagoya City Univ, Grad Sch Med Sci, Dept Anat & Neurosci, Mizuho Ku, Mizuho Cho, Nagoya, Aichi, Japan; [Okada, Ayaka; Inoshima, Yasuo] Gifu Univ, GeFAH, Educ & Res Ctr Food Anim Hlth, Gifu, Gifu, Japan; [Inoshima, Yasuo] Gifu Univ, Joint Grad Sch Vet Sci, Gifu, Gifu, Japan	Gifu University; Gifu University; Sylhet Agricultural University; Nagoya City University; Nagoya City University; Gifu University; Gifu University	Inoshima, Y (corresponding author), Gifu Univ, United Grad Sch Vet Sci, Gifu, Gifu, Japan.; Inoshima, Y (corresponding author), Gifu Univ, Cooperat Dept Vet Med, Lab Food & Environm Hyg, Gifu, Gifu, Japan.; Inoshima, Y (corresponding author), Gifu Univ, GeFAH, Educ & Res Ctr Food Anim Hlth, Gifu, Gifu, Japan.; Inoshima, Y (corresponding author), Gifu Univ, Joint Grad Sch Vet Sci, Gifu, Gifu, Japan.	inoshima@gifu-u.ac.jp			Ministry of Agriculture, Forestry, and Fisheries of Japan; OGAWA Science and Technology Foundation; Morinaga Foundation for Health and Nutrition	Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); OGAWA Science and Technology Foundation; Morinaga Foundation for Health and Nutrition	This study was partially supported by a research project grant for Improving Animal Disease Prevention Technologies to Combat Antimicrobial Resistance (2017-2021 FY to YI) from the Ministry of Agriculture, Forestry, and Fisheries of Japan. This study was also supported in part by the OGAWA Science and Technology Foundation and the Morinaga Foundation for Health and Nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban JJ, 2015, BIOCHEM BIOPH RES CO, V461, P76, DOI 10.1016/j.bbrc.2015.03.172; Benmoussa A, 2016, J NUTR, V146, P2206, DOI 10.3945/jn.116.237651; Cai MC, 2018, CELL STRESS CHAPERON, V23, P663, DOI 10.1007/s12192-018-0876-3; Crookenden MA, 2016, J DAIRY SCI, V99, P7661, DOI 10.3168/jds.2015-10786; Dai S, 2008, MOL THER, V16, P782, DOI 10.1038/mt.2008.1; Escudier B, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-10; Gheinani AH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22142-x; Hata T, 2010, BIOCHEM BIOPH RES CO, V396, P528, DOI 10.1016/j.bbrc.2010.04.135; Izumi H, 2012, J DAIRY SCI, V95, P4831, DOI 10.3168/jds.2012-5489; Kalra H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020170; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Lonnerdal B, 2003, AM J CLIN NUTR, V77, p1537S; Mather IH, 1998, J MAMMARY GLAND BIOL, V3, P259, DOI 10.1023/A:1018711410270; McMahon DJ, 2008, J DAIRY SCI, V91, P1709, DOI 10.3168/jds.2007-0819; Melnik BC, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-103; Oehmcke S, 2012, CELL MICROBIOL, V14, P107, DOI 10.1111/j.1462-5822.2011.01705.x; Ohno S, 2013, MOL THER, V21, P185, DOI 10.1038/mt.2012.180; Pap E, 2009, INFLAMM RES, V58, P1, DOI 10.1007/s00011-008-8210-7; Reinhardt TA, 2012, J PROTEOMICS, V75, P1486, DOI 10.1016/j.jprot.2011.11.017; Samuel M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06288-8; SCHACTERLE GR, 1973, ANAL BIOCHEM, V51, P654, DOI 10.1016/0003-2697(73)90523-X; Shandilya S, 2017, J AGR FOOD CHEM, V65, P9506, DOI 10.1021/acs.jafc.7b03123; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Somiya M, 2018, J EXTRACELL VESICLES, V7, DOI 10.1080/20013078.2018.1440132; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Pol E, 2014, J THROMB HAEMOST, V12, P1182, DOI 10.1111/jth.12602; Vaswani K, 2017, REPROD BIOL, V17, P341, DOI 10.1016/j.repbio.2017.09.007; Wang HW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/864894; Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878; Webber J, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19861; Yamada T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077359; Yamada T, 2012, J VET MED SCI, V74, P1523, DOI 10.1292/jvms.12-0032; Yamauchi M, 2019, DRUG DEV IND PHARM, V45, P359, DOI 10.1080/03639045.2018.1539743	33	25	26	8	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222613	10.1371/journal.pone.0222613	http://dx.doi.org/10.1371/journal.pone.0222613			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525238	Green Published, gold, Green Submitted			2022-12-26	WOS:000532225700041
J	Ueno, H; Ito, R; Abe, S; Ogino, H; Maruyama, M; Miyashita, H; Miyamoto, Y; Moritoh, Y; Tsujihata, Y; Takeuchi, K; Nishigaki, N				Ueno, Hikaru; Ito, Ryo; Abe, Shin-ichi; Ogino, Hitomi; Maruyama, Minoru; Miyashita, Hirohisa; Miyamoto, Yasufumi; Moritoh, Yusuke; Tsujihata, Yoshiyuki; Takeuchi, Koji; Nishigaki, Nobuhiro			GPR40 full agonism exerts feeding suppression and weight loss through afferent vagal nerve	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; FOOD-INTAKE; INSULIN-SECRETION; BODY-WEIGHT; FATTY-ACIDS; BRAIN-STEM; BETA-CELLS; TAK-875; MECHANISMS; RESISTANCE	GPR40/FFAR1 is a Gq protein-coupled receptor expressed in pancreatic beta cells and enteroendocrine cells, and mediates insulin and incretin secretion to regulate feeding behavior. Several GPR40 full agonists have been reported to reduce food intake in rodents by regulating gut hormone secretion in addition to their potent glucose-lowering effects; however, detailed mechanisms of feeding suppression are still unknown. In the present study, we characterized T-3601386, a novel compound with potent full agonistic activity for GPR40, by using in vitro Ca2+ mobilization assay in Chinese hamster ovary (CHO) cells expressing FFAR1 and in vivo hormone secretion assay. We also evaluated feeding suppression and weight loss after the administration of T-3601386 and investigated the involvement of the vagal nerve in these effects. T-3601386, but not a partial agonist fasiglifam, increased intracellular Ca2+ levels in CHO cells with low FFAR1 expression, and single dosing of T-3601386 in diet -induced obese (DIO) rats elevated plasma incretin levels, suggesting full agonistic properties of T-3601386 against GPR40. Multiple doses of T-3601386, but not fasiglifam, in DIO rats showed dose-dependent weight loss accompanied by feeding suppression and durable glucagon-like peptide -1 elevation, all of which were completely abolished in Ffar1(-/-) mice. Immunohistochemical analysis in the nuclei of the solitary tract demonstrated that T-3601386 increased the number of c-Fos positive cells, which also disappeared in Ffar1(-/-) mice. Surgical vagotomy and drug-induced deafferentation counteracted the feeding suppression and weight loss induced by the administration of T-3601386. These results suggest that T-3601386 exerts incretin release and weight loss in a GPR40-dependent manner, and that afferent vagal nerves are important for the feeding suppression induced by GPR40 full agonism. Our novel findings raise the possibility that GPR40 full agonist can induce periphery-derived weight reduction, which may provide benefits such as less adverse effects in central nervous system compared to centrally-acting anti-obesity drugs.	[Ueno, Hikaru; Ito, Ryo; Abe, Shin-ichi; Ogino, Hitomi; Maruyama, Minoru; Miyashita, Hirohisa; Miyamoto, Yasufumi; Tsujihata, Yoshiyuki; Takeuchi, Koji; Nishigaki, Nobuhiro] Takeda Pharmaceut Co Ltd, Cardiovasc Metab Drug Discovery Unit, Fujisawa, Kanagawa, Japan; [Moritoh, Yusuke] SCOHIA PHARMA Inc, Res & Dev Div, Fujisawa, Kanagawa, Japan; [Ueno, Hikaru] Takeda Pharmaceut Co Ltd, T CiRA Discovery, Fujisawa, Kanagawa, Japan	Takeda Pharmaceutical Company Ltd; Takeda Pharmaceutical Company Ltd	Ueno, H (corresponding author), Takeda Pharmaceut Co Ltd, Cardiovasc Metab Drug Discovery Unit, Fujisawa, Kanagawa, Japan.; Ueno, H (corresponding author), Takeda Pharmaceut Co Ltd, T CiRA Discovery, Fujisawa, Kanagawa, Japan.	hikaru.ueno@takeda.com	Nishigaki, Nobuhiro/AAZ-3584-2021	Nishigaki, Nobuhiro/0000-0002-7524-1429; Abe, Shin-ichi/0000-0003-4104-749X; Ueno, Hikaru/0000-0002-5595-8342	Takeda Pharmaceutical Company Limited	Takeda Pharmaceutical Company Limited(Takeda Pharmaceutical Company Ltd)	This study was funded by Takeda Pharmaceutical Company Limited. During the time this study was conducted, Takeda also provided support in the form of salaries for authors [HU, RI, SA, HO, MM, YMi, YT, KT, NN]. SCOHIA PHARMA Inc. did provide a salary for an author [YMo], but did not fund this study. These companies did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abbott CR, 2005, BRAIN RES, V1044, P127, DOI 10.1016/j.brainres.2005.03.011; Araki T, 2012, DIABETES OBES METAB, V14, P271, DOI 10.1111/j.1463-1326.2011.01525.x; Barrachina MD, 1997, P NATL ACAD SCI USA, V94, P10455, DOI 10.1073/pnas.94.19.10455; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Burant CF, 2012, LANCET, V379, P1403, DOI 10.1016/S0140-6736(11)61879-5; Camilleri M, 2015, GASTROENTEROLOGY, V148, P1219, DOI 10.1053/j.gastro.2014.09.016; Chepurny OG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22106-1; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Edfalk S, 2008, DIABETES, V57, P2280, DOI 10.2337/db08-0307; Egerod KL, 2018, MOL METAB, V12, P62, DOI 10.1016/j.molmet.2018.03.016; Finan B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007218; Fujiwara K, 2005, AM J PHYSIOL-ENDOC M, V289, pE670, DOI 10.1152/ajpendo.00035.2005; Fujiwara K, 2012, J NEUROCHEM, V121, P66, DOI 10.1111/j.1471-4159.2011.07563.x; Gorski JN, 2017, AM J PHYSIOL-ENDOC M, V313, pE37, DOI 10.1152/ajpendo.00435.2016; Gram DX, 2005, EUR J PHARMACOL, V509, P211, DOI 10.1016/j.ejphar.2004.12.039; Grill HJ, 2009, INT J OBESITY, V33, pS11, DOI 10.1038/ijo.2009.10; Hafizur R. M., 2015, INTEGR OBES DIABETES, V1, P44, DOI [DOI 10.15761/I0D.1000111, DOI 10.15761/IOD.1000111]; Ho JD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-01240-w; IKEDA H, 1981, DIABETES, V30, P1045, DOI 10.2337/diabetes.30.12.1045; Ito R, 2013, BRIT J PHARMACOL, V170, P568, DOI 10.1111/bph.12297; Ito R, 2016, J PHARMACOL EXP THER, V357, P217, DOI 10.1124/jpet.115.230730; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Iwasaki Y, 2017, NEUROPEPTIDES, V65, P77, DOI 10.1016/j.npep.2017.05.003; Iwasaki Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067198; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karpe F, 2011, DIABETES, V60, P2441, DOI 10.2337/db11-0425; Lin DCH, 2012, MOL PHARMACOL, V82, P843, DOI 10.1124/mol.112.079640; Luo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046300; Matsuda-Nagasumi K, 2013, DIABETES OBES METAB, V15, P538, DOI 10.1111/dom.12065; Miwatashi S, 2018, [No title captured], Patent No. [WO2018181847A1, 2018181847]; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Neary NM, 2005, ENDOCRINOLOGY, V146, P5120, DOI 10.1210/en.2005-0237; Negoro N, 2010, ACS MED CHEM LETT, V1, P290, DOI 10.1021/ml1000855; Nio Y, 2017, ENDOCRINOLOGY, V158, P1298, DOI 10.1210/en.2016-1825; Pachanski MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186033; Paxinos G, 2004, RAT BRAIN; Portha B, 2003, ANIMAL MODELS DIABET, P231; Schwartz GJ, 2006, PHILOS T R SOC B, V361, P1275, DOI 10.1098/rstb.2006.1862; Secher A, 2014, J CLIN INVEST, V124, P4473, DOI 10.1172/JCI75276; Shapiro H, 2005, BIOCHEM BIOPH RES CO, V335, P97, DOI 10.1016/j.bbrc.2005.07.042; SMITH GP, 1981, SCIENCE, V213, P1036, DOI 10.1126/science.7268408; Talsania T, 2005, ENDOCRINOLOGY, V146, P3748, DOI 10.1210/en.2005-0473; Tsujihata Y, 2011, J PHARMACOL EXP THER, V339, P228, DOI 10.1124/jpet.111.183772; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Ueno H, 2019, J PHARMACOL EXP THER, V370, P172, DOI 10.1124/jpet.118.255885; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Yabuki C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076280; Yamada Y, 2008, HORM METAB RES, V40, P539, DOI 10.1055/s-2008-1076699; Yamane S, 2012, J DIABETES INVEST, V3, P80, DOI 10.1111/j.2040-1124.2011.00143.x	50	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222653	10.1371/journal.pone.0222653	http://dx.doi.org/10.1371/journal.pone.0222653			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525244	Green Published, gold, Green Submitted			2022-12-26	WOS:000532225700044
J	Kim, BJ; Kim, GN; Kim, BR; Shim, TS; Kook, YH; Kim, BJ				Kim, Byoung-Jun; Kim, Ga-Na; Kim, Bo-Ram; Shim, Tae-Sun; Kook, Yoon-Hoh; Kim, Bum-Joon			New Mycobacteroides abscessus subsp. massiliense strains with recombinant hsp65 gene laterally transferred from Mycobacteroides abscessus subsp. abscessus: Potential for misidentification of M. abscessus strains with the hsp65-based method	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; SEQUENCE TYPING SCHEME; IDENTIFICATION; CLARITHROMYCIN; BOLLETII; DIFFERENTIATION; RESISTANCE; IMPACT; DNA	It has been reported that lateral gene transfer (LGT) events among Mycobacteroides abscessus strains are prevalent. The hsp65 gene, a chronometer gene for bacterial phylogenetic analysis, is resistant to LGT events, particularly among mycobacterial strains, rendering the hsp65-targeting method the most widely used method for mycobacterial detection. To determine the prevalence of M. abscessus strains that are subject to hsp65 LGT, we applied rpoB typing to 100 clinically isolated Korean strains of M. abscessus that had been identified by hsp65 sequence analysis. The analysis indicated the presence of 2 rough strains, showing a discrepancy between the 2 typing methods. MLST analysis based on the partial sequencing of seven housekeeping genes, erm(41) PCR and further hsp65 PCR-restriction enzyme and polymorphism analysis (PRA) were conducted to identify the two strains. The MLST results showed that the two strains belong to M. abscessus subsp. massiliense and not to M. abscessus subsp. abscessus, as indicated by the rpoB-based analysis, suggesting that their hsp65 genes are subject to LGT from M. abscessus subsp. abscessus. Further analysis of these strains using the hsp65 PRA method indicated that these strains possess a PRA pattern identical to that of M. abscessus subsp. abscessus and distinct from that of M. abscessus subsp. massiliense. In conclusion, we identified two M. abscessus subsp. massiliense rough strains from Korean patients with hsp65 genes that might be laterally transferred from M. abscessus subsp. abscessus. To the best of our knowledge, this is the first demonstration of possible LGT events associated with the hsp65 gene in mycobacteria. Our results also suggest that there is the potential for misidentification when the hsp65-based protocol is used for mycobacterial identification.	[Kim, Byoung-Jun; Kim, Ga-Na; Kim, Bo-Ram; Kook, Yoon-Hoh; Kim, Bum-Joon] Seoul Natl Univ, Coll Med, Liver Res Inst, Dept Microbiol & Immunol,Biomed Sci, Seoul, South Korea; [Kim, Byoung-Jun; Kim, Ga-Na; Kim, Bo-Ram; Kook, Yoon-Hoh; Kim, Bum-Joon] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Shim, Tae-Sun] Univ Ulsan, Asan Med Ctr, Dept Internal Med, Div Pulm & Crit Care Med,Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); University of Ulsan; Asan Medical Center	Kim, BJ (corresponding author), Seoul Natl Univ, Coll Med, Liver Res Inst, Dept Microbiol & Immunol,Biomed Sci, Seoul, South Korea.; Kim, BJ (corresponding author), Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea.	kbumjoon@snu.ac.kr	Kim, Bum Joon/AGY-4274-2022	Kim, Bum Joon/0000-0003-0085-6709	Seoul National University Hospital (SNUH) [04-2019-0270]	Seoul National University Hospital (SNUH)	This work was supported by Grant no. 04-2019-0270 from the Seoul National University Hospital (SNUH) Research Fund (B-JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekambi T, 2003, J CLIN MICROBIOL, V41, P5699, DOI 10.1128/JCM.41.12.5699-5708.2003; Blauwendraat C, 2012, EUR J CLIN MICROBIOL, V31, P1847, DOI 10.1007/s10096-011-1510-9; Choi WS, 2011, CLIN MICROBIOL INFEC, V17, P1084, DOI 10.1111/j.1469-0691.2010.03395.x; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Daley CL, 2002, CLIN CHEST MED, V23, P623, DOI 10.1016/S0272-5231(02)00021-7; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Gupta RS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00067; Harmsen D, 2004, ASM NEWS, V70, P19; Harris KA, 2012, J CLIN MICROBIOL, V50, P1758, DOI 10.1128/JCM.00155-12; Kim BJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057460, 10.1371/journal.pone.0068422]; Kim BJ, 1999, J CLIN MICROBIOL, V37, P1714, DOI 10.1128/JCM.37.6.1714-1720.1999; Kim BJ, 2013, GENOME ANNOUNC, V1; Kim BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179237; Kim BJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152703; Kim BJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-890; Kim BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038420; Kim H, 2005, INT J SYST EVOL MICR, V55, P1649, DOI 10.1099/ijs.0.63553-0; Kim HY, 2008, J CLIN MICROBIOL, V46, P3384, DOI 10.1128/JCM.00319-08; Kim HY, 2010, MICROBIOL IMMUNOL, V54, P347, DOI 10.1111/j.1348-0421.2010.00221.x; Koh WJ, 2011, AM J RESP CRIT CARE, V183, P405, DOI 10.1164/rccm.201003-0395OC; Kolbert CP, 1999, CURR OPIN MICROBIOL, V2, P299, DOI 10.1016/S1369-5274(99)80052-6; Krzywinska E, 2004, MICROBIOL-SGM, V150, P1707, DOI 10.1099/mic.0.27088-0; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Leao SC, 2011, INT J SYST EVOL MICR, V61, P2311, DOI 10.1099/ijs.0.023770-0; Machado GE, 2014, J CLIN MICROBIOL, V52, P2881, DOI 10.1128/JCM.00688-14; Macheras E, 2014, RES MICROBIOL, V165, P82, DOI 10.1016/j.resmic.2013.12.003; Macheras E, 2011, J CLIN MICROBIOL, V49, P491, DOI 10.1128/JCM.01274-10; Maurer FP, 2012, J ANTIMICROB CHEMOTH, V67, P2606, DOI 10.1093/jac/dks279; Medjahed H, 2010, TRENDS MICROBIOL, V18, P117, DOI 10.1016/j.tim.2009.12.007; Nash KA, 2009, ANTIMICROB AGENTS CH, V53, P1367, DOI 10.1128/AAC.01275-08; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Raz Y, 2010, GENETICS, V185, P327, DOI 10.1534/genetics.109.113613; Reva O, 2015, BMC EVOL BIOL, V15, DOI 10.1186/1471-2148-15-S1-S2; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sapriel G, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2448-1; TELENTI A, 1993, J CLIN MICROBIOL, V31, P175, DOI 10.1128/JCM.31.2.175-178.1993; Tortoli E, 2003, CLIN MICROBIOL REV, V16, P319, DOI 10.1128/CMR.16.2.319-354.2003; Tortoli E, 2016, INT J SYST EVOL MICR, V66, P4471, DOI 10.1099/ijsem.0.001376; Tortoli E, 2012, INFECT GENET EVOL, V12, P827, DOI 10.1016/j.meegid.2011.05.025; Turenne CY, 2001, J CLIN MICROBIOL, V39, P3637, DOI 10.1128/JCM.39.10.3638-3648.2001	42	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2019	14	9							e0220312	10.1371/journal.pone.0220312	http://dx.doi.org/10.1371/journal.pone.0220312			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4KS	31518354	Green Submitted, gold, Green Published			2022-12-26	WOS:000532219300007
J	Pataer, A; Ozpolat, B; Shao, RP; Cashman, NR; Plotkin, SS; Samuel, CE; Lin, SH; Kabil, NN; Wang, J; Majidi, M; Fang, BL; Roth, JA; Vaporciyan, AA; Wistuba, II; Hung, MC; Swisher, SG				Pataer, Apar; Ozpolat, Bulent; Shao, RuPing; Cashman, Neil R.; Plotkin, Steven S.; Samuel, Charles E.; Lin, Steven H.; Kabil, Nashwa N.; Wang, Jing; Majidi, Mourad; Fang, Bingliang; Roth, Jack A.; Vaporciyan, Ara A.; Wistuba, Ignacio I.; Hung, Mien-Chie; Swisher, Stephen G.			Therapeutic targeting of the PI4K2A/PKR lysosome network is critical for misfolded protein clearance and survival in cancer cells	ONCOGENE			English	Article							KINASE PKR; PI4KII-ALPHA; MECHANISM; PHOSPHORYLATION; DEGRADATION; INITIATION; VIRUSES; IMPACT; GROWTH; DEATH	The role of RNA-dependent protein kinase R (PKR) and its association with misfolded protein expression in cancer cells are unclear. Herein we report that PKR regulates misfolded protein clearance by preventing it release through exosomes and promoting lysosomal degradation of misfolded prion proteins in cancer cells. We demonstrated that PKR contributes to the lysosome function and regulates misfolded prion protein clearance. We hypothesized that PKR-associated lysosome function is critical for cancer but not normal cell survival, representing an effective approach for highly targeted cancer therapy. In screening a compound library, we identified two PKR-associated compounds 1 and 2 (Pac 1 and 2) did not affect normal cells but selectively induced cell death in cancer cells depending on their PKR expression status. Pac 1 significantly inhibited the growth of human lung and breast xenograft tumors in mice with no toxicity. Pac 1 binds to PI4K2A and disrupts the PKR/PI4K2A-associated lysosome complex, contributing to destabilization of cancer cell lysosomes and triggering cell death. We observed that PKR and PI4K2A play significant prognostic roles in breast cancer patients. These results demonstrate that targeting of a PI4K2A/PKR lysosome complex may be an effective approach for cancer therapy.	[Pataer, Apar; Shao, RuPing; Majidi, Mourad; Fang, Bingliang; Roth, Jack A.; Vaporciyan, Ara A.; Swisher, Stephen G.] Univ Texas MD Anderson Canc Ctr, Dept Thorac, Houston, TX 77030 USA; [Pataer, Apar; Shao, RuPing; Majidi, Mourad; Fang, Bingliang; Roth, Jack A.; Vaporciyan, Ara A.; Swisher, Stephen G.] Univ Texas MD Anderson Canc Ctr, Dept Cardiovasc Surg, Houston, TX 77030 USA; [Ozpolat, Bulent; Kabil, Nashwa N.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Cashman, Neil R.] Univ British Columbia, Dept Med Neurol, Vancouver, BC, Canada; [Cashman, Neil R.] Brain Res Ctr, Vancouver Coastal Hlth Res Inst, Vancouver, BC, Canada; [Cashman, Neil R.] Amorfix Life Sci Ltd, Mississauga, ON, Canada; [Plotkin, Steven S.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC, Canada; [Samuel, Charles E.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Lin, Steven H.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Wang, Jing] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat, Houston, TX 77030 USA; [Wistuba, Ignacio I.] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Mol & Cellular Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of British Columbia; Vancouver Coastal Health Research Institute; University of British Columbia; University of California System; University of California Santa Barbara; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Pataer, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Thorac, Houston, TX 77030 USA.; Pataer, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Cardiovasc Surg, Houston, TX 77030 USA.	apataer@mdanderson.org	Hung, Mien-Chie/ABD-5911-2021; Plotkin, Steven/AAO-3257-2020	Hung, Mien-Chie/0000-0003-4317-4740; Plotkin, Steven/0000-0001-8998-877X; Pataer, Apar/0000-0002-1960-3579; Ozpolat, Bulent/0000-0001-8602-7463	NIH/NCI [P30CA016672]; Homer Flower Gene Therapy Fund; Charles Rogers Gene Therapy Fund; Margaret W. Elkins Endowed Research Fund; Flora and Stuart Mason Lung Cancer Research Fund; Phalan Thoracic Gene Therapy Fund; George P. Sweeney Esophageal Research Fund	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Homer Flower Gene Therapy Fund; Charles Rogers Gene Therapy Fund; Margaret W. Elkins Endowed Research Fund; Flora and Stuart Mason Lung Cancer Research Fund; Phalan Thoracic Gene Therapy Fund; George P. Sweeney Esophageal Research Fund	This work was supported in part by the NIH/NCI under award number P30CA016672 and used and by the Homer Flower Gene Therapy Fund, the Charles Rogers Gene Therapy Fund, the Margaret W. Elkins Endowed Research Fund, the Flora and Stuart Mason Lung Cancer Research Fund, the Phalan Thoracic Gene Therapy Fund, and the George P. Sweeney Esophageal Research Fund (S.G. Swisher).	ALI A, 2011, PLOS ONE, V0006; Aronson LI, 2012, HAEMATOL-HEMATOL J, V97, P1119, DOI 10.3324/haematol.2012.064923; Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Balachandran Siddharth, 2007, V383, P277, DOI 10.1007/978-1-59745-335-6_18; Barber GN, 2001, CELL DEATH DIFFER, V8, P113, DOI 10.1038/sj.cdd.4400823; Baumlova A, 2014, EMBO REP, V15, P1085, DOI 10.15252/embr.201438841; Boya P, 2012, ANTIOXID REDOX SIGN, V17, P766, DOI 10.1089/ars.2011.4405; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Cortes Constanza J, 2013, Int J Cell Biol, V2013, P560421, DOI 10.1155/2013/560421; Craige B, 2008, MOL BIOL CELL, V19, P1415, DOI 10.1091/mbc.E07-12-1239; Davidson SM, 2017, ANNU REV PHARMACOL, V57, P481, DOI 10.1146/annurev-pharmtox-010715-103101; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fasen K, 2008, TRAFFIC, V9, P251, DOI 10.1111/j.1600-0854.2007.00679.x; Fehrenbacher N, 2005, CANCER RES, V65, P2993, DOI 10.1158/0008-5472.CAN-05-0476; Fehrenbacher N, 2008, CANCER RES, V68, P6623, DOI 10.1158/0008-5472.CAN-08-0463; Galluzzi L, 2014, NAT CELL BIOL, V16, P728, DOI 10.1038/ncb3005; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gregersen N, 2006, ANNU REV GENOM HUM G, V7, P103, DOI 10.1146/annurev.genom.7.080505.115737; Guo CC, 2015, ONCOTARGET, V6, P11114, DOI 10.18632/oncotarget.3573; Hamouda MA, 2014, ONCOTARGET, V5, P6252, DOI 10.18632/oncotarget.2193; Hugon J, 2009, EXPERT REV NEUROTHER, V9, P1455, DOI [10.1586/ern.09.92, 10.1586/ERN.09.92]; Jagus R, 1999, INT J BIOCHEM CELL B, V31, P123, DOI 10.1016/S1357-2725(98)00136-8; Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710; Kirkegaard T, 2009, BBA-MOL CELL RES, V1793, P746, DOI 10.1016/j.bbamcr.2008.09.008; Li J, 2010, ONCOGENE, V29, P2550, DOI 10.1038/onc.2010.14; Li JM, 2017, CANCER RES, V77, P6253, DOI 10.1158/0008-5472.CAN-17-0484; Marchal JA, 2014, FASEB J, V28, P1965, DOI 10.1096/fj.13-248294; Minogue Shane, 2012, Subcell Biochem, V58, P1, DOI 10.1007/978-94-007-3012-0_1; Morel M, 2009, J CELL MOL MED, V13, P1476, DOI 10.1111/j.1582-4934.2009.00849.x; Moreno-Gonzalez I, 2011, SEMIN CELL DEV BIOL, V22, P482, DOI 10.1016/j.semcdb.2011.04.002; Mouton-Liger F, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.552; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Pataer A, 2008, MOL CANCER THER, V7, P2528, DOI 10.1158/1535-7163.MCT-08-0083; Piao SF, 2016, ANN NY ACAD SCI, V1371, P45, DOI 10.1111/nyas.12953; Robinson JW, 2014, BIOCHEM J, V464, P145, DOI 10.1042/BJ20140497; Rochet Jean-Christophe, 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S1462399407000385; Samuel CE, 2012, CURR TOP MICROBIOL, V353, P163, DOI 10.1007/82_2011_148; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Silva JL, 2013, BIOSCI REP, V33; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Soto C, 2018, NAT NEUROSCI, V21, P1332, DOI 10.1038/s41593-018-0235-9; Sukhai MA, 2013, J CLIN INVEST, V123, P315, DOI 10.1172/JCI64180; Vilchez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6659; Waugh MG, 2012, CANCER LETT, V325, P125, DOI 10.1016/j.canlet.2012.06.009; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Zhang P, 2008, J VIROL, V82, P840, DOI 10.1128/JVI.01891-07; Zhang P, 2007, J VIROL, V81, P8192, DOI 10.1128/JVI.00426-07	49	9	9	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	4					801	813		10.1038/s41388-019-1010-4	http://dx.doi.org/10.1038/s41388-019-1010-4			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KF4EJ	31554935	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000509197200005
J	Stender, EGP; Andersen, CD; Fredslund, F; Holck, J; Solberg, A; Teze, D; Peters, GHJ; Christensen, BE; Aachmann, FL; Welner, DH; Svensson, B				Stender, Emil G. P.; Andersen, Christian Dybdahl; Fredslund, Folmer; Holck, Jesper; Solberg, Amalie; Teze, David; Peters, Gunther H. J.; Christensen, Bjorn E.; Aachmann, Finn L.; Welner, Ditte H.; Svensson, Birte			Structural and functional aspects of mannuronic acid?specific PL6 alginate lyase from the human gut microbe Bacteroides cellulosilyticus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						alginate lyase; crystal structure; molecular docking; enzyme kinetics; enzyme mechanism; enzyme mutation; asparagine ladder; Bacteroides cellulolyticus; imidazole rescue; parallel ?-helix	PARALLEL BETA-HELIX; STRUCTURE REFINEMENT; CATALYTIC MECHANISM; OLIGOALGINATE LYASE; CRYSTAL-STRUCTURE; CHONDROITINASE-B; CLONING; PREDICTION; RESIDUES; CLASSIFICATION	Alginate is a linear polysaccharide from brown algae consisting of 1,4-linked ?-d-mannuronic acid (M) and ?-l-guluronic acid (G) arranged in M, G, and mixed MG blocks. Alginate was assumed to be indigestible in humans, but bacteria isolated from fecal samples can utilize alginate. Moreover, genomes of some human gut microbiome?associated bacteria encode putative alginate-degrading enzymes. Here, we genome-mined a polysaccharide lyase family 6 alginate lyase from the gut bacterium Bacteroides cellulosilyticus (BcelPL6). The structure of recombinant BcelPL6 was solved by X-ray crystallography to 1.3 ? resolution, revealing a single-domain, monomeric parallel ?-helix containing a 10-step asparagine ladder characteristic of alginate-converting parallel ?-helix enzymes. Substitutions of the conserved catalytic site residues Lys-249, Arg-270, and His-271 resulted in activity loss. However, imidazole restored the activity of BcelPL6-H271N to 2.5% that of the native enzyme. Molecular docking oriented tetra-mannuronic acid for syn attack correlated with M specificity. Using biochemical analyses, we found that BcelPL6 initially releases unsaturated oligosaccharides of a degree of polymerization of 2?7 from alginate and polyM, which were further degraded to di- and trisaccharides. Unlike other PL6 members, BcelPL6 had low activity on polyMG and none on polyG. Surprisingly, polyG increased BcelPL6 activity on alginate 7-fold. LC?electrospray ionization?MS quantification of products and lack of activity on NaBH4-reduced octa-mannuronic acid indicated that BcelPL6 is an endolyase that further degrades the oligosaccharide products with an intact reducing end. We anticipate that our results advance predictions of the specificity and mode of action of PL6 enzymes.	[Stender, Emil G. P.; Andersen, Christian Dybdahl; Holck, Jesper; Teze, David; Svensson, Birte] Tech Univ Denmark, Dept Biotechnol & Biomed, Soltofts Pl,Bldg 224, DK-2800 Lyngby, Denmark; [Fredslund, Folmer; Welner, Ditte H.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2800 Lyngby, Denmark; [Solberg, Amalie; Christensen, Bjorn E.; Aachmann, Finn L.] Norwegian Univ Sci & Technol, NTNU, Dept Biotechnol & Food Sci, N-7491 Trondheim, Norway; [Peters, Gunther H. J.] Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark; Norwegian University of Science & Technology (NTNU); Technical University of Denmark	Svensson, B (corresponding author), Tech Univ Denmark, Dept Biotechnol & Biomed, Soltofts Pl,Bldg 224, DK-2800 Lyngby, Denmark.	bis@bio.dtu.dk	Stender, Emil/ABA-1588-2020; Fredslund, Folmer/ABH-5821-2020; teze, david/F-3217-2016; Holck, Jesper/Q-4399-2016; Aachmann, Finn Lillelund/G-4136-2015; Peters, Gunther H.J./T-7100-2017; Christensen, Bjorn E./G-6033-2015	Fredslund, Folmer/0000-0003-0881-1927; teze, david/0000-0002-6865-6108; Holck, Jesper/0000-0002-8072-1101; Andersen, Christian Dybdahl/0000-0002-5452-6951; Christensen, Bjorn E./0000-0001-9640-0225; Aachmann, Finn Lillelund/0000-0003-1613-4663; Stender, Emil G P/0000-0003-2011-7452; Peters, Gunther H.J./0000-0001-9754-2663; Christensen, Bjorn E./0000-0002-1135-9815; Welner, Ditte Hededam/0000-0001-9297-4133; Svensson, Birte/0000-0002-2993-8196	Innovation Fund Denmark [1308-00011B]; Technical University of Denmark; Carlsberg Foundation; Novo Nordisk Foundation [NNF10CC10165]; Research Council of Norway [294946]	Innovation Fund Denmark; Technical University of Denmark; Carlsberg Foundation(Carlsberg Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Research Council of Norway(Research Council of Norway)	Karina Jansen, Marzanna Due, and Julia Tanas Tanasi are gratefully acknowledged for technical assistance. The StrucSat project is supported by Innovation Fund Denmark Grant 1308-00011B and 1/3 Ph.D. stipend (to E. G. P. S.) from Technical University of Denmark. The NanoDSC is granted by the Carlsberg Foundation. Folmer Fredslund and Ditte H. Welner were supported by Novo Nordisk Foundation Grant NNF10CC10165. The Norwegian Seaweed Biorefinery Platform (SBP-N) is funded by the Research Council of Norway through Grant 294946.	Aarstad OA, 2012, BIOMACROMOLECULES, V13, P106, DOI 10.1021/bm2013026; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; AKIYAMA H, 1992, BIOSCI BIOTECH BIOCH, V56, P355, DOI 10.1271/bbb.56.355; Alahuhta M, 2011, ACTA CRYSTALLOGR F, V67, P1498, DOI 10.1107/S1744309111038449; An C, 2013, APPL ENVIRON MICROB, V79, P860, DOI 10.1128/AEM.02354-12; Bai SF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171576; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Bryan AW, 2011, P NATL ACAD SCI USA, V108, P11099, DOI 10.1073/pnas.1017504108; Bunkoczi G, 2011, ACTA CRYSTALLOGR D, V67, P303, DOI 10.1107/S0907444910051218; Cheng HR, 2006, BIOTECHNOL LETT, V28, P55, DOI 10.1007/s10529-005-4688-z; Donati I, 2005, BIOMACROMOLECULES, V6, P1031, DOI 10.1021/bm049306e; Dong S, 2014, J BIOL CHEM, V289, P29558, DOI 10.1074/jbc.M114.584573; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Farrell EK, 2012, BIOCHEMISTRY-US, V51, P10259, DOI 10.1021/bi301425r; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; GACESA P, 1987, FEBS LETT, V212, P199, DOI 10.1016/0014-5793(87)81344-3; Garron ML, 2014, CURR OPIN STRUC BIOL, V28, P87, DOI 10.1016/j.sbi.2014.07.012; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Gimmestad M, 2003, J BACTERIOL, V185, P3515, DOI 10.1128/JB.185.12.3515-3523.2003; Greenwood JR, 2010, J COMPUT AID MOL DES, V24, P591, DOI 10.1007/s10822-010-9349-1; Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864; HAUG A, 1967, ACTA CHEM SCAND, V21, P691, DOI 10.3891/acta.chem.scand.21-0691; Helbert W, 2019, P NATL ACAD SCI USA, V116, P6063, DOI 10.1073/pnas.1815791116; Huang WJ, 1999, J MOL BIOL, V294, P1257, DOI 10.1006/jmbi.1999.3292; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Inoue A, 2016, J BIOL CHEM, V291, P15551, DOI 10.1074/jbc.M115.713230; Iwamoto Y, 2001, BIOSCI BIOTECH BIOCH, V65, P133, DOI 10.1271/bbb.65.133; Jenkins J, 2001, PROG BIOPHYS MOL BIO, V77, P111, DOI 10.1016/S0079-6107(01)00013-X; Jenkins J, 1998, J STRUCT BIOL, V122, P236, DOI 10.1006/jsbi.1998.3985; Johnson KA, 2011, BIOCHEMISTRY-US, V50, P8264, DOI 10.1021/bi201284u; Kabisch A, 2014, ISME J, V8, P1492, DOI 10.1038/ismej.2014.4; Kawamoto H, 2006, MAR BIOTECHNOL, V8, P481, DOI 10.1007/s10126-005-6157-z; Koch H, 2019, ISME J, V13, P92, DOI 10.1038/s41396-018-0252-4; Krieger E, 2015, J COMPUT CHEM, V36, P996, DOI 10.1002/jcc.23899; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kristiansen KA, 2009, CARBOHYD POLYM, V77, P725, DOI 10.1016/j.carbpol.2009.02.018; Lee SI, 2012, APPL MICROBIOL BIOT, V95, P1643, DOI 10.1007/s00253-012-4266-y; Li MM, 2017, MAR DRUGS, V15, DOI 10.3390/md15040092; Li MM, 2016, ANAEROBE, V39, P19, DOI 10.1016/j.anaerobe.2016.02.003; Li SY, 2016, J BIOCHEM, V159, P77, DOI 10.1093/jb/mvv076; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Luis AS, 2018, NAT MICROBIOL, V3, P210, DOI 10.1038/s41564-017-0079-1; Lyu QQ, 2019, BBA-GEN SUBJECTS, V1863, P1167, DOI 10.1016/j.bbagen.2019.04.013; MAKI H, 1993, J GEN MICROBIOL, V139, P987, DOI 10.1099/00221287-139-5-987; Mathieu S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26104-1; Mathieu S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159415; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Messina L, 2016, FEBS LETT, V590, P2180, DOI 10.1002/1873-3468.12258; Michel G, 2004, J BIOL CHEM, V279, P32882, DOI 10.1074/jbc.M403421200; Mikami B, 2012, ACTA CRYSTALLOGR D, V68, P1207, DOI 10.1107/S090744491202495X; Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6; Ochiai A, 2010, J BIOL CHEM, V285, P24519, DOI 10.1074/jbc.M110.125450; Odunsi ST, 2010, OBESITY, V18, P1579, DOI 10.1038/oby.2009.421; Okolie CL, 2017, J FOOD BIOCHEM, V41, DOI 10.1111/jfbc.12392; Park D, 2014, J BIOL CHEM, V289, P8645, DOI 10.1074/jbc.M113.531111; Park HH, 2012, MAR BIOTECHNOL, V14, P189, DOI 10.1007/s10126-011-9402-7; Pojasek K, 2002, J BIOL CHEM, V277, P31179, DOI 10.1074/jbc.M201552200; Rahman MM, 2012, CARBOHYD RES, V360, P69, DOI 10.1016/j.carres.2012.05.019; Rozeboom HJ, 2008, J BIOL CHEM, V283, P23819, DOI 10.1074/jbc.M804119200; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Sievers Fabian, 2014, Curr Protoc Bioinformatics, V48, DOI 10.1002/0471250953.bi0313s48; Terrapon N, 2018, NUCLEIC ACIDS RES, V46, pD677, DOI 10.1093/nar/gkx1022; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Thomas F, 2013, J BIOL CHEM, V288, P23021, DOI 10.1074/jbc.M113.467217; Urtuvia V, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2363-x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Winter G, 2018, ACTA CRYSTALLOGR D, V74, P85, DOI 10.1107/S2059798317017235; Wolfram F, 2014, J BIOL CHEM, V289, P6006, DOI 10.1074/jbc.M113.533158; Xu F, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02040-17; Xu F, 2017, J BIOL CHEM, V292, P4457, DOI 10.1074/jbc.M116.766030; Xu X, 2016, CURR TOP MED CHEM, V16, P874, DOI 10.2174/1568026615666150827101239; Yao MF, 2017, FOOD HYDROCOLLOID, V72, P228, DOI 10.1016/j.foodhyd.2017.05.033; Yin FX, 2016, J BIOL CHEM, V291, P4399, DOI 10.1074/jbc.C115.708396; YODER MD, 1993, STRUCTURE, V1, P241, DOI 10.1016/0969-2126(93)90013-7	79	27	27	9	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2019	294	47					17915	17930		10.1074/jbc.RA119.010206	http://dx.doi.org/10.1074/jbc.RA119.010206			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY1UF	31530640	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000504206800018
J	Hoffman, HK; Fernandez, MV; Groves, NS; Freed, EO; van Engelenburg, SB				Hoffman, Huxley K.; Fernandez, Melissa V.; Groves, Nicholas S.; Freed, Eric O.; van Engelenburg, Schuyler B.			Genomic tagging of endogenous human ESCRT-I complex preserves ESCRT-mediated membrane-remodeling functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endosomal sorting complexes required for transport (ESCRT); human immunodeficiency virus (HIV); virus assembly; molecular cell biology; host-pathogen interaction; CRISPR; Cas; endogenous tag; membrane scission; method development; tumor susceptibility 101 (Tsg101)	HUMAN-IMMUNODEFICIENCY-VIRUS; SORTING COMPLEX; PLASMA-MEMBRANE; LATE DOMAIN; ENDOSOMAL TRANSPORT; MATRIX PROTEIN; HIV-1 VIRIONS; TYPE-1; TSG101; UBIQUITIN	The endosomal sorting complexes required for transport (ESCRT) machinery drives membrane scission for diverse cellular functions that require budding away from the cytosol, including cell division and transmembrane receptor trafficking and degradation. The ESCRT machinery is also hijacked by retroviruses, such as HIV-1, to release virions from infected cells. The crucial roles of the ESCRTs in cellular physiology and viral disease make it imperative to understand the membrane scission mechanism. Current methodological limitations, namely artifacts caused by overexpression of ESCRT subunits, obstruct our understanding of the spatiotemporal organization of the endogenous human ESCRT machinery. Here, we used CRISPR/Cas9-mediated knock-in to tag the critical ESCRT-I component tumor susceptibility 101 (Tsg101) with GFP at its native locus in two widely used human cell types, HeLa epithelial cells and Jurkat T cells. We validated this approach by assessing the function of these knock-in cell lines in cytokinesis, receptor degradation, and virus budding. Using this probe, we measured the incorporation of endogenous Tsg101 in released HIV-1 particles, supporting the notion that the ESCRT machinery initiates virus abscission by scaffolding early-acting ESCRT-I within the head of the budding virus. We anticipate that these validated cell lines will be a valuable tool for interrogating dynamics of the native human ESCRT machinery.	[Hoffman, Huxley K.; Groves, Nicholas S.; van Engelenburg, Schuyler B.] Univ Denver, Dept Biol Sci, Mol & Cellular Biophys Program, Denver, CO 80210 USA; [Fernandez, Melissa V.; Freed, Eric O.] NCI Frederick, Virus Cell Interact Sect, HIV Dynam & Replicat Program, Ctr Canc Res,NIH, Frederick, MD 21702 USA	University of Denver; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	van Engelenburg, SB (corresponding author), Univ Denver, Dept Biol Sci, Mol & Cellular Biophys Program, Denver, CO 80210 USA.	schuyler.vanengelenburg@du.edu		van Engelenburg, Schuyler/0000-0003-2100-3617; Fernandez, Melissa/0000-0001-7506-7961; Hoffman, Huxley/0000-0002-4509-0594	Boettcher Foundation Webb-Waring Biomedical Research Award; NIAID, National Institutes of Health [R01AI138625]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI138625] Funding Source: NIH RePORTER	Boettcher Foundation Webb-Waring Biomedical Research Award; NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Boettcher Foundation Webb-Waring Biomedical Research Award. This work was also supported by NIAID, National Institutes of Health, Grant R01AI138625. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Bishop N, 2002, J CELL BIOL, V157, P91, DOI 10.1083/jcb.200112080; Bishop N, 2001, J BIOL CHEM, V276, P11735, DOI 10.1074/jbc.M009863200; Bleck M, 2014, P NATL ACAD SCI USA, V111, P12211, DOI 10.1073/pnas.1321655111; Bouamr F, 2003, J VIROL, V77, P11882, DOI 10.1128/JVI.77.22.11882-11895.2003; Briggs JAG, 2003, EMBO J, V22, P1707, DOI 10.1093/emboj/cdg143; Broniarczyk J, 2010, INT J MOL MED, V25, P777, DOI 10.3892/ijmm_00000404; Buttler CA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04220-w; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Choudhuri K, 2014, NATURE, V507, P118, DOI 10.1038/nature12951; Christ L, 2017, TRENDS BIOCHEM SCI, V42, P42, DOI 10.1016/j.tibs.2016.08.016; Colombo M, 2013, J CELL SCI, V126, P5553, DOI 10.1242/jcs.128868; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Demirov DG, 2002, P NATL ACAD SCI USA, V99, P955, DOI 10.1073/pnas.032511899; Dussupt V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000339; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; FREED EO, 1994, J VIROL, V68, P5311, DOI 10.1128/JVI.68.8.5311-5320.1994; FREED EO, 1994, J VIROL, V68, P2503, DOI 10.1128/JVI.68.4.2503-2512.1994; Fujii K, 2009, VIROLOGY, V391, P284, DOI 10.1016/j.virol.2009.06.016; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goila-Gaur R, 2003, J VIROL, V77, P6507, DOI 10.1128/JVI.77.11.6507-6519.2003; Goliand I, 2018, CELL REP, V24, P1756, DOI 10.1016/j.celrep.2018.07.051; Helma J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050026; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; Hurley JH, 2018, BIOCHEM SOC T, V46, P1029, DOI 10.1042/BST20180019; Jimenez AJ, 2014, SCIENCE, V343, P986, DOI 10.1126/science.1247136; Katoh K, 2003, J BIOL CHEM, V278, P39104, DOI 10.1074/jbc.M301604200; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kumai T, 2013, BRIT J CANCER, V109, P2155, DOI 10.1038/bjc.2013.577; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Langelier C, 2006, J VIROL, V80, P9465, DOI 10.1128/JVI.01049-06; Lee J.-A., 2012, NEUROBIOLOGY, V21, P9, DOI DOI 10.5607/EN.2012.21.1.9; Lin YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079674; Lippincott-Schwartz J, 2017, ANNU REV VIROL, V4, P309, DOI 10.1146/annurev-virology-101416-041840; Loncle N, 2015, SCI REP-UK, V5, DOI 10.1038/srep08461; Madara JJ, 2015, FUTURE VIROL, V10, P537, DOI 10.2217/FVL.15.6; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Mattissek C, 2014, MOL MEMBR BIOL, V31, P111, DOI 10.3109/09687688.2014.894210; Medina GN, 2011, J VIROL, V85, P7353, DOI 10.1128/JVI.00141-11; Meng B, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0197-x; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Morita E, 2010, P NATL ACAD SCI USA, V107, P12889, DOI 10.1073/pnas.1005938107; Munshi UM, 2007, J BIOL CHEM, V282, P3847, DOI 10.1074/jbc.M607489200; Nabhan JF, 2012, P NATL ACAD SCI USA, V109, P4146, DOI 10.1073/pnas.1200448109; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nara A, 2002, CELL STRUCT FUNCT, V27, P29, DOI 10.1247/csf.27.29; Ott David E., 2009, V485, P15, DOI 10.1007/978-1-59745-170-3_2; Pincetic A, 2008, J BIOL CHEM, V283, P29822, DOI 10.1074/jbc.M804157200; Prescher J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004677; Pyrzynska B, 2009, MOL ONCOL, V3, P321, DOI 10.1016/j.molonc.2009.06.001; Quinney KB, 2019, P NATL ACAD SCI USA, V116, P6858, DOI 10.1073/pnas.1817898116; Ratz M, 2015, SCI REP-UK, V5, DOI 10.1038/srep09592; Samson RY, 2009, TRENDS MICROBIOL, V17, P507, DOI 10.1016/j.tim.2009.08.003; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/nmeth.1855, 10.1038/NMETH.1855]; Schuh AL, 2014, CRIT REV BIOCHEM MOL, V49, P242, DOI 10.3109/10409238.2014.881777; Sengupta P, 2011, NAT METHODS, V8, P969, DOI [10.1038/nmeth.1704, 10.1038/NMETH.1704]; Siarot L, 2018, BIOCHEM BIOPH RES CO, V503, P2970, DOI 10.1016/j.bbrc.2018.08.079; Skowyra ML, 2018, SCIENCE, V360, P49, DOI 10.1126/science.aar5078; Snapp EL, 2009, TRENDS CELL BIOL, V19, P649, DOI 10.1016/j.tcb.2009.08.002; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; Strickland M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01426-2; Stuchell MD, 2004, J BIOL CHEM, V279, P36059, DOI 10.1074/jbc.M405226200; Tanaka N, 2008, CANCER SCI, V99, P1293, DOI 10.1111/j.1349-7006.2008.00825.x; Urwin H, 2010, HUM MOL GENET, V19, P2228, DOI 10.1093/hmg/ddq100; Usami Y, 2007, J VIROL, V81, P6614, DOI 10.1128/JVI.00314-07; Van Engelenburg SB, 2014, SCIENCE, V343, P653, DOI 10.1126/science.1247786; Vardhana S, 2010, IMMUNITY, V32, P531, DOI 10.1016/j.immuni.2010.04.005; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012; Waheed AA, 2006, J BIOL CHEM, V281, P28699, DOI 10.1074/jbc.M603609200; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; YEE JK, 1994, METHOD CELL BIOL, V43, P99	85	10	10	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					16266	16281		10.1074/jbc.RA119.009372	http://dx.doi.org/10.1074/jbc.RA119.009372			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31519756	Green Published, hybrid			2022-12-26	WOS:000499478600032
J	Il Lim, H; Jun, SJ; Lee, SW				Il Lim, Hong; Jun, Sang Jin; Lee, Sung Woo			Glomerular hyperfiltration may be a novel risk factor of restrictive spirometry pattern: Analysis of the Korea National Health and Nutrition Examination Survey (KNHANES) 2009-2015	PLOS ONE			English	Article							LUNG-FUNCTION; RENAL HYPERFILTRATION; METABOLIC SYNDROME; INSULIN-RESISTANCE; CLINICAL-SIGNIFICANCE; ATHEROSCLEROSIS RISK; CARDIOVASCULAR RISK; PULMONARY-FUNCTION; PHYSICAL-ACTIVITY; VITAL CAPACITY	Background and objectives There have been limited studies regarding the association between glomerular hyperfiltration (GHF) and restrictive spirometry pattern (RSP) in Korean adults. Methods We used data of 23,189 adults from the Korea National Health and Nutritional Examination Survey 2009-2015 with a complete data set including spirometry, serum creatinine, and anthropometric measurements. Spirometry data included the forced expiratory volume in one second (FEV1) and forced vital capacity (FVC). We defined GHF as the > 90th percentile of age & sex adjusted estimated glomerular filtration rate (eGFR), and RSP was defined as an FVC < 80%-predicted value and an FEV1/FVC ratio >= 0.7. Results Participants with RSP showed higher blood pressure, fasting glucose, and triglyceride, reduced high density lipoprotein cholesterol, and central obesity, which resulted in a higher prevalence of metabolic syndrome (MetS) compared to those without RSP. Multivariate logistic regression revealed that the odds for RSP were significantly increased with an increased number of MetS components. In addition, increased eGFR was associated with decreased FVC, showing an inverted J-shaped relationship in a multivariate generalized additive model analysis. In the multivariate logistic regression analysis, the adjusted odds ratio and 95% confidence interval of GHF for RSP was 1.184 (1.026-1.368, P = 0.021), which was evident in groups without metabolic disorders. Conclusions We concluded that GHF was associated with increased odds for RSP, particularly in groups without metabolic disorders. Further prospective studies are needed to confirm our study results.	[Il Lim, Hong; Jun, Sang Jin; Lee, Sung Woo] Eulji Univ, Nowon Eulji Med Ctr, Dept Internal Med, Seoul, South Korea	Eulji University	Lee, SW (corresponding author), Eulji Univ, Nowon Eulji Med Ctr, Dept Internal Med, Seoul, South Korea.	neplsw@gmail.com		sangjin, Jeon/0000-0002-8975-9333; Lee, Sung Woo/0000-0002-4419-3938				Aaron SD, 1999, CHEST, V115, P869, DOI 10.1378/chest.115.3.869; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Bankir L, 2015, AM J PHYSIOL-RENAL, V309, pF2, DOI 10.1152/ajprenal.00614.2014; Baxmann AC, 2008, CLIN J AM SOC NEPHRO, V3, P348, DOI 10.2215/CJN.02870707; Bjornstad P, 2015, NEPHROL DIAL TRANSPL, V30, P1706, DOI 10.1093/ndt/gfv121; Cachat F, 2015, CLIN J AM SOC NEPHRO, V10, P382, DOI 10.2215/CJN.03080314; Cornelis T, 2011, SEMIN NEPHROL, V31, P4, DOI 10.1016/j.semnephrol.2010.10.002; D'Agati VD, 2016, NAT REV NEPHROL, V12, P453, DOI 10.1038/nrneph.2016.75; De Cosmo S, 2013, NEPHROL DIAL TRANSPL, V28, P29, DOI 10.1093/ndt/gfs290; Engstrom G, 2003, J INTERN MED, V253, P574, DOI 10.1046/j.1365-2796.2003.01138.x; Engstrom G, 2002, DIABETIC MED, V19, P167, DOI 10.1046/j.1464-5491.2002.00652.x; Engstrom G, 2002, CIRCULATION, V106, P2555, DOI 10.1161/01.CIR.0000037220.00065.0D; Ford ES, 2004, DIABETES CARE, V27, P2966, DOI 10.2337/diacare.27.12.2966; Fragoso CAV, 2011, J INVEST MED, V59, P1089, DOI 10.2310/JIM.0b013e31822bb213; Godfrey MS, 2016, CHEST, V149, P238, DOI 10.1378/chest.15-1045; Har R, 2013, DIABETOLOGIA, V56, P1166, DOI 10.1007/s00125-013-2857-5; Helal I, 2012, NAT REV NEPHROL, V8, P293, DOI 10.1038/nrneph.2012.19; Hwang HJ, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0106-4; Jankowich M, 2018, ANN AM THORAC SOC, V15, P1186, DOI 10.1513/AnnalsATS.201803-184OC; Kleiven O, 2018, SCAND J MED SCI SPOR, V28, P172, DOI 10.1111/sms.12878; Lazarus R, 1998, EUR RESPIR J, V12, P641, DOI 10.1183/09031936.98.12030641; Lee HM, 2009, CHEST, V136, P171, DOI 10.1378/chest.08-1901; Leone N, 2009, AM J RESP CRIT CARE, V179, P509, DOI 10.1164/rccm.200807-1195OC; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Litonjua AA, 2005, RESP MED, V99, P1583, DOI 10.1016/j.rmed.2005.03.023; Low S, 2018, DIABETES VASC DIS RE, V15, P417, DOI 10.1177/1479164118776465; Melsom T, 2019, AM J KIDNEY DIS, V73, P777, DOI 10.1053/j.ajkd.2018.11.011; Melsom T, 2011, DIABETES CARE, V34, P1546, DOI 10.2337/dc11-0235; Min HK, 2019, KIDNEY RES CLIN PRAC, V38, P196, DOI 10.23876/j.krcp.18.0147; Moualla M, 2017, THORAX, V72, P1113, DOI 10.1136/thoraxjnl-2016-209125; Mukai H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195585; Nakajima K, 2008, CHEST, V134, P712, DOI 10.1378/chest.07-3003; Navaneethan SD, 2016, AM J KIDNEY DIS, V68, P414, DOI 10.1053/j.ajkd.2016.03.415; Park JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188903; Park M, 2015, J AM SOC NEPHROL, V26, P1426, DOI 10.1681/ASN.2014010115; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Ruggenenti P, 2012, DIABETES CARE, V35, P2061, DOI 10.2337/dc11-2189; Sasaki M, 2011, ACTA MED OKAYAMA, V65, P81; Senechal M, 2014, MED SCI SPORT EXER, V46, P1475, DOI 10.1249/MSS.0000000000000266; Silva B, 2017, GERIATRICS-BASEL, V2, DOI 10.3390/geriatrics2040030; Sperandio EF, 2016, J BRAS PNEUMOL, V42, P22, DOI 10.1590/S1806-37562016000000030; Sumida K, 2017, AM J KIDNEY DIS, V70, P675, DOI 10.1053/j.ajkd.2017.05.021; Tomaszewski M, 2007, KIDNEY INT, V71, P816, DOI 10.1038/sj.ki.5002160; Tonneijck L, 2017, J AM SOC NEPHROL, V28, P1023, DOI 10.1681/ASN.2016060666; Venkateshiah SB, 2008, LUNG, V186, P19, DOI 10.1007/s00408-007-9052-8; Vogelmeier CF, 2017, AM J RESP CRIT CARE, V195, P557, DOI 10.1164/rccm.201701-0218PP; Wannamethee SG, 2010, DIABETES CARE, V33, P1990, DOI 10.2337/dc10-0324; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Wu IH, 2017, CHEST, V152, P394, DOI 10.1016/j.chest.2017.03.039; Yeh HC, 2005, DIABETES CARE, V28, P1472, DOI 10.2337/diacare.28.6.1472; Yilmaz S, 2016, MED SCI MONITOR, V22, P2779, DOI 10.12659/MSM.897480; Yoon JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094125	53	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0223050	10.1371/journal.pone.0223050	http://dx.doi.org/10.1371/journal.pone.0223050			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553782	gold, Green Published			2022-12-26	WOS:000532319200049
J	Pham-Duc, P; Cook, MA; Cong-Hong, H; Nguyen-Thuy, H; Padungtod, P; Nguyen-Thi, H; Dang-Xuan, S				Phuc Pham-Duc; Cook, Meghan A.; Hanh Cong-Hong; Hang Nguyen-Thuy; Padungtod, Pawin; Hien Nguyen-Thi; Sinh Dang-Xuan			Knowledge, attitudes and practices of livestock and aquaculture producers regarding antimicrobial use and resistance in Vietnam	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; ONE HEALTH	The use of antibiotics in livestock production is considered a major driver of antibiotic resistance on a global scale. In Vietnam, small- and medium-scale livestock producers dominate the domestic market and regulatory pushes have done little to decrease antibiotic use. In order to inform future policy directions, this study aims to explore knowledge, attitudes, and practices amongst livestock producers to identify their perspectives on antibiotic use and resistance. A total of 392 small- and medium-scale producers specialized in pig, poultry and aquaculture production participated in the study. The results showed that the primary reason for antibiotic use reported by producers was for the treatment of infections (69%). However, prophylactic use was also evident, with farmers reporting other reasons for antibiotic use such as "animals display abnormal symptoms or behaviour" (55%), the "weather is about to change" (25%), or "animals on neighboring farms fall ill" (27%). Only one-fifth of producers demonstrated favorable attitudes towards antibiotic use and preventing antibiotic resistance. Moreover, administering antibiotics remained the preferred countermeasure directly applied by farmers at the first indication of disease (17%), compared to enacting hygiene (10%) or quarantine (5%) measures. The results showed divergent trends amongst producers, with pig producers demonstrating higher levels of knowledge, more favorable attitudes, and higher self-reported utilization of good practice. Better knowledge, attitudes, and practices were also associated with producers who engaged in efforts to explore information on antibiotic use and resistance, which improved incrementally with the number of sources consulted and hours invested. However, there were some areas where increased knowledge or more favorable attitude scores did not translate into better practices. For instance, producers with higher levels of formal education performed significantly better than those with lower education in terms of knowledge and attitude, though both groups reported similar practices. The findings of this study may support future interventions to prevent both antibiotic misuse and the development of antimicrobial resistance.	[Phuc Pham-Duc; Cook, Meghan A.; Hanh Cong-Hong; Hien Nguyen-Thi; Sinh Dang-Xuan] Hanoi Univ Publ Hlth, Ctr Publ Hlth & Ecosyst Res, Hanoi, Vietnam; [Phuc Pham-Duc; Hanh Cong-Hong; Sinh Dang-Xuan] Vietnam Union Sci & Technol Assoc, Inst Environm & Sustainable Dev, Hanoi, Vietnam; [Hanh Cong-Hong] Vietnam Acad Sci & Technol, Inst Mat Sci, Hanoi, Vietnam; [Hang Nguyen-Thuy; Padungtod, Pawin] Food & Agr Org United Nat, Country Off Vietnam, Hanoi, Vietnam; [Sinh Dang-Xuan] Int Livestock Res Inst ILRI, Hanoi, Vietnam	Hanoi University of Public Health; Vietnam Academy of Science & Technology (VAST); Food & Agriculture Organization of the United Nations (FAO); CGIAR; International Livestock Research Institute (ILRI)	Dang-Xuan, S (corresponding author), Hanoi Univ Publ Hlth, Ctr Publ Hlth & Ecosyst Res, Hanoi, Vietnam.; Dang-Xuan, S (corresponding author), Vietnam Union Sci & Technol Assoc, Inst Environm & Sustainable Dev, Hanoi, Vietnam.; Dang-Xuan, S (corresponding author), Int Livestock Res Inst ILRI, Hanoi, Vietnam.	dxs@huph.edu.vn	Dang, Sinh/AAU-7680-2020	Dang, Sinh/0000-0002-0522-7808; Cook, Meghan/0000-0002-7964-6781; Nguyen Thi, Hien/0000-0003-1444-3120	United States Agency for International Development (USAID) [GHA-G-00-06-00001]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	This work was conducted with financial support from the United States Agency for International Development (USAID) grant number GHA-G-00-06-00001. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre E, 2017, FOOD DRUG LAW J, V72, P295; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Cassou E., 2018, CHALLENGE AGR POLLUT; CDDEP, 2015, STATE WORLDS ANTIBIO; Dang Pham Kim, 2013, Food and Public Health, V3, P267; Dang Pham Kim, 2013, Food and Public Health, V3, P247; Davies PR, 2012, TRANSBOUND EMERG DIS, V59, P18, DOI 10.1111/j.1865-1682.2012.01312.x; Goff DA, 2017, LANCET INFECT DIS, V17, pE56, DOI 10.1016/S1473-3099(16)30386-3; Van Nguyen K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1158; MARD, STAT AN FARM HONG KE; Nadimpalli M, 2018, CLIN INFECT DIS, V66, P963, DOI 10.1093/cid/cix879; Robinson TP, 2016, LANCET, V387, pE1, DOI 10.1016/S0140-6736(15)00730-8; Stokes HW, 2011, FEMS MICROBIOL REV, V35, P790, DOI 10.1111/j.1574-6976.2011.00273.x; Takele Beyene, 2016, Journal of Veterinary Science and Technology, V7, P285; Thrusfield M, 1997, VET EPIDEMIOLOGY, V2nd, P182; Tiongco M. M., 2011, FARM POLICY J, V8, P39; Tuyet-Hanh TT, 2017, INT J PUBLIC HEALTH, V62, pS75, DOI 10.1007/s00038-016-0912-y; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Van TTH, 2008, INT J FOOD MICROBIOL, V124, P217, DOI 10.1016/j.ijfoodmicro.2008.03.029; WHO, 2017, GUID US MED IMP ANT; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1; World Bank, 2017, VIETN FOOD SAF RISK	22	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0223115	10.1371/journal.pone.0223115	http://dx.doi.org/10.1371/journal.pone.0223115			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553776	Green Published, gold			2022-12-26	WOS:000532319200055
J	Du, XH; Zhu, XP; Yang, YP; Wang, YL; Arens, P; Liu, HC				Du, Xiaohua; Zhu, Xiaopei; Yang, Yaping; Wang, Yanli; Arens, Paul; Liu, Huichao			De novo transcriptome analysis of Viola xwittrockiana exposed to high temperature stress	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; MOLECULAR-MECHANISMS; TOLERANCE; EXPRESSION; GENE; IDENTIFICATION; DROUGHT; FAMILY; PLANTS	Around the world, pansies are one of the most popular garden flowers, but they are generally sensitive to high temperatures, and this limits the practicality of planting them during the warmest days of the year. However, a few pansy germplasms with improved heat tolerance have been discovered or bred, but the mechanisms of their heat resistance are not understood. In this study, we investigated the transcript profiles of a heat-tolerant pansy inbred line, DFM16, in response to high temperatures using RNAseq. Approximately 55.48 Gb of nucleotide data were obtained and assembled into 167,576 unigenes with an average length of 959 bp, of which, 5,708 genes were found to be differentially expressed after heat treatments. Real-time qPCR was performed to validate the expression profiles of the selected genes. Nine metabolic pathways were found to be significantly enriched, in the analysis of the differentially expressed genes. Several potentially interesting genes that encoded putative transcription regulators or key components involving heat shock protein (HSP), heat shock transcription factors (HSF), and antioxidants biosynthesis, were identified. These genes were highlighted to indicate their significance in response to heat stress and will be used as candidate genes to improve pansy heat-tolerance in the future.	[Du, Xiaohua; Zhu, Xiaopei; Yang, Yaping; Wang, Yanli; Liu, Huichao] Henan Inst Sci & Technol, Sch Hort & Landscape Architecture, Xinxiang, Henan, Peoples R China; [Du, Xiaohua; Zhu, Xiaopei; Yang, Yaping; Wang, Yanli; Liu, Huichao] Henan Prov Engn Res Ctr Hort Plant Resource Utili, Xinxiang, Henan, Peoples R China; [Arens, Paul] Wageningen Univ & Res, Wageningen, Netherlands	Henan Institute of Science & Technology; Wageningen University & Research	Liu, HC (corresponding author), Henan Inst Sci & Technol, Sch Hort & Landscape Architecture, Xinxiang, Henan, Peoples R China.; Liu, HC (corresponding author), Henan Prov Engn Res Ctr Hort Plant Resource Utili, Xinxiang, Henan, Peoples R China.	13683732063@163.com		Du, Xiaohua/0000-0001-8619-6419	International Science and Technology Cooperation Research Programme of Henan Province [182102410029]; Key Scientific Research Projects of Institutions of Higher Education of Henan Province [19A210011]	International Science and Technology Cooperation Research Programme of Henan Province; Key Scientific Research Projects of Institutions of Higher Education of Henan Province	This work was financially supported by the International Science and Technology Cooperation Research Programme of Henan Province (Grant No. 182102410029) and Key Scientific Research Projects of Institutions of Higher Education of Henan Province (Grant No. 19A210011).	Allakhverdiev SI, 2008, PHOTOSYNTH RES, V98, P529, DOI 10.1007/s11120-008-9334-x; Almeselmani M., 2009, Acta Agronomica Hungarica, V57, P1, DOI 10.1556/AAgr.57.2009.1.1; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Banerjee A, 2017, PROTOPLASMA, V254, P3, DOI 10.1007/s00709-015-0920-4; Banerjee A, 2016, PLANT BIOTECHNOL REP, V10, P185, DOI 10.1007/s11816-016-0401-z; Baniwal SK, 2004, J BIOSCIENCES, V29, P471, DOI 10.1007/BF02712120; Baxter A, 2014, J EXP BOT, V65, P1229, DOI 10.1093/jxb/ert375; Chang CC, 2007, PLANT CELL PHYSIOL, V48, P1098, DOI 10.1093/pcp/pcm080; Chen H., 2016, THESIS; Finka A, 2011, CELL STRESS CHAPERON, V16, P15, DOI 10.1007/s12192-010-0216-8; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Grover A, 2013, PLANT SCI, V205, P38, DOI 10.1016/j.plantsci.2013.01.005; Hasanuzzaman M, 2013, INT J MOL SCI, V14, P9643, DOI 10.3390/ijms14059643; Ikeda M, 2011, PLANT PHYSIOL, V157, P1243, DOI 10.1104/pp.111.179036; Kessler JR, 1999, SE FLORICULTURE, P29; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Miller G, 2007, PLANT PHYSIOL, V144, P1777, DOI 10.1104/pp.107.101436; Montero-Barrientos M, 2010, J PLANT PHYSIOL, V167, P659, DOI 10.1016/j.jplph.2009.11.012; Peng HuaTing, 2012, Journal of Shanghai Jiaotong University - Agricultural Science, V30, P66; Priya M, 2019, THEOR APPL GENET, V132, P1607, DOI 10.1007/s00122-019-03331-2; Qu AL, 2013, BIOCHEM BIOPH RES CO, V432, P203, DOI 10.1016/j.bbrc.2013.01.104; Scharf KD, 2012, BBA-GENE REGUL MECH, V1819, P104, DOI 10.1016/j.bbagrm.2011.10.002; Song AP, 2014, INT J MOL SCI, V15, P5063, DOI 10.3390/ijms15035063; Song XM, 2014, MOL GENET GENOMICS, V289, P541, DOI 10.1007/s00438-014-0833-5; Stief A, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/15592316.2014.970430; Sun LP, 2012, PLANT CELL REP, V31, P1473, DOI 10.1007/s00299-012-1262-8; Sun WH, 2010, BIOL PLANTARUM, V54, P614, DOI 10.1007/s10535-010-0111-2; Vanderauwera S, 2011, P NATL ACAD SCI USA, V108, P1711, DOI 10.1073/pnas.1018359108; von Koskull-Doring P, 2007, TRENDS PLANT SCI, V12, P452, DOI 10.1016/j.tplants.2007.08.014; Wang L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-289; Wang Y. J., 2006, Journal of Applied Horticulture (Lucknow), V8, P87; Xue Y, 2010, BIOL PLANTARUM, V54, P105, DOI 10.1007/s10535-010-0015-1; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zandalinas SI, 2018, PHYSIOL PLANTARUM, V162, P2, DOI 10.1111/ppl.12540; Zou Q., 1995, GUIDANCE PLANT PHYSL	39	2	2	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222344	10.1371/journal.pone.0222344	http://dx.doi.org/10.1371/journal.pone.0222344			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550256	Green Published, gold			2022-12-26	WOS:000532307700014
J	Ku, CC; Dodd, PJ				Ku, Chu-Chang; Dodd, Peter J.			Forecasting the impact of population ageing on tuberculosis incidence	PLOS ONE			English	Article							UNITED-STATES; OLDER-ADULTS; HONG-KONG; FERTILITY; MORTALITY; DYNAMICS; TIME	Background Tuberculosis (TB) disease reactivates from distant latent infection or recent (re)infection. Progression risks increase with age. Across the World Health Organisation Western Pacific region, many populations are ageing and have the highest per capita TB incidence rates in older age groups. However, methods for analysing age-specific TB incidence and forecasting epidemic trends while accounting for demographic change remain limited. Methods We applied the Lee-Carter models, which were originally developed for mortality modelling, to model the temporal trends in age-specific TB incidence data from 2005 to 2018 in Taiwan. Females and males were modelled separately. We combined our demographic forecasts, and age-specific TB incidence forecasts to project TB incidence until 2035. We compared TB incidence projections with demography fixed in 2018 to projections accounting for demographic change. Results Our models quantified increasing incidence rates with age and declining temporal trends. By 2035, the forecast suggests that the TB incidence rate in Taiwan will decrease by 54% (95% Prediction Interval (PI): 45%-59%) compared to 2015, while most age-specific incidence rates will reduce by more than 60%. In 2035, adults aged 65 and above will make up 78% of incident TB cases. Forecast TB incidence in 2035 accounting for demographic change will be 39% (95% PI: 36%-42%) higher than without population ageing. Conclusions Age-specific incidence forecasts coupled with demographic forecasts can inform the impact of population ageing on TB epidemics. The TB control programme in Taiwan should develop plans specific to older age groups and their care needs.	[Ku, Chu-Chang; Dodd, Peter J.] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England	University of Sheffield	Ku, CC (corresponding author), Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England.	cku1@sheffield.ac.uk	辜, 鉅璋/ACM-0702-2022	辜, 鉅璋/0000-0002-4719-117X; Dodd, Pete/0000-0001-5825-9347	Medical Research Council UK [MR/P022081/1]; MRC [MR/P022081/1] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by the Medical Research Council UK (grant MR/P022081/1 to PJD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arregui Sergio, 2018, Proc Natl Acad Sci U S A, V115, pE3238, DOI 10.1073/pnas.1720606115; Bras AL, 2014, INT J TUBERC LUNG D, V18, P1202, DOI 10.5588/ijtld.14.0158; Brooks-Pollock E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008479; Brouhns N, 2002, INSUR MATH ECON, V31, P373, DOI 10.1016/S0167-6687(02)00185-3; Coale Aj., 1990, ASIAN PACIFIC POPULA, Vvol. 4; Cowan SK, 2013, POPUL DEV REV, V39, P289, DOI 10.1111/j.1728-4457.2013.00592.x; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; Hagiya H, 1997, EPIDEMIOL INFECT, V2018, P1; Harris RC, 2019, LANCET GLOB HEALTH, V7, pE209, DOI 10.1016/S2214-109X(18)30452-2; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Hyndman RJ, 2008, INT J FORECASTING, V24, P323, DOI 10.1016/j.ijforecast.2008.02.009; Iqbal SA, 2018, AM J PUBLIC HEALTH, V108, pS315, DOI [10.2105/ajph.2018.304687, 10.2105/AJPH.2018.304687]; Kainz A, 2015, NEPHROL DIAL TRANSPL, V30, P113, DOI 10.1093/ndt/gfv073; Lee R., 2000, N AM I CAN ACTUARIAL, V4, P80, DOI 10.1080/10920277.2000.10595882; LEE RD, 1992, J AM STAT ASSOC, V87, P659, DOI 10.2307/2290201; Marais BJ, 2013, LANCET INFECT DIS, V13, P436, DOI 10.1016/S1473-3099(13)70015-X; National Development Council Taiwan, 2018, POP PROJ R O C TAIW; Negin J, 2015, INT J INFECT DIS, V32, P135, DOI 10.1016/j.ijid.2014.11.018; Onozaki I, 2015, TROP MED INT HEALTH, V20, P1128, DOI 10.1111/tmi.12534; Pratt RH, 2011, J AM GERIATR SOC, V59, P851, DOI 10.1111/j.1532-5415.2011.03369.x; R Core Team, 2018, R LANG ENV STAT COMP; Renshaw AE, 2008, INSUR MATH ECON, V42, P797, DOI 10.1016/j.insmatheco.2007.08.009; Rueda-Sabater C, 2008, J APPL STAT, V35, P1053, DOI 10.1080/02664760802192999; Schaaf HS, 2010, RESPIROLOGY, V15, P747, DOI 10.1111/j.1440-1843.2010.01784.x; Steenland K, 2006, EPIDEMIOLOGY, V17, P512, DOI 10.1097/01.ede.0000229155.05644.43; Suarez PG, 2001, J INFECT DIS, V184, P473, DOI 10.1086/322777; United Nations Publications, 2017, WORLD POP AG 2015; van Aart C, 2017, INT J TUBERC LUNG D, V21, P486, DOI 10.5588/ijtld.16.0548; Villegas AM, 2018, J STAT SOFTW, V84, P1, DOI 10.18637/jss.v084.i03; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P943, DOI 10.1017/S0950268807008552; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; World Health Organization, 2014, GLOB STRAT TARG TUB; Wu P, 2008, THORAX, V63, P312, DOI 10.1136/thx.2007.082354; Yue JC, 2018, INSUR MATH ECON, V78, P316, DOI 10.1016/j.insmatheco.2017.09.016	35	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222937	10.1371/journal.pone.0222937	http://dx.doi.org/10.1371/journal.pone.0222937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5RZ	31550293	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000532307700035
J	Costa, ACS; Pereira, DE; Verissimo, CM; Bomfim, MAD; Queiroga, RCRE; Madruga, MS; Alves, S; Bessa, RJB; Oliveira, MEG; Soares, JKB				Costa, Ana C. S.; Pereira, Diego E.; Verissimo, Caio M.; Bomfim, Marcos A. D.; Queiroga, Rita C. R. E.; Madruga, Marta S.; Alves, Susana; Bessa, Rui J. B.; Oliveira, Maria E. G.; Soares, Juliana K. B.			Developing cookies formulated with goat cream enriched with conjugated linoleic acid	PLOS ONE			English	Article							TRANS-FATTY-ACIDS; MILK; BISCUITS; SUGAR; QUALITY; PERFORMANCE; CALCIUM; BAKING; IMPACT; WHEAT	Goat fat is one of the best sources of conjugated linoleic acid (CLA), a fatty acid which has health benefits. However, though CLA is generated in ruminants, CLA consumption is limited to meats and milk products. This study aimed to replace vegetable fat with goat milk fat enriched with CLA. From differing fat sources, four cookie recipes were developed: CVF-vegetable fat cookies; CB-butter cookies; CG-goat milk fat cookies without CLA; CGCLA-goat milk fat cookies with CLA. The cookies were evaluated using physical (color and texture), physical-chemical parameters (lipids, proteins, total sugars, fiber, ash, moisture and Aw), consumer testing (n = 123), and lipid profiles. The CGCLA presented higher values in the color parameters. The highest and the lowest scores obtained for hardness were respectively 5.54 (CB) and 2.21 (CVF). Lipids and total sugars varied inversely; the highest percentages of lipids were in the CVF and CG samples which obtained lower total sugar content. There were no differences in acceptance or preference for the four formulations. The goat cream formulations (CG and CGCLA) were as well accepted as the CFV formulation. For lipid profiles, CFV presented the highest percentage of trans-fatty acids (TFA) at 16.76%. CGCLA presented 70% more CLA than either CB or CG, certifying that CGCLA presents CLA in relevant quantities, even after cooking. The CGCLA presented higher levels of CLA, and in this study it was verified that goat milk cream enriched with CLA can be used in producing cookies, adding functional and nutritional properties, and offering another alternative(s) to produce food from goat milk fat.	[Costa, Ana C. S.; Pereira, Diego E.; Verissimo, Caio M.; Queiroga, Rita C. R. E.; Madruga, Marta S.; Oliveira, Maria E. G.; Soares, Juliana K. B.] Univ Fed Paraiba, Food Sci & Technol Program, Joao Pessoa, Paraiba, Brazil; [Costa, Ana C. S.; Verissimo, Caio M.] Univ Fed Rural Pernambuco, Dept Rural Technol, Recife, PE, Brazil; [Bomfim, Marcos A. D.] Embrapa Goats & Sheep, Sobral, Brazil; [Queiroga, Rita C. R. E.; Oliveira, Maria E. G.] Univ Fed Paraiba, Dept Nutr, Bromatol Lab, Joao Pessoa, Paraiba, Brazil; [Alves, Susana; Bessa, Rui J. B.] Univ Lisbon, Fac Vet Med, Ctr Interdisciplinary Res Anim Hlth CIISA, Lisbon, Portugal; [Soares, Juliana K. B.] Univ Fed Campina Grande, Dept Nutr, Cuite, Brazil	Universidade Federal da Paraiba; Universidade Federal Rural de Pernambuco (UFRPE); Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal da Paraiba; Universidade de Lisboa; Universidade Federal de Campina Grande	Costa, ACS (corresponding author), Univ Fed Paraiba, Food Sci & Technol Program, Joao Pessoa, Paraiba, Brazil.; Costa, ACS (corresponding author), Univ Fed Rural Pernambuco, Dept Rural Technol, Recife, PE, Brazil.	acarolinasc@hotmail.com	Alves, Susana/Q-3889-2019; Bessa, Rui J. B./B-8006-2008	Alves, Susana/0000-0002-3171-9566; Bessa, Rui J. B./0000-0003-4109-3488; COSTA, ANA CAROLINA/0000-0001-5466-6463; Bomfim, Marcos Antonio Delmondes/0000-0002-1707-2970; PEREIRA, DIEGO/0000-0002-3563-3794				Abd El-Salam MH, 2014, J FOOD COMPOS ANAL, V33, P117, DOI 10.1016/j.jfca.2012.08.004; de Assis POA, 2016, INT DAIRY J, V56, P45, DOI 10.1016/j.idairyj.2015.11.002; Arimi JM, 2010, FOOD RES INT, V43, P1650, DOI 10.1016/j.foodres.2010.05.004; Association of Official Agricultural Chemists, 2012, OFF METH AN ASS OFF; Barbosa MQ, 2018, FOOD FUNCT, V9, P2891, DOI [10.1039/C7FO01764B, 10.1039/c7fo01764b]; Bertolin TE, 2013, FOOD SCI TECH-BRAZIL, V33, P345, DOI 10.1590/S0101-20612013005000054; Bick Marília Alessandra, 2014, Braz. J. Food Technol., V17, P121, DOI 10.1590/bjft.2014.015; Biguzzi C, 2014, FOOD QUAL PREFER, V35, P41, DOI 10.1016/j.foodqual.2014.02.001; Chung HJ, 2014, LWT-FOOD SCI TECHNOL, V57, P260, DOI 10.1016/j.lwt.2014.01.018; Commission Internationale de l'Eclairage-CIE, 1978, CIE PUBLICATION; Costa N, 2016, FOOD CONTROL, V64, P128, DOI 10.1016/j.foodcont.2015.12.010; Drewnowski A, 1998, FOOD QUAL PREFER, V9, P13, DOI 10.1016/S0950-3293(97)00017-7; Dutcosky S.D., 2013, ANALISE SENSORIAL AL; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ganguly R, 2016, J NUTR BIOCHEM, V31, P60, DOI 10.1016/j.jnutbio.2015.12.018; Ganguly R, 2015, FOOD CHEM TOXICOL, V78, P170, DOI 10.1016/j.fct.2015.02.004; Gokmen V, 2008, J CEREAL SCI, V48, P843, DOI 10.1016/j.jcs.2008.06.007; Gomes LC, 2015, SMALL RUMINANT RES, V124, P81, DOI 10.1016/j.smallrumres.2015.01.013; Gomez-Cortes P, 2018, TRENDS FOOD SCI TECH, V81, P1, DOI 10.1016/j.tifs.2018.08.014; Henneberg JWJ., 1864, BEITRAGE BEGRUNDUNG; Koba K, 2014, OBES RES CLIN PRACT, V8, pE525, DOI 10.1016/j.orcp.2013.10.001; Laguna L, 2014, LWT-FOOD SCI TECHNOL, V56, P494, DOI 10.1016/j.lwt.2013.12.025; Laguna L, 2011, LWT-FOOD SCI TECHNOL, V44, P737, DOI 10.1016/j.lwt.2010.05.034; Lara E, 2011, LWT-FOOD SCI TECHNOL, V44, P622, DOI 10.1016/j.lwt.2010.10.007; Lopez-Aliaga I, 2005, J DAIRY SCI, V88, P1024, DOI 10.3168/jds.S0022-0302(05)72770-3; Marques GD, 2016, LWT-FOOD SCI TECHNOL, V67, P118, DOI 10.1016/j.lwt.2015.11.044; Mele MC, 2013, PROSTAG LEUKOTR ESS, V89, P115, DOI 10.1016/j.plefa.2013.05.005; Nurgel C, 2004, J SCI FOOD AGR, V84, P1675, DOI 10.1002/jsfa.1860; Palmquist DL, 2003, J ANIM SCI, V81, P3250; Pareyt B, 2009, J FOOD ENG, V90, P400, DOI 10.1016/j.jfoodeng.2008.07.010; Park Y, 2009, J FOOD COMPOS ANAL, V22, pS4, DOI 10.1016/j.jfca.2008.12.002; Park Y, 2009, FOOD SCI BIOTECHNOL, V18, P586; PELEG M, 1992, J TEXTURE STUD, V23, P427, DOI 10.1111/j.1745-4603.1992.tb00032.x; Piclin N, 2008, J SENS STUD, V23, P558, DOI 10.1111/j.1745-459X.2008.00172.x; Razzaghi A, 2015, ANIM FEED SCI TECH, V210, P46, DOI 10.1016/j.anifeedsci.2015.09.014; Ripolles D, 2016, INT DAIRY J, V60, P70, DOI 10.1016/j.idairyj.2016.02.031; Ruiz-Nunez B, 2016, J NUTR BIOCHEM, V36, P1, DOI 10.1016/j.jnutbio.2015.12.007; Sharma P, 2013, FOOD BIOPROCESS TECH, V6, P1374, DOI 10.1007/s11947-011-0777-2; Soares JKB, 2013, NEUROSCI LETT, V552, P25, DOI 10.1016/j.neulet.2013.07.028; SUKHIJA PS, 1988, J AGR FOOD CHEM, V36, P1202, DOI 10.1021/jf00084a019; Tarancon P, 2013, FOOD RES INT, V53, P134, DOI 10.1016/j.foodres.2013.03.053; Santos LAT, 2015, FOOD CONTROL, V47, P141, DOI 10.1016/j.foodcont.2014.06.046; Tran NM, 2019, J MULTIVARIATE ANAL, V171, P1, DOI 10.1016/j.jmva.2018.10.004; Umesha SS, 2015, LWT-FOOD SCI TECHNOL, V62, P654, DOI 10.1016/j.lwt.2014.02.018; Verruck S, 2019, J FUNCT FOODS, V52, P243, DOI 10.1016/j.jff.2018.11.017	45	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0212534	10.1371/journal.pone.0212534	http://dx.doi.org/10.1371/journal.pone.0212534			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545797	Green Published, gold			2022-12-26	WOS:000532303200001
J	Kong, DJ; Liu, NN; Wang, WY; Akhtar, K; Li, N; Ren, GX; Feng, YZ; Yang, GH				Kong, Dejie; Liu, Nana; Wang, Weiyu; Akhtar, Kashif; Li, Na; Ren, Guangxin; Feng, Yongzhong; Yang, Gaihe			Soil respiration from fields under three crop rotation treatments and three straw retention treatments	PLOS ONE			English	Article							CARBON-DIOXIDE EMISSION; GAS EMISSIONS; TILLAGE; RESIDUE; WHEAT; DYNAMICS; SYSTEM; YIELD; FLUX; TEMPERATURE	Straw retention is an effective method to conserve soil water content and improve soil carbon stocks. However, how soil carbon dynamics respond to different straw retention practices remains unclear. In this study, we investigated soil respiration and soil carbon sequestration at depths of 0-100 cm. We conducted a two-year field experiment with three crop rotation treatments and three straw retention treatments in northwest China. The straw retention treatments included no straw retention (NS), retention of half the straw (HS), and retention of the total amount of straw (TS). The crop rotations treatments included winter wheat plus summer soybean (WS), winter wheat plus summer maize (WM), and winter wheat plus summer fallow (WF). Mean soil respiration rates under WS, WM, and WF treatments were 5.14, 6.53, and 5.49 mu mol.m(-2).s(-1); and 5.67, 5.47, and 6.03 mu mol.m(-2).s(-1) under TS, HS, and NS treatments. The mean soil water content were 15.50%, 15.57%, and 15.74% under WS, WM, and WF rotations, and 15.81%, 15.41%, and 15.50% under TS, HS, and NS treatments. The soil organic carbon (SOC) concentration was higher with increased straw retention, and lower at deeper soil depths. Mean SOC concentrations under different rotations and straw treatments of TS, HS, and NS, respectively were as follows: WS: 6.91, 6.63, 6.39 g/kg; WM: 6.90, 6.72, 6.57 g/kg; and WF: 6.49, 6.52, 6.37 g/kg. Soil temperature was the main determinant of soil respiration rates. We conclude that WS rotation resulted in lower soil respiration, WM rotation resulted in a higher soil carbon sequestration potential, and WF rotation resulted in higher soil water content. However, continued, long-term monitoring is needed to confirm the effect of rotations and straw retention on soil respiration and carbon sequestration in dryland cropping systems in northern China.	[Kong, Dejie; Wang, Weiyu; Akhtar, Kashif; Li, Na; Ren, Guangxin; Feng, Yongzhong; Yang, Gaihe] Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China; [Kong, Dejie] NingXia Acad Agr & Forestry Sci, Agr Biotechnol Ctr, Yinchuan, Ningxia, Peoples R China; [Kong, Dejie; Wang, Weiyu; Akhtar, Kashif; Li, Na; Ren, Guangxin; Feng, Yongzhong; Yang, Gaihe] Res Ctr Recycling Agr Engn Technol Shaanxi Prov, Yangling, Shaanxi, Peoples R China; [Liu, Nana] Ningxia Agr Inst Survey Design, Yinchuan, Ningxia, Peoples R China	Northwest A&F University - China	Feng, YZ; Yang, GH (corresponding author), Northwest A&F Univ, Coll Agron, Yangling, Shaanxi, Peoples R China.; Feng, YZ; Yang, GH (corresponding author), Res Ctr Recycling Agr Engn Technol Shaanxi Prov, Yangling, Shaanxi, Peoples R China.	fengyz@nwsuaf.edu.cn; ygh@nwsuaf.edu.cn	德杰, 孔/GRR-8605-2022	德杰, 孔/0000-0001-5749-5890	Shaanxi Provincial Government [2016KTCL02-11]; NingXia Academy of Agriculture and Forestry Sciences [QCYL2018-09]	Shaanxi Provincial Government; NingXia Academy of Agriculture and Forestry Sciences	This study was supported by Shaanxi Provincial Government (Projects 2016KTCL02-11) and supported by NingXia Academy of Agriculture and Forestry Sciences (Projects QCYL2018-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by Shaanxi Provincial Government (Projects 2016KTCL02-11) and supported by NingXia Academy of Agriculture and Forestry Sciences (Projects QCYL2018-09). We are thankful to Gaihe Yang for technical support, Guangxin Ren and Yongzhong Feng for his assistance in field management and measurements. Kashif Akhar and Huiying Li performed field experiment, Nana Liu and Weiyu Wang contributed reagents/materials/analysis tools: Dejie Kong wrote the paper. We are thankful to the anonymous reviewers for their constructive comments.	Al-Kaisi MM, 2005, J ENVIRON QUAL, V34, P437, DOI 10.2134/jeq2005.0437; Brankatschk G, 2017, AGRON SUSTAIN DEV, V37, DOI 10.1007/s13593-017-0464-4; Brye KR, 2006, SOIL SCI SOC AM J, V70, P1145, DOI 10.2136/sssaj2005.0151; Cao GL, 2008, CHINESE SCI BULL, V53, P784, DOI 10.1007/s11434-008-0145-4; Chen GQ, 2010, ENERG POLICY, V38, P6180, DOI 10.1016/j.enpol.2010.06.004; Chen SuYing, 2013, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V21, P519, DOI 10.3724/SP.J.1011.2013.00519; Deng XP, 2006, AGR WATER MANAGE, V80, P23, DOI 10.1016/j.agwat.2005.07.021; Di Bene C, 2016, ITAL J AGRON, V11, P209, DOI 10.4081/ija.2016.763; Gullett B, 2003, ATMOS ENVIRON, V37, P4893, DOI 10.1016/j.atmosenv.2003.08.011; Hu ZH, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-012-1394-z; Huang Y, 2004, SOIL BIOL BIOCHEM, V36, P973, DOI 10.1016/j.soilbio.2004.02.009; Ji SN, 2001, SOIL SCI SOC AM J, V65, P442, DOI 10.2136/sssaj2001.652442x; Kopke U, 2010, FIELD CROP RES, V115, P217, DOI 10.1016/j.fcr.2009.10.012; Lai R, 2017, CATENA, V151, P202, DOI 10.1016/j.catena.2016.12.013; Li LJ, 2013, EUR J SOIL BIOL, V54, P1, DOI 10.1016/j.ejsobi.2012.11.002; Liu C, 2014, GLOBAL CHANGE BIOL, V20, P1366, DOI 10.1111/gcb.12517; Liu EK, 2010, GEODERMA, V158, P173, DOI 10.1016/j.geoderma.2010.04.029; Liu Q., 2016, SCI REPORTS, V6; Liu Y, 2016, CLEAN-SOIL AIR WATER, V44, P867, DOI 10.1002/clen.201400478; Lokupitiya E, 2006, J ENVIRON QUAL, V35, P1413, DOI 10.2134/jeq2005.0157; Lu F, 2015, MITIG ADAPT STRAT GL, V20, P1545, DOI 10.1007/s11027-014-9564-5; Malhi SS, 2007, SOIL TILL RES, V96, P269, DOI 10.1016/j.still.2007.06.011; Mariko S, 2000, ECOL RES, V15, P363, DOI 10.1046/j.1440-1703.2000.00357.x; Miao YX, 2011, AGRON SUSTAIN DEV, V31, P397, DOI 10.1051/agro/2010034; Mu L, 2014, SPAN J AGRIC RES, V12, P265, DOI 10.5424/sjar/2014121-4895; Parkin TB, 2003, SOIL SCI SOC AM J, V67, P1763, DOI 10.2136/sssaj2003.1763; Plaza-Bonilla D., 2015, AGRONOMY SUSTAINABLE, V35; Quemada M, 1997, PLANT SOIL, V189, P127, DOI 10.1023/A:1004281804058; Ren C., 2016, SCI REPORTS, V6; Ren CJ, 2018, FOREST ECOL MANAG, V409, P170, DOI 10.1016/j.foreco.2017.11.011; Ren CJ, 2018, SOIL BIOL BIOCHEM, V116, P4, DOI 10.1016/j.soilbio.2017.09.028; Sainju UM, 2006, SOIL SCI SOC AM J, V70, P668, DOI 10.2136/sssaj2005.0089; Sainju UM, 2016, PLOS ONE, V11; Sainju UM, 2008, J ENVIRON QUAL, V37, P98, DOI 10.2134/jeq2006.0392; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Singh RJ, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-015-5085-2; Suh SU, 2006, ECOL RES, V21, P405, DOI 10.1007/s11284-005-0137-7; Tanveer SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072140; Tufekcioglu A, 2001, PLANT SOIL, V229, P117, DOI 10.1023/A:1004818422908; Wang XJ, 2012, BIORESOURCE TECHNOL, V120, P78, DOI 10.1016/j.biortech.2012.06.058; Wang XJ, 2018, FIELD CROP RES, V218, P11, DOI 10.1016/j.fcr.2017.12.003; Wang YJ, 2010, AGR SCI CHINA, V9, P1807, DOI 10.1016/S1671-2927(09)60279-0; Wang YP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0077810, 10.1371/journal.pone.0101303]; Wang ZT, 2016, AGRON SUSTAIN DEV, V36, DOI 10.1007/s13593-016-0366-x; Wuest SB, 2013, SOIL SCI SOC AM J, V77, P279, DOI 10.2136/sssaj2012.0110; Yang F, 2017, J ARID LAND, V9, P568, DOI 10.1007/s40333-017-0060-0; Zeng XY, 2007, RENEW SUST ENERG REV, V11, P976, DOI 10.1016/j.rser.2005.10.003; Zhang H, 2017, J ARID LAND, V9, P666, DOI 10.1007/s40333-017-0027-1; Zhang Ping, 2015, SCI REPORTS, V5	49	12	13	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0219253	10.1371/journal.pone.0219253	http://dx.doi.org/10.1371/journal.pone.0219253			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545801	gold, Green Published			2022-12-26	WOS:000532303200009
J	Maastrup, R; Walloee, S; Kronborg, H				Maastrup, Ragnhild; Walloee, Sisse; Kronborg, Hanne			Nipple shield use in preterm infants: Prevalence, motives for use and association with exclusive breastfeeding-Results from a national cohort study	PLOS ONE			English	Article							NEONATAL INTENSIVE-CARE; MOTHERS; DURATION	Background and aim Prevalence and motives for nipple shield use are not well studied in preterm infants and recommendations of nipple shield use in preterm infants are inconsistent. The aim of this study was to determine the prevalence of nipple shield use, explore the motives for nipple shield use and elucidate the association with exclusive breastfeeding in preterm infants. Methods The study was part of a prospective survey of a Danish national cohort of preterm infants based on questionnaires answered by the 1221 mothers of 1488 preterm infants with gestational age of 24-36 weeks. Data on nipple shield use was available for 1407 infants. Results Nipple shields were used by 54% of the mother-infant dyads for many different motives and was more often related to breastfeeding problems associated with the infant than with the mother. The most common motive for nipple shield use was "infant slipped the nipple" (52%). The lower the gestational age, the more frequently nipple shields were used for motives related to the infant. For those using a nipple shield, only the motive "infant fell asleep at the breast" was associated with a higher risk of not breastfeeding exclusively at discharge (OR 1.90 (95% CI 1.15; 3.13), p = 0.012), and "breast too engorged" with a lower risk of not breastfeeding exclusively (OR 0.32 (0.16; 0.63), p = 0.001), but overall nipple shield use was associated with failure of exclusive breastfeeding. Conclusion The present study does not give justifiable motives for nipple shield use, except for "breast too engorged". Nipple shields should not be recommended for infants falling asleep at the breast, instead, staff and mothers should be patient, allowing the dyad time skin-to-skin. The results indicate that the use of a nipple shield does not promote exclusive breastfeeding in preterm infants.	[Maastrup, Ragnhild] Copenhagen Univ Hosp, Rigshosp, Knowledge Ctr Breastfeeding Infants Special Needs, Dept Neonatol, Copenhagen, Denmark; [Maastrup, Ragnhild; Walloee, Sisse] Copenhagen Univ Hosp, Rigshosp, Juliane Marie Ctr, Res Unit Womens & Childrens Hlth, Copenhagen, Denmark; [Walloee, Sisse] Slagelse Hosp, Dept Obstet & Gynecol, Slagelse, Denmark; [Kronborg, Hanne] Aarhus Univ, Dept Publ Hlth, Sect Nursing, Aarhus, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Aarhus University	Maastrup, R (corresponding author), Copenhagen Univ Hosp, Rigshosp, Knowledge Ctr Breastfeeding Infants Special Needs, Dept Neonatol, Copenhagen, Denmark.; Maastrup, R (corresponding author), Copenhagen Univ Hosp, Rigshosp, Juliane Marie Ctr, Res Unit Womens & Childrens Hlth, Copenhagen, Denmark.	ragnhild.maastrup@regionh.dk		Maastrup, Ragnhild/0000-0001-8719-5717; Walloee, Sisse/0000-0002-9212-2122	Swedish Research Council; Soester Marie Dalgaards Foundation; Rigshospitalet, Copenhagen University Hospital; Department of Neonatology, Rigshospitalet, Copenhagen University Hospital; Novo Nordisk Foundation [NNF15OC0018156]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Soester Marie Dalgaards Foundation; Rigshospitalet, Copenhagen University Hospital; Department of Neonatology, Rigshospitalet, Copenhagen University Hospital; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The authors disclosed receipt of the following financial support for the research and authorship of this article: Funding to support the research was received from The Swedish Research Council http://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152.html (RM); Soester Marie Dalgaards Foundation https://www.diakonissestiftelsen.dk/default.aspx?ID%20=% 201177 (RM); Rigshospitalet, Copenhagen University Hospital https://www.rigshospitalet.dk/(RM); Department of Neonatology, Rigshospitalet, Copenhagen University Hospital https://www.rigshospitalet.dk/afdelinger-og-klinikker/julianemarie/neonatalklinikken/Sider/default.aspx (RM), and Novo Nordisk Foundation, grant number NNF15OC0018156 https://novonordiskfonden.dk/en/(RM).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloysius A., 2007, NEONATAL NURSING, V3, P96; Altman D.G., 1991, PRACTICAL STATISTIC; [Anonymous], 2013, WMA DECL HELS ETH PR; Blackmon LR, 2004, PEDIATRICS, V114, P1362, DOI 10.1542/peds.2004-1915; Clum D, 1996, J Hum Lact, V12, P287, DOI 10.1177/089033449601200413; Eglash A, 2010, BREASTFEED MED, V5, P147, DOI 10.1089/bfm.2010.0006; Ekstrom A, 2014, BREASTFEED MED, V9, P458, DOI 10.1089/bfm.2014.0026; Flacking R, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-016-1183-6; Froh EB, 2015, J PEDIATR NURS, V30, P521, DOI 10.1016/j.pedn.2015.01.023; Hanna S, 2013, MIDWIFERY, V29, P616, DOI 10.1016/j.midw.2012.05.005; Kronborg H, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12251; Labbok MH, 2012, BREASTFEED MED, V7, P397, DOI 10.1089/bfm.2012.9975; Maastrup R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108208; Maastrup R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089077; Maastrup R, 2012, J HUM LACT, V28, P370, DOI 10.1177/0890334412440846; Meier P P, 2000, J Hum Lact, V16, P106, DOI 10.1177/089033440001600205; Meier PP, 2013, PEDIATR CLIN N AM, V60, P209, DOI 10.1016/j.pcl.2012.10.007; Nyqvist KH, 2013, J HUM LACT, V29, P300, DOI 10.1177/0890334413489775; Nyqvist KH, 2015, NEO BFHI BABY FRIEND; Pincombe J, 2008, MIDWIFERY, V24, P55, DOI 10.1016/j.midw.2006.06.009; WHO UNICEF, 2009, BAB FRIENDL HOSP IN; Winterstein AG, 2013, JAMA PEDIATR, V167, P1118, DOI 10.1001/jamapediatrics.2013.2636	22	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222811	10.1371/journal.pone.0222811	http://dx.doi.org/10.1371/journal.pone.0222811			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539900	Green Published, gold			2022-12-26	WOS:000532297900031
J	Shinohara, N; Mizukoshi, A; Uchiyama, M; Tanaka, H				Shinohara, Naohide; Mizukoshi, Atsushi; Uchiyama, Mayumi; Tanaka, Hirofumi			Emission characteristics of diethylhexyl phthalate (DEHP) from building materials determined using a passive flux sampler and micro-chamber	PLOS ONE			English	Article							SEMIVOLATILE ORGANIC-COMPOUNDS; PREDICTING EMISSIONS; HISTORY METHOD; PVC; EXPOSURE; AIR; PLASTICIZER; ASSOCIATION; PARAMETERS; SYMPTOMS	Emission rates of diethylhexyl phthalate (DEHP) from building materials, such as vinyl floorings and wall paper, determined using a passive flux sampler (PFS) were constant over the week-long measurement period. Emission rates for vinyl floorings and wallpaper were linearly correlated to the inverse of diffusion distance, which corresponds to the internal depth of the PFS. Surface-air DEHP concentrations (y(0)) were estimated as 1.3-2.3 mu g/m(3) for materials having a boundary layer molecular diffusion rate-limiting step. The partition coefficient (Kmaterial-air) was estimated as 3.3-7.5 x 10(10) for these materials. Additionally, emission rates of DEHP from same building materials determined using a micro-chamber were 4.5-6.1 mu g/m(2)/h. Mass transfer coefficients in the micro-chamber (h(m)) were estimated by comparing the results using the PFS and micro-chamber, and these were 1.1-1.2 x 10(-3) and 8.1 x 10(-4) m/s for vinyl floorings (smooth surface) and wallpaper (rough surface), respectively. The thickness of boundary layer on the surface of building materials in the micro-chamber were estimated to be 2.5-2.6 and 3.7 mm for vinyl floorings and wallpaper, respectively.	[Shinohara, Naohide] Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil RISS, Tsukuba, Ibaraki, Japan; [Mizukoshi, Atsushi] Kindai Univ, Dept Environm Med & Behav Sci, Fac Med, Osakasayama, Osaka, Japan; [Uchiyama, Mayumi; Tanaka, Hirofumi] MC Evolve Technol Corp, Inashiki, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Shinohara, N (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil RISS, Tsukuba, Ibaraki, Japan.	n-shinohara@aist.go.jp	Mizukoshi, Atsushi/H-2783-2018; Shinohara, Naohide/L-8743-2018	Mizukoshi, Atsushi/0000-0002-2281-3526; Shinohara, Naohide/0000-0001-7675-6929	LIXIL JS Foundation [12-27]	LIXIL JS Foundation	This study was funded by a grant entitled "Dermal exposure assessment of phthalate esters in building materials: Development of test method of dermal exposure" (No. 12-27), from the LIXIL JS Foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MC Evolve Technologies Corporation provided support in the form of salaries for authors MU and HT but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshari A, 2004, INDOOR AIR, V14, P120, DOI 10.1046/j.1600-0668.2003.00220.x; Benning JL, 2013, ENVIRON SCI TECHNOL, V47, P2696, DOI 10.1021/es304725b; Bornehag CG, 2010, INT J ANDROL, V33, P333, DOI 10.1111/j.1365-2605.2009.01023.x; Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187; Cao J, 2017, INDOOR AIR, V27, P417, DOI 10.1111/ina.12312; Cao JP, 2016, ENVIRON SCI TECHNOL, V50, P825, DOI 10.1021/acs.est.5b04404; Carlstedt F, 2013, INDOOR AIR, V23, P32, DOI 10.1111/j.1600-0668.2012.00788.x; Clausen PA, 2004, ENVIRON SCI TECHNOL, V38, P2531, DOI 10.1021/es0347944; Clausen PA, 2012, ENVIRON SCI TECHNOL, V46, P909, DOI 10.1021/es2035625; Clausen PA, 2010, ATMOS ENVIRON, V44, P2760, DOI 10.1016/j.atmosenv.2010.04.020; Fujii M, 2003, ATMOS ENVIRON, V37, P5495, DOI 10.1016/j.atmosenv.2003.09.026; Hoshino K, 2006, J ENV ENG T AIJ, V604, P51; Hoshino K, 2007, J ENV ENG, V618, P69; ISO, 2011, 16000252011 ISO; JIS, 2008, A19042008 JIS; Kanazawa A, 2010, INDOOR AIR, V20, P72, DOI 10.1111/j.1600-0668.2009.00629.x; Liang YR, 2014, ENVIRON SCI TECHNOL, V48, P4475, DOI 10.1021/es405809r; Liu C, 2016, BUILD ENVIRON, V95, P283, DOI 10.1016/j.buildenv.2015.09.028; Liu C, 2012, ATMOS ENVIRON, V55, P347, DOI 10.1016/j.atmosenv.2012.03.030; Liu Z, 2013, BUILD ENVIRON, V64, P7, DOI 10.1016/j.buildenv.2013.02.012; Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139, DOI 10.1289/ehp.5658; Lyche JL, 2009, J TOXICOL ENV HEAL B, V12, P225, DOI 10.1080/10937400903094091; MOE, 1988, HDB ENV CHEM SUBST S, P411; Murakami S, ANN M ARCH I JAP 200, VD-2, P807; Strommen MR, 1999, ENVIRON SCI TECHNOL, V33, P1738, DOI 10.1021/es981035q; Tanabe S., 2010, S LAT TRENDS INT STA; Tanaka H., 2014, COMMUNICATION; Weschler CJ, 2008, ATMOS ENVIRON, V42, P9018, DOI 10.1016/j.atmosenv.2008.09.052; Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x; Wu Y, 2016, INDOOR AIR, V26, P903, DOI 10.1111/ina.12270; Xiong JY, 2016, BUILD ENVIRON, V95, P314, DOI 10.1016/j.buildenv.2015.09.027; Xiong JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049342; Xu Y, 2006, ENVIRON SCI TECHNOL, V40, P456, DOI 10.1021/es051517j; Xu Y, 2012, ENVIRON SCI TECHNOL, V46, P12534, DOI 10.1021/es302319m	34	5	5	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222557	10.1371/journal.pone.0222557	http://dx.doi.org/10.1371/journal.pone.0222557			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539387	Green Submitted, Green Published, gold			2022-12-26	WOS:000532297900016
J	Fata, A; Bojdy, A; Maleki, M; Farash, BRH; Ghazvini, K; Tajzadeh, P; Vakili, V; Moghaddas, E; Mastroeni, P; Rahmani, S				Fata, Abdolmajid; Bojdy, Amin; Maleki, Masoud; Farash, Bibi Razieh Hosseini; Ghazvini, Kiarash; Tajzadeh, Parastoo; Vakili, Vida; Moghaddas, Elham; Mastroeni, Pietro; Rahmani, Shadi			Fish tank granuloma: An emerging skin disease in Iran mimicking Cutaneous Leishmaniasis	PLOS ONE			English	Article							MYCOBACTERIUM-MARINUM INFECTION; DIAGNOSIS; PCR; DNA	Objective Mycobacterium marinum causes a rare cutaneous disease known as fish tank granuloma (FTG). The disease manifestations resemble those associated with Cutaneous Leishmaniasis (CL). The aim of this study was to determine whether FTG was the cause of cutaneous lesions in patients who were referred to the Parasitology laboratory of Imam Reza Hospital in Mashhad to be investigated for CL. Materials/Methods One hundered patients, clinically diagnosed with CL between April 2014 and March 2015, were included in this study. Ziehl-Neelsen staining was performed to identify acid-fast Mycobacterium in addition to bacterial cultures using Lowenstein-Jensen medium. Skin lesion samples were also collected and kept on DNA banking cards for PCR testing. Results Twenty-nine of the 100 individuals with skin lesions, and therefore suspected of suffering from CL, tested positive for Mycobacterium marinum by PCR. Of these, 21 (72.4%) were male and 8(27.6%) were female. In 97% of these cases the lesions were located on hands and fingers. These patients had a history of manipulating fish and had been in contact with aquarium water. A sporotrichoid appearance was observed in 58.6% of the patients with mycobacterial lesions; 67% of patients had multiple head appearance. Conclusion Patients suspected to have CL and who test negative for CL could be affected by FTG. Therefore, after obtaining an accurate case history, molecular diagnosis is recommended for cases that give a negative result by conventional methods.	[Fata, Abdolmajid; Farash, Bibi Razieh Hosseini] Mashhad Univ Med Sci, Cutaneous Leishmaniasis Res Ctr, Mashhad, Khorasan E Raza, Iran; [Fata, Abdolmajid; Farash, Bibi Razieh Hosseini; Moghaddas, Elham; Rahmani, Shadi] Mashhad Univ Med Sci, Fac Med, Dept Parasitol & Mycol, Mashhad, Khorasan E Raza, Iran; [Bojdy, Amin] Mashhad Univ Med Sci, Imam Reza Hosp, Dept Infect Dis, Mashhad, Khorasan E Raza, Iran; [Maleki, Masoud] Mashhad Univ Med Sci, Imam Reza Hosp, Dept Dermatol, Mashhad, Khorasan E Raza, Iran; [Ghazvini, Kiarash] Mashhad Univ Med Sci, Quem Hosp, Dept Microbiol, Mashhad, Khorasan E Raza, Iran; [Tajzadeh, Parastoo] Mashhad Univ Med Sci, Fac Nursing, Dept Med Lab Sci, Mashhad, Khorasan E Raza, Iran; [Vakili, Vida] Mashhad Univ Med Sci, Fac Med, Dept Social Med, Mashhad, Khorasan E Raza, Iran; [Mastroeni, Pietro] Univ Cambridge, Dept Vet Med, Cambridge, England	Mashhad University Medical Science; Mashhad University Medical Science; Mashhad University Medical Science; Mashhad University Medical Science; Mashhad University Medical Science; Mashhad University Medical Science; Mashhad University Medical Science; University of Cambridge	Farash, BRH (corresponding author), Mashhad Univ Med Sci, Cutaneous Leishmaniasis Res Ctr, Mashhad, Khorasan E Raza, Iran.; Farash, BRH (corresponding author), Mashhad Univ Med Sci, Fac Med, Dept Parasitol & Mycol, Mashhad, Khorasan E Raza, Iran.	hoseinifr@mums.ac.ir	moghaddas, elham/K-8397-2016; Tajzadeh, Parastoo/AAQ-2325-2020	Mastroeni, Pietro/0000-0003-3838-4962; Hosseini Farash, Bibi Razieh/0000-0003-2748-9435	Faculty of Medicine, Mashhad University of Medical Sciences [930798, A-820]	Faculty of Medicine, Mashhad University of Medical Sciences	This paper described work that was part of MSc thesis No. A-820 the research project No. 930798 approved and supported by Deputy of Research, Faculty of Medicine, Mashhad University of Medical Sciences.; This paper described work that was part of MSc thesis No. A-820 the research project No. 930798 approved and supported by Deputy of Research, Faculty of Medicine, Mashhad University of Medical Sciences. The authors also thank the colleagues in leishmaniasis laboratory of Emam Reza Hospital, Mashhad University of Medical Sciences, who provided the insight and expertise that assisted the research.	Abedi-Astaneh F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161317; Akilov OE, 2007, INT J DERMATOL, V46, P132, DOI 10.1111/j.1365-4632.2007.03154.x; Ang P, 2000, INT J DERMATOL, V39, P343, DOI 10.1046/j.1365-4362.2000.00916.x; [Anonymous], 2017, CUTANEOUS LEISHMANIA; Asakura T, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003131; Attarzadeh A, 2017, ROM REP PHYS, V69; Babamahmoodi F, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.10120; Baransk-Arybak W, POSTEPY DERMATOL ALE; Bartralot R, 2000, J CUTAN PATHOL, V27, P124, DOI 10.1034/j.1600-0560.2000.027003124.x; Beldi N, 2017, VECTOR-BORNE ZOONOT, V17, P416, DOI 10.1089/vbz.2016.2071; COLLINS CH, 1985, J HYG-CAMBRIDGE, V94, P135, DOI 10.1017/S0022172400061349; de Vries HJC, 2015, AM J CLIN DERMATOL, V16, P99, DOI 10.1007/s40257-015-0114-z; Dodiuk-Gad R, 2007, J AM ACAD DERMATOL, V57, P413, DOI 10.1016/j.jaad.2007.01.042; Dolenc-Voljc M, 2010, ACTA DERMATOVEN ALP, V19, P35; EDELSTEIN H, 1994, ARCH INTERN MED, V154, P1359, DOI 10.1001/archinte.154.12.1359; Farash BRH, 2013, JUNDISHAPUR J MICROB, V6, DOI 10.5812/jjm.8274; Fata A, 2009, IRAN J PARASITOL, V4, P37; Fata A, 2017, J PARAMED SCI REHABI, V6, P80, DOI [10.22038/jpsr.2017.14754.1376, DOI 10.22038/JPSR.2017.14754.1376]; GLUCKMAN SJ, 1995, CLIN DERMATOL, V13, P273, DOI 10.1016/0738-081X(95)00023-9; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hamzavi Y, 2015, IRAN J PARASITOL, V10, P78; Holakouie-Naieni K, 2017, ACTA TROP, V166, P67, DOI 10.1016/j.actatropica.2016.11.004; Hosseini F., 2013, International Research Journal of Biological Sciences, V2, P1; Izadi S, 2016, JUNDISHAPUR J MICROB, V9, DOI 10.5812/jjm.32885; Johnson MG, 2015, INFECTION, V43, P655, DOI 10.1007/s15010-015-0776-8; JOHNSTON JM, 1987, CLIN DERMATOL, V5, P68, DOI 10.1016/S0738-081X(87)80011-1; Karim S, 2013, CAN FAM PHYSICIAN, V59, P51; Khajedaluee M., 2014, Medical Journal of Mashhad University of Medical Sciences, V57, P647; Khazaei S, 2015, ARCH CLIN INFECT DIS, V10, DOI 10.5812/archcid.28511; Kox LFF, 1995, NEUROLOGY, V45, P2228, DOI 10.1212/WNL.45.12.2228; Lewis FMT, 2003, CLIN INFECT DIS, V37, P390, DOI 10.1086/376628; LORIA PR, 1976, ARCH DERMATOL, V112, P517, DOI 10.1001/archderm.112.4.517; Miranda A, 2012, T ROY SOC TROP MED H, V106, P544, DOI 10.1016/j.trstmh.2012.05.005; Nazari M, 2017, ASIAN PAC J TROP MED, V10, P88, DOI 10.1016/j.apjtm.2016.12.001; Nazzaro G, 2014, JAMA DERMATOL, V150, P1204, DOI 10.1001/jamadermatol.2014.1015; Neitzke-Abreu HC, 2014, IDCases, V1, P60, DOI 10.1016/j.idcr.2014.07.003; Neonakis IK, 2008, J MICROBIOL METH, V75, P1, DOI 10.1016/j.mimet.2008.05.023; Pate M, 2005, DIS AQUAT ORGAN, V64, P29, DOI 10.3354/dao064029; Pourmohammadi B, 2010, IRAN J PARASITOL, V5, P1; Rakotosamimanana N, 2017, INT J INFECT DIS, V56, P248, DOI 10.1016/j.ijid.2016.12.005; Steinbrink J, 2017, CUTIS, V100, P331; Streit M, 2008, HAUTARZT, V59, P59, DOI 10.1007/s00105-007-1447-1; Vanhooteghem O, 2017, EUR J DERMATOL, V27, P299, DOI 10.1684/ejd.2017.2976; Veraldi S, 2016, GIORN ITAL DERMAT V, V151, P569; Weigle KA, 2002, J CLIN MICROBIOL, V40, P601, DOI 10.1128/JCM.40.2.601-606.2002; Wortmann G, 2007, AM J TROP MED HYG, V76, P906, DOI 10.4269/ajtmh.2007.76.906	46	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0221367	10.1371/journal.pone.0221367	http://dx.doi.org/10.1371/journal.pone.0221367			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536497	Green Published, gold, Green Submitted			2022-12-26	WOS:000532262800017
J	Hausken, K; Levavi-Sivan, B				Hausken, Krist; Levavi-Sivan, Berta			Synteny and phylogenetic analysis of paralogous thyrostimulin beta subunits (GpB5) in vertebrates	PLOS ONE			English	Article							THYROID-STIMULATING HORMONE; AMINO-ACID-SEQUENCE; HETERODIMERIC GLYCOPROTEIN HORMONE; LEUCINE-RICH REPEAT; SEA LAMPREY; TSH RECEPTOR; THYROTROPIN; PROTEIN; GONADOTROPIN; EXPRESSION	At some point early in the vertebrate lineage, two whole genome duplication events (1R, 2R) took place that allowed for the diversification and sub-/neo-functionalization of the glycoprotein hormones (GpHs). All jawed vertebrates possess the GpHs luteinizing hormone (LH), follicle stimulating hormone (FSH), and thyroid stimulating hormone (TSH), each of which are heterodimers with a common alpha subunit and unique beta subunits. In 2002, a novel glycoprotein hormone named thyrostimulin was described to have unique GpA2 and GpB5 subunits that were homologous to the vertebrate alpha and beta subunits. The presence of GpA2 and GpB5 in representative protostomes and deuterostomes indicates their ancestry in the GpH family. There are several reports of GpH subunit evolution, but none have included GpA2 and GpB5 for species in each major vertebrate class. Thus, we addressed the ancestry of two paralogous GpB5 subunits (GpB5a and GpB5b) that were previously only recognized in two teleost species. Our search for orthologous GpB5a and GpB5b sequences in representative vertebrates and phylogenetic analysis, in addition to the currently published evolutionary scenarios of the GpH family, supports that GpB5a and GpB5b are paralogs that arose from the first vertebrate whole genome duplication event (1R). Syntenic analysis supports lineage specific losses of GpB5a in chondrichthyes, basal actinopterygians, and tetrapods, and retention in coelacanth and teleosts. Additionally, we were unable to identify GpA2 transcripts from tilapia mRNA, suggesting that this species does not produce heterodimeric thyrostimulin. While the conserved or even species-specific functional role of thyrostimulin or its individual subunits are still unknown in vertebrates, the analyses presented here provide context for future studies on the functional divergence of the GpH family.	[Hausken, Krist; Levavi-Sivan, Berta] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Anim Sci, Rehovot, Israel	Hebrew University of Jerusalem	Levavi-Sivan, B (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Anim Sci, Rehovot, Israel.	berta.sivan@mail.huji.ac.il		Levavi-Sivan, Berta/0000-0002-0183-9524; Hausken, Krist/0000-0003-2432-6702	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant [642893]; Israel Science Foundation (ISF) [1540/17]; BARD, the United States - Israel Binational Agricultural Research and Development Fund, Vaadia-BARD Postdoctoral Fellowship Award [FU-561-2017]	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant; Israel Science Foundation (ISF)(Israel Science Foundation); BARD, the United States - Israel Binational Agricultural Research and Development Fund, Vaadia-BARD Postdoctoral Fellowship Award	This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant Agreement no 642893 IMPRESS to BLS. The research was funded by the Israel Science Foundation (ISF) no. 1540/17 to BLS. This research was supported by BARD, the United States - Israel Binational Agricultural Research and Development Fund, Vaadia-BARD Postdoctoral Fellowship Award No. FU-561-2017 to KNH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2011, FASEB J, V25, P3687, DOI 10.1096/fj.11-188961; Alvarez E, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-90; Benton M.J., 2005, VERTEBRATE PALAEONTO; Bruser A, 2016, J BIOL CHEM, V291, P508, DOI 10.1074/jbc.M115.701102; Buechi HB, 2017, GEN COMP ENDOCR, V246, P309, DOI 10.1016/j.ygcen.2017.01.007; Cahoreau C, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00026; Caltabiano G, 2008, CELL MOL LIFE SCI, V65, P2484, DOI 10.1007/s00018-008-8002-9; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Chauvigne F, 2010, BIOL REPROD, V82, P1088, DOI 10.1095/biolreprod.109.082289; Dos Santos S, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-332; Dos Santos S, 2009, ENDOCRINOLOGY, V150, P3815, DOI 10.1210/en.2008-1743; Hausken KN, 2018, GEN COMP ENDOCR, V264, P16, DOI 10.1016/j.ygcen.2018.04.010; Henkel CV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032231; Hsu SY, 2002, MOL ENDOCRINOL, V16, P1538, DOI 10.1210/me.16.7.1538; Jansen HJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07650-6; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Karponis Dimitrios, 2017, Endocr Regul, V51, P117, DOI 10.1515/enr-2017-0012; Krause G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052920; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li MD, 1998, J ENDOCRINOL, V156, P529, DOI 10.1677/joe.0.1560529; LIAO TH, 1971, J BIOL CHEM, V246, P850; LIU WK, 1972, J BIOL CHEM, V247, P4365; LOOSFELT H, 1989, SCIENCE, V245, P525, DOI 10.1126/science.2502844; Macdonald LE, 2005, P NATL ACAD SCI USA, V102, P2496, DOI 10.1073/pnas.0409849102; Marquis TJ, 2017, CELL TISSUE RES, V367, P311, DOI 10.1007/s00441-016-2502-y; Maugars G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135184; Maugars G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111361; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; MOYLE WR, 1994, NATURE, V368, P251, DOI 10.1038/368251a0; Nagasaki H, 2006, J MOL ENDOCRINOL, V37, P39, DOI 10.1677/jme.1.01932; Nakabayashi K, 2002, J CLIN INVEST, V109, P1445, DOI 10.1172/JCI200214340; Nguyen NTT, 2018, NUCLEIC ACIDS RES, V46, pD816, DOI 10.1093/nar/gkx1003; Ohno S., 1970, EVOLUTION GENE DUPLI; Okada SL, 2006, MOL ENDOCRINOL, V20, P414, DOI 10.1210/me.2005-0270; Okajima Y, 2008, REGUL PEPTIDES, V148, P62, DOI 10.1016/j.regpep.2008.03.002; PAPKOFF H, 1971, J AM CHEM SOC, V93, P1531; Park JI, 2005, ENDOCRINE, V26, P267, DOI 10.1385/ENDO:26:3:267; PARMENTIER M, 1989, SCIENCE, V246, P1620, DOI 10.1126/science.2556796; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Querat B, 2000, BIOL REPROD, V63, P222, DOI 10.1095/biolreprod63.1.222; Rocco DA, 2016, GEN COMP ENDOCR, V234, P20, DOI 10.1016/j.ygcen.2015.12.011; Roch GJ, 2014, GENOME BIOL EVOL, V6, P1466, DOI 10.1093/gbe/evu118; Sacerdot C, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1559-1; SHOME B, 1974, J CLIN ENDOCR METAB, V39, P203, DOI 10.1210/jcem-39-1-203; Smith JJ, 2015, GENOME RES, V25, P1081, DOI 10.1101/gr.184135.114; Smith JJ, 2013, NAT GENET, V45, P415, DOI 10.1038/ng.2568; Sower SA, 2006, GEN COMP ENDOCR, V148, P22, DOI 10.1016/j.ygcen.2005.11.009; Sower SA, 2015, ENDOCRINOLOGY, V156, P3026, DOI 10.1210/en.2014-1797; SPRENGEL R, 1990, MOL ENDOCRINOL, V4, P525, DOI 10.1210/mend-4-4-525; Sudo S, 2005, ENDOCRINOLOGY, V146, P3596, DOI 10.1210/en.2005-0317; Sun SC, 2010, J BIOL CHEM, V285, P3758, DOI 10.1074/jbc.M109.066266; Swanson P, 2003, FISH PHYSIOL BIOCHEM, V28, P53, DOI 10.1023/B:FISH.0000030476.73360.07; Szkudlinski MW, 2002, PHYSIOL REV, V82, P473, DOI 10.1152/physrev.00031.2001; Tando Y, 2009, ZOOL SCI, V26, P409, DOI 10.2108/zsj.26.409; Tando Y, 2009, GEN COMP ENDOCR, V162, P329, DOI 10.1016/j.ygcen.2009.04.015; Uchida K, 2010, P NATL ACAD SCI USA, V107, P15832, DOI 10.1073/pnas.1002208107; Ulloa-Aguirre A, 2001, ARCH MED RES, V32, P520, DOI 10.1016/S0188-4409(01)00319-8; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Van Hiel MB, 2012, PEPTIDES, V34, P193, DOI 10.1016/j.peptides.2011.11.004; van Zeijl CJJ, 2010, MOL CELL ENDOCRINOL, V321, P231, DOI 10.1016/j.mce.2010.03.002; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; WAKO H, 1995, BBA-PROTEIN STRUCT M, V1247, P104, DOI 10.1016/0167-4838(94)00216-4; WALLIS M, 1975, BIOL REV, V50, P35, DOI 10.1111/j.1469-185X.1975.tb00989.x; Wang P, 2018, ENDOCRINOLOGY, V159, P3536, DOI 10.1210/en.2018-00550; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; Yebra-Pimentel ES, 2019, FISH SHELLFISH IMMUN, V88, P508, DOI 10.1016/j.fsi.2019.03.014	69	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222808	10.1371/journal.pone.0222808	http://dx.doi.org/10.1371/journal.pone.0222808			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536580	Green Submitted, Green Published, gold			2022-12-26	WOS:000532262800088
J	Pausch, F; Bischof, K; Trimborn, S				Pausch, Franziska; Bischof, Kai; Trimborn, Scarlett			Iron and manganese co-limit growth of the Southern Ocean diatom Chaetoceros debilis	PLOS ONE			English	Article							PHYTOPLANKTON COMMUNITIES; SUPEROXIDE DISMUTASES; PHOTOSYSTEM-II; DRAKE PASSAGE; TRACE-METALS; LIGHT; RESPONSES; PRYMNESIOPHYCEAE; PHOTOSYNTHESIS; TRANSPORT	In some parts of the Southern Ocean (SO), even though low surface concentrations of iron (Fe) and manganese (Mn) indicate FeMn co-limitation, we still lack an understanding on how Mn and Fe availability influences SO phytoplankton ecophysiology. Therefore, this study investigated the effects of Fe and Mn limitation alone as well as their combination on growth, photophysiology and particulate organic carbon production of the bloom forming Antarctic diatom Chaetoceros debilis. Our results clearly show that growth, photochemical efficiency and carbon production of C. debilis were co-limited by Fe and Mn as highest values were only reached when both nutrients were provided. Even though Mn-deficient cells had higher photochemical efficiencies than Fe-limited ones, they, however, displayed similar low growth and POC production rates, indicating that Mn limitation alone drastically impeded the cell's performance. These results demonstrate that similar to low Fe concentrations, low Mn availability inhibits growth and carbon production of C. debilis. As a result from different species-specific trace metal requirements, SO phytoplankton species distribution and productivity may therefore not solely depend on the input of Fe alone, but also critically on Mn acting together as important drivers of SO phytoplankton ecology and biogeochemistry.	[Pausch, Franziska; Trimborn, Scarlett] Helmholtz Ctr Polar & Marine Res, EcoTrace, Alfred Wegener Inst, Bremen, Germany; [Pausch, Franziska; Bischof, Kai; Trimborn, Scarlett] Univ Bremen, Marine Bot, Bremen, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bremen	Pausch, F (corresponding author), Helmholtz Ctr Polar & Marine Res, EcoTrace, Alfred Wegener Inst, Bremen, Germany.; Pausch, F (corresponding author), Univ Bremen, Marine Bot, Bremen, Germany.	Franziska.Pausch@awi.de	Trimborn, Scarlett/AAM-1061-2021	Trimborn, Scarlett/0000-0003-1434-9927; Pausch, Franziska/0000-0002-4207-1304; Bischof, Kai/0000-0002-4497-1920	Helmholtz Impulse Fond (HGF Young Investigators Group EcoTrace) [VH-NG-901]; Deutsche Forschungsgemeinschaft [TR 899/4-1]	Helmholtz Impulse Fond (HGF Young Investigators Group EcoTrace); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	ST and FP were funded by the Helmholtz Impulse Fond (HGF Young Investigators Group EcoTrace, VH-NG-901). ST was funded by Deutsche Forschungsgemeinschaft (TR 899/4-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderkamp AC, 2012, J PHYCOL, V48, P45, DOI 10.1111/j.1529-8817.2011.01098.x; Allen MD, 2007, PLANT PHYSIOL, V143, P263, DOI 10.1104/pp.106.088609; Assmy P, 2007, DEEP-SEA RES PT I, V54, P340, DOI 10.1016/j.dsr.2006.12.005; Behrenfeld MJ, 2013, ANNU REV MAR SCI, V5, P217, DOI 10.1146/annurev-marine-121211-172356; Behrenfeld MJ, 1999, SCIENCE, V283, P840, DOI 10.1126/science.283.5403.840; Boyd PW, 2010, NAT GEOSCI, V3, P675, DOI [10.1038/NGEO964, 10.1038/ngeo964]; Browning TJ, 2014, GEOPHYS RES LETT, V41, P2851, DOI 10.1002/2014GL059364; BUMA AGJ, 1991, LIMNOL OCEANOGR, V36, P1865, DOI 10.4319/lo.1991.36.8.1865; Cutter G.A., 2017, SAMPLING SAMPLE HAND, P139, DOI [10.25607/OBP-2, DOI 10.25607/OBP-2]; de Jong J, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2011JG001679; DEBAAR HJW, 1995, NATURE, V373, P412, DOI 10.1038/373412a0; DUCE RA, 1991, LIMNOL OCEANOGR, V36, P1715, DOI 10.4319/lo.1991.36.8.1715; GEIDER RJ, 1994, PHOTOSYNTH RES, V39, P275, DOI 10.1007/BF00014588; Gerringa LJA, 2000, MAR CHEM, V68, P335, DOI 10.1016/S0304-4203(99)00092-4; GREENE RM, 1992, PLANT PHYSIOL, V100, P565, DOI 10.1104/pp.100.2.565; GREENE RM, 1991, LIMNOL OCEANOGR, V36, P1772, DOI 10.4319/lo.1991.36.8.1772; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hathorne EC, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003907; Hoffmann LJ, 2008, POLAR BIOL, V31, P1067, DOI 10.1007/s00300-008-0448-6; Hopkinson BM, 2007, LIMNOL OCEANOGR, V52, P2540, DOI 10.4319/lo.2007.52.6.2540; Koch F, 2019, LIMNOL OCEANOGR, V64, P357, DOI 10.1002/lno.11045; Mackey KRM, 2008, LIMNOL OCEANOGR, V53, P900, DOI 10.4319/lo.2008.53.3.0900; MARTIN JH, 1990, NATURE, V345, P156, DOI 10.1038/345156a0; MEHLER AH, 1951, ARCH BIOCHEM BIOPHYS, V33, P65, DOI 10.1016/0003-9861(51)90082-3; Middag R, 2011, DEEP-SEA RES PT II, V58, P2661, DOI 10.1016/j.dsr2.2010.10.043; Middag R, 2013, LIMNOL OCEANOGR, V58, P287, DOI 10.4319/lo.2013.58.1.0287; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/ngeo1765, 10.1038/NGEO1765]; Moore JK, 2008, BIOGEOSCIENCES, V5, P631, DOI 10.5194/bg-5-631-2008; Morel FMM, 2003, SCIENCE, V300, P944, DOI 10.1126/science.1083545; Oxborough K, 2012, LIMNOL OCEANOGR-METH, V10, P142, DOI 10.4319/lom.2012.10.142; Peers G, 2004, LIMNOL OCEANOGR, V49, P1774, DOI 10.4319/lo.2004.49.5.1774; Petrou K, 2014, MAR BIOL, V161, P925, DOI 10.1007/s00227-014-2392-z; Raiswell R, 2006, GEOCHIM COSMOCHIM AC, V70, P2765, DOI 10.1016/j.gca.2005.12.027; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Rapp I, 2017, ANAL CHIM ACTA, V976, P1, DOI 10.1016/j.aca.2017.05.008; Raven JA, 1999, PHOTOSYNTH RES, V60, P111, DOI 10.1023/A:1006282714942; RAVEN JA, 1990, NEW PHYTOL, V116, P1, DOI 10.1111/j.1469-8137.1990.tb00505.x; Reinbothe C, 2006, P NATL ACAD SCI USA, V103, P4777, DOI 10.1073/pnas.0511066103; Saito MA, 2008, LIMNOL OCEANOGR, V53, P276, DOI 10.4319/lo.2008.53.1.0276; Schuback N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133235; Sedwick PN, 1997, GEOPHYS RES LETT, V24, P2515, DOI 10.1029/97GL02596; Smetacek V, 2004, ANTARCT SCI, V16, P541, DOI 10.1017/S0954102004002317; Strzepek RF, 2012, LIMNOL OCEANOGR, V57, P1182, DOI 10.4319/lo.2012.57.4.1182; Suggett DJ, 2009, MAR ECOL PROG SER, V376, P1, DOI 10.3354/meps07830; Suggett DJ, 2004, LIMNOL OCEANOGR-METH, V2, P316, DOI 10.4319/lom.2004.2.316; Sunda WG, 1996, LIMNOL OCEANOGR, V41, P373, DOI 10.4319/lo.1996.41.3.0373; SUNDA WG, 1983, LIMNOL OCEANOGR, V28, P924, DOI 10.4319/lo.1983.28.5.0924; Thomson PG, 2006, POLAR BIOL, V29, P337, DOI 10.1007/s00300-005-0060-y; Timmermans KR, 2001, MAR ECOL PROG SER, V217, P287, DOI 10.3354/meps217287; Trimborn S, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00167; Trimborn S, 2017, MAR ECOL PROG SER, V578, P35, DOI 10.3354/meps12250; Trimborn S, 2015, DEEP-SEA RES PT I, V98, P115, DOI 10.1016/j.dsr.2014.12.010; Tsuda A, 2005, PROG OCEANOGR, V64, P189, DOI 10.1016/j.pocean.2005.02.008; Twining BS, 2013, ANNU REV MAR SCI, V5, P191, DOI 10.1146/annurev-marine-121211-172322; van Leeuwe MA, 1998, J PHYCOL, V34, P496, DOI 10.1046/j.1529-8817.1998.340496.x; Wolfe-Simon F, 2005, J PHYCOL, V41, P453, DOI 10.1111/j.1529-8817.2005.00086.x; WRIGHT SW, 1991, MAR ECOL PROG SER, V77, P183, DOI 10.3354/meps077183	57	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0221959	10.1371/journal.pone.0221959	http://dx.doi.org/10.1371/journal.pone.0221959			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525212	Green Published, gold, Green Submitted			2022-12-26	WOS:000532225700018
J	Midya, V; Valla, J; Balasubramanian, H; Mathur, A; Singh, NC				Midya, Vishal; Valla, Jeffrey; Balasubramanian, Hymavathy; Mathur, Avantika; Singh, Nandini Chatterjee			Cultural differences in the use of acoustic cues for musical emotion experience	PLOS ONE			English	Article							RECOGNITION; EXPRESSION; PERFORMANCE; UNIVERSALS	Does music penetrate cultural differences with its ability to evoke emotion? The ragas of Hindustani music are specific sequences of notes that elicit various emotions: happy, romantic, devotion, calm, angry, longing, tension and sad. They can be presented in two modes, alaap and gat, which differ in rhythm, but match in tonality. Participants from Indian and Non-Indian cultures (N = 144 and 112, respectively) rated twenty-four pieces of Hindustani ragas on eight dimensions of emotion, in a free response task. Of the 192 between-group comparisons, ratings differed in only 9% of the instances, showing universality across multiple musical emotions. Robust regression analyses and machine learning methods revealed tonality best explained emotion ratings for Indian participants whereas rhythm was the primary predictor in Non-Indian listeners. Our results provide compelling evidence for universality in emotions in the auditory domain in the realm of musical emotion, driven by distinct acoustic features that depend on listeners' cultural backgrounds.	[Midya, Vishal; Valla, Jeffrey; Balasubramanian, Hymavathy; Mathur, Avantika; Singh, Nandini Chatterjee] Natl Brain Res Ctr, Language Literacy & Mus Lab, Manesar, Haryana, India; [Midya, Vishal] Penn State Univ, Penn State Coll Med, Dept Publ Hlth, Div Biostat & Bioinformat, Hershey, PA USA	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Singh, NC (corresponding author), Natl Brain Res Ctr, Language Literacy & Mus Lab, Manesar, Haryana, India.	nandini@nbrc.ac.in	MATHUR, AVANTIKA/AAK-9756-2020; MATHUR, AVANTIKA/AAR-2769-2021	Midya, Vishal/0000-0002-6643-5176; Mathur, Avantika/0000-0002-0152-3562; SIngh, Nandini/0000-0002-0005-5541				Balkwill LL, 2004, JPN PSYCHOL RES, V46, P337, DOI 10.1111/j.1468-5584.2004.00265.x; Balkwill LL, 1999, MUSIC PERCEPT, V17, P43, DOI 10.2307/40285811; Becker J., 2010, HDB MUSIC EMOTION TH, P127; Benamou M., 2003, COMP MUSICAL AFFECT, P57; Brown S, 2013, PSYCHOL MUSIC, V41, P229, DOI 10.1177/0305735611425896; Cameron DJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00366; CASTELLANO MA, 1984, J EXP PSYCHOL GEN, V113, P394, DOI 10.1037/0096-3445.113.3.394; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Chordia P, 2008, LECT NOTES COMPUT SC, V4969, P110; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; Ekman Paul, 1972, NEBRASKA S MOTIVATIO, V19, P207, DOI DOI 10.1037/0022-3514.53.4.712; Fritz T, 2009, CURR BIOL, V19, P573, DOI 10.1016/j.cub.2009.02.058; Giannantonio S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136685; Haidt J, 1999, COGNITION EMOTION, V13, P225, DOI 10.1080/026999399379267; Hastie T., 2009, UNSUPERVISED LEARNIN; Hejmadi A, 2000, PSYCHOL SCI, V11, P183, DOI 10.1111/1467-9280.00239; Hevner K, 1936, AM J PSYCHOL, V48, P246, DOI 10.2307/1415746; Huron D, 2001, ANN NY ACAD SCI, V930, P43, DOI 10.1111/j.1749-6632.2001.tb05724.x; Izard C. E., 1977, HUMAN EMOTIONS; Jairazbhoy N. A, 1995, RAGS N INDIAN MUSIC; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Juslin PN, 2001, MUSIC SCI, V5, P3, DOI 10.1177/10298649020050S101; Juslin PN, 2003, PSYCHOL BULL, V129, P770, DOI 10.1037/0033-2909.129.5.770; Lartillot O, 2008, ST CLASS DAT ANAL, P261, DOI 10.1007/978-3-540-78246-9_31; Laukka P., 2000, PSYCHOL MUSIC, V28, P181, DOI [10.1177/0305735600282007, DOI 10.1177/0305735600282007]; Laukka P, 2013, EMOTION, V13, P434, DOI 10.1037/a0031388; Liaw MA, 2018, PACKAGE RANDOMFOREST; Maher T., 1982, PSYCHOL MUSIC, V10, P11, DOI [10.1177/0305735682101002, DOI 10.1177/0305735682101002]; Mathur A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00513; MESQUITA B, 1992, PSYCHOL BULL, V112, P179, DOI 10.1037/0033-2909.112.2.179; Pampalk E, 2002, CONTENT BASED ORG VI; Rao C, 2013, BRAIN LANG, V124, P205, DOI 10.1016/j.bandl.2012.12.004; Ravignani A, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0007; Salamon J, 2012, IEEE T AUDIO SPEECH, V20, P1759, DOI 10.1109/TASL.2012.2188515; Savage PE, 2015, P NATL ACAD SCI USA, V112, P8987, DOI 10.1073/pnas.1414495112; Scherer K. R., 2001, MUSIC EMOTION THEORY, DOI DOI 10.1016/j.jsams.2011.06.003; Scherer KR, 2004, J NEW MUSIC RES, V33, P239, DOI 10.1080/0929821042000317822; Schwanenberg E., 1974, PSYCHE-STUTTGART, V28, P919; Sloboda J.A., 2001, SERIES AFFECTIVE SCI; Valla JM, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.02115; Venables WN, 1997, MODERN APPL STAT S P, P247; Wieczorkowska AA, 2010, STUD COMPUT INTELL, V274, P285	43	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2019	14	9							e0222380	10.1371/journal.pone.0222380	http://dx.doi.org/10.1371/journal.pone.0222380			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4KS	31518379	Green Published, gold, Green Submitted			2022-12-26	WOS:000532219300018
J	Chen, ZY; Prosperi, M; Bian, J; Min, J; Wang, M; Li, C				Chen, Zhaoyi; Prosperi, Mattia; Bian, Jiang; Min, Jae; Wang, Mo; Li, Chang			Clinical correlates of workplace injury occurrence and recurrence in adults	PLOS ONE			English	Article							DISPARITIES; ICD-9-CM	Objectives To examine the morbidities associated with workplace injury and to explore how clinical variables modify the risk of injury recurrence. Methods A case-control study was designed using Florida's statewide inpatient, outpatient, and emergency visits data obtained from the Healthcare Cost and Utilization Project. We included adults who were admitted for a workplace injury (WPI) or injury at other places (IOP), and a matched population of random controls without WPI/IOP. The associations between WPI and clinical morbidities were assessed by univariate and multivariable regression, ranking predictors by information gain, area under the receiver operating characteristic (AUROC), and odds ratios. We analyzed WPI recurrence using survival methods (Kaplan-Meier, Cox regression, survival decision trees) and developed prediction models via regularized logistic regression, random forest, and AdTree. Performance was assessed by 10-fold cross-validation comparing AUROC, sensitivity, specificity, and Harrell's c-index. Results A total of 80,712 WPI, 161,424 IOP, and 161,424 control patients were included; 485 distinct clinical diagnostic and 160 procedure codes were analyzed after filtering. Acute bronchitis and bronchiolitis, sprains and strains of shoulder and upper arm, ankle and foot, or other and unspecified parts of back, accidents caused by cutting and piercing instruments or objects, and overexertion and strenuous movements were identified as important consequences of WPI. The prediction models of injury recurrence identified several key factors, such as insurance type and prior injury events, although none of the models exhibited high predictive performance (best AUROC = 0.60, best c-index = 0.62). Conclusions WPI is associated to diverse serious physical comorbidity burden. There are demographic, social and clinical comorbidity components associated to the risk of WPI recurrence, although their predictive value is moderate, which warrants future investigation in other information source domains, e.g. deepening into the environmental and societal sphere.	[Chen, Zhaoyi; Prosperi, Mattia; Min, Jae] Univ Florida, Dept Epidemiol, Gainesville, FL USA; [Chen, Zhaoyi; Bian, Jiang] Univ Florida, Dept Hlth Outcomes & Biomed Informat, Gainesville, FL USA; [Wang, Mo] Univ Florida, Dept Management, Gainesville, FL USA; [Li, Chang] Zhejiang Gongshang Univ, Sch Business Adm, Hangzhou, Zhejiang, Peoples R China	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Zhejiang Gongshang University	Li, C (corresponding author), Zhejiang Gongshang Univ, Sch Business Adm, Hangzhou, Zhejiang, Peoples R China.	lichang@zjgsu.edu.cn	Wang, Mo/AAT-1501-2021; Min, Jae/L-6540-2015	Wang, Mo/0000-0001-7004-3549; Min, Jae/0000-0003-4112-9583	NIH-NCATS [UL1TR001427, UL1TR002389]; University of Florida (UF) One Health Center; UF "Creating the Healthiest Generation" Moonshot initiative - UF Office of the Provost; UF Office of Research; UF Health; UF College of Medicine; UF Clinical and Translational Science Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002389, UL1TR001427] Funding Source: NIH RePORTER	NIH-NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); University of Florida (UF) One Health Center; UF "Creating the Healthiest Generation" Moonshot initiative - UF Office of the Provost; UF Office of Research; UF Health; UF College of Medicine; UF Clinical and Translational Science Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by the grant UL1TR001427 and UL1TR002389 from NIH-NCATS, by the University of Florida (UF) One Health Center, and by UF "Creating the Healthiest Generation" Moonshot initiative, which is supported by the UF Office of the Provost, UF Office of Research, UF Health, UF College of Medicine and UF Clinical and Translational Science Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Applebaum KM, 2019, AM J IND MED, V62, P733, DOI 10.1002/ajim.23021; Boschetto P, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-11; Brown JA, 2007, AM J IND MED, V50, P633, DOI 10.1002/ajim.20503; Bureau of Labor Statistics USD of L, EMPL REP WORKPL INJ; Caruana R, 2004, P 10 ACM SIGKDD INT; Cho Y, 2015, ANN OCCUP ENVIRON ME, V27, DOI 10.1186/s40557-015-0056-1; Cullinan P, 2012, BRIT MED BULL, V104, P143, DOI 10.1093/bmb/lds028; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Health Innovation Program, 2000, AR DEPR IND; Konstantinidis A, 2011, AM SURG; Leigh JP, 2011, MILBANK Q, V89, P728, DOI 10.1111/j.1468-0009.2011.00648.x; Liberty Mutual Group, 2017, LIB MUT WORKPL SAF I; Nicholson VJ, 2008, AM J IND MED, V51, P393, DOI 10.1002/ajim.20565; Orchard C, 2020, J OCCUP REHABIL, V30, P40, DOI 10.1007/s10926-019-09844-3; Pichora D, 2010, INT J OCCUP ENV MED; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; R Core Team, 2016, R FDN STAT COMP; Ruseckaite R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-492; Schulte P, 2017, AM J PUBLIC HEALTH, V107, pE15, DOI 10.2105/AJPH.2017.303765e; Steege AL, 2014, AM J IND MED, V57, P527, DOI 10.1002/ajim.22297; Woolford MH, 2017, NEW SOLUT, V27, P16, DOI 10.1177/1048291117693389	21	1	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2019	14	9							e0222603	10.1371/journal.pone.0222603	http://dx.doi.org/10.1371/journal.pone.0222603			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JX6UW	31513669	gold, Green Published, Green Submitted			2022-12-26	WOS:000503868400001
J	Montgomery, MK; Bayliss, J; Keenan, S; Rhost, S; Ting, SB; Watt, MJ				Montgomery, Magdalene K.; Bayliss, Jacqueline; Keenan, Stacey; Rhost, Sarah; Ting, Stephen B.; Watt, Matthew J.			The role of Ap2a2 in PPAR alpha-mediated regulation of lipolysis in adipose tissue	FASEB JOURNAL			English	Article						PPAR alpha; endocytosis; beta-adrenergic signaling	ACTIVATED RECEPTOR-ALPHA; PROTEIN COMPLEX 2; BETA(2)-ADRENERGIC RECEPTOR; MOLECULAR-MECHANISM; AP2-SIGMA MUTATIONS; LIPID-METABOLISM; SKELETAL-MUSCLE; CLATHRIN; ADAPTER; SUBUNIT	Adipose tissue plays a major role in the regulation of systemic metabolic homeostasis, with the AP2 adaptor complex being important in clathrin-mediated endocytosis (CME) of various cell surface receptors, including glucose transporter 4, the insulin receptor, and beta-adrenergic receptors (ARs). One of the AP2 subunits, adaptor-related protein complex 2, alpha 2 subunit (Ap2a2), has recently been identified as a peroxisome proliferator activated receptor (PPAR)alpha target gene. The effects of PPAR alpha on the AP2 adaptor complex and CME are unknown. We generated adipocyte-specific Ap2a2 knockout mice and investigated their metabolism when fed a standard chow or high-fat diet, without and with supplementation with the PPAR alpha-agonist WY-14643 (WY). Although Ap2a2 deletion had only minor effects on glycaemic control, it led to substantial impairment in beta-adrenergic activation of lipolysis, as evidenced by a loss of cAMP response, PKA activation, and glycerol/fatty acid release. These differences were related to increased cell surface localization of the beta 2- and beta 3-ARs. Lipolytic defects were accompanied by impaired WY-mediated loss of fat mass and whole-body fat oxidation. This study demonstrates a novel role for PPAR alpha in beta-adrenergic regulation of adipose tissue lipolysis and for adipose tissue in supplying adequate substrate to other peripheral tissues to accommodate the increase in systemic fatty acid oxidation that occurs upon treatment with PPAR alpha agonists.	[Montgomery, Magdalene K.; Bayliss, Jacqueline; Keenan, Stacey; Watt, Matthew J.] Univ Melbourne, Sch Biomed Sci, Dept Physiol, Med Bldg 181,Cnr Grattan St & Royal Parade, Melbourne, Vic, Australia; [Rhost, Sarah; Ting, Stephen B.] Monash Univ, Alfred Ctr, Australian Ctr Blood Dis, Melbourne, Vic, Australia; [Ting, Stephen B.] Eastern Hlth, Box Hill Hosp, Dept Haematol, Melbourne, Vic, Australia	University of Melbourne; Monash University; Box Hill Hospital	Montgomery, MK (corresponding author), Univ Melbourne, Sch Biomed Sci, Dept Physiol, Med Bldg 181,Cnr Grattan St & Royal Parade, Melbourne, Vic, Australia.	magdalene.montgomery@unimelb.edu.au	Keenan, Stacey N/AAQ-2449-2020		Australian National Health and Medical Research Council (NHMRC) [APP1077703, APP1006420, APP1047554, APP1143224]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	The authors acknowledge support by research fellowships and project grants from the Australian National Health and Medical Research Council (NHMRC) (APP1077703 to M.J.W., APP1006420 and APP1047554 to S.B.T., and APP1143224 to M.K.M.). S.B.T. and M.J.W. share senior authorship. The authors declare no conflicts of interest.	Ahn S, 1999, J BIOL CHEM, V274, P1185, DOI 10.1074/jbc.274.3.1185; [Anonymous], 2013, BIO-PROTOCOL, DOI DOI 10.21769/BIOPROTOC.857; Arner P, 2018, CELL METAB, V28, P45, DOI 10.1016/j.cmet.2018.05.004; Beautrait A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15054; Bernhardt U, 2009, BIOL CHEM, V390, P883, DOI 10.1515/BC.2009.095; Brodsky FM, 2012, ANNU REV CELL DEV BI, V28, P309, DOI 10.1146/annurev-cellbio-101011-155716; Buroker NE, 2012, PROTEIN J, V31, P75, DOI 10.1007/s10930-011-9379-0; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; CARLSON LA, 1976, P ROY SOC MED, V69, P101, DOI 10.1177/00359157760690S226; Carman CV, 1998, CURR OPIN NEUROBIOL, V8, P335, DOI 10.1016/S0959-4388(98)80058-5; CARPENTIER JL, 1994, DIABETOLOGIA, V37, pS117, DOI 10.1007/BF00400835; Choi E, 2016, CELL, V166, P567, DOI 10.1016/j.cell.2016.05.074; Clarke SD, 1999, AM J CLIN NUTR, V70, P566; Ding QR, 2009, CELL RES, V19, P317, DOI 10.1038/cr.2008.299; Dong ZW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02360-5; Feinstein TN, 2013, J BIOL CHEM, V288, P27849, DOI 10.1074/jbc.M112.445098; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; Gaidarov I, 1996, J BIOL CHEM, V271, P20922, DOI 10.1074/jbc.271.34.20922; Gorvin CM, 2018, HUM MOL GENET, V27, P901, DOI 10.1093/hmg/ddy010; Gorvin CM, 2018, CELL REP, V22, P1054, DOI 10.1016/j.celrep.2017.12.089; Goto T, 2011, J LIPID RES, V52, P873, DOI 10.1194/jlr.M011320; Guzman M, 2004, J BIOL CHEM, V279, P27849, DOI 10.1074/jbc.M404087200; Han YH, 2016, DIABETES, V65, P2639, DOI 10.2337/db16-0283; HERTEL C, 1985, J BIOL CHEM, V260, P2547; Huijsman E, 2009, AM J PHYSIOL-ENDOC M, V297, pE505, DOI 10.1152/ajpendo.00190.2009; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jean-Alphonse F, 2014, J BIOL CHEM, V289, P3960, DOI 10.1074/jbc.M113.526350; Jockers R, 1996, J BIOL CHEM, V271, P9355, DOI 10.1074/jbc.271.16.9355; Kelly BT, 2014, SCIENCE, V345, P459, DOI 10.1126/science.1254836; Kersten S, 2017, BIOCHIMIE, V136, P75, DOI 10.1016/j.biochi.2016.12.019; KOKATNUR MG, 1969, J ATHEROSCLER RES, V10, P319, DOI 10.1016/S0368-1319(69)80035-9; Kotowski SJ, 2011, NEURON, V71, P278, DOI 10.1016/j.neuron.2011.05.036; Laporte SA, 2000, J BIOL CHEM, V275, P23120, DOI 10.1074/jbc.M002581200; Lee MS, 2008, GENES NUTR, V2, P327, DOI 10.1007/s12263-007-0068-8; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Li PP, 2005, AM J PHYSIOL-ENDOC M, V289, pE617, DOI 10.1152/ajpendo.00010.2005; Liu MH, 2014, SCI REP-UK, V4, DOI 10.1038/srep05538; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Miranda J, 2011, LIPIDS, V46, P1005, DOI 10.1007/s11745-011-3615-4; Mohktar RAM, 2016, AM J PHYSIOL-ENDOC M, V311, pE128, DOI 10.1152/ajpendo.00084.2016; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Moore RH, 1999, J CELL SCI, V112, P329; Mottillo EP, 2012, J BIOL CHEM, V287, P25038, DOI 10.1074/jbc.M112.374041; Nesbit MA, 2013, NEW ENGL J MED, V368, P2476, DOI 10.1056/NEJMoa1300253; Nesbit MA, 2013, NAT GENET, V45, P93, DOI 10.1038/ng.2492; Pagnon J, 2012, ENDOCRINOLOGY, V153, P4278, DOI 10.1210/en.2012-1127; Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039; Raajendiran A, 2019, CELL REP, V27, P1528, DOI 10.1016/j.celrep.2019.04.010; Ramakrishnan VM, 2018, TISSUE ENG PART B-RE, V24, P289, DOI [10.1089/ten.teb.2017.0061, 10.1089/ten.TEB.2017.0061]; Sahebkar A, 2014, EXPERT OPIN PHARMACO, V15, P493, DOI 10.1517/14656566.2014.876992; Schoonjans K, 1996, BBA-LIPID LIPID MET, V1302, P93, DOI 10.1016/0005-2760(96)00066-5; Stienstra R, 2007, PPAR RES, V2007, DOI 10.1155/2007/95974; Sugden MC, 2002, BIOCHEM J, V364, P361, DOI 10.1042/BJ20011699; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Tenenbaum A, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-140; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Traub LM, 1999, P NATL ACAD SCI USA, V96, P8907, DOI 10.1073/pnas.96.16.8907; Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358; Urrutia R, 1997, P NATL ACAD SCI USA, V94, P377, DOI 10.1073/pnas.94.2.377; van Hall G, 2015, SPORTS MED, V45, pS23, DOI 10.1007/s40279-015-0394-8; Volovyk ZM, 2006, J BIOL CHEM, V281, P9773, DOI 10.1074/jbc.M511435200; Watt MJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE500, DOI 10.1152/ajpendo.00361.2005; Wei J, 2014, J BIOL CHEM, V289, P33689, DOI 10.1074/jbc.M114.593764	66	10	10	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13267	13279		10.1096/fj.201900909RR	http://dx.doi.org/10.1096/fj.201900909RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31533003				2022-12-26	WOS:000507466100019
J	Zhang, BY; Swamy, S; Balijepalli, S; Panicker, S; Mooliyil, J; Sherman, MA; Parkkinen, J; Raghavendran, K; Suresh, MV				Zhang, Boya; Swamy, Samantha; Balijepalli, Sanjay; Panicker, Sreehari; Mooliyil, Jashitha; Sherman, Matthew A.; Parkkinen, Jaakko; Raghavendran, Krishnan; Suresh, Madathilparambil V.			Direct pulmonary delivery of solubilized curcumin reduces severity of lethal pneumonia	FASEB JOURNAL			English	Article						phagocytosis; macrophages; apoptosis; capillary Western blot; MTT	RESPIRATORY-DISTRESS-SYNDROME; NF-KAPPA-B; ACUTE INFLAMMATORY RESPONSE; GRAM-NEGATIVE PNEUMONIA; NLRP3 INFLAMMASOME; LUNG INJURY; MOUSE MODEL; KLEBSIELLA-PNEUMONIAE; PROTECTIVE ROLE; ACTIVATION	Acute respiratory distress syndrome (ARDS), the most severe form of acute lung injury, is associated with reduced lung compliance and hypoxemia. Curcumin exhibits potent anti-inflammatory properties but has poor solubility and rapid plasma clearance. To overcome these physiochemical limitations and uncover the full therapeutic potential of curcumin in lung inflammation, in this study we utilized a novel water-soluble curcumin formulation (CDC) and delivered it directly into the lungs of C57BL/6 mice inoculated with a lethal dose of Klebsiella pneumoniae (KP). Administration of CDC led to a significant reduction in mortality, in bacterial presence within blood and lungs, as well as in lung injury, inflammation, and oxidative stress. The expression of Klebsiella hemolysin gene; TNF-alpha; IFN-beta; nucleotide-binding domain, leucine-rich containing family, pyrin domain-containing-3; hypoxia-inducible factor 1/2 alpha; and NF-kappa B were also decreased following CDC treatment, suggesting modulation of the inflammasome complex and hypoxia signaling pathways as an underlying mechanism by which CDC reduces the severity of pneumonia. On a cellular level, CDC led to diminished cell death, improved viability, and protection of human lung epithelial cells in vitro. Overall, our studies demonstrate that CDC administration improves cell survival and reduces injury, inflammation, and mortality in a murine model of lethal gram-negative pneumonia. CDC, therefore, has promising anti-inflammatory potential in pneumonia and likely other inflammatory lung diseases, demonstrating the importance of optimizing the physicochemical properties of active natural products to optimize their clinical application.	[Zhang, Boya; Swamy, Samantha; Balijepalli, Sanjay; Panicker, Sreehari; Mooliyil, Jashitha; Raghavendran, Krishnan; Suresh, Madathilparambil V.] Univ Michigan, Dept Surg, 1150 West Med Ctr Dr, Ann Arbor, MI 48109 USA; [Sherman, Matthew A.] Childrens Natl Med Ctr, Dept Pediat, Washington, DC 20010 USA; [Parkkinen, Jaakko] Univ Helsinki, Inst Biomed, Helsinki, Finland	University of Michigan System; University of Michigan; Children's National Health System; University of Helsinki	Suresh, MV (corresponding author), Univ Michigan, Dept Surg, 1150 West Med Ctr Dr, Ann Arbor, MI 48109 USA.	madathil@umich.edu		Sherman, Matthew/0000-0002-5448-1538	U.S. National Institutes of Health, National Institute of General Medical Sciences [R01 GM111305-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111305] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge the support of U.S. National Institutes of Health, National Institute of General Medical Sciences Grant R01 GM111305-01 (to K.R.). The authors declare no conflicts of interest.	Aggarwal BB, 2013, MOL NUTR FOOD RES, V57, P1529, DOI 10.1002/mnfr.201200838; Ahn D, 2019, AM J RESP CELL MOL, V60, P158, DOI 10.1165/rcmb.2018-0021OC; Arroliga AC, 2002, CHEST, V121, P1972, DOI 10.1378/chest.121.6.1972; Ayodele OE, 2010, NEPHROLOGY, V15, P482, DOI 10.1111/j.1440-1797.2010.01290.x; Bauer T T, 2000, Semin Respir Infect, V15, P272; Bauer TT, 2006, CLIN INFECT DIS, V43, P748, DOI 10.1086/506430; Beekman C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195850; Cai SS, 2010, J IMMUNOL, V185, P6214, DOI 10.4049/jimmunol.0903843; Chen W, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001849; Jin CY, 2007, ACTA PHARMACOL SIN, V28, P1645, DOI 10.1111/j.1745-7254.2007.00651.x; Cochi SE, 2016, ANN AM THORAC SOC, V13, P1742, DOI 10.1513/AnnalsATS.201512-841OC; Codo AC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1214-5; Cooney JM, 2016, J NUTR BIOCHEM, V27, P181, DOI 10.1016/j.jnutbio.2015.08.030; D'Ignazio L, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5010010; D'Ignazio L, 2016, FEBS J, V283, P413, DOI 10.1111/febs.13578; Davidson BA, 1999, ANESTHESIOLOGY, V91, P486, DOI 10.1097/00000542-199908000-00024; Dolgachev VA, 2016, GENE THER, V23, P785, DOI 10.1038/gt.2016.58; Dolgachev V, 2018, GENE THER, V25, P359, DOI 10.1038/s41434-018-0022-y; Dolgachev VA, 2012, J TRAUMA ACUTE CARE, V72, P614, DOI 10.1097/TA.0b013e318243d9b1; Fadus Matthew C, 2017, J Tradit Complement Med, V7, P339, DOI 10.1016/j.jtcme.2016.08.002; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; Hoth JJ, 2007, SHOCK, V28, P447, DOI 10.1097/shk.0b013e318048801a; Hua KF, 2015, INFECT IMMUN, V83, P3396, DOI 10.1128/IAI.00125-15; Huet O, 2017, CRIT CARE MED, V45, pE184, DOI 10.1097/CCM.0000000000002070; Iregui M, 2002, CHEST, V122, P262, DOI 10.1378/chest.122.1.262; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Jung YJ, 2003, FASEB J, V17, P2115, DOI 10.1096/fj.03-0329fje; Karo-Atar D, 2016, MUCOSAL IMMUNOL, V9, P240, DOI 10.1038/mi.2015.56; Kim JJ, 2013, J KOREAN MED SCI, V28, P1415, DOI 10.3346/jkms.2013.28.10.1415; Kochanek Kenneth D, 2014, NCHS Data Brief, P1; Machado-Aranda DA, 2012, J TRAUMA ACUTE CARE, V72, P32, DOI 10.1097/TA.0b013e31823f0606; Miller PR, 2001, J TRAUMA, V51, P223, DOI 10.1097/00005373-200108000-00003; Obi AT, 2016, J VASC RES, V53, P186, DOI 10.1159/000447299; Peter Y, 2009, MOL CARCINOGEN, V48, P488, DOI 10.1002/mc.20485; Qin S, 2017, NUTR J, V16, DOI 10.1186/s12937-017-0293-y; Raghavendran K, 2005, SHOCK, V24, P132, DOI 10.1097/01.shk.0000169725.80068.4a; Reddy PH, 2018, J ALZHEIMERS DIS, V61, P843, DOI 10.3233/JAD-170512; Riviello ED, 2016, AM J RESP CRIT CARE, V193, P52, DOI 10.1164/rccm.201503-0584OC; Saidi SA, 2018, BIOPHARM DRUG DISPOS, V39, P18, DOI 10.1002/bdd.2108; Seligman R, 2008, CRIT CARE, V12, DOI 10.1186/cc6780; Serezani CHC, 2005, BLOOD, V106, P1067, DOI 10.1182/blood-2004-08-3323; Sharma N, 2018, INFLAMMOPHARMACOLOGY, V26, P349, DOI 10.1007/s10787-017-0402-8; Sherman MA, 2018, ANN SURG, V267, P382, DOI 10.1097/SLA.0000000000002070; Standiford TJ, 1996, J LEUKOCYTE BIOL, V59, P24, DOI 10.1002/jlb.59.1.24; Steinhauser ME, 1999, J IMMUNOL, V162, P392; STRIETER RM, 1994, J INVEST MED, V42, P640; Sun YF, 2017, J INTERF CYTOK RES, V37, P449, DOI 10.1089/jir.2017.0069; Suresh M. V., 2018, SHOCK; Suresh MV, 2016, CRIT CARE MED, V44, pE1054, DOI 10.1097/CCM.0000000000001879; Suresh MV, 2014, CRIT CARE MED, V42, pE642, DOI 10.1097/CCM.0000000000000488; Suresh MV, 2013, SURGERY, V154, P980, DOI 10.1016/j.surg.2013.05.023; Suresh MV, 2012, AM J RESP CELL MOL, V47, P280, DOI 10.1165/rcmb.2011-0175OC; Suresh MV, 2012, AM J RESP CELL MOL, V46, P797, DOI 10.1165/rcmb.2011-0358OC; Takala A, 2002, ANN MED, V34, P614, DOI 10.1080/078538902321117841; Taylor M, 2011, GASTROENTEROLOGY, V140, P2044, DOI 10.1053/j.gastro.2011.03.007; Tonnesen HH, 2002, INT J PHARMACEUT, V244, P127, DOI 10.1016/S0378-5173(02)00323-X; Wang XZ, 2017, ONCOL LETT, V13, P4825, DOI 10.3892/ol.2017.6053; Ward PA, 1999, ARCH SURG-CHICAGO, V134, P666, DOI 10.1001/archsurg.134.6.666; Willingham SB, 2009, J IMMUNOL, V183, P2008, DOI 10.4049/jimmunol.0900138; Xu YM, 2017, INFLUENZA OTHER RESP, V11, P457, DOI 10.1111/irv.12459; Zheng CY, 2011, JOVE-J VIS EXP, DOI 10.3791/2568	61	17	20	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13294	13309		10.1096/fj.201901047RR	http://dx.doi.org/10.1096/fj.201901047RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31530014	Green Submitted, Green Published, Bronze			2022-12-26	WOS:000507466100021
J	Gagnon, L; Cao, YB; Cho, A; Sedki, D; Huber, T; Sakmar, TP; Laporte, SA				Gagnon, Laurence; Cao, Yubo; Cho, Aaron; Sedki, Dana; Huber, Thomas; Sakmar, Thomas P.; Laporte, Stephane A.			Genetic code expansion and photocross-linking identify different beta-arrestin binding modes to the angiotensin II type 1 receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); angiotensin II; arrestin; receptor; photoaffinity labeling; angiotensin II type 1 receptor; biased signaling; p-azido-L-phenylalanine; unnatural amino acid	PROTEIN-COUPLED-RECEPTORS; BIASED-AGONISM; CROSS-LINKING; AMINO-ACIDS; SITE; PHOSPHORYLATION; TRAFFICKING; REVEALS; PEPTIDE; IDENTIFICATION	The angiotensin II (AngII) type 1 receptor (AT1R) is a member of the G protein- coupled receptor (GPCR) family and binds beta-arrestins (beta-arrs), which regulate AT1R signaling and trafficking. These processes can be biased by different ligands or mutations in the AGTR1 gene. As for many GPCRs, the exact details for AT1R-beta-arr interactions driven by AngII or beta-arr-biased ligands remain largely unknown. Here, we used the amber-suppression technology to site-specifically introduce the unnatural amino acid (UAA) p-azido-L-phenylalanine (azF) into the intracellular loops (ICLs) and the C-tail of AT1R. Our goal was to generate competent photoreactive receptors that can be cross-linked to beta-arrs in cells. We performed UV-mediated photolysis of 25 different azF-labeled AT1Rs to cross-link beta-arr1 to AngII-bound receptors, enabling us to map important contact sites in the C-tail and in the ICL2 and ICL3 of the receptor. The extent of AT1R-beta-arr1 cross-linking among azF-labeled receptors differed, revealing variability in beta-arr's contact mode with the different AT1R domains. Moreover, the signature of ligated AT1R-beta-arr complexes from a subset of azF-labeled receptors also differed between AngII and beta-arr-biased ligand stimulation of receptors and between azF-labeled AT1R bearing and that lacking a bias signaling mutation. These observations further implied distinct interaction modalities of the AT1R-beta-arr1 complex in biased signaling conditions. Our findings demonstrate that this photocross-linking approach is useful for understanding GPCR-beta-arr complexes in different activation states and could be extended to study other protein-protein interactions in cells.	[Gagnon, Laurence; Cho, Aaron; Sedki, Dana; Laporte, Stephane A.] McGill Univ, Ctr Hlth, Res Inst, Dept Med, Montreal, PQ H4A 3J1, Canada; [Cao, Yubo; Laporte, Stephane A.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1Y6, Canada; [Huber, Thomas; Sakmar, Thomas P.] Rockefeller Univ, Lab Chem Biol & Signal Transduct, New York, NY 10065 USA	McGill University; McGill University; Rockefeller University	Laporte, SA (corresponding author), McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ H4A 3J1, Canada.	stephane.laporte@mcgill.ca	Laporte, Stephane A/F-3282-2012; Laporte, Stephane/ABC-4228-2021; Huber, Thomas/A-8016-2008	Laporte, Stephane/0000-0002-0633-543X; Huber, Thomas/0000-0002-1844-262X	Canadian Institutes of Health Research (CIHR) [MOP-74603]; Fonds de recherche sante Quebec (FRQS); FRQS	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de recherche sante Quebec (FRQS); FRQS	This work was supported by Canadian Institutes of Health Research (CIHR) Grant MOP-74603 (to S. A. L.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a master's training scholarship from the Fonds de recherche sante Quebec (FRQS).; Supported by a doctoral training scholarship from the FRQS.	Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Arsenault J, 2010, PHARMACOGENET GENOM, V20, P377, DOI 10.1097/FPC.0b013e32833a6d4a; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Beautrait A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15054; Cahill TJ, 2017, P NATL ACAD SCI USA, V114, P2562, DOI 10.1073/pnas.1701529114; Cao YB, 2019, METHODS MOL BIOL, V1957, P59, DOI 10.1007/978-1-4939-9158-7_3; Coin I, 2013, CELL, V155, P1258, DOI 10.1016/j.cell.2013.11.008; Costa-Neto CM, 2016, MOL PHARMACOL, V90, P587, DOI 10.1124/mol.116.105940; Devost D, 2017, J BIOL CHEM, V292, P5443, DOI 10.1074/jbc.M116.763854; Fessart D, 2005, MOL ENDOCRINOL, V19, P491, DOI 10.1210/me.2004-0246; Fillion D, 2013, J BIOL CHEM, V288, P8187, DOI 10.1074/jbc.M112.442053; Grunbeck A, 2013, METHOD ENZYMOL, V520, P307, DOI 10.1016/B978-0-12-391861-1.00014-9; Grunbeck A, 2012, ACS CHEM BIOL, V7, P967, DOI 10.1021/cb300059z; Grunbeck A, 2011, BIOCHEMISTRY-US, V50, P3411, DOI 10.1021/bi200214r; Gurevich VV, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00125; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Hansen JL, 2004, MOL PHARMACOL, V65, P770, DOI 10.1124/mol.65.3.770; Heydenreich FM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07010-4; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; KENAKIN T, 1995, TRENDS PHARMACOL SCI, V16, P232, DOI 10.1016/S0165-6147(00)89032-X; Koole C, 2017, J BIOL CHEM, V292, P7131, DOI 10.1074/jbc.M117.779496; Lancia JK, 2014, BIOPOLYMERS, V101, P391, DOI 10.1002/bip.22395; Laporte SA, 1999, MOL ENDOCRINOL, V13, P578, DOI 10.1210/me.13.4.578; Lee MH, 2016, NATURE, V531, P665, DOI 10.1038/nature17154; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Liu WS, 2007, NAT METHODS, V4, P239, DOI 10.1038/NMETH1016; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; Mayer D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09204-y; Namkung Y, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat1631; Namkung Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12178; Nobles KN, 2007, J BIOL CHEM, V282, P21370, DOI 10.1074/jbc.M611483200; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Qian HW, 2001, MOL ENDOCRINOL, V15, P1706, DOI 10.1210/me.15.10.1706; Ranjan R, 2017, TRENDS CELL BIOL, V27, P861, DOI 10.1016/j.tcb.2017.05.008; Reyes-Alcaraz A, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0134-3; Sauliere A, 2012, NAT CHEM BIOL, V8, P622, DOI [10.1038/NCHEMBIO.961, 10.1038/nchembio.961]; Servant G, 1997, J BIOL CHEM, V272, P8653, DOI 10.1074/jbc.272.13.8653; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Shukla AK, 2011, TRENDS BIOCHEM SCI, V36, P457, DOI 10.1016/j.tibs.2011.06.003; Tanaka Y, 2008, MOL BIOSYST, V4, P473, DOI 10.1039/b803218a; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Valentin-Hansen L, 2014, J BIOL CHEM, V289, P18045, DOI 10.1074/jbc.M113.527085; Violin JD, 2010, J PHARMACOL EXP THER, V335, P572, DOI 10.1124/jpet.110.173005; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Wingler LM, 2019, CELL, V176, P468, DOI 10.1016/j.cell.2018.12.005; Wingler LM, 2019, CELL, V176, P479, DOI 10.1016/j.cell.2018.12.006; Xiang Z, 2014, ANGEW CHEM INT EDIT, V53, P2190, DOI 10.1002/anie.201308794; Ye SX, 2008, J BIOL CHEM, V283, P1525, DOI 10.1074/jbc.M707355200; Zhang HT, 2015, J BIOL CHEM, V290, P29127, DOI 10.1074/jbc.M115.689000; Zhou XE, 2017, CELL, V170, P457, DOI 10.1016/j.cell.2017.07.002; Zimmerman B, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002522; Zimmerman B, 2009, CELL SIGNAL, V21, P103, DOI 10.1016/j.cellsig.2008.09.013	56	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17409	17420		10.1074/jbc.RA119.010324	http://dx.doi.org/10.1074/jbc.RA119.010324			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31530642	hybrid, Green Published			2022-12-26	WOS:000503173500020
J	Kendall, AC; Pilkington, SM; Murphy, SA; Del Carratore, F; Sunarwidhi, AL; Kiezel-Tsugunova, M; Urquhart, P; Watson, REB; Breitling, R; Rhodes, LE; Nicolaou, A				Kendall, Alexandra C.; Pilkington, Suzanne M.; Murphy, Sharon A.; Del Carratore, Francesco; Sunarwidhi, Anggit L.; Kiezel-Tsugunova, Magdalena; Urquhart, Paula; Watson, Rachel E. B.; Breitling, Rainer; Rhodes, Lesley E.; Nicolaou, Anna			Dynamics of the human skin mediator lipidome in response to dietary omega-3 fatty acid supplementation	FASEB JOURNAL			English	Article						eicosapentaenoic acid; docosahexaenoic acid; inflammation; lipidomics; mass spectrometry	POLYUNSATURATED FATTY-ACIDS; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; DHA SUPPLEMENTATION; ENDOTHELIAL-CELLS; BRAIN-REGIONS; UVR EXPOSURE; EXPRESSION; EPA; N-3	Nutritional supplementation with fish oil or omega-3 (n-3) polyunsaturated fatty acids (PUFAs) has potential benefits for skin inflammation. Although the differential metabolism of the main n-3PUFA eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) could lead to distinct activities, there are no clinical studies comparing their relative efficacy in human skin. Following a 10-wk oral supplementation of healthy volunteers and using mass spectrometry-based lipidomics, we found that n-3PUFA mainly affected the epidermal mediator lipidome. EPA was more efficient than DHA in reducing production of arachidonic acid-derived lipids, and both n-3PUFA lowered N-acyl ethanolamines. In UV radiation-challenged skin (3 times the minimum erythemal dose), EPA attenuated the production of proinflammatory lipids, whereas DHA abrogated the migration of Langerhans cells, as assessed by immunohistochemistry. Interestingly, n-3PUFA increased the infiltration of CD4(+) and CD8(+) T cells but did not alter the erythemal response, either the sunburn threshold or the resolution of erythema, as assessed by spectrophotometric hemoglobin index readings. As EPA and DHA differentially impact cutaneous inflammation through changes in the network of epidermal lipids and dendritic and infiltrating immune cells, they should be considered separately when designing interventions for cutaneous disease.	[Kendall, Alexandra C.; Murphy, Sharon A.; Sunarwidhi, Anggit L.; Kiezel-Tsugunova, Magdalena; Urquhart, Paula; Nicolaou, Anna] Univ Manchester, Div Pharm & Optometry, Lab Lipid & Lipid Biol, Manchester, Lancs, England; [Pilkington, Suzanne M.; Watson, Rachel E. B.; Rhodes, Lesley E.] Univ Manchester, Div Musculoskeletal & Dermatol Sci, Sch Biol Sci, Fac Biol Med & Hlth, Manchester, Lancs, England; [Pilkington, Suzanne M.; Watson, Rachel E. B.; Rhodes, Lesley E.] Univ Manchester, Salford Royal Natl Hlth Serv NHS Fdn Trust, Ctr Dermatol Res, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Del Carratore, Francesco; Breitling, Rainer] Univ Manchester, Sch Chem, Fac Sci & Engn, Manchester, Lancs, England; [Watson, Rachel E. B.; Rhodes, Lesley E.; Nicolaou, Anna] Univ Manchester, Lydia Becker Inst Immunol & Inflammat, Fac Biol Med & Hlth, Manchester, Lancs, England; [Watson, Rachel E. B.; Rhodes, Lesley E.; Nicolaou, Anna] Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Natl Inst Hlth Res, Manchester Biomed Res Ctr, Manchester, Lancs, England	University of Manchester; University of Manchester; Salford Royal NHS Foundation Trust; University of Manchester; University of Manchester; University of Manchester; University of Manchester	Nicolaou, A (corresponding author), Univ Manchester, Div Pharm & Optometry, 2-019c Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	anna.nicolaou@manchester.ac.uk	Watson, Rachel E B/F-1090-2013; Del Carratore, Francesco/AAH-9752-2019; Sunarwidhi, Anggit/AAF-3938-2021; Nicolaou, Anna/D-4025-2018; Kendall, Alexandra/D-3717-2014; Rhodes, Lesley/H-5324-2015	Watson, Rachel E B/0000-0002-5162-7503; Del Carratore, Francesco/0000-0003-1647-7818; Nicolaou, Anna/0000-0002-1314-413X; Kendall, Alexandra/0000-0003-4419-0013; Pilkington, Suzanne/0000-0002-0426-1414; Rhodes, Lesley/0000-0002-9107-6654	Wellcome Trust [WT094028/AIA, WT094028/B]; National Institute of Health Research (NIHR) Clinical Research Network (CRN); NIHR Manchester Biomedical Research Centre; Biotechnology and Biological Sciences Research Council (BBSRC); University of Manchester Strategic Fund; Lembaga Pengelola Dana Pendidikan (LPDP), Republik Indonesia	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Health Research (NIHR) Clinical Research Network (CRN)(National Institute for Health Research (NIHR)); NIHR Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Manchester Strategic Fund; Lembaga Pengelola Dana Pendidikan (LPDP), Republik Indonesia	The authors thank Roger Meadows for his help with the microscopy and image analysis, Kanwal Sakhi for work on immunohistochemistry assays, Neil O'Hara for excellent technical support, and Jo Osman (all from University of Manchester) for excellent clinical support. This project was supported by The Wellcome Trust (Grants WT094028/AIA and WT094028/B). The authors acknowledge the support of the National Institute of Health Research (NIHR) Clinical Research Network (CRN) and the NIHR Manchester Biomedical Research Centre. The bioimaging facility microscopes used in this study were purchased with grants from the Biotechnology and Biological Sciences Research Council (BBSRC) and The Wellcome Trust, and the University of Manchester Strategic Fund. L.E.R., A.N., and R.E.B.W. were supported, in part, by the NIHR Manchester Biomedical Research Centre. A.L.S. was supported by a scholarship from Lembaga Pengelola Dana Pendidikan (LPDP), Republik Indonesia. The authors declare no conflicts of interest.	Ahmad N, 2004, J INVEST DERMATOL, V123, P417, DOI 10.1111/j.0022-202X.2004.23307.x; Allaire J, 2016, AM J CLIN NUTR, V104, P280, DOI 10.3945/ajcn.116.131896; Astarita G, 2015, BBA-MOL CELL BIOL L, V1851, P456, DOI 10.1016/j.bbalip.2014.11.012; Bascoul-Colombo C, 2016, BBA-MOL CELL BIOL L, V1861, P524, DOI 10.1016/j.bbalip.2016.03.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breitling R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-34; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; CHAPKIN RS, 1986, J LIPID RES, V27, P945; Chen HJ, 2003, J MOL CELL CARDIOL, V35, P769, DOI 10.1016/S0022-2828(03)00120-2; Chene G, 2007, BBA-MOL CELL BIOL L, V1771, P576, DOI 10.1016/j.bbalip.2007.02.014; Davidson EA, 2016, FASEB J, V30; Felton SJ, 2017, PHOTOCH PHOTOBIO SCI, V16, P564, DOI 10.1039/c6pp00337k; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Green P, 2009, PROSTAG LEUKOTR ESS, V80, P213, DOI 10.1016/j.plefa.2009.02.005; Han SC, 2015, J INVEST DERMATOL, V135, P1556, DOI 10.1038/jid.2014.488; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Hong S, 2014, AM J PHYSIOL-CELL PH, V307, pC1058, DOI 10.1152/ajpcell.00270.2014; Huang CY, 2015, MOL NUTR FOOD RES, V59, P751, DOI 10.1002/mnfr.201400687; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Hussain Z, 2017, BBA-MOL CELL BIOL L, V1862, P1546, DOI 10.1016/j.bbalip.2017.08.006; Kendall AC, 2016, BRIT J DERMATOL, V175, P163, DOI 10.1111/bjd.14521; Kendall AC, 2017, BBA-BIOMEMBRANES, V1859, P1679, DOI 10.1016/j.bbamem.2017.03.016; Kendall AC, 2015, J INVEST DERMATOL, V135, P1510, DOI 10.1038/jid.2015.41; Kendall AC, 2013, PROG LIPID RES, V52, P141, DOI 10.1016/j.plipres.2012.10.003; Kiezel-Tsugunova M, 2018, BIOCHEM SOC T, V46, P119, DOI 10.1042/BST20160469; Koch C, 2008, BRIT J DERMATOL, V158, P786, DOI 10.1111/j.1365-2133.2007.08430.x; KOJIMA T, 1991, DERMATOLOGICA, V182, P225, DOI 10.1159/000247800; Laidlaw BJ, 2016, NAT REV IMMUNOL, V16, P102, DOI 10.1038/nri.2015.10; Landman S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28346-5; Leishman E, 2016, BBA-MOL CELL BIOL L, V1861, P491, DOI 10.1016/j.bbalip.2016.03.003; Massey KA, 2013, FREE RADICAL BIO MED, V59, P45, DOI 10.1016/j.freeradbiomed.2012.08.565; Massey KA, 2011, BIOCHEM SOC T, V39, P1240, DOI 10.1042/BST0391240; Mayser P, 2002, BRIT J NUTR, V87, pS77, DOI 10.1079/BJN2001459; McDaniel JC, 2011, WOUND REPAIR REGEN, V19, P189, DOI 10.1111/j.1524-475X.2010.00659.x; Meijerink J, 2013, BRIT J PHARMACOL, V169, P772, DOI 10.1111/bph.12030; Nicolaou A, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00075; Nicolaou A, 2013, PROSTAG LEUKOTR ESS, V88, P131, DOI 10.1016/j.plefa.2012.03.009; Pilkington SM, 2016, EXP DERMATOL, V25, P962, DOI 10.1111/exd.13177; Pilkington SM, 2015, EXP DERMATOL, V24, P790, DOI 10.1111/exd.12734; Pilkington SM, 2014, MOL NUTR FOOD RES, V58, P580, DOI 10.1002/mnfr.201300405; Pilkington SM, 2013, AM J CLIN NUTR, V97, P646, DOI 10.3945/ajcn.112.049494; Pilkington SM, 2011, EXP DERMATOL, V20, P537, DOI 10.1111/j.1600-0625.2011.01294.x; Pinto AM, 2017, BRIT J NUTR, V118, P877, DOI 10.1017/S0007114517002628; Plourde M, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-5; Rahman MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028065; Ralf M, 2001, RADIAT RES, V156, P36, DOI 10.1667/0033-7587(2001)156[0036:DEAPSI]2.0.CO;2; Rhodes LE, 2009, FASEB J, V23, P3947, DOI 10.1096/fj.09-136077; Sampath H, 2005, ANNU REV NUTR, V25, P317, DOI 10.1146/annurev.nutr.25.051804.101917; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuchardt JP, 2016, PROSTAG LEUKOTR ESS, V115, P12, DOI 10.1016/j.plefa.2016.10.005; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shaikh SR, 2012, MOL ASPECTS MED, V33, P46, DOI 10.1016/j.mam.2011.10.002; Shaikh SR, 2009, J NUTR, V139, P1632, DOI 10.3945/jn.109.108720; Tang YN, 2013, DIABETES, V62, P618, DOI 10.2337/db12-0684; Toth BI, 2011, J INVEST DERMATOL, V131, P1095, DOI 10.1038/jid.2010.421; Verlengia R, 2004, J NUTR BIOCHEM, V15, P657, DOI 10.1016/j.jnutbio.2004.04.008; Walker CG, 2015, NUTRIENTS, V7, P6281, DOI 10.3390/nu7085285; Wood JT, 2010, J LIPID RES, V51, P1416, DOI 10.1194/jlr.M002436	60	20	20	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					13014	13027		10.1096/fj.201901501R	http://dx.doi.org/10.1096/fj.201901501R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31518521	Green Published			2022-12-26	WOS:000507461600108
J	Sun, PK; Ma, TF; Zhang, TL; Zhu, HW; Zhang, JY; Liu, YB; Ding, JP				Sun, Pengkai; Ma, Tengfei; Zhang, Tianlong; Zhu, Hanwen; Zhang, Jianyang; Liu, Yabing; Ding, Jianping			Molecular basis for the function of the ?? heterodimer of human NAD-dependent isocitrate dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; conformational change; enzyme mechanism; crystal structure; enzyme structure; inhibition mechanism; tricarboxylic acid cycle (TCA cycle) (Krebs cycle); isocitrate dehydrogenase; NAD-IDH; activation	OXIDATIVE DAMAGE; PIG-HEART; RETINITIS-PIGMENTOSA; CELLULAR DEFENSE; KINETIC-ANALYSIS; BINDING-SITES; KEY ROLE; SUBUNITS; MUTATIONS; INSIGHTS	Mammalian mitochondrial NAD-dependent isocitrate dehydrogenase (NAD-IDH) catalyzes the decarboxylation of isocitrate into ?-ketoglutarate in the tricarboxylic acid cycle. It exists as the ?(2)?? heterotetramer composed of the ?? and ?? heterodimers. Different from the ?? heterodimer that can be allosterically activated by CIT and ADP, the ?? heterodimer cannot be allosterically regulated by the activators; however, the molecular mechanism is unclear. We report here the crystal structures of the ?? heterodimer of human NAD-IDH with the ? subunit in apo form and in Ca2+-bound, NAD-bound, and NADH-bound forms. Structural analyses and comparisons reveal that the ?? heterodimer has a similar yet more compact overall structure compared with the ?? heterodimer and contains a pseudo-allosteric site that is structurally different from the allosteric site. In particular, the ?3-?3 and ?12-?8 loops of the ? subunit at the pseudo-allosteric site adopt significantly different conformations from those of the ? subunit at the allosteric site and hence impede the binding of the activators, explaining why the ?? heterodimer cannot be allosterically regulated by the activators. The structural data also show that NADH can compete with NAD to bind to the active site and inhibits the activity of the ?? heterodimer. These findings together with the biochemical data reveal the molecular basis for the function of the ?? heterodimer of human NAD-IDH.	[Sun, Pengkai; Ma, Tengfei; Zhang, Tianlong; Zhu, Hanwen; Zhang, Jianyang; Liu, Yabing; Ding, Jianping] Univ Chinese Acad Sci, Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol,CAS Ctr Excellence Mol Cel, 320 Yue Yang Rd, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS	Ding, JP (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Inst Biochem & Cell Biol,Shanghai Inst Biol Sci, State Key Lab Mol Biol,CAS Ctr Excellence Mol Cel, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	jpding@sibcb.ac.cn	Sun, Pengkai/AAH-2227-2021	Sun, Pengkai/0000-0003-2478-9109; ding, jian ping/0000-0001-7029-7346	National Natural Science Foundation of China [31870723, 31530013]; CAS Facility-based Open Research Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS Facility-based Open Research Program	This work was supported by National Natural Science Foundation of China Grants 31870723 and 31530013 and the CAS Facility-based Open Research Program. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ceccarelli C, 2002, J BIOL CHEM, V277, P43454, DOI 10.1074/jbc.M207306200; COHEN PF, 1972, BIOCHEMISTRY-US, V11, P1501, DOI 10.1021/bi00758a027; CUPP JR, 1993, BIOCHEMISTRY-US, V32, P9323, DOI 10.1021/bi00087a010; Dang L, 2016, ANN ONCOL, V27, P599, DOI 10.1093/annonc/mdw013; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; EHRLICH RS, 1983, J BIOL CHEM, V258, P7079; EHRLICH RS, 1981, J BIOL CHEM, V256, P1276; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fattal-Valevski A, 2017, NEUROGENETICS, V18, P57, DOI 10.1007/s10048-016-0507-z; Findlay AS, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.036426; GABRIEL JL, 1984, BIOCHEMISTRY-US, V23, P2773, DOI 10.1021/bi00307a037; Goncalves S, 2012, BIOCHEMISTRY-US, V51, P7098, DOI 10.1021/bi300483w; Hartong DT, 2008, NAT GENET, V40, P1230, DOI 10.1038/ng.223; HURLEY JH, 1989, P NATL ACAD SCI USA, V86, P8635, DOI 10.1073/pnas.86.22.8635; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; Kiefmann M, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.403; Kim SY, 2003, FREE RADICAL RES, V37, P309, DOI 10.1080/1071576021000050429; KIM YO, 1995, BIOCHEM J, V308, P63, DOI 10.1042/bj3080063; Kim YO, 1999, J BIOL CHEM, V274, P36866, DOI 10.1074/jbc.274.52.36866; Koh HJ, 2004, J BIOL CHEM, V279, P39968, DOI 10.1074/jbc.M402260200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee SM, 2002, FREE RADICAL BIO MED, V32, P1185, DOI 10.1016/S0891-5849(02)00815-8; Lin AP, 2003, J BIOL CHEM, V278, P12864, DOI 10.1074/jbc.M300154200; Lin AP, 2002, J BIOL CHEM, V277, P22475, DOI 10.1074/jbc.M202534200; Liu YB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21584-7; Ma TF, 2017, SCI REP-UK, V7, DOI 10.1038/srep41882; Ma TF, 2017, SCI REP-UK, V7, DOI 10.1038/srep40921; May JL, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aat0456; McAlister-Henn L, 2012, ARCH BIOCHEM BIOPHYS, V519, P112, DOI 10.1016/j.abb.2011.10.003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peng YJ, 2008, PROTEIN SCI, V17, P1542, DOI 10.1110/ps.035675.108; Pierrache LHM, 2017, OPHTHALMOLOGY, V124, P992, DOI 10.1016/j.ophtha.2017.03.010; RAMACHANDRAN N, 1980, J BIOL CHEM, V255, P8859; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Schrodinger, 2010, PYMOL MOL GRAPHICS S; STODDARD BL, 1993, BIOCHEMISTRY-US, V32, P9310, DOI 10.1021/bi00087a008; Taylor AB, 2008, J BIOL CHEM, V283, P10872, DOI 10.1074/jbc.M708719200; Waitkus MS, 2016, NEURO-ONCOLOGY, V18, P16, DOI 10.1093/neuonc/nov136; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu X, 2004, J BIOL CHEM, V279, P33946, DOI 10.1074/jbc.M404298200; Yang B, 2010, CELL RES, V20, P1188, DOI 10.1038/cr.2010.145; Yoshimi N, 2016, MOL PSYCHIATR, V21, P1504, DOI 10.1038/mp.2015.217; Zeng L, 2015, ONCOGENE, V34, P4758, DOI 10.1038/onc.2014.411; Zhang DX, 2015, CELL REP, V10, P1335, DOI 10.1016/j.celrep.2015.02.006; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944; Zhao WN, 1997, J BIOL CHEM, V272, P21811, DOI 10.1074/jbc.272.35.21811; Zheng JM, 2012, PHILOS T R SOC B, V367, P2656, DOI 10.1098/rstb.2011.0426; Zheng JM, 2010, NATURE, V465, P961, DOI 10.1038/nature09088	51	10	10	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					16214	16227		10.1074/jbc.RA119.010099	http://dx.doi.org/10.1074/jbc.RA119.010099			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31515270	Green Published, hybrid			2022-12-26	WOS:000499478600028
J	Liu, MJ; Wang, XQ; Ma, L; Cao, LJ; Liu, HL; Pu, DQ; Wei, SJ				Liu, Mengjia; Wang, Xiaoqiang; Ma, Ling; Cao, Lijun; Liu, Hongling; Pu, Deqiang; Wei, Shujun			Genome-wide developed microsatellites reveal a weak population differentiation in the hoverfly Eupeodes corollae (Diptera: Syrphidae) across China	PLOS ONE			English	Article							USER-FRIENDLY PROGRAM; EPISYRPHUS-BALTEATUS; GENETIC-VARIATION; DIVERSITY; MIGRATION; EFFICIENT; MARKERS; ECOLOGISTS; INSECTS; PRIMERS	The hoverfly, Eupeodes corollae, is a worldwide natural enemy of aphids and a plant pollinator. To provide insights into the biology of this species, we examined its population genetic structure by obtaining 1.15-GB random genomic sequences using next-generation sequencing and developing genome-wide microsatellite markers. A total of 79,138 microsatellite loci were initially isolated from the genomic sequences; after strict selection and further testing of 40 primer pairs in eight individuals, 24 polymorphic microsatellites with high amplification rates were developed. These microsatellites were used to examine the population genetic structure of 96 individuals from four field populations collected across southern to northern China. The number of alleles per locus ranged from 5 to 13 with an average of 8.75; the observed and expected heterozygosity varied from 0.235 to 0.768 and from 0.333 to 0.785, respectively. Population genetic structure analysis showed weak genetic differentiation among the four geographical populations of E. corollae, suggesting a high rate of gene flow reflecting likely widespread migration of E. corollae in China.	[Liu, Mengjia; Wang, Xiaoqiang; Pu, Deqiang] Sichuan Acad Agr Sci, Ind Crop Res Inst, Chengdu, Peoples R China; [Liu, Mengjia; Ma, Ling; Cao, Lijun; Wei, Shujun] Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China; [Liu, Hongling; Pu, Deqiang] Sichuan Acad Agr Sci, Inst Plant Protect, Chengdu, Peoples R China	Sichuan Academy of Agricultural Sciences (SAAS); Beijing Academy of Agriculture & Forestry; Sichuan Academy of Agricultural Sciences (SAAS)	Pu, DQ (corresponding author), Sichuan Acad Agr Sci, Ind Crop Res Inst, Chengdu, Peoples R China.; Wei, SJ (corresponding author), Beijing Acad Agr & Forestry Sci, Inst Plant & Environm Protect, Beijing, Peoples R China.; Pu, DQ (corresponding author), Sichuan Acad Agr Sci, Inst Plant Protect, Chengdu, Peoples R China.	pdqpudeqiang@163.com; shujun268@163.com	Wei, Shu-Jun/C-1109-2011; Cao, Lijun/ABA-6079-2021	Wei, Shu-Jun/0000-0001-7398-0968; Cao, Lijun/0000-0002-4595-0136	Applied Foundation of Science & Technology Department of Sichuan Province [2018YYJC0468]; Natural Science Foundation of Beijing Municipality [6184037]; Beijing Key Laboratory of Environmentally Friendly Pest Management on Northern Fruits [BZ0432]; BAAFS-MOU Pest Control Research Joint Laboratory	Applied Foundation of Science & Technology Department of Sichuan Province; Natural Science Foundation of Beijing Municipality(Beijing Natural Science Foundation); Beijing Key Laboratory of Environmentally Friendly Pest Management on Northern Fruits; BAAFS-MOU Pest Control Research Joint Laboratory	Financial support was provided by the Applied Foundation of Science & Technology Department of Sichuan Province (2018YYJC0468), the Natural Science Foundation of Beijing Municipality (6184037), the Beijing Key Laboratory of Environmentally Friendly Pest Management on Northern Fruits (BZ0432) and BAAFS-MOU Pest Control Research Joint Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim J, 2009, BIOTECHNIQUES, V46, P185, DOI 10.2144/000113084; Andrews S., 2010, FASTQC QUALITY CONTR; Bai XD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011370; Ball AD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-218; Barbir J, 2014, ACTA AGR SCAND B-S P, V64, P482, DOI 10.1080/09064710.2014.925575; Behura SK, 2006, MOL ECOL, V15, P3087, DOI 10.1111/j.1365-294X.2006.03014.x; Blacket MJ, 2012, MOL ECOL RESOUR, V12, P456, DOI 10.1111/j.1755-0998.2011.03104.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cao LJ, 2017, EVOL APPL, V10, P391, DOI 10.1111/eva.12461; Cao LJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26512; Castoe TA, 2010, MOL ECOL RESOUR, V10, P341, DOI 10.1111/j.1755-0998.2009.02750.x; Du LM, 2013, J HERED, V104, P154, DOI 10.1093/jhered/ess082; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Gardner MG, 2011, MOL ECOL RESOUR, V11, P1093, DOI 10.1111/j.1755-0998.2011.03037.x; Hu G, 2016, SCIENCE, V354, P1584, DOI 10.1126/science.aah4379; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jauker F, 2008, OECOLOGIA, V156, P819, DOI 10.1007/s00442-008-1034-x; Liedvogel M, 2011, TRENDS ECOL EVOL, V26, P561, DOI 10.1016/j.tree.2011.07.009; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Meglecz E, 2010, BIOINFORMATICS, V26, P403, DOI 10.1093/bioinformatics/btp670; Mengual X, 2008, MOL PHYLOGENET EVOL, V49, P715, DOI 10.1016/j.ympev.2008.09.011; Milankov V, 2010, EUR J ENTOMOL, V107, P305, DOI 10.14411/eje.2010.039; Milankov V, 2010, J INSECT CONSERV, V14, P77, DOI 10.1007/s10841-009-9226-1; Odermatt J, 2017, ANIM BEHAV, V127, P187, DOI 10.1016/j.anbehav.2017.03.015; Peng Y., 2010, IDBA PRACTICAL ITERA; Pritchard JK, 2000, GENETICS, V155, P945; Pu DQ, 2014, J APPL ECOL, V51, P1357, DOI 10.1111/1365-2664.12299; Putra NS, 2006, APPL ENTOMOL ZOOL, V41, P389, DOI 10.1303/aez.2006.389; Queiros J, 2015, MOL ECOL RESOUR, V15, P747, DOI 10.1111/1755-0998.12349; Raymond L, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00075.1; Raymond L, 2013, MOL ECOL, V22, P5329, DOI 10.1111/mec.12483; Raymond L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072997; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rojo S, 1996, ENTOMOL EXP APPL, V81, P53, DOI 10.1007/BF00187838; Rojo S., 1997, ARQUIPELAGO-LIFE MAR, V15, P65; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rotheray EL, 2012, CONSERV GENET, V13, P1283, DOI 10.1007/s10592-012-0371-9; SCOTT SM, 1990, ENTOMOPHAGA, V35, P163, DOI 10.1007/BF02374790; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Song W, 2017, B ENTOMOL RES, V107, P349, DOI 10.1017/S0007485316000936; Speight Martin C.D., 1996, Irish Naturalists' Journal, V25, P182; Stubbs A., 2002, BRIT HOVERFLIES ILLU, V2nd; SVENSSON BG, 1984, ECOL ENTOMOL, V9, P329, DOI 10.1111/j.1365-2311.1984.tb00856.x; Van Veen M. P., 2004, HOVERFLIES NW EUROPE; Verhoeven KJF, 2011, P ROY SOC B-BIOL SCI, V278, P2, DOI 10.1098/rspb.2010.1272; Wang YZ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17030362; Wei SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059654; Yao YX, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev104; Zhan S, 2014, NATURE, V514, P317, DOI 10.1038/nature13812; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052	52	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0215888	10.1371/journal.pone.0215888	http://dx.doi.org/10.1371/journal.pone.0215888			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557189	Green Submitted, Green Published, gold			2022-12-26	WOS:000532345500004
J	Yap, YS; Leong, MC; Chua, YW; Loh, KWJ; Lee, GE; Lim, EH; Dent, R; Ng, RCH; Lim, JHC; Singh, G; Tan, A; Guan, G; Wu, A; Lee, YF; Bhagat, AAS; Lim, DWT				Yap, Yoon-Sim; Leong, Man Chun; Chua, Yong Wei; Loh, Kiley Wei Jen; Lee, Guek Eng; Lim, Elaine Hsuen; Dent, Rebecca; Ng, Raymond Chee Hui; Lim, John Heng-Chi; Singh, Garima; Tan, Angela; Guan, Guofeng; Wu, Andrew; Lee, Yi Fang; Bhagat, Ali Asgar S.; Lim, Darren Wan-Teck			Detection and prognostic relevance of circulating tumour cells (CTCs) in Asian breast cancers using a label-free microfluidic platform	PLOS ONE			English	Article							CLINICAL ONCOLOGY/COLLEGE; AMERICAN SOCIETY; ENRICHMENT; ESTROGEN; RECOMMENDATIONS; PROGRESSION; SURVIVAL	Objectives We aimed to study the prevalence of CTCs in breast cancer (BC) patients undergoing neoadjuvant or palliative therapy with a label-free microfluidic platform (ClearCell FX), and its prognostic relevance in metastatic BC (mBC). Materials and methods Peripheral blood samples were collected from 108 BC patients before starting a new line of treatment ("baseline"), majority of whom had mBC (76/108; 70.4%). CTCs were retrieved by dean flow fractionation that enriched for larger cells, and enumerated using immunofluorescence-based staining. Progression-free survival (PFS) in mBC patients was analysed using Kaplan-Meier method; cox proportional hazard models were used for univariable and multivariable analyses. Results The detection rate of CTCs before starting a new line of treatment was 75.9% (n = 108; median: 8 CTCs/7.5 ml blood) at a cut off of >= 2 CTCs. PFS was inferior for mBC patients with baseline CTC count >= 5 CTCs/7.5 ml blood vs. those with <5 CTCs/7.5 ml blood (median PFS: 4.3 vs. 7.0 months; p-value: 0.037). The prognostic relevance of CTCs was most significant in patients with HER2(-) mBC (median PFS: 4.1 vs. 8.3 months; p-value: 0.032), luminal (HR+HER2-) subtype (median PFS: 4.2 vs. 8.3 months; p-value: 0.048), and patients who had one or more prior treatments (median PFS: 4.2 vs. 7.0 months; p-value: 0.02). On multivariable analysis, baseline CTC level (hazard ratio (HR): 1.84, p-value: 0.02) and pre-treatment status (HR: 1.87, p-value: 0.05) were independent predictors of PFS. Conclusions This work demonstrates the prognostic significance of CTCs in mBC detected using a label-free size-based enrichment platform.	[Yap, Yoon-Sim; Loh, Kiley Wei Jen; Lee, Guek Eng; Lim, Elaine Hsuen; Dent, Rebecca; Ng, Raymond Chee Hui; Lim, Darren Wan-Teck] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore; [Leong, Man Chun; Singh, Garima; Tan, Angela; Guan, Guofeng; Wu, Andrew; Lee, Yi Fang; Bhagat, Ali Asgar S.] Biolid Ltd, Singapore, Singapore; [Chua, Yong Wei] Singapore Gen Hosp, Dept Pathol, Singapore, Singapore; [Lim, Elaine Hsuen; Lim, Darren Wan-Teck] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore; [Lim, John Heng-Chi] Natl Canc Ctr Singapore, Clin Trials & Epidemiol Off, Singapore, Singapore	National Cancer Centre Singapore (NCCS); Singapore General Hospital; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National Cancer Centre Singapore (NCCS)	Yap, YS (corresponding author), Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore.	yap.y.s@nccs.com.sg	Loh, Kiley/AAJ-5190-2021; Lim, Darren Wan-Teck/V-8435-2019; Lim, Darren Wan Teck/L-2007-2016	Lim, Darren Wan-Teck/0000-0002-4655-0206; Lim, Darren Wan Teck/0000-0002-4655-0206; Yap, Yoon-Sim/0000-0002-0347-5066; Bhagat, Ali Asgar/0000-0002-4695-8762; Loh, Kiley Wei-Jen/0000-0003-0638-4677				Adams DL, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0706-4; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Babayan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075038; Bidard FC, 2010, ANN ONCOL, V21, P729, DOI 10.1093/annonc/mdp391; Bidard FC, 2016, CANCER RES, V76, DOI 10.1158/1538-7445.SABCS15-P2-02-17; Bidard F-C, 2013, CANC METASTASIS REV; Bidard F-C, 2013, CANC RES S, V73, DOI [10.1158/0008-5472.sabcs13-ot1-1-10, DOI 10.1158/0008-5472.SABCS13-OT1-1-10]; Cristofanilli M, 2005, J CLIN ONCOL, V23, P1420, DOI 10.1200/JCO.2005.08.140; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; Dayyani F, 2009, J CLIN ONCOL, V27; Fraser-Fish J, 2016, ANN ONCOL, V27, DOI 10.1093/annonc/mdw363.24; Gabriel MT, 2016, CLIN CHEM, V62, P571, DOI 10.1373/clinchem.2015.249706; Giordano A, 2012, ANN ONCOL, V23, P1144, DOI 10.1093/annonc/mdr434; Giordano A, 2012, MOL CANCER THER, V11, P2526, DOI 10.1158/1535-7163.MCT-12-0460; Giuliano M, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0440-8; Giuliano M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2907; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, pE48, DOI 10.1043/1543-2165-134.7.e48; Hayes DF, 2006, CLIN CANCER RES, V12, P4218, DOI 10.1158/1078-0432.CCR-05-2821; Horiguchi J, 2012, CANCER RES, V72, DOI 10.1158/0008-5472.SABCS12-P3-06-29; Hou HW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01259; Ignatiadis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015624; Kalinsky K, 2015, CLIN TRANSL ONCOL, V17, P539, DOI 10.1007/s12094-015-1275-1; Karhade M, 2014, BREAST CANCER RES TR, V147, P325, DOI 10.1007/s10549-014-3103-7; Khoo BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099409; Lee Y, 2018, CYTOM PART A, V93A, P1251, DOI 10.1002/cyto.a.23507; Lucci A, 2012, LANCET ONCOL, V13, P688, DOI 10.1016/S1470-2045(12)70209-7; Lv Q, 2016, CLIN TRANSL ONCOL, V18, P322, DOI 10.1007/s12094-015-1372-1; Mego M, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-014-0507-6; Paoletti C, 2016, MOL ONCOL, V10, P1078, DOI 10.1016/j.molonc.2016.04.006; Paolillo C, 2017, CLIN CANCER RES, V23, P6086, DOI 10.1158/1078-0432.CCR-17-1173; Peeters DJE, 2014, BRIT J CANCER, V110, P375, DOI 10.1038/bjc.2013.743; Pierga JY, 2017, ANN ONCOL, V28, P103, DOI 10.1093/annonc/mdw535; Sawada T, 2016, EBIOMEDICINE, V11, P173, DOI 10.1016/j.ebiom.2016.07.027; Tan CL, 2016, ONCOTARGET, V7, P23251, DOI 10.18632/oncotarget.8136; Tewes M, 2009, BREAST CANCER RES TR, V115, P581, DOI 10.1007/s10549-008-0143-x; Thiery JP, 2013, CANCER CELL, V23, P272, DOI 10.1016/j.ccr.2013.03.004; Wallwiener M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1423-6; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Wong NS, 2006, BREAST CANCER RES TR, V99, P63, DOI 10.1007/s10549-006-9181-4; Wong VCL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177276; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522	41	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0221305	10.1371/journal.pone.0221305	http://dx.doi.org/10.1371/journal.pone.0221305			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553731	Green Published, gold			2022-12-26	WOS:000532319200004
J	Lin, SD; Butler, JE; Boswell-Ruys, CL; Hoang, P; Jarvis, T; Gandevia, SC; McCaughey, EJ				Lin, Sophia D.; Butler, Jane E.; Boswell-Ruys, Claire L.; Phu Hoang; Jarvis, Tom; Gandevia, Simon C.; McCaughey, Euan J.			The frequency of bowel and bladder problems in multiple sclerosis and its relation to fatigue: A single centre experience	PLOS ONE			English	Article							QUALITY-OF-LIFE; SEXUAL DYSFUNCTION; PREVALENCE; URINARY; IMPACT; SCALE; VALIDATION; SYMPTOMS; CATHETER	Background Bowel and bladder problems affect more than 50% of people with Multiple Sclerosis (MS). These problems have a large impact on quality of life and place a significant burden on health systems. Objectives This study aimed to ascertain the frequency of bladder and bowel problems in a select Australian MS cohort and to investigate the relationships between level of disability, bladder and bowel problems, and fatigue. Methods Questionnaires on the nature and severity of MS symptoms were distributed to clients attending an Australian MS centre. Log-binomial regression and multiple linear regression models were used to investigate relationships between disability, fatigue, and bladder and bowel problems. Results and conclusions Of 167 questionnaires distributed, 136 were completed. Bladder problems were reported by 87 (74.4%) respondents, whilst 66 (48.9%) experienced functional constipation and 43 (31.9%) faecal incontinence. This frequency in our select Australian MS population is similar to that reported globally. There was a significant correlation between level of disability and: bladder problems (p = 0.015), faecal incontinence (p = 0.001), fatigue (p<0.001) and constipation (p = 0.016, relative risk: 1.16). Further investigation into the causal relationships between various MS symptoms may be beneficial in the development of novel therapeutic strategies for people with MS.	[Lin, Sophia D.; Butler, Jane E.; Boswell-Ruys, Claire L.; Phu Hoang; Gandevia, Simon C.; McCaughey, Euan J.] Neurosci Res Australia, Randwick, NSW, Australia; [Lin, Sophia D.; Butler, Jane E.; Boswell-Ruys, Claire L.; Phu Hoang; Gandevia, Simon C.; McCaughey, Euan J.] Univ New South Wales, Sch Med Sci, Kensington, NSW, Australia; [Phu Hoang; Jarvis, Tom] MS Ltd, Continence Clin, Sydney, NSW, Australia; [Phu Hoang] Australian Catholic Univ, Sydney, NSW, Australia; [Jarvis, Tom; Gandevia, Simon C.] Univ New South Wales, Univ New South Wales Med, Prince Wales Clin Sch, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney; Australian Catholic University; University of New South Wales Sydney	McCaughey, EJ (corresponding author), Neurosci Res Australia, Randwick, NSW, Australia.; McCaughey, EJ (corresponding author), Univ New South Wales, Sch Med Sci, Kensington, NSW, Australia.	e.mccaughey@neura.edu.au	Boswell-Ruys, Claire L/B-7018-2013	Lin, Sophia/0000-0003-3722-4334; Butler, Jane/0000-0002-5834-8152; McCaughey, Euan James/0000-0001-6596-110X	National Multiple Sclerosis Society (NMSS), USA; National Health and Medical Research Council (NHMRC), Australia	National Multiple Sclerosis Society (NMSS), USA(National Multiple Sclerosis Society); National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a pilot grant from the National Multiple Sclerosis Society (NMSS), USA and the National Health and Medical Research Council (NHMRC), Australia.PH and TJ are employed by MS Limited. MS Limited provided support in the form of salaries for PH and TJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Amarenco G., 2014, Annals of Physical and Rehabilitation Medicine, V57, P277, DOI 10.1016/j.rehab.2014.05.006; Amato MP, 2001, MULT SCLER J, V7, P340, DOI 10.1191/135245801681138059; [Anonymous], 2017, SPEC NURS AUSTR 2017; Bates D, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-78; Bethoux F., 2006, Annales de Readaptation et de Medecine Physique, V49, P355, DOI 10.1016/j.annrmp.2006.04.022; BETTS CD, 1993, J NEUROL NEUROSUR PS, V56, P245, DOI 10.1136/jnnp.56.3.245; Burks Jack, 2013, Int J MS Care, V15, P182, DOI 10.7224/1537-2073.2012-049; CHIA YW, 1995, J NEUROL, V242, P105, DOI 10.1007/BF00887825; Cincotta MC, 2016, MULT SCLER J, V22, P1438, DOI 10.1177/1352458516663854; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Crayton H, 2004, NEUROLOGY, V63, pS12, DOI 10.1212/WNL.63.11_suppl_5.S12; DasGupta R, 2003, DRUGS, V63, P153, DOI 10.2165/00003495-200363020-00003; FISK JD, 1994, CLIN INFECT DIS, V18, pS79, DOI 10.1093/clinids/18.Supplement_1.S79; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hennessey A, 1999, J NEUROL, V246, P1027, DOI 10.1007/s004150050508; Higginson IJ, 2006, J PALLIATIVE CARE, V22, P158, DOI 10.1177/082585970602200306; HINDS JP, 1990, GASTROENTEROLOGY, V98, P1538, DOI 10.1016/0016-5085(90)91087-M; Hunter KF, 2013, NEUROUROL URODYNAM, V32, P944, DOI 10.1002/nau.22356; Jongen PJ, 2015, BMC UROL, V15, DOI 10.1186/s12894-015-0100-z; Khan F, 2006, INT J REHABIL RES, V29, P87, DOI 10.1097/01.mrr.0000194393.56772.62; Khan F, 2009, DISABIL REHABIL, V31, P1567, DOI 10.1080/09638280802639566; Kos D, 2008, NEUROREHAB NEURAL RE, V22, P91, DOI 10.1177/1545968306298934; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lekka E, 2006, EUR UROL, V50, P806, DOI 10.1016/j.eururo.2005.12.015; Mills RJ, 2010, J NEUROL NEUROSUR PS, V81, P1049, DOI 10.1136/jnnp.2008.151340; Multiple Sclerosis International Federation, 2013, ATL MS 2013 MAPP MUL; Nortvedt MW, 2007, MULT SCLER J, V13, P106, DOI 10.1177/1352458506071210; Nortvedt MW, 2001, MULT SCLER J, V7, P231, DOI 10.1177/135245850100700404; Olek MJ, 2018, UPTODATE; Preziosi Giuseppe, 2009, Expert Rev Gastroenterol Hepatol, V3, P417, DOI 10.1586/egh.09.31; Rome Foundation, 2006, ROM 3 DIAGN CRIT FUN; Sansoni J, 2011, VALIDATION CLIN TRAN; Sansoni J, 2011, TECHNICAL MANUAL INS; Sansoni J, 2013, DIS COLON RECTUM, V56, P652, DOI 10.1097/DCR.0b013e318279c2ac; Schwartz CE, 1996, ARCH PHYS MED REHAB, V77, P165, DOI 10.1016/S0003-9993(96)90162-8; Simmons RD, 2010, J NEUROL, V257, P926, DOI 10.1007/s00415-009-5441-7; Wollin Judy, 2005, Br J Nurs, V14, P439	37	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222731	10.1371/journal.pone.0222731	http://dx.doi.org/10.1371/journal.pone.0222731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536557	Green Published, gold, Green Submitted			2022-12-26	WOS:000532262800080
J	Ratnasiri, AWG; Lee, HC; Lakshminrusimha, S; Parry, SS; Arief, VN; DeLacy, IH; Yang, JS; DiLibero, RJ; Logan, J; Basford, KE				Ratnasiri, Anura W. G.; Lee, Henry C.; Lakshminrusimha, Satyan; Parry, Steven S.; Arief, Vivi N.; DeLacy, Ian H.; Yang, Jo-Shing; DiLibero, Ralph J.; Logan, Julia; Basford, Kaye E.			Trends in maternal prepregnancy body mass index (BMI) and its association with birth and maternal outcomes in California, 2007-2016: A retrospective cohort study	PLOS ONE			English	Article							GESTATIONAL WEIGHT-GAIN; PRETERM BIRTH; FETAL MACROSOMIA; OBESITY; RISK; PREGNANCY; NUTRITION; HEALTH; INFANTS; SMOKING	Objective To determine recent trends in maternal prepregnancy body mass index (BMI) and to quantify its association with birth and maternal outcomes. Methods A population-based retrospective cohort study included resident women with singleton births in the California Birth Statistical Master Files (BSMF) database from 2007 to 2016. There were 4,621,082 women included out of 5,054,968 women registered in the database. 433,886 (8.6%) women were excluded due to invalid or missing information for BMI. Exposures were underweight (BMI < 18.5 kg/m(2)), normal weight (18.5-24.9 kg/m(2)), overweight (25.0-29.9 kg/m(2)), and obese (>= 30 kg/m(2)) at the onset of pregnancy. Obesity was subcategorized into class I (30.0-34.9 kg/m(2)), class II (35.0-39.9 kg/m(2)), and class III (>= 40 kg/m(2)), while adverse outcomes examined were low birth weight (LBW), very low birth weight (VLBW), macrosomic births, preterm birth (PTB), very preterm birth (VPTB), small-for-gestational-age birth (SGA), large-for-gestational-age birth (LGA), and cesarean delivery (CD). Descriptive analysis, simple linear regression, and multivariate logistic regression were performed, and adjusted odds ratios (AORs) with 95% confidence intervals (CIs) for associations were estimated. Results Over the ten-year study period, the prevalence of underweight and normal weight women at time of birth declined by 10.6% and 9.7%, respectively, while the prevalence of overweight and obese increased by 4.3% and 22.9%, respectively. VLBW increased significantly with increasing BMI, by 24% in overweight women and by 76% in women with class III obesity from 2007 to 2016. Women with class III obesity also had a significant increase in macrosomic birth (170%) and were more likely to deliver PTB (33%), VPTB (66%), LGA (231%), and CD (208%) than women with a normal BMI. However, obese women were less likely to have SGA infants; underweight women were 51% more likely to have SGA infants than women with a normal BMI. Conclusions In California from 2007 to 2016, there was a declining trend in women with prepregnancy normal weight, and a rising trend in overweight and obese women, particularly obesity class III. Both extremes of prepregnancy BMI were associated with an increased incidence of adverse neonatal outcomes; however, the worse outcomes were prominent in those women classified as obese.	[Ratnasiri, Anura W. G.; Parry, Steven S.; DiLibero, Ralph J.] Calif Dept Hlth Care Serv, Benefits Div, Sacramento, CA 95814 USA; [Ratnasiri, Anura W. G.; Arief, Vivi N.; DeLacy, Ian H.; Basford, Kaye E.] Univ Queensland, Fac Sci, Sch Agr & Food Sci, Brisbane, Qld, Australia; [Lee, Henry C.] Stanford Univ, Sch Med, Div Neonatol, Stanford, CA 94305 USA; [Lakshminrusimha, Satyan] Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA; [Yang, Jo-Shing] Univ Calif San Francisco, Anesthesia Room ML, San Francisco, CA 94143 USA; [Logan, Julia] Calif Publ Employees Retirement Syst, Hlth Plan Adm Div, Sacramento, CA USA; [Basford, Kaye E.] Univ Queensland, Fac Med, Sch Biomed Sci, Brisbane, Qld, Australia	California Department of Health Care Services; University of Queensland; Stanford University; University of California System; University of California Davis; University of California System; University of California San Francisco; University of Queensland	Ratnasiri, AWG (corresponding author), Calif Dept Hlth Care Serv, Benefits Div, Sacramento, CA 95814 USA.; Ratnasiri, AWG (corresponding author), Univ Queensland, Fac Sci, Sch Agr & Food Sci, Brisbane, Qld, Australia.	Anura.Ratnasiri2@dhcs.ca.gov	Basford, Kaye/T-9578-2019; Arief, Vivi N/A-6450-2018; Lee, Henry/GVS-2114-2022; Arief, Vivi/I-7111-2019	Basford, Kaye/0000-0003-0955-4504; Arief, Vivi/0000-0002-3980-1716; Lakshminrusimha, Satyan/0000-0001-6098-2155				Al Wattar BH, 2016, EUR J OBSTET GYN R B, V206, P147, DOI 10.1016/j.ejogrb.2016.09.016; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Bodnar LM, 2014, PAEDIATR PERINAT EP, V28, P203, DOI 10.1111/ppe.12120; BOYD ME, 1983, OBSTET GYNECOL, V61, P715; Branum Amy M, 2016, Natl Vital Stat Rep, V65, P1; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Carmichael SL, 2017, PEDIATR RES, V82, P8, DOI 10.1038/pr.2017.90; CATALANO PM, 2017, BMJ-BRIT MED J, V356, DOI DOI 10.1136/BMJ.J1; Christian P, 2015, SEMIN PERINATOL, V39, P361, DOI 10.1053/j.semperi.2015.06.009; Chu SY, 2007, OBES REV, V8, P385, DOI 10.1111/j.1467-789X.2007.00397.x; Chu SY, 2008, NEW ENGL J MED, V358, P1444, DOI 10.1056/NEJMoa0706786; Chu SY, 2007, DIABETES CARE, V30, P2070, DOI 10.2337/dc06-2559a; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Contu L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18051093; Cunningham SA, 2014, NEW ENGL J MED, V370, P1660, DOI 10.1056/NEJMc1402397; Deputy NP, 2018, MMWR-MORBID MORTAL W, V66, P1402, DOI 10.15585/mmwr.mm665152a3; Dietz PM, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.875; Dude AM, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.05.024; Eriksson JG, 2015, ANN MED, V47, P94, DOI 10.3109/07853890.2015.1004360; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Gillman MW, 2007, PEDIATR RES, V61, P625, DOI 10.1203/pdr.0b013e3180459fcd; Girsen AI, 2016, BJOG-INT J OBSTET GY, V123, P2001, DOI 10.1111/1471-0528.14027; Godfrey KM, 2017, LANCET DIABETES ENDO, V5, P53, DOI 10.1016/S2213-8587(16)30107-3; HACK M, 1993, NEW ENGL J MED, V329, P1649, DOI 10.1056/NEJM199311253292210; Han Z, 2012, J OBSTET GYNAECOL CA, V34, P721, DOI 10.1016/S1701-2163(16)35337-3; Ho A., 2016, OBSTET GYNAECOL REPR, V26, P259, DOI [10.1016/j.ogrm.2016.06.005, DOI 10.1016/J.OGRM.2016.06.005]; Huda SS, 2010, SEMIN FETAL NEONAT M, V15, P70, DOI 10.1016/j.siny.2009.09.006; Kelly A, 1996, INT J GYNECOL OBSTET, V53, P219, DOI 10.1016/0020-7292(96)02652-5; Khatibi A, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.002; Li WD, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0133-7; Lim CC, 2015, BEST PRACT RES CL OB, V29, P309, DOI 10.1016/j.bpobgyn.2014.10.008; Linabery AM, 2013, PEDIATR OBES, V8, P159, DOI 10.1111/j.2047-6310.2012.00100.x; Lindsay KL, 2018, J OBSTET GYNAECOL, V38, P60, DOI 10.1080/01443615.2017.1328670; Lisonkova S, 2017, JAMA-J AM MED ASSOC, V318, P1777, DOI 10.1001/jama.2017.16191; Lynch AM, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.12.011; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Martin Joyce A, 2015, Natl Vital Stat Rep, V64, P1; McDonald SD, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3428; Meehan S, 2014, PEDIATRICS, V133, P863, DOI 10.1542/peds.2013-1480; MESHARI AA, 1990, INT J GYNECOL OBSTET, V32, P215, DOI 10.1016/0020-7292(90)90348-O; Moussa HN, 2016, FUTUR SCI OA, V2, DOI 10.4155/fsoa-2016-0035; Naess M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166585; Nnam NM, 2015, P NUTR SOC, V74, P454, DOI 10.1017/S0029665115002396; Nohr EA, 2007, PAEDIATR PERINAT EP, V21, P5, DOI 10.1111/j.1365-3016.2007.00762.x; Ogden CL, 2015, NCHS DATA BRIEF, P1, DOI DOI 10.1017/S1368980017000088; Olsen IE, 2010, PEDIATRICS, V125, pE214, DOI 10.1542/peds.2009-0913; Oral E, 2001, EUR J OBSTET GYN R B, V99, P167, DOI 10.1016/S0301-2115(01)00416-X; Pai VV, 2018, PEDIATR RES, V83, P1146, DOI 10.1038/pr.2018.47; Parlee SD, 2014, BBA-MOL BASIS DIS, V1842, P495, DOI 10.1016/j.bbadis.2013.07.007; Ratnasiri Anura W G, 2018, Matern Health Neonatol Perinatol, V4, P15, DOI 10.1186/s40748-018-0084-2; Reichman NE, 2008, MATERN CHILD HLTH J, V12, P204, DOI 10.1007/s10995-007-0240-1; Reynolds RM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4539; Richards JL, 2016, JAMA-J AM MED ASSOC, V316, P410, DOI 10.1001/jama.2016.9635; Schroeder SA, 2018, NEW ENGL J MED, V379, P684, DOI 10.1056/NEJMe1809004; Scott-Pillai R, 2013, BJOG-INT J OBSTET GY, V120, P932, DOI 10.1111/1471-0528.12193; Shaw GM, 2014, PAEDIATR PERINAT EP, V28, P302, DOI 10.1111/ppe.12125; Siega-Riz AM, 2013, NUTR REV, V71, pS26, DOI 10.1111/nure.12074; Stewart ST, 2009, NEW ENGL J MED, V361, P2252, DOI 10.1056/NEJMsa0900459; Hung TH, 2016, TAIWAN J OBSTET GYNE, V55, P575, DOI 10.1016/j.tjog.2016.06.016; Tohyama C, 2019, PREEMPTIVE MED PUBLI; Torloni MR, 2009, J MATERN-FETAL NEO M, V22, P957, DOI 10.3109/14767050903042561; Zhang J, 2008, AM J OBSTET GYNECOL, V199, pS51, DOI 10.1016/j.ajog.2008.09.161	62	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222458	10.1371/journal.pone.0222458	http://dx.doi.org/10.1371/journal.pone.0222458			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536528	Green Submitted, gold, Green Published			2022-12-26	WOS:000532262800042
J	Bietti, LM; Bangerter, A; Knutsen, D; Mayor, E				Bietti, Lucas M.; Bangerter, Adrian; Knutsen, Dominique; Mayor, Eric			Cultural transmission in a food preparation task: The role of interactivity, innovation and storytelling	PLOS ONE			English	Article								Interactive conversation drives the transmission of cultural information in small groups and large networks. In formal (e.g. schools) and informal (e.g. home) learning settings, interactivity does not only allow individuals and groups to faithfully transmit and learn new knowledge and skills, but also to boost cumulative cultural evolution. Here we investigate how interactivity affects performance, teaching, learning, innovation and chosen diffusion mode (e.g. instructional discourse vs. storytelling) of previously acquired information in a transmission chain experiment. In our experiment, participants (n = 288) working in 48 chains with three generations of pairs had to learn and complete a collaborative food preparation task (ravioli-making), and then transmit their experience to a new generation of participants in an interactive and non-interactive condition. Food preparation is a real-world task that it is taught and learned across cultures and transmitted over generations in families and groups. Pairs were defined as teachers or learners depending on their role in the transmission chain. The number of good exemplars of ravioli each pair produced was taken as measurement of performance. Contrary to our expectations, the results did not reveal that (1) performance increased over generations or that (2) interactivity in transmission sessions promoted increased performance. However, the results showed that (3) interactivity promoted the transmission of more information from teachers to learners; (4) increased quantity of information transmission from teachers led to higher performance in learners; (5) higher performance generations introduced more innovations in transmission sessions; (6) learners applied those transmitted innovations to their performance which made them persist over generations; (7) storytelling was specialized for the transmission of non-routine, unexpected information. Our findings offer new insights on how interactivity, innovation and storytelling affect the cultural transmission of complex collaborative tasks.	[Bietti, Lucas M.; Bangerter, Adrian; Mayor, Eric] Univ Neuchatel, Inst Work & Org Psychol, Neuchatel, Switzerland; [Bietti, Lucas M.] Ctr Natl Rech Sci CNRS, Telecom Paris, Inst Interdisciplinaire Innovat, UMR 9217, Paris, France; [Knutsen, Dominique] Univ Lille, CNRS, CHU Lille, UMR 9193,SCALab,Sci Cognit & Sci Affect, Lille, France	University of Neuchatel; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); IMT - Institut Mines-Telecom; Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite de Lille - ISITE; CHU Lille; Universite de Lille	Bietti, LM (corresponding author), Univ Neuchatel, Inst Work & Org Psychol, Neuchatel, Switzerland.; Bietti, LM (corresponding author), Ctr Natl Rech Sci CNRS, Telecom Paris, Inst Interdisciplinaire Innovat, UMR 9217, Paris, France.	bietti@protonmail.com	Bietti, Lucas/GOV-5160-2022; Mayor, eric/AFT-8486-2022	Bietti, Lucas/0000-0002-4380-2615; Mayor, eric/0000-0001-9441-7592	Swiss National Science Foundation Ambizione Grant [PZ00P1_154968]	Swiss National Science Foundation Ambizione Grant	This research was funded by a Swiss National Science Foundation Ambizione Grant [PZ00P1_154968] to L.M.B. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; [Anonymous], PERSPECTIVES SOCIALL; Bangerter A, 2000, DISCOURSE PROCESS, V30, P237, DOI 10.1207/S15326950dp3003_2; Bangerter A, 2011, DISCOURSE PROCESS, V48, P183, DOI 10.1080/0163853X.2010.519765; Bartlett F. C., 1932, REMEMBERING; Bavelas JB, 2000, J PERS SOC PSYCHOL, V79, P941, DOI 10.1037/0022-3514.79.6.941; Bietti L.M., 2017, P 39 ANN C COGN SCI, P1641; Bietti LM, 2019, TOP COGN SCI, V11, P710, DOI 10.1111/tops.12358; Boyd B., 2009, ORIGINS STORIES EVOL; Boyd R., 1985, CULTURE EVOLUTIONARY; Brown D. E., 1991, HUMAN UNIVERSALS; Bruner J. S., 1990, ACTS MEANING; Caldwell CA, 2008, EVOL HUM BEHAV, V29, P165, DOI 10.1016/j.evolhumbehav.2007.12.001; Caldwell CA, 2018, REV PHILOS PSYCHOL, V9, P751, DOI 10.1007/s13164-017-0346-3; Caldwell CA, 2016, CURR DIR PSYCHOL SCI, V25, P191, DOI 10.1177/0963721416641049; Caldwell CA, 2009, PSYCHOL SCI, V20, P1478, DOI 10.1111/j.1467-9280.2009.02469.x; Carmody RN, 2009, J HUM EVOL, V57, P379, DOI 10.1016/j.jhevol.2009.02.011; Clark H.H., 1996, USING LANGUAGE; CLARK HH, 1989, COGNITIVE SCI, V13, P259, DOI 10.1207/s15516709cog1302_7; Currie A, 2017, STUD HIST PHILOS SCI, V62, P14, DOI 10.1016/j.shpsa.2017.03.003; Derex M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9398; Dessalles JL, 2010, EVOLUTION OF LANGUAGE, PROCEEDINGS, P99, DOI 10.1142/9789814295222_0013; Dunbar R, 2010, GROOMING GOSSIP EVOL; Dunbar RIM, 2004, REV GEN PSYCHOL, V8, P100, DOI 10.1037/1089-2680.8.2.100; Farmer N, 2018, HEALTH EDUC BEHAV, V45, P167, DOI 10.1177/1090198117736352; Fay N, 2018, EVOL HUM BEHAV, V39, P300, DOI 10.1016/j.evolhumbehav.2018.02.002; Garfield ZH., 2016, SOCIAL LEARNING INNO, P19; Hochberg ME, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0414; Kendal RL, 2018, TRENDS COGN SCI, V22, P651, DOI 10.1016/j.tics.2018.04.003; Kline MA, 2015, BEHAV BRAIN SCI, V38, DOI 10.1017/S0140525X14001071; Knutsen D, 2016, TOP COGN SCI, V8, P796, DOI 10.1111/tops.12218; Kraut RE, 2003, HUM-COMPUT INTERACT, V18, P13, DOI 10.1207/S15327051HCI1812_2; Labov W., 1976, ESSAYS VERBAL VISUAL, P12; Lombao D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14322-y; Mandelbaum J., 2013, HDB CONVERSATION ANA, P492, DOI DOI 10.1002/9781118325001.CH24; Maswood R, 2019, TOP COGN SCI, V11, P687, DOI 10.1111/tops.12348; McCabe M, 2015, J CONSUM CULT, V15, P48, DOI 10.1177/1469540513493202; McGuigan N, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0425; Mesoudi A, 2008, PHILOS T R SOC B, V363, P3489, DOI 10.1098/rstb.2008.0129; Mesoudi Alex, 2008, Biological Theory, V3, P63, DOI 10.1162/biot.2008.3.1.63; Miton H, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0677; Morgan TJH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7029; O'Brien Michael J., 2009, INNOVATION CULTURAL; Ramstead MJD, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01090; Silva KG, 2010, CHILD DEV, V81, P898, DOI 10.1111/j.1467-8624.2010.01441.x; Smith D, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02036-8; Sugiyama MS, 2001, EVOL HUM BEHAV, V22, P221; Tan R, 2011, EVOL HUM BEHAV, V32, P399, DOI 10.1016/j.evolhumbehav.2011.01.001; Utter J, 2018, J NUTR EDUC BEHAV, V50, P494, DOI 10.1016/j.jneb.2018.01.021; Wrangham RW, 1999, CURR ANTHROPOL, V40, P567, DOI 10.1086/300083; Zwirner E, 2015, SCI REP-UK, V5, DOI 10.1038/srep16781	52	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221278	10.1371/journal.pone.0221278	http://dx.doi.org/10.1371/journal.pone.0221278			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4SI	31532770	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000532239600005
J	Balsalobre-Fernandez, C; Cardiel-Garcia, M; Jimenez, SL				Balsalobre-Fernandez, Carlos; Cardiel-Garcia, Mario; Jimenez, Sergio L.			Bilateral and unilateral load-velocity profiling in a machine-based, single-joint, lower body exercise	PLOS ONE			English	Article							MOVEMENT VELOCITY; INTENSITY	Background To analyze the goodness of fit of the load-velocity relationship in a machine-based, single joint exercise performed both in a bilateral and unilateral manner, as well as to study its accuracy to estimate one repetition maximum (1-RM). Methods Fifteen resistance trained males performed an incremental test in the bilateral and unilateral leg extension exercise up to the 1-RM in two separate occasions. Mean vertical velocity of the weight plates in the leg extension machine was measured for every repetition using a smartphone application (My Lift). Results Linear regression analyses showed a high goodness of fit (R-2 > 0.93) and small standard errors of estimate (SEE < 5%1-RM) both in the bilateral and unilateral leg extension when individual load-velocity regressions for each participant were computed. Unilateral load velocity relationships showed significant differences in the intercept of the regression line with the Y-axis and the velocity at each percentage of the 1-RM (Cohen's d>1.0, p<0.05). Finally, non-significant differences were observed between actual and estimated 1-RM from the load-velocity relationships (r=0.88.0-96, Cohen's d<0.2, p>0.05). Conclusions This proof of concept highlights that computing load-velocity relationships in a machine based, single-joint, angular exercise can be appropriately performed by measuring the mean vertical velocity of the weight plates. These results could help strength and conditioning researchers and coaches who wish to analyze load-velocity relationship in other common machine-based exercises.	[Balsalobre-Fernandez, Carlos] Autonomous Univeris Madrid, Dept Phys Educ Sport & Human Movement, Madrid, Spain; [Cardiel-Garcia, Mario; Jimenez, Sergio L.] European Univ Madrid, Sch Sports Sci, Madrid, Spain	European University of Madrid	Balsalobre-Fernandez, C (corresponding author), Autonomous Univeris Madrid, Dept Phys Educ Sport & Human Movement, Madrid, Spain.	carlos.balsalobre@icloud.com	Jiménez, Sergio L./AAD-2148-2020	Jiménez, Sergio L./0000-0002-5069-6099				Balsalobre-Fernandez C, 2021, J STRENGTH COND RES, V35, P724, DOI 10.1519/JSC.0000000000002818; Balsalobre-Fernandez C, 2018, INT J SPORTS SCI COA, V13, P743, DOI 10.1177/1747954117738243; Balsalobre-Fernandez C, 2018, J SPORT SCI, V36, P64, DOI 10.1080/02640414.2017.1280610; Banyard HG, 2019, INT J SPORT PHYSIOL, V14, P246, DOI 10.1123/ijspp.2018-0147; Banyard HG, 2018, INT J SPORT PHYSIOL, V13, P763, DOI 10.1123/ijspp.2017-0610; Banyard HG, 2016, J STRENGTH COND RES, V1, DOI [10.1519/JSC.0000000000001657, DOI 10.1519/JSC.0000000000001]; Bobbert MF, 2012, J APPL PHYSIOL, V112, P1975, DOI 10.1152/japplphysiol.00787.2011; Conceicao F, 2016, J SPORT SCI, V34, P1099, DOI 10.1080/02640414.2015.1090010; Dorrell HF, 2020, J STRENGTH COND RES, V34, P46, DOI 10.1519/JSC.0000000000003089; Garcia-Ramos A, 2021, SPORT BIOMECH, V20, P261, DOI 10.1080/14763141.2018.1544662; Garcia-Ramos A, 2018, INT J SPORT PHYSIOL, V13, P474, DOI 10.1123/ijspp.2017-0374; Gonzalez-Badillo JJ, 2010, INT J SPORTS MED, V31, P347, DOI 10.1055/s-0030-1248333; Hernandez-Preciado JA, 2018, J STRENGTH COND RES, V32, P1909, DOI 10.1519/JSC.0000000000002437; Iglesias-Soler E, 2019, SPORT BIOMECH, V18, P174, DOI 10.1080/14763141.2018.1442873; Lake J, 2017, SPORTS, V5, DOI 10.3390/sports5030070; Munoz-Lopez M, 2017, INT J SPORT PHYSIOL, V12, P1249, DOI 10.1123/ijspp.2016-0657; Pareja-Blanco F, 2017, SCAND J MED SCI SPOR, V27, P724, DOI 10.1111/sms.12678; Perez-Castilla A, 2019, J STRENGTH COND RES, DOI [10.1519/JSC.0000000000002968, DOI 10.1519/JSC.0000000000002968]; Rejc E, 2010, EUR J APPL PHYSIOL, V108, P157, DOI 10.1007/s00421-009-1199-y; Rhea MR, 2004, J STRENGTH COND RES, V18, P918, DOI 10.1519/00124278-200411000-00040; Ruf L, 2018, J STRENGTH COND RES, V32, P681, DOI 10.1519/JSC.0000000000002369	21	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222632	10.1371/journal.pone.0222632	http://dx.doi.org/10.1371/journal.pone.0222632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525245	Green Published, Green Submitted, gold			2022-12-26	WOS:000532225700042
J	Zheng, YH; Li, SQ; Xu, SS				Zheng, Yuhua; Li, Shiqi; Xu, Shuangshuang			Transport oil product consumption and GHG emission reduction potential in China: An electric vehicle-based scenario analysis	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; CARBON-DIOXIDE EMISSIONS; CO2 EMISSIONS; ENERGY-CONSUMPTION; ROAD TRANSPORT; DECOMPOSITION ANALYSIS; IMPACTS; ELECTRIFICATION; SECTOR; TERM	China's transport sector is facing enormous challenges from soaring energy consumption and greenhouse gas (GHG) emissions. Transport electrification has been viewed as a major solution to transportation decarbonization, and electric vehicles (EVs) have attracted considerable attention from policymakers. This paper analyzes the effects of the introduction of EVs in China. A system dynamics model is developed and applied to assess the energy -saving and emission -reducing impacts of the projected penetration of EVs until the year 2030. Five types of scenarios of various EV penetration rates, electricity generation mixes, and the speed of technological improvement are discussed. Results confirm that reductions in transport GHG emissions and gasoline and diesel consumption by 3.0%16.2%, 4.4%-16.1%, and 15.8%-34.3%, respectively, will be achieved by 2030 under China's projected EV penetration scenarios. Results also confirm that if EV penetration is accompanied by decarbonized electricity generation, that is, the use of 55% coal by 2030, then total transport GHG emissions will be further reduced by 0.8%-4.4%. Moreover, further reductions of GHG emissions of up to 5.6% could be achieved through technological improvement. The promotion of EVs could substantially affect the reduction of transport GHG emissions in China, despite the uncertainty of the influence intensity, which is dependent on the penetration rate of EVs, the decarbonization of the power sector, and the technological improvement efficiency of EVs and internal combustion engine vehicles.	[Zheng, Yuhua; Li, Shiqi; Xu, Shuangshuang] China Univ Petr, Sch Econ & Management, Beijing, Peoples R China	China University of Petroleum	Zheng, YH (corresponding author), China Univ Petr, Sch Econ & Management, Beijing, Peoples R China.	cupbazyh@163.com		Zheng, Yuhua/0000-0001-7621-744X	China's National Social Science Fund [13ZD159]; Scientific Research Foundation of China University of Petroleum, Beijing [2462015YQ0716]	China's National Social Science Fund; Scientific Research Foundation of China University of Petroleum, Beijing	Y. Z. received the funding (No. 13&ZD159) for this work from China's National Social Science Fund. Y. Z. received the funding (No. 2462015YQ0716) for this work from Scientific Research Foundation of China University of Petroleum, Beijing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi P, 2019, J CLEAN PROD, V225, P1209, DOI 10.1016/j.jclepro.2019.03.334; [Anonymous], 2015, CLIMATE CHANGE 2014; BP Group, 2017, EN OUTL; Casals LC, 2016, J CLEAN PROD, V127, P425, DOI 10.1016/j.jclepro.2016.03.120; Dhar S, 2017, J CLEAN PROD, V146, P139, DOI 10.1016/j.jclepro.2016.05.111; Ding Ning, 2015, China Environmental Science, V35, P1592; Doucette RT, 2011, APPL ENERG, V88, P2315, DOI 10.1016/j.apenergy.2011.01.045; Du HB, 2017, J CLEAN PROD, V162, P882, DOI 10.1016/j.jclepro.2017.06.054; Eom J, 2012, ENERG POLICY, V45, P327, DOI 10.1016/j.enpol.2012.02.040; Geng Y, 2013, J CLEAN PROD, V58, P82, DOI 10.1016/j.jclepro.2013.06.034; Green F., 2015, CTR CLIMATE CHANGE E, V3, P4408; [郭栋 Guo Dong], 2016, [系统工程理论与实践, Systems Engineering-Theory & Practice], V36, P1593; Hofmann J, 2016, APPL ENERG, V184, P995, DOI 10.1016/j.apenergy.2016.06.042; Huo H, 2015, ATMOS ENVIRON, V108, P107, DOI 10.1016/j.atmosenv.2015.02.073; Huo H, 2012, ENERG POLICY, V43, P37, DOI 10.1016/j.enpol.2011.09.065; IEA, 2017, GLOBAL EV OUTLOOK 20; International Energy Agency, 2016, WORLD EN OUTL 2016; Jiang Zi-ying, 2015, China Environmental Science, V35, P3502; Kamiya G, 2019, TRANSPORT RES D-TR E, V69, P209, DOI 10.1016/j.trd.2019.01.027; Sumabat AK, 2016, APPL ENERG, V164, P795, DOI 10.1016/j.apenergy.2015.12.023; Lang JL, 2013, ENERGIES, V6, P2663, DOI 10.3390/en6052663; Liao Xia-wei, 2013, China Environmental Science, V33, P553; Liao Xiawei, 2013, Acta Scientiarum Naturalium Universitatis Pekinensis, V49, P885; Lin BQ, 2017, J CLEAN PROD, V150, P175, DOI 10.1016/j.jclepro.2017.02.171; Liu CQ, 2018, REPORT DEV NATL INT; [刘胜强 Liu Shengqiang], 2012, [气候变化研究进展, Advances in Climate Change Research], V8, P48; Liu T, 2018, ENERGY, V160, P544, DOI 10.1016/j.energy.2018.07.022; Liu T, 2018, IEEE T IND INFORM, V14, P1616, DOI 10.1109/TII.2018.2797322; Liu TJ, 2020, IEEE J EM SEL TOP P, V8, P893, DOI 10.1109/JESTPE.2019.2897764; Liu T, 2018, IEEE INT CON AUTO SC, P1, DOI 10.1109/COASE.2018.8560378; Liu Z, 2016, SPRINGER THESES-RECO, P1, DOI 10.1007/978-3-662-52864-8; Lu IJ, 2007, ENERG POLICY, V35, P3226, DOI 10.1016/j.enpol.2006.11.003; Luo X, 2017, ENERG POLICY, V107, P658, DOI 10.1016/j.enpol.2017.02.049; Mattila T, 2011, ENERG POLICY, V39, P1241, DOI 10.1016/j.enpol.2010.11.051; Ministry of Ecology and Environment of China, 2017, CHIN VEH ENV MAN ANN, V6, P3; Ministry of Industry and Information Technology of the People's Republic of China, 2018, INF DISCL CAT; Ministry of Industry and Information Technology P, CHIN AUT FUEL CONS Q; Mustapa SI, 2016, ENERG POLICY, V89, P171, DOI 10.1016/j.enpol.2015.11.016; Nanaki EA, 2016, RENEW ENERG, V99, P1153, DOI 10.1016/j.renene.2016.08.006; National Bureau of Statistics of China, 2018, CHIN STAT YB 2017; National Bureau of Statistics of People's Republic of China, 1990, CHIN EN STAT YB 1990; National Development and Reform Commission, 2015, GUID DEV REF COMM GU; Ong HC, 2011, RENEW SUST ENERG REV, V15, P3516, DOI 10.1016/j.rser.2011.05.006; Palencia JCG, 2016, APPL ENERG, V181, P96, DOI 10.1016/j.apenergy.2016.08.045; Pasaoglu G, 2012, ENERG POLICY, V40, P404, DOI 10.1016/j.enpol.2011.10.025; Pietzcker RC, 2014, ENERGY, V64, P95, DOI 10.1016/j.energy.2013.08.059; Pongthanaisawan J, 2013, APPL ENERG, V101, P288, DOI 10.1016/j.apenergy.2011.09.026; Qiao QY, 2017, APPL ENERG, V204, P1399, DOI 10.1016/j.apenergy.2017.05.041; Rangaraju S, 2015, APPL ENERG, V148, P496, DOI 10.1016/j.apenergy.2015.01.121; Teixeira ACR, 2016, ENERGY, V115, P1617, DOI 10.1016/j.energy.2016.07.095; Ruhnau O, 2019, ENERGY, V166, P989, DOI 10.1016/j.energy.2018.10.114; Shen W, 2014, ENVIRON SCI TECHNOL, V48, P7069, DOI 10.1021/es500524e; Society of Automotive Engineers of China, 2016, EN SAV NEW EN VEH TE; Tremblay A, 2006, INT J HYDROPOWER DAM, V13, P103; Trost T, 2017, ENERGY, V141, P1215, DOI 10.1016/j.energy.2017.10.006; Upadhyayula VKK, 2019, J CLEAN PROD, V209, P1604, DOI 10.1016/j.jclepro.2018.11.153; Wang N, 2018, ENERGY, V162, P841, DOI 10.1016/j.energy.2018.08.054; Wang Q., 2010, 2010 ENERGY DATA; Wang Y, 2016, RENEWABLE ENERGY RES, V34, P1032; Watabe A, 2019, ENERG POLICY, V130, P227, DOI 10.1016/j.enpol.2019.03.057; Weisser D, 2007, ENERGY, V32, P1543, DOI 10.1016/j.energy.2007.01.008; Wolfram P, 2017, APPL ENERG, V206, P531, DOI 10.1016/j.apenergy.2017.08.219; Wood R, 2009, ENERG POLICY, V37, P4943, DOI 10.1016/j.enpol.2009.06.060; Wu T, 2014, SUSTAINABILITY-BASEL, V6, P4877, DOI 10.3390/su6084877; Wu Y, 2012, ENERG POLICY, V48, P537, DOI 10.1016/j.enpol.2012.05.060; Yang Y, 2017, ENERG POLICY, V107, P561, DOI 10.1016/j.enpol.2017.05.021; Yin X, 2015, ENERG POLICY, V82, P233, DOI 10.1016/j.enpol.2015.03.021; Zhang HJ, 2016, APPL ENERG, V162, P1505, DOI 10.1016/j.apenergy.2015.08.124; Zhang LL, 2019, J CLEAN PROD, V207, P569, DOI 10.1016/j.jclepro.2018.10.003; Zhang M, 2011, APPL ENERG, V88, P2279, DOI 10.1016/j.apenergy.2010.12.077; Zhang X, 2017, GLOBAL ENVIRON CHANG, V44, P83, DOI 10.1016/j.gloenvcha.2017.03.003; Zhao FQ, 2019, J CLEAN PROD, V207, P702, DOI 10.1016/j.jclepro.2018.10.046; Zheng YH, 2013, ENERGY, V57, P336, DOI 10.1016/j.energy.2013.05.004	73	7	7	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222448	10.1371/journal.pone.0222448	http://dx.doi.org/10.1371/journal.pone.0222448			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4NC	31525217	Green Published, gold, Green Submitted			2022-12-26	WOS:000532225700028
J	Clark, CEF; Akter, Y; Hungerford, A; Thomson, P; Islam, MR; Groves, PJ; O'Shea, CJ				Clark, Cameron E. F.; Akter, Yeasmin; Hungerford, Alena; Thomson, Peter; Islam, Mohammed R.; Groves, Peter J.; O'Shea, Cormac J.			The intake pattern and feed preference of layer hens selected for high or low feed conversion ratio	PLOS ONE			English	Article							LAYING HENS; FOOD-INTAKE; EGG FORMATION; EFFICIENCY; CONSUMPTION; REQUIREMENTS; BEHAVIOR; CALCIUM; STRESS	Feed accounts for the greatest proportion of egg production costs and there is substantial variation in feed to egg conversion ratio (FCR) efficiency between individual hens. Despite this understanding, there is a paucity of information regarding layer hen feeding behaviour, diet selection and its impact on feed efficiency. It was hypothesised that variation in feed to egg conversion efficiency between hens may be influenced by feeding behaviour. For this experiment, two 35-bird groups of ISA Brown layers were selected from 450 individually caged hens at 25-30 weeks of age for either low FCR < 1.8 +/- 0.02 (high feed efficiency (HFE) or high FCR > 2.1 +/- 0.02 (low feed efficiency (LFE)). For each of these 70 hens, intake of an ad-libitum mash diet at 2-minute time intervals, 24 h a day, for 7 days was determined alongside behavioural assessment and estimation of the selection of components of the mash. The group selected for HFE had a lower feed intake, similar egg mass and associated lower FCR when compared with the LFE group. Whilst feed intake patterns were similar between HFE and LFE hens, there was a distinct intake pattern for all layer hens with intake rate increasing from 0300 to 1700 h with a sharp decline to 2200 h. High feed efficiency hens selected a diet with 25% more ash and 4% less gross energy than LFE hens. The LFE hens also spent more time eating with more walking events, but less time spent resting, drinking, preening and cage pecking events as compared with HFE hens. In summary, there was no contrasting diurnal pattern of feed consumption behaviour between the groups ranked on feed efficiency, however high feed efficiency hens consumed less feed and selected a diet with greater ash content and lower gross energy as compared with LFE hens. Our work is now focused on individual hen diet selection from mash diets with an aim of formulating precision, targeted diets for greater feed efficiency.	[Clark, Cameron E. F.; Hungerford, Alena; Thomson, Peter; Islam, Mohammed R.] Univ Sydney, Sch Life & Environm Sci, Camden, NSW, Australia; [Akter, Yeasmin; Groves, Peter J.] Univ Sydney, Poultry Res Fdn, Sydney Sch Vet Sci, Camden, NSW, Australia; [O'Shea, Cormac J.] Univ Nottingham, Sch Biosci, Loughborough, Leics, England	University of Sydney; University of Sydney; University of Nottingham	Clark, CEF (corresponding author), Univ Sydney, Sch Life & Environm Sci, Camden, NSW, Australia.	cameron.clark@sydney.edu.au	Thomson, Peter/V-7290-2019	Thomson, Peter/0000-0003-4428-444X; O'Shea, Cormac/0000-0002-1797-1941; Hungerford, Alena/0000-0002-5447-9358	Australian Eggs	Australian Eggs(Australian Eggs)	This work was supported by the Australian Eggs (www.australianeggs.org.au).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge Australian Eggs for providing funds for this research. The authors also thank Ms. Joy Gill, Ms. Melinda Hayter, Mr. Duwei Chen, & Ms. Kylie Warr for providing technical support to carry out this study.	Akter Y, 2018, J ANIM SCI, V96, P3482, DOI 10.1093/jas/sky188; AOAC, 1990, OFF METH AN; BRAASTAD BO, 1989, BRIT POULTRY SCI, V30, P533, DOI 10.1080/00071668908417177; BROOM DM, 1983, APPL ANIM ETHOL, V11, P79, DOI 10.1016/0304-3762(83)90090-1; BYERLY TC, 1980, POULTRY SCI, V59, P2500, DOI 10.3382/ps.0592500; Chah CC, 1971, THESIS; Choi JH, 2004, ASIAN AUSTRAL J ANIM, V17, P371, DOI 10.5713/ajas.2004.371; CLASSEN HL, 1982, POULTRY SCI, V61, P2065, DOI 10.3382/ps.0612065; CRONIN GM, 1986, EXPERIENTIA, V42, P198, DOI 10.1007/BF01952467; DUNCAN IJH, 1975, BRIT POULTRY SCI, V16, P145, DOI 10.1080/00071667508416172; FAIRFULL RW, 1984, CAN J ANIM SCI, V64, P513, DOI 10.4141/cjas84-062; Forbes J. Michael, 2007, P1, DOI [10.1079/9781845932794.0341, 10.1079/9781845932794.0041, 10.1079/9781845932794.0310, 10.1079/9781845932794.0365, 10.1079/9781845932794.0243, 10.1079/9781845932794.0000]; Gabarrou JF, 1998, BRIT POULTRY SCI, V39, P79, DOI 10.1080/00071669889439; HAMID R, 1989, Pertanika, V12, P27; Henson SM, 2012, J BIOL DYNAM, V6, P17, DOI 10.1080/17513758.2011.605913; Hurnik JF, 1985, DICT FARM ANIMAL BEH, P176; KADONO H, 1981, J APPL PHYSIOL, V51, P1145, DOI 10.1152/jappl.1981.51.5.1145; Khalil AM, 2010, TURK J VET ANIM SCI, V34, P433, DOI 10.3906/vet-0901-25; Leeson S, 2009, COMMERCIAL POULTRY N, P164; LUITING P, 1991, BRIT POULTRY SCI, V32, P763, DOI 10.1080/00071669108417402; LUITING P, 1991, POULTRY SCI, V70, P1663, DOI 10.3382/ps.0701663; MacLeod M. G., 1982, P 9 S EN MET EUR ASS, P297; MACLEOD MG, 1985, P NUTR SOC, V44, pA34; MARKS HL, 1984, POULTRY SCI, V63, P1617, DOI 10.3382/ps.0631617; McKinley MJ, 2004, NEWS PHYSIOL SCI, V19, P1, DOI 10.1152/nips.01470.2003; Molnar A, 2018, WORLD POULTRY SCI J, V74, P199, DOI 10.1017/S0043933918000247; MONGIN P, 1974, BRIT POULTRY SCI, V15, P349, DOI 10.1080/00071667408416118; MORRISON WD, 1978, POULTRY SCI, V57, P735, DOI 10.3382/ps.0570735; Pohle K, 2009, POULTRY SCI, V88, P1559, DOI 10.3382/ps.2009-00045; SAVORY CJ, 1977, BRIT POULTRY SCI, V18, P331, DOI 10.1080/00071667708416369; VANROOIJEN J, 1991, APPL ANIM BEHAV SCI, V30, P105, DOI 10.1016/0168-1591(91)90089-G; Waldroup PW, 2000, J APPL POULTRY RES, V9, P98, DOI 10.1093/japr/9.1.98; Willems OW, 2013, WORLD POULTRY SCI J, V69, P77, DOI 10.1017/S004393391300007X	33	4	6	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2019	14	9							e0222304	10.1371/journal.pone.0222304	http://dx.doi.org/10.1371/journal.pone.0222304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4IG	31513689	Green Published, Green Submitted, gold			2022-12-26	WOS:000532212700051
J	Ludlam, WG; Aoba, T; Cuellar, J; Bueno-Carrasco, MT; Makaju, A; Moody, JD; Franklin, S; Valpuesta, JM; Willardson, BM				Ludlam, W. Grant; Aoba, Takuma; Cuellar, Jorge; Teresa Bueno-Carrasco, M.; Makaju, Aman; Moody, James D.; Franklin, Sarah; Valpuesta, Jose M.; Willardson, Barry M.			Molecular architecture of the Bardet?Biedl syndrome protein 2-7-9 subcomplex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein assembly; protein complex; protein cross-linking; mass spectrometry (MS); electron microscopy (EM); homology modeling; Bardet-Biedl syndrome; Cilia transport; ciliopathy; integrated modeling	CHAPERONIN-LIKE PROTEIN; CHEMICAL CROSS-LINKING; BIEDL-SYNDROME PROTEIN; PRIMARY CILIUM; COMPLEX; BBSOME; MUTATIONS; IDENTIFICATION; BBS10; TRAFFICKING	Bardet-Biedl syndrome (BBS) is a genetic disorder characterized by malfunctions in primary cilia resulting from mutations that disrupt the function of the BBSome, an 8-subunit complex that plays an important role in protein transport in primary cilia. To better understand the molecular basis of BBS, here we used an integrative structural modeling approach consisting of EM and chemical cross-linking coupled with MS analyses, to analyze the structure of a BBSome 2-7-9 subcomplex consisting of three homologous BBS proteins, BBS2, BBS7, and BBS9. The resulting molecular model revealed an overall structure that resembles a flattened triangle. We found that within this structure, BBS2 and BBS7 form a tight dimer through a coiled-coil interaction and that BBS9 associates with the dimer via an interaction with the ?-helical domain of BBS2. Interestingly, a BBS-associated mutation of BBS2 (R632P) is located in its ?-helical domain at the interface between BBS2 and BBS9, and binding experiments indicated that this mutation disrupts the BBS2-BBS9 interaction. This finding suggests that BBSome assembly is disrupted by the R632P substitution, providing molecular insights that may explain the etiology of BBS in individuals harboring this mutation.	[Ludlam, W. Grant; Aoba, Takuma; Moody, James D.; Willardson, Barry M.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA; [Cuellar, Jorge; Teresa Bueno-Carrasco, M.; Valpuesta, Jose M.] CSIC, CNB, Campus Univ Autonoma Madrid, Madrid 28049, Spain; [Makaju, Aman; Franklin, Sarah] Univ Utah, Nora Eccles Harrison Cardiovasc Res & Trainin, Dept Internal Med, Salt Lake City, UT 84112 USA	Brigham Young University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Utah System of Higher Education; University of Utah	Willardson, BM (corresponding author), Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA.; Valpuesta, JM (corresponding author), CSIC, CNB, Campus Univ Autonoma Madrid, Madrid 28049, Spain.	jmv@cnb.csic.es; bmwillardson@chem.byu.edu	Cuéllar, Jorge/S-4269-2017; Cuéllar, Jorge/GOH-3100-2022	Cuéllar, Jorge/0000-0002-7789-807X; Cuéllar, Jorge/0000-0002-7789-807X; Ludlam, William/0000-0002-2701-8791; Moody, James/0000-0003-2266-5348; Willardson, Barry/0000-0002-8503-2268; Bueno-Carrasco, M Teresa/0000-0003-1586-2589	Spanish Ministry of Economy and Innovation [BFU2016-75984]; United States National Institutes of Health [EY012287]	Spanish Ministry of Economy and Innovation(Spanish Government); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Spanish Ministry of Economy and Innovation Grant BFU2016-75984 (to J. M. V.) and United States National Institutes of Health Grant EY012287 (to B. M. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Badano JL, 2003, AM J HUM GENET, V72, P650, DOI 10.1086/368204; Beales PL, 2003, AM J HUM GENET, V72, P1187, DOI 10.1086/375178; Bin J, 2009, HUM MUTAT, V30, pE737, DOI 10.1002/humu.21040; Chen JJ, 2011, INVEST OPHTH VIS SCI, V52, P5317, DOI 10.1167/iovs.11-7554; Chou HT, 2019, STRUCTURE, V27, P1384, DOI 10.1016/j.str.2019.06.006; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Datta P, 2015, P NATL ACAD SCI USA, V112, pE4400, DOI 10.1073/pnas.1510111112; Deveault C, 2011, HUM MUTAT, V32, P610, DOI 10.1002/humu.21480; Dodonova SO, 2015, SCIENCE, V349, P195, DOI 10.1126/science.aab1121; Eguether T, 2014, DEV CELL, V31, P279, DOI 10.1016/j.devcel.2014.09.011; Fauser S, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e104; Fernandez-Martinez J, 2016, CELL, V167, P1215, DOI 10.1016/j.cell.2016.10.028; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Harville HM, 2010, J MED GENET, V47, P262, DOI 10.1136/jmg.2009.071365; Herzog F, 2012, SCIENCE, V337, P1348, DOI 10.1126/science.1221483; Hilgendorf KI, 2016, CURR OPIN CELL BIOL, V39, P84, DOI 10.1016/j.ceb.2016.02.008; Jackson LP, 2012, DEV CELL, V23, P1255, DOI 10.1016/j.devcel.2012.10.017; Jin H, 2010, CELL, V141, P1208, DOI 10.1016/j.cell.2010.05.015; Jin H, 2009, CURR BIOL, V19, pR472, DOI 10.1016/j.cub.2009.04.015; Katoh Y, 2015, J CELL SCI, V128, P2351, DOI 10.1242/jcs.168740; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Kim JC, 2005, J CELL SCI, V118, P1007, DOI 10.1242/jcs.01676; Klink BU, 2017, ELIFE, V6, DOI 10.7554/eLife.27434; Knockenhauer KE, 2015, J BIOL CHEM, V290, P19569, DOI 10.1074/jbc.M115.649202; Lancaster MA, 2009, CURR OPIN GENET DEV, V19, P220, DOI 10.1016/j.gde.2009.04.008; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Laurier V, 2006, EUR J HUM GENET, V14, P1195, DOI 10.1038/sj.ejhg.5201688; Lechtreck KF, 2013, J CELL BIOL, V201, P249, DOI 10.1083/jcb.201207139; Leitner A, 2014, NAT PROTOC, V9, P120, DOI 10.1038/nprot.2013.168; Leitner A, 2012, STRUCTURE, V20, P814, DOI 10.1016/j.str.2012.03.007; Liew GM, 2014, DEV CELL, V31, P265, DOI 10.1016/j.devcel.2014.09.004; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Ma WF, 2013, EMBO J, V32, P926, DOI 10.1038/emboj.2013.41; Marabini R, 1996, J STRUCT BIOL, V116, P237, DOI 10.1006/jsbi.1996.0036; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mourao A, 2014, NAT STRUCT MOL BIOL, V21, P1035, DOI 10.1038/nsmb.2920; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nachury MV, 2018, CURR OPIN CELL BIOL, V51, P124, DOI 10.1016/j.ceb.2018.03.004; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Nishimura DY, 2001, HUM MOL GENET, V10, P865, DOI 10.1093/hmg/10.8.865; Novas R, 2015, FEBS LETT, V589, P3479, DOI 10.1016/j.febslet.2015.07.031; Pearring JN, 2013, PROG RETIN EYE RES, V36, P24, DOI 10.1016/j.preteyeres.2013.03.002; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plimpton RL, 2015, P NATL ACAD SCI USA, V112, P2413, DOI 10.1073/pnas.1419595112; Politis A, 2014, NAT METHODS, V11, P403, DOI [10.1038/NMETH.2841, 10.1038/nmeth.2841]; Russel D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001244; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schou KB, 2015, EMBO REP, V16, P1099, DOI 10.15252/embr.201540530; Seo S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002358; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Stoetzel C, 2006, NAT GENET, V38, P521, DOI 10.1038/ng1771; Stoetzel C, 2007, AM J HUM GENET, V80, P1, DOI 10.1086/510256; Subhramanyam UKT, 2014, ACTA CRYSTALLOGR F, V70, P1224, DOI 10.1107/S2053230X14014691; Tan D, 2016, ELIFE, V5, DOI 10.7554/eLife.12509; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; Walzthoeni T, 2013, CURR OPIN STRUC BIOL, V23, P252, DOI 10.1016/j.sbi.2013.02.008; Wang XR, 2017, MOL CELL PROTEOMICS, V16, P840, DOI 10.1074/mcp.M116.065326; Webb B, 2014, METHODS MOL BIOL, V1091, P277, DOI 10.1007/978-1-62703-691-7_20; Xu QW, 2015, SCI REP-UK, V5, DOI 10.1038/srep11855; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Ye F, 2018, J CELL BIOL, V217, P1847, DOI 10.1083/jcb.201709041; Zeng-Elmore X, 2014, J MOL BIOL, V426, P3713, DOI 10.1016/j.jmb.2014.07.033; Zhang QH, 2012, J BIOL CHEM, V287, P20625, DOI 10.1074/jbc.M112.341487	67	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					16385	16399		10.1074/jbc.RA119.010150	http://dx.doi.org/10.1074/jbc.RA119.010150			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31530639	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000499478600041
J	Amaral, P; de Carvalho, LR; Rocha, TAH; da Silva, NC; Vissoci, JRN				Amaral, Pedro; de Carvalho, Lucas Resende; Hernandes Rocha, Thiago Augusto; da Silva, Nubia Cristina; Nickenig Vissoci, Joao Ricardo			Geospatial modeling of microcephaly and zika virus spread patterns in Brazil	PLOS ONE			English	Article							HEALTH	Microcephaly and Zika Virus infection (ZIKV) were declared Public Health Emergencies of International Concern by the World Health Organization in 2016. Brazil was considered the epicenter of the outbreak. However, the occurrence of both ZIKV and microcephaly in Brazil was not evenly distributed across the country. To better understand this phenomenon, we investigate regional characteristics at the municipal level that can be associated with the incidence of microcephaly, our response variable, and its relationship with ZIKV and other predictors. All epidemiological data in this study was provided by the Ministry of Health official database (DATASUS). Microcephaly was only confirmed after birth and the diagnostic was made regardless of the mother's ZIKV status. Using exploratory spatial data analysis and spatial autoregressive Tobit models, our results show that microcephaly incidence is significantly, at 95% confidence level, related not only to ZIKV, but also to access to primary care, population size, gross national product, mobility and environmental attributes of the municipalities. There is also a significant spatial autocorrelation of the dependent variable. The results indicate that municipalities that show a high incidence of microcephaly tend to be clustered in space and that incidence of microcephaly varies considerably across regions when correlated only with ZIKV, i.e. that ZIKV alone cannot explain the differences in microcephaly across regions and their correlation is mediated by regional attributes.	[Amaral, Pedro; de Carvalho, Lucas Resende] Univ Fed Minas Gerais, Ctr Dev & Reg Planning, CEDEPLAR UFMG, Belo Horizonte, MG, Brazil; [Hernandes Rocha, Thiago Augusto] PAHO WHO, Brasilia, DF, Brazil; [Hernandes Rocha, Thiago Augusto; da Silva, Nubia Cristina] Univ Fed Minas Gerais, Ctr Higher Studies & Res Adm, CEPEAD UFMG, Belo Horizonte, MG, Brazil; [Nickenig Vissoci, Joao Ricardo] Duke Univ, Duke Sch Med, Dept Surg, Div Emergency Med, Durham, NC USA	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Duke University	Amaral, P (corresponding author), Univ Fed Minas Gerais, Ctr Dev & Reg Planning, CEDEPLAR UFMG, Belo Horizonte, MG, Brazil.	pedroamaral@cedeplar.ufmg.br	Carvalho, Lucas Resende de/AAB-7031-2019; Rocha, Thiago/AAW-3805-2020; Amaral, Pedro/AAQ-1486-2021	Carvalho, Lucas Resende de/0000-0002-3618-3967; Rocha, Thiago/0000-0002-6262-3276; Amaral, Pedro/0000-0002-2505-035X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PV, 2014, PAP REG SCI, V93, DOI 10.1111/pirs.12034; Amemiya T., 1985, ADV ECONOMETRICS; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7; Brasil-SINAN/SUS. Ministry of Health, 2019, SUST INF AGR NOT SI; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; Castro MC, 2018, P NATL ACAD SCI USA, V115, P6177, DOI 10.1073/pnas.1718476115; ESRI, 2014, ARCGIS DESKT; European Centre for Disease Prevention and Control, 2017, CURR ZIK TRANSM WORL; Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; Gelman Andrew, 1995, BAYESIAN DATA ANAL; IBGE, 2013, PROD INT BRUT MUN; IBGE (Instituto Brasileiro de Geografia e Estatistica), 2016, EST POP; Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/blt.16.178608, 10.2471/BLT.16.178608]; Kesrouani A, 2001, EARLY HUM DEV, V63, P79, DOI 10.1016/S0378-3782(01)00123-2; Laguardia J, 2004, EPIDEMIOL SERV SAUDE, V13, P135; LeSage J, 2009, STAT TEXTB MONOGR, P1; LOWRES N, 2019, PLOS MED, V16, DOI DOI 10.1371/JOURNAL.PMED.1002755; Macintyre S, 2002, SOC SCI MED, V55, P125, DOI 10.1016/S0277-9536(01)00214-3; Nsoesie EO, 2015, PLOS NEGLECT TROP D, V9, P1; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Ribeiro LC de Q, 2013, IBEU MUNICIPAL INDIC; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; Vissoci JRN, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006392; Wilhelm S, 2013, R J, V5, P130; World Health Organization, 2016, ZIK VIR COMPL PUBL H; Xavier DR, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311x00186615, 10.1590/0102-311X00186615]	29	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222668	10.1371/journal.pone.0222668	http://dx.doi.org/10.1371/journal.pone.0222668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6FU	31557165	Green Published, gold			2022-12-26	WOS:000532345500027
J	Woldesenbet, SA; Kalou, M; Mhlongo, D; Kufa, T; Makhanya, M; Adelekan, A; Diallo, K; Maleka, M; Singh, B; Parekh, B; Mohlala, A; Manyike, PT; Tucker, TJ; Puren, AJ				Woldesenbet, Selamawit Alemu; Kalou, Mireille; Mhlongo, Dumisani; Kufa, Tendesayi; Makhanya, Makhosazana; Adelekan, Adeboye; Diallo, Karidia; Maleka, Mahlatse; Singh, Beverley; Parekh, Bharat; Mohlala, Amanda; Manyike, Peter T.; Tucker, Tim J.; Puren, Adrian J.			An overview of the quality assurance programme for HIV rapid testing in South Africa: Outcome of a 2-year phased implementation of quality assurance program	PLOS ONE			English	Article								Objective This is the first large-scale assessment of the implementation of HIV Rapid Test Quality Improvement Initiative in South Africa. Methods We used a quasi-experimental one group post-test only design. The intervention implemented starting April 2014 comprised health-care worker training on quality assurance (QA) of HIV rapid testing and enrolment of the facilities in proficiency testing (PT), targeting 2,077 healthcare facilities in 32 high HIV burden districts. Following the intervention, two consecutive rounds of site assessments were undertaken. The first, conducted after a median of 7.5 months following the training, included 1,915 facilities that participated in the QA training, while the second, conducted after a median of one-year following the first-round assessment included 517 (27.0%) of the 1,915 facilities. In both assessments, the Stepwise-Process-for-Improving-the-quality-of-HIV-Rapid-Testing (SPI-RT) checklist was used to score facilities' performance in 7 domains: training, physical facility, safety, pre-testing, testing, post-testing and external quality assessment. Facilities' level of readiness for national certification was assessed. Result Between 2016 and 2017, there were four PT cycles. PT participation increased from 32.4% (620/1,915) in 2016 to 91.5% (1,753/1,915) in 2017. In each PT cycle, PT results were returned by 76%-87% of facilities and a satisfactory result (> 80%) was achieved by >= 95% of facilities. In the SPI-RT assessment, in round-one, 22.3% of facilities were close to or eligible for national certification-this significantly increased to 38.8% in round-two (P-value< 0.001). The median SPI-RT score for the domains HIV pre-testing (83.3%) and post-testing (72.2%) remained the same between the two rounds. The median score for the testing domain increased by 5.6% (to 77.8%). Conclusion Facilities performance on the domains that are critical for accuracy of diagnosis (i.e. pretesting, testing and post-testing) remained largely unchanged. This study provided several recommendations to improve QA implementation in South Africa, including the need to improve routine use of internal quality control for corrective actions.	[Woldesenbet, Selamawit Alemu; Kufa, Tendesayi; Singh, Beverley; Puren, Adrian J.] Natl Inst Communicable Dis, Ctr HIV & STI, Johannesburg, South Africa; [Woldesenbet, Selamawit Alemu; Kufa, Tendesayi] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Kalou, Mireille; Parekh, Bharat] Ctr Dis Control & Prevent, Int Lab Branch, Div Global HIV & TB, Ctr Global Hlth, Atlanta, GA USA; [Mhlongo, Dumisani] Natl Hlth Lab Serv, Natl Clin Lab Interface Programme, Johannesburg, South Africa; [Makhanya, Makhosazana; Adelekan, Adeboye; Diallo, Karidia] Ctr Dis Control & Prevent South Africa, Lab Branch, Pretoria, South Africa; [Maleka, Mahlatse] Acad Affairs Res & Qual Assurance Natl Hlth Lab S, Johannesburg, South Africa; [Mohlala, Amanda; Manyike, Peter T.; Tucker, Tim J.] Strateg Evaluat Advisory & Dev SEAD Consulting, Cape Town, South Africa; [Tucker, Tim J.] Univ Cape Town, Sch Publ Hlth & Family Med, Cape Town, South Africa; [Puren, Adrian J.] Univ Witwatersrand, Virol Dept, Johannesburg, South Africa	National Institute for Communicable Diseases (NICD); University of Witwatersrand; Centers for Disease Control & Prevention - USA; National Health Laboratory Service; University of Cape Town; University of Witwatersrand	Woldesenbet, SA (corresponding author), Natl Inst Communicable Dis, Ctr HIV & STI, Johannesburg, South Africa.; Woldesenbet, SA (corresponding author), Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.	selamawitw@nicd.ac.za		PAREKH, BHARAT/0000-0002-1088-4263; Woldesenbet, Selamawit/0000-0002-5023-3561; Kufa, Tendesayi/0000-0002-9797-616X	United States President's Emergency Plan for AIDS Relief (PEPFAR) [U2GGH001631]	United States President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The programme received financial support from the United States President's Emergency Plan for AIDS Relief (PEPFAR) through a cooperative agreement between the National Health Laboratory Service (NHLS) and the Centers for Disease Control and Prevention (CDC) [Grant Number = U2GGH001631]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the funding agencies. AJP is the principal investigator and senior (last) author in this paper and he received this award. The URL/website of the funder is https://www.cdc.gov.	Balisanga H, 2016, INT J INFECT DIS, V52, P62, DOI 10.1016/j.ijid.2016.08.029; Black V, 2009, BJOG-INT J OBSTET GY, V116, P1805, DOI 10.1111/j.1471-0528.2009.02357.x; Bock P, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.7.21780; Hsiao NY, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.7.21758; Hunter J, 2017, S AFRICAN HLTH REV 2; Jaya Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183044; Johnson CC, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.7.21755; Kosack CS, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21345; Kufa T, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.7.21753; Kufa T, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007391; Maleka M., 2017, NHLS HIV PROFICIENCY; Maleka M., 2016, NHLS HIV PROFICIENCY; Mashamba-Thompson TP, 2018, S AFR J HIV MED, V19, P1; Massyn N., 2018, DISTRICT HLTH BAROME; Matsoso MP, 2018, LANCET GLOB HEALTH, V6, pE1153, DOI 10.1016/S2214-109X(18)30323-1; Mayaphi SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164943; Meyers AFA, 2016, AFR J LAB MED, V5, DOI 10.4102/ajlm.v5i2.557; Mhlongo D, 2014, USE INTERNAL QUALITY; Moodley D, 2008, SAMJ S AFR MED J, V98, P707; Mwisongo A, 2016, AFR HEALTH SCI, V16, P646, DOI 10.4314/ahs.v16i3.2; NDOH, ID CLIN MAN VERS 18; PEPFAR, 2015, ACH EP CONTR S AFR P; PEPFAR, COUNTR REG OP PLAN C; QA/ QI Stakeholders Meeting, 2015, QA QI STAK M 22 23 O; SEAD, 2010, AN POCT VCT PERF S A; Shanks L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059906; Tucker TJ, 2017, CURR OPIN HIV AIDS, V12, P105, DOI 10.1097/COH.0000000000000350; UNAIDS data, 2018, SOURC UNAIDS SPEC AN; WHO/CDC, 2005, HIV RAP TEST TRAIN P; Wolpaw BJ, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-73; World Health Organization, CONS GUID HIV TEST S; Yao K, 2010, AM J CLIN PATHOL, V134, P568, DOI 10.1309/AJCPOPXR8MNTZ5PY	32	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0221906	10.1371/journal.pone.0221906	http://dx.doi.org/10.1371/journal.pone.0221906			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557176	Green Published, gold, Green Submitted			2022-12-26	WOS:000532345500013
J	Lu, XX; Chu, CC; Liu, X; Gao, YC; Wu, MM; Guo, F; Li, YH; Geng, C; Huang, Y; Zhang, Y; Zhao, SZ				Lu, Xiaoxiao; Chu, Chenchen; Liu, Xun; Gao, Yichen; Wu, Mianmian; Guo, Fang; Li, Yahong; Geng, Chao; Huang, Yue; Zhang, Yan; Zhao, Shaozhen			High-throughput RNA-sequencing identifies mesenchymal stem cell-induced immunological signature in a rat model of corneal allograft rejection	PLOS ONE			English	Article							STROMAL CELLS; TRANSPLANTATION; EXPRESSION; GRAFT; HSP70	Objective The immune rejection mediated by CD4(+) T cell and antigen presenting macrophages is the leading cause of corneal transplantation failure. Bone marrow-derived mesenchymal stem cells (BM-MSCs) possess robust immunomodulatory potentials, and have been shown by us and others to promote corneal allograft survival. However, the immunological mechanism underlying the protective effects of BM-MSCs remains unclear. Therefore, in the current study, this mechanism was investigated in a BM-MSC-treated rat model of corneal allograft rejection, in the hope to facilitate the search for novel interventional targets to corneal allograft rejection. Methods Lewis rats were subjected to corneal transplantation and then received subconjunctival injections of BM-MSCs (2x106 cells / 100 mu l PBS) immediately and at day 3 post-transplantation. The control group received the injections of PBS with the same volume. The clinical parameters of the corneal allografts, including opacity, edema, and neovascularization, were regularly evaluated after transplantation. On day 10 post-transplantation, the corneal allografts were collected and subjected to flow cytometry and high-throughput RNA sequencing (RNA-seq). GO enrichment and KEGG pathways were analyzed. The quantitative realtime PCR (qPCR) and immunohistochemistry (IHC) were employed to validate the expression of the selected target genes at transcript and protein levels, respectively. Results BM-MSC subconjunctival administration prolonged the corneal allograft survival, with reduced opacity, alleviated edema, and diminished neovascularization. Flow cytometry showed reduced CD4(+) T cells and CD68(+) macrophages as well as boosted regulatory T cells (Tregs) in the BM-MSC-treated corneal allografts as compared with the PBS-treated counterparts. Moreover, the RNA-seq and qPCR results demonstrated that the transcript abundance of Cytotoxic T-Lymphocyte Associated Protein 4 (Ctla4), Protein Tyrosine Phosphatase, Receptor Type C (Ptprc), and C-X-C Motif Chemokine Ligand 9 (Cxcl9) genes were increased in the allografts of BM-MSC group compared with PBS group; whereas the expression of Heat Shock Protein Family A (Hsp70) Member 8 (Hspa8) gene was downregulated. The expression of these genes was confirmed by IHC at protein level. Conclusion Subconjunctival injections of BM-MSCs promoted corneal allograft survival, reduced CD4(+) and CD68(+) cell infiltration, and enriched Treg population in the allografts. The BM-MSCinduced upregulation of Ctla4, Ptprc, Cxcl9 genes and downregulation of Hspa8 gene might contribute to the protective effects of BM-MSCs and subserve the potential interventional targets to corneal allograft rejection.	[Lu, Xiaoxiao; Chu, Chenchen; Liu, Xun; Gao, Yichen; Wu, Mianmian; Guo, Fang; Li, Yahong; Geng, Chao; Huang, Yue; Zhang, Yan; Zhao, Shaozhen] Tianjin Med Univ, Tianjin Key Lab Retinal Funct & Dis, Eye Inst, Eye Hosp, Tianjin, Peoples R China; [Lu, Xiaoxiao; Chu, Chenchen; Liu, Xun; Gao, Yichen; Wu, Mianmian; Guo, Fang; Li, Yahong; Geng, Chao; Huang, Yue] Tianjin Med Univ, Sch Optometry, Eye Hosp, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Zhang, Y; Zhao, SZ (corresponding author), Tianjin Med Univ, Tianjin Key Lab Retinal Funct & Dis, Eye Inst, Eye Hosp, Tianjin, Peoples R China.	yanzhang04@tmu.edu.cn; szhao04@tmu.edu.cn		Zhang, Yan/0000-0003-2050-6343	National Natural Science Foundation of China [81770890, 81600705]; Tianjin Municipal Science and Technology Commission [17JCZDJC35600]; training program for young and middle-aged backbone talents in colleges and universities in Tianjin; High-level Innovative Talent Program for Distinguished Scholar [YDYYRCXM-B2018-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Commission; training program for young and middle-aged backbone talents in colleges and universities in Tianjin; High-level Innovative Talent Program for Distinguished Scholar	This work was supported by the National Natural Science Foundation of China (81770890 to S.Z.; 81600705 to Y.H.), the key projects of Tianjin Municipal Science and Technology Commission (17JCZDJC35600 to Y.Z.), the training program for young and middle-aged backbone talents in colleges and universities in Tianjin to Y.Z., and the the High-level Innovative Talent Program for Distinguished Scholar (YDYYRCXM-B2018-02 to Y.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amouzegar A, 2016, J IMMUNOL, V196, P3983, DOI 10.4049/jimmunol.1600251; Ben Nasr M, 2015, ACTA DIABETOL, V52, P917, DOI 10.1007/s00592-015-0735-y; Ben Nasr M, 2015, PHARMACOL RES, V98, P1, DOI 10.1016/j.phrs.2015.03.019; Camirand G, 2014, J CLIN INVEST, V124, P4603, DOI 10.1172/JCI74087; Chai YJ, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030297; Coster DJ, 2005, AM J OPHTHALMOL, V140, P1112, DOI 10.1016/j.ajo.2005.07.024; Davies R, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00281; Di GH, 2017, INVEST OPHTH VIS SCI, V58, P4344, DOI 10.1167/iovs.17-21506; Ezzelarab MB, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00250; Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246, DOI 10.1002/jlb.61.3.246; Fiorina P, 2007, DIABETES, V56, P912, DOI 10.2337/db06-1445; Fiorina P, 2009, J IMMUNOL, V183, P993, DOI 10.4049/jimmunol.0900803; Hancock WW, 1996, P NATL ACAD SCI USA, V93, P13967, DOI 10.1073/pnas.93.24.13967; Inoue S, 2006, TRANSPLANTATION, V81, P1589, DOI 10.1097/01.tp.0000209919.90630.7b; Jia Z, 2018, BMC OPHTHALMOL, V18, DOI 10.1186/s12886-018-0802-6; Jia Z, 2012, EXP EYE RES, V102, P44, DOI 10.1016/j.exer.2012.06.008; Judge TA, 1996, J IMMUNOL, V156, P2294; Khiew SH, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92033; Kobolak J, 2016, METHODS, V99, P62, DOI 10.1016/j.ymeth.2015.09.016; Koper OM, 2018, ADV CLIN EXP MED, V27, P849, DOI 10.17219/acem/68846; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larkin DFP, 1997, CLIN EXP IMMUNOL, V107, P381, DOI 10.1111/j.1365-2249.1997.279-ce1171.x; Lechler RI, 2005, NAT MED, V11, P605, DOI 10.1038/nm1251; Leibler C, 2019, KIDNEY INT, V95, P774, DOI 10.1016/j.kint.2018.10.028; Lohan P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02666; Lu XX, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0593-3; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mirabelli P, 2014, EXP EYE RES, V125, P118, DOI 10.1016/j.exer.2014.06.006; Moravej A, 2017, IMMUNOL LETT, V182, P39, DOI 10.1016/j.imlet.2017.01.005; Perico N, 2011, CLIN J AM SOC NEPHRO, V6, P412, DOI 10.2215/CJN.04950610; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qiao SK, 2016, CELL PHYSIOL BIOCHEM, V40, P1656, DOI 10.1159/000453215; Rafiee P, 2006, AM J PHYSIOL-CELL PH, V291, pC931, DOI 10.1152/ajpcell.00474.2005; Sakurai J, 2000, J IMMUNOL, V164, P664, DOI 10.4049/jimmunol.164.2.664; Shalini PU, 2017, CELL IMMUNOL, V314, P18, DOI 10.1016/j.cellimm.2017.01.008; Sheu CC, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030308; Sohni A, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/130763; Stricher F, 2013, AUTOPHAGY, V9, P1937, DOI 10.4161/auto.26448; Tabbara Khalid F., 2008, International Ophthalmology, V28, P223, DOI 10.1007/s10792-007-9100-7; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trieb M, 2001, TRANSPL INT, V14, P281, DOI 10.1007/s001470100325; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Vellasamy S, 2016, CYTOTHERAPY, V18, P1270, DOI 10.1016/j.jcyt.2016.06.017; Xie CY, 2017, STEM CELL TRANSL MED, V6, P1120, DOI 10.1002/sctm.16-0204; Xilouri M, 2016, AGEING RES REV, V32, P13, DOI 10.1016/j.arr.2016.07.001; Ye H, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1853-7; Young JS, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01169; Yuan J, 2009, J OCUL PHARMACOL TH, V25, P345, DOI 10.1089/jop.2008.0125	49	5	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222515	10.1371/journal.pone.0222515	http://dx.doi.org/10.1371/journal.pone.0222515			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545822	gold, Green Published			2022-12-26	WOS:000532303200018
J	Kosilek, RP; Baumeister, SE; Ittermann, T; Grundling, M; Brunkhorst, FM; Felix, SB; Abel, P; Friesecke, S; Apfelbacher, C; Brandl, M; Schmidt, K; Hoffmann, W; Schmidt, CO; Chenot, JF; Volzke, H; Gensichen, JS				Kosilek, Robert P.; Baumeister, Sebastian E.; Ittermann, Till; Gruendling, Matthias; Brunkhorst, Frank M.; Felix, Stephan B.; Abel, Peter; Friesecke, Sigrun; Apfelbacher, Christian; Brandl, Magdalena; Schmidt, Konrad; Hoffmann, Wolfgang; Schmidt, Carsten O.; Chenot, Jean-Francois; Voelzke, Henry; Gensichen, Jochen S.			The association of intensive care with utilization and costs of outpatient healthcare services and quality of life	PLOS ONE			English	Article							RESOURCE UTILIZATION; SURVIVORS; OUTCOMES; UNIT; IMPACT; PHARMACISTS; ICU; POPULATION; MORTALITY; EUROQOL	Background Little is known about outpatient health services use following critical illness and intensive care. We examined the association of intensive care with outpatient consultations and quality of life in a population-based sample. Methods Cross-sectional analysis of data from 6,686 participants of the Study of Health in Pomerania (SHIP), which consists of two independent population-based cohorts. Statistical modeling was done using Poisson regression, negative binomial and generalized linear models for consultations, and a fractional response model for quality of life (EQ-5D-3L index value), with results expressed as prevalence ratios (PR) or percent change (PC). Entropy balancing was used to adjust for observed confounding. Results ICU treatment in the previous year was reported by 139 of 6,686 (2,1%) participants, and was associated with a higher probability (PR 1.05 [CI:1.03;1.07]), number (PC +58.0% [CI:22.8;103.2]) and costs (PC +64.1% [CI:32.0;103.9]) of annual outpatient consultations, as well as with a higher number of medications (PC +37.8% [CI:17.7;61.5]). Participants with ICU treatment were more likely to visit a specialist (PR 1.13 [CI:1.09; 1.16]), specifically internal medicine (PR 1.67 [CI:1.45;1.92]), surgery (PR 2.42 [CI:1.92;3.05]), psychiatry (PR 2.25 [CI:1.30;3.90]), and orthopedics (PR 1.54 [CI:1.11;2.14]). There was no significant effect regarding general practitioner consultations. ICU treatment was also associated with lower health-related quality of life (EQ-5D index value: PC -13.7% [CI:-27.0;-0.3]). Furthermore, quality of life was inversely associated with outpatient consultations in the previous month, more so for participants with ICU treatment. Conclusions Our findings suggest that ICU treatment is associated with an increased utilization of outpatient specialist services, higher medication intake, and impaired quality of life.	[Kosilek, Robert P.; Gensichen, Jochen S.] LMU Munchen, Inst Gen Practice & Family Med, Munich, Germany; [Baumeister, Sebastian E.] LMU Munchen, UNIKA T Augsburg, Chair Epidemiol, Augsburg, Germany; [Baumeister, Sebastian E.] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Independent Res Grp Clin Epidemiol, Munich, Germany; [Baumeister, Sebastian E.; Ittermann, Till; Hoffmann, Wolfgang; Schmidt, Carsten O.; Chenot, Jean-Francois; Voelzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Gruendling, Matthias] Univ Med Greifswald, Dept Anesthesiol, Greifswald, Germany; [Brunkhorst, Frank M.] Jena Univ Hosp, Integrated Res & Treatment Ctr, Ctr Sepsis Control & Care CSCC, Jena, Germany; [Felix, Stephan B.; Abel, Peter; Friesecke, Sigrun] Univ Med Greifswald, Dept Internal Med B, Med Intens Care Unit, Greifswald, Germany; [Felix, Stephan B.; Voelzke, Henry] DZHK German Ctr Cardiovasc Res, Partner Site Greifswald, Greifswald, Germany; [Apfelbacher, Christian; Brandl, Magdalena] Univ Regensburg, Inst Epidemiol & Prevent Med, Med Sociol, Regensburg, Germany; [Apfelbacher, Christian] Nanyang Technol Univ Singapore, Lee Kong Chian Sch Med, Family Med & Primary Care, Singapore, Singapore; [Schmidt, Konrad] Charite Univ Med Berlin, Inst Gen Practice & Family Med, Berlin, Germany; [Schmidt, Konrad] Jena Univ Hosp, Inst Gen Practice & Family Med, Jena, Germany; [Voelzke, Henry] German Ctr Diabet Res, Site Greifswald, Greifswald, Germany	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Greifswald Medical School; Greifswald Medical School; Friedrich Schiller University of Jena; Greifswald Medical School; German Centre for Cardiovascular Research; University of Regensburg; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Friedrich Schiller University of Jena	Kosilek, RP (corresponding author), LMU Munchen, Inst Gen Practice & Family Med, Munich, Germany.	robert_philipp.kosilek@med.uni-muenchen.de	Baumeister, Sebastian-Edgar/P-7894-2019; Chenot, Jean-Francois/F-8241-2011; Schmidt, Konrad/V-5469-2017; Schmidt, Carsten Oliver/AAH-2778-2019	Baumeister, Sebastian-Edgar/0000-0002-9391-6602; Chenot, Jean-Francois/0000-0001-8877-2950; Schmidt, Konrad/0000-0001-5879-0664; Schmidt, Carsten Oliver/0000-0001-5266-9396	German Federal Ministry of Education and Research (BMBF) [01ZZ96030, 01ZZ0701]; DZHK (German Center for Cardiovascular Research)	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); DZHK (German Center for Cardiovascular Research)	The Study of Health in Pomerania (SHIP) is part of the Community Medicine Research net (CMR) (http://www.medizin.uni-greifswald.de/icm) of the University of Greifswald, funded by grants from the German Federal Ministry of Education and Research (BMBF grants 01ZZ96030 and 01ZZ0701). This study was further supported by the DZHK (German Center for Cardiovascular Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN R., 1968, Research Ser.; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Angus DC, 2003, INTENS CARE MED, V29, P368, DOI 10.1007/s00134-002-1624-8; [Anonymous], 2012, BEVOLKERUNG ZUM STIC; [Anonymous], 2012, INTENSIVMEDIZINISCHE; Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Basu A, 2012, MED DECIS MAKING, V32, P56, DOI 10.1177/0272989X11416988; Baumeister SE, 2008, GASTROENTEROLOGY, V134, P85, DOI 10.1053/j.gastro.2007.10.024; Bell CM, 2011, JAMA-J AM MED ASSOC, V306, P840, DOI 10.1001/jama.2011.1206; Bock JO, 2015, GESUNDHEITSWESEN, V77, P53, DOI 10.1055/s-0034-1374621; Brandstetter S, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0544-5; Brilli RJ, 2001, CRIT CARE MED, V29, P2007, DOI 10.1097/00003246-200110000-00026; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Cheung AM, 2006, AM J RESP CRIT CARE, V174, P538, DOI 10.1164/rccm.200505-693OC; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Cuthbertson BH, 2010, CRIT CARE, V14, DOI 10.1186/cc8848; Desai SV, 2011, CRIT CARE MED, V39, P371, DOI 10.1097/CCM.0b013e3181fd66e5; Dowdy DW, 2005, INTENS CARE MED, V31, P611, DOI 10.1007/s00134-005-2592-6; Esper AM, 2011, CRIT CARE MED, V39, P2728, DOI 10.1097/CCM.0b013e318236f27e; Garland A, 2015, ANN AM THORAC SOC, V12, P202, DOI 10.1513/AnnalsATS.201405-201CME; Gayat E, 2018, CRIT CARE, V22, DOI 10.1186/s13054-017-1922-8; Greenland S, 2004, AM J EPIDEMIOL, V160, P301, DOI 10.1093/aje/kwh221; Griffiths J, 2013, CRIT CARE, V17, DOI 10.1186/cc12745; Hainmueller J, 2013, J STAT SOFTW, V54; Held N, 2019, TURK THORAC J, V20, P147, DOI 10.5152/TurkThoracJ.2018.18172; Hill AD, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1248-y; Hua M, 2015, CRIT CARE MED, V43, P430, DOI 10.1097/CCM.0000000000000717; Jeitziner MM, 2015, J CLIN NURS, V24, P1347, DOI 10.1111/jocn.12749; Jensen JF, 2015, INTENS CARE MED, V41, P763, DOI 10.1007/s00134-015-3689-1; John U, 2001, SOZ PRAVENTIV MED, V46, P186, DOI 10.1007/BF01324255; Kane SL, 2003, INTENS CARE MED, V29, P691, DOI 10.1007/s00134-003-1705-3; Kawachi I, 1997, SOC SCI MED, V45, P1121, DOI 10.1016/S0277-9536(97)00044-0; Krauth C, 2005, GESUNDHEITSWESEN, V67, P736, DOI 10.1055/s-2005-858698; Linko R, 2010, CRIT CARE, V14, DOI 10.1186/cc8957; Lone NI, 2016, AM J RESP CRIT CARE, V194, P198, DOI 10.1164/rccm.201511-2234OC; MacLaren R, 2008, CRIT CARE MED, V36, P3184, DOI 10.1097/CCM.0b013e31818f2269; Manning WG, 2005, J HEALTH ECON, V24, P465, DOI 10.1016/j.jhealeco.2004.09.011; Ramos-Goni JM, 2011, STATA J, V11, P120, DOI 10.1177/1536867X1101100108; Marra A, 2018, CRIT CARE MED, V46, P1393, DOI 10.1097/CCM.0000000000003218; Marti J, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0178-8; Morandi A, 2013, J AM GERIATR SOC, V61, P1128, DOI 10.1111/jgs.12329; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Oeyen SG, 2010, CRIT CARE MED, V38, P2386, DOI 10.1097/CCM.0b013e3181f3dec5; Rattay P, 2013, BUNDESGESUNDHEITSBLA, V56, P832, DOI 10.1007/s00103-013-1665-x; Rawal G, 2017, J TRANSL INTERN MED, V5, P90, DOI 10.1515/jtim-2016-0016; Reijneveld SA, 2001, INT J EPIDEMIOL, V30, P1407, DOI 10.1093/ije/30.6.1407; Ritter PL, 2001, J CLIN EPIDEMIOL, V54, P136, DOI 10.1016/S0895-4356(00)00261-4; Ruhl AP, 2017, INTENS CARE MED, V43, P980, DOI 10.1007/s00134-017-4827-8; Ruhl AP, 2015, ANN AM THORAC SOC, V12, P392, DOI 10.1513/AnnalsATS.201409-422OC; Stollings JL, 2018, ANN PHARMACOTHER, V52, P713, DOI 10.1177/1060028018759343; Szakmany A, 2019, CRIT CARE MED, V47, P15, DOI 10.1097/CCM.0000000000003424; Unroe M, 2010, ANN INTERN MED, V153, P167, DOI 10.7326/0003-4819-153-3-201008030-00007; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; VanderWeele TJ, 2011, BIOMETRICS, V67, P1406, DOI 10.1111/j.1541-0420.2011.01619.x; Vijayaraghavan BKT, 2018, INTENS CARE MED, V44, P1542, DOI 10.1007/s00134-018-5117-9; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Volzke H, 2011, INT J EPIDEMIOL, V40, P294, DOI 10.1093/ije/dyp394; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Williams TA, 2010, ANAESTH INTENS CARE, V38, P732, DOI 10.1177/0310057X1003800417; Zhao QY, 2017, J CAUSAL INFERENCE, V5, DOI 10.1515/jci-2016-0010	61	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222671	10.1371/journal.pone.0222671	http://dx.doi.org/10.1371/journal.pone.0222671			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5OJ	31539397	Green Submitted, Green Published, gold			2022-12-26	WOS:000532297900024
J	Salinas-de-Leon, P; Fierro-Arcos, D; Suarez-Moncada, J; Proano, A; Guachisaca-Salinas, J; Paez-Rosas, D				Salinas-de-Leon, Pelayo; Fierro-Arcos, Denisse; Suarez-Moncada, Jennifer; Proano, Alberto; Guachisaca-Salinas, Jacob; Paez-Rosas, Diego			A matter of taste: Spatial and ontogenetic variations on the trophic ecology of the tiger shark at the Galapagos Marine Reserve	PLOS ONE			English	Article							GALEOCERDO-CUVIER; STABLE-ISOTOPES; DISCRIMINATION FACTORS; CARBON ISOTOPES; CHELONIA-MYDAS; MIXING MODELS; DIET; DELTA-C-13; PATTERNS; TISSUES	Sharks are top predators across ocean food webs and have a major ecological role in marine ecosyst ems. Investigating the trophic ecology of this group of species is thus essential to understand ecosystem functioning and inform specific management actions aimed at shark conservation. The Galapagos Islands represent one of the last ocean wildernesses, where populations of sharks and other top marine predators come close to a pristine status. Here we provide the first study on the trophic ecology of the tiger shark (Galeocerdo cuvier) within the Galapagos Marine Reserve (GMR), using a combination of stable isotope analysis, satellite tracking, and passive acoustic telemetry to investigate ontogenetic and spatial variations at two regions. The mean estimated delta C-13 and delta(15N) at Isabela island (western region) were -13.9 +/- 0.5% and 13.7 +/- 0.7%; and for Santa Cruz island (central region) were -13.8 +/- 0.3% and 13.4 +/- 0.7%, respectively. Green sea turtles (Chelonia mydas) were the main prey item for large tiger sharks (>280 cm TL), while smaller sharks mainly fed on squid and pelagic fish. Tiger sharks exhibited a high degree of philopatry around green sea-turtle nesting areas, with the majority of sharks detected around green sea-turtle nesting areas for at least 10 months after their capture date, and some individuals were even present during the entire three-year study period. Although we did not report statistically significant differences between the two regions, isotopic and electronic tagging data suggest that tiger sharks in the Galapagos could be segregated into specific populations separated by geographical scales of < 100 km. The high productivity of the archipelago, along with the protection from industrial fishing granted by the GMR, result in abundant and predictable sources of prey. This high food abundance, combined with the presence of suitable habitats throughout the tiger shark life cycle, might result in a reduction of migratory behaviours when compared to movement patterns of tiger sharks in other ocean basins. Additional studies using genetic tools could provide further evidence on the presence of separate management units, as it has been recently revealed for other shark species inhabiting the GMR.	[Salinas-de-Leon, Pelayo; Fierro-Arcos, Denisse] Charles Darwin Fdn, Charles Darwin Res Stn, Puerto Ayora, Galapagos Islan, Ecuador; [Salinas-de-Leon, Pelayo] Natl Geog Soc, Pristine Seas, Washington, DC 20036 USA; [Suarez-Moncada, Jennifer; Proano, Alberto; Paez-Rosas, Diego] Galapagos Natl Pk, Puerto Ayora, Galapagos Islan, Ecuador; [Guachisaca-Salinas, Jacob] Univ Guayaquil, Fac Ciencias Nat, Guayaquil, Ecuador; [Paez-Rosas, Diego] Univ San Francisco Quito, Galapagos Sci Ctr, Isla San Cristobal, Galapagos Islan, Ecuador	National Geographic Society	Salinas-de-Leon, P (corresponding author), Charles Darwin Fdn, Charles Darwin Res Stn, Puerto Ayora, Galapagos Islan, Ecuador.; Salinas-de-Leon, P (corresponding author), Natl Geog Soc, Pristine Seas, Washington, DC 20036 USA.	pelayo.salinas@fcdarwin.org.ec	Páez-Rosas, Diego/X-3047-2019	Páez-Rosas, Diego/0000-0002-2446-9888; Salinas-de-Leon, Pelayo/0000-0001-9155-8373; Fierro Arcos, Denisse/0000-0002-5039-6272	IWC Schaffhausen; Helmsley Charitable Trust; National Geographic Pristine Seas; OCEARCH	IWC Schaffhausen; Helmsley Charitable Trust; National Geographic Pristine Seas(National Geographic Society); OCEARCH	This study was supported by IWC Schaffhausen (http://www.iwc.com/en/), The Helmsley Charitable Trust (https://helmsleytrust.org/), National Geographic Pristine Seas (https://www.nationalgeographic.org/projects/pristineseas/) and OCEARCH (www.ocearch.org) provided financial support for the acquisition of equipment, laboratory analysis, field costs and/or staff time. These funds were granted to the Charles Darwin Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Marrero D, 2018, MAR ECOL PROG SER, V593, P73, DOI 10.3354/meps12505; Afonso AS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184763; Aines AC, 2018, ENVIRON BIOL FISH, V101, P403, DOI 10.1007/s10641-017-0706-y; [Anonymous], 2017, TURK J ZOOL, V7; [Anonymous], 1984, TETHYS, V10, P195; Beebe W, 1926, ARCTURUS ADVENTURE A; Beebe William, 1924, GALAPAGOS WORLDS END; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Bui R, 2012, R PACKAGE VERSION, P3; Carrion-Cortez JA, 2010, J MAR BIOL ASSOC UK, V90, P1005, DOI 10.1017/S0025315410000226; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cortes E, 1999, ICES J MAR SCI, V56, P707, DOI 10.1006/jmsc.1999.0489; De Crosta MA, 1984, AGE DETERMINATION GR; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; Dicken ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177897; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Dulvy NK, 2004, FISH FISH, V5, P255, DOI 10.1111/j.1467-2679.2004.00158.x; ESTEVEZ S, 2014, PLOS ONE, V9, DOI DOI 10.1371/JOURNAL.PONE.0115946; Evans JS, 2018, PACKAGE SPATIALECO; Ferreira LC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116916; Friedlander AM, 2012, REV BIOL TROP, V60, P321; Graham F, 2016, DIVERS DISTRIB, V22, P534, DOI 10.1111/ddi.12425; Hammerschlag N, 2011, J EXP MAR BIOL ECOL, V398, P1, DOI 10.1016/j.jembe.2010.12.012; Hammerschlag N, 2016, BEHAV ECOL SOCIOBIOL, V70, P1777, DOI 10.1007/s00265-016-2183-2; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heithaus MR, 2007, J ANIM ECOL, V76, P837, DOI 10.1111/j.1365-2656.2007.01260.x; Heithaus MR, 2006, OIKOS, V114, P257; Heithaus MR, 2012, MAR FRESHWATER RES, V63, P1039, DOI 10.1071/MF12024; Hoenner X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040713; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; Hussey NE, 2010, COMP BIOCHEM PHYS A, V155, P445, DOI 10.1016/j.cbpa.2009.09.023; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jonsen I, 2016, SCI REP-UK, V6, DOI 10.1038/srep20625; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; Kim SL, 2012, J EXP BIOL, V215, P2495, DOI 10.1242/jeb.070656; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Lea JSE, 2018, ICES J MAR SCI, V75, P1383, DOI 10.1093/icesjms/fsx238; Lea JSE, 2015, SCI REP-UK, V5, DOI 10.1038/srep11202; Logan JM, 2008, J ANIM ECOL, V77, P838, DOI 10.1111/j.1365-2656.2008.01394.x; Lowe CG, 1996, ENVIRON BIOL FISH, V47, P203, DOI 10.1007/BF00005044; MacNeill MA, 2005, MAR ECOL PROG SER, V302, P199, DOI 10.3354/meps302199; Malpica-Cruz L, 2012, CAN J FISH AQUAT SCI, V69, P551, DOI 10.1139/F2011-172; MCCONNAUGHEY T, 1979, MAR BIOL, V53, P257, DOI 10.1007/BF00952434; Meyer CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084799; Meyer CG, 2009, MAR ECOL PROG SER, V381, P223, DOI 10.3354/meps07951; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Nakamura I, 2011, MAR ECOL PROG SER, V424, P237, DOI 10.3354/meps08980; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; Paez-Rosas D, 2018, PEERJ, V6, DOI 10.7717/peerj.4818; Paez-Rosas D, 2014, RAPID COMMUN MASS SP, V28, P2550, DOI 10.1002/rcm.7047; Paez-Rosas D, 2014, J MAR BIOL ASSOC UK, V94, P1099, DOI 10.1017/S002531541300163X; Paez-Rosas D, 2012, J EXP MAR BIOL ECOL, V424, P44, DOI 10.1016/j.jembe.2012.05.001; Palacios DM, 2004, DEEP-SEA RES PT II, V51, P43, DOI 10.1016/j.dsr2.2003.08.001; Papastamatiou YP, 2006, MAR ECOL PROG SER, V320, P239, DOI 10.3354/meps320239; Parnell AC, 2013, ENVIRONMETRICS, V24, P387, DOI 10.1002/env.2221; Pazmino DA, 2017, CONSERV GENET, V18, P1151, DOI 10.1007/s10592-017-0967-1; Penn M.J., 2022, PLOS ONE, V17, pe0268511, DOI [DOI 10.1371/JOURNAL.PONE, 10.1371/journal.pone.0268511, DOI 10.1371/JOURNAL.PONE.0268511]; Phillips DL, 2014, CAN J ZOOL, V92, P823, DOI 10.1139/cjz-2014-0127; QGIS Development Team, 2015, QGIS GEOGR INF SYST; R Core Team, 2021, R LANGUAGE ENV STAT; RANDALL JE, 1992, AUST J MAR FRESH RES, V43, P21; Reyes H, 2014, RESERVA MARINA GALAP; Ruiz-Cooley RI, 2010, MAR ECOL PROG SER, V399, P187, DOI 10.3354/meps08383; de Leon PS, 2016, PEERJ, V4, DOI 10.7717/peerj.1911; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Seminoff Jeffrey A., 2008, Endangered Species Research, V4, P57, DOI 10.3354/esr00066; Shiffman DS, 2012, MAR FRESHWATER RES, V63, P635, DOI 10.1071/MF11235; SIMPFENDORFER C, 1992, AUST J MAR FRESH RES, V43, P33, DOI 10.1071/MF9920033; Simpfendorfer CA, 2001, ENVIRON BIOL FISH, V61, P37, DOI 10.1023/A:1011021710183; Stevens JD, 2000, ICES J MAR SCI, V57, P476, DOI 10.1006/jmsc.2000.0724; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; White ER, 2015, CONSERV BIOL, V29, P1186, DOI 10.1111/cobi.12478; Wirsing AJ, 2007, OECOLOGIA, V153, P1031, DOI 10.1007/s00442-007-0802-3	75	7	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222754	10.1371/journal.pone.0222754	http://dx.doi.org/10.1371/journal.pone.0222754			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539419	Green Published, gold			2022-12-26	WOS:000532297900027
J	Lin, DPY; Chen, JKC; Tung, TH; Li, LPH				Lin, David Po-Yi; Chen, Joshua Kuang-Chao; Tung, Tao-Hsin; Li, Lieber Po-Hung			Differences in the impedance of cochlear implant devices within 24 hours of their implantation	PLOS ONE			English	Article							ELECTRODE; INSERTION	Cochlear implantation is a surgical procedure, which is performed on severely hearing-impaired patients. Impedance field telemetry is commonly used to determine the integrity of the cochlear implant device during and after surgery. At the Department of Otolaryngology, Cheng Hsin General Hospital (Taipei, Taiwan), the cochlear implant devices are switched on within 24 hours of their implantation. In the present study, the impedance changes of Advanced Bionics (TM) cochlear implant devices were compared with previous studies and other devices. The aim was to confirm previous hypotheses and to explore other potential associated factors that could influence impedance following cochlear implantation. The current study included 12 patients who underwent cochlear implantation at Cheng Hsin General Hospital with Advanced Bionics cochlear implant devices. The cochlear devices were all switched on within 24 hours of their implantation. The impedance was measured and compared across all contact channels of the electrode, both intra-operatively and post-operatively. The intra-operative impedance was compared with the switch-on impedance (within 24 hours of the cochlear implantation); the impedance was notably increased for all contact channels at switch-on. Of the 16 channels examined, 4 channels had a significant increase in impedance between the intra-operative measurement and the switch-on measurement. To the best of our knowledge, the impedance of a cochlear implant device can be affected by the diameter of the electrode, the position of the electrode arrays in the scala tympani, sheath formation and fibrosis surrounding the electrode after implantation and electrical stimulation during or after surgery. When the results of the current study were compared with previous studies, it was found that the impedance changes were opposite to that of Cochlear (TM) implant devices. This may be explained by the position of the electrode arrays, sheath formation, the blow-out effect and differences in electrical stimulation.	[Lin, David Po-Yi; Li, Lieber Po-Hung] Cheng Hsin Gen Hosp, Dept Otolaryngol, Taipei, Taiwan; [Chen, Joshua Kuang-Chao] Far Eastern Mem Hosp, Cochlear Implant Ctr, New Taipei, Taiwan; [Tung, Tao-Hsin] Cheng Hsin Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Li, Lieber Po-Hung] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan; [Li, Lieber Po-Hung] Natl Yang Ming Univ, Sch Med, Inst Brain Sci, Taipei, Taiwan	Cheng Hsin General Hospital; Far Eastern Memorial Hospital; Cheng Hsin General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Li, LPH (corresponding author), Cheng Hsin Gen Hosp, Dept Otolaryngol, Taipei, Taiwan.; Li, LPH (corresponding author), Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan.; Li, LPH (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Brain Sci, Taipei, Taiwan.	phli@gm.ym.edu.tw	Li, Lieber/AAG-7397-2022; Li, Lieber/AFL-7454-2022		Cheng Hsin General Hospital [10511]	Cheng Hsin General Hospital	This work was supported by Cheng Hsin General Hospital (10511) of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Vinamra, 2012, Cochlear Implants Int, V13, P113, DOI 10.1179/1754762811Y.0000000015; Chen JKC, 2016, OTOLARYNG HEAD NECK, V154, P771, DOI 10.1177/0194599816631514; Chen JKC, 2015, ACTA OTO-LARYNGOL, V135, P592, DOI 10.3109/00016489.2015.1006335; Chen JKC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071929; Chen JKC, 2010, PEDIATRICS, V125, pE793, DOI 10.1542/peds.2008-3620; Dhanasingh A, 2017, HEARING RES, V356, P93, DOI 10.1016/j.heares.2017.10.005; Gazibegovic D, 2017, EUR ARCH OTO-RHINO-L, V274, P1147, DOI 10.1007/s00405-016-4255-3; Hu HC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173367; Ishai R, 2017, HEARING RES, V348, P44, DOI 10.1016/j.heares.2017.02.012; Kawano A, 1998, ACTA OTO-LARYNGOL, V118, P313; Newbold C, 2004, J NEURAL ENG, V1, P218, DOI 10.1088/1741-2560/1/4/005; Newbold Carrie, 2014, Cochlear Implants Int, V15, P191, DOI 10.1179/1754762813Y.0000000050; Su GL, 2008, HEARING RES, V241, P64, DOI 10.1016/j.heares.2008.04.011; Tykocinski M, 2005, OTOL NEUROTOL, V26, P948, DOI 10.1097/01.mao.0000185056.99888.f3	14	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222711	10.1371/journal.pone.0222711	http://dx.doi.org/10.1371/journal.pone.0222711			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536550	Green Submitted, Green Published, gold			2022-12-26	WOS:000532262800075
J	Morais, TG; Teixeira, RFM; Domingos, T				Morais, Tiago G.; Teixeira, Ricardo F. M.; Domingos, Tiago			Detailed global modelling of soil organic carbon in cropland, grassland and forest soils	PLOS ONE			English	Article							LONG-TERM FERTILIZATION; LIFE-CYCLE ASSESSMENT; LAND-USE IMPACTS; CLIMATE-CHANGE; PROJECTED CHANGES; MINERAL SOILS; STOCKS; DYNAMICS; ROTHC; SEQUESTRATION	Assessments of the global carbon (C) cycle typically rely on simplified models which consider large areas as homogeneous in terms of the response of soils to land use or consider very broad land classes. For example, "cropland" is typically modelled as an aggregation of distinct practices and individual crops over large regions. Here, we use the process-based Rothamsted soil Carbon Model (RothC model), which has a history of being successfully applied at a global scale, to calculate attainable SOC stocks and C mineralization rates for each of c. 17,000 regions (combination of soil type and texture, climate type, initial land use and country) in the World, under near-past climate conditions. We considered 28 individual crops and, for each, multiple production practices, plus 16 forest types and 1 grassland class (total of 80 classes). We find that conversion to cropland can result in SOC increases, particularly when the soil remains covered with crop residues (an average gain of 12 t C/ha) or using irrigation (4 t C/ha), which are mutually reinforcing effects. Attainable SOC stocks vary significantly depending on the land use class, particularly for cropland. Common aggregations in global modelling of a single agricultural class would be inaccurate representations of these results. Attainable SOC stocks obtained here were compared to long-term experiment data and are well aligned with the literature. Our results provide a regional and detailed understanding of C sequestration that will also enable better greenhouse gas reporting at national level as alternatives to IPCC tier 2 defaults.	[Morais, Tiago G.; Teixeira, Ricardo F. M.; Domingos, Tiago] Univ Lisbon, MARETEC Marine Environm & Technol Ctr, Inst Super Tecn, LARSyS, Lisbon, Portugal	Universidade de Lisboa; Instituto Superior Tecnico	Morais, TG (corresponding author), Univ Lisbon, MARETEC Marine Environm & Technol Ctr, Inst Super Tecn, LARSyS, Lisbon, Portugal.	tiago.g.morais@tecnico.ulisboa.pt	Teixeira, Ricardo F.M./D-5872-2017; Domingos, Tiago/D-4558-2012	Teixeira, Ricardo F.M./0000-0001-9915-6264; Domingos, Tiago/0000-0002-6194-0405; G. Morais, Tiago/0000-0001-6558-0331	FCT/MCTES (PIDDAC) [UID/EEA/50009/2019]; Fundacao para a Ciencia e Tecnologia [SusAn/0001/2016, SFRH/BD/115407/2016, SFRH/BPD/111730/2015]	FCT/MCTES (PIDDAC)(Portuguese Foundation for Science and Technology); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by FCT/MCTES (PIDDAC) through project UID/EEA/50009/2019 and by project "Animal Future -Steering Animal Production Systems towards Sustainable Future", funded by the Fundacao para a Ciencia e Tecnologia (SusAn/0001/2016). T.G. Morais was supported by grant SFRH/BD/115407/2016 and R. F.M. Teixeira by grant SFRH/BPD/111730/2015 from Fundacao para a Ciencia e Tecnologia.; This work was supported by FCT/MCTES (PIDDAC) through project UID/EEA/50009/2019 and by project "Animal Future-Steering Animal Production Systems towards Sustainable Future", funded by the Fundacao para a Ciencia e Tecnologia (SusAn/0001/2016). T.G. Morais was supported by grant SFRH/BD/115407/2016 and R.F.M. Teixeira by grant SFRH/BPD/111730/2015 from Fundacao para a Ciencia e Tecnologia.	Aguilera E, 2018, SCI TOTAL ENVIRON, V621, P634, DOI 10.1016/j.scitotenv.2017.11.243; Alexander LV, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P3; Alvaro-Fuentes J, 2012, SOIL TILL RES, V120, P32, DOI 10.1016/j.still.2012.01.009; [Anonymous], 2009, WORLD BORDERS DATASE; APA, 2018, PORT NAT INV REP GRE; Arnell NW, 2013, NAT CLIM CHANGE, V3, P512, DOI [10.1038/nclimate1793, 10.1038/NCLIMATE1793]; Bationo A, 2001, NUTR CYCL AGROECOSYS, V61, P131, DOI 10.1023/A:1013355822946; Bationo A, 2007, AGR SYST, V94, P13, DOI 10.1016/j.agsy.2005.08.011; Batjes NH, 2011, AGR ECOSYST ENVIRON, V142, P365, DOI 10.1016/j.agee.2011.06.007; Berhongaray G, 2013, AGR ECOSYST ENVIRON, V181, P241, DOI 10.1016/j.agee.2013.10.002; Bidet-Caulet A, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.005.2007; Borgen SK, 2013, SOIL CARBON SEQUESTR, V27, P101; Brandao M, 2013, INT J LIFE CYCLE ASS, V18, P1243, DOI 10.1007/s11367-012-0381-3; Brejda JJ, 2000, SOIL SCI SOC AM J, V64, P974, DOI 10.2136/sssaj2000.643974x; Buchholz T, 2014, GCB BIOENERGY, V6, P305, DOI 10.1111/gcbb.12044; Cagnarini C, 2019, EUR J SOIL SCI, V70, P819, DOI 10.1111/ejss.12802; Cai ZC, 2006, GEODERMA, V136, P708, DOI 10.1016/j.geoderma.2006.05.008; Campbell EE, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/123004; Chapagain A. K., 2004, VALUE WATER RES REPO, V1, P1, DOI DOI 10.5194/HESS-15-1577-2011; CITEPA, 2017, RAPP NAT INV FRANC T; CLARIVATE ANALYTICS, 2017, INCITES J CITATION R; Coleman K, 1997, GEODERMA, V81, P29, DOI 10.1016/S0016-7061(97)00079-7; Curran M, 2016, ENVIRON SCI TECHNOL, V50, P2782, DOI 10.1021/acs.est.5b04681; de Brogniez D, 2015, EUR J SOIL SCI, V66, P121, DOI 10.1111/ejss.12193; Del Grosso SJ, 2016, ADV AGR SYST MODEL, V6, P89, DOI 10.2134/advagricsystmodel6.2013.0001.5; Ding SN, 2016, J ARID LAND, V8, P579, DOI 10.1007/s40333-016-0007-x; Doetterl S, 2015, NAT GEOSCI, V8, P780, DOI [10.1038/ngeo2516, 10.1038/NGEO2516]; Donat MG, 2016, NAT CLIM CHANGE, V6, P508, DOI [10.1038/nclimate2941, 10.1038/NCLIMATE2941]; Duiker SW, 1999, SOIL TILL RES, V52, P73, DOI 10.1016/S0167-1987(99)00059-8; Eggleston H.S., 2006, 2006 IPCC GUIDELINES, DOI DOI 10.11-10.89; Environment and Climate Change Canada (ECCC), 2019, TEMP CHANG CAN; ESDAC, 2017, LUCAS 2009 TOPSOIL D; FAO/IIASA, 2012, GLOB AGR ZON GAEZ V3, DOI [10.1029/97GB03657, DOI 10.1029/97GB03657]; FAO IIASA ISRIC ISSCAS JRC, 2012, HARM WORLD SOIL DAT, P3123; Farina R, 2013, GEODERMA, V200, P18, DOI 10.1016/j.geoderma.2013.01.021; Frank AB, 2006, SOIL TILL RES, V89, P78, DOI 10.1016/j.still.2005.06.009; Giardina CP, 2014, NAT CLIM CHANGE, V4, P822, DOI [10.1038/nclimate2322, 10.1038/NCLIMATE2322]; Gottschalk P, 2012, BIOGEOSCIENCES, V9, P3151, DOI 10.5194/bg-9-3151-2012; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Harris NL, 2012, SCIENCE, V336, P1573, DOI 10.1126/science.1217962; Hu T, 2018, AGR ECOSYST ENVIRON, V251, P141, DOI 10.1016/j.agee.2017.09.024; Ingram JSI, 2001, AGR ECOSYST ENVIRON, V87, P111, DOI 10.1016/S0167-8809(01)00145-1; IPCC, 1997, IPCC GUID NAT GREENH, V2; IPCC, 2003, GOOD PRACTICE GUIDAN; Jarvis SC, 1996, ADV AGRON, V57, P187, DOI 10.1016/S0065-2113(08)60925-6; Jebari A, 2016, THESIS; Jebari A, 2018, J ENVIRON QUAL, V47, P644, DOI 10.2134/jeq2017.07.0294; Jones C, 2005, GLOBAL CHANGE BIOL, V11, P154, DOI 10.1111/j.1365-2486.2004.00885.x; Joshi MM, 2013, CLIM DYNAM, V41, P1853, DOI 10.1007/s00382-013-1664-5; Koven CD, 2017, NAT CLIM CHANGE, V7, P817, DOI [10.1038/NCLIMATE3421, 10.1038/nclimate3421]; Kutsch W.L., 2009, SOIL CARBON DYNAMICS, DOI [10.1017/CBO9780511711794, DOI 10.1017/CBO9780511711794]; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lee XQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150709; Legaz BV, 2017, J CLEAN PROD, V140, P502, DOI 10.1016/j.jclepro.2016.05.077; Lehmann J, 2015, NATURE, V528, P60, DOI 10.1038/nature16069; Lemke RL, 2010, AGR ECOSYST ENVIRON, V135, P42, DOI 10.1016/j.agee.2009.08.010; LI CS, 1992, J GEOPHYS RES-ATMOS, V97, P9759, DOI 10.1029/92JD00509; Liu DL, 2011, GEODERMA, V165, P69, DOI 10.1016/j.geoderma.2011.07.005; Ludwig B, 2003, EUR J SOIL SCI, V54, P117, DOI 10.1046/j.1365-2389.2003.00496.x; Luo YQ, 2015, GLOBAL CHANGE BIOL, V21, P1737, DOI 10.1111/gcb.12766; Luo Z, 2015, BIOGEOSCIENCES, V12, P4373, DOI 10.5194/bg-12-4373-2015; Luo ZK, 2010, AGR ECOSYST ENVIRON, V139, P224, DOI 10.1016/j.agee.2010.08.006; Manna MC, 2005, FIELD CROP RES, V93, P264, DOI 10.1016/j.fcr.2004.10.006; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; Mila i Canals L, 2007, CES WORKING PAPERS, V2/07; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; Monforti F, 2015, RENEW SUST ENERG REV, V44, P519, DOI 10.1016/j.rser.2014.12.033; MORAIS TG, 2018, SUSTAINABILITY-BASEL, V10, DOI DOI 10.3390/su10124437; Morais TG, 2018, J CLEAN PROD, V192, P864, DOI 10.1016/j.jclepro.2018.05.061; Morais TG, 2016, INT J LIFE CYCLE ASS, V21, P1076, DOI 10.1007/s11367-016-1077-x; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; NASA, 2016, GLOB PREC AN; Nilsson MC, 2005, FRONT ECOL ENVIRON, V3, P421, DOI 10.2307/3868658; PARTON WJ, 1987, SOIL SCI SOC AM J, V51, P1173, DOI 10.2136/sssaj1987.03615995005100050015x; Pfister S, 2011, ENVIRON SCI TECHNOL, V45, P5761, DOI 10.1021/es1041755; Poeplau C, 2011, GLOBAL CHANGE BIOL, V17, P2415, DOI 10.1111/j.1365-2486.2011.02408.x; Popp A, 2014, NAT CLIM CHANGE, V4, P1095, DOI 10.1038/NCLIMATE2444; Powlson DS, 2014, NAT CLIM CHANGE, V4, P678, DOI 10.1038/NCLIMATE2292; Reichstein M, 2013, NATURE, V500, P287, DOI 10.1038/nature12350; Rey A, 2005, EUR J SOIL SCI, V56, P589, DOI 10.1111/j.1365-2389.2004.00699.x; Robinson Timothy P, 2014, PLoS One, V9, pe96084, DOI 10.1371/journal.pone.0096084; Roman P, 2015, FARMERS COMPOST HDB; Rothamsted Research, 2017, ROTH CARB MOD ROTHC; Schrumpf M, 2011, BIOGEOSCIENCES, V8, P1193, DOI 10.5194/bg-8-1193-2011; Shirato Y, 2004, SOIL SCI PLANT NUTR, V50, P149; Smith J, 2005, GLOBAL CHANGE BIOL, V11, P2141, DOI 10.1111/j.1365-2486.2005.001075.x; Smith J, 2007, GLOBAL CHANGE BIOL, V13, P342, DOI 10.1111/j.1365-2486.2006.01297.x; Smith P, 2004, GLOBAL CHANGE BIOL, V10, P1878, DOI 10.1111/j.1365-2486.2004.00854.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Souza DM, 2015, GLOBAL CHANGE BIOL, V21, P32, DOI 10.1111/gcb.12709; Taghizadeh-Toosi A, 2016, SCI REP-UK, V6, DOI 10.1038/srep32568; TEIXEIRA RFM, 2018, SUSTAINABILITY-BASEL, V10, DOI DOI 10.3390/su10114089; Teixeira RFM, 2018, ENVIRON SCI TECHNOL, V52, P12436, DOI 10.1021/acs.est.8b00721; Teixeira RFM, 2016, J CLEAN PROD, V112, P4283, DOI 10.1016/j.jclepro.2015.07.118; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; Toth G, 2013, ENVIRON MONIT ASSESS, V185, P7409, DOI 10.1007/s10661-013-3109-3; Vaclavik T, 2013, GLOBAL ENVIRON CHANG, V23, P1637, DOI 10.1016/j.gloenvcha.2013.09.004; Wang GC, 2016, SCI REP-UK, V6, DOI 10.1038/srep19327; Weihermuller L, 2013, EUR J SOIL SCI, V64, P567, DOI 10.1111/ejss.12036; Wieder WR, 2013, NAT CLIM CHANGE, V3, P909, DOI [10.1038/nclimate1951, 10.1038/NCLIMATE1951]; Zhang WJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10791	101	27	28	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222604	10.1371/journal.pone.0222604	http://dx.doi.org/10.1371/journal.pone.0222604			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536571	Green Submitted, Green Published, gold			2022-12-26	WOS:000532262800061
J	Thu, PT; Huang, WC; Chou, TK; Quan, NV; Chien, PV; Li, F; Shao, KT; Liao, TY				Pham The Thu; Huang, Wen-Chien; Chou, Tak-Kei; Nguyen Van Quan; Pham Van Chien; Li, Fan; Shao, Kwang-Tsao; Liao, Te-Yu			DNA barcoding of coastal ray-finned fishes in Vietnam	PLOS ONE			English	Article							FRESH-WATER FISHES; MITOCHONDRIAL-DNA; PERCIFORMES; SUBSTITUTIONS; PHYLOGENY; DIVERSITY; GENERA	DNA barcoding based on a fragment of the cytochrome c oxidase subunit I (COI) gene is widely applied in species identification and biodiversity studies. The aim of this study was to establish a comprehensive barcoding database of coastal ray-finned fishes in Vietnam. A total of 3,638 specimens were collected from fish landing sites in northern, central and southern Vietnam. Seven hundred and sixty-five COI sequences of ray-finned fishes were generated, belonging to 458 species, 273 genera, 113 families and 43 orders. A total of 59 species were newly recorded in Vietnam and sequences of six species were new to the Genbank and BOLD online databases. Only 32 species cannot be annotated to species level because difficulty in morphological identifications and their Kimura-2-Parameter (K2P) genetic distances to most similar sequences were more than 2%. Moreover, intra-specific genetic distances in some species are also higher than 2%, implying the existence of putative cryptic species. The mean K2P genetic distances within species, genera, families, orders and classes were 0.34%, 12.14%, 17.39%, 21.42%, and 24.80, respectively. Species compositions are quite different with only 16 common species among northern, central and southern Vietnam. This may attribute to multiple habitats and environmental factors across the 3,260 km Vietnamese coastline. Our results confirmed that DNA barcoding is an efficient and reliable tool for coastal fish identification in Vietnam, and also established a reliable DNA barcode reference library for these fishes. DNA barcodes will contribute to future efforts to achieve better monitoring, conservation, and management of fisheries in Vietnam.	[Pham The Thu; Nguyen Van Quan; Pham Van Chien] Vietnam Acad Sci & Technol, Inst Marine Environm & Resources, Hai Phong, Vietnam; [Huang, Wen-Chien] Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung, Taiwan; [Huang, Wen-Chien] Acad Sinica, Doctoral Degree Program Marine Biotechnol, Taipei, Taiwan; [Huang, Wen-Chien; Chou, Tak-Kei; Li, Fan; Liao, Te-Yu] Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung, Taiwan; [Shao, Kwang-Tsao] Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan; [Shao, Kwang-Tsao] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung, Taiwan	Vietnam Academy of Science & Technology (VAST); National Sun Yat Sen University; Academia Sinica - Taiwan; National Sun Yat Sen University; Academia Sinica - Taiwan; National Taiwan Ocean University	Liao, TY (corresponding author), Natl Sun Yat Sen Univ, Dept Oceanog, Kaohsiung, Taiwan.	swp0117@gmail.com		Huang, Wen Chien/0000-0002-9482-8188; Nguyen, Quan Van/0000-0002-5910-124X	Vietnam National Foundation for Science and Technology Development (NAFOSTED) [106.06-2018.31]; Ministry of Science and Technology [104-2611-M110-004, 105-2923-B-110-001-MY3, 106-2611M-110-008]	Vietnam National Foundation for Science and Technology Development (NAFOSTED)(National Foundation for Science & Technology Development (NAFOSTED)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study was funded by Vietnam National Foundation for Science and Technology Development (NAFOSTED) under grant number 106.06-2018.31 to the Vietnamese side and Ministry of Science and Technology (104-2611-M110-004; 105-2923-B-110-001-MY3; 106-2611M-110-008) to the Taiwanese side. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Claudio Oliveira and another anonymous referee for their constructive comments; to Jie-Cheng Chuang and Ming-hsien Chen of Sheng Long Biotech for their kind assistance during the survey in Ninh Thuan; to Zen-Wei Lin, Han-Ting Huang, Chih-Yen Tung, Po-Hao Chiu, Ching-Ju Chen, Jiehong Wei and You-Chen Liu for collecting specimens; to Wei-Cheng Jhuang, Sung-Yu Tsai and Wei-Che Hung for assistance in fish identification; and to Sih-Yu Chen for map drawing.	Abdullah Mohd Lutfi, 2017, Biodiversitas, V18, P1358; Alcantara SG, 2016, MITOCHONDRIAL DNA A, V27, P3837, DOI 10.3109/19401736.2014.958672; Aquino LMG, 2011, MITOCHONDR DNA, V22, P143, DOI 10.3109/19401736.2011.624613; Arroyave J, 2014, ECOL EVOL, V4, P4534, DOI 10.1002/ece3.1321; Ayudhaya Pradipunt Thongtam Na, 2017, Agriculture and Natural Resources, V51, P198, DOI 10.1016/j.anres.2017.07.001; Becker S, 2011, MITOCHONDR DNA, V22, P3, DOI 10.3109/19401736.2010.535528; Bellwood DR, 2010, J EVOLUTION BIOL, V23, P335, DOI 10.1111/j.1420-9101.2009.01904.x; Betancur-R R, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0958-3; Bui DC, 2001, P MAR FISH RES RES I, VII, P200; Chang C-H, DNA BARCODES NATIVE, P796; Costa FO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035858; Dao MS, 2003, ASSESSMENT MANAGEMEN; Duong TY, 2016, VIETNAM J BIOTECHNOL, V14, P29; Everly M, 2018, AM J TRANSPLANT, V18, P443; Fang GH, 2012, ACTA OCEANOL SIN, V31, P1, DOI 10.1007/s13131-012-0231-y; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Galimberti A, 2013, FOOD RES INT, V50, P55, DOI 10.1016/j.foodres.2012.09.036; Guo YS, 2016, MITOCHONDRIAL DNA A, V27, P2198, DOI 10.3109/19401736.2014.982624; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Ikejima J, 2004, MOL PHYLOGENET EVOL, V31, P904, DOI 10.1016/j.ympev.2003.10.006; Jaafar TNAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049623; Kaga T, 2013, ZOOTAXA, V3642, P4; KAUR S, 2015, INT J ENG RES GEN SC, V3, P602; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2018, MOL BIOL EVOL, V35, P1, DOI 10.1093/molbev/msx313; Lakra WS, 2011, MOL ECOL RESOUR, V11, P60, DOI 10.1111/j.1755-0998.2010.02894.x; Landi M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106135; Lavery S, 2006, NZ AQUATIC ENV BIODI; Leray M, 2015, P NATL ACAD SCI USA, V112, P2076, DOI 10.1073/pnas.1424997112; Lutaenko KA, 2011, P WORKSH COAST MAR B; Mecklenburg Catherine W., 2011, Marine Biodiversity, V41, P109, DOI 10.1007/s12526-010-0070-z; Nguyen H, 2017, VIETNAMS FISHERIES A; Nguyen KH, 2001, FAUNA VIETNAM; Nguyen KH, 1995, COLL MAR RES WORK, VIV, P121; Nguyen NT, 2005, BIODIVERSITY LIVING; Pham TT, 2007, B FS U RYUKYUS, V84; Qu LY, 2017, MITOCHONDRIAL DNA B, V2, P573, DOI 10.1080/23802359.2017.1372707; Randall JE, 2000, RAFFLES B ZOOL, P569; Reid BN, 2011, MOL ECOL RESOUR, V11, P956, DOI 10.1111/j.1755-0998.2011.03032.x; Rojana-anawat P, 2001, P SEAFDEC SEM FISH R; Seishi K, 2018, FISHES HA LONG BAY; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Steinke D, 2009, MAR BIOL, V156, P2641, DOI 10.1007/s00227-009-1284-0; Takagi, 2014, COASTAL DISASTERS CL, P175, DOI [10.1016/B978-0-12-800007-6.00008-3, DOI 10.1016/B978-0-12-800007-6.00008-3]; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tang KL, 2013, MITOCHONDR DNA, V24, P55, DOI 10.3109/19401736.2012.710226; Tran TTV, 2017, MITOCHONDRIAL DNA A, V28, P493, DOI 10.3109/24701394.2016.1143467; Tran D, 1985, MARINE RES COLLECTIO, P19; Tran TO, 2015, INT C BIOL ENV FOOD, P62, DOI [10.15242/IICBE.C0515016, DOI 10.15242/IICBE.C0515016]; Valdez-Moreno M, 2009, J FISH BIOL, V74, P377, DOI 10.1111/j.1095-8649.2008.02077.x; Vu DHQ, 2015, INT C BIOL ENV FOOD, P58, DOI [10.15242/IICBE.C0515014, DOI 10.15242/IICBE.C0515014]; Wang LJ, 2018, PEERJ, V6, DOI 10.7717/peerj.5013; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2009, MOL ECOL RESOUR, V9, P1077, DOI 10.1111/j.1755-0998.2009.02541.x; Xing BP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198109; ZAKARIAISMAIL M, 1994, HYDROBIOLOGIA, V285, P41, DOI 10.1007/BF00005652; Zhang JX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039076, 10.1371/journal.pone.0030621]; Zhang JB, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/978253	61	24	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222631	10.1371/journal.pone.0222631	http://dx.doi.org/10.1371/journal.pone.0222631			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536551	gold, Green Published, Green Submitted			2022-12-26	WOS:000532262800064
J	Sargent, DJ; Buti, M; Surbanovski, N; Brurberg, MB; Alsheikh, M; Kent, MP; Davik, J				Sargent, Daniel J.; Buti, Matteo; Surbanovski, Nada; Brurberg, May Bente; Alsheikh, Muath; Kent, Matthew P.; Davik, Jahn			Identification of QTLs for powdery mildew (Podosphaera aphanis; syn. Sphaerotheca macularis f. sp. fragariae) susceptibility in cultivated strawberry (Fragaria x ananassa)	PLOS ONE			English	Article							RESISTANCE LOCUS; GENE; FIELD; EXPRESSION; INHERITANCE; TUNNEL	Strawberry powdery mildew (Podosphaera aphanis Wallr.) is a pathogen which infects the leaves, fruit, stolon and flowers of the cultivated strawberry (Fragaria xananassa), causing major yield losses, primarily through unmarketable fruit. The primary commercial control of the disease is the application of fungicidal sprays. However, as the use of key active ingredients of commercial fungicides is becoming increasingly restricted, interest in developing novel strawberry cultivars exhibiting resistance to the pathogen is growing rapidly. In this study, a mapping population derived from a cross between two commercial strawberry cultivars ('Sonata' and 'Babette') was genotyped with single nucleotide polymorphism (SNP) markers from the Axiom iStraw90k genotyping array and phenotyped for powdery mildew susceptibility in both glasshouse and field environments. Three distinct, significant QTLs for powdery mildew resistance were identified across the two experiments. Through comparison with previous studies and scrutiny of the F. vesca genome sequence, candidate genes underlying the genetic control of this trait were identified.	[Sargent, Daniel J.; Surbanovski, Nada] PlantSci Consulting Ltd, Maidstone, Kent, England; [Sargent, Daniel J.; Surbanovski, Nada] Fdn Edmund Mach, Trentino, Italy; [Buti, Matteo] Univ Florence, Dept Agr Food Environm & Forestry, Florence, Italy; [Brurberg, May Bente; Davik, Jahn] Norwegian Inst Bioecon Res, Div Biotechnol & Plant Hlth, As, Norway; [Brurberg, May Bente; Alsheikh, Muath] Norwegian Univ Life Sci, Dept Plant Sci, As, Norway; [Alsheikh, Muath] Graminor Breeding Ltd, Ridabu, Norway; [Kent, Matthew P.] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, As, Norway	Fondazione Edmund Mach; University of Florence; Norwegian Institute of Bioeconomy Research; Norwegian University of Life Sciences; Norwegian University of Life Sciences	Davik, J (corresponding author), Norwegian Inst Bioecon Res, Div Biotechnol & Plant Hlth, As, Norway.	jahn.davik@nibio.no	Brurberg, May Bente/HFI-2864-2022; Sargent, Daniel James/A-2933-2014; BUTI, MATTEO/B-8019-2019	Sargent, Daniel James/0000-0002-6686-7147; BUTI, MATTEO/0000-0002-1430-7826; Davik, Jahn/0000-0002-3621-6888	Norwegian Research Council/RFF Hovedstaden [217587]; Autonomous Province of Trento	Norwegian Research Council/RFF Hovedstaden; Autonomous Province of Trento(Autonomous Province of Trento)	JD, MK, and, MBB were partly supported by grant number 217587 from the Norwegian Research Council/RFF Hovedstaden. DJS, MB, NS. were supported by a grant from the Autonomous Province of Trento to the Fondazione Edmund Mach. DJS and NS. are affiliated to PlantSci Consulting Ltd., and MA is affiliated to Graminor Breeding Ltd. These companies did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arya P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107987; Asalf B, 2014, PHYTOPATHOLOGY, V104, P954, DOI 10.1094/PHYTO-12-13-0345-R; Bassil NV, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1310-1; Cockerton HM, 2018, THEOR APPL GENET, V131, P1995, DOI 10.1007/s00122-018-3128-0; Colla P, 2012, PHYTOPARASITICA, V40, P515, DOI 10.1007/s12600-012-0252-2; Davik J, 2005, THEOR APPL GENET, V111, P256, DOI 10.1007/s00122-005-2019-3; Davis JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028800; Edger PP, 2019, NAT GENET, V51, P541, DOI 10.1038/s41588-019-0356-4; Edger PP, 2017, GIGASCIENCE, V7, DOI 10.1093/gigascience/gix124; Gilmour A. R., 1997, Journal of Agricultural, Biological, and Environmental Statistics, V2, P269, DOI 10.2307/1400446; Gilmour A.R., 2009, ASREML USER GUIDE RE; Jambagi S, 2017, J ADV PLANT BIOL, P40, DOI DOI 10.14302/ISSN.2638-4469.JAPB-17-1838; Janisiewicz WJ, 2016, CAN J PLANT PATHOL, V38, P430, DOI 10.1080/07060661.2016.1263807; Jiwan D, 2013, TRANSGENIC RES, V22, P1119, DOI 10.1007/s11248-013-9715-6; Jung S, 2014, NUCLEIC ACIDS RES, V42, pD1237, DOI 10.1093/nar/gkt1012; Kennedy C, 2013, HORTSCIENCE, V48, P1125, DOI 10.21273/HORTSCI.48.9.1125; Koishihara H, 2015, KOISHIHARA H, Patent No. # US20180112267A1; Lelpe DD, 2004, J MOL BIOL, V343, P1, DOI 10.1016/j.jmb.2004.08.023; Liu W, 2014, MOL PLANT, V7, P1740, DOI 10.1093/mp/ssu112; Lyngkjaer MF, 2000, AGRONOMIE, V20, P745, DOI 10.1051/agro:2000173; Miao LX, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15038400; NELSON MD, 1995, PHYTOPATHOLOGY, V85, P421, DOI 10.1094/Phyto-85-421; Noel L, 1999, PLANT CELL, V11, P2099, DOI 10.1105/tpc.11.11.2099; Pessina S, 2016, PLANT BIOTECHNOL J, V14, P2033, DOI 10.1111/pbi.12562; Pessina S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-618; Sargent DJ, 2016, PLANT SCI, V242, P140, DOI 10.1016/j.plantsci.2015.07.004; Sekhwal MK, 2015, INT J MOL SCI, V16, P19248, DOI 10.3390/ijms160819248; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; SIMPSON DW, 1987, J HORTIC SCI, V62, P329, DOI 10.1080/14620316.1987.11515788; Sombardier A, 2009, CAN J PLANT PATHOL, V31, P439, DOI 10.1080/07060660909507618; Tennessen JA, 2014, GENOME BIOL EVOL, V6, P3295, DOI 10.1093/gbe/evu261; Verma S, 2017, ACTA HORTIC, V1156, P75, DOI [10.17660/ActaHortic.2017.1156.10, 10.17660/actahortic.2017.1156.10]; WILLIAMS ER, 1986, BIOMETRIKA, V73, P279, DOI 10.1093/biomet/73.2.279; Xiao CL, 2001, PLANT DIS, V85, P901, DOI 10.1094/PDIS.2001.85.8.901; Zhou FS, 2001, PLANT CELL, V13, P337, DOI 10.1105/tpc.13.2.337	36	6	6	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222829	10.1371/journal.pone.0222829	http://dx.doi.org/10.1371/journal.pone.0222829			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536602	Green Published, gold, Green Submitted			2022-12-26	WOS:000532262800093
J	Vredenburg, VT; McNally, SVG; Sulaeman, H; Butler, HM; Yap, T; Koo, MS; Schmeller, DS; Dodge, C; Cheng, T; Lau, G; Briggs, CJ				Vredenburg, Vance T.; McNally, Samuel V. G.; Sulaeman, Hasan; Butler, Helen M.; Yap, Tiffany; Koo, Michelle S.; Schmeller, Dirk S.; Dodge, Celeste; Cheng, Tina; Lau, Gordon; Briggs, Cheryl J.			Pathogen invasion history elucidates contemporary host pathogen dynamics	PLOS ONE			English	Article							EMERGING INFECTIOUS-DISEASE; BATRACHOCHYTRIUM-DENDROBATIDIS; FUNGAL PATHOGEN; AMPHIBIAN DECLINES; CALIFORNIA; POPULATION; CHYTRIDIOMYCOSIS; EMERGENCE; VIRULENCE; COLLAPSE	Amphibians, the most threatened group of vertebrates, are seen as indicators of the sixth mass extinction on earth. Thousands of species are threatened with extinction and many have been affected by an emerging infectious disease, chytridiomycosis, caused by the fungal pathogen, Batrachochytrium dendrobatidis (Bd). However, amphibians exhibit different responses to the pathogen, such as survival and population persistence with infection, or mortality of individuals and complete population collapse after pathogen invasion. Multiple factors can affect host pathogen dynamics, yet few studies have provided a temporal view that encompasses both the epizootic phase (i.e. pathogen invasion and host collapse), and the transition to a more stable co-existence (i.e. recovery of infected host populations). In the Sierra Nevada mountains of California, USA, conspecific populations of frogs currently exhibit dramatically different host/Bd-pathogen dynamics. To provide a temporal context by which present day dynamics may be better understood, we use a Bd qPCR assay to test 1165 amphibian specimens collected between 1900 and 2005. Our historical analyses reveal a pattern of pathogen invasion and eventual spread across the Sierra Nevada over the last century. Although we found a small number of Bd-infections prior to 1970, these showed no sign of spread or increase in infection prevalence over multiple decades. After the late 1970s, when mass die offs were first noted, our data show Bd as much more prevalent and more spatially spread out, suggesting epizootic spread. However, across the similar to 400km(2) area, we found no evidence of a wave-like pattern, but instead discovered multiple, nearly-simultaneous invasions within regions. We found that Bd invaded and spread in the central Sierra Nevada (Yosemite National Park area) about four decades before it invaded and spread in the southern Sierra Nevada (Sequoia and Kings Canyon National Parks area), and suggest that the temporal pattern of pathogen invasion may help explain divergent contemporary host pathogen dynamics.	[Vredenburg, Vance T.; McNally, Samuel V. G.; Sulaeman, Hasan; Butler, Helen M.; Yap, Tiffany; Dodge, Celeste; Cheng, Tina; Lau, Gordon] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Vredenburg, Vance T.; Yap, Tiffany; Koo, Michelle S.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Yap, Tiffany] Ctr Biol Divers, Oakland, CA USA; [Schmeller, Dirk S.] Univ Toulouse, EcoLab, Toulouse, France; [Briggs, Cheryl J.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	California State University System; San Francisco State University; University of California System; University of California Berkeley; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); University of California System; University of California Santa Barbara	Vredenburg, VT (corresponding author), San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA.; Vredenburg, VT (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.	vancev@sfsu.edu	Schmeller, Dirk S/F-4324-2010; Schmeller, Dirk S./S-6431-2019	Schmeller, Dirk S/0000-0002-3860-9933; Schmeller, Dirk S./0000-0002-3860-9933; McNally, Sam/0000-0003-4577-9700; Sulaeman, Hasan/0000-0002-3061-2185; Koo, Michelle/0000-0003-0410-722X; Vredenburg, Vance/0000-0002-9682-1190	call "Mountains as Sentinels of Change" by the Belmont-Forum [ANR-15-MASC-0001-P3, DFG-SCHM 3059/6-1, NERC-1633948, NSFC-41661144004]; National Science Foundation [NSF LTREB DEB-1557190, NSF 1633948, NSF 0728279]; Axa Chair for Functional Mountain Ecology by Axa Research Fund; National Institutes of Health [NIH 5R01GM109499]	call "Mountains as Sentinels of Change" by the Belmont-Forum; National Science Foundation(National Science Foundation (NSF)); Axa Chair for Functional Mountain Ecology by Axa Research Fund(AXA Research Fund); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work, as part of the People, Pollution, and Pathogens Project (P3 project), was funded partly through the call "Mountains as Sentinels of Change" by the Belmont-Forum (ANR-15-MASC-0001-P3, DFG-SCHM 3059/6-1, NERC-1633948, and NSFC-41661144004). This work was also funded in part by National Science Foundation (Briggs, NSF LTREB DEB-1557190; Vredenburg, Belmont Forum project NSF 1633948; Vredenburg NSF 0728279), the Axa Chair for Functional Mountain Ecology by Axa Research Fund awarded to Schmeller, and the National Institutes of Health (Briggs, NIH 5R01GM109499). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizon S, 2009, J EVOLUTION BIOL, V22, P245, DOI 10.1111/j.1420-9101.2008.01658.x; Bataille A, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3127; Bataille A, 2013, MOL ECOL, V22, P4196, DOI 10.1111/mec.12385; Becker CG, 2017, FUNGAL ECOL, V26, P45, DOI 10.1016/j.funeco.2016.11.007; Becker RA, 1988, NEW S LANGUAGE PACIF; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; BRADFORD DF, 1991, J HERPETOL, V25, P174, DOI 10.2307/1564645; Briggs CJ, 2010, P NATL ACAD SCI USA; Butler H, 2017, SIERRA NEVADA RETROS; Catenazzi A, 2011, CONSERV BIOL, V25, P382, DOI 10.1111/j.1523-1739.2010.01604.x; Chaukulkar S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197710; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Collins JP, 2003, DIVERS DISTRIB, V9, P89, DOI 10.1046/j.1472-4642.2003.00012.x; Daszak P, 2005, ECOLOGY, V86, P3232, DOI 10.1890/05-0598; De Leon ME, 2017, ECOHEALTH, V14, P155, DOI 10.1007/s10393-016-1201-1; Drost CA, 1996, CONSERV BIOL, V10, P414, DOI 10.1046/j.1523-1739.1996.10020414.x; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Green DE, 2001, J HERPETOL, V35, P92, DOI 10.2307/1566028; Huss M, 2013, ECOHEALTH, V10, P339, DOI 10.1007/s10393-013-0895-6; Knapp RA, 2016, P NATL ACAD SCI USA, V113, P11889, DOI 10.1073/pnas.1600983113; Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; MAY RM, 1983, PROC R SOC SER B-BIO, V219, P281, DOI 10.1098/rspb.1983.0075; O'Hanlon SJ, 2018, SCIENCE, V360, P621, DOI 10.1126/science.aar1965; Phillips BL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1290; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Rodriguez D, 2014, MOL ECOL, V23, P774, DOI 10.1111/mec.12615; Rosenblum EB, 2013, P NATL ACAD SCI USA, V110, P9385, DOI 10.1073/pnas.1300130110; Savage AE, 2011, P NATL ACAD SCI USA; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; Sette CM, 2015, BIOL CONSERV, V192, P20, DOI 10.1016/j.biocon.2015.08.039; SHERMAN CK, 1993, J HERPETOL, V27, P186, DOI 10.2307/1564935; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Talley BL, 2015, BIOL CONSERV, V182, P254, DOI 10.1016/j.biocon.2014.12.007; Venter O, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.67; Voyles J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035374; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, 2007, J ZOOL, V271, P361, DOI 10.1111/j.1469-7998.2006.00258.x; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Vredenburg VT, 2004, P NATL ACAD SCI USA, V101, P7646, DOI 10.1073/pnas.0402321101; Vredenburg VT, 2008, THREATENED AMPHIBIAN, P126; Wake DB, 2008, P NATL ACAD SCI; Yap TA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188384; Yap TA, 2016, ECOHEALTH, V13, P145, DOI 10.1007/s10393-015-1071-y	46	9	9	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0219981	10.1371/journal.pone.0219981	http://dx.doi.org/10.1371/journal.pone.0219981			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536501	Green Published, Green Submitted, gold			2022-12-26	WOS:000532262800012
J	Cui, XJ; Yu, XY; Sun, G; Hu, T; Likhodii, S; Zhang, JM; Randell, E; Gao, X; Fan, ZZ; Zhang, WD				Cui, Xiujuan; Yu, Xiaoyan; Sun, Guang; Hu, Ting; Likhodii, Sergei; Zhang, Jingmin; Randell, Edward; Gao, Xiang; Fan, Zhaozhi; Zhang, Weidong			Differential metabolomics networks analysis of menopausal status	PLOS ONE			English	Article							ADIPOSE-TISSUE; ACID; PREVALENCE; CHOLINE; SEX	Menopause is an endocrine-related transition that induces a number of physiological and potentially pathological changes in middle-aged and elderly women. The intention of this research was to investigate the influence of menopause on the intricate relationships between major biochemical metabolites. The study involved metabolic profiling of 186 metabolic markers measured in blood plasma collected from 120 healthy female participants. We developed a method of network analysis using differential correlation that enabled us to detect and characterize differences in metabolites and changes in inter-relationships in preand post-menopausal women. A topological analysis was performed on the differential network that uncovered metabolite differences in pre-and post-menopausal women. In this analysis, our method identified two key metabolites, sphingomyelins and phosphatidylcholines, which may be useful in directing further studies into menopause-specific differences in the metabolome, and how these differences may underlie the body's response to stress and disease following the transition from pre- to post-menopausal status for women.	[Cui, Xiujuan; Yu, Xiaoyan; Zhang, Jingmin; Zhang, Weidong] Jilin Univ, Sch Pharmaceut Sci, Changchun, Peoples R China; [Cui, Xiujuan] Daqing Oil Field Gen Hosp, Dept Pharm, Daqing, Peoples R China; [Sun, Guang] Mem Univ, Fac Med, Discipline Med, St John, NF, Canada; [Hu, Ting] Mem Univ, Dept Comp Sci, St John, NF, Canada; [Likhodii, Sergei] BC Prov Toxicol Ctr, Prov Hlth Serv Author, Vancouver, BC, Canada; [Randell, Edward] Mem Univ, Fac Med, Dept Lab Med, St John, NF, Canada; [Gao, Xiang] Qingdao Univ, Coll Life Sci, Qingdao, Peoples R China; [Fan, Zhaozhi] Mem Univ, Dept Math & Stat, St John, NF, Canada; [Zhang, Weidong] Mem Univ, Fac Med, Discipline Genet, St John, NF, Canada	Jilin University; Memorial University Newfoundland; Memorial University Newfoundland; Memorial University Newfoundland; Qingdao University; Memorial University Newfoundland; Memorial University Newfoundland	Zhang, WD (corresponding author), Jilin Univ, Sch Pharmaceut Sci, Changchun, Peoples R China.; Zhang, WD (corresponding author), Mem Univ, Fac Med, Discipline Genet, St John, NF, Canada.	weidongzhang@jlu.edu.cn			Science and Technology Development Plan of Jilin Province, China [20180101302JC]; Youth technology backbone training program of Health department of Jilin Province, China [2017Q020]; Canadian Institutes of Health Research (CIHR) [MOP192552]; Baiqiuen Project of Jilin University [2018A08]	Science and Technology Development Plan of Jilin Province, China; Youth technology backbone training program of Health department of Jilin Province, China; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Baiqiuen Project of Jilin University	This work was supported by the Science and Technology Development Plan of Jilin Province (20180101302JC), Youth technology backbone training program of Health department of Jilin Province (2017Q020), China. Canadian Institutes of Health Research (CIHR) (operating grant: MOP192552). Baiqiuen Project of Jilin University (2018A08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auro K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5708; Fischer LM, 2007, AM J CLIN NUTR, V85, P1275; Gao X, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0095-9; Hu T, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005986; Hu T, 2016, BIOCOMPUT-PAC SYM, P120; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; Lizardo DY, 2018, BIOCHEMISTRY-US, V57, P22, DOI 10.1021/acs.biochem.7b00862; Mattsson C, 2007, CURR MED CHEM, V14, P2918, DOI 10.2174/092986707782359972; Maynar M, 2001, ENDOCR RES, V27, P357, DOI 10.1081/ERC-100106013; Milewicz A, 2001, Climacteric, V4, P273, DOI 10.1080/713605137; Pinto Rui Climaco, 2017, Adv Exp Med Biol, V965, P163, DOI 10.1007/978-3-319-47656-8_7; Sammaritano LR, 2012, AUTOIMMUN REV, V11, pA430, DOI 10.1016/j.autrev.2011.11.006; Santosa S, 2013, DIABETES, V62, P775, DOI 10.2337/db12-0912; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Srikanth VK, 2005, OSTEOARTHR CARTILAGE, V13, P769, DOI 10.1016/j.joca.2005.04.014; Steuer R, 2006, BRIEF BIOINFORM, V7, P151, DOI 10.1093/bib/bbl009; Twiss JJ, 2007, J AM ACAD NURSE PRAC, V19, P602, DOI 10.1111/j.1745-7599.2007.00260.x; Yamatani H, 2014, MENOPAUSE, V21, P170, DOI 10.1097/GME.0b013e318296431a; Yu ZH, 2012, AGING CELL, V11, P960, DOI 10.1111/j.1474-9726.2012.00865.x; Zeisel SH, 2006, NUTR REV, V64, P197, DOI [10.1301/nr.2006.janr.197-203, 10.1111/j.1753-4887.2006.tb00202.x]; ZEISEL SH, 1995, J NUTR, V125, P3049; Zhang L, 2018, CIRCULATION, V137, P1374, DOI 10.1161/CIRCULATIONAHA.117.031139; Zhang W, 2016, OSTEOARTHR CARTILAGE, V24, P827, DOI 10.1016/j.joca.2015.12.004; Zhang WD, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-015-0937-x; Zhang WD, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006286	25	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222353	10.1371/journal.pone.0222353	http://dx.doi.org/10.1371/journal.pone.0222353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532787	Green Published, gold, Green Submitted			2022-12-26	WOS:000532239600028
J	Liu, WN; Chang, CF; Chung, CH; Chien, WC; Huang, TC; Wu, YY; Ho, CL; Chen, JH				Liu, Wei-Nung; Chang, Chao-Feng; Chung, Chi-Hsiang; Chien, Wu-Chien; Huang, Tzu-Chuan; Wu, Yi-Ying; Ho, Ching-Liang; Chen, Jia-Hong			Clinical outcomes of bortezomib-based therapy in Taiwanese patients with multiple myeloma: A nationwide population-based study and a single-institute analysis	PLOS ONE			English	Article							INTERNATIONAL STAGING SYSTEM; IMPROVED SURVIVAL; EPIDEMIOLOGY	Purpose In a retrospective cohort study, we report the current epidemiology of patients with multiple myeloma (MM) and analyze the real-world clinical outcomes of bortezomib-based therapy. Materials and methods This retrospective study was mainly designed to evaluate the characteristics, treatment outcomes, and prognostic factors of patients with MM who received bortezomib-based therapy. We identified 5,726 patients in Taiwan with MM newly diagnosed between 2007 and 2015. Confidential data from the National Health Insurance Research Database (NHIRD) was used under strict guidelines, as it was made available in an electronic format for research purposes. In addition, we analyzed 96 patients who have been diagnosed with MM and were treated at the Tri-Service General Hospital (TSGH) between January 1, 2002, and December 31, 2018. Results Patients receiving first-line treatment with bortezomib had longer overall survival (OS) compared to those who received non-first-line treatment (p<0.001). In addition, the statistically lowest risk of mortality was when patients received first-line bortezomib followed by an autologous hematopoietic stem cell transplant (adjusted hazard ratio = 0.39, p<0.001). In the TSGH study, the patients were enrolled between January 1, 2002, and December 31, 2018, with an initial diagnosis of MM; there were 96 individuals treated with bortezomib. There was no statistically significant difference in the OS or progression-free survival (PFS) according to the gender, myeloma type, International Staging System stage, or treatment regimen. There was a significant difference in the PFS in patients receiving first-line bortezomib treatment with transplantation compared to those without transplantation (p = 0.021). Conclusions Bortezomib as a first-line treatment extended the OS in four-year mortality tracking and lowered the mortality risk according to the NHIRD analysis. In the TSGH analysis, the results indicated that the initial conditions of patients with MM have a lower influence on the OS and PFS after bortezomib-based therapy was administered.	[Liu, Wei-Nung; Huang, Tzu-Chuan; Wu, Yi-Ying; Ho, Ching-Liang; Chen, Jia-Hong] Triserv Gen Hosp, Natl Def Med Ctr, Dept Med, Div Hematol Oncol, Taipei, Taiwan; [Chang, Chao-Feng] Triserv Gen Hosp, Natl Def Med Ctr, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Chung, Chi-Hsiang; Chien, Wu-Chien] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chung, Chi-Hsiang] Natl Def Med Ctr, Taiwanese Injury Prevent & Safety Promot Assoc, Taipei, Taiwan; [Chien, Wu-Chien] Triserv Gen Hosp, Natl Def Med Ctr, Dept Med Res, Taipei, Taiwan; [Chen, Jia-Hong] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; Taipei Medical University	Chen, JH (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Med, Div Hematol Oncol, Taipei, Taiwan.; Chen, JH (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.	ndmc_tw.tw@yahoo.com.tw	Chung, Chi-Hsiang/AAY-3386-2021	Wu, Yi-Ying/0000-0003-0411-6265; Chen, Jia-Hong/0000-0001-6770-1598				Adams J, 2004, CANCER INVEST, V22, P304, DOI 10.1081/CNV-120030218; [Anonymous], 2010, LONGITUDINAL HLTH IN; [Anonymous], 2015, NATL HLTH INSURANCE; Attal M, 1996, NEW ENGL J MED, V335, P91, DOI 10.1056/NEJM199607113350204; Bross PF, 2004, CLIN CANCER RES, V10, P3954, DOI 10.1158/1078-0432.CCR-03-0781; Cartwright RA, 1999, BRIT J HAEMATOL, V106, P281, DOI 10.1046/j.1365-2141.1999.01480.x; Chen JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167227; Chen YC, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d637; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Huang SY, 2007, CANCER-AM CANCER SOC, V110, P896, DOI 10.1002/cncr.22850; Kane RC, 2006, CLIN CANCER RES, V12, P2955, DOI 10.1158/1078-0432.CCR-06-0170; Kastritis E, 2009, LEUKEMIA, V23, P1152, DOI 10.1038/leu.2008.402; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Lin Chung-King, 2009, Hematol Oncol Stem Cell Ther, V2, P385; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Rajkumar SV, 2014, LANCET ONCOL, V15, pE538, DOI 10.1016/S1470-2045(14)70442-5; Richardson PG, 2005, NEW ENGL J MED, V352, P2487, DOI 10.1056/NEJMoa043445; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; San Miguel JF, 2008, NEW ENGL J MED, V359, P906, DOI 10.1056/NEJMoa0801479; Snowden JA, 2011, BRIT J HAEMATOL, V154, P76, DOI 10.1111/j.1365-2141.2011.08574.x; Tang CH, 2018, CANCER EPIDEMIOL, V55, P136, DOI 10.1016/j.canep.2018.06.003	22	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222522	10.1371/journal.pone.0222522	http://dx.doi.org/10.1371/journal.pone.0222522			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527921	Green Published, gold, Green Submitted			2022-12-26	WOS:000532231400027
J	Saerchen, E; Liedtke-Gruener, S; Kopp, M; Heisterkamp, A; Lubatschowski, H; Ripken, T				Saerchen, Emanuel; Liedtke-Gruener, Susann; Kopp, Maximilian; Heisterkamp, Alexander; Lubatschowski, Holger; Ripken, Tammo			Femtosecond laser induced step-like structures inside transparent hydrogel due to laser induced threshold reduction	PLOS ONE			English	Article							WAVE-GUIDES; HEAT ACCUMULATION; NANOSURGERY; FABRICATION; MECHANISMS; BREAKDOWN; CATARACT; POLYMERS; PATTERNS; WRITTEN	In the area of laser material processing, versatile applications for cutting glasses and transparent polymers exist. However, parasitic effects such as the creation of step-like structures appear when laser cutting inside a transparent material. To date, these structures were only described empirically. This work establishes the physical and chemical mechanisms behind the observed effects and describes the influence of process and material parameters onto the creation of step-like structures in hydrogel, Dihydroxyethylmethacrylat (HEMA). By focusing laser pulses in HEMA, reduced pulse separation distance below 50 nm and rise in pulse energy enhances the creation of unintended step-like structures. Spatial resolved Raman-spectroscopy was used to measure the laser induced chemical modification, which results into a reduced breakdown threshold. The reduction in threshold influences the position of optical breakdown for the succeeding laser pulses and consequently leads to the step-like structures. Additionally, the experimental findings were supplemented with numerical simulations of the influence of reduced damage threshold onto the position of optical breakdown. In summary, chemical material change was defined as cause of the step-like structures. Furthermore, the parameters to avoid these structures were identified.	[Saerchen, Emanuel; Kopp, Maximilian; Heisterkamp, Alexander; Ripken, Tammo] Laser Zentrum Hannover eV, Hannover, Germany; [Saerchen, Emanuel; Liedtke-Gruener, Susann; Lubatschowski, Holger] Rowiak GmbH, Hannover, Germany; [Heisterkamp, Alexander; Lubatschowski, Holger] Leibniz Univ Hannover, Inst Fuer Quantenopt, Hannover, Germany; [Liedtke-Gruener, Susann] Leibniz Inst Surface Engn IOM, Leipzig, Germany	Leibniz University Hannover	Ripken, T (corresponding author), Laser Zentrum Hannover eV, Hannover, Germany.	t.ripken@lzh.de		Ripken, Tammo/0000-0003-3512-9544	German Research Association DFG [RI2066/5-1]	German Research Association DFG(German Research Foundation (DFG))	TR received support from the German Research Association DFG (RI2066/5-1). ROWIAK GmbH provided support in the form of salaries for authors [ES, SLG, HL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], THESIS; Bellouard Y, 2011, OPT EXPRESS, V19, P6807, DOI 10.1364/OE.19.006807; Bellucci R, 2013, ESASO COURSE SER, V3, P38, DOI 10.1159/000350902; Close N, 2004, CELL BIOCHEM BIOPHYS, P9; Ding L, 2006, OPT EXPRESS, V14, P11901, DOI 10.1364/OE.14.011901; Donaldson KE, 2013, J CATARACT REFR SURG, V39, P1753, DOI 10.1016/j.jcrs.2013.09.002; Eaton SM, 2005, OPT EXPRESS, V13, P4708, DOI 10.1364/OPEX.13.004708; Farjo AA, 2013, OPHTHALMOLOGY, V120, pE5, DOI 10.1016/j.ophtha.2012.08.013; Ferrer A, 2011, J APPL PHYS, V109, DOI 10.1063/1.3572268; Ganin D, 2015, PHYSCS PROC, V73, P67, DOI 10.1016/j.phpro.2015.09.123; Gattass RR, 2006, THESIS; Giniunas L, 2014, 8 INT C PHOT TECHN L, P5; Hammer DX, 1997, APPL OPTICS, V36, P5630, DOI 10.1364/AO.36.005630; Hammer DX, 1994, P SOC PHOTO-OPT INS, V2134, P24; Heberle J, 2014, J LASER MICRO NANOEN, V9, P103, DOI 10.2961/jlmn.2014.02.0005; Hnatovskya C, 2005, J APPL PHYS, V98, P1; Kazansky PG, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2722240; KELDYSH LV, 1965, SOV PHYS JETP-USSR, V20, P1307; Kniggendorf AK, 2016, CHEMOSPHERE, V161, P112, DOI 10.1016/j.chemosphere.2016.06.096; Kniggendorf AK, 2014, BIOMED OPT EXPRESS, V5, P2054, DOI 10.1364/BOE.5.002054; Konig K, 1999, CELL MOL BIOL, V45, P195; Korte F, 2003, APPL PHYS A-MATER, V77, P229, DOI 10.1007/s00339-003-2110-z; Kruer W.L., 2003, PHYS LASER PLASMA IN; Lubatschowski H, 2013, KLIN MONATSBL AUGENH, V230, P1207, DOI 10.1055/s-0033-1351058; Lubatschowski H., 2007, OPT PHOTONIK, V2, P49; Lubatschowski H, 2008, J REFRACT SURG, V24, P102, DOI 10.3928/1081597X-20080101-18; Matsuo S, 2015, OPT EXPRESS, V23, P165, DOI 10.1364/OE.23.000165; Mauclair C, 2008, OPT EXPRESS, V16, P5481, DOI 10.1364/OE.16.005481; Mayer WJ, 2014, OPHTHALMOLOGE, V111, P69, DOI 10.1007/s00347-013-2975-y; Miese C, 2011, OPT EXPRESS, V19, P19542, DOI 10.1364/OE.19.019542; Musgraves JD, 2011, OPT MATER EXPRESS, V1, P921, DOI 10.1364/OME.1.000921; Oujja M, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3274127; Riau AK, 2014, INVEST OPHTH VIS SCI, V55, P3186, DOI 10.1167/iovs.14-14434; Richter S, 2013, OPT EXPRESS, V21, P15452, DOI 10.1364/OE.21.015452; Saliminia A, 2006, J APPL PHYS, V99, DOI 10.1063/1.2196237; Salomao MQ, 2010, J CATARACT REFR SURG, V36, P1024, DOI 10.1016/j.jcrs.2010.03.025; Schaffer C.B, 2001, INTERACTION FEMTOSEC; Schmidt U, 2005, MACROMOL SYMP, V230, P133, DOI 10.1002/masy.200551152; Schumacher S., 2009, THESIS; Seiler T, 2014, OPHTHALMOLOGE, V111, P539, DOI 10.1007/s00347-013-2993-9; Shah L, 2005, PROC SPIE, V5714, P253, DOI 10.1117/12.590850; Shaltev MV., 2009, THESIS; Tan DZ, 2016, PROG MATER SCI, V76, P154, DOI 10.1016/j.pmatsci.2015.09.002; Tel A, 2014, INT J THERM SCI, V85, P47, DOI 10.1016/j.ijthermalsci.2014.06.005; Terakawa M, 2010, APPL PHYS A-MATER, V100, P1041, DOI 10.1007/s00339-010-5942-3; Tinne N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114437; Toratani E, 2006, MICROELECTRON ENG, V83, P1782, DOI 10.1016/j.mee.2006.01.194; Vartapetov SK, 2015, QUANTUM ELECTRON+, V45, P725, DOI 10.1070/QE2015v045n08ABEH015515; Vitek DN, 2010, OPT EXPRESS, V18, P24673, DOI 10.1364/OE.18.024673; Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6; Vogel A, 1999, APPL PHYS B-LASERS O, V68, P271, DOI 10.1007/s003400050617; Xu L., 2013, THESIS; Xu LS, 2011, OPT MATER EXPRESS, V1, P1416, DOI 10.1364/OME.1.001416; Ya Cheng, 2003, RIKEN Review, P101	54	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222293	10.1371/journal.pone.0222293	http://dx.doi.org/10.1371/journal.pone.0222293			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527880	Green Submitted, gold, Green Published			2022-12-26	WOS:000532231400015
J	Djima, MM; Ekouevi, DK; Gregoire, JP; Tchounga, B; Coffie, PA; Tran, VT; Toure, FY; Moisan, J				Djima, Mariam Mama; Ekouevi, Didier Koumavi; Gregoire, Jean-Pierre; Tchounga, Boris; Coffie, Patrick Ahuatchi; Viet-Thi Tran; Toure, Franck Y.; Moisan, Jocelyne			Use of non-HIV medication among people living with HIV and receiving antiretroviral treatment in Cote d'Ivoire, West Africa: A cross-sectional study	PLOS ONE			English	Article							DRUG-INTERACTIONS; INFECTED PATIENTS; PILL BURDEN; RISK; POLYPHARMACY; THERAPY; PREVALENCE; PREDICTORS; MORTALITY; MEDICINE	Background In Cote d'Ivoire, people living with HIV (PLHIV) have free access to antiretroviral therapy (ART) and cotrimoxazole. Yet, they may use other medications to treat non-HIV diseases. Scarce data are available regarding the use of non-HIV medications in Africa. This study describes the use of non-HIV medications and identifies the factors associated with their use by PLHIV on ART in Cote d'Ivoire. Methods A cross-sectional study was conducted in six HIV clinics in 2016. HIV-1-infected adults receiving ART for at least one year were eligible. A standardized questionnaire was used to collect demographics, HIV characteristics and medication use data. Associated factors were identified using a multivariate adjusted Poisson regression. Results A total of 1,458 participants (74% women) were enrolled. The median age was 44 years, and the median duration of ART was 81 months. A total of 696 (48%) participants reported having used at least one non-HIV medication. Among the 1,519 non-HIV medications used, 550 (36%) had not been prescribed and 397 (26%) were from the nervous system class. Individuals who were more likely to report the use of at least one non-HIV medication included those who had been treated in an Abidjan HIV clinic, had a high school education level, had a monthly income between 152 and 304 euros, had a poor perceived health status, had WHO advanced clinical stage, had used traditional medicine products and had not used cotrimoxazole. Conclusion Almost half PLHIV on ART reported using non-HIV medication. Further research is needed to assess whether the use of non-HIV medication is appropriate given about a third of those medications are not being prescribed.	[Djima, Mariam Mama; Ekouevi, Didier Koumavi; Tchounga, Boris; Coffie, Patrick Ahuatchi; Viet-Thi Tran; Toure, Franck Y.] CHU Treichville, PACCI, Abidjan, Cote Ivoire; [Djima, Mariam Mama] Inst Pasteur Cote dIvoire, Abidjan, Cote Ivoire; [Djima, Mariam Mama; Gregoire, Jean-Pierre; Moisan, Jocelyne] Univ Laval, Fac Pharm, Quebec City, PQ, Canada; [Ekouevi, Didier Koumavi] Univ Victor Segalen, Ctr Inserm 1219, ISPED, Bordeaux, France; [Ekouevi, Didier Koumavi] Univ Lome, Dept Sante Publ, Lome, Togo; [Gregoire, Jean-Pierre; Moisan, Jocelyne] Univ Laval, CHU Quebec, Ctr Rech, Axe Sante Populat & Prat Optimales Sante, Quebec City, PQ, Canada	Laval University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Laval University	Djima, MM (corresponding author), CHU Treichville, PACCI, Abidjan, Cote Ivoire.; Djima, MM (corresponding author), Inst Pasteur Cote dIvoire, Abidjan, Cote Ivoire.; Djima, MM (corresponding author), Univ Laval, Fac Pharm, Quebec City, PQ, Canada.	madjimar@gmail.com	Tran, Viet-Thi/F-1023-2018; Tran, Viet-Thi/Q-2789-2019	Tran, Viet-Thi/0000-0003-1863-6739; Tran, Viet-Thi/0000-0003-1863-6739; Tchounga, Boris Kevin/0000-0002-8747-9610; MAMA DJIMA, MARIAM/0000-0001-9099-9417; Gregoire, Jean-Pierre/0000-0002-1467-9750	French National Agency for Research on HIV and viral hepatitis (Agence Nationale de Recherche sur le Sida et les Hepatites Virales -ANRS) [12335]	French National Agency for Research on HIV and viral hepatitis (Agence Nationale de Recherche sur le Sida et les Hepatites Virales -ANRS)	This work was supported by the French National Agency for Research on HIV and viral hepatitis (Agence Nationale de Recherche sur le Sida et les Hepatites Virales -ANRS) [grant number 12335]. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrass CK, 2012, J AM GERIATR SOC, V60, P974, DOI 10.1111/j.1532-5415.2012.03948.x; Adams JL, 2012, INT J PSYCHIAT MED, V43, P105, DOI 10.2190/PM.43.2.a; Ajuoga E, 2008, RES SOC ADMIN PHARM, V4, P292, DOI 10.1016/j.sapharm.2007.08.001; Angwenyi V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199977; [Anonymous], 2011, RAPPORT ANNUEL DACTI; Aziz MM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194240; Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Beauliere A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011213; Blot M, 2012, REV MAL RESPIR, V29, P785, DOI 10.1016/j.rmr.2011.10.974; Brown TT, 2017, INTERD T GERONT GERI, V42, P59, DOI 10.1159/000448544; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Diouf A, 2017, REV EPIDEMIOL SANTE, V65, P295, DOI 10.1016/j.respe.2017.02.001; Eholie S P, 2009, Med Trop (Mars), V69, P520; Eholie SP, 2017, TROP MED INT HEALTH, V22, P1186, DOI 10.1111/tmi.12919; Ruiz ME, 2010, CURR DRUG SAF, V5, P315, DOI 10.2174/157488610792245966; Ford N, 2018, LANCET INFECT DIS, V18, pE76, DOI 10.1016/S1473-3099(17)30482-6; Furler MD, 2004, AIDS PATIENT CARE ST, V18, P568, DOI 10.1089/apc.2004.18.568; Furler MD, 2003, AIDS PATIENT CARE ST, V17, P155, DOI 10.1089/108729103321619764; Gimeno-Gracia M, 2015, HIV CLIN TRIALS, V16, P117, DOI 10.1179/1528433614Z.0000000012; Harris M, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/595762; Harris TG, 2018, AIDS, V32, P1563, DOI 10.1097/QAD.0000000000001870; Holtzman C, 2013, J GEN INTERN MED, V28, P1302, DOI 10.1007/s11606-013-2449-6; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Justice AC, 2018, AIDS, V32, P739, DOI [10.1097/QAD.0000000000001756, 10.1097/qad.0000000000001756]; Justice Amy C, 2010, Curr HIV/AIDS Rep, V7, P69, DOI 10.1007/s11904-010-0041-9; Kamekis A, 2018, J CLIN PHARM THER, V43, P26, DOI 10.1111/jcpt.12601; Krentz HB, 2012, ANTIVIR THER, V17, P833, DOI 10.3851/IMP2076; Lamas CC, 2017, INFECTION, V45, P801, DOI 10.1007/s15010-017-1041-0; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Marzolini C, 2011, J ANTIMICROB CHEMOTH, V66, P2107, DOI 10.1093/jac/dkr248; Marzolini C, 2010, ANTIVIR THER, V15, P413, DOI 10.3851/IMP1540; Moshabela M, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-182; Nombela N, 2006, JAIDS-J ACQ IMM DEF, V41, P225, DOI 10.1097/01.qai.0000179456.39185.9b; OMS, 2013, LIGN DIR COMB UT ANT; OMS, 2013, GLOB UPD HIV TREATM; Palella FJ, 2006, JAIDS-J ACQ IMM DEF, V43, P27, DOI 10.1097/01.qai.0000233310.90484.16; PELTZER K, 2008, BMC PUBLIC HEALTH, V8, DOI DOI 10.1186/1471-2458-8-2551471-2458-8-255; Peltzer Karl, 2009, Afr J Tradit Complement Altern Med, V7, P125; Peters B S, 2011, Adv Dent Res, V23, P23, DOI 10.1177/0022034511399082; Radtke KK, 2018, JAIDS-J ACQ IMM DEF, V78, P202, DOI 10.1097/QAI.0000000000001658; Ranzani A, 2018, JAIDS-J ACQ IMM DEF, V78, P193, DOI 10.1097/QAI.0000000000001653; Sander LD, 2015, TROP MED INT HEALTH, V20, P391, DOI 10.1111/tmi.12443; Schmidt CO, 2008, INT J PUBLIC HEALTH, V53, P165, DOI 10.1007/s00038-008-7068-3; Seden K, 2013, J ANTIMICROB CHEMOTH, V68, P1, DOI 10.1093/jac/dks346; Tadesse BT, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2713-1; Tayebati SK, 2017, INT MARIT HEALTH, V68, P39, DOI 10.5603/IMH.2017.0007; The Joint United Nations Programme on HIV and AIDS, 2010, UNAIDS REP GLOB AIDS; Tseng A, 2013, ANN PHARMACOTHER, V47, P1429, DOI 10.1177/1060028013504075; WHO, 2002, STRAT LOMS MED TRAD; WHO UNAIDS UNICEF, 2012, GLOB HIV AIDS RESP E; Wilson M, 2010, ISSUES COMORBIDITY H; World Health Organization, 2001, Afr Health Sci, V1, P30; Zhou ST, 2014, AIDS PATIENT CARE ST, V28, P311, DOI 10.1089/apc.2014.0010	54	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0221335	10.1371/journal.pone.0221335	http://dx.doi.org/10.1371/journal.pone.0221335			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4NC	31525222	Green Published, Green Submitted, gold			2022-12-26	WOS:000532225700011
J	Fantahun, M; Kebede, A; Yenew, B; Gemechu, T; Mamuye, Y; Tadesse, M; Brhane, B; Jibriel, A; Solomon, D; Yaregal, Z				Fantahun, Mengistu; Kebede, Abebaw; Yenew, Bazezew; Gemechu, Tufa; Mamuye, Yeshiwondm; Tadesse, Mengistu; Brhane, Bereket; Jibriel, Aisha; Solomon, Dawit; Yaregal, Zelalem			Diagnostic accuracy of Xpert MTB/RIF assay and non-molecular methods for the diagnosis of tuberculosis lymphadenitis	PLOS ONE			English	Article							NEEDLE-ASPIRATION-CYTOLOGY; EXTRAPULMONARY TUBERCULOSIS; RAPID DIAGNOSIS; CULTURE; PCR; MYCOBACTERIA; PERFORMANCE; SAMPLES; COMPLEX; TESTS	Background Tuberculous lymphadenitis (TBLN) diagnosis remains a challenge in resource limited countries like Ethiopia. Most diagnostic centers in Ethiopia use smear microscopy, but it has low sensitivity in detecting tubercle bacilli in fine needle aspiration (FNA) specimens. FNA cytology (FNAC) is another widely applicable diagnostic option but it has low specificity for diagnosing TBLN. In 2014, WHO recommended Xpert MTB/RIF assay to be used in detecting TB from FNA specimen by considering the diagnostic limitations of microscopy and cytology. In Ethiopia, there is limited data on Xpert MTB/RIF performance in detecting TBLN from FNA. Therefore, this study aimed to evaluate the diagnostic performance of Xpert MTB/RIF assay and non-molecular methods (cytology, microscopy and culture) for the diagnosis of TBLN. Methods A cross-sectional study was conducted on 152 presumptive TBLN patients at St. Paul's Hospital Millennium Medical College (SPHMMC) from December 2015 to May 2016 in Addis Ababa, Ethiopia. FNA specimens were collected from each patient. Individual patient specimens were examined by microscopy (acid fast and auramine 0 staining), cytology, Xpert MTB/RIF and culture. Each specimen was directly inoculated and its sediment following decontamination procedure onto two duplicate Lowenstein-Jensen (LJ) media. Composite culture (specimen positive by direct or concentrated or both culturing methods) and composite method (positive by either one of the non-molecular methods) were taken as reference methods. The data was captured and analyzed using software packages SPSS version 20 (SPSS Inc, Chicago, Illinois, USA). Sensitivity, specificity, positive predictive value, and negative predictive value were calculated. Result A total of 152 presumptive TBLN patients were enrolled in this study. Of these, 105(69%), 68(44.7%), 64(42%), 48(32%) and 33(22%) were positive for M. tuberculosis using composite method (positive by either one of the non-molecular method), composite culture, direct, and concentrated culture, respectively. TB positivity rate was 67.8%, 49.3%, 24.3%, and 14.5% using cytology, Xpert MTB/RIF, Auramine 0 (FM) microscopy, and Ziehl Nelson (ZN) microscopy, respectively. Using composite culture as reference, the sensitivity and specificity of Xpert MTB/RIF was 78% (95% CI: 73.7% to 82.3%) and 74% (95%Cl: 69.4% to 78.6%), respectively. However, the sensitivity of Xpert MTB/RF improved from 78% to 92% using composite method as a reference. The high positivity rate observed in purulent (70%) followed by caseous (66.7%) type of aspirates by Xpert MTB/RIF. Conclusion Xpert MTB/RIF assay has both considerable sensitivity and specificity; it may be employed for better diagnosis, management and treatment of presumptive TBLN patients.	[Fantahun, Mengistu; Brhane, Bereket; Jibriel, Aisha; Solomon, Dawit] St Pauls Hosp Millennium Med Coll, Pathol, Addis Ababa, Ethiopia; [Fantahun, Mengistu; Mamuye, Yeshiwondm] St Pauls Hosp Millennium Med Coll, Dept Microbiol, Addis Ababa, Ethiopia; [Kebede, Abebaw; Yenew, Bazezew; Tadesse, Mengistu; Yaregal, Zelalem] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia; [Gemechu, Tufa] Addis Ababa Univ, Pathol, Addis Ababa, Ethiopia	Addis Ababa University	Fantahun, M (corresponding author), St Pauls Hosp Millennium Med Coll, Pathol, Addis Ababa, Ethiopia.; Fantahun, M (corresponding author), St Pauls Hosp Millennium Med Coll, Dept Microbiol, Addis Ababa, Ethiopia.	mengistu.fann@gmail.com	Tessema, Bazezew Yenew/AAO-4148-2020	Yenew, Bazezew/0000-0002-8505-7000	Addis Ababa University; NIH/Fogarty International Center Global Infectious Diseases [D43TW009127]; FOGARTY INTERNATIONAL CENTER [D43TW009127] Funding Source: NIH RePORTER	Addis Ababa University; NIH/Fogarty International Center Global Infectious Diseases; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was supported by Addis Ababa University.; We would like to acknowledge Ethiopian Public Health Institute (EPHI), Addis Ababa University, and St. Paul's Hospital Millennium Medical College for their cooperation and all study participants; who were agreed to participate in this study. Moreover, we would like to acknowledge the Pathology department of SPHMMC and EPHI National Tuberculosis Reference Laboratory staffs for their encouragement and support druing the laboratory work. Abebaw Kebede is supported by a fellowship from the NIH/Fogarty International Center Global Infectious Diseases grant D43TW009127.	Abdissa K, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0720-z; Ageep A. K., 2012, International Journal of Tropical Medicine, V7, P53; AGUADO JM, 1987, J INFECTION, V14, P191, DOI 10.1016/S0163-4453(87)92177-3; Al-Ateah SM, 2012, SAUDI MED J, V33, P1100; Annam V, 2009, INDIAN J PATHOL MICR, V52, P349, DOI 10.4103/0377-4929.54991; [Anonymous], 2012, GLOB TUB REP 2012; Bezabih M, 2002, CYTOPATHOLOGY, V13, P284, DOI 10.1046/j.1365-2303.2002.00418.x; Biadglegne F, 2014, TUBERCULOSIS, V94, P502, DOI 10.1016/j.tube.2014.05.002; Biadglegne F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081918; Biadglegne F, 2013, JPN J INFECT DIS, V66, P263, DOI 10.7883/yoken.66.263; Buli G.A., 2015, AM J PHARM HLTH RES, V3, P116; Chao SS, 2002, OTOLARYNG HEAD NECK, V126, P176, DOI 10.1067/mhn.2002.121912; Denkinger CM, 2014, EUR RESPIR J, V44, P435, DOI 10.1183/09031936.00007814; Derese Y, 2012, J INFECT DEV COUNTR, V6, P53, DOI 10.3855/jidc.2050; Ergete W, 2000, ETHIOP J HEALTH DEV, V14, P99; Fanny ML, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-191; Garedew L, 2013, SCAND J INFECT DIS, V45, P512, DOI 10.3109/00365548.2013.773068; GRANGE JM, 1989, TUBERCLE, V70, P1, DOI 10.1016/0041-3879(89)90059-7; GUPTA AK, 1992, ACTA CYTOL, V36, P391; Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10; Honore-Bouakline S, 2003, J CLIN MICROBIOL, V41, P2323, DOI 10.1128/JCM.41.6.2323-2329.2003; Iwnetu R, 2009, SCAND J INFECT DIS, V41, P462, DOI 10.1080/00365540902897697; Mistry Y, 2012, NJMR, V2, P77; Mittal P, 2011, DIAGN CYTOPATHOL, V39, P822, DOI 10.1002/dc.21472; Mohapatra Prasanta Raghab, 2009, J Assoc Physicians India, V57, P585; Moure R, 2012, J CLIN MICROBIOL, V50, P513, DOI 10.1128/JCM.06467-11; Muluye D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-435; Nataraj G, 2002, J Postgrad Med, V48, P113; Nidhi Paliwal, 2011, Indian J Tuberc, V58, P102; Steingart K, 2006, LANCET INFECT DIS, V6, P570, DOI 10.1016/S1473-3099(06)70578-3; RADHIKA S, 1989, DIAGN CYTOPATHOL, V5, P260, DOI 10.1002/dc.2840050306; Reddy VCK, 2008, INDIAN J MED MICROBI, V26, P259; Tadesse M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137471; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; World Health Organization, 2011, WHOHTMTB20118; World Health Organization, 2011, WHOHTMTB20112; World Health Organization, 2014, GLOB TUB CONTR 2014; World Health Organization, 2014, WHOHTMTB20141; Zewdie O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2194-2	40	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222402	10.1371/journal.pone.0222402	http://dx.doi.org/10.1371/journal.pone.0222402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525214	Green Published, gold, Green Submitted			2022-12-26	WOS:000532225700027
J	John, GF; Hayworth, JS				John, Gerald F.; Hayworth, Joel S.			Enhanced effectiveness of oil dispersants in destabilizing water-in-oil emulsions	PLOS ONE			English	Article							CRUDE-OIL; CHEMICAL DESTABILIZATION	Oil impacting the northern Gulf of Mexico shoreline from the 2010 Deepwater Horizon accident was predominantly in the form of water-in-oil emulsions (WOE), a chemically weathered, highly viscous, neutrally buoyant material. Once formed, WOE are extremely difficult to destabilize. Commercially-available oil dispersants are largely ineffective de-emulsifiers as a result of the inability of dispersant surfactants to displace asphaltenes stabilizing the oil-water interface. This study investigated the effectiveness of the commercially-available dispersant Corexit 9500A, modified to enhance its polar fraction, in destabilizing WOE. Results suggest that Corexit modified to include between 20-60% fractional amount of either polar additive (1-octanol or hexylamine) will produce a modest increase in WOE instability, with a Corexit to hexylamine ratio of approximately 80/20 providing the most effective enhanced destabilization. Results support the hypothesis that modifying the fraction of polar constituents in commercial dispersants will increase asphaltene solubility, decrease oil-water interface stability, and enhance WOE instability.	[John, Gerald F.] Bryant Univ, Sci & Technol Dept, Smithfield, RI USA; [Hayworth, Joel S.] Auburn Univ, Civil Engn Dept, Auburn, AL 36849 USA	Bryant University; Auburn University System; Auburn University	Hayworth, JS (corresponding author), Auburn Univ, Civil Engn Dept, Auburn, AL 36849 USA.	jsh@auburn.edu			Bureau of Safety and Environmental Enforcement (BSEE), U.S. Department of Interior, Washington, D.C [M11PC00038]; U.S. Department of Interior, Bureau of Safety and Environmental Enforcement (BSEE)	Bureau of Safety and Environmental Enforcement (BSEE), U.S. Department of Interior, Washington, D.C; U.S. Department of Interior, Bureau of Safety and Environmental Enforcement (BSEE)	This study was funded by a grant to JSH from the Bureau of Safety and Environmental Enforcement (BSEE; https://www.bsee.gov/), U.S. Department of Interior, Washington, D.C., under Contract Number M11PC00038. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the U.S. Department of Interior, Bureau of Safety and Environmental Enforcement (BSEE) for supporting this study. Thanks also to Pamela Turner, Assistant Research Engineer at the National Center for Asphalt Testing, Auburn, AL, USA for assistance measuring sample viscosity, and to Dr. Vanisree Mulabagal, Dr. T. Prabhakar Clement, and graduate students Jingyi Qui and Lan Liu for their assistance.	[Anonymous], 2010, OIL BUDGET CALCULATO; [Anonymous], 2012, D327912A ASTM INT, DOI 10.1520/D3279-12; [Anonymous], 2016, D400616A ASTM INT, DOI 10.1520/D4006-16; BOERSMA WH, 1990, AICHE J, V36, P321, DOI 10.1002/aic.690360302; Chandrasekar S, 2006, ICES J MAR SCI, V63, P1418, DOI 10.1016/j.icesjms.2006.04.019; Chanton J, 2014, ENVIRON SCI TECHNOL, V49, P8; Clayton J. R, 1993, OIL SPILL DISPERSANT; Council NR, 2005, OIL SPILL DISP EFF E; Daling PS, 1999, SPILL SCI TECHNOL B, V5, P63, DOI 10.1016/S1353-2561(98)00051-6; Djuve J, 2001, COLLOID POLYM SCI, V279, P232, DOI 10.1007/s003960000413; Fingas M, 2003, MAR POLLUT BULL, V47, P369, DOI 10.1016/S0025-326X(03)00212-1; Fingas M, 1994, ARCT MAR OILSP PROGR; Fingas M, 1996, P 19 ARCT MAR OILSP; Fingas MF, 2004, J HAZARD MATER, V107, P1, DOI 10.1016/j.jhazmat.2003.11.005; Fingas MF, 1993, P 16 ARCT MAR OIL SP; Hayworth JS, 2011, HYDROL EARTH SYST SC, V15, P3639, DOI 10.5194/hess-15-3639-2011; Hayworth JS, 2011, ENVIRON SCI TECHNOL, V45, P4201, DOI 10.1021/es201242k; Hayworth JS, 2012, MARINE POLLUTION B, V64, P10; Kaku VJ, 2006, J ENVIRON ENG, V132, P93, DOI 10.1061/(ASCE)0733-9372(2006)132:1(93); Kokal S, 2005, SPE PROD FACIL, V20, P5, DOI 10.2118/77497-PA; Liu ZF, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035302; McLean JD, 1998, STRUCTURE DYNAMICS A; McLean JD, 1997, J COLLOID INTERF SCI, V189, P12; McNutt MK, 2012, P NATL ACAD SCI USA, V109, P20260, DOI 10.1073/pnas.1112139108; Michel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065087; OSAT-3, 2013, OSAT3; Pelz O., 2012, SELECTION SURROGATE; Sjoblom J, 2003, ADV COLLOID INTERFAC, V100, P399, DOI 10.1016/S0001-8686(02)00066-0; SJOBLOM J, 1990, COLLOID POLYM SCI, V268, P389, DOI 10.1007/BF01411682; SLRERL ALC Inc M, 2006, DISPERSANT EFFECTIVE; Valentine DL, 2014, P NATL ACAD SCI USA, V111, P5; Venosa AD, 2002, SPILL SCI TECHNOL B, V7, P299, DOI 10.1016/S1353-2561(02)00072-5; Venosa AD, 2013, MAR POLLUT BULL, V66, P73, DOI 10.1016/j.marpolbul.2012.11.009; WASAN DT, 1979, J RHEOL, V23, P181, DOI 10.1122/1.549524	34	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222460	10.1371/journal.pone.0222460	http://dx.doi.org/10.1371/journal.pone.0222460			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525215	Green Published, Green Submitted, gold			2022-12-26	WOS:000532225700030
J	Visvanathan, A; Mead, G; Dennis, M; Whiteley, W; Doubal, F; Lawton, J				Visvanathan, Akila; Mead, Gillian; Dennis, Martin; Whiteley, William; Doubal, Fergus; Lawton, Julia			Maintaining hope after a disabling stroke: A longitudinal qualitative study of patients' experiences, views, information needs and approaches towards making treatment decisions	PLOS ONE			English	Article							INTERMITTENT PNEUMATIC COMPRESSION; DEEP-VEIN THROMBOSIS; ISCHEMIC-STROKE; OLDER-ADULTS; OF-LIFE; CLOTS 3; SUPPORT; TRIAL; POSTSTROKE; DEMENTIA	Background Some treatments after a disabling stroke increase the likelihood patients will survive longer but with significant disability. Patients and doctors should make collaborative decisions regarding these treatments. However, this can be challenging. To better understand treatment decision-making in acute disabling stroke, we explored the experiences, views and needs of stroke survivors in hospital and six months later. Methods Fifteen patients who had a disabling stroke were interviewed within a week of their diagnosis; eleven were re-interviewed six months later. Data were analysed thematically and longitudinally. Results Patients' functional abilities prior to their stroke and need for hope of functional recovery appeared to impact on their involvement in decision-making. In the early period post stroke, patients who were functionally independent pre- stroke described being emotionally devastated and ill-prepared for the consequences of stroke. They appeared unaware that treatments offered might extend their life but with significant disability and took all treatments in the hope of functional recovery. Those who were dependent pre-stroke appeared to be more stoic, had considered treatment implications and decided against such treatments. At follow-up, all patients had varying unmet psychological needs which appeared to contribute to poor quality of life. In the early period post stroke, patients looked for various ways to cultivate and maintain hope of functional recovery. While patients continued to look for hope at six months, they also reported wishing they had been given realistic information in the early period after stroke in order to prepare for the consequences. Conclusion Stroke survivors may benefit from psychological support. A collaborative approach towards treatment decision-making may not be realistic in all patients especially when they may be emotionally distressed and looking to maintain a positive outlook. Communication strategies to balance maintaining hope without providing false hope may be appropriate. Patients' information needs may need reassessed at different time points.	[Visvanathan, Akila; Mead, Gillian; Dennis, Martin; Whiteley, William; Doubal, Fergus] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland; [Lawton, Julia] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Visvanathan, A (corresponding author), Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland.	avisvana@exseed.ed.ac.uk		Whiteley, William/0000-0002-4816-8991	Chief Scientist Office [CAF/16/01]	Chief Scientist Office	This study was supported by Chief Scientist Office CAF/16/01 (https://www.cso.scot.nhs.uk/outputs/cso-funded-research/caf/) to AV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson J, 2004, THESIS, V13, P171; Albrecht GL, 1999, SOC SCI MED, V48, P977, DOI 10.1016/S0277-9536(98)00411-0; Andersen HE, 2002, CLIN REHABIL, V16, P593, DOI 10.1191/0269215502cr528oa; [Anonymous], 1999, EDITORIAL CHALLENGE, P747; Association Stroke, 2018, STAT NAT STROK STAT; BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O; Bo K, 2005, 6 MONTH FUNCTIONAL R, P173; Campbell TC, 2010, CANCER J, V16, P461, DOI 10.1097/PPO.0b013e3181f30e07; Compare Angelo, 2011, Clin Pract Epidemiol Ment Health, V7, P148, DOI 10.2174/1745017901107010148; CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593; Counsell C, 2002, STROKE, V33, P1041, DOI 10.1161/hs0402.105909; Davis Bonnie, 2005, Clin Nurs Res, V14, P253, DOI 10.1177/1054773805275520; Dennis M, 2006, HEALTH TECHNOL ASSES, V10, P1; Dennis M, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19760; Dennis M, 2013, LANCET, V382, P516, DOI 10.1016/S0140-6736(13)61050-8; Ditto PH, 1996, HEALTH PSYCHOL, V15, P332, DOI 10.1037/0278-6133.15.5.332; Ditto PH, 2003, HEALTH PSYCHOL, V22, P605, DOI 10.1037/0278-6133.22.6.605; Forster A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001919.pub3; Frank C, 2017, CAN FAM PHYSICIAN, V63, P22; Fried TR, 2011, ARCH INTERN MED, V171, P75, DOI 10.1001/archinternmed.2010.318; Fried TR, 2006, PROSPECTIVE STUDY HL, P166; General Administration of Quality Supervision Inspection and Quarantine of the People's Republic of China, 2010, TECHNICAL GUIDELINES, P1; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Guba E., 1989, 4 GENERATION EVALUAT; Harrison M, 2017, TOP STROKE REHABIL, V24, P119, DOI 10.1080/10749357.2016.1196908; Holloway RG, AHA ASA SCI STATEMEN; Improvement NHS, CANC PSYCH CAR STROK; Johnston B, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0250-1; Killen A, 2016, INT PSYCHOGERIATR, V28, P495, DOI 10.1017/S1041610215001362; Klein A, 2012, NEUROCRIT CARE, V16, P456, DOI 10.1007/s12028-012-9677-1; Kneebone II, 2016, STEPPED PSYCHOL CARE, P8288; Lawton J, 2003, SOCIOL HEALTH ILL, V25, P23; Lin J, 2018, J VIB ENG TECHNOL, V6, DOI 10.1007/s42417-018-0004-9; Mckinstry B, 2000, GEN PRACTICE, P867; Mead N, 2010, BRIT J PSYCHIAT, V196, P96, DOI 10.1192/bjp.bp.109.064089; Menard C, 2012, CURR OPIN ONCOL, V24, P381, DOI 10.1097/CCO.0b013e328354b2f6; Mistry A, 2010, JRSM Short Rep, V1, P30, DOI 10.1258/shorts.2010.010032; Newell SA, 2002, SYSTEMATIC REV PSYCH, V94; Party SW, 2016, NATL CLIN GUIDELINE; Points M., 2018, SCOTTISH STROKE IMPR; Power TE, 2011, PATIENT EDUC COUNS, V83, P163, DOI 10.1016/j.pec.2010.05.021; Quinn TJ, 2009, STROKE, V40, P762, DOI [10.1161/STROKEAHA.108.522516, 10.1161/STROKEAHA.109.557256]; Reid J, 2013, PSYCHOL INTERVENTION, V8; Reuben DB., 2010, NIH PUBLIC ACCESS, V302, P2686; Rutten LJF, 2005, PATIENT EDUC COUNS, V57, P250, DOI 10.1016/j.pec.2004.06.006; Sandercock P, 2012, LANCET, V379, P2352, DOI 10.1016/S0140-6736(12)60768-5; Sentinel Stroke National Audit Programme, 2021, SENTINEL STROKE NATL; Sorensen LV, 2008, AGING MENT HEALTH, V12, P444, DOI 10.1080/13607860802224342; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Stroke I, 2011, NATL SENTINEL STROKE; Townsend N, 2012, CORONARY HEART DIS S, P107; Visvanathan A, 2015, PARENTERAL FLUID REG; Visvanathan A, 2017, INT J STROKE, V12, P920, DOI 10.1177/1747493017730746; von Sarnowski B, 2012, CLIN NEUROL NEUROSUR, V114, P627, DOI 10.1016/j.clineuro.2011.12.026; Weis J, 2003, SUPPORT CARE CANCER, V11, P763, DOI 10.1007/s00520-003-0536-7; Westendorp WF, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008530.pub2; Wilson T, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0555-9; Wrobleski KK, 2005, EXP AGING RES, V31, P217, DOI 10.1080/03610730590915452; Zussman R, 1997, ANNU REV SOCIOL, V23, P171, DOI 10.1146/annurev.soc.23.1.171	59	15	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2019	14	9							e0222500	10.1371/journal.pone.0222500	http://dx.doi.org/10.1371/journal.pone.0222500			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4KS	31518369	Green Published, gold, Green Submitted			2022-12-26	WOS:000532219300022
J	Yamaguchi, MS; Ganz, HH; Cho, AW; Zaw, TH; Jospin, G; McCartney, MM; Davis, CE; Eisen, JA; Coil, DA				Yamaguchi, Mei S.; Ganz, Holly H.; Cho, Adrienne W.; Zaw, Thant H.; Jospin, Guillaume; McCartney, Mitchell M.; Davis, Cristina E.; Eisen, Jonathan A.; Coil, David A.			Bacteria isolated from Bengal cat (Felis catus x Prionailurus bengalensis) anal sac secretions produce volatile compounds potentially associated with animal signaling	PLOS ONE			English	Article							SP-NOV.; SCENT-MARKING; VULPES-VULPES; RED FOX; GLAND SECRETIONS; WOLF CANIS; GEN. NOV.; DOGS; CHEMOSIGNALS; RECOGNITION	In social animals, scent secretions and marking behaviors play critical roles in communication, including intraspecific signals, such as identifying individuals and group membership, as well as interspecific signaling. Anal sacs are an important odor producing organ found across the carnivorans (species in the mammalian Order Carnivora). Secretions from the anal sac may be used as chemical signals by animals for behaviors ranging from defense to species recognition to signaling reproductive status. In addition, a recent study suggests that domestic cats utilize short-chain free fatty acids in anal sac secretions for individual recognition. The fermentation hypothesis is the idea that symbiotic microorganisms living in association with animals contribute to odor profiles used in chemical communication and that variation in these chemical signals reflects variation in the microbial community. Here we examine the fermentation hypothesis by characterizing volatile organic compounds (VOC) and bacteria isolated from anal sac secretions collected from a male Bengal cat (Felis catus x Prionailurus bengalensis), a cross between the domestic cat and the leopard cat. Both left and right anal sacs of a male Bengal cat were manually expressed (emptied) and collected. Half of the material was used to culture bacteria or to extract bacterial DNA and the other half was used for VOC analysis. DNA was extracted from the anal sac secretions and used for a 16S rRNA gene PCR amplification and sequencing based characterization of the microbial community. Additionally, some of the material was plated out in order to isolate bacterial colonies. Three taxa (Bacteroides fragilis, Tessaracoccus, and Finegoldia magna) were relatively abundant in the 16S rRNA gene sequence data and also isolated by culturing. Using Solid Phase Microextraction (SPME) gas chromatography-mass spectrometry (GC-MS), we tentatively identified 52 compounds from the Bengal cat anal sac secretions and 67 compounds from cultures of the three bacterial isolates chosen for further analysis. Among 67 compounds tentatively identified from bacterial isolates, 51 were also found in the anal sac secretion. We show that the bacterial community in the anal sac consists primarily of only a few abundant taxa and that isolates of these taxa produce numerous volatiles that are found in the combined anal sac volatile profile. Several of these volatiles are found in anal sac secretions from other carnivorans, and are also associated with known bacterial biosynthesis pathways. This is consistent with the fermentation hypothesis and the possibility that the anal sac is maintained at least in part to house bacteria that produce volatiles for the host.	[Yamaguchi, Mei S.; McCartney, Mitchell M.; Davis, Cristina E.] Univ Calif Davis, Dept Mech & Aerosp Engn, Davis, CA 95616 USA; [Ganz, Holly H.; Cho, Adrienne W.; Zaw, Thant H.; Jospin, Guillaume; Eisen, Jonathan A.; Coil, David A.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Eisen, Jonathan A.] Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA; [Eisen, Jonathan A.] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Eisen, JA (corresponding author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.; Eisen, JA (corresponding author), Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA.; Eisen, JA (corresponding author), Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA.	jaeisen@ucdavis.edu	Eisen, Jonathan A./H-2706-2019; McCartney, Mitchell/GNM-8128-2022	Eisen, Jonathan A./0000-0002-0159-2197; McCartney, Mitchell/0000-0001-7236-8400; Cho, Adrienne/0000-0001-6837-420X	NIH [UG3-OD023365, T32 HL007013, U01 EB0220003-01, 1P30ES023513-01A1]; NIH National Centre for Advancing Translational Sciences (NCATS) [UL1 TR000002]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001860] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES023513] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [UG3OD023365] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Centre for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Partial funding for this project was provided by various sources, including: the KittyBiome citizen science project, NIH training grant award T32 HL007013 (MSY), NIH award U01 EB0220003-01 (MSY, MMM, CED); NIH National Centre for Advancing Translational Sciences (NCATS) through award UL1 TR000002 (CED); NIH award UG3-OD023365 (CED); and NIH award 1P30ES023513-01A1 (CED). The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the funding agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albone ES, 1976, J CHEM ECOL, V2, P101, DOI 10.1007/BF00988029; ALBONE ES, 1977, J LIPID RES, V18, P474; ALBONE ES, 1974, LIFE SCI, V14, P387, DOI 10.1016/0024-3205(74)90069-1; Albone ES, 1984, MAMMALIAN SEMIOCHEMI; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ALWAIZ M, 1992, METABOLISM, V41, P135, DOI 10.1016/0026-0495(92)90140-6; Apps P, 2012, J CHEM ECOL, V38, P1450, DOI 10.1007/s10886-012-0206-7; ASA CS, 1985, ANIM BEHAV, V33, P1034, DOI 10.1016/S0003-3472(85)80043-9; Begg CM, 2003, ANIM BEHAV, V66, P917, DOI 10.1006/anbe.2003.2223; Bininda-Emonds ORP, 2001, BIOL J LINN SOC, V72, P1, DOI 10.1006/bijl.2000.0492; Burgener N, 2009, ANIM BEHAV, V77, P707, DOI 10.1016/j.anbehav.2008.11.022; Cai M, 2011, INT J SYST EVOL MICR, V61, P1767, DOI 10.1099/ijs.0.025932-0; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; CLAPPERTON BK, 1988, ANIM BEHAV, V36, P541, DOI 10.1016/S0003-3472(88)80025-3; Comeau AM, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00127-16; DECKER DM, 1992, J CHEM ECOL, V18, P1511, DOI 10.1007/BF00993225; Dewhirst FE, 2015, VET MICROBIOL, V175, P294, DOI 10.1016/j.vetmic.2014.11.019; Dickschat JS, 2005, THESIS; Drea CM, 2002, J COMP PSYCHOL, V116, P342, DOI 10.1037//0735-7036.116.4.342; Edgar RC, 2015, BIOINFORMATICS, V31, P3476, DOI 10.1093/bioinformatics/btv401; Ezaki T, 2001, INT J SYST EVOL MICR, V51, P1521, DOI 10.1099/00207713-51-4-1521; FELDMAN HN, 1994, CAN J ZOOL, V72, P1093, DOI 10.1139/z94-147; Finster KW, 2009, ANTON LEEUW INT J G, V96, P515, DOI 10.1007/s10482-009-9367-y; Glockner FO, 2017, J BIOTECHNOL, V261, P169, DOI 10.1016/j.jbiotec.2017.06.1198; Gnanandarajah JS, 2012, J APPL MICROBIOL, V113, P745, DOI 10.1111/j.1365-2672.2012.05390.x; Gorman M, 2009, J ZOOL, V172, P389; Gorman M.L., 1989, P57; GORMAN ML, 1976, ANIM BEHAV, V24, P141, DOI 10.1016/S0003-3472(76)80107-8; Haslam E, 1974, METABOLITES SHIKIMAT, P80; HEFETZ A, 1984, J ZOOL, V203, P205; Heider J, 1998, FEMS MICROBIOL REV, V22, P459, DOI 10.1111/j.1574-6976.1998.tb00381.x; Jang SS, 1997, J AM VET MED ASSOC, V210, P1610; Kampfer P, 2009, INT J SYST EVOL MICR, V59, P1545, DOI 10.1099/ijs.0.006841-0; Kirchoff NS, 2019, PEERJ, V7, DOI 10.7717/peerj.6103; Kiviranta H, 1998, Cent Eur J Public Health, V6, P296; Lawhon SD, 2013, J CLIN MICROBIOL, V51, P3804, DOI 10.1128/JCM.01432-13; Leclaire S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03356-x; Lee DW, 2008, INT J SYST EVOL MICR, V58, P785, DOI 10.1099/ijs.0.64868-0; Li GD, 2016, INT J SYST EVOL MICR, V66, P922, DOI 10.1099/ijsem.0.000812; Li Q, 2013, CURR BIOL, V23, P11, DOI 10.1016/j.cub.2012.10.047; LOVE DN, 1989, VET MICROBIOL, V19, P275, DOI 10.1016/0378-1135(89)90073-4; Martin-Vivaldi M, 2010, P ROY SOC B-BIOL SCI, V277, P123, DOI 10.1098/rspb.2009.1377; Maszenan AM, 1999, INT J SYST BACTERIOL, V49, P459, DOI 10.1099/00207713-49-2-459; McCOLL IAN, 1967, ANN ROY COLL SURG ENGL, V40, P36; Miyazaki M, 2018, J CHEM ECOL, V44, P364, DOI 10.1007/s10886-018-0951-3; Murdoch DA, 1999, ANAEROBE, V5, P555, DOI 10.1006/anae.1999.0197; NORDSTROM NKM, 1984, APPL ENVIRON MICROB, V47, P1360, DOI 10.1128/AEM.47.6.1360-1362.1984; Parales RE, 2008, ADV APPL MICROBIOL, V64, P1, DOI 10.1016/S0065-2164(08)00401-2; PoddarSarkar M, 1997, J LIPID MEDIAT CELL, V15, P285, DOI 10.1016/S0929-7855(96)00561-5; Preti G, 1976, J CHEM ECOL, V2, P177, DOI 10.1007/BF00987740; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; RAYMER J, 1985, J CHEM ECOL, V11, P593, DOI 10.1007/BF00988570; Rosell F, 2011, J ZOOL, V283, P143, DOI 10.1111/j.1469-7998.2010.00754.x; Schulz S, 2007, NAT PROD REP, V24, P814, DOI 10.1039/b507392h; Seck E., 2016, New Microbes and New Infections, V13, P3, DOI 10.1016/j.nmni.2016.05.002; SLOTS J, 1988, J CLIN PERIODONTOL, V15, P85, DOI 10.1111/j.1600-051X.1988.tb00999.x; Song Y, 2011, MANUAL CLIN MICROBIO, V10th, P803; STIRLING LA, 1977, J GEN MICROBIOL, V99, P119, DOI 10.1099/00221287-99-1-119; Theis KR, 2013, P NATL ACAD SCI USA, V110, P19832, DOI 10.1073/pnas.1306477110; TONZETICH J, 1981, ARCH ORAL BIOL, V26, P963, DOI 10.1016/0003-9969(81)90104-7; Wood WF, 2002, J CHEM ECOL, V28, P1865, DOI 10.1023/A:1020573404341; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Young Jae Song, 2015, 2015 3rd International Winter Conference on Brain-Computer Interface (BCI), P1, DOI 10.1109/IWW-BCI.2015.7073020; Yuan H, 2004, CAN J ZOOL, V82, P1596, DOI 10.1139/Z04-144; Zhang JX, 2008, J CHEM ECOL, V34, P398, DOI 10.1007/s10886-008-9441-3; Zhang JX, 2005, CHEM SENSES, V30, P727, DOI 10.1093/chemse/bji065; Zhang JX, 2002, J CHEM ECOL, V28, P1287, DOI 10.1023/A:1016246120479	68	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2019	14	9							e0216846	10.1371/journal.pone.0216846	http://dx.doi.org/10.1371/journal.pone.0216846			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4KS	31518350	Green Submitted, Green Published, gold			2022-12-26	WOS:000532219300002
J	Rothe, K; Spinner, CD; Ott, A; Querbach, C; Dommasch, M; Aldrich, C; Gebhardt, F; Schneider, J; Schmid, RM; Busch, DH; Katchanov, J				Rothe, Kathrin; Spinner, Christoph D.; Ott, Armin; Querbach, Christiane; Dommasch, Michael; Aldrich, Cassandra; Gebhardt, Friedemann; Schneider, Jochen; Schmid, Roland M.; Busch, Dirk H.; Katchanov, Juri			Strategies for increasing diagnostic yield of community-onset bacteraemia within the emergency department: A retrospective study	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; INTEGRATING RAPID DIAGNOSTICS; ANTIMICROBIAL STEWARDSHIP; CLINICAL IMPACT; CULTURES; ADULTS; VOLUME; CONTAMINATION; MICROBIOLOGY; COLLECTION	Bloodstream infections (BSI) are associated with high mortality. Therefore, reliable methods of detection are of paramount importance. Efficient strategies to improve diagnostic yield of bacteraemia within the emergency department (ED) are needed. We conducted a retrospective analysis of all ED encounters in a high-volume, city-centre university hospital within Germany during a five-year study period from October 2013 to September 2018. A time-series analysis was conducted for all ED encounters in which blood cultures (BCs) were collected. BC detection rates and diagnostic yield of community-onset bacteraemia were compared during the study period (which included 45 months prior to the start of a new diagnostic Antibiotic Stewardship (ABS) bundle and 15 months following its implementation). BCs were obtained from 5,191 out of 66,879 ED admissions (7.8%). Bacteraemia was detected in 1,013 encounters (19.5% of encounters where BCs were obtained). The overall yield of true bacteraemia (defined as yielding clinically relevant pathogens) was 14.4%. The new ABS-related diagnostic protocol resulted in an increased number of hospitalised patients with BCs collected in the ED (18% compared to 12.3%) and a significant increase in patients with two or more BC sets taken (59% compared to 25.4%), which resulted in an improved detection rate of true bacteraemia (2.5% versus 1.8% of hospital admissions) without any decrease in diagnostic yield. This simultaneous increase in BC rates without degradation of yield was a valuable finding that indicated success of this strategy. Thus, implementation of the new diagnostic ABS bundle within the ED, which included the presence of a skilled infectious disease (ID) team focused on obtaining BCs, appeared to be a valuable tool for the accurate and timely detection of community-onset bacteraemia.	[Rothe, Kathrin; Gebhardt, Friedemann; Busch, Dirk H.] Tech Univ Munich, Sch Med, Inst Med Microbiol Immunol & Hyg, Munich, Germany; [Spinner, Christoph D.; Schneider, Jochen; Schmid, Roland M.; Katchanov, Juri] Tech Univ Munich, Univ Hosp Rechts Isar, Sch Med, Dept Med 2, Munich, Germany; [Ott, Armin] Tech Univ Munich, Inst Med Informat Stat & Epidemiol, Munich, Germany; [Querbach, Christiane] Tech Univ Munich, Univ Hosp Rechts Isar, Sch Med, Pharm Dept, Munich, Germany; [Dommasch, Michael] Tech Univ Munich, Univ Hosp Rechts Isar, Sch Med, Dept Med 1, Munich, Germany; [Aldrich, Cassandra] Ludwigs Maximilians Univ Munich, Div Infect Dis & Trop Med, Munich, Germany; [Busch, Dirk H.] German Ctr Infect Res DZIF, Partner Site Munich, Munich, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich; University of Munich; German Center for Infection Research	Rothe, K (corresponding author), Tech Univ Munich, Sch Med, Inst Med Microbiol Immunol & Hyg, Munich, Germany.	kathrin.rothe@tum.de	Spinner, Christoph/H-7039-2019; Dommasch, Michael/AAL-6188-2021	Spinner, Christoph/0000-0002-3875-5367; Schneider, Jochen/0000-0002-0300-0159				Arendrup M, 1996, SCAND J INFECT DIS, V28, P609, DOI 10.3109/00365549609037969; Bauer KA, 2014, CLIN INFECT DIS, V59, pS134, DOI 10.1093/cid/ciu547; BENNETT IL, 1954, YALE J BIOL MED, V26, P241; Boyles TH, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1127-1; Chen AI, 2018, INFECT CONT HOSP EP, V39, P1353, DOI 10.1017/ice.2018.231; Chiu CW, 2015, J MICROBIOL IMMUNOL, V48, P92, DOI 10.1016/j.jmii.2013.08.004; Coburn B, 2012, JAMA-J AM MED ASSOC, V308, P502, DOI 10.1001/jama.2012.8262; Collazos-Blanco A, 2019, CLIN MICROBIOL INFEC, V25, P469, DOI 10.1016/j.cmi.2018.06.024; Dargere S, 2014, CLIN MICROBIOL INFEC, V20, pO920, DOI 10.1111/1469-0691.12656; Dik JWH, 2016, FUTURE MICROBIOL, V11, P93, DOI 10.2217/fmb.15.99; Dubourg G, 2019, EXPERT REV MOL DIAGN, V19, P161, DOI 10.1080/14737159.2019.1568241; Garcia RA, 2015, AM J INFECT CONTROL, V43, P1222, DOI 10.1016/j.ajic.2015.06.030; Goto M, 2013, CLIN MICROBIOL INFEC, V19, P501, DOI 10.1111/1469-0691.12195; Halverson S, 2013, J CLIN MICROBIOL, V51, P1721, DOI 10.1128/JCM.03422-12; Howard-Anderson J, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx080; Howie N, 2007, EMERG MED J, V24, P213, DOI 10.1136/emj.2006.039875; Idelevich EA, 2018, DTSCH ARZTEBL INT, V115, P822, DOI 10.3238/arztebl.2018.0822; Jaimes F, 2004, CLIN INFECT DIS, V38, P357, DOI 10.1086/380967; Kao CH, 2011, J MICROBIOL IMMUNOL, V44, P215, DOI 10.1016/j.jmii.2011.01.023; Katchanov J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195757; Kelly AM, 1998, J ACCID EMERG MED, V15, P254; Lamy B, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00697; Lee A, 2007, J CLIN MICROBIOL, V45, P3546, DOI 10.1128/JCM.01555-07; Lee CC, 2007, MEDICINE, V86, P138, DOI 10.1097/SHK.0b013e318067da56; Lee CC, 2012, AM J EMERG MED, V30, P1447, DOI 10.1016/j.ajem.2011.11.010; Lee CC, 2012, AM J EMERG MED, V30, P852, DOI 10.1016/j.ajem.2011.05.029; Lee CC, 2012, DIAGN MICR INFEC DIS, V73, P168, DOI 10.1016/j.diagmicrobio.2012.02.009; Leyssene D, 2011, EUR J CLIN MICROBIOL, V30, P1537, DOI 10.1007/s10096-011-1257-3; LI J, 1994, J CLIN MICROBIOL, V32, P2829, DOI 10.1128/JCM.32.11.2829-2831.1994; Linsenmeyer K, 2016, J HOSP MED, V11, P336, DOI 10.1002/jhm.2541; Lockwood AM, 2016, INFECT CONT HOSP EP, V37, P425, DOI 10.1017/ice.2015.313; Long B, 2016, J EMERG MED, V51, P529, DOI 10.1016/j.jemermed.2016.07.003; Mathieu C, 2019, EXPERT REV ANTI-INFE, V17, P79, DOI 10.1080/14787210.2019.1561275; Miller JM, 2018, CLIN INFECT DIS, V67, pE1, DOI 10.1093/cid/ciy381; Minejima E, 2016, EXPERT REV ANTI-INFE, V14, P1065, DOI 10.1080/14787210.2016.1233814; Mountain D, 2006, EUR J EMERG MED, V13, P76, DOI 10.1097/01.mej.0000188231.45109.ec; Opota O, 2015, CLIN MICROBIOL INFEC, V21, P313, DOI 10.1016/j.cmi.2015.01.003; Panday RSN, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214052; Patel R, 2018, CLIN INFECT DIS, V67, P799, DOI 10.1093/cid/ciy077; Perez KK, 2014, J INFECTION, V69, P216, DOI 10.1016/j.jinf.2014.05.005; POSES RM, 1991, MED DECIS MAKING, V11, P159, DOI 10.1177/0272989X9101100303; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Riedel S, 2008, J CLIN MICROBIOL, V46, P1381, DOI 10.1128/JCM.02033-07; Schmitz RPH, 2015, INT J ANTIMICROB AG, V46, pS5, DOI 10.1016/j.ijantimicag.2015.10.004; Shapiro NI, 2008, J EMERG MED, V35, P255, DOI 10.1016/j.jemermed.2008.04.001; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Takeshima T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148078; Weinstein MP, 1997, CLIN INFECT DIS, V24, P584, DOI 10.1093/clind/24.4.584; World Health Organization, 2016, DIAGN STEW GUID IMPL	49	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2019	14	9							e0222545	10.1371/journal.pone.0222545	http://dx.doi.org/10.1371/journal.pone.0222545			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4IG	31513683	gold, Green Published, Green Submitted			2022-12-26	WOS:000532212700089
J	Berkut, AA; Chugunov, AO; Mineev, KS; Peigneur, S; Tabakmakher, VM; Krylov, NA; Oparin, PB; Lihonosova, AF; Novikova, EV; Arseniev, AS; Grishin, EV; Tytgat, J; Efremov, RG; Vassilevski, AA				Berkut, Antonina A.; Chugunov, Anton O.; Mineev, Konstantin S.; Peigneur, Steve; Tabakmakher, Valentin M.; Krylov, Nikolay A.; Oparin, Peter B.; Lihonosova, Alyona F.; Novikova, Ekaterina, V; Arseniev, Alexander S.; Grishin, Eugene, V; Tytgat, Jan; Efremov, Roman G.; Vassilevski, Alexander A.			Protein surface topography as a tool to enhance the selective activity of a potassium channel blocker	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ion channel; molecular dynamics; neurotoxin; nuclear magnetic resonance (NMR); peptides; potassium channel; protein motif; protein structure; alpha-hairpinin; hefutoxin; pore blocker	HELICAL HAIRPIN STRUCTURE; ION CHANNELS; COUPLING-CONSTANTS; K+ CHANNEL; PEPTIDE; ORGANIZATION; INHIBITOR; RESIDUES; TARGETS; TOXINS	Tk-hefu is an artificial peptide designed based on the ?-hairpinin scaffold, which selectively blocks voltage-gated potassium channels K(v)1.3. Here we present its spatial structure resolved by NMR spectroscopy and analyze its interaction with channels using computer modeling. We apply protein surface topography to suggest mutations and increase Tk-hefu affinity to the K(v)1.3 channel isoform. We redesign the functional surface of Tk-hefu to better match the respective surface of the channel pore vestibule. The resulting peptide Tk-hefu-2 retains K(v)1.3 selectivity and displays ?15 times greater activity compared with Tk-hefu. We verify the mode of Tk-hefu-2 binding to the channel outer vestibule experimentally by site-directed mutagenesis. We argue that scaffold engineering aided by protein surface topography represents a reliable tool for design and optimization of specific ion channel ligands.	[Berkut, Antonina A.; Chugunov, Anton O.; Mineev, Konstantin S.; Tabakmakher, Valentin M.; Krylov, Nikolay A.; Oparin, Peter B.; Novikova, Ekaterina, V; Arseniev, Alexander S.; Grishin, Eugene, V; Efremov, Roman G.; Vassilevski, Alexander A.] Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117997, Russia; [Chugunov, Anton O.; Krylov, Nikolay A.; Lihonosova, Alyona F.; Efremov, Roman G.] Natl Res Univ Higher Sch Econ, Moscow 101000, Russia; [Chugunov, Anton O.; Mineev, Konstantin S.; Novikova, Ekaterina, V; Arseniev, Alexander S.; Efremov, Roman G.; Vassilevski, Alexander A.] State Univ, Moscow Inst Phys & Technol, Dolgoprudnyi 141700, Russia; [Peigneur, Steve; Tytgat, Jan] Univ Leuven, Toxicol & Pharmacol, B-3000 Leuven, Belgium; [Tabakmakher, Valentin M.] Far Eastern Fed Univ, Sch Biomed, Vladivostok 690950, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; HSE University (National Research University Higher School of Economics); Moscow Institute of Physics & Technology; KU Leuven; Far Eastern Federal University	Efremov, RG (corresponding author), Russian Acad Sci, 16-10 Miklukho Maklaya St, Moscow 117997, Russia.; Vassilevski, AA (corresponding author), Russian Acad Sci, Inst Bioorgan Chem, 16-10 Miklukho Maklaya St, Moscow 117997, Russia.	efremov@nmr.ru; avas@ibch.ru	Roman, Efremov/A-7460-2014; Tabakmakher, Valentin/M-6846-2013; Novikova, Ekaterina/D-4084-2014; Chugunov, Anton O/D-1058-2009; Mineev, Konstantin S/Q-3948-2018; Krylov, Nikolay A/A-8382-2014; Vassilevski, Alexander/S-3824-2016	Roman, Efremov/0000-0002-5474-4721; Tabakmakher, Valentin/0000-0002-6588-1561; Chugunov, Anton O/0000-0003-1331-3949; Mineev, Konstantin S/0000-0002-2418-9421; Krylov, Nikolay A/0000-0002-4520-0351; Vassilevski, Alexander/0000-0002-1359-0076; Peigneur, Steve/0000-0003-0504-5702	Molecular and Cell Biology Program of the Russian Academy of Sciences; Russian Academic Excellence Project "5-100"; Basic Research Program at the National Research University Higher School of Economics; F.W.O. Vlaanderen [GOC2319N, GOA4919N]; BOF, KU Leuven [CELSA/17/047]; KU Leuven Grant [PDM/19/164]	Molecular and Cell Biology Program of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Academic Excellence Project "5-100"(Ministry of Education and Science, Russian FederationProject 5-100, Ministry of Education and Science, Russian Federation); Basic Research Program at the National Research University Higher School of Economics; F.W.O. Vlaanderen(FWO); BOF, KU Leuven(KU Leuven); KU Leuven Grant	This work was supported by grants from the Molecular and Cell Biology Program of the Russian Academy of Sciences (to A. A. V. and A. O. C.), Russian Academic Excellence Project "5-100" and the Basic Research Program at the National Research University Higher School of Economics (to R. G. E., A. O. C., and N. A. K.), F.W.O. Vlaanderen Grants GOC2319N and GOA4919N and CELSA/17/047 (BOF, KU Leuven) (to J. T.), and KU Leuven Grant PDM/19/164 (to S. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Banerjee A, 2013, ELIFE, V2, DOI 10.7554/eLife.00594; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Berkut AA, 2014, J BIOL CHEM, V289, P14331, DOI 10.1074/jbc.M113.530477; Cahalan MD, 2009, IMMUNOL REV, V231, P59, DOI 10.1111/j.1600-065X.2009.00816.x; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chandy KG, 2017, CURR OPIN CHEM BIOL, V38, P97, DOI 10.1016/j.cbpa.2017.02.015; Chen XR, 2010, P NATL ACAD SCI USA, V107, P11352, DOI 10.1073/pnas.1000142107; Chi PB, 2016, PROTEIN SCI, V25, P1168, DOI 10.1002/pro.2886; Chugunov AO, 2016, SCI REP-UK, V6, DOI 10.1038/srep33112; Chugunov AO, 2013, J BIOL CHEM, V288, P19014, DOI 10.1074/jbc.M112.431650; Cumming JG, 2013, NAT REV DRUG DISCOV, V12, P948, DOI 10.1038/nrd4128; Dauplais M, 1997, J BIOL CHEM, V272, P4302, DOI 10.1074/jbc.272.7.4302; DeLano WL, 2002, PYMOL USERS MANUAL; Dux P, 1997, J BIOMOL NMR, V10, P301, DOI 10.1023/A:1018393225804; Feske S, 2015, ANNU REV IMMUNOL, V33, P291, DOI 10.1146/annurev-immunol-032414-112212; Gasparian ME, 2003, PROTEIN EXPRES PURIF, V31, P133, DOI 10.1016/S1046-5928(03)00159-1; Gasparini S, 1998, J BIOL CHEM, V273, P25393, DOI 10.1074/jbc.273.39.25393; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; Jen JC, 2016, NAT REV NEUROL, V12, P195, DOI 10.1038/nrneurol.2016.18; Kaczorowski GJ, 2008, J GEN PHYSIOL, V131, P399, DOI 10.1085/jgp.200709946; Kahn R, 2009, J BIOL CHEM, V284, P20684, DOI 10.1074/jbc.M109.021303; Keller R., 2004, COMPUTER AIDED RESON, V1; Kohling R, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a022871; Koromyslova AD, 2014, J CHEM INF MODEL, V54, P1189, DOI 10.1021/ci500158y; Kuldyushev NA, 2018, PROTEINS, V86, P1117, DOI 10.1002/prot.25583; Kuzmenkov AI, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1764, DOI 10.1134/S0006297915130118; Kuzmenkov AI, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw056; Lyukmanova EN, 2015, J BIOL CHEM, V290, P23616, DOI 10.1074/jbc.M115.656595; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; McCoy J., 2001, CURR PROTOC MOL BIOL, V16, P18; Morrison C, 2017, NAT BIOTECHNOL, V35, P108, DOI 10.1038/nbt.3783; Nolde SB, 2011, J BIOL CHEM, V286, P25145, DOI 10.1074/jbc.M110.200378; Obergrussberger A, 2015, CHANNELS, V9, P367, DOI 10.1080/19336950.2015.1079675; Oparin PB, 2012, BIOCHEM J, V446, P69, DOI 10.1042/BJ20120548; Ortiz E, 2015, TOXICON, V93, P125, DOI 10.1016/j.toxicon.2014.11.233; PAULING L, 1974, NATURE, V248, P769, DOI 10.1038/248769a0; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Ptacek LJ, 2015, ANNU REV PHYSIOL, V77, P475, DOI 10.1146/annurev-physiol-021014-071922; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; Shah NH, 2014, TRANSL STROKE RES, V5, P38, DOI 10.1007/s12975-013-0297-7; Shakkottai VG, 2001, J BIOL CHEM, V276, P43145, DOI 10.1074/jbc.M106981200; Srinivasan KN, 2002, J BIOL CHEM, V277, P30040, DOI 10.1074/jbc.M111258200; Urrego D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0094; Utkina LL, 2013, FEBS J, V280, P3594, DOI 10.1111/febs.12349; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vassilevski AA, 2008, BIOCHEM J, V411, P687, DOI [10.1042/BJ20071123, 10.1042/bj20071123]; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Wuthrich K, 1986, NMR PROTEINS NUCL AC	52	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2019	294	48					18349	18359		10.1074/jbc.RA119.010494	http://dx.doi.org/10.1074/jbc.RA119.010494			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KA1GS	31533989	Green Published, hybrid			2022-12-26	WOS:000505547900029
J	Yiangou, L; Grandy, RA; Osnato, A; Ortmann, D; Sinha, S; Vallier, L				Yiangou, Loukia; Grandy, Rodrigo A.; Osnato, Anna; Ortmann, Daniel; Sinha, Sanjay; Vallier, Ludovic			Cell cycle regulators control mesoderm specification in human pluripotent stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						stem cells; differentiation; cell cycle; signaling; gene expression; cyclin-dependent kinase (CDK); pluripotency; embryo development; mesoderm; RB transcriptional corepressor 1 (RB1); tissue regeneration	SMOOTH-MUSCLE SUBTYPES; DIFFERENTIATION; EXPRESSION; ALLOCATION; POLYCOMB; NANOG; STATE; CDK1; EFGF; MESENDODERM	The mesoderm is one of the three germ layers produced during gastrulation from which muscle, bones, kidneys, and the cardiovascular system originate. Understanding the mechanisms that control mesoderm specification could inform many applications, including the development of regenerative medicine therapies to manage diseases affecting these tissues. Here, we used human pluripotent stem cells to investigate the role of cell cycle in mesoderm formation. To this end, using small molecules or conditional gene knockdown, we inhibited proteins controlling G(1) and G(2)/M cell cycle phases during the differentiation of human pluripotent stem cells into lateral plate, cardiac, and presomitic mesoderm. These loss-of-function experiments revealed that regulators of the G(1) phase, such as cyclin-dependent kinases and pRb (retinoblastoma protein), are necessary for efficient mesoderm formation in a context-dependent manner. Further investigations disclosed that inhibition of the G(2)/M regulator cyclin-dependent kinase 1 decreases BMP (bone morphogenetic protein) signaling activity specifically during lateral plate mesoderm formation while reducing fibroblast growth factor/extracellular signaling-regulated kinase 1/2 activity in all mesoderm subtypes. Taken together, our findings reveal that cell cycle regulators direct mesoderm formation by controlling the activity of key developmental pathways.	[Yiangou, Loukia; Grandy, Rodrigo A.; Osnato, Anna; Ortmann, Daniel; Sinha, Sanjay; Vallier, Ludovic] Univ Cambridge, Wellcome Med Res Council, Anne McLaren Lab, Cambridge Stem Cell Inst, Cambridge CB2 0SZ, England; [Yiangou, Loukia; Grandy, Rodrigo A.; Osnato, Anna; Ortmann, Daniel; Vallier, Ludovic] Univ Cambridge, Dept Surg, Cambridge CB2 0QQ, England; [Yiangou, Loukia; Sinha, Sanjay] Univ Cambridge, Dept Med, Div Cardiovasc Med, Cambridge CB2 0QQ, England; [Yiangou, Loukia; Vallier, Ludovic] Wellcome Sanger Inst, Hinxton CB10 1SA, England; [Yiangou, Loukia] Leiden Univ, Dept Anat & Embryol, Med Ctr, Einthovenweg 20, NL-2333 ZC Leiden, Netherlands	University of Cambridge; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Vallier, L (corresponding author), Univ Cambridge, Wellcome Med Res Council, Anne McLaren Lab, Cambridge Stem Cell Inst, Cambridge CB2 0SZ, England.; Vallier, L (corresponding author), Univ Cambridge, Dept Surg, Cambridge CB2 0QQ, England.; Vallier, L (corresponding author), Wellcome Sanger Inst, Hinxton CB10 1SA, England.	lv225@cam.ac.uk	Sinha, Sanjay/AAF-1692-2021	Sinha, Sanjay/0000-0001-5900-1209; Vallier, Ludovic/0000-0002-3848-2602; Osnato, Anna/0000-0001-5241-1512; Yiangou, Loukia/0000-0003-1477-005X	Wellcome Ph.D. program [PSAG/048]; European Research Council [New-Chol 741707]; HORIZON 2020 Grant [668294]; British Heart Foundation Senior Research Fellowship [FS/13/29/30024]; Wellcome-Medical Research Council Cambridge Stem Cell Institute Core Support Grant [pSAG028]; Wellcome to the Wellcome Sanger Institute Core Support Grant [WT206194]; MRC [G0701448] Funding Source: UKRI	Wellcome Ph.D. program; European Research Council(European Research Council (ERC)European Commission); HORIZON 2020 Grant; British Heart Foundation Senior Research Fellowship; Wellcome-Medical Research Council Cambridge Stem Cell Institute Core Support Grant; Wellcome to the Wellcome Sanger Institute Core Support Grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Wellcome Ph.D. program Grant PSAG/048 (to L. Y.), European Research Council Grant New-Chol 741707 (to L. V., R. A. G., and A. O.), HORIZON 2020 Grant 668294 (to D. O.), British Heart Foundation Senior Research Fellowship FS/13/29/30024 (to S. S.), Wellcome-Medical Research Council Cambridge Stem Cell Institute Core Support Grant pSAG028, and Wellcome to the Wellcome Sanger Institute Core Support Grant WT206194. The authors declare that they have no conflicts of interest with the contents of this article.	Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Bernardo AS, 2011, CELL STEM CELL, V9, P144, DOI 10.1016/j.stem.2011.06.015; Bertero Alessandro, 2018, Curr Protoc Stem Cell Biol, V44, DOI 10.1002/cpsc.45; Bertero A, 2016, DEVELOPMENT, V143, P4405, DOI 10.1242/dev.138081; Berthet C, 2003, CURR BIOL, V13, P1775, DOI 10.1016/j.cub.2003.09.024; Berthet C, 2006, DEV CELL, V10, P563, DOI 10.1016/j.devcel.2006.03.004; Bienvenu F, 2010, NATURE, V463, P374, DOI 10.1038/nature08684; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brumbaugh J, 2014, STEM CELL REP, V2, P18, DOI 10.1016/j.stemcr.2013.12.005; Casey ES, 1998, DEVELOPMENT, V125, P3887; Cheung C, 2014, NAT PROTOC, V9, P929, DOI 10.1038/nprot.2014.059; Cheung C, 2012, NAT BIOTECHNOL, V30, P165, DOI 10.1038/nbt.2107; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Diril MK, 2012, P NATL ACAD SCI USA, V109, P3826, DOI 10.1073/pnas.1115201109; Gonzales KAU, 2015, CELL, V162, P564, DOI 10.1016/j.cell.2015.07.001; GRIFFIN K, 1995, DEVELOPMENT, V121, P2983; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Hu YP, 2016, ONCOTARGET, V7, P87124, DOI 10.18632/oncotarget.13547; ISAACS HV, 1995, INT J DEV BIOL, V39, P575; ISAACS HV, 1994, EMBO J, V13, P4469, DOI 10.1002/j.1460-2075.1994.tb06769.x; Kimelman D, 2000, CURR OPIN GENET DEV, V10, P350, DOI 10.1016/S0959-437X(00)00095-2; Kinder SJ, 1999, DEVELOPMENT, V126, P4691; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Mendjan S, 2014, CELL STEM CELL, V15, P310, DOI 10.1016/j.stem.2014.06.006; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Neganova I, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.464; Neganova I, 2009, ONCOGENE, V28, P20, DOI 10.1038/onc.2008.358; Olivera-Martinez I, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001415; Pauklin S, 2016, GENE DEV, V30, P421, DOI 10.1101/gad.271452.115; Pauklin S, 2013, CELL, V155, P135, DOI 10.1016/j.cell.2013.08.031; Radzisheuskaya A, 2013, NAT CELL BIOL, V15, P579, DOI 10.1038/ncb2742; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Rodaway A, 2001, CELL, V105, P169, DOI 10.1016/S0092-8674(01)00307-5; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Singh AM, 2015, STEM CELL REP, V5, P323, DOI 10.1016/j.stemcr.2015.07.005; Singh AM, 2013, STEM CELL REP, V1, P532, DOI 10.1016/j.stemcr.2013.10.009; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tam PPL, 1997, DEVELOPMENT, V124, P1631; TAM PPL, 1994, ANAT EMBRYOL, V189, P275; Teo AKK, 2011, GENE DEV, V25, P238, DOI 10.1101/gad.607311; Theunissen TW, 2017, DEVELOPMENT, V144, P4496, DOI 10.1242/dev.157404; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsutsui T, 1999, MOL CELL BIOL, V19, P7011; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Yiangou L, 2018, CELL STEM CELL, V22, P485, DOI 10.1016/j.stem.2018.03.016; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001; Yu YX, 2017, STEM CELL REP, V9, P752, DOI 10.1016/j.stemcr.2017.07.016	52	11	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2019	294	47					17903	17914		10.1074/jbc.RA119.008251	http://dx.doi.org/10.1074/jbc.RA119.008251			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY1UF	31515269	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000504206800017
J	Disser, NP; Sugg, KB; Talarek, JR; Sarver, DC; Rourke, BJ; Mendias, CL				Disser, Nathaniel P.; Sugg, Kristoffer B.; Talarek, Jeffrey R.; Sarver, Dylan C.; Rourke, Brennan J.; Mendias, Christopher L.			Insulin-like growth factor 1 signaling in tenocytes is required for adult tendon growth	FASEB JOURNAL			English	Article						tendon fibroblasts; protein synthesis; hypertrophy; extracellular matrix; IGF1	FACTOR-I; COLLAGEN-SYNTHESIS; PROTEIN-SYNTHESIS; TGF-BETA; RECEPTOR SUBSTRATE-1; BINDING-PROTEINS; STEM-CELLS; PHOSPHORYLATION; EXPRESSION; MUSCLE	Tenocytes serve to synthesize and maintain collagen fibrils and other extracellular matrix proteins in tendon. Despite the high prevalence of tendon injury, the underlying biologic mechanisms of postnatal tendon growth and repair are not well understood. IGF1 plays an important role in the growth and remodeling of numerous tissues but less is known about IGF1 in tendon. We hypothesized that IGF1 signaling is required for proper tendon growth in response to mechanical loading through regulation of collagen synthesis and cell proliferation. To test this hypothesis, we conditionally deleted the IGF1 receptor (IGF1R) in scleraxis (Scx)-expressing tenocytes using a tamoxifen-inducible Cre-recombinase system and caused tendon growth in adult mice via mechanical overload of the plantaris tendon. Compared with control Scx-expressing IGFIR-positive (Scx:IGFIR(+)) mice, in which IGF1R is present in tenocytes, mice that lacked IGF1R in their tenocytes [Scx-expressing IGFIR-negative (Scx:IGF1R(Delta)) mice] demonstrated reduced cell proliferation and smaller tendons in response to mechanical loading. Additionally, we identified that both the PI3K/protein kinase B and ERK pathways are activated downstream of IGF1 and interact in a coordinated manner to regulate cell proliferation and protein synthesis. These studies indicate that IGF1 signaling is required for proper postnatal tendon growth and support the potential use of IGF1 in the treatment of tendon disorders.	[Disser, Nathaniel P.; Talarek, Jeffrey R.; Rourke, Brennan J.; Mendias, Christopher L.] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA; [Sugg, Kristoffer B.; Talarek, Jeffrey R.; Sarver, Dylan C.; Rourke, Brennan J.; Mendias, Christopher L.] Univ Michigan, Med Sch, Dept Orthopaed Surg, Ann Arbor, MI 48109 USA; [Sugg, Kristoffer B.; Talarek, Jeffrey R.] Univ Michigan, Med Sch, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Sugg, Kristoffer B.] Univ Michigan, Dept Surg, Med Sch, Sect Plast & Reconstruct Surg, Ann Arbor, MI 48109 USA; [Mendias, Christopher L.] Weill Cornell Med Coll, Dept Physiol & Biophys, New York, NY USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cornell University	Mendias, CL (corresponding author), Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA.	mendiasc@hss.edu	Mendias, Christopher/C-5557-2018	Mendias, Christopher/0000-0002-2384-0171	U.S. National Institutes of Health (NIH) [R01-AR063649, F32-AR067086]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063649, F32AR067086] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors acknowledge technical contributions from Dr. David Oliver (Hospital for Special Surgery) and Dr. James Markworth (University of Michigan). The ScxCreERT2 mice were kindly provided by Dr. Ronen Schweitzer (Shriners Hospital for Children, Portland, OR, USA). This work was supported by U.S. National Institutes of Health (NIH) Grants R01-AR063649 and F32-AR067086. The authors declare no conflicts of interest.	Andreozzi F, 2004, CIRC RES, V94, P1211, DOI 10.1161/01.RES.0000126501.34994.96; Arndt S., 2019, J INVEST DERMATOL; Bahrami Shahram, 2016, Advances in Biological Regulation, V62, P37, DOI 10.1016/j.jbior.2016.05.001; Boros J, 2009, GENOME RES, V19, P1963, DOI 10.1101/gr.093047.109; Cook SJ, 1999, MOL CELL BIOL, V19, P330; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Couppe C, 2008, J APPL PHYSIOL, V105, P805, DOI 10.1152/japplphysiol.90361.2008; Dahlgren LA, 2002, J ORTHOP RES, V20, P910, DOI 10.1016/S0736-0266(02)00009-8; DeFea K, 1997, J BIOL CHEM, V272, P31400, DOI 10.1074/jbc.272.50.31400; Dietrich P, 2000, MAMM GENOME, V11, P196, DOI 10.1007/s003350010037; Doessing S, 2010, EUR J ENDOCRINOL, V163, P853, DOI 10.1530/EJE-10-0818; Ebi H, 2013, P NATL ACAD SCI USA, V110, P21124, DOI 10.1073/pnas.1314124110; Gehmert S, 2008, BIOCHEM BIOPH RES CO, V371, P752, DOI 10.1016/j.bbrc.2008.04.151; Geremia JM, 2018, EUR J APPL PHYSIOL, V118, P1725, DOI 10.1007/s00421-018-3904-1; Goodman CA, 2013, EXERC SPORT SCI REV, V41, P107, DOI 10.1097/JES.0b013e3182798a95; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Gumucio JP, 2019, FASEB J, V33, P7863, DOI 10.1096/fj.201802457RR; Gumucio JP, 2015, EXERC SPORT SCI REV, V43, P93, DOI 10.1249/JES.0000000000000041; Gumucio JP, 2014, J APPL PHYSIOL, V117, P1287, DOI 10.1152/japplphysiol.00720.2014; Gumucio JP, 2013, ENDOCRINE, V43, P12, DOI 10.1007/s12020-012-9751-7; Hamilton DL, 2014, AM J PHYSIOL-ENDOC M, V307, pE365, DOI 10.1152/ajpendo.00674.2013; Hansen M, 2013, SCAND J MED SCI SPOR, V23, P614, DOI 10.1111/j.1600-0838.2011.01431.x; Havis E, 2016, DEVELOPMENT, V143, P3839, DOI 10.1242/dev.136242; Heinemeier KM, 2012, SCAND J MED SCI SPOR, V22, pE1, DOI 10.1111/j.1600-0838.2012.01459.x; Herchenhan A, 2015, GROWTH HORM IGF RES, V25, P13, DOI 10.1016/j.ghir.2014.09.001; Howell K, 2017, SCI REP-UK, V7, DOI 10.1038/srep45238; Hudgens JL, 2016, AM J SPORT MED, V44, P1931, DOI 10.1177/0363546516637176; Huisman E, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-386; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kersten C, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-9; Kongsgaard M, 2009, SCAND J MED SCI SPOR, V19, P790, DOI 10.1111/j.1600-0838.2009.00949.x; Kongsgaard M, 2010, AM J SPORT MED, V38, P749, DOI 10.1177/0363546509350915; Lee CH, 2015, J CLIN INVEST, V125, P2690, DOI [10.1172/JCI84508, 10.1172/JCI81589]; Lejard V, 2011, J BIOL CHEM, V286, P5855, DOI 10.1074/jbc.M110.153106; Lelbach A., 2005, ACTA PHYSIOLOGICA HUNGARICA, V92, P97, DOI 10.1556/APhysiol.92.2005.2.1; Liao JF, 1997, J BIOL CHEM, V272, P25951, DOI 10.1074/jbc.272.41.25951; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Mead Matthew P, 2018, Transl Sports Med, V1, P5, DOI 10.1002/tsm2.6; Mendias CL, 2012, J APPL PHYSIOL, V113, P56, DOI 10.1152/japplphysiol.00301.2012; Millar NL, 2017, NAT REV RHEUMATOL, V13, P110, DOI 10.1038/nrrheum.2016.213; Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Nielsen RH, 2014, J APPL PHYSIOL, V117, P694, DOI 10.1152/japplphysiol.00157.2014; Nielsen RH, 2014, J APPL PHYSIOL, V116, P42, DOI 10.1152/japplphysiol.01084.2013; Olesen JL, 2006, J APPL PHYSIOL, V101, P183, DOI 10.1152/japplphysiol.00636.2005; Paxton JZ, 2012, TISSUE ENG PT A, V18, P277, DOI [10.1089/ten.tea.2011.0336, 10.1089/ten.TEA.2011.0336]; Pickard A, 2019, FASEB J, V33, P7479, DOI 10.1096/fj.201802366RR; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rutledge RG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009731; Schwartz AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120044; Scott A, 2005, J ORTHOP RES, V23, P1219, DOI 10.1016/j.orthres.2004.12.011; Scott A, 2007, ARTHRITIS RHEUM-US, V56, P871, DOI 10.1002/art.22426; Spindler KP, 1996, J ORTHOP RES, V14, P542, DOI 10.1002/jor.1100140407; Stefanovic B, 2013, WIRES RNA, V4, P535, DOI 10.1002/wrna.1177; Strutz F, 2001, KIDNEY INT, V59, P579, DOI 10.1046/j.1523-1755.2001.059002579.x; Sugg KB, 2018, AM J PHYSIOL-CELL PH, V314, pC389, DOI 10.1152/ajpcell.00258.2017; Sugg KB, 2017, FEBS LETT, V591, P801, DOI 10.1002/1873-3468.12571; Svensson RB, 2016, J APPL PHYSIOL, V121, DOI 10.1152/japplphysiol.00328.2016; Tahimic CGT, 2016, J BIOL CHEM, V291, P8140, DOI 10.1074/jbc.M115.693598; Tahimic Candice G T, 2013, Front Endocrinol (Lausanne), V4, P6, DOI 10.3389/fendo.2013.00006; Tan Q, 2013, STEM CELLS DEV, V22, P3128, DOI 10.1089/scd.2013.0073; Thomopoulos S, 2009, J ORTHOP RES, V27, P1209, DOI 10.1002/jor.20875; Vassilakos G, 2019, FASEB J, V33, P181, DOI 10.1096/fj.201800459R; Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011; Yakar S, 2010, J BONE MINER RES, V25, P2267, DOI 10.1002/jbmr.234; Yeung CYC, 2019, CURR TOP DEV BIOL, V133, P309, DOI 10.1016/bs.ctdb.2018.11.004	66	17	17	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12680	12695		10.1096/fj.201901503R	http://dx.doi.org/10.1096/fj.201901503R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31536390	Bronze, Green Published, Green Submitted			2022-12-26	WOS:000507461600084
J	van Senten, JR; Bebelman, MP; Fan, TS; Heukers, R; Bergkamp, ND; van Gasselt, P; Langemeijer, EV; Slinger, E; Lagerweij, T; Rahbar, A; Stigter-van Walsum, M; Maussang, D; Leurs, R; Musters, RJP; van Dongen, GAMS; Soderberg-Naucler, C; Wurdinger, T; Siderius, M; Smit, MJ				van Senten, Jeffrey R.; Bebelman, Maarten P.; Tian Shu Fan; Heukers, Raimond; Bergkamp, Nick D.; van Gasselt, Puck; Langemeijer, Ellen V.; Slinger, Erik; Lagerweij, Tonny; Rahbar, Afsar; Stigter-van Walsum, Marijke; Maussang, David; Leurs, Rob; Musters, Rene J. P.; van Dongen, Guus A. M. S.; Soderberg-Naucler, Cecilia; Wurdinger, Thomas; Siderius, Marco; Smit, Martine J.			The human cytomegalovirus-encoded G protein?coupled receptor UL33 exhibits oncomodulatory properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); cell signaling; oncogene; herpesvirus; glioblastoma; constitutive signaling; human cytomegalovirus (HCMV); UL33	EPSTEIN-BARR-VIRUS; COUPLED RECEPTOR; NUCLEIC-ACIDS; G-PROTEINS; US28; HOMOLOG; GLIOBLASTOMA; PROMOTES; CELLS; EXPRESSION	Herpesviruses can rewire cellular signaling in host cells by expressing viral G protein?coupled receptors (GPCRs). These viral receptors exhibit homology to human chemokine receptors, but some display constitutive activity and promiscuous G protein coupling. Human cytomegalovirus (HCMV) has been detected in multiple cancers, including glioblastoma, and its genome encodes four GPCRs. One of these receptors, US28, is expressed in glioblastoma and possesses constitutive activity and oncomodulatory properties. UL33, another HCMV-encoded GPCR, also displays constitutive signaling via G?(q), G?(i), and G?(s) proteins. However, little is known about the nature and functional effects of UL33-driven signaling. Here, we assessed UL33's signaling repertoire and oncomodulatory potential. UL33 activated multiple proliferative, angiogenic, and inflammatory signaling pathways in HEK293T and U251 glioblastoma cells. Notably, upon infection, UL33 contributed to HCMV-mediated STAT3 activation. Moreover, UL33 increased spheroid growth in vitro and accelerated tumor growth in different in vivo tumor models, including an orthotopic glioblastoma xenograft model. UL33-mediated signaling was similar to that stimulated by US28; however, UL33-induced tumor growth was delayed. Additionally, the spatiotemporal expression of the two receptors only partially overlapped in HCMV-infected glioblastoma cells. In conclusion, our results unveil that UL33 has broad signaling capacity and provide mechanistic insight into its functional effects. UL33, like US28, exhibits oncomodulatory properties, elicited via constitutive activation of multiple signaling pathways. UL33 and US28 might contribute to HCMV's oncomodulatory effects through complementing and converging cellular signaling, and hence UL33 may represent a promising drug target in HCMV-associated malignancies.	[van Senten, Jeffrey R.; Bebelman, Maarten P.; Tian Shu Fan; Heukers, Raimond; Bergkamp, Nick D.; van Gasselt, Puck; Langemeijer, Ellen V.; Slinger, Erik; Maussang, David; Leurs, Rob; Siderius, Marco; Smit, Martine J.] Vrije Univ, Div Med Chem, Fac Sci, AIMMS, De Boelelaan 1108, NL-1081 HZ Amsterdam, Netherlands; [Lagerweij, Tonny; Wurdinger, Thomas] Vrije Univ Amsterdam, Med Ctr, Canc Ctr Amsterdam, Neurooncol Res Grp, NL-1081 HV Amsterdam, Netherlands; [Rahbar, Afsar; Soderberg-Naucler, Cecilia] Karolinska Inst, Ctr Mol Med, Dept Med Solna, Microbial Pathogenesis Res Unit, S-17177 Stockholm, Sweden; [Rahbar, Afsar; Soderberg-Naucler, Cecilia] Karolinska Inst, Ctr Mol Med, Dept Neurol, S-17177 Stockholm, Sweden; [Stigter-van Walsum, Marijke] Vrije Univ Amsterdam, Med Ctr, Dept Otolaryngol Head & Neck Surg, NL-1081 HV Amsterdam, Netherlands; [Musters, Rene J. P.] Vrije Univ Amsterdam, Med Ctr, Dept Physiol, NL-1081 HV Amsterdam, Netherlands; [van Dongen, Guus A. M. S.] Vrije Univ Amsterdam, Med Ctr, Dept Radiol & Nucl Med, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Karolinska Institutet; Karolinska Institutet; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Smit, MJ (corresponding author), Vrije Univ, Div Med Chem, Fac Sci, AIMMS, De Boelelaan 1108, NL-1081 HZ Amsterdam, Netherlands.	mj.smit@vu.nl	Lagerweij, Tonny/AAY-7128-2020; Leurs, Rob/AAC-8508-2022; van Senten, Jeffrey/AAH-4348-2021; Wurdinger, Thomas/AAA-5645-2022; Leurs, Rob/ABB-4299-2021; Heukers, Raimond/H-9403-2013	Leurs, Rob/0000-0003-1354-2848; Langemeijer, E.V./0000-0002-3222-7328; van Dongen, Guus/0000-0001-5939-9851; Heukers, Raimond/0000-0003-4498-7751; Rahbar, Afsar/0000-0003-1158-2512; Bergkamp, Nick/0000-0001-5692-5975; Bebelman, Maarten/0000-0003-4007-5093; Smit, Martine/0000-0003-2713-0238; van Senten, Jeffrey Roy/0000-0002-1096-6891	Netherlands Organization for Scientific Research (NWO) [Vici 016.140.657, Vidi 700.54.425]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Organization for Scientific Research (NWO) Grants Vici 016.140.657 and Vidi 700.54.425 (to M. J. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Bais C, 1998, NATURE, V391, P86, DOI 10.1038/34193; Baryawno N, 2011, J CLIN INVEST, V121, P4043, DOI 10.1172/JCI57147; Bate SL, 2010, CLIN INFECT DIS, V50, P1439, DOI 10.1086/652438; Batich KA, 2017, CLIN CANCER RES, V23, P1898, DOI 10.1158/1078-0432.CCR-16-2057; Beisser PS, 1998, J VIROL, V72, P2352, DOI 10.1128/JVI.72.3.2352-2363.1998; Bongers G, 2010, J CLIN INVEST, V120, P3969, DOI 10.1172/JCI42563; Brouchet L, 2005, BRIT J CANCER, V92, P743, DOI 10.1038/sj.bjc.6602409; Cardin RD, 2009, J VIROL, V83, P7590, DOI 10.1128/JVI.00386-09; Casarosa P, 2003, J BIOL CHEM, V278, P50010, DOI 10.1074/jbc.M306530200; Case R, 2008, J VIROL, V82, P1884, DOI 10.1128/JVI.02550-06; CHEE MS, 1990, NATURE, V344, P774, DOI 10.1038/344774a0; Cheng S, 2017, P NATL ACAD SCI USA, V114, pE10586, DOI 10.1073/pnas.1710522114; Cobbs C, 2014, NEURO-ONCOLOGY, V16, P1435, DOI 10.1093/neuonc/nou295; Cobbs CS, 2002, CANCER RES, V62, P3347; Cox B, 2010, BRIT J CANCER, V102, P1665, DOI 10.1038/sj.bjc.6605675; de Wit RH, 2016, ONCOTARGET, V7, P67966, DOI 10.18632/oncotarget.11817; Dziurzynski K, 2012, NEURO-ONCOLOGY, V14, P246, DOI 10.1093/neuonc/nor227; Farrell HE, 2017, MBIO, V8, DOI 10.1128/mBio.01264-17; Farrell HE, 2013, J VIROL, V87, P4112, DOI 10.1128/JVI.03406-12; Farrell HE, 2011, J VIROL, V85, P6091, DOI 10.1128/JVI.02113-10; Fornara O, 2016, CELL DEATH DIFFER, V23, P261, DOI 10.1038/cdd.2015.91; Fraile-Ramos A, 2002, TRAFFIC, V3, P218, DOI 10.1034/j.1600-0854.2002.030307.x; Fraile-Ramos A, 2001, MOL BIOL CELL, V12, P1737, DOI 10.1091/mbc.12.6.1737; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; Griffiths P, 2015, J PATHOL, V235, P288, DOI 10.1002/path.4437; Gruijthuijsen YK, 2002, J VIROL, V76, P1328, DOI 10.1128/JVI.76.3.1328-1338.2002; Harkins L, 2002, LANCET, V360, P1557, DOI 10.1016/S0140-6736(02)11524-8; Heukers R, 2018, ONCOGENE, V37, P4110, DOI 10.1038/s41388-018-0255-7; Humby MS, 2016, J VIROL, V90, P2959, DOI 10.1128/JVI.02507-15; Krishna BA, 2017, MBIO, V8, DOI 10.1128/mBio.01754-17; Langemeijer EV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048935; Liu C, 2011, CLIN EXP MED, V11, P105, DOI 10.1007/s10238-010-0110-9; Lyngaa R, 2010, ONCOGENE, V29, P4388, DOI 10.1038/onc.2010.173; Margulies BJ, 2007, VIRUS RES, V123, P57, DOI 10.1016/j.virusres.2006.08.003; Margulies BJ, 1996, VIROLOGY, V225, P111, DOI 10.1006/viro.1996.0579; Martin JN, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P960; Maussang D, 2006, P NATL ACAD SCI USA, V103, P13068, DOI 10.1073/pnas.0604433103; Maussang D, 2009, CANCER RES, V69, P2861, DOI 10.1158/0008-5472.CAN-08-2487; Michaelis M, 2009, NEOPLASIA, V11, P1, DOI 10.1593/neo.81178; Mitchell DA, 2015, NATURE, V519, P366, DOI 10.1038/nature14320; Moepps B, 2008, CELL SIGNAL, V20, P1528, DOI 10.1016/j.cellsig.2008.04.010; O'Connor CM, 2012, J VIROL, V86, P11425, DOI 10.1128/JVI.05900-11; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Penfold MET, 2003, J VIROL, V77, P10404, DOI 10.1128/JVI.77.19.10404-10413.2003; Peng CW, 2016, MOL CLIN ONCOL, V4, P154, DOI 10.3892/mco.2015.692; Pu P, 2009, CANCER GENE THER, V16, P351, DOI 10.1038/cgt.2008.78; Pulvirenti T, 2011, CANCER RES, V71, P7280, DOI 10.1158/0008-5472.CAN-11-1531; Randolph-Habecker J, 2002, CYTOKINE, V19, P37, DOI 10.1006/cyto.2002.0874; Samanta M, 2003, J UROLOGY, V170, P998, DOI 10.1097/01.ju.0000080263.46164.97; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schlaeger EJ, 1999, CYTOTECHNOLOGY, V30, P71, DOI 10.1023/A:1008000327766; Seo JY, 2006, J VIROL, V80, P5611, DOI 10.1128/JVI.02630-05; Slinger E, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001180; Soroceanu L, 2011, CANCER RES, V71, P6643, DOI 10.1158/0008-5472.CAN-11-0744; Stanton RJ, 2010, J CLIN INVEST, V120, P3191, DOI 10.1172/JCI42955; Stragliotto G, 2013, INT J CANCER, V133, P1204, DOI 10.1002/ijc.28111; Taha MS, 2016, BRIT J NEUROSURG, V30, P307, DOI 10.3109/02688697.2015.1119241; Thompson MP, 2004, CLIN CANCER RES, V10, P803, DOI 10.1158/1078-0432.CCR-0670-3; Tschische P, 2011, BIOCHEM PHARMACOL, V82, P610, DOI 10.1016/j.bcp.2011.06.009; van Rijn S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01046; Varnum SM, 2004, J VIROL, V78, P10960, DOI 10.1128/JVI.78.20.10960-10966.2004; Vischer HF, 2014, NAT REV DRUG DISCOV, V13, P123, DOI 10.1038/nrd4189; Vomaske J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000304; Wakefield A, 2015, J NEURO-ONCOL, V125, P307, DOI 10.1007/s11060-015-1905-z; Waldhoer M, 2002, J VIROL, V76, P8161, DOI 10.1128/JVI.76.16.8161-8168.2002; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035	66	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					16297	16308		10.1074/jbc.RA119.007796	http://dx.doi.org/10.1074/jbc.RA119.007796			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31519750	Green Published, hybrid			2022-12-26	WOS:000499478600034
J	Vaca, RA; Golicher, DJ; Rodiles-Hernandez, R; Castillo-Santiago, MA; Bejarano, M; Navarrete-Gutierrez, DA				Abel Vaca, Raul; Golicher, Duncan John; Rodiles-Hernandez, Rocio; Angel Castillo-Santiago, Miguel; Bejarano, Marylin; Alejandro Navarrete-Gutierrez, Dario			Drivers of deforestation in the basin of the Usumacinta River: Inference on process from pattern analysis using generalised additive models	PLOS ONE			English	Article							LAND-COVER CHANGE; DRIVING FORCES; FIRE; FOREST; MEXICO; CONSERVATION; INFORMATION; POPULATION; ECOLOGY; SCIENCE	Quantifying patterns of deforestation and linking these patterns to potentially influencing variables is a key component of modelling and projecting land use change. Statistical methods based on null hypothesis testing are only partially successful for interpreting deforestation in the context of the processes that have led to their formation. Simplifications of cause-consequence relationships that are difficult to support empirically may influence environment and development policies because they suggest simple solutions to complex problems. Deforestation is a complex process driven by multiple proximate and underlying factors and a range of scales. In this study we use a multivariate statistical analysis to provide contextual explanation for deforestation in the Usumacinta River Basin based on partial pattern matching. Our approach avoided testing trivial null hypotheses of lack of association and investigated the strength and form of the response to drivers. As not all factors involved in deforestation are easily mapped as GIS layers, analytical challenges arise due to lack of a one to one correspondence between mappable attributes and drivers. We avoided testing simple statistical hypotheses such as the detectability of a significant linear relationship between deforestation and proximity to roads or water. We developed a series of informative generalised additive models based on combinations of layers that corresponded to hypotheses regarding processes. The importance of the variables representing accessibility was emphasised by the analysis. We provide evidence that land tenure is a critical factor in shaping the decision to deforest and that direct beam insolation has an effect associated with fire frequency and intensity. The effect of winter insolation was found to have many applied implications for land management. The methodology was useful for interpreting the relative importance of sets of variables representing drivers of deforestation. It was an informative approach, thus allowing the construction of a comprehensive understanding of its causes.	[Abel Vaca, Raul; Rodiles-Hernandez, Rocio] Colegio San Luis COLSAN, CONACYT Consorcio Invest Innovac & Desarrollo Zon, Fraccionamiento Colinas Parque, San Luis Potosi, San Luis Potosi, Mexico; [Golicher, Duncan John] Bournemouth Univ, Dept Life & Environm Sci, Poole, Dorset, England; [Angel Castillo-Santiago, Miguel; Alejandro Navarrete-Gutierrez, Dario] Colegio Frontera Sur, Lab Anal Informac Geograf & Estadist, San Cristobal de las Casa, Chiapas, Mexico; [Bejarano, Marylin] Pronat Sur AC, San Cristobal de las Casa, Chiapas, Mexico	Bournemouth University; El Colegio de la Frontera Sur (ECOSUR)	Vaca, RA (corresponding author), Colegio San Luis COLSAN, CONACYT Consorcio Invest Innovac & Desarrollo Zon, Fraccionamiento Colinas Parque, San Luis Potosi, San Luis Potosi, Mexico.	raul.vaca@colsan.edu.mx	Vaca, Raúl/AAF-9324-2020; Castillo-Santiago, Miguel A/B-8371-2014	Vaca, Raúl/0000-0003-0500-1291; Castillo-Santiago, Miguel A/0000-0002-3024-5514; Rodiles-Hernandez, Rocio/0000-0003-0355-5477	Comision Federal de Electricidad (CFE; Federal Electricity Commission); Consejo Nacional de Ciencia y Tecnologia (CONACYT; National Council on Science and Technology) [265570]; UK Space Agency & Ecometrica Ltd through Forests 2020 project	Comision Federal de Electricidad (CFE; Federal Electricity Commission); Consejo Nacional de Ciencia y Tecnologia (CONACYT; National Council on Science and Technology)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UK Space Agency & Ecometrica Ltd through Forests 2020 project	This work was supported by the Comision Federal de Electricidad (CFE; Federal Electricity Commission) (https://www.cfe.mx/Pages/Index.aspx) to RRH; the Consejo Nacional de Ciencia y Tecnologia (CONACYT; National Council on Science and Technology) for grant number 265570 (https://www.conacyt.gob.mx/) to RRH and the he UK Space Agency & Ecometrica Ltd through Forests 2020 project (https://ecometrica.com/space/forests2020) to MACS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix-Garcia J, 2005, WORLD DEV, V33, P219, DOI 10.1016/j.worlddev.2004.07.010; Alvarado E, 2008, ESTUD FRONT, V9, P73; Anderson DR, 2000, J WILDLIFE MANAGE, V64, P912, DOI 10.2307/3803199; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Barbier E.B., 1996, ENVIRON DEV ECON, V1, P203, DOI DOI 10.1017/S1355770X00000590; Beale CM, 2007, ECOGRAPHY, V30, P845, DOI 10.1111/j.2007.0906-7590.05338.x; Brotons L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062392; Burnham KP, 2001, WILDLIFE RES, V28, P111, DOI 10.1071/WR99107; Capdepont-Ballina JL, 2014, ESTUDIOS SOCIALES Y, V12, P144; Challenger A, 1998, UTILIZACION CONSERVA; Cherry S, 1998, WILDLIFE SOC B, V26, P947; Chowdhury RR, 2006, APPL GEOGR, V26, P129, DOI 10.1016/j.apgeog.2005.11.004; Cochrane MA, 2003, NATURE, V421, P913, DOI 10.1038/nature01437; Cochrane MA, 2001, CONSERV BIOL, V15, P1515, DOI 10.1046/j.1523-1739.2001.01091.x; Curtin CG, 2002, CONSERV BIOL, V16, P840, DOI 10.1046/j.1523-1739.2002.01212.x; DeFries R, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0173; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Ellis EA, 2017, LAND USE POLICY, V69, P474, DOI 10.1016/j.landusepol.2017.09.048; Fletes Ocón Héctor B., 2013, Región y sociedad, V25, P203; Flores-Santiago A., 1986, REV GEOGRAFIA AGRICO, V13-14, P104; Gandin J, 2012, APCBEE PROC, V1, P239, DOI 10.1016/j.apcbee.2012.03.039; Garcia-Barrios L, 2009, BIOSCIENCE, V59, P863, DOI 10.1525/bio.2009.59.10.8; Geist H, 2003, INT FOR REV, V5, P64, DOI 10.1505/IFOR.5.1.64.17426; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Geist HJ, 2001, LUCC REP SER, P136; Pignataro AG, 2016, J ENVIRON MANAGE, V181, P363, DOI 10.1016/j.jenvman.2016.06.036; Geoghegan J., 2004, GeoJournal, V61, P353, DOI 10.1007/s10708-004-5052-x; GRASS Development Team, 2017, GEOGR RES AN SUPP SY; Guerra Martínez Verónica, 2006, Invest. Geog, P7; Hamann R, 1996, ROUNDT M HELD UNPUB; Holland MB, 2014, WORLD DEV, V55, P21, DOI 10.1016/j.worlddev.2013.01.012; Hosonuma N, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044009; Hudson PH., 2005, RIVERS N AM, V1, P1031, DOI DOI 10.1016/B978-012088253-3/50026-2; Isaac-Marquez R., 2005, UNIV CIENC, V21, P56; Isaac-Márquez Ricardo, 2008, Región y sociedad, V20, P97; Johnson DH, 1999, J WILDLIFE MANAGE, V63, P763, DOI 10.2307/3802789; Lambin EF, 2001, GLOBAL ENVIRON CHANG, V11, P261, DOI 10.1016/S0959-3780(01)00007-3; Lambin EF, 2003, ANNU REV ENV RESOUR, V28, P205, DOI 10.1146/annurev.energy.28.050302.105459; Laurance WF, 2002, J BIOGEOGR, V29, P737, DOI 10.1046/j.1365-2699.2002.00721.x; March Mifsut I.y., 2010, CUENCAS HIDROGR FICA, P193; Mather AS, 2000, GEOGR J, V166, P2, DOI 10.1111/j.1475-4959.2000.tb00002.x; Mena CF, 2006, ENVIRON MANAGE, V37, P802, DOI 10.1007/s00267-003-0230-z; Mendoza E, 1999, BIODIVERS CONSERV, V8, P1621, DOI 10.1023/A:1008916304504; Nahed-Toral J, 2013, J CLEAN PROD, V43, P136, DOI 10.1016/j.jclepro.2012.12.019; Nester MR, 1996, J R STAT SOC C-APPL, V45, P401; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Pechony O, 2010, P NATL ACAD SCI USA, V107, P19167, DOI 10.1073/pnas.1003669107; R Core Team, 2018, R LANG ENV STAT COMP; Ramirez-Delgado JP, 2014, GEOCARTO INT, V6049, P1; Ressl R, 2009, REMOTE SENS ENVIRON, V113, P1113, DOI 10.1016/j.rse.2008.10.016; Diaz-Gallegos JR, 2010, SINGAPORE J TROP GEO, V31, P180, DOI 10.1111/j.1467-9493.2010.00396.x; Trejo DAR, 2008, AMBIO, V37, P548, DOI 10.1579/0044-7447-37.7.548; Roman-Cuesta RM, 2006, CONSERV BIOL, V20, P1074, DOI 10.1111/j.1523-1739.2006.00478.x; Rudel TK, 2009, CONSERV BIOL, V23, P1396, DOI 10.1111/j.1523-1739.2009.01332.x; Rzedowski J., 1978, VEGETACION MEXICO; Sanchez-Munguia A., 2005, USO SUELO AGROPECUAR; Sanfiorenzo-Barnhard C, 2009, MT RES DEV, V29, P320, DOI 10.1659/mrd.00013; SENFT RL, 1983, J RANGE MANAGE, V36, P553, DOI 10.2307/3898338; Stephens PA, 2005, J APPL ECOL, V42, P4, DOI 10.1111/j.1365-2664.2005.01002.x; Swart RJ, 2004, GLOBAL ENVIRON CHANG, V14, P137, DOI 10.1016/j.gloenvcha.2003.10.002; Therneau TM, 2009, RPART RECURSIVE PART; Trejo I, 2000, BIOL CONSERV, V94, P133, DOI 10.1016/S0006-3207(99)00188-3; Turner M.G., 2001, LANDSCAPE ECOLOGY TH; Vaca RA, 2019, J ENVIRON MANAGE, V230, P392, DOI 10.1016/j.jenvman.2018.09.055; Vaca RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042309; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Wyman MS, 2010, APPL GEOGR, V30, P329, DOI 10.1016/j.apgeog.2009.10.001	67	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222908	10.1371/journal.pone.0222908	http://dx.doi.org/10.1371/journal.pone.0222908			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5WE	31553749	Green Published, gold, Green Accepted			2022-12-26	WOS:000532319200042
J	Armstrong, C; Cassimeris, L; Santos, CD; Micoogullari, Y; Wagner, B; Babasyan, S; Brooks, S; Galantino-Homer, H				Armstrong, Caitlin; Cassimeris, Lynne; Santos, Claire Da Silva; Micoogullari, Yagmur; Wagner, Bettina; Babasyan, Susanna; Brooks, Samantha; Galantino-Homer, Hannah			The expression of equine keratins K42 and K124 is restricted to the hoof epidermal lamellae of Equus caballus	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; GENE CLUSTERS; PROTEINS; NAIL; CELL; MARKERS; DIFFERENTIATION; ORGANIZATION; MODULATORS; BIOMARKERS	The equine hoof inner epithelium is folded into primary and secondary epidermal lamellae which increase the dermo-epidermal junction surface area of the hoof and can be affected by laminitis, a common disease of equids. Two keratin proteins (K), K42 and K124, are the most abundant keratins in the hoof lamellar tissue of Equus caballus. We hypothesize that these keratins are lamellar tissue-specific and could serve as differentiation- and disease-specific markers. Our objective was to characterize the expression of K42 and K124 in equine stratified epithelia and to generate monoclonal antibodies against K42 and K124. By RT-PCR analysis, keratin gene (KRT) KRT42 and KRT124 expression was present in lamellar tissue, but not cornea, haired skin, or hoof coronet. In situ hybridization studies showed that KRT124 localized to the suprabasal and, to a lesser extent, basal cells of the lamellae, was absent from haired skin and hoof coronet, and abruptly transitions from KRT124-negative coronet to KRT124-positive proximal lamellae. A monoclonal antibody generated against full-length recombinant equine K42 detected a lamellar keratin of the appropriate size, but also cross-reacted with other epidermal keratins. Three monoclonal antibodies generated against N- and C-terminal K124 peptides detected a band of the appropriate size in lamellar tissue and did not cross-react with proteins from haired skin, corneal limbus, hoof coronet, tongue, glabrous skin, oral mucosa, or chestnut on immunoblots. K124 localized to lamellar cells by indirect immunofluorescence. This is the first study to demonstrate the localization and expression of a hoof lamellar-specific keratin, K124, and to validate anti-K124 monoclonal antibodies.	[Armstrong, Caitlin; Galantino-Homer, Hannah] Univ Penn, New Bolton Ctr, Sch Vet Med, Dept Clin Studies, Kennett Sq, PA 19348 USA; [Cassimeris, Lynne; Santos, Claire Da Silva; Micoogullari, Yagmur] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA; [Wagner, Bettina; Babasyan, Susanna] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Brooks, Samantha] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA; [Brooks, Samantha] Univ Florida, Genet Inst, Gainesville, FL USA; [Micoogullari, Yagmur] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Micoogullari, Yagmur] Harvard Med Sch, Boston, MA 02115 USA	University of Pennsylvania; Lehigh University; Cornell University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Galantino-Homer, H (corresponding author), Univ Penn, New Bolton Ctr, Sch Vet Med, Dept Clin Studies, Kennett Sq, PA 19348 USA.	hghomer@vet.upenn.edu	Brooks, Samantha/ABD-5279-2020	Brooks, Samantha/0000-0002-4500-2689; Wagner, Bettina/0000-0003-2370-6324; Galantino-Homer, Hannah/0000-0002-1435-100X	Lehigh University; Laminitis Research Fund; Raymond Firestone Trust; Tamworth Trust; Animal Health Foundation; American Association of Equine Practitioners Foundation; Grayson-Jockey Club Research Foundation; Bernice Barbour Foundation, Inc. [0048.412012]	Lehigh University; Laminitis Research Fund; Raymond Firestone Trust; Tamworth Trust; Animal Health Foundation; American Association of Equine Practitioners Foundation; Grayson-Jockey Club Research Foundation; Bernice Barbour Foundation, Inc.	This study was supported by: A Faculty Incentive Grant from Lehigh University to LC (https://research.cc.lehigh.edu/finding-funding), Grants from the Laminitis Research Fund to HGH, Raymond Firestone Trust to CA, HGH, and Tamworth Trust to HGH (University of Pennsylvania, School of Veterinary Medicine, https://www.vet.upenn.edu/giving/how-to-support-penn-vet); a grant from the Animal Health Foundation to HGH, (http://www.ahf-laminitis.org/), a grant from the American Association of Equine Practitioners Foundation to HGH (https://foundation.aaep.org/), and a grant from the Grayson-Jockey Club Research Foundation to HGH and BW https://www.grayson-jockeyclub.org/default.asp?section=2&area=Research&menu=2). Tissue bank samples were funded by a grant from the Bernice Barbour Foundation, Inc. to HGH (https://bernicebarbour.org/, #0048.412012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmer P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180359; Bragulla H, 2003, J EXP ZOOL PART B, V298B, P140, DOI 10.1002/jez.b.00031; Bragulla HH, 2009, J ANAT, V214, P516, DOI 10.1111/j.1469-7580.2009.01066.x; Carter RA, 2011, EQUINE VET J, V43, P543, DOI 10.1111/j.2042-3306.2010.00325.x; Carter RA, 2010, J ANIM SCI, V88, P3843, DOI 10.2527/jas.2010-2964; Cassimeris L, 2019, BMC VET RES, V15, DOI 10.1186/s12917-018-1748-x; Clark RK, 2014, EXP DERMATOL, V23, P677, DOI 10.1111/exd.12495; Collins SN, 2010, VET CLIN N AM-EQUINE, V26, P179, DOI 10.1016/j.cveq.2010.01.004; Daradka M, 2004, EQUINE VET J, V36, P236, DOI 10.2746/0425164044877198; Davies HMS, 2007, EQUINE PODIATRY, P42; de Berker D, 2000, BRIT J DERMATOL, V142, P89, DOI 10.1046/j.1365-2133.2000.03246.x; Ehrlich F, 2018, MOL BIOL EVOL; Engiles JB, 2015, VET PATHOL, V52, P928, DOI 10.1177/0300985815588604; Faleiros RR, 2009, J VET INTERN MED, V23, P174, DOI 10.1111/j.1939-1676.2008.0241.x; Fleckman P, 2013, ANAT REC, V296, P521, DOI 10.1002/ar.22660; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; GALANTINOHOMER H, 2010, J EQUINE VET SCI, V30, P101, DOI DOI 10.1016/j.jevs.2010.01.016; GROSENBAUGH DA, 1992, AM J VET RES, V53, P1859; Hesse M, 2004, EUR J CELL BIOL, V83, P19, DOI 10.1078/0171-9335-00354; Homberg M, 2014, INT REV CEL MOL BIO, V311, P265, DOI 10.1016/B978-0-12-800179-0.00007-6; Hood DM, 1999, VET CLIN N AM-EQUINE, V15, P437, DOI 10.1016/S0749-0739(17)30154-2; Jin L, 2014, MED RES REV, V34, P438, DOI 10.1002/med.21291; Karikoski NP, 2014, VET PATHOL; Ku NO, 2016, HEPATOLOGY, V64, P966, DOI 10.1002/hep.28493; Lane EB, 2004, J PATHOL, V204, P355, DOI 10.1002/path.1643; Lee CH, 2009, J CELL BIOL, V186, P409, DOI 10.1083/jcb.200810196; Leise BS, 2015, EQUINE VET J, V47, P478, DOI 10.1111/evj.12283; Liao H, 2007, J DERMATOL SCI, V48, P199, DOI 10.1016/j.jdermsci.2007.07.003; Linardi RL, 2015, VET DERMATOL, V26, P213, DOI 10.1111/vde.12214; Linder S, 2010, EXPERT REV MOL DIAGN, V10, P353, DOI 10.1586/ERM.10.14; Linn SC, 2019, EXP DERMATOL, V28, P383, DOI 10.1111/exd.13759; MacFadden BJ, 1992, FOSSIL HORSES SYSTEM, P229; McGowan KM, 2000, J INVEST DERMATOL, V114, P1101, DOI 10.1046/j.1523-1747.2000.00986.x; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Pollitt CC, 1996, EQUINE VET J, V28, P38, DOI 10.1111/j.2042-3306.1996.tb01588.x; Pollitt CC, 2010, VET CLIN N AM-EQUINE, V26, P29, DOI 10.1016/j.cveq.2010.01.005; Porter RM, 2000, LAB INVEST, V80, P1701, DOI 10.1038/labinvest.3780180; Ramms L, 2013, P NATL ACAD SCI USA, V110, P18513, DOI 10.1073/pnas.1313491110; Roland ES, 2005, J BIOMECH, V38, P2102, DOI 10.1016/j.jbiomech.2004.08.024; Schnabel CL, 2018, VET IMMUNOL IMMUNOP, V204, P28, DOI 10.1016/j.vetimm.2018.09.003; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Strnad P, 2012, CURR OPIN GASTROEN, V28, P209, DOI 10.1097/MOG.0b013e3283525cb8; Tong XM, 2004, J INVEST DERMATOL, V122, P965, DOI 10.1111/j.0022-202X.2004.22422.x; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wagner B, 2003, VET IMMUNOL IMMUNOP, V92, P45, DOI 10.1016/S0165-2427(03)00007-2; Wagner B, 2012, VET IMMUNOL IMMUNOP, V146, P125, DOI 10.1016/j.vetimm.2012.02.007; Wattle O, 2000, ACTA VET SCAND, V41, P363; WATTLE O, 1998, EQUINE VET J S, V26, P66; Wolenski FS, 2013, NAT PROTOC, V8, P900, DOI 10.1038/nprot.2013.014; Wu P, 2015, P NATL ACAD SCI USA, V112, pE6770, DOI 10.1073/pnas.1520566112; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385; Zimek A, 2006, EUR J CELL BIOL, V85, P83, DOI 10.1016/j.ejcb.2005.10.001	53	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0219234	10.1371/journal.pone.0219234	http://dx.doi.org/10.1371/journal.pone.0219234			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550264	Green Published, Green Submitted, gold			2022-12-26	WOS:000532307700002
J	Guevara, M; Vargas, R				Guevara, Mario; Vargas, Rodrigo			Downscaling satellite soil moisture using geomorphometry and machine learning	PLOS ONE			English	Article							PRECIPITATION; PROJECTIONS; VALIDATION; TOPOGRAPHY; FEEDBACKS; PRODUCTS; DYNAMICS; DROUGHT; NETWORK; MODELS	Annual soil moisture estimates are useful to characterize trends in the climate system, in the capacity of soils to retain water and for predicting land and atmosphere interactions. The main source of soil moisture spatial information across large areas (e.g., continents) is satellite-based microwave remote sensing. However, satellite soil moisture datasets have coarse spatial resolution (e.g., 25-50 km grids); and large areas from regional-to-global scales have spatial information gaps. We provide an alternative approach to predict soil moisture spatial patterns (and associated uncertainty) with higher spatial resolution across areas where no information is otherwise available. This approach relies on geomorphometry derived terrain parameters and machine learning models to improve the statistical accuracy and the spatial resolution (from 27km to 1km grids) of satellite soil moisture information across the conterminous United States on an annual basis (1991-2016). We derived 15 primary and secondary terrain parameters from a digital elevation model. We trained a machine learning algorithm (i.e., kernel weighted nearest neighbors) for each year. Terrain parameters were used as predictors and annual satellite soil moisture estimates were used to train the models. The explained variance for all models-years was > 70% (10-fold cross-validation). The 1km soil moisture grids (compared to the original satellite soil moisture estimates) had higher correlations (improving from r(2) = 0.1 to r(2) = 0.46) and lower bias (improving from 0.062 to 0.057 m3/m3) with field soil moisture observations from the North American Soil Moisture Database (n = 668 locations with available data between 19912013; 0-5cm depth). We conclude that the fusion of geomorphometry methods and satellite soil moisture estimates is useful to increase the spatial resolution and accuracy of satellite-derived soil moisture. This approach can be applied to other satellite-derived soil moisture estimates and regions across the world.	[Guevara, Mario; Vargas, Rodrigo] Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19717 USA	University of Delaware	Vargas, R (corresponding author), Univ Delaware, Dept Plant & Soil Sci, Newark, DE 19717 USA.	rvargas@udel.edu	Guevara, Mario/AAH-9539-2019; Vargas, Rodrigo/C-4720-2008	Guevara, Mario/0000-0002-9788-9947; Vargas, Rodrigo/0000-0001-6829-5333	CONACyT [382790]; National Science Foundation CIF21 DIBBs [1724843]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Science Foundation CIF21 DIBBs	MG acknowledges a fellowship from CONACyT (382790). RV acknowledges support from the National Science Foundation CIF21 DIBBs (Grant #1724843).	Afshar MH, 2017, REMOTE SENS ENVIRON, V196, P224, DOI 10.1016/j.rse.2017.05.017; Asner GP, 2010, NEW PHYTOL, V187, P569, DOI 10.1111/j.1469-8137.2010.03310.x; Bauer-Marschallingere B, 2019, IEEE T GEOSCI REMOTE, V57, P520, DOI 10.1109/TGRS.2018.2858004; Becker JJ, 2009, MAR GEOD, V32, P355, DOI 10.1080/01490410903297766; Bindlish R, 2015, IEEE GEOSCI REMOTE S, V12, P923, DOI 10.1109/LGRS.2014.2364151; Borra S, 2010, COMPUT STAT DATA AN, V54, P2976, DOI 10.1016/j.csda.2010.03.004; Brocca L, 2017, WATER-SUI, V9, DOI 10.3390/w9020140; Busch FA, 2012, HYDROL PROCESS, V26, P2696, DOI 10.1002/hyp.8363; Colliander A, 2017, REMOTE SENS ENVIRON, V191, P215, DOI 10.1016/j.rse.2017.01.021; Colliander A, 2017, IEEE GEOSCI REMOTE S, V14, P2107, DOI 10.1109/LGRS.2017.2753203; Conrad O, 2015, GEOSCI MODEL DEV, V8, P1991, DOI 10.5194/gmd-8-1991-2015; Cook BD, 2013, REMOTE SENS-BASEL, V5, P4045, DOI 10.3390/rs5084045; Coopersmith EJ, 2016, ADV WATER RESOUR, V98, P122, DOI 10.1016/j.advwatres.2016.10.007; Dai A. G., 2011, Interdisciplinary Reviews: Climate Change, V2, P45, DOI 10.1002/wcc.81; Diffenbaugh NS, 2015, P NATL ACAD SCI USA, V112, P3931, DOI 10.1073/pnas.1422385112; Dirmeyer PA, 2016, J HYDROMETEOROL, V17, P1049, DOI 10.1175/JHM-D-15-0196.1; Dorigo WA, 2011, HYDROL EARTH SYST SC, V15, P1675, DOI 10.5194/hess-15-1675-2011; Dorigo W, 2017, REMOTE SENS ENVIRON, V203, P185, DOI 10.1016/j.rse.2017.07.001; Dyer J, 2013, J HYDROMETEOROL, V14, P1826, DOI 10.1175/JHM-D-12-0163.1; Easterling DR, 2017, CLIMATE SCI SPECIAL, VI, P207, DOI [DOI 10.7930/J0H993CC, 10.7930/J0H993CC]; Entekhabi D., 2014, SMAP HDB SOIL MOISTU; Entekhabi D, 2010, P IEEE, V98, P704, DOI 10.1109/JPROC.2010.2043918; Florinsky IV, 2012, EURASIAN SOIL SCI+, V45, P445, DOI 10.1134/S1064229312040047; Florinsky IV, 2016, DIGITAL TERRAIN ANALYSIS IN SOIL SCIENCE AND GEOLOGY, 2ND EDITION, P265, DOI 10.1016/B978-0-12-804632-6.00009-2; Greve P, 2018, EARTH SYST DYNAM, V9, P227, DOI 10.5194/esd-9-227-2018; Gruber A, 2013, VADOSE ZONE J, V12, DOI 10.2136/vzj2012.0170; Guevara M., 1970, PROTOCOL DOWNSCALING, DOI [10.17504/protocols.io.6cahase, DOI 10.17504/PROTOCOLS.IO.6CAHASE]; Guevara M, 2018, SOIL-GERMANY, V4, P173, DOI 10.5194/soil-4-173-2018; He LM, 2017, J GEOPHYS RES-BIOGEO, V122, P1549, DOI 10.1002/2016JG003603; Hechenbichler K., 2006, 399 SFB 386; Hechenbichler K., 2004, WEIGHTED K NEAREST N; Hengl T., 2019, PREDICTIVE SOIL MAPP; Hengl T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105992; Heuvelink G.B. M., 1999, CARTOGRAPHICA, V36, P69; Hiemstra PH, 2009, COMPUT GEOSCI-UK, V35, P1711, DOI 10.1016/j.cageo.2008.10.011; Jin Y, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10040579; Kearney MR, 2018, J HYDROL, V561, P662, DOI 10.1016/j.jhydrol.2018.04.040; Lawston PM, 2017, GEOPHYS RES LETT, V44, P11860, DOI 10.1002/2017GL075733; Lindsay JB, 2005, HYDROL PROCESS, V19, P3113, DOI 10.1002/hyp.5835; Liu YY, 2012, REMOTE SENS ENVIRON, V123, P280, DOI 10.1016/j.rse.2012.03.014; Liu YY, 2011, HYDROL EARTH SYST SC, V15, P425, DOI 10.5194/hess-15-425-2011; Luo YQ, 2016, GLOBAL BIOGEOCHEM CY, V30, P40, DOI 10.1002/2015GB005239; Mason DC, 2016, INT J APPL EARTH OBS, V45, P178, DOI 10.1016/j.jag.2015.02.004; McBratney AB, 2003, GEODERMA, V117, P3, DOI 10.1016/S0016-7061(03)00223-4; McColl KA, 2017, NAT GEOSCI, V10, P100, DOI [10.1038/ngeo2868, 10.1038/NGEO2868]; Miralles DG, 2010, J HYDROMETEOROL, V11, P1423, DOI 10.1175/2010JHM1285.1; Molero B, 2016, REMOTE SENS ENVIRON, V180, P361, DOI 10.1016/j.rse.2016.02.045; Montzka C, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10030427; Murguia-Flores F, 2018, GEOSCI MODEL DEV, V11, P2009, DOI 10.5194/gmd-11-2009-2018; Naeimi V, 2012, IEEE T GEOSCI REMOTE, V50, P2566, DOI 10.1109/TGRS.2011.2177667; Naeimi V, 2009, IEEE T GEOSCI REMOTE, V47, P1999, DOI 10.1109/TGRS.2008.2011617; Nelson A, 2009, DEV SOIL SCI, V33, P65, DOI 10.1016/S0166-2481(08)00003-2; Nicolai-Shaw Nadine, 2015, J GEOPHYS RES-ATMOS, V120, P9955, DOI 10.1002/2015JD023305; Oliver MA, 2014, CATENA, V113, P56, DOI 10.1016/j.catena.2013.09.006; Owe M, 1998, WATER RESOUR RES, V34, P2319, DOI 10.1029/98WR01469; Pellenq J, 2003, J HYDROL, V276, P112, DOI 10.1016/S0022-1694(03)00066-0; Pike RJ, 2009, DEV SOIL SCI, V33, P3, DOI 10.1016/S0166-2481(08)00001-9; Piles M, 2011, IEEE T GEOSCI REMOTE, V49, P3156, DOI 10.1109/TGRS.2011.2120615; Planchon O, 2002, CATENA, V46, P159, DOI 10.1016/S0341-8162(01)00164-3; Quiring SM, 2016, B AM METEOROL SOC, V97, P1441, DOI 10.1175/BAMS-D-13-00263.1; R Core Team, 2018, R LANG ENV STAT COMP; Ranney KJ, 2015, ADV WATER RESOUR, V76, P81, DOI 10.1016/j.advwatres.2014.12.003; Reba ML, 2017, J CONTEMP WAT RES ED, V162, P128, DOI 10.1111/j.1936-704X.2017.03264.x; Reichstein M, 2019, NATURE, V566, P195, DOI 10.1038/s41586-019-0912-1; Samaniego L, 2018, NAT CLIM CHANGE, V8, P421, DOI 10.1038/s41558-018-0138-5; Schwingshackl C, 2017, J CLIMATE, V30, P7105, DOI [10.1175/JCLI-D-16-0727.1, 10.1175/jcli-d-16-0727.1]; Seneviratne SI, 2013, GEOPHYS RES LETT, V40, P5212, DOI 10.1002/grl.50956; Seneviratne SI, 2010, EARTH-SCI REV, V99, P125, DOI 10.1016/j.earscirev.2010.02.004; Singh RS, 2015, WATER RESOUR RES, V51, P2648, DOI 10.1002/2014WR015686; Stocker BD, 2018, NEW PHYTOL, V218, P1430, DOI 10.1111/nph.15123; Tadono T., 2014, ISPRS ANN PHOTOGRAMM, V2, P71, DOI 10.5194/isprsannals-II-4-71-2014; Tuanmu MN, 2014, GLOBAL ECOL BIOGEOGR, V23, P1031, DOI 10.1111/geb.12182; Tuttle S, 2016, SCIENCE, V352, P825, DOI 10.1126/science.aaa7185; van der Molen MK, 2011, AGR FOREST METEOROL, V151, P765, DOI 10.1016/j.agrformet.2011.01.018; Vargas R, 2018, SOIL SYST, V2, DOI 10.3390/soilsystems2030047; Vargas R, 2013, ECOSYSTEMS, V16, P749, DOI 10.1007/s10021-013-9648-1; Vilasa L, 2017, J GEOPHYS RES-ATMOS, V122, P4299, DOI 10.1002/2016JD026099; Wagner W, 1999, REMOTE SENS ENVIRON, V70, P191, DOI 10.1016/S0034-4257(99)00036-X; Walsh B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14856; Wang A., 2012, TRANSACTIONS OF THE, V28, P164; Warner DL, 2019, AGR FOREST METEOROL, V264, P80, DOI 10.1016/j.agrformet.2018.09.020; Western AW, 1999, WATER RESOUR RES, V35, P797, DOI 10.1029/1998WR900065; Wilson J.P., 2000, TERRAIN ANAL PRINCIP; Wilson JP, 2012, GEOMORPHOLOGY, V137, P107, DOI 10.1016/j.geomorph.2011.03.012; Yu G., 2008, DOWNSCALING GLOBAL S, DOI [10.1109/IGARSS.2008.4779325, DOI 10.1109/IGARSS.2008.4779325]	85	17	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0219639	10.1371/journal.pone.0219639	http://dx.doi.org/10.1371/journal.pone.0219639			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550248	gold, Green Published, Green Submitted			2022-12-26	WOS:000532307700003
J	Cohen, Y; Rubin, AE; Galperin, M				Cohen, Yigal; Rubin, Avia E.; Galperin, Mariana			Novel synergistic fungicidal mixtures of oxathiapiprolin protect sunflower seeds from downy mildew caused by Plasmopara halstedii	PLOS ONE			English	Article							BENZOTHIADIAZOLE INDUCES RESISTANCE; SYSTEMIC ACQUIRED-RESISTANCE; INFECTION; METALAXYL	Plenaris (oxathiapiprolin) applied to sunflower seedlings was highly effective in controlling downy mildew incited by the oomycete Plasmopara halstedii. In vitro assays revealed strong suppression of zoospore release and cystospore germination of P.halstedii by Plenaris. Bion (acibenzolar-S-methyl) and Apron (mefenoxam) were partially effective when used singly, but performed synergistically when mixed with Plenaris. Seed treatment (coating) with Plenaris provided dose-dependent control of the disease whereas Bion and Apron provided partial or poor control. However, seeds treated with mixtures containing reduced rates of Plenaris and full rates of Bion and/or Apron provided complete control of the disease due to the synergistic interaction between these components. Such mixtures should be used for seed treatment in the field to minimize selection pressure imposed on the pathogen.	[Cohen, Yigal; Rubin, Avia E.; Galperin, Mariana] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel	Bar Ilan University	Cohen, Y (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	ycohen@biu.ac.il		cohen, yigal/0000-0002-4443-1940				Albourie JM, 1998, EUR J PLANT PATHOL, V104, P235, DOI 10.1023/A:1008691123239; Ban R, 2004, DEV PLANT PATHOL, V16, P265; COHEN Y, 1974, CAN J BOT, V52, P231, DOI 10.1139/b74-027; COHEN Y, 1973, CAN J BOT, V51, P15, DOI 10.1139/b73-003; Cohen Y, 2018, PHYTOPARASITICA, V46, P689, DOI 10.1007/s12600-018-0702-6; Cohen Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204523; Cohen Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140015; Gascuel Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148513; Gascuel Q, 2015, MOL PLANT PATHOL, V16, P109, DOI 10.1111/mpp.12164; Gisi U, 1996, ANNU REV PHYTOPATHOL, V34, P549, DOI 10.1146/annurev.phyto.34.1.549; Gulya T, 2019, PLANT DIS, V103, P601, DOI 10.1094/PDIS-06-18-0980-FE; Iwebor M., 2018, Helia, V41, P141, DOI 10.1515/helia-2018-0015; Korosi K, 2011, J PHYTOPATHOL, V159, P471, DOI 10.1111/j.1439-0434.2011.01787.x; Kosman E, 1996, PHYTOPATHOLOGY, V86, P1263; Lawton KA, 1996, PLANT J, V10, P71, DOI 10.1046/j.1365-313X.1996.10010071.x; LEVY Y, 1986, Bulletin OEPP, V16, P651, DOI 10.1111/j.1365-2338.1986.tb00338.x; Miao JQ, 2018, PHYTOPATHOLOGY, V108, P1412, DOI 10.1094/PHYTO-01-18-0010-R; Miao JQ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00615; Molinero-Ruiz M. L., 2005, Helia, V28, P65, DOI 10.2298/HEL0542065M; Molinero-Ruiz ML, 2002, PLANT DIS, V86, P736, DOI 10.1094/PDIS.2002.86.7.736; Pasteris RJ, 2016, BIOORGAN MED CHEM, V24, P354, DOI 10.1016/j.bmc.2015.07.064; Perez L, 2003, CROP PROT, V22, P405, DOI 10.1016/S0261-2194(02)00198-9; Ramasamy AD, 2015, J HORTIC SCI BIOTECH, V90, P63, DOI 10.1080/14620316.2015.11513154; Ruiz M. L. M., 2000, P 15 INT SUNFL C TOU, pG11; Sharma R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1904-7; Spring O, 2006, J PLANT DIS PROTECT, V113, P224, DOI 10.1007/BF03356185; Spring O., 2000, Helia, V23, P19; Spring O, 2009, FUNGAL ECOL, V2, P75, DOI 10.1016/j.funeco.2008.12.003; Spring O, 2001, Z PFLANZENK PFLANZEN, V108, P329; Spring O, 2018, CRIT REV PLANT SCI, V37, P439, DOI 10.1080/07352689.2018.1530848; Spring O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167015; Tosi L, 1999, J PHYTOPATHOL, V147, P365, DOI 10.1046/j.1439-0434.1999.00097.x; Trojanova Z, 2017, PLANT PATHOL, V66, P171, DOI 10.1111/ppa.12593; Viranyi F., 2015, Helia, V38, P149, DOI 10.1515/helia-2015-0009; Viranyi F, 2018, DATASHEET PLASMOPARA; Weber-Boyvat M, 2013, BIOCHEM PHARMACOL, V86, P89, DOI 10.1016/j.bcp.2013.02.016	36	9	9	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222827	10.1371/journal.pone.0222827	http://dx.doi.org/10.1371/journal.pone.0222827			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545821	Green Published, gold			2022-12-26	WOS:000532303200037
J	Hayakawa, E; Watanabe, H; Menschaert, G; Holstein, TW; Baggerman, G; Schoofs, L				Hayakawa, Eisuke; Watanabe, Hiroshi; Menschaert, Gerben; Holstein, Thomas W.; Baggerman, Geert; Schoofs, Liliane			A combined strategy of neuropeptide prediction and tandem mass spectrometry identifies evolutionarily conserved ancient neuropeptides in the sea anemone Nematostella vectensis	PLOS ONE			English	Article							ELECTRON-TRANSFER DISSOCIATION; ANTHO-RFAMIDE; DROSOPHILA-MELANOGASTER; ENDOGENOUS PEPTIDES; LOCUSTA-MIGRATORIA; MOLECULAR-CLONING; NERVOUS-SYSTEM; PEPTIDOMICS; HYDRA; PRECURSOR	Neuropeptides are a class of bioactive peptides shown to be involved in various physiological processes, including metabolism, development, and reproduction. Although neuropeptide candidates have been predicted from genomic and transcriptomic data, comprehensive characterization of neuropeptide repertoires remains a challenge owing to their small size and variable sequences. De novo prediction of neuropeptides from genome or transcriptome data is difficult and usually only efficient for those peptides that have identified orthologs in other animal species. Recent peptidomics technology has enabled systematic structural identification of neuropeptides by using the combination of liquid chromatography and tandem mass spectrometry. However, reliable identification of naturally occurring peptides using a conventional tandem mass spectrometry approach, scanning spectra against a protein database, remains difficult because a large search space must be scanned due to the absence of a cleavage enzyme specification. We developed a pipeline consisting of in silico prediction of candidate neuropeptides followed by peptide-spectrum matching. This approach enables highly sensitive and reliable neuropeptide identification, as the search space for peptide-spectrum matching is highly reduced. Nematostella vectensis is a basal eumetazoan with one of the most ancient nervous systems. We scanned the Nematostella protein database for sequences displaying structural hallmarks typical of eumetazoan neuropeptide precursors, including amino- and carboxyterminal motifs and associated modifications. Peptide-spectrum matching was performed against a dataset of peptides that are cleaved in silico from these putative peptide precursors. The dozens of newly identified neuropeptides display structural similarities to bilaterian neuropeptides including tachykinin, myoinhibitory peptide, and neuromedin-U/pyrokinin, suggesting these neuropeptides occurred in the eumetazoan ancestor of all animal species.	[Hayakawa, Eisuke; Schoofs, Liliane] Katholieke Univ Leuven, Res Grp Funct Genom & Prote, Leuven, Belgium; [Hayakawa, Eisuke; Watanabe, Hiroshi] Okinawa Inst Sci & Technol, Evolutionary Neurobiol Unit, Onna, Okinawa, Japan; [Watanabe, Hiroshi; Holstein, Thomas W.] Heidelberg Univ, Ctr Organismal Studies COS, Heidelberg, Germany; [Menschaert, Gerben] Univ Ghent, Fac Biosci Engn, Lab Bioinformat & Computat Genom, Ghent, Belgium; [Baggerman, Geert] Univ Antwerp, CFP Ceproma, Antwerp, Belgium; [Baggerman, Geert] Appl Bio & Mol Syst ABS, VITO, Mol, Belgium	KU Leuven; Okinawa Institute of Science & Technology Graduate University; Ruprecht Karls University Heidelberg; Ghent University; University of Antwerp; VITO	Hayakawa, E (corresponding author), Katholieke Univ Leuven, Res Grp Funct Genom & Prote, Leuven, Belgium.; Hayakawa, E (corresponding author), Okinawa Inst Sci & Technol, Evolutionary Neurobiol Unit, Onna, Okinawa, Japan.	eisuke.hayakawa@oist.jp	Watanabe, Hiroshi/GOP-0177-2022; schoofs, liliane/ABD-2943-2020	Watanabe, Hiroshi/0000-0001-8887-5407; Holstein, Thomas/0000-0003-0480-4674; Hayakawa, Eisuke/0000-0003-1054-4266; Baggerman, Geert/0000-0002-0661-931X	KU Leuven Research Foundation [C14/15/049]	KU Leuven Research Foundation	The work was supported by KU Leuven Research Foundation grant C14/15/049 to LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SJ, 2017, PEPTIDES, V93, P51, DOI 10.1016/j.peptides.2017.05.005; ANASTASI A, 1963, ARCH BIOCHEM BIOPHYS, V101, P56, DOI 10.1016/0003-9861(63)90533-2; ANCTIL M, 1989, GEN PHARMACOL, V20, P381, DOI 10.1016/0306-3623(89)90277-2; Anctil M, 2009, COMP BIOCHEM PHYS D, V4, P268, DOI 10.1016/j.cbd.2009.07.001; Baggerman G, 2002, J BIOL CHEM, V277, P40368, DOI 10.1074/jbc.M206257200; Boonen K, 2007, GEN COMP ENDOCR, V152, P231, DOI 10.1016/j.ygcen.2007.05.002; Brighton PJ, 2004, PHARMACOL REV, V56, P231, DOI 10.1124/pr.56.2.3; Brown MR, 1999, PEPTIDES, V20, P1035, DOI 10.1016/S0196-9781(99)00097-2; CHIWAKATA C, 1991, ENDOCRINOLOGY, V128, P2441, DOI 10.1210/endo-128-5-2441; Christie AE, 2014, GEN COMP ENDOCR, V201, P87, DOI 10.1016/j.ygcen.2014.02.015; Clynen E, 2001, EUR J BIOCHEM, V268, P1929, DOI 10.1046/j.1432-1327.2001.02067.x; Clynen E, 2009, INSECT BIOCHEM MOLEC, V39, P491, DOI 10.1016/j.ibmb.2009.06.001; Conlon JM, 2005, GEN COMP ENDOCR, V142, P53, DOI 10.1016/j.ygcen.2004.11.016; Conzelmann M, 2013, P NATL ACAD SCI USA, V110, P8224, DOI 10.1073/pnas.1220285110; CRUZ LJ, 1987, J BIOL CHEM, V262, P15821; CUPO A, 1983, NEUROPEPTIDES, V3, P309, DOI 10.1016/0143-4179(83)90048-3; Dallas DC, 2015, PROTEOMICS, V15, P1026, DOI 10.1002/pmic.201400310; DARMER D, 1991, P NATL ACAD SCI USA, V88, P2555, DOI 10.1073/pnas.88.6.2555; Darmer D, 1998, BIOCHEM J, V332, P403, DOI 10.1042/bj3320403; De Haes W, 2015, BBA-PROTEINS PROTEOM, V1854, P812, DOI 10.1016/j.bbapap.2014.12.011; DELOOF A, 1990, COMP BIOCHEM PHYS B, V95, P459, DOI 10.1016/0305-0491(90)90003-C; Dircksen H, 2011, J PROTEOME RES, V10, P4478, DOI 10.1021/pr200284e; Duportets L, 1999, PEPTIDES, V20, P899, DOI 10.1016/S0196-9781(99)00079-0; EMESON RB, 1984, J NEUROSCI, V4, P2604; Falth M, 2007, MOL CELL PROTEOMICS, V6, P1188, DOI 10.1074/mcp.M700016-MCP200; Fricker LD, 2006, MASS SPECTROM REV, V25, P327, DOI 10.1002/mas.20079; Fricker LD, 2005, AAPS J, V7, DOI 10.1208/aapsj070244; Fu Q, 2007, J NEUROCHEM, V101, P1099, DOI 10.1111/j.1471-4159.2007.04482.x; Fujisawa T, 2012, INT J DEV BIOL, V56, P543, DOI 10.1387/ijdb.113477tf; Gajewski M, 1996, ROUX ARCH DEV BIOL, V205, P232, DOI 10.1007/BF00365801; GRIMMELIKHUIJZEN CJP, 1986, P NATL ACAD SCI USA, V83, P9817, DOI 10.1073/pnas.83.24.9817; GRIMMELIKHUIJZEN CJP, 1992, BIOCHEM BIOPH RES CO, V183, P375, DOI 10.1016/0006-291X(92)90491-3; HAND C, 1992, BIOL BULL, V182, P169, DOI 10.2307/1542110; HARADA M, 1982, BIOCHIM BIOPHYS ACTA, V705, P288, DOI 10.1016/0167-4838(82)90191-1; Hauser Frank, 2006, Briefings in Functional Genomics & Proteomics, V4, P321, DOI 10.1093/bfgp/eli003; Hauser F, 2010, J PROTEOME RES, V9, P5296, DOI 10.1021/pr100570j; Hayakawa E, 2007, FEBS J, V274, P5438, DOI 10.1111/j.1742-4658.2007.06071.x; Hayakawa E, 2013, J PROTEOME RES, V12, P5410, DOI 10.1021/pr400446z; Hokfelt T, 2000, NEUROPHARMACOLOGY, V39, P1337, DOI 10.1016/S0028-3908(00)00010-1; Hook V, 2008, ANNU REV PHARMACOL, V48, P393, DOI 10.1146/annurev.pharmtox.48.113006.094812; Hoshino A, 2012, C SERIES NEUROPEPTID, V1, P1, DOI DOI 10.4199/C00050ED1V01Y201112NPE001; Hummon AB, 2006, SCIENCE, V314, P647, DOI 10.1126/science.1124128; Jang YH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01794-9; Jekely G, 2013, P NATL ACAD SCI USA, V110, P8702, DOI 10.1073/pnas.1221833110; Koizumi O, 2007, BRAIN BEHAV EVOLUT, V69, P151, DOI 10.1159/000095204; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Lengfeld T, 2009, DEV BIOL, V330, P186, DOI 10.1016/j.ydbio.2009.02.004; LEUNG PS, 1992, REGUL PEPTIDES, V41, P71, DOI 10.1016/0167-0115(92)90515-V; LEVIEV I, 1995, P NATL ACAD SCI USA, V92, P11647, DOI 10.1073/pnas.92.25.11647; Lim J, 2006, J NEUROCHEM, V96, P1169, DOI 10.1111/j.1471-4159.2005.03614.x; LORENZ MW, 1995, J BIOL CHEM, V270, P21103, DOI 10.1074/jbc.270.36.21103; LUNDQUIST CT, 1994, PEPTIDES, V15, P761, DOI 10.1016/0196-9781(94)90027-2; Marlow HQ, 2009, DEV NEUROBIOL, V69, P235, DOI 10.1002/dneu.20698; MCFARLANE ID, 1991, J EXP BIOL, V156, P419; Mirabeau O, 2013, P NATL ACAD SCI USA, V110, pE2028, DOI 10.1073/pnas.1219956110; Moosler A, 1996, BIOCHEM BIOPH RES CO, V229, P596, DOI 10.1006/bbrc.1996.1849; Mori K, 2005, EMBO J, V24, P325, DOI 10.1038/sj.emboj.7600526; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; Neupert S, 2009, PEPTIDES, V30, P483, DOI 10.1016/j.peptides.2008.11.009; Oh Y, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001974; Pauls D., 2014, EUPA OPEN PROTEOM, V3, P114; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petruzziello F, 2012, J PROTEOME RES, V11, P886, DOI 10.1021/pr200709j; Peymen K, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007945; Predel R, 2001, J INSECT PHYSIOL, V47, P311, DOI 10.1016/S0022-1910(00)00129-3; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; REINSCHEID RK, 1994, J NEUROCHEM, V62, P1214; Sasaki K, 2013, MOL CELL PROTEOMICS, V12, P700, DOI 10.1074/mcp.M112.017400; SATO Y, 1993, P NATL ACAD SCI USA, V90, P3251, DOI 10.1073/pnas.90.8.3251; SCHMUTZLER C, 1992, J BIOL CHEM, V267, P22534; SCHOOFS L, 1991, REGUL PEPTIDES, V36, P111, DOI 10.1016/0167-0115(91)90199-Q; SCHOOFS L, 1988, PEPTIDES, V9, P1027, DOI 10.1016/0196-9781(88)90084-8; Southey BR, 2006, NUCLEIC ACIDS RES, V34, pW267, DOI 10.1093/nar/gkl161; Takahashi T, 2008, ACTA BIOL HUNG, V59, P227, DOI 10.1556/ABiol.59.2008.Suppl.32; Takahashi T, 2000, DEVELOPMENT, V127, P997; Takahashi T, 1997, P NATL ACAD SCI USA, V94, P1241, DOI 10.1073/pnas.94.4.1241; Van Bael S, 2018, J BIOL CHEM, V293, P6052, DOI [10.1074/jbc.RA117.000731, 10.1074/jbc.ra117.000731]; Van Camp KA, 2018, METHODS MOL BIOL, V1719, P241, DOI 10.1007/978-1-4939-7537-2_16; Veenstra JA, 2011, GEN COMP ENDOCR, V171, P160, DOI 10.1016/j.ygcen.2011.01.005; Watanabe H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6536; Watanabe H, 2009, DEV GROWTH DIFFER, V51, P167, DOI 10.1111/j.1440-169X.2009.01103.x; Williamson M, 2001, BIOCHEM BIOPH RES CO, V281, P544, DOI 10.1006/bbrc.2001.4402; Yamanaka N, 2010, P NATL ACAD SCI USA, V107, P2060, DOI 10.1073/pnas.0907471107; Yum S, 1998, BIOCHEM BIOPH RES CO, V248, P584, DOI 10.1006/bbrc.1998.8831; Yum S, 1998, FEBS LETT, V439, P31, DOI 10.1016/S0014-5793(98)01314-3; Zhang XZ, 2012, J PROTEOME RES, V11, P2819, DOI 10.1021/pr3001699; Zhang X, 2010, J NEUROCHEM, V112, P1168, DOI 10.1111/j.1471-4159.2009.06530.x; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745	88	13	13	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0215185	10.1371/journal.pone.0215185	http://dx.doi.org/10.1371/journal.pone.0215185			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545805	gold, Green Published, Green Submitted			2022-12-26	WOS:000532303200003
J	Stegemoller, EL; Zaman, A; Uzochukwu, J				Stegemoller, Elizabeth L.; Zaman, Andrew; Uzochukwu, Jennifer			Repetitive finger movement and circle drawing in persons with Parkinson's disease	PLOS ONE			English	Article							CORTICAL OSCILLATIONS; SIZE; PERFORMANCE	Little is known regarding how repetitive finger movement performance impacts other fine motor control tasks, such as circle drawing, in persons with Parkinson's disease (PD). Previous research has shown that impairments in repetitive finger movements emerge at rates near to and above 2 Hz in most persons with PD. Thus, the purpose of this study was to compare circle drawing performance in persons with PD that demonstrate impairment in repetitive finger movement and those that do not. Twenty-two participants with PD and twelve healthy older adults completed the study. Only participants with PD completed the repetitive finger movement task. From the kinematic data for the repetitive finger movement task, participants were grouped into Hasteners and Non-Hasteners. Participants with PD and the healthy older adults completed a series of circle drawing tasks at two different target sizes (1 cm and 2 cm) and three pacing conditions (Self-paced, 1.25 Hz, and 2.5 Hz). Kinematic and electromyography data were recorded and compared between groups. Results revealed that, in general, persons with PD demonstrate impairments in circle drawing and associated electromyography activity compared to healthy older adults. Moreover, persons with PD that hasten during repetitive finger movements demonstrate significantly increased movement rate during circle drawing, while those persons with PD that do not hasten demonstrate a significant increase in width variability. This suggests that differing motor control mechanisms may play a role in the performance of fine motor tasks in persons with PD. Continued research is needed to better understand differences in circle drawing performance among persons with PD to inform future development of patient-centered treatments.	[Stegemoller, Elizabeth L.; Zaman, Andrew; Uzochukwu, Jennifer] Iowa State Univ, Dept Kinesiol, Ames, IA 50011 USA; [Uzochukwu, Jennifer] Univ Alabama Birmingham, Dept Phys Therapy, Birmingham, AL USA	Iowa State University; University of Alabama System; University of Alabama Birmingham	Stegemoller, EL (corresponding author), Iowa State Univ, Dept Kinesiol, Ames, IA 50011 USA.	esteg@iastate.edu		Stegemoller, Elizabeth/0000-0002-5287-2295				Agostino R, 2013, MOVEMENT DISORD, V18, P560; Broeder S, 2014, NEUROSCIENCE, V263, P193, DOI 10.1016/j.neuroscience.2014.01.019; Dounskaia N, 2009, NEUROPSYCHOLOGIA, V47, P2504, DOI 10.1016/j.neuropsychologia.2009.04.020; Ginis P, 2018, ANN PHYS REHABIL MED, V61, P407, DOI 10.1016/j.rehab.2017.08.002; Letanneux A, 2014, MOVEMENT DISORD, V29, P1467, DOI 10.1002/mds.25990; Nackaerts E, 2016, NEUROREHAB NEURAL RE, V30, P431, DOI 10.1177/1545968315601361; PHILLIPS JG, 1994, J NEUROL, V241, P439, DOI 10.1007/BF00900963; Rocha PA, 2014, CLIN NEUROL NEUROSUR, V124, P127, DOI 10.1016/j.clineuro.2014.06.026; Smits EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097614; Spencer RMC, 2005, BRAIN COGNITION, V58, P84, DOI 10.1016/j.bandc.2004.09.010; Stegemoller EL, 2016, CLIN NEUROPHYSIOL, V127, P664, DOI 10.1016/j.clinph.2015.05.014; Stegemoller EL, 2009, MOVEMENT DISORD, V24, P1162, DOI 10.1002/mds.22535; Stegemoller EL, 2018, NEUROL RES, V22, P1; Stegemoller E, 2016, HUM MOVEMENT SCI, V49, P116, DOI 10.1016/j.humov.2016.06.015; Stegemoller EL, 2017, BEHAV BRAIN RES, V317, P141, DOI 10.1016/j.bbr.2016.09.036; Toma K, 2002, J NEUROPHYSIOL, V88, P3377, DOI 10.1152/jn.00281.2002; Tucha O, 2006, J NEURAL TRANSM, V113, P1575, DOI 10.1007/s00702-005-0437-7; Uzochukwu JC, 2019, J OCC THER, DOI [10.5014/ajot.2019.028738, DOI 10.5014/AJOT.2019.028738]; Van Gemmert AWA, 1999, NEUROPSYCHOLOGIA, V37, P685; Van Gemmert AWA, 2003, J NEUROL NEUROSUR PS, V74, P1502, DOI 10.1136/jnnp.74.11.1502; Van Gemmert AWA, 2001, BRAIN COGNITION, V47, P504, DOI 10.1006/brcg.2001.1328; Vingerhoets FJG, 1997, ANN NEUROL, V41, P58, DOI 10.1002/ana.410410111; Zaman A.F., 2018, J NEUROL RES, V8, P26	23	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222862	10.1371/journal.pone.0222862	http://dx.doi.org/10.1371/journal.pone.0222862			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545827	Green Published, gold			2022-12-26	WOS:000532303200038
J	Minami, T; Tachikawa, R; Matsumoto, T; Murase, K; Tanizawa, K; Inouchi, M; Handa, T; Oga, T; Hirai, T; Chin, K				Minami, Takuma; Tachikawa, Ryo; Matsumoto, Takeshi; Murase, Kimihiko; Tanizawa, Kiminobu; Inouchi, Morito; Handa, Tomohiro; Oga, Toru; Hirai, Toyohiro; Chin, Kazuo			Adrenal gland size in obstructive sleep apnea: Morphological assessment of hypothalamic pituitary adrenal axis activity	PLOS ONE			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; METABOLIC SYNDROME; MAJOR DEPRESSION; VISCERAL FAT; CORTISOL; VOLUME; CT; CATECHOLAMINES; ASSOCIATIONS; POPULATION	Objectives The association of obstructive sleep apnea (OSA) with hypothalamic pituitary adrenal (HPA) axis activation has not been fully understood from results of previous studies using hormonal assessments. We aimed to investigate the relationship between adrenal size, a potential marker reflecting HPA axis activity, and sleep parameters related to OSA. Methods We retrospectively reviewed data on 284 consecutive adult patients aged 20 to 80 y who had undergone polysomnography and abdominal computed tomography (CT). OSA was defined as none/mild (apnea-hypopnea index [AHI] < 15, n = 75), moderate (AHI 15 to 30, n = 80), and severe OSA (AHI >= 30, n = 129). Widths of adrenal body and limbs were measured by abdominal CT. Results Adrenal size was greater in participants with severe OSA than in those with none/mild or moderate OSA (adrenal body width: 6.03 mm, none/mild OSA; 6.09 mm, moderate OSA; 6.78 mm, severe OSA; p < 0.001; adrenal limb width: 3.75 mm, none/mild OSA; 3.95 mm, moderate OSA; 4.26 mm, severe OSA, p < 0.001). Multivariate regression analysis showed that not the 3% oxygen desaturation index and time of SpO(2) < 90% but a higher arousal index was the only determinant factor for increased adrenal limb width (beta = 0.27, p < 0.001) after adjusting for other variables that could affect adrenal size. Neither the arousal index nor hypoxic parameters were associated with adrenal body width. Conclusions Results indicated that adrenal glands may enlarge in response to long-standing sleep fragmentation, suggesting the involvement of OSA in HPA axis augmentation.	[Minami, Takuma; Tachikawa, Ryo; Matsumoto, Takeshi; Handa, Tomohiro; Hirai, Toyohiro] Kyoto Univ, Grad Sch Med, Dept Resp Med, Kyoto, Japan; [Murase, Kimihiko; Tanizawa, Kiminobu; Inouchi, Morito; Chin, Kazuo] Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Kyoto, Japan; [Oga, Toru] Kawasaki Med Sch, Dept Resp Med, Kurashiki, Okayama, Japan	Kyoto University; Kyoto University; Kawasaki Medical School	Chin, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Resp Care & Sleep Control Med, Kyoto, Japan.	chink@kuhp.kyoto-u.ac.jp	Matsumoto, Takeshi/AAR-4323-2020; Tanizawa, Kiminobu/GPC-4728-2022	Minami, Takuma/0000-0001-7353-1142; Tanizawa, Kiminobu/0000-0002-5719-0744	Japanese Ministry of Education, Culture, Sports, Science and Technology [26293198, 17H04182]; Intractable Respiratory Diseases and Pulmonary Hypertension Research Group; Ministry of Health, Labor and Welfare in Japan [H29-intractable diseases-general-027]; Research Foundation for Healthy Aging, Health, Labour and Welfare Sciences Research Grants; Research on Region Medical from the Ministry of Health, Labor and Welfare of Japan [H28-iryo-ippan-016, H30-iryo-ippan-009]; Japan Agency for Medical Research and Development [JP18ek0210096]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Intractable Respiratory Diseases and Pulmonary Hypertension Research Group; Ministry of Health, Labor and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Research Foundation for Healthy Aging, Health, Labour and Welfare Sciences Research Grants; Research on Region Medical from the Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology (26293198, 17H04182), the Intractable Respiratory Diseases and Pulmonary Hypertension Research Group, the Ministry of Health, Labor and Welfare in Japan (H29-intractable diseases-general-027), the Research Foundation for Healthy Aging, Health, Labour and Welfare Sciences Research Grants, Research on Region Medical from the Ministry of Health, Labor and Welfare of Japan (H28-iryo-ippan-016, H30-iryo-ippan-009), and Japan Agency for Medical Research and Development under Grant Number JP18ek0210096. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew H W Jr, 1966, Psychophysiology, V2, P263, DOI 10.1111/j.1469-8986.1966.tb02650.x; [Anonymous], 2005, Nihon Naika Gakkai Zasshi, V94, P794; BaHammam AS, 2016, SLEEP BREATH, V20, P447, DOI 10.1007/s11325-015-1223-x; Barcelo A, 2008, THORAX, V63, P946, DOI 10.1136/thx.2007.093740; Bisogni V, 2016, J THORAC DIS, V8, P243, DOI 10.3978/j.issn.2072-1439.2015.11.14; Bjorvatn B, 2018, J SLEEP RES, V27, DOI 10.1111/jsr.12647; Bradley TD, 2009, LANCET, V373, P82, DOI 10.1016/S0140-6736(08)61622-0; CARLSON JT, 1993, CHEST, V103, P1763, DOI 10.1378/chest.103.6.1763; Carsin-Vu A, 2016, EUR RADIOL, V26, P2494, DOI 10.1007/s00330-015-4063-y; Chin K, 2010, SLEEP, V33, P89, DOI 10.1093/sleep/33.1.89; Chin KZ, 1999, CIRCULATION, V100, P706, DOI 10.1161/01.CIR.100.7.706; Chopra S, 2017, J CLIN ENDOCR METAB, V102, P3172, DOI 10.1210/jc.2017-00619; DOBBIE JW, 1966, J ENDOCRINOL, V34, P479, DOI 10.1677/joe.0.0340479; Ekstedt M, 2004, PSYCHOSOM MED, V66, P925, DOI 10.1097/01.psy.0000145821.25453.f7; Elder GJ, 2014, SLEEP MED REV, V18, P215, DOI 10.1016/j.smrv.2013.05.001; Elmasry A, 2002, EUR RESPIR J, V19, P511, DOI 10.1183/09031936.02.00106402; FOLLENIUS M, 1991, SLEEP, V14, P211; Godoy-Matos AF, 2006, J ENDOCRINOL INVEST, V29, P159, DOI 10.1007/BF03344090; Gulmez I, 1996, ENDOCR J, V43, P573, DOI 10.1507/endocrj.43.573; Harada Yuka, 2014, Ann Am Thorac Soc, V11, P383, DOI 10.1513/AnnalsATS.201306-182OC; Hu MX, 2016, EUR RADIOL, V26, P4475, DOI 10.1007/s00330-016-4331-5; Iber C., 2007, AASM MANUAL SCORING; Imaki T, 2004, ENDOCR J, V51, P89, DOI 10.1507/endocrj.51.89; Jenkins PJ, 1999, BRIT J CANCER, V80, P1815, DOI 10.1038/sj.bjc.6690603; Kritikou I, 2016, EUR RESPIR J, V47, P531, DOI 10.1183/13993003.00319-2015; Lingam RK, 2003, AM J ROENTGENOL, V181, P843, DOI 10.2214/ajr.181.3.1810843; Loredo JS, 1999, CHEST, V116, P655, DOI 10.1378/chest.116.3.655; Ma S, 2008, NEUROSCIENCE, V154, P1639, DOI 10.1016/j.neuroscience.2008.04.068; Mansukhani MP, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0476-2; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Narkiewicz K, 1998, CIRCULATION, V98, P1071, DOI 10.1161/01.CIR.98.11.1071; Newman AB, 2001, AM J EPIDEMIOL, V154, P50, DOI 10.1093/aje/154.1.50; Nougaret S, 2010, EUR RADIOL, V20, P2348, DOI 10.1007/s00330-010-1804-9; Rubin RT, 1996, BIOL PSYCHIAT, V40, P89, DOI 10.1016/0006-3223(95)00358-4; RUBIN RT, 1995, ARCH GEN PSYCHIAT, V52, P213; RUBIN RT, 1991, INVEST RADIOL, V26, P465, DOI 10.1097/00004424-199105000-00015; Sasanabe R, 2006, HYPERTENS RES, V29, P315, DOI 10.1291/hypres.29.315; Saunamaeki T, 2007, ACTA NEUROL SCAND, V116, P277, DOI 10.1111/j.1600-0404.2007.00901.x; Schmoller A, 2009, METABOLISM, V58, P848, DOI 10.1016/j.metabol.2009.02.014; Schneller J, 2014, ACAD RADIOL, V21, P1465, DOI 10.1016/j.acra.2014.06.008; Selye H, 1936, NATURE, V138, P32, DOI 10.1038/138032a0; Sohaib SA, 1999, AM J ROENTGENOL, V172, P997, DOI 10.2214/ajr.172.4.10587135; SPATHSCHWALBE E, 1991, BIOL PSYCHIAT, V29, P575, DOI 10.1016/0006-3223(91)90093-2; Suzuki M, 1996, SLEEP, V19, P382, DOI 10.1093/sleep/19.5.382; Takegami M, 2009, SLEEP MED, V10, P556, DOI 10.1016/j.sleep.2008.04.015; Taylor KS, 2016, HYPERTENSION, V68, P1467, DOI 10.1161/HYPERTENSIONAHA.116.08212; Tomfohr LM, 2012, SLEEP MED REV, V16, P243, DOI 10.1016/j.smrv.2011.05.003; Tsatsoulis A, 2018, J CLIN MED, V7, DOI 10.3390/jcm7030037; Vgontzas AN, 2007, J CLIN ENDOCR METAB, V92, P4199, DOI 10.1210/jc.2007-0774; VINCENT JM, 1994, CLIN RADIOL, V49, P453, DOI 10.1016/S0009-9260(05)81739-8; Yildiz O, 2005, ENDOCR J, V52, P183, DOI 10.1507/endocrj.52.183; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	52	2	2	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222592	10.1371/journal.pone.0222592	http://dx.doi.org/10.1371/journal.pone.0222592			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539392	Green Published, gold			2022-12-26	WOS:000532297900018
J	Ger, RB; Zhou, SH; Elgohari, B; Elhalawani, H; Mackin, DM; Meier, JG; Nguyen, CM; Anderson, BM; Gay, C; Ning, J; Fuller, CD; Li, H; Howell, RM; Layman, RR; Mawlawi, O; Stafford, RJ; Aerts, H; Court, LE				Ger, Rachel B.; Zhou, Shouhao; Elgohari, Baher; Elhalawani, Hesham; Mackin, Dennis M.; Meier, Joseph G.; Nguyen, Callistus M.; Anderson, Brian M.; Gay, Casey; Ning, Jing; Fuller, Clifton D.; Li, Heng; Howell, Rebecca M.; Layman, Rick R.; Mawlawi, Osama; Stafford, R. Jason; Aerts, Hugo; Court, Laurence E.			Radiomics features of the primary tumor fail to improve prediction of overall survival in large cohorts of CT- and PET-imaged head and neck cancer patients	PLOS ONE			English	Article							CELL LUNG-CANCER; PROGNOSTIC VALUE; RECONSTRUCTION SETTINGS; TEXTURE FEATURES; IMPACT; CHEMORADIOTHERAPY; VARIABILITY; VOLUME	Radiomics studies require many patients in order to power them, thus patients are often combined from different institutions and using different imaging protocols. Various studies have shown that imaging protocols affect radiomics feature values. We examined whether using data from cohorts with controlled imaging protocols improved patient outcome models. We retrospectively reviewed 726 CT and 686 PET images from head and neck cancer patients, who were divided into training or independent testing cohorts. For each patient, radiomics features with different preprocessing were calculated and two clinical variables-HPV status and tumor volume-were also included. A Cox proportional hazards model was built on the training data by using bootstrapped Lasso regression to predict overall survival. The effect of controlled imaging protocols on model performance was evaluated by subsetting the original training and independent testing cohorts to include only patients whose images were obtained using the same imaging protocol and vendor. Tumor volume, HPV status, and two radiomics covariates were selected for the CT model, resulting in an AUC of 0.72. However, volume alone produced a higher AUC, whereas adding radiomics features reduced the AUC. HPV status and one radiomics feature were selected as covariates for the PET model, resulting in an AUC of 0.59, but neither covariate was significantly associated with survival. Limiting the training and independent testing to patients with the same imaging protocol reduced the AUC for CT patients to 0.55, and no covariates were selected for PET patients. Radiomics features were not consistently associated with survival in CT or PET images of head and neck patients, even within patients with the same imaging protocol.	[Ger, Rachel B.; Mackin, Dennis M.; Nguyen, Callistus M.; Gay, Casey; Li, Heng; Howell, Rebecca M.; Court, Laurence E.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA; [Ger, Rachel B.; Zhou, Shouhao; Mackin, Dennis M.; Meier, Joseph G.; Anderson, Brian M.; Fuller, Clifton D.; Li, Heng; Howell, Rebecca M.; Layman, Rick R.; Mawlawi, Osama; Stafford, R. Jason; Court, Laurence E.] MD Anderson Canc Ctr, UTHlth Sci Ctr, Houston Grad Sch Biomed Sci, Houston, TX 77030 USA; [Zhou, Shouhao; Ning, Jing] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Elgohari, Baher; Elhalawani, Hesham; Fuller, Clifton D.] Univ Texas MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA; [Meier, Joseph G.; Anderson, Brian M.; Layman, Rick R.; Mawlawi, Osama; Stafford, R. Jason; Court, Laurence E.] Univ Texas MD Anderson Canc Ctr, Dept Imaging Phys, Houston, TX 77030 USA; [Aerts, Hugo] Harvard Med Sch, Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School	Ger, RB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA.; Ger, RB (corresponding author), MD Anderson Canc Ctr, UTHlth Sci Ctr, Houston Grad Sch Biomed Sci, Houston, TX 77030 USA.	rbger@mdanderson.org	Anderson, Brian Mark/ABB-1934-2021; Aerts, Hugo/ABF-2821-2020; Fuller, Clifton D./AAB-4012-2019	Anderson, Brian Mark/0000-0002-2748-1444; Aerts, Hugo/0000-0002-2122-2003; Fuller, Clifton D./0000-0002-5264-3994; Mackin, Dennis/0000-0002-2557-5340; Elgohari, Baher/0000-0001-7694-6466; Court, Laurence/0000-0002-3241-6145; Layman, Rick R/0000-0003-0185-3390; Ger, Rachel/0000-0003-1244-7160; Meier, Joseph/0000-0001-6794-9200; Elhalawani, Hesham/0000-0001-9848-2623	NCI Grants [R21CA216572, P30CA016672]; Rosalie B. Hite Graduate Fellowship in Cancer Research - MD Anderson Cancer Center UTHealth Science Center at Houston Graduate School of Biomedical Sciences; NIH/NCI Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program Award [P50 CA097007-10]; National Institutes of Health (NIH); National Institute for Dental and Craniofacial Research Award [1R01DE025248-01/R56DE025248-01]; National Cancer Institute (NCI) Early Phase Clinical Trials in Imaging and Image-Guided Interventions Program [1R01CA218148-01]; National Science Foundation (NSF), Division of Mathematical Sciences; NIH Big Data to Knowledge (BD2K) Program of the National Cancer Institute Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science Award [1R01CA214825-01]; National Institute of Biomedical Imaging and Bioengineering (NIBIB) Research Education Program [R25EB025787]; Elekta AB; NATIONAL CANCER INSTITUTE [R01CA214825, R21CA216572, P30CA016672, R01CA218148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R25EB025787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025248] Funding Source: NIH RePORTER	NCI Grants; Rosalie B. Hite Graduate Fellowship in Cancer Research - MD Anderson Cancer Center UTHealth Science Center at Houston Graduate School of Biomedical Sciences; NIH/NCI Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Dental and Craniofacial Research Award; National Cancer Institute (NCI) Early Phase Clinical Trials in Imaging and Image-Guided Interventions Program; National Science Foundation (NSF), Division of Mathematical Sciences(National Science Foundation (NSF)); NIH Big Data to Knowledge (BD2K) Program of the National Cancer Institute Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science Award; National Institute of Biomedical Imaging and Bioengineering (NIBIB) Research Education Program; Elekta AB; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by NCI Grants R21CA216572 and P30CA016672. Rachel Ger is supported by the Rosalie B. Hite Graduate Fellowship in Cancer Research awarded by MD Anderson Cancer Center UTHealth Science Center at Houston Graduate School of Biomedical Sciences. Dr. Elhalawani was supported in part by the philanthropic donations from the Family of Paul W. Beach to Dr. G. Brandon Gunn, MD. Drs. Elhalawani and Fuller receive funding and projectrelevant salary support from NIH/NCI Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program Award (P50 CA097007-10). Dr. Fuller is a Sabin Family Foundation Fellow. Dr. Fuller receives funding and project-relevant salary support from the National Institutes of Health (NIH), including: National Institute for Dental and Craniofacial Research Award (1R01DE025248-01/R56DE025248-01); National Cancer Institute (NCI) Early Phase Clinical Trials in Imaging and Image-Guided Interventions Program (1R01CA218148-01); National Science Foundation (NSF), Division of Mathematical Sciences; NIH Big Data to Knowledge (BD2K) Program of the National Cancer Institute Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science Award (1R01CA214825-01); and National Institute of Biomedical Imaging and Bioengineering (NIBIB) Research Education Program (R25EB025787). Dr. Fuller has received direct industry grant support and travel funding from Elekta AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts HJWL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5006; Bogowicz M, 2017, ACTA ONCOL, V56, P1531, DOI 10.1080/0284186X.2017.1346382; Bogowicz M, 2017, INT J RADIAT ONCOL, V99, P921, DOI 10.1016/j.ijrobp.2017.06.002; Clark K, 2013, J DIGIT IMAGING, V26, P1045, DOI 10.1007/s10278-013-9622-7; Cook GJ, 2018, INT J RAD ONCOLOGY B; El Naqa I, 2009, PATTERN RECOGN, V42, P1162, DOI 10.1016/j.patcog.2008.08.011; Fave X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00665-z; Fave X, 2016, TRANSL CANCER RES, V5, P349, DOI 10.21037/tcr.2016.07.11; Fave X, 2015, COMPUT MED IMAG GRAP, V44, P54, DOI 10.1016/j.compmedimag.2015.04.006; Feliciani G, 2018, CONTRAST MEDIA MOL I, DOI 10.1155/2018/3574310; Folkert MR, 2017, PHYS MED BIOL, V62, P5327, DOI 10.1088/1361-6560/aa73cc; Foy JJ, 2018, MED IMAGING 2018 COM; Fried DV, 2016, RADIOLOGY, V278, P214, DOI 10.1148/radiol.2015142920; Fried DV, 2014, INT J RADIAT ONCOL, V90, P834, DOI 10.1016/j.ijrobp.2014.07.020; Galavis PE, 2010, ACTA ONCOL, V49, P1012, DOI 10.3109/0284186X.2010.498437; Ger RB, 2018, COMPUT MED IMAG GRAP, V69, P134, DOI 10.1016/j.compmedimag.2018.09.002; Ger RB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31509-z; Ger RB, 2018, JOVE; Hatt M, 2015, J NUCL MED, V56, P38, DOI 10.2967/jnumed.114.144055; Kann BH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32441-y; Kuno H, 2017, AM J NEURORADIOL, V38, P2334, DOI 10.3174/ajnr.A5407; Leijenaar RTH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11075; Lydiatt WM, 2017, CA-CANCER J CLIN, V67, P122, DOI 10.3322/caac.21389; Mackin D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20713-6; Mackin D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178524; Mackin D, 2015, INVEST RADIOL, V50, P757, DOI 10.1097/RLI.0000000000000180; Orlhac F, 2018, J NUCL MED, V59, P1321, DOI 10.2967/jnumed.117.199935; Ou D, 2017, ORAL ONCOL, V71, P150, DOI 10.1016/j.oraloncology.2017.06.015; Parmar C, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00272; Parmar C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11044; Shafiq-ul-Hassan M, 2017, MED PHYS, V44, P1050, DOI 10.1002/mp.12123; Shiri I, 2017, EUR RADIOL, V27, P4498, DOI 10.1007/s00330-017-4859-z; Thawani R., 2017, LUNG CANC; Vallieres M., 2017, DATA HEAD NECK PET C; Vallieres M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10371-5; van Velden FHP, 2016, MOL IMAGING BIOL, V18, P788, DOI 10.1007/s11307-016-0940-2; Vial A, 2018, TRANSL CANCER RES, V7, P803, DOI 10.21037/tcr.2018.05.02; Wu J, 2019, INT J RADIAT ONCOL, V104, P942, DOI 10.1016/j.ijrobp.2019.03.036; Yan JH, 2015, J NUCL MED, V56, P1667, DOI 10.2967/jnumed.115.156927; Zhang Lifei, 2015, Med Phys, V42, P1341, DOI 10.1118/1.4908210; Zhao BS, 2016, SCI REP-UK, V6, DOI 10.1038/srep23428	41	24	25	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222509	10.1371/journal.pone.0222509	http://dx.doi.org/10.1371/journal.pone.0222509			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536526	Green Published, Green Submitted, gold			2022-12-26	WOS:000532262800049
J	Rollin, G; Lages, J; Shepelyansky, DL				Rollin, Guillaume; Lages, Josr; Shepelyansky, Dima L.			Wikipedia network analysis of cancer interactions and world influence	PLOS ONE			English	Article							GASTRIC-CANCER; EPIDEMIOLOGY; COUNTRIES; MORTALITY	We apply the Google matrix algorithms for analysis of interactions and influence of 37 cancer types, 203 cancer drugs and 195 world countries using the network of 5 416 537 English Wikipedia articles with all their directed hyperlinks. The PageRank algorithm provides a ranking of cancers which has 60% and 70% overlaps with the top 10 deadliest cancers extracted from World Health Organization GLOBOCAN 2018 and Global Burden of Diseases Study 2017, respectively. The recently developed reduced Google matrix algorithm gives networks of interactions between cancers, drugs and countries taking into account all direct and indirect links between these selected 435 entities. These reduced networks allow to obtain sensitivity of countries to specific cancers and drugs. The strongest links between cancers and drugs are in good agreement with the approved medical prescriptions of specific drugs to specific cancers. We argue that this analysis of knowledge accumulated in Wikipedia provides useful complementary global information about interdependencies between cancers, drugs and world countries.	[Rollin, Guillaume; Lages, Josr] Univ Bourgogne Franche Comte, CNRS, UMR 6213, Inst UTINAM,OSU THETA, Besancon, France; [Shepelyansky, Dima L.] Univ Toulouse, UPS, CNRS, Lab Phys Theor,IRSAMC, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Franche-Comte; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Lages, J (corresponding author), Univ Bourgogne Franche Comte, CNRS, UMR 6213, Inst UTINAM,OSU THETA, Besancon, France.	jose.lages@utinam.cnrs.fr	Lages, Jose/D-6660-2013	Lages, Jose/0000-0001-5965-8876; Rollin, Guillaume/0000-0002-3315-6509	French "Investissements d'Avenir" program, project ISITEBFC [ANR-15-IDEX-0003]; Bourgogne Franche-Comte Region 2017-2020 APEX project; Programme Investissements d'Avenir [ANR-11-IDEX-0002-02, ANR-10-LABX-0037-NEXT]	French "Investissements d'Avenir" program, project ISITEBFC(French National Research Agency (ANR)); Bourgogne Franche-Comte Region 2017-2020 APEX project; Programme Investissements d'Avenir(French National Research Agency (ANR))	This work was supported by the French "Investissements d'Avenir" program, project ISITEBFC, contract ANR-15-IDEX-0003 (JL), by the Bourgogne Franche-Comte Region 2017-2020 APEX project, see http://perso.utinam.cnrs.fr/~lages/apex/(JL) and in part by the Programme Investissements d'Avenir ANR-11-IDEX-0002-02, reference ANR-10-LABX-0037-NEXT, project THETRACOM, (DLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altbach P G, 2017, IARC BIENNIAL REPORT; Badmus TA, 2010, UROLOGY, V76, P412, DOI 10.1016/j.urology.2010.03.020; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brenner H, 2009, EPIDEMIOLOGY STOMACH, P467, DOI [10.1007/978-1-60327-492-0_23, DOI 10.1007/978-1-60327-492-0_23]; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Butler, 2008, NATURE; Callaway Ewen, 2010, Nature, V468, P359, DOI 10.1038/468359a; Cancer Treatment Centers of America, 2018, TYP CANC; Chepelianskii AD, 2010, 10035455 ARXIV; Coquide C, 2019, ARXIV190506489; Coquide C, 2019, LECT NOTES BUS INF P, V373, P208, DOI 10.1007/978-3-030-36691-9_18; Coquide C, 2019, EUR PHYS J B, V92, DOI 10.1140/epjb/e2019-100132-6; Coquide C, 2019, EUR PHYS J B, V92, DOI 10.1140/epjb/e2018-90532-7; EB, 2018, ENCY BRITANNICA; El Zant S, 2018, IEEE ACCESS, V6, P47735, DOI 10.1109/ACCESS.2018.2867327; El Zant S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201397; Ermann L, 2015, REV MOD PHYS, V87, P1261, DOI 10.1103/RevModPhys.87.1261; Frahm K.M., 2016, ARXIV160202394; Frahm KM, 2016, EUR PHYS J B, V89, DOI 10.1140/epjb/e2016-70526-3; Frahm KM, 2017, WIKIPEDIA NETWORKS 2; GBD. Global Burden of Disease, 2010, LANCET; Giles J, 2005, NATURE, V438, P900, DOI 10.1038/438900a; Gunturu KS, 2013, THER ADV MED ONCOL, V5, P143, DOI 10.1177/1758834012469429; Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458; Kaatsch P, 2010, CANCER TREAT REV, V36, P277, DOI 10.1016/j.ctrv.2010.02.003; Karimi P, 2014, CANCER EPIDEM BIOMAR, V23, P700, DOI 10.1158/1055-9965.EPI-13-1057; Kimura T, 2012, CHIN J CANCER, V31, P421, DOI 10.5732/cjc.011.10324; Lages J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190812; Langville Amy, 2012, GOOGLES PAGERANK SCI; Lewoniewski W, 2017, INFORMATICS-BASEL, V4, DOI 10.3390/informatics4040043; Miranda-Filho Adalberto, 2018, Lancet Haematol, V5, pe14, DOI 10.1016/S2352-3026(17)30232-6; National Cancer Institute, 2018, LIST CANC DRUGS; Nielsen FA, 2012, SSRN ELECT J; Reagle J., 2012, GOOD FAITH COLLABORA; Rollin G, 2018, WIKI4CANCERS WIKIPED; Rollin G, 2019, IEEE ACCESS, V7, P26073, DOI 10.1109/ACCESS.2019.2899339; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Union for International Cancer Control, 2018, NEW GLOB CANC DAT GL; Wakai Kenji, 2005, Nihon Rinsho, V63, P207; Witschi H, 2001, TOXICOL SCI, V64, P4, DOI 10.1093/toxsci/64.1.4; Wold Health Organization, 2018, WORLD CANC DAY 2018; Wong MCS, 2017, SCI REP-UK, V7, DOI 10.1038/srep45846; Zhirov AO, 2010, EUR PHYS J B, V77, P523, DOI 10.1140/epjb/e2010-10500-7	44	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222508	10.1371/journal.pone.0222508	http://dx.doi.org/10.1371/journal.pone.0222508			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536541	Green Submitted, Green Published, gold			2022-12-26	WOS:000532262800048
J	Schmidt, AF; Kemp, MW; Milad, M; Miller, LA; Bridges, JP; Clarke, MW; Kannan, PS; Jobe, AH				Schmidt, Augusto F.; Kemp, Matthew W.; Milad, Mark; Miller, Lisa A.; Bridges, James P.; Clarke, Michael W.; Kannan, Paranthaman S.; Jobe, Alan H.			Oral dosing for antenatal corticosteroids in the Rhesus macaque	PLOS ONE			English	Article							INTRAMUSCULAR DEXAMETHASONE; CONTROLLED-TRIAL; PRETERM BIRTH; PHARMACOKINETICS; BIOAVAILABILITY; PREVENTION; REDUCTION; MORTALITY; WOMEN	Antenatal corticosteroids (ACS) are standard of care for women at risk of preterm delivery, although choice of drug, dose or route have not been systematically evaluated. Further, ACS are infrequently used in low resource environments where most of the mortality from prematurity occurs. We report proof of principle experiments to test betamethasone-phosphate (Beta-P) or dexamethasone-phosphate (Dex-P) given orally in comparison to the clinical treatment with the intramuscular combination drug beta-phosphate plus beta-acetate in a Rhesus Macaque model. First, we performed pharmacokinetic studies in non-pregnant monkeys to compare blood levels of the steroids using oral dosing with Beta-P, Dex-P and an effective maternal intramuscular dose of the beta-acetate component of the clinical treatment. We then evaluated maternal and fetal blood steroid levels with limited fetal sampling under ultrasound guidance in pregnant macaques. We found that oral Beta is more slowly cleared from plasma than oral Dex. The blood levels of both drugs were lower in maternal plasma of pregnant than in non-pregnant macaques. Using the pharmacokinetic data, we treated groups of 6-8 pregnant monkeys with oral Beta-P, oral Dex-P, or the maternal intramuscular clinical treatment and saline controls and measured pressure-volume curves to assess corticosteroid effects on lung maturation at 5d. Oral Beta-P improved the pressurevolume curves similarly to the clinical treatment. Oral Dex-P gave more variable and nonsignificant responses. We then compared gene expression in the fetal lung, liver and hippocampus between oral Beta-P and the clinical treatment by RNA-sequencing. The transcriptomes were largely similar with small gene expression differences in the lung and liver, and no differences in the hippocampus between the groups. As proof of principle, ACS therapy can be effective using inexpensive and widely available oral drugs. Clinical dosing strategies must carefully consider the pharmacokinetics of oral Beta-P or Dex-P to minimize fetal exposure while achieving the desired treatment responses.	[Schmidt, Augusto F.; Bridges, James P.; Kannan, Paranthaman S.; Jobe, Alan H.] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Neonatol & Pulm Biol, Cincinnati, OH 45221 USA; [Kemp, Matthew W.; Jobe, Alan H.] Univ Western Australia, Perth, WA, Australia; [Milad, Mark] Milad Pharmaceut Consulting LLC, Plymouth, MI USA; [Miller, Lisa A.] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Clarke, Michael W.] Univ Western Australia, Ctr Microscopy Characterizat & Anal, Metabol Australia, Perth, WA, Australia; [Schmidt, Augusto F.] Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Western Australia; University of California System; University of California Davis; University of Western Australia; University of Miami	Jobe, AH (corresponding author), Univ Western Australia, Perth, WA, Australia.	alan.jobe@cchmc.org	Senthamaraikannan, Paranthaman/H-3992-2018	Senthamaraikannan, Paranthaman/0000-0002-3333-3720; Clarke, Michael/0000-0002-9639-5670; Jobe, Alan/0000-0003-3632-4114; Bridges, James P./0000-0002-4815-117X	Bill and Melinda Gates Foundation [OPP-1132910]; Western Australian State Government; Australian Federal Government, through Bioplatforms Australia; National Collaborative Research Infrastructure Strategy (NCRIS); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Western Australian State Government; Australian Federal Government, through Bioplatforms Australia; National Collaborative Research Infrastructure Strategy (NCRIS)(Australian GovernmentDepartment of Industry, Innovation and Science); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were fully supported by a research grant OPP-1132910 from the Bill and Melinda Gates Foundation to AHJ, AFS and MWK. MWC is supported by infrastructure funding from the Western Australian State Government in partnership with the Australian Federal Government, through Bioplatforms Australia and the National Collaborative Research Infrastructure Strategy (NCRIS).	Althabe F, 2015, LANCET, V385, P629, DOI 10.1016/S0140-6736(14)61651-2; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BALLARD PL, 1995, AM J OBSTET GYNECOL, V173, P254, DOI 10.1016/0002-9378(95)90210-4; Brownfoot FC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006764.pub3; Dobin Alexander, 2015, Curr Protoc Bioinformatics, V51, DOI 10.1002/0471250953.bi1114s51; Egerman RS, 1997, OBSTET GYNECOL, V89, P276, DOI 10.1016/S0029-7844(96)00446-2; Egerman RS, 1998, AM J OBSTET GYNECOL, V179, P1120, DOI 10.1016/S0002-9378(98)70116-4; Elliott CL, 1996, ACTA OBSTET GYN SCAN, V75, P213, DOI 10.3109/00016349609047089; Glasziou P, 2017, LANCET, V390, P169, DOI 10.1016/S0140-6736(16)30946-1; Griffin JB, 2019, GLOB HEALTH-SCI PRAC, V7, P215, DOI 10.9745/GHSP-D-18-00402; Gyamfi-Bannerman C, 2016, NEW ENGL J MED, V374, P1311, DOI 10.1056/NEJMoa1516783; Jobe AH, 1998, PEDIATRICS, V102, P1116, DOI 10.1542/peds.102.5.1116; Jobe AH, 2000, AM J RESP CRIT CARE, V162, P1656, DOI 10.1164/ajrccm.162.5.2003044; Jobe AH, 2018, AM J OBSTET GYNECOL, V219, P62, DOI 10.1016/j.ajog.2018.04.007; Ke AB, 2019, CLIN PHARMACOL THER, V106, P164, DOI 10.1002/cpt.1438; Kemp MW, 2018, AM J PHYSIOL-REG I, V315, pR825, DOI 10.1152/ajpregu.00193.2017; Kemp MW, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.05.007; Kemp MW, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.08.017; LIGGINS GC, 1972, PEDIATRICS, V50, P515; Queckenberg C, 2011, CLIN THER, V33, P1831, DOI 10.1016/j.clinthera.2011.10.006; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Roberts D, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub3; Santolaya-Forgas J, 1998, AM J OBSTET GYNECOL, V179, P1124, DOI 10.1016/S0002-9378(98)70117-6; Schmidt AF, 2019, PEDIATR RES, V86, P589, DOI 10.1038/s41390-019-0519-0; Schmidt AF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45171-6; Schmidt AF, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2017.11.560; Senthamaraikannan P, 2016, J INFECT DIS, V214, P1597, DOI 10.1093/infdis/jiw408; TAN RC, 1999, AM J PHYSIOL, V277, pL114, DOI DOI 10.1152/AJPLUNG.1999.277.6.L1142; Vogel JP, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000398; WALJEE AK, 2017, BMJ-BRIT MED J, V357, DOI DOI 10.1136/BMJ.J1415; World Health Organization, 2015, WORLD REP AG HLTH, P3	32	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222817	10.1371/journal.pone.0222817	http://dx.doi.org/10.1371/journal.pone.0222817			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536601	gold, Green Published, Green Submitted			2022-12-26	WOS:000532262800092
J	Li, YC; Sze, NN; Wong, SC; Tsui, KL; So, FL				Li, Y. C.; Sze, N. N.; Wong, S. C.; Tsui, K. L.; So, F. L.			Experimental study of the temporal profile of breath alcohol concentration in a Chinese population after a light meal	PLOS ONE			English	Article							HONG-KONG; CRASH; BLOOD; MODEL; PHARMACOKINETICS; DRUGS; RISK	In forensic science, the Widmark equation is widely used to deduce the blood alcohol concentration (BAC) at different time points. But the linear model specified by Widmark might be deficient in predicting the breath alcohol concentration (BrAC) at different time points, and extrapolating the peak and the corresponding time. In order to establish the temporal profile of alcohol concentration which captures the effects of non-linear nature of alcohol absorption, elimination, and peak, in particular of Chinese population after a light meal, a drinking experiment was conducted in this study. To achieve this, a double-blind drinking experiment was conducted to measure the BrAC of 52 Chinese participants after a light meal in this study. Prior to the experiment, all participants were required to abstain from food for 4 hours, more importantly, from alcohol and sedatives for 24 hours. A standard light meal was provided about 30 minutes prior to the alcohol intake in the experiment. The BrAC was measured at a 10-minute interval during the absorption phase and 30-minute interval during the elimination phase respectively. The measurements were stopped when the BrAC fell to 0.010 mg/100 ml or below, or more than 8 hours after the alcohol intake. Then, the temporal profiles of BrAC, assuming linear and non-linear relationships, were established using Full Bayesian approach. The linear component indicated the alcohol impairment in normal social function, with which a light meal is usually accompanied with drinking. On the other hand, the non-linear (gamma distribution) part replicated the absorption phase, elimination phase, and the peak of alcohol concentration. The proposed model well performed than the conventional regression model. Additionally, the confounding factors including gender, body weight, and dosage were controlled for. Results should be useful for the development of cost-effective enforcement measures that could deter against drink driving.	[Li, Y. C.; Wong, S. C.] Univ Hong Kong, Dept Civil Engn, Hong Kong, Peoples R China; [Sze, N. N.] Hong Kong Polytech Univ, Dept Civil & Environm Engn, Hung Hom, Kowloon, Hong Kong, Peoples R China; [Tsui, K. L.] Pok Oi Hosp, Accid & Emergency Dept, Yuen Long, Hong Kong, Peoples R China; [So, F. L.] Tuen Mun Hosp, Accid & Emergency Dept, Tuen Mun, Hong Kong, Peoples R China	University of Hong Kong; Hong Kong Polytechnic University; Tuen Mun Hospital	Li, YC (corresponding author), Univ Hong Kong, Dept Civil Engn, Hong Kong, Peoples R China.	joeyliyc@connect.hku.hk	Wong, S.C./A-7258-2008; Sze, NN/S-1437-2018	Wong, S.C./0000-0003-1169-7045; Sze, NN/0000-0002-2597-8107	Research Postgraduate Studentship; Research Grant Council of the Hong Kong Special Administrative Region, China [718811, 17203017]; Francis S Y Bong Professorship in Engineering	Research Postgraduate Studentship; Research Grant Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Francis S Y Bong Professorship in Engineering	The research described here was supported by a Research Postgraduate Studentship to YCL, and a grant from the Research Grant Council of the Hong Kong Special Administrative Region, China (Project No. 718811 and 17203017 to SCW). Author SCW was also supported by the Francis S Y Bong Professorship in Engineering.	ANDREASSON R, 1995, FORENSIC SCI INT, V72, P1, DOI 10.1016/0379-0738(94)01687-Z; Audit Commission of HKSAR, 2015, ADM ROAD SAF MEAS; Barbour AD, 2001, SCI JUSTICE, V41, P53, DOI 10.1016/S1355-0306(01)71849-7; Barquin J, 2008, FORENSIC SCI INT, V177, P140, DOI 10.1016/j.forsciint.2007.11.012; Chen F, 2018, J SAFETY RES, V65, P153, DOI 10.1016/j.jsr.2018.02.010; Denney RC, 1995, ALCOHOL, DRUGS AND TRAFFIC SAFETY - T'95, VOLS 1 AND 2, P573; Department of Mental Health and Substance Dependence, 2000, INT GUID MON ALC CON; Drummer OH, 2004, ACCIDENT ANAL PREV, V36, P239, DOI 10.1016/S0001-4575(02)00153-7; Elliott S, 2009, SCI JUSTICE, V49, P19, DOI 10.1016/j.scijus.2008.06.001; Gullberg RG, 2007, FORENSIC SCI INT, V172, P33, DOI 10.1016/j.forsciint.2006.11.010; HOLFORD NHG, 1987, CLIN PHARMACOKINET, V13, P273, DOI 10.2165/00003088-198713050-00001; Jachau K, 2004, FORENSIC SCI INT, V143, P115, DOI 10.1016/j.forsciint.2004.03.023; Jones AW, 2010, FORENSIC SCI INT, V200, P1, DOI 10.1016/j.forsciint.2010.02.021; JONES AW, 1985, CLIN CHIM ACTA, V146, P175, DOI 10.1016/0009-8981(85)90056-7; Kim JH, 2013, ADDICTION, V108, P1217, DOI 10.1111/add.12116; KIM K, 1995, ACCIDENT ANAL PREV, V27, P469, DOI 10.1016/0001-4575(95)00001-G; Li YC, 2014, TRANSPORTMETRICA A, V10, P722, DOI 10.1080/23249935.2013.854425; Li YC, 2013, HONG KONG J EMERG ME, V20, P146, DOI 10.1177/102490791302000304; Li YC, 2013, ACCIDENT ANAL PREV, V59, P415, DOI 10.1016/j.aap.2013.06.033; Ma XX, 2017, ANAL METHODS ACCID R, V15, P29, DOI 10.1016/j.amar.2017.06.001; Mumenthaler MS, 2000, ALCOHOL CLIN EXP RES, V24, P1353, DOI 10.1097/00000374-200009000-00005; Pavlic M, 2007, FORENSIC SCI INT, V171, P16, DOI 10.1016/j.forsciint.2006.09.008; Ramaekers JG, 2004, DRUG ALCOHOL DEPEN, V73, P109, DOI 10.1016/j.drugalcdep.2003.10.008; ROBERTSON MD, 1994, ACCIDENT ANAL PREV, V26, P243, DOI 10.1016/0001-4575(94)90094-9; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Schechtman E, 2011, ACCIDENT ANAL PREV, V43, P2188, DOI 10.1016/j.aap.2011.06.013; Swift R, 2003, ADDICTION, V98, P73, DOI 10.1046/j.1359-6357.2003.00605.x; Tam TWM, 2005, FORENSIC SCI INT, V151, P23, DOI 10.1016/j.forsciint.2004.06.032; Widmark EMP, 1981, PRINCIPLES APPL MEDI; Wrieden WL, 2009, STAT METHODS MED RES, V18, P285, DOI 10.1177/0962280208094694; Yang Chi Ting, 2009, Legal Medicine, V11, P163, DOI 10.1016/j.legalmed.2009.02.031	31	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221237	10.1371/journal.pone.0221237	http://dx.doi.org/10.1371/journal.pone.0221237			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4SI	31532778	Green Submitted, Green Published, gold			2022-12-26	WOS:000532239600004
J	Martoni, F; Armstrong, K				Martoni, Francesco; Armstrong, Karen			Resolving an 87-year-old taxonomical curiosity with the description of Psylla frodobagginsi sp. nov. (Hemiptera: Sternorrhyncha: Psyllidae), a second distinct Psylla species on the New Zealand endemic plant kowhai	PLOS ONE			English	Article							PSYLLOIDEA	A recent DNA-based assessment of the psyllid fauna of New Zealand recorded high genetic variation between populations that were expected to belong to the same psyllid species. Among these, a number of populations of the kowhai psyllid Psylla apicalis (Ferris & Klyver, 1932), from a kowhai species, Sophora microphylla Aiton (Fabaceae), presented high genetic variability. This gave new endorsement of an 87-year-old observation made by the entomologists Ferris and Klyver who, when describing the kowhai psyllid, from Sophora tetraptera J.S. Muell., suggested that morphological variations could support more than one species. Accordingly, the morphological assessment conducted here, together with the genetic information now available, resulted in the description of Psylla frodobagginsi sp. nov. as a second New Zealand endemic psyllid species hosted by S. microphylla.	[Martoni, Francesco; Armstrong, Karen] Lincoln Univ, Bioprotect Res Ctr, Lincoln, New Zealand; [Martoni, Francesco] AgriBio Ctr, Agr Victoria Res, Bundoora, Vic, Australia	Lincoln University - New Zealand	Martoni, F (corresponding author), Lincoln Univ, Bioprotect Res Ctr, Lincoln, New Zealand.; Martoni, F (corresponding author), AgriBio Ctr, Agr Victoria Res, Bundoora, Vic, Australia.	francesco.martoni@agriculture.vic.gov.au	Martoni, Francesco/AAB-1742-2019	Martoni, Francesco/0000-0001-8064-4460	Lincoln University	Lincoln University	Thanks to Lincoln University for funding the publication of this manuscript. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Martin Steinbauer (La Trobe University, Melbourne) and an anonymous reviewer for comments and suggestions that helped improving a previous version of this manuscript. Thanks to Lincoln University for funding the publication of this manuscript. The basemap of distribution map (Fig 1) was provided by Roger Smith, courtesy of Geographx (https://geographx.co.nz).Thanks to Samuel DJ Brown and Simon R Bulman (The New Zealand Institute of Plant and Food Research), and Mike Bowie (Lincoln University) for providing specimens. Thanks to Hannah Evans for the help during field collections. Thanks to Professor Phil Lester (Victoria University, Wellington), for the encouragements in pursuing the idea of describing this species; and to John Marris (LUNZ), for the helpful comments and suggestions. Many thanks to Marie-Claude Lariviere (NZAC) for providing the holotype of Psylla apicalis. Part of the data published in this article was reported in FM's PhD thesis [32].	Brown SDJ, 2017, ZOOKEYS, P73, DOI 10.3897/zookeys.707.12649; Burckhardt D, 2014, FLA ENTOMOL, V97, P242, DOI 10.1653/024.097.0132; Burckhardt D, 2012, ZOOTAXA, P1; Cho G, 2019, SYST ENTOMOL, V44, P638, DOI 10.1111/syen.12345; Crosby TK, 1998, NEW ZEAL J ZOOL, V25, P175, DOI 10.1080/03014223.1998.9518148; Dale PJ., 1985, THESIS; FERRIS G. F., 1932, TRANS AND PROC NEW ZEALAND INST, V63, P34; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Henderson R, 2010, NZ INVENTORY BIODIVE, Vtwo, P400; Hollis D., 2004, Australian Psylloidea: jumping plantlice and lerp insects; Hollis D, 1997, J NAT HIST, V31, P237, DOI 10.1080/00222939700770131; ICZN, 1999, INT CODE ZOOLOGICAL; ICZN, 2012, ZOOTAXA, V3450, P1; Rendon-Mera DI, 2017, ZOOTAXA, V4350, P436, DOI 10.11646/zootaxa.4350.3.2; Martoni F., 2017, THESIS; Martoni F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214220; Martoni F, 2018, ZOOKEYS, P91, DOI 10.3897/zookeys.811.28829; Martoni F, 2018, DIVERSITY-BASEL, V10, DOI 10.3390/d10030050; Martoni F, 2017, J ECON ENTOMOL, V110, P2618, DOI 10.1093/jee/tox261; Martoni F, 2016, ZOOTAXA, V4144, P556, DOI 10.11646/zootaxa.4144.4.6; Ouvrard D, 2019, PSYLLIST WORLD PSYLL; Ouvrard D, 2015, SYST BIODIVERS, V13, P434, DOI 10.1080/14772000.2015.1046969; Percy DM, 2018, SYST ENTOMOL, V43, P762, DOI 10.1111/syen.12302; Percy DM, 2018, ZOOKEYS, P75, DOI 10.3897/zookeys.758.23019; Percy DM, 2017, ZOOKEYS, P1, DOI 10.3897/zookeys.649.10213; Syfert MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167764; Taylor GS, 2018, AUSTRAL ENTOMOL, V57, P297, DOI 10.1111/aen.12278; Taylor GS, 2016, ZOOTAXA, V4073, P1, DOI 10.11646/zootaxa.4073.1.1; Tolkien JRR, 1954, FELLOWSHIP RING; Tolkien JRR, 1954, THE 2 TOWERS; Tolkien JRR, 1955, RETURN KING; TUTHILL L. D., 1952, PACIFIC SCI, V6, P83	32	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221316	10.1371/journal.pone.0221316	http://dx.doi.org/10.1371/journal.pone.0221316			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532775	gold, Green Published, Green Submitted			2022-12-26	WOS:000532239600008
J	Shao, YY; Xuan, GT; Hu, ZC; Gao, ZM; Liu, L				Shao, Yuanyuan; Xuan, Guantao; Hu, Zhichao; Gao, Zongmei; Liu, Lei			Determination of the bruise degree for cherry using Vis-NIR reflection spectroscopy coupled with multivariate analysis	PLOS ONE			English	Article							SOLUBLE SOLIDS CONTENT; APPLE FRUIT FIRMNESS; AUTOMATIC DETECTION; IMAGE-ANALYSIS; SKIN DEFECTS; SWEET CHERRY; PREDICTION; PH; CLASSIFICATION; QUALITY	Determination and classification of the bruise degree for cherry can improve consumer satisfaction with cherry quality and enhance the industry's competiveness and profitability. In this study, visible and near infrared (Vis-NIR) reflection spectroscopy was used for identifying bruise degree of cherry in 350-2500 nm. Sampling spectral data were extracted from normal, slight and severe bruise samples. Principal component analysis (PCA) was implemented to determine the first few principal components (PCs) for cluster analysis among samples. Optimal wavelengths were selected by loadings of PCs from PCA and successive projection algorithm (SPA) method, respectively. Afterwards, these optimal wavelengths were empolyed to establish the classification models as inputs of least square-support vector machine (LS-SVM). Better performance for qualitative discrimination of the bruise degree for cherry was emerged in LS-SVM model based on five optimal wavelengths (603, 633, 679, 1083, and 1803 nm) selected directly by SPA, which showed acceptable results with the classification accuracy of 93.3%. Confusion matrix illustrated misclassification generally occurred in normal and slight bruise samples. Furthermore, the latent relation between spectral property of cherries in varying bruise degree and its firmness and soluble solids content (SSC) was analyzed. The result showed both colour, firmness and SSC were consistent with the Vis-NIR reflectance of cherries. Overall, this study revealed that Vis-NIR reflection spectroscopy integrated with multivariate analysis can be used as a rapid, intact method to determine the bruise degree of cherry, laying a foundation for cherry sorting and postharvest quality control.	[Shao, Yuanyuan; Xuan, Guantao; Liu, Lei] Shandong Agr Univ, Coll Mech & Elect Engn, Tai An, Shandong, Peoples R China; [Shao, Yuanyuan; Hu, Zhichao] Minist Agr, Nanjing Res Inst Agr Mechanizat, Nanjing, Jiangsu, Peoples R China; [Xuan, Guantao] Univ Missouri, Coll Agr Food & Nat Resources, Columbia, MO USA; [Gao, Zongmei] Washington State Univ, Dept Biol Syst Engn, Pullman, WA 99164 USA	Shandong Agricultural University; Chinese Academy of Agricultural Sciences; Nanjing Institute of Agricultural Mechanization, CAAS; Ministry of Agriculture & Rural Affairs; University of Missouri System; University of Missouri Columbia; Washington State University	Xuan, GT (corresponding author), Shandong Agr Univ, Coll Mech & Elect Engn, Tai An, Shandong, Peoples R China.; Hu, ZC (corresponding author), Minist Agr, Nanjing Res Inst Agr Mechanizat, Nanjing, Jiangsu, Peoples R China.; Xuan, GT (corresponding author), Univ Missouri, Coll Agr Food & Nat Resources, Columbia, MO USA.	xuangt@sina.com; zchu369@163.com			National Natural Science Foundation of China [31671632, 31701325]; China Scholarship Council [201709135004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	The study was supported by National Natural Science Foundation of China (Nos. 31671632 to GX, 31701325 to YS) and China Scholarship Council (No. 201709135004 to GX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranowski P, 2013, POSTHARVEST BIOL TEC, V86, P249, DOI 10.1016/j.postharvbio.2013.07.005; Baranowski P, 2012, J FOOD ENG, V110, P345, DOI 10.1016/j.jfoodeng.2011.12.038; Cao JP, 2015, J FOOD SCI, V80, pC234, DOI 10.1111/1750-3841.12743; Cortes V, 2016, POSTHARVEST BIOL TEC, V118, P148, DOI 10.1016/j.postharvbio.2016.04.011; Cortes V, 2017, J FOOD ENG, V204, P27, DOI 10.1016/j.jfoodeng.2017.02.017; Cubero S, 2011, FOOD BIOPROCESS TECH, V4, P487, DOI 10.1007/s11947-010-0411-8; Diaz-Mula HM, 2009, FOOD SCI TECHNOL INT, V15, P535, DOI 10.1177/1082013209351868; ElMasry G, 2008, LWT-FOOD SCI TECHNOL, V41, P337, DOI 10.1016/j.lwt.2007.02.022; Escribano S, 2017, POSTHARVEST BIOL TEC, V128, P112, DOI 10.1016/j.postharvbio.2017.01.016; Fan GQ, 2009, J FOOD ENG, V93, P416, DOI 10.1016/j.jfoodeng.2009.02.006; Fan SX, 2017, POSTHARVEST BIOL TEC, V134, P55, DOI 10.1016/j.postharvbio.2017.08.012; Guo WC, 2016, FOOD ANAL METHOD, V9, P38, DOI 10.1007/s12161-015-0165-z; Guyer D, 2000, COMPUT ELECTRON AGR, V29, P179, DOI 10.1016/S0168-1699(00)00146-0; Harker R., 2009, 4 AUSTR NZ AV GROW C; Hayama H, 2006, POSTHARVEST BIOL TEC, V41, P16, DOI 10.1016/j.postharvbio.2006.03.006; Hu MH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25055-x; Jia BB, 2017, J FOOD ENG, V208, P57, DOI 10.1016/j.jfoodeng.2017.03.023; Kappel F, 2009, CAN J PLANT SCI, V89, P713, DOI 10.4141/CJPS08186; Leiva-Valenzuela GA, 2013, J FOOD ENG, V115, P91, DOI 10.1016/j.jfoodeng.2012.10.001; Li BC, 2016, OPTIK, V127, P2624, DOI 10.1016/j.ijleo.2015.11.193; Li CH, 2018, J SPECTROSC, V2018, DOI 10.1155/2018/6935197; Li JB, 2016, COMPUT ELECTRON AGR, V127, P582, DOI 10.1016/j.compag.2016.07.016; Li JB, 2016, POSTHARVEST BIOL TEC, V112, P121, DOI 10.1016/j.postharvbio.2015.10.007; Li JB, 2013, POSTHARVEST BIOL TEC, V82, P59, DOI 10.1016/j.postharvbio.2013.02.016; Li JB, 2013, J FOOD ENG, V116, P324, DOI 10.1016/j.jfoodeng.2012.11.007; Li XL, 2018, POSTHARVEST BIOL TEC, V143, P112, DOI 10.1016/j.postharvbio.2018.05.003; Liu CH, 2015, FOOD CHEM, V173, P482, DOI 10.1016/j.foodchem.2014.10.052; Lopez-Garcia F, 2010, COMPUT ELECTRON AGR, V71, P189, DOI 10.1016/j.compag.2010.02.001; Lopez-Maestresalas A, 2016, FOOD CONTROL, V70, P229, DOI 10.1016/j.foodcont.2016.06.001; Lorente D, 2015, J FOOD ENG, V163, P17, DOI 10.1016/j.jfoodeng.2015.04.010; Lu Q, 2012, PROCEDIA ENVIRON SCI, V12, P1172, DOI 10.1016/j.proenv.2012.01.404; Lu Q, 2011, CZECH J FOOD SCI, V29, P595, DOI 10.17221/69/2010-CJFS; Luo X, 2012, J FOOD ENG, V109, P457, DOI 10.1016/j.jfoodeng.2011.10.035; Magwaza LS, 2015, SCI HORTIC-AMSTERDAM, V184, P179, DOI 10.1016/j.scienta.2015.01.001; Mendoza F, 2014, J FOOD ENG, V125, P59, DOI 10.1016/j.jfoodeng.2013.10.022; Mendoza F, 2011, POSTHARVEST BIOL TEC, V62, P149, DOI 10.1016/j.postharvbio.2011.05.009; Mo C, 2017, BIOSYST ENG, V159, P10, DOI 10.1016/j.biosystemseng.2017.03.015; Moghimi A, 2010, BIOSYST ENG, V106, P295, DOI 10.1016/j.biosystemseng.2010.04.002; Mollazade K, 2012, FOOD BIOPROCESS TECH, V5, P1465, DOI 10.1007/s11947-012-0821-x; Morais TCB, 2018, FOOD CHEM, V273, P31, DOI [10.1016/j.ifacol.2018.08.273, DOI 10.1016/J.IFACOL.2018.08.273]; Pappas CS, 2011, J FOOD COMPOS ANAL, V24, P17, DOI 10.1016/j.jfca.2010.07.001; Peng YK, 2008, POSTHARVEST BIOL TEC, V48, P52, DOI 10.1016/j.postharvbio.2007.09.019; Peng YanKun, 2011, Journal of Jiangsu University - Natural Science Edition, V32, P125; Prusky D, 2011, FOOD SECUR, V3, P463, DOI 10.1007/s12571-011-0147-y; Qin J, 2005, T ASAE, V48, P1963, DOI 10.13031/2013.19988; Santosh Chopde, 2017, Agricultural Reviews, V38, P94, DOI 10.18805/ag.v38i02.7940; Siedliska A, 2017, INT AGROPHYS, V31, P539, DOI 10.1515/intag-2016-0075; Siedliska A, 2014, COMPUT ELECTRON AGR, V106, P66, DOI 10.1016/j.compag.2014.05.012; Slaughter DC, 2013, J FOOD ENG, V116, P920, DOI 10.1016/j.jfoodeng.2013.01.007; Timm E. J., 1995, Applied Engineering in Agriculture, V11, P403; Washburn KE, 2017, J FOOD ENG, V205, P64, DOI 10.1016/j.jfoodeng.2017.02.025; Xing J, 2008, POSTHARVEST BIOL TEC, V49, P411, DOI 10.1016/j.postharvbio.2008.03.018; Xing J, 2006, COMPUT ELECTRON AGR, V52, P11, DOI 10.1016/j.compag.2006.01.006; Zhang S, 2017, POSTHARVEST BIOL TEC, V127, P44, DOI 10.1016/j.postharvbio.2016.12.008; Zhang SJ, 2013, MATH COMPUT MODEL, V58, P545, DOI 10.1016/j.mcm.2011.10.067; Zielinski AAF, 2014, COMPR REV FOOD SCI F, V13, P300, DOI 10.1111/1541-4337.12060	56	15	16	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222633	10.1371/journal.pone.0222633	http://dx.doi.org/10.1371/journal.pone.0222633			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JU7ZJ	31532801	Green Published, Green Submitted, gold			2022-12-26	WOS:000501890000001
J	Ahmed, OM; Ali, TM; Gaid, MAA; Elberry, AA				Ahmed, Osama M.; Ali, Tarek M.; Gaid, Mohamed A. Abdel; Elberry, Ahmed A.			Effects of enalapril and paricalcitol treatment on diabetic nephropathy and renal expressions of TNF-alpha, p53, caspase-3 and Bcl-2 in STZ-induced diabetic rats	PLOS ONE			English	Article							CISPLATIN-INDUCED NEPHROTOXICITY; RENIN-ANGIOTENSIN SYSTEM; OXIDATIVE STRESS; VITAMIN-D; GENE-EXPRESSION; INDUCED APOPTOSIS; BETA-CELL; KIDNEY; PROTEINURIA; INHIBITION	This study aimed to assess the renopreventive effect of enalapril and/or paricalcitol on streptozotocin (STZ) diabetes-induced nephropathy and to elucidate their mechanisms of action through investigation of the effects on renal oxidative stress, antioxidant defense system and expressions of TNF-alpha, p53, caspase-3, and Bcl-2. Diabetes mellitus was induced in fasting male Wistar rats by single intraperitoneal injection of STZ (45 mg /kg b.w.) dissolved in citrate buffer (pH 4.5). Ten days after STZ injection, the diabetic rats were treated with enalapril (25 mg/l of drinking water) and/or paricalcitol (8 mu g/ kg b.w. per os) dissolved in 5% DMSO daily for 4 weeks. The obtained data revealed that the treatment of diabetic Wistar rats with enalapril and/or paricalcitol led to significant decreases in the elevated serum urea, uric acid, creatinine, sodium and potassium levels; thereby reflecting the improvement of the impaired kidney function. The deteriorated kidney lipid peroxidation, GSH content and GST and catalase activities in diabetic rats were significantly ameliorated as a result of treatment with enalapril and/or paricalcitol. The elevated fasting and post-prandial serum glucose levels and the lowered serum insulin and C-peptide levels were also improved. The treatment with enalapril and paricalcitol in combination was the most potent in decreasing the elevated serum glucose levels. Moreover, the treatment of diabetic rats successfully prevented the diabetes-induced histopathological deleterious changes of kidney and islets of Langerhans of pancreas. In association, the immunohistochemically detected pro-inflammatory cytokine, TNF-alpha, and apoptotic mediators, p53 and caspase-3, were remarkably decreased in kidney of diabetic rats as a result of treatment while the expression of anti-apoptotic protein Bcl-2 was increased. Based on these findings, it can be concluded that enalapril and paricalcitol alone or in combination can prevent STZ diabetes-induced nephropathy through amelioration of the glycemic state and antioxidant defense system together with the suppression of oxidative stress, inflammation and apoptosis. However, the treatment of diabetic rats with enalapril and paricalcitol in combination has no further significant improvement effects on renal function and damage when compared with enalapril or paclitaxel treated diabetic groups.	[Ahmed, Osama M.; Gaid, Mohamed A. Abdel] Beni Suef Univ, Fac Sci, Zool Dept, Expt Obes & Diabet Res Lab,Physiol Div, Bani Suwayf, Egypt; [Ali, Tarek M.] Taif Univ, Coll Appl Med Sci, Dept Clin Labs, At Taif, Saudi Arabia; [Ali, Tarek M.] Beni Suef Univ, Fac Med, Dept Physiol, Bani Suwayf, Egypt; [Elberry, Ahmed A.] Beni Suef Univ, Fac Med, Clin Pharmacol Dept, Bani Suwayf, Egypt	Egyptian Knowledge Bank (EKB); Beni Suef University; Taif University; Egyptian Knowledge Bank (EKB); Beni Suef University; Egyptian Knowledge Bank (EKB); Beni Suef University	Ahmed, OM (corresponding author), Beni Suef Univ, Fac Sci, Zool Dept, Expt Obes & Diabet Res Lab,Physiol Div, Bani Suwayf, Egypt.	osama.ahmed@science.bsu.edu.org	Elberry, Ahmed A/I-1539-2012; Ali, Tarek/E-7358-2019; Ahmed, Osama/P-8126-2018	Elberry, Ahmed A/0000-0002-0073-3066; Ali, Tarek/0000-0002-2998-247X; Ahmed, Osama/0000-0003-3781-9709	College of Applied Medical Sciences, Taif University, Taif Saudi Arabia; Faculty of Science, Beni-Suef University, Beni Suef, Egypt	College of Applied Medical Sciences, Taif University, Taif Saudi Arabia; Faculty of Science, Beni-Suef University, Beni Suef, Egypt	This study was partially funded by College of Applied Medical Sciences, Taif University, P. O. Box 888, Taif 21974, Saudi Arabia and Faculty of Science, Beni-Suef University, Beni Suef, Egypt. There was no additional external funding received for this study.	Agrawal NK, 2013, ASIAN J PHARM CLIN R, V6, P66; Ahmed O., 2001, J UNION ARABIAN BIOL, V16, P585; Ahmed OM, 2012, J DIABETES COMPLICAT, V26, P491, DOI 10.1016/j.jdiacomp.2012.05.021; Ali TM, 2016, AM J MED SCI, V352, P208, DOI 10.1016/j.amjms.2016.04.016; Anderson S, 2009, KIDNEY INT, V75, P12, DOI 10.1038/ki.2008.556; Aperis G, 2011, J REN CARE, V37, P80, DOI 10.1111/j.1755-6686.2011.00229.x; Ashour MB., 2017, INT J PREV TREAT, V6, P34, DOI DOI 10.5923/J.IJPT.20170602.03; Banchroft J.D., 1996, THEORY PRACTICE HIST; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Bidani AK, 2007, AM J PHYSIOL-RENAL, V292, pF647, DOI 10.1152/ajprenal.00017.2006; BJORCK S, 1992, BMJ-BRIT MED J, V304, P339, DOI 10.1136/bmj.304.6823.339; Brown AJ, 1999, AM J PHYSIOL-RENAL, V277, pF157, DOI 10.1152/ajprenal.1999.277.2.F157; Capes SE, 2000, DIABETES CARE, V23, P377, DOI 10.2337/diacare.23.3.377; Chandran G, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/608512; CHRISTAKOS S, 1979, ENDOCRINOLOGY, V104, P1495, DOI 10.1210/endo-104-5-1495; COHEN G, 1970, ANAL BIOCHEM, V34, P30, DOI 10.1016/0003-2697(70)90083-7; de Brito Amaral LS, 2018, J DIABETES RES; de Cavanagh EMV, 2001, HYPERTENSION, V38, P1130, DOI 10.1161/hy1101.092845; El-Beshbishy HA, 2011, EUR J PHARMACOL, V668, P278, DOI 10.1016/j.ejphar.2011.06.051; Finch JL, 2012, AM J PHYSIOL-RENAL, V302, pF141, DOI 10.1152/ajprenal.00293.2011; Freundlich M, 2008, KIDNEY INT, V74, P1394, DOI 10.1038/ki.2008.408; Ghavami S, 2009, J MED GENET, V46, P497, DOI 10.1136/jmg.2009.066944; Gheith Osama, 2016, J Nephropharmacol, V5, P49; Gravellone L, 2011, INT J NEPHROL, V2011, DOI 10.4061/2011/419524; Hari P, 2013, INDIAN PEDIATR, V50, P923, DOI 10.1007/s13312-013-0262-2; He WC, 2011, J AM SOC NEPHROL, V22, P90, DOI 10.1681/ASN.2009121236; Hoshino J, 2015, AM J NEPHROL, V41, P337, DOI 10.1159/000431333; Hou JT, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4609750; Husain Kazim, 2015, World J Biol Chem, V6, P240, DOI 10.4331/wjbc.v6.i3.240; Hussein AM, 2010, BIOORGAN MED CHEM, V18, P2639, DOI 10.1016/j.bmc.2010.02.028; International Diabetes Federation, 2016, DIABETES ATLAS; Izquierdo MJ, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-159; Jones BE, 2000, J BIOL CHEM, V275, P705, DOI 10.1074/jbc.275.1.705; Kim JM, 2011, EXP GERONTOL, V46, P542, DOI 10.1016/j.exger.2011.02.011; Lau T, 2004, DIABETOLOGIA, V47, P240, DOI 10.1007/s00125-003-1295-1; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Lim AKH, 2014, INT J NEPHROL RENOV, V7, P361, DOI 10.2147/IJNRD.S40172; Mannervik B, 1981, Methods Enzymol, V77, P231; Martinez-Castelao A, 1998, KIDNEY INT, V54, pS130, DOI 10.1046/j.1523-1755.1998.06826.x; Mizobuchi M, 2007, J AM SOC NEPHROL, V18, P1796, DOI 10.1681/ASN.2006091028; Navarro JF, 2005, KIDNEY INT, V68, P98; Nita M, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3164734; Park JW, 2012, EUR J PHARMACOL, V683, P301, DOI 10.1016/j.ejphar.2012.03.019; Patschan D, 2016, INT J NEPHROL, V2016, DOI 10.1155/2016/6232909; Piscitelli P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03551-w; Poljsak B, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/956792; Pradeep SR, 2018, FOOD FUNCT, V9, P134, DOI [10.1039/c7fo01044c, 10.1039/C7FO01044C]; Preuss HG, 1998, J AM COLL NUTR, V17, P116, DOI 10.1080/07315724.1998.10718736; Rabinovitch A, 2001, ENDOCRINOLOGY, V142, P3649, DOI 10.1210/en.142.8.3649; Rammos G, 2008, INT UROL NEPHROL, V40, P419, DOI 10.1007/s11255-007-9244-4; Rani N, 2016, FREE RADICAL RES, V50, P1226, DOI 10.1080/10715762.2016.1228923; Roa M, 1985, PC STAT ONE WAY ANAL; Sagar P, EXPT TUBOLOINTERSTIT; Sanchez-Nino MD, 2012, AM J PHYSIOL-RENAL, V302, pF647, DOI 10.1152/ajprenal.00090.2011; Sha JB, 2017, MOL MED REP, V16, P7715, DOI 10.3892/mmr.2017.7522; SHAMISS A, 1995, AM J HYPERTENS, V8, P276, DOI 10.1016/0895-7061(94)00181-A; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; Stump CS, 2006, MAYO CLIN PROC, V81, P796, DOI 10.4065/81.6.796; Suarez-Martinez Edu, 2014, Ther Adv Cardiovasc Dis, V8, P224, DOI 10.1177/1753944714542593; Suh SH, 2013, KOREAN J PHYSIOL PHA, V17, P435, DOI 10.4196/kjpp.2013.17.5.435; Sznarkowska A, 2010, POSTEP HIG MED DOSW, V64, P396; Tan XY, 2008, J AM SOC NEPHROL, V19, P1741, DOI 10.1681/ASN.2007060666; Tikellis C, 2004, DIABETES, V53, P989, DOI 10.2337/diabetes.53.4.989; Tylicki L, 2012, J NEPHROL, V25, P900, DOI 10.5301/jn.5000134; Vermes E, 2003, CIRCULATION, V107, P1291, DOI 10.1161/01.CIR.0000054611.89228.92; Xin SB, 2016, MED SCI MONITOR, V22, P5173, DOI 10.12659/MSM.898177; Yang ZS, 2015, MOL CELL ENDOCRINOL, V414, P111, DOI 10.1016/j.mce.2015.07.023; Zafar M, 2010, INT J MORPHOL, V28, P135, DOI 10.4067/S0717-95022010000100019; Zhang CL, 2004, ACTA PHARMACOL SIN, V25, P691; Ziamajidi N, 2017, PHARM BIOL, V55, P526, DOI 10.1080/13880209.2016.1255978	71	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0214349	10.1371/journal.pone.0214349	http://dx.doi.org/10.1371/journal.pone.0214349			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527864	Green Published, Green Submitted, gold			2022-12-26	WOS:000532231400002
J	Macicame, I; Bhatt, N; Chissumba, RM; Eller, LA; Viegas, E; Araujo, K; Nwoga, C; Li, Q; Milazzo, M; Hills, NK; Lindan, C; Michael, NL; Robb, ML; Jani, I; Polyak, CS				Macicame, Ivalda; Bhatt, Nilesh; Chissumba, Raquel Matavele; Eller, Leigh Anne; Viegas, Edna; Araujo, Khelvon; Nwoga, Chiaka; Li, Qun; Milazzo, Mark; Hills, Nancy K.; Lindan, Christina; Michael, Nelson L.; Robb, Merlin L.; Jani, Ilesh; Polyak, Christina S.			HIV prevalence and risk behavior among male and female adults screened for enrolment into a vaccine preparedness study in Maputo, Mozambique	PLOS ONE			English	Article							NEED; SEX	Introduction Mozambique continues to have a significant burden of HIV. Developing strategies to control the HIV epidemic remains a key priority for the Mozambican public health community. The primary aim of this study was to determine HIV prevalence and risk behavior among males and females screened for a HIV vaccine preparedness study in Maputo, Mozambique. Methods Male and female participants between 18-35 years old were recruited from the general community and from female sex worker (FSW) and lesbian, gay, bisexual, and transgender (LGBT) associations in Maputo. All participants were screened for HIV and a questionnaire was administered to each participant to assess HIV risk behavior. Results A total of 1125 adults were screened for HIV infection, among whom 506 (45%) were male. Among men, 5.7% reported having had sex with men (MSM) and 12% of female participants reported having exchanged sex for money, goods or favors in the past 3 months. The overall HIV prevalence was 10.4%; 10.7% of women, and 10.1% of men were HIV infected; 41.4% of MSM were seropositive. HIV infection was associated with older age (25-35 years old) (OR: 6.13, 95% CI: 3.01, 12.5), MSM (OR: 9.07, 95% CI: 3.85, 21.4), self-perception of being at high-risk for HIV (OR: 3.99, 95% CI: 1.27, 12.5) and self-report of a history of a diagnosis of sexually transmitted infection (OR: 3.75, 95% CI: 1.57, 8.98). Conclusion In our cohort, HIV prevalence was much higher among MSM compared to the overall prevalence. Behavioral factors were found to be more associated with HIV prevalence than demographic factors. The study findings demonstrate the critical importance of directing services to minority communities, such as MSM, when prevention strategies are being devised for the general population.	[Macicame, Ivalda; Bhatt, Nilesh; Chissumba, Raquel Matavele; Viegas, Edna; Araujo, Khelvon; Jani, Ilesh] Minist Saude, Inst Nacl Saude, Maputo, Mozambique; [Eller, Leigh Anne; Nwoga, Chiaka; Li, Qun; Milazzo, Mark; Michael, Nelson L.; Robb, Merlin L.; Polyak, Christina S.] Walter Reed Army Inst Res, Mil HIV Res Program, Silver Spring, MD 20910 USA; [Eller, Leigh Anne; Nwoga, Chiaka; Li, Qun; Milazzo, Mark; Robb, Merlin L.; Polyak, Christina S.] Henry Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA; [Hills, Nancy K.; Lindan, Christina] Univ Calif San Francisco, San Francisco, CA 94143 USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); University of California System; University of California San Francisco	Polyak, CS (corresponding author), Walter Reed Army Inst Res, Mil HIV Res Program, Silver Spring, MD 20910 USA.; Polyak, CS (corresponding author), Henry Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.	cpolyak@hivresearch.org		Nwoga, Chiaka/0000-0002-4514-330X; Matavele Chissumba, Raquel/0000-0003-1957-340X	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067, 3167]; U.S. Department of Defense (DOD) [W81XWH-07-2-0067]; U.S. National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH064712] Funding Source: NIH RePORTER	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense); U.S. National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD). This research was funded, in part, by the U.S. National Institute of Allergy and Infectious Diseases. Material has been reviewed by the Walter Reed Army Institute of Research. There is no objection to its presentation and/or publication. The opinions or assertions contained herein are the private views of the authors, and are not to be construed as official, or as reflecting true views of the Department of the Army, the Department of Defense, or the National Institutes of Health. The investigators have adhered to the policies for protection of human subjects as prescribed in AR 70-25. Financial assistance was provided by the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. to the Instituto Nacional de Sau ' de (INS) under the terms of the Clinical Services Agreement No. 3167. The funders had no role in the study, data collection, analysis, decision to publish or preparation of the manuscript.	Adamson B, 2017, PHARMACOECON-OPEN, V1, P1, DOI 10.1007/s41669-016-0009-9; Bos JM, 2001, PHARMACOECONOMICS, V19, P937, DOI 10.2165/00019053-200119090-00005; Cai Y, 2016, J INT AIDS SOC, V19, P26, DOI 10.7448/IAS.19.3.20800; Dube K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084979; Fauci AS, 2014, NEW ENGL J MED, V370, P495, DOI 10.1056/NEJMp1313771; Inguane C, 2015, AIDS BEHAV, V19, P2184, DOI 10.1007/s10461-015-1068-0; Instituto Nacional de Saude INdEI ICF Internacional, INQ IND IM MAL HIV S; Larmarange J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013189; Logie CH, 2017, J INT AIDS SOC, V20, DOI [10.7448/IAS.20.01/21422, 10.7448/IAS.20.1.21385, 10.7448/IAS.20.1.21422]; Nala R, 2015, AIDS BEHAV, V19, P393, DOI 10.1007/s10461-014-0895-8; Pond MJ, 2014, CLIN INFECT DIS, V58, P631, DOI 10.1093/cid/cit752; Republica de Mocambique MdS, 2006, GUIA TRATAMENTO CONT; UNAIDS, AIDS NUMB 2015; van der Elst EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005340; Viegas EO, 2018, AIDS RES HUM RETROV, V34, P193, DOI [10.1089/aid.2017.0121, 10.1089/AID.2017.0121]; Viegas EO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121452; Zango A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063427	17	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0221682	10.1371/journal.pone.0221682	http://dx.doi.org/10.1371/journal.pone.0221682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527868	Green Submitted, Green Published, gold			2022-12-26	WOS:000532231400006
J	Sagara, H; Sekiryu, T; Imaizumi, K; Shintake, H; Sugiyama, U; Maehara, H				Sagara, Hideto; Sekiryu, Tetsuju; Imaizumi, Kimihiro; Shintake, Hiroaki; Sugiyama, Urara; Maehara, Hiroki			Impact of tear metrics on the reliability of perimetry in patients with dry eye	PLOS ONE			English	Article							FALSE-NEGATIVE RESPONSES; OPEN-ANGLE GLAUCOMA; FIELD; INDICATORS; THRESHOLD; FREQUENCY; BLINKING; FATIGUE; QUALITY	Background The application of artificial tears before performing perimetry can improve the reliability and results of perimetry in patients with glaucoma and dry eye (DE). However, the effects of ocular surface and tear film conditions on perimetry measurements and reliability have not been fully characterized. Methods This prospective, cross-sectional, multicenter study investigated tear metrics in perimetry and assessed the relationships that existed among ocular surface condition, tear condition, and perimetry reliability. Forty-three eyes (43 patients) with DE disease according to the 2016 Japanese diagnostic criteria of DE and 43 eyes (43 subjects) of age- and visual field mean deviation-matched normal control subjects were studied. Perimetry was performed using the Humphrey Field Analyzer (30-2 SITA-Standard). Schirmer's test, strip meniscometry value, blink rate, tear film break-up time (TFBUT), fluorescein staining of ocular surface, and Dry Eye-related Quality of Life Score (DEQS) were measured. Blink rate was remeasured during perimetry. TFBUT and fluorescein staining were re-evaluated after perimetry. Perimetry reliability was evaluated with fixation loss, false-positive, and false-negative rates. Results Blink rate during perimetry was significantly lower for both patients with DE and normal controls (both P<0.001). TFBUT after perimetry was significantly higher than before perimetry in patients with DE (P<0.001). Fluorescein staining of ocular surface was significantly increased in patients with DE and normal control subjects (P=0.002 and P<0.001, respectively). Spearman correlation analysis revealed that blink rate during perimetry was negatively correlated with fixation-loss rate (r=-0.393, P=0.009) in patients with DE. Conclusions Performing perimetry was associated with a significant change in tear condition and ocular surface condition in both patients with DE and normal control subjects. The changes in tear condition and ocular surface condition may impact the reliability of perimetry in patients with DE.	[Sagara, Hideto] Marui Eye Clin, Minamisoma City, Fukushima, Japan; [Sagara, Hideto; Sekiryu, Tetsuju; Imaizumi, Kimihiro; Shintake, Hiroaki; Sugiyama, Urara; Maehara, Hiroki] Fukushima Med Univ, Dept Ophthalmol, Sch Med, Minamisoma City, Fukushima, Japan	Fukushima Medical University	Sagara, H (corresponding author), Marui Eye Clin, Minamisoma City, Fukushima, Japan.; Sagara, H (corresponding author), Fukushima Med Univ, Dept Ophthalmol, Sch Med, Minamisoma City, Fukushima, Japan.	hide1234@ruby.ocn.ne.jp		Sekiryu, Tetsuju/0000-0001-8042-2729				Anderson D. R., 1999, AUTOMATED STATIC PER, P80; Arai T, 2018, BRIT J OPHTHALMOL, V102, P525, DOI 10.1136/bjophthalmol-2017-310309; Bengtsson B, 2000, INVEST OPHTH VIS SCI, V41, P2201; Bron AJ, 2003, CORNEA, V22, P640, DOI 10.1097/00003226-200310000-00008; Bron AJ, 2007, OCUL SURF, V5, P108; Carl Zeiss Meditec, 2017, HUMPHR FIELD AN 2 I; Dogru M, 2006, INVEST OPHTH VIS SCI, V47, P1895, DOI 10.1167/iovs.05-0802; HOLLAND MK, 1972, PSYCHOL REP, V31, P119, DOI 10.2466/pr0.1972.31.1.119; Horikoshi N, 2001, JPN J OPHTHALMOL, V45, P503, DOI 10.1016/S0021-5155(01)00371-9; Ibrahim OMA, 2011, INVEST OPHTH VIS SCI, V52, P2194, DOI 10.1167/iovs.10-5986; Ishikawa S, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012969; Johnson CA, 2014, J GLAUCOMA, V23, P288, DOI 10.1097/IJG.0b013e31829463ab; Kastelan S, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/696328; Kocabeyoglu S, 2013, CAN J OPHTHALMOL, V48, P110, DOI 10.1016/j.jcjo.2012.11.001; Kunimatsu, 2000, Jpn J Ophthalmol, V44, P190, DOI 10.1016/S0021-5155(99)00209-9; Lal SKL, 2002, PSYCHOPHYSIOLOGY, V39, P313, DOI 10.1017/S0048577201393095; Matsumoto C, 2003, JPN J OPHTHALMOL, V47, P22, DOI 10.1016/S0021-5155(02)00663-9; Milla E, 2012, BRIT J OPHTHALMOL, V96, P826, DOI 10.1136/bjophthalmol-2011-301015; Ohtsuki Masanori, 2001, Nippon Ganka Gakkai Zasshi, V105, P149; Pavlidis M, 2005, GRAEF ARCH CLIN EXP, V243, P228, DOI 10.1007/s00417-004-1033-5; RIEGER G, 1992, BRIT J OPHTHALMOL, V76, P157, DOI 10.1136/bjo.76.3.157; Sakane Y, 2013, JAMA OPHTHALMOL, V131, P1331, DOI 10.1001/jamaophthalmol.2013.4503; Schein OD, 1997, AM J OPHTHALMOL, V124, P723, DOI 10.1016/S0002-9394(14)71688-5; Schein OD, 1999, ARCH INTERN MED, V159, P1359, DOI 10.1001/archinte.159.12.1359; Schleicher R, 2008, ERGONOMICS, V51, P982, DOI 10.1080/00140130701817062; TSUBOTA K, 1995, ARCH OPHTHALMOL-CHIC, V113, P155, DOI 10.1001/archopht.1995.01100020037025; Tsubota K, 2017, OCUL SURF, V15, P65, DOI 10.1016/j.jtos.2016.09.003; Uchida H, 1996, JPN J OPHTHALMOL, V40, P548; Van Orden KF, 2000, BIOL PSYCHOL, V52, P221, DOI 10.1016/S0301-0511(99)00043-5; Wang JH, 2008, AM J OPHTHALMOL, V145, P795, DOI 10.1016/j.ajo.2007.12.035; Wang YF, 2011, INVEST OPHTH VIS SCI, V52, P4546, DOI 10.1167/iovs.10-6553; Yamazaki Y, 2002, JPN J OPHTHALMOL, V46, P89, DOI 10.1016/S0021-5155(01)00461-0; Yenice O, 2007, EYE, V21, P214, DOI 10.1038/sj.eye.6702252	33	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222467	10.1371/journal.pone.0222467	http://dx.doi.org/10.1371/journal.pone.0222467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4PG	31527920	gold, Green Submitted, Green Published			2022-12-26	WOS:000532231400023
J	Sung, JS; Kang, CW; Kang, S; Jang, Y; Chae, YC; Kim, BG; Cho, NH				Sung, Jin Sol; Kang, Chan Woo; Kang, Suki; Jang, Yeonsue; Chae, Young Chan; Kim, Baek Gil; Cho, Nam Hoon			ITGB4-mediated metabolic reprogramming of cancer-associated fibroblasts	ONCOGENE			English	Article							AEROBIC GLYCOLYSIS; OXIDATIVE STRESS; MITOPHAGY; EXPRESSION; CAVEOLIN-1; AUTOPHAGY; CELLS; PROGRESSION; APOPTOSIS; WARBURG	Integrin beta 4 (ITGB4) overexpression in cancer cells contributes to cancer progression. However, the role of stromal ITGB4 expression in cancer progression remains poorly understood, despite stromal ITGB4 overexpression in malignant cancers. In our study, ITGB4-overexpressing triple negative breast cancer (TNBC) cells provided cancer-associated fibroblasts (CAFs) with ITGB4 proteins via exosomes, which induced BNIP3L-dependent mitophagy and lactate production in CAFs. In coculture assays, the ITGB4-induced mitophagy and glycolysis were suppressed in CAFs by knocking down ITGB4 or inhibiting exosome generation in MDA-MB-231, or blocking c-Jun or AMPK phosphorylation in CAFs. ITGB4-overexpressing CAF-conditioned medium promoted the proliferation, epithelial-to-mesenchymal transition, and invasion of breast cancer cells. In a co-transplant mouse model, MDA-MB-231 made a bigger tumor mass with CAFs than ITGB4 knockdown MDA-MB-231. Herein, we presented how TNBC-derived ITGB4 protein triggers glycolysis in CAFs via BNIP3L-dependent mitophagy and suggested the possibility that ITGB4-induced mitophagy could be targeted as a cancer therapy.	[Sung, Jin Sol; Kang, Chan Woo; Kim, Baek Gil; Cho, Nam Hoon] Yonsei Univ, Coll Med, Brain Korea 21 Plus Project Med Sci, Seoul, South Korea; [Kang, Suki; Jang, Yeonsue; Kim, Baek Gil; Cho, Nam Hoon] Yonsei Univ, Dept Pathol, Coll Med, Seoul, South Korea; [Kang, Suki; Cho, Nam Hoon] Yonsei Univ, SBSI, Coll Med, Seoul, South Korea; [Chae, Young Chan] Ulsan Natl Inst Sci & Technol, Sch Life Sci, Ulsan, South Korea; [Cho, Nam Hoon] Yonsei Univ, Global 5 5 10 Syst Biol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Ulsan National Institute of Science & Technology (UNIST); Yonsei University	Kim, BG; Cho, NH (corresponding author), Yonsei Univ, Coll Med, Brain Korea 21 Plus Project Med Sci, Seoul, South Korea.; Kim, BG; Cho, NH (corresponding author), Yonsei Univ, Dept Pathol, Coll Med, Seoul, South Korea.; Cho, NH (corresponding author), Yonsei Univ, SBSI, Coll Med, Seoul, South Korea.; Cho, NH (corresponding author), Yonsei Univ, Global 5 5 10 Syst Biol, Seoul, South Korea.	bbaekiri@yuhs.ac; cho1988@yuhs.ac		KANG, SUKI/0000-0002-9957-3479; kang, chan woo/0000-0001-5822-5235; Jang, Yeonsue/0000-0001-5683-0001; Sung, Jin Sol/0000-0002-7899-8814; jo, namhun/0000-0002-0045-6441; KIM, BAEK GIL/0000-0001-6270-1433	Mid-Career Researcher Program through a National Research Foundation of Korea [2019R1A2B5B01069934]; Challenges in Creative Research through a National Research Foundation of Korea [2019R1I1A1A01060549]; Health Fellowship Foundation - Yuhan Corporation; Medical Illustration & Design, a part of the Medical Research Support Services of Yonsei University College of Medicine	Mid-Career Researcher Program through a National Research Foundation of Korea(National Research Foundation of Korea); Challenges in Creative Research through a National Research Foundation of Korea(National Research Foundation of Korea); Health Fellowship Foundation - Yuhan Corporation; Medical Illustration & Design, a part of the Medical Research Support Services of Yonsei University College of Medicine	This study was supported by the Mid-Career Researcher Program (no. 2019R1A2B5B01069934; NHC) and Challenges in Creative Research (no. 2019R1I1A1A01060549; BGK) through a National Research Foundation of Korea grant, and The Health Fellowship Foundation grants funded by Yuhan Corporation. The authors thank Medical Illustration & Design, a part of the Medical Research Support Services of Yonsei University College of Medicine, for all artistic support related to this work.	Cicenas J, 2018, CANCERS, V10, DOI 10.3390/cancers10010001; Esteban-Martinez L, 2017, EMBO J, V36, P1688, DOI 10.15252/embj.201695916; Frank M, 2012, BBA-MOL CELL RES, V1823, P2297, DOI 10.1016/j.bbamcr.2012.08.007; Fu YJ, 2017, ONCOTARGET, V8, P57813, DOI 10.18632/oncotarget.18175; Jezek J, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7010013; Ke HN, 2010, CANCER RES, V70, P3080, DOI 10.1158/0008-5472.CAN-09-2923; Kim BG, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.73; Kim BG, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3203; Kim BG, 2011, AM J PATHOL, V178, P373, DOI 10.1016/j.ajpath.2010.11.028; Kosgodage US, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00889; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kubli DA, 2012, CIRC RES, V111, P1208, DOI 10.1161/CIRCRESAHA.112.265819; Li X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00596-9; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Liu MH, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0160-x; Liu SY, 2016, ONCOTARGET, V7, P16282, DOI 10.18632/oncotarget.7646; Martinez-Outschoorn UE, 2011, CELL CYCLE, V10, P2504, DOI 10.4161/cc.10.15.16585; Martins D, 2013, CELL CYCLE, V12, P2684, DOI 10.4161/cc.25794; Maycotte P, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317698391; McKeown SR, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20130676; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Pavlides S, 2012, ANTIOXID REDOX SIGN, V16, P1264, DOI 10.1089/ars.2011.4243; Pavlides S, 2009, CELL CYCLE, V8, P3984, DOI 10.4161/cc.8.23.10238; PETERKOFSKY B, 1982, CANCER RES, V42, P1809; Quelo I, 2004, J BIOL CHEM, V279, P43893, DOI 10.1074/jbc.M406310200; Ratnikov BI, 2017, ONCOGENE, V36, P147, DOI 10.1038/onc.2016.198; Renschler MF, 2004, EUR J CANCER, V40, P1934, DOI 10.1016/j.ejca.2004.02.031; Roach PJ, 2011, MOL CELL BIOL, V31, P3082, DOI 10.1128/MCB.05565-11; Schwarten M, 2009, AUTOPHAGY, V5, P690, DOI 10.4161/auto.5.5.8494; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Sheen JH, 2011, CANCER CELL, V19, P613, DOI 10.1016/j.ccr.2011.03.012; Takahashi A, 2006, NAT CELL BIOL, V8, P1291, DOI 10.1038/ncb1491; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vallejo Abbe N, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4861; Witkiewicz AK, 2009, CANCER BIOL THER, V8, P1071, DOI 10.4161/cbt.8.11.8874; Wu KN, 2011, CELL CYCLE, V10, P4250, DOI 10.4161/cc.10.24.18551; Xiao B, 2017, J BIOL CHEM, V292, P16697, DOI 10.1074/jbc.M117.787739; Yang L, 2015, ONCOTARGET, V6, P25755, DOI 10.18632/oncotarget.4697	39	58	64	6	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	3					664	676		10.1038/s41388-019-1014-0	http://dx.doi.org/10.1038/s41388-019-1014-0			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KG1RJ	31534187				2022-12-26	WOS:000509718300013
J	Wang, L; Zhao, HY; Li, J; Xu, YQ; Lan, YJ; Yin, WK; Liu, XQ; Yu, L; Lin, SH; Du, MYF; Li, X; Xiao, Y; Zhang, YP				Wang, Li; Zhao, Hongying; Li, Jing; Xu, Yingqi; Lan, Yujia; Yin, Wenkang; Liu, Xiaoqin; Yu, Lei; Lin, Shihua; Du, Michael Yifei; Li, Xia; Xiao, Yun; Zhang, Yunpeng			Identifying functions and prognostic biomarkers of network motifs marked by diverse chromatin states in human cell lines	ONCOGENE			English	Article							FACTOR-BINDING SITES; REGULATORY NETWORK; DNA-DAMAGE; LEUKEMIA; DYNAMICS; GENES; EGR1	Epigenetic modifications play critical roles in modulating gene expression, yet their roles in regulatory networks in human cell lines remain poorly characterized. We integrated multiomics data to construct directed regulatory networks with nodes and edges labeled with chromatin states in human cell lines. We observed extensive association of diverse chromatin states and network motifs. The gene expression analysis showed that diverse chromatin states of coherent type-1 feedforward loop (C1-FFL) and incoherent type-1 feedforward loops (I1-FFL) contributed to the dynamic expression patterns of targets. Notably, diverse chromatin state compositions could help C1- or I1-FFL to control a large number of distinct biological functions in human cell lines, such as four different types of chromatin state compositions cooperating with K562-associated C1-FFLs controlling "regulation of cytokinesis," "G1/S transition of mitotic cell cycle," "DNA recombination," and "telomere maintenance," respectively. Remarkably, we identified six chromatin state-marked C1-FFL instances (HCFC1-NFYA-ABL1, THAP1-USF1-BRCA2, ZNF263-USF1-UBA52, MYC-ATF1-UBA52, ELK1-EGR1-CCT4, and YY1-EGR1-INO80C) could act as prognostic biomarkers of acute myelogenous leukemia though influencing cancer-related biological functions, such as cell proliferation, telomere maintenance, and DNA recombination. Our results will provide novel insight for better understanding of chromatin state-mediated gene regulation and facilitate the identification of novel diagnostic and therapeutic biomarkers of human cancers.	[Wang, Li; Zhao, Hongying; Xu, Yingqi; Lan, Yujia; Yin, Wenkang; Liu, Xiaoqin; Yu, Lei; Lin, Shihua; Li, Xia; Xiao, Yun; Zhang, Yunpeng] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Peoples R China; [Li, Jing] Heilongjiang Univ Chinese Med, Affiliated Hosp 1, Dept Ultrason Med, Harbin 150040, Peoples R China; [Du, Michael Yifei] Weston High Sch Massachusetts, 444 Wellesley St, Weston, MA 02493 USA	Harbin Medical University; Heilongjiang University of Chinese Medicine	Li, X; Xiao, Y; Zhang, YP (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Peoples R China.	lixia@hrbmu.edu.cn; xiaoyun@ems.hrbmu.edu.cn; zyp19871208@126.com	Xiao, Yun/A-8359-2013	Li, Xia/0000-0002-9794-2648; Xu, Yingqi/0000-0001-6879-639X	National Natural Science Foundation of China [31801115, 61803129, 61603116, 61873075]; China Postdoctoral Science Foundation [2018M631943, 2018M641860]; China Postdoctoral Science Special Foundation [2019T120280]; Hei Long Jiang Postdoctoral Foundation [LBH-Z17110, LBH-Z17218]; General Program of Natural Science Foundation of Heilongjiang Province [H2016055]; Fundamental Research Funds for the Provincial Universities [2017JCZX54, 2017JCZX51]; Heilongjiang Provincial Health and Family Planning Commission of Science Foundation [2018476, 2018477]; Heilongjiang Provincial planning office key subjects [GBB1318066]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); China Postdoctoral Science Special Foundation; Hei Long Jiang Postdoctoral Foundation; General Program of Natural Science Foundation of Heilongjiang Province; Fundamental Research Funds for the Provincial Universities; Heilongjiang Provincial Health and Family Planning Commission of Science Foundation; Heilongjiang Provincial planning office key subjects	This work was financially supported by the National Natural Science Foundation of China (31801115, 61803129, 61603116, and 61873075), the China Postdoctoral Science Foundation (2018M631943 and 2018M641860), the China Postdoctoral Science Special Foundation (2019T120280), the Hei Long Jiang Postdoctoral Foundation (LBH-Z17110 and LBH-Z17218), General Program of Natural Science Foundation of Heilongjiang Province (H2016055) and Fundamental Research Funds for the Provincial Universities (2017JCZX54 and 2017JCZX51). Heilongjiang Provincial Health and Family Planning Commission of Science Foundation (2018476 and 2018477). Heilongjiang Provincial planning office key subjects (GBB1318066).	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; [Anonymous], AM SOC CLIN ONCOL S; Arneson A, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0488-1; Bulut-Karslioglu A, 2012, NAT STRUCT MOL BIOL, V19, P1023, DOI 10.1038/nsmb.2382; Cancer Genome Atlas Research Network. Electronic address: wheeler@bcm.edu, 2017, Cell, V169, P1327, DOI 10.1016/j.cell.2017.05.046; Chepyala SR, 2016, SCI REP-UK, V6, DOI 10.1038/srep23607; Dasgupta Y, 2016, BLOOD, V127, P2131, DOI 10.1182/blood-2015-11-681171; de Hoon MJL, 2010, CURR BIOL, V20, pR735, DOI 10.1016/j.cub.2010.06.031; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Gkountela S, 2014, STEM CELL REV REP, V10, P230, DOI 10.1007/s12015-013-9490-z; Gui R, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00600; Hoffmeyer K, 2012, SCIENCE, V336, P1549, DOI 10.1126/science.1218370; Hong J, 2018, ELIFE, V7, DOI 10.7554/eLife.32323; Hsu YL, 2013, ONCOGENE, V32, P4436, DOI 10.1038/onc.2012.444; Hu JL, 2017, MOLECULES, V22, DOI 10.3390/molecules22122194; Hyka-Nouspikel N, 2012, STEM CELLS, V30, P1901, DOI 10.1002/stem.1177; Jin YL, 2016, J CLIN INVEST, V126, P3961, DOI 10.1172/JCI85239; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kittisopikul M, 2010, P NATL ACAD SCI USA, V107, P13300, DOI 10.1073/pnas.1003975107; Krapf G, 2010, ONCOGENE, V29, P3307, DOI 10.1038/onc.2010.53; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li XT, 2019, IEEE T CYBERNETICS, V49, P1680, DOI 10.1109/TCYB.2018.2817480; Libbrecht MW, 2015, GENOME RES, V25, P544, DOI 10.1101/gr.184341.114; Lu C, 2013, ONCOGENE, V32, P5602, DOI 10.1038/onc.2013.349; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Mahmoudi S, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2010.90; Maifrede S, 2017, MOL CANCER RES, V15, P967, DOI 10.1158/1541-7786.MCR-16-0468; Marco A, 2009, BIOINFORMATICS, V25, P2473, DOI 10.1093/bioinformatics/btp462; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Ocone A, 2015, BIOINFORMATICS, V31, P89, DOI 10.1093/bioinformatics/btv257; Pan X, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0291-9; Plaisier CL, 2016, CELL SYST, V3, P172, DOI 10.1016/j.cels.2016.06.006; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; Reavie L, 2013, CANCER CELL, V23, P362, DOI 10.1016/j.ccr.2013.01.025; Shizuka D, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0080; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Soshnev AA, 2016, MOL CELL, V62, P681, DOI 10.1016/j.molcel.2016.05.004; Steinbrecher D, 2018, LEUKEMIA LYMPHOMA, V59, P1614, DOI 10.1080/10428194.2017.1390236; Stoddart A, 2014, BLOOD, V123, P1069, DOI 10.1182/blood-2013-07-517953; Stuart JR, 2005, ONCOGENE, V24, P8085, DOI 10.1038/sj.onc.1208953; Sun LX, 2015, NUCLEIC ACIDS RES, V43, P6334, DOI 10.1093/nar/gkv598; Taher L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r117; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Wang L, 2019, INT J CANCER, V144, P1723, DOI 10.1002/ijc.31865; Weirick T, 2016, BRIEF BIOINFORM, V17, P678, DOI 10.1093/bib/bbv067; Wernicke S, 2006, BIOINFORMATICS, V22, P1152, DOI 10.1093/bioinformatics/btl038; Wong JJL, 2014, CANCER SCI, V105, P1457, DOI 10.1111/cas.12532; Wong K. -C., 2016, COMPUTATIONAL BIOL B, DOI 10.1201/b20026; Wu S, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-18; Yevshin I, 2017, NUCLEIC ACIDS RES, V45, pD61, DOI 10.1093/nar/gkw951; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang S, 2013, FEBS LETT, V587, P645, DOI 10.1016/j.febslet.2013.01.019; Zhao HY, 2016, BBA-GEN SUBJECTS, V1860, P1475, DOI 10.1016/j.bbagen.2016.04.008; Zhao HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep11938	57	8	9	0	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	3					677	689		10.1038/s41388-019-1005-1	http://dx.doi.org/10.1038/s41388-019-1005-1			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KG1RJ	31537905	Green Published, hybrid			2022-12-26	WOS:000509718300014
J	Schadeli, D; Serricchio, M; Ben Hamidane, H; Loffreda, A; Hemphill, A; Beneke, T; Gluenz, E; Graumann, J; Butikofer, P				Schadeli, David; Serricchio, Mauro; Ben Hamidane, Hisham; Loffreda, Alessio; Hemphill, Andrew; Beneke, Tom; Gluenz, Eva; Graumann, Johannes; Butikofer, Peter			Cardiolipin depletion-induced changes in the Trypanosoma brucei proteome	FASEB JOURNAL			English	Article						mitochondria; phospholipid; SILAC; oxidative phosphorylation; protozoa	SUBSTRATE LEVEL PHOSPHORYLATION; MEMBRANE-PROTEIN; ATP SYNTHASE; CYTOCHROME-C; SACCHAROMYCES-CEREVISIAE; COMPLEX-III; METABOLISM; BACTERIAL; TURNOVER; GROWTH	The mitochondrial signature glycerophospholipid, cardiolipin (CL), binds to transporters of the inner mitochondrial membrane and plays a central role in formation and stability of respiratory supercomplexes. Functional and structural requirement of CL for mitochondrial membrane proteins has been studied in vitro using purified reconstituted proteins or in CL synthesis knockout cells that are viable under specific growth conditions. However, no information is available on mitochondrial function, protein stability, or expression levels in cells during CL depletion. In contrast to yeast and mammalian cells, CL synthesis is essential in Trypanosoma brucei. By stable isotope labeling with amino acids in cell culture and mass spectrometry, we analyzed protein levels in T. brucei procyclic forms at different time points during depletion of CL using tightly controllable conditional CL synthase knockout mutants and identified a set of novel CL-dependent proteins (CLDPs) with unknown functions. Depletion of individual CLDPs using knockout or knockdown technologies showed that although CL synthesis is essential, expression of a given CLDP is not. In addition, ablation of CL synthesis leads to respiratory supercomplex instability and altered mitochondrial ultrastructure and function. Our findings suggest that CL may bind to and affect many more proteins in eukaryotes than previously thought.	[Schadeli, David; Serricchio, Mauro; Loffreda, Alessio; Butikofer, Peter] Univ Bern, Vetsuisse Fac, Inst Biochem & Mol Med, Bern, Switzerland; [Schadeli, David; Loffreda, Alessio] Univ Bern, Vetsuisse Fac, Grad Sch Cellular & Biomed Sci, Bern, Switzerland; [Hemphill, Andrew] Univ Bern, Vetsuisse Fac, Inst Parasitol, Bern, Switzerland; [Ben Hamidane, Hisham; Graumann, Johannes] Weill Cornell Med Coll Qatar, Doha, Qatar; [Beneke, Tom; Gluenz, Eva] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England; [Graumann, Johannes] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany	University of Bern; University of Bern; University of Bern; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Oxford; Max Planck Society	Butikofer, P (corresponding author), Inst Biochem & Mol Med, B uhlstr 28, CH-3012 Bern, Switzerland.	peter.buetikofer@ibmm.unibe.ch	Graumann, Johannes/C-5241-2008	Graumann, Johannes/0000-0002-3015-5850; Hemphill, Andrew/0000-0002-0622-2128; Beneke, Tom/0000-0001-9117-2649; Serricchio, Mauro/0000-0002-7094-9807	Swiss National Science Foundation [149353, 169355]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors thank Alena P. Zikova (University of South Bohemia, Ceske Budejovice, Czech Republic), Andre Schneider (University of Bern), and James D. Bangs (University of Buffalo, Buffalo, NY, USA) for antibodies, and Anant K. Menon (Weill Cornell Medical College New York, NY, USA) for advice. M.S. thanks K.D. for support. P.B. thanks A. Niederer and W. White for advice and stimulation. This work was supported by Swiss National Science Foundation Grants 149353 and 169355 (to P.B.). The authors declare no conflicts of interest.	Acehan D, 2011, BIOPHYS J, V100, P2184, DOI 10.1016/j.bpj.2011.03.031; Acestor N, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006908; Allemann N, 2000, MOL BIOCHEM PARASIT, V111, P87, DOI 10.1016/S0166-6851(00)00303-0; ARDAIL D, 1990, J BIOL CHEM, V265, P18797; BALL WB, 2018, FEBS LETT, V592, P1273, DOI DOI 10.1002/1873-3468.12887; Ban T, 2017, NAT CELL BIOL, V19, P856, DOI 10.1038/ncb3560; Bangs JD, 1996, J BIOL CHEM, V271, P18387, DOI 10.1074/jbc.271.31.18387; Beneke T, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170095; Besteiro S, 2005, TRENDS PARASITOL, V21, P185, DOI 10.1016/j.pt.2005.02.008; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Boyd KJ, 2018, BIOPHYS J, V114, P2116, DOI 10.1016/j.bpj.2018.04.001; Bruggisser J, 2017, J BIOL CHEM, V292, P3400, DOI 10.1074/jbc.M116.755983; Burkard GS, 2011, MOL BIOCHEM PARASIT, V175, P91, DOI 10.1016/j.molbiopara.2010.09.002; Charriere F, 2006, P NATL ACAD SCI USA, V103, P6847, DOI 10.1073/pnas.0602362103; Choi SY, 2007, CELL DEATH DIFFER, V14, P597, DOI 10.1038/sj.cdd.4402020; Cirovic O, 2014, METHODS MOL BIOL, V1188, P47, DOI 10.1007/978-1-4939-1142-4_4; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; Coustou V, 2003, J BIOL CHEM, V278, P49625, DOI 10.1074/jbc.M307872200; Dean S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140197; Desy S, 2012, MOL BIOCHEM PARASIT, V185, P161, DOI 10.1016/j.molbiopara.2012.07.005; Dobson L, 2015, NUCLEIC ACIDS RES, V43, pW408, DOI 10.1093/nar/gkv451; Dowhan W, 2004, BBA-BIOMEMBRANES, V1666, P19, DOI 10.1016/j.bbamem.2004.04.010; Duncan AL, 2016, P NATL ACAD SCI USA, V113, P8687, DOI 10.1073/pnas.1608396113; EBLE KS, 1990, J BIOL CHEM, V265, P19434; Farine L, 2013, BBA-MOL CELL BIOL L, V1831, P533, DOI 10.1016/j.bbalip.2012.09.008; Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794; FRY M, 1981, J BIOL CHEM, V256, P1874; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Gohil VM, 2004, J BIOL CHEM, V279, P42612, DOI 10.1074/jbc.M402545200; Gomez B, 1999, BIOCHEMISTRY-US, V38, P9031, DOI 10.1021/bi990603r; Gupta K, 2017, NATURE, V541, P421, DOI 10.1038/nature20820; Haines TH, 2009, BBA-BIOMEMBRANES, V1788, P1997, DOI 10.1016/j.bbamem.2009.09.008; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Klingenberg M, 2009, BBA-BIOMEMBRANES, V1788, P2048, DOI 10.1016/j.bbamem.2009.06.007; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Laage S, 2015, BBA-BIOMEMBRANES, V1848, P260, DOI 10.1016/j.bbamem.2014.08.021; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamb JR, 2001, J BIOL CHEM, V276, P21512, DOI 10.1074/jbc.M100235200; Lamour N, 2005, J BIOL CHEM, V280, P11902, DOI 10.1074/jbc.M414274200; LANDRISCINA C, 1976, LIPIDS, V11, P61, DOI 10.1007/BF02532585; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Lewis RNAH, 2009, BBA-BIOMEMBRANES, V1788, P2069, DOI 10.1016/j.bbamem.2009.03.014; Lykidis A, 2007, PROG LIPID RES, V46, P171, DOI 10.1016/j.plipres.2007.03.003; Maguire JJ, 2017, BBA-MOL CELL BIOL L, V1862, P8, DOI 10.1016/j.bbalip.2016.08.001; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; McCann AK, 2008, MOL BIOCHEM PARASIT, V159, P146, DOI 10.1016/j.molbiopara.2008.02.003; Mileykovskaya E, 2014, CHEM PHYS LIPIDS, V179, P42, DOI 10.1016/j.chemphyslip.2013.10.012; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Naguleswaran A, 2015, MBIO, V6, DOI 10.1128/mBio.00114-15; Nejad LD, 2018, MOL MICROBIOL, V109, P105, DOI 10.1111/mmi.13976; Niemann M, 2013, MOL CELL PROTEOMICS, V12, P515, DOI 10.1074/mcp.M112.023093; NOLAN DP, 1992, EUR J BIOCHEM, V209, P207, DOI 10.1111/j.1432-1033.1992.tb17278.x; Oberholzer M, 2006, MOL BIOCHEM PARASIT, V145, P117, DOI 10.1016/j.molbiopara.2005.09.002; Ortiz A, 1999, BIOPHYS J, V77, P2003, DOI 10.1016/S0006-3495(99)77041-4; Peikert CD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15272; Pennington ER, 2018, J BIOL CHEM, V293, P15933, DOI 10.1074/jbc.RA118.004948; Peyta L, 2016, BBA-BIOENERGETICS, V1857, P443, DOI 10.1016/j.bbabio.2016.01.002; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Pineau B, 2013, PLANT CELL, V25, P4195, DOI 10.1105/tpc.113.118018; Planas-Iglesias J, 2015, BIOPHYS J, V109, P1282, DOI 10.1016/j.bpj.2015.07.034; Ponting CP, 1999, TRENDS BIOCHEM SCI, V24, P130, DOI 10.1016/S0968-0004(99)01362-6; Pusnik M, 2011, CURR BIOL, V21, P1738, DOI 10.1016/j.cub.2011.08.060; Raemy E, 2016, CELL DEATH DIFFER, V23, P1165, DOI 10.1038/cdd.2015.166; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Renner LD, 2011, P NATL ACAD SCI USA, V108, P6264, DOI 10.1073/pnas.1015757108; Ruepp S, 1997, J CELL BIOL, V137, P1369, DOI 10.1083/jcb.137.6.1369; Sakamoto T, 2012, J BIOL CHEM, V287, P4590, DOI 10.1074/jbc.M111.314823; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; SCHLAME M, 1990, BIOCHEM J, V265, P79, DOI 10.1042/bj2650079; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Schlame M, 2017, BBA-MOL CELL BIOL L, V1862, P3, DOI 10.1016/j.bbalip.2016.08.010; Schmidt RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093875; Sedlak E, 1999, BIOCHEMISTRY-US, V38, P14966, DOI 10.1021/bi9914053; Serricchio M, 2013, MOL MICROBIOL, V87, P569, DOI 10.1111/mmi.12116; Serricchio M, 2012, P NATL ACAD SCI USA, V109, pE954, DOI 10.1073/pnas.1121528109; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Singha UK, 2008, MOL BIOCHEM PARASIT, V159, P30, DOI 10.1016/j.molbiopara.2008.01.003; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Tan BK, 2012, P NATL ACAD SCI USA, V109, P16504, DOI 10.1073/pnas.1212797109; Tian HF, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-32; Tielens AGM, 1998, PARASITOL TODAY, V14, P265, DOI 10.1016/S0169-4758(98)01263-0; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xu Y, 2016, NAT CHEM BIOL, V12, P641, DOI [10.1038/NCHEMBIO.2113, 10.1038/nchembio.2113]; Xu Y, 2014, CHEM PHYS LIPIDS, V179, P17, DOI 10.1016/j.chemphyslip.2013.10.005; Zhang M, 2003, J BIOL CHEM, V278, P35204, DOI 10.1074/jbc.M306729200; Zikova A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000436	90	7	7	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13161	13175		10.1096/fj.201901184RR	http://dx.doi.org/10.1096/fj.201901184RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31536395	Bronze			2022-12-26	WOS:000507466100011
J	Shan, SZ; Fang, B; Zhang, YF; Wang, CD; Zhou, J; Niu, CG; Gao, Y; Zhao, DY; He, JH; Wang, J; Zhang, XL; Li, QF				Shan, Shengzhou; Fang, Bin; Zhang, Yifan; Wang, Chuandong; Zhou, Jia; Niu, Chenguang; Gao, Ya; Zhao, Danyang; He, Jiahao; Wang, Jing; Zhang, Xiaoling; Li, Qingfeng			Mechanical stretch promotes tumoricidal M1 polarization via the FAK/NF-kappa B signaling pathway	FASEB JOURNAL			English	Article						mechanical force; macrophage polarization; cancer; immunotherapy; focal adhesion kinase	FOCAL ADHESION KINASE; NITRIC-OXIDE SYNTHASE; MACROPHAGE POLARIZATION; SHEAR-STRESS; ACTIVATION; INFLAMMATION; STRAIN; CELLS; MECHANOTRANSDUCTION; EXPRESSION	Macrophages (M phi s) can be used as a part of cell-based cancer immunotherapy. However, they may be hampered by a failure to effectively and stably regulate their polarization state to enhance their tumoricidal effects. In this work, mechanical stretch (MS), as a biology-free modulatory method, was shown to enhance M1 polarization and tumoricidal effects. By using an in vitro Flexcell Tension system, we found that murine M phi RAW264.7 cells showed higher M1 polarization related mRNA expression and cytokine release after MS. Further molecular analyses found that focal adhesion kinase and NF-kappa B activation occurred in the MS-induced M1 polarization. Coculture of MS-preconditioned M phi with B16F10 skin melanoma cells in vitro showed that the proliferation of B16F10 cells decreased, whereas caspase-3 induced apoptosis increased. Importantly, the injection of MS-preconditioned M phi into murine skin melanomas in vivo impeded tumor growth; lesions were characterized by increased amounts of M1 M phi, decreased tumor cell proliferation, and increased tumor cell apoptosis in the tumor microenvironment. Together, our results suggest that MS could be used as a simple preconditioning approach to prepare tumoricidal M1 M phi for cancer immunotherapy.	[Shan, Shengzhou; Fang, Bin; Zhang, Yifan; Zhou, Jia; Gao, Ya; Zhao, Danyang; He, Jiahao; Li, Qingfeng] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Plast & Reconstruct Surg, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China; [Wang, Chuandong; Zhang, Xiaoling] Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Orthoped Surg, 1665 Kongjiang Rd, Shanghai 200062, Peoples R China; [Niu, Chenguang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Endodont, Shanghai, Peoples R China; [Wang, Jing] Shanghai Jiao Tong Univ, Shanghai Childrens Hosp, Dept Otorhinolaryngol Head & Neck Surg, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, QF (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Plast & Reconstruct Surg, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.; Zhang, XL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xin Hua Hosp, Dept Orthoped Surg, 1665 Kongjiang Rd, Shanghai 200062, Peoples R China.	xlzhang@shsmu.edu.cn; dr.liqingfeng@yahoo.com	Zhang, Yifan/AAL-3403-2021	Zhang, Yifan/0000-0002-0283-0468; Gao, Ya/0000-0001-8104-3069	National Natural Science Foundation of China [81601698, 81601688, 81620108019, 81830078]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National Natural Science Foundation of China (81601698, 81601688, 81620108019, and 81830078). The authors declare no conflicts of interest.	BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Ballotta V, 2014, BIOMATERIALS, V35, P4919, DOI 10.1016/j.biomaterials.2014.03.002; Banes AJ, 1995, BIOCHEM CELL BIOL, V73, P349, DOI 10.1139/o95-043; Boniakowski AE, 2017, J IMMUNOL, V199, P17, DOI 10.4049/jimmunol.1700223; Brown JM, 2017, CLIN CANCER RES, V23, P3241, DOI 10.1158/1078-0432.CCR-16-3122; Chen DG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03225-9; Chu SY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09402-8; Cuhlmann S, 2011, CIRC RES, V108, P950, DOI 10.1161/CIRCRESAHA.110.233841; Dai Z, 2014, J PATHOL, V234, P316, DOI 10.1002/path.4395; Fereol S, 2006, CELL MOTIL CYTOSKEL, V63, P321, DOI 10.1002/cm.20130; Genard G, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0757-9; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gudipaty SA, 2017, NATURE, V543, P118, DOI 10.1038/nature21407; Guerra AD, 2017, THERANOSTICS, V7, P3732, DOI 10.7150/thno.20251; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; He L, 2018, NATURE, V555, P103, DOI 10.1038/nature25744; Huang Y, 2012, FASEB J, V26, P3351, DOI 10.1096/fj.11-199240; Ishida T, 1996, CIRC RES, V79, P310, DOI 10.1161/01.RES.79.2.310; Iwanowycz S, 2016, J BIOL CHEM, V291, P11491, DOI 10.1074/jbc.M115.702092; Knapik DM, 2014, ANTIOXID REDOX SIGN, V20, P970, DOI 10.1089/ars.2013.5467; Lee E, 2014, CELL TRANSPLANT, V23, P285, DOI 10.3727/096368912X663541; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liao M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/683739; Liu LN, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan2966; Long KB, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26860; Maa MC, 2011, BBA-MOL CELL RES, V1813, P136, DOI 10.1016/j.bbamcr.2010.09.004; MacKenzie A, 2001, IMMUNITY, V15, P825, DOI 10.1016/S1074-7613(01)00229-1; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mayer IA, 2016, ANNU REV MED, V67, P11, DOI 10.1146/annurev-med-062913-051343; Mennens SFB, 2017, RESULTS PROBL CELL D, V62, P209, DOI 10.1007/978-3-319-54090-0_9; Mills CD, 2016, CANCER RES, V76, P513, DOI 10.1158/0008-5472.CAN-15-1737; Mills CD, 2014, J INNATE IMMUN, V6, P716, DOI 10.1159/000364945; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moon DG, 2008, TISSUE ENG PT A, V14, P473, DOI 10.1089/tea.2007.0104; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nguyen QD, 2009, P NATL ACAD SCI USA, V106, P16375, DOI 10.1073/pnas.0901310106; O'Sullivan T, 2012, J EXP MED, V209, P1869, DOI 10.1084/jem.20112738; Oakes PW, 2014, CURR OPIN CELL BIOL, V30, P68, DOI 10.1016/j.ceb.2014.06.003; Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093; Perske C, 2010, AM J PATHOL, V177, P2046, DOI 10.2353/ajpath.2010.091111; Petzold T, 2009, AM J PHYSIOL-CELL PH, V297, pC814, DOI 10.1152/ajpcell.00226.2009; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Pitsillides AA, 1995, FASEB J, V9, P1614, DOI 10.1096/fasebj.9.15.8529841; Pongkitwitoon S, 2016, J BIOMECH, V49, P793, DOI 10.1016/j.jbiomech.2016.01.027; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Pugin J, 1998, AM J PHYSIOL-LUNG C, V275, pL1040, DOI 10.1152/ajplung.1998.275.6.L1040; Quinlan AMT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023272; Ransom RC, 2018, NATURE, V563, P514, DOI 10.1038/s41586-018-0650-9; Rivilis I, 2002, AM J PHYSIOL-HEART C, V283, pH1430, DOI 10.1152/ajpheart.00082.2002; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Sager HB, 2016, CIRC RES, V119, P853, DOI 10.1161/CIRCRESAHA.116.309001; Shikata Y, 2005, EXP CELL RES, V304, P40, DOI 10.1016/j.yexcr.2004.11.001; Shiratsuchi H, 2004, AM J PHYSIOL-CELL PH, V286, pC1358, DOI 10.1152/ajpcell.00553.2003; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Simanovich E, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01931; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tanaka Y, 2018, J CONTROL RELEASE, V270, P177, DOI 10.1016/j.jconrel.2017.12.006; Tomakidi P, 2014, CELL TISSUE RES, V357, P515, DOI 10.1007/s00441-014-1945-2; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang J, 2015, CELL MOL LIFE SCI, V72, P2091, DOI 10.1007/s00018-015-1853-y; Wang PP, 2019, THERANOSTICS, V9, P1714, DOI 10.7150/thno.30716; Wang Y, 2017, BIOMATERIALS, V112, P153, DOI 10.1016/j.biomaterials.2016.09.034; Watkins SK, 2007, J IMMUNOL, V178, P1357, DOI 10.4049/jimmunol.178.3.1357; Wehner S, 2010, AM J PHYSIOL-GASTR L, V299, pG1187, DOI 10.1152/ajpgi.00452.2009; Wong VW, 2012, NAT MED, V18, P148, DOI 10.1038/nm.2574; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Xu G, 2016, INT IMMUNOPHARMACOL, V38, P175, DOI 10.1016/j.intimp.2016.05.027; Xu XL, 2014, INFLAMMATION, V37, P956, DOI 10.1007/s10753-014-9816-2; Yang JH, 2000, AM J PATHOL, V156, P1797, DOI 10.1016/S0002-9440(10)65051-1; Yao Z, 2006, CANCER IMMUNOL IMMUN, V55, P56, DOI 10.1007/s00262-005-0024-7; Young SRL, 2010, BONE, V47, P74, DOI 10.1016/j.bone.2010.03.014; Zaman G, 1999, J BONE MINER RES, V14, P1123, DOI 10.1359/jbmr.1999.14.7.1123; Zhang M, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1387347; Zhang YM, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.145; Zhu ZL, 2015, BIOCHEM BIOPH RES CO, V468, P601, DOI 10.1016/j.bbrc.2015.10.157	79	13	13	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13254	13266		10.1096/fj.201900799RR	http://dx.doi.org/10.1096/fj.201900799RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31539281	Bronze			2022-12-26	WOS:000507466100018
J	Yu, R; Liu, T; Ning, CF; Tan, F; Jin, SB; Lendahl, U; Zhao, J; Nister, M				Yu, Rong; Liu, Tong; Ning, Chenfei; Tan, Fei; Jin, Shao-Bo; Lendahl, Urban; Zhao, Jian; Nister, Monica			The phosphorylation status of Ser-637 in dynamin-related protein 1 (Drp1) does not determine Drp1 recruitment to mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitochondria; mitochondrial metabolism; molecular dynamics; membrane protein; membrane transport; signal transduction; dynamin-related protein 1 (Drp1); mitochondrial dynamics; mitochondrial elongation factor 1; 2 (MIEF1; 2); mitochondrial fission factor (Mff); phosphorylation; MIEF1; 2 (MiD51; 49); dynamin-related GTPase; protein kinase A (PKA); subcellular localization	FISSION; CELL; MFF; MORPHOLOGY; FUSION; MITOFUSINS; KINASE; MID51; MEMBRANES; COMPLEX	Recruitment of the GTPase dynamin-related protein 1 (Drp1) to mitochondria is a central step required for mitochondrial fission. Reversible Drp1 phosphorylation has been implicated in the regulation of this process, but whether Drp1 phosphorylation at Ser-637 determines its subcellular localization and fission activity remains to be fully elucidated. Here, using HEK 293T cells and immunofluorescence, immunoblotting, RNAi, subcellular fractionation, co-immunoprecipitation assays, and CRISPR/Cas9 genome editing, we show that Drp1 phosphorylated at Ser-637 (Drp1(pS637)) resides both in the cytosol and on mitochondria. We found that the receptors mitochondrial fission factor (Mff) and mitochondrial elongation factor 1/2 (MIEF1/2) interact with and recruit Drp1(pS637) to mitochondria and that elevated Mff or MIEF levels promote Drp1(pS637) accumulation on mitochondria. We also noted that protein kinase A (PKA), which mediates phosphorylation of Drp1 on Ser-637, is partially present on mitochondria and interacts with both MIEFs and Mff. PKA knockdown did not affect the Drp1-Mff interaction, but slightly enhanced the interaction between Drp1 and MIEFs. In Drp1-deficient HEK 293T cells, both phosphomimetic Drp1-S637D and phospho-deficient Drp1-S637A variants, like wild-type Drp1, located to the cytosol and to mitochondria and rescued a Drp1 deficiency-induced mitochondrial hyperfusion phenotype. However, Drp1-S637D was less efficient than Drp1-WT and Drp1-S637A in inducing mitochondrial fission. In conclusion, the Ser-637 phosphorylation status in Drp1 is not a determinant that controls Drp1 recruitment to mitochondria.	[Yu, Rong; Liu, Tong; Ning, Chenfei; Tan, Fei; Zhao, Jian; Nister, Monica] Karolinska Inst, Karolinska Univ Hosp Solna, Dept Oncol Pathol, Stockholm, Sweden; [Jin, Shao-Bo; Lendahl, Urban] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Zhao, J; Nister, M (corresponding author), Karolinska Univ Hosp Solna, BioClinicum, J5-30, Stockholm, Sweden.	jian.zhao@ki.se; monica.nister@ki.se	Zhao, Jian/F-9991-2019	Zhao, Jian/0000-0001-5659-730X; LIU, Tong/0000-0002-9323-6543; Yu, Rong/0000-0002-8488-0417	Swedish Research Council; Swedish Cancer Society; ICMC (AstraZeneca); BRECT Consortium at Karolinska Institutet; Cancer Society in Stockholm; Karolinska Institutet Grants; Knut and Alice Wallenberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); ICMC (AstraZeneca)(AstraZeneca); BRECT Consortium at Karolinska Institutet; Cancer Society in Stockholm; Karolinska Institutet Grants; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by the Swedish Research Council (VR-NT, VR-MH, and VR-Linne), Swedish Cancer Society, ICMC (AstraZeneca), BRECT Consortium at Karolinska Institutet, Cancer Society in Stockholm and Karolinska Institutet Grants. This work was also supported by the Knut and Alice Wallenberg Foundation (CLICK facility). The authors declare that they have no conflicts of interest with the contents of this article.	Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Amer YO, 2018, BBA-BIOENERGETICS, V1859, P868, DOI 10.1016/j.bbabio.2018.04.005; Autret A, 2009, MOL CELL, V36, P355, DOI 10.1016/j.molcel.2009.10.011; Cereghetti GM, 2008, P NATL ACAD SCI USA, V105, P15803, DOI 10.1073/pnas.0808249105; Chan DC, 2012, ANNU REV GENET, V46, P265, DOI 10.1146/annurev-genet-110410-132529; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Chang CR, 2010, ANN NY ACAD SCI, V1201, P34, DOI 10.1111/j.1749-6632.2010.05629.x; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Filadi R, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0023-6; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Gandre-Babbe S, 2008, MOL BIOL CELL, V19, P2402, DOI 10.1091/mbc.E07-12-1287; Hajek P, 2007, J BIOL CHEM, V282, P5670, DOI 10.1074/jbc.M608168200; Imai Y, 2011, CURR OPIN NEUROBIOL, V21, P935, DOI 10.1016/j.conb.2011.10.016; Jahani-Asl A, 2015, HUM MOL GENET, V24, P4573, DOI 10.1093/hmg/ddv188; Jhun BS, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7120195; Kiefel BR, 2006, INT REV CYTOL, V254, P151, DOI 10.1016/S0074-7696(06)54004-5; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Koirala S, 2013, P NATL ACAD SCI USA, V110, pE1342, DOI 10.1073/pnas.1300855110; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Kostic M, 2015, CELL REP, V13, P376, DOI 10.1016/j.celrep.2015.08.079; Kraus F, 2017, J CELL SCI, V130, P2953, DOI 10.1242/jcs.199562; Lee JE, 2016, NATURE, V540, P139, DOI 10.1038/nature20555; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Liesa M, 2009, PHYSIOL REV, V89, P799, DOI 10.1152/physrev.00030.2008; Liu R, 2015, MOL BIOL CELL, V26, P4466, DOI 10.1091/mbc.E15-08-0591; Liu T, 2013, EXP CELL RES, V319, P2893, DOI 10.1016/j.yexcr.2013.07.010; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Lucero M, 2019, CNS NEUROSCI THER, V25, P837, DOI 10.1111/cns.13141; Macdonald PJ, 2014, MOL BIOL CELL, V25, P1905, DOI 10.1091/mbc.E14-02-0728; Merrill RA, 2014, INT J BIOCHEM CELL B, V48, P92, DOI 10.1016/j.biocel.2013.12.012; Merrill RA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000612; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Ong SB, 2010, CARDIOVASC RES, V88, P16, DOI 10.1093/cvr/cvq237; Otera H., 2012, INT J CELL BIOL, V2012, DOI [10.1155/2012/821676, DOI 10.1155/2012/821676]; Otera H, 2016, J CELL BIOL, V212, P531, DOI 10.1083/jcb.201508099; Otera H, 2013, BBA-MOL CELL RES, V1833, P1256, DOI 10.1016/j.bbamcr.2013.02.002; Otera H, 2010, J CELL BIOL, V191, P1141, DOI 10.1083/jcb.201007152; Pagliuso A, 2018, CELL MOL LIFE SCI, V75, P355, DOI 10.1007/s00018-017-2603-0; Palmer CS, 2011, EMBO REP, V12, P565, DOI 10.1038/embor.2011.54; Panchal K, 2019, MITOCHONDRION, V47, P151, DOI 10.1016/j.mito.2018.11.002; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Prudent J, 2016, CURR BIOL, V26, pR207, DOI 10.1016/j.cub.2016.01.009; Rojo M, 2002, J CELL SCI, V115, P1663; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Santel A, 2008, IUBMB LIFE, V60, P448, DOI 10.1002/iub.71; Schrader M, 2016, BBA-MOL CELL RES, V1863, P971, DOI 10.1016/j.bbamcr.2015.09.024; Schrepfer E, 2016, MOL CELL, V61, P683, DOI 10.1016/j.molcel.2016.02.022; Senft D, 2016, CURR OPIN CELL BIOL, V39, P43, DOI 10.1016/j.ceb.2016.02.001; Shin HW, 1999, J BIOL CHEM, V274, P2780, DOI 10.1074/jbc.274.5.2780; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tilokani L, 2018, ESSAYS BIOCHEM, V62, P341, DOI 10.1042/EBC20170104; Ugarte-Uribe B, 2014, J BIOL CHEM, V289, P30645, DOI 10.1074/jbc.M114.575779; Valsecchi F, 2013, PHYSIOLOGY, V28, P199, DOI 10.1152/physiol.00004.2013; Vyas S, 2016, CELL, V166, P555, DOI 10.1016/j.cell.2016.07.002; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Willems PHGM, 2015, CELL METAB, V22, P207, DOI 10.1016/j.cmet.2015.06.006; Wilson TJ, 2013, NEUROBIOL DIS, V51, P13, DOI 10.1016/j.nbd.2012.01.009; Yoon Y, 2003, MOL CELL BIOL, V23, P5409, DOI 10.1128/MCB.23.15.5409-5420.2003; Yoon Y, 2011, ANTIOXID REDOX SIGN, V14, P439, DOI 10.1089/ars.2010.3286; Yu R, 2019, EMBO J, V38, DOI 10.15252/embj.201899748; Yu R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00853-x; Zhang ZZ, 2016, FASEB J, V30, P466, DOI 10.1096/fj.15-274258; Zhao J, 2013, CELL MOL LIFE SCI, V70, P951, DOI 10.1007/s00018-012-1066-6; Zhao J, 2011, EMBO J, V30, P2762, DOI 10.1038/emboj.2011.198; Zhao J, 2009, J CELL SCI, V122, P2252, DOI 10.1242/jcs.038513; Zhou W, 2010, ATHEROSCLEROSIS, V211, P216, DOI 10.1016/j.atherosclerosis.2010.02.012; Zhu PP, 2004, J BIOL CHEM, V279, P35967, DOI 10.1074/jbc.M404105200	71	30	32	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17262	17277		10.1074/jbc.RA119.008202	http://dx.doi.org/10.1074/jbc.RA119.008202			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31533986	Green Published, hybrid			2022-12-26	WOS:000503173500009
J	D'Ippolito, RA; Minamino, N; Rivera-Casas, C; Cheema, MS; Bai, DL; Kasinsky, HE; Shabanowitz, J; Eirin-Lopez, JM; Ueda, T; Hunt, DF; Ausio, J				D'Ippolito, Robert Anthony; Minamino, Naoki; Rivera-Casas, Ciro; Cheema, Manjinder S.; Bai, Dina L.; Kasinsky, Harold E.; Shabanowitz, Jeffrey; Eirin-Lopez, Jose M.; Ueda, Takashi; Hunt, Donald F.; Ausio, Juan			Protamines from liverwort are produced by post-translational cleavage and C-terminal di-aminopropanelation of several male germ-specific H1 histones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						14-3-3 protein; mass spectrometry (MS); histone; electron microscopy (EM); chromatography; di-aminopropanelation; histone H1; Marchantia; mass spectrometry; protamines	ELECTRON-TRANSFER DISSOCIATION; NUCLEAR BASIC-PROTEIN; PHASE-SEPARATION; SPERM CHROMATIN; MOLECULAR CHARACTERIZATION; PEPTIDE IDENTIFICATION; SEQUENCE-ANALYSIS; SEXUAL SELECTION; H1-LIKE PROTEIN; EVOLUTION	Protamines are small, highly-specialized, arginine-rich, and intrinsically-disordered chromosomal proteins that replace histones during spermiogenesis in many organisms. Previous evidence supports the notion that, in the animal kingdom, these proteins have evolved from a primitive replication-independent histone H1 involved in terminal cell differentiation. Nevertheless, a direct connection between the two families of chromatin proteins is missing. Here, we primarily used electron transfer dissociation MS-based analyses, revealing that the protamines in the sperm of the liverwort Marchantia polymorpha result from post-translational cleavage of three precursor H1 histones. Moreover, we show that the mature protamines are further post-translationally modified by di-aminopropanelation, and previous studies have reported that they condense spermatid chromatin through a process consisting of liquid-phase assembly likely involving spinodal decomposition. Taken together, our results reveal that the interesting evolutionary ancestry of protamines begins with histone H1 in both the animal and plant kingdoms.	[D'Ippolito, Robert Anthony; Bai, Dina L.; Shabanowitz, Jeffrey] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [Minamino, Naoki; Ueda, Takashi] Natl Inst Basic Biol, Div Cellular Dynam, Nishigonaka 38, Okazaki, Aichi 4448585, Japan; [Rivera-Casas, Ciro; Eirin-Lopez, Jose M.] Florida Int Univ, Dept Biol Sci, Environm Epigenet Grp, North Miami, FL 33181 USA; [Cheema, Manjinder S.; Ausio, Juan] Univ Victoria, Dept Biochem & Microbiol, Petch Bldg 260, Victoria, BC V8W 3P6, Canada; [Kasinsky, Harold E.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Ueda, Takashi] SOKENDAI Grad Univ Adv Studies, Dept Basic Biol, Okazaki, Aichi 4448585, Japan; [Hunt, Donald F.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA	University of Virginia; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); State University System of Florida; Florida International University; University of Victoria; University of British Columbia; Graduate University for Advanced Studies - Japan; University of Virginia	Ausio, J (corresponding author), Univ Victoria, Dept Biochem & Microbiol, Petch Bldg 260, Victoria, BC V8W 3P6, Canada.	jausio@uvic.ca	Ueda, Takashi/G-6984-2011	Ueda, Takashi/0000-0002-5190-892X; Minamino, Naoki/0000-0003-4600-0084; D'Ippolito, Robert/0000-0001-7542-6629	Natural Science and Engineering Research Council of Canada (NSERC) [RGPIN-2017-04162]; National Institutes of Health [GMO37537]; Model Plant Facility, NIBB BioResource Center; Fundacion Ramon Areces (Spain)	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Model Plant Facility, NIBB BioResource Center; Fundacion Ramon Areces (Spain)	This work was supported by Natural Science and Engineering Research Council of Canada (NSERC) Grant RGPIN-2017-04162 (to J. A.), National Institutes of Health Grant GMO37537 (to D. F. H.), and by the Model Plant Facility, NIBB BioResource Center. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by funds provided by the Fundacion Ramon Areces (Spain).	Anderson LC, 2015, INT J MASS SPECTROM, V377, P617, DOI 10.1016/j.ijms.2014.06.023; AUSIO J, 1992, MOL CELL BIOCHEM, V115, P163; Ausio J, 1999, J BIOL CHEM, V274, P31115, DOI 10.1074/jbc.274.44.31115; Ausio Juan, 2007, P63; Balhorn R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-227; Bao JQ, 2016, REPRODUCTION, V151, pR55, DOI 10.1530/REP-15-0562; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bloch D.P., 1976, P139; BLOCH DP, 1969, GENETICS, V61, P93; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Borgia A, 2018, NATURE, V555, P61, DOI 10.1038/nature25762; Bowman JL, 2017, CELL, V171, P287, DOI 10.1016/j.cell.2017.09.030; Brunner AM, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-2; CARLOS S, 1993, J BIOL CHEM, V268, P185; CARLOS S, 1993, J BIOL CHEM, V268, P195; Cheema MS, 2015, GENES-BASEL, V6, P685, DOI 10.3390/genes6030685; COLE RD, 1984, ANAL BIOCHEM, V136, P24, DOI 10.1016/0003-2697(84)90303-8; Compton PD, 2012, ANAL CHEM, V84, P1781, DOI 10.1021/ac202807h; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Earley L, 2013, ANAL CHEM, V85, P8385, DOI 10.1021/ac401783f; Eirin-Lopez JM, 2009, BIOESSAYS, V31, P1062, DOI 10.1002/bies.200900050; ELSEVIER SM, 1991, EUR J BIOCHEM, V196, P167, DOI 10.1111/j.1432-1033.1991.tb15800.x; Erdel F, 2018, BIOPHYS J, V114, P2262, DOI 10.1016/j.bpj.2018.03.011; Fincato P, 2011, J EXP BOT, V62, P1155, DOI 10.1093/jxb/erq341; Fioretti FM, 2012, DNA CELL BIOL, V31, P1392, DOI 10.1089/dna.2011.1547; GREEN GR, 1994, MOL REPROD DEV, V37, P255, DOI 10.1002/mrd.1080370303; GUSSE M, 1981, EXP CELL RES, V136, P391, DOI 10.1016/0014-4827(81)90018-5; GUSSE M, 1978, CYTOBIOLOGIE, V16, P421; GUSSE M, 1980, CHROMOSOMA, V77, P57, DOI 10.1007/BF00292041; Harrison LG, 2005, J EXP ZOOL PART A, V303A, P76, DOI 10.1002/jez.a.115; Higo A, 2016, PLANT CELL PHYSIOL, V57, P325, DOI 10.1093/pcp/pcw005; Hoffmann J A, 1990, Protein Expr Purif, V1, P127, DOI 10.1016/1046-5928(90)90005-J; HOLTTA E, 1975, BIOCHEM J, V145, P373; HURLEY CK, 1977, ANAL BIOCHEM, V80, P624, DOI 10.1016/0003-2697(77)90687-X; Ishizaki K, 2008, PLANT CELL PHYSIOL, V49, P1084, DOI 10.1093/pcp/pcn085; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kasinsky HE, 2014, TISSUE CELL, V46, P415, DOI 10.1016/j.tice.2014.07.003; Kasinsky H. E., 1995, MEMOIRES MUSEUM HIST, P447; Kasinsky H. E., 1989, SPECIFICITY DISTRIBU, P73; Kasinsky HE, 2011, PROTEIN PEPTIDE LETT, V18, P755; KASINSKY HE, 1987, J EXP ZOOL, V243, P137, DOI 10.1002/jez.1402430116; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KENNEDY BP, 1981, J BIOL CHEM, V256, P9254; KREITNER GL, 1977, AM J BOT, V64, P464, DOI 10.2307/2441777; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lewis J, 2002, BIOCHEM CELL BIOL, V80, P353, DOI 10.1139/O02-083; Lewis JD, 2004, J MOL EVOL, V58, P673, DOI 10.1007/s00239-004-2589-8; Lewis JD, 2004, BIOCHEMISTRY-US, V43, P7766, DOI 10.1021/bi0360455; Lewis JD, 2004, P NATL ACAD SCI USA, V101, P4148, DOI 10.1073/pnas.0308721101; Lewis JD, 2003, CHROMOSOMA, V111, P473, DOI 10.1007/s00412-002-0226-0; LOUIE AJ, 1972, J BIOL CHEM, V247, P7962; Luke L, 2016, MOL BIOL EVOL, V33, P174, DOI 10.1093/molbev/msv209; MAAYAN R, 1995, ARCH ANDROLOGY, V34, P95, DOI 10.3109/01485019508987836; Macek B, 2006, MOL CELL PROTEOMICS, V5, P949, DOI 10.1074/mcp.T500042-MCP200; Marian CO, 2003, PLANT PHYSIOL, V133, P1336, DOI 10.1104/pp.103.026856; Marino G, 2015, ACS CHEM BIOL, V10, P1754, DOI 10.1021/acschembio.5b00189; Martens G, 2009, J CELL BIOCHEM, V108, P1399, DOI 10.1002/jcb.22373; Martin SE, 2000, ANAL CHEM, V72, P4266, DOI 10.1021/ac000497v; Martin-Coello J, 2009, P ROY SOC B-BIOL SCI, V276, P2427, DOI 10.1098/rspb.2009.0257; MARTINAGE A, 1990, EUR J BIOCHEM, V191, P449, DOI 10.1111/j.1432-1033.1990.tb19142.x; Minamino N, 2017, J PLANT RES, V130, P433, DOI 10.1007/s10265-017-0909-5; Niklas K. J., 1997, THESIS; OLIVA R, 1991, PROG NUCLEIC ACID RE, V40, P25; Oliva R, 2006, HUM REPROD UPDATE, V12, P417, DOI 10.1093/humupd/dml009; Olsen JV, 2004, P NATL ACAD SCI USA, V101, P13417, DOI 10.1073/pnas.0405549101; Paschalidis KA, 2005, PLANT PHYSIOL, V138, P2174, DOI 10.1104/pp.105.063941; Herraez MP, 2017, AQUACULTURE, V472, P45, DOI 10.1016/j.aquaculture.2016.03.007; POCCIA DL, 1992, TRENDS BIOCHEM SCI, V17, P223, DOI 10.1016/0968-0004(92)90382-J; Prigge ST, 2000, CELL MOL LIFE SCI, V57, P1236, DOI 10.1007/PL00000763; REYNOLDS WF, 1978, EXP CELL RES, V116, P269, DOI 10.1016/0014-4827(78)90448-2; Roque A, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-14; Rose CM, 2015, J AM SOC MASS SPECTR, V26, P1848, DOI 10.1007/s13361-015-1183-1; SAPERAS N, 1994, J MOL EVOL, V39, P282, DOI 10.1007/BF00160152; SAPERAS N, 1993, J EXP ZOOL, V265, P575, DOI 10.1002/jez.1402650514; Saperas N, 2006, FEBS J, V273, P4548, DOI 10.1111/j.1742-4658.2006.05461.x; Senko MW, 2013, ANAL CHEM, V85, P11710, DOI 10.1021/ac403115c; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Stephens AD, 2019, CURR OPIN CELL BIOL, V58, P76, DOI 10.1016/j.ceb.2019.02.006; Strom AR, 2017, NATURE, V547, P241, DOI 10.1038/nature22989; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Udeshi ND, 2008, NAT PROTOC, V3, P1709, DOI 10.1038/nprot.2008.159; VERDAGUER N, 1993, EUR J BIOCHEM, V214, P879, DOI 10.1111/j.1432-1033.1993.tb17991.x; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Watson M, 2019, ESSAYS BIOCHEM, V63, P147, DOI 10.1042/EBC20180068; WOUTERSTYROU D, 1995, BIOCHEM J, V309, P529, DOI 10.1042/bj3090529; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920	88	6	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					16364	16373		10.1074/jbc.RA119.010316	http://dx.doi.org/10.1074/jbc.RA119.010316			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31527083	hybrid, Green Published			2022-12-26	WOS:000499478600039
J	Harlow, K; Ferreira, CR; Sobreira, TJP; Casey, T; Stewart, K				Harlow, KaLynn; Ferreira, Christina R.; Sobreira, Tiago J. P.; Casey, Theresa; Stewart, Kara			Lipidome profiles of postnatal day 2 vaginal swabs reflect fat composition of gilt's postnatal diet	PLOS ONE			English	Article							MEDIUM-CHAIN TRIGLYCERIDES; NEONATAL PIGLETS; GENE-EXPRESSION; MILK; RELAXIN; COLOSTRUM; CONSUMPTION; BIOMARKERS; GROWTH; ALPHA	We hypothesized that postnatal development of the vagina is impacted by early nutritional environment. Our objective was to determine if lipid profiles of vaginal swabs were different between postnatal gilts suckled by sow or fed milk replacer the first 48 h after birth, with or without a lard-based fat supplement. Gilts (>1.3 kg) were selected at birth across 8 litters and assigned to one of four treatments: 1) suckled by sow (S, n = 8); 2) suckled by sow plus administration of a fat supplement (SF, n = 5); 3) bottle-fed solely milk replacer (B, n = 8); or 4) bottle-fed solely milk replacer plus administration of a fat supplement (BF, n = 7). At 48 h postnatal, vaginal swabs of gilts were taken with a cytology brush, and lipids were extracted for analysis using multiple reaction monitoring (MRM)-profiling. Lipids extracted from serum collected at 48 h from gilts, milk collected at 24 h from sows, and milk replacer were also analyzed with MRM-profiling. Receiver operating characteristic curve analysis found 18 lipids recovered from vaginal swabs that highly distinguished between S and B gilts [area-under-the-curve (AUC) > 0.9], including phosphatidylethanolamine with 34 carbons and four unsaturations in the fatty acyl residues [PE (34:4)]. Twelve lipids from vaginal swabs highly correlated (r > 0.6; p < 0.01) with nutrition source. Lipids with greater abundance in milk replacer drove association. For example, mean intensity of PE (34:4) was 149-fold higher in milk replacer than colostrum. Consequently, PE (34:4) was found to have 1.6- and 2.12-fold higher levels in serum and vaginal swab samples (p < 0.001), respectively, of B gilts as compared to S gilts. Findings support that vaginal swabs can be used to noninvasively study effects of perinatal nutrition on tissue composition.	[Harlow, KaLynn; Casey, Theresa; Stewart, Kara] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Ferreira, Christina R.; Sobreira, Tiago J. P.] Purdue Univ, Bindley Sci Ctr, Metabol Core, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Casey, T (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	theresa-casey@purdue.edu	Ferreira, Christina Ramires/F-4744-2012; Casey, Theresa Marie/F-1171-2015	Ferreira, Christina Ramires/0000-0003-3988-6454; Casey, Theresa Marie/0000-0002-8835-3550; Harlow, KaLynn/0000-0001-9729-5789	Purdue University as part of AgSEED Crossroads	Purdue University as part of AgSEED Crossroads	This activity was funded by Purdue University as part of AgSEED Crossroads funding to support Indiana's Agriculture and Rural Development. https://ag.purdue.edu/agseed/Pages/default.aspx; KS and TC received funding. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bagnell CA, 2005, ANN NY ACAD SCI, V1041, P248, DOI 10.1196/annals.1282.038; Bartol FF, 2013, J ANIM SCI, V91, P696, DOI 10.2527/jas.2012-5764; BARTOL FF, 1993, J REPROD FERTIL, P99; Bartol FF, 2009, ANN NY ACAD SCI, V1160, P158, DOI 10.1111/j.1749-6632.2008.03820.x; BENEVENGA NJ, 1989, J ANIM SCI, V67, P3331; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOURNE FJ, 1978, ANN RECH VET, V9, P239; Cai Y, 2009, INT J DEV BIOL, V53, P925, DOI 10.1387/ijdb.082846yc; Camp ME, 2014, REPRODUCTION, V148, P441, DOI 10.1530/REP-14-0257; Casey T, 2018, J APPL ANIM RES, V46, P667, DOI 10.1080/09712119.2017.1384733; Chen JC, 2011, REPRODUCTION, V141, P675, DOI 10.1530/REP-10-0320; Chong J, 2018, NUCL ACIDS RES; Davidson MH, 2012, J CLIN LIPIDOL, V6, P573, DOI 10.1016/j.jacl.2012.01.002; Delplanque B, 2015, J PEDIATR GASTR NUTR, V61, P8, DOI 10.1097/MPG.0000000000000818; DREW MD, 1990, CAN J ANIM SCI, V70, P655, DOI 10.4141/cjas90-077; Faraggi D, 2003, STAT MED, V22, P2515, DOI 10.1002/sim.1418; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gray CA, 2001, BIOL REPROD, V64, P797, DOI 10.1095/biolreprod64.3.797; HAMOSH M, 1985, PEDIATRICS, V75, P146; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; LANZA I, 1995, AM J VET RES, V56, P739; Le Dividich J, 2005, J AGR SCI-CAMBRIDGE, V143, P469, DOI 10.1017/S0021859605005642; LeDividich J, 1997, J ANIM SCI, V75, P707; Miller DJ, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105056; ODLE J, 1989, J ANIM SCI, V67, P3340; Peaker M, 2002, J MAMMARY GLAND BIOL, V7, P347, DOI 10.1023/A:1022860902083; Su GQ, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0788-3; WIELAND TM, 1993, J ANIM SCI, V71, P1863, DOI 10.2527/1993.7171863x; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Yan W, 2008, REPRODUCTION, V135, P705, DOI 10.1530/REP-08-0014; Yan WB, 2006, ENDOCRINOLOGY, V147, P4303, DOI 10.1210/en.2006-0397	31	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0215186	10.1371/journal.pone.0215186	http://dx.doi.org/10.1371/journal.pone.0215186			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557164	Green Submitted, gold, Green Published			2022-12-26	WOS:000532345500002
J	Miller, AW; Reynolds, AC; Minton, MS				Miller, A. Whitman; Reynolds, Amanda C.; Minton, Mark S.			A spherical falling film gas-liquid equilibrator for rapid and continuous measurements of CO2 and other trace gases	PLOS ONE			English	Article							CARBON-DIOXIDE; SURFACE CONDENSATION; SYSTEMS; WATERS; SPECTROSCOPY; VARIABILITY; FLUXES; FLOW	Use of gas-liquid equilibrators to measure trace gases such as CO2, methane, and radon in water bodies is widespread. Such measurements are critical for understanding a variety of water quality issues such as acidification due to elevated CO2 or other processes related ecosystem metabolism and function. However, because gas-liquid equilibrators rely on generating sufficient surface area for gas exchange between liquid and gas phases, most traditional equilibrators pass water through small orifices or interstitial spaces that rapidly clog in highly productive or turbid waters, conditions that are common in estuaries, coastal bays, and riverine systems. Likewise, in cold temperatures, such equilibrators are subject to freezing. Both situations lead to failure and limit utility, especially for long term, continuous environmental monitoring. Here we describe and test a gas-liquid equilibrator that relies on a continuous falling film of water over a spherical surface to drive gas exchange. Our results demonstrate that this design is accurate in its ability to equilibrate fully to aqueous CO2 concentrations, is functional across a wide range of gas concentrations, and has a response time that is comparable with other equilibrator designs. Because this equilibrator uses free flowing, falling water to produce a surface for gas exchange, our field trials have shown it to be very resistant to clogging and freezing, and therefore well suited to long term deployment in highly productive waters like estuaries where CO2 concentrations fluctuate hourly, daily, and seasonally. When generated across a spherical surface, the falling film is not adversely affected by tilting off vertical, conditions that are common on a ship, small vessel, or buoy.	[Miller, A. Whitman; Reynolds, Amanda C.; Minton, Mark S.] Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA	Smithsonian Institution; Smithsonian Environmental Research Center	Miller, AW (corresponding author), Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA.	millerw@si.edu		Minton, Mark/0000-0002-9439-4930	Smithsonian Institution Endowment	Smithsonian Institution Endowment	This study was funded in part by the Smithsonian Institution Endowment (https://www.si.edu/) to AWM. No additional external funding was received for this study. The funder had no role in study design data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by funds from the Smithsonian Institution Endowment. We thank Patrick Megonigal, Anson Hines, and William Ball for their useful discussions and intellectual support. We thank William Ball, Joseph Ricigliano, and Alex Lowe for critically reviewing this manuscript prior to submission, and Melissa Hagan and Mary Strecker for figure illustration.	Abril G, 2006, SCI TOTAL ENVIRON, V354, P246, DOI 10.1016/j.scitotenv.2004.12.051; Abril G, 2014, NATURE, V505, P395, DOI 10.1038/nature12797; Awad MM, P INT WAT TECHN C IW, V1, P30; Borges AV, 2011, TREATISE ON ESTUARINE AND COASTAL SCIENCE, VOL 5: BIOGEOCHEMISTRY, P119; BRUMFIELD LK, 1976, J HEAT TRANS-T ASME, V98, P496, DOI 10.1115/1.3450582; Cai WJ, 2011, ANNU REV MAR SCI, V3, P123, DOI 10.1146/annurev-marine-120709-142723; Cai WJ, 1998, LIMNOL OCEANOGR, V43, P657, DOI 10.4319/lo.1998.43.4.0657; Carey V., 1992, LIQUID VAPOR PHASE C; Chen CTA, 2013, BIOGEOSCIENCES, V10, P6509, DOI 10.5194/bg-10-6509-2013; Crawford JT, 2015, ENVIRON SCI TECHNOL, V49, P442, DOI 10.1021/es504773x; Frankignoulle M, 2001, WATER RES, V35, P1344, DOI 10.1016/S0043-1354(00)00369-9; Friedrichs G, 2010, LIMNOL OCEANOGR-METH, V8, P539, DOI 10.4319/lom.2010.8.539; Gulzow W, 2011, LIMNOL OCEANOGR-METH, V9, P176, DOI 10.4319/lom.2011.9.176; Hassan IA, 2015, J ADV RES FLUID MECH, V14, P14; Jafar F., 2007, 16 AUSTR FLUID MECH, P1193; Joesoef A, 2015, BIOGEOSCIENCES, V12, P6085, DOI 10.5194/bg-12-6085-2015; Johnson JE, 1999, ANAL CHIM ACTA, V395, P119, DOI 10.1016/S0003-2670(99)00361-X; Kortzinger A, 1996, MAR CHEM, V52, P133, DOI 10.1016/0304-4203(95)00083-6; Kortzinger A., 2009, METHODS SEAWATER ANA, P149; Kumar A, 2016, INT J ADV COMPUT SC, V7, P46; Li ZB, 2009, J PHYS CONF SER, V153, DOI 10.1088/1742-6596/153/1/012059; Licor.com, LI 7000 SPEC; Lowe AT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37764-4; Martin CR, 2017, ATMOS MEAS TECH, V10, P2383, DOI 10.5194/amt-10-2383-2017; MUDAWAR I, 1993, INT J HEAT MASS TRAN, V36, P3437, DOI 10.1016/0017-9310(93)90162-Y; Nusselt W, 1916, Z VER DTSCH ING, V60, P569; Nusselt W, 1916, Z VER DTSCH ING, V60, P541; POISSON A, 1993, J GEOPHYS RES-OCEANS, V98, P22759, DOI 10.1029/93JC02501; Ribatski G, 2005, INT J REFRIG, V28, P635, DOI 10.1016/j.ijrefrig.2004.12.002; Roberson J.A., 1988, HYDRAULIC ENG; Sabine CL, 1997, SURFACE WATER ATMOSP; Salisbury JE, 2008, ESTUAR COAST SHELF S, V77, P245, DOI 10.1016/j.ecss.2007.09.033; Santos IR, 2012, ENVIRON SCI TECHNOL, V46, P7685, DOI 10.1021/es301961b; Senseair.com, K30 3 SPEC; Takagi D, 2010, J FLUID MECH, V647, P221, DOI 10.1017/S0022112009993818; Wang ZA, 2016, LIMNOL OCEANOGR, V61, P1916, DOI 10.1002/lno.10347; Webb JR, 2016, LIMNOL OCEANOGR-METH, V14, P323, DOI 10.1002/lom3.10092; Yoon TK, 2016, BIOGEOSCIENCES, V13, P3915, DOI 10.5194/bg-13-3915-2016; Zhang XC, 2018, INT J LOW-CARBON TEC, V13, P424, DOI 10.1093/ijlct/cty042	39	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222303	10.1371/journal.pone.0222303	http://dx.doi.org/10.1371/journal.pone.0222303			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553777	Green Published, gold			2022-12-26	WOS:000532319200024
J	You, YY; Bai, C; Liu, XF; Xia, MH; Jia, T; Li, XG; Zhang, CL; Chen, YC; Zhao, SF; Wang, LQ; Wang, W; Yin, YQ; Xiu, YF; Niu, LL; Zhou, J; Ma, T; Du, Y; Liu, YH				You, Yuyan; Bai, Chao; Liu, Xuefeng; Xia, Maohua; Jia, Ting; Li, Xiaoguang; Zhang, Chenglin; Chen, Yucun; Zhao, Sufen; Wang, Liqin; Wang, Wei; Yin, Yanqiang; Xiu, Yunfang; Niu, Lili; Zhou, Jun; Ma, Tao; Du, Yang; Liu, Yanhui			Genome-wide analysis of methylation in giant pandas with cataract by methylation-dependent restriction-site associated DNA sequencing (MethylRAD)	PLOS ONE			English	Article							AGE-RELATED CATARACT; AILUROPODA-MELANOLEUCA; DENTAL ABNORMALITIES; GENE-EXPRESSION; POLYMORPHISMS; MARKERS; TOOL	The giant panda (Ailuropoda melanoleuca) is a native species to China. They are rare and endangered and are regarded as the 'national treasure' and 'living fossil' in China. For the time being, there are only about 2500 giant pandas in the world. Therefore, we still have to do much more efforts to protect the giant pandas. In captive wildlife, the cataract incidence of mammalian always increases with age. Currently, in China, the proportion of elderly giant pandas who suffering from cataract has reached 20%. The eye disorder thus has a strong influence on the physical health and life quality of the elderly giant pandas. To discover the genes associated with the pathogenesis of cataract in the elderly giant panda and achieve the goal of early assessment and diagnosis of cataract in giant pandas during aging, we performed whole genome methylation sequencing in 3 giant pandas with cataract and 3 healthy giant pandas using methylation-dependent restriction-site associated DNA sequencing (MethylRAD). In the present study, we obtained 3.62M reads, on average, for each sample, and identified 116 and 242 differentially methylated genes (DMGs) between the two groups under the context of CCGG and CCWGG on genome, respectively. Further KEGG and GO enrichment analyses determined a total of 110 DMGs that are involved in the biological functions associated with pathogenesis of cataract. Among them, 6 DMGs including EEA1, GARS, SLITRK4, GSTM3, CASP3, and EGLN3 have been linked with cataract in old age.	[You, Yuyan; Bai, Chao; Liu, Xuefeng; Jia, Ting; Zhang, Chenglin; Zhao, Sufen; Wang, Wei] Beijing Zoo, Beijing Key Lab Capt Wildlife Technol, Beijing, Peoples R China; [Xia, Maohua; Li, Xiaoguang; Ma, Tao; Du, Yang; Liu, Yanhui] Beijing Zoo, Beijing, Peoples R China; [Chen, Yucun; Xiu, Yunfang] Strait Fuzhou Giant Panda Res & Exchange Ctr, Fuzhou, Peoples R China; [Wang, Liqin; Niu, Lili] Chengdu Zoo, Chengdu, Peoples R China; [Yin, Yanqiang; Zhou, Jun] Chongqing Zoo, Chongqing, Peoples R China		You, YY (corresponding author), Beijing Zoo, Beijing Key Lab Capt Wildlife Technol, Beijing, Peoples R China.	youyy351@163.com	you, yuyan/AAL-3559-2021; Yin, Yanqiang/AAK-4749-2021; Zhang, Cheng/GRS-8698-2022		National Natural Science Foundation of China [NSFC 31872257]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the grant of the National Natural Science Foundation of China (NSFC 31872257).	Asbell PA, 2005, LANCET, V365, P599; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Billingsley G, 2006, AM J HUM GENET, V79, P702, DOI 10.1086/507712; Charakidas A, 2005, EUR J OPHTHALMOL, V15, P213, DOI 10.1177/112067210501500206; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Davis AP, 2011, NUCLEIC ACIDS RES, V39, pD1067, DOI 10.1093/nar/gkq813; Dor Y, 2018, LANCET, V392, P777, DOI 10.1016/S0140-6736(18)31268-6; DOSHNA CW, 2002, INVEST OPHTH VIS S1, V43; Galichanin K, 2012, EXP EYE RES, V97, P19, DOI 10.1016/j.exer.2012.02.003; Hammond CJ, 2001, INVEST OPHTH VIS SCI, V42, P601; Hasanova N, 2009, BRIT J OPHTHALMOL, V93, P1081, DOI 10.1136/bjo.2008.152272; Ho MC, 2010, J CLIN GERONTOL GERI, V1, P17, DOI 10.1016/j.jcgg.2010.10.006; Huang JY, 2015, INVEST OPHTH VIS SCI, V56; Jin Y, 2012, J COMP PATHOL, V146, P357, DOI 10.1016/j.jcpa.2011.08.001; Jin YP, 2015, J WILDLIFE DIS, V51, P849, DOI 10.7589/2014-12-289; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim JK, 2009, CELL MOL LIFE SCI, V66, P596, DOI 10.1007/s00018-008-8432-4; Lawless C, 2010, EXP GERONTOL, V45, P772, DOI 10.1016/j.exger.2010.01.018; Li B, 2016, INVEST OPHTH VIS SCI, V57, P4721, DOI 10.1167/iovs.16-19242; Li BY, 2006, AGING CELL, V5, P187, DOI [10.1111/j.1474-9726, DOI 10.1111/J.1474-9726]; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Mou KH, 2017, J DERMATOL SCI, V85, P162, DOI 10.1016/j.jdermsci.2016.12.011; Ottonello S, 2000, OPHTHALMOLOGICA, V214, P78, DOI 10.1159/000027474; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shu X, 2018, DNA CELL BIOL, V37, P560, DOI 10.1089/dna.2018.4141; Tinaztepe OE, 2017, CURRENT EYE RES, V42, P1, DOI [10.1080/J.2415465, DOI 10.1080/J.2415465]; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; Uno H, 1997, AGE, V20, P1, DOI 10.1007/s11357-997-0001-5; Urfer SR, 2011, AGE, V33, P451, DOI 10.1007/s11357-010-9158-4; Wang S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150130; Wang Y, 2015, CURR EYE RES, V40, P815, DOI 10.3109/02713683.2014.957778; Xiao FH, 2016, BRIEF FUNCT GENOMICS, V15, P454, DOI 10.1093/bfgp/elw009; Zhang Y, 2011, MOL VIS, V17, P2325; Zhou P, 2012, FASEB J, V26, P4897, DOI 10.1096/fj.12-213702	35	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222292	10.1371/journal.pone.0222292	http://dx.doi.org/10.1371/journal.pone.0222292			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553743	gold, Green Published			2022-12-26	WOS:000532319200023
J	Kim, MH; Mazenga, AC; Yu, XY; Simon, K; Nyasulu, P; Kazembe, PN; Kalua, T; Abrams, E; Ahmed, S				Kim, Maria H.; Mazenga, Alick C.; Yu, Xiaoying; Simon, Katie; Nyasulu, Phoebe; Kazembe, Peter N.; Kalua, Thokozani; Abrams, Elaine; Ahmed, Saeed			Factors associated with burnout amongst healthcare workers providing HIV care in Malawi	PLOS ONE			English	Article							QUADRUPLE AIM CARE; QUALITY-OF-CARE; PHYSICIAN BURNOUT; JOB-SATISFACTION; PROBLEM DRINKING; D PERSONALITY; SOUTH-AFRICA; STRESS; QUESTIONNAIRE; PERSPECTIVES	Context High rates of burnout have been reported in low and medium income countries and can detrimentally impact healthcare delivery. Understanding factors associated with burnout amongst health care workers providing HIV care may help develop interventions to prevent/treat burnout. Objectives We sought to understand factors associated with burnout amongst health care workers providing HIV care in Malawi. Methods This was a sub-study of a larger cross-sectional study measuring burnout prevalence amongst a convenience sample of healthcare workers providing HIV care in 89 health facilities in eight districts in Malawi. Burnout was measured using the Maslach Burnout Inventory. Anonymously administered surveys included questions about sociodemographics, work characteristics (work load, supervisor support, team interactions), depression, life stressors, assessment of type D personality, and career satisfaction. We performed univariable and multivariable regression analyses to explore associations between variables and burnout. Results We received 535 responses (response rate 99%). Factors associated with higher rates of burnout on multivariable regression analyses included individual level factors: male gender (OR 1.75 [CI 1.17, 2.63]; p = 0.007), marital status (widowed or divorced) (OR 3.24 [CI 1.32, 7.98]; p = 0.011), depression (OR 3.32 [CI 1.21, 9.10]; p = 0.020), type D personality type (OR 2.77 [CI 1.50, 5.12]; p = 0.001) as well as work related factors: working at a health center vs. a rural hospital (OR 2.02 [CI 1.19, 3.40]; p = 0.009); lack of a very supportive supervisor (OR 2.38 [CI 1.32, 4.29]; p = 0.004), dissatisfaction with work/team interaction (OR 1.76 [CI 1.17, 2.66]; p = 0.007), and career dissatisfaction (OR 0.76 [CI 0.60, 0.96]; p = 0.020). Conclusion This study identified several individual level vulnerabilities as well as work related modifiable factors. Improving the supervisory capacity of health facility managers and creating conditions for improved team dynamics may help reduce burnout amongst healthcare workers proving HIV care in Malawi.	[Kim, Maria H.; Mazenga, Alick C.; Simon, Katie; Nyasulu, Phoebe; Kazembe, Peter N.; Ahmed, Saeed] Childrens Fdn Malawi, Baylor Coll Med, Lilongwe, Malawi; [Kim, Maria H.; Simon, Katie; Kazembe, Peter N.; Ahmed, Saeed] Texas Childrens Hosp, Baylor Coll Med, Int Paediat AIDS Initiat, Houston, TX 77030 USA; [Yu, Xiaoying] Univ Texas Med Branch, Galveston, TX 77555 USA; [Kalua, Thokozani] Minist Hlth, Dept HIV & AIDS, Lilongwe, Malawi; [Abrams, Elaine] Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY USA; [Abrams, Elaine] Columbia Univ, Coll Phys & Surg, New York, NY USA	Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Medical Branch Galveston; Columbia University; Columbia University	Kim, MH (corresponding author), Childrens Fdn Malawi, Baylor Coll Med, Lilongwe, Malawi.; Kim, MH (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Int Paediat AIDS Initiat, Houston, TX 77030 USA.	mhkim@bcm.edu		Yu, Xiaoying/0000-0003-1659-2365; Simon, Katherine/0000-0001-9232-2653; Kalua, Thokozani/0000-0001-7384-9011	Fogarty International Center of the National Institutes of Health [K01 TW009644];  [674-A-00-10-00093-00]; FOGARTY INTERNATIONAL CENTER [K01TW009644] Funding Source: NIH RePORTER	Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was made possible through USAID cooperative agreement number 674-A-00-10-00093-00. M.H.K. was supported by the Fogarty International Center of the National Institutes of Health under award number K01 TW009644. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahola K, 2005, J AFFECT DISORDERS, V88, P55, DOI 10.1016/j.jad.2005.06.004; [Anonymous], 2018, MAL MIN HLTH INT HIV; Anyangwe Stella C E, 2007, Int J Environ Res Public Health, V4, P93, DOI 10.3390/ijerph2007040002; Armon G, 2014, PERS INDIV DIFFER, V58, P112, DOI 10.1016/j.paid.2013.10.020; Babor TF., 2001, AUDIT ALCOHOL USE DI; Berman A, 2003, DRUG USE DISORDERS I, DOI [10.1348/135910709X479069, DOI 10.1348/135910709X479069]; Beusenberg M, 1994, USERS GUIDE SELF REP; Bodenheimer T, 2014, ANN FAM MED, V12, P573, DOI 10.1370/afm.1713; Canadas-De la Fuente GA, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102102; Chikaphupha KR, 2016, MALAWI MED J, V28, P37, DOI 10.4314/mmj.v28i2.2; Chimwaza W, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-17; Coetzee B, 2011, AIDS CARE, V23, P146, DOI 10.1080/09540121.2010.498874; Coetzee SK, 2013, INT J NURS STUD, V50, P162, DOI 10.1016/j.ijnurstu.2012.11.002; Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49; Dieleman M, 2007, HEALTH POLICY PLANN, V22, P139, DOI 10.1093/heapol/czm006; Dugani S., 2018, GATES OPEN RES, V2, P4, DOI [DOI 10.12688/gatesopenres.12779.3, DOI 10.12688/gatesopenres.12779.1]; Epstein RM, 2016, LANCET, V388, P2216, DOI 10.1016/S0140-6736(16)31332-0; Gorgens-Ekermans G, 2012, J CLIN NURS, V21, P2275, DOI 10.1111/j.1365-2702.2012.04171.x; Guidroz AM, 2012, STRESS HEALTH, V28, P69, DOI 10.1002/smi.1405; Hana J, 2012, MALAWI MED J, V24, P46; Salvagioni DAJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185781; Jordaan I, 2007, S AFR J PSYCHOL, V37, P835, DOI 10.1177/008124630703700411; Khamisa N, 2015, INT J ENV RES PUB HE, V12, P652, DOI 10.3390/ijerph120100652; Kim MH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192983; Kim MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149527; Kruse GR, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-55; Lasebikan Victor Olufolahan, 2012, ISRN Nurs, V2012, P402157, DOI 10.5402/2012/402157; Leiter M P, 1999, J Health Hum Serv Adm, V21, P472; Llorent VJ, 2016, CIENC SAUDE COLETIVA, V21, P3286, DOI 10.1590/1413-812320152110.00732015; Manafa O, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-65; Marcelino G, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001050; Maslach C, 1997, EVALUATING STRESS BO, P191; McAuliffe E, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-13; Muula AS, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-97; Olley B O, 2003, Afr J Med Med Sci, V32, P297; Peltzer K, 2011, AFR J PSYCHIATRY, V14, P30; Perry L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084215; Pienaar J, 2006, S AFR J EDUC, V26, P541; Poghosyan L, 2010, RES NURS HEALTH, V33, P288, DOI 10.1002/nur.20383; Polman R, 2010, BRIT J HEALTH PSYCH, V15, P681, DOI 10.1348/135910709X479069; Ramirez-Baena L, 2019, J CLIN MED, V8, DOI 10.3390/jcm8010092; Rothmann S, 2007, S AFR J PSYCHOL, V37, P135, DOI 10.1177/008124630703700110; Salyers MP, 2017, J GEN INTERN MED, V32, P475, DOI 10.1007/s11606-016-3886-9; Schmiedeknecht K, 2015, GLOB HEALTH-SCI PRAC, V3, P85, DOI 10.9745/GHSP-D-14-00170; Seo HS, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016008; Shanafelt TD, 2010, ANN SURG, V251, P995, DOI 10.1097/SLA.0b013e3181bfdab3; Shanafelt TD, 2009, JAMA-J AM MED ASSOC, V302, P1338, DOI 10.1001/jama.2009.1385; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; Sikka R, 2015, BMJ QUAL SAF, V24, P608, DOI 10.1136/bmjqs-2015-004160; Smith HK, 2012, TESTING WORK CHARACT; Spector Paul E, 1998, J Occup Health Psychol, V3, P356, DOI 10.1037/1076-8998.3.4.356; Stewart RC, 2009, J AFFECT DISORDERS, V112, P126, DOI 10.1016/j.jad.2008.04.001; Suner-Soler R., 2014, BURN RES, V1, P82, DOI [DOI 10.1016/J.BURN.2014.07.004, 10.1016/j.burn.2014.07.004]; Tekin A, 2017, ARCH ENVIRON OCCUP H, V72, P173, DOI 10.1080/19338244.2016.1179168; Thorsen VC, 2011, BMC NURS, V10, DOI 10.1186/1472-6955-10-9; UNICEF, 2017, 2017 18 HLTH BUDG BR; West CP, 2018, J INTERN MED, V283, P516, DOI 10.1111/joim.12752; West CP, 2016, LANCET, V388, P2272, DOI 10.1016/S0140-6736(16)31279-X; West CP, 2014, JAMA INTERN MED, V174, P527, DOI 10.1001/jamainternmed.2013.14387; West MA, 2006, J ORGAN BEHAV, V27, P983, DOI 10.1002/job.396; World Health Organization, 2018, GLOBAL HLTH EXPENDIT; Zverev Y, 2008, COLLEGIUM ANTROPOL, V32, P27	62	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222638	10.1371/journal.pone.0222638	http://dx.doi.org/10.1371/journal.pone.0222638			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5RZ	31550281	Green Published, gold			2022-12-26	WOS:000532307700021
J	Diray-Arce, J; Knowles, A; Suvorov, A; O'Brien, J; Hansen, C; Bybee, SM; Gul, B; Khan, MA; Nielsen, BL				Diray-Arce, Joann; Knowles, Alisa; Suvorov, Anton; O'Brien, Jacob; Hansen, Collin; Bybee, Seth M.; Gul, Bilquees; Khan, M. Ajmal; Nielsen, Brent L.			Identification and evolutionary characterization of salt-responsive transcription factors in the succulent halophyte Suaeda fruticosa	PLOS ONE			English	Article							MADS-BOX GENE; TOLERANCE; STRESS; ARABIDOPSIS; ACID; MYB; DIVERGENCE; INSIGHTS; FAMILY; BHLH	Transcription factors are key regulatory elements that affect gene expression in response to specific signals, including environmental stresses such as salinity. Halophytes are specialized plants that have the ability to complete their life cycle in saline environments. In this study we have identified and characterized the evolutionary relationships of putative transcription factors (TF) in an obligate succulent halophyte, Suaeda fruticosa, that are involved in conferring salt tolerance. Using RNA-seq data we have analyzed the expression patterns of certain TF families, predicted protein-protein interactions, and analyzed evolutionary trajectories to elucidate their possible roles in salt tolerance. We have detected the top differentially expressed (DE) transcription factor families (MYB, CAMTA, MADS-box and bZIP) that show the most pronounced response to salinity. The majority of DE genes in the four afore-mentioned TF families cluster together on TF phylogenetic trees, which suggests common evolutionary origins and trajectories. This research represents the first comprehensive TF study of a leaf succulent halophyte including their evolutionary relationships with TFs in other halophyte and salt-senstive plants. These findings provide a foundation for understanding the function of salt-responsive transcription factors in salt tolerance and associated gene regulation in plants.	[Diray-Arce, Joann; Knowles, Alisa; O'Brien, Jacob; Hansen, Collin; Nielsen, Brent L.] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA; [Suvorov, Anton; Bybee, Seth M.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Gul, Bilquees; Khan, M. Ajmal] Univ Karachi, Inst Sustainable Halophyte Utilizat, Karachi, Pakistan	Brigham Young University; Brigham Young University; University of Karachi	Nielsen, BL (corresponding author), Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA.	brentnielsen@byu.edu	Suvorov, Anton/AAB-1774-2019	Suvorov, Anton/0000-0003-3898-9195; Arce, Joann Diray/0000-0003-2183-4269; Nielsen, Brent/0000-0001-6300-4816	Pakistan-US Science and Technology Cooperation Program (US Department of State, National Academy of Sciences, and Higher Education Commission of Pakistan); Department of Microbiology and Molecular Biology at Brigham Young University; Brigham Young University [2014]; Office of Research and Creative Activities, Brigham Young University [2016]	Pakistan-US Science and Technology Cooperation Program (US Department of State, National Academy of Sciences, and Higher Education Commission of Pakistan); Department of Microbiology and Molecular Biology at Brigham Young University; Brigham Young University; Office of Research and Creative Activities, Brigham Young University	This research has been supported by a grant from the Pakistan-US Science and Technology Cooperation Program (http://sites.nationalacademies.org/PGA/Pakistan/index.htm; Phase 4 project jointly funded by the US Department of State, National Academy of Sciences, and Higher Education Commission of Pakistan to BLN, BG and MAK), by the Department of Microbiology and Molecular Biology at Brigham Young University (to BLN), Brigham Young University (grant number 2014 to JDA), and by the Office of Research and Creative Activities, Brigham Young University (grant number 2016 to BLN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Anwer MU, 2014, ELIFE, V3, DOI 10.7554/eLife.02206; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Babitha KC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137098; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benn G, 2014, PLANT J, V80, P82, DOI 10.1111/tpj.12620; Boxall SF, 2005, PLANT PHYSIOL, V137, P969, DOI 10.1104/pp.104.054577; Diray-Arce J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1553-x; DIRAYARCE J, 2016, HALOPHYTES FOOD SECU, P157; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Finkelstein RR, 2002, CURR OPIN PLANT BIOL, V5, P26, DOI 10.1016/S1369-5266(01)00225-4; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Ganesan G, 2012, J EXP BOT, V63, P4549, DOI 10.1093/jxb/ers135; Ghanekar Ruchi, 2008, Int J Plant Genomics, V2008, P451327, DOI 10.1155/2008/451327; Glenn EP, 1999, CRIT REV PLANT SCI, V18, P227, DOI 10.1016/S0735-2689(99)00388-3; Golldack D, 2011, PLANT CELL REP, V30, P1383, DOI 10.1007/s00299-011-1068-0; Correa LGG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002944; Haddad F, 2010, METHODS MOL BIOL, V630, P261, DOI 10.1007/978-1-60761-629-0_17; Hameed A, 2012, ACTA PHYSIOL PLANT, V34, P2331, DOI 10.1007/s11738-012-1035-6; Hsieh TH, 2010, PLANTA, V231, P1459, DOI 10.1007/s00425-010-1147-4; Ji XY, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-151; Jiang Y, 2012, J INTEGR PLANT BIOL, V54, P616, DOI 10.1111/j.1744-7909.2012.01149.x; Jin HX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150504; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Kofuji R, 2003, MOL BIOL EVOL, V20, P1963, DOI 10.1093/molbev/msg216; Lai LB, 2005, PLANT CELL, V17, P2754, DOI 10.1105/tpc.105.034116; Lee S, 2008, PLANT PHYSIOL, V147, P156, DOI 10.1104/pp.107.114256; Liang CZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep35040; Long YC, 2015, J EXP BOT, V66, P1133, DOI 10.1093/jxb/eru548; Mirarab S, 2015, J COMPUT BIOL, V22, P377, DOI 10.1089/cmb.2014.0156; Mishra A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00829; Onai K, 2005, GENES CELLS, V10, P963, DOI 10.1111/j.1365-2443.2005.00892.x; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; Rahman H, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00177; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rohini G, 2014, DNA RES, V21, P69, DOI 10.1093/dnares/dst042; Roy S, 2016, PLANT SIGNAL BEHAV, V11, DOI 10.1080/15592324.2015.1117723; Saha G, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1349-z; Shaikhali J, 2012, J BIOL CHEM, V287, P27510, DOI 10.1074/jbc.M112.361394; Sharma R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126783; Shen HS, 2008, BMB REP, V41, P132, DOI 10.5483/BMBRep.2008.41.2.132; Smaczniak C, 2012, DEVELOPMENT, V139, P3081, DOI 10.1242/dev.074674; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Toda Y, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26256; Wang WQ, 2016, J INTEGR PLANT BIOL, V58, P91, DOI 10.1111/jipb.12369; Xie ZD, 2010, PLANT J, V64, P731, DOI 10.1111/j.1365-313X.2010.04364.x; Yang A, 2012, J EXP BOT, V63, P2541, DOI 10.1093/jxb/err431; Yang TB, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-19; You J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01092; Zhou XF, 2009, PLANT J, V60, P79, DOI 10.1111/j.1365-313X.2009.03931.x; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0; Zhu Q, 2010, GENE, V457, P1, DOI 10.1016/j.gene.2010.02.011; Zou J, 2009, J PLANT PHYSIOL, V166, P851, DOI 10.1016/j.jplph.2008.11.007	56	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222940	10.1371/journal.pone.0222940	http://dx.doi.org/10.1371/journal.pone.0222940			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545841	Green Published, gold			2022-12-26	WOS:000532303200043
J	Robbins, CJ; Allen, HA; Miller, KA; Chapman, P				Robbins, Chloe J.; Allen, Harriet A.; Miller, Karl A.; Chapman, Peter			The 'Saw but Forgot' error: A role for short-term memory failures in understanding junction crashes?	PLOS ONE			English	Article							VISUAL INTERVENTION INFLUENCE; SITUATION AWARENESS; WORKING-MEMORY; INATTENTIONAL BLINDNESS; RUTTING MITIGATION; MOTORCYCLES; PERCEPTION; KNOWLEDGE; LOOKING; SEARCH	Motorcyclists are involved in an exceptionally high number of crashes for the distance they travel, with one of the most common incidents being where another road user pulls out into the path of an oncoming motorcycle frequently resulting in a fatal collision. These instances have previously been interpreted as failures of visual attention, sometimes termed 'Look but Fail to See' (LBFTS) crashes, and interventions have focused on improving drivers' visual scanning and motorcycles' visibility. Here we show from a series of three experiments in a high-fidelity driving simulator, that when drivers' visual attention towards and memory for approaching vehicles is experimentally tested, drivers fail to report approaching motorcycles on between 13% and 18% of occasions. This happens even when the driver is pulling out into a safety-critical gap in front of the motorcycle, and often happens despite the driver having directly fixated on the oncoming vehicle. These failures in reporting a critical vehicle were not associated with how long the driver looked at the vehicle for, but were associated with drivers' subsequent visual search and the time that elapsed between fixating on the oncoming vehicle and pulling out of the junction. Here, we raise the possibility that interference in short-term memory might prevent drivers holding important visual information during these complex manoeuvres. This explanation suggests that some junction crashes on real roads that have been attributed to LBFTS errors may have been misclassified and might instead be the result of `Saw but Forgot' (SBF) errors. We provide a framework for understanding the role of short-term memory in such situations, the Perceive Retain Choose (PRC) model, as well as novel predictions and proposals for practical interventions that may prevent this type of crash in the future.	[Robbins, Chloe J.; Allen, Harriet A.; Miller, Karl A.; Chapman, Peter] Univ Nottingham, Sch Psychol, Nottingham, England; [Robbins, Chloe J.] Univ Sheffield, Sch Architecture, Sheffield, S Yorkshire, England	University of Nottingham; University of Sheffield	Robbins, CJ (corresponding author), Univ Nottingham, Sch Psychol, Nottingham, England.; Robbins, CJ (corresponding author), Univ Sheffield, Sch Architecture, Sheffield, S Yorkshire, England.	chloe.robbins@nottingham.ac.uk		Chapman, Peter/0000-0002-3891-4241; Miller, Karl/0000-0003-3284-8789	Economic and Social Research Council [ES/J500100/1]; ESRC	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was funded by the Economic and Social Research Council [grant number ES/J500100/1], an ESRC post-graduate studentship to Chloe Robbins. The funders played no role in the study design, data collection, analysis, decision to publish or the preparation of the manuscript.	ACEM, 2004, 12 ACEM; ADAMS MJ, 1995, HUM FACTORS, V37, P85, DOI 10.1518/001872095779049462; Amin Harsh Jigishbhai, 2015, J. Transp. Lit., V9, P5, DOI 10.1590/2238-1031.jtl.v9n3a1; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A. D., 1986, WORKING MEMORY OXFOR; Baddeley A, 2012, J COGN PSYCHOL, V24, P6, DOI 10.1080/20445911.2011.613820; Brendel E, 2014, EXP BRAIN RES, V232, P2337, DOI 10.1007/s00221-014-3930-0; Brilon W, 1999, TRANSPORT RES A-POL, V33, P161, DOI 10.1016/S0965-8564(98)00048-2; Brown ID, 2002, BEHAV RES ROAD SAFET; Clarke DD, 2007, ACCIDENT ANAL PREV, V39, P974, DOI 10.1016/j.aap.2007.01.002; Cohen MA, 2012, TRENDS COGN SCI, V16, P411, DOI 10.1016/j.tics.2012.06.013; DeLucia PR, 2013, CURR DIR PSYCHOL SCI, V22, P199, DOI 10.1177/0963721412471679; Department for Transport, 2014, FREE FLOW VEHICLE SP; Department for Transport, 2018, REP ROAD CAS GREAT B; Diwadkar VA, 1997, PSYCHOL SCI, V8, P302, DOI 10.1111/j.1467-9280.1997.tb00442.x; Drew T, 2013, PSYCHOL SCI, V24, P1848, DOI 10.1177/0956797613479386; Endsley Mica R, 1988, P HUMAN FACTORS SOC, P97; ENDSLEY MR, 1995, HUM FACTORS, V37, P65, DOI 10.1518/001872095779049499; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; FAGOT C, 1995, J EXP PSYCHOL HUMAN, V21, P275, DOI 10.1037/0096-1523.21.2.275; Faul F., 1992, GPOWER PRIORI POSTHO; Fleck MS, 2010, J EXP PSYCHOL-APPL, V16, P60, DOI 10.1037/a0018629; Gaunet F, 2001, COGNITIVE BRAIN RES, V11, P409, DOI 10.1016/S0926-6410(01)00013-1; Groeger J.A., 2002, P AUSTRALASIAN ROAD, P75; Gugerty LJ, 1997, J EXP PSYCHOL-APPL, V3, P42, DOI 10.1037/1076-898X.3.1.42; Hardiess G, 2008, J VISION, V8, DOI 10.1167/8.1.7; Hole GJ, 1996, ERGONOMICS, V39, P946, DOI 10.1080/00140139608964516; Horowitz TS, 1998, NATURE, V394, P575, DOI 10.1038/29068; Hurt H., 1981, DOTHS501160 NHTSA US, V1; Iskander J, 2018, ANN IEEE SYST CONF, P482; Johannsdottir KR, 2010, HUM FACTORS, V52, P663, DOI 10.1177/0018720810385427; Kingdom F. A. A., 2010, PSYCHOPHYSICS PRACTI; LeDoux J, 2012, NEURON, V73, P653, DOI 10.1016/j.neuron.2012.02.004; LEVELT WJM, 1982, COGNITIVE PSYCHOL, V14, P78, DOI 10.1016/0010-0285(82)90005-6; Levin DT, 2000, VIS COGN, V7, P397, DOI 10.1080/135062800394865; Liu DW, 2017, COMMUN NONLINEAR SCI, V47, P139, DOI 10.1016/j.cnsns.2016.11.007; Mack A, 2003, CURR DIR PSYCHOL SCI, V12, P180, DOI 10.1111/1467-8721.01256; Mahon A, 2018, ATTEN PERCEPT PSYCHO, V80, P1691, DOI 10.3758/s13414-018-1553-4; Most SB, 2001, PSYCHOL SCI, V12, P9, DOI 10.1111/1467-9280.00303; National Highway Traffic Safety Administration, 2018, 2017 FAT MOT VEH CRA; Pammer K, 2018, HUM FACTORS, V60, P5, DOI 10.1177/0018720817733901; RIESER JJ, 1989, J EXP PSYCHOL LEARN, V15, P1157, DOI 10.1037/0278-7393.15.6.1157; Robbins CJ, 2018, TRANSPORT RES F-TRAF, V58, P944, DOI 10.1016/j.trf.2018.07.023; Robbins CJ, 2018, HUM FACTORS, V60, P889, DOI 10.1177/0018720818778960; Sandamas G, 2015, SAGE OPEN, V5, DOI 10.1177/2158244015595443; Shelton AL, 2001, COGNITIVE PSYCHOL, V43, P274, DOI 10.1006/cogp.2001.0758; Simons DJ, 2009, PSYCHON B REV, V16, P398, DOI 10.3758/PBR.16.2.398; SPERLING G, 1960, PSYCHOL MONOGR, V74, P1, DOI 10.1037/h0093759; The MathWorks Inc, 2012, MATLAB STAT TOOLB RE; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; World Health Organisation, 2018, GLOB STAT REP ROAD S; Wu G, 2019, INT J PAVEMENT ENG, V20, P734, DOI 10.1080/10298436.2017.1334460; Zhu XY, 2019, INT J PAVEMENT ENG, V20, P573, DOI 10.1080/10298436.2017.1316646	54	2	2	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222905	10.1371/journal.pone.0222905	http://dx.doi.org/10.1371/journal.pone.0222905			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5QI	31545850	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000532303200040
J	Chau, Y; Li, FS; Levsh, O; Weng, JK				Chau, Yasmin; Li, Fu-Shuang; Levsh, Olesya; Weng, Jing-Ke			Exploration of icariin analog structure space reveals key features driving potent inhibition of human phosphodiesterase-5	PLOS ONE			English	Article							CRYSTAL-STRUCTURES; IN-VITRO; SELECTIVITY; VARDENAFIL; EXPRESSION; COMPLEX; ASSAY; PDE5	The natural product icariin inhibits human phosphodiesterase-5 (PDE5) and represents a unique pharmacophore for treating erectile dysfunction, pulmonary hypertension, and other diseases. In this study, we explore the available icariin-derived chemical scaffolds through medicinal chemistry to develop novel icariin PDE5 inhibitors with improved potency and specificity. We synthesized six novel semi-synthetic icariin analogs as well as three naturally occurring icariin analogs, and characterized the structure-activity relationship in the context of human PDE5 inhibition using in vitro enzyme inhibition and kinetics assays and molecular modeling. Mammalian-cell-based assays and in vitro enzyme inhibition assays against human PDE6C further helped to identify the most potent and selective icariin analogs. Our results reveal the synergistic contribution of functional groups at the C3 and C7 positions of the icariin backbone towards PDE5 inhibition. Whereas a hydrophobic and flexible alkanol group at the C7 position is sufficient to enhance icariin analog potency, combining this group with a hydrophilic sugar group at the C3 position leads to further enhancement of potency and promotes specificity towards PDE5 versus PDE6C. In particular, compounds 3 and 7 exhibit Ki values of 0.036 +/- 0.005 mu M and 0.036 +/- 0.007 mu M towards PDE5 respectively, which are approaching those of commercial PDE5 inhibitors, and can effectively reduce GMP levels in cultured human BJ-hTERT cells. This study identifies novel icariin analogs as potent and selective PDE5 inhibitors poised to become lead compounds for further pharmaceutical development.	[Chau, Yasmin; Li, Fu-Shuang; Levsh, Olesya; Weng, Jing-Ke] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Chau, Yasmin; Levsh, Olesya; Weng, Jing-Ke] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Weng, JK (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Weng, JK (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	wengj@wi.mit.edu			Pew Scholars Program in the Biomedical Sciences [27345]; Searle Scholars Program [15-SSP-162]	Pew Scholars Program in the Biomedical Sciences; Searle Scholars Program	This work was supported by the Pew Scholars Program in the Biomedical Sciences to J.K.W. (grant number 27345), https://www.pewtrusts.org/, and the Searle Scholars Program to J.K.W. (grant number 15-SSP-162), https://www.searlescholars.net/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Luke Whitesell for helpful discussion. This work was supported by the Pew Scholars Program in the Biomedical Sciences (grant number 27345), and the Searle Scholars Program (grant number 15-SSP-162).	Ahmad F, 2015, ORAL DIS, V21, pE25, DOI 10.1111/odi.12275; Aldrich C, 2017, ACS MED CHEM LETT, V8, P379, DOI 10.1021/acsmedchemlett.7b00056; Bisswanger H., 2012, PRACTICAL ENZYMOLOGY; Dell'Agli M, 2005, J AGR FOOD CHEM, V53, P1960, DOI 10.1021/jf048497+; Dell'Agli M, 2008, J NAT PROD, V71, P1513, DOI 10.1021/np800049y; Eardley I, 2002, BRIT J CLIN PHARMACO, V53, p61S, DOI 10.1046/j.0306-5251.2001.00034.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Francis SH, 2010, HDB CELL SIGNALING, P1439; Friebe A, 2017, N-S ARCH PHARMACOL, V390, P1177, DOI 10.1007/s00210-017-1429-5; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Huai Q, 2004, J BIOL CHEM, V279, P13095, DOI 10.1074/jbc.M311556200; Jiang XR, 1999, NAT GENET, V21, P111, DOI 10.1038/5056; Ke HM, 2007, CURR TOP MED CHEM, V7, P391, DOI 10.2174/156802607779941242; KINCAID RL, 1988, METHOD ENZYMOL, V159, P457; Li FS, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.109; Lyskov S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063906; Ma HP, 2011, J ETHNOPHARMACOL, V134, P519, DOI 10.1016/j.jep.2011.01.001; Mehrotra N, 2007, INT J IMPOT RES, V19, P253, DOI 10.1038/sj.ijir.3901522; Mostafa T, 2017, SEX MED REV, V5, P170, DOI 10.1016/j.sxmr.2016.02.004; Ning HX, 2006, UROLOGY, V68, P1350, DOI 10.1016/j.urology.2006.09.031; Pilz RB, 2003, CIRC RES, V93, P1034, DOI 10.1161/01.RES.0000103311.52853.48; de Tejada IS, 2006, EUR UROL, V50, P901, DOI 10.1016/j.eururo.2006.07.041; Shang NN, 2014, BIOCHEM PHARMACOL, V89, P86, DOI 10.1016/j.bcp.2014.02.013; Shen Jingshan, 2008, World Patent, Patent No. [2008014722A1, 2008014722]; Surapisitchat J, 2009, HDB CELL SIGNALING, P1409; Tipton K. F., 2014, PERSPECT SCI, V1, P131, DOI [10.1016/j.pisc.2014.02.012, DOI 10.1016/J.PISC.2014.02.012]; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wang H, 2008, MOL PHARMACOL, V73, P104, DOI 10.1124/mol.107.040212; Wang HC, 2006, J BIOL CHEM, V281, P21469, DOI 10.1074/jbc.M512527200; Wright PJ, 2006, INT J CLIN PRACT, V60, P967, DOI 10.1111/j.1742-1241.2006.01049.x; Wu H, 2003, PROG DRUG RES, V60, P1; Xin ZC, 2003, ASIAN J ANDROL, V5, P15; Xin ZC, 2001, CHINESE SCI BULL, V46, P1186, DOI 10.1007/BF02900599; Zhang KYJ, 2004, MOL CELL, V15, P279, DOI 10.1016/j.molcel.2004.07.005; Zhang XJ, 2005, INVEST OPHTH VIS SCI, V46, P3060, DOI 10.1167/iovs.05-0257	36	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222803	10.1371/journal.pone.0222803	http://dx.doi.org/10.1371/journal.pone.0222803			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539416	Green Published, Green Submitted, gold			2022-12-26	WOS:000532297900030
J	Ortiz-Ceballos, AI; Ortiz-Gamino, D; Andrade-Torres, A; Perez-Rodriguez, P; Lopez-Ortega, M				Ortiz-Ceballos, Angel, I; Ortiz-Gamino, Diana; Andrade-Torres, Antonio; Perez-Rodriguez, Paulino; Lopez-Ortega, Maurilio			Pontoscolex corethrurus: A homeless invasive tropical earthworm?	PLOS ONE			English	Article							NICHE CONSTRUCTION; NATIVE EARTHWORMS; TERRA PRETA; SOIL; BACTERIA; FOREST; GLOSSOSCOLECIDAE; GUT; BIODIVERSITY; CONSEQUENCES	The presence of earthworm species in crop fields is as old as agriculture itself. The earthworms Pontoscolex corethrurus (invasive) and Balanteodrilus pearsei (native) are associated with the emergence of agriculture and sedentism in the region Amazon and Maya, respectively. Both species have shifted their preference from their natural habitat to the cropland niche. They contrast in terms of intensification of agricultural land use (anthropic impact to the symbiotic soil microbiome). P. corethrurus inhabits conventional agroecosystems, while B. pearsei thrives in traditional agroecosystems, i.e., P. corethrurus has not yet been recorded in soils where B. pearsei dwells. The demographic behavior of these two earthworm species was assessed in the laboratory over 100 days, according to their origin (OE; P. corethrurus and B. pearsei) food quality (FQ; soil only, maize stubble, Mucuna pruriens), and soil moisture (SM; 25, 33, 42%). The results showed that OE, FQ, SM, and the OE x FQ interaction were highly significant for the survival, growth, and reproduction of earthworms. P. corethrurus showed a lower survival rate (> mortality). P. corethrurus survivors fed a diet of low-to-intermediate nutritional quality (soil and stubble maize, respectively) showed a greater capacity to grow and reproduce; however, it was surpassed by the native earthworm when fed a high-quality diet (M. pruriens). Besides, P. corethrurus displayed a low cocoon hatching (emergence of juveniles). These results suggest that the presence of the invasive species was associated with a negative interaction with the soil microbiota where the native species dwells, and with the absence of natural mutualistic bacteria (gut, nephridia, and cocoons). These results are consistent with the absence of P. corethrurus in milpa and pasture-type agricultural niches managed by peasants (agroecologists) to grow food regularly through biological soil management. Results reported here suggest that P. corethrurus is an invasive species that is neither wild nor domesticated, that is, its eco-evolutionary phylogeny needs to be derived based on its symbionts.	[Ortiz-Ceballos, Angel, I; Ortiz-Gamino, Diana; Andrade-Torres, Antonio; Lopez-Ortega, Maurilio] Univ Veracruzana, Inst Biotecnol & Ecol Aplicada INBIOTECA, Xalapa, Veracruz, Mexico; [Perez-Rodriguez, Paulino] Colegio Postgrad, Programa Estadist, Campus Montecillo, Montecillo, Estado De Mexic, Mexico	Universidad Veracruzana; Colegio de Postgraduados - Mexico	Ortiz-Ceballos, AI (corresponding author), Univ Veracruzana, Inst Biotecnol & Ecol Aplicada INBIOTECA, Xalapa, Veracruz, Mexico.	angortiz@uv.mx	Andrade-Torres, Antonio/A-7661-2011; Andrade-Torres, Antonio/GPS-7285-2022; Lopez, Maurilio/AAM-9557-2021; Ortiz-Ceballos, Angel I./A-5780-2011	Andrade-Torres, Antonio/0000-0001-9387-0483; Lopez, Maurilio/0000-0001-6484-1798; Ortiz-Ceballos, Angel I./0000-0001-8700-4503; Perez-Rodriguez, Paulino/0000-0002-3202-1784; Ortiz Gamino, Diana/0000-0002-5062-8440				Aira M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25081-9; Bender SF, 2016, TRENDS ECOL EVOL, V31, P440, DOI 10.1016/j.tree.2016.02.016; Blakemore RJ, 2009, ANNELIDS IN MODERN BIOLOGY, P254; Boivin NL, 2016, P NATL ACAD SCI USA, V113, P6388, DOI 10.1073/pnas.1525200113; Brussaard L, 2013, SOIL ECOLOGY AND ECOSYSTEM SERVICES, P201; Clement CR, 2015, P ROY SOC B-BIOL SCI, V282, P32, DOI 10.1098/rspb.2015.0813; Daane LL, 1999, APPL ENVIRON MICROB, V65, P2376; Davidson SK, 2013, MOL PHYLOGENET EVOL, V67, P188, DOI 10.1016/j.ympev.2012.12.005; Davidson SK, 2006, APPL ENVIRON MICROB, V72, P769, DOI 10.1128/AEM.72.1.769-775.2006; de Menezes AB, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy051; DENEVAN WM, 1992, ANN ASSOC AM GEOGR, V82, P369, DOI 10.1111/j.1467-8306.1992.tb01965.x; Dupont L, 2012, EUR J SOIL BIOL, V53, P70, DOI 10.1016/j.ejsobi.2012.09.001; Fernandez Marchan Daniel, 2018, European Journal of Soil Biology, V86, P49, DOI 10.1016/j.ejsobi.2018.03.004; Ford A, 2009, J ETHNOBIOL, V29, P213, DOI 10.2993/0278-0771-29.2.213; Fragoso C, 2016, APPL SOIL ECOL, V104, P116, DOI 10.1016/j.apsoil.2015.12.005; Fragoso GC, 2018, IMPORTANCIA LOMBRICE, DOI [10.15468/omvnpi, DOI 10.15468/OMVNPI]; Fuller DQ, 2017, ARCHAEOL INT, V20, P110, DOI 10.5334/ai-359; Fuller DQ, 2017, HUMAN DISPERSAL AND SPECIES MOVEMENT: FROM PREHISTORY TO THE PRESENT, P304; GILOTVILLENAVE C, 1994, EUR J SOIL BIOL, V30, P125; Glaser B, 2000, ORG GEOCHEM, V31, P669, DOI 10.1016/S0146-6380(00)00044-9; Gong X, 2018, SOIL BIOL BIOCHEM, V121, P120, DOI 10.1016/j.soilbio.2018.03.011; Han G, 2017, ACTA GEOL SIN-ENGL, V91, P1, DOI 10.1111/1755-6724.13059; Huerta E, 2006, CARIBB J SCI, V42, P359; Ikeda H, 2018, ECOL EVOL, V8, P1726, DOI 10.1002/ece3.3777; James SW, 2019, ZOOTAXA, V4545, P124, DOI 10.11646/zootaxa.4545.1.7; Kim JS, 2007, SOIL BIOL BIOCHEM, V39, P684, DOI 10.1016/j.soilbio.2006.08.010; Kowarik I., 2008, URBAN ECOLOGY INT PE, P321, DOI DOI 10.1007/978-0-387-73412-5_20; Laland KN, 1999, P NATL ACAD SCI USA, V96, P10242, DOI 10.1073/pnas.96.18.10242; LAVELLE P, 1987, BIOL FERT SOILS, V5, P188, DOI 10.1007/BF00256899; Lavelle P., 1981, I ECOLOGIA PUBLICATI, V6, P75; Leon YS, 2004, PEDOBIOLOGIA, V48, P215, DOI 10.1016/j.pedobi.2003.12.006; Levi C., 2018, FRONT ECOL EVOL, V5, P171, DOI [DOI 10.1111/geb.12364, 10.3389/fevo.2017.00171, DOI 10.3389/fevo.2017.00171]; Lima HN, 2002, GEODERMA, V110, P1, DOI 10.1016/S0016-7061(02)00141-6; Liu DF, 2018, SYMBIOSIS, V74, P21, DOI 10.1007/s13199-017-0491-6; Lobe JW, 2014, APPL SOIL ECOL, V83, P133, DOI 10.1016/j.apsoil.2014.03.020; LODGE DM, 1993, TRENDS ECOL EVOL, V8, P133, DOI 10.1016/0169-5347(93)90025-K; Lund MB, 2010, ENVIRON MICROBIOL, V12, P2142, DOI 10.1111/j.1462-2920.2009.02084.x; Lund MB, 2010, APPL ENVIRON MICROB, V76, P4738, DOI 10.1128/AEM.00108-10; Marichal R, 2010, APPL SOIL ECOL, V46, P443, DOI 10.1016/j.apsoil.2010.09.001; McNeil CL, 2012, QUATERN INT, V249, P19, DOI 10.1016/j.quaint.2011.06.055; Mercuri AM, 2018, NAT PLANTS, V4, P71, DOI 10.1038/s41477-017-0098-1; Moller P, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00529; Muller F., 1857, J NAT HIST 2, V20, P13, DOI 10.1080/00222935709487865; Nackley LL, 2017, TRENDS ECOL EVOL, V32, P814, DOI 10.1016/j.tree.2017.08.003; Nozaki M, 2009, SOIL BIOL BIOCHEM, V41, P762, DOI 10.1016/j.soilbio.2009.01.016; Orell T., 2019, NMNH EXTANT SPECIMEN, DOI [10.15468/hnhrg3, DOI 10.15468/HNHRG3]; Ortiz-Ceballos AI, 2005, PEDOBIOLOGIA, V49, P89, DOI 10.1016/j.pedobi.2004.08.006; Ortiz-Ceballos AI, 2004, BIOL FERT SOILS, V39, P438, DOI 10.1007/s00374-004-0732-8; Ortiz-Ceballos AI, 2016, PEERJ, V4, DOI 10.7717/peerj.2032; Ortiz-Gamino D, 2016, PEERJ, V4, DOI 10.7717/peerj.2572; Park IY, 2017, DEV COMP IMMUNOL, V67, P476, DOI 10.1016/j.dci.2016.09.003; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Perez-Jaramillo JE, 2016, PLANT MOL BIOL, V90, P635, DOI 10.1007/s11103-015-0337-7; Philippot L, 2013, NAT REV MICROBIOL, V11, P789, DOI 10.1038/nrmicro3109; Plaas E, 2019, ECOL ECON, V159, P291, DOI 10.1016/j.ecolecon.2019.02.003; Ponesakki V, 2017, GENOM DATA, V14, P91, DOI 10.1016/j.gdata.2017.10.002; Ponge JF, 2006, SOIL BIOL BIOCHEM, V38, P2008, DOI 10.1016/j.soilbio.2005.12.024; Ricciardi A, 2007, BIOL INVASIONS, V9, P309, DOI 10.1007/s10530-006-9034-4; Richardson David M., 2000, Diversity and Distributions, V6, P93, DOI 10.1046/j.1472-4642.2000.00083.x; RIGHI G, 1984, STUD NEOTROP FAUNA E, V19, P159, DOI 10.1080/01650528409360653; Rodrigues JLM, 2013, P NATL ACAD SCI USA, V110, P988, DOI 10.1073/pnas.1220608110; Schaefer CEGR, 2004, AUST J SOIL RES, V42, P401, DOI 10.1071/SR03106; Schramm A, 2003, ENVIRON MICROBIOL, V5, P804, DOI 10.1046/j.1462-2920.2003.00474.x; Schult N, 2016, INVERTEBR BIOL, V135, P314, DOI 10.1111/ivb.12145; Shweta M., 2012, INT J SCI RES PUBL, V2, P1; Simmons W, 2015, PEDOBIOLOGIA, V58, P153, DOI 10.1016/j.pedobi.2015.05.001; Stitzer MC, 2018, NEW PHYTOL, V220, P395, DOI 10.1111/nph.15350; Taheri S, 2018, MOL PHYLOGENET EVOL, V124, P60, DOI 10.1016/j.ympev.2018.02.021; Taheri S, 2018, SOIL BIOL BIOCHEM, V116, P277, DOI 10.1016/j.soilbio.2017.10.030; Thakuria D, 2010, ISME J, V4, P357, DOI 10.1038/ismej.2009.124; Topoliantz S, 2005, APPL SOIL ECOL, V28, P217, DOI 10.1016/j.apsoil.2004.08.003; Ueda M, 2014, CARBOHYD POLYM, V101, P511, DOI 10.1016/j.carbpol.2013.09.057; Uvarov AV, 2009, PEDOBIOLOGIA, V53, P1, DOI 10.1016/j.pedobi.2009.05.001; Vestergard M, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv025; Vigueira CC, 2013, HEREDITY, V110, P303, DOI 10.1038/hdy.2012.104; Watling J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199868; Willcox G., 2012, COMPANION ARCHAEOLOG, P161, DOI 10.1002/; ZACHMANN JE, 1993, APPL ENVIRON MICROB, V59, P1904, DOI 10.1128/AEM.59.6.1904-1910.1993	78	1	1	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222337	10.1371/journal.pone.0222337	http://dx.doi.org/10.1371/journal.pone.0222337			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539381	Green Published, Green Submitted, gold			2022-12-26	WOS:000532297900009
J	Shimoyama, S; Furukawa, T; Ogata, Y; Nikaido, Y; Koga, K; Sakamoto, Y; Ueno, S; Nakamura, K				Shimoyama, Shuji; Furukawa, Tomonori; Ogata, Yoshiki; Nikaido, Yoshikazu; Koga, Kohei; Sakamoto, Yui; Ueno, Shinya; Nakamura, Kazuhiko			Lipopolysaccharide induces mouse translocator protein (18 kDa) expression via the AP-1 complex in the microglial cell line, BV-2	PLOS ONE			English	Article							BENZODIAZEPINE BINDING-SITES; ACTIVATION; SP1; TRANSCRIPTION; RECEPTOR; CHOLESTEROL; INHIBITOR; PATHWAYS; PROMOTER; INJURY	It has been reported that neuroinflammation occurs in the central nervous system (CNS) in patients with neuropathic pain, Alzheimer's disease and autism spectrum disorder. The 18-kDa translocator protein TSPO is used as an imaging target in positron emission tomography to detect neuroinflammation, and its expression is correlated with microglial activation. However, the mechanism underlying the transcriptional regulation of Tspo induced by inflammation is not clear. Here, we revealed that lipopolysaccharide (LPS) -induced Tspo expression was activated by the AP-1 complex in a mouse microglial cell line, BV-2. Knock-down of c-Fos and c-Jun, the components of AP-1, reduced LPS-induced Tspo expression. Furthermore, the enrichment of Sp1 in the proximal promoter region of Tspo was increased in the presence of LPS. In addition, the binding of histone deacetylase 1 (HDAC1) to the enhancer region, which contains the AP-1 site, was decreased by LPS treatment, but there were no significant differences in HDAC1 binding to the proximal promoter region with or without LPS. These results indicated that HDAC1 is involved not in the proximal promoter region but in the enhancer region. Our study revealed that inflammatory signals induce the recruitment of AP -1 to the enhancer region and Sp1 to the proximal promoter region of the Tspo gene and that Sp1 may regulate the basal expression of Tspo.	[Shimoyama, Shuji; Ueno, Shinya; Nakamura, Kazuhiko] Hirosaki Univ, Grad Sch Med, Res Ctr Child Mental Dev, Hirosaki, Aomori, Japan; [Shimoyama, Shuji; Furukawa, Tomonori; Ogata, Yoshiki; Nikaido, Yoshikazu; Koga, Kohei; Ueno, Shinya] Hirosaki Univ, Grad Sch Med, Dept Neurophysiol, Hirosaki, Aomori, Japan; [Sakamoto, Yui; Nakamura, Kazuhiko] Hirosaki Univ, Grad Sch Med, Dept Neuropsychiat, Hirosaki, Aomori, Japan; [Nikaido, Yoshikazu] Hirosaki Univ, Grad Sch Med, Dept Anesthesiol, Hirosaki, Aomori, Japan; [Koga, Kohei] Hyogo Coll Med, Dept Neurophysiol, Nishinomiya, Hyogo, Japan	Hirosaki University; Hirosaki University; Hirosaki University; Hirosaki University; Hyogo College of Medicine	Nakamura, K (corresponding author), Hirosaki Univ, Grad Sch Med, Res Ctr Child Mental Dev, Hirosaki, Aomori, Japan.; Nakamura, K (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Neuropsychiat, Hirosaki, Aomori, Japan.	nakakazu@hirosaki-u.ac.jp		Shimoyama, Shuji/0000-0001-6777-0438	Hirosaki University Grant for Exploratory Research by Young Scientists and Newly appointed Scientists; Hirosaki University Institutional Research Grant [18K08846]	Hirosaki University Grant for Exploratory Research by Young Scientists and Newly appointed Scientists; Hirosaki University Institutional Research Grant	This work was supported by Hirosaki University Grant for Exploratory Research by Young Scientists and Newly appointed Scientists (to SS), Hirosaki University Institutional Research Grant (to SU and KN) and Grants-in-Aid for Scientific Research (C) #18K08846 (to SU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER BEE, 1992, BIOCHEM PHARMACOL, V44, P269, DOI 10.1016/0006-2952(92)90009-8; ANHOLT RRH, 1986, J BIOL CHEM, V261, P576; Arcuri C, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00191; Bae KR, 2014, J NEUROIMMUNE PHARM, V9, P424, DOI 10.1007/s11481-014-9540-6; Banati RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6452; Batarseh A, 2012, BBA-GENE REGUL MECH, V1819, P38, DOI 10.1016/j.bbagrm.2011.09.001; Batarseh A, 2010, BIOCHEMISTRY-US, V49, P4766, DOI 10.1021/bi100020e; Batarseh A, 2008, BIOCHEMISTRY-US, V47, P12886, DOI 10.1021/bi8012643; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; CHARBONNEAU P, 1986, CIRCULATION, V73, P476, DOI 10.1161/01.CIR.73.3.476; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Choi HS, 2002, BIOCHEM BIOPH RES CO, V296, P1005, DOI 10.1016/S0006-291X(02)02001-6; Cohen M, 2014, EMBO J, V33, P2906, DOI 10.15252/embj.201489293; DERIJARD B, 1995, SCIENCE, V267, P682, DOI 10.1126/science.7839144; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Donnell SLO, 2002, GLIA, V38, P85, DOI [10.1002/glia.10081, DOI 10.1002/GLIA.10081]; Furukawa T, 2017, PHARMACOL RES PERSPE, V5, DOI 10.1002/prp2.283; GEPPERT TD, 1994, MOL MED, V1, P93; GIULIAN D, 1986, J EXP MED, V164, P594, DOI 10.1084/jem.164.2.594; GROOM GN, 1995, J NUCL MED, V36, P2207; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hoing S, 2012, CELL STEM CELL, V11, P620, DOI 10.1016/j.stem.2012.07.005; Imamoto N, 2013, NEUROIMAGE, V79, P121, DOI 10.1016/j.neuroimage.2013.04.039; Jin JF, 2012, CLIN IMMUNOL, V143, P188, DOI 10.1016/j.clim.2012.01.019; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; KRUEGER KE, 1990, J BIOL CHEM, V265, P15015; Lacapere JJ, 2003, STEROIDS, V68, P569, DOI 10.1016/S0039-128X(03)00101-6; Lee Jae-Kyung, 2013, Methods Mol Biol, V1041, P17, DOI 10.1007/978-1-62703-520-0_3; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; MINDEN A, 1994, MOL CELL BIOL, V14, P6683, DOI 10.1128/MCB.14.10.6683; Owen GI, 1998, J BIOL CHEM, V273, P10696, DOI 10.1074/jbc.273.17.10696; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rashid K, 2018, BBA-GENE REGUL MECH, V1861, P1119, DOI 10.1016/j.bbagrm.2018.10.018; Sandiego CM, 2015, P NATL ACAD SCI USA, V112, P12468, DOI 10.1073/pnas.1511003112; SAWADA M, 1989, BRAIN RES, V491, P394, DOI 10.1016/0006-8993(89)90078-4; Shimoyama S, 2014, BBA-GENE REGUL MECH, V1839, P107, DOI 10.1016/j.bbagrm.2013.12.004; Suzuki K, 2013, JAMA PSYCHIAT, V70, P49, DOI 10.1001/jamapsychiatry.2013.272; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wang W, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00384; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1	42	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222861	10.1371/journal.pone.0222861	http://dx.doi.org/10.1371/journal.pone.0222861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536603	gold, Green Published, Green Submitted			2022-12-26	WOS:000532262800098
J	Greene, JR; Merrett, KL; Heyert, AJ; Simmons, LF; Migliori, CM; Vogt, KC; Castro, RS; Phillips, PD; Baker, JL; Lindberg, GE; Fox, DT; Del Sesto, RE; Koppisch, AT				Greene, Joshua R.; Merrett, Kahla L.; Heyert, Alexanndra J.; Simmons, Lucas F.; Migliori, Camille M.; Vogt, Kristen C.; Castro, Rebeca S.; Phillips, Paul D.; Baker, Joseph L.; Lindberg, Gerrick E.; Fox, David T.; Del Sesto, Rico E.; Koppisch, Andrew T.			Scope and efficacy of the broad-spectrum topical antiseptic choline geranate	PLOS ONE			English	Article							IONIC LIQUIDS; IN-VITRO; ANTIMICROBIAL PEPTIDES; ANTIBIOTIC-RESISTANCE; MOLECULAR-MECHANISM; BIOFILM RESISTANCE; AMBER; DIVERSITY; IMPACT	Choline geranate (also described as Choline And GEranic acid, or CAGE) has been developed as a novel biocompatible antiseptic material capable of penetrating skin and aiding the transdermal delivery of co-administered antibiotics. The antibacterial properties of CAGE were analyzed against 24 and 72 hour old biofilms of 11 clinically isolated ESKAPE pathogens (defined as Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumanii, Pseudomonas aeruginosa, and Enterobacter sp, respectively), including multidrug resistant (MDR) isolates. CAGE was observed to eradicate in vitro biofilms at concentrations as low as 3.56 mM (0.156% v:v) in as little as 2 hours, which represents both an improved potency and rate of biofilm eradication relative to that reported for most common standard-of-care topical antiseptics in current use. In vitro time-kill studies on 24 hour old Staphylococcus aureus biofilms indicate that CAGE exerts its antibacterial effect upon contact and a 0.1% v:v solution reduced biofilm viability by over three orders of magnitude (a 3log10 reduction) in 15 minutes. Furthermore, disruption of the protective layer of exopolymeric substances in mature biofilms of Staphylococcus aureus by CAGE (0.1% v:v) was observed in 120 minutes. Insight into the mechanism of action of CAGE was provided with molecular modeling studies alongside in vitro antibiofilm assays. The geranate ion and geranic acid components of CAGE are predicted to act in concert to integrate into bacterial membranes, affect membrane thinning and perturb membrane homeostasis. Taken together, our results show that CAGE demonstrates all properties required of an effective topical antiseptic and the data also provides insight into how its observed antibiofilm properties may manifest.	[Greene, Joshua R.; Merrett, Kahla L.; Heyert, Alexanndra J.; Simmons, Lucas F.; Phillips, Paul D.; Lindberg, Gerrick E.; Koppisch, Andrew T.] No Arizona Univ, Dept Chem, Flagstaff, AZ 86011 USA; [Migliori, Camille M.; Del Sesto, Rico E.] Dixie State Univ, Dept Chem, St George, UT 84770 USA; [Vogt, Kristen C.; Castro, Rebeca S.; Baker, Joseph L.] Coll New Jersey, Dept Chem, Ewing, NJ USA; [Lindberg, Gerrick E.; Koppisch, Andrew T.] No Arizona Univ, Ctr Mat Interfaces Res & Applicat, Flagstaff, AZ 86011 USA; [Fox, David T.] Los Alamos Natl Lab, Div Chem, Los Alamos, NM USA	Northern Arizona University; Utah System of Higher Education; Dixie State University; College of New Jersey; Northern Arizona University; United States Department of Energy (DOE); Los Alamos National Laboratory	Koppisch, AT (corresponding author), No Arizona Univ, Dept Chem, Flagstaff, AZ 86011 USA.; Del Sesto, RE (corresponding author), Dixie State Univ, Dept Chem, St George, UT 84770 USA.; Koppisch, AT (corresponding author), No Arizona Univ, Ctr Mat Interfaces Res & Applicat, Flagstaff, AZ 86011 USA.	delsesto@dixie.edu; Andy.Koppisch@nau.edu		Baker, Joseph/0000-0003-1286-6605; Lindberg, Gerrick/0000-0002-5292-4200	National Science Foundation [CHE-1412628, CHE-1412629, ACI-1550562, ACI-1550528, OAC-1828163, OAC-1826915]; National Institutes of Health/National Institute on Minority Health and Health Disparities [NIH/NIMHD RCMI U54MD012388]; NAU Office of the Vice President for Research via the Faculty Grants program; Arizona's Technology and Research Initiative Fund; National Institute on Minority Health and Health Disparities [U54MD012388] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/National Institute on Minority Health and Health Disparities; NAU Office of the Vice President for Research via the Faculty Grants program; Arizona's Technology and Research Initiative Fund; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The material reported within this manuscript is based upon work supported by the following agencies: National Science Foundation through awards CHE-1412628 (A.T.K.), CHE-1412629 (R.E.D.S.), ACI-1550562 (G.E.L.), and ACI-1550528 (J.L.B. and K.C.V.). https://www.nsf.gov/; National Institutes of Health/National Institute on Minority Health and Health Disparities through award NIH/NIMHD RCMI U54MD012388 (Baldwin/Stearns-MPI) to A.T.K., https://www.nimhd.nih.gov/; NAU Office of the Vice President for Research via the Faculty Grants program to A.T.K. The sponsors of this work played no role in the study design, data collection, decision to publish or preparation of the manuscript.; J.L.B. and K.C.V. acknowledge use of the ELSA high performance computing cluster at The College of New Jersey for conducting simulations reported in this paper. This cluster is funded by the National Science Foundation under grant numbers OAC-1828163 and OAC-1826915. Some simulations and analysis were performed with Northern Arizona University's Monsoon computing cluster, which is funded in part by Arizona's Technology and Research Initiative Fund. We are grateful to Aubrey Funke in the Histology and Imaging Core facility at Northern Arizona University for assistance with SEM experiments, to Hunter Burgin for assistance with assay development, and to Nathan Nieto and Emily Cope (NAU Dept of Biological Sciences) for helpful discussions.	Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000; [Anonymous], 2013, ANTIBIOTIC RESISTANC; Babuji Y, 2017, INTRO PARSL PYTHON P; Banerjee A, 2018, P NATL ACAD SCI USA, V115, pE11000, DOI 10.1073/pnas.1815526115; Banerjee A, 2018, P NATL ACAD SCI USA, V115, P7296, DOI 10.1073/pnas.1722338115; Banerjee A, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201601411; Bertelsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047745; Busetti A, 2010, GREEN CHEM, V12, P420, DOI 10.1039/b919872e; Camplin Aimee L, 2014, Ann Clin Microbiol Antimicrob, V13, P19, DOI 10.1186/1476-0711-13-19; Capriotti K, 2018, J CLIN RES DERMATOL, V5, P1, DOI DOI 10.15226/2378-1726/5/1/00174; Carson L, 2009, GREEN CHEM, V11, P492, DOI 10.1039/b821842k; CASE DA, 2016, AMBER 2018; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Dickson CJ, 2014, J CHEM THEORY COMPUT, V10, P865, DOI 10.1021/ct4010307; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Food Drug Administration HHS, 2017, FED REGISTER, V82, P60474; Frederix M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101115; Garrison AT, 2018, J MED CHEM, V61, P3962, DOI 10.1021/acs.jmedchem.7b01903; Gilbert P, 2005, J APPL MICROBIOL, V99, P703, DOI 10.1111/j.1365-2672.2005.02664.x; Grage SL, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00065; Huang HW, 2006, BBA-BIOMEMBRANES, V1758, P1292, DOI 10.1016/j.bbamem.2006.02.001; Ibsen KN, 2018, ACS BIOMATER SCI ENG, V4, P2370, DOI 10.1021/acsbiomaterials.8b00486; Institute CaLS, 2015, PERF STAND ANT SUS S; International A, E2799 ASTM INT, p[West Conshohocken, 9]; Johani K, 2018, J ANTIMICROB CHEMOTH, V73, P494, DOI 10.1093/jac/dkx391; Joo HS, 2012, CHEM BIOL, V19, P1503, DOI 10.1016/j.chembiol.2012.10.022; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Justo JA, 2014, INFECT DRUG RESIST, V7, P343, DOI 10.2147/IDR.S51388; Khandelia H, 2008, BBA-BIOMEMBRANES, V1778, P1528, DOI 10.1016/j.bbamem.2008.02.009; Lebeaux D, 2014, MICROBIOL MOL BIOL R, V78, P510, DOI 10.1128/MMBR.00013-14; Lebeaux D, 2013, PATHOGENS, V2, P288, DOI 10.3390/pathogens2020288; Leid JG, 2012, J ANTIMICROB CHEMOTH, V67, P138, DOI 10.1093/jac/dkr408; Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001; Lovejoy KS, 2012, CRYST GROWTH DES, V12, P5357, DOI 10.1021/cg300969u; Lovejoy KS, 2012, ANAL CHEM, V84, P9169, DOI 10.1021/ac301873s; Lovejoy KS, 2011, ANAL CHEM, V83, P2921, DOI 10.1021/ac102944w; Ludtke S, 1995, BIOCHEMISTRY-US, V34, P16764, DOI 10.1021/bi00051a026; Martinez L, 2009, J COMPUT CHEM, V30, P2157, DOI 10.1002/jcc.21224; PASENKIEWICZGIERUL, 2007, BIOPHYS J, pA64; Pendleton JN, 2013, EXPERT REV ANTI-INFE, V11, P297, DOI [10.1586/eri.13.12, 10.1586/ERI.13.12]; Pendleton JN, 2015, INT J ANTIMICROB AG, V46, P131, DOI 10.1016/j.ijantimicag.2015.02.016; Rogers RD, 2018, P NATL ACAD SCI USA, V115, pE10999, DOI 10.1073/pnas.1814976115; Ruegg TL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4490; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Skjevik AA, 2015, CHEM COMMUN, V51, P4402, DOI 10.1039/c4cc09584g; Solinski AE, 2017, J AM CHEM SOC, V139, P7188, DOI 10.1021/jacs.7b03879; Solomon SL, 2014, AM FAM PHYSICIAN, V89, P938; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Tam VH, 2010, ANTIMICROB AGENTS CH, V54, P3717, DOI 10.1128/AAC.00207-10; Tanner EEL, 2018, J CONTROL RELEASE, V286, P137, DOI 10.1016/j.jconrel.2018.07.029; Toke O, 2005, BIOPOLYMERS, V80, P717, DOI 10.1002/bip.20286; Tseng BS, 2013, ENVIRON MICROBIOL, V15, P2865, DOI 10.1111/1462-2920.12155; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558; Yoo B, 2016, LANGMUIR, V32, P5403, DOI 10.1021/acs.langmuir.6b00768; Zakrewsky M, 2016, ADV HEALTHC MATER, V5, P1282, DOI 10.1002/adhm.201600086; Zakrewsky M, 2014, P NATL ACAD SCI USA, V111, P13313, DOI 10.1073/pnas.1403995111	58	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222211	10.1371/journal.pone.0222211	http://dx.doi.org/10.1371/journal.pone.0222211			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527873	Green Published, Green Submitted, gold			2022-12-26	WOS:000532231400012
J	Labib, RM; Ayoub, IM; Michel, HE; Mehanny, M; Kamil, V; Hany, M; Magdy, M; Moataz, A; Maged, B; Mohamed, A				Labib, Rola M.; Ayoub, Iriny M.; Michel, Haidy E.; Mehanny, Mina; Kamil, Verena; Hany, Meryl; Magdy, Mirette; Moataz, Aya; Maged, Boula; Mohamed, Ahmed			Appraisal on the wound healing potential of Melaleuca alternifolia and Rosmarinus officinalis L. essential oil-loaded chitosan topical preparations	PLOS ONE			English	Article							TEA TREE OIL; ACID	The present study investigates the wound healing potential of three chitosan-based topical preparations loaded with either tea tree essential oil, rosemary essential oil or a mixture of both oils in vivo. Essential oils of M. alternifolia and R. officinalis were analyzed using GC/ MS. Essential oil-loaded chitosan topical preparations were formulated. Wound healing potential was evaluated in vivo using an excision wound model in rats. GC/MS analysis of M. alternifolia and R. officinalis essential oils revealed richness in oxygenated monoterpenes, representing 51.06% and 69.61% of the total oil composition, respectively. Topical application of chitosan-based formulation loaded with a mixture of tea tree and rosemary oils resulted in a significant increase in wound contraction percentage compared to either group treated with individual essential oils and the untreated group. Histopathological examination revealed that topical application of tea tree and rosemary oil combination demonstrated complete re-epithelialization associated with activated hair follicles. The high percentage of oxygenated monoterpenes in both essential oils play an important role in the antioxidant and wound healing potential observed herein. Incorporation of tea tree and rosemary essential oils in chitosan-based preparations in appropriate combination could efficiently promote different stages of wound healing.	[Labib, Rola M.; Ayoub, Iriny M.] Ain Shams Univ, Fac Pharm, Dept Pharmacognosy, Cairo, Egypt; [Michel, Haidy E.] Ain Shams Univ, Fac Pharm, Dept Pharmcol & Toxicol, Cairo, Egypt; [Mehanny, Mina] Ain Shams Univ, Fac Pharm, Dept Pharmaceut & Ind Pharm, Cairo, Egypt; [Mehanny, Mina] Saarland Univ, Helmholtz Ctr Infect Res HZI, Helmholtz Inst Pharmaceut Res Saarland HIPS, Saarbrucken, Germany; [Kamil, Verena; Hany, Meryl; Magdy, Mirette; Moataz, Aya; Maged, Boula; Mohamed, Ahmed] Ain Shams Univ, Fac Pharm, Drug Design Program, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Ain Shams University; Helmholtz Association; Helmholtz-Center for Infection Research; Saarland University; Egyptian Knowledge Bank (EKB); Ain Shams University	Labib, RM (corresponding author), Ain Shams Univ, Fac Pharm, Dept Pharmacognosy, Cairo, Egypt.	rolamilad@pharma.asu.edu.eg	Ayoub, Iriny/AAH-3014-2019; Michel, Haidy/P-1872-2019; Michel, Haidy/CAG-5823-2022; Labib, Rola M./F-3988-2016	Ayoub, Iriny/0000-0003-2382-8241; Michel, Haidy/0000-0003-4174-5749; Michel, Haidy/0000-0003-4174-5749; Labib, Rola M./0000-0002-7531-4552; Mehanny, Mina/0000-0002-2648-5830				Abu-Al-Basal MA, 2010, J ETHNOPHARMACOL, V131, P443, DOI 10.1016/j.jep.2010.07.007; Adams R.P, 2017, IDENTIFICATION ESSEN, V5th; Amin MA, 2014, ARCH PHARM RES, V37, P1016, DOI 10.1007/s12272-013-0308-y; Barbosa ID, 2016, FOOD CONTROL, V59, P468, DOI 10.1016/j.foodcont.2015.06.017; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Brand C, 2001, INFLAMM RES, V50, P213, DOI 10.1007/s000110050746; Budovsky A, 2015, WOUND REPAIR REGEN, V23, P171, DOI 10.1111/wrr.12274; Caner C, 1998, J FOOD SCI, V63, P1049, DOI 10.1111/j.1365-2621.1998.tb15852.x; Carson CF, 2006, CLIN MICROBIOL REV, V19, P50, DOI 10.1128/CMR.19.1.50-62.2006; Chin KB, 2013, J ALTERN COMPLEM MED, V19, P942, DOI 10.1089/acm.2012.0787; Delaquis PJ, 2002, INT J FOOD MICROBIOL, V74, P101, DOI 10.1016/S0168-1605(01)00734-6; Drury S., 2011, TEA TREE OIL MED KIT; Elkady WM, 2018, IND CROP PROD, V118, P188, DOI 10.1016/j.indcrop.2018.03.051; Farag RS, 2004, PHYTOTHER RES, V18, P30, DOI 10.1002/ptr.1348; Fiume MM, 2018, INT J TOXICOL, V37, p12S, DOI 10.1177/1091581818800020; Hammer KA, 2015, INT J ANTIMICROB AG, V45, P106, DOI 10.1016/j.ijantimicag.2014.10.011; Kant V, 2014, INT IMMUNOPHARMACOL, V20, P322, DOI 10.1016/j.intimp.2014.03.009; Kasuya A, 2014, J DERMATOL SCI, V76, P169, DOI 10.1016/j.jdermsci.2014.11.001; Kweon DK, 2003, BIOMATERIALS, V24, P1595, DOI 10.1016/S0142-9612(02)00566-5; Labib RM, 2017, MOLECULES, V22, DOI 10.3390/molecules22091384; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Patrulea V, 2015, EUR J PHARM BIOPHARM, V97, P417, DOI 10.1016/j.ejpb.2015.08.004; Pazyar N, 2013, INT J DERMATOL, V52, P784, DOI 10.1111/j.1365-4632.2012.05654.x; Pelissari FM, 2009, J AGR FOOD CHEM, V57, P7499, DOI 10.1021/jf9002363; Ponrasu T, 2012, INT WOUND J, V9, P613, DOI 10.1111/j.1742-481X.2011.00924.x; Raafat D, 2009, MICROB BIOTECHNOL, V2, P186, DOI 10.1111/j.1751-7915.2008.00080.x; Raskovic A, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-225; Saha K, 1997, J ETHNOPHARMACOL, V56, P139, DOI 10.1016/S0378-8741(97)01522-5; Saporito F, 2018, INT J NANOMED, V13, P175, DOI 10.2147/IJN.S152529; Sardari K., 2006, COMP CLIN PATHOL, V16, P197, DOI [10.1007/s00580-006-0657-8, DOI 10.1007/S00580-006-0657-8]; Satchell Andrew C, 2002, Australas J Dermatol, V43, P175, DOI 10.1046/j.1440-0960.2002.00590.x; SATOH K, 1978, CLIN CHIM ACTA, V90, P37; Shi CM, 2006, J SURG RES, V133, P185, DOI 10.1016/j.jss.2005.12.013; Silva CJ, 2007, FLAVOUR FRAG J, V22, P474, DOI 10.1002/ffj.1823; Syed TA, 1999, TROP MED INT HEALTH, V4, P284, DOI 10.1046/j.1365-3156.1999.00396.x; Takaki I, 2008, J MED FOOD, V11, P741, DOI 10.1089/jmf.2007.0524; Tripathi S, 2009, INT J BIOL MACROMOL, V45, P372, DOI 10.1016/j.ijbiomac.2009.07.006; Wang LN, 2011, J AGR FOOD CHEM, V59, P12411, DOI 10.1021/jf203165k; Woollard A C, 2007, J Wound Care, V16, P255; Yadav E, 2017, J ESSENT OIL RES, V29, P201, DOI 10.1080/10412905.2016.1232665; Yu MH, 2013, FOOD CHEM, V136, P1047, DOI 10.1016/j.foodchem.2012.08.085	41	26	26	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0219561	10.1371/journal.pone.0219561	http://dx.doi.org/10.1371/journal.pone.0219561			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525200	Green Submitted, Green Published, gold			2022-12-26	WOS:000532225700005
J	Rhie, A; Son, HY; Kwak, SJ; Lee, S; Kim, DY; Lew, BL; Sim, WY; Seo, JS; Kwon, O; Kim, JI; Jo, SJ				Rhie, Arang; Son, Ho-Young; Kwak, Soo Jung; Lee, Seungbok; Kim, Dong Young; Lew, Bark-Lynn; Sim, Woo-Young; Seo, Jeong-Sun; Kwon, Ohsang; Kim, Jong-Il; Jo, Seong Jin			Genetic variations associated with response to dutasteride in the treatment of male subjects with androgenetic alopecia	PLOS ONE			English	Article							MALE-PATTERN BALDNESS; TRANS-RETINOIC ACID; BINDING-PROTEINS; PROSTATE-CANCER; HAIR FOLLICLE; RECEPTOR GENE; EXPRESSION; METABOLISM; ENZYMES; CYTOCHROME-P450	Dutasteride, a dual inhibitor of both type I and II 5 alpha-reductases, is used to treat male pattern hair loss (MPHL). However, patient response to dutasteride varies in each individual, the cause of which is yet to be identified. To identify genetic variants associated with response to dutasteride treatment for MPHL, a total of 42 men with moderate MPHL who had been treated with dutasteride for 6 months were genotyped and analysed by quantitative linear regression, case-control association tests, and Fisher's exact test. The synonymous single nucleotide polymorphism (SNP) rs72623193 in DHRS9 was most significantly associated with response to dutasteride, followed by the non-synonymous SNP rs2241057 in CYP26B1. Additionally, variants in ESR1, SRD5A1, CYP19A1, and RXRG are suggested to be associated with response to dutasteride. Cumulative effect and interaction among these SNPs were presented in both additive and non-additive models.	[Rhie, Arang; Son, Ho-Young; Kwak, Soo Jung; Lee, Seungbok; Seo, Jeong-Sun; Kim, Jong-Il] Seoul Natl Univ, Med Res Ctr, Genom Med Inst GMI, Seoul, South Korea; [Rhie, Arang] NHGRI, Genome Informat Sect, Computat & Stat Genom Branch, NIH, Bethesda, MD 20892 USA; [Son, Ho-Young; Kwak, Soo Jung; Lee, Seungbok; Seo, Jeong-Sun; Kim, Jong-Il] Seoul Natl Univ, Dept Biomed Sci, Coll Med, Seoul, South Korea; [Son, Ho-Young; Kwak, Soo Jung; Lee, Seungbok; Seo, Jeong-Sun; Kim, Jong-Il] Seoul Natl Univ, Dept Biochem & Mol Biol, Coll Med, Seoul, South Korea; [Kim, Dong Young; Kwon, Ohsang; Jo, Seong Jin] Seoul Natl Univ, Dept Dermatol, Coll Med, Seoul, South Korea; [Kim, Dong Young; Kwon, Ohsang; Jo, Seong Jin] Seoul Natl Univ Hosp, Biomed Res Inst, Lab Cutaneous Aging & Hair Res, Seoul, South Korea; [Kim, Dong Young; Kwon, Ohsang; Jo, Seong Jin] Seoul Natl Univ, Med Res Ctr, Inst Human Environm Interface Biol, Coll Med, Seoul, South Korea; [Lew, Bark-Lynn; Sim, Woo-Young] Kyung Hee Univ, Coll Med, Dept Dermatol, Seoul, South Korea	Seoul National University (SNU); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Kyung Hee University	Jo, SJ (corresponding author), Seoul Natl Univ, Dept Dermatol, Coll Med, Seoul, South Korea.; Jo, SJ (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Lab Cutaneous Aging & Hair Res, Seoul, South Korea.; Jo, SJ (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Human Environm Interface Biol, Coll Med, Seoul, South Korea.	sj.jo@snu.ac.kr	Seo, Jeong-Sun/J-2763-2012; KIM, JONG-IL/D-1019-2011; Rhie, Arang/AAP-8907-2021; SON, HO YOUNG/AAJ-3905-2020; KWON, OHSANG/J-2733-2012	KIM, JONG-IL/0000-0002-7240-3744; Rhie, Arang/0000-0002-9809-8127; Ho-young, Son/0000-0001-6326-5071; KWON, OHSANG/0000-0003-0464-5124; Seungbok, Lee/0000-0002-3145-8714; Jo, Seong Jin/0000-0002-2501-7672	SK Telecom Research Fund [34-2014-0120]	SK Telecom Research Fund	This study was supported by the SK Telecom Research Fund (Grant No. 34-2014-0120 to OK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brockschmidt FF, 2011, BRIT J DERMATOL, V165, P1293, DOI 10.1111/j.1365-2133.2011.10708.x; Chetyrkin SV, 2001, J BIOL CHEM, V276, P22278, DOI 10.1074/jbc.M102076200; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ellis JA, 2001, J INVEST DERMATOL, V116, P452, DOI 10.1046/j.1523-1747.2001.01261.x; Eun HC, 2010, J AM ACAD DERMATOL, V63, P252, DOI 10.1016/j.jaad.2009.09.018; Everts HB, 2004, J INVEST DERMATOL, V123, P258, DOI 10.1111/j.0022-202X.2004.23223.x; Everts HB, 2007, J INVEST DERMATOL, V127, P1593, DOI 10.1038/sj.jid.5700753; Everts HB, 2013, J INVEST DERMATOL, V133, P325, DOI 10.1038/jid.2012.393; Hayes VM, 2007, INT J CANCER, V120, P776, DOI 10.1002/ijc.22408; Hayes VM, 2005, CANCER EPIDEM BIOMAR, V14, P993, DOI 10.1158/1055-9965.EPI-04-0778; Heilmann S, 2013, J INVEST DERMATOL, V133, P1489, DOI 10.1038/jid.2013.43; Hillmer AM, 2005, AM J HUM GENET, V77, P140, DOI 10.1086/431425; Hillmer AM, 2008, AM J HUM GENET, V82, P737, DOI 10.1016/j.ajhg.2007.11.014; Hillmer AM, 2009, HUM GENET, V126, P255, DOI 10.1007/s00439-009-0668-z; Kaufman KD, 1998, J AM ACAD DERMATOL, V39, P578, DOI 10.1016/S0190-9622(98)70007-6; Krumm N, 2012, GENOME RES, V22, P1525, DOI 10.1101/gr.138115.112; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levy-Nissenbaum E, 2005, EUR J DERMATOL, V15, P339; Li R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002746; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Lorie EP, 2009, BRIT J DERMATOL, V160, P26, DOI 10.1111/j.1365-2133.2008.08895.x; Lorie EP, 2009, ARCH DERMATOL RES, V301, P475, DOI 10.1007/s00403-009-0937-7; Lorie EP, 2009, BBA-MOL CELL BIOL L, V1791, P220, DOI 10.1016/j.bbalip.2008.12.004; Markova NG, 2003, MOL GENET METAB, V78, P119, DOI 10.1016/S1096-7192(02)00226-3; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1; NORWOOD OT, 1975, SOUTHERN MED J, V68, P1359, DOI 10.1097/00007611-197511000-00009; Nyholt DR, 2003, J INVEST DERMATOL, V121, P1561, DOI 10.1111/j.1523-1747.2003.12615.x; Oh HS, 1996, P NATL ACAD SCI USA, V93, P12525, DOI 10.1073/pnas.93.22.12525; Ohnemus U, 2004, J INVEST DERMATOL, V122, P7, DOI 10.1046/j.0022-202X.2003.22120.x; Ohnemus U, 2006, ENDOCR REV, V27, P677, DOI 10.1210/er.2006-0020; Olsen EA, 2006, J AM ACAD DERMATOL, V55, P1014, DOI 10.1016/j.jaad.2006.05.007; Prodi DA, 2008, J INVEST DERMATOL, V128, P2268, DOI 10.1038/jid.2008.60; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rexer BN, 2002, BIOL REPROD, V67, P1555, DOI 10.1095/biolreprod.102.007021; Richards JB, 2008, NAT GENET, V40, P1282, DOI 10.1038/ng.255; Roos TC, 1998, PHARMACOL REV, V50, P315; Sinclair R, 1998, BRIT MED J, V317, P865, DOI 10.1136/bmj.317.7162.865; Soref CM, 2001, J BIOL CHEM, V276, P24194, DOI 10.1074/jbc.M100332200; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; White JA, 2000, P NATL ACAD SCI USA, V97, P6403, DOI 10.1073/pnas.120161397; Whiting DA, 1998, INT J DERMATOL, V37, P561, DOI 10.1046/j.1365-4362.1998.00542.x	45	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222533	10.1371/journal.pone.0222533	http://dx.doi.org/10.1371/journal.pone.0222533			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525235	Green Published, Green Submitted, gold			2022-12-26	WOS:000532225700035
J	Beato, M; Bigby, AEJ; De Keijzer, KL; Nakamura, FY; Coratella, G; McErlain-Naylor, SA				Beato, Marco; Bigby, Alexander E. J.; De Keijzer, Kevin L.; Nakamura, Fabio Y.; Coratella, Giuseppe; McErlain-Naylor, Stuart A.			Post-activation potentiation effect of eccentric overload and traditional weightlifting exercise on jumping and sprinting performance in male athletes	PLOS ONE			English	Article							POSTACTIVATION POTENTIATION; SOCCER PLAYERS; MAXIMAL POWER; RELIABILITY; PROTOCOLS; DIRECTION; MUSCLE; SPEED; SQUAT	The aim of this study was to evaluate the post-activation potentiation (PAP) effects following eccentric overload (EOL) and traditional weightlifting (TW) exercise on standing long jump (SLJ), countermovement jump (CMJ), and 5 m sprint acceleration performance. Ten male athletes were involved in a randomized, crossover study. The subjects performed 3 sets of 6 repetitions of EOL or TW half squat exercise followed by SLJ, CMJ, and 5 m sprint tests at 1 min, 3 min and 7 min, in separate sessions using a randomized order. Bayes factor (BF10) was reported to show the strength of the evidence. Differences were found using EOL for SLJ distance at 3 min (BF10 = 7.24, +8%), and 7 min (BF10 = 19.5, +7%), for CMJ at 3 min (BF10 = 3.25, +9%), and 7 min (BF10 = 4.12, +10.5%). Differences were found using TW exercise for SLJ at 3 min (BF10 = 3.88, +9%), and 7 min (BF10 = 12.4, +9%), CMJ at 3 min (BF10 = 7.42, +9.5%), and 7 min (BF10 = 12.4, +12%). No meaningful differences were found between EOL and TW exercises for SLJ (BF10 = 0.33), CMJ (BF10 = 0.27), and 5 m sprint (BF10 = 0.22). In conclusion, EOL and TW exercises acutely increase SLJ and CMJ, but not 5 m sprint performance. The PAP time window was found between 3 min and 7 min using both protocols. This study did not find differences between EOL and TW exercises, and so both methodologies can be used to stimulate a PAP response.	[Beato, Marco; Bigby, Alexander E. J.; De Keijzer, Kevin L.; McErlain-Naylor, Stuart A.] Univ Suffolk, Sch Hlth & Sports Sci, Ipswich, Suffolk, England; [Nakamura, Fabio Y.] Univ Fed Paraiba, Associate Grad Program Phys Educ UPE, Joao Pessoa, Paraiba, Brazil; [Nakamura, Fabio Y.] James Cook Univ, Coll Healthcare Sci, Townsville, Qld, Australia; [Coratella, Giuseppe] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy	Universidade Federal da Paraiba; James Cook University; University of Milan	Beato, M (corresponding author), Univ Suffolk, Sch Hlth & Sports Sci, Ipswich, Suffolk, England.	M.Beato@uos.ac.uk	de Keijzer, Kevin/ABE-9091-2021; McErlain-Naylor, Stuart A./AAS-9715-2020	McErlain-Naylor, Stuart A./0000-0002-9745-138X; Beato, Marco/0000-0001-5373-2211; CORATELLA, GIUSEPPE/0000-0001-7523-9102				Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Baudry S, 2007, J APPL PHYSIOL, V102, P1394, DOI 10.1152/japplphysiol.01254.2006; Bauer P, 2019, J STRENGTH COND RES, V33, P995, DOI 10.1519/JSC.0000000000002422; Beato M, 2019, J HUM KINET, V69, DOI [10.2478/hukin-2018-0050, DOI 10.2478/HUKIN-2018-0050]; Beato M, 2021, J STRENGTH COND RES, V35, P2616, DOI 10.1519/JSC.0000000000003214; Beato M, 2021, J STRENGTH COND RES, V35, P1825, DOI 10.1519/JSC.0000000000003005; Beato M, 2018, J STRENGTH COND RES, V32, P289, DOI 10.1519/JSC.0000000000002371; Bevan HR, 2010, J STRENGTH COND RES, V24, P701, DOI 10.1519/JSC.0b013e3181c7b68a; Bianchi M, 2019, J SPORT MED PHYS FIT, V59, P910, DOI 10.23736/S0022-4707.18.08804-7; Bishop D, 2003, SPORTS MED, V33, P439, DOI 10.2165/00007256-200333060-00005; Coratella G, 2018, J STRENGTH COND RES, V32, P921, DOI 10.1519/JSC.0000000000002463; Cormie P, 2011, SPORTS MED, V41, P125, DOI 10.2165/11538500-000000000-00000; Cuenca-Fernandez F, 2015, J STRENGTH COND RES, V29, P647, DOI 10.1519/JSC.0000000000000696; de Hoyo M, 2015, INT J SPORTS MED, V36, P308, DOI 10.1055/s-0034-1395521; Dello Iacono A, 2018, J SPORT SCI, V36, P2375, DOI 10.1080/02640414.2018.1458400; Dello Iacono A, 2018, J SPORT SCI, V36, P1269, DOI 10.1080/02640414.2017.1374657; Dello Iacono A, 2016, J STRENGTH COND RES, V30, P3122, DOI 10.1519/JSC.0000000000001393; Docherty D, 2007, INT J SPORT PHYSIOL, V2, P439, DOI 10.1123/ijspp.2.4.439; Enright K, 2018, SCI MED FOOTBALL, V2, P177, DOI 10.1080/24733938.2017.1411603; Golas A, 2017, J STRENGTH COND RES, V31, P3010, DOI 10.1519/JSC.0000000000001917; Golas A, 2016, J HUM KINET, V52, P95, DOI 10.1515/hukin-2015-0197; Gonzalo-Skok O, 2017, INT J SPORT PHYSIOL, V12, P951, DOI 10.1123/ijspp.2016-0251; Lee M.D., 2013, BAYESIAN COGNITIVE M; Markovic G, 2004, J STRENGTH COND RES, V18, P551, DOI 10.1519/00124278-200408000-00028; Mola JN, 2014, J STRENGTH COND RES, V28, P1529, DOI 10.1519/JSC.0000000000000313; Robbins DW, 2005, J STRENGTH COND RES, V19, P898; Sainani KL, 2018, MED SCI SPORT EXER, V50, P2611, DOI 10.1249/MSS.0000000000001737; Sainani KL, 2018, MED SCI SPORT EXER, V50, P2166, DOI 10.1249/MSS.0000000000001645; Sale DG, 2002, EXERC SPORT SCI REV, V30, P138, DOI 10.1097/00003677-200207000-00008; Scott SL, 2004, J STRENGTH COND RES, V18, P201; Seitz LB, 2016, SPORTS MED, V46, P231, DOI 10.1007/s40279-015-0415-7; Suchomel TJ, 2016, SPORTS MED, V46, P1419, DOI 10.1007/s40279-016-0486-0; Tillin NA, 2009, SPORTS MED, V39, P147, DOI 10.2165/00007256-200939020-00004; Tous-Fajardo J, 2016, INT J SPORT PHYSIOL, V11, P66, DOI 10.1123/ijspp.2015-0010; VANDOORN J, 2019, JASP GUIDELINES COND; Vicens-Bordas J, 2018, J SCI MED SPORT, V21, P2, DOI 10.1016/j.jsams.2017.09.001; Westfall PH, 1997, BIOMETRIKA, V84, P419, DOI 10.1093/biomet/84.2.419	37	24	25	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2019	14	9							e0222466	10.1371/journal.pone.0222466	http://dx.doi.org/10.1371/journal.pone.0222466			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4IG	31513671	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000532212700084
J	Hanner, AS; Dunworth, M; Casero, RA; MacDiarmid, CW; Park, MH				Hanner, Ashleigh S.; Dunworth, Matthew; Casero, Robert A., Jr.; MacDiarmid, Colin W.; Park, Myung Hee			Elevation of cellular Mg2+ levels by the Mg2+ transporter, Alr1, supports growth of polyamine-deficient Saccharomyces cerevisiae cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene knockout; polyamine; yeast genetics; yeast metabolism; cell growth; magnesium transport	MAGNESIUM TRANSPORT; SPE2-DELTA MUTANT; PROTEIN; SPERMIDINE; IDENTIFICATION; HOMEOSTASIS; EXTRACTION; HYPUSINE; DELETION; CORA	The polyamines putrescine, spermidine, and spermine are required for normal eukaryotic cellular functions. However, the minimum requirement for polyamines varies widely, ranging from very high concentrations (mm) in mammalian cells to extremely low in the yeast Saccharomyces cerevisiae. Yeast strains deficient in polyamine biosynthesis (spe1?, lacking ornithine decarboxylase, and spe2?, lacking SAM decarboxylase) require externally supplied polyamines, but supplementation with as little as 10(?8) m spermidine restores their growth. Here, we report that culturing a spe1? mutant or a spe2? mutant in a standard polyamine-free minimal medium (SDC) leads to marked increases in cellular Mg2+ content. To determine which yeast Mg2+ transporter mediated this increase, we generated mutant strains with a deletion of SPE1 or SPE2 combined with a deletion of one of the three Mg2+ transporter genes, ALR1, ALR2, and MNR2, known to maintain cytosolic Mg2+ concentration. Neither Alr2 nor Mnr2 was required for increased Mg2+ accumulation, as all four double mutants (spe1? alr2?, spe2? alr2?, spe1? mnr2?, and spe2? mnr2?) exhibited significant Mg2+ accumulation upon polyamine depletion. In contrast, a spe2? alr1? double mutant cultured in SDC exhibited little increase in Mg2+ content and displayed severe growth defects compared with single mutants alr1? and spe2? under polyamine-deficient conditions. These findings indicate that Alr1 is required for the up-regulation of the Mg2+ content in polyamine-depleted cells and suggest that elevated Mg2+ can support growth of polyamine-deficient S. cerevisiae mutants. Up-regulation of cellular polyamine content in a Mg2+-deficient alr1? mutant provided further evidence for a cross-talk between Mg2+ and polyamine metabolism.	[Hanner, Ashleigh S.; Park, Myung Hee] NIDCR, Mol & Cellular Biochem Sect, NIH, Bldg 30,Rm 3A300,30 Convent Dr, Bethesda, MD 20892 USA; [Dunworth, Matthew; Casero, Robert A., Jr.] Johns Hopkins Univ, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [MacDiarmid, Colin W.] Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Johns Hopkins University; Johns Hopkins Medicine; University of Wisconsin System; University of Wisconsin Madison	Park, MH (corresponding author), NIDCR, Mol & Cellular Biochem Sect, NIH, Bldg 30,Rm 3A300,30 Convent Dr, Bethesda, MD 20892 USA.	mhpark@nih.gov	MacDiarmid, Colin/AAV-5920-2021	MacDiarmid, Colin/0000-0001-8578-5756; Dunworth, Matthew/0000-0002-8852-169X	National Institute of Dental and Craniofacial Research, National Institutes of Health; NIH [R01-GM56285, R01-CA204345]; NATIONAL CANCER INSTITUTE [R01CA204345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056285] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the intramural program of the National Institute of Dental and Craniofacial Research, National Institutes of Health (M. H. P.), NIH R01-CA204345 (R. A. C.), and by NIH R01-GM56285 (C. W. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BALASUNDARAM D, 1993, P NATL ACAD SCI USA, V90, P4693, DOI 10.1073/pnas.90.10.4693; Bui DM, 1999, J BIOL CHEM, V274, P20438, DOI 10.1074/jbc.274.29.20438; Casero RA, 2018, NAT REV CANCER, V18, P681, DOI 10.1038/s41568-018-0050-3; Chattopadhyay MK, 2008, P NATL ACAD SCI USA, V105, P6554, DOI 10.1073/pnas.0710970105; Chattopadhyay MK, 2006, YEAST, V23, P751, DOI 10.1002/yea.1393; da Costa BMT, 2007, APPL MICROBIOL BIOT, V77, P411, DOI 10.1007/s00253-007-1177-4; Dever TE, 2018, J BIOL CHEM, V293, P18719, DOI 10.1074/jbc.TM118.003338; Eide DJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r77; Gardner RC, 2003, CURR OPIN PLANT BIOL, V6, P263, DOI 10.1016/S1369-5266(03)00032-3; Giaever G, 2014, GENETICS, V197, P451, DOI 10.1534/genetics.114.161620; Graschopf A, 2001, J BIOL CHEM, V276, P16216, DOI 10.1074/jbc.M101504200; HE Y, 1993, EUR J BIOCHEM, V217, P89, DOI 10.1111/j.1432-1033.1993.tb18222.x; IGARASHI K, 1973, BIOCHIM BIOPHYS ACTA, V299, P325, DOI 10.1016/0005-2787(73)90356-0; Igarashi K, 2015, IUBMB LIFE, V67, P160, DOI 10.1002/iub.1363; KABRA PM, 1986, J CHROMATOGR, V380, P19, DOI 10.1016/S0378-4347(00)83621-X; Kahana C, 2009, ESSAYS BIOCHEM, V46, P47, DOI [10.1042/BSE0460004, 10.1042/bse0460004]; Klompmaker SH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01930-5; Lane DJR, 2018, BBA-MOL BASIS DIS, V1864, P2793, DOI 10.1016/j.bbadis.2018.05.007; Lee JM, 2006, CURR GENET, V49, P7, DOI 10.1007/s00294-005-0037-y; Lim PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020896; Looke M, 2011, BIOTECHNIQUES, V50, P325, DOI 10.2144/000113672; MacDiarmid CW, 1998, J BIOL CHEM, V273, P1727, DOI 10.1074/jbc.273.3.1727; Mandal S, 2013, P NATL ACAD SCI USA, V110, P2169, DOI 10.1073/pnas.1219002110; MARUYAMA T, 1994, BBA-BIOMEMBRANES, V1194, P289, DOI 10.1016/0005-2736(94)90311-5; Matthies D, 2016, CELL, V164, P747, DOI 10.1016/j.cell.2015.12.055; Nichols CG, 2018, J BIOL CHEM, V293, P18779, DOI 10.1074/jbc.TM118.003344; Nishimura K, 2012, AMINO ACIDS, V42, P703, DOI 10.1007/s00726-011-0986-z; Palombo I, 2013, BIOCHEMISTRY-US, V52, P4842, DOI 10.1021/bi4007397; PARK MH, 1981, P NATL ACAD SCI-BIOL, V78, P2869, DOI 10.1073/pnas.78.5.2869; Park MH, 2018, J BIOL CHEM, V293, P18710, DOI 10.1074/jbc.TM118.003341; Payandeh J, 2013, BBA-BIOMEMBRANES, V1828, P2778, DOI 10.1016/j.bbamem.2013.08.002; Pegg AE, 2011, METHODS MOL BIOL, V720, P3, DOI 10.1007/978-1-61779-034-8_1; Pisat NP, 2009, GENETICS, V183, P873, DOI 10.1534/genetics.109.106419; Quamme GA, 2010, AM J PHYSIOL-CELL PH, V298, pC407, DOI 10.1152/ajpcell.00124.2009; Romani AMP, 2011, ARCH BIOCHEM BIOPHYS, V512, P1, DOI 10.1016/j.abb.2011.05.010; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Wachek M, 2006, FEBS J, V273, P4236, DOI 10.1111/j.1742-4658.2006.05424.x; Wang YR, 2018, METALLOMICS, V10, DOI 10.1039/c8mt00269j; Zhou H, 2009, P NATL ACAD SCI USA, V106, P15750, DOI 10.1073/pnas.0908332106	39	1	1	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					17131	17142		10.1074/jbc.RA119.009705	http://dx.doi.org/10.1074/jbc.RA119.009705			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31548311	hybrid, Green Published			2022-12-26	WOS:000501801900052
J	Fukuura, K; Inoue, Y; Miyajima, C; Watanabe, S; Tokugawa, M; Morishita, D; Ohoka, N; Komada, M; Hayashi, H				Fukuura, Keishi; Inoue, Yasumichi; Miyajima, Chiharu; Watanabe, Shin; Tokugawa, Muneshige; Morishita, Daisuke; Ohoka, Nobumichi; Komada, Masayuki; Hayashi, Hidetoshi			The ubiquitin-specific protease USP17 prevents cellular senescence by stabilizing the methyltransferase SET8 and transcriptionally repressing p21	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; deubiquitylation (deubiquitination); histone methylation; posttranslational modification (PTM); senescence; p21; SET8; USP17	3' UNTRANSLATED REGION; MIR-502 BINDING-SITE; HISTONE H4; DEUBIQUITINATING ENZYMES; GENE-EXPRESSION; PR-SET7; POLYMORPHISM; DEGRADATION; CYCLE; TRANSITION	Su(var)3?9, Enhancer-of-zeste, and Trithorax (SET) domain-containing protein 8 (SET8) is the sole enzyme that monomethylates Lys-20 of histone H4 (H4K20). SET8 has been implicated in the regulation of multiple biological processes, such as gene transcription, the cell cycle, and senescence. SET8 quickly undergoes ubiquitination and degradation by several E3 ubiquitin ligases; however, the enzyme that deubiquitinates SET8 has not yet been identified. Here we demonstrated that ubiquitin-specific peptidase 17?like family member (USP17) deubiquitinates and therefore stabilizes the SET8 protein. We observed that USP17 interacts with SET8 and removes polyubiquitin chains from SET8. USP17 knockdown not only decreased SET8 protein levels and H4K20 monomethylation but also increased the levels of the cyclin-dependent kinase inhibitor p21. As a consequence, USP17 knockdown suppressed cell proliferation. We noted that USP17 was down-regulated in replicative senescence and that USP17 inhibition alone was sufficient to trigger cellular senescence. These results reveal a regulatory mechanism whereby USP17 prevents cellular senescence by removing ubiquitin marks from and stabilizing SET8 and transcriptionally repressing p21.	[Fukuura, Keishi; Inoue, Yasumichi; Miyajima, Chiharu; Watanabe, Shin; Tokugawa, Muneshige; Morishita, Daisuke; Hayashi, Hidetoshi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Cell Signaling, Nagoya, Aichi 4678603, Japan; [Inoue, Yasumichi; Miyajima, Chiharu; Hayashi, Hidetoshi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Innovat Therapeut Sci, Cooperat Major Nanopharmaceut Sci, Nagoya, Aichi 4678603, Japan; [Ohoka, Nobumichi] Natl Inst Hlth Sci, Div Mol Target & Gene Therapy Prod, Kawasaki, Kanagawa 2109501, Japan; [Komada, Masayuki] Tokyo Inst Technol, Cell Biol Unit, Inst Innovat Res, Yokohama, Kanagawa 2268501, Japan; [Komada, Masayuki] Tokyo Inst Technol, Sch Life Sci & Technol, Yokohama, Kanagawa 2268501, Japan	Nagoya City University; Nagoya City University; National Institute of Health Sciences - Japan; Tokyo Institute of Technology; Tokyo Institute of Technology	Inoue, Y; Hayashi, H (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Cell Signaling, Nagoya, Aichi 4678603, Japan.; Inoue, Y; Hayashi, H (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Innovat Therapeut Sci, Cooperat Major Nanopharmaceut Sci, Nagoya, Aichi 4678603, Japan.	yainoue@phar.nagoya-cu.ac.jp; hhayashi@phar.nagoya-cu.ac.jp		Inoue, Yasumichi/0000-0002-1667-1381	Japan Society for the Promotion of Science (JSPS) [24590085, 15K07936, 15K07937, 18K06660]; JSPS [24700983]; Nagoya City University; Kidani Memorial Trust Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation; Inamori Foundation; Aichi Cancer Research Foundation; Ichiro Kanehara Foundation; Ono Medical Research Foundation	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nagoya City University; Kidani Memorial Trust Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation(Takeda Science Foundation (TSF)); Inamori Foundation; Aichi Cancer Research Foundation(Aichi Cancer Research Foundation); Ichiro Kanehara Foundation; Ono Medical Research Foundation	This work was supported by Grants-in-Aid for Scientific Research (C) 24590085, 15K07936, 15K07937, and 18K06660 from the Japan Society for the Promotion of Science (JSPS); Grant-in-Aid for Young Scientists (B) 24700983 from JSPS, and a grant-in-aid for research from Nagoya City University. The authors declare that they have no conflicts of interest with the contents of this article.; Recipients of a scholarship from the Kidani Memorial Trust Foundation.; Supported by the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the Takeda Science Foundation, the Inamori Foundation, the Aichi Cancer Research Foundation, the Ichiro Kanehara Foundation, and the Ono Medical Research Foundation.	Abbas T, 2010, MOL CELL, V40, P9, DOI 10.1016/j.molcel.2010.09.014; Beck DB, 2012, GENE DEV, V26, P325, DOI 10.1101/gad.177444.111; Burrows JF, 2005, GENOMICS, V85, P524, DOI 10.1016/j.ygeno.2004.11.013; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Centore RC, 2010, MOL CELL, V40, P22, DOI 10.1016/j.molcel.2010.09.015; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Ding CM, 2012, EXP THER MED, V3, P689, DOI 10.3892/etm.2012.469; Ducker C, 2019, NUCLEIC ACIDS RES, V47, P4495, DOI 10.1093/nar/gkz166; Guo ZJ, 2012, INT J CANCER, V131, P1318, DOI 10.1002/ijc.27352; Inoue Y, 2007, EMBO J, V26, P2083, DOI 10.1038/sj.emboj.7601652; Inoue Y, 2017, FEBS LETT, V591, P3682, DOI 10.1002/1873-3468.12869; Inoue Y, 2011, J BIOL CHEM, V286, P6311, DOI 10.1074/jbc.M110.177683; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Jorgensen S, 2013, NUCLEIC ACIDS RES, V41, P2797, DOI 10.1093/nar/gkt012; Kawarada Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep35483; Kim J, 2014, MOL CELL BIOL, V34, P4177, DOI 10.1128/MCB.00530-14; Lin YW, 2017, ONCOTARGET, V8, P75127, DOI 10.18632/oncotarget.20561; Liu B, 2016, ONCOTARGET, V7, P34277, DOI 10.18632/oncotarget.9099; Liu TZ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13923; McClurg UL, 2015, ONCOTARGET, V6, P9657, DOI 10.18632/oncotarget.3922; McFarlane C, 2010, CANCER RES, V70, P3329, DOI 10.1158/0008-5472.CAN-09-4152; Milite C, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0268-4; Miyajima C, 2015, BIOL PHARM BULL, V38, P618, DOI 10.1248/bpb.b15-00003; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Oda H, 2010, MOL CELL, V40, P364, DOI 10.1016/j.molcel.2010.10.011; Pereg Y, 2010, NAT CELL BIOL, V12, P400, DOI 10.1038/ncb2041; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Shen YQ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-470; Shih CT, 2017, AGING CELL, V16, P797, DOI 10.1111/acel.12607; Song FJ, 2009, CLIN CANCER RES, V15, P6292, DOI 10.1158/1078-0432.CCR-09-0826; Song HH, 2015, INT J CLIN EXP PATHO, V8, P10707; Takawa M, 2012, CANCER RES, V72, P3217, DOI 10.1158/0008-5472.CAN-11-3701; Tanaka H, 2017, CELL REP, V18, P2148, DOI 10.1016/j.celrep.2017.02.021; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Wang CJ, 2012, CANCER GENET-NY, V205, P373, DOI 10.1016/j.cancergen.2012.04.010; Wang JL, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7090118; Wang ZW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10185; Wu SM, 2010, GENE DEV, V24, P2531, DOI 10.1101/gad.1984210; Yang F, 2012, EMBO J, V31, P110, DOI 10.1038/emboj.2011.364; Yin Y, 2008, CELL CYCLE, V7, P1423, DOI 10.4161/cc.7.10.5867; Zhai K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00637-x; Zheng NN, 2016, CELL CYCLE, V15, P3042, DOI 10.1080/15384101.2016.1234552	44	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					16429	16439		10.1074/jbc.RA119.009006	http://dx.doi.org/10.1074/jbc.RA119.009006			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31533987	Green Published, hybrid			2022-12-26	WOS:000499478600044
J	Blasius, TL; Takao, D; Verhey, KJ				Blasius, T. Lynne; Takao, Daisuke; Verhey, Kristen J.			NPHP proteins are binding partners of nucleoporins at the base of the primary cilium	PLOS ONE			English	Article							NUCLEAR-PORE COMPLEX; PERMEABILITY BARRIER; INV COMPARTMENT; CILIARY ENTRY; TRANSPORT; DISEASE; INVERSIN; SIGNAL; GENES; LOCALIZATION	Cilia are microtubule-based organelles that protrude from the surface of eukaryotic cells to generate motility and to sense and respond to environmental cues. In order to carry out these functions, the complement of proteins in the cilium must be specific for the organelle. Regulation of protein entry into primary cilia has been shown to utilize mechanisms and components of nuclear gating, including nucleoporins of the nuclear pore complex (NPC). We show that nucleoporins also localize to the base of motile cilia on the surface of trachea epithelial cells. How nucleoporins are anchored at the cilium base has been unclear as transmembrane nucleoporins, which anchor nucleoporins at the nuclear envelope, have not been found to localize at the cilium. Here we use the directed yeast two-hybrid assay to identify direct interactions between nucleoporins and nephronophthisis proteins (NPHPs) which localize to the cilium base and contribute to cilium assembly and identity. We validate NPHP-nucleoporin interactions in mammalian cells using the knocksideways assay and demonstrate that the interactions occur at the base of the primary cilium using bimolecular fluorescence complementation. We propose that NPHP proteins anchor nucleoporins at the base of primary cilia to regulate protein entry into the organelle.	[Blasius, T. Lynne; Takao, Daisuke; Verhey, Kristen J.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Verhey, KJ (corresponding author), Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.	kjverhey@umich.edu	Takao, Daisuke/U-1849-2019	Takao, Daisuke/0000-0001-6136-6733	National Institutes of Health [R01GM116204]; Japan Society for the Promotion of Science; National Institute of Diabetes and Digestive and Kidney Diseases [P30DK092926]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by a grant from the National Institutes of Health to KJV (R01GM116204) and a Postdoctoral Fellowship for Research Abroad from the Japan Society for the Promotion of Science to DT. The work was supported by Grant Number P30DK092926 (MCDTR) from the National Institute of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anvarian Z, 2019, NAT REV NEPHROL, V15, P199, DOI 10.1038/s41581-019-0116-9; Apelt L, 2016, MOL CELL PROTEOMICS, V15, P2594, DOI 10.1074/mcp.M115.054627; Baade I, 2019, CURR OPIN CELL BIOL, V58, P1, DOI 10.1016/j.ceb.2018.11.004; Borlido J, 2014, CELL CYCLE, V13, P14, DOI 10.4161/cc.27299; Braun DA, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028191; Breslow DK, 2013, J CELL BIOL, V203, P129, DOI 10.1083/jcb.201212024; Chatel G, 2011, CELL SIGNAL, V23, P1555, DOI 10.1016/j.cellsig.2011.05.023; Christie M, 2016, J MOL BIOL, V428, P2060, DOI 10.1016/j.jmb.2015.10.023; Czarnecki PG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7023; D'Angelo MA, 2012, DEV CELL, V22, P446, DOI 10.1016/j.devcel.2011.11.021; del Viso F, 2016, DEV CELL, V38, P478, DOI 10.1016/j.devcel.2016.08.002; Dishinger JF, 2010, NAT CELL BIOL, V12, P703, DOI 10.1038/ncb2073; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Elliott KH, 2019, DEV BIOL, V447, P28, DOI 10.1016/j.ydbio.2018.03.007; Endicott SJ, 2018, CURR BIOL, V28, P1643, DOI 10.1016/j.cub.2018.04.014; Endicott SJ, 2015, DEVELOPMENT, V142, P4068, DOI 10.1242/dev.126953; Fakhro KA, 2011, P NATL ACAD SCI USA, V108, P2915, DOI 10.1073/pnas.1019645108; Fan SL, 2011, MOL BIOL CELL, V22, P4539, DOI 10.1091/mbc.E11-03-0267; Floch AG, 2014, METHOD CELL BIOL, V122, P1, DOI 10.1016/B978-0-12-417160-2.00001-1; Fukui H, 2012, FEBS LETT, V586, P2273, DOI 10.1016/j.febslet.2012.05.064; Funabashi T, 2017, MOL BIOL CELL, V28, P624, DOI 10.1091/mbc.E16-09-0648; Garcia-Gonzalo FR, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028134; Goncalves J, 2017, MOL CELLS, V40, P243, DOI 10.14348/molcells.2017.0054; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gupta GD, 2015, CELL, V163, P1484, DOI 10.1016/j.cell.2015.10.065; Hampoelz B, 2019, ANNU REV BIOPHYS, V48, P515, DOI 10.1146/annurev-biophys-052118-115308; Han YH, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002063; Hayama R, 2017, CURR OPIN CELL BIOL, V46, P110, DOI 10.1016/j.ceb.2017.05.003; Hoff S, 2013, NAT GENET, V45, P951, DOI 10.1038/ng.2681; Horie C, 2002, MOL BIOL CELL, V13, P1615, DOI 10.1091/mbc.01-12-0570; Hua Kiet, 2017, Cilia, V6, P5, DOI 10.1186/s13630-017-0045-9; Hurd TW, 2011, J CELL SCI, V124, P718, DOI 10.1242/jcs.070839; Jensen VL, 2017, CURR OPIN CELL BIOL, V47, P83, DOI 10.1016/j.ceb.2017.03.012; Johnson CA, 2019, DEV CELL, V49, P161, DOI 10.1016/j.devcel.2019.03.009; Kee HL, 2012, NAT CELL BIOL, V14, P431, DOI 10.1038/ncb2450; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kim SJ, 2014, MOL CELL PROTEOMICS, V13, P2911, DOI 10.1074/mcp.M114.040915; Lin DH, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1015; Lin DH, 2019, ANN REV BIOCH; Lin YC, 2013, NAT CHEM BIOL, V9, P437, DOI [10.1038/NCHEMBIO.1252, 10.1038/nchembio.1252]; Liu HL, 2009, MOL BIOL CELL, V20, P616, DOI 10.1091/mbc.E08-06-0628; Lu L, 2018, CELL MOL LIFE SCI, V75, P597, DOI 10.1007/s00018-017-2629-3; Madugula V, 2016, J CELL SCI, V129, P3922, DOI 10.1242/jcs.194019; Mansfeld J, 2006, MOL CELL, V22, P93, DOI 10.1016/j.molcel.2006.02.015; Matsuura Y, 2016, J MOL BIOL, V428, P2025, DOI 10.1016/j.jmb.2015.09.025; McClure-Begley Tristan D, 2017, Cilia, V6, P8, DOI 10.1186/s13630-017-0052-x; Mitchison HM, 2017, J PATHOL, V241, P294, DOI 10.1002/path.4843; Mollet G, 2005, HUM MOL GENET, V14, P645, DOI 10.1093/hmg/ddi061; Morgan D, 2002, HUM MOL GENET, V11, P3345, DOI 10.1093/hmg/11.26.3345; Mossaid I, 2015, CELLS-BASEL, V4, P706, DOI 10.3390/cells4040706; Nakajima Y, 2018, KIDNEY INT, V93, P1108, DOI 10.1016/j.kint.2017.11.016; Nakano H, 2011, CELL CYCLE, V10, P425, DOI 10.4161/cc.10.3.14721; Ori A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.4; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Pascual-Garcia P, 2019, CURR OPIN CELL BIOL, V58, P126, DOI 10.1016/j.ceb.2019.04.001; Raices M, 2017, CURR OPIN CELL BIOL, V46, P26, DOI 10.1016/j.ceb.2016.12.006; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; Robinson M.S., 2013, CURR PROTOC CELL BIO, V61, P11; Robinson MS, 2010, DEV CELL, V18, P324, DOI 10.1016/j.devcel.2009.12.015; Saka Y, 2007, DEVELOPMENT, V134, P4209, DOI 10.1242/dev.010645; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Schmidt HB, 2016, TRENDS BIOCHEM SCI, V41, P46, DOI 10.1016/j.tibs.2015.11.001; Schwartz M, 2015, NUCLEUS-PHILA, V6, P40, DOI 10.1080/19491034.2015.1004260; Shiba D, 2010, CYTOSKELETON, V67, P112, DOI 10.1002/cm.20428; Shiba D, 2009, J CELL SCI, V122, P44, DOI 10.1242/jcs.037408; Stavru F, 2006, J CELL BIOL, V173, P477, DOI 10.1083/jcb.200601002; Takao D, 2017, CURR BIOL, V27, P2296, DOI 10.1016/j.cub.2017.06.044; Takao D, 2014, CURR BIOL, V24, P2288, DOI 10.1016/j.cub.2014.08.012; Torrado B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162033; Tsuji T, 2016, CYTOSKELETON, V73, P45, DOI 10.1002/cm.21264; Vollmer B, 2012, EMBO J, V31, P4072, DOI 10.1038/emboj.2012.256; Warburton-Pitt SRF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004866; Warburton-Pitt SRF, 2012, J CELL SCI, V125, P2592, DOI 10.1242/jcs.095539; Watanabe D, 2003, DEVELOPMENT, V130, P1725, DOI 10.1242/dev.00407; Wiegering A, 2018, EMBO J, V37, DOI 10.15252/embj.201797791	75	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222924	10.1371/journal.pone.0222924	http://dx.doi.org/10.1371/journal.pone.0222924			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JD1OG	31553752	Green Published, gold			2022-12-26	WOS:000489743400001
J	Kim, TY; Chang, HE; Lee, SW; Seo, SH; Hong, YJ; Park, JS; Park, KU				Kim, Tae Yeul; Chang, Ho Eun; Lee, Seong-Wook; Seo, Soo Hyun; Hong, Yun Ji; Park, Jeong Su; Park, Kyoung Un			A novel strategy for interpreting the T-SPOT. TB test results read by an ELISPOT plate imager	PLOS ONE			English	Article							ASSAYS; TUBERCULOSIS; VARIABILITY; DIAGNOSIS	Background The T-SPOT.TB can be read by an ELISPOT plate imager as an alternative to a labor-intensive and time-consuming manual reading, but its accuracy has not been sufficiently discussed to date. Methods 1,423 test results obtained from manual reading using a microscope and an ELISPOT plate imager were compared. The agreement of qualitative test results was assessed using Cohen's kappa coefficient. The relationship of spot counts was studied using Bland-Altman analysis. Results The overall percent agreement of the qualitative test results was 95.43% with a kappa coefficient of 0.91. Positive test results with the maximum net spot count of 8 and borderline test results showed relatively high discordance. The agreement of spot counts in panel A, panel B, and nil control was good, and variability did not increase with higher spot counts. On the basis of study findings, a novel strategy for interpreting the test results by an ELISPOT plate imager was proposed. Conclusions To increase diagnostic accuracy, positive test results with the maximum net spot count of 8 and borderline test results should be manually confirmed. Our strategy could be a practical guide for laboratories to build their own strategies for interpreting the test results by an ELISPOT plate imager.	[Kim, Tae Yeul; Chang, Ho Eun; Seo, Soo Hyun; Hong, Yun Ji; Park, Jeong Su; Park, Kyoung Un] Seoul Natl Univ, Dept Lab Med, Bundang Hosp, Seongnam Si, Gyeonggi Do, South Korea; [Chang, Ho Eun; Lee, Seong-Wook] Dankook Univ, Dept Mol Biol, Yongin, Gyeonggi Do, South Korea; [Hong, Yun Ji; Park, Kyoung Un] Seoul Natl Univ, Dept Lab Med, Coll Med, Seoul, South Korea	Seoul National University (SNU); Dankook University; Seoul National University (SNU)	Park, KU (corresponding author), Seoul Natl Univ, Dept Lab Med, Bundang Hosp, Seongnam Si, Gyeonggi Do, South Korea.; Park, KU (corresponding author), Seoul Natl Univ, Dept Lab Med, Coll Med, Seoul, South Korea.	m91w95pf@snu.ac.kr	Park, Kyoung Un/J-5473-2012	Park, Kyoung Un/0000-0002-2402-7633; Lee, Seong-Wook/0000-0003-1718-7601; Kim, Tae Yeul/0000-0002-6405-5305				Agarwal S, 2016, TUBERCULOSIS, V101, pS92, DOI 10.1016/j.tube.2016.09.013; Al-Orainey IO, 2009, ANN THORAC MED, V4, P5, DOI 10.4103/1817-1737.44778; [Anonymous], 2018, LAT TUB INF UPD CONS; [Anonymous], 2018, GLOB TUB REP 2018; Ashoor I, 2013, AM J TRANSPLANT, V13, P1871, DOI 10.1111/ajt.12286; De Rose R, 2005, J IMMUNOL METHODS, V297, P177, DOI 10.1016/j.jim.2004.12.009; Doan TN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188631; Franken WPJ, 2009, CLIN VACCINE IMMUNOL, V16, P1439, DOI 10.1128/CVI.00456-08; Hawkins N, 2006, J IMMUNOL METHODS, V316, P52, DOI 10.1016/j.jim.2006.08.005; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Janetzki S, 2004, J IMMUNOL METHODS, V291, P175, DOI 10.1016/j.jim.2004.06.008; Janetzki S, 2015, NAT PROTOC, V10, P1098, DOI 10.1038/nprot.2015.068; King TC, 2015, AM J RESP CRIT CARE, V192, P367, DOI 10.1164/rccm.201501-0199OC; Ramos JM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-169; Rego K, 2018, TUBERCULOSIS, V108, P178, DOI 10.1016/j.tube.2017.12.005; Ringshausen FC, 2012, J OCCUP MED TOXICOL, V7, DOI 10.1186/1745-6673-7-6; Sundararaman S, 2015, CELLS-BASEL, V4, P21, DOI 10.3390/cells4010021; Tang Patrick, 2017, Curr Treat Options Infect Dis, V9, P371, DOI 10.1007/s40506-017-0135-7; van Zyl-Smit RN, 2009, AM J RESP CRIT CARE, V180, P49, DOI 10.1164/rccm.200811-1704OC; Wang JY, 2007, EMERG INFECT DIS, V13, P553, DOI 10.3201/eid1304.051195	21	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222920	10.1371/journal.pone.0222920	http://dx.doi.org/10.1371/journal.pone.0222920			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553764	Green Published, gold			2022-12-26	WOS:000532319200044
J	Mekanda, FMO; Monamele, CG; Nemg, FBS; Yonga, GM; Ouapi, D; Beng, VP; Batejat, C; Caro, V; Manuguerra, JC; Demanou, M				Mekanda, Franck-Martin Obam; Monamele, Chavely Gwladys; Nemg, Fredy Brice Simo; Yonga, Gilde Martial; Ouapi, Diane; Beng, Veronique Penlap; Batejat, Christophe; Caro, Valerie; Manuguerra, Jean-Claude; Demanou, Maurice			Molecular characterization of measles virus strains circulating in Cameroon during the 2013-2016 epidemics	PLOS ONE			English	Article							GENETIC-CHARACTERIZATION; ELIMINATION; WORLDWIDE; GENOTYPES; PROGRESS	The first genotyping data on measles virus (MeV) strains in Cameroon dates from 1994, while other studies were realized in 2001 and 2011 with the establishment of MeV virological surveillance. However, the genetic data of MeV strains circulating in Cameroon remains fragmented and concentrated in certain regions, hence the need for an update. The objective of this study was to have recent data on MeV genotypes circulating in Cameroon. Ninety throat swabs collected during recent measles outbreaks were analyzed by MeV genotyping RT-PCR using the nucleoprotein gene N. The resulting sequences were analyzed on the basis of 450 nucleotides with MEGA 7 software. Overall genome analysis was performed on 40/90 sequences. The strains were from all ten regions and all belonged to cluster 1 of genotype B3. The genotype B3 has been circulating in Cameroon for long periods of time; efforts must be made in immunization for its elimination.	[Mekanda, Franck-Martin Obam; Monamele, Chavely Gwladys; Nemg, Fredy Brice Simo; Yonga, Gilde Martial; Ouapi, Diane; Demanou, Maurice] Ctr Pasteur Cameroon CPC, Dept Virol, WHO Natl Measles Reference Lab, Yaounde, Centre, Cameroon; [Mekanda, Franck-Martin Obam; Beng, Veronique Penlap] Univ Yaounde I, Fac Sci, Yaounde, Centre, Cameroon; [Batejat, Christophe; Caro, Valerie; Manuguerra, Jean-Claude] Inst Pasteur, Unite Rech & Expertise Environm & Risques Infecti, Cellule Intervent Biol Urgence CIBU, Paris, France	University of Yaounde I; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Demanou, M (corresponding author), Ctr Pasteur Cameroon CPC, Dept Virol, WHO Natl Measles Reference Lab, Yaounde, Centre, Cameroon.	demanou@pasteur-yaounde.org		Demanou, Maurice/0000-0002-9275-0874; Batejat, Christophe/0000-0002-2344-5710				Alla A, 2006, J MED VIROL, V78, P1465, DOI 10.1002/jmv.20720; Dabbagh A, 2017, MMWR-MORBID MORTAL W, V66, P1148, DOI 10.15585/mmwr.mm6642a6; Demanou M, 2013, VIROL J VIROLOGY J, V10, P1; El Mubarak HS, 2002, J GEN VIROL, V83, P1437, DOI 10.1099/0022-1317-83-6-1437; Eom H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0188957; Focus E., 2016, WKLY EPIDEMIOL REC, V21, P265; Gouandjika-Vasilache I, 2006, J MED VIROL, V78, P964, DOI 10.1002/jmv.20648; Griffin DE, 2007, FIELDS VIROLOGY, V1, P1551; Haddad-Boubaker S, 2010, VIRUS RES, V153, P258, DOI 10.1016/j.virusres.2010.08.011; Hanses F, 1999, J GEN VIROL, V80, P871, DOI 10.1099/0022-1317-80-4-871; HEYMANN DL, 1983, LANCET, V2, P1470; Heymann DL, 1979, YALE J BIOL MED, P1979; Kouomou DW, 2002, J MED VIROL, V68, P433, DOI 10.1002/jmv.10222; Lacroix L, 2008, Rev Med Suisse, V4, P920; Mahamud A, 2013, CLIN INFECT DIS, V57, pE160, DOI 10.1093/cid/cit442; MCBEAN AM, 1976, T ROY SOC TROP MED H, V70, P206, DOI 10.1016/0035-9203(76)90040-7; Mulders MN, 2016, MMWR-MORBID MORTAL W, V65, P438, DOI 10.15585/mmwr.mm6517a3; Ndombo PK, 2018, MOL CHARACTERISATION; Patel MK, 2016, MMWR-MORBID MORTAL W, V65, P1228, DOI 10.15585/mmwr.mm6544a6; Plan S., 2012, GALAXY CLUSTERS GIAN, P44; Rota PA, 2003, J INFECT DIS, V187, pS270, DOI 10.1086/368042; ROTA PA, 1994, VIROLOGY, V198, P724, DOI 10.1006/viro.1994.1086; Salvi C, 2018, EUROPE OBSERVES 4 FO, P2017; World Health Organization, 2016, WEEKLY EPIDEMIOLOGIC, V91, P287, DOI DOI 10.1186/1750-9378-2-15.VOIR	24	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222428	10.1371/journal.pone.0222428	http://dx.doi.org/10.1371/journal.pone.0222428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553766	Green Published, gold			2022-12-26	WOS:000532319200026
J	Jarret, T; Stockert, A; Kotz, SA; Tillmann, B				Jarret, Tatiana; Stockert, Anika; Kotz, Sonja A.; Tillmann, Barbara			Implicit learning of artificial grammatical structures after inferior frontal cortex lesions	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; BROCAS AREA; BASAL GANGLIA; COGNITIVE CONTROL; CHUNK STRENGTH; NEURAL BASIS; BRAIN BASIS; LANGUAGE; SYNTAX; ERP	Objective Previous research associated the left inferior frontal cortex with implicit structure learning. The present study tested patients with lesions encompassing the left inferior frontal gyrus (LIFG; including Brodmann areas 44 and 45) to further investigate this cognitive function, notably by using non-verbal material, implicit investigation methods, and by enhancing potential remaining function via dynamic attending. Patients and healthy matched controls were exposed to an artificial pitch grammar in an implicit learning paradigm to circumvent the potential influence of impaired language processing. Methods Patients and healthy controls listened to pitch sequences generated within a finite-state grammar (exposure phase) and then performed a categorization task on new pitch sequences (test phase). Participants were not informed about the underlying grammar in either the exposure phase or the test phase. Furthermore, the pitch structures were presented in a highly regular temporal context as the beneficial impact of temporal regularity (e.g. meter) in learning and perception has been previously reported. Based on the Dynamic Attending Theory (DAT), we hypothesized that a temporally regular context helps developing temporal expectations that, in turn, facilitate event perception, and thus benefit artificial grammar learning. Results Electroencephalography results suggest preserved artificial grammar learning of pitch structures in patients and healthy controls. For both groups, analyses of event-related potentials revealed a larger early negativity (100-200 msec post-stimulus onset) in response to ungrammatical than grammatical pitch sequence events. Conclusions These findings suggest that (i) the LIFG does not play an exclusive role in the implicit learning of artificial pitch grammars, and (ii) the use of non-verbal material and an implicit task reveals cognitive capacities that remain intact despite lesions to the LIFG. These results provide grounds for training and rehabilitation, that is, learning of non-verbal grammars that may impact the relearning of verbal grammars.	[Jarret, Tatiana; Tillmann, Barbara] Lyon Neurosci Res Ctr, Auditory Cognit & Psychoacoust Team, U1028, INSERM,CNRS,UMR5292, Villeurbanne, France; [Jarret, Tatiana; Tillmann, Barbara] Univ Lyon 1, Villeurbanne, France; [Stockert, Anika] Univ Leipzig, Dept Neurol, Language & Aphasia Lab, Leipzig, Germany; [Kotz, Sonja A.] Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Germany; [Kotz, Sonja A.] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol, Maastricht, Netherlands; [Kotz, Sonja A.] Maastricht Univ, Fac Psychol & Neurosci, Dept Psychopharmacol, Maastricht, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Leipzig University; Max Planck Society; Maastricht University; Maastricht University	Tillmann, B (corresponding author), Lyon Neurosci Res Ctr, Auditory Cognit & Psychoacoust Team, U1028, INSERM,CNRS,UMR5292, Villeurbanne, France.; Tillmann, B (corresponding author), Univ Lyon 1, Villeurbanne, France.	Barbara.Tillmann@cnrs.fr		Stockert, Anika/0000-0001-5804-2498	EBRAMUS ITN [238157]; LabEx CeLyA ("Centre Lyonnais d'Acoustique") [ANR-10-LABX-60]	EBRAMUS ITN; LabEx CeLyA ("Centre Lyonnais d'Acoustique")	This research was supported by a grant from EBRAMUS ITN to BT and SAK (Europe BRAin and MUSic) (Grant Agreement number 238157). The team "Auditory cognition and psychoacoustics" is part of the LabEx CeLyA ("Centre Lyonnais d'Acoustique", grant ANR-10-LABX-60 to BT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a grant from EBRAMUS ITN to BT and SAK (Europe BRAin and MUSic) (Grant Agreement number 238157). The team "Auditory cognition and psycho acoustics" is part of the LabEx CeLyA ("Centre Lyonnais d'Acoustique", ANR-10-LABX-60). We thank Ina Koch for her help in EEG recordings.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; ALTMANN GTM, 1995, J EXP PSYCHOL LEARN, V21, P899, DOI 10.1037/0278-7393.21.4.899; Antonenko D, 2012, NEUROIMAGE, V62, P1667, DOI 10.1016/j.neuroimage.2012.05.074; Bigand E, 1998, CAH PSYCHOL COGN, V17, P577; BRUNNER RJ, 1982, BRAIN LANG, V16, P281, DOI 10.1016/0093-934X(82)90087-6; Carrion RE, 2007, NEUROREPORT, V18, P191, DOI 10.1097/WNR.0b013e328011b8ae; Christiansen MH, 2010, COGNITION, V116, P382, DOI 10.1016/j.cognition.2010.05.015; Conway CM, 2009, CURR DIR PSYCHOL SCI, V18, P275, DOI 10.1111/j.1467-8721.2009.01651.x; Cope TE, 2017, NEUROPSYCHOLOGIA, V104, P201, DOI 10.1016/j.neuropsychologia.2017.08.022; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Embick D, 2000, P NATL ACAD SCI USA, V97, P6150, DOI 10.1073/pnas.100098897; Ferdinand NK, 2008, J COGNITIVE NEUROSCI, V20, P629, DOI 10.1162/jocn.2008.20046; Fiebach CJ, 2005, HUM BRAIN MAPP, V24, P79, DOI 10.1002/hbm.20070; Floel A, 2009, NEUROIMAGE, V47, P1974, DOI 10.1016/j.neuroimage.2009.05.046; Folia V, 2010, ARTIFICIAL LANGUAGE, P188; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Forkstam C, 2006, NEUROIMAGE, V32, P956, DOI 10.1016/j.neuroimage.2006.03.057; Francois C, 2011, CEREB CORTEX, V21, P2357, DOI 10.1093/cercor/bhr022; Francois C, 2010, NEUROREPORT, V21, P928, DOI 10.1097/WNR.0b013e32833ddd5e; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Friederici AD, 2003, NEUROIMAGE, V20, pS8, DOI 10.1016/j.neuroimage.2003.09.003; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Friederici AD, 2012, PSYCHOL RES-PSYCH FO, V76, P204, DOI 10.1007/s00426-011-0357-0; Friederici AD, 2011, PHYSIOL REV, V91, P1357, DOI 10.1152/physrev.00006.2011; Fu QF, 2013, CONSCIOUS COGN, V22, P22, DOI 10.1016/j.concog.2012.10.008; Gelfand JR, 2003, NEURON, V38, P831, DOI 10.1016/S0896-6273(03)00285-X; Goranskaya D, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00551; Goschke T, 2001, J COGNITIVE NEUROSCI, V13, P370, DOI 10.1162/08989290151137412; Horvath RA, 2011, LATERALITY, V16, P620, DOI 10.1080/1357650X.2010.515990; Huber W, 1984, Adv Neurol, V42, P291; Jakuszeit M, 2013, CORTEX, V49, P2861, DOI 10.1016/j.cortex.2013.05.014; Jones D, 2009, HASKELL'09: PROCEEDINGS OF THE 2009 ACM SIGPLAN HASKELL SYMPOSIUM, P81; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; JONES MR, 1989, PSYCHOL REV, V96, P459, DOI 10.1037/0033-295X.96.3.459; JONES MR, 1976, PSYCHOL REV, V83, P323, DOI 10.1037/0033-295x.83.5.323; Juffs A, 2004, T PHILOL SOC, V102, P199, DOI 10.1111/j.0079-1636.2004.00135.x; KNOWLTON BJ, 1994, J EXP PSYCHOL LEARN, V20, P79, DOI 10.1037/0278-7393.20.1.79; Kotz SA, 2003, J INT NEUROPSYCH SOC, V9, P1053, DOI 10.1017/S1355617703970093; Kotz SA, 2015, CORTEX, V68, P48, DOI 10.1016/j.cortex.2015.02.021; Kotz SA, 2010, TRENDS COGN SCI, V14, P392, DOI 10.1016/j.tics.2010.06.005; Kotz SA, 2009, BRAIN LANG, V109, P68, DOI 10.1016/j.bandl.2008.06.002; Kotz SA, 2009, CORTEX, V45, P982, DOI 10.1016/j.cortex.2009.02.010; Lieberman MD, 2004, J COGNITIVE NEUROSCI, V16, P427, DOI 10.1162/089892904322926764; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Maess B, 2001, NAT NEUROSCI, V4, P540, DOI 10.1038/87502; McDonald JL, 2006, J MEM LANG, V55, P381, DOI 10.1016/j.jml.2006.06.006; Meulemans T, 1997, J EXP PSYCHOL LEARN, V23, P1007; Musso M, 2003, NAT NEUROSCI, V6, P774, DOI 10.1038/nn1077; Novick JM, 2005, COGN AFFECT BEHAV NE, V5, P263, DOI 10.3758/CABN.5.3.263; Opitz B, 2003, NEUROIMAGE, V19, P1730, DOI 10.1016/S1053-8119(03)00170-8; Opitz B, 2007, HUM BRAIN MAPP, V28, P585, DOI 10.1002/hbm.20287; Opitz B, 2012, CORTEX, V48, P664, DOI 10.1016/j.cortex.2011.02.013; Parkinson RB, 2009, BRAIN LANG, V110, P61, DOI 10.1016/j.bandl.2009.05.005; Patel AD, 2008, APHASIOLOGY, V22, P776, DOI 10.1080/02687030701803804; Petersson KM, 2012, BRAIN LANG, V120, P83, DOI 10.1016/j.bandl.2010.08.003; Petersson KM, 2004, COGNITIVE SCI, V28, P383, DOI 10.1016/j.cogsci.2003.12.003; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; REBER AS, 1967, J VERB LEARN VERB BE, V6, P855, DOI 10.1016/S0022-5371(67)80149-X; REBER AS, 1989, J EXP PSYCHOL GEN, V118, P219, DOI 10.1037/0096-3445.118.3.219; REED J, 1994, J EXP PSYCHOL LEARN, V20, P585, DOI 10.1037/0278-7393.20.3.585; Rohrmeier M, 2011, CONSCIOUS COGN, V20, P214, DOI 10.1016/j.concog.2010.07.004; Roser ME, 2011, J COGNITIVE NEUROSCI, V23, P1088, DOI 10.1162/jocn.2010.21508; Saffran JR, 2003, ANN NY ACAD SCI, V999, P1, DOI [10.1196/annals.1284.001, DOI 10.1196/ANNALS.1284.001]; Sakai K, 1999, J NEUROSCI, V19, P10074; Sammler D, 2011, CORTEX, V47, P659, DOI 10.1016/j.cortex.2010.04.007; Schankin A, 2011, NEUROREPORT, V22, P642, DOI 10.1097/WNR.0b013e328349d146; Schuchard J, 2013, J PSYCHOLINGUIST RES, V27, P1; Seger CA, 2000, PSYCHOBIOLOGY, V28, P283; Seidler RD, 2005, EXP BRAIN RES, V165, P114, DOI 10.1007/s00221-005-2284-z; Selchenkova T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112233; Selchenkova T, 2014, Q J EXP PSYCHOL, V67, P2360, DOI 10.1080/17470218.2014.929155; Shao J., 1995, JACKKNIFE BOOTSTRAP, DOI [DOI 10.1007/978-1-4612-0795-5, 10.1007/978-1-4612-0795-5]; Tettamanti M, 2002, NEUROIMAGE, V17, P700, DOI 10.1006/nimg.2002.1201; Tillmann B, 2006, NEUROIMAGE, V31, P1771, DOI 10.1016/j.neuroimage.2006.02.028; Tillmann B, 2003, COGNITIVE BRAIN RES, V16, P145, DOI 10.1016/S0926-6410(02)00245-8; Tillmann B, 2010, Q J EXP PSYCHOL, V63, P1646, DOI 10.1080/17470210903511228; Udden J., 2018, OXFORD HDB PSYCHOLIN, P755, DOI DOI 10.1093/OXFORDHB/9780198786825.013.33; Udden J, 2008, BRAIN RES, V1224, P69, DOI 10.1016/j.brainres.2008.05.070; Ullman MT, 2006, CORTEX, V42, P480, DOI 10.1016/S0010-9452(08)70382-4; Ullman MT, 2005, BRAIN LANG, V93, P185, DOI 10.1016/j.bandl.2004.10.001; Ullman MT, 2001, NAT REV NEUROSCI, V2, P717, DOI 10.1038/35094573; Vaquero JMM, 2006, EXP BRAIN RES, V175, P97, DOI 10.1007/s00221-006-0523-6; Vinter A, 1999, Q J EXP PSYCHOL-A, V52, P857, DOI 10.1080/027249899390846; Wagenmakers E.J, 2014, BAYESIAN COGNITIVE M, DOI DOI 10.1017/CBO9781139087759	84	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222385	10.1371/journal.pone.0222385	http://dx.doi.org/10.1371/journal.pone.0222385			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5OJ	31539390	Green Published, Green Submitted, gold			2022-12-26	WOS:000532297900011
J	Lee, GT; Rosenfeld, JA; Kim, WT; Kwon, YS; Palapattu, G; Mehra, R; Kim, WJ; Kim, IY				Lee, Geun Taek; Rosenfeld, Jeffrey A.; Kim, Won Tae; Kwon, Young Suk; Palapattu, Ganesh; Mehra, Rohit; Kim, Wun-Jae; Kim, Isaac Yi			TCF4 induces enzalutamide resistance via neuroendocrine differentiation in prostate cancer	PLOS ONE			English	Article							SMALL-MOLECULE ANTAGONISTS; ANDROGEN RECEPTOR; IN-VITRO; CELLS; CATENIN; ABIRATERONE; MECHANISMS; SURVIVAL; GROWTH	In treating patients with castration resistant prostate cancer (CRPC), enzalutamide, the second-generation androgen receptor (AR) antagonist, is an accepted standard of care. However, clinical benefits are limited to a median time of 4.8 months because resistance inevitably emerges. To determine the mechanism of treatment resistance, we carried out a RNA sequence analysis and found increased expression levels of neuroendocrine markers in the enzalutamide-resistant LNCaP human prostate cancer (CaP) cell line when compared to the parental cell line. Subsequent studies demonstrated that Transcription Factor-4 (TCF4), a transcription factor implicated in WNT signaling, mediated neuroendocrine differentiation (NED) in response to enzalutamide treatment and was elevated in the enzalutamide-resistant LNCaP. In addition, we observed that PTHrP mediated enzalutamide resistance in tissue culture and inducible TCF4 overexpression resulted in enzalutamide-resistance in a mouse xenograft model. Finally, small molecule inhibitors of TCF4 or PTHrP partially reversed enzalutamide resistance in CaP cells. When tissues obtained from men who died of metastatic CaP were examined, a positive correlation was found between the expression levels of TCF4 and PTHrP. Taken together, the current results indicate that TCF4 induces enzalutamide resistance via NED in CaP.	[Lee, Geun Taek; Rosenfeld, Jeffrey A.; Kim, Won Tae; Kwon, Young Suk; Kim, Isaac Yi] Rutgers State Univ, Rutgers Canc Inst New Jersey, Sect Urol Oncol, New Brunswick, NJ 08901 USA; [Lee, Geun Taek; Rosenfeld, Jeffrey A.; Kim, Won Tae; Kwon, Young Suk; Kim, Isaac Yi] Rutgers State Univ, Div Urol, Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ 08901 USA; [Kim, Won Tae; Kim, Wun-Jae] Chungbuk Natl Univ, Dept Urol, Coll Med, Cheongju, South Korea; [Palapattu, Ganesh; Mehra, Rohit] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Chungbuk National University; University of Michigan System; University of Michigan	Kim, IY (corresponding author), Rutgers State Univ, Rutgers Canc Inst New Jersey, Sect Urol Oncol, New Brunswick, NJ 08901 USA.; Kim, IY (corresponding author), Rutgers State Univ, Div Urol, Rutgers Robert Wood Johnson Med Sch, New Brunswick, NJ 08901 USA.	kimiy@cinj.rutgers.edu			Prostate Cancer Research Program Idea Development Award for Established Investigators from the United States Department of Defense Office of the Congressionally Directed Medical Research Program [W81XWH-17-1-0359]; cancer center grant from the National Cancer Institute [P30CA072720]; Marion and Norman Tanzman Charitable Foundation; NATIONAL CANCER INSTITUTE [P30CA072720] Funding Source: NIH RePORTER	Prostate Cancer Research Program Idea Development Award for Established Investigators from the United States Department of Defense Office of the Congressionally Directed Medical Research Program; cancer center grant from the National Cancer Institute; Marion and Norman Tanzman Charitable Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Prostate Cancer Research Program Idea Development Award for Established Investigators from the United States Department of Defense Office of the Congressionally Directed Medical Research Program (W81XWH-17-1-0359), cancer center grant from the National Cancer Institute (Grant P30CA072720), generous support from the Marion and Norman Tanzman Charitable Foundation and Mr. Malcolm Wernik.	Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Aparicio A, 2011, CANCER DISCOV, V1, P466, DOI 10.1158/2159-8290.CD-11-0259; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Beltran H, 2012, J CLIN ONCOL, V30, pE386, DOI 10.1200/JCO.2011.41.5166; Bishop JL, 2015, ONCOTARGET, V6, P234, DOI 10.18632/oncotarget.2703; Calcagni A, 2016, ELIFE, V5, DOI 10.7554/eLife.17047; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; Dang Q, 2015, MOL ONCOL, V9, P1241, DOI 10.1016/j.molonc.2015.02.010; DaSilva J, 2009, CANCER RES, V69, P7402, DOI 10.1158/0008-5472.CAN-08-4687; DaSilva JO, 2013, PROSTATE, V73, P801, DOI 10.1002/pros.22624; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Efstathiou E, 2015, EUR UROL, V67, P53, DOI 10.1016/j.eururo.2014.05.005; Fang L, 2016, CANCER RES, V76, P891, DOI 10.1158/0008-5472.CAN-15-1519; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Ha YS, 2013, DRUG TODAY, V49, P7, DOI 10.1358/dot.2013.49.1.1910724; Ha YS, 2014, EXPERT OPIN DRUG DIS, V9, P837, DOI 10.1517/17460441.2014.918947; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Komiya A, 2013, MOL CLIN ONCOL, V1, P257, DOI 10.3892/mco.2013.69; Komiya A, 2009, INT J UROL, V16, P37, DOI 10.1111/j.1442-2042.2008.02175.x; Lallous N, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-015-0864-1; Lee E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141589; Lee GT, 2014, BRIT J CANCER, V110, P1634, DOI 10.1038/bjc.2014.23; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maroto P, 2016, CRIT REV ONCOL HEMAT, V100, P127, DOI 10.1016/j.critrevonc.2015.07.011; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Mosquera JM, 2013, NEOPLASIA, V15, P1, DOI 10.1593/neo.121550; Prekovic S, 2016, MOL CANCER THER, V15, P1702, DOI 10.1158/1535-7163.MCT-15-0892; Ramadan WH, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S80488; Ramos RN, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/806025; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Richie JP, 1996, UROLOGY, V47, P80, DOI 10.1016/S0090-4295(96)80013-6; ROSENBLATT M, 1988, ANN NY ACAD SCI, V548, P137, DOI 10.1111/j.1749-6632.1988.tb18800.x; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Sainio M, 2018, PATHOL RES PRACT, V214, P848, DOI 10.1016/j.prp.2018.04.015; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Shah RB, 2004, CANCER RES, V64, P9209, DOI 10.1158/0008-5472.CAN-04-2442; Shore ND, 2016, LANCET ONCOL, V17, P153, DOI 10.1016/S1470-2045(15)00518-5; Siddique HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060664; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Steinestel J, 2015, ONCOTARGET, DOI [10.18632/oncotarget.3925, DOI 10.18632/ONCOTARGET.3925]; Suzman DL, 2014, PROSTATE, V74, P1278, DOI 10.1002/pros.22844; Suzuki K, 2007, PROSTATE CANCER P D, V10, P301, DOI 10.1038/sj.pcan.4500956; Svensson C, 2014, NUCLEIC ACIDS RES, V42, P999, DOI 10.1093/nar/gkt921; Syed Khaja Azharuddin Sajid, 2011, PLoS One, V6, pe26539, DOI 10.1371/journal.pone.0026539; Tan HL, 2014, CLIN CANCER RES, V20, P890, DOI 10.1158/1078-0432.CCR-13-1982; Thiele S, 2015, J BONE MINER RES, V30, P488, DOI 10.1002/jbmr.2362; Titus MA, 2005, CLIN CANCER RES, V11, P4653, DOI 10.1158/1078-0432.CCR-05-0525; Wang G, 2008, CANCER RES, V68, P9918, DOI 10.1158/0008-5472.CAN-08-1718; Wang HB, 2008, J CELL SCI, V121, P2578, DOI 10.1242/jcs.030742; Wang W, 2008, AM J SURG PATHOL, V32, P65, DOI 10.1097/PAS.0b013e318058a96b; Wang YF, 2014, J CLIN INVEST, V124, P1646, DOI 10.1172/JCI71812; Wei W, 2010, INT J CANCER, V126, P2426, DOI 10.1002/ijc.24810; Yuan TC, 2007, ENDOCR-RELAT CANCER, V14, P531, DOI 10.1677/ERC-07-0061	54	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0213488	10.1371/journal.pone.0213488	http://dx.doi.org/10.1371/journal.pone.0213488			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536510	gold, Green Published, Green Submitted			2022-12-26	WOS:000532262800001
J	Moore, PJ; Lyons, TJ; Gallacher, J				Moore, P. J.; Lyons, T. J.; Gallacher, J.		Alzheimers Dis Neuroimaging Initia	Using path signatures to predict a diagnosis of Alzheimer's disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; STRUCTURAL MRI; BIOMARKERS; DEMENTIA	The path signature is a means of feature generation that can encode nonlinear interactions in data in addition to the usual linear terms. It provides interpretable features and its output is a fixed length vector irrespective of the number of input points or their sample times. In this paper we use the path signature to provide features for identifying people whose diagnosis subsequently converts to Alzheimer's disease. In two separate classification tasks we distinguish converters from 1) healthy individuals, and 2) individuals with mild cognitive impairment. The data used are time-ordered measurements of the whole brain, ventricles and hippocampus from the Alzheimer's Disease Neuroimaging Initiative (ADNI). We find two nonlinear interactions which are predictive in both cases. The first interaction is change of hippocampal volume with time, and the second is a change of hippocampal volume relative to the volume of the whole brain. While hippocampal and brain volume changes are well known in Alzheimer's disease, we demonstrate the power of the path signature in their identification and analysis without manual feature selection. Sequential data is becoming increasingly available as monitoring technology is applied, and the path signature method is shown to be a useful tool in the processing of this data.	[Moore, P. J.; Lyons, T. J.] Univ Oxford, Math Inst, Oxford, England; [Gallacher, J.] Univ Oxford, Dept Psychiat, Oxford, England	University of Oxford; University of Oxford	Moore, PJ (corresponding author), Univ Oxford, Math Inst, Oxford, England.	moorep@maths.ox.ac.uk		Gallacher, John/0000-0002-2394-5299; Moore, Paul/0000-0001-6171-4072	Dementias Platform UK through the UK Medical Research Council (MRC) [MR/L023784/2]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant) [U01 AG024904]; DOD ADNI (Department of Defense award) [W81XWH-12-2-0012]; MRC; EPSRC [EP/S026347/1]; Alan Turing Institute under EPSRC grant [EP/N510129/1]; Alzheimer's Disease Neuroimaging Initiative (ADNI); National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; AbbVie; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd; Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; Canadian Institutes of Health Research; MRC [MR/L023784/2] Funding Source: UKRI	Dementias Platform UK through the UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD ADNI (Department of Defense award); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Alan Turing Institute under EPSRC grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Alzheimer's Disease Neuroimaging Initiative (ADNI); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); AbbVie(AbbVie); Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); CereSpir, Inc.; Cogstate(CogState Limited); Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals, Inc.; Eli Lilly and Company(Eli Lilly); EuroImmun; F. Hoffmann-La Roche Ltd(Hoffmann-La Roche); Genentech, Inc.(Roche HoldingGenentech); Fujirebio; GE Healthcare(General ElectricGE Healthcare); IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Lumosity; Lundbeck(Lundbeck Corporation); Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Piramal Imaging; Servier(Servier); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Transition Therapeutics; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Dementias Platform UK funded this project through the UK Medical Research Council (MRC) grant ref MR/L023784/2 (core funding). The Dementias Platform is a multi-million pound public-private partnership, developed and led by the MRC, to accelerate progress in and open up dementias research. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JG is supported by the MRC. TJL is supported by the EPSRC under program grant EP/S026347/1 and by the Alan Turing Institute under EPSRC grant EP/N510129/1. PJM has been supported by the MRC and is currently supported by the Alan Turing Institute under EPSRC grant EP/N510129/1. PJM and TJL are members of the DATASIG team (www.datasig.co.uk).; Data used in preparation of this article were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database adni.loni.usc.edu. As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wpcontent/uploads/how_to_apply/ADNI_ Acknowledgement_List.pdf. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.;Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.;Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health www.fnih.org.	Arribas IP, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0334-0; Boedihardjo H, 2016, ADV MATH, V293, P720, DOI 10.1016/j.aim.2016.02.011; Bron EE, 2015, NEUROIMAGE, V111, P562, DOI 10.1016/j.neuroimage.2015.01.048; Chen K.-T., 1958, T AM MATH SOC, P395, DOI [10.2307/1993193, DOI 10.1090/S0002-9947-1958-0106258-0]; Chevyrev I., 2016, PRIMER SIGNATURE MET; Chincarini A, 2016, NEUROIMAGE, V125, P834, DOI 10.1016/j.neuroimage.2015.10.065; Christ M, 2018, NEUROCOMPUTING, V307, P72, DOI 10.1016/j.neucom.2018.03.067; Ellis KA, 2009, INT PSYCHOGERIATR, V21, P672, DOI 10.1017/S1041610209009405; Ganz M, 2015, NEUROIMAGE, V122, P131, DOI 10.1016/j.neuroimage.2015.08.006; Gauthier S, 2006, LANCET, V367, P1262, DOI 10.1016/S0140-6736(06)68542-5; Hambly B, 2010, ANN MATH, V171, P109, DOI 10.4007/annals.2010.171.109; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI [10.1007/b94608, DOI 10.1007/B94608]; Lebedev AV, 2014, NEUROIMAGE-CLIN, V6, P115, DOI 10.1016/j.nicl.2014.08.023; Li H, 2014, CURR EYE RES, V9, P1, DOI DOI 10.1109/JSTARS.2014.2348173; Lovestone S, 2009, ANN NY ACAD SCI, V1180, P36, DOI 10.1111/j.1749-6632.2009.05064.x; Lyons T., 2002, SYSTEM CONTROL ROUGH; Lyons T., 2014, ARXIV14054537; Moore PJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211558; Nestor PJ, 2004, NAT MED, V10, pS34, DOI 10.1038/nrn1433; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Sarica A, 2018, EDITORIAL MACHINE LE; Schmitter D, 2015, NEUROIMAGE-CLIN, V7, P7, DOI 10.1016/j.nicl.2014.11.001; Sorensen L, 2017, NEUROIMAGE-CLIN, V13, P470, DOI 10.1016/j.nicl.2016.11.025; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Weiner, 2018, TADPOLE CHALLENGE PR; Weiner MW, 2017, RECENT PUBLICATIONS; Westman E, 2011, NEUROIMAGE, V58, P818, DOI 10.1016/j.neuroimage.2011.06.065; Xie Z., 2017, IEEE T PATTERN ANAL	28	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222212	10.1371/journal.pone.0222212	http://dx.doi.org/10.1371/journal.pone.0222212			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536538	Green Published, Green Submitted, gold			2022-12-26	WOS:000532262800030
J	Ngobeni, H; Tempia, S; Cohen, AL; Walaza, S; Kuonza, L; Musekiwa, A; von Gottberg, A; Hellferscee, O; Wolter, N; Treurnicht, FK; Moyes, J; Naby, F; Mekgoe, O; Cohen, C				Ngobeni, Hetani; Tempia, Stefano; Cohen, Adam L.; Walaza, Sibongile; Kuonza, Lazarus; Musekiwa, Alfred; von Gottberg, Anne; Hellferscee, Orienka; Wolter, Nicole; Treurnicht, Florette K.; Moyes, Jocelyn; Naby, Fathima; Mekgoe, Omphile; Cohen, Cheryl			The performance of different case definitions for severe influenza surveillance among HIV-infected and HIV-uninfected children aged < 5 years in South Africa, 2011-2015	PLOS ONE			English	Article								In 2014, the World Health Organization (WHO) proposed a new severe influenza surveillance case definition, which has not been evaluated in a high human immunodeficiency virus (HIV) prevalence setting. Our study aimed to assess the performance of this proposed case definition in identifying influenza among HIV-uninfected and HIV-infected children aged < 5 years in South Africa. We prospectively enrolled children aged < 5 years hospitalised with physician-diagnosed lower respiratory tract infection (LRTI) at two surveillance sites from January 2011 to December 2015. Epidemiologic and clinical data were collected. We tested nasopharyngeal aspirates for influenza using reverse transcription polymerase chain reaction. We used logistic regression to assess factors associated with influenza positivity among HIV-infected and HIV-uninfected children. We calculated sensitivity and specificity for different signs and symptoms and combinations of these for laboratory-confirmed influenza. We enrolled 2,582 children < 5 years of age with LRTI of whom 87% (2,257) had influenza and HIV results, of these 14% (318) were HIV-infected. The influenza detection rate was 5% (104/1,939) in HIV-uninfected and 5% (16/318) in HIV-infected children. Children with measured fever (.38 degrees C) were two times more likely to test positive for influenza than those without measured fever among the HIV-uninfected (OR 2.2, 95% Confidence Interval (CI) 1.5-3.4; p<0.001). No significant association was observed between fever and influenza infection among HIV-infected children. Cough alone had sensitivity of 95% (95% CI 89-98%) in HIV-uninfected and of 100% (95% CI 79-100%) in HIV-infected children but low specificity: 7% (95% CI 6-8%) and 6% (95% CI 3-9%) in HIV-uninfected and HIV-infected children, respectively. The WHO post-2014 case definition for severe acute respiratory illness (SARI-an acute respiratory infection with history of fever or measured fever of. 38 degrees C and cough; with onset within the last ten days and requires hospitalization), had a sensitivity of 66% (95% CI 56-76%) and specificity of 46% (95% CI 44-48%) among HIV-uninfected and a sensitivity of 63% (95% CI 35-84%) and a specificity of 42% (95% CI 36-48%) among HIV-infected children. The sensitivity and specificity of the WHO post-2014 case definition for SARI were similar among HIV-uninfected and HIV-infected children. Our findings support the adoption of the 2014 WHO case definition for children aged < 5 years irrespective of HIV infection status.	[Ngobeni, Hetani; Kuonza, Lazarus] South African Field Epidemiol Training Programme, Johannesburg, South Africa; [Ngobeni, Hetani; Kuonza, Lazarus; Musekiwa, Alfred] Univ Pretoria, Sch Hlth Syst & Publ Hlth, Pretoria, South Africa; [Tempia, Stefano; Walaza, Sibongile; von Gottberg, Anne; Hellferscee, Orienka; Wolter, Nicole; Treurnicht, Florette K.; Moyes, Jocelyn; Naby, Fathima; Mekgoe, Omphile; Cohen, Cheryl] Natl Inst Communicable Dis Natl Hlth Lab Serv, Ctr Resp Dis & Meningitis, Johannesburg, South Africa; [Tempia, Stefano; Cohen, Adam L.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Tempia, Stefano] Ctr Dis Control & Prevent, Influenza Program, Pretoria, South Africa; [Tempia, Stefano] MassGenics, Duluth, GA USA; [Cohen, Adam L.] World Hlth Org, Vaccines & Biol, Global Immunizat Monitoring & Surveillance Team, Geneva, Switzerland; [Kuonza, Lazarus; Moyes, Jocelyn; Cohen, Cheryl] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [von Gottberg, Anne; Wolter, Nicole] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, South Africa	University of Pretoria; Centers for Disease Control & Prevention - USA; World Health Organization; University of Witwatersrand; University of Witwatersrand	Ngobeni, H (corresponding author), South African Field Epidemiol Training Programme, Johannesburg, South Africa.; Ngobeni, H (corresponding author), Univ Pretoria, Sch Hlth Syst & Publ Hlth, Pretoria, South Africa.	hetani@gmail.com		Musekiwa, Alfred/0000-0001-5880-3680; Kuonza, Lazarus/0000-0001-5338-320X; Tempia, Stefano/0000-0003-4395-347X; von Gottberg, Anne/0000-0002-0243-7455				Africa S, 2015, EPIDEMIOLOGY INFLUEN, V20, P2009; Casalegno J, 2014, PERFORMANCE INFLUENZ, P2009; Dorrington RE, 2020, PROGR 2020 TARGETS H, P1; Falsey AR, 2015, INFLUENZA OTHER RESP, V9, P23, DOI 10.1111/irv.12316; Fitzner J, 2018, B WORLD HEALTH ORGAN, V96, P122, DOI 10.2471/BLT.17.194514; Glencross D, 2002, CYTOMETRY, V50, P69, DOI 10.1002/cyto.10068; Gupta V, 2012, VALIDITY CLIN CASE D, P321; Health Department SA, 2006, PRACTICE GUIDELINES; Hirve S, 2012, B WORLD HEALTH ORGAN, V90, P804, DOI 10.2471/BLT.12.108837; Human Science Research Council, 2012, AFRICAN NATL HIV P; Iuliano A.D., 2017, LANCET, V6736, P1, DOI [10.1016/S0140-6736(17)33293-2, DOI 10.1016/S0140-6736(17)33293-2]; Madhi SA, 2000, INCREASED BURDEN RES; Pretorius MA, 2018, RESP VIRAL COINFECTI, V206, P159; Tempia S, EFFECTS ATTRIBUTABLE; Tempia S, 2009, MORTALITY ASS SEAS P, P1998; Thursky K, 2003, J CLIN VIROL, V27, P170, DOI 10.1016/S1386-6532(02)00172-5; WHO, 2012, WHO INT GLOB EP SURV; World Health Organization, 2011, WHO GLOB TECHN CONS; YOUNKIN SW, 1983, ANTIMICROB AGENTS CH, V23, P577, DOI 10.1128/AAC.23.4.577	19	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222294	10.1371/journal.pone.0222294	http://dx.doi.org/10.1371/journal.pone.0222294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536552	Green Submitted, Green Published, gold			2022-12-26	WOS:000532262800034
J	Tamirat, MZ; Koivu, M; Elenius, K; Johnson, MS				Tamirat, Mahlet Z.; Koivu, Marika; Elenius, Klaus; Johnson, Mark S.			Structural characterization of EGFR exon 19 deletion mutation using molecular dynamics simulation	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; KINASE DOMAIN; 1ST-LINE TREATMENT; ACTIVATION; MECHANISM; SENSITIVITY; INHIBITION; PARAMETERS; RELEVANCE	Epidermal growth factor receptor (EGFR) is a tyrosine kinase receptor important in diverse biological processes including cell proliferation and survival. Upregulation of EGFR activity due to over-expression or mutation is widely implicated in cancer. Activating somatic mutations of the EGFR kinase are postulated to affect the conformation and/or stability of the protein, shifting the EGFR inactive-active state equilibrium towards the activated state. Here, we examined a common EGFR deletion mutation, Delta(746)ELREA(750), which is frequently observed in non-small cell lung cancer patients. By using molecular dynamics simulation, we investigated the structural effects of the mutation that lead to the experimentally reported increases in kinase activity. Simulations of the active form wild-type and Delta ELREA EGFRs revealed the deletion stabilizes the alpha C helix of the kinase domain, which is located adjacent to the deletion site, by rigidifying the flexible beta 3-alpha C loop that accommodates the ELREA sequence. Consequently, the aC helix is stabilized in the "alpha C-in" active conformation that would prolong the time of the activated state. Moreover, in the mutant kinase, a salt bridge between E762 and K745, which is key for EGFR activity, was also stabilized during the simulation. Additionally, the interaction between EGFR and ATP was favored by Delta ELREA EGFR over wild-type EGFR, as reflected by the number of hydrogen bonds formed and the free energy of binding. Simulation of inactive EGFR suggested the deletion would promote a shift from the inactive conformation towards active EGFR, which is supported by the inward movement of the alpha C helix. The MDS results also align with the effects of tyrosine kinase inhibitors on Delta ELREA and wild-type EGFR lung cancer cell lines, where more pronounced inhibition was observed against Delta ELREA than for wild-type EGFR by inhibitors recognizing the active kinase conformation.	[Tamirat, Mahlet Z.; Johnson, Mark S.] Abo Akad Univ, Fac Sci & Engn, Struct Bioinformat Lab, Biochem, Turku, Finland; [Koivu, Marika; Elenius, Klaus] Univ Turku, Medic Res Labs, Turku, Finland; [Koivu, Marika; Elenius, Klaus] Univ Turku, Inst Biomed, Turku, Finland; [Koivu, Marika; Elenius, Klaus] Univ Turku, Turku Biosci Ctr, Turku, Finland; [Koivu, Marika; Elenius, Klaus] Abo Akad Univ, Turku, Finland; [Koivu, Marika] Univ Turku, Turku Doctoral Programme Mol Med, Turku, Finland; [Elenius, Klaus] Univ Turku, Dept Oncol & Radiotherapy, Turku, Finland; [Elenius, Klaus] Turku Univ Hosp, Turku, Finland	Abo Akademi University; University of Turku; University of Turku; University of Turku; Abo Akademi University; University of Turku; University of Turku; University of Turku	Johnson, MS (corresponding author), Abo Akad Univ, Fac Sci & Engn, Struct Bioinformat Lab, Biochem, Turku, Finland.	johnson4@abo.fi	Elenius, Klaus/AAI-7594-2021	Elenius, Klaus/0000-0001-5700-0827; Koivu, Marika/0000-0002-4371-2142; Tamirat, Mahlet/0000-0003-3249-4765	Academy of Finland [308317, 320005, 274728, 316796]; Sigrid Juselius Foundation; Tor, Joe and Pentti Borg memorial fund; Abo Akademi Doctoral Network of Informational and Structural Biology; Cancer Foundation of Finland; Turku University Central Hospital	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Tor, Joe and Pentti Borg memorial fund; Abo Akademi Doctoral Network of Informational and Structural Biology; Cancer Foundation of Finland; Turku University Central Hospital	This research is part of the Drug Discovery and Diagnostics strategic area of Abo Akademi University and University of Turku, and was supported by grants to M.S.J. from the Academy of Finland (308317, 320005), Sigrid Juselius Foundation and Tor, Joe and Pentti Borg memorial fund. M.Z.T. is funded by the Abo Akademi Doctoral Network of Informational and Structural Biology. K.E. is supported by Academy of Finland Grants 274728 and 316796, the Cancer Foundation of Finland, and Turku University Central Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Hasenahuer MA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189147; [Anonymous], 2018, SCHRODINGER RELEASE; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Case D. A., AMBER 2018; de Gunst MM, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-56; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Foster SA, 2016, CANCER CELL, V29, P477, DOI 10.1016/j.ccell.2016.02.010; Fuller SJ, 2008, J MOL CELL CARDIOL, V44, P831, DOI 10.1016/j.yjmcc.2008.02.278; Furuyama K, 2013, CANCER SCI, V104, P584, DOI 10.1111/cas.12125; Gajiwala KS, 2013, STRUCTURE, V21, P209, DOI 10.1016/j.str.2012.11.014; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; Guha U, 2008, P NATL ACAD SCI USA, V105, P14112, DOI 10.1073/pnas.0806158105; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Irmer D, 2007, ONCOGENE, V26, P5693, DOI 10.1038/sj.onc.1210383; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; Kannan S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01491-z; Kumar A, 2008, J CLIN ONCOL, V26, P1742, DOI 10.1200/JCO.2007.12.1178; Kurppa KJ, 2016, ONCOGENE, V35, P1283, DOI 10.1038/onc.2015.185; Leahy DJ, 2004, ADV PROTEIN CHEM, V68, P1; Lemmon MA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020768; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262; Melvin RL, 2016, J MOL GRAPH MODEL, V67, P44, DOI 10.1016/j.jmgm.2016.05.001; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Oliveira S, 2006, EXPERT OPIN BIOL TH, V6, P605, DOI 10.1517/14712598.6.6.605; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Ou SHI, 2017, J THORAC ONCOL, V12, P446, DOI 10.1016/j.jtho.2016.11.2224; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Roskoski R, 2014, PHARMACOL RES, V87, P42, DOI 10.1016/j.phrs.2014.06.001; RStudio Team, 2018, RSTUDIO INT DEV ENV; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Seashore-Ludlow B, 2015, CANCER DISCOV, V5, P1210, DOI 10.1158/2159-8290.CD-15-0235; Seshacharyulu P, 2012, EXPERT OPIN THER TAR, V16, P15, DOI 10.1517/14728222.2011.648617; Sgambato A, 2012, CURR MED CHEM, V19, P3337, DOI 10.2174/092986712801215973; Shan YB, 2013, P NATL ACAD SCI USA, V110, P7270, DOI 10.1073/pnas.1220843110; Siegelin MD, 2014, LAB INVEST, V94, P129, DOI 10.1038/labinvest.2013.147; Sogabe S, 2013, ACS MED CHEM LETT, V4, P201, DOI 10.1021/ml300327z; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Su J, 2017, ONCOTARGET, V8, P111246, DOI 10.18632/oncotarget.22768; Sullivan I, 2017, FRONT MED-LAUSANNE, V3, DOI 10.3389/fmed.2016.00076; Tvorogov D, 2009, J BIOL CHEM, V284, P5582, DOI 10.1074/jbc.M805438200; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Vogt PK, 2012, NAT REV CANCER, V12, P639, DOI 10.1038/nrc3320; Wang ZH, 2014, METHOD ENZYMOL, V548, P1, DOI 10.1016/B978-0-12-397918-6.00001-X; Wieduwilt MJ, 2008, CELL MOL LIFE SCI, V65, P1566, DOI 10.1007/s00018-008-7440-8; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XZ, 2007, J MED GENET, V44, P166, DOI 10.1136/jmg.2006.046102; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	61	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222814	10.1371/journal.pone.0222814	http://dx.doi.org/10.1371/journal.pone.0222814			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536605	Green Published, gold, Green Submitted			2022-12-26	WOS:000532262800091
J	Bobillo-Perez, S; Sole-Ribalta, A; Balaguer, M; Esteban, E; Girona-Alarcon, M; Hernandez-Platero, L; Segura, S; Felipe, A; Cambra, FJ; Launes, C; Jordan, I				Bobillo-Perez, Sara; Sole-Ribalta, Anna; Balaguer, Monica; Esteban, Elisabeth; Girona-Alarcon, Monica; Hernandez-Platero, Lluisa; Segura, Susana; Felipe, Aida; Cambra, Francisco Jose; Launes, Cristian; Jordan, Iolanda			Procalcitonin to stop antibiotics after cardiovascular surgery in a pediatric intensive care unit-The PROSACAB study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; GUIDED DECISION-MAKING; EARLY-ONSET SEPSIS; NOSOCOMIAL INFECTIONS; MANAGEMENT; MULTICENTER; GUIDELINES; BIOMARKER; EXPOSURE; KINETICS	Introduction and objective Children admitted to the pediatric intensive care unit after cardiovascular surgery usually require treatment with antibiotics due to suspicion of infection. The aim of this study was to assess the effectiveness of procalcitonin in decreasing the duration of antibiotic treatment in children after cardiovascular surgery. Methods Prospective, interventional study carried out in a pediatric intensive care unit. Included patients under 18 years old admitted after cardiopulmonary bypass. Two groups were compared, depending on the implementation of the PCT-guided protocol to stop or de-escalate the antibiotic treatment (Group 1, 2011-2013 and group 2, 2014-2018). This new protocol was based on the decrease of the PCT value by 20% or 50% with respect to the maximum value of PCT. Primary endpoints were mortality, stewardship indication, duration of antibiotic treatment, and antibiotic-free days. Results 886 patients were recruited. There were 226 suspicions of infection (25.5%), and they were confirmed in 38 cases (16.8%). The global rate of infections was 4.3%. 102 patients received broad-spectrum antibiotic (4.7 +/- 1.7 days in group 1, 3.9 +/- 1 days in group 2 with p = 0.160). The rate of de-escalation was higher in group 2 (30/62, 48.4%) than in group 1 (24/ 92, 26.1%) with p = 0.004. A reduction of 1.1 days of antibiotic treatment (group 1, 7.7 +/- 2.2 and group 2, 6.7 +/- 2.2, with p = 0.005) and 2 more antibiotic free-days free in PICU in group 2 were observed (p = 0.001), without adverse outcomes. Conclusions Procalcitonin-guided protocol for stewardship after cardiac surgery seems to be safe and useful to decrease the antibiotic exposure. This protocol could help to reduce the duration of broad-spectrum antibiotics and the duration of antibiotics in total, without developing complications or adverse effects.	[Bobillo-Perez, Sara; Sole-Ribalta, Anna; Balaguer, Monica; Esteban, Elisabeth; Girona-Alarcon, Monica; Hernandez-Platero, Lluisa; Segura, Susana; Felipe, Aida; Cambra, Francisco Jose; Jordan, Iolanda] Univ Barcelona, Hosp St Joan de Deu, Pediat Intens Care Unit, Barcelona, Spain; [Bobillo-Perez, Sara] Univ Barcelona, Inst Recerca Hosp St Joan de Deu, Disorders Immun & Respirat Pediat Crit Patients R, Barcelona, Spain; [Launes, Cristian] Univ Barcelona, Hosp St Joan de Deu, Pediat Dept, Barcelona, Spain; [Launes, Cristian; Jordan, Iolanda] CIBERESP, Inst Recerca Hosp St Joan de Deu, Pediat Infect Dis Res Grp, Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Cambra, FJ (corresponding author), Univ Barcelona, Hosp St Joan de Deu, Pediat Intens Care Unit, Barcelona, Spain.	fjcambra@sjdhospitalbarcelona.org	Pérez, Sara Bobillo/E-8224-2018; lasosa, Francisco José Cambra/ABH-4656-2020; Launes, Cristian/ABD-8312-2020; Girona-Alarcon, Monica/ABH-4405-2020; BOBILLO-PEREZ, SARA/W-8374-2019	Pérez, Sara Bobillo/0000-0001-8889-2995; Launes, Cristian/0000-0002-0913-9303; Girona-Alarcon, Monica/0000-0002-2752-7481; BOBILLO-PEREZ, SARA/0000-0001-8889-2995				Alvarez P, 2012, PEDIATR CARDIOL, V33, P735, DOI 10.1007/s00246-012-0202-2; Andriolo BNG, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010959.pub2; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Perez SB, 2016, BIOMARK INSIGHTS, V11, P123, DOI [10.4137/bmi.s40658, 10.4137/BMI.S40658]; Bobillo S, 2018, BIOMARK INSIGHTS, V13, DOI 10.1177/1177271917751900; Bobillo-Perez S, 2018, BIOMARK INSIGHTS, V13, DOI 10.1177/1177271918792244; Bouadma L, 2010, LANCET, V375, P463, DOI 10.1016/S0140-6736(09)61879-1; Carrillo F.J., 2015, J OPEN INNOVAT TECHN, V1, DOI DOI 10.1186/S40852-015-0017-5; Davidson J, 2013, PEDIATR RES, V74, P413, DOI 10.1038/pr.2013.124; Davidson J, 2012, INTENS CARE MED, V38, P1184, DOI 10.1007/s00134-012-2544-x; de Jong E, 2016, LANCET INFECT DIS, V16, P819, DOI 10.1016/S1473-3099(16)00053-0; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Edwards FH, 2006, ANN THORAC SURG, V81, P397, DOI 10.1016/j.athoracsur.2005.06.034; European Centre for Disease Prevention and Control, 2016, ANN EP REP 2016 HLTH; Gelijns AC, 2014, J AM COLL CARDIOL, V64, P372, DOI 10.1016/j.jacc.2014.04.052; Grisaru-Soen G, 2009, PEDIATR CRIT CARE ME, V10, P202, DOI 10.1097/PCC.0b013e31819a37c5; Guardia Cami M T, 2008, An Pediatr (Barc), V69, P34; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Huang DT, 2018, NEW ENGL J MED, V379, P236, DOI [10.1056/NEJMoa1802670, 10.1056/nejmoa1802670]; Huang HB, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0338-6; Jaworski R, 2018, ADV MED SCI-POLAND, V63, P112, DOI 10.1016/j.advms.2017.10.003; Garcia IJ, 2012, PEDIATR CRIT CARE ME, V13, P441, DOI 10.1097/PCC.0b013e31823890de; Keren R, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.5.e70; Lacour-Gayet Francois, 2004, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V7, P185, DOI 10.1053/j.pcsu.2004.02.011; Launes C, 2016, J INFECTION, V72, P250, DOI 10.1016/j.jinf.2015.12.001; Mermel LA, 2009, CLIN INFECT DIS, V49, P1, DOI 10.1086/599376; Nobre V, 2008, AM J RESP CRIT CARE, V177, P498, DOI 10.1164/rccm.200708-1238OC; O'Keefe Scott, 2017, J Clin Med Res, V9, P10; Sariego-Jamardo A, 2017, J CRIT CARE, V41, P119, DOI 10.1016/j.jcrc.2017.05.009; Schuetz P, 2012, COCHRANE DB SYST REV, P1; Schuetz P, 2017, CPT-PHARMACOMET SYST, P1; Slieker JC, 2017, GASTROENT RES PRACT, V2017, DOI 10.1155/2017/3457614; Stocker M, 2017, LANCET, V390, P871, DOI [10.1016/S0140-6736(17)31444-7, 10.1016/s0140-6736(17)31444-7]; Stocker M, 2010, NEONATOLOGY, V97, P165, DOI 10.1159/000241296; WHO, 2011, WHO LIB CAT PUBL DAT; Wirz Y, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2125-7; World Health Organization, 2014, ANTIMICROBIAL RESIST, VVolume 61, P383, DOI 10.1007/s13312-014-0374-3	37	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0220686	10.1371/journal.pone.0220686	http://dx.doi.org/10.1371/journal.pone.0220686			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532769	Green Published, gold, Green Submitted			2022-12-26	WOS:000532239600002
J	Egbuta, MA; McIntosh, S; Waters, DLE; Vancov, T; Liu, L				Egbuta, Mary A.; McIntosh, Shane; Waters, Daniel L. E.; Vancov, Tony; Liu, Lei			Chemical volatiles present in cotton gin trash: A by-product of cotton processing	PLOS ONE			English	Article							ESSENTIAL OIL; QUANTITATIVE-ANALYSIS; GLANDULAR TRICHOMES; BIOACTIVE COMPOUNDS; STEAM DISTILLATION; ETHANOL-PRODUCTION; ALPHA-BISABOLOL; EXTRACTION; IDENTIFICATION; CONSTITUENTS	Cotton gin trash (CGT), a waste product of cotton gins, make up about 10% of each bale of cotton bolls ginned. The current study investigates high value volatile compounds in CGT to add value to this by-product. The volatile compounds in CGT and different parts of the cotton plant were extracted using various methods, identified by gas chromatography-mass spectrometry (GC-MS) or nuclear magnetic resonance (NMR) spectroscopy, and then quantified by gas chromatography-flame ionisation detection (GC-FID) against available standards. Terpenoids including monoterpenoids and sesquiterpenoids were found to be the most abundant, making up 64.66% (area under peak) of total volatiles extracted by hydrodistillation. The major extractable terpenoids in CGT were alpha-pinene (13.69-23.05 mu g/g), beta-caryophyllene (3.99-74.32 mu g/g), alpha-humulene (2.00-25.71 mu g/g), caryophyllene oxide (41.50-102.08 mu g/g) and beta-bisabolol (40.05-137.32 mu g/g). Recoveries varied between different extraction methods. The terpenoids were found to be more abundant in the calyx (659.12 mu g/g) and leaves (627.72 mu g/g) than in stalks (112.97 mu g/g) and stems (24.24 mu g/g) of the cotton plant, indicating the possible biological origin of CGT volatiles. This study is the first to identify and quantify the different terpenoids present in CGT and significantly, beta-bisabolol, an abundant compound (sesquiterpene alcohol) which may have valuable biological prospects. These findings therefore contribute to identifying alternative management strategies and uses of CGT.	[Egbuta, Mary A.; McIntosh, Shane; Waters, Daniel L. E.; Vancov, Tony; Liu, Lei] Southern Cross Univ, Southern Cross Plant Sci, Lismore, NSW, Australia; [McIntosh, Shane; Vancov, Tony] New South Wales Dept Primary Ind, Wollongbar, NSW, Australia; [Waters, Daniel L. E.] Charles Sturt Univ, ARC ITTC Funct Grains, Wagga Wagga, NSW, Australia	Southern Cross University; NSW Department of Primary Industries; Charles Sturt University	Liu, L (corresponding author), Southern Cross Univ, Southern Cross Plant Sci, Lismore, NSW, Australia.	ben.liu@scu.edu.au	mcintosh, shane/AAL-4279-2021; Liu, Lei/AAM-2739-2021	Liu, Lei/0000-0002-3710-7042; Waters, Daniel/0000-0002-8622-3162	Cotton Research Development Corporation (CRDC), Australia; CRDC [DAN1504]	Cotton Research Development Corporation (CRDC), Australia(Cotton R&D Corp); CRDC	The funder, Cotton Research Development Corporation (CRDC), Australia, had a role to play in the decision to publish this manuscript. Approval was sought and received prior to submission of the manuscript. L.L., S.M. and T.V. received the research grant from CRDC, Agreement Number DAN1504 (https://www.crdc.com.au/). M.E. PhD scholarship was paid as part of this award.	Agblevor FA, 2003, APPL BIOCHEM BIOTECH, V105, P219, DOI 10.1385/ABAB:105:1-3:219; Azmir J, 2013, J FOOD ENG, V117, P426, DOI 10.1016/j.jfoodeng.2013.01.014; Azwanida N., 2015, MED AROMAT PLANTS, V4, P2167, DOI [10.4172/2167-0412.1000196, DOI 10.4172/2167-0412.1000196]; BELL AA, 1986, COTTON PHYSL BOOK 2, P00597; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Berka-Zougali B, 2012, INT J MOL SCI, V13, P4673, DOI 10.3390/ijms13044673; Bourland FM, 2017, J COTTON SCI, V21, P296; Boykin J.C., 2013, P BELTW COTT PROD RE, P774; Braun NA, 2003, J ESSENT OIL RES, V15, P63, DOI 10.1080/10412905.2003.9712064; Cai CP, 2014, MOL BIOL REP, V41, P4941, DOI 10.1007/s11033-014-3360-x; Cavalieri E, 2004, BIOCHEM BIOPH RES CO, V315, P589, DOI 10.1016/j.bbrc.2004.01.088; Chaudhary MR, 2011, HARVESTING GINNING C; Chen QF, 2011, MINI-REV MED CHEM, V11, P1153, DOI 10.2174/138955711797655399; Chen W, 2010, BIOCHEM PHARMACOL, V80, P247, DOI 10.1016/j.bcp.2010.03.021; Chen Y, 2014, REV BRAS FARMACOGN, V24, P626, DOI 10.1016/j.bjp.2014.11.001; Chen Y, 2012, J INTEGR AGR, V11, P1836, DOI 10.1016/S2095-3119(12)60188-9; De Lucca AJ, 2011, J ESSENT OIL RES, V23, P47, DOI 10.1080/10412905.2011.9700457; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Ding MQ, 2015, MOL GENET GENOMICS, V290, P151, DOI 10.1007/s00438-014-0904-7; Egbuta MA, 2017, MOLECULES, V22, DOI 10.3390/molecules22010093; Eisenring M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00234; ELZEN GW, 1984, J CHEM ECOL, V10, P1251, DOI 10.1007/BF00988552; ELZEN GW, 1985, J AGR FOOD CHEM, V33, P1079, DOI 10.1021/jf00066a015; Fahn A, 2002, ISRAEL J PLANT SCI, V50, pS59; Fisheries QD of A and, 2010, INSECT PEST MANAGEME; Fitriady MA, 2017, AIP CONF PROC, V1803, DOI 10.1063/1.4973159; Hajaji S, 2017, ACTA PARASITOL, V62, P290, DOI 10.1515/ap-2017-0036; Haleem N, 2014, CARBOHYD POLYM, V113, P249, DOI 10.1016/j.carbpol.2014.07.023; Haypek E, 2000, BRAZ J CHEM ENG, V17, P705, DOI 10.1590/S0104-66322000000400034; HEDIN PA, 1972, PHYTOCHEMISTRY, V11, P2356, DOI 10.1016/S0031-9422(00)88415-0; HEDIN PA, 1975, PHYTOCHEMISTRY, V14, P2087, DOI 10.1016/0031-9422(75)83137-2; Hernandez Y, 2009, FOOD CHEM, V114, P734, DOI 10.1016/j.foodchem.2008.10.021; Huang XZ, 2013, PLANT PHYSIOL BIOCH, V73, P302, DOI 10.1016/j.plaphy.2013.10.017; Huchelmann A, 2017, PLANT PHYSIOL, V175, P6, DOI 10.1104/pp.17.00727; Huynh Q, 2012, J PHYS CONF SER, V352, DOI 10.1088/1742-6596/352/1/012053; Jeoh T, 2001, BIOMASS BIOENERG, V21, P109, DOI 10.1016/S0961-9534(01)00028-9; Gil-Chavez GJ, 2013, COMPR REV FOOD SCI F, V12, P5, DOI 10.1111/1541-4337.12005; JOHNS MR, 1992, J SCI FOOD AGR, V58, P49, DOI 10.1002/jsfa.2740580109; Kamatou GPP, 2010, J AM OIL CHEM SOC, V87, P1, DOI 10.1007/s11746-009-1483-3; Kasperbauer MJ, 2004, CROP SCI, V44, P198, DOI 10.2135/cropsci2004.1980; King DJ, 2006, NEW PHYTOL, V172, P440, DOI 10.1111/j.1469-8137.2006.01842.x; Knox O, 2006, COMPOSTING AUSTR COT, P46; Lima F. W. J., 2013, International Journal of Medicinal and Aromatic Plants, V3, P1; LOUGHRIN JH, 1994, P NATL ACAD SCI USA, V91, P11836, DOI 10.1073/pnas.91.25.11836; McIntosh S, 2014, BIORESOURCE TECHNOL, V173, P42, DOI 10.1016/j.biortech.2014.09.063; MINYARD JP, 1968, J ORG CHEM, V33, P909, DOI 10.1021/jo01266a116; Mu'azu K, 2009, NIGER J BASIC APPL S, V17, P218; Okoh OO, 2010, FOOD CHEM, V120, P308, DOI 10.1016/j.foodchem.2009.09.084; Omar J, 2016, J FOOD SCI, V81, pC867, DOI 10.1111/1750-3841.13257; Opitz S, 2008, J CHEM ECOL, V34, P508, DOI 10.1007/s10886-008-9453-z; Pare PW, 1997, PLANT PHYSIOL, V114, P1161, DOI 10.1104/pp.114.4.1161; Perveen S.S., 2001, PAK J BIOL SCI, V4, P554; Rassem H.A.H., 2016, AUSTR J BASIC APPL S, V10, P117; Rogers GM, 2002, VET CLIN N AM-FOOD A, V18, P267, DOI 10.1016/S0749-0720(02)00020-8; Rose USR, 2005, PLANTA, V222, P327, DOI 10.1007/s00425-005-1528-2; Shen JC, 2011, BIOPROC BIOSYST ENG, V34, P33, DOI 10.1007/s00449-010-0444-4; Siddique AB, 2016, ARAB J CHEM, V9, pS1185, DOI 10.1016/j.arabjc.2012.01.004; Srivastava JK, 2010, MOL MED REP, V3, P895, DOI 10.3892/mmr.2010.377; Nerio LS, 2010, BIORESOURCE TECHNOL, V101, P372, DOI 10.1016/j.biortech.2009.07.048; THOMPSON AC, 1971, AM J BOT, V58, P803, DOI 10.2307/2441557; THOMPSON AC, 1971, PLANT PHYSIOL, V48, P50, DOI 10.1104/pp.48.1.50; Voon HC, 2012, COMPR REV FOOD SCI F, V11, P34, DOI 10.1111/j.1541-4337.2011.00169.x; Wang GD, 2008, PLANT PHYSIOL, V148, P1254, DOI 10.1104/pp.108.125187; WEYERSTAHL P, 1989, Flavour and Fragrance Journal, V4, P93, DOI 10.1002/ffj.2730040302; Yang CQ, 2013, PHYTOCHEMISTRY, V96, P46, DOI 10.1016/j.phytochem.2013.09.009; Zhang XZ, 2012, IND CROP PROD, V39, P162, DOI 10.1016/j.indcrop.2012.02.029	66	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222146	10.1371/journal.pone.0222146	http://dx.doi.org/10.1371/journal.pone.0222146			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532804	Green Published, gold, Green Submitted			2022-12-26	WOS:000532239600023
J	Schumer, G; Hansen, EC; Anders, PJ; Blankenship, SM				Schumer, Gregg; Hansen, Eric C.; Anders, Paul J.; Blankenship, Scott M.			Development of a quantitative polymerase chain reaction assay and environmental DNA sampling methods for Giant Gartersnake (Thamnophis gigas)	PLOS ONE			English	Article							CYTOCHROME-B	The Giant Gartersnake (Thamnophis gigas) is a low density visually evasive species with a low detection probability based on standard field survey methods (e.g., traps, visual census). Habitat loss has resulted in extirpations or serious declines for T. gigas populations throughout the southern two thirds of its historic range. Uncertainty regarding its current distribution and occupancy present management challenges for the species. Enhancing survey sensitivity through development of environmental DNA sampling (eDNA) methods would improve compliance monitoring under the Endangered Species Act, recovery planning for T. gigas, and evaluation of Californias Central Valley tule marsh habitat on which this species depends. To address these needs, we designed and validated diagnostic quantitative Polymerase Chain Reaction (qPCR) assays for identifying portions of the Cytochrome B (CytB) and the Nicotinamide adenine dinucleotide (NADH) dehydrogenase subunit 4 (ND4) genes of the T. gigas mitochondrial genome. The designed ND4 qPCR assay was not specific to T. gigas DNA and amplified DNA from a closely related and spatially co-occurring Thamnophis species (T.s. fitchi). The CytB T. gigas qPCR assay proved specific to a species level with a sensitivity that reliably detected T. gigas DNA at a concentration of 2.0x10-5 ng mu L-1. To assess detection range, coordinated field sampling was conducted at aquatic sites with an observed and documented population of T. gigas. The T. gigas qPCR assay reliably detected DNA from samples taken 300m downstream from the known source. We then used environmental eDNA sampling and qPCR analysis to augment unsuccessful trap surveys in the southern range of T. gigas and detected DNA in 28 of the 52 locations sampled, confirming that T. gigas was still present at some sites where physical trapping failed to identify presence. QPCR-based DNA detection coupled with eDNA sampling methods provides an effective means to obtain critical population metrics from this otherwise cryptic, federally protected and hard to study organism, offering great promise for elucidating patterns of occupancy with greater efficiency and at far less cost than trapping methods, particularly where detection probabilities are low.	[Schumer, Gregg; Blankenship, Scott M.] Cramer Fish Sci Genidaqs, West Sacramento, CA 95691 USA; [Hansen, Eric C.] Eric Hansen Consulting, Sacramento, CA USA; [Anders, Paul J.] Cramer Fish Sci, Moscow, ID USA		Schumer, G (corresponding author), Cramer Fish Sci Genidaqs, West Sacramento, CA 95691 USA.	greggs@fishsciences.net		Blankenship, Scott/0000-0001-6371-9475				Bergman PS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153500; Brode J, 1988, SPECIAL PUBLICATION, P25; California Natural Diversity Database, 2016, COMP PRINT SENS SPEC; Casazza Michael L., 2000, Herpetological Review, V31, P91; Dahl T., 1990, WETLANDS LOSSES US 1; Dickert C, 2005, CALIF FISH GAME, V91, P255; Dickert C, 2003, PROGR REPORT SAN JOA; Fish U.S. and Wildlife Service, 2015, 2015 REV DRAFT REC P; Fitch HS, 1940, BIOGEOGRAPHICAL STUD, V44, P1; Frayer WE, 1989, WETLANDS CALIFORNIA, V1; Goebel AM, 1999, MOL PHYLOGENET EVOL, V11, P163, DOI 10.1006/mpev.1998.0538; Halstead BJ, 2009, US GEOLOGICAL SURVEY; Halstead BJ, 2017, EVALUATION EFFICACY; Halstead BJ, 2011, J WILDLIFE MANAGE, V75, P450, DOI 10.1002/jwmg.55; Hansen EC, 2008, IMPLEMENTATION PRIOR; Hansen EC, 2008, COMPLETED PARTIAL FU; Hansen EC, 2011, COMP PATHOLOGY HLTH; Hansen EC, 2004, YEAR 2003 INVESTIGAT; Hansen E, 2017, PLOS BIOL, V15, DOI [10.1371/journal.pbio.200110, 10.1371/journal.pbio.2001110]; Hansen GE, 1996, STATUS GIANT GARTER, P9; Hanson G., 1998, Bericht uber das 4. Alpenlandisches Expertenforum zum Thema 'Zeitgemasse Almbewirtschaftung sowie Bewertung von Almflachen und Waldweiden' am 24. und 25. Marz 1998 an der BAL Gumpenstein., P9; Hanson GE, 1980, STATUS GIANT GARTER; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Johns GC, 1998, MOL BIOL EVOL, V15, P1481, DOI 10.1093/oxfordjournals.molbev.a025875; MORITZ C, 1992, SYST BIOL, V41, P273, DOI 10.2307/2992567; Sloan J, 2004, PROGR REPORT SAN JOA, P18; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; U.S. Fish and Wildlife Service, 1993, FED REGISTER, V58, P54053; U.S. Fish and Wildlife Service, 1999, DRAFT REC PLAN GIANT; U.S. Fish and Wildlife Service, 2012, SACR FISH WILDL SACR; U.S. Fish and Wildlife Service, 2006, SACR FISH WILDL SACR, V46; Vernooy R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000417; Wylie GD, 2008, SURVEYS CURRENT DIST, P24; Wylie GD, 1997, 1996 PROGR REPORT GI	35	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222493	10.1371/journal.pone.0222493	http://dx.doi.org/10.1371/journal.pone.0222493			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525228	Green Published, Green Submitted, gold			2022-12-26	WOS:000532225700032
J	Peng, MX; Li, Z; Niu, DH; Liu, XJ; Dong, ZG; Li, JL				Peng, Maoxiao; Li, Zhi; Niu, Donghong; Liu, Xiaojun; Dong, Zhiguo; Li, Jiale			Complement factor B/C2 in molluscs regulates agglutination and illuminates evolution of the Bf/C2 family	FASEB JOURNAL			English	Article						gene duplication; Sinonovacula constricta; invertebrate complement system; bivalve; innate immunity	INNATE IMMUNE-RESPONSE; RAZOR CLAM; FACTOR-B; EXPRESSION CHARACTERIZATION; MOLECULAR-CLONING; PROTEIN-B; C3 GENE; ACTIVATION; HOMOLOG; PATHWAY	Complement factor B/C2 family (Bf/C2F) proteins are core complement system components in vertebrates that are absent in invertebrates and have been lost by numerous species, raising evolutionary questions. At least 3 duplication events have occurred from Cnidaria (ancestor) to mammals. Type II Bf/C2 genes appeared during separation of Proterostomia and Deuterostomes. The second event occurred during separation of vertebrates and invertebrates, yielding type II-2 Bf/C2. The third event occurred when jawed and jawless fish were separated, eventually producing Bf and C2 genes. Herein, we report the second mollusc Sinonovacula constricta Bf/C2-type gene (Sept). ScBf is similar to Ruditapes decussatus Bf-like because both lack the first complement control protein module at the N terminus present in mammalian Bf/C2 proteins. Uniquely, the Ser protease (SP) module at the C terminus of ScBf is similar to 50 aa longer than in other complement factor B/C2-type (Bf/C2T) proteins, and is Glu-rich. Bf/C2T proteins in molluscs lack the catalytic Ser in the SP module. Surprisingly, ScBf regulates rabbit erythrocyte agglutination, during which it is localized on the erythrocyte surface. Thus, ScBf may mediate the agglutination cascade and may be an upstream regulator of this process. Our findings provide new insight into the origin of the Bf/C2F.	[Peng, Maoxiao; Li, Zhi; Niu, Donghong; Liu, Xiaojun; Dong, Zhiguo; Li, Jiale] Shanghai Ocean Univ, Key Lab Explorat & Utilizat Aquat Genet Resources, 999 Huchenghuan Rd, Shanghai 201306, Peoples R China; [Peng, Maoxiao; Li, Zhi; Niu, Donghong; Liu, Xiaojun; Dong, Zhiguo; Li, Jiale] Shanghai Ocean Univ, Coll Fisheries & Life Sci, 999 Huchenghuan Rd, Shanghai 201306, Peoples R China; [Niu, Donghong] Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China; [Li, Jiale] Shanghai Ocean Univ, Shanghai Engn Res Ctr Aquaculture, Shanghai, Peoples R China; [Niu, Donghong; Dong, Zhiguo; Li, Jiale] Jiangsu Ocean Univ, Coinnovat Ctr Jiangsu Marine Bioind Technol, Lianyungang, Peoples R China	Shanghai Ocean University; Shanghai Ocean University; Shanghai Ocean University; Shanghai Ocean University; Jiangsu Ocean University	Li, JL (corresponding author), Shanghai Ocean Univ, Key Lab Explorat & Utilizat Aquat Genet Resources, 999 Huchenghuan Rd, Shanghai 201306, Peoples R China.; Li, JL (corresponding author), Shanghai Ocean Univ, Coll Fisheries & Life Sci, 999 Huchenghuan Rd, Shanghai 201306, Peoples R China.	jlli2009@126.com	Dong, Zhiguo/AAT-7015-2020; li, jia/GVT-7587-2022	Dong, Zhiguo/0000-0001-7652-3316; Liu, Xiaojun/0000-0002-0332-2940; Peng, Maoxiao/0000-0002-4855-1202; Li, Zhi/0000-0002-4255-4170	National Natural Science Foundation of China [31101897]; 863 Hi-Tech Research and Development Program of China [2012AA10A400-3]; Shanghai Universities Knowledge Service Platform [ZF1206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Shanghai Universities Knowledge Service Platform	The authors thank Joao C. R. Cardoso (Universidade do Algarve) and Deborah M. Power (Universidade do Algarve, Faro, Portugal) for their guidance on building a phylogenetic tree. This work was supported by grants from the National Natural Science Foundation of China (Grant 31101897), the 863 Hi-Tech Research and Development Program of China (Grant 2012AA10A400-3), and the Shanghai Universities Knowledge Service Platform (Grant ZF1206). The authors declare no conflicts of interest.	AHEARN JM, 1989, ADV IMMUNOL, V46, P183, DOI 10.1016/S0065-2776(08)60654-9; Ariki S, 2008, J IMMUNOL, V181, P7994, DOI 10.4049/jimmunol.181.11.7994; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; Ding YL, 2019, EMBO J, V38, DOI 10.15252/embj.201899819; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Guo YM, 2014, CELL REP, V9, P1183, DOI 10.1016/j.celrep.2014.10.020; He YN, 2008, FISH SHELLFISH IMMUN, V24, P768, DOI 10.1016/j.fsi.2008.03.004; HOURCADE D, 1989, ADV IMMUNOL, V45, P381, DOI 10.1016/S0065-2776(08)60697-5; KAM CM, 1987, J BIOL CHEM, V262, P3444; Kimura A, 2009, IMMUNOBIOLOGY, V214, P165, DOI 10.1016/j.imbio.2009.01.003; Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x; Mathern DR, 2015, CLIN J AM SOC NEPHRO, V10, P1636, DOI 10.2215/CJN.06230614; Matsumoto M, 1997, P NATL ACAD SCI USA, V94, P8720, DOI 10.1073/pnas.94.16.8720; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257; Milder FJ, 2007, NAT STRUCT MOL BIOL, V14, P224, DOI 10.1038/nsmb1210; Morikis D, 2005, STRUCTURAL BIOLOGY OF THE COMPLEMENT SYSTEM, P1; Nakao M, 2016, EVOLUTION OF THE IMMUNE SYSTEM: CONSERVATION AND DIVERSIFICATION, P151, DOI 10.1016/B978-0-12-801975-7.00006-2; Niu DH, 2018, FISH SHELLFISH IMMUN, V79, P11, DOI 10.1016/j.fsi.2018.04.062; Niu DH, 2015, GENE, V555, P297, DOI 10.1016/j.gene.2014.11.020; Niu DH, 2013, FISH SHELLFISH IMMUN, V35, P581, DOI 10.1016/j.fsi.2013.06.001; Nonaka M, 2004, IMMUNOL REV, V198, P203, DOI 10.1111/j.0105-2896.2004.00118.x; NONAKA M, 1994, J IMMUNOL, V152, P2263; Nonaka M., 2014, EVOLUTION COMPLEMENT; Nonaka M, 2006, IMMUNOGENETICS, V58, P701, DOI 10.1007/s00251-006-0142-1; PANGBURN MK, 1986, BIOCHEM J, V235, P723, DOI 10.1042/bj2350723; Peng MX, 2017, DEV COMP IMMUNOL, V73, P184, DOI 10.1016/j.dci.2017.03.027; Peng MX, 2016, FISH SHELLFISH IMMUN, V55, P223, DOI 10.1016/j.fsi.2016.05.024; Pinto MR, 2007, ADV EXP MED BIOL, V598, P372; Prado-Alvarez M, 2009, FISH SHELLFISH IMMUN, V26, P305, DOI 10.1016/j.fsi.2008.11.015; Sarma JV, 2011, CELL TISSUE RES, V343, P227, DOI 10.1007/s00441-010-1034-0; Sekiguchi R, 2015, DEV COMP IMMUNOL, V50, P58, DOI 10.1016/j.dci.2014.12.008; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; SMITH CA, 1984, J EXP MED, V159, P324, DOI 10.1084/jem.159.1.324; Smith LC, 1998, J IMMUNOL, V161, P6784; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Terado T, 2003, J IMMUNOL, V171, P2461, DOI 10.4049/jimmunol.171.5.2461; UEDA A, 1987, J IMMUNOL, V138, P1143; Volanakis JE, 1996, PROTEIN SCI, V5, P553; Wei Z, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08681-5; Wei Z, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06812-y; Xie ShuMei, 2015, Journal of Fisheries of China, V39, P799; Xu YY, 2001, P NATL ACAD SCI USA, V98, P14577, DOI 10.1073/pnas.261428398; Yee A, 2014, SEMIN THROMB HEMOST, V40, P17, DOI 10.1055/s-0033-1363155; Yoshizaki FY, 2005, IMMUNOGENETICS, V56, P930, DOI 10.1007/s00251-004-0752-4; Zhong L, 2012, FISH SHELLFISH IMMUN, V33, P504, DOI 10.1016/j.fsi.2012.06.001; Zhu Y, 2005, EMBO J, V24, P382, DOI 10.1038/sj.emboj.7600533	48	4	4	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13323	13333		10.1096/fj.201901142RR	http://dx.doi.org/10.1096/fj.201901142RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31550175	Bronze			2022-12-26	WOS:000507466100023
J	Kearney, AL; Cooke, KC; Norris, DM; Zadoorian, A; Krycer, JR; Fazakerley, DJ; Burchfield, JG; James, DE				Kearney, Alison L.; Cooke, Kristen C.; Norris, Dougall M.; Zadoorian, Armella; Krycer, James R.; Fazakerley, Daniel J.; Burchfield, James G.; James, David E.			Serine 474 phosphorylation is essential for maximal Akt2 kinase activity in adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; serine; threonine protein kinase; phosphorylation; cell signaling; adipocyte; insulin; substrate specificity; mTOR complex (mTORC); protein synthesis; glucose transport; Akt Ser(474) phosphorylation; Akt W80A; chemical genetics; GLUT4; MK2206	INSULIN ACTION; PROTEIN-SYNTHESIS; CRYSTAL-STRUCTURE; GLUCOSE; ACTIVATION; CELL; INHIBITOR; REVEALS; AKT/PKB; TRANSLOCATION	The Ser/Thr protein kinase Akt regulates essential biological processes such as cell survival, growth, and metabolism. Upon growth factor stimulation, Akt is phosphorylated at Ser(474); however, how this phosphorylation contributes to Akt activation remains controversial. Previous studies, which induced loss of Ser(474) phosphorylation by ablating its upstream kinase mTORC2, have implicated Ser(474) phosphorylation as a driver of Akt substrate specificity. Here we directly studied the role of Akt2 Ser(474) phosphorylation in 3T3-L1 adipocytes by preventing Ser(474) phosphorylation without perturbing mTORC2 activity. This was achieved by utilizing a chemical genetics approach, where ectopically expressed S474A Akt2 was engineered with a W80A mutation to confer resistance to the Akt inhibitor MK2206, and thus allow its activation independent of endogenous Akt. We found that insulin-stimulated phosphorylation of four bona fide Akt substrates (TSC2, PRAS40, FOXO1/3a, and AS160) was reduced by ?50% in the absence of Ser(474) phosphorylation. Accordingly, insulin-stimulated mTORC1 activation, protein synthesis, FOXO nuclear exclusion, GLUT4 translocation, and glucose uptake were attenuated upon loss of Ser(474) phosphorylation. We propose a model where Ser(474) phosphorylation is required for maximal Akt2 kinase activity in adipocytes.	[Kearney, Alison L.; Cooke, Kristen C.; Norris, Dougall M.; Zadoorian, Armella; Krycer, James R.; Fazakerley, Daniel J.; Burchfield, James G.; James, David E.] Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [James, David E.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Norris, Dougall M.] Univ Cambridge, Wellcome Trust Med Res Council, Inst Metab Sci, Metab Res Labs, Cambridge CB2 0QQ, England	University of Sydney; University of Sydney; University of Cambridge	Fazakerley, DJ; Burchfield, JG (corresponding author), Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Sydney, NSW 2006, Australia.	djf72@cam.ac.uk; james.burchfleld@sydney.edu.au; david.james@sydney.edu.au	Fazakerley, Daniel/J-2652-2019; Burchfield, James/C-1779-2019	Fazakerley, Daniel/0000-0001-8241-2903; Burchfield, James/0000-0002-6609-6151; Cooke, Kristen/0000-0002-3534-1660; Norris, Dougall M./0000-0001-8201-4999; Krycer, James/0000-0003-1536-7270; James, David/0000-0001-5946-5257; Kearney, Alison/0000-0002-5736-3393	Australian Research Council [DP180103482]; National Health and Medical Research Council [GNT1120201]; Diabetes Australia [Y19G-FAZD]; Chen Family research scholarship; National Health and Medical Research Council; Australian Diabetes Society Skip Martin early career fellowship	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia; Chen Family research scholarship; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Diabetes Society Skip Martin early career fellowship	This work was supported by Australian Research Council project grant DP180103482 (to D. E. J. and J. G. B.), National Health and Medical Research Council project grant GNT1120201 (to D. E. J.), and Diabetes Australia research grant Y19G-FAZD to (D. J. F., J. G. B., and J. R. K.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by a Research Training Program scholarship and a Chen Family research scholarship.; Supported by an National Health and Medical Research Council early career fellowship and Australian Diabetes Society Skip Martin early career fellowship.; Supported by a National Health and Medical Research Council senior principal research fellowship. To whom correspondence may be addressed.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Balasuriya N, 2018, J BIOL CHEM, V293, P10744, DOI 10.1074/jbc.RA118.002357; Balzano D, 2015, J BIOL CHEM, V290, P24975, DOI 10.1074/jbc.M115.651570; Barbaric Ivana, 2007, Briefings in Functional Genomics & Proteomics, V6, P91, DOI 10.1093/bfgp/elm008; Beg M, 2017, ELIFE, V6, DOI 10.7554/eLife.26896; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Burchfield JG, 2013, TRAFFIC, V14, P259, DOI 10.1111/tra.12035; Cherrin C, 2010, CANCER BIOL THER, V9, P493, DOI 10.4161/cbt.9.7.11100; Chu N, 2018, CELL, V174, P897, DOI 10.1016/j.cell.2018.07.003; Crouthamel MC, 2009, CLIN CANCER RES, V15, P217, DOI 10.1158/1078-0432.CCR-08-1253; Czech MP, 2003, P NATL ACAD SCI USA, V100, P11198, DOI 10.1073/pnas.2135308100; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; Dangelmaier C, 2014, THROMB HAEMOSTASIS, V111, P508, DOI 10.1160/TH13-06-0484; Duan XW, 2018, BIOCHEMISTRY-US, V57, P3606, DOI 10.1021/acs.biochem.8b00361; Ebner M, 2017, MOL CELL, V65, P416, DOI 10.1016/j.molcel.2016.12.028; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fazakerley DJ, 2019, J LIPID RES, V60, P1720, DOI 10.1194/jlr.R087510; Fazakerley DJ, 2015, J BIOL CHEM, V290, P23528, DOI 10.1074/jbc.M115.657361; Fujita KA, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000810; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Green CJ, 2008, J BIOL CHEM, V283, P27653, DOI 10.1074/jbc.M802623200; Gross SM, 2015, J CELL SCI, V128, P2509, DOI 10.1242/jcs.168773; Hoehn KL, 2008, CELL METAB, V7, P421, DOI 10.1016/j.cmet.2008.04.005; Humphrey SJ, 2013, CELL METAB, V17, P1009, DOI 10.1016/j.cmet.2013.04.010; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; Kajno E, 2015, BIOCHEM J, V468, P425, DOI 10.1042/BJ20150191; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Krycer JR, 2011, J BIOL CHEM, V286, P20637, DOI 10.1074/jbc.M111.227082; Kubota H, 2018, CELL SYST, V7, P118, DOI 10.1016/j.cels.2018.05.013; Kubota H, 2012, MOL CELL, V46, P820, DOI 10.1016/j.molcel.2012.04.018; Kumar A, 2010, DIABETES, V59, P1397, DOI 10.2337/db09-1061; Kumar CC, 2005, ONCOGENE, V24, P7493, DOI 10.1038/sj.onc.1209087; Kuznetsova IM, 2014, INT J MOL SCI, V15, P23090, DOI 10.3390/ijms151223090; Liu PD, 2014, NATURE, V508, P541, DOI 10.1038/nature13079; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; MARSHALL S, 1989, J BIOL CHEM, V264, P2029; MARSHALL S, 1989, J BIOL CHEM, V264, P2037; Meier R, 1997, J BIOL CHEM, V272, P30491, DOI 10.1074/jbc.272.48.30491; Moore SF, 2011, J BIOL CHEM, V286, P24553, DOI 10.1074/jbc.M110.202341; Mora A, 2005, BIOCHEM J, V385, P639, DOI 10.1042/BJ20041782; Morrow JK, 2011, RECENT PAT ANTI-CANC, V6, P146; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; Murray ER, 2017, AGING-US, V9, P2461, DOI 10.18632/aging.101346; Ng Y, 2008, CELL METAB, V7, P348, DOI 10.1016/j.cmet.2008.02.008; Norris DM, 2017, J CELL SCI, V130, P2757, DOI 10.1242/jcs.205369; Oatey PB, 1999, BIOCHEM J, V344, P511, DOI 10.1042/0264-6021:3440511; Risso G, 2015, BIOCHEM J, V468, P203, DOI 10.1042/BJ20150041; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shi YH, 2012, PROTEIN SCI, V21, P1197, DOI 10.1002/pro.2107; Stockli J, 2019, MOL METAB, V25, P83, DOI 10.1016/j.molmet.2019.05.002; Tan SX, 2015, J BIOL CHEM, V290, P11337, DOI 10.1074/jbc.M114.623686; Tan SX, 2012, MOL CELL BIOL, V32, P4946, DOI 10.1128/MCB.00761-12; Tan SX, 2012, J BIOL CHEM, V287, P6128, DOI 10.1074/jbc.M111.318238; Tang YF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11365; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Vincent EE, 2011, BRIT J CANCER, V104, P1755, DOI 10.1038/bjc.2011.132; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6	67	21	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16729	16739		10.1074/jbc.RA119.010036	http://dx.doi.org/10.1074/jbc.RA119.010036			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31548312	Green Published, hybrid			2022-12-26	WOS:000501801900021
J	Suematsu, R; Miyamoto, T; Saijo, S; Yamasaki, S; Tada, Y; Yoshida, H; Miyake, Y				Suematsu, Rie; Miyamoto, Tomofumi; Saijo, Shinobu; Yamasaki, Sho; Tada, Yoshifumi; Yoshida, Hiroki; Miyake, Yasunobu			Identification of lipophilic ligands of Siglec5 and-14 that modulate innate immune responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lectin; cell-surface receptor; lipid-protein interaction; cellular immune response; innate immunity; cardiolipin; cytokine response; lipophilic ligands; Siglec; Trichophyton	SIALIC ACIDS; PAIRED RECEPTORS; BINDING; CARDIOLIPIN; RECOGNITION; CELLS; NEUTROPHIL; SIALOADHESIN; METABOLISM; DISCOVERY	Sialic acid-binding immunoglobulin-like lectins (Siglecs) are a family of cell-surface immune receptors that bind to sialic acid at terminal glycan residues. Siglecs also recognize nonsialic acid ligands, many of which remain to be characterized. Here, we found that Siglec5 and Siglec14 recognize lipid compounds produced by Trichophyton, a fungal genus containing several pathogenic species. Biochemical approaches revealed that the Siglec ligands are fungal alkanes and triacylglycerols, an unexpected finding that prompted us to search for endogenous lipid ligands of Siglecs. Siglec5 weakly recognized several endogenous lipids, but the mitochondrial lipid cardiolipin and the anti-inflammatory lipid 5-palmitic acid-hydroxystearic acid exhibited potent ligand activity on Siglec5. Further, the hydrophobic stretch in the Siglec5 N terminus region was found to be required for efficient recognition of these lipids. Notably, this hydrophobic stretch was dispensable for recognition of sialic acid. Siglec5 inhibited cell activation upon ligand binding, and accordingly, the lipophilic ligands suppressed interleukin-8 (IL-8) production in Siglec5-expressing human monocytic cells. Siglec14 and Siglec5 have high sequence identity in the extracellular region, and Siglec14 also recognized the endogenous lipids. However, unlike Siglec5, Siglec14 transduces activating signals upon ligand recognition. Indeed, the endogenous lipids induced IL-8 production in Siglec14-expressing human monocytic cells. These results indicated that Siglec5 and Siglec14 can recognize lipophilic ligands that thereby modulate innate immune responses. To our knowledge, this is the first study reporting the binding of Siglecs to lipid ligands, expanding our understanding of the biological function and importance of Siglecs in the innate immunity.	[Suematsu, Rie; Yoshida, Hiroki; Miyake, Yasunobu] Saga Univ, Fac Med, Dept Biomol Sci, Div Mol & Cellular Immunosci, Saga 8498501, Japan; [Suematsu, Rie; Tada, Yoshifumi] Saga Univ, Fac Med, Dept Rheumatol, Saga 8498501, Japan; [Miyamoto, Tomofumi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Nat Prod Chem, Fukuoka, Fukuoka 8128582, Japan; [Saijo, Shinobu; Yamasaki, Sho] Chiba Univ, Med Mycol Res Ctr, Div Mol Immunol, Chiba 2608673, Japan; [Yamasaki, Sho] Osaka Univ, Immunol Frontier Res Ctr, Res Inst Microbial Dis, Dept Mol Immunol, Suita, Osaka 5650871, Japan; [Yamasaki, Sho] Osaka Univ, Immunol Frontier Res Ctr, Lab Mol Immunol, Suita, Osaka 5650871, Japan	Saga University; Saga University; Kyushu University; Chiba University; Osaka University; Osaka University	Yoshida, H; Miyake, Y (corresponding author), Saga Univ, Fac Med, Dept Biomol Sci, Div Mol & Cellular Immunosci, Saga 8498501, Japan.	yoshidah@cc.saga-u.ac.jp; ymiyake@cc.saga-u.ac.jp		Hiroki, Yoshida/0000-0003-3447-117X	Takeda Science Foundation [17K08888, 16K08842]	Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by Grants-in-Aid for Scientific research 17K08888 (to Y. M.) and 16K08842 (to H. Y.) and the Takeda Science Foundation (to Y. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Ali SR, 2014, J EXP MED, V211, P1231, DOI 10.1084/jem.20131853; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Angata T, 2006, FASEB J, V20, P1964, DOI 10.1096/fj.06-5800com; Avril T, 2006, INFECT IMMUN, V74, P4133, DOI 10.1128/IAI.02094-05; Avril T, 2006, J LEUKOCYTE BIOL, V80, P787, DOI 10.1189/jlb.1005559; Carlin AF, 2009, J EXP MED, V206, P1691, DOI 10.1084/jem.20090691; Chatterjee M, 2003, GLYCOBIOLOGY, V13, P351, DOI 10.1093/glycob/cwg027; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Crocker PR, 2005, CURR OPIN PHARMACOL, V5, P431, DOI 10.1016/j.coph.2005.03.003; Esquenazi D, 2003, MYCOSES, V46, P197, DOI 10.1046/j.1439-0507.2003.00873.x; Fong JJ, 2015, EMBO J, V34, P2775, DOI 10.15252/embj.201591407; Fukuda R, 2013, BIOSCI BIOTECH BIOCH, V77, P1149, DOI 10.1271/bbb.130164; Furukawa A, 2013, P NATL ACAD SCI USA, V110, P17438, DOI 10.1073/pnas.1312649110; Gonzalvez F, 2005, CELL DEATH DIFFER, V12, P614, DOI 10.1038/sj.cdd.4401571; Greene CM, 2004, INFECT IMMUN, V72, P3684, DOI 10.1128/IAI.72.6.3684-3687.2004; Han S, 2005, NAT CHEM BIOL, V1, P93, DOI 10.1038/nchembio713; Heikema AP, 2010, INFECT IMMUN, V78, P3237, DOI 10.1128/IAI.01273-09; Jones C, 2003, MOL MICROBIOL, V49, P1213, DOI 10.1046/j.1365-2958.2003.03634.x; Khatua B, 2013, INDIAN J MED RES, V138, P648; Khatua B, 2012, J LEUKOCYTE BIOL, V91, P641, DOI 10.1189/jlb.0511260; Nguyen KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106239; Lubbers J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02807; Miyake Y, 2013, IMMUNITY, V38, P1050, DOI 10.1016/j.immuni.2013.03.010; Monteiro VG, 2005, PARASITOL RES, V97, P380, DOI 10.1007/s00436-005-1460-1; Nicholas DA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176793; Nutku E, 2003, BLOOD, V101, P5014, DOI 10.1182/blood-2002-10-3058; O'Reilly MK, 2010, METHOD ENZYMOL, V478, P343, DOI 10.1016/S0076-6879(10)78017-4; Ohtsuka M, 2004, P NATL ACAD SCI USA, V101, P8126, DOI 10.1073/pnas.0401119101; Rapoport EM, 2005, BIOCHEMISTRY-MOSCOW+, V70, P330, DOI 10.1007/s10541-005-0119-y; Razi N, 1998, P NATL ACAD SCI USA, V95, P7469, DOI 10.1073/pnas.95.13.7469; Rogero MM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040432; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Secundino I, 2016, J MOL MED, V94, P219, DOI 10.1007/s00109-015-1341-8; Sinha M, 2015, FUNGAL BIOL-UK, V119, P274, DOI 10.1016/j.funbio.2015.01.001; Sorice M, 2000, CLIN EXP IMMUNOL, V122, P277, DOI 10.1046/j.1365-2249.2000.01353.x; Sorice M, 2004, CELL DEATH DIFFER, V11, P1133, DOI 10.1038/sj.cdd.4401457; Sturley SL, 2012, J LIPID RES, V53, P1800, DOI 10.1194/jlr.R028290; Suman M, 2009, J CHROMATOGR A, V1216, P3758, DOI 10.1016/j.chroma.2009.02.055; Syed I, 2018, CELL METAB, V27, P419, DOI 10.1016/j.cmet.2018.01.001; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Toyonaga K, 2016, IMMUNITY, V45, P1245, DOI 10.1016/j.immuni.2016.10.012; Ueda Y, 2013, FASEB J, V27, P3284, DOI 10.1096/fj.12-226548; Van Breedam W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000730; Varki A, 2006, GLYCOBIOLOGY, V16, p1R, DOI 10.1093/glycob/cwj008; von Gunten S, 2005, BLOOD, V106, P1423, DOI 10.1182/blood-2004-10-4112; Wan M, 2014, ATHEROSCLEROSIS, V235, P592, DOI 10.1016/j.atherosclerosis.2014.05.913; Yamaji T, 2002, J BIOL CHEM, V277, P6324, DOI 10.1074/jbc.M110146200; Yamanaka M, 2009, GLYCOBIOLOGY, V19, P841, DOI 10.1093/glycob/cwp052; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yonekawa A, 2014, IMMUNITY, V41, P402, DOI 10.1016/j.immuni.2014.08.005; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339; Zhuravleva MA, 2008, J MOL BIOL, V375, P437, DOI 10.1016/j.jmb.2007.10.009; Zou ZC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024559	54	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16776	16788		10.1074/jbc.RA119.009835	http://dx.doi.org/10.1074/jbc.RA119.009835			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31551352	Green Published, hybrid			2022-12-26	WOS:000501801900025
J	Michalski, D; Ontiveros, JG; Russo, J; Charley, PA; Anderson, JR; Heck, AM; Geiss, BJ; Wilusz, J				Michalski, Daniel; Ontiveros, J. Gustavo; Russo, Joseph; Charley, Phillida A.; Anderson, John R.; Heck, Adam M.; Geiss, Brian J.; Wilusz, Jeffrey			Zika virus noncoding sfRNAs sequester multiple host-derived RNA-binding proteins and modulate mRNA decay and splicing during infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						flavivirus; RNA splicing; RNA turnover; RNA editing; RNA virus; 5??3?-exoribonuclease (XRN1); post-transcriptional regulation; subgenomic flavivirus RNA (sfRNA); Zika virus	SUBGENOMIC RNA; GENE-EXPRESSION; GLOBAL ANALYSIS; FLAVIVIRUSES; DEGRADATION; INTERFERENCE; ASSOCIATION; PSEUDOKNOT; NETWORKS; SNORNA	Insect-borne flaviviruses produce a 300?500?base long noncoding RNA, termed subgenomic flavivirus RNA (sfRNA), by stalling the cellular 5??3?-exoribonuclease 1 (XRN1) via structures located in their 3? UTRs. In this study, we demonstrate that sfRNA production by Zika virus represses XRN1 analogous to what we have previously shown for other flaviviruses. Using protein?RNA reconstitution and a stringent RNA pulldown assay with human choriocarcinoma (JAR) cells, we demonstrate that the sfRNAs from both dengue type 2 and Zika viruses interact with a common set of 21 RNA-binding proteins that contribute to the regulation of post-transcriptional processes in the cell, including splicing, RNA stability, and translation. We found that four of these sfRNA-interacting host proteins, DEAD-box helicase 6 (DDX6) and enhancer of mRNA decapping 3 (EDC3) (two RNA decay factors), phosphorylated adaptor for RNA export (a regulator of the biogenesis of the splicing machinery), and apolipoprotein B mRNA-editing enzyme catalytic subunit 3C (APOBEC3C, a nucleic acid?editing deaminase), inherently restrict Zika virus infection. Furthermore, we demonstrate that the regulations of cellular mRNA decay and RNA splicing are compromised by Zika virus infection as well as by sfRNA alone. Collectively, these results reveal the large extent to which Zika virus?derived sfRNAs interact with cellular RNA-binding proteins and highlight the potential for widespread dysregulation of post-transcriptional control that likely limits the effective response of these cells to viral infection.	[Michalski, Daniel; Russo, Joseph; Charley, Phillida A.; Anderson, John R.; Geiss, Brian J.; Wilusz, Jeffrey] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Ontiveros, J. Gustavo; Heck, Adam M.; Geiss, Brian J.; Wilusz, Jeffrey] Colorado State Univ, Cell & Mol Biol Program, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University	Wilusz, J (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.; Wilusz, J (corresponding author), Colorado State Univ, Cell & Mol Biol Program, Ft Collins, CO 80523 USA.	jeffrey.wilusz@colostate.edu	Geiss, Brian/J-3021-2017	Geiss, Brian/0000-0001-8180-5772; Heck, Adam/0000-0002-2485-759X; Wilusz, Jeffrey/0000-0001-8535-3435	National Institutes of Health [AI123136, AI130497, AI32668]; National Science Foundation NRT Award [1450032]; National Science Foundation GRFP award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI132668, R21AI130497] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation NRT Award; National Science Foundation GRFP award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI123136 and AI130497 (to J. W.) and Grant AI32668 (to B. J. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by National Science Foundation NRT Award 1450032 and by a National Science Foundation GRFP award.	Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963; Ashraf U, 2019, TRENDS MICROBIOL, V27, P268, DOI 10.1016/j.tim.2018.11.004; Bidet K, 2014, BIOCHEM J, V462, P215, DOI 10.1042/BJ20140456; Boulon S, 2004, MOL CELL, V16, P777, DOI 10.1016/j.molcel.2004.11.013; Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892; Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897; Charley PA, 2018, J BIOL CHEM, V293, P285, DOI [10.1074/jbc.M117.805796, 10.1074/jbc.m117.805796]; Cheadle C, 2005, ANN NY ACAD SCI, V1058, P196, DOI 10.1196/annals.1359.026; Chemudupati M, 2019, BBA-MOL CELL RES, V1866, P382, DOI 10.1016/j.bbamcr.2018.09.012; Cross ST, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1536; Darman RB, 2015, CELL REP, V13, P1033, DOI 10.1016/j.celrep.2015.09.053; De Maio FA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005841; Ezegbunam W, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1455; Ferguson NM, 2018, NATURE, V559, P490, DOI 10.1038/s41586-018-0318-5; Flobinus A, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10030137; Flobinus A, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8100272; Ford LP, 1999, GENE DEV, V13, P188, DOI 10.1101/gad.13.2.188; Frabutt DA, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8090255; Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Gee P, 2011, J VIROL, V85, P9726, DOI 10.1128/JVI.05288-11; Girard C, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1998; Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16; Gonzalez MC, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-96; Gutierrez-Bugallo G, 2019, NAT ECOL EVOL, V3, P561, DOI 10.1038/s41559-019-0836-z; Haimovich G, 2013, CELL, V153, P1000, DOI 10.1016/j.cell.2013.05.012; Hanson G, 2018, NAT REV MOL CELL BIO, V19, P20, DOI 10.1038/nrm.2017.91; Hu BX, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0882-6; Iwakawa HO, 2008, J VIROL, V82, P10162, DOI 10.1128/JVI.01027-08; Kfir N, 2015, CELL REP, V11, P618, DOI 10.1016/j.celrep.2015.03.048; Kung CP, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00762; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Lerner T, 2019, GENES-BASEL, V10, DOI 10.3390/genes10010013; Liao KC, 2018, RNA, V24, P803, DOI 10.1261/rna.064006.117; Lu YY, 2014, MOL CELL, V55, P758, DOI 10.1016/j.molcel.2014.06.032; Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369; Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004; Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009; Moon SL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004708; Moon SL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003762; Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112; Mourao A, 2010, RNA, V16, P1205, DOI 10.1261/rna.2009910; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; Nandy A, 2017, PROTEINS, V85, P1983, DOI 10.1002/prot.25352; Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170; Neumann T, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2849-7; Ostareck DH, 2014, WIRES RNA, V5, P659, DOI 10.1002/wrna.1237; Peng ZG, 2011, HEPATOLOGY, V53, P1080, DOI 10.1002/hep.24160; Picelli S, 2014, GENOME RES, V24, P2033, DOI 10.1101/gr.177881.114; Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y; Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007; Pompon J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006535; Raices M, 2017, CURR OPIN CELL BIOL, V46, P26, DOI 10.1016/j.ceb.2016.12.006; Russo J, 2017, METHODS, V120, P39, DOI 10.1016/j.ymeth.2017.02.003; Scheller U, 2018, BMC MED GENOMICS, V11, DOI 10.1186/s12920-018-0358-6; Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12; Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160; Schott J, 2010, WIRES RNA, V1, P432, DOI 10.1002/wrna.13; Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sharma S, 2016, SCI REP-UK, V6, DOI 10.1038/srep39100; Sharma S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7881; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10; Siriwardena SU, 2016, CHEM REV, V116, P12688, DOI 10.1021/acs.chemrev.6b00296; Slonchak A, 2018, ANTIVIR RES, V159, P13, DOI 10.1016/j.antiviral.2018.09.006; Smith HC, 2017, RNA BIOL, V14, P1153, DOI 10.1080/15476286.2016.1259783; Sokoloski KJ, 2008, METHOD ENZYMOL, V448, P139, DOI 10.1016/S0076-6879(08)02608-6; Soto-Acosta R, 2018, ELIFE, V7, DOI 10.7554/eLife.39023; St John AL, 2013, NAT REV MICROBIOL, V11, P420, DOI 10.1038/nrmicro3030; Steckelberg AL, 2018, P NATL ACAD SCI USA, V115, P6404, DOI 10.1073/pnas.1802429115; Sun M, 2013, MOL CELL, V52, P52, DOI 10.1016/j.molcel.2013.09.010; Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16; Wu G, 2018, RNA, V24, P1056, DOI 10.1261/rna.065383.117; Yeh SC, 2018, DNA CELL BIOL, V37, P154, DOI 10.1089/dna.2017.4059; Yoshimoto R, 2017, RNA, V23, P47, DOI 10.1261/rna.058065.116; Zhu YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121608	79	27	28	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					16282	16296		10.1074/jbc.RA119.009129	http://dx.doi.org/10.1074/jbc.RA119.009129			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31519749	hybrid, Green Published			2022-12-26	WOS:000499478600033
J	Little, JP; Rayward, L; Pearcy, MJ; Izatt, MT; Green, D; Labrom, RD; Askin, GN				Little, J. Paige; Rayward, Lionel; Pearcy, Mark J.; Izatt, Maree T.; Green, Daniel; Labrom, Robert D.; Askin, Geoffrey N.			Predicting spinal profile using 3D non-contact surface scanning: Changes in surface topography as a predictor of internal spinal alignment	PLOS ONE			English	Article							IDIOPATHIC SCOLIOSIS; MORPHOLOGY	Introduction 3D non-contact surface scanners capture highly accurate, calibrated images of surface topography for 3D structures. This study sought to establish the efficacy and accuracy of using 3D surface scanning to characterise spinal curvature and sagittal plane contour. Methods 10 healthy female adults with a mean age of 25 years, (standard deviation: 3.6 years) underwent both MRI and 3D surface scanning (3DSS) (Artec Eva, Artec Group Inc., Luxembourg) while lying in the lateral decubitus position on a rigid substrate. Prior to 3DSS, anatomical landmarks on the spinous processes of each participant were demarcated using stickers attached to the skin surface. Following 3DSS, oil capsules (fiducial markers) were overlaid on the stickers and the subject underwent MRI. MRI stacks were processed to measure the thoracolumbar spinous process locations, providing an anatomical reference. 3D coordinates for the markers (surface stickers and MRI oil capsules) and for the spinous processes mapped the spinal column profiles and were compared to assess the quality of fit between the 3DSS and MRI marker positions. Results The RMSE for the polynomials fit to the spinous process, fiducial and surface marker profiles ranged from 0.17-1.15mm for all subjects. The MRI fiducial marker location was well aligned with the spinous process profile in the thoracic and upper lumbar spine for nine of the subjects. Over the 10 subjects, the mean RMSE between the MRI and 3D scan sagittal profiles for all surface markers was 9.8mm (SD 4.2mm). Curvature was well matched for seven of the subjects, with two showing differing curvatures across the lumbar spine due to inconsistent subject positioning. Conclusion Comparison of the observed trends for vertebral position measured from MRI and 3DSS, suggested the surface markers may provide a useful method for measuring internal changes in sagittal curvature or skeletal changes.	[Little, J. Paige; Rayward, Lionel; Pearcy, Mark J.; Izatt, Maree T.; Labrom, Robert D.; Askin, Geoffrey N.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Biomech & Spine Res Grp, Brisbane, Qld, Australia; [Green, Daniel] Sealy Australia, Wacol, Australia; [Labrom, Robert D.] Wesley Hosp, Brisbane, Qld, Australia; [Askin, Geoffrey N.] Mater Hlth Serv, Brisbane, Qld, Australia	Queensland University of Technology (QUT); Wesley Hospital; Mater Health Services	Little, JP (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Biomech & Spine Res Grp, Brisbane, Qld, Australia.	j2.little@qut.edu.au	Izatt, Maree T./ABF-8372-2021; Rayward, Lionel/ABE-2280-2021	Izatt, Maree T./0000-0002-4926-3077; Rayward, Lionel/0000-0001-5066-5631; Labrom, Robert/0000-0003-0601-1475; Little, J Paige/0000-0001-8377-5343; Askin, Geoffrey/0000-0002-1734-0082; Pearcy, Mark/0000-0002-1108-6503	Sealy of Australia	Sealy of Australia	This work was supported by Sealy of Australia who provided support in the form of salary for authors [JPL, DG], and a student scholarship [LR], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barczyk-Pawelec K, 2012, BIOL SPORT, V29, P129, DOI 10.5604/20831862.988969; Bolliger SA, 2008, EUR RADIOL, V18, P273, DOI 10.1007/s00330-007-0737-4; Catan H, 2007, EUR SPINE J, V16, P1203, DOI 10.1007/s00586-006-0281-y; Clin J, 2011, MED BIOL ENG COMPUT, V49, P743, DOI 10.1007/s11517-011-0737-z; Ebrahim M, 2014, PROCEEDINGS OF THE ASME INTERNATIONAL TECHNICAL CONFERENCE AND EXHIBITION ON PACKAGING AND INTEGRATION OF ELECTRONIC AND PHOTONIC MICROSYSTEMS, 2013, VOL 2; FROBIN W, 1981, PHOTOGRAMM ENG REM S, V47, P1717; Ghaneei M, 2019, COMPUT METHOD BIOMEC, V22, P696, DOI 10.1080/10255842.2019.1584795; Goldberg CJ, 2001, SPINE, V26, P42, DOI 10.1097/00007632-200101010-00009; Gorton GE, 2012, SPINE, V37, P957, DOI 10.1097/BRS.0b013e31823a012e; Grant CA, 2019, MED ENG PHYS, V63, P63, DOI 10.1016/j.medengphy.2018.11.004; Haex B., 2005, BACK BED ERGONOMIC A; Izatt M., 2019, BRIT MED J OPEN; Knott P., 2016, SCOLIOSIS SPINAL DIS, P11; Kotwicki T, 2007, SCOLIOSIS SPINAL DIS, V2, DOI 10.1186/1748-7161-2-18; Lain A, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00257; Liljenqvist UR, 2002, J BONE JOINT SURG AM, V84A, P359, DOI 10.2106/00004623-200203000-00005; Morl F, 2006, EUR SPINE J, V15, P742, DOI 10.1007/s00586-005-0960-0; Ng K., 2018, SCOLIOSIS SPINAL DIS, V13, P28; Niven L, 2009, J ARCHAEOL SCI, V36, P2018, DOI 10.1016/j.jas.2009.05.021; Patias P, 2010, SCOLIOSIS SPINAL DIS, V5, DOI 10.1186/1748-7161-5-12; Petit Y, 2002, CAN J SURG, V45, P453; Schmid S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135689; Stern D, 2011, PHYS MED BIOL, V56, P7505, DOI 10.1088/0031-9155/56/23/011	23	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222453	10.1371/journal.pone.0222453	http://dx.doi.org/10.1371/journal.pone.0222453			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557174	Green Published, gold			2022-12-26	WOS:000532345500020
J	Curra, C; Kehrer, J; Lemgruber, L; Silva, PAGC; Bertuccini, L; Superti, F; Pace, T; Ponzi, M; Frischknecht, F; Siden-Kiamos, I; Mair, GR				Curra, Chiara; Kehrer, Jessica; Lemgruber, Leandro; Silva, Patricia A. G. C.; Bertuccini, Lucia; Superti, Fabiana; Pace, Tomasino; Ponzi, Marta; Frischknecht, Friedrich; Siden-Kiamos, Inga; Mair, Gunnar R.			Malaria transmission through the mosquito requires the function of the OMD protein	PLOS ONE			English	Article							PLASMODIUM-BERGHEI; GLIDING MOTILITY; ACTIN; REVEALS; MIDGUT; CTRP; DISRUPTION; INFECTION; INVASION; EGRESS	Ookinetes, one of the motile and invasive forms of the malaria parasite, rely on gliding motility in order to establish an infection in the mosquito host. Here we characterize the protein PBANKA_0407300 which is conserved in the Plasmodium genus but lacks significant similarity to proteins of other eukaryotes. It is expressed in gametocytes and throughout the invasive mosquito stages of P. berghei, but is absent from asexual blood stages. Mutants lacking the protein developed morphologically normal ookinetes that were devoid of productive motility although some stretching movement could be detected. We therefore named the protein Ookinete Motility Deficient (OMD). Several key factors known to be involved in motility however were normally expressed and localized in the mutant. Importantly, the mutant failed to establish an infection in the mosquito which resulted in a total malaria transmission blockade.	[Curra, Chiara; Siden-Kiamos, Inga] FORTH, Inst Mol Biol & Biotechnol, Iraklion, Greece; [Kehrer, Jessica; Lemgruber, Leandro; Frischknecht, Friedrich; Mair, Gunnar R.] Heidelberg Univ, Med Sch, Ctr Infect Dis, Integrat Parasitol, Heidelberg, Germany; [Silva, Patricia A. G. C.; Mair, Gunnar R.] Inst Med Mol, Lisbon, Portugal; [Bertuccini, Lucia; Superti, Fabiana; Ponzi, Marta] Natl Inst Hlth, Core Facil, Rome, Italy; [Bertuccini, Lucia; Superti, Fabiana] Natl Inst Hlth, Natl Ctr Innovat Technol Publ Hlth, Rome, Italy; [Pace, Tomasino; Ponzi, Marta] Natl Inst Hlth, Dept Infect Dis, Rome, Italy; [Mair, Gunnar R.] Iowa State Univ, Biomed Sci, Ames, IA 50011 USA; [Lemgruber, Leandro] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland	Foundation for Research & Technology - Hellas (FORTH); Ruprecht Karls University Heidelberg; Universidade de Lisboa; Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Iowa State University; University of Glasgow	Siden-Kiamos, I (corresponding author), FORTH, Inst Mol Biol & Biotechnol, Iraklion, Greece.; Mair, GR (corresponding author), Heidelberg Univ, Med Sch, Ctr Infect Dis, Integrat Parasitol, Heidelberg, Germany.; Mair, GR (corresponding author), Inst Med Mol, Lisbon, Portugal.; Mair, GR (corresponding author), Iowa State Univ, Biomed Sci, Ames, IA 50011 USA.	inga@imbb.forth.gr; mair@iastate.edu	Bertuccini, Lucia/AAI-6683-2021; , Fabiana/F-2100-2015	Bertuccini, Lucia/0000-0002-4278-2376; Curra, Chiara/0000-0001-7851-1087; , Fabiana/0000-0003-4909-7598; Lemgruber, Leandro/0000-0003-2832-6806; Frischknecht, Friedrich/0000-0002-8332-6668; Siden-Kiamos, Inga/0000-0003-1572-5840; Mair, Gunnar/0000-0002-5187-3691	CellNetworks cluster of Heidelberg University through EcTop2 [EXC81]; CellNetworks cluster of Heidelberg University [EXC81]; European Research Council [ERC-SG 281719]; EU FP7 research network EVIMalaR; Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/SAU-MIC/122082/2010, PTDC/BIA-BCM/105610/2008, SFRH/BPD/72619/2010]; project: "Towards multistage drugs to fight poverty related and neglected parasitic diseases: synthetic and natural compounds directed against Leishmania, Plasmodium and Schistosoma life stages and assessment of their mechanisms of action" - Italian Nation; General Secretariat for Research and Technology, Ministry of Education, Greece [MIS-448301 (2013SE01380036)]; European Regional Development Fund (Sectoral Operational Programme: Competitiveness and Entrepreneurship, NSRF 2007-2013)/European Commission; I-MOVE Fellowship Programme [PCOFUND-GA-2010-267332]	CellNetworks cluster of Heidelberg University through EcTop2; CellNetworks cluster of Heidelberg University; European Research Council(European Research Council (ERC)European Commission); EU FP7 research network EVIMalaR; Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); project: "Towards multistage drugs to fight poverty related and neglected parasitic diseases: synthetic and natural compounds directed against Leishmania, Plasmodium and Schistosoma life stages and assessment of their mechanisms of action" - Italian Nation; General Secretariat for Research and Technology, Ministry of Education, Greece; European Regional Development Fund (Sectoral Operational Programme: Competitiveness and Entrepreneurship, NSRF 2007-2013)/European Commission; I-MOVE Fellowship Programme	This work was supported by the CellNetworks cluster of Heidelberg University (EXC81; German Research Foundation) through EcTop2 and a postdoctoral fellowship to LL; the European Research Council (ERC-SG 281719) and the EU FP7 research network EVIMalaR to FF; the Fundacao para a Ciencia e a Tecnologia (FCT) grants PTDC/SAU-MIC/122082/2010 and PTDC/BIA-BCM/105610/2008 to GRM, and SFRH/BPD/72619/2010 to PAGC; the project: "Towards multistage drugs to fight poverty related and neglected parasitic diseases: synthetic and natural compounds directed against Leishmania, Plasmodium and Schistosoma life stages and assessment of their mechanisms of action", funded by the Italian National Research Programme PRIN-2015 to MP; the framework of the BIOSYS research project, Action KRIPIS, project No MIS-448301 (2013SE01380036) funded by the General Secretariat for Research and Technology, Ministry of Education, Greece and the European Regional Development Fund (Sectoral Operational Programme: Competitiveness and Entrepreneurship, NSRF 2007-2013)/European Commission to ISK. CC was supported by a fellowship from the I-MOVE Fellowship Programme - PCOFUND-GA-2010-267332 (Marie Curie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Brochet M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001806; Bushell E, 2017, CELL, V170, P260, DOI 10.1016/j.cell.2017.06.030; Capitani M, 2009, FEBS LETT, V583, P3863, DOI 10.1016/j.febslet.2009.10.053; Collins MN, 2011, STRUCTURE, V19, P324, DOI 10.1016/j.str.2010.11.017; Curra C, 2017, EXP PARASITOL, V181, P82, DOI 10.1016/j.exppara.2017.08.001; Deligianni E, 2013, CELL MICROBIOL, V15, P1438, DOI 10.1111/cmi.12131; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dessens JT, 1999, EMBO J, V18, P6221, DOI 10.1093/emboj/18.22.6221; Dessens JT, 2003, MOL MICROBIOL, V49, P319, DOI 10.1046/j.1365-2958.2003.03566.x; Frenal K, 2017, NAT REV MICROBIOL, V15, P645, DOI 10.1038/nrmicro.2017.86; Gomes-Santos CSS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002046; Guttery DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002948; Jacot D, 2016, CELL HOST MICROBE, V20, P731, DOI 10.1016/j.chom.2016.10.020; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Mair GR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000767; Moon RW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000599; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Patzewitz EM, 2013, CELL REP, V3, P622, DOI 10.1016/j.celrep.2013.01.032; Siden-Kiamos I, 2006, MOL BIOCHEM PARASIT, V150, P308, DOI 10.1016/j.molbiopara.2006.09.003; Siden-Kiamos I, 2006, MOL MICROBIOL, V60, P1355, DOI 10.1111/j.1365-2958.2006.05189.x; Siden-Kiamos I, 2012, MOL BIOCHEM PARASIT, V181, P186, DOI 10.1016/j.molbiopara.2011.11.002; Siden-Kiamos I, 2011, CELL MICROBIOL, V13, P1996, DOI 10.1111/j.1462-5822.2011.01686.x; Templeton TJ, 2000, MOL MICROBIOL, V36, P1, DOI 10.1046/j.1365-2958.2000.01821.x; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; WINGER LA, 1988, PARASITE IMMUNOL, V10, P193, DOI 10.1111/j.1365-3024.1988.tb00214.x; Yuda M, 1999, J EXP MED, V190, P1711, DOI 10.1084/jem.190.11.1711; Yuda M, 2001, MOL BIOCHEM PARASIT, V116, P65, DOI 10.1016/S0166-6851(01)00304-8	28	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222226	10.1371/journal.pone.0222226	http://dx.doi.org/10.1371/journal.pone.0222226			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553751	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000532319200018
J	Christenson, A; Johansson, E; Reynisdottir, S; Torgerson, J; Hemmingsson, E				Christenson, Anne; Johansson, Eva; Reynisdottir, Signy; Torgerson, Jarl; Hemmingsson, Erik			"...or else I close my ears" How women with obesity want to be approached and treated regarding gestational weight management: A qualitative interview study	PLOS ONE			English	Article							MATERNAL OBESITY; FOCUS GROUPS; INDIVIDUAL INTERVIEWS; GAIN; CARE; PREGNANCY; OUTCOMES; INTERVENTIONS; PERSPECTIVES; METAANALYSIS	Introduction The importance of helping pregnant women maintain a healthy lifestyle and prevent excessive gestational weight gain is well recognized, but pregnant women do not always perceive communication about body weight as respectful or helpful. Furthermore, fear of inducing shame or guilt can prohibit some midwives from talking about body weight, especially if the woman has obesity. We aimed to explore what women of reproductive age with obesity regard to be the most important and relevant aspects when discussing gestational weight management. Methods Qualitative interview study using focus groups and individual semi-structured interviews with 17 women of reproductive age (19-39 y) with obesity. Thematic analysis was used to analyze the data. Results We identified three themes: 1) Importance of obtaining vital medical information; 2) A wish to feel understood and treated with respect; 3) Midwives' approach is crucial in sensitive key situations, which include bringing up the subject of body weight, weighing, providing weightrelated information, coaching lifestyle modification, dealing with emotional reactions and ending a conversation. Conclusions A majority of the interviewed women wished to receive information about risks about obesity and gestational weight gain, and recommendations on weight management. However, the risk of midwives offending someone by raising the topic may be increased if the pregnant woman believe that gestational weight gain is uncontrollable by the individual. Also, several situations during maternity care meetings can be stigmatizing and make women less receptive to advice or support. Women suggest that a good working alliance is likely to be achieved if midwives have knowledge about the causes of obesity, take interest in the patients' background, have a non-judgmental approach and refrain from giving unsolicited advice.	[Christenson, Anne; Reynisdottir, Signy] Acad Specialist Ctr, Stockholm Hlth Serv, Obes Ctr, Stockholm, Sweden; [Christenson, Anne] Karolinska Inst, Dept Med, Stockholm, Sweden; [Johansson, Eva] Karolinska Inst, Dept Publ Hlth Sci IHCAR, Stockholm, Sweden; [Torgerson, Jarl] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden; [Hemmingsson, Erik] Swedish Sch Sports & Hlth Sci, Astrand Lab Work Physiol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; University of Gothenburg; Swedish School of Sport & Health Sciences	Christenson, A (corresponding author), Acad Specialist Ctr, Stockholm Hlth Serv, Obes Ctr, Stockholm, Sweden.; Christenson, A (corresponding author), Karolinska Inst, Dept Med, Stockholm, Sweden.	anne.christenson@ki.es						Allen-Walker V, 2017, MIDWIFERY, V49, P95, DOI 10.1016/j.midw.2016.12.006; Barter C., 2000, INT J SOC RES METHOD, V3, P307, DOI [10.1080/13645570050178594, DOI 10.1080/13645570050178594]; Beckman M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181715; Bjermo H, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1624-6; Blomberg M, 2011, OBSTET GYNECOL, V117, P1065, DOI 10.1097/AOG.0b013e318214f1d1; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brownfoot FC, 2016, BJOG-INT J OBSTET GY, V123, P254, DOI 10.1111/1471-0528.13735; Bye A, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1745-x; CATALANO PM, 2017, BMJ-BRIT MED J, V356, DOI DOI 10.1136/BMJ.J1; Christensen AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166167; Christenson A, 2018, MIDWIFERY, V63, P1, DOI 10.1016/j.midw.2018.04.020; Das UN, 2010, NUTRITION, V26, P459, DOI 10.1016/j.nut.2009.09.020; DEJONG W, 1980, J HEALTH SOC BEHAV, V21, P75, DOI 10.2307/2136696; Dencker A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0969-x; Denison FC, 2019, BJOG-INT J OBSTET GY, V126, pE62, DOI 10.1111/1471-0528.15386; Deputy NP, 2018, MMWR-MORBID MORTAL W, V66, P1402, DOI 10.15585/mmwr.mm665152a3; Devlieger R, 2016, EUR J OBSTET GYN R B, V201, P203, DOI 10.1016/j.ejogrb.2016.04.005; DiCicco-Bloom B, 2006, MED EDUC, V40, P314, DOI 10.1111/j.1365-2929.2006.02418.x; Farpour-Lambert NJ, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00546; Fieril KP, 2017, MIDWIFERY, V44, P1, DOI 10.1016/j.midw.2016.10.011; Forsberg L, 2012, CLIN ACQUISITION RET; Foster H.J., 2014, BR J MIDWIFERY, V22, P254, DOI [DOI 10.12968/BJOM.2014.22.4.254, DOI 10.12968/BJ0M.2014.22.4.254]; Gresham E, 2016, PUBLIC HEALTH NUTR, V19, P2975, DOI 10.1017/S1368980016001245; Guest G, 2017, INT J SOC RES METHOD, V20, P693, DOI 10.1080/13645579.2017.1281601; Haby K, 2015, MIDWIFERY, V31, P685, DOI 10.1016/j.midw.2015.03.014; Hansson LM, 2014, BODY IMAGE, V11, P43, DOI 10.1016/j.bodyim.2013.10.004; Heslehurst N, 2013, MIDWIFERY, V29, P736, DOI 10.1016/j.midw.2012.07.007; Hill B, 2013, OBES REV, V14, P435, DOI 10.1111/obr.12022; Holton S, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1538-7; Jelsma JGM, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1471-9; Jones C, 2017, MIDWIFERY, V53, P87, DOI 10.1016/j.midw.2017.07.011; Kapadia MZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132650; Kaplowitz MD, 2000, QUAL QUANT, V34, P419, DOI 10.1023/A:1004844425448; Knight-Agarwal CR, 2016, WOMEN BIRTH, V29, P189, DOI 10.1016/j.wombi.2015.10.008; Lambert SD, 2008, J ADV NURS, V62, P228, DOI 10.1111/j.1365-2648.2007.04559.x; Lavender T, 2016, HEALTH EXPECT, V19, P222, DOI 10.1111/hex.12339; Lindhardt CL, 2014, ACTA OBSTET GYN SCAN, V93, P698, DOI 10.1111/aogs.12401; Lindhardt CL, 2015, MIDWIFERY, V31, P678, DOI 10.1016/j.midw.2015.03.010; Lindholm ES, 2010, ACTA OBSTET GYN SCAN, V89, P840, DOI 10.3109/00016340903428370; Lindsay AC, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111412; Linne Y, 2004, OBES RES, V12, P1166, DOI 10.1038/oby.2004.146; Lundahl B, 2013, PATIENT EDUC COUNS, V93, P157, DOI 10.1016/j.pec.2013.07.012; Malta MB, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0957-1; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Malterud K, 2016, QUAL HEALTH RES, V26, P1753, DOI 10.1177/1049732315617444; McDonald SD, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.05.039; McDowell M, 2019, J MIDWIFERY WOM HEAL, V64, P46, DOI 10.1111/jmwh.12927; Mirijello A, 2015, J AFFECT DISORDERS, V179, P95, DOI 10.1016/j.jad.2015.03.030; Nilses C, 2017, SEX REPROD HEALTHC, V11, P47, DOI 10.1016/j.srhc.2016.08.004; Nyman VMK, 2010, MIDWIFERY, V26, P424, DOI 10.1016/j.midw.2008.10.008; Olander EK, 2016, NURS EDUC TODAY, V42, P59, DOI 10.1016/j.nedt.2016.04.009; Oliver I, 2012, IEEE IC COMP COM NET; Organization WH, 2018, OBESITY OVERWEIGHT D; Patton MQ., 2015, QUALITATIVE RES EVAL, V4th, DOI [10.1016/j.ymeth.2015.04.005, DOI 10.1016/J.YMETH.2015.04.005]; Puhl RM, 2018, PEDIATR OBES, V13, P533, DOI 10.1111/ijpo.12275; Robillard PY, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00615; Rohatgi KW, 2017, PEERJ, V5, DOI 10.7717/peerj.4091; Rosenthal M, 2016, CURR PHARM TEACH LEA, V8, P509, DOI 10.1016/j.cptl.2016.03.021; Ruifrok AE, 2014, AM J PERINAT, V31, P353, DOI 10.1055/s-0033-1352484; Santos S, 2019, BJOG-INT J OBSTET GY, V126, P984, DOI 10.1111/1471-0528.15661; Schoenberg N.E., 2000, INT J SOC RES METHOD, V3, P63, DOI [DOI 10.1080/136455700294932, 10.1080/136455700294932]; Shub Alexis, 2013, BMC Res Notes, V6, P278, DOI 10.1186/1756-0500-6-278; Sogg S, 2018, SURG OBES RELAT DIS, V14, P682, DOI 10.1016/j.soard.2018.01.013; The national board of health and welfare, 2016, SWED PREGN DAT BAS; Universal health coverage and universal access, 2013, B WHO; Vieten C, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1757-6; Wahedi M, 2016, BR J MIDWIFERY, V24, P724, DOI DOI 10.12968/BJ0M.2016.24.10.724; Yang ZJ, 2019, AUST NZ J OBSTET GYN, V59, P367, DOI 10.1111/ajo.12866	68	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222543	10.1371/journal.pone.0222543	http://dx.doi.org/10.1371/journal.pone.0222543			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5BF	31536545	Green Published, gold, Green Submitted			2022-12-26	WOS:000532262800053
J	Kitanaka, N; Nakano, R; Sakai, M; Kitanaka, T; Namba, S; Konno, T; Nakayama, T; Sugiya, H				Kitanaka, Nanako; Nakano, Rei; Sakai, Manabu; Kitanaka, Taku; Namba, Shinichi; Konno, Tadayoshi; Nakayama, Tomohiro; Sugiya, Hiroshi			ERK1/ATF-2 signaling axis contributes to interleukin-1 beta-induced MMP-3 expression in dermal fibroblasts	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PRO-INFLAMMATORY CYTOKINES; AP-1 TARGET GENES; N-TERMINAL KINASE; MATRIX METALLOPROTEINASES; C-JUN; TRANSCRIPTION FACTOR; SKIN FIBROBLASTS; GROWTH-FACTORS; WOUND REPAIR	Matrix metalloproteinases (MMPs) play a pivotal role in tissue remodeling by degrading the extracellular matrix (ECM) components. This mechanism is implicated in a variety of physiological and pathological cellular processes including wound healing. One of the key proteins involved in this process is the proinflammatory cytokine interleukin-1 beta (IL-1 beta, which induces the expression of MMP-3 mRNA and the secretion of MMP-3 protein by dermal fibroblasts. In this study, we first investigated the contribution of activating transcription factor 2 (ATF-2) to IL-1 beta-induced MMP-3 expression in dermal fibroblasts. Our results showed that in cells transfected with ATF-2 siRNA or treated with the ATF-2 inhibitor SBI-0087702, IL-1 beta induced MMP-3 mRNA expression was reduced. We also demonstrated that IL-1 beta stimulates the phosphorylation of ATF-2. These observations suggest that ATF-2 plays an important role in IL-1 beta-induced MMP-3 expression. Next, we investigated the role of MAPK signaling in ATF-2 activation. In cells treated with the extracellular signal-regulated kinase (ERK) inhibitor FR180240, as well as in cells transfected with ERK1 and ERK2 siRNAs, IL 1 beta-induced MMP-3 mRNA expression was reduced. In addition, we showed that IL-1 beta induced the phosphorylation of ERK1/2. These observations suggest that ERK1 and ERK2 are involved in IL-1 beta-induced MMP-3 expression. However, ERK1 and ERK2 do seem to play different roles. While the ERK inhibitor FR180204 inhibited IL-1 beta-induced ATF-2 phosphorylation, only in cells transfected with ERK1 siRNA, but not ERK2 siRNA, IL-1 beta-induced ATF-2 phosphorylation was reduced. These findings suggest that the ERK1/ATF-2 signaling axis contributes to IL-1 beta-induced MMP-3 expression in dermal fibroblasts.	[Kitanaka, Nanako; Nakano, Rei; Kitanaka, Taku; Namba, Shinichi; Konno, Tadayoshi; Sugiya, Hiroshi] Nihon Univ, Coll Bioresource Sci, Lab Vet Biochem, Fujisawa, Kanagawa, Japan; [Kitanaka, Nanako; Nakano, Rei; Kitanaka, Taku; Namba, Shinichi; Konno, Tadayoshi; Sugiya, Hiroshi] Nihon Univ, Coll Bioresource Sci, Lab Vet Internal Med 3, Fujisawa, Kanagawa, Japan; [Kitanaka, Nanako; Nakano, Rei; Kitanaka, Taku; Namba, Shinichi; Konno, Tadayoshi; Sugiya, Hiroshi] Nihon Univ, Coll Bioresource Sci, Lab Vet Radiotherapy 4, Fujisawa, Kanagawa, Japan; [Nakano, Rei] RIKEN, Lab Cellular Funct Convers Technol, Ctr Integrat Med Sci, Tsurumi Ku, Suehiro Cho, Yokohama, Kanagawa, Japan; [Sakai, Manabu] Nihon Univ, Labs Vet Internal Med, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan; [Nakayama, Tomohiro] Nihon Univ, Labs Vet Radiotherapy, Coll Bioresource Sci, Fujisawa, Kanagawa, Japan	Nihon University; Nihon University; Nihon University; RIKEN; Nihon University; Nihon University	Sugiya, H (corresponding author), Nihon Univ, Coll Bioresource Sci, Lab Vet Biochem, Fujisawa, Kanagawa, Japan.; Sugiya, H (corresponding author), Nihon Univ, Coll Bioresource Sci, Lab Vet Internal Med 3, Fujisawa, Kanagawa, Japan.; Sugiya, H (corresponding author), Nihon Univ, Coll Bioresource Sci, Lab Vet Radiotherapy 4, Fujisawa, Kanagawa, Japan.	sugiya.hiroshi@nihon-u.ac.jp	Nakayama, Tomohiro/GYU-0303-2022	Namba, Shinichi/0000-0002-9182-3656	Ministry of Education, Science, Sports, and Culture of Japan [18K14594]; Nihon University Multidisciplinary Research Grant [17-019]	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nihon University Multidisciplinary Research Grant	This research is supported by Grant-inAid for Scientific Research (#18K14594 to RN) from the Ministry of Education, Science, Sports, and Culture of Japan (https://www.jsps.go.jp/jgrantsinaid/).This research is supported by Nihon University Multidisciplinary Research Grant for 2017 (17-019 to TN) (http://www.nihon-u.ac.jp/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELHAFIZ HA, 1992, MOL ENDOCRINOL, V6, P2079, DOI 10.1210/me.6.12.2079; Agren MS, 2015, EUR J CELL BIOL, V94, P12, DOI 10.1016/j.ejcb.2014.10.001; Angel P, 2002, BIOCHEM PHARMACOL, V64, P949, DOI 10.1016/S0006-2952(02)01158-9; Babaei S, 2015, J INVEST SURG, V28, P196, DOI 10.3109/08941939.2014.1002642; Baecker V, 2012, IMAGEJ US DEV C; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenneisen P, 2000, J BIOL CHEM, V275, P4336, DOI 10.1074/jbc.275.6.4336; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Bullard KM, 1999, ANN SURG, V230, P260, DOI 10.1097/00000658-199908000-00017; Bullard KM, 1999, J SURG RES, V84, P31, DOI 10.1006/jsre.1999.5599; Chambers M, 2013, EXP CELL RES, V319, P1398, DOI 10.1016/j.yexcr.2013.04.010; Chaudhary AK, 2013, MUTAT RES-REV MUTAT, V753, P7, DOI 10.1016/j.mrrev.2013.01.002; Cobb MH, 2000, TRENDS BIOCHEM SCI, V25, P7, DOI 10.1016/S0968-0004(99)01508-X; Florin L, 2004, ONCOGENE, V23, P7005, DOI 10.1038/sj.onc.1207938; Fremin C, 2007, HEPATOLOGY, V45, P1035, DOI 10.1002/hep.21551; Fuchs SY, 2000, J BIOL CHEM, V275, P12560, DOI 10.1074/jbc.275.17.12560; Gao D, 2011, J CELL PHYSIOL, V226, P2869, DOI 10.1002/jcp.22630; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI12466; Hosseini M, 2006, INVEST OPHTH VIS SCI, V47, P1469, DOI 10.1167/iovs.05-0451; Hsieh HL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-110; Hubner G, 1996, CYTOKINE, V8, P548, DOI 10.1006/cyto.1996.0074; Hwang BM, 2013, EXP DERMATOL, V22, P371, DOI 10.1111/exd.12137; Kaminska B., 1997, BIOCHIM BIOPHYS ACTA, V1754, P253; Kitanaka T, 2017, SCI REP-UK, V7, DOI 10.1038/srep39914; Kuroda K, 1997, ARCH DERMATOL RES, V289, P567, DOI 10.1007/s004030050241; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Li FF, 2009, BIOCHEM BIOPH RES CO, V382, P259, DOI 10.1016/j.bbrc.2009.02.165; Li XY, 1996, GENE DEV, V10, P517, DOI 10.1101/gad.10.5.517; Li YY, 2014, J INVEST DERMATOL, V134, P643, DOI 10.1038/jid.2013.303; Madlener M, 1998, EXP CELL RES, V242, P201, DOI 10.1006/excr.1998.4049; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Martins VL, 2013, CELL TISSUE RES, V351, P255, DOI 10.1007/s00441-012-1410-z; Mauviel A, 2009, J INVEST DERMATOL, V129, P7, DOI 10.1038/jid.2008.385; MELOCHE S, 1995, J CELL PHYSIOL, V163, P577, DOI 10.1002/jcp.1041630319; Miriam F-F, 2010, BIOCHIM BIOPHYS ACTA, V1803, P3, DOI DOI 10.1016/J.BBAMCR.2009.07.004; Namba S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182923; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Parsons SL, 1997, BRIT J SURG, V84, P160, DOI 10.1002/bjs.1800840206; Pittayapruek P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060868; Prontera C, 1996, EXP CELL RES, V224, P183, DOI 10.1006/excr.1996.0126; Radtke S, 2013, J CELL SCI, V126, P2381, DOI 10.1242/jcs.115832; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Ravanti L, 2000, INT J MOL MED, V6, P391; Ricote M, 2006, J PATHOL, V208, P401, DOI 10.1002/path.1910; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shin J, 2013, CELL SIGNAL, V25, P2540, DOI 10.1016/j.cellsig.2013.08.014; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Sinfield JK, 2013, BIOCHEM BIOPH RES CO, V430, P419, DOI 10.1016/j.bbrc.2012.11.071; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Song H, 2006, CANCER RES, V66, P10487, DOI 10.1158/0008-5472.CAN-06-1461; Sylvester J, 2012, CELL PHYSIOL BIOCHEM, V30, P563, DOI 10.1159/000341438; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Tabandeh MR, 2014, INT J BIOL MACROMOL, V65, P424, DOI 10.1016/j.ijbiomac.2014.01.055; Tabandeh MR, 2013, PHYTOTHER RES, V27, P1149, DOI 10.1002/ptr.4839; Tsai EY, 1996, MOL CELL BIOL, V16, P459; Tsuchiya H, 2015, VET IMMUNOL IMMUNOP, V168, P223, DOI 10.1016/j.vetimm.2015.10.003; Utz ER, 2010, J SURG RES, V159, P633, DOI 10.1016/j.jss.2009.08.021; VANDAM H, 1995, EMBO J, V14, P1798, DOI 10.1002/j.1460-2075.1995.tb07168.x; Vincenti MP, 2007, J CELL PHYSIOL, V213, P355, DOI 10.1002/jcp.21208; Wang Q, 2013, BIOCHEM J, V449, P771, DOI 10.1042/BJ20121170; Watson G, 2017, PHARMACOL RES, V119, P347, DOI 10.1016/j.phrs.2017.02.004; Weinheimer-Haus EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119106; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Westermarck J, 2000, CANCER RES, V60, P7156; Wilczynska KM, 2006, J BIOL CHEM, V281, P34955, DOI 10.1074/jbc.M604616200; Xue ML, 2006, EXPERT OPIN THER TAR, V10, P143, DOI 10.1517/14728222.10.1.143; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yu T, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/950472; Zhu F, 2004, CARCINOGENESIS, V25, P1847, DOI 10.1093/carcin/bgh202	75	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222869	10.1371/journal.pone.0222869	http://dx.doi.org/10.1371/journal.pone.0222869			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536594	Green Published, Green Submitted, gold			2022-12-26	WOS:000532262800099
J	Tanaskovic, O; Falzacappa, MVV; Pelicci, PG				Tanaskovic, Olga; Falzacappa, Maria Vittoria Verga; Pelicci, Pier Giuseppe			Human cord blood (hCB)-CD34(+) humanized mice fail to reject human acute myeloid leukemia cells	PLOS ONE			English	Article							MOUSE MODEL; ENGRAFTMENT	Since their appearance, humanized mice carrying human immune system seemed promising tools to study the crosstalk between cancer and immunity. The NOD-scidIL2Rgamma(null) (NSG) mice engrafted with human cord blood (hCB)-CD34(+) cells have been proposed to be a valuable tool to reproduce human immune system in mouse. However, the lack of solid evidences on the functionality of their human immune components limits their usage in immune-oncology. We report that (hCB)-CD34(+) cells lose their ability to propagate and originate bone marrow-derived human immune cells after two serial transplantations in NSG mice. We demonstrate that transplants of bone marrow patient-derived acute myeloid leukemias (hAMLs) grow very similarly in the humanized (hCB)-CD34(+) NSG and parental NSG mice. The similar extent of engraftment and development of leukemias in (hCB)-CD34(+) NSG and controls suggests a poor human immune response against not compatible hAMLs. Our findings suggest that (hCB)-CD34(+) NSG mice are transient and/or incomplete carriers of the human immune system and, therefore, represent a suboptimal tool to study the interaction between tumor and immune cells.	[Tanaskovic, Olga; Falzacappa, Maria Vittoria Verga; Pelicci, Pier Giuseppe] European Inst Oncol IRCCS, Dept Expt Oncol IEO, Milan, Italy; [Pelicci, Pier Giuseppe] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy	IRCCS European Institute of Oncology (IEO); University of Milan	Tanaskovic, O; Pelicci, PG (corresponding author), European Inst Oncol IRCCS, Dept Expt Oncol IEO, Milan, Italy.; Pelicci, PG (corresponding author), Univ Milan, Dept Oncol & Hematooncol, Milan, Italy.	olga.tanaskovic@ieo.it; piergiuseppe.pelicci@ieo.it		Tanaskovic, Olga/0000-0003-2477-9015	Ministero della Salute [RF 2013-02356924]; Associazione italiana per la ricerca sul cancro (AIRC 2013); Associazione italiana per la ricerca sul cancro (AIRC Fellowship 2017) [19499]	Ministero della Salute(Ministry of Health, Italy); Associazione italiana per la ricerca sul cancro (AIRC 2013)(Fondazione AIRC per la ricerca sul cancro); Associazione italiana per la ricerca sul cancro (AIRC Fellowship 2017)(Fondazione AIRC per la ricerca sul cancro)	This work was funded by PG.P. Ministero della Salute (RF 2013-02356924). http://www.salute.gov.it/portale/home.html; Associazione italiana per la ricerca sul cancro (AIRC 2013). https://www.airc.it/; O.T. Associazione italiana per la ricerca sul cancro (AIRC Fellowship 2017, contract number 19499). https://www.airc.it/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspord C, 2013, CANCER IMMUNOL RES, V1, P402, DOI 10.1158/2326-6066.CIR-13-0114-T; Falzacappa MVV, 2012, FEBS J, V279, P3559, DOI 10.1111/j.1742-4658.2012.08727.x; Greenblatt MB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044664; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; King MA, 2009, CLIN EXP IMMUNOL, V157, P104, DOI 10.1111/j.1365-2249.2009.03933.x; LAPIDOT T, 1992, SCIENCE, V255, P1137, DOI 10.1126/science.1372131; Liu DF, 2012, J CLIN INVEST, V122, P2221, DOI 10.1172/JCI59535; Morton JJ, 2016, CANCER RES, V76, P6153, DOI 10.1158/0008-5472.CAN-16-1260; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Walsh NC, 2017, ANNU REV PATHOL-MECH, V12, P187, DOI 10.1146/annurev-pathol-052016-100332; Watanabe Y, 2009, INT IMMUNOL, V21, P843, DOI 10.1093/intimm/dxp050; Wiekmeijer AS, 2014, BIORESEARCH OPEN ACC, V3, P110, DOI 10.1089/biores.2014.0008	15	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0217345	10.1371/journal.pone.0217345	http://dx.doi.org/10.1371/journal.pone.0217345			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536492	Green Published, Green Submitted, gold			2022-12-26	WOS:000532262800004
J	Ganho-Avila, A; Goncalves, OF; Guiomar, R; Boggio, PS; Asthana, MK; Krypotos, AM; Almeida, J				Ganho-Avila, Ana; Goncalves, Oscar F.; Guiomar, Raquel; Boggio, Paulo Sergio; Asthana, Manish Kumar; Krypotos, Angelos-Miltiadis; Almeida, Jorge			The effect of cathodal tDCS on fear extinction: A cross-measures study	PLOS ONE			English	Article							DIRECT-CURRENT STIMULATION; PREFRONTAL CORTEX; ANXIETY DISORDER; PANIC DISORDER; RECONSOLIDATION; MECHANISMS; AVOIDANCE; HUMANS; ACQUISITION; RESPONSES	Background Extinction-based procedures are often used to inhibit maladaptive fear responses. However, because extinction procedures show efficacy limitations, transcranial direct current stimulation (tDCS) has been suggested as a promising add-on enhancer. Objective In this study, we tested how cathodal tDCS over the right dorsolateral prefrontal cortex affects extinction and tried to unveil the processes at play that boost the effectiveness of extinction procedures and its translational potential to the treatment of anxiety disorders. Methods We implemented a fear conditioning paradigm whereby 41 healthy women (mean age = 20.51 +/- 5.0) were assigned to either cathodal tDCS (n = 27) or sham tDCS (n = 16). Fear responses were measured with self-reports, autonomic responses, and implicit avoidance tendencies. Results Cathodal tDCS shows no statistically significant effect in extinction, according to selfreports, and seems to even negatively affect fear conditioned skin conductance responses. However, one to three months after the tDCS session and extinction, we found a group difference in the action tendencies towards the neutral stimuli (F (1, 41) = 12.04, p =.001,.p2 =.227), with the cathodal tDCS group (as opposed to the sham group) showing a safety learning (a positive bias towards the CS-), with a moderate effect size. This suggests that cathodal tDCS may foster stimuli discrimination, leading to a decreased generalization effect. Discussion Cathodal tDCS may have enhanced long-term distinctiveness between threatening cues and perceptively similar neutral cues through a disambiguation process of the value of the neutral stimuli-a therapeutic target in anxiety disorders. Future studies should confirm these results and extend the study of cathodal tDCS effect on short term avoidance tendencies.	[Ganho-Avila, Ana; Guiomar, Raquel; Almeida, Jorge] Univ Coimbra, Cognit & Behav Ctr Res & Intervent, Fac Psychol & Educ Sci, Proact Lab, Coimbra, Portugal; [Ganho-Avila, Ana; Goncalves, Oscar F.] Univ Minho, Sch Psychol, Neuropsychophysiol Lab, CiPsi, Braga, Portugal; [Goncalves, Oscar F.] Harvard Med Sch, Spaulding Rehabil Hosp, Spaulding Neuromodulat Ctr, Boston, MA 02115 USA; [Boggio, Paulo Sergio; Asthana, Manish Kumar] Univ Prebiteriana Mackenzie, Ctr Hlth & Biol Sci, Social & Cognit Neurosci Lab, Sao Paulo, Brazil; [Boggio, Paulo Sergio; Asthana, Manish Kumar] Univ Prebiteriana Mackenzie, Ctr Hlth & Biol Sci, Dev Disorders Program, Sao Paulo, Brazil; [Asthana, Manish Kumar] Indian Inst Technol, Dept Humanities & Social Sci, Roorkee, Uttar Pradesh, India; [Krypotos, Angelos-Miltiadis] Univ Utrecht, Dept Clin Psychol, Utrecht, Netherlands	Universidade de Coimbra; Universidade do Minho; Harvard University; Harvard Medical School; Spaulding Rehabilitation Hospital; Universidade Presbiteriana Mackenzie; Universidade Presbiteriana Mackenzie; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee; Utrecht University	Ganho-Avila, A (corresponding author), Univ Coimbra, Cognit & Behav Ctr Res & Intervent, Fac Psychol & Educ Sci, Proact Lab, Coimbra, Portugal.; Ganho-Avila, A (corresponding author), Univ Minho, Sch Psychol, Neuropsychophysiol Lab, CiPsi, Braga, Portugal.	ganhoavila@fpce.uc.pt	Boggio, Paulo S/K-6272-2012; Krypotos, Angelos-Miltiadis/ABD-1739-2020; Guiomar, Raquel/ABH-9355-2022; Asthana, Manish/AAE-8450-2019; Ganho-Ávila, Ana/AGU-8094-2022; Gonçalves, Óscar F./G-5278-2010	Boggio, Paulo S/0000-0002-6109-0447; Krypotos, Angelos-Miltiadis/0000-0001-9704-6520; Guiomar, Raquel/0000-0001-9611-1167; Asthana, Manish/0000-0002-0270-8913; Ganho-Ávila, Ana/0000-0001-5355-6166; Gonçalves, Óscar F./0000-0003-2735-9155; Almeida, Jorge/0000-0002-6302-7564	Foundation for Science and Technology, Portugal [SFRH/BD/80945/2011, PTDC/MHC-PAP/5618/2014, POCI-01-0145FEDER-016836, POCI-01-0145-FEDER-016836, PTDC/MHC-PCN/3575/2012, PTDC/MHC-PCN/0522/2014, PTDC/MHC-PCN/6805/2014]; Programa COMPETE [SFRH/BD/80945/2011, PTDC/MHC-PAP/5618/2014, POCI-01-0145FEDER-016836, POCI-01-0145-FEDER-016836, PTDC/MHC-PCN/3575/2012, PTDC/MHC-PCN/0522/2014, PTDC/MHC-PCN/6805/2014]; Portuguese Foundation for Science and Technology; Portuguese Ministry of Education and Science; FEDER through COMPETE2020 under the PT2020 Partnership Agreement [UID/PSI/01662/2013, POCI-01-0145-FEDER007653]; Proaction Laboratory;  [POCI-01-0145-FEDER016836]	Foundation for Science and Technology, Portugal(Portuguese Foundation for Science and Technology); Programa COMPETE; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); Portuguese Ministry of Education and Science(Portuguese Foundation for Science and Technology); FEDER through COMPETE2020 under the PT2020 Partnership Agreement; Proaction Laboratory; 	AGA is supported by the Foundation for Science and Technology, Portugal and Programa COMPETE [grants numbers SFRH/BD/80945/2011, PTDC/MHC-PAP/5618/2014 (POCI-01-0145FEDER-016836); http://www.poci-compete2020.pt/].JA is supported by the Foundation for Science and Technology, Portugal and Programa COMPETE [grants numbers PTDC/MHC-PAP/5618/2014 (POCI-01-0145-FEDER-016836), PTDC/MHC-PCN/3575/2012, PTDC/MHC-PCN/0522/2014, PTDC/MHC-PCN/6805/2014; https://www.fct.pt/index.phtml.en].The Cognitive and Behavioral Center for Research and Intervention of the Faculty of Psychology and Educational Sciences of the University of Coimbra is supported by the Portuguese Foundation for Science and Technology and the Portuguese Ministry of Education and Science through national funds and co-financed by FEDER through COMPETE2020 under the PT2020 Partnership Agreement [UID/PSI/01662/2013; https://www.portugal2020.pt].The Psychology Research Centre of the University of Minho is supported by the Portuguese Foundation for Science and Technology and the Portuguese Ministry of Education and Science through national funds and co-financed by FEDER through COMPETE2020 under the PT2020 Partnership Agreement (POCI-01-0145-FEDER007653). The Proaction Laboratory and the PTDC/MHC-PAP/5618/2014 (POCI-01-0145-FEDER016836) directly supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abend R, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.197; Adhikari A, 2015, NATURE, V527, P179, DOI 10.1038/nature15698; Ahs F, 2015, NEUROIMAGE, V122, P262, DOI 10.1016/j.neuroimage.2015.07.051; Alberini CM, 2013, CURR BIOL, V23, pR746, DOI 10.1016/j.cub.2013.06.046; Almeida J, 2017, CORTEX, V94, P176, DOI 10.1016/j.cortex.2017.07.001; Ardolino G, 2005, J PHYSIOL-LONDON, V568, P653, DOI 10.1113/jphysiol.2005.088310; Asthana Manish, 2013, Front Psychiatry, V4, P107, DOI 10.3389/fpsyt.2013.00107; Bell CC., 1994, JAMA-J AM MED ASSOC, V272, P828, DOI [10.1001/jama.1994.03520100096046, DOI 10.1001/JAMA.1994.03520100096046]; BINDMAN LJ, 1962, NATURE, V196, P584, DOI 10.1038/196584a0; Boddez Y, 2013, J BEHAV THER EXP PSY, V44, P201, DOI 10.1016/j.jbtep.2012.08.003; Boucsein W, 2012, PSYCHOPHYSIOLOGY, V49, P1017, DOI 10.1111/j.1469-8986.2012.01384.x; Boucsein W, 2012, ELECTRODERMAL ACTIVITY, SECOND EDITION, P1, DOI 10.1007/978-1-4614-1126-0; BROWN TA, 1995, J CONSULT CLIN PSYCH, V63, P408, DOI 10.1037/0022-006X.63.3.408; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Canavarro C, 2007, AVALIACAO PSICOLOGIC, P305; Dittert N, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00076; Dunsmoor JE, 2015, BIOL PSYCHIAT, V78, P203, DOI 10.1016/j.biopsych.2014.12.008; Dymond S, 2015, BEHAV THER, V46, P561, DOI 10.1016/j.beth.2014.10.001; Feeser M, 2014, BRAIN STIMUL, V7, P105, DOI 10.1016/j.brs.2013.08.006; Frijda NH, 2010, BIOL PSYCHOL, V84, P570, DOI 10.1016/j.biopsycho.2010.01.005; Ganho-Avila A, 2019, MEAS EVAL COUNS DEV, V52, P223, DOI 10.1080/07481756.2019.1594916; Golkar A, 2017, BEHAV RES THER, V92, P87, DOI 10.1016/j.brat.2017.02.004; Heeren A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124182; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; Ironside M, 2016, BIOL PSYCHIAT, V79, P823, DOI 10.1016/j.biopsych.2015.06.012; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; KELLER MB, 1994, J NERV MENT DIS, V182, P290, DOI 10.1097/00005053-199405000-00007; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Krause MR, 2017, CURR BIOL, V27, P3086, DOI 10.1016/j.cub.2017.09.020; Kronberg G, 2017, BRAIN STIMUL, V10, P51, DOI 10.1016/j.brs.2016.10.001; Krypotos AM, 2014, CLIN PSYCHOL SCI, V2, P336, DOI 10.1177/2167702613503139; Krypotos AM, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00189; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; Lang P. J., INT AFFECTIVE DIGITI; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; Lebron-Milad K, 2012, BIOL MOOD ANXIETY DI, V2, DOI [10.1186/2045-5380-2-7, 10.1186/2045-5380-2-3]; Lefaucheur JP, 2017, CLIN NEUROPHYSIOL, V128, P56, DOI 10.1016/j.clinph.2016.10.087; Lonsdorf TB, 2019, BIOL PSYCHIAT, V85, P1074, DOI 10.1016/j.biopsych.2019.02.011; Lonsdorf TB, 2017, NEUROSCI BIOBEHAV R, V77, P247, DOI 10.1016/j.neubiorev.2017.02.026; Luyten L, 2017, NEUROBIOL LEARN MEM, V144, P208, DOI 10.1016/j.nlm.2017.07.014; Marquez-Ruiz J, 2012, P NATL ACAD SCI USA, V109, P6710, DOI 10.1073/pnas.1121147109; Mauss I, 2009, COGNITION EMOTION, V23, P209, DOI 10.1080/02699930802204677; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Moors A, 2006, PSYCHOL BULL, V132, P297, DOI 10.1037/0033-2909.132.2.297; Morriss J, 2015, BIOL MOOD ANXIETY DI, V5, DOI 10.1186/s13587-015-0019-8; Mungee A, 2016, BRAIN SCI, V6, DOI 10.3390/brainsci6040055; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Rinck M, 2007, J BEHAV THER EXP PSY, V38, P105, DOI 10.1016/j.jbtep.2006.10.001; Rusticus SA, 2015, PRACTICAL ASSESSMENT, V19; Schiller D, 2013, P NATL ACAD SCI USA, V110, P20040, DOI 10.1073/pnas.1320322110; Schroyens N, 2017, FRONT BEHAV NEUROSCI, V11, DOI [10.3309/fnbeh.2017.00065, 10.3389/fnbeh.2017.00065]; Shiozawa P, 2014, J DEPRESSION ANXIETY, P1; Shiozawa P, 2014, BIOL PSYCHIAT, V75, pE17, DOI 10.1016/j.biopsych.2013.07.014; SOLOMON RL, 1953, J ABNORM SOC PSYCH, V48, P291, DOI 10.1037/h0058943; Spielberger C. D., 1989, STATE TRAIT ANXIETY; Thair H, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00641; van 't Wout M, 2016, BRAIN STIMUL, V9, P531, DOI 10.1016/j.brs.2016.03.004; Vervliet B, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00351; Vidal-Gonzalez I, 2006, LEARN MEMORY, V13, P728, DOI 10.1101/lm.306106; Voroslakos M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02928-3; Zaghi S, 2010, NEUROSCIENTIST, V16, P285, DOI 10.1177/1073858409336227; Zheng X, 2011, NEUROIMAGE, V58, P26, DOI 10.1016/j.neuroimage.2011.06.018	66	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221282	10.1371/journal.pone.0221282	http://dx.doi.org/10.1371/journal.pone.0221282			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4SI	31532768	Green Submitted, Green Published, gold			2022-12-26	WOS:000532239600006
J	Costa, J; Figueiredo, P; Nakamura, F; Rago, V; Rebelo, A; Brito, J				Costa, Julio; Figueiredo, Pedro; Nakamura, Fabio; Rago, Vincenzo; Rebelo, Antonio; Brito, Joao			Intra-individual variability of sleep and nocturnal cardiac autonomic activity in elite female soccer players during an international tournament	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; JOINT CONSENSUS STATEMENT; ATHLETIC PERFORMANCE; TRAINING LOAD; EXERCISE; RESPONSES; RECOVERY; MEDICINE; RECOMMENDATIONS; INTERVENTIONS	Purpose To describe individual sleeping patterns and nocturnal cardiac autonomic activity of National team female soccer players during an international tournament. Materials and methods Twenty elite female soccer players (aged 25.2 +/- 3.1 years) wore wrist actigraph units and heart rate (HR) monitors during night-sleep throughout 9 consecutive days (6 day-time training sessions [DT], 2 day-time matches [DM], and 1 evening-time match [EM]) of an international tournament. Training and match loads were monitored using the session-rating of perceived exertion (s-RPE) and wearable 18-Hz GPS (total distance covered [TD], training and match exposure time, and high-speed running [HSR]) to characterize training and match loads. Results Individually, s-RPE, TD, exposure time, and HSR during training sessions ranged from 20 to 680 arbitrary units (AU), 892 to 5176 m, 20 to 76 min, and 80 to 1140 m, respectively. During matches, s-RPE, TD, exposure time, and HSR ranged from 149 to 876 AU, 2236 to 11210 m, 20 to 98 min, and 629 to 3213 m, respectively. Individually, players slept less than recommended (< 7 hours) on several days of the tournament, especially after EM (n = 8; TST ranging between 6:00-6:54 h). Total sleep time coefficient of variation (CV) ranged between 3.1 and 18.7%. However, all players presented good sleep quality (i.e., sleep efficiency.75%; individual range between: 75-98%) on each day of the tournament. Most of the players presented small fluctuations in nocturnal cardiac autonomic activity (individual nocturnal heart rate variability [HRV] ranged from 3.91-5.37 ms and HRV CV ranged from 2.8-9.0%), while two players presented higher HRV CV (11.5 and 11.7%; respectively). Conclusion Overall, this study highlights the substantial individual variability in sleep and HRV measures, suggesting the adoption of an individual approach to monitor sleep, training and match loads and recovery, to better understand how players cope with highly demanding competitions.	[Costa, Julio; Rago, Vincenzo; Rebelo, Antonio] Univ Porto, Fac Sport, CIFI2D, Ctr Res Educ Innovat & Intervent Sport, Porto, Portugal; [Costa, Julio; Figueiredo, Pedro; Rago, Vincenzo; Brito, Joao] Portuguese Football Federat, FPF, Portugal Football Sch, Oeiras, Portugal; [Figueiredo, Pedro] Univ Inst Maia, Res Ctr Sports Sci Hlth Sci & Human Dev, CIDESD, ISMAI, Maia, Portugal; [Nakamura, Fabio] Associate Grad Program Phys Educ UPE UFPB, Joao Pessoa, Paraiba, Brazil	Universidade do Porto; Instituto Universitario da Maia (ISMAI)	Costa, J (corresponding author), Univ Porto, Fac Sport, CIFI2D, Ctr Res Educ Innovat & Intervent Sport, Porto, Portugal.; Costa, J (corresponding author), Portuguese Football Federat, FPF, Portugal Football Sch, Oeiras, Portugal.	jahdc@hotmail.com	Rago, Vincenzo/AAC-8370-2020; Figueiredo, Pedro/J-4178-2013; Costa, Júlio Alejandro/J-4568-2019; Brito, Joao/D-2104-2014	Rago, Vincenzo/0000-0002-9445-4008; Figueiredo, Pedro/0000-0001-5515-3694; Costa, Júlio Alejandro/0000-0002-8225-8667; Brito, Joao/0000-0003-1301-1078	FIFA Research Scholarship 2017 (International Centre for Sports Studies [CIES]); FIFA Research Scholarship 2017 (Federation Internationale de Football Association [FIFA]); Fundacao para a Ciencia e a Tecnologia [SFRH/BD/128531/2017, SFRH/BD/129324/2017]	FIFA Research Scholarship 2017 (International Centre for Sports Studies [CIES]); FIFA Research Scholarship 2017 (Federation Internationale de Football Association [FIFA]); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	FIFA Research Scholarship 2017 (International Centre for Sports Studies [CIES] and Federation Internationale de Football Association [FIFA]) funding was provided for this study. The study was also supported by two individual doctoral grants from Fundacao para a Ciencia e a Tecnologia: Julio Costa (SFRH/BD/128531/2017) and Vincenzo Rago (SFRH/BD/129324/2017).	Achten J, 2003, SPORTS MED, V33, P517, DOI 10.2165/00007256-200333070-00004; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Al Haddad H, 2009, INT J SPORT PHYSIOL, V4, P435, DOI 10.1123/ijspp.4.4.435; Alsaadi SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095824; Andersson H, 2010, SCAND J MED SCI SPOR, V20, P740, DOI 10.1111/j.1600-0838.2009.00989.x; Beato M, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01288; Bellenger CR, 2016, INT J SPORT PHYSIOL, V11, P685, DOI 10.1123/ijspp.2015-0495; BLAND JM, 1995, BRIT MED J, V310, P446, DOI 10.1136/bmj.310.6977.446; Boullosa DA, 2013, INT J SPORT PHYSIOL, V8, P400, DOI 10.1123/ijspp.8.4.400; Brandenberger G, 2005, AUTON NEUROSCI-BASIC, V121, P81, DOI 10.1016/j.autneu.2005.06.002; Breneman CB, 2019, BEHAV SLEEP MED, V17, P459, DOI 10.1080/15402002.2017.1395337; Buchheit M, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00073; Buchheit M, 2010, EUR J APPL PHYSIOL, V109, P869, DOI 10.1007/s00421-010-1422-x; Buman MP, 2011, J SLEEP RES, V20, P28, DOI 10.1111/j.1365-2869.2010.00866.x; Camm AJ, 1996, EUR HEART J, V17, P354; Claudino JG, 2019, BMJ OPEN SPORT EXERC, V5, DOI 10.1136/bmjsem-2018-000475; Costa JA, 2018, INT J SPORT PHYSIOL, V13, P638, DOI 10.1123/ijspp.2017-0681; Costa JA, 2019, INT J SPORT PHYSIOL, V14, P779, DOI 10.1123/ijspp.2018-0652; de Freitas VH, 2015, INT J SPORT PHYSIOL, V10, P553, DOI 10.1123/ijspp.2014-0365; Esco MR, 2014, J HUM KINET, V42, P103, DOI 10.2478/hukin-2014-0065; Fallon KE, 2007, BRIT J SPORT MED, V41, P41, DOI 10.1136/bjsm.2006.030999; Flatt AA, 2017, J SPORT MED PHYS FIT, V57, P907, DOI 10.23736/S0022-4707.16.06322-2; Flatt AA, 2017, J SCI MED SPORT, V20, P606, DOI 10.1016/j.jsams.2016.10.017; Flatt AA, 2017, J STRENGTH COND RES, V31, P531, DOI 10.1519/JSC.0000000000001482; Flatt AA, 2016, J STRENGTH COND RES, V30, P378, DOI 10.1519/JSC.0000000000001095; Flatt AA, 2015, INT J SPORT PHYSIOL, V10, P994, DOI 10.1123/ijspp.2014-0556; Foster C, 2001, J STRENGTH COND RES, V15, P109, DOI 10.1519/00124278-200102000-00019; Fullagar H, 2016, CHRONOBIOL INT, V33, P490, DOI 10.3109/07420528.2016.1149190; Fullagar HHK, 2016, J SPORT SCI, V34, P1333, DOI 10.1080/02640414.2015.1135249; Fullagar HHK, 2015, SPORTS MED, V45, P161, DOI 10.1007/s40279-014-0260-0; Gaudino P, 2014, INT J SPORTS MED, V35, P489, DOI 10.1055/s-0033-1355418; Gupta L, 2017, SPORTS MED, V47, P1317, DOI 10.1007/s40279-016-0650-6; GURGEL I, 2018, PROVINCIA, P1, DOI DOI 10.1080/13651501.2018.1539180; Halson SL, 2014, SPORTS MED, V44, P13, DOI 10.1007/s40279-014-0147-0; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Juliff LE, 2018, J STRENGTH COND RES, V32, P189, DOI 10.1519/JSC.0000000000001793; King M, 2009, J STRENGTH COND RES, V23, P1795, DOI 10.1519/JSC.0b013e3181b3f81f; Kolling S, 2016, CHRONOBIOL INT, V33, P73, DOI 10.3109/07420528.2015.1118384; Lastella M, 2019, SLEEP HEALTH, V5, P141, DOI 10.1016/j.sleh.2018.10.013; Lastella M, 2015, EUR J SPORT SCI, V15, P94, DOI 10.1080/17461391.2014.932016; Mah CD, 2011, SLEEP, V34, P943, DOI 10.5665/SLEEP.1132; Mann TN, 2014, SPORTS MED, V44, P1113, DOI 10.1007/s40279-014-0197-3; Meeusen R, 2013, MED SCI SPORT EXER, V45, P186, DOI 10.1249/MSS.0b013e318279a10a; Michael S, 2018, J SCI MED SPORT, V21, P1079, DOI 10.1016/j.jsams.2018.01.015; Milewski MD, 2014, J PEDIATR ORTHOPED, V34, P129, DOI 10.1097/BPO.0000000000000151; Milner CE, 2009, J SLEEP RES, V18, P272, DOI 10.1111/j.1365-2869.2008.00718.x; Mourot L, 2004, CLIN PHYSIOL FUNCT I, V24, P10, DOI 10.1046/j.1475-0961.2003.00523.x; Nakamura FY, 2016, J SPORT SCI, V34, P2262, DOI 10.1080/02640414.2016.1186282; Nakamura FY, 2018, J STRENGTH COND RES; Nedelec M, 2019, J STRENGTH COND RES, V33, P174, DOI 10.1519/JSC.0000000000002906; Nedelec M, 2018, SPORTS MED-OPEN, V4, DOI 10.1186/s40798-018-0151-2; Ohayon M, 2017, SLEEP HEALTH, V3, P6, DOI 10.1016/j.sleh.2016.11.006; Parak J., ACCURACY FIRSTBEAT B; Pichot V, 2000, MED SCI SPORT EXER, V32, P1729, DOI 10.1097/00005768-200010000-00011; Plews DJ, 2017, INT J SPORT PHYSIOL, V12, P697, DOI 10.1123/ijspp.2016-0343; Roberts SSH, 2019, BRIT J SPORT MED, V53, P513, DOI 10.1136/bjsports-2018-099322; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; Samuels C, 2008, NEUROL CLIN, V26, P169, DOI 10.1016/j.ncl.2007.11.012; Sargent C, 2016, CHRONOBIOL INT, V33, P667, DOI 10.3109/07420528.2016.1167715; Sargent C, 2014, EUR J SPORT SCI, V14, pS310, DOI 10.1080/17461391.2012.696711; Sargent C, 2014, CHRONOBIOL INT, V31, P1160, DOI 10.3109/07420528.2014.957306; Scott D, 2018, J SPORT SCI, V36, P1523, DOI 10.1080/02640414.2017.1398894; Simpson NS, 2017, SCAND J MED SCI SPOR, V27, P266, DOI 10.1111/sms.12703; Staunton C, 2017, J SCI MED SPORT, V20, P786, DOI 10.1016/j.jsams.2016.11.016; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Van Dongen HPA, 2005, J SLEEP RES, V14, P201, DOI 10.1111/j.1365-2869.2005.00453.x; VUORI I, 1988, ACTA PHYSIOL SCAND, V133, P3; Watson AM, 2017, CURR SPORT MED REP, V16, P413, DOI 10.1249/JSR.0000000000000418; Watson NF, 2015, SLEEP, V38, P843, DOI 10.5665/sleep.4716; Wong KK, 2018, RES EDUC POLICY LOCA, P1	70	25	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0218635	10.1371/journal.pone.0218635	http://dx.doi.org/10.1371/journal.pone.0218635			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527865	Green Published, gold, Green Submitted			2022-12-26	WOS:000532231400003
J	Vetrovsky, T; Siranec, M; Marencakova, J; Tufano, JJ; Capek, V; Bunc, V; Belohlavek, J				Vetrovsky, Tomas; Siranec, Michal; Marencakova, Jitka; Tufano, James J.; Capek, Vaclav; Bunc, Vaclav; Belohlavek, Jan			Validity of six consumer-level activity monitors for measuring steps in patients with chronic heart failure	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; ACTIGRAPH; PEDOMETER; ASSOCIATION; RELIABILITY; VALIDATION; ACCURACY; TRACKERS; WORN	Introduction Although numerous activity trackers have been validated in healthy populations, validation is lacking in chronic heart failure patients who normally walk at a slower pace, making it difficult for researchers and clinicians to implement activity monitors during physical activity interventions. Methods Six consumer-level activity monitors were validated in a 3-day field study in patients with chronic heart failure and healthy individuals under free living conditions. Furthermore, the same devices were evaluated in a lab-based study during treadmill walking at speeds of 2.4, 3.0, 3.6, and 4.2 km.h(-1). Concordance correlation coefficients (CCC) were used to evaluate the agreement between the activity monitors and the criterion, and mean absolute percentage errors (MAPE) were calculated to assess differences between each device and the criterion (MAPE <10% was considered as a threshold for validity). Results In the field study of healthy individuals, all but one of the activity monitors showed a substantial correlation (CCC >= 0.95) with the criterion device and MAPE <10%. In patients with heart failure, the correlation of only two activity monitors (Garmin vivofit 3 and Withings Go) was classified as at least moderate (CCC >= 0.90) and none of the devices had MAPE <10%. In the lab-based study at speeds 4.2 and 3.6 km.h(-1), all activity monitors showed substantial to almost perfect correlations (CCC >= 0.95) with the criterion and MAPE in the range 1%-3%. However, at slower speeds of 3.0 and 2.4 km.h(-1), the accuracy of all devices substantially deteriorated: their correlation with the criterion decreased below 90% and their MAPE increased to 4-8% and 10-45%, respectively. Conclusions Even though none of the tested activity monitors fall within arbitrary thresholds for validity, most of them perform reasonably well enough to be useful tools that clinicians can use to simply motivate chronic heart failure patients to walk more.	[Vetrovsky, Tomas; Marencakova, Jitka; Tufano, James J.; Bunc, Vaclav] Charles Univ Prague, Fac Phys Educ & Sport, Prague, Czech Republic; [Siranec, Michal; Belohlavek, Jan] Charles Univ Prague, Fac Med 1, Dept Med 2, Dept Cardiovasc Med, Prague, Czech Republic; [Siranec, Michal; Belohlavek, Jan] Gen Univ Hosp Prague, Prague, Czech Republic; [Capek, Vaclav] Charles Univ Prague, Fac Med 2, Prague, Czech Republic	Charles University Prague; Charles University Prague; General University Hospital Prague; Charles University Prague	Vetrovsky, T (corresponding author), Charles Univ Prague, Fac Phys Educ & Sport, Prague, Czech Republic.	tomas.vetrovsky@gmail.com	Tufano, James J/O-7363-2017; Marenčáková, Jitka/D-9406-2017; Tufano, James/AAD-4416-2019; Vetrovsky, Tomas/S-1476-2017; Capek, Vaclav/D-8555-2016	Tufano, James J/0000-0001-8325-0344; Marenčáková, Jitka/0000-0003-1981-818X; Tufano, James/0000-0001-8325-0344; Vetrovsky, Tomas/0000-0003-2529-7069; Capek, Vaclav/0000-0002-8574-7001	Charles University Grant Agency [GAUK 1302317]; Czech Health Research Council of the Ministry of Health of the Czech Republic [NV18-09-00146]	Charles University Grant Agency; Czech Health Research Council of the Ministry of Health of the Czech Republic	The study was supported by grants from Charles University Grant Agency (GAUK 1302317, https://www.cuni.cz/UKEN-753.html) and from Czech Health Research Council of the Ministry of Health of the Czech Republic (NV18-09-00146, http://www.azvcr.cz/en).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamakis M., 2017, J MOB TECHNOL MED, V6, P26, DOI [10.7309/jmtm.6.1.4, DOI 10.7309/JMTM.6.1.4]; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Alshurafa N, 2014, P INT C PERV TECHN R; An HS, 2017, EUR J SPORT SCI, V17, P360, DOI 10.1080/17461391.2016.1255261; Boudreaux BD, 2018, MED SCI SPORT EXER, V50, P624, DOI 10.1249/MSS.0000000000001471; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Chen MD, 2016, MED SCI SPORT EXER, V48, P1942, DOI 10.1249/MSS.0000000000000984; Conraads VM, 2012, EUR J HEART FAIL, V14, P451, DOI 10.1093/eurjhf/hfs048; Crouter SE, 2003, MED SCI SPORT EXER, V35, P1455, DOI 10.1249/01.MSS.0000078932.61440.A2; DeShaw K.J., 2018, J MEAS PHYS BEHAV, V1, P130, DOI [10.1123/jmpb.2018-0017, DOI 10.1123/JMPB.2018-0017]; Ehrler F, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5916; Evenson KR, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0314-1; Ferguson T, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0201-9; Figueiredo P, 2013, MED SCI SPORT EXER, V45, P415, DOI 10.1249/MSS.0b013e318277968f; Figueroa IA, 2018, INT J EXERC SCI, V2, P27; Fokkema T, 2017, MED SCI SPORT EXER, V49, P793, DOI 10.1249/MSS.0000000000001146; Harris T, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002210; Henriksen A, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9157; HOODLESS DJ, 1994, INT J CARDIOL, V43, P39, DOI 10.1016/0167-5273(94)90088-4; Jehn M, 2010, INT J SPORTS MED, V31, P186, DOI 10.1055/s-0029-1243641; John D, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18041206; John D, 2012, MED SCI SPORT EXER, V44, pS86, DOI 10.1249/MSS.0b013e3182399f5e; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Lee JA, 2015, J SPORT SCI, V33, P991, DOI 10.1080/02640414.2014.981848; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Long L, 2019, COCHRANE DB SYST REV, V8, P860; McBride GB, 2005, HAM2005062 NIWA; Moy ML, 2010, J REHABIL RES DEV, V47, P485, DOI 10.1682/JRRD.2009.07.0091; Nolte K, 2015, EUR J PREV CARDIOL, V22, P582, DOI 10.1177/2047487314526071; Panizzolo FA, 2014, J BIOMECH, V47, P3719, DOI 10.1016/j.jbiomech.2014.09.015; Paul S.S., 2015, BMJ OPEN SPORT EXERC, V1, DOI [DOI 10.1136/BMJSEM-2015-000013, 10.1136/bmjsem-2015-000013]; Piepoli MF, 2011, EUR J HEART FAIL, V13, P347, DOI 10.1093/eurjhf/hfr017; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Shoemaker MJ, 2017, CARDIOPULM PHYS THER, V28, P3; Simunek A, 2016, ACTA GYMNICA, P25, DOI [10.1016/j.jbiomech.2014.09.015, DOI 10.1016/J.JBIOMECH.2014.09.015]; Simunek A, 2019, PEDIATR EXERC SCI, V31, P130, DOI 10.1123/pes.2018-0019; Thorup CB, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-011742; Toth LP., 2018, TRANSL J AM COLL SPO, V3, P52; Treacy D, 2017, PHYS THER, V97, P581, DOI 10.1093/ptj/pzx010; Tudor-Locke C, 2014, MED SCI SPORTS EXERC, V47, P1; Van Remoortel H, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-84; Vetrovsky T, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5520-8; Vetrovsky T, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1257-x; Walsh JT, 1997, AM J CARDIOL, V79, P1364, DOI 10.1016/S0002-9149(97)00141-0; Welk GJ, 2012, MED SCI SPORT EXER, V44, pS39, DOI 10.1249/MSS.0b013e3182399d8f	46	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2019	14	9							e0222569	10.1371/journal.pone.0222569	http://dx.doi.org/10.1371/journal.pone.0222569			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JR2UL	31518367	Green Published, Green Submitted, gold			2022-12-26	WOS:000499486400001
J	Esteves, P; Dard, L; Brillac, A; Hubert, C; Sarlak, S; Rousseau, B; Dumon, E; Izotte, J; Bonneu, M; Lacombe, D; Dupuy, JW; Amoedo, N; Rossignol, R				Esteves, Pauline; Dard, Laetitia; Brillac, Aurelia; Hubert, Christophe; Sarlak, Saharnaz; Rousseau, Benoit; Dumon, Elodie; Izotte, Julien; Bonneu, Marc; Lacombe, Didier; Dupuy, Jean-William; Amoedo, Nivea; Rossignol, Rodrigue			Nuclear control of lung cancer cells migration, invasion and bioenergetics by eukaryotic translation initiation factor 3F	ONCOGENE			English	Article							METASTASIS; HALLMARKS; INDUCTION; PHENOTYPE; APOPTOSIS; PATHWAY; GROWTH; STAT3	The basic understanding of the biological effects of eukaryotic translation initiation factors (EIFs) remains incomplete, notably for their roles independent of protein translation. Different EIFs exhibit nuclear localization and DNA-related functions have been proposed, but the understanding of EIFs novel functions beyond protein translation lacks of integrative analyses between the genomic and the proteomic levels. Here, the noncanonical function of EIF3F was studied in human lung adenocarcinoma by combining methods that revealed both the protein-protein and the protein-DNA interactions of this factor. We discovered that EIF3F promotes cell metastasis in vivo. The underpinning molecular mechanisms involved the regulation of a cluster of 34 metastasis-promoting genes including Snail2, as revealed by proteomics combined with immuno-affinity purification of EIF3F and ChIP-seq/Q-PCR analyses. The interaction between EIF3F and signal transducer and activator of transcription 3 (STAT3) controlled the EIF3F-mediated increase in Snail2 expression and cellular invasion, which were specifically abrogated using the STAT3 inhibitor Nifuroxazide or knockdown approaches. Furthermore, EIF3F overexpression reprogrammed energy metabolism through the activation of AMP-activated protein kinase and the stimulation of oxidative phosphorylation. Our findings demonstrate the role of EIF3F in the molecular control of cell migration, invasion, bioenergetics, and metastasis. The discovery of a role for EIF3F-STAT3 interaction in the genetic control of cell migration and metastasis in human lung adenocarcinoma could lead to the development of diagnosis and therapeutic strategies.	[Esteves, Pauline; Dard, Laetitia; Brillac, Aurelia; Hubert, Christophe; Sarlak, Saharnaz; Rousseau, Benoit; Dumon, Elodie; Izotte, Julien; Bonneu, Marc; Lacombe, Didier; Dupuy, Jean-William; Rossignol, Rodrigue] Bordeaux Univ, 146 Rue Leo Saignat, F-33000 Bordeaux, France; [Esteves, Pauline; Dard, Laetitia; Brillac, Aurelia; Hubert, Christophe; Sarlak, Saharnaz; Dumon, Elodie; Lacombe, Didier; Rossignol, Rodrigue] INSERM U1211, F-33000 Bordeaux, France; [Rousseau, Benoit; Izotte, Julien] Univ Bordeaux, Transgen Anim Facil A2, F-33000 Bordeaux, France; [Bonneu, Marc; Dupuy, Jean-William] Funct Genom Ctr CGFB, Prote Facil, 146 Rue Leo Saignat, F-33076 Bordeaux, France; [Bonneu, Marc] Bordeaux INP, Ave Fac, F-33405 Talence, France; [Amoedo, Nivea; Rossignol, Rodrigue] Funct Genom Ctr CGFB, CELLOMET, 146 Rue Leo Saignat, F-33000 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Rossignol, R (corresponding author), Bordeaux Univ, 146 Rue Leo Saignat, F-33000 Bordeaux, France.; Rossignol, R (corresponding author), INSERM U1211, F-33000 Bordeaux, France.; Rossignol, R (corresponding author), Funct Genom Ctr CGFB, CELLOMET, 146 Rue Leo Saignat, F-33000 Bordeaux, France.	rodrigue.rossignol@u-bordeaux.fr	Dupuy, Jean-William JWD/F-5335-2012	Dupuy, Jean-William JWD/0000-0002-2448-4797; sarlak, saharnaz/0000-0001-6949-3753; Esteves, Pauline/0000-0002-4787-339X	French National Institute for Scientific and Medical Research (INSERM); Brazilian National Council for Scientific and Technological Development (CnPq); CAPES-COFECUB; Fondation ARC; French National Institute against Cancer (Inca); Ligue Regionale contre le cancer; Plan Cancer;  [H2020-MSCA-ITN-2016/722605]	French National Institute for Scientific and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Brazilian National Council for Scientific and Technological Development (CnPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES-COFECUB(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fondation ARC; French National Institute against Cancer (Inca); Ligue Regionale contre le cancer(Ligue nationale contre le cancer); Plan Cancer; 	This work was supported, in part, by the French National Institute for Scientific and Medical Research (INSERM), the Brazilian National Council for Scientific and Technological Development (CnPq), CAPES-COFECUB, Plan Cancer, Fondation ARC (N.A), French National Institute against Cancer (Inca), Ligue Regionale contre le cancer, and H2020-MSCA-ITN-2016/722605 - TRANSMIT (Translating the Role of Mitochondria in Tumorigenesis).	Aguilar E, 2016, STEM CELLS, V34, P1163, DOI 10.1002/stem.2286; Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Anjomshoaa A, 2009, BRIT J CANCER, V101, P822, DOI 10.1038/sj.bjc.6605229; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; BERNDTSON WE, 1991, J ANIM SCI, V69, P67; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Chu J, 2016, TRENDS CELL BIOL, V26, P918, DOI 10.1016/j.tcb.2016.06.005; Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, pD1100, DOI 10.1093/nar/gkw936; Dong CF, 2013, CANCER CELL, V23, P316, DOI 10.1016/j.ccr.2013.01.022; Faubert B, 2017, CELL, V171, P358, DOI 10.1016/j.cell.2017.09.019; Gao BC, 2015, BBA-GENE REGUL MECH, V1849, P753, DOI 10.1016/j.bbagrm.2014.11.006; Giese A, 1996, INT J CANCER, V67, P275, DOI 10.1002/(SICI)1097-0215(19960717)67:2<275::AID-IJC20>3.0.CO;2-9; Grossman RL, 2016, NEW ENGL J MED, V375, P1109, DOI 10.1056/NEJMp1607591; Han SY, 2018, INT J MOL MED, V42, P1644, DOI 10.3892/ijmm.2018.3733; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Henriet E, 2017, HEPATOLOGY, V66, P2016, DOI 10.1002/hep.29336; Hensley CT, 2016, CELL, V164, P681, DOI 10.1016/j.cell.2015.12.034; Higareda-Mendoza AE, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-10; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Gutierrez-Fernandez MJ, 2015, BMC BIOCHEM, V16, DOI 10.1186/s12858-015-0054-5; Jia DY, 2017, PHYS BIOL, V14, DOI 10.1088/1478-3975/aa6f90; Johnson DE, 2018, NAT REV CLIN ONCOL, V15, P234, DOI 10.1038/nrclinonc.2018.8; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kathagen-Buhmann A, 2016, NEURO-ONCOLOGY, V18, P1219, DOI 10.1093/neuonc/now024; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Liu MH, 2019, J CLIN MED, V8, DOI 10.3390/jcm8060822; Melser S, 2013, CELL METAB, V17, P719, DOI 10.1016/j.cmet.2013.03.014; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Moretti J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000545; Mori S, 2009, ONCOGENE, V28, P2796, DOI 10.1038/onc.2009.139; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Perego M, 2018, ONCOGENE, V37, P302, DOI 10.1038/onc.2017.341; Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043; Rodrigues MF, 2016, BIOCHEM J, V473, P703, DOI 10.1042/BJ20150645; Rosland GV, 2019, CANCER METAB, V7, DOI 10.1186/s40170-019-0197-8; Shi J, 2006, ONCOGENE, V25, P4923, DOI 10.1038/sj.onc.1209495; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Sinnberg T, 2016, EBIOMEDICINE, V8, P132, DOI 10.1016/j.ebiom.2016.04.037; Strudwick S, 2002, DIFFERENTIATION, V70, P10, DOI 10.1046/j.1432-0436.2002.700102.x; Stuelten CH, 2018, NAT REV CANCER, V18, P296, DOI 10.1038/nrc.2018.15; Tamura T, 2015, MOL CLIN ONCOL, V3, P217, DOI 10.3892/mco.2014.410; Taylor CA, 2007, EXP CELL RES, V313, P437, DOI 10.1016/j.yexcr.2006.09.030; Vaklavas C, 2015, CANCER BIOL THER, V16, P1471, DOI 10.1080/15384047.2015.1071729; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wen FS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034194; Williams D, 2019, CLIN EXP METASTAS, V36, P211, DOI 10.1007/s10585-019-09967-0; Wu KL, 2015, LUNG CANCER, V88, P187, DOI 10.1016/j.lungcan.2015.02.012; Zhu YX, 2016, SCI REP-UK, V6, DOI 10.1038/srep20253	51	9	9	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	3					617	636		10.1038/s41388-019-1009-x	http://dx.doi.org/10.1038/s41388-019-1009-x			20	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KG1RJ	31527668	Green Published, hybrid			2022-12-26	WOS:000509718300010
J	Orrego, LM; Cabello-Donayre, M; Vargas, P; Martinez-Garcia, M; Sanchez, C; Pineda-Molina, E; Jimenez, M; Molina, R; Perez-Victoria, JM				Orrego, Lina M.; Cabello-Donayre, Maria; Vargas, Paola; Martinez-Garcia, Marta; Sanchez, Clara; Pineda-Molina, Estela; Jimenez, Maribel; Molina, Ricardo; Perez-Victoria, Jose M.			Heme synthesis through the life cycle of the heme auxotrophic parasite Leishmania major	FASEB JOURNAL			English	Article						porphyrins; trypanosomatid protozoa; ferrochelatase; leishmaniasis	PORPHYRIN BIOSYNTHESIS; TRYPANOSOMA-CRUZI; HUMAN FERROCHELATASE; GENE-EXPRESSION; HEMOGLOBIN; RESISTANCE; PATHWAY; PROTEIN; PROMASTIGOTES; UROPORPHYRIA	Heme is an essential molecule synthetized through a broadly conserved 8-step route that has been lost in trypanosomatid parasites. Interestingly, Leishmania reacquired by horizontal gene transfer from gamma-proteobacteria the genes coding for the last 3 enzymes of the pathway. Here we show that intracellular amastigotes of Leishmania major can scavenge heme precursors from the host cell to fulfill their heme requirements, demonstrating the functionality of this partial pathway. To dissect its role throughout the L. major life cycle, the significance of L. major ferrochelatase (LmFeCH), the terminal enzyme of the route, was evaluated. LmFeCH expression in a heterologous system demonstrated its activity. Knockout promastigotes lacking imfech were not able to use the ferrochelatase substrate protoporphyrin IX as a source of heme. In vivo infection of Phlebotomus perniciosus with knockout promastigotes shows that LmFeCH is not required for their development in the sandfly. In contrast, the replication of intracellular amastigotes was hampered in vitro by the deletion of lmfech. However, LmFeCH(-/-) parasites produced disease in a cutaneous leishmaniasis murine model in a similar way as control parasites. Therefore, although L. major can synthesize de novo heme from macrophage precursors, this activity is dispensable being an unsuited target for leishmaniasis treatment.	[Orrego, Lina M.; Cabello-Donayre, Maria; Vargas, Paola; Martinez-Garcia, Marta; Sanchez, Clara; Pineda-Molina, Estela; Perez-Victoria, Jose M.] CSIC, IPBLN, PTS Granada, Granada 18016, Spain; [Jimenez, Maribel; Molina, Ricardo] Inst Salud Carlos III, Ctr Nacl Microbiol, Serv Parasitol, Unidad Entomol Med, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM)	Perez-Victoria, JM (corresponding author), CSIC, IPBLN, PTS Granada, Granada 18016, Spain.	josepv@ipb.csic.es	/AAB-5411-2019; Vargas, Paola/V-8566-2018; Zapata, Lina María Orrego/AAU-5152-2021; García, Marta Martínez/AAA-1218-2020; Donayre, María Cabello/AAB-2142-2020	/0000-0003-0552-5837; Vargas, Paola/0000-0002-9034-1006; Cabello-Donayre, Maria/0000-0002-6196-5813	Spanish Ministerio de Economia y Competitividad [SAF2016-80228-R]; Junta de Andalucia [BIO1786]; European Regional Development Fund (FEDER) from the European Union; Administrative Department of Science, Technology and Innovation (COLCIENCIAS) fellowship from the Colombian Ministerio de Ciencia, Tecnologia e Innovacion	Spanish Ministerio de Economia y Competitividad(Spanish Government); Junta de Andalucia(Junta de Andalucia); European Regional Development Fund (FEDER) from the European Union; Administrative Department of Science, Technology and Innovation (COLCIENCIAS) fellowship from the Colombian Ministerio de Ciencia, Tecnologia e Innovacion(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	The authors thank Santiago Castanys [Instituto de Parasitologia y Biomedicina Lopez-Neyra-Consejo Superior de Investigaciones Cientificas (IPBLN-CSIC)] for critical reading of the manuscript. The authors also thank Dr. Harry A. Dailey (University of Georgia, Athens, GA, USA), Stephen M. Beverley (Washington University School of Medicine, St. Louis, MO, USA), Santiago Castanys (IPBLN-CSIC) and Martin C. Taylor (London School of Hygiene and Tropical Medicine, London, United Kingdom), and Bruce Branchini (Connecticut College, New London, CT, USA) for kindly providing, respectively, the Delta hemG and Delta hemH bacteria strains, the Leishmania pXG vectors, the anti-LRos3 antibody, and the luciferase vector pTb-AMLuc used throughout this research work. The authors thank Dr. Eva Gluenz and Dr. Tom Beneke (University of Oxford, Oxford, United Kingdom) and Dr. Yvon Sterkers and Jose-Juan Lopez-Rubio (University of Montpellier, Montpellier, France) for kindly providing the plasmids and for valuable technical advice used in CRISPR/Cas9 systems. The authors also thank Miguel Angel Toro for assistance in bioinformatics tools. This work was supported by the Spanish Ministerio de Economia y Competitividad (SAF2016-80228-R to J.M.P.-V.), the Junta de Andalucia (BIO1786 to J.M.P.-V.), and European Regional Development Fund (FEDER) from the European Union to J.M.P.-V. L.M.O. is a student of the Ph.D. Biochemistry and Molecular Biology Program of the University of Granada, and recipient of an Administrative Department of Science, Technology and Innovation (COLCIENCIAS) fellowship from the Colombian Ministerio de Ciencia, Tecnologia e Innovacion. The authors declare no conflicts of interest.	Akilov OE, 2007, EXP DERMATOL, V16, P651, DOI 10.1111/j.1600-0625.2007.00578.x; Alam MZ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00033; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Alves JMP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023518; Armas AM, 2019, BIOCHIMIE, V156, P118, DOI 10.1016/j.biochi.2018.10.009; Bates PA, 2007, INT J PARASITOL, V37, P1097, DOI 10.1016/j.ijpara.2007.04.003; Beneke T, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170095; Bonday ZQ, 1997, J BIOL CHEM, V272, P21839, DOI 10.1074/jbc.272.35.21839; Burden AE, 1999, BBA-PROTEIN STRUCT M, V1435, P191, DOI 10.1016/S0167-4838(99)00196-X; Burza S, 2018, LANCET, V392, P951, DOI 10.1016/S0140-6736(18)31204-2; Cabello-Donayre M, 2020, CELL MOL LIFE SCI, V77, P1827, DOI 10.1007/s00018-019-03258-3; Cabello-Donayre M, 2016, MOL MICROBIOL, V101, P895, DOI 10.1111/mmi.13430; CAMADRO JM, 1991, BIOCHEM J, V277, P17, DOI 10.1042/bj2770017; Campos-Salinas J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002179; Campos-Salinas J, 2011, MOL MICROBIOL, V79, P1430, DOI 10.1111/j.1365-2958.2010.07531.x; Carvalho S, 2009, ACTA TROP, V109, P131, DOI 10.1016/j.actatropica.2008.10.007; Cenci U, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0664-6; CHANG CS, 1985, MOL BIOCHEM PARASIT, V16, P267, DOI 10.1016/0166-6851(85)90069-6; CHANG KP, 1975, P NATL ACAD SCI USA, V72, P2979, DOI 10.1073/pnas.72.8.2979; Huynh C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002795; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dailey HA, 2000, CELL MOL LIFE SCI, V57, P1909, DOI 10.1007/PL00000672; Dillon LAL, 2015, NUCLEIC ACIDS RES, V43, P6799, DOI 10.1093/nar/gkv656; Dutta S, 2008, EUKARYOT CELL, V7, P1146, DOI 10.1128/EC.00365-07; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Fernandes MC, 2016, MBIO, V7, DOI 10.1128/mBio.00027-16; Ghobakhloo N, 2019, TROP MED INT HEALTH, V24, P116, DOI 10.1111/tmi.13042; Ghorbani M, 2018, DRUG DES DEV THER, V12, P25, DOI 10.2147/DDDT.S146521; Ghosh S, 2012, J CLIN MICROBIOL, V50, P2774, DOI 10.1128/JCM.00966-12; Goldberg DE, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006511; Goto Y, 2017, PARASITOL RES, V116, P457, DOI 10.1007/s00436-016-5313-x; Hao GF, 2011, CHIMIA, V65, P961, DOI 10.2533/chimia.2011.961; Heinemann IU, 2008, ARCH BIOCHEM BIOPHYS, V474, P238, DOI 10.1016/j.abb.2008.02.015; Hunter GA, 2011, J PORPHYR PHTHALOCYA, V15, P350, DOI 10.1142/S108842461100332X; Inbar E, 2017, MBIO, V8, DOI [10.1128/mBio.00029-17, 10.1128/mbio.00029-17]; Jimenez MI, 1996, LANCET, V347, P264, DOI 10.1016/S0140-6736(96)90441-9; Kamhawi S, 2006, TRENDS PARASITOL, V22, P439, DOI 10.1016/j.pt.2006.06.012; Ke HJ, 2014, J BIOL CHEM, V289, P34827, DOI 10.1074/jbc.M114.615831; Kelly JX, 2003, MOL BIOCHEM PARASIT, V126, P43, DOI 10.1016/S0166-6851(02)00248-7; Koreny L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003088; Koreny L, 2010, INT J PARASITOL, V40, P149, DOI 10.1016/j.ijpara.2009.11.007; Kraeva N, 2014, MOL BIOCHEM PARASIT, V198, P11, DOI 10.1016/j.molbiopara.2014.11.002; Krishnamurthy G, 2005, J BIOL CHEM, V280, P5884, DOI 10.1074/jbc.M411845200; Lara FA, 2007, BIOCHEM BIOPH RES CO, V355, P16, DOI 10.1016/j.bbrc.2006.12.238; Lechuga GC, 2019, J DRUG TARGET, V27, P767, DOI 10.1080/1061186X.2018.1536982; Liu D, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00083; Lukes J, 2014, MOL BIOCHEM PARASIT, V195, P115, DOI 10.1016/j.molbiopara.2014.05.007; Luz NF, 2012, J IMMUNOL, V188, P4460, DOI 10.4049/jimmunol.1103072; Lwoff M., 1933, ANN I PASTEUR PARIS, V51, P703; Martinez-Garcia M, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-015-1284-5; Martins VT, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002148, 10.1371/annotation/427655ac-c278-41f5-95ca-6279c562752f]; MCGHEE RB, 1980, MICROBIOL REV, V44, P140, DOI 10.1128/MMBR.44.1.140-173.1980; McLatchie AP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002571; Mittra B, 2013, J EXP MED, V210, P401, DOI 10.1084/jem.20121368; Molina R., 1993, Research and Reviews in Parasitology, V51, P87; Molina R., 2017, METHODS SAND FLY RES; Morio F, 2008, J CLIN MICROBIOL, V46, P3845, DOI 10.1128/JCM.01098-08; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Nagaraj VA, 2017, TRENDS PARASITOL, V33, P583, DOI 10.1016/j.pt.2017.04.005; Nagaraj VA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003522; NAKAHIGASHI K, 1991, P NATL ACAD SCI USA, V88, P10520, DOI 10.1073/pnas.88.23.10520; Opperdoes FR, 2007, TRENDS PARASITOL, V23, P149, DOI 10.1016/j.pt.2007.02.004; Opperdoes Fred R., 2008, P123; Pace D, 2014, J INFECTION, V69, pS10, DOI 10.1016/j.jinf.2014.07.016; PADMANABAN G, 1989, TRENDS BIOCHEM SCI, V14, P492, DOI 10.1016/0968-0004(89)90182-5; Patzoldt WL, 2006, P NATL ACAD SCI USA, V103, P12329, DOI 10.1073/pnas.0603137103; Perez-Victoria JM, 2011, ANTIMICROB AGENTS CH, V55, P3838, DOI 10.1128/AAC.00065-11; Ponka P, 1999, AM J MED SCI, V318, P241, DOI 10.1097/00000441-199910000-00004; Qin XH, 2011, FASEB J, V25, P653, DOI 10.1096/fj.10-170811; Rastrojo A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-223; Rathnapala UL, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006396; Rochette Annie, 2008, BMC Genomics, V9, P255, DOI 10.1186/1471-2164-9-255; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Sacks D, 2001, ANNU REV MICROBIOL, V55, P453, DOI 10.1146/annurev.micro.55.1.453; Sah JF, 2002, J BIOL CHEM, V277, P14902, DOI 10.1074/jbc.M200107200; Saha S, 2019, J IMMUNOL, V202, P827, DOI 10.4049/jimmunol.1800958; SALZMAN TA, 1982, COMP BIOCHEM PHYS B, V72, P663, DOI 10.1016/0305-0491(82)90523-5; Sant'Anna C, 2009, PROTEOMICS, V9, P1782, DOI 10.1002/pmic.200800730; SASARMAN A, 1979, J GEN MICROBIOL, V113, P297, DOI 10.1099/00221287-113-2-297; SCHLEIN Y, 1994, PARASITOLOGY, V109, P23, DOI 10.1017/S0031182000077726; Sengupta S, 1999, J BIOL CHEM, V274, P2758, DOI 10.1074/jbc.274.5.2758; Soares MP, 2016, IMMUNITY, V44, P492, DOI 10.1016/j.immuni.2016.02.016; Sollelis L, 2015, CELL MICROBIOL, V17, P1405, DOI 10.1111/cmi.12456; Srivastava P, 2010, INFECT GENET EVOL, V10, P1145, DOI 10.1016/j.meegid.2010.07.009; Svarovska Anna, 2010, PLoS Negl Trop Dis, V4, pe580, DOI 10.1371/journal.pntd.0000580; Thakur AK, 2013, EXP PARASITOL, V135, P595, DOI 10.1016/j.exppara.2013.09.008; Tripodi Karina E J, 2011, Enzyme Res, V2011, P873230, DOI 10.4061/2011/873230; van Zandbergen G, 2004, J IMMUNOL, V173, P6521, DOI 10.4049/jimmunol.173.11.6521; Vasudevan D, 2016, NITRIC OXIDE-BIOL CH, V59, P54, DOI 10.1016/j.niox.2016.08.002; Vikeved E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004326; Wu B, 2013, P NATL ACAD SCI USA, V110, P7748, DOI 10.1073/pnas.1304049110; Wu B, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000475; Wu CK, 2001, NAT STRUCT BIOL, V8, P156, DOI 10.1038/84152; Zaidi A, 2015, BIOCHIMIE, V115, P120, DOI 10.1016/j.biochi.2015.05.016; Zwerschke D, 2014, BIOSCIENCE REP, V34, P391, DOI 10.1042/BSR20140081	95	8	8	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13367	13385		10.1096/fj.201901274RR	http://dx.doi.org/10.1096/fj.201901274RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31553893	Bronze			2022-12-26	WOS:000507466100027
J	Linkenauger, SA; Weser, V; Proffitt, DR				Linkenauger, Sally A.; Weser, Veronica; Proffitt, Dennis R.			Choosing efficient actions: Deciding where to walk	PLOS ONE			English	Article							ENERGY-EXPENDITURE; COST; GRADIENT; HUMANS	Humans evolved to be endurance animals. Our ancestors were persistence hunters; they would chase animals, including gazelles, until they ran them into exhaustion. Put simply, people evolved in an ecological niche that selected for endurance and efficiency of locomotion. To locomote to any destination, one could take countless different paths, each requiring different amounts of energy. Because the ground is typically not flat or homogeneous, the straight direct path is often not the most energetically efficient. For hills below 14 degrees, the direct straight path up the hill is the most energetically efficient. However, for hills above 14 degrees, walkers would minimize their absolute energy expenditure by taking a zigzagged path so that their gradient of ascension is 14 degrees [1]. In three experiments, we assessed the degree to which people make bioenergetically efficient decisions about locomotion through path selection. In Experiment 1, people were immersed into a virtual environment and adjusted the angle of ascension of a virtual path up hills of various gradients so that when taking the path, they would expend the least amount of energy when they reached the top. The second experiment was of a similar design, but was conducted in the real word. In the last experiment, in a virtual environment, participants choose between two paths up hills of various gradient, where these paths varied in the energy required for ascent. Participants made these judgements both before and after motor experience with gradient climbing on an incline trainer. For steep hills, we found that people choose much straighter paths over the bioenergetically optimal zigzagged paths. Motor experience did lead to higher probability for choosing optimal paths for steep hills, but lead to less optimal paths for shallower ones. These results show clearly that individuals show a straight path bias when deciding how to ascend hills.	[Linkenauger, Sally A.] Univ Lancaster, Dept Psychol, Lancaster, England; [Weser, Veronica; Proffitt, Dennis R.] Univ Virginia, Dept Psychol, Gilmer Hall, Charlottesville, VA 22903 USA	Lancaster University; University of Virginia	Linkenauger, SA (corresponding author), Univ Lancaster, Dept Psychol, Lancaster, England.	s.linkenauger@gmail.com		Linkenauger, Sally/0000-0002-6056-0187				Atkinson B, 2010, NZ S ISLAND; Attenborough D, 2003, THE LIFE OF MAMMALS; Bhalla M, 1999, J EXP PSYCHOL HUMAN, V25, P1076, DOI 10.1037/0096-1523.25.4.1076; BOBBERT AC, 1960, J APPL PHYSIOL, V15, P1015, DOI 10.1152/jappl.1960.15.6.1015; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; CARRIER DR, 1984, CURR ANTHROPOL, V25, P483, DOI 10.1086/203165; CAVANAGH PR, 1982, MED SCI SPORT EXER, V14, P30, DOI 10.1249/00005768-198201000-00006; CORLETT EN, 1972, APPL ERGON, V3, P195, DOI 10.1016/0003-6870(72)90100-7; Gigerenzer G., 2007, GUT FEELINGS; Gomenuka NA, 2014, SCAND J MED SCI SPOR, V24, pE165, DOI 10.1111/sms.12129; HATZE H, 1977, BIOL CYBERN, V27, P9, DOI 10.1007/BF00357705; Lin DC, 1980, THESIS; Llobera M, 2007, J THEOR BIOL, V249, P206, DOI 10.1016/j.jtbi.2007.07.020; MINETTI AE, 1994, ACTA PHYSIOL SCAND, V150, P315, DOI 10.1111/j.1748-1716.1994.tb09692.x; MINETTI AE, 1995, J APPL PHYSIOL, V79, P1698, DOI 10.1152/jappl.1995.79.5.1698; MINETTI AE, 1993, J PHYSIOL-LONDON, V472, P725, DOI 10.1113/jphysiol.1993.sp019969; Minetti AE, 2002, J APPL PHYSIOL, V93, P1039, DOI 10.1152/japplphysiol.01177.2001; Proffitt DR, 2013, ACTION SCIENCE: FOUNDATIONS OF AN EMERGING DISCIPLINE, P171; Proffitt DR, 1995, PSYCHON B REV, V2, P409, DOI 10.3758/BF03210980; Rees WG, 2004, COMPUT GEOSCI-UK, V30, P203, DOI 10.1016/j.cageo.2003.11.001; Salvendy G, 1974, INT J PROD RES, V12, P519, DOI DOI 10.1080/00207547408919572; SPARROW WA, 1994, PSYCHOPHYSIOLOGY, V31, P338, DOI 10.1111/j.1469-8986.1994.tb02442.x; Sparrow WA, 1999, HUM MOVEMENT SCI, V18, P137, DOI 10.1016/S0167-9457(99)00005-6; Sparrow WA, 1998, PSYCHON B REV, V5, P173, DOI 10.3758/BF03212943; SPARROW WA, 1987, J MOTOR BEHAV, V19, P240	25	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0219729	10.1371/journal.pone.0219729	http://dx.doi.org/10.1371/journal.pone.0219729			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6FU	31557187	Green Published, gold			2022-12-26	WOS:000532345500008
J	Banigbe, B; Audet, CM; Okonkwo, P; Arije, OO; Bassi, E; Clouse, K; Simmons, M; Aliyu, MH; Freedberg, KA; Ahonkhai, AA				Banigbe, Bolanle; Audet, Carolyn M.; Okonkwo, Prosper; Arije, Olujide O.; Bassi, Elizabeth; Clouse, Kate; Simmons, Melynda; Aliyu, Muktar H.; Freedberg, Kenneth A.; Ahonkhai, Aima A.			Effect of PEPFAR funding policy change on HIV service delivery in a large HIV care and treatment network in Nigeria	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY PROGRAMS; INFECTED PATIENTS; FINANCIAL INCENTIVES; AFRICA; TRANSITIONS; CRITERIA; ADULTS; AIDS	The transition to PEPFAR 2.0 with its focus on country ownership was accompanied by substantial funding cuts. We describe the impact of this transition on HIV care in a large network of HIV clinics in Nigeria. We surveyed 30 comprehensive HIV treatment clinics to assess services supported before (October 2013-September 2014) and after (October 2014-September 2015) the PEPFAR funding policy change, the impact of these policy changes on service delivery areas, and response of clinics to the change. We compared differences in support for staffing, laboratory services, and clinical operations pre- and post-policy change using paired t-tests. We used framework analysis to assess answers to open ended questions describing responses to the policy change. Most sites (83%, n = 25) completed the survey. The majority were public (60%, n = 15) and secondary (68%, n = 17) facilities. Clinics had a median of 989 patients in care (IQR: 543-3326). All clinics continued to receive support for first and second line antiretrovirals and CD4 testing after the policy change, while no clinics received support for other routine drug monitoring labs. We found statistically significant reductions in support for viral load testing, staff employment, defaulter tracking, and prevention services (92% vs. 64%, p = 0.02; 80% vs. 20%, 100% vs. 44%, 84% vs. 16%, respectively, p<0.01 for all) after the policy change. Service delivery was hampered by interrupted laboratory services and reduced wages and staff positions leading to reduced provider morale, and compromised quality of care. Almost all sites (96%) introduced user fees to address funding shortages. Clinics in Nigeria are experiencing major challenges in providing routine HIV services as a result of PEPFAR's policy changes. Funding cutbacks have been associated with compromised quality of care, staff shortages, and reliance on fee-based care for historically free services. Sustainable HIV services funding models are urgently needed.	[Banigbe, Bolanle; Okonkwo, Prosper; Bassi, Elizabeth] APIN Publ Hlth Initiat APIN, Abuja, Nigeria; [Audet, Carolyn M.; Clouse, Kate; Simmons, Melynda; Aliyu, Muktar H.; Ahonkhai, Aima A.] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Global Hlth, Nashville, TN 37232 USA; [Audet, Carolyn M.; Aliyu, Muktar H.] Vanderbilt Univ, Med Ctr, Dept Hlth Policy, Nashville, TN USA; [Audet, Carolyn M.] Friends Global Hlth, Maputo, Mozambique; [Arije, Olujide O.] Obafemi Awolowo Univ, Inst Publ Hlth, Ife, Nigeria; [Clouse, Kate; Ahonkhai, Aima A.] Vanderbilt Univ, Med Ctr, Div Infect Dis, Nashville, TN 37232 USA; [Freedberg, Kenneth A.; Ahonkhai, Aima A.] Massachusetts Gen Hosp, Div Infect Dis & Gen Internal Med, Boston, MA 02114 USA; [Freedberg, Kenneth A.; Ahonkhai, Aima A.] Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA; [Freedberg, Kenneth A.; Ahonkhai, Aima A.] Harvard Med Sch, Boston, MA 02115 USA; [Freedberg, Kenneth A.] Harvard Univ, Ctr AIDS Res CFAR, Boston, MA 02115 USA; [Freedberg, Kenneth A.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA USA	Vanderbilt University; Vanderbilt University; Obafemi Awolowo University; Vanderbilt University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard T.H. Chan School of Public Health	Ahonkhai, AA (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Inst Global Hlth, Nashville, TN 37232 USA.; Ahonkhai, AA (corresponding author), Vanderbilt Univ, Med Ctr, Div Infect Dis, Nashville, TN 37232 USA.; Ahonkhai, AA (corresponding author), Massachusetts Gen Hosp, Div Infect Dis & Gen Internal Med, Boston, MA 02114 USA.; Ahonkhai, AA (corresponding author), Massachusetts Gen Hosp, Med Practice Evaluat Ctr, Boston, MA 02114 USA.; Ahonkhai, AA (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	aima.a.ahonkhai@vumc.org	Arije, Olujide O/J-6002-2016	Arije, Olujide O/0000-0001-5192-3698; Ahonkhai, Aimalohi/0000-0003-0666-4767; Clouse, Kate/0000-0002-0190-7398; Ojikutu, Bisola/0000-0001-7957-8881; Aliyu, Muktar/0000-0001-9504-4679	National Institute of Allergy and Infectious Disease [K23 AI106406, R01 AI058736]; centers for disease control and prevention [NU2GGH000924]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058736, K23AI106406, R37AI058736] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); centers for disease control and prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by K23 AI106406: AA; National Institute of Allergy and Infectious Disease; https://www.niaid.nih.gov.R01 AI058736: KAF, AA; National Institute of Allergy and Infectious Disease; https://www.niaid.nih.gov.NU2GGH000924: BB, PO; centers for disease control and prevention; cdc.gov.	Ahonkhai AA, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-427; APIN Public Health Initiatives, 2018, US PRACT AR; Atun R, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.010407; Ayadi F., 2008, J SUSTAINABLE DEV AF, V10, P234; Bassett IV, 2015, CURR OPIN HIV AIDS, V10, P451, DOI 10.1097/COH.0000000000000196; Bisson GP, 2006, AIDS, V20, P1333, DOI 10.1097/01.aids.0000232245.36039.2b; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Cailhol J, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-52; Clouse K, 2017, AIDS CARE, V30, P1, DOI DOI 10.1080/09540121; Cromer C, 2004, FAMILY PLANNING GRAD; El-Sadr WM, 2017, JAMA INTERN MED, V177, P1083, DOI 10.1001/jamainternmed.2017.2158; Geng EH, 2010, JAIDS-J ACQ IMM DEF, V53, P405, DOI 10.1097/QAI.0b013e3181b843f0; Getahun H, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000391; Ghosn J, 2005, AIDS, V19, P1643, DOI 10.1097/01.aids.0000181322.17679.b2; HIV/AIDS Division Federal Ministry of Health, 2014, NAT OP PLAN EL MOTH; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Katz IT, 2015, AIDS CARE, V27, P1298, DOI 10.1080/09540121.2015.1051502; Katz IT, 2013, NEW ENGL J MED, V369, P1385, DOI 10.1056/NEJMp1310982; Kavanagh MM, 2014, JAIDS-J ACQ IMM DEF, V65, P247, DOI 10.1097/QAI.0000000000000093; Lawn SD, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-258; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; Mahal A, 2008, AIDS, V22, pS95, DOI 10.1097/01.aids.0000327629.62350.59; Medecins Sans Frontieres, 2010, NO TIM QUIT HIV AIDS; Mee P, 2008, AIDS, V22, P1971, DOI 10.1097/QAD.0b013e32830e4cd8; Mosoko JJ, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-32; Odekunle FF, 2016, PAN AFR MED J, V25, DOI 10.11604/pamj.2016.25.143.9987; PEPFAR, 2010, SUMM HIV AIDS PARTN; PEPFAR, C BUDG JUST SUPPL FI; PEPFAR, 2014, PEPFAR 3 0 CONTR EP; PEPFAR, 2016, SUST HIV EP CONTR PF; Rawizza HE, 2011, CLIN INFECT DIS, V53, P1283, DOI 10.1093/cid/cir729; Renner M., 2003, QUALITATIVE DATA ANA, P1, DOI DOI 10.1207/S15430421TIP3903; Souteyrand YP, 2008, AIDS, V22, pS161, DOI 10.1097/01.aids.0000327637.59672.02; UNAIDS, 2014, UNAIDS GAP REP; UNAIDS, 2014, 90 90 90 AMB TREATM; Vallejo A, 2006, VIRAL IMMUNOL, V19, P759, DOI 10.1089/vim.2006.19.759; Vermund SH, 2012, AIDS, V26, P1303, DOI 10.1097/QAD.0b013e3283552185; Vogus A, 2015, GLOB HEALTH-SCI PRAC, V3, P274, DOI 10.9745/GHSP-D-14-00227	38	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0221809	10.1371/journal.pone.0221809	http://dx.doi.org/10.1371/journal.pone.0221809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553735	Green Published, gold			2022-12-26	WOS:000532319200006
J	Wang, WY; Chu, CM; Wu, YS; Sung, CS; Ho, ST; Pan, HH; Wang, KY				Wang, Wei-Yun; Chu, Chi-Ming; Wu, Yi-Syuan; Sung, Chun-Sung; Ho, Shung-Tai; Pan, Hsueh-Hsing; Wang, Kwua-Yun			Evaluation of the pain intensity differences among hospitalized cancer patients based on a nursing information system	PLOS ONE			English	Article							ELECTRONIC MEDICAL-RECORDS; NUMERIC RATING-SCALE; OF-LIFE; MANAGEMENT; CARE; QUALITY; OUTCOMES; DOCUMENTATION; VARIABILITY; INPATIENTS	Evaluating the absolute difference in pain intensity and the percentage difference in pain intensity could facilitate an understanding of pain reduction among cancer patients during repeated hospitalizations. Examinations of the absolute differences in pain intensity and the percentage differences in pain intensity according to the worst pain intensity and last evaluated pain intensity before discharge are lacking. The aim of this study was to evaluate the absolute and percentage difference in pain intensities among cancer patients with moderate or severe pain from their 1st to 18th hospitalizations from 2011-2013. A population-based retrospective cohort study was conducted. Pain intensity was assessed using scales and was recorded in a nursing information system. The absolute and percentage difference in pain intensities were examined via the one-sample Kolmogorov-Smirnov test, and group differences in moderate or severe pain were evaluated with the Mann-Whitney U test. For moderate pain patients, the mean absolute difference in pain intensity was 1.52, and the percentage difference in pain intensity was 29.0%; both these values were significant. More significant changes in the absolute and percentage difference in pain intensities were associated with severe pain patients. Both the average absolute difference in pain intensity (3.09) and the percentage difference in pain intensity (38.5%) in patients with severe pain were significantly higher than the average absolute difference in pain intensity (1.52) and the percentage difference in pain intensity (29.0%) in patients with moderate pain. Cancer patients with moderate and severe pain experienced pain reductions of approximately 30% and 40%, respectively. Early pain management intervention in patients with severe pain is necessary to achieve an obvious analgesic effect, and the formula of the percentage difference in pain intensity should be incorporated into the nursing information system to alert clinicians for early detection of the effectiveness of cancer pain management.	[Wang, Wei-Yun] Triserv Gen Hosp, Dept Nursing, Taipei, Taiwan; [Wang, Wei-Yun; Pan, Hsueh-Hsing; Wang, Kwua-Yun] Natl Def Med Ctr, Sch Nursing, Taipei, Taiwan; [Chu, Chi-Ming] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Wu, Yi-Syuan] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Sung, Chun-Sung; Ho, Shung-Tai] Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Sung, Chun-Sung] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Wang, Kwua-Yun] Taipei Vet Gen Hosp, Dept Nursing, Taipei, Taiwan; [Wang, Wei-Yun] Triserv Gen Hosp, Taipei, Taiwan; [Chu, Chi-Ming; Wu, Yi-Syuan; Pan, Hsueh-Hsing] Natl Def Med Ctr, Taipei, Taiwan; [Sung, Chun-Sung; Ho, Shung-Tai; Wang, Kwua-Yun] Taipei Vet Gen Hosp, Taipei, Taiwan	Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Tri-Service General Hospital; National Defense Medical Center; Taipei Veterans General Hospital	Wang, KY (corresponding author), Natl Def Med Ctr, Sch Nursing, Taipei, Taiwan.; Wang, KY (corresponding author), Taipei Vet Gen Hosp, Dept Nursing, Taipei, Taiwan.; Wang, KY (corresponding author), Taipei Vet Gen Hosp, Taipei, Taiwan.	kywang7@vghtpe.gov.tw		Chu, Cordia/0000-0002-3683-5638; Wu, Yi-Syuan/0000-0001-9609-6489; /0000-0002-8170-5162	Tri-Service General Hospital [TSGH-C108-165]	Tri-Service General Hospital	This study was financially supported by grants from the Tri-Service General Hospital (TSGH-C108-165).	Alghadir A, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001162; Carr ECJ, 2014, J ADV NURS, V70, P1391, DOI 10.1111/jan.12301; Chauny JM, 2014, EUR J PAIN, V18, P1103, DOI 10.1002/j.1532-2149.2014.00452.x; Chen YF, 2013, THESIS NAT DIGITAL L; Costa WA, 2017, CLINICS, V72, P758, DOI 10.6061/clinics/2017(12)07; de Rond MEJ, 2000, PAIN, V89, P25, DOI 10.1016/S0304-3959(00)00344-4; DeRemer CE, 2011, SOUTH MED J, V104, P629, DOI 10.1097/SMJ.0b013e3182296f20; Dijkstra BM, 2014, EUR J PAIN, V18, P3, DOI 10.1002/j.1532-2149.2013.00337.x; Dobscha SK, 2015, PAIN MED, V16, P855, DOI 10.1111/pme.12643; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Earle CC, 2003, J CLIN ONCOL, V21, P1133, DOI 10.1200/JCO.2003.03.059; Everdingen MHJVDBV, 2007, ANN ONCOL, V18, P1437, DOI 10.1093/annonc/mdm056; Farrar JT, 2010, NAT MED, V16, P1284, DOI 10.1038/nm.2249; Farrar JT, 2010, ANESTHESIOLOGY, V112, P1464, DOI 10.1097/ALN.0b013e3181de0e6d; Farrar JT, 2003, J PAIN SYMPTOM MANAG, V25, P406, DOI 10.1016/S0885-3924(03)00162-3; Farrar JT, 2000, PAIN, V88, P287, DOI 10.1016/S0304-3959(00)00339-0; Fraenkel L, 2012, J GEN INTERN MED, V27, P555, DOI 10.1007/s11606-011-1926-z; Heden L, 2016, EUR J PAIN, V20, P223, DOI 10.1002/ejp.711; Hirschfeld G, 2013, PAIN, V154, P154, DOI 10.1016/j.pain.2012.10.008; Kim HJ, 2014, PAIN MED, V15, P2037, DOI 10.1111/pme.12578; Krebs EE, 2010, J GEN INTERN MED, V25, P194, DOI 10.1007/s11606-009-1194-3; Li TY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108432; Lucenteforte E, 2012, INTERN EMERG MED, V7, P477, DOI 10.1007/s11739-012-0815-8; Marinsek M, 2007, EUR J PAIN, V11, P773, DOI 10.1016/j.ejpain.2006.12.002; Martoni AA, 2007, ANN ONCOL, V18, P158, DOI 10.1093/annonc/mdl314; Mearis M, 2014, J PAIN SYMPTOM MANAG, V48, P451, DOI 10.1016/j.jpainsymman.2013.09.016; O'Malley AS, 2010, J GEN INTERN MED, V25, P177, DOI 10.1007/s11606-009-1195-2; Paice JA, 1997, CANCER NURS, V20, P88, DOI 10.1097/00002820-199704000-00002; Rebecca B, 2014, SUPPORT CARE CANCER, V22, P2067, DOI 10.1007/s00520-014-2191-6; Samuels JG, 2009, J NURS CARE QUAL, V24, P223, DOI 10.1097/NCQ.0b013e318194fcec; Voepel-Lewis T, 2010, AM J CRIT CARE, V19, P55, DOI 10.4037/ajcc2010624; Volkman JE, 2015, PAIN MED, V16, P1690, DOI 10.1111/pme.12753; Wang WY, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002099; Witkin LR, 2013, PAIN MED, V14, P779, DOI 10.1111/pme.12075; Wright AA, 2016, JAMA-J AM MED ASSOC, V315, P284, DOI 10.1001/jama.2015.18604; Zheng NT, 2014, J PAIN SYMPTOM MANAG, V48, P582, DOI 10.1016/j.jpainsymman.2013.11.010; Zylla D, 2014, Br J Anaesth, V113, pi109, DOI 10.1093/bja/aeu351	37	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222516	10.1371/journal.pone.0222516	http://dx.doi.org/10.1371/journal.pone.0222516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553746	Green Published, Green Submitted, gold			2022-12-26	WOS:000532319200029
J	Mahjoubi, M; Aliyu, H; Cappello, S; Naifer, M; Souissi, Y; Cowan, DA; Cherif, A				Mahjoubi, Mouna; Aliyu, Habibu; Cappello, Simone; Naifer, Mohamed; Souissi, Yasmine; Cowan, Don A.; Cherif, Ameur			The genome of Alcaligenes aquatilis strain BU33N: Insights into hydrocarbon degradation capacity	PLOS ONE			English	Article							SP-NOV.; POLLUTED SEAWATER; OIL-SPILL; CRUDE-OIL; BACTERIUM; ALGORITHM; GENE; TOOL	Environmental contamination with hydrocarbons though natural and anthropogenic activities is a serious threat to biodiversity and human health. Microbial bioremediation is considered as the effective means of treating such contamination. This study describes a biosurfactant producing bacterium capable of utilizing crude oil and various hydrocarbons as the sole carbon source. Strain BU33N was isolated from hydrocarbon polluted sediments from the Bizerte coast (northern Tunisia) and was identified as Alcaligenes aquatilis on the basis of 16S rRNA gene sequence analysis. When grown on crude oil and phenanthrene as sole carbon and energy sources, isolate BU33N was able to degrade similar to 86%, similar to 56% and 70% of TERHc, n-alkanes and phenanthrene, respectively. The draft genome sequence of the A. aquatilis strain BU33N was assembled into one scaffold of 3,838,299 bp (G+C content of 56.1%). Annotation of the BU33N genome resulted in 3,506 protein-coding genes and 56 rRNA genes. A large repertoire of genes related to the metabolism of aromatic compounds including genes encoding enzymes involved in the complete degradation of benzoate were identified. Also genes associated with resistance to heavy metals such as copper tolerance and cobalt-zinc-cadmium resistance were identified in BU33N. This work provides insight into the genomic basis of biodegradation capabilities and bioremediation/detoxification potential of A. aquatilis BU33N.	[Mahjoubi, Mouna; Naifer, Mohamed; Souissi, Yasmine; Cherif, Ameur] Univ Manouba, ISBST, BVBGR LR11ES31, Biotechpole SidiThabet, Ariana, Tunisia; [Aliyu, Habibu] Karlsruhe Inst Technol, Inst Proc Engn Life Sci Tech Biol 2, Karlsruhe, Germany; [Cappello, Simone] CNR Messina Sp San Raineri, Ist Ambiente Marino Costiero IAMC, Messina, Italy; [Cowan, Don A.] Univ Pretoria, Ctr Microbial Ecol & Genom, Pretoria, South Africa	Universite de la Manouba; Helmholtz Association; Karlsruhe Institute of Technology; Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); University of Pretoria	Cherif, A (corresponding author), Univ Manouba, ISBST, BVBGR LR11ES31, Biotechpole SidiThabet, Ariana, Tunisia.	cherif.ameur@gmail.com	Cherif, Ameur/AAC-6136-2021; Souissi, Yasmine/ABF-1356-2020; Aliyu, Habibu/AFU-6931-2022; Aliyu, Habibu/AAV-7027-2020; Cowan, Don/E-3991-2012	Aliyu, Habibu/0000-0002-9870-8167; Mahjoubi, Mouna/0000-0002-0474-1530; Souissi, Yasmine/0000-0003-3435-3165; Cowan, Don/0000-0001-8059-861X				Abbas S, 2015, ANTON LEEUW INT J G, V108, P859, DOI 10.1007/s10482-015-0540-1; Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Almagro G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115516; [Anonymous], 2009, AM J AGRIC ENV SCI; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cappello S, 2014, BRAZ J MICROBIOL, V45, P1317, DOI 10.1590/S1517-83822014000400023; Crisafi F, 2016, MAR POLLUT BULL, V106, P119, DOI 10.1016/j.marpolbul.2016.03.017; Duran RE, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00528; Euzeby JP, 1996, INT J SYST BACTERIOL, V46, P830, DOI 10.1099/00207713-46-3-830; Genovese M, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00162; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Hassanshahian M, 2014, MAR ENVIRON RES, V95, P28, DOI 10.1016/j.marenvres.2013.12.010; Head IM, 2006, NAT REV MICROBIOL, V4, P173, DOI 10.1038/nrmicro1348; Jiang Zhibing, 2010, Acta Ecologica Sinica, V30, P8; Joo HS, 2006, WATER RES, V40, P3029, DOI 10.1016/j.watres.2006.06.021; Ju SY, 2016, J BIOTECHNOL, V218, P73, DOI 10.1016/j.jbiotec.2015.12.001; KALMAN S, 1993, APPL ENVIRON MICROB, V59, P1131, DOI 10.1128/AEM.59.4.1131-1137.1993; Katoh K, 2014, METHODS MOL BIOL, V1079, P131, DOI 10.1007/978-1-62703-646-7_8; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lee I, 2016, INT J SYST EVOL MICR, V66, P1100, DOI 10.1099/ijsem.0.000760; Liu XY, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00222-16; Lu CY, 2017, INT J SYST EVOL MICR, V67, P939, DOI 10.1099/ijsem.0.001719; Macchi M, 2018, WORLD J MICROB BIOT, V34, DOI 10.1007/s11274-017-2391-6; Magthalin CJ, 2016, MATER TODAY-PROC, V3, P3697, DOI 10.1016/j.matpr.2016.11.015; Mahjoubi M, 2013, NEW BIOTECHNOL, V30, P723, DOI 10.1016/j.nbt.2013.03.004; Meier-Kolthoff JP, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-60; Nakano M, 2014, BIOCONTROL SCI, V19, P23, DOI 10.4265/bio.19.23; Niazy Z, 2016, POLLUTION, V2, P67, DOI 10.7508/pj.2016.01.007; Pal S, 2017, GENOMICS, V109, P374, DOI 10.1016/j.ygeno.2017.06.002; Paliwal V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084000; Pan XD, 2016, SCI REP-UK, V6, DOI 10.1038/srep20317; PAOLILLO M, 2019, MICROBIOLOGY RESOURC, V8, DOI DOI 10.1128/MRA.01664-18; Pinzon NM, 2009, APPL MICROBIOL BIOT, V82, P975, DOI 10.1007/s00253-009-1896-9; Rani S, 2017, MAR GENOM, V34, P19, DOI 10.1016/j.margen.2017.02.005; Rehfuss M, 2005, SYST APPL MICROBIOL, V28, P421, DOI 10.1016/j.syapm.2005.03.003; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Santisi S, 2015, BRAZ J MICROBIOL, V46, P377, DOI 10.1590/S1517-838246120131276; Schroll G, 2001, SYST APPL MICROBIOL, V24, P37, DOI 10.1078/0723-2020-00001; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Seo JS, 2009, INT J ENV RES PUB HE, V6, P278, DOI 10.3390/ijerph6010278; Serrano AE, 2017, STAND GENOMIC SCI, V12, DOI 10.1186/s40793-017-0252-4; Singha LP, 2017, GENOME ANNOUNCEMENTS, V5, DOI [10.1128/genomeA.01346-17, 10.1128/genomea.01346-17]; Stanton SL, 2013, S AFR J BOT, V86, P41, DOI 10.1016/j.sajb.2013.01.007; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Van Trappen S, 2005, INT J SYST EVOL MICR, V55, P2571, DOI 10.1099/ijs.0.63849-0; Yamanashi T, 2015, BIOSCI BIOTECH BIOCH, V79, P830, DOI 10.1080/09168451.2014.993915; Yoon SH, 2017, INT J SYST EVOL MICR, V67, P1613, DOI 10.1099/ijsem.0.001755; Youssef NH, 2004, J MICROBIOL METH, V56, P339, DOI 10.1016/j.mimet.2003.11.001	50	8	10	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0221574	10.1371/journal.pone.0221574	http://dx.doi.org/10.1371/journal.pone.0221574			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550268	Green Published, Green Submitted, gold			2022-12-26	WOS:000532307700008
J	Hassen, AM; Taye, G; Gizaw, M; Hussien, FM				Hassen, Anissa Mohammed; Taye, Girma; Gizaw, Muluken; Hussien, Foziya Mohammed			Quality of life and associated factors among patients with breast cancer under chemotherapy at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia	PLOS ONE			English	Article								Background Breast cancer is the most common cancer affecting women in Ethiopia with increasing burden, and chemotherapy treatment produces a detrimental effect on individual wellbeing. Since last few years quality of life has been the primary goal of cancer treatment, yet little research has been conducted on quality of life of breast cancer patients under chemotherapy. Objective To determine the quality of life and associated factors among patients with breast cancer under chemotherapy at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia. Methods Institution based cross-sectional study was conducted on 404 patients with breast cancer, who took at least one cycle of chemotherapy treatment using face to face interview at oncology unit of Tikur Anbessa specialized hospital day care center from February to April 2018. The validated Amharic version of European organization for research and treatment of cancer core 30 (EORTC QLQ-C30) and quality of life questionnaire specific to breast (QLQ-BR23) was used to measure health related quality of life. Both descriptive and inferential statistics were used. For the purpose of interpretation quality of life score was dichotomized in to two using the calculated mean score, which is 53 as a cutoff point, then, bi-variable and multivariable logistic regression was used to describe association between dependent and independent variables. Hence, patients who score above 53 for quality of life were considered to have good quality of life. Result Of the total sample, overall response rate was 99.77%. The average quality of life score of patients with breast cancer under chemotherapy treatment was 52.98 (SD = 25.61). Majority of patients had scored poor in emotional functioning, sexual functioning, and financial difficulties. Educational status of college and above, being divorced, higher household income, higher scores of physical and social functioning were associated with significantly improved (better) quality of life. Lower scores of fatigue, insomnia, financial difficulties and systemic therapy side effects all were associated with better scores of quality of life of breast cancer patients. Whereas, patients receiving < = 2 cycles of chemotherapy had significantly lower scores of quality of life. Conclusion and recommendation Quality of life of breast cancer patients under chemotherapy treatment is poor in comparison with the reference data and international findings. Therefore, quality of life assessment should be incorporated in patient's treatment protocol. And financial aids may significantly improve the quality of life of breast cancer patients under chemotherapy treatment.	[Hassen, Anissa Mohammed; Hussien, Foziya Mohammed] Wollo Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Dessie, Ethiopia; [Taye, Girma; Gizaw, Muluken] Addis Ababa Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Addis Ababa, Ethiopia	Addis Ababa University	Hassen, AM (corresponding author), Wollo Univ, Coll Med & Hlth Sci, Dept Publ Hlth, Dessie, Ethiopia.	anisa.moh26@gmail.com	Hussien, Foziya Mohammed/CAF-3288-2022; Mohammed, Anissa/GNP-7326-2022	Hussien, Foziya Mohammed/0000-0003-0583-5405; Mohammed, Anissa/0000-0002-1580-4269	Addis Ababa University	Addis Ababa University	The fund was obtained from Addis Ababa University. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson N, 1993, JNCI-J NATL CANCER I, V85, P78; Bekele MA, 2016, ASSESSING QUALITY LI; Costanzo E, 2007, BRIT J CANCER, V97, P7; Davies N., 2009, NURSING STANDARD, V23, P8; Dubashi B, 2010, INDIAN J CANCER, V47, P5; Ediebah D, 2014, BRIT J CANCER, V110, P7; Eisenbraun J, 2010, PHYTOMEDICINE, V18, P7; Fayers P., 2011, EORTC QLQ C30 SCORIN; Foubert J., 2006, NURSING STANDARD, V20, P8; Grabsch B, 2006, PALLIAT SUPPORT CARE, V4, P10; Haddou B, 2017, BJMMR, V21, P11; Hoyer M, 2011, ACTA ONCOL, V50, P12; International Agency For Resarch on Cancer, 2012, EST BREAST CANC INC; Ishak W, 2012, INNOV CLIN NEUROSCI, V9, P16; Jaiyesimi A, 2007, AFRICAN J MED MED SC, V36, P8; Jassim G, 2013, BMC, V13, P14; Kantelhardt E, 2014, INT J CANCER, V135, P8; Lobo S, 2014, ACTA PAUL ENFERM, V27, P6; Manandhar S, 2014, ASIAN PAC J CANCER P, V15, P5; Mohsin S, 2015, PAK ARMAED FORCES ME, V66, P5; Nakitare S., 2002, THESIS, P78; Nedjat S, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-61; Osoba D., 2011, THER ADV MED ONCOL, V3, P15; Paul B, 2002, ASSESSING QUALITY LI; Perry S, 2007, BIOPROCESS INT, V5, P14; Sabate E., 2003, ADHERENCE LONG TERM, P110; Safaee A, 2008, INDIAN J CANC, V45; Scott NW, 2008, EORTC QLQ C30 REFERE, V2nd, P427; Sharma A, 2013, INT J SURG ONCOLOGY, P6; Smets E, 1998, SUPPPORT CARE CANC, V6, P8; Tigeneh W, 2015, INT J CANC RES MOL M, P1, DOI [10.16966/2381-3318.103, DOI 10.16966/2381-3318.103]; World Health Organization, 2015, CANC GROW PUBL HLTH; World Health Organization. International Agency for Research on Cancer (IARC), 2013, LAT WORLD CANC STAT; Yan B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153714	34	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222629	10.1371/journal.pone.0222629	http://dx.doi.org/10.1371/journal.pone.0222629			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539399	gold, Green Published			2022-12-26	WOS:000532297900021
J	de Silva, JR; Amir, A; Lau, YL; Ooi, CH; Fong, MY				de Silva, Jeremy Ryan; Amir, Amirah; Lau, Yee Ling; Ooi, Choo-Huck; Fong, Mun Yik			Distribution of the Duffy genotypes in Malaysian Borneo and its relation to Plasmodium knowlesi malaria susceptibility	PLOS ONE			English	Article							BLOOD-GROUP GENOTYPE; NATURAL-SELECTION; VIVAX; DISEASE; POLYMORPHISM; HUMANS; SABAH	The Duffy blood group plays a key role in Plasmodium knowlesi and Plasmodium vivax invasion into human erythrocytes. The geographical distribution of the Duffy alleles differs between regions with the FY* A allele having high frequencies in many Asian populations, the FY*B allele is found predominately in European populations and the FY*Bes allele found predominantly in African regions. A previous study in Peninsular Malaysia indicated high homogeneity of the dominant FY* A/FY* A genotype. However, the distribution of the Duffy genotypes in Malaysian Borneo is currently unknown. In the present study, the distribution of Duffy blood group genotypes and allelic frequencies among P. knowlesi infected patients as well as healthy individuals in Malaysian Borneo were determined. A total of 79 P. knowlesi patient blood samples and 76 healthy donor samples were genotyped using allele specific polymerase chain reaction (ASP-PCR). Subsequently a P. knowlesi invasion assay was carried out on FY* AB/ FY* A and FY* A/ FY* A Duffy genotype blood to investigate if either genotype conferred increased susceptibility to P. knowlesi invasion. Our results show almost equal distribution between the homozygous FY*A/FY*A and heterozygous FY*A/ FY* B genotypes. This is in stark contrast to the Duffy distribution in Peninsular Malaysia and the surrounding Southeast Asian region which is dominantly FY*A/FY*A. The mean percent invasion of FY*A/FY*A and FY*A/FY*B blood was not significantly different indicating that neither blood group confers increased susceptibility to P. knowlesi invasion.	[de Silva, Jeremy Ryan; Amir, Amirah; Lau, Yee Ling; Fong, Mun Yik] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Ooi, Choo-Huck] Sarawak State Hlth Dept, Jalan Diplomat,Off Jalan Bako, Sarawak, Malaysia	Universiti Malaya	Fong, MY (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	fongmy@um.edu.my	Amir, Amirah/AAB-9628-2021; FONG, MUN YIK/B-5443-2010; Lau, Yee Ling/C-6996-2009	Amir, Amirah/0000-0001-9189-8925; Lau, Yee Ling/0000-0002-2037-2165	University Malaya Frontier Research Grant 2017 [FG01517AFR]; Fundamental Research Grant Scheme of the Ministry of Higher Education Malaysia [FP036-2015A]	University Malaya Frontier Research Grant 2017; Fundamental Research Grant Scheme of the Ministry of Higher Education Malaysia	MYF was funded by the University Malaya Frontier Research Grant 2017 (FG01517AFR) and Fundamental Research Grant Scheme of the Ministry of Higher Education Malaysia (FP036-2015A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24623; Anstee DJ, 2010, BLOOD, V115, P4635, DOI 10.1182/blood-2010-01-261859; Babinszki A, 1999, PRENATAL DIAG, V19, P533, DOI 10.1002/(SICI)1097-0223(199906)19:6<533::AID-PD570>3.0.CO;2-5; Barber BE, 2013, CLIN INFECT DIS, V56, P383, DOI 10.1093/cid/cis902; BARNWELL JW, 1989, J EXP MED, V169, P1795, DOI 10.1084/jem.169.5.1795; Cavasini CE, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-167; CHAUDHURI A, 1995, BLOOD, V85, P615, DOI 10.1182/blood.V85.3.615.bloodjournal853615; CUTBUSH M, 1950, HEREDITY, V4, P383, DOI 10.1038/hdy.1950.31; De Silva JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108951; Fong MY, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3118-8; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Hamblin MT, 2002, AM J HUM GENET, V70, P369, DOI 10.1086/338628; Howes RE, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1265; IKIN EW, 1951, NATURE, V168, P1077, DOI 10.1038/1681077b0; Imwong M, 2009, J CLIN MICROBIOL, V47, P4173, DOI 10.1128/JCM.00811-09; Iwamoto S, 1996, BIOCHEM BIOPH RES CO, V222, P852, DOI 10.1006/bbrc.1996.0833; Jongwutiwes S, 2004, EMERG INFECT DIS, V10, P2211, DOI 10.3201/eid1012.040293; King CL, 2011, P NATL ACAD SCI USA, V108, P20113, DOI 10.1073/pnas.1109621108; Lee JS, 2003, J IMMUNOL, V170, P5244, DOI 10.4049/jimmunol.170.10.5244; Lim KL, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1984-8; Liu Z, 2012, CHINESE MED J-PEKING, V125, P1076, DOI 10.3760/cma.j.issn.0366-6999.2012.06.021; Malaysia Ministry of Health, 2018, ZOON MAL PREV PROGR; Martins ML, 2017, MOL CELL PROBE, V35, P20, DOI 10.1016/j.mcp.2017.06.001; MASON SJ, 1977, BRIT J HAEMATOL, V36, P327, DOI 10.1111/j.1365-2141.1977.tb00656.x; MATHEW S, 1994, CYTOGENET CELL GENET, V67, P68, DOI 10.1159/000133801; MILLER LH, 1975, SCIENCE, V189, P561, DOI 10.1126/science.1145213; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; Moghaddam EM, 2014, ASIAN PAC J TROP MED, V7, P202, DOI 10.1016/S1995-7645(14)60021-3; MONHATY SS, 2011, J RURAL TROP PUB HLT, V10, P53; Moyes CL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002780; Nathalang Oytip, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P204; Nathalang O, 2015, ANN LAB MED, V35, P618, DOI 10.3343/alm.2015.35.6.618; Ng OT, 2008, EMERG INFECT DIS, V14, P814, DOI 10.3201/eid1405.070863; Noizat-Pirenne F, 2013, CR BIOL, V336, P152, DOI 10.1016/j.crvi.2012.09.011; Peng C T, 2000, Kaohsiung J Med Sci, V16, P63; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Shimizu Y, 2000, HUM BIOL, V72, P511; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Singh B, 2010, Med J Malaysia, V65, P166; William T, 2011, EMERG INFECT DIS, V17, P1248, DOI 10.3201/eid1707.101017; Zhou SH, 2015, J CLIN LAB ANAL, V29, P203, DOI 10.1002/jcla.21751; Zhu HB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-27	42	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222681	10.1371/journal.pone.0222681	http://dx.doi.org/10.1371/journal.pone.0222681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536563	gold, Green Published, Green Submitted			2022-12-26	WOS:000532262800069
J	Elnaem, MH; Mohamed, MHN; Huri, HZ				Elnaem, Mohamed Hassan; Mohamed, Mohamad Haniki Nik; Huri, Hasniza Zaman			Pharmacist-led academic detailing improves statin therapy prescribing for Malaysian patients with type 2 diabetes: Quasi-experimental design	PLOS ONE			English	Article							PRIMARY-CARE; INTERVENTION; IMPACT; POPULATION; ATTAINMENT; MELLITUS; QUALITY	Objective Previous reports have highlighted the suboptimal utilization and prescription of statin therapy among patients with type 2 diabetes mellitus (T2DM) in the Malaysian clinical practice. This study aims to test the impact of a pharmacist-led academic detailing program on improving the overall statin therapy prescribing in Malaysian hospital and primary care settings. Methods As a quasi-experimental design with a control group and pre-tests., we examined 1,598 medical records of T2DM subjects in six healthcare facilities in the state of Pahang, Malaysia. In all study sites, there was a pre and post-intervention assessment of the percentage of appropriate statin therapy prescribing that complied with the clinical guidelines with no potential safety issues. The intervention was an academic detailing program offered to the health care providers in three study sites, while the other three sites served as the control group. A comparison of the overall percentage of appropriate statin therapy prescribing before and after the academic detailing was performed in all intervention and control sites. Results Overall, 797 medical records were examined in the pre-intervention phase, and 801 records were evaluated in the post-intervention phase. The academic detailing program was associated with a statistically significant difference in the proportion of appropriate statin therapy prescribing between the post-intervention phase compared to the pre-intervention phase (n = 246, 61.7% versus n = 188, 47.1%), p = 0.001. Whereas, the appropriate statin therapy prescribing in the control study sites experienced a modest change from 53.8% (214/398) to 56.7% (228/402), p = 0.220. The academic detailing showed significant increases in the proportions of appropriate statin therapy prescribing in both hospital and primary care settings. Conclusions The academic detailing program was found to be significantly associated with a positive impact on the overall statin therapy prescribing among patients with T2DM in Malaysian hospital and primary care settings.	[Elnaem, Mohamed Hassan; Mohamed, Mohamad Haniki Nik] Int Islamic Univ Malaysia, Fac Pharm, Dept Pharm Practice, Kuantan, Pahang, Malaysia; [Huri, Hasniza Zaman] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia	International Islamic University Malaysia; Universiti Malaya	Elnaem, MH (corresponding author), Int Islamic Univ Malaysia, Fac Pharm, Dept Pharm Practice, Kuantan, Pahang, Malaysia.	drmelnaem@gmail.com	HURI, HASNIZA ZAMAN/B-8612-2010; Elnaem, Mohamed Hassan/O-9248-2017	HURI, HASNIZA ZAMAN/0000-0002-6423-8515; Elnaem, Mohamed Hassan/0000-0003-0873-6541	Research Management Center, International Islamic University Malaysia [RIGS17-122-0697]	Research Management Center, International Islamic University Malaysia	This work is supported by Grant Number: RIGS17-122-0697 from Research Management Center, International Islamic University Malaysia.	Avorn J, 2017, JAMA-J AM MED ASSOC, V317, P361, DOI 10.1001/jama.2016.16036; Benedict AW, 2018, J MANAG CARE SPEC PH, V24, P114, DOI 10.18553/jmcp.2018.24.2.114; Bucheit JD, 2018, J CLIN LIPIDOL, V12, P367, DOI 10.1016/j.jacl.2017.11.010; Costa JD, 2016, J PHARM HEALTH SERV, V7, P105, DOI 10.1111/jphs.12133; Doellner JF, 2017, J AM PHARM ASSOC, V57, pS197, DOI 10.1016/j.japh.2017.03.002; Elnaem MH, 2017, TROP J PHARM RES, V16, P3005, DOI 10.4314/tjpr.v16i12.27; Elnaem MH, 2019, THER CLIN RISK MANAG, V15, P137, DOI 10.2147/TCRM.S182716; Elnaem MH, 2018, J EVAL CLIN PRACT, V24, P521, DOI 10.1111/jep.12903; Falk E, 2017, ATHEROSCLEROSIS, V262, P198, DOI 10.1016/j.atherosclerosis.2017.02.006; Fischer MA, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0785-8; Gil-Guillen V, 2015, BRIT J GEN PRACT, V65, pE32, DOI 10.3399/bjgp15X683137; Godman B, 2015, EXPERT REV PHARM OUT, V15, P323, DOI 10.1586/14737167.2015.967221; James P, 2004, DIABETIC MED, V21, P1108, DOI 10.1111/j.1464-5491.2004.01301.x; Kuiper JG, 2017, CLIN THER, V39, P819, DOI 10.1016/j.clinthera.2017.03.001; Lama S, 2017, INT J CLIN PHARM-NET, V39, P919, DOI 10.1007/s11096-017-0483-x; Lowrie R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113370; Malaysian Clinical Practice Guideline, 2015, MANAGEMENT TYPE 2 DI, P1; Naughton C, 2007, FAM PRACT, V24, P475, DOI 10.1093/fampra/cmm044; Naugler C, 2017, CAN J CARDIOL, V33, P682, DOI 10.1016/j.cjca.2017.02.005; Renner HM, 2017, J AM PHARM ASSOC, V57, pS236, DOI 10.1016/j.japh.2017.04.009; Said AH, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013573; Simon SR, 2005, AM J MED, V118, P521, DOI 10.1016/j.amjmed.2004.12.023; Siti Fauziah A, 2014, MALAYSIAN STAT MED 2; Thomas JS, 2015, QJM-INT J MED, V108, P369, DOI 10.1093/qjmed/hcu213; Tunney RK, 2017, ANN PHARMACOTHER, V51, P394, DOI 10.1177/1060028016687322; Wander GS, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0519-1; Wisniewski CS, 2014, AM J HEALTH-SYST PH, V71, P128, DOI 10.2146/ajhp130225	27	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0220458	10.1371/journal.pone.0220458	http://dx.doi.org/10.1371/journal.pone.0220458			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536502	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000532262800013
J	Maheshwari, P; Kummari, D; Palakolanu, SR; Tejaswi, UN; Nagaraju, M; Rajasheker, G; Jawahar, G; Jalaja, N; Rathnagiri, P; Kishor, PBK				Maheshwari, P.; Kummari, Divya; Palakolanu, Sudhakar Reddy; Tejaswi, U. Nagasai; Nagaraju, M.; Rajasheker, G.; Jawahar, G.; Jalaja, N.; Rathnagiri, P.; Kishor, P. B. Kavi			Genome-wide identification and expression profile analysis of nuclear factor Y family genes in Sorghum bicolor L. (Moench)	PLOS ONE			English	Article							TIME PCR DATA; TRANSCRIPTION FACTOR; DROUGHT TOLERANCE; ABSCISIC-ACID; REGULATORY ELEMENTS; BINDING; STRESS; OVEREXPRESSION; SIGNAL; ABA	Members of the plant Heme Activator Protein (HAP) or NUCLEAR FACTOR Y (NF-Y) are trimeric transcription factor complexes composed of the NF-YA, NF-YB and NF-YC subfamilies. They bind to the CCAAT box in the promoter regions of the target genes and regulate gene expressions. Plant NF-Ys were reported to be involved in adaptation to several abiotic stresses as well as in development. In silico analysis of Sorghum bicolor genome resulted in the identification of a total of 42 NF-Y genes, among which 8 code for the SbNF-YA, 19 for SbNF-YB and 15 for the SbNF-YC subunits. Analysis was also performed to characterize gene structures, chromosomal distribution, duplication status, protein subcellular localizations, conserved motifs, ancestral protein sequences, miRNAs and phylogenetic tree construction. Phylogenetic relationships and ortholog predictions displayed that sorghum has additional NF-YB genes with unknown functions in comparison with Arabidopsis. Analysis of promoters revealed that they harbour many stress-related cis-elements like ABRE and HSE, but surprisingly, DRE and MYB elements were not detected in any of the subfamilies. SbNF-YA1, 2, and 6 were found upregulated under 200 mM salt and 200 mM mannitol stresses. While NF-YA7 appeared associated with high temperature (40 degrees C) stress, NF-YA8 was triggered by both cold (4 degrees C) and high temperature stresses. Among NF-YB genes, 7, 12, 15, and 16 were induced under multiple stress conditions such as salt, mannitol, ABA, cold and high temperatures. Likewise, NF-YC 6, 11, 12, 14, and 15 were enhanced significantly in a tissue specific manner under multiple abiotic stress conditions. Majority of the mannitol (drought)-inducible genes were also induced by salt, high temperature stresses and ABA. Few of the high temperature stress-induced genes are also induced by cold stress (NF-YA2, 4, 6, 8, NF-YB2, 7, 10, 11, 12, 14, 16, 17, NF-YC4, 6, 12, and 13) thus suggesting a cross talk among them. This work paves the way for investigating the roles of diverse sorghum NF-Y proteins during abiotic stress responses and provides an insight into the evolution of diverse NF-Y members.	[Maheshwari, P.; Nagaraju, M.; Rajasheker, G.; Jawahar, G.; Kishor, P. B. Kavi] Osmania Univ, Dept Genet, Hyderabad, India; [Kummari, Divya; Palakolanu, Sudhakar Reddy] Int Crops Res Inst Semi Arid Trop, Hyderabad, India; [Tejaswi, U. Nagasai; Jalaja, N.] Vignans Fdn Sci Technol & Res, Dept Biotechnol, Guntur, Andhra Pradesh, India; [Nagaraju, M.] ICMR Natl Inst Nutr, Dept Biochem, Hyderabad, India; [Rathnagiri, P.] Genomix CARL Pvt Ltd, Rayalapuram Rd, Kadapa, Andhra Pradesh, India; [Rathnagiri, P.] Genomix Mol Diagnost Pvt Ltd, Hyderabad, India; [Rathnagiri, P.] Genomix Biotech Inc, Atlanta, GA USA	Osmania University; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Vignan's Foundation for Science, Technology & Research (VFSTR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Nutrition (NIN)	Kishor, PBK (corresponding author), Osmania Univ, Dept Genet, Hyderabad, India.	pbkavi@yahoo.com	MARKA, NAGARAJU/Y-7001-2019	Gandra, Jawahar/0000-0003-1217-676X; Kavi Kishor, Polavarapu/0000-0002-9587-7547; Marka, Nagaraju/0000-0002-9170-8543	Council of Scientific and Industrial Research (CSIR), New Delhi, India [381/1442/17/EMR-II, 38(1325)/12/EMR-II]; CSIR; CSIR, New Delhi; UGC, New Delhi; DST-SERB, New Delhi	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); CSIR, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); UGC, New Delhi(University Grants Commission, India); DST-SERB, New Delhi	This project was financially supported by the Council of Scientific and Industrial Research (CSIR), New Delhi, India (through grant numbers 381/1442/17/EMR-II and 38(1325)/12/EMR-II). We have received financial support from CSIR for the year 2018-2019. For the current financial year 2019-2020, we have not yet received financial support from CSIR. The company Genomix Molecular Diagnostics Pvt Ltd., Kukatpally, Hyderabad, India, provided support in the form of salary for Dr. Rathnagiri Polavarapu (RP). Maheshwari acknowledges the financial support from the CSIR, New Delhi, for Research Associateship. Jawahar acknowledges the financial support from UGC, New Delhi. RG acknowledges the financial support from DST-SERB, New Delhi. The specific roles of this author are articulated in the 'author contributions' section. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; PBK is thankful to the CSIR, New Delhi for providing Research Grant and CSIR-Emeritus Fellowship. Maheshwari acknowledges the financial support from the CSIR, New Delhi, for Research Associateship. Jawahar acknowledges the financial support from UGC, New Delhi. RG acknowledges the financial support from DST-SERB, New Delhi. We thank Dr. Prashanth Suravajhala, BISR, Jaipur for his critical comments.	Alam MM, 2015, PLANT BIOTECHNOL J, V13, P85, DOI 10.1111/pbi.12239; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Ballif J, 2011, PLANT PHYSIOL BIOCH, V49, P579, DOI 10.1016/j.plaphy.2011.01.013; Batistic O, 2009, BBA-MOL CELL RES, V1793, P985, DOI 10.1016/j.bbamcr.2008.10.006; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Cao SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021805; CARAS IW, 1987, SCIENCE, V238, P1280, DOI 10.1126/science.2446389; Chen M, 2014, PLANT BIOTECHNOL J, V12, P447, DOI [10.1111/pbi.12151, 10.1111/pbi.12270]; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Dai Xinbin, 2011, Nucleic Acids Res, V39, pW155, DOI 10.1093/nar/gkr319; E ZG, 2018, J EXP BOT, V69, P2495, DOI 10.1093/jxb/ery087; Fang YJ, 2014, J EXP BOT, V65, P2119, DOI 10.1093/jxb/eru072; Fedorova L, 2003, GENETICA, V118, P123, DOI 10.1023/A:1024145407467; Feng ZJ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01142; Frontini M, 2004, CELL CYCLE, V3, P217; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Barbosa EGG, 2013, PLANT MOL BIOL REP, V31, P719, DOI 10.1007/s11105-012-0541-4; Gu ZL, 2002, MOL BIOL EVOL, V19, P256, DOI 10.1093/oxfordjournals.molbev.a004079; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Chu HD, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113290; Hackenberg D, 2012, MOL PLANT, V5, P876, DOI 10.1093/mp/ssr107; HAHN S, 1988, MOL CELL BIOL, V8, P655, DOI 10.1128/MCB.8.2.655; Han X, 2013, J EXP BOT, V64, P4589, DOI 10.1093/jxb/ert262; Han ZM, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.02045, 10.3389/fpls.2015.01270, 10.3389/fpls.2016.01270, 10.3389/fpls.2016.01814]; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang MK, 2015, PLANT CELL, V27, P3099, DOI 10.1105/tpc.15.00750; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Kim IS, 1996, MOL CELL BIOL, V16, P4003; Kim JS, 2011, PLANT CELL PHYSIOL, V52, P2136, DOI 10.1093/pcp/pcr143; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; Koralewski TE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018055; Kwong RW, 2003, PLANT CELL, V15, P5, DOI 10.1105/tpc.006973; Laloum T, 2013, TRENDS PLANT SCI, V18, P157, DOI 10.1016/j.tplants.2012.07.004; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Letunic I, 2004, NUCLEIC ACIDS RES, V32, pD142, DOI 10.1093/nar/gkh088; Li LL, 2013, PLANTA, V238, P345, DOI 10.1007/s00425-013-1894-0; Li S, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2334-2; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Liang MX, 2014, PLANTA, V239, P107, DOI 10.1007/s00425-013-1964-3; Liu JX, 2010, PLANT CELL, V22, P782, DOI 10.1105/tpc.109.072173; Mace ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3320; Malviya N, 2016, PHYSIOL MOL BIOL PLA, V22, P33, DOI 10.1007/s12298-016-0349-z; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Nekrutenko A, 2003, GENE, V306, P99, DOI 10.1016/S0378-1119(03)00427-X; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Ni ZY, 2013, PLANT MOL BIOL, V82, P113, DOI 10.1007/s11103-013-0040-5; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pereira SLS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199187; Petroni K, 2012, PLANT CELL, V24, P4777, DOI 10.1105/tpc.112.105734; Quach T, 2015, MOL GENET GENOMICS, V290, P1095, DOI 10.1007/s00438-014-0978-2; Reddy PS, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00529; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Roy SW, 2006, NAT REV GENET, V7, P211, DOI 10.1038/nrg1807; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Siefers N, 2009, PLANT PHYSIOL, V149, P625, DOI 10.1104/pp.108.130591; Sorin C, 2014, NEW PHYTOL, V202, P1197, DOI 10.1111/nph.12735; Soyano T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003352; Steidl S, 2004, J MOL BIOL, V342, P515, DOI 10.1016/j.jmb.2004.07.011; Stephenson TJ, 2007, PLANT MOL BIOL, V65, P77, DOI 10.1007/s11103-007-9200-9; Stephenson TJ, 2011, FUNCT INTEGR GENOMIC, V11, P327, DOI 10.1007/s10142-011-0212-9; Stief A, 2014, PLANT CELL, V26, P1792, DOI 10.1105/tpc.114.123851; Sun XC, 2014, GENE, V551, P214, DOI 10.1016/j.gene.2014.08.059; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Testa A, 2005, J BIOL CHEM, V280, P13606, DOI 10.1074/jbc.M414039200; Thirumurugan T, 2008, MOL GENET GENOMICS, V279, P279, DOI 10.1007/s00438-007-0312-3; Tuberosa R, 2002, ANN BOT-LONDON, V89, P941, DOI 10.1093/aob/mcf134; Van Ha C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114107; Wang Y, 2018, PLANTA, V247, P559, DOI 10.1007/s00425-017-2809-2; Warpeha KM, 2007, PLANT PHYSIOL, V143, P1590, DOI 10.1104/pp.106.089904; Washida H, 1999, PLANT MOL BIOL, V40, P1, DOI 10.1023/A:1026459229671; XING YY, 1993, EMBO J, V12, P4647, DOI 10.1002/j.1460-2075.1993.tb06153.x; Xu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111354; Xu Q, 2013, NAT GENET, V45, P59, DOI 10.1038/ng.2472; Hoang XLT, 2017, CURR GENOMICS, V18, P483, DOI [10.2174/1389101918666170227150057, 10.2174/1389202918666170227150057]; Yan DH, 2013, PLANT MOL BIOL REP, V31, P363, DOI 10.1007/s11105-012-0508-5; Yan HR, 2014, PLANT CELL PHYSIOL, V55, P2060, DOI 10.1093/pcp/pcu133; Yang J, 2016, BIOL PLANTARUM, V60, P419, DOI 10.1007/s10535-016-0624-4; Yang SH, 2008, MOL GENET GENOMICS, V280, P187, DOI 10.1007/s00438-008-0355-0; Yang WJ, 2017, CROP J, V5, P21, DOI 10.1016/j.cj.2016.06.014; Yang X, 2011, PLANT PHYSIOL, V156, P1397, DOI 10.1104/pp.111.173427; Zhang F, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00642; Zhang HW, 2014, MOL PLANT, V7, P1522, DOI 10.1093/mp/ssu063; Zhang T, 2015, PLANT PHYSIOL BIOCH, V94, P153, DOI 10.1016/j.plaphy.2015.05.001; Zhang XH, 2011, BIOTECHNOL LETT, V33, P403, DOI 10.1007/s10529-010-0436-0; Zhao BT, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-29	90	14	17	7	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222203	10.1371/journal.pone.0222203	http://dx.doi.org/10.1371/journal.pone.0222203			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536532	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000532262800029
J	Tamaki, S; Kanazawa, A; Sato, J; Tamura, Y; Asahara, T; Takahashi, T; Matsumoto, S; Yamashiro, Y; Watada, H				Tamaki, Shoko; Kanazawa, Akio; Sato, Junko; Tamura, Yoshifumi; Asahara, Takashi; Takahashi, Takuya; Matsumoto, Satoshi; Yamashiro, Yuichiro; Watada, Hirotaka			Clinical factors associated with bacterial translocation in Japanese patients with type 2 diabetes: A retrospective study	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; CHAIN FATTY-ACIDS; MECHANISMS; SECRETION; OBESITY	Objective To explore clinical factors associated with bacterial translocation in Japanese patients with type 2 diabetes mellitus (T2DM). Methods The data of 118 patients with T2DM were obtained from two previous clinical studies, and were retrospectively analyzed regarding the clinical parameters associated with bacterial translocation defined as detection of bacteremia and levels of plasma lipopolysaccharide binding protein (LBP), the latter of which is thought to reflect inflammation caused by endotoxemia. Results LBP level was not significantly different between patients with and without bacteremia. No clinical factors were significantly correlated with the detection of bacteremia. On the other hand, plasma LBP level was significantly correlated with HbA1c (r = 0.312), fasting blood glucose (r = 0.279), fasting C-peptide (r = 0.265), body mass index (r = 0.371), high-density lipoprotein cholesterol (r = -0.241), and inflammatory markers (high-sensitivity C-reactive protein, r = 0.543; and interleukin-6, r = 0.456). Multiple regression analysis identified body mass index, HbA1c, high-sensitivity C-reactive protein, and interleukin-6 as independent determinants of plasma LBP level. Conclusion The plasma LBP level was similar in patients with and without bacteremia. While both bacteremia and LBP are theoretically associated with bacterial translocation, the detection of bacteremia was not associated with LBP level in T2DM.	[Tamaki, Shoko; Kanazawa, Akio; Sato, Junko; Tamura, Yoshifumi; Watada, Hirotaka] Juntendo Univ, Dept Metab & Endocrinol, Grad Sch Med, Tokyo, Japan; [Tamura, Yoshifumi; Watada, Hirotaka] Juntendo Univ, Sportol Ctr, Grad Sch Med, Tokyo, Japan; [Asahara, Takashi; Takahashi, Takuya; Matsumoto, Satoshi; Yamashiro, Yuichiro] Juntendo Univ, Probiot Res Lab, Grad Sch Med, Tokyo, Japan; [Asahara, Takashi; Takahashi, Takuya; Matsumoto, Satoshi] Yakult Cent Inst, Tokyo, Japan; [Watada, Hirotaka] Juntendo Univ, Ctr Therapeut Innovat Diabet, Grad Sch Med, Tokyo, Japan; [Watada, Hirotaka] Juntendo Univ, Ctr Identificat Diabet Therapeut Targets, Grad Sch Med, Tokyo, Japan	Juntendo University; Juntendo University; Juntendo University; Yakult Honsha Company, Limited; Juntendo University; Juntendo University	Kanazawa, A (corresponding author), Juntendo Univ, Dept Metab & Endocrinol, Grad Sch Med, Tokyo, Japan.	akana@juntendo.ac.jp	Sato, Junko/GQQ-8846-2022; Tamura, Yoshifumi/AFK-2430-2022	Tamura, Yoshifumi/0000-0002-1685-7821; Sato, Junko/0000-0002-9784-5362				Amar J, 2011, DIABETOLOGIA, V54, P3055, DOI 10.1007/s00125-011-2329-8; Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Balzan S, 2007, J GASTROEN HEPATOL, V22, P464, DOI 10.1111/j.1440-1746.2007.04933.x; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Christiansen CB, 2018, AM J PHYSIOL-GASTR L, V315, pG53, DOI 10.1152/ajpgi.00346.2017; Ge Q, 2012, ENDOCRINOLOGY, V153, P5285, DOI 10.1210/en.2012-1623; Lecube A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023366; Moreno-Navarrete JM, 2015, DIABETOLOGIA, V58, P2424, DOI 10.1007/s00125-015-3692-7; Mehta NN, 2010, DIABETES, V59, P172, DOI 10.2337/db09-0367; Miura K, 2016, J BIOL CHEM, V291, P11504, DOI 10.1074/jbc.M115.709048; Moreno-Navarrete JM, 2012, INT J OBESITY, V36, P1442, DOI 10.1038/ijo.2011.256; Novitsky TJ, 1998, ANN NY ACAD SCI, V851, P416, DOI 10.1111/j.1749-6632.1998.tb09018.x; Peraneva L, 2013, ACTA DIABETOL, V50, P351, DOI 10.1007/s00592-012-0421-2; Sato J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12535-9; Sato J, 2014, DIABETES CARE, V37, P2343, DOI 10.2337/dc13-2817; Schumann RR, 1996, MOL CELL BIOL, V16, P3490; Sucajtys-Szulc E, 2018, MOL CELL BIOCHEM, V446, P11, DOI 10.1007/s11010-018-3268-1; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Yamashiro K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171521; Yokoyama Y, 2016, DIGEST SURG, V33, P220, DOI 10.1159/000444459	21	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222598	10.1371/journal.pone.0222598	http://dx.doi.org/10.1371/journal.pone.0222598			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536546	Green Submitted, Green Published, gold			2022-12-26	WOS:000532262800060
J	Yang, J; Pak, JH; Maki, M; Kim, SC				Yang, JiYoung; Pak, Jae-Hong; Maki, Masayuki; Kim, Seung-Chul			Multiple origins and the population genetic structure of Rubus takesimensis (Rosaceae) on Ulleung Island: Implications for the genetic consequences of anagenetic speciation	PLOS ONE			English	Article							JUAN FERNANDEZ ARCHIPELAGO; NONCODING REGIONS; SUBGENUS RUBUS; MOLECULAR-DATA; ULLUNG ISLAND; ASTERACEAE; DIVERSITY; NUCLEAR; EVOLUTION; PHYLOGENY	To determine the origin and genetic consequences of anagenesis in Rubus takesimensis on Ulleung Island, Korea, we compared the genetic diversity and population structure of R. takesimensis with those of its continental progenitor R. crataegifolius. We broadly sampled a total of 315 accessions in 35 populations and sequenced five noncoding regions of chloroplast DNA. Rubus takesimensis emerged as nonmonophyletic and several geographically diverse continental populations were likely responsible for the origin of R. takesimensis; the majority of R. takesimensis accessions were sisters to the clade containing accessions of R. crataegifolius, primarily from the Korean peninsula, while rare accessions from three populations shared common ancestors with the ones from the southern part of the Korean peninsula, Jeju Island, and Japan. A few accessions from the Chusan population originated independently from the Korean peninsula. Of 129 haplotypes, 81 and 48 were found exclusively in R. crataegifolius and R. takesimensis, respectively. We found unusually high genetic diversity in two regions on Ulleung Island and no geographic population structure. For R. crataegifolius, two major haplotype groups were found; one for the northern mainland Korean peninsula, and the other for the southern Korean peninsula and the Japanese archipelago. Compared with populations of R. crataegifolius sampled from Japan, much higher haplotype diversity was found in populations from the Korean peninsula. The patterns of genetic consequences in R. takesimensis need to be verified for other endemic species based on chloroplast DNA and independent nuclear markers to synthesize emerging patterns of anagenetic speciation on Ulleung Island.	[Yang, JiYoung; Pak, Jae-Hong] Kyungpook Natl Univ, Res Inst Dok Do & Ulleung Do Isl, Dept Biol, Daegu, Gyeongsangbuk D, South Korea; [Maki, Masayuki] Tohoku Univ, Bot Gardens, Sendai, Miyagi, Japan; [Kim, Seung-Chul] Sungkyunkwan Univ, Dept Biol Sci, Suwon, Gyeonggi Do, South Korea	Kyungpook National University; Tohoku University; Sungkyunkwan University (SKKU)	Pak, JH (corresponding author), Kyungpook Natl Univ, Res Inst Dok Do & Ulleung Do Isl, Dept Biol, Daegu, Gyeongsangbuk D, South Korea.; Kim, SC (corresponding author), Sungkyunkwan Univ, Dept Biol Sci, Suwon, Gyeonggi Do, South Korea.	jhpak@knu.ac.kr; sonchus96@skku.edu	Kim, Seung-Chul/AAR-6157-2020	Kim, Seung-Chul/0000-0003-0559-6782	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2016R1A6A1A0511910]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), which is funded by the Ministry of Education (2016R1A6A1A0511910), to J-HP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alice LA, 1999, AM J BOT, V86, P81, DOI 10.2307/2656957; ANTONIUS K, 1994, MOL ECOL, V3, P177, DOI 10.1111/j.1365-294X.1994.tb00119.x; Asker S. E., 1992, APOMIXIS PLANTS; Barker NP, 2009, S AFR J BOT, V75, P560, DOI 10.1016/j.sajb.2009.05.006; Birky CW, 1996, GENETICS, V144, P427; Bohle UR, 1996, P NATL ACAD SCI USA, V93, P11740, DOI 10.1073/pnas.93.21.11740; Cha Jae Seok, 2010, Journal of Korean Nature, V3, P151; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Crawford Daniel J., 2016, KOREAN JOURNAL OF PLANT TAXONOMY, V46, P129, DOI 10.11110/kjpt.2016.46.2.129; Denk T, 2010, TAXON, V59, P351, DOI 10.1002/tax.592002; Eliasson U., 1974, OPERA BOTANICA SOC B, V36, P1; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fu XY, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Hamrick J. L., 1989, PLANT POPULATION GEN, P43; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Han J-S, 2014, COLLECTION TREATISES, V41, P131; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hart MW, 2007, BIOL LETTERS, V3, P509, DOI 10.1098/rsbl.2007.0307; HERRERA CM, 1984, ECOL MONOGR, V54, P1, DOI 10.2307/1942454; Hoerandl Elvira, 2007, V147, P169; ITO M, 1990, BOT MAG TOKYO, V103, P449, DOI 10.1007/BF02491263; JORDANO P, 1982, OIKOS, V38, P183, DOI 10.2307/3544018; Jorgensen TH, 2001, PERSPECT PLANT ECOL, V4, P29, DOI 10.1078/1433-8319-00013; Kim P, 2015, HIST 3 KINGDOMS SAMG; Kim SC, 1996, SYST BOT, V21, P417, DOI 10.2307/2419668; Kim SC, 1996, P NATL ACAD SCI USA, V93, P7743, DOI 10.1073/pnas.93.15.7743; Kim SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002139; Kim Y.K., 1985, J JAP ASS MINERAL PE, V80, P128, DOI DOI 10.2465/GANKO1941.80.128; Kollmann J, 2000, AM J BOT, V87, P1592, DOI 10.2307/2656735; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JH, 2013, J PLANT RES, V126, P193, DOI 10.1007/s10265-012-0519-1; Lee W, 2017, J PLANT BIOL, V60, P163, DOI 10.1007/s12374-016-0421-9; Levey D.J., 1986, Tasks for Vegetation Science, V15, P147; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lopez-Sepulveda P, 2015, SYST BOT, V40, P888, DOI 10.1600/036364415X689311; Lopez-sepulveda P, 2017, PLANT SPEC BIOL, V32, P223, DOI 10.1111/1442-1984.12144; Lopez-Sepulveda P, 2015, J PLANT RES, V128, P73, DOI 10.1007/s10265-014-0666-7; Lopez-Sepulveda P, 2013, AM J BOT, V100, P722, DOI 10.3732/ajb.1200541; MADDISON WP, 1992, MACCLADE VERSION 3 0; Majesky L, 2015, PLANT SYST EVOL, V301, P2105, DOI 10.1007/s00606-015-1218-x; Majesky L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041868; Manos PS, 2001, INT J PLANT SCI, V162, P1361, DOI 10.1086/322949; Mort ME, 2002, SYST BOT, V27, P271; Murai KI, 2018, INT J MOD PHYS B, V32, DOI 10.1142/S0217979218400374; MURRAY KG, 1993, VEGETATIO, V108, P217; Naruhashi N., 1980, Acta Horticulturae, P177; Nielsen LR, 2004, HEREDITY, V93, P434, DOI 10.1038/sj.hdy.6800520; Oh Sang-Hun, 2015, Korean Journal of Plant Taxonomy, V45, P213, DOI 10.11110/kjpt.2015.45.3.213; Pfosser M, 2005, PLANT SYST EVOL, V256, P159, DOI 10.1007/s00606-005-0374-9; Pfosser MF, 2002, SYST BOT, V27, P351; Pons O, 1996, GENETICS, V144, P1237; Pusik Kim, 2012, SILLA ANN SAMGUK SAG; Qi XS, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-41; Qi XS, 2012, NEW PHYTOL, V196, P617, DOI 10.1111/j.1469-8137.2012.04242.x; Qiu YX, 2009, NEW PHYTOL, V183, P480, DOI 10.1111/j.1469-8137.2009.02876.x; Rejmanek M, 2015, GAYANA BOT, V72, P27, DOI 10.4067/S0717-66432015000100004; ROGSTAD SH, 1991, PLANT SYST EVOL, V175, P115, DOI 10.1007/BF00937841; Sakaguchi S, 2012, MOL ECOL, V21, P3823, DOI 10.1111/j.1365-294X.2012.05652.x; SANG T, 1994, AM J BOT, V81, P1494, DOI 10.2307/2445322; SANG T, 1995, SYST BOT, V20, P55, DOI 10.2307/2419632; Sarhanova P, 2017, ANN BOT-LONDON, V120, P317, DOI 10.1093/aob/mcx033; SCHILLING EE, 1994, AM J BOT, V81, P248, DOI 10.2307/2445640; Schneider S, 1999, GENETICS, V152, P1079; Setoguchi H, 2000, AM J BOT, V87, P793, DOI 10.2307/2656887; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Simeone MC, 2013, BOT J LINN SOC, V172, P478, DOI 10.1111/boj.12059; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Snow B, 1988, BIRDS BERRIES STUDY, P60; Sochor M, 2016, BOT J LINN SOC, V181, P610, DOI 10.1111/boj.12436; Sochor M, 2015, MOL PHYLOGENET EVOL, V89, P13, DOI 10.1016/j.ympev.2015.04.007; Stuessy TF, 2007, SYST ASSOC SPEC VOL, P117; Stuessy TF, 2006, J BIOGEOGR, V33, P1259, DOI 10.1111/j.1365-2699.2006.01504.x; Stuessy TF, 2014, BOT J LINN SOC, V174, P276, DOI 10.1111/boj.12088; SUZUKI W, 1990, Plant Species Biology, V5, P263, DOI 10.1111/j.1442-1984.1990.tb00186.x; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAJIMA F, 1989, GENETICS, V123, P585; Takayama Koji, 2016, Journal of Japanese Botany, V91, P83; Takayama K, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv102; Takayama K, 2015, NEW PHYTOL, V205, P415, DOI 10.1111/nph.13000; Takayama K, 2013, J PLANT RES, V126, P323, DOI 10.1007/s10265-012-0529-z; Takayama K, 2012, ANN BOT-LONDON, V109, P321, DOI 10.1093/aob/mcr280; Thompson MM, 1995, HORTSCIENCE, V30, P1447, DOI 10.21273/HORTSCI.30.7.1447; Wang JF, 2013, J BIOGEOGR, V40, P1741, DOI 10.1111/jbi.12114; Wang Y, 2013, INT CONF MEAS, P702, DOI 10.1109/ICMTMA.2013.176; WASSMUTH R, 1999, MANUAL FLOWERING PLA, V1; Weber HE, 1996, FOLIA GEOBOT PHYTOTX, V31, P373, DOI 10.1007/BF02815381; Woong Lee, 2010, KOR J PL TAXONOMY, V40, P157; Yang J, 2012, CAN J PLANT SCI, V92, P461, DOI [10.4141/CJPS2011-180, 10.4141/cjps2011-180]; Yang JY, 2006, J PLANT BIOL, V49, P44, DOI 10.1007/BF03030787; Yu Jae-Pyoung, 2013, Journal of Asia-Pacific Biodiversity, V6, P175	94	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222707	10.1371/journal.pone.0222707	http://dx.doi.org/10.1371/journal.pone.0222707			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536553	Green Published, gold, Green Submitted			2022-12-26	WOS:000532262800074
J	Cunningham, PN; Wang, ZY; Grove, ML; Cooper-DeHoff, RM; Beitelshees, AL; Gong, Y; Gums, JG; Johnson, JA; Turner, ST; Boerwinkle, E; Chapman, AB				Cunningham, Patrick N.; Wang, Zhiying; Grove, Megan L.; Cooper-DeHoff, Rhonda M.; Beitelshees, Amber L.; Gong, Yan; Gums, John G.; Johnson, Julie A.; Turner, Stephen T.; Boerwinkle, Eric; Chapman, Arlene B.			Hypertensive APOL1 risk allele carriers demonstrate greater blood pressure reduction with angiotensin receptor blockade compared to low risk carriers	PLOS ONE			English	Article							INFLUENCING ANTIHYPERTENSIVE RESPONSE; GENOMIC ASSOCIATION ANALYSIS; PLASMA-RENIN ACTIVITY; CARDIOVASCULAR-DISEASE; KIDNEY-DISEASE; VARIANTS ASSOCIATE; AFRICAN-AMERICANS; DPP6 GENE; NEPHROPATHY; PROTEIN	Background Hypertension (HTN) disproportionately affects African Americans (AAs), who respond better to thiazide diuretics than other antihypertensives. Variants of the APOL1 gene found in AAs are associated with a higher rate of kidney disease and play a complex role in cardiovascular disease. Methods AA subjects from four HTN trials (n = 961) (GERA1, GERA2, PEAR1, and PEAR2) were evaluated for blood pressure (BP) response based on APOL1 genotype after 4-9 weeks of monotherapy with thiazides, beta blockers, or candesartan. APOL1 G1 and G2 variants were determined by direct sequencing or imputation. Results Baseline systolic BP (SBP) and diastolic BP (DBP) levels did not differ based on APOL1 genotype. Subjects with 1-2 APOL1 risk alleles had a greater SBP response to candesartan (-12.2 +/- 1.2 vs -7.5 +/- 1.8 mmHg, p = 0.03; GERA2), and a greater decline in albuminuria with candesartan (-8.3 +/- 3.1 vs +3.7 +/- 4.3 mg/day, p = 0.02). APOL1 genotype did not associate with BP response to thiazides or beta blockers. GWAS was performed to determine associations with BP response to candesartan depending on APOL1 genotype. While no SNPs reached genome wide significance, SNP rs10113352, intronic in CSMD1, predicted greater office SBP response to candesartan (p = 3.7 x 10(-7)) in those with 1-2 risk alleles, while SNP rs286856, intronic in DPP6, predicted greater office SBP response (p = 3.2 x 10(-7)) in those with 0 risk alleles. Conclusions Hypertensive AAs without overt kidney disease who carry 1 or more APOL1 risk variants have a greater BP and albuminuria reduction in response to candesartan therapy. BP response to thiazides or beta blockers did not differ by APOL1 genotype. Future studies confirming this initial finding in an independent cohort are required.	[Cunningham, Patrick N.; Chapman, Arlene B.] Univ Chicago, Sect Nephrol, Chicago, IL 60637 USA; [Wang, Zhiying; Grove, Megan L.; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Dept Epidemiol Human Genet & Environm Sci, Human Genet Ctr, Sch Publ Hlth, Houston, TX 77030 USA; [Cooper-DeHoff, Rhonda M.; Gong, Yan; Gums, John G.; Johnson, Julie A.] Univ Florida, Coll Pharm, Dept Pharmacotherapy & Translat Res, Gainesville, FL USA; [Cooper-DeHoff, Rhonda M.; Gong, Yan; Gums, John G.; Johnson, Julie A.] Univ Florida, Coll Med, Div Cardiovasc Med, Gainesville, FL USA; [Beitelshees, Amber L.] Univ Maryland, Dept Med, Endocrinol Diabet & Nutr Div, Baltimore, MD 21201 USA; [Turner, Stephen T.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	University of Chicago; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University System of Maryland; University of Maryland Baltimore; Mayo Clinic; Baylor College of Medicine	Cunningham, PN (corresponding author), Univ Chicago, Sect Nephrol, Chicago, IL 60637 USA.	pcunning@medicine.bsd.uchicago.edu	Turner, Stephen/GXM-4654-2022	Cunningham, Patrick/0000-0002-4588-8280	National Institutes of Health, Pharmacogenetics Research Network [U01 GM074492]; NIH National Center for Research Resources [M01 RR00082, UL1 RR029890, UL1 RR025008, M01 RR00039, UL1 RR024150]; National Center for Advancing Translational Sciences [UL1 TR000064, UL1 TR000454, UL1 TR000135]; Mayo Foundation; NIH [HL74735, HL53330]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER	National Institutes of Health, Pharmacogenetics Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Mayo Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	PEAR1 and PEAR2 was supported by a grant from the National Institutes of Health (https://www.nih.gov/), grant U01 GM074492, funded as part of the Pharmacogenetics Research Network (JAJ). PEAR1 was also supported by the following grants from the NIH National Center for Research Resources: grant M01 RR00082 and UL1 RR029890 to the University of Florida, grants UL1 RR025008 and M01 RR00039 (ABC) to Emory University, and UL1 RR024150 to Mayo Clinic. PEAR2 was also supported by the National Center for Advancing Translational Sciences under the award number UL1 TR000064 (University of Florida); UL1 TR000454 (Emory University) and UL1 TR000135 (Mayo Clinic), and the Mayo Foundation. GERA was supported by NIH grants HL74735, HL53330 (STT), and the Mayo Foundation (https://www.mayo.edu/research).	Canzanello VJ, 2008, AM J HYPERTENS, V21, P61, DOI 10.1038/ajh.2007.24; Chapman AB, 2002, KIDNEY INT, V61, P1047, DOI 10.1046/j.1523-1755.2002.00200.x; Chen TK, 2017, KIDNEY INT, V92, P964, DOI 10.1016/j.kint.2017.03.028; Chen TK, 2017, ARTERIOSCL THROM VAS, V37, P1765, DOI [10.1161/ATVBAHA.117.309384, 10.1161/atvbaha.117.309384]; Chittani M, 2015, J HYPERTENS, V33, P1301, DOI 10.1097/HJH.0000000000000541; Dummer PD, 2015, SEMIN NEPHROL, V35, P222, DOI 10.1016/j.semnephrol.2015.04.008; Fisher NDL, 1999, KIDNEY INT, V56, P635, DOI 10.1046/j.1523-1755.1999.00579.x; Franceschini N, 2018, JAMA CARDIOL, V3, P712, DOI 10.1001/jamacardio.2018.1827; Freedman BI, 2016, KIDNEY INT, V90, P440, DOI 10.1016/j.kint.2016.04.027; Freedman BI, 2015, KIDNEY INT, V87, P176, DOI 10.1038/ki.2014.255; Freedman BI, 2010, J AM SOC NEPHROL, V21, P1422, DOI 10.1681/ASN.2010070730; Fu YL, 2017, J AM SOC NEPHROL, V28, P1106, DOI 10.1681/ASN.2016050550; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Gong Y, 2016, HYPERTENSION, V67, P556, DOI 10.1161/HYPERTENSIONAHA.115.06345; Gong Y, 2012, CIRC-CARDIOVASC GENE, V5, P686, DOI 10.1161/CIRCGENETICS.112.964080; Grove ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068095; Hamadeh IS, 2014, CLIN PHARMACOL THER, V96, P175, DOI 10.1038/clpt.2014.62; He J, 2013, CIRC-CARDIOVASC GENE, V6, P598, DOI 10.1161/CIRCGENETICS.113.000307; Honda M, 2006, BIOL PHARM BULL, V29, P772, DOI 10.1248/bpb.29.772; Howard G, 2013, JAMA INTERN MED, V173, P46, DOI 10.1001/2013.jamainternmed.857; Hughson MD, 2018, KIDNEY INT REP, V3, P89, DOI 10.1016/j.ekir.2017.08.007; Ito K, 2014, CIRC RES, V114, P845, DOI 10.1161/CIRCRESAHA.114.302347; Jerng HH, 2009, CHANNELS, V3, P448, DOI 10.4161/chan.3.6.10216; Johnson JA, 2009, AM HEART J, V157, P442, DOI 10.1016/j.ahj.2008.11.018; Kasembeli AN, 2015, J AM SOC NEPHROL, V26, P2882, DOI 10.1681/ASN.2014050469; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Koriyama H, 2010, J ATHEROSCLER THROMB, V17, P1054, DOI 10.5551/jat.4291; Kraus DM, 2006, J IMMUNOL, V176, P4419, DOI 10.4049/jimmunol.176.7.4419; Kruzel-Davila E, 2017, J AM SOC NEPHROL, V28, P1117, DOI 10.1681/ASN.2016050546; Ku E, 2017, KIDNEY INT, V91, P443, DOI 10.1016/j.kint.2016.09.033; Langefeld CD, 2015, KIDNEY INT, V87, P169, DOI 10.1038/ki.2014.254; Larsen CP, 2015, MODERN PATHOL, V28, P95, DOI 10.1038/modpathol.2014.92; Li XG, 2009, CHINESE MED J-PEKING, V122, P2989, DOI 10.3760/cma.j.issn.0366-6999.2009.24.014; Li Y, 2010, GENET EPIDEMIOL, V34, P816; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Liao C, 2013, EUR J MED GENET, V56, P484, DOI 10.1016/j.ejmg.2013.06.008; Ma LJ, 2016, KIDNEY INT, V90, P389, DOI 10.1016/j.kint.2016.02.032; Ma LJ, 2015, J AM SOC NEPHROL, V26, P339, DOI 10.1681/ASN.2013091017; Mukamal KJ, 2016, ARTERIOSCL THROM VAS, V36, P398, DOI 10.1161/ATVBAHA.115.305970; Nadkarni GN, 2017, KIDNEY INT, V92, P793, DOI 10.1016/j.kint.2017.05.030; Nadkarni GN, 2017, J AM COLL CARDIOL, V69, P1564, DOI 10.1016/j.jacc.2017.01.040; Oliveira-Paula GH, 2017, BASIC CLIN PHARMACOL, V120, P284, DOI 10.1111/bcpt.12682; Price DA, 1999, J AM SOC NEPHROL, V10, P2382; Prontera P, 2014, NEUROGENETICS, V15, P237, DOI 10.1007/s10048-014-0418-9; Rau T, 2009, CLIN PHARMACOL THER, V85, P269, DOI 10.1038/clpt.2008.218; Schwartz GL, 2013, AM J HYPERTENS, V26, P957, DOI 10.1093/ajh/hpt047; Strop P, 2004, J MOL BIOL, V343, P1055, DOI 10.1016/j.jmb.2004.09.003; ten Sande JN, 2016, HEART RHYTHM, V13, P905, DOI 10.1016/j.hrthm.2015.12.006; Turner ST, 2013, HYPERTENSION, V62, P391, DOI 10.1161/HYPERTENSIONAHA.111.00436; Turner ST, 2012, HYPERTENSION, V59, P1204, DOI 10.1161/HYP.0b013e31825b30f8; Turner ST, 2010, AM J HYPERTENS, V23, P1014, DOI 10.1038/ajh.2010.98; WEIR MR, 1995, HYPERTENSION, V26, P124, DOI 10.1161/01.HYP.26.1.124; Williams SF, 2014, WORLD J CARDIOL, V6, P878, DOI 10.4330/wjc.v6.i9.878; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Zineh I, 2004, CLIN PHARMACOL THER, V76, P536, DOI 10.1016/j.clpt.2004.08.020	55	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221957	10.1371/journal.pone.0221957	http://dx.doi.org/10.1371/journal.pone.0221957			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532792	Green Published, Green Submitted, gold			2022-12-26	WOS:000532239600017
J	Richards, HL; Wells, RT; Evans, AR; Fitzgerald, EMG; Adams, JW				Richards, Hazel L.; Wells, Rod T.; Evans, Alistair R.; Fitzgerald, Erich M. G.; Adams, Justin W.			The extraordinary osteology and functional morphology of the limbs in Palorchestidae, a family of strange extinct marsupial giants	PLOS ONE			English	Article							NORTHERN-TERRITORY; WEE-JASPER; MEGAFAUNA; FORELIMB; MAMMALS; AUSTRALIA; KANGAROOS; MUSCULATURE; CLIMATE; SIZE	The Palorchestidae are a family of marsupial megafauna occurring across the eastern Australian continent from the late Oligocene through to their extinction in the Late Pleistocene. The group is known for their odd 'tapir-like' crania and distinctive clawed forelimbs, but their appendicular anatomy has never been formally described. We provide the first descriptions of the appendicular skeleton and body mass estimates for three palorchestid species, presenting newly-identified, and in some cases associated, material of mid-Miocene Propalorchestes, Plio-Pleistocene Palorchestes parvus and Pleistocene Palorchestes azael alongside detailed comparisons with extant and fossil vombatiform marsupials. We propose postcranial diagnostic characters at the family, genus and species level. Specialisation in the palorchestid appendicular skeleton evidently occurred much later than in the cranium and instead correlates with increasing body size within the lineage. We conclude that palorchestid forelimbs were highly specialised for the manipulation of their environment in the acquisition of browse, and that they may have adopted bipedal postures to feed. Our results indicate palorchestids were bigger than previously thought, with the largest species likely weighing over 1000 kg. Additionally, we show that P. azael exhibits some of the most unusual forelimb morphology of any mammal, with a uniquely fixed humeroulnar joint unlike any of their marsupial kin, living or extinct.	[Richards, Hazel L.; Evans, Alistair R.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Richards, Hazel L.; Evans, Alistair R.; Fitzgerald, Erich M. G.; Adams, Justin W.] Museums Victoria, Geosci, Melbourne, Vic, Australia; [Wells, Rod T.] Flinders Univ S Australia, Coll Sci & Engn, Ecol & Evolut, Adelaide, SA, Australia; [Wells, Rod T.] South Australian Museum, Palaeontol, Adelaide, SA, Australia; [Adams, Justin W.] Monash Univ, Fac Med Nursing & Hlth Sci, Sch Biomed Sci, Dept Anat & Dev Biol, Clayton, Vic, Australia	Monash University; Flinders University South Australia; South Australian Museum; Monash University	Richards, HL (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.; Richards, HL (corresponding author), Museums Victoria, Geosci, Melbourne, Vic, Australia.	hazel.l.richards@gmail.com	Evans, Alistair R/D-4239-2011; Richards, Hazel L/AEP-5970-2022	Evans, Alistair R/0000-0002-4078-4693; Adams, Justin/0000-0002-6214-9850; Richards, Hazel/0000-0002-9272-6815	Australian Government Research Training Program Scholarship; Robert Blackwood Partnership PhD Top-Up Scholarship; Department of Anatomy and Developmental Biology, Monash University; Australian Research Council [DP180101797]	Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); Robert Blackwood Partnership PhD Top-Up Scholarship; Department of Anatomy and Developmental Biology, Monash University; Australian Research Council(Australian Research Council)	This research was supported by an Australian Government Research Training Program Scholarship, Robert Blackwood Partnership PhD Top-Up Scholarship (HLR), internal funds from the Department of Anatomy and Developmental Biology, Monash University (JWA), and the Australian Research Council DP180101797 (ARE).; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams B., 2012, COMP OSTEOLOGY LAB F, V1, P333, DOI [10.1016/C2010-0-68475-6, DOI 10.1016/C2010-0-68475-6]; ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x; Archer M., 1991, RIVERSLEIGH; Archer M, 1978, ALCHERINGA, V2, P1, DOI 10.1080/03115517808619074; Arena DA, 2016, LETHAIA, V49, P43, DOI 10.1111/let.12131; Bartholomai A., 1962, Memoirs of the Queensland Museum, V14, P33; Black K., 1999, AUST MAMMAL, V21, P20; Black K.H., 2008, THESIS; Black Karen, 1997, Memoirs of the Queensland Museum, V41, P181; Black KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048213; Black KH, 2010, AM MUS NOVIT, P1, DOI 10.1206/666.1; Black KH, 2012, EARTH LIFE GLOBAL BI, P983, DOI DOI 10.1007/978-90-481-3428-1_35; Camens AB, 2010, THESIS; Campione NE., 2016, MASSTIMATE BODY MASS; Campione NE, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-60; Carey SP, 2011, QUATERNARY SCI REV, V30, P591, DOI 10.1016/j.quascirev.2010.11.021; Casinos A, 1996, LETHAIA, V29, P87, DOI 10.1111/j.1502-3931.1996.tb01842.x; Cockburn A., 1988, P28; COOMBS MC, 1983, T AM PHILOS SOC, V73, P1, DOI 10.2307/3137420; Davis A. C., 1997, Memoirs of the Queensland Museum, V41, P315; Dawson RS, 2015, AUST J ZOOL, V63, P192, DOI 10.1071/ZO15007; DeSantis LRG, 2017, PALEOBIOLOGY, V43, P181, DOI 10.1017/pab.2016.50; Duncan Jacqui, 2001, Australian Archaeology, V53, P16; Dunkley J., 2010, WEE JASPER CAVES; FINCH ME, 1988, AUST J ZOOL, V36, P251, DOI 10.1071/ZO9880251; FLANNERY T F, 1986, BMR (Bureau of Mineral Resources) Journal of Australian Geology and Geophysics, V10, P65; Flannery T.F., 1985, P234; Flannery T. F., 1984, AUSTR ZOOLOGIST, V22, P385; FLEAGLE JG, 1992, J HUM EVOL, V22, P285, DOI 10.1016/0047-2484(92)90060-M; Fletcher H. O., 1945, AUSTRALIAN MUS MAG, V8, P361; Fujiwara S, 2012, P ROY SOC B-BIOL SCI, V279, P2561, DOI 10.1098/rspb.2012.0190; Gilles A., 2016, 2016 IEEE INT C MULT, P1, DOI DOI 10.1109/ICMEW.2016.7574699; Gillespie R, 2008, RADIOCARBON, V50, P75, DOI 10.1017/S003382220004337X; Gillespie R, 2012, QUATERNARY SCI REV, V37, P38, DOI 10.1016/j.quascirev.2012.01.013; Harvey Kathryn J., 2010, Australian Mammalogy, V32, P1, DOI 10.1071/AM08022; Hildebrand M., 1985, P89; Hopkins S.S., 2018, METHODS PALEOECOLOGY, P7, DOI [10.1007/978-3-319-94265-0_2, DOI 10.1007/978-3-319-94265-0_2]; Janis CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109888; Johnson, 2006, AUSTRALIAS MAMMAL EX; Joyce E, 1976, ARTEFACT, V1, P47; Long J.A., 2002, PREHISTORIC MAMMALS; MACKNESS B. S., 2008, P LINNEAN SOC NEW S, V130, P21, DOI DOI 10.1111/j.1095-8312.1918.tb01147.x; Mackness Brian, 1995, Memoirs of the Queensland Museum, V38, P603; MACLEOD N, 1993, AM J SCI, V293A, P300, DOI 10.2475/ajs.293.A.300; Marshall L.G., 1974, Memoirs of the National Museum of Victoria, VNo. 35, P63; Marshall L.G., 1990, Current Mammalogy, V2, P433; McAfee R. K., 2007, THESIS; Megirian D, 2010, PALEOBIOLOGY, V36, P658, DOI 10.1666/09047.1; Megirian Dirk, 1996, Beagle, V13, P9; Munson CJ., 1992, POSTCRANIAL DESCRIPT, P1; MURRAY P, 1990, Beagle, V7, P39; Murray P., 1984, P600; Murray P., 2000, MEMOIRS QUEEN VICTOR, V105, P1; MURRAY P F, 1986, Beagle, V3, P195; Murray Peter, 2000, MAGNT Research Report, V6, P1; Murray Peter, 1991, P1071; Murray PF, 1998, WOMBATS, P1; Owen R, 1874, T ZOOLOGICAL SOC LON, V8, P483; Owen R., 1873, P ROY SOC LONDON, P386; Owen R., 1877, RES FOSSIL REMAINS E; Owen R, 1869, P ROYAL SOC LONDON 1, V18, P196; Piper K. J., 2006, ALCHERINGA, V1, P281; PLEDGE N S, 1991, Records of the South Australian Museum (Adelaide), V25, P161; Price GJ, 2008, ZOOL J LINN SOC-LOND, V153, P369, DOI 10.1111/j.1096-3642.2008.00387.x; Price Gilbert J., 2005, Memoirs of the Queensland Museum, V51, P202; R Core Team, 2018, R LANG ENV STAT COMP; Richardson, 1989, FAUNA AUSTR; Ruff C., 1990, P119; Schaller O., 2007, ILLUSTRATED VET ANAT; SCHMIDT VA, 1984, AUST J EARTH SCI, V31, P361, DOI 10.1080/08120098408729298; Schwartz Leah R. S., 2016, Memoirs of Museum Victoria, V74, P263; Scott, 1915, MONOGRAPH NOTOTHERIU; Scott G.G., 1988, RECORDS S AUSTR MUSE, V22, P95; Shean DA., 2007, THESIS; Smith FA, 2018, SCIENCE, V360, P310, DOI 10.1126/science.aao5987; Stirling E., 1913, MEMOIRS ROYAL SOC S, V1, P127; Stirton R. A., 1967, Bulletin Bureau of Mineral Resources Geology and Geophysics Australia, V85, P1; Stock C., 1925, CENOZOIC GRAVIGRADE; Strahan R., 1995, MAMMALS AUSTR, V2nd; Szalay F. S., 1994, EVOLUTIONARY HIST MA; TAYLOR BK, 1978, J MORPHOL, V157, P347, DOI 10.1002/jmor.1051570307; Theden-Ringl F, 2018, HOLOCENE, V28, P1467, DOI 10.1177/0959683618777073; Toledo N., 2017, J MAMM EVOL, V25, P525; Trusler P., 2016, THESIS; Trusler Peter W., 2016, Memoirs of Museum Victoria, V74, P291; TYNDALEBISCOE H, 2005, LIFE MARSUPIALS, pNIL6; Vickers-Rich P, 1999, WILDLIFE GONDWANA DI; Wakefield NA, 1967, NATURALISTS DIARY; Warburton NM, 2017, ANAT REC, V300, P1589, DOI 10.1002/ar.23612; Warburton NM, 2012, AUST J ZOOL, V60, P246, DOI 10.1071/ZO12059; Wells R.T., 1978, P103; Wells RT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208020; White Jennifer L., 1993, Journal of Vertebrate Paleontology, V13, P230; WINDSOR DE, 1971, J ZOOL, V163, P165, DOI 10.1111/j.1469-7998.1971.tb04530.x; Woods J. T., 1958, Memoirs of the Queensland Museum, V13, P177; Wroe S, 2004, P ROY SOC B-BIOL SCI, V271, pS34, DOI 10.1098/rsbl.2003.0095; Wroe S, 2003, PALEOBIOLOGY, V29, P403, DOI 10.1666/0094-8373(2003)029<0403:AAMFPB>2.0.CO;2; Wroe S, 2013, P NATL ACAD SCI USA, V110, P8777, DOI 10.1073/pnas.1302698110; YOUNG GC, 1996, AUSTR PHANEROZOIC TI	99	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2019	14	9							e0221824	10.1371/journal.pone.0221824	http://dx.doi.org/10.1371/journal.pone.0221824			69	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB3QG	31518353	Green Submitted, Green Published, gold			2022-12-26	WOS:000488471200002
J	Akram, M; Reimann, J; Dietl, A; Menzel, A; Versantvoort, W; Kartal, B; Jetten, MSM; Barends, TRM				Akram, Mohd; Reimann, Joachim; Dietl, Andreas; Menzel, Andreas; Versantvoort, Wouter; Kartal, Boran; Jetten, Mike S. M.; Barends, Thomas R. M.			A nitric oxide?binding heterodimeric cytochrome c complex from the anammox bacterium Kuenenia stuttgartiensis binds to hydrazine synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome c; bacterial metabolism; oxidation-reduction (redox); nitric oxide; crystal structure; ultraviolet-visible spectroscopy (UV-visible spectroscopy); anaerobic ammonium oxidation; anammox; nitrogen cycle	HEME PROTEIN; NITROGEN; SULFUR; DEHYDROGENASE; SEDIMENTATION; LOCALIZATION; REACTIVITY; RELEVANCE; LIGATION; ENZYME	Anaerobic ammonium oxidation (anammox) is a microbial process responsible for significant nitrogen loss from the oceans and other ecosystems. The redox reactions at the heart of anammox are catalyzed by large multiheme enzyme complexes that rely on small cytochrome c proteins for electron shuttling. Among the most highly abundant of these cytochromes is a unique heterodimeric complex composed of class I and class II c-type cytochromes called NaxLS, which has distinctive biochemical and spectroscopic properties. Here, we present the 1.7 ? resolution crystal structure of this complex from the anammox organism Kuenenia stuttgartiensis (KsNaxLS). The structure reveals that the heme irons in each subunit exhibit a rare His/Cys ligation, which, as we show by substitution, causes the observed unusual spectral properties. Unlike its individual subunits, the KsNaxLS complex binds nitric oxide (NO) only at the distal heme side, forming 6cNO adducts. This is likely due to steric immobilization of the proximal heme-binding motifs upon complex formation, a finding that may be of functional relevance, because NO is an intermediate in the central anammox metabolism. Pulldown experiments with K. stuttgartiensis cell-free extract showed that the KsNaxLS complex binds specifically to one of the central anammox enzyme complexes, hydrazine synthase, which uses NO as one of its substrates. It is therefore possible that the KsNaxLS complex plays a role in binding the volatile NO to retain it in the cell for transfer to hydrazine synthase. Alternatively, we propose that KsNaxLS may shuttle electrons to this enzyme complex.	[Akram, Mohd; Dietl, Andreas; Barends, Thomas R. M.] Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany; [Reimann, Joachim; Versantvoort, Wouter; Jetten, Mike S. M.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Microbiol, NL-6525 AJ Nijmegen, Netherlands; [Menzel, Andreas] Paul Scherrer Inst, Coherent Xray Scattering Grp, WLGA 223, CH-5232 Villigen, Switzerland; [Kartal, Boran] Max Planck Inst Marine Microbiol, Microbial Physiol Grp, Celsiusstr 1, D-28359 Bremen, Germany	Max Planck Society; Radboud University Nijmegen; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Max Planck Society	Barends, TRM (corresponding author), Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany.	Thomas.Barends@mpimf-heidelberg.mpg.de	Menzel, Andreas/C-4388-2012; Kartal, Boran/ABD-5400-2021; Jetten, Mike/B-8834-2011	Menzel, Andreas/0000-0002-0489-609X; Jetten, Mike/0000-0002-4691-7039; Kartal, Boran/0000-0003-4199-952X; Versantvoort, Wouter/0000-0001-5418-2741	Max Planck Society; Netherlands Organization for Scientific Research (NWO) [824.15.011]; European Research Council [640422, 339880]; SIAM Gravitation Grant on Anaerobic Microbiology (Netherlands Organization for Scientific Research, NWO/OCW) Gravitation SIAM [024.002.002]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission); SIAM Gravitation Grant on Anaerobic Microbiology (Netherlands Organization for Scientific Research, NWO/OCW) Gravitation SIAM	This work was supported by the Max Planck Society. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Netherlands Organization for Scientific Research (NWO) Grant 824.15.011 (to B. K.).; Supported by European Research Council Starting Grant 640422.; Supported by European Research Council Advanced Grant 339880 and SIAM Gravitation Grant on Anaerobic Microbiology (Netherlands Organization for Scientific Research, NWO/OCW) Gravitation SIAM 024.002.002.	Alric J, 2004, J BIOL CHEM, V279, P26090, DOI 10.1074/jbc.M400361200; AMBLER RP, 1991, BIOCHIM BIOPHYS ACTA, V1058, P42, DOI 10.1016/S0005-2728(05)80266-X; Andrew CR, 2005, BIOCHEMISTRY-US, V44, P8664, DOI 10.1021/bi050428g; Andrew CR, 2002, BIOCHEMISTRY-US, V41, P2353, DOI 10.1021/bi011419k; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Bertini I, 2004, J BIOL INORG CHEM, V9, P224, DOI 10.1007/s00775-003-0511-2; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; de Almeida NM, 2016, BBA-BIOENERGETICS, V1857, P1694, DOI 10.1016/j.bbabio.2016.07.006; de Almeida NM, 2015, J BACTERIOL, V197, P2432, DOI 10.1128/JB.00186-15; Denkmann K, 2012, ENVIRON MICROBIOL, V14, P2673, DOI 10.1111/j.1462-2920.2012.02820.x; Dietl A, 2015, NATURE, V527, P404, DOI 10.1038/nature15517; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Grein F, 2010, BIOCHEMISTRY-US, V49, P8290, DOI 10.1021/bi1007673; Grisham MB, 1996, METHOD ENZYMOL, V268, P237; Heun M, 2012, APPL ENVIRON MICROB, V78, P4400, DOI 10.1128/AEM.07895-11; Hough MA, 2015, ADV MICROB PHYSIOL, V67, P1, DOI 10.1016/bs.ampbs.2015.08.001; Hu ZY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09797-4; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kartal B, 2013, FEMS MICROBIOL REV, V37, P428, DOI 10.1111/1574-6976.12014; Kartal B, 2011, NATURE, V479, P127, DOI 10.1038/nature10453; Kartal B, 2011, METHOD ENZYMOL, V486, P89, DOI [10.1016/S0076-6879(11)86004-0, 10.1016/B978-0-12-381294-0.00004-3]; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krest CM, 2015, NAT CHEM, V7, P696, DOI [10.1038/NCHEM.2306, 10.1038/nchem.2306]; Lam P, 2011, ANNU REV MAR SCI, V3, P317, DOI 10.1146/annurev-marine-120709-142814; Lin CI, 2013, CHEM SOC REV, V42, P4377, DOI 10.1039/c2cs35438a; Maalcke WJ, 2016, J BIOL CHEM, V291, P17077, DOI 10.1074/jbc.M116.735530; Maalcke WJ, 2014, J BIOL CHEM, V289, P1228, DOI 10.1074/jbc.M113.525147; Manole A, 2015, J BIOL INORG CHEM, V20, P675, DOI 10.1007/s00775-015-1253-7; MAYHEW SG, 1978, EUR J BIOCHEM, V85, P535, DOI 10.1111/j.1432-1033.1978.tb12269.x; Moser CC, 2008, BBA-BIOENERGETICS, V1777, P1032, DOI 10.1016/j.bbabio.2008.04.021; Motomura T, 2017, J BIOL CHEM, V292, P9599, DOI 10.1074/jbc.M116.746263; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Perera R, 2003, P NATL ACAD SCI USA, V100, P3641, DOI 10.1073/pnas.0737142100; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; RAPHAEL AL, 1991, J AM CHEM SOC, V113, P1038, DOI 10.1021/ja00003a045; Rathnayake RMLD, 2018, ENVIRON SCI TECHNOL, V52, P5744, DOI 10.1021/acs.est.8b00876; Reijerse EJ, 2007, BIOCHEMISTRY-US, V46, P7804, DOI 10.1021/bi7003526; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shi L, 2005, BIOTECHNIQUES, V38, P297, DOI 10.2144/05382PT01; SMULEVICH G, 1994, INORG CHEM, V33, P4629, DOI 10.1021/ic00099a012; Strous M, 2006, NATURE, V440, P790, DOI 10.1038/nature04647; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Ukita S, 2010, FEMS MICROBIOL LETT, V313, P61, DOI 10.1111/j.1574-6968.2010.02122.x; van der Star WRL, 2008, BIOTECHNOL BIOENG, V101, P286, DOI 10.1002/bit.21891; Van Driessche G, 2006, FEBS J, V273, P2801, DOI 10.1111/j.1742-4658.2006.05296.x; van Niftrik L, 2008, J BACTERIOL, V190, P708, DOI 10.1128/JB.01449-07; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yoshimura T, 1996, BBA-PROTEIN STRUCT M, V1292, P39, DOI 10.1016/0167-4838(95)00187-5	52	7	7	12	67	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16712	16728		10.1074/jbc.RA119.008788	http://dx.doi.org/10.1074/jbc.RA119.008788			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31548310	Green Published, hybrid			2022-12-26	WOS:000501801900020
J	Wang, XQ; Chen, JX; Shi, SJ; Sheng, SH; Kleyman, TR				Wang, Xueqi; Chen, Jingxin; Shi, Shujie; Sheng, Shaohu; Kleyman, Thomas R.			Analyses of epithelial Na+ channel variants reveal that an extracellular ?-ball domain critically regulates ENaC gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epithelial sodium channel (ENaC); genetic polymorphism; acid-sensing ion channel (ASIC); patch clamp; Xenopus; amiloride; blood pressure; degenerin; Na plus self-inhibition; nonvoltage-gated ion channel	CONSERVED CHARGED RESIDUES; CELL-SURFACE EXPRESSION; OF-FUNCTION MUTATION; SODIUM-CHANNEL; BETA-SUBUNIT; MISSING HERITABILITY; SELF-INHIBITION; R563Q MUTATION; ALPHA-SUBUNIT; GAMMA-SUBUNIT	Epithelial Na+ channel (ENaC)-mediated Na+ transport has a key role in the regulation of extracellular fluid volume, blood pressure, and extracellular [K+]. Among the thousands of human ENaC variants, only a few exist whose functional consequences have been experimentally tested. Here, we used the Xenopus oocyte expression system to investigate the functional roles of four nonsynonymous human ENaC variants located within the ?7-strand and its adjacent loop of the ?-subunit extracellular ?-ball domain. ?R350W?? and ?G355R?? channels exhibited 2.5- and 1.8-fold greater amiloride-sensitive currents than WT ??? human ENaCs, respectively, whereas ?V351A?? channels conducted significantly less current than WT. Currents in ?H354R??-expressing oocytes were similar to those expressing WT. Surface expression levels of three mutants (?R350W??, ?V351A??, and ?G355R??) were similar to that of WT. However, three mutant channels (?R350W??, ?H354R??, and ?G355R??) exhibited a reduced Na+ self-inhibition response. Open probability of ?R350W?? was significantly greater than that of WT. Moreover, other Arg-350 variants, including ?R350G, ?R350L, and ?R350Q, also had significantly increased channel activity. A direct comparison of ?R350W and two previously reported gain?of?function variants revealed that ?R350W increases ENaC activity similarly to ?W493R, but to a much greater degree than does ?C479R. Our results indicate that ?R350W along with ?R350G, ?R350L, and ?R350Q, and ?G355R are novel gain?of?function variants that function as gating modifiers. The location of these multiple functional variants suggests that the ?ENaC ?-ball domain portion that interfaces with the palm domain of ?ENaC critically regulates ENaC gating.	[Wang, Xueqi; Chen, Jingxin; Shi, Shujie; Sheng, Shaohu; Kleyman, Thomas R.] Univ Pittsburgh, Dept Med, Renal Electrolyte Div, Pittsburgh, PA 15261 USA; [Kleyman, Thomas R.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15261 USA; [Kleyman, Thomas R.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Wang, Xueqi] Cent S Univ, Dept Nephrol, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China; [Wang, Xueqi] Cent S Univ, Xiangya Hosp 3, Changsha 410013, Hunan, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central South University; Central South University	Sheng, SH (corresponding author), Univ Pittsburgh, Renal Electrolyte Div, S929 Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	shaohu@pitt.edu	Sheng, Shaohu/G-7052-2016	Sheng, Shaohu/0000-0002-7198-1702; , Thomas/0000-0002-2413-5415	National Institutes of Health [R01 HL147818, R03 DK119752, P30 DK079307]; Xiangya Scholar Fund from The Third Xiangya Hospital, Central South University, China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL147818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307, R03DK119752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Xiangya Scholar Fund from The Third Xiangya Hospital, Central South University, China; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 HL147818, R03 DK119752, and P30 DK079307 and the Xiangya Scholar Fund (to X. W.) from The Third Xiangya Hospital, Central South University, China. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Azad AK, 2009, HUM MUTAT, V30, P1093, DOI 10.1002/humu.21011; Baker EH, 1998, LANCET, V351, P1388, DOI 10.1016/S0140-6736(97)07306-6; Bandyopadhyay B, 2017, BIOINFORM BIOL INSIG, V11, DOI 10.1177/1177932217735096; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Campuzano O, 2019, HUM MUTAT, V40, P749, DOI 10.1002/humu.23730; Chalfant ML, 1999, J BIOL CHEM, V274, P32889, DOI 10.1074/jbc.274.46.32889; Chen JX, 2015, J BIOL CHEM, V290, P25140, DOI 10.1074/jbc.M115.665398; Chen JX, 2013, AM J PHYSIOL-RENAL, V304, pF207, DOI 10.1152/ajprenal.00563.2012; Chen JX, 2011, J BIOL CHEM, V286, P27436, DOI 10.1074/jbc.M111.232058; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Collier DM, 2014, J GEN PHYSIOL, V144, P337, DOI 10.1085/jgp.201411208; Collier DM, 2012, J BIOL CHEM, V287, P40907, DOI 10.1074/jbc.M112.417519; Collier DM, 2011, J BIOL CHEM, V286, P6027, DOI 10.1074/jbc.M110.198127; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Dhanjal MK, 2006, BJOG-INT J OBSTET GY, V113, P595, DOI 10.1111/j.1471-0528.2006.00899.x; Eastwood AL, 2012, PHYSIOLOGY, V27, P282, DOI 10.1152/physiol.00006.2012; Eaton DC, 2009, ANNU REV PHYSIOL, V71, P403, DOI 10.1146/annurev.physiol.010908.163250; Edelheit O, 2014, FEBS J, V281, P2097, DOI 10.1111/febs.12765; Edelheit O, 2011, AM J PHYSIOL-RENAL, V300, pF887, DOI 10.1152/ajprenal.00648.2010; Firsov D, 1999, J BIOL CHEM, V274, P2743, DOI 10.1074/jbc.274.5.2743; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Hanukoglu I, 2016, GENE, V579, P95, DOI 10.1016/j.gene.2015.12.061; Harris M, 2008, J BIOL CHEM, V283, P7455, DOI 10.1074/jbc.M707399200; Heidrich E, 2015, J BIOL CHEM, V290, P11569, DOI 10.1074/jbc.M115.640763; Huber R, 2010, CELL PHYSIOL BIOCHEM, V25, P145, DOI 10.1159/000272059; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Hughey RP, 2003, J BIOL CHEM, V278, P37073, DOI 10.1074/jbc.M307003200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jones ESW, 2011, CARDIOVASC J AFR, V22, P241, DOI 10.5830/CVJA-2010-084; Juang JMJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep06733; Kashlan OB, 2018, AM J PHYSIOL-RENAL, V314, pF483, DOI 10.1152/ajprenal.00195.2017; Kashlan OB, 2015, J BIOL CHEM, V290, P568, DOI 10.1074/jbc.M114.606152; Kleyman TR, 2018, ANNU REV PHYSIOL, V80, P263, DOI 10.1146/annurev-physiol-021317-121143; Konstas AA, 2003, AM J PHYSIOL-CELL PH, V284, pC447, DOI 10.1152/ajpcell.00385.2002; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Noreng S, 2018, ELIFE, V7, DOI 10.7554/eLife.39340; Polfus LM, 2016, CSH MOL CASE STUD, V2, DOI 10.1101/mcs.a001255; Rauh R, 2013, AM J PHYSIOL-LUNG C, V304, pL43, DOI 10.1152/ajplung.00093.2012; Rauh R, 2010, J PHYSIOL-LONDON, V588, P1211, DOI 10.1113/jphysiol.2009.180224; Ray EC, 2016, AM J PHYSIOL-RENAL, V311, pF908, DOI 10.1152/ajprenal.00426.2016; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Salih M, 2017, J AM SOC NEPHROL, V28, P3290, DOI 10.1681/ASN.2016111163; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Shekarabi M, 2017, CELL METAB, V25, P285, DOI 10.1016/j.cmet.2017.01.007; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng SH, 2002, J BIOL CHEM, V277, P50098, DOI 10.1074/jbc.M209975200; Sheng SH, 2007, J BIOL CHEM, V282, P20180, DOI 10.1074/jbc.M611761200; Sheng SH, 2018, J BIOL CHEM, V293, P17582, DOI 10.1074/jbc.RA118.003618; Shobair M, 2016, J BIOL CHEM, V291, P3682, DOI 10.1074/jbc.M115.678052; Soundararajan R, 2010, J BIOL CHEM, V285, P30363, DOI 10.1074/jbc.R110.155341; Terker AS, 2016, KIDNEY INT, V89, P127, DOI 10.1038/ki.2015.289; The NHLBI Trans-Omics for Precision Medicine (TOPMed) Whole Genome Sequencing Program, 2018, BRAVO VAR BROWS; Warnock DG, 2014, NAT REV NEPHROL, V10, P146, DOI 10.1038/nrneph.2013.275; Weisz OA, 2000, J BIOL CHEM, V275, P39886, DOI 10.1074/jbc.M003822200; Zhang Y, 2017, DNA CELL BIOL, V36, P1151, DOI 10.1089/dna.2017.3731	59	2	2	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16765	16775		10.1074/jbc.RA119.010001	http://dx.doi.org/10.1074/jbc.RA119.010001			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31551351	Green Published, hybrid			2022-12-26	WOS:000501801900024
J	Baek, YM; Jang, KJ; Lee, H; Yoon, S; Baek, A; Lee, K; Kim, DE				Baek, Yu Mi; Jang, Kyoung-Jin; Lee, Hyobeen; Yoon, Soojin; Baek, Ahruem; Lee, Kangseok; Kim, Dong-Eun			The bacterial endoribonuclease RNase E can cleave RNA in the absence of the RNA chaperone Hfq	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ribonuclease; endoribonuclease; RNA degradation; mRNA decay; RNA processing; RNA turnover; protein expression; RNA chaperone Hfq; RNase E; small guide RNA (sRNA)	ESCHERICHIA-COLI; MESSENGER-RNA; TARGET RECOGNITION; TERMINAL DOMAIN; DEGRADATION; DEGRADOSOME; BINDING; DECAY; INHIBITION; RIBOSOME	RNase E is a component of the RNA degradosome complex and plays a key role in RNA degradation and maturation in Escherichia coli. RNase E?mediated target RNA degradation typically involves the RNA chaperone Hfq and requires small guide RNAs (sRNAs) acting as a seed by binding to short (7?12-bp) complementary regions in target RNA sequences. Here, using recombinantly expressed and purified proteins, site-directed mutagenesis, and RNA cleavage and protein cross-linking assays, we investigated Hfq-independent RNA decay by RNase E. Exploring its RNA substrate preferences in the absence of Hfq, we observed that RNase E preferentially cleaves AU-rich sites of single-stranded regions of RNA substrates that are annealed to an sRNA that contains a monophosphate at its 5?-end. We further found that the quaternary structure of RNase E is also important for complete, Hfq-independent cleavage at sites both proximal and distal to the sRNA-binding site within target RNAs containing monophosphorylated 5?-ends. Of note, genetic RNase E variants with unstable quaternary structure exhibited decreased catalytic activity. In summary, our results show that RNase E can degrade its target RNAs in the absence of the RNA chaperone Hfq. We conclude that RNase E?mediated, Hfq-independent RNA decay in E. coli requires a cognate sRNA sequence for annealing to the target RNA, a 5?-monophosphate at the RNA 5?-end, and a stable RNase E quaternary structure.	[Baek, Yu Mi; Jang, Kyoung-Jin; Lee, Hyobeen; Yoon, Soojin; Baek, Ahruem; Kim, Dong-Eun] Konkuk Univ, Dept Biosci & Biotechnol, Seoul 05029, South Korea; [Lee, Kangseok] Chung Ang Univ, Dept Life Sci, Seoul 06974, South Korea	Konkuk University; Chung Ang University	Kim, DE (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, Seoul 05029, South Korea.	kimde@konkuk.ac.kr	Kim, Dong-Eun/D-8304-2011	Kim, Dong-Eun/0000-0001-6545-8387; Baek, Yu Mi/0000-0002-3043-1237; Baek, Ahruem/0000-0001-6672-6339	Konkuk University	Konkuk University	This work was supported by research funds of Konkuk University in 2018. The authors declare that they have no conflicts of interest with the contents of this article.	Afonyushkin T, 2005, NUCLEIC ACIDS RES, V33, P1678, DOI 10.1093/nar/gki313; Bandyra KJ, 2018, MOL CELL, V72, P275, DOI 10.1016/j.molcel.2018.08.039; Bandyra KJ, 2012, MOL CELL, V47, P943, DOI 10.1016/j.molcel.2012.07.015; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BOUVET P, 1992, NATURE, V360, P488, DOI 10.1038/360488a0; Callaghan AJ, 2005, NATURE, V437, P1187, DOI 10.1038/nature04084; Callaghan AJ, 2003, BIOCHEMISTRY-US, V42, P13848, DOI 10.1021/bi0351099; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Caruthers JM, 2006, J BIOL CHEM, V281, P27046, DOI 10.1074/jbc.M602467200; Celesnik H, 2007, MOL CELL, V27, P79, DOI 10.1016/j.molcel.2007.05.038; Chao YJ, 2017, MOL CELL, V65, P39, DOI 10.1016/j.molcel.2016.11.002; Chen HY, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20159000; Coburn GA, 1999, GENE DEV, V13, P2594, DOI 10.1101/gad.13.19.2594; Desnoyers G, 2013, TRENDS GENET, V29, P92, DOI 10.1016/j.tig.2012.10.004; Deutscher MP, 2003, J BIOL CHEM, V278, P45041, DOI 10.1074/jbc.R300031200; Garrey SM, 2009, J BIOL CHEM, V284, P31843, DOI 10.1074/jbc.M109.063263; Gopel Y, 2016, NUCLEIC ACIDS RES, V44, P824, DOI 10.1093/nar/gkv1161; Ikeda Y, 2011, MOL MICROBIOL, V79, P419, DOI 10.1111/j.1365-2958.2010.07454.x; Jiang XQ, 2004, P NATL ACAD SCI USA, V101, P9211, DOI 10.1073/pnas.0401382101; Kaberdin VR, 2000, J MOL BIOL, V301, P257, DOI 10.1006/jmbi.2000.3962; Kim D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090610; Kime L, 2010, MOL MICROBIOL, V76, P590, DOI 10.1111/j.1365-2958.2009.06935.x; Kushner SR, 2002, J BACTERIOL, V184, P4658, DOI 10.1128/JB.184.17.4658-4665.2002; Leroy A, 2002, MOL MICROBIOL, V45, P1231, DOI 10.1046/j.1365-2958.2002.03104.x; Li ZW, 1999, EMBO J, V18, P2878, DOI 10.1093/emboj/18.10.2878; Mackie GA, 2000, J BIOL CHEM, V275, P25069, DOI 10.1074/jbc.C000363200; Mackie GA, 2013, NAT REV MICROBIOL, V11, P45, DOI 10.1038/nrmicro2930; MCDOWALL KJ, 1995, NATURE, V374, P287, DOI 10.1038/374287a0; MCDOWALL KJ, 1994, J BIOL CHEM, V269, P10790; McDowall KJ, 1996, J MOL BIOL, V255, P349, DOI 10.1006/jmbi.1996.0027; Miczak A, 1996, P NATL ACAD SCI USA, V93, P3865, DOI 10.1073/pnas.93.9.3865; Miller E M, 1995, Methods Mol Biol, V47, P105; Morita T, 2005, GENE DEV, V19, P2176, DOI 10.1101/gad.1330405; Morita T, 2004, MOL MICROBIOL, V54, P1063, DOI 10.1111/j.1365-2958.2004.04329.x; Pfeiffer V, 2009, NAT STRUCT MOL BIOL, V16, P840, DOI 10.1038/nsmb.1631; Pileur F, 2000, NUCLEIC ACIDS RES, V28, P3674, DOI 10.1093/nar/28.18.3674; Prevost K, 2011, GENE DEV, V25, P385, DOI 10.1101/gad.2001711; Richards J, 2012, MOL MICROBIOL, V86, P1063, DOI 10.1111/mmi.12040; Santiago-Frangos A, 2016, P NATL ACAD SCI USA, V113, pE6089, DOI 10.1073/pnas.1613053113; Soper T, 2010, P NATL ACAD SCI USA, V107, P9602, DOI 10.1073/pnas.1004435107; Tsai YC, 2012, NUCLEIC ACIDS RES, V40, P10417, DOI 10.1093/nar/gks739; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3	44	14	13	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					16465	16478		10.1074/jbc.RA119.010105	http://dx.doi.org/10.1074/jbc.RA119.010105			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31540970	Green Published, hybrid			2022-12-26	WOS:000499478600047
J	Jarman, R; Mattioni, C; Russell, K; Chambers, FM; Bartlett, D; Martin, MA; Cherubini, M; Villani, F; Webb, J				Jarman, Rob; Mattioni, Claudia; Russell, Karen; Chambers, Frank M.; Bartlett, Debbie; Martin, M. Angela; Cherubini, Marcello; Villani, Fiorella; Webb, Julia			DNA analysis of Castanea sativa (sweet chestnut) in Britain and Ireland: Elucidating European origins and genepool diversity	PLOS ONE			English	Article							FRAXINUS-EXCELSIOR L.; GENETIC DIVERSITY; CHLOROPLAST DNA; POSTGLACIAL COLONIZATION; PAIRWISE RELATEDNESS; POPULATION-STRUCTURE; BRITISH-ISLES; MILL.; REFUGIA; DOMESTICATION	Castanea sativa is classified as non-indigenous in Britain and Ireland. It was long held that it was first introduced into Britain by the Romans, until a recent study found no corroborative evidence of its growing here before c. AD 650. This paper presents new data on the genetic diversity of C. sativa in Britain and Ireland and potential ancestral sources in continental Europe. Microsatellite markers and analytical methods tested in previous European studies were used to genotype over 600 C. sativa trees and coppice stools, sampled from ancient semi-natural woodlands, secondary woodlands and historic cultural sites across Britain and Ireland. A single overall genepool with a diverse admixture of genotypes was found, containing two sub groups differentiating Wales from Ireland, with discrete geographical and typological clusters. C. sativa genotypes in Britain and Ireland were found to relate predominantly to some sites in Portugal, Spain, France, Italy and Romania, but not to Greece, Turkey or eastern parts of Europe. C. sativa has come to Britain and Ireland from these western European areas, which had acted as refugia in the Last Glacial Maximum; we compare its introduction with the colonization/translocation of oak, ash, beech and hazel into Britain and Ireland. Clones of C. sativa were identified in Britain, defining for the first time the antiquity of some ancient trees and coppice stools, evincing both natural regeneration and anthropogenic propagation over many centuries and informing the chronology of the species' arrival in Britain. This new evidence on the origins and antiquity of British and Irish C. sativa trees enhances their conservation and economic significance, important in the context of increasing threats from environmental change, pests and pathogens.	[Jarman, Rob; Chambers, Frank M.; Webb, Julia] Univ Gloucestershire, Sch Nat & Social Sci, Ctr Environm Change & Quaternary Res, Cheltenham, Glos, England; [Mattioni, Claudia; Cherubini, Marcello; Villani, Fiorella] CNR, Ist Ric Ecosistemi Terrestri IRET, Porano, Italy; [Russell, Karen] K Russell Consulting Ltd, Huntingdon, England; [Bartlett, Debbie] Univ Greenwich, Fac Engn & Sci, Chatham, England; [Martin, M. Angela] Univ Cordoba, Dept Genet, Cordoba, Spain	University of Gloucestershire; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca sugli Ecosistemi Terrestri (IRET); University of Greenwich; Universidad de Cordoba	Jarman, R (corresponding author), Univ Gloucestershire, Sch Nat & Social Sci, Ctr Environm Change & Quaternary Res, Cheltenham, Glos, England.	rjarman1@glos.ac.uk	Martín, M. Angela/K-2157-2014	Martín, M. Angela/0000-0002-2674-9111; Jarman, Rob/0000-0002-3560-1266; MATTIONI, CLAUDIA/0000-0002-7009-9224; Webb, Julia/0000-0002-1652-965X	University of Greenwich (UK); Future Trees Trust (FTT)	University of Greenwich (UK); Future Trees Trust (FTT)	RJ received funding for this study from the University of Greenwich (UK). The Future Trees Trust (FTT) funded Karen Russell `KR' (K Russell Consulting Ltd) to provide samples from the FTT collection for DNA analysis. DNA analysis was undertaken by Dr Claudia Mattioni 'CM' (IRET), whose laboratory costs for this project were contributed to by FTT; RJ and KR prepared a preliminary report to FTT. FTT also supported Rob Jarman `RJ' (University of Gloucestershire) by contributing to the laboratory costs of DNA analysis of the Historic trees samples, undertaken by Dr Claudia Mattioni (IRET). The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript	Ally D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000454; [Anonymous], 2013, NFI PREL EST QUANT B; [Anonymous], 2012, LIME TREES BASSWOODS; [Anonymous], 2017, ANC TREE INV; Lopez-Saez JA, 2017, VEG HIST ARCHAEOBOT, V26, P167, DOI 10.1007/s00334-016-0575-x; Aravanopoulos Filippos A., 2001, Forest Snow and Landscape Research, V76, P429; Barreneche T, 2004, THEOR APPL GENET, V108, P558, DOI 10.1007/s00122-003-1462-2; Beare Philip O Sullivan, 2009, NATURAL HIST IRELAND; Beccaro GL, 2012, SILVAE GENET, V61, P292, DOI 10.1515/sg-2012-0037; Garzon MB, 2007, ECOGRAPHY, V30, P120, DOI [10.1111/j.2006.0906-7590.04813.x, 10.1111/j.0906-7590.2007.04813.x]; Boccacci P, 2009, GENET RESOUR CROP EV, V56, P851, DOI 10.1007/s10722-009-9406-6; Botanical Society of Britain & Ireland, BSBI DISTR DAT; Bounous G., 2005, Horticultural Reviews, V31, P291; Brown JA, 2016, TREE GENET GENOMES, V12, DOI 10.1007/s11295-016-1079-7; Buck EJ, 2003, MOL ECOL NOTES, V3, P239, DOI 10.1046/j.1471-8286.2003.00410.x; Buck EJ, 2006, THESIS; Buckley P., 2004, ENGL NAT RES REP; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Commission Forestry, REG PROV NAT SEED ZO; Conedera M, 2004, VEG HIST ARCHAEOBOT, V13, P161, DOI 10.1007/s00334-004-0038-7; Conedera M, 2016, EUROPEAN ATLAS FORES; CUNLIFFE B, 2009, PROCEEDINGS OF THE P, V75, P55; Diez CM, 2015, NEW PHYTOL, V206, P436, DOI 10.1111/nph.13181; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Fernandez-Cruz J, 2012, CONSERV GENET, V13, P1589, DOI 10.1007/s10592-012-0408-0; Fineschi S, 2003, CAN J FOREST RES, V33, P2503, DOI 10.1139/X03-179; Forbes AC, 1932, P ROY IRISH ACAD C, V41, P168; Godwin H., 1975, HIST BRIT FLORA; Harmer R., 1995, 259 RIN FOR AUTH; Heuertz M, 2004, MOL ECOL, V13, P3437, DOI 10.1111/j.1365-294X.2004.02333.x; Huntley B., 1983, ATLAS PRESENT POLLEN; Jarman R, 2019, BRITANNIA-CAMBRIDGE, V50, P49, DOI 10.1017/S0068113X19000011; Jarman R, 2017, COST ACTION FP1301 R, DOI [10.13140/RG.2.2.32665.42080, DOI 10.13140/RG.2.2.32665.42080]; Jarman R, 2018, DENDROCHRONOLOGIA, V51, P10, DOI 10.1016/j.dendro.2018.07.001; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Konovalov DA, 2008, MOL ECOL RESOUR, V8, P256, DOI 10.1111/j.1471-8286.2007.01940.x; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Krebs P, 2019, QUATERNARY SCI REV, V206, P111, DOI 10.1016/j.quascirev.2019.01.002; Kremer A., 2015, INT OAKS, V26, P19; Ledger PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121517; Lowe Andrew, 2005, Botanical Journal of Scotland, V57, P59; Lusini I, 2014, CONSERV GENET, V15, P283, DOI 10.1007/s10592-013-0537-0; Lynch M, 1999, GENETICS, V152, P1753; Magri D, 2006, NEW PHYTOL, V171, P199, DOI 10.1111/j.1469-8137.2006.01740.x; Marinoni D, 2003, MOL BREEDING, V11, P127, DOI 10.1023/A:1022456013692; Martin MA, 2010, TREE GENET GENOMES, V6, P735, DOI 10.1007/s11295-010-0287-9; Mattioni C, 2008, TREE GENET GENOMES, V4, P563, DOI 10.1007/s11295-008-0132-6; Mattioni C, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-017-1123-2; Miller AC, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu065; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Packham JR, 2012, J ECOL, V100, P1557, DOI 10.1111/j.1365-2745.2012.02017.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; PEETERS AG, 1988, GRANA, V27, P203, DOI 10.1080/00173138809428927; Pereira-Lorenzo S, 2019, ANN APPL BIOL, V174, P74, DOI 10.1111/aab.12474; Pereira-Lorenzo S, 2012, HANDB PLANT BREED, V8, P729, DOI 10.1007/978-1-4419-0763-9_19; Perica M, 2017, TREE GENET GENOMES, V13, P1; Perrier X., 2006, DARWIN SOFTWARE; Petit RJ, 2002, FOREST ECOL MANAG, V156, P49, DOI 10.1016/S0378-1127(01)00634-X; PIGOTT M, 2017, TREE GENET GENOMES, V13, P28, DOI [10.1016/J.56854, DOI 10.1016/J.56854]; Preston CD, 2004, BOT J LINN SOC, V145, P257, DOI 10.1111/j.1095-8339.2004.00284.x; Pritchard JK, 2000, GENETICS, V155, P945; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Rackham O., 2003, ANCIENT WOODLAND; Rackham O, 2006, WOODLANDS; Rambaut A, 2016, FIGTREE VERSION 1 4; Ramos-Cabrer A. M., 2006, Advances in Horticultural Science, V20, P113; Rippon S., 2013, LANDSCAPES, V14, P33, DOI 10.1179/1466203513Z.0000000005; Roces-Diaz JV, 2018, PALAEOGEOGR PALAEOCL, V491, P152, DOI 10.1016/j.palaeo.2017.12.004; Rousset F., GENEPOP WEB; Silva Evelyn J., 1706, DISCOURSE FOREST TRE; Sjolund MJ, 2017, J BIOGEOGR, V44, P2475, DOI 10.1111/jbi.13053; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; Squatriti P, 2013, LANDSCAPE AND CHANGE IN EARLY MEDIEVAL ITALY: CHESTNUTS, ECONOMY, AND CULTURE, P1; Stace C.A., 2015, ALIEN PLANTS; Sutherland BG, 2010, MOL ECOL, V19, P2196, DOI 10.1111/j.1365-294X.2009.04376.x; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Vaughan SP, 2007, FOREST ECOL MANAG, V242, P419, DOI 10.1016/j.foreco.2007.01.059; Wang J, 2017, HEREDITY, V119, P302, DOI 10.1038/hdy.2017.52	79	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222936	10.1371/journal.pone.0222936	http://dx.doi.org/10.1371/journal.pone.0222936			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553775	Green Accepted, Green Published, gold			2022-12-26	WOS:000532319200046
J	Kranner, BP; Afrooz, ARMN; Fitzgerald, NJM; Boehm, AB				Kranner, Benjamin P.; Afrooz, A. R. M. Nabiul; Fitzgerald, Nicole J. M.; Boehm, Alexandria B.			Fecal indicator bacteria and virus removal in stormwater biofilters: Effects of biochar, media saturation, and field conditioning	PLOS ONE			English	Article							ESCHERICHIA-COLI REMOVAL; FILTRATION-ELUTION METHOD; POROUS-MEDIA; PYROLYSIS TEMPERATURE; TRANSPORT BEHAVIOR; SOLUTION CHEMISTRY; ACTIVATED CARBON; CELL PROPERTIES; F-RNA; SYSTEMS	Stormwater biofilters are used to attenuate the flow and volume of runoff and reduce pollutant loading to aquatic systems. However, the capacity of biofilters to remove microbial contaminants remains inadequate. While biochar has demonstrated promise as an amendment to improve microbial removal in laboratory-scale biofilters, it is uncertain if the results are generalizable to the field. To assess biochar performance in a simulated field setting, sand and biochar-amended sand biofilters were periodically dosed with natural stormwater over a 61-week conditioning phase. Impact of media saturation was assessed by maintaining biofilters with and without a saturated zone. Biochar-amended biofilters demonstrated improved Escherichia coli removal over sand biofilters during the first 31 weeks of conditioning though media type did not impact E. coli removal during the last 30 weeks of conditioning. Presence of a saturated zone was not a significant factor influencing E. coli removal across the entire conditioning phase. Following conditioning, biofilters underwent challenge tests using stormwater spiked with wastewater to assess their capacity to remove wastewater-derived E. coli, enterococci, and male-specific (F+) coliphage. In challenge tests, biochar-amended biofilters demonstrated enhanced removal of all fecal indicators relative to sand biofilters. Additionally, saturated biofilters demonstrated greater removal of fecal indicators than unsaturated biofilters for both media types. Discrepant conclusions from the conditioning phase and challenge tests may be due to variable influent chemistry, dissimilar transport of E. coli indigenous to stormwater and those indigenous to wastewater, and differences in E. coli removal mechanisms between tests. Mobilization tests conducted following challenge tests showed minimal (<2.5%) observable mobilization of fecal indicators, regardless of media type and presence of a saturated zone. While our results emphasize the challenge of translating biochar's performance from the laboratory to the field, findings of this study inform biofilter design to remove microbial contaminants from urban stormwater.	[Kranner, Benjamin P.; Boehm, Alexandria B.] Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA; [Kranner, Benjamin P.; Fitzgerald, Nicole J. M.; Boehm, Alexandria B.] Engn Res Ctr ERC Reinventing Nat Urban Water Infr, Stanford, CA 94305 USA; [Afrooz, A. R. M. Nabiul] Calif State Water Resources Control Board, Sacramento, CA USA; [Fitzgerald, Nicole J. M.] Colorado Sch Mines, Dept Civil & Environm Engn, Golden, CO 80401 USA	Stanford University; Colorado School of Mines	Boehm, AB (corresponding author), Stanford Univ, Dept Civil & Environm Engn, Stanford, CA 94305 USA.; Boehm, AB (corresponding author), Engn Res Ctr ERC Reinventing Nat Urban Water Infr, Stanford, CA 94305 USA.	aboehm@stanford.edu		Boehm, Alexandria/0000-0002-8162-5090	NSF [EEC-1028968]	NSF(National Science Foundation (NSF))	This work received funding from NSF through grant number EEC-1028968, NSF = US National Science Foundation (www.nsf.gov) to AB. The sponsor played no role in the study design, data collection and analysis, decision to publish or prep of the manuscript.	Abit SM, 2014, J ENVIRON QUAL, V43, P371, DOI 10.2134/jeq2013.06.0236; Abit SM, 2012, ENVIRON SCI TECHNOL, V46, P8097, DOI 10.1021/es300797z; Abu-Lail NI, 2003, BIOMACROMOLECULES, V4, P1000, DOI 10.1021/bm034055f; Afrooz ARMN, 2018, ENVIRON SCI-WAT RES, V4, P2160, DOI 10.1039/c8ew00297e; Afrooz ARMN, 2017, ECOL ENG, V102, P320, DOI 10.1016/j.ecoleng.2017.02.053; Afrooz ARMN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167489; Ahmad M, 2014, CHEMOSPHERE, V99, P19, DOI 10.1016/j.chemosphere.2013.10.071; Alhashimi HA, 2017, RESOUR CONSERV RECY, V118, P13, DOI 10.1016/j.resconrec.2016.11.016; Ambrose RF, 2015, WIRES WATER, V2, P131, DOI 10.1002/wat2.1064; [Anonymous], SANT CLAR VALL URB R; Arnold JW, 2000, POULTRY SCI, V79, P1839, DOI 10.1093/ps/79.12.1839; Ballona Creek Watershed Management Group, 2016, ENH WAT MAN PROGR BA; Barrett ME, 2013, J ENVIRON ENG-ASCE, V139, P462, DOI 10.1061/(ASCE)EE.1943-7870.0000551; Becker MW, 2004, J CONTAM HYDROL, V69, P195, DOI 10.1016/j.jconhyd.2003.08.001; Bell CD, 2019, J SUSTAIN WATER BUIL, V5, DOI 10.1061/JSWBAY.0000871; Bolster CH, 2009, J ENVIRON QUAL, V38, P465, DOI 10.2134/jeq2008.0137; Bolster CH, 2012, J ENVIRON QUAL, V41, P124, DOI 10.2134/jeq2011.0207; California Stormwater Quality Association (CASQA), 2003, CAL STORMW QUAL ASS; Chandrasena GI, 2014, J HYDROL, V519, P814, DOI 10.1016/j.jhydrol.2014.08.015; Chandrasena GI, 2012, WATER SCI TECHNOL, V66, P1132, DOI 10.2166/wst.2012.283; Chung JW, 2014, J ENVIRON QUAL, V43, P2096, DOI 10.2134/jeq2014.05.0199; Díaz Carolina, 2007, Mat. Res., V10, P11, DOI 10.1590/S1516-14392007000100004; Dietz ME, 2006, ENVIRON SCI TECHNOL, V40, P1335, DOI 10.1021/es051644f; Dietz ME, 2007, WATER AIR SOIL POLL, V186, P351, DOI 10.1007/s11270-007-9484-z; FONTES DE, 1991, APPL ENVIRON MICROB, V57, P2473, DOI 10.1128/AEM.57.9.2473-2481.1991; Foppen JW, 2008, WATER RES, V42, P211, DOI 10.1016/j.watres.2007.06.064; Fraser AN, 2018, WATER-SUI, V10, DOI 10.3390/w10081065; George's County P, 2000, LOW IMPACT DEV DESIG; Geosyntec Consultants Wright Water Engineers, 2016, INT STORMW BEST MAN; Grebel JE, 2013, ENVIRON ENG SCI, V30, P437, DOI 10.1089/ees.2012.0312; Hathaway JM, 2011, J ENVIRON ENG, V137, P1103, DOI 10.1061/(ASCE)EE.1943-7870.0000444; Haznedaroglu BZ, 2009, ENVIRON SCI TECHNOL, V43, P1838, DOI 10.1021/es802531k; Jarvis B, 2010, J APPL MICROBIOL, V109, P1660, DOI 10.1111/j.1365-2672.2010.04792.x; Kim HN, 2009, ENVIRON SCI TECHNOL, V43, P4340, DOI 10.1021/es8026055; Krometis LAH, 2007, WATER RES, V41, P506, DOI 10.1016/j.watres.2006.09.029; Krometis LAH, 2010, J WATER HEALTH, V8, P44, DOI 10.2166/wh.2009.032; Krometis LAH, 2009, J ENVIRON ENG-ASCE, V135, P758, DOI 10.1061/(ASCE)EE.1943-7870.0000040; Larry Walker Associates Geosyntec Consultants, 2011, VENT COUNT TECHN GUI; Lau AYT, 2017, CHEMOSPHERE, V169, P89, DOI 10.1016/j.chemosphere.2016.11.048; Li YL, 2012, ECOL ENG, V49, P137, DOI 10.1016/j.ecoleng.2012.08.007; Liu Y, 2008, ENVIRON SCI TECHNOL, V42, P443, DOI 10.1021/es071861b; McLellan SL, 2004, APPL ENVIRON MICROB, V70, P4658, DOI 10.1128/AEM.70.8.4658-4665.2004; MEMPIN R, 2013, BMC MICROBIOL, V13, DOI DOI 10.1186/1471-2180-13-13; Mendez J, 2004, J VIROL METHODS, V117, P19, DOI 10.1016/j.jviromet.2003.11.013; Mohanty SK, 2015, WATER RES, V85, P208, DOI 10.1016/j.watres.2015.08.026; Mohanty SK, 2014, ENVIRON SCI TECHNOL, V48, P11535, DOI 10.1021/es5033162; Mohanty SK, 2014, WATER RES, V61, P288, DOI 10.1016/j.watres.2014.05.026; Mohanty SK, 2013, ENVIRON SCI TECHNOL, V47, P10791, DOI 10.1021/es305136b; Olivieri A., 2015, WATER INTELL ONLINE, DOI [10.2166/9781780403809, DOI 10.2166/9781780403809]; Parker JC, 1984, DETERMINING TRANSPOR; Peng J, 2016, WATER-SUI, V8, DOI 10.3390/w8120600; Pintelon TRR, 2012, BIOTECHNOL BIOENG, V109, P1031, DOI 10.1002/bit.24381; Reddy KR, 2014, J GEOTECH GEOENVIRON, V140, DOI 10.1061/(ASCE)GT.1943-5606.0001015; Rippy MA, 2015, WIRES WATER, V2, P577, DOI 10.1002/wat2.1096; Roberts KG, 2010, ENVIRON SCI TECHNOL, V44, P827, DOI 10.1021/es902266r; Sasidharan S, 2016, SCI TOTAL ENVIRON, V548, P100, DOI 10.1016/j.scitotenv.2015.12.126; Schafer A, 1998, J CONTAM HYDROL, V33, P149, DOI 10.1016/S0169-7722(98)00069-2; Schneider DA, 2004, J BIOL CHEM, V279, P8262, DOI 10.1074/jbc.M311996200; Seagren EA, 1999, J CONTAM HYDROL, V37, P111, DOI 10.1016/S0169-7722(98)00157-0; Silliman SE, 2001, WATER RESOUR RES, V37, P2699, DOI 10.1029/2001WR000331; Sinton LW, 1996, J MICROBIOL METH, V25, P257, DOI 10.1016/0167-7012(95)00100-X; Stevik TK, 2004, WATER RES, V38, P1355, DOI 10.1016/j.watres.2003.12.024; Suliman W, 2017, ENVIRON SCI TECHNOL, V51, P5071, DOI 10.1021/acs.est.6b04535; Tang P, 2017, ENVIRON SCI POLLUT R, V24, P9210, DOI 10.1007/s11356-017-8458-y; Ulrich BA, 2017, ENVIRON SCI-WAT RES, V3, P726, DOI 10.1039/c7ew00070g; United States Department of Agriculture Natural Resources Conservation Service, 1986, URB HYDR SMALL WAT T, V55; United States Environmental Protection Agency, 2000, LOW IMP DEV LID LIT, DOI [10.1016/j.biocon.2009.12.004, DOI 10.1016/J.BIOCON.2009.12.004]; United States Environmental Protection Agency, 2015, REV COL POSS IND FEC; US Department of Agriculture Natural Resources Conservation Service, WEB SOIL SURV; Velten S, 2007, WATER RES, V41, P1973, DOI 10.1016/j.watres.2007.01.021; Wolfand JM, 2018, ENVIRON SCI TECHNOL, V52, P6370, DOI 10.1021/acs.est.8b00408; Yang W, 2019, ENVIRON POLLUT, V246, P855, DOI 10.1016/j.envpol.2018.12.075; Zhang L, 2012, WATER ENVIRON RES, V84, P485, DOI 10.2175/106143012X13280358613589; 2009, URB STORMW MAN US, P1	74	17	18	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222719	10.1371/journal.pone.0222719	http://dx.doi.org/10.1371/journal.pone.0222719			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553761	Green Published, gold			2022-12-26	WOS:000532319200034
J	Gaspard, P; Mosnier, A; Simon, L; Ali-Brandmeyer, O; Rabaud, C; Larocca, S; Heck, B; Aho-Glele, S; Pothier, P; Ambert-Balay, K				Gaspard, Philippe; Mosnier, Anne; Simon, Loic; Ali-Brandmeyer, Olivia; Rabaud, Christian; Larocca, Sabrina; Heck, Beatrice; Aho-Glele, Serge; Pothier, Pierre; Ambert-Balay, Katia			Gastroenteritis and respiratory infection outbreaks in French nursing homes from 2007 to 2018: Morbidity and all-cause lethality according to the individual characteristics of residents	PLOS ONE			English	Article							CARE FACILITIES; INFLUENZA; MORTALITY; NOROVIRUS; EPIDEMIOLOGY; DEATHS; ADULTS	Background Gastroenteritis (GE) and respiratory tract infection (RTI) outbreaks are a significant issue in nursing homes. This study aimed to describe GE and RTI outbreaks with infection and all-cause lethality rates according to the individual characteristics of nursing home residents. Methods Clinical and virological surveillance were conducted (2007 to 2018). Virus stratifications for the analysis were: outbreaks with positive norovirus or influenza identifications (respectively NoV+ or Flu+), episodes with no NoV or influenza identification or testing (respectively No-Vor Flu-). Associations between individual variables (sex, age, length of stay (LOS), autonomy status) and infection and lethality rates were tested with univariate and Mantel-Haenszel (MH) methods. Results 61 GE outbreaks and 76 RTI oubreaks (total 137 outbreaks) were recorded involving respectively 4309 and 5862 residents. In univariate analysis, higher infection rates and age were associated in NoV+, NoV-, and Flu+ contexts, and lower infection rates were associated with longer stays (NoV+ and NoV-). In MH stratified analysis (virus, sex (female/male)) adjusted for LOS (< 4 or.4 years), the odds of being infected remained significant among older residents (.86 years): NoV+/male (Odds ratio (ORMH): 1.64, 95% confidence interval (CI): 1.16-2.30) and Flu+/female and male (respectively ORMH: 1.50, CI: 1.27-1.79 and 1.73, CI: 1.28-2.33). In univariate analysis, lower autonomy status (NoV+, Flu+ and Flu-) and increased age (Flu+) were associated with higher lethality. In MH adjusted analysis, significant ORage adjusted for autonomy was: Flu+/>= 86 years compared with <86 years, 1.97 (1.19-3.25) and ORautonomy adjusted for age for the more autonomous group (compared with the less autonomous group) was: Flu+, 0.41 (0.24-0.69); Flu-, 0.42 (0.20, 0.90). Conclusion The residents of nursing homes are increasingly elderly and dependent. The specific infection and lethality risks according to these two factors indicate that surveillance and infection control measures are essential and of high priority.	[Gaspard, Philippe; Larocca, Sabrina; Heck, Beatrice] Rouffach Hosp Ctr, Hosp Hyg Serv, Rouffach, France; [Gaspard, Philippe] Univ Franche Comte, UMR Chronoenvironm 6249, Besancon, France; [Mosnier, Anne] Open Rome, Paris, France; [Simon, Loic; Ali-Brandmeyer, Olivia; Rabaud, Christian] Nancy Univ Hosp, Coordinat Ctr Nosocomial Infect Control, Eastern Reg, Nancy, France; [Aho-Glele, Serge] Dijon Univ Hosp, Dept Epidemiol & Infect Control, Dijon, France; [Pothier, Pierre; Ambert-Balay, Katia] Univ Burgundy Franche Comte, AgroSup Dijon, PAM UMR A 02 102, Dijon, France; [Pothier, Pierre; Ambert-Balay, Katia] Univ Hosp, Natl Reference Ctr Gastroenteritis Viruses, Lab Biol & Pathol, Dijon, France	Universite de Franche-Comte; CHU de Nancy; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; CHU Dijon Bourgogne	Gaspard, P (corresponding author), Rouffach Hosp Ctr, Hosp Hyg Serv, Rouffach, France.; Gaspard, P (corresponding author), Univ Franche Comte, UMR Chronoenvironm 6249, Besancon, France.	ph.gaspard@ch-rouffach.fr	Serge, Aho Glele Ludwig/AAP-8863-2021; AHO, ludwig/AAR-5753-2021	Serge, Aho Glele Ludwig/0000-0001-7590-8644; 				Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266; BARKER WH, 1982, ARCH INTERN MED, V142, P85, DOI 10.1001/archinte.142.1.85; Barret AS, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.29.20859; Benaim C., 2005, Annales de Readaptation et de Medecine Physique, V48, P336, DOI 10.1016/j.annrmp.2005.04.005; Bernard H, 2014, EPIDEMIOL INFECT, V142, P63, DOI 10.1017/S0950268813000435; Brummel NE, 2017, AM J RESP CRIT CARE, V196, P64, DOI 10.1164/rccm.201605-0939OC; Campe H, 2016, EPIDEMIOL INFECT, V144, P1045, DOI 10.1017/S0950268815002228; Casalegno J, 2017, EUROSURVEILLANCE, V22, P26, DOI [10.2807/1560-7917.ES.2017.22.14.30504, 10.2807/1560-7917.es.2017.22.14.30504]; Duchamp MB, 2010, CLIN MICROBIOL INFEC, V16, P317, DOI 10.1111/j.1469-0691.2010.03169.x; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; European Centre for Disease Prevention and Control, PROT POINT PREV SURV; Falsey AR, 2015, INFLUENZA OTHER RESP, V9, P23, DOI 10.1111/irv.12316; Friesema IHM, 2009, EPIDEMIOL INFECT, V137, P1722, DOI 10.1017/S095026880900274X; Gaspard P, 2015, J HOSP INFECT, V91, P19, DOI 10.1016/j.jhin.2015.05.012; Gaspard P, 2015, PRESSE MED, V44, pE311, DOI 10.1016/j.lpm.2015.04.041; Harris JP, 2008, EMERG INFECT DIS, V14, P1546, DOI 10.3201/eid1410.080188; Institut national de veille sanitaire, ENQ NAT PREV 2006 IN; Karst SM, 2010, VIRUSES-BASEL, V2, P748, DOI 10.3390/v2030748; Lemaitre M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-162; Montoya Ana, 2011, Aging health, V7, P889; Petrignani M, 2015, J HOSP INFECT, V89, P163, DOI 10.1016/j.jhin.2014.11.015; Rainwater-Lovett K, 2014, INFLUENZA OTHER RESP, V8, P74, DOI 10.1111/irv.12203; Rondy M, 2017, J INFECTION, V75, P381, DOI 10.1016/j.jinf.2017.09.010; Schanzer DL, 2008, VACCINE, V26, P4697, DOI 10.1016/j.vaccine.2008.06.087; Turbelin C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065919; Ursic T, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1962-8; Utsumi M, 2010, AGE AGEING, V39, P299, DOI 10.1093/ageing/afq029; van Asten L, 2011, EPIDEMIOLOGY, V22, P336, DOI 10.1097/EDE.0b013e31821179af	28	8	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222321	10.1371/journal.pone.0222321	http://dx.doi.org/10.1371/journal.pone.0222321			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550261	gold, Green Published			2022-12-26	WOS:000532307700013
J	Welch, D; Kahen, E; Fridley, B; Brohl, AS; Cubitt, CL; Reed, DR				Welch, Darcy; Kahen, Elliot; Fridley, Brooke; Brohl, Andrew S.; Cubitt, Christopher L.; Reed, Damon R.			Small molecule inhibition of lysine-specific demethylase 1 (LSD1) and histone deacetylase (HDAC) alone and in combination in Ewing sarcoma cell lines	PLOS ONE			English	Article							GENOMIC LANDSCAPE; TRIAL; GROWTH; OSTEOSARCOMA; CHEMOTHERAPY; PANOBINOSTAT; ANTAGONIST; MECHANISM	Ewing Sarcoma (ES) is characterized by recurrent translocations between EWSR1 and members of the ETS family of transcription factors. The transcriptional activity of the fusion oncoprotein is dependent on interaction with the nucleosome remodeling and deactylase (NuRD) co-repressor complex. While inhibitors of both histone deacetylase (HDAC) and lysine-specific demethylase-1 (LSD1) subunits of the NuRD complex demonstrate single agent activity in preclinical models, combination strategies have not been investigated. We selected 7 clinically utilized chemotherapy agents, or active metabolites thereof, for experimentation: doxorubicin, cyclophosphamide, vincristine, etoposide and irinotecan as well as the HDAC inhibitor romidepsin and the reversible LSD1 inhibitor SP2509. All agents were tested at clinically achievable concentrations in 4 ES cell lines. All possible 2 drug combinations were then tested for potential synergy. Order of addition of second-line conventional combination therapy agents was tested with the addition of SP2509. In two drug experiments, synergy was observed with several combinations, including when SP2509 was paired with topoisomerase inhibitors or romidepsin. Addition of SP2509 after treatment with second-line combination therapy agents enhanced treatment effect. Our findings suggest promising combination treatment strategies that utilize epigenetic agents in ES.	[Welch, Darcy; Kahen, Elliot; Reed, Damon R.] H Lee Moffitt Canc Ctr & Res Inst, Sunshine Lab, Tampa, FL 33612 USA; [Welch, Darcy; Kahen, Elliot; Cubitt, Christopher L.] H Lee Moffitt Canc Ctr & Res Inst, Translat Res Core, Tampa, FL USA; [Fridley, Brooke] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat, Tampa, FL USA; [Brohl, Andrew S.; Reed, Damon R.] H Lee Moffitt Canc Ctr & Res Inst, Sarcoma Dept, Tampa, FL 33612 USA; [Brohl, Andrew S.; Reed, Damon R.] H Lee Moffitt Canc Ctr & Res Inst, Chem Biol & Mol Med Program, Tampa, FL 33612 USA; [Reed, Damon R.] H Lee Moffitt Canc Ctr & Res Inst, Adolescent & Young Adult Program, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Reed, DR (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Sunshine Lab, Tampa, FL 33612 USA.; Reed, DR (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Sarcoma Dept, Tampa, FL 33612 USA.; Reed, DR (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Chem Biol & Mol Med Program, Tampa, FL 33612 USA.; Reed, DR (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Adolescent & Young Adult Program, Tampa, FL 33612 USA.	damon.reed@moffitt.org	Brohl, Andrew/ABB-6710-2020	Reed, Damon/0000-0002-8238-2465; Cubitt, Christopher/0000-0001-6343-7451	National Pediatric Cancer Foundation; Translational Research Core at the H. Lee Moffitt Cancer Center & Research Institute, a NCI designated Comprehensive Cancer Center [P30-CA076292]; NATIONAL CANCER INSTITUTE [P30CA076292] Funding Source: NIH RePORTER	National Pediatric Cancer Foundation; Translational Research Core at the H. Lee Moffitt Cancer Center & Research Institute, a NCI designated Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was generously supported by the National Pediatric Cancer Foundation (www.nationalpcf.org). This work has been supported in part by the Translational Research Core at the H. Lee Moffitt Cancer Center & Research Institute, a NCI designated Comprehensive Cancer Center (P30-CA076292). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaqer SF, 2017, ONCOTARGET, V8, P73372, DOI 10.18632/oncotarget.19637; Brohl AS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004475; Cassier PA, 2013, BRIT J CANCER, V109, P909, DOI 10.1038/bjc.2013.442; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Crompton BD, 2014, CANCER DISCOV, V4, P1326, DOI 10.1158/2159-8290.CD-13-1037; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; El-Najjar Nahed, 2011, J Chem Biol, V4, P97, DOI 10.1007/s12154-010-0052-4; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Fang J, 2013, AAPS J, V15, P15, DOI 10.1208/s12248-012-9409-7; Feng ZZ, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0252-7; Fiskus W, 2014, LEUKEMIA, V28, P2155, DOI 10.1038/leu.2014.119; Franzetti GA, 2017, ONCOGENE, V36, P3505, DOI 10.1038/onc.2016.498; Goldsby RE, 2013, EUR J CANCER, V49, P2384, DOI 10.1016/j.ejca.2013.03.018; Gorlick R, 2013, PEDIATR BLOOD CANCER, V60, P1009, DOI 10.1002/pbc.24429; Gupta S, 2016, PROSTATE CANCER P D, V19, P349, DOI 10.1038/pcan.2016.21; Hayami S, 2011, INT J CANCER, V128, P574, DOI 10.1002/ijc.25349; Haydn T, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.239; Kahen E, 2016, CANCER CHEMOTH PHARM, V78, P313, DOI 10.1007/s00280-016-3077-8; Kalin JH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02242-4; Maes T, 2018, CANCER CELL, V33, P495, DOI 10.1016/j.ccell.2018.02.002; May WA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080060; McGrath JP, 2016, CANCER RES, V76, P1975, DOI 10.1158/0008-5472.CAN-15-2333; Meyers PA, 2005, J CLIN ONCOL, V23, P2004, DOI 10.1200/JCO.2005.06.031; Mohammad HP, 2015, CANCER CELL, V28, P57, DOI 10.1016/j.ccell.2015.06.002; Palmerini E, 2018, ACTA ONCOL, V57, P958, DOI 10.1080/0284186X.2018.1449250; Pishas KI, 2018, MOL CANCER THER, V17, P1902, DOI 10.1158/1535-7163.MCT-18-0373; Reed DR, 2017, CANCER-AM CANCER SOC, V123, P2206, DOI 10.1002/cncr.30589; Romo-Morales A, 2019, PEDIATR BLOOD CANCER, V66, DOI 10.1002/pbc.27888; Rudolph T, 2007, MOL CELL, V26, P103, DOI 10.1016/j.molcel.2007.02.025; Sankar S, 2013, ONCOGENE, V32, P5089, DOI 10.1038/onc.2012.525; Sankar S, 2014, CLIN CANCER RES, V20, P4584, DOI 10.1158/1078-0432.CCR-14-0072; Sato T, 2017, CANCER RES, V77, P470, DOI 10.1158/0008-5472.CAN-16-0834; Sehrawat A, 2018, P NATL ACAD SCI USA, V115, pE4179, DOI 10.1073/pnas.1719168115; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Sonnemann J, 2007, J CANCER RES CLIN, V133, P847, DOI 10.1007/s00432-007-0227-8; Sonnemann J, 2018, BRIT J HAEMATOL, V183, P494, DOI 10.1111/bjh.14983; Thomas S, 2016, ANN ONCOL, V27, P947, DOI 10.1093/annonc/mdw044; Tirode F, 2014, CANCER DISCOV, V4, P1342, DOI 10.1158/2159-8290.CD-14-0622; Wagner LM, 2015, CLIN SARCOMA RES, V5, DOI 10.1186/s13569-015-0035-x; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Womer RB, 2012, J CLIN ONCOL, V30, P4148, DOI 10.1200/JCO.2011.41.5703; Yu D, 2015, SCI REP-UK, V5, DOI 10.1038/srep16991; Zollner SK, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aam8429	43	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222228	10.1371/journal.pone.0222228	http://dx.doi.org/10.1371/journal.pone.0222228			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550266	Green Published, gold			2022-12-26	WOS:000532307700011
J	Bo, AB; Kim, JD; Kim, YS; Sin, HT; Kim, HJ; Khaitov, B; Ko, YK; Park, KW; Choi, JS				Bo, Aung B.; Kim, Jae D.; Kim, Young S.; Sin, Hun T.; Kim, Hye J.; Khaitov, Botir; Ko, Young K.; Park, Kee W.; Choi, Jung S.			Isolation, identification and characterization of Streptomyces metabolites as a potential bioherbicide	PLOS ONE			English	Article							HERBICIDAL ACTIVITY; BIOLOGICAL-CONTROL; PATHOGENS; AGENTS; RESISTANT; WEEDS	Bioactive herbicidal compounds produced by soil microorganisms might be used to creating a bioherbicide for biological weed control. A total of 1,300 bacterial strains were isolated and screened for herbicidal activity against grass and broadleaf weeds. Among primarily selected 102 strains, the herbicidal activity of bacterial fermentation broths from the following three isolates strain-101, strain-128, and strain-329 reduced the growth of D. sanguinalis by 66.7%, 78.3%, and 100%, respectively as compared with control. Phylogenetic analysis of 16S rRNA gene sequencing determined that the strain-329 has 99% similarity to Streptomyces anulatus (HBUM 174206). The potential bioherbicidal efficacy of Streptomyces strain-329 was tested on grass and broadleaf weeds for phytotoxic activity through pre- and post-emergence applications. At pre-emergence application, the phytotoxic efficacy to D. sanguinalis and S. bicolor on seed germination were 90.4% and 81.3%, respectively at the 2x concentration, whereas in the case of Solanum nigrum, 85.2% phytotoxic efficacy was observed at the 4x concentration. The efficacy of Streptomyces strain-329 was substantially higher at post-emergence application, presenting 100% control of grass and broadleaf weeds at the 1x concentration. Two herbicidal compounds coded as 329-C1 and 329-C3 were extracted and purified by column chromatography and high-performance liquid chromatography methods. The active compound 329-C3 slightly increased leaf electrolytic leakage and MDA production as concentration-dependent manner. These results suggest that new Streptomyces sp. strain-329 produced bioherbicidal metabolites and may provide a new lead molecule for production an efficient bioherbicide to regulate grass and broadleaf weeds.	[Bo, Aung B.; Sin, Hun T.; Khaitov, Botir; Park, Kee W.] Chungnam Natl Univ, Dept Crop Sci, Daejeon, South Korea; [Kim, Jae D.; Kim, Young S.; Kim, Hye J.; Ko, Young K.; Choi, Jung S.] Korea Res Inst Chem Technol, Ecofriendly & New Mat Res Grp, Daejeon, South Korea	Chungnam National University; Korea Research Institute of Chemical Technology (KRICT)	Park, KW (corresponding author), Chungnam Natl Univ, Dept Crop Sci, Daejeon, South Korea.; Choi, JS (corresponding author), Korea Res Inst Chem Technol, Ecofriendly & New Mat Res Grp, Daejeon, South Korea.	parkkw@cnu.ac.kr; jschoi@krict.re.kr		Khaitov, Botir/0000-0001-6314-1597; Park, Kee Woong/0000-0003-0053-9543	grant "Cooperative Research Program for Agriculture Science & Technology Development" from Rural Development Administration, Republic of Korea [PJ013479]	grant "Cooperative Research Program for Agriculture Science & Technology Development" from Rural Development Administration, Republic of Korea	This work was supported by a grant "Cooperative Research Program for Agriculture Science & Technology Development (PJ013479)" from Rural Development Administration, Republic of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arasu MV, 2009, J MYCOL MED, V19, P22, DOI 10.1016/j.mycmed.2008.12.002; Basilio A, 2003, J APPL MICROBIOL, V95, P814, DOI 10.1046/j.1365-2672.2003.02049.x; Buege J A, 1978, Methods Enzymol, V52, P302; CAI XY, 2016, HORTICULTURAE, V2, DOI DOI 10.1104/PP.108.118372; CHRISTY AL, 1993, ACS SYM SER, V524, P87; Chun JC, 2002, PESTIC BIOCHEM PHYS, V72, P153, DOI 10.1016/S0048-3575(02)00008-1; Daguerre Y, 2014, FUNGAL BIOL REV, V28, P97, DOI 10.1016/j.fbr.2014.11.001; Daniel JJ, 2018, BIOCATAL AGR BIOTECH, V14, P314, DOI 10.1016/j.bcab.2018.04.001; Dayan FE, 2008, PLANT PHYSIOL, V147, P1062, DOI 10.1104/pp.108.118372; DEFRANK J, 1985, WEED SCI, V33, P271, DOI 10.1017/S0043174500082242; Dhanasekaran D., 2012, Archives of Phytopathology and Plant Protection, V45, P505, DOI 10.1080/03235408.2011.587988; El-Sayed MG, 2014, J AM SCI, V10, P11, DOI [10.1111/j.1574-6976.2012.00349.x, DOI 10.1111/J.1574-6976.2012.00349.X]; El-Sayed W, 2005, Z PFLANZENK PFLANZEN, V112, P209; Ghorbani R, 2005, ADV AGRON, V86, P191, DOI 10.1016/S0065-2113(05)86004-3; Ha S, 2017, J MICROBIOL BIOTECHN, V27, P947, DOI 10.4014/jmb.1611.11005; Harding DP, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00659; HAYAKAWA M, 1987, J FERMENT BIOENG, V65, P501, DOI 10.1016/0385-6380(87)90108-7; HEISEY RM, 1985, ACS SYM SER, V268, P337; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Hoagland R. E., 2016, American Journal of Plant Sciences, V7, P2376, DOI 10.4236/ajps.2016.716208; Hwang EI, 2005, J MICROBIOL BIOTECHN, V15, P434; Igarashi M, 1997, J ANTIBIOT, V50, P1020, DOI 10.7164/antibiotics.50.1020; Isrvan U., 2002, PHYTOPARASITICA, V30, P1; Ji Y G, 2006, BIOTECHNOLOGY, V16, P88; KUSTER E., 1963, MICROBIOL ESPANOLA, V16, P193; Lee Boyoung, 2013, Weed & Turfgrass Science, V2, P38; Lee HB, 2003, LETT APPL MICROBIOL, V36, P387, DOI 10.1046/j.1472-765X.2003.01327.x; NAKAJIMA M, 1991, J ANTIBIOT, V44, P293, DOI 10.7164/antibiotics.44.293; Rana SS, 2016, PRINCIPLES PRACTICES, P138; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sondhia S, 2003, J GEOBIOS, V30, P173; Stergiopoulos I, 2013, FEMS MICROBIOL REV, V37, P67, DOI 10.1111/j.1574-6976.2012.00349.x; Subhashini DV, 2012, INDIAN J AGR SCI, V82, P12; Todero I, 2018, SCI HORTIC-AMSTERDAM, V241, P285, DOI 10.1016/j.scienta.2018.07.009; Vasilakoglou IB, 2000, WEED TECHNOL, V14, P524, DOI 10.1614/0890-037X(2000)014[0524:PRBECG]2.0.CO;2; Walton JD, 1996, PLANT CELL, V8, P1723, DOI 10.1105/tpc.8.10.1723; Won OJ, 2016, J FAC AGR KYUSHU U, V61, P47; Xu WP, 2009, WEED SCI, V57, P547, DOI 10.1614/WS-08-154.1; Yandoc CB, 2005, WEED TECHNOL, V19, P19, DOI 10.1614/WT-03-104R1; Yasuor H, 2008, PEST MANAG SCI, V64, P1031, DOI 10.1002/ps.1604	40	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222933	10.1371/journal.pone.0222933	http://dx.doi.org/10.1371/journal.pone.0222933			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545849	Green Published, gold			2022-12-26	WOS:000532303200042
J	Eren, C				Eren, Canan			An analysis on HBsAg, Anti-HCV, Anti-HIV1/2 and VDRL test results in blood donors according to gender, age range and years	PLOS ONE			English	Article							TRANSFUSION-TRANSMISSIBLE INFECTIONS; HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-C VIRUS; B-VIRUS; SEROPREVALENCE; SYPHILIS	Objective Blood transfusion is the most frequently used and life-saving therapeutic procedure today. Transmission of virus, bacteria and parasitic microorganisms may occur due to transfusion (Transfusion transmitted infections-TTIs). Hepatitis B and C, human immunodeficiency virus (HIV) and syphilis (Treponema pallidum) bear the risk of transmission by transfusion. Hepatitis B surface antigen (HBsAg), anti-HCV, anti-HIV 1/2 and syphilis antibody (VDRL: Venereal Disease Research Laboratory) are routinely controlled in all donated blood samples. The aim of the present study was to analyze the seroprevalence rates of blood donors through screening test results according to duration, age range and gender. Material and methods Data of all blood donors obtained from blood Centre of Marmara University Pendik Training and Research Hospital between January 2013 and October 2018 were analyzed retrospectively. Serum samples of the donors were analyzed for HBsAg, anti-HCV, anti-HIV 1/2 and VDRL. Test results of 114.240 donors were scanned. Gender, age range and distribution by years of these donors were analyzed. According to age distribution of donors were divided into 4 groups. Results There were 114.240 participants including 106.153 (92.9%) males and 8.087 (7.1%) females. The positivity rate of HBsAg was detected 0.4% (36/8087) in females and 0.5% (500/106.153) in males. The positivity rate of anti-HCV was detected 0.4% (32/8.087) in females and 0.3% (344/106.153) in males. The positivity rate of anti HIV 1/2 was 0.1% (9/ 8.087) in females and 0.1% (92/106.153) in males whereas the positivity rate of VDRL was 0.5% (41/8.087) in females and 0.3% (362/ 106.153) in males. Positivity rate for HBsAg and HCV were lower in the cases between 18 and 30 years of age. The positivity rates for antiHIV 1/2 was not significantly different according to the age range. Positivity rate for VDRL was higher in the cases at 51 years of age and older. Conclusion No difference was found between men and women in terms of HBsAg, anti-HCV and antiHIV 1/2 positivity. However, VDRL test positivity was significantly higher in female participants. Furthermore, HBsAg, anti-HCV and VDRL positivity rates increased by age.	[Eren, Canan] Marmara Univ Pend Training & Res Hosp, Med Microbiol & Blood Ctr, Istanbul, Turkey		Eren, C (corresponding author), Marmara Univ Pend Training & Res Hosp, Med Microbiol & Blood Ctr, Istanbul, Turkey.	cananeren21@gmail.com	Eren, Canan/AAA-8964-2021	Eren, Canan/0000-0003-4726-8840				Agus N, 2008, ANKEM, V22, P7; Akcam FZ, 2009, INT J INFECT DIS, V13, P274, DOI 10.1016/j.ijid.2008.07.005; [Anonymous], 2017, GLOB HEP REP 2017, P2017; Cao WW, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3051-7; Chandekar Sushama A, 2017, J Lab Physicians, V9, P283, DOI 10.4103/0974-2727.214246; Diarra A, 2009, TRANSFUS CLIN BIOL, V16, P444, DOI 10.1016/j.tracli.2009.09.004; Egglestone S I, 2000, Commun Dis Public Health, V3, P158; Glynn SA, 2013, TRANSFUSION, V53, P438, DOI 10.1111/j.1537-2995.2012.03742.x; Gureser A. S., 2015, Turk Hijyen ve Deneysel Biyoloji Dergisi, V72, P123, DOI 10.5505/TurkHijyen.2015.30974; Icel O, 2016, OTSBD, V1, P1; Kader C, 2010, KLIMIK J, V23, P95, DOI 10.5152/kd.2010.27; Niazi SUK, 2016, 12 ANN C AS ASS TRAN, P368; Noubiap JJN, 2013, INT J INFECT DIS, V17, pE832, DOI 10.1016/j.ijid.2012.12.007; Okoroiwu HU, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5555-x; Schweitzer A, 2015, LANCET, V386, P1546, DOI 10.1016/S0140-6736(15)61412-X; Seitz R, 2010, TRANSFUS MED HEMOTH, V37, P112, DOI 10.1159/000314497; Sheikh MY, 2013, GUT LIVER, V7, P66, DOI 10.5009/gnl.2013.7.1.66; Tagny CT, 2010, TRANSFUSION MED, V20, P1, DOI 10.1111/j.1365-3148.2009.00958.x; Temiz H., 2008, Infeksiyon Dergisi = Turkish Journal of Infection, V22, P79; Tessema B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-111; Turan H, 2011, KLIMIK J, V24, P36, DOI 10.5152/kd.2011.07; Umolu Patience Idia, 2005, Afr Health Sci, V5, P55; Uzun B, 2013, TRANSFUS APHER SCI, V49, P511, DOI 10.1016/j.transci.2013.02.039; van der Bij AK, 2006, TRANSFUSION, V46, P1729, DOI 10.1111/j.1537-2995.2006.00964.x; World Health Organization, BLOOD SAF AV; World Health Organization, 2015, REP GLOB SEX TRANSM	26	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0219709	10.1371/journal.pone.0219709	http://dx.doi.org/10.1371/journal.pone.0219709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536507	Green Submitted, gold, Green Published			2022-12-26	WOS:000532262800011
J	Janes, H; Brown, MD; Glidden, DV; Mayer, KH; Buchbinder, SP; McMahan, VM; Schechter, M; Guanira, J; Casapia, M				Janes, Holly; Brown, Marshall D.; Glidden, David, V; Mayer, Kenneth H.; Buchbinder, Susan P.; McMahan, Vanessa M.; Schechter, Mauro; Guanira, Juan; Casapia, Martin			Evaluating the impact of policies recommending PrEP to subpopulations of men and transgender women who have sex with men based on demographic and behavioral risk factors	PLOS ONE			English	Article							HIV PREEXPOSURE PROPHYLAXIS; COST-EFFECTIVENESS; DECISION-ANALYSIS; BLADDER-CANCER; PREVENTION; INFECTION; EFFICACY; MARKERS; TRIAL; ACQUISITION	Introduction Developing guidelines to inform the use of antiretroviral pre-exposure prophylaxis (PrEP) for HIV prevention in resource-limited settings must necessarily be informed by considering the resources and infrastructure needed for PrEP delivery. We describe an approach that identifies subpopulations of cisgender men who have sex with men (MSM) and transgender women (TGW) to prioritize for the rollout of PrEP in resource-limited settings. Methods We use data from the iPrEx study, a multi-national phase III study of PrEP for HIV prevention in MSM/TGW, to build statistical models that identify subpopulations at high risk of HIV acquisition without PrEP, and with high expected PrEP benefit. We then evaluate empirically the population impact of policies recommending PrEP to these subpopulations, and contrast these with existing policies. Results A policy recommending PrEP to a high risk subpopulation of MSM/TGW reporting condomless receptive anal intercourse over the last 3 months (estimated 3.3% 1-year HIV incidence) yields an estimated 1.95% absolute reduction in 1-year HIV incidence at the population level, and 3.83% reduction over 2 years. Importantly, such a policy requires rolling PrEP out to just 59.7% of MSM/TGW in the iPrEx population. We find that this policy is identical to that which prioritizes MSM/TGW with high expected PrEP benefit. It is estimated to achieve nearly the same reduction in HIV incidence as the PrEP guideline put forth by the US Centers for Disease Control, which relies on the measurement of more behavioral risk factors and which would recommend PrEP to a larger subset of the MSM/TGW population (86% vs. 60%). Conclusions These findings may be used to focus future mathematical modelling studies of PrEP in resource-limited settings on prioritizing PrEP for high-risk subpopulations of MSM/TGW. The statistical approach we took could be employed to develop PrEP policies for other at-risk populations and resource-limited settings.	[Janes, Holly; Brown, Marshall D.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Glidden, David, V] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Mayer, Kenneth H.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Mayer, Kenneth H.] Fenway Hlth, Fenway Inst, Boston, MA 02215 USA; [Buchbinder, Susan P.] San Francisco Dept Publ Hlth, Bridge HIV, San Francisco, CA USA; [McMahan, Vanessa M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Schechter, Mauro] Univ Fed Rio de Janeiro, Projeto Praca Onze, Rio De Janeiro, Brazil; [Guanira, Juan] Asociac Civil Impacta Salud & Educ, Lima, Peru; [Casapia, Martin] Asociac Civil Selva Amazon, Iquitos, Peru	Fred Hutchinson Cancer Center; University of California System; University of California San Francisco; Harvard University; Beth Israel Deaconess Medical Center; Fenway Health; San Francisco Department of Public Health; University of Washington; University of Washington Seattle; Universidade Federal do Rio de Janeiro	Janes, H (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	hjanes@fredhutch.org	Glidden, David/AAD-4730-2020	Glidden, David/0000-0001-5888-1419; Casapia Morales, Wilfredo Martin/0000-0002-5972-0948	National Cancer Institute [R01 CA152089]; National Institute of Allergy and Infectious Diseases [R03 AI122908, U01 AI106499, U01 AI064002, P30 AI060354]; NATIONAL CANCER INSTITUTE [R01CA152089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI122908, U01AI106499, P30AI060354] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Cancer Institute (https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-cancer-institutenci) (grant R01 CA152089 to HEJ), the National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov/) (R03 AI122908 to DVG; U01 AI106499 to PLA; U01 AI064002 to RMG; P30 AI060354 to KHM). The sponsor (NIH) critically reviewed the iPrEx protocol prior to study start and any amendments. The sponsors or funders did not play any role in the decision to publish or preparation of the manuscript. Other authors received no specific funding for the work.	Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Bartholow BN, 2005, JAIDS-J ACQ IMM DEF, V39, P90, DOI 10.1097/01.qai.0000143600.41363.78; Benchikh A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-635; Buchbinder SP, 2014, LANCET INFECT DIS, V14, P468, DOI 10.1016/S1473-3099(14)70025-8; Burgener A, 2016, 21 INT AIDS C JUL 18; Carnegie NB, 2015, JAIDS-J ACQ IMM DEF, V69, P119, DOI 10.1097/QAI.0000000000000555; Chen A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108742; Cohen S, 2014, 21 C RETR OPP INF BO; Cohen S, 2014, 9 INT C HIV TREATM P; Den RB, 2015, J CLIN ONCOL, V33, P944, DOI 10.1200/JCO.2014.59.0026; Dorresteijn JAN, 2011, BRIT MED J, V343, P1; endinghiv.org.au, 2016, TRUV LIC PREP ACON; Flynn MN, 2005, J INFECT DIS, V191, P654, DOI 10.1086/428404; Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145; Garrett KL, 2016, CROI 2016; Gibson S, 2015, NAT HIV PREV C VANC, P229; Glidden DV, 2016, CLIN INFECT DIS, V62, P1172, DOI 10.1093/cid/ciw022; Gomez GB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001401; Grant RM, 2014, LANCET INFECT DIS, V14, P820, DOI 10.1016/S1473-3099(14)70847-3; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Gunter L, LECT NOTES COMPUTER, P149; GUYATT GH, 1995, JAMA-J AM MED ASSOC, V274, P1800, DOI 10.1001/jama.274.22.1800; Haberer JE, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001511; Halloran ME., 2010, DESIGN ANAL VACCINE; Hanscom B, 2016, JAIDS-J ACQ IMM DEF, V73, P606, DOI 10.1097/QAI.0000000000001160; Hoagland B, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21472; Hosek S, 2016, J ACQ IMMUN DEF SYND, V74, P21; Hosek SG, 2017, JAIDS-J ACQ IMM DEF, V74, P21, DOI 10.1097/QAI.0000000000001179; Hunink MGM, 2014, DECISION MAKING IN HEALTH AND MEDICINE: INTEGRATING EVIDENCE AND VALUES, 2ND EDITION, P1, DOI 10.1017/CBO9781139506779; Janes H, 2018, AIDS RES HUM RETROV, V34, P645, DOI [10.1089/aid.2018.0031, 10.1089/AID.2018.0031]; Janes H, 2014, INT J BIOSTAT, V10, P99, DOI 10.1515/ijb-2012-0052; Janes H, 2014, MED DECIS MAKING, V34, P159, DOI 10.1177/0272989X13493147; Janes H, 2011, ANN INTERN MED, V154, P253, DOI 10.7326/0003-4819-154-4-201102150-00006; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kashuba ADM, 2012, LANCET, V379, P2409, DOI 10.1016/S0140-6736(11)61852-7; Kerr KF, 2016, J CLIN ONCOL, V34, P2534, DOI 10.1200/JCO.2015.65.5654; Kessler J, 2014, EVALUATING IMPACT PR; Klatt NR, 2017, SCIENCE, V356, P938, DOI 10.1126/science.aai9383; Koblin B, 2004, LANCET, V364, P41, DOI 10.1016/S0140-6736(04)16588-4; Koblin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070413; Kooperberg C, 2005, GENET EPIDEMIOL, V28, P157, DOI 10.1002/gepi.20042; Kovalchik SA, 2013, NEW ENGL J MED, V369, P245, DOI 10.1056/NEJMoa1301851; Liu AY, 2016, JAMA INTERN MED, V176, P75, DOI 10.1001/jamainternmed.2015.4683; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; McAuliffe TL, 2007, HEALTH PSYCHOL, V26, P60, DOI 10.1037/0278-6133.26.1.60; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Mirzaei Mojtaba, 2016, Mater Sociomed, V28, P46, DOI 10.5455/msm.2016.28.46-50; Molina J, 2015, DEMAND PREP ORAL TDF; Murnane PM, 2015, AM J EPIDEMIOL, V182, P848, DOI 10.1093/aje/kwv202; Naranbhai V, 2012, J INFECT DIS, V206, P993, DOI 10.1093/infdis/jis465; NELSON W, 1972, TECHNOMETRICS, V14, P945, DOI 10.2307/1267144; Nichols BE, 2016, LANCET INFECT DIS, V16, P1423, DOI 10.1016/S1473-3099(16)30311-5; Patterson KB, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003174; PAUKER SG, 1978, SEMIN NUCL MED, V8, P324, DOI 10.1016/S0001-2998(78)80018-X; PAUKER SG, 1975, NEW ENGL J MED, V293, P229, DOI 10.1056/NEJM197507312930505; Pletcher MJ, 2017, J AM HEART ASSOC, V6, P2; Ruczinski I, 2003, J COMPUT GRAPH STAT, V12, P475, DOI 10.1198/1061860032238; Schackman BR, 2012, CURR OPIN HIV AIDS, V7, P587, DOI 10.1097/COH.0b013e3283582c8b; Schroder KEE, 2003, ANN BEHAV MED, V26, P76, DOI 10.1207/S15324796ABM2602_02; Sinclair JC, 2001, J CLIN EPIDEMIOL, V54, P253, DOI 10.1016/S0895-4356(01)00347-X; Thanassoulis G, 2016, CIRCULATION, V133, P1574, DOI 10.1161/CIRCULATIONAHA.115.018383; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; THOMSON KA, 2016, CURR OPIN HIV AIDS, V11, P18, DOI DOI 10.1097/C0H.0000000000000207; US Public Health Service, 2014, PREEXP PROPH PREV HI; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten A, 2012, AIDS, V26, pF13, DOI 10.1097/QAD.0b013e3283522272; Vickers AJ, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-14; Vickers AJ, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-30; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vickers AJ, 2013, CANCER-AM CANCER SOC, V119, P143, DOI 10.1002/cncr.27692; Vickers AJ, 2009, CANCER-AM CANCER SOC, V115, P5460, DOI 10.1002/cncr.24615; Williams BL, 2016, 21 INT AIDS C JUL 18; World Health Organization, 2015, GUID START ANT THER; World Health Organization, 2014, POL BRIEF CONS GUID; Xiao S, 2004, BIOMETRICS, V60, P874, DOI 10.1111/j.0006-341X.2004.00242.x; Zheng WJ, 2018, STAT MED, V37, P261, DOI 10.1002/sim.7296	77	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222183	10.1371/journal.pone.0222183	http://dx.doi.org/10.1371/journal.pone.0222183			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536518	Green Submitted, Green Published, gold			2022-12-26	WOS:000532262800112
J	Shaw, CB; Foster, BH; Borgese, M; Boutin, RD; Bateni, C; Boonsri, P; Bayne, CO; Szabo, RM; Nayak, KS; Chaudhari, AJ				Shaw, Calvin B.; Foster, Brent H.; Borgese, Marissa; Boutin, Robert D.; Bateni, Cyrus; Boonsri, Pattira; Bayne, Christopher O.; Szabo, Robert M.; Nayak, Krishna S.; Chaudhari, Abhijit J.			Real-time three-dimensional MRI for the assessment of dynamic carpal instability	PLOS ONE			English	Article							SCAPHOLUNATE INSTABILITY; WRIST; JOINT; RECONSTRUCTION; ARTHROGRAPHY; DIAGNOSIS; REGULARIZATION; BIOMECHANICS; MOTION	Background Carpal instability is defined as a condition where wrist motion and/or loading creates mechanical dysfunction, resulting in weakness, pain and decreased function. When conventional methods do not identify the instability patterns, yet clinical signs of instability exist, the diagnosis of dynamic instability is often suggested to describe carpal derangement manifested only during the wrist's active motion or stress. We addressed the question: can advanced MRI techniques provide quantitative means to evaluate dynamic carpal instability and supplement standard static MRI acquisition? Our objectives were to (i) develop a real-time, three-dimensional MRI method to image the carpal joints during their active, uninterrupted motion; and (ii) demonstrate feasibility of the method for assessing metrics relevant to dynamic carpal instability, thus overcoming limitations of standard MRI. Methods Twenty wrists (bilateral wrists of ten healthy participants) were scanned during radial-ulnar deviation and clenched-fist maneuvers. Images resulting from two real-time MRI pulse sequences, four sparse data-acquisition schemes, and three constrained image reconstruction techniques were compared. Image quality was assessed via blinded scoring by three radiologists and quantitative imaging metrics. Results Real-time MRI data-acquisition employing sparse radial sampling with a gradient-recalled-echo acquisition and constrained iterative reconstruction appeared to provide a practical tradeoff between imaging speed (temporal resolution up to 135 ms per slice) and image quality. The method effectively reduced streaking artifacts arising from data undersampling and enabled the derivation of quantitative measures pertinent to evaluating dynamic carpal instability. Conclusion This study demonstrates that real-time, three-dimensional MRI of the moving wrist is feasible and may be useful for the evaluation of dynamic carpal instability.	[Shaw, Calvin B.; Borgese, Marissa; Boutin, Robert D.; Bateni, Cyrus; Boonsri, Pattira; Chaudhari, Abhijit J.] Univ Calif Davis, Dept Radiol, Sacramento, CA 95817 USA; [Foster, Brent H.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Bayne, Christopher O.; Szabo, Robert M.] Univ Calif Davis, Dept Orthopaed Surg, Sacramento, CA 95817 USA; [Nayak, Krishna S.] Univ Southern Calif, Ming Hsieh Dept Elect Engn, Los Angeles, CA 90007 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of Southern California	Chaudhari, AJ (corresponding author), Univ Calif Davis, Dept Radiol, Sacramento, CA 95817 USA.	ajchaudhari@ucdavis.edu		Chaudhari, Abhijit/0000-0002-4211-1900; Borgese, Marissa/0000-0001-7295-4143; Nayak, Krishna/0000-0001-5735-3550	National Institutes of Health (NIH) [K12 HD051958, R03 EB015099]; National Center for Advancing Translational Sciences, NIH [UL1 TR001860, TL1 TR001861]; UC Davis Imaging Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD051958] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR001861, UL1TR001860] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences, NIH; UC Davis Imaging Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the National Institutes of Health (NIH) grants K12 HD051958 and R03 EB015099, the National Center for Advancing Translational Sciences, NIH, grant UL1 TR001860 and linked award TL1 TR001861, and the UC Davis Imaging Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belge M, 2002, INVERSE PROBL, V18, P1161, DOI 10.1088/0266-5611/18/4/314; Boutin RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084004; BURNETT KR, 1987, AM J ROENTGENOL, V149, P959, DOI 10.2214/ajr.149.5.959; Chantelot C, 2014, ORTHOP TRAUMATOL-SUR, V100, pS45, DOI 10.1016/j.otsr.2013.06.015; Chennagiri RJR, 2013, J HAND SURG-EUR VOL, V38, P727, DOI 10.1177/1753193412473861; Draper CE, 2009, J ORTHOP RES, V27, P571, DOI 10.1002/jor.20790; Fessler J., 2016, IMAGE RECONSTRUCTION; GarciaElias M, 1997, HAND CLIN, V13, P151; Gelberman RH, 2000, J BONE JOINT SURG AM, V82A, P578, DOI 10.2106/00004623-200004000-00013; GILULA LA, 1978, RADIOLOGY, V129, P641, DOI 10.1148/129.3.641; Haims AH, 2003, RADIOLOGY, V227, P701, DOI 10.1148/radiol.2273020398; Henrichon SS, 2020, SKELETAL RADIOL, V49, P241, DOI 10.1007/s00256-019-03266-1; Hobby JL, 2001, RADIOLOGY, V220, P589, DOI 10.1148/radiol.2203001429; Huang JZ, 2011, MED IMAGE ANAL, V15, P670, DOI 10.1016/j.media.2011.06.001; Jiang MF, 2013, MAGN RESON IMAGING, V31, P1218, DOI 10.1016/j.mri.2012.12.003; Kakar S, 2016, J WRIST SURG, V5, P306, DOI 10.1055/s-0035-1570463; KAUER JMG, 1986, CLIN ORTHOP RELAT R, P16; Krupinski EA, 2008, MED PHYS, V35, P645, DOI 10.1118/1.2830376; Krupinski EA, 2010, ATTEN PERCEPT PSYCHO, V72, P1205, DOI 10.3758/APP.72.5.1205; Kuo CE, 2008, J HAND SURG-AM, V33A, P998, DOI 10.1016/j.jhsa.2008.04.027; Laulan J, 2015, ORTHOP TRAUMATOL-SUR, V101, pS1, DOI 10.1016/j.otsr.2014.06.025; Lee SK, 2011, J HAND SURG-AM, V36A, P1149, DOI 10.1016/j.jhsa.2011.05.009; Leng SA, 2011, MED PHYS, V38, pS50, DOI 10.1118/1.3577759; Lingala SG, 2017, MAGN RESON MED, V78, P2275, DOI 10.1002/mrm.26611; Lingala SG, 2017, MAGN RESON MED, V77, P112, DOI 10.1002/mrm.26090; Lingala SG, 2013, PHYS MED BIOL, V58, P7309, DOI 10.1088/0031-9155/58/20/7309; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Manuel J, 2010, HAND CLIN, V26, P129, DOI 10.1016/j.hcl.2009.08.006; MIKIC ZD, 1984, J BONE JOINT SURG AM, V66A, P371, DOI 10.2106/00004623-198466030-00009; Moser T, 2007, AM J ROENTGENOL, V188, P1278, DOI 10.2214/AJR.06.0288; PALMER AK, 1984, CLIN ORTHOP RELAT R, P26; Poddar S, 2016, IEEE T MED IMAGING, V35, P1106, DOI 10.1109/TMI.2015.2509245; Quick HH, 2002, J MAGN RESON IMAGING, V15, P710, DOI 10.1002/jmri.10120; Rainbow MJ, 2016, J HAND SURG-EUR VOL, V41, P7, DOI 10.1177/1753193415616939; Ramamurthy NK, 2016, J HAND SURG-EUR VOL, V41, P22, DOI 10.1177/1753193415610515; RUBY LK, 1988, J HAND SURG-AM, V13A, P1, DOI 10.1016/0363-5023(88)90189-X; SCHERNBERG F, 1990, J HAND SURG-BRIT EUR, V15B, P220, DOI 10.1016/0266-7681(90)90127-P; Schimmerl-Metz SM, 1999, J HAND SURG-AM, V24A, P1237, DOI 10.1053/jhsu.1999.1237; SHELLOCK F G, 1991, Magnetic Resonance Quarterly, V7, P104; TALEISNIK J, 1988, J BONE JOINT SURG AM, V70A, P1262, DOI 10.2106/00004623-198870080-00025; TALEISNIK J, 1980, CLIN ORTHOP RELAT R, P73; Theumann NH, 2006, RADIOLOGY, V238, P950, DOI 10.1148/radiol.2383050013; Tosun O, 2017, ACTA RADIOL, V58, P1358, DOI 10.1177/0284185117692175; Uecker M., 2012, IMAG MED, V4, P461, DOI [10.2217/iim.12.32, DOI 10.2217/IIM.12.32]; Uecker M, 2010, NMR BIOMED, V23, P986, DOI 10.1002/nbm.1585; VOLZ RG, 1980, CLIN ORTHOP RELAT R, P112; Weiss APC, 1998, J HAND SURG-AM, V23A, P205, DOI 10.1016/S0363-5023(98)80115-9; Wolf JM, 2008, HAND CLIN, V24, P301, DOI 10.1016/j.hcl.2008.03.002; Wollstein R, 2013, J HAND SURG-ASIAN-PA, V18, P179, DOI 10.1142/S0218810413500214; Zhang S., 2011, OPEN MED IMAGING J, V5, P1, DOI [DOI 10.2174/1874347101105010001, 10.2174/1874347101105010001]; Zhang S, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-39; Zhao K, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4030405	52	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222704	10.1371/journal.pone.0222704	http://dx.doi.org/10.1371/journal.pone.0222704			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536561	Green Published, gold, Green Submitted			2022-12-26	WOS:000532262800073
J	Ody, A; Thibaut, T; Berline, L; Changeux, T; Andre, JM; Chevalier, C; Blanfune, A; Blanchot, J; Ruitton, S; Stiger-Pouvreau, V; Connan, S; Grelet, J; Aurelle, D; Guene, M; Bataille, H; Bachelier, C; Guillemain, D; Schmidt, N; Fauvelle, V; Guasco, S; Menard, F				Ody, Anouck; Thibaut, Thierry; Berline, Leo; Changeux, Thomas; Andre, Jean-Michel; Chevalier, Cristele; Blanfune, Aurelie; Blanchot, Jean; Ruitton, Sandrine; Stiger-Pouvreau, Valerie; Connan, Solene; Grelet, Jacques; Aurelle, Didier; Guene, Mathilde; Bataille, Hubert; Bachelier, Celine; Guillemain, Dorian; Schmidt, Natascha; Fauvelle, Vincent; Guasco, Sophie; Menard, Frederic			From In Situ to satellite observations of pelagic Sargassum distribution and aggregation in the Tropical North Atlantic Ocean	PLOS ONE			English	Article							MANGAREVENSE GRUNOW SETCHELL; INVASIVE BROWN-ALGAE; GULF-OF-MEXICO; TURBINARIA-ORNATA; FLOATING SARGASSUM; GOLDEN TIDES; CORAL-REEF; MUTICUM; MACROALGAE; FUCALES	The present study reports on observations carried out in the Tropical North Atlantic in summer and autumn 2017, documenting Sargassum aggregations using both ship-deck observations and satellite sensor observations at three resolutions (MSI-10 m, OLCI-300 m, VIIRS-750 m and MODIS-1 km). Both datasets reported that in summer, Sargassum aggregations were mainly observed off Brazil and near the Caribbean Islands, while they accumulated near the African coast in autumn. Based on in situ observations, we propose a five-class typology allowing standardisation of the description of in situ Sargassum raft shapes and sizes. The most commonly observed Sargassum raft type was windrows, but large rafts composed of a quasi-circular patch hundreds of meters wide were also observed. Satellite imagery showed that these rafts formed larger Sargassum aggregations over a wide range of scales, with smaller aggregations (of tens of m(2) area) nested within larger ones (of hundreds of km(2)). Match-ups between different satellite sensors and in situ observations were limited for this dataset, mainly because of high cloud cover during the periods of observation. Nevertheless, comparisons between the two datasets showed that satellite sensors successfully detected Sargassum abundance and aggregation patterns consistent with in situ observations. MODIS and VIIRS sensors were better suited to describing the Sargassum aggregation distribution and dynamics at Atlantic scale, while the new sensors, OLCI and MSI, proved their ability to detect Sargassum aggregations and to describe their (sub-) mesoscale nested structure. The high variability in raft shape, size, thickness, depth and biomass density observed in situ means that caution is called for when using satellite maps of Sargassum distribution and biomass estimation. Improvements would require additional in situ and airborne observations or very high-resolution satellite imagery.	[Ody, Anouck; Thibaut, Thierry; Berline, Leo; Changeux, Thomas; Andre, Jean-Michel; Chevalier, Cristele; Blanfune, Aurelie; Blanchot, Jean; Ruitton, Sandrine; Aurelle, Didier; Schmidt, Natascha; Fauvelle, Vincent; Guasco, Sophie; Menard, Frederic] Aix Marseille Univ, Univ Toulon, CNRS, IRD,MIO UM 110, Marseille, France; [Stiger-Pouvreau, Valerie; Connan, Solene] Univ Bretagne Occident UBO, Inst Univ Europeen Mer IUEM, LEMAR UMR 6539, Technopole Brest Iroise, Plouzane, France; [Grelet, Jacques; Bachelier, Celine] Technopole Brest Iroise, US191 IMAGO, IRD DR Quest, Site Pointe Diable, Plouzane, France; [Guene, Mathilde] Univ Antilles, UMR BOREA, Campus Fouillole,BP 592, Pointe A Pitre, Guadeloupe, France; [Bataille, Hubert] IRD, IRD Images, Marseille, France; [Guillemain, Dorian] Aix Marseille Univ, CNRS, IRD, IRSTEA,OSU PYTHEAS, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); UDICE-French Research Universities; Sorbonne Universite; Universite des Antilles; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); INRAE; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Thibaut, T (corresponding author), Aix Marseille Univ, Univ Toulon, CNRS, IRD,MIO UM 110, Marseille, France.	thierry.thibaut@univ-amu.fr	Menard, Frederic/C-3913-2008; Ruitton, Sandrine/AAT-4752-2021; Berline, Leo/AAM-8802-2021; THIBAUT, Thierry/S-4354-2019; Berline, Leo/AAJ-5885-2021; Blanfuné, Aurélie/AAN-2680-2021; Changeux, Thomas/AAE-5326-2019	Menard, Frederic/0000-0003-1162-660X; Ruitton, Sandrine/0000-0003-4485-9979; THIBAUT, Thierry/0000-0001-8530-9266; Blanfuné, Aurélie/0000-0001-7389-4947; Changeux, Thomas/0000-0002-0418-3321; Schmidt, Natascha/0000-0002-6194-3999; Aurelle, Didier/0000-0002-3922-7291	TOSCA program of the Centre National d'Etudes Spatiales of the SAREDAs4 project; European FEDER Fund [1166-39417]; Institut de recherche pour le developpement (IRD)	TOSCA program of the Centre National d'Etudes Spatiales of the SAREDAs4 project; European FEDER Fund; Institut de recherche pour le developpement (IRD)	This study was supported by the TOSCA program of the Centre National d'Etudes Spatiales through the funding of the SAREDAs4 project and the project leading to this publication has received funding from European FEDER Fund under project 1166-39417. AO postdoctoral fellowship was funded by Institut de recherche pour le developpement (IRD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral-Zettler LA, 2017, ECOL EVOL, V7, P516, DOI 10.1002/ece3.2630; Andrefouet S, 2004, CORAL REEFS, V23, P26, DOI 10.1007/s00338-003-0367-5; Andrefouet S, 2017, J APPL PHYCOL, V29, P3097, DOI 10.1007/s10811-017-1165-8; [Anonymous], REP SIT PEL SARG CAR; [Anonymous], SAT BAS SARG WATCH S; Ardron J, 2011, SARGASSO SEA ALLIANC, V24; Aristegui J, 2017, INFORM PRESENCIA TRI, P28; BOUCHON C, 1992, Proceedings of the Gulf and Caribbean Fisheries Institute, P171; Britton-Simmons KH, 2004, MAR ECOL PROG SER, V277, P61, DOI 10.3354/meps277061; Brodie J, 2018, AQUAT CONSERV, V28, P872, DOI 10.1002/aqc.2905; Brooks MT, 2018, MAR ECOL PROG SER, V599, P1, DOI 10.3354/meps12646; Butler J.N., 1983, STUDIES SARGASSUM SA; Clerc S, 2018, 32 MPC TEAM; de Vaugelas J, 1999, OCEANOL ACTA, V22, P85, DOI 10.1016/S0399-1784(99)80035-8; DEAL Guadeloupe, 2018, MES RAM SARG 48; Dierssen HM, 2015, REMOTE SENS ENVIRON, V167, P247, DOI 10.1016/j.rse.2015.01.027; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Franks J., 2011, P GULF CARIB FISH I, V64, P6; Gower J, 2005, INT J REMOTE SENS, V26, P2005, DOI 10.1080/01431160500075857; Gower JFR, 2011, INT J REMOTE SENS, V32, P1917, DOI 10.1080/01431161003639660; Gower J, 2006, IEEE T GEOSCI REMOTE, V44, P3619, DOI 10.1109/TGRS.2006.882258; Gower J, 2013, REMOTE SENS LETT, V4, P764, DOI 10.1080/2150704X.2013.796433; Hernandez-Carrasco I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26857-9; HOWARD KL, 1969, BOT MAR, V12, P244, DOI 10.1515/botm.1969.12.1-4.244; Hu CM, 2016, MAR POLLUT BULL, V107, P15, DOI 10.1016/j.marpolbul.2016.04.045; Hu CM, 2015, REMOTE SENS ENVIRON, V167, P229, DOI 10.1016/j.rse.2015.05.022; Hu CM, 2010, REMOTE SENS ENVIRON, V114, P2048, DOI 10.1016/j.rse.2010.04.011; Hu CM, 2009, REMOTE SENS ENVIRON, V113, P2118, DOI 10.1016/j.rse.2009.05.012; Komatsu T, 2007, J MARINE SYST, V67, P245, DOI 10.1016/j.jmarsys.2006.05.018; Krummel O, 1891, PETERMANNS GEOGR MIT, V37, P129; Lapointe BE, 2018, HARMFUL ALGAL BLOOMS: A COMPENDIUM DESK REFERENCE, P515; Le Lann K, 2012, MAR ENVIRON RES, V80, P1, DOI 10.1016/j.marenvres.2012.05.011; Lehahn Y, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003927; Lellouche JM, 2013, OCEAN SCI, V9, P57, DOI 10.5194/os-9-57-2013; Liu F, 2018, LIMNOL OCEANOGR, V63, P1762, DOI 10.1002/lno.10806; Liu F, 2013, MAR ENVIRON RES, V83, P38, DOI 10.1016/j.marenvres.2012.10.007; Marks LM, 2015, BIOINVASIONS REC, V4, P243, DOI 10.3391/bir.2015.4.4.02; Marmorino GO, 2011, DEEP-SEA RES PT I, V58, P316, DOI 10.1016/j.dsr.2011.01.001; Miller KA, 2007, BIOL INVASIONS, V9, P609, DOI 10.1007/s10530-006-9060-2; Mineur F, 2015, J SEA RES, V98, P91, DOI 10.1016/j.seares.2014.11.004; Owens R.G., 2018, ECMWF FORECAST USER, DOI 10.21957/m1cs7h; Parr A.E., 1939, QUANTITATIVE OBSERVA; Plouguerne E, AQUATIC BOT, V85, P337; Putman NF, 2018, PROG OCEANOGR, V165, P205, DOI 10.1016/j.pocean.2018.06.009; Qi L, 2017, GEOPHYS RES LETT, V44, P11501, DOI 10.1002/2017GL075525; Riosmena-Rodriguez R, 2012, BOT MAR, V55, P547, DOI 10.1515/bot-2012-0120; RUENESS J, 1989, MAR POLLUT BULL, V20, P173, DOI 10.1016/0025-326X(89)90488-8; Sakamoto SX, 2012, PROC SPIE, V8525, DOI 10.1117/12.999308; Schell JM, 2015, OCEANOGRAPHY, V28, P8, DOI 10.5670/oceanog.2015.70; Schmidt N, 2019, ENVIRON SCI TECHNOL, V53, P7513, DOI 10.1021/acs.est.9b01585; Setyawidati N, 2018, J APPL PHYCOL, V30, P159, DOI 10.1007/s10811-017-1208-1; Siuda A, 2011, SARGASSO SEA ALLIANC, V18; Smetacek V, 2013, NATURE, V504, P84, DOI 10.1038/nature12860; Staehr PA, 2000, MAR ECOL PROG SER, V207, P79, DOI 10.3354/meps207079; Stiger V, 1999, BOT MAR, V42, P295, DOI 10.1515/BOT.1999.033; Stiger V, 1999, MAR ECOL PROG SER, V191, P91, DOI 10.3354/meps191091; STONER AW, 1984, MAR ECOL PROG SER, V20, P185, DOI 10.3354/meps020185; STONER AW, 1983, DEEP-SEA RES, V30, P469, DOI 10.1016/0198-0149(83)90079-1; Tanniou A, 2015, TALANTA, V132, P451, DOI 10.1016/j.talanta.2014.09.002; Thiel M, 2005, OCEANOGR MAR BIOL, V42, P181, DOI DOI 10.1201/9780203507810.CH6; UNEP, 2016, PAPER SARGASSUM SEAW; VERLAQUE M, 1994, OCEANOL ACTA, V17, P1; Wang MQ, 2018, GEOPHYS RES LETT, V45, P12359, DOI 10.1029/2018GL078858; Wang MQ, 2018, INT J REMOTE SENS, V39, P3852, DOI 10.1080/01431161.2018.1447161; Wang MQ, 2017, GEOPHYS RES LETT, V44, P3265, DOI 10.1002/2017GL072932; Wang MQ, 2016, REMOTE SENS ENVIRON, V183, P350, DOI 10.1016/j.rse.2016.04.019; Webster R.K., 2013, SHORE BEACH, P81, DOI DOI 10.1002/9781118485545.CH1; Winge O, 1923, SARGASSO SEA ITS BOU; WOODCOCK AH, 1993, J EXP MAR BIOL ECOL, V170, P117, DOI 10.1016/0022-0981(93)90132-8; Xing QG, 2017, IEEE GEOSCI REMOTE S, V14, P1815, DOI 10.1109/LGRS.2017.2737079; Zhong Y., 2012, LIMNOLOGY OCEANOGRAP, V2, P12, DOI [10.1215/21573689-1573372, DOI 10.1215/21573689-1573372]	71	30	30	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222584	10.1371/journal.pone.0222584	http://dx.doi.org/10.1371/journal.pone.0222584			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527915	Green Published, Green Submitted, gold			2022-12-26	WOS:000532231400030
J	Bawankule, R; Shetye, S; Singh, A; Singh, A; Kumar, K				Bawankule, Rahul; Shetye, Sadanand; Singh, Ashish; Singh, Abhishek; Kumar, Kaushalendra			Epidemiological investigation and management of bloody diarrhea among children in India	PLOS ONE			English	Article							BIRTH-WEIGHT; DEVELOPING-COUNTRIES; CHILDHOOD DIARRHEA; CARE SEEKING; RISK; SIZE	Background The evidence on the factors associated with childhood bloody diarrhea in developing countries in general and India, in particular, is somewhat limited. Our study, therefore, examines -the prevalence of bloody diarrhea; the magnitude of treatment of bloody diarrhea (use of both oral rehydration and antibiotics (pills, syrups, and injections)); and several other associated factors with bloody diarrhea in the youngest children under five years in the Indian context. Methods We used data from the National Family Health Survey (NFHS)-4 conducted in 2015-16. We used a multivariable binary logistic regression model to identify the factors associated with bloody diarrhea. We also applied a multinomial logistic regression model to identify associated factors with the treatment of bloody diarrhea amongst the youngest children below five years. Findings The overall prevalence of bloody diarrhea in the youngest children was about 9 percent in the last two weeks preceding the survey. There was a significant difference in the mean age of those children having bloody diarrhea and watery diarrhea during the same period. Children whose stools were disposed of unsafely and those who belonged to households with neither a place nor water for washing hands were more likely to suffer from bloody diarrhea compared to their counterparts with these facilities. About a little less than one-fifth of the youngest children (16%) received adequate treatment of bloody diarrhea. The treatment of bloody diarrhea was associated with the health facility and maternal and children's socioeconomic and demographic characteristics. Conclusion The study shows that household environmental risk factors are important predictors of bloody diarrhea amongst the youngest children. Still, 28% of those children did not receive any treatment of bloody diarrhea in India. There is also a clear need to promote the practice of safe disposal of children's stools and handwashing among mothers and children. Mothers need to be sensitized about the necessity of an immediate visit to a health facility/center in case of bloody diarrhea.	[Bawankule, Rahul; Singh, Abhishek; Kumar, Kaushalendra] Int Inst Populat Sci, Mumbai, Maharashtra, India; [Shetye, Sadanand] BKL Walawalkar Hosp & Rural Med Coll, Kasarwadi Sawarde, India; [Singh, Ashish] Indian Inst Technol, SJM Sch Management, Mumbai, Maharashtra, India	International Institute for Population Sciences; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Bawankule, R (corresponding author), Int Inst Populat Sci, Mumbai, Maharashtra, India.	rahulbams2010@gmail.com	Bawankule, Rahul/HII-4191-2022; Singh, Abhishek/ABC-7813-2020; Kumar, Kaushalendra/ABC-7943-2020	Singh, Abhishek/0000-0001-6263-4410; Kumar, Kaushalendra/0000-0001-5913-0297				Ahmed F, 1997, AM J TROP MED HYG, V56, P258, DOI 10.4269/ajtmh.1997.56.258; AlKubaisy W, 2015, INT ARCH MED, V8, DOI [10.3823/1603, DOI 10.3823/1603]; [Anonymous], 2009, DIARRH WHY CHILDR AR; [Anonymous], 2018, PNEUM DIARRH PROGR R; Anteneh ZA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4021-5; Ayalneh AA, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0561-7; Aziz FAA, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6266-z; Bado AR, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.30166; Barakat M, 2011, J PEDIATR GASTR NUTR, V52, P60, DOI 10.1097/MPG.0b013e3181da215b; Bawankule R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169713; Bawankule R, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3948-2; Bedford KJA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100038; Boerma JT, 1996, B WORLD HEALTH ORGAN, V74, P209; Brooks JT, 2003, AM J TROP MED HYG, V68, P671, DOI 10.4269/ajtmh.2003.68.671; Bruce N, 2014, AM J PUBLIC HEALTH, V104, P647, DOI 10.2105/AJPH.2013.301658; Casburn-Jones AC, 2004, GUT, V53, P296, DOI 10.1136/gut.2003.022103; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; Degefa G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193035; Evans DJ Jr, 1996, MED MICROBIOLOGY; Fissehaye Tedros, 2018, BMC Res Notes, V11, P749, DOI 10.1186/s13104-018-3850-3; Freeman MC, 2016, T ROY SOC TROP MED H, V110, P386, DOI 10.1093/trstmh/trw043; Gao WL, 2014, AM J TROP MED HYG, V91, P1197, DOI 10.4269/ajtmh.14-0179; Gebretsadik Achamyelesh, 2015, Int J Family Med, V2015, P516532, DOI 10.1155/2015/516532; Giannella, 1996, MED MICROBIOLOGY; Government of India International Institute for Population Sciences (IIPS) and ICF, 2022, NATL FAMILY HLTH SUR; Hajeebhoy N, 2014, INT BREASTFEED J, V9, DOI 10.1186/1746-4358-9-12; Hale TL, 1996, MED MICROBIOLOGY, P22; Holtz LR, 2009, GASTROENTEROLOGY, V136, P1887, DOI 10.1053/j.gastro.2009.02.059; Hong Tang Kim, 2003, Southeast Asian J Trop Med Public Health, V34, P187; Islam MM, 2014, MATERN CHILD HLTH J, V18, P1462, DOI 10.1007/s10995-013-1386-7; Keusch GT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P371; Kuskonmaz B, 2009, TURKISH J PEDIATR, V51, P133; Lam F, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.010501; Lule SA, 2012, TROP MED INT HEALTH, V17, P1465, DOI 10.1111/j.1365-3156.2012.03091.x; Malhotra N, 2013, ACTA PAEDIATR, V102, pE413, DOI 10.1111/apa.12304; Ministry of Drinking Water and Sanitation (Govt. of India), 2017, SWACHH BHAR MISS NRD; Ministry of Panchayati Raj, 2014, HDB GRAM PANCH SAN; Mohua (Ministry of Housing and Urban Affairs), 2017, GUID SWACHH BHAR MIS; Murphy MS, 2008, BRIT MED J, V336, P1010, DOI 10.1136/bmj.39542.440417.BE; Nasrin D, 2013, AM J TROP MED HYG, V89, P3, DOI 10.4269/ajtmh.12-0749; Njuguna C, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1814-6; Perez-Perez GI, 1996, MED MICROBIOLOGY; PerezCuevas R, 1996, J DIARRHOEAL DIS RES, V14, P260; Rabie T, 2006, TROP MED INT HEALTH, V11, P258, DOI 10.1111/j.1365-3156.2006.01568.x; Rahman AE, 2014, B WORLD HEALTH ORGAN, V92, P664, DOI 10.2471/BLT.13.134809; Sarker Abdur Razzaque, 2016, Glob Pediatr Health, V3, p2333794X16680901, DOI 10.1177/2333794X16680901; UNICEF, 2016, ENDING CHILD DEATHS; UNICEF India, 2015, HANDW SOAPS SCH MIDD; United Nations Children Fund (UNICEF), 2007, WAT ENV SAN CHILDR W; WHO UNICEF, 2008, INT MAN CHILDH ILLN; Wilson SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033273; World Health Organization, 1994, MAN BLOOD DIARRH YOU; World Health Organization, 2005, TREATM DIARRH MAN PH; World Health Organization, 2013, POCK BOOK HOSP CAR C; Yilmaz M, 2012, EUR J GASTROEN HEPAT, V24, P688, DOI 10.1097/MEG.0b013e328352721a	55	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2019	14	9							e0222208	10.1371/journal.pone.0222208	http://dx.doi.org/10.1371/journal.pone.0222208			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4KS	31518363	Green Published, gold, Green Submitted			2022-12-26	WOS:000532219300016
J	Farooq, Z; Abdullah, E; Banday, S; Ganai, SA; Rashid, R; Mushtaq, A; Rashid, S; Altaf, M				Farooq, Zeenat; Abdullah, Ehsaan; Banday, Shahid; Ganai, Shabir Ahmad; Rashid, Romana; Mushtaq, Arjamand; Rashid, Samia; Altaf, Mohammad			Vigilin protein Vgl1 is required for heterochromatin-mediated gene silencing in Schizosaccharomyces pombe	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; chromatin modification; gene silencing; histone methylation; heterochromatin	KH-DOMAIN PROTEIN; NUCLEAR-MEMBRANE; HISTONE H3; LYSINE-9 METHYLATION; CHROMODOMAIN PROTEIN; EPIGENETIC CONTROL; RNA INTERFERENCE; BINDING PROTEIN; YEAST; CHROMATIN	Heterochromatin is a conserved feature of eukaryotic genomes and regulates various cellular processes, including gene silencing, chromosome segregation, and maintenance of genome stability. In the fission yeast Schizosaccharomyces pombe, heterochromatin formation involves methylation of lysine 9 in histone H3 (H3K9), which recruits Swi6/HP1 proteins to heterochromatic loci. The Swi6/HP1?H3K9me3 chromatin complex lies at the center of heterochromatic macromolecular assemblies and mediates many functions of heterochromatin by recruiting a diverse set of regulators. However, additional factors may be required for proper heterochromatin organization, but they are not fully known. Here, using several molecular and biochemical approaches, we report that Vgl1, a member of a large family of multiple KH-domain proteins, collectively known as vigilins, is indispensable for the heterochromatin-mediated gene silencing in S. pombe. ChIP analysis revealed that Vgl1 binds to pericentromeric heterochromatin in an RNA-dependent manner and that Vgl1 deletion leads to loss of H3K9 methylation and Swi6 recruitment to centromeric and telomeric heterochromatic loci. Furthermore, we show that Vgl1 interacts with the H3K9 methyltransferase, Clr4, and that loss of Vgl1 impairs Clr4 recruitment to heterochromatic regions of the genome. These findings uncover a novel role for Vgl1 as a key regulator in heterochromatin-mediated gene silencing in S. pombe.	[Farooq, Zeenat; Abdullah, Ehsaan; Banday, Shahid; Ganai, Shabir Ahmad; Rashid, Romana; Mushtaq, Arjamand; Rashid, Samia; Altaf, Mohammad] Univ Kashmir, Dept Biotechnol, Chromatin & Epigenet Lab, Srinagar 190006, Jammu & Kashmir, India; [Ganai, Shabir Ahmad] SKUAST Kashmir, Fac Agr, Div Basic Sci & Humanities, Sopore 193201, Jammu & Kashmir, India	University of Kashmir; Sher-e-Kashmir University of Agricultural Sciences & Technology of Kashmir (SKUAST Kashmir)	Altaf, M (corresponding author), Univ Kashmir, Dept Biotechnol, Chromatin & Epigenet Lab, Srinagar 190006, Jammu & Kashmir, India.	altafbhat@uok.edu.in		ganai, shabir ahmad/0000-0002-4668-8248	Department of Biotechnology, Government of India [BT/PR16122/BRB/10/1478/2016, BT/PR22348/BRB/10/1625/2017]; DST-SERB, Government of India [EMR/2016/000958]; DST-SERB [YSS/2015/001267]; University Grants Commission [23/12/2012(ii) EU-V]; DST INSPIRE Grant [IF150792]	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); DST-SERB, Government of India; DST-SERB; University Grants Commission(University Grants Commission, India); DST INSPIRE Grant	This work was supported by Department of Biotechnology, Government of India, Grants BT/PR16122/BRB/10/1478/2016 and BT/PR22348/BRB/10/1625/2017 and DST-SERB Grant EMR/2016/000958, Government of India (to M. A.); from DST-SERB in the form of Start-Up Grant for Young Scientists YSS/2015/001267 (to S. A. G.); University Grants Commission 23/12/2012(ii) EU-V for Senior Research fellowship (to Z. F.); and DST INSPIRE Grant IF150792 (to R. R.) for doctoral fellowship. The authors declare that they have no conflicts of interest with the contents of this article.	ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Allshire RC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018770; Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; Altaf M, 2007, MUTAT RES-FUND MOL M, V618, P81, DOI 10.1016/j.mrfmmm.2006.09.009; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Banday S, 2016, J BIOL CHEM, V291, P20021, DOI 10.1074/jbc.M116.743211; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barrales RR, 2016, GENE DEV, V30, P133, DOI 10.1101/gad.271288.115; Bayne EH, 2010, CELL, V140, P666, DOI 10.1016/j.cell.2010.01.038; Bernard P, 2001, SCIENCE, V294, P2539, DOI 10.1126/science.1064027; Bloom KS, 2014, ANNU REV GENET, V48, P457, DOI 10.1146/annurev-genet-120213-092033; Bonasio R, 2014, ANNU REV GENET, V48, P433, DOI 10.1146/annurev-genet-120213-092323; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Buker SM, 2007, NAT STRUCT MOL BIOL, V14, P200, DOI 10.1038/nsmb1211; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Cabianca DS, 2016, NUCLEUS-PHILA, V7, P301, DOI 10.1080/19491034.2016.1187354; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Castel SE, 2013, NAT REV GENET, V14, P100, DOI 10.1038/nrg3355; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Cortes A, 1999, EMBO J, V18, P3820, DOI 10.1093/emboj/18.13.3820; Cortes A, 2000, MOL CELL BIOL, V20, P3860, DOI 10.1128/MCB.20.11.3860-3869.2000; Dejgaard K, 1996, EUR J BIOCHEM, V241, P425, DOI 10.1111/j.1432-1033.1996.00425.x; Dodson RE, 1997, J BIOL CHEM, V272, P12249, DOI 10.1074/jbc.272.19.12249; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; Ekwall K, 1996, J CELL SCI, V109, P2637; Farooq Z, 2016, MUTAT RES-REV MUTAT, V768, P46, DOI 10.1016/j.mrrev.2016.03.005; Gerace EL, 2010, MOL CELL, V39, P360, DOI 10.1016/j.molcel.2010.07.017; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gonzalez-Sandoval A, 2016, TRENDS GENET, V32, P485, DOI 10.1016/j.tig.2016.05.004; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Harr JC, 2016, EMBO REP, V17, P139, DOI 10.15252/embr.201541809; Heo L, 2013, NUCLEIC ACIDS RES, V41, pW384, DOI 10.1093/nar/gkt458; Hirschmann WD, 2014, NUCLEIC ACIDS RES, V42, P4043, DOI 10.1093/nar/gkt1392; Holoch D, 2015, NAT REV GENET, V16, P71, DOI 10.1038/nrg3863; Huertas D, 2004, CURR BIOL, V14, P1611, DOI 10.1016/j.cub.2004.09.024; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Laskowski RA, 2018, PROTEIN SCI, V27, P129, DOI 10.1002/pro.3289; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Martienssen R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a019323; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Mekhail K, 2010, NAT REV MOL CELL BIO, V11, P317, DOI 10.1038/nrm2894; Mizuguchi T, 2015, FEBS LETT, V589, P2975, DOI 10.1016/j.febslet.2015.06.008; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Tessarz P, 2014, NAT REV MOL CELL BIO, V15, P703, DOI 10.1038/nrm3890; Towbin BD, 2013, TRENDS BIOCHEM SCI, V38, P356, DOI 10.1016/j.tibs.2013.04.004; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe T, 2003, CHROMOSOME RES, V11, P137, DOI 10.1023/A:1022815931524; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Volpe T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003731; Weber V, 1997, EUR J BIOCHEM, V249, P309, DOI 10.1111/j.1432-1033.1997.00309.x; WINTERSBERGER U, 1995, YEAST, V11, P929, DOI 10.1002/yea.320111004; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhou J, 2008, RNA, V14, P1773, DOI 10.1261/rna.1036308	66	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2019	294	48					18029	18040		10.1074/jbc.RA119.009262	http://dx.doi.org/10.1074/jbc.RA119.009262			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KA1GS	31554660	hybrid, Green Published			2022-12-26	WOS:000505547900002
J	Hu, HQ; An, T; Kurasawa, Y; Zhou, Q; Li, ZY				Hu, Huiqing; An, Tai; Kurasawa, Yasuhiro; Zhou, Qing; Li, Ziyin			The trypanosome-specific proteins FPRC and CIF4 regulate cytokinesis initiation by recruiting CIF1 to the cytokinesis initiation site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokinesis; cell division; cell cycle; Trypanosoma brucei; parasite; CIF1; CIF4; cleavage furrow; FPRC; sleeping sickness	FLAGELLUM ATTACHMENT ZONE; LIFE-CYCLE STAGES; POLO-LIKE KINASE; BLOOD-STREAM; COMPLEX; MORPHOGENESIS; SEGREGATION; EXPRESSION; MORPHOLOGY; REVEALS	The evolutionarily early divergent human parasite Trypanosoma brucei proliferates through binary cell fission in both its tsetse fly vector and mammalian host. The parasite divides unidirectionally along the longitudinal cell axis from the anterior cell tip toward the posterior cell tip through a mechanism distinct from that in the cells of its human host. Initiation of cytokinesis in T. brucei is regulated by two evolutionarily conserved protein kinases, the Polo-like kinase TbPLK and the Aurora B kinase TbAUK1, and a cohort of trypanosome-specific proteins, including the three cytokinesis initiation factors CIF1, CIF2, and CIF3. Here, using RNAi, in situ epitope tagging of proteins, GST pulldown, and coimmunoprecipitation assays, and immunofluorescence and scanning electron microscopy analyses, we report the identification and functional characterization of two trypanosome-specific proteins, flagellum attachment zone tip?localizing protein required for cytokinesis (FPRC) and CIF4. We found that the two proteins colocalize to the distal tips of the new and the old flagellum attachment zones and are required for cytokinesis initiation. Knockdown of FPRC or CIF4 disrupted the localization of CIF1, suggesting that they function upstream of CIF1. Moreover, depletion of CIF4 abolished FPRC localization, indicating that CIF4 acts upstream of FPRC. Together, these results identify two new cytokinesis regulators in T. brucei and integrate them into the CIF1-mediated cytokinesis regulatory pathway. These findings highlight the existence of a cytokinesis pathway in T. brucei that is different from that of its mammalian host and therefore suggest that cytokinesis in T. brucei could potentially be exploited as a new drug target.	[Hu, Huiqing; An, Tai; Kurasawa, Yasuhiro; Zhou, Qing; Li, Ziyin] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Li, ZY (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	Ziyin.Li@uth.tmc.edu	; Zhou, Qing/A-8296-2019	Li, Ziyin/0000-0002-3960-9716; Zhou, Qing/0000-0003-2096-1960	National Institutes of Health [AI101437, AI118736]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118736, R01AI101437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants AI101437 and AI118736. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Burki F, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016147; de Graffenried CL, 2008, J CELL BIOL, V181, P431, DOI 10.1083/jcb.200708082; Gheiratmand L, 2013, J BIOL CHEM, V288, P3489, DOI 10.1074/jbc.M112.417428; Hammarton TC, 2007, MOL MICROBIOL, V65, P1229, DOI 10.1111/j.1365-2958.2007.05866.x; Hilton NA, 2018, MOL MICROBIOL, V109, P306, DOI 10.1111/mmi.13986; Hu HQ, 2017, J CELL SCI, V130, P4108, DOI 10.1242/jcs.207134; Hu HQ, 2015, J BIOL CHEM, V290, P30453, DOI 10.1074/jbc.M115.694109; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Kumar P, 2006, EUKARYOT CELL, V5, P92, DOI 10.1128/EC.5.1.92-102.2006; Kurasawa Y, 2018, J BIOL CHEM, V293, P10275, DOI 10.1074/jbc.RA118.003113; Li Z, 2010, EUKARYOT CELL, V9, P705, DOI 10.1128/EC.00330-09; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Li ZY, 2006, EUKARYOT CELL, V5, P1026, DOI 10.1128/EC.00129-06; Li ZY, 2012, EUKARYOT CELL, V11, P1180, DOI 10.1128/EC.00145-12; Li ZY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000575; Li ZY, 2002, J BIOL CHEM, V277, P15486, DOI 10.1074/jbc.M109029200; Ogbadoyi E, 2000, CHROMOSOMA, V108, P501, DOI 10.1007/s004120050402; Oliferenko S, 2009, GENE DEV, V23, P660, DOI 10.1101/gad.1772009; Perry JA, 2018, MOL MICROBIOL, V107, P344, DOI 10.1111/mmi.13885; Pham KTM, 2019, J CELL SCI, V132, DOI 10.1242/jcs.230581; Ploubidou A, 1999, J CELL SCI, V112, P4641; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Shen SY, 2001, MOL BIOCHEM PARASIT, V113, P171, DOI 10.1016/S0166-6851(00)00383-2; Sunter JD, 2016, TRENDS PARASITOL, V32, P309, DOI 10.1016/j.pt.2015.12.010; Tu XM, 2006, J BIOL CHEM, V281, P9677, DOI 10.1074/jbc.M511504200; Urbaniak MD, 2013, J PROTEOME RES, V12, P2233, DOI 10.1021/pr400086y; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wei Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073869; Wheeler RJ, 2013, MOL MICROBIOL, V90, P1339, DOI 10.1111/mmi.12436; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Zhang X, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00199-19; Zhou Q, 2018, J BIOL CHEM, V293, P16177, DOI 10.1074/jbc.RA118.004888; Zhou Q, 2018, J BIOL CHEM, V293, P8508, DOI 10.1074/jbc.RA118.002106; Zhou Q, 2016, CELL CYCLE, V15, P2379, DOI 10.1080/15384101.2016.1181882; Zhou Q, 2016, J BIOL CHEM, V291, P14395, DOI 10.1074/jbc.M116.726133; Zhou Q, 2016, P NATL ACAD SCI USA, V113, P3287, DOI 10.1073/pnas.1601596113; Zhou Q, 2011, J CELL SCI, V124, P3848, DOI 10.1242/jcs.087676	38	16	16	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16672	16683		10.1074/jbc.RA119.010538	http://dx.doi.org/10.1074/jbc.RA119.010538			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31540971	Green Published, hybrid			2022-12-26	WOS:000501801900017
J	Mekuria, LA; de Wit, TFR; Spieker, N; Koech, R; Nyarango, R; Ndwiga, S; Fenenga, CJ; Ogink, A; Schultsz, C; van't Hoog, A				Mekuria, Legese A.; de Wit, Tobias F. R.; Spieker, Nicole; Koech, Ramona; Nyarango, Robert; Ndwiga, Stanley; Fenenga, Christine J.; Ogink, Alice; Schultsz, Constance; van't Hoog, Anja			Analyzing data from the digital healthcare exchange platform for surveillance of antibiotic prescriptions in primary care in urban Kenya: A mixed-methods study	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; ANTIMICROBIAL RESISTANCE; PRACTITIONERS; PHYSICIANS; SETTINGS; CENTERS; DELHI	Background Knowledge of antibiotic prescription practices in low- and middle-income countries is limited due to a lack of adequate surveillance systems. Objective To assess the prescription of antibiotics for the treatment of acute respiratory tract infections (ARIs) in primary care. Method An explanatory sequential mixed-methods study was conducted in 4 private not-for-profit outreach clinics located in slum areas in Nairobi, Kenya. Claims data of patients who received healthcare between April 1 and December 27, 2016 were collected in real-time through a mobile telephone-based healthcare data and payment exchange platform (branded as M-TIBA). These data were used to calculate the percentage of ARIs for which antibiotics were prescribed. In-depth interviews were conducted among 12 clinicians and 17 patients to explain the quantitative results. Results A total of 49,098 individuals were registered onto the platform, which allowed them to access healthcare at the study clinics through M-TIBA. For 36,210 clinic visits by 21,913 patients, 45,706 diagnoses and 85,484 medication prescriptions were recorded. ARIs were the most common diagnoses (17,739; 38.8%), and antibiotics were the most frequently prescribed medications (21,870; 25.6%). For 78.5% (95% CI: 77.9%, 79.1%) of ARI diagnoses, antibiotics were prescribed, most commonly amoxicillin (45%; 95% CI: 44.1%, 45.8%). These relatively high levels of prescription were explained by high patient load, clinician and patient perceptions that clinicians should prescribe, lack of access to laboratory tests, off-loading near-expiry drugs, absence of policy and surveillance, and the use of treatment guidelines that are not up-to-date. Clinicians in contrast reported to strictly follow the Kenyan treatment guidelines. Conclusion This study showed successful quantification of antibiotic prescription and the prescribing pattern using real-world data collected through M-TIBA in private not-for-profit clinics in Nairobi.	[Mekuria, Legese A.; de Wit, Tobias F. R.; Schultsz, Constance; van't Hoog, Anja] Amsterdam Inst Global Hlth & Dev AIGHD, Amsterdam, Netherlands; [Mekuria, Legese A.; de Wit, Tobias F. R.; Schultsz, Constance; van't Hoog, Anja] Univ Amsterdam, Med Ctr, Locat AMC, Amsterdam, Netherlands; [de Wit, Tobias F. R.; Fenenga, Christine J.; Ogink, Alice] PharmAccess Fdn, Amsterdam, Netherlands; [Spieker, Nicole; Koech, Ramona] PharmAccess Fdn, Nairobi, Kenya; [Nyarango, Robert; Ndwiga, Stanley] Gertrudes Childrens Hosp, Nairobi, Kenya	University of Amsterdam	Mekuria, LA (corresponding author), Amsterdam Inst Global Hlth & Dev AIGHD, Amsterdam, Netherlands.; Mekuria, LA (corresponding author), Univ Amsterdam, Med Ctr, Locat AMC, Amsterdam, Netherlands.	legesealex@gmail.com		van't Hoog, Anja/0000-0002-6358-0394	Gilead Sciences Inc., USA; Joep Lange Institute, the Netherlands; Ministry of Foreign Affairs, the Netherlands; PharmAccess Foundation, the Netherlands	Gilead Sciences Inc., USA(Gilead Sciences); Joep Lange Institute, the Netherlands(Netherlands Government); Ministry of Foreign Affairs, the Netherlands; PharmAccess Foundation, the Netherlands(Netherlands Government)	Legese A. Mekuria is a post-doc researcher at AIGHD. The present study was conducted in an ongoing project supported by Gilead Sciences Inc., USA, Joep Lange Institute, the Netherlands, Ministry of Foreign Affairs, the Netherlands, and PharmAccess Foundation, the Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank clinicians and patients who participated in the present study. The Gertrude's Foundation is thanked for support of healthcare provision to study participants. The Gertrude's Children's Hospital in Nairobi, Kenya, should receive our sincere appreciation for ethical approval of this study. We would like to extend our thanks to PharmAccess Foundation in Kenya and the Netherlands for technical assistance.	[Anonymous], 2016, DED VERS 7 0 23 WEB; Bagger K, 2015, EUR J GEN PRACT, V21, P118, DOI 10.3109/13814788.2014.1001361; Barlam TF, 2016, CLIN INFECT DIS, V62, pE51, DOI 10.1093/cid/ciw118; Bastawrous A, 2013, J ROY SOC MED, V106, P130, DOI 10.1177/0141076812472620; Center for Disease Dynamics Economics & Policy 2015, 2015, STATE WORLDS ANTIBIO; Chirima T, 2016, SA PHARM J, V83, P44; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Cull, 2002, EORTC QUALITY LIFE G; Dekker ARJ, 2015, FAM PRACT, V32, P401, DOI 10.1093/fampra/cmv019; Ebell MH, 2015, AM J MANAG CARE, V21, pE567; Frieden T., 2019, CENT DIS CONTROL PRE, V114, DOI CS239559-B; Global Antibiotic Resistance Partnership-Kenya Working Group, 2011, SIT AN REC ANT US RE; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Gulliford MC, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006245; Hallsworth M, 2016, LANCET, V387, P1743, DOI 10.1016/S0140-6736(16)00215-4; Harris AM, 2016, ANN INTERN MED, V164, P425, DOI 10.7326/M15-1840; Holstiege J, 2015, J AM MED INFORM ASSN, V22, P236, DOI 10.1136/amiajnl-2014-002886; Huang Y, 2013, BR J GEN PRACT, pe788; Kotwani A, 2014, TROP MED INT HEALTH, V19, P761, DOI 10.1111/tmi.12327; Kotwani A, 2010, FAM PRACT, V27, P684, DOI 10.1093/fampra/cmq059; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Mash B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032358; Ministry of Medical Services Ministry of Public Health and Sanitation [Republic of Kenya], 2009, CLIN MAN REF GUID, V2; Ncube NBQ, 2017, SAMJ S AFR MED J, V107, P119, DOI [10.7196/SAMJ.2017.v107i2.11276, 10.7196/samj.2017.v107i2.11276]; Ofori-Asenso R, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3428-8; Petersen I, 2007, J ANTIMICROB CHEMOTH, V60, pI43, DOI 10.1093/jac/dkm156; Ranji SR, 2006, AHRQ PUBLICATION, V4; Ranji SR, 2008, MED CARE, V46, P847, DOI 10.1097/MLR.0b013e318178eabd; Roca I., 2015, New Microbes and New Infections, V6, P22, DOI 10.1016/j.nmni.2015.02.007; Rodrigues AT, 2013, INT J ANTIMICROB AG, V41, P203, DOI 10.1016/j.ijantimicag.2012.09.003; SAFARICOM UAP INSURANCE COMPANY LTD (UAP) and CAREPAY LIMITED (CarePay), M TIBA PROGR BON SCH; Salvi S, 2015, LANCET GLOB HEALTH, V3, pE776, DOI 10.1016/S2214-109X(15)00152-7; Sanou AM, 2016, ECON MICROBIOL, V6, P556; Seale Anna C, 2017, Wellcome Open Res, V2, P92, DOI 10.12688/wellcomeopenres.12527.1; StataCorp, 2011, STAT STAT SOFTW REL; Strumilo J, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0463-6; Tonkin-Crine SK, 2017, COCHRANE DB SYST REV, V9; Ventola C Lee, 2014, P T, V39, P356; Wang J, 2014, JAMA INTERN MED, V174, P1914, DOI 10.1001/jamainternmed.2014.5214; Wonca International Classification Committee (WICC), INT CLASSIFICATION P; World Health Organization, 2002, WORLD HLTH SURV GUID; World Health Organization, ANT RES; [No title captured], DOI DOI 10.1136/BMJ.I3410	43	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222651	10.1371/journal.pone.0222651	http://dx.doi.org/10.1371/journal.pone.0222651			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557170	Green Published, gold			2022-12-26	WOS:000532345500026
J	Fahey, CA; Chevrier, J; Crause, M; Obida, M; Bornman, R; Eskenazi, B				Fahey, Carolyn A.; Chevrier, Jonathan; Crause, Madelein; Obida, Muvhulawa; Bornman, Riana; Eskenazi, Brenda			Seasonality of antenatal care attendance, maternal dietary intake, and fetal growth in the VHEMBE birth cohort, South Africa	PLOS ONE			English	Article							MULTIPLE IMPUTATION; WEIGHT-GAIN; RESTRICTION; WOMEN	Background Seasonality of food availability, physical activity, and infections commonly occurs within rural communities in low and middle-income countries with distinct rainy seasons. To better understand the implications of these regularly occurring environmental stressors for maternal and child health, this study examined seasonal variation in nutrition and health care access of pregnant women and infants in rural South Africa. Methods We analyzed data from the Venda Health Examination of Mothers, Babies and their Environment (VHEMBE) birth cohort study of 752 mother-infant pairs recruited at delivery from August 2012 to December 2013 in the Vhembe District of Limpopo Province, the northernmost region of South Africa. We used truncated Fourier series regression to assess seasonality of antenatal care (ANC) attendance, dietary intake, and birth size. We additionally regressed ANC attendance on daily rainfall values. Models included adjustment for sociodemographic characteristics. Results Maternal ANC attendance, dietary composition, and infant birth size exhibited significant seasonal variation in both unadjusted and adjusted analyses. Adequate frequency of ANC attendance during pregnancy (>= 4 visits) was highest among women delivering during the gardening season and lowest during the lean (rainy) season. High rainfall during the third trimester was also negatively associated with adequate ANC attendance (adjusted OR = 0.59, 95% CI: 0.40, 0.86). Carbohydrate intake declined during the harvest season and increased during the vegetable gardening and lean seasons, while fat intake followed the opposite trend. Infant birth weight, length, and head circumference z-scores peaked following the gardening season and were lowest after the harvest season. Maternal protein intake and ANC <= 12 weeks did not significantly vary by season or rainfall. Conclusions Seasonal patterns were apparent in ANC utilization, dietary intake, and fetal growth in rural South Africa. Interventions to promote maternal and child health in similar settings should consider seasonal factors.	[Fahey, Carolyn A.; Eskenazi, Brenda] Univ Calif Berkeley, Sch Publ Hlth, Ctr Environm Res & Childrens Hlth CERCH, Berkeley, CA 94720 USA; [Chevrier, Jonathan] McGill Univ, Fac Med, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Crause, Madelein; Obida, Muvhulawa; Bornman, Riana] Univ Pretoria, Univ Pretoria Inst Sustainable Malaria Control UP, Sch Hlth Syst & Publ Hlth, Pretoria, South Africa	University of California System; University of California Berkeley; McGill University; University of Pretoria	Fahey, CA; Eskenazi, B (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Ctr Environm Res & Childrens Hlth CERCH, Berkeley, CA 94720 USA.	cfahey@berkeley.edu; eskenazi@berkeley.edu		Fahey, Carolyn A./0000-0001-9865-2397	U.S. National Institute of Environmental Health Sciences (NIEHS) [R01ES020360-01]; Canada Research Chairs program (CRC)	U.S. National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Canada Research Chairs program (CRC)(Canada Research ChairsAustralian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	Funding for the VHEMBE study was provided by the U.S. National Institute of Environmental Health Sciences (NIEHS: https://www.niehs.nih.gov/index.cfm) (B. Eskenazi, Award ID: R01ES020360-01) and the Canada Research Chairs program (CRC: http://www.chairschaires.gc.ca/home-accueil-eng.aspx) (J. Chevrier). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS B, 1995, OBSTET GYNECOL, V86, P163, DOI 10.1016/0029-7844(95)00118-B; [Anonymous], 2004, 40 FAO UN; [Anonymous], 2008, ANT CAR COV LEAST ON; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Ceesay SM, 1997, BMJ-BRIT MED J, V315, P786, DOI 10.1136/bmj.315.7111.786; Chodick G, 2009, HUM BIOL, V81, P463, DOI 10.3378/027.081.0405; Cox NJ, 2006, STATA J, V6, P561, DOI 10.1177/1536867X0600600408; Currie J, 2013, P NATL ACAD SCI USA, V110, P13228, DOI 10.1073/pnas.1307582110; Darrow LA, 2009, EPIDEMIOLOGY, V20, P699, DOI 10.1097/EDE.0b013e3181a66e96; De Cock N, 2013, FOOD SECUR, V5, P269, DOI 10.1007/s12571-013-0247-y; Ebonwu J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191903; Famine Early Warning Systems Network, SO AFR SEAS CAL TYP; Ferro-Luzzi A, 1993, NUTR SEASONALITY DIM; Finlayson K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001373; Fulford AJC, 2006, PAEDIATR PERINAT EP, V20, P251, DOI 10.1111/j.1365-3016.2006.00714.x; Funk C, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.66; Glassman A, 2013, J HEALTH POPUL NUTR, V31, P48; Haddad DN, 2016, INT J GYNECOL OBSTET, V132, P64, DOI 10.1016/j.ijgo.2015.06.041; Haklay M, 2008, IEEE PERVAS COMPUT, V7, P12, DOI 10.1109/MPRV.2008.80; Hasan SMT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212116; Hughes MM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-310; Kotir Julius H., 2011, Environment Development and Sustainability, V13, P587, DOI 10.1007/s10668-010-9278-0; Lincetto O, 2006, ANTENATAL CARE OPPOR; MacIntyre UE, 2001, PUBLIC HEALTH NUTR, V4, P53, DOI 10.1079/PHN200040; Matsuoka S, 2010, HEALTH POLICY, V95, P255, DOI 10.1016/j.healthpol.2009.12.011; Myer L, 2003, J MIDWIFERY WOM HEAL, V48, P268, DOI 10.1016/S1526-9523(02)00421-X; National Department of Health and ICF, 2019, S AFR DEM HLTH SURV; Pell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053747; Rao S, 2009, INT J EPIDEMIOL, V38, P1094, DOI 10.1093/ije/dyp223; Rayco-Solon P, 2005, AM J CLIN NUTR, V81, P134; Reason CJC, 2005, INT J CLIMATOL, V25, P1835, DOI 10.1002/joc.1228; Royston P, 2011, J STAT SOFTW, V45, P1, DOI 10.18637/jss.v045.i04; Seaman SR, 2013, STAT METHODS MED RES, V22, P278, DOI 10.1177/0962280210395740; Seaman SR, 2012, BIOMETRICS, V68, P129, DOI 10.1111/j.1541-0420.2011.01666.x; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; Simkhada B, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-34; Strauss RS, 1999, J NUTR, V129, P988, DOI 10.1093/jn/129.5.988; Titaley CR, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-61; Toe LC, 2015, J NUTR, V145, P634, DOI 10.3945/jn.114.203448; Vaitla B, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000101; WHO (World Health Organization), 2011, WHO ANTHR VERS 3 2 2; World Health Organization, 2002, ANT CAR RAND TRIAL M	43	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222888	10.1371/journal.pone.0222888	http://dx.doi.org/10.1371/journal.pone.0222888			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553767	gold, Green Published			2022-12-26	WOS:000532319200040
J	Chang, TE; Park, S; Yang, QH; Loustalot, F; Butler, J; Ritchey, MD				Chang, Tiffany E.; Park, Soyoun; Yang, Quanhe; Loustalot, Fleetwood; Butler, Javed; Ritchey, Matthew D.			Association between long-term adherence to class-I recommended medications and risk for potentially preventable heart failure hospitalizations among younger adults	PLOS ONE			English	Article							HYDRALAZINE-ISOSORBIDE DINITRATE; CLINICAL EFFECTIVENESS; MEDICARE; IMPACT; MANAGEMENT; BENEFICIARIES; NONADHERENCE; OUTCOMES; THERAPY; COPAYMENT	Background Five guideline-recommended medication categories are available to treat patients who have heart failure (HF) with reduced ejection fraction. However, adherence to these medications is often suboptimal, which places patients at increased risk for poor health outcomes, including hospitalization. We aimed to examine the association between adherence to these medications and potentially preventable HF hospitalizations among younger insured adults with newly diagnosed HF. Methods and results Using the 2008-2012 IBM MarketScan Commercial database, we followed 26,439 individuals aged 18-64 years with newly diagnosed HF and calculated their adherence (using the proportion of days covered (PDC) algorithm) to the five guideline-recommended medication categories: angiotensin-converting enzyme inhibitors/angiotensin-receptor blockers; beta blockers; aldosterone receptor antagonists; hydralazine; and isosorbide dinitrate. We determined the association between PDC and long-term preventable HF hospitalizations (observation years 3-5) as defined by the United States (U.S.) Agency for Healthcare Research and Quality. Overall, 49.0% of enrollees had good adherence (PDC.80%), which was more common among enrollees who were older, male, residing in higher income counties, initially diagnosed with HF in an outpatient setting, and who filled prescriptions for fewer medication categories assessed. Adherence differed by medication category and was lowest for isosorbide dinitrate (PDC = 60.7%). In total, 7.6% of enrollees had preventable HF hospitalizations. Good adherers, compared to poor adherers (PDC< 40%), were 15% less likely to have a preventable hospitalization (HR 0.85, 95% confidence interval, 0.75-0.96). Conclusion We found that approximately half of insured U.S. adults aged 18-64 years with newly diagnosed HF had good adherence to their HF medications. Patients with good adherence, compared to those with poor adherence, were less likely to have a potentially preventable HF hospitalization 3-5 years after their initial diagnosis. Because HF is a chronic condition that requires long-term management, future studies may want to assess the effectiveness of interventions in sustaining adherence.	[Chang, Tiffany E.; Park, Soyoun; Yang, Quanhe; Loustalot, Fleetwood; Ritchey, Matthew D.] Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA; [Chang, Tiffany E.] IHRC Inc, Atlanta, GA USA; [Butler, Javed] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA	Centers for Disease Control & Prevention - USA; University of Mississippi; University of Mississippi Medical Center	Ritchey, MD (corresponding author), Ctr Dis Control & Prevent, Div Heart Dis & Stroke Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.	mritchey@cdc.gov		Park, Soyoun/0000-0003-1862-6370	NIGMS NIH HHS [U54 GM115428] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agency for Healthcare Research and Quality, GUID PREV QUAL IND H; Agency for Healthcare Research & Quality, PREV QUAL IND TECHN; Aguilar KM, 2015, J MANAG CARE SPEC PH, V21, P670, DOI 10.18553/jmcp.2015.21.8.670; Ambardekar AV, 2009, AM HEART J, V158, P644, DOI 10.1016/j.ahj.2009.07.034; Andersson C, 2014, HEART FAIL CLIN, V10, P377, DOI 10.1016/j.hfc.2014.04.003; Bagchi AD, 2007, CLIN THER, V29, P1771, DOI 10.1016/j.clinthera.2007.08.015; Bansilal S, 2016, J AM COLL CARDIOL, V68, P789, DOI 10.1016/j.jacc.2016.06.005; Bellera CA, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-20; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Chang LL, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007998; Choudhry NK, 2011, ARCH INTERN MED, V171, P814, DOI 10.1001/archinternmed.2010.495; Choudhry NK, 2009, AM J MANAG CARE, V15, P457; Cole JA, 2006, PHARMACOTHERAPY, V26, P1157, DOI 10.1592/phco.26.8.1157; Cox ZL, 2017, CLIN CARDIOL, V40, P620, DOI 10.1002/clc.22711; Fitzgerald AA, 2011, J CARD FAIL, V17, P664, DOI 10.1016/j.cardfail.2011.04.011; Gourzoulidis G, 2017, HEALTH POLICY, V121, P363, DOI 10.1016/j.healthpol.2017.02.008; Hansen LG, 2011, WHITE PAPER HLTH RES; Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a; Heldenbrand S, 2016, J AM PHARM ASSOC, V56, P293, DOI 10.1016/j.japh.2015.12.014; Hincapie AL, 2015, J MANAG CARE SPEC PH, V21, P391, DOI 10.18553/jmcp.2015.21.5.391; Hood SR, 2018, PHARMACOTHERAPY, V38, P539, DOI 10.1002/phar.2107; IMS Health, 2008, UN SYST CLASS USC; Khazanie P, 2016, CIRC-HEART FAIL, V9, P1, DOI 10.1161/CIRCHEARTFAILURE.115.002444; Kronish IM, 2013, PROG CARDIOVASC DIS, V55, P590, DOI 10.1016/j.pcad.2013.02.001; Kuhle J, PQA MEASURES USED CM; Lloyd JT, 2019, MED CARE, V57, P218, DOI 10.1097/MLR.0000000000001067; Lopert R, 2012, AM J MANAG CARE, V18, P556; Mockler M, 2009, AM J CARDIOL, V103, P834, DOI 10.1016/j.amjcard.2008.11.058; Murray MD, 2007, ANN INTERN MED, V146, P714, DOI 10.7326/0003-4819-146-10-200705150-00005; Nair KV, 2011, PATIENT PREFER ADHER, V5, P195, DOI 10.2147/PPA.S18481; National Quality Forum, 2010, NAT VOL CONS STAND M; Nau DP, PROPORTION DAYS COVE; Riegel B, 2014, PATIENT PREFER ADHER, V8, P1, DOI 10.2147/PPA.S54520; Ruppar TM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002606; Shah KS, 2017, J AM COLL CARDIOL, V70, P2476, DOI 10.1016/j.jacc.2017.08.074; Sherman BW, 2009, AM J MANAG CARE, V15, pE53; Shimp LA, 2012, J AM PHARM ASSOC, V52, P768, DOI 10.1331/JAPhA.2012.11186; Sueta CA, 2015, AM J CARDIOL, V116, P413, DOI 10.1016/j.amjcard.2015.04.058; Svensson S, 2000, INT J CARDIOL, V76, P157, DOI 10.1016/S0167-5273(00)00374-0; Tang J, 2008, STROKE, V39, P1938, DOI 10.1161/STROKEAHA.107.504688; US Food and Drug Administration, NAT DRUG COD DIR; USDHHS HRSA, AR HLTH RES FIL AHRF; Will JC, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110260; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Yang QH, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006056; Zhang YT, 2014, J GEN INTERN MED, V29, P602, DOI 10.1007/s11606-013-2692-x; Ziaeian B, 2017, JACC-HEART FAIL, V5, P632, DOI 10.1016/j.jchf.2017.04.008; Zuckerman RB, 2016, NEW ENGL J MED, V374, P1543, DOI 10.1056/NEJMsa1513024	48	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222868	10.1371/journal.pone.0222868	http://dx.doi.org/10.1371/journal.pone.0222868			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545830	Green Published, gold			2022-12-26	WOS:000532303200039
J	Gong, J; Simon, GE; Liu, S				Gong, Jue; Simon, Gregory E.; Liu, Shan			Machine learning discovery of longitudinal patterns of depression and suicidal ideation	PLOS ONE			English	Article							SYMPTOMS; TIME; TRAJECTORIES; SEVERITY; PHQ-9; RISK	Background and aim Depression is often accompanied by thoughts of self-harm, which are a strong predictor of subsequent suicide attempt and suicide death. Few empirical data are available regarding the temporal correlation between depression symptoms and suicidal ideation. We investigated the anecdotal concern that suicidal ideation may increase during a period of depression improvement. Data Longitudinal Patient Health Questionnaire (PHQ)-9 is a questionnaire of 9 multiple-choice questions to assess the frequency of depressive symptoms within the previous two weeks. We analyzed a chronic depression treatment population's electronic health record (EHR) data, containing 610 patients' longitudinal PHQ-9 scores (62% age 45 and older; 68% female) within 40 weeks. Methods The irregular and sparse EHR data were transformed into continuous trajectories using Gaussian process regression. We first estimated the correlations between the symptoms (total score of the first 8 questions; PHQ-8) and suicide ideation (9th question score; Item 9) using the cross-correlation function. We then used an artificial neural network (ANN) to discover subtypes of depression patterns from the fitted depression trajectories. In addition, we conducted a separate analysis using the unfitted raw PHQ scores to examine PHQ-8's and Item 9's pattern changes. Results Results showed that the majority of patients' PHQ-8 and Item 9 scores displayed strong temporal correlations. We found five patterns in the PHQ-8 and the Item 9 trajectories. We also found 8% - 13% of the patients have experienced an increase in suicidal ideation during the improvement of their PHQ-8. Using a trajectory-based method for subtype pattern detection in depression progression, we provided a better understanding of temporal correlations between depression symptoms over time.	[Gong, Jue; Liu, Shan] Univ Washington, Dept Ind & Syst Engn, Seattle, WA 98195 USA; [Simon, Gregory E.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA USA; [Simon, Gregory E.] Univ Washington, Psychiat & Behav Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Kaiser Permanente; University of Washington; University of Washington Seattle	Liu, S (corresponding author), Univ Washington, Dept Ind & Syst Engn, Seattle, WA 98195 USA.	liushan@uw.edu			National Science Foundation [CMMI-1824623]	National Science Foundation(National Science Foundation (NSF))	JG and SL are supported by the National Science Foundation grant CMMI-1824623. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmedani BK, 2017, AM J PREVENTIVE MED; Anderson HD, 2015, J AM BOARD FAM MED, V28, P65, DOI 10.3122/jabfm.2015.01.140181; Bayley KB, 2013, MED CARE, V51, pS80, DOI 10.1097/MLR.0b013e31829b1d48; Berlin KS, 2014, J PEDIATR PSYCHOL, V39, P188, DOI 10.1093/jpepsy/jst085; Coupland C, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/BMJ.h517, 10.1136/bmj.h517]; Dong J.L., 1999, P 5 ACM SIGKDD INT C, P43, DOI [10.1145/312129.312191, DOI 10.1145/312129.312191]; Ellis TE, 2012, PSYCHOTHERAPY, V49, P72, DOI 10.1037/a0026746; Franklin JC, 2017, PSYCHOL BULL, V143, P187, DOI 10.1037/bul0000084; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Gunn J, 2013, J AFFECT DISORDERS, V148, P338, DOI 10.1016/j.jad.2012.12.021; Jacobson O, 2016, P 15 WORKSH BIOM NAT, P191; Kahn MG, 2012, MED CARE, V50, pS60, DOI 10.1097/MLR.0b013e318259bff4; Kaplan D, 2004, SAGE HDB QUANTITATIV, Vxiii; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Lasko TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066341; Lin Y, 2018, IISE TRANS, V50, P1076, DOI 10.1080/24725854.2018.1470357; Lin Y, 2018, IEEE T RELIAB, V67, P328, DOI 10.1109/TR.2017.2767941; Lin Y, 2016, MATH BIOSCI, V282, P191, DOI 10.1016/j.mbs.2016.10.008; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Mittal V, 2009, PSYCHIAT SERV, V60, P384, DOI 10.1176/appi.ps.60.3.384; Musliner KL, 2016, J AFFECT DISORDERS, V192, P199, DOI 10.1016/j.jad.2015.12.030; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rehfeld K, 2011, NONLINEAR PROC GEOPH, V18, P389, DOI 10.5194/npg-18-389-2011; Ribeiro JD, 2016, PSYCHOL MED, V46, P225, DOI 10.1017/S0033291715001804; Simon GE, 2018, AM J PSYCHIAT, V175, P434, DOI [10.1176/appi.ajp.2017.17080844, 10.1176/appi.ajp.2018.17101167]; Simon GE, 2013, PSYCHIAT SERV, V64, P1195, DOI 10.1176/appi.ps.201200587; Snippe E, 2015, MINDFULNESS, V6, P1053, DOI 10.1007/s12671-014-0354-7; Somaraki V, 2010, LECT NOTES COMPUTER, V6171; Swingler K., 1996, APPL NEURAL NETWORKS; Team TTD, 2016, ABS160502688 ARXIV; Twisk J, 2012, J CLIN EPIDEMIOL, V65, P1078, DOI 10.1016/j.jclinepi.2012.04.010; Valuck RJ, 2012, J AM BOARD FAM MED, V25, P582, DOI 10.3122/jabfm.2012.05.110053; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; van Loo HM, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-156; Zhang ZH, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.02.05; Zhong QY, 2018, BMC MED INFORM DECIS, V18, DOI [10.1186/s12911-018-0617-7, 10.1186/S12911-018-0617-7]	36	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222665	10.1371/journal.pone.0222665	http://dx.doi.org/10.1371/journal.pone.0222665			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5OJ	31539408	Green Published, gold			2022-12-26	WOS:000532297900023
J	Agbota, G; Polman, K; Wieringa, FT; Campos-Ponce, M; Accrombessi, M; Yovo, E; Roucher, C; Ezinmegnon, S; Marcos, JY; Vachot, L; Tissieres, P; Massougbodji, A; Fievet, N; Cot, M; Briand, V				Agbota, Gino; Polman, Katja; Wieringa, Frank T.; Campos-Ponce, Maiza; Accrombessi, Manfred; Yovo, Emmanuel; Roucher, Clementine; Ezinmegnon, Sem; Marcos, Javier Yugueros; Vachot, Laurence; Tissieres, Pierre; Massougbodji, Achille; Fievet, Nadine; Cot, Michel; Briand, Valerie			Maternal malaria but not schistosomiasis is associated with a higher risk of febrile infection in infant during the first 3 months of life: A mother-child cohort in Benin	PLOS ONE			English	Article							HEMOGLOBIN CONCENTRATION; EARLY-PREGNANCY; PREVALENCE; FALCIPARUM; RECEPTOR; ANEMIA	Background Malaria and schistosomiasis represent two of the most prevalent and disabling parasitic infections in developing countries. Few studies have evaluated the effect of maternal schistosomiasis and malaria in the peri-conceptional period on infant's risk of infection. Methods In Benin, women were followed from the preconception period until delivery. Subsequently, their children were followed from birth to 3 months of age. Pre-pregnancy malaria, malaria in pregnancy (MiP)-determined monthly using a thick blood smear-and urinary schistosomiasis-determined once before pregnancy and once at delivery using urine filtration-were the main maternal exposures. Infant's febrile infection (fever with respiratory, gastrointestinal and/or cutaneous clinical signs anytime during follow-up) was the main outcome. In a secondary analysis, we checked the relation of malaria and schistosomiasis with infant's hemoglobin (Hb) concentration. Both effects were separately assessed using logistic/mixed linear regression models. Results The prevalence of MiP was 35.7% with 10.8% occurring during the 1st trimester, and the prevalence of schistosomiasis was 21.8%. From birth to 3 months, 25.3% of infants had at least one episode of febrile infection. In multivariate analysis, MiP, particularly malaria in the 1st trimester, was significantly associated with a higher risk of infant's febrile infection (aOR = 4.99 [1.1; 22.6], p = 0.03). In secondary results, pre-pregnancy malaria and schistosomiasis were significantly associated with a lower infant's Hb concentration during the first 3 months. Conclusion We evidenced the deleterious effect of maternal parasitic infections on infant's health. Our results argue in favor of the implementation of preventive strategies as early as in the periconception.	[Agbota, Gino; Accrombessi, Manfred; Yovo, Emmanuel; Fievet, Nadine; Cot, Michel; Briand, Valerie] Univ Paris 05, Sorbonne Paris Cite, MERIT, IRD, Paris, France; [Agbota, Gino; Massougbodji, Achille] CERPAGE, Cotonou, Benin; [Polman, Katja; Roucher, Clementine] Inst Trop Med, Dept Biomed Sci, Antwerp, Belgium; [Campos-Ponce, Maiza] Vrije Univ Amsterdam, Dept Hlth Sci, Infect Dis Sect, Amsterdam, Netherlands; [Wieringa, Frank T.] IRD UM SupAgro, Inst Rech Dev, Nutripass, UMR204, Montpellier, France; [Ezinmegnon, Sem; Marcos, Javier Yugueros; Vachot, Laurence] Med Diagnost Discovery Dept MD3, BioMerieux, Marcy Letoile, France; [Ezinmegnon, Sem; Tissieres, Pierre] Univ Paris Saclay, Inst Biol Integrat Cellule, UMR 9198, Paris, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Institute of Tropical Medicine (ITM); Vrije Universiteit Amsterdam; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; bioMerieux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay	Agbota, G (corresponding author), Univ Paris 05, Sorbonne Paris Cite, MERIT, IRD, Paris, France.; Agbota, G (corresponding author), CERPAGE, Cotonou, Benin.	ginodric@yahoo.fr	Wieringa, Frank Tammo/K-7565-2017; Accrombessi, Manfred/W-1546-2017; Cot, Michel/E-7633-2011	Wieringa, Frank Tammo/0000-0002-6010-355X; Accrombessi, Manfred/0000-0001-9550-9413; Cot, Michel/0000-0003-3014-4294; Fievet, Nadine/0000-0003-2272-9794; Campos Ponce, Maiza/0000-0003-1700-4756; AGBOTA, Gino/0000-0001-7726-0984; YOVO, Emmanuel Koffi/0000-0003-1082-5113	Fondation pour la Recherche Medicale (FRM) [ECO20160736054]; French Agence Nationale de la Recherche [ANR-13-JSV1-0004]; Fondation Simone Beer under the Fondation de France [00074147]; bioMerieux	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); French Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation Simone Beer under the Fondation de France; bioMerieux	Fondation pour la Recherche Medicale (FRM, grant number ECO20160736054) for PhD scholarship. The French Agence Nationale de la Recherche [ANR-13-JSV1-0004, grant 2013] and the Fondation Simone Beer under the auspices of the Fondation de France [00074147, grant 2017] funded RECIPAL project. bioMerieux funded SEPSIS project. NO - The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SE, JYM and LV contributed to data collection in the framework of SEPSIS project and to the final revision of the manuscript in their own names and not on behalf of their employer.	Accrombessi M, 2019, CLIN INFECT DIS, V69, P1385, DOI 10.1093/cid/ciy1073; Accrombessi M, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019014; Accrombessi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129510; Ajanga A, 2006, T ROY SOC TROP MED H, V100, P59, DOI 10.1016/j.trstmh.2005.06.024; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Huynh BT, 2015, CLIN INFECT DIS, V60, P598, DOI 10.1093/cid/ciu848; Chico RM, 2012, JAMA-J AM MED ASSOC, V307, P2079, DOI 10.1001/jama.2012.3428; Collier CH, 2013, MATERN CHILD HLTH J, V17, P1940, DOI 10.1007/s10995-013-1220-2; Colomer J, 1990, Paediatr Perinat Epidemiol, V4, P196, DOI 10.1111/j.1365-3016.1990.tb00638.x; Cot M, 2003, AM J EPIDEMIOL, V157, P203, DOI 10.1093/aje/kwf192; de Pee S, 2002, J NUTR, V132, P2215, DOI 10.1093/jn/132.8.2215; Djenontin A, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-83; Dorman EK, 2002, ULTRASOUND OBST GYN, V19, P165, DOI 10.1046/j.0960-7692.2001.00545.x; Erhardt JG, 2004, J NUTR, V134, P3127, DOI 10.1093/jn/134.11.3127; Fievet N, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-251; Friedman JF, 2007, TRENDS PARASITOL, V23, P159, DOI 10.1016/j.pt.2007.02.006; Gbedande K, 2013, INFECT IMMUN, V81, P2686, DOI 10.1128/IAI.00237-13; King CL, 1998, J IMMUNOL, V160, P3578; Le Port A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027516; Mischlinger J, 2018, TROP MED INT HEALTH, V23, P980, DOI 10.1111/tmi.13124; Mombo-Ngoma G, 2017, INT J PARASITOL, V47, P69, DOI 10.1016/j.ijpara.2016.11.001; Olveda RM, 2016, LANCET INFECT DIS, V16, P199, DOI 10.1016/S1473-3099(15)00345-X; Onzo-Aboki A, 2019, ACTA TROP, V191, P185, DOI 10.1016/j.actatropica.2019.01.004; PETERS PA, 1976, J PARASITOL, V62, P154, DOI 10.2307/3279081; Rachas A, 2012, CLIN INFECT DIS, V55, P672, DOI 10.1093/cid/cis490; Ramakrishnan U, 2012, PAEDIATR PERINAT EP, V26, P285, DOI 10.1111/j.1365-3016.2012.01281.x; SIEGRIST D, 1992, ACTA TROP, V50, P317, DOI 10.1016/0001-706X(92)90066-7; World Health Organization, FACT SHEETS DET MAL; World Health Organization, 2008, DEF CONCL CONS M H 1; World Health Organization, 2006, WHO CHILD GROWTH STA; World Health Organization, FACT SHEETS DET SCHI; Yu ZB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061627; Zhang YT, 2016, J PEDIATR-US, V175, P106, DOI 10.1016/j.jpeds.2016.05.011	33	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222864	10.1371/journal.pone.0222864	http://dx.doi.org/10.1371/journal.pone.0222864			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JP8YO	31536589	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000498544800001
J	Bergot, E; De Leotoing, L; Bendjenana, H; Tournier, C; Vainchtock, A; Nachbaur, G; Humbert, M				Bergot, Emmanuel; De Leotoing, Lucie; Bendjenana, Hakim; Tournier, Charlene; Vainchtock, Alexandre; Nachbaur, Gaelle; Humbert, Marc			Hospital burden of pulmonary arterial hypertension in France	PLOS ONE			English	Article							ECONOMIC BURDEN; COSTS; CARE; EPIDEMIOLOGY; GUIDELINES; DIAGNOSIS; OUTCOMES; US	Background & aims Pulmonary arterial hypertension is a severe disease associated with frequent hospitalisations. This retrospective analysis of the French medical information PMSI-MSO database aimed to describe incident cases of patients with pulmonary arterial hypertension hospitalised in France in 2013 and to document associated hospitalisation costs from the national health insurance perspective. Methods Cases of pulmonary arterial hypertension were identified using a diagnostic algorithm. All cases hospitalised in 2013 with no hospitalisation the previous two years were retained. All hospital stays during the year following the index hospitalisation were extracted, and classified as incident stays, monitoring stays or stays due to disease worsening. Costs were attributed from French national tariffs. Results 384 patients in France were hospitalised with incident pulmonary arterial hypertension in 2013. Over the following twelve months, patients made 1,271 stays related to pulmonary arterial hypertension (415 incident stays, 604 monitoring stays and 252 worsening stays). Mean age was 59.6 years and 241 (62.8%) patients were women. Liver disease and connective tissue diseases were documented in 62 patients (16.1%) each. Thirty-one patients (8.1%) died during hospitalisation and four (1.0%) received a lung/heart-lung transplantation. The total annual cost of these hospitalisations was (sic) 3,640,382. (sic) 2,985,936 was attributable to standard tariffs (82.0%), (sic) 463,325 to additional ICU stays (12.7%) and (sic) 191,118 to expensive drugs (5.2%). The mean cost/stay was (sic) 2,864, ranging from (sic) 1,282 for monitoring stays to (sic) 7,285 for worsening stays. Conclusions Although pulmonary arterial hypertension is rare, it carries a high economic burden.	[Bergot, Emmanuel] CHU Caen, Serv Pneumol & Oncol Thorac, Caen, France; [Bergot, Emmanuel] Unicaen, UFR Sante, Caen, France; [De Leotoing, Lucie; Tournier, Charlene; Vainchtock, Alexandre] HEVA, Lyon, France; [Bendjenana, Hakim; Nachbaur, Gaelle] GlaxoSmithKline, Rueil Malmaison, France; [Humbert, Marc] Univ Paris Sud, Univ Paris Saclay, Fac Med, Le Kremlin Bicetre, France; [Humbert, Marc] Hop Bicetre, AP HP, Serv Pneumol, Le Kremlin Bicetre, France; [Humbert, Marc] INSERM, UMR S 999, Le Kremlin Bicetre, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Caen Normandie; GlaxoSmithKline; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Bergot, E (corresponding author), CHU Caen, Serv Pneumol & Oncol Thorac, Caen, France.; Bergot, E (corresponding author), Unicaen, UFR Sante, Caen, France.	bergot.e@gmail.com	Humbert, Marc/ABD-5112-2021; Humbert, Marc/AAC-8459-2019	Humbert, Marc/0000-0003-0703-2892	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	This study was initiated and funded by GlaxoSmithKline. The sponsor delegated management of the study and data analysis to HEVA (Lyon, France). Representatives of the funders (listed as authors of the study) were involved in study design, the decision to publish, and reviewed the final manuscript before submission. They had no role in data collection or analysis.; The writing and preparation of this manuscript was funded by GlaxoSmithKline. Initial data analyses were undertaken by CT, who is employee of HEVA (Lyon, France) and received funding from GlaxoSmithKline. Editorial support in drafting this manuscript was provided by Adam Doble of Foxymed (Paris, France), and was funded by GlaxoSmithKline. All authors had complete access to the data that supports this publication and have contributed to a draft and approved the manuscript for publication. The corresponding author had the final responsibility to submit for publication.	Angalakuditi Mallik, 2010, J Med Econ, V13, P393, DOI 10.3111/13696998.2010.496694; Bezin J, 2017, PHARMACOEPIDEM DR S, V26, P954, DOI 10.1002/pds.4233; Bouee S, 2013, VALUE HEALTH, V16, pA521, DOI 10.1016/j.jval.2013.08.1256; Burke JP, 2015, AM J MANAG CARE, V21, pS47; Chevalier P, 2014, VALUE HEALTH, V17, pA593, DOI 10.1016/j.jval.2014.08.2037; Escribano-Subias P, 2016, INT J CARDIOL, V203, P938, DOI 10.1016/j.ijcard.2015.11.039; Farber HW, 2015, CHEST, V148, P1043, DOI 10.1378/chest.15-0300; Galie N, 2009, EUR RESPIR J, V34, P1219, DOI 10.1183/09031936.00139009; Galie N, 2016, REV ESP CARDIOL, V69, P177, DOI 10.1016/j.rec.2016.01.002; Gu SY, 2016, PHARMACOECONOMICS, V34, P533, DOI 10.1007/s40273-015-0361-0; Heresi GA, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0399-1; Hoeper MM, 2016, LANCET RESP MED, V4, P306, DOI 10.1016/S2213-2600(15)00543-3; Hoeper MM, 2016, INT J CARDIOL, V203, P612, DOI 10.1016/j.ijcard.2015.11.001; Hoeper MM, 2014, EUR RESPIR REV, V23, P450, DOI 10.1183/09059180.00007814; Hoeper MM, 2013, INT J CARDIOL, V168, P871, DOI 10.1016/j.ijcard.2012.10.026; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Johnson Samuel, 2013, J Med Econ, V16, P1414, DOI 10.3111/13696998.2013.849713; Kirson NY, 2011, APPL HEALTH ECON HEA, V9, P293, DOI 10.2165/11592430-000000000-00000; Ling Y, 2012, AM J RESP CRIT CARE, V186, P790, DOI 10.1164/rccm.201203-0383OC; Maladie Assurance, 2018, PROP ASS MAL 2019; McGoon MD, 2012, EUR RESPIR REV, V21, P8, DOI 10.1183/09059180.00008211; McGoon MD, 2013, J AM COLL CARDIOL, V62, pD51, DOI 10.1016/j.jacc.2013.10.023; Molinari N, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0469-6; Montani D, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-97; Murali S, 2006, CURR OPIN CRIT CARE, V12, P228, DOI 10.1097/01.ccx.0000224867.78581.0c; Provencher S, 2005, CHEST, V128, p622S, DOI 10.1378/chest.128.6_suppl.622S; Said Qayyim, 2012, J Med Econ, V15, P500, DOI 10.3111/13696998.2012.665109; Scan Sante, 2017, PLATEFORME RESTITUTI; Sikirica M, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0676-0; Wilkens H, 2010, RESP MED, V104, P902, DOI 10.1016/j.rmed.2010.01.002; World Health Organization, 2010, INT CLASS DIS	31	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0221211	10.1371/journal.pone.0221211	http://dx.doi.org/10.1371/journal.pone.0221211			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536491	Green Published, Green Submitted, gold			2022-12-26	WOS:000532262800015
J	Ontoria, Y; Cuesta-Gracia, A; Ruiz, JM; Romero, J; Perez, M				Ontoria, Yaiza; Cuesta-Gracia, Ainhoa; Ruiz, Juan M.; Romero, Javier; Perez, Marta			The negative effects of short-term extreme thermal events on the seagrass Posidonia oceanica are exacerbated by ammonium additions	PLOS ONE			English	Article							EELGRASS ZOSTERA-MARINA; COLUMN NITRATE ENRICHMENT; CLIMATE-CHANGE; PHOTOSYNTHETIC RESPONSES; PHYSIOLOGICAL-RESPONSES; ENVIRONMENTAL STRESSORS; CYMODOCEA-NODOSA; WATER-QUALITY; HEAT WAVES; IN-SITU	Global warming is increasingly affecting our biosphere. However, in addition to global warming, a panoply of local stressors caused by human activities is having a profound impact on our environment. The risk that these local stressors could modify the response of organisms to global warming has attracted interest and fostered research on their combined effect, especially with a view to identifying potential synergies. In coastal areas, where human activities are heavily concentrated, this scenario is particularly worrying, especially for foundation species such as seagrasses. In this study we explore these potential interactions in the seagrass Posidonia oceanica. This species is endemic to the Mediterranean Sea. It is well known that the Mediterranean is already experiencing the effects of global warming, especially in the form of heat waves, whose frequency and intensity are expected to increase in the coming decades. Moreover, this species is especially sensitive to stress and plays a key role as a foundation species. The aim of this work is thus to evaluate plant responses (in terms of photosynthetic efficiency and growth) to the combined effects of short-term temperature increases and ammonium additions.To achieve this, we conducted a mesocosm experiment in which plants were exposed to three thermal treatments (20 degrees C, 30 degrees C and 35 degrees C) and three ammonium concentrations (ambient, 30 mu M and 120 mu M) in a full factorial experiment. We assessed plant performance by measuring chlorophyll fluorescence variables (maximum quantum yield (F-v/F-m), effective quantum yield of photosystem II (Delta F/F-m'), maximum electron transport rate (ETRmax) and non-photochemical quenching (NPQ)), shoot growth rate and leaf necrosis incidence. At ambient ammonium concentrations, P. oceanica tolerates short-term temperature increases up to 30 degrees C. However, at 35 degrees C, the plant loses functionality as indicated by a decrease in photosynthetic performance, an inhibition of plant growth and an increase of the necrosis incidence in leaves. On the other hand, ammonium additions at control temperatures showed only a minor effect on seagrass performance. However, the combined effects of warming and ammonium were much worse than those of each stressor in isolation, given that photosynthetic parameters and, above all, leaf growth were affected. This serves as a warning that the impact of global warming could be even worse than expected (based on temperature-only approaches) in environments that are already subject to eutrophication, especially in persistent seagrass species living in oligotrophic environments.	[Ontoria, Yaiza; Cuesta-Gracia, Ainhoa; Romero, Javier; Perez, Marta] Univ Barcelona, Dept Evolutionary Biol Ecol & Environm Sci, Barcelona, Spain; [Ruiz, Juan M.] Spanish Inst Oceanog, Oceanog Ctr Murcia, Seagrass Ecol Grp, Murcia, Spain	University of Barcelona; Spanish Institute of Oceanography	Ontoria, Y (corresponding author), Univ Barcelona, Dept Evolutionary Biol Ecol & Environm Sci, Barcelona, Spain.	yaizaontoria@ub.edu	Ontoria, Yaiza/AAA-9113-2021	RUIZ FERNANDEZ, JUAN MANUEL/0000-0002-5974-1407; Ontoria, Yaiza/0000-0002-5157-1570	European Union [CTM2013-48027-C3-1-R, CTM2013-48027-C3-2-R, CTM2017-86695-C3-1-R]; Spanish Government [CTM2013-48027-C3-1-R, CTM2013-48027-C3-2-R, CTM2017-86695-C3-1-R]; Spanish Ministry of Economy and Competitiveness [BES-2014-069593]	European Union(European Commission); Spanish Government(Spanish GovernmentEuropean Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by the European Union and the Spanish Government through the RECCAM (Seagrass meadows resilience to global warming: an analysis based on responses at ecophysiological, population and ecosystem levels, CTM2013-48027-C3-1-R and CTM2013-48027-C3-2-R) and UMBRAL (Responses of benthic marine vegetation to stress: critical transitions, resilience, and management opportunities, CTM2017-86695-C3-1-R) projects; and by the Spanish Ministry of Economy and Competitiveness (via grant BES-2014-069593 awarded to Y. Ontoria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcoverro T, 2001, MAR ECOL PROG SER, V211, P105, DOI 10.3354/meps211105; Alcoverro T, 1998, J EXP MAR BIOL ECOL, V230, P1, DOI 10.1016/S0022-0981(98)00022-7; Alcoverro T, 1997, MAR ECOL PROG SER, V146, P155, DOI 10.3354/meps146155; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2008, PERMANOVA PRIMER GUI; Arevalo R, 2007, MAR POLLUT BULL, V55, P104, DOI 10.1016/j.marpolbul.2006.08.023; Arnaud-Haond S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030454; Ashraf M, 2013, PHOTOSYNTHETICA, V51, P163, DOI 10.1007/s11099-013-0021-6; Beca-Carretero P, 2018, MAR POLLUT BULL, V134, P27, DOI 10.1016/j.marpolbul.2017.12.057; Boudouresque C.-F., 2012, PROTECTION CONSERVAT; Brown CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065765; Brun FG, 2008, MAR ECOL PROG SER, V365, P67, DOI 10.3354/meps07512; Brun FG, 2002, MAR ECOL PROG SER, V225, P177, DOI 10.3354/meps225177; BULTHUIS DA, 1987, AQUAT BOT, V27, P27, DOI 10.1016/0304-3770(87)90084-2; BURKHOLDER JM, 1994, MAR ECOL PROG SER, V105, P121, DOI 10.3354/meps105121; BURKHOLDER JM, 1992, MAR ECOL PROG SER, V81, P163, DOI 10.3354/meps081163; Burkholder JM, 2007, J EXP MAR BIOL ECOL, V350, P46, DOI 10.1016/j.jembe.2007.06.024; Campbell S, 2003, J EXP MAR BIOL ECOL, V291, P57, DOI 10.1016/S0022-0981(03)00090-X; Campbell SJ, 2006, J EXP MAR BIOL ECOL, V330, P455, DOI 10.1016/j.jembe.2005.09.017; Ceccherelli G, 2018, OECOLOGIA, V186, P1137, DOI 10.1007/s00442-018-4075-9; Clarke K.R., 2006, PRIMER V6 USER MANUA; Collier CJ, 2014, MAR POLLUT BULL, V83, P483, DOI 10.1016/j.marpolbul.2014.03.050; Collier CJ, 2011, LIMNOL OCEANOGR, V56, P2200, DOI 10.4319/lo.2011.56.6.2200; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; Cote IM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2592; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Diaz-Almela E, 2007, GLOBAL CHANGE BIOL, V13, P224, DOI 10.1111/j.1365-2486.2006.01260.x; Duarte B, 2016, BIOL INVASIONS, V18, P2189, DOI 10.1007/s10530-015-0958-4; Dunne RP, 2010, CORAL REEFS, V29, P145, DOI 10.1007/s00338-009-0569-6; Durako MJ, 2002, AQUAT BOT, V73, P173, DOI 10.1016/S0304-3770(02)00020-7; Egea LG, 2018, MAR POLLUT BULL, V134, P14, DOI 10.1016/j.marpolbul.2018.02.029; Galli G, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00136; Gera A, 2012, ENVIRON MONIT ASSESS, V184, P3675, DOI 10.1007/s10661-011-2215-3; Green E.P., 2003, WORLD ATLAS SEAGRASS, V47, DOI [10.1515/BOT.2004.029, DOI 10.1515/BOT.2004.029]; Greve TM, 2003, LIMNOL OCEANOGR, V48, P210, DOI 10.4319/lo.2003.48.1.0210; Guerrero-Meseguer L, 2017, ENVIRON POLLUT, V230, P40, DOI 10.1016/j.envpol.2017.06.039; Gunderson AR, 2016, ANNU REV MAR SCI, V8, P357, DOI 10.1146/annurev-marine-122414-033953; Hallett CS, 2018, REG ENVIRON CHANGE, V18, P1357, DOI 10.1007/s10113-017-1264-8; Halpern BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8615; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hendriks IE, 2017, AQUAT BOT, V139, P32, DOI 10.1016/j.aquabot.2017.02.004; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Holmer M, 2003, BIOGEOCHEMISTRY, V66, P223, DOI 10.1023/B:BIOG.0000005326.35071.51; Hughes BB, 2013, P NATL ACAD SCI USA, V110, P15313, DOI 10.1073/pnas.1302805110; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Invers O, 2004, J EXP MAR BIOL ECOL, V303, P97, DOI 10.1016/j.jembe.2003.11.005; IPCC (Intergovernmental Panel on Climate Change), 2007, CLIMATE CHANGE 2007, DOI [10.1256/004316502320517344, DOI 10.1256/004316502320517344]; Jorda G, 2012, NAT CLIM CHANGE, V2, P821, DOI [10.1038/NCLIMATE1533, 10.1038/nclimate1533]; Kaldy JE, 2014, J EXP MAR BIOL ECOL, V453, P108, DOI 10.1016/j.jembe.2013.12.020; Kaldy JE, 2013, BOT MAR, V56, P75, DOI 10.1515/bot-2012-0144; Karydis M, 2012, ENVIRON MONIT ASSESS, V184, P4931, DOI 10.1007/s10661-011-2313-2; Kerouel R, 1997, MAR CHEM, V57, P265, DOI 10.1016/S0304-4203(97)00040-6; Kilminster K, 2015, SCI TOTAL ENVIRON, V534, P97, DOI 10.1016/j.scitotenv.2015.04.061; Koch MS, 2007, J EXP MAR BIOL ECOL, V341, P91, DOI 10.1016/j.jembe.2006.10.004; Koch M, 2013, GLOBAL CHANGE BIOL, V19, P103, DOI 10.1111/j.1365-2486.2012.02791.x; Lee KS, 2007, J EXP MAR BIOL ECOL, V350, P144, DOI 10.1016/j.jembe.2007.06.016; Leoni V, 2008, AQUAT CONSERV, V18, P202, DOI 10.1002/aqc.842; Marba N, 2002, ENVIRON CONSERV, V29, P509, DOI 10.1017/S037689290200036X; Marba N, 1998, MAR ECOL PROG SER, V174, P269, DOI 10.3354/meps174269; Marba N, 2014, BIOL CONSERV, V176, P183, DOI 10.1016/j.biocon.2014.05.024; Marba N, 2010, GLOBAL CHANGE BIOL, V16, P2366, DOI 10.1111/j.1365-2486.2009.02130.x; Marin L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00921; Marin-Guirao L, 2018, MAR POLLUT BULL, V135, P617, DOI 10.1016/j.marpolbul.2018.07.050; Marin-Guirao L, 2016, SCI REP-UK, V6, DOI 10.1038/srep28615; Marin-Guirao L, 2013, MAR ENVIRON RES, V84, P60, DOI 10.1016/j.marenvres.2012.12.001; Massa SI, 2009, HYDROBIOLOGIA, V619, P195, DOI 10.1007/s10750-008-9609-4; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Moore KA, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P361; Moreno-Marin F, 2018, LIMNOL OCEANOGR, V63, P1528, DOI 10.1002/lno.10789; Moreno-Marin F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152971; Mozetic P, 2008, MAR ECOL-EVOL PERSP, V29, P483, DOI 10.1111/j.1439-0485.2008.00257.x; Nixon SW, 2009, GLOBAL LOSS COASTAL, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; Oliver ECJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03732-9; Olsen YS, 2012, ESTUAR COAST, V35, P1205, DOI 10.1007/s12237-012-9521-z; Ontoria Y, 2019, MAR ENVIRON RES, V145, P27, DOI 10.1016/j.marenvres.2019.02.002; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Pages JF, 2018, MAR POLLUT BULL, V134, P55, DOI 10.1016/j.marpolbul.2017.10.036; Pages JF, 2010, J EXP MAR BIOL ECOL, V386, P34, DOI 10.1016/j.jembe.2010.02.017; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; PEREZ M, 1992, AQUAT BOT, V43, P51, DOI 10.1016/0304-3770(92)90013-9; Perez M, 2007, J EXP MAR BIOL ECOL, V344, P149, DOI 10.1016/j.jembe.2006.12.020; PIRC H, 1986, AQUAT BOT, V26, P203, DOI 10.1016/0304-3770(86)90021-5; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; Ralph PJ, 1998, MAR ECOL PROG SER, V171, P123, DOI 10.3354/meps171123; Repolho T, 2017, SCI REP, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]; Roca G, 2016, ECOL INDIC, V63, P310, DOI 10.1016/j.ecolind.2015.12.007; Ruiz JM, 2001, MAR ECOL PROG SER, V215, P107, DOI 10.3354/meps215107; Ruiz JM, 2001, MAR POLLUT BULL, V42, P749, DOI 10.1016/S0025-326X(00)00215-0; Salo T, 2014, J EXP MAR BIOL ECOL, V457, P143, DOI 10.1016/j.jembe.2014.04.008; Sanchez E, 2004, GLOBAL PLANET CHANGE, V44, P163, DOI 10.1016/j.gloplacha.2004.06.010; Savva I, 2018, ECOL EVOL, V8, P12032, DOI 10.1002/ece3.4663; Schar C, 2004, NATURE, V432, P559, DOI 10.1038/432559a; SHORT FT, 2001, GLOB SEAGR RES METH, P155, DOI DOI 10.1016/B978-044450891-1/50009-8; Traboni C, 2018, MAR ENVIRON RES, V141, P12, DOI 10.1016/j.marenvres.2018.07.007; Tutar O, 2017, MAR ENVIRON RES, V132, P94, DOI 10.1016/j.marenvres.2017.10.011; van der Heide T, 2008, OECOLOGIA, V158, P411, DOI 10.1007/s00442-008-1155-2; vanKatwijk MM, 1997, MAR ECOL PROG SER, V157, P159, DOI 10.3354/meps157159; Vargas-Yanez M, 2007, CAMBIO CLIMATICO MED; Villazan B, 2015, MAR ECOL PROG SER, V536, P149, DOI 10.3354/meps11435; Villazan B, 2013, MAR ECOL PROG SER, V493, P141, DOI 10.3354/meps10517; Villazan B, 2013, MAR ECOL PROG SER, V488, P133, DOI 10.3354/meps10395; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wernberg T, 2016, SCIENCE, V353, P169, DOI 10.1126/science.aad8745; Wilkinson AD, 2017, SCI REP-UK, V7, DOI 10.1038/srep45404; York PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076377; ZIEMAN JC, 1974, AQUACULTURE, V4, P139, DOI 10.1016/0044-8486(74)90029-5	108	17	17	8	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222798	10.1371/journal.pone.0222798	http://dx.doi.org/10.1371/journal.pone.0222798			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536606	Green Published, gold, Green Submitted			2022-12-26	WOS:000532262800087
J	Yun, HH; Lim, JT; Yang, SH; Park, PS				Yun, Ho Hyun; Lim, Jung Taek; Yang, Se-Hyun; Park, Phil Sun			Occult periprosthetic femoral fractures occur frequently during a long, trapezoidal, double-tapered cementless femoral stem fixation in primary THA	PLOS ONE			English	Article							TOTAL HIP-ARTHROPLASTY; MORPHOLOGY; FEMUR; PAIN	The present study aimed to investigate the prevalence and clinical consequences of occult intra-operative periprosthetic femoral fractures in total hip arthroplasty (THA). Between 2012 and 2017, a total of 113 primary THAs were enrolled. The mean age of the patients was 66.4 +/- 7.6 years. We assessed occult intra-operative periprosthetic femoral fractures with the use of computed tomography (CT) and risk factors, including age, sex, body mass index, diagnosis, stem size, and radiographic parameters of proximal femoral geometry were analyzed. We also assessed the differences in thigh pain and stem subsidence and alignment between the patients with and without occult periprosthetic femoral fracture. Occult intra-operative periprosthetic femoral fractures were found in 13 of 113 hips (11.5%). In 9/13 (69.2%) of occult fractures, fracture lines were started from the region below the tip of the lesser trochanter. Six periprosthetic femoral fractures (5.3%) were found during the operation. Out of the five hips that had detected femoral fractures around the lesser trochanter intra-operatively, four hips (80%) showed concurrent occult fractures on different levels. The female sex (P =.01) and canal filling ratio at 7 cm below the tip of the lesser trochanter (P =.01) were significantly different between the patients with and without occult periprosthetic femoral fracture. The sex was significantly associated with an increased risk in predicting an occult intra-operative periprosthetic femoral fracture (odds ratio of male, 0.25 compared with the female; 95% CI, 0.08-0.85; p =.02). There was a significant difference in the incidence of thigh pain between occult fracture group and non-occult fracture group (P <.05). There were no significant differences in stem subsidence and alignment between the patients with and without occult periprosthetic femoral fracture. All 13 cases of occult intra-operative periprosthetic femoral fractures were healed at the final follow-up. Occult periprosthetic femoral fractures are common during a long, trapezoidal, double-tapered cementless femoral stem fixation in primary THA, that CT scans are helpful to identify them, and that these fractures do not adversely affect the implant's survival if a rigid fixation of the implants has been achieved.	[Yun, Ho Hyun; Lim, Jung Taek; Yang, Se-Hyun; Park, Phil Sun] Seoul Vet Hosp, Dept Orthopaed Surg, Seoul, South Korea	Seoul Veterans Hospital	Yun, HH (corresponding author), Seoul Vet Hosp, Dept Orthopaed Surg, Seoul, South Korea.	3188vun@naver.com						Abdel MP, 2016, BONE JOINT J, V98B, P468, DOI 10.1302/0301-620X.98B4.37203; Al-Najjim M, 2016, J ORTHOP, V13, P322, DOI 10.1016/j.jor.2016.06.026; Barrack RL, 2000, J ARTHROPLASTY, V15, P590, DOI 10.1054/arth.2000.6634; Berend KR, 2004, J ARTHROPLASTY, V19, P17, DOI 10.1016/j.arth.2004.06.008; Brown Jonathon M, 2017, Am J Orthop (Belle Mead NJ), V46, P232; Cahir JG, 2007, CLIN RADIOL, V62, P1163, DOI 10.1016/j.crad.2007.04.018; Capello WN, 2014, CLIN ORTHOP RELAT R, V472, P604, DOI 10.1007/s11999-013-3137-x; Cooper HJ, 2011, J ARTHROPLASTY, V26, P78, DOI 10.1016/j.arth.2011.04.003; Dammerer D, 2018, INT ORTHOP; Davidson D, 2008, J BONE JOINT SURG AM, V90A, P2000, DOI 10.2106/JBJS.H.00331; DORR LD, 1993, BONE, V14, P231, DOI 10.1016/8756-3282(93)90146-2; Froimson MI, 2007, J ARTHROPLASTY, V22, P1, DOI 10.1016/j.arth.2006.03.003; Gomez-Barrena E, 2017, CLIN ORTHOP RELAT R, V475, P495, DOI 10.1007/s11999-016-5208-2; Ha YC, 2007, J ARTHROPLASTY, V22, P184, DOI 10.1016/j.arth.2006.02.169; Haidukewych GJ, 2006, J BONE JOINT SURG AM, V88A, P1952, DOI 10.2106/JBJS.E.00890; Hallan G, 2007, J BONE JOINT SURG BR, V89B, P1574, DOI 10.1302/0301-620X.89B12.18969; Hasegawa K, 2017, CLIN ORTHOP RELAT R, V475, P484, DOI 10.1007/s11999-016-5138-z; Imre N, 2012, SURG RADIOL ANAT, V34, P427, DOI 10.1007/s00276-011-0930-7; Ishii S, 2016, J ARTHROPLASTY, V31, P1524, DOI 10.1016/j.arth.2016.01.016; Jo WL, 2016, J ARTHROPLASTY, V31, P1279, DOI 10.1016/j.arth.2015.12.016; Khalily C, 2002, J ARTHROPLASTY, V17, P463, DOI 10.1054/arth.2002.32171; Malekmotiei L, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023699; Melvin JS, 2014, J ARTHROPLASTY, V29, P1285, DOI 10.1016/j.arth.2013.12.024; NOBLE PC, 1988, CLIN ORTHOP RELAT R, P148; Olory Bruno, 2004, Acta Orthop Belg, V70, P31; Reddy A V Gurava, 2017, J Orthop Case Rep, V7, P31, DOI 10.13107/jocr.2250-0685.792; Reikeras O, 2017, J ARTHROPLASTY, V32, P1543, DOI 10.1016/j.arth.2016.12.008; Ricioli W, 2015, INT ORTHOP, V39, P1939, DOI 10.1007/s00264-015-2961-x; Romagnoli S, 2002, J ARTHROPLASTY, V17, P108, DOI 10.1054/arth.2002.32689; Schiessel A, 2004, SKELETAL RADIOL, V33, P142, DOI 10.1007/s00256-003-0728-8; Sugano N, 1998, J BONE JOINT SURG BR, V80B, P711, DOI 10.1302/0301-620X.80B4.8319; Tannast M, 2007, AM J ROENTGENOL, V188, P1540, DOI 10.2214/AJR.06.0921; Umer Masood, 2010, J Orthop Surg (Hong Kong), V18, P279; Vidalain JP, 2011, INT ORTHOP, V35, P189, DOI 10.1007/s00264-010-1117-2; Wang FD, 2014, J COMPUT ASSIST TOMO, V38, P828, DOI 10.1097/RCT.0000000000000125; Yeung Y, 2006, J ARTHROPLASTY, V21, P508, DOI 10.1016/j.arth.2005.04.037	36	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0221731	10.1371/journal.pone.0221731	http://dx.doi.org/10.1371/journal.pone.0221731			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536499	gold, Green Submitted, Green Published			2022-12-26	WOS:000532262800019
J	Huffaker, R; Fearne, A				Huffaker, Ray; Fearne, Andrew			Reconstructing systematic persistent impacts of promotional marketing with empirical nonlinear dynamics	PLOS ONE			English	Article							SINGULAR SPECTRUM ANALYSIS; TIME-SERIES; MODELS	An empirical question of long-standing interest is how price promotions affect a brand's sale shares in the fast-moving consumer-goods market. We investigated this question with concurrent promotions and sales records of specialty beer brands pooled over Tesco stores in the UK. Most brands were continuously promoted, rendering infeasible a conventional approach of establishing impact against an off-promotion sales baseline, and arguing in favor of a dynamics approach. Moreover, promotion/sales records were volatile without easily-discernable regularity. Past work conventionally attributed volatility to the impact of exogenous random shocks on stable markets, and reasoned that promotions have only an ephemeral impact on sales shares in stationary mean-reverting stochastic markets, or a persistent freely-wandering impact in nonstationary markets. We applied new empirical methods from the applied sciences to uncover an overlooked alternative: 'systematic persistence' in which promotional impacts evolve systematically in an endogenously-unstable market governed by deterministic-nonlinear dynamics. We reconstructed real-world market dynamics from the Tesco dataset, and detected deterministic-nonlinear market dynamics. We used reconstructed market dynamics to identify a complex network of systematic interactions between promotions and sales shares among competing brands, and quantified/ characterized the dynamics of these interactions. For the majority of weeks in the study, we found that: (1) A brand's promotions drove down own sales shares (a possibility recognized in the literature), but `cannibalized' sales shares of competing brands (perhaps explaining why brands were promoted despite a negative marginal impact on own sales shares); and (2) Competitive interactions between brands owned by the same multinational brewery differed from those with outside brands. In particular, brands owned by the same brewery enjoyed a `mutually-beneficial' relationship in which an incremental increase in the sales share of one marginally increased the sales share of the other. Alternatively, the sales shares of brands owned by different breweries preyed on each other's market shares.	[Huffaker, Ray] Univ Florida, Dept Agr & Biol Engn, Gainesville, FL 32611 USA; [Fearne, Andrew] Univ East Anglia, Norwich Business Sch, Norwich, Norfolk, England	State University System of Florida; University of Florida; University of East Anglia	Huffaker, R (corresponding author), Univ Florida, Dept Agr & Biol Engn, Gainesville, FL 32611 USA.	rhuffaker@ufl.edu		Huffaker, Ray/0000-0003-3434-3709	USDA/NIFA	USDA/NIFA(United States Department of Agriculture (USDA))	This work was supported by USDA/NIFA Multistate regional project to Professor Ray Huffaker. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2018, SIMPLEX PROJECTION; [Anonymous], OR VERS 2019; [Anonymous], 2016, ECONOMIST; BASS FM, 1972, J MARKETING RES, V9, P298, DOI 10.2307/3149541; BLATTBERG RC, 1995, MARKET SCI, V14, pG122, DOI 10.1287/mksc.14.3.G122; Brandt C, 2012, PHYS REV LETT, V88; BREEDEN JL, 1990, PHYS REV A, V42, P5817, DOI 10.1103/PhysRevA.42.5817; Brown T, 1996, VINYL RETEC AND TUTORIAL '96, TECHNICAL PAPERS, P55; Constantine W., 2014, FRACTAL FRACTAL TIME; Csardi G., 2006, INT J COMPLEX SYST, P1695; DEKIMPE MG, 1995, MARKET SCI, V14, P1, DOI 10.1287/mksc.14.1.1; DelVecchio D, 2006, J RETAILING, V82, P203, DOI 10.1016/j.jretai.2005.10.001; Deyle E, 2018, P ROY SOC B-BIOL SCI, V283; Deyle E, 2011, PLOS ONE, V6, P1; Dhrymes P.J., 1972, ANN ECON SOC MEAS, V1, P291; Di Narzo A, 2013, TSERIESCHAOS ANAL NO; DODSON JA, 1978, J MARKETING RES, V15, P72, DOI 10.2307/3150402; Ellenberg J., 2015, NOT BE WRONG; Elsner J., 2010, SINGULAR SPECTRUM AN; FEDER G, 1979, AM J AGR ECON, V61, P97, DOI 10.2307/1239507; Furrer R, 2018, TOOLS SPATIAL DATA; Gabaix Xavier, 2008, FDN POSITIVE NORMATI; Galtier F, 2013, GLOB FOOD SECUR-AGR, V2, P72, DOI 10.1016/j.gfs.2013.02.001; Gammelgaard J, 2013, GLOBAL BREWERY IND M, P1; Gedenik K, 2010, SALES PROMOTION; Ghil M, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000092; Golyandina N., 2001, ANAL TIME SERIES STR, DOI DOI 10.1201/9781420035841; Golyandina N, 2014, COMPUT STAT DATA AN, V71, P934, DOI 10.1016/j.csda.2013.04.009; Gotoda H, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.022201; Hassani H., 2007, DATA SCI J, V5, P239, DOI DOI 10.6339/JDS.2007.05(2).396; Huffaker R, 2017, NONLINEAR TIME SERIES ANALYSIS WITH R; Itoh N, 2013, NONLINEAR PROC GEOPH, V20, P467, DOI 10.5194/npg-20-467-2013; Kantz H., 1997, NONLINEAR TIME SERIE; KAPLAN D, 1995, UNDERSTANDING NONLIN; Moskvina V, 2003, COMMUN STAT-SIMUL C, V32, P319, DOI 10.1081/SAC-120017494; Odum E. P., 1953, FUNDAMENTALS ECOLOGY; ORESKES N, 1994, SCIENCE, V263, P641, DOI 10.1126/science.263.5147.641; Rykiel E, 1991, ECOLOGICAL MODELING, V90, P229; Schreiber T, 1997, PHYS REV LETT, V78, P843, DOI 10.1103/PhysRevLett.78.843; Sprott JC, 2003, CHAOS TIME SERIES AN; Sugihara G, 2012, SCIENCE, V338, P496, DOI 10.1126/science.1227079; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; THEILER J, 1986, PHYS REV A, V34, P2427, DOI 10.1103/PhysRevA.34.2427; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Theiler J., 1990, Lincoln Laboratory Journal, V3, P63; Valera HGA, 2016, AGR ECON-BLACKWELL, V47, P683, DOI 10.1111/agec.12265; Vautard R., 1999, ANAL CLIMATE VARIABI; Williams GP, 1997, CHAOS THEORY TAMED; ZHU Z, 2018, ASIA COMMUN PHOTON	50	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221167	10.1371/journal.pone.0221167	http://dx.doi.org/10.1371/journal.pone.0221167			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4SI	31532779	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000532239600003
J	Yue, L; Yan, M; Tremblay, ML; Lin, TJ; Li, H; Yang, T; Song, X; Xie, TH; Xie, ZP				Yue, Lei; Yan, Min; Tremblay, Michel L.; Lin, Tong-Jun; Li, Hua; Yang, Ting; Song, Xia; Xie, Tianhong; Xie, Zhongping			PTP1B negatively regulates nitric oxide-mediated Pseudomonas aeruginosa killing by neutrophils	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHATASES; INNATE IMMUNE-RESPONSES; SIGNAL-TRANSDUCTION; CYSTIC-FIBROSIS; LUNG; INFECTION; INFLAMMATION; ROLES	Neutrophils play a critical role in host defense against Pseudomonas aeruginosa infection. Mechanisms underlying the negative regulation of neutrophil function in bacterial clearance remain incompletely defined. Here, we demonstrate that protein tyrosine phosphatase-1B (PTP1B) is a negative regulator of P. aeruginosa clearance by neutrophils. PTP1B-deficient neutrophils display greatly enhanced bacterial phagocytosis and killing, which are accompanied by increased Toll-like receptor 4 (TLR4) signaling activation and nitric oxide (NO) production following P. aeruginosa infection. Interestingly, PTP1B deficiency mainly upregulates the production of IL-6 and IFN-beta, leads to enhanced TLR4-dependent STAT1 activation and iNOS expression by neutrophils following P. aeruginosa infection. Further studies reveal that PTP1B and STAT1 are physically associated. These findings demonstrate a negative regulatory mechanism in neutrophil underlying the elimination of P. aeruginosa infection though a PTP1B-STAT1 interaction.	[Yue, Lei; Li, Hua; Yang, Ting; Song, Xia; Xie, Tianhong; Xie, Zhongping] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biol, Kunming, Yunnan, Peoples R China; [Yan, Min] Kunming Med Univ, Dept Microbiol & Immunol, Kunming, Yunnan, Peoples R China; [Tremblay, Michel L.] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Dept Biochem, Montreal, PQ, Canada; [Lin, Tong-Jun] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Lin, Tong-Jun] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Peking Union Medical College; Kunming Medical University; McGill University; Dalhousie University; Dalhousie University	Xie, ZP (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biol, Kunming, Yunnan, Peoples R China.	xz218@126.com		Yue, Lei/0000-0001-5201-4373	National Natural Science Foundation of China [81471564, 81800012, 31560271]; Yunnan Natural Science Foundation [2016FB037, 2017FB019]; PUMC Youth Fund [3332016114]; Fundamental Research Funds for the Central Universities [2016ZX350070]; CAMS Innovation Fund for Medical Sciences [2016-I2M1-019]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Yunnan Natural Science Foundation(Natural Science Foundation of Yunnan Province); PUMC Youth Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); CAMS Innovation Fund for Medical Sciences	This work received grant support from National Natural Science Foundation of China (81800012) (http://www.nsfc.gov.cn), Yunnan Natural Science Foundation (2016FB037, 2017FB019) (http://kjt.yn.gov.cn/), PUMC Youth Fund (3332016114) (http://www.cams.ac.cn) and Fundamental Research Funds for the Central Universities (2016ZX350070) (http://www.cams.ac.cn) to LY. MY has received grant support from National Natural Science Foundation of China (31560271) (http://www.nsfc.gov.cn).TJL has received grant support from National Natural Science Foundation of China (81471564) (http://www.nsfc.gov.cn).ZX is supported by CAMS Innovation Fund for Medical Sciences (2016-I2M1-019) (http://www.cams.ac.cn).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Atherton-Fessler S, 1993, Semin Cell Biol, V4, P433, DOI 10.1006/scel.1993.1051; BERGER M, 1991, CLIN REV ALLERG, V9, P119; Bhagirath AY, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0339-5; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; Choi J, 2018, INT J CHRONIC OBSTR, V13, P3077, DOI 10.2147/COPD.S173759; Cigana C, 2016, SCI REP-UK, V6, DOI 10.1038/srep21465; Cilloniz C, 2016, CHEST, V150, P415, DOI 10.1016/j.chest.2016.03.042; CRIPPS AW, 1995, IMMUNOL CELL BIOL, V73, P418, DOI 10.1038/icb.1995.65; Futosi K, 2013, INT IMMUNOPHARMACOL, V17, P638, DOI 10.1016/j.intimp.2013.06.034; Heinonen KM, 2009, P NATL ACAD SCI USA, V106, P9368, DOI 10.1073/pnas.0812109106; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Ji DB, 2011, MOL CARCINOGEN, V50, P945, DOI 10.1002/mc.20762; Jin YH, 2019, EUR REV MED PHARMACO, V23, P5020, DOI 10.26355/eurrev_201906_18094; Junkins RD, 2014, AM J PATHOL, V184, P2310, DOI 10.1016/j.ajpath.2014.05.009; Junkins RD, 2013, J IMMUNOL, V190, P5178, DOI 10.4049/jimmunol.1203196; Kim HY, 2017, MOL IMMUNOL, V82, P75, DOI 10.1016/j.molimm.2016.12.016; Kim YI, 2015, INT J MOL MED, V36, P1165, DOI 10.3892/ijmm.2015.2308; Koh AY, 2009, INFECT IMMUN, V77, P5300, DOI 10.1128/IAI.00501-09; Lavoie EG, 2011, MICROBES INFECT, V13, P1133, DOI 10.1016/j.micinf.2011.07.011; Lesina M, 2014, SEMIN IMMUNOL, V26, P80, DOI 10.1016/j.smim.2014.01.002; Lewis RS, 2011, J IMMUNOL, V187, P3798, DOI 10.4049/jimmunol.1002993; Liang XL, 2019, FASEB J, V33, P3562, DOI 10.1096/fj.201802002R; Lund IK, 2005, J MOL ENDOCRINOL, V34, P339, DOI 10.1677/jme.1.01694; Luu K, 2014, IMMUNOL CELL BIOL, V92, P761, DOI 10.1038/icb.2014.51; Manda-Handzlik A, 2015, ADV EXP MED BIOL, V857, P51, DOI 10.1007/5584_2015_117; Miller CC, 2013, J CYST FIBROS, V12, P817, DOI 10.1016/j.jcf.2013.01.008; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Myers MP, 2001, J BIOL CHEM, V276, P47771, DOI 10.1074/jbc.C100583200; O'Sullivan R, 2008, IMMUNOBIOLOGY, V213, P469, DOI 10.1016/j.imbio.2007.11.007; Parker D, 2016, PHYSIOL REV, V96, P19, DOI 10.1152/physrev.00009.2015; Pike KA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005020; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Ryu JC, 2017, MUCOSAL IMMUNOL, V10, P757, DOI 10.1038/mi.2016.73; van Heeckeren A, 1997, J CLIN INVEST, V100, P2810, DOI 10.1172/JCI119828; van Heeckeren AM, 2000, AM J RESP CRIT CARE, V161, P271, DOI 10.1164/ajrccm.161.1.9903019; Vareechon C, 2017, CELL HOST MICROBE, V21, P611, DOI 10.1016/j.chom.2017.04.001; Villarino AV, 2017, NAT IMMUNOL, V18, P374, DOI 10.1038/ni.3691; Walford Hannah H, 2013, JAKSTAT, V2, pe25301, DOI 10.4161/jkst.25301; Wiese J, 2017, MAR DRUGS, V15, DOI 10.3390/md15060191; Xu HM, 2008, MOL IMMUNOL, V45, P3545, DOI 10.1016/j.molimm.2008.05.006; Yue L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205521; Yue L, 2016, AM J PATHOL, V186, P1234, DOI 10.1016/j.ajpath.2016.01.005; Zhang S, 2007, DRUG DISCOV TODAY, V12, P373, DOI 10.1016/j.drudis.2007.03.011	44	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222753	10.1371/journal.pone.0222753	http://dx.doi.org/10.1371/journal.pone.0222753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532798	Green Published, Green Submitted, gold			2022-12-26	WOS:000532239600037
J	Sugawara, M; Umehara, Y; Kaga, A; Hayashi, M; Ishimoto, M; Sato, S; Mitsui, H; Minamisawa, K				Sugawara, Masayuki; Umehara, Yosuke; Kaga, Akito; Hayashi, Masaki; Ishimoto, Masao; Sato, Shusei; Mitsui, Hisayuki; Minamisawa, Kiwamu			Symbiotic incompatibility between soybean and Bradyrhizobiumarises from one amino acid determinant in soybean Rj2 protein	PLOS ONE			English	Article							GLYCINE-SOJA SIEB.; GENETIC DIVERSITY; NODULATING BRADYRHIZOBIA; INEFFECTIVE NODULATION; RHIZOBIUM-FREDII; JAPONICUM; MAX; RESISTANCE; WILD; IDENTIFICATION	Cultivated soybean (Glycine max) carrying the Rj2 allele restricts nodulation with specific Bradyrhizobium strains via host immunity, mediated by rhizobial type III secretory protein NopP and the host resistance protein Rj2. Here we found that the single isoleucine residue I490 in Rj2 is required for induction of symbiotic incompatibility. Furthermore, we investigated the geographical distribution of the Rj2-genotype soybean in a large set of germplasm by single nucleotide polymorphism (SNP) genotyping using a SNP marker for I490. By allelic comparison of 79 accessions in the Japanese soybean mini-core collection, we suggest substitution of a single amino acid residue (R490 to I490) in Rj2 induces symbiotic incompatibility with Bradyrhizobium diazoefficiens USDA 122. The importance of I490 was verified by complementation of rj2-soybean by the dominant allele encoding the Rj2 protein containing I490 residue. The Rj2 allele was also found in Glycine soja, the wild progenitor of G. max, and their single amino acid polymorphisms were associated with the Rj2-nodulation phenotype. By SNP genotyping against 1583 soybean accessions, we detected the Rj2-genotype in 5.4% of G. max and 7.7% of G. soja accessions. Distribution of the Rj2-genotype soybean plants was relatively concentrated in the temperate Asian region. These results provide important information about the mechanism of host genotype-specific symbiotic incompatibility mediated by host immunity and suggest that the Rj2 gene has been maintained by environmental conditions during the process of soybean domestication.	[Sugawara, Masayuki; Sato, Shusei; Mitsui, Hisayuki; Minamisawa, Kiwamu] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi, Japan; [Umehara, Yosuke; Hayashi, Masaki] Natl Agr & Food Res Org, Inst Agrobiol Sci, Tsukuba, Ibaraki, Japan; [Kaga, Akito; Ishimoto, Masao] Natl Agr & Food Res Org, Natl Inst Crop Sci, Tsukuba, Ibaraki, Japan; [Hayashi, Masaki] Natl Agr & Food Res Org, Cent Reg Agr Res Ctr, Tsukuba, Ibaraki, Japan	Tohoku University; National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan	Sugawara, M (corresponding author), Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi, Japan.	msugawara@ige.tohoku.ac.jp	Sugawara, Masayuki/AAV-6030-2021; Sato, Shusei/A-3616-2015	Sugawara, Masayuki/0000-0002-3058-4348; Sato, Shusei/0000-0002-0293-5366; Minamisawa, Kiwamu/0000-0001-7302-4079	Takano Life Science Research Foundation; JSPS KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan [19K05760, 26252065, 18H02112]; Ministry of Agriculture, Forestry and Fisheries of Japan [SFC2003]	Takano Life Science Research Foundation; JSPS KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported by grants from the Takano Life Science Research Foundation (to MS), JSPS KAKENHI Grant Numbers 19K05760 (to MS), 26252065 (to KM) and 18H02112 (to KM) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Ministry of Agriculture, Forestry and Fisheries of Japan (Genomics-Based Technology for Agricultural Improvement, SFC2003 to KM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao S., 1989, Japanese Journal of Soil Science and Plant Nutrition, V60, P53; [Anonymous], 1989, PLANT MOL BIOL MANUA; [Anonymous], 2004, SOYBEANS IMPROVEMENT; BROUGHTON WJ, 1971, BIOCHEM J, V125, P1075, DOI 10.1042/bj1251075; BUENDIACLAVERIA AM, 1994, SYST APPL MICROBIOL, V17, P155, DOI 10.1016/S0723-2020(11)80001-9; CALDWELL BE, 1966, CROP SCI, V6, P427, DOI 10.2135/cropsci1966.0011183X000600050010x; Cesari S, 2018, NEW PHYTOL, V219, P17, DOI 10.1111/nph.14877; COLE MA, 1973, ANTIMICROB AGENTS CH, V4, P248, DOI 10.1128/AAC.4.3.248; Devine TE, 1996, PLANT SOIL, V186, P173, DOI 10.1007/BF00035072; DEVINE TE, 1987, CROP SCI, V27, P635, DOI 10.2135/cropsci1987.0011183X002700040005x; Devine TE, 1981, USDA TECH B; Ferguson BJ, 2019, PLANT CELL ENVIRON, V42, P41, DOI 10.1111/pce.13348; Gassmann W, 2012, MOL PLANT MICROBE IN, V25, P862, DOI 10.1094/MPMI-01-12-0024-IA; Hayashi M, 2011, BREEDING SCI, V61, P544, DOI 10.1270/jsbbs.61.544; Htwe A. Z., 2015, African Journal of Microbiology Research, V9, P2183; Hyten DL, 2006, P NATL ACAD SCI USA, V103, P16666, DOI 10.1073/pnas.0604379103; ISHIZUKA J, 1991, SOIL SCI PLANT NUTR, V37, P15, DOI 10.1080/00380768.1991.10415005; Itakura M, 2009, ISME J, V3, P326, DOI 10.1038/ismej.2008.88; Kaga A, 2011, BREEDING SCI, V61, P566, DOI 10.1270/jsbbs.61.566; Kereszt A, 2007, NAT PROTOC, V2, P948, DOI 10.1038/nprot.2007.141; Kim MY, 2011, BREEDING SCI, V61, P445, DOI 10.1270/jsbbs.61.445; Kim MY, 2010, P NATL ACAD SCI USA, V107, P22032, DOI 10.1073/pnas.1009526107; Kourelis J, 2018, PLANT CELL, V30, P285, DOI 10.1105/tpc.17.00579; KUYKENDALL LD, 1992, CAN J MICROBIOL, V38, P501, DOI 10.1139/m92-082; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Maekawa T, 2008, MOL PLANT MICROBE IN, V21, P375, DOI 10.1094/MPMI-21-4-0375; Delamuta JRM, 2013, INT J SYST EVOL MICR, V63, P3342, DOI 10.1099/ijs.0.049130-0; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Oliveira MF, 2010, FIELD CROP RES, V119, P277, DOI 10.1016/j.fcr.2010.07.021; Qi XP, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5340; Saeki Y, 2008, SOIL SCI PLANT NUTR, V54, P718, DOI 10.1111/j.1747-0765.2008.00300.x; Saeki Y, 2006, SOIL SCI PLANT NUTR, V52, P418, DOI 10.1111/j.1747-0765.2006.00050.x; Saeki Y, 2014, ADVANCES IN BIOLOGY AND ECOLOGY OF NITROGEN FIXATION, P195, DOI 10.5772/57165; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; SCHOLLA MH, 1984, INT J SYST BACTERIOL, V34, P484, DOI 10.1099/00207713-34-4-484; Sedivy EJ, 2017, NEW PHYTOL, V214, P539, DOI 10.1111/nph.14418; SENARATNE R, 1987, PLANT SOIL, V103, P45, DOI 10.1007/BF02370666; Soe KM, 2013, SCIENCEASIA, V39, P574, DOI 10.2306/scienceasia1513-1874.2013.39.574; Song QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054985; Sugawara M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05663-x; Suzuki K, 2008, SOIL SCI PLANT NUTR, V54, P237, DOI 10.1111/j.1747-0765.2007.00236.x; Tsukui T, 2013, APPL ENVIRON MICROB, V79, P1048, DOI 10.1128/AEM.03297-12; VEST G, 1972, CROP SCI, V12, P692, DOI 10.2135/cropsci1972.0011183X001200050042x; Vinuesa P, 2008, APPL ENVIRON MICROB, V74, P6987, DOI 10.1128/AEM.00875-08; Wang LX, 2006, EUPHYTICA, V151, P215, DOI 10.1007/s10681-006-9142-3; Wu LJ, 2011, FEMS MICROBIOL ECOL, V76, P439, DOI 10.1111/j.1574-6941.2011.01064.x; Yamakawa T, 2003, SOIL SCI PLANT NUTR, V49, P835, DOI 10.1080/00380768.2003.10410345; Yang SH, 2018, J APPL MICROBIOL, V125, P853, DOI 10.1111/jam.13897; Yang SM, 2010, P NATL ACAD SCI USA, V107, P18735, DOI 10.1073/pnas.1011957107; Zheng FY, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2736-9; Zhong Y, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4521-4; Zhou T, 2004, MOL GENET GENOMICS, V271, P402, DOI 10.1007/s00438-004-0990-z	54	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2019	14	9							e0222469	10.1371/journal.pone.0222469	http://dx.doi.org/10.1371/journal.pone.0222469			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4KS	31518373	Green Submitted, Green Published, gold			2022-12-26	WOS:000532219300021
J	Mendlowitz, AB; Shanbour, A; Downar, J; Vila-Rodriguez, F; Daskalakis, ZJ; Isaranuwatchai, W; Blumberger, DM				Mendlowitz, Andrew B.; Shanbour, Alaa; Downar, Jonathan; Vila-Rodriguez, Fidel; Daskalakis, Zafiris J.; Isaranuwatchai, Wanrudee; Blumberger, Daniel M.			Implementation of intermittent theta burst stimulation compared to conventional repetitive transcranial magnetic stimulation in patients with treatment resistant depression: A cost analysis	PLOS ONE			English	Article							MAJOR DEPRESSION; ELECTROCONVULSIVE-THERAPY; PREFRONTAL CORTEX; RTMS; MANAGEMENT; SAFETY; EFFICACY; NETWORK; MOOD	Background Repetitive transcranial magnetic stimulation (rTMS) is an evidence-based treatment for depression that is increasingly implemented in healthcare systems across the world. A new form of rTMS called intermittent theta burst stimulation (iTBS) can be delivered in 3 min and has demonstrated comparable effectiveness to the conventional 37.5 min 10Hz rTMS protocol in patients with depression. Objectives To compare the direct treatment costs per course and per remission for iTBS compared to 10Hz rTMS treatment in depression. Methods We conducted a cost analysis from a healthcare system perspective using patient-level data from a large randomized non-inferiority trial (THREE-D). Depressed adults 18 to 65 received either 10Hz rTMS or iTBS treatment. Treatment costs were calculated using direct healthcare costs associated with equipment, coils, physician assessments and technician time over the course of treatment. Cost per remission was estimated using the proportion of patients achieving remission following treatment. Deterministic sensitivity analyses and non-parametric bootstrapping was used to estimate uncertainty. Results From a healthcare system perspective, the average cost per patient was USD$1,108 (SD 166) for a course of iTBS and $1,844 (SD 304) for 10Hz rTMS, with an incremental net savings of $735 (95% CI 688 to 783). The average cost per remission was $3,695 (SD 552) for iTBS and $6,146 (SD 1,015) for 10Hz rTMS, with an average incremental net savings of $2,451 (95% CI 2,293 to 2,610). Conclusions The shorter session durations and treatment capacity increase associated with 3 min iTBS translate into significant cost-savings per patient and per remission when compared to 10Hz rTMS.	[Mendlowitz, Andrew B.; Daskalakis, Zafiris J.; Blumberger, Daniel M.] Ctr Addict & Mental Hlth, Temerty Ctr Therapeut Brain Intervent, Toronto, ON, Canada; [Mendlowitz, Andrew B.; Isaranuwatchai, Wanrudee] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Mendlowitz, Andrew B.] Toronto Hlth Econ & Technol Assessment Collaborat, Toronto, ON, Canada; [Shanbour, Alaa; Downar, Jonathan; Daskalakis, Zafiris J.; Blumberger, Daniel M.] Univ Toronto, Fac Med, Dept Psychiat & Inst Med Sci, Toronto, ON, Canada; [Downar, Jonathan] Univ Hlth Network, MRI Guided rTMS Clin, Toronto, ON, Canada; [Downar, Jonathan] Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada; [Vila-Rodriguez, Fidel] Univ British Columbia Hosp, Noninvas Neurostimulat Therapies NINET Lab, Vancouver, BC, Canada; [Vila-Rodriguez, Fidel] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Isaranuwatchai, Wanrudee] St Michaels Hosp, Ctr Excellence Econ Anal Res, Li Ka Shing Knowledge Inst, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of British Columbia; University of British Columbia; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Blumberger, DM (corresponding author), Ctr Addict & Mental Hlth, Temerty Ctr Therapeut Brain Intervent, Toronto, ON, Canada.; Blumberger, DM (corresponding author), Univ Toronto, Fac Med, Dept Psychiat & Inst Med Sci, Toronto, ON, Canada.	daniel.blumberger@camh.ca	Downar, Jonathan/I-9002-2016	Downar, Jonathan/0000-0002-5140-174X; Mendlowitz, Andrew/0000-0002-0178-5087; Vila-Rodriguez, Fidel/0000-0002-8273-8820	Canadian Institutes of Health Research (CIHR) [MOP-136801]; Temerty Family Foundation; Campbell Family Mental Health Research Institute at the Centre for Addiction and Mental Health; Grant Family Foundation; Tina Buchan and the Buchan Family Fund through the University Health Network	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Temerty Family Foundation; Campbell Family Mental Health Research Institute at the Centre for Addiction and Mental Health; Grant Family Foundation; Tina Buchan and the Buchan Family Fund through the University Health Network	The THREE-D trial was funded by the Canadian Institutes of Health Research (CIHR) (grant number MOP-136801) and supported by the Temerty Family Foundation, Grant Family Foundation and Campbell Family Mental Health Research Institute at the Centre for Addiction and Mental Health and Tina Buchan and the Buchan Family Fund through the University Health Network. Magventure provided in-kind equipment support in the form of two coils and two high performance coolers at each site. Magventure had no role in the study design, data analysis, interpretation, or preparation of this manuscript. None of the investigators receive any financial compensation or hold any interest in Magventure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker N, 2015, BRAIN STIMUL, V8, P208, DOI 10.1016/j.brs.2014.11.002; Baldwin RC, 1997, J AFFECT DISORDERS, V46, P163, DOI 10.1016/S0165-0327(97)00143-2; Blumberger DM, 2018, LANCET, V391, P1683, DOI 10.1016/S0140-6736(18)30295-2; Brooks M., 2018, MEDSCAPE MED NEWS; Brunoni AR, 2017, JAMA PSYCHIAT, V74, P143, DOI 10.1001/jamapsychiatry.2016.3644; Canadian Agency for Drugs and Technology in Health, 2016, ENV SCAN; Di Lazzaro V, 2011, J NEUROPHYSIOL, V105, P2150, DOI 10.1152/jn.00781.2010; Downar J, 2016, CAN MED ASSOC J, V188, P1175, DOI 10.1503/cmaj.151316; Duprat R, 2016, J AFFECT DISORDERS, V200, P6, DOI 10.1016/j.jad.2016.04.015; Friedrich M J, 2017, JAMA, V317, P1517, DOI 10.1001/jama.2017.3826; Gaynes BN, 2014, J CLIN PSYCHIAT, V75, P477, DOI 10.4088/JCP.13r08815; George MS, 2013, CURR OPIN PSYCHIATR, V26, P13, DOI 10.1097/YCO.0b013e32835ab46d; George MS, 2010, ARCH GEN PSYCHIAT, V67, P507, DOI 10.1001/archgenpsychiatry.2010.46; GEORGE MS, 1995, NEUROREPORT, V6, P1853, DOI 10.1097/00001756-199510020-00008; Getty SS, 2017, MENT ILLN, V9, P63, DOI 10.4081/mi.2017.7181; Glick H.A., 2014, EC EVALUATION CLIN T; Health Quality Ontario, 2016, Ont Health Technol Assess Ser, V16, P1; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Li CT, 2014, BRAIN, V137, P2088, DOI 10.1093/brain/awu109; Lisanby SH, 2007, NEW ENGL J MED, V357, P1939, DOI 10.1056/NEJMct075234; Malhi GS, 2005, ACTA PSYCHIAT SCAND, V112, P302, DOI 10.1111/j.1600-0447.2005.00602.x; McClintock SM, 2018, J CLIN PSYCHIAT, V79; Milev RV, 2016, CAN J PSYCHIAT, V61, P561, DOI 10.1177/0706743716660033; National Institute for Health and Care Excellence, 2015, REP TRANSCR MAG STIM; Nemeroff CB, 2007, J CLIN PSYCHIAT, V68, P17; O'Reardon JP, 2007, BIOL PSYCHIAT, V62, P1208, DOI 10.1016/j.biopsych.2007.01.018; Oberman L, 2011, J CLIN NEUROPHYSIOL, V28, P67, DOI 10.1097/WNP.0b013e318205135f; Olchanski N, 2013, CLIN THER, V35, P512, DOI 10.1016/j.clinthera.2012.09.001; PascualLeone A, 1996, LANCET, V348, P233, DOI 10.1016/S0140-6736(96)01219-6; Plewnia C, 2014, J AFFECT DISORDERS, V156, P219, DOI 10.1016/j.jad.2013.12.025; Rizvi SJ, 2014, CAN J PSYCHIAT, V59, P349, DOI 10.1177/070674371405900702; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Rush AJ, 2006, NEUROPSYCHOPHARMACOL, V31, P1841, DOI 10.1038/sj.npp.1301131; Souery D, 1999, EUR NEUROPSYCHOPHARM, V9, P83, DOI 10.1016/S0924-977X(98)00004-2; U.S. Centers for Medicare and Medicaid Services, 2018, PHYS FEE SCHED SEARC; Vallejo-Torres L, 2015, PSYCHOL MED, V45, P1459, DOI 10.1017/S0033291714002554; WHO, 2011, GLOBAL BURDEN MENTAL	37	11	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2019	14	9							e0222546	10.1371/journal.pone.0222546	http://dx.doi.org/10.1371/journal.pone.0222546			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4IG	31513675	gold, Green Submitted, Green Published			2022-12-26	WOS:000532212700090
J	Elkhatib, W; Smith, CL; Senatore, A				Elkhatib, Wassim; Smith, Carolyn L.; Senatore, Adriano			A Na+ leak channel cloned from Trichoplax adhaerens extends extracellular pH and Ca2+ sensing for the DEG/ENaC family close to the base of Metazoa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						patch clamp; invertebrate; evolution; sodium channel; acid-sensing ion channel (ASIC); calcium; molecular evolution; amiloride; Ca2+block; DEG; ENaC sodium channels; proton block; Trichoplax adhaerens	PROTON BINDING-SITES; ION-CHANNEL; PARADOXICAL STIMULATION; FUNCTIONAL EXPRESSION; SODIUM-CHANNEL; ACID; ENAC; FMRFAMIDE; SELECTIVITY; CLONING	Acid-sensitive ion channels belonging to the degenerin/epithelial sodium channel (DEG/ENaC) family activate in response to extracellular protons and are considered unique to deuterostomes. However, sensitivity to pH/protons is more widespread, where, for example, human ENaC Na+ leak channels are potentiated and mouse BASIC and Caenorhabditis elegans ACD-1 Na+ leak channels are blocked by extracellular protons. For many DEG/ENaC channels, extracellular Ca2+ ions modulate gating, and in some cases, the binding of protons and Ca2+ is interdependent. Here, we functionally characterize a DEG/ENaC channel from the early-diverging animal Trichoplax adhaerens, TadNaC6, that conducts Na+-selective leak currents in vitro sensitive to blockade by both extracellular protons and Ca2+. We determine that proton block is enhanced in low external Ca2+ concentration, whereas calcium block is enhanced in low external proton concentration, indicative of competitive binding of these two ligands to extracellular sites of the channel protein. TadNaC6 lacks most determinant residues for proton and Ca2+ sensitivity in other DEG/ENaC channels, and a mutation of one conserved residue (S353A) associated with Ca2+ block in rodent BASIC channels instead affected proton sensitivity, all indicative of independent evolution of H+ and Ca2+ sensitivity. Strikingly, TadNaC6 was potently activated by the general DEG/ENaC channel blocker amiloride, a rare feature only reported for the acid-activated channel ASIC3. The sequence and structural divergence of TadNaC6, coupled with its noncanonical functional features, provide unique opportunities for probing the proton, Ca2+, and amiloride regulation of DEG/ENaC channels and insight into the possible core-gating features of ancestral ion channels.	[Elkhatib, Wassim; Senatore, Adriano] Univ Toronto, Dept Biol, 3359 Mississauga Rd, Mississauga, ON L5L 1C6, Canada; [Smith, Carolyn L.] NINDS, NIH, Bethesda, MD 20892 USA	University of Toronto; University Toronto Mississauga; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Senatore, A (corresponding author), Univ Toronto, Dept Biol, 3359 Mississauga Rd, Mississauga, ON L5L 1C6, Canada.	adriano.senatore@utoronto.ca			Government of Canada Natural Sciences and Engineering Research Council of Canada [RGPIN-2016-06023]; Canada Foundation for Innovation (CFI) [35297]	Government of Canada Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation)	This work was supported by Government of Canada Natural Sciences and Engineering Research Council of Canada Grant RGPIN-2016-06023 (to A. S.) and Canada Foundation for Innovation (CFI) Grant 35297 (to A. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams CM, 1999, J BIOL CHEM, V274, P15500, DOI 10.1074/jbc.274.22.15500; Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Assmann M, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0084-2; Babini E, 2002, J BIOL CHEM, V277, P41597, DOI 10.1074/jbc.M205877200; Bargeton B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37426-5; Bohlen CJ, 2011, NATURE, V479, P410, DOI 10.1038/nature10607; Boiko N, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.411736; Boscardin E, 2016, BRIT J PHARMACOL, V173, P2671, DOI 10.1111/bph.13533; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chen JX, 2015, J BIOL CHEM, V290, P25140, DOI 10.1074/jbc.M115.665398; Cheng YR, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0448-y; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Coric T, 2005, J PHYSIOL-LONDON, V568, P725, DOI 10.1113/jphysiol.2005.087734; Coric T, 2008, FASEB J, V22, P1914, DOI 10.1096/fj.07-100313; Derby CD, 2016, CHEM SENSES, V41, P381, DOI 10.1093/chemse/bjw057; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Eastwood AL, 2012, PHYSIOLOGY, V27, P282, DOI 10.1152/physiol.00006.2012; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gautschi I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175293; Golubovic A, 2007, J BIOL CHEM, V282, P35098, DOI 10.1074/jbc.M706849200; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Grunder S, 2015, J EXP BIOL, V218, P551, DOI 10.1242/jeb.111666; Grunder Stefan, 2010, Int J Physiol Pathophysiol Pharmacol, V2, P73; Hanukoglu I, 2017, FEBS J, V284, P525, DOI 10.1111/febs.13840; Immke DC, 2003, NEURON, V37, P75, DOI 10.1016/S0896-6273(02)01130-3; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jeziorski MC, 2000, J PHYSIOL-LONDON, V526, P13, DOI 10.1111/j.1469-7793.2000.00013.x; Kellenberger S, 2001, J GEN PHYSIOL, V118, P679, DOI 10.1085/jgp.118.6.679; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Krauson AJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196894; Krauson AJ, 2013, J BIOL CHEM, V288, P34375, DOI 10.1074/jbc.M113.504324; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lenzig P, 2019, PFLUG ARCH EUR J PHY, V471, P329, DOI 10.1007/s00424-018-2223-z; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Li WG, 2011, J BIOL CHEM, V286, P42635, DOI 10.1074/jbc.M111.289058; Liebeskind BJ, 2015, P NATL ACAD SCI USA, V112, pE846, DOI 10.1073/pnas.1501195112; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Lingueglia E, 2006, PEPTIDES, V27, P1138, DOI 10.1016/j.peptides.2005.06.037; Lynagh T, 2018, P NATL ACAD SCI USA, V115, P8430, DOI 10.1073/pnas.1806614115; Lynagh T, 2017, ELIFE, V6, DOI 10.7554/eLife.24630; Mano I, 1999, BIOESSAYS, V21, P568, DOI 10.1002/(SICI)1521-1878(199907)21:7&lt;568::AID-BIES5&gt;3.0.CO;2-L; Mayorova TD, 2019, BIOL OPEN, V8, DOI 10.1242/bio.045674; Mayorova TD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190905; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Paukert M, 2004, J GEN PHYSIOL, V124, P383, DOI 10.1085/jgp.200308973; Paukert M, 2008, J BIOL CHEM, V283, P572, DOI 10.1074/jbc.M706811200; Peng GD, 2015, MOL PHYLOGENET EVOL, V84, P145, DOI 10.1016/j.ympev.2014.06.016; Perry SJ, 2001, J NEUROSCI, V21, P5559, DOI 10.1523/JNEUROSCI.21-15-05559.2001; Qadri YJ, 2012, AM J PHYSIOL-CELL PH, V302, pC943, DOI 10.1152/ajpcell.00019.2012; Sakai H, 1999, J PHYSIOL-LONDON, V519, P323, DOI 10.1111/j.1469-7793.1999.0323m.x; Schaefer L, 2000, FEBS LETT, V471, P205, DOI 10.1016/S0014-5793(00)01403-4; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; Schmidt A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111549; Sebe-Pedros A, 2018, NAT ECOL EVOL, V2, P1176, DOI 10.1038/s41559-018-0575-6; Senatore A, 2017, J EXP BIOL, V220, P3381, DOI 10.1242/jeb.162396; Shi Shujie, 2013, Curr Mol Pharmacol, V6, P28; Smith CL, 2019, P NATL ACAD SCI USA, V116, P8901, DOI 10.1073/pnas.1815655116; Smith CL, 2017, J GEN PHYSIOL, V149, P483, DOI 10.1085/jgp.201611683; Smith CL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136098; Smith CL, 2014, CURR BIOL, V24, P1565, DOI 10.1016/j.cub.2014.05.046; Smith ESJ, 2007, NEUROSCI LETT, V426, P12, DOI 10.1016/j.neulet.2007.07.047; Springauf A, 2010, J PHYSIOL-LONDON, V588, P809, DOI 10.1113/jphysiol.2009.182931; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Staruschenko A, 2005, BIOPHYS J, V88, P3966, DOI 10.1529/biophysj.104.056804; Syntichaki P, 2004, PHYSIOL REV, V84, P1097, DOI 10.1152/physrev.00043.2003; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; van Giesen Lena, 2017, F1000Res, V6, P1753, DOI 10.12688/f1000research.12013.1; Varoqueaux F, 2018, CURR BIOL, V28, P3495, DOI 10.1016/j.cub.2018.08.067; Vyvers A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-36125-5; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Wang Y, 2009, BIOCHEMISTRY-US, V48, P10005, DOI 10.1021/bi9014902; Warnock DG, 2014, NAT REV NEPHROL, V10, P146, DOI 10.1038/nrneph.2013.275; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Wiemuth D, 2014, PFLUG ARCH EUR J PHY, V466, P1725, DOI 10.1007/s00424-013-1403-0; Wiemuth D, 2010, J BIOL CHEM, V285, P30404, DOI 10.1074/jbc.M110.153064; Yang L, 2014, J GEN PHYSIOL, V144, P245, DOI 10.1085/jgp.201411220; Yang XN, 2017, J BIOL CHEM, V292, P21662, DOI 10.1074/jbc.M117.814707; Yu Y, 2010, NEURON, V68, P61, DOI 10.1016/j.neuron.2010.09.001; Zuo ZC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04424-0	83	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					16320	16336		10.1074/jbc.RA119.010542	http://dx.doi.org/10.1074/jbc.RA119.010542			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31527080	Green Published, hybrid			2022-12-26	WOS:000499478600036
J	Tavano, A; Schroger, E; Kotz, SA				Tavano, Alessandro; Schroger, Erich; Kotz, Sonja A.			Beta power encodes contextual estimates of temporal event probability in the human brain	PLOS ONE			English	Article							ORIENTING ATTENTION; BAND OSCILLATIONS; PARIETAL CORTEX; ELAPSED TIME; SHORT-TERM; EEG; EXPECTATION; COMPONENT; DYNAMICS; REPRESENTATION	To prepare for an impending event of unknown temporal distribution, humans internally increase the perceived probability of event onset as time elapses. This effect is termed the hazard rate of events. We tested how the neural encoding of hazard rate changes by providing human participants with prior information on temporal event probability. We recorded behavioral and electroencephalographic (EEG) data while participants listened to continuously repeating five-tone sequences, composed of four standard tones followed by a nontarget deviant tone, delivered at slow (1.6 Hz) or fast (4 Hz) rates. The task was to detect a rare target tone, which equiprobably appeared at either position two, three or four of the repeating sequence. In this design, potential target position acts as a proxy for elapsed time. For participants uninformed about the target's distribution, elapsed time to uncertain target onset increased response speed, displaying a significant hazard rate effect at both slow and fast stimulus rates. However, only in fast sequences did prior information about the target's temporal distribution interact with elapsed time, suppressing the hazard rate. Importantly, in the fast, uninformed condition pre-stimulus power synchronization in the beta band (Beta 1, 15-19 Hz) predicted the hazard rate of response times. Prior information suppressed pre-stimulus power synchronization in the same band, while still significantly predicting response times. We conclude that Beta 1 power does not simply encode the hazard rate, but-more generally-internal estimates of temporal event probability based upon contextual information.	[Tavano, Alessandro; Schroger, Erich] Univ Leipzig, Inst Psychol, BioCog Cognit Incl Biol Psychol, Leipzig, Germany; [Tavano, Alessandro] Max Planck Inst Empir Aesthet, Dept Neurosci, Frankfurt, Germany; [Kotz, Sonja A.] Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Germany; [Kotz, Sonja A.] Maastricht Univ, Fac Psychol & Neurosci, Dept Neuropsychol & Psychopharmacol, Maastricht, Netherlands	Leipzig University; Max Planck Society; Maastricht University	Tavano, A (corresponding author), Univ Leipzig, Inst Psychol, BioCog Cognit Incl Biol Psychol, Leipzig, Germany.; Tavano, A (corresponding author), Max Planck Inst Empir Aesthet, Dept Neurosci, Frankfurt, Germany.	alessandro.tavano@ae.mpg.de	; Schroger, Erich/C-3079-2009	Tavano, Alessandro/0000-0002-2096-5542; Schroger, Erich/0000-0002-8321-6629	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation); DFG [2268/6-1]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Reinhart-Koselleck Project	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Reinhart-Koselleck Project(German Research Foundation (DFG))	ES was awarded a Reinhart-Koselleck Project grant by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation). SAK was awarded a DFG grant (2268/6-1).; This work was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Reinhart-Koselleck Project grant awarded to E. Schroger and by a DFG grant (2268/6-1) awarded to Sonja A. Kotz. The authors would like to thank Matt Craddock, Maren Grigutch, Philipp Ruhnau, Michael Schwartze, Burkhard Maess, Peter Lakatos, David Poeppel, and an anonymous reviewer for insightful discussions and help with the experimental setup and data analyses, and Katrin Ina Koch for data collection.	Ahveninen J, 2002, NEUROIMAGE, V16, P1052, DOI 10.1006/nimg.2002.1142; American National Standards Institute, 1996, S361996 ANSI; Arnal LH, 2015, CEREB CORTEX, V25, P3077, DOI 10.1093/cercor/bhu103; Arnal LH, 2012, TRENDS COGN SCI, V16, P390, DOI 10.1016/j.tics.2012.05.003; Bendixen A, 2008, NEUROIMAGE, V41, P1111, DOI 10.1016/j.neuroimage.2008.03.040; Bermudez MA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0468; BERTELSON P, 1967, Q J EXP PSYCHOL, V19, P272, DOI 10.1080/14640746708400102; Bolger D, 2014, J COGNITIVE NEUROSCI, V26, P593, DOI 10.1162/jocn_a_00511; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Budd TW, 1998, INT J PSYCHOPHYSIOL, V31, P51, DOI 10.1016/S0167-8760(98)00040-3; Chang A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00327; Chennu S, 2013, J NEUROSCI, V33, P11194, DOI 10.1523/JNEUROSCI.0114-13.2013; Correa A, 2004, PERCEPT PSYCHOPHYS, V66, P264, DOI 10.3758/BF03194878; Cotti J, 2011, NEUROIMAGE, V54, P1221, DOI 10.1016/j.neuroimage.2010.09.038; Coull JT, 2008, CURR OPIN NEUROBIOL, V18, P137, DOI 10.1016/j.conb.2008.07.011; Coull JT, 2014, PROCD SOC BEHV, V126, P41, DOI 10.1016/j.sbspro.2014.02.311; Coull JT, 2011, NEUROPSYCHOPHARMACOL, V36, P3, DOI 10.1038/npp.2010.113; Cowan N, 1997, PSYCHON B REV, V4, P393, DOI 10.3758/BF03210799; Cowan N, 2008, PROG BRAIN RES, V169, P323, DOI 10.1016/S0079-6123(07)00020-9; Cui X, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000167; Davranche K, 2011, J COGNITIVE NEUROSCI, V23, P3318, DOI 10.1162/jocn_a_00030; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dien J, 2003, COGNITIVE BRAIN RES, V15, P137, DOI 10.1016/S0926-6410(02)00147-7; Elithorn A, 1955, Q J EXP PSYCHOL, V11, P211; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Fujioka T, 2015, J NEUROSCI, V35, P15187, DOI 10.1523/JNEUROSCI.2397-15.2015; Fujioka T, 2012, J NEUROSCI, V32, P1791, DOI 10.1523/JNEUROSCI.4107-11.2012; Garrido MI, 2009, CLIN NEUROPHYSIOL, V120, P453, DOI 10.1016/j.clinph.2008.11.029; Garrido MI, 2009, J NEUROPHYSIOL, V101, P2620, DOI 10.1152/jn.90291.2008; Genovesio A, 2006, J NEUROPHYSIOL, V95, P3281, DOI 10.1152/jn.01011.2005; Griffin IC, 2001, FRONT BIOSCI-LANDMRK, V6, pD660, DOI 10.2741/Griffin; Gulberti A, 2015, NEUROIMAGE-CLIN, V9, P436, DOI 10.1016/j.nicl.2015.09.013; Hauk O, 2006, NEUROIMAGE, V30, P1383, DOI 10.1016/j.neuroimage.2005.11.048; Hultin L, 1996, ELECTROEN CLIN NEURO, V98, P435, DOI 10.1016/0013-4694(96)95507-8; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Jaramillo S, 2011, NAT NEUROSCI, V14, P246, DOI 10.1038/nn.2688; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Kopell N, 2011, P NATL ACAD SCI USA, V108, P3779, DOI 10.1073/pnas.1019676108; Kopell N, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00187; Lee JH, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003164; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Leventhal DK, 2012, NEURON, V73, P523, DOI 10.1016/j.neuron.2011.11.032; Luce RD, 1986, RESPONSE TIMES THEIR; Luft CDB, 2015, J NEUROPHYSIOL, V113, P3159, DOI 10.1152/jn.00753.2014; Macmillan N. A., 1991, DETECTION THEORY USE; Maimon G, 2006, NAT NEUROSCI, V9, P948, DOI 10.1038/nn1716; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Merchant H, 2015, PHILOS T R SOC B, V370, P91, DOI 10.1098/rstb.2014.0093; Michalareas G, 2016, NEURON, V89, P384, DOI 10.1016/j.neuron.2015.12.018; Miniussi C, 1999, BRAIN, V122, P1507, DOI 10.1093/brain/122.8.1507; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; Nobre AC, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.004.2007; Nobre K, 2010, ATTENTION TIME; NOVAK GP, 1990, ELECTROEN CLIN NEURO, V75, P255, DOI 10.1016/0013-4694(90)90105-S; Onton J, 2006, PROG BRAIN RES, V159, P99, DOI 10.1016/S0079-6123(06)59007-7; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Patel AD, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00057; Pfurtscheller G, 2003, CLIN NEUROPHYSIOL, V114, P1226, DOI 10.1016/S1388-2457(03)00067-1; Rahne T, 2008, J NEUROSCI METH, V172, P74, DOI 10.1016/j.jneumeth.2008.04.006; Rohenkohl G, 2011, J NEUROSCI, V31, P14076, DOI 10.1523/JNEUROSCI.3387-11.2011; Schroger E, 2015, EUR J NEUROSCI, V41, P641, DOI 10.1111/ejn.12816; Schulze K, 2013, MEMORY, V21, P377, DOI 10.1080/09658211.2012.731070; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Sokolov EN, 2002, ORIENTING RESPONSE I, P241; Spitzer B, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0170-17.2017; Sussman E, 2002, COGNITIVE BRAIN RES, V13, P393, DOI 10.1016/S0926-6410(01)00131-8; Sussman ES, 2007, J PSYCHOPHYSIOL, V21, P164, DOI 10.1027/0269-8803.21.34.164; Sussman ES, 2005, NEUROREPORT, V16, P1519, DOI 10.1097/01.wnr.0000177002.35193.4c; Tavano A, 2014, EUR J NEUROSCI, V39, P308, DOI 10.1111/ejn.12404; Theil H., 1950, NEDERLANDSCHE AKAD W, V53, P1397; Todorovic A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120288; Vangkilde S, 2012, J EXP PSYCHOL HUMAN, V38, P1183, DOI 10.1037/a0026343; Viola FC, 2009, CLIN NEUROPHYSIOL, V120, P868, DOI 10.1016/j.clinph.2009.01.015; Wacongne C, 2012, J NEUROSCI, V32, P3665, DOI 10.1523/JNEUROSCI.5003-11.2012; Widmann A, 2015, J NEUROSCI METH, V250, P34, DOI 10.1016/j.jneumeth.2014.08.002; Wilsch A, 2015, CEREB CORTEX, V25, P1938, DOI 10.1093/cercor/bhu004; Woodrow H, 1914, PSYCHOL MONOGR, V17, P1; Yang T, 2007, NATURE, V447, P1075, DOI 10.1038/nature05852	82	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222420	10.1371/journal.pone.0222420	http://dx.doi.org/10.1371/journal.pone.0222420			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6FU	31557168	Green Published, gold, Green Submitted			2022-12-26	WOS:000532345500019
J	Babaei, M; Liu, YK; Wuerzberger-Davis, SM; McCaslin, EZ; DiRusso, CJ; Yeo, AT; Kagermazova, L; Miyamoto, S; Gilmore, TD				Babaei, Milad; Liu, Yuekun; Wuerzberger-Davis, Shelly M.; McCaslin, Ethan Z.; DiRusso, Christopher J.; Yeo, Alan T.; Kagermazova, Larisa; Miyamoto, Shigeki; Gilmore, Thomas D.			CRISPR/Cas9-based editing of a sensitive transcriptional regulatory element to achieve cell type-specific knockdown of the NEMO scaffold protein	PLOS ONE			English	Article							NF-KAPPA-B; ALTERNATIVE PROMOTER; CRISPR; GAMMA; MUTATIONS; GENE; EXPRESSION; DELETION; PATHWAY	The use of alternative promoters for the cell type-specific expression of a given mRNA/protein is a common cell strategy. NEMO is a scaffold protein required for canonical NF-kappa B signaling. Transcription of the NEMO gene is primarily controlled by two promoters: one (promoter B) drives NEMO transcription in most cell types and the second (promoter D) is largely responsible for NEMO transcription in liver cells. Herein, we have used a CRISPR/Cas9-based approach to disrupt a core sequence element of promoter B, and this genetic editing essentially eliminates expression of NEMO mRNA and protein in 293T human kidney cells. By cell subcloning, we have isolated targeted 293T cell lines that express no detectable NEMO protein, have defined genomic alterations at promoter B, and do not support activation of canonical NF-kappa B signaling in response to treatment with tumor necrosis factor. Nevertheless, non-canonical NF-kappa B signaling is intact in these NEMO-deficient cells. Expression of ectopic wildtype NEMO, but not certain human NEMO disease mutants, in the edited cells restores downstream NF-kappa B signaling in response to tumor necrosis factor. Targeting of the promoter B element does not substantially reduce NEMO expression (from promoter D) in the human SNU423 liver cancer cell line. Thus, we have created a strategy for selectively eliminating cell type-specific expression from an alternative promoter and have generated 293T cell lines with a functional knockout of NEMO. The implications of these findings for further studies and for therapeutic approaches to target canonical NF-kappa B signaling are discussed.	[Babaei, Milad; Liu, Yuekun; McCaslin, Ethan Z.; DiRusso, Christopher J.; Yeo, Alan T.; Kagermazova, Larisa; Gilmore, Thomas D.] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA; [Wuerzberger-Davis, Shelly M.; Miyamoto, Shigeki] Univ Wisconsin, McArdle Lab Canc Res, Carbone Canc Ctr, Dept Oncol, 1400 Univ Ave, Madison, WI 53706 USA	Boston University; University of Wisconsin System; University of Wisconsin Madison	Gilmore, TD (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	gilmore@bu.edu		Gilmore, Thomas/0000-0002-1910-768X	National Institutes of Health [CA077474, GM117350]; Boston University Undergraduate Research Opportunities Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston University Undergraduate Research Opportunities Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the National Institutes of Health (www.nih.gov) grants CA077474 (to S.M.) and GM117350 (to T.D.G.). M. B., Y.L., L.K, and E.Z.M. were supported by funds from the Boston University Undergraduate Research Opportunities Program (www.bu.edu/urop).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayoubi TA, 2011, FASEB J, V10, P453; Beraza N, 2009, J EXP MED, V206, P1727, DOI 10.1084/jem.20082152; Cote SM, 2013, BIOCHEMISTRY-US, V52, P9141, DOI 10.1021/bi401368r; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Davuluri RV, 2008, TRENDS GENET, V24, P167, DOI 10.1016/j.tig.2008.01.008; Floor SN, 2016, ELIFE, V5, DOI 10.7554/eLife.10921; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Fusco F, 2004, HUM MOL GENET, V13, P1763, DOI 10.1093/hmg/ddh192; Fusco F, 2006, GENE, V383, P99, DOI 10.1016/j.gene.2006.07.022; Fusco F, 2012, HUM MOL GENET, V21, P1260, DOI 10.1093/hmg/ddr556; Galgoczy P, 2001, GENE, V271, P93, DOI 10.1016/S0378-1119(01)00492-9; Gilmore TD, 2011, CURR TOP MICROBIOL, V349, P245, DOI 10.1007/82_2010_105; Glass Z, 2018, TRENDS BIOTECHNOL, V36, P173, DOI 10.1016/j.tibtech.2017.11.006; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Han Y, 2015, ARTERIOSCL THROM VAS, V35, P312, DOI 10.1161/ATVBAHA.114.305017; Herscovitch M, 2008, BIOCHEM BIOPH RES CO, V367, P103, DOI 10.1016/j.bbrc.2007.12.123; Jackson SS, 2015, METHODS MOL BIOL, V1280, P197, DOI 10.1007/978-1-4939-2422-6_11; Kawai T, 2012, BLOOD, V119, P5458, DOI 10.1182/blood-2011-05-354167; Ku CL, 2007, J MED GENET, V44, P16, DOI 10.1136/jmg.2006.044446; Lawhorn IEB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113232; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Ngoc LV, 2017, GENE DEV, V31, P1289, DOI 10.1101/gad.303149.117; Ngoc LV, 2017, GENE DEV, V31, P6, DOI 10.1101/gad.293837.116; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Maier HJ, 2013, ONCOGENE, V32, P2690, DOI 10.1038/onc.2012.272; Maubach G, 2017, TRENDS MOL MED, V23, P1138, DOI 10.1016/j.molmed.2017.10.004; Miyamoto S, 1998, MOL CELL BIOL, V18, P19, DOI 10.1128/MCB.18.1.19; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Pan YC, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav7199; Puar YR, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6030082; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Reddy A, 2017, CELL, V171, P481, DOI 10.1016/j.cell.2017.09.027; Salt BH, 2008, J ALLERGY CLIN IMMUN, V121, P976, DOI 10.1016/j.jaci.2007.11.014; Sanjana NE, 2016, SCIENCE, V353, P1545, DOI 10.1126/science.aaf7613; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Shaffer R, 2019, BIOCHEMISTRY-US, V58, P2906, DOI 10.1021/acs.biochem.8b01316; Stepanenko A, 2015, MUTAT RES-FUND MOL M, V771, P56, DOI 10.1016/j.mrfmmm.2014.12.006; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Vacik T, 2017, PROTOPLASMA, V254, P1201, DOI 10.1007/s00709-016-1071-y; Xin DD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002377; Zhang J, 2013, CANCER DISCOV, V3, P1228, DOI 10.1158/2159-8290.CD-13-0253	44	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222588	10.1371/journal.pone.0222588	http://dx.doi.org/10.1371/journal.pone.0222588			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553754	Green Submitted, gold, Green Published			2022-12-26	WOS:000532319200032
J	Svenson, KL; Long, LL; Ciciotte, SL; Adams, MD				Svenson, Karen L.; Long, Lauren L.; Ciciotte, Steven L.; Adams, Mark D.			A mutation in mouse Kruppel-like factor 15 alters the gut microbiome and response to obesogenic diet	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; KLF15; EXPRESSION; REGULATOR; OBESITY; ENVIRONMENT; HOMEOSTASIS; ACTIVATION; GENOTYPE	We identified a mouse strain, HLB444, carrying an N-ethyl-N-nitrosourea (ENU)-induced mutation in a highly conserved C2H2 zinc-finger DNA binding motif of the transcriptional regulator KLF15 that exhibits resistance to diet-induced obesity. Characterization of the HLB444 mutant model on high-fat and chow diets revealed a number of phenotypic differences compared to wild-type controls. When fed a high fat diet, HLB444 had lower body fat, resistance to hepatosteatosis, lower circulating glucose and improved insulin sensitivity compared to C57BL/6J controls. Gut microbial profiles in HLB444 generated from 16S rRNA sequencing of fecal samples differed from controls under both chow and high fat diets. HLB444 shares similar phenotypic traits with engineered full- and adipose-specific Klf15 knockout strains; however, some phenotypic differences between this mutant and the other models suggest that the Klf15 mutation in HLB444 is a hypomorphic variant. The HLB444 model will inform further annotation of transcriptional functions of KLF15, especially with respect to the role of the first zinc-finger domain.	[Svenson, Karen L.; Ciciotte, Steven L.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Long, Lauren L.; Adams, Mark D.] Jackson Lab, Farmington, CT USA	Jackson Laboratory; Jackson Laboratory	Svenson, KL (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	karen.svenson@jax.org		Adams, Mark/0000-0003-3161-7460; Svenson, Karen/0000-0002-7928-1911	National Institutes of Health, NIDDK [DK087790]; Jackson Laboratory Scientific Services award (SSIF2017)	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Jackson Laboratory Scientific Services award (SSIF2017)	This work was supported by a grant to KLS by National Institutes of Health, NIDDK grant number DK087790, and by a Jackson Laboratory Scientific Services award (SSIF2017) to KLS and MDA. Funders played no role in the study design, data collection, data analysis, decision to publish or in preparation of the manuscript.	Aggarwal A, 2017, CELL REP, V21, P2367, DOI 10.1016/j.celrep.2017.11.004; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Anderson MJ, 2005, PERMANOVA FRTRAN COM, DOI [10.1371/journal.pone.0116704, DOI 10.1371/JOURNAL.PONE.0116704]; Arends D, 2010, BIOINFORMATICS, V26, P2990, DOI 10.1093/bioinformatics/btq565; Austin MA, 1998, AM J CARDIOL, V81, p7B, DOI 10.1016/S0002-9149(98)00031-9; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bradberry J Chris, 2013, P T, V38, P681; Cao S, 2005, J BIOL CHEM, V280, P1901, DOI 10.1074/jbc.M407941200; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Chaillou T, 2013, J APPL PHYSIOL, V115, P1065, DOI 10.1152/japplphysiol.00611.2013; Clarke SF, 2012, GUT MICROBES, V3, P186, DOI 10.4161/gmic.20168; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ericsson AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116704; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Feingold K.R., 2000, ENDOTEXT; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Friswell MK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008584; Fu SN, 2012, CELL METAB, V15, P623, DOI 10.1016/j.cmet.2012.03.007; Gray S, 2002, J BIOL CHEM, V277, P34322, DOI 10.1074/jbc.M201304200; Gray S, 2007, CELL METAB, V5, P305, DOI 10.1016/j.cmet.2007.03.002; Haldar SM, 2012, P NATL ACAD SCI USA, V109, P6739, DOI 10.1073/pnas.1121060109; Han SX, 2019, NAT METAB, V1, P422, DOI 10.1038/s42255-019-0054-7; Hodin CM, 2011, AM J PATHOL, V179, P2885, DOI 10.1016/j.ajpath.2011.08.030; Jeyaraj D, 2012, NATURE, V483, P96, DOI 10.1038/nature10852; Jung DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077851; Kaser A, 2011, EXP CELL RES, V317, P2772, DOI 10.1016/j.yexcr.2011.07.008; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leenders JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036754; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liberzon D, 2011, IEEE DECIS CONTR P, P417, DOI 10.1109/CDC.2011.6160335; Lim S, 2014, REV ENDOCR METAB DIS, V15, P329, DOI 10.1007/s11154-014-9298-4; Lodhi IJ, 2012, CELL METAB, V16, P189, DOI 10.1016/j.cmet.2012.06.013; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Matoba K, 2017, CELL REP, V21, P3129, DOI 10.1016/j.celrep.2017.11.032; McConnell BB, 2010, PHYSIOL REV, V90, P1337, DOI 10.1152/physrev.00058.2009; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Moore JX, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160287; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Nagare T, 2011, J BIOL CHEM, V286, P37458, DOI 10.1074/jbc.M111.242651; Nakagawa H, 2014, CANCER CELL, V26, P331, DOI 10.1016/j.ccr.2014.07.001; Neve B, 2005, P NATL ACAD SCI USA, V102, P4807, DOI 10.1073/pnas.0409177102; Nordestgaard BG, 2014, LANCET, V384, P626, DOI 10.1016/S0140-6736(14)61177-6; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Otteson DC, 2004, INVEST OPHTH VIS SCI, V45, P2522, DOI 10.1167/iovs.04-0072; Pabona JMP, 2010, ENDOCRINOLOGY, V151, P3396, DOI 10.1210/en.2009-1370; Pan FW, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0440-5; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Peters LL, 2002, PHYSIOL GENOMICS, V11, P185, DOI 10.1152/physiolgenomics.00077.2002; Prosdocimo DA, 2014, J BIOL CHEM, V289, P5914, DOI 10.1074/jbc.M113.531384; Ravussin Y, 2012, OBESITY, V20, P738, DOI 10.1038/oby.2011.111; Reifsnyder PC, 2000, GENOME RES, V10, P1568, DOI 10.1101/gr.147000; Rodriguez E, 2009, CELL RES, V19, P1041, DOI 10.1038/cr.2009.103; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Sheng LL, 2018, FASEB J, V32, P6371, DOI 10.1096/fj.201800370R; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Svenson KL, 2008, J LIPID RES, V49, P2452, DOI 10.1194/jlr.M800303-JLR200; Svenson KL, 2003, J APPL PHYSIOL, V94, P1650, DOI 10.1152/japplphysiol.01029.2003; Svenson KL, 2002, CIRCULATION; Turnbaugh PJ, 2008, CELL, V134, P708, DOI 10.1016/j.cell.2008.08.025; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Zhang LL, 2015, CELL REP, V13, P2368, DOI 10.1016/j.celrep.2015.11.038	74	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222536	10.1371/journal.pone.0222536	http://dx.doi.org/10.1371/journal.pone.0222536			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553739	Green Submitted, Green Published, gold			2022-12-26	WOS:000532319200030
J	Benjamin, A; Cavalcante, SC; Jamal, LF; Arakaki-Sanchez, D; de Lima, JN; Pilotto, JH; de Oliveira, FI; Souza, TNL; Lourenco, MC; de Mello, MB; do Brasil, PEAA; Barreira, D; Rolla, V				Benjamin, Aline; Cavalcante, Solange Cesar; Jamal, Leda Fatima; Arakaki-Sanchez, Denise; de Lima, Josue Nazareno; Pilotto, Jose Henrique; de Oliveira Junior, Francisco Ivanildo; Lobato Souza, Tamara Newman; Lourenco, Maria Cristina; de Mello, Maeve Brito; Alvarenga Americano do Brasil, Pedro Emmanuel; Barreira, Draurio; Rolla, Valeria			Accuracy of Determine TB-LAM Ag to detect TB in HIV infected patients associated with diagnostic methods used in Brazilian public health units	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; ANTIGEN	Background Determine TB-LAM Ag (LAM) is a point of care test developed to diagnose tuberculosis (TB). The aim of this study was to evaluate the diagnostic performance of LAM in people living with HIV using Brazilian public health network algorithm for TB diagnosis. Methods and findings A cross-sectional study design was used to enroll 199 adult patients in two sites in Rio de Janeiro and two in Sao Paulo. The study enrolled HIV-infected patients with CD4 counts <= 200 cells/mm(3) (in the Alere PIMA CD4 assay at study screening), patients coughing for at least 2 weeks or presenting a chest radiography suggestive of TB. LAM, in conjunction with sputum smear microscopy or Xpert MTB/RIF (Xpert) as compared to Mycobacterium tuberculosis culture, which was used as a reference standard. TB prevalence was 24.6%. Overall accuracy of LAM was 79.9% (73.8%-84.9%), positive and negative predictive values were 62.2% (46.1%-75.9%) and 84% (77.5%-88.8%), respectively. The overall LAM sensitivity was 46.9% (33.7%-60.6%) and specificity was 90.7% (84.9%-94.4%). The best performance of LAM was observed among patients with CD4 counts <= 50 cells/mm(3) (sensitivity = 70.4% and specificity = 85.9%). When 2 respiratory smears were used in conjunction with LAM, sensitivity increased 22%, as compared to just 2 smears. Furthermore, LAM when used in conjunction with two respiratory smears, was as sensitive as compared to a single one. However, no improvement in TB diagnosis occurred when LAM was used with Xpert as compared to Xpert alone. Among 14 LAM false positive tests, Non-Tuberculosis Mycobacteria were isolated in three cases. Conclusion LAM is a point of care test that increased TB diagnosis in immunosuppressed HIV-infected patients when used in conjunction with smear microscopy, but not when used with Xpert in Brazilian public health network sites. Use of LAM test should be considered in settings where immunosuppressed HIV patients need rapid TB diagnosis.	[Benjamin, Aline; Cavalcante, Solange Cesar; Rolla, Valeria] Fundacao Oswaldo Cruz, Natl Inst Infect Dis Evandro Chagas, Clin Reasearch Lab Mycobacteria, Rio De Janeiro, Brazil; [Jamal, Leda Fatima] Hlth Secretariat State Sao Paulo, STD AIDS Reference & Training Ctr, Sao Paulo, Brazil; [Arakaki-Sanchez, Denise; de Lima, Josue Nazareno] Minist Hlth, Natl TB Program, Brasilia, DF, Brazil; [Pilotto, Jose Henrique] Nova Iguacu Gen Hosp, STD AIDS Serv, Rio De Janeiro, Brazil; [Pilotto, Jose Henrique] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, Brazil; [de Oliveira Junior, Francisco Ivanildo; Lobato Souza, Tamara Newman] Inst Infect Dis Emilio Ribas, Sao Paulo, Brazil; [Lourenco, Maria Cristina] Fundacao Oswaldo Cruz, Bacteriol & Bioassay Lab, Natl Inst Infect Dis Evandro Chagas, Rio De Janeiro, Brazil; [de Mello, Maeve Brito] Pan Amer Hlth Org, Washington, DC USA; [Alvarenga Americano do Brasil, Pedro Emmanuel] Fundacao Oswaldo Cruz, Natl Inst Infect Dis Evandro Chagas, Clin Res Lab Immunizat & Surveillance Hlth, Rio De Janeiro, Brazil; [Barreira, Draurio] Unitaid, Geneva, Switzerland	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Pan American Health Organization; Fundacao Oswaldo Cruz	Benjamin, A (corresponding author), Fundacao Oswaldo Cruz, Natl Inst Infect Dis Evandro Chagas, Clin Reasearch Lab Mycobacteria, Rio De Janeiro, Brazil.	aline.benjamin@ini.fiocruz.br	Rolla, Valeria Cavalcanti/AAI-6078-2021; Brasil, Pedro E A A/B-4357-2008; Pilotto, Jose Henrique/AAD-9773-2019; Arakaki-Sanchez, Denise/M-4766-2013	Rolla, Valeria Cavalcanti/0000-0002-0841-1408; Brasil, Pedro E A A/0000-0002-6700-2268; Pilotto, Jose Henrique/0000-0003-0521-8597; de Oliveira Junior, Francisco Ivanildo/0000-0003-0767-0536	Brazilian Tuberculosis Control Program; President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [NU2GGH001152]	Brazilian Tuberculosis Control Program; President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research has been supported by Brazilian Tuberculosis Control Program and by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of Cooperative Agreement Number NU2GGH001152. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the funding agencies.	[Anonymous], 2015, US LAT FLOW UR LIP A; Balcha TT, 2014, TROP MED INT HEALTH, V19, P734, DOI 10.1111/tmi.12308; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de Vigilancia das Doencas Transmissiveis, 2015, RED TEST RAP TUB BRA; Drain PK, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx167; ELLIOTT AM, 1993, TUBERCLE LUNG DIS, V74, P191, DOI 10.1016/0962-8479(93)90010-U; Flores LL, 2011, CLIN VACCINE IMMUNOL, V18, P1616, DOI 10.1128/CVI.05205-11; Gupta-Wright A, 2018, LANCET, V392, P292, DOI [10.1016/S0140-6736(18)31267-4, 10.1016/s0140-6736(18)31267-4]; Johnson JL, 1998, INT J TUBERC LUNG D, V2, P397; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Medeiros MF, 2014, APPL IMMUNOHISTO M M, V22, P222, DOI 10.1097/PAI.0b013e31828dc70c; Minion J, 2011, EUR RESPIR J, V38, P1398, DOI 10.1183/09031936.00025711; Ministerio da Saude, REC DIAGN TUB MEIO T, P1405, DOI [10.1183/09031936.00025711, DOI 10.1183/09031936.00025711]; Ministerio da Saude (BR), 2008, MAN NAC VIG LAB TUB; Ministerio da Saude Secretaria de Vigilancia^ em Saude Programa Nacional de Controle da Tuberculose, 2013, MAN REC TUB, P288; Murray JF, 2005, INT J TUBERC LUNG D, V9, P826; N'Dhatz M., 1994, Revue de Pneumologie Clinique, V50, P317; Nahas AA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01205; Peter JG, 2012, EUR RESPIR J, V40, P1211, DOI 10.1183/09031936.00201711; Peter JG, 2016, LANCET, V387, P1187, DOI 10.1016/S0140-6736(15)01092-2; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807	21	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0221038	10.1371/journal.pone.0221038	http://dx.doi.org/10.1371/journal.pone.0221038			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550246	gold, Green Published			2022-12-26	WOS:000532307700005
J	Knerich, V; Jones, AA; Seyedin, S; Siu, C; Dinh, L; Mostafavi, S; Barr, AM; Panenka, WJ; Thornton, AE; Honer, WG; Rutherford, AR				Knerich, Verena; Jones, Andrea A.; Seyedin, Sam; Siu, Christopher; Dinh, Louie; Mostafavi, Sara; Barr, Alasdair M.; Panenka, William J.; Thornton, Allen E.; Honer, William G.; Rutherford, Alexander R.			Social and structural factors associated with substance use within the support network of adults living in precarious housing in a socially marginalized neighborhood of Vancouver, Canada	PLOS ONE			English	Article							DRUG-USE; HOMELESS; SEX; YOUTH; RISK; METHAMPHETAMINE; INTERVENTIONS; PREVENTION; MORTALITY; DISORDER	Background The structure of a social network as well as peer behaviours are thought to affect personal substance use. Where substance use may create health risks, understanding the contribution of social networks to substance use may be valuable for the design and implementation of harm reduction or other interventions. We examined the social support network of people living in precarious housing in a socially marginalized neighborhood of Vancouver, and analysed associations between social network structure, personal substance use, and supporters' substance use. Methods An ongoing, longitudinal study recruited 246 participants from four single room occupancy hotels, with 201 providing social network information aligned with a 6-month observation period. Use of tobacco, alcohol, cannabis, cocaine (crack and powder), methamphetamine, and heroin was recorded at monthly visits. Ego- and graph-level measures were calculated; the dispersion and prevalence of substances in the network was described. Logistic mixed effects models were used to estimate the association between ego substance use and peer substance use. Permutation analysis was done to test for randomness of substance use dispersion on the social network. Results The network topology corresponded to residence (Hotel) with two clusters differing in demographic characteristics (Cluster 1 -Hotel A: 94% of members, Cluster 2 -Hotel B: 95% of members). Dispersion of substance use across the network demonstrated differences according to network topology and specific substance. Methamphetamine use (overall 12%) was almost entirely limited to Cluster 1, and absent from Cluster 2. Different patterns were observed for other substances. Overall, ego substance use did not differ over the six-month period of observation. Ego heroin, cannabis, or crack cocaine use was associated with alter use of the same substances. Ego methamphetamine, powder cocaine, or alcohol use was not associated with alter use, with the exception for methamphetamine in a densely using part of the network. For alters using multiple substances, cannabis use was associated with lower ego heroin use, and lower ego crack cocaine use. Permutation analysis also provided evidence that dispersion of substance use, and the association between ego and alter use was not random for all substances. Conclusions In a socially marginalized neighborhood, social network topology was strongly influenced by residence, and in turn was associated with type(s) of substance use. Associations between personal use and supporter's use of a substance differed across substances. These complex associations may merit consideration in the design of interventions to reduce risk and harms associated with substance use in people living in precarious housing.	[Knerich, Verena] Ludwig Maximilians Univ Munchen, Dept Comp Sci, Munich, Germany; [Knerich, Verena] Ludwig Maximilians Univ Munchen, Dept Cultural Anthropol, Munich, Germany; [Knerich, Verena; Jones, Andrea A.; Seyedin, Sam; Siu, Christopher; Panenka, William J.; Honer, William G.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Dinh, Louie] Univ British Columbia, Dept Comp Sci, Vancouver, BC, Canada; [Mostafavi, Sara] Univ British Columbia, Dept Stat, Vancouver, BC, Canada; [Mostafavi, Sara] Univ British Columbia, Dept Off, Med Genet, Vancouver, BC, Canada; [Barr, Alasdair M.] Univ British Columbia, Dept Anesthesia Pharmacol & Therapeut, Vancouver, BC, Canada; [Thornton, Allen E.] Simon Fraser Univ, Dept Psychol, Burnaby, BC, Canada; [Rutherford, Alexander R.] Simon Fraser Univ, Dept Math, Burnaby, BC, Canada	University of Munich; University of Munich; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; Simon Fraser University; Simon Fraser University	Rutherford, AR (corresponding author), Simon Fraser Univ, Dept Math, Burnaby, BC, Canada.	arruther@sfu.ca		Dinh, Louie/0000-0003-0457-0142; Panenka, William/0000-0001-7143-6512; Barr, Alasdair/0000-0002-3407-1574	Simon Fraser University Big Data Initiative; Canadian Institutes of Health Research grants [CBG-101827, MOP-137103]; British Columbia Mental Health and Addictions Services; Jack Bell Chair in Schizophrenia at the University of British Columbia	Simon Fraser University Big Data Initiative; Canadian Institutes of Health Research grants(Canadian Institutes of Health Research (CIHR)); British Columbia Mental Health and Addictions Services; Jack Bell Chair in Schizophrenia at the University of British Columbia	VK and ARR were supported in part by the Simon Fraser University Big Data Initiative during this research. The study was funded by Canadian Institutes of Health Research grants CBG-101827 and MOP-137103 (http://www.cihrirsc.gc.ca/).Additional support was provided by British Columbia Mental Health and Addictions Services. WGH was supported by the Jack Bell Chair in Schizophrenia at the University of British Columbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge RW, 2018, LANCET, V391, P241, DOI 10.1016/S0140-6736(17)31869-X; Barman-Adhikari A, 2015, J SOC SOC WORK RES, V6, P433, DOI 10.1086/682709; BARRERA M, 1981, AM J COMMUN PSYCHOL, V9, P435, DOI 10.1007/BF00918174; Barrera M., 1980, CONNECTIONS, V3, P8; Bates D.M., LME4 MIXED EFFECTS M; Bennett DA, 2005, NEUROEPIDEMIOLOGY, V25, P163, DOI 10.1159/000087446; Bennett DA, 2006, LANCET NEUROL, V5, P406, DOI 10.1016/S1474-4422(06)70417-3; Bertholet N, 2013, ADDICT SCI CLIN PRAC, V8, DOI 10.1186/1940-0640-8-15; Christakis NA, 2004, BRIT MED J, V329, P184, DOI 10.1136/bmj.329.7459.184; Christakis NA, 2013, STAT MED, V32, P556, DOI 10.1002/sim.5408; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Deans Gregory D, 2013, CMAJ Open, V1, pE68, DOI 10.9778/cmajo.20130002; Dombrowski Kirk, 2013, World J AIDS, V3, P1; Duncan GJ, 2005, J ABNORM CHILD PSYCH, V33, P375, DOI 10.1007/s10802-005-3576-2; El-Bassel N, 1998, SOC SERV REV, V72, P379, DOI 10.1086/515764; El-Bassel N, 2006, J URBAN HEALTH, V83, P602, DOI 10.1007/s11524-006-9075-0; Ferrence R, 2001, ADDICTION, V96, P165, DOI 10.1046/j.1360-0443.2001.96116512.x; Friedman SR, 1997, SEX TRANSM DIS, V24, P322, DOI 10.1097/00007435-199707000-00003; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Gaetz S, 2012, CANADIAN DEFINITION; GOEHL L, 1993, AM J DRUG ALCOHOL AB, V19, P251, DOI 10.3109/00952999309001617; Gruenewald PJ, 2013, AM J PUBLIC HEALTH, V103, P1262, DOI 10.2105/AJPH.2012.300779; Hastie T., 1986, STAT SCI, V1, P297; HONER WG, 1987, LANCET, V2, P451; Honer WG, 2017, CAN J PSYCHIAT, V62, P482, DOI 10.1177/0706743717693781; Hurd YL, 2017, TRENDS NEUROSCI, V40, P124, DOI 10.1016/j.tins.2016.12.006; Jones AA, 2018, JAMA PSYCHIAT, V75, P298, DOI 10.1001/jamapsychiatry.2017.4432; Jones AA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008876; Jones AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079754; Kelly JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100121; Krausz M, 2015, LANCET PSYCHIAT, V2, pE5, DOI 10.1016/S2215-0366(15)00045-0; Lakon CM, 2006, SOC SCI MED, V63, P2489, DOI 10.1016/j.socscimed.2006.06.015; Latkin CA, 2017, J URBAN HEALTH, V94, P534, DOI 10.1007/s11524-017-0170-1; Latkin CA, 2015, BEHAV MED, V41, P90, DOI 10.1080/08964289.2015.1034645; Latkin CA, 2013, AM PSYCHOL, V68, P210, DOI 10.1037/a0032704; Luchenski S, 2018, LANCET, V391, P266, DOI 10.1016/S0140-6736(17)31959-1; Marshall BDL, 2011, LANCET, V377, P1429, DOI 10.1016/S0140-6736(10)62353-7; Mason Michael, 2004, Subst Use Misuse, V39, P1751, DOI 10.1081/LSUM-200033222; McDonald LJ, 2011, AM J ADDICTION, V20, P100, DOI 10.1111/j.1521-0391.2010.00117.x; Melander LA, 2016, J CHILD ADOLES SUBST, V25, P78, DOI 10.1080/1067828X.2014.918003; Miller WC, 2018, LANCET, V392, P747, DOI 10.1016/S0140-6736(18)31487-9; Min MO, 2013, J SUBST ABUSE TREAT, V45, P325, DOI 10.1016/j.jsat.2013.04.006; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Rice E, 2013, ADDICTION, V108, P1625, DOI 10.1111/add.12255; Rice E, 2012, AM J PUBLIC HEALTH, V102, P141, DOI 10.2105/AJPH.2011.300295; Rice E, 2011, PREV SCI, V12, P80, DOI 10.1007/s11121-010-0191-4; Rothenberg R B, 1995, NIDA Res Monogr, V151, P3; Schroeder JR, 2001, ANN EPIDEMIOL, V11, P389, DOI 10.1016/S1047-2797(01)00225-3; Stone A, 2016, ALCOHOL TREAT Q, V34, P315, DOI 10.1080/07347324.2016.1182818; Tobin KE, 2014, INT J DRUG POLICY, V25, P591, DOI 10.1016/j.drugpo.2013.12.006; Tracy EM, 2016, J SUBST ABUSE TREAT, V62, P55, DOI 10.1016/j.jsat.2015.11.002; Valente T., 2003, CONNECTIONS CONNECT, V25, P11; Valente Thomas W, 2004, Subst Use Misuse, V39, P1685, DOI 10.1081/JA-200033210; Valente TW, 2017, ANNU REV PUBL HEALTH, V38, P103, DOI 10.1146/annurev-publhealth-031816-044528; Valente TW, 2012, SCIENCE, V337, P49, DOI 10.1126/science.1217330; Vila-Rodriguez F, 2013, AM J PSYCHIAT, V170, P1213, DOI 10.1176/appi.ajp.2013.13020215; Wu L., 2019, MIXED EFFECTS MODELS, P113	59	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222611	10.1371/journal.pone.0222611	http://dx.doi.org/10.1371/journal.pone.0222611			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5QI	31545818	Green Submitted, Green Published, gold			2022-12-26	WOS:000532303200023
J	Kraus, EC; Stout, MJ				Kraus, Emily C.; Stout, Michael J.			Seed treatment using methyl jasmonate induces resistance to rice water weevil but reduces plant growth in rice	PLOS ONE			English	Article							FITNESS COSTS; DEFENSE; COLEOPTERA; TOMATO; TOLERANCE; HERBIVORE; STRESS; ACID	The jasmonic acid cascade plays a pivotal role in induced plant resistance to herbivores. There have been a number of investigations into the potential uses of derivatives of this hormone for pest management. Understanding the phenotypic plasticity of plant defense traits interactions in agricultural systems may facilitate the development of novel and improved management practices, which is desirable as management of insects in most agricultural systems is currently heavily reliant on insecticides. The rice water weevil (RWW), Lissorhoptrus oryzophilus Kuschel, is a pest of rice, Oryza sativa, in the southern U.S. and globally. The effects of the jasmonic acid derivative, methyl jasmonate (MJ), on induced defenses to RWW in rice, and the potential costs of MJ-induced resistance to plant growth and fitness, were tested in a series of field and greenhouse trials. It was hypothesized that seed treatments with MJ would reduce densities of larval RWW. A second hypothesis was that MJ seed treatments would alter emergence, biomass accumulation, and yield of rice. The final hypothesis was that induction of plant resistance to the RWW would diminish as the time from seed treatment increased. In order to investigate these hypotheses, RWW densities were determined in greenhouse and field trials. Plant growth was measured in the field by assessing plant emergence, root and shoot biomass, time of heading, and yield (grain mass). Results indicated that MJ seed treatments induced resistance to RWW, although this effect decayed over time. Additionally, there were costs to plant growth and fitness; emergence and heading were delayed and biomass was reduced. Importantly, however, yields on a per-plant were not significantly reduced by MJ treatment. Overall, these results are promising and show the potential for the use of jasmonate elicitors as part of a pest management program in rice.	[Kraus, Emily C.; Stout, Michael J.] Louisiana State Univ, AgCtr, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kraus, EC (corresponding author), Louisiana State Univ, AgCtr, Baton Rouge, LA 70803 USA.	krausec07@gmail.com			Louisiana Rice Research Board; USDA National Institute of Food and Agriculture, Hatch project [0218143]; Louisiana Agricultural Consultants Association in 2017; Ray and Dorothy Young Endowed Assistantship in Agricultural Pest Management in 2018	Louisiana Rice Research Board; USDA National Institute of Food and Agriculture, Hatch project; Louisiana Agricultural Consultants Association in 2017; Ray and Dorothy Young Endowed Assistantship in Agricultural Pest Management in 2018	MJS was supported by a grant from the Louisiana Rice Research Board and by the USDA National Institute of Food and Agriculture, Hatch project accession number 0218143. ECK was supported by a scholarship from the Louisiana Agricultural Consultants Association in 2017 and the Ray and Dorothy Young Endowed Assistantship in Agricultural Pest Management in 2018. Funders had no role in the design, data collection, analysis, decision to publish, or preparation of the manuscript.	Baldwin IT, 1998, P NATL ACAD SCI USA, V95, P8113, DOI 10.1073/pnas.95.14.8113; Campos ML, 2014, J CHEM ECOL, V40, P657, DOI 10.1007/s10886-014-0468-3; Cipollini DF, 1997, OECOLOGIA, V111, P84, DOI 10.1007/s004420050211; Dar TA, 2015, ENVIRON EXP BOT, V115, P49, DOI 10.1016/j.envexpbot.2015.02.010; Erb M, 2012, TRENDS PLANT SCI, V17, P250, DOI 10.1016/j.tplants.2012.01.003; Gomez S, 2010, PLANT BIOLOGY, V12, P512, DOI 10.1111/j.1438-8677.2009.00234.x; Gordy JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136689; Guo Q, 2018, CURR OPIN PLANT BIOL, V44, P72, DOI 10.1016/j.pbi.2018.02.009; Haas J, 2018, ENTOMOL EXP APPL, V166, P412, DOI 10.1111/eea.12678; Hamm JC, 2010, J CHEM ECOL, V36, P192, DOI 10.1007/s10886-010-9751-0; Heil M, 2002, TRENDS PLANT SCI, V7, P61, DOI 10.1016/S1360-1385(01)02186-0; Hemmi A, 2004, MAR ECOL PROG SER, V273, P109, DOI 10.3354/meps273109; Lortzing T, 2016, CURR OPIN INSECT SCI, V14, P32, DOI 10.1016/j.cois.2016.01.002; Mitchell C, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01132; NGUESSAN FK, 1994, ENVIRON ENTOMOL, V23, P665, DOI 10.1093/ee/23.3.665; Pankaj, 2013, NEMATOLOGY, V15, P15, DOI 10.1163/156854112X641754; Paudel S, 2014, ARTHROPOD-PLANT INTE, V8, P539, DOI 10.1007/s11829-014-9335-y; Redman AM, 2001, OECOLOGIA, V126, P380, DOI 10.1007/s004420000522; Shang HW, 2004, J ENTOMOL SCI, V39, P623, DOI 10.18474/0749-8004-39.4.623; Stout MJ, 2002, J ECON ENTOMOL, V95, P715, DOI 10.1603/0022-0493-95.4.715; Thaler JS, 1999, NATURE, V399, P686, DOI 10.1038/21420; Thaler JS, 1996, J CHEM ECOL, V22, P1767, DOI 10.1007/BF02028503; Thaler JS, 2001, ECOL ENTOMOL, V26, P312, DOI 10.1046/j.1365-2311.2001.00324.x; Tiffin P, 2000, EVOL ECOL, V14, P523, DOI 10.1023/A:1010881317261; Underwood NC, 1998, OECOLOGIA, V114, P376, DOI 10.1007/s004420050460; Verma V, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0771-y	26	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222800	10.1371/journal.pone.0222800	http://dx.doi.org/10.1371/journal.pone.0222800			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545832	Green Published, Green Submitted, gold			2022-12-26	WOS:000532303200036
J	Sadowski, A; Wojcieszak, MM				Sadowski, Arkadiusz; Wojcieszak, Monika Malgorzata			Geographic differentiation of agritourism activities in Poland vs. cultural and natural attractiveness of destinations at district level	PLOS ONE			English	Article							RURAL TOURISM; SUSTAINABILITY	One of the trends in today's tourism sector is the development of environmentally-friendly tourism activities which rely on natural resources of cultural heritage and on biodiversity. This is definitely the case for agritourism, a form of rural tourism. The purpose of this paper is to identify the development aspects of Polish agritourism with particular emphasis on natural and cultural attractiveness. To demonstrate the relationship between agritourism activities of Polish farms and the cultural and natural attractiveness, the Hellwig's synthetic development indicator was used. As shown by research, the cultural and natural attractiveness of a destination is an important exogenous development factor. Another finding was that the intensified efforts undertaken by the farmers to access EU funds were not focused on areas with valuable natural or cultural resources and an untapped agritourism potential; instead, they were oriented at regions dominated by semi-subsistence or family farms. For a large part of farmers, the new form of support is about to become a source of additional incomes.	[Sadowski, Arkadiusz; Wojcieszak, Monika Malgorzata] Poznan Univ Life Sci, Fac Econ & Social Sci, Dept Econ & Econ Policy Agribusiness, Poznan, Poland	Poznan University of Life Sciences	Sadowski, A (corresponding author), Poznan Univ Life Sci, Fac Econ & Social Sci, Dept Econ & Econ Policy Agribusiness, Poznan, Poland.	sadowski@up.poznan.pl		Wojcieszak-Zbierska, Monika/0000-0002-9962-2648; Sadowski, Arkadiusz/0000-0002-8236-1007				Ackovska M, 2016, BALKAN NEAR E J SOCI, V2, P121; Aganowski M., 2012, ZESZYTY NAUKOWE UNIW, V705, P7; [Anonymous], 2017, REP AG RESTR MOD AGR; [Anonymous], 2016, POL AGR FOOD EC; Arroyo CG, 2013, TOURISM MANAGE, V37, P39, DOI 10.1016/j.tourman.2012.12.007; Aswani S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195440; Badulescu D, 2015, AGR ECON-CZECH, V61, P72, DOI 10.17221/94/2014-AGRICECON; Baer-Nawrocka A, 2018, BERICHTE CABER LANDW, V96, P1, DOI DOI 10.1016/S2212-5671(15)00265-8; Bajgier-Kowalska M., 2016, PRZEDSIBIORCZO EDUKA, V12, P256; Balinska A., 2016, STOWARZYSZENIE EKONO, V21, P21; Barbieri C, 2008, SOCIOL RURALIS, V48, P166, DOI 10.1111/j.1467-9523.2008.00450.x; Barbieri C, 2013, J SUSTAIN TOUR, V21, P252, DOI 10.1080/09669582.2012.685174; Barbu I., 2016, ANALELE U CONSTANTIN, V6, P253; Bedrac M, 2010, EKON POLJOPR, V57, P243; bniewska M., 1997, AGROTURYSTYKA KOSZTY; Boguslavsky M. V., 2014, PROBLEMI SOVREMENNOG, V1, P5; Brandth B, 2011, J RURAL STUD, V27, P35, DOI 10.1016/j.jrurstud.2010.09.002; Brelik A., 2011, OECONOMIA, V10, P19; Central Statsistical Office, 2011, RUR AR POL; Cha F, 2004, J ANKANG NORMAL COLL, V16, P29; Chase LC, 2017, SAGE INT ENCY TRAVEL; Chase LC, 2018, J AGRIC FOOD SYST CO, V8, P13, DOI 10.5304/jafscd.2018.081.016; Chirit<comma>escu V., 2011, AGR EC RURAL DEV, P241; Chrysolite BP, RESPONSIBLE TOURISM, P1; Ciani A, 2017, NEW DIRECT TOUR ANAL, V41, P68; Ciepiela GA, 2010, OECONOMIA, V9, P45; Cigale D., 2012, AGRITOURISM EMBEDDED, P27; Ciszewska A., 2009, TRWALOSC EFEKTYWNOSC; CONG F, 2003, J DALI U, V4, P10; Di Domenico M, DEV TOURISM RES, P21; Dubois C., 2012, AGRITOURISM EMBEDDED, P33; Ehrlich K, 2017, NEW DIRECT TOUR ANAL, V41, P84; Fagioli F. F., 2014, Rivista di Economia Agraria, V69, P155; Ferens E., 2013, ZESZYTY NAUKOWE SGGW, V102, P113; Flanigan S, 2015, J RURAL STUD, V41, P129, DOI 10.1016/j.jrurstud.2015.08.002; Fleischer A, 2005, TOURISM MANAGE, V26, P493, DOI 10.1016/j.tourman.2003.10.003; Gartner W. C., 2004, International Journal of Tourism Research, V6, P151, DOI 10.1002/jtr.481; Gevrenova T., 2015, TRAKIA J SCI, V13, P321, DOI 10.15547/tjs.2015.s.02.068; Hjalager AM, 2010, TOURISM MANAGE, V31, P1, DOI 10.1016/j.tourman.2009.08.012; Iakovidou O., 1997, Medit, V8, P44; Idris K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150741; Jafari J, 2000, ENCY TOURISM; Jalinik M., 2007, TURYSTYKA ROZWOJU OB, P343; Jalinik M., 2009, UWARUNKOWANIA CZYNIK; Jurincic I., 2012, AGRITOURISM EMBEDDED, P44; Kapusta F., 2008, AGROBIZNES; Kizos T, 2007, S EUR SOC POLIT, V12, P59, DOI 10.1080/13608740601155443; Kruczek Z., 2014, REGIONY TURYSTYCZNE; Krzyzanowska K, 2013, BUDOWANIE KONKURENCY; Kurczewski R., 2016, TURYSTYKA WIEJSKA ZA, P9; Kurek W., 2012, TURYSTYKA; Kurtyka-Marcak I, 2017, J AGRIBUSSINESS RURA, V2, P383, DOI [10.17306/J.JARD.2017.00257, DOI 10.17306/J.JARD.2017.00257]; Lijewski T, 2017, GEOGRAFIA TURYSTYKI; Lubke S., 2012, AGRITOURISM EMBEDDED, P60; Lukasiewicz K., 2017, ROCZNIKI NAUKOWE STO, V29, P147; Ma B, 1996, THEORY PRACTICE REGI; Marques H., 2006, Tourism Economics, V12, P147; Marsat J. - B., 2012, AGRITOURISM EMBEDDED, P68; Mikrut K, 2017, NEW DIRECT TOUR ANAL, V41, P156; Mlynarczyk K, 2002, AGROTURYSTYKA; Moller H, 2004, ECOL SOC, V9; Naminse EY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194912; Ollenburg C., 2006, FARM TOURISM AUSTR F; Oppermann M, 1996, ANN TOURISM RES, V23, P86, DOI 10.1016/0160-7383(95)00021-6; Pakurar M, 2008, ECOTOXICOLOGIE ZOOTE, V7, P777; Palka E., 2010, KIERUNKI ROZWOJU POZ, P1; Panasiuk A., 2017, INTERCATHEDRA, V33, P83; Perpar A., 2012, AGRITOURISM EMBEDDED, P84; Pfund JL, 2011, ENVIRON MANAGE, V48, P334, DOI 10.1007/s00267-011-9689-1; Phelan C, 2011, TOUR PLAN DEV, V8, P121, DOI 10.1080/21568316.2011.573912; Phillip S, 2010, TOURISM MANAGE, V31, P754, DOI 10.1016/j.tourman.2009.08.001; Potocnik Slavic I., 2012, AGRITOURISM EMBEDDED, P88; Potocnik-Slavic I, 2013, EUR COUNTRYS, V5, P265, DOI 10.2478/euco-2013-0017; Przezborska L, 2006, AGROTURYSTYKA; Przezborska-Skobiej L., 2015, UWARUNKOWANIA ROZWOJ; Przezborska-Skobiej L, 2016, WIES ROLNICTWO, V2, P173, DOI DOI 10.7366/WIR022016/08; Przezborska-Skobiej L., 2016, TURYSTYKA WIEJSKA ZA; Roberts L., 2001, RURAL TOURISM RECREA; Roman M, 2015, POL J MANAG STUD, V11, P136; Romano A, 2016, PSICOLOG SOC, V11, P3, DOI 10.1482/82878; Rosner A., 2014, MONITORING ROZWOJU O; Sadowski A, 2013, POCZTA GOSPODARSTWA; Schilling BJ, 2014, J AGR RESOUR ECON, V39, P69; Sieczko A., 2015, ASS AGR AGRIBUSINESS, V18, P315; Sikora J, 2012, EC PROBLEMS TURISTS, V1, P219; Sikora J., 2012, AGROTURYSTYKA PRZEDS; Sikora J, 2017, NEW DIRECT TOUR ANAL, V41, P288; Soare I., 2011, Revista de Turism, P66; Sonnino R, 2004, SOCIOL RURALIS, V44, P285, DOI 10.1111/j.1467-9523.2004.00276.x; Streifeneder T, 2016, TOUR MANAG PERSPECT, V20, P251, DOI 10.1016/j.tmp.2016.10.003; Sznajder M., 2009, AGRITOURISM; Sznajder M., 2017, METROPOLITAN COMMUTE; Szwichtenberg A., 1998, TURYZM, V8, P248; Valdivia C, 2014, TOUR MANAG PERSPECT, V11, P18, DOI 10.1016/j.tmp.2014.02.004; Vodopivec Rozman J., 2012, AGRITOURISM EMBEDDED, P30; Vogt L, 2013, EC AGROALIMENTARE, V15, P77; Weaver DB, 1997, TOURISM MANAGE, V18, P357, DOI 10.1016/S0261-5177(97)00039-3; Wiatrak AP, 1996, ZAGADNIENIA EKONOMIK, V1, P35; Wojciechowska J., 2009, PROCESY UWARUNKOWANI; Wojcieszak M, 2018, INTERCATHEDRA, V34, P4; Wojcieszak M., 2016, TURYSTYKA WIEJSKA ZA, P42; Wojcieszak M., 2017, UWARUNKOWANIA ROZWOJ; Woods M, 2011, KEY IDEAS GEOGR, P1; Wysocki F., 2005, STATYSTYKA OPISOWA; Yang ZS, 2010, HABITAT INT, V34, P374, DOI 10.1016/j.habitatint.2009.11.002; Zawadka J., 2016, SCI YB, P396; Zoto S, 2013, EUROPEAN ACAD RES, V1, P20	107	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222576	10.1371/journal.pone.0222576	http://dx.doi.org/10.1371/journal.pone.0222576			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5OJ	31539382	Green Published, gold, Green Submitted			2022-12-26	WOS:000532297900017
J	Altemus, MA; Goo, LE; Little, AC; Yates, JA; Cheriyan, HG; Wu, ZF; Merajver, SD				Altemus, Megan A.; Goo, Laura E.; Little, Andrew C.; Yates, Joel A.; Cheriyan, Hannah G.; Wu, Zhi Fen; Merajver, Sofia D.			Breast cancers utilize hypoxic glycogen stores via PYGB, the brain isoform of glycogen phosphorylase, to promote metastatic phenotypes	PLOS ONE			English	Article							INDUCIBLE FACTOR; METABOLIC SWITCH; CELL-MIGRATION; TUMOR HYPOXIA; EXPRESSION; HIF-1-ALPHA; FACTOR-1-ALPHA; ADAPTATION; PREDICTS; KINASE-3	In breast cancer, tumor hypoxia has been linked to poor prognosis and increased metastasis. Hypoxia activates transcriptional programs in cancer cells that lead to increased motility and invasion, as well as various metabolic changes. One of these metabolic changes, an increase in glycogen metabolism, has been further associated with protection from reactive oxygen species damage that may lead to premature senescence. Here we report that breast cancer cells significantly increase glycogen stores in response to hypoxia. We found that knockdown of the brain isoform of an enzyme that catalyzes glycogen breakdown, glycogen phosphorylase B (PYGB), but not the liver isoform, PYGL, inhibited glycogen utilization in estrogen receptor negative and positive breast cancer cells; whereas both independently inhibited glycogen utilization in the normal-like breast epithelial cell line MCF-10A. Functionally, PYGB knockdown and the resulting inhibition of glycogen utilization resulted in significantly decreased wound-healing capability in MCF-7 cells and a decrease in invasive potential of MDA-MB-231 cells. Thus, we identify PYGB as a novel metabolic target with potential applications in the management and/or prevention of metastasis in breast cancer.	[Altemus, Megan A.; Cheriyan, Hannah G.] Univ Michigan, Grad Program Canc Biol, Ann Arbor, MI 48109 USA; [Altemus, Megan A.; Goo, Laura E.; Little, Andrew C.; Yates, Joel A.; Cheriyan, Hannah G.; Wu, Zhi Fen; Merajver, Sofia D.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Altemus, Megan A.; Goo, Laura E.; Little, Andrew C.; Yates, Joel A.; Cheriyan, Hannah G.; Wu, Zhi Fen; Merajver, Sofia D.] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Merajver, SD (corresponding author), Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA.; Merajver, SD (corresponding author), Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA.	smeravje@med.umich.edu		Merajver, Sofia/0000-0002-6823-7130; Little, Andrew/0000-0003-0135-1032; Abraham, Hannah/0000-0001-8871-3440; Yates, Joel/0000-0002-1462-8494	Rogel Cancer Center; Rogel Cancer Center Nancy Newton Loeb Fund; NIH [T32CA009676]; RCC core grant [P30 CA046592]; Breast Cancer Research Foundation; Metavivor Foundation; NATIONAL CANCER INSTITUTE [T32CA009676, P30CA046592] Funding Source: NIH RePORTER	Rogel Cancer Center; Rogel Cancer Center Nancy Newton Loeb Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RCC core grant; Breast Cancer Research Foundation; Metavivor Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	MAA was partially supported by the Rogel Cancer Center, the Rogel Cancer Center Nancy Newton Loeb Fund, an NIH T-32 Training Fellowship (T32CA009676), and the RCC core grant (P30 CA046592). This work was also supported by the Breast Cancer Research Foundation, https://www.bcrf.org (to SDM), and the Metavivor Foundation, https://www.metavivor.org (to SDM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg J.M., 2015, BIOCHEMISTRY-US, DOI [10.1007/978-3-8274-2989-6., DOI 10.1007/978-3-8274-2989-6]; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Chan DA, 2007, CANCER METAST REV, V26, P333, DOI 10.1007/s10555-007-9063-1; Chen J, 2010, BRIT J CANCER, V102, P351, DOI 10.1038/sj.bjc.6605486; Copple BL, 2010, LIVER INT, V30, P669, DOI 10.1111/j.1478-3231.2010.02205.x; Dales JP, 2005, INT J CANCER, V116, P734, DOI 10.1002/ijc.20984; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; EBERT BL, 1995, J BIOL CHEM, V270, P29083, DOI 10.1074/jbc.270.49.29083; Favaro E, 2012, CELL METAB, V16, P751, DOI 10.1016/j.cmet.2012.10.017; Generali D, 2006, CLIN CANCER RES, V12, P4562, DOI 10.1158/1078-0432.CCR-05-2690; Giatromanolaki A, 2004, CLIN CANCER RES, V10, P7972, DOI 10.1158/1078-0432.CCR-04-1068; Hiraga T, 2007, CANCER RES, V67, P4157, DOI 10.1158/0008-5472.CAN-06-2355; Ignatoski KMW, 1999, BREAST CANCER RES TR, V54, P173, DOI 10.1023/A:1006135331912; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kronblad A, 2006, INT J CANCER, V118, P2609, DOI 10.1002/ijc.21676; Lei JJ, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-66; Lu CW, 2008, J BIOL CHEM, V283, P28106, DOI 10.1074/jbc.M803508200; Luo DC, 2011, MOL CANCER RES, V9, P234, DOI 10.1158/1541-7786.MCR-10-0214; Mak P, 2010, CANCER CELL, V17, P319, DOI 10.1016/j.ccr.2010.02.030; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Pelletier J, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00018; Pescador N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009644; Rao GS, 2000, INT J RADIAT ONCOL, V48, P1519, DOI 10.1016/S0360-3016(00)01358-4; Rousset M, 1981, CANC RES; Saez I, 2014, J CEREBR BLOOD F MET, V34, P945, DOI 10.1038/jcbfm.2014.33; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Schindl M, 2002, CLIN CANC RES; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Semenza GL, 2010, CURR OPIN GENET DEV, V20, P51, DOI 10.1016/j.gde.2009.10.009; Shen GM, 2010, FEBS LETT, V584, P4366, DOI 10.1016/j.febslet.2010.09.040; Spivak-Kroizman TR, 2013, CANCER RES, V73, P3235, DOI 10.1158/0008-5472.CAN-11-1433; Tracey WR, 2004, AM J PHYSIOL-HEART C, V286, pH1177, DOI 10.1152/ajpheart.00652.2003; Vaupel P, 2004, METHOD ENZYMOL, V381, P335; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Vigoda A, 2003, MOL CELL BIOCHEM, V254, P311, DOI 10.1023/A:1027302021428; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Zhang H, 2012, ONCOGENE, V31, P1757, DOI 10.1038/onc.2011.365; Zhang WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116634; Zois CE, 2014, BIOCHEM PHARMACOL, V92, P3, DOI 10.1016/j.bcp.2014.09.001	46	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0220973	10.1371/journal.pone.0220973	http://dx.doi.org/10.1371/journal.pone.0220973			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536495	Green Published, gold, Green Submitted			2022-12-26	WOS:000532262800014
J	Bandyopadhyay, A; Bose, I; Chattopadhyay, K				Bandyopadhyay, Arnab; Bose, Indrani; Chattopadhyay, Krishnananda			Osmolytes ameliorate the effects of stress in the absence of the heat shock protein Hsp104 in Saccharomyces cerevisiae	PLOS ONE			English	Article							YEAST PSI+ PRION; GUANIDINE-HYDROCHLORIDE; MOLECULAR CHAPERONES; INTRACELLULAR TREHALOSE; DESICCATION TOLERANCE; ORGANIC OSMOLYTES; IN-VIVO; DISEASE; AGGREGATION; ACCUMULATION	Aggregation of the prion protein has strong implications in the human prion disease. Sup35p is a yeast prion, and has been used as a model protein to study the disease mechanism. We have studied the pattern of Sup35p aggregation inside live yeast cells under stress, by using confocal microscopy, fluorescence activated cell sorting and western blotting. Heat shock proteins are a family of proteins that are produced by yeast cells in response to exposure to stressful conditions. Many of the proteins behave as chaperones to combat stress-induced protein misfolding and aggregation. In spite of this, yeast also produce small molecules called osmolytes during stress. In our work, we tried to find the reason as to why yeast produce osmolytes and showed that the osmolytes are paramount to ameliorate the long-term effects of lethal stress in Saccharomyces cerevisiae, either in the presence or absence of Hsp104p.	[Bandyopadhyay, Arnab; Chattopadhyay, Krishnananda] CSIR Indian Inst Chem Biol, Struct Biol & Bioinformat Div, Kolkata, India; [Bose, Indrani] Western Carolina Univ, Dept Biol, Cullowhee, NC 28723 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); University of North Carolina; Western Carolina University	Chattopadhyay, K (corresponding author), CSIR Indian Inst Chem Biol, Struct Biol & Bioinformat Div, Kolkata, India.; Bose, I (corresponding author), Western Carolina Univ, Dept Biol, Cullowhee, NC 28723 USA.	ibose@email.wcu.edu; krish@iicb.res.in		Chattopadhyay, Krishnananda/0000-0002-1449-8909	CSIR (MIND) - UGC	CSIR (MIND) - UGC	This work received funding from CSIR (MIND) to KC and also is funded by a fellowship from UGC to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson J., 2004, GUIDE YEAST GENETICS; Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Alexandre H, 1998, MICROBIOL-SGM, V144, P1103, DOI 10.1099/00221287-144-4-1103; Bandara A, 2009, FEMS YEAST RES, V9, P1208, DOI 10.1111/j.1567-1364.2009.00569.x; Botstein D, 1997, SCIENCE, V277, P1259, DOI 10.1126/science.277.5330.1259; Burg MB, 2008, J BIOL CHEM, V283, P7309, DOI 10.1074/jbc.R700042200; Byrne LJ, 2007, P NATL ACAD SCI USA, V104, P11688, DOI 10.1073/pnas.0701392104; Chang BS, 1996, J PHARM SCI, V85, P1325, DOI 10.1021/js960080y; Chebotareva NA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1239, DOI 10.1007/s10541-005-0070-y; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Collins S, 2001, J CLIN NEUROSCI, V8, P387, DOI 10.1054/jocn.2001.0919; Conlin LK, 2007, MOL CELL BIOL, V27, P1505, DOI 10.1128/MCB.01158-06; Das A, 2019, INT J BIOL MACROMOL, V127, P365, DOI 10.1016/j.ijbiomac.2019.01.062; Das A, 2017, INT J BIOL MACROMOL, V105, P645, DOI 10.1016/j.ijbiomac.2017.07.074; Desplats P, 2005, PLANT PHYSIOL BIOCH, V43, P133, DOI 10.1016/j.plaphy.2005.01.008; Dickenmann M, 2008, AM J KIDNEY DIS, V51, P491, DOI 10.1053/j.ajkd.2007.10.044; Eaglestone SS, 2000, P NATL ACAD SCI USA, V97, P240, DOI 10.1073/pnas.97.1.240; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Ferreira PC, 2001, MOL MICROBIOL, V40, P1357, DOI 10.1046/j.1365-2958.2001.02478.x; FOSTER JD, 1993, VET REC, V133, P339, DOI 10.1136/vr.133.14.339; Gibney PA, 2015, P NATL ACAD SCI USA, V112, P6116, DOI 10.1073/pnas.1506289112; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Greene LE, 2009, PROTEIN PEPTIDE LETT, V16, P635, DOI 10.2174/092986609788490221; Gregoire S, 2012, KOREAN J CHEM ENG, V29, P693, DOI 10.1007/s11814-012-0060-x; Halfmann R, 2011, MOL CELL, V43, P72, DOI 10.1016/j.molcel.2011.05.013; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; Hidalgo IH, 2016, BIOTECHNIQUES, V61, P137, DOI 10.2144/000114452; HIGHTOWER LE, 1991, CELL, V66, P191, DOI 10.1016/0092-8674(91)90611-2; Hill AF, 1999, LANCET, V353, P183, DOI 10.1016/S0140-6736(98)12075-5; HSIAO K, 1992, NAT GENET, V1, P68, DOI 10.1038/ng0492-68; Hsich G, 1996, NEW ENGL J MED, V335, P924, DOI 10.1056/NEJM199609263351303; Jain NK, 2009, PROTEIN SCI, V18, P24, DOI 10.1002/pro.3; Jung GM, 2001, CURR MICROBIOL, V43, P7, DOI 10.1007/s002840010251; Kaushik JK, 2003, J BIOL CHEM, V278, P26458, DOI 10.1074/jbc.M300815200; Kayingo G, 2001, ARCH MICROBIOL, V177, P29, DOI 10.1007/s00203-001-0358-2; Khan SH, 2010, IUBMB LIFE, V62, P891, DOI 10.1002/iub.406; Kim SH, 2006, BIOCHEM CELL BIOL, V84, P30, DOI 10.1139/O05-148; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Ma JQ, 2014, P NATL ACAD SCI USA, V111, P8476, DOI 10.1073/pnas.1403224111; Mactier R A, 1989, ASAIO Trans, V35, P122, DOI 10.1097/00002480-198904000-00002; MARTIN J, 1992, SCIENCE, V258, P995, DOI 10.1126/science.1359644; Moseley PL, 1997, J APPL PHYSIOL, V83, P1413, DOI 10.1152/jappl.1997.83.5.1413; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; Papp E, 2006, HANDB EXP PHARM, V172, P405; Pasantes-Morales H, 1998, ADV EXP MED BIOL, V442, P209; Ratnakumar S, 2006, FEMS YEAST RES, V6, P902, DOI 10.1111/j.1567-1364.2006.00066.x; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sabate R, 2012, BIOMACROMOLECULES, V13, P474, DOI 10.1021/bm201527m; Sethi R, 2018, FEMS YEAST RES, V18, DOI 10.1093/femsyr/foy058; Shaked GA, 2003, BRAIN RES, V983, P137, DOI 10.1016/S0006-8993(03)03045-2; Shaw CE, 1998, ANN NEUROL, V43, P390, DOI 10.1002/ana.410430319; Singer MA, 1998, TRENDS BIOTECHNOL, V16, P460, DOI 10.1016/S0167-7799(98)01251-7; Singer MA, 1998, MOL CELL, V1, P639, DOI 10.1016/S1097-2765(00)80064-7; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Street TO, 2006, P NATL ACAD SCI USA, V103, P13997, DOI 10.1073/pnas.0606236103; Takalo Mari, 2013, Am J Neurodegener Dis, V2, P1; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Tapia H, 2015, P NATL ACAD SCI USA, V112, P6122, DOI 10.1073/pnas.1506415112; TARCZYNSKI MC, 1993, SCIENCE, V259, P508, DOI 10.1126/science.259.5094.508; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Wang AJ, 1997, BIOCHEMISTRY-US, V36, P9101, DOI 10.1021/bi970247h; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Yeh E, 2000, MOL BIOL CELL, V11, P3949, DOI 10.1091/mbc.11.11.3949	68	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222723	10.1371/journal.pone.0222723	http://dx.doi.org/10.1371/journal.pone.0222723			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536559	Green Published, gold, Green Submitted			2022-12-26	WOS:000532262800076
J	Christensen, S; Halili, MA; Strange, N; Petit, GA; Huston, WM; Martin, JL; McMahon, RM				Christensen, Signe; Halili, Maria A.; Strange, Natalie; Petit, Guillaume A.; Huston, Wilhelmina M.; Martin, Jennifer L.; McMahon, Roisin M.			Oxidoreductase disulfide bond proteins DsbA and DsbB form an active redox pair in Chlamydia trachomatis, a bacterium with disulfide dependent infection and development	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; FUNCTIONAL-CHARACTERIZATION; CRYSTAL-STRUCTURE; CYCLE; BIOGENESIS; SECRETION; ENZYME; IDENTIFICATION; ENTEROTOXIN; COMPONENTS	Chlamydia trachomatis is an obligate intracellular bacterium with a distinctive biphasic developmental cycle that alternates between two distinct cell types; the extracellular infectious elementary body (EB) and the intracellular replicating reticulate body (RB). Members of the genus Chlamydia are dependent on the formation and degradation of protein disulfide bonds. Moreover, disulfide cross-linking of EB envelope proteins is critical for the infection phase of the developmental cycle. We have identified in C. trachomatis a homologue of the Disulfide Bond forming membrane protein Escherichia coli (E. coli) DsbB (hereafter named CtDsbB) and-using recombinant purified proteins-demonstrated that it is the redox partner of the previously characterised periplasmic oxidase C. trachomatis Disulfide Bond protein A (CtDsbA). CtDsbA protein was detected in C. trachomatis inclusion vacuoles at 20 h post infection, with more detected at 32 and similar levels at 44 h post infection as the developmental cycle proceeds. As a redox pair, CtDsbA and CtDsbB largely resemble their homologous counterparts in E. coli; CtDsbA is directly oxidised by CtDsbB, in a reaction in which both periplasmic cysteine pairs of CtDsbB are required for complete activity. In our hands, this reaction is slow relative to that observed for E. coli equivalents, although this may reflect a non-native expression system and use of a surrogate quinone cofactor. CtDsbA has a second non-catalytic disulfide bond, which has a small stabilising effect on the protein's thermal stability, but which does not appear to influence the interaction of CtDsbA with its partner protein CtDsbB. Expression of CtDsbA during the RB replicative phase and during RB to EB differentiation coincided with the oxidation of the chlamydial outer membrane complex (COMC). Together with our demonstration of an active redox pairing, our findings suggest a potential role for CtDsbA and CtDsbB in the critical disulfide bond formation step in the highly regulated development cycle.	[Christensen, Signe] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Christensen, Signe; Halili, Maria A.; Petit, Guillaume A.; Martin, Jennifer L.; McMahon, Roisin M.] Griffith Univ, Griffith Inst Drug Discovery, Nathan, Qld, Australia; [Strange, Natalie; Huston, Wilhelmina M.] Univ Technol Sydney, Sch Life Sci, Broadway, NSW, Australia; [Christensen, Signe] Lund Univ, Dept Biochem & Struct Biol, Lund, Sweden; [Martin, Jennifer L.] Univ Wollongong, Vice Chancellors Unit, Wollongong, NSW, Australia	University of Queensland; Griffith University; University of Technology Sydney; Lund University; University of Wollongong	McMahon, RM (corresponding author), Griffith Univ, Griffith Inst Drug Discovery, Nathan, Qld, Australia.; Huston, WM (corresponding author), Univ Technol Sydney, Sch Life Sci, Broadway, NSW, Australia.	Wilhelmina.Huston@uts.edu.au; roisin.mcmahon@griffith.edu.au	Christensen, Signe/GQP-7049-2022; Huston, Wilhelmina/S-7269-2019; Halili, Maria A/J-8362-2014; Christensen, Signe/C-7989-2017; McMahon, Roisin/A-9823-2014; Martin, Jennifer L./A-6039-2010; Huston, Wilhelmina/B-9984-2008	Halili, Maria A/0000-0003-4407-5269; Christensen, Signe/0000-0001-9556-1545; Strange, Natalie/0000-0002-9356-8070; McMahon, Roisin/0000-0001-5437-0355; Martin, Jennifer L./0000-0002-9225-8863; Petit, Guillaume Axel/0000-0002-8251-0754; Huston, Wilhelmina/0000-0002-0879-1287	Ramaciotti Health Investment Grant [2017HIG0094]; NHMRC [1099151, 1144046]; Griffith University Postgraduate Research Scholarship; Griffith University International Postgraduate Research Scholarship; UQI Tuition Fee Award; University Technology Sydney Faculty of Science Staff Development Fund; UTS Doctoral Scholarship	Ramaciotti Health Investment Grant; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Griffith University Postgraduate Research Scholarship(Griffith University); Griffith University International Postgraduate Research Scholarship; UQI Tuition Fee Award; University Technology Sydney Faculty of Science Staff Development Fund; UTS Doctoral Scholarship	RMM, MH and GP are supported by a Ramaciotti (www.perpetual.com.au/ramaciotti) Health Investment Grant (2017HIG0094) awarded to RMM. RMM and SC were also supported by a NHMRC (www.nhmrc.gov.au) Project Grant (1099151) awarded to JLM. GP is further supported by a Griffith University Postgraduate Research Scholarship and a Griffith University International Postgraduate Research Scholarship (www.griffith.edu.au/research-study/scholarships).SC was further supported by a UQI Tuition Fee Award (www.scholarships.uq.edu.au/).WMH is supported by University Technology Sydney (www.uts.edu.au) Faculty of Science Staff Development Funding and NS is supported by a UTS Doctoral Scholarship. This work is also supported by a NHMRC Project Grant (1144046) awarded to JLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 1996, INFECT IMMUN, V64, P4378, DOI 10.1128/IAI.64.10.4378-4380.1996; Arts IS, 2013, MBIO, V4, DOI 10.1128/mBio.00912-13; Bader M, 1999, CELL, V98, P217, DOI 10.1016/S0092-8674(00)81016-8; Bader MW, 2000, J BIOL CHEM, V275, P26082, DOI 10.1074/jbc.M003850200; BARDWELL JCA, 1991, CELL, V67, P581, DOI 10.1016/0092-8674(91)90532-4; BAVOIL P, 1984, INFECT IMMUN, V44, P479, DOI 10.1128/IAI.44.2.479-485.1984; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Betts-Hampikian HJ, 2011, J BACTERIOL, V193, P6950, DOI 10.1128/JB.05163-11; Braun P, 2001, J BIOL CHEM, V276, P26030, DOI 10.1074/jbc.M007122200; Chim N, 2013, BMC STRUCT BIOL, V13, DOI 10.1186/1472-6807-13-23; Chivers PT, 1997, BIOCHEMISTRY-US, V36, P4061, DOI 10.1021/bi9628580; Christensen S, 2019, CRIT REV MICROBIOL, V45, P33, DOI 10.1080/1040841X.2018.1538933; Christensen S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168485; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FOREMAN DT, 1995, MOL MICROBIOL, V18, P237, DOI 10.1111/j.1365-2958.1995.mmi_18020237.x; HACKSTADT T, 1985, J BACTERIOL, V161, P25, DOI 10.1128/JB.161.1.25-31.1985; HATCH TP, 1986, J BACTERIOL, V165, P379, DOI 10.1128/jb.165.2.379-385.1986; HATCH TP, 1984, J BACTERIOL, V157, P13, DOI 10.1128/JB.157.1.13-20.1984; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Hiniker A, 2004, J BIOL CHEM, V279, P12967, DOI 10.1074/jbc.M311391200; Huston WM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-190; Inaba K, 2002, EMBO J, V21, P2646, DOI 10.1093/emboj/21.11.2646; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Ireland PM, 2014, ANTIOXID REDOX SIGN, V20, P606, DOI 10.1089/ars.2013.5375; Ito K, 2008, CURR OPIN STRUC BIOL, V18, P450, DOI 10.1016/j.sbi.2008.02.002; JACOBDUBUISSON F, 1994, P NATL ACAD SCI USA, V91, P11552, DOI 10.1073/pnas.91.24.11552; JANDER G, 1994, EMBO J, V13, P5121, DOI 10.1002/j.1460-2075.1994.tb06841.x; Kobayashi T, 1997, P NATL ACAD SCI USA, V94, P11857, DOI 10.1073/pnas.94.22.11857; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kurz M, 2009, ANTIOXID REDOX SIGN, V11, P1485, DOI [10.1089/ars.2008.2420, 10.1089/ARS.2008.2420]; Landeta C, 2018, NAT MICROBIOL, V3, P270, DOI 10.1038/s41564-017-0106-2; de Abreu ICME, 2014, ARQ BRAS ENDOCRINOL, V58, P251, DOI 10.1590/0004-2730000002831; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; McMahon RM, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00938-17, 10.1128/iai.00938-17]; McMahon RM, 2014, BBA-PROTEINS PROTEOM, V1844, P1391, DOI 10.1016/j.bbapap.2014.01.013; Miki T, 2008, MICROB PATHOGENESIS, V44, P151, DOI 10.1016/j.micpath.2007.09.001; Mukhopadhyay S, 2006, MOL CELL PROTEOMICS, V5, P2311, DOI 10.1074/mcp.M600214-MCP200; NEWHALL WJ, 1987, INFECT IMMUN, V55, P162, DOI 10.1128/IAI.55.1.162-168.1987; Nicholson TL, 2003, J BACTERIOL, V185, P3179, DOI 10.1128/JB.185.10.3179-3189.2003; Premkumar L, 2013, ACTA CRYSTALLOGR D, V69, P1981, DOI 10.1107/S0907444913017800; Raulston JE, 2002, INFECT IMMUN, V70, P535, DOI 10.1128/IAI.70.2.535-543.2002; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Saka HA, 2011, MOL MICROBIOL, V82, P1185, DOI 10.1111/j.1365-2958.2011.07877.x; SARDINIA LM, 1988, J GEN MICROBIOL, V134, P997; Shouldice SR, 2011, ANTIOXID REDOX SIGN, V14, P1729, DOI 10.1089/ars.2010.3344; Stamm M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057731; STIRLING P, 1983, FEMS MICROBIOL LETT, V19, P133; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Takahashi YH, 2004, J BIOL CHEM, V279, P47057, DOI 10.1074/jbc.M407153200; Totsika M, 2009, J BACTERIOL, V191, P3901, DOI 10.1128/JB.00143-09; Urban A, 2001, J BACTERIOL, V183, P587, DOI 10.1128/JB.183.2.587-596.2001; Vogel H, 2011, METHODS MOL BIOL, V772, P105, DOI 10.1007/978-1-61779-228-1_6; Walden PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081440; YU J, 1992, MOL MICROBIOL, V6, P1949, DOI 10.1111/j.1365-2958.1992.tb01368.x; Zhang HZ, 1996, MOL MICROBIOL, V21, P787, DOI 10.1046/j.1365-2958.1996.431403.x; Zheng K, 2014, MBIO, V5, DOI [10.1128/mBio.00942-13, 10.1128/mBio.00958-13]; Zhou YP, 2008, MOL CELL, V31, P896, DOI 10.1016/j.molcel.2008.08.028	57	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222595	10.1371/journal.pone.0222595	http://dx.doi.org/10.1371/journal.pone.0222595			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536549	Green Published, Green Submitted, gold			2022-12-26	WOS:000532262800059
J	Feuchtner, J; Mathewos, A; Solomon, A; Timotewos, G; Aynalem, A; Wondemagegnehu, T; Gebremedhin, A; Adugna, F; Griesel, M; Wienke, A; Addissie, A; Jemal, A; Kantelhardt, EJ				Feuchtner, Jana; Mathewos, Assefa; Solomon, Asmare; Timotewos, Genebo; Aynalem, Abreha; Wondemagegnehu, Tigeneh; Gebremedhin, Amha; Adugna, Fekadu; Griesel, Mirko; Wienke, Andreas; Addissie, Adamu; Jemal, Ahmedin; Kantelhardt, Eva Johanna			Addis Ababa population-based pattern of cancer therapy, Ethiopia	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; BREAST-CANCER; CERVICAL-CANCER; BARRIERS; RADIOTHERAPY; DIAGNOSIS; SURVIVAL; SURGERY; WOMEN; CARE	Cancer in Sub-Saharan Africa is becoming an important challenge for health services due to rising numbers of patients. In Addis Ababa with around 3.5 million inhabitants, more than 2000 cases are diagnosed annually. In this retrospective population-based cohort study we assessed completeness of and waiting time for cancer-therapy among patients registered in the Addis Ababa City Cancer Registry (AACCR), Ethiopia. Patient hospital files were retrieved to complete the data from AACCR. A total of 588 files were found (51% of those diagnosed from January to March 2012 and 2014). We analyzed completeness and waiting time of chemotherapy and radiotherapy; with completeness defined as >= 85% therapy received according to local guidelines. Analysis was done for the five most common cancer-types commonly treated with chemotherapy (breast, colorectal, non-Hodgkin's lymphoma, lung and ovarian) and the four most common cancer-types commonly treated with radiotherapy (breast, cervical, head and neck and rectal). In our study, half of the patients (54.1%) received adequately dosed chemotherapy and 24.5% of patients received adequately dosed radiotherapy. The median waiting time was 2.1 months (Range: 0 to 20.72) for chemotherapy and 7 months (Range: 0.17 to 21.8) for radiotherapy. This study underscores the need for health system measures to improve cancer-directed therapy in Ethiopia, especially concerning radiotherapy.	[Feuchtner, Jana; Griesel, Mirko; Wienke, Andreas; Kantelhardt, Eva Johanna] Martin Luther Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, Halle, Germany; [Mathewos, Assefa; Solomon, Asmare; Timotewos, Genebo; Aynalem, Abreha; Wondemagegnehu, Tigeneh; Adugna, Fekadu] Addis Ababa Univ, Radiotherapy Ctr, Addis Ababa, Ethiopia; [Gebremedhin, Amha] Addis Ababa Univ, Dept Internal Med, Div Hematol, Addis Ababa, Ethiopia; [Addissie, Adamu] Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia; [Jemal, Ahmedin] Amer Canc Soc, Surveillance & Hlth Serv Res, Atlanta, GA 30329 USA; [Kantelhardt, Eva Johanna] Martin Luther Univ Halle Wittenberg, Med Fac, Dept Gynaecol, Halle, Germany	Martin Luther University Halle Wittenberg; Addis Ababa University; Addis Ababa University; Addis Ababa University; American Cancer Society; Martin Luther University Halle Wittenberg	Kantelhardt, EJ (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Med Epidemiol Biostat & Informat, Halle, Germany.; Kantelhardt, EJ (corresponding author), Martin Luther Univ Halle Wittenberg, Med Fac, Dept Gynaecol, Halle, Germany.	eva.kantelhardt@uk-halle.de	Wienke, Andreas/AAN-3707-2020	Griesel, Mirko/0000-0002-1633-3788; Endalew, Solomon Asmare/0000-0002-4102-0257	German Ministry of Education and Research [01DG12006]; German Ministry for Economic and Development Cooperation (BMZ) through the ESTHER University and Hospital Partnership Initiative of German International Cooperation (GIZ); Surveillance and Health Service Research Program; American Cancer Society; World Health Organization country office; Bayer Foundation	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Ministry for Economic and Development Cooperation (BMZ) through the ESTHER University and Hospital Partnership Initiative of German International Cooperation (GIZ); Surveillance and Health Service Research Program; American Cancer Society(American Cancer Society); World Health Organization country office(World Health Organization); Bayer Foundation(Bayer AG)	The research leading to these results has received funding from the German Ministry of Education and Research under grant agreement n degrees 01DG12006; the German Ministry for Economic and Development Cooperation (BMZ) through the ESTHER University and Hospital Partnership Initiative of German International Cooperation (GIZ); the Surveillance and Health Service Research Program, American Cancer Society and the World Health Organization country office. FJ received a doctoral fellowship by the Bayer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Wahab M, 2013, LANCET ONCOL, V14, pE168, DOI 10.1016/S1470-2045(12)70532-6; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Arndt V, 2003, J CLIN ONCOL, V21, P1440, DOI 10.1200/JCO.2003.08.071; Barton MB, 2006, LANCET ONCOL, V7, P584, DOI 10.1016/S1470-2045(06)70759-8; Bhatia RK, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.18.00088; Birhan W, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-39; Birhanu Z, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-83; BONADONNA G, 1995, NEW ENGL J MED, V332, P901, DOI 10.1056/NEJM199504063321401; Cazap E, 2016, J CLIN ONCOL, V34, P14, DOI 10.1200/JCO.2015.61.9189; Dedey F, 2016, HEALTH EDUC BEHAV, V43, P420, DOI 10.1177/1090198115620417; Delaney G, 2005, CANCER-AM CANCER SOC, V104, P1129, DOI 10.1002/cncr.21324; Denny L, 2017, LANCET, V389, P861, DOI 10.1016/S0140-6736(16)31795-0; Dye TD, 2010, CANCER-AM CANCER SOC, V116, P577, DOI 10.1002/cncr.24776; Eber-Schulz P, 2018, BREAST CANCER RES TR, V170, P111, DOI 10.1007/s10549-018-4724-z; Frie KG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207928; Frie KG, 2018, BREAST CARE, V13, P39, DOI 10.1159/000481087; Gyorki DE, 2012, ARCH SURG-CHICAGO, V147, P1135, DOI 10.1001/archsurg.2012.1265; Harding R, 2011, EUR J CANCER, V47, P51, DOI 10.1016/j.ejca.2010.08.003; Harford JB, 2015, LANCET ONCOL, V16, pE385, DOI 10.1016/S1470-2045(15)00160-6; Jedy-Agba E, 2016, LANCET GLOB HEALTH, V4, pE923, DOI 10.1016/s2214-109x(16)30259-5; Kantelhardt EJ, 2014, INT J CANCER, V135, P702, DOI 10.1002/ijc.28691; Kantelhardt EJ, 2014, ONCOLOGIST, V19, P727, DOI 10.1634/theoncologist.2013-0326; Kingham TP, 2013, LANCET ONCOL, V14, pE158, DOI 10.1016/S1470-2045(12)70472-2; Mostert S, 2011, LANCET ONCOL, V12, P719, DOI 10.1016/S1470-2045(11)70128-0; Otieno E S, 2010, East Afr Med J, V87, P147; Rosenblatt E, 2018, RADIOTHER ONCOL, V128, P400, DOI 10.1016/j.radonc.2018.05.014; Shiferaw S, 2018, CANCER MED-US, V7, P903, DOI 10.1002/cam4.1334; Sullivan R, 2015, LANCET ONCOL, V16, P1193, DOI 10.1016/S1470-2045(15)00223-5; Timotewos G, 2018, CANCER EPIDEMIOL, V53, P93, DOI 10.1016/j.canep.2018.01.008; Woldeamanuel YW, 2013, LANCET ONCOL, V14, P289, DOI 10.1016/S1470-2045(12)70399-6; World Health Organization, WHO WHOS CANC PAIN L	31	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0219519	10.1371/journal.pone.0219519	http://dx.doi.org/10.1371/journal.pone.0219519			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536505	gold, Green Submitted, Green Published			2022-12-26	WOS:000532262800010
J	Flaherty, RA; Borges, EC; Sutton, JA; Aronoff, DM; Gaddy, JA; Petroff, MG; Manning, SD				Flaherty, Rebecca A.; Borges, Elena C.; Sutton, Jessica A.; Aronoff, David M.; Gaddy, Jennifer A.; Petroff, Margaret G.; Manning, Shannon D.			Genetically distinct Group B Streptococcus strains induce varying macrophage cytokine responses	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; COLONIZING STRAINS; GENE-EXPRESSION; CORD; INFECTION; DIVERSITY; DISEASE; SEPSIS	Group B Streptococcus (GBS) is an opportunistic pathogen that causes preterm birth and neonatal disease. Although GBS is known to exhibit vast diversity in virulence across strains, the mechanisms of GBS-associated pathogenesis are incompletely understood. We hypothesized that GBS strains of different genotypes would vary in their ability to elicit host inflammatory responses, and that strains associated with neonatal disease would induce different cytokine profiles than those associated with colonization. Using a multi-plexed, antibody-based protein detection array, we found that production of a discrete number of inflammatory mediators by THP-1 macrophage-like cells was universally induced in response to challenge with each of five genetically distinct GBS isolates, while other responses appeared to be strain-specific. Key array responses were validated by ELISA using the initial five strains as well as ten additional strains with distinct genotypic and phenotypic characteristics. Interestingly, IL-6 was significantly elevated following infection with neonatal infection-associated sequence type (ST)-17 strains and among strains possessing capsule (cps) type III. Significant differences in production of IL1-beta, IL-10 and MCP-2 were also identified across STs and cps types. These data support our hypothesis and suggest that unique host innate immune responses reflect strain -specific differences in virulence across GBS isolates. Such data might inform the development of improved diagnostic or prognostic strategies against invasive GBS infections.	[Flaherty, Rebecca A.; Borges, Elena C.; Petroff, Margaret G.; Manning, Shannon D.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Sutton, Jessica A.] Meharry Med Coll, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37208 USA; [Sutton, Jessica A.; Aronoff, David M.; Gaddy, Jennifer A.] Vanderbilt Univ, Med Ctr, Dept Med, Div Infect Dis, Nashville, TN USA; [Petroff, Margaret G.] Michigan State Univ, Pathobiol & Diagnost Invest, E Lansing, MI 48824 USA	Michigan State University; Meharry Medical College; Vanderbilt University; Michigan State University	Manning, SD (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	mannin71@msu.edu	Flaherty, Rebecca/CAJ-5715-2022; Manning, Shannon/GXA-0622-2022	Manning, Shannon/0000-0001-9581-0660; Aronoff, David/0000-0003-4587-6121	National Institutes of Health [AI134036, HD090061, HD091429]; Michigan State University; National Institutes of Health NIAID Training Grant [5T32HL007737-20]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD090061] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007737] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan State University; National Institutes of Health NIAID Training Grant; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by three grants from the National Institutes of Health (www.nih.gov): AI134036 (DMA, SDM, JAG), HD090061 (JAG, DMA, SDM), and HD091429; and funds from Michigan State University (SDM; www.msu.edu).JAS was supported by National Institutes of Health NIAID Training Grant 5T32HL007737-20. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders AP, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12623; Berner R, 2002, PEDIATR RES, V51, P304, DOI 10.1203/00006450-200203000-00007; Berner R, 2001, PEDIATR RES, V49, P691, DOI 10.1203/00006450-200105000-00014; Biondo C, 2014, INFECT IMMUN, V82, P4508, DOI 10.1128/IAI.02104-14; Chaudhry H, 2013, IN VIVO, V27, P669; D'Elia RV, 2013, CLIN VACCINE IMMUNOL, V20, P319, DOI 10.1128/CVI.00636-12; Doran KS, 2004, MOL MICROBIOL, V54, P23, DOI 10.1111/j.1365-2958.2004.04266.x; Flaherty RA, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00211; Horvath B, 2014, J PERINAT MED, V42, P441, DOI 10.1515/jpm-2013-0186; Jones N, 2003, J CLIN MICROBIOL, V41, P2530, DOI 10.1128/JCM.41.6.2530-2536.2003; Korir ML, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02786; Korir ML, 2017, VIRULENCE, V8, P924, DOI 10.1080/21505594.2016.1252016; Korir ML, 2017, CLIN MICROBIOL REV, V30, P973, DOI 10.1128/CMR.00019-17; Korir ML, 2014, INFECT IMMUN, V82, P4587, DOI 10.1128/IAI.02181-14; Lin FYC, 2006, J CLIN MICROBIOL, V44, P1257, DOI 10.1128/JCM.44.4.1257-1261.2006; Luan SL, 2005, J CLIN MICROBIOL, V43, P3727, DOI 10.1128/JCM.43.8.3727-3733.2005; Manning SD, 2008, CLIN INFECT DIS, V46, P1829, DOI 10.1086/588296; Manning SD, 2009, J CLIN MICROBIOL, V47, P1143, DOI 10.1128/JCM.01424-08; Phares CR, 2008, JAMA-J AM MED ASSOC, V299, P2056, DOI 10.1001/jama.299.17.2056; Rogers LM, 2018, PATHOG IMMUN; Rosati E, 1998, SCAND J IMMUNOL, V47, P314; Singh P, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00015-16; Springman AC, 2009, J BACTERIOL, V191, P5419, DOI 10.1128/JB.00369-09; Sugitharini V, 2013, INFLAMM RES, V62, P1025, DOI 10.1007/s00011-013-0661-9; Vallejo JG, 2000, J IMMUNOL, V165, P419, DOI 10.4049/jimmunol.165.1.419; Vanderhoeven JP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003920; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Wennekamp J, 2008, IMMUNOL REV, V225, P114, DOI 10.1111/j.1600-065X.2008.00673.x	28	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222910	10.1371/journal.pone.0222910	http://dx.doi.org/10.1371/journal.pone.0222910			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536604	Green Published, gold, Green Submitted			2022-12-26	WOS:000532262800102
J	Gooch, A; Zhang, P; Hu, ZM; Son, NL; Avila, N; Fischer, J; Roberts, G; Sellon, R; Westenfelder, C				Gooch, Anna; Zhang, Ping; Hu, Zhuma; Son, Natasha Loy; Avila, Nicole; Fischer, Julie; Roberts, Gregory; Sellon, Rance; Westenfelder, Christof			Interim report on the effective intraperitoneal therapy of insulin-dependent diabetes mellitus in pet dogs using "Neo-Islets," aggregates of adipose stem and pancreatic islet cells (INAD 012-776)	PLOS ONE			English	Article							SUSCEPTIBILITY GENES; STROMAL CELLS; CANINE; TRANSPLANTATION; SURVIVAL; HUMANS; KIDNEY; MICE; AUTOANTIBODIES; ANGIOGENESIS	We previously reported that allogeneic, intraperitoneally administered "Neo-Islets," composed of cultured pancreatic islet cells co-aggregated with high numbers of immunoprotective and cytoprotective Adipose-derived Stem Cells, reestablished, through omental engraftment, redifferentiation and splenic and omental up-regulation of regulatory T-cells, normoglycemia in autoimmune Type-1 Diabetic Non-Obese Diabetic (NOD) mice without the use of immunosuppressive agents or encapsulation devices. Based on these observations, we are currently testing this Neo-Islet technology in an FDA guided pilot study (INAD 012776) in insulin-dependent, spontaneously diabetic pet dogs by ultrasound-guided, intraperitoneal administration of 2x10e5 Neo-Islets/kilogram body weight to metabolically controlled (blood glucose, triglycerides, thyroid and adrenal functions) and sedated animals. We report here interim observations on the first 4 canine Neo-Islet-treated, insulin-dependent pet dogs that are now in the early to intermediate-term follow-up phase of the planned 3 year study (> 6 months post treatment). Current results from this translational study indicate that in dogs, Neo-Islets appear to engraft, redifferentiate and physiologically produce insulin, and are rejected by neither auto- nor allo-immune responses, as evidenced by (a) an absent IgG response to the allogeneic cells contained in the administered Neo-Islets, and (b) progressively improved glycemic control that achieves up to a 50% reduction in daily insulin needs paralleled by a statistically significant decrease in serum glucose concentrations. This is accomplished without the use of anti-rejection drugs or encapsulation devices. No adverse or serious adverse events related to the Neo-Islet administration have been observed to date. We conclude that this minimally invasive therapy has significant translational relevance to veterinary and clinical Type 1 diabetes mellitus by achieving complete and at this point partial glycemic control in two species, i.e., diabetic mice and dogs, respectively.	[Gooch, Anna; Zhang, Ping; Hu, Zhuma; Westenfelder, Christof] SymbioCellTech LLC, Salt Lake City, UT 84108 USA; [Son, Natasha Loy; Avila, Nicole; Fischer, Julie] Vet Specialty Hosp, San Diego, CA USA; [Roberts, Gregory; Sellon, Rance] Washington State Univ, Dept Vet Clin Sci, Pullman, WA 99164 USA; [Westenfelder, Christof] Univ Utah, Dept Med, Div Nephrol, Salt Lake City, UT 84112 USA	Washington State University; Utah System of Higher Education; University of Utah	Westenfelder, C (corresponding author), SymbioCellTech LLC, Salt Lake City, UT 84108 USA.; Westenfelder, C (corresponding author), Univ Utah, Dept Med, Div Nephrol, Salt Lake City, UT 84112 USA.	chistof.westenfelder@hsc.utah.edu		Westenfelder, MD, Christof/0000-0002-2349-9874				Abalovich AG, 2009, TRANSPL P, V41, P328, DOI 10.1016/j.transproceed.2008.08.159; Adin CA, 2017, YALE J BIOL MED, V90, P509; Ahlgren KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105473; ALEJANDRO R, 1988, TRANSPLANTATION, V45, P1036, DOI 10.1097/00007890-198806000-00008; Butte A J, 2001, Pac Symp Biocomput, P6; Catchpole B, 2013, VET J, V195, P139, DOI 10.1016/j.tvjl.2012.11.013; Chen T, 2015, AM J TRANSPLANT, V15, P618, DOI 10.1111/ajt.13049; Davison LJ, 2008, VET IMMUNOL IMMUNOP, V126, P83, DOI 10.1016/j.vetimm.2008.06.016; Davison LJ, 2011, RES VET SCI, V91, P58, DOI 10.1016/j.rvsc.2010.08.007; de Groot M, 2004, J SURG RES, V121, P141, DOI 10.1016/j.jss.2004.02.018; Dolgin E, 2014, NAT MED, V20, P9, DOI 10.1038/nm0114-9; Fall T, 2008, J VET INTERN MED, V22, P1296, DOI 10.1111/j.1939-1676.2008.0199.x; Fall T, 2010, J VET INTERN MED, V24, P1322, DOI 10.1111/j.1939-1676.2010.0630.x; Fall T, 2007, J VET INTERN MED, V21, P1209, DOI 10.1892/07-021.1; Gebler A, 2012, TRENDS MOL MED, V18, P128, DOI 10.1016/j.molmed.2011.10.004; Gilor C, 2016, J VET INTERN MED, V30, P927, DOI 10.1111/jvim.14357; Gregory JM, 2019, DIABETES, V68, P1565, DOI 10.2337/db19-0324; Gregory JM, 2015, DIABETES, V64, P3439, DOI 10.2337/db15-0071; Guptill L, 2003, VET J, V165, P240, DOI 10.1016/S1090-0233(02)00242-3; Holder AL, 2015, VET IMMUNOL IMMUNOP, V167, P130, DOI 10.1016/j.vetimm.2015.07.014; Inverardi L, 2013, MESENCHYMAL STROMAL, P571, DOI [10.1007/978-1-4614-5711-4_33, DOI 10.1007/978-1-4614-5711-4_33]; Lablanche S, 2018, LANCET DIABETES ENDO, V6, P527, DOI 10.1016/S2213-8587(18)30078-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCandless EE, 2006, J IMMUNOL, V177, P8053, DOI 10.4049/jimmunol.177.11.8053; Morgan MJ, 2008, CAN VET J, V49, P583; O'Kell AL, 2017, DIABETES, V66, P1443, DOI 10.2337/db16-1551; Pancotto Theresa E, 2017, J Clin Mov Disord, V4, P5, DOI 10.1186/s40734-017-0053-3; PORKSEN N, 2002, AM J PHYSIOL-ENDOC M, V282, pE69, DOI DOI 10.1152/AJPENDO.00516.2000; Sakata N, 2010, WORLD J GASTROENTERO, V16, P1215, DOI 10.3748/wjg.v16.i10.1215; Shields EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129809; Short AD, 2007, J HERED, V98, P518, DOI 10.1093/jhered/esm048; Togel F, 2009, J CELL MOL MED, V13, P2109, DOI 10.1111/j.1582-4934.2008.00641.x; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; Tonne JM, 2013, DIS MODEL MECH, V6, P1236, DOI 10.1242/dmm.012591; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Vrabelova D, 2014, DOMEST ANIM ENDOCRIN, V47, P119, DOI 10.1016/j.domaniend.2013.01.006; Vrabelova D, 2014, VET SURG, V43, P631, DOI 10.1111/j.1532-950X.2014.12224.x; WARNOCK GL, 1994, TRANSPLANTATION, V57, P17, DOI 10.1097/00007890-199401000-00004; Westenfelder C, 2017, STEM CELL TRANSL MED, V6, P1631, DOI 10.1002/sctm.17-0005; Woolcott OO, 2012, PANCREAS, V41, P31, DOI 10.1097/MPA.0b013e318221fd0e; Yan XQ, 2012, J CELL BIOCHEM, V113, P1437, DOI 10.1002/jcb.24015	43	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0218688	10.1371/journal.pone.0218688	http://dx.doi.org/10.1371/journal.pone.0218688			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536503	gold, Green Published, Green Submitted			2022-12-26	WOS:000532262800009
J	Miller, DR; Lebowitz, JJ; Guenther, DT; Refowich, AJ; Hansen, C; Maurer, AP; Khoshbouei, H				Miller, Douglas R.; Lebowitz, Joseph J.; Guenther, Dylan T.; Refowich, Alexander J.; Hansen, Carissa; Maurer, Andrew P.; Khoshbouei, Habibeh			Methamphetamine regulation of activity and topology of ventral midbrain networks	PLOS ONE			English	Article							INDUCED ENHANCEMENT; DOPAMINE RELEASE; CONNECTIVITY; NEURONS; AMPHETAMINE; SYSTEM	The ventral midbrain supports a variety of functions through the heterogeneity of neurons. Dopaminergic and GABA neurons within this region are particularly susceptible targets of amphetamine-class psychostimulants such as methamphetamine. While this has been evidenced through single-neuron methods, it remains unclear whether and to what extent the local neuronal network is affected and if so, by which mechanisms. Both GABAergic and dopaminergic neurons were heavily featured within the primary ventral midbrain network model system. Using spontaneous calcium activity, our data suggest methamphetamine decreased total network output via a D-2 receptor-dependent manner. Over culture duration, functional connectivity between neurons decreased significantly but was unaffected by methamphetamine. However, across culture duration, exposure to methamphetamine significantly altered changes in network assortativity. Here we have established primary ventral midbrain networks culture as a viable model system that reveals specific changes in network activity, connectivity, and topology modulation by methamphetamine. This network culture system enables control over the type and number of neurons that comprise a network and facilitates detection of emergent properties that arise from the specific organization. Thus, the multidimensional properties of methamphetamine can be unraveled, leading to a better understanding of its impact on the local network structure and function.	[Miller, Douglas R.; Lebowitz, Joseph J.; Guenther, Dylan T.; Refowich, Alexander J.; Hansen, Carissa; Maurer, Andrew P.; Khoshbouei, Habibeh] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Maurer, Andrew P.] Univ Florida, McKnight Brain Inst, Gainesville, FL 32610 USA; [Maurer, Andrew P.] Univ Florida, Dept Biomed Engn, Gainesville, FL 32610 USA; [Maurer, Andrew P.] Univ Florida, Dept Civil & Coastal Engn, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Maurer, AP; Khoshbouei, H (corresponding author), Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA.; Maurer, AP (corresponding author), Univ Florida, McKnight Brain Inst, Gainesville, FL 32610 USA.; Maurer, AP (corresponding author), Univ Florida, Dept Biomed Engn, Gainesville, FL 32610 USA.; Maurer, AP (corresponding author), Univ Florida, Dept Civil & Coastal Engn, Gainesville, FL 32610 USA.	drewmaurer@ufl.edu; habibeth@ufl.edu		Guenther, Dylan/0000-0001-5100-0076; Hansen, Carissa/0000-0002-1652-2669; Miller, Douglas/0000-0001-5589-1857	U.S. National Institutes of Health (NIH) [DA026947, NS071122, OD020026, DA026947S1, DA043895]; NIH [RM01MH109548]; McKnight Brain Institute Trainee Enhancement Opportunity	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Brain Institute Trainee Enhancement Opportunity	H.K. acknowledges funding from the U.S. National Institutes of Health (NIH) DA026947, NS071122, OD020026, DA026947S1, DA043895. A.P.M. acknowledges funding from the NIH RM01MH109548. DM Acknowledges funding from the McKnight Brain Institute Trainee Enhancement Opportunity. The funders had no role in study design, data collection and analysis, decision topublish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adhikari S, 2016, SCI REP, V7, P1, DOI [10.1016/j.bios.2016.07.082, DOI 10.1016/J.BIOS.2016.07.082]; Aertsen AMHJ, 1989, DYNAMICS NEURONAL FI, V61; Balkenius A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129614; Beckstead MJ, 2004, NEURON, V42, P939, DOI 10.1016/j.neuron.2004.05.019; Bettencourt LMA, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021915; Bonifazi P, 2009, SCIENCE, V326, P1419, DOI 10.1126/science.1175509; Branch SY, 2012, J NEUROPHYSIOL, V108, P802, DOI 10.1152/jn.00094.2012; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Chambers B, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005078; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Colon-Perez LM, 2018, NEUROPHARMACOLOGY, V137, P178, DOI 10.1016/j.neuropharm.2018.04.031; Dechery JB, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006153; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Dubbs A, 2016, FRONT NEUROINFORM, V10, DOI 10.3389/fninf.2016.00006; Goodwin JS, 2009, J BIOL CHEM, V284, P2978, DOI 10.1074/jbc.M805298200; Gutierrez A, 2018, NEUROTOX RES, V33, P671, DOI 10.1007/s12640-018-9871-9; Heysieattalab S, 2016, SYNAPSE, V70, P325, DOI 10.1002/syn.21905; Hiolski EM, 2016, NEUROTOXICOLOGY, V56, P215, DOI 10.1016/j.neuro.2016.08.004; Huang YH, 1999, NEUROPSYCHOPHARMACOL, V21, P427, DOI 10.1016/S0893-133X(99)00029-9; Jiao DL, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00162; Krasnova IN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019179; Krasnova IN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008790; Kravitz AV, 2012, NAT NEUROSCI, V15, P816, DOI 10.1038/nn.3100; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Lautenschlager J, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00044; Liang X, 2015, J NEUROSCI, V35, P8081, DOI 10.1523/JNEUROSCI.3188-14.2015; Lim S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39243-w; Lin M, 2016, J NEUROSCI, V36, P10376, DOI 10.1523/JNEUROSCI.1392-16.2016; Margolis EB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042365; Morales M, 2017, NAT REV NEUROSCI, V18, P73, DOI 10.1038/nrn.2016.165; Moszczynska A, 2017, J PHARMACOL EXP THER, V362, P474, DOI 10.1124/jpet.116.238501; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Nephew BC, 2018, J AFFECT DISORDERS, V229, P213, DOI 10.1016/j.jad.2017.12.089; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Nowotny T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.128106; O'Neill B, 2017, ACS CHEM NEUROSCI, V8, P310, DOI 10.1021/acschemneuro.6b00300; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Orsini CA, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0081-18.2018; Padgett CL, 2012, NEURON, V73, P978, DOI 10.1016/j.neuron.2011.12.031; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; Reznichenko L, 2012, J NEUROSCI, V32, P9992, DOI 10.1523/JNEUROSCI.1270-12.2012; Rice ME, 2000, PROG BRAIN RES, V125, P277; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Runfeldt MJ, 2014, J NEUROPHYSIOL, V112, P1205, DOI 10.1152/jn.00071.2014; Saha K, 2014, J BIOL CHEM, V289, P22246, DOI 10.1074/jbc.M114.563056; Sambo D, 2017, FASEB J, V31; Sambo DO, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02087-x; Schroeter MS, 2015, J NEUROSCI, V35, P5459, DOI 10.1523/JNEUROSCI.4259-14.2015; Surmeier DJ, 2017, NAT REV NEUROSCI, V18, P101, DOI 10.1038/nrn.2016.178; Teller S, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003796; VALLAR L, 1989, TRENDS PHARMACOL SCI, V10, P74, DOI 10.1016/0165-6147(89)90082-5; Woodman MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064339; Xi ZX, 2009, NEUROSCIENCE, V161, P392, DOI 10.1016/j.neuroscience.2009.03.060	55	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222957	10.1371/journal.pone.0222957	http://dx.doi.org/10.1371/journal.pone.0222957			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536584	gold, Green Published, Green Submitted			2022-12-26	WOS:000532262800103
J	Trainito, CI; Sweeney, DC; Cemazar, J; Schmelz, EM; Francais, O; Le Pioufle, B; Davalos, RV				Trainito, Claudia, I; Sweeney, Daniel C.; Cemazar, Jaka; Schmelz, Eva M.; Francais, Olivier; Le Pioufle, Bruno; Davalos, Rafael, V			Characterization of sequentially-staged cancer cells using electrorotation	PLOS ONE			English	Article							DIELECTRIC-PROPERTIES; COMBINED DIELECTROPHORESIS; YEAST-CELLS; SEPARATION; PROGRESSION; BLOOD; SUBPOPULATIONS; WATER	The identification and separation of cells from heterogeneous populations is critical to the diagnosis of diseases. Label-free methodologies in particular have been developed to manipulate individual cells using properties such as density and morphology. The electrical properties of malignant cells, including the membrane capacitance and cytoplasmic conductivity, have been demonstrated to be altered compared to non-malignant cells of similar origin. Here, we exploit these changes to characterize individual cells in a sequentially-staged in vitro cancer model using electrorotation (EROT)-the rotation of a cell induced by a rotating electric field. Using a microfabricated device, a dielectrophoretic force to suspend cells while measuring their angular velocity resulting from an EROT force applied at frequencies between 3 kHz to 10 MHz. We experimentally determine the EROT response for cells at three stages of malignancy and analyze the resultant spectra by considering models that include the effect of the cell membrane alone (single-shell model) and the combined effect of the cell membrane and nucleus (double-shell model). We find that the cell membrane is largely responsible for a given cell's EROT response between 3 kHz and 10 MHz. Our results also indicate that membrane capacitance, membrane conductance, and cytoplasmic conductivity increase with an increasingly malignant phenotype. Our results demonstrate the potential of using electrorotation as a means making of non-invasive measurements to characterize the dielectric properties of cancer cells.	[Trainito, Claudia, I; Francais, Olivier; Le Pioufle, Bruno] ENS Paris Saclay, Inst Alembert, CNRS, SATIE, Paris, France; [Sweeney, Daniel C.; Cemazar, Jaka; Davalos, Rafael, V] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA; [Schmelz, Eva M.] Virginia Tech, Dept Human Nutr Food & Exercise, Blacksburg, VA USA; [Francais, Olivier] UPE, ESYCOM FRE 2028, ESIEE Paris, Noisy Le Grand, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Universite Gustave-Eiffel; ESIEE Paris	Davalos, RV (corresponding author), Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA 24061 USA.	davalos@vt.edu	Le Pioufle, Bruno/B-6951-2013; Sweeney, Daniel Christopher/AAL-4856-2020	Le Pioufle, Bruno/0000-0002-0010-2475; Sweeney, Daniel Christopher/0000-0002-1289-1627; Trainito, Claudia/0000-0002-2728-9364	LabeX LaSIPS [ANR-10-LABX-0040-LaSIPS, nANR-11-IDEX-0003-02]; COST [TD1104]; NSF CAREER Award [CBET-1055913]; NSF IGERT [DGE-09661]; NIH [R01CA213423]; NATIONAL CANCER INSTITUTE [R01CA213423] Funding Source: NIH RePORTER	LabeX LaSIPS; COST(European Cooperation in Science and Technology (COST)); NSF CAREER Award(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF IGERT(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to acknowledge the generous financial support provided by the LabeX LaSIPS (ANR-10-LABX-0040-LaSIPS) managed by the French National Research Agency under the "Investissements d'avenir" program (nANR-11-IDEX-0003-02) and COST TD1104, www.electroporation.net.The authors would like to thank the NSF CAREER Award CBET-1055913, the NSF IGERT DGE-09661, and the NIH R01CA213423 for their gracious support of this work.	Alberts B, 2002, MOL BIOL CELL CELL; Anderson AS, 2013, EXP CELL RES, V319, P1431, DOI 10.1016/j.yexcr.2013.02.017; ARNOLD WM, 1988, J ELECTROSTAT, V21, P151, DOI 10.1016/0304-3886(88)90027-7; BECKER FF, 1995, P NATL ACAD SCI USA, V92, P860, DOI 10.1073/pnas.92.3.860; BECKER FF, 1994, J PHYS D APPL PHYS, V27, P2659, DOI 10.1088/0022-3727/27/12/030; Bhonsle SP, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/1475-925X-14-S3-S3; Braschler T, 2008, LAB CHIP, V8, P280, DOI 10.1039/b710303d; Buchner R, 1999, CHEM PHYS LETT, V306, P57, DOI 10.1016/S0009-2614(99)00455-8; Cemazar J, 2016, BIOMICROFLUIDICS, V10, DOI 10.1063/1.4939947; Chatterjee Sabarni K, 2005, Future Oncol, V1, P37, DOI 10.1517/14796694.1.1.37; Cohen CA, 2013, CANCER PREV RES, V6, P1182, DOI 10.1158/1940-6207.CAPR-13-0227; Creekmore AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017676; Douglas TA, 2017, ELECTROPHORESIS, V38, P1507, DOI 10.1002/elps.201600530; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Fredriksson S, 2007, NAT METHODS, V4, P327, DOI 10.1038/NMETH1020; Gascoyne P, 2002, LAB CHIP, V2, P70, DOI [10.1039/b110990c, 10.1039/b110090c]; Gascoyne PRC, 2009, ELECTROPHORESIS, V30, P1388, DOI 10.1002/elps.200800373; GASCOYNE PRC, 1992, MEAS SCI TECHNOL, V3, P439, DOI 10.1088/0957-0233/3/5/001; GASCOYNE PRC, 1993, BIOCHIM BIOPHYS ACTA, V1149, P119, DOI 10.1016/0005-2736(93)90032-U; Geuzaine C, 2009, INT J NUMER METH ENG, V79, P1309, DOI 10.1002/nme.2579; Han SI, 2013, ANALYST, V138, P1529, DOI 10.1039/c3an36261b; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HOLZEL R, 1992, BIOCHIM BIOPHYS ACTA, V1104, P195, DOI 10.1016/0005-2736(92)90150-K; Hu Q, 2009, J APPL PHYS, V106, DOI 10.1063/1.3173344; HUANG Y, 1991, MEAS SCI TECHNOL, V2, P1142, DOI 10.1088/0957-0233/2/12/005; Jiang W G, 1995, Eur J Surg Oncol, V21, P307, DOI 10.1016/S0748-7983(95)91690-3; KESTIN J, 1978, J PHYS CHEM REF DATA, V7, P941, DOI 10.1063/1.555581; Kirby RC, 2006, ACM T MATH SOFTWARE, V32, P417, DOI 10.1145/1163641.1163644; MARSZALEK P, 1991, BIOPHYS J, V59, P982, DOI 10.1016/S0006-3495(91)82312-8; Mohamed H, 2009, J CHROMATOGR A, V1216, P8289, DOI 10.1016/j.chroma.2009.05.036; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Morgan H., 2003, AC ELECTROKINETICS; Pethig R., 2005, IEE Proceedings Nanobiotechnology, V152, P189, DOI 10.1049/ip-nbt:20050040; PETHIG R, 1992, J PHYS D APPL PHYS, V25, P881, DOI 10.1088/0022-3727/25/5/022; Pethig R, 2003, IEEE ENG MED BIOL, V22, P43, DOI 10.1109/MEMB.2003.1266046; POHL HA, 1958, J APPL PHYS, V29, P1182, DOI 10.1063/1.1723398; Roberts PC, 2005, NEOPLASIA, V7, P944, DOI 10.1593/neo.05358; Salmanzadeh A, 2013, INTEGR BIOL-UK, V5, P843, DOI [10.1039/c3ib00008g, 10.1039/c3b00008g]; Salmanzadeh A, 2013, BIOMICROFLUIDICS, V7, DOI 10.1063/1.4788921; Salmanzadeh A, 2012, BIOMICROFLUIDICS, V6, DOI 10.1063/1.3699973; Salmanzadeh A, 2012, LAB CHIP, V12, P182, DOI 10.1039/c1lc20701f; Salomon S, 2011, ELECTROPHORESIS, V32, P1508, DOI 10.1002/elps.201000675; Sano MB, 2011, BIOSENS BIOELECTRON, V30, P13, DOI 10.1016/j.bios.2011.07.048; SUROWIEC AJ, 1988, IEEE T BIO-MED ENG, V35, P257, DOI 10.1109/10.1374; Trainito CI, 2015, ELECTROPHORESIS, V36, P1115, DOI 10.1002/elps.201400482; Vona G, 2000, AM J PATHOL, V156, P57, DOI 10.1016/S0002-9440(10)64706-2; Wang K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061158; Yang J, 1999, BIOPHYS J, V76, P3307, DOI 10.1016/S0006-3495(99)77483-7; YING H, 1992, PHYS MED BIOL, V37, P1499, DOI 10.1088/0031-9155/37/7/003	49	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222289	10.1371/journal.pone.0222289	http://dx.doi.org/10.1371/journal.pone.0222289			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536516	gold, Green Submitted, Green Published			2022-12-26	WOS:000532262800033
J	Vallabhajosyula, S; Dunlay, SM; Barsness, GW; Vallabhajosyula, S; Vallabhajosyula, S; Sundaragiri, PR; Gersh, BJ; Jaffe, AS; Kashani, K				Vallabhajosyula, Saraschandra; Dunlay, Shannon M.; Barsness, Gregory W.; Vallabhajosyula, Saarwaani; Vallabhajosyula, Shashaank; Sundaragiri, Pranathi R.; Gersh, Bernard J.; Jaffe, Allan S.; Kashani, Kianoush			Temporal trends, predictors, and outcomes of acute kidney injury and hemodialysis use in acute myocardial infarction-related cardiogenic shock	PLOS ONE			English	Article							DIALYSIS; RISK	Background There are limited data on acute kidney injury (AKI) complicating acute myocardial infarction with cardiogenic shock (AMI-CS). This study sought to evaluate 15-year national prevalence, temporal trends and outcomes of AKI with no need for hemodialysis (AKI-ND) and requiring hemodialysis (AKI-D) following AMI-CS. Methods This was a retrospective cohort study from 2000-2014 from the National Inpatient Sample (20% stratified sample of all community hospitals in the United States). Adult patients (>18 years) admitted with a primary diagnosis of AMI and secondary diagnosis of CS were included. The primary outcome was in-hospital mortality in cohorts with no AKI, AKI-ND, and AKI-D. Secondary outcomes included predictors, resource utilization and disposition. Results During this 15-year period, 440,257 admissions for AMI-CS were included, with AKI in 155,610 (35.3%) and hemodialysis use in 14,950 (3.4%). Older age, black race, non-private insurance, higher comorbidity, organ failure, and use of cardiac and non-cardiac organ support were associated with the AKI development and hemodialysis use. There was a 2.6-fold higher adjusted risk of developing AKI in 2014 compared to 2000. Presence of AKI-ND and AKI-D was associated with a 1.3 and 1.7-fold higher adjusted risk of mortality. Compared to the cohort without AKI, AKI-ND and AKI-D were associated with longer length of stay (9 +/- 10,12 +/- 13, and 18 +/- 19 days respectively; p<0.001) and higher hospitalization costs ($101,859 +/- 116,204, $159,804 +/- 190,766, and $265,875 +/- 254,919 respectively; p<0.001). Conclusion AKI-ND and AKI-D are associated with higher in-hospital mortality and resource utilization in AMI-CS.	[Vallabhajosyula, Saraschandra; Dunlay, Shannon M.; Barsness, Gregory W.; Vallabhajosyula, Saarwaani; Gersh, Bernard J.; Jaffe, Allan S.] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA; [Vallabhajosyula, Saraschandra; Vallabhajosyula, Shashaank; Kashani, Kianoush] Mayo Clin, Div Pulm & Crit Care Med, Dept Med, Rochester, MN 55905 USA; [Dunlay, Shannon M.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA; [Sundaragiri, Pranathi R.] Mayo Clin, Dept Med, Div Hosp Internal Med, Rochester, MN USA; [Kashani, Kianoush] Mayo Clin, Div Nephrol & Hypertens, Dept Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Vallabhajosyula, S (corresponding author), Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA.; Vallabhajosyula, S (corresponding author), Mayo Clin, Div Pulm & Crit Care Med, Dept Med, Rochester, MN 55905 USA.	Vallabhajosyula.Saraschandra@mayo.edu	Vallabhajosyula, Saraschandra/I-9707-2019	Vallabhajosyula, Saraschandra/0000-0002-1631-8238	Clinical and Translational Science Award (CTSA) from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) [UL1 TR000135]	Clinical and Translational Science Award (CTSA) from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Dr. Saraschandra Vallabhajosyula is supported by the Clinical and Translational Science Award (CTSA) Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH.	Adegbala O, 2019, AM J CARDIOL, V123, P1816, DOI 10.1016/j.amjcard.2019.02.038; Adler C, 2013, RESUSCITATION, V84, P194, DOI 10.1016/j.resuscitation.2012.06.013; Ahmed A, 2015, J CRIT CARE, V30, P988, DOI 10.1016/j.jcrc.2015.05.007; Amin AP, 2012, ARCH INTERN MED, V172, P246, DOI 10.1001/archinternmed.2011.1202; Chan L, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004509; Correa A, 2018, J CARD FAIL, V24, P442, DOI 10.1016/j.cardfail.2018.05.001; Dasta JF, 2019, J PHARM PRACT, V32, P292, DOI 10.1177/0897190019852556; Hsu RK, 2016, CLIN J AM SOC NEPHRO, V11, P14, DOI 10.2215/CJN.04520415; Jentzer JC, 2018, CHEST, V154, P416, DOI 10.1016/j.chest.2017.12.021; Jentzer JC, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008169; Kane-Gill SL, 2015, AM J KIDNEY DIS, V65, P860, DOI 10.1053/j.ajkd.2014.10.018; Kashani K, 2019, CLIN J AM SOC NEPHRO, V14, P941, DOI 10.2215/CJN.01250119; Ko DT, 2008, J AM COLL CARDIOL, V51, P716, DOI 10.1016/j.jacc.2007.10.039; Kotecha A, 2018, J CRIT CARE, V43, P122, DOI 10.1016/j.jcrc.2017.08.044; Lauridsen MD, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1170-8; Lim HS, 2018, SHOCK, V50, P167, DOI 10.1097/SHK.0000000000001052; Moman RN, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0468-5; Ostermann M, 2019, CHEST, V156, P594, DOI 10.1016/j.chest.2019.04.004; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Ronco C, 2017, NEPHROL DIAL TRANSPL, V32, P408, DOI 10.1093/ndt/gfx016; Sakhuja A, 2019, MAYO CLIN PROC, V94, P1509, DOI 10.1016/j.mayocp.2019.01.040; Sakhuja A, 2015, AM J RESP CRIT CARE, V192, P951, DOI 10.1164/rccm.201502-0329OC; Siew ED, 2015, KIDNEY INT, V87, P46, DOI 10.1038/ki.2014.293; Sinha SS, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.117.003616; Tumlin JA, 2018, CRIT CARE MED, V46, P949, DOI 10.1097/CCM.0000000000003092; Vallabhajosyula S, 2019, AGING-US, V11, P4774, DOI 10.18632/aging.102104; Vallabhajosyula S, 2019, IJC HEART VASC, V24, DOI 10.1016/j.ijcha.2019.100414; Vallabhajosyula S, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0571-2; Vallabhajosyula S, 2020, ASAIO J, V66, P497, DOI 10.1097/MAT.0000000000001039; Vallabhajosyula S, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.011954; Vallabhajosyula S, 2019, ESC HEART FAIL, V6, P874, DOI 10.1002/ehf2.12482; Vallabhajosyula S, 2019, AM J CARDIOL, V124, P491, DOI 10.1016/j.amjcard.2019.05.038; Vallabhajosyula S, 2019, JACC-HEART FAIL, V7, P469, DOI 10.1016/j.jchf.2018.12.007; Vallabhajosyula S, 2019, J AM COLL CARDIOL, V73, P1781, DOI 10.1016/j.jacc.2019.01.053; Vallabhajosyula S, 2019, INT J CARDIOL, V285, P6, DOI 10.1016/j.ijcard.2019.03.008; Vallabhajosyula S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.010193; Vallabhajosyula S, 2019, AM J CARDIOL, V123, P489, DOI 10.1016/j.amjcard.2018.10.029; Vallabhajosyula S, 2018, CIRC-CARDIOVASC INTE, V11, DOI 10.1161/CIRCINTERVENTIONS.118.006930; Vallabhajosyula S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009608; Vallabhajosyula S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190965; Vallabhajosyula S, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.11.36; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073	42	38	38	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222894	10.1371/journal.pone.0222894	http://dx.doi.org/10.1371/journal.pone.0222894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532793	Green Published, gold, Green Submitted			2022-12-26	WOS:000532239600038
J	Barker, D; Gillum, KT; Niemuth, NA; Kodihalli, S				Barker, Douglas; Gillum, Karen T.; Niemuth, Nancy A.; Kodihalli, Shantha			Therapeutic efficacy of equine botulism heptavalent antitoxin against all seven botulinum neurotoxins in symptomatic guinea pigs	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; A BOTULISM; CLOSTRIDIUM-BARATII; UNITED-STATES; OUTBREAK; IDENTIFICATION; TOXIN; RECOVERY	Botulism neurotoxins are highly toxic and are potential agents for bioterrorism. The development of effective therapy is essential to counter the possible use of these toxins in military and bioterrorism scenarios, and to provide treatment in cases of natural intoxication. Guinea pigs were intoxicated with a lethal dose of botulinum neurotoxin serotypes A, B, C, D, E, F or G, and at onset of the clinical disease intoxicated animals were treated with either BAT (R) [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G)-(Equine)] or placebo. BAT product treatment significantly (p<0.0001) enhanced survival compared to placebo for all botulinum neurotoxin serotypes and arrested or mitigated the progression of clinical signs of botulism intoxication. These results demonstrated the therapeutic efficacy of BAT product in guinea pigs and provided supporting evidence of effectiveness for licensure of BAT product under FDA 21 CFR Part 601 (Subpart H Animal Rule) as a therapeutic for botulism intoxication to serotypes A, B, C, D, E, F or G in adults and pediatric patients.	[Barker, Douglas; Kodihalli, Shantha] Emergent BioSolut Canada Inc, Res & Dev, Winnipeg, MB, Canada; [Gillum, Karen T.; Niemuth, Nancy A.] Battelle Biomed Res Ctr, Columbus, OH USA		Kodihalli, S (corresponding author), Emergent BioSolut Canada Inc, Res & Dev, Winnipeg, MB, Canada.	skodihalli@ebsi.com		Barker, Douglas/0000-0002-1174-3964	Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services (DHHS) [HHSO100200600017C]	Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services (DHHS)	This work was funded by the Biomedical Advanced Research and Development Authority (BARDA), Department of Health and Human Services (DHHS) under contract HHSO100200600017C. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adekar SP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003023; [Anonymous], 2015, PRODUCT DEV ANIMAL R, P54; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Atassi MZ, 1999, CRIT REV IMMUNOL, V19, P219; BALL AP, 1979, Q J MED, V48, P473; Carlella M.A., 1964, PHS999FP1 PUBL, P113; CDC, 2019, BOT ANN SUMM 2017; Cheng LW, 2009, INFECT IMMUN, V77, P4305, DOI 10.1128/IAI.00405-09; Cheng WQ, 2012, J PHARM SCI-US, V101, P1701, DOI 10.1002/jps.23076; CICCARELLI AS, 1977, APPL ENVIRON MICROB, V34, P843, DOI 10.1128/AEM.34.6.843-848.1977; COLEBATCH JG, 1989, LANCET, V2, P1216; DEMARCHI J, 1958, Bull Acad Natl Med, V142, P580; Dembek ZF, 2007, DISASTER MED PUBLIC, V1, P122, DOI 10.1097/DMP.0b013e318158c5fd; Derman Y, 2016, TOXINS, V8, DOI 10.3390/toxins8090257; Emanuel A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209019; Fan YF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174187; FDA, 2005, GUID IND EST MAX SAF; GANGAROSA EJ, 1971, AM J EPIDEMIOL, V93, P93, DOI 10.1093/oxfordjournals.aje.a121239; Garcia-Rodriguez C, 2018, TOXINS, V10, DOI 10.3390/toxins10030105; Gelzleichter TR, 1999, J APPL TOXICOL, V19, pS35, DOI 10.1002/(SICI)1099-1263(199912)19:1+<S35::AID-JAT612>3.0.CO;2-9; Harvey SM, 2002, J CLIN MICROBIOL, V40, P2260, DOI 10.1128/JCM.40.6.2260-2262.2002; Kiris E, 2014, CURR TOP MED CHEM, V14, P2044, DOI 10.2174/1568026614666141022093350; Kodihalli S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186892; KOENIG MG, 1967, AM J MED, V42, P208, DOI 10.1016/0002-9343(67)90020-4; Kongsaengdao S, 2006, CLIN INFECT DIS, V43, P1247, DOI 10.1086/508176; Li MX, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197011; MANN JM, 1981, AM J PUBLIC HEALTH, V71, P266, DOI 10.2105/AJPH.71.3.266; McCarty CL, 2015, MMWR-MORBID MORTAL W, V64, P802, DOI 10.15585/mmwr.mm6429a6; MCCROSKEY LM, 1991, J CLIN MICROBIOL, V29, P2618, DOI 10.1128/JCM.29.11.2618-2620.1991; METZGER JF, 1979, REV INFECT DIS, V1, P689; Middlebrook J. L, 1997, TXB MILITARY MED MED, P643; National Research Council, 1996, GUIDE CARE USE LAB A, V7th ed., P140, DOI [10.17226/5140, DOI 10.17226/5140]; OGUMA K, 1990, LANCET, V336, P1449, DOI 10.1016/0140-6736(90)93157-K; Pirazzini M, 2017, PHARMACOL REV, V69, P200, DOI 10.1124/pr.116.012658; Ravichandran E, 2006, J PHARMACOL EXP THER, V318, P1343, DOI 10.1124/jpet.106.104661; Richardson JS, 2020, CLIN INFECT DIS, V70, P1950, DOI 10.1093/cid/ciz515; Rusnak JM, 2009, HUM VACCINES, V5, P794, DOI 10.4161/hv.9420; SEALS JE, 1981, AM J EPIDEMIOL, V113, P436, DOI 10.1093/oxfordjournals.aje.a113111; Shapiro RL, 1998, ANN INTERN MED, V129, P221, DOI 10.7326/0003-4819-129-3-199808010-00011; Simpson LL, 2009, VACCINES FOR BIODEFENSE AND EMERGING AND NEGLECTED DISEASES, P891, DOI 10.1016/B978-0-12-369408-9.00046-9; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Sobel J, 2005, CLIN INFECT DIS, V41, P1167, DOI 10.1086/444507; SONNABEND O, 1981, J INFECT DIS, V143, P22, DOI 10.1093/infdis/143.1.22; TACKET CO, 1984, AM J MED, V76, P794, DOI 10.1016/0002-9343(84)90988-4; Takahashi H, 2009, HYBRIDOMA, V28, P63, DOI 10.1089/hyb.2008.0066; TELZAK EE, 1990, J INFECT DIS, V161, P340, DOI 10.1093/infdis/161.2.340; TERRANOVA W, 1978, AM J EPIDEMIOL, V108, P150, DOI 10.1093/oxfordjournals.aje.a112599; Townes JM, 1996, ANN INTERN MED, V125, P558, DOI 10.7326/0003-4819-125-7-199610010-00004; WEBER JT, 1993, J INFECT DIS, V167, P451, DOI 10.1093/infdis/167.2.451; Yu PA, 2018, CLIN INFECT DIS, V66, pS57, DOI 10.1093/cid/cix816	50	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222670	10.1371/journal.pone.0222670	http://dx.doi.org/10.1371/journal.pone.0222670			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527885	gold, Green Published, Green Submitted			2022-12-26	WOS:000532231400038
J	Lamas-Fernandez, C; Hayward, G; Moore, M; Monks, T				Lamas-Fernandez, Carlos; Hayward, Gail; Moore, Michael; Monks, Thomas			A mathematical model for designing networks of C-Reactive Protein point of care testing	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; LOCATION	One approach to improving antibiotic stewardship in primary care may be to support all General Practitioners (GPs) to have access to point of care C-Reactive Protein tests to guide their prescribing decisions in patients presenting with symptoms of lower respiratory tract infection. However, to date there has been no work to understand how clinical commissioning groups might approach the practicalities of system-wide implementation. We aimed to develop an accessible service delivery modelling tool that, based on open data, could generate a layout of the geographical distribution of point of care facilities that minimised the cost and travel distance for patients across a given region. We considered different implementation models where point of care tests were placed at either GP surgeries, pharmacies or both. We analysed the trade-offs between cost and travel found by running the model under different configurations and analysing the model results in four regions of England (two urban, two rural). Our model suggests that even under assumptions of short travel distances for patients (e.g. under 500m), it is possible to achieve a meaningful reduction in the number of necessary point of care testing facilities to serve a region by referring some patients to be tested at nearby GP surgeries or pharmacies. In our test cases pharmacy-led implementation models resulted in some patients having to travel long distances to obtain a test, beyond the desired travel limits. These results indicate that an efficient implementation strategy for point of care tests over a geographic region, potentially building on primary care networks, might lead to significant cost reduction in equipment and associated personnel training, maintenance and quality control costs; as well as achieving fair access to testing facilities.	[Lamas-Fernandez, Carlos] Univ Southampton, NIHR CLAHRC Wessex, Southampton, Hants, England; [Hayward, Gail] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, NIHR Community Healthcare MIC, Oxford, England; [Moore, Michael] Univ Southampton, Primary Care & Populat Sci, Southampton, Hants, England; [Monks, Thomas] Univ Exeter, Med Sch, Exeter, Devon, England	University of Southampton; University of Oxford; University of Southampton; University of Exeter	Lamas-Fernandez, C (corresponding author), Univ Southampton, NIHR CLAHRC Wessex, Southampton, Hants, England.	C.Lamas-Fernandez@soton.ac.uk	; Moore, Michael/C-3447-2011	Lamas-Fernandez, Carlos/0000-0001-5329-7619; Moore, Michael/0000-0002-5127-4509; Hayward, Gail/0000-0003-0852-627X	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) Wessex; National Institute for Health Research (NIHR) Community Healthcare MedTech and In-Vitro Diagnostic Cooperative	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) Wessex; National Institute for Health Research (NIHR) Community Healthcare MedTech and In-Vitro Diagnostic Cooperative	This article presents independent research funded by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) Wessex (CLF, TM, MM), and by the National Institute for Health Research (NIHR) Community Healthcare MedTech and In-Vitro Diagnostic Cooperative (GH). The views expressed in this publication are those of the author(s) and not necessarily those of the National Health Service, the NIHR or the Department of Health and Social Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi-Javid A, 2017, COMPUT OPER RES, V79, P223, DOI 10.1016/j.cor.2016.05.018; Andre M, 2004, SCAND J INFECT DIS, V36, P192, DOI 10.1080/00365540410019372; [Anonymous], 2017, OPENSTREETMAP CONTRI; Butler CC, 2007, BRIT J GEN PRACT, V57, P785; Cals JWL, 2010, ANN FAM MED, V8, P124, DOI 10.1370/afm.1090; Cals JWL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1374; Chan TCY, 2018, OPER RES, V66, P358, DOI 10.1287/opre.2017.1660; Daskin MS, 2005, INT SER OPER RES MAN, V70, P43, DOI 10.1007/1-4020-8066-2_3; Digital NHS, 2018, GP GP PRACT REL DAT; Excellence NI for H and C, 2014, EXCELLENCE NI H C PN; Huddy JR, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009959; IACOBUCCI G, 2019, BMJ-BRIT MED J, V364, DOI DOI 10.1136/BMJ.L304; Johnson M, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-024558; Little P, 2013, LANCET, V382, P1175, DOI 10.1016/S0140-6736(13)60994-0; Luxen D., 2011, P 19 ACM SIGSPATIAL, P513, DOI [10.1145/2093973.2094062, DOI 10.1145/2093973.2094062]; Meskarian R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183942; Monks T, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0444-0; Oppong R, 2013, BRIT J GEN PRACT, V63, pE465, DOI 10.3399/bjgp13X669185; Oppong R, 2011, EUR J HEALTH ECON, V12, P319, DOI 10.1007/s10198-010-0239-1; Pope A, 2017, LOCATION PHARM ENGLA	20	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222676	10.1371/journal.pone.0222676	http://dx.doi.org/10.1371/journal.pone.0222676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527896	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000532231400039
J	Yu, WH; Hao, XH; Yang, FM; Ma, J; Zhao, Y; Li, YY; Wang, JB; Xu, HJ; Chen, LX; Liu, Q; Duan, SQ; Yang, YP; Huang, F; He, ZL				Yu, Wenhai; Hao, Xianhui; Yang, Fengmei; Ma, Jin; Zhao, Yuan; Li, Yanyan; Wang, Junbin; Xu, Hongjie; Chen, Lixiong; Liu, Quan; Duan, Suqin; Yang, Yaping; Huang, Fen; He, Zhanlong			Hematological and biochemical parameters for Chinese rhesus macaque	PLOS ONE			English	Article							MONKEYS MACACA-MULATTA; NONHUMAN-PRIMATES; AGE; VALUES; SEX; COMPLEMENT; GENDER; VIRUS; TRANSPLANTATION; HOMEOSTASIS	Rhesus macaque is an important animal model in biomedical research, especially human disease, developmental, translational, and pre-clinical research. Blood physiological and biochemical parameters are important markers for physiology, pathology, and toxicology research. However, these parameters have not been systematically reported for Chinese rhesus macaques. To characterize the reference for these parameters, this study collected 1805 Chinese rhesus macaques living in Southwestern China. A total of 24 blood physiological indexes and 27 biochemical parameters were determined. Sex and age were found to affect these parameters. In conclusion, a comprehensive and systematic reference of hematological and biochemical parameters for Chinese rhesus macaque was established in this work on the basis of a large cohort. Such reference will benefit biomedical research employing rhesus macaques as animal models.	[Yu, Wenhai; Yang, Fengmei; Ma, Jin; Zhao, Yuan; Li, Yanyan; Wang, Junbin; Xu, Hongjie; Chen, Lixiong; Liu, Quan; Duan, Suqin; Yang, Yaping; He, Zhanlong] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biol, Kunming, Yunnan, Peoples R China; [Hao, Xianhui; Huang, Fen] Kunming Univ Sci & Technol, Med Fac, Kunming, Yunnan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Peking Union Medical College; Kunming University of Science & Technology	He, ZL (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biol, Kunming, Yunnan, Peoples R China.; Huang, F (corresponding author), Kunming Univ Sci & Technol, Med Fac, Kunming, Yunnan, Peoples R China.	huangfen6789@163.com; hzl612@126.com	xu, hong/GSD-8903-2022		PUMC young Fund [3332019008, 2017310038]; Natural Science Foundation of Yunnan province [2018FB132]; Fundamental Research Funds for the Central Universities [2016ZX310179-3, 2016ZX310179-4]; CAMS Innovation Fund for Medical Sciences [2019-I2M-1-004, 2018-I2M-3-002, 2016-I2M-2-1-001]	PUMC young Fund; Natural Science Foundation of Yunnan province(Natural Science Foundation of Yunnan Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); CAMS Innovation Fund for Medical Sciences	This study was supported by PUMC young Fund (3332019008 and 2017310038), Natural Science Foundation of Yunnan province to (2018FB132) to WY, the Fundamental Research Funds for the Central Universities (2016ZX310179-3, 2016ZX310179-4) to WY and FY, and CAMS Innovation Fund for Medical Sciences (2019-I2M1-004, 2018-I2M-3-002, 2016-I2M-2-1-001,) to WY, YZ, and ZH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by PUMC young Fund (3332019008 and 2017310038), Natural Science Foundation of Yunnan province to (2018FB132), the Fundamental Research Funds for the Central Universities (2016ZX310179-3 and 2016ZX310179-4), and CAMS Innovation Fund for Medical Sciences (2019-I2M-1-004, 2018-I2M-3-002 and 2016-I2M-2-1-001).	Antony JM, 2015, VACCINE, V33, P3073, DOI 10.1016/j.vaccine.2014.12.004; Aoyama A, 2015, AM J TRANSPLANT, V15, P1415, DOI 10.1111/ajt.13130; Arnold JN, 2006, IMMUNOL LETT, V106, P103, DOI 10.1016/j.imlet.2006.05.007; Berger M, 2018, J NEUROPHYSIOL, V119, P796, DOI 10.1152/jn.00614.2017; Black MJ, 2015, AM J PHYSIOL-REG I, V309, pR1153, DOI 10.1152/ajpregu.00403.2014; Buchl SJ, 1997, LAB ANIM SCI, V47, P528; Chen YN, 2009, XENOTRANSPLANTATION, V16, P496, DOI 10.1111/j.1399-3089.2009.00554.x; Clarke EV, 2014, J LEUKOCYTE BIOL, V96, P745, DOI 10.1189/jlb.3MR0214-109R; Coleman K, 2014, ILAR J, V55, P333, DOI 10.1093/ilar/ilu019; Dai JJ, 2000, ACTA LAB SCI SINICA, V8, P224; Davey RT, 2016, NEW ENGL J MED, V375, P1448, DOI 10.1056/NEJMoa1604330; Eastman AJ, 2018, J INFECT DIS, V217, P656, DOI 10.1093/infdis/jix545; Finkelman FD, 2016, J ALLERGY CLIN IMMUN, V137, P1674, DOI 10.1016/j.jaci.2016.02.015; GOODRICH JA, 1995, J MED PRIMATOL, V24, P17, DOI 10.1111/j.1600-0684.1995.tb00140.x; Hallan S, 2008, AM J KIDNEY DIS, V51, P10, DOI 10.1053/j.ajkd.2007.09.013; Han CY, 2016, 3RD INTERNATIONAL CONFERENCE ON EDUCATION REFORM AND MODERN MANAGEMENT, 2016, P190; Harding JD, 2017, ILAR J, V58, P59, DOI 10.1093/ilar/ilw042; Hauser SN, 2018, HEARING RES, V357, P33, DOI 10.1016/j.heares.2017.11.004; He QL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189837; Heald AE, 2015, NEW ENGL J MED, V373, P339, DOI 10.1056/NEJMoa1410345; Hirano Y, 2018, NMR BIOMED, V31, DOI 10.1002/nbm.3864; Huang F, 2016, HEPATOLOGY, V64, P350, DOI 10.1002/hep.28668; Hui YJ, 2016, INT J BIOCHEM CELL B, V81, P20, DOI 10.1016/j.biocel.2016.10.011; Ibanez-Contreras A, 2018, EXP GERONTOL, V101, P80, DOI 10.1016/j.exger.2017.11.003; John WS, 2018, J PHARMACOL EXP THER, V364, P300, DOI 10.1124/jpet.117.244194; Khalil R, 2018, MOL CELL ENDOCRINOL, V465, P61, DOI 10.1016/j.mce.2017.11.011; Kimura T, 2007, J AM ASSOC LAB ANIM, V46, P33; Kodihalli S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186892; Koga T, 2005, INT J TOXICOL, V24, P377, DOI 10.1080/10915810500208058; Kozlosky JC, 2015, REGUL TOXICOL PHARM, V73, P27, DOI 10.1016/j.yrtph.2015.06.008; Kristic J, 2014, J GERONTOL A-BIOL, V69, P779, DOI 10.1093/gerona/glt190; Kuiken T, 2017, VET RES, V48, DOI 10.1186/s13567-017-0486-6; Lee JH, 2012, CLIN TRANSPLANT, V26, P736, DOI 10.1111/j.1399-0012.2012.01607.x; Lemieux I, 2002, EUR J CLIN INVEST, V32, P909, DOI 10.1046/j.1365-2362.2002.01092.x; Li S, 2008, KIDNEY INT, V73, P637, DOI 10.1038/sj.ki.5002747; Loh RKS, 2013, AUST FAM PHYSICIAN, V42, P195; Loria A, 2007, AM J PHYSIOL-RENAL, V293, pF506, DOI 10.1152/ajprenal.00066.2007; Magness CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r60; Martin M, 2016, IMMUNOL REV, V274, P218, DOI 10.1111/imr.12462; Mauvais-Jarvis F, 2018, PHYSIOL BEHAV, V187, P20, DOI 10.1016/j.physbeh.2017.08.016; Miller AA, 2007, CLIN EXP PHARMACOL P, V34, P1037, DOI 10.1111/j.1440-1681.2007.04732.x; MOODY DB, 1978, ARCH OTO-RHINO-LARYN, V220, P47, DOI 10.1007/BF00456301; Nikkila M, 1996, ATHEROSCLEROSIS, V119, P181, DOI 10.1016/0021-9150(95)05645-9; Paz MFCJ, 2018, J CELL BIOCHEM, V119, P2923, DOI 10.1002/jcb.26487; Pennisi E, 2007, SCIENCE, V316, P216, DOI 10.1126/science.316.5822.216; PERRETTA G, 1991, J MED PRIMATOL, V20, P345; Pinto-Santini DM, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-017-0379-9; Pucic M, 2012, GLYCOBIOLOGY, V22, P975, DOI 10.1093/glycob/cws062; Rao M, 2017, ONCOTARGET, V8, P85909, DOI 10.18632/oncotarget.20719; Redlberger S, 2017, VET J, V229, P45, DOI 10.1016/j.tvjl.2017.10.017; Sato A, 2005, CONTEMP TOP LAB ANIM, V44, P29; Schmitt CA, 2018, INT J OBESITY, V42, P765, DOI 10.1038/ijo.2017.301; Shen Guo, 2011, Sichuan Journal of Zoology, V30, P254; Thierry B, 2000, J ZOO WILDLIFE MED, V31, P179, DOI 10.1638/1042-7260(2000)031[0179:HAPBVF]2.0.CO;2; Wang Z, 2005, IMMUNOLOGY MACACA MU, V26, P68; Wouters D, 2015, HAEMATOLOGICA, V100, P1388, DOI 10.3324/haematol.2015.128538; Xie L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064892; Zhao T, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00171	58	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222338	10.1371/journal.pone.0222338	http://dx.doi.org/10.1371/journal.pone.0222338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527891	Green Published, Green Submitted, gold			2022-12-26	WOS:000532231400016
J	Okazaki, F; Tsuji, Y; Seto, Y; Ogami, C; Yamamoto, Y; To, H				Okazaki, Fumiyasu; Tsuji, Yasuhiro; Seto, Yoshihiro; Ogami, Chika; Yamamoto, Yoshihiro; To, Hideto			Effects of a rifampicin pre-treatment on linezolid pharmacokinetics	PLOS ONE			English	Article							COMBINATION THERAPY; P-GLYCOPROTEIN; METABOLISM; INDUCTION	Linezolid is an oxazolidinone antibiotic that effectively treats methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE). Since rifampicin induces other antibiotic effects, it is combined with linezolid in therapeutic regimes. However, linezolid blood concentrations are reduced by this combination, which increases the risk of the emergence of antibiotic-resistant bacteria. We herein demonstrated that the combination of linezolid with rifampicin inhibited its absorption and promoted its elimination, but not through microsomal enzymes. Our results indicate that the combination of linezolid with rifampicin reduces linezolid blood concentrations via metabolic enzymes.	[Okazaki, Fumiyasu; Seto, Yoshihiro; Ogami, Chika; To, Hideto] Univ Toyama, Fac Pharmaceut Sci, Dept Med Pharmaceut, Toyama, Japan; [Tsuji, Yasuhiro] Nihon Univ, Ctr Pharmacist Educ, Sch Pharm, Chiba, Japan; [Yamamoto, Yoshihiro] Univ Toyama, Dept Clin Infect Dis, Grad Sch Med & Pharmaceut Sci Res, Toyama, Japan	University of Toyama; Nihon University; University of Toyama	Tsuji, Y (corresponding author), Nihon Univ, Ctr Pharmacist Educ, Sch Pharm, Chiba, Japan.	tsuji.yasuhiro@nihon-u.ac.jp		Tsuji, Yasuhiro/0000-0002-7967-2947; Ogami, Chika/0000-0002-2493-9616	Japan Society for the Promotion of Science [17K08438]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research Grant number 17K08438. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashizawa N, 2016, J INFECT CHEMOTHER, V22, P331, DOI 10.1016/j.jiac.2015.11.012; Bodin K, 2005, BBA-MOL CELL BIOL L, V1687, P84, DOI 10.1016/j.bbalip.2004.11.003; Cabellos C, 2014, J INFECT CHEMOTHER, V20, P563, DOI 10.1016/j.jiac.2014.05.008; Chan GNY, 2013, ANTIMICROB AGENTS CH, V57, P4481, DOI 10.1128/AAC.00486-13; Drusano GL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101311; Egle H, 2005, CLIN PHARMACOL THER, V77, P451, DOI 10.1016/j.clpt.2005.01.020; Forrest GN, 2010, CLIN MICROBIOL REV, V23, P14, DOI 10.1128/CMR.00034-09; Fung HB, 2001, CLIN THER, V23, P356, DOI 10.1016/S0149-2918(01)80043-6; Gandelman K, 2011, J CLIN PHARMACOL, V51, P229, DOI 10.1177/0091270010366445; Hamel J. C., 2000, Infection, V28, P60, DOI 10.1007/PL00012242; Holmstock N, 2013, MOL PHARMACEUT, V10, P1056, DOI 10.1021/mp300512r; MacGowan AP, 2003, J ANTIMICROB CHEMOTH, V51, P17, DOI 10.1093/jac/dkg248; MacLeod AK, 2015, CANCER RES, V75, P4573, DOI 10.1158/0008-5472.CAN-15-1454; Mealey KL, 2004, J VET PHARMACOL THER, V27, P257, DOI 10.1111/j.1365-2885.2004.00607.x; Ouwerkerk-Mahadevan S, 2016, CLIN PHARMACOKINET, V55, P197, DOI 10.1007/s40262-015-0314-y; Perlroth J, 2008, ARCH INTERN MED, V168, P805, DOI 10.1001/archinte.168.8.805; SANDERS WE, 1976, ANN INTERN MED, V85, P82, DOI 10.7326/0003-4819-85-1-82; Slatter JG, 2001, DRUG METAB DISPOS, V29, P1136; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Tian R, 2005, DRUG METAB DISPOS, V33, P547, DOI 10.1124/dmd.104.002485; Tsuji Y, 2017, BRIT J CLIN PHARMACO, V83, P1758, DOI 10.1111/bcp.13262; Vergidis P, 2011, ANTIMICROB AGENTS CH, V55, P1182, DOI 10.1128/AAC.00740-10; Wynalda MA, 2000, DRUG METAB DISPOS, V28, P1014	23	5	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2019	14	9							e0214037	10.1371/journal.pone.0214037	http://dx.doi.org/10.1371/journal.pone.0214037			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4KS	31518346	Green Submitted, Green Published, gold			2022-12-26	WOS:000532219300001
J	Sugimoto, A; Yamashita, Y; Kanda, T; Murata, T; Tsurumi, T				Sugimoto, Atsuko; Yamashita, Yoriko; Kanda, Teru; Murata, Takayuki; Tsurumi, Tatsuya			Epstein-Barr virus genome packaging factors accumulate in BMRF1-cores within viral replication compartments	PLOS ONE			English	Article							DISULFIDE BOND FORMATION; REPAIR FACTORS; DNA; PROTEIN; GENE; VP26; LOCALIZATION; REACTIVATION; COMPONENT; BINDING	Productive replication of Epstein-Barr virus (EBV) during the lytic cycle occurs in discrete sites within nuclei, termed replication compartments. We previously proposed that replication compartments consist of two subnuclear domains: "ongoing replication foci" and "BMRF1-cores". Viral genome replication takes place in ongoing replication foci, which are enriched with viral replication proteins, such as BALF5 and BALF2. Amplified DNA and BMRF1 protein accumulate in BMRF1-cores, which are surrounded by ongoing replication foci. We here determined the locations of procapsid and genome-packaging proteins of EBV via three-dimensional (3D) surface reconstruction and correlative fluorescence microscopy-electron microscopy (FM-EM). The results revealed that viral factors required for DNA packaging, such as BGLF1, BVRF1, and BFLF1 proteins, are located in the innermost subdomains of the BMRF1-cores. In contrast, capsid structural proteins, such as BBRF1, BORF1, BDLF1, and BVRF2, were found both outside and inside the BMRF1-cores. Based on these observations, we propose a model in which viral procapsids are assembled outside the BMRF1-cores and subsequently migrate therein, where viral DNA encapsidation occurs. To our knowledge, this is the first report describing capsid assembly sites in relation to EBV replication compartments.	[Sugimoto, Atsuko; Kanda, Teru; Murata, Takayuki; Tsurumi, Tatsuya] Aichi Canc Ctr Res Inst, Div Virol, Chikusa Ku, Nagoya, Aichi, Japan; [Sugimoto, Atsuko; Murata, Takayuki] Nagoya Univ, Grad Sch Med, Dept Virol, Showa Ku, Nagoya, Aichi, Japan; [Sugimoto, Atsuko; Murata, Takayuki] Fujita Hlth Univ, Sch Med, Dept Virol & Parasitol, Toyoake, Aichi, Japan; [Yamashita, Yoriko] Nagoya City Univ, Grad Sch Med Sci, Dept Expt Pathol & Tumor Biol, Nagoya, Aichi, Japan; [Kanda, Teru] Tohoku Med & Pharmaceut Univ, Fac Med, Div Microbiol, Sendai, Miyagi, Japan	Aichi Cancer Center; Nagoya University; Fujita Health University; Nagoya City University; Tohoku Medical & Pharmaceutical University	Murata, T (corresponding author), Aichi Canc Ctr Res Inst, Div Virol, Chikusa Ku, Nagoya, Aichi, Japan.; Murata, T (corresponding author), Nagoya Univ, Grad Sch Med, Dept Virol, Showa Ku, Nagoya, Aichi, Japan.; Murata, T (corresponding author), Fujita Hlth Univ, Sch Med, Dept Virol & Parasitol, Toyoake, Aichi, Japan.	tmurata@fujita-hu.ac.jp	Kanda, Teru/J-7313-2019; Murata, Takayuki/I-2621-2013	Murata, Takayuki/0000-0001-7228-0839; Kanda, Teru/0000-0002-1391-3349	Ministry of Education, Science, Sports, Culture and Technology of Japan [12J04062, 17J06368, 18K17362, 24659213, 19K07580]; Japan Agency for Medical Research, Development (Japanese Initiative for Progress of Research on Infectious Disease for Global Epidemic) [JP17fm0208016]; Takeda Science Foundation	Ministry of Education, Science, Sports, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research, Development (Japanese Initiative for Progress of Research on Infectious Disease for Global Epidemic); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Science, Sports, Culture and Technology of Japan (12J04062, 17J06368, 18K17362 to A. S., 24659213 to T. T., 19K07580 to T. M.), and Japan Agency for Medical Research, Development (Japanese Initiative for Progress of Research on Infectious Disease for Global Epidemic, JP17fm0208016 to T. M.), and the Takeda Science Foundation (to T. M.). The funders had no role in the study.	Albright BS, 2015, J VIROL, V89, P443, DOI 10.1128/JVI.01913-14; Albright BS, 2011, J VIROL, V85, P8616, DOI 10.1128/JVI.00123-11; BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; BOOY FP, 1994, P NATL ACAD SCI USA, V91, P5652, DOI 10.1073/pnas.91.12.5652; Bruck I, 2001, GENOME BIOL, V2; Chi JHI, 2000, J VIROL, V74, P1468, DOI 10.1128/JVI.74.3.1468-1476.2000; CHO MS, 1985, J VIROL, V56, P860, DOI 10.1128/JVI.56.3.860-866.1985; Conway JF, 2011, ALPHAHERPESVIRUSES: MOLECULAR VIROLOGY, P175; Daikoku T, 2006, J BIOL CHEM, V281, P11422, DOI 10.1074/jbc.M510314200; Daikoku T, 2005, J VIROL, V79, P3409, DOI 10.1128/JVI.79.6.3409-3418.2005; FIXMAN ED, 1995, J VIROL, V69, P2998, DOI 10.1128/JVI.69.5.2998-3006.1995; Germi R, 2012, J GEN VIROL, V93, P1769, DOI 10.1099/vir.0.043265-0; Henson BW, 2009, J VIROL, V83, P3877, DOI 10.1128/JVI.01733-08; Johannsen E, 2004, P NATL ACAD SCI USA, V101, P16286, DOI 10.1073/pnas.0407320101; Kim HS, 2011, J VIROL, V85, P12698, DOI 10.1128/JVI.05791-11; Kudoh A, 2003, J VIROL, V77, P851, DOI 10.1128/JVI.77.2.851-861.2003; Kudoh A, 2009, J VIROL, V83, P6641, DOI 10.1128/JVI.00049-09; LI JS, 1987, J VIROL, V61, P2947, DOI 10.1128/JVI.61.9.2947-2949.1987; Loret S, 2008, J VIROL, V82, P8605, DOI 10.1128/JVI.00904-08; McNab AR, 1998, J VIROL, V72, P1060, DOI 10.1128/JVI.72.2.1060-1070.1998; Murata T, 2014, MICROBIOL IMMUNOL, V58, P307, DOI 10.1111/1348-0421.12155; Murayama K, 2009, J BIOL CHEM, V284, P35896, DOI 10.1074/jbc.M109.051581; Newcomb WW, 2000, J VIROL, V74, P1663, DOI 10.1128/JVI.74.4.1663-1673.2000; NEWCOMB WW, 1993, J MOL BIOL, V232, P499, DOI 10.1006/jmbi.1993.1406; Newcomb WW, 2001, J VIROL, V75, P10923, DOI 10.1128/JVI.75.22.10923-10932.2001; Pavlova S, 2013, J VIROL, V87, P2011, DOI 10.1128/JVI.02533-12; Sheaffer AK, 2000, J VIROL, V74, P6838, DOI 10.1128/JVI.74.15.6838-6848.2000; Sugimoto A, 2013, J VIROL, V87, P6693, DOI 10.1128/JVI.00219-13; Sugimoto A, 2011, J VIROL, V85, P6127, DOI 10.1128/JVI.00258-11; Taus NS, 1998, VIROLOGY, V252, P115, DOI 10.1006/viro.1998.9439; Toropova K, 2011, J VIROL, V85, P7513, DOI 10.1128/JVI.00837-11; Trus BL, 2007, MOL CELL, V26, P479, DOI 10.1016/j.molcel.2007.04.010; Trus BL, 1996, J MOL BIOL, V263, P447, DOI 10.1016/S0022-2836(96)80018-0; TSURUMI T, 1993, J VIROL, V67, P7648, DOI 10.1128/JVI.67.12.7648-7653.1993; Visalli RJ, 2019, VIROLOGY, V529, P152, DOI 10.1016/j.virol.2019.01.003; Wang WH, 2015, J VIROL, V89, P8922, DOI 10.1128/JVI.01114-15; ZHOU ZH, 1995, NAT STRUCT BIOL, V2, P1026, DOI 10.1038/nsb1195-1026	37	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2019	14	9							e0222519	10.1371/journal.pone.0222519	http://dx.doi.org/10.1371/journal.pone.0222519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB3QG	31518362	Green Published, Green Submitted, gold			2022-12-26	WOS:000488471200001
J	Wang, LL; Liu, YM; Shu, XL; Lu, SY; Xie, XB; Shi, QS				Wang, Lingling; Liu, Yamin; Shu, Xiulin; Lu, Shunying; Xie, Xiaobao; Shi, Qingshan			Complexation and conformation of lead ion with poly-gamma-glutamic acid in soluble state	PLOS ONE			English	Article							EXTRACELLULAR POLYMERIC SUBSTANCES; NATURAL ORGANIC-MATTER; HEAVY-METALS; POLY(GAMMA-GLUTAMIC ACID); BIOSORPTION PROPERTIES; WATER TREATMENT; REMOVAL; ADSORPTION; EPS; BINDING	Complexation of microbial polymer in soluble state could impact the solubility, mobility, and bioavailability of heavy metals in the environment. The complexation of a bacterial exopolymer, poly-gamma-glutamic acid (gamma- PGA), with Pb2+ was studied using the polarographic method and circular dichroism measurement in soluble state. The number of available binding sites was determined based on the Chau's method and was found to be 0.04, 1.12, 3.56 and 4.51 mmol/(g dry weight of gamma- PGA) at pH 3.4, 4.2, 5.0 and 6.2, respectively. Further, the number of binding sites was determined based on the Ruzic's method and was found to be 3.60 and 4.41 mmol/(g dry weight of gamma-PGA) for pH 5.0 and 6.2, respectively. The constant (expressed as log K) values were 5.8 and 6.0 at pH 5.0 and 6.2. Compared to biopolymers secreted by other microorganisms, such as extracellular polymeric substances extraction from activated sludge, gamma-PGA was a more efficient Pb2+ carrier from pH 5.0 to 6.2. The secondary structure of gamma-PGA varied significantly when Pb2+ added. Ca2+ or Mg2+ replace a portion of the adsorbed Pb2+. However, the portion of Pb2+ involved in changing the gamma-PGA conformation was not easily replaced by Ca2+ and Mg2+.	[Wang, Lingling; Liu, Yamin; Shu, Xiulin; Lu, Shunying; Xie, Xiaobao; Shi, Qingshan] Guangdong Inst Microbiol, State Key Lab Appl Microbiol Southern China, Guangdong Prov Key Lab Microbial Culture Collect, Guangdong Open Lab Appl Microbiol, Guangzhou, Peoples R China	Guangdong Academy of Sciences; Institute of Microbiology, Guangdong Academy of Sciences	Xie, XB; Shi, QS (corresponding author), Guangdong Inst Microbiol, State Key Lab Appl Microbiol Southern China, Guangdong Prov Key Lab Microbial Culture Collect, Guangdong Open Lab Appl Microbiol, Guangzhou, Peoples R China.	xiaobaoxie@126.com; shiqingshan@hotmail.com	wang, lingling/O-5918-2014	wang, lingling/0000-0003-4067-1995; Shi, Qing-Shan/0000-0003-4228-3080	National Natural Science Foundation of China [21607031, 51802046]; Science Project of Guangdong Province, China [2018A030313656]; Guangdong Province Science and Technology Innovation Strategy Special Fund [2018B020206001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Project of Guangdong Province, China; Guangdong Province Science and Technology Innovation Strategy Special Fund	This work was funded by the National Natural Science Foundation of China (No. 21607031 to LLW, 51802046 to XLS) https://isisn.nsfc.gov.cn/egrantweb/, the Science Project of Guangdong Province, China (2018A030313656 to XLS) http://pro.gdstc.gov.cn/egrantweb/and the Guangdong Province Science and Technology Innovation Strategy Special Fund (2018B020206001 to QS) http://pro.gdstc.gov.cn/egrantweb/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti C, 2008, EUR J PHARM BIOPHARM, V70, P226, DOI 10.1016/j.ejpb.2008.04.004; Bajaj I, 2011, BIORESOURCE TECHNOL, V102, P5551, DOI 10.1016/j.biortech.2011.02.047; Bhatnagar A, 2017, CHEMOSPHERE, V166, P497, DOI 10.1016/j.chemosphere.2016.09.098; Bhattacharjee A, 2009, J PHYS CHEM B, V113, P13007, DOI 10.1021/jp905848x; Bostrom M, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.168103; Burakov AE, 2018, ECOTOX ENVIRON SAFE, V148, P702, DOI 10.1016/j.ecoenv.2017.11.034; Comte S, 2008, J HAZARD MATER, V151, P185, DOI 10.1016/j.jhazmat.2007.05.070; Comte S, 2006, ENZYME MICROB TECH, V38, P246, DOI 10.1016/j.enzmictec.2005.06.023; d'Abzac P, 2010, COLLOID SURFACE B, V80, P161, DOI 10.1016/j.colsurfb.2010.05.043; Decho AW, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00922; Fu FL, 2011, J ENVIRON MANAGE, V92, P407, DOI 10.1016/j.jenvman.2010.11.011; Garcia-Alvarez M, 2005, MACROMOL BIOSCI, V5, P30, DOI 10.1002/mabi.200400146; Guibaud G, 2005, PROCESS BIOCHEM, V40, P661, DOI 10.1016/j.procbio.2004.01.059; Gupta VK, 2015, ENVIRON ENG RES, V20, P1, DOI 10.4491/eer.2015.018; He LM, 2000, ENVIRON SCI TECHNOL, V34, P1694, DOI 10.1021/es991119e; Ihsanullah, 2016, SEP PURIF TECHNOL, V157, P141, DOI 10.1016/j.seppur.2015.11.039; MCLEAN RJC, 1990, APPL ENVIRON MICROB, V56, P3671, DOI 10.1128/AEM.56.12.3671-3677.1990; O'Connor D, 2018, SCI TOTAL ENVIRON, V619, P815, DOI 10.1016/j.scitotenv.2017.11.132; Ogunleye A, 2015, MICROBIOL-SGM, V161, P1, DOI 10.1099/mic.0.081448-0; Perret S, 2000, WATER RES, V34, P3614, DOI 10.1016/S0043-1354(00)00112-3; Rajan YC, 2014, J AGR FOOD CHEM, V62, P4803, DOI 10.1021/jf5011484; Sajid M, 2018, SEP PURIF TECHNOL, V191, P400, DOI 10.1016/j.seppur.2017.09.011; Sakamoto S, 2016, J ENVIRON RADIOACTIV, V165, P151, DOI 10.1016/j.jenvrad.2016.10.004; Siao FY, 2009, J AGR FOOD CHEM, V57, P777, DOI 10.1021/jf803006r; Sillanpaa M, 2018, CHEMOSPHERE, V190, P54, DOI 10.1016/j.chemosphere.2017.09.113; Sirisansaneeyakul S, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2338-y; Srivastava A, 2018, CRIT REV BIOTECHNOL, V38, P1176, DOI 10.1080/07388551.2018.1451984; Tourney J, 2014, CHEM GEOL, V386, P115, DOI 10.1016/j.chemgeo.2014.08.011; Vandenbossche M, 2015, CRIT REV ENV SCI TEC, V45, P1644, DOI 10.1080/10643389.2014.966425; Wang H, 2014, CHINESE J INORG CHEM, V30, P37; WANG L, 2017, SCI REP UK, V7; Wang LL, 2012, ENVIRON SCI TECHNOL, V46, P737, DOI 10.1021/es203540w; Yao J, 2007, J BIOMAT SCI-POLYM E, V18, P193, DOI 10.1163/156856207779116702; Yin YR, 2013, ENVIRON MONIT ASSESS, V185, P6713, DOI 10.1007/s10661-013-3059-9; Zanuy D, 1998, INT J BIOL MACROMOL, V23, P175, DOI 10.1016/S0141-8130(98)00047-6; Zhang S.M., 2015, PLOS ONE, V10; Zhang YN, 2018, ENVIRON SCI TECHNOL, V52, P10490, DOI 10.1021/acs.est.8b03258	37	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2019	14	9							e0218742	10.1371/journal.pone.0218742	http://dx.doi.org/10.1371/journal.pone.0218742			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4KS	31518361	gold, Green Published, Green Submitted			2022-12-26	WOS:000532219300005
J	Bazaldua, C; Cardoso-Taketa, A; Trejo-Tapia, G; Camacho-Diaz, B; Arellano, J; Ventura-Zapata, E; Villarreal, ML				Bazaldua, Crescencio; Cardoso-Taketa, Alexandre; Trejo-Tapia, Gabriela; Camacho-Diaz, Brenda; Arellano, Jesus; Ventura-Zapata, Elsa; Luisa Villarreal, Maria			Improving the production of podophyllotoxin in hairy roots of Hyptis suaveolens induced from regenerated plantlets	PLOS ONE			English	Article							CELL-SUSPENSION CULTURES; HEXANDRUM; LIGNANS; RESISTANCE; THIAMINE; DEFENSE; DISEASE; SYSTEM; L.	Ten Hyptis suaveolens hairy root lines were established by infecting nodal explants with K599+pGus-GFP+ and ATCC15834+pTDT strains from Agrobacterium rhizogenes. Genetic transformation was confirmed by epifluorescence and plagiotropic hairy root growth in absence of growth regulators. Cytotoxicity was determined using the sulforhodamine B method, and the production of podophyllotoxin (PTOX) was measured by high performance thin layer chromatography scanning. Through these methodologies, HsTD10 was identified as the hairy root line with the highest cytotoxicity and PTOX production, which was corroborated by liquid chromatography-mass spectrometry and micrOTOF-Q II. A suspension culture of HsTD10 was established in which PTOX and carbohydrate consumption during growth kinetics were quantified by high-performance liquid chromatography. Procedures to increase the production and retrieval of PTOX in the HsTD10 line included selection of culture medium, addition of thiamine, and modification of the PTOX extraction method. The best combination of these variables was MS medium at 75% of its components with the addition of 2 mg L-1 of thiamine, extraction with methanol-dichloromethane, and sonication at 40 +/- 5 degrees C. During kinetics, growth-associated PTOX accumulation was observed. The specific growth rate (mu) was 0.11 d(-1). The highest concentration of PTOX obtained with HsTD10 (5.6 mg g(-1) DW) was 100 times higher than that reported for roots of wild plants and 56 times higher than that for in vitro nontransformed roots of H. suaveolens.	[Bazaldua, Crescencio; Trejo-Tapia, Gabriela; Camacho-Diaz, Brenda; Ventura-Zapata, Elsa] Inst Politecn Nacl, Ctr Desarrollo Prod Biot, Dept Biotecnol, Yautepec, Morelos, Mexico; [Bazaldua, Crescencio; Cardoso-Taketa, Alexandre; Luisa Villarreal, Maria] Univ Autonoma Estado Morelos, Ctr Invest Biotecnol, Lab Plantas Med, Cuernavaca, Morelos, Mexico; [Arellano, Jesus] Univ Autonoma Estado Morelos, Ctr Invest Biotecnol, Lab Bot Estruct, Cuernavaca, Morelos, Mexico	Instituto Politecnico Nacional - Mexico; Universidad Autonoma del Estado de Morelos; Universidad Autonoma del Estado de Morelos	Bazaldua, C (corresponding author), Inst Politecn Nacl, Ctr Desarrollo Prod Biot, Dept Biotecnol, Yautepec, Morelos, Mexico.; Bazaldua, C; Villarreal, ML (corresponding author), Univ Autonoma Estado Morelos, Ctr Invest Biotecnol, Lab Plantas Med, Cuernavaca, Morelos, Mexico.	cbazaldua@ipn.mx; luisav@uaem.mx	Trejo-Tapia, Gabriela/M-3725-2013	Trejo-Tapia, Gabriela/0000-0002-7479-9332	CONACYT Ciencia Basica [222714]	CONACYT Ciencia Basica	This work was supported from a grant from CONACYT Ciencia Basica (222714) to MLV. The funder had no role in study design,data collecton and analysis,decision to publish, or preparation of the manuscript.	Abdel-Monaim MF, 2011, AFR J BIOTECHNOL, V10, P10842; Ahmad R, 2007, TROP J PHARM RES, V6, P803; Ahn IP, 2005, PLANT PHYSIOL, V138, P1505, DOI 10.1104/pp.104.058693; Alam MA, 2009, TURK J BOT, V33, P1; Anbazhagan VR, 2008, IN VITRO CELL DEV-PL, V44, P494, DOI 10.1007/s11627-008-9134-1; Arroo R. R. J., 2002, Phytochemistry Reviews, V1, P27, DOI 10.1023/A:1015824000904; Baldi Ashish, 2008, Biotechnology Journal, V3, P1256, DOI 10.1002/biot.200800173; Bazaldua C, 2014, JCPBS, V4, P37; Bedir E., 2002, Trends in new crops and new uses. Proceedings of the Fifth National Symposium, Atlanta, Georgia, USA, 10-13 November, 2001, P545; Boik J., 2001, J NAT PROD; Borges García Misterbino, 2011, Rev. colomb. biotecnol, V13, P221; Boubakri H, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-31; Caspeta L, 2005, PLANTA MED, V71, P1084, DOI 10.1055/s-2005-873170; Chattopadhyay S, 2001, BIOTECHNOL LETT, V23, P2063, DOI 10.1023/A:1013704116860; Chen G, 2013, IND ENG CHEM RES, V52, P1927, DOI 10.1021/ie303127c; Cong LH, 2015, PHYTOCHEMISTRY, V115, P70, DOI 10.1016/j.phytochem.2015.01.001; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Espinosa RA, 2002, BIOTECNOL VEG, V2, P39; Farkya S, 2008, J BIOSCI BIOENG, V105, P140, DOI 10.1263/jbb.105.140; Gang DR, 1999, J BIOL CHEM, V274, P7516, DOI 10.1074/jbc.274.11.7516; Giri A, 2000, CYTOTECHNOLOGY, V34, P17, DOI 10.1023/A:1008138230896; Hammouri MK, 1998, J AGR FOOD CHEM, V46, P1428, DOI 10.1021/jf970437z; Hano C, 2006, PLANTA, V223, P975, DOI 10.1007/s00425-005-0156-1; Jiménez-Mariña Liudmila, 2016, Agron. Mesoam, V27, P177, DOI 10.15517/am.v27i1.21897; Kamal A, 2017, ARAB J CHEM, V10, pS2539, DOI 10.1016/j.arabjc.2013.09.027; Koulman A, 2003, PLANTA MED, V69, P733, DOI 10.1055/s-2003-42776; Lautie E, 2008, J ETHNOPHARMACOL, V120, P402, DOI 10.1016/j.jep.2008.09.014; Mohagheghzadeh A., 2006, IRAN J PHARM SCI, V2, P47; Moraes RM, 2000, ECON BOT, V54, P471, DOI 10.1007/BF02866546; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nader BL, 2006, PLANTA MED, V72, P842, DOI 10.1055/s-2006-931601; Ooi CT, 2013, WORLD J MICROB BIOT, V29, P421, DOI 10.1007/s11274-012-1194-z; Renouard S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19040990; Renouard S, 2011, J AGR FOOD CHEM, V59, P8101, DOI 10.1021/jf201410p; Samadi A, 2014, PHARMACOGN MAG, V10, P154, DOI 10.4103/0973-1296.131027; Seidel V, 2002, PLANTA, V215, P1031, DOI 10.1007/s00425-002-0834-1; Sharma KV, 2013, INT J CHEM PHARM SCI, V4, P1; Shimon-Kerner N, 2000, PLANT CELL TISS ORG, V62, P89, DOI 10.1023/A:1026506426420; Thilip C, 2015, 3 BIOTECH, V5, P949, DOI 10.1007/s13205-015-0297-2; Vasilev NP, 2005, FITOTERAPIA, V76, P50, DOI 10.1016/j.fitote.2004.10.008; Veloz RA, 2013, PHARMACOGN RES, V5, P93, DOI 10.4103/0974-8490.110538; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wink Michael, 2005, Plant Genetic Resources Characterization and Utilization, V3, P90, DOI 10.1079/PGR200575; Zhou J, 2013, J EXP BOT, V64, P3261, DOI 10.1093/jxb/ert166	44	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2019	14	9							e0222464	10.1371/journal.pone.0222464	http://dx.doi.org/10.1371/journal.pone.0222464			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4IG	31513694	Green Published, gold			2022-12-26	WOS:000532212700083
J	Sistiaga, M; Herrmann, B; Larsen, RB; Brinkhof, J				Sistiaga, Manu; Herrmann, Bent; Larsen, Roger Bertrand; Brinkhof, Jesse			Quantification of bell-shaped size selectivity in shrimp trawl fisheries using square mesh panels and a sorting cone after a Nordmore grid	PLOS ONE			English	Article							REDFISH SEBASTES SPP.; BY-CATCH; CODENDS; DIAMOND; REDUCTION; BYCATCH; DESIGN; GULF	Shrimp trawlers in the Barents Sea use a Nordmore sorting grid ahead of a small-mesh codend to avoid bycatch while catching shrimps efficiently. However, small fish can still pass through the grid to enter the codend, which increases their risk of being retained. In this study, we quantified the selectivity of a standard Nordmore grid used together with one of two different codend designs, namely a diamond mesh codend with square mesh panels and a codend with a square mesh sorting cone section, for deep-water shrimp (Pandalus borealis), redfish (Sebastes spp.), and American plaice (Hippoglossoides platessoides). For the first time, the selective properties of these two alternative designs were estimated and compared to those of a Nordmore grid used together with a 35-mm diamond mesh codend, which is the compulsory gear used in the fishery today. With this traditional codend, the size selectivity of both bycatch species showed the expected characteristic bell-shaped size selection pattern, with low retention probability of very small fish and bigger fish but with high retention probability of certain sizes of juveniles. Using the square mesh sorting cone significantly reduced the maximum retention risk of redfish. The maximum retention with the diamond mesh codend with square mesh panels was estimated to be 14% lower than that of the traditional codend, but the difference was not statistically significant. The two alternative codend designs did not result in any significant reduction in bycatch of American plaice.	[Sistiaga, Manu; Herrmann, Bent; Brinkhof, Jesse] SINTEF Ocean, Trondheim, Norway; [Sistiaga, Manu] Inst Marine Res, Bergen, Norway; [Herrmann, Bent; Larsen, Roger Bertrand; Brinkhof, Jesse] Arctic Univ Norway, UiT, Tromso, Norway	SINTEF; Institute of Marine Research - Norway; UiT The Arctic University of Tromso	Sistiaga, M (corresponding author), SINTEF Ocean, Trondheim, Norway.; Sistiaga, M (corresponding author), Inst Marine Res, Bergen, Norway.	manu.sistiaga@hi.no	Larsen, Roger B./AAY-4314-2021	Herrmann, Bent/0000-0003-1325-6198; Larsen, Roger B./0000-0003-2884-5817	Arctic University of Norway (UIT) in Tromso; Norwegian Seafood Research Fund [901303]; Directorate of Fisheries of Norway	Arctic University of Norway (UIT) in Tromso; Norwegian Seafood Research Fund; Directorate of Fisheries of Norway	This work was supported by the Arctic University of Norway (UIT) in Tromso, the Norwegian Seafood Research Fund (Grant number 901303), and the Directorate of Fisheries of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broadhurst MK, 1996, FISH RES, V27, P203, DOI 10.1016/0165-7836(95)00469-6; Broadhurst MK, 2004, FISH RES, V67, P183, DOI 10.1016/j.fishres.2003.09.043; Chernick M., 2007, WILEY SERIES PROBABI; DEALTERIS JT, 1993, ICES MAR SC, V196, P128; Eayrs S, 2007, GUIDE BYCATCH REDUCT; FONTEYNE R, 1992, FISH RES, V13, P221, DOI 10.1016/0165-7836(92)90078-8; Garcia EG, 2007, ADV MAR BIOL, V52, P147, DOI 10.1016/S0065-2881(06)52002-4; Gullestad P, 2015, MAR POLICY, V54, P1, DOI 10.1016/j.marpol.2014.09.025; He PG, 2011, FISH RES, V111, P100, DOI 10.1016/j.fishres.2011.07.001; He PG, 2007, ICES J MAR SCI, V64, P1551, DOI 10.1093/icesjms/fsm098; Herrmann B, 2018, FISH RES, V207, P49, DOI 10.1016/j.fishres.2018.05.028; Herrmann Bent, 2012, Journal of Northwest Atlantic Fishery Science, V44, P1, DOI 10.2960/J.v44.m680; Herrmann B, 2013, AQUAT LIVING RESOUR, V26, P109, DOI 10.1051/alr/2013051; Herrmann B, 2013, FISH RES, V146, P59, DOI 10.1016/j.fishres.2013.04.004; ICES, 2018, ICES ADV FISH OPP CA, DOI [10.17895/ices.pub.4593, DOI 10.17895/ICES.PUB.4593]; ICES, 2021, ICES SCI REPORTS, V3, P58, DOI [10.17895/ices.pub.8196, DOI 10.17895/ICES.PUB.8196]; ISAKSEN B, 1992, FISH RES, V13, P335, DOI 10.1016/0165-7836(92)90086-9; Jacobsen JA., 1994, ICES FTFB WG M MONTP; Larsen RB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209621; Larsen RB, 2018, FISH RES, V208, P267, DOI 10.1016/j.fishres.2018.08.007; Larsen RB, 2018, ICES J MAR SCI, V75, P351, DOI 10.1093/icesjms/fsx117; Larsen RB, 2017, MAR COAST FISH, V9, P479, DOI 10.1080/19425120.2017.1360421; Larsen RB, 2016, FISH RES, V183, P385, DOI 10.1016/j.fishres.2016.07.013; LEHMANN K, 1993, ICES MAR SC, V196, P80; Madsen N, 2002, FISH RES, V57, P223, DOI 10.1016/S0165-7836(01)00355-1; MILLAR RB, 1992, FISH RES, V13, P205, DOI 10.1016/0165-7836(92)90077-7; O'Neill FG, 2006, FISH RES, V78, P333, DOI 10.1016/j.fishres.2005.12.012; Silva CNS, 2012, LAT AM J AQUAT RES, V40, P124, DOI 10.3856/vol40-issue1-fulltext-12; Sistiaga M, 2010, FISH RES, V105, P187, DOI 10.1016/j.fishres.2010.05.006; Thomassen T., 1975, 1975K51 ICES CM; THORSTEINSSON G, 1992, FISH RES, V13, P255, DOI 10.1016/0165-7836(92)90080-D; Thorsteinsson G, 1995, ICES FTFB WG M AB SC; Valdermarsen JW., 1986, FAO EXPERT CONSULTAT; WALSH SJ, 1992, FISH RES, V13, P235, DOI 10.1016/0165-7836(92)90079-9; Wileman D., 1996, 215 ICES COOP RES, P126, DOI 10.17895/ices.pub.4628	36	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2019	14	9							e0222391	10.1371/journal.pone.0222391	http://dx.doi.org/10.1371/journal.pone.0222391			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4IG	31513691	Green Published, gold			2022-12-26	WOS:000532212700066
J	Han, EC; Choi, SY; Lee, Y; Park, JW; Hong, SH; Lee, HJ				Han, Eun-Chong; Choi, Song-Yi; Lee, Youngkyun; Park, Jin-Woo; Hong, Su-Hyung; Lee, Heon-Jin			Extracellular RNAs in periodontopathogenic outer membrane vesicles promote TNF-alpha production in human macrophages and cross the blood-brain barrier in mice	FASEB JOURNAL			English	Article						microRNA; periodontitis; small RNA; extracellular vesicle; Aggregatibacter actinomycetemcomitans	CYTOLETHAL DISTENDING TOXIN; NECROSIS-FACTOR-ALPHA; AGGREGATIBACTER-ACTINOMYCETEMCOMITANS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; ALZHEIMERS-DISEASE; MICRORNAS; EXOSOMES; INTERLEUKIN-1-BETA; PERIODONTITIS; SECRETION	Among the main bacteria implicated in the pathology of periodontal disease, Aggregatibacter actinomycetemcomitans (Aa) is well known for causing loss of periodontal attachment and systemic disease. Recent studies have suggested that secreted extracellular RNAs (exRNAs) from several bacteria may be important in periodontitis, although their role is unclear. Emerging evidence indicates that exRNAs circulate in nanosized bilayered and membranous extracellular vesicles (EVs) known as outer membrane vesicles (OMVs) in gram-negative bacteria. In this study, we analyzed the small RNA expression profiles in activated human macrophage-like cells (U937) infected with OMVs from Aa and investigated whether these cells can harbor exRNAs of bacterial origin that have been loaded into the host RNA-induced silencing complex, thus regulating host target transcripts. Our results provide evidence for the cytoplasmic delivery and activity of microbial EV-derived small exRNAs in host gene regulation. The production of TNF-alpha was promoted by exRNAs via the TLR-8 and NF-kappa B signaling pathways. Numerous studies have linked periodontal disease to neuroinflammatory diseases but without elucidating specific mechanisms for the connection. We show here that intracardiac injection of Aa OMVs in mice showed successful delivery to the brain after crossing the blood brain barrier, the exRNA cargos increasing expression of TNF-alpha in the mouse brain. The current study indicates that host gene regulation by microRNAs originating from OMVs of the periodontal pathogen Aa is a novel mechanism for host gene regulation and that the transfer of OMV exRNAs to the brain may cause neuroinflammatory diseases like Alzheimer's.	[Han, Eun-Chong; Choi, Song-Yi; Hong, Su-Hyung; Lee, Heon-Jin] Kyungpook Natl Univ, Sch Dent, Dept Microbiol & Immunol, 2177 Dalgubeol Daero, Daegu 41940, South Korea; [Lee, Youngkyun] Kyungpook Natl Univ, Sch Dent, Dept Biochem, Daegu, South Korea; [Park, Jin-Woo] Kyungpook Natl Univ, Sch Dent, Dept Periodontol, Daegu, South Korea; [Lee, Heon-Jin] Kyungpook Natl Univ, Brain Sci & Engn Inst, Daegu, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University; Kyungpook National University	Lee, HJ (corresponding author), Kyungpook Natl Univ, Sch Dent, Dept Microbiol & Immunol, 2177 Dalgubeol Daero, Daegu 41940, South Korea.	heonlee@knu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Korean Government [MSIT 2017R1A5A2015391, 2018R1D1A3B07043539]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Korean Government(National Research Foundation of Korea)	The authors thank Dr. Eph Tunkle and Dr. Scott Young (U.S. National Institutes of Health, Bethesda, MD, USA) for critical reading of this manuscript. This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Korean Government (MSIT 2017R1A5A2015391 and 2018R1D1A3B07043539). The authors declare no conflicts of interest.	Ando-Suguimoto ES, 2014, CYTOKINE, V66, P46, DOI 10.1016/j.cyto.2013.12.014; Andras IE, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2015.1131804; Belibasakis GN, 2012, CYTOKINE, V59, P124, DOI 10.1016/j.cyto.2012.03.016; Bitto NJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07288-4; Blix IJS, 1999, J PERIODONTAL RES, V34, P34, DOI 10.1111/j.1600-0765.1999.tb02219.x; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; CHATTERJ.SN, 1967, J GEN MICROBIOL, V49, P1; Chen NH, 2017, IUBMB LIFE, V69, P297, DOI 10.1002/iub.1625; Choi JW, 2017, J DENT RES, V96, P458, DOI 10.1177/0022034516685071; Choi JW, 2018, CELL BIOCHEM BIOPHYS, V76, P293, DOI 10.1007/s12013-016-0770-5; Choi JW, 2017, EXP BIOL MED, V242, P1475, DOI 10.1177/1535370217723166; Choi S, 2019, J AM GERIATR SOC, V67, P1234, DOI 10.1111/jgs.15828; Choi SY, 2019, TISSUE ENG PT A, V25, P1146, DOI [10.1089/ten.tea.2018.0257, 10.1089/ten.TEA.2018.0257]; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Dinkins MB, 2014, NEUROBIOL AGING, V35, P1792, DOI 10.1016/j.neurobiolaging.2014.02.012; Dominy SS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3333; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Furuse Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106434; Gantier MP, 2008, J IMMUNOL, V180, P2117, DOI 10.4049/jimmunol.180.4.2117; Gao L, 2018, PROTEIN CELL, V9, P488, DOI 10.1007/s13238-018-0548-1; Garcia-Contreras M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05787-y; Gaur S, 2015, GERIATR GERONTOL INT, V15, P391, DOI 10.1111/ggi.12425; Ghosal A, 2015, MICROBIOLOGYOPEN, V4, P252, DOI 10.1002/mbo3.235; Graves D, 2008, J PERIODONTOL, V79, P1585, DOI 10.1902/jop.2008.080183; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Han XB, 2012, J BIOL CHEM, V287, P13778, DOI 10.1074/jbc.M112.342683; Henderson B, 2010, PERIODONTOL 2000, V54, P78, DOI 10.1111/j.1600-0757.2009.00331.x; Henry T, 2004, RES MICROBIOL, V155, P437, DOI 10.1016/j.resmic.2004.04.007; Kamer AR, 2008, ALZHEIMERS DEMENT, V4, P242, DOI 10.1016/j.jalz.2007.08.004; Kamer AR, 2009, J NEUROIMMUNOL, V216, P92, DOI 10.1016/j.jneuroim.2009.08.013; Kaparakis-Liaskos M, 2015, NAT REV IMMUNOL, V15, P375, DOI 10.1038/nri3837; Kato S, 2002, MICROB PATHOGENESIS, V32, P1, DOI 10.1006/mpat.2001.0474; Kieselbach T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138591; Kononen E, 2014, PERIODONTOL 2000, V65, P46, DOI 10.1111/prd.12016; Koeppen K, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005672; Konig MF, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaj1921; Kourembanas S, 2015, ANNU REV PHYSIOL, V77, P13, DOI 10.1146/annurev-physiol-021014-071641; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Lee HJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061487; Lee HJ, 2014, EXP BIOL MED, V239, P1275, DOI 10.1177/1535370214544269; Lee HJ, 2013, EXP BIOL MED, V238, P339, DOI 10.1258/ebm.2012.012251; Lee HJ, 2012, FEMS MICROBIOL LETT, V326, P131, DOI 10.1111/j.1574-6968.2011.02441.x; Matsumoto J, 2017, CURR PHARM DESIGN, V23, P6206, DOI 10.2174/1381612823666170913164738; Mulcahy LA, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24641; Naqvi AR, 2014, INNATE IMMUN-LONDON, V20, P540, DOI 10.1177/1753425913501914; Nishihara T, 2004, PERIODONTOL 2000, V36, P14, DOI 10.1111/j.1600-0757.2004.03671.x; Njock MS, 2015, BLOOD, V125, P3202, DOI 10.1182/blood-2014-11-611046; O'Donoghue EJ, 2016, CELL MICROBIOL, V18, P1508, DOI 10.1111/cmi.12655; Okinaga T, 2015, J INTERF CYTOK RES, V35, P431, DOI 10.1089/jir.2014.0127; Olsen I, 2016, J ORAL MICROBIOL, V8, DOI 10.3402/jom.v8.33029; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Patton JG, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27494; Pritchard AB, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00336; Rompikuntal PK, 2012, INFECT IMMUN, V80, P31, DOI 10.1128/IAI.06069-11; Thay B, 2014, INFECT IMMUN, V82, P4034, DOI 10.1128/IAI.01980-14; WISPELWEY B, 1989, INFECT IMMUN, V57, P2559, DOI 10.1128/IAI.57.8.2559-2562.1989; Wu YF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07991-4; Yoon YJ, 2014, BMB REP, V47, P531, DOI 10.5483/BMBRep.2014.47.10.164; Yuan DF, 2017, BIOMATERIALS, V142, P1, DOI 10.1016/j.biomaterials.2017.07.011; Yucel-Lindberg T, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.8; Yuyama K, 2015, FEBS LETT, V589, P84, DOI 10.1016/j.febslet.2014.11.027; Yuyama K, 2014, J BIOL CHEM, V289, P24488, DOI 10.1074/jbc.M114.577213	65	46	49	10	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13412	13422		10.1096/fj.201901575R	http://dx.doi.org/10.1096/fj.201901575R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31545910	Bronze, Green Published			2022-12-26	WOS:000507466100030
J	Lanzillo, B; Piscosquito, G; Marcuccio, L; Lanzillo, A; Vitale, DF				Lanzillo, Bernardo; Piscosquito, Giuseppe; Marcuccio, Laura; Lanzillo, Anna; Vitale, Dino Franco			Prognosis of severe acquired brain injury: Short and long-term outcome determinants and their potential clinical relevance after rehabilitation. A comprehensive approach to analyze cohort studies	PLOS ONE			English	Article							MODELS; PREDICTION	Background Accurate prognostic evaluation is a key factor in the clinical management of patients affected by severe acute brain injury (ABI) and helps planning focused therapies, better caregiver's support and allocation of resources. Aim of the study was to assess factors independently associated with both the short and long-term outcomes after rehabilitation in patients affected by ABI in the setting of a single Rehabilitation Unit specifically allocated to these patients. Methods and findings In all patients (567) with age. 18 years discharged from the Unit in the period 2006/2015 demographic, etiologic, comorbidity indicators, and descriptors of the disability burden (at hospital admission and discharge) were evaluated as potential prognostic factors of both short-term (4 classes of disability status at discharge) and long-term (mortality) outcomes. A comprehensive analytical method was adopted to combine several tasks. Select the factors with a significant independent association with the outcome, assess the relative weights and the "stability" (by bootstrap resampling) of them and estimate the role of the prognostic models in the clinical framework considering "cost" and "benefits". The generalized ordered logistic model for ordinal dependent variables was used for the short-term outcome while the Cox proportional hazard model was used for the long-term outcome. The final shortterm model identified 7 factors that independently account for 37% of the outcome variability as shown by pseudo R-2 (pR(2)) = 0.37. The disability status descriptors show the strongest association since they account for more than 60% of the pR(2), followed by age (14.8%), the presence of percutaneous endoscopic gastrostomy or nasogastric intubation (14.4%), a longer stay in the acute ward (5.9%) and concomitant coronary disease (1.3%). The final multivariable Cox model identified 4 factors that independently account for 52% of the outcome variability (R-2 = 0.52). The disability extent and the disability recovered lead the long-term mortality since they account for the 53% of the global R-2. The relevant effect of age (42%) is appreciable only after 2 years given the significant interaction with time. A longer stay in the acute ward explains the remaining fraction (5%). Considering 'cost and benefits', the decision curve analysis shows that the clinical benefit achieved by using both prognostic models is greater than the other possible action strategies, namely 'treat all' and 'treat none. Several less obvious characteristics of the prognostic models are appreciated by integrating the results of multiple analytical methods. Conclusion The comprehensive analytical tool aimed to integrate statistical significance, weight, "stability" and clinical "net" benefit, gives back a prognostic framework explaining a relevant portion of both outcomes' variability in which the strong association of the disability status with both outcomes is comparable to and followed by a time modulated role of age. Our data do not support a differentiated association of traumatic vs non-traumatic etiology. The results encourage the use of integrated approach to analyze cohort data.	[Lanzillo, Bernardo; Piscosquito, Giuseppe; Marcuccio, Laura; Lanzillo, Anna; Vitale, Dino Franco] IRCCS Telese Terme, Ist Clin Maugeri, Via Bagni Vecchi 1, Telese T, BN, Italy; [Vitale, Dino Franco] Casa Cura San Michele, Via Montella 16, Maddaloni, CE, Italy		Vitale, DF (corresponding author), IRCCS Telese Terme, Ist Clin Maugeri, Via Bagni Vecchi 1, Telese T, BN, Italy.; Vitale, DF (corresponding author), Casa Cura San Michele, Via Montella 16, Maddaloni, CE, Italy.	dinofranco.vitale@fastwebnet.it	Lanzillo, Anna/ABF-5999-2021; bernardo, lanzillo/F-1496-2019; piscosquito, giuseppe/A-9053-2018	Lanzillo, Anna/0000-0003-2385-401X; bernardo, lanzillo/0000-0001-5473-0701; piscosquito, giuseppe/0000-0001-6768-8936				Avesani R, 2013, EUR J PHYS REHAB MED, V49, P611; Colantonio A, 2011, J REHABIL MED, V43, P311, DOI 10.2340/16501977-0783; Cullen NK, 2008, BRAIN INJURY, V22, P1013, DOI 10.1080/02699050802530581; Formisano R, 2017, NEUROL SCI, V38, P181, DOI 10.1007/s10072-016-2724-5; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Gao JX, 2015, INT J CLIN EXP MED, V8, P19881; Gray DS, 2000, ARCH PHYS MED REHAB, V81, P1447, DOI 10.1053/apmr.2000.16343; Lanzillo B, 2015, EUR J PHYS REHAB MED, V51, P587; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Nieto FJ, 1996, AM J EPIDEMIOL, V143, P1059; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Royston P, 2008, MULTIVARIATE MODEL B, P183; Royston P, 2011, FLEXIBLE PARAMETRIC, P275; Sauerbrei W, 2007, BIOMETRICAL J, V49, P453, DOI 10.1002/bimj.200610328; Shorrocks AF, 2013, J ECON INEQUAL, V11, P99, DOI 10.1007/s10888-011-9214-z; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Smania N, 2013, J HEAD TRAUMA REHAB, V28, P131, DOI 10.1097/HTR.0b013e31823c0127; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; Vickers AJ, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-53; Vickers AJ, 2008, AM STAT, V62, P314, DOI 10.1198/000313008X370302; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Williams R, 2006, STATA J, V6, P58, DOI 10.1177/1536867X0600600104	25	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0216507	10.1371/journal.pone.0216507	http://dx.doi.org/10.1371/journal.pone.0216507			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557186	gold, Green Published			2022-12-26	WOS:000532345500005
J	Keutgen, AJ; Wszelaczynska, E; Poberezny, J; Przewodowska, A; Przewodowski, W; Milczarek, D; Tatarowska, B; Flis, B; Keutgen, N				Keutgen, Anna Jadwiga; Wszelaczynska, Elzbieta; Poberezny, Jaroslaw; Przewodowska, Agnieszka; Przewodowski, Wlodzimierz; Milczarek, Dorota; Tatarowska, Beata; Flis, Bogdan; Keutgen, Norbert			Antioxidant properties of potato tubers (Solanum tuberosum L.) as a consequence of genetic potential and growing conditions	PLOS ONE			English	Article							CHLOROGENIC ACID; CULTIVATION; HEALTH; COMPONENTS; NUTRITION; LOCATION; QUALITY	The concentrations of the bioactive compounds in potato tubers are determined by both genetic potential and environmental factors. The purpose of the experiment was to determine the influence of organic and integrated production on the expression of the genetic potential with respect to the antioxidant properties of potato tubers and to evaluate its stability under different environmental conditions. This phenotyping was performed on seven new breeding lines (tetraploid clones) and three modern cultivars: Jelly, Satina and Tajfun. The results indicated that production system and location significantly influenced the antioxidant capacity measured by FRAP method. Organic farming and the location Chwalowice were characterized by higher values. Furthermore, anitioxidative capacity measured by FRAP method was correlated with chlorogenic acid content (r = 0.590**) and glutathione fractions, especially with the reduced form (GSH, r = 0.692**). Multidimensional comparative analysis (MCA) proved a better development of antioxidant properties of potato tubers in the organic cultivation system when compared with the integrated. Especially favorable were growing conditions at Boguchwala (organic) and worst at Mlocho ' w (integrated). From all investigated varieties, the best antioxidant properties were found in 'Satina' and 'Jelly'. Clones TG-97403 and 13-VIII-45 developed the weakest health promoting traits.	[Keutgen, Anna Jadwiga; Keutgen, Norbert] BOKU Univ Nat Resources & Life Sci, Div Vegetables & Ornamentals, Dept Crop Sci, Vienna, Austria; [Wszelaczynska, Elzbieta; Poberezny, Jaroslaw] UTP Univ Sci & Technol, Dept Microbiol & Food Technol, Bydgoszcz, Poland; [Przewodowska, Agnieszka; Przewodowski, Wlodzimierz] Bonin Res Ctr, Plant Breeding & Acclimatizat Inst IHAR, Natl Res Inst, Bonin, Poland; [Milczarek, Dorota; Tatarowska, Beata; Flis, Bogdan] Mlochow Res Ctr, Plant Breeding & Acclimatizat Inst IHAR, Natl Res Inst, Mlochow, Poland	University of Natural Resources & Life Sciences, Vienna; Bydgoszcz University of Science & Technology; Institute of Plant Breeding & Acclimatization; Institute of Plant Breeding & Acclimatization	Keutgen, AJ (corresponding author), BOKU Univ Nat Resources & Life Sci, Div Vegetables & Ornamentals, Dept Crop Sci, Vienna, Austria.	anna.keutgen@boku.ac.at	Pobereżny, Jarosław/AAS-7388-2021; Wszelaczyńska, Elżbieta/AAS-7418-2021; Keutgen, Norbert/AAU-4045-2021; Keutgen, Norbert/G-1659-2019	Pobereżny, Jarosław/0000-0002-5446-3145; Wszelaczyńska, Elżbieta/0000-0003-4694-2522; Keutgen, Norbert/0000-0002-6625-5458; Keutgen, Norbert/0000-0002-6625-5458; Przewodowska, Agnieszka/0000-0002-4645-3772; Milczarek, Dorota/0000-0002-1914-9038; Tatarowska, Beata/0000-0003-2004-5671; Przewodowski, Wlodzimierz/0000-0002-4456-4727	National Science Centre Poland (Narodowe Centrum Nauki PL) [DEC-2013/11/B/NZ9/00778]; BOKU Vienna Open Access Publishing Fund	National Science Centre Poland (Narodowe Centrum Nauki PL); BOKU Vienna Open Access Publishing Fund	This work was financed by the resources of National Science Centre Poland (Narodowe Centrum Nauki PL) granted based on a decision number DEC-2013/11/B/NZ9/00778 entitled `Influence of genotype and environment on bioactive compounds and antioxidative potential in potato tubers'. Publication was supported by BOKU Vienna Open Access Publishing Fund.	Akyol H, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060835; ALBRECHT JA, 1993, J FOOD QUALITY, V16, P311, DOI 10.1111/j.1745-4557.1993.tb00116.x; Bartova V, 2013, EUR J AGRON, V49, P20, DOI 10.1016/j.eja.2013.02.009; Beals KA, 2019, AM J POTATO RES, V96, P102, DOI 10.1007/s12230-018-09705-4; Burlingame B, 2009, J FOOD COMPOS ANAL, V22, P494, DOI 10.1016/j.jfca.2009.09.001; Camin F, 2007, J SCI FOOD AGR, V87, P1330, DOI 10.1002/jsfa.2853; Camire ME, 2009, CRIT REV FOOD SCI, V49, P823, DOI 10.1080/10408390903041996; Eberhardt MV, 2000, NATURE, V405, P903, DOI 10.1038/35016148; Ezekiel R, 2013, FOOD RES INT, V50, P487, DOI 10.1016/j.foodres.2011.04.025; Ferrer-Gallego R, 2015, CHEM SENSES, V40, P381, DOI 10.1093/chemse/bjv018; Friedman M, 1997, J AGR FOOD CHEM, V45, P1523, DOI 10.1021/jf960900s; Galani JHY, 2017, HORTIC PLANT J, V3, P73, DOI 10.1016/j.hpj.2017.07.004; GRIFFITHS DW, 1992, J SCI FOOD AGR, V58, P41, DOI 10.1002/jsfa.2740580108; Grudzinska M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153980; Gugala M, 2017, PLANT SOIL ENVIRON, V63, P231, DOI 10.17221/196/2017-PSE; Gumul D, 2011, ACTA SCI POLON-TECHN, V10, P73; Hamouz K, 2005, PLANT SOIL ENVIRON, V51, P397, DOI 10.17221/3603-PSE; Hamouz K, 2013, PLANT SOIL ENVIRON, V59, P465, DOI 10.17221/460/2013-PSE; Keutgen AJ, 2008, FOOD CHEM, V107, P1413, DOI 10.1016/j.foodchem.2007.09.071; Keutgen AJ, 2020, POTATO RES, V63, P75, DOI 10.1007/s11540-019-09429-w; King JC, 2013, ADV NUTR, V4, p393S, DOI 10.3945/an.112.003525; Leo L, 2008, J AGR FOOD CHEM, V56, P4154, DOI 10.1021/jf073322w; Lombardo S, 2017, J FOOD COMPOS ANAL, V62, P189, DOI 10.1016/j.jfca.2017.05.014; Lombardo S, 2013, J FOOD COMPOS ANAL, V32, P28, DOI 10.1016/j.jfca.2013.08.003; Lombardo S, 2012, FOOD CHEM, V133, P1249, DOI 10.1016/j.foodchem.2011.10.005; Lovat C, 2016, CRIT REV FOOD SCI, V56, P2278, DOI 10.1080/10408398.2013.830208; Main Inspectorate of Plant Health and Seed Inspection (PIORIN), 2014, MET INT PROD ZIEMN; Mangge H, 2014, WORLD J CARDIOL, V6, P462, DOI 10.4330/wjc.v6.i6.462; McGill CR, 2013, ANN MED, V45, P467, DOI 10.3109/07853890.2013.813633; Murr C, 2009, ATHEROSCLEROSIS, V202, P543, DOI 10.1016/j.atherosclerosis.2008.04.047; Nowacki W., 2012, CHARACTERISTIC COUNT; Pinhero R. G., 2016, American Journal of Plant Sciences, V7, P69, DOI 10.4236/ajps.2016.71008; Raymundo R, 2018, EUR J AGRON, V100, P87, DOI 10.1016/j.eja.2017.11.008; Reddivari L, 2007, J AGR FOOD CHEM, V55, P8073, DOI 10.1021/jf071543w; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Smith-Spangler C, 2012, ANN INTERN MED, V157, P348, DOI 10.7326/0003-4819-157-5-201209040-00007; Tatarowska B, 2019, AM J POTATO RES, V96, P493, DOI 10.1007/s12230-019-09732-9; Tsao R., 2009, GLOBAL SCI BOOKS FOO, P125; Wang QY, 2011, NUTR CANCER, V63, P1044, DOI 10.1080/01635581.2011.597538; Willcox JK, 2004, CRIT REV FOOD SCI, V44, P275, DOI 10.1080/10408690490468489; Wszelaczynska E., 2004, Acta Scientiarum Polonorum - Agricultura, V3, P175	41	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222976	10.1371/journal.pone.0222976	http://dx.doi.org/10.1371/journal.pone.0222976			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553784	Green Published, gold			2022-12-26	WOS:000532319200048
J	Lee, CH; Kuo, FC; Tang, WH; Lu, CH; Su, SC; Liu, JS; Hsieh, CH; Hung, YJ; Lin, FH				Lee, Chien-Hsing; Kuo, Feng-Chih; Tang, Wen-Hao; Lu, Chieh-Hua; Su, Sheng-Chiang; Liu, Jhih-Syuan; Hsieh, Chang-Hsun; Hung, Yi-Jen; Lin, Fu-Huang			Serum E-selectin concentration is associated with risk of metabolic syndrome in females	PLOS ONE			English	Article							SOLUBLE E-SELECTIN; CELL-ADHESION MOLECULE-1; ESSENTIAL-HYPERTENSION; DIABETIC-PATIENTS; GLYCEMIC CONTROL; PREVALENCE; OBESITY; EXPRESSION; CORRELATE; DISEASE	Objectives Traits of metabolic syndrome (MetS) and biomarkers of inflammation and endothelial dysfunction were examined. We investigated the differences of various biomarkers among individuals with or without Mets in a gender-specific manner. The gender-specific associations between E-selectin and MetS were further evaluated. Methods A total of 205 patients were recruited from the outpatient clinics of Tri-Service General Hospital, Taipei, Taiwan. Inclusion criteria were age between 20-75 years and BMI < 35 kg/m(2). Demographic, anthropometric and MetS index data were compared between genders. Markers of inflammation and endothelial dysfunction were compared between individuals with or without MetS by gender. Results Age-adjusted E-selectin values showed significant positive correlations with BMI, waist-hip ratio, fasting plasma glucose, systolic and diastolic blood pressure, triglycerides, TNF-alpha, hsCRP and ICAM-1, and inverse correlation with HDL cholesterol. E-selectin levels were positively correlated with numbers of MetS components in females (P < 0.001) but not in males (P = 0.125). Conclusions Increased E-selectin levels are significantly associated with increased MetS risk in females, but not in males.	[Lee, Chien-Hsing; Kuo, Feng-Chih; Lu, Chieh-Hua; Su, Sheng-Chiang; Liu, Jhih-Syuan; Hsieh, Chang-Hsun] Triserv Gen Hosp, Natl Def Med Ctr, Dept Internal Med, Div Endocrinol & Metab, Taipei, Taiwan; [Tang, Wen-Hao; Hung, Yi-Jen] Triserv Gen Hosp, Div Endocrinol & Metab, Dept Internal Med, Song Shan Branch, Taipei, Taiwan; [Lin, Fu-Huang] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; Tri-Service General Hospital; National Defense Medical Center	Lin, FH (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.	noldling@ms10.hinet.net			Ministry of Science and Technology [MOST 104-2314-B-016-026, MOST 104-2314-B-016-053, MOST 105-2314-B-016-040-MY3]; Tri-Service General Hospital in Taiwan [TSGH-C104-199, TSGH-C105-005-S03, TSGH-C105-005-S04, TSGH-C105-120, TSGHC105-185, TSGH-C106-006-S01, TSGH-C106-006-S02, TSGH-C106-007-S01, TSGH-C107-005-007-S05, TSGH-C106-161, MAB-105-084]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Tri-Service General Hospital in Taiwan	This work was supported by research grants from the Ministry of Science and Technology (MOST 104-2314-B-016-026, MOST 104-2314-B-016-053, MOST 105-2314-B-016-040-MY3) and Tri-Service General Hospital (TSGH-C104-199, TSGH-C105-005-S03, TSGH-C105-005-S04, TSGH-C105-120, TSGHC105-185, TSGH-C106-006-S01, TSGH-C106-006-S02, TSGH-C106-007-S01, TSGH-C107-005-007-S05, TSGH-C106-161, MAB-105-084) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 1998, ARTERIOSCL THROM VAS, V18, P723, DOI 10.1161/01.ATV.18.5.723; Abramov Y, 2001, FERTIL STERIL, P7651; Bener A, 2010, BOSNIAN J BASIC MED, V10, P210, DOI 10.17305/bjbms.2010.2687; Boulbou MS, 2004, INT ANGIOL, V23, P18; Calabresi L, 2002, ARTERIOSCL THROM VAS, V22, P656, DOI 10.1161/hq0402.105901; Carter AM, 1997, DIABETIC MED, V14, P423, DOI 10.1002/(SICI)1096-9136(199706)14:6<423::AID-DIA421>3.0.CO;2-F; Ceriello A, 2004, DIABETES, V53, P701, DOI 10.2337/diabetes.53.3.701; Cockerill GW, 1999, ARTERIOSCL THROM VAS, V19, P910, DOI 10.1161/01.ATV.19.4.910; Cominacini L, 1997, DIABETOLOGIA, V40, P584, DOI 10.1007/s001250050719; COMINACINI L, 1995, DIABETOLOGIA, V38, P1122; Daniel Y, 2001, AM J REPROD IMMUNOL, V45, P154, DOI 10.1111/j.8755-8920.2001.450306.x; De Caterina R, 2001, AM J HYPERTENS, V14, P259, DOI 10.1016/S0895-7061(00)01276-0; Eder K, 2009, INFLAMM RES, V58, P727, DOI 10.1007/s00011-009-0060-4; Elhadd TA, 2003, INT ANGIOL, V22, P222; Er LK, 2012, AGING MALE, V15, P227, DOI 10.3109/13685538.2012.720742; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Gundogan K, 2009, METAB SYNDR RELAT D, V7, P427, DOI 10.1089/met.2008.0068; Hung YJ, 2010, DIABETES CARE, V33, P1840, DOI 10.2337/dc09-1073; Hwang LC, 2006, J FORMOS MED ASSOC, V105, P626, DOI 10.1016/S0929-6646(09)60161-3; Hwang S-J, 1997, CIRC J, P96; Hydrie MZI, 2009, METAB SYNDR RELAT D, V7, P119, DOI 10.1089/met.2008.0055; Jager A, 2000, DIABETES, V49, P485, DOI 10.2337/diabetes.49.3.485; Kawamura T, 1998, DIABETOLOGIA, V41, P911, DOI 10.1007/s001250051007; Kitaya K, 2010, MODERN PATHOL, V23, P1136, DOI 10.1038/modpathol.2010.98; Kowalska I, 2002, METABOLISM, V51, P733, DOI 10.1053/meta.2002.32802; Mabry RM, 2010, DIABETIC MED, V27, P593, DOI 10.1111/j.1464-5491.2010.02998.x; Matsumoto K, 2002, METABOLISM, V51, P932, DOI 10.1053/meta.2002.33354; Matsumoto K, 2002, DIABETES RES CLIN PR, V55, P131, DOI 10.1016/S0168-8227(01)00296-0; Misra A, 2009, METAB SYNDR RELAT D, V7, P497, DOI 10.1089/met.2009.0024; Palomo IG, 2009, MOL MED REP, V2, P481, DOI 10.3892/mmr_00000125; Pan WH, 2008, ASIA PAC J CLIN NUTR, V17, P37; Piercy KT, 2002, J SURG RES, V105, P215, DOI 10.1006/jsre.2002.6405; Roldan V, 2003, THROMB HAEMOSTASIS, V90, P1007, DOI 10.1160/TH02-09-0083; Rubin D, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-32; Ryo M, 2004, CIRC J, V68, P975, DOI 10.1253/circj.68.975; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Troseid M, 2005, SCAND J CLIN LAB INV, V65, P283, DOI 10.1080/00365510510013811; Tsou M.T., 2012, ADV AGING RES, V1, P53; Turhan H, 2006, INT J CARDIOL, V108, P224, DOI 10.1016/j.ijcard.2005.05.008; Vigano P, 1998, FERTIL STERIL, V69, P774, DOI 10.1016/S0015-0282(97)00565-7; Wang Z, 2012, HYPERTENS RES, V35, P413, DOI 10.1038/hr.2011.204; Weiss TW, 2013, METABOLISM, V62, P1008, DOI 10.1016/j.metabol.2013.01.019; Yasui T, 2009, EUR J ENDOCRINOL, V161, P267, DOI 10.1530/EJE-09-0063; Zanni MV, 2010, CLIN ENDOCRINOL, V73, P48, DOI 10.1111/j.1365-2265.2009.03741.x	44	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222815	10.1371/journal.pone.0222815	http://dx.doi.org/10.1371/journal.pone.0222815			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550292	Green Published, gold			2022-12-26	WOS:000532307700026
J	Santotoribio, JD; del Valle-Vazquez, L; Garcia-de la Torre, A; del Castillo-Otero, D; Lopez-Saez, JB; del Pino, MJS				Santotoribio, Jose D.; del Valle-Vazquez, Luis; Garcia-de la Torre, Angela; del Castillo-Otero, Daniel; Lopez-Saez, Juan-Bosco; Sanchez del Pino, Maria J.			The diagnostic value of pleural fluid homocysteine in malignant pleural effusion	PLOS ONE			English	Article							TUMOR-MARKERS; CARCINOEMBRYONIC ANTIGEN; DIFFERENTIAL-DIAGNOSIS; ACCURACY; MANAGEMENT	Background Pleural fluid homocysteine (HCY) can be useful for diagnosis of malignant pleural effusion (MPE). There are no published studies comparing the diagnostic accuracy of HCY with other tumour markers in pleural fluid for diagnosis of MPE. The aim was to compare the accuracy of HCY with that of carcinoembryonic antigen (CEA), cancer antigen (CA) 15.3, CA19.9 and CA125 in pleural fluid and to develop a probabilistic model using these biomarkers to differentiate benign (BPE) from MPE. Methods Patients with pleural effusion were randomly included. HCY, CEA, CA15.3, CEA19.9 and CA125 were quantified in pleural fluid. Patients were classified into two groups: MPE or BPE. By applying logistic regression analysis, a multivariate probabilistic model was developed using pleural fluid biomarkers. The diagnostic accuracy was determined by receiver operating characteristic (ROC) curves and calculating the area under the curve (AUC). Results Population of study comprised 133 patients (72 males and 61 females) aged between 1 and 96 years (median = 70 years), 81 BPE and 52 MPE. The logistic regression analysis included HCY (p< 0.0001) and CEA (p = 0.0022) in the probabilistic model and excluded the other tumour markers. The probabilistic model was: HCY+CEA = Probability(%) = 100x( 1 +e(-z))(-1), where Z = 0.5471x[ HCY]+0.3846x[ CEA]-8.2671. The AUCs were 0.606, 0.703, 0.778, 0.800, 0.846 and 0.948 for CA125, CA19.9, CEA, CA15.3, HCY and HCY+CEA, respectively. Conclusions Pleural fluid HCY has higher accuracy for diagnosis of MPE than CEA, CA15.3, CA19.9 and CA125. The combination of HCY and CEA concentrations in pleural fluid significantly improves the diagnostic accuracy of the test.	[Santotoribio, Jose D.] Puerto Real Univ Hosp, Dept Lab Med, Cadiz, Spain; [Santotoribio, Jose D.; Sanchez del Pino, Maria J.] Cadiz Univ, Sch Med, Dept Biomed Biotechnol & Publ Hlth, Cadiz, Spain; [del Valle-Vazquez, Luis] Hlth Ctr Las Beatas, Seville, Spain; [Garcia-de la Torre, Angela] Virgen Victoria Univ Hosp, Dept Lab Med, Malaga, Spain; [Garcia-de la Torre, Angela] Inst Invest Biomed Malaga IBIMA, Malaga, Spain; [del Castillo-Otero, Daniel] Puerto Real Univ Hosp, Dept Pneumol, Cadiz, Spain; [del Castillo-Otero, Daniel; Lopez-Saez, Juan-Bosco] Cadiz Univ, Sch Med, Dept Med, Cadiz, Spain; [Lopez-Saez, Juan-Bosco] Puerto Real Univ Hosp, Dept Internal Med, Cadiz, Spain	Universidad de Cadiz; Hospital Universitario Puerto Real; Universidad de Malaga; Universidad de Cadiz; Hospital Universitario Puerto Real; Universidad de Cadiz; Hospital Universitario Puerto Real	Santotoribio, JD (corresponding author), Puerto Real Univ Hosp, Dept Lab Med, Cadiz, Spain.; Santotoribio, JD (corresponding author), Cadiz Univ, Sch Med, Dept Biomed Biotechnol & Publ Hlth, Cadiz, Spain.	josediego.santotoribio@uca.es	Santotoribio, Jose D/L-8738-2016; LOPEZ-SAEZ, JUAN-BOSCO/J-5449-2014	Santotoribio, Jose D/0000-0002-8851-7551; LOPEZ-SAEZ, JUAN-BOSCO/0000-0002-4897-5283; del Valle Vazquez, Luis/0000-0001-9365-422X				[Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Chen S, 2015, CLIN CHIM ACTA, V441, P142, DOI 10.1016/j.cca.2014.12.029; Cobo E, 2002, MED CLIN-BARCELONA, V119, P230; Santotoribio JD, 2010, MED CLIN-BARCELONA, V135, P574, DOI 10.1016/j.medcli.2009.06.023; Egan AM, 2014, QJM-INT J MED, V107, P179, DOI 10.1093/qjmed/hct245; Ferreiro L, 2015, MED CLIN-BARCELONA, V145, P171, DOI 10.1016/j.medcli.2014.08.005; Gaspar MJ, 2008, ANTICANCER RES, V28, P2947; Heffner JE, 2008, MAYO CLIN PROC, V83, P235, DOI 10.4065/83.2.235; Li DD, 2014, TUMOR BIOL, V35, P6003, DOI 10.1007/s13277-014-1795-2; Liang QL, 2008, THORAX, V63, P35, DOI 10.1136/thx.2007.077958; Lippi G, 2012, CLIN CHEM LAB MED, V50, P2075, DOI 10.1515/cclm-2012-0372; Maroto-Sanchez B, 2016, CLIN CHEM LAB MED, V54, P1561, DOI 10.1515/cclm-2015-1040; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Porcel JM, 2004, CHEST, V126, P1757, DOI 10.1378/chest.126.6.1757; Roberts ME, 2010, THORAX, V65, P32, DOI 10.1136/thx.2010.136994; RUCKDESCHEL JC, 1995, SEMIN ONCOL, V22, P58; Santotoribio JD, 2015, TUMOR BIOL, V36, P7941, DOI 10.1007/s13277-015-3517-9; Shi HZ, 2008, RESPIROLOGY, V13, P518, DOI 10.1111/j.1440-1843.2008.01291.x; Thomas JM, 2013, CLIN CHEST MED, V34, P459, DOI 10.1016/j.ccm.2013.05.004; Trape J, 2004, TUMOR BIOL, V25, P276, DOI 10.1159/000081392; Trape J, 2012, TUMOR BIOL, V33, P1661, DOI 10.1007/s13277-012-0422-3; Volaric D, 2018, BIOCHEM MEDICA, V28, DOI 10.11613/BM.2018.010706; Wang YM, 2013, CLIN CHIM ACTA, V421, P230, DOI 10.1016/j.cca.2013.03.013; Wu Q, 2015, EXP THER MED, V9, P232, DOI 10.3892/etm.2014.2039; Yang Y, 2017, RESPIRATION, V94, P62, DOI 10.1159/000468545	25	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222616	10.1371/journal.pone.0222616	http://dx.doi.org/10.1371/journal.pone.0222616			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550262	gold, Green Published			2022-12-26	WOS:000532307700020
J	Petitte, J; Doherty, M; Ladd, J; Marin, CL; Siles, S; Michelou, V; Damon, A; Eckert, EQ; Huang, X; Rice, JW				Petitte, Jennifer; Doherty, Michael; Ladd, Jacob; Marin, Cassandra L.; Siles, Samuel; Michelou, Vanessa; Damon, Amanda; Eckert, Erin Quattrini; Huang, Xiang; Rice, John W.			Use of high-content analysis and machine learning to characterize complex microbial samples via morphological analysis	PLOS ONE			English	Article							COATINGS; TOOL	High Content Analysis (HCA) has become a cornerstone of cellular analysis within the drug discovery industry. To expand the capabilities of HCA, we have applied the same analysis methods, validated in numerous mammalian cell models, to microbiology methodology. Image acquisition and analysis of various microbial samples, ranging from pure cultures to culture mixtures containing up to three different bacterial species, were quantified and identified using various machine learning processes. These HCA techniques allow for faster cell enumeration than standard agar-plating methods, identification of "viable but not plate culturable" microbe phenotype, classification of antibiotic treatment effects, and identification of individual microbial strains in mixed cultures. These methods greatly expand the utility of HCA methods and automate tedious and low-throughput standard microbiological methods.	[Petitte, Jennifer; Doherty, Michael; Ladd, Jacob; Marin, Cassandra L.; Siles, Samuel; Michelou, Vanessa; Damon, Amanda; Eckert, Erin Quattrini; Huang, Xiang; Rice, John W.] Novozymes North Amer Inc, Durham, NC 27709 USA		Rice, JW (corresponding author), Novozymes North Amer Inc, Durham, NC 27709 USA.	jri@novozymes.com		Rice, John/0000-0001-5713-5430				Barros RC, 2017, J BIOMED MATER RES A, V105, P2252, DOI 10.1002/jbm.a.36092; Berg G, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00491; Berg G, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00148, 10.3389/fmicb.2014.00491]; Brodersen DE, 2000, CELL, V103, P1143, DOI 10.1016/S0092-8674(00)00216-6; Domingues JFD, 2015, ACTA BIOMATER, V18, P1, DOI 10.1016/j.actbio.2015.02.028; Durr O, 2018, ASSAY DRUG DEV TECHN, V16, P343, DOI 10.1089/adt.2018.859; Gilbert JA, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0069-1; Grote M, 2018, HIST PHIL LIFE SCI, V40, DOI 10.1007/s40656-017-0175-9; Hein CD, 2008, PHARM RES-DORDR, V25, P2216, DOI 10.1007/s11095-008-9616-1; Jones LH, 2017, NAT REV DRUG DISCOV, V16, P285, DOI 10.1038/nrd.2016.244; Jordan MI, 2015, SCIENCE, V349, P255, DOI 10.1126/science.aaa8415; Koydemir HC, 2015, LAB CHIP, V15, P1284, DOI 10.1039/c4lc01358a; Li M, 2015, ACTA PHARMACOL SIN, V36, P769, DOI 10.1038/aps.2015.28; Moellering RC, 2006, CLIN INFECT DIS, V42, pS3, DOI 10.1086/491708; Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4; Riss TL, 2004, CELL VIABILITY ASSAY; Rohde A, 2015, FOOD MICROBIOL, V46, P395, DOI 10.1016/j.fm.2014.09.002; Sincock SA, 2001, METHOD CELL BIOL, V64, P511; SORENSEN K, 1986, J IMMUNOL METHODS, V95, P291, DOI 10.1016/0022-1759(86)90419-9; Stiefel P, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0376-x; Sutton S., MICROBIOLOGY TOPICS; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; van der Heijden MGA, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002378; Vives-Rego J, 2000, FEMS MICROBIOL REV, V24, P429, DOI 10.1111/j.1574-6976.2000.tb00549.x; Wang Y, 2016, CURR OPIN BIOTECH, V41, P34, DOI 10.1016/j.copbio.2016.04.018; WATANAKUNAKORN C, 1984, J ANTIMICROB CHEMOTH, V14, P7, DOI 10.1093/jac/14.suppl_D.7; Zoffmann S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39387-9	27	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222528	10.1371/journal.pone.0222528	http://dx.doi.org/10.1371/journal.pone.0222528			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545814	Green Published, gold			2022-12-26	WOS:000532303200020
J	Zhu, XC; Gopurenko, D; Serrano, M; Spencer, MA; Pieterse, PJ; Skoneczny, D; Lepschi, BJ; Reigosa, MJ; Gurr, GM; Callaway, RM; Weston, LA				Zhu, Xiaocheng; Gopurenko, David; Serrano, Miguel; Spencer, Mark A.; Pieterse, Petrus J.; Skoneczny, Dominik; Lepschi, Brendan J.; Reigosa, Manuel J.; Gurr, Geoff M.; Callaway, Ragan M.; Weston, Leslie A.			Genetic evidence for plural introduction pathways of the invasive weed Paterson's curse (Echium plantagineum L.) to southern Australia	PLOS ONE			English	Article							PYRROLIZIDINE ALKALOIDS; INTERREGIONAL HYBRIDS; POPULATION-GENETICS; HISTORY; PLANT; AMPLIFICATION; EVOLUTION; RELEASE; REGIONS; BIOLOGY	Paterson's curse (Echium plantagineum L. (Boraginaceae)), is an herbaceous annual native to Western Europe and northwest Africa. It has been recorded in Australia since the 1800's and is now a major weed in pastures and rangelands, but its introduction history is poorly understood. An understanding of its invasion pathway and subsequent genetic structure is critical to the successful introduction of biological control agents and for provision of informed decisions for plant biosecurity efforts. We sampled E. plantagineum in its native (Iberian Peninsula), non-native (UK) and invaded ranges (Australia and South Africa) and analysed three chloroplast gene regions. Considerable genetic diversity was found among E. plantagineum in Australia, suggesting a complex introduction history. Fourteen haplotypes were identified globally, 10 of which were co-present in Australia and South Africa, indicating South Africa as an important source population, likely through contamination of traded goods or livestock. Haplotype 4 was most abundant in Australia (43%), and in historical and contemporary UK populations (80%), but scarce elsewhere (< 17%), suggesting that ornamental and/or other introductions from genetically impoverished UK sources were also important. Collectively, genetic evidence and historical records indicate E. plantagineum in southern Australia exists as an admixture that is likely derived from introduced source populations in both the UK and South Africa.	[Zhu, Xiaocheng; Gurr, Geoff M.; Weston, Leslie A.] Charles Sturt Univ, Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia; [Zhu, Xiaocheng; Gopurenko, David; Gurr, Geoff M.; Weston, Leslie A.] Charles Sturt Univ, NSW Dept Primary Ind, Wagga Wagga, NSW, Australia; [Serrano, Miguel] Univ Santiago de Compostela, Fac Pharm, Dept Bot, Santiago De Compostela, Spain; [Spencer, Mark A.] Nat Hist Museum, Dept Life Sci, London, England; [Pieterse, Petrus J.] Stellenbosch Univ, Dept Agron, Private Bag X1, Matieland, South Africa; [Skoneczny, Dominik] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Lepschi, Brendan J.] Ctr Australian Natl Biodivers Res, Australian Natl Herbarium, Canberra, ACT, Australia; [Reigosa, Manuel J.] Univ Vigo, Fac Biol, Dept Plant Biol & Soil Sci, Vigo, Pontevedra, Spain; [Callaway, Ragan M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA	Charles Sturt University; Charles Sturt University; NSW Department of Primary Industries; Universidade de Santiago de Compostela; Natural History Museum London; Stellenbosch University; University of Melbourne; Universidade de Vigo; University of Montana System; University of Montana	Zhu, XC (corresponding author), Charles Sturt Univ, Graham Ctr Agr Innovat, Wagga Wagga, NSW, Australia.; Zhu, XC (corresponding author), Charles Sturt Univ, NSW Dept Primary Ind, Wagga Wagga, NSW, Australia.	xzhu@csu.edu.au	Zhu, Xiaocheng/B-6963-2015; GURR, GEOFFREY M/F-3519-2011; Serrano, Miguel/AAX-7557-2020; Zhu, Xiaocheng/AAB-4897-2021; Gopurenko, David/H-3341-2014; Weston, Leslie/M-4557-2015; Reigosa Roger, Manuel Joaquin/K-3551-2013	Zhu, Xiaocheng/0000-0003-4468-1090; Serrano, Miguel/0000-0003-3079-2355; Zhu, Xiaocheng/0000-0003-4468-1090; Gopurenko, David/0000-0003-2886-1614; Weston, Leslie/0000-0002-1029-7982; Reigosa Roger, Manuel Joaquin/0000-0003-0527-1849; Gurr, Geoff/0000-0001-5008-7966	Australian Research Council [DP130104346]; Graham Centre for Agricultural Innovation (associated internal funding)	Australian Research Council(Australian Research Council); Graham Centre for Agricultural Innovation (associated internal funding)	This project was funded by the Australian Research Council (Discovery Project: DP130104346) to LAW and the Graham Centre for Agricultural Innovation (associated internal funding) to XZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker BS, 2017, MOL ECOL, V26, P1131, DOI 10.1111/mec.13998; Barnard M, 1963, HIST AUSTR; Bena G, 1998, MOL PHYLOGENET EVOL, V9, P552, DOI 10.1006/mpev.1998.0493; BURDON JJ, 1986, AUST J BIOL SCI, V39, P369, DOI 10.1071/BI9860369; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Clements DR, 2001, CAN J PLANT SCI, V81, P325, DOI 10.4141/P99-128; Correia M, 2016, J ECOL, V104, P1391, DOI 10.1111/1365-2745.12612; Cristescu ME, 2015, MOL ECOL, V24, P2212, DOI 10.1111/mec.13117; Cronk Q.C.B., 2001, PLANT INVADERS THREA; Darling JA, 2008, MOL ECOL, V17, P4992, DOI 10.1111/j.1365-294X.2008.03978.x; Dehnen-Schmutz K, 2007, DIVERS DISTRIB, V13, P527, DOI 10.1111/j.1472-4642.2007.00359.x; Estoup A, 2010, MOL ECOL, V19, P4113, DOI 10.1111/j.1365-294X.2010.04773.x; Evans KJ, 2007, AUST SYST BOT, V20, P187, DOI 10.1071/SB06044; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faulkner KT, 2016, BIOL INVASIONS, V18, P73, DOI 10.1007/s10530-015-0990-4; Filipe JC, 2016, PLANT ECOL DIVERS, V9, P381, DOI 10.1080/17550874.2016.1261950; Gau RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067944; GIBBS P.E., 1971, LAGASCALIA, V1, P27; Gildenhuys E, 2015, BOT J LINN SOC, DOI [10.1111/boj.12238, DOI 10.1111/BOJ.12238]; Gopurenko David, 2013, Records of the Western Australian Museum, P253; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hamilton MB, 1999, MOL ECOL, V8, P521; Handley LJL, 2011, BIOCONTROL, V56, P409, DOI 10.1007/s10526-011-9386-2; Henderson L., 2001, PLANT PROTECTION RES; Ireson JE, 2003, BIOL CONTROL, V26, P117, DOI 10.1016/S1049-9644(02)00128-7; Kannan R, 2013, BIOL INVASIONS, V15, P1287, DOI 10.1007/s10530-012-0365-z; Keller SR, 2012, MOL ECOL, V21, P4721, DOI 10.1111/j.1365-294X.2012.05751.x; Kloot P. M., 1982, AUSTR WEEDS, V1, P29; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; Loudon J.C., 1830, LOUDONS HORTUS BRITA; Massy C., 2007, AUSTR MERINO STORY N; Michaelides SN, 2015, MOL ECOL, V24, P2702, DOI 10.1111/mec.13206; Montesinos D, 2018, ECOL EVOL, V8, P7378, DOI 10.1002/ece3.4080; Montesinos D, 2017, ECOGRAPHY, V40, P801, DOI 10.1111/ecog.02653; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Museum NH, ECH PLANT L PURPL VI; Nei M., 1987, MOL EVOLUTIONARY GEN; Novak SJ, 2001, BIOSCIENCE, V51, P114, DOI 10.1641/0006-3568(2001)051[0114:TPIASG]2.0.CO;2; NRM SatSTCA, 2016, PAT CURS 2009; Petit R, 2006, CONTRIB; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; PIGGIN C M, 1977, Muelleria, V3, P215; PIGGIN CM, 1982, J AUST I AGR SCI, V48, P3; Pimentel D., 2002, BIOL INVASIONS EC EN; Pysek P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024890; Retief E, 1998, BOTHALIA, V28, P167, DOI 10.4102/abc.v28i2.634; Rivas-Martinez S., 2017, PLANT VEGETATION VEG, VVolume 12, P131, DOI DOI 10.1007/978-3-319-54784-8_5; Shaik RS, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cow030; Skoneczny D, 2017, 8 WORLD C ALL; Skoneczny D, 2015, INT J MOL SCI, V16, P26721, DOI 10.3390/ijms161125979; SLATKIN M, 1991, GENETICS, V127, P627; Su NY, 2013, FLA ENTOMOL, V96, P765, DOI 10.1653/024.096.0309; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; USDA, 2017, WEED RISK ASS ECH PL; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Welsh F., 1998, HIST S AFRICA; Weston L. A., 2011, 23rd Asian-Pacific Weed Science Society Conference. Volume 1: weed management in a changing world, Cairns, Queensland, Australia, 26-29 September 2011, P576; Weston PA, 2013, PHYTOCHEM REV, V12, P831, DOI 10.1007/s11101-013-9306-4; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Work TT, 2005, BIOL INVASIONS, V7, P323, DOI 10.1007/s10530-004-1663-x; Zhu X, 2014, 19 AUSTR WEEDS C; Zhu XC, 2017, SCI REP-UK, V7, DOI 10.1038/srep42792; Zhu XC, 2016, J EXP BOT, V67, P3777, DOI 10.1093/jxb/erw182; Zimmerman H. G, 2003, INVASIVE ALIEN SPECI, P45	66	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222696	10.1371/journal.pone.0222696	http://dx.doi.org/10.1371/journal.pone.0222696			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536564	Green Published, gold, Green Submitted			2022-12-26	WOS:000532262800071
J	Lensen, RCMM; Moons, CPH; Diederich, C				Lensen, Rian C. M. M.; Moons, Christel P. H.; Diederich, Claire			Physiological stress reactivity and recovery related to behavioral traits in dogs (Canis familiaris)	PLOS ONE			English	Article							CHROMOGRANIN-A CONCENTRATIONS; SALIVARY CORTISOL; STARTLING STIMULI; RESPONSES; TEMPERAMENT; PERSONALITY; VALIDATION; ANXIETY; MARKER; GUIDE	This study investigated whether stress responsiveness (in one context) can be used to predict dog behavior in daily life. On two occasions (N-T1 = 32 puppies; N-T2 = 16 young adults), dogs' physiological stress response after a behavioral test at home was measured in terms of reactivity (10 min post-test) and recovery (40 min post-test) for three salivary markers: cortisol, chromogranin A (CgA) and secretory immunoglobulin A (sIgA). For each marker, it was determined whether dogs with a strong physiological response displayed different behavior in daily life compared to dogs with a weaker physiological response. The results revealed three main findings: first, for CgA and cortisol, different patterns were identified according to sample time. High reactivity related to desirable traits, whereas slow recovery after the behavioral test related to undesirable traits. The findings suggest that increased levels of CgA and cortisol 10 minutes after the behavioral test reflected an adaptive stress response, whereas elevated levels 40 minutes after the test reflected unsuccessful coping. Second, patterns for sIgA differed from CgA and cortisol: significant associations were only found with behavioral traits at T2, mostly considered desirable and related to Trainability. Possibly, the delayed reaction pattern of sIgA caused this difference between markers, as sIgA reflects the (secondary) immune response to stress, due to immunosuppressive effects of cortisol. Third, predictive capacity of puppies' physiological stress response (T1) was inconclusive, and contrary relations were found with behavioral traits at T2, suggesting that developmental factors play an important role. This study provides new insights about the relation between stress physiology and behavioral traits, and methodological advice is given to study these patterns further. In conclusion, physiological markers could provide additional insights in dogs' tendencies to display certain behaviors, especially at the young adult stage. Further studies are needed to confirm these patterns.	[Lensen, Rian C. M. M.; Diederich, Claire] Univ Namur, Dept Vet Med IVRU, Namur, Belgium; [Moons, Christel P. H.] Univ Ghent, Dept Nutr Genet & Ethol, Merelbeke, Belgium	University of Namur; Ghent University	Diederich, C (corresponding author), Univ Namur, Dept Vet Med IVRU, Namur, Belgium.	claire.diederich@unamur.be		DIEDERICH, Claire/0000-0002-0063-3903	Federal Public Service of Health, Food Chain Safety and Environment; Public Service of Wallonia [RT 10/12 CONDOG]	Federal Public Service of Health, Food Chain Safety and Environment; Public Service of Wallonia	This study (author Rian Lensen) was supported by the Federal Public Service of Health, Food Chain Safety and Environment (https://www.health.belgium.be/en), and the Public Service of Wallonia (https://spw.wallonie.be/); contract RT 10/12 CONDOG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi H, 2005, AM J VET RES, V66, P1830, DOI 10.2460/ajvr.2005.66.1830; Appleby D, 2003, VET CLIN N AM-SMALL, V33, P321, DOI 10.1016/S0195-5616(02)00101-8; Barnard S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149831; Beerda B, 1999, PHYSIOL BEHAV, V66, P243, DOI 10.1016/S0031-9384(98)00290-X; Beerda B, 1998, APPL ANIM BEHAV SCI, V58, P365, DOI 10.1016/S0168-1591(97)00145-7; Beerda B, 2000, ANIM WELFARE, V9, P49; Bennett A, 2010, DOMEST ANIM ENDOCRIN, V39, P171, DOI 10.1016/j.domaniend.2010.04.003; Bosch JA, 2002, INT REV NEUROBIOL, V52, P213; Carere C, 2010, CURR ZOOL, V56, P728, DOI 10.1093/czoolo/56.6.728; Cava F, BIOL VARIATION DESIR; Cobb ML, 2016, DOMEST ANIM ENDOCRIN, V57, P31, DOI 10.1016/j.domaniend.2016.04.003; Day MJ, 2007, J COMP PATHOL, V137, pS10, DOI 10.1016/j.jcpa.2007.04.005; Dreschel NA, 2005, APPL ANIM BEHAV SCI, V95, P153, DOI 10.1016/j.applanim.2005.04.009; Duffy DL, 2012, APPL ANIM BEHAV SCI, V138, P99, DOI 10.1016/j.applanim.2012.02.011; Escribano D, 2013, ANIMAL, V7, P640, DOI 10.1017/S1751731112002005; Forstmeier W, 2017, BIOL REV, V92, P1941, DOI 10.1111/brv.12315; Foyer P, 2014, APPL ANIM BEHAV SCI, V155, P93, DOI 10.1016/j.applanim.2014.03.006; Glenk LM, 2014, J VET BEHAV, V9, P98, DOI 10.1016/j.jveb.2014.02.005; Haverbeke A, 2008, PHYSIOL BEHAV, V93, P59, DOI 10.1016/j.physbeh.2007.07.014; Hekman Jessica P, 2014, Animals (Basel), V4, P331, DOI 10.3390/ani4020331; Hennessy MB, 1998, APPL ANIM BEHAV SCI, V61, P63, DOI 10.1016/S0168-1591(98)00179-8; Hennessy MB, 2013, APPL ANIM BEHAV SCI, V149, P1, DOI 10.1016/j.applanim.2013.09.004; Hiby EF, 2006, PHYSIOL BEHAV, V89, P385, DOI 10.1016/j.physbeh.2006.07.012; Horvath Z, 2007, HORM BEHAV, V52, P621, DOI 10.1016/j.yhbeh.2007.08.001; Hsu YY, 2003, J AM VET MED ASSOC, V223, P1293, DOI 10.2460/javma.2003.223.1293; Ivkovic N, 2015, ACTA FAC MEDICAE NAI, V32, P91, DOI 10.1515/afmnai-2015-0010; Jones AC, 2005, APPL ANIM BEHAV SCI, V95, P1, DOI 10.1016/j.applanim.2005.04.008; Kanai K, 2008, J VET SCI, V9, P421, DOI 10.4142/jvs.2008.9.4.421; Kennedy B, 2001, LIFE SCI, V69, P87, DOI 10.1016/S0024-3205(01)01111-0; Kikkawa A, 2005, J VET MED SCI, V67, P707, DOI 10.1292/jvms.67.707; Kikkawa A, 2003, J VET MED SCI, V65, P689, DOI 10.1292/jvms.65.689; King T, 2003, APPL ANIM BEHAV SCI, V82, P45, DOI 10.1016/S0168-1591(03)00040-6; Kobelt AJ, 2003, RES VET SCI, V75, P157, DOI 10.1016/S0034-5288(03)00080-8; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Lensen CMM, 2015, J VET BEHAV, V10, P504, DOI 10.1016/j.jveb.2015.08.006; Ley J, 2007, APPL ANIM BEHAV SCI, V104, P71, DOI 10.1016/j.applanim.2006.03.021; Lucassen PJ, 2014, ACTA NEUROPATHOL, V127, P109, DOI 10.1007/s00401-013-1223-5; Mills DS, 2003, APPL ANIM BEHAV SCI, V81, P265, DOI 10.1016/S0168-1591(02)00286-1; Mormede P, 2007, PHYSIOL BEHAV, V92, P317, DOI 10.1016/j.physbeh.2006.12.003; Nakane H, 1998, BIOMED RES-TOKYO, V19, P401, DOI 10.2220/biomedres.19.401; Ng ZY, 2014, APPL ANIM BEHAV SCI, V159, P69, DOI 10.1016/j.applanim.2014.07.009; Ninomiya S, 2011, ANIM SCI J, V82, P787, DOI 10.1111/j.1740-0929.2011.00896.x; Ott S, 2014, RES VET SCI, V97, P124, DOI 10.1016/j.rvsc.2014.06.002; Overall KL, 2013, MANUAL CLIN BEHAV ME, V1st; Protopopova A, 2016, PHYSIOL BEHAV, V159, P95, DOI 10.1016/j.physbeh.2016.03.020; Rayment DJ, 2015, APPL ANIM BEHAV SCI, V163, P1, DOI 10.1016/j.applanim.2014.11.020; Riemer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101237; Rosado B, 2010, APPL ANIM BEHAV SCI, V123, P124, DOI 10.1016/j.applanim.2010.01.009; Salimetrics LLC, 2013, SALIVA COLLECTION HA; Sandri M, 2015, J VET BEHAV, V10, P302, DOI 10.1016/j.jveb.2015.03.011; Schalke E, 2007, APPL ANIM BEHAV SCI, V105, P369, DOI 10.1016/j.applanim.2006.11.002; Sforzini E, 2009, J VET BEHAV, V4, P3, DOI 10.1016/j.jveb.2008.09.035; Sherman BL, 2015, J VET BEHAV, V10, P94, DOI 10.1016/j.jveb.2014.12.007; Siniscalchi M, 2013, RES VET SCI, V94, P49, DOI 10.1016/j.rvsc.2012.02.017; SKANDAKUMAR S, 1995, ANIM WELFARE, V4, P339; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Svobodova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090820; Toda M, 2008, ARCH ORAL BIOL, V53, P964, DOI 10.1016/j.archoralbio.2008.04.002; Uher J, 2011, DEV PSYCHOBIOL, V53, P521, DOI 10.1002/dev.20544; van den Berg L, 2006, BEHAV GENET, V36, P882, DOI 10.1007/s10519-006-9089-0; Wolf M, 2008, P NATL ACAD SCI USA, V105, P15825, DOI 10.1073/pnas.0805473105; Wormald D, 2016, APPL ANIM BEHAV SCI, V180, P93, DOI 10.1016/j.applanim.2016.04.007	62	12	12	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222581	10.1371/journal.pone.0222581	http://dx.doi.org/10.1371/journal.pone.0222581			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527914	Green Published, gold, Green Submitted			2022-12-26	WOS:000532231400029
J	Senkerikova, R; Frankova, S; Jirsa, M; Kreidlova, M; Merta, D; Neroldova, M; Chmelova, K; Spicak, J; Sperl, J				Senkerikova, Renata; Frankova, Sona; Jirsa, Milan; Kreidlova, Miluse; Merta, Dusan; Neroldova, Magdalena; Chmelova, Klara; Spicak, Julius; Sperl, Jan			PNPLA3 rs738409 G allele carriers with genotype 1b HCV cirrhosis have lower viral load but develop liver failure at younger age	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; GREATER-THAN-G; HEPATOCELLULAR-CARCINOMA; FIBROSIS PROGRESSION; CONFERS SUSCEPTIBILITY; GENETIC-VARIATION; INCREASED RISK; VARIANT; DISEASE; POLYMORPHISM	Background PNPLA3 rs738409 minor allele c.444G represents a risk factor for liver steatosis and fibrosis progression also in chronic hepatitis C (HCV). We investigated its impact on the timing of liver transplantation (LT) in patients with genotype 1b HCV cirrhosis. Methods We genotyped and evaluated 172 LT candidates with liver cirrhosis owing to chronic HCV infection, genotype 1b. One hundred patients needed LT for chronic liver failure (CLF) and 72 for a small hepatocellular carcinoma (HCC) in the cirrhotic liver without CLF. Population controls (n = 647) were selected from the Czech cross-sectional study MONICA. Results The CLF patients were younger (53.5 +/- 7.2 vs. 59.6 +/- 6.6, P < 0.001) with more advanced liver disease than HCC patients (Child-Pugh's score 9.1 +/- 1.8 vs. 7.1 +/- 1.9, P < 0.001, MELD 14.1 +/- 3.9 vs. 11.1 +/- 3.7, P < 0.001). PNPLA3 G allele increased the risk of LT for CLF in both allelic and recessive models (CG + GG vs. CC: OR, 1.90; 95% CI, 1.017-3.472, P = 0.045 and GG vs. CC + CG: OR, 2.94; 95% CI, 1.032-7.513, P = 0.042). Multivariate analysis identified younger age (P < 0.001) and the G allele (P < 0.05) as risk factors for CLF. The genotype frequencies between the CLF group and MONICA study significantly differed in both, allelic and recessive model (P = 0.004, OR 1.87, 95% CI 1.222-2.875; P < 0.001, OR 3.33, 95% CI 1.824-6.084, respectively). The OR values almost doubled in the recessive model compared with the allelic model suggesting the additive effect of allele G. In contrast, genotype frequencies in the HCC group were similar to the MONICA study in both models. Pretransplant viral load was significantly lower in GG than in CC + CG genotypes (median, IQR; 162,500 (61,550-319,000) IU/ml vs. 570,000 (172,000-1,595,000) IU/ml, P < 0.0009). Conclusions Our results suggest that PNPLA3 rs738409 G allele carriage may be associated with a faster progression of HCV cirrhosis to chronic liver failure.	[Senkerikova, Renata; Frankova, Sona; Chmelova, Klara; Spicak, Julius; Sperl, Jan] Inst Clin & Expt Med, Transplant Ctr, Dept Hepatogastroenterol, Prague, Czech Republic; [Senkerikova, Renata; Jirsa, Milan; Neroldova, Magdalena; Chmelova, Klara; Sperl, Jan] Charles Univ Prague, Fac Med 1, Prague, Czech Republic; [Jirsa, Milan; Neroldova, Magdalena] Inst Clin & Expt Med, Lab Expt Hepatol, Prague, Czech Republic; [Kreidlova, Miluse] Charles Univ Prague, Inst Med Biochem & Lab Diagnost, Fac Med 1, Prague, Czech Republic; [Kreidlova, Miluse] Gen Univ Hosp Prague, Prague, Czech Republic; [Merta, Dusan] Inst Clin & Expt Med, Anesthesiol Resuscitat & Intens Care Dept, Prague, Czech Republic	Institute for Clinical & Experimental Medicine (IKEM); Charles University Prague; Institute for Clinical & Experimental Medicine (IKEM); Charles University Prague; General University Hospital Prague; Institute for Clinical & Experimental Medicine (IKEM)	Sperl, J (corresponding author), Inst Clin & Expt Med, Transplant Ctr, Dept Hepatogastroenterol, Prague, Czech Republic.; Sperl, J (corresponding author), Charles Univ Prague, Fac Med 1, Prague, Czech Republic.	jan.sperl@ikem.cz	Neroldova, Magdalena/M-2298-2017	Neroldova, Magdalena/0000-0002-3792-9564	Ministry of Health, Czech Republic [00023001]	Ministry of Health, Czech Republic(Ministry of Health, Czech RepublicCzech Republic Government)	The study was supported by the project (Ministry of Health, Czech Republic) for development of research organization 00023001 (Institute for Clinical and Experimental Medicine, Prague, Czech Republic) - institutional support. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abul-Husn NS, 2018, NEW ENGL J MED, V378, P1096, DOI 10.1056/NEJMoa1712191; Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Aleman S, 2013, CLIN INFECT DIS, V57, P230, DOI 10.1093/cid/cit234; Ali M, 2016, CLIN GASTROENTEROL H, V14, P295, DOI 10.1016/j.cgh.2015.08.018; Jimenez-Sousa MA, 2018, J CLIN VIROL, V103, P71, DOI 10.1016/j.jcv.2018.04.008; BasuRay S, 2019, P NATL ACAD SCI USA, V116, P9521, DOI 10.1073/pnas.1901974116; Belli LS, 2018, J HEPATOL, V69, P810, DOI 10.1016/j.jhep.2018.06.010; Cifkova R, 2010, ATHEROSCLEROSIS, V211, P676, DOI 10.1016/j.atherosclerosis.2010.04.007; Clarke GM, 2011, NAT PROTOC, V6, P121, DOI 10.1038/nprot.2010.182; Di Bisceglie AM, 2008, NEW ENGL J MED, V359, P2429, DOI 10.1056/NEJMoa0707615; Eslam M, 2016, HEPATOLOGY, V64, P34, DOI 10.1002/hep.28475; European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, 2016, J Hepatol, V64, P433, DOI 10.1016/j.jhep.2015.10.006; Falleti E, 2011, LIVER INT, V31, P1137, DOI 10.1111/j.1478-3231.2011.02534.x; Fan JH, 2016, GUT LIVER, V10, P456, DOI 10.5009/gnl15261; Ferrarese A, 2018, WORLD J GASTROENTERO, V24, P4403, DOI 10.3748/wjg.v24.i38.4403; Hofmann S, 2018, BBA-MOL CELL BIOL L, V1863, P1041, DOI 10.1016/j.bbalip.2018.06.002; Huang CF, 2015, J HEPATOL, V62, P512, DOI 10.1016/j.jhep.2014.10.011; Kozlitina J, 2014, NAT GENET, V46, P352, DOI 10.1038/ng.2901; Liu YL, 2014, J HEPATOL, V61, P75, DOI 10.1016/j.jhep.2014.02.030; Manchiero C, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2887-6; Pascasio JM, 2017, J HEPATOL, V67, P1168, DOI 10.1016/j.jhep.2017.08.008; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Mazzaferro V, 2009, LANCET ONCOL, V10, P35, DOI 10.1016/S1470-2045(08)70284-5; Merz A, 2011, J BIOL CHEM, V286, P3018, DOI 10.1074/jbc.M110.175018; Nkontchou G, 2011, J VIRAL HEPATITIS, V18, pE516, DOI 10.1111/j.1365-2893.2011.01441.x; Nunez-Torres R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168265; Rembeck K, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-82; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Sagnelli C, 2016, CLIN MICROBIOL INFEC, V22, P372, DOI 10.1016/j.cmi.2015.11.025; Salameh H, 2015, AM J GASTROENTEROL, V110, P846, DOI 10.1038/ajg.2015.137; Scheiner B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143429; Shen JH, 2015, J LIPID RES, V56, P167, DOI 10.1194/jlr.M048777; Sherman KE, 2018, DIGEST DIS SCI, V63, P2969, DOI 10.1007/s10620-018-5278-y; Singal AG, 2014, AM J GASTROENTEROL, V109, P325, DOI 10.1038/ajg.2013.476; Speliotes EK, 2010, HEPATOLOGY, V52, P904, DOI 10.1002/hep.23768; Stickel F, 2015, HEPATOBIL SURG NUTR, V4, P152, DOI 10.3978/j.issn.2304-3881.2014.11.04; Trepo E, 2014, HEPATOLOGY, V59, P2170, DOI 10.1002/hep.26767; Trepo E, 2012, HEPATOLOGY, V55, P1307, DOI 10.1002/hep.25518; Trunecka P, 2018, DIGEST LIVER DIS, V50, P490, DOI 10.1016/j.dld.2017.12.030; Valenti L, 2010, HEPATOLOGY, V51, P1209, DOI 10.1002/hep.23622; van der Meer AJ, 2017, J HEPATOL, V66, P485, DOI 10.1016/j.jhep.2016.10.017; Vespasiani-Gentilucci U, 2016, SCAND J GASTROENTERO, V51, P967, DOI 10.3109/00365521.2016.1161066; Wang Y, 2019, HEPATOLOGY, V69, P2427, DOI 10.1002/hep.30583; Xu RF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09284; Yang J, 2019, INT J CANCER, V144, P533, DOI 10.1002/ijc.31910; Yao FY, 2001, HEPATOLOGY, V33, P1394, DOI 10.1053/jhep.2001.24563	46	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222609	10.1371/journal.pone.0222609	http://dx.doi.org/10.1371/journal.pone.0222609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527889	Green Submitted, Green Published, gold			2022-12-26	WOS:000532231400033
J	Ulrich, AK; Sanchez, J; Lama, JR; Manhart, LE; Goodreau, SM; Duerr, AC				Ulrich, Angela K.; Sanchez, Jorge; Lama, Javier R.; Manhart, Lisa E.; Goodreau, Steven M.; Duerr, Ann C.			Correlates of concurrent partnerships and patterns of condom use among men who have sex with men and transgender women in Peru	PLOS ONE			English	Article							ANAL INTERCOURSE; AGREEMENT TYPE; ALCOHOL-USE; HIV; PREVALENCE; LIMA; BEHAVIOR; RISK	Background In Peru, there is an ongoing high-incidence HIV epidemic among men who have sex with men (MSM) and transgender women (TW). Sexual concurrency, or having sex with a partner in between two acts of sex with another partner, may be a key factor in onward HIV transmission. In this study, we quantify concurrency, evaluate factors associated with con currency, and assess condom use with concurrent partners among MSM and TW in Peru. Methods We conducted a secondary analysis of data from the 2011 Peruvian Biobehavioral Survey. Pearson's Chi-squared test was used to identify individual-level characteristics associated with concurrency. We estimated the association between participant characteristics, concurrent partnerships, partnership type (stable vs. non-stable), and CLAI within the context of concurrent partnerships using multivariate and repeated-measure Poisson regression. Results 3-month cumulative prevalence of concurrency was higher among TW compared to MSM (30.7% vs 25.2%, p = 0.014). Among those with concurrent stable and non-stable partners, 45% used condoms with both partners (95% CI: 40%-50%) and 30% preferentially had CLAI with the stable partner only (95%CI: 26%-35%). Factors associated with CLAI within the context of concurrent partnerships varied between MSM and TW. Conclusions Although concurrency is common among TW and MSM in Peru, patterns of concurrency and differential condom use may vary between TW and MSM. Future research may explore differential condom use with stable and non-stable partners to better understand behavioral factors that may alter vulnerability to HIV in TW compared to MSM.	[Ulrich, Angela K.; Duerr, Ann C.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Ulrich, Angela K.; Manhart, Lisa E.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Sanchez, Jorge; Lama, Javier R.] Asociac Civil Impacta Salud & Educ, Lima, Peru; [Sanchez, Jorge] Ctr Invest Tecnol Biorned & Medioambientales, Callao, Peru; [Goodreau, Steven M.] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; [Ulrich, Angela K.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Minnesota System; University of Minnesota Twin Cities	Ulrich, AK (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.; Ulrich, AK (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	ulric063@fhcrc.org		Ulrich, Angela/0000-0002-4360-9719	National Institutes of Health [NIH T32 CA 80416-14]; NATIONAL CANCER INSTITUTE [T32CA080416] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by the National Institutes of Health, NIH T32 CA 80416-14 to AKU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimora AA, 2007, AM J PUBLIC HEALTH, V97, P2230, DOI 10.2105/AJPH.2006.099069; Baggaley RF, 2010, INT J EPIDEMIOL, V39, P1048, DOI 10.1093/ije/dyq057; Carnegie N. B., 2012, PLoS ONE, V7, pe43048, DOI 10.1371/journal.pone.0043048; Crawford JM, 2001, INT J STD AIDS, V12, P164, DOI 10.1258/0956462011916965; Desai M, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5011; Eaton JW, 2011, AIDS BEHAV, V15, P687, DOI 10.1007/s10461-010-9787-8; Goodreau SM, 2007, SEX TRANSM INFECT, V83, P458, DOI 10.1136/sti.2007.025627; Goodreau SM, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-12; Goodreau SM, 2012, AIDS BEHAV, V16, P312, DOI 10.1007/s10461-010-9858-x; Herrera MC, 2016, DRUG ALCOHOL DEPEN, V161, P147, DOI 10.1016/j.drugalcdep.2016.01.030; Hoff CC, 2010, AIDS CARE, V22, P827, DOI 10.1080/09540120903443384; Hosking W, 2013, J HOMOSEXUAL, V60, P711, DOI 10.1080/00918369.2013.773819; Leblanc NM, 2017, J ADV NURS, V73, P1583, DOI 10.1111/jan.13228; Lyons A, 2014, AIDS BEHAV, V18, P801, DOI 10.1007/s10461-013-0613-y; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Morris M, 2014, AIDS BEHAV, V18, P783, DOI 10.1007/s10461-013-0618-6; Morris M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014092; Morris SR, 2011, CURR OPIN HIV AIDS, V6, P326, DOI 10.1097/COH.0b013e3283476c29; Nelson SJ, 2007, SEX TRANSM DIS, V34, P801, DOI [10.1097/OLQ.0b013e318063c734, 10.1007/978-1-59745-040-9]; Poteat T, 2016, GLOB PUBLIC HEALTH, V11, P835, DOI 10.1080/17441692.2015.1134615; Rosenberg ES, 2012, SEX TRANSM DIS, V39, P741, DOI 10.1097/OLQ.0b013e31825ec09b; Sanchez J, 2007, JAIDS-J ACQ IMM DEF, V44, P578, DOI 10.1097/QAI.0b013e318033ff82; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Sawers L, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-44; Senn TE, 2009, SEX TRANSM INFECT, V85, P343, DOI 10.1136/sti.2009.035758; Silva-Santisteban A, 2012, AIDS BEHAV, V16, P872, DOI 10.1007/s10461-011-0053-5; StataCorp, 2014, STAT STAT SOFTW REL; Tabet S, 2002, AIDS, V16, P1271, DOI 10.1097/00002030-200206140-00010; UNAIDS, 2019, 2016 UNAIDS PER FACT; UNAIDS (United National Programme on AIDS), 2009, CONS CONC SEX PARTN; Wang HD, 2016, LANCET HIV, V3, pE361, DOI 10.1016/S2352-3018(16)30087-X; Wray TB, 2016, DRUG ALCOHOL REV, V35, P148, DOI 10.1111/dar.12271	32	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222114	10.1371/journal.pone.0222114	http://dx.doi.org/10.1371/journal.pone.0222114			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4NC	31525225	Green Published, gold, Green Submitted			2022-12-26	WOS:000532225700021
J	Yamamoto, M; Yamauchi, M; Sugimoto, T				Yamamoto, Masahiro; Yamauchi, Mika; Sugimoto, Toshitsugu			Prevalent vertebral fracture is dominantly associated with spinal microstructural deterioration rather than bone mineral density in patients with type 2 diabetes mellitus	PLOS ONE			English	Article							POSTMENOPAUSAL WOMEN; SCLEROSTIN LEVELS; OLDER-ADULTS; SCORE TBS; RISK; BMD; CLASSIFICATION; FRAGILITY; SEVERITY; QUALITY	Background An assessment of bone strength based on bone mineral density (BMD) underestimates the risk of fracture in patients with diabetes mellitus (T2DM). However, using the trabecular bone score (TBS) for estimating bone microarchitecture, previous studies showed that bone fragility is associated with deterioration of the microstructure concomitantly with decreased BMD. This study was conducted to clarify which of these skeletal-related factors had a more prominent relationship with bone fragility. Research design and methods A retrospective cross-sectional study was performed at Shimane University Hospital. A total of 548 Japanese patients with T2DM [257 postmenopausal women and 291 men aged over 50 years] were included. TBS of the spine was computed from dual-energy X-ray absorptiometry images obtained from BMD measurements. Results Vertebral fractures (VFs) were identified in 74 (28.8%) women and 115 (39.5%) men. A relationship between BMD and VFs was observed in the limited subgroup of women with a BMD T-score <-1.0. According to multivariate logistic regression analysis, low TBS was significantly correlated with prevalent VFs, independent of BMD in both genders, except for men with a BMD T-score > -1.0. The decision tree showed that the priority factor for determining VFs was TBS, not BMD. Conclusion Spinal microarchitecture represented by TBS was a more dominant skeletal factor for bone fragility than the decrease in bone mass, independent of BMD, in patients with T2DM. This observation suggests that loss of structural bone quality was crucial underlying pathogenesis for bone brittleness in these populations, regardless of gender. An integrated assessment of bone strength by BMD and TBS would help diagnose diabetic osteoporosis.	[Yamamoto, Masahiro; Yamauchi, Mika; Sugimoto, Toshitsugu] Shimane Univ, Fac Med, Internal Med 1, Izumo, Shimane, Japan	Shimane University	Yamamoto, M (corresponding author), Shimane Univ, Fac Med, Internal Med 1, Izumo, Shimane, Japan.	masa-ya@med.shimae-u.ac.jp	yamamoto, Masahiro/F-9094-2011	yamamoto, Masahiro/0000-0003-3859-0125	Japan Society for the Promotion of Science (JSPS) [25460900]; Asahi Kasei Pharma Corporation; Eli Lilly Japan K.K	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Asahi Kasei Pharma Corporation; Eli Lilly Japan K.K(Eli Lilly)	This work was supported by Grants-inAids for Scientific Research (C) Grant No. 25460900 (to MY) from Japan Society for the Promotion of Science (JSPS) (https://www.jsps.go.jp/english/index.html) and Asahi Kasei Pharma Corporation and Eli Lilly Japan K.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, South Med J, V94, P569; Baleanu F, 2019, INT J CLIN PRACT, V73, DOI 10.1111/ijcp.13347; Bonaccorsi G, 2017, AGING CLIN EXP RES, V29, P951, DOI 10.1007/s40520-016-0634-2; Chen FP, 2019, MENOPAUSE, V26, P182, DOI 10.1097/GME.0000000000001185; Choi YJ, 2016, J CLIN DENSITOM, V19, P507, DOI 10.1016/j.jocd.2016.04.001; Delmas PD, 2003, BONE, V33, P522, DOI 10.1016/S8756-3282(03)00241-2; Dhaliwal R, 2014, OSTEOPOROSIS INT, V25, P1969, DOI 10.1007/s00198-014-2704-7; Ferrari SL, 2018, OSTEOPOROSIS INT, V29, P2585, DOI 10.1007/s00198-018-4650-2; Fink HA, 2005, J BONE MINER RES, V20, P1216, DOI 10.1359/JBMR.050314; Gallagher JC, 2005, J CLIN ENDOCR METAB, V90, P1583, DOI 10.1210/jc.2004-0826; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Heilmeier U, 2015, OSTEOPOROSIS INT, V26, P1283, DOI 10.1007/s00198-014-2988-7; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Kershaw TS, 2007, PERSPECT SEX REPRO H, V39, P141, DOI 10.1363/3914107; Kim JH, 2015, J CLIN ENDOCR METAB, V100, P475, DOI 10.1210/jc.2014-2047; Kurosaki M, 2010, HEPATOL RES, V40, P251, DOI 10.1111/j.1872-034X.2009.00607.x; Leslie WD, 2013, J CLIN ENDOCR METAB, V98, P602, DOI 10.1210/jc.2012-3118; Ma LL, 2012, EUR J EPIDEMIOL, V27, P319, DOI 10.1007/s10654-012-9674-x; Martineau P, 2018, BONE, V113, P161, DOI 10.1016/j.bone.2018.05.026; Nakamura T, 2012, JOINT INT CONF SOFT, P1013, DOI 10.1109/SCIS-ISIS.2012.6505400; Schwartz AV, 2011, JAMA-J AM MED ASSOC, V305, P2184, DOI 10.1001/jama.2011.715; Schwartz AV, 2009, J CLIN ENDOCR METAB, V94, P2380, DOI 10.1210/jc.2008-2498; Silva BC, 2014, J BONE MINER RES, V29, P518, DOI 10.1002/jbmr.2176; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P427, DOI 10.1007/s00198-006-0253-4; vom Scheidt A, 2019, BONE, V122, P156, DOI 10.1016/j.bone.2019.02.014; Xue YF, 2018, J CLIN DENSITOM, V21, P185, DOI 10.1016/j.jocd.2017.09.003; Yamamoto M, 2015, ENDOCR J, V62, P299, DOI 10.1507/endocrj.EJ15-0129; Yamamoto M, 2013, J CLIN ENDOCR METAB, V98, P4030, DOI 10.1210/jc.2013-2143; Yamamoto M, 2009, DIABETES CARE, V32, P2263, DOI 10.2337/dc09-0901; Yamamoto M, 2009, J BONE MINER RES, V24, P702, DOI 10.1359/JBMR.081207; Zhukouskaya VV, 2016, OSTEOPOROSIS INT, V27, P49, DOI 10.1007/s00198-015-3212-0	31	13	14	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222571	10.1371/journal.pone.0222571	http://dx.doi.org/10.1371/journal.pone.0222571			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525243	Green Published, Green Submitted, gold			2022-12-26	WOS:000532225700037
J	Wang, YN; Lu, YX; Liu, J; Jin, Y; Bi, HC; Zhao, Q; Liu, ZX; Li, YQ; Hu, JJ; Sheng, H; Jiang, YM; Zhang, C; Tian, F; Chen, Y; Pan, ZZ; Chen, G; Zeng, ZL; Liu, KY; Ogasawara, M; Yun, JP; Ju, HQ; Feng, JX; Xie, D; Gao, S; Jia, WH; Kopetz, S; Xu, RH; Wang, F				Wang, Ying-Nan; Lu, Yun-Xin; Liu, Jie; Jin, Ying; Bi, Hui-Chang; Zhao, Qi; Liu, Ze-Xian; Li, Ying-Qin; Hu, Jia-Jia; Sheng, Hui; Jiang, Yi-Ming; Zhang, Chao; Tian, Feng; Chen, Yang; Pan, Zhi-Zhong; Chen, Gong; Zeng, Zhao-Lei; Liu, Kai-Yan; Ogasawara, Marcia; Yun, Jin-Ping; Ju, Huai-Qiang; Feng, Jian-Xiong; Xie, Dan; Gao, Song; Jia, Wei-Hua; Kopetz, Scott; Xu, Rui-Hua; Wang, Feng			AMPK alpha 1 confers survival advantage of colorectal cancer cells under metabolic stress by promoting redox balance through the regulation of glutathione reductase phosphorylation	ONCOGENE			English	Article							ACTIVATED PROTEIN-KINASE; NEGATIVE REGULATOR; COLON-CANCER; AMPK; GROWTH; EXPRESSION; NUTRIENT; RECEPTOR; GENE	Patients with stage II or III colorectal cancer (CRC) exhibit various clinical outcomes after radical treatments. The 5-year survival rate was between 50 and 87%. However, the underlying mechanisms of the variation remain unclear. Here we show that AMPK alpha 1 is overexpressed in CRC patient specimens and the high expression is correlated with poor patient survival. We further reveal a previously unrecognized function of AMPK alpha 1, which maintains high level of reduced glutathione to keep reduction-oxidation reaction (redox) homeostasis under stress conditions, thus promoting CRC cell survival under metabolic stress in vitro and enhancing tumorigenesis in vivo. Mechanistically, AMPK alpha 1 regulate the glutathione reductase (GSR) phosphorylation possibly through residue Thr507 which enhances its activity. Suppression of AMPK alpha 1 by using nano-sized polymeric vector induces a favorable therapeutic effect, especially when in combination with oxaliplatin. Our study uncovers a novel function of AMPK alpha 1 in redox regulation and identifies a promising therapeutic strategy for treatment of CRC.	[Wang, Ying-Nan; Lu, Yun-Xin; Jin, Ying; Zhao, Qi; Liu, Ze-Xian; Hu, Jia-Jia; Sheng, Hui; Zhang, Chao; Chen, Yang; Zeng, Zhao-Lei; Liu, Kai-Yan; Yun, Jin-Ping; Ju, Huai-Qiang; Feng, Jian-Xiong; Xie, Dan; Gao, Song; Jia, Wei-Hua; Xu, Rui-Hua; Wang, Feng] Sun Yat Sen Univ, Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China; [Wang, Ying-Nan; Lu, Yun-Xin; Jin, Ying; Zhao, Qi; Liu, Ze-Xian; Hu, Jia-Jia; Sheng, Hui; Zhang, Chao; Chen, Yang; Pan, Zhi-Zhong; Chen, Gong; Zeng, Zhao-Lei; Liu, Kai-Yan; Yun, Jin-Ping; Ju, Huai-Qiang; Feng, Jian-Xiong; Xie, Dan; Gao, Song; Jia, Wei-Hua; Xu, Rui-Hua; Wang, Feng] Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China; [Liu, Jie; Li, Ying-Qin] Sun Yat Sen Univ, Sch Engn, Dept Biomed Engn, Guangzhou 510006, Guangdong, Peoples R China; [Jin, Ying; Xu, Rui-Hua; Wang, Feng] Sun Yat Sen Univ, Dept Med Oncol, Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China; [Bi, Hui-Chang; Jiang, Yi-Ming] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China; [Tian, Feng; Kopetz, Scott] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Pan, Zhi-Zhong; Chen, Gong] Sun Yat Sen Univ, Canc Ctr, Dept Colorectal Surg, Guangzhou 510060, Guangdong, Peoples R China; [Ogasawara, Marcia] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; University of Texas System; UTMD Anderson Cancer Center; Sun Yat Sen University; University of Texas System; UTMD Anderson Cancer Center	Xu, RH; Wang, F (corresponding author), Sun Yat Sen Univ, Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China.; Xu, RH; Wang, F (corresponding author), Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China.; Xu, RH; Wang, F (corresponding author), Sun Yat Sen Univ, Dept Med Oncol, Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China.; Kopetz, S (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA.	skopetz@mdanderson.org; xurh@sysucc.org.cn; wangfeng@sysucc.org.cn	Kopetz, Scott/AAC-1387-2019; Chen, Yang/L-7304-2018; xu, rui/GRX-5734-2022; Liu, Zexian/D-1153-2011; Chen, Yang/AFL-4729-2022; Xu, Rui-Hua/AAW-4766-2021	Kopetz, Scott/0000-0001-9647-3416; Chen, Yang/0000-0001-7661-5923; Liu, Zexian/0000-0001-9698-0610; Xu, Rui-Hua/0000-0001-9771-8534; Gao, Song/0000-0001-7427-6681	National Key Research and Development Program of China [2017YFC1308900, 2018YFC1313300]; Natural Science Foundation of Guangdong Province [2014A030312015, 2017A030313485]; National Natural Science Foundation of China [81872011, 81572392]; Science and Technology Program of Guangdong [2019B020227002]; Science and Technology Program of Guangzhou [201904020046, 201803040019, 201704020228]; Guangzhou Health and Medical Collaborative Innovation Project [201704020220]; Sun Yat-sen University Clinical Research 5010 Program [2018014]	National Key Research and Development Program of China; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Program of Guangdong; Science and Technology Program of Guangzhou; Guangzhou Health and Medical Collaborative Innovation Project; Sun Yat-sen University Clinical Research 5010 Program	This study was supported, in part, by the National Key Research and Development Program of China (2017YFC1308900, 2018YFC1313300), Natural Science Foundation of Guangdong Province (2014A030312015, 2017A030313485); National Natural Science Foundation of China (81872011, 81572392); Science and Technology Program of Guangdong (2019B020227002), Science and Technology Program of Guangzhou (201904020046, 201803040019, 201704020228), Guangzhou Health and Medical Collaborative Innovation Project (201704020220), and the Sun Yat-sen University Clinical Research 5010 Program (2018014). FW is the Young Physician Scientist Program of Sun Yat-sen University Cancer Center.	[Anonymous], 2013, Cancer Discov, V3, pOF15, DOI 10.1158/2159-8290.CD-RW2013-018; Bhandaru M, 2014, J INVEST DERMATOL, V134, P1763, DOI 10.1038/jid.2014.26; Bi HC, 2014, CARCINOGENESIS, V35, P2264, DOI 10.1093/carcin/bgu174; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Chen DL, 2014, HEPATOLOGY, V60, P598, DOI 10.1002/hep.27118; Chen WQ, 2015, CHIN J CANCER, V34, DOI 10.1186/s40880-015-0042-6; Chiu YC, 2009, CARCINOGENESIS, V30, P1651, DOI 10.1093/carcin/bgp156; Faubert B, 2015, CANCER LETT, V356, P165, DOI 10.1016/j.canlet.2014.01.018; Faubert B, 2013, CELL METAB, V17, P113, DOI 10.1016/j.cmet.2012.12.001; Fu X, 2013, MOL CELL BIOL, V33, P4517, DOI 10.1128/MCB.01078-13; Goh V, 2012, J NUCL MED, V53, P687, DOI 10.2967/jnumed.111.098525; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hari DM, 2013, J AM COLL SURGEONS, V217, P181, DOI 10.1016/j.jamcollsurg.2013.04.018; Hoffman NJ, 2015, CELL METAB, V22, P922, DOI 10.1016/j.cmet.2015.09.001; Huang FY, 2006, GYNECOL ONCOL, V103, P219, DOI 10.1016/j.ygyno.2006.02.028; Jeon SM, 2015, ARCH PHARM RES, V38, P346, DOI 10.1007/s12272-015-0549-z; Jeon Sang-Min, 2012, Cell Logist, V2, P197; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Ju HQ, 2016, J PINEAL RES, V60, P27, DOI 10.1111/jpi.12285; Kato K, 2002, ONCOGENE, V21, P6082, DOI 10.1038/sj.onc.1205737; Lee YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078709; Li M, 2005, WORLD J GASTROENTERO, V11, P4685, DOI 10.3748/wjg.v11.i30.4685; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Lu SC, 2009, MOL ASPECTS MED, V30, P42, DOI 10.1016/j.mam.2008.05.005; Ma MZ, 2015, CANCER LETT, V368, P88, DOI 10.1016/j.canlet.2015.07.031; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Phoenix Kathryn N, 2012, Genes Cancer, V3, P51, DOI 10.1177/1947601912452883; Saito Y, 2015, CELL STEM CELL, V17, P585, DOI 10.1016/j.stem.2015.08.019; Santoro V, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv394; Schreuders EH, 2015, GUT, V64, P1637, DOI 10.1136/gutjnl-2014-309086; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2015, CELL STEM CELL, V17, P503, DOI 10.1016/j.stem.2015.10.007; Sung JJY, 2015, GUT, V64, P121, DOI 10.1136/gutjnl-2013-306503; Svensson RU, 2012, NATURE, V485, P590, DOI 10.1038/485590a; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Yu K, 2019, NUCLEIC ACIDS RES, V47, pD451, DOI 10.1093/nar/gky1052; Yuan SQ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0174-2; Yun J, 2015, SCIENCE, V350, P1391, DOI 10.1126/science.aaa5004; Zeng ZL, 2014, CLIN CANCER RES, V20, P1042, DOI 10.1158/1078-0432.CCR-13-0171; Zhao G, 2013, MOL CANCER THER, V12, P83, DOI 10.1158/1535-7163.MCT-12-0534-T; Zhou Q, 2015, CHIN J CANCER, V34, P1, DOI 10.1186/s40880-015-0026-6	43	10	10	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	3					637	650		10.1038/s41388-019-1004-2	http://dx.doi.org/10.1038/s41388-019-1004-2			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KG1RJ	31530934	hybrid, Green Published			2022-12-26	WOS:000509718300011
J	Lauenstein, JU; Udgata, A; Bartram, A; Sutter, D; Fisher, DI; Halabi, S; Eyckerman, S; Gay, NJ				Lauenstein, Johannes U.; Udgata, Atul; Bartram, Alex; De Sutter, Delphine; Fisher, David I.; Halabi, Samer; Eyckerman, Sven; Gay, Nicholas J.			Phosphorylation of the multifunctional signal transducer B-cell adaptor protein (BCAP) promotes recruitment of multiple SH2/SH3 proteins including GRB2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Toll-like receptor (TLR); phosphorylation; Src homology 2 domain (SH2 domain); Src homology 3 domain (SH3 domain); signal transduction; B-cell adaptor protein; immunity; kinase signaling; phosphoinositide 3-kinase; virotrap	BRUTONS-TYROSINE KINASE; TOLL-LIKE RECEPTORS; PHOSPHOINOSITIDE 3-KINASE; PHOSPHOLIPASE-C; ACTIVATION; COMPLEX; BINDING; CD19; PI3K; IDENTIFICATION	B-cell adaptor protein (BCAP) is a multimodular, multifunctional signal transducer that regulates signal transduction pathways in leukocytes, including macrophages, B-cells, and T-cells. In particular, BCAP suppresses inflammatory signaling by Toll-like receptors (TLRs). However, how BCAP itself is regulated and what its interaction partners are is unclear. Here, using human immune cell lines, including THP-1 cells, we characterized the complex phosphorylation patterns of BCAP and used a novel protein complex trapping strategy, called virotrap, to identify its interaction partners. This analysis identified known interactions of BCAP with phosphoinositide 3-kinase (PI3K) p85 subunit and NCK adaptor protein (NCK), together with previously unknown interactions of BCAP with Src homology 2 (SH2) and SH3 domain-containing adaptor proteins, notably growth factor receptor-bound protein 2 (GRB2) and CRK-like proto-oncogene, adaptor protein (CRKL). We show that the SH3 domain of GRB2 can bind to BCAP independently of BCAP phosphorylation status, suggesting that the SH2 domains mediate interactions with activated receptor tyrosine kinase complexes including the CD19 subunit of the B-cell receptor. Our results also suggested that the PI3K p85 subunit binds to BCAP via SH3 domains forming an inactive complex that is then activated by sequential binding with the SH2 domains. Taken together, our results indicate that BCAP is a complex hub that processes signals from multiple pathways in diverse cell types of the immune system.	[Lauenstein, Johannes U.; Udgata, Atul; Bartram, Alex; Halabi, Samer; Gay, Nicholas J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [De Sutter, Delphine; Eyckerman, Sven] Univ Ghent VIB, VIB, Ctr Med Biotechnol, Dept Biomol Med, A Baertsoenkaai 3, B-9000 Ghent, Belgium; [Fisher, David I.] AstraZeneca, IMED Biotech Unit, Discovery Biol, Discovery Sci, Cambridge CB4 0WG, England	University of Cambridge; Flanders Institute for Biotechnology (VIB); Ghent University; AstraZeneca	Gay, NJ (corresponding author), Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England.	njg11@cam.ac.uk			Wellcome Trust Investigator Award [WT100321/z/12/Z]; AstraZeneca [RG82667]	Wellcome Trust Investigator Award(Wellcome Trust); AstraZeneca(AstraZeneca)	This work was supported by Wellcome Trust Investigator Award WT100321/z/12/Z (to N. J. G.) and AstraZeneca Studentship RG82667 (to J. U. L. and N. J. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Aiba Y, 2008, BLOOD, V111, P1497, DOI 10.1182/blood-2007-08-109769; Alldridge LC, 2003, EXP CELL RES, V290, P93, DOI 10.1016/S0014-4827(03)00310-0; Alugupalli KR, 2007, J IMMUNOL, V178, P3740, DOI 10.4049/jimmunol.178.6.3740; Bisson N, 2011, NAT BIOTECHNOL, V29, P653, DOI 10.1038/nbt.1905; Bonham KS, 2014, CELL, V156, P705, DOI 10.1016/j.cell.2014.01.019; Brooks SR, 2000, J IMMUNOL, V164, P3123, DOI 10.4049/jimmunol.164.6.3123; Busconi L, 2007, J IMMUNOL, V179, P7397, DOI 10.4049/jimmunol.179.11.7397; Castello A, 2013, NAT IMMUNOL, V14, P966, DOI 10.1038/ni.2685; Chattopadhyay S, 2014, CYTOKINE GROWTH F R, V25, P533, DOI 10.1016/j.cytogfr.2014.06.002; Chaudhary A, 2007, IMMUNOL CELL BIOL, V85, P249, DOI 10.1038/sj.icb7100030; Deason K, 2018, J EXP MED, V215, P2413, DOI 10.1084/jem.20171810; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Eyckerman S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11416; Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713; Gowda Chandrika, 2017, Advances in Biological Regulation, V65, P16, DOI 10.1016/j.jbior.2017.06.001; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Gresset A, 2010, J BIOL CHEM, V285, P35836, DOI 10.1074/jbc.M110.166512; Gururajan M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000863; Halabi S, 2017, J BIOL CHEM, V292, P652, DOI 10.1074/jbc.M116.761528; Hartman AD, 2006, EXP HEMATOL, V34, P1360, DOI 10.1016/j.exphem.2006.05.019; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Inabe K, 2002, BLOOD, V99, P584, DOI 10.1182/blood.V99.2.584; Jabara HH, 2012, NAT IMMUNOL, V13, P612, DOI 10.1038/ni.2305; Jang IK, 2009, IMMUNOL REV, V232, P150, DOI 10.1111/j.1600-065X.2009.00842.x; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leu CM, 2014, CELL MOL IMMUNOL, V11, P120, DOI 10.1038/cmi.2013.53; Liu CH, 2013, MOL CELL PROTEOMICS, V12, P1335, DOI 10.1074/mcp.O112.020404; Luo L, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14133; Maruoka M, 2005, FEBS LETT, V579, P2986, DOI 10.1016/j.febslet.2005.04.052; Matsumura T, 2010, BIOCHEM BIOPH RES CO, V400, P265, DOI 10.1016/j.bbrc.2010.08.055; Ni MJ, 2012, P NATL ACAD SCI USA, V109, P267, DOI 10.1073/pnas.1111957108; O'Brien R, 2000, PROTEIN SCI, V9, P570; Okada T, 2000, IMMUNITY, V13, P817, DOI 10.1016/S1074-7613(00)00079-0; Ottinger EA, 1998, J BIOL CHEM, V273, P729, DOI 10.1074/jbc.273.2.729; Phelan JD, 2018, NATURE, V560, P387, DOI 10.1038/s41586-018-0290-0; Rawlings DJ, 2012, NAT REV IMMUNOL, V12, P282, DOI 10.1038/nri3190; Shi Y, 2009, BMB REP, V42, P840, DOI 10.5483/BMBRep.2009.42.12.840; Song S, 2011, J IMMUNOL, V187, P619, DOI 10.4049/jimmunol.0903425; Suthers AN, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00775; Szili D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096381; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Troutman TD, 2012, P NATL ACAD SCI USA, V109, P273, DOI 10.1073/pnas.1118579109; Vandemoortele G, 2016, SCI REP-UK, V6, DOI 10.1038/srep27220; Viglianti GA, 2003, IMMUNITY, V19, P837, DOI 10.1016/S1074-7613(03)00323-6; Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang Y, 2008, BIOCHEMISTRY-US, V47, P441, DOI 10.1021/bi7010515; Yamazaki T, 2002, J EXP MED, V195, P535, DOI 10.1084/jem.20011751	48	5	5	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2019	294	52					19852	19861		10.1074/jbc.RA119.009931	http://dx.doi.org/10.1074/jbc.RA119.009931			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JZ3MK	31527084	Green Published, hybrid			2022-12-26	WOS:000505005800003
J	Scafaro, AP; De Vleesschauwer, D; Bautsoens, N; Hannah, MA; den Boer, B; Galle, A; Van Rie, J				Scafaro, Andrew P.; De Vleesschauwer, David; Bautsoens, Nadine; Hannah, Matthew A.; den Boer, Bart; Galle, Alexander; Van Rie, Jeroen			A single point mutation in the C-terminal extension of wheat Rubisco activase dramatically reduces ADP inhibition via enhanced ATP binding affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ribulose-1; 5-bisphosphate carboxylase; oxygenase (RuBisCO); ADP; ATP; thioredoxin; plant biochemistry; plant; C-terminal extension (CTE); carbon fixation; light regulation; Rubisco activase (Rca); wheat	RIBULOSE-BISPHOSPHATE CARBOXYLASE; MITOCHONDRIA; HYDROLYSIS; MECHANISM; ADENOSINE; ISOFORMS; STRESS; LYSINE; STATE	Ribulose-1,5-bisphosphate carboxylase/oxygenase (Rubisco) activase (Rca) is a AAA(+) enzyme that uses ATP to remove inhibitors from the active site of Rubisco, the central carboxylation enzyme of photosynthesis. Rca ? and ? isoforms exist in most higher plant species, with the ? isoform being identical to the ? form but having an additional 25?45 amino acids at the Rca C terminus, known as the C-terminal extension (CTE). Rca is inhibited by ADP, and the extent of ADP sensitivity of the Rca complex can be modulated by the CTE of the ? isoform, particularly in relation to a disulfide bond structure that is specifically reduced by the redox-regulatory enzyme thioredoxin-f. Here, we introduced single point mutations of Lys-428 in the CTE of Rca-? from wheat (Triticum aestivum) (TaRca2-?). Substitution of Lys-428 with Arg dramatically altered ADP inhibition, independently of thioredoxin-f regulation. We determined that the reduction in ADP inhibition in the K428R variant is not due to a change in ADP affinity, as the apparent constant for ADP binding was not altered by the K428R substitution. Rather, we observed that the K428R substitution strongly increased ATP substrate affinity and ATP-dependent catalytic velocity. These results suggest that the Lys-428 residue is involved in interacting with the ?-phosphate of ATP. Considering that nucleotide-dependent Rca activity regulates Rubisco and thus photosynthesis during fluctuating irradiance, the K428R substitution could potentially provide a mechanism for boosting the performance of wheat grown in the dynamic light environments of the field.	[Scafaro, Andrew P.; De Vleesschauwer, David; Bautsoens, Nadine; Hannah, Matthew A.; den Boer, Bart; Galle, Alexander; Van Rie, Jeroen] Innovat Ctr Gent, BASF Belgium Coordinat Ctr, Technol Pk 101, B-9052 Ghent, Belgium		Scafaro, AP (corresponding author), Australian Natl Univ, Res Sch Biol, ARC Ctr Excellence Plant Energy Biol, Canberra, ACT 2601, Australia.	andrew.scafaro@anu.edu.au		Galle, Alexander/0000-0001-6927-7911; Scafaro, Andrew/0000-0003-3738-1145	Marie Sklodowska-Curie Individual Fellowship [706115]; Australian Research Council [CE140100008]	Marie Sklodowska-Curie Individual Fellowship; Australian Research Council(Australian Research Council)	Supported by Marie Sklodowska-Curie Individual Fellowship 706115 Heat Wheat and currently by Australian Research Council Grant CE140100008.	Andersson I, 2008, J EXP BOT, V59, P1555, DOI 10.1093/jxb/ern091; Barta C, 2011, METHODS MOL BIOL, V684, P375, DOI 10.1007/978-1-60761-925-3_29; Buchert F, 2012, BBA-BIOENERGETICS, V1817, P2038, DOI 10.1016/j.bbabio.2012.06.007; Carmo-Silva AE, 2013, PLANT PHYSIOL, V161, P1645, DOI 10.1104/pp.112.213348; Carmo-Silva E, 2015, PLANT CELL ENVIRON, V38, P1817, DOI 10.1111/pce.12425; Cleland WW, 1998, CHEM REV, V98, P549, DOI 10.1021/cr970010r; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Hartl M, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20177819; Hazra S, 2015, J BIOL CHEM, V290, P24222, DOI 10.1074/jbc.M115.651745; Henderson JN, 2013, BBA-PROTEINS PROTEOM, V1834, P87, DOI 10.1016/j.bbapap.2012.09.006; Hermida-Carrera C, 2016, PLANT PHYSIOL, V171, P2549, DOI 10.1104/pp.16.01846; Hosp F, 2017, MITOCHONDRION, V33, P58, DOI 10.1016/j.mito.2016.07.012; JORDAN DB, 1983, J BIOL CHEM, V258, P3752; Keown JR, 2014, BIOCHEM J, V464, P413, DOI 10.1042/BJ20140676; Loganathan N, 2016, P NATL ACAD SCI USA, V113, P14019, DOI 10.1073/pnas.1610758113; Mueller-Cajar O, 2014, PHOTOSYNTH RES, V119, P191, DOI 10.1007/s11120-013-9819-0; Nagarajan R, 2018, PLANT MOL BIOL, V96, P69, DOI 10.1007/s11103-017-0680-y; Pearce FG, 2006, BIOCHEM J, V399, P525, DOI 10.1042/BJ20060430; Pearce FG, 2003, J BIOL CHEM, V278, P32526, DOI 10.1074/jbc.M305493200; Portis AR, 2003, PHOTOSYNTH RES, V75, P11, DOI 10.1023/A:1022458108678; Portis AR, 2008, J EXP BOT, V59, P1597, DOI 10.1093/jxb/erm240; ROBINSON SP, 1989, ARCH BIOCHEM BIOPHYS, V268, P93, DOI 10.1016/0003-9861(89)90568-7; SALVUCCI ME, 1992, ARCH BIOCHEM BIOPHYS, V298, P688, DOI 10.1016/0003-9861(92)90467-B; SALVUCCI ME, 1987, PLANT PHYSIOL, V85, P66, DOI 10.1104/pp.85.1.66; Scafaro AP, 2019, PLANT PHYSIOL, V181, P43, DOI 10.1104/pp.19.00425; Scales JC, 2014, PHOTOSYNTH RES, V119, P355, DOI 10.1007/s11120-013-9964-5; Schrader SM, 2006, FUNCT PLANT BIOL, V33, P921, DOI 10.1071/FP06059; Schurmann P, 2008, ANTIOXID REDOX SIGN, V10, P1235, DOI 10.1089/ars.2007.1931; Serban AJ, 2018, J BIOL CHEM, V293, P19451, DOI 10.1074/jbc.RA118.005047; Sharkey TD, 2005, PLANT CELL ENVIRON, V28, P269, DOI 10.1111/j.1365-3040.2005.01324.x; SHEN JB, 1991, J BIOL CHEM, V266, P8963; STITT M, 1982, PLANT PHYSIOL, V70, P971, DOI 10.1104/pp.70.4.971; Stotz M, 2011, NAT STRUCT MOL BIOL, V18, P1366, DOI 10.1038/nsmb.2171; Sweetlove LJ, 2002, PLANT J, V32, P891, DOI 10.1046/j.1365-313X.2002.01474.x; To KY, 1999, PLANTA, V209, P66, DOI 10.1007/s004250050607; Wang Q, 2018, J CHEM PHYS, V148, DOI 10.1063/1.5005930; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969; WANG ZY, 1991, BIOCHIM BIOPHYS ACTA, V1079, P263, DOI 10.1016/0167-4838(91)90067-A; WANG ZY, 1993, BIOCHIM BIOPHYS ACTA, V1202, P47, DOI 10.1016/0167-4838(93)90061-U; Zhang N, 1999, P NATL ACAD SCI USA, V96, P9438, DOI 10.1073/pnas.96.16.9438; Zhang N, 2001, PHOTOSYNTH RES, V68, P29, DOI 10.1023/A:1011845506196	41	9	9	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 22	2019	294	47					17931	17940		10.1074/jbc.RA119.010684	http://dx.doi.org/10.1074/jbc.RA119.010684			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JY1UF	31530638	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000504206800019
J	Frendo-Cumbo, S; Jaldin-Fincati, JR; Coyaud, E; Laurent, EMN; Townsend, LK; Tan, JMJ; Xavier, RJ; Pillon, NJ; Raught, B; Wright, DC; Brumell, JH; Klip, A				Frendo-Cumbo, Scott; Jaldin-Fincati, Javier R.; Coyaud, Etienne; Laurent, Estelle M. N.; Townsend, Logan K.; Tan, Joel M. J.; Xavier, Ramnik J.; Pillon, Nicolas J.; Raught, Brian; Wright, David C.; Brumell, John Hunter; Klip, Amira			Deficiency of the autophagy gene ATG16L1 induces insulin resistance through KLHL9/KLHL13/CUL3-mediated IRS1 degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Akt PKB; autophagy; cell signaling; insulin; insulin receptor substrate 1 (IRS-1); E3 ubiquitin ligase; insulin signaling; Kelch-like gene family	ENDOPLASMIC-RETICULUM STRESS; RECEPTOR SUBSTRATE 1; SKELETAL-MUSCLE; PHOSPHATIDYLINOSITOL 3-KINASE; ADIPOSE-TISSUE; OBESITY; PHOSPHORYLATION; PROTEINS; NRF2; PROTEASOME	Connections between deficient autophagy and insulin resistance have emerged, however, the mechanism through which reduced autophagy impairs insulin-signaling remains unknown. We examined mouse embryonic fibroblasts lacking Atg16l1 (ATG16L1 KO mouse embryonic fibroblasts (MEFs)), an essential autophagy gene, and observed deficient insulin and insulin-like growth factor-1 signaling. ATG16L1 KO MEFs displayed reduced protein content of insulin receptor substrate-1 (IRS1), pivotal to insulin signaling, whereas IRS1myc overexpression recovered downstream insulin signaling. Endogenous IRS1 protein content and insulin signaling were restored in ATG16L1 KO mouse embryonic fibroblasts (MEF) upon proteasome inhibition. Through proximity-dependent biotin identification (BioID) and co-immunoprecipitation, we found that Kelch-like proteins KLHL9 and KLHL13, which together form an E3 ubiquitin (Ub) ligase complex with cullin 3 (CUL3), are novel IRS1 interactors. Expression of Klhl9 and Klhl13 was elevated in ATG16L1 KO MEFs and siRNA-mediated knockdown of Klhl9, Klhl13, or Cul3 recovered IRS1 expression. Moreover, Klhl13 and Cul3 knockdown increased insulin signaling. Notably, adipose tissue of high-fat fed mice displayed lower Atg16l1 mRNA expression and IRS1 protein content, and adipose tissue KLHL13 and CUL3 expression positively correlated to body mass index in humans. We propose that ATG16L1 deficiency evokes insulin resistance through induction of Klhl9 and Klhl13, which, in complex with Cul3, promote proteasomal IRS1 degradation.	[Frendo-Cumbo, Scott; Jaldin-Fincati, Javier R.; Tan, Joel M. J.; Brumell, John Hunter; Klip, Amira] Hosp Sick Children, Cell Biol Program, 686 Bay St PGCRL, Toronto, ON M5G 0A4, Canada; [Frendo-Cumbo, Scott; Klip, Amira] Univ Toronto, Dept Physiol, Med Sci Bldg, Toronto, ON M5S 1A8, Canada; [Brumell, John Hunter] Univ Toronto, Dept Mol Genet, 100 Coll St, Toronto, ON M5S 1A8, Canada; [Klip, Amira] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Brumell, John Hunter] Univ Toronto, Inst Med Sci, 100 Coll St, Toronto, ON M5S 1A8, Canada; [Raught, Brian] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Coyaud, Etienne; Laurent, Estelle M. N.; Raught, Brian] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2C1, Canada; [Townsend, Logan K.; Wright, David C.] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada; [Xavier, Ramnik J.] Harvard Med Sch, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Xavier, Ramnik J.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Boston, MA 02114 USA; [Pillon, Nicolas J.] Karolinska Inst, Dept Physiol, S-17177 Stockholm, Sweden; [Pillon, Nicolas J.] Karolinska Inst, Dept Pharmacol, S-17177 Stockholm, Sweden; [Brumell, John Hunter] Hosp Sick Children, SickKids IBD Ctr, 555 Univ Ave, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Guelph; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Karolinska Institutet; Karolinska Institutet; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Brumell, JH; Klip, A (corresponding author), Hosp Sick Children, Cell Biol Program, 686 Bay St PGCRL, Toronto, ON M5G 0A4, Canada.	john.brumell@sickkids.ca; amira@sickkids.ca	Laurent, Estelle/AFV-5442-2022; COYAUD, Etienne/ABD-9726-2020; Pillon, Nicolas J/M-4170-2019	COYAUD, Etienne/0000-0002-5893-4557; Pillon, Nicolas J/0000-0003-1107-9490; Frendo-Cumbo, Scott/0000-0002-9047-4650; Wright, David/0000-0003-3867-8901; Jaldin-Fincati, Javier Roberto/0000-0002-9490-4785	Canadian Institutes of Health Research (CIHR) [FDN 154329, FDN-143203, PJT 156093]; Canadian Foundation for Innovation; Ontario Innovation Trust; Natural Sciences and Engineering Research Council (NSERC) Alexander Graham Bell Canada Graduate Scholarship-Doctoral; PricewaterhouseCoopers Student Bursary; Restracomp-Hospital for Sick Children scholarship; Natural Sciences and Engineering Research Council (NSERC); Tier II Canada Research Chair in Lipids, Metabolism and Health grant; Tier I Canada Research Chair holder on Cell Biology of Insulin Action; Canada Research Chair in Proteomics and Molecular Medicine; Pitblado Chair in Cell Biology at the Hospital for Sick Children	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Innovation Trust; Natural Sciences and Engineering Research Council (NSERC) Alexander Graham Bell Canada Graduate Scholarship-Doctoral; PricewaterhouseCoopers Student Bursary; Restracomp-Hospital for Sick Children scholarship; Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Tier II Canada Research Chair in Lipids, Metabolism and Health grant; Tier I Canada Research Chair holder on Cell Biology of Insulin Action; Canada Research Chair in Proteomics and Molecular Medicine; Pitblado Chair in Cell Biology at the Hospital for Sick Children	This work was supported by Canadian Institutes of Health Research (CIHR) Grants FDN 154329 (to J. H. B.), FDN-143203 (to A. K.), and PJT 156093 (to B. R.), a John Evans Leadership Fund infrastructure grant from the Canadian Foundation for Innovation and the Ontario Innovation Trust (to J. H. B.), Natural Sciences and Engineering Research Council (NSERC) Alexander Graham Bell Canada Graduate Scholarship-Doctoral, a PricewaterhouseCoopers Student Bursary, and a Restracomp-Hospital for Sick Children scholarship (to S. F.-C.), a Natural Sciences and Engineering Research Council (NSERC) Post-graduate Scholarship award (to L. K. T.), a Tier II Canada Research Chair in Lipids, Metabolism and Health grant (to D. C. W.), a Tier I Canada Research Chair holder on Cell Biology of Insulin Action (to A. K.), a Canada Research Chair in Proteomics and Molecular Medicine (to B. R.), and the Pitblado Chair in Cell Biology at the Hospital for Sick Children (to J. H. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Bjornholm M, 1997, DIABETES, V46, P524, DOI 10.2337/diabetes.46.3.524; Bollinger LM, 2015, OBESITY, V23, P1185, DOI 10.1002/oby.21081; Boura-Halfon S, 2010, MOL ENDOCRINOL, V24, P2179, DOI 10.1210/me.2010-0072; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Cai JJ, 2018, CELL REP, V25, P1708, DOI 10.1016/j.celrep.2018.10.040; Carvalho E, 1999, FASEB J, V13, P2173, DOI 10.1096/fasebj.13.15.2173; Chiu TT, 2011, CELL SIGNAL, V23, P1546, DOI 10.1016/j.cellsig.2011.05.022; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Conway KL, 2013, GASTROENTEROLOGY, V145, P1347, DOI 10.1053/j.gastro.2013.08.035; Copple IM, 2010, J BIOL CHEM, V285, P16782, DOI 10.1074/jbc.M109.096545; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Coyaud E, 2015, MOL CELL PROTEOMICS, V14, P1781, DOI 10.1074/mcp.M114.045658; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Czuczman MA, 2014, NATURE, V509, P230, DOI 10.1038/nature13168; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Dhanoa BS, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-13; Eng JK, 2013, PROTEOMICS, V13, P22, DOI 10.1002/pmic.201200439; Fraser J, 2017, ESSAYS BIOCHEM, V61, P597, DOI 10.1042/EBC20170091; Frendo-Cumbo S, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12877; Galluzzi L, 2019, CELL, V177, P1682, DOI 10.1016/j.cell.2019.05.026; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hotamisligil GS, 2005, DIABETES, V54, pS73, DOI 10.2337/diabetes.54.suppl_2.S73; Jaldin-Fincati JR, 2018, AM J PHYSIOL-ENDOC M, V315, pE204, DOI 10.1152/ajpendo.00008.2018; Jaldin-Fincati JR, 2017, TRENDS ENDOCRIN MET, V28, P597, DOI 10.1016/j.tem.2017.05.002; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kang SG, 2007, J BIOL CHEM, V282, P6090, DOI 10.1074/jbc.M610659200; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Lee AV, 2000, MOL CELL BIOL, V20, P1489, DOI 10.1128/MCB.20.5.1489-1496.2000; Liu GM, 2010, NAT BIOTECHNOL, V28, P1015, DOI 10.1038/nbt1010-1015; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Liu Y, 2015, DIABETES, V64, P36, DOI 10.2337/db14-0267; Maixner N, 2016, PHYSIOLOGY, V31, P270, DOI 10.1152/physiol.00048.2015; Mallo GV, 2008, J CELL BIOL, V182, P741, DOI 10.1083/jcb.200804131; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Maurer K, 2015, CELL HOST MICROBE, V17, P429, DOI 10.1016/j.chom.2015.03.001; Meng QY, 2011, J BIOL CHEM, V286, P32324, DOI 10.1074/jbc.M111.254417; Nakao R, 2009, MOL CELL BIOL, V29, P4798, DOI 10.1128/MCB.01347-08; Olokoba Abdulfatai B, 2012, Oman Med J, V27, P269, DOI 10.5001/omj.2012.68; Ozoe A, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00024; Papp D, 2012, FEBS LETT, V586, P1795, DOI 10.1016/j.febslet.2012.05.016; Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24; Pedrioli PGA, 2010, METHODS MOL BIOL, V604, P213, DOI 10.1007/978-1-60761-444-9_15; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Potashnik R, 2003, DIABETOLOGIA, V46, P639, DOI 10.1007/s00125-003-1097-5; Rondinone CM, 1997, P NATL ACAD SCI USA, V94, P4171, DOI 10.1073/pnas.94.8.4171; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Shibutani ST, 2014, CELL RES, V24, P58, DOI 10.1038/cr.2013.159; Stienstra R, 2014, DIABETOLOGIA, V57, P1505, DOI 10.1007/s00125-014-3255-3; Subramani S, 2013, EMBO REP, V14, P143, DOI 10.1038/embor.2012.220; Sumara I, 2007, DEV CELL, V12, P887, DOI 10.1016/j.devcel.2007.03.019; Sun XJ, 1999, DIABETES, V48, P1359, DOI 10.2337/diabetes.48.7.1359; Sylow L, 2014, CELL SIGNAL, V26, P323, DOI 10.1016/j.cellsig.2013.11.007; Thirone ACP, 2006, TRENDS ENDOCRIN MET, V17, P70, DOI 10.1016/j.tem.2006.01.005; Weernink PAO, 2000, EUR J BIOCHEM, V267, P5237, DOI 10.1046/j.1432-1327.2000.01599.x; Xu JL, 2012, DIABETES, V61, P3208, DOI 10.2337/db11-1716; Xu XS, 2008, MOL CELL, V30, P403, DOI 10.1016/j.molcel.2008.03.009; Xu XS, 2012, J BIOL CHEM, V287, P40758, DOI 10.1074/jbc.M112.405209; Yamamoto S, 2018, CELL REP, V23, P3286, DOI 10.1016/j.celrep.2018.05.032; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yin J, 2009, AM J PHYSIOL-ENDOC M, V296, pE333, DOI 10.1152/ajpendo.90760.2008; Zhande R, 2002, MOL CELL BIOL, V22, P1016, DOI 10.1128/MCB.22.4.1016-1026.2002; Zhang YM, 2018, NAT REV ENDOCRINOL, V14, P356, DOI 10.1038/s41574-018-0009-1; Zhang Z, 2016, P NATL ACAD SCI USA, V113, pE6418, DOI 10.1073/pnas.1614467113; Zhou LJ, 2009, MOL PHARMACOL, V76, P596, DOI 10.1124/mol.109.057067	73	12	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					16172	16185		10.1074/jbc.RA119.009110	http://dx.doi.org/10.1074/jbc.RA119.009110			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31515271	hybrid, Green Published			2022-12-26	WOS:000499478600025
J	Andrade, ACB; Viana, JMS; Pereira, HD; Pinto, VB; Silva, FFE				Bastos Andrade, Andrea Carla; Soriano Viana, Jose Marcelo; Pereira, Helcio Duarte; Pinto, Vitor Batista; Fonseca e Silva, Fabyano			Linkage disequilibrium and haplotype block patterns in popcorn populations	PLOS ONE			English	Article							GENOMIC PREDICTION; REGION; LD; INFERENCE; SELECTION; SNPS; MAP; HOT	Linkage disequilibrium (LD) analysis provides information on the evolutionary aspects of populations. Recently, haplotype blocks have been used to increase the power of quantitative trait loci detection in genome-wide association studies and the prediction accuracy of genomic selection. Our objectives were as follows: to compare the degree of LD, LD decay, and LD decay extent in popcorn populations; to characterize the number and length of haplotype blocks in the populations; and to determine whether maize chromosomes also have a pattern of interspaced regions of high and low rates of recombination. We used a biparental population, a synthetic, and a breeding population, genotyped for approximately 75,000 single nucleotide polymorphisms (SNPs). The sample size ranged from 190 to 192 plants. For the whole-genome LD and haplotype block analyses, we assumed a window of 500 kb. To characterize the block and step patterns of LD in the populations, we constructed LD maps by chromosome, defining a cold spot as a chromosome segment including SNPs with the same LDU position. The LD and haplotype block analyses were also performed at the intragenic level, selecting 12 genes related to zein, starch, cellulose, and fatty acid biosynthesis. The populations with the higher and lower frequencies of vertical bar D'vertical bar values greater than 0.75 were the biparental (65-74%) and the breeding population (26-58%), respectively. There were slight differences between the populations regarding the average distance for SNPs with vertical bar D'vertical bar values greater than 0.75 (in the range of approximately 207 to 229 kb). The level of LD expressed by the r(2) values was low in the populations (0.02, 0.04, and 0.04, on average) but comparable to some non-isolated human populations. The frequency of r(2) values greater than 0.75 was lower in the biparental population (0.2-0.5%) and higher in the other populations (0.2-1.6%). The average distance for SNPs with r(2) values greater than 0.75 was much higher in the biparental population (approximately 80 to 126 kb). In the other populations, the ranges were approximately 6 to 19 and 6 to 35 kb. The heatmaps for the regions covered by the first 100 SNPs in each chromosome, in each population (1 to 3.3 Mb, approximately), provided evidence that the comparatively few high r(2) values (close to 1.0) occurred only for SNPs in close proximity, especially in the synthetic and breeding populations. Due to the reduced number of SNPs in the haplotype blocks (2 to 3) in the populations, it is not expected advantage of a haplotype-based association study as well as genomic selection along generations. The results concerning LD decay (rapid decay after 5-10 kb) and LD decay extent (along up to 300 kb) are in the range observed with maize inbred line panels. The LD maps indicate that maize chromosomes had a pattern of regions of extensive LD interspaced with regions of low LD. However, our simulated LD map provides evidence that this pattern can reflect regions with differences in allele frequencies and LD levels (expressed by vertical bar D'vertical bar) and not regions with high and low rates of recombination.	[Bastos Andrade, Andrea Carla; Soriano Viana, Jose Marcelo; Pereira, Helcio Duarte; Pinto, Vitor Batista] Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil; [Fonseca e Silva, Fabyano] Univ Fed Vicosa, Dept Anim Sci, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa	Viana, JMS (corresponding author), Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil.	jmsviana@ufv.br	Viana, José Marcelo Soriano/G-2119-2012; Pinto, Vitor/I-2886-2017; Andrade, Andrea/B-3339-2014	Viana, José Marcelo Soriano/0000-0002-5063-4648; Pinto, Vitor/0000-0002-8119-7268; Andrade, Andrea/0000-0003-0111-1792	National Council for Scientific and Technological Development (CNPq) [301638/2017-9, 404836/2018-6]; Brazilian Federal Agency for Support and Evaluation of Graduate Education (Capes) [001]; Foundation for Research Support of Minas Gerais State (Fapemig) [CAG APQ 01153/17]	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Federal Agency for Support and Evaluation of Graduate Education (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Foundation for Research Support of Minas Gerais State (Fapemig)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by Grants 301638/2017-9 and 404836/2018-6 -National Council for Scientific and Technological Development (CNPq); Scholarship (Finance Code 001) -Brazilian Federal Agency for Support and Evaluation of Graduate Education (Capes); and Grant CAG APQ 01153/17 -Foundation for Research Support of Minas Gerais State (Fapemig); Authors: ACBA (scholarship), JMSV (grants), HDP (scholarship), VBP (scholarship); http://www.cnpq.br/, http://www.capes.gov.br/, and https://fapemig.br/pt/.	Akesaka T, 2004, J HUM GENET, V49, P603, DOI 10.1007/s10038-004-0195-7; Anderson SL, 2018, PLANT GENOME-US, V11, DOI 10.3835/plantgenome2017.11.0102; Angius A, 2008, HUM HERED, V65, P9, DOI 10.1159/000106058; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett Jeffrey C, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.ip71; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Collins A, 2009, MOL BIOTECHNOL, V41, P83, DOI 10.1007/s12033-008-9110-3; Evans DM, 2005, AM J HUM GENET, V76, P681, DOI 10.1086/429274; Evseeva I, 2010, EUR J HUM GENET, V18, P924, DOI 10.1038/ejhg.2010.32; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gore MA, 2009, SCIENCE, V326, P1115, DOI 10.1126/science.1177837; Hess M, 2017, GENET SEL EVOL, V49, DOI 10.1186/s12711-017-0329-y; Jeffreys AJ, 2004, PHILOS T ROY SOC B, V359, P141, DOI 10.1098/rstb.2003.1372; Jiao YP, 2017, NATURE, V546, P524, DOI 10.1038/nature22971; Jonas D, 2016, J DAIRY SCI, V99, P4537, DOI 10.3168/jds.2015-10433; Khatkar MS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-187; Knaus BJ, 2017, MOL ECOL RESOUR, V17, P44, DOI 10.1111/1755-0998.12549; Knueppel S, 2015, PACKAGE HAPESTXXR; LEWONTIN RC, 1964, GENETICS, V49, P49; Ma YS, 2016, MOL BREEDING, V36, DOI 10.1007/s11032-016-0504-9; Maldonado C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212925; Maniatis N, 2002, P NATL ACAD SCI USA, V99, P2228, DOI 10.1073/pnas.042680999; McKay SD, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-74; Nuchnoi P, 2008, J HUM GENET, V53, P850, DOI 10.1007/s10038-008-0309-8; Pardo L, 2009, EUR J HUM GENET, V17, P802, DOI 10.1038/ejhg.2008.248; Pengelly RJ, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1854-0; Qanbari S, 2010, ANIM GENET, V41, P346, DOI 10.1111/j.1365-2052.2009.02011.x; Qanbari S, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-103; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Shifman S, 2003, HUM MOL GENET, V12, P771, DOI 10.1093/hmg/ddg088; Viana JMS, 2018, HEREDITY, V120, P283, DOI 10.1038/s41437-017-0027-0; Viana JMS, 2013, GENETICA, V141, P389, DOI 10.1007/s10709-013-9738-1; Tapper WJ, 2003, ANN HUM GENET, V67, P487, DOI 10.1046/j.1469-1809.2003.00050.x; Thirunavukkarasu N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-877; Truntzler M, 2012, THEOR APPL GENET, V125, P731, DOI 10.1007/s00122-012-1866-y; Viana JMS, 2017, MOL BREEDING, V37, DOI [10.1007/s11032-017-0700-2, DOI 10.1007/S11032-017-0700-2]; Viana JMS, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-016-1800-5; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; Weir BS, 2008, ANNU REV GENOM HUM G, V9, P129, DOI 10.1146/annurev.genom.9.081307.164347; Wimmer V, 2012, BIOINFORMATICS, V28, P2086, DOI 10.1093/bioinformatics/bts335; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Zhang WH, 2002, P NATL ACAD SCI USA, V99, P17004, DOI 10.1073/pnas.012672899	42	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0219417	10.1371/journal.pone.0219417	http://dx.doi.org/10.1371/journal.pone.0219417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553737	Green Submitted, Green Published, gold			2022-12-26	WOS:000532319200003
J	Diaz-Garcia, L; Rodriguez-Bonilla, L; Phillips, M; Lopez-Hernandez, A; Grygleski, E; Atucha, A; Zalapa, J				Diaz-Garcia, Luis; Rodriguez-Bonilla, Lorraine; Phillips, Matthew; Lopez-Hernandez, Arnoldo; Grygleski, Edward; Atucha, Amaya; Zalapa, Juan			Comprehensive analysis of the internal structure and firmness in American cranberry (Vaccinium macrocarpon Ait.) fruit	PLOS ONE			English	Article							SHELF-LIFE; TOMATO; QUANTIFICATION; PHENOMICS; VARIETIES; TEXTURE; QUALITY; STORAGE; SHAPE	Background Cranberry (Vaccinium macrocarpon L.) fruit quality traits encompass many properties. Although visual appearance and fruit nutritional constitution have usually been the most important attributes, cranberry textural properties such as firmness have recently gained importance in the industry. Fruit firmness has become a quality standard due to the recent demand increase for sweetened and dried cranberries (SDC), which are currently the most profitable cranberry product. Traditionally, this trait has been measured by the cranberry industry using compression tests; however, it is poorly understood how fruit firmness is influenced by other characteristics. Results In this study, we developed a high-throughput computer-vision method to measure the internal structure of cranberry fruit, which may in turn influence cranberry fruit firmness. We measured the internal structure of 16 cranberry cultivars measured over a 40-day period, representing more than 3000 individual fruit evaluated for 10 different traits. The internal structure data paired with fruit firmness values at each evaluation period allowed us to explore the correlations between firmness and internal morphological characteristics. Conclusions Our study highlights the potential use of internal structure and firmness data as a decision-making tool for cranberry processing, especially to determine optimal harvest times and ensure high quality fruit. In particular, this study introduces novel methods to define key parameters of cranberry fruit that have not been characterized in cranberry yet. This project will aid in the future evaluation of cranberry cultivars for in SDC production.	[Diaz-Garcia, Luis; Rodriguez-Bonilla, Lorraine; Phillips, Matthew; Atucha, Amaya; Zalapa, Juan] Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA; [Diaz-Garcia, Luis] Inst Nacl Invest Forestales Agr & Pecuarias, Aguascalientes, Aguascalientes, Mexico; [Lopez-Hernandez, Arnoldo] Univ Wisconsin, Dept Food Sci, 1605 Linden Dr, Madison, WI 53706 USA; [Grygleski, Edward] Valley Corp, Tomah, WI USA; [Zalapa, Juan] Univ Wisconsin, Vegetable Crops Res Unit, USDA ARS, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison	Diaz-Garcia, L; Zalapa, J (corresponding author), Univ Wisconsin, Dept Hort, 1575 Linden Dr, Madison, WI 53706 USA.; Diaz-Garcia, L (corresponding author), Inst Nacl Invest Forestales Agr & Pecuarias, Aguascalientes, Aguascalientes, Mexico.; Zalapa, J (corresponding author), Univ Wisconsin, Vegetable Crops Res Unit, USDA ARS, Madison, WI 53715 USA.	diaz.antonio@inifap.gob.mx; juan.zalapa@ars.usda.gov			USDA-ARS [5090-21220-004-00-D]; WI-DATCP (SCBG Project) [14-002]; Ocean Spray Cranberries, Inc.; Wisconsin Cranberry Growers Association; Cranberry Institute; Consejo Nacional de Ciencia y Tecnologi'a (Mexico); Gabelman-Seminis Graduate Fellowship; UW Madison SciMed GRS	USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); WI-DATCP (SCBG Project); Ocean Spray Cranberries, Inc.; Wisconsin Cranberry Growers Association; Cranberry Institute; Consejo Nacional de Ciencia y Tecnologi'a (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Gabelman-Seminis Graduate Fellowship; UW Madison SciMed GRS	This project was supported by USDA-ARS (project no. 5090-21220-004-00-D provided to JZ); WI-DATCP (SCBG Project #14-002); Ocean Spray Cranberries, Inc.; Wisconsin Cranberry Growers Association; Cranberry Institute. LDG was supported by the Consejo Nacional de Ciencia y Tecnologi ' a (Mexico), and the Gabelman-Seminis Graduate Fellowship. LRB was supported by the UW Madison SciMed GRS. Edward Grygleski is affiliated with the commercial company Valley Corporation. Valley Corporation provided support in the form of salaries for author (EG), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Alston J.M., 2014, EC IMPACT N AM CRANB; Brewer MT, 2006, PLANT PHYSIOL, V141, P15, DOI 10.1104/pp.106.077867; Celik H, 2008, SCI HORTIC-AMSTERDAM, V117, P345, DOI 10.1016/j.scienta.2008.05.005; Chaib J, 2007, J EXP BOT, V58, P1915, DOI 10.1093/jxb/erm046; Chapman NH, 2012, PLANT PHYSIOL, V159, P1644, DOI 10.1104/pp.112.200634; Depypere L, 2009, PLANT SYST EVOL, V279, P219, DOI 10.1007/s00606-009-0158-8; Diaz-Garcia L, 2018, PEERJ, V6, DOI 10.7717/peerj.5461; Diaz-Garcia L, 2018, MOL GENET GENOMICS, V293, P1379, DOI 10.1007/s00438-018-1464-z; FAOSTAT, 2016, CRANB STAT 2016 FAOS; FDA, 2016, FOOD LAB REV NUTR SU; Figas MR, 2015, GENET RESOUR CROP EV, V62, P189, DOI 10.1007/s10722-014-0142-1; Forney C. F., 2010, FRESH PROD, V4, P67; Forney CF, 2003, HORTTECHNOLOGY, V13, P267, DOI 10.21273/HORTTECH.13.2.0267; Gallardo RK, 2018, HORTSCIENCE, V53, P1467, DOI [10.21273/hortsci13219-18, 10.21273/HORTSCI13219-18]; Gonzalo MJ, 2008, THEOR APPL GENET, V116, P647, DOI 10.1007/s00122-007-0698-7; Gorny JR, 2000, J FOOD SCI, V65, P541, DOI 10.1111/j.1365-2621.2000.tb16044.x; Gunes G, 2002, J AGR FOOD CHEM, V50, P5932, DOI 10.1021/jf025572c; Hadfield KA, 1998, PLANT PHYSIOL, V117, P337, DOI 10.1104/pp.117.2.337; Hurtado M, 2013, SCI HORTIC-AMSTERDAM, V164, P625, DOI 10.1016/j.scienta.2013.10.028; Jarolmasjed S, 2016, POSTHARVEST BIOL TEC, V118, P35, DOI 10.1016/j.postharvbio.2016.03.014; Jesse E., 1993, EC IMPACT WISCONSIN, V2538; Konopacka D, 2004, POSTHARVEST BIOL TEC, V32, P205, DOI 10.1016/j.postharvbio.2003.11.012; Kumar S, 2012, FOOD CHEM, V131, P1223, DOI 10.1016/j.foodchem.2011.09.108; Magwaza LS, 2014, POSTHARVEST BIOL TEC, V95, P1, DOI 10.1016/j.postharvbio.2014.03.014; Meli VS, 2010, P NATL ACAD SCI USA, V107, P2413, DOI 10.1073/pnas.0909329107; Ozgen M, 2002, POSTHARVEST BIOL TEC, V24, P291, DOI 10.1016/S0925-5214(01)00154-5; Prohens J, 2012, EUPHYTICA, V186, P517, DOI 10.1007/s10681-012-0652-x; R Core Team, 2021, R LANGUAGE ENV STAT; Saladie M, 2007, PLANT PHYSIOL, V144, P1012, DOI 10.1104/pp.107.097477; Song GQ, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: TEMPERATE FRUITS, P197, DOI 10.1007/978-3-642-16057-8_10; United State Department of Agriculture Economic Research Service (USDA-ERS), 2017, FRUIT TREE NUTS OUTL; United State Department of Agriculture National Agriculture Statistics Service (USDA NASS), 2017, NAT STAT CRANB; Valley Corp, CRANB VAR INF; Vorsa N, 2000, ACTA HORTIC, V574, P215, DOI 10.17660/ActaHortic.2002.574.32; Vorsa N, 2012, HANDB PLANT BREED, V8, P191, DOI 10.1007/978-1-4419-0763-9_6; Vvedenskaya IO, 2004, PLANT SCI, V167, P1043, DOI 10.1016/j.plantsci.2004.06.001; Walter A, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0056-8; Wang YF, 2017, PLANT SCI, V262, P91, DOI 10.1016/j.plantsci.2017.06.004; Well-Hansen L., 2018, COMMUNICATION; Yoshioka Y, 2010, EUPHYTICA, V171, P409, DOI 10.1007/s10681-009-0071-9; Zhang BH, 2014, FOOD RES INT, V62, P326, DOI 10.1016/j.foodres.2014.03.012; Zude M, 2006, J FOOD ENG, V77, P254, DOI 10.1016/j.jfoodeng.2005.06.027	42	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222451	10.1371/journal.pone.0222451	http://dx.doi.org/10.1371/journal.pone.0222451			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553750	Green Submitted, Green Published, gold			2022-12-26	WOS:000532319200027
J	Goede, LL; Pflugrad, H; Schmitz, B; Lanfermann, H; Tryc, AB; Barg-Hock, H; Klempnauer, J; Weissenborn, K; Ding, XQ				Goede, Lukas Laurids; Pflugrad, Henning; Schmitz, Birte; Lanfermann, Heinrich; Tryc, Anita Blanka; Barg-Hock, Hannelore; Klempnauer, Juergen; Weissenborn, Karin; Ding, Xiao-Qi			Quantitative magnetic resonance imaging indicates brain tissue alterations in patients after liver transplantation	PLOS ONE			English	Article							NEUROPSYCHOLOGICAL STATUS RBANS; NORMAL-APPEARING BRAIN; LONG-TERM; REPEATABLE BATTERY; WHITE-MATTER; DIFFUSION; MRI; COMPLICATIONS; ABNORMALITIES; METABOLISM	Purpose To investigate cerebral microstructural alterations in patients treated with calcineurin inhibitors (CNI) after orthotopic liver transplantation (OLT) using quantitative magnetic resonance imaging (qMRI) and a cross-sectional study design. Methods Cerebral qMRI was performed in 85 patients in a median 10 years after OLT compared to 31 healthy controls. Patients were treated with different dosages of CNI or with a CNI-free immunosuppression (CNI-free: n = 19; CNI-low: n = 36; CNI-standard: n = 30). T2-, T2*and T2'- relaxation times, as well as apparent diffusion coefficient (ADC) and fractional anisotropy (FA) were measured in brain gray and white matter by using the regions of interest method. Results In comparison to controls, patients revealed significantly increased T2, T2*, T2', ADC and reduced FA, predominantly in the frontal white matter, indicating microstructural brain alterations represented by increased free water (increased T2), reduced neuronal metabolism (increased T2') and a lower degree of spatial organization of the nervous fibers (reduced FA). CNI-low and CNI-free patients showed more alterations than CNI-standard patients. Analysis of their history revealed impairment of kidney function while under standard CNI dose suggesting that these patients may be more vulnerable to toxic CNI side-effects. Conclusion Our findings suggest that the individual sensitivity to toxic side effects should be considered when choosing an appropriate immunosuppressive regimen in patients after liver transplantation.	[Goede, Lukas Laurids; Pflugrad, Henning; Tryc, Anita Blanka; Weissenborn, Karin] Hannover Med Sch, Dept Neurol, Hannover, Germany; [Goede, Lukas Laurids; Schmitz, Birte; Lanfermann, Heinrich; Ding, Xiao-Qi] Hannover Med Sch, Inst Diagnost & Intervent Neuroradiol, Hannover, Germany; [Goede, Lukas Laurids; Pflugrad, Henning; Tryc, Anita Blanka; Weissenborn, Karin] Hannover Med Sch, Integrated Res & Treatment Ctr Transplantat IFB T, Hannover, Germany; [Barg-Hock, Hannelore; Klempnauer, Juergen] Hannover Med Sch, Clin Visceral & Transplant Surg, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School	Ding, XQ (corresponding author), Hannover Med Sch, Inst Diagnost & Intervent Neuroradiol, Hannover, Germany.	ding.xiaoqi@mh-hannover.de	Lanfermann, Heinrich/AAR-4069-2021	Goede, Lukas Laurids/0000-0001-6026-185X	German Federal Ministry of Education and Research [01EO1302]; German Research Foundation (DFG); Hannover Medical School (MHH)	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); Hannover Medical School (MHH)	This study was supported by a grant from the German Federal Ministry of Education and Research (reference number: 01EO1302) to LLG and German Research Foundation (DFG) to BS. We acknowledge support by the German Research Foundation (DFG) and the Open Access Publication Fund of Hannover Medical School (MHH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg F, 2011, SCAND J SURG, V100, P14, DOI 10.1177/145749691110000104; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bammer R, 2003, EUR J RADIOL, V45, P169, DOI 10.1016/S0720-048X(02)00303-0; Bernhardt M, 2015, LIVER TRANSPLANT, V21, P224, DOI 10.1002/lt.24035; Blinkenberg M, 1999, NEUROLOGY, V53, P149, DOI 10.1212/WNL.53.1.149; Dawe RJ, 2014, NEUROBIOL AGING, V35, P1549, DOI 10.1016/j.neurobiolaging.2014.01.144; Ding XQ, 2008, EUR J PAEDIATR NEURO, V12, P298, DOI 10.1016/j.ejpn.2007.08.012; Ding XQ, 2008, J MAGN RESON IMAGING, V27, P998, DOI 10.1002/jmri.21289; Ding XQ, 2009, EUR RADIOL, V19, P1537, DOI 10.1007/s00330-009-1296-7; Ding XQ, 2004, INVEST RADIOL, V39, P740, DOI 10.1097/00004424-200412000-00005; Dogan F, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20151007; Eylers VV, 2016, AM J NEURORADIOL, V37, P447, DOI 10.3174/ajnr.A4557; Filippi M, 2001, NEUROLOGY, V56, P304, DOI 10.1212/WNL.56.3.304; Martinez RG, 2010, TRANSPLANTATION, V89, P589, DOI 10.1097/TP.0b013e3181ca7bb3; Goldbecker A, 2013, GUT, V62, P1497, DOI 10.1136/gutjnl-2012-303262; Herynek V, 2012, J MAGN RESON IMAGING, V35, P1332, DOI 10.1002/jmri.23599; Herzer K, 2016, CLIN TRANSPLANT, V30, P487, DOI 10.1111/ctr.12708; HOLLAND BA, 1986, AM J NEURORADIOL, V7, P201; Holst B, 2009, MULT SCLER, V15, P701, DOI 10.1177/1352458509103713; Howell D, 2002, STAT METHODS PSYCHOL, V5th ed; Leppert IR, 2009, J MAGN RESON IMAGING, V29, P258, DOI 10.1002/jmri.21646; Lewis MB, 2003, NEUROLOGY, V61, P1174, DOI 10.1212/01.WNL.0000089487.42870.C6; Loubinoux I, 1997, STROKE, V28, P419, DOI 10.1161/01.STR.28.2.419; Lyng H, 2000, MAGNET RESON MED, V43, P828, DOI 10.1002/1522-2594(200006)43:6<828::AID-MRM8>3.0.CO;2-P; Mooney S, 2007, ARCH CLIN NEUROPSYCH, V22, P175, DOI 10.1016/j.acn.2006.12.005; MUELLER AR, 1994, TRANSPLANTATION, V58, P155, DOI 10.1097/00007890-199407270-00006; Pflugrad H, 2018, LIVER TRANSPLANT, V24, P56, DOI 10.1002/lt.24984; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Rompianesi G, 2015, TRANSPL INT, V28, P864, DOI 10.1111/tri.12564; Wagner M, 2012, AM J NEURORADIOL, V33, P2081, DOI 10.3174/ajnr.A3138; Wagner M, 2012, J MAGN RESON IMAGING, V36, P1347, DOI 10.1002/jmri.23777; Weissenborn K, 2013, NEURORADIOLOGY, V55, P819, DOI 10.1007/s00234-013-1176-3	32	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222934	10.1371/journal.pone.0222934	http://dx.doi.org/10.1371/journal.pone.0222934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553760	gold, Green Published			2022-12-26	WOS:000532319200045
J	Sistere-Oro, M; Lopez-Serrano, S; Veljkovic, V; Pina-Pedrero, S; Vergara-Alert, J; Cordoba, L; Perez-Maillo, M; Pleguezuelos, P; Vidal, E; Segales, J; Nielsen, J; Fomsgaard, A; Darji, A				Sistere-Oro, Marta; Lopez-Serrano, Sergi; Veljkovic, Veljko; Pina-Pedrero, Sonia; Vergara-Alert, Julia; Cordoba, Lorena; Perez-Maillo, Monica; Pleguezuelos, Patricia; Vidal, Enric; Segales, Joaquim; Nielsen, Jens; Fomsgaard, Anders; Darji, Ayub			DNA vaccine based on conserved HA-peptides induces strong immune response and rapidly clears influenza virus infection from vaccinated pigs	PLOS ONE			English	Article							A VIRUSES; RESPIRATORY CHALLENGE; PROTEIN VACCINE; PROTECTION; FLAGELLIN; ANTIBODIES; H5N1; IMMUNOGENICITY; TRANSMISSION; IMMUNIZATION	Swine influenza virus (SIVs) infections cause a significant economic impact to the pork industry. Moreover, pigs may act as mixing vessel favoring genome reassortment of diverse influenza viruses. Such an example is the pandemic H1N1 (pH1N1) virus that appeared in 2009, harboring a combination of gene segments from avian, pig and human lineages, which rapidly reached pandemic proportions. In order to confront and prevent these possible emergences as well as antigenic drift phenomena, vaccination remains of vital importance. The present work aimed to evaluate a new DNA influenza vaccine based on distinct conserved HA-peptides fused with flagellin and applied together with Diluvac Forte as adjuvant using a needle-free device (IntraDermal Application of Liquids, IDAL (R)). Two experimental pig studies were performed to test DNA-vaccine efficacy against SIVs in pigs. In the first experiment, SIV-seronegative pigs were vaccinated with VC4-flagellin DNA and intranasally challenged with a pH1N1. In the second study, VC4-flagellin DNA vaccine was employed in SIV-seropositive animals and challenged intranasally with an H3N2 SIV-isolate. Both experiments demonstrated a reduction in the viral shedding after challenge, suggesting vaccine efficacy against both the H1 and H3 influenza virus subtypes. In addition, the results proved that maternally derived antibodies (MDA) did not constitute an obstacle to the vaccine approach used. Moreover, elevated titers in antibodies both against H1 and H3 proteins in serum and in bronchoalveolar lavage fluids (BALFs) was detected in the vaccinated animals along with a markedly increased mucosal IgA response. Additionally, vaccinated animals developed stronger neutralizing antibodies in BALFs and higher inhibiting hemagglutination titers in sera against both the pH1N1 and H3N2 influenza viruses compared to unvaccinated, challenged-pigs. It is proposed that the described DNA-vaccine formulation could potentially be used as a multivalent vaccine against SIV infections.	[Sistere-Oro, Marta; Lopez-Serrano, Sergi; Pina-Pedrero, Sonia; Vergara-Alert, Julia; Cordoba, Lorena; Perez-Maillo, Monica; Pleguezuelos, Patricia; Vidal, Enric; Darji, Ayub] UAB, IRTA, CReSA, Campus Univ Autonoma Barcelona, Barcelona, Spain; [Veljkovic, Veljko] Biomed Protect, Galveston, TX USA; [Segales, Joaquim] UAB, IRTA, CReSA, Campus Univ Autonoma Barcelona, Barcelona, Spain; [Segales, Joaquim] UAB, Bellaterra Cerdanyola Valles, Fac Vet, Dept Sanitat & Anat Anim, Barcelona, Spain; [Nielsen, Jens; Fomsgaard, Anders] Statens Serum Inst, Dept Virus & Microbiol Special Diagnost, Virus Res & Dev Lab, Copenhagen S, Denmark	Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona; Statens Serum Institut	Darji, A (corresponding author), UAB, IRTA, CReSA, Campus Univ Autonoma Barcelona, Barcelona, Spain.	ayub.darji@irta.cat	Vidal, Enric/P-2901-2019; Vidal, Enric/I-1679-2014; Segalés, Joaquim/A-4933-2011; Pina-Pedrero, Sonia/U-2217-2017	Vidal, Enric/0000-0002-4965-3286; Vidal, Enric/0000-0002-4965-3286; Segalés, Joaquim/0000-0002-1539-7261; Pina-Pedrero, Sonia/0000-0001-5475-4770; Fomsgaard, Anders/0000-0003-4304-0603; Lopez-Serrano, Sergi/0000-0002-0968-7713	Spanish Government, Ministerio de Economia y Competitividad de Espana (MINECO) [AGL2013-48923-C2-2-R]; European Comission (EC) under Horizon 2020 [Transvac2-730964-INFRAIA-2016-1]; CERCA Programme/Generalitat de Catalunya; MINECO [BES-2014-068506]	Spanish Government, Ministerio de Economia y Competitividad de Espana (MINECO); European Comission (EC) under Horizon 2020; CERCA Programme/Generalitat de Catalunya; MINECO(Spanish Government)	This work was funded in part by the Spanish Government, Ministerio de Economia y Competitividad de Espana (MINECO), project: AGL2013-48923-C2-2-R, and by the collaborative infrastructure project funded by the European Comission (EC) under Horizon 2020, project Transvac2-730964-INFRAIA-2016-1. IRTA is supported by CERCA Programme/Generalitat de Catalunya. M.S.O. is supported by MINECO (scholarship no BES-2014-068506). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.The authors thank all personnel from IRTA CReSA field studies and BSL-3 laboratories and animal facilities for their transcendent assistance provided in both research studies. Authors also are thankful to Dr. Marta Jime ' nez from MSD Animal Health who supplied the IDAL1 device. Moreover, we also appreciate the courtesy from the personnel of CESAC (Centre de Sanitat Avicola de Catalunya, Reus, Spain) for kindly providing the chicken red blood cells.	Alexander DJ, 2000, REV SCI TECH OIE, V19, P197, DOI 10.20506/rst.19.1.1220; Bikour MH, 1996, CAN J VET RES, V60, P312; Borggren M, 2016, VACCINE, V34, P3634, DOI 10.1016/j.vaccine.2016.05.030; Borggren M, 2015, HUM VACC IMMUNOTHER, V11, P1983, DOI 10.1080/21645515.2015.1011987; Brown IH, 2011, CURR TOP MICOBIOL, V370, P133; BUSQUETS N, 2010, VET RES, V41, DOI DOI 10.1051/VETRES/2009049; Caron G, 2005, J IMMUNOL, V175, P1551, DOI 10.4049/jimmunol.175.3.1551; CASTRUCCI MR, 1993, VIROLOGY, V193, P503, DOI 10.1006/viro.1993.1155; Colombatti A, 2015, WO, Patent No. [2015/166010, 2015166010]; Delaney KN, 2010, VIRAL IMMUNOL, V23, P201, DOI 10.1089/vim.2009.0107; Department of health and human services. Food and drug administration. Center for biologics evaluation and research, 2007, GUID IND CLIN DAT NE; Detmer SE, 2013, INFLUENZA OTHER RESP, V7, P2, DOI 10.1111/irv.12199; Durrwald R, 2010, EMERG INFECT DIS, V16, P1029, DOI 10.3201/eid1606.100138; Farina C, 2004, INT IMMUNOL, V16, P799, DOI 10.1093/intimm/dxh083; Galindo-Cardiel I, 2013, VIRUS RES, V173, P180, DOI 10.1016/j.virusres.2012.12.018; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gorres JP, 2011, CLIN VACCINE IMMUNOL, V18, P1987, DOI 10.1128/CVI.05171-11; Grund C, 2011, VACCINE, V29, P5567, DOI 10.1016/j.vaccine.2011.01.006; He WQ, 2015, J VIROL, V89, P3610, DOI 10.1128/JVI.03099-14; Herve PL, 2014, J VIROL, V88, P325, DOI 10.1128/JVI.01141-13; Honko AN, 2006, INFECT IMMUN, V74, P1113, DOI 10.1128/IAI.74.2.1113-1120.2006; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Karlsson I, 2018, VET IMMUNOL IMMUNOP, V195, P25, DOI 10.1016/j.vetimm.2017.11.007; Kitikoon P, 2006, VET IMMUNOL IMMUNOP, V112, P117, DOI 10.1016/j.vetimm.2006.02.008; Kothalawala H, 2006, VET QUART, V28, P45, DOI 10.1080/01652176.2006.9695207; Krammer F, 2012, J VIROL, V86, P10302, DOI 10.1128/JVI.01336-12; Landolt Gabriele A., 2007, Animal Health Research Reviews, V8, P1, DOI 10.1017/S1466252307001272; Lange E, 2009, J GEN VIROL, V90, P2119, DOI 10.1099/vir.0.014480-0; Leung YHC, 2013, VACCINE, V31, P3536, DOI 10.1016/j.vaccine.2013.05.076; Liu G, 2012, VACCINE, V30, P6833, DOI 10.1016/j.vaccine.2012.09.013; Liu G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020928; Ma JH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-227; Ma Wenjun, 2010, Animal Health Research Reviews, V11, P81, DOI 10.1017/S146625231000006X; Marcelin G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026335; Margine I, 2013, J VIROL, V87, P10435, DOI 10.1128/JVI.01715-13; Markowska-Daniel I, 2011, VET IMMUNOL IMMUNOP, V142, P81, DOI 10.1016/j.vetimm.2011.03.019; Martin-Valls GE, 2014, VET MICROBIOL, V170, P266, DOI 10.1016/j.vetmic.2014.02.031; McDonald WF, 2007, J INFECT DIS, V195, P1607, DOI 10.1086/517613; Okutani M, 2018, ANIM SCI J, V89, P979, DOI 10.1111/asj.13021; Olsen CW, 2000, VET MICROBIOL, V74, P149, DOI 10.1016/S0378-1135(00)00175-9; Olvera A, 2011, VACCINE, V29, P2797, DOI 10.1016/j.vaccine.2011.01.105; Rahn J, 2015, VACCINE, V33, P2414, DOI 10.1016/j.vaccine.2015.03.052; RAZ E, 1994, P NATL ACAD SCI USA, V91, P9519, DOI 10.1073/pnas.91.20.9519; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sandbulte MR, 2015, VACCINES-BASEL, V3, P22, DOI 10.3390/vaccines3010022; Shim BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027953; Sibila M, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-165; Simon G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115815; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Song L, 2009, VACCINE, V27, P5875, DOI 10.1016/j.vaccine.2009.07.060; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; The European agency for the evaluation of medical products, 1997, NOT GUID HARM REQ IN, P19; Tsybalova LM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201429; Van Reeth K, 2004, VIRUS RES, V103, P115, DOI 10.1016/j.virusres.2004.02.023; Van Reeth K, 2003, VACCINE, V21, P1375, DOI 10.1016/S0264-410X(02)00688-6; Veljkovic V, 2014, VACCINE, V32, P6569, DOI 10.1016/j.vaccine.2014.07.007; Veljkovic V, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-62; Veljkovic V, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-21; Vergara-Alert J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040524; Vincent AL, 2017, VET MICROBIOL, V206, P35, DOI 10.1016/j.vetmic.2016.11.026; Vincent AL, 2010, VACCINE, V28, P2782, DOI 10.1016/j.vaccine.2010.01.049; Waffarn EE, 2011, J IMMUNOL, V186, P3823, DOI 10.4049/jimmunol.1002090; Wang BZ, 2010, PLOS ONE, V5; Wang SX, 2008, VACCINE, V26, P2100, DOI 10.1016/j.vaccine.2008.02.033; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Weimer ET, 2009, VACCINE, V27, P6762, DOI 10.1016/j.vaccine.2009.08.080; Wijnans L, 2016, INFLUENZA OTHER RESP, V10, P2, DOI 10.1111/irv.12351; Wood JM, 2003, VACCINE, V21, P1786, DOI 10.1016/S0264-410X(03)00073-2; World Organisation for Animal Health (OIE), 2012, MANUAL DIAGNOSTIC TE, V6th; Young F, 2011, VACCINE, V29, P8788, DOI 10.1016/j.vaccine.2011.09.077; Zimmerman Jeffrey J., 2012, DIS SWINE, P557	74	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222201	10.1371/journal.pone.0222201	http://dx.doi.org/10.1371/journal.pone.0222201			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LE4TZ	31553755	Green Published, gold, Green Submitted			2022-12-26	WOS:000526713800001
J	Lim, JH; Cho, JH; Jung, HY; Choi, JY; Park, SH; Kim, YL; Kim, HK; Huh, S; Yoo, ES; Won, DI; Kim, CD				Lim, Jeong-Hoon; Cho, Jang-Hee; Jung, Hee-Yeon; Choi, Ji-Young; Park, Sun-Hee; Kim, Yong-Lim; Kim, Hyung-Kee; Huh, Seung; Yoo, Eun Sang; Won, Dong-Il; Kim, Chan-Duck			Excellent outcome after desensitization in high immunologic risk kidney transplantation	PLOS ONE			English	Article							POSITIVE CROSS-MATCH; ABO BLOOD-GROUP; ANTIBODY; RECIPIENTS; PROTOCOLS; DIALYSIS	Introduction HLA-incompatible (HLAi) and ABO-incompatible (ABOi) kidney transplantation (KT) has been on the increase over the last decade. However, there are wide variations in outcomes from these procedures. In this study we evaluated the graft and patient outcomes in incompatible KT and non-sensitized KT. Methods Patients who underwent KT between January 2012 and April 2018 were enrolled and reviewed. We divided kidney transplant recipients (KTRs) into five groups as follows: HLAi (n = 50); ABOi (n = 65); HLAi+ABOi (n = 5); control (n = 428); and living-donor control (LD control, n = 218). We compared the risk of rejection, graft function, graft survival, and patient survival between incompatible KTRs and control/LD control KTRs. Results Although the incidence of active antibody-mediated rejection in HLAi group tends to be higher than in control and LD control groups (6.0% vs. 2.8%, P = 0.20; 6.0% vs. 3.7%, P = 0.44, respectively), the rejection-free survival, graft survival, and patient survival were not significantly different from those of the control and LD control groups in all three incompatible KT groups (all P>0.05). Graft function during the study period was also not different between incompatible KTRs and control/LD control groups (both P>0.05). Using Cox regression analysis, neither HLAi nor ABOi were risk factors for graft failure. Some infectious diseases such as urinary tract infection and cytomegalovirus infection were more common in the HLAi group than in the control/LD control group (both P<0.05), but only one infection-related death occurred in HLAi KTRs. Infection risks were similar in the ABOi and HLAi+ABOi groups compared to controls. Conclusion Our results showed favorable outcomes for incompatible KT after desensitization. Although desensitization therapy for incompatible KT has improved access to transplantation for KT candidates with high immunological risk, more clinical data are clearly needed.	[Lim, Jeong-Hoon; Cho, Jang-Hee; Jung, Hee-Yeon; Choi, Ji-Young; Park, Sun-Hee; Kim, Yong-Lim; Kim, Chan-Duck] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Internal Med, Sch Med, Daegu, South Korea; [Kim, Hyung-Kee; Huh, Seung] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Surg, Sch Med, Daegu, South Korea; [Yoo, Eun Sang] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Urol, Sch Med, Daegu, South Korea; [Won, Dong-Il] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Clin Pathol, Sch Med, Daegu, South Korea	Kyungpook National University; Kyungpook National University Hospital; Kyungpook National University; Kyungpook National University Hospital; Kyungpook National University; Kyungpook National University Hospital; Kyungpook National University; Kyungpook National University Hospital	Kim, CD (corresponding author), Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Dept Internal Med, Sch Med, Daegu, South Korea.	drcdkim@knu.ac.kr	Cho, Jang-hee/ABD-3534-2020; Park, Sun/GSD-9620-2022; Lim, Jeong-Hoon/ABE-6003-2020	Cho, Jang-hee/0000-0002-7031-5214; Lim, Jeong-Hoon/0000-0001-5517-9886; Won, Dong Il/0000-0002-1983-2515	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI13C1232]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI13C1232). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alheim M, 2018, HUM IMMUNOL, V79, P132, DOI 10.1016/j.humimm.2017.11.006; Barnett ANR, 2014, TRANSPL INT, V27, P187, DOI 10.1111/tri.12234; Chung BH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123638; Chung BH, 2014, TRANSPL INT, V27, P49, DOI 10.1111/tri.12199; Couzi L, 2015, TRANSPL INT, V28, P1205, DOI 10.1111/tri.12621; Dall A, 2008, CLIN J AM SOC NEPHRO, V3, pS68, DOI 10.2215/CJN.02770707; Garcia-Garcia G, 2012, NEFROLOGIA, V32, P1, DOI 10.3265/Nefrologia.pre2012.Jan.11333; Gloor JM, 2003, AM J TRANSPLANT, V3, P1017, DOI 10.1034/j.1600-6143.2003.00180.x; Gordon EJ, 2010, SEMIN NEPHROL, V30, P81, DOI 10.1016/j.semnephrol.2009.10.009; Gordon EJ, 2009, NEPHROL DIAL TRANSPL, V24, P1103, DOI 10.1093/ndt/gfn691; Haas M, 2016, AM J TRANSPLANT, V16, P1352, DOI 10.1111/ajt.13661; Haririan A, 2009, AM J TRANSPLANT, V9, P536, DOI 10.1111/j.1600-6143.2008.02524.x; Ingsathit A, 2013, TRANSPL P, V45, P1427, DOI 10.1016/j.transproceed.2012.08.029; Irish WD, 2010, AM J TRANSPLANT, V10, P2279, DOI 10.1111/j.1600-6143.2010.03179.x; Jeon HJ, 2019, KIDNEY RES CLIN PRAC, V38, P116, DOI 10.23876/j.krcp.18.0068; Ko EJ, 2017, TRANSPL INT, V30, P1215, DOI 10.1111/tri.12979; Kong JM, 2013, CLIN TRANSPLANT, V27, P875, DOI 10.1111/ctr.12249; Lee KH, 2018, TRANSPL P, V50, P1063, DOI 10.1016/j.transproceed.2018.01.048; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Marfo K, 2011, CLIN J AM SOC NEPHRO, V6, P922, DOI 10.2215/CJN.08140910; Massad MG, 1997, ANN THORAC SURG, V64, P1120, DOI 10.1016/S0003-4975(97)00807-2; Milland J, 2006, TISSUE ANTIGENS, V68, P459, DOI 10.1111/j.1399-0039.2006.00721.x; Montgomery JR, 2012, TRANSPLANTATION, V93, P603, DOI 10.1097/TP.0b013e318245b2af; Montgomery RA, 2011, NEW ENGL J MED, V365, P318, DOI 10.1056/NEJMoa1012376; Opelz G, 2015, TRANSPLANTATION, V99, P400, DOI 10.1097/TP.0000000000000312; Padmanabhan A, 2009, TRANSPLANTATION, V87, P1889, DOI 10.1097/TP.0b013e3181a76ae1; PORT FK, 1993, JAMA-J AM MED ASSOC, V270, P1339, DOI 10.1001/jama.270.11.1339; Saito PK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100270; Takahashi K, 2004, AM J TRANSPLANT, V4, P1089, DOI 10.1111/j.1600-6143.2004.00464.x; Tyden G, 2007, TRANSPLANTATION, V84, pS27, DOI 10.1097/01.tp.0000296102.94695.c0; Uchida J, 2010, TRANSPL P, V42, P3998, DOI 10.1016/j.transproceed.2010.09.043; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Yoon HE, 2009, J KOREAN MED SCI, V24, pS148, DOI 10.3346/jkms.2009.24.S1.S148; Zhang X, 2009, AM J TRANSPLANT, V9, P2459, DOI 10.1111/j.1600-6143.2009.02819.x	34	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222537	10.1371/journal.pone.0222537	http://dx.doi.org/10.1371/journal.pone.0222537			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550258	Green Published, gold			2022-12-26	WOS:000532307700016
J	Gyebnar, G; Klimaj, Z; Entz, L; Fabo, D; Rudas, G; Barsi, P; Kozak, LR				Gyebnar, Gyula; Klimaj, Zoltan; Entz, Laszlo; Fabo, Daniel; Rudas, Gabor; Barsi, Peter; Kozak, Lajos R.			Personalized microstructural evaluation using a Mahalanobis-distance based outlier detection strategy on epilepsy patients' DTI data - Theory, simulations and example cases	PLOS ONE			English	Article							FOCAL CORTICAL DYSPLASIA; TEMPORAL-LOBE EPILEPSY; WHITE-MATTER; IN-VIVO; MULTIVARIATE-ANALYSIS; IMPROVES DETECTION; COMPONENT ANALYSIS; DIFFUSION; BRAIN; ORIENTATION	Quantitative MRI methods have recently gained extensive interest and are seeing substantial developments; however, their application in single patient vs control group comparisons is often limited by inherent statistical difficulties. One such application is detecting malformations of cortical development (MCDs) behind drug resistant epilepsies, a task that, especially when based solely on conventional MR images, may represent a serious challenge. We aimed to develop a novel straightforward voxel-wise evaluation method based on the Mahalanobis-distance, combining quantitative MRI data into a multidimensional parameter space and detecting lesion voxels as outliers. Simulations with standard multivariate Gaussian distribution and resampled DTI-eigenvalue data of 45 healthy control subjects determined the optimal critical value, cluster size threshold, and the expectable lesion detection performance through ROC-analyses. To reduce the effect of false positives emanating from registration artefacts and gyrification differences, an automatic classification method was applied, fine-tuned using a leave-one-out strategy based on diffusion and T1-weighted data of the controls. DWI processing, including thorough corrections and robust tensor fitting was performed with ExploreDTI, spatial coregistration was achieved with the DARTEL tools of SPM12. Additional to simulations, clusters of outlying diffusion profile, concordant with neuroradiological evaluation and independent calculations with the MAP07 toolbox were identified in 12 cases of a 13 patient example population with various types of MCDs. The multidimensional approach proved sufficiently sensitive in pinpointing regions of abnormal tissue microstructure using DTI data both in simulations and in the heterogeneous example population. Inherent limitations posed by registration artefacts, age-related differences, and the different or mixed pathologies limit the generalization of specificity estimation. Nevertheless, the proposed statistical method may aid the everyday examination of individual subjects, ever so more upon extending the framework with quantitative information from other modalities, e.g. susceptibility mapping, relaxometry, or perfusion.	[Gyebnar, Gyula; Klimaj, Zoltan; Rudas, Gabor; Barsi, Peter; Kozak, Lajos R.] Semmelweis Univ, Magnet Resonance Res Ctr, Budapest, Hungary; [Entz, Laszlo; Fabo, Daniel] Natl Inst Clin Neurosci, Budapest, Hungary	Semmelweis University	Gyebnar, G (corresponding author), Semmelweis Univ, Magnet Resonance Res Ctr, Budapest, Hungary.	gyebnargyula@gmail.com	Kozak, Lajos R/B-4194-2011	Kozak, Lajos R/0000-0003-0368-3663; Klimaj, Zoltan/0000-0001-9700-5382; Fabo, Daniel/0000-0001-5141-5351	Hungarian National Brain Research Program [KTIA/NAP_13-1-2013-0001:5, 2017-1.2.1-NKP-2017-00002]; Hungarian NRDIO (National Research, Development and Innovation Office) [K128040]; Bolyai Research Fellowship Program of the Hungarian Academy of Sciences;  [EFOP3.6.3-VEKOP-16-2017-00009]	Hungarian National Brain Research Program; Hungarian NRDIO (National Research, Development and Innovation Office); Bolyai Research Fellowship Program of the Hungarian Academy of Sciences; 	This study was supported by the EFOP3.6.3-VEKOP-16-2017-00009 project, the Hungarian National Brain Research Program grants KTIA/NAP_13-1-2013-0001:5 and 2017-1.2.1-NKP-2017-00002, and the Hungarian NRDIO (National Research, Development and Innovation Office) Grant: K128040. LRK also received support from the Bolyai Research Fellowship Program of the Hungarian Academy of Sciences.	Adler S, 2017, NEUROIMAGE-CLIN, V15, P95, DOI 10.1016/j.nicl.2017.04.017; Ahmed B, 2015, EPILEPSY BEHAV, V48, P21, DOI 10.1016/j.yebeh.2015.04.055; Alexander AL, 2000, MAGNET RESON MED, V44, P283, DOI 10.1002/1522-2594(200008)44:2<283::AID-MRM16>3.0.CO;2-V; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Avants B, 2008, ACAD RADIOL, V15, P1360, DOI 10.1016/j.acra.2008.07.007; Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bava S, 2010, BRAIN RES, V1327, P38, DOI 10.1016/j.brainres.2010.02.066; Beyer K, 1999, LECT NOTES COMPUT SC, V1540, P217; Bhaganagarapu K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00343; Bien CG, 2009, ARCH NEUROL-CHICAGO, V66, P1491, DOI 10.1001/archneurol.2009.283; Blumcke I, 2017, NEW ENGL J MED, V377, P1648, DOI 10.1056/NEJMoa1703784; Bonilha L, 2015, AM J NEURORADIOL, V36, P719, DOI 10.3174/ajnr.A4185; Caprihan A, 2008, NEUROIMAGE, V42, P675, DOI 10.1016/j.neuroimage.2008.04.255; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Chung SW, 2008, NEUROIMAGE, V39, P1693, DOI 10.1016/j.neuroimage.2007.10.039; Colombo N, 2018, NEUROIMAGING EVALUAT, P1; De Maesschalck R, 2000, CHEMOMETR INTELL LAB, V50, P1, DOI 10.1016/S0169-7439(99)00047-7; Dean DC, 2017, NEUROIMAGE-CLIN, V14, P54, DOI 10.1016/j.nicl.2017.01.002; Dyrby TB, 2014, NEUROIMAGE, V103, P202, DOI 10.1016/j.neuroimage.2014.09.005; El Azami M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161498; Filippi CG, 2013, PEDIATR RADIOL, V43, P1196, DOI 10.1007/s00247-013-2677-2; Fonseca Viviane de Carvalho, 2012, Front Neurol, V3, P121, DOI 10.3389/fneur.2012.00121; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fushimi Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148925; Gaser C., 2016, MANUAL COMPUTATIONAL; GNANADESIKAN R, 1972, BIOMETRICS, V28, P81, DOI 10.2307/2528963; Gyebnar G, 2017, PSYCHIAT RES; Hayasaka S, 2006, NEUROIMAGE, V30, P768, DOI 10.1016/j.neuroimage.2005.10.052; Heller R, 2007, NEUROIMAGE, V37, P1178, DOI 10.1016/j.neuroimage.2007.05.051; Hong SJ, 2017, NEUROLOGY, V88, P734, DOI 10.1212/WNL.0000000000003632; Hong SJ, 2014, NEUROLOGY, V83, P48, DOI 10.1212/WNL.0000000000000543; Huppertz HJ, 2008, EPILEPSIA, V49, P772, DOI 10.1111/j.1528-1167.2007.01436.x; Huppertz HJ, 2005, EPILEPSY RES, V67, P35, DOI 10.1016/j.eplepsyres.2005.07.009; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jeong JW, 2014, HUM BRAIN MAPP, V35, P3216, DOI 10.1002/hbm.22396; Jezzard P, 1998, MAGNET RESON MED, V39, P801, DOI 10.1002/mrm.1910390518; Jin B, 2018, EPILEPSIA, V59, P982, DOI 10.1111/epi.14064; Koay CG, 2016, NEUROIMAGE, V126, P151, DOI 10.1016/j.neuroimage.2015.11.046; Kulikova S, 2015, BRAIN STRUCT FUNCT, V220, P3657, DOI 10.1007/s00429-014-0881-y; Kwan P, 2011, NEW ENGL J MED, V365, P919, DOI 10.1056/NEJMra1004418; Lazar NA, 2002, NEUROIMAGE, V16, P538, DOI 10.1006/nimg.2002.1107; Leemans A., 2009, P 17 ANN M INT SOC M, P3537; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Lindemer ER, 2015, NEUROBIOL AGING, V36, P2447, DOI 10.1016/j.neurobiolaging.2015.05.011; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; McCagh J, 2009, EPILEPSY RES, V86, P1, DOI 10.1016/j.eplepsyres.2009.04.007; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Naylor MG, 2014, HUM BRAIN MAPP, V35, P831, DOI 10.1002/hbm.22217; Penny K. I., 1996, J R STAT SOC C-APPL, V45, P73, DOI 10.2307/2986224; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Rudrapatna SU, 2014, NEUROIMAGE, V97, P363, DOI 10.1016/j.neuroimage.2014.04.013; Sage CA, 2009, HUM BRAIN MAPP, V30, P3657, DOI 10.1002/hbm.20794; Salimi-Khorshidi G, 2014, NEUROIMAGE, V90, P449, DOI 10.1016/j.neuroimage.2013.11.046; Schnitzer D., 2014, P 22 EUR S ART NEUR; Simon L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083947; Sisodiya SM, 2004, LANCET NEUROL, V3, P29, DOI 10.1016/S1474-4422(03)00620-3; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Sun SW, 2006, NEUROIMAGE, V32, P1195, DOI 10.1016/j.neuroimage.2006.04.212; Takeshita T, 1993, DOC AN REC 1993 P 2; TAXT T, 1994, IEEE T MED IMAGING, V13, P470, DOI 10.1109/42.310878; Tournier JD, 2008, NEUROIMAGE, V42, P617, DOI 10.1016/j.neuroimage.2008.05.002; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Urbach H, 2015, CLIN NEURORADIOL, V25, P151, DOI 10.1007/s00062-015-0387-x; Urbach H., 2011, CLIN NEURORADIOLOGY; van Diessen E, 2013, EPILEPSIA, V54, P1855, DOI 10.1111/epi.12350; Van Hecke W, 2010, HUM BRAIN MAPP, V31, P98, DOI 10.1002/hbm.20848; Wagner J, 2011, BRAIN, V134, P2844, DOI 10.1093/brain/awr204; Whelan CD, 2015, EPILEPSIA, V56, P1551, DOI 10.1111/epi.13103; Winston GP, 2014, EPILEPSY RES, V108, P336, DOI 10.1016/j.eplepsyres.2013.11.004; Wu YC, 2011, NEUROIMAGE, V58, P829, DOI 10.1016/j.neuroimage.2011.06.067; Xiang SM, 2008, PATTERN RECOGN, V41, P3600, DOI 10.1016/j.patcog.2008.05.018; Young K, 2010, MAGN RESON MED, V63, P20, DOI 10.1002/mrm.22190; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072	78	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222720	10.1371/journal.pone.0222720	http://dx.doi.org/10.1371/journal.pone.0222720			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545838	Green Published, gold			2022-12-26	WOS:000532303200030
J	Myles, O; Grafton, B; Clarke, P; MacLeod, C				Myles, Owen; Grafton, Ben; Clarke, Patrick; MacLeod, Colin			GIVE me your attention: Differentiating goal identification and goal execution components of the anti-saccade effect	PLOS ONE			English	Article							WORKING-MEMORY; INHIBITORY CONTROL; COGNITIVE CONTROL; ANTISACCADE; ANXIETY; TASK; EFFICIENCY; CORTEX	The anti-saccade task is a commonly used method of assessing individual differences in cognitive control. It has been shown that a number of clinical disorders are characterised by increased anti-saccade cost. However, it remains unknown whether this reflects impaired goal identification or impaired goal execution, because, to date, no procedure has been developed to independently assess these two components of anti-saccade cost. The aim of the present study was to develop such an assessment task, which we term the Goal Identification Vs. Execution (GIVE) task. Fifty-one undergraduate students completed a conventional anti-saccade task, and our novel GIVE task. Our findings revealed that individual differences in anti-saccade goal identification costs and goal execution costs were uncorrelated, when assessed using the GIVE task, but both predicted unique variance in the conventional anti-saccade cost measure. These results confirm that the GIVE task is capable of independently assessing variation in the goal identification and goal execution components of the anti-saccade effect. We discuss how this newly introduced assessment procedure now can be employed to illuminate the specific basis of the increased anti-saccade cost that characterises various forms of clinical dysfunction.	[Myles, Owen; Grafton, Ben; MacLeod, Colin] Univ Western Australia, Ctr Adv Res Emot, Perth, WA, Australia; [Clarke, Patrick] Curtin Univ, Bentley, WA, Australia	University of Western Australia; Curtin University	Myles, O (corresponding author), Univ Western Australia, Ctr Adv Res Emot, Perth, WA, Australia.	owen.myles@research.uwa.edu.au		MacLeod, Colin/0000-0003-2407-7339; Clarke, Patrick/0000-0003-0303-4479; Myles, Owen/0000-0003-2756-3746; Grafton, Ben/0000-0002-9920-4278	Australian Research Council [DP170104533, FL170100167]; Australian Government Research Training Program (RTP) Scholarship	Australian Research Council(Australian Research Council); Australian Government Research Training Program (RTP) Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	This work was supported by Australian Research Council Grants DP170104533 and FL170100167 (https://www.arc.gov.au/), and an Australian Government Research Training Program (RTP) Scholarship (https://www.education.gov.au/research-training-program).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agam Y, 2010, NEUROIMAGE, V52, P336, DOI 10.1016/j.neuroimage.2010.04.010; Ansari TL, 2011, NEUROPSYCHOLOGIA, V49, P1146, DOI 10.1016/j.neuropsychologia.2011.01.019; Ansari TL, 2010, COGNITION EMOTION, V24, P241, DOI 10.1080/02699930903381531; Carvalho N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105355; Crawford TJ, 2011, EXP BRAIN RES, V208, P385, DOI 10.1007/s00221-010-2488-8; De Lissnyder E, 2011, COGNITION EMOTION, V25, P886, DOI 10.1080/02699931.2010.514711; Derakshan N, 2009, EUR PSYCHOL, V14, P168, DOI 10.1027/1016-9040.14.2.168; Derakshan N, 2009, EXP PSYCHOL, V56, P48, DOI 10.1027/1618-3169.56.1.48; Everling S, 1998, NEUROPSYCHOLOGIA, V36, P885, DOI 10.1016/S0028-3932(98)00020-7; GIBSON JM, 1987, J NEUROL NEUROSUR PS, V50, P853, DOI 10.1136/jnnp.50.7.853; Hunt AR, 2002, MEM COGNITION, V30, P529, DOI 10.3758/BF03194954; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; Kaufman LD, 2010, J ALZHEIMERS DIS, V19, P781, DOI 10.3233/JAD-2010-1275; KITAGAWA M, 1994, NEUROLOGY, V44, P2285, DOI 10.1212/WNL.44.12.2285; Klapetek A, 2016, J VISION, V16, DOI 10.1167/16.1.11; Liu X, 2004, NEUROIMAGE, V22, P1097, DOI 10.1016/j.neuroimage.2004.02.033; Manoach DS, 2004, J NEUROL NEUROSUR PS, V75, P1719, DOI 10.1136/jnnp.2003.025981; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Olk B, 2015, COGN NEUROSCI NEUROP, V14, P1; Owen AM, 1997, NEUROPSYCHOLOGIA, V35, P519, DOI 10.1016/S0028-3932(96)00101-7; Rey-Mermet A, 2019, J EXP PSYCHOL GEN, V148, P1335, DOI 10.1037/xge0000593; ROBERTS RJ, 1994, J EXP PSYCHOL GEN, V123, P374, DOI 10.1037/0096-3445.123.4.374; Soper D.S, A PRIORI SAMPLE SIZE; Sweeney JA, 2001, NEUROBIOL AGING, V22, P39, DOI 10.1016/S0197-4580(00)00175-5; VANSTEENBERGEN H, 2011, FRONT PSYCHOL, V2, P1; Wagenmakers EJ, 2011, J PERS SOC PSYCHOL, V100, P426, DOI 10.1037/a0022790; Zheng YY, 2000, PSYCHON B REV, V7, P113, DOI 10.3758/BF03210729	28	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222710	10.1371/journal.pone.0222710	http://dx.doi.org/10.1371/journal.pone.0222710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5QI	31545831	Green Published, gold			2022-12-26	WOS:000532303200029
J	Wengert, GJ; Schmutzer, M; Bickel, H; Sora, MC; Polanec, SH; Weber, M; Schueller-Weidekamm, C				Wengert, Georg J.; Schmutzer, Marc; Bickel, Hubert; Sora, Mircea-Constantin; Polanec, Stephan H.; Weber, Micheal; Schueller-Weidekamm, Claudia			Reliability of high-resolution ultrasound and magnetic resonance arthrography of the shoulder in patients with sports-related shoulder injuries	PLOS ONE			English	Article							ROTATOR CUFF TEARS; MR ARTHROGRAPHY; ACCURACY; DIAGNOSIS; LESIONS; DISORDERS; ANTERIOR	Introduction The shoulder, a very complex joint, offers a wide range of pathologies. Intraarticular abnormalities and rotator cuff injuries are mainly assessed and diagnosed by magnetic resonance arthrography (MRA). In contrast to this well-established gold standard, high-resolution ultrasound (US) offers an additional easy and excellent modality to assess the shoulder joint. Therefore, the purpose of this study was to evaluate in which anatomic structures and pathologies comparable results of US and MRA could be achieved. Materials and methods In this IRB-approved prospective study 67 patients with clinically suspected labral lesions, rotator cuff rupture, or injury of the long head of the biceps (LHB) tendon were enrolled. Each participant was examined with high resolution US, and directly followed by MRA at 3 Tesla with a standard sequence protocol. To evaluate the agreement of the diagnostic performance between US and MRA a weighted kappa statistic was used. Results Both of the investigated modalities yielded a moderate to almost perfect agreement in assessing a wide range of shoulder joint pathologies. For the rotator cuff, consistency was found in 71.64% for the supraspinatus tendon, in 95.52% for the infraspinatus tendon, in 83.58% for the subscapularis tendon, and in 98.51% for the teres minor tendon. The diagnostic accuracy between both modalities was 80.60% for the LHB tendon, 77.61% for the posterior labroligamentous complex, 83.58% for the acromioclavicular joint, and 91.04% for the assessment of osseous irregularities and impaction fractures. Conclusions High resolution US is a reliable imaging modality for the rotator cuff, the LHB tendon, and the acromioclavicular joint, so for these structures we recommend a preference for US over MRA based on its diagnostic accuracy, comfortability, cost effectiveness, and availability. If the diagnosis remains elusive, for all other intraarticular structures we recommend MRA for further diagnostic assessment.	[Wengert, Georg J.; Schmutzer, Marc; Bickel, Hubert; Polanec, Stephan H.; Weber, Micheal; Schueller-Weidekamm, Claudia] Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Sora, Mircea-Constantin] Sigmund Freund Univ, Med Fac, Morphol Ctr, Vienna, Austria	Medical University of Vienna	Wengert, GJ (corresponding author), Med Univ Vienna, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.	georg.wengert@meduniwien.ac.at		Wengert, Georg J./0000-0002-1854-9128; Sora, Constantin/0000-0002-0944-1609				Arirachakaran A, 2017, SKELETAL RADIOL, V46, P149, DOI 10.1007/s00256-016-2525-1; Beggs Ian BS, 2014, MUSCULOSKELETAL ULTR; Chauhan NS, 2016, POL J RADIOL, V81, P491, DOI 10.12659/PJR.897830; de Jesus JO, 2009, AM J ROENTGENOL, V192, P1701, DOI 10.2214/AJR.08.1241; Elbinoune I, 2016, PAN AFR MED J, V24, DOI 10.11604/pamj.2016.24.235.9068; Farrar Nicholas Greville, 2013, Open Orthop J, V7, P338, DOI 10.2174/1874325001307010338; Ferri M, 2005, AM J ROENTGENOL, V184, P180, DOI 10.2214/ajr.184.1.01840180; Jonas SC, 2012, ACTA ORTHOP, V83, P267, DOI 10.3109/17453674.2012.672090; Kompel AJ, 2017, CURR REV MUSCULOSKE, V10, P425, DOI 10.1007/s12178-017-9433-4; Lenza M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009020.pub2; LOH B, 2016, ANN TRANSL MED, V4, P66561, DOI DOI 10.21037/; Lugo R, 2008, EUR J RADIOL, V68, P16, DOI 10.1016/j.ejrad.2008.02.051; Modi CS, 2013, ORTHOPEDICS, V36, pE337, DOI 10.3928/01477447-20130222-23; Nakata W, 2011, RADIOGRAPHICS, V31, P791, DOI 10.1148/rg.313105507; Naredo E, 2002, ANN RHEUM DIS, V61, P132, DOI 10.1136/ard.61.2.132; Ottenheijm RP, 2010, ARCH PHYS MED REHAB, V91, P1616, DOI 10.1016/j.apmr.2010.07.017; Ottenheijm RPG, 2015, ANN FAM MED, V13, P53, DOI 10.1370/afm.1734; Ottenheijm RPG, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-115; Pavic R, 2013, INJURY, V44, pS26, DOI 10.1016/S0020-1383(13)70194-3; Roy JS, 2015, BRIT J SPORT MED, V49, P1316, DOI 10.1136/bjsports-2014-094148; Scutellari PN, 1998, EUR J RADIOL, V27, pS31, DOI 10.1016/S0720-048X(98)00040-0; Tian CY, 2013, EUR J RADIOL, V82, P651, DOI 10.1016/j.ejrad.2012.11.038; Viera AJ, 2005, FAM MED, V37, P360; Whiting P, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8250; Zanetti M, 1999, ACTA RADIOL, V40, P296, DOI 10.3109/02841859909175557	25	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222783	10.1371/journal.pone.0222783	http://dx.doi.org/10.1371/journal.pone.0222783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545834	gold, Green Published			2022-12-26	WOS:000532303200033
J	Cho, I; Cohen, AS				Cho, Isu; Cohen, Adam S.			Explaining age-related decline in theory of mind: Evidence for intact competence but compromised executive function	PLOS ONE			English	Article							FALSE-BELIEF; INDIVIDUAL-DIFFERENCES; ATTRIBUTION; TASKS	Previous studies suggest theory of mind (ToM) ability declines with age. However, prior tasks not only required ToM competence but also imposed high executive function (EF) demands, so decline in ToM ability could be caused by deterioration in ToM competence, EF, or both. It was predicted that if the elderly have intact ToM competence but compromised EF, then they should perform similarly to younger adults when using ToM tasks that lower executive demands, such as spontaneous-response tasks. Results showed that on tasks with reduced demands, older adults tracked belief to the same extent as younger adults, despite their declining EF. The findings support a model in which age-related decline in ToM ability is primarily caused by compromised EF, not ToM competence, suggesting that underlying ToM mechanisms are still intact in the elderly. We discuss implications of this work for competence-performance issues in ToM processing and the underlying sources of age-related deterioration of ToM.	[Cohen, Adam S.] Western Univ, Dept Psychol, London, ON, Canada; Western Univ, Brain & Mind Inst, London, ON, Canada; [Cohen, Adam S.] Univ Hawaii Manoa, Dept Psychol, Honolulu, HI 96822 USA	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Hawaii System; University of Hawaii Manoa	Cohen, AS (corresponding author), Western Univ, Dept Psychol, London, ON, Canada.; Cohen, AS (corresponding author), Univ Hawaii Manoa, Dept Psychol, Honolulu, HI 96822 USA.	cohen9@hawaii.edu	Cho, Isu/AAX-2091-2020	Cho, Isu/0000-0003-2270-3068; Cohen, Adam/0000-0003-2719-3351	Social Science Research Fund from the University of Western Ontario [R5061A04]	Social Science Research Fund from the University of Western Ontario	This work was supported by the Social Science Research Fund grant R5061A04 from the University of Western Ontario (AC). The funder played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apperly IA, 2012, Q J EXP PSYCHOL, V65, P825, DOI 10.1080/17470218.2012.676055; Apperly IA, 2009, PSYCHOL REV, V116, P953, DOI 10.1037/a0016923; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Bailey PE, 2008, J GERONTOL B-PSYCHOL, V63, pP219, DOI 10.1093/geronb/63.4.P219; Baillargeon R, 2010, TRENDS COGN SCI, V14, P110, DOI 10.1016/j.tics.2009.12.006; Carlson SM, 2001, CHILD DEV, V72, P1032, DOI 10.1111/1467-8624.00333; Charlton RA, 2009, PSYCHOL AGING, V24, P338, DOI 10.1037/a0015225; Chomsky N., 1964, ASPECTS THEORY SYNTA; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; German TP, 2006, COGNITION, V101, P129, DOI 10.1016/j.cognition.2005.05.007; Grainger SA, 2018, Q J EXP PSYCHOL, V71, P1980, DOI 10.1177/1747021817734690; Henry JD, 2013, PSYCHOL AGING, V28, P826, DOI 10.1037/a0030677; Hyde DC, 2018, J NEUROSCI, V38, P4264, DOI 10.1523/JNEUROSCI.0264-17.2018; JASP Team, 2018, JASP VERSION 0 10 0; Kiraly I, 2018, P NATL ACAD SCI USA, V115, P11477, DOI 10.1073/pnas.1803505115; Leslie AM, 2004, TRENDS COGN SCI, V8, P528, DOI 10.1016/j.tics.2004.10.001; Maylor EA, 2002, BRIT J PSYCHOL, V93, P465, DOI 10.1348/000712602761381358; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Patel Tushar, 2015, J Anaesthesiol Clin Pharmacol, V31, P37, DOI 10.4103/0970-9185.150534; Perner J, 2005, SCIENCE, V308, P214, DOI 10.1126/science.1111656; Phillips LH, 2011, COGNITION, V120, P236, DOI 10.1016/j.cognition.2011.05.003; Piper BJ, 2012, BEHAV RES METHODS, V44, P110, DOI 10.3758/s13428-011-0096-6; Rakoczy H, 2012, BRIT J PSYCHOL, V103, P58, DOI 10.1111/j.2044-8295.2011.02040.x; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Salthouse TA, 2003, J EXP PSYCHOL GEN, V132, P566, DOI 10.1037/0096-3445.132.4.566; Schaafsma SM, 2015, TRENDS COGN SCI, V19, P65, DOI 10.1016/j.tics.2014.11.007; Scott RM, 2017, CURR DIR PSYCHOL SCI, V26, P68, DOI 10.1177/0963721416673174; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Southgate V, 2007, PSYCHOL SCI, V18, P587, DOI 10.1111/j.1467-9280.2007.01944.x; Surian L, 2007, PSYCHOL SCI, V18, P580, DOI 10.1111/j.1467-9280.2007.01943.x; Warnell KR, 2019, COGNITION, V191, DOI 10.1016/j.cognition.2019.06.009; Wechsler D., WECHSLER ABBREVIATED, DOI [10.4103/0970-9185.150534, DOI 10.4103/0970-9185.150534]	35	10	10	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222890	10.1371/journal.pone.0222890	http://dx.doi.org/10.1371/journal.pone.0222890			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5OJ	31539418	gold, Green Published			2022-12-26	WOS:000532297900039
J	Pugh, MJ; Swan, AA; Amuan, ME; Eapen, BC; Jaramillo, CA; Delgado, R; Tate, DF; Yaffe, K; Wang, CP				Pugh, Mary Jo; Swan, Alicia A.; Amuan, Megan E.; Eapen, Blessen C.; Jaramillo, Carlos A.; Delgado, Roxana; Tate, David F.; Yaffe, Kristine; Wang, Chen-Pin			Deployment, suicide, and overdose among comorbidity phenotypes following mild traumatic brain injury: A retrospective cohort study from the Chronic Effects of Neurotrauma Consortium	PLOS ONE			English	Article							POLYTRAUMA-CLINICAL-TRIAD; MISERABLE MINORITY; RISK-FACTORS; CHRONIC PAIN; VETERANS; AFGHANISTAN; IRAQ; ASSOCIATION; DISABILITY; SEVERITY	Mild traumatic brain injury in the Veteran population is frequently comorbid with pain, posttraumatic stress disorder, and/or depression. However, not everyone exposed to mild traumatic brain injury experiences these comorbidities and it is unclear what factors contribute to this variability. The objective of this study was to identify comorbidity phenotypes among Post-9/11 deployed Veterans with no or mild traumatic brain injury and examine the association of comorbidity phenotypes with adverse outcomes. We found that Veterans with mild traumatic brain injury (n = 93,003) and no brain injury (n = 434,378) were mean age of 32.0 (SD 9.21) on entering Department of Veterans Health Administration care, were predominantly Caucasian non-Hispanic (64.69%), and served in the Army (61.31%). Latent class analysis revealed five phenotypes in each subcohort; Moderately Healthy and Mental Health phenotypes were common to both. The Healthy phenotype was found only in no brain injury. Unique phenotypes in mild traumatic brain injury included Moderately Healthy+Decline, Polytrauma, and Polytrauma+Improvement. There was substantial variation in adverse outcomes. The Polytrauma+Improvement phenotype had the lowest likelihood of adverse outcomes. There were no differences between Moderately Healthy+Decline and Polytrauma phenotypes. Phenotypes of comorbidity vary significantly by traumatic brain injury status including divergence in phenotypes (and outcomes) over time in the mild traumatic brain injury subcohort. Understanding risk factors for the divergence between Polytrauma vs. Polytrauma+Improvement and Moderately Healthy vs. Moderately Healthy+Decline, will improve our ability to proactively mitigate risk, better understand the early patterns of comorbidity that are associated with neurodegenerative sequelae following mild traumatic brain injury, and plan more patient-centered care.	[Pugh, Mary Jo; Amuan, Megan E.] VA Salt Lake City Hlth Care Syst, Informat Decis Enhancement & Analyt Sci Ctr, Salt Lake City, UT 84148 USA; [Pugh, Mary Jo] Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84132 USA; [Swan, Alicia A.] Univ Texas San Antonio, Dept Psychol, San Antonio, TX USA; [Eapen, Blessen C.] VA Greater Los Angeles Hlth Care Syst, Dept Phys Med & Rehabil, Los Angeles, CA USA; [Eapen, Blessen C.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Jaramillo, Carlos A.; Delgado, Roxana] South Texas Vet Hlth Care Syst, Polytrauma Rehabil Ctr, San Antonio, TX USA; [Tate, David F.] Univ Missouri, Missouri Inst Mental Hlth, St Louis, MO 63121 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat Neurol & Epidemiol, San Francisco, CA 94143 USA; [Wang, Chen-Pin] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA	US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; University of Texas System; University of Texas at San Antonio (UTSA); US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Missouri System; University of Missouri Saint Louis; University of California System; University of California San Francisco; University of Texas System; University of Texas Health San Antonio	Pugh, MJ (corresponding author), VA Salt Lake City Hlth Care Syst, Informat Decis Enhancement & Analyt Sci Ctr, Salt Lake City, UT 84148 USA.; Pugh, MJ (corresponding author), Univ Utah, Sch Med, Dept Internal Med, Salt Lake City, UT 84132 USA.	MaryJo.Pugh@hsc.utah.edu	Swan, Alicia A/O-3536-2018; Delgado, Roxana/CAF-1964-2022; Tate, David/G-5166-2011	Swan, Alicia A/0000-0003-2412-0499; Delgado, Roxana/0000-0002-8922-4857; Pugh, Mary Jo/0000-0003-4196-7763; Tate, David/0000-0003-0213-1920	U.S. Department of Veterans Affairs funds [I01CX001246]; U.S. Department of Defense [W81XWH-13-2-0095-04]; Veterans Affairs [I01CX001135] Funding Source: NIH RePORTER	U.S. Department of Veterans Affairs funds; U.S. Department of Defense(United States Department of Defense); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by U.S. Department of Veterans Affairs funds, I01CX001246, https://www.research.va.gov, to MJP; and U.S. Department of Defense W81XWH-13-2-0095-04, http://cdmrp.army.mil, to KY. The sponsors played no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amick MM, 2018, J HEAD TRAUMA REHAB, V33, pE30, DOI 10.1097/HTR.0000000000000308; Bosco MA, 2013, HEADACHE J HEAD FACE; Brickell TA, 2014, MIL MED, V179, P827, DOI 10.7205/MILMED-D-13-00506; Collett GA., 2016, DRUGS-REAL WOR OUTC, V3, P45; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Edens EL, 2011, AM J ADDICTION, V20, P412, DOI 10.1111/j.1521-0391.2011.00166.x; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Jaramillo CA, 2015, BRAIN IMAGING BEHAV, V9, P445, DOI 10.1007/s11682-015-9402-8; Johnson DC, 2014, AM J PSYCHIAT, V171, P844, DOI 10.1176/appi.ajp.2014.13040502; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Military Health System, 2016, SURV CAS DEF 13 0 NE; North CS, 2004, AM J PUBLIC HEALTH, V94, P103, DOI 10.2105/AJPH.94.1.103; Peixoto C, 2018, J PAIN RES, V11, P1927, DOI 10.2147/JPR.S165077; Peterson R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132664; Pugh MJ, 2018, ARCH PHYS MED REHAB, V99, pS40, DOI 10.1016/j.apmr.2017.05.021; Pugh MJ, 2016, BRAIN INJURY, V30, P1481, DOI 10.1080/02699052.2016.1219055; Pugh MJV, 2014, MED CARE, V52, P172, DOI 10.1097/MLR.0000000000000059; Rohling ML, 2012, CLIN NEUROPSYCHOL, V26, P197, DOI 10.1080/13854046.2011.647085; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Swan AA, 2018, BRAIN INJURY, V32, P1197, DOI 10.1080/02699052.2018.1495340; Tanielian T., 2017, IMPROVING SUPPORT AM, DOI 10.7249/RR1873; The Management of Concussion-mild Traumatic Brain Injury Working Group, VA DOD CLIN PRACT GU; Wang C-P, 2012, RESIDUAL DIAGNOSTICS; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906	26	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222674	10.1371/journal.pone.0222674	http://dx.doi.org/10.1371/journal.pone.0222674			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5OJ	31539410	Green Published, Green Submitted, gold			2022-12-26	WOS:000532297900025
J	Schwaiger, T; Sehl, J; Karte, C; Schafer, A; Huhr, J; Mettenleiter, TC; Schroder, C; Kollner, B; Ulrich, R; Blohmid, U				Schwaiger, Theresa; Sehl, Julia; Karte, Claudia; Schaefer, Alexander; Huehr, Jane; Mettenleiter, Thomas C.; Schroeder, Charlotte; Koellner, Bernd; Ulrich, Reiner; Blohmid, Ulrike			Experimental H1N1pdm09 infection in pigs mimics human seasonal influenza infections	PLOS ONE			English	Article							DELTA-T-CELLS; A VIRUS-INFECTION; IMMUNE-RESPONSES; H1N1 VIRUS; RELATIVE LYMPHOPENIA; SWINE; PROTECTION; LYMPHOCYTES; CHALLENGE; MEMORY	Pigs are anatomically, genetically and physiologically comparable to humans and represent a natural host for influenza A virus (IAV) infections. Thus, pigs may represent a relevant biomedical model for human IAV infections. We set out to investigate the systemic as well as the local immune response in pigs upon two subsequent intranasal infections with IAV H1N1pdm09. We detected decreasing numbers of peripheral blood lymphocytes after the first infection. The simultaneous increase in the frequencies of proliferating cells correlated with an increase in infiltrating leukocytes in the lung. Enhanced perforin expression in a ss and.d T cells in the respiratory tract indicated a cytotoxic T cell response restricted to the route of virus entry such as the nose, the lung and the bronchoalveolar lavage. Simultaneously, increasing frequencies of CD8 alpha alpha expressing alpha beta T cells were observed rapidly after the first infection, which may have inhibited uncontrolled inflammation in the respiratory tract. Taking together, the results of this study demonstrate that experimental IAV infection in pigs mimics major characteristics of human seasonal IAV infections.	[Schwaiger, Theresa; Sehl, Julia; Schroeder, Charlotte; Ulrich, Reiner] Friedrich Loeffler Inst, Dept Expt Anim Facil & Biorisk Management, Greifswald, Germany; [Sehl, Julia; Mettenleiter, Thomas C.] Friedrich Loeffler Inst, Inst Mol Virol & Cell Biol, Greifswald, Germany; [Karte, Claudia] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany; [Schaefer, Alexander; Huehr, Jane; Koellner, Bernd; Blohmid, Ulrike] Friedrich Loeffler Inst, Inst Immunol, Greifswald, Germany; [Ulrich, Reiner] Univ Leipzig, Fac Vet Med, Inst Vet Pathol, Leipzig, Germany	Friedrich Loeffler Institute; Friedrich Loeffler Institute; Friedrich Loeffler Institute; Friedrich Loeffler Institute; Leipzig University	Blohmid, U (corresponding author), Friedrich Loeffler Inst, Inst Immunol, Greifswald, Germany.	Ulrike.Blohm@fli.de	Blohm, Ulrike/AAW-1851-2020; Schäfer, Alexander/M-5897-2019	Blohm, Ulrike/0000-0003-4597-248X; Schäfer, Alexander/0000-0002-4258-0651; Huhr, Jane/0000-0002-2235-9618	Federal Excellence Initiative of Mecklenburg Western Pomerania; European Social Fund (ESF) [ESF_14-BM-A55-00xx_16]	Federal Excellence Initiative of Mecklenburg Western Pomerania; European Social Fund (ESF)(European Social Fund (ESF))	This study was funded by Federal Excellence Initiative of Mecklenburg Western Pomerania and European Social Fund (ESF) Grant KoInfekt (ESF_14-BM-A55-00xx_16) to TCM.	AntalSzalmas P, 1997, J LEUKOCYTE BIOL, V61, P721, DOI 10.1002/jlb.61.6.721; Baumann CL, 2010, J EXP MED, V207, P2689, DOI 10.1084/jem.20101111; Brandes M, 2005, SCIENCE, V309, P264, DOI 10.1126/science.1110267; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Cawthon AG, 2002, J IMMUNOL, V169, P3492, DOI 10.4049/jimmunol.169.7.3492; Cawthon AG, 2001, J IMMUNOL, V167, P2577, DOI 10.4049/jimmunol.167.5.2577; Chen Wei-wei, 2010, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V24, P331; Cheroutre H, 2004, ANNU REV IMMUNOL, V22, P217, DOI 10.1146/annurev.immunol.22.012703.104522; Cheroutre H, 2008, IMMUNITY, V28, P149, DOI 10.1016/j.immuni.2008.01.005; Chun JK, 2011, INFECT CHEMOTHER, V43, P36, DOI 10.3947/ic.2011.43.1.36; Coskun O, 2010, J CLIN VIROL, V47, P388, DOI 10.1016/j.jcv.2010.01.007; Cunha BA, 2009, CLIN INFECT DIS, V49, P1454, DOI 10.1086/644496; de Freitas DN, 2015, REV SOC BRAS MED TRO, V48, P514, DOI 10.1590/0037-8682-0163-2015; Denning TL, 2007, J IMMUNOL, V178, P4230, DOI 10.4049/jimmunol.178.7.4230; Ferrari M, 2008, VET RES COMMUN, V32, pS199, DOI 10.1007/s11259-008-9161-8; Forberg H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100619; Fox A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031535; Giamarellos-Bourboulis EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008393; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; Graaf A, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0204-0; Heinen PP, 2001, J GEN VIROL, V82, P2697, DOI 10.1099/0022-1317-82-11-2697; Heinen PP, 2001, VET IMMUNOL IMMUNOP, V82, P39, DOI 10.1016/S0165-2427(01)00342-7; Hong MJ, 2018, MUCOSAL IMMUNOL, V11, P894, DOI 10.1038/mi.2017.93; Imai M, 2012, CURR OPIN VIROL, V2, P160, DOI 10.1016/j.coviro.2012.03.003; Indavarapu A, 2011, INDIAN J MED RES, V134, P389; Jester B, 2018, AM J EPIDEMIOL, V187, P2596, DOI 10.1093/aje/kwy165; Kappes MA, 2012, VACCINE, V30, P280, DOI 10.1016/j.vaccine.2011.10.098; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; Khatri M, 2010, J VIROL, V84, P11210, DOI 10.1128/JVI.01211-10; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Kim WI, 2006, ARCH VIROL, V151, P23, DOI 10.1007/s00705-005-0615-9; Konno A, 2002, BLOOD, V100, P4090, DOI 10.1182/blood-2002-04-1136; Kurt-Jones EA, 2002, BLOOD, V100, P1860, DOI 10.1182/blood.V100.5.1860.h81702001860_1860_1868; Lahn M, 2000, J MOL MED, V78, P409, DOI 10.1007/s001090000123; Lahn M, 1999, NAT MED, V5, P1150, DOI 10.1038/13476; Larsen DL, 2000, VET MICROBIOL, V74, P117, DOI 10.1016/S0378-1135(00)00172-3; Loving CL, 2012, VACCINE, V30, P5830, DOI 10.1016/j.vaccine.2012.07.033; Mamerow S, 2019, VET MICROBIOL, V231, P160, DOI 10.1016/j.vetmic.2019.03.013; Merekoulias G, 2010, PLOS CURR, V2, DOI [10.1371/currents.rrn1154, DOI 10.1371/CURRENTS.RRN1154]; Nascimbeni M, 2004, BLOOD, V104, P478, DOI 10.1182/blood-2003-12-4395; Nelson MI, 2015, TRENDS MICROBIOL, V23, P142, DOI 10.1016/j.tim.2014.12.002; Nelson MI, 2014, J VIROL, V88, P10110, DOI 10.1128/JVI.01080-14; Nelson MI, 2012, J GEN VIROL, V93, P2195, DOI 10.1099/vir.0.044974-0; ORTOLANI C, 1993, BIOCHEM BIOPH RES CO, V191, P601, DOI 10.1006/bbrc.1993.1260; PESCOVITZ MD, 1985, J IMMUNOL, V134, P37; Piet B, 2011, J CLIN INVEST, V121, P2254, DOI 10.1172/JCI44675; Pizzolla A, 2018, J CLIN INVEST, V128, P721, DOI 10.1172/JCI96957; Pomorska-Mol M, 2014, ARCH VIROL, V159, P2605, DOI 10.1007/s00705-014-2116-1; Qin G, 2011, J VIROL, V85, P10109, DOI 10.1128/JVI.05341-11; Qin G, 2009, J INFECT DIS, V200, P858, DOI 10.1086/605413; Quinones-Parra S, 2014, P NATL ACAD SCI USA, V111, P1049, DOI 10.1073/pnas.1322229111; Rajao DS, 2015, ILAR J, V56, P44, DOI 10.1093/ilar/ilv002; Roden AC, 2008, ARCH PATHOL LAB MED, V132, P1774, DOI 10.1043/1543-2165-132.11.1774; Shen HH, 2013, CLIN LAB, V59, P337, DOI 10.7754/Clin.Lab.2012.120417; Sinkora M, 2009, DEV COMP IMMUNOL, V33, P273, DOI 10.1016/j.dci.2008.07.011; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x; Sridhar S, 2013, NAT MED, V19, P1305, DOI 10.1038/nm.3350; Takamatsu HH, 2002, VET IMMUNOL IMMUNOP, V87, P223, DOI 10.1016/S0165-2427(02)00083-1; Talker SC, 2016, J VIROL, V90, P9364, DOI 10.1128/JVI.01211-16; Talker SC, 2015, VET RES, V46, DOI 10.1186/s13567-015-0182-3; Terebuh P, 2010, INFLUENZA OTHER RESP, V4, P387, DOI 10.1111/j.1750-2659.2010.00175.x; van de Sandt CE, 2014, J VIROL, V88, P1684, DOI 10.1128/JVI.02843-13; VANOERS NSC, 1993, J IMMUNOL, V151, P777; Walker LJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00223; Wang ZF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7833; Weaver EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018314; Wilkinson TM, 2012, NAT MED, V18, P274, DOI 10.1038/nm.2612; Zhao Y, 2012, AM J RESP CRIT CARE, V186, P1292, DOI 10.1164/rccm.201207-1245OC; Zhou X, 2011, VACCINE, V29, P2169, DOI 10.1016/j.vaccine.2010.12.029	70	16	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222943	10.1371/journal.pone.0222943	http://dx.doi.org/10.1371/journal.pone.0222943			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JB0JC	31539406	Green Published, gold			2022-12-26	WOS:000488238200001
J	Park, J; Gil, JR; Shin, Y; Won, SE; Huh, J; You, MW; Park, HJ; Sung, YS; Kim, KW				Park, Jisuk; Gil, Jea Ryung; Shin, Youngbin; Won, Sang Eun; Huh, Jimi; You, Myung-Won; Park, Hyo Jung; Sung, Yu Sub; Kim, Kyung Won			Reliable and robust method for abdominal muscle mass quantification using CT/MRI: An explorative study in healthy subjects	PLOS ONE			English	Article							LENGTH-OF-STAY; BODY-COMPOSITION; ADIPOSE-TISSUE; SARCOPENIA; OUTCOMES; PREDICTOR; FRAILTY; AREA; CT; COMPLICATIONS	Background Quantification of abdominal muscle mass by cross-sectional imaging has been increasingly used to diagnose sarcopenia; however, the technical method for quantification has not been standardized yet. We aimed to determine an optimal method to measure the abdominal muscle area. Methods Among 50 consecutive subjects who underwent abdominal CT and MRI for possible liver donation, total abdominal muscle area (TAMA) and total psoas muscle area (TPA) at the L3 inferior endplate level were measured by two blinded readers. Inter-scan agreement between CT and MRI and inter-reader agreement between the two readers were evaluated using intraclass correlation coefficient (ICC) and within-subject coefficient of variation (WSCV). To evaluate the effect of measurement level, one reader measured TAMA and TPA at six levels from the L2 to L4 vertebral bodies. Results TAMA was a more reliable biomarker than TPA in terms of inter-scan agreement (ICC: 0.928 vs. 0.788 for reader 1 and 0.853 vs. 0.821 for reader 2, respectively; WSCV: 8.3% vs. 23.4% for reader 1 and 10.4% vs. 22.3% for reader 2, respectively) and inter-reader agreement (ICC: 0.986 vs. 0.886 for CT and 0.865 vs. 0.669 for MRI, respectively; WSCV: 8.2% vs. 16.0% for CT and 11.6% vs. 29.7% for MRI, respectively). In terms of the measurement llevel, TAMA did not differ from the L2(inf) to L4(inf) levels, whereas TPA increased with a decrease in measurement level. Conclusions TAMA is a better biomarker than TPA in terms of inter-scan and inter-reader agreement and robustness to the measurement level. CT was a more reliable imaging modality than MRI. Our results support the use of TAMA measured by CT as a standard biomarker for abdominal muscle area measurement.	[Park, Jisuk; Gil, Jea Ryung; Shin, Youngbin; Won, Sang Eun; Huh, Jimi; You, Myung-Won; Park, Hyo Jung; Sung, Yu Sub; Kim, Kyung Won] Univ Ulsan, Asan Med Ctr, Dept Radiol, Asan Image Metr,Coll Med, Seoul, South Korea; [Gil, Jea Ryung] VHS Med Ctr, Dept Radiol, Seoul, South Korea; [Shin, Youngbin; Won, Sang Eun; Sung, Yu Sub; Kim, Kyung Won] Univ Ulsan, Asan Med Ctr, Asan Med Inst Convergence Sci & Technol, Dept Biomed Engn,Coll Med, Seoul, South Korea; [Huh, Jimi] Ajou Univ, Sch Med, Dept Radiol, Med Ctr, Suwon, South Korea; [You, Myung-Won] Kyung Hee Univ Hosp, Dept Radiol, Seoul, South Korea	University of Ulsan; Asan Medical Center; Veterans Health Service Medical Center; University of Ulsan; Asan Medical Center; Ajou University; Kyung Hee University; Kyung Hee University Hospital	Sung, YS; Kim, KW (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Radiol, Asan Image Metr,Coll Med, Seoul, South Korea.; Sung, YS; Kim, KW (corresponding author), Univ Ulsan, Asan Med Ctr, Asan Med Inst Convergence Sci & Technol, Dept Biomed Engn,Coll Med, Seoul, South Korea.	asmilez.sung@gmail.com; kyungwon_kim@amc.seoul.kr		Kim, Kyung Won/0000-0002-1532-5970; Park, Hyo Jung/0000-0002-2364-9940	Korea Health Industry Development Institute (KHIDI) of the Republic of Korea [HI18C1216]	Korea Health Industry Development Institute (KHIDI) of the Republic of Korea	This research was supported by a grant from the Korea Health Industry Development Institute (KHIDI) of the Republic of Korea (No. HI18C1216).; Funding source: This research was supported by a grant from the Korea Health Industry Development Institute (KHIDI) of the Republic of Korea (No. HI18C1216).	Amur S, 2015, CLIN PHARMACOL THER, V98, P34, DOI 10.1002/cpt.136; Barret M, 2014, PRESSE MED, V43, P628, DOI 10.1016/j.lpm.2013.12.021; Boutin RD, 2015, AM J ROENTGENOL, V205, pW255, DOI 10.2214/AJR.15.14635; Caan BJ, 2018, JAMA ONCOL, V4, P798, DOI 10.1001/jamaoncol.2018.0137; Cao L, 2016, J AM MED DIR ASSOC, V17, P675, DOI 10.1016/j.jamda.2016.06.001; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dahya V, 2016, AM HEART J, V182, P21, DOI 10.1016/j.ahj.2016.08.016; Derstine BA, 2018, J NUTR HEALTH AGING, V22, P180, DOI 10.1007/s12603-017-0983-3; Derstine BA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29825-5; DiMartini A, 2013, LIVER TRANSPLANT, V19, P1172, DOI 10.1002/lt.23724; Du Y, 2014, SURGERY, V156, P521, DOI 10.1016/j.surg.2014.04.027; Englesbe MJ, 2010, J AM COLL SURGEONS, V211, P271, DOI 10.1016/j.jamcollsurg.2010.03.039; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fosbol MO, 2015, CLIN PHYSIOL FUNCT I, V35, P81, DOI 10.1111/cpf.12152; Ganapathi AM, 2014, J THORAC CARDIOV SUR, V147, P186, DOI 10.1016/j.jtcvs.2013.09.011; Harimoto N, 2013, BRIT J SURG, V100, P1523, DOI 10.1002/bjs.9258; Hasselager R, 2014, LANGENBECK ARCH SURG, V399, P287, DOI 10.1007/s00423-014-1174-x; Jaap K, 2016, AM SURGEON, V82, P1221; Joglekar S, 2015, J SURG ONCOL, V112, P117, DOI 10.1002/jso.23968; Klopfenstein BJ, 2012, BRIT J RADIOL, V85, pE826, DOI 10.1259/bjr/57987644; Lee CS, 2014, CLIN TRANSPLANT, V28, P1092, DOI 10.1111/ctr.12422; Lee JSJ, 2011, J VASC SURG, V53, P912, DOI 10.1016/j.jvs.2010.10.111; Lee SJ, 2004, AM J CLIN NUTR, V80, P1215; Malekpour M, 2017, AM SURGEON, V83, P1203; Montano-Loza AJ, 2014, LIVER TRANSPLANT, V20, P640, DOI 10.1002/lt.23863; Mourtzakis M, 2008, APPL PHYSIOL NUTR ME, V33, P997, DOI 10.1139/H08-075; Peng P, 2012, J GASTROINTEST SURG, V16, P1478, DOI 10.1007/s11605-012-1923-5; Rutten IJG, 2017, J CACHEXIA SARCOPENI, V8, P630, DOI 10.1002/jcsm.12180; Schweitzer L, 2016, J NUTR, V146, P2143, DOI 10.3945/jn.116.236844; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sur MD, 2015, ANN SURG ONCOL, V22, P3897, DOI 10.1245/s10434-015-4763-1; Tamandl D, 2016, EUR RADIOL, V26, P1359, DOI 10.1007/s00330-015-3963-1; Tandon P, 2016, AM J TRANSPLANT, V16, P2766, DOI 10.1111/ajt.13832; van der Werf A, 2018, EUR J CLIN NUTR, V72, P288, DOI 10.1038/s41430-017-0034-5; Yip C, 2014, EUR RADIOL, V24, P998, DOI 10.1007/s00330-014-3110-4; Yoon DY, 2008, ACAD RADIOL, V15, P62, DOI 10.1016/j.acra.2007.07.013; Yoshizumi T, 2014, HEPATOL RES, V44, P313, DOI 10.1111/hepr.12119	38	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222042	10.1371/journal.pone.0222042	http://dx.doi.org/10.1371/journal.pone.0222042			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536542	gold, Green Submitted, Green Published			2022-12-26	WOS:000532262800027
J	Cunningham, R; Poppe, K; Peterson, D; Every-Palmer, S; Soosay, I; Jackson, R				Cunningham, Ruth; Poppe, Katrina; Peterson, Debbie; Every-Palmer, Susanna; Soosay, Ian; Jackson, Rod			Prediction of cardiovascular disease risk among people with severe mental illness: A cohort study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; CARE; SCHIZOPHRENIA; PREVALENCE; DISORDER	Objective To determine whether contemporary sex-specific cardiovascular disease (CVD) risk prediction equations underestimate CVD risk in people with severe mental illness from the cohort in which the equations were derived. Methods We identified people with severe mental illness using information on prior specialist mental health treatment. This group were identified from the PREDICT study, a prospective cohort study of 495,388 primary care patients aged 30 to 74 years without prior CVD that was recently used to derive new CVD risk prediction equations. CVD risk was calculated in participants with and without severe mental illness using the new equations and the predicted CVD risk was compared with observed risk in the two participant groups using survival methods. Results 28,734 people with a history of recent contact with specialist mental health services, including those without a diagnosis of a psychotic disorder, were identified in the PREDICT cohort. They had a higher observed rate of CVD events compared to those without such a history. The PREDICT equations underestimated the risk for this group, with a mean observed:predicted risk ratio of 1.29 in men and 1.64 in women. In contrast the PREDICT algorithm performed well for those without mental illness. Conclusions Clinicians using CVD risk assessment tools that do not include severe mental illness as a predictor could by underestimating CVD risk by about one-third in men and two-thirds in women in this patient group. All CVD risk prediction equations should be updated to include mental illness indicators.	[Cunningham, Ruth; Peterson, Debbie] Univ Otago Wellington, Dept Publ Hlth, Wellington, New Zealand; [Poppe, Katrina; Jackson, Rod] Univ Auckland, Sch Populat Hlth, Sect Epidemiol & Biostat, Auckland, New Zealand; [Every-Palmer, Susanna] Univ Otago Wellington, Dept Psychol Med, Wellington, New Zealand; [Soosay, Ian] Univ Auckland, Sch Med & Hlth Sci, Auckland, New Zealand	University of Otago; University of Auckland; University of Otago; University of Auckland	Cunningham, R (corresponding author), Univ Otago Wellington, Dept Publ Hlth, Wellington, New Zealand.	Ruth.Cunningham@otago.ac.nz; k.poppe@auckland.ac.nz; rt.jackson@auckland.ac.nz		Every-Palmer, Susanna/0000-0001-6455-9741; Cunningham, Ruth/0000-0003-0090-3579	National Heart Foundation of New Zealand [1685]	National Heart Foundation of New Zealand	This study was supported by a grant from the National Heart Foundation of New Zealand, Project Grant reference 1685. All authors were named investigators on this grant application, and RC, DP and KP received funding from this grant. https://www.heartfoundation.org.nz/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson J., 2014, NZDEP2013 INDEX DEPR; Attar R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189289; Baller JB, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0416-y; Correll CU, 2017, WORLD PSYCHIATRY, V16, P163, DOI 10.1002/wps.20420; Cunningham R, 2014, NZ MED J, V127; Cunningham R, 2015, GEN HOSP PSYCHIAT, V37, P501, DOI 10.1016/j.genhosppsych.2015.06.003; De Hert M, 2011, WORLD PSYCHIATRY, V10, P52, DOI 10.1002/j.2051-5545.2011.tb00014.x; Foguet-Boreu Q, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0833-6; Foley DL, 2015, AUST NZ J PSYCHIAT; Hippisley-Cox J, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2099; Jones S, 2008, ACTA PSYCHIAT SCAND, V118, P169, DOI 10.1111/j.1600-0447.2008.01211.x; Le Cook B, 2014, JAMA-J AM MED ASSOC, V311, P172, DOI 10.1001/jama.2013.284985; McLean G, 2014, SCHIZOPHR RES, V159, P176, DOI 10.1016/j.schres.2014.07.022; Ministry of Health, 2018, CARD DIS RISK ASS MA; National Institute for Health and Care Excellence (NICE), 2014, CG181 NICE; New Zealand Guidelines Group, 2009, NZ CARD GUID HDB; O'Neil A, 2016, J AFFECT DISORDERS, V196, P117, DOI 10.1016/j.jad.2016.02.029; Osborn DPJ, 2015, JAMA PSYCHIAT, V72, P143, DOI 10.1001/jamapsychiatry.2014.2133; Osby U, 2014, NORD J PSYCHIAT, V68, P251, DOI 10.3109/08039488.2013.797022; Public Procurement Regulatory Authority (PPRA), 2020, ANN REP 2019; Pylypchuk R, 2018, LANCET, V391, P1897, DOI [10.1016/s0140-6736(18)30664-0, 10.1016/S0140-6736(18)30664-0]; Rigal A, 2018, PSYCHIAT RES, V263, P41, DOI 10.1016/j.psychres.2018.02.035; Ruggeri M, 2000, BRIT J PSYCHIAT, V177, P149, DOI 10.1192/bjp.177.2.149; Vancampfort D, 2016, WORLD PSYCHIATRY, V15, P166, DOI 10.1002/wps.20309; Wells S, 2017, INT J EPIDEMIOL, V46, P22, DOI 10.1093/ije/dyv312; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	26	23	23	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221521	10.1371/journal.pone.0221521; 10.1371/journal.pone.0221521.r001; 10.1371/journal.pone.0221521.r002; 10.1371/journal.pone.0221521.r003; 10.1371/journal.pone.0221521.r004	http://dx.doi.org/10.1371/journal.pone.0221521; 10.1371/journal.pone.0221521.r001; 10.1371/journal.pone.0221521.r002; 10.1371/journal.pone.0221521.r003; 10.1371/journal.pone.0221521.r004			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JB3PW	31532772	gold, Green Published, Green Submitted			2022-12-26	WOS:000488470200002
J	Heffer, AM; Proano, J; Roztocil, E; Phipps, RP; Feldon, SE; Huxlin, KR; Sime, PJ; Libby, RT; Woeller, CF; Kuriyan, AE				Heffer, Alison M.; Proano, Jacob; Roztocil, Elisa; Phipps, Richard P.; Feldon, Steven E.; Huxlin, Krystel R.; Sime, Patricia J.; Libby, Richard T.; Woeller, Collynn F.; Kuriyan, Ajay E.			The polyether ionophore salinomycin targets multiple cellular pathways to block proliferative vitreoretinopathy pathology	PLOS ONE			English	Article							COLLAGEN GEL CONTRACTION; PIGMENT EPITHELIAL-CELLS; GROWTH-FACTORS; RISK-FACTORS; MATRIX; RPE; INHIBITION; STRATEGY; KINASE; CANCER	Proliferative vitreoretinopathy (PVR) is characterized by membranes that form in the vitreous cavity and on both surfaces of the retina, which results in the formation of tractional membranes that can cause retinal detachment and intrinsic fibrosis of the retina, leading to retina foreshortening. Currently, there are no pharmacologic therapies that are effective in inhibiting or preventing PVR formation. One of the key aspects of PVR pathogenesis is retinal pigment epithelial (RPE) cell epithelial mesenchymal transition (EMT). Here we show that the polyether ionophore compound salinomycin (SNC) effectively inhibits TGF beta-induced EMT of RPE cells. SNC blocks the activation of TGF beta-induced downstream targets alpha smooth muscle actin (alpha SMA) and collagen 1 (Col1A1). Additionally, SNC inhibits TGF beta-induced RPE cell migration and contraction. We show that SNC functions to inhibit RPE EMT by targeting both the pTAK1/p38 and Smad2 signaling pathways upon TGF beta stimulation. Additionally, SNC is able to inhibit aSMA and Col1A1 expression in RPE cells that have already undergone TGF beta-induced EMT. Together, these results suggest that SNC could be an effective therapeutic compound in both the prevention and treatment of PVR.	[Heffer, Alison M.; Proano, Jacob; Roztocil, Elisa; Feldon, Steven E.; Huxlin, Krystel R.; Libby, Richard T.; Woeller, Collynn F.; Kuriyan, Ajay E.] Univ Rochester, Flaum Eye Inst, Rochester, NY 14604 USA; [Phipps, Richard P.] Univ Rochester, Dept Environm Med, Rochester, NY USA; [Feldon, Steven E.; Huxlin, Krystel R.; Libby, Richard T.; Kuriyan, Ajay E.] Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA; [Sime, Patricia J.] Univ Rochester, Dept Med, Rochester, NY USA; [Proano, Jacob] Lake Erie Coll Osteopath Med, Erie, PA USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester	Heffer, AM; Woeller, CF; Kuriyan, AE (corresponding author), Univ Rochester, Flaum Eye Inst, Rochester, NY 14604 USA.; Kuriyan, AE (corresponding author), Univ Rochester, Ctr Visual Sci, Rochester, NY 14627 USA.	alison_heffer@urmc.rochester.edu; Collynn_Woeller@URMC.Rochester.edu; ajay_kuriyan@urmc.rochester.edu		Huxlin, Krystel/0000-0001-7138-6156; Feldon, Steven/0000-0003-0603-9312; Woeller, Collynn/0000-0001-7197-5057	Research to Prevent Blindness;  [NIHP30EY001319]; NATIONAL EYE INSTITUTE [P30EY001319] Funding Source: NIH RePORTER	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Research to Prevent Blindness Unrestricted Grant (to the Flaum Eye Institute) and NIHP30EY001319 (David Williams, Center for Visual Sciences). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams GW, 1997, ARCH OPHTHALMOL-CHIC, V115, P335, DOI 10.1001/archopht.1997.01100150337005; ANDERSON DH, 1981, INVEST OPHTH VIS SCI, V21, P10; Antoszczak M, 2015, ANTI-CANCER AGENT ME, V15, P575, DOI 10.2174/1871520615666150101130209; BAUDOUIN C, 1993, OPHTHALMIC RES, V25, P52, DOI 10.1159/000267221; Bourlier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031274; Cardillo JA, 1997, OPHTHALMOLOGY, V104, P1166, DOI 10.1016/S0161-6420(97)30167-5; Chen Zhenna, 2015, Mol Vis, V21, P706; Choi K, 2012, MOL VIS, V18, P1010; Dvashi Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122229; Gamulescu MA, 2006, EXP EYE RES, V83, P212, DOI 10.1016/j.exer.2005.12.007; George SJ, 2009, J MOL CELL CARDIOL, V46, P610, DOI 10.1016/j.yjmcc.2009.02.008; Grierson I, 1987, SEMINARS OPHTHALMOLO, V2, P99, DOI [10.3109/08820538709062514, DOI 10.3109/08820538709062514]; Gu L, 2007, ACTA PHARMACOL SIN, V28, P382, DOI 10.1111/j.1745-7254.2007.00468.x; He H, 2017, SCI REP-UK, V7, DOI 10.1038/srep43736; Hinton DR, 2002, EYE, V16, P422, DOI 10.1038/sj.eye.6700190; Hiscott P, 1999, PROG RETIN EYE RES, V18, P167, DOI 10.1016/S1350-9462(98)00024-X; HISCOTT PS, 1984, BRIT J OPHTHALMOL, V68, P708, DOI 10.1136/bjo.68.10.708; Hu HH, 2018, CHEM-BIOL INTERACT, V292, P76, DOI 10.1016/j.cbi.2018.07.008; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jonkman JEN, 2014, CELL ADHES MIGR, V8, P440, DOI 10.4161/cam.36224; Jun Eun Jung, 2007, Korean J Ophthalmol, V21, P244, DOI 10.3341/kjo.2007.21.4.244; Kiilgaard JF, 2007, INVEST OPHTH VIS SCI, V48, P355, DOI 10.1167/iovs.05-1565; Lei HT, 2010, EXP EYE RES, V90, P376, DOI 10.1016/j.exer.2009.11.003; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; MONTESANO R, 1988, P NATL ACAD SCI USA, V85, P4894, DOI 10.1073/pnas.85.13.4894; Naujokat C, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/950658; Naujokat C, 2010, MOL MED REP, V3, P555, DOI 10.3892/mmr_00000296; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Peng HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014750; Pennock S, 2014, PROG RETIN EYE RES, V40, P16, DOI 10.1016/j.preteyeres.2013.12.006; Pennock S, 2011, AM J PATHOL, V179, P2931, DOI 10.1016/j.ajpath.2011.08.043; RAYMOND MC, 1990, INVEST OPHTH VIS SCI, V31, P1079; SCHIRO JA, 1991, CELL, V67, P403, DOI 10.1016/0092-8674(91)90191-Z; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shih YH, 2017, INVEST OPHTH VIS SCI, V58, P430, DOI 10.1167/iovs.16-20018; Tseng W, 2004, AM J OPHTHALMOL, V137, P1105, DOI 10.1016/j.ajo.2004.02.008; Woeller CF, 2015, J BIOL CHEM, V290, P3563, DOI 10.1074/jbc.M114.601872; Yang CH, 1997, CURR EYE RES, V16, P1119, DOI 10.1076/ceyr.16.11.1119.5106; Zhang CY, 2016, CHEM-BIOL INTERACT, V248, P74, DOI 10.1016/j.cbi.2016.02.004; Zhou S, 2013, CURR MED CHEM, V20, P4095	40	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222596	10.1371/journal.pone.0222596	http://dx.doi.org/10.1371/journal.pone.0222596			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527897	Green Published, Green Submitted, gold			2022-12-26	WOS:000532231400032
J	Ryan, JP; Cline, DE; Joseph, JE; Margolina, T; Santora, JA; Kudela, RM; Chavez, FP; Pennington, JT; Wahl, C; Michisaki, R; Benoit-Bird, K; Forney, KA; Stimpert, AK; DeVogelaere, A; Black, N; Fischer, M				Ryan, John P.; Cline, Danelle E.; Joseph, John E.; Margolina, Tetyana; Santora, Jarrod A.; Kudela, Raphael M.; Chavez, Francisco P.; Pennington, J. Timothy; Wahl, Christopher; Michisaki, Reiko; Benoit-Bird, Kelly; Forney, Karin A.; Stimpert, Alison K.; DeVogelaere, Andrew; Black, Nancy; Fischer, Mark			Humpback whale song occurrence reflects ecosystem variability in feeding and migratory habitat of the northeast Pacific	PLOS ONE			English	Article							CALIFORNIA CURRENT IMPLICATIONS; MEGAPTERA-NOVAEANGLIAE; HIERARCHICAL STRUCTURE; ACOUSTIC DETECTIONS; TROPHIC TRANSFER; CURRENT SYSTEM; MONTEREY BAY; DOMOIC ACID; WEST-COAST; EL-NINO	This study examines the occurrence of humpback whale (Megaptera novaeangliae) song in the northeast Pacific from three years of continuous recordings off central California (36.713 degrees N, 122.186 degrees W). Song is prevalent in this feeding and migratory habitat, spanning nine months of the year (SeptemberMay), peaking in winter (NovemberJanuary), and reaching a maximum of 86% temporal coverage (during November 2017). From the rise of song in fall through the end of peak occurrence in winter, song length increases significantly from month to month. The seasonal peak in song coincides with the seasonal trough in day length and sighting-based evidence of whales leaving Monterey Bay, consistent with seasonal migration. During the seasonal song peak, diel variation shows maximum occurrence at night (69% of the time), decreasing during dawn and dusk (52%), and further decreasing with increasing solar elevation during the day, reaching a minimum near solar noon (30%). Song occurrence increased 44% and 55% between successive years. Sighting data within the acoustic detection range of the hydrophone indicate that variation in local population density was an unlikely cause of this large interannual variation. Hydrographic data and modeling of acoustic transmission indicate that changes in neither habitat occupancy nor acoustic transmission were probable causes. Conversely, the positive interannual trend in song paralleled major ecosystem variations, including similarly large positive trends in wind-driven upwelling, primary productivity, and krill abundance. Further, the lowest song occurrence during the first year coincided with anomalously warm ocean temperatures and an extremely toxic harmful algal bloom that affected whales and other marine mammals in the region. These major ecosystem variations may have influenced the health and behavior of humpback whales during the study period.	[Ryan, John P.; Cline, Danelle E.; Chavez, Francisco P.; Pennington, J. Timothy; Wahl, Christopher; Michisaki, Reiko; Benoit-Bird, Kelly] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Joseph, John E.; Margolina, Tetyana] Naval Postgrad Sch, Dept Oceanog, Monterey, CA USA; [Santora, Jarrod A.] Univ Calif Santa Cruz, Dept Appl Math, Santa Cruz, CA USA; [Kudela, Raphael M.] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; [Forney, Karin A.] NOAA, Marine Mammal & Turtle Div, Southwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Moss Landing, CA USA; [Forney, Karin A.] San Jose State Univ, Moss Landing Marine Labs, Moss Landing, CA USA; [Stimpert, Alison K.] San Jose State Univ, Moss Landing Marine Labs, BioacousticsNertebrate Ecol, Moss Landing, CA USA; [DeVogelaere, Andrew] NOAA, Monterey Bay Natl Marine Sanctuary, Natl Ocean Serv, Monterey, CA USA; [Black, Nancy] Monterey Bay Whale Watch, Monterey, CA USA; [Fischer, Mark] Aguason Acoust, Santa Clara, CA USA	Monterey Bay Aquarium Research Institute; United States Department of Defense; United States Navy; Naval Postgraduate School; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; National Oceanic Atmospheric Admin (NOAA) - USA; California State University System; San Jose State University; Moss Landing Marine Laboratories; California State University System; San Jose State University; Moss Landing Marine Laboratories; National Oceanic Atmospheric Admin (NOAA) - USA; National Ocean Service, NOAA	Ryan, JP (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.	ryjo@mbari.org	Margolina, Tetyana/ABD-3917-2021	Margolina, Tetyana/0000-0003-1594-5974; Wahl, Christopher/0000-0001-9675-068X; Ryan, John Phillip/0000-0001-7954-5369; Michisaki, Reiko/0000-0002-3295-3856	David and Lucile Packard Foundation; NOAA ECOHAB Program [NA11NOS4780030]; NSF [1514756]; Central and Northern California Ocean Observing System [NOAA NA16NOS0120021]	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NOAA ECOHAB Program(National Oceanic Atmospheric Admin (NOAA) - USA); NSF(National Science Foundation (NSF)); Central and Northern California Ocean Observing System	This study was funded by the David and Lucile Packard Foundation, through an annual grant to Monterey Bay Aquarium Research Institute (JPR, DEC, FPC, JTP, CW, RM, KBB). The Santa Cruz Wharf DA time-series (RMK) was supported by the Central and Northern California Ocean Observing System (NOAA NA16NOS0120021) and NOAA ECOHAB Program (NA11NOS4780030). This research was enabled by the Monterey Accelerated Research System (MARS) cabled observatory supported by NSF Award 1514756.; We gratefully acknowledge the support of MBARI MARS and R/V Rachel Carson operations teams for supporting deployment and operation of the hydrophone used in this study, and Edward T. Peltzer for the software used for Model 1 linear regression. We thank the scientists of the NOAA-Fisheries Rockfish Recruitment and Ecosystem Assessment Survey for their dedicated support for monitoring ocean and forage species conditions and the crew of the NOAA R/V Reuben Lasker. We also thank the NOAA California Current Integrated Ecosystem Assessment (CCIEA) for providing the status of ecological integrity indicators.	Au WWL, 2006, J ACOUST SOC AM, V120, P1103, DOI 10.1121/1.2211547; Au WWL, 2000, MAR MAMMAL SCI, V16, P530, DOI 10.1111/j.1748-7692.2000.tb00949.x; Auad G, 2011, PROG OCEANOGR, V91, P576, DOI 10.1016/j.pocean.2011.09.004; Baker CS, 2013, MAR ECOL PROG SER, V494, P291, DOI 10.3354/meps10508; BAKER CS, 1990, NATURE, V344, P238, DOI 10.1038/344238a0; BAKER CS, 1994, MOL ECOL, V3, P313, DOI 10.1111/j.1365-294X.1994.tb00071.x; Barber R.T., 1981, P31; Becker EA, 2019, DIVERS DISTRIB, V25, P626, DOI 10.1111/ddi.12867; Becker EA, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8020149; Benson SR, 2002, PROG OCEANOGR, V54, P279, DOI 10.1016/S0079-6611(02)00054-X; Bettridge S, 2015, NOAATMNMFSSWFSC540 U; Calambokidis J, 1996, MAR MAMMAL SCI, V12, P215, DOI 10.1111/j.1748-7692.1996.tb00572.x; Calambokidis J, 2004, MAR MAMMAL SCI, V20, P63, DOI 10.1111/j.1748-7692.2004.tb01141.x; Calambokidis J, 2000, MAR ECOL PROG SER, V192, P295, DOI 10.3354/meps192295; CALAMBOKIDIS J, 2017, SCA17NP13 INT WHAL C, V17, P13; Calambokidis J, 2015, AQUAT MAMM, V41, P39, DOI 10.1578/AM.41.1.2015.39; Carr ME, 2003, DEEP-SEA RES PT II, V50, P3199, DOI 10.1016/j.dsr2.2003.07.015; Cates KA, 2019, GEN COMP ENDOCR, V279, P164, DOI 10.1016/j.ygcen.2019.03.013; CHAMBERLIN TC, 1965, SCIENCE, V148, P754, DOI 10.1126/science.148.3671.754; Charif RA, 2001, MAR MAMMAL SCI, V17, P751, DOI 10.1111/j.1748-7692.2001.tb01297.x; Chavez FP, 2002, PROG OCEANOGR, V54, P205, DOI 10.1016/S0079-6611(02)00050-2; Chavez FP, 2009, PROG OCEANOGR, V83, P80, DOI 10.1016/j.pocean.2009.07.032; Cholewiak DM, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171298; Cholewiak DM, 2013, MAR MAMMAL SCI, V29, pE312, DOI 10.1111/mms.12005; CLAPHAM PJ, 1990, MAR MAMMAL SCI, V6, P155, DOI 10.1111/j.1748-7692.1990.tb00238.x; Clark CW, 2004, P ROY SOC B-BIOL SCI, V271, P1051, DOI 10.1098/rspb.2004.2699; COLLINS MD, 1993, J ACOUST SOC AM, V93, P1736, DOI 10.1121/1.406739; DAWBIN W H, 1991, Memoirs of the Queensland Museum, V30, P255; Espanol-Jimenez S, 2018, MAR MAMMAL SCI, V34, P718, DOI 10.1111/mms.12477; Fire SE, 2010, AQUAT MAMM, V36, P342, DOI 10.1578/AM.36.4.2010.342; Fire SE, 2009, HARMFUL ALGAE, V8, P658, DOI 10.1016/j.hal.2008.12.002; Fleming AH, 2016, GLOBAL CHANGE BIOL, V22, P1214, DOI 10.1111/gcb.13171; Fournet MEH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31527-x; FRANKEL AS, 1995, CAN J ZOOL, V73, P1134, DOI 10.1139/z95-135; Garland EC, 2011, CURR BIOL, V21, P687, DOI 10.1016/j.cub.2011.03.019; Gedamke J., 2016, NOAA OCEAN NOISE STR; Gentemann CL, 2017, GEOPHYS RES LETT, V44, P312, DOI 10.1002/2016GL071039; HELWEG DA, 1994, ETHOLOGY, V98, P298, DOI 10.1111/j.1439-0310.1994.tb01078.x; HUYER A, 1983, PROG OCEANOGR, V12, P259, DOI 10.1016/0079-6611(83)90010-1; Kowarski K, 2018, MAR MAMMAL SCI, V34, P169, DOI 10.1111/mms.12447; Kudela Raphael, 2005, Oceanography, V18, P184; Lane JQ, 2010, LIMNOL OCEANOGR-METH, V8, P645, DOI 10.4319/lom.2010.8.0645; Magnusdottir EE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210057; MATTILA DK, 1987, J MAMMAL, V68, P880, DOI 10.2307/1381574; McCabe RM, 2016, GEOPHYS RES LETT, V43, P10366, DOI 10.1002/2016GL070023; MCSWEENEY DJ, 1989, MAR MAMMAL SCI, V5, P139, DOI 10.1111/j.1748-7692.1989.tb00328.x; Mercado E, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01156; Noad MJ, 2000, NATURE, V408, P537, DOI 10.1038/35046199; Norris TF, 1999, J ACOUST SOC AM, V106, P506, DOI 10.1121/1.427071; Office of National Marine Sanctuaries, 2015, MONT BAY NAT MAR SAN; PAYNE RS, 1971, SCIENCE, V173, P585, DOI 10.1126/science.173.3997.585; Pennington JT, 2000, DEEP-SEA RES PT II, V47, P947, DOI 10.1016/S0967-0645(99)00132-0; Ralston S, 2015, J MARINE SYST, V146, P26, DOI 10.1016/j.jmarsys.2014.06.013; Rudnick DL, 2017, PROG OCEANOGR, V154, P64, DOI 10.1016/j.pocean.2017.03.002; Ryan J., 2016, P OCEANS 2016 MTS IE, P1; Ryan JP, 2017, GEOPHYS RES LETT, V44, P5571, DOI 10.1002/2017GL072637; RYTHER JH, 1969, SCIENCE, V166, P72, DOI 10.1126/science.166.3901.72; Sakuma KM, 2016, CAL COOP OCEAN FISH, V57, P163; Santora JA, 2017, MAR ECOL PROG SER, V580, P205, DOI 10.3354/meps12278; Santora JA, 2014, ECOL APPL, V24, P1730, DOI 10.1890/13-1605.1; Santora JA, 2012, PROG OCEANOGR, V106, P154, DOI 10.1016/j.pocean.2012.08.005; Santora JA, 2011, PROG OCEANOGR, V91, P397, DOI 10.1016/j.pocean.2011.04.002; Santos J. C., 2018, SCI REP, V8, P1, DOI DOI 10.1038/S41598-018-25742-9; Scholin CA, 2000, NATURE, V403, P80, DOI 10.1038/47481; Schwing FB, 1996, NOAATMNMFSSWFSC231 U; Smith JN, 2008, ANIM BEHAV, V76, P467, DOI 10.1016/j.anbehav.2008.02.013; STEIGER GH, 1991, MAR MAMMAL SCI, V7, P306, DOI 10.1111/j.1748-7692.1991.tb00105.x; Stimpert AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051214; Szoboszlai AI, 2015, ECOL INFORM, V29, P45, DOI 10.1016/j.ecoinf.2015.07.003; Thompson T, 2018, ST ANTONYS SER, P59, DOI 10.1007/978-3-319-64072-3_3; Trainer VL, 2012, HARMFUL ALGAE, V14, P271, DOI 10.1016/j.hal.2011.10.025; Urban R. J., 2000, Journal of Cetacean Research and Management, V2, P101; Van Dolah FM, 2005, MARINE MAMMAL RESEARCH: CONSERVATION BEYOND CRISIS, P85; Vu ET, 2012, AQUAT BIOL, V14, P175, DOI 10.3354/ab00390; Wright AJ, 2010, J MAR BIOL ASSOC UK, V90, P1489, DOI 10.1017/S0025315410000913	75	17	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222456	10.1371/journal.pone.0222456	http://dx.doi.org/10.1371/journal.pone.0222456			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525231	gold, Green Published, Green Submitted			2022-12-26	WOS:000532225700029
J	Zhang, SL; Shi, W; Ramsay, ES; Bliskovsky, V; Eiden, AM; Connors, D; Steinsaltz, M; DuBois, W; Mock, BA				Zhang, Shuling; Shi, Wei; Ramsay, Edward S.; Bliskovsky, Valery; Eiden, Adrian Max; Connors, Daniel; Steinsaltz, Matthew; DuBois, Wendy; Mock, Beverly A.			The transcription factor MZF1 differentially regulates murine Mtor promoter variants linked to tumor susceptibility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						single-nucleotide polymorphism (SNP); transcription regulation; genetic polymorphism; mammalian target of rapamycin (mTOR); general transcription factor (GTF); B cells; Mtor promoter; myeloid zinc finger protein 1 (MZF1); plasmacytoma; SCAN-zinc finger (SCAN-ZF) transcription factor	FINGER PROTEIN MZF1; GENE; EXPRESSION; CANCER; BINDING; LOCUS; CELLS; PCTR2; CD34	Mechanistic target of rapamycin (MTOR) is a highly conserved serine/threonine kinase that critically regulates cell growth, proliferation, differentiation, and survival. Previously, we have implicated Mtor as a plasmacytoma-resistance locus, Pctr2, in mice. Here, we report that administration of the tumor-inducing agent pristane decreases Mtor gene expression to a greater extent in mesenteric lymph nodes of BALB/cAnPt mice than of DBA/2N mice. We identified six allelic variants in the Mtor promoter region in BALB/cAnPt and DBA/2N mice. To determine the effects of these variants on Mtor transcription, we constructed a series of luciferase reporters containing these promoter variants and transfected them into mouse plasmacytoma cells. We could attribute the differences in Mtor promoter activity between the two mouse strains to a C ? T change at the ?6 position relative to the transcriptional start site Tssr 40273; a T at this position in the BALB promoter creates a consensus binding site for the transcription factor MZF1 (myeloid zinc finger 1). Results from electrophoretic mobility shift assays and DNA pulldown assays with ChIP-PCR confirmed that MZF1 binds to the cis-element TGGGGA located in the ?6/?1 Mtor promoter region. Of note, MZF1 significantly and differentially down-regulated Mtor promoter activity, with MZF1 overexpression reducing Mtor expression more strongly in BALB mice than in DBA mice. Moreover, MZF1 overexpression reduced Mtor expression in both fibroblasts and mouse plasmacytoma cells, and Mzf1 knockdown increased Mtor expression in BALB3T3 and NIH3T3 fibroblast cells. Our results provide evidence that MZF1 down-regulates Mtor expression in pristane-induced plasmacytomas in mice.	[Zhang, Shuling; Ramsay, Edward S.; Bliskovsky, Valery; Eiden, Adrian Max; Connors, Daniel; Steinsaltz, Matthew; DuBois, Wendy; Mock, Beverly A.] NIAID, Lab Canc Biol & Genet, Ctr Canc Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Shi, Wei] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Mock, BA (corresponding author), 37 Convent Dr,Bldg 37,Rm 3146, Bethesda, MD 20892 USA.	mockb@mail.nih.gov	Mock, Beverly/B-3110-2015	Mock, Beverly/0000-0003-2479-4549	Intramural Research Program of the National Institutes of Health, National Cancer Institute	Intramural Research Program of the National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bendavit G, 2016, J BIOL CHEM, V291, P25476, DOI 10.1074/jbc.M116.760249; Bliskovsky V, 2003, P NATL ACAD SCI USA, V100, P14982, DOI 10.1073/pnas.2431627100; Boutouja F, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8010018; Cao Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050302; Deng Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/868131; Eguchi T, 2015, J CELL BIOCHEM, V116, P2146, DOI 10.1002/jcb.25203; Grabiner BC, 2014, CANCER DISCOV, V4, P554, DOI 10.1158/2159-8290.CD-13-0929; Hromas R, 1996, CURR TOP MICROBIOL, V211, P159; Janku F, 2018, NAT REV CLIN ONCOL, V15, P273, DOI 10.1038/nrclinonc.2018.28; Jin ZN, 2016, ONCOTARGET, V7, P57464, DOI 10.18632/oncotarget.10805; Nguyen JT, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao5838; Kim J, 2019, NAT CELL BIOL, V21, P63, DOI 10.1038/s41556-018-0205-1; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Mock BA, 1997, BLOOD, V90, P4092, DOI 10.1182/blood.V90.10.4092; MOCK BA, 1993, P NATL ACAD SCI USA, V90, P9499, DOI 10.1073/pnas.90.20.9499; Moeenrezakhanlou A, 2008, J LEUKOCYTE BIOL, V84, P519, DOI 10.1189/jlb.1207833; MORRIS JF, 1995, BLOOD, V86, P3640; MORRIS JF, 1994, MOL CELL BIOL, V14, P1786, DOI 10.1128/MCB.14.3.1786; Mudduluru G, 2010, MOL CANCER RES, V8, P159, DOI 10.1158/1541-7786.MCR-09-0326; NORDAN RP, 1986, SCIENCE, V233, P566, DOI 10.1126/science.3726549; PERROTTI D, 1995, MOL CELL BIOL, V15, P6075; Piszczatowski RT, 2014, BIOCHEM BIOPH RES CO, V451, P137, DOI 10.1016/j.bbrc.2014.07.082; POTTER M, 1962, NATURE, V193, P1086, DOI 10.1038/1931086a0; Rastogi C, 2018, P NATL ACAD SCI USA, V115, pE3692, DOI 10.1073/pnas.1714376115; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Sintes J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01602-4; Villar VH, 2017, MOL CELL ONCOL, V4, DOI 10.1080/23723556.2017.1297284; Villar VH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14124; Vishwamitra D, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0324-2; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Xu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060080; Zhang SL, 2013, J IMMUNOL, V191, P1692, DOI 10.4049/jimmunol.1201767; Zhang SL, 2011, BLOOD, V117, P1228, DOI 10.1182/blood-2010-05-287821; Zhang SL, 2003, ONCOGENE, V22, P2285, DOI 10.1038/sj.onc.1206257; Zhang SL, 2001, MOL CELL BIOL, V21, P310, DOI 10.1128/MCB.21.1.310-318.2001	35	7	7	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16756	16764		10.1074/jbc.RA119.009779	http://dx.doi.org/10.1074/jbc.RA119.009779			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31548308	Green Published, hybrid			2022-12-26	WOS:000501801900023
J	Rybchyn, MS; Islam, KS; Brennan-Speranza, TC; Cheng, ZQ; Brennan, SC; Chang, WH; Mason, RS; Conigrave, AD				Rybchyn, Mark S.; Islam, Kazi S.; Brennan-Speranza, Tara C.; Cheng, Zhiqiang; Brennan, Sarah C.; Chang, Wenhan; Mason, Rebecca S.; Conigrave, Arthur David			Homer1 mediates CaSR-dependent activation of mTOR complex 2 and initiates a novel pathway for AKT-dependent ?-catenin stabilization in osteoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); Akt PKB; mTOR complex (mTORC); scaffold protein; osteoblast; cell signaling; ?-catenin; bone formation; calcium-sensing receptor (CaSR); family C G-protein?coupled receptor; Homer1	CALCIUM-SENSING RECEPTOR; MAMMALIAN TARGET; PROTEIN; KINASE; PHOSPHORYLATION; RICTOR; ROLES; COLOCALIZATION; MINERALIZATION; INHIBITION	The calcium-sensing receptor (CaSR) is critical for skeletal development, but its mechanism of action in osteoblasts is not well-characterized. In the central nervous system (CNS), Homer scaffolding proteins form signaling complexes with two CaSR-related members of the G protein?coupled receptor (GPCR) family C, metabotropic glutamate receptor 1 (mGluR1) and mGluR5. Here, we show that CaSR and Homer1 are co-expressed in mineralized mouse bone and also co-localize in primary human osteoblasts. Co-immunoprecipitation experiments confirmed that Homer1 associates with CaSR in primary human osteoblasts. The CaSR?Homer1 protein complex, whose formation was increased in response to extracellular Ca2+, was bound to mechanistic target of rapamycin (mTOR) complex 2 (mTORC2), a protein kinase that phosphorylates and activates AKT Ser/Thr kinase (AKT) at Ser(473). siRNA-based gene-silencing assays with primary osteoblasts revealed that both CaSR and Homer1 are required for extracellular Ca2+-stimulated AKT phosphorylation and thereby inhibit apoptosis and promote AKT-dependent ?-catenin stabilization and cellular differentiation. To confirm the role of the CaSR?Homer1 complex in AKT initiation, we show that in HEK-293 cells, co-transfection with both Homer1c and CaSR, but neither with Homer1c nor CaSR alone, establishes sensitivity of AKT?Ser(473) phosphorylation to increases in extracellular Ca2+ concentrations. These findings indicate that Homer1 mediates CaSR-dependent AKT activation via mTORC2 and thereby stabilizes ?-catenin in osteoblasts.	[Rybchyn, Mark S.; Brennan-Speranza, Tara C.; Mason, Rebecca S.] Univ Sydney, Sch Med Sci, Discipline Physiol, Sydney, NSW 2006, Australia; [Rybchyn, Mark S.; Brennan-Speranza, Tara C.; Brennan, Sarah C.; Mason, Rebecca S.; Conigrave, Arthur David] Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia; [Islam, Kazi S.; Brennan, Sarah C.; Conigrave, Arthur David] Univ Sydney, Charles Perkins Ctr D17, Sch Life & Environm Sci, Sydney, NSW 2006, Australia; [Cheng, Zhiqiang; Chang, Wenhan] Univ Calif San Francisco, Sch Med, San Francisco, CA 94121 USA	University of Sydney; University of Sydney; University of Sydney; University of California System; University of California San Francisco	Mason, RS (corresponding author), Univ Sydney, Anderson Stuart Bldg,F13, Sydney, NSW 2006, Australia.; Conigrave, AD (corresponding author), Univ Sydney, Charles Perkins Ctr D17, Sydney, NSW 2006, Australia.	rebecca.mason@sydney.edu.au; arthur.conigrave@sydney.edu.au	Mason, Rebecca/AHB-5478-2022	Speranza, Tara/0000-0001-5472-4969; Conigrave, Arthur/0000-0002-7232-3891; Mason, Rebecca/0000-0003-1534-9697; Islam, Kazi Saiful/0000-0002-3287-9297	National Health and Medical Research Council of Australia [1008282]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council of Australia Grant 1008282. The authors declare that they have no conflicts of interest with the contents of this article.	Avila-Flores A, 2005, J BIOL CHEM, V280, P10091, DOI 10.1074/jbc.M412296200; Bai M, 1998, J BIOL CHEM, V273, P23605, DOI 10.1074/jbc.273.36.23605; Baron R, 2013, NAT MED, V19, P179, DOI 10.1038/nm.3074; Bockaert J, 2010, ANNU REV PHARMACOL, V50, P89, DOI 10.1146/annurev.pharmtox.010909.105705; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Brennan TC, 2009, BRIT J PHARMACOL, V157, P1291, DOI 10.1111/j.1476-5381.2009.00305.x; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Chang WH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159945; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Dvorak-Ewell MM, 2011, J BONE MINER RES, V26, P2935, DOI 10.1002/jbmr.520; Ebner M, 2017, J CELL BIOL, V216, P343, DOI 10.1083/jcb.201610060; Esen E, 2013, CELL METAB, V17, P745, DOI 10.1016/j.cmet.2013.03.017; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Goltzman D, 2015, NAT REV ENDOCRINOL, V11, P298, DOI 10.1038/nrendo.2015.30; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jiang XG, 2007, J PROTEOME RES, V6, P2287, DOI 10.1021/pr070056t; Khanna N, 2013, P NATL ACAD SCI USA, V110, P15979, DOI 10.1073/pnas.1310434110; Kubota T, 2009, J BONE MINER METAB, V27, P265, DOI 10.1007/s00774-009-0064-8; Levinger I, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12700; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Manolagas SC, 2010, TRENDS ENDOCRIN MET, V21, P369, DOI 10.1016/j.tem.2010.01.010; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; McCormick WD, 2010, J BIOL CHEM, V285, P14170, DOI 10.1074/jbc.M109.071084; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Ranganathan R, 1997, CURR BIOL, V7, pR770, DOI 10.1016/S0960-9822(06)00401-5; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; Rong R, 2003, NAT NEUROSCI, V6, P1153, DOI 10.1038/nn1134; Ruat M, 2013, BEST PRACT RES CL EN, V27, P429, DOI 10.1016/j.beem.2013.03.001; Rybchyn MS, 2011, J BIOL CHEM, V286, P23771, DOI 10.1074/jbc.M111.251116; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sequeira VB, 2012, MOL ENDOCRINOL, V26, P574, DOI 10.1210/me.2011-1161; Shiraishi-Yamaguchi Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-206; SLATER M, 1994, J BONE MINER RES, V9, P161; Srivastava AK, 1998, MOL CELL BIOCHEM, V182, P135, DOI 10.1023/A:1006857527588; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; VoynoYasenetskaya TA, 1996, J BIOL CHEM, V271, P21081, DOI 10.1074/jbc.271.35.21081; Wang J, 2010, J CELL BIOCHEM, V111, P1531, DOI 10.1002/jcb.22883; Ward BK, 2004, J CLIN ENDOCR METAB, V89, P3721, DOI 10.1210/jc.2003-031653; Worley PF, 2007, CELL CALCIUM, V42, P363, DOI 10.1016/j.ceca.2007.05.007; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8	50	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					16337	16350		10.1074/jbc.RA118.006587	http://dx.doi.org/10.1074/jbc.RA118.006587			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31527082	Green Published, hybrid			2022-12-26	WOS:000499478600037
J	Seidler, PM; Boyer, DR; Murray, KA; Yang, TXP; Bentzel, M; Sawaya, MR; Rosenberg, G; Cascio, D; Williams, CK; Newell, KL; Ghetti, B; DeTure, MA; Dickson, DW; Vinters, HV; Eisenberg, DS				Seidler, Paul Matthew; Boyer, David R.; Murray, Kevin A.; Yang, Tianxiao P.; Bentzel, Megan; Sawaya, Michael R.; Rosenberg, Gregory; Cascio, Duilio; Williams, Christopher Kazu; Newell, Kathy L.; Ghetti, Bernardino; DeTure, Michael A.; Dickson, Dennis W.; Vinters, Harry V.; Eisenberg, David S.			Structure-based inhibitors halt prion-like seeding by Alzheimer's disease?and tauopathy?derived brain tissue samples	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid; tau protein; tauopathy; prion; fibril; crystal structure; inhibitor; protein aggregation; seeding; protein structure; neurodegeneration; structural biology; seeding; zipper interface	TAU; TAUOPATHIES; PROPAGATE; PROTEINS; CORE	In Alzheimer's disease (AD) and tauopathies, tau aggregation accompanies progressive neurodegeneration. Aggregated tau appears to spread between adjacent neurons and adjacent brain regions by prion-like seeding. Hence, inhibitors of this seeding offer a possible route to managing tauopathies. Here, we report the 1.0 ? resolution micro-electron diffraction structure of an aggregation-prone segment of tau with the sequence SVQIVY, present in the cores of patient-derived fibrils from AD and tauopathies. This structure illuminates how distinct interfaces of the parent segment, containing the sequence VQIVYK, foster the formation of distinct structures. Peptide-based fibril-capping inhibitors designed to target the two VQIVYK interfaces blocked proteopathic seeding by patient-derived fibrils. These VQIVYK inhibitors add to a panel of tau-capping inhibitors that targets specific polymorphs of recombinant and patient-derived tau fibrils. Inhibition of seeding initiated by brain tissue extracts differed among donors with different tauopathies, suggesting that particular fibril polymorphs of tau are associated with certain tauopathies. Donors with progressive supranuclear palsy exhibited more variation in inhibitor sensitivity, suggesting that fibrils from these donors were more polymorphic and potentially vary within individual donor brains. Our results suggest that a subset of inhibitors from our panel could be specific for particular disease-associated polymorphs, whereas inhibitors that blocked seeding by extracts from all of the tauopathies tested could be used to broadly inhibit seeding by multiple disease-specific tau polymorphs. Moreover, we show that tau-capping inhibitors can be transiently expressed in HEK293 tau biosensor cells, indicating that nucleic acid?based vectors can be used for inhibitor delivery.	[Seidler, Paul Matthew; Boyer, David R.; Murray, Kevin A.; Yang, Tianxiao P.; Bentzel, Megan; Sawaya, Michael R.; Rosenberg, Gregory; Cascio, Duilio; Eisenberg, David S.] Univ Calif Los Angeles, Dept Chem & Biochem, UCLA DOE Inst, Mol Biol Inst, Los Angeles, CA 90095 USA; [Seidler, Paul Matthew; Boyer, David R.; Murray, Kevin A.; Yang, Tianxiao P.; Bentzel, Megan; Sawaya, Michael R.; Rosenberg, Gregory; Cascio, Duilio; Eisenberg, David S.] Univ Calif Los Angeles, Dept Biol Chem, UCLA DOE Inst, Mol Biol Inst, Los Angeles, CA 90095 USA; [Seidler, Paul Matthew; Boyer, David R.; Murray, Kevin A.; Yang, Tianxiao P.; Bentzel, Megan; Sawaya, Michael R.; Rosenberg, Gregory; Cascio, Duilio; Eisenberg, David S.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Williams, Christopher Kazu; Vinters, Harry V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Vinters, Harry V.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Newell, Kathy L.; Ghetti, Bernardino] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [DeTure, Michael A.; Dickson, Dennis W.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA	United States Department of Energy (DOE); University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Indiana University System; Indiana University Bloomington; Mayo Clinic	Eisenberg, DS (corresponding author), Univ Calif Los Angeles, 611 Charles E Young Dr,Boyer 201, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu		Yang, Tianxiao/0000-0002-4479-5154; Sawaya, Michael/0000-0003-0874-9043	NIA, National Institutes of Health (NIH) [1R01 AG061847, RF1 AG054022, PHS P30-AG010133]; NINDS, NIH [1F32 NS095661]; BrightFocus Foundation [A2016588F]; United States Public Health Service National Research Service Award [5T32GM008496]; University of California-Caltech Medical Scientist Training Program; National ScienceFoundation GraduateResearch Fellowships Program; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG035982, RF1AG054022, R56AG061847, R01AG029430] Funding Source: NIH RePORTER	NIA, National Institutes of Health (NIH); NINDS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); BrightFocus Foundation(BrightFocus Foundation); United States Public Health Service National Research Service Award; University of California-Caltech Medical Scientist Training Program; National ScienceFoundation GraduateResearch Fellowships Program; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIA, National Institutes of Health (NIH), Grants 1R01 AG061847 (to D. S. E.), RF1 AG054022 (to D. S. E.), and PHS P30-AG010133 (to B. G.); NINDS, NIH, Grant 1F32 NS095661 (to P. M. S.); BrightFocus Foundation Grant A2016588F (to P. M. S.); United States Public Health Service National Research Service Award 5T32GM008496 (to K. A. M.); the University of California-Caltech Medical Scientist Training Program (to K. A. M.); the National ScienceFoundationGraduateResearch Fellowships Program(to D. R. B.); and the Howard Hughes Medical Institute. D. S. E. is SAB chair and equity holder of ADRx, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Chung DEC, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0691-9; Clavaguera F, 2013, P NATL ACAD SCI USA, V110, P9535, DOI 10.1073/pnas.1301175110; DeLano W. L., 2012, PYMOL MOL GRAPHICS S; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Falcon B, 2018, ACTA NEUROPATHOL, V136, P699, DOI 10.1007/s00401-018-1914-z; Falcon B, 2018, NATURE, V561, P137, DOI 10.1038/s41586-018-0454-y; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Gibbons GS, 2018, J NEUROPATH EXP NEUR, V77, P216, DOI 10.1093/jnen/nly010; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Guenther EL, 2018, NAT STRUCT MOL BIOL, V25, P463, DOI 10.1038/s41594-018-0064-2; Guerrero-Ferreira R., 2019, 2 NEW POLYMORPHIC ST, DOI [10.1101/654582, DOI 10.1101/654582]; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Iadanza MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06761-6; Kaufman SK, 2018, ACTA NEUROPATHOL, V136, P57, DOI 10.1007/s00401-018-1855-6; Li B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03169-0; Morozova OA, 2013, BIOCHEMISTRY-US, V52, P6960, DOI 10.1021/bi400866w; Mudher A, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0488-7; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Rodriguez JA, 2015, NATURE, V525, P486, DOI 10.1038/nature15368; Sade D, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.170229; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seidler PM, 2018, NAT CHEM, V10, P170, DOI [10.1038/nchem.2889, 10.1038/NCHEM.2889]; Sievers SA, 2011, NATURE, V475, P96, DOI 10.1038/nature10154; Weismiller HA, 2018, J BIOL CHEM, V293, P17336, DOI 10.1074/jbc.RA118.005316; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643; Woerman AL, 2016, P NATL ACAD SCI USA, V113, pE8187, DOI 10.1073/pnas.1616344113; Zhang WJ, 2019, ELIFE, V8, DOI 10.7554/eLife.43584	32	31	31	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					16451	16464		10.1074/jbc.RA119.009688	http://dx.doi.org/10.1074/jbc.RA119.009688			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31537646	hybrid, Green Published			2022-12-26	WOS:000499478600046
J	Watanabe, N; Kidokoro, M; Suzuki, Y; Tanaka, M; Inoue, S; Tsukamoto, H; Hirayama, N; Hsieh, PW; Tseng, CP; Nakagawa, Y; Inokuchi, S				Watanabe, Nobuo; Kidokoro, Masako; Suzuki, Yusuke; Tanaka, Makiko; Inoue, Shigeaki; Tsukamoto, Hideo; Hirayama, Noriaki; Hsieh, Pei-Wen; Tseng, Ching-Ping; Nakagawa, Yoshihide; Inokuchi, Sadaki			A pull-down and slot blot-based screening system for inhibitor compounds of the podoplanin-CLEC-2 interaction	PLOS ONE			English	Article							PLATELET-AGGREGATION; RECEPTOR CLEC-2; IDENTIFICATION; METASTASIS	Podoplanin, a transmembrane glycoprotein, is overexpressed in certain types of tumors and induces platelet aggregation by binding to C-type lectin-like receptor 2 (CLEC-2) on the platelet membrane. Activated platelets release granule components, which in turn, trigger epithelial-mesenchymal transition and confer invasive capacity to the tumor cells. Therefore, blocking the podoplanin-CLEC-2 interaction by a small-molecule compound is a potential therapeutic strategy to prevent cancer metastasis and invasion. To effectively identify such inhibitory compounds, we have developed a pull-down-based inhibitory compound screening system. An immunoglobulin Fc domain-CLEC-2 fusion protein was used as a bait to capture podoplanin derived from podoplanin-overexpressing HeLa cells in the presence and absence of the test compound. The protein complex was then pulled down using protein A beads. To shorten the turnaround time, increase throughput, and decrease the workload for the operators, centrifugal filter units were employed to separate free and bound podoplanin, instead of using customary aspiration-centrifugation washing cycles. Slot blotting was also utilized in lieu of gel electrophoresis and electrical transfer. Thus, the use of our pull down screening system could facilitate the effective selection of potential inhibitor compounds of the podoplanin-CLEC-2 interaction for cancer therapy. Importantly, our methodology is also applicable to targeting other protein-protein interactions.	[Watanabe, Nobuo; Kidokoro, Masako; Suzuki, Yusuke; Tanaka, Makiko; Inoue, Shigeaki; Nakagawa, Yoshihide; Inokuchi, Sadaki] Tokai Univ, Dept Emergency & Crit Care Med, Sch Med, Isehara, Kanagawa, Japan; [Tsukamoto, Hideo] Tokai Univ, Dept Educ, Sch Med, Isehara, Kanagawa, Japan; [Tsukamoto, Hideo] Tokai Univ, Res Support Ctr, Sch Med, Isehara, Kanagawa, Japan; [Hirayama, Noriaki] Tokai Univ, Inst Adv Biosci, Isehara, Kanagawa, Japan; [Hsieh, Pei-Wen] Chang Gung Univ, Coll Med, Grad Inst Nat Prod, Taoyuan, Taiwan; [Hsieh, Pei-Wen] Chang Gung Mem Hosp, Dept Anesthesiol, Taoyuan, Taiwan; [Tseng, Ching-Ping] Chang Gung Univ, Coll Med, Dept Med Biotechnol & Lab Sci, Taoyuan, Taiwan; [Tseng, Ching-Ping] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan, Taiwan; [Tseng, Ching-Ping] Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan	Tokai University; Tokai University; Tokai University; Tokai University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Inokuchi, S (corresponding author), Tokai Univ, Dept Emergency & Crit Care Med, Sch Med, Isehara, Kanagawa, Japan.	inokuchi@is.icc.u-tokai.ac.jp		Hsieh, Pei-Wen/0000-0002-8882-4711	Institute for Advanced Life Science Research of Tokai University; Institute for Advanced Biosciences of Tokai University	Institute for Advanced Life Science Research of Tokai University; Institute for Advanced Biosciences of Tokai University	This work was supported by a grant from the Institute for Advanced Life Science Research of Tokai University to Sadaki Inokuchi.; This work was supported by a grant from the Institute for Advanced Biosciences of Tokai University. We wish to acknowledge Drs. Yoshiaki Okada and Takuma Araki and Ms. Akiko Sasaki of the Department of Education and the Research Support Center of Tokai University for their technical support.	Chang YW, 2015, ONCOTARGET, V6, P42733, DOI 10.18632/oncotarget.5811; Christou CM, 2008, BIOCHEM J, V411, P133, DOI 10.1042/BJ20071216; Grigorian AL, 2005, PROTEIN SCI, V14, P902, DOI 10.1110/ps.041048805; Kato Y, 2003, J BIOL CHEM, V278, P51599, DOI 10.1074/jbc.M309935200; Kato Y, 2008, CANCER SCI, V99, P54, DOI 10.1111/j.1349-7006.2007.00634.x; Kato Y, 2015, ONCOTARGET, V6, P36003, DOI 10.18632/oncotarget.5339; Migliorini E, 2018, BIOINTERPHASES, V13, DOI 10.1116/1.5045122; Payne H, 2017, BLOOD, V129, P2013, DOI 10.1182/blood-2016-09-742999; Sekiguchi T, 2016, ONCOTARGET, V7, P3934, DOI 10.18632/oncotarget.6598; Suzuki-Inoue K, 2007, J BIOL CHEM, V282, P25993, DOI 10.1074/jbc.M702327200; Takemoto A, 2017, CANCER METAST REV, V36, P225, DOI 10.1007/s10555-017-9672-2; Takemoto A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42186; Tanaka M, 2015, MOL MED REP, V12, P4029, DOI 10.3892/mmr.2015.3966; Tsukiji N, 2018, BLOOD ADV, V2, P2214, DOI 10.1182/bloodadvances.2018016261; Ugorski M, 2016, AM J CANCER RES, V6, P370; Watanabe N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07080-4; Watson AA, 2009, BIOCHEMISTRY-US, V48, P10988, DOI 10.1021/bi901427d; Wu YY, 2016, INT J ONCOL, V48, P2310, DOI 10.3892/ijo.2016.3445	18	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222331	10.1371/journal.pone.0222331	http://dx.doi.org/10.1371/journal.pone.0222331			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553741	gold, Green Published			2022-12-26	WOS:000532319200025
J	Corbeau, A; Collet, J; Fontenille, M; Weimerskirch, H				Corbeau, Alexandre; Collet, Julien; Fontenille, Melissa; Weimerskirch, Henri			How do seabirds modify their search behaviour when encountering fishing boats?	PLOS ONE			English	Article							AREA-RESTRICTED SEARCH; 1ST-PASSAGE TIME; FINE-SCALE; LONGLINE FISHERY; HABITAT USE; ALBATROSSES; TRACKING; LIFE; RECOGNITION; PREDATORS	Seabirds are well known to be attracted by fishing boats to forage on offal and baits. We used recently developed loggers that record accurate GPS position and detect the presence of boats through their radar emissions to examine how albatrosses use Area Restricted Search (ARS) and if so, have specific ARS behaviours, when attending boats. As much as 78.5% of locations with a radar detection (contact with boat) during a trip occurred within ARS: 36.8% of all large-scale ARS (n = 212) and 14.7% of all small-scale ARS (n = 1476) were associated with the presence of a boat. During small-scale ARS, birds spent more time and had greater sinuosity during boat-associated ARS compared with other ARS that we considered natural. For, small-scale ARS associated with boats, those performed over shelves were longer in duration, had greater sinuosity, and birds spent more time sitting on water compared with oceanic ARS associated with boats. We also found that the proportion of small-scale ARS tend to be more frequently nested in larger-scale ARS was higher for birds associated with boats and that ARS behaviour differed between oceanic (tuna fisheries) and shelf-edge (mainly Patagonian toothfish fisheries) habitats. We suggest that, in seabird species attracted by boats, a significant amount of ARS behaviours are associated with boats, and that it is important to be able to separate ARS behaviours associated to boats from natural searching behaviours. Our study suggest that studying ARS characteristics should help attribute specific behaviours associated to the presence of boats and understand associated risks between fisheries.	[Corbeau, Alexandre; Collet, Julien; Fontenille, Melissa; Weimerskirch, Henri] La Rochelle Univ, Ctr Etud Biol Chize, UMR7372, CNRS, Villiers En Bois, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Corbeau, A (corresponding author), La Rochelle Univ, Ctr Etud Biol Chize, UMR7372, CNRS, Villiers En Bois, France.	alexandre.corbeau@cebc.cnrs.fr	Collet, Julien/AAO-3785-2020	Collet, Julien/0000-0002-3285-5535; CORBEAU, Alexandre/0000-0002-7728-7199	Institiut Polaire Francais Paul Emile Victor (IPEV) [109]; Terres Australes and Antarctique Francaises (TAAF); European Research Council under the European Community [ERC-2012-ADG_20120314]	Institiut Polaire Francais Paul Emile Victor (IPEV); Terres Australes and Antarctique Francaises (TAAF); European Research Council under the European Community(European Research Council (ERC))	The Institiut Polaire Francais Paul Emile Victor (IPEV, programme 109 to HW) and the Terres Australes and Antarctique Francaises (TAAF) provided logistical and financial support, and HW had programs EARLYLIFE, funded by a European Research Council Advanced Grant under the European Community's Seven Framework Program FP7/2007-2013 (Grant Agreement ERC-2012-ADG_20120314 to HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Orea R. J., 2011, Endangered Species Research, V14, P91, DOI 10.3354/esr00347; Barraquand F, 2008, ECOLOGY, V89, P3336, DOI 10.1890/08-0162.1; BENHAMOU S, 1992, J THEOR BIOL, V159, P67, DOI 10.1016/S0022-5193(05)80768-4; Bennison A, 2018, ECOL EVOL, V8, P13, DOI 10.1002/ece3.3593; Bicknell AWJ, 2013, J APPL ECOL, V50, P649, DOI 10.1111/1365-2664.12072; Bodey TW, 2014, CURR BIOL, V24, pR514, DOI 10.1016/j.cub.2014.04.041; BROTHERS N, 1991, BIOL CONSERV, V55, P255, DOI 10.1016/0006-3207(91)90031-4; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Collet J, 2017, ECOL EVOL, V7, P3335, DOI 10.1002/ece3.2677; Collet J, 2015, MAR ECOL PROG SER, V526, P199, DOI 10.3354/meps11233; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; de Grissac S, 2017, ECOL EVOL, V7, P6766, DOI 10.1002/ece3.3210; Delord K, 2005, CCAMLR SCI, V12, P53; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Gremillet D, 2008, P R SOC B, V275, P1149, DOI 10.1098/rspb.2007.1763; Hamer KC, 2009, J ANIM ECOL, V78, P880, DOI 10.1111/j.1365-2656.2009.01549.x; Heerah K, 2019, BIOL CONSERV, V234, P192, DOI 10.1016/j.biocon.2019.03.037; Hill S, 2000, J FISH BIOL, V56, P1497; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Johnson PCD, 2014, METHODS ECOL EVOL, V5, P944, DOI 10.1111/2041-210X.12225; Joo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071246; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Langrock R, 2012, ECOLOGY, V93, P2336, DOI 10.1890/11-2241.1; Lascelles BG, 2016, DIVERS DISTRIB, V22, P422, DOI 10.1111/ddi.12411; Lavielle M, 1999, STOCH PROC APPL, V83, P79, DOI 10.1016/S0304-4149(99)00023-X; Lavielle M, 2005, SIGNAL PROCESS, V85, P1501, DOI 10.1016/j.sigpro.2005.01.012; Pacheco-Cobos L, 2019, P NATL ACAD SCI USA, V116, P10339, DOI 10.1073/pnas.1814476116; Pante E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073051; Pereira JM, 2018, MAR BIOL, V165, DOI 10.1007/s00227-018-3316-0; Phillips RA, 2003, AUK, V120, P1082, DOI 10.1642/0004-8038(2003)120[1082:EOSTOA]2.0.CO;2; Pinaud D, 2008, J APPL ECOL, V45, P91, DOI 10.1111/j.1365-2664.2007.01370.x; Rollinson DP, 2016, REV SEABIRD BYCATCH; Sabarros PS, 2014, DEEP-SEA RES PT II, V107, P77, DOI 10.1016/j.dsr2.2013.06.023; STEARNS SC, 1980, OIKOS, V35, P266, DOI 10.2307/3544434; Suryan RM, 2006, DEEP-SEA RES PT II, V53, P370, DOI 10.1016/j.dsr2.2006.01.012; Tasker ML, 2000, ICES J MAR SCI, V57, P531, DOI 10.1006/jmsc.2000.0714; Torres LG, 2013, MAR ECOL PROG SER, V473, P275, DOI 10.3354/meps10071; Torres LG, 2011, MAR ECOL PROG SER, V428, P289, DOI 10.3354/meps09068; Trost SG, 2014, PHYSIOL MEAS, V35, P2183, DOI 10.1088/0967-3334/35/11/2183; Votier SC, 2004, NATURE, V427, P727, DOI 10.1038/nature02315; Weimerskirch H, 1997, MAR ECOL PROG SER, V151, P245, DOI 10.3354/meps151245; Weimerskirch H, 2018, CONSERV BIOL, V32, P240, DOI 10.1111/cobi.12965; Weimerskirch H, 2002, SCIENCE, V295, P1259, DOI 10.1126/science.1068034; Weimerskirch H, 1997, BIOL CONSERV, V79, P257, DOI 10.1016/S0006-3207(96)00084-5; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; Weimerskirch H, 2018, J ANIM ECOL, V87, P945, DOI 10.1111/1365-2656.12817; Weimerskirch H, 2014, J EXP MAR BIOL ECOL, V450, P68, DOI 10.1016/j.jembe.2013.10.021	47	7	7	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222615	10.1371/journal.pone.0222615	http://dx.doi.org/10.1371/journal.pone.0222615			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550257	Green Published, gold			2022-12-26	WOS:000532307700019
J	Dolzani, P; Assirelli, E; Pulsatelli, L; Meliconi, R; Mariani, E; Neri, S				Dolzani, Paolo; Assirelli, Elisa; Pulsatelli, Lia; Meliconi, Riccardo; Mariani, Erminia; Neri, Simona			Ex vivo physiological compression of human osteoarthritis cartilage modulates cellular and matrix components	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; GENE-EXPRESSION; CHONDROCYTES; MECHANOTRANSDUCTION	Mechanical stimulation appears to play a key role in cartilage homeostasis maintenance, but it can also contribute to osteoarthritis (OA) pathogenesis. Accumulating evidence suggests that cartilage loading in the physiological range contributes to tissue integrity maintenance, whereas excessive or reduced loading have catabolic effects. However, how mechanical stimuli can regulate joint homeostasis is still not completely elucidated and few data are available on human cartilage. We aimed at investigating human OA cartilage response to ex vivo loading at physiological intensity. Cartilage explants from ten OA patients were subjected to ex vivo controlled compression, then recovered and used for gene and protein expression analysis of cartilage homeostasis markers. Compressed samples were compared to uncompressed ones in presence or without interleukin 1 beta (IL-1 beta) or interleukin 4 (IL-4). Cartilage explants compressed in combination with IL-4 treatment showed the best histological scores. Mechanical stimulation was able to significantly modify the expression of collagen type II (collagen 2), aggrecan, SOX9 transcription factor, cartilage oligomeric matrix protein (COMP), collagen degradation marker C2C and vascular endothelial growth factor (VEGF). Conversely, ADAMTS4 metallopeptidase, interleukin 4 receptor alpha (IL4Ra), chondroitin sulfate 846 epitope (CS846), procollagen type 2 C-propeptide (CPII) and glycosaminoglycans (GAG) appeared not modulated. Our data suggest that physiological compression of OA human cartilage modulates the inflammatory milieu by differently affecting the expression of components and homeostasis regulators of the cartilage extracellular matrix.	[Dolzani, Paolo; Assirelli, Elisa; Pulsatelli, Lia; Mariani, Erminia; Neri, Simona] IRCCS Ist Ortoped Rizzoli, Lab Immunoreumatol & Rigeneraz Tiss, Bologna, Italy; [Meliconi, Riccardo] IRCCS Ist Ortoped Rizzoli, Unita Med & Reumatol, Bologna, Italy; [Meliconi, Riccardo] Univ Bologna, Dipartimento Sci Biomed & Neuromotorie, Bologna, Italy; [Mariani, Erminia] Univ Bologna, Dipartimento Sci Med & Chirurg, Bologna, Italy	University of Bologna; University of Bologna	Neri, S (corresponding author), IRCCS Ist Ortoped Rizzoli, Lab Immunoreumatol & Rigeneraz Tiss, Bologna, Italy.	simona.neri@ior.it	Mariani, Erminia/C-6881-2019; Assirelli, Elisa/F-1435-2019; Dolzani, Paolo/C-6955-2019; Pulsatelli, Lia/D-4092-2019; Mariani, Erminia/AAE-8110-2021; Neri, Simona/C-6874-2019	Mariani, Erminia/0000-0002-4407-6707; Assirelli, Elisa/0000-0001-5678-6506; Dolzani, Paolo/0000-0002-9341-2703; Pulsatelli, Lia/0000-0003-3031-170X; Mariani, Erminia/0000-0002-4407-6707; Neri, Simona/0000-0003-3257-6293	Italian Health Ministry; Bologna University RFO Fund; "Ricerca corrente Rizzoli Orthopaedic Institute" funds	Italian Health Ministry(Ministry of Health, Italy); Bologna University RFO Fund; "Ricerca corrente Rizzoli Orthopaedic Institute" funds	This work was supported by Italian Health Ministry 5x1000 Fund, by Bologna University RFO Fund and by "Ricerca corrente Rizzoli Orthopaedic Institute" funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DE, 2017, FRONT BIOENG BIOTECH, V5, DOI 10.3389/fbioe.2017.00076; Assirelli E, OSTEOARTHRITIS CARTI, V20, pS242; Assirelli E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096925; Barbosa I, 2003, GLYCOBIOLOGY, V13, P647, DOI 10.1093/glycob/cwg082; Beckmann R, 2014, INT J MOL SCI, V15, P15456, DOI 10.3390/ijms150915456; Buckwalter J A, 1997, Iowa Orthop J, V17, P80; Chen C.Y, 2018, INT J MOL SCI, V19; Clements KM, 2001, OSTEOARTHR CARTILAGE, V9, P499, DOI 10.1053/joca.2000.0417; DAVIS MA, 1989, AM J EPIDEMIOL, V130, P278, DOI 10.1093/oxfordjournals.aje.a115334; Erhart-Hledik JC, 2012, OSTEOARTHR CARTILAGE, V20, P1309, DOI 10.1016/j.joca.2012.07.018; Gassner R, 1999, J IMMUNOL, V163, P2187; Goldring MB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2592; Gosset M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2024; Grogan SP, 2012, TISSUE ENG PT A, V18, P1784, DOI [10.1089/ten.tea.2011.0506, 10.1089/ten.TEA.2011.0506]; Jeon JE, 2012, OSTEOARTHR CARTILAGE, V20, P906, DOI 10.1016/j.joca.2012.04.019; Jorgensen AE, 2017, J RHEUMATOL, V44, P410, DOI 10.3899/jrheum.160226; Leong DJ, 2011, ANN NY ACAD SCI, V1240, P32, DOI 10.1111/j.1749-6632.2011.06301.x; Leung YY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202554; McCutchen CN, 2017, J BIOMECH, V64, P49, DOI 10.1016/j.jbiomech.2017.08.032; Neri S, 2013, J BONE JOINT SURG AM, V95A, P1852, DOI 10.2106/JBJS.L.01715; Nishimuta JF, 2012, OSTEOARTHR CARTILAGE, V20, P422, DOI 10.1016/j.joca.2012.01.004; O'Conor CJ, 2014, P NATL ACAD SCI USA, V111, P1316, DOI 10.1073/pnas.1319569111; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Pulsatelli L, 2005, CLIN EXP RHEUMATOL, V23, P487; Quicke JG, 2015, OSTEOARTHR CARTILAGE, V23, P1445, DOI 10.1016/j.joca.2015.05.002; Racunica TL, 2007, ARTHRIT RHEUM-ARTHR, V57, P1261, DOI 10.1002/art.22990; Rytter Soren, 2009, J Occup Med Toxicol, V4, P19, DOI 10.1186/1745-6673-4-19; Sanchez-Adams J, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0451-6; Saxby DJ, 2017, OSTEOARTHR CARTILAGE, V25, P190, DOI 10.1016/j.joca.2016.09.023; Scholtes S, 2018, J CELL PHYSIOL, V233, P699, DOI 10.1002/jcp.25933; Servin-Vences MR, 2017, ELIFE, V6, DOI 10.7554/eLife.21074; Sun HB, 2010, ANN NY ACAD SCI, V1211, P37, DOI 10.1111/j.1749-6632.2010.05808.x; Torzilli PA, 2010, OSTEOARTHR CARTILAGE, V18, P97, DOI 10.1016/j.joca.2009.07.012; Varady NH, 2016, OSTEOARTHR CARTILAGE, V24, P27, DOI 10.1016/j.joca.2015.08.018; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wang QG, 2009, BIOCHEM BIOPH RES CO, V379, P738, DOI 10.1016/j.bbrc.2008.12.111; Wojdasiewicz P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/561459	37	16	16	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222947	10.1371/journal.pone.0222947	http://dx.doi.org/10.1371/journal.pone.0222947			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550275	Green Published, gold			2022-12-26	WOS:000532307700036
J	Sanchez-Rodriguez, MA; Zacarias-Flores, M; Arronte-Rosales, A; Mendoza-Nunez, VM				Sanchez-Rodriguez, Martha A.; Zacarias-Flores, Mariano; Arronte-Rosales, Alicia; Manuel Mendoza-Nunez, Victor			Association between hot flashes severity and oxidative stress among Mexican postmenopausal women: A cross-sectional study	PLOS ONE			English	Article							MIDDLE-AGED WOMEN; QUALITY-OF-LIFE; VASOMOTOR SYMPTOMS; MENOPAUSE; RISK; DEPRESSION; INSOMNIA; ANXIETY; PATHOPHYSIOLOGY; VALIDATION	Objective To assess the association between hot flashes (HFs) severity and oxidative stress (OS) in Mexican postmenopausal women. Methods A cross-sectional study was carried out with perimenopausal women aged 40-59 years community-dwelling from Mexico City, Mexico. They participated in Menopause and Oxidative Stress Project. The baseline sample consisted of 476 women recruited to participate; 161 women were excluded due to different reasons. Hence, 315 women were selected to establish two groups, a) 145 premenopausal women (yet with menstrual bleeding), and b) 170 postmenopausal women (without menses). All women were free of cardiovascular, kidney, hepatic or cancer disease, and without antioxidant supplement intake for at least six months prior to the beginning of the study; none had previously received hormone therapy. As OS markers, we measured plasma malondialdehyde using the TBARS assay, erythrocyte superoxide dismutase (SOD) and glutathione peroxidase (GPx), uric acid, and total antioxidant status; also, we calculated SOD/GPx ratio, antioxidant gap and an oxidative stress score ranging from 0 to 7. The HFs were evaluated using the Menopause Rating Scale. The women completed Spanish version of the Athens Insomnia Scale, Zung Self-Rating Anxiety Scale and Zung Self-Rating Depression Scale and a questionnaire of prooxidant factors. Results Stress score increased with HFs severity (mild 2.7 +/- 0.17, moderate 2.9 +/- 0.20 and severe 3.7 +/- 0.20, p = 0.001) in postmenopausal women. We observed a positive correlation between HFs severity and stress score, r = 0.247 (p = 0.001) in postmenopausal women; other test scores were not correlated. Severe HFs were a risk factor for OS (OR = 5.12, 95%CI: 1.99-13.17, p<0.05) in an adjusted multivariate analysis by different postmenopausal symptoms and pro-oxidant factors; we did not see any association in premenopausal women. Conclusion Our findings suggest an association between HFs severity and OS in Mexican postmenopausal women.	[Sanchez-Rodriguez, Martha A.; Arronte-Rosales, Alicia; Manuel Mendoza-Nunez, Victor] Univ Nacl Autonoma Mexico, Unidad Invest Gerontol, Fac Estudios Super Zaragoza, Mexico City, DF, Mexico; [Zacarias-Flores, Mariano] Hosp Gustavo Baz Prada, Inst Salud Estado Mexico, Div Ginecol & Obstet, Nezahualcoyotl, Estado De Mexic, Mexico	Universidad Nacional Autonoma de Mexico	Sanchez-Rodriguez, MA (corresponding author), Univ Nacl Autonoma Mexico, Unidad Invest Gerontol, Fac Estudios Super Zaragoza, Mexico City, DF, Mexico.	masanrod@yahoo.com.mx	Mendoza-Núñez, Víctor Manuel/AFL-2465-2022	Mendoza-Núñez, Víctor Manuel/0000-0002-9137-3405	Secretaria de Educacion, Ciencia, Tecnologia e Innovacion de la Ciudad de Mexico [SECITI/042/2018]; Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico [DGAPA-PAPIIT IN306517]	Secretaria de Educacion, Ciencia, Tecnologia e Innovacion de la Ciudad de Mexico; Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico)	This project was supported by a grant from the Secretaria de Educacion, Ciencia, Tecnologia e Innovacion de la Ciudad de Mexico SECITI/042/2018, Red colaborativa de Investigacion Traslacional para el Envejecimiento Saludable de la Ciudad de Mexico (RECITES). The work was supported by Direccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico, grant number DGAPA-PAPIIT IN306517.	Aedo M Sócrates, 2006, Rev. chil. obstet. ginecol., V71, P402; Avis Nancy E, 2005, Am J Med, V118 Suppl 12B, P37, DOI 10.1016/j.amjmed.2005.09.057; Avis NE, 2009, MENOPAUSE, V16, P860, DOI 10.1097/gme.0b013e3181a3cdaf; Ayers B, 2013, CLIMACTERIC, V16, P235, DOI 10.3109/13697137.2012.688078; Biglia N, 2017, CLIMACTERIC, V20, P306, DOI 10.1080/13697137.2017.1315089; Birben E, 2012, WORLD ALLERGY ORGAN, V5, P9, DOI 10.1097/WOX.0b013e3182439613; Bonaccorsi G, 2015, TAIWAN J OBSTET GYNE, V54, P290, DOI 10.1016/j.tjog.2014.09.009; Bortolato M, 2008, ADV DRUG DELIVER REV, V60, P1527, DOI 10.1016/j.addr.2008.06.002; Broekmans FJ, 2009, ENDOCR REV, V30, P465, DOI 10.1210/er.2009-0006; Cagnacci A, 2015, CLIMACTERIC, V18, P631, DOI 10.3109/13697137.2014.999659; CARROLL BJ, 1973, ARCH GEN PSYCHIAT, V28, P361; Chedraui P, 2007, MATURITAS, V57, P271, DOI 10.1016/j.maturitas.2007.01.009; Chen AF, 2012, CLIN SCI, V123, P73, DOI 10.1042/CS20110562; de Campos HH, 2006, CLIMACTERIC, V9, P312, DOI 10.1080/13697130600871947; de Haan JB, 2003, REDOX REP, V8, P69, DOI 10.1179/135100003125001378; deHaan JB, 1996, HUM MOL GENET, V5, P283, DOI 10.1093/hmg/5.2.283; Doshi Sejal B, 2013, J Midlife Health, V4, P140, DOI 10.4103/0976-7800.118990; Freeman EW, 2014, MENOPAUSE, V21, P924, DOI [10.1097/GME.0000000000000196, 10.1097/gme.0000000000000196]; Grases G, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/430216; Halliwell B, 2007, BIOCHEM SOC T, V35, P1147, DOI 10.1042/BST0351147; Heinemann Lothar A J, 2003, Health Qual Life Outcomes, V1, P28, DOI 10.1186/1477-7525-1-28; Jentzsch AM, 1996, FREE RADICAL BIO MED, V20, P251, DOI 10.1016/0891-5849(95)02043-8; Kronenberg F, 2010, J NUTR, V140, p1380S, DOI 10.3945/jn.109.120840; Kumar S, 2010, BBA-GEN SUBJECTS, V1800, P1127, DOI 10.1016/j.bbagen.2010.04.011; Leal M, 2000, OBSTET GYNECOL, V95, P804, DOI 10.1016/S0029-7844(00)00822-X; Mendoza-Nunez VM, 2011, REJUV RES, V14, P25, DOI 10.1089/rej.2010.1054; Miller N J, 1998, Methods Mol Biol, V108, P285; Muka T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157417; Napolitano A, 2011, CURR MED CHEM, V18, P1832, DOI 10.2174/092986711795496863; Olatunji BO, 2006, J ANXIETY DISORD, V20, P543, DOI 10.1016/j.janxdis.2005.08.002; Ozkaya E, 2011, INT J GYNECOL OBSTET, V113, P235, DOI 10.1016/j.ijgo.2010.12.020; Pachman DR, 2010, INT J WOMENS HEALTH, V2, P123; PY W, 2017, BMC WOMENS HEALTH, V17, P1, DOI DOI 10.1186/S12905-016-0358-7; REMACLE J, 1992, BIOCHEM J, V286, P41, DOI 10.1042/bj2860041; Sanchez-Rodriguez MA, 1998, ACTA BIOQUIM CLIN L, V32, P812; Sanchez-Rodriguez MA, 2012, MENOPAUSE, V19, P361, DOI 10.1097/gme.0b013e318229977d; Sanchez-Rodriguez MA, 2010, ANN NUTR METAB, V56, P302, DOI 10.1159/000309601; Shanafelt TD, 2002, MAYO CLIN PROC, V77, P1207, DOI 10.4065/77.11.1207; Soldatos CR, 2000, J PSYCHOSOM RES, V48, P555, DOI 10.1016/S0022-3999(00)00095-7; Soldatos CR, 2003, J PSYCHOSOM RES, V55, P263, DOI 10.1016/S0022-3999(02)00604-9; Soules M R, 2001, Menopause, V8, P402, DOI 10.1097/00042192-200111000-00004; Strehlow K, 2003, CIRC RES, V93, P170, DOI 10.1161/01.RES.0000082334.17947.11; SUBBIAH MTR, 1993, J CLIN ENDOCR METAB, V77, P1095, DOI 10.1210/jc.77.4.1095; Sussman M, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0217-y; Terauchi M, 2012, MATURITAS, V72, P61, DOI 10.1016/j.maturitas.2012.01.014; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V13, P508, DOI 10.1001/archpsyc.1965.01730060026004	47	7	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0214264	10.1371/journal.pone.0214264	http://dx.doi.org/10.1371/journal.pone.0214264			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5RZ	31550247	Green Submitted, Green Published, gold			2022-12-26	WOS:000532307700001
J	Caarls, PJ; van Schijndel, MA; van den Berk, G; Boenink, AD; Boerman, D; Lijmer, JG; Honig, A; Terra, M; Thijs, A; Verwey, B; van Waarde, JA; van Wijngaarden, J; van Busschbach, JJ				Caarls, P. J.; van Schijndel, M. A.; van den Berk, G.; Boenink, A. D.; Boerman, D.; Lijmer, J. G.; Honig, A.; Terra, M.; Thijs, A.; Verwey, B.; van Waarde, J. A.; van Wijngaarden, J.; van Busschbach, J. J.		MPU Study Grp	Factors influencing the admission decision for Medical Psychiatry Units: A concept mapping approach	PLOS ONE			English	Article							MENTAL-HEALTH; CARE; EVOLUTION; QUALITY; MODELS	Objective Medical Psychiatry Units (MPUs), also known as Complexity Intervention Units (CIUs), provide care for complex patients suffering from both psychiatric and physical disorders. Because there is no consensus on the indications for admission to an MPU, daily practice and effectiveness research are hampered. This study therefore used a concept mapping approach to investigate which organizational and medical factors determine the decision to admit a patient to an MPU. Methods The first step of the concept mapping approach was to create a list of factors determining MPU admission from literature. Secondly, clinical experts sorted and ranked these factors. The sorted and ranked data were then analyzed, and a draft conceptual framework was created. A final conceptual MPU admission framework was then drawn during an expert consensus meeting and recommendations for implementation were suggested. Results Thirteen clinical experts defined 90 factors from literature, which were sorted and ranked by 40 experts from 21 Dutch hospitals. This concept mapping approach resulted in a five-cluster solution for an MPU admission framework based on: 1. Staff competencies and organizational pre-requisites; 2. Patient context; 3. Patient characteristics; 4. Medical needs and capabilities; and 5. Psychiatric symptoms and behavioral problems. Furthermore, three inclusion and two exclusion criteria were formulated to help the clinicians decide whether or not to admit patients to an MPU. These criteria can be implemented in daily practice. Conclusion Implementing the five criteria derived from this conceptual framework will help make the admission decision for complex patients with psychiatric and physical disorders to an MPU more correct, consistent, and transparent.	[Caarls, P. J.; van Schijndel, M. A.; van Busschbach, J. J.] Univ Med Ctr, Erasmus Med Ctr, Rotterdam, Netherlands; [van Schijndel, M. A.; Boerman, D.; Verwey, B.; van Waarde, J. A.] Rijnstate Hosp, Arnhem, Netherlands; [van den Berk, G.; Lijmer, J. G.; Honig, A.] Onze Lieve Vrouw Hosp, Amsterdam, Netherlands; [Boenink, A. D.; Honig, A.; Terra, M.; Thijs, A.] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [van Wijngaarden, J.] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Rijnstate Hospital; Onze Lieve Vrouwe Gasthuis Hospital; University of Amsterdam; Erasmus University Rotterdam	Caarls, PJ (corresponding author), Univ Med Ctr, Erasmus Med Ctr, Rotterdam, Netherlands.	p.caarls@erasmusmc.nl		Boenink, Annette/0000-0001-9791-8800				Alberque C, 2009, PSYCHOSOMATICS, V50, P354, DOI 10.1176/appi.psy.50.4.354; Beckers T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199668; BRUNS W, 1990, GEN HOSP PSYCHIAT, V12, P137, DOI 10.1016/0163-8343(90)90071-J; BUCKLEY P, 1994, PSYCHOSOMATICS, V35, P515, DOI 10.1016/S0033-3182(94)71719-9; Chiu A, 2009, ARCH GERONTOL GERIAT, V49, P233, DOI 10.1016/j.archger.2008.08.008; Eytan A, 2004, EUR PSYCHIAT, V19, P499, DOI 10.1016/j.eurpsy.2004.09.004; Faught DD, 2013, NURS EDUC, V38, P122, DOI 10.1097/NNE.0b013e31828dc27b; FAVA GA, 1985, PSYCHOTHER PSYCHOSOM, V43, P194, DOI 10.1159/000287879; GERTLER R, 1995, GEN HOSP PSYCHIAT, V17, P26, DOI 10.1016/0163-8343(94)00063-J; Guthrie E, 2016, BJPSYCH BULL, V40, P175, DOI 10.1192/pb.bp.115.051771; Johnsen JA, 2000, EVAL PROGRAM PLANN, V23, P67, DOI 10.1016/S0149-7189(99)00038-5; KATHOL RG, 1994, GEN HOSP PSYCHIAT, V16, P1, DOI 10.1016/0163-8343(94)90080-9; Kathol RG, 1999, INT CONGR SER, V1174, P13; KATHOL RG, 1992, PSYCHOSOMATICS, V33, P376, DOI 10.1016/S0033-3182(92)71942-2; Kathol RG, 2010, J PSYCHOSOM RES, V68, P293, DOI 10.1016/j.jpsychores.2009.06.012; Kathol RG, 2009, PSYCHOSOMATICS, V50, P93, DOI 10.1176/appi.psy.50.2.93; Kishi Y, 1999, PSYCHOSOMATICS, V40, P345, DOI 10.1016/S0033-3182(99)71230-2; Leue C, 2010, J PSYCHOSOM RES, V68, P295, DOI 10.1016/j.jpsychores.2009.04.010; Marra D, 2003, REV MED INTERNE, V24, P279, DOI 10.1016/S0248-8663(03)00051-1; Regan Judy, 2005, Tenn Med, V98, P448; STOUDEMIRE A, 1987, HOSP COMMUNITY PSYCH, V38, P815; TROCHIM WMK, 1989, EVAL PROGRAM PLANN, V12, P1, DOI 10.1016/0149-7189(89)90016-5; van Manen JG, 2012, J PERS DISORD, V26, P481, DOI 10.1521/pedi.2012.26.4.481; Van Schijndel M., 2018, P SOC COMPUTATION LI, P1, DOI [10.1159/000485001, DOI 10.1159/000485001]; van Schijndel MA, 2017, NED TIJDSCHR GENEES, V161; van Schijndel MA, 2019, PSYCHOTHER PSYCHOSOM, V88, P127, DOI 10.1159/000493689; van Schijndel MA, 2018, GEN HOSP PSYCHIAT, V55, P27, DOI 10.1016/j.genhosppsych.2018.09.009; van Waarde J A, 2004, Ned Tijdschr Geneeskd, V148, P209; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wulsin LR, 2006, MED CLIN N AM, V90, P647, DOI 10.1016/j.mcna.2006.05.005	30	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0221807	10.1371/journal.pone.0221807	http://dx.doi.org/10.1371/journal.pone.0221807			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4PG	31527872	Green Submitted, gold, Green Published			2022-12-26	WOS:000532231400007
J	Di Pane, J; Joly, L; Koubbi, P; Giraldo, C; Monchy, S; Tavernier, E; Marchal, P; Loots, C				Di Pane, Julien; Joly, Lea; Koubbi, Philippe; Giraldo, Carolina; Monchy, Sebastien; Tavernier, Eric; Marchal, Paul; Loots, Christophe			Ontogenetic shift in the energy allocation strategy and physiological condition of larval plaice (Pleuronectes platessa)	PLOS ONE			English	Article							RNA-DNA RATIOS; NUTRITIONAL CONDITION; RNA/DNA RATIOS; DEPENDENT MORTALITY; NORTHERN ANCHOVY; HABITAT QUALITY; CLUPEA-HARENGUS; CLASS STRENGTH; GROWTH-RATE; FISH	Condition indices aim to evaluate the physiological status of fish larvae by estimating both the level of starvation and potential of survival. Histological indices reveal direct effects of starvation whereas biochemical indices such as lipid classes or RNA:DNA ratios are used as proxies of condition, giving information on the amount of energy reserves and growth rate, respectively. We combined these three indices to evaluate ontogenetic variations of growth performance, lipid dynamics and nutritional condition of plaice larvae caught in the field during winter 2017 in the eastern English Channel and the Southern Bight of the North Sea. RNA:DNA ratios showed that larvae at the beginning of metamorphosis (stage 4) had a lower growth rate than younger individuals (stages 2 and 3). A significant increase in the proportion of triglycerides also occurred at stage 4, indicating energy storage. Histological indices indicated that most of the larvae were in good condition, even younger ones with low lipid reserves. There was, however, an increase in the proportion of healthy individuals over ontogeny, especially with respect to liver vacuoles which were larger and more numerous for stage 4 larvae. Combined together, these condition indices revealed the ontogenetic shift in the energy allocation strategy of plaice larvae. Young larvae (stages 2 and 3) primarily allocate energy towards somatic growth. The decrease in growth performance for stage 4 was not related to poor condition, but linked to a higher proportion of energy stored as lipids. Since the quantity of lipid reserves is particularly important for plaice larvae to withstand starvation during metamorphosis, this could be considered as a second critical period after the one of exogenous feeding for larval survival and recruitment success.	[Di Pane, Julien; Joly, Lea; Giraldo, Carolina; Marchal, Paul; Loots, Christophe] IFREMER, Channel & North Sea Fisheries Res Unit, Boulogne Sur Mer, France; [Koubbi, Philippe] Sorbonne Univ, UFR Terre Environm Biodiversie 918, Paris, France; [Monchy, Sebastien; Tavernier, Eric] LOG Lab Oceanol & Geosci, Wimereux, France	Ifremer; UDICE-French Research Universities; Sorbonne Universite	Loots, C (corresponding author), IFREMER, Channel & North Sea Fisheries Res Unit, Boulogne Sur Mer, France.	Christophe.Loots@ifremer.fr	Di Pane, Julien/AAT-1291-2020; Di Pane, Julien/GWV-1895-2022	Di Pane, Julien/0000-0003-0973-2702; Marchal, Paul/0000-0003-2047-4599; Giraldo, Carolina/0000-0003-0278-522X; Joly, Lea/0000-0002-7484-4340; MONCHY, Sebastien/0000-0001-5808-4700	IFREMER; Pole Metropolitain de la Cote d'Opale; Recherche marine et littorale en Cote dOpale, des milieux aux ressources, aux usages et a la qualite des produits de la mer; SFR Campus de la mer (grant 2019 ULCO)	IFREMER; Pole Metropolitain de la Cote d'Opale; Recherche marine et littorale en Cote dOpale, des milieux aux ressources, aux usages et a la qualite des produits de la mer; SFR Campus de la mer (grant 2019 ULCO)	This work was supported by IFREMER and the Pole Metropolitain de la Cote d'Opale through the PhD of Julien Di Pane. This work was also supported by Recherche marine et littorale en Cote dOpale, des milieux aux ressources, aux usages et a la qualite des produits de la merhttps://marco.univ-littoral.fr/.This study was partly funded by the SFR Campus de la mer (grant 2019 ULCO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackman RG, 1989, MARINE BIOGENIC LIPI, DOI [10.1016/j.plefa.2016.02.004, DOI 10.1016/J.PLEFA.2016.02.004]; Ahlstrom EH, 1984, ONTOGENY SYSTEMATICS; Amara R, 2003, ESTUAR COAST SHELF S, V56, P807, DOI 10.1016/S0272-7714(02)00315-3; ANDERSON J T, 1988, Journal of Northwest Atlantic Fishery Science, V8, P55; BAILEY KM, 1989, ADV MAR BIOL, V25, P1; Bakun A., 1998, REINVENTING FISHERIE, DOI [10.1007/978-94-011-4433-9_25, DOI 10.1007/978-94-011-4433-9_25]; Barbut L, 2019, LIMNOL OCEANOGR, V64, P1150, DOI 10.1002/lno.11104; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Benoit HP, 1999, MAR ECOL PROG SER, V184, P231, DOI 10.3354/meps184231; Benoit HP, 2000, CAN J FISH AQUAT SCI, V57, P856, DOI 10.1139/cjfas-57-4-856; Beverton RJH, 1995, NETH J SEA RES, V34, P1, DOI 10.1016/0077-7579(95)90010-1; BREWSTER B, 1987, J FISH BIOL, V31, P805, DOI 10.1111/j.1095-8649.1987.tb05281.x; Buckley L, 1999, HYDROBIOLOGIA, V401, P265, DOI 10.1023/A:1003798613241; Buckley LJ, 2008, MAR ECOL PROG SER, V371, P221, DOI 10.3354/meps07648; BUCKLEY LJ, 1979, J FISH RES BOARD CAN, V36, P1497, DOI 10.1139/f79-217; Caldarone EM, 2005, MAR ECOL PROG SER, V293, P241, DOI 10.3354/meps293241; Catalan IA, 2006, MAR ECOL PROG SER, V307, P219, DOI 10.3354/meps307219; CHAMBERS RC, 1989, CAN J FISH AQUAT SCI, V46, P1633, DOI 10.1139/f89-208; Christensen MN, 1999, J EXP MAR BIOL ECOL, V237, P225, DOI 10.1016/S0022-0981(98)00215-9; Ciotti BJ, 2010, J FISH BIOL, V77, P2181, DOI 10.1111/j.1095-8649.2010.02786.x; CLEMMESEN C, 1994, MAR BIOL, V118, P377, DOI 10.1007/BF00350294; CLEMMESEN CM, 1987, J CONSEIL, V43, P122; Comerford S, 2013, MAR ECOL PROG SER, V476, P215, DOI 10.3354/meps10118; Costalago D, 2011, ESTUAR COAST SHELF S, V93, P350, DOI 10.1016/j.ecss.2011.05.005; Craig JK, 2007, MAR ECOL PROG SER, V343, P251, DOI 10.3354/meps06864; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Denis J, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3180-3; DEPLANO M, 1991, MAR BIOL, V108, P361, DOI 10.1007/BF01313645; Diaz MV, 2018, MAR FRESHWATER RES, V69, P455, DOI 10.1071/MF17178; Diaz MV, 2014, FISH RES, V160, P60, DOI 10.1016/j.fishres.2013.11.009; EHRLICH KF, 1974, MAR BIOL, V24, P39, DOI 10.1007/BF00402845; Ehrlich KF., 1974, EARLY LIFE HIST FISH, P301, DOI 10.1007/978-3-642-65852-5_26; Enes P, 2009, FISH PHYSIOL BIOCHEM, V35, P519, DOI 10.1007/s10695-008-9259-5; Fernandez-Diaz C, 2001, J FISH BIOL, V58, P1086, DOI [10.1006/jfbi.2000.1514, 10.1111/j.1095-8649.2001.tb00557.x]; FERRON A, 1994, ADV MAR BIOL, V30, P217, DOI 10.1016/S0065-2881(08)60064-4; FOLCH J, 1957, J BIOL CHEM, V226, P497; Foley CJ, 2016, ECOL INDIC, V60, P346, DOI 10.1016/j.ecolind.2015.07.005; FONDS M, 1992, NETH J SEA RES, V29, P127, DOI 10.1016/0077-7579(92)90014-6; FRASER AJ, 1988, MAR BIOL, V99, P307, DOI 10.1007/BF02112122; Geffen AJ, 2007, J SEA RES, V58, P35, DOI 10.1016/j.seares.2007.02.004; GIBSON RN, 1994, NETH J SEA RES, V32, P191, DOI 10.1016/0077-7579(94)90040-X; Giraldo C., 2012, ECOLOGIE TROPHIQUE P; Giraldo C, 2017, POLAR BIOL, V40, P313, DOI 10.1007/s00300-016-1956-4; Giraldo C, 2011, POLAR SCI, V5, P252, DOI 10.1016/j.polar.2011.04.004; Gisbert E, 2008, HISTOL HISTOPATHOL; HAKANSON JL, 1989, MAR BIOL, V102, P143, DOI 10.1007/BF00428274; Hjort J., 1914, P RAPPORTS PROCRS VE; Houde ED, 1997, J FISH BIOL, V51, P52, DOI 10.1111/j.1095-8649.1997.tb06093.x; Houde Edward D., 2009, Journal of Northwest Atlantic Fishery Science, V41, P53; HOVENKAMP F, 1992, MAR ECOL PROG SER, V82, P95, DOI 10.3354/meps082095; Hufnagl M, 2013, J SEA RES, V84, P26, DOI 10.1016/j.seares.2012.10.007; ILES TD, 1982, SCIENCE, V215, P627, DOI 10.1126/science.215.4533.627; Infante MFLJLZ, 2008, FEED DIG FUNCT FISHE, DOI [10.1201/b10749-8, DOI 10.1201/B10749-8]; Koubbi P, 2007, CYBIUM, V31, P67; Lazo J.P., 2011, LARVAL FISH NUTR, P3, DOI 10.1002/9780470959862.ch1; Le Pape O, 2015, FISH FISH, V16, P373, DOI 10.1111/faf.12063; Levin PS, 2005, ESTUAR COAST SHELF S, V64, P70, DOI 10.1016/j.ecss.2005.02.007; MARGULIES D, 1993, MAR BIOL, V115, P317, DOI 10.1007/BF00346350; Martoja R, 1967, INITIATION TECHNIQUE; McFadzen IRB, 1997, J EXP MAR BIOL ECOL, V212, P239, DOI 10.1016/S0022-0981(96)02755-4; Meyer S, 2012, J MARINE SYST, V93, P11, DOI 10.1016/j.jmarsys.2011.09.010; Nagelkerken I, 2015, FISH FISH, V16, P362, DOI 10.1111/faf.12057; Nash RDM, 2007, MAR ECOL PROG SER, V344, P231, DOI 10.3354/meps06933; Nash RDM, 2000, J SEA RES, V44, P101, DOI 10.1016/S1385-1101(00)00044-7; OCONNELL CP, 1976, J EXP MAR BIOL ECOL, V25, P285, DOI 10.1016/0022-0981(76)90130-1; PEPIN P, 1991, CAN J FISH AQUAT SCI, V48, P503, DOI 10.1139/f91-065; Pepin P, 2016, ICES J MAR SCI, V73, P196, DOI 10.1093/icesjms/fsv160; Peters J, 2015, MAR ECOL PROG SER, V531, P277, DOI 10.3354/meps11292; Petitgas P, 2013, FISH OCEANOGR, V22, P121, DOI 10.1111/fog.12010; Planes S, 2004, MOL ECOL, V13, P2049, DOI 10.1111/j.1365-294X.2004.02202.x; RILEY JOHN D., 1966, J CONS CONS PERMA INT EXPLOR MER, V30, P204; ROBINSON SMC, 1988, CAN J FISH AQUAT SCI, V45, P1422, DOI 10.1139/f88-166; Ronnestad I, 2013, REV AQUACULT, V5, pS59, DOI 10.1111/raq.12010; RYLAND J. S., 1966, J CONS CONS PERMA INT EXPLOR MER, V30, P177; Sargent JR, LIPIDS HYDROCARBONS; SEGNER H, 1994, MAR BIOL, V119, P471, DOI 10.1007/BF00347544; Selleslagh J, 2013, J MAR BIOL ASSOC UK, V93, P479, DOI 10.1017/S0025315412000483; SHELBOURNE JE, 1957, J MAR BIOL ASSOC UK, V36, P539, DOI 10.1017/S0025315400025832; Sieg A., 1998, OCEANOGR LIT REV, V9, P1693; Silva L, 2015, MAR BIOL, V162, P753, DOI 10.1007/s00227-015-2621-0; Sogard SM, 1997, SIZE SELECTIVE MORTA; Somarakis S, 2017, MAR ECOL PROG SER, DOI [10.3354/meps12328, DOI 10.3354/MEPS12328]; THEILACKER GH, 1989, FISH B-NOAA, V87, P457; THEILACKER GH, 1986, FISH B-NOAA, V84, P1; van der Veer HW, 2010, MAR ECOL PROG SER, V416, P215, DOI 10.3354/meps08786; van der Veer HW, 2000, ICES J MAR SCI, V57, P202, DOI 10.1006/jmsc.1999.0523; VANBEEK FA, 1989, HELGOLANDER MEERESUN, V43, P461; VANDERVEER HW, 1993, MAR ECOL PROG SER, V101, P81, DOI 10.3354/meps101081; Diaz MV, 2013, NEOTROP ICHTHYOL, V11, P649, DOI 10.1590/S1679-62252013000300018; Vigliola L, 1998, MAR ECOL PROG SER, V168, P45, DOI 10.3354/meps168045; Wennhage H, 1998, J SEA RES, V39, P103, DOI 10.1016/S1385-1101(97)00011-7; Yandi I, 2015, HELGOLAND MAR RES, V69, P25, DOI 10.1007/s10152-014-0414-3; YUFERA M, 1993, J EXP MAR BIOL ECOL, V169, P259, DOI 10.1016/0022-0981(93)90196-U	93	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222261	10.1371/journal.pone.0222261	http://dx.doi.org/10.1371/journal.pone.0222261			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525738	gold, Green Submitted, Green Published			2022-12-26	WOS:000532225700024
J	Singh, DR; Harvey, CM; Bohara, P; Nath, D; Singh, S; Szabo, S; Karki, K				Singh, Devendra Raj; Harvey, Chloe M.; Bohara, Pushpalata; Nath, Dhirendra; Singh, Sunita; Szabo, Sylvia; Karki, Kshitij			Factors associated with newborn care knowledge and practices in the upper Himalayas	PLOS ONE			English	Article							NEONATAL-MORTALITY; NEPAL; MOTHERS; PERCEPTIONS; SURVIVAL; DISTRICT; SAFETY; HOME	Background Globally, neonatal deaths remain a major public health challenge and account for the majority of deaths occurring among children under five years of age. Despite Nepal's significant achievements in meeting the maternal and child health targets of the Millennium Development Goals, an estimated 23,000 Nepalese children under five years die every year, with three out of five babies dying within the first 28 days of life. This study therefore aimed to examine the level of knowledge and practices of newborn care among Nepalese mothers in the upper Himalayas and the factors associated with these. Materials and methods A community based cross-sectional study was conducted among 302 randomly selected mothers with children under two years of age in Tripurasundari Municipality of Dolpa district, an upper Himalayan region of Nepal. Mothers were interviewed using semi-structured questionnaires. Mean score for knowledge and Bloom's criteria for practice were considered to categorize newborn care knowledge and practices. Multivariate logistic regression was used to identify factors associated with the newborn care knowledge and practices. Results In this study, 147 (48.7%) of the mothers were found to have inadequate knowledge of newborn care, while 102 (33.8%) mothers had reported unsatisfactory newborn care practices. Mothers with at least secondary level of formal education were more likely to possess adequate newborn care knowledge compared to mothers who never attended school (AOR 4.93 at 95% CI 1.82-13.33). Mothers whose first pregnancy occurred between the ages of 20-24 years (AOR 3.89 at 95% CI 1.81-8.37) were also more likely to possess adequate newborn care knowledge, compared to mothers with a younger age at first pregnancy. Furthermore, mothers who had completed at least four ANC visits (AOR 2.89 at 95% CI 1.04-7.96), mothers who had completed three PNC visits (AOR 2.79 at 95% CI 1.16-6.72) and mothers who reported that their nearest health facility was less than one hour (30-59 minutes) walking distance (AOR 3.66 at 95% CI 1.43-9.33) had higher odds of having adequate newborn care knowledge. Similarly, mothers whose household monthly income was more than $100 (AOR 4.17 at 95% CI 1.75-9.69), mothers who had completed three PNC visits (AOR 3.27 at 95% CI 1.16-9.20) and mothers with adequate newborn care knowledge (AOR 15.35 at 95% CI 5.82-40.47) were found to be more likely to practice a satisfactory level of newborn care practices in adjusted analysis. Conclusion The study revealed high prevalence of inadequate newborn care and knowledge amongst mothers in upper Himalayan dwellings. Approximately one third of all interviewed mothers practiced suboptimal newborn care. The results indicate an urgent need to increase awareness of neonatal services available to mothers and to prioritize investments by local governments in neonatal health services, in order to improve accessibility and quality of care for mothers and newborns.	[Singh, Devendra Raj; Bohara, Pushpalata; Karki, Kshitij] Purbanchal Univ, Asian Coll Adv Studies, Dept Publ Hlth, Lalitpur, Nepal; [Singh, Devendra Raj; Nath, Dhirendra] Southeast Asia Dev Act Network SADAN, Res & Innovat Sect, Lalitpur, Nepal; [Harvey, Chloe M.; Szabo, Sylvia] Univ Southampton, Dept Social Stat & Demog, Southampton, Hants, England; [Singh, Sunita] Minist Hlth & Populat, Sukraraj Trop & Infect Dis Hosp, Kathmandu, Nepal; [Szabo, Sylvia] Asian Inst Technol, Dept Dev & Sustainabil, Pathum Thani, Thailand; [Karki, Kshitij] Grp Tech Assistance, Program & Res Dept, Lalitpur, Nepal	University of Southampton; Asian Institute of Technology	Singh, DR (corresponding author), Purbanchal Univ, Asian Coll Adv Studies, Dept Publ Hlth, Lalitpur, Nepal.; Singh, DR (corresponding author), Southeast Asia Dev Act Network SADAN, Res & Innovat Sect, Lalitpur, Nepal.	dsingh3797@gmail.com	Nath, Dhirendra/X-7398-2018; Singh, Devendra Raj/R-2197-2019; Karki, Kshitij/ABE-7737-2020	Nath, Dhirendra/0000-0001-5481-4550; Singh, Devendra Raj/0000-0003-1450-9476; Harvey, Chloe Mercedes/0000-0002-3732-2973; Karki, Kshitij/0000-0002-6039-8909				Abdullahi A, 2016, INT J GEN MED, V9, P79, DOI 10.2147/IJGM.S98436; Acharya LB, 2000, HEALTH POLICY PLANN, V15, P223, DOI 10.1093/heapol/15.2.223; Al-Ayed IH, 2010, J FAM COMMUNITY MED, V17, P22, DOI 10.4103/1319-1683.68785; Bennett J, 1999, INT J EPIDEMIOL, V28, P1172, DOI 10.1093/ije/28.6.1172; Berhe M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175902; Berhea TA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202542; Beun MH, 2003, J HEALTH POPUL NUTR, V21, P367; Bhattarai B, 2008, MARRIAGE FAM REV, V44, P318, DOI 10.1080/01494920802255943; Bloom B.S., 1956, TAXONOMY ED OBJECTIV; Central Bureau of Statistics, 2014, NAT POP HOUS CENS 20; Dhakal Sulochana, 2007, BMC Pregnancy Childbirth, V7, P19, DOI 10.1186/1471-2393-7-19; Family Health Division, 2009, AAM SUR PROGR POL GU; Glenton C, 2010, SOC SCI MED, V70, P1920, DOI 10.1016/j.socscimed.2010.02.034; Gul S, 2014, INT J HEALTH SCI-IJH, V8, P167, DOI 10.12816/0006083; Kaphle S, 2013, MIDWIFERY, V29, P1173, DOI 10.1016/j.midw.2013.06.002; Kibaru Elizabeth Gathoni, 2016, BMC Res Notes, V9, P481; Lamichhane R, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3922-z; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Mehata S, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1532-0; Ministry of Health and Population; New ERA; and ICF, 2011, NEP DEM HLTH SURV 20, DOI [10.1007/978-94-6091-391-4_15, DOI 10.1007/978-94-6091-391-4_15]; Ministry of Health-MOH/Nepal New ERA/Nepal ICF., 2017, NEP DEM HLTH SURV 20; Misgna HG, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0931-y; MoHP[Nepal], 2016, NEP EV NEWB ACT PLAN; Mullany LC, 2005, J TROP PEDIATRICS, V51, P82, DOI 10.1093/tropej/fmh083; Mullany LC, 2006, LANCET, V367, P910, DOI 10.1016/S0140-6736(06)68381-5; National Planning Commission, 2016, NEP MILL DEV GOALS F; Neupane S, 2014, J EPIDEMIOL GLOB HEA, V4, P213, DOI 10.1016/j.jegh.2014.02.001; Paudel D, 2011, TRENDS DETERMINANTS; Shah R, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0454-y; Sharma SR, 2014, BMC PUBLIC HEALTH, V14, P1, DOI [10.1186/1471-2458-14-1, DOI 10.1186/1471-2458-14-1]; Sreeramareddy Chandrashekhar T, 2006, BMC Pregnancy Childbirth, V6, P27, DOI 10.1186/1471-2393-6-27; UNICEF, 2016, STATE WORLDS CHILDRE; United Nations, 2016, SUST DEV GOALS REP; United Nations Children's Fund; National Planning Commission, 2015, MON SIT CHILDR WOM N; V. D. of Health, 2017, ANN SCH SELF REP IMM; WHO, 2017, WHO REC NEWB HLTH; World Health Organization, 2006, NEON PER MORT COUNTR; World Health Organization, 2019, WORLD HLTH STAT MON	39	7	7	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222582	10.1371/journal.pone.0222582	http://dx.doi.org/10.1371/journal.pone.0222582			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4NC	31525242	gold, Green Published, Green Submitted			2022-12-26	WOS:000532225700039
J	Dias, MM; Adamoski, D; dos Reis, LM; Ascencao, CFR; de Oliveira, KRS; Mafra, ACP; Bastos, ACD; Quintero, M; Cassago, CD; Ferreira, IM; Fidelis, CHV; Rocco, SA; Bajgelman, MC; Stine, Z; Berindan-Neagoe, I; Calin, GA; Ambrosio, ALB; Dias, SMG				Dias, Marilia M.; Adamoski, Douglas; dos Reis, Larissa M.; Ascencao, Carolline F. R.; de Oliveira, Krishina R. S.; Paschoalini Mafra, Ana Carolina; da Silva Bastos, Alliny Cristiny; Quintero, Melissa; Cassago, Carolina de G.; Ferreira, Igor M.; Fidelis, Carlos H., V; Rocco, Silvana A.; Bajgelman, Marcio Chaim; Stine, Zachary; Berindan-Neagoe, Ioana; Calin, George A.; Berteli Ambrosio, Andre Luis; Gomes Dias, Sandra Martha			GLS2 is protumorigenic in breast cancers	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ASPARAGINE SYNTHETASE; GLUTAMINE-METABOLISM; GROWTH; ROLES; ACTIVATION; PATHWAY; CELLS; TRANSFORMATION; CONTRIBUTES	Many types of cancers have a well-established dependence on glutamine metabolism to support survival and growth, a process linked to glutaminase 1 (GLS) isoforms. Conversely, GLS2 variants often have tumor-suppressing activity. Triple-negative (TN) breast cancer (testing negative for estrogen, progesterone, and Her2 receptors) has elevated GLS protein levels and reportedly depends on exogenous glutamine and GLS activity for survival. Despite having high GLS levels, we verified that several breast cancer cells (including TN cells) express endogenous GLS2, defying its role as a bona fide tumor suppressor. Moreover, ectopic GLS2 expression rescued cell proliferation, TCA anaplerosis, redox balance, and mitochondrial function after GLS inhibition by the small molecule currently in clinical trials CB-839 or GLS knockdown of GLS-dependent cell lines. In several cell lines, GLS2 knockdown decreased cell proliferation and glutamine-linked metabolic phenotypes. Strikingly, long-term treatment of TN cells with another GLS-exclusive inhibitor bis-2 '-(5-phenylacetamide-1,3,4-thiadiazol-2-yl)ethyl sulfide (BPTES) selected for a drug-resistant population with increased endogenous GLS2 and restored proliferative capacity. GLS2 was linked to enhanced in vitro cell migration and invasion, mesenchymal markers (through the ERK-ZEB1-vimentin axis under certain conditions) and in vivo lung metastasis. Of concern, GLS2 amplification or overexpression is linked to an overall, disease-free and distant metastasis-free worse survival prognosis in breast cancer. Altogether, these data establish an unforeseen role of GLS2 in sustaining tumor proliferation and underlying metastasis in breast cancer and provide an initial framework for exploring GLS2 as a novel therapeutic target.	[Dias, Marilia M.; Adamoski, Douglas; dos Reis, Larissa M.; Ascencao, Carolline F. R.; de Oliveira, Krishina R. S.; Paschoalini Mafra, Ana Carolina; da Silva Bastos, Alliny Cristiny; Quintero, Melissa; Cassago, Carolina de G.; Ferreira, Igor M.; Rocco, Silvana A.; Bajgelman, Marcio Chaim; Berteli Ambrosio, Andre Luis; Gomes Dias, Sandra Martha] Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Biosci Natl Lab LNBio, BR-13083970 Campinas, SP, Brazil; [Dias, Marilia M.; Adamoski, Douglas; dos Reis, Larissa M.; Ascencao, Carolline F. R.; de Oliveira, Krishina R. S.; Paschoalini Mafra, Ana Carolina; da Silva Bastos, Alliny Cristiny] Univ Estadual Campinas, Grad Program Genet & Mol Biol, Inst Biol, UNICAMP, Campinas, SP, Brazil; [Fidelis, Carlos H., V] Univ Estadual Campinas, Inst Chem, ThoMSon Mass Spectrometry Lab, BR-13083970 Campinas, SP, Brazil; [Stine, Zachary] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Berindan-Neagoe, Ioana] Univ Med & Pharm Iuliu Hatieganu, Res Ctr Funct Genom Biomed & Translat Med, Cluj Napoca 400337, Romania; [Berindan-Neagoe, Ioana] Univ Med & Pharm Iuliu Hatieganu, MedFuture Res Ctr Adv Med, Cluj Napoca 400349, Romania; [Berindan-Neagoe, Ioana] Oncol Inst Prof Dr Ion Chiricuta, Dept Funct Genom & Expt Pathol, Cluj Napoca 400015, Romania; [Calin, George A.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, 1515 Holcombe Blvd,Unit 1950, Houston, TX 77030 USA; [Calin, George A.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Inference & Noncoding RNAs, 1515 Holcombe Blvd,Unit 1950, Houston, TX 77030 USA; [Berteli Ambrosio, Andre Luis] Univ Sao Paulo, Sao Carlos Inst Phys IFSC, BR-13563120 Sao Carlos, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Estadual de Campinas; The Wistar Institute; Iuliu Hatieganu University of Medicine & Pharmacy; Iuliu Hatieganu University of Medicine & Pharmacy; Oncology Institute Prof. Dr. Ion Chiricuta; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Universidade de Sao Paulo	Ambrosio, ALB; Dias, SMG (corresponding author), Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Biosci Natl Lab LNBio, BR-13083970 Campinas, SP, Brazil.; Ambrosio, ALB (corresponding author), Univ Sao Paulo, Sao Carlos Inst Phys IFSC, BR-13563120 Sao Carlos, SP, Brazil.	andre@ifsc.usp.br; sandra.dias@lnbio.cnpem.br	Dias, Marília M/C-3014-2012; Bajgelman, Marcio Chaim/A-8146-2019; Rocco, Silvana Aparecida/Q-3828-2019; Reis, Larissa Menezes dos/T-9867-2019; Ambrosio, Andre/AAB-1178-2020; Escobar, Melissa Quintero/AAN-8999-2021; Rocco, Silvana Aparecida/H-6300-2014; Fidelis, Carlos HV/B-9696-2012; Adamoski, Douglas/J-8570-2014	Bajgelman, Marcio Chaim/0000-0003-3371-1143; Rocco, Silvana Aparecida/0000-0003-4551-3443; Escobar, Melissa Quintero/0000-0002-2645-7418; Rocco, Silvana Aparecida/0000-0003-4551-3443; Adamoski, Douglas/0000-0001-5062-2586; Mafra, Ana Carolina/0000-0002-2547-9033; Menezes dos Reis, Larissa/0000-0003-1597-0176; Dias, Marilia/0000-0003-1415-9023; Calin, George/0000-0001-6704-5615	Sao Paulo State Research Foundation, FAPESP [2012/14298-9, 2014/20673-2, 2014/15968-3, 2015/25832-4, 2013/05668-0, 2013/23510-4, 2012/11577-4, 2014/18061-9, 2014/17820-3, 2016/06625-0, 2014/06512-6, 2011/10127-2, 2012/09452-9]; LNBio; National Institutes of Health (NIH/NCATS) grant through the NIH Common Fund, Office of Strategic Coordination (OSC) [UH3TR00943-01]; NCI [1R01 CA182905-01, 1R01CA222007-01A1]; NIGMS [1R01GM122775-01]; U54 grant UPR/MDACC Partnership for Excellence in Cancer Research 2016 Pilot Project [CA096297/CA096300]; DOD [CA160445P1]; Chronic Lymphocytic Leukemia Moonshot Flagship project; Sister Institution Network Fund (SINF) 2017 grant; Estate of C. G. Johnson, Jr	Sao Paulo State Research Foundation, FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); LNBio; National Institutes of Health (NIH/NCATS) grant through the NIH Common Fund, Office of Strategic Coordination (OSC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U54 grant UPR/MDACC Partnership for Excellence in Cancer Research 2016 Pilot Project; DOD(United States Department of Defense); Chronic Lymphocytic Leukemia Moonshot Flagship project; Sister Institution Network Fund (SINF) 2017 grant; Estate of C. G. Johnson, Jr	This work was supported by the Sao Paulo State Research Foundation, FAPESP, under grants 2012/14298-9 (ALBA) and 2014/20673-2 (ALBA), 2014/15968-3 (SMGD), 2015/25832-4 (SMGD) and fellowships 2013/05668-0 (IMF) 2013/23510-4 (CFRA), 2012/11577-4 (MMD), 2014/18061-9 (LMR), 2014/17820-3 (DAM), 2016/06625-0 (ACPM), 2014/06512-6 (KRSO), 2011/10127-2 (CAGC), and 2012/09452-9 (MQE). We thank LNBio for financial support and access to all facilities (PBQT, LCCMI, LPP, LEC, LVV, and LIB). Data used in this publication were generated by the National Cancer Institute Clinical Proteomic Tumor Analysis Consortium (CPTAC). The results published here are in whole or part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/. We thank Dr Alessandra Girasole for expert technical support. GAC is the Felix L. Haas Endowed Professor in Basic Science. Work in GAC's laboratory is supported by National Institutes of Health (NIH/NCATS) grant UH3TR00943-01 through the NIH Common Fund, Office of Strategic Coordination (OSC), the NCI grants 1R01 CA182905-01 and 1R01CA222007-01A1, an NIGMS 1R01GM122775-01 grant, a U54 grant #CA096297/CA096300 UPR/MDACC Partnership for Excellence in Cancer Research 2016 Pilot Project, a Team DOD (CA160445P1) grant, a Chronic Lymphocytic Leukemia Moonshot Flagship project, a Sister Institution Network Fund (SINF) 2017 grant, and the Estate of C. G. Johnson, Jr.	Bastide C, 2002, PROSTATE CANCER P D, V5, P311, DOI 10.1038/sj.pcan.4500606; Billin AN, 2000, MOL CELL BIOL, V20, P8845, DOI 10.1128/MCB.20.23.8845-8854.2000; Cassago A, 2012, P NATL ACAD SCI USA, V109, P1092, DOI 10.1073/pnas.1112495109; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Davis FM, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-76; de Guzzi Cassago CA, 2018, BIOCHEMISTRY-US; Elgadi KM, 1999, PHYSIOL GENOMICS, V1, P51, DOI 10.1152/physiolgenomics.1999.1.2.51; Gameiro PA, 2013, CELL METAB, V17, P372, DOI 10.1016/j.cmet.2013.02.002; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Gross MI, 2014, MOL CANCER THER, V13, P890, DOI 10.1158/1535-7163.MCT-13-0870; Hollestelle A, 2007, MOL CANCER RES, V5, P195, DOI 10.1158/1541-7786.MCR-06-0263; Hu WW, 2010, P NATL ACAD SCI USA, V107, P7455, DOI 10.1073/pnas.1001006107; Jang MH, 2015, HUM PATHOL, V46, P1267, DOI 10.1016/j.humpath.2015.05.010; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Katt WP, 2017, FUTURE MED CHEM, V9, P223, DOI 10.4155/fmc-2016-0190; Kim J, 2016, ONCOTARGET, V7, P85021, DOI 10.18632/oncotarget.13116; Kim RK, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2014.99; Koh LWH, 2013, ANTIOXID REDOX SIGN, V19, P2261, DOI 10.1089/ars.2012.4999; Kung HN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002229; Kuo T, 2016, CANC LETT, V383, P1; Lampa M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185092; Lee SY, 2016, ONCOTARGET, V7, P7925, DOI 10.18632/oncotarget.6879; Lee YZ, 2014, ONCOTARGET, V5, P6087, DOI 10.18632/oncotarget.2173; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liu CY, 2015, ONCOTARGET, V6, P15966, DOI 10.18632/oncotarget.3862; Liu J, 2014, ONCOTARGET, V5, P2635, DOI 10.18632/oncotarget.1862; Liu W, 2012, P NATL ACAD SCI USA, V109, P8983, DOI 10.1073/pnas.1203244109; Lorenzi PL, 2008, MOL CANCER THER, V7, P3123, DOI 10.1158/1535-7163.MCT-08-0589; Martin-Rufian M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038380; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Nitta M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010767; Panosyan EH, 2014, MOL CANCER RES, V12, P694, DOI 10.1158/1541-7786.MCR-13-0576; Pavlova NN, 2018, CELL METAB, V27, P428, DOI 10.1016/j.cmet.2017.12.006; Pieter A, 2012, CANCER BIOL THER, V13, P1185, DOI 10.4161/cbt.21348; Sanchez-Tillo E, 2011, AM J CANCER RES, V1, P897; Seltzer MJ, 2010, CANCER RES, V70, P8981, DOI 10.1158/0008-5472.CAN-10-1666; Shin S, 2010, MOL CELL, V38, P114, DOI 10.1016/j.molcel.2010.02.020; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Sircar K, 2012, AM J PATHOL, V180, P895, DOI 10.1016/j.ajpath.2011.11.030; SOMMERS CL, 1994, BREAST CANCER RES TR, V31, P325, DOI 10.1007/BF00666165; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Suzuki S, 2010, P NATL ACAD SCI USA, V107, P7461, DOI 10.1073/pnas.1002459107; Szeliga M, 2015, NEUROCHEM INT, V88, P6, DOI 10.1016/j.neuint.2014.11.004; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; UBUKA T, 1971, J NATL CANCER I, V46, P291; Wang BG, 2016, ONCOTARGET, V7, P20357, DOI 10.18632/oncotarget.7952; Wang JB, 2010, CANCER CELL, V18, P207, DOI 10.1016/j.ccr.2010.08.009; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; Xiao DB, 2015, ONCOTARGET, V6, P40655, DOI 10.18632/oncotarget.5821; Xu D, 2011, J CELL BIOL, V193, P409, DOI 10.1083/jcb.201010100; Yuneva MO, 2012, CELL METAB, V15, P157, DOI 10.1016/j.cmet.2011.12.015; Zacharias NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16327-z; Zhang C.J., 2016, BIOENERG OPEN ACCESS, V5, P1	53	15	17	0	17	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	3					690	702		10.1038/s41388-019-1007-z	http://dx.doi.org/10.1038/s41388-019-1007-z			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KG1RJ	31541193				2022-12-26	WOS:000509718300015
J	Ko, J; Kang, HJ; Kim, DA; Kim, MJ; Ryu, ES; Lee, S; Ryu, JH; Roncal, C; Johnson, RJ; Kang, DH				Ko, Jiyeon; Kang, Hyun-Jung; Kim, Dal-Ah; Kim, Mi-Jin; Ryu, Eun-Sun; Lee, Shina; Ryu, Jung-Hwa; Roncal, Carlos; Johnson, Richard J.; Kang, Duk-Hee			Uric acid induced the phenotype transition of vascular endothelial cells via induction of oxidative stress and glycocalyx shedding	FASEB JOURNAL			English	Article						EndoMT; reactive oxygen species; hyperuricemia; syndecan-1	EPITHELIAL-MESENCHYMAL TRANSITION; FIBROBLASTS; ALLOPURINOL; DYSFUNCTION; FIBROSIS; MYOFIBROBLASTS; PROLIFERATION; INHIBITION; GENERATION; MECHANISM	Recent data suggested a causative role of uric acid (UA) in the development of renal disease, in which endothelial dysfunction is regarded as the key mechanism. Endothelial-to-mesenchymal transition (EndoMT) and shedding of the glycocalyx are early changes of endothelial dysfunction. We investigated whether UA induced EndoMT in HUVECs and an animal model of hyperuricemia fed with 2% oxonic acid for 4 wk. UA induced EndoMT in HUVECs with a generation of reactive oxygen species via the activation of membranous NADPH oxidase (from 15 min) and mitochondria (from 6 h) along with glycocalyx shedding (from 6 h), which were blocked by probenecid. GM6001, an inhibitor of matrix metalloproteinase, alleviated UA-induced glycocalyx shedding and EndoMT. Antioxidants including N-acetyl cysteine, apocynin, and mitotempo ameliorated EndoMT; however, they did not change glycocalyx shedding in HUVECs. In the kidney of hyperuricemic rats, endothelial staining in peritubular capillaries (PTCs) was substantially decreased with a de novo expression of alpha-smooth muscle actin in PTCs. Plasma level of syndecan-1 was increased in hyperuricemic rats, which was ameliorated by allopurinol. UA caused a phenotypic transition of endothelial cells via induction of oxidative stress with glycocalyx shedding, which could be one of the mechanisms of UA-induced endothelial dysfunction and kidney disease.	[Ko, Jiyeon; Kang, Hyun-Jung; Kim, Dal-Ah; Ryu, Eun-Sun; Lee, Shina; Ryu, Jung-Hwa; Kang, Duk-Hee] Ewha Womans Univ, Coll Med, Ewha Med Res Ctr, Div Nephrol,Dept Internal Med, Seoul, South Korea; [Kim, Mi-Jin] CHA Univ, Dept Biotechnol, Seongnam, South Korea; [Roncal, Carlos; Johnson, Richard J.] Univ Colorado, Div Renal Dis & Hypertens, Anschutz Med Campus, Aurora, CO USA	Ewha Womans University; Pochon Cha University; University of Colorado System; University of Colorado Anschutz Medical Campus	Kang, DH (corresponding author), Ewha Womans Univ, Coll Med, Div Nephrol, 260 Gonghang Daero, Seoul 07804, South Korea.	dhkang@ewha.ac.kr			National Research Foundation of Korea (NRF) - Government of Korea (MSIT) [NRF-2015R1A2A1A15053374, NRF-2017R1A2B2005849]	National Research Foundation of Korea (NRF) - Government of Korea (MSIT)	This work was supported by the National Research Foundation of Korea (NRF) funded by the Government of Korea (MSIT) (NRF-2015R1A2A1A15053374 and NRF-2017R1A2B2005849). The authors declare no conflicts of interest.	Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Butler R, 2000, HYPERTENSION, V35, P746, DOI 10.1161/01.HYP.35.3.746; Chappell D, 2009, CIRC RES, V104, P1313, DOI 10.1161/CIRCRESAHA.108.187831; Corry DB, 2008, J HYPERTENS, V26, P269, DOI 10.1097/HJH.0b013e3282f240bf; Dejana E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14361; Doehner W, 2002, CIRCULATION, V105, P2619, DOI 10.1161/01.CIR.0000017502.58595.ED; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Farquharson CA, 2002, CIRCULATION, V106, P221, DOI 10.1161/01.CIR.0000022140.61460.1D; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Fukawa T, 2012, EXP CELL RES, V318, P1926, DOI 10.1016/j.yexcr.2012.05.023; Henry CBS, 2000, AM J PHYSIOL-HEART C, V279, pH2815, DOI 10.1152/ajpheart.2000.279.6.H2815; Hofmann-Kiefer KF, 2009, EUR J MED RES, V14, P526; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kanbay M, 2013, HEART, V99, P759, DOI 10.1136/heartjnl-2012-302535; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kang DH, 2002, J AM SOC NEPHROL, V13, P2888, DOI 10.1097/01.ASN.0000034910.58454.FD; Khosla UM, 2005, KIDNEY INT, V67, P1739, DOI 10.1111/j.1523-1755.2005.00273.x; Lanaspa MA, 2012, J BIOL CHEM, V287, P40732, DOI 10.1074/jbc.M112.399899; Li JH, 2009, AM J PATHOL, V175, P1380, DOI 10.2353/ajpath.2009.090096; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Mazzali M, 2002, AM J PHYSIOL-RENAL, V282, pF991, DOI 10.1152/ajprenal.00283.2001; Montorfano I, 2014, LAB INVEST, V94, P1068, DOI 10.1038/labinvest.2014.100; Nieuwdorp M, 2005, CURR OPIN LIPIDOL, V16, P507, DOI 10.1097/01.mol.0000181325.08926.9c; Noble MIM, 2008, QJM-INT J MED, V101, P513, DOI 10.1093/qjmed/hcn024; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Ryu ES, 2013, AM J PHYSIOL-RENAL, V304, pF471, DOI 10.1152/ajprenal.00560.2012; Sanchez-Lozada LG, 2007, AM J PHYSIOL-RENAL, V292, pF1238, DOI 10.1152/ajprenal.00164.2006; Sautin YY, 2007, AM J PHYSIOL-CELL PH, V293, pC584, DOI 10.1152/ajpcell.00600.2006; Schwartz IF, 2011, J VASC RES, V48, P252, DOI 10.1159/000320356; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Torres IP, 2016, AM J PHYSIOL-HEART C, V310, pH1468, DOI 10.1152/ajpheart.00006.2016; VanTeeffelen JW, 2007, TRENDS CARDIOVAS MED, V17, P101, DOI 10.1016/j.tcm.2007.02.002; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Weiner DE, 2008, J AM SOC NEPHROL, V19, P1204, DOI 10.1681/ASN.2007101075; Xavier S, 2015, J AM SOC NEPHROL, V26, P817, DOI 10.1681/ASN.2013101137; Yu MA, 2010, J HYPERTENS, V28, P1234, DOI 10.1097/HJH.0b013e328337da1d; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zharikov S, 2008, AM J PHYSIOL-CELL PH, V295, pC1183, DOI 10.1152/ajpcell.00075.2008; Zuurbier CJ, 2005, J APPL PHYSIOL, V99, P1471, DOI 10.1152/japplphysiol.00436.2005	44	36	36	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13334	13345		10.1096/fj.201901148R	http://dx.doi.org/10.1096/fj.201901148R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31553887	Bronze			2022-12-26	WOS:000507466100024
J	Park, R; Kim, H; Jang, M; Jo, D; Park, YI; Namkoong, S; Lee, JI; Jang, IS; Park, J				Park, Rackhyun; Kim, Hyunju; Jang, Minsu; Jo, Daum; Park, Yea-In; Namkoong, Sim; Lee, Jin I.; Jang, Ik-Soon; Park, Junsoo			LNX1 contributes to tumor growth by down-regulating p53 stability	FASEB JOURNAL			English	Article						MDM2; Numb; ubiquitination	E3 UBIQUITIN LIGASE; PROTEIN; MDM2; NUMB; SUPPRESSOR; INTERACTS; LEUKEMIA; DOMAIN	The well-known tumor suppressor p53 inhibits the formation of various cancers by inducing cell cycle arrest and apoptosis. Although p53 mutations are commonly found in many cancers, p53 is functionally inactivated in tumor cells that retain wild-type p53. Here, we show that the ligand of numb protein X1 (LNX1) inhibited p53-dependent transcription by decreasing the half-life of p53. We generated LNX1 knockout (KO) cells in p53 wild-type cancer cells (A549, HCT116, and MCF7) using the clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 gene-editing system. LNX1 KO activated p53-dependent transcription by increasing the stability of p53. Moreover, lentivirus-mediated overexpression of LNX1 decreased p53 protein levels and inhibited p53-dependent transcription. LNX1 interacted with p53 and mouse double minute 2 (MDM2) and increased the ubiquitination of p53 in an MDM2-dependent manner. Finally, we demonstrated that LNX1 was required for efficient tumor growth both in cell culture and in a mouse tumor xenograft model. These results collectively indicated that LNX1 contributed to tumor growth by inhibiting p53-dependent signaling in p53 wild-type cancer cells.	[Park, Rackhyun; Kim, Hyunju; Jang, Minsu; Jo, Daum; Park, Yea-In; Lee, Jin I.; Park, Junsoo] Yonsei Univ, Div Biol Sci & Technol, 1 Yonseidae Gil, Wonju 26493, Kangwon Provinc, South Korea; [Namkoong, Sim] Kangwon Natl Univ, Dept Biochem, Chunchon, South Korea; [Jang, Ik-Soon] Korea Basic Sci Inst, Div Bioconvergence Anal, Daejeon, South Korea	Yonsei University; Kangwon National University; Korea Basic Science Institute (KBSI)	Park, J (corresponding author), Yonsei Univ, Div Biol Sci & Technol, 1 Yonseidae Gil, Wonju 26493, Kangwon Provinc, South Korea.	junsoo@yonsei.ac.kr			National Research Foundation of Korea (NRF) - Korean government [2016R1A2B4009665, 2019R1A2C1006511]	National Research Foundation of Korea (NRF) - Korean government(National Research Foundation of Korea)	This study was supported by National Research Foundation of Korea (NRF) grants funded by the Korean government (2016R1A2B4009665 and 2019R1A2C1006511). The authors declare no conflicts of interest.	Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Carter S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-221; Chen JX, 2005, INT J BIOCHEM CELL B, V37, P2273, DOI 10.1016/j.biocel.2005.02.028; Chene P, 2004, MOL CANCER RES, V2, P20; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Danovi SA, 2010, NAT REV CANCER, V10, P602, DOI 10.1038/nrc2919; den Engelsman J, 2003, J BIOL CHEM, V278, P4699, DOI 10.1074/jbc.M211403200; Dho SE, 1998, J BIOL CHEM, V273, P9179, DOI 10.1074/jbc.273.15.9179; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Hu TT, 2015, CELL BIOCHEM FUNCT, V33, P443, DOI 10.1002/cbf.3130; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Juven-Gershon T, 1998, MOL CELL BIOL, V18, P3974, DOI 10.1128/MCB.18.7.3974; Lenihan JA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187352; Lenihan JA, 2014, GENE, V552, P39, DOI 10.1016/j.gene.2014.09.011; Ma L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188665; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Nie J, 2002, EMBO J, V21, P93, DOI 10.1093/emboj/21.1.93; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Sheng WW, 2017, FASEB J, V31, P2429, DOI 10.1096/fj.201601240R; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; Weiss A, 2007, FEBS LETT, V581, P5131, DOI 10.1016/j.febslet.2007.09.062; Wolting CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026248; Young P, 2005, MOL CELL NEUROSCI, V30, P238, DOI 10.1016/j.mcn.2005.07.015; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zheng D, 2011, MOL BIOL REP, V38, P2771, DOI 10.1007/s11033-010-0422-6	27	4	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13216	13227		10.1096/fj.201900366R	http://dx.doi.org/10.1096/fj.201900366R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31533005	Bronze			2022-12-26	WOS:000507466100015
J	Raybuck, AL; Lee, K; Cho, SH; Li, JX; Thomas, JW; Boothby, MR				Raybuck, Ariel L.; Lee, Keunwook; Cho, Sung Hoon; Li, Jingxin; Thomas, James W.; Boothby, Mark R.			mTORC1 as a cell-intrinsic rheostat that shapes development, preimmune repertoire, and function of B lymphocytes	FASEB JOURNAL			English	Article						immunity; signaling; protein malnutrition	LIVED PLASMA-CELLS; ANTIBODY-RESPONSES; IMMUNE-RESPONSE; VITAMIN-A; DIFFERENTIATION; EXPRESSION; ROLES; MICE; METABOLISM; COMPLEX	Ample evidence indicates that nutrient concentrations in extracellular milieux affect signaling mediated by environmental sensor proteins. For instance, the mechanistic target of rapamycin (mTOR) is reduced during protein malnutrition and is known to be modulated by concentrations of several amino acids when in a multiprotein signaling complex that contains regulatory-associated protein of mTOR. We hypothesized that a partial decrease in mTOR complex 1 (mTORC1) activity intrinsic to B-lineage cells would perturb lymphocyte development or function, or both. We show that a cell-intrinsic decrease in mTORC1 activity impacted developmental progression, antigen receptor repertoire, and function along the B lineage. Thus, preimmune repertoires of B-lineage cells were altered in the marrow and periphery in a genetic model of regulatory-associated protein of mTOR haploinsufficiency. An additional role for mTORC1 was revealed when a B-cell antigen receptor transgene was found to circumvent the abnormal B-cell development haploinsufficient B cells were profoundly impaired in responses to antigen in vivo. Collectively, our findings indicate that mTORC1 serves as a rheostat that shapes differentiation along the B lineage, the preimmune repertoire, and antigen-driven selection of mature B cells. The findings also reveal a range in the impact of this nutrient sensor on activity-response relationships for distinct endpoints.	[Raybuck, Ariel L.; Cho, Sung Hoon; Li, Jingxin; Boothby, Mark R.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, A-5301 MCN,1161 21st Ave S, Nashville, TN 37232 USA; [Cho, Sung Hoon; Boothby, Mark R.] Vanderbilt Univ, Med Ctr, Vanderbilt Inst Infect Immunol & Inflammat, Nashville, TN USA; [Thomas, James W.; Boothby, Mark R.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Boothby, Mark R.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA; [Lee, Keunwook] Hallym Univ, Dept Biomed Sci, Chunchon, Gangwon Do, South Korea	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Hallym University	Boothby, MR (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, A-5301 MCN,1161 21st Ave S, Nashville, TN 37232 USA.	mark.boothby@vanderbilt.edu	Li, Jing/GYU-5036-2022	Thomas, James/0000-0002-2098-6458	U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases [AI113292, AI051448]; NIH National Heart, Lung, and Blood Institute Grant [HL106812]; Korean Ministry of Science [NRF-2014M3A9D5A01073841]; NIH Shared Instrumentation Grant [1S10OD018015]; Cancer Center Support Grant [CA068485]; Diabetes Research Center Grant [DK0205930]	U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases; NIH National Heart, Lung, and Blood Institute Grant; Korean Ministry of Science; NIH Shared Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; Diabetes Research Center Grant	This work was supported by U.S. National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases Grant AI113292 to M.R.B., and AI051448 to J.W.T., NIH National Heart, Lung, and Blood Institute Grant HL106812 to M.R.B., Korean Ministry of Science Grant NRF-2014M3A9D5A01073841 to K.L., and NIH Shared Instrumentation Grant 1S10OD018015, as well as a scholarships via the Cancer Center Support Grant CA068485 and Diabetes Research Center Grant DK0205930 to help defray costs of Vanderbilt cores. The authors declare no conflicts of interest.	Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bennett Nancy M., 2012, Morbidity and Mortality Weekly Report, V61, P816; Boothby M, 2017, IMMUNITY, V46, P743, DOI 10.1016/j.immuni.2017.04.009; Boothby MR, 2019, GENE DEV, V33, P26, DOI 10.1101/gad.320192.118; Bortnick A, 2013, J IMMUNOL, V190, P5913, DOI 10.4049/jimmunol.1300161; Cancro MP, 2004, IMMUNOL REV, V197, P89, DOI 10.1111/j.0105-2896.2004.0099.x; CARLOMAGNO MA, 1982, INFECT IMMUN, V38, P195, DOI 10.1128/IAI.38.1.195-200.1982; Carlson CS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3680; Caro-Maldonado A, 2012, SEMIN IMMUNOL, V24, P405, DOI 10.1016/j.smim.2012.12.002; Cho SH, 2013, J IMMUNOL, V191, P3169, DOI 10.4049/jimmunol.1301106; Clark MR, 2014, NAT REV IMMUNOL, V14, P69, DOI 10.1038/nri3570; Cohen S, 2017, EUR J IMMUNOL, V47, P225, DOI 10.1002/eji.201646423; Corcoran AE, 1996, EMBO J, V15, P1924, DOI 10.1002/j.1460-2075.1996.tb00543.x; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Dorner T, 2007, IMMUNITY, V27, P384, DOI 10.1016/j.immuni.2007.09.002; DREIZEN S, 1979, INT J VITAM NUTR RES, V49, P220; Duan B, 2006, AUTOIMMUN REV, V5, P403, DOI 10.1016/j.autrev.2005.10.007; Efeyan A, 2012, TRENDS MOL MED, V18, P524, DOI 10.1016/j.molmed.2012.05.007; Foci RA, 2010, NUTRITION, V26, P1021, DOI 10.1016/j.nut.2009.08.026; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; Gronwall C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00066; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Harputlugil E, 2014, CELL REP, V8, P1160, DOI 10.1016/j.celrep.2014.07.018; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; HOLT L E Jr, 1960, Bull N Y Acad Med, V36, P431; Hoshii T, 2012, J CLIN INVEST, V122, P2114, DOI 10.1172/JCI62279; Howard JK, 1999, J CLIN INVEST, V104, P1051, DOI 10.1172/JCI6762; Ibrahim MK, 2017, CLIN MICROBIOL REV, V30, P919, DOI 10.1128/CMR.00119-16; Iwata TN, 2016, J IMMUNOL, V197, P2250, DOI 10.4049/jimmunol.1600492; Jones DD, 2016, J CLIN INVEST, V126, P4250, DOI 10.1172/JCI86504; Kalaitzidis D, 2012, CELL STEM CELL, V11, P429, DOI 10.1016/j.stem.2012.06.009; Keating R, 2013, NAT IMMUNOL, V14, P1266, DOI 10.1038/ni.2741; Kometani K, 2015, CURR OPIN IMMUNOL, V33, P64, DOI 10.1016/j.coi.2015.01.017; Lamming DW, 2015, ONCOTARGET, V6, P31233, DOI 10.18632/oncotarget.5180; Lee JH, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf2885; Lee K, 2013, BLOOD, V122, P2369, DOI 10.1182/blood-2013-01-477505; Lee K, 2012, J EXP MED, V209, P713, DOI 10.1084/jem.20111470; Lee SK, 2011, J EXP MED, V208, P1377, DOI 10.1084/jem.20102065; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; Malin S, 2010, NAT IMMUNOL, V11, P171, DOI 10.1038/ni.1827; MALYNN BA, 1990, J EXP MED, V171, P843, DOI 10.1084/jem.171.3.843; MCMURRAY DN, 1981, AM J CLIN NUTR, V34, P2117, DOI 10.1093/ajcn/34.10.2117; Mejia P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7050; Merrell KT, 2006, IMMUNITY, V25, P953, DOI 10.1016/j.immuni.2006.10.017; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Meyer-Bahlburg A, 2008, J EXP MED, V205, P155, DOI 10.1084/jem.20071088; Montecino-Rodriguez E, 2012, IMMUNITY, V36, P13, DOI 10.1016/j.immuni.2011.11.017; Najera O, 2004, CLIN DIAGN LAB IMMUN, V11, P577, DOI 10.1128/CDLI.11.3.577-580.2004; NOHR CW, 1986, J SURG RES, V40, P432, DOI 10.1016/0022-4804(86)90211-8; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Pallard C, 1999, IMMUNITY, V10, P525, DOI 10.1016/S1074-7613(00)80052-7; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Peng YJ, 2006, J PHYSIOL-LONDON, V577, P705, DOI 10.1113/jphysiol.2006.114033; Petro JB, 2002, J BIOL CHEM, V277, P48009, DOI 10.1074/jbc.M200305200; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Ray JP, 2015, IMMUNITY, V43, P690, DOI 10.1016/j.immuni.2015.08.017; Raybuck AL, 2018, J IMMUNOL, V200, P2627, DOI 10.4049/jimmunol.1701321; Robins HS, 2009, BLOOD, V114, P4099, DOI 10.1182/blood-2009-04-217604; Ross AC, 2012, AM J CLIN NUTR, V96, p1166S, DOI 10.3945/ajcn.112.034637; Rother MB, 2016, SCI REP-UK, V6, DOI 10.1038/srep33924; Rowland SL, 2013, IMMUNOL RES, V55, P231, DOI 10.1007/s12026-012-8366-7; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Shapiro-Shelef M, 2005, J EXP MED, V202, P1471, DOI 10.1084/jem.20051611; Su TT, 2004, IMMUNOL REV, V197, P161, DOI 10.1111/j.0105-2896.2004.0102.x; Teague BN, 2007, J IMMUNOL, V178, P7511, DOI 10.4049/jimmunol.178.12.7511; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Villamor E, 2005, CLIN MICROBIOL REV, V18, P446, DOI 10.1128/CMR.18.3.446-464.2005; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; YANCOPOULOS GD, 1988, J EXP MED, V168, P417, DOI 10.1084/jem.168.1.417; Yang JL, 2016, ELIFE, V5, DOI 10.7554/eLife.17936; Zeng H, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar5701; Zeng H, 2016, IMMUNITY, V45, P540, DOI 10.1016/j.immuni.2016.08.017	78	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13202	13215		10.1096/fj.201900069R	http://dx.doi.org/10.1096/fj.201900069R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31533002	Bronze, Green Published			2022-12-26	WOS:000507466100014
J	Sheffield, DA; Jepsen, LR; Feeney, SJ; Bertucci, MC; Sriratana, A; Naughtin, MJ; Dyson, JM; Coppel, RL; Mitchell, CA				Sheffield, David A.; Jepsen, Lene R.; Feeney, Sandra J.; Bertucci, Micka C.; Sriratana, Absorn; Naughtin, Monica J.; Dyson, Jennifer M.; Coppel, Ross L.; Mitchell, Christina A.			The myotubularin MTMR4 regulates phagosomal phosphatidylinositol 3-phosphate turnover and phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phagocytosis; phosphatidylinositol phosphatase; Fc-gamma receptor; macrophage; mycobacteria; innate immunity; myotubularin-related protein-4 (MTMR4); phagosome; phosphatidylinositol 3-phosphate (PtdIns(3)P)	INOSITOL POLYPHOSPHATE 5-PHOSPHATASE; PHOSPHATASE MTMR4; RECEPTOR; MATURATION; INHIBITION; MEMBRANE; PTEN; TRANSLOCATION; DEGRADATION; SECRETION	Macrophage phagocytosis is required for effective clearance of invading bacteria and other microbes. Coordinated phosphoinositide signaling is critical both for phagocytic particle engulfment and subsequent phagosomal maturation to a degradative organelle. Phosphatidylinositol 3-phosphate (PtdIns(3)P) is a phosphoinositide that is rapidly synthesized and degraded on phagosomal membranes, where it recruits FYVE domain? and PX motif?containing proteins that promote phagosomal maturation. However, the molecular mechanisms that regulate PtdIns(3)P removal from the phagosome have remained unclear. We report here that a myotubularin PtdIns(3)P 3-phosphatase, myotubularin-related protein-4 (MTMR4), regulates macrophage phagocytosis. MTMR4 overexpression reduced and siRNA-mediated Mtmr4 silencing increased levels of cell-surface immunoglobulin receptors (i.e. Fc? receptors (Fc?Rs)) on RAW 264.7 macrophages, associated with altered pseudopodal F-actin. Furthermore, MTMR4 negatively regulated the phagocytosis of IgG-opsonized particles, indicating that MTMR4 inhibits Fc?R-mediated phagocytosis, and was dynamically recruited to phagosomes of macrophages during phagocytosis. MTMR4 overexpression decreased and Mtmr4-specific siRNA expression increased the duration of PtdIns(3)P on phagosomal membranes. Macrophages treated with Mtmr4-specific siRNA were more resistant to Mycobacterium marinum?induced phagosome arrest, associated with increased maturation of mycobacterial phagosomes, indicating that extended PtdIns(3)P signaling on phagosomes in the Mtmr4-knockdown cells permitted trafficking of phagosomes to acidic late endosomal and lysosomal compartments. In conclusion, our findings indicate that MTMR4 regulates PtdIns(3)P degradation in macrophages and thereby controls phagocytosis and phagosomal maturation.	[Sheffield, David A.; Jepsen, Lene R.; Feeney, Sandra J.; Bertucci, Micka C.; Sriratana, Absorn; Naughtin, Monica J.; Dyson, Jennifer M.; Mitchell, Christina A.] Monash Univ, Monash Biomed Discovery Inst, Wellington Rd, Clayton, Vic 3800, Australia; [Sheffield, David A.; Jepsen, Lene R.; Feeney, Sandra J.; Bertucci, Micka C.; Sriratana, Absorn; Naughtin, Monica J.; Dyson, Jennifer M.; Mitchell, Christina A.] Monash Univ, Dept Biochem & Mol Biol, Wellington Rd, Clayton, Vic 3800, Australia; [Sheffield, David A.; Coppel, Ross L.] Monash Univ, Dept Microbiol, Wellington Rd, Clayton, Vic 3800, Australia	Monash University; Monash University; Monash University	Mitchell, CA (corresponding author), Fac Med Nursing & Hlth Sci, Bldg 64,Level 1 43 Rain Forest Walk,Wellington Rd, Clayton, Vic 3800, Australia.	Christina.mitchell@monash.edu		Mitchell, Christina A/0000-0001-9372-3192	National Health and Medical Research Council Australia (NHMRC) [545989]; Cancer Council Victoria (Australia) [APP1143557]; NHMRC Medical and Dental Postgraduate scholarship; Novo Nordisk Foundation [NNF16OC0018764]	National Health and Medical Research Council Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria (Australia)(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); NHMRC Medical and Dental Postgraduate scholarship(National Health and Medical Research Council (NHMRC) of Australia); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by National Health and Medical Research Council Australia (NHMRC) Project Grant 545989 and Cancer Council Victoria (Australia) Grant APP1143557. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by an NHMRC Medical and Dental Postgraduate scholarship.; Supported by Novo Nordisk Foundation Project Grant NNF16OC0018764.	Anes E, 2006, CELL MICROBIOL, V8, P939, DOI 10.1111/j.1462-5822.2005.00675.x; Bajno L, 2000, J CELL BIOL, V149, P697, DOI 10.1083/jcb.149.3.697; Beresford N, 2007, BIOCHEM J, V406, P13, DOI 10.1042/BJ20070670; Beresford NJ, 2009, J ANTIMICROB CHEMOTH, V63, P928, DOI 10.1093/jac/dkp031; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Chua J, 2004, J BIOL CHEM, V279, P36982, DOI 10.1074/jbc.M405082200; Cullen Peter J, 2012, Subcell Biochem, V59, P65, DOI 10.1007/978-94-007-3015-1_3; Davies Elizabeth M, 2012, Subcell Biochem, V58, P281, DOI 10.1007/978-94-007-3012-0_8; Dewitt S, 2006, J CELL SCI, V119, P443, DOI 10.1242/jcs.02756; Dewitt S, 2009, J CELL BIOL, V184, P197, DOI 10.1083/jcb.200806047; Dove SK, 2009, BIOCHEM J, V419, P1, DOI 10.1042/BJ20081950; Dussault AA, 2006, BIOL PROCED ONLINE, V8, P1, DOI 10.1251/bpo114; Ellson CD, 2001, CURR BIOL, V11, P1631, DOI 10.1016/S0960-9822(01)00447-X; Falasca M, 2007, J BIOL CHEM, V282, P28226, DOI 10.1074/jbc.M704357200; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; GREENBERG S, 1991, J CELL BIOL, V113, P757, DOI 10.1083/jcb.113.4.757; Hazeki K, 2012, FEBS LETT, V586, P4010, DOI 10.1016/j.febslet.2012.09.043; Henry RM, 2004, J CELL BIOL, V164, P185, DOI 10.1083/jcb.200307080; Horan KA, 2007, BLOOD, V110, P4480, DOI 10.1182/blood-2007-02-073874; Huynh KK, 2007, PHYSIOLOGY, V22, P366, DOI 10.1152/physiol.00028.2007; Jean S, 2012, MOL BIOL CELL, V23, P2723, DOI 10.1091/mbc.E12-05-0375; Kamen LA, 2008, J IMMUNOL, V180, P7497, DOI 10.4049/jimmunol.180.11.7497; Kamen LA, 2007, MOL BIOL CELL, V18, P2463, DOI 10.1091/mbc.e07-01-0061; Kim GHE, 2014, TRAFFIC, V15, P1143, DOI 10.1111/tra.12199; Kong AM, 2006, MOL CELL BIOL, V26, P6065, DOI 10.1128/MCB.00203-06; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Lorenzo O, 2006, J CELL SCI, V119, P2953, DOI 10.1242/jcs.03040; Lu N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001245; Maffucci T, 2003, EMBO J, V22, P4178, DOI 10.1093/emboj/cdg402; Marat AL, 2016, EMBO J, V35, P561, DOI 10.15252/embj.201593564; McConnachie G, 2003, BIOCHEM J, V371, P947, DOI 10.1042/BJ20021848; MELLMAN IS, 1983, J CELL BIOL, V96, P887, DOI 10.1083/jcb.96.3.887; Naughtin MJ, 2010, J CELL SCI, V123, P3071, DOI 10.1242/jcs.060103; Neukomm LJ, 2011, DEVELOPMENT, V138, P2003, DOI 10.1242/dev.060012; Niedergang F, 2003, J CELL BIOL, V161, P1143, DOI 10.1083/jcb.200210069; Pedersen NM, 2012, TRAFFIC, V13, P1547, DOI 10.1111/j.1600-0854.2012.01400.x; Plant PJ, 2009, BIOCHEM J, V419, P57, DOI 10.1042/BJ20081866; Poon IKH, 2010, CELL DEATH DIFFER, V17, P381, DOI 10.1038/cdd.2009.195; Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128; Song ZM, 2017, J LEUKOCYTE BIOL, V101, P1155, DOI 10.1189/jlb.1A0716-305R; Spiegelhalter C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009014; Sun J, 2007, J LEUKOCYTE BIOL, V82, P1437, DOI 10.1189/jlb.0507289; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; Taguchi-Atarashi N, 2010, TRAFFIC, V11, P468, DOI 10.1111/j.1600-0854.2010.01034.x; Tan T, 2006, CELL MICROBIOL, V8, P1417, DOI 10.1111/j.1462-5822.2006.00721.x; Tobias NJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000553; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; van der Poel CE, 2011, J IMMUNOL, V186, P2699, DOI 10.4049/jimmunol.1003526; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Vieira OV, 2004, MOL CELL BIOL, V24, P4593, DOI 10.1128/MCB.24.10.4593-4604.2004; Vieira OV, 2001, J CELL BIOL, V155, P19, DOI 10.1083/jcb.200107069; Yeung T, 2006, CURR OPIN CELL BIOL, V18, P429, DOI 10.1016/j.ceb.2006.06.006; Yu JJ, 2010, J BIOL CHEM, V285, P8454, DOI 10.1074/jbc.M109.075036; Zou W, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000679	56	2	3	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16684	16697		10.1074/jbc.RA119.009133	http://dx.doi.org/10.1074/jbc.RA119.009133			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31543504	Green Published, hybrid			2022-12-26	WOS:000501801900018
J	Abdallah, FF; Darwish, HW; Darwish, IA; Naguib, IA				Abdallah, Fatma F.; Darwish, Hany W.; Darwish, Ibrahim A.; Naguib, Ibrahim A.			Orthogonal projection to latent structures and first derivative for manipulation of PLSR and SVR chemometric models' prediction: A case study	PLOS ONE			English	Article							PYRIDOSTIGMINE BROMIDE; CHROMATOGRAPHIC METHOD; CAPILLARY-ELECTROPHORESIS; LIQUID-CHROMATOGRAPHY; PLASMA; METABOLITES; NEOSTIGMINE; VALIDATION; HYDROCHLOROTHIAZIDE; PHARMACOKINETICS	Novel manipulations of the well-established multivariate calibration models namely; partial least square regression (PLSR) and support vector regression (SVR) are introduced in the presented comparative study. Two preprocessing methods comprising first derivatization and orthogonal projection to latent structures (OPLS) are implemented prior to modeling with PLSR and SVR. Quantitative determination of pyridostigmine bromide (PR) in existence of its two associated substances; impurity a (IMP A) and impurity b (IMP B); was utilized as a case study for achieving comparison. A series consisting of 16 mixtures with numerous percentages of the studied compounds was applied for implementation of a 3 factor 4 level experimental design. Additionally, a series consisting of 9 mixtures was employed in an independent test to verify the predictive power of the suggested models. Significant improvement of predictive abilities of the two studied chemometric models was attained via implementation of OPLS processing method. The root mean square error of prediction RMSEP for the test set mixtures was employed as a key comparison tool. About PLSR model, RMSEP was found 0.5283 without preprocessing method, 1.1750 when first derivative data was used and 0.2890 when OPLS preprocessing method was applied. With regard to SVR model, RMSEP was found 0.2173 without preprocessing method, 0.3516 when first derivative data was used and 0.1819 when OPLS preprocessing method was applied.	[Abdallah, Fatma F.; Naguib, Ibrahim A.] Beni Suef Univ, Fac Pharm, Pharmaceut Analyt Chem Dept, Alshaheed Shehata Ahmad Hegazy St, Bani Suwayf, Egypt; [Darwish, Hany W.; Darwish, Ibrahim A.] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh, Saudi Arabia; [Darwish, Hany W.] Cairo Univ, Fac Pharm, Analyt Chem Dept, Kasr El Aini St, Cairo, Egypt; [Naguib, Ibrahim A.] Taif Univ, Coll Pharm, Dept Pharmaceut Chem, Al Hawiah, Taif, Saudi Arabia	Egyptian Knowledge Bank (EKB); Beni Suef University; King Saud University; Egyptian Knowledge Bank (EKB); Cairo University; Taif University	Darwish, HW (corresponding author), King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh, Saudi Arabia.; Darwish, HW (corresponding author), Cairo Univ, Fac Pharm, Analyt Chem Dept, Kasr El Aini St, Cairo, Egypt.	hdarwish@ksu.edu.sa	darwish, hany/ABD-2160-2020; Naguib, Ibrahim A/ABM-0813-2022	Naguib, Ibrahim A/0000-0002-5923-1466; Darwish, Ibrahim A/0000-0003-3821-623X	Deanship of Scientific Research at King Saud University [RGP-322]	Deanship of Scientific Research at King Saud University(King Saud University)	HWD received funds from Deanship of Scientific Research at King Saud University through the Research Group Project no. RGP-322 and they play no role in the study.; The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding of this research through the Research Group Project no. RGP-322.	Abu-Qare AW, 2001, J PHARMACEUT BIOMED, V26, P281, DOI 10.1016/S0731-7085(01)00403-4; Abu-Qare AW, 2001, J CHROMATOGR B, V754, P503, DOI 10.1016/S0378-4347(01)00040-8; Ali NW, 2015, JPC-J PLANAR CHROMAT, V28, P316, DOI 10.1556/1006.2015.28.4.8; Altria KD, 1996, J CAPILLARY ELECTROP, V3, P13; [Anonymous], 2005, MARTINDALE EXTRA PHA, V34th ed.; [Anonymous], 2013, HER MAJESTYS; [Anonymous], 2001, IND MERCK; Bagtash M, 2018, J CHEMOMETR, V32, DOI 10.1002/cem.3014; BARBER HE, 1975, BRIT J PHARMACOL, V55, P335, DOI 10.1111/j.1476-5381.1975.tb06936.x; BIRTLEY RDN, 1966, BRIT J PHARM CHEMOTH, V26, P393, DOI 10.1111/j.1476-5381.1966.tb01919.x; BLICK DW, 1994, TOXICOL APPL PHARM, V126, P311, DOI 10.1006/taap.1994.1121; BREYERPFAFF U, 1985, CLIN PHARMACOL THER, V37, P495, DOI 10.1038/clpt.1985.78; CHAN K, 1976, J CHROMATOGR, V120, P349, DOI 10.1016/S0021-9673(76)80012-X; Cherstniakova S, 2003, CLIN PHARMACOL THER, V73, pP27, DOI 10.1016/S0009-9236(03)90453-X; COHAN SL, 1976, NEUROLOGY, V26, P536, DOI 10.1212/WNL.26.6.536; Cristianini N, 2000, INTRO SUPPORT VECTOR; DAVISON SC, 1980, METHOD FIND EXP CLIN, V2, P77; DERUYTER MGM, 1980, J CHROMATOGR, V183, P193, DOI 10.1016/S0378-4347(00)81693-X; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; ELLIN RI, 1982, J CHROMATOGR, V228, P235; Gasteiger J., 2003, HDB CHEMOINFORMATICS, P3; Gunn S. R., 1998, ISIS TECH REP, V14, P5; Hadley M, 2000, J CHROMATOGR B, V745, P177, DOI 10.1016/S0378-4347(00)00153-5; Havel Josef, 2002, J Capill Electrophor Microchip Technol, V7, P107; Ivanovic D, 2007, ACTA CHROMATOGR, V18, P143; KORNFELD P, 1970, NEUROLOGY, V20, P634, DOI 10.1212/WNL.20.7.634; Naguib I.A., 2017, B FAC PHARM CAIRO U, V55, P287, DOI 10.1016/j.bfopcu.2017.09.002; Naguib IA, 2019, J CHROMATOGR SCI, V57, P653, DOI 10.1093/chromsci/bmz043; Naguib IA, 2014, SPECTROCHIM ACTA A, V130, P350, DOI 10.1016/j.saa.2014.04.024; Needham SR, 2003, J CHROMATOGR B, V796, P347, DOI 10.1016/j.jchromb.2003.08.021; Parrella F, THESIS; Sapolsky RM, 1998, NATURE, V393, P308, DOI 10.1038/30606; Scholkopf B., 2002, LEARNING KERNELS; SORENSEN PS, 1984, NEUROLOGY, V34, P1020, DOI 10.1212/WNL.34.8.1020; Suykens JA, 1999, J WORLD SCI; Tapp HS, 2009, TRAC-TREND ANAL CHEM, V28, P1322, DOI 10.1016/j.trac.2009.08.006; The United States Pharmacopeia, 2011, NAT FORM 29; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Urban-Horth JS., 1994, COMPUTER INTENSIVE S; WOLD S, 1984, SIAM J SCI STAT COMP, V5, P735, DOI 10.1137/0905052; Xu M., 2011, J ZHANGGUO YAOFANG, V22, P743; Xu Y, 2006, CRIT REV ANAL CHEM, V36, P177, DOI 10.1080/10408340600969486; YAKATAN GJ, 1979, J CHROMATOGR, V164, P399, DOI 10.1016/S0378-4347(00)81242-6; Zhao B, 2006, J PHARM PHARM SCI, V9, P71	44	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222197	10.1371/journal.pone.0222197	http://dx.doi.org/10.1371/journal.pone.0222197			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553757	Green Published, gold			2022-12-26	WOS:000532319200017
J	Rodriguez-Centeno, J; Manguan-Garcia, C; Perona, R; Sastre, L				Rodriguez-Centeno, Javier; Manguan-Garcia, Cristina; Perona, Rosario; Sastre, Leandro			Structure of Dictyostelium discoideum telomeres. Analysis of possible replication mechanisms	PLOS ONE			English	Article							DNA; COMPLEX; CELLS; RECOMBINATION; MAINTENANCE; SEQUENCE; GENOME; PATHWAY; GENES; TRF1	Telomeres are nucleo-protein structures that protect the ends of eukaryotic chromosomes. They are not completely synthesized during DNA replication and are elongated by specific mechanisms. The structure of the telomeres and the elongation mechanism have not been determined in Dictyostelium discoideum. This organism presents extrachromosomal palindromic elements containing two copies of the rDNA, also present at the end of the chromosomes. In this article the structure of the terminal region of the rDNA is shown to consist of repetitions of the A(G)n sequence where the number of Gs is variable. These repeats extend as a 3' single stranded region. The G-rich region is preceded by four tandem repetitions of two different DNA motifs. D. discoideum telomere reverse transcriptase homologous protein (TERTHP) presented RNase-sensitive enzymatic activity and was required to maintain telomere structure since terthp-mutant strains presented reorganizations of the DNA terminal regions. These modifications were different in several terthp-mutants and changed with their prolonged culture and subcloning. However, the terthp gene is not essential for D. discoideum proliferation. Telomeres could be maintained in terthp-mutant strains by homologous recombination mechanisms such as ALT (Alternative Lengthening of Telomeres) or HAATI (heterochromatin amplification-mediated and telomerase-independent). In agreement with this hypothesis, the expression of mRNAs coding for several proteins involved in homologous recombination was induced in terthp-mutant strains. Extrachromosomal rDNA could serve as substrate in these DNA homologous recombination reactions.	[Rodriguez-Centeno, Javier; Manguan-Garcia, Cristina; Perona, Rosario; Sastre, Leandro] UAM, CSIC, Inst Invest Biomed, IdiPaz, Madrid, Spain; [Manguan-Garcia, Cristina; Perona, Rosario; Sastre, Leandro] CIBER Enfermedades Raras CIBERER, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Sastre, L (corresponding author), UAM, CSIC, Inst Invest Biomed, IdiPaz, Madrid, Spain.; Sastre, L (corresponding author), CIBER Enfermedades Raras CIBERER, Madrid, Spain.	lsastre@iib.uam.es		Rodriguez-Centeno, Javier/0000-0001-8137-2225; Sastre, Leandro/0000-0003-3613-5938	Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain - FEDER funds [PI14-01495, PI17-01401]	Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain - FEDER funds	RP and LS were funded by grants PI14-01495 and PI17-01401 (Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III, Spain supported by FEDER funds), https://portalfis.isciii.es/es/Paginas/inicio.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertuch AA, 2016, RNA BIOL, V13, P696, DOI 10.1080/15476286.2015.1094596; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Casacuberta E, 2005, CYTOGENET GENOME RES, V110, P152, DOI 10.1159/000084947; Casacuberta E, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070192; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Chung I, 2012, NUCLEUS-PHILA, V3, P263, DOI 10.4161/nucl.20326; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2004, NAT REV MOL CELL BIO, V5, P323, DOI 10.1038/nrm1359; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; EMERY HS, 1981, CELL, V26, P411, DOI 10.1016/0092-8674(81)90210-5; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; Fajkus P, 2016, PLANT J, V85, P337, DOI 10.1111/tpj.13115; FIRTEL RA, 1976, J MOL BIOL, V102, P831, DOI 10.1016/0022-2836(76)90294-1; Fulcher N, 2014, CELL MOL LIFE SCI, V71, P847, DOI 10.1007/s00018-013-1469-z; Galardi-Castilla M, 2008, DEV BIOL, V316, P260, DOI 10.1016/j.ydbio.2008.01.026; Giraud-Panis MJ, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00048; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; Heidel AJ, 2011, GENOME RES, V21, P1882, DOI 10.1101/gr.121137.111; HENDERSON ER, 1989, MOL CELL BIOL, V9, P345, DOI 10.1128/MCB.9.1.345; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Henson JD, 2010, FEBS LETT, V584, P3800, DOI 10.1016/j.febslet.2010.06.009; HUGHES JE, 1988, NUCLEIC ACIDS RES, V16, P2338, DOI 10.1093/nar/16.5.2338; Jain D, 2010, ANNU REV GENET, V44, P243, DOI 10.1146/annurev-genet-102108-134841; Jain D, 2010, NATURE, V467, P223, DOI 10.1038/nature09374; Jiang WQ, 2005, MOL CELL BIOL, V25, P2708, DOI 10.1128/MCB.25.7.2708-2721.2005; Kim NW, 1997, NUCLEIC ACIDS RES, V25, P2595, DOI 10.1093/nar/25.13.2595; KYRION G, 1992, MOL CELL BIOL, V12, P5159, DOI 10.1128/MCB.12.11.5159; Lazzerini-Denchi E, 2016, NAT REV MOL CELL BIO, V17, P364, DOI 10.1038/nrm.2016.43; Linger BR, 2009, CRIT REV BIOCHEM MOL, V44, P434, DOI 10.3109/10409230903307329; Loomis WF, 2014, DEV BIOL, V391, P1, DOI 10.1016/j.ydbio.2014.04.001; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; LUSTIG AJ, 1986, P NATL ACAD SCI USA, V83, P1398, DOI 10.1073/pnas.83.5.1398; Maringele L, 2004, GENE DEV, V18, P2663, DOI 10.1101/gad.316504; Martinez P, 2015, TRENDS BIOCHEM SCI, V40, P504, DOI 10.1016/j.tibs.2015.06.003; McElligott R, 1997, EMBO J, V16, P3705, DOI 10.1093/emboj/16.12.3705; Nabetani A, 2011, J BIOCHEM, V149, P5, DOI 10.1093/jb/mvq119; Nassir N, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008188; O'Sullivan RJ, 2014, TRENDS CELL BIOL, V24, P675, DOI 10.1016/j.tcb.2014.07.007; O'Sullivan RJ, 2010, NAT REV MOL CELL BIO, V11, P171, DOI 10.1038/nrm2848; Pang KM, 1999, PLASMID, V41, P187, DOI 10.1006/plas.1999.1391; Perona R, 2016, TELOMERE - A COMPLEX END OF A CHROMOSOME, P77, DOI 10.5772/65353; Potts PR, 2007, NAT STRUCT MOL BIOL, V14, P581, DOI 10.1038/nsmb1259; Poulet A, 2012, NUCLEIC ACIDS RES, V40, P2566, DOI 10.1093/nar/gkr1116; Savage SA, 2014, PROG MOL BIOL TRANSL, V125, P41, DOI 10.1016/B978-0-12-397898-1.00002-5; Schaap P, 2011, DEV GROWTH DIFFER, V53, P452, DOI 10.1111/j.1440-169X.2011.01263.x; Schmidt JC, 2015, GENE DEV, V29, P1095, DOI 10.1101/gad.263863.115; Sepsiova R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154225; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; Sucgang R, 2003, NUCLEIC ACIDS RES, V31, P2361, DOI 10.1093/nar/gkg348; Tokutake Y, 1998, BIOCHEM BIOPH RES CO, V247, P765, DOI 10.1006/bbrc.1998.8876; Williams JG, 2010, GENETICS, V185, P717, DOI 10.1534/genetics.110.119297; Wu L, 2006, CELL, V126, P49, DOI 10.1016/j.cell.2006.05.037; Zhong ZH, 2007, J BIOL CHEM, V282, P29314, DOI 10.1074/jbc.M701413200	56	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222909	10.1371/journal.pone.0222909	http://dx.doi.org/10.1371/journal.pone.0222909			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550289	Green Published, gold			2022-12-26	WOS:000532307700032
J	Fuertes, E; Carsin, AE; Garcia-Larsen, V; Guerra, S; Pin, I; Leynaert, B; Accordini, S; Martinez-Moratalla, J; Anto, JM; Urrutia, I; Le Gouellec, A; Heinrich, J; Gislason, T; Jogi, R; Janson, C; Jarvis, D; Garcia-Aymerich, J				Fuertes, Elaine; Carsin, Anne-Elie; Garcia-Larsen, Vanessa; Guerra, Stefano; Pin, Isabelle; Leynaert, Benedicte; Accordini, Simone; Martinez-Moratalla, Jesus; Anto, Josep M.; Urrutia, Isabel; Le Gouellec, Audrey; Heinrich, Joachim; Gislason, Thorarinn; Jogi, Rain; Janson, Christer; Jarvis, Debbie; Garcia-Aymerich, Judith			The role of C-reactive protein levels on the association of physical activity with lung function in adults	PLOS ONE			English	Article							RESPIRATORY HEALTH SURVEY; POPULATION; DECLINE; EXERCISE	Objective Regular physical activity may be associated with improved lung function via reduced systemic inflammation, although studies exploring this mechanism are rare. We evaluated the role of C-reactive protein in blood, which is a common marker of systemic inflammation, on the association of physical activity with forced expiratory volume in one second and forced vital capacity. Methods Cross-sectional data on spirometry, C-reactive protein levels and self-reported physical activity (yes/no; >= 2 times and.1hr per week of vigorous physical activity) were available in the European Community Respiratory Health Survey (N = 2347 adults, 49.3% male, 28-56 years-old). A subsample was also assessed 10 years later using the International Physical Activity Questionnaire, and tertiles of Metabolic Equivalent of Task-minutes per week spent in vigorous, moderate and walking activities were calculated (N = 671, 49.6% male, 40-67 years-old). Adjusted cross-sectional mixed linear regression models and the "mediate" package in "R" were used to assess the presence of mediation. Results Despite positive significant associations between nearly all physical activity metrics with forced expiratory volume in one second and forced vital capacity, there was no evidence that C-reactive protein levels played a role. An influence of C-reactive protein levels was only apparent in the smaller subsample when comparing the medium to low tertiles of moderate activity (mean difference [95% CIs]: 21.1ml [5.2, 41.9] for forced expiratory volume in one second and 17.3ml [2.6, 38.0] for forced vital capacity). Conclusions In a population of adults, we found no consistent evidence that the association of physical activity with forced expiratory volume in one second or forced vital capacity is influenced by the level of C-reactive protein in blood.	[Fuertes, Elaine; Carsin, Anne-Elie; Guerra, Stefano; Anto, Josep M.; Garcia-Aymerich, Judith] ISGlobal, Barcelona, Spain; [Fuertes, Elaine; Carsin, Anne-Elie; Guerra, Stefano; Anto, Josep M.; Garcia-Aymerich, Judith] Univ Pompeu Fabra UPF, Barcelona, Spain; [Fuertes, Elaine; Carsin, Anne-Elie; Guerra, Stefano; Anto, Josep M.; Garcia-Aymerich, Judith] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Fuertes, Elaine; Jarvis, Debbie] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Garcia-Larsen, Vanessa] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Program Human Nutr, Baltimore, MD USA; [Guerra, Stefano] Univ Arizona, Asthma & Airway Dis Res Ctr, Tucson, AZ 85721 USA; [Pin, Isabelle] CHU Grenoble Alpes, Dept Pediat, Grenoble, France; [Pin, Isabelle] INSERM, Inst Adv Biosci, Grenoble, France; [Pin, Isabelle] Univ Grenoble Alpes, Grenoble, France; [Leynaert, Benedicte] INSERM, Pathophysiol & Epidemiol Resp Dis, UMR 1152, Paris, France; [Leynaert, Benedicte] Univ Paris Diderot Paris, UMR 1152, Paris, France; [Accordini, Simone] Univ Verona, Dept Diagnost & Publ Hlth, Unit Epidemiol & Med Stat, Verona, Italy; [Martinez-Moratalla, Jesus] Hosp Univ Albacete, Serv Neumol Complejo, Serv Salud Castilla La Mancha SESCAM, Albacete, Spain; [Martinez-Moratalla, Jesus] Univ Castilla La Mancha, Fac Med Albacete, Albacete, Spain; [Urrutia, Isabel] Galdakao Hosp, Dept Resp, Galdakao, Spain; [Le Gouellec, Audrey] Univ Grenoble Alpes, TIMC IMAG, CHU Grenoble Alpes, Grenoble INP,CNRS, Grenoble, France; [Heinrich, Joachim] Helmholtz Zentrum Munchen, Inst Epidemiol, German Res Ctr Environm Hlth, Munich, Germany; [Heinrich, Joachim] Ludwig Maximilians Univ Munchen, Univ Hosp Munich, Inst & Outpatient Clin Occupat Social & Environm, Munich, Germany; [Gislason, Thorarinn] Landspitali Univ Hosp Reykjavik, Dept Resp Med & Sleep, Reykjavik, Iceland; [Jogi, Rain] Tartu Univ Hosp, Lung Clin, Tartu, Estonia; [Janson, Christer] Uppsala Univ, Dept Med Sci Resp Allergy & Sleep Res, Uppsala, Sweden; [Jarvis, Debbie] Imperial Coll London, MRC PHE Ctr Environm & Hlth, London, England	ISGlobal; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Imperial College London; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Arizona; CHU Grenoble Alpes; Institut National de la Sante et de la Recherche Medicale (Inserm); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of Verona; Universidad de Castilla-La Mancha; Galdakao Hospital; CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Landspitali National University Hospital; Imperial College London	Fuertes, E (corresponding author), ISGlobal, Barcelona, Spain.; Fuertes, E (corresponding author), Univ Pompeu Fabra UPF, Barcelona, Spain.; Fuertes, E (corresponding author), CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain.; Fuertes, E (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London, England.	e.fuertes@imperial.ac.uk	Carsin, Anne-Elie/AAF-6815-2021; J, Garcia-Aymerich/G-6867-2014; le gouellec, audrey/M-6072-2014; Heinrich, Joachim/N-1720-2013	Carsin, Anne-Elie/0000-0003-3981-977X; J, Garcia-Aymerich/0000-0002-7097-4586; Heinrich, Joachim/0000-0002-9620-1629; Fuertes, Elaine/0000-0003-0205-9025; Leynaert, Benedicte/0000-0001-5045-2492; Jarvis, Deborah/0000-0002-1753-3896; Le Gouellec, audrey/0000-0002-4905-3854	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Individual Fellowship scheme (H2020-MSCA-IF-2015) [704268]; European Union [633212]; MRC [MR/L01341X/1, G0901214] Funding Source: UKRI	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Individual Fellowship scheme (H2020-MSCA-IF-2015); European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The results reported herein correspond to the specific aims of the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Individual Fellowship scheme (H2020-MSCA-IF-2015; proposal number 704268; https://ec.europa.eu/research/mariecurieactions/actions/individual-fellowships_ en), awarded to the Principal Investigator EF. These results also correspond to the specific aims of the Ageing Lungs in European Cohorts (ALEC) Study (www.alecstudy.org), awarded to the Principal Investigator DJ, which has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No. 633212 (https://ec.europa.eu/programmes/horizon2020/).The local investigators and funding agencies for the participating European Community Respiratory Health Survey (ECRHS II and ECRHS III) centres are reported in the Supplementary File. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ISGlobal is a member of CERCA Programme/Generalitat de Catalunya. An abstract of this work was presented at the European Respiratory Society International Congress in September, 2018. The local investigators and funding agencies for the European Community Respiratory Health Survey (ECRHS II and ECRHS III) are reported in the Supplementary Material (S1 Appendix).	BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Fogarty AW, 2007, THORAX, V62, P515, DOI 10.1136/thx.2006.066969; Fuertes E, 2018, THORAX, V73, P376, DOI 10.1136/thoraxjnl-2017-210947; Garcia-Aymerich J, 2007, AM J RESP CRIT CARE, V175, P458, DOI 10.1164/rccm.200607-896OC; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Hamer M, 2012, PHYS ACTIVITY INFLAM, DOI [10.1161/CIRCULATIONAHA.112.103879, DOI 10.1161/CIRCULATIONAHA.112.103879]; Haneuse S, 2019, JAMA-J AM MED ASSOC, V321, P602, DOI 10.1001/jama.2018.21554; Imai K, 2010, PSYCHOL METHODS, V15, P309, DOI 10.1037/a0020761; Janson C, 2001, EUR RESPIR J, V18, P598, DOI 10.1183/09031936.01.00205801; Jarvis D, 2002, EUR RESPIR J, V20, P1071, DOI 10.1183/09031936.02.00046802; Jenkins AR, 2018, CHEST, V153, P1281, DOI 10.1016/j.chest.2018.01.054; Kasapis C, 2005, J AM COLL CARDIOL, V45, P1563, DOI 10.1016/j.jacc.2004.12.077; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Shaaban R, 2006, RESP MED, V100, P2112, DOI 10.1016/j.rmed.2006.03.027; Tingley D., 2014, MEDIATION R PACKAGE; VanderWeele TJ, 2015, EXPLANATION CAUSAL I; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607	18	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222578	10.1371/journal.pone.0222578	http://dx.doi.org/10.1371/journal.pone.0222578			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545813	Green Published, gold			2022-12-26	WOS:000532303200021
J	Makaruk, H; Porter, JM; Sadowski, J; Bodasinska, A; Zielinski, J; Niznikowski, T; Mastalerz, A				Makaruk, Hubert; Porter, Jared Marak; Sadowski, Jerzy; Bodasinska, Anna; Zielinski, Janusz; Niznikowski, Tomasz; Mastalerz, Andrzej			The effects of combining focus of attention and autonomy support on shot accuracy in the penalty kick	PLOS ONE			English	Article							ADDITIVE BENEFITS; EXTERNAL FOCUS; PERFORMANCE	The penalty kick is of great importance in the sport of soccer. Therefore, the aim of this study was to test predictions of the OPTIMAL theory and identify key attentional and motivational factors that impact the accuracy of the penalty kick. The following six groups of moderately skilled participants performed penalty kicks following instructions that directed their focus of attention or impacted their autonomy support: external focus with autonomy support (EF/AS), external focus alone (EF), internal focus with autonomy support (IF/AS), internal focus alone (IF), autonomy support alone (AS) and control (C) groups. The analysis showed that the EF/AS group demonstrated better kicking accuracy relatively to the IF/AS, IF and C groups, but there were no significant differences between the EF/AS and EF or AS groups. Interestingly, the EF/AS group showed higher self-efficacy compared to the EF, IF/AS, IF and C groups. The finding suggest that a combination of attentional and motivational factors may produce benefits in motor performance.	[Makaruk, Hubert] Jozef Pilsudski Univ Phys Educ Warsaw, Dept Athlet & Swimming, Warsaw, Poland; [Makaruk, Hubert; Sadowski, Jerzy; Bodasinska, Anna; Zielinski, Janusz; Niznikowski, Tomasz] Fac Phys Educ & Sport Biala Podlaska, Biala Podlaska, Poland; [Porter, Jared Marak] Univ Tennessee, Dept Kinesiol Recreat & Sport Studies, Knoxville, TN USA; [Sadowski, Jerzy] Jozef Pilsudski Univ Phys Educ Warsaw, Dept Theory & Technol Sport, Warsaw, Poland; [Bodasinska, Anna] Jozef Pilsudski Univ Phys Educ Warsaw, Dept Sport Games, Warsaw, Poland; [Niznikowski, Tomasz] Jozef Pilsudski Univ Phys Educ Warsaw, Dept Gymnast, Warsaw, Poland; [Mastalerz, Andrzej] Jozef Pilsudski Univ Phys Educ Warsaw, Dept Biomech, Warsaw, Poland	Jozef Pilsudski University Physical Education in Warsaw; Jozef Pilsudski University Physical Education in Warsaw; University of Tennessee System; University of Tennessee Knoxville; Jozef Pilsudski University Physical Education in Warsaw; Jozef Pilsudski University Physical Education in Warsaw; Jozef Pilsudski University Physical Education in Warsaw; Jozef Pilsudski University Physical Education in Warsaw	Makaruk, H (corresponding author), Jozef Pilsudski Univ Phys Educ Warsaw, Dept Athlet & Swimming, Warsaw, Poland.; Makaruk, H (corresponding author), Fac Phys Educ & Sport Biala Podlaska, Biala Podlaska, Poland.	hubert.makaruk@awf-bp.edu.pl	Mastalerz, Andrzej/AAJ-5837-2020; Niźnikowski, Tomasz/HGA-6448-2022; Sadowski, Jerzy/D-4881-2019	Mastalerz, Andrzej/0000-0003-2031-5563; Niźnikowski, Tomasz/0000-0003-1107-7532; Zielinski, Janusz/0000-0001-6708-8383; Makaruk, Hubert/0000-0002-2118-4051				Abdollahipour R, 2017, PSYCHOL SPORT EXERC, V32, P17, DOI 10.1016/j.psychsport.2017.05.004; Almeida CH, 2016, INT J PERF ANAL SPOR, V16, P508, DOI 10.1080/24748668.2016.11868905; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bar-Eli M., 2009, SOCCER SOC, V10, P183; BARELI M, 1988, SOCCER J, V33, P49; Binsch O, 2010, HUM MOVEMENT SCI, V29, P277, DOI 10.1016/j.humov.2009.12.002; Chiviacowsky S, 2014, PSYCHOL SPORT EXERC, V15, P505, DOI 10.1016/j.psychsport.2014.05.003; Dalton K, 2015, INT J SPORTS SCI COA, V10, P815, DOI 10.1260/1747-9541.10.5.815; Englert C, 2015, INT J SPORT EXERC PS, V13, P121, DOI 10.1080/1612197X.2014.932828; Feltz D.L., 2008, SELF EFFICACY SPORT; Franks I. M., 1997, SOCCER J, V42, P30; Graham-Smith P., 1999, J SPORTS SCI, V17, P905, DOI DOI 10.1080/026404199365461; Halperin I, 2017, PSYCHOL RES-PSYCH FO, V81, P1051, DOI 10.1007/s00426-016-0790-1; HANCOCK GR, 1995, J MOTOR BEHAV, V27, P241, DOI 10.1080/00222895.1995.9941714; Iwatsuki T, 2017, HUM MOVEMENT SCI, V55, P264, DOI 10.1016/j.humov.2017.08.016; Kerwin D. G., 2006, ENG SPORT, V6, P321, DOI DOI 10.1007/978-0-387-46050-5_57; Larson-Hall J., 2012, RES METHODS 2 LANGUA, P245; Lees A, 2011, SPORT BIOMECH, V10, P125, DOI 10.1080/14763141.2011.569565; Magill R, 2014, MOTOR LEARNING CONTR, P423; McGarry T, 2000, J SPORT SCI, V18, P401, DOI 10.1080/02640410050074331; Navarro M, 2013, J SPORT SCI, V31, P921, DOI 10.1080/02640414.2012.762602; NAYLOR JC, 1963, J EXP PSYCHOL, V65, P217, DOI 10.1037/h0041060; Pascua LAM, 2015, J SPORT SCI, V33, P58, DOI 10.1080/02640414.2014.922693; Sitzmann T, 2013, PERS PSYCHOL, V66, P531, DOI 10.1111/peps.12035; Timmis MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115179; Turvey M. T., 1996, DEXTERITY ITS DEV, P171; Wood G, 2011, COGN PROCESS, V12, P257, DOI 10.1007/s10339-011-0393-0; Wulf G, 2001, Q J EXP PSYCHOL-A, V54, P1143, DOI 10.1080/02724980143000118; Wulf G, 2016, PSYCHON B REV, V23, P1382, DOI 10.3758/s13423-015-0999-9; Wulf G, 2015, HUM MOVEMENT SCI, V40, P176, DOI 10.1016/j.humov.2014.11.015; Wulf G, 2014, HUM MOVEMENT SCI, V37, P12, DOI 10.1016/j.humov.2014.06.004; Wulf G, 2013, INT REV SPORT EXER P, V6, P77, DOI 10.1080/1750984X.2012.723728; Zachry T., 2005, THESIS	33	8	9	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0213487	10.1371/journal.pone.0213487	http://dx.doi.org/10.1371/journal.pone.0213487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5QI	31545800	Green Published, Green Submitted, gold			2022-12-26	WOS:000532303200002
J	Shaharir, SS; Said, MSM; Mohd, R; Cader, RA; Mustafar, R; Rahman, RA				Shaharir, Syahrul Sazliyana; Said, Mohd Shahrir Mohamed; Mohd, Rozita; Cader, Rizna Abdul; Mustafar, Ruslinda; Rahman, Rahana Abdul			Predictors of SLE relapse in pregnancy and post-partum among multi-ethnic patients in Malaysia	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CLASSIFICATION CRITERIA; INTERNATIONAL CONSENSUS; REVISED CRITERIA; SINGLE-CENTER; DISEASE; OUTCOMES; FLARE; HYDROXYCHLOROQUINE; DEFINITION	Flare of Systemic Lupus Erythematosus (SLE) may occur during pregnancy and puerperium. We studied the prevalence and factors associated with SLE relapse during pregnancy and post-partum period in a multi-ethnic SLE cohort. Consecutive SLE patients who attended the outpatient clinic were reviewed for previous history of pregnancies in our institution. Patients who had a complete antenatal, delivery, and post-partum follow up were included. Their medical records were retrospectively analysed to assess the disease activity at pre-pregnancy/conception, during antenatal, and post-partum period. Presence of flare episodes during pregnancy and puerperium were recorded. The pregnancy outcomes recorded include live birth, foetal loss, prematurity and intra-uterine growth restrictions (IUGR). Univariate and multivariable logistic regression with generalized estimating equations (GEE) analyses were performed to determine the factors associated with disease relapse and the pregnancy outcomes. A total of 120 patients with 196 pregnancies were included, with a live birth rate of 78.6%. Four (2.0%) were diagnosed to have SLE during pregnancy. The flare rate in pregnancy was 40.1% while post-partum 17.4%. Majority of the relapse in pregnancy occurred in haematological system (62.3%) followed by renal (53.2%), musculoskeletal (22.1%), and mucocutaneous (14.3%). In GEE analyses, active disease at conception was the independent predictor of SLE relapse during and after pregnancy, whereas older maternal age and Malay ethnicity were associated with higher flare during post-partum. HCQ use was significantly associated with reduced risk of flare in univariate analysis but it was no longer significant in the GEE analyses. Presence of disease flare in pregnancy was significantly associated with prematurity. In conclusion, pregnancy in SLE need to be planned during quiescent state as pre-pregnant active disease was associated with disease relapse in both during and after pregnancy. Malay patients had an increased risk of post-partum flare but further larger prospective studies are needed to confirm the association between pregnancies in the different ancestral background.	[Shaharir, Syahrul Sazliyana; Said, Mohd Shahrir Mohamed] Univ Kebangsaan Malaysia Med Ctr UKMMC, Dept Internal Med, Rheumatol Unit, Jalan Yaacob Latiff, Kuala Lumpur, Malaysia; [Mohd, Rozita; Cader, Rizna Abdul; Mustafar, Ruslinda] Univ Kebangsaan Malaysia Med Ctr UKMMC, Dept Internal Med, Nephrol Unit, Jalan Yaacob Latiff, Kuala Lumpur, Malaysia; [Rahman, Rahana Abdul] Univ Kebangsaan Malaysia Med Ctr UKMMC, Dept Obstet & Gynaecol, Jalan Yaacob Latiff, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia; Universiti Kebangsaan Malaysia	Shaharir, SS (corresponding author), Univ Kebangsaan Malaysia Med Ctr UKMMC, Dept Internal Med, Rheumatol Unit, Jalan Yaacob Latiff, Kuala Lumpur, Malaysia.	ssazliyana@gmail.com	Said, Mohd Shahrir Mohamed/AAR-2680-2020; MOHAMED SAID, PROF DR MOHD SHAHRIR/J-5065-2014	MOHAMED SAID, PROF DR MOHD SHAHRIR/0000-0003-1459-1844				Aly EAH, 2016, MIDDLE EAST FERTIL S, V21, P168, DOI 10.1016/j.mefs.2015.12.003; Andrade RM, 2006, RHEUMATOLOGY, V45, P1380, DOI 10.1093/rheumatology/kel222; Ateka-Barrutia O, 2013, CLIN MED, V13, P580, DOI 10.7861/clinmedicine.13-6-580; Baer AN, 2011, OBSTET GYNECOL SURV, V66, P639, DOI 10.1097/OGX.0b013e318239e1ee; Buyon JP, 2015, ANN INTERN MED, V163, P153, DOI 10.7326/M14-2235; Buyon JP, 1999, LUPUS, V8, P677, DOI 10.1191/096120399680411272; Calvert N, 2018, CLIN SARCOMA RES, V8, DOI 10.1186/s13569-018-0090-1; Carmona F, 1999, EUR J OBSTET GYN R B, V83, P137, DOI 10.1016/S0301-2115(98)00312-1; Carvalheiras G, 2010, CLIN REV ALLERG IMMU, V38, P302, DOI 10.1007/s12016-009-8161-y; Cervera Ricard, 2002, Autoimmunity Reviews, V1, P354, DOI 10.1016/S1568-9972(02)00082-4; Chakravarty EF, 2005, AM J OBSTET GYNECOL, V192, P1897, DOI 10.1016/j.ajog.2005.02.063; Chen DY, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/2413637; Chen YE, 2008, CLIN J AM SOC NEPHRO, V3, P46, DOI 10.2215/CJN.03280807; Clowse MEB, 2005, ARTHRITIS RHEUM-US, V52, P514, DOI 10.1002/art.20864; Clowse MEB, 2007, RHEUM DIS CLIN N AM, V33, P237, DOI 10.1016/j.rdc.2007.01.002; Clowse MEB, 2006, ARTHRITIS RHEUM, V54, P3640, DOI 10.1002/art.22159; Clowse MEB, 2011, J RHEUMATOL, V38, P1012, DOI 10.3899/jrheum.100746; Cortes-Hernandez J, 2002, RHEUMATOLOGY, V41, P643, DOI 10.1093/rheumatology/41.6.643; De Bandt M, 2000, ANN MED INTERNE, V151, P87; Surita FGD, 2007, SAO PAULO MED J, V125, P91, DOI 10.1590/S1516-31802007000200005; Eudy A, 2018, PREGNANCY HYPERTENS, V13, pS26, DOI [10.1016/j.preghy.2018.08.080, DOI 10.1016/J.PREGHY.2018.08.080]; Eudy AM, 2018, ANN RHEUM DIS, V77, P855, DOI 10.1136/annrheumdis-2017-212535; Georgiou PE, 2000, RHEUMATOLOGY, V39, P1014, DOI 10.1093/rheumatology/39.9.1014; Gilda Parastandechehr STF, 2016, CAN PREGNANCY INDUCE, V1, P27; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Jamia Azdina Jamal, 2011, Pharmacognosy Journal, V3, P15, DOI 10.5530/pj.2011.24.4; Ko HS, 2011, INT J MED SCI, V8, P577, DOI 10.7150/ijms.8.577; Kobayashi N, 1999, AM J REPROD IMMUNOL, V42, P153; Ku M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159364; Lateef A, 2013, BEST PRACT RES CL RH, V27, P435, DOI 10.1016/j.berh.2013.07.005; Levy RA, 2001, LUPUS, V10, P401, DOI 10.1191/096120301678646137; Lewis MJ, 2017, RHEUMATOLOGY, V56, P67, DOI 10.1093/rheumatology/kew399; LIMA F, 1995, SEMIN ARTHRITIS RHEU, V25, P184, DOI 10.1016/S0049-0172(95)80030-1; LOCKSHIN MD, 1984, AM J MED, V77, P893, DOI 10.1016/0002-9343(84)90538-2; LOCKSHIN MD, 1989, ARTHRITIS RHEUM, V32, P665, DOI 10.1002/anr.1780320602; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Medina-Quinones CV, 2016, ARTHRIT CARE RES, V68, P981, DOI 10.1002/acr.22774; MEEHAN RT, 1987, J RHEUMATOL, V14, P252; MINTZ G, 1986, J RHEUMATOL, V13, P732; Miyakis S, 2006, J THROMB HAEMOST, V4, P295, DOI 10.1111/j.1538-7836.2006.01753.x; Mokbel A, 2013, EGYPT RHEUMATOL, V35, P133, DOI 10.1016/j.ejr.2013.02.002; Moroni G, 2002, AM J KIDNEY DIS, V40, P713, DOI 10.1053/ajkd.2002.35678; NOSSENT HC, 1990, J RHEUMATOL, V17, P771; Ostensen M, 2004, BEST PRACT RES CL RH, V18, P219, DOI 10.1016/j.berh.2004.01.002; PETRI M, 1991, ARTHRITIS RHEUM, V34, P1538; PETRI M, 1992, AM J REPROD IMMUNOL, V28, P188, DOI 10.1111/j.1600-0897.1992.tb00788.x; PETRI M, 1991, ARTHRITIS RHEUM, V34, P937, DOI 10.1002/art.1780340802; Petri M, 2007, RHEUM DIS CLIN N AM, V33, P227, DOI 10.1016/j.rdc.2007.01.003; Petri M, 2012, ARTHRITIS RHEUM-US, V64, P2677, DOI 10.1002/art.34473; RUBBERT A, 1992, AM J REPROD IMMUNOL, V28, P205, DOI 10.1111/j.1600-0897.1992.tb00792.x; Ruiz-Irastorza G, 2004, ARTHRIT RHEUM-ARTHR, V51, P78, DOI 10.1002/art.20081; Ruiz-Irastorza G, 2011, EUR J CLIN INVEST, V41, P672, DOI 10.1111/j.1365-2362.2010.02443.x; RuizIrastorza G, 1996, BRIT J RHEUMATOL, V35, P133; Ruperto N, 2011, LUPUS, V20, P453, DOI 10.1177/0961203310388445; Saavedra MA, 2015, LUPUS, V24, P180, DOI 10.1177/0961203314552116; Shaharir SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166270; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tandon A, 2004, ARTHRITIS RHEUM-US, V50, P3941, DOI 10.1002/art.20638; Teh CL, 2017, LUPUS, V26, P218, DOI 10.1177/0961203316664996; TINCANI A, 1992, CLIN EXP RHEUMATOL, V10, P439; Uramoto KM, 1999, ARTHRITIS RHEUM, V42, P46, DOI 10.1002/1529-0131(199901)42:1<46::AID-ANR6>3.0.CO;2-2; UROWITZ MB, 1993, ARTHRITIS RHEUM, V36, P1392, DOI 10.1002/art.1780361011; WONG KL, 1991, ARCH INTERN MED, V151, P269, DOI 10.1001/archinte.151.2.269; Yang HX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104375; Yang MJ, 2015, J CHIN MED ASSOC, V78, P235, DOI 10.1016/j.jcma.2014.11.008; Yap DYH, 2015, KIDNEY DIS-BASEL, V1, P100, DOI 10.1159/000430458; Yusoff Z, 2018, SHS WEB C, V45, DOI [10.1051/shsconf/20184505002, DOI 10.1051/SHSCONF/20184505002]; Zhan ZP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176457; ZHOU YF, 2018, BMJ OPEN, V8, DOI DOI 10.1136/BMJOPEN-2017-020909	69	9	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222343	10.1371/journal.pone.0222343	http://dx.doi.org/10.1371/journal.pone.0222343			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539383	Green Published, gold			2022-12-26	WOS:000532297900010
J	Chen, HH; Lin, CH; Chen, DY; Chao, WC; Chen, YH; Hung, WT; Chou, YY; Wu, YD; Chen, CC				Chen, Hsin-Hua; Lin, Ching-Heng; Chen, Der-Yuan; Chao, Wen-Cheng; Chen, Yi-Hsing; Hung, Wei-Ting; Chou, Yin-Yi; Wu, Yi-Da; Chen, Chien-Chih			Risk of major autoimmune diseases in female breast cancer patients: A nationwide, population-based cohort study	PLOS ONE			English	Article							MONONUCLEAR-CELLS; PERIPHERAL-BLOOD; T-CELL; POLYMYOSITIS; DERMATOMYOSITIS; AUTOANTIBODIES; MYOSITIS; TAIWAN; IPILIMUMAB; ANTIBODIES	Background Breast cancer is one of the most common malignancies among women. However, there remains no consensus in current literature on the incidence of autoimmune diseases among breast cancer patients. The purpose of this study was to evaluate the risks of major autoimmune diseases (MAD) including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), Sjogren's syndrome (SS) and dermatomyositis (DMtis)/polymyositis (PM) in female breast cancer patients. Methods Using the Taiwanese National Health Insurance Research Database (NHIRD) records from 2003 to 2013, we identified newly-diagnosed female breast cancer patients and randomly selected females without breast cancer in the period 2007 to 2013 into a control group. We matched the two cohorts using a 1:4 ratio based on age, and the year of index date for comparison of the risk of major autoimmune diseases. We estimated and compared the relative risks of autoimmune diseases in female breast cancer patients and females without breast cancer. Results A total of 54,311 females with breast cancer and 217,244 matched females without breast cancer were included in this study. For SLE, the incidence rates were 2.3 (breast cancer group) vs. 10.0 (control group) per 100,000 women years; for RA rates were 19.3 (breast cancer group) vs. 42.7 (control group) per 100,000 women years; and for SS rates were 20.5 (breast cancer group) vs. 38.2 (control group) per 100,000 women years. After adjusting for potential confounders, the hazard ratios (95% confidence intervals) for female breast cancer patients vs. control group were 0.04 (0.01-0.24) for SLE; 0.03 (0.02-0.04) for RA; and 0.21 (0.09-0.48) for SS. Conclusion Female breast cancer patients had lower risks of SLE, RA and SS when compared to female individuals without breast cancer. However, there was no significant difference in the risk of developing DMtis/PM between both groups.	[Chen, Hsin-Hua; Chen, Chien-Chih] Natl Chung Hsing Univ, PhD Program Translat Med, Taichung, Taiwan; [Chen, Hsin-Hua; Lin, Ching-Heng; Chao, Wen-Cheng] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Hsin-Hua; Chen, Yi-Hsing] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Chen, Hsin-Hua] Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan; [Chen, Hsin-Hua] Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung, Taiwan; [Chen, Hsin-Hua] Tunghai Univ, Dept Ind Engn & Enterprise Informat, Taichung, Taiwan; [Chen, Hsin-Hua] Natl Yang Ming Univ, Inst Publ Hlth & Community, Med Res Ctr, Taipei, Taiwan; [Chen, Der-Yuan] China Med Univ Hosp, Rheumatol & Immunol Ctr, Taichung, Taiwan; [Chen, Der-Yuan] China Med Univ Hosp, Rheumatol & Immunol Ctr, Translat Med Lab, Taichung, Taiwan; [Chen, Der-Yuan] China Med Univ, Sch Med, Taichung, Taiwan; [Chen, Yi-Hsing; Hung, Wei-Ting; Chou, Yin-Yi; Wu, Yi-Da] Taichung Vet Gen Hosp, Dept Internal Med, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Chien-Chih] Taichung Vet Gen Hosp, Dept Radiat Oncol, Taichung, Taiwan	National Chung Hsing University; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Chung Hsing University; National Chung Hsing University; Tunghai University; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Taichung Veterans General Hospital; Taichung Veterans General Hospital	Chen, CC (corresponding author), Natl Chung Hsing Univ, PhD Program Translat Med, Taichung, Taiwan.; Chen, CC (corresponding author), Taichung Vet Gen Hosp, Dept Radiat Oncol, Taichung, Taiwan.	chiencheh@gmail.com	Huang, James/ADK-6342-2022		Taichung Veterans General Hospital [CE16241B]	Taichung Veterans General Hospital	This study was supported by Taichung Veterans General Hospital grant CE16241B to HHC.	Betteridge ZE, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3275; Blair HA, 2017, DRUGS, V77, P1221, DOI 10.1007/s40265-017-0775-4; Chen D, 2014, CLIN EXP RHEUMATOL, V32, P615; Cheng TM, 2003, HEALTH AFFAIR, V22, P61, DOI 10.1377/hlthaff.22.3.61; CHOW WH, 1995, CANCER CAUSE CONTROL, V6, P9, DOI 10.1007/BF00051675; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; ENGEL AG, 1984, ANN NEUROL, V16, P209, DOI 10.1002/ana.410160207; Fang YF, 2016, CLIN RHEUMATOL, V35, P1977, DOI 10.1007/s10067-016-3296-8; Fasth AER, 2009, J IMMUNOL, V183, P4792, DOI 10.4049/jimmunol.0803688; Hengstman GJD, 2002, J NEUROL, V249, P69, DOI 10.1007/PL00007850; Jaberipour M, 2010, PATHOL ONCOL RES, V16, P547, DOI 10.1007/s12253-010-9256-8; Khalife Esmat, 2018, Asian Pac J Cancer Prev, V19, P3019; Kuo CF, 2011, BRIT J DERMATOL, V165, P1273, DOI 10.1111/j.1365-2133.2011.10595.x; Kwon ED, 2014, LANCET ONCOL, V15, P700, DOI 10.1016/S1470-2045(14)70189-5; Lin X, 2014, ANN RHEUM DIS, V73, DOI [10.1136/annrheumdis-2014-205521, 10.1136/annrheumdis-2013-204584]; LOVE LA, 1991, MEDICINE, V70, P360, DOI 10.1097/00005792-199111000-00002; Mao H, 2010, CURR CANCER DRUG TAR, V10, P728, DOI 10.2174/156800910793605811; MARGUERIE C, 1990, Q J MED, V77, P1019, DOI 10.1093/qjmed/77.1.1019; Mease PJ, 2017, ANN RHEUM DIS, V76, P1550, DOI 10.1136/annrheumdis-2016-210724; Pontarini E, 2018, CURR OPIN RHEUMATOL, V30, P215, DOI 10.1097/BOR.0000000000000473; Rutjes SA, 1997, CLIN EXP IMMUNOL, V109, P32, DOI 10.1046/j.1365-2249.1997.4081308.x; Scheinecker C, 2010, J AUTOIMMUN, V35, P269, DOI 10.1016/j.jaut.2010.06.018; See LC, 2013, SEMIN ARTHRITIS RHEU, V43, P381, DOI 10.1016/j.semarthrit.2013.06.001; Selva-O'Callaghan A, 2006, ARTHRIT RHEUM-ARTHR, V55, P791, DOI 10.1002/art.22237; Shah AA, 2017, CLIN EXP RHEUMATOL, V35, pS71; SIGURGEIRSSON B, 1992, NEW ENGL J MED, V326, P363, DOI 10.1056/NEJM199202063260602; Tao JH, 2017, INFLAMMATION, V40, P328, DOI 10.1007/s10753-016-0470-8; Tjarnlund A, 2018, ANN RHEUM DIS, V77, P55, DOI 10.1136/annrheumdis-2017-211751; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; van Amelsfort JMR, 2004, ARTHRITIS RHEUM, V50, P2775, DOI 10.1002/art.20499; Venalis P, 2014, RHEUMATOLOGY, V53, P397, DOI 10.1093/rheumatology/ket279; Zhu T, 2016, CLIN PHARM DRUG DEV, V5, P408, DOI 10.1002/cpdd.251	32	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222860	10.1371/journal.pone.0222860	http://dx.doi.org/10.1371/journal.pone.0222860			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536611	Green Submitted, gold, Green Published			2022-12-26	WOS:000532262800097
J	Pero, R; Angrisano, T; Brancaccio, M; Falanga, A; Lombardi, L; Natale, F; Laneri, S; Lombardo, B; Galdiero, S; Scudiero, O				Pero, Raffaela; Angrisano, Tiziana; Brancaccio, Mariarita; Falanga, Annarita; Lombardi, Lucia; Natale, Francesco; Laneri, Sonia; Lombardo, Barbara; Galdiero, Stefania; Scudiero, Olga			Beta-defensins and analogs in Helicobacter pylori infections: mRNA expression levels, DNA methylation, and antibacterial activity	PLOS ONE			English	Article							GASTRIC EPITHELIAL-CELLS; CPG ISLAND METHYLATION; PROMOTER METHYLATION; HOST-DEFENSE; CANCER; GENE; INFLAMMATION; RISK; INDUCTION; HEPATITIS	Antimicrobial peptides can protect the gastric mucosa from bacteria, but Helicobacter pylori (H. pylori) can equally colonize the gastric apparatus. To understand beta-defensin function in H. pylori-associated chronic gastritis, we investigated susceptibility, human beta-defensin mRNA expression, and DNA methylation changes to promoters in the gastric mucosa with or without H. pylori infection. We studied the expression of HBD2 (gene name DEFB4A), HBD3 (DEFB103A), and HBD4 (DEFB104) using real-time PCR in 15 control and 10 H. pylori infection patient gastric specimens. This study demonstrates that H. pylori infection is related to gastric enhancement of inducible HBD2, but inducible HBD3 and HBD4 expression levels remained unchanged. HBD2 gene methylation levels were overall higher in H. pylori-negative samples than in H. pylori-positive samples. We also assessed antimicrobial susceptibility using growth on blood agar. The H. pylori strain Tox+ was susceptible to all defensins tested and their analogs (3N, 3NI). These results show that HBD2 is involved in gastritis development driven by H. pylori, which facilitates the creation of an epigenetic field during H. pylori-associated gastric tumorigenesis.	[Pero, Raffaela; Lombardo, Barbara; Scudiero, Olga] Univ Napoli Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Pero, Raffaela; Scudiero, Olga] Univ Napoli Federico II, Task Force Studi Microbioma, Naples, Italy; [Angrisano, Tiziana; Natale, Francesco] Univ Napoli Federico II, Dipartimento Biol, Naples, Italy; [Brancaccio, Mariarita] Staz Zool Anton Dohrn, Dipartimento Biol Evoluz Organismi Marini, Naples, Italy; [Falanga, Annarita; Laneri, Sonia; Galdiero, Stefania] Univ Napoli Federico II, Dipartimento Farm, Naples, Italy; [Lombardi, Lucia] Univ Napoli Federico II, Dipartimento Agr, Naples, Italy; [Lombardo, Barbara; Scudiero, Olga] CEINGE Biotecnol Avanzate Scarl, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; Stazione Zoologica Anton Dohrn di Napoli; University of Naples Federico II; University of Naples Federico II; CEINGE Biotecnologie Avanzate	Pero, R; Scudiero, O (corresponding author), Univ Napoli Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy.; Pero, R; Scudiero, O (corresponding author), Univ Napoli Federico II, Task Force Studi Microbioma, Naples, Italy.; Scudiero, O (corresponding author), CEINGE Biotecnol Avanzate Scarl, Naples, Italy.	pero@unina.it; olga.scudiero@unina.it	Galdiero, Stefania/M-3225-2019; Brancaccio, Mariarita/AAC-4285-2021; Lombardi, Lucia/ABH-2872-2021; Angrisano, Tiziana/AAC-5353-2022; Natale, Francesco/AAG-6525-2019; Scudiero, Olga/AAC-5358-2022; PERO, Raffaela/L-1461-2015	Galdiero, Stefania/0000-0002-7849-7024; Brancaccio, Mariarita/0000-0002-4161-512X; Lombardi, Lucia/0000-0002-5202-9847; Natale, Francesco/0000-0001-5366-9005; Scudiero, Olga/0000-0002-4916-4976; Lombardo, Barbara/0000-0003-3884-1043; PERO, Raffaela/0000-0003-2182-5530	Regione Campania [D62/07000110002, 2012/0140203]	Regione Campania(Regione Campania)	Support for this study was provided by Legge Regionale N.5, Annualita 2007 from Regione Campania, D62/07000110002 to OS, and Finanziamenti per l'Avvio di Ricerche Originali 2012 from University of Naples of "Federico II", 2012/0140203 to RP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrisano T, 2011, NUCLEIC ACIDS RES, V39, P1993, DOI 10.1093/nar/gkq864; Angrisano T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156671; Bajaj-Elliott M, 2002, GUT, V51, P356, DOI 10.1136/gut.51.3.356; Bauer B, 2013, HELICOBACTER, V18, P6, DOI 10.1111/hel.12000; Belot MP, 2018, EPIGENETICS-US, V13, P459, DOI 10.1080/15592294.2018.1469893; Boughan PK, 2006, J BIOL CHEM, V281, P11637, DOI 10.1074/jbc.M510275200; Chan AOO, 2006, CURR MOL MED, V6, P401, DOI 10.2174/156652406777435417; Chan AOO, 2003, GUT, V52, P502, DOI 10.1136/gut.52.4.502; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chiariotti L, 2016, ADV EXP MED BIOL, V879, P91, DOI 10.1007/978-3-319-24738-0_5; Chiariotti L, 2013, MED MICROBIOL IMMUN, V202, P327, DOI 10.1007/s00430-013-0301-6; Coretti L, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/8392523; Correa P, 2007, GASTROENTEROLOGY, V133, P659, DOI 10.1053/j.gastro.2007.06.026; di Martino O, 2016, GENES CELLS, V21, P648, DOI 10.1111/gtc.12373; Enomoto S, 2007, CANCER SCI, V98, P1853, DOI 10.1111/j.1349-7006.2007.00625.x; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Gigek CO, 2012, EPIGENOMICS-UK, V4, P279, DOI [10.2217/EPI.12.22, 10.2217/epi.12.22]; Grubman A, 2010, CELL MICROBIOL, V12, P626, DOI 10.1111/j.1462-5822.2009.01421.x; Hamanaka Y, 2001, GUT, V49, P481, DOI 10.1136/gut.49.4.481; Hase K, 2003, GASTROENTEROLOGY, V125, P1613, DOI 10.1053/j.gastro.2003.08.028; Hayashi Y, 2013, GUT, V62, P1536, DOI 10.1136/gutjnl-2011-301625; Hosaka Y, 2008, EUR J GASTROEN HEPAT, V20, P1151, DOI 10.1097/MEG.0b013e3283052ddb; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; Isomoto H, 2005, WORLD J GASTROENTERO, V11, P4782, DOI 10.3748/wjg.v11.i31.4782; Issa JPJ, 2001, CANCER RES, V61, P3573; Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004; Kawauchi K, 2006, WORLD J GASTROENTERO, V12, P5793, DOI 10.3748/wjg.v12.i36.5793; Keller S, 2013, ONCOL LETT, V6, P86, DOI 10.3892/ol.2013.1312; Kondo Y, 2000, HEPATOLOGY, V32, P970, DOI 10.1053/jhep.2000.19797; Lombardi L, 2019, BIOMACROMOLECULES, V20, P1362, DOI 10.1021/acs.biomac.8b01740; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Macarthur M, 2004, AM J PHYSIOL-GASTR L, V286, pG515, DOI 10.1152/ajpgi.00475.2003; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Muhammad JS, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftv128; Murayama A, 2006, EMBO J, V25, P1081, DOI 10.1038/sj.emboj.7601012; Nigro E, 2015, SCI REP, V21, P5; Nishi Y, 2005, WORLD J GASTROENTERO, V11, P99, DOI 10.3748/wjg.v11.i1.99; Niwa T, 2010, CANCER RES, V70, P1430, DOI 10.1158/0008-5472.CAN-09-2755; O'Neil DA, 2003, MOL IMMUNOL, V40, P445, DOI 10.1016/S0161-5890(03)00161-5; Ohara T, 2005, HEPATO-GASTROENTEROL, V52, P1320; Ohata H, 2004, INT J CANCER, V109, P138, DOI 10.1002/ijc.11680; Otte JM, 2009, EUR J CLIN INVEST, V39, P126, DOI 10.1111/j.1365-2362.2008.02071.x; Patel SR, 2013, CELL MICROBIOL, V15, P2080, DOI 10.1111/cmi.12174; Pero R, 2017, MOLECULES, V7, P3; Resnick MB, 2006, GUT, V55, P1717, DOI 10.1136/gut.2006.095646; Rutter M, 2004, GASTROENTEROLOGY, V126, P451, DOI 10.1053/j.gastro.2003.11.010; Scudiero O, 2015, INT J NANOMED, V10, P6523, DOI 10.2147/IJN.S89610; Scudiero O, 2013, ANTIMICROB AGENTS CH, V57, P1701, DOI 10.1128/AAC.00934-12; Scudiero O, 2010, ANTIMICROB AGENTS CH, V54, P2312, DOI 10.1128/AAC.01550-09; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Shin CM, 2010, CANCER SCI, V101, P1337, DOI 10.1111/j.1349-7006.2010.01535.x; Sobiak B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040914; Stauffer JK, 2012, HEPATOLOGY, V56, P1567, DOI 10.1002/hep.25674; Taha AS, 2005, DIGEST LIVER DIS, V37, P51, DOI 10.1016/j.dld.2004.07.019; Tsunoda T, 1999, BIOINFORMATICS, V15, P622, DOI 10.1093/bioinformatics/15.7.622; Uehara N, 2003, J MED MICROBIOL, V52, P41, DOI 10.1099/jmm.0.04985-0; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; Ushijima T, 2007, J BIOCHEM MOL BIOL, V40, P142; Vordenbaumen S, 2010, J PEDIATR GASTR NUTR, V50, P596, DOI 10.1097/MPG.0b013e3181cd26cd; Wada A, 1999, BIOCHEM BIOPH RES CO, V263, P770, DOI 10.1006/bbrc.1999.1452; Wehkamp J, 2003, J CLIN PATHOL, V56, P352, DOI 10.1136/jcp.56.5.352; Yakirevich E, 2013, GASTROENTEROL CLIN N, V42, P261, DOI 10.1016/j.gtc.2013.01.004; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243; Zhao CH, 2012, HISTOL HISTOPATHOL, V27, P1271, DOI 10.14670/HH-27.1271	64	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222295	10.1371/journal.pone.0222295	http://dx.doi.org/10.1371/journal.pone.0222295			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31537016	Green Published, gold, Green Submitted			2022-12-26	WOS:000532262800035
J	Marais, F; Kallon, II; Dudley, LD				Marais, Frederick; Kallon, Idriss Ibrahim; Dudley, Lilian Diana			Continuity of care for TB patients at a South African hospital: A qualitative participatory study of the experiences of hospital staff	PLOS ONE			English	Article							TUBERCULOSIS-CONTROL; HEALTH SYSTEMS; CAPE-TOWN; INFECTION; CONTEXT	Background Ensuring effective clinical management and continuity of TB care across hospital and primary health-care services remains challenging in South Africa. The high burden of TB, coupled with numerous health system problems, influence the TB care delivered by hospital staff. Objective To understand factors from the perspectives of hospital staff that influence the clinical management and discharge of TB patients, and to elicit recommendations to improve continuity of care for TB patients. Design Participatory action research was used to engage hospital staff working with TB patients admitted to a central public hospital in the Western Cape province, South Africa. Data were collected through eight focus group discussions with nurses, junior doctors and ward administrators. Data analysis was done using Miles and Huberman's framework to identify emerging patterns and to develop categories with themes and sub-themes. The participants influenced all phases of the research process to inform better practices in TB clinical management and discharge planning at the hospital. Results The emerging themes and sub-themes were categorized into two overall sections: The clinical care management process and the discharge and referral process. Nurses expressed a fear of exposure to TB and MDR-TB due to challenges in clinical and infection-prevention control. Clinical hierarchies, poor interdisciplinary teamwork, limited task shifting and poor communication interfered with effective clinical and discharge processes. A high workload, staff shortages and inadequate skills resulted in insufficient information and health education for TB patients and their caregivers. Despite awareness of the patients' socio-economic challenges, some aspects of care were not patient-centered, and caregivers were not included in discharge planning. Communication between the hospital and referral points was inefficient and poorly supported by information systems. Hospital staff recommended improved infection prevention and control practices and interdisciplinary teamwork in the hospital, that TB education for patients be integrated with hospital staff functions, with more patient-centered discharge planning, and improved communication across hospitals and primary health care levels. Conclusions Interdisciplinary teamwork, more patient-centered care, and better communication within the hospital and with primary health-care services are needed for improved continuity of care for TB patients. Further studies on factors contributing to, and interventions to improve, continuity of TB care in similar hospital settings are needed.	[Marais, Frederick; Dudley, Lilian Diana] Stellenbosch Univ, Fac Med & Hlth Sci, Div Hlth Syst & Publ Hlth, Cape Town, South Africa; [Marais, Frederick] Western Cape Govt Hlth, Cape Town, South Africa; [Kallon, Idriss Ibrahim] Univ Cape Town, Sch Publ Hlth & Family Med, Div Social & Behav Sci, Cape Town, South Africa	Stellenbosch University; University of Cape Town	Marais, F (corresponding author), Stellenbosch Univ, Fac Med & Hlth Sci, Div Hlth Syst & Publ Hlth, Cape Town, South Africa.; Marais, F (corresponding author), Western Cape Govt Hlth, Cape Town, South Africa.	frederick.marais@westerncape.gov.za	Kallon, Idriss/GZK-8516-2022	Kallon, Idriss Ibrahim/0000-0001-8903-4001	South African Medical Research Council Self Initiated Research Grant; South Africa Netherlands Research Programme on Alternative Development (SANPAD)	South African Medical Research Council Self Initiated Research Grant(South African Medical Research Council); South Africa Netherlands Research Programme on Alternative Development (SANPAD)	This work was supported by: L Dudley, South African Medical Research Council Self Initiated Research Grant; L Dudley, 10/61, South Africa Netherlands Research Programme on Alternative Development (SANPAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2015, EUR RESPIR J, V45, P1364, DOI 10.1183/09031936.00138414; Arends T, 2017, THESIS; Atkins S, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-275; Baum F, 2006, J EPIDEMIOL COMMUN H, V60, P854, DOI 10.1136/jech.2004.028662; Bergold J., 2012, FORUM QUALITATIVE SO, DOI [10.17169/fqs-13.1.1801, DOI 10.17169/FQS-13.1.1801]; Churchyard GJ, 2014, SAMJ S AFR MED J, V104, P244, DOI [10.7196/samj.7689, 10.7196/SAMJ.7689]; de Vries E, 2011, SAMJ S AFR MED J, V101, P760; Department of Health, 2013, NAT HLTH CAR FAC BAS; Dudley L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190258; Dyers RE, 2016, SAMJ S AFR MED J, V106, P181, DOI [10.7196/SAMJ.2016.v106i2.10079, 10.7196/SAMJ.2016.V106I2.10079]; Edginton ME, 2005, INT J TUBERC LUNG D, V9, P398; Ford N, 2016, J INT AIDS SOC, V19, P1; Foy R, 2010, ANN INTERN MED, V152, P247, DOI 10.7326/0003-4819-152-4-201002160-00010; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Goncalves-Bradley DC, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000313.pub5; Grobler L, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1601-5; Harling G, 2008, SOC SCI MED, V66, P492, DOI 10.1016/j.socscimed.2007.08.026; Haynes RB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub3; Jagosh J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1949-1; Janson J, 2012, PUBLIC HEALTH ACTION, V2, P61, DOI 10.5588/pha.12.0003; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Kendall EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083480; Klopper M, 2013, EMERG INFECT DIS, V19, P449, DOI [10.3201/EID1903.120246, 10.3201//EID1903.120246]; Kolbe-Alexander T, 2014, J SCI MED SPORT, V18, pe98; Lei X, 2015, INT J INFECT DIS, V34, P20, DOI 10.1016/j.ijid.2015.02.015; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Loveday M, 2008, INT J TUBERC LUNG D, V12, P1042; Malotle MM, 2017, PUBLIC HEALTH ACTION, V7, P258, DOI 10.5588/pha.17.0070; Marais BJ, 2013, LANCET INFECT DIS, V13, P436, DOI 10.1016/S1473-3099(13)70015-X; Mayan M. J., 2015, QUALITATIVE HLTH RES, V26, P69; Meiqari L, 2019, HEALTH RES POLICY SY, V17, DOI 10.1186/s12961-019-0426-1; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Minshew N. J., 1997, QUAL REP, V3, P303; National Department of Health SA, 2014, STRAT PLAN 2015 2019; O'Hara LM, 2017, INT J TUBERC LUNG D, V21, P320, DOI 10.5588/ijtld.16.0591; Oni T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-575; Padarath A, 2017, S AFRICAN HLTH REV; Probandari A, 2008, GLOBAL HEALTH ACTION, V1, DOI 10.3402/gha.v1i0.1831; Punch K.F., 2005, INTRO SOCIAL RES QUA; Reeves S, 2017, COCHRANE DB SYST REV, V6, P10; Rotter T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006632.pub2; Sissolak D, 2010, INT J INFECT DIS, V14, pE423, DOI 10.1016/j.ijid.2009.06.030; Sissolak D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-262; Statistics South Africa, 2012, CENS 2011 STAT REL P; Stewart DW, 2014, APPL SOCIAL RES METH, V20, P109; Sullivan SS, 2017, NURS OUTLOOK, V65, P597, DOI 10.1016/j.outlook.2017.01.014; TB DOTS Strategy Coordination, 2014, TB DOTS STRATEGY COO; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Von Holdt K, 2007, STATE NATION S AFRIC, P312; Wang L, 2009, INT J TUBERC LUNG D, V13, P1486; Wang LX, 2010, B WORLD HEALTH ORGAN, V88, P937, DOI 10.2471/BLT.09.071753; Western Cape Government: Health, 2013, HEALTHC 2030; WHO, 2016, GLOB TUB REP; WHO, 2014, END TB STRAT	55	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222421	10.1371/journal.pone.0222421	http://dx.doi.org/10.1371/journal.pone.0222421			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4SI	31532797	Green Submitted, Green Published, gold			2022-12-26	WOS:000532239600030
J	Keating, SM; Rountree, W; Grebe, E; Pappas, AL; Stone, M; Hampton, D; Todd, CA; Poniewierski, MS; Sanchez, A; Porth, CG; Denny, TN; Busch, MP				Keating, Sheila M.; Rountree, Wes; Grebe, Eduard; Pappas, Andrea L.; Stone, Mars; Hampton, Dylan; Todd, Christopher A.; Poniewierski, Marek S.; Sanchez, Ana; Porth, Cassandra G.; Denny, Thomas N.; Busch, Michael P.		EQAPOL Limiting Antigen LAg Incide	Development of an international external quality assurance program for HIV-1 incidence using the Limiting Antigen Avidity assay	PLOS ONE			English	Article							TESTING ALGORITHM; POPULATION; INFECTIONS; INDEX	Laboratory assays for identifying recent HIV-1 infections are widely used for estimating incidence in cross-sectional population-level surveys in global HIV-1surveillance. Adequate assay and laboratory performance are required to ensure accurate incidence estimates. The NIAID-supported External Quality Assurance Program Oversight Laboratory (EQA-POL) established a proficiency testing program for the most widely-used incidence assay, the HIV-1 Limiting Antigen Avidity EIA (LAg), with US Centers for Disease Control and Prevention (CDC)-approved kits manufactured by Sedia Biosciences Corporation and Maxim Biomedical. The objective of this program is to monitor the performance of participating laboratories. Four rounds of blinded external proficiency (EP) panels were distributed to up to twenty testing sites (7 North American, 5 African, 4 Asian, 2 South American and 2 European). These panels consisted of ten plasma samples: three blinded well-characterized HIV-1-seropositive samples that were included as replicates and an HIV-negative control. The seropositive samples spanned the dynamic range of the assay and are categorized as either recent or long-term infection. Participating sites performed the assay according to manufacturers' instructions and completed an online survey to gather information on kit manufacturer, lot of kit used, laboratory procedures and the experience of technicians. On average, fifteen sites participated in each round of testing, with an average of four sites testing with only the Maxim assay, seven testing with only the Sedia assay and five sites utilizing both assays. Overall, the Sedia and Maxim assays yielded similar infection status categorization across the laboratories; however, for most of the nine HIV+ samples tested, there were significant differences in the optical density readouts, ODn (N = 8) and OD (N = 7), between LAg kit manufacturers (p < 0.05 based on mixed effects models. The EQAPOL LAg program is important for monitoring laboratory performance as well as detecting variations between manufacturers of HIV-1 incidence assays.	[Keating, Sheila M.; Grebe, Eduard; Stone, Mars; Hampton, Dylan; Busch, Michael P.] Vitalant Res Inst, San Francisco, CA 94118 USA; [Keating, Sheila M.; Grebe, Eduard; Stone, Mars; Busch, Michael P.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Rountree, Wes; Pappas, Andrea L.; Todd, Christopher A.; Poniewierski, Marek S.; Sanchez, Ana; Porth, Cassandra G.; Denny, Thomas N.] Duke Univ, Duke Human Vaccine Inst, Durham, NC USA	Vitalant; Vitalant Research Institute; University of California System; University of California San Francisco; Duke University	Busch, MP (corresponding author), Vitalant Res Inst, San Francisco, CA 94118 USA.	MBusch@vitalant.org		Grebe, Eduard/0000-0001-7046-7245; Keating, Sheila/0000-0002-8324-3694	Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272201000045C, HHSN272201700061C, IAA-Y1-HB-5026-01]	Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services	This program was funded by the Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract Nos. HHSN272201000045C and HHSN272201700061C entitled "External Quality Assurance Program Oversight Laboratory (EQAPOL)" (PI: T.N.D.) and grant no. IAA-Y1-HB-5026-01 entitled "Global HIV panel project" (PI: M.P.B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyrer C, 1997, LANCET, V349, P649, DOI 10.1016/S0140-6736(05)61594-2; Blaizot S, 2017, AIDS RES HUM RETROV, V33, P472, DOI [10.1089/aid.2016.0123, 10.1089/AID.2016.0123]; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Busch MP, 2010, AIDS, V24, P2763, DOI 10.1097/QAD.0b013e32833f1142; Duong YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033328; Gary MA, 2003, J VIROL METHODS, V113, P79, DOI 10.1016/S0166-0934(03)00222-2; Hallett TB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005720; Highleyman L., 1999, BETA, V12, P78; Janssen RS, 1998, JAMA-J AM MED ASSOC, V281, P1893; Justman JE, 2018, NEW ENGL J MED, V378, P1859, DOI 10.1056/NEJMp1801934; Kassanjee R, 2014, AIDS, V28, P2439, DOI 10.1097/QAD.0000000000000429; Kassanjee R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020027; Keating SM, 2012, J CLIN MICROBIOL, V50, P3968, DOI 10.1128/JCM.01454-12; Kim AA, 2018, AIDS RES HUM RETROV, V34, P863, DOI [10.1089/aid.2017.0316, 10.1089/AID.2017.0316]; Laeyendecker O, 2008, JAIDS-J ACQ IMM DEF, V48, P211, DOI 10.1097/QAI.0b013e3181743980; Mei JV, 2011, J ACQ IMMUN DEF SYND, V58, P7; Murphy G, 2017, EPIDEMIOL INFECT, V145, P925, DOI 10.1017/S0950268816002910; Murphy G, 2008, EURO SURVEILL, V13; Ostrowski M, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv138; Parekh BS, 2011, AIDS RES HUM RETROV, V27, P265, DOI 10.1089/aid.2010.0159; Rawal BD, 2003, JAIDS-J ACQ IMM DEF, V33, P349, DOI 10.1097/00126334-200307010-00009; Rountree W, 2014, J IMMUNOL METHODS, V409, P72, DOI 10.1016/j.jim.2014.01.007; Schlusser KE, 2017, AIDS RES HUM RETROV, V33, P555, DOI 10.1089/aid.2016.0245; Sempa JB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220345; Sharma S, 2019, AIDS, V33, P1335, DOI 10.1097/QAD.0000000000002219; Soodla P, 2018, HIV MED, V19, P33, DOI 10.1111/hiv.12535; Suligoi B, 2003, JAIDS-J ACQ IMM DEF, V32, P424, DOI 10.1097/00126334-200304010-00012; Suligoi B, 2011, J CLIN MICROBIOL, V49, P2610, DOI 10.1128/JCM.02115-10; Young CL, 2003, AIDS RES HUM RETROV, V19, P481, DOI 10.1089/088922203766774522	29	5	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222290	10.1371/journal.pone.0222290	http://dx.doi.org/10.1371/journal.pone.0222290			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525218	gold, Green Published, Green Submitted			2022-12-26	WOS:000532225700025
J	Freeman, CG; Saccone, EJ; Chouinard, PA				Freeman, Cody G.; Saccone, Elizabeth J.; Chouinard, Philippe A.			Low-level sensory processes play a more crucial role than high-level cognitive ones in the size-weight illusion	PLOS ONE			English	Article							HEAVINESS; INDEPENDENCE; PERCEPTION; ATTENTION; DENSITY; OBJECTS; EXPECTANCIES; VOLUME; PRIORS; CUES	The size-weight illusion (SWI) pertains to the experience of perceiving the smaller of two equally weighted objects as heavier. Competing theories to explain the illusion can be generally grouped into cognitive and sensory theories, which place more importance on top-down processing of cognitive expectations and bottom-up processing of sensory information about the size and weight of objects, respectively. The current study examined the relative contribution of these two general explanations. This was done by varying the amounts of cognitive load in a dual-task and the quality of somatosensory feedback by wearing or not wearing gloves. Participants placed their hands through a curtain inside a box so they could not see the test objects. Inside the box, they were presented with either a small or large sphere of varying weights, which they explored manually without vision. Participants provided magnitude estimates about each object's weight in four experimental conditions (no-load with gloves, no-load without gloves, low-load without gloves, and high-load without gloves). The dual-task involved the visual presentation of a cross on a computer monitor that changed in both colour and orientation. With foot pedals, the participants responded to a target colour and / or orientation, which varied across conditions, while they hefted an object. Some conditions were designed to be more cognitively taxing than others (high-load > low-load > no-load conditions). The results revealed that the strength of the SWI diminished when participants wore the gloves but did not change as cognitive load increased on the dual-task. We conclude that the illusion is more influenced by bottom-up sensory than top-down cognitive processes.	[Freeman, Cody G.; Saccone, Elizabeth J.; Chouinard, Philippe A.] La Trobe Univ, Sch Psychol & Publ Hlth, Dept Psychol & Counselling, Melbourne, Vic, Australia	La Trobe University	Chouinard, PA (corresponding author), La Trobe Univ, Sch Psychol & Publ Hlth, Dept Psychol & Counselling, Melbourne, Vic, Australia.	p.chouinard@latrobe.edu.au	Chouinard, Philippe/AEP-6474-2022	Chouinard, Philippe/0000-0001-9817-0689; Saccone, Elizabeth/0000-0001-5763-6198	Australian Research Council [DP170103189]; School of Psychology and Public Health at La Trobe University	Australian Research Council(Australian Research Council); School of Psychology and Public Health at La Trobe University	The authors would like to thank the School of Psychology and Public Health at La Trobe University (www.latrobe.edu.au/schoolpsychology-and-public-health) for providing a research allocation to CGF and the Australian Research Council (www.arc.gov.au) for awarding a grant (DP170103189) to PAC, both of which provided financial support for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amazeen EL, 1999, J EXP PSYCHOL HUMAN, V25, P102, DOI 10.1037/0096-1523.25.1.102; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Baugh LA, 2016, J NEUROPHYSIOL, V116, P1615, DOI 10.1152/jn.00282.2016; Bell-Krotoski J, 1993, J Hand Ther, V6, P114; Buckingham G, 2016, J NEUROPHYSIOL, V115, P1946, DOI 10.1152/jn.00587.2015; Buckingham G, 2016, Q J EXP PSYCHOL, V69, P1831, DOI 10.1080/17470218.2015.1100642; Buckingham G, 2014, EXP BRAIN RES, V232, P1623, DOI 10.1007/s00221-014-3926-9; Buckingham G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054709; Buckingham G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009709; Charpentier A., 1891, ARCHIVE PHYSIOLOGIE, V3, P122; Chouinard PA, 2009, NEUROIMAGE, V44, P200, DOI 10.1016/j.neuroimage.2008.08.023; COLE JD, 1992, J PHYSIOL-LONDON, V449, P503, DOI 10.1113/jphysiol.1992.sp019099; Dijker AJM, 2008, COGNITION, V106, P1109, DOI 10.1016/j.cognition.2007.05.009; Dijker AJM, 2014, PSYCHON B REV, V21, P1404, DOI 10.3758/s13423-014-0634-1; Ellis RR, 1998, PERCEPTION, V27, P193, DOI 10.1068/p270193; ELLIS RR, 1993, PERCEPT PSYCHOPHYS, V53, P315, DOI 10.3758/BF03205186; Flanagan JR, 2008, CURR BIOL, V18, P1742, DOI 10.1016/j.cub.2008.09.042; Flanagan JR, 2000, NAT NEUROSCI, V3, P737, DOI 10.1038/76701; Flournoy, 1894, ANN PSYCHOL, V1, P198, DOI [DOI 10.3406/PSY.1894.1051, 10.3406/psy.1894.1051]; Gregory RL, 1997, PHILOS T ROY SOC B, V352, P1121, DOI 10.1098/rstb.1997.0095; HARSHFIELD SP, 1970, PSYCHON SCI, V20, P365, DOI 10.3758/BF03335692; Huang I, 1945, J GEN PSYCHOL, V33, P65, DOI 10.1080/00221309.1945.10544495; Huang LQ, 2005, COGNITION, V94, pB101, DOI 10.1016/j.cognition.2004.06.006; IBM Corporation, 2015, STAT PACK SOC SCI VE; Ishihara S., 1960, TESTS COLOUR BLINDNE; Jarosz AF, 2014, J PROBL SOLVING, V7, P2, DOI 10.7771/1932-6246.1167; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Kahneman D., 1973, ATTENTION EFFORT; Kloos H, 2002, BRIT J DEV PSYCHOL, V20, P171, DOI 10.1348/026151002166398; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; LOGAN GD, 1979, J EXP PSYCHOL HUMAN, V5, P189; MASIN SC, 1988, PERCEPT PSYCHOPHYS, V44, P309, DOI 10.3758/BF03210411; McGlone F, 2010, NEUROSCI BIOBEHAV R, V34, P148, DOI 10.1016/j.neubiorev.2009.08.004; Noguchi Y, 2012, J COGNITIVE NEUROSCI, V24, P1983, DOI 10.1162/jocn_a_00262; Oberle CD, 2003, PERCEPT PSYCHOPHYS, V65, P831, DOI 10.3758/BF03194818; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PETERS H B, 1961, Am J Optom Arch Am Acad Optom, V38, P487; Peters MAK, 2016, PEERJ, V4, DOI 10.7717/peerj.2124; Peters MAK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119794; Piaget J., 2003, PSYCHOL INTELLIGENCE; Plaisier MA, 2019, PSYCHOL SCI, V30, P822, DOI 10.1177/0956797619837981; Plaisier MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep17719; ROSS J, 1970, PERCEPT PSYCHOPHYS, V7, P161, DOI 10.3758/BF03208648; Rowe MJ, 2002, ADV EXP MED BIOL, V508, P47; Saccone EJ, PSYCHONOMIC B UNPUB; Saccone EJ, 2019, I-PERCEPTION, V10, DOI 10.1177/2041669519850590; Saccone EJ, 2019, PSYCHON B REV, V26, P77, DOI 10.3758/s13423-018-1519-5; Schneider W, 1982, AUTOMATIC CONTROL PR; Schwartz S, 2005, CEREB CORTEX, V15, P770, DOI 10.1093/cercor/bhh178; STEVENS JC, 1970, PERCEPT PSYCHOPHYS, V8, P225, DOI 10.3758/BF03210210; Thouless RH, 1931, B J PSYCHOL-GEN SECT, V21, P339, DOI 10.1111/j.2044-8295.1931.tb00597.x; Travis SL, 2017, J EXP PSYCHOL HUMAN, V43, P1944, DOI 10.1037/xhp0000458; Trewartha KM, 2017, COGNITION, V163, P121, DOI 10.1016/j.cognition.2017.02.014; Wagenmakers EJ, 2007, PSYCHON B REV, V14, P779, DOI 10.3758/BF03194105; WICKELGREN WA, 1977, ACTA PSYCHOL, V41, P67, DOI 10.1016/0001-6918(77)90012-9; Wickens C. D., 2007, APPL ATTENTION THEOR; Wolf C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190624; Wolfe H. K., 1898, PSYCHOL REV, V5, P25, DOI [DOI 10.1037/H0073342, 10.1037/h0073342]; ZWISLOCKI JJ, 1980, PERCEPT PSYCHOPHYS, V28, P28, DOI 10.3758/BF03204312	59	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2019	14	9							e0222564	10.1371/journal.pone.0222564	http://dx.doi.org/10.1371/journal.pone.0222564			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4KS	31518376	gold, Green Published, Green Submitted			2022-12-26	WOS:000532219300026
J	Cui, KS; Liu, C; Li, X; Zhang, Q; Li, YJ				Cui, Kaisa; Liu, Cheng; Li, Xu; Zhang, Qiang; Li, Youjun			Comprehensive characterization of the rRNA metabolism-related genes in human cancer	ONCOGENE			English	Article							COLON-CANCER; END-POINTS; EXOSOME; BOP1; TUMORIGENESIS; DEFINITIONS; EXPRESSION; SIGNATURES; DATABASE; ONTOLOGY	Although rRNA metabolism-related genes have been reported to be associated with human cancer, a systematic assessment of rRNA metabolism-related genes across human cancers is lacking. Thus, we performed a Pan-cancer analysis of rRNA metabolism-related genes across 20 human cancers. Here, we examined mRNA expression, mutation, DNA methylation, copy number variation (CNV) and clinical landscape of rRNA metabolism-related genes in more than 8600 patients across 20 human cancers from The Cancer Genome Atlas (TCGA) dataset. Besides, ten independent Gene Expression Omnibus (GEO) datasets, Cancer Cell Line Encyclopedia (CCLE) dataset and Project Achilles dataset were used to verify our study. A landscape of rRNA metabolism-related genes was established across 20 human cancers. The results suggest that rRNA metabolism-related genes are upregulated in multiple cancers, particularly in digestive and respiratory system cancers. Most of the upregulated genes were driven by CNV gain rather than mutation or DNA hypomethylation. We systematically identified CNV-driven rRNA metabolism-related genes with clinical relevance, including EXOSC8. Finally, functional experiments confirmed the oncogenic roles of EXOSC8 in colorectal carcinoma. Our study highlights the important roles of rRNA metabolism-related genes in tumorigenesis as prognostic biomarkers.	[Cui, Kaisa; Liu, Cheng; Li, Xu; Zhang, Qiang; Li, Youjun] Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Peoples R China; [Cui, Kaisa; Liu, Cheng; Li, Xu; Zhang, Qiang; Li, Youjun] Wuhan Univ, Sch Med, Med Res Inst, Wuhan 430071, Peoples R China	Wuhan University; Wuhan University	Li, YJ (corresponding author), Wuhan Univ, Coll Life Sci, Hubei Key Lab Cell Homeostasis, Wuhan 430072, Peoples R China.; Li, YJ (corresponding author), Wuhan Univ, Sch Med, Med Res Inst, Wuhan 430071, Peoples R China.	liy7@whu.edu.cn	Cui, Kaisa/AAM-6601-2020	Cui, Kaisa/0000-0001-7255-2689	National Key R&D Program of China [2016YFC1302300]; National Nature Science Foundation of China [81772609]; Medical Science Advancement Program (Basic Medical Sciences) of Wuhan University [TFJC2018005]	National Key R&D Program of China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Science Advancement Program (Basic Medical Sciences) of Wuhan University	We thank the TCGA, GEO, CCLE and Project Achilles teams. We thank Professor Jinxiang Zhang (Wuhan Union Hospital, Wuhan) for providing the CRC patient samples. This work was supported by grants from the National Key R&D Program of China (2016YFC1302300), National Nature Science Foundation of China (81772609) and Medical Science Advancement Program (Basic Medical Sciences) of Wuhan University (TFJC2018005).	Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bhattacharya C, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-82; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Calo E, 2018, NATURE, V554, P112, DOI 10.1038/nature25449; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Chestkov IV, 2018, SCHIZOPHR RES, V197, P305, DOI 10.1016/j.schres.2018.01.001; Choudhury P, 2019, RNA BIOL, V16, P54, DOI 10.1080/15476286.2018.1556149; Chung KY, 2011, HEPATOLOGY, V54, P307, DOI 10.1002/hep.24372; Cowling VH, 2014, ONCOGENE, V33, P3519, DOI 10.1038/onc.2013.338; Dolezal JM, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4178-z; Driscoll JJ, 2009, CANCER J, V15, P401, DOI 10.1097/PPO.0b013e3181bdc2e0; Ehrlich M, 2009, EPIGENOMICS-UK, V1, P239, DOI 10.2217/EPI.09.33; Foroutan M, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2435-4; Gamazon ER, 2015, BRIEF FUNCT GENOMICS, V14, P352, DOI 10.1093/bfgp/elv017; Gantenbein N, 2018, EUR J CANCER, V101, P165, DOI 10.1016/j.ejca.2018.07.001; Ge ZQ, 2018, CELL REP, V23, P213, DOI 10.1016/j.celrep.2018.03.047; Gong J, 2017, CELL REP, V21, P1968, DOI 10.1016/j.celrep.2017.10.070; Haag S, 2015, RNA, V21, P180, DOI 10.1261/rna.047910.114; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Helleday T, 2014, NAT REV GENET, V15, P585, DOI 10.1038/nrg3729; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Killian A, 2006, GENE CHROMOSOME CANC, V45, P874, DOI 10.1002/gcc.20351; Kulkarni S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182705; Li WJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0523-z; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lin TC, 2016, ELIFE, V5, DOI 10.7554/eLife.11288; Liu TZ, 2016, CANCER RES, V76, P572, DOI 10.1158/0008-5472.CAN-15-0671; Maruvka YE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083100; Mayakonda A, 2018, GENOME RES, V28, P1747, DOI 10.1101/gr.239244.118; McIver SC, 2014, BLOOD, V124, P2285, DOI 10.1182/blood-2014-04-571083; Meyers RM, 2017, NAT GENET, V49, P1779, DOI 10.1038/ng.3984; Miluzio A, 2011, CANCER CELL, V19, P765, DOI 10.1016/j.ccr.2011.04.018; Pan Y, 2018, MOL CARCINOGEN, V57, P1780, DOI 10.1002/mc.22896; Prieto JL, 2007, GENE DEV, V21, P2041, DOI 10.1101/gad.436707; Punt CJA, 2007, JNCI-J NATL CANCER I, V99, P998, DOI 10.1093/jnci/djm024; Rohrmoser M, 2007, MOL CELL BIOL, V27, P3682, DOI 10.1128/MCB.00172-07; Ruggero D, 2014, BLOOD, V124, P2784, DOI 10.1182/blood-2014-04-526301; Schaub FX, 2018, CELL SYST, V6, P282, DOI 10.1016/j.cels.2018.03.003; Shen HX, 2017, CELL DEATH DIFFER, V24, P1253, DOI 10.1038/cdd.2017.63; Sloan KE, 2014, RNA, V20, P540, DOI 10.1261/rna.043471.113; Song JL, 2018, J CELL MOL MED, V22, P6304, DOI 10.1111/jcmm.13922; Srivastava L, 2010, MOL CELL BIOL, V30, P2947, DOI 10.1128/MCB.00226-10; Stransky N, 2015, NATURE, V528, P84, DOI 10.1038/nature15736; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tai P, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-48; Tang XL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00396-9; Tsoi H, 2017, ONCOGENE, V36, P6109, DOI 10.1038/onc.2017.86; Van Dijk EL, 2007, RNA, V13, P1027, DOI 10.1261/rna.575107; Wang YM, 2018, CELL REP, V25, P1304, DOI 10.1016/j.celrep.2018.10.001; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Yan DM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15749-z; Ye YQ, 2019, NAT METAB, V1, P431, DOI 10.1038/s42255-019-0045-8; Zhu YH, 2017, CELL DEATH DIFFER, V24, P2199, DOI 10.1038/cdd.2017.151	57	28	28	2	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	4					786	800		10.1038/s41388-019-1026-9	http://dx.doi.org/10.1038/s41388-019-1026-9			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KF4EJ	31548613				2022-12-26	WOS:000509197200004
J	Kim, SM; Park, M; Yee, SM; Ji, KY; Lee, EH; Nguyen, TV; Nguyen, THL; Jang, J; Kim, EM; Choi, HR; Yun, CH; Kang, HS				Kim, Su-Man; Park, Min; Yee, Su-Min; Ji, Kon-Young; Lee, Eun-Hee; Thi-Van Nguyen; Thi Hong-Loan Nguyen; Jang, Jin; Kim, Eun-Mi; Choi, Ha-Rim; Yun, Chul-Ho; Kang, Hyung-Sik			Axl is a key regulator of intestinal gamma delta T-cell homeostasis	FASEB JOURNAL			English	Article						CCL25; migration; bacterial resistance	RECEPTOR TYROSINE KINASE; EPITHELIAL-CELLS; CHEMOKINE TECK; LYMPHOCYTES; EXPRESSION; MIGRATION; TRAFFICKING; ADHESION; ORIGIN; CCL25	Gut-homing gamma delta T cells are induced by chemokines and cell adhesion molecules and play a critical role in homeostasis and mucosal immunity; however, little is known regarding their upstream regulators. We investigated the role of Axl as a specific regulator of chemokines and cell adhesion molecule in the distribution of intestinal gamma delta T cells. The population of gamma delta T-cell receptor-positive cells including V gamma 1 and V gamma 7 subsets was remarkably increased in the intraepithelial lymphocytes of Axl(-/-) mice compared with those of wild-type (WT) mice. An increased number of migrated gamma delta T cells were observed in the coculture with intraepithelial cells from Axl(-/-) mice. The mRNA expression level of chemokine (C-C motif) ligand (CCL) 25 was specifically higher in the small intestine of Axl(-/-) mice than in WT mice. In adoptive transfer, the migration of both thymic and extrathymic gamma delta T cells was increased in Axl(-/-) mice. The activation of Axl signaling down-regulated CCL25 expression via ERK signaling pathway and reduced the population of gamma delta T cells. Systemic dissemination was suppressed in Axl(-/-) mice infected with Salmonella typhimurium. Thus, our findings suggest that Axl plays a critical role in regulating the migration of gamma delta T cells for the maintenance of homeostasis and bacterial resistance.	[Kim, Su-Man; Park, Min; Yee, Su-Min; Ji, Kon-Young; Thi-Van Nguyen; Thi Hong-Loan Nguyen; Jang, Jin; Yun, Chul-Ho; Kang, Hyung-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, 77 Yongbong Ro, Gwangju 500757, South Korea; [Lee, Eun-Hee] Deagu Gyeongbuk Med Innovat Fdn, Daegu, South Korea; [Kim, Eun-Mi] Korea Inst Toxicol, Predict Model Res Ctr, Daejeon, South Korea; [Choi, Ha-Rim] Nambu Univ, Dept Nursing, Gwangju, South Korea	Chonnam National University; Korea Institute of Toxicology; Nambu University	Kang, HS (corresponding author), Chonnam Natl Univ, Sch Biol Sci & Technol, 77 Yongbong Ro, Gwangju 500757, South Korea.	kanghs@jnu.ac.kr	Ji, Kon-Young/GZB-2640-2022	Kim, Su-Man/0000-0002-0588-8294	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science [NRF-2018R1A2B6005139]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Basic Research Laboratory [NRF-2018R1A4A1023882]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Basic Research Laboratory(National Research Foundation of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), and funded by the Ministry of Science (NRF-2018R1A2B6005139) and the Basic Research Laboratory (NRF-2018R1A4A1023882). The authors declare no conflicts of interest.	Allen MP, 2002, MOL CELL BIOL, V22, P599, DOI 10.1128/MCB.22.2.599-613.2002; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; Costa MFS, 2012, EUR J IMMUNOL, V42, P1250, DOI 10.1002/eji.201142021; Cox D, 2010, NAT REV DRUG DISCOV, V9, P804, DOI 10.1038/nrd3266; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Edelblum KL, 2015, GASTROENTEROLOGY, V148, P1417, DOI 10.1053/j.gastro.2015.02.053; Ericsson A, 2004, EUR J IMMUNOL, V34, P2720, DOI 10.1002/eji.200425125; FUJIHASHI K, 1992, J EXP MED, V175, P695, DOI 10.1084/jem.175.3.695; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Guy-Grand D, 2013, J EXP MED, V210, P1839, DOI 10.1084/jem.20122588; Hayday A, 2008, MUCOSAL IMMUNOL, V1, P172, DOI 10.1038/mi.2008.8; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Inagaki-Ohara K, 2004, J IMMUNOL, V173, P1390, DOI 10.4049/jimmunol.173.2.1390; Jameson JM, 2004, FRONT BIOSCI-LANDMRK, V9, P2640, DOI 10.2741/1423; JANEWAY CA, 1988, IMMUNOL TODAY, V9, P73, DOI 10.1016/0167-5699(88)91267-4; Kim SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11634-x; KOMANO H, 1995, P NATL ACAD SCI USA, V92, P6147, DOI 10.1073/pnas.92.13.6147; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Kurd N, 2014, IMMUNITY, V41, P167, DOI 10.1016/j.immuni.2014.08.004; Linger RMA, 2013, ONCOGENE, V32, P3420, DOI 10.1038/onc.2012.355; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Marsal J, 2002, EUR J IMMUNOL, V32, P3488, DOI 10.1002/1521-4141(200212)32:12<3488::AID-IMMU3488>3.0.CO;2-E; Miles A, 2008, AM J PHYSIOL-GASTR L, V294, pG1257, DOI 10.1152/ajpgi.00266.2007; Mudduluru G, 2011, ONCOGENE, V30, P2888, DOI 10.1038/onc.2011.13; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; NEUBAUER A, 1994, BLOOD, V84, P1931; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; Parmo-Cabanas M, 2007, J LEUKOCYTE BIOL, V82, P380, DOI 10.1189/jlb.1206726; Penido C, 2008, INT IMMUNOL, V20, P129, DOI 10.1093/intimm/dxm128; Qin G, 2009, J INFECT DIS, V200, P858, DOI 10.1086/605413; Ribeiro S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00015; Bono MR, 2007, CYTOKINE GROWTH F R, V18, P33, DOI 10.1016/j.cytogfr.2007.01.004; Shankar SL, 2006, J NEUROSCI, V26, P5638, DOI 10.1523/JNEUROSCI.5063-05.2006; Sokol CL, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016303; Su DL, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/985753; Suzuki S, 1998, EUR J IMMUNOL, V28, P3719, DOI 10.1002/(SICI)1521-4141(199811)28:11<3719::AID-IMMU3719>3.3.CO;2-F; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Uehara S, 2002, J IMMUNOL, V168, P2811, DOI 10.4049/jimmunol.168.6.2811; Waldmann TA, 2003, NAT MED, V9, P269, DOI 10.1038/nm0303-269; Wang X, 1997, J MED MICROBIOL, V46, P657, DOI 10.1099/00222615-46-8-657; Wu YL, 2014, INT J BIOL SCI, V10, P119, DOI 10.7150/ijbs.7823; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; Wurbel MA, 2001, BLOOD, V98, P2626, DOI 10.1182/blood.V98.9.2626; Wurbel MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016442; Zeremski M, 2007, J VIRAL HEPATITIS, V14, P675, DOI 10.1111/j.1365-2893.2006.00838.x; Zhang JH, 2005, CELL MOL IMMUNOL, V2, P271; Zhang LY, 2013, J MED VIROL, V85, P149, DOI 10.1002/jmv.23435; Zheng J, 2013, CELL MOL IMMUNOL, V10, P50, DOI 10.1038/cmi.2012.43; Zlotnik A, 2011, NAT REV IMMUNOL, V11, P597, DOI 10.1038/nri3049	54	3	3	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13386	13397		10.1096/fj.201901356R	http://dx.doi.org/10.1096/fj.201901356R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31550172				2022-12-26	WOS:000507466100028
J	Ajit, D; Trzeciakiewicz, H; Tseng, JH; Wander, CM; Chen, YJ; Ajit, A; King, DP; Cohen, TJ				Ajit, Deepa; Trzeciakiewicz, Hanna; Tseng, Jui-Heng; Wander, Connor M.; Chen, Youjun; Ajit, Aditi; King, Diamond P.; Cohen, Todd J.			A unique tau conformation generated by an acetylation-mimic substitution modulates P301S-dependent tau pathology and hyperphosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; Alzheimer disease; excitotoxicity; neuroinflammation; post-translational modification (PTM); tau protein (tau)	SLOW AXONAL-TRANSPORT; POSTTRANSLATIONAL MODIFICATIONS; NEUROFIBRILLARY TANGLES; POSTSYNAPTIC DENSITY-95; SYNAPTIC PLASTICITY; MICROTUBULE-BINDING; WILD-TYPE; ACCUMULATION; AGGREGATION; CLEAVAGE	Abnormal intracellular accumulation of aggregated tau is a hallmark feature of Alzheimer's disease and other tauopathies. Pathological tau can undergo a range of post-translational modifications (PTMs) that are implicated as triggers of disease pathology. Recent studies now indicate that tau acetylation, in particular, controls both microtubule binding and tau aggregation, thereby acting as a central regulator of tau's biochemical properties and providing avenues to exploit for potential therapies. Here, using cell-based assays and tau transgenic mice harboring an acetylation-mimic mutation at residue Lys-280 (K280Q), we evaluated whether this substitution modifies the neurodegenerative disease pathology associated with the aggregate-prone tau P301S variant. Strikingly, the addition of a K280Q-substituted variant altered P301S-mediated tau conformation and reduced tau hyperphosphorylation. We further evaluated neurodegeneration markers in K280Q acetylation-mimic mice and observed reduced neuroinflammation as well as restored levels of N-methyl-d-aspartate receptors and post-synaptic markers compared with the parental mice. Thus, substituting a single lysine residue in the context of a P301S disease-linked mutation produces a unique tau species that abrogates some of the cardinal features of tauopathy. The findings of our study indicate that a complex tau PTM code likely regulates tau pathogenesis, highlighting the potential utility of manipulating and detoxifying tau strains through site-specific tau-targeting approaches.	[Ajit, Deepa; Trzeciakiewicz, Hanna; Tseng, Jui-Heng; Wander, Connor M.; Chen, Youjun; Ajit, Aditi; King, Diamond P.; Cohen, Todd J.] Univ N Carolina, UNC Neurosci Ctr, Dept Neurol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Cohen, TJ (corresponding author), Univ N Carolina, UNC Neurosci Ctr, Dept Neurol, Chapel Hill, NC 27599 USA.	toddcohen@neurology.unc.edu	, Pathology Services Core/CEZ-2246-2022; , UNC Neuroscience Microscopy Core/AAE-8305-2022	Ajit, Deepa/0000-0002-6062-7070; Tseng, Jui-Heng/0000-0002-9036-9121	National Institutes of Health [R21AG058080]; National Center for Advancing Translational Sciences (NCATS) [UL1TR001111]; Alzheimer's Association [NIRG-14-321219]; Association for Frontotemporal Degeneration (AFTD) pilot grant; American Federation for Aging Research (AFAR) [RAG15247]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG058080] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences (NCATS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Alzheimer's Association(Alzheimer's Association); Association for Frontotemporal Degeneration (AFTD) pilot grant; American Federation for Aging Research (AFAR); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grant R21AG058080 (to T. J. C.), the National Center for Advancing Translational Sciences (NCATS) Grant UL1TR001111 (to T. J. C.), Alzheimer's Association Grant NIRG-14-321219 (to T. J. C.), an Association for Frontotemporal Degeneration (AFTD) pilot grant (to T. J. C.), and American Federation for Aging Research (AFAR) Grant RAG15247 (to T. J. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abisambra J, 2013, BIOL PSYCHIAT, V74, P367, DOI 10.1016/j.biopsych.2013.02.027; Basurto-Islas G, 2008, J NEUROPATH EXP NEUR, V67, P470, DOI 10.1097/NEN.0b013e31817275c7; Blair LJ, 2015, J NEUROCHEM, V133, P1, DOI 10.1111/jnc.13033; Carlonnagno Y, 2017, J BIOL CHEM, V292, P15277, DOI 10.1074/jbc.M117.794602; Cohen TJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1255; Cook C, 2014, HUM MOL GENET, V23, P104, DOI 10.1093/hmg/ddt402; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dickey CA, 2006, J NEUROSCI, V26, P6985, DOI 10.1523/JNEUROSCI.0746-06.2006; Dong YN, 2004, J NEUROSCI, V24, P11035, DOI 10.1523/JNEUROSCI.3722-04.2004; Eroglu B, 2010, MOL CELL BIOL, V30, P4626, DOI 10.1128/MCB.01493-09; Fischer D, 2009, BIOCHEMISTRY-US, V48, P10047, DOI 10.1021/bi901090m; Fontaine SN, 2015, HUM MOL GENET, V24, P3971, DOI 10.1093/hmg/ddv135; Fontaine SN, 2015, J BIOL CHEM, V290, P13115, DOI 10.1074/jbc.M115.637595; Ganguly A, 2017, J CELL BIOL, V216, P2059, DOI 10.1083/jcb.201604028; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; Gorsky MK, 2016, SCI REP-UK, V6, DOI 10.1038/srep22685; Grinberg LT, 2013, ACTA NEUROPATHOL, V125, P581, DOI 10.1007/s00401-013-1080-2; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; Haj-Yahya M, 2018, J AM CHEM SOC, V140, P6611, DOI 10.1021/jacs.8b02668; Hurtado DE, 2010, AM J PATHOL, V177, P1977, DOI 10.2353/ajpath.2010.100346; Iba M, 2015, ACTA NEUROPATHOL, V130, P349, DOI 10.1007/s00401-015-1458-4; Iba M, 2013, J NEUROSCI, V33, P1024, DOI 10.1523/JNEUROSCI.2642-12.2013; Irwin DJ, 2013, AM J PATHOL, V183, P344, DOI 10.1016/j.ajpath.2013.04.025; Irwin DJ, 2012, BRAIN, V135, P807, DOI 10.1093/brain/aws013; Ittner A, 2018, NEURON, V99, P13, DOI 10.1016/j.neuron.2018.06.003; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Jicha GA, 1999, J NEUROSCI RES, V55, P713, DOI 10.1002/(SICI)1097-4547(19990315)55:6<713::AID-JNR6>3.0.CO;2-G; Jinwal UK, 2013, FASEB J, V27, P1450, DOI 10.1096/fj.12-220889; Kamah A, 2014, BIOCHEMISTRY-US, V53, P3020, DOI 10.1021/bi500006v; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Min SW, 2018, J NEUROSCI, V38, P3680, DOI 10.1523/JNEUROSCI.2369-17.2018; Min SW, 2015, NAT MED, V21, P1154, DOI 10.1038/nm.3951; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Miyata Y, 2012, CHEM BIOL, V19, P1391, DOI 10.1016/j.chembiol.2012.07.026; Mondragon-Rodriguez S, 2008, INT J EXP PATHOL, V89, P81, DOI 10.1111/j.1365-2613.2007.00568.x; Morris M, 2015, NAT NEUROSCI, V18, P1183, DOI 10.1038/nn.4067; Narasimhan S, 2017, J NEUROSCI, V37, P11406, DOI 10.1523/JNEUROSCI.1230-17.2017; Salter MW, 2017, NAT MED, V23, P1018, DOI 10.1038/nm.4397; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Sankaranarayanan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125614; Sarkar M, 2008, J NEUROSCI RES, V86, P2763, DOI 10.1002/jnr.21721; Schneider A, 1999, BIOCHEMISTRY-US, V38, P3549, DOI 10.1021/bi981874p; Shimura H, 2004, J BIOL CHEM, V279, P17957, DOI 10.1074/jbc.M400351200; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Song LX, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0011-1; Tracy TE, 2016, NEURON, V90, P245, DOI 10.1016/j.neuron.2016.03.005; Trzeciakiewicz H, 2017, SCI REP-UK, V7, DOI 10.1038/srep44102; Tseng JH, 2017, CELL REP, V20, P2169, DOI 10.1016/j.celrep.2017.07.082; Utton MA, 2002, J NEUROSCI, V22, P6394; Yang XM, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00048; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Yuen EY, 2008, MOL PHARMACOL, V74, P360, DOI 10.1124/mol.108.046813	52	9	9	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16698	16711		10.1074/jbc.RA119.009674	http://dx.doi.org/10.1074/jbc.RA119.009674			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31543505	hybrid, Green Published			2022-12-26	WOS:000501801900019
J	Balkunde, R; Foroughi, L; Ewan, E; Emenecker, R; Cavalli, V; Dixit, R				Balkunde, Rachappa; Foroughi, Layla; Ewan, Eric; Emenecker, Ryan; Cavalli, Valeria; Dixit, Ram			Mechanism of microtubule plus-end tracking by the plant-specific SPR1 protein and its development as a versatile plus-end marker	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						microtubule; microtubule-associated protein (MAP); Arabidopsis thaliana; molecular imaging; plant physiology; cytoskeleton; end binding 1; microtubule-associated protein; SPIRAL1 (SPR1)	BINDING PROTEIN; CELL ELONGATION; GROWTH; ORGANIZATION; EB1; ENCODES	Microtubules are cytoskeletal polymers that perform diverse cellular functions. The plus ends of microtubules promote polymer assembly and disassembly and connect the microtubule tips to other cellular structures. The dynamics and functions of microtubule plus ends are governed by microtubule plus end?tracking proteins (+TIPs). Here we report that the Arabidopsis thaliana SPIRAL1 (SPR1) protein, which regulates directional cell expansion, is an autonomous +TIP. Using in vitro reconstitution experiments and total internal reflection fluorescence microscopy, we demonstrate that the conserved N-terminal region of SPR1 and its GGG motif are necessary for +TIP activity whereas the conserved C-terminal region and its PGGG motif are not. We further show that the N- and C-terminal regions, either separated or when fused in tandem (NC), are sufficient for +TIP activity and do not significantly perturb microtubule plus-end dynamics compared with full-length SPR1. We also found that exogenously expressed SPR1-GFP and NC-GFP label microtubule plus ends in plant and animal cells. These results establish SPR1 as a new type of intrinsic +TIP and reveal the utility of NC-GFP as a versatile microtubule plus-end marker.	[Balkunde, Rachappa; Foroughi, Layla; Emenecker, Ryan; Dixit, Ram] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Balkunde, Rachappa; Foroughi, Layla; Emenecker, Ryan; Dixit, Ram] Washington Univ, Ctr Engn Mechnobiol, St Louis, MO 63130 USA; [Ewan, Eric; Cavalli, Valeria] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63110 USA; [Cavalli, Valeria] Washington Univ, Sch Med, Ctr Regenerat Med, St Louis, MO 63110 USA; [Cavalli, Valeria] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Dixit, R (corresponding author), Washington Univ, Dept Biol, St Louis, MO 63130 USA.; Dixit, R (corresponding author), Washington Univ, Ctr Engn Mechnobiol, St Louis, MO 63130 USA.	ramdixit@wustl.edu		Balkunde, Rachappa/0000-0002-6059-9532; Emenecker, Ryan/0000-0001-7055-2773; Dixit, Ram/0000-0001-7881-2859	NINDS, National Institute of Health [R01 NS082446]; National Science Foundation CAREER Program [1453726]; NIGMS, National Institute of Health [R01 GM114678]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114678] Funding Source: NIH RePORTER	NINDS, National Institute of Health; National Science Foundation CAREER Program(National Science Foundation (NSF)); NIGMS, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by NINDS, National Institute of Health Grant R01 NS082446 (to V. C.) and National Science Foundation CAREER Program Grant 1453726 and NIGMS, National Institute of Health Grant R01 GM114678 (to R. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akhmanova A, 2010, J CELL SCI, V123, P3415, DOI 10.1242/jcs.062414; Belghasem M, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-113680; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Dixit R, 2006, MOL BIOL CELL, V17, P1298, DOI 10.1091/mbc.E05-09-0864; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; Furutani I, 2000, DEVELOPMENT, V127, P4443; Galva C, 2014, PLANT CELL, V26, P4409, DOI 10.1105/tpc.114.131482; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; Komaki S, 2010, J CELL SCI, V123, P451, DOI 10.1242/jcs.062703; Kumar A, 2017, STRUCTURE, V25, P924, DOI 10.1016/j.str.2017.04.010; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Lindeboom JJ, 2019, J CELL BIOL, V218, P190, DOI 10.1083/jcb.201805047; Ma YT, 2004, CURR BIOL, V14, P725, DOI 10.1016/j.cub.2004.03.061; Maurer SP, 2014, CURR BIOL, V24, P372, DOI 10.1016/j.cub.2013.12.042; Maurer SP, 2012, CELL, V149, P371, DOI 10.1016/j.cell.2012.02.049; Maurer SP, 2011, P NATL ACAD SCI USA, V108, P3988, DOI 10.1073/pnas.1014758108; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Nakajima K, 2006, PLANT CELL PHYSIOL, V47, P513, DOI 10.1093/pcp/pcj020; Nakajima K, 2004, PLANT CELL, V16, P1178, DOI 10.1105/tpc.017830; Salaycik KJ, 2005, J CELL SCI, V118, P4113, DOI 10.1242/jcs.02531; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sedbrook JC, 2004, PLANT CELL, V16, P1506, DOI 10.1105/tpc.020644; Stepanova T, 2003, J NEUROSCI, V23, P2655; Wong JH, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-0987-5; Yang C, 2017, J CELL BIOL, V216, P3179, DOI 10.1083/jcb.201701024; Yang WL, 2013, BIOCHEM J, V449, P605, DOI 10.1042/BJ20121121; Young RE, 2011, ADVAN PL BIO, V2, P95, DOI 10.1007/978-1-4419-0987-9_5	27	2	3	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					16374	16384		10.1074/jbc.RA119.008866	http://dx.doi.org/10.1074/jbc.RA119.008866			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31527079	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000499478600040
J	Bunch, TA; Kanassatega, RS; Lepak, VC; Colson, BA				Bunch, Thomas A.; Kanassatega, Rhye-Samuel; Lepak, Victoria C.; Colson, Brett A.			Human cardiac myosin?binding protein C restricts actin structural dynamics in a cooperative and phosphorylation-sensitive manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; cardiac muscle; contractile protein; phosphorylation; spectroscopy; cardiac myosin?binding protein C (cMyBP-C); motor protein; myofilament; protein kinase A (PKA); structural dynamics	N-TERMINAL DOMAINS; F-ACTIN; MYBP-C; ROTATIONAL-DYNAMICS; REGULATORY DOMAIN; MASS-SPECTROMETRY; THIN-FILAMENTS; LIGHT-CHAIN; MYOSIN; BINDING	Cardiac myosin?binding protein C (cMyBP-C) is a thick filament-associated protein that influences actin-myosin interactions. cMyBP-C alters myofilament structure and contractile properties in a protein kinase A (PKA) phosphorylation-dependent manner. To determine the effects of cMyBP-C and its phosphorylation on the microsecond rotational dynamics of actin filaments, we attached a phosphorescent probe to F-actin at Cys-374 and performed transient phosphorescence anisotropy (TPA) experiments. Binding of cMyBP-C N-terminal domains (C0?C2) to labeled F-actin reduced rotational flexibility by 20?25?, indicated by increased final anisotropy of the TPA decay. The effects of C0?C2 on actin TPA were highly cooperative (n = ?8), suggesting that the cMyBP-C N terminus impacts the rotational dynamics of actin spanning seven monomers (i.e. the length of tropomyosin). PKA-mediated phosphorylation of C0?C2 eliminated the cooperative effects on actin flexibility and modestly increased actin rotational rates. Effects of Ser to Asp phosphomimetic substitutions in the M-domain of C0?C2 on actin dynamics only partially recapitulated the phosphorylation effects. C0?C1 (lacking M-domain/C2) similarly exhibited reduced cooperativity, but not as reduced as by phosphorylated C0?C2. These results suggest an important regulatory role of the M-domain in cMyBP-C effects on actin structural dynamics. In contrast, phosphomimetic substitution of the glycogen synthase kinase (GSK3?) site in the Pro/Ala-rich linker of C0?C2 did not significantly affect the TPA results. We conclude that cMyBP-C binding and PKA-mediated phosphorylation can modulate actin dynamics. We propose that these N-terminal cMyBP-C?induced changes in actin dynamics help explain the functional effects of cMyBP-C phosphorylation on actin-myosin interactions.	[Bunch, Thomas A.; Kanassatega, Rhye-Samuel; Lepak, Victoria C.; Colson, Brett A.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85724 USA	University of Arizona	Colson, BA (corresponding author), Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85724 USA.	bcolson@email.arizona.edu		Colson, Brett/0000-0002-5721-4320; Kanassatega, Rhye-Samuel/0000-0001-9007-6524	National Institutes of Health [R00 HL122397, R01 HL141564]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL141564, R00HL122397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grants R00 HL122397 and R01 HL141564 (to B. A. C.). The authors declare that they have no conflicts of interest with the contents of this article.The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bardswell SC, 2010, J BIOL CHEM, V285, P5674, DOI 10.1074/jbc.M109.066456; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Belknap B, 2014, BIOCHEMISTRY-US, V53, P6717, DOI 10.1021/bi500787f; Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Bezold KL, 2013, J BIOL CHEM, V288, P21496, DOI 10.1074/jbc.M113.474346; Bunch TA, 2018, J MOL CELL CARDIOL, V125, P140, DOI 10.1016/j.yjmcc.2018.10.009; Chen PP, 2010, J GEN PHYSIOL, V136, P615, DOI 10.1085/jgp.201010448; Colson BA, 2016, P NATL ACAD SCI USA, V113, P3233, DOI 10.1073/pnas.1521281113; Colson BA, 2012, P NATL ACAD SCI USA, V109, P20437, DOI 10.1073/pnas.1213027109; Colson BA, 2012, J MOL CELL CARDIOL, V53, P609, DOI 10.1016/j.yjmcc.2012.07.012; Colson BA, 2010, J PHYSIOL-LONDON, V588, P981, DOI 10.1113/jphysiol.2009.183897; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Ge Y, 2009, P NATL ACAD SCI USA, V106, P12658, DOI 10.1073/pnas.0813369106; Gruen M, 1999, FEBS LETT, V453, P254, DOI 10.1016/S0014-5793(99)00727-9; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; Harris SP, 2016, P NATL ACAD SCI USA, V113, P1558, DOI 10.1073/pnas.1518891113; Hopkins SC, 2002, J MOL BIOL, V318, P1275, DOI 10.1016/S0022-2836(02)00189-4; Jeffries CM, 2008, J MOL BIOL, V377, P1186, DOI 10.1016/j.jmb.2008.01.080; Jia WT, 2010, J PROTEOME RES, V9, P1843, DOI 10.1021/pr901006h; Kampourakis T, 2018, J BIOL CHEM, V293, P14270, DOI 10.1074/jbc.AC118.004816; Kampourakis T, 2014, P NATL ACAD SCI USA, V111, P18763, DOI 10.1073/pnas.1413922112; Kensler RW, 2011, J STRUCT BIOL, V174, P44, DOI 10.1016/j.jsb.2010.12.003; Kulikovskaya I, 2003, J GEN PHYSIOL, V122, P761, DOI 10.1085/jgp.200308941; Kuster DWD, 2013, CIRC RES, V112, P633, DOI 10.1161/CIRCRESAHA.112.275602; Lee K, 2015, J MOL BIOL, V427, P274, DOI 10.1016/j.jmb.2014.10.023; Lin AY, 2012, J MOL BIOL, V420, P87, DOI 10.1016/j.jmb.2012.04.005; Lu YL, 2011, J MOL BIOL, V413, P908, DOI 10.1016/j.jmb.2011.09.026; Luther PK, 2011, P NATL ACAD SCI USA, V108, P11423, DOI 10.1073/pnas.1103216108; Mamidi R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602445; MOOS C, 1978, J MOL BIOL, V124, P571, DOI 10.1016/0022-2836(78)90172-9; Mun JY, 2014, P NATL ACAD SCI USA, V111, P2170, DOI 10.1073/pnas.1316001111; Mun JY, 2011, J MOL BIOL, V410, P214, DOI 10.1016/j.jmb.2011.05.010; Neuberger G, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-1; OKAGAKI T, 1993, J CELL BIOL, V123, P619, DOI 10.1083/jcb.123.3.619; Orlova A, 2011, J MOL BIOL, V412, P379, DOI 10.1016/j.jmb.2011.07.056; Ponnam S, 2019, P NATL ACAD SCI USA, V116, P15485, DOI 10.1073/pnas.1903033116; Previs MJ, 2016, P NATL ACAD SCI USA, V113, P3239, DOI 10.1073/pnas.1522236113; Previs MJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400205; Prochniewicz E, 2004, BIOCHEMISTRY-US, V43, P10642, DOI 10.1021/bi049914e; Prochniewicz E, 1996, J MOL BIOL, V255, P446, DOI 10.1006/jmbi.1996.0037; Prochniewicz E, 1997, BIOCHEMISTRY-US, V36, P12845, DOI 10.1021/bi971201r; Prochniewicz E, 2009, P NATL ACAD SCI USA, V106, P7822, DOI 10.1073/pnas.0812007106; PROCHNIEWICZNAKAYAMA E, 1983, J CELL BIOL, V97, P1663, DOI 10.1083/jcb.97.6.1663; Risi C, 2018, STRUCTURE, V26, P1604, DOI 10.1016/j.str.2018.08.007; Rosas PC, 2015, CIRC-HEART FAIL, V8, P582, DOI 10.1161/CIRCHEARTFAILURE.114.001550; Rybakova IN, 2011, J BIOL CHEM, V286, P2008, DOI 10.1074/jbc.M110.170605; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sadayappan S, 2011, CIRC RES, V109, P141, DOI 10.1161/CIRCRESAHA.111.242560; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; Squire JM, 2003, J MOL BIOL, V331, P713, DOI 10.1016/S0022-2836(03)00781-2; SQUIRE JM, 1982, J MOL BIOL, V155, P467, DOI 10.1016/0022-2836(82)90482-X; Thomas DD, 2011, COMPREHENSIVE BIOPHYSICS, VOL 4: MOLECULAR MOTORS AND MOTILITY, P226, DOI 10.1016/B978-0-12-374920-8.00415-X; THOMAS DD, 1979, J MOL BIOL, V132, P257, DOI 10.1016/0022-2836(79)90259-6; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Weith A, 2012, J MOL CELL CARDIOL, V52, P219, DOI 10.1016/j.yjmcc.2011.09.019; Whitten AE, 2008, P NATL ACAD SCI USA, V105, P18360, DOI 10.1073/pnas.0808903105; Witayavanitkul N, 2014, J BIOL CHEM, V289, P8818, DOI 10.1074/jbc.M113.541128; Zoghbi ME, 2008, P NATL ACAD SCI USA, V105, P2386, DOI 10.1073/pnas.0708912105	58	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					16228	16240		10.1074/jbc.RA119.009543	http://dx.doi.org/10.1074/jbc.RA119.009543			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31519753	hybrid, Green Published			2022-12-26	WOS:000499478600029
J	Hamid, M; Brooks, MB; Madhani, F; Ali, H; Naseer, MJ; Becerra, M; Amanullah, F				Hamid, Meherunissa; Brooks, Meredith B.; Madhani, Falak; Ali, Hassan; Naseer, Mohammad Junaid; Becerra, Mercedes; Amanullah, Farhana		Childhood Tb Karachi Grp	Risk factors for unsuccessful tuberculosis treatment outcomes in children	PLOS ONE			English	Article							CHILDHOOD TUBERCULOSIS; DIAGNOSIS; DISEASE; BURDEN	Objective Pakistan has a high pediatric burden of tuberculosis, but few studies describe the treatment experience of children with tuberculosis in Pakistan. We sought to identify risk factors for unsuccessful treatment outcomes in children with drug-susceptible tuberculosis identified in eight hospitals in Karachi, Pakistan. Design We conducted a retrospective cohort study among children (< 15 years old) treated with first-line anti-tuberculosis drugs for presumed or confirmed drug-susceptible tuberculosis between 2016 and 2017. We assessed risk factors for experiencing an unsuccessful treatment outcome through multivariable logistic regression analysis. Results In total, 1,665 children initiated tuberculosis treatment, including 916 (55.0%) identified through intensified case finding. Unsuccessful treatment outcomes were experienced by 197 (11.8%) children, comprising 27 (1.6%) deaths, 16 (1.0%) treatment failures, and 154 (9.3%) lost to follow-up. An additional 47 (2.8%) children had outcomes not evaluable. In multivariable analysis, children 0-4 years old (OR: 1.80, 95% CI: 1.07-3.04), males (OR: 1.48, 95% CI: 1.04, 2.11), and those with bacteriologic confirmation of disease (OR: 3.39, 95% CI: 1.98, 5.80) had increased odds of experiencing an unsuccessful treatment outcome. Conclusion Our findings suggest a need to deploy strategies to identify children earlier in the disease process and point to the need for interventions tailored for young children once treatment is initiated.	[Hamid, Meherunissa; Madhani, Falak; Ali, Hassan; Naseer, Mohammad Junaid; Amanullah, Farhana] Indus Hlth Network, Global Hlth Directorate, Karachi, Sindh, Pakistan; [Brooks, Meredith B.; Becerra, Mercedes] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Amanullah, Farhana] Indus Hosp, Dept Pediat, Karachi, Sindh, Pakistan	Harvard University; Harvard Medical School	Hamid, M (corresponding author), Indus Hlth Network, Global Hlth Directorate, Karachi, Sindh, Pakistan.	meherunissa.hamid@ghd.ihn.org.pk		Hamid, Meherunissa/0000-0002-8569-304X; Brooks, Meredith/0000-0001-8431-5517	Global Fund; Provincial TB Control Program (PTP), Sindh; National TB Control Program (NTP)-Pakistan	Global Fund; Provincial TB Control Program (PTP), Sindh; National TB Control Program (NTP)-Pakistan	This work is part of the Zero TB Initiative funded by the Global Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We express our deep gratitude to the management of (1) The Indus Hospital, (2) National Institute of Child Health, (3) Dr. Ruth K.M. Pfau Civil Hospital Karachi, (4) Murshid Hospital and Health Care Centre, (5) Sindh Government Hospital Korangi, (6) Sindh Government Hospital New Karachi, (7) Sindh Government Hospital Qatar, and (8) Sindh Government Hospital Liaquatabad for their willingness to collaborate and allowing us to conduct the childhood TB program in their hospitals. We are also indebted to the Provincial TB Control Program (PTP), Sindh, and the National TB Control Program (NTP)-Pakistan for their support. We thank the faculty of the Harvard Medical School Center for Global Health Delivery-Dubai that organized a Scientific Manuscript Writing Workshop in April 2018 for the feedback on the manuscript draft and analysis.; This work is part of the Zero TB Initiative funded by the Global Fund.	Aketi L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153914; Alavi SM, 2015, CASP J INTERN MED, V6, P213; [Anonymous], 2013, DEF REP FRAM TUB 201; [Anonymous], 2017, MAN CHILDH TUB; Aw B, 2017, PUBLIC HEALTH ACTION, V7, P199, DOI 10.5588/pha.16.0123; Dodd PJ, 2014, LANCET GLOB HEALTH, V2, pE453, DOI 10.1016/S2214-109X(14)70245-1; Harries A, 2006, MALAWI MED J, V17; Hesseling AC, 2002, INT J TUBERC LUNG D, V6, P1038; Ho J, 2016, INT J MYCOBACT, V5, P374, DOI 10.1016/j.ijmyco.2016.09.023; Jenkins HE, 2014, LANCET, V383, P1572, DOI 10.1016/S0140-6736(14)60195-1; LAGHARI M, 2018, PEERJ, V6, P84410, DOI DOI 10.1016/J.2545; Marais BJ, 2006, CLIN INFECT DIS, V42, pE69, DOI 10.1086/502652; Newton SM, 2008, LANCET INFECT DIS, V8, P498, DOI 10.1016/S1473-3099(08)70182-8; Ogbudebe CL, 2018, HEALTH SERV INSIGHTS, V11, DOI 10.1177/1178632918757490; Satyanarayana S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013338; Seddon JA, 2014, INFECT DRUG RESIST, V7, P153, DOI 10.2147/IDR.S45090; Tilahun G, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3193-8; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807	18	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222776	10.1371/journal.pone.0222776	http://dx.doi.org/10.1371/journal.pone.0222776			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553758	Green Submitted, gold, Green Published			2022-12-26	WOS:000532319200036
J	Hiraoka, Y; Okochi, Y; Ohshimo, S; Shimose, T; Ashida, H; Sato, T; Ando, Y				Hiraoka, Yuko; Okochi, Yumi; Ohshimo, Seiji; Shimose, Tamaki; Ashida, Hiroshi; Sato, Takuya; Ando, Yasuhiro			Lipid and fatty acid dynamics by maternal Pacific bluefin tuna	PLOS ONE			English	Article							THUNNUS-ORIENTALIS; REPRODUCTIVE-PERFORMANCE; RECRUITMENT; LARVAL; EGG; BIOLOGY; WALLEYE; GROWTH; FISH; ACCUMULATION	Lipid and fatty acid composition of female Pacific bluefin tuna (PBF, Thunnus orientalis) reproductive and somatic tissues in southwestern North Pacific and Sea of Japan spawning grounds are compared. Total lipid (TL) levels are higher in liver than white muscle tissues. An increased gonadosomatic index (GSI) during the early spawning season coincided with decreased TL. Levels of triacylglycerols (TAG) in PBF liver tissues from the Nansei Islands and Sea of Japan, and white muscle in fishes from the Sea of Japan, decreased during the spawning season, while TAG in ovary tissues did not. Concurrent reductions in TL and increases in GSI early in the spawning season suggest TAG depletion was caused by allocation from liver and white muscle tissues to oocytes, that the liver is one of the important lipid-storage organs in PBF, and this species mostly reliant on capital deposits as a mixed capital-income breeder. Differences of docosahexaenoic acid (DHA) levels between spawning grounds were lower in ovary than in muscle and liver tissues. However, eicosapentaenoic (EPA) and arachidonic acid (ARA) levels that influence egg development and embryo and larval growth are significantly higher in PBF tissues from the Sea of Japan than Nansei Islands, which coincided with larval quality. These suggest a maternal effect exists, with egg quality influencing offspring survival, and that the reproductive strategy of PBF varies according to local variation at each spawning ground.	[Hiraoka, Yuko; Ashida, Hiroshi; Sato, Takuya] Japan Fisheries Res & Educ Agcy, Natl Res Inst Far Seas Fisheries, Bluefin Tuna Resources Dept, Shizuoka, Shizuoka, Japan; [Okochi, Yumi] JAPAN NUS Co Ltd, Environm Management Unit, Shinjuku Ku, Tokyo, Japan; [Ohshimo, Seiji] Japan Fisheries Res & Educ Agcy, Seikai Natl Fisheries Res Inst, Fisheries Management & Oceanog Dept, Nagasaki, Nagasaki, Japan; [Shimose, Tamaki] Japan Fisheries Res & Educ Agcy, Seikai Natl Fisheries Res Inst, Res Ctr Subtrop Fisheries, Ishigaki, Okinawa, Japan; [Ando, Yasuhiro] Hokkaido Univ, Fac Fisheries Sci, Hakodate, Hokkaido, Japan	Japan Fisheries Research & Education Agency (FRA); Japan NUS; Japan Fisheries Research & Education Agency (FRA); Japan Fisheries Research & Education Agency (FRA); Hokkaido University	Hiraoka, Y (corresponding author), Japan Fisheries Res & Educ Agcy, Natl Res Inst Far Seas Fisheries, Bluefin Tuna Resources Dept, Shizuoka, Shizuoka, Japan.	yhira415@affrc.go.jp	Oshimo, Seiji/H-8674-2014; 環, 下瀬/AAF-7833-2021	環, 下瀬/0000-0003-2505-3611; Hiraoka, Yuko/0000-0002-1073-9234; OHSHIMO, Seiji/0000-0002-2883-7588	Japan Fisheries Agency	Japan Fisheries Agency	This work was supported by a grant from the Japan Fisheries Agency. JAPAN NUS Co. Ltd provided support in the form of salary for Yumi Okochi. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Aranda G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076445; Ashida H, 2015, ENVIRON BIOL FISH, V98, P1173, DOI 10.1007/s10641-014-0350-8; BALON EK, 1975, J FISH RES BOARD CAN, V32, P821, DOI 10.1139/f75-110; BARON CB, 1984, J LIQ CHROMATOGR, V7, P2793, DOI 10.1080/01483918408067046; Bell JG, 2003, AQUACULTURE, V218, P491, DOI 10.1016/S0044-8486(02)00370-8; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chen KS, 2006, FISHERIES SCI, V72, P985, DOI 10.1111/j.1444-2906.2006.01247.x; Collette BB, 1983, FAO SPECIES CATALOGU, V2; Dhurmeea Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194558; Fuiman LA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1414; Fuiman LA, 2011, J EXP MAR BIOL ECOL, V407, P155, DOI 10.1016/j.jembe.2011.06.004; Furuita H, 2000, AQUACULTURE, V187, P387, DOI 10.1016/S0044-8486(00)00319-7; Grande M, 2016, J FISH BIOL, V89, P2434, DOI 10.1111/jfb.13125; Hachero-Cruzado I, 2012, AQUAC RES, V43, P1439, DOI 10.1111/j.1365-2109.2011.02946.x; Harford WJ, 2017, FISH OCEANOGR, V26, P396, DOI 10.1111/fog.12205; Henderson BA, 1996, CAN J FISH AQUAT SCI, V53, P127, DOI 10.1139/cjfas-53-1-127; ISC, 2018, 18 M INT SCI COMM TU; Ishida Y, 2018, FISH OCEANOGR, V27, P41, DOI 10.1111/fog.12232; Ishihara T, 2019, ENVIRON BIOL FISH, V102, P581, DOI 10.1007/s10641-019-00855-w; Johnson RB, 2009, REV FISH SCI, V17, P78, DOI 10.1080/10641260802590004; Johnston TA, 2007, ECOL FRESHW FISH, V16, P295, DOI 10.1111/j.1600-0633.2006.00219.x; Johnston TA, 2002, ECOLOGY, V83, P1777, DOI 10.2307/3071764; Jusup M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021903; Kitagawa T, 2010, J EXP MAR BIOL ECOL, V393, P23, DOI 10.1016/j.jembe.2010.06.016; Lane RL, 2006, N AM J AQUACULT, V68, P141, DOI 10.1577/A05-009.1; Marshall CT, 1999, NATURE, V402, P288, DOI 10.1038/46272; Masuma Shukei, 2006, Bulletin of Fisheries Research Agency, P157; Matsumoto Y, 2018, LIPIDS, V53, P919, DOI 10.1002/lipd.12098; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; McBride RS, 2015, FISH FISH, V16, P23, DOI 10.1111/faf.12043; Mourente G, 2001, FISH PHYSIOL BIOCHEM, V24, P351, DOI 10.1023/A:1015011609017; Muhling BA, 2018, ICES J MAR SCI, V75, P1341, DOI 10.1093/icesjms/fsy017; Nakatsuka S, 2017, MAR POLICY, V78, P107, DOI 10.1016/j.marpol.2017.01.017; Ohshimo S, 2018, AQUAT LIVING RESOUR, V31, DOI 10.1051/alr/2018022; Ohshimo S, 2018, FISH RES, V204, P390, DOI 10.1016/j.fishres.2018.03.017; Ohshimo S, 2017, B MAR SCI, V93, P769, DOI 10.5343/bms.2016.1094; Okochi Y, 2016, FISH RES, V174, P30, DOI 10.1016/j.fishres.2015.08.020; OLSEN RE, 1989, J EXP MAR BIOL ECOL, V129, P189, DOI 10.1016/0022-0981(89)90056-7; Perez KO, 2015, J FISH BIOL, V86, P1286, DOI 10.1111/jfb.12637; Rainuzzo JR, 1997, AQUACULTURE, V155, P103, DOI 10.1016/S0044-8486(97)00121-X; Sargent J, 1995, BROODSTOCK MANAGEMEN, P353, DOI DOI 10.1016/S0044-8486(97)00122-1; Shimose T, 2015, BIOL ECOLOGY BLUEFIN, P78, DOI DOI 10.1201/B18714-7; Shimose T., 2015, BIOL ECOLOGY BLUEFIN, P47; Shimose T, 2016, ENVIRON BIOL FISH, V99, P351, DOI 10.1007/s10641-016-0478-9; Stephens PA, 2009, ECOLOGY, V90, P2057, DOI 10.1890/08-1369.1; Tanaka Y, 2006, MAR ECOL PROG SER, V319, P225, DOI 10.3354/meps319225; Team RC, 2016, R LANG ENV STAT COMP; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Watai M, 2018, MAR ECOL PROG SER, V607, P207, DOI 10.3354/meps12807; Watai M, 2017, MAR FRESHWATER RES, V68, P2008, DOI 10.1071/MF16337; Wiegand MD, 2007, CAN J FISH AQUAT SCI, V64, P700, DOI 10.1139/F07-033; Wiegand MD, 1996, REV FISH BIOL FISHER, V6, P259, DOI 10.1007/BF00122583; Yabe H, 1966, REP NANKAI REG FISH, V23, P95; Zudaire I, 2014, FISH RES, V160, P50, DOI 10.1016/j.fishres.2013.12.010	55	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222824	10.1371/journal.pone.0222824	http://dx.doi.org/10.1371/journal.pone.0222824			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553780	gold, Green Published			2022-12-26	WOS:000532319200038
J	Gonzalez, SM; Aguilar-Jimenez, W; Trujillo-Gil, E; Zapata, W; Su, RC; Ball, TB; Rugeles, MT				Gonzalez, Sandra M.; Aguilar-Jimenez, Wbeimar; Trujillo-Gil, Edison; Zapata, Wildeman; Su, Ruey-Chyi; Ball, T. Blake; Rugeles, Maria T.			Vitamin D treatment of peripheral blood mononuclear cells modulated immune activation and reduced susceptibility to HIV-1 infection of CD4(+) T lymphocytes	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; KAPPA-B; 1,25-DIHYDROXYVITAMIN D-3; EXPRESSION; CD38; REPLICATION; DIFFERENTIATION; INTERLEUKIN-10; GLYCOPROTEIN; TRANSMISSION	Introduction Mucosal immune activation, in the context of sexual transmission of HIV-1 infection, is crucial, as the increased presence of activated T cells enhance susceptibility to infection. In this regard, it has been proposed that immunomodulatory compounds capable of modulating immune activation, such as Vitamin D (VitD) may reduce HIV-1 transmission and might be used as a safe and cost-effective strategy for prevention. Considering this, we examined the in vitro effect of the treatment of peripheral blood mononuclear cells (PBMCs) with the active form of VitD, calcitriol, on cellular activation, function and susceptibility of CD4+ T cells to HIV-1 infection. Methods We treated PBMCs from healthy HIV unexposed individuals (Co-HC) and frequently exposed, HIV-1 seronegative individuals (HESNs) from Colombia and from healthy nonexposed individuals from Canada (Ca-HC) with calcitriol and performed in vitro HIV-1 infection assays using X4- and R5-tropic HIV-1 strains respectively. In addition, we evaluated the activation and function of T cells and the expression of viral co-receptors, and select antiviral genes following calcitriol treatment. Results Calcitriol reduced the frequency of infected CD4(+) T cells and the number of viral particles per cell, for both, X4- and R5-tropic viruses tested in the Co-HC and the Ca-HC, respectively, but not in HESNs. Furthermore, in the Co-HC, calcitriol reduced the frequency of polyclonally activated T cells expressing the activation markers HLA-DR and CD38, and those HLA-DR(+)CD38(-), whereas increased the subpopulation HLA-DR(-)CD38(+). Calcitriol treatment also decreased production of granzyme, IL-2 and MIP-1 beta by T cells and increased the transcriptional expression of the inhibitor of NF-kB and the antiviral genes cathelicidin (CAMP) and APOBEC3G in PBMCs from Co-HC. Conclusion Our in vitro findings suggest that VitD treatment could reduce HIV-1 transmission through a specific modulation of the activation levels and function of T cells, and the production of antiviral factors. In conclusion, VitD remains as an interesting potential strategy to prevent HIV1 transmission that should be further explored.	[Gonzalez, Sandra M.; Aguilar-Jimenez, Wbeimar; Trujillo-Gil, Edison; Zapata, Wildeman; Rugeles, Maria T.] Univ Antioquia UdeA, Fac Med, Grp Inmunovirol, Medellin, Colombia; [Gonzalez, Sandra M.; Su, Ruey-Chyi; Ball, T. Blake] Publ Hlth Agcy Canada, Natl HIV & Retrovirol Lab, JC Wilt Infect Dis Res Ctr, Winnipeg, MB, Canada; [Zapata, Wildeman] Univ Cooperat Colombia, Grp Infettare, Fac Med, Medellin, Colombia; [Su, Ruey-Chyi; Ball, T. Blake] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada	Universidad de Antioquia; Public Health Agency of Canada; Universidad Cooperativa de Colombia; University of Manitoba	Rugeles, MT (corresponding author), Univ Antioquia UdeA, Fac Med, Grp Inmunovirol, Medellin, Colombia.	maria.rugeles@udea.edu.co	Zapata, Wildeman/ABE-5082-2020	Zapata, Wildeman/0000-0002-7351-8738; Aguilar Jimenez, Wbeimar/0000-0002-0790-055X; Rugeles, Maria T./0000-0001-7855-1409	Colciencias [111574455024, 111565740508, 647-2014]; ELAP program Canadian scholarship	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); ELAP program Canadian scholarship	This investigation was supported by Colciencias (Code 111574455024 and Code 111565740508). SMG is a recipient of a doctoral scholarship from Colciencias (647-2014) and the ELAP program Canadian scholarship. The funders had no role in study design, data collection, and analyses, decision to publish, or preparation of the manuscript.	Aguilar-Jimenez W, 2016, JAIDS-J ACQ IMM DEF, V73, P497, DOI 10.1097/QAI.0000000000001150; Aguilar-Jimenez W, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.015; Aguilar-Jimenez W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082717; Barr T, 2016, PROG NEURO-PSYCHOPH, V65, DOI 10.1016/j.pnpbp.2015.09.001; Bensi T, 2009, EXPERT OPIN THER TAR, V13, P141, DOI [10.1517/14728220802637147, 10.1517/14728220802637147 ]; Biswas P, 1998, J VIROL, V72, P8380, DOI 10.1128/JVI.72.10.8380-8383.1998; Card CM, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-141; Card CM, 2009, J INFECT DIS, V199, P1318, DOI 10.1086/597801; Chege D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043670; Cohen-Lahav M, 2006, NEPHROL DIAL TRANSPL, V21, P889, DOI 10.1093/ndt/gfi254; Coussens AK, 2015, P NATL ACAD SCI USA, V112, P8052, DOI 10.1073/pnas.1500909112; Fulcher JA, 2017, AIDS RES HUM RETROV, V33, P788, DOI [10.1089/aid.2017.0014, 10.1089/AID.2017.0014]; Giulietti A, 2007, DIABETES RES CLIN PR, V77, P47, DOI 10.1016/j.diabres.2006.10.007; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Hansdottir S, 2010, J IMMUNOL, V184, P965, DOI 10.4049/jimmunol.0902840; Hewison M, 2003, J IMMUNOL, V170, P5382, DOI 10.4049/jimmunol.170.11.5382; Khoo AL, 2011, CLIN EXP IMMUNOL, V164, P72, DOI 10.1111/j.1365-2249.2010.04315.x; Koning FA, 2005, J IMMUNOL, V175, P6117, DOI 10.4049/jimmunol.175.9.6117; Kuebler PJ, 2016, J INFECT DIS, V213, P569, DOI 10.1093/infdis/jiv425; Lachmann R, 2015, AIDS, V29, P1127, DOI 10.1097/QAD.0000000000000666; Lajoie J, 2012, MUCOSAL IMMUNOL, V5, P277, DOI 10.1038/mi.2012.7; Lawn SD, 2001, CLIN MICROBIOL REV, V14, P753, DOI 10.1128/CMR.14.4.753-777.2001; Lin R, 2004, BIOESSAYS, V26, P21, DOI 10.1002/bies.10368; LOCARDI C, 1990, J VIROL, V64, P5874, DOI 10.1128/JVI.64.12.5874-5882.1990; Mandrekar P, 2006, ALCOHOL CLIN EXP RES, V30, P135, DOI 10.1111/j.1530-0277.2006.00012.x; Matilainen JM, 2010, J STEROID BIOCHEM, V121, P142, DOI 10.1016/j.jsbmb.2010.03.020; McLaren PJ, 2010, J INFECT DIS, V202, pS339, DOI 10.1086/655968; Meditz AL, 2011, J VIROL, V85, P10189, DOI 10.1128/JVI.02529-10; Neve A, 2014, CLIN EXP MED, V14, P275, DOI 10.1007/s10238-013-0249-2; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; PAUZA CD, 1993, J LEUKOCYTE BIOL, V53, P157, DOI 10.1002/jlb.53.2.157; Penna G, 2000, J IMMUNOL, V164, P2405, DOI 10.4049/jimmunol.164.5.2405; Ragab D, 2016, CYTOKINE, V85, P5, DOI 10.1016/j.cyto.2016.05.024; Sandoval-Montes C, 2005, J LEUKOCYTE BIOL, V77, P513, DOI 10.1189/jlb.0404262; Sarkar S, 2016, CRIT REV CL LAB SCI, V53, P132, DOI 10.3109/10408363.2015.1094443; Savarino A, 1999, FASEB J, V13, P2265, DOI 10.1096/fasebj.13.15.2265; Savarino A, 2003, FASEB J, V17, P461, DOI 10.1096/fj.02-0512fje; Shapira-Nahor O, 1998, AIDS, V12, P1731; Szabo G, 1996, ALCOHOL CLIN EXP RES, V20, P900, DOI 10.1111/j.1530-0277.1996.tb05269.x; Vidyarani M, 2009, EXP MOL PATHOL, V86, P69, DOI 10.1016/j.yexmp.2008.10.002; Villegas-Ospina S, 2017, HORM MOL BIOL CLIN I, V29, P93, DOI 10.1515/hmbci-2016-0037; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; WuWong JR, 2013, JCVD, V1, P15; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	44	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222878	10.1371/journal.pone.0222878	http://dx.doi.org/10.1371/journal.pone.0222878			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550271	Green Published, gold			2022-12-26	WOS:000532307700029
J	Hsiao, JJ; Huang, YJ; Chen, HI; Jiang, JA; Wang, JC; Wu, YF; Nee, TE				Hsiao, Jui-Ju; Huang, Yi-Jen; Chen, Hung-Ing; Jiang, Joe-Air; Wang, Jen-Cheng; Wu, Ya-Fen; Nee, Tzer-En			Intensive measures of luminescence in GaN/InGaN heterostructures	PLOS ONE			English	Article							JUNCTION; SIMULATION	The intensive measures of luminescence in a GaN/InGaN multiple quantum well system are used to examine the thermodynamics and phenomenological structure. The radiative/nonradiative transitions along with absorbed or emitted phonons that occur between the different quantum states of the electrons and holes associated with these processes make the quantum efficiency of a semiconductor nanosystem in an equilibrium state an extensive property. It has long been recognized that tuning of the indium (In) composition in InGaN interlayers gives the potential to obtain a spectrum in the near-infrared to near-ultraviolet spectral range. The thermodynamic intensive properties, including the Debye temperature, carrier temperature, and junction temperature, are the most appropriate metrics to describe the optical-related interactions inherent in a given heterostructure and so can be used as the state variables for understanding the quantum exchange behaviors. The energetic features of the quantum processes are characterized based on analysis of the intensive parameters as determined by means of electroluminescence (EL) and photoluminescence (PL) spectroscopy and current-voltage measurement and then correlated with the designed InGaN/GaN microstructures. According to the McCumber-Sturge theory, the EL and PL Debye temperatures obtained experimentally signal the strength of the electron-phonon and photon-phonon interaction, respectively, while the EL and PL carrier/junction temperatures correspond to the carrier localization. Higher EL Debye temperatures and lower EL carrier/junction temperatures reflect significantly higher luminescence quantum yields, indicative of electron-phonon coupling in the transfer of thermal energy between the confined electrons and the enhancement by excited phonons of heat-assisted emissions. On the other hand, the observation of low luminescence efficiency, corresponding to the lower PL Debye temperatures and higher PL carrier/junction temperatures, is attributed to photon-phonon coupling. These findings are in good accordance to the dependence of the EL and PL quantum efficiency on the In-content of the InGaN/GaN barriers, suggesting that the characteristic Debye and carrier/junction temperatures are intensive parameters useful for assessing the optical properties of a nano-engineered semiconductor heterostructure.	[Hsiao, Jui-Ju; Huang, Yi-Jen; Chen, Hung-Ing; Wang, Jen-Cheng; Nee, Tzer-En] Chang Gung Univ, Grad Inst Electroopt Engn, Taoyuan, Taiwan; [Hsiao, Jui-Ju; Huang, Yi-Jen; Chen, Hung-Ing; Wang, Jen-Cheng; Nee, Tzer-En] Chang Gung Univ, Dept Elect Engn, Taoyuan, Taiwan; [Jiang, Joe-Air] Natl Taiwan Univ, Dept Biomechatron Engn, Taipei, Taiwan; [Wu, Ya-Fen] Ming Chi Univ Technol, Dept Elect Engn, New Taipei, Taiwan; [Nee, Tzer-En] Linkou Chang Gung Mem Hosp, Dept Oral & Maxillofacial Surg, Taoyuan, Taiwan	Chang Gung University; Chang Gung University; National Taiwan University; Ming Chi University of Technology; Chang Gung Memorial Hospital	Nee, TE (corresponding author), Chang Gung Univ, Grad Inst Electroopt Engn, Taoyuan, Taiwan.; Nee, TE (corresponding author), Chang Gung Univ, Dept Elect Engn, Taoyuan, Taiwan.; Nee, TE (corresponding author), Linkou Chang Gung Mem Hosp, Dept Oral & Maxillofacial Surg, Taoyuan, Taiwan.	neete@mail.cgu.edu.tw		Nee, Tzer-En/0000-0002-8293-7678	Ministry of Science and Technology of the Republic of China [MOST 103-2112-M-182-001]	Ministry of Science and Technology of the Republic of China(Ministry of Science and Technology, Taiwan)	This study was financially supported by the Ministry of Science and Technology of the Republic of China under contract No. MOST 103-2112-M-182-001. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurashitov JN, 1996, PHYS REV LETT, V77, P4708, DOI 10.1103/PhysRevLett.77.4708; Compagnone F, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.125314; Dehkhoda F, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aaa56d; Dervos CT, 2004, SENSORS-BASEL, V4, P58, DOI 10.3390/s40500058; Eliseev PG, 2003, J APPL PHYS, V93, P5404, DOI 10.1063/1.1567055; Feng ZC, 2006, PROC SPIE, V6337, DOI 10.1117/12.677653; Fiory AT, 2003, J ELECTRON MATER, V32, P1043, DOI 10.1007/s11664-003-0087-1; Grimvall G, 1986, THERMOPHYSICAL PROPE; Guo ZQ, 2017, AIP ADV, V7, DOI 10.1063/1.4974877; Hsiao JJ, 2015, J LUMIN, V168, P309, DOI 10.1016/j.jlumin.2015.08.024; Jena D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.136805; Kastoryano MJ, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.110501; Keppens A, 2010, J APPL PHYS, V108, DOI 10.1063/1.3463411; Keppens A, 2008, J APPL PHYS, V104, DOI 10.1063/1.3009966; Lee JC, 2011, IEEE T NANOTECHNOL, V10, P827, DOI 10.1109/TNANO.2010.2084097; Levard H, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4881938; Li CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03249-z; McCluskey MD, 1998, APPL PHYS LETT, V73, P1281, DOI 10.1063/1.122149; Nee TE, 2006, J CRYST GROWTH, V287, P468, DOI 10.1016/j.jcrysgro.2005.11.068; Nee TE, 2007, J APPL PHYS, V101, DOI 10.1063/1.2422709; Ota H, 2007, INT EL DEVICES MEET, P65, DOI 10.1109/IEDM.2007.4418864; Poppe A, 2006, P IEEE SEMICOND THER, P191, DOI 10.1109/STHERM.2006.1625227; Radisavljevic B, 2013, NAT MATER, V12, P815, DOI [10.1038/NMAT3687, 10.1038/nmat3687]; Sardar DK, 1998, J APPL PHYS, V83, P1195, DOI 10.1063/1.366815; Shigehiro T, 2013, J PHYS CHEM C, V117, P532, DOI 10.1021/jp307853t; Tsuchiya H, 2001, J APPL PHYS, V89, P4023, DOI 10.1063/1.1354653; Tsutsui M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1141; VARSHNI YP, 1967, PHYSICA, V34, P149, DOI 10.1016/0031-8914(67)90062-6; Wing WJ, 2015, J APPL PHYS, V118, DOI 10.1063/1.4931378; Xi Y, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1849838; Xu H, 2011, J PHYS D APPL PHYS, V44, DOI 10.1088/0022-3727/44/41/415102; Yu S, 1996, J APPL PHYS, V80, P2815, DOI 10.1063/1.363199; Zhang JZ, 2015, J APPL PHYS, V117, DOI 10.1063/1.4905717; Ziman J. M., 1960, ELECT PHONONS	34	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222928	10.1371/journal.pone.0222928	http://dx.doi.org/10.1371/journal.pone.0222928			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LD8MB	31550270	gold, Green Published			2022-12-26	WOS:000526280700001
J	Burman, DD				Burman, Douglas D.			Hippocampal connectivity with sensorimotor cortex during volitional finger movements: Laterality and relationship to motor learning	PLOS ONE			English	Article							THETA-BURST STIMULATION; WORKING-MEMORY; SEQUENCE; IMPLICIT; HUMANS; OSCILLATIONS; PERFORMANCE; MODULATION; NAVIGATION; INCREASES	Hippocampal interactions with the motor system are often assumed to reflect the role of memory in motor learning. Here, we examine hippocampal connectivity with sensorimotor cortex during two tasks requiring paced movements, one with a mnemonic component (sequence learning) and one without (repetitive tapping). Functional magnetic resonance imaging activity was recorded from thirteen right-handed subjects; connectivity was identified from sensorimotor cortex correlations with psychophysiological interactions in hippocampal activity between motor and passive visual tasks. Finger movements in both motor tasks anticipated the timing of the metronome, reflecting cognitive control, yet evidence of motor learning was limited to the sequence learning task; nonetheless, hippocampal connectivity was observed during both tasks. Connectivity from corresponding regions in the left and right hippocampus overlapped extensively, with improved sensitivity resulting from their conjunctive (global) analysis. Positive and negative connectivity were both evident, with positive connectivity in sensorimotor cortex ipsilateral to the moving hand during unilateral movements, whereas negative connectivity was prominent in whichever hemisphere was most active during movements. Results implicate the hippocampus in volitional finger movements even in the absence of motor learning or recall.	[Burman, Douglas D.] NorthShore Univ Hlth Syst, Dept Radiol, Evanston, IL 60201 USA	NorthShore University Health System	Burman, DD (corresponding author), NorthShore Univ Hlth Syst, Dept Radiol, Evanston, IL 60201 USA.	Dburman2@northshore.org						Albouy G, 2008, NEURON, V58, P261, DOI 10.1016/j.neuron.2008.02.008; Albouy G, 2015, NEUROIMAGE, V108, P423, DOI 10.1016/j.neuroimage.2014.12.049; Albouy G, 2013, HIPPOCAMPUS, V23, P985, DOI 10.1002/hipo.22183; Axmacher N, 2010, P NATL ACAD SCI USA, V107, P3228, DOI 10.1073/pnas.0911531107; Balleine B.W., 2010, HUMAN RODENT HOMOLOG; Barnett AJ, 2014, NEUROPSYCHOLOGIA, V64, P1, DOI 10.1016/j.neuropsychologia.2014.09.011; Battaglia FP, 2011, TRENDS COGN SCI, V15, P310, DOI 10.1016/j.tics.2011.05.008; Beisteiner R, 2004, EUR J NEUROSCI, V19, P465, DOI 10.1111/j.1460-9568.2004.03115.x; Bertram E, 2007, EPILEPSIA, V48, P65, DOI 10.1111/j.1528-1167.2007.01068.x; Bestmann S, 2008, CEREB CORTEX, V18, P1281, DOI 10.1093/cercor/bhm159; Bunge SA, 2004, BRAIN COGNITION, V56, P141, DOI 10.1016/j.bandc.2003.08.001; Burman DD, 2013, BRAIN LANG, V124, P184, DOI 10.1016/j.bandl.2012.12.007; Caplan JB, 2003, J NEUROSCI, V23, P4726; Catani M, 2012, CORTEX, V48, P273, DOI 10.1016/j.cortex.2011.12.001; Cruikshank LC, 2012, J NEUROPHYSIOL; Ekstrom AD, 2005, HIPPOCAMPUS, V15, P881, DOI 10.1002/hipo.20109; Ekstrom AD, 2014, NEUROIMAGE, V85, P667, DOI 10.1016/j.neuroimage.2013.06.049; Fernandez-Seara MA, 2009, NEUROIMAGE, V47, P1797, DOI 10.1016/j.neuroimage.2009.05.061; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gheysen F, 2010, EXP BRAIN RES, V202, P795, DOI 10.1007/s00221-010-2186-6; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Hlustik P, 2004, J CLIN NEUROPHYSIOL, V21, P180; Hlustik P, 2001, CEREB CORTEX, V11, P312, DOI 10.1093/cercor/11.4.312; Hsieh LT, 2014, NEURON, V81, P1165, DOI 10.1016/j.neuron.2014.01.015; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Igloi K, 2010, P NATL ACAD SCI USA, V107, P14466, DOI 10.1073/pnas.1004243107; Jacobs J, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0304; Kaplan R, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001267; Kelemen E, 2010, DYNAMIC GROUPING HIP; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Kober SE, 2011, INT J PSYCHOPHYSIOL, V79, P347, DOI 10.1016/j.ijpsycho.2010.12.002; Lang CE, 2004, J NEUROPHYSIOL, V91, P1722, DOI 10.1152/jn.00805.2003; Lang CE, 2003, J NEUROPHYSIOL, V90, P1160, DOI 10.1152/jn.00130.2003; Lee TD, 1994, COGNITIVE EFFORT MOT; Lega BC, 2012, HIPPOCAMPUS, V22, P748, DOI 10.1002/hipo.20937; Li KM, 2009, COMPUT MED IMAG GRAP, V33, P131, DOI 10.1016/j.compmedimag.2008.10.011; MacDonald C.J., 2014, TIMING TIME PERCEPT, V2, P51, DOI [10.1163/22134468-00002020, DOI 10.1163/22134468-00002020, 10.1163/22134468-00002020.]; MacDonald CJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0463; MacDonald CJ, 2011, NEURON, V71, P737, DOI 10.1016/j.neuron.2011.07.012; Miller J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04847-9; Mukamel R, 2010, CURR BIOL, V20, P750, DOI 10.1016/j.cub.2010.02.045; Perfetti B, 2011, J NEUROSCI, V31, P14810, DOI 10.1523/JNEUROSCI.1319-11.2011; Pignatelli M, 2012, J PHYSIOL-PARIS, V106, P81, DOI 10.1016/j.jphysparis.2011.09.007; Qin SZ, 2016, BRAIN STRUCT FUNCT, V221, P3237, DOI 10.1007/s00429-015-1098-4; R-Core-Team, 2015, LANG ENV STAT COMP; Ramnani N, 2000, J NEUROPHYSIOL, V84, P3026, DOI 10.1152/jn.2000.84.6.3026; Rose M, 2011, J NEUROSCI, V31, P13739, DOI 10.1523/JNEUROSCI.3020-11.2011; Rudner M, 2008, COGN PROCESS, V9, P19, DOI 10.1007/s10339-007-0183-x; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; Schwabe L, 2013, HIPPOCAMPUS, V23, P1035, DOI 10.1002/hipo.22175; Seamans JK, 1998, J NEUROSCI, V18, P1613; Slobounov S, 2002, CLIN NEUROPHYSIOL, V113, P2013, DOI 10.1016/S1388-2457(02)00298-5; Steele CJ, 2010, J NEUROSCI, V30, P8332, DOI 10.1523/JNEUROSCI.5569-09.2010; Teo JTH, 2011, CEREB CORTEX, V21, P1627, DOI 10.1093/cercor/bhq231; Volkmann J, 1998, J NEUROPHYSIOL, V79, P2149, DOI 10.1152/jn.1998.79.4.2149; Wilkinson L, 2010, J COGNITIVE NEUROSCI, V22, P427, DOI 10.1162/jocn.2009.21208; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Yusoff Ahmad Nazlim, 2010, MALAYSIAN J MED HLTH, V6, P71	58	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222064	10.1371/journal.pone.0222064	http://dx.doi.org/10.1371/journal.pone.0222064			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5BF	31536543	gold, Green Submitted, Green Published			2022-12-26	WOS:000532262800028
J	Elser, JL; Progar, ALA; Steensma, KMM; Caskin, TP; Kerr, SR; Shwiff, SA				Elser, Julie L.; Progar, Amber L. Adams; Steensma, Karen M. M.; Caskin, Tyler P.; Kerr, Susan R.; Shwiff, Stephanie A.			Economic and livestock health impacts of birds on dairies: Evidence from a survey of Washington dairy operators	PLOS ONE			English	Article							EUROPEAN STARLINGS; ESCHERICHIA-COLI; SALMONELLA-ENTERICA; OHIO	The survey described in this research paper aimed to investigate the economic and health impacts of birds on dairies. Birds are common pests on dairies, consuming and contaminating feed intended for cattle. As a result, dairy operators experience increased feed costs and increased pathogen and disease risk. We surveyed dairy operators attending the 2017 Washington Dairy Conference to examine the impact of birds on dairies in Washington State. Dairy operators reported feed losses valued at $55 per cow resulting in annual losses totaling $5.5 million in the Western region of the state and $9.2 million in the Eastern region of the state. Shooting was the most commonly used bird management method and European starlings (Sternus vulgaris) were the most frequently implicated species statewide. Bird abundance greater than 10,000 birds per day was associated with larger herd size and with self-reported presence of Johne's disease and Salmonella.	[Elser, Julie L.; Shwiff, Stephanie A.] USDA, Wildlife Res Ctr, APHIS, WS, Ft Collins, CO 80521 USA; [Progar, Amber L. Adams; Caskin, Tyler P.; Kerr, Susan R.] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA; [Steensma, Karen M. M.] Trinity Western Univ, Dept Biol, Langley, BC V2Y 1Y1, Canada	United States Department of Agriculture (USDA); Washington State University; Trinity Western University	Elser, JL (corresponding author), USDA, Wildlife Res Ctr, APHIS, WS, Ft Collins, CO 80521 USA.	Julie.L.Elser@usda.gov		Shwiff, Stephanie/0000-0001-9065-9017	National Institute of Food and Agriculture, U.S. Department of Agriculture through the Western Sustainable Agriculture Research and Education program [2015-38640-23779, SW16-013]; USDA Animal and Plant Health Inspection Service	National Institute of Food and Agriculture, U.S. Department of Agriculture through the Western Sustainable Agriculture Research and Education program; USDA Animal and Plant Health Inspection Service	This material is based upon work that is supported by the National Institute of Food and Agriculture, U.S. Department of Agriculture, under award number 2015-38640-23779 through the Western Sustainable Agriculture Research and Education program under subaward number SW16-013. USDA is an equal opportunity employer and service provider. ALAP, KMMS, SAS, and SRK were recipients of this award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported in part by USDA Animal and Plant Health Inspection Service. This research does not represent USDA policy.	[Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Banrie, 2013, FEED STUD EX EFF FIS; Blair P. D., 2009, INPUT OUTPUT ANAL FD, DOI DOI 10.1017/CBO9780511626982; Carlson JC, 2018, J DAIRY SCI, V101, P1777, DOI 10.3168/jds.2017-12858; Carlson James C., 2011, Human-Wildlife Interactions, V5, P112; Carlson JC, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-9; Carlson JC, 2011, J APPL ECOL, V48, P479, DOI 10.1111/j.1365-2664.2010.01935.x; Daugovish O, 2008, P VERT PEST C; Depenbusch Brandon E., 2011, Human-Wildlife Interactions, V5, P58; Gibbons J, 2009, APPL ANIM BEHAV SCI, V116, P163, DOI 10.1016/j.applanim.2008.08.009; Medhanie GA, 2014, J DAIRY SCI, V97, P5230, DOI 10.3168/jds.2014-8045; Navarro-Gonzalez N, 2016, P VERTEBRATE PEST C; Pedersen K, 2006, J WILDLIFE DIS, V42, P46, DOI 10.7589/0090-3558-42.1.46; Pedersen Kerri, 2007, Human-Wildlife Conflicts, V1, P68; Shave ME, 2018, J APPL ECOL, V55, P2451, DOI 10.1111/1365-2664.13172; Shwiff SA, 2012, J DAIRY SCI, V95, P6820, DOI 10.3168/jds.2011-5216; Steensma K, 2016, P VERTEBRATE PEST C; Steensma KM, 2009, EFFICACY BIRD DETERR; Steensma KM, 2017, 14012 FW USDA W SUST; TREYZ GI, 1992, INT REGIONAL SCI REV, V14, P221, DOI 10.1177/016001769201400301; Upper Midwest Market Administrator's Office, 2017, 2016 FED MILK ORD MA; Werner SJ, 2014, CROP PROT, V65, P221, DOI 10.1016/j.cropro.2014.08.004; Williams ML, 2011, J APPL MICROBIOL, V111, P982, DOI 10.1111/j.1365-2672.2011.05102.x	23	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222398	10.1371/journal.pone.0222398	http://dx.doi.org/10.1371/journal.pone.0222398			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536534	Green Published, Green Submitted, gold			2022-12-26	WOS:000532262800041
J	Kurosawa, Y; Sato, S; Okuyama, T; Taoka, M				Kurosawa, Yae; Sato, Shigehiro; Okuyama, Tsuneo; Taoka, Masato			Sequential two-step chromatographic purification of infectious poliovirus using ceramic fluoroapatite and ceramic hydroxyapatite columns	PLOS ONE			English	Article							VIRUS; VECTORS; VACCINE; POLIOMYELITIS	Infectious virus purification techniques are important for vaccine development and gene therapy applications. However, the standardized one-step purification technique using ceramic hydroxyapatite (CHAp) has proven unsuitable for poliovirus. Therefore, we designed a sequential two-step chromatographic technique for purification of the infectious Sabin type 2 vaccine strain of poliovirus from the cell culture supernatant. In the first step, we removed protein contaminants from the Sabin type 2 virus fraction by pH gradient elution on a ceramic fluoroapatite column. In the second step, we removed double-stranded DNA derived from host cells by diluting the virus fraction, directly loading it on a CHAp column, and purifying it using a phosphate gradient with 1 M sodium chloride. This process achieved removal rates of more than 99.95% and 99.99% for proteins and double-stranded DNA, respectively, and was highly reproducible and scalable. Furthermore, it is likely that it will be applicable to other virus species.	[Kurosawa, Yae; Okuyama, Tsuneo] HOYA Technosurg Corp, R&D Dept, Akishima, Tokyo, Japan; [Kurosawa, Yae; Sato, Shigehiro] Iwate Med Univ, Dept Microbiol, Lab Infect Dis & Immunol, Shiwa, Iwate, Japan; [Okuyama, Tsuneo] Prot Technos Inst, Atsugi, Kanagawa, Japan; [Okuyama, Tsuneo; Taoka, Masato] Tokyo Metropolitan Univ, Grad Sch Sci & Engn, Dept Chem, Lab Biophys & Biochem, Hachioji, Tokyo, Japan; [Sato, Shigehiro] SI Biotechnol Co Ltd, Morioka, Iwate, Japan	Iwate Medical University; Tokyo Metropolitan University	Kurosawa, Y (corresponding author), HOYA Technosurg Corp, R&D Dept, Akishima, Tokyo, Japan.; Kurosawa, Y (corresponding author), Iwate Med Univ, Dept Microbiol, Lab Infect Dis & Immunol, Shiwa, Iwate, Japan.	yae.kurosawa@pc.hoya.co.jp						[Anonymous], 2013, POL VACC IN IPOL; [Anonymous], 2015, WHO TECHN REP SER, V993; [Anonymous], BULLETIN, V5667; [Anonymous], BULLETIN, V3111; Ballew HC, 2000, CLIN VIROLOGY MANUAL, P131; Blanche F, 2000, GENE THER, V7, P1055, DOI 10.1038/sj.gt.3301190; Braas G, 1996, BIOSEPARATION, V6, P211; Burns CC, 2006, J VIROL, V80, P3259, DOI 10.1128/JVI.80.7.3259-3272.2006; Food and Drug Administration, 1999, GUID IND CONT FORM C; Fountzilas C, 2017, ONCOTARGET, V8, P102617, DOI 10.18632/oncotarget.18309; Freitag R, 2012, BIOTECHNOL J, V7, P90, DOI 10.1002/biot.201100015; Gagnon P, 2005, BIOPROCESS INT WORLD; Gallagher S. R, 2009, CURR PROTOC MOL BIOL, V85, DOI DOI 10.16.1-10.6.27; HUYGHE BG, 1995, HUM GENE THER, V6, P1403, DOI 10.1089/hum.1995.6.11-1403; International Conference on Harmonization (ICH), 1999, ICH Q6B PROC ACC CRI; Jiang ZJ, 2011, PROTEIN EXPRES PURIF, V80, P203, DOI 10.1016/j.pep.2011.07.009; Kalbfuss B, 2008, J CHROMATOGR B, V873, P102, DOI 10.1016/j.jchromb.2008.08.002; KAPLITT MG, 1994, NAT GENET, V8, P148, DOI 10.1038/ng1094-148; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kolmas J, 2016, CERAM INT, V42, P2472, DOI 10.1016/j.ceramint.2015.10.048; Kotterman MA, 2014, NAT REV GENET, V15, P445, DOI 10.1038/nrg3742; Kuiper M, 2002, BIOTECHNOL BIOENG, V80, P445, DOI 10.1002/bit.10388; Kurosawa Y, 2014, BULLETIN, V6549; Kurosawa Y, 2012, MED BIOL, V156, P410; Kurosawa Y, 2009, MED BIOL, V153, P607; Kurosawa Y., 2012, WORLD J VIROL, V02, P155, DOI [10.4236/wjv.2012.23020, DOI 10.4236/WJV.2012.23020]; Lee DS, 2009, BIOCHEM BIOPH RES CO, V378, P640, DOI 10.1016/j.bbrc.2008.11.096; Morenweiser R, 2005, GENE THER, V12, pS103, DOI 10.1038/sj.gt.3302624; Nawa M, 1996, MICROBIOL IMMUNOL, V40, P365, DOI 10.1111/j.1348-0421.1996.tb01081.x; O'Riordan CR, 2000, J GENE MED, V2, P444, DOI 10.1002/1521-2254(200011/12)2:6<444::AID-JGM132>3.0.CO;2-1; Okada K, 2013, J INFECT DIS, V208, P275, DOI 10.1093/infdis/jit155; Racaniello VR., 2007, FIELDS VIROLOGY, P797; SAHA K, 1994, J VIROL METHODS, V46, P349, DOI 10.1016/0166-0934(94)90005-1; Saito M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053893; Shimizu Hiroyuki, 2012, Virus (Nagoya), V62, P57; Smith GP, 2005, BIOTECHNIQUES, V39, P879, DOI 10.2144/000112032; Verdijk P, 2011, EXPERT REV VACCINES, V10, P635, DOI [10.1586/erv.11.51, 10.1586/ERV.11.51]; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	38	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222199	10.1371/journal.pone.0222199	http://dx.doi.org/10.1371/journal.pone.0222199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536514	Green Published, gold, Green Submitted			2022-12-26	WOS:000532262800113
J	Ouadi, L; Bruez, E; Bastien, S; Vallance, J; Lecomte, P; Domec, JC; Rey, P				Ouadi, Loris; Bruez, Emilie; Bastien, Sylvie; Vallance, Jessica; Lecomte, Pascal; Domec, Jean-Christophe; Rey, Patrice			Ecophysiological impacts of Esca, a devastating grapevine trunk disease, on Vitis vinifera L.	PLOS ONE			English	Article							CARBON-ISOTOPE DISCRIMINATION; SAP-FLUX; STOMATAL CONDUCTANCE; HYDRAULIC CONDUCTANCE; STABLE OXYGEN; GAS-EXCHANGE; PLANTS; TREES; RESPONSES; DROUGHT	Esca is a Grapevine Trunk Disease (GTD) caused by a broad range of taxonomically unrelated fungal pathogens. These attack grapevine wood tissues inducing necroses even in the conductive vascular tissues, thus affecting the vine physiology and potentially leading to plant death. However, the influence of Esca on leaf and whole-plant water transport disruption remains poorly understood. In this paper, a detailed analysis of xylem-related physiological parameters in grapevines that expressed Esca-foliar symptoms was carried out. The experiments were conducted in a vineyard in the Bordeaux region (France) on cv. Cabernet-Sauvignon (Vitis vinifera L.) grapevines, which were monitored for Esca-foliar symptoms over a two-year period. Heat dissipation sap-flow sensors were installed during the summer on grapevines having expressed or not Esca-foliar symptoms. Leaf water potential, stomatal conductance and leaf transpiration were also measured. Physiological monitoring showed that sap flow density and whole-plant transpiration of Esca-infected grapevines decreased significantly a week before the first foliar symptoms appeared. When atmospheric water demand (Vapour Pressure Deficit, VPD) was the highest, both parameters tended to be about twice as low in symptomatic grapevines as in asymptomatic ones. Sap flow density data at the maximum transpiration-time, was systematically 29-30% lower in Esca-infected grapevines compared to control plants before or after the appearance of Esca-foliar symptoms. This trend was observed whatever the temperatures and VPD values measured. In Esca-diseased plants, larger amounts of necrotic wood, mainly white rot, were found in the trunk and cordon of symptomatic grapevines compared to healthy ones, suggesting necroses have an influence in reducing the whole-plant hydraulic capacity. This study reveals that the use of physiological monitoring methods, together with the visual monitoring of foliar symptoms, could prove useful in providing accurate measurements of Esca disease severity.	[Ouadi, Loris; Bruez, Emilie; Bastien, Sylvie; Vallance, Jessica; Lecomte, Pascal; Rey, Patrice] INRA, ISVV, UMR1065, Sante & Agroecol Vignoble SAVE, Villenave Dornon, France; [Bruez, Emilie; Bastien, Sylvie; Vallance, Jessica; Domec, Jean-Christophe] Bordeaux Sci Agro, INRA, UMR1391, ISPA, Villenave Dornon, France; [Bruez, Emilie] Univ Bordeaux, ISVV, UR OEnol, Villenave Dornon, France; [Rey, Patrice] Univ Bordeaux, ISVV, UMR1065, Bordeaux Sci Agro,Sante & Agroecol Vignoble SAVE, Villenave Dornon, France	INRAE; INRAE; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Rey, P (corresponding author), INRA, ISVV, UMR1065, Sante & Agroecol Vignoble SAVE, Villenave Dornon, France.; Rey, P (corresponding author), Univ Bordeaux, ISVV, UMR1065, Bordeaux Sci Agro,Sante & Agroecol Vignoble SAVE, Villenave Dornon, France.	patrice.rey@inra.fr	Domec, Jean-Christophe/AFV-5999-2022; domec, jean-christophe/P-9251-2019	Domec, Jean-Christophe/0000-0003-0478-2559; domec, jean-christophe/0000-0003-0478-2559; Rey, Patrice/0000-0002-7250-0114; LECOMTE, Pascal/0000-0002-0479-0295; Vallance, Jessica/0000-0002-5581-4453	Industrial Chair GTDfree (French National Research Agency); Industrial Chair GTDfree (Hennessy Company); Bordeaux Sciences Agro (PAL project); National Science Foundation [NSF-EAR-1344703, NSF-IOS-1754893]	Industrial Chair GTDfree (French National Research Agency)(French National Research Agency (ANR)); Industrial Chair GTDfree (Hennessy Company); Bordeaux Sciences Agro (PAL project); National Science Foundation(National Science Foundation (NSF))	Funding for this project was provided by the Industrial Chair GTDfree (French National Research Agency and the Hennessy Company) and Bordeaux Sciences Agro (PAL project). We also would like to acknowledge the support of the National Science Foundation, awards #NSF-EAR-1344703 and NSF-IOS-1754893. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARATAUD F, 1995, PLANT SOIL, V172, P29, DOI 10.1007/BF00020856; Barbour MM, 2007, FUNCT PLANT BIOL, V34, P83, DOI 10.1071/FP06228; Barbour MM, 2002, PLANT CELL ENVIRON, V25, P1483, DOI 10.1046/j.0016-8025.2002.00931.x; Bellee A, 2017, PLANT PATHOL, V66, P763, DOI 10.1111/ppa.12623; Bertsch C, 2013, PLANT PATHOL, V62, P243, DOI 10.1111/j.1365-3059.2012.02674.x; Breda N, 2006, ANN FOREST SCI, V63, P625, DOI 10.1051/forest:2006042; Brodribb TJ, 2003, PLANT PHYSIOL, V132, P2166, DOI 10.1104/pp.103.023879; Bruez E., 2013, THESIS; BRUGNOLI E, 1988, PLANT PHYSIOL, V88, P1418, DOI 10.1104/pp.88.4.1418; CABIBEL B, 1991, AGRONOMIE, V11, P669, DOI 10.1051/agro:19910804; Carbonneau A, 2015, GRAPEVINE PHYSL TERR; Crous PW, 1996, MYCOLOGIA, V88, P786, DOI 10.2307/3760973; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; Domec JC, 2013, NEW PHYTOL, V199, P452, DOI 10.1111/nph.12263; Domec JC, 2010, TREE PHYSIOL, V30, P1001, DOI 10.1093/treephys/tpq054; Domec JC, 2009, PLANT CELL ENVIRON, V32, P1500, DOI 10.1111/j.1365-3040.2009.02014.x; Edwards J, 2007, PHYTOPATHOL MEDITERR, V46, P1000; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1993, NATURE, V363, P439, DOI 10.1038/363439a0; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; Fischer M, 2003, VITIS, V42, P109; Fischer M, 2006, PHYTOPATHOL MEDITERR, V45, pS30; Fussler L, 2008, PHYTOPATHOLOGY, V98, P571, DOI 10.1094/PHYTO-98-5-0571; Gerbore J, 2014, FEMS MICROBIOL ECOL, V90, P153, DOI 10.1111/1574-6941.12380; GOULDEN ML, 1994, FUNCT ECOL, V8, P125, DOI 10.2307/2390121; GRANIER A, 1987, TREE PHYSIOL, V3, P309, DOI 10.1093/treephys/3.4.309; Grosman J., 2012, PHYTOMA, V651, P31; Harmandon F., 2004, EFFETS TOXIQUES ARSE, P8; Hofstetter V, 2012, FUNGAL DIVERS, V54, P51, DOI 10.1007/s13225-012-0171-z; Johnson DM, 2016, TREE PHYSIOL, V36, P983, DOI 10.1093/treephys/tpw031; Kahmen A, 2011, P NATL ACAD SCI USA, V108, P1981, DOI 10.1073/pnas.1018906108; Larignon P, 1997, EUR J PLANT PATHOL, V103, P147, DOI 10.1023/A:1008638409410; Larignon P, 2014, VIGNERON CHAMPENOIS, V135, P27; Larignon P, 2009, CR BIOL, V332, P765, DOI 10.1016/j.crvi.2009.05.005; Lecomte P, 2012, PLANT DIS, V96, P924, DOI 10.1094/PDIS-09-11-0776-RE; Lecomte P., 2008, PHYTOMA, V616, P37; Lecomte P, 2018, PHYTOPATHOL MEDITERR, V57, P472, DOI 10.14601/Phytopathol_Mediterr-22025; Lima MRM, 2017, PHYTOPATHOLOGY, V107, P669, DOI 10.1094/PHYTO-11-16-0410-R; Liminana JM, 2009, PHYTOPATHOL MEDITERR, V48, P92; Loustau D, 1998, ANN SCI FOREST, V55, P29, DOI 10.1051/forest:19980103; Maher N, 2012, J INT SCI VIGNE VIN, V46, P15; McElrone AJ, 2010, TREE PHYSIOL, V30, P761, DOI 10.1093/treephys/tpq026; Meier U, 2001, BBCH MONOGRAPH GROWT; Meinzer FC, 2009, FUNCT ECOL, V23, P922, DOI 10.1111/j.1365-2435.2009.01577.x; Mondello V, 2018, PHYTOPATHOL MEDITERR, V57, P369, DOI 10.14601/Phytopathol_Mediterr-23942; Mostert F., 2006, PHYTOPATHOL MEDITERR, V45, P1000; Pangle RE, 2015, ECOL EVOL, V5, P1618, DOI 10.1002/ece3.1422; Pataki DE, 1998, J EXP BOT, V49, P871, DOI 10.1093/jexbot/49.322.871; Petit AN, 2006, PHYTOPATHOLOGY, V96, P1060, DOI 10.1094/PHYTO-96-1060; Pierron R., 2015, THESIS; Pouzoulet J, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00253; Pouzoulet J, 2013, APPL MICROBIOL BIOT, V97, P10163, DOI 10.1007/s00253-013-5299-6; RCore Team, 2020, R LANG ENV STAT COMP; Ritchie G. A., 1975, Advances in Ecological Research, V9, P165, DOI 10.1016/S0065-2504(08)60290-1; Sack L, 2006, ANNU REV PLANT BIOL, V57, P361, DOI 10.1146/annurev.arplant.56.032604.144141; Scheidegger Y, 2000, OECOLOGIA, V125, P350, DOI 10.1007/s004420000466; SCHOLANDER PF, 1965, SCIENCE, V148, P339, DOI 10.1126/science.148.3668.339; SMITH BN, 1970, PLANT PHYSIOL, V46, P738, DOI 10.1104/pp.46.5.738; Surico G, 2006, PHYTOPATHOL MEDITE S, V45, P1000, DOI [10.1400/52262, DOI 10.1400/52262]; Travadon R, 2016, FUNGAL ECOL, V24, P82, DOI 10.1016/j.funeco.2016.09.003; Viret O, 2012, RENCONTRE TECHNIQUES, P46; Wagschal I., 2008, Plant-microbe interactions, P367; Ward EJ, 2017, TREES-STRUCT FUNCT, V31, P1737, DOI 10.1007/s00468-017-1556-0; Zhang JW, 1997, TREE PHYSIOL, V17, P461	64	13	13	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222586	10.1371/journal.pone.0222586	http://dx.doi.org/10.1371/journal.pone.0222586			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KN6EB	31536576	Green Published, Green Submitted, gold			2022-12-26	WOS:000514927900001
J	Cubero, M; Marti, S; Dominguez, MA; Gonzalez-Diaz, A; Berbel, D; Ardanuy, C				Cubero, Meritxell; Marti, Sara; Angeles Dominguez, Ma; Gonzalez-Diaz, Aida; Berbel, Damaris; Ardanuy, Carmen			Hypervirulent Klebsiella pneumoniae serotype K1 clinical isolates form robust biofilms at the air-liquid interface	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; LIVER-ABSCESS; VIRULENCE; CAPSULE; RESISTANCE; CLONES; GENE; K2	The prevalence of a new hypervirulent and hypermucoviscous K. pneumoniae phenotype (Hmv) is increasing worldwide, mainly linked to serotypes K1 and K2. Since capsular thickness can directly affect the capability to form biofilms, we aimed to evaluate the association between the Hmv phenotype with adhesion and biofilm formation in a collection of clinical K. pneumoniae isolates. We selected 38 Hmv clinical isolates [15 serotype K1; 9 serotype K2; 3 non-K1/K2 (rmpA(+)); 11 non-K1/K2 (rmpA(-))] and 7 non-Hmv clinical isolates. The Hmv phenotype was assessed through the mucoviscosity test. Serum resistance was determined by bacterial viability tests in pooled human serum. Adhesion was evaluated with the Biofilm Ring Test (R), and biofilm formation was identified by crystal violet staining (Solid-Liquid, SLI-biofilm) or visual examination (Air-Liquid, ALI-biofilm). This study linked for the first time the formation of robust ALI-biofilm plugs by K. pneumoniae to the capsular serotype K1, a group of hypervirulent strains which are generally highly susceptible to the antimicrobial agents. Among all the studied isolates, the capsular serotype K1 presented lower initial adhesion despite having the adhesins mrkD and fimH but higher ALI-biofilm formation than isolates with other capsular serotypes (K2 or non-K1/K2). This structure might confer increased resistance to a group of hypervirulent K. pneumoniae serotype K1.	[Cubero, Meritxell; Marti, Sara; Angeles Dominguez, Ma; Gonzalez-Diaz, Aida; Berbel, Damaris; Ardanuy, Carmen] Hosp Univ Bellvitge, Inst Invest Biomed Bellvitge IDIBELL, Dept Microbiol, Barcelona, Spain; [Cubero, Meritxell; Marti, Sara; Gonzalez-Diaz, Aida; Berbel, Damaris; Ardanuy, Carmen] ISCIII, Res Network Resp Dis CIBERES, Madrid, Spain; [Angeles Dominguez, Ma] Spanish Network Res Infect Dis REIPI, Barcelona, Spain; [Angeles Dominguez, Ma; Ardanuy, Carmen] Univ Barcelona, Dept Patol & Terapeut Expt, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of Barcelona	Marti, S; Ardanuy, C (corresponding author), Hosp Univ Bellvitge, Inst Invest Biomed Bellvitge IDIBELL, Dept Microbiol, Barcelona, Spain.; Marti, S; Ardanuy, C (corresponding author), ISCIII, Res Network Resp Dis CIBERES, Madrid, Spain.; Ardanuy, C (corresponding author), Univ Barcelona, Dept Patol & Terapeut Expt, Barcelona, Spain.	smartinm@bellvitgehospital.cat; c.ardanuy@bellvitgehospital.cat	Marti, Sara/D-4823-2014; Cubero, Meritxell/AAV-4585-2020	Marti, Sara/0000-0002-0405-2305; Berbel, Damaris/0000-0002-3689-3360; Gonzalez Diaz, Aida/0000-0002-8326-1307; Cubero, Meritxell/0000-0001-7648-0686	CIBER de Enfermedades Respiratorias, CIBERES [CB06/06/0037]; European Regional Development Fund (ERDF); col.legi de farmaceuticsde Barcelona through the award "Beques col.legials del COFB"; Biofilm Control (Biopole Clermont-Limagne)	CIBER de Enfermedades Respiratorias, CIBERES; European Regional Development Fund (ERDF)(European Commission); col.legi de farmaceuticsde Barcelona through the award "Beques col.legials del COFB"; Biofilm Control (Biopole Clermont-Limagne)	CA received funding for this study from CIBER de Enfermedades Respiratorias (www.ciberes.org), CIBERES (CB06/06/0037), run by the Instituto de Salud Carlos III (ISCIII, Madrid, Spain) and by the European Regional Development Fund (ERDF). CA also received funding from the collegi de farmaceuticsde Barcelona (www.cofb.net) through the award "Beques col.legials del COFB". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Biofilm Control (Biopole Clermont-Limagne) provided support in the form of research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantar-Curiel MD, 2013, VIRULENCE, V4, P129, DOI 10.4161/viru.22974; Armitano J, 2014, ENV MICROBIOL REP, V6, P534, DOI 10.1111/1758-2229.12171; Bachman MA, 2011, INFECT IMMUN, V79, P3309, DOI 10.1128/IAI.05114-11; Brisse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004982; Carabarin-Lima A, 2016, J MED MICROBIOL, V65, P729, DOI 10.1099/jmm.0.000291; Chabane YN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111660; Chavant P, 2007, J MICROBIOL METH, V68, P605, DOI 10.1016/j.mimet.2006.11.010; Cubero M, 2016, CLIN MICROBIOL INFEC, V22, P154, DOI 10.1016/j.cmi.2015.09.025; Diago-Navarro E, 2014, J INFECT DIS, V210, P803, DOI 10.1093/infdis/jiu157; Fang CT, 2007, CLIN INFECT DIS, V45, P284, DOI 10.1086/519262; Fang CT, 2004, J EXP MED, V199, P697, DOI 10.1084/jem.20030857; Guo YJ, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00024; Hadjifrangiskou M, 2012, J BACTERIOL, V194, P6195, DOI 10.1128/JB.01012-12; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hentzien M, 2017, MED MALADIES INFECT, V47, P171, DOI 10.1016/j.medmal.2016.10.002; Holt KE, 2015, P NATL ACAD SCI USA, V112, pE3574, DOI 10.1073/pnas.1501049112; Kanj SS, 2011, MAYO CLIN PROC, V86, P250, DOI 10.4065/mcp.2010.0674; Lai YC, 2003, J BACTERIOL, V185, P788, DOI 10.1128/JB.185.3.788-800.2003; MERINO S, 1992, INFECT IMMUN, V60, P2529, DOI 10.1128/IAI.60.6.2529-2535.1992; NASSIF X, 1986, INFECT IMMUN, V54, P603, DOI 10.1128/IAI.54.3.603-608.1986; Patel G, 2013, CASE REP INFECT DIS, V2013, DOI 10.1155/2013/676340; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Puig C, 2014, APPL ENVIRON MICROB, V80, P7088, DOI 10.1128/AEM.02544-14; Puig C, 2014, INFECT IMMUN, V82, P1591, DOI 10.1128/IAI.01445-13; Schembri MA, 2004, J BACTERIOL, V186, P1249, DOI 10.1128/JB.186.5.1249-1257.2004; Shon AS, 2013, VIRULENCE, V4, P107, DOI 10.4161/viru.22718; Stahlhut SG, 2012, FEMS IMMUNOL MED MIC, V65, P350, DOI 10.1111/j.1574-695X.2012.00965.x; Struve C, 2003, FEMS MICROBIOL LETT, V218, P149, DOI 10.1016/S0378-1097(02)01117-5; Struve C, 2015, MBIO, V6, DOI 10.1128/mBio.00630-15; Wang HB, 2015, ACS APPL MATER INTER, V7, P13007, DOI 10.1021/acsami.5b03041; Wu JH, 2008, EXP BIOL MED, V233, P64, DOI 10.3181/0706-RM-170; Wu KM, 2009, J BACTERIOL, V191, P4492, DOI 10.1128/JB.00315-09; Wu MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020923	34	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222628	10.1371/journal.pone.0222628	http://dx.doi.org/10.1371/journal.pone.0222628			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532800	Green Published, Green Submitted, gold			2022-12-26	WOS:000532239600033
J	Madden, MJL; Young, RG; Brown, JW; Miller, SE; Frewin, AJ; Hanner, RH				Madden, Mary J. L.; Young, Robert G.; Brown, John W.; Miller, Scott E.; Frewin, Andrew J.; Hanner, Robert H.			Using DNA barcoding to improve invasive pest identification at US ports-of-entry	PLOS ONE			English	Article							INTERNATIONAL-TRADE; GENETIC DIVERSITY; CROP LOSSES; COMPLEX; PATHWAYS; IMPACT; NORTH; FAUNA	Interception of potential invasive species at ports-of-entry is essential for effective biosecurity and biosurveillance programs. However, taxonomic assessment of the immature stages of most arthropods is challenging; characters for identification are often dependent on adult morphology and reproductive structures. This study aims to strengthen the identification of such specimens through DNA barcoding, with a focus on microlepidoptera. A sample of 241 primarily immature microlepidoptera specimens intercepted at U.S. ports-of-entry from 2007 to 2011 were selected for analysis. From this sample, 201 COI-5P sequences were generated and analyzed for concordance between morphology-based and DNA-based identifications. The retrospective analysis of the data over 10 years (2009 to 2019) using the Barcode of Life Data (BOLD) system demonstrates the importance of establishing and growing DNA barcode reference libraries for use in specimen identification. Additionally, analysis of specimen identification using public data (43.3% specimens identified) vs. non-public data (78.6% specimens identified) highlights the need to encourage researchers to make data publicly accessible. DNA barcoding surpassed morphological identification with 42.3% (public) and 66.7% (non-public) of the sampled specimens achieving a species-level identification, compared to 38.3% species-level identification by morphology. Whilst DNA barcoding was not able to identify all specimens in our dataset, its incorporation into border security programs as an adjunct to morphological identification can provide secondary lines of evidence and lower taxonomic resolution in many cases. Furthermore, with increased globalization, database records need to be clearly annotated for suspected specimen origin versus interception location.	[Madden, Mary J. L.; Young, Robert G.; Frewin, Andrew J.; Hanner, Robert H.] Univ Guelph, Dept Integrated Biol, Guelph, ON, Canada; [Brown, John W.; Miller, Scott E.] Smithsonian Inst, Natl Museum Nat Hist, Dept Entomol, Washington, DC 20560 USA	University of Guelph; Smithsonian Institution; Smithsonian National Museum of Natural History	Young, RG (corresponding author), Univ Guelph, Dept Integrated Biol, Guelph, ON, Canada.	ryoung04@uoguelph.ca	Young, Robert/AAM-1670-2020	Young, Robert/0000-0002-6731-2506; Miller, Scott/0000-0002-4138-1378; Madden, Mary/0000-0002-3898-125X	Growing Forward, a federal provincial-territorial initiative; Flowers Canada (Ontario) Inc.; Ontario Ministry of Agriculture and Food, and Rural Affairs (OMAFRA); USDA, ARS, Systematic Entomology Laboratory, Washington, DC	Growing Forward, a federal provincial-territorial initiative; Flowers Canada (Ontario) Inc.; Ontario Ministry of Agriculture and Food, and Rural Affairs (OMAFRA); USDA, ARS, Systematic Entomology Laboratory, Washington, DC	This project was funded in part through Growing Forward, a federal provincial-territorial initiative with funding awarded to RH. The Agricultural Adaptation Council assists in the delivery of Growing Forward programs in Ontario. Additional funding was provided by Flowers Canada (Ontario) Inc. and the Ontario Ministry of Agriculture and Food, and Rural Affairs (OMAFRA) to RH. The sponsors did not play a role in the study design, data collection and analysis, decision to publish, or preparation of this manuscript.; Continued progress on DNA barcoding Lepidoptera from the Smithsonian collection has been made by collaboration between the University of Guelph and the Smithsonian, with help from many people, including those listed in Levesque-Beaudin et al. (2017). Contributions by JWB were supported by the USDA, ARS, Systematic Entomology Laboratory, Washington, DC.	Augustin Sylvie, 2012, Bulletin OEPP, V42, P515, DOI 10.1111/epp.2600; Bacon SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047689; Benson Dennis A, 2005, Nucleic Acids Res, V33, pD34; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Bonants PJM, 2014, DETECTION DIAGNOSTIC, P119; Borisenko AV, 2009, MOL ECOL RESOUR, V9, P27, DOI 10.1111/j.1755-0998.2009.02629.x; Brabrand A, 2014, RIVER RES APPL, V30, P602, DOI 10.1002/rra.2669; Brasier CM, 2008, PLANT PATHOL, V57, P792, DOI 10.1111/j.1365-3059.2008.01886.x; Caffrey JM, 2014, MANAG BIOL INVASION, V5, P1, DOI 10.3391/mbi.2014.5.1.01; Castalanelli MA, 2010, J ASIA-PAC ENTOMOL, V13, P243, DOI 10.1016/j.aspen.2010.04.003; Costa FO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035858; Curry CJ, 2018, FRESHW SCI, V37, P178, DOI 10.1086/696613; Dewaard JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018290; Early R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12485; Frewin A., 2013, CAB Reviews, V8, P1, DOI 10.1079/PAVSNNR20138018; Gilligan TM, 2019, J ECON ENTOMOL, V112, P603, DOI 10.1093/jee/toy402; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hanner R., 2009, DATA STANDARDS BARCO; Harwood TD, 2009, ECOL MODEL, V220, P3353, DOI 10.1016/j.ecolmodel.2009.08.014; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Ivanova NV, 2009, MOL ECOL RESOUR, V9, P35, DOI 10.1111/j.1755-0998.2009.02630.x; Janzen DH, 2012, INVERTEBR SYST, V26, P478, DOI 10.1071/IS12038; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Kenis M, 2007, B ENTOMOL RES, V97, P489, DOI 10.1017/S0007485307005184; Ko HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053451; Lenda M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099786; Levesque-Beaudin V., 2017, GENOME, V60, P962, DOI [10.1139/gen-2017-0178, DOI 10.1139/GEN-2017-0178]; Liu ZF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175788; Mastrangelo T, 2014, J ECON ENTOMOL, V107, P970, DOI 10.1603/EC13403; McCullough DG, 2006, BIOL INVASIONS, V8, P611, DOI 10.1007/s10530-005-1798-4; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Milic D, 2019, J INSECT CONSERV, V23, P29, DOI 10.1007/s10841-018-0111-7; Moser WK, 2009, J FOREST, V107, P57; Moslonka-Lefebvre M, 2011, PHYTOPATHOLOGY, V101, P392, DOI 10.1094/PHYTO-07-10-0192; Navia D, 2010, EXP APPL ACAROL, V51, P225, DOI 10.1007/s10493-009-9327-2; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Oliveira CM, 2014, CROP PROT, V56, P50, DOI 10.1016/j.cropro.2013.10.022; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Phillips JD, 2019, ECOL EVOL, V9, P2996, DOI 10.1002/ece3.4757; Porter TM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200177; Pramual P, 2014, J ASIA-PAC ENTOMOL, V17, P549, DOI 10.1016/j.aspen.2014.05.006; Prosser S, 2013, MOL ECOL RESOUR, V13, P1151, DOI 10.1111/1755-0998.12132; Puillandre N, 2011, INVERTEBR SYST, V25, P322, DOI 10.1071/IS11022; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Schachat SR, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.161002; Serrao NR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099546; Smith A, 2012, MOL ECOLOGY RESOURCE, V13, P168, DOI DOI 10.1111/1755-0998; Stehr F.W., 1987, P288; Suffert M., 2018, Bulletin OEPP, V48, P144, DOI 10.1111/epp.12462; Sweeney BW, 2011, J N AM BENTHOL SOC, V30, P195, DOI 10.1899/10-016.1; Vanninen I, 2011, AGR FOOD SCI, V20, P96, DOI 10.2137/145960611795163033; Vernooy R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000417; Watts C, 2019, AUSTRAL ENTOMOL, V58, P675, DOI 10.1111/aen.12384; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Whittle PJL, 2013, DIVERS DISTRIB, V19, P629, DOI 10.1111/ddi.12056; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Wilson A. D., 2010, Journal of Entomology, V7, P60, DOI 10.3923/je.2010.60.79; Wilson John James, 2012, Methods Mol Biol, V858, P17, DOI 10.1007/978-1-61779-591-6_3; Wilson JRU, 2013, S AFR J SCI, V109, DOI 10.1590/sajs.2013/20120111; Worner SP, 2006, J APPL ECOL, V43, P858, DOI 10.1111/j.1365-2664.2006.01202.x; Zahiri R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092797	66	25	26	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222291	10.1371/journal.pone.0222291	http://dx.doi.org/10.1371/journal.pone.0222291			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527883	Green Published, Green Submitted, gold			2022-12-26	WOS:000532231400014
J	Arabuli, T; Negm, MW; Matsuda, T; Kitashima, Y; Abramishvili, T; Akimov, IA; Zhovnerchuk, OV; Popov, SY; Gotoh, T				Arabuli, Tea; Negm, Mohamed Waleed; Matsuda, Tomoko; Kitashima, Yasuki; Abramishvili, Tea; Akimov, Igor Andrijovych; Zhovnerchuk, Olga Valentynivna; Popov, Sergei Yakovlevich; Gotoh, Tetsuo			Morphological identification of Amphitetranychus species (Acari: Tetranychidae) with crossbreeding, esterase zymograms and DNA barcode data	PLOS ONE			English	Article							SEQUENCES	The genus Amphitetranychus Oudemans (Tetranychidae) consists of only three species, A. quercivorus (Ehara & Gotoh), A. savenkoae (Reck) and A. viennensis (Zacher). The original description of A. savenkoae was extremely simple and had no drawing of the aedeagus; however, a subsequent study described only the aedeagus. The present study investigated all three species in detail using a combination of morphological traits, crossbreeding experiments, esterase zymograms and the mitochondrial cytochrome c oxidase subunit I (COI) gene. Morphological differences in the peritremes and male aedeagi were observed among the three species. Complete reproductive isolation was confirmed in the reciprocal crosses between the morphologically similar A. savenkoae and A. quercivorus (no female offspring were produced). Esterase zymograms differed interspecifically, but not intraspecifically (among individuals in a given species). All three species formed clearly separate clades with 100% bootstrap values in the COI tree, and A. savenkoae was more closely related to A. quercivorus than to A. viennensis, which corresponded to the morphological similarity of their aedeagi and setal counts on tarsi IV. A key to Amphitetranychus species is provided.	[Arabuli, Tea; Negm, Mohamed Waleed; Matsuda, Tomoko; Kitashima, Yasuki; Gotoh, Tetsuo] Ibaraki Univ, Fac Agr, Lab Appl Entomol & Zool, Ami, Ibaraki, Japan; [Arabuli, Tea] Ilia State Univ, Inst Zool, Kakutsa Cholokashvilli Ave, Tbilisi, Georgia; [Arabuli, Tea] Agr Univ Georgia, Inst Entomol, Kakha Bendukidze Campus, Tbilisi, Georgia; [Negm, Mohamed Waleed] Assiut Univ, Fac Agr, Dept Plant Protect, Assiut, Egypt; [Negm, Mohamed Waleed] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Abramishvili, Tea] Lab Minist Agr, Dept Plant Pest Diagnost, Tbilisi, Georgia; [Akimov, Igor Andrijovych; Zhovnerchuk, Olga Valentynivna] Natl Acad Sci Ukraine, Schmalhausen Inst Zool, Kiev, Ukraine; [Popov, Sergei Yakovlevich] Russian State Agr Univ, Dept Plant Protect, Moscow Timiryazev Agr Acad, Moscow, Russia; [Gotoh, Tetsuo] Ryutsu Keizai Univ, Fac Econ, Ryugasaki, Ibaraki, Japan	Ibaraki University; Ilia State University; Egyptian Knowledge Bank (EKB); Assiut University; Japan Society for the Promotion of Science; National Academy of Sciences Ukraine; Schmalhausen Institute of Zoology of NASU; Russian State Agrarian University - Moscow Timiryazev Agricultural Academy	Gotoh, T (corresponding author), Ibaraki Univ, Fac Agr, Lab Appl Entomol & Zool, Ami, Ibaraki, Japan.; Gotoh, T (corresponding author), Ryutsu Keizai Univ, Fac Econ, Ryugasaki, Ibaraki, Japan.	tetsuo.gotoh.acari@vc.ibaraki.ac.jp	Popov, Sergei Ya., Y., Y.A./A-8494-2016; Zhovnerchuk, Olga/D-6101-2016; Negm, Mohamed W./X-8797-2018; Zhovnerchuk, Olga/AGI-6598-2022	Zhovnerchuk, Olga/0000-0002-1878-7767; Negm, Mohamed W./0000-0003-3479-0496; Arabuli, Tea/0000-0003-0794-0487; Matsuda, Tomoko/0000-0002-4709-4302	Japan Society for the Promotion of Science KAKENHI [JP25292033, JP17H03775, JP17F17397]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by: Tetsuo Gotoh, Japan Society for the Promotion of Science KAKENHI Grant Numbers JP25292033 and JP17H03775 (Grant-in-Aid for Scientific Research B), http://www.jsps.go.jp/english/; and by: Mohamed Waleed Negm, Japan Society for the Promotion of Science KAKENHI Grant Number JP17F17397 (Grant-in-Aid for JSPS Research Fellow). The funder (Japan Society for the Promotion of Science KAKENHI) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Nihon BioData Corporation provided support in the form of salaries for Tomoko Matsuda, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akimov .A, 2016, UKRAINIAN ENTOMOLOGI, V592, P105; Arabuli T, 2008, P GEORGIAN ACAD SC B, V6, P86; EHARA S, 1990, International Journal of Acarology, V16, P55; Ehara Shozo, 1999, Species Diversity, V4, P63; EHARA SHOZO, 1956, JOUR FAC SCI HOKKAIDO UNIV SER VL ZOOL, V12, P244; Enohara K, 1996, JPN J APPL ENTOMOL Z, V40, P311, DOI 10.1303/jjaez.40.311; Geijskes D. C., 1939, Mededelingen van de Landbouwhoogeschool te Wageningen, V42, P1; Gotoh Tetsuo, 1992, Journal of the Acarological Society of Japan, V1, P45; Gotoh T, 2007, APPL ENTOMOL ZOOL, V42, P579, DOI 10.1303/aez.2007.579; Gotoh T, 2009, INT J ACAROL, V35, P485, DOI 10.1080/01647950903431156; Helle W, 1985, THEIR BIOL NATURAL E; Hirst S, 1920, P ZOOL SOC LOND, V1920, P49; Keifer HH., 1975, MITES INJURIOUS EC P, P327; Khaing TM, 2013, J ASIA-PAC ENTOMOL, V16, P155, DOI 10.1016/j.aspen.2012.12.003; Klimov PB, 2004, ANN ENTOMOL SOC AM, V97, P322, DOI 10.1603/0013-8746(2004)097[0322:MAOMVI]2.0.CO;2; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lindquist E.E., 1985, P3; Matsuda T, 2013, J ECON ENTOMOL, V106, P463, DOI 10.1603/EC12328; Matsuda T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108672; Migeon A., 2019, SPIDER MITES WEB COM; Mitrofanov V.I., 1987, KEYS TETRANYCHID MIT; Navajas M, 1999, ENTOMOL EXP APPL, V90, P113, DOI 10.1023/A:1003524217318; Navajas M, 1997, B ENTOMOL RES, V87, P283, DOI 10.1017/S0007485300037238; Oudemans A. C., 1931, Entomologische Berichten 's Gravenhage, VVol. 8, P221; Pritchard AE, 1955, MEMOIR SERIES, V2; Reck G. F., 1956, T I ZOOLOGYI AKAD NA, V15, P5; Reck GF, 1959, GRUZINSKOI SSR, V1, P1; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sokal RR, 1995, BIOMETRY; Sourassou NF, 2012, EXP APPL ACAROL, V57, P15, DOI 10.1007/s10493-012-9534-0; SPSS, 2009, MAN PASW R STAT BAS; Tseng Y.-H., 1990, Taiwan Museum Special Publication Series, P1; Wainstein BA, 1960, TETRANYCHOID MITES K, V5; Zacher F., 1921, Z ANGEW ENTOMOL, V7, P181, DOI [10.1111/j.1439-0418.1921.tb01629.x, DOI 10.1111/J.1439-0418.1921.TB01629.X]; Zacher F., 1920, VORLAUFIGE DIAGNOSEN, P1; Zhovnerchuk OV, 2013, P 5 INT SCI C READ M, P68	36	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2019	14	9							e0221951	10.1371/journal.pone.0221951	http://dx.doi.org/10.1371/journal.pone.0221951			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4KS	31518372	gold, Green Submitted, Green Published			2022-12-26	WOS:000532219300015
J	Hornemann, S; Schwarz, P; Rushing, EJ; Connolly, MD; Zuckermann, RN; Yam, AY; Aguzzi, A				Hornemann, Simone; Schwarz, Petra; Rushing, Elisabeth J.; Connolly, Michael D.; Zuckermann, Ronald N.; Yam, Alice Y.; Aguzzi, Adriano			Enhanced detection of prion infectivity from blood by preanalytical enrichment with peptoid-conjugated beads	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; SCRAPIE INFECTIVITY; STAINLESS-STEEL; PROTEIN PRP; TRANSMISSION; VARIANT; MICE; BSE; TRANSFUSION; PROPAGATION	Prions cause transmissible infectious diseases in humans and animals and have been found to be transmissible by blood transfusion even in the presymptomatic stage. However, the concentration of prions in body fluids such as blood and urine is extremely low; therefore, direct diagnostic tests on such specimens often yield false-negative results. Quantitative preanalytical prion enrichment may significantly improve the sensitivity of prion assays by concentrating trace amounts of prions from large volumes of body fluids. Here, we show that beads conjugated to positively charged peptoids not only captured PrP aggregates from plasma of prion-infected hamsters, but also adsorbed prion infectivity in both the symptomatic and preclinical stages of the disease. Bead absorbed prion infectivity efficiently transmitted disease to transgenic indicator mice. We found that the readout of the peptoid-based misfolded protein assay (MPA) correlates closely with prion infectivity in vivo, thereby validating the MPA as a simple, quantitative, and sensitive surrogate indicator of the presence of prions. The reliable and sensitive detection of prions in plasma will enable a wide variety of applications in basic prion research and diagnostics.	[Hornemann, Simone; Schwarz, Petra; Rushing, Elisabeth J.; Aguzzi, Adriano] Univ Zurich, Inst Neuropathol, Zurich, Switzerland; [Yam, Alice Y.] Novartis Vaccines & Diagnost Inc, Emeryville, CA USA; [Connolly, Michael D.; Zuckermann, Ronald N.] Lawrence Berkeley Natl Lab, Mol Foundry, Biol Nanostruct Facil, Berkeley, CA USA; [Yam, Alice Y.] Sutro Biopharma, San Francisco, CA USA	University of Zurich; Novartis; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Hornemann, S; Aguzzi, A (corresponding author), Univ Zurich, Inst Neuropathol, Zurich, Switzerland.	Simone.Hornemann@usz.ch; Adriano.Aguzzi@usz.ch		Aguzzi, Adriano/0000-0002-0344-6708; Hornemann, Simone/0000-0002-2674-9891	European Research Council [670958]; Swiss National Foundation [179040]; SystemsX.ch [SynucleiX 2015/320, PrionX: 2014/260]; GELU Foundation; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DEAC02-05CH11231]; Novartis Research Foundation; Clinical Research Priority Program "Small RNAs"; Clinical Research Priority Program "Human Hemato-Lymphatic Diseases"	European Research Council(European Research Council (ERC)European Commission); Swiss National Foundation(Swiss National Science Foundation (SNSF)); SystemsX.ch; GELU Foundation; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); Novartis Research Foundation; Clinical Research Priority Program "Small RNAs"; Clinical Research Priority Program "Human Hemato-Lymphatic Diseases"	AA is the recipient of an Advanced Grant of the European Research Council (grant No 670958), and is supported by the Swiss National Foundation (grant No 179040), the Clinical Research Priority Programs "Small RNAs" and "Human Hemato-Lymphatic Diseases" (https://www.uzh.ch/en/research/medicine/clinic.html), SystemsX.ch (grant No PrionX: 2014/260 and SynucleiX 2015/320), and the GELU Foundation. SH is the recipient of grants from SystemsX.ch (grant No SynucleiX 2015/320). Work at the Molecular Foundry was supported by the Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under Contract No. DEAC02-05CH11231. This study was supported by the Novartis Research Foundation (https://www.novartis.com/our-science/novartis-institutesbiomedical-research).The funder provided support in the form of general funding, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RJ, 1983, NATURE, V303, P718, DOI 10.1038/303718a0; Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Aguzzi A, 1996, NATURE, V383, P666, DOI 10.1038/383666a0; Aguzzi A, 2006, NAT CLIN PRACT NEURO, V2, P321, DOI 10.1038/ncpneuro0214; Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Bougard D, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aag1257; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown P, 1999, TRANSFUSION, V39, P1169, DOI 10.1046/j.1537-2995.1999.39111169.x; Brown P, 1998, TRANSFUSION, V38, P810, DOI 10.1046/j.1537-2995.1998.38998408999.x; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Denkers ND, 2016, J GEN VIROL, V97, P2023, DOI 10.1099/jgv.0.000515; Douet JY, 2014, EMERG INFECT DIS, V20, P114, DOI 10.3201/eid2001.130353; Edgeworth JA, 2010, P NATL ACAD SCI USA, V107, P14402, DOI 10.1073/pnas.1004036107; Edgeworth JA, 2011, LANCET, V377, P487, DOI 10.1016/S0140-6736(10)62308-2; Edgeworth JA, 2009, P NATL ACAD SCI USA, V106, P3479, DOI 10.1073/pnas.0813342106; Falsig J, 2008, HFSP J, V2, P332, DOI 10.2976/1.2990786; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Fischer MB, 2000, NATURE, V408, P479, DOI 10.1038/35044100; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; Frontzek K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163601; Gao CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015725; Haybaeck J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001257; Herrmann US, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1923; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Holada K, 2000, LANCET, V356, P1772, DOI 10.1016/S0140-6736(05)71968-1; Holada K, 2002, J VIROL, V76, P4649, DOI 10.1128/JVI.76.9.4649-4650.2002; HORNSHAW MP, 1995, BIOCHEM BIOPH RES CO, V214, P993, DOI 10.1006/bbrc.1995.2384; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; KIMBERLIN RH, 1986, J GEN VIROL, V67, P255, DOI 10.1099/0022-1317-67-2-255; Kranich J, 2010, J EXP MED, V207, P2271, DOI 10.1084/jem.20092401; Lau AL, 2007, P NATL ACAD SCI USA, V104, P11551, DOI 10.1073/pnas.0704260104; LAURSEN SE, 1986, J PHARMACOL METHOD, V16, P355, DOI 10.1016/0160-5402(86)90038-0; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Luhr KM, 2009, J GEN VIROL, V90, P2821, DOI 10.1099/vir.0.012302-0; Margalith I, 2012, J BIOL CHEM, V287, P18872, DOI 10.1074/jbc.M112.355958; Mastrianni JA, 2010, GENET MED, V12, P187, DOI 10.1097/GIM.0b013e3181cd7374; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; McGuire LI, 2016, ANN NEUROL, V80, P160, DOI 10.1002/ana.24679; MENEI P, 1994, J BIOMED MATER RES, V28, P1079, DOI 10.1002/jbm.820280913; Miller MB, 2011, J VIROL, V85, P2813, DOI 10.1128/JVI.02451-10; Orru CD, 2011, MBIO, V2, DOI 10.1128/mBio.00078-11; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Polymenidou M, 2011, BRAIN PATHOL, V21, P209, DOI 10.1111/j.1750-3639.2010.00439.x; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ramakrishnan Muthannan Andavar, 2016, World J Virol, V5, P85, DOI 10.5501/wjv.v5.i2.85; Raper D, 2016, TRENDS NEUROSCI, V39, P581, DOI 10.1016/j.tins.2016.07.001; REED L. J., 1938, AMER JOUR HYG, V27, P493; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; Segarra C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069632; SIMON RJ, 1992, P NATL ACAD SCI USA, V89, P9367, DOI 10.1073/pnas.89.20.9367; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Weissmann C, 2002, J INFECT DIS, V186, pS157, DOI 10.1086/344575; Yakovleva O, 2004, TRANSFUSION, V44, P1700, DOI 10.1111/j.0041-1132.2004.04198.x; Yam AY, 2011, BIOCHEMISTRY-US, V50, P4322, DOI 10.1021/bi200215j; Zhu CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144983; Zobeley E, 1999, MOL MED, V5, P240, DOI 10.1007/BF03402121	69	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2019	14	9							e0216013	10.1371/journal.pone.0216013	http://dx.doi.org/10.1371/journal.pone.0216013			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4IG	31513666	gold, Green Submitted, Green Published			2022-12-26	WOS:000532212700005
J	Huang, YJ; Paillard, S; Kumar, V; King, GJ; Fitt, BDL; Delourme, R				Huang, Yong-Ju; Paillard, Sophie; Kumar, Vinod; King, Graham J.; Fitt, Bruce D. L.; Delourme, Regine			Oilseed rape (Brassica napus) resistance to growth of Leptosphaeria maculans in leaves of young plants contributes to quantitative resistance in stems of adult plants	PLOS ONE			English	Article							BLACKLEG RESISTANCE; POLYGENIC RESISTANCE; FIELD-RESISTANCE; MAJOR GENE; IN-FIELD; A-GROUP; CANKER; IDENTIFICATION; EPIDEMIOLOGY; DISEASE	Key message: One QTL for resistance against Leptosphaeria maculans growth in leaves of young plants in controlled environments overlapped with one QTL detected in adult plants in field experiments. The fungal pathogen Leptosphaeria maculans initially infects leaves of oilseed rape (Brassica napus) in autumn in Europe and then grows systemically from leaf lesions along the leaf petiole to the stem, where it causes damaging phoma stem canker (blackleg) in summer before harvest. Due to the difficulties of investigating resistance to L. maculans growth in leaves and petioles under field conditions, identification of quantitative resistance typically relies on end of season stem canker assessment on adult plants. To investigate whether quantitative resistance can be detected in young plants, we first selected nine representative DH (doubled haploid) lines from an oilseed rape DY ('Darmor-bzh' x 'Yudal') mapping population segregating for quantitative resistance against L. maculans for controlled environment experiment (CE). We observed a significant correlation between distance grown by L. maculans along the leaf petiole towards the stem (r = 0.91) in CE experiments and the severity of phoma stem canker in field experiments. To further investigate quantitative trait loci (QTL) related to resistance against growth of L. maculans in leaves of young plants in CE experiments, we selected 190 DH lines and compared the QTL detected in CE experiments with QTL related to stem canker severity in stems of adult plants in field experiments. Five QTL for resistance to L. maculans growth along the leaf petiole were detected; collectively they explained 35% of the variance. Two of these were also detected in leaf lesion area assessments and each explained 10-12% of the variance. One QTL on A02 co-localized with a QTL detected in stems of adult plants in field experiments. This suggests that resistance to the growth of L. maculans from leaves along the petioles towards the stems contributes to the quantitative resistance assessed in stems of adult plants in field experiments at the end of the growing season.	[Huang, Yong-Ju; Fitt, Bruce D. L.] Univ Hertfordshire, Sch Life & Med Sci, Hatfield, Herts, England; [Paillard, Sophie; Kumar, Vinod; Delourme, Regine] Univ Rennes, Agrocampus Ouest, INRA, IGEPP, Rennes, France; [King, Graham J.] Southern Cross Univ, Lismore, NSW, Australia	University of Hertfordshire; INRAE; Institut Agro; Agrocampus Ouest; Universite de Rennes; Southern Cross University	Huang, YJ (corresponding author), Univ Hertfordshire, Sch Life & Med Sci, Hatfield, Herts, England.	y.huang8@herts.ac.uk	King, Graham J/AAW-3368-2020	King, Graham J/0000-0002-5975-6051; Bruce D. L., Fitt/0000-0003-3981-6456	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/I017585/1, M028348/1, P00489X/1]; Innovate UK [102100, 102641]; AHDB Cereals Oilseeds [RD-2140021105]; Department for Environment, Food and Rural Affairs [CH0104]; Perry Foundation; Felix Thornley Cobbold Agricultural Trust [5CXXXII]; Chadacre Agricultural Trust [GRA 3/53]; BBSRC [BB/M028348/1, BB/P00489X/1, BB/N005112/1, BB/I017585/1, BB/R019819/1] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Innovate UK(UK Research & Innovation (UKRI)Innovate UK); AHDB Cereals Oilseeds; Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Perry Foundation; Felix Thornley Cobbold Agricultural Trust; Chadacre Agricultural Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The UK Biotechnology and Biological Sciences Research Council (BBSRC, BB/I017585/1, M028348/1 and P00489X/1), the Innovate UK (102100 and 102641), AHDB Cereals & Oilseeds (RD-2140021105), the Department for Environment, Food and Rural Affairs (CH0104) (Defra), the Perry Foundation, the Felix Thornley Cobbold Agricultural Trust (5CXXXII) and the Chadacre Agricultural Trust (GRA 3/53) supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balesdent MH, 2006, EUR J PLANT PATHOL, V114, P53, DOI 10.1007/s10658-005-2104-0; Balesdent MH, 2001, PHYTOPATHOLOGY, V91, P70, DOI 10.1094/PHYTO.2001.91.1.70; Bebber DP, 2013, NAT CLIM CHANGE, V3, P985, DOI [10.1038/nclimate1990, 10.1038/NCLIMATE1990]; Beddington J, 2010, PHILOS T R SOC B, V365, P61, DOI 10.1098/rstb.2009.0201; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Brun H, 2010, NEW PHYTOL, V185, P285, DOI 10.1111/j.1469-8137.2009.03049.x; Carter HE, 2014, MOL PLANT PATHOL, V15, P513, DOI 10.1111/mpp.12106; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chartrain L, 2004, PHYTOPATHOLOGY, V94, P497, DOI 10.1094/PHYTO.2004.94.5.497; Clarke WE, 2016, THEOR APPL GENET, V129, P1887, DOI 10.1007/s00122-016-2746-7; Delourme R, 2008, THEOR APPL GENET, V117, P1055, DOI 10.1007/s00122-008-0844-x; Delourme R, 2008, ANN APPL BIOL, V153, P259, DOI 10.1111/j.1744-7348.2008.00258.x; Delourme R, 2006, EUR J PLANT PATHOL, V114, P41, DOI 10.1007/s10658-005-2108-9; Delourme R, 2014, INFECT GENET EVOL, V27, P490, DOI 10.1016/j.meegid.2013.12.019; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Fitt BDL, 2006, EUR J PLANT PATHOL, V114, P3, DOI 10.1007/s10658-005-2233-5; Foisset N, 1996, THEOR APPL GENET, V93, P1017, DOI 10.1007/BF00230119; Fomeju BF, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00772; Hahn Matthias, 2014, Journal of Chemical Biology, V7, P133, DOI 10.1007/s12154-014-0113-1; Howlett BJ, 2004, CAN J PLANT PATHOL, V26, P245; Huang YJ, 2016, THEOR APPL GENET, V129, P169, DOI 10.1007/s00122-015-2620-z; Huang YJ, 2009, PLANT PATHOL, V58, P314, DOI 10.1111/j.1365-3059.2008.01957.x; Huang YJ, 2006, NEW PHYTOL, V170, P129, DOI 10.1111/j.1469-8137.2006.01651.x; Huang YJ, 2005, EUR J PLANT PATHOL, V111, P263, DOI 10.1007/s10658-004-4421-0; Huang YJ, 2003, PLANT PATHOL, V52, P245, DOI 10.1046/j.1365-3059.2003.00813.x; Huang YJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197752; Huang YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084924; Hughes DJ, 2011, PEST MANAG SCI, V67, P1082, DOI 10.1002/ps.2151; Jestin C, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0356-8; Jestin C, 2012, OPEN J GENET CYTOL, V2, P190, DOI DOI 10.4236/0JGEN.2012.24025; Kumar V, 2018, THEOR APPL GENET, V131, P1627, DOI 10.1007/s00122-018-3103-9; Larkan NJ, 2013, NEW PHYTOL, V197, P595, DOI 10.1111/nph.12043; Larkan NJ, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0877-2; Larkan NJ, 2015, PLANT BIOTECHNOL J, V13, P983, DOI 10.1111/pbi.12341; Li H, 2007, AUSTRALAS PLANT PATH, V36, P439, DOI 10.1071/AP07048; Lindhout P, 2002, EUPHYTICA, V124, P217, DOI 10.1023/A:1015686601404; Liu SY, 2006, PLANT PATHOL, V55, P401, DOI 10.1111/j.1365-3059.2006.01354.x; McDonald Bruce, 2010, New Phytol, V185, P3, DOI 10.1111/j.1469-8137.2009.03108.x; Payne RW, 2011, GUIDE GENSTAT RELEAS; Pilet ML, 1998, THEOR APPL GENET, V96, P23, DOI 10.1007/s001220050704; Pilet ML, 2001, CROP SCI, V41, P197, DOI 10.2135/cropsci2001.411197x; Pilet-Nayel ML, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01838; Raman H R, 2013, PLANT BREEDING LAB F; Raman H, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01622; Raman R, 2012, THEOR APPL GENET, V125, P405, DOI 10.1007/s00122-012-1842-6; Rimmer SR, 2006, CAN J PLANT PATHOL, V28, pS288, DOI 10.1080/07060660609507386; Rouxel T, 2003, EUR J PLANT PATHOL, V109, P871, DOI 10.1023/A:1026189225466; Rouxel T, 2017, NEW PHYTOL, V214, P526, DOI 10.1111/nph.14411; Sewell TR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15545-9; Soanes DM, 2008, TRENDS MICROBIOL, V16, P507, DOI 10.1016/j.tim.2008.08.002; Sprague SJ, 2006, EUR J PLANT PATHOL, V114, P33, DOI 10.1007/s10658-005-3683-5; Stachowiak A, 2006, EUR J PLANT PATHOL, V114, P67, DOI 10.1007/s10658-005-2931-z; Toscano-Underwood C, 2001, PLANT PATHOL, V50, P28, DOI 10.1046/j.1365-3059.2001.00526.x; Travadon R, 2009, PLANT PATHOL, V58, P461, DOI 10.1111/j.1365-3059.2008.02014.x; West JS, 2001, PLANT PATHOL, V50, P10, DOI 10.1046/j.1365-3059.2001.00546.x; West JS, 1999, ANN APPL BIOL, V135, P535, DOI 10.1111/j.1744-7348.1999.tb00885.x; Yu F, 2005, THEOR APPL GENET, V110, P969, DOI 10.1007/s00122-004-1919-y; Yu FQ, 2008, GENOME, V51, P64, DOI 10.1139/g07-103; Zhang XH, 2018, CROP PASTURE SCI, V69, P40, DOI 10.1071/CP16401; Zhang XH, 2016, EUR J PLANT PATHOL, V145, P659, DOI 10.1007/s10658-015-0819-0	62	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2019	14	9							e0222540	10.1371/journal.pone.0222540	http://dx.doi.org/10.1371/journal.pone.0222540			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4IG	31513677	Green Published, Green Submitted, gold			2022-12-26	WOS:000532212700088
J	O'Connor, CM; Leonard, D; Wiredja, D; Avelar, RA; Wang, ZZ; Schlatzer, D; Bryson, B; Tokala, E; Taylor, SE; Upadhyay, A; Sangodkar, J; Gingras, AC; Westermarck, J; Xu, WQ; DiFeo, A; Brautigan, DL; Haider, S; Jackson, M; Narla, G				O'Connor, Caitlin M.; Leonard, Daniel; Wiredja, Danica; Avelar, Rita A.; Wang, Zhizhi; Schlatzer, Daniela; Bryson, Benjamin; Tokala, Eesha; Taylor, Sarah E.; Upadhyay, Aditya; Sangodkar, Jaya; Gingras, Anne-Claude; Westermarck, Jukka; Xu, Wenqing; DiFeo, Analisa; Brautigan, David L.; Haider, Shozeb; Jackson, Mark; Narla, Goutham			Inactivation of PP2A by a recurrent mutation drives resistance to MEK inhibitors	ONCOGENE			English	Article							PROTEIN PHOSPHATASE 2A; PURIFICATION-MASS SPECTROMETRY; A-ALPHA; SUBUNIT INTERACTION; MOLECULAR-DYNAMICS; COMPLEXES; PPP2R1A; OVARIAN; IDENTIFICATION; SIMULATION	The serine/threonine Protein Phosphatase 2A (PP2A) functions as a tumor suppressor by negatively regulating multiple oncogenic signaling pathways. The canonical PP2A holoenzyme comprises a scaffolding subunit (PP2A A alpha/beta), which serves as the platform for binding of both the catalytic C subunit and one regulatory B subunit. Somatic heterozygous missense mutations in PPP2R1A, the gene encoding the PP2A A alpha scaffolding subunit, have been identified across multiple cancer types, but the effects of the most commonly mutated residue, Arg-183, on PP2A function have yet to be fully elucidated. In this study, we used a series of cellular and in vivo models and discovered that the most frequent A alpha R183W mutation formed alternative holoenzymes by binding of different PP2A regulatory subunits compared with wild-type A alpha, suggesting a rededication of PP2A functions. Unlike wild-type A alpha, which suppressed tumorigenesis, the R183W mutant failed to suppress tumor growth in vivo through activation of the MAPK pathway in RAS-mutant transformed cells. Furthermore, cells expressing R183W were less sensitive to MEK inhibitors. Taken together, our results demonstrate that the R183W mutation in PP2A A alpha scaffold abrogates the tumor suppressive actions of PP2A, thereby potentiating oncogenic signaling and reducing drug sensitivity of RAS-mutant cells.	[O'Connor, Caitlin M.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Leonard, Daniel; Taylor, Sarah E.; Jackson, Mark] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Wiredja, Danica; Schlatzer, Daniela] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Avelar, Rita A.; DiFeo, Analisa] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Wang, Zhizhi; Xu, Wenqing] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Bryson, Benjamin; Tokala, Eesha; Upadhyay, Aditya; Jackson, Mark] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Sangodkar, Jaya; Narla, Goutham] Univ Michigan, Dept Internal Med Genet Med, Ann Arbor, MI 48109 USA; [Gingras, Anne-Claude] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada; [Gingras, Anne-Claude] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Westermarck, Jukka] Univ Turku, Turku Ctr Biotechnol, Turku, Finland; [Westermarck, Jukka] Abo Akad Univ, Turku, Finland; [DiFeo, Analisa; Narla, Goutham] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA; [DiFeo, Analisa] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Brautigan, David L.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA USA; [Haider, Shozeb] UCL, Dept Pharmaceut & Biol Chem, London, England	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle; Case Western Reserve University; University of Michigan System; University of Michigan; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Turku; Abo Akademi University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Virginia; University of London; University College London	Narla, G (corresponding author), Univ Michigan, Dept Internal Med Genet Med, Ann Arbor, MI 48109 USA.; Narla, G (corresponding author), Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI 48109 USA.	gnarla@med.umich.edu	Westermarck, Jukka/AAL-6464-2020; Gingras, Anne-Claude/E-9982-2010; Narla, Goutham/AAZ-5710-2020; Gingras, Anne-Claude/ABA-8341-2020; Bryson, Benjamin L/D-1070-2014; O'Connor, Caitlin M./AAC-5203-2020; Haider, Shozeb/B-3452-2015	Westermarck, Jukka/0000-0001-7478-3018; Gingras, Anne-Claude/0000-0002-6090-4437; Narla, Goutham/0000-0003-4098-4203; Gingras, Anne-Claude/0000-0002-6090-4437; Bryson, Benjamin L/0000-0003-4131-0200; O'Connor, Caitlin M./0000-0002-7840-6399; Haider, Shozeb/0000-0003-2650-2925; DiFeo, Analisa/0000-0001-8319-6763; Taylor, Sarah/0000-0003-2743-8099	NIH/NCI [R01CA181654, T32GM008803]; National Center for Advancing Translational Sciences (NCATS) component of the National Institutes of Health [4UL1TR000439]; Athymic Animal and Preclinical Therapeutics of the Case Comprehensive Cancer Center at Case Western Reserve University (NIH) [P30 CA043703]; Cytometry and Imaging Microscopy cores of the Case Comprehensive Cancer Center at Case Western Reserve University (NIH) [P30 CA043703]; Pardee-Gerstacker Professorship in Cancer Research	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Advancing Translational Sciences (NCATS) component of the National Institutes of Health; Athymic Animal and Preclinical Therapeutics of the Case Comprehensive Cancer Center at Case Western Reserve University (NIH); Cytometry and Imaging Microscopy cores of the Case Comprehensive Cancer Center at Case Western Reserve University (NIH); Pardee-Gerstacker Professorship in Cancer Research	The authors wish to acknowledge the Young Scientist Foundation and the students who worked on this project through this program, including Aditya Upadhyay. This work was partially supported by the NIH/NCI R01CA181654 (to GN) and T32GM008803 (to CMO). This publication was made possible in part by the Clinical and Translational Science Collaborative of Cleveland, 4UL1TR000439 from the National Center for Advancing Translational Sciences (NCATS) component of the National Institutes of Health and NIH roadmap for Medical Research. This research was supported by the Athymic Animal and Preclinical Therapeutics and Cytometry and Imaging Microscopy cores of the Case Comprehensive Cancer Center at Case Western Reserve University (funded by NIH P30 CA043703). GN is supported by the Pardee-Gerstacker Professorship in Cancer Research.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bonomi M, 2009, J COMPUT CHEM, V30, P1615, DOI 10.1002/jcc.21305; Calin GA, 2000, ONCOGENE, V19, P1191, DOI 10.1038/sj.onc.1203389; Casado P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003573; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Caunt CJ, 2015, NAT REV CANCER, V15, P577, DOI 10.1038/nrc4000; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chen W, 2005, CANCER RES, V65, P8183, DOI 10.1158/0008-5472.CAN-05-1103; Cipriano R, 2011, P NATL ACAD SCI USA, V108, P8668, DOI 10.1073/pnas.1015022108; DeLano WL, 2009, ABSTR PAP AM CHEM S, V238; Doerr S, 2016, J CHEM THEORY COMPUT, V12, P1845, DOI 10.1021/acs.jctc.6b00049; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Garbe JC, 2009, CANCER RES, V69, P7557, DOI 10.1158/0008-5472.CAN-09-0270; Grinthal A, 2010, P NATL ACAD SCI USA, V107, P2467, DOI 10.1073/pnas.0914073107; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Haesen D, 2016, CANCER RES, V76, P5719, DOI 10.1158/0008-5472.CAN-15-3342; Harvey MJ, 2009, J CHEM THEORY COMPUT, V5, P1632, DOI 10.1021/ct9000685; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hoang LN, 2015, HISTOPATHOLOGY, V66, P664, DOI 10.1111/his.12581; Holt SV, 2012, CANCER RES, V72, P1804, DOI 10.1158/0008-5472.CAN-11-1780; Horn T, 2011, NAT METHODS, V8, P341, DOI 10.1038/NMETH.1581; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jeong AL, 2016, SCI REP-UK, V6, DOI 10.1038/srep27391; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Junk DJ, 2013, NEOPLASIA, V15, P1086, DOI 10.1593/neo.131114; Kamburov A, 2015, P NATL ACAD SCI USA, V112, pE5486, DOI 10.1073/pnas.1516373112; Kauko O, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaq1093; Kauko O, 2015, SCI REP-UK, V5, DOI 10.1038/srep13099; Knight JDR, 2017, NAT METHODS, V14, P645, DOI 10.1038/nmeth.4330; Letourneux C, 2006, EMBO J, V33, P3489; McClinch K, 2018, CANCER RES, V78, P2065, DOI 10.1158/0008-5472.CAN-17-0123; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Morris JH, 2014, NAT PROTOC, V9, P2539, DOI 10.1038/nprot.2014.164; O'Connor CM, 2019, J BIOL CHEM, V294, P5923, DOI 10.1074/jbc.RA119.007593; PALLAS DC, 1990, CELL, V60, P167, DOI 10.1016/0092-8674(90)90726-U; Price DJ, 2004, J CHEM PHYS, V121, P10096, DOI 10.1063/1.1808117; Rahman M, 2013, ANTICANCER RES, V33, P113; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Roberts PJ, 2012, CLIN CANCER RES, V18, P5290, DOI 10.1158/1078-0432.CCR-12-0563; Ruediger R, 2001, ONCOGENE, V20, P1892, DOI 10.1038/sj.onc.1204279; Ruediger R, 2011, MOL CELL BIOL, V31, P3832, DOI 10.1128/MCB.05744-11; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Sablina AA, 2010, CANCER RES, V70, P10474, DOI 10.1158/0008-5472.CAN-10-2855; Sangodkar J, 2017, J CLIN INVEST, V127, P2081, DOI 10.1172/JCI89548; Sangodkar J, 2016, FEBS J, V283, P1004, DOI 10.1111/febs.13573; Schlatzer D, 2017, ANAL CHEM, V89, P5325, DOI 10.1021/acs.analchem.6b05070; Seshacharyulu P, 2013, CANCER LETT, V335, P9, DOI 10.1016/j.canlet.2013.02.036; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Shih IM, 2011, AM J PATHOL, V178, P1442, DOI 10.1016/j.ajpath.2011.01.009; Skliros A, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/1/014001; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Taylor SE, 2019, CANCER RES, V79, P4242, DOI 10.1158/0008-5472.CAN-19-0218; Tsytlonok M, 2013, STRUCTURE, V21, P1954, DOI 10.1016/j.str.2013.08.028; Walter G, 2012, CELL CYCLE, V11, P451, DOI 10.4161/cc.11.3.19057; Wiemann S, 2016, NAT METHODS, V13, P191, DOI 10.1038/nmeth.3776; Wiredja DD, 2017, BIOINFORMATICS; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Zhou J, 2003, BIOCHEM J, V369, P387, DOI 10.1042/BJ20021244	59	18	19	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	3					703	717		10.1038/s41388-019-1012-2	http://dx.doi.org/10.1038/s41388-019-1012-2			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KG1RJ	31541192	Green Accepted, Green Submitted			2022-12-26	WOS:000509718300016
J	Khoshnevis, S; Dreggors, RE; Hoffmann, TFR; Ghalei, H				Khoshnevis, Sohail; Dreggors, R. Elizabeth; Hoffmann, Tobias F. R.; Ghalei, Homa			A conserved Bcd1 interaction essential for box C/D snoRNP biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ribosome assembly; RNA; RNA binding protein; RNA modification; RNA methylation; small nucleolar RNA (snoRNA); ribonuclear protein (RNP); assembly factor; box C; D snoRNA; snoRNP assembly; Bcd1; Snu13; small nucleolar ribonucleoprotein (snoRNP) assembly; zinc finger HIT-type containing 6 (ZNHIT6); ribosome biogenesis; posttranscriptional regulation; rRNA processing	PRE-18S RIBOSOMAL-RNA; SSU PROCESSOME; PROTEIN; HSP90; METHYLATION; PREDICTION; RVB1/RVB2; REGIONS; 15.5K; MOTIF	Precise modification and processing of rRNAs are required for the production of ribosomes and accurate translation of proteins. Small nucleolar ribonucleoproteins (snoRNPs) guide the folding, modification, and processing of rRNAs and are thus critical for all eukaryotic cells. Bcd1, an essential zinc finger HIT protein functionally conserved in eukaryotes, has been implicated as an early regulator for biogenesis of box C/D snoRNPs and controls steady-state levels of box C/D snoRNAs through an unknown mechanism. Using a combination of genetic and biochemical approaches, here we found a conserved N-terminal motif in Bcd1 from Saccharomyces cerevisiae that is required for interactions with box C/D snoRNAs and the core snoRNP protein, Snu13. We show that both the Bcd1?snoRNA and Bcd1?Snu13 interactions are critical for snoRNP assembly and ribosome biogenesis. Our results provide mechanistic insight into Bcd1 interactions that likely control the early steps of snoRNP maturation and contribute to the essential role of this protein in maintaining the steady-state levels of snoRNAs in the cell.	[Khoshnevis, Sohail] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Dreggors, R. Elizabeth; Ghalei, Homa] Emory Univ, Grad Program Biochem Cell & Dev Biol BCDB, Atlanta, GA 30322 USA; [Khoshnevis, Sohail; Dreggors, R. Elizabeth; Hoffmann, Tobias F. R.; Ghalei, Homa] Emory Univ, Dept Biochem, Sch Med, Atlanta, GA 30322 USA; [Hoffmann, Tobias F. R.] Spelman Coll, Dept Biol, Atlanta, GA 30314 USA	Emory University; Emory University; Emory University; Spelman College	Ghalei, H (corresponding author), Emory Univ, Grad Program Biochem Cell & Dev Biol BCDB, Atlanta, GA 30322 USA.; Ghalei, H (corresponding author), Emory Univ, Dept Biochem, Sch Med, Atlanta, GA 30322 USA.	hghalei@emory.edu	Ghalei, Homa/AAT-1320-2021	Ghalei, Homa/0000-0003-0168-4654	Department of Biochemistry at Emory School of Medicine startup funds	Department of Biochemistry at Emory School of Medicine startup funds	This work was supported by Department of Biochemistry at Emory School of Medicine startup funds (to H. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Back R, 2013, STRUCTURE, V21, P1834, DOI 10.1016/j.str.2013.07.024; Barandun J, 2018, CURR OPIN STRUC BIOL, V49, P85, DOI 10.1016/j.sbi.2018.01.008; Baudin-Baillieu A, 2009, NUCLEIC ACIDS RES, V37, P7665, DOI 10.1093/nar/gkp816; Bizarro J, 2014, J CELL BIOL, V207, P463, DOI 10.1083/jcb.201404160; Boulon S, 2008, J CELL BIOL, V180, P579, DOI 10.1083/jcb.200708110; Bragantini B, 2016, J MOL BIOL, V428, P2488, DOI 10.1016/j.jmb.2016.04.028; Cahill NM, 2002, EMBO J, V21, P3816, DOI 10.1093/emboj/cdf376; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheung KLY, 2010, J MOL BIOL, V404, P478, DOI 10.1016/j.jmb.2010.10.003; Cloutier P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15615; Decatur WA, 2003, J BIOL CHEM, V278, P695, DOI 10.1074/jbc.R200023200; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dunbar DA, 1997, MOL CELL BIOL, V17, P5803, DOI 10.1128/MCB.17.10.5803; Erales J, 2017, P NATL ACAD SCI USA, V114, P12934, DOI 10.1073/pnas.1707674114; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gong J, 2017, CELL REP, V21, P1968, DOI 10.1016/j.celrep.2017.10.070; Henras AK, 2015, WIRES RNA, V6, P225, DOI 10.1002/wrna.1269; Hiley SL, 2005, NUCLEIC ACIDS RES, V33, P3048, DOI 10.1093/nar/gki608; Kakihara Y, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0404-4; Kakihara Y, 2012, BBA-MOL CELL RES, V1823, P101, DOI 10.1016/j.bbamcr.2011.08.016; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Klinge S, 2019, NAT REV MOL CELL BIO, V20, P116, DOI 10.1038/s41580-018-0078-y; Kos M, 2010, MOL CELL, V37, P809, DOI 10.1016/j.molcel.2010.02.024; Kos-Braun IC, 2017, MICROB CELL, V4, P179, DOI 10.15698/mic2017.05.575; Kos-Braun IC, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000245; Kressler D, 1999, MOL CELL BIOL, V19, P8633; Krogh N, 2016, NUCLEIC ACIDS RES, V44, P7884, DOI 10.1093/nar/gkw482; Kufel J, 2019, TRENDS GENET, V35, P104, DOI 10.1016/j.tig.2018.11.005; Lo Monaco P, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8040106; Marcel V, 2013, CANCER CELL, V24, P318, DOI 10.1016/j.ccr.2013.08.013; Massenet S, 2017, RNA BIOL, V14, P680, DOI 10.1080/15476286.2016.1243646; McKeegan KS, 2007, MOL CELL BIOL, V27, P6782, DOI 10.1128/MCB.01097-07; McKeegan KS, 2009, MOL CELL BIOL, V29, P4971, DOI 10.1128/MCB.00752-09; Mullineux ST, 2012, BIOCHIMIE, V94, P1521, DOI 10.1016/j.biochi.2012.02.001; Nano N, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0399; Omer AD, 2002, P NATL ACAD SCI USA, V99, P5289, DOI 10.1073/pnas.082101999; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Paul A, 2019, RNA, V25, P496, DOI 10.1261/rna.067967.118; Peng WT, 2003, CELL, V113, P919, DOI 10.1016/S0092-8674(03)00466-5; Prieto MB, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0037-5; Rothe B, 2014, NUCLEIC ACIDS RES, V42, P10731, DOI 10.1093/nar/gku612; Ryan Owen W, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot086827; Ryan OW, 2014, ELIFE, V3, DOI 10.7554/eLife.03703; Schopf FH, 2019, MOL CELL, V74, P73, DOI 10.1016/j.molcel.2019.02.011; Schultz A, 2006, MOL CELL BIOL, V26, P5146, DOI 10.1128/MCB.02374-05; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sloan KE, 2017, RNA BIOL, V14, P1138, DOI 10.1080/15476286.2016.1259781; Snider J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-216; Szewczak LBW, 2002, CHEM BIOL, V9, P1095, DOI 10.1016/S1074-5521(02)00239-9; Talkish J, 2016, RNA, V22, P852, DOI 10.1261/rna.055780.115; Tran EJ, 2003, EMBO J, V22, P3930, DOI 10.1093/emboj/cdg368; Venema J, 1996, EMBO J, V15, P5701, DOI 10.1002/j.1460-2075.1996.tb00954.x; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Watkins NJ, 2012, WIRES RNA, V3, P397, DOI 10.1002/wrna.117; Watkins NJ, 2000, CELL, V103, P457, DOI 10.1016/S0092-8674(00)00137-9; Watkins NJ, 2002, MOL CELL BIOL, V22, P8342, DOI 10.1128/MCB.22.23.8342-8352.2002; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Zhao RM, 2008, J CELL BIOL, V180, P563, DOI 10.1083/jcb.200709061; Zhou CY, 2017, CELL REP, V19, P2033, DOI 10.1016/j.celrep.2017.05.029	60	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 29	2019	294	48					18360	18371		10.1074/jbc.RA119.010222	http://dx.doi.org/10.1074/jbc.RA119.010222			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	KA1GS	31537647	hybrid, Green Published			2022-12-26	WOS:000505547900030
J	Ndi, M; Masuyer, G; Dawitz, H; Carlstrom, A; Michel, M; Elofsson, A; Rapp, M; Stenmark, P; Ott, M				Ndi, Mama; Masuyer, Geoffrey; Dawitz, Hannah; Carlstrom, Andreas; Michel, Mirco; Elofsson, Arne; Rapp, Mikaela; Stenmark, Pal; Ott, Martin			Structural basis for the interaction of the chaperone Cbp3 with newly synthesized cytochrome b during mitochondrial respiratory chain assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						respiratory chain; protein assembly; protein cross-linking; membrane biogenesis; mitochondria; structural biology; assembly factor; complex III; electron transfer chain; mMitochondrial translation; ubiquinol?cytochrome c chaperone domain	TRANSLATION; TRANSCRIPTS; MSS51P; COX1P	Assembly of the mitochondrial respiratory chain requires the coordinated synthesis of mitochondrial and nuclear encoded subunits, redox co-factor acquisition, and correct joining of the subunits to form functional complexes. The conserved Cbp3?Cbp6 chaperone complex binds newly synthesized cytochrome b and supports the ordered acquisition of the heme co-factors. Moreover, it functions as a translational activator by interacting with the mitoribosome. Cbp3 consists of two distinct domains: an N-terminal domain present in mitochondrial Cbp3 homologs and a highly conserved C-terminal domain comprising a ubiquinol?cytochrome c chaperone region. Here, we solved the crystal structure of this C-terminal domain from a bacterial homolog at 1.4 ? resolution, revealing a unique all-helical fold. This structure allowed mapping of the interaction sites of yeast Cbp3 with Cbp6 and cytochrome b via site-specific photo?cross-linking. We propose that mitochondrial Cbp3 homologs carry an N-terminal extension that positions the conserved C-terminal domain at the ribosomal tunnel exit for an efficient interaction with its substrate, the newly synthesized cytochrome b protein.	[Ndi, Mama; Masuyer, Geoffrey; Dawitz, Hannah; Carlstrom, Andreas; Michel, Mirco; Elofsson, Arne; Rapp, Mikaela; Stenmark, Pal; Ott, Martin] Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden; [Masuyer, Geoffrey] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England; [Michel, Mirco; Elofsson, Arne] Stockholm Univ, Sci Life Labs, SE-17121 Stockholm, Sweden; [Stenmark, Pal] Lund Univ, Dept Expt Med Sci, SE-22184 Lund, Sweden	Stockholm University; University of Bath; Stockholm University; Lund University	Stenmark, P; Ott, M (corresponding author), Stockholm Univ, Dept Biochem & Biophys, SE-10691 Stockholm, Sweden.; Stenmark, P (corresponding author), Lund Univ, Dept Expt Med Sci, SE-22184 Lund, Sweden.	stenmark@dbb.su.se; martin.ott@dbb.su.se	Masuyer, Geoffrey/AAO-5977-2021	Masuyer, Geoffrey/0000-0002-9527-2310; Ndi, Mama/0000-0001-6460-0783; Stenmark, Pal/0000-0003-4777-3417; Ott, Martin/0000-0001-6367-3091	Knut och Alice Wallenberg Foundation; Swedish Research Council [2018-03406, 2018-03694]; Swedish Cancer Society	Knut och Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society)	This work was supported by a grant from Knut och Alice Wallenberg Foundation (to M. O.), by Swedish Research Council Grants 2018-03406 (to P. S.) and 2018-03694 (to M. O.), and by funds from the Swedish Cancer Society (to P. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Amunts A, 2014, SCIENCE, V343, P1485, DOI 10.1126/science.1249410; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrientos A, 2004, EMBO J, V23, P3472, DOI 10.1038/sj.emboj.7600358; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chin JW, 2003, CHEM BIOL, V10, P511, DOI 10.1016/S1074-5521(03)00123-6; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Desai N, 2017, SCIENCE, V355, P528, DOI 10.1126/science.aal2415; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Gildea RJ, 2014, ACTA CRYSTALLOGR D, V70, P2652, DOI 10.1107/S1399004714017039; Gruschke S, 2012, J CELL BIOL, V199, P137, DOI 10.1083/jcb.201206040; Gruschke S, 2011, J CELL BIOL, V194, P155, DOI 10.1083/jcb.2011031321941c; Gruschke S, 2010, J BIOL CHEM, V285, P19022, DOI 10.1074/jbc.M110.113837; Hildenbeutel M, 2014, J CELL BIOL, V205, P511, DOI 10.1083/jcb.201401009; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MITTELMEIER TM, 1995, MOL CELL BIOL, V15, P780; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ndi M, 2018, J MOL BIOL, V430, P3892, DOI 10.1016/j.jmb.2018.04.036; Ott M, 2016, ANNU REV BIOCHEM, V85, P77, DOI 10.1146/annurev-biochem-060815-014334; Perez-Martinez X, 2003, EMBO J, V22, P5951, DOI 10.1093/emboj/cdg566; Rathore S, 2019, NAT STRUCT MOL BIOL, V26, P50, DOI 10.1038/s41594-018-0169-7; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; RODEL G, 1986, CURR GENET, V11, P41, DOI 10.1007/BF00389424; Sammito M, 2015, ACTA CRYSTALLOGR D, V71, P1921, DOI 10.1107/S1399004715010846; Thorn A, 2013, ACTA CRYSTALLOGR D, V69, P2251, DOI 10.1107/S0907444913027534; Tucker EJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004034; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Xia D, 2013, BBA-BIOENERGETICS, V1827, P1278, DOI 10.1016/j.bbabio.2012.11.008	31	2	2	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16663	16671		10.1074/jbc.RA119.010483	http://dx.doi.org/10.1074/jbc.RA119.010483			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31537648	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000501801900016
J	Hemmerlin, A; Huchelmann, A; Tritsch, D; Schaller, H; Bach, TJ				Hemmerlin, Andrea; Huchelmann, Alexandre; Tritsch, Denis; Schaller, Hubert; Bach, Thomas J.			The specific molecular architecture of plant 3-hydroxy-3-methylglutaryl-CoA lyase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetyl coenzyme A (acetyl-CoA); Arabidopsis; senescence; mitochondria; peroxisome; protein structure; enzyme inactivation; 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) lyase; cytotoxicity; inhibition; P100 domain; subcellular localization	COENZYME-A LYASE; BETA-METHYLGLUTARYL-COENZYME; HMG-COA LYASE; AMINO-ACID CATABOLISM; METABOLISM; ENZYME; PROTEIN; IDENTIFICATION; PURIFICATION; MEVALONATE	3-Hydroxy-3-methylglutaryl-CoA (HMG-CoA) lyase (HMGL) is involved in branched-chain amino acid catabolism leading to acetyl-CoA production. Here, using bioinformatics analyses and protein sequence alignments, we found that in Arabidopsis thaliana a single gene encodes two HMGL isoforms differing in size (51 kDa, HMGL51 and 46 kDa, HMGL46). Similar to animal HMGLs, both isoforms comprised a C-terminal type 1 peroxisomal retention motif, and HMGL51 contained a mitochondrial leader peptide. We observed that only a shortened HMGL (35 kDa, HMGL35) is conserved across all kingdoms of life. Most notably, all plant HMGLs also contained a specific N-terminal extension (P100) that is located between the N-terminal mitochondrial targeting sequence TP35 and HMGL35 and is absent in bacteria and other eukaryotes. Interestingly, using HMGL enzyme assays, we found that rather than HMGL46, homodimeric recombinant HMGL35 is the active enzyme catalyzing acetyl-CoA and acetoacetate synthesis when incubated with (S)-HMG-CoA. This suggested that the plant-specific P100 peptide may inactivate HMGL according to specific physiological requirements. Therefore, we investigated whether the P100 peptide in HMGL46 alters its activity, possibly by modifying the HMGL46 structure. We found that induced expression of a cytosolic HMGL35 version in A. thaliana delays germination and leads to rapid wilting and chlorosis in mature plants. Our results suggest that in plants, P100-mediated HMGL inactivation outside of peroxisomes or mitochondria is crucial, protecting against potentially cytotoxic effects of HMGL activity while it transits to these organelles.	[Hemmerlin, Andrea; Huchelmann, Alexandre; Schaller, Hubert; Bach, Thomas J.] Univ Strasbourg, CNRS, Inst Biol Mol Plantes, 12 Rue Gen Zimmer, F-67084 Strasbourg, France; [Tritsch, Denis] Inst Chim Strasbourg, 4 Rue Blaise Pascal, F-67081 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Hemmerlin, A (corresponding author), Univ Strasbourg, CNRS, Inst Biol Mol Plantes, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	andrea.hemmerlin@ibmp-cnrs.unistra.fr		Huchelmann, Alexandre/0000-0001-9302-405X; Bach, Thomas J./0000-0001-7551-0417; Hemmerlin, Andrea/0000-0002-3383-7355	CNRS; Universite de Strasbourg; French Ministry of Research	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported by the CNRS and Universite de Strasbourg. The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of a Ph.D. fellowship from the French Ministry of Research.	ALAM A, 1991, BIOCHEM SOC T, V19, pS164, DOI 10.1042/bst019164s; ANDERSON DH, 1989, J BACTERIOL, V171, P6468, DOI 10.1128/jb.171.12.6468-6472.1989; Anderson MD, 1998, PLANT PHYSIOL, V118, P1127, DOI 10.1104/pp.118.4.1127; Arnedo M, 2012, J LIPID RES, V53, P2046, DOI 10.1194/jlr.M025700; Ashmarina LI, 1996, BIOCHEM J, V315, P71, DOI 10.1042/bj3150071; Ashmarina LI, 1999, J LIPID RES, V40, P70; BACH TJ, 1986, EUR J BIOCHEM, V154, P103, DOI 10.1111/j.1432-1033.1986.tb09364.x; BACH TJ, 1990, RECENT ADV PHYTOCHEM, V24, P1; BACH TJ, 1991, LIPIDS, V26, P637, DOI 10.1007/BF02536429; BACHHAWAT BK, 1955, J BIOL CHEM, V216, P727; Baltscheffsky M, 1997, BBA-PROTEIN STRUCT M, V1337, P113, DOI 10.1016/S0167-4838(96)00158-6; Binder S, 2007, PHYSIOL PLANTARUM, V129, P68, DOI 10.1111/j.1399-3054.2006.00800.x; BUCHER NLR, 1960, BIOCHIM BIOPHYS ACTA, V40, P491, DOI 10.1016/0006-3002(60)91390-1; Casals N, 2003, J BIOL CHEM, V278, P29016, DOI 10.1074/jbc.M304276200; Chavez-Aviles M, 2010, MOL BIOL REP, V37, P1787, DOI 10.1007/s11033-009-9611-6; CLINKENBEARD KD, 1975, J BIOL CHEM, V250, P3108; Cullingford TE, 1998, BIOCHEM J, V329, P373; Diaz-Perez AL, 2016, REV ENVIRON SCI BIO, V15, P1, DOI 10.1007/s11157-015-9385-3; EDMOND J, 1974, J BIOL CHEM, V249, P66; FOGELMAN AM, 1975, J BIOL CHEM, V250, P1771; Forouhar F, 2006, J BIOL CHEM, V281, P7533, DOI 10.1074/jbc.M507996200; Fu ZJ, 2010, J BIOL CHEM, V285, P26341, DOI 10.1074/jbc.M110.139931; Fu ZJ, 2006, J BIOL CHEM, V281, P7526, DOI 10.1074/jbc.M506880200; Fukao T, 2014, J INHERIT METAB DIS, V37, P541, DOI 10.1007/s10545-014-9704-9; GIBSON KM, 1990, CLIN CHEM, V36, P297; GONDET L, 1992, BIOCHEM BIOPH RES CO, V186, P888, DOI 10.1016/0006-291X(92)90829-A; Hegardt FG, 1999, BIOCHEM J, V338, P569, DOI 10.1042/0264-6021:3380569; Hemmerlin A, 1998, PLANT J, V14, P65, DOI 10.1046/j.1365-313X.1998.00095.x; Hemmerlin A, 2006, PLANT PHYSIOL, V142, P441, DOI 10.1104/pp.106.086652; Hemmerlin A, 2006, ARCH BIOCHEM BIOPHYS, V448, P93, DOI 10.1016/j.abb.2005.10.017; HEPPER CM, 1969, BIOCHEM J, V114, P379, DOI 10.1042/bj1140379; HermansLokkerbol A, 1996, J CHROMATOGR A, V752, P123, DOI 10.1016/S0021-9673(96)00526-2; Hildebrandt TM, 2018, PLANT MOL BIOL, V98, P121, DOI 10.1007/s11103-018-0767-0; Hildebrandt TM, 2015, MOL PLANT, V8, P1563, DOI 10.1016/j.molp.2015.09.005; HRUZ PW, 1992, BIOCHEMISTRY-US, V31, P6842, DOI 10.1021/bi00144a026; HRUZ PW, 1992, PROTEIN SCI, V1, P1144, DOI 10.1002/pro.5560010908; Hu JP, 2012, PLANT CELL, V24, P2279, DOI 10.1105/tpc.112.096586; Huchelmann A, 2016, BIOCHIMIE, V127, P95, DOI 10.1016/j.biochi.2016.04.021; Koroleva OA, 2005, PLANT J, V41, P162, DOI 10.1111/j.1365-313X.2004.02281.x; KRAMER PR, 1980, J BIOL CHEM, V255, P1023; Krishnakumar V, 2015, NUCLEIC ACIDS RES, V43, pD1003, DOI 10.1093/nar/gku1200; Lang C, 2001, J LIPID RES, V42, P22; Lu Y, 2011, PLANT PHYSIOL, V155, P1589, DOI 10.1104/pp.110.170118; LYNEN F, 1958, BIOCHEM Z, V330, P269; Madsen L, 1999, BIOCHEM PHARMACOL, V57, P1011, DOI 10.1016/S0006-2952(99)00004-0; MESSNER B, 1975, EUR J BIOCHEM, V53, P255, DOI 10.1111/j.1432-1033.1975.tb04064.x; MITCHELL GA, 1993, J BIOL CHEM, V268, P4376; Montgomery C, 2012, J BIOL CHEM, V287, P33227, DOI 10.1074/jbc.M112.393231; Moore BD, 2004, TRENDS PLANT SCI, V9, P221, DOI 10.1016/j.tplants.2004.03.005; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; NARASIMHAN C, 1994, ARCH BIOCHEM BIOPHYS, V312, P467, DOI 10.1006/abbi.1994.1333; NARASIMHAN C, 1992, BIOCHEMISTRY-US, V31, P11224, DOI 10.1021/bi00160a037; Nemecek-Marshall M, 1999, J BACTERIOL, V181, P7493, DOI 10.1128/JB.181.24.7493-7499.1999; NEMETHY EK, 1983, BIOCHIM BIOPHYS ACTA, V760, P343, DOI 10.1016/0304-4165(83)90371-9; NES WD, 1982, BIOCHEM BIOPH RES CO, V108, P1258, DOI 10.1016/0006-291X(82)92135-0; NES WD, 1985, PROC R SOC SER B-BIO, V225, P425, DOI 10.1098/rspb.1985.0071; Peng C, 2015, PLANT PHYSIOL, V169, P1807, DOI 10.1104/pp.15.00461; Pie J, 2003, J PHYSIOL BIOCHEM, V59, P311, DOI 10.1007/BF03179889; Pie J, 2007, MOL GENET METAB, V92, P198, DOI 10.1016/j.ymgme.2007.06.020; Popjak G, 1971, Harvey Lect, V65, P127; PRASANNA P, 1987, INT J BIOCHEM, V19, P385, DOI 10.1016/0020-711X(87)90013-9; Puisac B, 2012, MOL BIOL REP, V39, P4777, DOI 10.1007/s11033-011-1270-8; Roberts JR, 1997, BIOCHEMISTRY-US, V36, P7594, DOI 10.1021/bi970207d; ROBERTS JR, 1994, J BIOL CHEM, V269, P17841; ROBERTS JR, 1995, J BIOL CHEM, V270, P17311, DOI 10.1074/jbc.270.29.17311; Sauvaire Y., 1987, METABOLISM STRUCTURE, P107; SCHER DS, 1989, BIOCHIM BIOPHYS ACTA, V1003, P321, DOI 10.1016/0005-2760(89)90239-7; SIDDIQI MA, 1967, J BACTERIOL, V93, P207, DOI 10.1128/JB.93.1.207-214.1967; STEGINK LD, 1968, J BIOL CHEM, V243, P5272; Taylor NL, 2004, PLANT PHYSIOL, V134, P838, DOI 10.1104/pp.103.035675; VANDERHEIJDEN R, 1994, PLANT CELL TISS ORG, V38, P345, DOI 10.1007/BF00033895; WANDERS RJA, 1988, CLIN CHIM ACTA, V171, P95, DOI 10.1016/0009-8981(88)90294-X; Wang RW, 2007, FEBS LETT, V581, P3164, DOI 10.1016/j.febslet.2007.05.082; WEBER T, 1993, Z NATURFORSCH C, V48, P444; WYSOCKI SJ, 1986, J INHERIT METAB DIS, V9, P225, DOI 10.1007/BF01799652	75	1	1	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					16186	16197		10.1074/jbc.RA119.008839	http://dx.doi.org/10.1074/jbc.RA119.008839			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31515272	Green Published, hybrid			2022-12-26	WOS:000499478600026
J	Chiu, LJV; Tauer, LW; Grohn, YT; Smith, RL				Chiu, Leslie J. Verteramo; Tauer, Loren W.; Grohn, Yrjo T.; Smith, Rebecca L.			Mastitis risk effect on the economic consequences of paratuberculosis control in dairy cattle: A stochastic modeling study	PLOS ONE			English	Article							AVIUM SUBSPECIES PARATUBERCULOSIS; GENERIC CLINICAL MASTITIS; POLYMERASE-CHAIN-REACTION; JOHNES-DISEASE; MILK-PRODUCTION; MANAGEMENT-PRACTICES; CONTROL PROGRAMS; FECAL CULTURE; INFECTION; ELISA	The benefits and efficacy of control programs for herds infected with Mycobacterium avium subsp. paratuberculosis (MAP) have been investigated under various contexts. However, most previous research investigated paratuberculosis control programs in isolation, without modeling the potential association with other dairy diseases. This paper evaluated the benefits of MAP control programs when the herd is also affected by mastitis, a common disease causing the largest losses in dairy production. The effect of typically suggested MAP controls were estimated under the assumption that MAP infection increased the rate of clinical mastitis. We evaluated one hundred twenty three control strategies comprising various combinations of testing, culling, and hygiene, and found that the association of paratuberculosis with mastitis alters the ranking of specific MAP control programs, but only slightly alters the cost-benefit difference of particular MAP control components, as measured by the distribution of net present value of a representative U.S. dairy operation. In particular, although testing and culling for MAP resulted in a reduction in MAP incidence, that control led to lower net present value (NPV) per cow. When testing was used, ELISA was more economically beneficial than alternative testing regimes, especially if mastitis was explicitly modeled as more likely in MAP-infected animals, but ELISA testing was only significantly associated with higher NPV if mastitis was not included in the model at all. Additional hygiene was associated with a lower NPV per cow, although it lowered MAP prevalence. Overall, the addition of an increased risk of mastitis in MAP-infected animals did not change model recommendations as much as failing to consider.	[Chiu, Leslie J. Verteramo; Grohn, Yrjo T.] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY USA; [Tauer, Loren W.] Cornell Univ, Cornell SC Johnson Business Coll, Charles H Dyson Sch Appl Econ & Management, Ithaca, NY USA; [Smith, Rebecca L.] Univ Illinois, Coll Vet Med, Dept Pathobiol, Urbana, IL 61801 USA	Cornell University; Cornell University; University of Illinois System; University of Illinois Urbana-Champaign	Smith, RL (corresponding author), Univ Illinois, Coll Vet Med, Dept Pathobiol, Urbana, IL 61801 USA.	rlsdvm@illinois.edu		Smith, Rebecca/0000-0002-8343-794X	USDA-NIFA Award [2014-67015-2240]	USDA-NIFA Award	This work was funded by USDA-NIFA Award No. 2014-67015-2240 to YTG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adaska JM, 2003, PREV VET MED, V60, P255, DOI 10.1016/S0167-5877(03)00120-X; Aly SS, 2010, J DAIRY SCI, V93, P1030, DOI 10.3168/jds.2009-2611; Aly SS, 2012, J VET DIAGN INVEST, V24, P821, DOI 10.1177/1040638712452107; [Anonymous], 2015, TESTS FEES; Arrazuria R, 2014, ARCH MED VET, V46, P39, DOI 10.4067/S0301-732X2014000100006; Bar D, 2008, J DAIRY SCI, V91, P2205, DOI 10.3168/jds.2007-0573; Bar D, 2007, J DAIRY SCI, V90, P4643, DOI 10.3168/jds.2007-0145; Barkema HW, 2018, TRANSBOUND EMERG DIS, V65, P125, DOI 10.1111/tbed.12723; Benedictus A, 2008, PREV VET MED, V83, P215, DOI 10.1016/j.prevetmed.2007.07.008; Besser T., 2015, NEW STRATEGIES JOHNE; Breen JE, 2009, J DAIRY SCI, V92, P2551, DOI 10.3168/jds.2008-1369; Chiu LJV, 2018, J DAIRY SCI, V101, P6443, DOI 10.3168/jds.2017-13175; Cho J, 2013, CAN J AGR ECON, V61, P583, DOI 10.1111/j.1744-7976.2012.01270.x; Clark DL, 2008, J DAIRY SCI, V91, P2620, DOI 10.3168/jds.2007-0902; Collins MT, 2010, J DAIRY SCI, V93, P1638, DOI 10.3168/jds.2009-2664; Collins MT, 2006, JAVMA-J AM VET MED A, V229, P1912, DOI 10.2460/javma.229.12.1912; Collins MT, 2015, TESTING SERVICES; Cornell University Animal Health Diagnostic Center, 2015, TEST FEE SCHED; Dieguez FJ, 2008, VET REC, V162, P614, DOI 10.1136/vr.162.19.614; Dorshorst NC, 2006, PREV VET MED, V75, P92, DOI 10.1016/j.prevetmed.2006.02.002; Ferrouillet C, 2009, PREV VET MED, V88, P128, DOI 10.1016/j.prevetmed.2008.08.001; Garcia AB, 2015, J DAIRY SCI, V98, P5019, DOI 10.3168/jds.2014-9241; Gonda MG, 2007, PREV VET MED, V80, P103, DOI 10.1016/j.prevetmed.2007.01.011; Groenendaal H, 2003, J AM VET MED ASSOC, V223, P1757, DOI 10.2460/javma.2003.223.1757; Groenendaal H, 2002, PREV VET MED, V54, P225, DOI 10.1016/S0167-5877(02)00027-2; Groenendaal H, 2008, JAVMA-J AM VET MED A, V233, P1852, DOI 10.2460/javma.233.12.1852; HARRIS TR, 1986, AM J AGR ECON, V68, P298, DOI 10.2307/1241431; Indiana Animal Disease Diagnostic Laboratory, 2015, FEE SCHED; Karszes J., 2014, DAIRY REPLACEMENT PR; Konboon M, 2018, NESTED COMPARTMENTAL, P1; Kudahl A, 2004, PREV VET MED, V62, P119, DOI 10.1016/j.prevetmed.2003.11.008; Kudahl AB, 2008, J DAIRY SCI, V91, P4599, DOI 10.3168/jds.2008-1257; Kudahl AB, 2007, PREV VET MED, V78, P118, DOI 10.1016/j.prevetmed.2006.10.004; Leite F, 2013, J VET DIAGN INVEST, V25, P27, DOI 10.1177/1040638712466395; LEVY H, 1992, MANAGE SCI, V38, P555, DOI 10.1287/mnsc.38.4.555; Lombard JE, 2005, JAVMA-J AM VET MED A, V227, P1975, DOI 10.2460/javma.2005.227.1975; Marce C, 2010, J DAIRY SCI, V93, P4455, DOI 10.3168/jds.2010-3139; Marce C, 2009, THERIOGENOLOGY, V71, P807, DOI 10.1016/j.theriogenology.2008.10.017; Massaro T, 2013, J BIOL SYST, V21, DOI 10.1142/S021833901340010X; Meens E, 2014, 12 INT C PAR PARM IT; Mitchell RM, 2015, PREV VET MED, V118, P215, DOI 10.1016/j.prevetmed.2014.12.009; Moravkova M, 2012, APPL ENVIRON MICROB, V78, P6608, DOI 10.1128/AEM.01264-12; Nielsen SS, 2011, J DAIRY SCI, V94, P1849, DOI 10.3168/jds.2010-3817; Nielsen SS, 2009, J DAIRY SCI, V92, P149, DOI 10.3168/jds.2008-1488; Pillars RB, 2009, PREV VET MED, V90, P223, DOI 10.1016/j.prevetmed.2009.04.009; Pradhan AK, 2009, J DAIRY SCI, V92, P1811, DOI 10.3168/jds.2008-1486; Radia D, 2013, VET REC, V173, P343, DOI 10.1136/vr.101408; Raizman EA, 2007, PREV VET MED, V78, P179, DOI 10.1016/j.prevetmed.2006.10.006; Robins J, 2015, VET RES, V46, DOI 10.1186/s13567-015-0195-y; Rossi G, 2017, J DAIRY SCI, V100, P7446, DOI 10.3168/jds.2017-12721; Smith RL, 2017, PREV VET MED, V138, P17, DOI 10.1016/j.prevetmed.2017.01.007; Smith RL, 2010, J DAIRY SCI, V93, P3513, DOI 10.3168/jds.2009-2742; Smith RL, 2016, J DAIRY SCI, V99, P1383, DOI 10.3168/jds.2015-9822; Smith RL, 2015, PREV VET MED, V122, P298, DOI 10.1016/j.prevetmed.2015.10.008; Sorge US, 2011, J DAIRY SCI, V94, P754, DOI 10.3168/jds.2010-3404; Sweeney RW, 2006, J VET DIAGN INVEST, V18, P2, DOI 10.1177/104063870601800102; Sweeney RW, 2014, 12 INT C PAR PARM IT; Taddei S, 2004, J VET DIAGN INVEST, V16, P503, DOI 10.1177/104063870401600603; Tiwari A, 2005, VET MICROBIOL, V109, P147, DOI 10.1016/j.vetmic.2005.05.011; USDA, 2008, AGR PRIC SUMM 2003 2; USDA:ERS, 2010, MILK COST PROD EST; USDA-NASS, 2015, QUICK STATS; van Schaik G, 2005, PREV VET MED, V72, P221, DOI 10.1016/j.prevetmed.2005.01.019; VanLeeuwen JA, 2010, PREV VET MED, V94, P54, DOI 10.1016/j.prevetmed.2009.11.012; Vitale N, 2014, 12 INT C PAR PARM IT; Whitlock RH, 2000, VET MICROBIOL, V77, P387, DOI 10.1016/S0378-1135(00)00324-2; Wolf R, 2014, J DAIRY SCI, V97, P2822, DOI 10.3168/jds.2013-7454	67	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0217888	10.1371/journal.pone.0217888	http://dx.doi.org/10.1371/journal.pone.0217888			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM6FU	31557171	Green Published, gold, Green Submitted			2022-12-26	WOS:000532345500006
J	Fong, JH				Fong, Joelle H.			Out-of-pocket health spending among Medicare beneficiaries: Which chronic diseases are most costly?	PLOS ONE			English	Article							CARE EXPENDITURES; FINANCIAL BURDEN; INSURANCE; ADULTS; RISE	Background Little is known about the impact of different types of chronic diseases on older adults' out-of-pocket healthcare spending and whether certain diseases trigger higher spending needs than others. Methods We use data from the 2014 Health and Retirement Study representing a weighted population of 35,939,270 Medicare beneficiaries aged 65+. Generalized linear models are applied to estimate the effect of different chronic diseases on total out-of-pocket expenditure, adjusted for demographics, socio-economic status, physical health, and other factors. We also decompose total spending by expenditure categories (inpatient, non-inpatient, and prescription drug spending). Sensitivity analysis is performed using a younger sample of older adults aged 50-64. Results Cardiovascular disease, diabetes, hypertension and cancer, induce significantly higher adjusted out-of-pocket spending among older adults than other conditions. These results hold regardless how the spending differences are assessed (absolute or percentage terms). For Medicare beneficiaries, cardiovascular disease is associated with an excess out-of-pocket spending of $317 per year, followed by diabetes ($237), hypertension ($150), and cancer ($144). Prescription drug spending is singularly the most important driver of additional expenses for cardiovascular disease, diabetes and hypertension, while non-inpatient services spending accounts for the bulk of increased spending among those with cancer. Conclusions Our finding that major noncommunicable diseases impact individuals' out-of-pocket medical spending differentially-and that service drivers of increased spending may be heterogeneous across disease types-suggest that health professionals and policymakers should recognize that certain chronic diseases exert greater financial toll on the elderly. Interventions to promote more cost efficient healthcare services and consumer choices can help older adults better cope with these expensive long-lasting conditions and reduce the overall burden of noncommunicable diseases.	[Fong, Joelle H.] Natl Univ Singapore, Lee Kuan Yew Sch Publ Policy, Singapore, Singapore	National University of Singapore	Fong, JH (corresponding author), Natl Univ Singapore, Lee Kuan Yew Sch Publ Policy, Singapore, Singapore.	j.fong@nus.edu.sg	Fong, Joelle H./AAB-7371-2019	Fong, Joelle H./0000-0003-0267-6779	Singapore Ministry of Education Start-up Grant at the National University of Singapore; United States National Institute on Aging; Social Security Administration	Singapore Ministry of Education Start-up Grant at the National University of Singapore(Ministry of Education, SingaporeNational University of Singapore); United States National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Social Security Administration	JF is funded by the Singapore Ministry of Education Start-up Grant at the National University of Singapore.; This article uses data from Health and Retirement Study (HRS) Wave 2014. HRS is supported by the United States National Institute on Aging and the Social Security Administration. I am grateful to seminar participants at the 2017 Australian Conference for Health Economists for their feedback on an earlier draft.	Akincigil A, 2015, 201528 CTR RET RES B; American Cancer Society, 2016, CANC TREATMENT SURVI; American Heart Association, 2017, CARD DIS COSTL BURD; [Anonymous], 2013, STAT AG HLTH AM 2013; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Centers for Medicare & Medicaid Services, 2012, CHRONIC CONDITIONS M; Chen A, 2016, ANNU REV ECON, V8, P291, DOI 10.1146/annurev-economics-080315-015317; Chi CH, 2008, HEALTH ECON, V17, P961, DOI 10.1002/hec.1312; Crystal S, 2000, J GERONTOL B-PSYCHOL, V55, pS51; Cubanski J, 2014, MUCH I ENOUGH OUT PR; Davidoff AJ, 2013, CANCER-AM CANCER SOC, V119, P1257, DOI 10.1002/cncr.27848; Dieleman JL, 2016, JAMA-J AM MED ASSOC, V316, P2627, DOI 10.1001/jama.2016.16885; Dranove D, 2006, HEALTH AFFAIR, V25, pW74, DOI 10.1377/hlthaff.25.w74; Duan N., 1983, J BUS STAT, V1, P115, DOI DOI 10.2307/1391852; Finkelstein EA, 2009, HEALTH AFFAIR, V28, pW822, DOI 10.1377/hlthaff.28.5.w822; Goldman D.P., 2011, FORUM HLTH EC POLICY, V14, P4, DOI [10.2202/1558-9544.1267, DOI 10.2202/1558-9544.1267]; Health and Retirement Study, 2017, SAMPL SIZ RESP RAT; Hendershot Eleanor, 2005, J Pediatr Oncol Nurs, V22, P31, DOI 10.1177/1043454204272539; Himmelstein DU, 2005, HLTH AFF, V24, P570; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hu TW, 1999, HEALTH ECON, V8, P309, DOI 10.1002/(SICI)1099-1050(199906)8:4<309::AID-HEC440>3.0.CO;2-N; Hwang W, 2001, HEALTH AFFAIR, V20, P267, DOI 10.1377/hlthaff.20.6.267; Kang HA, 2015, VALUE HEALTH, V18, pA269, DOI 10.1016/j.jval.2015.03.1570; Kaye HS, 2010, HEALTH AFFAIR, V29, P11, DOI 10.1377/hlthaff.2009.0535; Ladusingh L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196835; Langa KM, 2004, VALUE HEALTH, V7, P186, DOI 10.1111/j.1524-4733.2004.72334.x; Lee JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127199; Li R, 2014, DIABETES CARE, V37, P1629, DOI 10.2337/dc13-1997; Lopez AD, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0200-8; Lu K, 2014, VALUE HEALTH, V17, pA262, DOI 10.1016/j.jval.2014.03.1526; Manning WG, 2001, J HEALTH ECON, V20, P461, DOI 10.1016/S0167-6296(01)00086-8; Manning WG., 1981, HEAL EC HEAL EC, V137, P103; McCullagh P, 1989, GEN LINEAR MODELS; Narang AK, 2017, JAMA ONCOL, V3, P757, DOI 10.1001/jamaoncol.2016.4865; Numico G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120827; Paez KA, 2009, HEALTH AFFAIR, V28, P15, DOI 10.1377/hlthaff.28.1.15; Sakharkar P, 2016, VALUE HEALTH, V19, pA14, DOI 10.1016/j.jval.2016.03.275; Schoenberg NE, 2007, GERONTOLOGIST, V47, P423, DOI 10.1093/geront/47.4.423; Song X, 2014, VALUE HEALTH, V17, pA81, DOI 10.1016/j.jval.2014.03.474; Stewart ST, 2004, GERONTOLOGIST, V44, P48, DOI 10.1093/geront/44.1.48; Ward BW, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130389; Wong CY, 2017, HEALTH ECON, V26, P962, DOI 10.1002/hec.3376; World Health Organization, 2019, NONC DIS PROGR MON 2	43	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222539	10.1371/journal.pone.0222539	http://dx.doi.org/10.1371/journal.pone.0222539			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5OJ	31539389	Green Published, gold			2022-12-26	WOS:000532297900015
J	Laudicina, NM; Rodriguez, F; DeSilva, JM				Laudicina, Natalie M.; Rodriguez, Frankee; DeSilva, Jeremy M.			Reconstructing birth in Australopithecus sediba	PLOS ONE			English	Article							NEONATAL BRAIN SIZE; VIRTUAL RECONSTRUCTION; EVOLUTION; PELVIS; DIMENSIONS; OBSTETRICS; CHILDBIRTH; AFARENSIS; MECHANISM; PRIMATES	Hominin birth mechanics have been examined and debated from limited and often fragmentary fossil pelvic material. Some have proposed that birth in the early hominin genus Australopithecus was relatively easy and ape-like, while others have argued for a more complex, human-like birth mechanism in australopiths. Still others have hypothesized a unique birth mechanism, with no known modern equivalent. Preliminary work on the pelvis of the recently discovered 1.98 million-year-old hominin Australopithecus sediba found it to possess a unique combination of Homo and Australopithecus-like features. Here, we create a composite pelvis of Australopithecus sediba to reconstruct the birth process in this early hominin. Consistent with other hominin species, including modern humans, the fetus would enter the pelvic inlet in a transverse direction. However, unlike in modern humans, the fetus would not need additional rotations to traverse the birth canal. Further fetal rotation is unnecessary even with a Homo-like pelvic midplane expansion, not seen in earlier hominin species. With a birth canal shape more closely associated with specimens from the genus Homo and a lack of cephalopelvic or shoulder constraints, we therefore find evidence to support the hypothesis that the pelvic morphology of Australopithecus sediba is a result of locomotor, rather than strictly obstetric constraints.	[Laudicina, Natalie M.; Rodriguez, Frankee] Boston Univ, Dept Anthropol, Boston, MA 02215 USA; [Laudicina, Natalie M.] Grand Valley State Univ, Biomed Sci Dept, Grand Rapids, MI 49504 USA; [DeSilva, Jeremy M.] Dartmouth Coll, Dept Anthropol, Hanover, NH 03755 USA; [DeSilva, Jeremy M.] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa	Boston University; Grand Valley State University; Dartmouth College; University of Witwatersrand	Laudicina, NM (corresponding author), Boston Univ, Dept Anthropol, Boston, MA 02215 USA.; Laudicina, NM (corresponding author), Grand Valley State Univ, Biomed Sci Dept, Grand Rapids, MI 49504 USA.	laudicin@gvsu.edu		Laudicina, Natalie/0000-0002-6180-2803	Boston University; Dartmouth College	Boston University; Dartmouth College	This research was funded by Boston University and Dartmouth College.	ABITBOL MM, 1991, AM J PHYS ANTHROPOL, V85, P135, DOI 10.1002/ajpa.1330850203; American College of Obstetricians and Gynecologists, 2002, SHOULD DYST; Becker I, 2010, J ANAT, V217, P475, DOI 10.1111/j.1469-7580.2010.01300.x; BERGE C, 1984, J HUM EVOL, V13, P573, DOI 10.1016/S0047-2484(84)80029-9; Berge C, 2010, J HUM EVOL, V58, P262, DOI 10.1016/j.jhevol.2009.11.006; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Bogin B, 1999, ANNU REV ANTHROPOL, V28, P109, DOI 10.1146/annurev.anthro.28.1.109; Bonmati A, 2010, P NATL ACAD SCI USA, V107, P18386, DOI 10.1073/pnas.1012131107; Cameron N, 2017, AM J PHYS ANTHROPOL, V163, P633, DOI 10.1002/ajpa.23234; Carlson KJ, 2011, SCIENCE, V333, P1402, DOI 10.1126/science.1203922; Churchill IRU, 2018, J KNOT THEOR RAMIF, V27, DOI 10.1142/S0218216518920013; Churchill SE, 2013, SCIENCE, V340, DOI 10.1126/science.1233477; Claxton AG, 2016, J HUM EVOL, V99, P10, DOI 10.1016/j.jhevol.2016.06.001; de Leon MSP, 2008, P NATL ACAD SCI USA, V105, P13764, DOI 10.1073/pnas.0803917105; Desilva JM, 2017, ANAT REC, V300, P890, DOI 10.1002/ar.23573; DeSilva JM, 2008, J HUM EVOL, V55, P1064, DOI 10.1016/j.jhevol.2008.07.008; DeSilva JM, 2013, SIENCE, V340, P6129; Dirks PHGM, 2010, SCIENCE, V328, P205, DOI 10.1126/science.1184950; Dunsworth HM, 2016, OBSTETRICAL DILEMMA, P29; Dunsworth H, 2015, ANNU REV ANTHROPOL, V44, P55, DOI 10.1146/annurev-anthro-102214-013918; Dunsworth HM, 2018, PERSPECT BIOL MED, V61, P249, DOI 10.1353/pbm.2018.0040; Dunsworth HM, 2012, P NATL ACAD SCI USA, V109, P15212, DOI 10.1073/pnas.1205282109; Elder JH, 1936, PROC R SOC SER B-BIO, V120, P409, DOI 10.1098/rspb.1936.0043; Fremondiere P, 2016, AM J PHYS ANTHROPOL, V159, P148; Gherman RB, 1998, AM J OBSTET GYNECOL, V178, P1126, DOI 10.1016/S0002-9378(98)70312-6; Haeusler M, 2016, AM J PHYS ANTHROPOL, V159, P165; HAUSLER M, 1995, J HUM EVOL, V29, P363, DOI 10.1006/jhev.1995.1063; Hirata S, 2011, BIOL LETTERS, V7, P686, DOI 10.1098/rsbl.2011.0214; Jolly A., 1973, International Zoo Yearbook, V13, P391, DOI 10.1111/j.1748-1090.1973.tb02188.x; JOLLY A, 1972, FOLIA PRIMATOL, V18, P108, DOI 10.1159/000155472; JORDAAN HVF, 1976, AM J PHYS ANTHROPOL, V44, P271, DOI 10.1002/ajpa.1330440209; Joulin D, 1864, MEDECINE, P29; Kibii JM, 2011, SCIENCE, V333, P1407, DOI 10.1126/science.1202521; Leigh SR, 2004, AM J PRIMATOL, V62, P139, DOI 10.1002/ajp.20012; LEUTENEGGER W, 1987, J HUM EVOL, V16, P291, DOI 10.1016/0047-2484(87)90004-2; LEUTENEGGER W, 1974, J HUM EVOL, V3, P207, DOI 10.1016/0047-2484(74)90179-1; LEUTENEGGER W, 1972, NATURE, V240, P568, DOI 10.1038/240568a0; Lovejoy CO, 2016, VERTEBR PALEOBIOL PA, P155, DOI 10.1007/978-94-017-7429-1_8; MCHENRY HM, 1986, J HUM EVOL, V15, P177, DOI 10.1016/S0047-2484(86)80044-6; Rosenberg K, 2002, BJOG-INT J OBSTET GY, V109, P1199, DOI 10.1046/j.1471-0528.2002.00010.x; ROSENBERG KR, 1992, YEARB PHYS ANTHROPOL, V35, P89; RUFF CB, 1995, AM J PHYS ANTHROPOL, V98, P527, DOI 10.1002/ajpa.1330980412; Ruff C, 2010, J HUM EVOL, V58, P166, DOI 10.1016/j.jhevol.2009.10.003; Schultz AH, 1949, AM J PHYS ANTHROP-NE, V7, P401, DOI 10.1002/ajpa.1330070307; Simpson SW, 2008, SCIENCE, V322, P1089, DOI 10.1126/science.1163592; Tague RG, 1998, J HUM EVOL, V35, P75, DOI 10.1006/jhev.1998.0223; Tague RG, 1986, J HUM EVOL, V15, P165; Trevathan W, 2000, J HUM EVOL, V39, P583, DOI 10.1006/jhev.2000.0434; Trevathan W., 1987, HUMAN BIRTH EVOLUTIO; TREVATHAN WR, 1988, AM ANTHROPOL, V90, P674, DOI 10.1525/aa.1988.90.3.02a00100; Trevathan WR, 1996, MED ANTHROPOL Q, V10, P287, DOI 10.1525/maq.1996.10.2.02a00100; Warrener AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118903; WASHBURN SL, 1960, SCI AM, V203, P63; Weaver TD, 2009, P NATL ACAD SCI USA; Wells JCK, 2012, AM J PHYS ANTHROPOL, V149, P40, DOI 10.1002/ajpa.22160; Wood BA, 1996, J HUM EVOL, V31, P563, DOI 10.1006/jhev.1996.0080	56	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221871	10.1371/journal.pone.0221871	http://dx.doi.org/10.1371/journal.pone.0221871			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4SI	31532788	Green Submitted, Green Published, gold			2022-12-26	WOS:000532239600015
J	Oosterom, N; de Jonge, R; Smith, DEC; Pieters, R; Tissing, WJE; Fiocco, M; van Zelst, BD; van den Heuvel-Eibrink, MM; Heil, SG				Oosterom, Natanja; de Jonge, Robert; Smith, Desiree E. C.; Pieters, Rob; Tissing, Wim J. E.; Fiocco, Marta; van Zelst, Bertrand D.; van den Heuvel-Eibrink, Marry M.; Heil, Sandra G.			Changes in intracellular folate metabolism during high-dose methotrexate and Leucovorin rescue therapy in children with acute lymphoblastic leukemia	PLOS ONE			English	Article							FOLINIC ACID; VITAMER DISTRIBUTION; PLASMA HOMOCYSTEINE; METHIONINE; ACCUMULATION; DEPLETION; 5-METHYLTETRAHYDROFOLATE; PHARMACOKINETICS; DEFICIENCY; INFUSIONS	Background Methotrexate (MTX) is an important anti-folate agent in pediatric acute lymphoblastic leukemia (ALL) treatment. Folinic acid rescue therapy (Leucovorin) is administered after MTX to reduce toxicity. Previous studies hypothesized that Leucovorin could `rescue' both normal healthy cells and leukemic blasts from cell death. We assessed whether Leucovorin is able to restore red blood cell folate levels after MTX. Methods We prospectively determined erythrocyte folate levels (5-methyltetrahydrofolate (THF) and non-methyl THF) and serum folate levels in 67 children with ALL before start (T0) and after stop (T1) of HD-MTX and Leucovorin courses. Results Erythrocyte folate levels increased between T0 and T1 (mean +/- SD: 416.7 +/- 145.5 nmol/L and 641.2 +/- 196.3 nmol/L respectively, p< 0.001). This was due to an increase in 5-methyl THF levels (mean increase: 217.7 +/- 209.5 nmol/L, p< 0.001), whereas non-methyl THF levels did not change (median increase: 0.6 nmol/L [-9.9-11.1], p = 0.676). Serum folate levels increased between T0 and T1 (median increase: 29.2 nmol/L [32.9-74.0], p< 0.001). Results were not significantly affected by age, sex, ALL immunophenotype and MTHFR c.677C> T genotype. Conclusion Intracellular folate levels accumulate after HD-MTX and Leucovorin therapy in children with ALL, suggesting that Leucovorin restores the intracellular folate pool. Future studies are necessary to assess concomitant lower uptake of MTX.	[Oosterom, Natanja; Pieters, Rob; Tissing, Wim J. E.; Fiocco, Marta; van den Heuvel-Eibrink, Marry M.] Princess Maxima Ctr Pediat Oncol, Utrecht, Netherlands; [Oosterom, Natanja; van Zelst, Bertrand D.; Heil, Sandra G.] Univ Med Ctr Rotterdam, Dept Clin Chem, Erasmus MC, Rotterdam, Netherlands; [de Jonge, Robert; Smith, Desiree E. C.] Vrije Univ Amsterdam Med Ctr, Dept Clin Chem, Amsterdam, Netherlands; [de Jonge, Robert] Acad Med Ctr, Dept Clin Chem, Amsterdam, Netherlands; [Tissing, Wim J. E.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Oncol, Groningen, Netherlands; [Fiocco, Marta] Leiden Univ, Math Inst, Leiden, Netherlands; [Fiocco, Marta] Leiden Univ, Dept Biomed Data Sci, Med Ctr, Leiden, Netherlands	Erasmus University Rotterdam; Erasmus MC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Heil, SG (corresponding author), Univ Med Ctr Rotterdam, Dept Clin Chem, Erasmus MC, Rotterdam, Netherlands.	s.heil@erasmusmc.nl	Dijkstra, Sander/F-2513-2017	Dijkstra, Sander/0000-0001-5368-757X; Smith, Desiree/0000-0003-2053-3392	Stichting Kinderen Kankervrij, Amstelveen, The Netherlands [197]	Stichting Kinderen Kankervrij, Amstelveen, The Netherlands(Netherlands Government)	This project was supported by Stichting Kinderen Kankervrij, Amstelveen, The Netherlands, with grant number 197.	Arabelovic S, 2007, J AM COLL NUTR, V26, P453, DOI 10.1080/07315724.2007.10719635; BORSI JD, 1991, EUR J CANCER, V27, P1006, DOI 10.1016/0277-5379(91)90269-J; BROXSON EH, 1989, CANCER RES, V49, P5879; BUNNI MA, 1989, CANCER CHEMOTH PHARM, V23, P353, DOI 10.1007/BF00435835; Chan ESL, 2010, NAT REV RHEUMATOL, V6, P175, DOI 10.1038/nrrheum.2010.5; den Boer E, 2013, ANAL BIOANAL CHEM, V405, P1673, DOI 10.1007/s00216-012-6581-7; den Hoed MAH, 2015, PHARMACOGENOMICS J, V15, P248, DOI 10.1038/tpj.2014.63; Ducros V, 2006, CLIN CHEM LAB MED, V44, P987, DOI 10.1515/CCLM.2006.178; Fiskerstrand T, 1997, J PHARMACOL EXP THER, V282, P1305; Funk RS, 2014, ARTHRITIS RHEUMATOL, V66, P3476, DOI 10.1002/art.38865; Gatta G, 2014, LANCET ONCOL, V15, P35, DOI 10.1016/S1470-2045(13)70548-5; GOLDMAN I D, 1987, NCI (National Cancer Institute) Monographs, P17; GRAHAM ML, 1992, CANCER CHEMOTH PHARM, V31, P217, DOI 10.1007/BF00685551; Holmboe L, 2012, BRIT J CLIN PHARMACO, V73, P106, DOI 10.1111/j.1365-2125.2011.04054.x; Kabanova S, 2009, INT J MED SCI, V6, P156; Kalhan SC, 2012, REV ENDOCR METAB DIS, V13, P109, DOI 10.1007/s11154-012-9215-7; KAMEN BA, 1981, BRIT J HAEMATOL, V49, P355, DOI 10.1111/j.1365-2141.1981.tb07237.x; KAMEN BA, 1984, J PEDIATR-US, V104, P131, DOI 10.1016/S0022-3476(84)80610-1; Kamps WA, 2010, LEUKEMIA, V24, P309, DOI 10.1038/leu.2009.258; Kao TT, 2013, ZEBRAFISH, V10, P326, DOI 10.1089/zeb.2013.0876; Pauley JL, 2013, CANCER CHEMOTH PHARM, V72, P369, DOI 10.1007/s00280-013-2206-x; PAYET B, 1987, CANCER CHEMOTH PHARM, V19, P319; Pieters R, 2016, J CLIN ONCOL, V34, P2591, DOI 10.1200/JCO.2015.64.6364; PRIEST DG, 1991, J NATL CANCER I, V83, P1806, DOI 10.1093/jnci/83.24.1806; Pui CH, 2011, J CLIN ONCOL, V29, P551, DOI 10.1200/JCO.2010.30.7405; REFSUM H, 1991, CANCER RES, V51, P828; Salzer WL, 2012, J PEDIAT HEMATOL ONC, V34, pE1, DOI 10.1097/MPH.0b013e31820ee239; SCOTT JM, 1981, LANCET, V2, P337; Skarby TVC, 2006, LEUKEMIA, V20, P1955, DOI 10.1038/sj.leu.2404404; Smith DEC, 2006, CLIN CHEM LAB MED, V44, P450, DOI 10.1515/CCLM.2006.085; Smulders YM, 2006, BRIT J HAEMATOL, V132, P623, DOI 10.1111/j.1365-2141.2005.05913.x; Smulders YM, 2007, J NUTR BIOCHEM, V18, P693, DOI 10.1016/j.jnutbio.2006.11.010; Sterba J, 2006, CLIN CHEM, V52, P692, DOI 10.1373/clinchem.2005.061150; STRAW J A, 1987, NCI (National Cancer Institute) Monographs, P41; Strickland KC, 2013, CLIN CHEM LAB MED, V51, P607, DOI 10.1515/cclm-2012-0561; THYSS A, 1989, BRIT J CANCER, V59, P627, DOI 10.1038/bjc.1989.127; TISHLER M, 1988, ARTHRITIS RHEUM, V31, P906, DOI 10.1002/art.1780310712; Trevin LR, 2009, J CLIN ONCOL, V27, P5972, DOI 10.1200/JCO.2008.20.4156; van Ede AE, 2002, RHEUMATOLOGY, V41, P658, DOI 10.1093/rheumatology/41.6.658; Wennerstrand P, 2013, EUR J CLIN PHARMACOL, V69, P1641, DOI 10.1007/s00228-013-1521-9; WOLFROM C, 1993, J CLIN ONCOL, V11, P827, DOI 10.1200/JCO.1993.11.5.827; WOLFROM C, 1990, EUR J CLIN PHARMACOL, V39, P377, DOI 10.1007/BF00315414	42	6	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0221591	10.1371/journal.pone.0221591	http://dx.doi.org/10.1371/journal.pone.0221591			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527879	Green Published, gold, Green Submitted			2022-12-26	WOS:000532231400005
J	Yi, HM; Cai, BH; Ai, X; Liu, RB; Li, KY; Zhang, W				Yi, Huiming; Cai, Baohuan; Ai, Xi; Liu, Ruobing; Li, Kaiyan; Zhang, Wei			Value of contrast-enhanced ultrasound for preoperative assessment of liver reserve function in patients with liver tumors	PLOS ONE			English	Article							INDOCYANINE GREEN CLEARANCE; ULTRASONOGRAPHY; SCORE	This study aimed to investigate the value of contrast-enhanced ultrasound (CEUS) for pre-operative assessment of liver reserve function in patients with liver tumors. The indocyanine green (ICG) clearance tests and CEUS examinations of 45 noncirrhotic patients with liver tumors were performed prior to liver resection. Parameters time to peak (TtoPk), arrival time (Atm) as well as perfusion parameters A, k and A x k were generated from time-intensity curve (TIC) of CEUS. The correlation analyses of the ICG clearance per unit time (ICGK) and the retention rate at 15 min (ICGR15) with TtoPk, Atm, A, k and A x k were performed, and the diagnostic ability as well as optimal cut-off values of TtoPk and Atm for differentiating patients with ICGR15>10% from ICGR15<10% were analyzed. There were significant correlations of ICGK with TtoPk and Atm, and the correlation coefficients were 0.363 (p = 0.014) and -0.482 (p = 0.001), respectively. Significant correlations of ICGR15 with TtoPk and Atm were revealed, and the correlation coefficients were -0.416 (p = 0.004) and 0.303 (p = 0.043), respectively. No correlation of ICGK or ICGR15 with A, k and A x k was found in this study. There were significant differences in TtoPk and Atm between patients with ICGR15>10% and ICGR15<10% (p = 0.028 and p = 0.026, respectively). TtoPk and Atm both had good diagnostic abilities in diagnosing patients with ICGR15>10% verusus ICGR15<10% (AUROC = 0.711 and 0.721, respectively). For ICGR15>10% vs ICGR15, the optimal cut-off values of TtoPk and Atm were 13.307 s and 11.007 s, respectively, while the sensitivity and specificity were 75.0% and 72.7%, 60.6% and 75.0%, respectively. This study revealed that CEUS has the potential to be a new method to evaluate the liver reserve function of patients. With the optimal cut-off values of TtoPk and Atm, qualitative assessment of patients with ICGR15> 10% could be more easily achieved by CEUS with good diagnostic abilities.	[Yi, Huiming; Liu, Ruobing; Li, Kaiyan; Zhang, Wei] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Med Ultrasound, Wuhan, Hubei, Peoples R China; [Cai, Baohuan] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Pediat, Wuhan, Hubei, Peoples R China; [Ai, Xi] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Hepat Surg, Wuhan, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhang, W (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Med Ultrasound, Wuhan, Hubei, Peoples R China.	zhangweitjh@qq.com		Zhang, Wei/0000-0001-9959-2584				Chijiiwa K, 2000, AM J SURG, V179, P161, DOI 10.1016/S0002-9610(00)00274-9; Cosgrove D, 2009, MED BIOL ENG COMPUT, V47, P813, DOI 10.1007/s11517-009-0434-3; De Gasperi A, 2016, WORLD J HEPATOL, V8, P355, DOI 10.4254/wjh.v8.i7.355; El-Desoky A, 1999, BRIT J SURG, V86, P1005, DOI 10.1046/j.1365-2168.1999.01186.x; Erdogan D, 2004, LIVER INT, V24, P117, DOI 10.1111/j.1478-3231.2004.00901.x; Gupta Sachin, 2012, Trop Gastroenterol, V33, P129; Haegele S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165481; Ibis C, 2017, MED SCI MONITOR, V23, P4973, DOI 10.12659/MSM.907306; Kim HJ, 2015, HPB, V17, P159, DOI 10.1111/hpb.12295; Ohno N, 2015, DIAGNOSTICS, V5, P210, DOI 10.3390/diagnostics5020210; Quaia E, 2011, EUR RADIOL, V21, P604, DOI 10.1007/s00330-010-1965-6; Seyama Y, 2009, HEPATOL RES, V39, P107, DOI 10.1111/j.1872-034X.2008.00441.x; Sheng QS, 2009, HEPATOB PANCREAT DIS, V8, P46; Shinohara H, 1996, HEPATOLOGY, V23, P137, DOI 10.1053/jhep.1996.v23.pm0008550033; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Takano S, 2000, BRIT J SURG, V87, P65, DOI 10.1046/j.1365-2168.2000.01308.x; Wang L, 2019, J GASTROINTESTINAL S, V13, P1; Wang YY, 2018, J SURG ONCOL, V118, P440, DOI 10.1002/jso.25184; Wang ZW, 2015, SEMIN CANCER BIOL, V35, pS224, DOI 10.1016/j.semcancer.2015.01.001; Wildner D, 2019, CLIN HEMORHEOL MICRO, V71, P39, DOI 10.3233/CH-180378; Wu HP, 2012, ULTRASOUND MED BIOL, V38, P443, DOI 10.1016/j.ultrasmedbio.2011.12.008; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhan Y, 2019, INT J HYPERTHER, V35, P105, DOI 10.1080/02656736.2018.1483533	23	0	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222514	10.1371/journal.pone.0222514	http://dx.doi.org/10.1371/journal.pone.0222514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527916	Green Published, Green Submitted, gold			2022-12-26	WOS:000532231400026
J	Oyesanya, TO				Oyesanya, Tolu O.			Veterans Health Administration nurses' training and beliefs related to care of patients with traumatic brain injury	PLOS ONE			English	Article							KNOWLEDGE; RECOVERY; MANAGEMENT; OUTCOMES	Background Veteran patients with traumatic brain injury (TBI) and their family members regularly receive care from nurses. Understanding nurses' training and beliefs can provide direction for intervention work aimed at ensuring the best possible care is delivered to this population. Aims We examined Veterans Health Administration (VHA) nurses' training and beliefs related to care of patients with moderate-to-severe TBI. Design and methods We conducted an exploratory, cross-sectional survey with 211 VHA nurses and analyzed data using descriptive statistics. Results The average years of nursing experience was 18 years, and 90% reported ever caring for a patient with TBI. Most nurses (70%) reported only seeing patients with TBI <1-2 times per year in their current role; 20% reported seeing these patients 1-2 times per month. Even with infrequent care, almost 50% reported previously receiving TBI-related training. Beliefs items with the highest accuracy indicated nurses agreed that they need specialized training to care for patients with TBI and that TBI recovery may continue for several years (96.39% accuracy respectively). The beliefs item with the lowest accuracy indicated focus on whether nurses agreed that TBI severity was important in developing care plans (27.84% accuracy). Nurses reported the need for clarity of the nursing role in caring for patients with TBI (77.32% agreement). Conclusion VHA nurses do have accurate beliefs about caring for Veteran patients with moderate-to-severe TBI; however, there is the need for further role clarification regarding nursing care of patients with TBI. Impact These findings have implications for development of education and training interventions for nurses who care for Veteran patients with TBI.	[Oyesanya, Tolu O.] Duke Univ, Sch Nursing, Durham, NC 27706 USA	Duke University	Oyesanya, TO (corresponding author), Duke Univ, Sch Nursing, Durham, NC 27706 USA.	tolu.oyesanya@duke.edu		Oyesanya, Tolu/0000-0001-8821-4510				American Association of Neuroscience Nurses, 2008, NURS MAN AD SEV TRAU; [Anonymous], 2014, CLIN PRACTICE GUIDEL; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Baker Mark J, 2011, Nurse Educ Pract, V11, P268, DOI 10.1016/j.nepr.2010.11.020; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Defense and Veterans Brain Injury Center, 2014, TBI MIL; Defense Medical Surveillance System (DMSS) Theater Medical Data Store (TMDS) and Armed Forces Health Surveillance Center (AFHSC), 2014, DOD WORLDW TBI; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Department of Veteran Affairs, 2016, VET INF COMP INFR; Department of Veterans Affairs, 2013, VHA HDB; Edwards Geraldine, 2006, Br J Nurs, V15, P1180; Ernst WJ, 2009, J HEAD TRAUMA REHAB, V24, P213, DOI 10.1097/HTR.0b013e3181a7ecd8; Farhad K, 2013, J NEUROTRAUM, V30, P84, DOI 10.1089/neu.2011.2283; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hoge C. W., 2009, DTIC DOCUMENT; Jaimes LM, 2015, REHABIL NURS, V40, P74, DOI 10.1002/rnj.156; Lehman C, 2015, SPECIALTY PRACTICE R, P511; Linden MA, 2012, NURS RES, V61, P58, DOI 10.1097/NNR.0b013e31823ca253; Linden MA, 2011, INT J NURS STUD, V48, P62, DOI 10.1016/j.ijnurstu.2010.05.011; Mansour A, 2015, PSYCHOLOGY, V6, P323, DOI [10.4236/psych.2015.64033, DOI 10.4236/PSYCH.2015.64033]; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Maydeu-Olivares A, 2017, STRUCT EQU MODELING, V24, P495, DOI 10.1080/10705511.2017.1289816; McQuillan K. A., 2002, TRAUMA NURSING RESUS, P394; Melnyk Bernadette Mazurek, 2004, Worldviews Evid Based Nurs, V1, P185, DOI 10.1111/j.1524-475X.2004.04024.x; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Oyesanya T. O., J NURS MEAS; Oyesanya T. O., 2017, J CLIN NURS; Oyesanya TO, 2017, J CLIN NURS, V26, P1562, DOI 10.1111/jocn.13457; Oyesanya TO, 2016, WESTERN J NURS RES, V38, P1114, DOI 10.1177/0193945916636629; Pedersen E.R., 2015, PUBLIC PRIVATE PARTN; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Sandoval WA, 2016, REV RES EDUC, V40, P457, DOI 10.3102/0091732X16669319; Seel RT, 2015, ARCH PHYS MED REHAB, V96, pS197, DOI 10.1016/j.apmr.2015.02.034; Sharp SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101176; Shih TH, 2009, EDUC RES REV-NETH, V4, P26, DOI 10.1016/j.edurev.2008.01.003; StataCorp L. P, 2007, STATA DATA ANAL STAT, V10; Thoroddsen A, 2010, INT J NURS TERMIN CL, V21, P69, DOI 10.1111/j.1744-618X.2010.01148.x; Veterans Health Administration, 2009, VHA DIR 2010 012 MAR; Watts DD, 2011, J NEUROSCI NURS, V43, P122, DOI 10.1097/JNN.0b013e3182135af6; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	42	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222585	10.1371/journal.pone.0222585	http://dx.doi.org/10.1371/journal.pone.0222585			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4NC	31525241	gold, Green Published, Green Submitted			2022-12-26	WOS:000532225700040
J	Seol, BR; Jeoung, JW; Park, KH				Seol, Bo Ram; Jeoung, Jin Wook; Park, Ki Ho			Ocular and systemic risk factors associated with recurrent disc hemorrhage in primary open-angle glaucoma	PLOS ONE			English	Article							NORMAL-TENSION GLAUCOMA; LATERAL DECUBITUS POSITION; INTRAOCULAR-PRESSURE; PROGRESSION	Purpose To evaluate the risk factors associated with recurrent disc hemorrhage (DH), defined for the present study as at least 3 occurrences of DH in primary open-angle glaucoma (POAG). Methods A total of 178 POAG patients (89 eyes showing at least 3 occurrences of DH and 89 age matched control eyes with a minimum of 10 years' follow-up without DH) were included in a retrospective, case-control study. Ocular factors were evaluated by a retrospective chart review, and systemic factors were evaluated by a telephone survey. Associations between factors and recurrent DH were investigated by logistic regression analysis. The Kaplan Meier survival analysis and Cox proportional-hazards regression models were used to evaluate glaucoma progression and to identify the factors predictive of glaucoma progression. Results Univariate regression analysis revealed the association of recurrent DH with low baseline intraocular pressure (IOP) [odds ratio (OR), 0.88; 95% confidential interval (CI), 0.80-0.98; P = 0.014], lower percentage reduction of IOP (OR, 0.96; 95% CI, 0.93-0.99; P = 0.020), cold extremities (OR, 2.80; 95% CI, 1.03-7.60; P = 0.043), prone or lateral decubitus sleeping position (OR, 2.14; 95% CI, 1.13-4.03; P = 0.019), and sleeping disorders (OR, 2.33; 95% CI, 1.05-5.15; P = 0.037). Multivariate regression analysis revealed that a lower percentage reduction in IOP (OR, 0.96; 95% CI, 0.93-1.00; P = 0.046) increased the risk of recurrent DH. The control group exhibited a greater cumulative probability of non-progression than the recurrent DH group (P = 0.01, by log-rank test). The Cox proportional-hazards regression model showed that recurrent DH was associated with glaucoma progression [hazard ratio (HR), 1.88; 95% CI; 1.66-3.05; P = 0.01. Conclusions Among the ocular and systemic factors, only lower-percentage reduction of IOP in POAG was associated with recurrent DH. DH recurrence is associated with glaucoma progression and may be dependent on IOP.	[Seol, Bo Ram] VHS Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Seol, Bo Ram; Jeoung, Jin Wook; Park, Ki Ho] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea	Veterans Health Service Medical Center; Seoul National University (SNU); Seoul National University Hospital	Park, KH (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea.	kihopark@snu.ac.kr						Ang GS, 2008, BRIT J OPHTHALMOL, V92, P1129, DOI 10.1136/bjo.2007.135269; Bengtsson B, 2008, OPHTHALMOLOGY, V115, P2044, DOI 10.1016/j.ophtha.2008.05.031; Budenz DL, 2006, OPHTHALMOLOGY, V113, P2137, DOI 10.1016/j.ophtha.2006.06.022; de Beaufort HC, 2010, GRAEF ARCH CLIN EXP, V248, P839, DOI 10.1007/s00417-010-1306-0; De Moraes CG, 2012, ARCH OPHTHALMOL-CHIC, V130, P1541, DOI [10.1001/jamaophthalmol.2013.1137, 10.1001/archophthalmol.2012.2324]; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; Healey PR, 1998, OPHTHALMOLOGY, V105, P216, DOI 10.1016/S0161-6420(98)92704-X; Heijl A, 2011, ACTA OPHTHALMOL, V89, P749, DOI 10.1111/j.1755-3768.2009.01852.x; HENDRICKX KH, 1994, OPHTHALMOLOGY, V101, P1165; Ishida K, 2000, AM J OPHTHALMOL, V129, P707, DOI 10.1016/S0002-9394(00)00441-4; JONAS JB, 1994, AM J OPHTHALMOL, V118, P1; Kim KN, 2015, OPHTHALMOLOGY, V120, P731; Kim KN, 2013, OPHTHALMOLOGY, V120, P731, DOI 10.1016/j.ophtha.2012.09.021; Kim SH, 2006, OPHTHALMOLOGY, V113, P598, DOI 10.1016/j.ophtha.2005.12.018; Kim YD, 2010, EYE, V24, P567, DOI 10.1038/eye.2009.163; KITAZAWA Y, 1986, OPHTHALMOLOGY, V93, P853; Laemmer R, 2010, GRAEF ARCH CLIN EXP, V248, P1683, DOI 10.1007/s00417-010-1474-y; Lee JY, 2012, ACTA OPHTHALMOL, V90, pE68, DOI 10.1111/j.1755-3768.2011.02208.x; Malihi M, 2012, OPHTHALMOLOGY, V119, P987, DOI 10.1016/j.ophtha.2011.11.024; Miyake T, 2006, J GLAUCOMA, V15, P164, DOI 10.1097/00061198-200604000-00014; Musch DC, 2008, OPHTHALMOLOGY, V115, P927, DOI 10.1016/j.ophtha.2007.08.010; Park HYL, 2015, INVEST OPHTH VIS SCI, V56, P7524, DOI 10.1167/iovs.15-17502; Shim SH, 2015, AM J OPHTHALMOL, V160, P1191, DOI 10.1016/j.ajo.2015.09.006; Siegner SW, 1996, OPHTHALMOLOGY, V103, P1014, DOI 10.1016/S0161-6420(96)30572-1; Soares AS, 2004, OPHTHALMOLOGY, V111, P1653, DOI 10.1016/j.ophtha.2004.03.023; Suh MH, 2011, CLIN EXP OPHTHALMOL, V39, P513, DOI 10.1111/j.1442-9071.2010.02482.x; Suh MH, 2012, J GLAUCOMA, V21, P358, DOI 10.1097/IJG.0b013e3182120700; Tezel G, 2001, ARCH OPHTHALMOL-CHIC, V119, P813	28	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222166	10.1371/journal.pone.0222166	http://dx.doi.org/10.1371/journal.pone.0222166			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525246	gold, Green Published, Green Submitted			2022-12-26	WOS:000532225700022
J	Brown, JC				Brown, Jay C.			Control of human testis-specific gene expression	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR; TRANSCRIPTION; EVOLUTION; ARCHITECTURE; MECHANISMS; PROMOTERS; DOMAINS	Background As a result of decades of effort by many investigators we now have an advanced level of understanding about several molecular systems involved in the control of gene expression. Examples include CpG islands, promoters, mRNA splicing and epigenetic signals. It is less clear, however, how such systems work together to integrate the functions of a living organism. Here I describe the results of a study to test the idea that a contribution might be made by focusing on genes specifically expressed in a particular tissue, the human testis. Experimental design A database of 239 testis-specific genes was accumulated and each was examined for the presence of features relevant to control of gene expression. These include: (1) the presence of a promoter, (2) the presence of a CpG island (CGI) within the promoter, (3) the presence in the promoter of a transcription factor binding site near the transcription start site, (4) the level of gene expression, and (5) the above features in genes of testis-specific cell types such as spermatocyte and spermatid that differ in their extent of differentiation. Results Of the 107 database genes with an annotated promoter, 56 were found to have one or more transcription factor binding sites near the transcription start site. Three of the binding sites observed, Pax-5, AP-2 alpha A and GR alpha, stand out in abundance suggesting they may be involved in testis-specific gene expression. Compared to less differentiated testis-specific cells, genes of more differentiated cells were found to be (1) more likely to lack a CGI, (2) more likely to lack introns and (3) higher in expression level. The results suggest genes of more differentiated cells have a reduced need for CGI-based regulatory repression, reduced usage of gene splicing and a smaller set of expressed proteins.	[Brown, Jay C.] Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA	University of Virginia	Brown, JC (corresponding author), Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA.	jcb2g@virginia.edu		Brown, Jay/0000-0003-0978-7244				ADAMS B, 1992, GENE DEV, V6, P1589, DOI 10.1101/gad.6.9.1589; Ahn J, 2017, PLOS ONE, V12; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Bogdanovic O, 2009, CHROMOSOMA, V118, P549, DOI 10.1007/s00412-009-0221-9; Brown JC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202927; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Djureinovic D, 2014, MOL HUM REPROD, V20, P476, DOI 10.1093/molehr/gau018; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Gagniuc P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-512; Gestri G, 2009, HUM GENET, V126, P791, DOI 10.1007/s00439-009-0730-x; Grzybowska EA, 2012, BIOCHEM BIOPH RES CO, V424, P1, DOI 10.1016/j.bbrc.2012.06.092; Hill M.A, 2019, EMBRYOLOGY SPERMATOZ; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Lee TI, 2000, ANNU REV GENET, V34, P77, DOI 10.1146/annurev.genet.34.1.77; Lei HX, 2011, P NATL ACAD SCI USA, V108, P17985, DOI 10.1073/pnas.1113076108; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Liu FJ, 2011, BIOL PHARM BULL, V34, P28, DOI 10.1248/bpb.34.28; McManus S, 2011, EMBO J, V30, P2388, DOI 10.1038/emboj.2011.140; Mikhaylova LM, 2008, GENETICS, V179, P305, DOI 10.1534/genetics.107.080267; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Pauls K, 2005, INT J CANCER, V115, P470, DOI 10.1002/ijc.20913; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Ross M. H., 2006, HISTOLOGY TEXT ATLAS; Roy AL, 2015, TRENDS BIOCHEM SCI, V40, P165, DOI 10.1016/j.tibs.2015.01.007; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; SCHULTZ R, 1993, MOL CELL ENDOCRINOL, V95, P115, DOI 10.1016/0303-7207(93)90036-J; Shaul O, 2017, INT J BIOCHEM CELL B, V91, P145, DOI 10.1016/j.biocel.2017.06.016; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; TRAINER TD, 1987, AM J SURG PATHOL, V11, P797, DOI 10.1097/00000478-198710000-00007; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; van Steensel B, 2017, CELL, V169, P780, DOI 10.1016/j.cell.2017.04.022; Vinson C, 2012, EPIGENOMICS-UK, V4, P655, DOI [10.2217/EPI.12.55, 10.2217/epi.12.55]; Weintraub AS, 2017, CELL, V171, P1573, DOI 10.1016/j.cell.2017.11.008; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004	41	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2019	14	9							e0215184	10.1371/journal.pone.0215184	http://dx.doi.org/10.1371/journal.pone.0215184			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4IG	31514204	gold, Green Submitted, Green Published			2022-12-26	WOS:000532212700004
J	Rixen, S; Havemeyer, A; Tyl-Bielicka, A; Pysniak, K; Gajewska, M; Kulecka, M; Ostrowski, J; Mikula, M; Clement, B				Rixen, Sophia; Havemeyer, Antje; Tyl-Bielicka, Anita; Pysniak, Kazimiera; Gajewska, Marta; Kulecka, Maria; Ostrowski, Jerzy; Mikula, Michal; Clement, Bernd			Mitochondrial amidoxime-reducing component 2 (MARC2) has a significant role in N-reductive activity and energy metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene KO; transgenic mice; drug metabolism; enzyme catalysis; molybdenum; energy metabolism; lipid metabolism; mitochondrial amideoxime-reducing component (mARC); N reduction; xenobiotic metabolism	CYTOCHROME B(5); GENE; INVOLVEMENT; RAT; PEROXISOMES; EXPRESSION; ENZYMES; SYSTEM	The mitochondrial amidoxime-reducing component (MARC) is a mammalian molybdenum-containing enzyme. All annotated mammalian genomes harbor two MARC genes, MARC1 and MARC2, which share a high degree of sequence similarity. Both molybdoenzymes reduce a variety of N-hydroxylated compounds. Besides their role in N-reductive drug metabolism, only little is known about their physiological functions. In this study, we characterized an existing KO mouse model lacking the functional MARC2 gene and fed a high-fat diet and also performed in vivo and in vitro experiments to characterize reductase activity toward known MARC substrates. MARC2 KO significantly decreased reductase activity toward several N-oxygenated substrates, and for typical MARC substrates, only small residual reductive activity was still detectable in MARC2 KO mice. The residual detected reductase activity in MARC2 KO mice could be explained by MARC1 expression that was hardly unaffected by KO, and we found no evidence of significant activity of other reductase enzymes. These results clearly indicate that MARC2 is mainly responsible for N-reductive biotransformation in mice. Striking phenotypical features of MARC2 KO mice were lower body weight, increased body temperature, decreased levels of total cholesterol, and increased glucose levels, supporting previous findings that MARC2 affects energy pathways. Of note, the MARC2 KO mice were resistant to high-fat diet-induced obesity. We propose that the MARC2 KO mouse model could be a powerful tool for predicting MARC-mediated drug metabolism and further investigating MARC's roles in energy homeostasis.	[Rixen, Sophia; Havemeyer, Antje; Clement, Bernd] Univ Kiel, Dept Pharmaceut & Med Chem, Inst Pharmaceut, D-24118 Kiel, Germany; [Tyl-Bielicka, Anita; Pysniak, Kazimiera; Gajewska, Marta; Ostrowski, Jerzy; Mikula, Michal] Maria Sklodowska Curie Inst, Dept Genet, Ctr Canc, PL-02781 Warsaw, Poland; [Kulecka, Maria; Ostrowski, Jerzy] Ctr Postgrad Med Educ, Dept Gastroenterol Hepatol & Clin Oncol, PL-02781 Warsaw, Poland	University of Kiel; Maria Sklodowska-Curie National Research Institute of Oncology; Centre of Postgraduate Medical Education - Poland	Clement, B (corresponding author), Univ Kiel, Dept Pharmaceut & Med Chem, Inst Pharmaceut, D-24118 Kiel, Germany.	mikula.michal@coi.pl; bclement@pharmazie.uni-kiel.de	Mikula, Michal/G-8276-2011; Kulecka, Maria/AAW-8629-2020	Mikula, Michal/0000-0003-3447-7328; Kulecka, Maria/0000-0002-9830-8892; Pysniak, Kazimiera/0000-0001-6461-2768; Gajewska, Marta/0000-0002-7421-0444	 [GW10MM]		Supported by internal grant GW10MM.	Altschul SF, 1996, METHOD ENZYMOL, V266, P460; Andersson S, 2005, DRUG METAB DISPOS, V33, P570, DOI 10.1124/dmd.104.002972; Bauch E, 2015, CHEMMEDCHEM, V10, P360, DOI 10.1002/cmdc.201402437; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Brown SDM, 2012, DIS MODEL MECH, V5, P289, DOI 10.1242/dmm.009878; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; ELGHOMARI K, 1987, EUR J DRUG METAB PH, V12, P253, DOI 10.1007/BF03189908; Eriksson B, 2002, LANCET, V360, P1441, DOI 10.1016/S0140-6736(02)11469-3; Froriep D, 2013, XENOBIOTICA, V43, P780, DOI 10.3109/00498254.2013.767481; Gonzalez FJ, 2005, MUTAT RES-FUND MOL M, V569, P101, DOI 10.1016/j.mrfmmm.2004.04.021; Gruenewald S, 2008, J MED CHEM, V51, P8173, DOI 10.1021/jm8010417; Gunther B. R, 1983, European Patent, Patent No. [EP0094560A1, 0094560]; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Havemeyer A, 2006, J BIOL CHEM, V281, P34796, DOI 10.1074/jbc.M607697200; Havemeyer A, 2011, DRUG METAB REV, V43, P524, DOI 10.3109/03602532.2011.608682; Heinemann V, 2013, BRIT J CANCER, V108, P766, DOI 10.1038/bjc.2013.62; Hennig EE, 2014, J CELL MOL MED, V18, P1762, DOI 10.1111/jcmm.12328; Islinger M, 2007, J BIOL CHEM, V282, P23055, DOI 10.1074/jbc.M610910200; Jakobs HH, 2014, CHEMMEDCHEM, V9, P2381, DOI 10.1002/cmdc.201402127; Jakobs HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105371; KhromovBorisov NN, 1997, MUTAT RES-FUND MOL M, V379, P95, DOI 10.1016/S0027-5107(97)00112-7; Kotthaus J, 2011, BIOCHEM J, V433, P383, DOI 10.1042/BJ20100960; Krompholz N, 2012, CHEM RES TOXICOL, V25, P2443, DOI 10.1021/tx300298m; Kubitza C, 2018, P NATL ACAD SCI USA, V115, P11958, DOI 10.1073/pnas.1808576115; Malik AN, 2007, BIOCHEM BIOPH RES CO, V357, P237, DOI 10.1016/j.bbrc.2007.03.132; NEGISHI K, 1994, MUTAT RES-REV GENET, V318, P227, DOI 10.1016/0165-1110(94)90016-7; Neve EPA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138487; Neve EPA, 2012, J BIOL CHEM, V287, P6307, DOI 10.1074/jbc.M111.328237; Ott G, 2015, J BIOL INORG CHEM, V20, P265, DOI 10.1007/s00775-014-1216-4; Page R, 1997, BIOCHEM BIOPH RES CO, V232, P49, DOI 10.1006/bbrc.1997.6224; Plitzko B, 2016, DRUG METAB DISPOS, V44, P1617, DOI 10.1124/dmd.116.071845; Plitzko B, 2015, J BIOL CHEM, V290, P10126, DOI 10.1074/jbc.M115.640052; Plitzko B, 2013, J BIOL CHEM, V288, P20228, DOI 10.1074/jbc.M113.474916; Schneider J, 2018, CHEM RES TOXICOL, V31, P447, DOI 10.1021/acs.chemrestox.7b00329; Sparacino-Watkins CE, 2014, J BIOL CHEM, V289, P10345, DOI 10.1074/jbc.M114.555177; van Waterschoot RAB, 2008, MOL PHARMACOL, V73, P1029, DOI 10.1124/mol.107.043869; Wahl B, 2010, J BIOL CHEM, V285, P37847, DOI 10.1074/jbc.M110.169532; Wang X, 2016, BIOCHEM PHARMACOL, V105, P80, DOI 10.1016/j.bcp.2016.03.001; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200; Wilkinson P, 2010, NUCLEIC ACIDS RES, V38, pD570, DOI 10.1093/nar/gkp799; Wu CL, 2016, NUCLEIC ACIDS RES, V44, pD313, DOI 10.1093/nar/gkv1104	41	9	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17593	17602		10.1074/jbc.RA119.007606	http://dx.doi.org/10.1074/jbc.RA119.007606			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31554661	Green Published, hybrid			2022-12-26	WOS:000503173500033
J	Liu, L; Li, L; Ma, C; Shi, YD; Liu, CC; Xiao, ZK; Zhang, Y; Tian, F; Gao, Y; Zhang, J; Ying, WT; Wang, PG; Zhang, LW				Liu, Li; Li, Ling; Ma, Cheng; Shi, Yangde; Liu, Congcong; Xiao, Zikang; Zhang, Yong; Tian, Fang; Gao, Yang; Zhang, Jie; Ying, Wantao; Wang, Peng George; Zhang, Lianwen			O-GlcNAcylation of Thr(12)/Ser(56) in short-form O-GlcNAc transferase (sOGT) regulates its substrate selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						O-GlcNAcylation; O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT); cell proliferation; cell cycle; enzyme kinetics; G2; M arrest; sOGT; substrate selectivity	BETA-N-ACETYLGLUCOSAMINE; CELL-CYCLE; PROTEIN; IDENTIFICATION; EXPRESSION; PEPTIDE; NUCLEAR; DOMAIN; SP1; PHOSPHORYLATION	O-GlcNAcylation is a ubiquitous protein glycosylation playing different roles on variant proteins. O-GlcNAc transferase (OGT) is the unique enzyme responsible for the sugar addition to nucleocytoplasmic proteins. Recently, multiple O-GlcNAc sites have been observed on short-form OGT (sOGT) and nucleocytoplasmic OGT (ncOGT), both of which locate in the nucleus and cytoplasm in cell. Moreover, O-GlcNAcylation of Ser(389) in ncOGT (1036 amino acids) affects its nuclear translocation in HeLa cells. To date, the major O-GlcNAcylation sites and their roles in sOGT remain unknown. Here, we performed LC-MS/MS and mutational analyses to seek the major O-GlcNAcylation site on sOGT. We identified six O-GlcNAc sites in the tetratricopeptide repeat domain in sOGT, with Thr(12) and Ser(56) being two ?key? sites. Thr(12) is a dominant O-GlcNAcylation site, whereas the modification of Ser(56) plays a role in regulating sOGT O-GlcNAcylation, partly through Thr(12). In vitro activity and pulldown assays demonstrated that O-GlcNAcylation does not affect sOGT activity but does affect sOGT-interacting proteins. In HEK293T cells, S56A bound to and hence glycosylated more proteins in contrast to T12A and WT sOGT. By proteomic and bioinformatics analyses, we found that T12A and S56A differed in substrate proteins (e.g. HNRNPU and PDCD6IP), which eventually affected cell cycle progression and/or cell proliferation. These findings demonstrate that O-GlcNAcylation modulates sOGT substrate selectivity and affects its role in the cell. The data also highlight the regulatory role of O-GlcNAcylation at Thr(12) and Ser(56).	[Liu, Li; Li, Ling; Shi, Yangde; Liu, Congcong; Xiao, Zikang; Wang, Peng George; Zhang, Lianwen] Nankai Univ, Coll Pharm, Tianjin 300353, Peoples R China; [Liu, Li; Li, Ling; Shi, Yangde; Liu, Congcong; Xiao, Zikang; Wang, Peng George; Zhang, Lianwen] Nankai Univ, Tianjin Key Lab Mol Drug Res, Tianjin 300353, Peoples R China; [Ma, Cheng; Wang, Peng George] Georgia State Univ, Ctr Diagnost & Therapeut, Dept Chem, Atlanta, GA 30303 USA; [Zhang, Yong; Tian, Fang; Ying, Wantao] Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing 102206, Peoples R China; [Zhang, Yong] Sichuan Univ, West China Hosp, West China Washington Mitochondria & Metab Res Ct, MOH,Key Lab Transplant Engn & Immunol, Chengdu 610041, Sichuan, Peoples R China; [Gao, Yang; Zhang, Jie] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China	Nankai University; Nankai University; University System of Georgia; Georgia State University; Academy of Military Medical Sciences - China; Sichuan University; Nankai University	Zhang, LW (corresponding author), Nankai Univ, Coll Pharm, Tianjin 300353, Peoples R China.; Zhang, LW (corresponding author), Nankai Univ, Tianjin Key Lab Mol Drug Res, Tianjin 300353, Peoples R China.; Ying, WT (corresponding author), Beijing Inst LifeOm, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing 102206, Peoples R China.	yingwantao@mail.ncpsb.org.cn; lianwen@nankai.edu.cn	Zhang, Yong/X-5075-2019; WANG, Peng/GSN-5263-2022	Zhang, Yong/0000-0003-0513-8941	National Natural Science Foundation of China [31470795]; Tianjin Municipal Science and Technology Commission [15JCYBJC24100]; "Fundamental Research Funds for the Central Universities," Nankai University [63191148]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Commission; "Fundamental Research Funds for the Central Universities," Nankai University	This work was supported by National Natural Science Foundation of China Grant 31470795, Tianjin Municipal Science and Technology Commission Grant 15JCYBJC24100, and "Fundamental Research Funds for the Central Universities," Nankai University, Grant 63191148. The authors declare that they have no conflicts of interest with the contents of this article.	Abbastabar M, 2018, DNA REPAIR, V69, P63, DOI 10.1016/j.dnarep.2018.07.008; Andrali SS, 2007, J BIOL CHEM, V282, P15589, DOI 10.1074/jbc.M701762200; Ayeni JO, 2014, FLY, V8, P140, DOI 10.4161/19336934.2014.969147; Bullen JW, 2014, J BIOL CHEM, V289, P10592, DOI 10.1074/jbc.M113.523068; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Chalkley RJ, 2009, P NATL ACAD SCI USA, V106, P8894, DOI 10.1073/pnas.0900288106; Charoensuksai P, 2015, BIOCHEM J, V466, P587, DOI 10.1042/BJ20141072; Chen XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043724, 10.1371/journal.pone.0036895]; Fan Q, 2018, BIOCHEM BIOPH RES CO, V499, P354, DOI 10.1016/j.bbrc.2018.03.164; Gao Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P155, DOI 10.1016/S0003-9861(03)00234-0; Garcia-Gutierrez L, 2019, GENES-BASEL, V10, DOI 10.3390/genes10030244; Griffin ME, 2016, MOL BIOSYST, V12, P1756, DOI 10.1039/c6mb00138f; Hanover JA, 2003, ARCH BIOCHEM BIOPHYS, V409, P287, DOI 10.1016/S0003-9861(02)00578-7; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200; Iyer SPN, 2003, J BIOL CHEM, V278, P5399, DOI 10.1074/jbc.M209384200; Kaasik K, 2013, CELL METAB, V17, P291, DOI 10.1016/j.cmet.2012.12.017; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Kulinski M, 2018, LEUKEMIA LYMPHOMA, V59, P1051, DOI 10.1080/10428194.2017.1359740; Lazarus BD, 2006, GLYCOBIOLOGY, V16, P415, DOI 10.1093/glycob/cwj078; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Lim K, 2010, BIOCHEM BIOPH RES CO, V393, P314, DOI 10.1016/j.bbrc.2010.01.128; Liu XY, 2014, FASEB J, V28, P3362, DOI 10.1096/fj.13-246850; Luanpitpong S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10886-x; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Ma XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063452; Miller MW, 1999, ARCH BIOCHEM BIOPHYS, V367, P51, DOI 10.1006/abbi.1999.1237; Mizuguchi-Hata C, 2013, BBA-MOL CELL RES, V1833, P2682, DOI 10.1016/j.bbamcr.2013.06.008; Noach N, 2007, GLYCOBIOLOGY, V17, P1357, DOI 10.1093/glycob/cwm105; Qiu HY, 2016, DIGEST DIS SCI, V61, P795, DOI 10.1007/s10620-015-3937-9; Riu IH, 2008, BIOCHEM BIOPH RES CO, V372, P203, DOI 10.1016/j.bbrc.2008.05.034; Roos MD, 1997, MOL CELL BIOL, V17, P6472, DOI 10.1128/MCB.17.11.6472; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Selvan N, 2017, NAT CHEM BIOL, V13, P882, DOI 10.1038/nchembio.2404; Seo HG, 2016, SCI REP-UK, V6, DOI 10.1038/srep34614; Smits AH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks941; Song M, 2008, CELL SIGNAL, V20, P94, DOI 10.1016/j.cellsig.2007.09.002; Srivastava RK, 2007, CELL CYCLE, V6, P2953, DOI 10.4161/cc.6.23.4951; Tai HC, 2004, J AM CHEM SOC, V126, P10500, DOI 10.1021/ja047872b; Vito P, 1999, J BIOL CHEM, V274, P1533, DOI 10.1074/jbc.274.3.1533; Wang LH, 2007, RAPID COMMUN MASS SP, V21, P2985, DOI 10.1002/rcm.3173; Wang Y, 2016, INT J CLIN EXP PATHO, V9, P10451; Whelan SA, 2008, J BIOL CHEM, V283, P21411, DOI 10.1074/jbc.M800677200; Yang WH, 2008, P NATL ACAD SCI USA, V105, P17345, DOI 10.1073/pnas.0806198105; Yang XY, 2001, P NATL ACAD SCI USA, V98, P6611, DOI 10.1073/pnas.111099998; Yu Q, 2013, DNA CELL BIOL, V32, P451, DOI 10.1089/dna.2013.2061; Zhan QL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071663; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7; Zhang LL, 2019, SEMIN CELL DEV BIOL, V90, P161, DOI 10.1016/j.semcdb.2018.07.006; Zhang Y, 2018, J PROTEOMICS, V170, P14, DOI 10.1016/j.jprot.2017.09.014; Zhou F, 2013, BIOCHEM BIOPH RES CO, V438, P427, DOI 10.1016/j.bbrc.2013.07.091	52	11	12	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16620	16633		10.1074/jbc.RA119.009085	http://dx.doi.org/10.1074/jbc.RA119.009085			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31527085	hybrid, Green Published			2022-12-26	WOS:000501801900013
J	James, C; Muller, M; Goldberg, MW; Lenz, C; Urlaub, H; Kehlenbach, RH				James, Christina; Mueller, Marret; Goldberg, Martin W.; Lenz, Christof; Urlaub, Henning; Kehlenbach, Ralph H.			Proteomic mapping by rapamycin-dependent targeting of APEX2 identifies binding partners of VAPB at the inner nuclear membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear envelope; biotin; peroxidase; endoplasmic reticulum (ER); nuclear pore; APEX; emerin; proteomic proximity mapping; RAPIDS; VAPB	AMYOTROPHIC-LATERAL-SCLEROSIS; SUBCELLULAR-LOCALIZATION; PROTEIN COMPLEXES; BIOTINYLATION; EMERIN; ASSOCIATION; CHROMATIN; CELLS; INTERACTS; JUNCTIONS	Vesicle-associated membrane protein?associated protein B (VAPB) is a tail-anchored protein that is present at several contact sites of the endoplasmic reticulum (ER). We now show by immunoelectron microscopy that VAPB also localizes to the inner nuclear membrane (INM). Using a modified enhanced ascorbate peroxidase 2 (APEX2) approach with rapamycin-dependent targeting of the peroxidase to a protein of interest, we searched for proteins that are in close proximity to VAPB, particularly at the INM. In combination with stable isotope labeling with amino acids in cell culture (SILAC), we confirmed many well-known interaction partners at the level of the ER with a clear distinction between specific and nonspecific hits. Furthermore, we identified emerin, TMEM43, and ELYS as potential interaction partners of VAPB at the INM and the nuclear pore complex, respectively.	[James, Christina; Mueller, Marret; Kehlenbach, Ralph H.] Georg August Univ Gottingen, Dept Mol Biol, Gottingen Ctr Mol Biosci GZMB, Fac Med, Humboldtallee 23, D-37073 Gottingen, Germany; [Goldberg, Martin W.] Univ Durham, Sch Biol & Biomed Sci, Durham DH1 3LE, England; [Lenz, Christof; Urlaub, Henning] Univ Med Ctr Gottingen, Inst Clin Chem, Bioanalyt Grp, Robert Koch Str 40, D-37075 Gottingen, Germany; [Lenz, Christof; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, Fassberg 11, D-37077 Gottingen, Germany	University of Gottingen; Durham University; University of Gottingen; Max Planck Society	Kehlenbach, RH (corresponding author), Georg August Univ Gottingen, Dept Mol Biol, Gottingen Ctr Mol Biosci GZMB, Fac Med, Humboldtallee 23, D-37073 Gottingen, Germany.	rkehlen@gwdg.de		Kehlenbach, Ralph/0000-0003-4920-9916; Goldberg, Martin/0000-0002-0610-4332	Deutsche Forschungsgemeinschaft [SFB1190]; BBSRC [BB/R014094/1] Funding Source: UKRI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB1190 (to R. H. K. and H. U.). The authors declare that they have no conflicts of interest with the contents of this article.	Atanassov I, 2013, PROTEOMICS, V13, P2947, DOI 10.1002/pmic.201300035; Bar DZ, 2018, NAT METHODS, V15, P127, DOI 10.1038/nmeth.4533; Baron Y, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-39; Belshaw PJ, 1996, P NATL ACAD SCI USA, V93, P4604, DOI 10.1073/pnas.93.10.4604; Bengtsson L, 2008, J CELL SCI, V121, P536, DOI 10.1242/jcs.019281; Blenski M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020334; Branon TC, 2018, NAT BIOTECHNOL, V36, P880, DOI 10.1038/nbt.4201; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cartegni L, 1997, HUM MOL GENET, V6, P2257, DOI 10.1093/hmg/6.13.2257; Casson J, 2017, J CELL SCI, V130, P3851, DOI 10.1242/jcs.207829; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947; Cheng LC, 2019, NUCLEUS-PHILA, V10, P126, DOI 10.1080/19491034.2019.1618175; Cho IT, 2017, J BIOL CHEM, V292, P16382, DOI 10.1074/jbc.M117.795286; Chojnowski A, 2018, ISCIENCE, V10, P40, DOI 10.1016/j.isci.2018.11.023; Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515; Costello JL, 2017, J CELL BIOL, V216, P331, DOI 10.1083/jcb.201607055; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; Fasana E, 2010, FASEB J, V24, P1419, DOI 10.1096/fj.09-147850; FOISNER R, 1993, CELL, V73, P1267, DOI 10.1016/0092-8674(93)90355-T; Franke WW, 2014, CELL TISSUE RES, V357, P159, DOI 10.1007/s00441-014-1865-1; Franz C, 2007, EMBO REP, V8, P165, DOI 10.1038/sj.embor.7400889; FURUKAWA K, 1995, EMBO J, V14, P1626, DOI 10.1002/j.1460-2075.1995.tb07151.x; Gasteier JE, 2003, J BIOL CHEM, V278, P38902, DOI 10.1074/jbc.M306229200; GERACE L, 1980, CELL, V19, P277, DOI 10.1016/0092-8674(80)90409-2; Gillespie PJ, 2007, CURR BIOL, V17, P1657, DOI 10.1016/j.cub.2007.08.041; Gingras AC, 2019, CURR OPIN CHEM BIOL, V48, P44, DOI 10.1016/j.cbpa.2018.10.017; Han S, 2017, CELL CHEM BIOL, V24, P404, DOI 10.1016/j.chembiol.2017.02.002; Hung V, 2017, ELIFE, V6, DOI 10.7554/eLife.24463; Hung V, 2014, MOL CELL, V55, P332, DOI 10.1016/j.molcel.2014.06.003; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Johnson B, 2018, P NATL ACAD SCI USA, V115, pE7331, DOI 10.1073/pnas.1805757115; Kim DI, 2016, TRENDS CELL BIOL, V26, P804, DOI 10.1016/j.tcb.2016.09.004; Kuijpers M, 2013, EMBO J, V32, P2056, DOI 10.1038/emboj.2013.131; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179; Lee SY, 2016, CELL REP, V15, P1837, DOI 10.1016/j.celrep.2016.04.064; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; Liang WC, 2011, ANN NEUROL, V69, P1005, DOI 10.1002/ana.22338; Lobingier BT, 2017, CELL, V169, P350, DOI 10.1016/j.cell.2017.03.022; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Mick DU, 2015, DEV CELL, V35, P497, DOI 10.1016/j.devcel.2015.10.015; Moustaqim-Barrette A, 2014, HUM MOL GENET, V23, P1975, DOI 10.1093/hmg/ddt594; Murphy R, 1996, NATURE, V383, P357, DOI 10.1038/383357a0; Murphy SE, 2016, BBA-MOL CELL BIOL L, V1861, P952, DOI 10.1016/j.bbalip.2016.02.009; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Ohba T, 2004, J CELL BIOL, V167, P1051, DOI 10.1083/jcb.200409149; Paek J, 2017, CELL, V169, P338, DOI 10.1016/j.cell.2017.03.028; Pfaff J, 2016, J CELL SCI, V129, P502, DOI 10.1242/jcs.179333; Rasala BA, 2006, P NATL ACAD SCI USA, V103, P17801, DOI 10.1073/pnas.0608484103; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Saiz-Ros N, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020120; Salpingidou G, 2007, J CELL BIOL, V178, P897, DOI 10.1083/jcb.200702026; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; SOULLAM B, 1995, J CELL BIOL, V130, P15, DOI 10.1083/jcb.130.1.15; Stoica R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4996; SUKEGAWA J, 1993, CELL, V72, P29, DOI 10.1016/0092-8674(93)90047-T; Tran D, 2012, J CELL SCI, V125, P2831, DOI 10.1242/jcs.102111; Udeshi ND, 2017, NAT METHODS, V14, P1167, DOI 10.1038/nmeth.4465; Ungricht R, 2015, J CELL BIOL, V209, P687, DOI 10.1083/jcb.201409127; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wu MY, 2008, JNCI-J NATL CANCER I, V100, P1247, DOI 10.1093/jnci/djn253; Zuleger N, 2011, J CELL BIOL, V193, P109, DOI 10.1083/jcb.201009068	66	18	18	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					16241	16254		10.1074/jbc.RA118.007283	http://dx.doi.org/10.1074/jbc.RA118.007283			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31519755	Green Accepted, hybrid, Green Published			2022-12-26	WOS:000499478600030
J	Lindquist, C; Bjorndal, B; Bakke, HG; Slettom, G; Karoliussen, M; Rustan, AC; Thoresen, GH; Skorve, J; Nygard, OK; Berge, RK				Lindquist, Carine; Bjorndal, Bodil; Bakke, Hege G.; Slettom, Grete; Karoliussen, Marie; Rustan, Arild C.; Thoresen, G. Hege; Skorve, Jon; Nygard, Ottar K.; Berge, Rolf Kristian			A mitochondria-targeted fatty acid analogue influences hepatic glucose metabolism and reduces the plasma insulin/glucose ratio in male Wistar rats	PLOS ONE			English	Article							CARBOXYKINASE PEPCK-M; TETRADECYLTHIOACETIC ACID; LIVER; OXIDATION; GLUCONEOGENESIS; ACCUMULATION; QUANTITATION; HOMEOSTASIS; PATHWAY; TISSUE	A fatty acid analogue, 2-(tridec-12-yn-1-ylthio)acetic acid (1-triple TTA), was previously shown to have hypolipidemic effects in rats by targeting mitochondrial activity predominantly in liver. This study aimed to determine if 1-triple TTA could influence carbohydrate metabolism. Male Wistar rats were treated for three weeks with oral supplementation of 100 mg/kg body weight 1-triple TTA. Blood glucose and insulin levels, and liver carbohydrate metabolism gene expression and enzyme activities were determined. In addition, human myotubes and Huh7 liver cells were treated with 1-triple TTA, and glucose and fatty acid oxidation were determined. The level of plasma insulin was significantly reduced in 1-triple TTA-treated rats, resulting in a 32% reduction in the insulin/glucose ratio. The hepatic glucose and glycogen levels were lowered by 22% and 49%, respectively, compared to control. This was accompanied by lower hepatic gene expression of phosphenolpyruvate carboxykinase, the rate-limiting enzyme in gluconeogenesis, and Hnf4A, a regulator of gluconeogenesis. Gene expression of pyruvate kinase, catalysing the final step of glycolysis, was also reduced by 1-triple TTA. In addition, pyruvate dehydrogenase activity was reduced, accompanied by 10-15-fold increased gene expression of its regulator pyruvate dehydrogenase kinase 4 compared to control, suggesting reduced entry of pyruvate into the TCA cycle. Indeed, the NADPH-generating enzyme malic enzyme 1 (ME1) catalysing production of pyruvate from malate, was increased 13-fold at the gene expression level. Despite the decreased glycogen level, genes involved in glycogen synthesis were not affected in livers of 1-triple TTA treated rats. In contrast, the pentose phosphate pathway seemed to be increased as the hepatic gene expression of glucose-6-phosphate dehydrogenase (G6PD) was higher in 1-triple TTA treated rats compared to controls. In human Huh7 liver cells, but not in myotubes, 1-triple-TTA reduced glucose oxidation and induced fatty acid oxidation, in line with previous observations of increased hepatic mitochondrial palmitoyl-CoA oxidation in rats. Importantly, this work recognizes the liver as an important organ in glucose homeostasis. The mitochondrially targeted fatty acid analogue 1-triple TTA seemed to lower hepatic glucose and glycogen levels by inhibition of gluconeogenesis. This was also linked to a reduction in glucose oxidation accompanied by reduced PHD activity and stimulation of ME1 and G6PD, favouring a shift from glucose- to fatty acid oxidation. The reduced plasma insulin/glucose ratio indicate that 1-triple TTA may improve glucose tolerance in rats.	[Lindquist, Carine; Bjorndal, Bodil; Skorve, Jon; Nygard, Ottar K.; Berge, Rolf Kristian] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Lindquist, Carine; Slettom, Grete; Nygard, Ottar K.; Berge, Rolf Kristian] Haukeland Hosp, Dept Heart Dis, Bergen, Norway; [Bakke, Hege G.; Karoliussen, Marie; Rustan, Arild C.; Thoresen, G. Hege] Univ Oslo, Dept Pharm, Sect Pharmacol & Pharmaceut Biosci, Oslo, Norway; [Thoresen, G. Hege] Univ Oslo, Dept Pharmacol, Inst Clin Med, Oslo, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Oslo; University of Oslo	Berge, RK (corresponding author), Univ Bergen, Dept Clin Sci, Bergen, Norway.; Berge, RK (corresponding author), Haukeland Hosp, Dept Heart Dis, Bergen, Norway.	rolf.berge@uib.no	Bjørndal, Bodil/HDN-4287-2022		BB - Bergen Research Foundation; CL - Western Norway Regional Health Authority	BB - Bergen Research Foundation; CL - Western Norway Regional Health Authority	Funded by BB - Bergen Research Foundation; CL - Western Norway Regional Health Authority. The study sponsor was not involved in the design of the study; the collection, analysis, and interpretation of data; writing the report; or the decision to submit the report for publication.	Barcia-Vieitez R, 2014, IUBMB LIFE, V66, P775, DOI 10.1002/iub.1329; Berge RK, 2005, BIOCHIMIE, V87, P15, DOI 10.1016/j.biochi.2004.11.011; BERGE RK, 1984, EUR J BIOCHEM, V141, P637, DOI 10.1111/j.1432-1033.1984.tb08239.x; Bjorndal B, 2013, DIGEST DIS SCI, V58, P97, DOI 10.1007/s10620-012-2321-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buse MG, 2006, AM J PHYSIOL-ENDOC M, V290, pE1, DOI 10.1152/ajpendo.00329.2005; Chakravarty K, 2005, CRIT REV BIOCHEM MOL, V40, P129, DOI 10.1080/10409230590935479; Chavalit T, 2013, BBA-GENE REGUL MECH, V1829, P987, DOI 10.1016/j.bbagrm.2013.05.001; CONSOLI A, 1992, DIABETES CARE, V15, P430, DOI 10.2337/diacare.15.3.430; Gaster M, 2001, APMIS, V109, P735, DOI 10.1034/j.1600-0463.2001.d01-140.x; Gaster M, 2001, APMIS, V109, P726, DOI 10.1034/j.1600-0463.2001.d01-139.x; HARPER P, 1993, CLIN CHEM, V39, P592; HENRY RR, 1995, DIABETES, V44, P936, DOI 10.2337/diabetes.44.8.936; Hessvik NP, 2010, J LIPID RES, V51, P2090, DOI 10.1194/jlr.M003319; Iizuka K, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020181; Jeoung NH, 2006, BIOCHEM J, V397, P417, DOI 10.1042/BJ20060125; Lindquist C, 2017, J LIPID RES, V58, P1362, DOI 10.1194/jlr.M074849; Morral N, 2003, TRENDS ENDOCRIN MET, V14, P169, DOI 10.1016/S1043-2760(03)00031-6; Mosseri R, 2000, METABOLISM, V49, P321, DOI 10.1016/S0026-0495(00)90132-X; Muna ZA, 2002, BIOCHEM PHARMACOL, V63, P1127, DOI 10.1016/S0006-2952(01)00934-0; Muna ZA, 2000, FREE RADICAL BIO MED, V28, P1068, DOI 10.1016/S0891-5849(00)00196-9; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Reuter SE, 2005, ANN CLIN BIOCHEM, V42, P387, DOI 10.1258/0004563054889954; Reuter SE, 2008, ANN CLIN BIOCHEM, V45, P585, DOI 10.1258/acb.2008.008045; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schleicher ED, 2000, KIDNEY INT, V58, pS13, DOI 10.1046/j.1523-1755.2000.07703.x; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; Stark R, 2014, BBA-GEN SUBJECTS, V1840, P1313, DOI 10.1016/j.bbagen.2013.10.033; Stark R, 2014, J BIOL CHEM, V289, P7257, DOI 10.1074/jbc.C113.544759; Tomiyasu M, 2010, EUR J RADIOL, V73, P300, DOI 10.1016/j.ejrad.2008.10.019; Urbaniak G, 2013, RES RANDOMIZER, P644, DOI [10.1111/j.1432-1033.1984.tb08239.x, DOI 10.1111/J.1432-1033.1984.TB08239.X]; Vigerust NF, 2012, J NUTR BIOCHEM, V23, P1384, DOI 10.1016/j.jnutbio.2011.08.006; Wensaas AJ, 2007, J LIPID RES, V48, P961, DOI 10.1194/jlr.D600047-JLR200; WILLUMSEN N, 1993, J LIPID RES, V34, P13; Xu HF, 2016, J DAIRY SCI, V99, P783, DOI 10.3168/jds.2015-9736; Zhang S, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-10	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222558	10.1371/journal.pone.0222558	http://dx.doi.org/10.1371/journal.pone.0222558			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550253	Green Published, gold			2022-12-26	WOS:000532307700017
J	Saunders, B; Saito, T; Klosterhoff, R; de Oliveira, LF; Barreto, G; Perim, P; Pinto, AJ; Lima, F; de Sapinto, AL; Gualano, B				Saunders, Bryan; Saito, Tiemi; Klosterhoff, Rafael; de Oliveira, Luana Farias; Barreto, Gabriel; Perim, Pedro; Pinto, Ana Jessica; Lima, Fernanda; de Sapinto, Ana Lucia; Gualano, Bruno			"I put it in my head that the supplement would help me": Open-placebo improves exercise performance in female cyclists	PLOS ONE			English	Article							TIME; INTENSITY; ENDURANCE; CAFFEINE; HEALTH; PAIN	This study investigated the effect of open-placebo on cycling time-trial (TT) performance. Twenty-eight trained female cyclists completed a 1-km cycling TT following a control session or an open-placebo intervention. The intervention consisted of an individual presentation, provided by a medic, in which the concept of open-placebo was explained to the participant, before she ingested two red and white capsules containing flour; 15 min later, they performed the TT. In the control session, the participant sat quietly for 20 min. Heart rate and ratings of perceived exertion (RPE) were monitored throughout exercise, while blood lactate was determined pre- and post-exercise. Post-exercise questionnaires were employed to gain insight into the perceived influence of the supplement on performance. Open-placebo improved time-to-completion (P = 0.039, 103.6 +/- 5.0 vs. 104.4 +/- 5.1 s, -0.7 +/- 1.8 s, -0.7 +/- 1.7%) and mean power output (P = 0.01, 244.8 +/- 34.7 vs. 239.7 +/- 33.2, +5.1 +/- 9.5 W) during the TT. Individual data analysis showed that 11 individuals improved, 13 remained unchanged and 4 worsened their performance with open-placebo. Heart rate, RPE and blood lactate were not different between sessions (all P>0.05). Positive expectation did not appear necessary to induce performance improvements, suggesting unconscious processes occurred, although a lack of an improvement appeared to be associated with a lack of belief. Open-placebo improved 1-km cycling TT performance in trained female cyclists. Although the intervention was successful for some individuals, individual variation was high, and some athletes did not respond or even performed worse. Thus, open-placebo interventions should be carefully considered by coaches and practitioners, while further studies are warranted.	[Saunders, Bryan; Saito, Tiemi; Klosterhoff, Rafael; de Oliveira, Luana Farias; Barreto, Gabriel; Perim, Pedro; Pinto, Ana Jessica; Lima, Fernanda; de Sapinto, Ana Lucia; Gualano, Bruno] Univ Sao Paulo, Appl Physiol & Nutr Res Grp, Sch Phys Educ & Sport, Rheumatol Div,Fac Med FMUSP, Sao Paulo, Brazil; [Saunders, Bryan] Univ Sao Paulo, Inst Orthopaed & Traumatol, Fac Med FMUSP, Sao Paulo, Brazil; [Klosterhoff, Rafael] Univ Fed Parana, Dept Biochem & Mol Biol, Curitiba, Parana, Brazil; [Lima, Fernanda; de Sapinto, Ana Lucia; Gualano, Bruno] Univ Sao Paulo, Div Rheumatol, Lab Assessment & Conditioning Rheumatol LACRE, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Parana; Universidade de Sao Paulo	Saunders, B (corresponding author), Univ Sao Paulo, Appl Physiol & Nutr Res Grp, Sch Phys Educ & Sport, Rheumatol Div,Fac Med FMUSP, Sao Paulo, Brazil.; Saunders, B (corresponding author), Univ Sao Paulo, Inst Orthopaed & Traumatol, Fac Med FMUSP, Sao Paulo, Brazil.	drbryansaunders@outlook.com	Gualano, Bruno/C-7190-2012; Gualano, Bruno/ABA-9571-2020; Pinto, Ana Jessica/E-9869-2018; Pinto, Ana Jessica/Y-6637-2019; de Oliveira, Luana Farias/O-8142-2016; de Oliveira, Luana Farias/AAS-3124-2021; Saunders, Bryan/AAJ-7734-2020	Gualano, Bruno/0000-0001-7100-8681; Gualano, Bruno/0000-0001-7100-8681; Pinto, Ana Jessica/0000-0002-1363-7233; Pinto, Ana Jessica/0000-0002-1363-7233; de Oliveira, Luana Farias/0000-0001-8225-5784; de Oliveira, Luana Farias/0000-0001-8225-5784; Saunders, Bryan/0000-0003-0995-9077	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2016/50438-0, 2017/04973-4, 2017/15314-1, 2018/01594-5, 2015/26937-4]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Bryan Saunders (2016/50438-0 and 2017/04973-4), Gabriel Barreto (2017/15314-1), Pedro Perim (2018/01594-5) and Ana Jessica Pinto (2015/26937-4) have been financially supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) Finance Code 001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amanzio M, 1999, J NEUROSCI, V19, P484, DOI 10.1523/JNEUROSCI.19-01-00484.1999; Bailey SJ, 2009, J APPL PHYSIOL, V107, P1743, DOI 10.1152/japplphysiol.00810.2009; Bandeira Marina, 2002, Estud. psicol. (Natal), V7, P251, DOI 10.1590/S1413-294X2002000200006; Beedie, 2017, PERMANCE ENHANCEM, V5, P89, DOI [https://doi.org/10.1016/j.peh.2016.10.001, DOI 10.1016/J.PEH.2016.10.001]; Beedie C, 2018, BRIT J SPORT MED, V52, P817, DOI 10.1136/bjsports-2017-097747; Beedie C, 2018, EUR J SPORT SCI, V18, P1383, DOI 10.1080/17461391.2018.1496144; Beedie CJ, 2008, J SPORT SCI MED, V7, P166; Beedie CJ, 2006, MED SCI SPORT EXER, V38, P2159, DOI 10.1249/01.mss.0000233805.56315.a9; Bellinger P.M., 2014, J SCI CYCLING, V3, P23; Bellinger PM, 2016, EUR J SPORT SCI, V16, P829, DOI 10.1080/17461391.2015.1120782; Benedetti F, 2007, J NEUROSCI, V27, P11934, DOI 10.1523/JNEUROSCI.3330-07.2007; Benedetti F, 2013, PHYSIOL REV, V93, P1207, DOI 10.1152/physrev.00043.2012; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Broelz EK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198388; Clark VR, 2000, MED SCI SPORT EXER, V32, P1642; Colloca L, 2009, PAIN, V144, P28, DOI 10.1016/j.pain.2009.01.033; Decroix L, 2016, INT J SPORT PHYSIOL, V11, P204, DOI 10.1123/ijspp.2015-0153; Drust B, 2005, CHRONOBIOL INT, V22, P21, DOI 10.1081/CBI-200041039; Grotle M, 2017, J PHYSIOTHER, V63, P183, DOI 10.1016/j.jphys.2017.05.002; Hoenemeyer TW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20993-y; Hurst P, 2017, MED SCI SPORT EXER, V49, P1877, DOI [10.1249/MSS.0000000000001297, 10.1249/mss.0000000000001297]; Kaptchuk TJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015591; Kelley JM, 2012, PSYCHOTHER PSYCHOSOM, V81, P312, DOI 10.1159/000337053; Klitzman R, 2007, BMJ-BRIT MED J, V335, P514, DOI 10.1136/bmj.39325.646887.94; Landry M, 2013, OCHSNER J, V13, P334; LUNDH LG, 1987, SCAND J PSYCHOL, V28, P128, DOI 10.1111/j.1467-9450.1987.tb00747.x; Maughan RJ, 2018, BRIT J SPORT MED, V52, P439, DOI 10.1136/bjsports-2018-099027; McQuillan JA, 2017, INT J SPORT NUTR EXE, V27, P255, DOI 10.1123/ijsnem.2016-0212; Paton CD, 2006, EUR J SPORT SCI, V6, P25, DOI 10.1080/17461390500422796; Price DD, 2008, ANNU REV PSYCHOL, V59, P565, DOI 10.1146/annurev.psych.59.113006.095941; Ross R, 2015, MED SCI SPORT EXER, V47, P1672, DOI 10.1249/MSS.0000000000000584; Saunders B, 2017, SCAND J MED SCI SPOR, V27, P1240, DOI 10.1111/sms.12793; Saunders B, 2014, INT J SPORT PHYSIOL, V9, P627, DOI [10.1123/IJSPP.2013-0295, 10.1123/ijspp.2013-0295]; Schaefer M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192758; Schaefer M, 2016, PSYCHOTHER PSYCHOSOM, V85, P373, DOI 10.1159/000447242; SCHEIER MF, 1985, HEALTH PSYCHOL, V4, P219, DOI 10.1037/0278-6133.4.3.219; Swinton PA, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00041; Wiles JD, 2006, J SPORT SCI, V24, P1165, DOI 10.1080/02640410500457687	38	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222982	10.1371/journal.pone.0222982	http://dx.doi.org/10.1371/journal.pone.0222982			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5RZ	31550286	Green Published, gold			2022-12-26	WOS:000532307700038
J	Girma, G; Natsume, S; Carluccio, AV; Takagi, H; Matsumura, H; Uemura, A; Muranaka, S; Takagi, H; Stavolone, L; Gedil, M; Spillane, C; Terauchi, R; Tamiru, M				Girma, Gezahegn; Natsume, Satoshi; Carluccio, Anna Vittoria; Takagi, Hiroki; Matsumura, Hideo; Uemura, Aiko; Muranaka, Satoru; Takagi, Hiroko; Stavolone, Livia; Gedil, Melaku; Spillane, Charles; Terauchi, Ryohei; Tamiru, Muluneh			Identification of candidate flowering and sex genes in white Guinea yam (D. rotundata Poir.) by SuperSAGE transcriptome profiling	PLOS ONE			English	Article							EXPRESSION ANALYSIS; TIME; INTENSITY; DIVERSITY; PACKAGE; COMPLEX; PROTEIN; SAGE	Dioecy (distinct male and female individuals) and scarce to non-flowering are common features of cultivated yam (Dioscorea spp.). However, the molecular mechanisms underlying flowering and sex determination in Dioscorea are largely unknown. We conducted Super-SAGE transcriptome profiling of male, female and monoecious individuals to identify flowering and sex-related genes in white Guinea yam (D. rotundata), generating 20,236 unique tags. Of these, 13,901 were represented by a minimum of 10 tags. A total 88 tags were significantly differentially expressed in male, female and monoecious plants, of which 18 corresponded to genes previously implicated in flower development and sex determination in multiple plant species. We validated the SuperSAGE data with quantitative real-time PCR (qRT-PCR)-based analysis of the expression of three candidate genes. We further investigated the flowering patterns of 1938 D. rotundata accessions representing diverse geographical origins over two consecutive years. Over 85% of accessions were either male or non-flowering, less than 15% were female, while monoecious plants were rare. Intensity of flowering varied between male and female plants, with the former flowering more abundantly than the latter. Candidate genes identified in this study can be targeted for further validation and to induce regular flowering in poor to non-flowering cultivars. Findings of the study provide important inputs for further studies aiming to overcome the challenge of flowering in yams and to improve efficiency of yam breeding.	[Girma, Gezahegn; Carluccio, Anna Vittoria; Stavolone, Livia; Gedil, Melaku] Int Inst Trop Agr IITA, Biosci Ctr, Ibadan, Oyo State, Nigeria; [Girma, Gezahegn; Spillane, Charles] Natl Univ Ireland Galway, Plant & AgriBiosci Res Ctr PABC, Ryan Inst, Galway, Ireland; [Natsume, Satoshi; Takagi, Hiroki; Matsumura, Hideo; Uemura, Aiko; Terauchi, Ryohei; Tamiru, Muluneh] Iwate Biotechnol Res Ctr IBRC, Dept Genom & Breeding, Kitakami, Iwate, Japan; [Muranaka, Satoru; Takagi, Hiroko] Japan Int Res Ctr Agr Sci JIRCAS, Tsukuba, Ibaraki, Japan; [Girma, Gezahegn] Purdue Univ, Dept Bot & Plant Pathol, W Lafayette, IN 47907 USA; [Matsumura, Hideo] Shinshu Univ, Gene Res Ctr, Ueda, Nagano, Japan; [Stavolone, Livia] CNR, Inst Sustainable Plant Protect, Bari, Italy; [Tamiru, Muluneh] La Trobe Univ, Dept Anim Plant & Soil Sci, AgriBioBldg, Melbourne, Vic, Australia	CGIAR; International Institute of Tropical Agriculture (IITA); Ollscoil na Gaillimhe-University of Galway; Japan International Research Center for Agricultural Sciences; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Shinshu University; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Protezione Sostenibile delle Piante (IPSP-CNR); La Trobe University	Muranaka, S (corresponding author), Japan Int Res Ctr Agr Sci JIRCAS, Tsukuba, Ibaraki, Japan.	s.muranaka@cgiar.org	Stavolone, Livia/AAY-2967-2020; Carluccio, Anna Vittoria/AAI-3463-2021; Terauchi, Ryohei/Y-2992-2019; Girma, Gezahegn/ABB-5812-2020; Gedil, Melaku/H-9445-2019	Stavolone, Livia/0000-0002-0691-1302; Terauchi, Ryohei/0000-0002-0095-4651; Gedil, Melaku/0000-0002-6258-6014; Girma, Gezahegn/0000-0001-9702-3521	Japan International Research Center for Agricultural Sciences (JIRCAS); Netherlands Ministry of Foreign Affairs; National University of Ireland Galway	Japan International Research Center for Agricultural Sciences (JIRCAS)(Japan International Research Center for Agricultural Sciences); Netherlands Ministry of Foreign Affairs; National University of Ireland Galway	The project was funded by the Japan International Research Center for Agricultural Sciences (JIRCAS). The work was conducted as part of the international collaborative research project "Use of genomic information and molecular tools for yam germplasm utilization and improvement for West Africa (EDITS-Yam)".; This work was conducted as part of the international collaborative research project "Use of genomic information and molecular tools for yam germplasm utilization and improvement for West Africa (EDITS-Yam)" funded by the Japan International Research Center for Agricultural Sciences (JIRCAS). GG acknowledges support from the Netherlands Ministry of Foreign Affairs, and a PhD International Merit Scholarship fee waiver from the National University of Ireland Galway.	Acosta IF, 2009, SCIENCE, V323, P262, DOI 10.1126/science.1164645; Alexandersson E, 2005, PLANT MOL BIOL, V59, P469, DOI 10.1007/s11103-005-0352-1; ALONSO JM, 1995, PLANT PHYSIOL, V109, P541, DOI 10.1104/pp.109.2.541; [Anonymous], 2009, TROPICAL ROOT TUBER; Aryal R, 2014, PLANT SCI, V217, P56, DOI 10.1016/j.plantsci.2013.10.018; Bi HG, 2013, PLANT PHYSIOL BIOCH, V70, P512, DOI 10.1016/j.plaphy.2013.06.017; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Cormier F, 2019, THEOR APPL GENET, V132, P1733, DOI 10.1007/s00122-019-03311-6; Dansi A, 1999, GENET RESOUR CROP EV, V46, P371, DOI 10.1023/A:1008698123887; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Fukuchi-Mizutani M, 2000, PLANT SCI, V160, P129, DOI 10.1016/S0168-9452(00)00373-3; Futamura N, 1999, PLANT CELL PHYSIOL, V40, P524, DOI 10.1093/oxfordjournals.pcp.a029573; Girma G, 2014, THEOR APPL GENET, V127, P1783, DOI 10.1007/s00122-014-2339-2; Gowda M, 2004, PLANT PHYSIOL, V134, P890, DOI 10.1104/pp.103.034496; Hamadina EI, 2009, J AGR SCI-CAMBRIDGE, V147, P469, DOI 10.1017/S0021859609008697; HAMON P, 1990, EUPHYTICA, V46, P101, DOI 10.1007/BF00022303; Heijmans K, 2012, J EXP BOT, V63, P5397, DOI 10.1093/jxb/ers233; IPGRI/ IITA, 1997, DESCR YAM DIOSC SPP; Jaligot E, 2011, ANN BOT-LONDON, V108, P1453, DOI 10.1093/aob/mcq266; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Ling Hua, 2008, Pak J Biol Sci, V11, P763, DOI 10.3923/pjbs.2008.763.767; Liu SA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-228; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LIVAK KJ, 1997, USER B, V2; Ma H, 2000, CELL, V101, P5, DOI 10.1016/S0092-8674(00)80618-2; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; MARTIN FW, 1966, J HERED, V57, P95, DOI 10.1093/oxfordjournals.jhered.a107485; Matsumura H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012010; Micheli F, 1998, GENE, V220, P13, DOI 10.1016/S0378-1119(98)00431-4; Mignouna HD, 2007, GENOME MAPPING MOL B, P271; Ming R, 2011, ANNU REV PLANT BIOL, V62, P485, DOI 10.1146/annurev-arplant-042110-103914; Momose M, 2013, BREEDING SCI, V63, P435, DOI 10.1270/jsbbs.63.435; Murase K, 2017, GENES CELLS, V22, P115, DOI 10.1111/gtc.12453; Nielsen KL, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl714; Nyaboga E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00463; Oda A, 2004, FEBS LETT, V557, P259, DOI 10.1016/S0014-5793(03)01470-4; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Scarcelli N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019954; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Sha AH, 2014, J GENET, V93, P43, DOI 10.1007/s12041-014-0331-x; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Smirnova A, 2013, PLANT PHYSIOL, V161, P196, DOI 10.1104/pp.112.206656; Spigler RB, 2008, HEREDITY, V101, P507, DOI 10.1038/hdy.2008.100; Su CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080462; Suzuki H, 2004, PLANT J, V38, P994, DOI 10.1111/j.1365-313X.2004.02101.x; Tamiru M, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0419-x; Terauchi R KG, 1999, SEX DETERMINATION PL; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Wang M, 2012, PLANT SCI, V196, P125, DOI 10.1016/j.plantsci.2012.08.004; Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375; Yang YJ, 2014, PLANT CELL, V26, P2038, DOI 10.1105/tpc.114.124867; Yoo SY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000642; Zhao XT, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3089584	55	12	12	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0216912	10.1371/journal.pone.0216912	http://dx.doi.org/10.1371/journal.pone.0216912			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545796	Green Submitted, Green Published, gold			2022-12-26	WOS:000532303200005
J	Guirro, M; Costa, A; Gual-Grau, A; Herrero, P; Torrell, H; Canela, N; Arola, L				Guirro, Maria; Costa, Andrea; Gual-Grau, Andreu; Herrero, Pol; Torrell, Helena; Canela, Nuria; Arola, Lluis			Effects from diet-induced gut microbiota dysbiosis and obesity can be ameliorated by fecal microbiota transplantation: A multiomics approach	PLOS ONE			English	Article							HIGH-FAT; MODULATION; COMMUNITY	Obesity and its comorbidities are currently considered an epidemic, and the involved pathophysiology is well studied. Hypercaloric diets are tightly related to the obesity etiology and also cause alterations in gut microbiota functionality. Diet and antibiotics are known to play crucial roles in changes in the microbiota ecosystem and the disruption of its balance; therefore, the manipulation of gut microbiota may represent an accurate strategy to understand its relationship with obesity caused by diet. Fecal microbiota transplantation, during which fecal microbiota from a healthy donor is transplanted to an obese subject, has aroused interest as an effective approach for the treatment of obesity. To determine its success, a multiomics approach was used that combined metagenomics and metaproteomics to study microbiota composition and function. To do this, a study was performed in rats that evaluated the effect of a hypercaloric diet on the gut microbiota, and this was combined with antibiotic treatment to deplete the microbiota before fecal microbiota transplantation to verify its effects on gut microbiota-host homeostasis. Our results showed that a high-fat diet induces changes in microbiota biodiversity and alters its function in the host. Moreover, we found that antibiotics depleted the microbiota enough to reduce its bacterial content. Finally, we assessed the use of fecal microbiota transplantation as a complementary obesity therapy, and we found that it reversed the effects of antibiotics and reestablished the microbiota balance, which restored normal functioning and alleviated microbiota disruption. This new approach could be implemented to support the dietary and healthy habits recommended as a first option to maintain the homeostasis of the microbiota.	[Guirro, Maria; Gual-Grau, Andreu; Arola, Lluis] Univ Rovira & Virgili, Biochem & Biotechnol Dept, Nutrigen Res Grp, Tarragona, Spain; [Guirro, Maria; Costa, Andrea; Herrero, Pol; Torrell, Helena; Canela, Nuria] Univ Rovira & Virgili, Unique Sci & Tech Infrastruct ICTS, EURECAT, Ctr Tecnol Catalunya,Ctr Omic Sci COS,Joint Unit, Reus, Spain; [Arola, Lluis] Ctr Tecnol Catalunya, Biotechnol Area, Eurecat, Reus, Spain	Universitat Rovira i Virgili; Universitat Rovira i Virgili	Canela, N (corresponding author), Univ Rovira & Virgili, Unique Sci & Tech Infrastruct ICTS, EURECAT, Ctr Tecnol Catalunya,Ctr Omic Sci COS,Joint Unit, Reus, Spain.	nuria.canela@eurecat.org	Arola, Lluís/C-6074-2011; Herrero, Pol/I-1912-2015; Canela, Nuria/I-5401-2015; Torrell Galceran, Helena/R-7895-2017	Arola, Lluís/0000-0003-2767-1974; Herrero, Pol/0000-0002-8746-7214; Canela, Nuria/0000-0003-0261-2396; Costa Lopez, Andrea/0000-0002-8393-4639; Gual-Grau, Andreu/0000-0002-8901-3582; Torrell Galceran, Helena/0000-0001-5487-4289; Guirro, Maria/0000-0002-3330-0312				Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Behr C, 2017, ARCH TOXICOL, V91, P3439, DOI 10.1007/s00204-017-1949-2; Boi SK, 2016, OBESITY, V24, P2140, DOI 10.1002/oby.21620; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Cani PD, 2011, PHARMACOL THERAPEUT, V130, P202, DOI 10.1016/j.pharmthera.2011.01.012; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Daniel H, 2014, ISME J, V8, P295, DOI 10.1038/ismej.2013.155; del Bas JM, 2018, INT J OBESITY, V42, P746, DOI 10.1038/ijo.2017.284; Frohlich EE, 2016, BRAIN BEHAV IMMUN, V56, P140, DOI 10.1016/j.bbi.2016.02.020; Grasa L, 2015, MICROB ECOL, V70, P835, DOI 10.1007/s00248-015-0613-8; Guirro M, 2019, J PROTEOME RES; Guirro M, 2018, ELECTROPHORESIS, V39, P1692, DOI 10.1002/elps.201700476; Ha M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139774; Heinritz SN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154329; Hernandez-Jarguin A, 2018, TICKS TICK-BORNE DIS, V9, P1241, DOI 10.1016/j.ttbdis.2018.04.020; Heymsfield SB, 2017, NEW ENGL J MED, V376, P254, DOI 10.1056/NEJMra1514009; Hoban AE, 2016, NEUROSCIENCE, V339, P463, DOI 10.1016/j.neuroscience.2016.10.003; Janssen AWF, 2015, FASEB J, V29, P3111, DOI 10.1096/fj.14-269514; Lai ZL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33893-y; Lamendella R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-103; Le Bastard Q, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24342-x; Lee P, 2019, DIABETES OBES METAB, V21, P479, DOI 10.1111/dom.13561; Lee S, 2018, J NUTR, V148, P209, DOI 10.1093/jn/nxx027; Matsunaga N, 2018, ANAEROBE, V51, P124, DOI 10.1016/j.anaerobe.2018.05.001; Nilsson C, 2012, ACTA PHARMACOL SIN, V33, P173, DOI 10.1038/aps.2011.203; Oberbach A, 2017, J PROTEOME RES, V16, P1593, DOI 10.1021/acs.jproteome.6b00973; Ottman N, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00104; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Schreiber W, 1999, MICROBIOL-SGM, V145, P1839, DOI 10.1099/13500872-145-8-1839; Schuijt TJ, 2016, GUT, V65, P575, DOI 10.1136/gutjnl-2015-309728; Shen J, 2013, MOL ASPECTS MED, V34, P39, DOI 10.1016/j.mam.2012.11.001; Sun WJ, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8308671; Tanca A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00391; Tulstrup MVL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144854; Verdu EF, 2006, GUT, V55, P182, DOI 10.1136/gut.2005.066100; Villamil SI, 2018, NUTR RES, V50, P25, DOI 10.1016/j.nutres.2017.11.008; Wang S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31353-1; Wei FW, 2019, SCI CHINA LIFE SCI, V62, P168, DOI 10.1007/s11427-018-9423-3; Xiao MM, 2017, APPL MICROBIOL BIOT, V101, P3077, DOI 10.1007/s00253-017-8215-7; Zhang YC, 2014, TOXICOL APPL PHARM, V277, P138, DOI 10.1016/j.taap.2014.03.009; Zhao L, 2017, FOOD FUNCT, V8, P4644, DOI [10.1039/c7fo01383c, 10.1039/C7FO01383C]; ZHOU D, 2017, SCI REP, V7, DOI DOI 10.1038/S41598-016-0028-X	42	35	37	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0218143	10.1371/journal.pone.0218143	http://dx.doi.org/10.1371/journal.pone.0218143			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545802	Green Published, gold			2022-12-26	WOS:000532303200007
J	de Araujo, NNF; Lin-Wang, HT; Germano, JD; Farsky, PS; Feldman, A; Rossi, FH; Izukawa, NM; Higuchi, MD; Neto, FS; Hirata, MH; Bertolami, MC				Ferreira de Araujo, Neire Niara; Lin-Wang, Hui Tzu; Germano, Juliana de Freitas; Farsky, Pedro Silvio; Feldman, Andre; Rossi, Fabio Henrique; Izukawa, Nilo Mitsuru; Higuchi, Maria de Lourdes; Savioli Neto, Felicio; Hirata, Mario Hiroyuki; Bertolami, Marcelo Chiara			Dysregulation of microRNAs and target genes networks in human abdominal aortic aneurysm tissues	PLOS ONE			English	Article							5-LIPOXYGENASE PATHWAY; SMOOTH-MUSCLE; LET-7; PATHOGENESIS; ASSOCIATION; EXPRESSION; BIOMARKERS; CHEMOKINE; MODELS	Background Abdominal aortic aneurysm (AAA) is a pathological enlargement of infrarenal aorta close to the aortic bifurcation, and it is an important cause of mortality in the elderly. Therefore, the biomarker identification for early diagnosis is of great interest for clinical benefit. It is known that microRNAs (miRNAs) have important roles via target genes regulation in many diseases. This study aimed to identify miRNAs and their target genes involved in the pathogenesis of AAA. Methods Tissue samples were obtained from patients who underwent AAA surgery and from organ donors (control group). Quantitative PCR Array was applied to assess 84 genes and 384 miRNAs aiming to identify differentially expressed targets (AAA n = 6, control n = 6), followed by validation in a new cohort (AAA n = 18, control n = 6) by regular qPCR. The functional interaction between validated miRNAs and target genes was performed by the Ingenuity Pathway Analysis (IPA) software. Results The screening cohort assessed by PCR array identified 10 genes and 59 miRNAs differentially expressed (>= 2-fold change, p< 0.05). Among these, IPA identified 5 genes and 9 miRNAs with paired interaction. ALOX5, PTGIS, CX3CL1 genes, and miR-193a-3p, 125b-5p, 150-5p maintained a statistical significance in the validation cohort. IPA analysis based on the validated genes and miRNAs revealed that eicosanoid and metalloproteinase/TIMP synthesis are potentially involved in AAA. Conclusion Paired interactions of differentially expressed ALOX5, PTGIS, CX3CL1 genes, and miR193b-3p, 125b-5p, 150-5p revealed a potentially significant role of the eicosanoid synthesis and metalloproteinase/TIMP pathways in the AAA pathogenesis.	[Ferreira de Araujo, Neire Niara; Farsky, Pedro Silvio; Feldman, Andre; Savioli Neto, Felicio; Bertolami, Marcelo Chiara] Dante Pazzanese Inst Cardiol, Dept Clin Cardiol, Sao Paulo, Brazil; [Lin-Wang, Hui Tzu; Hirata, Mario Hiroyuki] Dante Pazzanese Inst Cardiol, Lab Mol Invest Cardiol, Sao Paulo, Brazil; [Germano, Juliana de Freitas; Hirata, Mario Hiroyuki] Univ Sao Paulo, Sch Pharmaceut Sci, Sao Paulo, Brazil; [Rossi, Fabio Henrique; Izukawa, Nilo Mitsuru] Dante Pazzanese Inst Cardiol, Dept Vasc Surg, Sao Paulo, Brazil; [Higuchi, Maria de Lourdes] Univ Sao Paulo, Sch Med, Heart Inst, Lab Cardiac Pathol, Sao Paulo, Brazil	Instituto Dante Pazzanese de Cardiologia; Instituto Dante Pazzanese de Cardiologia; Universidade de Sao Paulo; Instituto Dante Pazzanese de Cardiologia; Universidade de Sao Paulo	de Araujo, NNF (corresponding author), Dante Pazzanese Inst Cardiol, Dept Clin Cardiol, Sao Paulo, Brazil.	neireniara@hotmail.com	Hirata, Mario Hiroyuki/C-9718-2013; de Lourdes Higuchi, Maria/K-3886-2017	Hirata, Mario Hiroyuki/0000-0002-9521-7979; de Lourdes Higuchi, Maria/0000-0002-1673-6456; Lin-Wang, Hui Tzu/0000-0002-7027-7748; ROSSI, FABIO/0000-0001-9423-3638				Abdul-Hussien H, 2007, AM J PATHOL, V170, P809, DOI 10.2353/ajpath.2007.060522; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bhamidipati CM, 2014, ARTERIOSCL THROM VAS, V34, P2669, DOI 10.1161/ATVBAHA.114.304016; Biros E, 2014, CLIN SCI, V126, P795, DOI 10.1042/CS20130599; Busch S, 2015, J IMMUNOL, V194, P1646, DOI 10.4049/jimmunol.1402163; Defawe OD, 2003, CARDIOVASC RES, V60, P205, DOI 10.1016/S0008-6363(03)00513-3; DEWITT DL, 1983, J CLIN INVEST, V72, P1882, DOI 10.1172/JCI111151; Elmore JR, 1998, ANN VASC SURG, V12, P221, DOI 10.1007/s100169900144; Esquela-Kerscher A, 2008, CELL CYCLE, V7, P759, DOI 10.4161/cc.7.6.5834; Folkesson M, 2007, THROMB HAEMOSTASIS, V98, P427, DOI 10.1160/TH06-11-0638; Gerstmeier J, 2016, FASEB J, V30, P1892, DOI 10.1096/fj.201500210R; Golledge J, 2006, ARTERIOSCL THROM VAS, V26, P2605, DOI 10.1161/01.ATV.0000245819.32762.cb; Golledge J, 2010, AM J PATHOL, V176, P2098, DOI 10.2353/ajpath.2010.090416; Iaconetti C, 2015, CARDIOVASC RES, V107, P522, DOI 10.1093/cvr/cvv141; Iyer V, 2017, ATHEROSCLEROSIS, V261, P78, DOI 10.1016/j.atherosclerosis.2017.03.010; Kin K, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.000745; Koh W., 2010, BMC GENOMICS S1, V11, P1; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Lederle FA, 2001, J VASC SURG, V34, P122, DOI 10.1067/mva.2001.115275; LEDERLE FA, 1988, ARCH INTERN MED, V148, P1753, DOI 10.1001/archinte.148.8.1753; Lee H, 2016, PROTEIN CELL, V7, P100, DOI 10.1007/s13238-015-0212-y; Lee JM, 2012, J IMMUNOL, V189, P5284, DOI 10.4049/jimmunol.1003738; Lindholt JS, 1999, EUR J VASC ENDOVASC, V17, P472, DOI 10.1053/ejvs.1999.0835; Lindholt JS, 2001, EUR J VASC ENDOVASC, V21, P51, DOI 10.1053/ejvs.2000.1262; Ma XH, 2018, INT J MOL MED, V41, P2350, DOI 10.3892/ijmm.2018.3426; Maegdefessel L, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003441; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mima K, 2016, CLIN CANCER RES, V22, P3841, DOI 10.1158/1078-0432.CCR-15-2173; Moll FL, 2011, EUR J VASC ENDOVASC, V41, pS1, DOI 10.1016/j.ejvs.2010.09.011; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Olena AF, 2014, JCELL PHYSL, V222, P540; Pahl MC, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-25; Pande RL, 2008, J VASC INTERV RADIOL, V19, pS2, DOI 10.1016/j.jvir.2008.03.010; Raffort J, 2016, CARDIOVASC RES, V110, P165, DOI 10.1093/cvr/cvw046; Reed WW, 1997, ARCH INTERN MED, V157, P2064, DOI 10.1001/archinte.157.18.2064; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; Rothman A, 2017, PULM CIRC, V7, P455, DOI 10.1177/2045893217704206; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scholer N, 2010, EXP HEMATOL, V38, P1126, DOI 10.1016/j.exphem.2010.10.004; Siedlinski M, 2017, SCI REP, V7, P1; Sun JS, 2012, ARTERIOSCL THROM VAS, V32, P15, DOI 10.1161/ATVBAHA.111.235002; Monteiro JAT, 2014, J VASC SURG, V59, P1393, DOI 10.1016/j.jvs.2013.04.064; Wang K, 2012, J BIOL CHEM, V287, P589, DOI 10.1074/jbc.M111.266940; Wang XR, 2012, ONCOL LETT, V3, P955, DOI 10.3892/ol.2012.609; Wanhainen A, 2017, ATHEROSCLEROSIS, V256, P82, DOI 10.1016/j.atherosclerosis.2016.11.007; WEISS HJ, 1979, BLOOD, V53, P244; Yi XY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180704; Zhang WW, 2015, CLIN BIOCHEM, V48, P988, DOI 10.1016/j.clinbiochem.2015.04.016; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108	51	8	8	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222782	10.1371/journal.pone.0222782	http://dx.doi.org/10.1371/journal.pone.0222782			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539405	gold, Green Published			2022-12-26	WOS:000532297900028
J	Hsiao, PL; Hsu, SF; Chen, PH; Tsai, HW; Lu, HY; Wang, YS; Lee, LW				Hsiao, Pei-Lin; Hsu, Shu-Feng; Chen, Po-Han; Tsai, Hsiao-Wei; Lu, Hsin-Ying; Wang, Yue-Sheng; Lee, Li-Wen			Does a spinal implant alter dual energy X-ray absorptiometry body composition measurements?	PLOS ONE			English	Article							LEAST-SIGNIFICANT-CHANGE; CROSS-CALIBRATION; DENSITOMETRY; PREVALENCE; PRECISION; METAL	Background Most manufacturer manuals do not verify the use of dual energy X-ray absorptiometry for body composition analysis in subjects with a metal implant. This study aimed to quantify the effects of a spinal implant on body composition, and to determine whether unadjusted lean mass estimates are valid for patients with a spinal implant. Methods A total of 30 healthy subjects were recruited. Three consecutive scans were performed for each participant, one with and two without extraneous spinal implant, without repositioning between scans. Lean, fat and bone estimates in the total body, trunk and limb were measured. Results Precision errors for all total and regional body compositions were within the recommended ranges. Bone masses in the trunk and total body were significantly increased with spinal implant, and the increases exceeded the least significant change. For total and regional lean and fat estimates, the measurements between subjects with and without metal implants were in substantial to almost perfect agreement and the differences were not significant and did not exceed the least significant change. Conclusions Spinal metal artifacts significantly increased the total body and trunk bone mass but the differences in lean- and fat-related estimates at total and regional body levels and all estimates in the extremity remained within the clinical acceptable range. Thus, a spinal implant may not compromise screening of patients for fat and lean masses using dual energy X-ray absorptiometry. Application of image reconstruction or a filtering algorithm may help reduce the effect of metallic artifacts and further study is needed.	[Hsiao, Pei-Lin; Tsai, Hsiao-Wei; Lu, Hsin-Ying; Wang, Yue-Sheng; Lee, Li-Wen] Chang Gung Mem Hosp, Dept Diagnost Radiol, Chiayi, Taiwan; [Hsu, Shu-Feng] Chang Gung Mem Hosp, Dept Nursing, Chiayi, Taiwan; [Chen, Po-Han] Chang Gung Mem Hosp, Dept Orthoped Surg, Yunlin, Taiwan; [Lee, Li-Wen] Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi Campus, Chiayi, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University of Science & Technology	Lee, LW (corresponding author), Chang Gung Mem Hosp, Dept Diagnost Radiol, Chiayi, Taiwan.; Lee, LW (corresponding author), Chang Gung Univ Sci & Technol, Dept Nursing, Chiayi Campus, Chiayi, Taiwan.	m4572@cgmh.org.tw	Lee, Li-Wen/AAY-3542-2021	Lee, Li-Wen/0000-0001-8019-1772	Chang Gung Medical Foundation [CMRPG6H0201]	Chang Gung Medical Foundation	The first author (PLH) received funding from the Chang Gung Medical Foundation (grant no. CMRPG6H0201). UPL of the funder website: https://www.cgmh.org.tw/.The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cawkwell GD, 1998, J CLIN DENSITOM, V1, P141, DOI 10.1385/JCD:1:2:141; Cole JH, 2005, J CLIN DENSITOM, V8, P57, DOI 10.1385/JCD:8:1:057; Di Monaco M, 2011, ARCH GERONTOL GERIAT, V52, P71, DOI 10.1016/j.archger.2010.02.002; Diessel E, 2000, J APPL PHYSIOL, V89, P599, DOI 10.1152/jappl.2000.89.2.599; Giangregorio LM, 2003, CAN ASSOC RADIOL J, V54, P305; Giangregorio LM, 2003, CAN ASSOC RADIOL J, V54, P270; Griffiths MR, 1997, J BONE MINER RES, V12, P119, DOI 10.1359/jbmr.1997.12.1.119; Hangartner TN, 2007, OSTEOPOROSIS INT, V18, P513, DOI 10.1007/s00198-006-0280-1; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Laskey MA, 1996, NUTRITION, V12, P45, DOI 10.1016/0899-9007(95)00017-8; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; LUKASKI HC, 1993, J NUTR, V123, P438, DOI 10.1093/jn/123.suppl_2.438; Madsen OR, 1999, CLIN PHYSIOL, V19, P238; Messina C, 2015, EUR RADIOL, V25, P1504, DOI 10.1007/s00330-014-3509-y; Ng BK, 2018, AM J CLIN NUTR, V108, P708, DOI 10.1093/ajcn/nqy158; Pietrobelli A, 1996, AM J PHYSIOL-ENDOC M, V271, pE941, DOI 10.1152/ajpendo.1996.271.6.E941; Rothney MP, 2009, OBESITY, V17, P1281, DOI 10.1038/oby.2009.14; Shepherd JA, 2006, J CLIN DENSITOM, V9, P31, DOI 10.1016/j.jocd.2006.05.005; Shepherd JA, 2007, J CLIN DENSITOM, V10, P249, DOI 10.1016/j.jocd.2007.05.002; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Watts NB, 2004, OSTEOPOROSIS INT, V15, P847, DOI 10.1007/s00198-004-1681-7	22	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222758	10.1371/journal.pone.0222758	http://dx.doi.org/10.1371/journal.pone.0222758			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536597	Green Published, Green Submitted, gold			2022-12-26	WOS:000532262800082
J	Masterson, TD; Bobak, C; Rapuano, KM; Shearrer, GE; Gilbert-Diamond, D				Masterson, Travis D.; Bobak, Carly; Rapuano, Kristina M.; Shearrer, Grace E.; Gilbert-Diamond, Diane			Association between regional brain volumes and BMI z-score change over one year in children	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS; HIPPOCAMPAL VOLUMES; WEIGHT; ADOLESCENTS; FOOD; OVERWEIGHT; OBESITY; IMAGES; RISK	Purpose Associations between brain region volume and weight status have been observed in children cross-sectionally. However, it is unclear if differences in brain region volume precede weight gain. Methods Two high-quality structural brain images were obtained approximately one year apart in 53 children aged 9-12 years old. Children's height and weight were also measured at each scan. Structural images were processed using the FreeSurfer software-package providing volume measures for regions of interest including the entorhinal cortex, nucleus accumbens, and hippocampus. Age- and sex-adjusted BMI z-scores (BMIz) were calculated at both timepoints. The association between brain region volume and BMIz was examined cross-sectionally using linear regression and longitudinally using structural equation modeling. All models were adjusted by estimated cranial volume to account for individual variation in head size and were corrected for multiple comparisons (pFDR<0.05). Results The sample of children was primarily healthy weight at baseline (79.78%). Cross-sectionally at the one-year follow-up, a positive relationship was observed between right hippocampal volume and BMIz (beta = 0.43, 95% CI = (0.10, 0.77)). Longitudinally a negative relationship was observed between right entorhinal volume at baseline and BMIz at the one-year followup (beta = -0.25, 95% CI = (-0.44, -0.07)). Conclusion These results suggest that measured volumes from certain regions of the brain that have been associated with BMI in adults are associated with both concurrent BMIz and BMIz change over one-year in a primarily healthy weight sample of children. As the entorhinal cortex integrates signals from both reward and control regions, this region may be particularly important to weight management during child development.	[Masterson, Travis D.; Gilbert-Diamond, Diane] Geisel Sch Med Dartmouth Coll, Norris Cotton Canc Ctr, Dept Epidemiol, Hanover, NH 03755 USA; [Bobak, Carly] Dartmouth Coll, Geisel Sch Med, Dept Biomed Data Sci, Hanover, NH 03755 USA; [Rapuano, Kristina M.] Yale Univ, Dept Psychol, New Haven, CT USA; [Shearrer, Grace E.] Univ N Carolina, Dept Nutr, Chapel Hill, NC 27515 USA	Norris Cotton Cancer Center; Dartmouth College; Yale University; University of North Carolina; University of North Carolina Chapel Hill	Masterson, TD (corresponding author), Geisel Sch Med Dartmouth Coll, Norris Cotton Canc Ctr, Dept Epidemiol, Hanover, NH 03755 USA.	travis.d.masterson@dartmouth.edu	Rapuano, Kristina/J-6489-2019	Bobak, Carly/0000-0001-8631-4753	National Institute of Child Health and Human Development [NICHD076097, R01HD092604]; Nation Institute of Drug Abuse [NIDAT32DA037202]; National Institute of Child Health and Human Development Grants [NICHD076097, R01HD092604]; National Institute of Drug Abuse [T32DA037202]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD092604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA037202] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Nation Institute of Drug Abuse; National Institute of Child Health and Human Development Grants; National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work is supported by: D.G.-D., Grant Numbers: NICHD076097 and R01HD092604, National Institute of Child Health and Human Development, https://www.nichd.nih.gov; T.D.M., Grant Numbers: NIDAT32DA037202, the Nation Institute of Drug Abuse, https://www.nida.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Uku Vainik for discussions on his paper as well as suggestions related to the statistical analysis and Reina Kato Lansigan for help with recruitment and project management. This work was supported by National Institute of Child Health and Human Development Grants NICHD076097 (to D. G.-D.), R01HD092604 (to D. G.-D.), and the National Institute of Drug Abuse T32DA037202 (to T.D.M).; We would like to thank Uku Vainik for discussions on his paper as well as suggestions related to the statistical analysis and Reina Kato Lansigan for help with recruitment and project management. This work was supported by National Institute of Child Health and Human Development Grants NICHD076097 (to D. G.-D.), R01HD092604 (to D. G.-D.), and the National Institute of Drug Abuse T32DA037202 (to T.D.M).	Aanes S, 2015, NEUROIMAGE, V105, P76, DOI 10.1016/j.neuroimage.2014.10.023; Bauer CCC, 2015, PEDIATR OBES, V10, P196, DOI 10.1111/ijpo.241; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Bruehl Hannah, 2011, Neurosci Med, V2, P34; Burger KS, 2014, NEUROIMAGE, V99, P122, DOI 10.1016/j.neuroimage.2014.05.066; Canto Cathrin B., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/381243; CARSKADON MA, 1993, J ADOLESCENT HEALTH, V14, P190, DOI 10.1016/1054-139X(93)90004-9; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Coveleskie K, 2015, NUTR DIABETES, V5, DOI 10.1038/nutd.2014.45; Crockett L.J., 1988, PUBERTAL DEV SCALE P; Davidson TL, 2007, CURR OPIN PHARMACOL, V7, P613, DOI 10.1016/j.coph.2007.10.008; DAVIDSON TL, 1993, BEHAV NEURAL BIOL, V59, P167, DOI 10.1016/0163-1047(93)90925-8; Demos KE, 2012, J NEUROSCI, V32, P5549, DOI 10.1523/JNEUROSCI.5958-11.2012; Deshmukh-Taskar P, 2006, EUR J CLIN NUTR, V60, P48, DOI 10.1038/sj.ejcn.1602266; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gilmore A, VARIATIONS STRUCTURA, DOI [10.1101/581876, DOI 10.1101/581876]; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; Horstmann A, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00058; Inokuchi M, 2011, ANN HUM BIOL, V38, P747, DOI 10.3109/03014460.2011.620625; KELLEY AE, 1982, NEUROSCIENCE, V7, P2321, DOI 10.1016/0306-4522(82)90198-1; KENNY DA, 1979, J APPL PSYCHOL, V64, P372, DOI 10.1037/0021-9010.64.4.372; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Mestre ZL, 2017, INT J OBESITY, V41, P1496, DOI 10.1038/ijo.2017.130; Moreno-Lopez L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049185; Nouwen A, 2017, NEUROIMAGE-CLIN, V16, P43, DOI 10.1016/j.nicl.2017.07.004; Ogden CL, 2002, PEDIATRICS, V109, P45, DOI 10.1542/peds.109.1.45; Raji CA, 2010, HUM BRAIN MAPP, V31, P353, DOI 10.1002/hbm.20870; Rapuano KM, 2015, CEREBRAL CORTEX, V26; Rapuano KM, 2017, P NATL ACAD SCI USA, V114, P160, DOI 10.1073/pnas.1605548113; Schmajuk NA, 2001, BEHAV BRAIN RES, V118, P123, DOI 10.1016/S0166-4328(00)00319-3; Schwimmer JB, 2003, JAMA-J AM MED ASSOC, V289, P1813, DOI 10.1001/jama.289.14.1813; Selig JP, 2012, AUTOREGRESSIVE CROSS, DOI [10.1001/jama.291.23.2847, DOI 10.1001/JAMA.291.23.2847]; Skinner AC, 2018, PEDIATRICS, V142, DOI [10.1542/peds.2018-1916, 10.1542/peds.2017-3459, 10.1542/peds.2018-0725]; Team CR, 2016, R LANG ENV STAT COMP; Vainik U, NEUROBEHAVIOURAL COR, DOI [10.1101/204917, DOI 10.1101/204917]; Vainik U, 2018, P NATL ACAD SCI USA, V115, P9312, DOI 10.1073/pnas.1718206115; Valk SL, 2015, HUM BRAIN MAPP, V36, P2364, DOI 10.1002/hbm.22776; Wallner-Liebmann S, 2010, OBESITY, V18, P1552, DOI 10.1038/oby.2010.26; Wang GJ, 2006, P NATL ACAD SCI USA, V103, P15641, DOI 10.1073/pnas.0601977103; Widya RL, 2011, AM J CLIN NUTR, V93, P1190, DOI 10.3945/ajcn.110.006304; Willette AA, 2015, AGEING RES REV, V20, P86, DOI 10.1016/j.arr.2014.03.007; Yerys BE, 2009, HUM BRAIN MAPP, V30, P3426, DOI 10.1002/hbm.20767	43	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0221995	10.1371/journal.pone.0221995	http://dx.doi.org/10.1371/journal.pone.0221995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536539	Green Submitted, Green Published, gold			2022-12-26	WOS:000532262800022
J	Rodriguez-Poncelas, A; Franch-Nadal, J; Coll-de Tuero, G; Mata-Cases, M; Alonso-Fernandez, M; Mur-Marti, T; Ruiz, A; Giraldez-Garcia, C; Regidor, E				Rodriguez-Poncelas, Antonio; Franch-Nadal, Josep; Coll-de Tuero, Gabriel; Mata-Cases, Manel; Alonso-Fernandez, Margarita; Mur-Marti, Teresa; Ruiz, Antonio; Giraldez-Garcia, Carolina; Regidor, Enrique			High levels of fasting glucose and glycosylated hemoglobin values are associated with hyperfiltration in a Spanish prediabetes cohort. The PREDAPS Study	PLOS ONE			English	Article							GLOMERULAR HYPERFILTRATION; RENAL HYPERFILTRATION; DIABETIC-NEPHROPATHY; RISK; POPULATION; DEFINITION; OBESITY	Aim This study aimed to investigate whether different levels of fasting plasma glucose (FPG) and hemoglobin Al c (HbA1 c) in prediabetes are associated with hyperfiltration. Methods A prospective cohort of 2,022 individuals aged 30-74 years took part in the PREDAPS Study. One cohort of 1,184 participants with prediabetes and another cohort of 838 participants with normal FPG and normal HbA1 c were followed for 5 years. Hyperfiltration was defined as an estimated glomerular filtration rate (eGFR) above the age- and gender-specific 95th percentile for healthy control participants, while hypofiltration was defined as an eGFR below the 5th percentile. The prevalence of hyperfiltration was compared for different levels of prediabetes: level 1 of prediabetes: FPG <100 mg/dL plus HbAl c 5.7-6.0% or FPG 100-109 mg/dL plus HbAl c < 5.7%; level 2 of prediabetes: FPG <100 mg/dL plus HbAl c 6.1-6.4% or FPG 100-109 mg/dL plus HbAl c 5.7-6.0% or FPG 110-125 mg/dL plus HbAl c <5.7% and level 3 of prediabetes: FPG 100-109 mg/dL plus HbAl c 6.1-6.4% or FPG 110-125 mg/dL plus HbAl c 5.7-6.4%. Results The participants with hyperfiltration were significantly younger, had a higher percentage of active smokers, and lower levels of hemoglobin and less use of ACEIs or ARBs. Only level 3 prediabetes based on FPG 100-109 mg/dL plus HbA1c 6.1-6.4% or FPG 110-125 mg/dL plus HbA1c 5.7-6.4% had a significantly higher odds ratio (OR) of hyperfiltration (OR 1.69 (1.05-2.74); P < 0.001) compared with no prediabetes (FPG < 100 mg/dL and HbA1c < 5.7%) after adjustment for different factors. The odds ratios for different levels of HbA1c alone in prediabetes increased progressively, but not significantly. Conclusions Level 3 of prediabetes based on FPG 100-109 mg/dL plus HbA1c 6.1-6.4% or FPG 110-125 mg/dL plus HbA1c 5.7-6.4% had a significantly higher OR of hyperfiltration compared with participants without prediabetes.	[Rodriguez-Poncelas, Antonio; Coll-de Tuero, Gabriel] IDIAP Gol & Gorina, USR Girona, METHARISC Grp, Girona, Spain; [Rodriguez-Poncelas, Antonio; Mata-Cases, Manel] Grup Recerca Epidemiol Diabetis Atencio Primar DA, Barcelona, Spain; [Rodriguez-Poncelas, Antonio; Franch-Nadal, Josep; Mata-Cases, Manel; Alonso-Fernandez, Margarita; Mur-Marti, Teresa; Ruiz, Antonio; Giraldez-Garcia, Carolina; Regidor, Enrique] RedGDPS Fdn, Madrid, Spain; [Franch-Nadal, Josep; Mata-Cases, Manel] USR Barcelona Ciutat IDIAP Jordi Gol, Barcelona, Spain; [Franch-Nadal, Josep; Mata-Cases, Manel] CIBER Diabet & Enfermedades Metabol Asociadas CIB, Madrid, Spain; [Franch-Nadal, Josep] Univ Barcelona, Dept Med, Barcelona, Spain; [Coll-de Tuero, Gabriel] Univ Girona, Dept Ciencias Med, Girona, Spain; [Alonso-Fernandez, Margarita] Ctr Salud La Eria, Asturias, Spain; [Alonso-Fernandez, Margarita] Univ Oviedo, Dept Med Prevent & Salud Publ, Asturias, Spain; [Mur-Marti, Teresa] Mutua Terrassa, Barcelona, Spain; [Ruiz, Antonio] Ctr Salud Univ Pinto, Madrid, Spain; [Giraldez-Garcia, Carolina] Hosp Univ Infanta Elena, Madrid, Spain; [Regidor, Enrique] Univ Complutense Madrid, Fac Med, Dept Salud Publ & Materno Infantil, Madrid, Spain; [Regidor, Enrique] CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain; [Regidor, Enrique] Hosp Clin San Carlos IdISSC, Inst Invest Sanitaria, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona; Universitat de Girona; University of Oviedo; Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Clinico San Carlos	Franch-Nadal, J (corresponding author), RedGDPS Fdn, Madrid, Spain.; Franch-Nadal, J (corresponding author), USR Barcelona Ciutat IDIAP Jordi Gol, Barcelona, Spain.; Franch-Nadal, J (corresponding author), CIBER Diabet & Enfermedades Metabol Asociadas CIB, Madrid, Spain.; Franch-Nadal, J (corresponding author), Univ Barcelona, Dept Med, Barcelona, Spain.	josep.franch@gmail.com	Stefanadis, Christodoulos/ABH-2232-2020; mata-cases, manel/W-9485-2019; Franch-Nadal, Josep/AAC-1945-2019	Stefanadis, Christodoulos/0000-0001-5974-6454; mata-cases, manel/0000-0003-3693-3622; Franch-Nadal, Josep/0000-0002-5175-1555				Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Brenner BM, 1996, KIDNEY INT, V49, P1774, DOI 10.1038/ki.1996.265; Cachat F, 2015, CLIN J AM SOC NEPHRO, V10, P382, DOI 10.2215/CJN.03080314; Chagnac A, 2003, J AM SOC NEPHROL, V14, P1480, DOI 10.1097/01.ASN.0000068462.38661.89; Chagnac A, 2008, NEPHROL DIAL TRANSPL, V23, P3946, DOI 10.1093/ndt/gfn379; Goldberg I, 2018, EUR J INTERN MED, V57, P39, DOI 10.1016/j.ejim.2018.07.013; Helal I, 2012, NAT REV NEPHROL, V8, P293, DOI 10.1038/nrneph.2012.19; HOSTETTER TH, 1992, DIABETES CARE, V15, P1205, DOI 10.2337/diacare.15.9.1205; Hoy WE, 2003, KIDNEY INT, V63, P31, DOI 10.1046/j.1523-1755.63.s83.8.x; Hu W, 2015, BMC ENDOCR DISORD, V15, DOI 10.1186/s12902-015-0043-0; Kawata I, 2019, ACTA DIABETOL, V56, P525, DOI 10.1007/s00592-019-01287-9; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Magee GM, 2009, DIABETOLOGIA, V52, P691, DOI 10.1007/s00125-009-1268-0; Melsom T, 2016, AM J KIDNEY DIS, V67, P841, DOI 10.1053/j.ajkd.2015.10.025; Melsom T, 2011, DIABETES CARE, V34, P1546, DOI 10.2337/dc11-0235; Mogensen C E, 1990, J Diabet Complications, V4, P159, DOI 10.1016/0891-6632(90)90015-W; Moriya T, 2012, KIDNEY INT, V81, P486, DOI 10.1038/ki.2011.404; Naderpoor N, 2017, SCI REP-UK, V7, DOI 10.1038/srep45522; Nerpin E, 2008, DIABETES CARE, V31, P1550, DOI 10.2337/dc08-0369; Okada R, 2012, RENAL FAILURE, V34, P1084, DOI 10.3109/0886022X.2012.717516; Okada R, 2012, NEPHROL DIAL TRANSPL, V27, P1821, DOI 10.1093/ndt/gfr651; Panagiotakos DB, 2006, NUTR METAB CARDIOVAS, V16, P559, DOI 10.1016/j.numecd.2005.08.006; Premaratne E, 2015, DIABETES METAB, V41, P5, DOI 10.1016/j.diabet.2014.10.003; Pruijm M, 2010, NEPHROL DIAL TRANSPL, V25, P2225, DOI 10.1093/ndt/gfq008; Rodriguez-Poncelas A, 2018, J NEPHROL, V31, P743, DOI 10.1007/s40620-018-0524-0; Ruggenenti P, 2012, DIABETES CARE, V35, P2061, DOI 10.2337/dc11-2189; Serrano R, 2013, REV ESP SALUD PUBLIC, V87, P121, DOI [10.4321/S1135-57272013000200003, 10.4321/s1135-57272013000200003]; Stevens LA, 2010, AM J KIDNEY DIS, V56, P486, DOI 10.1053/j.ajkd.2010.03.026; Sun ZJ, 2016, NEPHROL DIAL TRANSPL, V31, P1295, DOI 10.1093/ndt/gfv385; Sunder-Plassmann G, 2004, AM J KIDNEY DIS, V43, P396, DOI 10.1053/j.ajkd.2003.11.017; Tomaszewski M, 2007, KIDNEY INT, V71, P816, DOI 10.1038/sj.ki.5002160; Vallon V, 2003, J AM SOC NEPHROL, V14, P530, DOI 10.1097/01.ASN.0000051700.07403.27; Wahba IM, 2007, CLIN J AM SOC NEPHRO, V2, P550, DOI 10.2215/CJN.04071206; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15	35	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222848	10.1371/journal.pone.0222848	http://dx.doi.org/10.1371/journal.pone.0222848			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536578	Green Published, Green Submitted, gold			2022-12-26	WOS:000532262800096
J	Stien, N; Saeterbakken, AH; Hermans, E; Vereide, VA; Olsen, E; Andersen, V				Stien, Nicolay; Saeterbakken, Atle Hole; Hermans, Espen; Vereide, Vegard Albert; Olsen, Elias; Andersen, Vidar			Comparison of climbing-specific strength and endurance between lead and boulder climbers	PLOS ONE			English	Article							FINGER FLEXOR MUSCLES; HEMODYNAMIC KINETICS; ROCK; PERFORMANCE; ELITE; DETERMINANTS; CONTRACTIONS; RESPONSES; RECOVERY; EXERCISE	Albeit differences in climbing-specific strength of the forearms have been demonstrated between lead and boulder climbers, little is known about the potential differences in force and power output of the upper body pulling-apparatus between disciplines. The aim of this study was to compare the climbing-specific upper-body strength and finger flexor endurance between lead and boulder climbers, as well as to examine the relative utilization of force when testing on a ledge hold compared to a jug hold. Sixteen boulder climbers (red-point climbing grade 17.9 +/- 3.3) and fifteen lead climbers (red-point climbing grade 20.5 +/- 3.5) performing on an advanced level volunteered for the study. Peak force, average force and rate of force development (RFD) were measured during an isometric pull-up, average velocity in dynamic pull-up, and finger flexor endurance in an intermittent test to fatigue. The isometric pull-up was performed on a ledge hold (high finger strength requirements) and on a jug hold (very low finger strength requirements). Boulder climbers demonstrated a higher maximal and explosive strength in all strength and power measurements (26.2-52.9%, ES = 0.90-1.12, p = 0.006-0.023), whereas the finger flexor endurance test showed no significant difference between the groups (p = 0.088). Both groups were able to utilize 57-69% of peak force, average force and RFD in the ledge condition compared to the jug condition, but the relative utilization was not different between the groups (p = 0.290-0.996). In conclusion, boulder climbers were stronger and more explosive compared to lead climbers, whereas no differences in finger flexor endurance were observed. Performing climbing-specific tests on a smaller hold appears to limit the force and power output equally between the two groups.	[Stien, Nicolay; Saeterbakken, Atle Hole; Hermans, Espen; Vereide, Vegard Albert; Olsen, Elias; Andersen, Vidar] Western Norway Univ Appl Sci, Fac Educ Arts & Sports, Sogndal, Norway	Western Norway University of Applied Sciences	Saeterbakken, AH (corresponding author), Western Norway Univ Appl Sci, Fac Educ Arts & Sports, Sogndal, Norway.	atle.saeterbakken@hvl.no						Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; Amca A, 2015, 33 INT C BIOM SPORTS; Amca AM, 2012, J SPORT SCI, V30, P669, DOI 10.1080/02640414.2012.658845; Balas J, 2016, EUR J SPORT SCI, V16, P764, DOI 10.1080/17461391.2015.1119198; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Deyhle MR, 2015, J STRENGTH COND RES, V29, P2006, DOI 10.1519/JSC.0000000000000823; Draper N., 2015, SPORTS TECHNOL, V8, P88, DOI [10.1080/19346182.2015.1107081, DOI 10.1080/19346182.2015.1107081]; Esposito F, 2009, EUR J APPL PHYSIOL, V105, P81, DOI 10.1007/s00421-008-0877-5; Fanchini M, 2013, J STRENGTH COND RES, V27, P310, DOI 10.1519/JSC.0b013e3182577026; Fryer S, 2017, EUR J SPORT SCI, V17, P1177, DOI 10.1080/17461391.2017.1353135; Fryer S, 2015, INT J SPORTS MED, V36, P137, DOI 10.1055/s-0034-1385887; Fryer SM, 2015, J STRENGTH COND RES, V29, P1633, DOI 10.1519/JSC.0000000000000804; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Grant S, 2001, J SPORT SCI, V19, P499, DOI 10.1080/026404101750238953; Kodejska J., 2015, ACTA UNIVERSITATIS C, V51, P48, DOI [10.14712/23366052.2015.31, DOI 10.14712/23366052.2015.31]; Laffaye G, 2014, INT J SPORTS MED, V35, P670, DOI 10.1055/s-0033-1358473; Levernier G, 2017, J STRENGTH COND RES; Levernier G, 2021, SPORT BIOMECH, V20, P495, DOI 10.1080/14763141.2019.1584236; Limonta E, 2016, J SPORT SCI, V34, P133, DOI 10.1080/02640414.2015.1035738; Macdonald JH, 2011, WILD ENVIRON MED, V22, P140, DOI 10.1016/j.wem.2010.11.012; MacLeod D, 2007, J SPORT SCI, V25, P1433, DOI 10.1080/02640410600944550; Mermier CM, 2000, BRIT J SPORT MED, V34, P359, DOI 10.1136/bjsm.34.5.359; Michailov M, 2009, MED SPORT, P231, DOI DOI 10.2478/V10036-009-0036-Z; Michailov ML, 2018, RES Q EXERCISE SPORT, V89, P246, DOI 10.1080/02701367.2018.1441484; Noe F, 2001, GAIT POSTURE, V13, P86, DOI 10.1016/S0966-6362(00)00098-9; Quaine F, 2003, INT J SPORTS MED, V24, P424; SALE D, 1981, Canadian Journal of Applied Sport Sciences, V6, P87; Sheel AW, 2003, MED SCI SPORT EXER, V35, P1225, DOI 10.1249/01.MSS.0000074443.17247.05; Tillin NA, 2012, EXP PHYSIOL, V97, P630, DOI 10.1113/expphysiol.2011.063040; Tillin NA, 2010, MED SCI SPORT EXER, V42, P781, DOI 10.1249/MSS.0b013e3181be9c7e; Vigouroux L, 2006, J SPORT SCI, V24, P181, DOI 10.1080/02640410500127785; Vigouroux L, 2018, J SPORTS SCI, P1; VOLLESTAD NK, 1988, J APPL PHYSIOL, V64, P1421, DOI 10.1152/jappl.1988.64.4.1421; Wall CB, 2004, J STRENGTH COND RES, V18, P77; Watts PB, 2004, EUR J APPL PHYSIOL, V91, P361, DOI 10.1007/s00421-003-1036-7; White DJ, 2010, J STRENGTH COND RES, V24, P1356, DOI 10.1519/JSC.0b013e3181cf75bd; Woollings KY, 2015, BRIT J SPORT MED, V49, P1094, DOI 10.1136/bjsports-2014-094372	37	16	16	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222529	10.1371/journal.pone.0222529	http://dx.doi.org/10.1371/journal.pone.0222529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536569	Green Published, Green Submitted, gold			2022-12-26	WOS:000532262800052
J	Showa, SP; Nyabadza, F; Hove-Musekwa, SD				Showa, Sarudzai P.; Nyabadza, Farai; Hove-Musekwa, Senelani D.			On the efficiency of HIV transmission: Insights through discrete time HIV models	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TO-CELL SPREAD; INFECTION; BLOOD; DYNAMICS; REPLICATION; LYMPHOCYTES; RISK	There are different views on which of the two forms of viral spread is more efficient in vivo between cell-free and cell-associated virus. In this study, discrete time human immunodeficiency virus models are formulated and analysed with the goal of determining the form of viral spread that is more efficient in vivo. It is shown that on its own, cell-free viral spread cannot sustain an infection owing to the low infectivity of cell-free virus and cell-associated virus can sustain an infection because of the high infectivity of cell-associated virus. When acting concurrently, cell-associated virus is more efficient in spreading the infection upon exposure to the virus. However, in the long term, the two forms of viral spread contribute almost equally. Both forms of viral spread are shown to be able to initiate an infection.	[Showa, Sarudzai P.; Hove-Musekwa, Senelani D.] Natl Univ Sci & Technol, Dept Appl Math, Bulawayo, Zimbabwe; [Nyabadza, Farai] Univ Johannesburg, Dept Math & Appl Math, Auckland Pk Campus, Johannesburg, South Africa	National University of Science & Technology - Zimbabwe; University of Johannesburg	Showa, SP (corresponding author), Natl Univ Sci & Technol, Dept Appl Math, Bulawayo, Zimbabwe.	showa.sarudzai@gmail.com	Nyabadza, Farai/AAW-4942-2020	Nyabadza, Farai/0000-0003-3468-5581				Abela IA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002634; Anderson DJ, 2010, J INFECT DIS, V202, P333, DOI 10.1086/653620; Anderson DJ, 2010, AIDS, V24, P163, DOI 10.1097/QAD.0b013e32833424c8; Bangham CRM, 2003, J GEN VIROL, V84, P3177, DOI 10.1099/vir.0.19334-0; BARBOSA P, 1994, AIDS RES HUM RETROV, V10, P53, DOI 10.1089/aid.1994.10.53; Barreto-de-Souza V, 2014, AM J REPROD IMMUNOL, V71, P589, DOI 10.1111/aji.12240; Boeras DI, 2011, P NATL ACAD SCI USA, V108, pE1156, DOI 10.1073/pnas.1103764108; BRINCHMANN JE, 1991, J VIROL, V65, P2019, DOI 10.1128/JVI.65.4.2019-2023.1991; Butler DA, 2008, AIDS, V22, P1667, DOI 10.1097/QAD.0b013e32830bfed8; Butler DM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000447; Carr JM, 1999, VIROLOGY, V265, P319, DOI 10.1006/viro.1999.0047; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Elaiw AM, 2016, AIP ADV, V6, DOI 10.1063/1.4960987; EMBRETSON J, 1993, NATURE, V362, P359, DOI 10.1038/362359a0; Frange P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069144; Gianella S, 2012, VIROLOGY, V434, P2, DOI 10.1016/j.virol.2012.09.010; GUPTA P, 1989, J VIROL, V63, P2361, DOI 10.1128/JVI.63.5.2361-2365.1989; Heath L, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001416; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Iwami S, 2015, ELIFE, V4, DOI 10.7554/eLife.08150; KIRSCHNER D, 1996, NOTIES AMS, V43, P193; Kolodkin-Gal D, 2013, J VIROL, V87, P13589, DOI 10.1128/JVI.03108-12; Komarova NL, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1049; Kramer A, 2010, STAT BIOL HEALTH, P1; Lai XL, 2014, SIAM J APPL MATH, V74, P898, DOI 10.1137/130930145; Lin JZ, 2017, APPL MATH COMPUT, V315, P516, DOI 10.1016/j.amc.2017.08.004; Mothes W, 2010, J VIROL, V84, P8360, DOI 10.1128/JVI.00443-10; Pantaleo G, 1998, NATURE, V362, P341; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Peters B, 2004, LANCET, V363, P518, DOI 10.1016/S0140-6736(04)15538-4; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rosenberg YJ, 1999, SEMIN IMMUNOL, V11, P139, DOI 10.1006/smim.1999.0169; Rousseau CM, 2004, J INFECT DIS, V190, P1880, DOI 10.1086/425076; Sagar M, 2014, J INFECT DIS, V210, pS667, DOI 10.1093/infdis/jiu369; SATO H, 1992, VIROLOGY, V186, P712, DOI 10.1016/0042-6822(92)90038-Q; Sedaghat AR, 2008, P NATL ACAD SCI USA, V105, P4832, DOI 10.1073/pnas.0711372105; Sedaghat AR, 2009, ANTIVIR THER, V14, P263; Showa Sarudzai P, 2014, BMC Res Notes, V7, P737, DOI 10.1186/1756-0500-7-737; Showa SP, 2017, BIOL MED, V9, P420; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Srivastava PK, 2010, DIFFER EQUAT DYN SYS, V18, P385, DOI 10.1007/s12591-010-0074-y; Srivastava PK, 2010, NONLINEAR ANAL-REAL, V11, P612, DOI 10.1016/j.nonrwa.2008.10.037; Sturmer M, 2008, ANTIVIR THER, V13, P729; Virgin HW, 2010, NATURE, V464, P224, DOI 10.1038/nature08898; von Kleist M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000720; Wang JL, 2016, APPL MATH COMPUT, V291, P149, DOI 10.1016/j.amc.2016.06.032; Wang SF, 2012, APPL MATH MODEL, V36, P1313, DOI 10.1016/j.apm.2011.07.086; WESTERMANN J, 1990, IMMUNOL TODAY, V11, P406, DOI 10.1016/0167-5699(90)90160-B; ZACK JA, 1992, J VIROL, V66, P1717, DOI 10.1128/JVI.66.3.1717-1725.1992; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhu TF, 1996, J VIROL, V70, P3098, DOI 10.1128/JVI.70.5.3098-3107.1996	52	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222574	10.1371/journal.pone.0222574	http://dx.doi.org/10.1371/journal.pone.0222574			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532803	gold, Green Published, Green Submitted			2022-12-26	WOS:000532239600032
J	Ni, SS; Zhou, Y; Chen, Y; Du, XY; Zhang, SC				Ni, Shousheng; Zhou, Yang; Chen, Yan; Du, Xiaoyuan; Zhang, Shicui			Identification of ATP synthase alpha subunit as a new maternal factor capable of protecting zebrafish embryos from bacterial infection	FASEB JOURNAL			English	Article						Danio rerio; maternal immunity; antibacterial activity; depolarization; permeabilization	ZINC-FINGER PROTEIN; GENE-EXPRESSION; BINDING PROTEIN; HYBRIDIZATION; PROGRESSION; RESOLUTION; MECHANISM; SUGGESTS; COMPLEX	Previous studies have shown that ATP synthase alpha subunit (ATP5A1) plays multiple roles, but our understanding of its biologic functions remains poor and incomprehensive. Here, we clearly demonstrated that zebrafish ATP5A1 was a newly characterized lipoteichoic acid (LTA)- and LPS-binding protein abundantly stored in the eggs and embryos of zebrafish. Zebrafish ATP5A1 acted not only as a pattern recognition receptor, capable of identifying LTA and LPS, but also as an effector molecule, capable of inhibiting the growth of both gram-positive and -negative bacteria. ATP5A1 could disrupt the bacterial membranes by a combined action of membrane depolarization and permeabilization. We also found that the N-terminal 65 residues were critical for the antibacterial activity of zebrafish ATP5A1. In particular, we showed that microinjection of exogenous recombinant (r)ATP5A1 into early embryos could promote their resistance against pathogenic Aeromonas hydrophila challenge, and this pathogen-resistant activity was markedly reduced by the coinjection of anti-ATP5A1 antibody or by the knockdown with morpholino for atp5a1 but not by the coinjection of anti-actin antibody. Moreover, each egg/embryo contains a sufficient amount of ATP5A1 in vivo to kill A. hydrophila. Furthermore, the N-terminal 65 residues 1-65 of ATP5A1 alpha subunit (rA(1-)(65)) with in vitro antibacterial activity also promoted the resistance of embryos against A. hydrophila, but the N-terminal 69 residues 66-134 (rA(66)(-)(134)) or C-terminal residues 135-551 (rA(135)(-)(551)) of ATP5A1 alpha subunit without in vitro antibacterial activity did not. Finally, we showed that the antibacterial activity of the N-terminal 65 residues of ATP5A1 alpha subunit was conserved throughout animal evolution. Collectively, these results indicate that ATP5A1 is a novel maternal immunocompetent factor that can protect the early embryos of zebrafish from bacterial infection. This work also provides a new viewpoint for understanding the biologic roles of ATP5A1, which is ubiquitously present in animals.	[Ni, Shousheng; Zhou, Yang; Chen, Yan; Zhang, Shicui] Ocean Univ China, Inst Evolut & Marine Biodivers, Dept Marine Biol, Qingdao, Peoples R China; [Du, Xiaoyuan] State Ocean Adm, North China Sea Environm Monitoring Ctr, Qingdao, Peoples R China; [Zhang, Shicui] Pilot Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China	Ocean University of China; State Oceanic Administration; Qingdao National Laboratory for Marine Science & Technology	Zhang, SC (corresponding author), Ocean Univ China, Dept Marine Biol, 5 Yushan Rd, Qingdao 266003, Peoples R China.	sczhang@ouc.edu.cn			Ministry of Science and Technology (MOST) of China [2018YFD0900505]; Fundamental Research Funds for the Central Universities [201562029, 201861022]	Ministry of Science and Technology (MOST) of China(Ministry of Science and Technology, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The authors are grateful to Dr. Bo Dong (Institute of Evolution and Marine Biodiversity, Ocean University of China) for the gift of ascidian cDNAs. This work was supported by the Ministry of Science and Technology (MOST) of China (2018YFD0900505) and the Fundamental Research Funds for the Central Universities (201562029 and 201861022). The authors declare no conflicts of interest.	AKIYAMA S, 1994, BBA-GENE STRUCT EXPR, V1219, P129, DOI 10.1016/0167-4781(94)90255-0; Artuso L, 2012, BBA-BIOENERGETICS, V1817, P1002, DOI 10.1016/j.bbabio.2012.03.019; AVNI A, 1991, J BIOL CHEM, V266, P7317; Baran AA, 2007, GENOME RES, V17, P566, DOI 10.1101/gr.6089707; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Capaldi RA, 2002, TRENDS BIOCHEM SCI, V27, P154, DOI 10.1016/S0968-0004(01)02051-5; CHEN XJ, 1995, EMBO J, V14, P3277, DOI 10.1002/j.1460-2075.1995.tb07331.x; Das N, 2015, FREE RADICAL RES, V49, P954, DOI 10.3109/10715762.2015.1017477; Du XY, 2018, FASEB J, V32, P979, DOI 10.1096/fj.201700694R; Feng J, 2008, J GERONTOL A-BIOL, V63, P1137, DOI 10.1093/gerona/63.11.1137; Gao Z, 2014, EUR J IMMUNOL, V44, P3680, DOI 10.1002/eji.201444734; Ginsburg I, 2002, LANCET INFECT DIS, V2, P171, DOI 10.1016/S1473-3099(02)00226-8; Godbout R, 1997, CYTOGENET CELL GENET, V77, P253, DOI 10.1159/000134588; Ishii H, 2012, DEV GROWTH DIFFER, V54, P753, DOI 10.1111/dgd.12003; Jonckheere AI, 2013, BRAIN, V136, P1544, DOI 10.1093/brain/awt086; Li ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001940; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martinez-Cruz O, 2011, J BIOENERG BIOMEMBR, V43, P119, DOI 10.1007/s10863-011-9340-0; Minoda Y, 2006, BIOCHEM BIOPH RES CO, V344, P1023, DOI 10.1016/j.bbrc.2006.04.006; NELSON N, 1973, J BIOL CHEM, V248, P2049; Neupane Prashant, 2019, BioMolecular Concepts, V10, P1, DOI 10.1515/bmc-2019-0001; Okuno D, 2011, J BIOCHEM, V149, P655, DOI 10.1093/jb/mvr049; Reed TT, 2009, BRAIN RES, V1274, P66, DOI 10.1016/j.brainres.2009.04.009; Schnaufer A, 2005, EMBO J, V24, P4029, DOI 10.1038/sj.emboj.7600862; Sergeant N, 2003, NEUROSCIENCE, V117, P293, DOI 10.1016/S0306-4522(02)00747-9; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Wang X, 2016, J BIOL CHEM, V291, P4019, DOI 10.1074/jbc.M115.679167; Wang ZP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004498; Xu GY, 2016, J NEURO-ONCOL, V126, P405, DOI 10.1007/s11060-015-1984-x; YOTOV WV, 1993, BIOCHEM BIOPH RES CO, V191, P142, DOI 10.1006/bbrc.1993.1195; YUAN HB, 1992, J BIOL CHEM, V267, P14697; Yuan LS, 2018, ONCOL REP, V39, P525, DOI 10.3892/or.2017.6132	32	11	11	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12983	13001		10.1096/fj.201901290R	http://dx.doi.org/10.1096/fj.201901290R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31518507	Green Published			2022-12-26	WOS:000507461600106
J	Benny, P; Yamasato, K; Yunits, B; Zhu, X; Ching, T; Garmire, LX; Berry, MJ; Towner, D				Benny, Paula; Yamasato, Kelly; Yunits, Breck; Zhu, Xun; Ching, Travers; Garmire, Lana X.; Berry, Marla J.; Towner, Dena			Maternal cardiovascular-related single nucleotide polymorphisms, genes, and pathways associated with early-onset preeclampsia	PLOS ONE			English	Article							RISK-FACTORS; DISEASE; WOMEN; SUSCEPTIBILITY; PREVALENCE	Introduction Preeclampsia is a medical condition complicated with hypertension and proteinuria during pregnancy. While preeclampsia affects approximately 5% of pregnancies, it remains without a cure. In addition, women who had preeclampsia during pregnancy have been reported to have an increased risk for cardiovascular disease later in life. However, the disease etiology and molecular mechanisms remain poorly understood. The paucity in the literature on preeclampsia associated maternal cardiovascular risk in different ethnic populations also present a need for more research. Therefore, the objective of this study was to identify cardiovascular/metabolic single nucleotide polymorphisms (SNPs), genes, and regulatory pathways associated with early-onset preeclampsia. Materials and methods We compared maternal DNAs from 31 women with early-onset preeclampsia with those from a control group of 29 women without preeclampsia who delivered full-term normal birth-weight infants. Women with multiple gestations and/or known medical disorders associated with preeclampsia (pregestational diabetes, chronic hypertension, renal disease, hyperthyroidism, and lupus) were excluded. The MetaboChip genotyping array with approximately 197,000 SNPs associated with metabolic and cardiovascular traits was used. Single nucleotide polymorphism analysis was performed using the SNPAssoc program in R. The Truncated Product Method was used to identify significantly associated genes. Ingenuity Pathway Analysis and Ingenuity Causal Network Analysis were used to identify significantly associated disease processes and regulatory gene networks respectively. Results The early-onset preeclampsia group included 45% Filipino, 26% White, 16% other Asian, and 13% Native Hawaiian and other Pacific Islanders, which did not differ from the control group. There were no SNPs associated with early-onset preeclampsia after correction for multiple comparisons. However, through gene-based tests, 68 genes and 23 cardiovascular disease-related processes were found to be significantly associated. Associated gene regulatory networks involved cellular movement, cardiovascular disease, and inflammatory disease. Conclusions Multiple cardiovascular genes and diseases demonstrate associations with early-onset preeclampsia. This unfolds new areas of research regarding the genetic determinants of earlyonset preeclampsia and their relation to future cardiovascular disease.	[Benny, Paula; Yunits, Breck] Univ Hawaii, Canc Ctr, Honolulu, HI 96822 USA; [Yamasato, Kelly; Towner, Dena] Univ Hawaii Manoa, John A Burns Sch Med, Dept Obstet Gynecol & Womens Hlth, Honolulu, HI 96822 USA; [Zhu, Xun; Ching, Travers] Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA; [Garmire, Lana X.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Berry, Marla J.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA	Cancer Research Center of Hawaii; University of Hawaii System; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; University of Michigan System; University of Michigan; University of Hawaii System; University of Hawaii Manoa	Yamasato, K (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Obstet Gynecol & Womens Hlth, Honolulu, HI 96822 USA.	kyamasat@hawaii.edu		Ching, Travers/0000-0002-5577-3516; Towner, Dena/0000-0002-1767-4197	National Institute on Minority Health and Health Disparities (NIMHD) [U54MD007584]; National Institutes of Health (NIH) "RCMI Multidisciplinary And Translational Research Infrastructure eXpansion (RMATRIX)" [G12MD007601];  [MD000173-13]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047320] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007601, U54MD007584] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities (NIMHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institutes of Health (NIH) "RCMI Multidisciplinary And Translational Research Infrastructure eXpansion (RMATRIX)"; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by: National Institute on Minority Health and Health Disparities (NIMHD) (U54MD007584), National Institutes of Health (NIH) "RCMI Multidisciplinary And Translational Research Infrastructure eXpansion (RMATRIX)", G12MD007601 (NIMHD/NIH) Bioscience Research Infrastructure Development for Grants Enhancement and Success (BRIDGES) to DT. This work was also supported by: MD000173-13 Partnerships for Cardiometabolic Disparities in Native and Pacific peoples Research Core to KY. The funders had no role in the study design, analysis, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIMHD or NIH.	[Anonymous], GENE; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Benedetto C, 2007, ACTA OBSTET GYN SCAN, V86, P678, DOI 10.1080/00016340701415269; Boyd HA, 2013, AM J EPIDEMIOL, V178, P1611, DOI 10.1093/aje/kwt189; Brown MC, 2013, EUR J EPIDEMIOL, V28, P1, DOI 10.1007/s10654-013-9762-6; Chappell S, 2006, CLIN SCI, V110, P443, DOI 10.1042/CS20050323; Ching T, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0052-x; Ching T, 2014, MOL HUM REPROD, V20, P885, DOI 10.1093/molehr/gau046; Cnattingius S, 2004, AM J MED GENET A, V130A, P365, DOI 10.1002/ajmg.a.30257; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Gordon JB, 2009, J AM COLL CARDIOL, V54, P1911, DOI 10.1016/j.jacc.2009.04.102; Holobotovskyy V, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5038; Johnson MP, 2013, MOL HUM REPROD, V19, P423, DOI 10.1093/molehr/gat011; Kaartokallio T, 2015, SCI REP-UK, V5, DOI 10.1038/srep14107; Kawasaki K, 2015, MOL HUM REPROD, V21, P217, DOI 10.1093/molehr/gau096; Kleinrouweler CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068991; Liu LX, 2015, TOHOKU J EXP MED, V236, P89, DOI 10.1620/tjem.236.89; Loset M, 2014, PREGNANCY HYPERTENS, V4, P178, DOI 10.1016/j.preghy.2014.03.005; Mishra J, 2019, GENE, V704, P68, DOI 10.1016/j.gene.2019.04.036; Murphy M, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.06.035; Nakagawa K, 2016, MATERN CHILD HLTH J, V20, P1814, DOI 10.1007/s10995-016-1984-2; Nishizawa H, 2007, PLACENTA, V28, P487, DOI 10.1016/j.placenta.2006.05.010; Oudejans CBM, 2007, HUM GENET, V120, P607, DOI 10.1007/s00439-006-0259-1; Rani U, 2018, PREGNANCY HYPERTENS, V13, P214, DOI 10.1016/j.preghy.2018.06.023; Rao AK, 2006, AM J OBSTET GYNECOL, V195, P834, DOI 10.1016/j.ajog.2006.06.079; Shaarawy M, 2001, J SOC GYNECOL INVEST, V8, P27, DOI 10.1016/S1071-5576(00)00091-5; Sharma S, 2019, PEERJ, V7, DOI 10.7717/peerj.6321; Sitras V, 2015, PLACENTA, V36, P170, DOI 10.1016/j.placenta.2014.11.017; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; Stekkinger E, 2009, OBSTET GYNECOL, V114, P1076, DOI 10.1097/AOG.0b013e3181b7b242; Sun CJ, 2009, J PERINAT MED, V37, P609, DOI 10.1515/JPM.2009.103; Tuteja G, 2012, PLACENTA, V33, P1055, DOI 10.1016/j.placenta.2012.09.016; Uma R, 2010, J MATERN-FETAL NEO M, V23, P874, DOI 10.3109/14767050903456667; Vance CJ, 2015, ANN VASC SURG, V29, P1105, DOI 10.1016/j.avsg.2015.03.037; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Wojcik GL, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0191-2; Zhang GX, 2016, MED SCI MONITOR, V22, P2202, DOI 10.12659/MSM.896552	38	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222672	10.1371/journal.pone.0222672	http://dx.doi.org/10.1371/journal.pone.0222672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557190	Green Published, gold			2022-12-26	WOS:000532345500028
J	Morita, T; Ando, M; Ohtsu, Y				Morita, Tomohiro; Ando, Michihito; Ohtsu, Yui			Mass evacuation and increases in long-term care benefits: Lessons from the Fukushima nuclear disaster	PLOS ONE			English	Article							EAST JAPAN EARTHQUAKE; FUNCTIONAL DISABILITY; EXCESS MORTALITY; OLDER-PEOPLE; HEALTH; IMPACT; PREVALENCE; TSUNAMI	Background Though mass evacuation may increase the need for long-term care (LTC) services, how the need for LTC services increases and how the public LTC system affects it is not well understood. We evaluated changes in public LTC benefits for the people living in the mandatory evacuation areas established after the 2011 Fukushima nuclear disaster and examined the roles of the universal LTC insurance system in Japan. Methods In order to evaluate the effect of the mandatory evacuation on LTC benefits, we examined the trends of LTC benefits in the Fukushima evacuation group and the nationwide non-evacuation group. We first decomposed per-elderly-individual benefits at the municipality level into the LTC certification rate and per-certified-individual benefits, and then implemented difference-in-differences analysis using these variables as outcomes. Results Per-elderly-individual benefits significantly increased from 2012 onward in the evacuation group, and this was explained by an increase in the certification rate rather than in per-certified-individual benefits. Increases in per-elderly-individual benefits and the certification rate in the post-disaster period were observed in all but the highest care level, and the corresponding outcomes for the highest care level decreased immediately after the disaster. We also found that the increase in the certification rate had been mostly realized by an increase in the number of certified individuals. Conclusions The increase in LTC benefits can be associated with the impact of the increase in the number of people newly certified to receive LTC benefits after the mandatory evacuation. In order to cope with the increase in utilization of long-term care and associated costs after disasters in aging societies, both formal long-term care services and social support for informal care for evacuees should be considered important.	[Morita, Tomohiro] Soma Cent Hosp, Internal Med, Soma, Fukushima, Japan; [Ando, Michihito] Rikkyo Univ, Dept Econ, Toshima Ku, Tokyo, Japan; [Ohtsu, Yui] Saitama Univ, Grad Sch Humanities & Social Sci, Sakura Ku, Saitama, Japan	Rikkyo University; Saitama University	Morita, T (corresponding author), Soma Cent Hosp, Internal Med, Soma, Fukushima, Japan.	t.morita526@gmail.com	Ando, Michihito/AAD-2335-2021	Morita, Tomohiro/0000-0002-8621-4602; Ando, Michihito/0000-0002-5294-2994	Rikkyo University Special Fund for Research [15FK-1]; Rikkyo University; Health and Labour Sciences Research Grants [H30-Tokei-Ippan-005]; Ministry of Welfare, Labour and Welfare	Rikkyo University Special Fund for Research; Rikkyo University(Rikkyo University); Health and Labour Sciences Research Grants(Ministry of Health, Labour and Welfare, Japan); Ministry of Welfare, Labour and Welfare	This research was funded by Rikkyo University Special Fund for Research (Grant number 15FK-1) funded by Rikkyo University (M.A. and Y.O.). Health and Labour Sciences Research Grants (Grant Number H30-Tokei-Ippan-005) funded by Ministry of Welfare, Labour and Welfare (M.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COTTON J, 1988, REV ECON STAT, V70, P236, DOI 10.2307/1928307; Council NR Grid I, 2016, GLOBAL REPORT INTERN; Dobkin C, 2018, AM ECON REV, V108, P308, DOI 10.1257/aer.20161038; Fernandez Lauren S, 2002, Prehosp Disaster Med, V17, P67; Finkelstein A, 2007, Q J ECON, V122, P1, DOI 10.1162/qjec.122.1.1; Hasegawa J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122631; Matsuyama Y, 2018, TOHOKU J EXP MED, V244, P163, DOI 10.1620/tjem.244.163; Ministry of Internal Affairs and Communications, PORT SIT OFF STAT JA; Morita T, 2017, J EPIDEMIOL COMMUN H, V71, P974, DOI 10.1136/jech-2016-208652; Morita T, 2016, J EPIDEMIOL COMMUN H, V70, P738, DOI 10.1136/jech-2015-206983; OECD, 2012, JAP APOS S COMP SYST; Solon G, 2015, J HUM RESOUR, V50, P301, DOI 10.3368/jhr.50.2.301; Tomata Y, 2015, SOC SCI MED, V147, P296, DOI 10.1016/j.socscimed.2015.11.016; Tomata Y, 2014, J EPIDEMIOL COMMUN H, V68, P530, DOI 10.1136/jech-2013-203541; Tsutsui T, 2007, J AM GERIATR SOC, V55, P1458, DOI 10.1111/j.1532-5415.2007.01281.x; Uchimura M, 2014, J EPIDEMIOL COMMUN H, V68, P874, DOI 10.1136/jech-2014-204063; Yasumura S, 2013, PUBLIC HEALTH, V127, P186, DOI 10.1016/j.puhe.2012.10.019	17	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0218835	10.1371/journal.pone.0218835	http://dx.doi.org/10.1371/journal.pone.0218835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5WE	31553728	Green Published, Green Submitted, gold			2022-12-26	WOS:000532319200002
J	Lefebvre, MJ; deFrance, SD; Kamenov, GD; Keegan, WF; Krigbaum, J				Lefebvre, Michelle J.; deFrance, Susan D.; Kamenov, George D.; Keegan, William F.; Krigbaum, John			The zooarchaeology and isotopic ecology of the Bahamian hutia (Geocapromys ingrahami): Evidence for pre-Columbian anthropogenic management	PLOS ONE			English	Article							CARBON-ISOTOPE; SAHARAN DUST; DIET; RATIOS; ISLAND; RECONSTRUCTION; CONSERVATION; MAMMALS; BIOLOGY; EARTH	Bahamian hutias (Geocapromys ingrahami) are the only endemic terrestrial mammal in The Bahamas and are currently classified as a vulnerable species. Drawing on zooarchaeological and new geochemical datasets, this study investigates human management of Bahamian hutias as cultural practice at indigenous Lucayan settlements in The Bahamas and the Turks & Caicos Islands. In order to determine how hutia diet and distribution together were influenced by Lucayan groups we conducted isotopic analysis on native hutia bone and tooth enamel recovered at the Major's Landing site on Crooked Island in The Bahamas and introduced hutias from the Palmetto Junction site on Providenciales in the Turks & Caicos Islands. Results indicate that some hutias consumed C-13-enriched foods that were either provisioned or available for opportunistic consumption. Strontium isotope ratios for hutia tooth enamel show a narrow range consistent with local origin for all of the archaeological specimens. In contrast, analysis of strontium isotopes in modern Bahamian hutia teeth from animals relocated to Florida from The Bahamas demonstrates that these animals rapidly lost their Bahamian signature and adopted a Florida signature. Therefore, strontium should be used cautiously for determining hutia provenance, particularly for individuals that were translocated between islands. Overall, our findings suggest that ancient human presence did not always result in hutia vulnerability and that the impact to hutia populations was variable across pre-Columbian indigenous settlements.	[Lefebvre, Michelle J.; Keegan, William F.] Florida Museum Nat Hist, Gainesville, FL 32611 USA; [deFrance, Susan D.; Krigbaum, John] Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA; [Kamenov, George D.] Univ Florida, Dept Geol Sci, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Lefebvre, MJ (corresponding author), Florida Museum Nat Hist, Gainesville, FL 32611 USA.; Krigbaum, J (corresponding author), Univ Florida, Dept Anthropol, Gainesville, FL 32611 USA.	mlefebvre@floridamuseum.ufl.edu; krigbaum@ufl.edu						Ambrose S. H., 1993, PREHISTORIC HUMAN BO, P1; Ambrose S.H., 1993, INVESTIGATIONS ANCIE, P59; Bentley RA, 2006, J ARCHAEOL METHOD TH, V13, P135, DOI 10.1007/s10816-006-9009-x; Berman M.J., 2013, OXFORD HDB CARIBBEAN, P264; Berman MJ, 2000, LAT AM ANTIQ, V11, P219, DOI 10.2307/972175; BORROTO-PAEZ R., 2012, TERRESTRIAL MAMMALS, P221; Borroto-Paez R, 2017, J MAMMAL, V98, P964, DOI 10.1093/jmammal/gyx017; Burton JH, 2013, ACS SYM SER, V1147, P309; Carew JL, 1997, DEVEL SEDIM, V54, P91; Carlson L. A., 1999, THESIS; Carr RS., 2006, ARCHAEOLOGICAL HIST, P83; Ciofalo AJ, 2018, J ARCHAEOL SCI-REP, V21, P305, DOI 10.1016/j.jasrep.2018.07.022; Clough G. C, 1971, Atoll Res Bull, VNo. 138, P1; CLOUGH GC, 1972, J MAMMAL, V53, P807, DOI 10.2307/1379215; CLOUGH GC, 1974, J MAMMAL, V55, P670, DOI 10.2307/1379560; CLOUGH GC, 1973, NAT HIST, V82, P66; Colten RH., 2014, J CARIBB ARCHAEOL, V14, P23, DOI [10.1080/14614103.2018.1500157, DOI 10.1080/14614103.2018.1500157]; Colten RH, 2019, ENVIRON ARCHAEOL, V24, P211, DOI 10.1080/14614103.2018.1500157; Cooke SB, 2017, ANNU REV ECOL EVOL S, V48, P301, DOI 10.1146/annurev-ecolsys-110316-022754; Courcelle M, 2019, MOL PHYLOGENET EVOL, V136, P241, DOI 10.1016/j.ympev.2019.03.007; Craton Michael, 1992, ISLANDERS STREAM HIS; deFrance SD, 1991, ZOOARCHAEOLOGICAL RE; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; DuChemin G., 2005, THESIS; Eisenberg JF, 2012, TERRESTRIAL MAMMALS; Fabre PH, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0266; Figueredo A.E., 2015, J CARIBB ARCHAEOL, V15, P120; Froehle AW, 2012, AM J PHYS ANTHROPOL, V147, P352, DOI 10.1002/ajpa.21651; Froehle AW, 2010, J ARCHAEOL SCI, V37, P2662, DOI 10.1016/j.jas.2010.06.003; Giovas CM, 2016, J ARCHAEOL SCI, V69, P39, DOI 10.1016/j.jas.2016.03.006; Goodall PMP, 2012, TERRESTRIAL MAMMALS, P110; Howe RJ, 1971, INT ZOO YB, V11, P89, DOI DOI 10.1111/J.1748-1090.1971.TB01862.X; Jordan K.C., 2012, TERRESTRIAL MAMMALS, P115; Jordan K. C., 1989, THESIS; Keegan W. F., 1997, BAHAMIAN ARCHAEOLOGY; Keegan W.F., 2008, TALKING TAINO CARIBB; KEEGAN WF, 1988, AM ANTIQUITY, V53, P320, DOI 10.2307/281022; Keegan WF., 2017, CARIBBEAN COLUMBUS, DOI 10.1093/acprof:oso/9780190605247.001.0001; Keegan WF, 2018, 2018 LONG ISLAND BAH; Keegan William F, 1992, PEOPLE WHO DISCOVERE; Krigbaum J, 2013, J ISL COAST ARCHAEOL, V8, P210, DOI 10.1080/15564894.2012.756082; KRUEGER HW, 1984, ACS SYM SER, V258, P205; Laffoon JE, 2013, ARCHAEOMETRY, V55, P742, DOI 10.1111/j.1475-4754.2012.00698.x; Laffoon JE, 2016, FLA MUS NAT HIST-RIP, P147; Laffoon JE, 2019, ENVIRON ARCHAEOL, V24, P132, DOI 10.1080/14614103.2017.1322831; Laffoon JE, 2012, J ARCHAEOL SCI; LAWRENCE BARBARA, 1934, OCCAS PAPERS BOSTON SOC NAT HIST, V8, P189; LEETHORP JA, 1991, J ARCHAEOL SCI, V18, P343, DOI 10.1016/0305-4403(91)90070-6; LeFebvre M.J., 2018, ARCHAEOLOGY CARIBBEA, P149; LeFebvre MJ, 2019, ENVIRON ARCHAEOL, V24, P115, DOI 10.1080/14614103.2018.1503809; MARINO BD, 1991, NATURE, V349, P127, DOI 10.1038/349127a0; McArthur J. M., 2004, GEOLOGIC TIME SCALE, P96, DOI DOI 10.1017/CBO9780511536045.008; Morgan GS, 2019, LATE QUATERNARY FOSS, P428; Morsink J., 2013, THESIS; Morsink J, 2019, ENVIRON ARCHAEOL, V24, P149, DOI 10.1080/14614103.2018.1440690; Newsom L. A., 2004, LAND SEA NATIVE AM U; Nieves-Rivera A.M., 2001, PR NSS NEWS, V59, P92; Norr L., 2002, TUTU ARCHAEOLOGICAL; Ostapkowicz J, PROVENANCING TAINO L; Ostapkowicz J, 2013, J ARCHAEOL SCI, V40, P4675, DOI 10.1016/j.jas.2013.07.015; Pestle WJ, 2018, J ARCHAEOL SCI-REP, V17, P393, DOI 10.1016/j.jasrep.2017.11.032; Pestle WJ, 2013, J ISL COAST ARCHAEOL, V8, P228, DOI 10.1080/15564894.2013.797943; Pourmand A, 2014, GEOLOGY, V42, P675, DOI 10.1130/G35624.1; Price TD, 2002, ARCHAEOMETRY, V44, P117, DOI 10.1111/1475-4754.00047; Sauer Carl, 1966, EARLY SPANISH MAIN; Schroeder H, 2018, P NATL ACAD SCI USA, V115, P2341, DOI 10.1073/pnas.1716839115; Schultinga R, 2018, QUATERNARY RES, V89, P394, DOI 10.1017/qua.2018.8; Somerville AD, 2013, J ARCHAEOL SCI, V40, P1539, DOI 10.1016/j.jas.2012.10.029; Steadman DW, 2017, J ISL COAST ARCHAEOL, V12, P572, DOI 10.1080/15564894.2017.1305469; Stokes Anne V, 1998, THESIS; Swart PK, 2014, GEOLOGY, V42, P671, DOI 10.1130/G35744.1; Turvey S, 2008, GEOCAPROMYS INGRAHAM, DOI [10.2305/IUCN.UK.2008.RLTS.T9002A12949103.en, DOI 10.2305/IUCN.UK.2008.RLTS.T9002A12949103.EN]; Turvey ST, 2017, J MAMMAL, V98, P918, DOI 10.1093/jmammal/gyw154; Upham NS, 2017, J MAMMAL, V98, P950, DOI 10.1093/jmammal/gyx077; Upham NS, 2017, J MAMMAL, V98; Vaughan T. A., 2011, MAMMALOGY; Veloz Maggiolo M., 1992, REV ARQUEOLOGIA AM, V6, P125; Wing ES, 2008, INTERD CONTRIB ARCH, P405, DOI 10.1007/978-0-387-71303-8_21; Wing ES, 2012, TERRESTRIAL MAMMALS, P342; Wing ES., 1982, J N WORLD ARCHAEOL, V5, P13; Woods CA, 2012, TERRESTRIAL MAMMALS, P335	82	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0220284	10.1371/journal.pone.0220284	http://dx.doi.org/10.1371/journal.pone.0220284			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5RZ	31550252	Green Published, gold			2022-12-26	WOS:000532307700004
J	Cardoso-Sousa, L; Aguiar, EMG; Caixeta, DC; Vilela, DD; da Costa, DP; Silva, TL; Cunha, TM; Faria, PR; Espindola, FS; Jardim, AC; Vieira, AA; Oliveira, TL; Goulart, LR; Sabino-Silva, R				Cardoso-Sousa, Leia; Gomes Aguiar, Emilia Maria; Caixeta, Douglas Carvalho; Vilela, Danielle Diniz; da Costa, Danilo Pereira; Silva, Tamires Lopes; Cunha, Thulio Marquez; Faria, Paulo Rogerio; Espindola, Foued Salmen; Jardim, Ana Carolina; Vieira, Alexandre Antonio; Oliveira, Tales Lyra; Goulart, Luiz Ricardo; Sabino-Silva, Robinson			Effects of salbutamol and phlorizin on acute pulmonary inflammation and disease severity in experimental sepsis	PLOS ONE			English	Article							ACUTE LUNG INJURY; OXIDATIVE STRESS; SEPTIC SHOCK; GLUCOSE; CANAGLIFLOZIN; ABSORPTION; MANAGEMENT; MORTALITY; CYTOKINES; PROTECTS	Respiratory infection can be exacerbated by the high glucose concentration in the airway surface liquid (ASL). We investigated the effects of salbutamol and phlorizin on the pulmonary function, oxidative stress levels and SGLT1 activity in lung, pulmonary histopathological damages and survival rates of rats with sepsis. Sepsis was induced by cecal ligation and puncture surgery (CLP). Twenty-four hours after surgery, CLP rats were intranasally treated with saline, salbutamol or phlorizin. After 2 hours, animals were anesthetized and sacrificed. Sepsis promoted atelectasis and bronchial inflammation, and led to increased expression of SGLT1 on cytoplasm of pneumocytes. Salbutamol treatment reduced bronchial inflammation and promoted hyperinsuflation in CLP rats. The interferon-gamma and Interleucin-1 beta concentrations in bronchoalveolar lavage (BAL) were closely related to the bronchial inflammation regulation. Salbutamol stimulated SGLT1 in plasma membrane; whereas, phlorizin promoted the increase of SGLT1 in cytoplasm. Phlorizin reduced catalase activity and induced a significant decrease in the survival rate of CLP rats. Taken together, sepsis promoted atelectasis and lung inflammation, which can be associated with SGLT1 inhibition. The loss of function of SGLT1 by phlorizin are related to the augmented disease severity, increased atelectasis, bronchial inflammation and a significant reduction of survival rate of CLP rats. Alternatively salbutamol reduced BAL inflammatory cytokines, bronchial inflammation, atelectasis, and airway damage in sepsis. These data suggest that this selective beta 2-adrenergic agonist may protect lung of septic acute effects.	[Cardoso-Sousa, Leia; Gomes Aguiar, Emilia Maria; da Costa, Danilo Pereira; Vieira, Alexandre Antonio; Sabino-Silva, Robinson] Univ Fed Uberlandia, Inst Biomed Sci, Dept Physiol, Uberlandia, MG, Brazil; [Caixeta, Douglas Carvalho; Vilela, Danielle Diniz; Espindola, Foued Salmen; Goulart, Luiz Ricardo] Univ Fed Uberlandia, Inst Biotechnol, Uberlandia, MG, Brazil; [Silva, Tamires Lopes] Univ Fed Uberlandia, Inst Biomed Sci, Lab Immunoparasitol Dr Mario Endsfeldz Camargo, Uberlandia, MG, Brazil; [Cunha, Thulio Marquez] Univ Fed Uberlandia, Sch Med, Dept Pulmonol, Uberlandia, MG, Brazil; [Faria, Paulo Rogerio] Univ Fed Uberlandia, Inst Biomed Sci, Dept Morphol, Uberlandia, MG, Brazil; [Jardim, Ana Carolina] Univ Fed Uberlandia, Inst Biomed Sci, Lab Virol, Uberlandia, MG, Brazil; [Oliveira, Tales Lyra] Municipal Univ Sao Caetano, Fac Med, Sao Paulo, Brazil; [Goulart, Luiz Ricardo] Univ Calif Davis, Dept Med Microbiol & Immunol, Davis, CA 95616 USA	Universidade Federal de Uberlandia; Universidade Federal de Uberlandia; Universidade Federal de Uberlandia; Universidade Federal de Uberlandia; Universidade Federal de Uberlandia; Universidade Federal de Uberlandia; University of California System; University of California Davis	Sabino-Silva, R (corresponding author), Univ Fed Uberlandia, Inst Biomed Sci, Dept Physiol, Uberlandia, MG, Brazil.	robinsonsabino@gmail.com	Jardim, Ana Carolina/H-3615-2012; de Oliveira, Tales Lyra/W-7524-2018; Sabino-Silva, Robinson/I-2264-2012	Jardim, Ana Carolina/0000-0002-6348-7923; de Oliveira, Tales Lyra/0000-0003-4831-3009; Sabino-Silva, Robinson/0000-0002-2104-5780; Lopes Silva, Tamires/0000-0001-5118-0556; Caixeta, Douglas Carvalho/0000-0002-2363-6584	CNPq; CAPES; FAPEMIG; Federal University of Uberlandia; National Institute of Science and Technology in Theranostics and Nanobiotechnology (CNPq) [465669/2014-0]	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Federal University of Uberlandia; National Institute of Science and Technology in Theranostics and Nanobiotechnology (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This research was supported by a grant from CNPq, CAPES, Federal University of Uberlandia and FAPEMIG. Our best regards to National Institute of Science and Technology in Theranostics and Nanobiotechnology (CNPq Process N.: 465669/2014-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschenbach JR, 2002, J NUTR, V132, P1254, DOI 10.1093/jn/132.6.1254; Banks WA, 1995, NEUROIMMUNOMODULAT, V2, P241, DOI 10.1159/000097202; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Cinel Ismail, 2012, J Thorac Dis, V4, P30, DOI 10.3978/j.issn.2072-1439.2010.08.04; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Cohen J, 2015, LANCET INFECT DIS, V15, P581, DOI 10.1016/S1473-3099(15)70112-X; Craciun FL, 2014, SHOCK, V41, P97, DOI 10.1097/SHK.0000000000000073; Demling RH, 2000, WORLD J SURG, V24, P673, DOI 10.1007/s002689910109; Doggrell SA, 2014, EXPERT OPIN PHARMACO, V15, P437, DOI 10.1517/14656566.2014.868885; Eteraf-Oskouei T, 2017, RES PHARM SCI, V12, P364, DOI 10.4103/1735-5362.213981; Goncalves-de-Albuquerque CF, 2016, PLOS ONE, V11; Inagaki N, 2013, DIABETES OBES METAB, V15, P1136, DOI 10.1111/dom.12149; Kang HJ, 2016, THER CLIN RISK MANAG, V12, P287, DOI 10.2147/TCRM.S97989; Koepsell H, 2016, PHARMACOL THERAPEUT, V7258, P30196; Li YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep22747; Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058; Meade MO, 2008, JAMA-J AM MED ASSOC, V299, P637, DOI 10.1001/jama.299.6.637; Melo IS, 2016, EPILEPSY BEHAV, V61, P258, DOI 10.1016/j.yebeh.2016.05.026; OKUSAWA S, 1988, J CLIN INVEST, V81, P1162, DOI 10.1172/JCI113431; Oliveira TL, 2016, SCI REP-UK, V6, DOI 10.1038/srep21752; Ozogul B, 2015, DRUG RES, V65, P192, DOI 10.1055/s-0034-1375683; Polidori D, 2013, DIABETES CARE, V36, P2154, DOI 10.2337/dc12-2391; Powell DR, 2013, J PHARMACOL EXP THER, V345, P250, DOI 10.1124/jpet.113.203364; Prenner BM, 2008, CURR OPIN PULM MED, V14, P57; Raffay T, 2014, NEONATOLOGY, V106, P126, DOI 10.1159/000362684; Reddy RC, 2001, IMMUNOL RES, V24, P273, DOI 10.1385/IR:24:3:273; Sabino-Silva R, 2013, DIABETOL METAB SYNDR, V5, DOI 10.1186/1758-5996-5-64; Sabino-Silva R, 2010, AM J PHYSIOL-ENDOC M, V299, pE1028, DOI 10.1152/ajpendo.00395.2010; Santiago MB, 2013, EXP PHYSIOL, V98, P556, DOI 10.1113/expphysiol.2012.066241; Santos RS, 2016, ANESTH ANALG, V122, P1089, DOI 10.1213/ANE.0000000000001173; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Theobaldo MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074369; Vilela DD, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6978625; Vinuales C, 2012, CELL PHYSIOL BIOCHEM, V30, P173, DOI 10.1159/000339056; Walley ER, 1996, INFECT IMMUN, V64, P4733, DOI 10.1128/IAI.64.11.4733-4738.1996; WICHTERMAN KA, 1980, J SURG RES, V29, P189, DOI 10.1016/0022-4804(80)90037-2; Zhang XX, 2017, INFLAMMATION, V40, P351, DOI 10.1007/s10753-016-0481-5; Zhao HY, 2016, J HISTOCHEM CYTOCHEM, V64, P125, DOI 10.1369/0022155415610168; ZHENG H, 1995, IMMUNITY, V3, P9, DOI 10.1016/1074-7613(95)90154-X	39	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222575	10.1371/journal.pone.0222575	http://dx.doi.org/10.1371/journal.pone.0222575			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536570	gold, Green Published, Green Submitted			2022-12-26	WOS:000532262800054
J	Dado-Senn, B; Skibiel, AL; Fabris, TF; Dahl, GE; Laporta, J				Dado-Senn, Bethany; Skibiel, Amy L.; Fabris, Thiago F.; Dahl, Geoffrey E.; Laporta, Jimena			Dry period heat stress induces microstructural changes in the lactating mammary gland	PLOS ONE			English	Article							CALF BIRTH-WEIGHT; GENE-EXPRESSION; HOLSTEIN COWS; LATE-GESTATION; PERFORMANCE; TRANSITION; ORGANELLES; APOPTOSIS; FILAMENTS; ABATEMENT	The bovine dry period is a non -lactating period between consecutive lactations characterized by mammary gland involution and redevelopment phases to replace senescent mammary epithelial cells with active cells primed for the next lactation. Dairy cows exposed to heat stress during the dry period experience milk yield reductions between 3-7.5 kg/d in the next lactation, partially attributed to processes associated with mammary cell growth and turnover during the dry period. However, the carry-over impact of dry period heat stress on mammary morphology during lactation has yet to be determined. In the current study, we hypothesized that exposure to heat stress during the dry period would alter alveolar microstructure and cellular turnover (i.e. proliferation and apoptosis) during lactation. Cows were either subjected to heat stress (HT, access to shade; n = 12) or cooling (CL, access to shade, fans, and soakers; n = 12) for a 46 d dry period. Upon calving, all cows were treated similarly with access to cooling for their entire lactation. Six cows per treatment were randomly selected for mammary gland biopsies at 14, 42, and 84 days in milk. Tissues were sectioned and stained for histological analysis. During lactation, HT cows produced 4 kg less colostrum and 3.7 kg less milk compared with CL cows. Lactating mammary gland microstructure was impacted after exposure to dry period heat stress; HT cows had fewer alveoli and a higher proportion of connective tissue in the mammary gland relative to CL cows, however alveolar area was similar between treatments. Rates of mammary epithelial cell proliferation and apoptosis were similar between treatment groups. This suggests that heat stress exposure during the dry period leads to reductions in milk yield that could be caused, in part, by a reduction in alveoli number in the lactating mammary gland but not to dynamic alterations in cellular turnover once lactation is established.	[Dado-Senn, Bethany; Skibiel, Amy L.; Fabris, Thiago F.; Dahl, Geoffrey E.; Laporta, Jimena] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA; [Skibiel, Amy L.] Univ Idaho, Dept Anim & Vet Sci, Moscow, ID 83843 USA	State University System of Florida; University of Florida; Idaho; University of Idaho	Laporta, J (corresponding author), Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA.	jlaporta@ufl.edu	Dahl, Geoffrey/AAC-4953-2019; Laporta, Jimena/AAX-3093-2021	Dado-Senn, Bethany/0000-0002-6104-7334	University of Florida Institute of Food and Agricultural Sciences Climate Change; Florida's Agricultural, Natural Resource and Human Systems 2016 Seed Fund Grant; USDA NIFA AFRI Foundational Program [2015-67015-23409]	University of Florida Institute of Food and Agricultural Sciences Climate Change; Florida's Agricultural, Natural Resource and Human Systems 2016 Seed Fund Grant; USDA NIFA AFRI Foundational Program	Funding was provided through University of Florida Institute of Food and Agricultural Sciences Climate Change; and Florida's Agricultural, Natural Resource and Human Systems 2016 Seed Fund Grant awarded to Dr. Laporta. The authors acknowledge USDA NIFA AFRI Foundational Program (Award#2015-67015-23409) awarded to Dr. Dahl for additional funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adin G, 2009, LIVEST SCI, V124, P189, DOI 10.1016/j.livsci.2009.01.014; Akers R.M., 2002, LACTATION MAMMARY GL, V1st; Avendano-Reyes L, 2006, LIVEST SCI, V105, P198, DOI 10.1016/j.livsci.2006.06.009; Baumgard LH, 2013, ANNU REV ANIM BIOSCI, V1, P311, DOI 10.1146/annurev-animal-031412-103644; Bernabucci U, 2010, ANIMAL, V4, P1167, DOI 10.1017/S175173111000090X; Capuco AV, 2003, J ANIM SCI, V81, P18; Capuco AV, 2001, J DAIRY SCI, V84, P2177, DOI 10.3168/jds.S0022-0302(01)74664-4; Capuco AV, 1997, J DAIRY SCI, V80, P477, DOI 10.3168/jds.S0022-0302(97)75960-5; Collier RJ, 2008, J DAIRY SCI, V91, P445, DOI 10.3168/jds.2007-0540; COLLIER RJ, 1982, J ANIM SCI, V54, P309, DOI 10.2527/jas1982.542309x; Dado-Senn, 2018, J DAIRY SCI S2, V101, P151; Dado-Senn B, 2018, SCI REP, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Davis SR, 1998, J DAIRY RES, V65, P1, DOI 10.1017/S0022029997002562; De Vries LD, 2010, J DAIRY SCI, V93, P2433, DOI 10.3168/jds.2009-2764; Dikmen S, 2008, J DAIRY SCI, V91, P3395, DOI 10.3168/jds.2008-1072; do Amaral BC, 2011, J DAIRY SCI, V94, P86, DOI 10.3168/jds.2009-3004; do Amaral BC, 2009, J DAIRY SCI, V92, P5988, DOI 10.3168/jds.2009-2343; Enger BD, 2018, VET RES, V49, DOI 10.1186/s13567-018-0542-x; Fabris TF, 2017, J DAIRY SCI, V100, P6733, DOI 10.3168/jds.2016-12313; Farr VC, 1996, J DAIRY SCI, V79, P543, DOI 10.3168/jds.S0022-0302(96)76398-1; Ferreira FC, 2016, J DAIRY SCI, V99, P9931, DOI 10.3168/jds.2016-11566; Gebremedhin KG, 2001, J THERM BIOL, V26, P537, DOI 10.1016/S0306-4565(00)00048-6; HOLST BD, 1987, J DAIRY SCI, V70, P935, DOI 10.3168/jds.S0022-0302(87)80097-8; Hu H, 2016, ANIM PROD SCI, V56, P918, DOI 10.1071/AN14420; HURLEY WL, 1989, J DAIRY SCI, V72, P1637, DOI 10.3168/jds.S0022-0302(89)79276-6; Lang SLC, 2012, J EXP BIOL, V215, P2904, DOI 10.1242/jeb.067058; LASZLO A, 1992, CELL PROLIFERAT, V25, P59, DOI 10.1111/j.1365-2184.1992.tb01482.x; Li L, 2015, CELL STRESS CHAPERON, V20, P381, DOI 10.1007/s12192-014-0559-7; Miller N, 2006, J DAIRY SCI, V89, P4669, DOI 10.3168/jds.S0022-0302(06)72517-6; Monteiro APA, 2016, J DAIRY SCI, V99, P8443, DOI 10.3168/jds.2016-11072; Robertshaw D., 2004, Dukes' physiology of domestic animals, P962; Safayi S, 2010, J DAIRY SCI, V93, P1478, DOI 10.3168/jds.2009-2422; SHYY TT, 1989, J CELL BIOL, V108, P997, DOI 10.1083/jcb.108.3.997; Skibiel AL, 2018, SCI REP, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Skibiel AL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206046; Sonna LA, 2002, J APPL PHYSIOL, V92, P1725, DOI 10.1152/japplphysiol.01143.2001; St-Pierre NR, 2003, J DAIRY SCI, V86, pE52, DOI 10.3168/jds.S0022-0302(03)74040-5; Tao S, 2013, J DAIRY SCI, V96, P4079, DOI 10.3168/jds.2012-6278; Tao S, 2012, J DAIRY SCI, V95, P7128, DOI 10.3168/jds.2012-5697; Tao S, 2011, J DAIRY SCI, V94, P5976, DOI 10.3168/jds.2011-4329; Thompson I. M., 2012, Professional Animal Scientist, V28, P628; TRINIDAD P, 1990, J DAIRY SCI, V73, P639, DOI 10.3168/jds.S0022-0302(90)78715-2; Val-Arreola D, 2004, J DAIRY SCI, V87, P3789, DOI 10.3168/jds.S0022-0302(04)73518-3; WELCH WJ, 1985, J CELL BIOL, V101, P1198, DOI 10.1083/jcb.101.4.1198; Wheelock JB, 2010, J DAIRY SCI, V93, P644, DOI 10.3168/jds.2009-2295; Wohlgemuth SE, 2016, J DAIRY SCI, V99, P4875, DOI 10.3168/jds.2015-10649; WOLFENSON D, 1988, J DAIRY SCI, V71, P809, DOI 10.3168/jds.S0022-0302(88)79621-6; Yousef M. K., 1985, STRESS PHYSL LIVESTO; Zimbleman R. B., 2009, P SW NUTR C, P158	49	25	26	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222120	10.1371/journal.pone.0222120	http://dx.doi.org/10.1371/journal.pone.0222120			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX5TK	31536517	Green Submitted, Green Published, gold			2022-12-26	WOS:000521942600001
J	Nogoy, FM; Jung, YJ; Kang, KK; Cho, YG				Nogoy, Franz Marielle; Jung, Yu Jin; Kang, Kwon-Kyoo; Cho, Yong-Gu			Physico-chemical characterization and transcriptome analysis of 5-methyltryptophan resistant lines in rice	PLOS ONE			English	Article							ANTHRANILATE SYNTHASE; TRYPTOPHAN ACCUMULATION; TRANSGENIC RICE; GENE; SUBUNIT; MUTANT; SELECTION; BIOSYNTHESIS; EXPRESSION; PLANTS	Mutation breeding has brought significant contributions to the development of high value crops. It steered the first studies to generate plants with desired mutations of genes encoding key enzymes involved in important metabolic pathways. Molecular characterization of 5-methyl tryptophan (5-MT) resistant plants has revealed different base changes in alpha unit of anthranilate synthase (OsASA) gene that can lead to insensitivity to feedback inhibition of anthranilate synthase. The objective of this study was to perform in silico analysis of microarray data from five progressing time points during grain filling of rice. Results showed various differentially expressed genes. Enrichment of these genes revealed their roles in amino acid transportation during grain filling. Surprisingly, among all DEGs, only LOC_Os06g42560, a tryptophan synthase beta chain, was found to be directly related to tryptophan biosynthesis. It might affect amino acid content during grain filling. For physicochemical analysis, different grain and eating qualities parameters were measured using mutant rice lines. Evaluation results showed that 5MT resistant-lines (5MT R-lines) showed approximately 60% chalkiness after milling although it had 20 times higher tryptophan content measured in mu g/100 mg seeds. Taste quality of these 5MT R-lines in general was not affected significantly. However, other parameters such as peak time of viscosity and gelatinization temperature showed different results compared to the wildtype. Mutant lines generated in this study are important resources for high tryptophan content, although they have lower grain quality than the wildtype. They might be useful for developing new high nutrient rice varieties.	[Nogoy, Franz Marielle; Cho, Yong-Gu] Chungbuk Natl Univ, Dept Crop Sci, Cheongju, South Korea; [Jung, Yu Jin; Kang, Kwon-Kyoo] Hankyong Natl Univ, Dept Hort, Ansung, South Korea; [Nogoy, Franz Marielle] Cent Luzon State Univ, Coll Agr, Dept Crop Sci, Munoz, Nueva Ecija, Philippines	Chungbuk National University; Hankyong National University; Central Luzon State University	Cho, YG (corresponding author), Chungbuk Natl Univ, Dept Crop Sci, Cheongju, South Korea.; Kang, KK (corresponding author), Hankyong Natl Univ, Dept Hort, Ansung, South Korea.	kykang@hknu.ac.kr; ygcho@cbnu.ac.kr	Cho, Yong-Gu/AAV-1904-2021	Cho, Yong-Gu/0000-0003-3213-6669	NextGeneration BioGreen 21 Program (Plant Molecular Breeding Center) [PJ013207]; Rural Development Administration, Republic of Korea	NextGeneration BioGreen 21 Program (Plant Molecular Breeding Center)(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This research was supported by the NextGeneration BioGreen 21 Program (Plant Molecular Breeding Center, No. PJ013207), Rural Development Administration, Republic of Korea.	Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Cho HJ, 2000, PLANT PHYSIOL, V123, P1069, DOI 10.1104/pp.123.3.1069; Cho YG, 2014, AGR FORESTRY LIVESTO; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Hanafy MS, 2006, PLANT SCI, V171, P670, DOI 10.1016/j.plantsci.2006.06.016; HYDE EI, 1991, EUR J BIOCHEM, V201, P569, DOI 10.1111/j.1432-1033.1991.tb16316.x; Ishihara A, 2007, METABOLOMICS, V3, P319, DOI 10.1007/s11306-007-0072-4; Ishikawa Y, 2003, PLANT SCI, V164, P1037, DOI 10.1016/S0168-9452(03)00107-9; JULIANO BO, 1971, CEREAL SCI TODAY, V16, P334; Kambhampati S, 2019, PLANT METHODS, V15, DOI 10.1186/s13007-019-0430-z; KANG KK, 1993, EUPHYTICA, V69, P95, DOI 10.1007/BF00021731; Kanno T, 2004, PLANT MOL BIOL, V54, P11, DOI 10.1023/B:PLAN.0000028729.79034.07; KIM DG, 2007, J CONTROL AUTOM SYST, V1, P1; Kim DS, 2005, PHYSIOL PLANTARUM, V123, P302, DOI 10.1111/j.1399-3054.2005.00468.x; Kubo M., 2004, Journal of Food Distribution Research, V35, P128; LEE HY, 1991, THEOR APPL GENET, V82, P405, DOI 10.1007/BF00588590; Lee HyeJung, 2014, Plant Breeding and Biotechnology, V2, P301, DOI 10.9787/PBB.2014.2.3.301; LESTER G, 1968, J BACTERIOL, V96, P1768, DOI 10.1128/JB.96.5.1768-1773.1968; MARMORSTEIN RQ, 1989, J BIOL CHEM, V264, P9149; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Moffett JR, 2003, IMMUNOL CELL BIOL, V81, P247, DOI 10.1046/j.1440-1711.2003.t01-1-01177.x; NIYOGI KK, 1992, PLANT CELL, V4, P721, DOI 10.1105/tpc.4.6.721; Nogoy F. M., 2018, Plant Breeding and Biotechnology, V6, P233, DOI 10.9787/PBB.2018.6.3.233; RANCH JP, 1983, PLANT PHYSIOL, V71, P136, DOI 10.1104/pp.71.1.136; TAM YY, 1995, PLANT PHYSIOL, V107, P77, DOI 10.1104/pp.107.1.77; Tozawa Y, 2001, PLANT PHYSIOL, V126, P1493, DOI 10.1104/pp.126.4.1493; Wakasa K, 2006, J EXP BOT, V57, P3069, DOI 10.1093/jxb/erl068; Yamada T, 2004, MOL BREEDING, V14, P363, DOI 10.1007/s11032-004-0184-8; Zhang XH, 2001, PLANT PHYSIOL, V127, P131, DOI 10.1104/pp.127.1.131	31	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0222262	10.1371/journal.pone.0222262	http://dx.doi.org/10.1371/journal.pone.0222262			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532784	Green Published, gold, Green Submitted			2022-12-26	WOS:000532239600025
J	Benito-Leon, J; Contador, I; Vega, S; Villarejo-Galende, A; Bermejo-Pareja, F				Benito-Leon, Julian; Contador, Israel; Vega, Saturio; Villarejo-Galende, Alberto; Bermejo-Pareja, Felix			Non-steroidal anti-inflammatory drugs use in older adults decreases risk of Alzheimer's disease mortality	PLOS ONE			English	Article							3 ELDERLY POPULATIONS; ESSENTIAL TREMOR; COGNITIVE FUNCTION; DEMENTIA; PREVALENCE; MEMORY; NEUROINFLAMMATION; PARKINSONISM; DECLINE; HEALTH	Alzheimer disease (AD) mortality risk in a large cohort of subjects treated or not with nonsteroidal anti-inflammatory drugs (NSAIDs) is unknown. Our objective was to determine whether NSAIDs use is associated with decreased risk of AD mortality. In this prospective, population-based study (Neurological Disorders in Central Spain [NEDICES]) of 5,072 people without AD (aged 65 years and older), sociodemographic, comorbidity factors, and current medications were recorded at baseline. Community-dwelling older adults were followed for a median of 12.7 years, after which the death certificates of deceased participants were examined. 2,672 (52.7%) of 5,072 participants died, including 504 (18.9%) NSAIDs users and 2,168 (81.1%) non-users. Of the 2,672 deceased participants, 113 (4.2%) had AD as a cause of death (8 [1.6%] among NSAIDs users and 105 [4.8%] among non-users, chi-square = 10.70, p = 0.001). In an unadjusted Cox model, risk of AD mortality was decreased in NSAIDs users (hazard ratio [HR] for AD mortality = 0.35, 95% confidence interval [CI] 0.17-0.72, p = 0.004) when compared to non-users. After adjusting for numerous demographic factors and co-morbidities, the HR for AD mortality in NSAIDs users was 0.29, 95% CI 0.12-0.73, p = 0.009. Stratified analyses showed a significantly decreased risk of AD mortality with aspirin, whereas non-aspirin NSAIDs only showed a statistical trend toward significance in the adjusted Cox regression models. NSAIDs use was associated with 71% decreased risk of AD mortality in older adults. Our results support the hypothesis that NSAIDs use is a protective factor of developing AD.	[Benito-Leon, Julian; Villarejo-Galende, Alberto] Univ Hosp 12 Octubre, Dept Neurol, Madrid, Spain; [Benito-Leon, Julian; Villarejo-Galende, Alberto] Network Ctr Biomed Res Neurodegenerat Dis CIBERNE, Madrid, Spain; [Benito-Leon, Julian; Villarejo-Galende, Alberto; Bermejo-Pareja, Felix] Univ Complutense Madrid, Dept Med, Madrid, Spain; [Contador, Israel] Univ Salamanca, Dept Basic Psychol Psychobiol & Methodol Behav Sc, Salamanca, Spain; [Vega, Saturio] Arevalo Hlth Ctr, Arevalo, Avila, Spain; [Bermejo-Pareja, Felix] Univ Hosp 12 Octubre, Clin Res Unit I 12, Madrid, Spain	Hospital Universitario 12 de Octubre; Complutense University of Madrid; University of Salamanca; Hospital Universitario 12 de Octubre	Benito-Leon, J (corresponding author), Univ Hosp 12 Octubre, Dept Neurol, Madrid, Spain.; Benito-Leon, J (corresponding author), Network Ctr Biomed Res Neurodegenerat Dis CIBERNE, Madrid, Spain.; Benito-Leon, J (corresponding author), Univ Complutense Madrid, Dept Med, Madrid, Spain.	jbenitol67@gmail.com	Benito-León, Julián/AAA-1331-2019; Villarejo, Alberto/ABF-1064-2020	Benito-León, Julián/0000-0002-1769-4809; Villarejo, Alberto/0000-0002-6834-7620; Contador, Israel/0000-0002-7841-1307	Fondo Europeo de Desarrollo Regional (FEDER); Sanidad de Castilla y Leon (SACYL) funds	Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Sanidad de Castilla y Leon (SACYL) funds	This research was supported by Fondo Europeo de Desarrollo Regional (FEDER) and Sanidad de Castilla y Leon (SACYL) funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MM, 2019, CUREUS, V11, DOI 10.7759/cureus.4620; American Psychiatric A, 1994, DIAGN STAT MAN MENT; Benito-Leon J, 2006, NEUROLOGY, V66, P69, DOI 10.1212/01.wnl.0000192393.05850.ec; Benito-Leon J, 2004, NEUROLOGY, V62, P734, DOI 10.1212/01.WNL.0000113727.73153.68; Benito-Leon J, 2003, MOVEMENT DISORD, V18, P267, DOI 10.1002/mds.10362; Benito-Leon J, 2003, MOVEMENT DISORD, V18, P389, DOI 10.1002/mds.10376; Benito-Leon J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004607; Benito-Leon J, 2015, PARKINSONISM RELAT D, V21, P622, DOI 10.1016/j.parkreldis.2015.03.023; Benito-Leon J, 2014, NEUROLOGY, V82, P1441, DOI 10.1212/WNL.0000000000000350; Benito-Leon J, 2013, NEUROLOGY, V81, P60, DOI 10.1212/WNL.0b013e318297ef2b; Benito-Leon J, 2010, J ALZHEIMERS DIS, V22, P159, DOI 10.3233/JAD-2010-100972; Benito-Leon J, 2010, J ALZHEIMERS DIS, V21, P95, DOI 10.3233/JAD-2010-100180; Bermejo-Pareja F, 2008, REV NEUROLOGIA, V46, P416, DOI 10.33588/rn.4607.2008134; Bermejo-Pareja F, 2008, J NEUROL SCI, V264, P63, DOI 10.1016/j.jns.2007.07.021; Bermejo-Pareja F, 2009, J GERIATR PSYCH NEUR, V22, P246, DOI 10.1177/0891988709335794; Bermejo-Pareja F, 2010, J ALZHEIMERS DIS, V22, P949, DOI 10.3233/JAD-2010-101110; Buchhave P, 2012, ARCH GEN PSYCHIAT, V69, P98, DOI 10.1001/archgenpsychiatry.2011.155; Choi SH, 2013, J NEUROCHEM, V124, P59, DOI 10.1111/jnc.12059; Choi SH, 2009, AGING-US, V1, P234, DOI 10.18632/aging.100021; Diaz-Guzman J, 2008, NEUROEPIDEMIOLOGY, V30, P247, DOI 10.1159/000135643; Hankey GJ, 2006, LANCET, V367, P606, DOI 10.1016/S0140-6736(06)68040-9; Hoyer S, 1996, ACTA NEUROL SCAND, V93, P18; Imbimbo BP, 2009, EXPERT OPIN INV DRUG, V18, P1147, DOI 10.1517/13543780903066780; Jaturapatporn D, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006378.pub2; Kotilinek LA, 2008, BRAIN, V131, P651, DOI 10.1093/brain/awn008; Louis ED, 2010, J NEUROL NEUROSUR PS, V81, P997, DOI 10.1136/jnnp.2009.202838; McGeer PL, 2018, J ALZHEIMERS DIS, V62, P1219, DOI 10.3233/JAD-170706; MCGEER PL, 1990, LANCET, V335, P1037, DOI 10.1016/0140-6736(90)91101-F; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Meyer PF, 2019, NEUROLOGY, V92, pE2070, DOI 10.1212/WNL.0000000000007232; Morales JM, 2004, PUBLIC HEALTH, V118, P426, DOI 10.1016/j.puhe.2003.10.007; Nevado-Holgado AJ, 2017, COMPUT STRUCT BIOTEC, V15, P1, DOI 10.1016/j.csbj.2016.10.003; Prestia A, 2013, NEUROLOGY, V80, P1048, DOI 10.1212/WNL.0b013e3182872830; Romero JP, 2014, J ALZHEIMERS DIS, V41, P213, DOI 10.3233/JAD-132765; Sanz-Blasco S, 2018, CURR ALZHEIMER RES, V15, P504, DOI 10.2174/1567205015666171227154016; Varga Z, 2017, CUREUS, V9, DOI 10.7759/cureus.1144; Vega S, 2010, J CLIN EPIDEMIOL, V63, P215, DOI 10.1016/j.jclinepi.2009.03.005; Wang J, 2015, J ALZHEIMERS DIS, V44, P385, DOI 10.3233/JAD-141506; Woodling NS, 2016, ACS CHEM NEUROSCI, V7, P454, DOI 10.1021/acschemneuro.6b00016; Zhang CX, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00083	40	24	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222505	10.1371/journal.pone.0222505	http://dx.doi.org/10.1371/journal.pone.0222505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527913	Green Published, gold, Green Submitted			2022-12-26	WOS:000532231400025
J	Li, FF; Gong, L; Li, JS; Liu, XY; Zhao, CY				Li, Fei-Fei; Gong, Lu; Li, Jun-Sheng; Liu, Xiao-Yan; Zhao, Cai-Yun			Low genetic differentiation yet high phenotypic variation in the invasive populations of Spartina alterniflora in Guangxi, China	PLOS ONE			English	Article							PACIFIC COAST; DIVERSITY; HYBRIDIZATION; EVOLUTION; DENSIFLORA; ADMIXTURE; PLASTICITY; DISPERSAL; SOFTWARE; PARADOX	Genetic variation and population structure may reflect important information for invasion success of exotic plant species and thus help improve management of invasive plants. Spartina alterniflora is an invasive plant that is a major threat to the economy and environment of the coastal regions in China. We analyzed the genetic structure and diversity of six populations of S. alterniflora differing in invasion histories in Guangxi, China. A total of 176 individuals from the six populations produced 348 AFLP fragments. The average heterozygosity was significantly lower than in the native population. And genetic bottlenecks were also detected in most populations. Standardized F-ST statistics (phi(pt) = 0.015) and AMOVA results indicated weak genetic differentiation. Genetic admixture and obviously isolation by distance indicated populations in Guangxi come from a pre-admixed population by a single introduction. High phenotypic variations of S. alterniflora in Guangxi influenced by soil salinity and temperature might be an important reason for the successful invasion.	[Li, Fei-Fei; Gong, Lu; Li, Jun-Sheng; Liu, Xiao-Yan; Zhao, Cai-Yun] Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China	Chinese Research Academy of Environmental Sciences	Zhao, CY (corresponding author), Chinese Res Inst Environm Sci, State Key Lab Environm Criteria & Risk Assessment, Beijing, Peoples R China.	zhaocycraes@126.com	Li, Feifei/AAJ-1778-2020	Li, Feifei/0000-0003-4733-6268	National Key Research and Development Program of China [2017YFC0506200]; Foundation of the Chinese Research Academy of Environmental Sciences [2012-YSKY-05]	National Key Research and Development Program of China; Foundation of the Chinese Research Academy of Environmental Sciences	This work was financially supported by grants from The National Key Research and Development Program of China 2017YFC0506200 and the Foundation of the Chinese Research Academy of Environmental Sciences 2012-YSKY-05.; We thank Zhao Xiang-Jian, Deng Zhen-Zhen, Sun Hong-Yu, and Guang Xi for assistance with sample collection. This work was financially supported by grants from the National Key Research and Development Program of China (2017YFC0506200) and the Foundation of the Chinese Research Academy of Environmental Sciences (2012-YSKY-05).	Ainouche ML, 2004, NEW PHYTOL, V161, P165, DOI 10.1046/j.1469-8137.2003.00926.x; An SQ, 2007, WEED RES, V47, P183, DOI 10.1111/j.1365-3180.2007.00559.x; Ayres DR, 2008, AM J BOT, V95, P713, DOI 10.3732/ajb.2007358; Baisakh N, 2009, AQUAT BOT, V91, P262, DOI 10.1016/j.aquabot.2009.07.007; Bernik BM, 2016, BIOL INVASIONS, V18, P1485, DOI 10.1007/s10530-016-1096-3; Blum MJ, 2004, MOL ECOL NOTES, V4, P39, DOI 10.1046/j.1471-8286.2003.00556.x; Caiyun Z, 2015, INVASION MANAGEMENT; CALLAWAY JC, 1992, ESTUARIES, V15, P218, DOI 10.2307/1352695; Castillo JM, 2018, ECOL EVOL, V8, P4992, DOI 10.1002/ece3.4063; Castillo JM, 2016, BIOL INVASIONS, V18, P2159, DOI 10.1007/s10530-015-0991-3; CHUNG CH, 1993, ECOL ENG, V2, P261, DOI 10.1016/0925-8574(93)90019-C; Cornuet JM, 1996, GENETICS, V144, P2001; Cristescu ME, 2015, MOL ECOL, V24, P2212, DOI 10.1111/mec.13117; Davis HG, 2004, P NATL ACAD SCI USA, V101, P13804, DOI 10.1073/pnas.0405230101; Deng ZF, 2007, HYDROBIOLOGIA, V583, P195, DOI 10.1007/s10750-006-0529-x; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ellstrand NC, 2006, EUPHYTICA, V148, P35, DOI 10.1007/s10681-006-5939-3; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Facon B, 2008, CURR BIOL, V18, P363, DOI 10.1016/j.cub.2008.01.063; Frankham R, 2005, HEREDITY, V94, P385, DOI 10.1038/sj.hdy.6800634; Gan XJ, 2009, ESTUAR COAST SHELF S, V83, P211, DOI 10.1016/j.ecss.2009.03.026; Grevstad FS, 2003, BIOL CONTROL, V27, P32, DOI 10.1016/S1049-9644(02)00181-0; Guanmin H, 2009, GROWTH CHARACTERISTI; Hurka Herbert, 2003, Biological Invasions, V5, P281; Huska D, 2016, BIOL INVASIONS, V18, P2137, DOI 10.1007/s10530-015-0956-6; Idaszkin YL, 2011, PLANT ECOL, V212, P553, DOI 10.1007/s11258-010-9844-4; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Karn E, 2017, EVOL APPL, V10, P616, DOI 10.1111/eva.12478; Kirwan ML, 2009, GLOBAL CHANGE BIOL, V15, P1982, DOI 10.1111/j.1365-2486.2008.01834.x; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Le Roux JJ, 2008, DIVERS DISTRIB, V14, P935, DOI 10.1111/j.1472-4642.2008.00504.x; Li B, 2009, ECOL ENG, V35, P511, DOI 10.1016/j.ecoleng.2008.05.013; Li JM, 2016, OECOLOGIA, V182, P755, DOI 10.1007/s00442-016-3699-x; Li Y, 2018, J ECOL, V106, P1595, DOI 10.1111/1365-2745.12926; Liu WW, 2017, ECOLOGY, V98, P1591, DOI 10.1002/ecy.1815; Liu WW, 2016, J ECOL, V104, P173, DOI 10.1111/1365-2745.12487; Mo Z., 2010, GUANGXI SCI, V17, P170, DOI DOI 10.13656/j.cnki.gxkx.2010.02.009; Naegele RP, 2015, PHYTOPATHOLOGY, V105, P110, DOI 10.1094/PHYTO-02-14-0031-R; NESTLER J, 1977, ESTUAR COAST MAR SCI, V5, P707, DOI 10.1016/0302-3524(77)90043-3; Novy A, 2010, WETLANDS, V30, P603, DOI 10.1007/s13157-010-0046-6; Ort BS, 2016, BIOL INVASIONS, V18, P2267, DOI 10.1007/s10530-016-1177-3; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pritchard JK, 2010, DOCUMENTATION STRUCT; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Rius M, 2014, TRENDS ECOL EVOL, V29, P233, DOI 10.1016/j.tree.2014.02.003; Roman J, 2007, TRENDS ECOL EVOL, V22, P454, DOI 10.1016/j.tree.2007.07.002; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Schierenbeck KA, 2009, BIOL INVASIONS, V11, P1093, DOI 10.1007/s10530-008-9388-x; Strong DR, 2016, BIOL INVASIONS, V18, P2237, DOI 10.1007/s10530-015-0980-6; THOMPSON JD, 1991, NEW PHYTOL, V117, P115, DOI 10.1111/j.1469-8137.1991.tb00951.x; Utomo HS, 2009, AQUAT BOT, V90, P30, DOI 10.1016/j.aquabot.2008.05.003; van Boheemen LA, 2017, MOL ECOL, V26, P5421, DOI 10.1111/mec.14293; VIVIANSMITH G, 1994, WETLANDS, V14, P316, DOI 10.1007/BF03160638; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang Q, 2006, ACTA PHYTOTAXON SIN, V44, P559, DOI 10.1360/aps06044; Wang SP, 2019, EVOLUTION, V73, P303, DOI 10.1111/evo.13676; Xia L, 2015, CLEAN-SOIL AIR WATER, V43, P1672, DOI 10.1002/clen.201300882; Xiao DR, 2009, ESTUAR COAST SHELF S, V83, P105, DOI 10.1016/j.ecss.2009.03.024; [赵相健 Zhao Xiangjian], 2015, [生态科学, Ecologic Science], V34, P119	61	4	5	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222646	10.1371/journal.pone.0222646	http://dx.doi.org/10.1371/journal.pone.0222646			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527890	gold, Green Published, Green Submitted			2022-12-26	WOS:000532231400034
J	Khavari, A; Ehrlicher, AJ				Khavari, Adele; Ehrlicher, Allen Joseph			Nuclei deformation reveals pressure distributions in 3D cell clusters	PLOS ONE			English	Article							SIZE; STRESS; GROWTH; BINDING; STRAIN; VOLUME; SHAPE; GELS	Measuring pressures within complex multi-cellular environments is critical for studying mechanobiology as these forces trigger diverse biological responses, however, these studies are difficult as a deeply embedded yet well-calibrated probe is required. In this manuscript, we use endogenous cell nuclei as pressure sensors by introducing a fluorescent protein localized to the nucleus and confocal microscopy to measure the individual nuclear volumes in 3D multi-cellular aggregates. We calibrate this measurement of nuclear volume to pressure by quantifying the nuclear volume change as a function of osmotic pressure in isolated 2D culture. Using this technique, we find that in multicellular structures, the nuclear compressive mechanical stresses are on the order of MPa, increase with cell number in the cluster, and that the distribution of stresses is homogenous in spherical cell clusters, but highly asymmetric in oblong clusters. This approach may facilitate quantitative mechanical measurements in complex and extended biological structures both in vitro and in vivo.	[Khavari, Adele] Chalmers Univ Technol, Appl Chem Chem & Chem Engn, Gothenburg, Sweden; [Khavari, Adele; Ehrlicher, Allen Joseph] McGill Univ, Dept Bioengn, Montreal, PQ, Canada	Chalmers University of Technology; McGill University	Ehrlicher, AJ (corresponding author), McGill Univ, Dept Bioengn, Montreal, PQ, Canada.	allen.ehrlicher@mcgill.ca			Chalmers University of Technology, Department of Chemistry and Chemical Engineering; NSERC (Natural Science and Engineering Research Council of Canada) [RGPIN/05843-2014, EQPEQ/4723392015]; CIHR (Canadian Institutes of Health Research) [143327]; Canadian Cancer Society [703930]	Chalmers University of Technology, Department of Chemistry and Chemical Engineering; NSERC (Natural Science and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR (Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS))	AK was funded by Chalmers University of Technology, Department of Chemistry and Chemical Engineering. AJE was funded by NSERC (Natural Science and Engineering Research Council of Canada) RGPIN/05843-2014 & EQPEQ/4723392015, CIHR (Canadian Institutes of Health Research) Grant #143327, and Canadian Cancer Society Grant #703930.	Albro MB, 2007, J BIOMECH ENG-T ASME, V129, P503, DOI 10.1115/1.2746371; Belaadi N, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5020027; Brunner CA, 2006, EUR BIOPHYS J BIOPHY, V35, P713, DOI 10.1007/s00249-006-0079-1; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Campas O, 2014, NAT METHODS, V11, P183, DOI [10.1038/NMETH.2761, 10.1038/nmeth.2761]; Chan YHM, 2010, ORGANOGENESIS, V6, P88, DOI 10.4161/org.6.2.11464; Cheng G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004632; Chow KH, 2012, NAT REV CANCER, V12, P196, DOI 10.1038/nrc3219; Dao M, 2003, J MECH PHYS SOLIDS, V51, P2259, DOI 10.1016/j.jmps.2003.09.019; Dolega ME, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14056; Driscoll TP, 2015, BIOPHYS J, V108, P2783, DOI 10.1016/j.bpj.2015.05.010; Ehrlicher AJ, 2011, NATURE, V478, P260, DOI 10.1038/nature10430; Ehrlicher AJ, 2015, P NATL ACAD SCI USA, V112, P6619, DOI 10.1073/pnas.1505652112; Fedorchak GR, 2014, PROG BIOPHYS MOL BIO, V115, P76, DOI 10.1016/j.pbiomolbio.2014.06.009; Finan JD, 2010, J CELL BIOCHEM, V109, P460, DOI 10.1002/jcb.22437; Finan JD, 2009, ANN BIOMED ENG, V37, P477, DOI 10.1007/s10439-008-9618-5; Guilak F, 1995, J BIOMECH, V28, P1529, DOI 10.1016/0021-9290(95)00100-X; Guo M, 2017, P NATL ACAD SCI USA, V114, pE8618, DOI 10.1073/pnas.1705179114; Guo M, 2014, CELL, V158, P822, DOI 10.1016/j.cell.2014.06.051; Guo M, 2013, BIOPHYS J, V105, P1562, DOI 10.1016/j.bpj.2013.08.037; Haase K, 2016, SCI REP-UK, V6, DOI 10.1038/srep21300; Han YL, 2018, P NATL ACAD SCI USA, V115, P4075, DOI 10.1073/pnas.1722619115; Irianto J, 2013, BIOPHYS J, V104, P759, DOI 10.1016/j.bpj.2013.01.006; Jansen KA, 2017, SEMIN CELL DEV BIOL, V71, P75, DOI 10.1016/j.semcdb.2017.07.027; Jevtic P, 2015, CURR BIOL, V25, P45, DOI 10.1016/j.cub.2014.10.051; Khavari A, 2016, SCI REP-UK, V6, DOI 10.1038/srep30854; Kim DH, 2015, J CELL SCI, V128, P3375, DOI 10.1242/jcs.166330; Knight MM, 2002, BBA-GEN SUBJECTS, V1570, P1, DOI 10.1016/S0304-4165(02)00144-7; Kobayashi T, 2010, CURR OPIN CELL BIOL, V22, P669, DOI 10.1016/j.ceb.2010.08.023; Liang XJ, 2007, SENSOR ACTUAT A-PHYS, V133, P349, DOI 10.1016/j.sna.2006.06.045; Lietor-Santos JJ, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.060402; Mahaffy RE, 2004, BIOPHYS J, V86, P1777, DOI 10.1016/S0006-3495(04)74245-9; Mohagheghian E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04245-1; Mukherjee RN, 2016, NUCLEUS-PHILA, V7, P167, DOI 10.1080/19491034.2016.1162933; Nia HT, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-016-0004; Oswald Elizabeth S, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P3659; Puig-de-Morales M, 2001, J APPL PHYSIOL, V91, P1152, DOI 10.1152/jappl.2001.91.3.1152; Stylianopoulos T, 2012, P NATL ACAD SCI USA, V109, P15101, DOI 10.1073/pnas.1213353109; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Vukovic LD, 2016, J CELL SCI, V129, P1115, DOI 10.1242/jcs.181263; Wang K, 2016, ACS APPL MATER INTER, V8, P5082, DOI 10.1021/acsami.5b10531; Willis L, 2016, P NATL ACAD SCI USA, V113, pE8238, DOI 10.1073/pnas.1616768113; Zhou EH, 2009, P NATL ACAD SCI USA, V106, P10632, DOI 10.1073/pnas.0901462106	43	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2019	14	9							e0221753	10.1371/journal.pone.0221753	http://dx.doi.org/10.1371/journal.pone.0221753			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4IG	31513673	Green Published, gold			2022-12-26	WOS:000532212700020
J	Ng, CL; Qian, Y; Schulz, C				Ng, Chun L.; Qian, Yue; Schulz, Cordula			Notch and Delta are required for survival of the germline stem cell lineage in testes of Drosophila melanogaster	PLOS ONE			English	Article							GENE-EXPRESSION; NICHE FORMATION; SELF-RENEWAL; APOPTOSIS; SYSTEM; RHO; DIFFERENTIATION; PROLIFERATION; MORPHOGENESIS; INHIBITION	In all metazoan species, sperm is produced from germline stem cells. These self-renew and produce daughter cells that amplify and differentiate dependent on interactions with somatic support cells. In the male gonad of Drosophila melanogaster, the germline and somatic cyst cells co-differentiate as cysts, an arrangement in which the germline is completely enclosed by cytoplasmic extensions from the cyst cells. Notch is a developmentally relevant receptor in a pathway requiring immediate proximity with the signal sending cell. Here, we show that Notch is expressed in the cyst cells of wild-type testes. Notch becomes activated in the transition zone, an apical area of the testes in which the cyst cells express stage-specific transcription factors and the enclosed germline finalizes transit-amplifying divisions. Reducing the ligand Delta from the germline cells via RNA-Interference or reducing the receptor Notch from the cyst cells via CRISPR resulted in cell death concomitant with loss of germline cells from the transition zone. This shows that Notch signaling is essential for the survival of the germline stem cell lineage.	[Ng, Chun L.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Qian, Yue] Univ North Georgia, Dept Biol, Oakwood, GA USA; [Schulz, Cordula] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of North Georgia; University System of Georgia; University of Georgia	Schulz, C (corresponding author), Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA.	cschulz@uga.edu			National Science Foundation (NSF) [0841419, 1355099]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by the National Science Foundation (NSF) grants #0841419 and #1355099 (https://www.nsf.gov) to CS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker R, 1996, DEVELOPMENT, V122, P617; Berset T, 2001, SCIENCE, V291, P1055, DOI 10.1126/science.1055642; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bray SJ, 2016, NAT REV MOL CELL BIO, V17, P722, DOI 10.1038/nrm.2016.94; Dorsky RI, 1997, NATURE, V385, P67, DOI 10.1038/385067a0; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Fabrizio JJ, 2003, DEV BIOL, V258, P117, DOI 10.1016/S0012-1606(03)00127-1; Fairchild MJ, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007026; Fuller Margaret T., 1993, P71; Gao YT, 2015, FEBS LETT, V589, P207, DOI 10.1016/j.febslet.2014.12.002; Gratz Scott J, 2015, Curr Protoc Mol Biol, V111, DOI 10.1002/0471142727.mb3102s111; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Hayashi S, 2002, GENESIS, V34, P58, DOI 10.1002/gene.10137; Hori K, 2013, J CELL SCI, V126, P2135, DOI 10.1242/jcs.127308; Hudson AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070678; Jain R, 2010, ANN NY ACAD SCI, V1188, P184, DOI 10.1111/j.1749-6632.2009.05099.x; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kitadate Y, 2010, P NATL ACAD SCI USA, V107, P14241, DOI 10.1073/pnas.1003462107; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Le Gall M, 2008, DEV BIOL, V313, P556, DOI 10.1016/j.ydbio.2007.10.030; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; MacGrogan D, 2010, CURR TOP DEV BIOL, V92, P333, DOI 10.1016/S0070-2153(10)92011-5; Mason HA, 2006, DEV NEUROSCI-BASEL, V28, P49, DOI 10.1159/000090752; Matunis E, 1997, DEVELOPMENT, V124, P4383; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Murata A., 2016, BIOLOGY, V5, P1; Nefedova Y, 2008, BLOOD, V111, P2220, DOI 10.1182/blood-2007-07-102632; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Parrott BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036460; Perdigoto CN, 2011, DEVELOPMENT, V138, P4585, DOI 10.1242/dev.065292; Qian Y, 2014, DEV BIOL, V394, P217, DOI 10.1016/j.ydbio.2014.08.019; Sarkar A, 2007, CURR BIOL, V17, P1253, DOI 10.1016/j.cub.2007.06.048; Schulz C, 2002, DEVELOPMENT, V129, P4523; Song XQ, 2007, DEVELOPMENT, V134, P1071, DOI 10.1242/dev.003392; Van Doren M, 1998, CURR BIOL, V8, P243; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; XU T, 1993, DEVELOPMENT, V117, P1223; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Ye QF, 2012, ONCOL LETT, V3, P879, DOI 10.3892/ol.2012.572; Zacharioudaki E, 2014, METHODS, V68, P173, DOI 10.1016/j.ymeth.2014.03.029; Zandy NL, 2008, CELL CYCLE, V7, P444, DOI 10.4161/cc.7.4.5452; Zandy NL, 2007, P NATL ACAD SCI USA, V104, P17686, DOI 10.1073/pnas.0703077104; Zoller Richard, 2012, Spermatogenesis, V2, P145; Zweidler-McKay PA, 2005, BLOOD, V106, P3898, DOI 10.1182/blood-2005-01-0355	49	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2019	14	9							e0222471	10.1371/journal.pone.0222471	http://dx.doi.org/10.1371/journal.pone.0222471			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4IG	31513679	gold, Green Published, Green Submitted			2022-12-26	WOS:000532212700085
J	Trigiani, LJ; Royea, J; Tong, XK; Hamel, E				Trigiani, Lianne J.; Royea, Jessika; Tong, Xin-Kang; Hamel, Edith			Comparative benefits of simvastatin and exercise in a mouse model of vascular cognitive impairment and dementia	FASEB JOURNAL			English	Article						white matter; inflammation; memory; cerebrovascular reactivity; cerebral blood flow	WHITE-MATTER INTEGRITY; CEREBRAL-BLOOD-FLOW; ALZHEIMERS-DISEASE; PHYSICAL-EXERCISE; TRANSFORMING GROWTH-FACTOR-BETA-1; HIPPOCAMPAL NEUROGENESIS; REDUCED RISK; CHOLESTEROL; MEMORY; PATHOLOGY	Aerobic physical exercise (EX) and controlling cardiovascular risk factors in midlife can improve and protect cognitive function in healthy individuals and are considered to be effective at reducing late-onset dementia incidence. By investigating commonalities between these preventative approaches, we sought to identify possible targets for effective interventions. We compared the efficacy of EX and simvastatin (SV) pharmacotherapy to counteract cognitive deficits induced by a high-cholesterol diet (2%, HCD) in mice overexpressing TGF-beta 1 (TGF mice), a model of vascular cognitive impairment and dementia. Cognitive deficits were found in hypercholesterolemic mice for object recognition memory, and both SV and EX prevented this decline. EX improved stimulus-evoked cerebral blood flow responses and was as effective as SV in normalizing endothelium-dependent vasodilatory responses in cerebral arteries. The up-regulation of galectin-3 positive microglial cells in white matter (WM) of HCD-fed TGF mice with cognitive deficits was significantly reduced by both SV and EX concurrently with cognitive recovery. Altered hippocampal neurogenesis, gray matter astrogliosis, or microgliosis did not correlate with cognitive deficits or benefits. Overall, results indicate that SV and EX prevented cognitive decline in hypercholesterolemic mice and that they share common sites of action in preventing endothelial cell dysfunction and reducing WM inflammation.	[Trigiani, Lianne J.; Royea, Jessika; Tong, Xin-Kang; Hamel, Edith] McGill Univ, Montreal Neurol Inst, Lab Cerebrovasc Res, 3801 Univ St, Montreal, PQ H3A 2B4, Canada	McGill University	Trigiani, LJ; Hamel, E (corresponding author), McGill Univ, Montreal Neurol Inst, Lab Cerebrovasc Res, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	lianne.trigiani@mail.mcgill.ca; edith.hamel@mcgill.ca			Canadian Institutes of Health Research (CIHR) [MOP-126001]; Alzheimer Society of Canada; Canadian Vascular Network (CVN); Canadian Consortium on Neurodegeneration in Aging (CCNA); CIHR; Fonds de Recherche du Quebec-Sante; Healthy Brains for Healthy Lives	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alzheimer Society of Canada; Canadian Vascular Network (CVN); Canadian Consortium on Neurodegeneration in Aging (CCNA); CIHR(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Healthy Brains for Healthy Lives	The authors thank Dr. L. Mucke and the J. David Gladstone Institutes for providing the TGF transgenic mice for breeding (Gladstone Institute of Neurological Disease and Department of Neurology, University of California-San Francisco San Francisco, CA, USA). This study was supported by grants from the Canadian Institutes of Health Research (CIHR; Grant MOP-126001 to E.H.), the Alzheimer Society of Canada, the Canadian Vascular Network (CVN), and the Canadian Consortium on Neurodegeneration in Aging (CCNA), and studentships (to L.J.T.) from CIHR, Alzheimer Society of Canada, Fonds de Recherche du Quebec-Sante, and Healthy Brains for Healthy Lives. The authors declare no conflicts of interest.	Ahlskog JE, 2011, MAYO CLIN PROC, V86, P876, DOI 10.4065/mcp.2011.0252; Angelopoulos P, 2008, INT J NEUROSCI, V118, P1659, DOI 10.1080/00207450701392068; Anstey KJ, 2008, AM J GERIAT PSYCHIAT, V16, P343, DOI 10.1097/JGP.0b013e31816b72d4; Barnes Jill N, 2018, Brain Plast, V4, P65, DOI 10.3233/BPL-180075; Belarbi K, 2011, NEUROBIOL DIS, V43, P486, DOI 10.1016/j.nbd.2011.04.022; Bettermann K, 2012, J STROKE CEREBROVASC, V21, P436, DOI 10.1016/j.jstrokecerebrovasdis.2010.11.002; Bherer Louis, 2013, J Aging Res, V2013, P197326, DOI [10.1155/2013/657508, 10.1155/2013/197326]; Boyle PA, 2016, ANN CLIN TRANSL NEUR, V3, P791, DOI 10.1002/acn3.343; Brugniaux JV, 2014, J CEREBR BLOOD F MET, V34, P1873, DOI 10.1038/jcbfm.2014.142; Buckwalter MS, 2006, AM J PATHOL, V169, P154, DOI 10.2353/ajpath.2006.051272; Chapman SB, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00075; Chen BR, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000787; Cuello AC, 2017, TRENDS PHARMACOL SCI, V38, P956, DOI 10.1016/j.tips.2017.07.005; Czuba E, 2017, METAB BRAIN DIS, V32, P935, DOI 10.1007/s11011-017-0015-3; Dalla Y, 2010, PHARMACOL REP, V62, P784, DOI 10.1016/S1734-1140(10)70339-X; Dao AT, 2015, MOL NEUROBIOL, V52, P1067, DOI 10.1007/s12035-014-8916-1; de Assis GG, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00584; deIpolyi AR, 2008, NEUROBIOL AGING, V29, P253, DOI 10.1016/j.neurobiolaging.2006.10.021; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; DeVito LM, 2010, BEHAV BRAIN RES, V215, P318, DOI 10.1016/j.bbr.2009.09.014; Diederich K, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00047; Dougherty Ryan J, 2016, Alzheimers Dement (Amst), V4, P14, DOI 10.1016/j.dadm.2016.03.005; Dufouil C, 2005, NEUROLOGY, V64, P1531, DOI 10.1212/01.WNL.0000160114.42643.31; Endo F, 2015, CELL REP, V11, P592, DOI 10.1016/j.celrep.2015.03.053; Fields RD, 2010, SCIENCE, V330, P768, DOI 10.1126/science.1199139; Franciosi S, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-42; Gaertner RF, 2005, NEUROBIOL DIS, V19, P38, DOI 10.1016/j.nbd.2004.11.008; Garcia-Mesa Y, 2011, J ALZHEIMERS DIS, V24, P421, DOI 10.3233/JAD-2011-101635; Gomez-Pinilla F, 2013, COMPR PHYSIOL, V3, P403, DOI 10.1002/cphy.c110063; Graham NL, 2004, J NEUROL NEUROSUR PS, V75, P61; Grammas P, 2002, AM J PATHOL, V160, P1583, DOI 10.1016/S0002-9440(10)61105-4; Haag MDM, 2009, J NEUROL NEUROSUR PS, V80, P13, DOI 10.1136/jnnp.2008.150433; Harris JJ, 2012, J NEUROSCI, V32, P356, DOI 10.1523/JNEUROSCI.3430-11.2012; Heverin M, 2015, BEHAV BRAIN RES, V278, P356, DOI 10.1016/j.bbr.2014.10.018; Hillis JM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0651-2; Hohsfield LA, 2014, MOL CELL NEUROSCI, V63, P83, DOI 10.1016/j.mcn.2014.10.006; Holmberg E, 2006, J NEUROTRAUM, V23, P1366, DOI 10.1089/neu.2006.23.1366; Horder H, 2018, NEUROLOGY, V90, pE1298, DOI 10.1212/WNL.0000000000005290; Iadecola C, 2013, NEURON, V80, P844, DOI 10.1016/j.neuron.2013.10.008; Iturria-Medina Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11934; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kantarci K, 2017, NEUROBIOL AGING, V56, P172, DOI 10.1016/j.neurobiolaging.2017.04.024; Kitabatake Y, 2007, NEUROSURG CLIN N AM, V18, P105, DOI 10.1016/j.nec.2006.10.008; Kitayama J, 2007, STROKE, V38, P2136, DOI 10.1161/STROKEAHA.107.481879; Kril JJ, 2002, J NEUROL NEUROSUR PS, V72, P747, DOI 10.1136/jnnp.72.6.747; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; Li L, 2006, ANN NEUROL, V60, P729, DOI 10.1002/ana.21053; Lifshitz V, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.01.006; Malaguarnera L, 2006, NEUROPATHOLOGY, V26, P307, DOI 10.1111/j.1440-1789.2006.00701.x; Martin MG, 2014, EMBO REP, V15, P1036, DOI 10.15252/embr.201439225; McFarland AJ, 2014, INT J MOL SCI, V15, P20607, DOI 10.3390/ijms151120607; Murrell CJ, 2013, AGE, V35, P905, DOI 10.1007/s11357-012-9414-x; Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5; Nicolakakis N, 2011, J CEREBR BLOOD F MET, V31, P200, DOI 10.1038/jcbfm.2010.78; Notkola IL, 1998, NEUROEPIDEMIOLOGY, V17, P14, DOI 10.1159/000026149; Padurariu M, 2012, PSYCHIAT DANUB, V24, P152; Patten Anna R, 2015, Brain Plast, V1, P97, DOI 10.3233/BPL-150016; Prins ND, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.10; Rahimian R, 2018, DRUG DISCOV TODAY, V23, P375, DOI 10.1016/j.drudis.2017.11.004; Raj D, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00206; Schreurs BG, 2010, NEUROSCI BIOBEHAV R, V34, P1366, DOI 10.1016/j.neubiorev.2010.04.010; Shabir O, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0465-5; Shobin E, 2017, GEROSCIENCE, V39, P199, DOI 10.1007/s11357-017-9965-y; Smit RAJ, 2016, CIRCULATION, V134, P212, DOI 10.1161/CIRCULATIONAHA.115.020627; Stapleton PA, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-54; Stein A, 2015, MOL THER, V23, P1160, DOI 10.1038/mt.2015.69; Sun ZY, 2017, PSYCHIAT RES, V257, P249, DOI 10.1016/j.psychres.2017.07.075; Tarkowski E, 2002, NEUROBIOL AGING, V23, P237, DOI 10.1016/S0197-4580(01)00285-8; Tarkowski E, 2003, BRAIN RES BULL, V61, P255, DOI 10.1016/S0361-9230(03)00088-1; Tong X. K., 2015, BRAIN BRAIN PET C VA; Tong XK, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1199-0; Tong XK, 2015, J CEREBR BLOOD F MET, V35, P512, DOI 10.1038/jcbfm.2014.226; Tong XK, 2012, J NEUROSCI, V32, P4705, DOI 10.1523/JNEUROSCI.0169-12.2012; Tong XK, 2005, J NEUROSCI, V25, P11165, DOI 10.1523/JNEUROSCI.4031-05.2005; Trigiani LJ, 2017, J CEREBR BLOOD F MET, V37, P2649, DOI 10.1177/0271678X17714655; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32; Voss MW, 2013, HUM BRAIN MAPP, V34, P2972, DOI 10.1002/hbm.22119; Vuorinen M, 2011, DEMENT GERIATR COGN, V31, P119, DOI 10.1159/000323810; Wang XX, 2015, AM J ALZHEIMERS DIS, V30, P729, DOI 10.1177/1533317513495107; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Wiesmann M, 2013, J CEREBR BLOOD F MET, V33, P1696, DOI 10.1038/jcbfm.2013.159; Wyss-Coray T, 2000, AM J PATHOL, V156, P139, DOI 10.1016/S0002-9440(10)64713-X; Yamamoto N, 2016, GLIA, V64, P952, DOI 10.1002/glia.22974; Zambon D, 2010, AM J MED, V123, P267, DOI 10.1016/j.amjmed.2009.08.015; Zissimopoulos JM, 2017, JAMA NEUROL, V74, P225, DOI [10.1001/jamaneurol.2016.3783, 10.1001/ja]; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	86	7	8	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13280	13293		10.1096/fj.201901002R	http://dx.doi.org/10.1096/fj.201901002R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31557051	Green Published, hybrid			2022-12-26	WOS:000507466100020
J	Wu, Y; Yue, ZJ; Wang, QG; Lv, Q; Liu, H; Bai, YG; Li, SH; Xie, MJ; Bao, JX; Ma, J; Wang, ZC; Zhu, XY				Wu, Yue; Yue, Zhijie; Wang, Qiguang; Lv, Qiang; Liu, Huan; Bai, Yungang; Li, Shaohua; Xie, Manjiang; Bao, Junxiang; Ma, Jin; Wang, Zhongchao; Zhu, Xianyang			BKCa compensates impaired coronary vasoreactivity through RhoA/ROCK pathway in hind-limb unweighted rats	FASEB JOURNAL			English	Article						hind-limb unweighting; coronary artery; vasoconstriction	RHO-KINASE PATHWAY; SIMULATED MICROGRAVITY; ARTERIES; CHANNEL; SPACEFLIGHT; BETA-1-SUBUNIT; ADAPTATION; EXPRESSION; PREVENTION; RECEPTOR	Previous studies have demonstrated cardiac and vascular remodeling induced by microgravity exposure. Yet, as the most important branch of vasculatures circulating the heart, the coronary artery has been seldomly studied about its adaptations under microgravity conditions. Large-conductance Ca2+-activated potassium channel (BKCa) and the Ras homolog family member A (RhoA)/Rho kinase (ROCK) pathway play key roles in control of vascular tone and mediation of microgravity-induced vascular adjustments. Therefore, we investigated the adaptation of coronary vasoreactivity to simulated microgravity and the role of BKCa and the RhoA/ROCK pathway in it. Four-week-old hind-limb unweighted (HU) rats were adopted to simulate effects of microgravity. Right coronary artery (RCA) constriction was measured by isometric force recording. The activity and expression of BKCa and the RhoA/ROCK pathway were examined by Western blot, patch-clamp recordings, and immunoprecipitation. We found HU significantly decreased RCA vasoconstriction to KC1, serotonin, and U-46619, but increased protein expression and current densities of BKCa, inhibition of which by iberiotoxin (IBTX) further decreased RCA vasoconstriction (P < 0.05). Expression of RhoA and ROCK as well as active RhoA and phosphorylation of myosin light chain (MLC) at Ser(19) and MLC phosphatase target-1 at Thr(696) were significantly increased by HU, and ROCK inhibitor Y-27632 exerted greater suppressing effect on HU RCA vasoconstriction than that of control (P < 0.05). BKca opener NS1619 increased HU RCA vasoconstriction, which was blocked by both RhoA and ROCK inhibitor, similar to the effect of IBTX. These results indicate that HU impairs coronary vasoconstriction but enhances BKca activity acting as a protective mechanism avoiding excessive decrease of coronary vasoreactivity through activation of the RhoA/ROCK pathway.	[Wu, Yue; Wang, Qiguang; Wang, Zhongchao; Zhu, Xianyang] Northern Theater Command, Gen Hosp, Dept Congenital Heart Dis, 83 Wenhua Rd, Shenyang 110016, Peoples R China; [Wu, Yue] Northern Theater Command, Gen Hosp, Dept Med Adm, Shenyang, Peoples R China; [Yue, Zhijie; Lv, Qiang; Liu, Huan; Bai, Yungang; Li, Shaohua; Xie, Manjiang; Bao, Junxiang; Ma, Jin; Wang, Zhongchao] Fourth Mil Med Univ, Dept Aerosp Physiol, Xian, Peoples R China; [Yue, Zhijie] Army Med Univ, Affiliated Hosp, Bethune Med Noncommissioned Officer NCO Sch, Dept Cardiol, Shijiazhuang, Hebei, Peoples R China	Air Force Military Medical University; Army Medical University	Wang, ZC; Zhu, XY (corresponding author), Northern Theater Command, Gen Hosp, Dept Congenital Heart Dis, 83 Wenhua Rd, Shenyang 110016, Peoples R China.	5139005wzc@163.com; xyangz2011@163.com			National Natural Science Foundation of China [81701858]; Natural Science Foundation of Liaoning Province [20180540108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province)	The experiments in this study were performed in the Department of Congenital Heart Disease, General Hospital of Northern Theater Command, and Department of Aerospace Physiology, Fourth Military Medical University. The authors thank their staffs for help with the animal and equipment maintenance. This study was supported by the National Natural Science Foundation of China (Grant 81701858) and the Natural Science Foundation of Liaoning Province (Grant 20180540108). The authors declare no conflicts of interest.	Amberg GC, 2003, CIRC RES, V93, P965, DOI 10.1161/01.RES.0000100068.43006.36; Arbeille P, 2001, EUR J APPL PHYSIOL, V86, P157, DOI 10.1007/s004210100473; Barnes EA, 2018, AM J PHYSIOL-LUNG C, V315, pL265, DOI 10.1152/ajplung.00060.2018; Behnke BJ, 2013, FASEB J, V27, P399, DOI 10.1096/fj.12-218503; Carrick-Ranson G, 2013, EXP PHYSIOL, V98, P501, DOI 10.1113/expphysiol.2012.067488; Demontis GC, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00547; Dong Ming, 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P322; Dorfman TA, 2007, J APPL PHYSIOL, V103, P8, DOI 10.1152/japplphysiol.01162.2006; Feng J, 2008, CIRCULATION, V118, pS46, DOI 10.1161/CIRCULATIONAHA.107.755827; Gao Fang, 2012, Shengli Xuebao, V64, P14; Hu XQ, 2012, DRUG DISCOV TODAY, V17, P974, DOI 10.1016/j.drudis.2012.04.002; Hu Y, 2014, J TRAUMA ACUTE CARE, V76, P394, DOI 10.1097/TA.0b013e3182aa2d98; Hughson RL, 2018, NAT REV CARDIOL, V15, P167, DOI 10.1038/nrcardio.2017.157; Li M, 2010, P NATL ACAD SCI USA, V107, P19096, DOI 10.1073/pnas.1002685107; Lin LJ, 2009, J APPL PHYSIOL, V107, P1710, DOI 10.1152/japplphysiol.00493.2009; Loirand G, 2006, CIRC RES, V98, P322, DOI 10.1161/01.RES.0000201960.04223.3c; Loirand G, 2013, PHYSIOL REV, V93, P1659, DOI 10.1152/physrev.00021.2012; Loirand G, 2010, NAT REV CARDIOL, V7, P637, DOI 10.1038/nrcardio.2010.136; Morey-Holton E, 2005, ADV SPACE B, V10, P7, DOI 10.1016/S1569-2574(05)10002-1; Satoh K, 2011, AM J PHYSIOL-HEART C, V301, pH287, DOI 10.1152/ajpheart.00327.2011; Shimokawa H, 2014, EUR HEART J, V35, P3180, DOI 10.1093/eurheartj/ehu427; Singh H, 2012, J PHYSIOL-LONDON, V590, P5937, DOI 10.1113/jphysiol.2011.215533; Summers SM, 2008, VASC PHARMACOL, V48, P208, DOI 10.1016/j.vph.2008.03.006; Taylor CR, 2013, FASEB J, V27, P2282, DOI 10.1096/fj.12-222687; Wang ZC, 2015, J PHYSIOL BIOCHEM, V71, P205, DOI 10.1007/s13105-015-0398-8; Wang ZC, 2017, CELL PHYSIOL BIOCHEM, V42, P1013, DOI 10.1159/000478683; Wang ZC, 2015, J PHYSIOL-LONDON, V593, P4561, DOI 10.1113/JP270823; Xie MJ, 2010, AM J PHYSIOL-CELL PH, V298, pC1489, DOI 10.1152/ajpcell.00474.2009; Xie Man-Jiang, 2005, Shengli Xuebao, V57, P439; Xie MJ, 2005, AM J PHYSIOL-HEART C, V289, pH1265, DOI 10.1152/ajpheart.00074.2005; Zhang LF, 2001, J APPL PHYSIOL, V91, P2415, DOI 10.1152/jappl.2001.91.6.2415; Zhang LF, 2018, PHYSIOL REV, V98, P59, DOI 10.1152/physrev.00017.2016; Zhang LF, 2013, EUR J APPL PHYSIOL, V113, P2873, DOI 10.1007/s00421-013-2597-8; Zhang R, 2009, J APPL PHYSIOL, V106, P251, DOI 10.1152/japplphysiol.01278.2007	34	4	5	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13358	13366		10.1096/fj.201901273R	http://dx.doi.org/10.1096/fj.201901273R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31530101	Bronze			2022-12-26	WOS:000507466100026
J	Shin, G; Jeong, D; Kim, H; Im, JS; Lee, JK				Shin, Gwangsu; Jeong, Dongsoo; Kim, Hyunsup; Im, Jun-Sub; Lee, Joon-Kyu			RecQL4 tethering on the pre-replicative complex induces unscheduled origin activation and replication stress in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA replication; cell cycle; checkpoint control; cyclin-dependent kinase (CDK); cell division cycle 7-related protein kinase (Cdc7); chromatin immunoprecipitation (ChiP); origin activation; RecQL4; replication stress; replication timing; transcription-replication conflicts; replication initiation; pre-replicative complex	PROTEIN PHOSPHATASE 1; DNA POLYMERASE-ALPHA; INITIATION; MCM10; PHOSPHORYLATION; STABILITY; GENOME; RIF1; TRANSCRIPTION; ASSOCIATION	Sequential activation of DNA replication origins is precisely programmed and critical to maintaining genome stability. RecQL4, a member of the conserved RecQ family of helicases, plays an essential role in the initiation of DNA replication in mammalian cells. Here, we showed that RecQL4 protein tethered on the pre-replicative complex (pre-RC) induces early activation of late replicating origins during S phase. Tethering of RecQL4 or its N terminus on pre-RCs via fusion with Orc4 protein resulted in the recruitment of essential initiation factors, such as Mcm10, And-1, Cdc45, and GINS, increasing nascent DNA synthesis in late replicating origins during early S phase. In this origin activation process, tethered RecQL4 was able to recruit Cdc45 even in the absence of cyclin-dependent kinase (CDK) activity, whereas CDK phosphorylation of RecQL4 N terminus was required for interaction with and origin recruitment of And-1 and GINS. In addition, forced activation of replication origins by RecQL4 tethering resulted in increased replication stress and the accumulation of ssDNAs, which can be recovered by transcription inhibition. Collectively, these results suggest that recruitment of RecQL4 to replication origins is an important step for temporal activation of replication origins during S phase. Further, perturbation of replication timing control by unscheduled origin activation significantly induces replication stress, which is mostly caused by transcription-replication conflicts.	[Shin, Gwangsu; Jeong, Dongsoo; Kim, Hyunsup; Lee, Joon-Kyu] Seoul Natl Univ, Interdisciplinary Grad Program Genet Engn, Seoul 08826, South Korea; [Im, Jun-Sub; Lee, Joon-Kyu] Seoul Natl Univ, Dept Biol Educ, Seoul 08826, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Lee, JK (corresponding author), Seoul Natl Univ, Interdisciplinary Grad Program Genet Engn, Seoul 08826, South Korea.; Lee, JK (corresponding author), Seoul Natl Univ, Dept Biol Educ, Seoul 08826, South Korea.	joonlee@snu.ac.kr			National Research Foundation of Korea (NRF) [NRF-2014R1A1A2058846, NRF-2017R1A2B2010660]; Korea government	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government(Korean Government)	This work was supported by the National Research Foundation of Korea (NRF) Grants NRF-2014R1A1A2058846 and NRF-2017R1A2B2010660 funded by the Korea government (to J.-K. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdurashidova G, 2000, SCIENCE, V287, P2023, DOI 10.1126/science.287.5460.2023; Abe T, 2011, BBA-MOL CELL RES, V1813, P473, DOI 10.1016/j.bbamcr.2011.01.001; Alver RC, 2017, CELL REP, V18, P2508, DOI 10.1016/j.celrep.2017.02.042; Araki H, 2016, EMBO J, V35, P907, DOI 10.15252/embj.201694227; Azuara V, 2006, NAT PROTOC, V1, P2171, DOI 10.1038/nprot.2006.353; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Blumenfeld B, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061138; Cadoret JC, 2008, P NATL ACAD SCI USA, V105, P15837, DOI 10.1073/pnas.0805208105; Chattopadhyay S, 2007, MOL BIOL CELL, V18, P4085, DOI 10.1091/mbc.E06-12-1148; Deegan TD, 2016, EMBO J, V35, P961, DOI 10.15252/embj.201593552; Fu HQ, 2018, CURR OPIN CELL BIOL, V52, P43, DOI 10.1016/j.ceb.2018.01.004; Garcia-Rubio ML, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005674; Goren A, 2008, GENE DEV, V22, P1319, DOI 10.1101/gad.468308; Hamperl S, 2016, CELL, V167, P1455, DOI 10.1016/j.cell.2016.09.053; Hansel-Hertsch R, 2017, NAT REV MOL CELL BIO, V18, P279, DOI 10.1038/nrm.2017.3; Hayano M, 2012, GENE DEV, V26, P137, DOI 10.1101/gad.178491.111; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Hiraga S, 2017, EMBO REP, V18, P403, DOI 10.15252/embr.201641983; Hiraga S, 2014, GENE DEV, V28, P372, DOI 10.1101/gad.231258.113; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Im JS, 2015, CELL CYCLE, V14, P1001, DOI 10.1080/15384101.2015.1007001; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Jones RM, 2013, ONCOGENE, V32, P3744, DOI 10.1038/onc.2012.387; Kang YH, 2013, P NATL ACAD SCI USA, V110, P19760, DOI 10.1073/pnas.1320202110; Kanoh Y, 2015, NAT STRUCT MOL BIOL, V22, P889, DOI 10.1038/nsmb.3102; Keller H, 2014, NUCLEIC ACIDS RES, V42, P12614, DOI 10.1093/nar/gku993; KITSBERG D, 1993, NATURE, V366, P588, DOI 10.1038/366588a0; Kliszczak M, 2015, ONCOTARGET, V6, P40464, DOI 10.18632/oncotarget.6342; Klusmann I, 2016, CELL REP, V17, P1845, DOI 10.1016/j.celrep.2016.10.036; Kohler C, 2016, CELL CYCLE, V15, P974, DOI 10.1080/15384101.2016.1152424; Kumagai A, 2011, J CELL BIOL, V193, P995, DOI 10.1083/jcb.201102003; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Larasati, 2017, GENES-BASEL, V8, DOI 10.3390/genes8010003; Larizza L, 2006, CANCER LETT, V232, P107, DOI 10.1016/j.canlet.2005.07.042; Li Y, 2012, ONCOGENE, V31, P643, DOI 10.1038/onc.2011.261; Liu SQ, 2012, NUCLEIC ACIDS RES, V40, P10780, DOI 10.1093/nar/gks849; Lu HM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02146-3; Lu HM, 2016, CELL REP, V16, P161, DOI 10.1016/j.celrep.2016.05.079; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Moiseeva T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01401-x; Monnat RJ, 2010, SEMIN CANCER BIOL, V20, P329, DOI 10.1016/j.semcancer.2010.10.002; Muramatsu S, 2010, GENE DEV, V24, P602, DOI 10.1101/gad.1883410; Park SY, 2019, BIOCHEM BIOPH RES CO, V509, P379, DOI 10.1016/j.bbrc.2018.12.151; Parker MW, 2017, CRIT REV BIOCHEM MOL, V52, P107, DOI 10.1080/10409238.2016.1274717; REIKOFSKI J, 1992, BIOTECHNOL ADV, V10, P535, DOI 10.1016/0734-9750(92)91451-J; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Schwab RA, 2015, MOL CELL, V60, P351, DOI 10.1016/j.molcel.2015.09.012; Shamanna RA, 2014, CARCINOGENESIS, V35, P2415, DOI 10.1093/carcin/bgu137; Singh DK, 2012, MUTAT RES-FUND MOL M, V736, P15, DOI 10.1016/j.mrfmmm.2011.06.002; Sukackaite R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01910-1; Tanaka S, 2011, CURR BIOL, V21, P2055, DOI 10.1016/j.cub.2011.11.038; Todorovic V, 2005, MOL CELL, V19, P567, DOI 10.1016/j.molcel.2005.07.005; Vassin VM, 2009, J CELL SCI, V122, P4070, DOI 10.1242/jcs.053702; Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235; Yamazaki S, 2012, EMBO J, V31, P3667, DOI 10.1038/emboj.2012.180; Yeeles JTP, 2015, NATURE, V519, P431, DOI 10.1038/nature14285; Yeo CQX, 2016, CELL REP, V15, P132, DOI 10.1016/j.celrep.2016.03.011; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	58	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					16255	16265		10.1074/jbc.RA119.009996	http://dx.doi.org/10.1074/jbc.RA119.009996			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31519754	hybrid, Green Published			2022-12-26	WOS:000499478600031
J	Guerrero, JM; Adluru, N; Bendlin, BB; Goldsmith, HH; Schaefer, SM; Davidson, RJ; Kecskemeti, SR; Zhang, H; Alexander, AL				Guerrero, Jose M.; Adluru, Nagesh; Bendlin, Barbara B.; Goldsmith, H. Hill; Schaefer, Stacey M.; Davidson, Richard J.; Kecskemeti, Steven R.; Zhang, Hui; Alexander, Andrew L.			Optimizing the intrinsic parallel diffusivity in NODDI: An extensive empirical evaluation	PLOS ONE			English	Article							NEURITE ORIENTATION DISPERSION; WHITE-MATTER MICROSTRUCTURE; AXON DIAMETER; DENSITY; MODEL; MRI	Purpose NODDI is widely used in parameterizing microstructural brain properties. The model includes three signal compartments: intracellular, extracellular, and free water. The neurite compartment intrinsic parallel diffusivity (d(parallel to)) is set to 1.7 mu m(2).ms(-1), though the effects of this assumption have not been extensively explored. This work investigates the optimality of d(parallel to) = 1.7 mu m(2).ms(-1) under varying imaging protocol, age groups, sex, and tissue type in comparison to other biologically plausible values of d(parallel to). Methods Model residuals were used as the optimality criterion. The model residuals were evaluated in function of d(parallel to) over the range from 0.5 to 3.0 mu m(2).ms(-1). This was done with respect to tissue type (i.e., white matter versus gray matter), sex, age (infancy to late adulthood), and diffusion-weighting protocol (maximum b-value). Variation in the estimated parameters with respect to d(parallel to) was also explored. Results Results show d(parallel to) = 1.7 mu m(2).ms(-1) is appropriate for adult brain white matter but it is suboptimal for gray matter with optimal values being significantly lower. d(parallel to) = 1.7 mu m(2).ms(-1) was also suboptimal in the infant brain for both white and gray matter with optimal values being significantly lower. Minor optimum d(parallel to) differences were observed versus diffusion protocol. No significant sex effects were observed. Additionally, changes in d(parallel to) resulted in significant changes to the estimated NODDI parameters. Conclusion The default (d(parallel to)) of 1.7 mu m(2).ms(-1) is suboptimal in gray matter and infant brains.	[Guerrero, Jose M.; Alexander, Andrew L.] Univ Wisconsin, Dept Med Phys, 1530 Med Sci Ctr, Madison, WI 53706 USA; [Adluru, Nagesh; Goldsmith, H. Hill; Kecskemeti, Steven R.; Alexander, Andrew L.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Bendlin, Barbara B.] Univ Wisconsin, Dept Med, Madison, WI USA; [Goldsmith, H. Hill] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA; [Schaefer, Stacey M.; Davidson, Richard J.] Univ Wisconsin, Ctr Hlth Minds, Madison, WI USA; [Zhang, Hui] UCL, Dept Comp Sci, London, England	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of London; University College London	Guerrero, JM (corresponding author), Univ Wisconsin, Dept Med Phys, 1530 Med Sci Ctr, Madison, WI 53706 USA.; Adluru, N (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.	jguerrerogon@wisc.edu; adluru@wisc.edu	Alexander, Andrew/ABA-2806-2020	Zhang, Hui/0000-0002-5426-2140; Davidson, Richard/0000-0002-8506-4964	National Institute of Child Health and Human Development [IDDRC U54 HD090256]; NIH [R01 NS092870, R01AG037639, R01AG027161, RF1 AG059312, P50AG033514, P50 NIMH100031, R01 MH101504, R01 AG037639]; BRAIN Initiative [R01-EB022883]; UW CPCP [AI117924]; UWMadison SciMed Graduate Research Scholars Advanced Opportunity Fellowship; NSF Graduate Research Fellowship Program; Bill and Melinda Gates Foundation [P50 MH084051, R01 MH59785]; National Institute on Aging [P01-AG020166, U19 AG051426]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB022883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101504, R01MH043454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092870] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG059312, U19AG051426, R01AG027161, P50AG033514, R01AG037639] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BRAIN Initiative; UW CPCP; UWMadison SciMed Graduate Research Scholars Advanced Opportunity Fellowship; NSF Graduate Research Fellowship Program(National Science Foundation (NSF)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by a core grant to the Waisman Center from the National Institute of Child Health and Human Development (IDDRC U54 HD090256). Additional support was provided by NIH grant R01 NS092870 (to AA), BRAIN Initiative R01-EB022883 (to NA), UW CPCP AI117924 (to NA), NIH grant R01AG037639, NIH grant R01AG027161, RF1 AG059312 (to BBB, NA), and NIH grant P50AG033514. JMG is supported by a UWMadison SciMed Graduate Research Scholars Advanced Opportunity Fellowship, and the NSF Graduate Research Fellowship Program. Data collection for this study was supported by the Bill and Melinda Gates Foundation, grants P50 MH084051, R01 MH59785, the National Institute on Aging grants P01-AG020166 and U19 AG051426, and NIH grants P50 NIMH100031, R01 MH101504, R01 AG037639.; This study was supported in part by a core grant to the Waisman Center from the National Institute of Child Health and Human Development (IDDRC U54 HD090256). Additional support was provided by NIH grant R01 NS092870 (to AA), BRAIN Initiative R01-EB022883 (to NA), UW CPCP AI117924 (to NA), NIH grant R01AG037639, NIH grant R01AG027161, RF1 AG059312 (to BBB, NA), and NIH grant P50AG033514. JMG is supported by a UW-Madison SciMed Graduate Research Scholars Advanced Opportunity Fellowship, and the NSF Graduate Research Fellowship Program. Data collection for this study was supported by the Bill and Melinda Gates Foundation, grants P50 MH084051, R01 MH59785, the National Institute on Aging grants P01-AG020166 and U19 AG051426, and NIH grants P50 NIMH100031, R01 MH101504, R01 AG037639.	Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; [Anonymous], 2009, DIRECTIONAL STAT; Assaf Y, 2005, NEUROIMAGE, V27, P48, DOI 10.1016/j.neuroimage.2005.03.042; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; Billiet T, 2015, NEUROBIOL AGING, V36, P2107, DOI 10.1016/j.neurobiolaging.2015.02.029; Billiet T, 2014, NEUROIMAGE-CLIN, V4, P649, DOI 10.1016/j.nicl.2014.04.005; Caverzasi E, 2016, J NEUROIMAGING, V26, P494, DOI 10.1111/jon.12359; Colgan N, 2016, NEUROIMAGE, V125, P739, DOI 10.1016/j.neuroimage.2015.10.043; Daducci A, 2015, NEUROIMAGE, V105, P32, DOI 10.1016/j.neuroimage.2014.10.026; Dean DC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09915-6; Faria AV, 2010, NEUROIMAGE, V52, P415, DOI 10.1016/j.neuroimage.2010.04.238; Farooq H, 2016, SCI REP-UK, V6, DOI 10.1038/srep38927; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Fukutomi H, 2018, NEUROIMAGE, V182, P488, DOI 10.1016/j.neuroimage.2018.02.017; Genc E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04268-8; Grussu F, 2017, ANN CLIN TRANSL NEUR, V4, P663, DOI 10.1002/acn3.445; Guerrero J.M., 2016, INVESTIGATING EFFECT; Jelescu IO, 2017, FRONT PHYS-LAUSANNE, V5, DOI 10.3389/fphy.2017.00061; Jelescu IO, 2016, NMR BIOMED, V29, P33, DOI 10.1002/nbm.3450; Jelescu IO, 2015, NEUROIMAGE, V107, P242, DOI 10.1016/j.neuroimage.2014.12.009; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jespersen SN, 2007, NEUROIMAGE, V34, P1473, DOI 10.1016/j.neuroimage.2006.10.037; Jespersen SN, 2018, NEUROIMAGE, V182, P329, DOI 10.1016/j.neuroimage.2017.08.039; Kaden E, 2016, NEUROIMAGE, V139, P346, DOI 10.1016/j.neuroimage.2016.06.002; Kamagata K, 2016, EUR RADIOL, V26, P2567, DOI 10.1007/s00330-015-4066-8; Kunz N, 2014, NEUROIMAGE, V96, P288, DOI 10.1016/j.neuroimage.2014.03.057; Mukherjee P, 2002, AM J NEURORADIOL, V23, P1445; Novikov D.S., 2016, ARXIV160909144, V10; Novikov DS, 2018, NEUROIMAGE, V174, P518, DOI 10.1016/j.neuroimage.2018.03.006; Owen JP, 2014, J NEUROSCI, V34, P6214, DOI 10.1523/JNEUROSCI.4495-13.2014; Skinner NP, 2017, MAGN RESON MED, V77, P1639, DOI 10.1002/mrm.26243; Stanisz GJ, 1997, MAGNET RESON MED, V37, P103, DOI 10.1002/mrm.1910370115; SZAFER A, 1995, MAGNET RESON MED, V33, P697, DOI 10.1002/mrm.1910330516; Szczepankiewicz F, 2015, NEUROIMAGE, V104, P241, DOI 10.1016/j.neuroimage.2014.09.057; Tariq M, 2016, NEUROIMAGE, V133, P207, DOI 10.1016/j.neuroimage.2016.01.046; Veraart J., 2018, P INT SOC MAGN RESON, V27, P1094; Veraart J., 2016, ARXIV160909145; Veraart J, 2018, NEUROIMAGE, V182, P360, DOI 10.1016/j.neuroimage.2017.09.030; Yoshida S, 2013, PEDIATR RADIOL, V43, P15, DOI 10.1007/s00247-012-2496-x; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	41	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0217118	10.1371/journal.pone.0217118	http://dx.doi.org/10.1371/journal.pone.0217118			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553719	Green Published, gold, Green Submitted			2022-12-26	WOS:000532319200001
J	Liu, ZH; Wang, WY; Huang, TY; Wang, CF; Huang, Y; Tang, Y; Huang, J				Liu, Zehui; Wang, Wanyan; Huang, Tingyu; Wang, Cunfang; Huang, Ying; Tang, Yong; Huang, Jin			CH(II), a cerebroprotein hydrolysate, exhibits potential neuro-protective effect on Alzheimer's disease	PLOS ONE			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; PEPTIDERGIC DRUG CEREBROLYSIN; OXIDATIVE STRESS; PATHOGENESIS; MEMANTINE; APOPTOSIS; ISCHEMIA; DAMAGE	Alzheimer's disease (AD) is a progressive neurodegenerative disorder, and is the most common type of cognitive impairment and dementia. There is a pressing need to improve the clinical efficacy and quality of life for AD patients, as limited treatments options for AD patients have been developed until now. In this study, we aim to investigate the protective effect of CH(II), a cerebroprotein hydrolysate consisted of abundant biological peptides, on preclinical model of AD. We found that CH(II) treatment effectively protects oxygen glucose deprivation (OGD)-induced N2A cell viability impairment and cell apoptosis. In addition, CH (II) significantly reduces H2O2-induced ROS accumulation and exhibits the protective activities against H2O2-induced oxidative injury. Intriguingly, we found that CH(II) treatment can effectively promote neurite outgrowth of N2A cells. Moreover, CH(II) obviously improve the cognitive and memorial function in scopolamine-induced amnesia mice model. Taken together, this study provides evidences of the neuroprotective activities of CH(II) and offers a potential therapeutic strategy for AD patients.	[Liu, Zehui; Wang, Wanyan; Huang, Jin] East China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai Key Lab New Drug Design, Sch Pharm, Shanghai, Peoples R China; [Huang, Tingyu; Wang, Cunfang] Guangdong Long Fu Pharmaceut Co Ltd, Guangzhou, Guangdong, Peoples R China; [Huang, Ying] Guangdong Inst Drug Control, Guangzhou, Guangdong, Peoples R China; [Tang, Yong] Guangxi Med Univ, Wuming Hosp, Dept Urol, Guangxi, Peoples R China	East China University of Science & Technology; Guangxi Medical University	Huang, J (corresponding author), East China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai Key Lab New Drug Design, Sch Pharm, Shanghai, Peoples R China.; Huang, Y (corresponding author), Guangdong Inst Drug Control, Guangzhou, Guangdong, Peoples R China.; Tang, Y (corresponding author), Guangxi Med Univ, Wuming Hosp, Dept Urol, Guangxi, Peoples R China.	huangying_gdidc@126.com; yong_tang_md@outlook.com; huangjin@ecust.edu.cn		Tang, Yong/0000-0001-9214-4412	National Natural Science Foundation of China [81773775]; Open Funding Project of the State Key Laboratory of Bioreactor Engineering, State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Guangxi Normal University) [CMEMR2017-B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Funding Project of the State Key Laboratory of Bioreactor Engineering, State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Guangxi Normal University)	This study was supported by the National Natural Science Foundation of China (81773775), Open Funding Project of the State Key Laboratory of Bioreactor Engineering, State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Guangxi Normal University, CMEMR2017-B01). The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisen PS, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0283-5; Cerquera-Jaramillo MA, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/2941783; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; An L, 2016, GENETICS MOL RES GMR, V15; Armstrong RA, 2006, FOLIA NEUROPATHOL, V44, P1; Bredesen E, 2006, CELL DEATH NERVOUS S; Cai ZY, 2009, NEUROCHEM RES, V34, P1226, DOI 10.1007/s11064-008-9899-y; Cardenas A, 2010, J NEUROCHEM, V74, P2041; Cummings J, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0207-9; Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Darsalia V, 2005, STROKE, V36, P1790, DOI 10.1161/01.STR.0000173151.36031.be; Emmerzaal TL, 2015, J ALZHEIMERS DIS, V43, P739, DOI 10.3233/JAD-141086; Gu Y, 2012, NAT NEUROSCI, V15, P1700, DOI 10.1038/nn.3260; Gutmann B, 2002, NEUROTOX RES, V4, P59, DOI 10.1080/10298420290007637; Hartbauer M, 2001, J NEURAL TRANSM, V108, P459, DOI 10.1007/s007020170067; Howard R, 2012, NEW ENGL J MED, V366, P893, DOI 10.1056/NEJMoa1106668; Hyde C, 2013, AGE AGEING, V42, P14, DOI 10.1093/ageing/afs165; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Klinkenberg I, 2010, NEUROSCI BIOBEHAV R, V34, P1307, DOI 10.1016/j.neubiorev.2010.04.001; Li XK, 2016, J MED CHEM, V59, P8326, DOI 10.1021/acs.jmedchem.6b00636; Liu XR, 2017, APOPTOSIS, V22, P639, DOI 10.1007/s10495-017-1349-3; Masliah E, 2012, DRUG TODAY, V48, P3, DOI 10.1358/dot.2012.48(Suppl.A).1739716; Masters CL, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.56; Niedzielska E, 2016, MOL NEUROBIOL, V53, P4094, DOI 10.1007/s12035-015-9337-5; Olson Bradley J S C, 2007, Curr Protoc Protein Sci, VChapter 3, DOI 10.1002/0471140864.ps0304s48; Patterson C, 2018, WORLD ALZHEIMER REPO; Portelius E, 2006, NEUROSCI LETT, V409, P215, DOI 10.1016/j.neulet.2006.09.044; Qing S, 2015, CELLULAR PHYSL BIOCH, P37; Radogna F, 2016, ONCOGENE, V35, P3839, DOI 10.1038/onc.2015.455; Rockenstein E, 2015, STEM CELL RES, V15, P54, DOI 10.1016/j.scr.2015.04.008; SAFER DJ, 1971, BIOL PSYCHIAT, V3, P347; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Sharma HS, 2016, NEURODEGENER DIS MAN, V6, P453, DOI 10.2217/nmt-2016-0037; Sharma HS, 2010, ANN NY ACAD SCI, V1199, P125, DOI 10.1111/j.1749-6632.2009.05329.x; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Siqueira IR, 2004, BRAIN RES, V1025, P226, DOI 10.1016/j.brainres.2004.08.005; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Takano T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00044-2; TAYLOR CP, 1995, J NEUROSCI METH, V59, P121, DOI 10.1016/0165-0270(94)00202-R; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Xia Q, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0686-7; Yoshimura T, 2006, J NEUROSCI, V26, P10626, DOI 10.1523/JNEUROSCI.3824-06.2006; Zhang L, 2013, STROKE, V44, P1965, DOI 10.1161/STROKEAHA.111.000831; Zhu XW, 2007, BBA-MOL BASIS DIS, V1772, P494, DOI 10.1016/j.bbadis.2006.10.014	46	3	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222757	10.1371/journal.pone.0222757	http://dx.doi.org/10.1371/journal.pone.0222757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545823	gold, Green Published			2022-12-26	WOS:000532303200032
J	Carey, M; Bryant, J; Zucca, A; Hall, A; Grady, A; Dilworth, S; Peek, K				Carey, Mariko; Bryant, Jamie; Zucca, Alison; Hall, Alix; Grady, Alice; Dilworth, Sophie; Peek, Kerry			How well do cancer survivor self-classifications of anxiety, depression and stress agree with a standardised tool? Results of a cross-sectional study	PLOS ONE			English	Article							PSYCHOLOGICAL DISTRESS; EMOTIONAL DISTRESS; RANDOMIZED-TRIAL; PATIENT; SCALES; IMPLEMENTATION; OUTCOMES; CARE	Background There is poor uptake of psychosocial interventions offered to people with cancer who record high scores on distress screening scales. Intervention uptake may be influenced by a mismatch between consumer (bottom-up) and professional (top-down) paradigms of wellbeing. The current research aims to compare cancer survivors' 'self-judgements' about their levels of anxiety, depression and stress, to classifications derived via a professional-driven measure, the Depression, Anxiety and Stress Scale (DASS-21). Methods A cross-sectional study was undertaken with haematological cancer survivors recruited from three population-based cancer registries in Australia. Consenting participants were mailed a questionnaire package; and non-responders received a second questionnaire package after 3-weeks and a reminder call after 6-weeks. The consumer-driven perspective was assessed via three separate single items asking survivors to self-classify their levels of anxiety, depression and stress over the past week on a scale from 'normal' to 'extremely severe'. The professional-driven classification was assessed via the DASS-21. Kappa statistics were used to assess agreement between consumer- and professional-driven measures. Results Of 2,971 eligible haematological cancer survivors, 1,239 (42%) provided written consent and were mailed a questionnaire package. Of these, 984 (79%) returned a completed questionnaire. The simple kappa for agreement between the DASS-21 and self-classified measures for anxiety was 0.47 (95% CI: 0.39 to 0.54, p<0.0001). The weighted kappa for agreement between the DASS-21 and self-classified measures of depression was 0.60 (95% CI: 0.53 to 0.67, p<0.0001) and for measures of stress was 0.51 (95% CI: 0.44 to 0.59, p<0.0001). Conclusions Moderate agreement between self-classification and professional-driven assessments was found. The value of screening is predicated on the assumption that those with identified needs will be offered and take up services that will benefit them. Our results suggest that to improve the utility of distress screening it may be important to include assessment of survivor views about their symptoms.	[Carey, Mariko; Bryant, Jamie; Zucca, Alison; Hall, Alix; Dilworth, Sophie] Univ Newcastle, Fac Hlth & Med, Sch Med & Publ Hlth, Hlth Behav Res Collaborat, Callaghan, NSW, Australia; [Carey, Mariko; Bryant, Jamie; Zucca, Alison; Hall, Alix; Grady, Alice; Dilworth, Sophie; Peek, Kerry] Univ Newcastle, Prior Res Ctr Hlth Behav, Callaghan, NSW, Australia; [Carey, Mariko; Bryant, Jamie; Zucca, Alison; Hall, Alix; Grady, Alice; Dilworth, Sophie] Hunter Med Res Inst, New Lambton Hts, NSW, Australia; [Grady, Alice] Populat Hlth, Hunter New England Local Hlth Dist, Wallsend, NSW, Australia; [Dilworth, Sophie] Community Aged Care Serv, Hunter New England Local Hlth Dist, Wallsend, NSW, Australia; [Peek, Kerry] Univ Sydney, Discipline Physiotherapy, Cumberland Campus, Lidcombe, NSW, Australia	University of Newcastle; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Sydney	Carey, M (corresponding author), Univ Newcastle, Fac Hlth & Med, Sch Med & Publ Hlth, Hlth Behav Res Collaborat, Callaghan, NSW, Australia.; Carey, M (corresponding author), Univ Newcastle, Prior Res Ctr Hlth Behav, Callaghan, NSW, Australia.; Carey, M (corresponding author), Hunter Med Res Inst, New Lambton Hts, NSW, Australia.	Mariko.Carey@newcastle.edu.au	HALL, ALIX/AAX-8626-2021; CAREY, MARIKO/ABC-2842-2021; Peek, Kerry/R-7885-2019; Bryant, Jamie/G-8000-2013	HALL, ALIX/0000-0002-1043-6110; CAREY, MARIKO/0000-0002-0549-1115; Peek, Kerry/0000-0002-2194-3353; Bryant, Jamie/0000-0001-9378-5852; Dilworth, Sophie/0000-0002-3023-8074	Priority-driven Collaborative Cancer Research Scheme [569290]; Cancer Council NSW [CSR 11-02]; University of Newcastle; Hunter Medical Research Institute; NHMRC Boosting Dementia Leadership Fellowship [APP1136168]; NHMRC-ARC Dementia Research Development Fellowship [APP1105809]; beyond blue; Australian Government through Cancer Australia	Priority-driven Collaborative Cancer Research Scheme; Cancer Council NSW(Cancer Council New South Wales); University of Newcastle; Hunter Medical Research Institute; NHMRC Boosting Dementia Leadership Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC-ARC Dementia Research Development Fellowship(Australian Research CouncilNational Health and Medical Research Council (NHMRC) of Australia); beyond blue; Australian Government through Cancer Australia(Australian Government)	This grant No. 569290 was awarded through the Priority-driven Collaborative Cancer Research Scheme and co-funded by beyond blue and the Australian Government through Cancer Australia (https://canceraustralia.gov.au/). It also received funding support from a Strategic Research Partnership Grant (CSR 11-02) from Cancer Council NSW (https://www.cancercouncil.com.au/research/) to the Newcastle Cancer Control Collaborative (New-3C), and infrastructure funding from the University of Newcastle (https://www.newcastle.edu.au/) and Hunter Medical Research Institute (https://hmri.org.au/).A/Prof Mariko Carey is supported by a NHMRC Boosting Dementia Leadership Fellowship (APP1136168; https://nhmrc.gov.au/) and Dr. Jamie Bryant is supported by an NHMRC-ARC Dementia Research Development Fellowship (APP1105809; https://nhmrc.gov.au/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Carlson LE, 2012, J CLIN ONCOL, V30, P1160, DOI 10.1200/JCO.2011.39.5509; Clara IP, 2001, J PSYCHOPATHOL BEHAV, V23, P61, DOI 10.1023/A:1011095624717; Clover KA, 2015, PSYCHO-ONCOLOGY, V24, P812, DOI 10.1002/pon.3729; Denlinger CS, 2014, J NATL COMPR CANC NE, V12, P34, DOI 10.6004/jnccn.2014.0005; Dilworth S, 2014, PSYCHO-ONCOLOGY, V23, P601, DOI 10.1002/pon.3474; Faller H, 2016, J PSYCHOSOM RES, V81, P24, DOI 10.1016/j.jpsychores.2015.12.004; Hall AE, 2016, SUPPORT CARE CANCER, V24, P4413, DOI 10.1007/s00520-016-3282-3; Hammond CTC, 2008, FERTIL STERIL, V90, P1256, DOI 10.1016/j.fertnstert.2007.08.081; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; Mackenzie LJ, 2014, ANN ONCOL, V25, P889, DOI 10.1093/annonc/mdu023; Maunsell E, 1996, J CLIN ONCOL, V14, P2747, DOI 10.1200/JCO.1996.14.10.2747; McLachlan SA, 2001, J CLIN ONCOL, V19, P4117, DOI 10.1200/JCO.2001.19.21.4117; Meijer A, 2013, J PSYCHOSOM RES, V75, P1, DOI 10.1016/j.jpsychores.2013.01.012; Mitchell AJ, 2013, ACTA ONCOL, V52, P216, DOI 10.3109/0284186X.2012.745949; Myer Rod, 2000, LIVING DREAM STORY V, P77; Paul C, 2013, EUR J CANCER CARE, V22, P281, DOI 10.1111/ecc.12048; Salmon P, 2015, PSYCHO-ONCOLOGY, V24, P262, DOI 10.1002/pon.3640; Smith T, 2007, CANCER-AM CANCER SOC, V109, P1, DOI 10.1002/cncr.22387; Teunissen SCCM, 2007, PALLIATIVE MED, V21, P341, DOI 10.1177/0269216307079067; Tuinman MA, 2008, CANCER-AM CANCER SOC, V113, P870, DOI 10.1002/cncr.23622; Turon H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210111	23	2	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222107	10.1371/journal.pone.0222107	http://dx.doi.org/10.1371/journal.pone.0222107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5OJ	31539386	Green Published, Green Submitted, gold			2022-12-26	WOS:000532297900007
J	Bradley, PW; Brawner, MD; Raffel, TR; Rohr, JR; Olson, DH; Blaustein, AR				Bradley, Paul W.; Brawner, Michael D.; Raffel, Thomas R.; Rohr, Jason R.; Olson, Deanna H.; Blaustein, Andrew R.			Shifts in temperature influence how Batrachochytrium dendrobatidis infects amphibian larvae	PLOS ONE			English	Article							FUNGAL PATHOGEN; HOST SUSCEPTIBILITY; CLIMATE-CHANGE; DISEASE; CHYTRIDIOMYCOSIS; EXTINCTION; MORTALITY; DECLINES; EXTREME; TRANSMISSION	Many climate change models predict increases in frequency and magnitude of temperature fluctuations that might impact how ectotherms are affected by disease. Shifts in temperature might especially affect amphibians, a group with populations that have been challenged by several pathogens. Because amphibian hosts invest more in immunity at warmer than cooler temperatures and parasites might acclimate to temperature shifts faster than hosts (creating lags in optimal host immunity), researchers have hypothesized that a temperature shift from cold-to-warm might result in increased amphibian sensitivity to pathogens, whereas a shift from warm-to-cold might result in decreased sensitivity. Support for components of this climate-variability based hypothesis have been provided by prior studies of the fungus Batrachochytrium dendrobatidis (Bd) that causes the disease chytridiomycosis in amphibians. We experimentally tested whether temperature shifts before exposure to Batrachochytrium dendrobatidis (Bd) alters susceptibility to the disease chytridiomycosis in the larval stage of two amphibian species-western toads (Anaxyrus boreas) and northern red legged frogs (Rana aurora). Both host species harbored elevated Bd infection intensities under constant cold (15 degrees C) temperature in comparison to constant warm (20 degrees C) temperature. Additionally, both species experienced an increase in Bd infection abundance after shifted from 15 degrees C to 20 degrees C, compared to a constant 20 degrees C but they experienced a decrease in Bd after shifted from 20 degrees C to 15 degrees C, compared to a constant 15 degrees C. These results are in contrast to prior studies of adult amphibians highlighting the potential for species and stage differences in the temperature-dependence of chytridiomycosis.	[Bradley, Paul W.] Oregon State Univ, Environm Sci Grad Program, Corvallis, OR 97331 USA; [Brawner, Michael D.; Blaustein, Andrew R.] Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA; [Raffel, Thomas R.] Oakland Univ, Dept Biol, Rochester, MI 48063 USA; [Rohr, Jason R.] Univ S Florida, Dept Integrat Biol, Tampa, FL 33620 USA; [Olson, Deanna H.] ARS, USDA, Pacific Northwest Res Stn, Corvallis, OR USA; [Bradley, Paul W.] Univ San Diego, Dept Biol, San Diego, CA 92110 USA	Oregon State University; Oregon State University; Oakland University; State University System of Florida; University of South Florida; United States Department of Agriculture (USDA); University of San Diego	Bradley, PW (corresponding author), Oregon State Univ, Environm Sci Grad Program, Corvallis, OR 97331 USA.; Bradley, PW (corresponding author), Univ San Diego, Dept Biol, San Diego, CA 92110 USA.	paulwilliambradley@gmail.com	Rohr, Jason R./AAJ-5856-2021	Bradley, Paul/0000-0002-4428-5744	National Science Foundation [EF1241889]; National Institutes of Health [R01GM109499, R01TW010286]; U.S. Department of Agriculture [NRI 2006-01370, 200935102-0543]; U.S. Environmental Protection Agency [CAREER 83518801]; NSF [IOS 1121529, 1651888]; U.S. Forest Service Pacific Northwest Research Station, Corvallis, Oregon; FOGARTY INTERNATIONAL CENTER [R01TW010286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109499] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture(United States Department of Agriculture (USDA)); U.S. Environmental Protection Agency(United States Environmental Protection Agency); NSF(National Science Foundation (NSF)); U.S. Forest Service Pacific Northwest Research Station, Corvallis, Oregon(United States Department of Agriculture (USDA)United States Forest Service); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants from the National Science Foundation (EF1241889), National Institutes of Health (R01GM109499, R01TW010286), U.S. Department of Agriculture (NRI 2006-01370, 200935102-0543), and U.S. Environmental Protection Agency (CAREER 83518801) to JRR and NSF grants IOS 1121529 and 1651888 to TRR. Support was provided by the U.S. Forest Service Pacific Northwest Research Station, Corvallis, Oregon to DHO. No sponsor nor funder played any role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Anderegg WRL, 2013, NAT CLIM CHANGE, V3, P30, DOI 10.1038/nclimate1635; Bancroft BA, 2008, BEHAV ECOL, V19, P879, DOI 10.1093/beheco/arn044; Bannerman JA, 2014, OIKOS, V123, P89, DOI 10.1111/j.1600-0706.2013.00686.x; BEISWENGER RE, 1978, J HERPETOL, V12, P499, DOI 10.2307/1563355; Ben-Horin T, 2013, ECOLOGY, V94, P161, DOI 10.1890/11-2257.1; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Blaustein AR, 2012, PHILOS T R SOC B, V367, P1688, DOI 10.1098/rstb.2012.0011; Blaustein Andrew R., 2010, Diversity, V2, P281; Blaustein AR, 2005, CONSERV BIOL, V19, P1460, DOI 10.1111/j.1523-1739.2005.00195.x; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Buck JC, 2012, FRESHWATER BIOL, V57, P61, DOI 10.1111/j.1365-2427.2011.02695.x; Cohen JM, 2017, ECOL LETT, V20, P184, DOI 10.1111/ele.12720; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Garner TWJ, 2009, OIKOS, V118, P783, DOI 10.1111/j.1600-0706.2008.17202.x; Gervasi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054490; Gervasi SS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167882; Han BA, 2008, BEHAV ECOL SOCIOBIOL, V63, P241, DOI 10.1007/s00265-008-0655-8; Hoover DL, 2014, ECOLOGY, V95, P2646, DOI 10.1890/13-2186.1; Horton RM, 2016, CURR CLIM CHANGE REP, V2, P242, DOI 10.1007/s40641-016-0042-x; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Karlstrom EL, 1962, TOAD GENUS BUFO SIER; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Lawler JJ, 2010, CONSERV BIOL, V24, P38, DOI 10.1111/j.1523-1739.2009.01403.x; Li YM, 2013, INTEGR ZOOL, V8, P145, DOI 10.1111/1749-4877.12001; Liu X, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2506; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Marantelli Gerry, 2004, Pacific Conservation Biology, V10, P173; McCallum ML, 2007, J HERPETOL, V41, P483, DOI 10.1670/0022-1511(2007)41[483:ADOECD]2.0.CO;2; McMahon TA, 2015, ECOHEALTH, V12, P188, DOI 10.1007/s10393-014-0989-9; McMahon TA, 2014, NATURE, V511, P224, DOI 10.1038/nature13491; Muths E, 2008, BIOL CONSERV, V141, P1484, DOI 10.1016/j.biocon.2008.03.011; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Parris MJ, 2004, ECOLOGY, V85, P3385, DOI 10.1890/04-0383; Pearl CA, 2007, J HERPETOL, V41, P145, DOI 10.1670/0022-1511(2007)41[145:OOTAPB]2.0.CO;2; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Piovia-Scott J, 2011, BIOL CONSERV, V144, P2913, DOI 10.1016/j.biocon.2011.08.008; Rachowicz LJ, 2004, DIS AQUAT ORGAN, V61, P75, DOI 10.3354/dao061075; Raffel TR, 2006, FUNCT ECOL, V20, P819, DOI 10.1111/j.1365-2435.2006.01159.x; Raffel TR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2039; Raffel TR, 2013, NAT CLIM CHANGE, V3, P146, DOI [10.1038/nclimate1659, 10.1038/NCLIMATE1659]; Raffel TR, 2010, ECOHEALTH, V7, P526, DOI 10.1007/s10393-010-0358-2; Rohr JR, 2008, P NATL ACAD SCI USA, V105, P17436, DOI 10.1073/pnas.0806368105; Rohr JR, 2013, CONSERV PHYSIOL, V1, DOI 10.1093/conphys/cot022; Rohr JR, 2010, P NATL ACAD SCI USA, V107, P8269, DOI 10.1073/pnas.0912883107; Rummukainen M, 2012, WIRES CLIM CHANGE, V3, P115, DOI 10.1002/wcc.160; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Searle CL, 2011, CONSERV BIOL, V25, P965, DOI 10.1111/j.1523-1739.2011.01708.x; Shoo LP, 2011, J APPL ECOL, V48, P487, DOI 10.1111/j.1365-2664.2010.01942.x; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stebbins R. C., 2021, NATURAL HIST AMPHIBI; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Teskey R, 2015, PLANT CELL ENVIRON, V38, P1699, DOI 10.1111/pce.12417; Utltsch GR, TADPOLES BIOL ANURAN; Venesky MD, 2014, BIOL REV, V89, P477, DOI 10.1111/brv.12064; Voyles J, 2017, OECOLOGIA, V184, P363, DOI 10.1007/s00442-017-3866-8; Voyles J, 2012, ECOL EVOL, V2, P2241, DOI 10.1002/ece3.334; Wake DB, 2012, SCIENCE, V335, P1052, DOI 10.1126/science.1218364; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1; Xie GY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160746	63	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222237	10.1371/journal.pone.0222237	http://dx.doi.org/10.1371/journal.pone.0222237			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536533	Green Submitted, gold, Green Published			2022-12-26	WOS:000532262800031
J	Reuschel, E; Toelge, M; Entleutner, K; Deml, L; Seelbach-Goebel, B				Reuschel, Edith; Toelge, Martina; Entleutner, Kathrin; Deml, Ludwig; Seelbach-Goebel, Birgit			Cytokine profiles of umbilical cord blood mononuclear cells upon in vitro stimulation with lipopolysaccharides of different vaginal gram-negative bacteria	PLOS ONE			English	Article							TNF-ALPHA PRODUCTION; LPS-INDUCED RELEASE; PRETERM LABOR; NEONATAL SEPSIS; INFLAMMATORY CYTOKINES; CHEMICAL-STRUCTURE; PREMATURE RUPTURE; PROTEUS-MIRABILIS; ESCHERICHIA-COLI; CEREBRAL-PALSY	Inflammatory immune responses induced by lipopolysaccharides (LPS) of gram-negative bacteria play an important role in the pathogenesis of preterm labor and delivery, and in neonatal disorders. To better characterize LPS-induced inflammatory response, we determined the cytokine profile of umbilical cord blood mononuclear cells (UBMC) stimulated with LPS of seven vaginal gram-negative bacteria commonly found in pregnant women with preterm labor and preterm rupture of membrane. UBMC from ten newborns of healthy volunteer mothers were stimulated with purified LPS of Escherichia coli, Enterobacter aerogenes, Klebsiella pneumoniae, Proteus mirabilis, Acinetobacter calcoaceticus, Citrobacter freundii, and Pseudomonas aeruginosa. UBMC supernatants were tested for the presence of secreted pro-inflammatory cytokines (IL-6, IL-1 beta, TNF), anti-inflammatory cytokine (IL-10), TH1-type cytokines (IL-12, IFN-gamma), and chemokines (IL-8, MIP-1 alpha, MIP-1 beta, MCP-1) by Luminex technology. The ten cytokines were differentially induced by the LPS variants. LPS of E. coli and E. aerogenes showed the strongest stimulatory activity and P. aeruginosa the lowest. Interestingly, the ability of UBMC to respond to LPS varied greatly among donors, suggesting a strong individual heterogeneity in LPS-triggered inflammatory response.	[Reuschel, Edith; Entleutner, Kathrin; Seelbach-Goebel, Birgit] Univ Regensburg, Hosp Barmherzige Brueder, Dept Obstet & Gynecol, Clin St Hedwig, Regensburg, Germany; [Toelge, Martina; Deml, Ludwig] Univ Hosp Regensburg, Inst Med Microbiol, Regensburg, Germany; [Toelge, Martina] MicroBIOMix GmbH, Regensburg, Germany; [Deml, Ludwig] Lophius Biosci GmbH, Regensburg, Germany	University of Regensburg; University of Regensburg	Reuschel, E (corresponding author), Univ Regensburg, Hosp Barmherzige Brueder, Dept Obstet & Gynecol, Clin St Hedwig, Regensburg, Germany.	Edith.Reuschel@barmherzige-regensburg.de	Malfertheiner, Sara Fill/AAW-3419-2021	Malfertheiner, Sara Fill/0000-0002-4274-2526	University of Regensburg	University of Regensburg	This work was supported by institutional research funds of the University of Regensburg to BSG. MT receives salary from MicroBIOMIX and LD receives salary from Lophius Biosciences. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abdallah MW, 2012, J NEUROIMMUNOL, V252, P75, DOI 10.1016/j.jneuroim.2012.07.013; Al-Amin MM, 2016, NEUROSCIENCE, V318, P84, DOI 10.1016/j.neuroscience.2016.01.002; Belderbos ME, 2009, CLIN IMMUNOL, V133, P228, DOI 10.1016/j.clim.2009.07.003; Berthet J, 2012, CLIN IMMUNOL, V145, P189, DOI 10.1016/j.clim.2012.09.004; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Brandenburg K, 2016, J STRUCT BIOL, V194, P68, DOI 10.1016/j.jsb.2016.01.014; Brocklehurst P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000262.pub4; BRYN K, 1978, EUR J BIOCHEM, V86, P311, DOI 10.1111/j.1432-1033.1978.tb12312.x; Burnichon G, 2004, MED MALADIES INFECT, V34, P166, DOI 10.1016/j.medmal.2003.12.007; Chawanpaiboon S, 2019, LANCET GLOB HEALTH, V7, pE37, DOI 10.1016/S2214-109X(18)30451-0; Cooke R, 2008, DEV MED CHILD NEUROL, V50, P9, DOI 10.1111/j.1469-8749.2007.00009.x; Dammann O, 1997, PEDIATR RES, V42, P1, DOI 10.1203/00006450-199707000-00001; del Campo R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029577; Dembinski J, 2002, CYTOKINE, V18, P116, DOI 10.1006/cyto.2002.0880; Di Simone N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180642; EGGESBO JB, 1994, CYTOKINE, V6, P521, DOI 10.1016/1043-4666(94)90080-9; EGGESBO JB, 1995, CYTOKINE, V7, P562, DOI 10.1006/cyto.1995.0076; Elovitz MA, 2011, INT J DEV NEUROSCI, V29, P663, DOI 10.1016/j.ijdevneu.2011.02.011; Ernst W, 2015, CYTOKINE, V73, P91, DOI 10.1016/j.cyto.2015.01.023; Gangloff SC, 1999, CLIN INFECT DIS, V28, P491, DOI 10.1086/515176; Rodrigo FGM, 2014, PEDIATR NEONATOL, V55, P381, DOI 10.1016/j.pedneo.2013.12.007; Goldenberg RL, 2002, OBSTET GYNECOL, V100, P1020, DOI 10.1016/S0029-7844(02)02212-3; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; Hagberg H, 2005, BJOG-INT J OBSTET GY, V112, P16, DOI 10.1111/j.1471-0528.2005.00578.x; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; HARAGUCHI GE, 1991, MICROB PATHOGENESIS, V10, P351, DOI 10.1016/0882-4010(91)90080-T; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; HILLIER SL, 1988, NEW ENGL J MED, V319, P972, DOI 10.1056/NEJM198810133191503; Jaekal J, 2007, J MICROBIOL BIOTECHN, V17, P1862; Jansky L, 2003, PHYSIOL RES, V52, P593; Kassim Z, 2003, EUR J PEDIATR, V162, P644, DOI 10.1007/s00431-003-1240-9; KAWAHARA K, 1987, EUR J BIOCHEM, V163, P489, DOI 10.1111/j.1432-1033.1987.tb10895.x; Kooistra O, 2003, CARBOHYD RES, V338, P2667, DOI 10.1016/j.carres.2003.07.004; Korzeniewski SJ, 2014, J PERINAT MED, V42, P731, DOI 10.1515/jpm-2014-0250; Krohn MA, 1997, J INFECT DIS, V175, P606, DOI 10.1093/infdis/175.3.606; Kumolosasi E, 2014, TROP J PHARM RES, V13, P536, DOI 10.4314/tjpr.v13i4.8; Kunze M, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.01.181; LETTIERI L, 1993, AM J OBSTET GYNECOL, V168, P1480, DOI 10.1016/S0002-9378(11)90785-6; LEVITON A, 1993, DEV MED CHILD NEUROL, V35, P553; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; Lindner H, 1997, BLOOD, V89, P1931, DOI 10.1182/blood.V89.6.1931; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Maeshima N, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00003; Manktelow BN, 2001, ARCH DIS CHILD-FETAL, V85, pF33, DOI 10.1136/fn.85.1.F33; Martin Joyce A, 2018, Natl Vital Stat Rep, V67, P1; Martinelli P, 2012, J MATERN-FETAL NEO M, V25, P29, DOI 10.3109/14767058.2012.714981; Mathias B, 2017, SHOCK, V47, P606, DOI 10.1097/SHK.0000000000000800; McKenna KC, 2009, J IMMUNOL METHODS, V341, P68, DOI 10.1016/j.jim.2008.10.019; Menon R, 2004, J PERINAT MED, V32, P391, DOI 10.1515/JPM.2004.134; Menon R, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.027; Michel O, 2003, J ALLERGY CLIN IMMUN, V112, P923, DOI 10.1016/j.jaci.2003.05.001; Miller SP, 2006, PEDIATRICS, V117, P1626, DOI 10.1542/peds.2005-1767; Mizoguchi M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207085; Naegelen I, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/817038; Netea MG, 2002, TRENDS IMMUNOL, V23, P135, DOI 10.1016/S1471-4906(01)02169-X; Ng PY, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00166; Ovalle A, 2009, REV MED CHILE, V137, P1201, DOI /S0034-98872009000900010; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; PANKUCH GA, 1984, OBSTET GYNECOL, V64, P802; Pappas A, 2014, JAMA PEDIATR, V168, P137, DOI 10.1001/jamapediatrics.2013.4248; Peltier Morgan R, 2003, Reprod Biol Endocrinol, V1, P122; Perfetto CO, 2015, J ASSIST REPROD GEN, V32, P977, DOI 10.1007/s10815-015-0481-7; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Rodrigues J, 2014, CASE REP PEDIAT, V2014, DOI 10.1155/2014/195204; Romero R, 2001, PAEDIATR PERINAT EP, V15, P41, DOI 10.1046/j.1365-3016.2001.00007.x; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Romero R, 2014, J MATERN-FETAL NEO M, V27, P975, DOI 10.3109/14767058.2013.847918; Rosmanova R, 2000, Akush Ginekol (Sofiia), V39, P19; Sadeghi K, 2007, J INFECT DIS, V195, P296, DOI 10.1086/509892; Schildberger A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/697972; Schulz D, 2019, CYTOKINE, V116, P97, DOI 10.1016/j.cyto.2018.12.017; Seelbach-Goebel B, 2013, GEBURTSH FRAUENHEILK, V73, P1218, DOI 10.1055/s-0033-1360195; Shatrov JG, 2010, OBSTET GYNECOL, V116, P387, DOI 10.1097/AOG.0b013e3181e90046; Shete Vishal B, 2009, J Lab Physicians, V1, P73, DOI 10.4103/0974-2727.59704; SIDORCZYK Z, 1983, EUR J BIOCHEM, V137, P15, DOI 10.1111/j.1432-1033.1983.tb07789.x; Sirota L, 2000, ACTA PAEDIATR, V89, P331; Soraisham AS, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.034; Sorensen HJ, 2009, SCHIZOPHRENIA BULL, V35, P631, DOI 10.1093/schbul/sbn121; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Sugitharini V, 2014, CYTOKINE, V69, P211, DOI 10.1016/j.cyto.2014.06.003; SUSSKIND M, 1995, CARBOHYD RES, V269, pC1, DOI 10.1016/0008-6215(95)00002-B; Usluoglu N, 2007, EUR J IMMUNOL, V37, P2317, DOI 10.1002/eji.200636388; Viswanathan R, 2011, EPIDEMIOL INFECT, V139, P226, DOI 10.1017/S0950268810000701; Walker KF, 2016, LANCET, V387, P2068, DOI 10.1016/S0140-6736(16)00590-0; Watt S, 2003, J CLIN MICROBIOL, V41, P1929, DOI 10.1128/JCM.41.5.1929-1935.2003; Wood NS, 2000, NEW ENGL J MED, V343, P378, DOI 10.1056/NEJM200008103430601; Yanowitz TD, 1998, J PEDIATR-US, V132, P28, DOI 10.1016/S0022-3476(98)70480-9; Yerkovich ST, 2007, PEDIATR RES, V62, P547, DOI 10.1203/PDR.0b013e3181568105	90	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222465	10.1371/journal.pone.0222465	http://dx.doi.org/10.1371/journal.pone.0222465			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536529	Green Published, gold			2022-12-26	WOS:000532262800043
J	Yang, E; Mundy, C; Rappaport, EF; Pacifici, M; Billings, PC				Yang, Evan; Mundy, Christina; Rappaport, Eric F.; Pacifici, Maurizio; Billings, Paul C.			Identification and characterization of a novel heparan sulfate-binding domain in Activin A longest variants and implications for function	PLOS ONE			English	Article							SKELETAL DEVELOPMENT; STRUCTURAL BASIS; INHIBIN; PROTEIN; GROWTH; RECEPTOR; FOLLISTATIN; INSIGHTS; RANGE; BETA	Activins regulate numerous processes including inflammation and are synthesized as precursors consisting of a long N-terminal pro-region and a mature protein. Genomic human databases currently list three activin A (Act A) variants termed X1, X2 and X3. The X3 variant is the shortest, lacks N-terminal segments present in X1 and X2, and has been the focus of most past literature. Here, we asked whether these variants are expressed by human cells and tissues and what structural features are contained within their pro-regions. Human monocytic-like cells THP1 and U937 expressed X1 and X2 variants after exposure to phorbol ester or granulocyte-macrophage colony-stimulating factor, while X2 transcripts were present in placenta. Expression vectors encoding full length X2 or X3 variants resulted in production and secretion of biologically active Act A from cultured cells. Previous studies reported a putative HS-binding domain (HBD) in the X3 pro-region. Here, we identified a novel HBD with consensus HS-binding motifs near the N-terminal end of X1 and X2 proregions. Peptides encompassing this new domain interacted with substrate-bound HS with nanomolar affinity, while peptides from putative X3 HBD did not. In good agreement, full length X2 pro-region interacted with heparin-agarose, while the X3 pro-region did not. In sum, our study reveals that Act A variants are expressed by inflammatory cells and placenta and yield biological activity. The high affinity HBD in X1 and X2 pro-region and its absence in X3 could greatly influence overall Act A distribution, availability and activity in physiological and pathological circumstances.	[Yang, Evan; Mundy, Christina; Pacifici, Maurizio; Billings, Paul C.] Childrens Hosp Philadelphia, Div Orthopaed Surg, Translat Res Program Pediat Orthopaed, Philadelphia, PA 19104 USA; [Rappaport, Eric F.] Childrens Hosp Philadelphia, Mol Genet Core, Philadelphia, PA 19104 USA; [Yang, Evan] Harvard Med Sch, Grad Program Biol & Biomed Sci BBS, Boston, MA 02115 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Harvard Medical School	Billings, PC (corresponding author), Childrens Hosp Philadelphia, Div Orthopaed Surg, Translat Res Program Pediat Orthopaed, Philadelphia, PA 19104 USA.	BillingsP@email.chop.edu	Rappaport, Eric/GRO-4051-2022		Institute of Arthritis, Musculoskeletal and Skin Disease at the National Institutes of Health [RO1AR061758, RO1AR071946]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR071946, R01AR061758] Funding Source: NIH RePORTER	Institute of Arthritis, Musculoskeletal and Skin Disease at the National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants RO1AR061758 and RO1AR071946 to MP from the Institute of Arthritis, Musculoskeletal and Skin Disease at the National Institutes of Health.	Abe M, 2002, J LEUKOCYTE BIOL, V72, P347; Antsiferova M, 2012, J CELL SCI, V125, P3929, DOI 10.1242/jcs.094789; Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; BARTON DE, 1989, GENOMICS, V5, P91, DOI 10.1016/0888-7543(89)90091-8; Billings PC, 2018, J BIOL CHEM, V293, P14371, DOI 10.1074/jbc.RA118.003191; Billings PC, 2015, CONNECT TISSUE RES, V56, P272, DOI 10.3109/03008207.2015.1045066; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Capurro MI, 2008, DEV CELL, V14, P700, DOI 10.1016/j.devcel.2008.03.006; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; de Kretser DM, 2012, MOL CELL ENDOCRINOL, V359, P101, DOI 10.1016/j.mce.2011.10.009; Dundas CM, 2013, APPL MICROBIOL BIOT, V97, P9343, DOI 10.1007/s00253-013-5232-z; Farokhzad OC, 2000, NUCLEIC ACIDS RES, V28, P2256, DOI 10.1093/nar/28.11.2256; Fromm JR, 1997, ARCH BIOCHEM BIOPHYS, V343, P92, DOI 10.1006/abbi.1997.0147; Gandhi NS, 2012, BBA-PROTEINS PROTEOM, V1824, P1374, DOI 10.1016/j.bbapap.2012.07.002; GENTRY LE, 1988, MOL CELL BIOL, V8, P4162, DOI 10.1128/MCB.8.10.4162; GRAY AM, 1990, SCIENCE, V247, P1328, DOI 10.1126/science.2315700; Hagemann AI, 2009, DEVELOPMENT, V136, P2803, DOI 10.1242/dev.034124; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Hatsell SJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4358; Hefferan TE, 2000, J CELL BIOCHEM, V78, P380, DOI 10.1002/1097-4644(20000901)78:3<380::AID-JCB4>3.0.CO;2-L; Huegel J, 2013, DEV DYNAM, V242, P1021, DOI 10.1002/dvdy.24010; Huegel J, 2013, DEV BIOL, V377, P100, DOI 10.1016/j.ydbio.2013.02.008; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; Johnson KE, 2016, MOL CELL ENDOCRINOL, V422, P84, DOI 10.1016/j.mce.2015.12.007; Jones KL, 2004, MOL CELL ENDOCRINOL, V225, P119, DOI 10.1016/j.mce.2004.07.010; Khachigian LM, 2004, CARDIOVASC DRUG REV, V22, P1; Kirkpatrick CA, 2006, DEV BIOL, V300, P570, DOI 10.1016/j.ydbio.2006.09.011; Li SL, 2010, J BIOL CHEM, V285, P36645, DOI 10.1074/jbc.M110.177865; Makanji Y, 2014, ENDOCR REV, V35, P747, DOI 10.1210/er.2014-1003; Mason AJ, 1996, MOL ENDOCRINOL, V10, P1055, DOI 10.1210/me.10.9.1055; MAYO KE, 1994, TRENDS ENDOCRIN MET, V5, P407, DOI 10.1016/1043-2760(95)92523-L; McDowell N, 1997, CURR BIOL, V7, P671, DOI 10.1016/S0960-9822(06)00294-6; Mundy C, 2018, J BIOL CHEM, V293, P7703, DOI 10.1074/jbc.RA117.000264; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nagaraj SH, 2007, BRIEF BIOINFORM, V8, P6, DOI 10.1093/bib/bbl015; Ohkawara B, 2002, CURR BIOL, V12, P205, DOI 10.1016/S0960-9822(01)00684-4; Pacifici M, 2016, CYTOKINE GROWTH F R, V27, P93, DOI 10.1016/j.cytogfr.2015.12.007; Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x; Salazar VS, 2016, NAT REV ENDOCRINOL, V12, P203, DOI 10.1038/nrendo.2016.12; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Schultz V, 2017, J BIOL CHEM, V292, P2495, DOI 10.1074/jbc.M116.761585; SCHWARTZ NB, 1977, P NATL ACAD SCI USA, V74, P5721, DOI 10.1073/pnas.74.12.5721; Shore EM, 2008, BONE, V43, P427, DOI 10.1016/j.bone.2008.05.013; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Sierra-Filardi E, 2011, BLOOD, V117, P5092, DOI 10.1182/blood-2010-09-306993; STEWART AG, 1986, FEBS LETT, V206, P329, DOI 10.1016/0014-5793(86)81006-7; SUGINO K, 1993, J BIOL CHEM, V268, P15579; VALE W, 1986, NATURE, V321, P776, DOI 10.1038/321776a0; Verrecchio A, 2000, J BIOL CHEM, V275, P7701, DOI 10.1074/jbc.275.11.7701; Walton KL, 2012, MOL CELL ENDOCRINOL, V359, P2, DOI 10.1016/j.mce.2011.06.030; Wang XL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12052; Whalen DM, 2013, P NATL ACAD SCI USA, V110, P16420, DOI 10.1073/pnas.1310097110; Xia Y, 2009, J ENDOCRINOL, V202, P1, DOI 10.1677/JOE-08-0549; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Ye S, 2001, BIOCHEMISTRY-US, V40, P14429, DOI 10.1021/bi011000u; Yu J, 1996, IMMUNOLOGY, V88, P368, DOI 10.1046/j.1365-2567.1996.d01-675.x	57	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222784	10.1371/journal.pone.0222784	http://dx.doi.org/10.1371/journal.pone.0222784			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536599	Green Submitted, Green Published, gold			2022-12-26	WOS:000532262800085
J	Alger, SA; Burnham, PA; Brody, AK				Alger, Samantha A.; Burnham, P. Alexander; Brody, Alison K.			Flowers as viral hot spots: Honey bees (Apis mellifera) unevenly deposit viruses across plant species	PLOS ONE			English	Article							DEFORMED-WING-VIRUS; TRANSMISSION; PATHOGEN; BUMBLEBEES; DIVERSITY; INFECTION; IMMUNITY; IMPACTS; THREAT; L.	RNA viruses, once considered specific to honey bees, are suspected of spilling over from managed bees into wild pollinators; however, transmission routes are largely unknown. A widely accepted yet untested hypothesis states that flowers serve as bridges in the transmission of viruses between bees. Here, using a series of controlled experiments with captive bee colonies, we examined the role of flowers in bee virus transmission. We first examined if honey bees deposit viruses on flowers and whether bumble bees become infected after visiting contaminated flowers. We then examined whether plant species differ in their propensity to harbor viruses and if bee visitation rates increase the likelihood of virus deposition on flowers. Our experiment demonstrated, for the first time, that honey bees deposit viruses on flowers. However, the two viruses we examined, black queen cell virus (BQCV) and deformed wing virus (DWV), were not equally distributed across plant species, suggesting that differences in floral traits, virus ecology and/or foraging behavior may mediate the likelihood of deposition. Bumble bees did not become infected after visiting flowers previously visited by honey bees suggesting that transmission via flowers may be a rare occurrence and contingent on multiplicative factors and probabilities such as infectivity of virus strain across bee species, immunocompetence, virus virulence, virus load, and the probability a bumble bee will contact a virus particle on a flower. Our study is among the first to experimentally examine the role of flowers in bee virus transmission and uncovers promising avenues for future research.	[Alger, Samantha A.; Burnham, P. Alexander; Brody, Alison K.] Univ Vermont, Dept Biol, Burlington, VT 05405 USA	University of Vermont	Alger, SA (corresponding author), Univ Vermont, Dept Biol, Burlington, VT 05405 USA.	salger@uvm.edu		Alger, Samantha/0000-0001-7787-1312	Northeast Sustainable Agriculture Research and Education (SARE) [GNE15-094]; National Science Foundation Graduate Research Fellowship [DGE-1451866]; Switzer Foundation Switzer Environmental Fellowship	Northeast Sustainable Agriculture Research and Education (SARE); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Switzer Foundation Switzer Environmental Fellowship	Funding was provided by a graduate student grant to SAA from Northeast Sustainable Agriculture Research and Education (SARE) (GNE15-094; https://www.nesare.org/), a National Science Foundation Graduate Research Fellowship (DGE-1451866; https://www.nsfgrfp.org/) to SAA, and a Switzer Foundation Switzer Environmental Fellowship to SAA (https://www.switzernetwork.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Joseph Schall and Elizabeth Whalen for their assistance in the laboratory; Humberto Boncristiani for his advice with experimental design; Sara Helms Cahan, Taylor Ricketts, and Joseph Schall for editorial comments on the manuscript. Funding was provided by a graduate student grant from Northeast Sustainable Agriculture Research and Education (SARE) (GNE15-094), a National Science Foundation Graduate Research Fellowship (DGE-1451866), and a Switzer Foundation Switzer Environmental Fellowship.	Adler LS, 2018, ECOLOGY, V99, P2535, DOI 10.1002/ecy.2503; Alger SA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217822; Andres A, 2009, J NUTR BIOCHEM, V20, P563, DOI 10.1016/j.jnutbio.2009.04.004; Annoscia D, 2017, SCI REP, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]; Arenas A, 2019, BEHAV ECOL SOCIOBIOL, V73, DOI 10.1007/s00265-019-2644-5; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; Braman SK, 2018, ENVIRON ENTOMOL, V47, P1203, DOI 10.1093/ee/nvy117; CHANG CF, 1969, AGR BIOL CHEM TOKYO, V33, P398, DOI 10.1080/00021369.1969.10859325; Chen YP, 2006, APPL ENVIRON MICROB, V72, P606, DOI 10.1128/AEM.72.1.606-611.2006; Chen YP, 2005, APPL ENVIRON MICROB, V71, P436, DOI 10.1128/AEM.71.1.436-441.2005; Colla SR, 2006, BIOL CONSERV, V129, P461, DOI 10.1016/j.biocon.2005.11.013; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; DURRER S, 1994, P ROY SOC B-BIOL SCI, V258, P299, DOI 10.1098/rspb.1994.0176; Evans JD, 2011, TRENDS MICROBIOL, V19, P614, DOI 10.1016/j.tim.2011.09.003; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Hernandez IG, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.189910; Genersch E, 2006, J INVERTEBR PATHOL, V91, P61, DOI 10.1016/j.jip.2005.10.002; Ghazoul J, 2006, J ECOL, V94, P295, DOI 10.1111/j.1365-2745.2006.01098.x; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Graham James M, 2000, ANN M SW ED RES ASS; Graystock P, 2016, INT J PARASITOL-PAR, V5, P64, DOI 10.1016/j.ijppaw.2015.10.001; Graystock P, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1371; Graystock P, 2014, PEERJ, V2, DOI 10.7717/peerj.522; Hegland SJ, 2006, ECOL ENTOMOL, V31, P532, DOI 10.1111/j.1365-2311.2006.00812.x; HEINRICH B, 1979, ECOLOGY, V60, P245, DOI 10.2307/1937652; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Leat N, 2000, J GEN VIROL, V81, P2111, DOI 10.1099/0022-1317-81-8-2111; Levitt AL, 2013, VIRUS RES, V176, P232, DOI 10.1016/j.virusres.2013.06.013; Li JL, 2011, J ECON ENTOMOL, V104, P732, DOI 10.1603/EC10355; Manley R, 2015, J APPL ECOL, V52, P331, DOI 10.1111/1365-2664.12385; Manson JS, 2010, OECOLOGIA, V162, P81, DOI 10.1007/s00442-009-1431-9; Mazzei M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113448; McArt SH, 2014, ECOL LETT, V17, P624, DOI 10.1111/ele.12257; McMahon DP, 2015, J ANIM ECOL, V84, P615, DOI 10.1111/1365-2656.12345; Melathopoulos A, 2017, J INVERTEBR PATHOL, V146, P24, DOI 10.1016/j.jip.2017.04.003; Otterstatter MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002771; Portlas ZM, 2018, PLANT GENET RESOUR-C, V16, P498, DOI [10.1017/S1479262118000072, 10.1017/s1479262118000072]; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Purkiss T, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1071; R Core Team, 2021, R LANGUAGE ENV STAT; Ravoet J, 2014, J INVERTEBR PATHOL, V122, P55, DOI 10.1016/j.jip.2014.08.007; Richardson LL, 2016, ECOLOGY, V97, P325, DOI 10.1890/15-0263.1; Richardson LL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2471; Simone-Finstrom MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034601; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Wilfert L, 2016, SCIENCE, V351, P594, DOI 10.1126/science.aac9976; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102	49	29	30	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221800	10.1371/journal.pone.0221800	http://dx.doi.org/10.1371/journal.pone.0221800			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532764	Green Published, Green Submitted, gold			2022-12-26	WOS:000532239600011
J	Tangedal, S; Nielsen, R; Aanerud, M; Persson, LJ; Wiker, HG; Bakke, PS; Hiemstra, PS; Eagan, TM				Tangedal, Solveig; Nielsen, Rune; Aanerud, Marianne; Persson, Louise J.; Wiker, Harald G.; Bakke, Per S.; Hiemstra, Pieter S.; Eagan, Tomas M.			Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients	PLOS ONE			English	Article							LUNG MICROBIOME; BACTERIAL; DYNAMICS	Background Exacerbations of chronic obstructive pulmonary disease (COPD) are debilitating events and spur disease progression. Infectious causes are frequent; however, it is unknown to what extent exacerbations are caused by larger shifts in the airways' microbiota. The aim of the current study was to analyse the changes in microbial composition between stable state and during exacerbations, and the corresponding immune response. Methods The study sample included 36 COPD patients examined at stable state and exacerbation from the Bergen COPD Cohort and Exacerbations studies, and one patient who delivered sputum on 13 different occasions during the three-year study period. A physician examined the patients at all time points, and sputum induction was performed by stringent protocol. Only induced sputum samples were used in the current study, not spontaneously expectorated sputum. Sputum inflammatory markers (IL-6, IL-8, IL-18, IP-10, MIG, TNF-alpha) and antimicrobial peptides (AMPs, i.e. LL-37/hCAP-18, SLPI) were measured in supernatants, whereas target gene sequencing (16S rRNA) was performed on corresponding cell pellets. The microbiome bioinformatics platform QIIME2 (TM) and the statistics environment R were applied for bioinformatics analyses. Results Levels of IP-10, MIG, TNF-alpha and AMPs were significantly different between the two disease states. Of 36 sample pairs, 24 had significant differences in the 12 most abundant genera between disease states. The diversity was significantly different in several individuals, but not when data was analysed on a group level. The one patient case study showed longitudinal dynamics in microbiota unrelated to disease state. Conclusion Changes in the sputum microbiota with changing COPD disease states are common, and are accompanied by changes in inflammatory markers. However, the changes are highly individual and heterogeneous events.	[Tangedal, Solveig; Nielsen, Rune; Wiker, Harald G.; Bakke, Per S.; Eagan, Tomas M.] Univ Bergen, Fac Med, Dept Clin Sci, Bergen, Norway; [Tangedal, Solveig; Nielsen, Rune; Aanerud, Marianne; Persson, Louise J.; Eagan, Tomas M.] Haukeland Hosp, Dept Thorac Med, Bergen, Norway; [Hiemstra, Pieter S.] Leiden Univ, Dept Pulmonol, Med Ctr, Leiden, Netherlands; [Wiker, Harald G.] Haukeland Hosp, Dept Microbiol, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Bergen; Haukeland University Hospital	Tangedal, S (corresponding author), Univ Bergen, Fac Med, Dept Clin Sci, Bergen, Norway.; Tangedal, S (corresponding author), Haukeland Hosp, Dept Thorac Med, Bergen, Norway.	stangedal@gmail.com	Eagan, Tomas ML/P-3554-2014; Eagan, Tomas Mikal/AHC-9127-2022; Nielsen, Rune/O-3131-2016	Eagan, Tomas ML/0000-0001-8725-9960; Nielsen, Rune/0000-0003-2799-0430; Tangedal, Solveig/0000-0001-8060-5306; Wiker, Harald Gotten/0000-0001-9452-243X	Centre for Clinical Research, Haukeland University Hospital; Bergen Medical Research Foundation	Centre for Clinical Research, Haukeland University Hospital; Bergen Medical Research Foundation	The Bergen COPD cohort study was supported by the Centre for Clinical Research, Haukeland University Hospital. Cost of analyses for the Luminex analyses was provided from a personal grant from the Bergen Medical Research Foundation to T. E in 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agusti AGN, 2003, EUR RESPIR J, V21, P347, DOI 10.1183/09031936.03.00405703; Barnes PJ, 2016, J ALLERGY CLIN IMMUN, V138, P16, DOI 10.1016/j.jaci.2016.05.011; Bolyen E., 2018, PEERJ PREPR, DOI [10.7287/peerj.preprints.27295v2, DOI 10.7287/PEERJ.PREPRINTS.27295V2, 10.7287/peerj.preprints.27295v1]; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Caramori G, 2018, CHEST, V153, P1424, DOI 10.1016/j.chest.2017.10.033; Davis NM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0605-2; Eagan TML, 2010, EUR RESPIR J, V35, P540, DOI 10.1183/09031936.00088209; Egesten A, 2007, J INFECT DIS, V195, P684, DOI 10.1086/510857; Fenwick PS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128757; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2018, GLOBAL STRATEGY DIAG; Gloor GB, 2016, CAN J MICROBIOL, V62, P692, DOI 10.1139/cjm-2015-0821; Gronseth Rune, 2017, ERJ Open Res, V3, DOI 10.1183/23120541.00019-2017; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2014, J CLIN MICROBIOL, V52, P2813, DOI 10.1128/JCM.00035-14; Hurst JR, 2010, NEW ENGL J MED, V363, P1128, DOI 10.1056/NEJMoa0909883; Husebo GR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109721; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; Mayhew D, 2018, THORAX, V73, P422, DOI 10.1136/thoraxjnl-2017-210408; O'Donnell R, 2006, THORAX, V61, P448, DOI 10.1136/thx.2004.024463; Oksanen J., 2018, R PACKAGE VERSION, V2, P4; Persson LJP, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01328-2016; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Sapey E, 2006, THORAX, V61, P250, DOI 10.1136/thx.2005.041822; Seemungal TAR, 2000, AM J RESP CRIT CARE, V161, P1608, DOI 10.1164/ajrccm.161.5.9908022; Sethi S, 2002, NEW ENGL J MED, V347, P465, DOI 10.1056/NEJMoa012561; Su YC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02530; Sze MA, 2015, AM J RESP CRIT CARE, V192, P438, DOI 10.1164/rccm.201502-0223OC; Tangedal S, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0645-3; Tangedal S, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0138-6; Tjabringa GS, 2005, FEMS IMMUNOL MED MIC, V45, P151, DOI 10.1016/j.femsim.2005.03.004; Tufvesson E, 2015, INT J CHRONIC OBSTR, V10, P881, DOI 10.2147/COPD.S78748; Wang Z, 2016, EUR RESPIR J, V47, P1082, DOI 10.1183/13993003.01406-2015; Waters JP, 2013, J PATHOL, V230, P132, DOI 10.1002/path.4187; Wilkinson TMA, 2006, CHEST, V129, P317, DOI 10.1378/chest.129.2.317; Yue JC, 2005, COMMUN STAT-THEOR M, V34, P2123, DOI 10.1080/STA-200066418	37	15	15	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222449	10.1371/journal.pone.0222449	http://dx.doi.org/10.1371/journal.pone.0222449			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527888	Green Published, Green Submitted, gold			2022-12-26	WOS:000532231400022
J	de Miranda, MC; Rodrigues, MA; Campos, ACD; Faria, JAQA; Kunrath-Lima, M; Mignery, GA; Schechtman, D; Goes, AM; Nathanson, MH; Gomes, DA				de Miranda, Marcelo Coutinho; Rodrigues, Michele Angela; de Angelis Campos, Ana Carolina; Quintao Arantes Faria, Jerusa Araujo; Kunrath-Lima, Marianna; Mignery, Gregory A.; Schechtman, Deborah; Goes, Alfredo Miranda; Nathanson, Michael H.; Gomes, Dawidson A.			Epidermal growth factor (EGF) triggers nuclear calcium signaling through the intranuclear phospholipase C?-4 (PLC?4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calcium intracellular release; phospholipase C; epidermal growth factor receptor (EGFR); nucleus; inositol 1; 4; 5-trisphosphate (IP3); protein kinase C (PKC); calcium; EGFR; nucleus; phospholipase C?-4; proliferation	CELL-CYCLE; FACTOR RECEPTOR; LIVER-REGENERATION; CATALYTIC-ACTIVITY; EXPRESSION; PHOSPHORYLATION; TRANSLOCATION; INSULIN; PURIFICATION; ACTIVATION	Calcium (Ca2+) signaling within the cell nucleus regulates specific cellular events such as gene transcription and cell proliferation. Nuclear and cytosolic Ca2+ levels can be independently regulated, and nuclear translocation of receptor tyrosine kinases (RTKs) is one way to locally activate signaling cascades within the nucleus. Nuclear RTKs, including the epidermal growth factor receptor (EGFR), are important for processes such as transcriptional regulation, DNA-damage repair, and cancer therapy resistance. RTKs can hydrolyze phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2) within the nucleus, leading to Ca2+ release from the nucleoplasmic reticulum by inositol 1,4,5-trisphosphate receptors. PI(4,5)P-2 hydrolysis is mediated by phospholipase C (PLC). However, it is unknown which nuclear PLC isoform is triggered by EGFR. Here, using subcellular fractionation, immunoblotting and fluorescence, siRNA-based gene knockdowns, and FRET-based biosensor reporter assays, we investigated the role of PLC?4 in epidermal growth factor (EGF)-induced nuclear Ca2+ signaling and downstream events. We found that EGF-induced Ca2+ signals are inhibited when translocation of EGFR is impaired. Nuclear Ca2+ signals also were reduced by selectively buffering inositol 1,4,5-trisphosphate (InsP(3)) within the nucleus. EGF induced hydrolysis of nuclear PI(4,5)P-2 by the intranuclear PLC?4, rather than by PLC?1. Moreover, protein kinase C, a downstream target of EGF, was active in the nucleus of stimulated cells. Furthermore, PLC?4 and InsP(3) modulated cell cycle progression by regulating the expression of cyclins A and B1. These results provide evidence that EGF-induced nuclear signaling is mediated by nuclear PLC?4 and suggest new therapeutic targets to modulate the proliferative effects of this growth factor.	[de Miranda, Marcelo Coutinho; Rodrigues, Michele Angela; de Angelis Campos, Ana Carolina; Kunrath-Lima, Marianna; Gomes, Dawidson A.] Univ Fed Minas Gerais, Dept Biochem & Immunol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil; [Quintao Arantes Faria, Jerusa Araujo] Univ Fed Amazonas, Dept Physiol Sci, BR-69080900 Manaus, Amazonas, Brazil; [Mignery, Gregory A.] Loyola Univ Chicago, Stritch Sch Med, Dept Cell & Mol Physiol, Maywood, IL 60153 USA; [Schechtman, Deborah] Univ Sao Paulo, Dept Biochem, Av Prof Lineu Prestes 748, BR-05508900 Sao Paulo, SP, Brazil; [Goes, Alfredo Miranda] Univ Fed Minas Gerais, Dept Pathol, Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil; [de Miranda, Marcelo Coutinho; Rodrigues, Michele Angela; de Angelis Campos, Ana Carolina; Nathanson, Michael H.; Gomes, Dawidson A.] Yale Univ, Internal Med, Sect Digest Dis, New Haven, CT 06520 USA	Universidade Federal de Minas Gerais; Universidade Federal de Amazonas; Loyola University Chicago; Universidade de Sao Paulo; Universidade Federal de Minas Gerais; Yale University	Gomes, DA (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Bloco Q4,Sala 238,Av Antonio Carlos 6627, BR-31270901 Belo Horizonte, MG, Brazil.	dawidson@icb.ufmg.br	schechtman, deborah/B-7572-2012; Faria, Jerusa Araujo Quintao Arantes/AAB-5215-2020; Gomes, Dawidson Assis/O-1372-2013	Faria, Jerusa Araujo Quintao Arantes/0000-0001-7974-0295; Gomes, Dawidson Assis/0000-0001-7714-991X; Miranda, Marcelo/0000-0002-9021-4912; Nathanson, Michael/0000-0001-9964-0160; Schechtman, Deborah/0000-0002-8874-7023	National Institutes of Health [R03 TW08709, P01 DK57751, P30 DK34989, S10 OD023598, R01 DK45710, DK114041, S10OD020142, DK112797]; INCT-Regenera, Rede Mineira de Engenharia de Tecidos e Terapia Celular (REMETTEC) [RED-00570-16]; FAPEMIG; CAPES; CNPq; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK112797, P30DK034989, P01DK057751, R01DK114041] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD023598] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INCT-Regenera, Rede Mineira de Engenharia de Tecidos e Terapia Celular (REMETTEC); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants R03 TW08709, P01 DK57751, P30 DK34989, S10 OD023598, R01 DK45710, DK114041, S10OD020142, and DK112797, by "INCT-Regenera, Rede Mineira de Engenharia de Tecidos e Terapia Celular (REMETTEC)", Grant RED-00570-16, FAPEMIG, CAPES, and CNPq. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akutagawa A, 2006, J BIOCHEM, V140, P619, DOI 10.1093/jb/mvj194; ASANO M, 1994, J BIOL CHEM, V269, P12360; Berridge MJ, 2016, PHYSIOL REV, V96, P1261, DOI 10.1152/physrev.00006.2016; Bootman MD, 2009, J CELL SCI, V122, P2337, DOI 10.1242/jcs.028100; BOYER JL, 1990, METHOD ENZYMOL, V192, P501; Brand TM, 2011, DISCOV MED, V12, P419; Carpenter G, 2009, EXP CELL RES, V315, P1556, DOI 10.1016/j.yexcr.2008.09.027; Campos ACD, 2011, BIOCHEM BIOPH RES CO, V412, P341, DOI 10.1016/j.bbrc.2011.07.100; Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980; Faenza I, 2007, ENDOCRINOLOGY, V148, P1108, DOI 10.1210/en.2006-1003; Faenza I, 2013, FEBS J, V280, P6311, DOI 10.1111/febs.12450; Fima E, 2001, ONCOGENE, V20, P6794, DOI 10.1038/sj.onc.1204885; Fiume R, 2009, FASEB J, V23, P957, DOI 10.1096/fj.08-121244; Follo MY, 2009, P NATL ACAD SCI USA, V106, P16811, DOI 10.1073/pnas.0907109106; Faraco CCF, 2018, J STRUCT BIOL, V202, P61, DOI 10.1016/j.jsb.2017.12.007; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Gomes DA, 2008, J BIOL CHEM, V283, P4344, DOI 10.1074/jbc.M706550200; Gomes DA, 2006, CAN J PHYSIOL PHARM, V84, P325, DOI 10.1139/Y05-117; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Huang W, 2004, J LIPID RES, V45, P1519, DOI 10.1194/jlr.M400088-JLR200; Huang WC, 2011, J BIOL CHEM, V286, P20558, DOI 10.1074/jbc.M111.240796; Huo LF, 2010, P NATL ACAD SCI USA, V107, P16125, DOI 10.1073/pnas.1000743107; Kapoor N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083715; Khamphaya T, 2018, HEPATOLOGY, V67, P560, DOI 10.1002/hep.29588; Kumar V, 2008, J BIOL CHEM, V283, P14072, DOI 10.1074/jbc.M708551200; Kunrath-Lima M, 2018, CELL SIGNAL, V49, P59, DOI 10.1016/j.cellsig.2018.05.011; Lee SB, 1996, J BIOL CHEM, V271, P25, DOI 10.1074/jbc.271.1.25; Leung DW, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-15; Li C, 2009, ONCOGENE, V28, P3801, DOI 10.1038/onc.2009.234; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Liu NS, 1996, J BIOL CHEM, V271, P355, DOI 10.1074/jbc.271.1.355; Malhas A, 2011, TRENDS CELL BIOL, V21, P362, DOI 10.1016/j.tcb.2011.03.008; Manzoli L, 1997, CANCER RES, V57, P2137; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Martelli AM, 2006, BBA-MOL CELL BIOL L, V1761, P542, DOI 10.1016/j.bbalip.2006.02.009; Michalopoulos GK, 2017, HEPATOLOGY, V65, P1384, DOI 10.1002/hep.28988; Moccia F, 2003, J CELL PHYSIOL, V194, P139, DOI 10.1002/jcp.10198; Nagano K, 1999, J BIOL CHEM, V274, P2872, DOI 10.1074/jbc.274.5.2872; Nakamura Y, 2017, J BIOCHEM, V161, P315, DOI 10.1093/jb/mvw094; NISHIBE S, 1990, SCIENCE, V250, P1253, DOI 10.1126/science.1700866; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Poli A, 2014, ONCOTARGET, V5, P11526, DOI 10.18632/oncotarget.2578; Poli A, 2013, CELL CYCLE, V12, P1713, DOI 10.4161/cc.24806; Pusl T, 2002, J BIOL CHEM, V277, P27517, DOI 10.1074/jbc.M203002200; Ramazzotti G, 2008, CELL SIGNAL, V20, P2013, DOI 10.1016/j.cellsig.2008.07.009; Ratti S, 2017, J CELL BIOCHEM, V118, P1969, DOI 10.1002/jcb.25894; Rodrigues MA, 2008, HEPATOLOGY, V48, P1621, DOI 10.1002/hep.22424; Rodrigues MA, 2007, J BIOL CHEM, V282, P17061, DOI 10.1074/jbc.M700490200; Sandvig K, 2002, FEBS LETT, V529, P49, DOI 10.1016/S0014-5793(02)03182-4; Shi Y, 2012, CARCINOGENESIS, V33, P1468, DOI 10.1093/carcin/bgs171; STEHNOBITTEL L, 1995, NEURON, V14, P163, DOI 10.1016/0896-6273(95)90250-3; Subramanian K, 1997, CELL, V89, P963, DOI 10.1016/S0092-8674(00)80281-0; Ueasilamongkol P, 2020, HEPATOLOGY, V71, P583, DOI 10.1002/hep.30839; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Wang YN, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-13	56	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16650	16662		10.1074/jbc.RA118.006961	http://dx.doi.org/10.1074/jbc.RA118.006961			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31537645	hybrid, Green Published			2022-12-26	WOS:000501801900015
J	Nielsen, BS; Zonta, F; Farkas, T; Litman, T; Nielsen, MS; Macaulay, N				Nielsen, Brian Skriver; Zonta, Francesco; Farkas, Thomas; Litman, Thomas; Nielsen, Morten Schak; Macaulay, Nanna			Structural determinants underlying permeant discrimination of the Cx43 hemichannel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						connexin; permeability; pharmacology; biophysics; computer modeling; connexon (hemichannel); gap junction; connexin 30; connexin 43; ion conductivity; membrane channel	GAP-JUNCTION CHANNELS; CONNEXIN HEMICHANNELS; ATP RELEASE; MOLECULAR-DYNAMICS; EXTRACELLULAR LOOP; CHARGE SELECTIVITY; MIMETIC PEPTIDES; N-TERMINUS; PERMEABILITY; CONDUCTANCE	Connexin (Cx) gap junction channels comprise two hemichannels in neighboring cells, and their permeability is well-described, but permeabilities of the single Cx hemichannel remain largely unresolved. Moreover, determination of isoform-specific Cx hemichannel permeability is challenging because of concurrent expression of other channels with similar permeability profiles and inhibitor sensitivities. The mammalian Cx hemichannels Cx30 and Cx43 are gated by extracellular divalent cations, removal of which promotes fluorescent dye uptake in both channels but atomic ion conductance only through Cx30. To determine the molecular determinants of this difference, here we employed chimeras and mutagenesis of predicted pore-lining residues in Cx43. We expressed the mutated channels in Xenopus laevis oocytes to avoid background activity of alternative channels. Oocytes expressing a Cx43 hemichannel chimera containing the N terminus or the first extracellular loop from Cx30 displayed ethidium uptake and, unlike WT Cx43, ion conduction, an observation further supported by molecular dynamics simulations. Additional C-terminal truncation of the chimeric Cx43 hemichannel elicited an even greater ion conductance with a magnitude closer to that of Cx30. The inhibitory profile for the connexin hemichannels depended on the permeant, with conventional connexin hemichannel inhibitors having a higher potency toward the ion conductance pathway than toward fluorescent dye uptake. Our results demonstrate a permeant-dependent, isoform-specific inhibition of connexin hemichannels. They further reveal that the outer segments of the pore-lining region, including the N terminus and the first extracellular loop, together with the C terminus preclude ion conductance of the open Cx43 hemichannel.	[Nielsen, Brian Skriver; Macaulay, Nanna] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci, DK-2200 Copenhagen, Denmark; [Farkas, Thomas; Litman, Thomas] Univ Copenhagen, Fac Hlth & Med Sci, Dept Immunol & Microbiol, DK-2200 Copenhagen, Denmark; [Nielsen, Morten Schak] Univ Copenhagen, Fac Hlth & Med Sci, Dept Biomed Sci, DK-2200 Copenhagen, Denmark; [Zonta, Francesco] ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai 201210, Peoples R China	University of Copenhagen; University of Copenhagen; University of Copenhagen; ShanghaiTech University	Macaulay, N (corresponding author), Univ Copenhagen, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	macaulay@sund.ku.dk	MacAulay, Nanna/AER-7709-2022; Nielsen, Morten Schak/C-1494-2009; Zonta, Francesco/GXW-1979-2022	MacAulay, Nanna/0000-0002-7800-6600; Nielsen, Morten Schak/0000-0002-9718-5421; Zonta, Francesco/0000-0001-8729-1071; Nielsen, Brian Skriver/0000-0002-3018-3309; Litman, Thomas/0000-0002-6068-901X; Farkas, Thomas/0000-0003-1903-6081	Faculty of Health andMedical Sciences, University of Copenhagen; National Natural Science Foundation of China [31770776]	Faculty of Health andMedical Sciences, University of Copenhagen; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Faculty of Health andMedical Sciences, University of Copenhagen (to B. S. N. and N. M.) and by National Natural Science Foundation of China Grant 31770776 (to F. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Abbaci M, 2008, BIOTECHNIQUES, V45, P33, DOI 10.2144/000112810; Alstrom JS, 2015, J NEUROPHYSIOL, V114, P3014, DOI 10.1152/jn.00575.2015; Bahima L, 2006, J CELL PHYSIOL, V206, P95, DOI 10.1002/jcp.20440; Bao XY, 2004, AM J PHYSIOL-CELL PH, V286, pC647, DOI 10.1152/ajpcell.00295.2003; Bargiello TA, 2018, BBA-BIOMEMBRANES, V1860, P22, DOI 10.1016/j.bbamem.2017.04.028; BARRIO LC, 1991, P NATL ACAD SCI USA, V88, P8410, DOI 10.1073/pnas.88.19.8410; Bennett BC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms9770; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berger AC, 2014, J CELL SCI, V127, P1751, DOI 10.1242/jcs.138230; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Braet K, 2003, J CELL PHYSIOL, V197, P205, DOI 10.1002/jcp.10365; Bruzzone S, 2001, FASEB J, V15, P10; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; Contreras JE, 2003, P NATL ACAD SCI USA, V100, P11388, DOI 10.1073/pnas.1434298100; Contreras JE, 2002, P NATL ACAD SCI USA, V99, P495, DOI 10.1073/pnas.012589799; D'hondt C, 2009, BIOESSAYS, V31, P953, DOI 10.1002/bies.200800236; DAHL G, 1991, EUR J BIOCHEM, V197, P141, DOI 10.1111/j.1432-1033.1991.tb15892.x; Dahl G, 2007, CELL COMMUN ADHES, V14, P259, DOI 10.1080/15419060801891018; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dong LX, 2006, J PHYSIOL-LONDON, V576, P787, DOI 10.1113/jphysiol.2006.113837; Ebihara L, 1996, BIOPHYS J, V71, P742, DOI 10.1016/S0006-3495(96)79273-1; Essenfelder GM, 2004, HUM MOL GENET, V13, P1703, DOI 10.1093/hmg/ddh191; Fenton RA, 2010, CELL MOL LIFE SCI, V67, P829, DOI 10.1007/s00018-009-0218-9; Figueroa VA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00265; Gemel J, 2006, J CELL SCI, V119, P2258, DOI 10.1242/jcs.02953; Hansen DB, 2014, J BIOL CHEM, V289, P26058, DOI 10.1074/jbc.M114.582155; Hansen DB, 2014, FEBS LETT, V588, P1446, DOI 10.1016/j.febslet.2014.01.036; HARRIS AL, 1981, J GEN PHYSIOL, V77, P95, DOI 10.1085/jgp.77.1.95; Harris AL, 2007, PROG BIOPHYS MOL BIO, V94, P120, DOI 10.1016/j.pbiomolbio.2007.03.011; Harris Andrew L., 2009, P165, DOI 10.1007/978-1-59745-489-6_7; Hofer A, 1998, GLIA, V24, P141, DOI 10.1002/(SICI)1098-1136(199809)24:1<141::AID-GLIA13>3.0.CO;2-R; Hu XG, 1999, FEBS LETT, V451, P113, DOI 10.1016/S0014-5793(99)00558-X; Hu XG, 2006, BIOPHYS J, V90, P140, DOI 10.1529/biophysj.105.066373; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; John SA, 1999, J BIOL CHEM, V274, P236, DOI 10.1074/jbc.274.1.236; Kang J, 2008, J NEUROSCI, V28, P4702, DOI 10.1523/JNEUROSCI.5048-07.2008; Kronengold J, 2003, J GEN PHYSIOL, V122, P389, DOI 10.1085/jgp.200308861; Kyle JW, 2008, J CELL SCI, V121, P2744, DOI 10.1242/jcs.032482; Lai A, 2006, J CELL SCI, V119, P532, DOI 10.1242/jcs.02770; Li HY, 1996, J CELL BIOL, V134, P1019, DOI 10.1083/jcb.134.4.1019; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lopez W, 2016, P NATL ACAD SCI USA, V113, pE7986, DOI 10.1073/pnas.1609378113; Lopez W, 2014, CHANNELS, V8, P1, DOI 10.4161/chan.26789; Ma MY, 2006, BIOPHYS J, V90, P151, DOI 10.1529/biophysj.105.066381; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; Maeda S, 2009, NATURE, V458, P597, DOI 10.1038/nature07869; Musa H, 2004, J PHYSIOL-LONDON, V557, P863, DOI 10.1113/jphysiol.2003.059386; Myers JB, 2018, NATURE, V564, P372, DOI 10.1038/s41586-018-0786-7; Nielsen BS, 2017, J BIOL CHEM, V292, P19999, DOI 10.1074/jbc.M117.805986; Nielsen BS, 2017, NEUROCHEM RES, V42, P2537, DOI 10.1007/s11064-017-2243-7; Nielsen MS, 2012, COMPR PHYSIOL, V2, P1981, DOI 10.1002/cphy.c110051; Oh S, 2008, J PHYSIOL-LONDON, V586, P2445, DOI 10.1113/jphysiol.2008.150805; Orellana JA, 2011, BIOCHEM BIOPH RES CO, V409, P603, DOI 10.1016/j.bbrc.2011.05.031; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Ramachandran S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000712; Retamal MA, 2007, J NEUROSCI, V27, P13781, DOI 10.1523/JNEUROSCI.2042-07.2007; Retamal MA, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00001; Ripps H, 2004, CELL MOL NEUROBIOL, V24, P647, DOI 10.1023/B:CEMN.0000036403.43484.3d; Roux L, 2015, J NEUROSCI, V35, P15339, DOI 10.1523/JNEUROSCI.0861-15.2015; Saez JC, 2010, EXP CELL RES, V316, P2377, DOI 10.1016/j.yexcr.2010.05.026; Sanchez HA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00354; Sanchez HA, 2013, J GEN PHYSIOL, V142, P3, DOI 10.1085/jgp.201310962; Scemes E, 2009, PFLUG ARCH EUR J PHY, V457, P1207, DOI 10.1007/s00424-008-0591-5; Silverman W, 2008, AM J PHYSIOL-CELL PH, V295, pC761, DOI 10.1152/ajpcell.00227.2008; Skerrett IM, 2001, CELL COMMUN ADHES, V8, P179, DOI 10.3109/15419060109080720; Sohl G, 2003, CELL COMMUN ADHES, V10, P173, DOI 10.1080/15419060390262877; Spray DC, 2006, GLIA, V54, P758, DOI 10.1002/glia.20429; Srinivas M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37221-2; Stout CE, 2002, J BIOL CHEM, V277, P10482, DOI 10.1074/jbc.M109902200; Tong JJ, 2011, AM J PHYSIOL-CELL PH, V300, pC1055, DOI 10.1152/ajpcell.00384.2010; Tong XL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143876; Tong XL, 2014, J PHYSIOL-LONDON, V592, P5187, DOI 10.1113/jphysiol.2014.280636; Trexler EB, 2000, BIOPHYS J, V79, P3036, DOI 10.1016/S0006-3495(00)76539-8; Valiunas V, 2000, PFLUG ARCH EUR J PHY, V440, P366, DOI 10.1007/s004240000294; Valiunas V, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00075; Veenstra RD, 1996, J BIOENERG BIOMEMBR, V28, P327, DOI 10.1007/BF02110109; VERSELIS VK, 1994, NATURE, V368, P348, DOI 10.1038/368348a0; Wang HZ, 1997, J GEN PHYSIOL, V109, P491, DOI 10.1085/jgp.109.4.491; Wang JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1112, DOI 10.1152/ajpcell.00097.2007; Wang N, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0304-2; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Weber PA, 2004, BIOPHYS J, V87, P958, DOI 10.1529/biophysj.103.036350; Wei HY, 2014, TOXICOLOGY, V323, P32, DOI 10.1016/j.tox.2014.06.005; Xin L, 2012, BIOPHYS J, V102, P1022, DOI 10.1016/j.bpj.2012.02.008; Xin L, 2010, BIOPHYS J, V99, P2077, DOI 10.1016/j.bpj.2010.07.032; Ye ZC, 2003, J NEUROSCI, V23, P3588, DOI 10.1523/jneurosci.23-09-03588.2003; Ye ZC, 2009, GLIA, V57, P258, DOI 10.1002/glia.20754; Zhou XW, 1997, BIOPHYS J, V72, P1946, DOI 10.1016/S0006-3495(97)78840-4; Zonta F, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00170; Zonta F, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00085; Zonta F, 2012, J BIOMOL STRUCT DYN, V29, P985, DOI 10.1080/073911012010525027	91	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16789	16803		10.1074/jbc.RA119.007732	http://dx.doi.org/10.1074/jbc.RA119.007732			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31554662	Green Published, hybrid			2022-12-26	WOS:000501801900026
J	Fisher, OS; Sendzik, MR; Ross, MO; Lawton, TJ; Hoffman, BM; Rosenzweig, AC				Fisher, Oriana S.; Sendzik, Madison R.; Ross, Matthew O.; Lawton, Thomas J.; Hoffman, Brian M.; Rosenzweig, Amy C.			PCuAC domains from methane-oxidizing bacteria use a histidine brace to bind copper	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metalloprotein; crystal structure; metal homeostasis; bioinformatics; copper transport; copper chaperone; histidine brace; methanotroph	CYTOCHROME-C-OXIDASE; CRYSTAL-STRUCTURE; PROTEIN; MONOOXYGENASE; CHAPERONES; OXIDATION; INSIGHTS; METALLOENZYME; ENVIRONMENT; EXPRESSION	Copper is critically important for methanotrophic bacteria because their primary metabolic enzyme, particulate methane monooxygenase (pMMO), is copper-dependent. In addition to pMMO, many other copper proteins are encoded in the genomes of methanotrophs, including proteins that contain periplasmic copper-A chaperone (PCuAC) domains. Using bioinformatics analyses, we identified three distinct classes of PCuAC domain-containing proteins in methanotrophs, termed PmoF1, PmoF2, and PmoF3. PCuAC domains from other types of bacteria bind a single Cu(I) ion via an HXnMX21/22HXM motif, which is also present in PmoF3, but PmoF1 and PmoF2 lack this motif entirely. Instead, the PCuAC domains of PmoF1 and PmoF2 bind only Cu(II), and PmoF1 binds additional Cu(II) ions in a His-rich extension to its PCuAC domain. Crystal structures of the PmoF1 and PmoF2 PCuAC domains reveal that Cu(II) is coordinated by an N-terminal histidine brace HX10H motif. This binding site is distinct from those of previously characterized PCuAC domains but resembles copper centers in CopC proteins and lytic polysaccharide monooxygenase (LPMO) enzymes. Bioinformatics analysis of the entire PCuAC family reveals previously unappreciated diversity, including sequences that contain both the HXnMX21/22HXM and HX10H motifs, and sequences that lack either set of copper-binding ligands. These findings provide the first characterization of an additional class of copper proteins from methanotrophs, further expand the PCuAC family, and afford new insight into the biological significance of histidine brace-mediated copper coordination.	[Sendzik, Madison R.; Ross, Matthew O.; Hoffman, Brian M.; Rosenzweig, Amy C.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Rosenzweig, Amy C.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Fisher, Oriana S.] Lehigh Univ, Dept Chem, Bethlehem, PA 18015 USA; [Lawton, Thomas J.] Johns Hopkins Appl Phys Lab, Laurel, MD 20723 USA	Northwestern University; Northwestern University; Lehigh University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Rosenzweig, AC (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.; Rosenzweig, AC (corresponding author), Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.	amyr@northwestern.edu		Fisher, Oriana/0000-0003-3215-0831; Sendzik, Madison/0000-0003-1363-6297; Rosenzweig, Amy/0000-0001-8472-4134; Ross, Matthew/0000-0003-2115-9806	National Institutes of Health [GM118035, GM111097]; Department of Energy [DE-SC0016284]; DOE Office of Science [DE-AC02-06CH11356]; NASA Ames Research Center [NNA06CB93G]; NCI, National Institutes of Health, Cancer Center [P30 CA060553]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008382, R35GM118035] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); DOE Office of Science(United States Department of Energy (DOE)); NASA Ames Research Center(National Aeronautics & Space Administration (NASA)); NCI, National Institutes of Health, Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Prof. Steven Almo (Albert Einstein College of Medicine) for providing the His<INF>6</INF>-PmoF1 plasmid, Dr. Rahul Purohit for assistance with crystallographic data collection, and Bidemi Godo for assistance with protein purification. Biochemistry and crystallography resources were supported by National Institutes of Health Grant GM118035, and EPR spectroscopic experiments were supported by National Institutes of Health Grant GM111097. All other experiments conducted by O.S.F., M.R.S., and M.O.R were supported by Department of Energy grant DE-SC0016284. We thank the staff of the LS-CAT beamlines of the Advanced Photon Source, which is a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11356. The Quantitative Bio-element Imaging Center at Northwestern is supported by NASA Ames Research Center Grant NNA06CB93G. The Keck Biophysics Facility at Northwestern is supported in part by NCI, National Institutes of Health, Cancer Center Support Grant P30 CA060553.	Abriata LA, 2008, NAT CHEM BIOL, V4, P599, DOI 10.1038/nchembio.110; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arguello JM, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00073; Arnesano F, 2005, J PROTEOME RES, V4, P63, DOI 10.1021/pr049862f; Banci L, 2005, P NATL ACAD SCI USA, V102, P3994, DOI 10.1073/pnas.0406150102; Battistoni A, 2001, J BIOL CHEM, V276, P30315, DOI 10.1074/jbc.M010527200; Blundell KLIM, 2014, BIOCHEM J, V459, P525, DOI 10.1042/BJ20140017; Canonica F, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw8478; Chillappagari S, 2009, J BACTERIOL, V191, P2362, DOI 10.1128/JB.01616-08; Ciano L, 2018, NAT CATAL, V1, P571, DOI 10.1038/s41929-018-0110-9; Dash BP, 2015, BBA-BIOENERGETICS, V1847, P202, DOI 10.1016/j.bbabio.2014.11.001; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fisher OS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06681-5; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Hemsworth GR, 2014, NAT CHEM BIOL, V10, P122, DOI 10.1038/nchembio.1417; Hirooka K, 2012, J BACTERIOL, V194, P5675, DOI 10.1128/JB.00919-12; Jen FEC, 2015, FASEB J, V29, P3828, DOI 10.1096/fj.15-270751; Johansen KS, 2016, TRENDS PLANT SCI, V21, P926, DOI 10.1016/j.tplants.2016.07.012; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalyuzhnaya MG, 2015, METAB ENG, V29, P142, DOI 10.1016/j.ymben.2015.03.010; Karlin S, 1997, P NATL ACAD SCI USA, V94, P14225, DOI 10.1073/pnas.94.26.14225; Kenney GE, 2016, METALLOMICS, V8, P931, DOI 10.1039/c5mt00289c; Larsen O, 2016, MICROBIOLOGYOPEN, V5, P254, DOI 10.1002/mbo3.324; Lawton TJ, 2016, BIOCHEMISTRY-US, V55, P2278, DOI 10.1021/acs.biochem.6b00175; Lieberman RL, 2005, NATURE, V434, P177, DOI 10.1038/nature03311; Lima C. D., 2005, U. S. Patent, Patent No. [20030086918A1, 20030086918]; Meier KK, 2018, CHEM REV, V118, P2593, DOI 10.1021/acs.chemrev.7b00421; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pogni R, 2000, J INORG BIOCHEM, V79, P333, DOI 10.1016/S0162-0134(99)00166-X; Potterton L, 2018, ACTA CRYSTALLOGR D, V74, P68, DOI 10.1107/S2059798317016035; Purohit R, 2018, P NATL ACAD SCI USA, V115, P2108, DOI 10.1073/pnas.1721783115; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Ro SY, 2018, J BIOL CHEM, V293, P10457, DOI 10.1074/jbc.RA118.003348; Ross MO, 2019, SCIENCE, V364, P566, DOI 10.1126/science.aav2572; Ross MO, 2019, J AM CHEM SOC, V141, P4678, DOI 10.1021/jacs.8b13610; SAKAGUCHI U, 1979, J CHEM SOC DALTON, P600, DOI 10.1039/dt9790000600; Serventi F, 2012, J BIOL CHEM, V287, P38812, DOI 10.1074/jbc.M112.406173; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sirajuddin S, 2015, BIOCHEMISTRY-US, V54, P2283, DOI 10.1021/acs.biochem.5b00198; Sirajuddin S, 2014, J BIOL CHEM, V289, P21782, DOI 10.1074/jbc.M114.581363; Skubak P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3777; Smith SM, 2011, BIOCHEMISTRY-US, V50, P10231, DOI 10.1021/bi200801z; Stewart LJ, 2019, METALLOMICS, V11, P50, DOI 10.1039/c8mt00218e; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Studier FW, 2014, METHODS MOL BIOL, V1091, P17, DOI 10.1007/978-1-62703-691-7_2; TANOKURA M, 1983, BIOCHIM BIOPHYS ACTA, V742, P576, DOI 10.1016/0167-4838(83)90276-5; Thompson AK, 2012, BBA-BIOENERGETICS, V1817, P955, DOI 10.1016/j.bbabio.2012.01.003; Trasnea PI, 2018, ACS CHEM BIOL, V13, P1388, DOI 10.1021/acschembio.8b00293; Trasnea PI, 2016, MOL MICROBIOL, V100, P345, DOI 10.1111/mmi.13321; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; Udagedara SR, 2019, J INORG BIOCHEM, V195, P194, DOI 10.1016/j.jinorgbio.2019.03.007; Vaaje-Kolstad G, 2017, CURR OPIN STRUC BIOL, V44, P67, DOI 10.1016/j.sbi.2016.12.012; Vu VV, 2016, CELL MOL LIFE SCI, V73, P2809, DOI 10.1007/s00018-016-2251-9; Wheeler TJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-7; Zhang L, 2006, J AM CHEM SOC, V128, P5834, DOI 10.1021/ja058528x	56	4	4	3	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					16351	16363		10.1074/jbc.RA119.010093	http://dx.doi.org/10.1074/jbc.RA119.010093			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31527086	Green Published, hybrid			2022-12-26	WOS:000499478600038
J	Beyene, D; Bitew, A; Fantew, S; Mihret, A; Evans, M				Beyene, Degefu; Bitew, Adane; Fantew, Surafel; Mihret, Amete; Evans, Martin			Multidrug-resistant profile and prevalence of extended spectrum beta-lactamase and carbapenemase production in fermentative Gram-negative bacilli recovered from patients and specimens referred to National Reference Laboratory, Addis Ababa, Ethiopia	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; ENTEROBACTERIACEAE; EPIDEMIOLOGY; INFECTION; COLI	Background The emergence of multidrug-resistance (MDR), production of extended-spectrum beta-lactamases, and carbapenemase in members of fermentative gram-negative bacilli are a serious threat to public health. Objective The aim of this study was to determine the burden of multi-drug resistance, the production of extended-spectrum beta-lactamases (ESBLs), and carbapenemase in fermentative Gramnegative bacilli in Ethiopian Public Health Institute. Materials and methods A cross-sectional study was carried out from December 2017 to June 2018. Different clinical samples were collected, inoculated, and incubated according to standard protocols related to each sample. Bacterial identification was performed by using the VITEKR 2 compact system using the GNR card. Antimicrobial susceptibility testing was carried out by the KirbyBauer disc diffusion method. Production of ESBL and carbapenemase were confirmed by combination disc and modified Hodge Test method respectively. Results A total of 238 fermentative Gram-negative bacilli were recovered during the study period, among which E.coli were the predominant isolates followed by K. pneumoniae. The highest percentage of antibiotic resistance was noted against ampicillin (100%) followed by trimethoprim/sulfamethoxazole (81.9%). The isolates showed better sensitivity towards carbapenem drugs. Out of 238 isolates, 94.5% were MDR and of which 8.8% and 0.8% were extensively and pan drug resistant, respectively. Nearly 67% and 2% of isolates were producers of ESBL and carbapenemase, respectively. The isolation rates of MDR, ESBL, and carbapenemase producing stains of the isolates were >= 70% in intensive care unit while the isolation rates in other wards were <= 25%. Conclusions The findings of this study revealed that the burden of MDR and ESBL was high and carbapenemase producing isolates were also identified which is concerning. This situation warrants a consistent surveillance of antimicrobial resistance of fermentative Gram-negative bacilli and implementation of an efficient infection control program.	[Beyene, Degefu; Fantew, Surafel; Mihret, Amete] Ethiopian Publ Hlth Inst, Clin Bacteriol & Mycol Res Case Team, Addis Ababa, Ethiopia; [Bitew, Adane] Addis Ababa Univ, Coll Hlth Sci, Dept Med Lab Sci, Addis Ababa, Ethiopia; [Evans, Martin] Amer Soc Microbiol, New York, NY USA	Addis Ababa University	Beyene, D (corresponding author), Ethiopian Publ Hlth Inst, Clin Bacteriol & Mycol Res Case Team, Addis Ababa, Ethiopia.	degefuf@gmail.com		beyene, degefu/0000-0001-7902-984X; Mihret, Adane/0000-0003-3183-4772				[Anonymous], 2013, NATURE, V495, P141, DOI 10.1038/495141a; Bassetti M, 2011, CRIT CARE, V15, DOI 10.1186/cc9997; Belete W, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210866; Ben-Ami R, 2009, CLIN INFECT DIS, V49, P682, DOI 10.1086/604713; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Carlet J, 2014, INDIAN J CRIT CARE M, V18, P643, DOI 10.4103/0972-5229.142171; CDC, 2013, ANTIBIOTIC RESISTANC; Clinical Laboratory Standards Institute (CLSI), 2018, M100S27 CLSI S; Demilie T, 2012, ETHIOPIAN J HLTH SCI, V22; Derese B, 2016, THER CLIN RISK MANAG, V12, P251, DOI 10.2147/TCRM.S99831; Duthey B, 2013, 6 WHO; Emine K, 2005, JPN J INFECT DIS, V58, P228; Eshetie S, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0054-7; Fournier PE, 2006, CLIN INFECT DIS, V42, P692, DOI 10.1086/500202; Hasanin A, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.177.4307; Hsueh PR, 2002, EMERG INFECT DIS, V8, P63, DOI 10.3201/eid0801.000454; Kateregga JN, 2015, BMC PHARMACOL TOXICO, V16, DOI 10.1186/s40360-015-0013-1; Kibret M, 2011, AFR HEALTH SCI, V11, pS40; Legese MH, 2017, INFECT DRUG RESIST, V10, P27, DOI 10.2147/IDR.S127177; Leski T, 2012, INT J ANTIMICROB AG, V40, P282, DOI 10.1016/j.ijantimicag.2012.05.019; Livermore DM, 2003, CLIN INFECT DIS, V36, pS11, DOI 10.1086/344654; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Manyahi Joel, 2014, BMC Res Notes, V7, P500, DOI 10.1186/1756-0500-7-500; Mengistu Abayneh, 2018, CANADIAN J INFECT DI, V2018, P8; Moquet O, 2011, EMERG INFECT DIS, V17, P143, DOI [10.3201/eid1701.100224, 10.3201/eid1701.100244]; Moyo Sabrina J, 2010, BMC Res Notes, V3, P348, DOI 10.1186/1756-0500-3-348; Mulisa G., 2016, J EMERG INFECT DIS, V1, P1; Mushi MF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/303104; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Nurjahan Begum, 2015, BANGLADESH J MED MIC, V9, P7; Obeng-Nkrumah N, 2013, AM J TROP MED HYG, V89, P960, DOI 10.4269/ajtmh.12-0642; Oduyebo O O, 2015, Niger Postgrad Med J, V22, P223, DOI 10.4103/1117-1936.173973; Ouedraogo AS, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1655-3; Paskovaty A, 2005, INT J ANTIMICROB AG, V25, P1, DOI 10.1016/j.ijantimicag.2004.09.001; Paterson DL, 2006, AM J INFECT CONTROL, V34, pS20, DOI 10.1016/j.ajic.2006.05.238; Perez F, 2013, CLEV CLIN J MED, V80, P225, DOI 10.3949/ccjm.80a.12182; Puneet Bhatt, 2015, NEW MICROBES NEW INF, P8; Sharma A, 2011, INDIAN J MED MICROBI, V29, P91, DOI 10.4103/0255-0857.81774; Shashwati Nema, 2014, J Nat Sci Biol Med, V5, P30, DOI 10.4103/0976-9668.127280; Siraj SM, 2015, MICROBIOL RES, V5, P1, DOI DOI 10.5376/mmr.2015.04.0001; Tada T, 2013, INT J ANTIMICROB AG, V42, P372, DOI 10.1016/j.ijantimicag.2013.06.014; Teklu DS, 2019, ANTIMICROB RESIST IN, V8, DOI 10.1186/s13756-019-0488-4; World Health Organization, 2014, ANT RES GLOB REP SUR; Yadav KK, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0085-0; 2011, WORLD HLTH DAY, P1	45	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222911	10.1371/journal.pone.0222911	http://dx.doi.org/10.1371/journal.pone.0222911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553773	gold, Green Published			2022-12-26	WOS:000532319200043
J	Haque, AB; Das, SA; Biswas, AR				Haque, Alifa Bintha; Das, Sudipta Arka; Biswas, Aparna Riti			DNA analysis of elasmobranch products originating from Bangladesh reveals unregulated elasmobranch fishery and trade on species of global conservation concern	PLOS ONE			English	Article							GENETIC IDENTIFICATION; MOLECULAR-GENETICS; SHARKS; MANAGEMENT; ALGORITHM; ACCURATE	Trade involving elasmobranch products in Bangladesh is a four-decade-long practice in large scale and there is little understanding of its impact on species composition, population, and subsequent conservation. Capacity for monitoring and identification is lacking in landing and shark processing centres. A rapid survey and collection of tissue samples were performed in three landings and nine shark processing centres between 2016 and 2017 in the south-eastern coastal region of Bangladesh. Sequencing for a 707-bp fragment of the mitochondrial cytochrome c oxidase subunit I (COI) gene was used to assess the taxonomic status and species composition from 71 elasmobranch tissue samples collected from the shark processing centre only. Good quality COI sequences were obtained for 34 specimens representing 21 species-the majority of which are threatened with extinction. A total of ten species of sharks (Carcharhinus brevipinna, C. amboinensis, C. leucas, C. sorrah, C. amblyrhynchoides, Chiloscyllium burmensis, Galeocerdo cuvier, Rhincodon typus, Scoliodon laticaudus, and Sphyrna lewini), eleven species of rays (Aetomylaeus maculatus, Gymnura poecilura, Mobula mobular, M. kuhlii, Neotrygon indica, Pateobatis uarnacoides, Rhinoptera javanica, and R. jayakari), including three species of guitarfish (Glaucostegus granulatus, G. obtusus, and G. typus), were identified. Four species (14.7% of samples) were found to be listed in the Convention on International Trade in Endangered Species of Wild Fauna and Flora (CITES) in Appendix II. Sixteen species (59% of the specimens) were threatened with extinction according to IUCN Red List, whereas 41% were data deficient or not assessed. The results have important implications for the management of regional fisheries and the conservation of elasmobranchs as they 1) represent a preliminary understanding of elasmobranch diversity in trade; 2) depict a lack of awareness and monitoring; and 3) demonstrate a need for urgent monitoring and regulation of elasmobranch trade in Bangladesh.	[Haque, Alifa Bintha; Biswas, Aparna Riti] Univ Dhaka, Dept Zool, Dhaka, Bangladesh; [Haque, Alifa Bintha] Univ Oxford, Dept Zool, Oxford, England; [Das, Sudipta Arka] Univ Dhaka, Dept Biochem & Mol Biol, Dhaka, Bangladesh	University of Dhaka; University of Oxford; University of Dhaka	Haque, AB (corresponding author), Univ Dhaka, Dept Zool, Dhaka, Bangladesh.; Haque, AB (corresponding author), Univ Oxford, Dept Zool, Oxford, England.	alifa.haque@du.ac.bd		Biswas, Aparna/0000-0001-9792-9331; Haque, Alifa Bintha/0000-0001-8250-0030	Biotechnology Research Centre, University of Dhaka; Biotechnology Research Centre; University of Dhaka (DU)	Biotechnology Research Centre, University of Dhaka; Biotechnology Research Centre; University of Dhaka (DU)	The genetic work was partially (30%) funded by Biotechnology Research Centre, University of Dhaka. It was a small grant received by the 1st author. There is no grant number available. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; The authors are thankful to the Biotechnology Research Centre and University of Dhaka (DU) for partially financing the genetic work and the Department of Zoology, DU for hosting the research and all volunteers helping the data collection. The authors also thank Scott Trageser for helping in editing the manuscript and for providing valuable comments.	Abercrombie DL, 2005, CONSERV GENET, V6, P775, DOI 10.1007/s10592-005-9036-2; Akhilesh KV, 2014, CHECKLIST CHON DRICH; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Anonymous, 2012, FAO Fisheries and Aquaculture Circular, V1076, P1; [Anonymous], GLOBAL PRIORITIES CO; Caballero S, 2012, MOL ECOL RESOUR, V12, P233, DOI 10.1111/j.1755-0998.2011.03089.x; Camhi MD, 2009, CONSERVATION STATUS; Cardenosa D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185368; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; CASTRO JI, 1999, 380 FAO; Chapman DD, 2003, CONSERV GENET, P4; Clarke SC, 2006, CONSERV BIOL, V20, P201, DOI 10.1111/j.1523-1739.2005.00247.x; Clarke SC, 2006, ECOL LETT, V9, P1115, DOI 10.1111/j.1461-0248.2006.00968.x; Compagno LJV, 2001, SHARKS WORLD ANNOTAT; Compagno LJV, 1984, SHARKS WORLD ANNOTAT; Dent Felix, 2015, FAO Fisheries and Aquaculture Technical Paper, V590, P1; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; DoF, 2017, DOF YB FISH STAT BAN; Dudgeon CL, 2012, J FISH BIOL, V80, P1789, DOI 10.1111/j.1095-8649.2012.03265.x; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fields AT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114844; Frankham R, 2003, CR BIOL, V326, pS22, DOI 10.1016/S1631-0691(03)00023-4; FRSS, 2016, YB FISH STAT BANGL, V33; FRSS, 2014, FISH STAT YB BANGL, V30; Graham NAJ, 2010, AQUAT CONSERV, V20, P543, DOI 10.1002/aqc.1116; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haque Alifa Bintha, 2018, Traffic Bulletin, V30, P7; Hasan M., 2017, J FISH LIVEST PROD, V5, P2, DOI 10.4172/2332-2608.1000221; Henderson AC, 2007, FISH RES, V86, P159, DOI 10.1016/j.fishres.2007.05.012; Henderson AC, 2016, ZOOL J LINN SOC-LOND, V176, P399, DOI 10.1111/zoj.12309; Hoq M.E., 2011, SHARK FISHERIES BAY; Hossain MA, 2015, AQUAT CONSERV, V25, P781, DOI 10.1002/aqc.2466; Jabado RW, 2015, AQUAT CONSERV, V25, P800, DOI 10.1002/aqc.2477; Jabado RW, 2018, FISH FISH; Last P. R., 2016, P1; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Liu SYV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079373; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Moore ABM, 2012, REV FISH BIOL FISHER, V22, P35, DOI 10.1007/s11160-011-9222-x; Morgan A, 2010, FISH RES, V101, P32, DOI 10.1016/j.fishres.2009.09.004; O'Malley MP, 2017, AQUAT CONSERV, V27, P394, DOI 10.1002/aqc.2670; Schindler DE, 2002, ECOL APPL, V12, P735, DOI 10.2307/3060985; Sembiring A, 2015, FISH RES, V164, P130, DOI 10.1016/j.fishres.2014.11.003; Shamsuzzaman MM, 2017, TURK J FISH AQUAT SC, V17, P833, DOI 10.4194/1303-2712-v17_4_19; Shivji M, 2002, CONSERV BIOL, V16, P1036, DOI 10.1046/j.1523-1739.2002.01188.x; Spaet JLY, 2015, FISH RES, V161, P356, DOI 10.1016/j.fishres.2014.08.022; Steinke D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10123-5; Vannuccini S., 1999, SHARK UTILIZATION MA; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2008, MAR FRESHWATER RES, V59, P57, DOI 10.1071/MF07148; Wynen L, 2009, MAR FRESHWATER RES, V60, P554, DOI 10.1071/MF08201; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	55	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222273	10.1371/journal.pone.0222273	http://dx.doi.org/10.1371/journal.pone.0222273			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553744	Green Published, gold, Green Submitted			2022-12-26	WOS:000532319200022
J	Cheng, YX; Zhang, N; Hussain, S; Ahmed, S; Yang, WT; Wang, SC				Cheng, Yuxin; Zhang, Na; Hussain, Saddam; Ahmed, Sajjad; Yang, Wenting; Wang, Shucai			Integration of a FT expression cassette into CRISPR/Cas9 construct enables fast generation and easy identification of transgene-free mutants in Arabidopsis	PLOS ONE			English	Article							GENE FAMILY; RNA; MULTIPLEX; VERNALIZATION; PROTEIN; DOMAIN; TIME	The CRISPR/Cas9 genome editing technique has been widely used to generate transgenefree mutants in different plant species. Several different methods including fluorescence marker-assisted visual screen of transgene-free mutants and programmed self-elimination of CRISPR/Cas9 construct have been used to increase the efficiency of genome edited transgene-free mutant isolation, but the overall time length required to obtain transgene-free mutants has remained unchanged in these methods. We report here a method for fast generation and easy identification of transgene-free mutants in Arabidopsis. By generating and using a single FT expression cassette-containing CRISPR/Cas9 construct, we targeted two sites of the AITR1 gene. We obtained many early bolting plants in T1 generation, and found that about two thirds of these plants have detectable mutations. We then analyzed T2 generations of two representative lines of genome edited early bolting T1 plants, and identified plants without early bolting phenotype, i.e., transgene-free plants, for both lines. Further more, aitr1 homozygous mutants were successful obtained for both lines from these transgene-free plants. Taken together, these results suggest that the method described here enables fast generation, and at the mean time, easy identification of transgene-free mutants in plants.	[Cheng, Yuxin; Zhang, Na; Hussain, Saddam; Ahmed, Sajjad; Yang, Wenting; Wang, Shucai] Northeast Normal Univ, Key Lab Mol Epigenet MOE, Changchun, Jilin, Peoples R China; [Wang, Shucai] Linyi Univ, Coll Life Sci, Linyi, Shandong, Peoples R China	Northeast Normal University - China; Linyi University	Wang, SC (corresponding author), Northeast Normal Univ, Key Lab Mol Epigenet MOE, Changchun, Jilin, Peoples R China.; Wang, SC (corresponding author), Linyi Univ, Coll Life Sci, Linyi, Shandong, Peoples R China.	wangshucai@yahoo.com		Wang, Shucai/0000-0001-7619-2385; cheng, yu xin/0000-0001-8157-9592	National Key R&D Program of China [2016YFD0101902]	National Key R&D Program of China	This work was supported by the National Key R&D Program of China (2016YFD0101902). The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Bull SE, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat6086; Chen KL, 2019, ANNU REV PLANT BIOL, V70, P667, DOI 10.1146/annurev-arplant-050718-100049; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dai XM, 2016, PLANT CELL ENVIRON, V39, P897, DOI 10.1111/pce.12695; Gao XH, 2016, PLANT PHYSIOL, V171, P1794, DOI 10.1104/pp.16.00663; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Guo HY, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00295; He YB, 2018, MOL PLANT, V11, P1210, DOI 10.1016/j.molp.2018.05.005; Hu JH, 2018, NATURE, V556, P57, DOI 10.1038/nature26155; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jung C, 2009, TRENDS PLANT SCI, V14, P563, DOI 10.1016/j.tplants.2009.07.005; Jung JH, 2012, J BIOL CHEM, V287, P16007, DOI 10.1074/jbc.M111.337485; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Lu HP, 2017, PLANT BIOTECHNOL J, V15, P1371, DOI 10.1111/pbi.12788; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Mockler TC, 2004, P NATL ACAD SCI USA, V101, P12759, DOI 10.1073/pnas.0404552101; Nan HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097669; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Nishimasu H, 2018, SCIENCE, V361, P1259, DOI 10.1126/science.aas9129; Putterill J, 2016, CURR OPIN PLANT BIOL, V33, P77, DOI 10.1016/j.pbi.2016.06.008; Putterill J, 2013, FUNCT PLANT BIOL, V40, P1199, DOI 10.1071/FP13087; Ratcliffe OJ, 2003, PLANT CELL, V15, P1159, DOI 10.1105/tpc.009506; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shimatani Z, 2017, NAT BIOTECHNOL, V35, P441, DOI 10.1038/nbt.3833; Sun HB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029238; Tamada Y, 2009, PLANT CELL, V21, P3257, DOI 10.1105/tpc.109.070060; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Tian HN, 2017, PLANT CELL ENVIRON, V40, P2958, DOI 10.1111/pce.13058; Tian HN, 2015, SCI REP-UK, V5, DOI 10.1038/srep17587; Wahl V, 2013, SCIENCE, V339, P704, DOI 10.1126/science.1230406; Wang JW, 2009, CELL, V138, P738, DOI 10.1016/j.cell.2009.06.014; Wang SC, 2005, PLANT CELL, V17, P1979, DOI 10.1105/tpc.105.031096; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Wickland DP, 2015, MOL PLANT, V8, P983, DOI 10.1016/j.molp.2015.01.007; Yamagishi N, 2014, PLANT BIOTECHNOL J, V12, P60, DOI 10.1111/pbi.12116; Yamagishi N, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00171; Yant L, 2009, CURR OPIN PLANT BIOL, V12, P580, DOI 10.1016/j.pbi.2009.07.006; Zsogon A, 2018, NAT BIOTECHNOL, V36, P1211, DOI 10.1038/nbt.4272	41	7	7	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0218583	10.1371/journal.pone.0218583	http://dx.doi.org/10.1371/journal.pone.0218583			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545795	Green Published, Green Submitted, gold			2022-12-26	WOS:000532303200008
J	Dixit, S; Jangid, VK; Grover, A				Dixit, Shikha; Jangid, Vinod Kumar; Grover, Anita			Evaluation of suitable reference genes in Brassica juncea and its wild relative Camelina sativa for qRT-PCR analysis under various stress conditions	PLOS ONE			English	Article							TIME RT-PCR; INTERNAL REFERENCE GENES; HOUSEKEEPING GENES; NORMALIZATION; EXPRESSION; SELECTION; QUANTIFICATION; VALIDATION; RESISTANCE; GENOME	Quantitative real-time PCR (qRT-PCR) is an efficient method to estimate the gene expression levels but the accuracy of its result largely depends on the stability of the reference gene. Many studies have reported considerable variation in the expression of reference genes (RGs) in different tissue and conditions. Therefore, screening for appropriate RGs with stable expression is crucial for functional analysis of the target gene. Two closely related crucifers Brassica juncea (cultivated) and Camelina sativa (wild) respond differently towards various abiotic and biotic stress where C. sativa exhibits higher tolerance to various stress. Comparative gene expression analysis of the target genes between two such species is the key approach to understand the mechanism of a plant's response to stress. However, using an unsuitable RG can lead to misinterpretation of expression levels of the target gene in such studies. In this investigation, the stability of seven candidate RGs including traditional housekeeping genes (HKGs) and novel candidate RGs were identified across diverse sample sets of B. juncea and C. sativa representing- hormone treated, wounded, Alternaria brassicae inoculated and combination treated samples (exogenous hormone treatment followed by A. brassicae inoculation). In this investigation, we identified stable RGs in both the species and the most suitable RGs to perform an unbiased comparative gene expression analysis between B. juncea and C. sativa. Results revealed that TIPS41 and PP2A were identified as the overall best performing RGs in both the species. However, the most suitable RG for each sample subset representing different condition must be individually selected. In Hormone treated and wounded samples TIPS41 expressed stably in both the species and in A. brassicae inoculated and combination treatment performance of PP2A was the best. In this study, for the first time, we have identified and validated stable reference gene in C. sativa for accurate normalization of gene expression data.	[Dixit, Shikha; Jangid, Vinod Kumar; Grover, Anita] Natl Inst Plant Biotechnol, Plant Pathogen Interact Lab, Pusa Campus, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB)	Grover, A (corresponding author), Natl Inst Plant Biotechnol, Plant Pathogen Interact Lab, Pusa Campus, New Delhi, India.	anitagrover@hotmail.com			National Institute for Plant Biotechnology, Pusa campus, New Delhi, India; Indian Agricultural Research Institute, New Delhi; Department of Biotechnology, Ministry of Science and Technology, New Delhi, India	National Institute for Plant Biotechnology, Pusa campus, New Delhi, India; Indian Agricultural Research Institute, New Delhi(Indian Council of Agricultural Research (ICAR)); Department of Biotechnology, Ministry of Science and Technology, New Delhi, India(Department of Biotechnology (DBT) India)	All the necessary funding for this research was provided by National Institute for Plant Biotechnology, Pusa campus, New Delhi, India. SD was provided Ph.D. research fellowship by Indian Agricultural Research Institute, New Delhi and VKJ received DBT-Junior research fellowship by Department of Biotechnology, Ministry of Science and Technology, New Delhi, India.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Chen X, 2010, ANAL BIOCHEM, V405, P138, DOI 10.1016/j.ab.2010.05.032; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Derveaux S, 2010, METHODS, V50, P227, DOI 10.1016/j.ymeth.2009.11.001; Duan MM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01605; Ellis Danielle R., 2004, BMC Plant Biology, V4, P1, DOI 10.1186/1471-2229-4-1; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Heydarian Z, 2018, GENE, V9, P1; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Kundu A, 2013, PLANT CELL REP, V32, P1647, DOI 10.1007/s00299-013-1478-2; Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575; Li H, 2005, FIELD CROP RES, V91, P185, DOI 10.1016/j.fcr.2004.06.006; Liu JJ, 2019, PLANT PROTECT SCI, V55, P61, DOI 10.17221/20/2018-PPS; Lourenco SDN, 2018, ACTA GEOTECH, V13, P1, DOI 10.1007/s11440-017-0570-0; Mazumder M, 2013, PLANT PHYSIOL BIOCH, V70, P43, DOI 10.1016/j.plaphy.2013.04.025; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Sharma G, 2002, EUPHYTICA, V125, P411, DOI 10.1023/A:1016050631673; Spoel SH, 2007, P NATL ACAD SCI USA, V104, P18842, DOI 10.1073/pnas.0708139104; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang CF, 2016, COMPUT INTEL NEUROSC, V2016, DOI 10.1155/2016/9482073; Wang Z, 2014, MOL GENET GENOMICS, V289, P1023, DOI 10.1007/s00438-014-0853-1; Yang HL, 2014, GENE, V538, P113, DOI 10.1016/j.gene.2013.12.057; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]; Zhu X, 2012, EVALUATION NEW REFER, V7; Zubr J, 2003, IND CROP PROD, V17, P161, DOI 10.1016/S0926-6690(02)00091-2	37	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222530	10.1371/journal.pone.0222530	http://dx.doi.org/10.1371/journal.pone.0222530			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539385	Green Published, gold			2022-12-26	WOS:000532297900014
J	Edae, EA; Rouse, MN				Edae, Erena A.; Rouse, Matthew N.			Bulked segregant analysis RNA-seq (BSR-Seq) validated a stem resistance locus in Aegilops umbellulata, a wild relative of wheat	PLOS ONE			English	Article							CONFERRING RESISTANCE; RUST; IDENTIFICATION; SEQUENCE; UG99; GENES; INTROGRESSION; TAUSCHII; MARKERS; PROTEIN	Many disease resistance genes that have been transferred from wild relatives to cultivated wheat have played a significant role in wheat production worldwide. Ae. umbellulata is one of the species within the genus Aegilops that have been successfully used as sources of resistance genes to leaf rust, stem rust and powdery mildew. The objectives of the current work was to validate the map position of a major QTL that confers resistance to the stem rust pathogen races Ug99 (TTKSK) and TTTTF with an independent bi-parental mapping population and to refine the QTL region with a bulk segregant analysis approach. Two F-2 bi-parental mapping populations were developed from stem rust resistant Ae. umbellulata accessions (PI 298905 and PI 5422375) and stem rust susceptible accessions (PI 542369 and PI 554395). Firstly, one of the two populations was used to map the chromosome location of the resistance gene. Later on, the 2nd population was used to validate the chromosome location in combination with a bulk segregant analysis approach. For the bulk segregant analysis, RNA was extracted from a bulk of leaf tissues of 12 homozygous resistant F-3 families, and a separate bulk of 11 susceptible homozygous F-3 families derived from the PI 5422375 and PI 554395 cross. The RNA samples of the two bulks and the two parents were sequenced for SNPs identification. Stem rust resistance QTL was validated on chromosome 2U of Ae. umbellulata in the same region in both populations. With bulk segregant analysis, the QTL position was delimited within 3.2 Mbp. Although there were a large number of genes in the orthologous region of the detected QTL on chromosome 2D of Ae. tauschii, we detected only two Ae. umbellulata NLR genes which can be considered as a potential candidate genes.	[Edae, Erena A.; Rouse, Matthew N.] Univ Minnesota, Dept Plant Pathol, St Paul, MN 55455 USA; [Rouse, Matthew N.] United State Dept Agr Agr Serv, Cereal Dis Lab, St Paul, MN 55155 USA	University of Minnesota System; University of Minnesota Twin Cities	Edae, EA; Rouse, MN (corresponding author), Univ Minnesota, Dept Plant Pathol, St Paul, MN 55455 USA.; Rouse, MN (corresponding author), United State Dept Agr Agr Serv, Cereal Dis Lab, St Paul, MN 55155 USA.	edaex001@umn.edu; matthew.rouse@ars.usda.gov	Rouse, Matthew N/G-5474-2011		United States Department of Agriculture-Agricultural Research Service	United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funded with the financial support from United States Department of Agriculture-Agricultural Research Service.	Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Canovas A, 2010, MAMM GENOME, V21, P592, DOI 10.1007/s00335-010-9297-z; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; Edae EA, 2017, G3-GENES GENOM GENET, V7, P1551, DOI 10.1534/g3.117.039966; Edae EA, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3370-2; Ellis JG, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00641; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; GILL BS, 1985, PLANT DIS, V69, P314; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Jupe F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-75; Koboldt DC, 2009, BIOINFORMATICS, V25, P2283, DOI 10.1093/bioinformatics/btp373; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082333; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu SZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036406; Liu WX, 2011, CHROMOSOME RES, V19, P669, DOI 10.1007/s10577-011-9226-3; Liu WX, 2011, THEOR APPL GENET, V122, P1537, DOI 10.1007/s00122-011-1553-4; Luo MC, 2017, NATURE, V551, P498, DOI 10.1038/nature24486; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; O'Neil ST, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-465; Olson EL, 2013, THEOR APPL GENET, V126, P2477, DOI 10.1007/s00122-013-2148-z; Olson EL, 2013, THEOR APPL GENET, V126, P1179, DOI 10.1007/s00122-013-2045-5; Ozgen M, 2004, BREEDING SCI, V54, P287, DOI 10.1270/jsbbs.54.287; Ramirez-Gonzalez RH, 2015, PLANT BIOTECHNOL J, V13, P613, DOI 10.1111/pbi.12281; Rouse MN, 2011, PLANT DIS, V95, P762, DOI 10.1094/PDIS-12-10-0940; Saintenac C, 2013, SCIENCE, V341, P783, DOI 10.1126/science.1239022; Schneider A, 2008, EUPHYTICA, V163, P1, DOI 10.1007/s10681-007-9624-y; SEARS E. R., 1956, BROOKHAVEN SYMPOSIA IN BIOL, V9, P1; Singh RP, 2008, ADV AGRON, V98, P271, DOI 10.1016/S0065-2113(08)00205-8; Singh RP, 2015, PHYTOPATHOLOGY, V105, P872, DOI 10.1094/PHYTO-01-15-0030-FI; Stakman E.C., 1962, IDENTIFICATION PHYSL, P54; Steuernagel B, 2015, BIOINFORMATICS, V31, P1665, DOI 10.1093/bioinformatics/btv005; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Wulff BBH, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00692; Zhang WJ, 2017, P NATL ACAD SCI USA, V114, pE9483, DOI 10.1073/pnas.1706277114; Zou C, 2016, PLANT BIOTECHNOL J, V14, P1941, DOI 10.1111/pbi.12559	38	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0215492	10.1371/journal.pone.0215492	http://dx.doi.org/10.1371/journal.pone.0215492			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539379	Green Published, Green Submitted, gold			2022-12-26	WOS:000532297900003
J	Zhang, WB; Hu, C; Wang, XJ; Bai, SS; Cao, SB; Kobelski, M; Lambert, JR; Gu, JK; Zhan, Y				Zhang, Wenbo; Hu, Cheng; Wang, Xiaojie; Bai, Shanshan; Cao, Subing; Kobelski, Margaret; Lambert, James R.; Gu, Jingkai; Zhan, Yang			Role of GDF15 in methylseleninic acid-mediated inhibition of cell proliferation and induction of apoptosis in prostate cancer cells	PLOS ONE			English	Article							GROWTH-DIFFERENTIATION FACTOR-15; SELENIUM-INDUCED APOPTOSIS; ANDROGEN RECEPTOR; GENE-EXPRESSION; TRANSGENIC ADENOCARCINOMA; ABIRATERONE ACETATE; ANTIGEN-EXPRESSION; MOUSE PROSTATE; IN-VIVO; PROGRESSION	The growth inhibitory efficacy of methylseleninic acid (MSA) in prostate cancer cells has been documented extensively. However, our understanding of the immediate targets that are key to the growth inhibitory effects of MSA remains limited. Here, using multiple preclinical prostate cancer models, we demonstrated in vitro and in vivo that GDF15 is a most highly induced, immediate target of MSA. We further showed that knockdown of GDF15 mitigates MSA inhibition of cell proliferation and induction of apoptosis. Analysis of gene expression data from over 1000 primary and 200 metastatic prostate cancer samples revealed that GDF15 expression is decreased in metastatic prostate cancers compared to primary tumors and that lower GDF15 levels in primary tumors are associated with higher Gleason scores and shorter survival of the patients. Additionally, pathways that are negatively correlated with GDF15 levels in clinical samples are also negatively correlated with MSA treatment in cultured cells. Since most, if not all, of these pathways have been implicated in prostate cancer progression, suppressing their activities by inducing GDF15 is consistent with the anticancer effects of MSA in prostate cancer. Overall, this study provides support for GDF15 as an immediate target of MSA in prostate cancer cells.	[Zhang, Wenbo; Hu, Cheng; Wang, Xiaojie; Bai, Shanshan; Gu, Jingkai; Zhan, Yang] Jilin Univ, Sch Life Sci, Natl Engn Lab AIDS Vaccine, Changchun, Jilin, Peoples R China; [Wang, Xiaojie; Bai, Shanshan; Cao, Subing; Kobelski, Margaret] Tulane Univ, Sch Med, Dept Struct & Cellular Biol, Tulane Canc Ctr, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Lambert, James R.] Univ Colorado, Dept Pathol, Sch Med, Aurora, CO USA	Jilin University; Tulane University; University of Colorado System; University of Colorado Anschutz Medical Campus	Zhan, Y (corresponding author), Jilin Univ, Sch Life Sci, Natl Engn Lab AIDS Vaccine, Changchun, Jilin, Peoples R China.	yangzhan@jlu.edu.cn		Kobelski, Margaret/0000-0002-8829-4562	Jilin Scientific and Technological Development Program [20180414034GH]; National Natural Science Foundation of China [81430087]	Jilin Scientific and Technological Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Y.Z. was funded by Jilin Scientific and Technological Development Program and the Grant No. 20180414034GH. The website is http://kjt.jl.gov.cn/.J.G.was funded by the National Natural Science Foundation of China Project 81430087. The website is http://www.nsfc.gov.cn/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appierto V, 2007, ONCOGENE, V26, P3952, DOI 10.1038/sj.onc.1210171; Beltran H, 2016, NAT MED, V22, P298, DOI 10.1038/nm.4045; Chen SJ, 2007, PROSTATE, V67, P557, DOI 10.1002/pros.20551; Cheng JC, 2011, ENDOCRINOLOGY, V152, P2987, DOI 10.1210/en.2011-0059; Cheung PK, 2004, CANCER RES, V64, P5929, DOI 10.1158/0008-5472.CAN-04-1216; Cho SD, 2004, MOL CANCER THER, V3, P605; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Dong Y, 2004, CANCER RES, V64, P19, DOI 10.1158/0008-5472.CAN-03-2789; Dong Y, 2003, CANCER RES, V63, P52; Emmerson PJ, 2017, NAT MED, V23, P1215, DOI 10.1038/nm.4393; Erho N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066855; Fizazi K, 2012, LANCET ONCOL, V13, P983, DOI 10.1016/S1470-2045(12)70379-0; Gasparian AV, 2002, MOL CANCER THER, V1, P1079; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Gundimeda U, 2008, J BIOL CHEM, V283, P34519, DOI 10.1074/jbc.M807007200; Hood BL, 2005, MOL CELL PROTEOMICS, V4, P1741, DOI 10.1074/mcp.M500102-MCP200; Husaini Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115189; Ip C, 1998, J NUTR, V128, P1845, DOI 10.1093/jn/128.11.1845; Ip C, 2000, CANCER RES, V60, P2882; Jiang C, 2001, CANCER RES, V61, P3062; Kakehi Y, 2004, PROSTATE, V59, P351, DOI 10.1002/pros.10365; Kawahara T, 2010, UROL INT, V84, P198, DOI 10.1159/000277599; Kelly JA, 2009, CANCER LETT, V277, P38, DOI 10.1016/j.canlet.2008.11.013; Klein KA, 1997, NAT MED, V3, P402, DOI 10.1038/nm0497-402; Knudsen KE, 2009, CLIN CANCER RES, V15, P4792, DOI 10.1158/1078-0432.CCR-08-2660; Lambert JR, 2006, J CELL PHYSIOL, V208, P566, DOI 10.1002/jcp.20692; Lambert JR, 2015, PROSTATE, V75, P255, DOI 10.1002/pros.22911; Latonen L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03573-6; Lee SO, 2006, PROSTATE, V66, P1070, DOI 10.1002/pros.20329; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li GX, 2008, CARCINOGENESIS, V29, P1005, DOI 10.1093/carcin/bgn007; Li J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122249; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Liu T, 2003, CANCER RES, V63, P5034; Liu YB, 2015, PROSTATE, V75, P1001, DOI 10.1002/pros.22987; Marshall JR, 2017, ONCOTARGET, V8, P26312, DOI 10.18632/oncotarget.15460; Min KW, 2016, ONCOGENE, V35, P377, DOI 10.1038/onc.2015.95; Ohta Y, 2009, CHEM RES TOXICOL, V22, P1795, DOI 10.1021/tx900202m; Park SH, 2012, J BIOL CHEM, V287, P19841, DOI 10.1074/jbc.M111.330639; Piccolo SR, 2012, GENOMICS, V100, P337, DOI 10.1016/j.ygeno.2012.08.003; Pinto JT, 2007, INT J CANCER, V120, P1410, DOI 10.1002/ijc.22500; Rasiah KK, 2006, CANCER EPIDEM BIOMAR, V15, P711, DOI 10.1158/1055-9965.EPI-05-0752; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Senapati S, 2010, ONCOGENE, V29, P1293, DOI 10.1038/onc.2009.420; Sinha I, 2014, CANCER MED-US, V3, P252, DOI 10.1002/cam4.198; Sinha I, 2012, INT J CANCER, V130, P1430, DOI 10.1002/ijc.26141; Smith ML, 2004, ANTICANCER RES, V24, P1401; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tsui KH, 2012, J MOL ENDOCRINOL, V49, P153, DOI 10.1530/JME-11-0149; Vanhara P, 2012, PROSTATE CANCER P D, V15, P320, DOI 10.1038/pcan.2012.6; Wang L, 2018, ANN ONCOL, V29, P352, DOI 10.1093/annonc/mdx689; Wang L, 2016, CANCER PREV RES, V9, P35, DOI 10.1158/1940-6207.CAPR-15-0236; Wang L, 2011, PROSTATE, V71, P1429, DOI 10.1002/pros.21360; Wang L, 2009, CANCER PREV RES, V2, P484, DOI 10.1158/1940-6207.CAPR-08-0173; Wang XY, 2013, BIOCHEM PHARMACOL, V85, P597, DOI 10.1016/j.bcp.2012.11.025; Wu Y, 2005, CANCER RES, V65, P9073, DOI 10.1158/0008-5472.CAN-05-2016; Zhan Y, 2013, INT J CANCER, V133, P2225, DOI 10.1002/ijc.28202; Zhang Haitao, 2005, Cancer Genomics & Proteomics, V2, P97; Zhao HJ, 2004, MOL BIOL CELL, V15, P506, DOI 10.1091/mbc.E03-07-0501	61	7	8	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222812	10.1371/journal.pone.0222812	http://dx.doi.org/10.1371/journal.pone.0222812			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539407	Green Published, Green Submitted, gold			2022-12-26	WOS:000532297900032
J	Eldaebes, MMAS; Landry, TG; Bance, ML				Eldaebes, Mostafa M. A. S.; Landry, Thomas G.; Bance, Manohar L.			Repair of subtotal tympanic membrane perforations: A temporal bone study of several tympanoplasty materials	PLOS ONE			English	Article							CARTILAGE TYMPANOPLASTY; MOTION	The aim of this project was to investigate the effects of different types of graft material, and different remaining segments of the native TM on its motion. In twelve human temporal bones, controlled TM perforations were made to simulate three different conditions. (1) Central perforation leaving both annular and umbo rims of native TM. (2) Central perforation leaving only a malleal rim of native TM. (3) Central perforation leaving only an annular rim of native TM. Five different graft materials (1) perichondrium (2) silastic (3) thin cartilage (4) thick cartilage (5) Lotriderm (R) cream were used to reconstruct each perforation condition. Umbo and stapes vibrations to acoustic stimuli from 250 to 6349 Hz were measured using a scanning laser Doppler vibrometer. Results showed that at low frequencies: in the Two Rims condition, all grafting materials except thick cartilage and Lotriderm cream showed no significant difference in umbo velocity from the Normal TM, while only Lotriderm cream showed a significant decrease in stapes velocity; in the Malleal Rim condition, all materials showed a significant decrease in both umbo and stapes velocities; in the Annular Rim condition, all grafting materials except Lotriderm and perichondrium showed no significant difference from the Normal TM in stapes velocity. Umbo data might not be reliable in some conditions because of coverage by the graft. At middle and high frequencies: all materials showed a significant difference from the Normal TM in both umbo and stapes velocities for all perforation conditions except in the Annular Rim condition, in which silastic and perichondrium showed no significant difference from the Normal TM at umbo velocity in the middle frequencies. In the low frequencies, the choice of repair material does not seem to have a large effect on sound transfer. Our data also suggests that the annular rim could be important for low frequency sound transfer.	[Eldaebes, Mostafa M. A. S.; Landry, Thomas G.; Bance, Manohar L.] Nova Scotia Hlth Author, Div Otolaryngol, Dept Surg, Halifax, NS, Canada; [Eldaebes, Mostafa M. A. S.] Univ Hlth Network, Ctr Adv Hearing & Balance Testing, Toronto, ON, Canada; [Bance, Manohar L.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Cambridge	Bance, ML (corresponding author), Nova Scotia Hlth Author, Div Otolaryngol, Dept Surg, Halifax, NS, Canada.; Bance, ML (corresponding author), Univ Cambridge, Dept Clin Neurosci, Cambridge, England.	mlb59@cam.ac.uk			Dept. of Surgery, Dalhousie University	Dept. of Surgery, Dalhousie University	This work was supported by: MB, Dept. of Surgery, Dalhousie University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnisalo AA, 2010, HEARING RES, V263, P78, DOI 10.1016/j.heares.2009.11.005; Aarnisalo AA, 2009, OTOL NEUROTOL, V30, P1209, DOI 10.1097/MAO.0b013e3181bc398e; ADKINS WY, 1990, LARYNGOSCOPE, V100, P244; Aernouts J, 2012, THESIS; Allardyce BJ, 2016, J MECH BEHAV BIOMED, V64, P65, DOI 10.1016/j.jmbbm.2016.07.017; Chien WD, 2006, AUDIOL NEURO-OTOL, V11, P183, DOI 10.1159/000091815; Dornhoffer JL, 1997, LARYNGOSCOPE, V107, P1094, DOI 10.1097/00005537-199708000-00016; Eldaebes MMAS, 2018, OTOL NEUROTOL, V39, P995, DOI 10.1097/MAO.0000000000001888; Gea SLR, 2010, JARO-J ASSOC RES OTO, V11, P1, DOI 10.1007/s10162-009-0192-9; Gerber MJ, 2000, LARYNGOSCOPE, V110, P1994, DOI 10.1097/00005537-200012000-00002; Haynes David S, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P283, DOI 10.1097/01.moo.0000172820.97322.8d; Jesic SD, 2011, ARCH OTOLARYNGOL, V137, P139, DOI 10.1001/archoto.2010.242; KRINGLEBOTN M, 1995, J ACOUST SOC AM, V98, P192, DOI 10.1121/1.413746; Lee CF, 2007, LARYNGOSCOPE, V117, P725, DOI 10.1097/mlg.0b013e318031f0e7; Lee JC, 2012, OTOL NEUROTOL, V33, P586, DOI 10.1097/MAO.0b013e31824b78ba; LIM DJ, 1970, ACTA OTO-LARYNGOL, V70, P176, DOI 10.3109/00016487009181875; Mehta RP, 2006, OTOL NEUROTOL, V27, P136, DOI 10.1097/01.mao.0000176177.17636.53; MILEWSKI C, 1993, LARYNGOSCOPE, V103, P1352; Mohamad SH, 2012, OTOL NEUROTOL, V33, P699, DOI 10.1097/MAO.0b013e318254fbc2; Murbe D, 2002, LARYNGOSCOPE, V112, P1769; O'Connor KN, 2008, LARYNGOSCOPE, V118, P483, DOI 10.1097/MLG.0b013e31815b0d9f; Rosowski JJ, 2009, HEARING RES, V253, P83, DOI 10.1016/j.heares.2009.03.010; Van Rompaey V, 2013, OTOL NEUROTOL, V34, P180, DOI 10.1097/MAO.0b013e31826bf16d; Voss SE, 2000, HEARING RES, V150, P43, DOI 10.1016/S0378-5955(00)00177-5; Voss SE, 2001, ACTA OTO-LARYNGOL, V121, P169; Zahnert T, 2000, AM J OTOL, V21, P322, DOI 10.1016/S0196-0709(00)80039-3	26	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222728	10.1371/journal.pone.0222728	http://dx.doi.org/10.1371/journal.pone.0222728			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536572	Green Published, gold, Green Submitted			2022-12-26	WOS:000532262800078
J	Hugdahl, K; Kazimierczak, K; Beresniewicz, J; Kompus, K; Westerhausen, R; Ersland, L; Gruner, R; Specht, K				Hugdahl, Kenneth; Kazimierczak, Katarzyna; Beresniewicz, Justyna; Kompus, Kristiina; Westerhausen, Rene; Ersland, Lars; Gruner, Renate; Specht, Karsten			Dynamic up- and down-regulation of the default (DMN) and extrinsic (EMN) mode networks during alternating task-on and task-off periods	PLOS ONE			English	Article							BRAIN NETWORKS; FUNCTIONAL CONNECTIVITY; EEG-ALPHA; ATTENTION; FMRI; REGIONS; CORTEX; INDIVIDUALS; RELEVANCE; PARADIGM	Using fMRI, Hugdahl et al. (2015) reported the existence of a general-domain cortical network during active task-processing which was non-specific to the cognitive task being processed. They labelled this network the extrinsic mode network (EMN). The EMN would be predicted to be negatively, or anti-correlated with the classic default mode network (DMN), typically observed during periods of rest, such that while the EMN should be down-regulated and the DMN up-regulated in the absence of demands for task-processing, the reverse should occur when demands change from resting to task-processing. This would require alternating periods of task-processing and resting and analyzing data continuously when demands change from active to passive periods and vice versa. We were particularly interested in how the networks interact in the critical transition points between conditions. For this purpose, we used an auditory task with multiple cognitive demands in a standard fMRI block-design. Task-present (ON) blocks were alternated with an equal number of task-absent, or rest (OFF) blocks to capture network dynamics across time and changing environmental demands. To achieve this, we specified the onset of each block, and used a finite-impulse response function (FIR) as basis function for estimation of the fMRI-BOLD response. During active (ON) blocks, the results showed an initial rapid onset of activity in the EMN network, which remained throughout the period, and faded away during the first scan of the OFF-block. During OFF blocks, activity in the DMN network showed an initial time-lag where neither the EMN nor the DMN was active, after which the DMN was up-regulated. Studying network dynamics in alternating passive and active periods may provide new insights into brain network interaction and regulation.	[Hugdahl, Kenneth; Kazimierczak, Katarzyna; Beresniewicz, Justyna; Kompus, Kristiina; Specht, Karsten] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway; [Hugdahl, Kenneth] Haukeland Hosp, Div Psychiat, Bergen, Norway; [Hugdahl, Kenneth; Gruner, Renate] Haukeland Hosp, Dept Radiol, Bergen, Norway; [Westerhausen, Rene] Univ Oslo, Inst Psychol, Oslo, Norway; [Ersland, Lars] Haukeland Hosp, Dept Clin Engn, Bergen, Norway; [Gruner, Renate; Specht, Karsten] Haukeland Hosp, Mohn Med Imaging & Visualizat Ctr, Bergen, Norway; [Specht, Karsten] UiT Arctic Univ Norway, Dept Educ, Tromso, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Oslo; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; UiT The Arctic University of Tromso	Hugdahl, K (corresponding author), Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway.; Hugdahl, K (corresponding author), Haukeland Hosp, Div Psychiat, Bergen, Norway.; Hugdahl, K (corresponding author), Haukeland Hosp, Dept Radiol, Bergen, Norway.	hugdahl@uib.no	Westerhausen, René/D-2441-2013; Grüner, Renate/ABD-8797-2020	Westerhausen, René/0000-0001-7107-2712; Hugdahl, Kenneth/0000-0002-0008-4326	European Research Council (ERC AdG) [693124]; Western Norway Health Authorities (Helse-Vest) [912045]; Research Council of Norway (NORMENT) [223273]	European Research Council (ERC AdG)(European Research Council (ERC)); Western Norway Health Authorities (Helse-Vest); Research Council of Norway (NORMENT)(Research Council of Norway)	The present study was supported by grants to Kenneth Hugdahl from European Research Council (ERC AdG #693124), the Western Norway Health Authorities (Helse-Vest, #912045), and the Research Council of Norway (NORMENT #223273). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen P, 2019, NEUROSCI BIOBEHAV R, V99, P90, DOI 10.1016/j.neubiorev.2019.02.004; ASBJORNSEN AE, 1995, BRAIN LANG, V49, P189, DOI 10.1006/brln.1995.1029; Bandettini P. A, 1999, FUNCTIONAL MRI; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; BRYDEN MP, 1983, BRAIN LANG, V18, P236, DOI 10.1016/0093-934X(83)90018-4; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2012, NEUROIMAGE, V62, P1137, DOI 10.1016/j.neuroimage.2011.10.035; Bush G, 2006, NAT PROTOC, V1, P308, DOI 10.1038/nprot.2006.48; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Callard F, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00321; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; Di X, 2014, PEERJ, V2, DOI 10.7717/peerj.367; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Downar J, 2002, J NEUROPHYSIOL, V87, P615, DOI 10.1152/jn.00636.2001; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Fedorenko E, 2013, P NATL ACAD SCI USA, V110, P16616, DOI 10.1073/pnas.1315235110; Fedorenko E, 2011, P NATL ACAD SCI USA, V108, P16428, DOI 10.1073/pnas.1112937108; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Gadea M, 2000, J CLIN EXP NEUROPSYC, V22, P793, DOI 10.1076/jcen.22.6.793.959; Gadea M, 2016, APPL PSYCHOPHYS BIOF, V41, P157, DOI 10.1007/s10484-015-9323-8; Gao W, 2012, HUM BRAIN MAPP, V33, P192, DOI 10.1002/hbm.21204; Gonzalez-Castillo J, 2012, P NATL ACAD SCI USA, V109, P5487, DOI 10.1073/pnas.1121049109; Gratton C, 2018, NEURON, V98, P439, DOI 10.1016/j.neuron.2018.03.035; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Helland T, 2000, CHILD NEUROPSYCHOL, V6, P37, DOI 10.1076/0929-7049(200003)6:1;1-B;FT037; Hommet C, 2010, J NUTR HEALTH AGING, V14, P751, DOI 10.1007/s12603-010-0097-7; HUGDAHL K, 1986, CORTEX, V22, P417, DOI 10.1016/S0010-9452(86)80005-3; Hugdahl K, 2000, HUM BRAIN MAPP, V10, P87, DOI 10.1002/(SICI)1097-0193(200006)10:2<87::AID-HBM50>3.0.CO;2-V; Hugdahl K, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00430; Hugdahl K, 2011, BRAIN COGNITION, V76, P211, DOI 10.1016/j.bandc.2011.03.006; Hugdahl K, 2009, SCAND J PSYCHOL, V50, P11, DOI 10.1111/j.1467-9450.2008.00676.x; Kershner JR, 2016, J LEARN DISABIL-US, V49, P282, DOI 10.1177/0022219414547222; Kompus K, 2012, BRAIN LANG, V121, P240, DOI 10.1016/j.bandl.2012.03.004; Krieger-Redwood K, 2016, NEUROIMAGE, V141, P366, DOI 10.1016/j.neuroimage.2016.07.060; Lee MH, 2013, AM J NEURORADIOL, V34, P1866, DOI 10.3174/ajnr.A3263; Lee MS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040370, 10.1371/journal.pone.0035710]; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Mak LE, 2017, BRAIN CONNECT, V7, P25, DOI 10.1089/brain.2016.0438; Margulies DS, 2017, P NATL ACAD SCI USA, V114, P12641, DOI 10.1073/pnas.1717374114; Margulies DS, 2016, P NATL ACAD SCI USA, V113, P12574, DOI 10.1073/pnas.1608282113; Mitra A, 2018, SCAND J PSYCHOL, V59, P83, DOI 10.1111/sjop.12422; Mitra A, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0546; Mittner M, 2014, J NEUROSCI, V34, P16286, DOI 10.1523/JNEUROSCI.2062-14.2014; Northoff G, 2011, SCHIZOPHR RES, V127, P202, DOI 10.1016/j.schres.2010.11.009; Nygard M., 2012, FRONTIERS HUMAN NEUR; OBRZUT JE, 1993, NEUROPSYCHOLOGIA, V31, P1411, DOI 10.1016/0028-3932(93)90107-B; OLeary DS, 1996, BRAIN LANG, V53, P20, DOI 10.1006/brln.1996.0034; Popa D, 2009, J NEUROSCI, V29, P1191, DOI 10.1523/JNEUROSCI.4867-08.2009; Posner M. I., 1997, IMAGES MIND; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; Power JD, 2013, CURR OPIN NEUROBIOL, V23, P223, DOI 10.1016/j.conb.2012.12.009; Provost JS, 2015, EUR J NEUROSCI, V41, P835, DOI 10.1111/ejn.12821; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ramot M, 2012, J NEUROSCI, V32, P10458, DOI 10.1523/JNEUROSCI.0877-12.2012; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Sauseng P, 2006, EXP BRAIN RES, V170, P295, DOI 10.1007/s00221-005-0211-y; Sauseng P, 2005, EUR J NEUROSCI, V22, P2917, DOI 10.1111/j.1460-9568.2005.04482.x; SHANKWEILER D, 1967, Q J EXP PSYCHOL, V19, P59, DOI 10.1080/14640746708400069; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sormaz M, 2018, P NATL ACAD SCI USA, V115, P9318, DOI 10.1073/pnas.1721259115; Spreng RN, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00145; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Tallus J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139318; van den Noort M, 2008, NEUROIMAGE, V40, P902, DOI 10.1016/j.neuroimage.2007.11.051; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; Vatansever D, 2017, P NATL ACAD SCI USA, V114, P12821, DOI 10.1073/pnas.1710521114; Westerhausen R, 2010, NEUROPSYCHOLOGIA, V48, P2075, DOI 10.1016/j.neuropsychologia.2010.03.028	73	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0218358	10.1371/journal.pone.0218358	http://dx.doi.org/10.1371/journal.pone.0218358			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5BF	31536496	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000532262800007
J	Manig, F; Hellwig, M; Pietz, F; Henle, T				Manig, Friederike; Hellwig, Michael; Pietz, Franziska; Henle, Thomas			Quantitation of free glycation compounds in saliva	PLOS ONE			English	Article							MAILLARD REACTION-PRODUCTS; CHRONIC KIDNEY-DISEASE; SQUAMOUS-CELL CARCINOMA; AMINO-ACID PROFILE; LIQUID-CHROMATOGRAPHY; METABOLIC TRANSIT; EARLY-DIAGNOSIS; END-PRODUCTS; PYRRALINE; PROTEINS	In the course of the Maillard reaction, which occurs during heating of food but also under physiological condition, a broad spectrum of reaction products is formed. Among them, the advanced glycation endproducts (AGEs) N-epsilon-carboxymethyllysine (CML), pyrraline (Pyr), methylglyoxal-derived hydroimidazolone 1 (MG-H1) and N-epsilon-carboxyethyllysine (CEL) are the quantitatively dominating compounds during later reaction stages. Those dietary glycation compounds are under discussion as to be associated with chronic inflammation and the pathophysiological consequences of diseases such as diabetes. In the present study, the concentration of individual glycation compounds in saliva was monitored for the first time and related to their dietary uptake. Fasting saliva of 33 metabolically healthy subjects was analyzed with HPLC-MS/MS. The observed levels of individual glycation compounds ranged from 0.5 to 55.2 ng/ml and differed both intra- and interindividually. Patterns did not correlate with subject-related features such as vegetarianism or sports activities, indicating that dietary intake may play an important role. Therefore, six volunteers were asked to eat a raw food diet free of glycation compounds for two days. Within two days, salivary Pyr was lowered from median 1.7 ng/ml to a minimum level below the limit of detection, and MG-H1 decreased from 3.6 to 1.7 ng/ml in in a time-dependent manner after two days. Salivary CML and CEL concentrations were not affected. Therefore, measuring Pyr and MG-H1 in saliva is a suitable diagnostic tool to monitor the dietary intake and metabolic transit of glycation compounds present in heated foods.	[Manig, Friederike; Hellwig, Michael; Pietz, Franziska; Henle, Thomas] Tech Univ Dresden, Chair Food Chem, Dresden, Germany	Technische Universitat Dresden	Manig, F; Hellwig, M; Henle, T (corresponding author), Tech Univ Dresden, Chair Food Chem, Dresden, Germany.	friederike.manig@chemie.tu-dresden.de; michael.hellwig@chemie.tu-dresden.de; thomas.henle@chemie.tu-dresden.de		Hellwig, Michael/0000-0001-8528-6893	German Federal Ministry for Research and Education (BMBF) [01EA1703]; Joint Programm Initiative (JPI)	German Federal Ministry for Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Joint Programm Initiative (JPI)	Data were generated as part of the European SALIVAGES project. The Joint Programm Initiative (JPI) supports the SALIVAGES consortium within the programme "A healthy diet for a healthy life" (HDHL). The authors acknowledge the German Federal Ministry for Research and Education (BMBF) for support of the project for FM (grant number 01EA1703). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072128; Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565; AHMED MU, 1986, J BIOL CHEM, V261, P4889; Ahmed N, 2005, DIABETOLOGIA, V48, P1590, DOI 10.1007/s00125-005-1810-7; Ahmed N, 2005, MOL NUTR FOOD RES, V49, P691, DOI 10.1002/mnfr.200500008; BATTISTONE GC, 1961, ARCH ORAL BIOL, V3, P161, DOI 10.1016/0003-9969(61)90133-9; BROWNLEE M, 1984, ANN INTERN MED, V101, P527, DOI 10.7326/0003-4819-101-4-527; Buttler RM, 2018, STEROIDS, V138, P26, DOI 10.1016/j.steroids.2018.05.013; Cheng F, 2015, CLIN CHIM ACTA, V447, P23, DOI 10.1016/j.cca.2015.05.008; Delatour T, 2006, AMINO ACIDS, V30, P25, DOI 10.1007/s00726-005-0249-y; Delgado-Povedano MM, 2016, TALANTA, V146, P310, DOI 10.1016/j.talanta.2015.07.066; Dolan K, 2004, DRUG ALCOHOL REV, V23, P213, DOI 10.1080/09595230410001704208; Erbersdobler HF, 2007, MOL NUTR FOOD RES, V51, P423, DOI 10.1002/mnfr.200600154; Erbersdobler HF, 2001, NAHRUNG, V45, P177, DOI 10.1002/1521-3803(20010601)45:3&lt;177::AID-FOOD177&gt;3.0.CO;2-A; Ferreira AEN, 2003, BIOCHEM J, V376, P109, DOI 10.1042/BJ20030496; FINOT PA, 1981, PROG FOOD NUTR SCI, V5, P193; Forster A, 2005, ANN NY ACAD SCI, V1043, P474, DOI 10.1196/annals.1333.054; GLOMB MA, 1995, J BIOL CHEM, V270, P10017, DOI 10.1074/jbc.270.17.10017; Gopal P, 2014, EUR RESPIR J, V43, P430, DOI 10.1183/09031936.00135312; Gualtero DF, 2016, ACTA ODONTOL SCAND, V74, P170, DOI 10.3109/00016357.2015.1110249; Gupta Shruti, 2015, J Diabetes Sci Technol, V9, P91, DOI 10.1177/1932296814552673; Macias-Cervantes MH, 2015, NUTRITION, V31, P446, DOI 10.1016/j.nut.2014.10.004; Hanssen NMJ, 2013, J CLIN ENDOCR METAB, V98, pE1369, DOI 10.1210/jc.2013-1068; Hartman ML, 2016, PEDIATR ENDOCR REV P, V13, P602; Hassaneen M, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00083; Hellwig M, 2017, J AGR FOOD CHEM, V65, P3532, DOI 10.1021/acs.jafc.7b00797; Hellwig M, 2014, ANGEW CHEM INT EDIT, V53, P10316, DOI 10.1002/anie.201308808; Hellwig M, 2014, AMINO ACIDS, V46, P289, DOI 10.1007/s00726-013-1501-5; Hellwig M, 2013, EUR FOOD RES TECHNOL, V237, P47, DOI 10.1007/s00217-013-2027-5; Hellwig M, 2012, EUR FOOD RES TECHNOL, V235, P99, DOI 10.1007/s00217-012-1738-3; Hellwig M, 2011, CHEMBIOCHEM, V12, P1270, DOI 10.1002/cbic.201000759; Hellwig M, 2009, J AGR FOOD CHEM, V57, P6474, DOI 10.1021/jf901224p; Henle T, 1996, Z LEBENSM UNTERS FOR, V202, P72, DOI 10.1007/BF01229689; HENLE T, 1993, Z LEBENSM UNTERS FOR, V196, P1, DOI 10.1007/BF01192975; Hoonhorst SJM, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0363-2; Javaid Mohammad A, 2016, J Oral Biol Craniofac Res, V6, P66, DOI 10.1016/j.jobcr.2015.08.006; Kaczor-Urbanowicz KE, 2017, EXP BIOL MED, V242, P459, DOI 10.1177/1535370216681550; Krause R, 2003, EUR FOOD RES TECHNOL, V216, P277, DOI 10.1007/s00217-002-0649-0; Lasisi TJ, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0222-x; LEDL F, 1990, ANGEW CHEM INT EDIT, V29, P565, DOI 10.1002/anie.199005653; LEE K, 1994, MAILLARD REACTIONS C, P358; LIAPPIS N, 1986, KLIN PADIATR, V198, P25, DOI 10.1055/s-2008-1026847; Maessen MFH, 2017, J SCI MED SPORT, V20, P921, DOI 10.1016/j.jsams.2017.03.011; Mark AB, 2014, DIABETES CARE, V37, P88, DOI 10.2337/dc13-0842; Morzel M, 2017, PHYSIOL BEHAV, V173, P116, DOI 10.1016/j.physbeh.2017.02.005; NAKAYAMA T, 1980, AGR BIOL CHEM TOKYO, V44, P1201, DOI 10.1080/00021369.1980.10864104; Okura T, 2017, J DIABETES RES HINDA, V2017, P1; Pfaffe T, 2011, CLIN CHEM, V57, P675, DOI 10.1373/clinchem.2010.153767; Rad HM, 2014, J ORAL REHABIL, V41, P759, DOI 10.1111/joor.12197; Arantes LMRB, 2018, EXPERT REV MOL DIAGN, V18, P85, DOI 10.1080/14737159.2017.1404906; Reddy I, 2012, J ORAL SCI, V54, P279, DOI 10.2334/josnusd.54.279; Renda R, 2017, RENAL FAILURE, V39, P452, DOI 10.1080/0886022X.2017.1308256; Scheijen JLJM, 2018, CLIN NUTR, V37, P919, DOI 10.1016/j.clnu.2017.03.019; Schievano E, 2015, TALANTA, V140, P36, DOI 10.1016/j.talanta.2015.03.004; Schwarzenbolz U, 2016, J AGR FOOD CHEM, V64, P5071, DOI 10.1021/acs.jafc.6b01375; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; Pham TAV, 2017, ACTA ODONTOL SCAND, V75, P551, DOI 10.1080/00016357.2017.1356467; Tuohy KM, 2006, MOL NUTR FOOD RES, V50, P847, DOI 10.1002/mnfr.200500126; Uribarri J, 2010, J AM DIET ASSOC, V110, P911, DOI 10.1016/j.jada.2010.03.018; van Eupen MGA, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-149; van Waateringe RP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179330; VINING RF, 1987, J STEROID BIOCHEM, V27, P81, DOI 10.1016/0022-4731(87)90297-4; Vlassara H, 2002, P NATL ACAD SCI USA, V99, P15596, DOI 10.1073/pnas.242407999; Vlassara H, 2016, DR VLASSARAS AGE LES; Vlassara H, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-013-0453-1; Walsh MC, 2006, AM J CLIN NUTR, V84, P531, DOI 10.1093/ajcn/84.3.531; Yajamanam N, 2016, SAUDI J KIDNEY DIS T, V27, P312, DOI 10.4103/1319-2442.178549	67	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0220208	10.1371/journal.pone.0220208	http://dx.doi.org/10.1371/journal.pone.0220208			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JX5WJ	31532774	Green Submitted, gold, Green Published			2022-12-26	WOS:000503804600001
J	McCartney, B; Martinez-del-Rincon, J; Devereux, B; Murphy, B				McCartney, Ben; Martinez-del-Rincon, Jesus; Devereux, Barry; Murphy, Brian			A zero-shot learning approach to the development of brain-computer interfaces for image retrieval	PLOS ONE			English	Article							OBJECTS	Brain decoding-the process of inferring a person's momentary cognitive state from their brain activity-has enormous potential in the field of human-computer interaction. In this study we propose a zero-shot EEG-to-image brain decoding approach which makes use of state-of-the-art EEG preprocessing and feature selection methods, and which maps EEG activity to biologically inspired computer vision and linguistic models. We apply this approach to solve the problem of identifying viewed images from recorded brain activity in a reliable and scalable way. We demonstrate competitive decoding accuracies across two EEG datasets, using a zero-shot learning framework more applicable to real-world image retrieval than traditional classification techniques.	[McCartney, Ben; Martinez-del-Rincon, Jesus; Devereux, Barry; Murphy, Brian] Queens Univ Belfast, Belfast, Antrim, North Ireland; [Murphy, Brian] BrainWaveBank Ltd, Belfast, Antrim, North Ireland	Queens University Belfast	McCartney, B (corresponding author), Queens Univ Belfast, Belfast, Antrim, North Ireland.	bmccartney06@qub.ac.uk	Martinez del Rincon, Jesus/C-7067-2008	Martinez del Rincon, Jesus/0000-0002-9574-4138; McCartney, Ben/0000-0001-5515-3432				Acharya UR, 2015, KNOWL-BASED SYST, V88, P85, DOI 10.1016/j.knosys.2015.08.004; Bhat S, 2015, EUR NEUROL, V74, P202, DOI 10.1159/000441447; Bojanowski P., 2016, ARXIV PREPRINT ARXIV; Caceres CA, 2017, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00041; Carlson TA, 2007, J COGNITIVE NEUROSCI, P1; Carlson T, 2013, J VISION, V13, DOI 10.1167/13.10.1; Cecchi Marco, 2015, Alzheimers Dement (Amst), V1, P387, DOI 10.1016/j.dadm.2015.08.004; Clarke A, 2015, TRENDS COGN SCI, V19, P677, DOI 10.1016/j.tics.2015.08.008; Clarke A, 2015, CEREB CORTEX, V25, P3602, DOI 10.1093/cercor/bhu203; Clarke A, 2013, CEREB CORTEX, V23, P187, DOI 10.1093/cercor/bhs002; Clarke A, 2011, J COGNITIVE NEUROSCI, V23, P1887, DOI 10.1162/jocn.2010.21544; Deng J., 2009, 2009 IEEE COMPUTER S, P248, DOI DOI 10.1109/CVPR.2009.5206848; Devereux BJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28865-1; Frome A., 2013, NEURIPS, P2121; Guclu U, 2015, SEMANTIC VECTOR SPAC; Hamilton W., 2013, BIOL INSPIRED OBJECT; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; HURST HE, 1951, T AM SOC CIV ENG, V116, P770; Jas M., 2016, 2016 INT WORKSH PATT, P1; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; Kaneshiro B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135697; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Kriegeskorte N, 2015, ANNU REV VIS SCI, V1, P417, DOI 10.1146/annurev-vision-082114-035447; Larson MJ, 2014, INT J PSYCHOPHYSIOL, V93, P283, DOI 10.1016/j.ijpsycho.2014.06.007; Leeds DD, 2013, J VISION, V13, DOI 10.1167/13.13.25; Li YQ, 2008, PATTERN RECOGN LETT, V29, P1285, DOI 10.1016/j.patrec.2008.01.030; Lindeberg T, 2012, SCHOLARPEDIA, V7, P10491, DOI [DOI 10.4249/SCHOLARPEDIA.10491, 10.4249/scholarpedia.10491]; Makeig S, 1996, ADV NEUR IN, V8, P145; Matran-Fernandez Ana, 2014, 2014 6th Computer Science and Electronic Engineering Conference (CEEC). Proceedings, P127, DOI 10.1109/CEEC.2014.6958567; Mitchell J, 2010, COGNITIVE SCI, V34, P1388, DOI 10.1111/j.1551-6709.2010.01106.x; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Murphy B., 2009, P 2009 C EMP METH NA, P619, DOI [10.3115/1699571.1699594, DOI 10.3115/1699571.1699594]; Nishimoto S, 2011, CURR BIOL, V21, P1641, DOI 10.1016/j.cub.2011.08.031; Nolan H, 2010, J NEUROSCI METH, V192, P152, DOI 10.1016/j.jneumeth.2010.07.015; Palatucci M.M., 2011, THOUGHT RECOGNITION; Pedroso RV, 2012, BRAZ J OTORHINOLAR, V78, P126, DOI 10.1590/S1808-86942012000400023; Pennington J, 2014, EMNLP, V14, P1532, DOI DOI 10.3115/V1/D14-1162; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Qian Gang, 2002, P INT C IM PROC, V2; Ramos-Murguialday A, 2015, J NEUROPHYSIOL, V7; Sajda P, 2010, HUM-COMPUT INT-SPRIN, P133, DOI 10.1007/978-1-84996-272-8_9; Sarnthein J, 2009, CLIN NEUROPHYSIOL, V120, P1835, DOI 10.1016/j.clinph.2009.08.014; Schwartz AB, 2006, NEURON, V52, P205, DOI 10.1016/j.neuron.2006.09.019; Sudre G, 2012, NEUROIMAGE, V62, P451, DOI 10.1016/j.neuroimage.2012.04.048; Trask A., 2015, ARXIV150602338; Vidal J., 1973, ANNUAL REVIEW OF BIO; Vorobyov S, 2002, BIOL CYBERN, V86, P293, DOI 10.1007/s00422-001-0298-6; Yang J, 2007, LECT NOTES COMPUT SC, V4663, P197	48	4	4	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0214342	10.1371/journal.pone.0214342	http://dx.doi.org/10.1371/journal.pone.0214342			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4NC	31525201	Green Published, Green Submitted, gold			2022-12-26	WOS:000532225700003
J	Morard, MRS; Martins, RB; Ribeiro, ACL; Lima, PGR; Carvalho, BD; Santiago, JCB				Santos Morard, Maria Ribeiro; Martins, Ricardo Betanho; Lopes Ribeiro, Ana Carolina; Rocha Lima, Pedro Guimaraes; Carvalho, Beatriz dos Santos; Baldelim Santiago Junior, Jose Carlos			Primary hyperhidrosis prevalence and characteristics among medical students in Rio de Janeiro	PLOS ONE			English	Article							PRIMARY PALMAR HYPERHIDROSIS; EPIDEMIOLOGIC SURVEY; IMPACT	Background Hyperhidrosis is a pathological condition defined by excessive sweating beyond thermoregulatory physiological needs, which can cause substantial psychological impact and impairment of daily activities. Studies regarding its prevalence, however, are scarce and vary widely in their findings. The population of medical students is a particularly interesting subset for its recurring demand of physical contact during patient examination or procedures, and the potential for professional adversity. We aimed at furthering the comprehension of this disease prevalence and characteristics among medical students. Methods Questionnaires inquiring about the presence and characteristics of Primary Hyperhidrosis (PH) were applied through either written or digital means to all eligible medical students enrolled in three Medical Schools in the State of Rio de Janeiro who agreed to take part in the study. Demographic data regarding gender, ethnicity, current age, weight and height was collected in addition to clinical data (sweat site, age of onset, familial history, severity and previous treatments). Severity was evaluated through the Hyperhidrosis Disease Severity Scale (HDSS) and a symptoms survey. Findings Our response rate was roughly 1/3 of all eligible students (900/2700). PH prevalence was 20.56% (185/900). It was similar between men and women (23.08% and 19.41%, respectively) and strongly associated with family history of the disease (Prevalence Ratio of 4.27). Regarding ethnicity, of the total sample 73.78% (664/900) self-declared white, among which 19.28% (128/664) had PH. Mixed-race and other ethnicities encompassed 26.22% (236/ 900) of the sample, among which 24.15% (57/236) had PH. Most positive subjects (64.32%) presented associated forms of PH. Overall involvement of each site (both associated and isolated) was: 63.78% axillary, 50.81% palmar, 43.24% plantar, 20.54% craniofacial, 18.38% facial flushing and 2.16% gustatory sweating. Mean current age was 23.11(+/- 4.04) years for PH patients, and age of onset was <= 18 years in 93.94% of cases. Regarding body mass index (BMI), 71.09% of PH patients had BMI<25kg/m(2) and only 4.69% presented BMI >= 30kg/m(2), none >= 35kg/m(2). Some degree of life quality impairment was reported by 89.20% of PH patients, and 23.89% had HDSS 3 or 4 (moderate to severe). Conclusions PH prevalence among Rio de Janeiro medical students was 20.56%, similar between men and women, predominating associated presentations, axillary, palmar and plantar sites, strong familial history, age of onset before 18 years, and some degree of life impairment.	[Santos Morard, Maria Ribeiro; Martins, Ricardo Betanho; Rocha Lima, Pedro Guimaraes] UNIRIO Univ Fed Estado Rio de Janeiro, Rio De Janeiro, RJ, Brazil; [Santos Morard, Maria Ribeiro; Lopes Ribeiro, Ana Carolina] UNESA Univ Estacio Sa, Rio De Janeiro, RJ, Brazil; [Rocha Lima, Pedro Guimaraes; Carvalho, Beatriz dos Santos; Baldelim Santiago Junior, Jose Carlos] FMP Fac Med Petropolis, Petropolis, RJ, Brazil	Universidade Federal do Estado do Rio de Janeiro	Morard, MRS; Martins, RB (corresponding author), UNIRIO Univ Fed Estado Rio de Janeiro, Rio De Janeiro, RJ, Brazil.; Morard, MRS (corresponding author), UNESA Univ Estacio Sa, Rio De Janeiro, RJ, Brazil.	maria.rlk@terra.com.br; betanhom@gmail.com		Betanho Martins, Ricardo/0000-0001-8466-6114; Ribeiro Santos Morard, Maria/0000-0002-8636-0896	UNESA Programa Pesquisa Produtividade	UNESA Programa Pesquisa Produtividade	This study was supported by grants from UNESA Programa Pesquisa Produtividade for MRSM (R$1'200/month for 12 months). http://portal.estacio.br/unidades/universidade-est%C3% A1cio-de-s%C3%A1/pesquisas/pesquisaprodutividade/; ACLR received R$180/month for 12 months from PIBIC/UNESA. (http://portal.estacio.br/unidades/universidade-est%C3%A1cio-de-s% C3%A1/pesquisas/inicia%C3%A7%C3%A3o-cient %C3%ADfica/); RBM received R$400/month for 6 months from IC/UNIRIO. http://www.unirio.br/propg/diretoria-de-pesquisa/o-que-fazer-paraingressar-na-iniciacao-cientifica/iniciacao-cientifica/editais/vigencia-de-bolsa-ic-2018-2019.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ak M, 2013, J HEALTH PSYCHOL, V18, P704, DOI 10.1177/1359105312454908; Ak M, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-5; Augustin M, 2013, DERMATOLOGY, V227, P10, DOI 10.1159/000351292; Bahar R, 2016, J AM ACAD DERMATOL, V75, P1126, DOI 10.1016/j.jaad.2016.07.001; Doolittle J, 2016, ARCH DERMATOL RES, V308, P743, DOI 10.1007/s00403-016-1697-9; Fenili R, 2009, AN BRAS DERMATOL, V84, P361, DOI 10.1590/S0365-05962009000400007; Fujimoto T, 2013, J DERMATOL, V40, P886, DOI 10.1111/1346-8138.12258; Hashmonai M, 2017, CLIN AUTON RES, V27, P379, DOI 10.1007/s10286-017-0456-0; Hasimoto EN, 2018, J BRAS PNEUMOL, V44, P292, DOI [10.1590/S1806-37562017000000379, 10.1590/s1806-37562017000000379]; Lai FC, 2015, CLIN AUTON RES, V25, P105, DOI 10.1007/s10286-014-0259-5; Li X, 2007, CHINESE MED J-PEKING, V120, P2215, DOI 10.1097/00029330-200712020-00011; Lima SO, 2017, J VASC SURG, V66, P1806, DOI 10.1016/j.jvs.2017.05.126; Lima SO, 2015, AN BRAS DERMATOL, V90, P661, DOI 10.1590/abd1806-4841.20153859; Liu YD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153719; Maillard H, 2015, ANN DERMATOL VENER, V142, P252, DOI 10.1016/j.annder.2014.11.005; Menzinger Sebastien, 2017, Rev Med Suisse, V13, P710; Varella AYM, 2016, REV ASSOC MED BRAS, V62, P843, DOI 10.1590/1806-9282.62.09.843; Moraites E, 2014, DERMATOL CLIN, V32, P457, DOI 10.1016/j.det.2014.06.006; Muthusamy A, 2016, J CLIN DIAGN RES, V10, pCC8, DOI 10.7860/JCDR/2016/19495.8061; Sanclemente G, 2017, ACTAS DERMO-SIFILOGR, V108, P244, DOI 10.1016/j.ad.2016.11.008; Schick CH, 2016, THORAC SURG CLIN, V26, P389, DOI 10.1016/j.thorsurg.2016.06.002; Shayesteh A, 2016, DERMATOLOGY, V232, P586, DOI 10.1159/000448032; Silva Sobrinho Sandoval Lage da, 2017, Rev. Col. Bras. Cir., V44, P323, DOI 10.1590/0100-69912017004005; Stefaniak T, 2013, J DERMATOL, V40, P819, DOI 10.1111/1346-8138.12238; Strutton DR, 2004, J AM ACAD DERMATOL, V51, P241, DOI 10.1016/j.jaad.2003.12.040; Tu YR, 2007, EUR J CARDIO-THORAC, V31, P737, DOI 10.1016/j.ejcts.2007.01.020; Westphal Fernando Luiz, 2011, Rev. Col. Bras. Cir., V38, P392	27	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2019	14	9							e0220664	10.1371/journal.pone.0220664	http://dx.doi.org/10.1371/journal.pone.0220664			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4KS	31518360	Green Submitted, gold, Green Published			2022-12-26	WOS:000532219300009
J	Civciristov, S; Huang, C; Liu, BN; Marquez, EA; Gondin, AB; Schittenhelm, RB; Ellisdon, AM; Canals, M; Halls, ML				Civciristov, Srgjan; Huang, Cheng; Liu, Bonan; Marquez, Elsa A.; Gondin, Arisbel B.; Schittenhelm, Ralf B.; Ellisdon, Andrew M.; Canals, Meritxell; Halls, Michelle L.			Ligand-dependent spatiotemporal signaling profiles of the ?-opioid receptor are controlled by distinct protein-interaction networks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); opiate opioid; cell compartmentalization; protein complex; proteomics; extracellular signal?regulated kinase (ERK); desmosome; Ras-related C3 botulinum toxin substrate 1 (Rac1); cell signaling; opioid-based analgesics	BETA-CATENIN; N-CADHERIN; LOCALIZATION; MORPHINE; PLAKOGLOBIN; ACTIVATION; IQGAP1; CELLS; DYNAMICS; ADHESION	Ligand-dependent differences in the regulation and internalization of the ?-opioid receptor (MOR) have been linked to the severity of adverse effects that limit opiate use in pain management. MOR activation by morphine or [d-Ala(2),N-MePhe(4), Gly-ol]enkephalin (DAMGO) causes differences in spatiotemporal signaling dependent on MOR distribution at the plasma membrane. Morphine stimulation of MOR activates a G?(i/o)?G???protein kinase C (PKC) ? phosphorylation pathway that limits MOR distribution and is associated with a sustained increase in cytosolic extracellular signal-regulated kinase (ERK) activity. In contrast, DAMGO causes a redistribution of the MOR at the plasma membrane (before receptor internalization) that facilitates transient activation of cytosolic and nuclear ERK. Here, we used proximity biotinylation proteomics to dissect the different protein-interaction networks that underlie the spatiotemporal signaling of morphine and DAMGO. We found that DAMGO, but not morphine, activates Ras-related C3 botulinum toxin substrate 1 (Rac1). Both Rac1 and nuclear ERK activity depended on the scaffolding proteins IQ motif-containing GTPase-activating protein-1 (IQGAP1) and Crk-like (CRKL) protein. In contrast, morphine increased the proximity of the MOR to desmosomal proteins, which form specialized and highly-ordered membrane domains. Knockdown of two desmosomal proteins, junction plakoglobin or desmocolin-1, switched the morphine spatiotemporal signaling profile to mimic that of DAMGO, resulting in a transient increase in nuclear ERK activity. The identification of the MOR-interaction networks that control differential spatiotemporal signaling reported here is an important step toward understanding how signal compartmentalization contributes to opioid-induced responses, including anti-nociception and the development of tolerance and dependence.	[Civciristov, Srgjan; Liu, Bonan; Gondin, Arisbel B.; Canals, Meritxell; Halls, Michelle L.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol Theme, 389 Royal Parade, Parkville, Vic 3052, Australia; [Huang, Cheng; Schittenhelm, Ralf B.] Monash Univ, Monash Prote & Metabol Facil, Clayton, Vic 3800, Australia; [Huang, Cheng; Marquez, Elsa A.; Schittenhelm, Ralf B.; Ellisdon, Andrew M.] Monash Univ, Monash Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Canals, Meritxell] Univ Nottingham, Ctr Membrane Prot & Receptors, Sch Life Sci, Univ Pk, Nottingham, England	Monash University; Monash University; Monash University; University of Nottingham	Halls, ML (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol Theme, 389 Royal Parade, Parkville, Vic 3052, Australia.	michelle.halls@monash.edu	Gondin, Arisbel B/X-3943-2019	Schittenhelm, Ralf/0000-0001-8738-1878; Canals, Meritxell/0000-0002-7942-5006; Civciristov, Srgjan/0000-0002-9320-9668; Halls, Michelle/0000-0001-8555-8959; Batista Gondin, Arisbel/0000-0002-1751-4062	National Health and Medical Research Council (NHMRC) [1121029]; NHMRC RD Wright Fellowship [1061687]; Monash Fellowship	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC RD Wright Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Monash Fellowship(Monash University)	This work was supported by National Health and Medical Research Council (NHMRC) Project Grant 1121029 (to M. L. H. and M. C.), NHMRC RD Wright Fellowship 1061687 (to M. L. H.), and a Monash Fellowship (to M. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahlbeck K, 2011, CURR MED RES OPIN, V27, P439, DOI 10.1185/03007995.2010.545379; Alibardi L, 2004, J HISTOCHEM CYTOCHEM, V52, P1561, DOI 10.1369/jhc.4A6300.2004; Antoku S, 2009, J CELL SCI, V122, P4228, DOI 10.1242/jcs.054627; Arai A, 2006, CELL SIGNAL, V18, P2162, DOI 10.1016/j.cellsig.2006.05.001; Bass-Zubek AE, 2008, J CELL BIOL, V181, P605, DOI 10.1083/jcb.200712133; Bierkamp C, 1999, DEVELOPMENT, V126, P371; Bigliardi PL, 2015, BRIT J PHARMACOL, V172, P501, DOI 10.1111/bph.12687; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Cho IT, 2017, J BIOL CHEM, V292, P16382, DOI 10.1074/jbc.M117.795286; Civciristov S, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aan1188; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dinkel BA, 2018, J BIOL CHEM, V293, P14022, DOI 10.1074/jbc.RA118.003097; Franke WW, 2009, CELL TISSUE RES, V338, P1, DOI 10.1007/s00441-009-0849-z; Gao C, 2011, J NEUROSCI, V31, P8533, DOI 10.1523/JNEUROSCI.1300-11.2011; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Godsel LM, 2005, J CELL BIOL, V171, P1045, DOI 10.1083/jcb.200510038; Gondin AB, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00104; Green KJ, 2007, J INVEST DERMATOL, V127, P2499, DOI 10.1038/sj.jid.5701015; Halls ML, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac9177; Halls Michelle L, 2015, Methods Mol Biol, V1335, P131, DOI 10.1007/978-1-4939-2914-6_10; Harvey CD, 2008, P NATL ACAD SCI USA, V105, P19264, DOI 10.1073/pnas.0804598105; Hung V, 2016, NAT PROTOC, V11, P456, DOI 10.1038/nprot.2016.018; Inada M, 2016, INT J MOL MED, V37, P1521, DOI 10.3892/ijmm.2016.2568; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jensen DD, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3447; Johnson JL, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015297; Just S, 2013, MOL PHARMACOL, V83, P633, DOI 10.1124/mol.112.082875; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Komatsu N, 2011, MOL BIOL CELL, V22, P4647, DOI 10.1091/mbc.E11-01-0072; Kowalczyk AP, 2013, PROG MOL BIOL TRANSL, V116, P95, DOI 10.1016/B978-0-12-394311-8.00005-4; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kwiatkowski AV, 2007, CURR OPIN CELL BIOL, V19, P551, DOI 10.1016/j.ceb.2007.08.005; Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179; Liao D, 2007, MOL CELL NEUROSCI, V35, P456, DOI 10.1016/j.mcn.2007.04.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobingier BT, 2017, CELL, V169, P350, DOI 10.1016/j.cell.2017.03.022; Masuho Ikuo, 2015, Methods Mol Biol, V1335, P107, DOI 10.1007/978-1-4939-2914-6_8; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Miess E, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aas9609; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Paek J, 2017, CELL, V169, P338, DOI 10.1016/j.cell.2017.03.028; Quillinan N, 2011, J NEUROSCI, V31, P4434, DOI 10.1523/JNEUROSCI.4874-10.2011; Roberts BJ, 2011, EXP CELL RES, V317, P2814, DOI 10.1016/j.yexcr.2011.09.003; Robinson TE, 2002, SYNAPSE, V46, P271, DOI 10.1002/syn.10146; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Rubio ME, 2005, MOL CELL NEUROSCI, V30, P118, DOI 10.1016/j.mcn.2005.06.005; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1; Rubsam M, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029207; Salomon D, 1997, J CELL BIOL, V139, P1325, DOI 10.1083/jcb.139.5.1325; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schrage R, 2017, CURR OPIN PHARMACOL, V32, P85, DOI 10.1016/j.coph.2016.12.001; Seong E, 2015, CELL ADHES MIGR, V9, P202, DOI 10.4161/19336918.2014.994919; Shafraz O, 2018, ELIFE, V7, DOI 10.7554/eLife.37629; Shirao T, 2001, NEUROSCI RES, V40, P1, DOI 10.1016/S0168-0102(01)00209-7; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Tanaka H, 2012, NEUROCHEM INT, V61, P240, DOI 10.1016/j.neuint.2012.05.008; Troyanovsky RB, 1996, J CELL SCI, V109, P3069; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; White CD, 2012, CELL SIGNAL, V24, P826, DOI 10.1016/j.cellsig.2011.12.005; Wiens KM, 2005, J NEUROSCI, V25, P10627, DOI 10.1523/JNEUROSCI.1947-05.2005; Witcher LL, 1996, J BIOL CHEM, V271, P10904, DOI 10.1074/jbc.271.18.10904	66	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					16198	16213		10.1074/jbc.RA119.008685	http://dx.doi.org/10.1074/jbc.RA119.008685			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31515267	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000499478600027
J	Li, YL; Huang, TF; Fu, Y; Wang, TT; Zhao, TS; Guo, S; Sun, YJ; Yang, Y; Li, CZ				Li, Yongli; Huang, Tengfei; Fu, Yun; Wang, Tingting; Zhao, Tiesuo; Guo, Sheng; Sun, Yanjie; Yang, Yun; Li, Changzheng			Antitumor activity of a novel dual functional podophyllotoxin derivative involved PI3K/AKT/mTOR pathway	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NF-KAPPA-B; PYRROLIDINE DITHIOCARBAMATE; CYTOTOXIC ACTIVITY; TOPOISOMERASE-II; COPPER COMPLEX; UP-REGULATION; SOLID TUMORS; CANCER; CELLS	The progression of cancer through local expansion and metastasis is well recognized, but preventing these characteristic cancer processes is challenging. To this end, a new strategy is required. In this study, we presented a novel dual functional podophyllotoxin derivative, 2-pyridinealdehyde hydrazone dithiocarbamate S-propionate podophyllotoxin ester (Ptox(Pdp)), which inhibited both matrix metalloproteinases and Topoisomerase II. This new podophyllotoxin derivative exhibited significant anti-proliferative, anti-metastatic that correlated with the downregulation of matrix metalloproteinase. In a xenograft animal local expansion model, Ptox(Pdp) was superior to etoposide in tumor repression. A preliminary mechanistic study revealed that Ptox(Pdp) induced apoptosis and autophagy via the PI3K/AKT/mTOR pathway. Furthermore, Ptox(Pdp) could also inhibit epithelial-mesenchymal transition, which was achieved by downregulating both PI3K/AKT/mTOR and NF-kappa B/Snail pathways. Taken together, our results reveal that Ptox(Pdp) is a promising antitumor drug candidate.	[Li, Yongli] Xinxiang Med Univ, Sanquan Coll, Coll Basic Med Sci, Xinxiang, Henan, Peoples R China; [Huang, Tengfei; Fu, Yun; Wang, Tingting; Zhao, Tiesuo; Guo, Sheng; Yang, Yun; Li, Changzheng] Xinxiang Med Univ, Coll Basic Med Sci, Xinxiang, Henan, Peoples R China; [Sun, Yanjie; Li, Changzheng] Xinxiang Med Univ, Sanquan Coll, Expt Teaching Ctr Biol & Basic Med, Xinxiang, Henan, Peoples R China	Xinxiang Medical University; Xinxiang Medical University; Xinxiang Medical University	Li, YL (corresponding author), Xinxiang Med Univ, Sanquan Coll, Coll Basic Med Sci, Xinxiang, Henan, Peoples R China.; Li, CZ (corresponding author), Xinxiang Med Univ, Coll Basic Med Sci, Xinxiang, Henan, Peoples R China.; Li, CZ (corresponding author), Xinxiang Med Univ, Sanquan Coll, Expt Teaching Ctr Biol & Basic Med, Xinxiang, Henan, Peoples R China.	changzhenl@yahoo.com; liyongli@sqmc.edu		Li, changzheng/0000-0002-6226-5843; Wang, Tingting/0000-0002-8320-3190	National Natural Science Foundation of China [21571153]; Science and Technology Department of Henan Province [14300510012, 152300410118]; Key Research Project Funding Program of Higher Educational Institutions of Henan Province [19A310021]; Sanquan College of Xinxiang Medical University [SQTD201703, SQTD201903]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Henan Province; Key Research Project Funding Program of Higher Educational Institutions of Henan Province; Sanquan College of Xinxiang Medical University	This work was supported by the National Natural Science Foundation of China, 21571153 to CL; the Science and Technology Department of Henan Province, 14300510012 and152300410118 to CL; the Sanquan College of Xinxiang Medical University, SQTD201703 to CL; the Sanquan College of Xinxiang Medical University, SQTD201903 to YL and the Key Research Project Funding Program of Higher Educational Institutions of Henan Province, 19A310021 to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achyut BR, 2016, ONCOTARGETS THER, V9, P1047, DOI 10.2147/OTT.S102907; Aguirre-Alvarado C, 2016, ONCOTARGET, V7, P23772, DOI 10.18632/oncotarget.8180; Bedford MR, 2013, J CLIN PHARMACOL, V53, P885, DOI 10.1002/jcph.113; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Buac D, 2012, MINI-REV MED CHEM, V12, P1193, DOI 10.2174/138955712802762040; Castro M. A., 2003, Phytochemistry Reviews, V2, P219, DOI 10.1023/B:PHYT.0000045496.97369.f9; Cattaruzza L, 2011, INT J CANCER, V128, P206, DOI 10.1002/ijc.25311; Cau SBA, 2011, BRIT J PHARMACOL, V164, P372, DOI 10.1111/j.1476-5381.2011.01360.x; Cau SBA, 2015, BASIC CLIN PHARMACOL, V117, P234, DOI 10.1111/bcpt.12400; Chen SW, 2004, BIOORG MED CHEM LETT, V14, P5063, DOI 10.1016/j.bmcl.2004.07.094; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dong R, 2007, BRAZ J MED BIOL RES, V40, P1071, DOI 10.1590/S0100-879X2007000800007; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Fu Y, 2014, INT J ONCOL, V45, P2092, DOI 10.3892/ijo.2014.2611; Fumarola C, 2014, BIOCHEM PHARMACOL, V90, P197, DOI 10.1016/j.bcp.2014.05.011; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Gulhati P, 2011, CANCER RES, V71, P3246, DOI 10.1158/0008-5472.CAN-10-4058; Gumireddy K, 2009, NAT CELL BIOL, V11, P1297, DOI 10.1038/ncb1974; Higuchi M, 1998, ONCOGENE, V17, P2753, DOI 10.1038/sj.onc.1202211; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Huang TF, 2015, INT J ONCOL, V47, P1854, DOI 10.3892/ijo.2015.3158; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Johansson AC, 2010, APOPTOSIS, V15, P527, DOI 10.1007/s10495-009-0452-5; Kamal A, 2015, EXPERT OPIN THER PAT, V25, P1025, DOI 10.1517/13543776.2015.1051727; Kim KS, 2009, EUR J PHARMACOL, V613, P167, DOI 10.1016/j.ejphar.2009.04.026; Kurosu T, 2003, ONCOGENE, V22, P4459, DOI 10.1038/sj.onc.1206755; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Leppard JB, 2005, CHROMOSOMA, V114, P75, DOI 10.1007/s00412-005-0345-5; Li JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14814; Li WQ, 2013, BIOORGAN MED CHEM, V21, P2363, DOI 10.1016/j.bmc.2013.01.069; Liu YQ, 2007, MED CHEM RES, V16, P319, DOI 10.1007/s00044-007-9010-2; Lopez G, 2009, CLIN CANCER RES, V15, P3472, DOI 10.1158/1078-0432.CCR-08-2714; Mansouri-Torshizi H, 2011, BIOINORG CHEM APPL, V2011, DOI 10.1155/2011/394506; Meunier B, 2008, ACCOUNTS CHEM RES, V41, P69, DOI 10.1021/ar7000843; Milacic V, 2006, CANCER RES, V66, P10478, DOI 10.1158/0008-5472.CAN-06-3017; Nadella V, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00106; Nardon C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084248; Nistico P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011908; Ok K, 2013, B KOREAN CHEM SOC, V34, P1051, DOI 10.5012/bkcs.2013.34.4.1051; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Orrenius S, 1996, BIOCHEM SOC T, V24, P1032, DOI 10.1042/bst0241032; Pan XH, 2011, CANCER LETT, V313, P181, DOI 10.1016/j.canlet.2011.09.001; Perlman H, 1999, CELL DEATH DIFFER, V6, P48, DOI 10.1038/sj.cdd.4400453; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Ponnurangam S, 2013, MOL CANCER THER, V12, P598, DOI 10.1158/1535-7163.MCT-12-0907; Reynolds CP, 2005, METH MOLEC MED, V111, P335; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Serrano-Gomez SJ, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0502-x; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shay G, 2015, MATRIX BIOL, V44-46, P200, DOI 10.1016/j.matbio.2015.01.019; Showkat Mehvish, 2014, Mol Biol Int, V2014, P686984, DOI 10.1155/2014/686984; Solovyan VT, 2002, J BIOL CHEM, V277, P21458, DOI 10.1074/jbc.M110621200; Song YJ, 2012, ANGIOGENESIS, V15, P421, DOI 10.1007/s10456-012-9270-4; Spano D, 2012, CLIN EXP METASTAS, V29, P381, DOI 10.1007/s10585-012-9457-5; Strimpakos AS, 2009, CANCER TREAT REV, V35, P148, DOI 10.1016/j.ctrv.2008.09.006; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang TT, 2016, MOLECULES, V21, DOI 10.3390/molecules21081088; Xiao L, 2014, EUR J MED CHEM, V80, P267, DOI 10.1016/j.ejmech.2014.03.082; YOKOYAMA M, 1991, CANCER RES, V51, P3229; Zhang KJ, 2011, HEPATO-GASTROENTEROL, V58, P1; Zhang L, 2017, MOLECULES, V22, DOI 10.3390/molecules22040628; Zhang L, 2016, EUR J MED CHEM, V123, P226, DOI 10.1016/j.ejmech.2016.07.050; Zhang WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116634; Zhao W, 2015, SCI REP-UK, V5, DOI 10.1038/srep17175; ZHOU JX, 2011, PLOS ONE, V6, DOI DOI 10.1371/JOURNAL.PONE.0018986	69	12	12	9	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0215886	10.1371/journal.pone.0215886	http://dx.doi.org/10.1371/journal.pone.0215886			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557166	gold, Green Published			2022-12-26	WOS:000532345500003
J	Moumi, NA; Das, B; Promi, ZT; Bristy, NA; Bayzid, MS				Moumi, Nazifa Ahmed; Das, Badhan; Promi, Zarin Tasnim; Bristy, Nishat Anjum; Bayzid, Md Shamsuzzoha			Quartet-based inference of cell differentiation trees from ChIP-Seq histone modification data	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; TRANSITIONS; EVOLUTION; H3K4ME3	Understanding cell differentiation-the process of generation of distinct cell-types-plays a pivotal role in developmental and evolutionary biology. Transcriptomic information and epigenetic marks are useful to elucidate hierarchical developmental relationships among cell-types. Standard phylogenetic approaches such as maximum parsimony, maximum likelihood and neighbor joining have previously been applied to ChIP-Seq histone modification data to infer cell-type trees, showing how diverse types of cells are related. In this study, we demonstrate the applicability and suitability of quartet-based phylogenetic tree estimation techniques for constructing cell-type trees. We propose two quartet-based pipelines for constructing cell phylogeny. Our methods were assessed for their validity in inferring hierarchical differentiation processes of various cell-types in H3K4me3, H3K27me3, H3K36me3, and H3K27ac histone mark data. We also propose a robust metric for evaluating cell-type trees.	[Moumi, Nazifa Ahmed; Das, Badhan; Promi, Zarin Tasnim; Bristy, Nishat Anjum; Bayzid, Md Shamsuzzoha] Bangladesh Univ Engn & Technol, Dept Comp Sci & Engn, Dhaka, Bangladesh	Bangladesh University of Engineering & Technology (BUET)	Bayzid, MS (corresponding author), Bangladesh Univ Engn & Technol, Dept Comp Sci & Engn, Dhaka, Bangladesh.	shams_bayzid@cse.buet.ac.bd		Das, Badhan/0000-0002-5327-9952	Information and Communication Technology Division (ICT Division), Government of the People's Republic of Bangladesh	Information and Communication Technology Division (ICT Division), Government of the People's Republic of Bangladesh	This work was partially supported by the Information and Communication Technology Division (ICT Division), Government of the People's Republic of Bangladesh.; We thank Rezwana Reaz for providing necessary scripts to set up the quartet-based pipelines using QFM. This work was partially supported by the Information and Communication Technology Division (ICT Division), Government of the People's Republic of Bangladesh.	Aberer AJ, 2013, SYST BIOL, V62, P162, DOI 10.1093/sysbio/sys078; Aberer AJ, 2011, IEEE INT C BIOINFORM, P118, DOI 10.1109/BIBM.2011.70; Allman ES, 2011, J MATH BIOL, V62, P833, DOI 10.1007/s00285-010-0355-7; Ane C, 2007, MOL BIOL EVOL, V24, P412; [Anonymous], 2009, BATCH EFFECTS NOISE; [Anonymous], 2011, PRINCIPAL COMPONENT; Arendt D, 2008, NAT REV GENET, V9, P868, DOI 10.1038/nrg2416; Avni E, 2015, SYST BIOL, V64, P233, DOI 10.1093/sysbio/syu087; Bayzid MS, 2013, BIOINFORMATICS, V29, P2277, DOI 10.1093/bioinformatics/btt394; Benayoun BA, 2014, CELL, V158, P673, DOI 10.1016/j.cell.2014.06.027; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bryder D, 2006, AM J PATHOL, V169, P338, DOI 10.2353/ajpath.2006.060312; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; DeGiorgio M, 2010, MOL BIOL EVOL, V27, P552, DOI 10.1093/molbev/msp250; Degnan JH, 2006, PLOS GENET, V2, P762, DOI 10.1371/journal.pgen.0020068; Degnan JH, 2013, SYST BIOL, V62, P574, DOI 10.1093/sysbio/syt023; Edwards SV, 2007, P NATL ACAD SCI USA, V104, P5936, DOI 10.1073/pnas.0607004104; Ferrari KJ, 2014, MOL CELL, V53, P49, DOI 10.1016/j.molcel.2013.10.030; Fishburn P. C., 1985, INTERVAL ORDERS INTE; Gifford CA, 2013, CELL, V153, P1149, DOI 10.1016/j.cell.2013.04.037; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Gu X, 2016, BRIEF BIOINFORM, V17, P249, DOI 10.1093/bib/bbv041; Hay ED, 1995, ACTA ANAT, V154, P8; Hofherr SE, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017076, 10.1371/journal.pone.0023376]; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kin K, 2015, J EXP ZOOL PART B, V324, P653, DOI 10.1002/jez.b.22657; Kin K, 2015, CELL REP, V10, P1398, DOI 10.1016/j.celrep.2015.01.062; Koyanagi KO, 2015, GENOME BIOL EVOL, V7, P699, DOI 10.1093/gbe/evv024; Kubatko LS, 2007, SYSTEMATIC BIOL, V56, P17, DOI 10.1080/10635150601146041; Leache AD, 2011, SYST BIOL, V60, P126, DOI 10.1093/sysbio/syq073; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Liu XY, 2016, NATURE, V537, P558, DOI 10.1038/nature19362; LOBE CG, 1992, CURR TOP DEV BIOL, V27, P351, DOI 10.1016/S0070-2153(08)60539-6; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Martin C, 2007, CURR OPIN CELL BIOL, V19, P266, DOI 10.1016/j.ceb.2007.04.002; Mirarab S, 2014, BIOINFORMATICS, V30, pI541, DOI 10.1093/bioinformatics/btu462; Mirarab S, 2014, SCIENCE, V346, P1337, DOI 10.1126/science.1250463; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Nair Nishanth Ulhas, 2013, Algorithms in Bioinformatics. 13th International Workshop, WABI 2013. Proceedings: LNCS 8126, P326, DOI 10.1007/978-3-642-40453-5_25; Nair NU, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2297-3; Nair NU, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-269; Okada H, 1997, AM J PHYSIOL-RENAL, V273, pF563, DOI 10.1152/ajprenal.1997.273.4.F563; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Reaz R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104008; Rivera CM, 2013, CELL, V155, P39, DOI 10.1016/j.cell.2013.09.011; Roch S, 2015, THEOR POPUL BIOL, V100, P56, DOI 10.1016/j.tpb.2014.12.005; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Sakai N, 2013, BBA-MOL BASIS DIS, V1832, P911, DOI 10.1016/j.bbadis.2013.03.001; Snir S, 2010, IEEE ACM T COMPUT BI, V7, P704, DOI 10.1109/TCBB.2008.133; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; STEEL M, 1992, J CLASSIF, V9, P91, DOI 10.1007/BF02618470; Suzuki S, 2017, TRANSCR-AUSTIN, V8, P26, DOI 10.1080/21541264.2016.1246076; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; Wilkinson M, 1996, MOL BIOL EVOL, V13, P437, DOI 10.1093/oxfordjournals.molbev.a025604; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng RB, 2019, NUCLEIC ACIDS RES, V47, pD729, DOI 10.1093/nar/gky1094	62	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0221270	10.1371/journal.pone.0221270	http://dx.doi.org/10.1371/journal.pone.0221270			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557185	gold, Green Published			2022-12-26	WOS:000532345500009
J	Munch, MM; Chambers, LC; Manhart, LE; Domogala, D; Lopez, A; Fredricks, DN; Srinivasan, S				Munch, Matthew M.; Chambers, Laura C.; Manhart, Lisa E.; Domogala, Dan; Lopez, Anthony; Fredricks, David N.; Srinivasan, Sujatha			Optimizing bacterial DNA extraction in urine	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS; CHAIN-REACTION; IDENTIFICATION; MICROBIOME; PCR; SPECIMENS; WOMEN	Urine is an acceptable, non-invasive sample for investigating the human urogenital microbiota and for the diagnosis of sexually transmitted infections. However, low quantities of bacterial DNA and PCR inhibitors in urine may prevent efficient PCR amplification for molecular detection of bacteria. Furthermore, cold temperatures used to preserve DNA and bacteria in urine can promote precipitation of crystals that interfere with DNA extraction. Saline, Dulbecco's Phosphate Buffered Saline, or Tris-EDTA buffer were added to urine from adult men to determine if crystal precipitation could be reversed without heating samples beyond ambient temperature. Total bacterial DNA concentrations and PCR inhibition were measured using quantitative PCR assays to compare DNA yields with and without buffer addition. Dissolution of crystals with Tris-EDTA prior to urine centrifugation was most effective in increasing bacterial DNA recovery and reducing PCR inhibition. DNA recovery using Tris-EDTA was further tested by spiking urine with DNA from bacterial isolates and median concentrations of Lactobacillus jensenii and Escherichia coli 16S rRNA gene copies were found to be higher in urine processed with Tris-EDTA. Maximizing bacterial DNA yield from urine may facilitate more accurate assessment of bacterial populations and increase detection of specific bacteria in the genital tract.	[Munch, Matthew M.; Domogala, Dan; Lopez, Anthony; Fredricks, David N.; Srinivasan, Sujatha] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Chambers, Laura C.; Manhart, Lisa E.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Manhart, Lisa E.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Fredricks, David N.] Univ Washington, Dept Med, Seattle, WA USA; [Fredricks, David N.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Srinivasan, S (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.	ssriniva@fredhutch.org			National Institute of Allergy and Infectious Diseases [U19 AI113173, R01 AI110666]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110666, U19AI113173] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by grants from the National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov/), U19 AI113173 to LEM and DNF and R01 AI110666 to LEM and DNF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy MG, 2017, OBSTET GYNECOL, V129, P500, DOI 10.1097/AOG.0000000000001892; Ackerman AL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210306; Alanee S, 2019, PROSTATE, V79, P81, DOI 10.1002/pros.23713; Apoola A, 2011, SEX TRANSM INFECT, V87, P110, DOI 10.1136/sti.2010.042861; BRUNZEL NA, 2018, FUNDAMENTALS URINE B; Chambers LC, 2019, SEX TRANSM INFECT, V95, P212, DOI 10.1136/sextrans-2018-053634; Chen ZR, 2018, INT UROGYNECOL J, V29, P1775, DOI 10.1007/s00192-018-3679-2; Daudon M, 2015, CLIN CHEM LAB MED, V53, pS1479, DOI 10.1515/cclm-2015-0860; Dong QF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019709; Fogazzi GB, 1996, NEPHROL DIAL TRANSPL, V11, P379, DOI 10.1093/oxfordjournals.ndt.a027276; Fok C, 2018, INT UROGYNECOL J, V29, P1765, DOI 10.1007/s00192-018-3732-1; Frolund M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201380; Gottschick C, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0305-3; Haber MH, 2002, CLIN LAB MED, P533; Hilt EE, 2014, J CLIN MICROBIOL, V52, P871, DOI 10.1128/JCM.02876-13; Horwitz D, 2015, J INFECTION, V71, P358, DOI 10.1016/j.jinf.2015.05.014; Karstens L, 2018, NAT REV UROL, V15, P735, DOI 10.1038/s41585-018-0104-z; Karstens L, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00078; KHAN G, 1991, J CLIN PATHOL, V44, P360, DOI 10.1136/jcp.44.5.360; Khot PD, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-73; Komesu Y, 2018, INT UROGYNECOL J, V29, P1785, DOI 10.1007/s00192-018-3683-6; Kramer H, 2018, INT UROL NEPHROL, V50, P1123, DOI 10.1007/s11255-018-1860-7; Lewis DA, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00041; Ling ZX, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01032; Liu FP, 2017, ONCOTARGET, V8, P100678, DOI 10.18632/oncotarget.21126; Liu FP, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00126; Mahony J, 1998, J CLIN MICROBIOL, V36, P3122, DOI 10.1128/JCM.36.11.3122-3126.1998; McKechnie ML, 2009, J CLIN MICROBIOL, V47, P1871, DOI 10.1128/JCM.00120-09; Meyer T, 2016, MICROORGANISMS, V4, DOI 10.3390/microorganisms4030025; Moustafa A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22660-8; Napierala M, 2015, DIAGN MICR INFEC DIS, V82, P194, DOI 10.1016/j.diagmicrobio.2015.03.016; Nelson DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014116; Nienhouse V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114185; Papp JR, 2014, MMWR RECOMM REP, V63, P1; Pearce MM, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.009; Popovic VB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29054-w; Price TK, 2016, J CLIN MICROBIOL, V54, P1216, DOI 10.1128/JCM.00044-16; Rani A, 2017, TRANSL RES, V181, P59, DOI 10.1016/j.trsl.2016.08.008; Saetun P, 2009, AM J PHYSIOL-RENAL, V296, pF1346, DOI 10.1152/ajprenal.90736.2008; Schmidt K, 2017, J ANTIMICROB CHEMOTH, V72, P104, DOI 10.1093/jac/dkw397; Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x; Shrestha E, 2018, J UROLOGY, V199, P161, DOI 10.1016/j.juro.2017.08.001; Siddiqui H, 2011, BMC MICROBIOL, V11, P1; Siddiqui H, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-205; Simerville JA, 2005, AM FAM PHYSICIAN, V71, P1153; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Srinivasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010197; Thomas-White K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03968-5; Thomas-White K, 2016, CURR BLADDER DYSFUNC, V11, P18, DOI 10.1007/s11884-016-0345-8; Thomas-White K, 2018, INT UROGYNECOL J, V29, P1797, DOI 10.1007/s00192-018-3767-3; Thomas-White KJ, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.07.049; Thomas-White KJ, 2016, INT UROGYNECOL J, V27, P723, DOI 10.1007/s00192-015-2847-x; Van Der Pol B, 2016, J CLIN MICROBIOL, V54, P7, DOI 10.1128/JCM.02025-15; Wang HN, 2017, ONCOTARGET, V8, P88122, DOI 10.18632/oncotarget.21490; Wolfe AJ, 2012, J CLIN MICROBIOL, V50, P1376, DOI 10.1128/JCM.05852-11; Wu JF, 2018, CLIN TRANSPLANT, V32, DOI 10.1111/ctr.13436; Wu P, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00167; Wu P, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00488	58	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222962	10.1371/journal.pone.0222962	http://dx.doi.org/10.1371/journal.pone.0222962			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550285	gold, Green Published			2022-12-26	WOS:000532307700037
J	Hardardottir, HM; Male, R; Nilsen, F; Dalvin, S				Hardardottir, Hulda Maria; Male, Rune; Nilsen, Frank; Dalvin, Sussie			Effects of chitin synthesis inhibitor treatment on Lepeophtheirus salmonis (Copepoda, Caligidae) larvae	PLOS ONE			English	Article							SEA LICE; MOLECULAR CHARACTERIZATION; 1 GENE; DIFLUBENZURON; GROWTH; TEFLUBENZURON; RESISTANCE; REGULATOR; INSECTICIDES; EXPRESSION	The salmon louse (Lepeophtheirus salmonis) is an ectoparasite infecting Atlantic salmon (Salmo salar), which causes substantial problems to the salmon aquaculture and threatens wild salmon. Chitin synthesis inhibitors (CSIs) are used to control L. salmonis in aquaculture. CSIs act by interfering with chitin formation and molting. In the present study, we investigated the action of four CSIs: diflubenzuron (DFB), hexaflumuron (HX), lufenuron (LF), and teflubenzuron (TFB) on larval molt. As the mode of action of CSIs remains unknown, we selected key enzymes in chitin metabolism and investigated if CSI treatment influenced the transcriptional level of these genes. All four CSIs interfered with the nauplius II molt to copepodids in a dose-dependent manner. The EC50 values were 93.2 nM for diflubenzuron, 1.2 nM for hexaflumuron, 22.4 nM for lufenuron, and 11.7 nM for teflubenzuron. Of the investigated genes, only the transcriptional level of L. salmonis chitin synthase 1 decreased significantly in hexaflumuron and diflubenzuron-treated larvae. All the tested CSIs affected the molt of nauplius II L. salmonis larvae but at different concentrations. The larvae were most sensitive to hexaflumuron and less sensitive to diflubenzuron. None of the CSIs applied had a strong impact on the transcriptional level of chitin synthesis or chitinases genes in L. salmonis. Further research is necessary to get more knowledge of the nature of the inhibition of CSI and may require methods such as studies of protein structure and enzymological studies.	[Hardardottir, Hulda Maria; Male, Rune; Nilsen, Frank; Dalvin, Sussie] Univ Bergen, Sea Lice Res Ctr, Dept Biol Sci, Bergen, Norway; [Dalvin, Sussie] Inst Marine Res, Sea Lice Res Ctr, Bergen, Norway	University of Bergen; Institute of Marine Research - Norway	Dalvin, S (corresponding author), Univ Bergen, Sea Lice Res Ctr, Dept Biol Sci, Bergen, Norway.; Dalvin, S (corresponding author), Inst Marine Res, Sea Lice Res Ctr, Bergen, Norway.	sussie.dalvin@hi.no	Dalvin, Sussie/AAL-6893-2021	Dalvin, Sussie/0000-0002-6092-4710	Research Council of Norway, SFI-Sea Lice Research Centre [203513/O30]	Research Council of Norway, SFI-Sea Lice Research Centre(Research Council of Norway)	This research was fully funded by the Research Council of Norway, SFI-Sea Lice Research Centre, grant number 203513/O30 to HMH, RM, FN, and SD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaen SM, 2016, J FISH DIS, V39, P1213, DOI 10.1111/jfd.12463; Aaen SM, 2015, TRENDS PARASITOL, V31, P72, DOI 10.1016/j.pt.2014.12.006; Abehsera S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122602; Al-Mokhlef A. A., 2012, Annals of Agricultural Science (Cairo), V57, P113, DOI 10.1016/j.aoas.2012.03.010; Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; BINNINGTON KC, 1985, TISSUE CELL, V17, P131, DOI 10.1016/0040-8166(85)90021-7; Branson EJ, 2000, AQUAC RES, V31, P861, DOI 10.1046/j.1365-2109.2000.00509.x; CHRISTIANSEN ME, 1982, MAR BIOL, V66, P217, DOI 10.1007/BF00397025; CHRISTIANSEN ME, 1978, MAR BIOL, V50, P29, DOI 10.1007/BF00390539; Coppen GDA, 1996, PESTIC SCI, V46, P183, DOI 10.1002/(SICI)1096-9063(199602)46:2&lt;183::AID-PS343&gt;3.0.CO;2-1; Costello MJ, 2009, J FISH DIS, V32, P115, DOI 10.1111/j.1365-2761.2008.01011.x; CUNNINGHAM PA, 1986, ENVIRON POLLUT A, V40, P63, DOI 10.1016/0143-1471(86)90058-9; Douris V, 2016, P NATL ACAD SCI USA, V113, P14692, DOI 10.1073/pnas.1618258113; Eichner C, 2015, EXP PARASITOL, V151, P39, DOI 10.1016/j.exppara.2015.01.011; Eichner C, 2014, EXP PARASITOL, V140, P44, DOI 10.1016/j.exppara.2014.03.014; Frost P, 2003, VET PARASITOL, V118, P169, DOI 10.1016/j.vetpar.2003.09.020; Gangishetti U, 2009, EUR J CELL BIOL, V88, P167, DOI 10.1016/j.ejcb.2008.09.002; GIJSWIJT MJ, 1979, PESTIC BIOCHEM PHYS, V12, P87, DOI 10.1016/0048-3575(79)90098-1; Hamre LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073539; Hamre LA, 2009, PARASITOL INT, V58, P451, DOI 10.1016/j.parint.2009.08.009; Hardardottir HM, 2019, COMP BIOCHEM PHYS A, V227, P123, DOI 10.1016/j.cbpa.2018.10.008; JULIN AM, 1978, MOSQ NEWS, V38, P256; Karimzadeh R, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.5001; Khajepour S, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.10201; Langford KH, 2011, ENV SCREENING VET ME; Li XG, 2015, COMP BIOCHEM PHYS B, V187, P110, DOI 10.1016/j.cbpb.2015.05.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macken A, 2015, ENVIRON TOXICOL CHEM, V34, P1533, DOI 10.1002/etc.2920; MAYER RT, 1981, EXPERIENTIA, V37, P337, DOI 10.1007/BF01959848; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Merzendorfer H, 2012, INSECT BIOCHEM MOLEC, V42, P264, DOI 10.1016/j.ibmb.2011.12.008; Mommaerts V, 2006, PEST MANAG SCI, V62, P752, DOI 10.1002/ps.1238; Muthukrishnan S, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P193, DOI 10.1016/B978-0-12-384747-8.10007-8; NIMMO DR, 1979, B ENVIRON CONTAM TOX, V22, P767, DOI 10.1007/BF02027022; Niu SW, 2018, DEV COMP IMMUNOL, V85, P161, DOI 10.1016/j.dci.2018.04.013; Norwegian Veterinary Institute, 2016, US THER AG SALM LIC, P6; Olsvik PA, 2015, AQUAT TOXICOL, V167, P143, DOI 10.1016/j.aquatox.2015.07.008; Perez-Farinos G, 1998, PESTIC BIOCHEM PHYS, V61, P169, DOI 10.1006/pest.1998.2356; Poley JD, 2018, INT J PARASITOL-DRUG, V8, P174, DOI 10.1016/j.ijpddr.2018.02.007; POST LC, 1974, PESTIC BIOCHEM PHYS, V4, P473, DOI 10.1016/0048-3575(74)90072-8; Ritchie G, 2002, DIS AQUAT ORGAN, V51, P101, DOI 10.3354/dao051101; Saidy EL, 1989, PESTIC BIOCH PHYSL, V222, P211, DOI [10.1673/031.012.10201, DOI 10.1673/031.012.10201]; Sandlund L, 2016, MOL BIOCHEM PARASIT, V208, P65, DOI 10.1016/j.molbiopara.2016.06.007; SAVITZ JD, 1994, MAR ENVIRON RES, V37, P297, DOI 10.1016/0141-1136(94)90056-6; Skilbrei OT, 2015, DIS AQUAT ORGAN, V113, P187, DOI 10.3354/dao02832; Sun RF, 2015, J AGR FOOD CHEM, V63, P6847, DOI 10.1021/acs.jafc.5b02460; Suzuki Y, 2017, J PESTIC SCI, V42, P93, DOI 10.1584/jpestics.D17-023; Tan SH, 2000, MAR BIOTECHNOL, V2, P126; Tom M, 2014, J EXP BIOL, V217, P4193, DOI 10.1242/jeb.109009; Van Leeuwen T, 2012, P NATL ACAD SCI USA, V109, P4407, DOI 10.1073/pnas.1200068109; VANECK WH, 1979, INSECT BIOCHEM, V9, P295, DOI 10.1016/0020-1790(79)90009-X; WEIS JS, 1987, AQUAT TOXICOL, V10, P279, DOI 10.1016/0166-445X(87)90003-8; Xia WK, 2014, INT J MOL SCI, V15, P3711, DOI 10.3390/ijms15033711; Zhang JZ, 2006, INSECT BIOCHEM MOLEC, V36, P712, DOI 10.1016/j.ibmb.2006.06.002; Zhang X, 2013, INSECT SCI, V20, P158, DOI 10.1111/j.1744-7917.2012.01568.x	55	3	3	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222520	10.1371/journal.pone.0222520	http://dx.doi.org/10.1371/journal.pone.0222520			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545833	Green Published, gold			2022-12-26	WOS:000532303200019
J	Potashkin, JA; Bottero, V; Santiago, JA; Quinn, JP				Potashkin, Judith A.; Bottero, Virginie; Santiago, Jose A.; Quinn, James P.			Computational identification of key genes that may regulate gene expression reprogramming in Alzheimer's patients	PLOS ONE			English	Article							ENTORHINAL CORTEX; COGNITIVE IMPAIRMENT; SENILE PLAQUES; DISEASE; ATROPHY; HIPPOCAMPAL; BRAIN; MORPHOLOGY; DIAGNOSIS; PATHOLOGY	The dementia epidemic is likely to expand worldwide as the aging population continues to grow. A better understanding of the molecular mechanisms that lead to dementia is expected to reveal potentially modifiable risk factors that could contribute to the development of prevention strategies. Alzheimer's disease is the most prevalent form of dementia. Currently we only partially understand some of the pathophysiological mechanisms that lead to development of the disease in aging individuals. In this study, Switch Miner software was used to identify key switch genes in the brain whose expression may lead to the development of Alzheimer's disease. The results indicate that switch genes are enriched in pathways involved in the proteasome, oxidative phosphorylation, Parkinson's disease, Huntington's disease, Alzheimer's disease and metabolism in the hippocampus and posterior cingulate cortex. Network analysis identified the krupel like factor 9 (KLF9), potassium channel tetramerization domain 2 (KCTD2), Sp1 transcription factor (SP1) and chromodomain helicase DNA binding protein 1 (CHD1) as key transcriptional regulators of switch genes in the brain of AD patients. These transcriptions factors have been implicated in conditions associated with Alzheimer's disease, including diabetes, glucocorticoid signaling, stroke, and sleep disorders. The specific pathways affected reveal potential modifiable risk factors by lifestyle changes.	[Potashkin, Judith A.; Bottero, Virginie] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Cellular & Mol Pharmacol Dept, N Chicago, IL 60064 USA; [Santiago, Jose A.] NeuroHub Analyt LLC, Chicago, IL USA; [Quinn, James P.] Q Regulating Syst LLC, Gurnee, IL USA	Chicago Medical School; Rosalind Franklin University Medical & Science	Potashkin, JA (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Cellular & Mol Pharmacol Dept, N Chicago, IL 60064 USA.	judy.potashkin@rosalindfranklin.edu	Santiago, Jose A./CAJ-2999-2022	Santiago, Jose A./0000-0002-1431-5789; Potashkin, Judith/0000-0002-8782-3071	National Institute on Aging (NIA) [R01AG062176]; NATIONAL INSTITUTE ON AGING [R01AG062176] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	J.A.P. received funding from National Institute on Aging (NIA) (https://www.nia.nih.gov/) grant number R01AG062176. The NIA had not role in the design, data collection and analysis, decision to publish or preparation of this manuscript. NeuroHub Analytics, LLC. and Q Regulating Systems, LLC provided support in the form of salaries for authors J.P.Q. and J.A.S., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.; This study was funded by the National Institute on Aging (NIA) grant number R01AG062176 to JAP. The NIA had no role in the design, data collection and analysis, decision to publish or preparation of this manuscript.	Angelie E, 2001, AM J NEURORADIOL, V22, P119; BEACH TG, 1989, GLIA, V2, P420, DOI 10.1002/glia.440020605; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berson A, 2017, CURR BIOL, V27, P3579, DOI 10.1016/j.cub.2017.10.024; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Boada M, 2014, MOL PSYCHIATR, V19, P682, DOI 10.1038/mp.2013.86; Bobinski M, 1999, LANCET, V353, P38, DOI 10.1016/S0140-6736(05)74869-8; BOURAS C, 1994, CEREB CORTEX, V4, P138, DOI 10.1093/cercor/4.2.138; BRAAK H, 1992, NEUROSCI RES, V15, P6, DOI 10.1016/0168-0102(92)90014-4; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Caberlotto L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078919; Canet G, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00739; Citron BA, 2008, J NEUROSCI RES, V86, P2499, DOI 10.1002/jnr.21695; Citron Bruce A, 2015, Am J Neurodegener Dis, V4, P40; Cui AF, 2019, J CLIN INVEST, V129, P2266, DOI 10.1172/JCI66062; DAVIES L, 1988, NEUROLOGY, V38, P1688, DOI 10.1212/WNL.38.11.1688; de la Monte Suzanne M, 2008, J Diabetes Sci Technol, V2, P1101; DELEON MJ, 1989, LANCET, V2, P672; Dennis G, 2003, GENOME BIOL, V4; Du AT, 2003, NEUROLOGY, V60, P481, DOI 10.1212/01.WNL.0000044400.11317.EC; Fiscon G, 2018, GENES-BASEL, V9, DOI 10.3390/genes9090437; Fiscon G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26081-5; Fox NC, 1996, ANN NY ACAD SCI, V777, P226, DOI 10.1111/j.1749-6632.1996.tb34423.x; Frisoni GB, 1999, NEUROLOGY, V52, P91, DOI 10.1212/WNL.52.1.91; Green CD, 2017, CELL REP, V18, P2957, DOI 10.1016/j.celrep.2017.03.001; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; Ibanez V, 1998, NEUROLOGY, V50, P1585, DOI 10.1212/WNL.50.6.1585; Jack CR, 1998, NEUROLOGY, V51, P993, DOI 10.1212/WNL.51.4.993; Ju YES, 2014, NAT REV NEUROL, V10, P115, DOI 10.1038/nrneurol.2013.269; Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248; Liang WS, 2008, PHYSIOL GENOMICS, V33, P240, DOI 10.1152/physiolgenomics.00242.2007; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Liang WS, 2007, PHYSIOL GENOMICS, V28, P311, DOI 10.1152/physiolgenomics.00208.2006; MAPES J, 2017, PLOS GENET, V13, DOI DOI 10.1371/JOURNAL.PGEN.1006815; Metsaars WP, 2003, NEUROBIOL AGING, V24, P563, DOI 10.1016/S0197-4580(02)00134-3; MIELKE R, 1994, DEMENTIA, V5, P36, DOI 10.1159/000106692; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Morris JC, 2001, J MOL NEUROSCI, V17, P101, DOI 10.1385/JMN:17:2:101; Ouanes S, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00043; Paci P, 2017, SCI REP-UK, V7, DOI 10.1038/srep44797; Palumbo MC, 2014, PLANT CELL, V26, P4617, DOI 10.1105/tpc.114.133710; Patterson C, 2018, STATE ART DEMENTIA R; Pirone L, 2016, BIOCHIMIE, V131, P106, DOI 10.1016/j.biochi.2016.09.013; PRICE JL, 1991, NEUROBIOL AGING, V12, P295, DOI 10.1016/0197-4580(91)90006-6; Rajan KB, 2015, NEUROLOGY, V85, P898, DOI 10.1212/WNL.0000000000001774; Reiman EM, 2005, P NATL ACAD SCI USA, V102, P8299, DOI 10.1073/pnas.0500579102; ROGERS J, 1985, J NEUROSCI, V5, P2801; Schoberleitner I, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00003; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797; Traylor M, 2016, ANN NEUROL, V79, P739, DOI 10.1002/ana.24621; Xia JG, 2015, NAT PROTOC, V10, P823, DOI 10.1038/nprot.2015.052	54	15	15	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222921	10.1371/journal.pone.0222921	http://dx.doi.org/10.1371/journal.pone.0222921			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545826	gold, Green Published			2022-12-26	WOS:000532303200041
J	Lawrence, DW; Shornick, LP; Kornbluth, J				Lawrence, Donald W.; Shornick, Laurie P.; Kornbluth, Jacki			Mice deficient in NKLAM have attenuated inflammatory cytokine production in a Sendai virus pneumonia model	PLOS ONE			English	Article							NF-KAPPA-B; UBIQUITIN LIGASE NKLAM; LYTIC-ASSOCIATED MOLECULE; STAT1; AUTOPHAGY; INVOLVEMENT; ACTIVATION; EXPRESSION; P65	Recent studies have begun to elucidate a role for E3 ubiquitin ligases as important mediators of the innate immune response. Our previous work defined a role for the ubiquitin ligase natural killer lytic-associated molecule (NKLAM/RNF19b) in mouse and human innate immunity. Here, we present novel data describing a role for NKLAM in regulating the immune response to Sendai virus (SeV), a murine model of paramyxoviral pneumonia. NKLAM expression was significantly upregulated by SeV infection. SeV-infected mice that are deficient in NKLAM demonstrated significantly less weight loss than wild type mice. In vivo, Sendai virus replication was attenuated in NKLAM(-/-) mice. Autophagic flux and the expression of autophagy markers LC3 and p62/SQSTM1 were also less in NKLAM(-/-) mice. Using flow cytometry, we observed less neutrophils and macrophages in the lungs of NKLAM(-/-) mice during SeV infection. Additionally, phosphorylation of STAT1 and NF kappa B p65 was lower in NKLAM(-/-) than wild type mice. The dysregulated phosphorylation profile of STAT1 and NF kappa B in NKLAM(-/-) mice correlated with decreased expression of numerous proinflammatory cytokines that are regulated by STAT1 and/or NF kappa B. The lack of NKLAM and the resulting attenuated immune response is favorable to NKLAM(-/-) mice receiving a low dose of SeV; however, at a high dose of virus, NKLAM(-/-) mice succumbed to the infection faster than wild type mice. In conclusion, our novel results indicate that NKLAM plays a role in regulating the production of pro-inflammatory cytokines during viral infection.	[Lawrence, Donald W.; Kornbluth, Jacki] St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA; [Shornick, Laurie P.] St Louis Univ, Dept Biol, St Louis, MO 63104 USA; [Shornick, Laurie P.; Kornbluth, Jacki] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA; [Kornbluth, Jacki] Vet Affairs St Louis Hlth Care Syst, St Louis, MO 63106 USA	Saint Louis University; Saint Louis University; Saint Louis University	Kornbluth, J (corresponding author), St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA.; Kornbluth, J (corresponding author), St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA.; Kornbluth, J (corresponding author), Vet Affairs St Louis Hlth Care Syst, St Louis, MO 63106 USA.	jacki.kornbluth@health.slu.edu		Lawrence, Donald/0000-0001-5912-6992	VA Merit Award from the U.S. Department of Veterans Affairs, Biomedical Laboratory Research and Development Service [1 IO1BX000705]; Veterans Affairs [I01BX000705] Funding Source: NIH RePORTER	VA Merit Award from the U.S. Department of Veterans Affairs, Biomedical Laboratory Research and Development Service(US Department of Veterans Affairs); Veterans Affairs(US Department of Veterans Affairs)	These studies were supported by a VA Merit Award (1 IO1BX000705) to J.K. from the U.S. Department of Veterans Affairs, Biomedical Laboratory Research and Development Service. The contents do not represent the views of the U.S. Department of Veterans Affairs or the U.S. Government. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. There was no additional funding received for this study.	Bharaj P, 2017, J VIROL, V91, DOI [10.1128/JVI.00833-17, 10.1128/jvi.00833-17]; Bhattacharya S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-549; Burke SJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE131, DOI 10.1152/ajpendo.00347.2013; De Filippo K, 2008, J IMMUNOL, V180, P4308, DOI 10.4049/jimmunol.180.6.4308; de Leseleuc L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002015; Delpeut S, 2012, J VIROL, V86, P8527, DOI 10.1128/JVI.00807-12; DUNN SM, 1994, BLOOD, V83, P2469, DOI 10.1182/blood.V83.9.2469.2469; Fink K, 2008, J IMMUNOL, V180, P6911, DOI 10.4049/jimmunol.180.10.6911; HIMES SR, 1993, ONCOGENE, V8, P3189; Hoover RG, 2009, J IMMUNOL, V183, P6913, DOI 10.4049/jimmunol.0901679; Hou L, 2017, AUTOPHAGY, V13, P1709, DOI 10.1080/15548627.2017.1356950; Hsieh YY, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-59; Kamperschroer C, 2002, J IMMUNOL, V169, P340, DOI 10.4049/jimmunol.169.1.340; Kim MO, 2004, J NEUROCHEM, V90, P297, DOI 10.1111/j.1471-4159.2004.02487.x; Kozlowski M, 1999, J IMMUNOL, V163, P1775; Ladner CL, 2004, ANAL BIOCHEM, V326, P13, DOI 10.1016/j.ab.2003.10.047; Lawrence DW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194202; Lawrence DW, 2016, CELL SIGNAL, V28, P1833, DOI 10.1016/j.cellsig.2016.08.014; Lawrence DW, 2015, IMMUNOBIOLOGY, V220, P83, DOI 10.1016/j.imbio.2014.08.016; Lawrence DW, 2012, CELL IMMUNOL, V279, P46, DOI 10.1016/j.cellimm.2012.09.004; Letsiou E, 2017, TRANSL RES, V181, P71, DOI 10.1016/j.trsl.2016.09.002; Li M, 2018, J VIROL, V92, DOI 10.1128/JVI.02193-17; Liu Q, 2016, CELL MOL IMMUNOL, V13, P3, DOI 10.1038/cmi.2015.74; Livingstone M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133482; Newton AH, 2016, SEMIN IMMUNOPATHOL, V38, P471, DOI 10.1007/s00281-016-0558-0; Saraiva M, 2005, J IMMUNOL, V175, P1041, DOI 10.4049/jimmunol.175.2.1041; Satoh JI, 2013, GENE REGUL SYST BIO, V7, P41, DOI 10.4137/GRSB.S11433; Schanton M, 2018, REPRODUCTION, V155, pR1, DOI 10.1530/REP-17-0512; Shornick LP, 2008, J IMMUNOL, V180, P3319, DOI 10.4049/jimmunol.180.5.3319; Subramanian G, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006877; Suto H, 2009, INT IMMUNOL, V21, P467, DOI 10.1093/intimm/dxp014; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Vadlamudi RK, 1998, FEBS LETT, V435, P138, DOI 10.1016/S0014-5793(98)01021-7; Vestergaard C, 2005, CYTOKINE, V29, P49, DOI 10.1016/j.cyto.2004.09.008; Wang YT, 2014, J IMMUNOL, V192, P1855, DOI 10.4049/jimmunol.1302552; Wang YP, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00206; Weng CM, 2018, BIOCHEM PHARMACOL, V151, P1, DOI 10.1016/j.bcp.2018.02.028; Wickremasinghe MI, 2004, J BIOL CHEM, V279, P27199, DOI 10.1074/jbc.M403107200; Wu CL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02073-3; Xia M, 2014, J VIROL, V88, P5152, DOI 10.1128/JVI.03851-13; Xin D, 2018, J BIOL CHEM, V293, P11996, DOI 10.1074/jbc.RA117.001201; Yang Y, 2016, INT J CLIN EXP MED, V9, P7986; Yeruva S, 2008, INT J COLORECTAL DIS, V23, P305, DOI 10.1007/s00384-007-0396-6; You Yingjian, 2013, Methods Mol Biol, V945, P123, DOI 10.1007/978-1-62703-125-7_9	44	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222802	10.1371/journal.pone.0222802	http://dx.doi.org/10.1371/journal.pone.0222802			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539400	Green Submitted, gold, Green Published			2022-12-26	WOS:000532297900029
J	Lietz, AP; Weaver, DT; Melamed, A; Rauh-Hain, JA; Wright, JD; Wright, AA; Knudsen, AB; Pandharipande, PV				Lietz, Anna P.; Weaver, Davis T.; Melamed, Alexander; Rauh-Hain, Jose Alejandro; Wright, Jason D.; Wright, Alexi A.; Knudsen, Amy B.; Pandharipande, Pari, V			Potential survival benefits from optimized chemotherapy implementation in advanced ovarian cancer: Projections from a microsimulation model	PLOS ONE			English	Article							HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; NEOADJUVANT CHEMOTHERAPY; EPITHELIAL OVARIAN; PRIMARY SURGERY; OPEN-LABEL; BEVACIZUMAB; PACLITAXEL; CARBOPLATIN; CISPLATIN; TRIAL	Background Ovarian cancer is often diagnosed in advanced stages, when survival is poor. Treatment advances have been made, but are inconsistently implemented. Our purpose was to project the maximum life expectancy gains that could be achieved in women with stage IIIC epithelial ovarian cancer if the implementation of available chemotherapy regimens could be optimized. Methods We used a microsimulation model to estimate life expectancy benefits associated with "optimized" implementation of four post-operative chemotherapy options: standard intravenous chemotherapy; intraperitoneal + intravenous chemotherapy; bevacizumab + intravenous chemotherapy; and hyperthermic intraperitoneal chemotherapy + intravenous chemotherapy. Optimized implementation was defined as follows. Patients triaged to primary cytoreductive surgery received intraperitoneal + intravenous chemotherapy if optimally or completely cytoreduced, and bevacizumab + intravenous chemotherapy if suboptimally cytoreduced. Patients triaged to neoadjuvant chemotherapy received hyperthermic intraperitoneal chemotherapy at interval cytoreductive surgery if optimally or completely cytoreduced, and standard IV chemotherapy if suboptimally cytoreduced. Life expectancy associated with optimized implementation was compared with that of current utilization practices, estimated using published literature and the National Cancer Database. Effects of model uncertainty were evaluated in sensitivity analyses. Results Life expectancy associated with optimized implementation vs. current practice was 76.7 vs. 64.5 months (life expectancy gain = 12.2 months). Providing intraperitoneal + intravenous chemotherapy to all eligible patients was the largest driver of life expectancy gains, due to both the potential benefit conferred by intraperitoneal + intravenous chemotherapy and the proportion of eligible women who do not receive intraperitoneal + intravenous chemotherapy in current practice. Conclusion Population-level life expectancy in stage IIIC epithelial ovarian cancer could be substantially improved through greater uptake of available chemotherapy regimens.	[Lietz, Anna P.; Weaver, Davis T.; Knudsen, Amy B.; Pandharipande, Pari, V] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA; [Melamed, Alexander] Massachusetts Gen Hosp, Div Gynecol Oncol, Vincent Obstet & Gynecol, Boston, MA 02114 USA; [Rauh-Hain, Jose Alejandro] Univ Texas MD Anderson Canc Ctr, Gynecol Oncol & Reprod Med Dept, Houston, TX 77030 USA; [Wright, Jason D.] Columbia Univ Coll Phys & Surg, Dept Obstet & Gynecol, Div Gynecol Oncol, New York, NY 10032 USA; [Wright, Alexi A.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Wright, Alexi A.; Knudsen, Amy B.; Pandharipande, Pari, V] Harvard Med Sch, Boston, MA 02115 USA; [Weaver, Davis T.] Case Western Reserve Univ, Sch Med, Cleveland, OH USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Texas System; UTMD Anderson Cancer Center; Columbia University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Case Western Reserve University	Pandharipande, PV (corresponding author), Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA.; Pandharipande, PV (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	ppandharipande@mgh.harvard.edu		Weaver, Davis/0000-0003-3086-497X				Alberts DS, 1996, NEW ENGL J MED, V335, P1950, DOI 10.1056/NEJM199612263352603; American Cancer Society, 2019, CANC FACTS FIG 2015; American Cancer Society, OV CANC STAG 2018; American Cancer Society, SURV RAT OV CANC STA; Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Bilimoria KY, 2008, ANN SURG ONCOL, V15, P683, DOI 10.1245/s10434-007-9747-3; Bookman MA, 2009, J CLIN ONCOL, V27, P1419, DOI 10.1200/JCO.2008.19.1684; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Chan JK, 2016, NEW ENGL J MED, V374, P738, DOI 10.1056/NEJMoa1505067; Clamp AR, 2017, ANN ONCOL, V28; Coleman RL, 2013, NAT REV CLIN ONCOL, V10, P211, DOI 10.1038/nrclinonc.2013.5; Frey Melissa K, 2017, Gynecol Oncol Res Pract, V4, P4, DOI 10.1186/s40661-017-0039-8; Katsumata N, 2013, LANCET ONCOL, V14, P1020, DOI 10.1016/S1470-2045(13)70363-2; Katsumata N, 2009, LANCET, V374, P1331, DOI 10.1016/S0140-6736(09)61157-0; Kehoe S, 2015, LANCET, V386, P249, DOI 10.1016/S0140-6736(14)62223-6; McLaughlin JR, 2013, JNCI-J NATL CANCER I, V105, P141, DOI 10.1093/jnci/djs494; Melamed A, 2016, GYNECOL ONCOL, V143, P236, DOI 10.1016/j.ygyno.2016.09.002; Moore K, 2018, NEW ENGL J MED, V379, P2495, DOI 10.1056/NEJMoa1810858; MURPHY AG, 2019, J CLIN ONCOL, V37, DOI DOI 10.1200/JCO.18.01568; Oza AM, 2015, LANCET ONCOL, V16, P928, DOI 10.1016/S1470-2045(15)00086-8; Passot G, 2014, EJSO-EUR J SURG ONC, V40, P529, DOI 10.1016/j.ejso.2013.11.019; Perren TJ, 2011, NEW ENGL J MED, V365, P2484, DOI 10.1056/NEJMoa1103799; Schlappe BA, 2016, GYNECOL ONCOL, V142, P13, DOI 10.1016/j.ygyno.2016.05.015; Siegel RL, 2018, CA-CANCER J CLIN, V68, P30; van Driel WJ, 2018, NEW ENGL J MED, V378, P230, DOI 10.1056/NEJMoa1708618; Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806; Weaver DT, 2018, GYNECOL ONCOL, V149, P256, DOI 10.1016/j.ygyno.2018.02.007; Wright AA, 2016, GYNECOL ONCOL, V143, P3, DOI 10.1016/j.ygyno.2016.05.022; Wright AA, 2015, J CLIN ONCOL, V33, P2841, DOI 10.1200/JCO.2015.61.4776; Wright JD, 2016, OBSTET GYNECOL, V127, P985, DOI 10.1097/AOG.0000000000001436; Wu YS, 2017, ONCOTARGET, V8, P10703, DOI 10.18632/oncotarget.12926	31	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222828	10.1371/journal.pone.0222828	http://dx.doi.org/10.1371/journal.pone.0222828			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539415	Green Published, gold			2022-12-26	WOS:000532297900034
J	Park, M; Lee, SM; Yoon, HJ				Park, Minseon; Lee, Seung Min; Yoon, Hyung-Jin			Association between alcohol intake and measures of incident CKD: An analysis of nationwide health screening data	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; DRINKING PATTERN; POSTMENOPAUSAL WOMEN; INSULIN SENSITIVITY; RISK-FACTORS; FOLLOW-UP; CONSUMPTION; ALBUMINURIA; POPULATION	To evaluate the association between alcohol intake and incident chronic kidney disease measures as well as the sex differences in this association, we analyzed health screening data of 14,190,878 adults who underwent health screening >= 3 times and had glomerular filtration rate (eGFR) >= 60 mL/min/1.73 m(2) and normal proteinuria at baseline. eGFR was calculated with the Chronic Kidney Disease Epidemiology Collaboration equation. Proteinuria was defined as >= 1+ dipstick proteinuria and low eGFR as <60 mL/min/1.73 m(2). The risk of incident proteinuria and low eGFR was analyzed with an extended Cox model with alcohol intake level as a time-varying determinant and the annual change of eGFR with generalized linear model. A J-shape association of alcohol intake with the incident proteinuria was observed in men (adjusted hazard ratio [aHR], 0.961, 95% confidence interval [CI], 0.953-0.970 in men drinking alcohol <10 g/day; aHR 1.139, 95% CI, 1.123-1.154 in men drinking alcohol >= 40 g/day, compared with non-drinking men), and a positive association was seen in women (aHR, 1.034, 95% CI, 1.023-1.044 in women drinking alcohol <10 g/day; aHR, 1.094, 95% CI, 1.034-1.158 in women drinking alcohol >= 40 g/day, compared with non-drinking women). In both sexes, an inverse association of alcohol intake with the annual eGFR decline and incident low eGFR was observed. This study observed a beneficial effect of moderate alcohol intake on incident proteinuria in men and a protective effect of alcohol intake of any amount on the annual eGFR decline and incident low eGFR in both sexes. The long-term implications of these observations need to be elucidated with future studies.	[Park, Minseon] Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea; [Lee, Seung Min; Yoon, Hyung-Jin] Seoul Natl Univ, Dept Biomed Engn, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Yoon, HJ (corresponding author), Seoul Natl Univ, Dept Biomed Engn, Coll Med, Seoul, South Korea.	hjyoon@snu.ac.kr		Lee, SeungMin/0000-0001-5762-2618; Yoon, Hyung-Jin/0000-0003-4432-4894	MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center) support program [IITP-2019-2018-0-01833]	MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center) support program	This research was supported by the MSIT (Ministry of Science and ICT), Korea, under the ITRC (Information Technology Research Center) support program (IITP-2019-2018-0-01833) supervised by the IITP (Institute for Information & Communications Technology Promotion).	Brien SE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d636; Burchfiel CM, 1997, ARTERIOSCL THROM VAS, V17, P760, DOI 10.1161/01.ATV.17.4.760; Chen N, 2010, NEPHROLOGY, V15, P31, DOI 10.1111/j.1440-1797.2010.01309.x; Colafella KMM, 2018, NAT REV NEPHROL, V14, P185, DOI 10.1038/nrneph.2017.189; Davies MJ, 2002, JAMA-J AM MED ASSOC, V287, P2559, DOI 10.1001/jama.287.19.2559; HOJNACKI JL, 1991, ATHEROSCLEROSIS, V88, P49, DOI 10.1016/0021-9150(91)90256-3; Hsu YH, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-254; Joosten MM, 2008, DIABETOLOGIA, V51, P1375, DOI 10.1007/s00125-008-1031-y; Kaartinen K, 2009, NEPHRON CLIN PRACT, V112, pC86, DOI 10.1159/000213086; Koning SH, 2015, KIDNEY INT, V87, P1009, DOI 10.1038/ki.2014.414; Kronborg J, 2008, NEPHROL DIAL TRANSPL, V23, P2818, DOI 10.1093/ndt/gfn148; Matsumoto A, 2017, HYPERTENS RES, V40, P771, DOI 10.1038/hr.2017.25; Matsushita K, 2015, LANCET DIABETES ENDO, V3, P514, DOI 10.1016/S2213-8587(15)00040-6; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; McCarthy ET, 2015, PROSTAG OTH LIPID M, V116, P88, DOI 10.1016/j.prostaglandins.2014.10.006; McFadden CB, 2005, AM J HYPERTENS, V18, P276, DOI 10.1016/j.amjhyper.2004.07.020; METCALF PA, 1993, CLIN CHEM, V39, P1793; Nair S, 2014, DIABETES CARE, V37, P483, DOI 10.2337/dc13-1770; Park JT, 2008, J KOREAN MED SCI, V23, P199, DOI 10.3346/jkms.2008.23.2.199; Park M, 2015, J AM SOC NEPHROL, V26, P1426, DOI 10.1681/ASN.2014010115; Reynolds K, 2008, KIDNEY INT, V73, P870, DOI 10.1038/sj.ki.5002774; Robles NR, 2013, INT UROL NEPHROL, V45, P553, DOI 10.1007/s11255-013-0380-8; Roerecke M, 2017, LANCET PUBLIC HEALTH, V2, pE108, DOI 10.1016/S2468-2667(17)30003-8; Room R, 2005, LANCET, V365, P519, DOI 10.1016/S0140-6736(05)70276-2; Sato KK, 2014, AM J NEPHROL, V40, P516, DOI 10.1159/000370051; Schaeffner ES, 2005, ARCH INTERN MED, V165, P1048, DOI 10.1001/archinte.165.9.1048; Seong SC, 2017, INT J EPIDEMIOL, V46, P799, DOI 10.1093/ije/dyw253; Shankar A, 2006, AM J EPIDEMIOL, V164, P263, DOI 10.1093/aje/kwj173; Uehara S, 2016, J EPIDEMIOL, V26, P464, DOI 10.2188/jea.JE20150158; Vatsalya Vatsalya, 2016, Curr Drug Abuse Rev, V9, P87, DOI 10.2174/1874473710666170125151410; Webster AC, 2017, LANCET, V389, P1238, DOI 10.1016/S0140-6736(16)32064-5; White SL, 2009, NEPHROL DIAL TRANSPL, V24, P2464, DOI 10.1093/ndt/gfp114; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Zakhari S, 1997, ALCOHOL HEALTH RES W, V21, P21	34	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222123	10.1371/journal.pone.0222123	http://dx.doi.org/10.1371/journal.pone.0222123			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539384	gold, Green Published, Green Submitted			2022-12-26	WOS:000532297900008
J	Stara, J; Kocourek, F				Stara, Jitka; Kocourek, Frantisek			Cabbage stem flea beetle's (Psylliodes chrysocephala L.) susceptibility to pyrethroids and tolerance to thiacloprid in the Czech Republic	PLOS ONE			English	Article							COLORADO POTATO BEETLE; BASE-LINE SUSCEPTIBILITY; CROSS-RESISTANCE; NEONICOTINOID INSECTICIDES; COLEOPTERA NITIDULIDAE; BROWN PLANTHOPPER; MELIGETHES-AENEUS; OILSEED RAPE; HEMIPTERA; POPULATIONS	The cabbage stem flea beetle (CSFB), Psylliodes chrysocephala (Coleoptera: Chrysomelidae), has recently become a major pest species in winter oilseed rape in the Czech Republic. The susceptibility of CSFB populations from two localities to six pyrethroids, two neonicotinoids, one organophosphate and one oxadiazine was evaluated in 2015-2018 in glass vial experiments. The susceptibility of CSFB to thiacloprid and thiamethoxam was evaluated in feeding experiment in 2017 and 2018. High susceptibility of CSFB populations to lambda-cyhalothrin, cypermethrin, esfenvalerate, tau-fluvalinate, etofenprox, deltamethrin, chlorpyrifos, indoxacarb and acetamiprid was observed in the glass vial experiments. The LC50 and LC90 data obtained for pyrethroids in these experiments in 2015 represent baseline for CSFB resistance monitoring to pyrethroids in the Czech Republic. High tolerance of CSFB to thiacloprid of CSFB was demonstrated in glass vial and the feeding experiment, too.	[Stara, Jitka; Kocourek, Frantisek] Crop Res Inst, Dept Integrated Crop Protect Insect Pests, Div Crop Protect & Plant Hlth, Prague, Czech Republic	Czech Crop Research Institute (CRI)	Stara, J (corresponding author), Crop Res Inst, Dept Integrated Crop Protect Insect Pests, Div Crop Protect & Plant Hlth, Prague, Czech Republic.	stara@vurv.cz	Kocourek, František/AAZ-1566-2021		ministry of Agriculture of the Czech Republic [MZE-RO0418, NAZV QK 1820081]	ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	The work was financially supported through a grant from the projects MZE-RO0418 and NAZV QK 1820081 of the ministry of Agriculture of the Czech Republic.	Charaabi K, 2018, PEST MANAG SCI, V74, P1297, DOI 10.1002/ps.4833; Denholm I., 2002, P BRIGHT CROP PROT C, P161; Dewar AM, 2017, PEST MANAG SCI, V73, P1305, DOI 10.1002/ps.4511; Eickermann M, 2011, J PLANT DIS PROTECT, V118, P134, DOI 10.1007/BF03356393; Elbert A, 2000, PEST MANAG SCI, V56, P60, DOI 10.1002/(SICI)1526-4998(200001)56:1<60::AID-PS88>3.0.CO;2-K; Foster SP, 2003, PEST MANAG SCI, V59, P166, DOI 10.1002/ps.570; Gorman K, 2007, PEST MANAG SCI, V63, P555, DOI 10.1002/ps.1364; Gorman K, 2010, PEST MANAG SCI, V66, P1186, DOI 10.1002/ps.1989; Heimbach U, 2013, PEST MANAG SCI, V69, P209, DOI 10.1002/ps.3351; Hojland DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146045; Jones CM, 2011, PESTIC BIOCHEM PHYS, V101, P53, DOI 10.1016/j.pestbp.2011.07.004; Liu ZW, 2006, J NEUROCHEM, V99, P1273, DOI 10.1111/j.1471-4159.2006.04167.x; Manjon C, 2018, CURR BIOL, V28, P1137, DOI 10.1016/j.cub.2018.02.045; Mota-Sanchez D, 2006, PEST MANAG SCI, V62, P30, DOI 10.1002/ps.1120; Nauen R, 2005, ARCH INSECT BIOCHEM, V58, P200, DOI 10.1002/arch.20043; Olson ER, 2000, J ECON ENTOMOL, V93, P447, DOI 10.1603/0022-0493-93.2.447; Puinean AM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000999; Puinean AM, 2010, PESTIC BIOCHEM PHYS, V97, P129, DOI 10.1016/j.pestbp.2009.06.008; SARINGER G, 1984, Z ANGEW ENTOMOL, V98, P50; SONE S, 1995, J PESTIC SCI, V20, P541; Wang YH, 2009, ENTOMOL EXP APPL, V131, P20, DOI 10.1111/j.1570-7458.2009.00827.x; Yu SJ, 2007, PEST MANAG SCI, V63, P63, DOI 10.1002/ps.1309; Zamojska J, 2017, PHYTOPARASITICA, V45, P407, DOI 10.1007/s12600-017-0588-8; Zamojska J, 2014, J INSECT SCI, V14, DOI 10.1093/jisesa/ieu127; Zhang H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169475; Zhao JZ, 2000, J ECON ENTOMOL, V93, P1508, DOI 10.1603/0022-0493-93.5.1508; Zimmer CT, 2014, PESTIC BIOCHEM PHYS, V108, P1, DOI 10.1016/j.pestbp.2013.11.005; Zimmer CT, 2014, ENTOMOL EXP APPL, V150, P279, DOI 10.1111/eea.12162; Zimmer CT, 2011, PEST MANAG SCI, V67, P599, DOI 10.1002/ps.2137	29	3	4	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0214702	10.1371/journal.pone.0214702	http://dx.doi.org/10.1371/journal.pone.0214702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539393	Green Submitted, Green Published, gold			2022-12-26	WOS:000532297900001
J	Du, HM; Wang, ZC; Fan, YQ; Li, CJ; Yao, J				Du, Haiming; Wang, Zaichao; Fan, Yiqun; Li, Chengjun; Yao, Juan			Dual-Subpopulation as reciprocal optional external archives for differential evolution	PLOS ONE			English	Article							GLOBAL OPTIMIZATION; MUTATION STRATEGIES; CROSSOVER RATE; ALGORITHM; ENSEMBLE; PARAMETERS; SELECTION	Differential Evolution (DE) is powerful for global optimization problems. Among DE algorithms, JADE and its variants, whose mutation strategy is DE/current-to-pbest/1 with optional archive, have good performance. A significant feature of the above mutation strategy is that one individual for difference operation comes from the union of the optional external archive and the population. In existing DE algorithms based on the mutation strategy-JADE and its variants, individuals eliminated from the population are send to the archive. In this paper, we propose a scheme for managing the optional external archive. According to our scheme, two subpopulations are maintained in the population. Each of them regards the other as the archive. In experiments, our scheme is applied in JADE and two of its variants -SHADE and L-SHADE. Experimental results show that our scheme can enhance JADE and its variants. Moreover, it can be seen that L-SHADE with our scheme performs significantly better than four DE algorithms, CoBiDE, MPEDE, EDEV, and MLCCDE.	[Du, Haiming; Wang, Zaichao] Zhengzhou Univ Light Ind, Sch Elect & Informat Engn, Zhengzhou, Henan, Peoples R China; [Fan, Yiqun; Li, Chengjun] China Univ Geosci, Sch Comp Sci, Wuhan, Hubei, Peoples R China; [Yao, Juan] Huazhong Agr Univ, Coll Informat, Wuhan, Hubei, Peoples R China	Zhengzhou University of Light Industry; China University of Geosciences; Huazhong Agricultural University	Du, HM (corresponding author), Zhengzhou Univ Light Ind, Sch Elect & Informat Engn, Zhengzhou, Henan, Peoples R China.	duhaiming-007@zzuli.edu.cn		Li, Chengjun/0000-0002-0779-622X	Zhengzhou University of Light Industry [2013BSJJ026, 2013XGGJS011]; Henan Provincial Education Department, China [14B510022]; Project for Foundations and Frontiers Research of Henan Province, China [112300410144]	Zhengzhou University of Light Industry; Henan Provincial Education Department, China; Project for Foundations and Frontiers Research of Henan Province, China	This work was supported by the Doctoral Fund (2013BSJJ026) and Backbone Teacher Fund (2013XGGJS011) of Zhengzhou University of Light Industry, the Science and Technology Fund of Henan Provincial Education Department, China (14B510022), the Project for Foundations and Frontiers Research of Henan Province, China (112300410144).	Alba E, 2002, IEEE T EVOLUT COMPUT, V6, P443, DOI 10.1109/TEVC.2002.800880; Ali MZ, 2017, IEEE T CYBERNETICS, V47, P2768, DOI 10.1109/TCYB.2016.2617301; Ali MZ, 2015, APPL SOFT COMPUT, V33, P304, DOI 10.1016/j.asoc.2015.04.019; Auger A, 2005, IEEE C EVOL COMPUTAT, P1769; Awad NH, 2017, INFORM SCIENCES, V378, P215, DOI 10.1016/j.ins.2016.10.039; Awad NH, 2016, IEEE C EVOL COMPUTAT, P2958, DOI 10.1109/CEC.2016.7744163; Brest J, 2006, IEEE T EVOLUT COMPUT, V10, P646, DOI 10.1109/TEVC.2006.872133; Brest J, 2011, SOFT COMPUT, V15, P2157, DOI 10.1007/s00500-010-0644-5; Cui LZ, 2018, INFORM SCIENCES, V422, P122, DOI 10.1016/j.ins.2017.09.002; Cui LZ, 2016, COMPUT OPER RES, V67, P155, DOI 10.1016/j.cor.2015.09.006; Das S, 2016, SWARM EVOL COMPUT, V27, P1, DOI 10.1016/j.swevo.2016.01.004; Das S, 2014, IEEE T CYBERNETICS, V44, P966, DOI 10.1109/TCYB.2013.2278188; Dorronsoro B, 2011, IEEE T EVOLUT COMPUT, V15, P67, DOI 10.1109/TEVC.2010.2081369; Du W, 2017, IEEE T CYBERNETICS, V47, P244, DOI 10.1109/TCYB.2015.2512942; Epitropakis MG, 2011, IEEE T EVOLUT COMPUT, V15, P99, DOI 10.1109/TEVC.2010.2083670; Fan QQ, 2016, IEEE T CYBERNETICS, V46, P219, DOI 10.1109/TCYB.2015.2399478; Fu CM, 2017, APPL SOFT COMPUT, V57, P60, DOI 10.1016/j.asoc.2017.03.032; Gao WF, 2015, IEEE T CYBERNETICS, V45, P1094, DOI 10.1109/TCYB.2014.2345478; Ghasemia M, 2016, APPL SOFT COMPUT, V40, P342, DOI 10.1016/j.asoc.2015.11.033; Ghosh A, 2017, IEEE ACCESS, V5, P26944, DOI 10.1109/ACCESS.2017.2773825; Ghosh A, 2017, APPL SOFT COMPUT, V57, P329, DOI 10.1016/j.asoc.2017.03.003; Gong WY, 2014, APPL SOFT COMPUT, V15, P149, DOI 10.1016/j.asoc.2013.11.005; Gonuguntla V, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/287607; Guo SM, 2015, IEEE T EVOLUT COMPUT, V19, P717, DOI 10.1109/TEVC.2014.2375933; Guo SM, 2015, IEEE T EVOLUT COMPUT, V19, P31, DOI 10.1109/TEVC.2013.2297160; Guo ZL, 2017, SOFT COMPUT, V21, P3759, DOI 10.1007/s00500-016-2029-x; Li GH, 2016, APPL SOFT COMPUT, V47, P577, DOI 10.1016/j.asoc.2016.06.011; Li YL, 2015, IEEE T CYBERNETICS, V45, P1798, DOI 10.1109/TCYB.2014.2360752; Liang JJ, 2006, IEEE T EVOLUT COMPUT, V10, P281, DOI 10.1109/TEVC.2005.857610; Liao JL, 2016, SOFT COMPUT, V20, P2801, DOI 10.1007/s00500-015-1682-9; Mallipeddi R, 2014, 2014 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P1760, DOI 10.1109/CEC.2014.6900601; Mallipeddi R, 2011, APPL SOFT COMPUT, V11, P1679, DOI 10.1016/j.asoc.2010.04.024; Mallipeddi R, 2010, LECT NOTES COMPUT SC, V6466, P71, DOI 10.1007/978-3-642-17563-3_9; Mohammadi A, 2018, SMALL BUS ECON, V50, P275, DOI 10.1007/s11187-016-9825-7; Qin AK, 2009, IEEE T EVOLUT COMPUT, V13, P398, DOI 10.1109/TEVC.2008.927706; Qiu X, 2017, IEEE T CYBERNETICS, V47, P995, DOI 10.1109/TCYB.2016.2536167; Rakshit P, 2013, IEEE T SYST MAN CY-S, V43, P814, DOI 10.1109/TSMCA.2012.2226024; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Tanabe R, 2014, 2014 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P1658, DOI 10.1109/CEC.2014.6900380; Tanabe R, 2013, 2013 IEEE CONGRESS ON EVOLUTIONARY COMPUTATION (CEC), P71; Tang LX, 2015, IEEE T EVOLUT COMPUT, V19, P560, DOI 10.1109/TEVC.2014.2360890; Tatsis VA, 2017, SOFT COMPUT, V21, P2105, DOI 10.1007/s00500-015-1911-2; Tian MN, 2017, APPL SOFT COMPUT, V56, P286, DOI 10.1016/j.asoc.2017.03.010; Trelea IC, 2003, INFORM PROCESS LETT, V85, P317, DOI 10.1016/S0020-0190(02)00447-7; Wang Y, 2014, APPL SOFT COMPUT, V18, P232, DOI 10.1016/j.asoc.2014.01.038; Wang Y, 2011, IEEE T EVOLUT COMPUT, V15, P55, DOI 10.1109/TEVC.2010.2087271; Wu GH, 2018, INFORM SCIENCES, V423, P172, DOI 10.1016/j.ins.2017.09.053; Wu GH, 2016, INFORM SCIENCES, V329, P329, DOI 10.1016/j.ins.2015.09.009; Xu YL, 2015, COMPUT OPTIM APPL, V61, P243, DOI 10.1007/s10589-014-9701-9; Yang M, 2015, IEEE T CYBERNETICS, V45, P302, DOI 10.1109/TCYB.2014.2339495; Yang M, 2013, GECCO'13: PROCEEDINGS OF THE 2013 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P145; Yi WC, 2016, EXPERT SYST APPL, V44, P1, DOI 10.1016/j.eswa.2015.09.031; Yu WJ, 2014, IEEE T CYBERNETICS, V44, P1080, DOI 10.1109/TCYB.2013.2279211; Zhang JQ, 2009, IEEE T EVOLUT COMPUT, V13, P945, DOI 10.1109/TEVC.2009.2014613; Zhang SX, 2019, INFORM SCIENCES, V482, P86, DOI 10.1016/j.ins.2018.12.065; Zhang X, 2017, SOFT COMPUT, V21, P7107, DOI 10.1007/s00500-016-2253-4; Zheng LM, 2017, INFORM SCIENCES, V399, P13, DOI 10.1016/j.ins.2017.02.055; Zheng LM, 2017, SOFT COMPUT, P1; Zhou XH, 2017, RES SER CHIN DREAM, P1, DOI 10.1007/978-981-10-4986-6_1; Zhou YZ, 2017, IEEE T CYBERNETICS, V47, P2742, DOI 10.1109/TCYB.2017.2676882; Zhu W, 2013, INFORM SCIENCES, V223, P164, DOI 10.1016/j.ins.2012.09.019	61	0	0	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222103	10.1371/journal.pone.0222103	http://dx.doi.org/10.1371/journal.pone.0222103			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JX9DN	31536535	Green Published, Green Submitted, gold			2022-12-26	WOS:000504027600001
J	Islam, MA; Neuhoff, C; Rony, SA; Grosse-Brinkhaus, C; Uddin, MJ; Holker, M; Tesfaye, D; Tholen, E; Schellander, K; Proll-Cornelissen, MJ				Islam, Md Aminul; Neuhoff, Christiane; Rony, Sharmin Aqter; Grosse-Brinkhaus, Christine; Uddin, Muhammad Jasim; Hoelker, Michael; Tesfaye, Dawit; Tholen, Ernst; Schellander, Karl; Proell-Cornelissen, Maren Julia			PBMCs transcriptome profiles identified breed-specific transcriptome signatures for PRRSV vaccination in German Landrace and Pietrain pigs	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; SYNDROME-VIRUS; GENE-EXPRESSION; INNATE; RESISTANCE; RESPONSES; PROTEIN; MEISHAN; ADAM-17	Porcine reproductive and respiratory syndrome (PRRS) is a devastating viral disease affecting the swine industry worldwide. Genetic variation in host immunity has been considered as one of the potential determinants to improve the immunocompetence, thereby resistance to PRRS. Therefore, the present study aimed to investigate the breed difference in innate immune response to PRRSV vaccination between German Landrace (DL) and Pietrain (Pi) pigs. We analyzed microarray-based transcriptome profiles of peripheral blood mononuclear cells (PBMCs) collected before (0 h) and 24 h after PRRSV vaccination from purebred DL and Pi pigs with three biological replicates. In total 4,269 transcripts were identified to be differentially expressed in PBMCs in at least any of four tested contrast pairs (i.e. DL-24h vs. DL-0h, Pi-24h vs. Pi-0h, DL-0h vs. Pi-0h and DL-24h vs. Pi-24h). The number of vaccine-induced differentially expressed genes (DEGs) was much higher (2,459) in DL pigs than that of Pi pigs (291). After 24 h of PRRSV vaccination, 1,046 genes were differentially expressed in PMBCs of DL pigs compared to that of Pi (DL-24h vs. Pi-24h), indicating the breed differences in vaccine responsiveness. The top biological pathways significantly affected by DEGs of both breeds were linked to immune response functions. The network enrichment analysis identified ADAM17, STAT1, MMS19, RPA2, BAD, UCHL5 and APC as potential regulatory genes for the functional network of PRRSV vaccine response specific for DL; while FOXO3, IRF2, ADRBK1, FHL3, PPP2CB and NCOA6 were found to be the most potential hubs of Pi specific transcriptome network. In conclusion, our data provided insights of breed-specific host transcriptome responses to PRRSV vaccination which might contribute in better understanding of PPRS resistance in pigs.	[Islam, Md Aminul; Neuhoff, Christiane; Rony, Sharmin Aqter; Grosse-Brinkhaus, Christine; Hoelker, Michael; Tesfaye, Dawit; Tholen, Ernst; Schellander, Karl; Proell-Cornelissen, Maren Julia] Univ Bonn, Inst Anim Sci, Dept Anim Breeding & Husb, Endenicher Allee 15, Bonn, Germany; [Islam, Md Aminul; Uddin, Muhammad Jasim] Bangladesh Agr Univ, Fac Vet Sci, Dept Med, Mymensingh, Bangladesh; [Rony, Sharmin Aqter] Bangladesh Agr Univ, Fac Vet Sci, Dept Parasitol, Mymensingh, Bangladesh; [Uddin, Muhammad Jasim] Univ Queensland, Sch Vet Sci, Gatton Campus, Brisbane, Qld, Australia; [Hoelker, Michael; Schellander, Karl] Univ Bonn, Fac Agr, Teaching & Res Stn Frankenforst, Konigswinter, Germany	University of Bonn; Bangladesh Agricultural University (BAU); Bangladesh Agricultural University (BAU); University of Queensland; University of Bonn	Proll-Cornelissen, MJ (corresponding author), Univ Bonn, Inst Anim Sci, Dept Anim Breeding & Husb, Endenicher Allee 15, Bonn, Germany.	mpro@itw.uni-bonn.de	Große-Brinkhaus, Christine/AAF-6712-2020; Islam, Aminul/AAE-9484-2019	Große-Brinkhaus, Christine/0000-0002-6190-4463; Islam, Aminul/0000-0003-1979-9652; Uddin, Muhammad Jasim/0000-0002-6732-5534; Rony, Sharmin Aqter/0000-0002-2754-0571	"Umweltvertragliche und Standortgerechte Landwirtschaft (USL)" program of the State of North Rhine-Westphalia, Germany [17-02.04.01-4/15]	"Umweltvertragliche und Standortgerechte Landwirtschaft (USL)" program of the State of North Rhine-Westphalia, Germany	This work was financially supported by the "Umweltvertragliche und Standortgerechte Landwirtschaft (USL)" program of the State of North Rhine-Westphalia, Germany with the grant number 17-02.04.01-4/15 to Prof. Dr. Karl Schellander; https://www.usl.uni-bonn.de/.	Abella G, 2016, RES VET SCI, V104, P117, DOI 10.1016/j.rvsc.2015.12.014; Ait-Ali T, 2011, IMMUNOGENETICS, V63, P437, DOI 10.1007/s00251-011-0518-8; Badaoui B, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-220; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Boddicker N, 2012, J ANIM SCI, V90, P1733, DOI 10.2527/jas.2011-4464; Breuer K, 2013, NUCLEIC ACIDS RES, V41, P24, DOI DOI 10.1093/NARL0KS1147; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Christopher-Hennings J, 2001, J VET DIAGN INVEST, V13, P133, DOI 10.1177/104063870101300207; Clapperton M, 2005, VET IMMUNOL IMMUNOP, V104, P131, DOI 10.1016/j.vetimm.2004.10.009; Coghill ID, 2003, J BIOL CHEM, V278, P24139, DOI 10.1074/jbc.M213259200; Drew JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113071; Etzerodt A, 2014, J BIOL CHEM, V289, P778, DOI 10.1074/jbc.M113.520213; Eydmann ME, 1997, CANCER GENET CYTOGEN, V93, P167, DOI 10.1016/S0165-4608(96)00200-2; Flori L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022717; Franaszczyk M, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-192; Gao Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-292; Gardy JL, 2009, TRENDS IMMUNOL, V30, P249, DOI 10.1016/j.it.2009.03.009; Glass Elizabeth J., 2012, Frontiers in Genetics, V3, P263, DOI 10.3389/fgene.2012.00263; Gomes AR, 2013, CHIN J CANCER, V32, P365, DOI 10.5732/cjc.012.10277; Gooz M, 2006, J BIOL CHEM, V281, P21004, DOI 10.1074/jbc.M512096200; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Guo LJ, 2014, J VIROL, V88, P10448, DOI 10.1128/JVI.01117-14; Halbur PG, 1998, J ANIM BREED GENET, V115, P181, DOI 10.1111/j.1439-0388.1998.tb00341.x; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Hu ZL, 2013, NUCLEIC ACIDS RES, V41, pD871, DOI 10.1093/nar/gks1150; Islam MA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171828; Islam MS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3249-2; Koltes JE, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1635-9; Kommadath A, 2017, SCI REP-UK, V7, DOI 10.1038/srep46203; Kou HP, 2008, P NATL ACAD SCI USA, V105, P15714, DOI 10.1073/pnas.0710736105; Koyama S, 2008, CYTOKINE, V43, P336, DOI 10.1016/j.cyto.2008.07.009; Kumagai K, 2006, INVEST OPHTH VIS SCI, V47, P2300, DOI 10.1167/iovs.05-0810; Labarque G, 2003, VET MICROBIOL, V95, P187, DOI 10.1016/S0378-1135(03)00157-3; Levy DE, 2003, CURR OPIN IMMUNOL, V15, P52, DOI 10.1016/S0952-7915(02)00011-0; Li YP, 2014, VET IMMUNOL IMMUNOP, V162, P65, DOI 10.1016/j.vetimm.2014.09.007; Loving CL, 2015, VET IMMUNOL IMMUNOP, V167, P1, DOI 10.1016/j.vetimm.2015.07.003; Lunney Joan K, 2011, BMC Proc, V5 Suppl 4, pS30, DOI 10.1186/1753-6561-5-S4-S30; Lunney JK, 2010, VIRUS RES, V154, P161, DOI 10.1016/j.virusres.2010.08.004; Machida T, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0393-4; MacNeil LT, 2011, GENOME RES, V21, P645, DOI 10.1101/gr.097378.109; Mudunuri U, 2009, BIOINFORMATICS, V25, P555, DOI 10.1093/bioinformatics/btn654; Murtaugh MP, 2002, VIRAL IMMUNOL, V15, P533, DOI 10.1089/088282402320914485; Nathalie MD, 2004, BIOCHIM BIOPHYS ACTA, V1644, P179; Nelsen CJ, 1999, J VIROL, V73, P270, DOI 10.1128/JVI.73.1.270-280.1999; Opriessnig T, 2009, J ANIM SCI, V87, P1582, DOI 10.2527/jas.2008-1390; Petry DB, 2005, J ANIM SCI, V83, P1494; Ponsuksili S, 2007, PHYSIOL GENOMICS, V29, P267, DOI 10.1152/physiolgenomics.00178.2006; Proll MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187735; Reiner G, 2010, J ANIM BREED GENET, V127, P100, DOI 10.1111/j.1439-0388.2009.00818.x; Rowland Raymond R. R., 2012, Frontiers in Genetics, V3, P260, DOI 10.3389/fgene.2012.00260; Schroyen M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2547-z; Siegrist C.-A., 2012, VACCINES-BASEL, V6th ed., P14; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Vestal DJ, 2011, J INTERF CYTOK RES, V31, P89, DOI 10.1089/jir.2010.0102; Vroon A, 2005, J IMMUNOL, V174, P4400, DOI 10.4049/jimmunol.174.7.4400; Wilkinson JM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2720-4; Xia J, 2014, NUCLEIC ACIDS RES, V42, P26, DOI DOI 10.1093/NALL0KU443; Xiao SQ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-544; Xing JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086101; Zhang XX, 1999, VIROLOGY, V262, P152, DOI 10.1006/viro.1999.9914	61	7	8	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222513	10.1371/journal.pone.0222513	http://dx.doi.org/10.1371/journal.pone.0222513			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536525	Green Submitted, Green Published, gold			2022-12-26	WOS:000532262800050
J	Munoz, R; Hileeto, D; Cruz-Munoz, W; Wood, GA; Xu, P; Man, S; Viloria-Petit, A; Kerbel, RS				Munoz, Raquel; Hileeto, Denise; Cruz-Munoz, William; Wood, Geoffrey A.; Xu, Ping; Man, Shan; Viloria-Petit, Alicia; Kerbel, Robert S.			Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; GENE COPY NUMBER; C-MET; TYROSINE KINASE; ADJUVANT CHEMOTHERAPY; THERAPEUTIC TARGET; PROTEIN EXPRESSION; ANTITUMOR-ACTIVITY; TUMOR-REGRESSION; CELL-LINES	Metronomic chemotherapy using the 5-FU prodrug uracil-tegafur (UFT) and cyclophosphamide (CTX) was previously shown to only modestly delay primary tumor growth, but nevertheless markedly suppressed the development of micro-metastasis in an orthotopic breast cancer xenograft model, using the metastatic variant of the MDA-MB-231 cell line, 231/LM2-4. Furthermore, a remarkable prolongation of survival, with no toxicity, was observed in a model of postsurgical advanced metastatic disease. A question that has remained unanswered is the seemingly selective anti-metastatic mechanisms of action responsible for this treatment. We assessed the in vivo effect of metronomic UFT, CTX or their combination, on vascular density, collagen deposition and c-Met (cell mediators or modulators of tumor cell invasion or dissemination) via histochemistry/immunohistochemistry of primary tumor sections. We also assessed the effect of continuous exposure to low and non-toxic doses of active drug metabolites 5-fluorouracil (5-FU), 4-hydroperoxycyclophosphamide (4-HC) or their combination, on 231/LM2-4 cell invasiveness in vitro. In the in vivo studies, a significant reduction in vascular density and p-Met[Y1003] levels was associated with UFT+CTX treatment. All treatments reduced intratumoral collagen deposition. In the in vitro studies, a significant reduction of collagen IV invasion by all treatments was observed. The 3D structures formed by 231/LM2-4 on Matrigel showed a predominantly Mass phenotype under treated conditions and Stellate phenotype in untreated cultures. Taken together, the results suggest the low-dose metronomic chemotherapy regimens tested can suppress several mediators of tumor invasiveness highlighting a new perspective for the anti-metastatic efficacy of metronomic chemotherapy.	[Munoz, Raquel; Cruz-Munoz, William; Xu, Ping; Man, Shan; Kerbel, Robert S.] Sunnybrook Res Inst, Biol Sci Platform, Toronto, ON, Canada; [Hileeto, Denise] Univ Waterloo, Sch Optometry & Vis Sci, Waterloo, ON, Canada; [Wood, Geoffrey A.] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON, Canada; [Viloria-Petit, Alicia] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON, Canada; [Kerbel, Robert S.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Munoz, Raquel] Univ Valladolid, Dept Biochem Physiol & Mol Biol, Valladolid, Spain	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Waterloo; University of Guelph; University of Guelph; University of Toronto; Universidad de Valladolid	Munoz, R; Kerbel, RS (corresponding author), Sunnybrook Res Inst, Biol Sci Platform, Toronto, ON, Canada.	rmunoz@bio.uva.es; robert.kerbel@sri.utoronto.ca	Wood, Geoffrey/ABB-2052-2021	Wood, Geoffrey/0000-0003-1756-8607; Munoz, Raquel/0000-0001-9861-0349	Canadian Institutes of Health Research [364411]; Canadian Breast Cancer Foundation; Ontario Veterinary College Bull Fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Ontario Veterinary College Bull Fellowship	This work was supported by grants from Canadian Institutes of Health Research grant 364411 and Canadian Breast Cancer Foundation to RSK, and an Ontario Veterinary College Bull Fellowship to AVP and RM.	Allegrini G, 2012, ANGIOGENESIS, V15, P275, DOI 10.1007/s10456-012-9260-6; Andre N, 2017, TRENDS CANCER, V3, P319, DOI 10.1016/j.trecan.2017.03.011; Barrow-McGee R, 2014, INT J BIOCHEM CELL B, V49, P69, DOI 10.1016/j.biocel.2014.01.009; Basaki Yuji, 2001, Angiogenesis, V4, P163, DOI 10.1023/A:1014059528046; Benton G, 2011, INT J CANCER, V128, P1751, DOI 10.1002/ijc.25781; Bertolini F, 2003, CANCER RES, V63, P4342; Bisogno G, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.18_suppl.LBA2; Black PC, 2010, BJU INT, V106, P1799, DOI 10.1111/j.1464-410X.2010.09424.x; Bocci G, 2005, ANN ONCOL, V16, P1243, DOI 10.1093/annonc/mdi240; Bocci G, 2002, CANCER RES, V62, P6938; Browder T, 2000, CANCER RES, V60, P1878; Cazzaniga ME, 2017, INT J BREAST CANCER, V2017, DOI 10.1155/2017/1683060; Cazzaniga ME, 2016, BREAST CANCER RES TR, V160, P501, DOI 10.1007/s10549-016-4009-3; Cazzaniga ME, 2017, CANCER LETT, V400, P252, DOI 10.1016/j.canlet.2016.12.019; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Chen MHS, 2008, MODERN PATHOL, V21, P1183, DOI 10.1038/modpathol.2008.90; Colleoni M, 2002, ANN ONCOL, V13, P73, DOI 10.1093/annonc/mdf013; Colleoni M, 2016, J CLIN ONCOL, V34, P3400, DOI 10.1200/JCO.2015.65.6595; Daenen LG, 2009, MOL CANCER THER, V8, P2872, DOI 10.1158/1535-7163.MCT-09-0583; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Ferrer-Font L, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3748; Friedl P, 2012, NAT CELL BIOL, V14, P777, DOI 10.1038/ncb2548; Fujii M, 2008, J CANCER RES CLIN, V134, P1319, DOI 10.1007/s00432-008-0417-z; Gaule PB, 2014, EXPERT OPIN THER TAR, V18, P999, DOI 10.1517/14728222.2014.938050; Ghiringhelli F, 2007, CANCER IMMUNOL IMMUN, V56, P641, DOI 10.1007/s00262-006-0225-8; Hackl C, 2013, GUT, V62, P259, DOI 10.1136/gutjnl-2011-301585; Hanahan D, 2000, J CLIN INVEST, V105, P1045, DOI 10.1172/JCI9872; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hashimoto K, 2010, MOL CANCER THER, V9, P996, DOI 10.1158/1535-7163.MCT-09-0960; Hirsch FR, 2003, J CLIN ONCOL, V21, P3798, DOI 10.1200/JCO.2003.11.069; Ho-Yen CM, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0547-6; Inoue T, 2004, CANCER SCI, V95, P803, DOI 10.1111/j.1349-7006.2004.tb02185.x; Jedeszko C, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010722; John T, 2009, ONCOGENE, V28, pS14, DOI 10.1038/onc.2009.197; Kang JY, 2003, CANCER RES, V63, P1101; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kerbel RS, 2004, NAT REV CANCER, V4, P423, DOI 10.1038/nrc1369; Kermorgant S, 2005, CELL CYCLE, V4, P352, DOI 10.4161/cc.4.3.1519; Klement G, 2000, J CLIN INVEST, V105, pR15, DOI 10.1172/JCI8829; Knight JF, 2013, P NATL ACAD SCI USA, V110, pE1301, DOI 10.1073/pnas.1210353110; Kurebayashi J, 1997, CLIN CANCER RES, V3, P653; Liu YY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173693; Lovitt CJ, 2015, J CANCER RES CLIN, V141, P951, DOI 10.1007/s00432-015-1950-1; Mai A, 2014, J CELL SCI, V127, P1938, DOI 10.1242/jcs.140657; Man S, 2002, CANCER RES, V62, P2731; Manni A, 2002, CLIN EXP METASTAS, V19, P95, DOI 10.1023/A:1014536909007; McLean KE, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-50; Montagna E, 2018, BREAST CARE, V13, P177, DOI 10.1159/000487630; Munoz R, 2006, CANCER RES, V66, P3386, DOI 10.1158/0008-5472.CAN-05-4411; Munzone E, 2015, NAT REV CLIN ONCOL, V385, P1843; Nagai N, 2008, MED ONCOL, V25, P214, DOI 10.1007/s12032-007-9023-1; Nakanishi H, 1999, CANCER LETT, V142, P31, DOI 10.1016/S0304-3835(99)00114-7; Noguchi S, 2005, J CLIN ONCOL, V23, P2172, DOI 10.1200/JCO.2005.02.158; Pasini F, 2018, INVEST NEW DRUG, V36, P927, DOI 10.1007/s10637-018-0631-8; Pasquier E, 2010, NAT REV CLIN ONCOL, V7, P455, DOI 10.1038/nrclinonc.2010.82; Patten SG, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-683; Penel N, 2012, CRIT REV ONCOL HEMAT, V82, P40, DOI 10.1016/j.critrevonc.2011.04.009; Ponzo MG, 2010, CELL CYCLE, V9, P1043, DOI 10.4161/cc.9.6.11033; Pozner-Moulis S, 2006, CANCER RES, V66, P7976, DOI 10.1158/0008-5472.CAN-05-4335; Puri N, 2007, CLIN CANCER RES, V13, P2246, DOI 10.1158/1078-0432.CCR-06-0776; Rakha EA, 2009, CLIN CANCER RES, V15, P2302, DOI 10.1158/1078-0432.CCR-08-2132; Saunders NA, 2012, EMBO MOL MED, V4, P675, DOI 10.1002/emmm.201101131; Shaked Y, 2016, CANCER RES, V76, P5983, DOI 10.1158/0008-5472.CAN-16-0136; Simkens LHJ, 2015, LANCET, V385, P1843, DOI 10.1016/S0140-6736(14)62004-3; Tanaka F, 2007, SURG TODAY, V37, P923, DOI 10.1007/s00595-007-3578-5; Uchida J, 2007, ONCOL REP, V18, P313; Ueda H, 2008, ONCOL REP, V19, P1355; Vidi Pierre-Alexandre, 2013, Methods Mol Biol, V945, P193, DOI 10.1007/978-1-62703-125-7_13; Viloria-Petit AM, 2009, P NATL ACAD SCI USA, V106, P14028, DOI 10.1073/pnas.0906796106; Wu JJ, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2597-2; Wu JJ, 2014, CANCER LETT, V353, P272, DOI 10.1016/j.canlet.2014.07.033; Xie YQ, 2014, MOL ENDOCRINOL, V28, P1629, DOI 10.1210/me.2014-1078; Xiong GF, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-1; Yonekura K, 1999, CLIN CANCER RES, V5, P2185; Zucali PA, 2008, ANN ONCOL, V19, P1605, DOI 10.1093/annonc/mdn240	76	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222580	10.1371/journal.pone.0222580	http://dx.doi.org/10.1371/journal.pone.0222580			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536574	Green Published, gold, Green Submitted			2022-12-26	WOS:000532262800055
J	Sung, JM; Cho, IJ; Sung, D; Kim, S; Kim, HC; Chae, MH; Kavousi, M; Rueda-Ochoa, OL; Ikram, MA; Franco, OH; Chang, HJ				Sung, Ji Min; Cho, In-Jeong; Sung, David; Kim, Sunhee; Kim, Hyeon Chang; Chae, Myeong-Hun; Kavousi, Maryam; Rueda-Ochoa, Oscar L.; Ikram, M. Arfan; Franco, Oscar H.; Chang, Hyuk-Jae			Development and verification of prediction models for preventing cardiovascular diseases	PLOS ONE			English	Article							HEART-DISEASE; RISK; FRAMINGHAM; VALIDATION; SCORE	Objectives Cardiovascular disease (CVD) is one of the major causes of death worldwide. For improved accuracy of CVD prediction, risk classification was performed using national time-series health examination data. The data offers an opportunity to access deep learning (RNNLSTM), which is widely known as an outstanding algorithm for analyzing time-series datasets. The objective of this study was to show the improved accuracy of deep learning by comparing the performance of a Cox hazard regression and RNN-LSTM based on survival analysis. Methods and findings We selected 361,239 subjects (age 40 to 79 years) with more than two health examination records from 2002-2006 using the National Health Insurance System-National Health Screening Cohort (NHIS-HEALS). The average number of health screenings (from 2002-2013) used in the analysis was 2.9 +/- 1.0. Two CVD prediction models were developed from the NHIS-HEALS data: a Cox hazard regression model and a deep learning model. In an internal validation of the NHIS-HEALS dataset, the Cox regression model showed a highest time-dependent area under the curve (AUC) of 0.79 (95% CI 0.70 to 0.87) for in females and 0.75 (95% CI 0.70 to 0.80) in males at 2 years. The deep learning model showed a highest time-dependent AUC of 0.94 (95% CI 0.91 to 0.97) for in females and 0.96 (95% CI 0.95 to 0.97) in males at 2 years. Layer-wise Relevance Propagation (LRP) revealed that age was the variable that had the greatest effect on CVD, followed by systolic blood pressure (SBP) and diastolic blood pressure (DBP), in that order. Conclusion The performance of the deep learning model for predicting CVD occurrences was better than that of the Cox regression model. In addition, it was confirmed that the known risk factors shown to be important by previous clinical studies were extracted from the study results using LRP.	[Sung, Ji Min] Yonsei Univ, Yonsei Univ Hlth Syst, Integrat Res Ctr Cerebrovasc & Cardiovasc Dis, Coll Med, Seoul, South Korea; [Cho, In-Jeong] Ewha Womans Univ, Div Cardiol, Coll Med, Seoul, South Korea; [Sung, David] Data Sci Team KT NexR, Seoul, South Korea; [Kim, Sunhee] Yonsei Univ, Yonsei Univ Hlth Syst, Coll Med, Seoul, South Korea; [Kim, Hyeon Chang; Chang, Hyuk-Jae] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, Seoul, South Korea; [Kim, Hyeon Chang] Yonsei Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Chae, Myeong-Hun] Selves AI Inc, AI R&D Lab, Seoul, South Korea; [Kavousi, Maryam; Rueda-Ochoa, Oscar L.; Ikram, M. Arfan; Franco, Oscar H.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Rueda-Ochoa, Oscar L.] Univ Ind Santander UIS, Fac Hlth, Sch Med, Bucaramanga, Colombia; [Ikram, M. Arfan] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Chang, Hyuk-Jae] Yonsei Univ, Severance Biomed Sci Inst, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Ewha Womans University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Erasmus University Rotterdam; Erasmus MC; Universidad Industrial de Santander; Erasmus University Rotterdam; Erasmus MC; Yonsei University; Yonsei University Health System	Chang, HJ (corresponding author), Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, Seoul, South Korea.; Chang, HJ (corresponding author), Yonsei Univ, Severance Biomed Sci Inst, Coll Med, Seoul, South Korea.	hjchang@yuhs.ac	Kavousi, Maryam/F-1174-2018; Ikram, M. Arfan/AAM-5225-2021; Franco, Óscar H/ABE-2305-2020; Kim, Hyeon Chang/F-8796-2019	Kavousi, Maryam/0000-0001-5976-6519; Franco, Óscar H/0000-0002-4606-4929; Rueda-Ochoa, Oscar L./0000-0003-2684-9005; Chang, Hyuk-Jae/0000-0002-6139-7545; Sung, David/0000-0003-3475-3468; Kim, Hyeon Chang/0000-0001-7867-1240; Ikram, Mohammad Arfan/0000-0003-0372-8585	Institute for Information & communications Technology Promotion (IITP) grant - Korea government(MSIT) [2018-0-00861]	Institute for Information & communications Technology Promotion (IITP) grant - Korea government(MSIT)(Institute for Information & Communication Technology Planning & Evaluation (IITP), Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea)	This study was supported by Institute for Information & communications Technology Promotion (IITP) grant funded by the Korea government(MSIT) (No.2018-0-00861, Intelligent SW Technology Development for Medical Data Analysis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambale-Venkatesh B, 2017, CIRC RES, V121, P1092, DOI 10.1161/CIRCRESAHA.117.311312; Arras L., 2017, ARXIV PREPRINT ARXIV; Bach S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130140; Baesens B, 2005, J OPER RES SOC, V56, P1089, DOI 10.1057/palgrave.jors.2601990; Chi Chih-Lin, 2007, AMIA Annu Symp Proc, P130; Cho IJ, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.117.004197; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Dean J., 2012, P 25 INT C NEURAL IN, DOI DOI 10.5555/2999134.2999271; Deo RC, 2015, CIRCULATION, V132, P1920, DOI 10.1161/CIRCULATIONAHA.115.001593; Dezfouli HN, 2012, 2012 INT C STAT SCI, P1; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; Goldstein BA, 2016, EUR HEART J, V19; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hinton G, 2012, IEEE SIGNAL PROC MAG, V29, P82, DOI 10.1109/MSP.2012.2205597; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Hofman A, 2015, EUR J EPIDEMIOL, V30, P661, DOI 10.1007/s10654-015-0082-x; Jarrett D, 2019, IEEE J BIOMED HLTH I; Khatibi V, 2010, EXPERT SYST APPL, V37, P8536, DOI 10.1016/j.eswa.2010.05.022; Kukar M, 1999, ARTIF INTELL MED, V16, P25, DOI 10.1016/S0933-3657(98)00063-3; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lloyd-Jones DM, 2006, CIRCULATION, V113, P791, DOI 10.1161/CIRCULATIONAHA.105.548206; Min S, 2017, BRIEF BIOINFORM, V18, P851, DOI 10.1093/bib/bbw068; Mosca L, 2011, CIRCULATION, V124, P2145, DOI 10.1161/CIRCULATIONAHA.110.968792; Narain R, 2016, PATIENT PREFER ADHER, V10, P1259, DOI 10.2147/PPA.S108203; Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694; Ras G., 2018, EXPLAINABLE INTERPRE, P19; Ruwanpathirana T, 2015, CARDIOVASC THER, V33, P62, DOI 10.1111/1755-5922.12110; SAS Institute Inc, 2015, SASSTAT 141 USERS GU; Seong SC, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016640; Street W. N., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P540; Tieleman T., 2012, COURSERA NEURAL NETW, V4, P26; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Vikulova DN, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012178; Waljee AK, 2010, AM J GASTROENTEROL, V105, P1224, DOI 10.1038/ajg.2010.173; Wang TY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27337-w; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837	39	4	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222809	10.1371/journal.pone.0222809	http://dx.doi.org/10.1371/journal.pone.0222809			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536581	Green Published, Green Submitted, gold			2022-12-26	WOS:000532262800089
J	Lemon, J; Cooper, J; Defres, S; Easton, A; Sadarangani, M; Griffiths, MJ; Pollard, AJ; Solomon, T; Kneen, R				Lemon, Jennifer; Cooper, Jessie; Defres, Sylviane; Easton, Ava; Sadarangani, Manish; Griffiths, Michael J.; Pollard, Andrew J.; Solomon, Tom; Kneen, Rachel			Understanding parental perspectives on outcomes following paediatric encephalitis: A qualitative study	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS; CHILDREN	Background Encephalitis, characterised as inflammation of the brain tissue, is an important cause of acquired brain injury in children. Objective clinical outcomes vary significantly between affected patients, however they do not always correlate with quality of life as reported by parents. The aim of this study was to explore how parents experience and interpret outcomes in relation to their child who has been affected by encephalitis. Methods Data were derived from in-depth, semi-structured interviews, with 15 parents of 12 children and young people affected by encephalitis. Paediatric cases were identified from the retrospective arm of the research programme 'ENCEPH-UK-Understanding and Improving the Outcome of Encephalitis', and from the prospective UK childhood meningitis and encephalitis cohort study (UK-ChiMES, 2012 to 2016). Data were analysed thematically. Results Parents' perspectives on important outcomes for their child and family changed during the different stages of the encephalitis illness trajectory: from acute illness, recovery and rehabilitation, then reintegration into everyday life. Parents' understanding of their children's overall outcome was informed by their own experiences, involving comparisons with other children and reflections on their child's problems before, during and after the acute illness. Conclusion Outcomes in paediatric encephalitis need to be understood in terms of the context of the patient and family experience as well as the timeframe of recovery. The research highlights the need to include more patient, parent and/or carer reported outcome measures during patient assessment, and that assessment should be repeated during recovery as family concerns change. In the longer term, these parameters could be included in clinical and rehabilitation practice to further support child recovery.	[Lemon, Jennifer; Defres, Sylviane; Easton, Ava; Griffiths, Michael J.; Solomon, Tom; Kneen, Rachel] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England; [Lemon, Jennifer; Griffiths, Michael J.; Kneen, Rachel] Alder Hey Childrens NHS Fdn Trust, Liverpool, Merseyside, England; [Cooper, Jessie] City Univ London, Sch Hlth Sci, Div Hlth Serv Res & Management, London, England; [Defres, Sylviane] Royal Liverpool Univ, Trop Infect Dis Unit, Liverpool, Merseyside, England; [Defres, Sylviane] Broadgreen NHS Trust, Liverpool, Merseyside, England; [Easton, Ava] Encephalitis Soc, Malton, England; [Sadarangani, Manish] BC Childrens Hosp, Vaccine Evaluat Ctr, Res Inst, Vancouver, BC, Canada; [Sadarangani, Manish] Univ British Columbia, Dept Pediat, Div Infect Dis, Vancouver, BC, Canada; [Griffiths, Michael J.; Solomon, Tom] Univ Liverpool, NIHR Hlth Protect Res Unit Emerging & Zoonot Infe, Liverpool, Merseyside, England; [Pollard, Andrew J.] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England; [Pollard, Andrew J.] NIHR Oxford Biomed Res Ctr, Oxford, England; [Solomon, Tom] Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England	University of Liverpool; Alder Hey Children's NHS Foundation Trust; City University London; University of Liverpool; BC Childrens Hospital; University of British Columbia; University of British Columbia; University of Liverpool; University of Oxford; University of Oxford; Walton Centre	Solomon, T (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.; Solomon, T (corresponding author), Univ Liverpool, NIHR Hlth Protect Res Unit Emerging & Zoonot Infe, Liverpool, Merseyside, England.; Solomon, T (corresponding author), Walton Ctr NHS Fdn Trust, Liverpool, Merseyside, England.	tsolomon@liv.ac.uk	Sadarangani, Manish/V-5609-2019	Solomon, Tom/0000-0001-7266-6547; Sadarangani, Manish/0000-0002-9985-6452; Easton, Ava/0000-0002-1739-2915	NIHR Programme Grants for Applied Research Understanding and improving outcomes in encephalitis' [PRPG-108-10048]; Meningitis Research Foundation (MRF) [1103.0]; Pfizer [WS2301162]; MRC [G116/194, MC_PC_15096] Funding Source: UKRI	NIHR Programme Grants for Applied Research Understanding and improving outcomes in encephalitis'; Meningitis Research Foundation (MRF)(Meningitis Research Foundation (MRF)); Pfizer(Pfizer); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This publication was made possible by the NIHR Programme Grants for Applied Research Understanding and improving outcomes in encephalitis' (grant number PRPG-108-10048) www.nihr.ac.uk, funding from the Meningitis Research Foundation (MRF-grant number 1103.0) www.meningitis.org and Pfizer (grant number WS2301162) www.pfizer.co.uk.The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004611; Andersson K, 2016, BRAIN INJURY, V30, P829, DOI 10.3109/02699052.2016.1146963; Bagdure D, 2016, PEDIATR NEUROL, V61, P58, DOI 10.1016/j.pediatrneurol.2016.04.014; Black N., 2013, BMJ-BRIT MED J, V346, P7896; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; BRENNER MH, 1995, MED CARE, V33, pAS236; Cooper J, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2608-2; Cooper J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151145; Easton A., 2016, LIFE ENCEPHALITIS NA; Elbers JM, 2007, PEDIATRICS, V119, pE399, DOI 10.1542/peds.2006-1494; Florance NR, 2009, ANN NEUROL, V66, P11, DOI 10.1002/ana.21756; Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X; Gray DE, 2014, DOING QUALITATIVE RE; Hacohen Y, 2012, J NEUROL NEUROSURG P; Harman NL, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-70; Jmor F, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-134; Khandaker G, 2016, DEV MED CHILD NEUROL, V58, P1108, DOI 10.1111/dmcn.13197; Kneen R, 2012, J INFECTION, V64, P449, DOI 10.1016/j.jinf.2011.11.013; Kumar R, 2009, CLIN INFECT DIS, V48, P400, DOI 10.1086/596309; Lewthwaite P, 2010, B WORLD HEALTH ORGAN, V88, P584, DOI 10.2471/BLT.09.071357; Mikaeloff Y, 2007, EUR J PAEDIATR NEURO, V11, P90, DOI 10.1016/j.ejpn.2006.11.007; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024; Ramanuj PP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103496; Rayamajhi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122608; Rismanchi N, 2015, PEDIATR NEUROL, V53, P200, DOI 10.1016/j.pediatrneurol.2015.05.017; Solomon T, 2003, LANCET, V361, P821, DOI 10.1016/S0140-6736(03)12709-2; Tyerman E, 2017, BRAIN INJURY, P1; Wickstrom R, 2017, ACTA PAEDIATR, V106, P463, DOI 10.1111/apa.13682; WILLIAMSON PR, 2017, TRIALS S3, V18, DOI DOI 10.1186/S13063-017-1978-4; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; World Health Organization, COMM LANG FUNCT DIS; Ziebland S, 2013, UNDERSTANDING USING	32	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0220042	10.1371/journal.pone.0220042	http://dx.doi.org/10.1371/journal.pone.0220042			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525232	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000532225700006
J	Ren, AY; Du, K; Jia, XB; Yang, R; Wang, J; Chen, SY; Lai, SJ				Ren, Anyong; Du, Kun; Jia, Xianbo; Yang, Rui; Wang, Jie; Chen, Shi-Yi; Lai, Song-Jia			Genetic diversity and population structure of four Chinese rabbit breeds	PLOS ONE			English	Article							TOOL SET; DISCOVERY; ASSOCIATION; FRAMEWORK	There are a few well-known indigenous breeds of Chinese rabbits in Sichuan and Fujian provinces, for which the genetic diversity and population structure have been poorly investigated. In the present study, we successfully employed the restriction-site-associated DNA sequencing (RAD-seq) approach to comprehensively discover genome-wide SNPs of 104 rabbits from four Chinese indigenous breeds: 30 Sichuan White, 34 Tianfu Black, 32 Fujian Yellow and eight Fujian Black. A total of 7,055,440 SNPs were initially obtained, from which 113,973 high-confidence SNPs (read depth > 3, calling rate = 100% and biallelic SNPs) were selected to study the genetic diversity and population structure. The mean polymorphism information content (PIC) and nucleotide diversity (Pi) of each breed slightly varied with ranging from 0.2000 to 0.2281 and from 0.2678 to 0.2902, respectively. On the whole, Fujian Yellow rabbits showed the highest genetic diversity, which was followed by Tianfu Black and Sichuan White rabbits. The principal component analysis (PCA) revealed that the four breeds were clearly distinguishable. Our results first reveal the genetic differences among these four rabbit breeds in the Sichuan and Fujian provinces and also provide a high-confidence set of genome-wide SNPs for Chinese indigenous rabbits that could be employed for gene linkage and association analyses in the future.	[Ren, Anyong; Du, Kun; Jia, Xianbo; Wang, Jie; Chen, Shi-Yi; Lai, Song-Jia] Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Peoples R China; [Yang, Rui] Sichuan Anim Sci Acad, Anim Breeding & Genet Key Lab Sichuan Prov, Chengdu, Peoples R China	Sichuan Agricultural University	Chen, SY; Lai, SJ (corresponding author), Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu, Peoples R China.	sychensau@gmail.com; laisj5794@163.com		Lai, Song-jia/0000-0003-2830-2425	Earmarked Fund for China Agriculture Research System [CARS-44-A-2]; Science & Technology Department of Sichuan Province [2016NYZ0046]	Earmarked Fund for China Agriculture Research System; Science & Technology Department of Sichuan Province	This study was financially supported by the Earmarked Fund for China Agriculture Research System (CARS-44-A-2) and Science & Technology Department of Sichuan Province (2016NYZ0046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Ban Z, 1996, CHINESE J RABBIT FAR, V1, P15; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Chen SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165434; Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ginestet C, 2011, J R STAT SOC A STAT, V174, P245, DOI 10.1111/j.1467-985X.2010.00676_9.x; Graham-Jones O., 2001, VET J, V161, P22; Kang JL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02853-3; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Long JR, 2003, ANIM GENET, V34, P82, DOI 10.1046/j.1365-2052.2003.00945.x; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Monnerot M, 1994, GENET SEL EVOL S1, V26, P1; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rodriguez-Ezpeleta N, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00195; Rogel-Gaillard Claire, 2009, V3, P165, DOI 10.1007/978-3-540-73835-0_7; Rong Min, 2008, Chinese Journal of Animal Science, V44, P1; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Wan XY, 2014, J VET MED SCI, V76, P369, DOI 10.1292/jvms.13-0304; Wang W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174299; Whitman B.D., 2004, DOMESTIC RABBITS THE; Wu L, 2012, P 10 WORLD RABBIT C; Xie X-L, 2012, FUJIAN J AGR SCI, V33, P37; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011	27	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222503	10.1371/journal.pone.0222503	http://dx.doi.org/10.1371/journal.pone.0222503			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525233	Green Submitted, Green Published, gold			2022-12-26	WOS:000532225700033
J	Kuenze, G; Duran, AM; Woods, H; Brewer, KR; McDonald, EF; Vanoye, CG; George, AL; Sanders, CR; Meiler, J				Kuenze, Georg; Duran, Amanda M.; Woods, Hope; Brewer, Kathryn R.; McDonald, Eli Fritz; Vanoye, Carlos G.; George, Alfred L., Jr.; Sanders, Charles R.; Meiler, Jens			Upgraded molecular models of the human KCNQ1 potassium channel	PLOS ONE			English	Article							LONG QT SYNDROME; I-KS; VOLTAGE-SENSOR; STRUCTURAL BASIS; UNRELATED PATIENTS; SLOW ACTIVATION; S4-S5 LINKER; ION CHANNELS; MUTATIONS; PROTEIN	The voltage-gated potassium channel KCNQ1 (KV7.1) assembles with the KCNE1 accessory protein to generate the slow delayed rectifier current, IKS, which is critical for membrane repolarization as part of the cardiac action potential. Loss-of-function (LOF) mutations in KCNQ1 are the most common cause of congenital long QT syndrome (LQTS), type 1 LQTS, an inherited genetic predisposition to cardiac arrhythmia and sudden cardiac death. A detailed structural understanding of KCNQ1 is needed to elucidate the molecular basis for KCNQ1 LOF in disease and to enable structure-guided design of new anti-arrhythmic drugs. In this work, advanced structural models of human KCNQ1 in the resting/closed and activated/open states were developed by Rosetta homology modeling guided by newly available experimentally-based templates: X. leavis KCNQ1 and various resting voltage sensor structures. Using molecular dynamics (MD) simulations, the capacity of the models to describe experimentally established channel properties including state-dependent voltage sensor gating charge interactions and pore conformations, PIP2 binding sites, and voltage sensor-pore domain interactions were validated. Rosetta energy calculations were applied to assess the utility of each model in interpreting mutation-evoked KCNQ1 dysfunction by predicting the change in protein thermodynamic stability for 50 experimentally characterized KCNQ1 variants with mutations located in the voltage-sensing domain. Energetic destabilization was successfully predicted for folding-defective KCNQ1 LOF mutants whereas wild type-like mutants exhibited no significant energetic frustrations, which supports growing evidence that mutation-induced protein destabilization is an especially common cause of KCNQ1 dysfunction. The new KCNQ1 Rosetta models provide helpful tools in the study of the structural basis for KCNQ1 function and can be used to generate hypotheses to explain KCNQ1 dysfunction.	[Kuenze, Georg; Duran, Amanda M.; Woods, Hope; Brewer, Kathryn R.; McDonald, Eli Fritz; Sanders, Charles R.; Meiler, Jens] Vanderbilt Univ, Ctr Struct Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Kuenze, Georg; Duran, Amanda M.; Woods, Hope; McDonald, Eli Fritz; Meiler, Jens] Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA; [Brewer, Kathryn R.; Sanders, Charles R.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Vanoye, Carlos G.; George, Alfred L., Jr.] Northwestern Univ, Dept Pharmacol, Feinberg Sch Med, Chicago, IL 60611 USA; [Meiler, Jens] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Northwestern University; Feinberg School of Medicine; Vanderbilt University	Meiler, J (corresponding author), Vanderbilt Univ, Ctr Struct Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.; Meiler, J (corresponding author), Vanderbilt Univ, Dept Chem, Nashville, TN 37235 USA.; Meiler, J (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA.	jens@meilerlab.org		George, Alfred/0000-0002-3993-966X; Kuenze, Georg/0000-0003-1799-346X; Meiler, Jens/0000-0001-8945-193X; Brewer, Kathryn/0000-0001-7003-2938; McDonald, Eli/0000-0002-0572-330X; Woods, Hope/0000-0001-6615-545X; Sanders, Charles/0000-0003-2046-2862	NIH [R01 HL122010, R01 GM080403]; German Research Foundation [KU 3510/1-1]; American Heart Association [18POST34080422]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065086, T32GM008320, R01GM080403] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R01 HL122010 and R01 GM080403. GK was supported by fellowships from the German Research Foundation (KU 3510/1-1) and the American Heart Association (18POST34080422). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott GW, 2014, NEW J SCI, V2014, P1, DOI [10.1155/2014/237431, DOI 10.1155/2014/237431]; Alford RF, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004398; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Barlow KA, 2018, J PHYS CHEM B, V122, P5389, DOI 10.1021/acs.jpcb.7b11367; Barro-Soria R, 2017, P NATL ACAD SCI USA, V114, pE7367, DOI 10.1073/pnas.1710335114; Barro-Soria R, 2015, P NATL ACAD SCI USA, V112, pE7286, DOI 10.1073/pnas.1516238112; Barro-Soria R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4750; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Bender BJ, 2016, BIOCHEMISTRY-US, V55, P4748, DOI 10.1021/acs.biochem.6b00444; Berliner N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107353; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BEZANILLA F, 1994, ANNU REV BIOPH BIOM, V23, P819, DOI 10.1146/annurev.bb.23.060194.004131; Boulet IR, 2007, J PHYSIOL-LONDON, V585, P325, DOI 10.1113/jphysiol.2007.145813; Butterwick JA, 2010, J MOL BIOL, V403, P591, DOI 10.1016/j.jmb.2010.09.012; Case D. A., 2016, AMBER 2016; Chan PJ, 2012, J GEN PHYSIOL, V139, P135, DOI 10.1085/jgp.201110672; Chen LP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15079; Choi G, 2004, CIRCULATION, V110, P2119, DOI 10.1161/01.CIR.0000144471.98080.CA; Choveau FS, 2011, J BIOL CHEM, V286, P707, DOI 10.1074/jbc.M110.146324; Chung DY, 2009, P NATL ACAD SCI USA, V106, P743, DOI 10.1073/pnas.0811897106; Cui JM, 2016, BIOPHYS J, V110, P14, DOI 10.1016/j.bpj.2015.11.023; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Davis IW, 2006, STRUCTURE, V14, P265, DOI 10.1016/j.str.2005.10.007; Delemotte L, 2011, P NATL ACAD SCI USA, V108, P6109, DOI 10.1073/pnas.1102724108; Dickson CJ, 2014, J CHEM THEORY COMPUT, V10, P865, DOI 10.1021/ct4010307; DiMaio F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020450; Duran AM, 2018, PROTEIN SCI, V27, P341, DOI 10.1002/pro.3335; Eckey K, 2014, J BIOL CHEM, V289, P22749, DOI 10.1074/jbc.M114.589796; Eldstrom J, 2015, HEART RHYTHM, V12, P386, DOI 10.1016/j.hrthm.2014.10.029; Fajac I, 2017, PHARMACOL THERAPEUT, V170, P205, DOI 10.1016/j.pharmthera.2016.11.009; Farinha CM, 2013, FEBS J, V280, P4396, DOI 10.1111/febs.12392; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Gofman Y, 2012, STRUCTURE, V20, P1343, DOI 10.1016/j.str.2012.05.016; Gront D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023294; Hedley PL, 2009, HUM MUTAT, V30, P1486, DOI 10.1002/humu.21106; Henrion U, 2012, P NATL ACAD SCI USA, V109, P8552, DOI 10.1073/pnas.1116938109; Hite RK, 2014, ELIFE, V3, DOI 10.7554/eLife.04366; Homeyer N, 2006, J MOL MODEL, V12, P281, DOI 10.1007/s00894-005-0028-4; Hou PP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01911-8; Huang H, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar2631; Itoh H, 2010, HEART RHYTHM, V7, P1411, DOI 10.1016/j.hrthm.2010.06.013; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kang CB, 2008, BIOCHEMISTRY-US, V47, P7999, DOI 10.1021/bi800875q; Kapplinger JD, 2009, HEART RHYTHM, V6, P1297, DOI 10.1016/j.hrthm.2009.05.021; Kasimova MA, 2015, SCI REP-UK, V5, DOI 10.1038/srep07474; Kintzer AF, 2016, NATURE, V531, P258, DOI 10.1038/nature17194; Kroncke BM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501228; Kroncke BM, 2016, BIOCHEMISTRY-US, V55, P5002, DOI 10.1021/acs.biochem.6b00537; Kroncke BM, 2015, BIOCHEMISTRY-US, V54, P2551, DOI 10.1021/acs.biochem.5b00189; Kubota T, 2000, J CARDIOVASC ELECTR, V11, P1048, DOI 10.1111/j.1540-8167.2000.tb00178.x; Labro AJ, 2011, J BIOL CHEM, V286, P717, DOI 10.1074/jbc.M110.146977; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li B, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.117.001754; Li P, 2014, SCI REP-UK, V4, DOI 10.1038/srep04973; Li QF, 2014, NAT STRUCT MOL BIOL, V21, P244, DOI 10.1038/nsmb.2768; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Ma LJ, 2011, BIOPHYS J, V100, P885, DOI 10.1016/j.bpj.2010.12.3726; Marinko JT, 2019, CHEM REV, V119, P5537, DOI 10.1021/acs.chemrev.8b00532; Millat G, 2006, CLIN GENET, V70, P214, DOI 10.1111/j.1399-0004.2006.00671.x; Nakajo K, 2007, J GEN PHYSIOL, V130, P269, DOI 10.1085/jgp.200709805; Nakajo K, 2015, J PHYSIOL-LONDON, V593, P2617, DOI 10.1113/jphysiol.2014.287672; Nakajo K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5100; Napolitano C, 2005, JAMA-J AM MED ASSOC, V294, P2975, DOI 10.1001/jama.294.23.2975; Ortiz AR, 2002, PROTEIN SCI, V11, P2606, DOI 10.1110/ps.0215902; Panaghie G, 2007, J GEN PHYSIOL, V129, P121, DOI 10.1085/jgp.200609612; Restier L, 2008, J PHYSIOL-LONDON, V586, P4179, DOI 10.1113/jphysiol.2008.157511; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Ruscic KJ, 2013, P NATL ACAD SCI USA, V110, pE559, DOI 10.1073/pnas.1222616110; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sachyani D, 2014, STRUCTURE, V22, P1582, DOI 10.1016/j.str.2014.07.016; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schlebach JP, 2015, J AM CHEM SOC, V137, P8758, DOI 10.1021/jacs.5b03743; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Seebohm G, 2006, BIOPHYS J, V90, P2235, DOI 10.1529/biophysj.105.067165; Silva JR, 2009, P NATL ACAD SCI USA, V106, P11102, DOI 10.1073/pnas.0904505106; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Smith JA, 2007, BIOCHEMISTRY-US, V46, P14141, DOI 10.1021/bi701597s; Smith JL, 2016, J ARRYTHM, V32, P373, DOI 10.1016/j.joa.2015.11.009; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Stefl S, 2013, J MOL BIOL, V425, P3919, DOI 10.1016/j.jmb.2013.07.014; Strutz-Seebohm N, 2011, CELL PHYSIOL BIOCHEM, V27, P443, DOI 10.1159/000329965; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Sun J, 2017, CELL, V169, P1042, DOI 10.1016/j.cell.2017.05.019; Swanton E, 2005, P NATL ACAD SCI USA, V102, P4342, DOI 10.1073/pnas.0407287102; Tapper AR, 2001, J BIOL CHEM, V276, P38249; Tester DJ, 2005, HEART RHYTHM, V2, P507, DOI 10.1016/j.hrthm.2005.01.020; Thompson E, 2018, CHANNELS, V12, P276, DOI 10.1080/19336950.2018.1499369; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Tobelaim WS, 2017, CHANNELS, V11, P686, DOI 10.1080/19336950.2017.1388478; Tobelaim WS, 2017, P NATL ACAD SCI USA, V114, pE869, DOI 10.1073/pnas.1612622114; Vanoye CG, HIGH THROUGHPUT FUNC, P2574; Viklund H, 2008, BIOINFORMATICS, V24, P1662, DOI 10.1093/bioinformatics/btn221; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Wang YH, 2011, J MEMBRANE BIOL, V239, P137, DOI 10.1007/s00232-010-9333-7; Wang YH, 2012, J GEN PHYSIOL, V140, P653, DOI 10.1085/jgp.201210847; Werry D, 2013, P NATL ACAD SCI USA, V110, pE996, DOI 10.1073/pnas.1214875110; Westhoff M, 2019, P NATL ACAD SCI USA, V116, P7879, DOI 10.1073/pnas.1811623116; Wisten A, 2012, RESUSCITATION, V83, P1229, DOI 10.1016/j.resuscitation.2012.05.015; Wu D, 2010, J GEN PHYSIOL, V135, P595, DOI 10.1085/jgp.201010408; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Wu J, 2016, J ARRYTHM, V32, P381, DOI 10.1016/j.joa.2015.12.006; Xu XL, 2008, J GEN PHYSIOL, V131, P589, DOI 10.1085/jgp.200809976; Xu Y, 2013, BIOPHYS J, V105, P2461, DOI 10.1016/j.bpj.2013.09.058; Yang T, 2013, MOL PHARMACOL, V83, P481, DOI 10.1124/mol.112.081513; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103; Zaydman MA, 2014, ELIFE, V3, DOI 10.7554/eLife.03606; Zaydman MA, 2013, P NATL ACAD SCI USA, V110, P13180, DOI 10.1073/pnas.1305167110; Zheng RJ, 2010, BIOCHEM J, V428, P75, DOI 10.1042/BJ20090977; Zhou X, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00259	119	18	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2019	14	9							e0220415	10.1371/journal.pone.0220415	http://dx.doi.org/10.1371/journal.pone.0220415			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4KS	31518351	Green Submitted, Green Published, gold			2022-12-26	WOS:000532219300008
J	Radom, M; Machnicka, MA; Krwawicz, J; Bujnicki, JM; Formanowicz, P				Radom, Marcin; Machnicka, Magdalena A.; Krwawicz, Joanna; Bujnicki, Janusz M.; Formanowicz, Piotr			Petri net-based model of the human DNA base excision repair pathway	PLOS ONE			English	Article							ESCHERICHIA-COLI; AP-ENDONUCLEASE; FUNCTIONAL-CHARACTERIZATION; SUBSTRATE-SPECIFICITY; OXIDIZED BASES; THYMINE GLYCOL; HUMAN NEIL3; GLYCOSYLASE; PROTEIN; DAMAGE	Cellular DNA is daily exposed to several damaging agents causing a plethora of DNA lesions. As a first aid to restore DNA integrity, several enzymes got specialized in damage recognition and lesion removal during the process called base excision repair (BER). A large number of DNA damage types and several different readers of nucleic acids lesions during BER pathway as well as two sub-pathways were considered in the definition of a model using the Petri net framework. The intuitive graphical representation in combination with precise mathematical analysis methods are the strong advantages of the Petri net-based representation of biological processes and make Petri nets a promising approach for modeling and analysis of human BER. The reported results provide new information that will aid efforts to characterize in silico knockouts as well as help to predict the sensitivity of the cell with inactivated repair proteins to different types of DNA damage. The results can also help in identifying the by-passing pathways that may lead to lack of pronounced phenotypes associated with mutations in some of the proteins. This knowledge is very useful when DNA damage-inducing drugs are introduced for cancer therapy, and lack of DNA repair is desirable for tumor cell death.	[Radom, Marcin; Formanowicz, Piotr] Poznan Univ Tech, Inst Comp Sci, Poznan, Poland; [Radom, Marcin; Formanowicz, Piotr] Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland; [Machnicka, Magdalena A.; Bujnicki, Janusz M.] Int Inst Mol & Cell Biol, Lab Bioinformat & Prot Engn, Warsaw, Poland; [Machnicka, Magdalena A.] Univ Warsaw, Inst Informat, Warsaw, Poland; [Krwawicz, Joanna] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Krwawicz, Joanna] Int Inst Mol & Cell Biol, Lab Struct Biol, Warsaw, Poland; [Bujnicki, Janusz M.] Adam Mickiewicz Univ, Fac Biol, Inst Mol Biol & Biotechnol, Poznan, Poland	Poznan University of Technology; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; University of Warsaw; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; Adam Mickiewicz University	Formanowicz, P (corresponding author), Poznan Univ Tech, Inst Comp Sci, Poznan, Poland.; Formanowicz, P (corresponding author), Polish Acad Sci, Inst Bioorgan Chem, Poznan, Poland.; Bujnicki, JM (corresponding author), Int Inst Mol & Cell Biol, Lab Bioinformat & Prot Engn, Warsaw, Poland.; Bujnicki, JM (corresponding author), Adam Mickiewicz Univ, Fac Biol, Inst Mol Biol & Biotechnol, Poznan, Poland.	iamb@genesilico.pl; piotr@cs.put.poznan.pl	Formanowicz, Piotr/M-3606-2014; Radom, Marcin/AAJ-6958-2020	Formanowicz, Piotr/0000-0003-2719-3677; Radom, Marcin/0000-0002-4174-7069; Machnicka, Magdalena/0000-0002-2257-2961	Foundation for Polish Science (FNP) [TEAM/2009-4/2]; International Institute of Molecular and Cell Biology in Warsaw; Norway Grants through the Polish-Norwegian Research Programme [POL-NOR/207085/65/2013]; National Science Centre (Poland) [2012/07/B/ST6/01537, 2014/13/B/NZ1/03991]; Foundation for Polish Science (FNP, START fellowship); Institute of Bioorganic Chemistry, Polish Academy of Sciences	Foundation for Polish Science (FNP)(Foundation for Polish Science); International Institute of Molecular and Cell Biology in Warsaw; Norway Grants through the Polish-Norwegian Research Programme; National Science Centre (Poland); Foundation for Polish Science (FNP, START fellowship); Institute of Bioorganic Chemistry, Polish Academy of Sciences	J.M.B. was supported by the Foundation for Polish Science (FNP, TEAM/2009-4/2) and by the statutory funds of the International Institute of Molecular and Cell Biology in Warsaw, M.A.M. was supported by the Foundation for Polish Science (FNP, START fellowship), J.K. was supported by the grant (POL-NOR/207085/65/2013) from Norway Grants through the Polish-Norwegian Research Programme operated by The National Centre for Research and Development (NCBiR) and by the National Science Centre (Poland) grant (2014/13/B/NZ1/03991), P.F. and M.R. were supported by the National Science Centre (Poland) grant (No. 2012/07/B/ST6/01537) and by the statutory funds of the Institute of Bioorganic Chemistry, Polish Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamann MD, 2014, MECH AGEING DEV, V135, P1, DOI 10.1016/j.mad.2013.12.008; Aceytuno RD, 2017, NUCLEIC ACIDS RES, V45, P6238, DOI 10.1093/nar/gkx275; Almeida KH, 2007, DNA REPAIR, V6, P695, DOI 10.1016/j.dnarep.2007.01.009; Balakrishnan L, 2013, ANNU REV BIOCHEM, V82, P119, DOI 10.1146/annurev-biochem-072511-122603; Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; Bjelland S, 2003, MUTAT RES-FUND MOL M, V531, P37, DOI 10.1016/j.mrfmmm.2003.07.002; Bochtler M, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600178; Brooks SC, 2013, BBA-PROTEINS PROTEOM, V1834, P247, DOI 10.1016/j.bbapap.2012.10.005; BURGERS PMJ, 1991, J BIOL CHEM, V266, P22698; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Chen M, 2011, NAT COMPUT, V10, P1077, DOI 10.1007/s11047-009-9151-y; Cortazar D, 2011, NATURE, V470, P419, DOI 10.1038/nature09672; D'Errico M, 2017, FREE RADICAL BIO MED, V107, P278, DOI 10.1016/j.freeradbiomed.2016.12.002; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; Dherin C, 1999, NUCLEIC ACIDS RES, V27, P4001, DOI 10.1093/nar/27.20.4001; Dolan D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055190; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Fleming AM, 2017, ACS CHEM BIOL, V12, P2417, DOI 10.1021/acschembio.7b00636; Fleming AM, 2017, FREE RADICAL BIO MED, V107, P35, DOI 10.1016/j.freeradbiomed.2016.11.030; Formanowicz D, 2013, J BIOMED INFORM, V46, P1030, DOI 10.1016/j.jbi.2013.07.013; Fortini P, 2003, MUTAT RES-FUND MOL M, V531, P127, DOI 10.1016/j.mrfmmm.2003.07.004; Goto M, 2014, FREE RADICAL BIO MED, V76, P136, DOI 10.1016/j.freeradbiomed.2014.07.044; Grin IR, 2010, FEBS LETT, V584, P1553, DOI 10.1016/j.febslet.2010.03.009; Hadi MZ, 2000, NUCLEIC ACIDS RES, V28, P3871, DOI 10.1093/nar/28.20.3871; Hadi MZ, 2002, J MOL BIOL, V316, P853, DOI 10.1006/jmbi.2001.5382; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P10203, DOI 10.1093/nar/gks845; Heiner M, 2009, NAT COMPUT SER, P367, DOI 10.1007/978-3-540-88869-7_19; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; Hofestadt R., 1994, Systems Analysis and Modelling Simulation, V16, P113; Hu JP, 2005, J BIOL CHEM, V280, P40544, DOI 10.1074/jbc.M508772200; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; Jacobs AL, 2012, CHROMOSOMA, V121, P1, DOI 10.1007/s00412-011-0347-4; Jain AK., 1988, TECHNOMETRICS; Kaufman L., 2009, FINDING GROUPS DATA; Kim Yun-Jeong, 2012, Curr Mol Pharmacol, V5, P3; Kisby GE, 1997, NEUROREPORT, V8, P1337, DOI 10.1097/00001756-199704140-00004; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; Koch I, 2007, WILEY BOOK SERIES BI, P139, DOI 10.1002/9780470253489; Koch I., 2010, MODELING SYSTEMBIO; Koch I, 2013, METABOLITES, V3, P673, DOI 10.3390/metabo3030673; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Krokeide SZ, 2013, DNA REPAIR, V12, P1159, DOI 10.1016/j.dnarep.2013.04.026; Krwawicz J, 2007, ACTA BIOCHIM POL, V54, P413, DOI 10.18388/abp.2007_3219; Kuchta K, 2012, NUCLEIC ACIDS RES, V40, pD1235, DOI 10.1093/nar/gkr962; Larsen E, 2003, MOL CELL BIOL, V23, P5346, DOI 10.1128/MCB.23.15.5346-5353.2003; Lee CYI, 2009, BIOCHEMISTRY-US, V48, P1850, DOI 10.1021/bi8018898; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; Liu MM, 2012, PROTEIN EXPRES PURIF, V84, P130, DOI 10.1016/j.pep.2012.04.022; Liu PF, 2003, DNA REPAIR, V2, P199, DOI 10.1016/S1568-7864(02)00198-2; Maiti A, 2009, J BIOL CHEM, V284, P36680, DOI 10.1074/jbc.M109.062356; Marenstein DR, 2003, J BIOL CHEM, V278, P9005, DOI 10.1074/jbc.M212168200; Marwan W, 2011, NAT COMPUT, V10, P639, DOI 10.1007/s11047-009-9152-x; Masaoka A, 2003, BIOCHEMISTRY-US, V42, P5003, DOI 10.1021/bi0273213; Meas R, 2016, SCI REP-UK, V6, DOI 10.1038/srep27122; Meira LB, 2001, CANCER RES, V61, P5552; Milacic Marija, 2012, Cancers (Basel), V4, P1180, DOI 10.3390/cancers4041180; Milanowska K, 2011, NUCLEIC ACIDS RES, V39, pD788, DOI 10.1093/nar/gkq1087; Mokkapati SK, 2004, BIOCHEMISTRY-US, V43, P11596, DOI 10.1021/bi049097i; Moore SPG, 2013, DNA REPAIR, V12, P1152, DOI 10.1016/j.dnarep.2013.10.002; MURATA T, 1989, P IEEE, V77, P541, DOI 10.1109/5.24143; O'Brien PJ, 2004, J BIOL CHEM, V279, P9750, DOI 10.1074/jbc.M312232200; Ocampo-Hafalla MT, 2006, DNA REPAIR, V5, P444, DOI 10.1016/j.dnarep.2005.12.004; Orlic-Milacic M, 2015, BASE EXCISION REPAIR, P52, DOI [10.1111/j.1538-7836.2012.04930.x, DOI 10.1111/J.1538-7836.2012.04930.X]; Pan FY, 2016, SCI REP-UK, V6, DOI 10.1038/srep28614; Pieretti M, 2001, MUTAT RES-GENOMICS, V432, P53, DOI 10.1016/S1383-5726(00)00002-9; Radom M, 2017, BIOINFORMATICS, V33, P3822, DOI 10.1093/bioinformatics/btx492; Rahmanian S, 2014, DNA REPAIR, V22, P89, DOI 10.1016/j.dnarep.2014.07.011; Reddy V N, 1993, Proc Int Conf Intell Syst Mol Biol, V1, P328; Reynolds JJ, 2012, NUCLEIC ACIDS RES, V40, P6608, DOI 10.1093/nar/gks318; RoldanArjona T, 1997, P NATL ACAD SCI USA, V94, P8016, DOI 10.1073/pnas.94.15.8016; Sackmann A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-482; Saito Y, 2012, TOHOKU J EXP MED, V226, P75, DOI 10.1620/tjem.226.75; Saparbaev M, 2002, J BIOL CHEM, V277, P26987, DOI 10.1074/jbc.M111100200; Sato M, 2003, ONCOGENE, V22, P7243, DOI 10.1038/sj.onc.1206977; Semenenko VA, 2005, RADIAT RES, V164, P180, DOI 10.1667/RR3402; Semenenko VA, 2004, RADIAT RES, V161, P451, DOI 10.1667/RR3140; Senejani AG, 2014, CELL REP, V6, P1, DOI 10.1016/j.celrep.2013.12.017; Shinmura K, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/7308501; SibghatUllah, 1996, BIOCHEMISTRY-US, V35, P12926, DOI 10.1021/bi961022u; Slyvka A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07458-4; Sokhansanj BA, 2002, NUCLEIC ACIDS RES, V30, P1817, DOI 10.1093/nar/30.8.1817; Sokhansanj BA, 2006, CANCER EPIDEM BIOMAR, V15, P1000, DOI 10.1158/1055-9965.EPI-05-0817; Sugo N, 2000, EMBO J, V19, P1397, DOI 10.1093/emboj/19.6.1397; Sukhanova M, 2010, MUTAT RES-FUND MOL M, V685, P80, DOI 10.1016/j.mrfmmm.2009.08.009; Sun H, 2017, ONCOGENE, V36, P194, DOI 10.1038/onc.2016.188; Talhaoui I, 2013, NUCLEIC ACIDS RES, V41, P912, DOI 10.1093/nar/gks1149; Tsutakawa SE, 2014, DNA REPAIR, V19, P95, DOI 10.1016/j.dnarep.2014.03.022; Vidal AE, 2001, NUCLEIC ACIDS RES, V29, P1285, DOI 10.1093/nar/29.6.1285; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Wyatt MD, 1999, BIOESSAYS, V21, P668, DOI 10.1002/(SICI)1521-1878(199908)21:8<668::AID-BIES6>3.3.CO;2-4; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; Yoon JH, 2003, NUCLEIC ACIDS RES, V31, P5399, DOI 10.1093/nar/gkg730; Zhou T, 2016, ONCOTARGET, V7, P6902, DOI 10.18632/oncotarget.6849	95	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2019	14	9							e0217913	10.1371/journal.pone.0217913	http://dx.doi.org/10.1371/journal.pone.0217913			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4KS	31518347	Green Submitted, Green Published, gold			2022-12-26	WOS:000532219300003
J	van Dulm, E; Tholen, ATR; Pettersson, A; van Rooijen, MS; Willemsen, I; Molenaar, P; Damen, M; Gruteke, P; Oostvogel, P; Kuijper, EJ; Hertogh, CMPM; Vandenbroucke-Grauls, CMJE; Scholing, M				van Dulm, Eline; Tholen, Aletta T. R.; Pettersson, Annika; van Rooijen, Martijn S.; Willemsen, Ina; Molenaar, Peter; Damen, Marjolein; Gruteke, Paul; Oostvogel, Paul; Kuijper, Ed J.; Hertogh, Cees M. P. M.; Vandenbroucke-Grauls, Christina M. J. E.; Scholing, Maarten			High prevalence of multidrug resistant Enterobacteriaceae among residents of long term care facilities in Amsterdam, the Netherlands	PLOS ONE			English	Article							LACTAMASE-PRODUCING ENTEROBACTERIACEAE; ESBL-PRODUCING ENTEROBACTERIACEAE; ESCHERICHIA-COLI; TRANSMISSION DYNAMICS; NURSING-HOMES; CARRIAGE; COMMUNITY; BACTERIA	Introduction The aim of this study was to determine the rate of asymptomatic carriage and spread of multidrug-resistant micro-organisms (MDRO) and to identify risk factors for extended spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) carriage in 12 long term care facilities (LTCFs) in Amsterdam, the Netherlands. Materials and methods From November 2014 to august 2015, feces and nasal swabs from residents from LTCFs in Amsterdam, the Netherlands were collected and analyzed for presence of multidrug-resistant Gram-negative bacteria (MDRGN), including ESBL-E, carbapenemase-producing Enterobacteriaceae (CPE), colistin-resistant Enterobacteriaceae and methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). Logistic regression analysis was performed to assess associations between variables and ESBL-carriage. Results In total, 385 residents from 12 LTCFs (range 15-48 residents per LTCF) were enrolled. The prevalence of carriage of MDRGN was 18.2% (range among LTCFs 0-47%) and the prevalence of ESBL-E alone was 14.5% (range among LTCFs: 0-34%). Of 63 MDRGN positive residents, 50 (79%) were ESBL-E positive of which 43 (86%) produced CTX-M. Among 44 residents with ESBL-E positive fecal samples of whom data on contact precautions were available at the time of sampling, only 9 (20%) were already known as ESBL-E carriers. The prevalence for carriage of MRSA was 0.8% (range per LTCF: 0-7%) and VRE 0%. One CPE colonized resident was found. All fecal samples tested negative for presence of plasmid mediated resistance for colistin (MCR-1). Typing of isolates by Amplified Fragment Length Polymorphism (AFLP) showed five MDRGN clusters, of which one was found in multiple LTCFs and four were found in single LTCFs, suggesting transmission within and between LTCFs. In multivariate analysis only the presence of MDRO in the preceding year remained a risk factor for ESBL-E carriage. Conclusions The ESBL-carriage rate of residents in LTCFs is nearly two times higher than in the general population but varies considerably among LTCFs in Amsterdam, whereas carriage of MRSA and VRE is low. The majority (80%) of ESBL-E positive residents had not been detected by routine culture of clinical specimens at time of sampling. Current infection control practices in LTCFs in Amsterdam do not prevent transmission. Both improvement of basic hygiene, and funding for laboratory screening, should allow LTCFs in Amsterdam to develop standards of care to prevent transmission of ESBL-E.	[van Dulm, Eline; van Rooijen, Martijn S.; Oostvogel, Paul] Publ Hlth Serv Amsterdam, Dept Infect Dis, Amsterdam, Netherlands; [Tholen, Aletta T. R.] Natl Inst Publ Hlth & Environm RIVM, Ctr Zoonoses & Environm Microbiol, Bilthoven, Netherlands; [Pettersson, Annika; Vandenbroucke-Grauls, Christina M. J. E.] Vrije Univ Amsterdam, Dept Med Microbiol & Infect Control, Amsterdam UMC, Amsterdam, Netherlands; [Willemsen, Ina] Amphia Hosp, Dept Med Microbiol & Infect Control, Breda, Netherlands; [Molenaar, Peter] Natl Inst Publ Hlth & Environm RIVM, Natl Coordinat Ctr Communicable Dis Control, Bilthoven, Netherlands; [Damen, Marjolein] Maasstad Gen Hosp, Dept Med Microbiol, Rotterdam, Netherlands; [Gruteke, Paul; Scholing, Maarten] OLVG Lab BV, Dept Med Microbiol, Amsterdam, Netherlands; [Kuijper, Ed J.] Leiden Univ, Dept Med Microbiol, Med Ctr, Leiden, Netherlands; [Hertogh, Cees M. P. M.] Vrije Univ Amsterdam, Dept Gen Practice & Elderly Care Med, Amsterdam UMC, Amsterdam, Netherlands	Public Health Service Amsterdam; Netherlands National Institute for Public Health & the Environment; University of Amsterdam; Vrije Universiteit Amsterdam; Amphia Hospital; Netherlands National Institute for Public Health & the Environment; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Vrije Universiteit Amsterdam	Scholing, M (corresponding author), OLVG Lab BV, Dept Med Microbiol, Amsterdam, Netherlands.	publicationsmscholing@gmail.com	Vandenbroucke-Grauls, Christina/AAO-7953-2020; Kuijper, ed/AAB-7853-2022	Vandenbroucke-Grauls, Christina/0000-0003-2074-1597; Kuijper, ed/0000-0001-5726-2405; Gruteke, Paul/0000-0003-1788-5960; Oostvogel, Paul/0000-0003-0502-8400	Public Health Service Amsterdam [RD kp2157]	Public Health Service Amsterdam	This study was funded by a research and development grant (R&D kp2157) of the Public Health Service Amsterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler A, 2012, CLIN MICROBIOL INFEC, V18, pE497, DOI 10.1111/j.1469-0691.2012.03999.x; Agerso Y, 2012, J ANTIMICROB CHEMOTH, V67, P582, DOI 10.1093/jac/dkr507; [Anonymous], 2012, NVMM GUIDELINE LAB D; Bonten M J M, 2016, Ned Tijdschr Geneeskd, V160, pD852; Dautzenberg MJD, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009971; Dhanji H, 2010, INT J ANTIMICROB AG, V36, P355, DOI 10.1016/j.ijantimicag.2010.06.007; Doumith M, 2012, J CLIN MICROBIOL, V50, P3108, DOI 10.1128/JCM.01468-12; EUCAST, BREAKP TABL INT MICS; Hilty M, 2012, CLIN INFECT DIS, V55, P967, DOI 10.1093/cid/cis581; IGZ, 2016, EINDR TOEZ IGZ OP 15; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; Kluytmans-van den Bergh MFQ, 2016, J CLIN MICROBIOL, V54, P2919, DOI 10.1128/JCM.01648-16; Molenaar M, NVMM NAJ AM NETH; Mulvey MR, 2003, J CLIN MICROBIOL, V41, P460, DOI 10.1128/JCM.41.1.460-462.2003; Nijhuis RHT, 2016, J ANTIMICROB CHEMOTH, V71, P2344, DOI 10.1093/jac/dkw192; Overdevest I, 2016, EUROSURVEILLANCE, V21, P24, DOI 10.2807/1560-7917.ES.2016.21.42.30376; Platteel TN, 2015, CLIN MICROBIOL INFEC, V21, P141, DOI 10.1016/j.cmi.2014.09.014; Price LB, 2013, MBIO, V4, DOI 10.1128/mBio.00377-13; Reuland EA, 2016, J ANTIMICROB CHEMOTH, V71, P1076, DOI 10.1093/jac/dkv441; Reuland EA, 2013, CLIN MICROBIOL INFEC, V19, P542, DOI 10.1111/j.1469-0691.2012.03947.x; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Tacconelli E, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12427; Terveer EM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178598; Tschudin-Sutter S, 2012, CLIN INFECT DIS, V55, P1505, DOI 10.1093/cid/cis770; van Buul LW, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2012.04.004; van den Dool C, 2016, INFECT CONT HOSP EP, V37, P761, DOI 10.1017/ice.2016.59; Verhoef L, 2016, J ANTIMICROB CHEMOTH, V71, P2586, DOI 10.1093/jac/dkw183; Verhoef Stobberingh, 2017, EUR C CLIN MICR INF; Willemsen I, 2015, INFECT CONT HOSP EP, V36, P394, DOI 10.1017/ice.2014.76; Willemsen I, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-26	30	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2019	14	9							e0222200	10.1371/journal.pone.0222200	http://dx.doi.org/10.1371/journal.pone.0222200			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4IG	31513682	Green Submitted, Green Published, gold			2022-12-26	WOS:000532212700040
J	Sparks, RP; Arango, AS; Starr, ML; Aboff, ZL; Hurst, LR; Rivera-Kohr, DA; Zhang, C; Harnden, KA; Jenkins, JL; Guida, WC; Tajkhorshid, E; Fratti, RA				Sparks, Robert P.; Arango, Andres S.; Starr, Matthew L.; Aboff, Zachary L.; Hurst, Logan R.; Rivera-Kohr, David A.; Zhang, Chi; Harnden, Kevin A.; Jenkins, Jermaine L.; Guida, Wayne C.; Tajkhorshid, Emad; Fratti, Rutilio A.			A small-molecule competitive inhibitor of phosphatidic acid binding by the AAA plus protein NSF/Sec18 blocks the SNARE-priming stage of vacuole fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						phosphatidic acid; SNARE proteins; membrane fusion; membrane lipid; membrane trafficking; -SNAP; NSF; Sec17; Sec18	ETHYLMALEIMIDE-SENSITIVE FACTOR; PARTICLE MESH EWALD; IN-VITRO; SOFTWARE NEWS; ALPHA-SNAP; DYNAMICS; DOCKING; SEC18P; NSF; MECHANISM	The homeostasis of most organelles requires membrane fusion mediated by soluble N-ethylmaleimide-sensitive factor (NSF) attachment protein receptors (SNAREs). SNAREs undergo cycles of activation and deactivation as membranes move through the fusion cycle. At the top of the cycle, inactive cis-SNARE complexes on a single membrane are activated, or primed, by the hexameric ATPase associated with the diverse cellular activities (AAA+) protein, N-ethylmaleimide-sensitive factor (NSF/Sec18), and its co-chaperone alpha-SNAP/Sec17. Sec18-mediated ATP hydrolysis drives the mechanical disassembly of SNAREs into individual coils, permitting a new cycle of fusion. Previously, we found that Sec18 monomers are sequestered away from SNAREs by binding phosphatidic acid (PA). Sec18 is released from the membrane when PA is hydrolyzed to diacylglycerol by the PA phosphatase Pah1. Although PA can inhibit SNARE priming, it binds other proteins and thus cannot be used as a specific tool to further probe Sec18 activity. Here, we report the discovery of a small-molecule compound, we call IPA (inhibitor of priming activity), that binds Sec18 with high affinity and blocks SNARE activation. We observed that IPA blocks SNARE priming and competes for PA binding to Sec18. Molecular dynamics simulations revealed that IPA induces a more rigid NSF/Sec18 conformation, which potentially disables the flexibility required for Sec18 to bind to PA or to activate SNAREs. We also show that IPA more potently and specifically inhibits NSF/Sec18 activity than does N-ethylmaleimide, requiring the administration of only low micromolar concentrations of IPA, demonstrating that this compound could help to further elucidate SNARE-priming dynamics.	[Sparks, Robert P.; Starr, Matthew L.; Hurst, Logan R.; Rivera-Kohr, David A.; Zhang, Chi; Tajkhorshid, Emad; Fratti, Rutilio A.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Harnden, Kevin A.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Arango, Andres S.; Aboff, Zachary L.; Tajkhorshid, Emad; Fratti, Rutilio A.] Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA; [Tajkhorshid, Emad] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Jenkins, Jermaine L.] Univ Rochester, Med Ctr, Struct Biol & Biophys Facil, Rochester, NY 14642 USA; [Guida, Wayne C.] Univ S Florida, Dept Chem, Tampa, FL 33620 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Rochester; State University System of Florida; University of South Florida	Fratti, RA (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.; Fratti, RA (corresponding author), Univ Illinois, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA.	rfratti@illinois.edu	Tajkhorshid, Emad/AAN-8323-2021	Sparks, Robert/0000-0002-0485-8317	National Institutes of Health [R01-GM101132, P41-GM104601, U01-GM111251, U54-GM087519]; National Science Foundation [MCB 1818310]; Office of Naval Research [ONR N00014-16-1-2535]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI078498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM111251, U54GM087519, R01GM101132, P41GM104601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants R01-GM101132 (to R. A. F.) and P41-GM104601, U01-GM111251, and U54-GM087519 (to E. T.), National Science Foundation Grant MCB 1818310 (to R. A. F.), and Office of Naval Research Grant ONR N00014-16-1-2535 (to E. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beauchamp KA, 2011, J CHEM THEORY COMPUT, V7, P3412, DOI 10.1021/ct200463m; Capelluto DGS, 2014, BIOPHYS J, V106, P1101, DOI 10.1016/j.bpj.2014.01.032; Chang LF, 2012, NAT STRUCT MOL BIOL, V19, P268, DOI 10.1038/nsmb.2237; Cheever ML, 2001, NAT CELL BIOL, V3, P613, DOI 10.1038/35083000; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Ribeiro LND, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18573-7; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; DEWOLF FA, 1993, BIOCHEMISTRY-US, V32, P6688, DOI 10.1021/bi00077a023; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fratti RA, 2007, J BIOL CHEM, V282, P13133, DOI 10.1074/jbc.M700584200; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Furst J, 2003, EMBO J, V22, P4365, DOI 10.1093/emboj/cdg420; GLICK BS, 1987, NATURE, V326, P309, DOI 10.1038/326309a0; Gowers R. J., 2016, 15 PYTH SCI C SCIPY, P98, DOI [10.25080/majora-629-541a-00e, DOI 10.25080/MAJORA-629-541A-00E, DOI 10.25080/MAJORA-629E541A-00E]; GRIFFIN EA, 1986, BIOCHEMISTRY-US, V25, P7875, DOI 10.1021/bi00372a013; GUNTHERAUSBORN S, 1995, J BIOL CHEM, V270, P29279; HAAS A, 1994, J CELL BIOL, V126, P87, DOI 10.1083/jcb.126.1.87; Haas A, 1996, EMBO J, V15, P3296, DOI 10.1002/j.1460-2075.1996.tb00694.x; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Humphrey W., 1996, J MOL GRAPHICS, V14, P33; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Ko YJ, 2014, P NATL ACAD SCI USA, V111, P7677, DOI 10.1073/pnas.1400036111; Koike S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09617-9; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Matsuoka K, 1998, MOL CELL, V2, P703, DOI 10.1016/S1097-2765(00)80168-9; Matveeva EA, 2001, J BIOL CHEM, V276, P12174, DOI 10.1074/jbc.M007394200; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; Mencher S.K., 2005, BMC CLIN PHARM, V5, P3, DOI DOI 10.1186/1472-6904-5-3; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Mima J, 2009, J BIOL CHEM, V284, P27114, DOI 10.1074/jbc.M109.010223; Miner GE, 2017, TRAFFIC, V18, P315, DOI 10.1111/tra.12479; Miner GE, 2016, J BIOL CHEM, V291, P17651, DOI 10.1074/jbc.M116.725366; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Pande VS, 2010, METHODS, V52, P99, DOI 10.1016/j.ymeth.2010.06.002; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; RODRIGUEZ L, 1994, MOL BIOL CELL, V5, P773, DOI 10.1091/mbc.5.7.773; Sasser T, 2012, J BIOL CHEM, V287, P2221, DOI 10.1074/jbc.M111.317420; Shah VM, 2018, J CONTROL RELEASE, V291, P169, DOI 10.1016/j.jconrel.2018.10.021; Slepushkin VA, 1997, J BIOL CHEM, V272, P2382; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Song HK, 2017, ELIFE, V6, DOI 10.7554/eLife.26646; Sparks RP, 2019, METHODS MOL BIOL, V1860, P199, DOI 10.1007/978-1-4939-8760-3_12; Sparks RP, 2019, METHODS MOL BIOL, V1860, P191, DOI 10.1007/978-1-4939-8760-3_11; Sparks RP, 2016, BIOCHEM BIOPH RES CO, V479, P551, DOI 10.1016/j.bbrc.2016.09.108; Starr ML, 2019, J BIOL CHEM, V294, P3100, DOI 10.1074/jbc.RA118.006552; Starr ML, 2016, TRAFFIC, V17, P1091, DOI 10.1111/tra.12423; Steel GJ, 1999, BIOCHEMISTRY-US, V38, P7764, DOI 10.1021/bi990315v; Studier FW, 2014, METHODS MOL BIOL, V1091, P17, DOI 10.1007/978-1-62703-691-7_2; TAGAYA M, 1993, J BIOL CHEM, V268, P2662; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; White KI, 2018, ELIFE, V7, DOI 10.7554/eLife.38888; Whiteheart SW, 2001, INT REV CYTOL, V207, P71; WILSON DW, 1989, NATURE, V339, P355, DOI 10.1038/339355a0; Zhao CX, 2007, FEBS LETT, V581, P2140, DOI 10.1016/j.febslet.2007.03.032; Zhao ML, 2016, J MOL BIOL, V428, P1912, DOI 10.1016/j.jmb.2015.10.026; Zhao ML, 2015, NATURE, V518, P61, DOI 10.1038/nature14148	60	4	4	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 15	2019	294	46					17168	17185		10.1074/jbc.RA119.008865	http://dx.doi.org/10.1074/jbc.RA119.008865			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JW6QG	31515268	Green Published, hybrid			2022-12-26	WOS:000503173500001
J	Tremblay, JR; Lopez, K; Ku, HT				Tremblay, Jacob R.; Lopez, Kasandra; Ku, Hsun Teresa			A GLIS3?CD133?WNT-signaling axis regulates the self-renewal of adult murine pancreatic progenitor-like cells in colonies and organoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pancreas; endocrinology; stem cells; cell therapy; Wnt signaling; ?-catenin; cell replacement; GLIS family zinc finger 3; progenitor cell; self-renewal	NEONATAL DIABETES-MELLITUS; FOCAL ADHESION KINASE; ZINC-FINGER PROTEIN; BETA-CATENIN; STEM-CELLS; IN-VITRO; SURVIVAL SIGNALS; ENDOCRINE-CELLS; MOUSE PANCREAS; FORMING CELLS	The existence and regenerative potential of resident stem and progenitor cells in the adult pancreas are controversial topics. A question that has been only minimally addressed is the capacity of a progenitor cell to self-renew, a key attribute that defines stem cells. Previously, our laboratory has identified putative stem and progenitor cells from the adult murine pancreas. Using an ex vivo colony/organoid culture system, we demonstrated that these stem/progenitor-like cells have self-renewal and multilineage differentiation potential. We have named these cells pancreatic colony-forming units (PCFUs) because they can give rise to three-dimensional colonies. However, the molecular mechanisms by which PCFUs self-renew have remained largely unknown. Here, we tested the hypothesis that PCFU self-renewal requires GLIS family zinc finger 3 (GLIS3), a zinc-finger transcription factor important in pancreas development. Pancreata from 2- to 4-month-old mice were dissociated, sorted for CD133(high)CD71(low) ductal cells, known to be enriched for PCFUs, and virally transduced with shRNAs to knock down GLIS3 and other proteins. We then plated these cells into our colony assays and analyzed the resulting colonies for protein and gene expression. Our results revealed a previously unknown GLIS3?to?CD133?to?WNT signaling axis in which GLIS3 and CD133 act as factors necessary for maintaining WNT receptors and signaling molecules in colonies, allowing responses to WNT ligands. Additionally, we found that CD133, but not GLIS3 or WNT, is required for phosphoinositide 3-kinase (PI3K)/AKT Ser/Thr kinase (AKT)-mediated PCFU survival. Collectively, our results uncover a molecular pathway that maintains self-renewal of adult murine PCFUs.	[Tremblay, Jacob R.; Lopez, Kasandra; Ku, Hsun Teresa] City Hope Natl Med Ctr, Beckman Res Inst, Diabet & Metab Res Inst, Dept Translat Res & Cellular Therapeut, Duarte, CA 91006 USA; [Tremblay, Jacob R.; Ku, Hsun Teresa] City Hope Natl Med Ctr, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91006 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope	Ku, HT (corresponding author), City Hope Natl Med Ctr, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91006 USA.; Ku, HT (corresponding author), City Hope Natl Med Ctr, Dept Translat Res & Cellular Therapeut, Duarte, CA 91010 USA.	hku@coh.org		Ku, Hsun/0000-0001-5662-9893	National Institutes of Health [R01DK099734]; Wanek Family Project of Type 1 Diabetes; Norman and Melinda Payson Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099734] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wanek Family Project of Type 1 Diabetes; Norman and Melinda Payson Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grant R01DK099734 and a grant from Wanek Family Project of Type 1 Diabetes (to H. T. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Recipient of pre-doctoral support from the Norman and Melinda Payson Fellowship.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Arndt K, 2013, P NATL ACAD SCI USA, V110, P5582, DOI 10.1073/pnas.1215438110; Atkinson MA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007641; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Biechele S, 2011, DEV BIOL, V355, P275, DOI 10.1016/j.ydbio.2011.04.029; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Brembeck FH, 2004, GENE DEV, V18, P2225, DOI 10.1101/gad.317604; Brescia P, 2013, STEM CELLS, V31, P857, DOI 10.1002/stem.1317; Brossa A, 2018, STEM CELL TRANSL MED, V7, P283, DOI 10.1002/sctm.17-0158; Carpenter RL, 2014, CANCERS, V6, P897, DOI 10.3390/cancers6020897; Chen EY, 2014, P NATL ACAD SCI USA, V111, P5349, DOI 10.1073/pnas.1317731111; Criscimanna A, 2011, GASTROENTEROLOGY, V141, P1451, DOI 10.1053/j.gastro.2011.07.003; de Lau W, 2014, GENE DEV, V28, P305, DOI 10.1101/gad.235473.113; Dimitri P, 2015, J CLIN ENDOCR METAB, V100, pE1362, DOI 10.1210/jc.2015-1827; Dimitri P, 2011, EUR J ENDOCRINOL, V164, P437, DOI 10.1530/EJE-10-0893; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dorrell C, 2014, STEM CELL RES, V13, P275, DOI 10.1016/j.scr.2014.07.006; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Ghazalli N, 2015, STEM CELLS DEV, V24, P1995, DOI 10.1089/scd.2015.0007; Han T, 2017, NAT COMMUN, V8, P1, DOI 10.1038/ncomms15945; Herbst F, 2012, MOL THER, V20, P1014, DOI 10.1038/mt.2012.46; Hirano T, 2000, ONCOGENE, V19, P2548, DOI 10.1038/sj.onc.1203551; Horn PA, 1999, BLOOD, V93, P1435, DOI 10.1182/blood.V93.4.1435; Hossini AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154770; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Jeon K, 2019, STEM CELLS, V37, P202, DOI 10.1002/stem.2941; Jetten AM, 2018, CELL MOL LIFE SCI, V75, P3473, DOI 10.1007/s00018-018-2841-9; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jin L, 2016, STEM CELL RES, V16, P40, DOI 10.1016/j.scr.2015.11.015; Jin Liang, 2014, Rev Diabet Stud, V11, P35, DOI 10.1900/RDS.2014.11.35; Jin L, 2014, STEM CELLS DEV, V23, P899, DOI 10.1089/scd.2013.0466; Jin L, 2013, P NATL ACAD SCI USA, V110, P3907, DOI 10.1073/pnas.1301889110; Kang HS, 2016, STEM CELLS, V34, P2772, DOI 10.1002/stem.2449; Kang HS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157138; Kang HS, 2009, MOL CELL BIOL, V29, P6366, DOI 10.1128/MCB.01259-09; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Kim YS, 2012, MOL CELLS, V34, P193, DOI 10.1007/s10059-012-0109-z; Kim YS, 2003, NUCLEIC ACIDS RES, V31, P5513, DOI 10.1093/nar/gkg776; Kim YS, 2002, J BIOL CHEM, V277, P30901, DOI 10.1074/jbc.M203563200; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee J, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317695534; Lee SY, 2017, ONCOTARGET, V8, P77041, DOI 10.18632/oncotarget.20334; Liu CJ, 2016, J BIOL CHEM, V291, P15540, DOI 10.1074/jbc.M115.712976; Liu GZ, 2003, MOL CELL BIOL, V23, P5825, DOI 10.1128/MCB.23.16.5825-5835.2003; Ma B, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00378; Maekawa M, 2011, NATURE, V474, P225, DOI 10.1038/nature10106; Mak AB, 2012, CELL REP, V2, P951, DOI 10.1016/j.celrep.2012.09.016; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Moon Y, 2016, CLIN EXP METASTAS, V33, P487, DOI 10.1007/s10585-016-9793-y; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nogueira TC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003532; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rappa G, 2013, EXP CELL RES, V319, P810, DOI 10.1016/j.yexcr.2013.01.003; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Ridgway RA, 2012, CARCINOGENESIS, V33, P2369, DOI 10.1093/carcin/bgs284; Ring DB, 2003, DIABETES, V52, P588, DOI 10.2337/diabetes.52.3.588; Rurale G, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00730; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Sancho R, 2014, CELL STEM CELL, V15, P139, DOI 10.1016/j.stem.2014.06.019; Sedgwick AE, 2016, CANCERS, V8, DOI 10.3390/cancers8090080; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Shimozato O, 2015, ONCOGENE, V34, P1949, DOI 10.1038/onc.2014.141; Taddei ML, 2002, CANCER RES, V62, P6489; Tang Y, 2008, J BIOL CHEM, V283, P23956, DOI 10.1074/jbc.M800351200; Ten Berge D, 2011, NAT CELL BIOL, V13, P1070, DOI 10.1038/ncb2314; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tremblay JR, 2016, JOVE-J VIS EXP, DOI 10.3791/54016; Wang J, 2005, TISSUE CELL, V37, P25, DOI 10.1016/j.tice.2004.09.002; Watanabe N, 2009, FEBS LETT, V583, P2108, DOI 10.1016/j.febslet.2009.05.039; Wedeken L, 2017, STEM CELLS DEV, V26, P599, DOI 10.1089/scd.2016.0328; Wei YY, 2013, P NATL ACAD SCI USA, V110, P6829, DOI 10.1073/pnas.1217002110; Wen XJ, 2017, J MOL ENDOCRINOL, V58, pR73, DOI 10.1530/JME-16-0232; Winkler M, 2011, JOVE-J VIS EXP, DOI 10.3791/3148; Xiao XW, 2013, J CLIN INVEST, V123, P2207, DOI 10.1172/JCI66323; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yang Y, 2011, DIABETOLOGIA, V54, P2595, DOI 10.1007/s00125-011-2255-9; Yang YS, 2013, EMBO MOL MED, V5, P92, DOI 10.1002/emmm.201201398; ZeRuth GT, 2013, MOL ENDOCRINOL, V27, P1692, DOI 10.1210/me.2013-1117; Zhang S, 2012, ANAT REC, V295, P2104, DOI 10.1002/ar.22592	82	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					16634	16649		10.1074/jbc.RA118.002818	http://dx.doi.org/10.1074/jbc.RA118.002818			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31533988	hybrid, Green Published			2022-12-26	WOS:000501801900014
J	Liu, LY; Li, CZ; Han, YC; Wang, ZB; Feng, L; Zhi, XY; Yang, BF; Lei, YP; Du, WL; Li, YB				Liu, Liyuan; Li, Chuanzong; Han, Yingchun; Wang, Zhanbiao; Feng, Lu; Zhi, Xiaoyu; Yang, Beifang; Lei, Yaping; Du, Wenli; Li, Yabing			Adjusting cotton planting density under the climatic conditions of Henan Province, China	PLOS ONE			English	Article							RADIATION INTERCEPTION; POPULATION-DENSITY; LIGHT INTERCEPTION; SPATIAL-DISTRIBUTION; YIELD COMPONENTS; MAIZE; CANOPY; ARCHITECTURE; RESPONSES; PHOTOSYNTHESIS	The growth and development of cotton are closely related to climatic variables such as temperature and solar radiation. Adjusting planting density is one of the most effective measures for maximizing cotton yield under certain climatic conditions. The objectives of this study were (1) to determine the optimum planting density and the corresponding leaf area index (LAI) and yield under the climatic conditions of Henan Province, China, and (2) to learn how climatic conditions influence cotton growth, yield, and yield components. A three-year (2013-2015) field experiment was conducted in Anyang, Henan Province, using cultivar SCRC28 across six planting density treatments: 15,000, 33,000, 51,000, 69,000, 87,000, and 105,000 plants ha(-1). The data showed that the yield attributes, including seed cotton yield, lint yield, dry matter accumulation, and the LAI, increased as planting density increased. Consequently, the treatment of the maximum density with 105,000 plants ha(-1) was the highest-yielding over three years, with the LAIs averaged across the three years being 0.37 at the bud stage, 2.36 at the flower and boll-forming stage, and 1.37 at the bollopening stage. Furthermore, the correlation between the cotton yield attributes and meteorological conditions indicated that light interception (LI) and the diurnal temperature range were the climatic factors that most strongly influenced cotton seed yield. Moreover, the influence of the number of growing degree days (GDD) on cotton was different at different growth stages. These observations will be useful for determining best management practices for cotton production under the climatic conditions of Henan Province, China.	[Liu, Liyuan; Li, Chuanzong; Han, Yingchun; Wang, Zhanbiao; Feng, Lu; Zhi, Xiaoyu; Yang, Beifang; Lei, Yaping; Du, Wenli; Li, Yabing] Chinese Acad Agr Sci, Inst Cotton Res, Anyang, Henan, Peoples R China; [Liu, Liyuan; Li, Chuanzong; Han, Yingchun; Wang, Zhanbiao; Feng, Lu; Zhi, Xiaoyu; Yang, Beifang; Lei, Yaping; Du, Wenli; Li, Yabing] State Key Lab Cotton Biol, Anyang, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Li, YB (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, Anyang, Henan, Peoples R China.; Li, YB (corresponding author), State Key Lab Cotton Biol, Anyang, Henan, Peoples R China.	criliyabing1@163.com	Yabing, Li/GLU-9964-2022		National Key Research and Development Project [2017YFD0201906]	National Key Research and Development Project	This work was supported by the National Key Research and Development Project grant 2017YFD0201906 to Y. Li. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bednarz CW, 2006, CROP SCI, V46, P950, DOI 10.2135/cropsci2005.08-0276; Bednarz CW, 2005, AGRON J, V97, P235; Begna SH, 1997, J AGRON CROP SCI, V179, P9, DOI 10.1111/j.1439-037X.1997.tb01142.x; Boquet DJ, 2005, AGRON J, V97, P279, DOI 10.2134/agronj2005.0279; Boroomandan P, 2009, Pak J Biol Sci, V12, P378, DOI 10.3923/pjbs.2009.378.382; Chen G.P., 2012, ACTA AGRON SIN, V38, P80, DOI [10.3724/SP.J.1006.2012.00080, DOI 10.3724/SP.J.1006.2012.00080]; Chenu K, 2005, FUNCT PLANT BIOL, V32, P1123, DOI 10.1071/FP05091; Clover GRG, 2001, J AGR SCI, V136, P169, DOI 10.1017/S002185960100853X; Dai JL, 2015, FIELD CROP RES, V180, P207, DOI 10.1016/j.fcr.2015.06.008; Dong HZ, 2006, FIELD CROP RES, V98, P106, DOI 10.1016/j.fcr.2005.12.008; Duvrick D. N., 1999, CROP SCI, V39, P1622; Echarte L, 2000, FIELD CROP RES, V68, P1, DOI 10.1016/S0378-4290(00)00101-5; Escobar-Gutierrez AJ, 2009, AGR FOREST METEOROL, V149, P1244, DOI 10.1016/j.agrformet.2009.02.011; Evans LT, 1999, CROP SCI, V39, P1544, DOI 10.2135/cropsci1999.3961544x; Flenet F, 1996, AGRON J, V88, P185, DOI 10.2134/agronj1996.00021962008800020011x; GALANOPOULOUSENDOUKA S, 1980, AGRON J, V72, P347, DOI 10.2134/agronj1980.00021962007200020022x; Gerardeaux E, 2009, J AGR SCI, V147, P155, DOI 10.1017/S0021859608008381; Giuliani R, 2000, PLANT CELL ENVIRON, V23, P783, DOI 10.1046/j.1365-3040.2000.00600.x; Hecht VL, 2019, PLANT SOIL, V439, P179, DOI 10.1007/s11104-018-3764-9; Iizumi T, 2015, GLOB FOOD SECUR-AGR, V4, P46, DOI 10.1016/j.gfs.2014.11.003; Jones MA, 1997, CROP SCI, V37, P797, DOI 10.2135/cropsci1997.0011183X003700030017x; Kaggwa-Asiimwe R, 2013, FIELD CROP RES, V145, P52, DOI 10.1016/j.fcr.2013.02.005; Liu TN, 2015, FIELD CROP RES, V170, P32, DOI 10.1016/j.fcr.2014.09.015; Liu Y, 2015, CROP SCI, V55, P1806, DOI 10.2135/cropsci2014.10.0735; Maddonni GA, 2001, FIELD CROP RES, V71, P183, DOI 10.1016/S0378-4290(01)00158-7; Mao LL, 2014, FIELD CROP RES, V155, P67, DOI 10.1016/j.fcr.2013.09.021; Mariscal MJ, 2000, AGR FOREST METEOROL, V100, P183, DOI 10.1016/S0168-1923(99)00137-9; McConnell JS, 2004, J PLANT NUTR, V27, P1183, DOI 10.1081/PLN-120038543; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Sarlikioti V, 2011, ANN BOT-LONDON, V107, P875, DOI 10.1093/aob/mcr006; Srinivasan V, 2017, GLOBAL CHANGE BIOL, V23, P1626, DOI 10.1111/gcb.13526; TETIOKAGHO F, 1988, AGRON J, V80, P935, DOI 10.2134/agronj1988.00021962008000060019x; Tian B, 2015, BIOCHEM SYST ECOL, V60, P150, DOI 10.1016/j.bse.2015.04.014; Tiwari RS, 2013, EUPHYTICA, V194, P1, DOI 10.1007/s10681-013-0927-x; Tsimba R, 2013, FIELD CROP RES, V150, P135, DOI 10.1016/j.fcr.2013.05.028; van Ittersum MK, 2013, FIELD CROP RES, V143, P1, DOI 10.1016/j.fcr.2012.12.012; [王春艳 WANG Chunyan], 2006, [棉花学报, Cotton Science], V18, P223; Wiechers D, 2011, AGR FOREST METEOROL, V151, P906, DOI 10.1016/j.agrformet.2011.02.016; Xu WJ, 2017, FIELD CROP RES, V212, P126, DOI 10.1016/j.fcr.2017.05.006; Xue HY, 2015, FIELD CROP RES, V184, P17, DOI 10.1016/j.fcr.2015.09.004; Yang GZ, 2014, J INTEGR AGR, V13, P2154, DOI 10.1016/S2095-3119(13)60727-3; Yang GZ, 2010, AGR SCI CHINA, V9, P1749, DOI 10.1016/S1671-2927(09)60273-X; Yang YM, 2014, AGR WATER MANAGE, V144, P42, DOI 10.1016/j.agwat.2014.06.001; Zhang HN, 2012, P NATL ACAD SCI USA, V109, P10275, DOI 10.1073/pnas.1200156109; Zhi XY, 2016, J INTEGR AGR, V15, P1469, DOI 10.1016/S2095-3119(15)61174-1; Zhi XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113409	46	0	0	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222395	10.1371/journal.pone.0222395	http://dx.doi.org/10.1371/journal.pone.0222395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557178	Green Published, gold			2022-12-26	WOS:000532345500016
J	Zongo, A; Simpson, S; Johnson, JA; Eurich, DT				Zongo, Arsene; Simpson, Scot; Johnson, Jeffrey A.; Eurich, Dean T.			Optimal threshold of adherence to lipid lowering drugs in predicting acute coronary syndrome, stroke, or mortality: A cohort study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASES; RISK; METAANALYSIS; PREVENTION	Objective Thresholds defining medication adherence are rarely evidence-based. A threshold of 0.8 is typically presumed to achieve improved outcomes. We aimed to assess the optimal threshold of adherence to lipid-lowering drugs (LLD) in predicting cardiovascular-related (CV) outcomes in patients with hypertension. Design Cohort study of new users of LLDs. Setting Comprehensive healthcare administrative databases of the province of Alberta (Canada) from 2008 to 2016. Participants Patients with hypertension, who were new users of LLDs. Patients who had the outcomes prior to the initiation of LLD were excluded. Main outcomes measures Hospitalization for acute coronary syndrome (ACS)/stroke, CV-related mortality and all-sscause mortality. Statistical analysis Adherence to LLDs was assessed as the proportion of days covered (PDC) by any LLD, from drug initiation to censoring, outcome, or study end. Three methods were used to assess the threshold: Contal and O'Quigley method, minimum distance method, and Youden's J index. Cox regressions were used to assess the risk associated with each method-specific threshold and Akaike information criteria were used to retain the optimal threshold after adjustment. Results 52229 patients were included; 4.0% were hospitalized for ACS/stroke, 3.4% died, and 1.3% died from CV-related cause. In predicting ACS/stroke, CV-related and all-cause mortality, the optimal adherence threshold was 0.52 (range: 0.51-0.54), 0.79 (0.45-0.87), and 0.84 (0.79-0.89), respectively. These results were consistent among patients aged >= 65 years (n = 19804). However, the results varied among those aged < 65 years, where the incidence rates of outcomes were low. Conclusion In new-users of LLDs with hypertension, approximately 50% days covered by LLDs may be enough to prevent long-term occurrence of ACS, or stroke. However, a threshold near 0.80 may be needed to prevent or reduce the risk of all-cause or CV-related mortality.	[Zongo, Arsene; Johnson, Jeffrey A.; Eurich, Dean T.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Zongo, Arsene] Univ Laval, Fac Pharm, Quebec City, PQ, Canada; [Zongo, Arsene] CHU Quebec Univ Laval Res Ctr, Populat Hlth & Optimal Hlth Practices Res Unit, Quebec City, PQ, Canada; [Simpson, Scot] Univ Alberta, Fac Pharm & Pharmaceut Sci, Edmonton, AB, Canada	University of Alberta; Laval University; University of Alberta	Eurich, DT (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	deurich@ualberta.ca	Zongo, Arsene/AAC-3790-2020	Zongo, Arsene/0000-0001-8812-3088	Institute of Health Economics; Government of Canada	Institute of Health Economics; Government of Canada(CGIAR)	This work was supported by a grant from the Institute of Health Economics. DTE is a Canada Research Chair supported by the Government of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Banach M, 2016, INT J CARDIOL, V225, P184, DOI 10.1016/j.ijcard.2016.09.075; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Contal C, 1999, COMPUT STAT DATA AN, V30, P253, DOI 10.1016/S0167-9473(98)00096-6; Corella D, 2014, AGEING RES REV, V18, P53, DOI 10.1016/j.arr.2014.08.002; Hajian-Tilaki K, 2013, CASP J INTERN MED, V4, P627; Indrayan A., 2012, MED BIOSTATISTICS, P1008; Karve S, 2009, CURR MED RES OPIN, V25, P2303, DOI 10.1185/03007990903126833; Lo-Ciganic WH, 2015, MED CARE, V53, P720, DOI 10.1097/MLR.0000000000000394; Mahmood SS, 2014, LANCET, V383, P999, DOI 10.1016/S0140-6736(13)61752-3; Mandrekar JN, 2003, P 28 SAS US GROUP IN; McCormick N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135834; McCormick N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092286; Mrekar J.N., CUTPOINT DETERMINATI; Naci H, 2013, EUR J PREV CARDIOL, V20, P641, DOI 10.1177/2047487313480435; North BJ, 2012, CIRC RES, V110, P1097, DOI 10.1161/CIRCRESAHA.111.246876; O'Donnel CJ, 2008, REV ESP CARDIOL, V61, P299, DOI 10.1016/S1885-5857(08)60118-8; Poulter NR, 2015, LANCET, V386, P801, DOI 10.1016/S0140-6736(14)61468-9; SACKETT DL, 1975, LANCET, V1, P1205; Stewart J, 2017, JRSM CARDIOVASC DIS, V6, DOI 10.1177/2048004016687211; Thavendiranathan P, 2006, ARCH INTERN MED, V166, P2307, DOI 10.1001/archinte.166.21.2307; Toms JD, 2015, AVIAN CONSERV ECOL, V10, DOI 10.5751/ACE-00715-100102	22	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0223062	10.1371/journal.pone.0223062	http://dx.doi.org/10.1371/journal.pone.0223062			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553787	Green Published, gold			2022-12-26	WOS:000532319200052
J	Van Hedger, SC; Heald, SLM; Nusbaum, HC				Van Hedger, Stephen C.; Heald, Shannon L. M.; Nusbaum, Howard C.			Absolute pitch can be learned by some adults	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; CRITICAL PERIOD; WORKING-MEMORY; STUDENTS; MUSIC; IDENTIFICATION; AMERICAN; JUDGMENT; CHILDREN	Absolute pitch (AP), the rare ability to name any musical note without the aid of a reference note, is thought to depend on an early critical period of development. Although recent research has shown that adults can improve AP performance in a single training session, the best learners still did not achieve note classification levels comparable to performance of a typical, "genuine" AP possessor. Here, we demonstrate that these "genuine" levels of AP performance can be achieved within eight weeks of training for at least some adults, with the best learner passing all measures of AP ability after training and retaining this knowledge for at least four months after training. Alternative explanations of these positive results, such as improving accuracy through adopting a slower, relative pitch strategy, are not supported based on joint analyses of response time and accuracy. The results also did not appear to be driven by extreme familiarity with a single instrument or octave range, as the post-training AP assessments used eight different timbres and spanned over seven octaves. Yet, it is also important to note that a majority of the participants only exhibited modest improvements in performance, suggesting that adult AP learning is difficult and that near-perfect levels of AP may only be achievable by subset of adults. Overall, these results demonstrate that explicit perceptual training in some adults can lead to AP performance that is behaviorally indistinguishable from AP that manifests within a critical period of development. Implications for theories of AP acquisition are discussed.	[Van Hedger, Stephen C.; Heald, Shannon L. M.; Nusbaum, Howard C.] Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA; [Van Hedger, Stephen C.; Heald, Shannon L. M.; Nusbaum, Howard C.] Univ Chicago, Ctr Pract Wisdom, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Van Hedger, SC (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.; Van Hedger, SC (corresponding author), Univ Chicago, Ctr Pract Wisdom, Chicago, IL 60637 USA.	svanhedg@uwo.ca	Van Hedger, Stephen Charles/V-3248-2019	Van Hedger, Stephen Charles/0000-0002-2448-9088				Athos EA, 2007, P NATL ACAD SCI USA, V104, P14795, DOI 10.1073/pnas.0703868104; Bachem A, 1937, J ACOUST SOC AM, V9, P146, DOI 10.1121/1.1915919; Baharloo S, 1998, AM J HUM GENET, V62, P224, DOI 10.1086/301704; Baharloo S, 2000, AM J HUM GENET, V67, P755, DOI 10.1086/303057; Bahr N., 2005, PSYCHOL MUSIC, V33, P58, DOI [10.1177/0305735605048014, DOI 10.1177/0305735605048014]; Bermudez P, 2009, MUSIC PERCEPT, V27, P89, DOI 10.1525/MP.2009.27.2.89; BRADY PT, 1970, J ACOUST SOC AM, V48, P883, DOI 10.1121/1.1912227; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Crowe S, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-100; Crozier J.B., 1997, PSYCHOL MUSIC, V25, P110, DOI DOI 10.1177/0305735697252002; CUDDY LL, 1968, J ACOUST SOC AM, V43, P1069, DOI 10.1121/1.1910941; Deutsch D, 2006, J ACOUST SOC AM, V119, P719, DOI 10.1121/1.2151799; Deutsch D, 2013, J ACOUST SOC AM, V134, P3853, DOI 10.1121/1.4824450; Deutsch D, 2013, PSYCHOLOGY OF MUSIC, THIRD EDITION, P141, DOI 10.1016/B978-0-12-381460-9.00005-5; Deutsch D, 2013, J ACOUST SOC AM, V133, P1859, DOI 10.1121/1.4792217; Deutsch D, 2009, J ACOUST SOC AM, V125, P2398, DOI 10.1121/1.3081389; Dohn A, 2014, MUSIC PERCEPT, V31, P359, DOI 10.1525/MP.2014.31.4.359; Gervain J., 2013, FRONT SYST NEUROSCI, V7, P1; HARTMAN EB, 1954, AM J PSYCHOL, V67, P1, DOI 10.2307/1418067; Heald S. L., 2014, FRONTIERS SYSTEMS NE, V8, P1, DOI DOI 10.3389/FNINS.2014; Heald SLM, 2017, PSYCHOL LEARN MOTIV, V67, P53, DOI 10.1016/bs.plm.2017.03.003; Hedger SC, 2013, PSYCHOL SCI, V24, P1496, DOI 10.1177/0956797612473310; HELLER MA, 1972, PSYCHON SCI, V26, P222; Levitin DJ, 2003, MUSIC PERCEPT, V21, P105, DOI 10.1525/mp.2003.21.1.105; Lundin R., 1963, MUSIC EDUC J, V49, P49, DOI [10.2307/3389949, DOI 10.2307/3389949]; Macmillan NA, 2005, DETECTION THEORY USE; Marsman M, 2017, EUR J DEV PSYCHOL, V14, P545, DOI 10.1080/17405629.2016.1259614; Mathot S, 2012, BEHAV RES METHODS, V44, P314, DOI 10.3758/s13428-011-0168-7; Miyazaki K, 2006, MUSIC PERCEPT, V24, P63, DOI 10.1525/mp.2006.24.1.63; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Ross DA, 2005, EPILEPSY BEHAV, V7, P578, DOI 10.1016/j.yebeh.2005.05.019; Ross DA, 2004, J ACOUST SOC AM, V116, P1793, DOI 10.1121/1.1758973; Ross DA, 2009, ANN NY ACAD SCI, V1169, P199, DOI 10.1111/j.1749-6632.2009.04847.x; Rush M., 1989, EXPT INVESITAGTION E, P401; Russo FA, 2003, MUSIC PERCEPT, V21, P119, DOI 10.1525/mp.2003.21.1.119; Smith NA, 2008, J ACOUST SOC AM, V123, pEL77, DOI 10.1121/1.2896106; Smith PL, 2018, PSYCHON B REV, V25, P2083, DOI 10.3758/s13423-018-1451-8; TAKEUCHI AH, 1993, PSYCHOL BULL, V113, P345, DOI 10.1037/0033-2909.113.2.345; Van Hedger SC, 2018, ACTA PSYCHOL, V191, P251, DOI 10.1016/j.actpsy.2018.10.007; Van Hedger SC, 2018, J EXP PSYCHOL HUMAN, V44, P1268, DOI 10.1037/xhp0000536; Van Hedger SC, 2018, Q J EXP PSYCHOL, V71, P879, DOI 10.1080/17470218.2017.1307427; Van Hedger SC, 2017, PSYCHON B REV, V24, P481, DOI 10.3758/s13423-016-1099-1; Van Hedger SC, 2016, COGNITION, V154, P139, DOI 10.1016/j.cognition.2016.06.001; Van Hedger SC, 2015, J ACOUST SOC AM, V138, P436, DOI 10.1121/1.4922952; Van Hedger SC, 2015, COGNITION, V140, P95, DOI 10.1016/j.cognition.2015.03.012; VIANELLO MA, 1968, PERCEPT MOTOR SKILL, V26, P576, DOI 10.2466/pms.1968.26.2.576; Vitouch O, 2003, MUSIC PERCEPT, V21, P111, DOI 10.1525/mp.2003.21.1.111; Ward W.D., 1982, PSYCHOL MUSIC, V2nd ed., P431; Wilson SJ, 2012, MUSIC PERCEPT, V29, P285, DOI 10.1525/MP.2012.29.3.285; Wong YK, 2018, ACQUIRING ABSOLUTE P, DOI [10.1101/355933, DOI 10.1101/355933]	50	7	7	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0223047	10.1371/journal.pone.0223047	http://dx.doi.org/10.1371/journal.pone.0223047			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	JC2ZT	31550277	Green Submitted, Green Published, gold			2022-12-26	WOS:000489146900001
J	Luo, JF; Deng, DZ; Zhang, L; Zhu, XW; Chen, DC; Zhou, JX				Luo, Jiufu; Deng, Dongzhou; Zhang, Li; Zhu, Xinwei; Chen, Dechao; Zhou, Jinxing			Soil and vegetation conditions changes following the different sand dune restoration measures on the Zoige Plateau	PLOS ONE			English	Article							PLANT FUNCTIONAL TYPES; COMMUNITY COMPOSITION; DESERTIFICATION; COMPETITION; SUCCESSION; NITROGEN; STABILIZATION; DEGRADATION; AMENDMENTS; STRATEGIES	Alpine sand dunes restoration is extremely difficult but important in the ecosystem restoration. Sand dunes are known as harsh soil and poor seed bank which freed from advantages on plants growth naturally. Effective restoration measures are required to guide the sand dune restoration. Here, indigenous grass (Elymus nutans) was sown in sand dune on the Zoige Plateau and treated with no sand barrier (CK) and environmental friendly materials including wicker sand barrier (wicker) and sandbag sand barrier (sandbag). The soil conditions were assessed by measuring the soil moisture and nutrients of the topsoil, and interspecific relationship and population niche were utilized to analyze the plant community structure variances among different restoration measures. Results showed that the soil and vegetation in the sand barriers measures were better than that in the CK. The soil moisture in the sandbag measure was 16.67% higher than that in the wicker measure. The nutrients content and microbial biomass were also the best in the sandbag measures. The ratio of strong association was the highest in the sandbag measure and the lowest in the CK, whereas the plants had the highest none association ratio in the CK. In addition, the average population niche overlap ranked by sandbag (0.39)> wicker (0.32)> CK (0.26). Thus, incorporation of sand barriers and indigenous grass seeding in alpine sand dunes could promote the sand dune restoration. And the sandbag measure showed a stronger improvement effect on the sand dune soil and vegetation conditions than the wicker measure.	[Luo, Jiufu; Zhou, Jinxing] Beijing Forestry Univ, Key Lab State Forestry Adm Soil & Water Conservat, Beijing, Peoples R China; [Luo, Jiufu; Zhou, Jinxing] Beijing Forestry Univ, Jianshui Res Field Stn, Beijing, Peoples R China; [Deng, Dongzhou; Chen, Dechao] Sichuan Acad Forestry, Chengdu, Peoples R China; [Zhang, Li; Zhu, Xinwei] Sichuan Aba Forestry Sci & Technol Res Inst, Wenchuan, Peoples R China	Beijing Forestry University; Beijing Forestry University	Zhou, JX (corresponding author), Beijing Forestry Univ, Key Lab State Forestry Adm Soil & Water Conservat, Beijing, Peoples R China.; Zhou, JX (corresponding author), Beijing Forestry Univ, Jianshui Res Field Stn, Beijing, Peoples R China.	zjx001@bjfu.edu.cn	Jinxing, Zhou/I-6015-2017	Jinxing, Zhou/0000-0003-2182-9849	Special Fund for Forest Scientific Research in the Public Welfare [201504401]; National Science & Technology Pillar Program [2015BAC05B01]; Sichuan Province Science and Technology Support Program [2016FZ0042]; Composition and Characteristics of Biological Soil Crusts in the Alpine Sand Dunes on the Northwest of Sichuan [2019CZZX24]	Special Fund for Forest Scientific Research in the Public Welfare; National Science & Technology Pillar Program; Sichuan Province Science and Technology Support Program; Composition and Characteristics of Biological Soil Crusts in the Alpine Sand Dunes on the Northwest of Sichuan	This study was funded by the Special Fund for Forest Scientific Research in the Public Welfare (no. 201504401), the National Science & Technology Pillar Program (no. 2015BAC05B01), Sichuan Province Science and Technology Support Program (no. 2016FZ0042), and the Composition and Characteristics of Biological Soil Crusts in the Alpine Sand Dunes on the Northwest of Sichuan (no. 2019CZZX24).	Abd El-Salam MM, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5164-z; Alvarez-Yepiz JC, 2014, OECOLOGIA, V175, P725, DOI 10.1007/s00442-014-2929-3; Anthwal Smriti, 2008, Environmentalist, V28, P261, DOI 10.1007/s10669-007-9137-1; Aponte C, 2010, BIOGEOCHEMISTRY, V101, P77, DOI 10.1007/s10533-010-9418-5; Bewick S, 2015, THEOR ECOL-NETH, V8, P81, DOI 10.1007/s12080-014-0227-7; Breckle SW, 2008, ARID DUNE ECOSYSTEMS, P79; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Callaway RM, 1996, ECOLOGY, V77, P2130, DOI 10.2307/2265707; Chauhan S. S., 2003, Environmentalist, V23, P219, DOI 10.1023/B:ENVR.0000017366.67642.79; Chen Yan-Rui, 2008, Zhiwu Shengtai Xuebao, V32, P1126, DOI 10.3773/j.issn.1005-264x.2008.05.017; COLWELL RK, 1971, ECOLOGY, V52, P567, DOI 10.2307/1934144; Cornwell WK, 2009, ECOL MONOGR, V79, P109, DOI 10.1890/07-1134.1; de Santiago A, 2019, LAND DEGRAD DEV, V30, P1121, DOI 10.1002/ldr.3298; Diaz S, 1997, J VEG SCI, V8, P463, DOI 10.2307/3237198; Dietterich LH, 2017, RESTOR ECOL, V25, P201, DOI 10.1111/rec.12423; Dong ZB, 2010, ENVIRON EARTH SCI, V59, P1731, DOI 10.1007/s12665-009-0155-9; Fan BL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168000; Fan DQ, 2017, J FORESTRY RES, V28, P115, DOI 10.1007/s11676-016-0289-z; Gao JQ, 2014, WETLANDS, V34, P235, DOI 10.1007/s13157-013-0487-9; Gong Rong, 2016, Chinese Journal of Plant Ecology, V40, P554, DOI 10.17521/cjpe.2015.0446; Harpole WS, 2011, OECOLOGIA, V166, P197, DOI 10.1007/s00442-010-1808-9; Hu YF, 2016, ECOL ENG, V94, P88, DOI 10.1016/j.ecoleng.2016.05.061; [姜鑫贵 Jiang Xingui], 2016, [林业科学, Scientia Silvae Sinicae], V52, P55; Kong YangYun, 2017, Acta Prataculturae Sinica, V26, P44; Kuster TM, 2016, PLANT SOIL, V406, P117, DOI 10.1007/s11104-016-2856-7; Levine JM, 2009, NATURE, V461, P254, DOI 10.1038/nature08251; LI YQ, 2017, SUSTAINABILITY-BASEL, V9, DOI DOI 10.3390/SU9040662; Lian J, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9020211; Liao ChengRui, 2018, Journal of Nanjing Forestry University (Natural Sciences Edition), V42, P89; Lichter J, 2000, J ECOL, V88, P825, DOI 10.1046/j.1365-2745.2000.00503.x; [林丽 Lin Li], 2012, [中国草地学报, Chinese Journal of Grassland], V34, P42; Lou Yan-jing, 2008, Shengtaixue Zazhi, V27, P509; Ma Kun, 2016, Shengtaixue Zazhi, V35, P1988, DOI 10.13292/j.1000-4890.201608.010; Manzoni S, 2010, ECOL MONOGR, V80, P89, DOI 10.1890/09-0179.1; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Nemoto M, 1997, ECOL RES, V12, P325, DOI 10.1007/BF02529462; Odriozola I, 2017, PERSPECT PLANT ECOL, V28, P36, DOI 10.1016/j.ppees.2017.07.002; Ohsowski BM, 2018, RESTOR ECOL, V26, P63, DOI 10.1111/rec.12528; Planka E.R., 1973, Annual Rev Ecol Syst, V4, P53; Pontes LD, 2015, AGRON SUSTAIN DEV, V35, P1297, DOI 10.1007/s13593-015-0314-1; Qing Ye, 2015, Acta Prataculturae Sinica, V24, P38; Raji BA, 2004, ENVIRON MONIT ASSESS, V99, P181, DOI 10.1007/s10661-004-4018-2; Roze F, 2004, RESTOR ECOL, V12, P29, DOI 10.1111/j.1061-2971.2004.00264.x; Shen ST, 2017, J MT SCI-ENGL, V14, P2003, DOI 10.1007/s11629-016-4133-x; [税伟 Shui Wei], 2017, [生态学报, Acta Ecologica Sinica], V37, P277; Wang T, 2002, SCI CHINA SER D, V45, P23, DOI 10.1007/BF02878385; Wei YJ, 2017, J INNER MONGOLIA AGR, V6, P86; Wu F, 2018, J INTEGR ENVIRON SCI, V15, P139, DOI 10.1080/1943815X.2018.1471725; [谢胜波 Xie Shengbo], 2014, [中国沙漠, Journal of Desert Research], V34, P42; Yan QL, 2005, PLANT SOIL, V277, P175, DOI 10.1007/s11104-005-6836-6; Yang TT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198805; Yu KF, 2017, J MT SCI-ENGL, V14, P77, DOI 10.1007/s11629-016-3929-z; [于洋 Yu Yang], 2014, [中国沙漠, Journal of Desert Research], V34, P67; [袁立敏 Yuan Limin], 2014, [水土保持通报, Bulletin of Soil and Water Conservation], V34, P46; Zhang ZH, 2010, ECOL RES, V25, P1151, DOI 10.1007/s11284-010-0740-0; Zhao JZ, 2002, INT J SUST DEV WORLD, V9, P292, DOI 10.1080/13504500209470124; Zou Chang-xin, 2018, Journal of Ecology and Rural Environment, V34, P961, DOI 10.11934/j.issn.1673-4831.2018.11.001	57	3	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0216975	10.1371/journal.pone.0216975	http://dx.doi.org/10.1371/journal.pone.0216975			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539377	Green Submitted, Green Published, gold			2022-12-26	WOS:000532297900004
J	Marinho-Neto, FA; Claudiano, GS; Yunis-Aguinaga, J; Cueva-Quiroz, VA; Kobashigawa, KK; Cruz, NRN; Moraes, FR; Moraes, JRE				Marinho-Neto, Fausto A.; Claudiano, Gustavo S.; Yunis-Aguinaga, Jefferson; Cueva-Quiroz, Victor A.; Kobashigawa, Karina K.; Cruz, Nathan R. N.; Moraes, Flavio R.; Moraes, Julieta R. E.			Morphological, microbiological and ultrastructural aspects of sepsis by Aeromonas hydrophila in Piaractus mesopotamicus	PLOS ONE			English	Article							LACTOCOCCUS-GARVIEAE INFECTION; ANTIBIOTIC SUSCEPTIBILITY; VIRULENCE FACTORS; L.; ASSOCIATION; ENTEROTOXIN; PREVALENCE; ZEBRAFISH; GENES; EELS	Aeromonas bacteria can cause an infection characterized by septicemia and is one of the most common pathogens in tropical fish. This disease is responsible for high morbidity and mortality rates, causing considerable losses in aquaculture. Thus, the understanding of its pathophysiology is crucial to develop control strategies of this bacterial infection in farmed fish. This study aimed to characterize early pathological aspects of acute sepsis in pacu (Piaractus mesopotamicus) experimentally infected with Aeromonas hydrophila. A total of 160 juvenile pacus were inoculated intraperitoneally with A. hydrophila (1.78 x 10(9) CFU/mL) and at 0 (control), 1, 3, 6, and 9 hours post-inoculation (hpi), animals were anesthetized and samples were collected for microbiological, light microscopy and transmission electron microscopy (TEM) analyzes. The results showed the occurrence of hemodynamic alterations, such as hemorrhage and congestion, which were observed mainly after 6 and 9 hpi. It was possible to re-isolate Aeromonas at all sampling times except in control group. However, just after 9 hpi it was possible to find the bacteria in all fish and tissues. Light microscopy analyses revealed a degenerative process, necrosis and vascular damage mainly at 6 and 9 hpi. According to the ultrastructural examination, areas of cellular death were identified in all examined tissues, especially at 6 and 9 hpi. However, the most severe, related to necrosis, were observed after 6 and 9 hpi. The findings suggested that this bacterium spreads in the first hpi through the fish organs, mainly affecting spleen, liver and kidney, causing irreversible lesions at the molecular level.	[Marinho-Neto, Fausto A.; Claudiano, Gustavo S.; Cruz, Nathan R. N.; Moraes, Flavio R.; Moraes, Julieta R. E.] Sao Paulo State Univ UNESP, Sch Agr & Vet Sci, Dept Vet Pathol, Jaboticabal, SP, Brazil; [Claudiano, Gustavo S.] Fed Univ Western Para UFOPA, Inst Biodivers & Forests, Santarem, Para, Brazil; [Yunis-Aguinaga, Jefferson; Cueva-Quiroz, Victor A.; Moraes, Flavio R.; Moraes, Julieta R. E.] Aquaculture Ctr UNESP, Jaboticabal, SP, Brazil; [Kobashigawa, Karina K.] Sao Paulo State Univ UNESP, Sch Agr & Vet Sci, Dept Vet Surg & Clin, Jaboticabal, SP, Brazil	Universidade Estadual Paulista; Universidade Federal do Oeste do Para; Universidade Estadual Paulista	Moraes, JRE (corresponding author), Sao Paulo State Univ UNESP, Sch Agr & Vet Sci, Dept Vet Pathol, Jaboticabal, SP, Brazil.; Moraes, JRE (corresponding author), Aquaculture Ctr UNESP, Jaboticabal, SP, Brazil.	julietaengracia@gmail.com	MORAES, JULIETA/AAC-3365-2019; Quiroz, Victor Alexander Alexander Cueva/T-7913-2017; Moraes, Julieta R. E./L-8484-2017; da Silva Claudiano, Gustavo/AAQ-5730-2020; Yunis Aguinaga, Jefferson/M-9808-2016	MORAES, JULIETA/0000-0002-8384-8781; Quiroz, Victor Alexander Alexander Cueva/0000-0002-9793-9297; Moraes, Julieta R. E./0000-0002-8384-8781; da Silva Claudiano, Gustavo/0000-0002-5063-9123; Yunis Aguinaga, Jefferson/0000-0002-1959-4350	Sao Paulo State Research Support Foundation - FAPESP [2014/10231-2, 2011/20280-2]; National Council for Scientific and Technological Development - CNPq [441054/2014-5]	Sao Paulo State Research Support Foundation - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors are grateful for the support of the Sao Paulo State Research Support Foundation - FAPESP projects no 2014/10231-2 and 2011/20280-2 and the National Council for Scientific and Technological Development - CNPq process 441054/2014-5). All grants were awarded to JREM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius C, 2003, J FISH DIS, V26, P499, DOI 10.1046/j.1365-2761.2003.00485.x; Aguado-Urda M, 2014, VET MICROBIOL, V171, P248, DOI 10.1016/j.vetmic.2014.03.029; Albert MJ, 2000, J CLIN MICROBIOL, V38, P3785, DOI 10.1128/JCM.38.10.3785-3790.2000; Aoki T., 2011, FISH DIS DISORDERS V, P427; Avci H, 2014, J FISH DIS, V37, P481, DOI 10.1111/jfd.12132; Bancroft JD, 2018, THEORY PRACTICE HIST, V8th; Beaz-Hidalgo R, 2013, J FISH DIS, V36, P371, DOI 10.1111/jfd.12025; Borchardt MA, 2003, EMERG INFECT DIS, V9, P224; Boyd C.E., 2018, WATER TEMPERATURE AQ; Carraschi SP, 2012, ECOTOX ENVIRON SAFE, V83, P115, DOI 10.1016/j.ecoenv.2012.06.016; Carriero MM, 2016, J FISH DIS, V39, P1285, DOI 10.1111/jfd.12457; Chong RSM, 2015, J FISH DIS, V38, P839, DOI 10.1111/jfd.12293; Chopra AK, 1999, MICROBES INFECT, V1, P1129, DOI 10.1016/S1286-4579(99)00202-6; Chopra AK, 2000, INFECT IMMUN, V68, P2808, DOI 10.1128/IAI.68.5.2808-2818.2000; Claudiano GS, 2019, FISH SHELLFISH IMMUN, V88, P259, DOI 10.1016/j.fsi.2019.01.044; Cyrino JEP, 2004, TOPICOS ESPECIAIS PI, P343; Cyrino JEP, 2004, TOPICOS ESPECIAISEM, P533; Failde LD, 2013, MICROB PATHOGENESIS, V65, P82, DOI 10.1016/j.micpath.2013.09.003; Das A, 2011, VET IMMUNOL IMMUNOP, V142, P207, DOI 10.1016/j.vetimm.2011.05.017; DEODHAR LP, 1991, J CLIN MICROBIOL, V29, P853, DOI 10.1128/JCM.29.5.853-856.1991; Durigan JG, 1994, REV UNIMAR, V16, P229; El Aamri F, 2015, VET PATHOL, V52, P209, DOI 10.1177/0300985814520638; FAO, 2016, CONTRIBUTING FOOD SE; Farto R, 2011, DIS AQUAT ORGAN, V95, P167, DOI 10.3354/dao02342; Fichi G, 2013, J FISH DIS, V36, P823, DOI 10.1111/jfd.12048; Garcia-Leme J., 1989, HORMONES INFLAMMATIO; Gudmundsdottir BK, 2014, J FISH DIS, V37, P511, DOI 10.1111/jfd.12139; Holliman A., 1993, Aquaculture for veterinarians: fish husbandry and medicine., P223; Lin B, 2007, MOL IMMUNOL, V44, P295, DOI 10.1016/j.molimm.2006.03.001; Lowry R, 2014, ADV MICROB PHYSIOL, V65, P203, DOI 10.1016/bs.ampbs.2014.08.007; Matsuyama T, 2001, FISH SHELLFISH IMMUN, V11, P549, DOI 10.1006/fsim.2000.0332; McDaniel D., 1979, PROCEDURES DETECTION; Monaghan SJ, 2015, J FISH DIS, V38, P477, DOI 10.1111/jfd.12260; Rantin FT, 1998, COMP BIOCHEM PHYS A, V119, P991, DOI 10.1016/S1095-6433(98)00016-6; Rau S, 2007, VET CLIN PATH, V36, P253, DOI 10.1111/j.1939-165X.2007.tb00220.x; Robbins S.L., 2005, PATOLOGIA ROBBINS CO, V23, P482; Roberts RJ., 2012, FISH PATHOL, V4, DOI [10.1002/9781118222942, DOI 10.1002/9781118222942]; Salimon J, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-429; Salles M J, 1999, Rev Assoc Med Bras (1992), V45, P86, DOI 10.1590/S0104-42301999000100015; Sarkar A., 2012, J AQUACULT RES DEV, V3, P2, DOI [10.4172/2155-9546.1000146, DOI 10.4172/2155-9546.1000146]; Scoaris DD, 2008, ANTON LEEUW INT J G, V93, P111, DOI 10.1007/s10482-007-9185-z; Sen K, 2004, J APPL MICROBIOL, V97, P1077, DOI 10.1111/j.1365-2672.2004.02398.x; SHOTTS E B, 1985, Fish Pathology, V20, P37; Sinha S, 2004, J MED MICROBIOL, V53, P527, DOI 10.1099/jmm.0.05269-0; Suanyuk N, 2014, J FISH DIS, V37, P385, DOI 10.1111/jfd.12127; Suhet MI, 2011, THESIS; Valiente E, 2008, MICROB PATHOGENESIS, V45, P386, DOI 10.1016/j.micpath.2008.09.001; Vilches S, 2004, APPL ENVIRON MICROB, V70, P6914, DOI 10.1128/AEM.70.11.6914-6919.2004; Wong CYF, 1998, MICROBIOL-SGM, V144, P291, DOI 10.1099/00221287-144-2-291	49	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222626	10.1371/journal.pone.0222626	http://dx.doi.org/10.1371/journal.pone.0222626			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539396	Green Published, gold			2022-12-26	WOS:000532297900020
J	Clark, DP; Holbrook, M; Lee, CL; Badea, CT				Clark, Darin P.; Holbrook, Matthew; Lee, Chang-Lung; Badea, Cristian T.			Photon-counting cine-cardiac CT in the mouse	PLOS ONE			English	Article							DUAL-ENERGY CT; COMPUTED-TOMOGRAPHY; RECONSTRUCTION; MICE; DIFFERENTIATION	The maturation of photon-counting detector (PCD) technology promises to enhance routine CT imaging applications with high-fidelity spectral information. In this paper, we demonstrate the power of this synergy and our complementary reconstruction techniques, performing 4D, cardiac PCD-CT data acquisition and reconstruction in a mouse model of atherosclerosis, including calcified plaque. Specifically, in vivo cardiac micro-CT scans were performed in four ApoE knockout mice, following their development of calcified plaques. The scans were performed with a prototype PCD (DECTRIS, Ltd.) with 4 energy thresholds. Projections were sampled every 10 ms with a 10 ms exposure, allowing the reconstruction of 10 cardiac phases at each of 4 energies (40 total 3D volumes per mouse scan). Reconstruction was performed iteratively using the split Bregman method with constraints on spectral rank and spatio-temporal gradient sparsity. The reconstructed images represent the first in vivo, 4D PCD-CT data in a mouse model of atherosclerosis. Robust regularization during iterative reconstruction yields high-fidelity results: an 8-fold reduction in noise standard deviation for the highest energy threshold (relative to unregularized algebraic reconstruction), while absolute spectral bias measurements remain below 13 Hounsfield units across all energy thresholds and scans. Qualitatively, image domain material decomposition results show clear separation of iodinated contrast and soft tissue from calcified plaque in the in vivo data. Quantitatively, spatial, spectral, and temporal fidelity are verified through a water phantom scan and a realistic MOBY phantom simulation experiment: spatial resolution is robustly preserved by iterative reconstruction (10% MTF: 2.8-3.0 lp/mm), left-ventricle, cardiac functional metrics can be measured from iodine map segmentations with similar to 1% error, and small calcifications (615 mu m) can be detected during slow moving phases of the cardiac cycle. Given these preliminary results, we believe that PCD technology will enhance dynamic CT imaging applications with high-fidelity spectral and material information.	[Clark, Darin P.; Holbrook, Matthew; Badea, Cristian T.] Duke Univ, Dept Radiol, Ctr In Vivo Microscopy, Durham, NC 27706 USA; [Lee, Chang-Lung] Duke Univ, Dept Radiat Oncol, Durham, NC USA	Duke University; Duke University	Badea, CT (corresponding author), Duke Univ, Dept Radiol, Ctr In Vivo Microscopy, Durham, NC 27706 USA.	cristian.badea@duke.edu	Badea, Cristian/B-6681-2011; Badea, Cristian T/M-3323-2019	Badea, Cristian/0000-0002-1850-2522; Badea, Cristian T/0000-0002-1850-2522; Holbrook, Matthew/0000-0002-5832-8725; Lee (He/Him/His), Chang-Lung/0000-0002-0673-633X	NIH National Cancer Institute [R01 CA196667, U24 CA220245]; NATIONAL CANCER INSTITUTE [R01CA196667, U24CA220245] Funding Source: NIH RePORTER	NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	All work was performed at the Duke Center for In Vivo Microscopy and was supported by the NIH National Cancer Institute (CTB; https://www.cancer.gov/; R01 CA196667, U24 CA220245). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZ RE, 1976, PHYS MED BIOL, V21, P733, DOI 10.1088/0031-9155/21/5/002; Ashton JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088129; Badea CT, 2019, PHYS MED BIOL, V64, DOI 10.1088/1361-6560/ab03e2; Ballabriga R, 2006, 2006 IEEE NUCL SCI S; Brehm M, 2015, MED PHYS, V42, P1948, DOI 10.1118/1.4916083; Candes EJ, 2011, J ACM, V58, DOI 10.1145/1970392.1970395; Chae EJ, 2008, RADIOLOGY, V249, P671, DOI 10.1148/radiol.2492071956; Chen GH, 2015, MED PHYS, V42, P4698, DOI 10.1118/1.4926430; Clark DP, 2019, PROC SPIE, V10948, DOI 10.1117/12.2512816; Clark DP, 2018, PROC SPIE, V10573, DOI 10.1117/12.2293628; Clark D. P., 2018, 5 INT C IMAGE FORMAT; Clark DP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180324; Clark DP, 2015, MED PHYS, V42, P6317, DOI 10.1118/1.4931407; Clark DP, 2013, PHYS MED BIOL, V58, P1683, DOI 10.1088/0031-9155/58/6/1683; Clarke D, 2016, SMALL ANIMAL SURGICAL EMERGENCIES, P1; Cormode DP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04659-9; Crujea C, 2018, PROC SPIE, V10573, DOI 10.1117/12.2293016; Gao H, 2011, INVERSE PROBL, V27, DOI 10.1088/0266-5611/27/11/115012; Graser A, 2009, RADIOLOGY, V252, P433, DOI 10.1148/radiol.2522080557; Gutjahr R, 2016, INVEST RADIOL, V51, P421, DOI 10.1097/RLI.0000000000000251; Holbrook M, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aa9b45; Johnson TRC, 2007, EUR RADIOL, V17, P1510, DOI 10.1007/s00330-006-0517-6; Johnson TRC, 2011, MED RADIOL DIAGN IMA, P1, DOI 10.1007/978-3-642-01740-7; Lee CL, 2014, INT J RADIAT ONCOL, V88, P686, DOI 10.1016/j.ijrobp.2013.11.238; Leng S, MED IMAGING 2016 PHY; Leng S, 2018, INVEST RADIOL, V53, P655, DOI 10.1097/RLI.0000000000000488; Meganck JA, 2017, MOL IMAGING BIOL, V19, P499, DOI 10.1007/s11307-016-1026-x; Mukundan S, 2006, AM J ROENTGENOL, V186, P300, DOI 10.2214/AJR.05.0523; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Rigie DS, 2015, PHYS MED BIOL, V60, P1741, DOI 10.1088/0031-9155/60/5/1741; Rossler AC, 2017, ACAD RADIOL, V24, P184, DOI 10.1016/j.acra.2016.09.017; SEGARS W, 2007, J NUCL MED, V48, P203; Shikhaliev PM, 2008, PHYS MED BIOL, V53, P5595, DOI 10.1088/0031-9155/53/20/002; Siewerdsen J. H., 2014, CONE BEAM COMPUTED T, P37; Symons R, 2017, MED PHYS, V44, P5120, DOI 10.1002/mp.12301; Taguchi K, 2018, MED PHYS, V45, P1985, DOI 10.1002/mp.12863; Taguchi K, 2013, MED PHYS, V40, DOI 10.1118/1.4820371; Tao SZ, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aadc90; Willemink MJ, 2018, RADIOLOGY, V289, P293, DOI 10.1148/radiol.2018172656; Yu LF, 2012, AM J ROENTGENOL, V199, pS9, DOI 10.2214/AJR.12.9121; Yu ZC, 2016, J COMPUT ASSIST TOMO, V40, P663, DOI 10.1097/RCT.0000000000000412; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhou W, 2017, J MED IMAGING, V4, DOI 10.1117/1.JMI.4.4.043502	44	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0218417	10.1371/journal.pone.0218417	http://dx.doi.org/10.1371/journal.pone.0218417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536493	Green Published, Green Submitted, gold			2022-12-26	WOS:000532262800008
J	Estes, SJ; Soliman, AM; Epstein, AJ; Bond, JC; Gordon, K; Missmer, SA				Estes, Stephanie J.; Soliman, Ahmed M.; Epstein, Andrew J.; Bond, Julia C.; Gordon, Keith; Missmer, Stacey A.			National trends in inpatient endometriosis admissions: Patients, procedures and outcomes, 2006-2015	PLOS ONE			English	Article							POSTOPERATIVE COMPLICATIONS; MANAGEMENT; HYSTERECTOMY; SURGERY; HEALTH; CONSENSUS; RESECTION; BURDEN; RATES; WOMEN	Introduction Despite guidance towards minimally invasive, outpatient procedures for endometriosis, many patients nonetheless receive inpatient care. Our objective was to assess trends in patient and hospital characteristics, surgical complications and hospital charges for women with an endometriosis-related inpatient admission in the United States. Methods We conducted a pooled cross-sectional analysis of Healthcare Cost and Utilization Project Nationwide Inpatient Sample data. Visits were stratified into three time-period-defined cohorts (2006-2007, 2010-2011, and 2014 through the first three quarters of 2015). Visits were included if the patient was aged 18-49 years and the primary diagnosis code was for endometriosis (International Classification of Diseases, 9th Revision code 617.xx). We evaluated counts of inpatient admissions and rates of patient and hospital characteristics. Results The number of inpatient admissions with a primary diagnosis code for endometriosis decreased by 72.8% from 2006 to 2015. At the same time, among those admitted for inpatient care for endometriosis, the proportions who had Medicaid insurance and multiple documented comorbidities increased. From 2006 to 2015, mean total hospital charges increased by 75% to $39,662 in 2015 US dollars, although average length of stay increased by <1 day. Conclusions The number of inpatient admissions with a primary diagnosis of endometriosis decreased over the past decade, while surgical complications and associated hospital charges increased. The share of patients with multiple comorbidities increased and an increasing proportion of inpatient endometriosis admissions were covered by Medicaid and occurred at urban teaching hospitals. These findings suggest a demographic shift in patients receiving inpatient care for endometriosis towards more complex, vulnerable patients.	[Estes, Stephanie J.] Penn State Hlth, Dept Obstet & Gynecol, Hershey, PA 17033 USA; [Soliman, Ahmed M.; Gordon, Keith] AbbVie Inc, N Chicago, IL USA; [Epstein, Andrew J.; Bond, Julia C.] Medicus Econ, Philadelphia, PA USA; [Missmer, Stacey A.] Michigan State Univ, Dept Obstet Gynecol & Reprod Biol, Grand Rapids, MI USA; [Missmer, Stacey A.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; AbbVie; Michigan State University; Harvard University; Harvard T.H. Chan School of Public Health	Estes, SJ (corresponding author), Penn State Hlth, Dept Obstet & Gynecol, Hershey, PA 17033 USA.	sestes@pennstatehealth.psu.edu		Bond, Julia/0000-0002-2988-7755	AbbVie, Inc; Good Publication Practice (GPP3)	AbbVie, Inc(AbbVie); Good Publication Practice (GPP3)	The design and financial support for the study were provided by AbbVie, Inc (URL: https://www.abbvie.com/).AS and KG are employees of AbbVie. AE and JB are employees of Medicus Economics, which received a research contract from AbbVie to conduct this research. SE and SM have served as research consultants for AbbVie. AbbVie participated in data analysis, interpretation and review of results, preparation of the manuscript, and decision to publish. The development of this study and manuscript followed the Principles of Good Publication Practice (GPP3) for Company-Sponsored Medical Research.	Abo C, 2018, FERTIL STERIL, V109, P172, DOI 10.1016/j.fertnstert.2017.10.001; Alexander AL, 2019, OBSTET GYNECOL, V133, P6, DOI 10.1097/AOG.0000000000002990; Cohen SL, 2014, JSLS-J SOC LAPAROEND, V18, DOI 10.4293/JSLS.2014.00096; Dunselman GAJ, 2014, HUM REPROD, V29, P400, DOI 10.1093/humrep/det457; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Eskenazi B, 1997, OBSTET GYN CLIN N AM, V24, P235, DOI 10.1016/S0889-8545(05)70302-8; Facchin F, 2017, HUM REPROD, V32, P1855, DOI 10.1093/humrep/dex249; Falcone T, 2018, OBSTET GYNECOL, V131, P557, DOI 10.1097/AOG.0000000000002469; Farquhar CM, 2002, OBSTET GYNECOL, V99, P229, DOI 10.1016/S0029-7844(01)01723-9; Fuldeore MJ, 2017, GYNECOL OBSTET INVES, V82, P453, DOI 10.1159/000452660; Gambone JC, 2002, FERTIL STERIL, V78, P961, DOI 10.1016/S0015-0282(02)04216-4; Gao X, 2006, FERTIL STERIL, V86, P1561, DOI 10.1016/j.fertnstert.2006.06.015; Giudice LC, 2010, NEW ENGL J MED, V362, P2389, DOI 10.1056/NEJMcp1000274; Gordts S, 2017, FERTIL STERIL, V108, P872, DOI 10.1016/j.fertnstert.2017.08.036; Houchens R., 2016, HCUP METHODS SERIES; Houchens RL., 2014, HCUP NIS RELATED REP; Howard BV, 2005, CIRCULATION, V111, P1462, DOI 10.1161/01.CIR.0000159344.21672.FD; Johnson NP, 2017, HUM REPROD, V32, P315, DOI 10.1093/humrep/dew293; Lagana AS, 2017, INT J WOMENS HEALTH, V9, P323, DOI 10.2147/IJWH.S119729; Lagana AS, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3617179; Lee J, 2014, J MINIM INVAS GYN, V21, P656, DOI 10.1016/j.jmig.2014.01.012; Louis GMB, 2011, FERTIL STERIL, V96, P360, DOI 10.1016/j.fertnstert.2011.05.087; Missmer SA, 2004, AM J EPIDEMIOL, V160, P784, DOI 10.1093/aje/kwh275; Morgan DM, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2017.12.218; National Institute for Health and Care Excellence, 2017, END DIAGN MAN; Nisolle M, 2019, BEST PRACT RES CLIN, DOI 10.1016/j.bpobgyn.2019.01; Practice Comm Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P591, DOI 10.1016/j.fertnstert.2012.05.031; Raffaelli R, 2018, EUR J OBSTET GYN R B, V231, P214, DOI 10.1016/j.ejogrb.2018.10.057; Rehmer JM, 2019, OBSTET GYNECOL SURV, V74, P232, DOI 10.1097/OGX.0000000000000660; Rizk B, 2014, FACTS VIEWS VIS OBGY, V6, P219; Smorgick N, 2018, SEMIN REPROD MED, V36, P116, DOI 10.1055/s-0038-1676088; Soliman AM, 2017, J WOMENS HEALTH, V26, P644, DOI 10.1089/jwh.2016.6043; Soliman AM, 2017, FERTIL STERIL, V107, P1181, DOI 10.1016/j.fertnstert.2017.03.020; Surrey ES, 2017, ADV THER, V34, P2436, DOI 10.1007/s12325-017-0619-3; Vercellini P, 2018, EXPERT REV PHARM OUT, V18, P1, DOI 10.1080/14737167.2018.1411803; Vitale SG, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7924021; Walsh CA, 2009, EUR J OBSTET GYN R B, V144, P3, DOI 10.1016/j.ejogrb.2009.01.003; Zondervan KT, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0008-5	38	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222889	10.1371/journal.pone.0222889	http://dx.doi.org/10.1371/journal.pone.0222889			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536593	Green Published, gold, Green Submitted			2022-12-26	WOS:000532262800100
J	Smith, SD; Colgan, P; Yang, F; Rieke, EL; Soupir, ML; Moorman, TB; Allen, HK; Howe, A				Smith, Schuyler D.; Colgan, Phillip; Yang, Fan; Rieke, Elizabeth L.; Soupir, Michelle L.; Moorman, Thomas B.; Allen, Heather K.; Howe, Adina			Investigating the dispersal of antibiotic resistance associated genes from manure application to soil and drainage waters in simulated agricultural farmland systems	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; SWINE; TRANSPORT; ABUNDANCE; BACTERIA; DIVERSE; TYLOSIN; FATE	Manure from animals that have been treated with antibiotics is often used to fertilize agricultural soils and its application has previously been shown to enrich for genes associated with antibiotic resistance in agroecosystems. To investigate the magnitude of this effect, we designed a column experiment simulating manure-treated agricultural soil that utilizes artificial subsurface drainage to determine the duration and extent which this type of manure fertilization impacts the set of genes associated with antibiotic resistance in drainage water. We classified ARGs in manure-treated drainage effluent water by its source of origin. Overall, we found that 61% and 7% of the total abundance of ARGs found in drainage water samples could be attributed to manure enrichment and manure addition, respectively. Among these ARGs, we identified 75 genes unique to manure that persisted in both soil and drainage water throughout a drainage season typical of the Upper Midwestern United States. While most of these genes gradually decreased in abundance over time, the IS6100-associated tet(33) gene accrued. These results demonstrate the influence of manure applications on the composition of the resistome observed in agricultural drainage water and highlight the importance of anthropogenic ARGs in the environment.	[Smith, Schuyler D.; Howe, Adina] Iowa State Univ, Bioinformat & Computat Biol Dept, Ames, IA 50011 USA; [Smith, Schuyler D.; Colgan, Phillip; Yang, Fan; Rieke, Elizabeth L.; Soupir, Michelle L.; Howe, Adina] Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA 50011 USA; [Moorman, Thomas B.; Allen, Heather K.] ARS, USDA, Ames, IA USA	Iowa State University; Iowa State University; United States Department of Agriculture (USDA)	Howe, A (corresponding author), Iowa State Univ, Bioinformat & Computat Biol Dept, Ames, IA 50011 USA.; Howe, A (corresponding author), Iowa State Univ, Dept Agr & Biosyst Engn, Ames, IA 50011 USA.	adina@iastate.edu		Rieke, Elizabeth/0000-0003-2287-3884; Smith, Schuyler/0000-0001-5720-5611; Howe, Adina/0000-0002-7705-343X	AFRI food safety grant from the USDA National Institute of Food and Agriculture [2016-68003-24604]	AFRI food safety grant from the USDA National Institute of Food and Agriculture	This project was supported by AFRI food safety grant no. 2016-68003-24604 from the USDA National Institute of Food and Agriculture (https://nifa.usda.gov/program/agriculture-andfood-research-initiative-afri) to AH, MLS, TBM, and HKA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril C, 2010, ANTIMICROB AGENTS CH, V54, P3052, DOI 10.1128/AAC.00304-10; Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; Allen HK, 2009, ISME J, V3, P243, DOI 10.1038/ismej.2008.86; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2014, ANTIMICROBIAL RESIST; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chen QL, 2016, ENVIRON INT, V92-93, P1, DOI 10.1016/j.envint.2016.03.026; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; Dale VH, 2010, SPRINGER SERIES ENV; Davies J, 2010, MICROBIOL MOL BIOL R, V74, P417, DOI 10.1128/MMBR.00016-10; Dinnes DL, 2002, AGRON J, V94, P153, DOI 10.2134/agronj2002.0153; Fish JA, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00291; Garder JL, 2014, J ENVIRON QUAL, V43, P1484, DOI 10.2134/jeq2013.09.0379; Groh JL, 2007, APPL ENVIRON MICROB, V73, P492, DOI 10.1128/AEM.01086-06; Helmers MJ, 2012, J ENVIRON QUAL, V41, P1531, DOI 10.2134/jeq2011.0473; Inoue H, 2017, B WORLD HEALTH ORGAN, V95, P242, DOI 10.2471/BLT.17.191890; Jechalke S, 2014, TRENDS MICROBIOL, V22, P536, DOI 10.1016/j.tim.2014.05.005; Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109; Luby EM, 2016, SCI TOTAL ENVIRON, V550, P1126, DOI 10.1016/j.scitotenv.2016.01.132; Marti R, 2014, APPL ENVIRON MICROB, V80, P3258, DOI 10.1128/AEM.00231-14; Martinez JL, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00001; Martinez JL, 2009, P ROY SOC B-BIOL SCI, V276, P2521, DOI 10.1098/rspb.2009.0320; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P430, DOI 10.1111/j.1574-6976.2008.00157.x; McArthur AG, 2013, ANTIMICROB AGENTS CH, V57, P3348, DOI 10.1128/AAC.00419-13; Mcisaac GF, 2004, BIOGEOCHEMISTRY, V70, P251, DOI 10.1023/B:BIOG.0000049342.08183.90; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Muurinen J, 2017, ENVIRON SCI TECHNOL, V51, P5989, DOI 10.1021/acs.est.7b00551; Phillips I, 2004, J ANTIMICROB CHEMOTH, V53, P28, DOI 10.1093/jac/dkg483; Poole K, 2012, ANTIBIOTIC DISCOVERY AND DEVELOPMENT, VOLS 1 AND 2, P349, DOI 10.1007/978-1-4614-1400-1_10; Pruden A, 2006, ENVIRON SCI TECHNOL, V40, P7445, DOI 10.1021/es060413l; Riber L, 2014, FEMS MICROBIOL ECOL, V90, P206, DOI 10.1111/1574-6941.12403; Rieke EL, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03197; Rieke EL, 2018, SCI TOTAL ENVIRON, V610, P1173, DOI 10.1016/j.scitotenv.2017.08.116; Section S, 2018, ASSESSING PATHOGEN P; Smith SD., 2019, J OPEN SOURCE SOFTW, V4, P1441, DOI [10.21105/joss.01442, DOI 10.21105/JOSS.01442]; Tauch A, 2002, PLASMID, V48, P117, DOI 10.1016/S0147-619X(02)00120-8; Udikovic-Kolic N, 2014, P NATL ACAD SCI USA, V111, P15202, DOI 10.1073/pnas.1409836111; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Van Goethem MW, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0424-5; Van Katwyk SR, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0640-2; Wu N, 2010, ENVIRON SCI TECHNOL, V44, P6933, DOI 10.1021/es1007802; You YQ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00284; Yu ZY, 2017, FOOD MICROBIOL, V64, P23, DOI 10.1016/j.fm.2016.12.009; Zhu YG, 2013, P NATL ACAD SCI USA, V110, P3435, DOI 10.1073/pnas.1222743110; Zucker Brown, 1998, AGR DRAINAGE B, V871	46	13	13	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222470	10.1371/journal.pone.0222470	http://dx.doi.org/10.1371/journal.pone.0222470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527917	Green Published, gold, Green Submitted			2022-12-26	WOS:000532231400024
J	Dietze, E; Brykala, D; Schreuder, LT; Jazdzewski, K; Blarquez, O; Brauer, A; Dietze, M; Obremske, M; Ott, F; Pienczewska, A; Schouten, S; Hopmans, EC; Slowinski, M				Dietze, Elisabeth; Brykala, Dariusz; Schreuder, Laura T.; Jazdzewski, Krzysztof; Blarquez, Olivier; Brauer, Achim; Dietze, Michael; Obremske, Milena; Ott, Florian; Pienczewska, Anna; Schouten, Stefan; Hopmans, Ellen C.; Slowinski, Michal			Human-induced fire regime shifts during 19th century industrialization: A robust fire regime reconstruction using northern Polish lake sediments	PLOS ONE			English	Article							BIOMASS BURNING EMISSIONS; CLIMATE-CHANGE; HYDROLOGICAL DYNAMICS; MACROSCOPIC CHARCOAL; SOURCE AREA; LEVOGLUCOSAN; HISTORY; FOREST; COMBUSTION; TRANSPORT	Fire regime shifts are driven by climate and natural vegetation changes, but can be strongly affected by human land management. Yet, it is poorly known how humans have influenced fire regimes prior to active wildfire suppression. Among the last 250 years, the human contribution to the global increase in fire occurrence during the mid-19th century is especially unclear, as data sources are limited. Here, we test the extent to which forest management has driven fire regime shifts in a temperate forest landscape. We combine multiple fire proxies (macroscopic charcoal and fire-related biomarkers) derived from highly resolved lake sediments (i.e., 3-5 years per sample), and apply a new statistical approach to classify source area- and temperature-specific fire regimes (biomass burnt, fire episodes). We compare these records with independent climate and vegetation reconstructions. We find two prominent fire regime shifts during the 19th and 20th centuries, driven by an adaptive socio-ecological cycle in human forest management. Although individual fire episodes were triggered mainly by arson (as described in historical documents) during dry summers, the biomass burnt increased unintentionally during the mid-19th century due to the plantation of flammable, fast-growing pine tree monocultures needed for industrialization. State forest management reacted with active fire management and suppression during the 20th century. However, pine cover has been increasing since the 1990s and climate projections predict increasingly dry conditions, suggesting a renewed need for adaptations to reduce the increasing fire risk.	[Dietze, Elisabeth] Alfred Wegener Inst Helmholtz Ctr Polar & Marine, Res Unit Potsdam, Polar Terr Environm Syst, Potsdam, Germany; [Dietze, Elisabeth; Brauer, Achim] GFZ German Res Ctr Geosci, Sect Climate Dynam & Landscape Evolut, Potsdam, Germany; [Brykala, Dariusz] Polish Acad Sci, Inst Geog & Spatial Org, Torun, Poland; [Schreuder, Laura T.; Schouten, Stefan; Hopmans, Ellen C.] Royal Netherlands Inst Sea Res, Dept Marine Microbiol & Biogeochem, Texel, Netherlands; [Schreuder, Laura T.; Schouten, Stefan; Hopmans, Ellen C.] Univ Utrecht, Texel, Netherlands; [Jazdzewski, Krzysztof] Museum Koscierzyna Land, Koscierzyna, Poland; [Blarquez, Olivier] Univ Montreal, Dept Geog, Montreal, PQ, Canada; [Dietze, Michael] GFZ German Res Ctr Geosci, Sect Geomorphol, Potsdam, Germany; [Obremske, Milena] Polish Acad Sci, Inst Geol Sci, Warsaw, Poland; [Ott, Florian] Max Planck Inst Sci Human Hist, Dept Archaeol, Jena, Germany; [Pienczewska, Anna] Kaziemierz Wielki Univ, Inst Geog, Bydgoszcz, Poland; [Schouten, Stefan] Univ Utrecht, Fac Geosci, Utrecht, Netherlands; [Slowinski, Michal] Polish Acad Sci, Inst Geog & Spatial Org, Warsaw, Poland	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Polish Academy of Sciences; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University; Universite de Montreal; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Polish Academy of Sciences; Institute of Geological Sciences of the Polish Academy of Sciences; Utrecht University; Polish Academy of Sciences	Dietze, E (corresponding author), Alfred Wegener Inst Helmholtz Ctr Polar & Marine, Res Unit Potsdam, Polar Terr Environm Syst, Potsdam, Germany.; Dietze, E (corresponding author), GFZ German Res Ctr Geosci, Sect Climate Dynam & Landscape Evolut, Potsdam, Germany.	edietze@awi.de	Słowiński, Michał/B-6546-2011; Dietze, Elisabeth/AFJ-4450-2022; Dietze, Elisabeth/AAF-4616-2022; Brykała, Dariusz/L-2091-2017	Słowiński, Michał/0000-0002-3011-2682; Dietze, Elisabeth/0000-0003-4817-8441; Dietze, Elisabeth/0000-0003-4817-8441; Brykała, Dariusz/0000-0002-0105-4153; Ott, Florian/0000-0001-7319-7180; Brauer, Achim/0000-0002-6655-9451	Helmholtz Association [VH-VI-415]; National Science Centre of Poland [DEC-2011/03/D/HS3/03631, 2015/17/B/ST10/03430, 2011/03/D/HS3/03631]; Netherlands Organisation for Scientific Research [824.14.001]	Helmholtz Association(Helmholtz Association); National Science Centre of Poland(National Science Centre, Poland); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	We received funding for this work by the following grants: A.B.: grant number VH-VI-415, the Helmholtz Association; M.O.: DEC-2011/03/D/HS3/03631, the National Science Centre of Poland; M.S.: 2015/17/B/ST10/03430, the National Science Centre of Poland; D.B.: 2011/03/D/HS3/03631, the National Science Centre of Poland; S.S., L.T.S.: 824.14.001, the Netherlands Organisation for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolf C, 2018, GLOBAL ECOL BIOGEOGR, V27, P199, DOI 10.1111/geb.12682; Akagi SK, 2011, ATMOS CHEM PHYS, V11, P4039, DOI 10.5194/acp-11-4039-2011; Ali AA, 2012, P NATL ACAD SCI USA, V109, P20966, DOI 10.1073/pnas.1203467109; Andela N, 2017, SCIENCE, V356, P1356, DOI 10.1126/science.aal4108; Archibald S, 2013, P NATL ACAD SCI USA, V110, P6442, DOI 10.1073/pnas.1211466110; Argiriadis E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30606-3; Arneth A, 2017, NAT GEOSCI, V10, P79, DOI [10.1038/ngeo2882, 10.1038/NGEO2882]; Balch JK, 2017, P NATL ACAD SCI USA, V114, P2946, DOI 10.1073/pnas.1617394114; Battistel D, 2017, HOLOCENE, V27, P997, DOI 10.1177/0959683616678466; Bienias D., 2009, DZIEDZICTWO TECHNICZ, P43; Blarquez O, 2018, QUATERNARY SCI REV, V180, P63, DOI 10.1016/j.quascirev.2017.11.022; Blarquez O, 2013, GEOPHYS RES LETT, V40, P2667, DOI 10.1002/grl.50504; Bowman DMJS, 2011, J BIOGEOGR, V38, P2223, DOI 10.1111/j.1365-2699.2011.02595.x; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Broda J., 2000, HIST LESNICTWA POLSC; BROEKAERT WF, 1995, PLANT PHYSIOL, V108, P1353, DOI 10.1016/j.chiabu.2021.105188; Buntgen U, 2011, SCIENCE, V331, P578, DOI 10.1126/science.1197175; Christian HJ, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002347; CLARK JS, 1994, BIOGEOCHEMISTRY, V24, P35, DOI 10.1007/BF00001306; CLARK JS, 1988, QUATERNARY RES, V30, P67, DOI 10.1016/0033-5894(88)90088-9; Conedera M, 2009, QUATERNARY SCI REV, V28, P555, DOI 10.1016/j.quascirev.2008.11.005; Cyzman W, 2008, JEDNOLITY PROGRAM GO; Dietze E, 2018, QUATERNARY SCI REV, V201, P44, DOI 10.1016/j.quascirev.2018.10.005; Dost P., 1967, WESTPREUSSEN JB, V17, P83; Engling G, 2006, ATMOS ENVIRON, V40, pS299, DOI 10.1016/j.atmosenv.2005.12.069; Fabbri D, 2009, ATMOS ENVIRON, V43, P2286, DOI 10.1016/j.atmosenv.2009.01.030; Ferretti DF, 2005, SCIENCE, V309, P1714, DOI 10.1126/science.1115193; Fraser MP, 2000, ENVIRON SCI TECHNOL, V34, P4560, DOI 10.1021/es991229l; Gavin DG, 2006, ECOLOGY, V87, P1722, DOI 10.1890/0012-9658(2006)87[1722:WCCOSF]2.0.CO;2; Geissler A, 1997, 130 JAHRE OSTBAHN BE; Girardin MP, 2013, NEW PHYTOL, V199, P1001, DOI 10.1111/nph.12322; Gitkowski T., 2009, PROMOTIO GEOGRAPHICA, V4; Gunderson L. H., 2002, Panarchy: understanding transformations in human and natural systems; Han YM, 2016, SCI REP-UK, V6, DOI 10.1038/srep20719; Hasel K, 2002, FORSTGESCHICHTE GRUN; Hawthorne D, 2018, QUATERN INT, V488, P3, DOI 10.1016/j.quaint.2017.03.046; Higuera PE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001744; Higuera PE, 2007, QUATERNARY SCI REV, V26, P1790, DOI 10.1016/j.quascirev.2007.03.010; Higuera PE, 2011, ECOL APPL, V21, P3211, DOI 10.1890/11-0387.1; Higuera PE, 2009, ECOL MONOGR, V79, P201, DOI 10.1890/07-2019.1; Hopmans EC, 2013, ORG GEOCHEM, V58, P86, DOI 10.1016/j.orggeochem.2013.02.003; Houston Durrant T.H., 2016, EUROPEAN ATLAS FORES, P132, DOI DOI 10.2788/038466; Kaplan JO, 2009, QUATERNARY SCI REV, V28, P3016, DOI 10.1016/j.quascirev.2009.09.028; Keane R.E., 2015, WILDLAND FUEL FUNDAM, DOI [10.1007/978-3-319-09015-3_5, DOI 10.1007/978-3-319-09015-3]; Keeley JE, 2009, INT J WILDLAND FIRE, V18, P116, DOI 10.1071/WF07049; Knicker H, 2013, GEODERMA, V197, P43, DOI 10.1016/j.geoderma.2012.12.021; Konig A., 1905, ENTWICKLUNG STAATLIC; Kuo LJ, 2008, ORG GEOCHEM, V39, P1466, DOI 10.1016/j.orggeochem.2008.04.026; Kuo LJ, 2011, CHEMOSPHERE, V85, P797, DOI 10.1016/j.chemosphere.2011.06.074; Larsen JN, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT B: REGIONAL ASPECTS, P1567; Legrand M, 2016, CLIM PAST, V12, DOI 10.5194/cp-12-2033-2016; Lhotka O, 2018, THEOR APPL CLIMATOL, V131, P1043, DOI 10.1007/s00704-016-2031-3; Loader C., 2013, LOCFIT LOCAL REGRESS; Marcisz K, 2017, QUATERNARY SCI REV, V177, P145, DOI 10.1016/j.quascirev.2017.10.018; Marcisz K, 2016, SCI REP-UK, V6, DOI 10.1038/srep33907; Marcisz K, 2015, QUATERNARY SCI REV, V112, P138, DOI 10.1016/j.quascirev.2015.01.019; Marlon JR, 2008, NAT GEOSCI, V1, P697, DOI 10.1038/ngeo313; Marlon JR, 2016, BIOGEOSCIENCES, V13, P3225, DOI 10.5194/bg-13-3225-2016; McGrath MJ, 2015, BIOGEOSCIENCES, V12, P4291, DOI 10.5194/bg-12-4291-2015; McWethy DB, 2013, GLOBAL ECOL BIOGEOGR, V22, P900, DOI 10.1111/geb.12038; Mitus M., 2000, ANN U M CURIESKODO B, V50/51, P239; Molinari C, 2013, GLOBAL ECOL BIOGEOGR, V22, P1248, DOI 10.1111/geb.12090; Mullaugh KM, 2014, CHEMOSPHERE, V107, P51, DOI 10.1016/j.chemosphere.2014.03.014; Munteanu C, 2015, GLOBAL ENVIRON CHANG, V34, P83, DOI 10.1016/j.gloenvcha.2015.06.015; Niklasson M, 2010, J ECOL, V98, P1319, DOI 10.1111/j.1365-2745.2010.01710.x; Ott F, 2018, HOLOCENE, V28, P464, DOI 10.1177/0959683617729448; Pausas JG, 2017, J ECOL, V105, P289, DOI 10.1111/1365-2745.12691; Pechony O, 2010, P NATL ACAD SCI USA, V107, P19167, DOI 10.1073/pnas.1003669107; Peters ME, 2007, QUATERNARY RES, V67, P304, DOI 10.1016/j.yqres.2006.10.004; Power MJ, 2013, HOLOCENE, V23, P3, DOI 10.1177/0959683612450196; Pyne SJ, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0166; Roos CI, 2018, P NATL ACAD SCI USA, V115, P8143, DOI 10.1073/pnas.1805259115; Ruddiman WF, 2015, SCIENCE, V348, P38, DOI 10.1126/science.aaa7297; San-Miguel-Ayanz J, 2012, APPROACHES TO MANAGING DISASTER - ASSESSING HAZARDS, EMERGENCIES AND DISASTER IMPACTS, P87; Sang XF, 2016, GEOPHYS RES LETT, V43, P5419, DOI 10.1002/2016GL069179; Schmidl C, 2008, ATMOS ENVIRON, V42, P126, DOI 10.1016/j.atmosenv.2007.09.028; Schreuder LT, 2018, GEOCHIM COSMOCHIM AC, V227, P171, DOI 10.1016/j.gca.2018.02.020; Schupbach S, 2015, QUATERNARY SCI REV, V115, P123, DOI 10.1016/j.quascirev.2015.03.004; Schutte R., 1893, DANZIG; Seidl R, 2017, NAT CLIM CHANGE, V7, P395, DOI [10.1038/NCLIMATE3303, 10.1038/nclimate3303]; Simoneit BRT, 1999, ATMOS ENVIRON, V33, P173, DOI 10.1016/S1352-2310(98)00145-9; Slowinski M, 2019, J ENVIRON MANAGE, V236, P755, DOI 10.1016/j.jenvman.2019.02.002; Slowinski M, 2015, QUATERN INT, V388, P64, DOI 10.1016/j.quaint.2014.06.018; Steffen W, 2011, AMBIO, V40, P739, DOI 10.1007/s13280-011-0185-x; Stephens SL, 2013, SCIENCE, V342, P41, DOI 10.1126/science.1240294; Szczygie R., 2016, CZERWONA KSIGA POARO, P463; Taylor AH, 2016, P NATL ACAD SCI USA, V113, P13684, DOI 10.1073/pnas.1609775113; Theuerkauf M, 2016, VEG HIST ARCHAEOBOT, V25, P541, DOI 10.1007/s00334-016-0572-0; Tinner W, 2006, HOLOCENE, V16, P287, DOI 10.1191/0959683606hl925rr; Trachsel M, 2017, HOLOCENE, V27, P860, DOI 10.1177/0959683616675939; Trollope WSW, 2002, FOREST FIRE RES WILD; Vachula RS, 2018, PALAEOGEOGR PALAEOCL, V508, P166, DOI 10.1016/j.palaeo.2018.07.032; van der Werf GR, 2013, CLIM PAST, V9, P289, DOI 10.5194/cp-9-289-2013; van Marle MJE, 2017, GEOSCI MODEL DEV, V10, P3329, DOI 10.5194/gmd-10-3329-2017; Vanniere B, 2016, QUATERNARY SCI REV, V132, P206, DOI 10.1016/j.quascirev.2015.11.012; Wang Z, 2010, SCIENCE, V330, P1663, DOI 10.1126/science.1197257; Ward DS, 2018, GLOBAL BIOGEOCHEM CY, V32, P122, DOI 10.1002/2017GB005787; Whitlock C., 2001, Tracking environmental change using lake sediments. Volume 3: Terrestrial, algal, and siliceous indicators, P75; Whitlock C, 2018, CONSERV BIOL, V32, P84, DOI 10.1111/cobi.12960; Wo A., 1999, KLIMAT POLSKI; Wojcik G, 1993, UWARUNKOWANIA PRZYRO, P107; Young D, 2017, MIXTOOLS TOOLS ANAL; Zumbrunnen T, 2009, ECOSYSTEMS, V12, P73, DOI 10.1007/s10021-008-9207-3	103	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222011	10.1371/journal.pone.0222011	http://dx.doi.org/10.1371/journal.pone.0222011			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JC2ZR	31525210	Green Published, Green Submitted, gold			2022-12-26	WOS:000489146700001
J	Seol, BR; Kang, TG; Gu, B				Seol, Bo Ram; Kang, Tae Gu; Gu, Bonhyeok			Intraocular pressure according to different types of tonometry (non-contact and Goldmann applanation) in patients with different degrees of bilateral tearing	PLOS ONE			English	Article								Purpose To investigate intraocular pressure (IOP) readings by non-contact tonometry (NCT) and Goldmann applanation tonometry (GAT) for patients with different degrees of bilateral tearing. Methods In this study, we reviewed the medical charts of patients complaining of different degrees of bilateral tearing. The tear meniscus height (TMH) and lOP with NCT and GAT were measured. In each patient, a comparison of IOP readings between the eye with lower TMH and the contralateral eye with higher TMH was evaluated. The TMH was graded as follows: grade 1 (low): TMH < 0.2 mm; grade 2 (moderate): 0.2 mm <= TMH < 0.6 mm; grade 3 (high): TMH >= 0.6 mm. Subsequently, a comparison of 10P readings among eyes with low, moderate, and high TMH was also performed. Results A total of 120 eyes of 60 patients were enrolled. When comparing the two eyes of a patient, the eye with higher TMH showed higher NCT readings and larger difference in IOP readings between the two tonometries than the eye with lower TMH (P < 0.001 and P < 0.001, respectively). When TMH was classified into grades according to the degree, the high TMH eyes showed higher NCT readings than did the low and moderate TMH eyes (P < 0.001 and P = 0.001, respectively). In addition, the high TMH eyes showed a larger difference in IOP readings between the two tonometries than did the low and moderate TMH eyes (P < 0.001 and P < 0.001, respectively). Conclusion Eyes with higher TMH showed higher NCT readings and a larger difference in IOP between the two tonometries (NCT and GAT) than those with lower TMH. In patients with tearing, the NCT value may be inaccurate, so it is necessary to measure the GAT.	[Seol, Bo Ram; Kang, Tae Gu; Gu, Bonhyeok] Vet Hlth Serv VHS Med Ctr, Dept Ophthalmol, Seoul, South Korea		Seol, BR (corresponding author), Vet Hlth Serv VHS Med Ctr, Dept Ophthalmol, Seoul, South Korea.	gorong20@hanmail.net		Seol, Bo Ram/0000-0002-3490-0854	VHS Medical Center Research Grant, Republic of Korea [VHSMC 18033]	VHS Medical Center Research Grant, Republic of Korea	This study was supported by a VHS Medical Center Research Grant, Republic of Korea (grant number: VHSMC 18033).	Allingham RR, 2011, SHIELDS TXB GLAUCOMA; Allingham RR, 2005, SHIELDS TXB GLAUCOMA; Burkat CN, 2005, OPHTHALMOLOGY, V112, P344, DOI 10.1016/j.ophtha.2004.07.030; Cook JA, 2012, OPHTHALMOLOGY, V119, P1552, DOI 10.1016/j.ophtha.2012.02.030; Damji KF, 2003, J GLAUCOMA, V12, P69, DOI 10.1097/00061198-200302000-00015; EHLERS N, 1975, ACTA OPHTHALMOL, V53, P652; EHLERS N, 1975, ACTA OPHTHALMOL, V53, P34; Farhood QK, 2013, CLIN OPHTHALMOL, V7, P23, DOI 10.2147/OPTH.S38418; FORBES M, 1974, ARCH OPHTHALMOL-CHIC, V91, P134, DOI 10.1001/archopht.1974.03900060140012; GROLMAN B, 1972, AMER J OPT ARCH AM A, V49, P646; Ito K, 2012, J GLAUCOMA, V21, P35, DOI 10.1097/IJG.0b013e31820275b4; JONES LT, 1966, AM J OPHTHALMOL, V62, P47, DOI 10.1016/0002-9394(66)91676-X; Kawai M, 2007, CORNEA, V26, P403, DOI 10.1097/ICO.0b013e318033c242; Martinez-de-la-Casa JM, 2011, ACTA OPHTHALMOL, V89, P676, DOI 10.1111/j.1755-3768.2009.01774.x; SAGAN W, 1975, AM J OPTOM PHYS OPT, V52, P288; SORENSEN PN, 1975, ACTA OPHTHALMOL, V53, P513; Tonnu PA, 2005, BRIT J OPHTHALMOL, V89, P851, DOI 10.1136/bjo.2004.056622; WHITACRE MM, 1993, SURV OPHTHALMOL, V38, P1, DOI 10.1016/0039-6257(93)90053-A; Yilmaz I, 2014, CLIN OPHTHALMOL, V8, P1069, DOI [10.2147/OPTH.S63915, 10.2147/OPTH.S6391]	19	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222652	10.1371/journal.pone.0222652	http://dx.doi.org/10.1371/journal.pone.0222652			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525237	Green Published, gold, Green Submitted			2022-12-26	WOS:000532225700043
J	Dong, YH; Zhu, HL; Shen, YY; Zhang, WT; Zhang, L				Dong, Yaohua; Zhu, Hongling; Shen, Yuanyuan; Zhang, Wenting; Zhang, Li			Antibacterial activity of silver nanoparticles of different particle size against Vibrio Natriegens	PLOS ONE			English	Article							COMET ASSAY; DNA; BACTERIA; DAMAGE; IONS; RNA	In this study, we describe the synthesis and characterization of silver nanoparticles (Ag-NPs) of different sizes and evaluated their antibacterial activity. Particles size and morphology were characterized by transmission electron microscopy. Evaluation of the bacteriostatic effects was performed by ultraviolet-visible spectrophotometry and comet assays. The smaller the particle size of Ag-NPs, the smaller the value of the minimum inhibitory concentration (MIC) and minimum bactericidal concentrations (MBC), indicating the greater the antibacterial activity. The antibacterial activity was determined by the generation of reactive oxygen species (ROS) by bacteria and by bacterial membrane damage. In this study, we determined ROS-induced damage of bacteria caused by Ag-NPs. In conclusion, our findings indicated that Ag-NPs were effective at different particle sizes and concentrations and that the smaller the particle size of Ag-NPs, the greater the antibacterial activity.	[Dong, Yaohua; Zhu, Hongling; Shen, Yuanyuan; Zhang, Wenting; Zhang, Li] Shanghai Maritime Univ, Coll Ocean Sci & Engn, Shanghai, Peoples R China; [Dong, Yaohua] Shanghai Jiao Tong Univ, Sch Mech Engn, Shanghai, Peoples R China	Shanghai Maritime University; Shanghai Jiao Tong University	Shen, YY (corresponding author), Shanghai Maritime Univ, Coll Ocean Sci & Engn, Shanghai, Peoples R China.	yyshen@shmtu.edu.cn			Natural Science Foundation of China [51609133]; Chinese Postdoctoral Science Foundation [2017M620153]; Shanghai science and technology commission project [17DZ1202906]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shanghai science and technology commission project	This work was financially sponsored by the Natural Science Foundation of China (No. 51609133), the Chinese Postdoctoral Science Foundation (No. 2017M620153), and Shanghai science and technology commission project (No. 17DZ1202906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Adams LK, 2006, WATER RES, V40, P3527, DOI 10.1016/j.watres.2006.08.004; Akter M, 2018, J ADV RES, V9, P1, DOI 10.1016/j.jare.2017.10.008; Azqueta A, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00288; Baruwati B, 2013, ACS SUSTAIN CHEM ENG, V1, P753, DOI 10.1021/sc400024a; Becerra MC, 2003, LUMINESCENCE, V18, P334, DOI 10.1002/bio.742; Chao JB, 2011, ANAL CHEM, V83, P6875, DOI 10.1021/ac201086a; Costanza J, 2011, ENVIRON SCI TECHNOL, V45, P7591, DOI 10.1021/es200666n; Dong ZH, 2011, BIOFOULING, V27, P487, DOI 10.1080/08927014.2011.584369; Fu J, 2010, J BIOMED MATER RES A, V79A, P665; Giovannelli L, 2002, J CEREBR BLOOD F MET, V22, P697, DOI 10.1097/00004647-200206000-00008; Kimura K, 2004, MICROBIOL-SGM, V150, P4115, DOI 10.1099/mic.0.27467-0; Li Y, 2012, ACS NANO, V6, P5164, DOI 10.1021/nn300934k; Liu JY, 2010, ACS NANO, V4, P6903, DOI 10.1021/nn102272n; Liu T, 2014, COLLOID SURFACE B, V116, P793, DOI 10.1016/j.colsurfb.2014.01.010; Lok CN, 2006, J PROTEOME RES, V5, P916, DOI 10.1021/pr0504079; Mahmoudi M, 2012, ACS NANO, V6, P2656, DOI 10.1021/nn300042m; Nasrollahzadeh M, 2014, SPECTROCHIM ACTA A, V132, P423, DOI 10.1016/j.saa.2014.04.186; OLIVER RP, 1984, CARLSBERG RES COMMUN, V49, P647, DOI 10.1007/BF02907497; Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06; Pramanik A, 2012, COLLOID SURFACE B, V96, P50, DOI 10.1016/j.colsurfb.2012.03.021; Sotiriou GA, 2012, LANGMUIR, V28, P15929, DOI 10.1021/la303370d; Steinigeweg D, 2012, CHEM COMMUN, V48, P8682, DOI 10.1039/c2cc33850e; Taglietti A, 2012, LANGMUIR, V28, P8140, DOI 10.1021/la3003838; Zhang LL, 2007, J NANOPART RES, V9, P479, DOI 10.1007/s11051-006-9150-1	25	85	88	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2019	14	9							e0222322	10.1371/journal.pone.0222322	http://dx.doi.org/10.1371/journal.pone.0222322			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LC0BY	31518380	gold, Green Published, Green Submitted			2022-12-26	WOS:000524996900001
J	Lee, J; Park, J; Kim, YH; Lee, NH; Song, KM				Lee, Jangho; Park, Joon; Kim, Young Ho; Lee, Nam Hyouck; Song, Kyung-Mo			Irisin promotes C2C12 myoblast proliferation via ERK-dependent CCL7 upregulation	PLOS ONE			English	Article							CELL-PROLIFERATION; FAT; METASTASIS	Irisin is an exercise-induced myokine that has various physiological functions, such as roles in energy expenditure, glucose/lipid metabolism, and muscle development. In muscle development, myoblast proliferation is known to be a first step, and recent studies have reported that an increased irisin level is involved in the promotion of cell proliferation in various cell types, including myoblasts. However, the exact mechanism of action by which irisin promotes myoblast proliferation has not been reported. In this study, we aimed to determine the pro-proliferative effect of irisin on C2C12 myoblasts and its mechanism of action. Irisin induced C2C12 cell proliferation and upregulated the mRNA levels of markers of proliferation Pcna, Mki67, and Mcm2. Irisin increased extracellular signal-regulated kinase (ERK) phosphorylation, and U0126, an ERK pathway inhibitor, suppressed irisin-induced C2C12 cell proliferation. Transcriptomic and qRT-PCR analysis showed that Ccl2, Ccl7, Ccl8, and C3 are potential downstream regulators of ERK signaling that promote C2C12 cell proliferation. Knockdown of Ccl7 revealed that irisin upregulates chemokine (C-C motif) ligand 7 (CCL7) and subsequently promotes C2C12 cell proliferation. These results suggest that irisin promotes C2C12 myoblast proliferation via ERK-dependent CCL7 upregulation and may aid in understanding how irisin contributes to muscle development.	[Lee, Jangho; Park, Joon] Korea Food Res Inst, Res Div Food Functional, Wanju Gun, Jeollabuk Do, South Korea; [Park, Joon] Korea Univ Sci & Technol, Dept Food Biotechnol, Daejeon, South Korea; [Kim, Young Ho; Lee, Nam Hyouck; Song, Kyung-Mo] Korea Food Res Inst, Res Div Strateg Food Technol, Wanju Gun, Jeollabuk Do, South Korea	Korea Food Research Institute (KFRI); University of Science & Technology (UST); Korea Food Research Institute (KFRI)	Song, KM (corresponding author), Korea Food Res Inst, Res Div Strateg Food Technol, Wanju Gun, Jeollabuk Do, South Korea.	rudah@kfri.re.kr			Korea Food Research Institute (KFRI) - Ministry of Science and ICT [E0186400-02]	Korea Food Research Institute (KFRI) - Ministry of Science and ICT	This research was supported by Main Research Program (E0186400-02) of the Korea Food Research Institute (KFRI) funded by the Ministry of Science and ICT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin S, 2014, PEPTIDES, V61, P130, DOI 10.1016/j.peptides.2014.09.014; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Ford J, 2018, FRONT IMMUNOL, V9; Fu Y, 2015, LAB INVEST, V95, P1246, DOI 10.1038/labinvest.2015.106; Jurikova M, 2016, ACTA HISTOCHEM, V118, P544, DOI 10.1016/j.acthis.2016.05.002; Ke BC, 2016, NEUROREPORT, V27, P849, DOI 10.1097/WNR.0000000000000625; Lee YS, 2016, ONCOTARGET, V7, P36842, DOI 10.18632/oncotarget.9209; Liu SW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175498; Liu X, 2018, J CELL MOL MED, V22, P808, DOI 10.1111/jcmm.13360; Liu YY, 2018, PEERJ, V6, DOI 10.7717/peerj.4928; Longo A, 2005, J CELL BIOCHEM, V94, P635, DOI 10.1002/jcb.20336; Maddaluno M, 2011, ATHEROSCLEROSIS, V217, P113, DOI 10.1016/j.atherosclerosis.2011.04.002; Mahgoub MO, 2018, PEPTIDES, V104, P15, DOI 10.1016/j.peptides.2018.03.018; Parikh N, 2018, AGING CELL, V17, DOI 10.1111/acel.12691; Perakakis N, 2017, NAT REV ENDOCRINOL, V13, P324, DOI 10.1038/nrendo.2016.221; Qiao XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep18732; Reza MM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01131-0; Rodriguez A, 2015, INT J OBESITY, V39, P397, DOI 10.1038/ijo.2014.166; Song HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110273; Ultimo Simona, 2018, Oncotarget, V9, P17220, DOI 10.18632/oncotarget.24991; Wyler L, 2014, BRIT J CANCER, V110, P686, DOI 10.1038/bjc.2013.755; Yang ZG, 2015, INT J CLIN EXP PATHO, V8, P6490; Zhang YZ, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004031	23	10	10	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2019	14	9							e0222559	10.1371/journal.pone.0222559	http://dx.doi.org/10.1371/journal.pone.0222559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4KS	31518371	Green Published, gold, Green Submitted			2022-12-26	WOS:000532219300024
J	Murphy, JM				Murphy, James M.			The long-awaited structure of HIPK2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Homeodomain-interacting protein kinases (HIPKs) are kinases that phosphorylate transcription factors involved in cell proliferation, differentiation, and apoptosis. Their structures have been long sought because of their potential as drug targets in cancers and fibrosis. Agnew and colleagues present the first crystal structure of the HIPK2 kinase domain, complexed with the small-molecule inhibitor CX-4945, revealing important structural differences from related protein kinases of the DYRK family. This structure provides a starting point to exploit HIPK2's distinct structural features to develop selective small-molecule inhibitors of this kinase.	[Murphy, James M.] Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia; [Murphy, James M.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia	Walter & Eliza Hall Institute; University of Melbourne	Murphy, JM (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia.	jamesm@wehi.edu.au	Murphy, James/B-4863-2017	Murphy, James/0000-0003-0195-3949	National Health and Medical Research Council of Australia [1105754, 1124735, 1124737, IRIISS 9000433]; Victorian Government Operational Infrastructure Support Scheme	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government Operational Infrastructure Support Scheme	This work was supported by Fellowship 1105754, Grants 1124735 and 1124737, and IRIISS 9000433 (to J. M. M.) from the National Health and Medical Research Council of Australia and the Victorian Government Operational Infrastructure Support Scheme. The author declares that he has no conflicts of interest with the contents of this article.	Agnew C, 2019, J BIOL CHEM, V294, P13545, DOI 10.1074/jbc.RA119.009725; Jacobsen AV, 2017, BIOCHEM SOC T, V45, P665, DOI 10.1042/BST20160331; Kannan N, 2004, PROTEIN SCI, V13, P2059, DOI 10.1110/ps.04637904; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kung JE, 2016, STRUCTURE, V24, P7, DOI 10.1016/j.str.2015.10.020	5	2	2	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 13	2019	294	37					13560	13561		10.1074/jbc.H119.010675	http://dx.doi.org/10.1074/jbc.H119.010675			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IY5GA	31519758	Green Published, hybrid			2022-12-26	WOS:000486418600004
J	Niu, T; Zhao, MY; Jiang, Y; Xing, XD; Shi, X; Cheng, L; Jin, HY; Liu, K				Niu, Tian; Zhao, Mengya; Jiang, Yan; Xing, Xindan; Shi, Xin; Cheng, Lu; Jin, Huiyi; Liu, Kun			Endomucin restores depleted endothelial glycocalyx in the retinas of streptozotocin-induced diabetic rats	FASEB JOURNAL			English	Article						inflammation; blood-retinal barrier; diabetic retinopathy	MACULAR EDEMA; INFLAMMATION; PATHOGENESIS; DEGRADATION; RETINOPATHY; MUCINS; LAYER	Endothelial glycocalyx plays a significant role in the development and progression of diabetic complications. Endomucin (EMCN) is an anti-inflammatory membrane glycoprotein that is mainly expressed in venous and capillary endothelial cells. However, the function of EMCN in diabetic retinopathy (DR) progression is still completely unknown. We first investigated the change of EMCN expression in the retina and human retinal microvascular endothelial cells. We then overexpressed EMCN in the retina with adeno-associated virus and induced DR with streptozotocin (STZ). We analyzed EMCN's effect on the integrity of endothelial glycocalyx under conditions of DR. Furthermore, we investigated EMCN's protective effect against inflammation and blood-retinal barrier (BRB) destruction. We found that EMCN is specifically expressed in retinal endothelial cells and that its levels are decreased during hyperglycemia in vitro and in vivo. Overexpression of EMCN can restore the retinal endothelial glycocalyx of STZ-induced diabetic rats. Furthermore, EMCN overexpression can decrease leukocyte -endothelial adhesion to ameliorate inflammation and stabilize the BRB to inhibit vessel leakage in rats with DR. EMCN may protect patients with diabetes from retinal vascular degeneration by restoring the endothelial glycocalyx. EMCN may thus represent a novel therapeutic strategy for DR because it targets endothelial glycocalyx degradation associated with this disease.	[Niu, Tian; Zhao, Mengya; Xing, Xindan; Shi, Xin; Cheng, Lu; Jin, Huiyi; Liu, Kun] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Ophthalmol, 100 Haining Rd, Shanghai 200080, Peoples R China; [Jiang, Yan] Nanjing Med Univ, Shanghai Gen Hosp, Dept Ophthalmol, Shanghai, Peoples R China	Shanghai Jiao Tong University; Nanjing Medical University	Liu, K (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Ophthalmol, 100 Haining Rd, Shanghai 200080, Peoples R China.	drliukun@sjtu.edu.cn		Niu, Tian/0000-0002-0377-3151	National Key Research and Development Program of China [2016YFC0904800]; National Natural Science Foundation of China [81470638, 81870667]; Shanghai Medical Excellent Discipline Leader Program [2017BR056]; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support Program [20161426]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Medical Excellent Discipline Leader Program; Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support Program	This study was funded by grants from the National Key Research and Development Program of China (2016YFC0904800), the National Natural Science Foundation of China (81470638 and 81870667), the Shanghai Medical Excellent Discipline Leader Program (2017BR056), and the Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support Program (20161426). All study sponsors had no role in the study design or in the collection, analysis, and interpretation of data. The authors declare no conflicts of interest.	Abu El-Asrar AM, 2012, MIDDLE EAST AFR J OP, V19, P70, DOI 10.4103/0974-9233.92118; Argueso P, 2009, J BIOL CHEM, V284, P23037, DOI 10.1074/jbc.M109.033332; Banerjee PJ, 2017, OPHTHALMOLOGY, V124, P757, DOI 10.1016/j.ophtha.2017.01.021; Broekhuizen LN, 2010, DIABETOLOGIA, V53, P2646, DOI 10.1007/s00125-010-1910-x; Brown DM, 2013, OPHTHALMOLOGY, V120, P2013, DOI 10.1016/j.ophtha.2013.02.034; Caballero S, 2007, DIABETES, V56, P960, DOI 10.2337/db06-1254; Capitao M, 2016, J CELL BIOCHEM, V117, P2443, DOI 10.1002/jcb.25575; Chibber R, 2007, CURR DIABETES REV, V3, P3, DOI 10.2174/157339907779802139; Ciulla TA, 2016, RETINA-J RET VIT DIS, V36, P1292, DOI 10.1097/IAE.0000000000000876; Das A, 2015, OPHTHALMOLOGY, V122, P1375, DOI 10.1016/j.ophtha.2015.03.024; dela Paz NG, 2009, CELL TISSUE RES, V335, P5, DOI 10.1007/s00441-008-0706-5; Dogne S, 2016, DIABETES, V65, P2742, DOI 10.2337/db15-1662; Ford JA, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002269; Gilbert RE, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0410-8; Grant MB, 2004, EXPERT OPIN INV DRUG, V13, P1275, DOI 10.1517/13543784.13.10.1275; Hanisch FA, 2001, BIOL CHEM, V382, P143, DOI 10.1515/BC.2001.022; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Joussen AM, 2004, FASEB J, V18, P1450, DOI 10.1096/fj.03-1476fje; Joussen AM, 2001, AM J PATHOL, V158, P147, DOI 10.1016/S0002-9440(10)63952-1; Kady NM, 2018, DIABETES, V67, P769, DOI 10.2337/db17-1034; Kataoka H, 2016, MICROSC RES TECHNIQ, V79, P31, DOI 10.1002/jemt.22602; Kern TS, 2007, EXP DIABETES RES, DOI 10.1155/2007/95103; Kinoshita M, 2001, FEBS LETT, V499, P121, DOI 10.1016/S0014-5793(01)02520-0; Klaassen I, 2013, PROG RETIN EYE RES, V34, P19, DOI 10.1016/j.preteyeres.2013.02.001; Kuhn A, 2002, J INVEST DERMATOL, V119, P1388, DOI 10.1046/j.1523-1747.2002.19647.x; Kumase F, 2010, ACTA MED OKAYAMA, V64, P277; Leasher JL, 2016, DIABETES CARE, V39, P1643, DOI 10.2337/dc15-2171; Matter K, 1999, INT REV CYTOL, V186, P117; Middleton J, 2002, BLOOD, V100, P3853, DOI 10.1182/blood.V100.12.3853; Morgan SM, 1999, BLOOD, V93, P165, DOI 10.1182/blood.V93.1.165.401k25_165_175; Mulivor AW, 2002, AM J PHYSIOL-HEART C, V283, pH1282, DOI 10.1152/ajpheart.00117.2002; Park DY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15296; Park-Windhol C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16852-x; Pelaseyed T, 2014, IMMUNOL REV, V260, P8, DOI 10.1111/imr.12182; Pick R, 2017, BLOOD, V130, P847, DOI 10.1182/blood-2016-11-749622; Rabelink TJ, 2015, NAT REV NEPHROL, V11, P667, DOI 10.1038/nrneph.2015.162; Schnoor M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/946509; Seelenmeyer C, 2003, J CELL SCI, V116, P1305, DOI 10.1242/jcs.00312; SIEBENLIST U, 1994, ANNU REV CELL BIOL, V10, P405, DOI 10.1146/annurev.cb.10.110194.002201; Sieve I, 2018, VASC PHARMACOL, V100, P26, DOI 10.1016/j.vph.2017.09.002; Simo R, 2015, PROG RETIN EYE RES, V48, P160, DOI 10.1016/j.preteyeres.2015.04.003; Singh A, 2011, AM J PHYSIOL-RENAL, V300, pF40, DOI 10.1152/ajprenal.00103.2010; Stitt AW, 2013, CLIN SCI, V125, P1, DOI 10.1042/CS20120588; Yu CG, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1803989; Zahr A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10363	45	9	10	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13346	13357		10.1096/fj.201901161R	http://dx.doi.org/10.1096/fj.201901161R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31545913	Bronze			2022-12-26	WOS:000507466100025
J	Wang, Y; Agarwal, E; Bertolini, I; Ghosh, JC; Seo, JH; Altieri, DC				Wang, Yuan; Agarwal, Ekta; Bertolini, Irene; Ghosh, Jagadish C.; Seo, Jae Ho; Altieri, Dario C.			IDH2 reprograms mitochondria! dynamics in cancer through a HIF-1 alpha-regulated pseudohypoxic state	FASEB JOURNAL			English	Article						mitochondria; ROS; tumor cell motility; HIF-1 alpha metastasis	CELL-MIGRATION; OXIDATIVE STRESS; TUMOR-GROWTH; PROMOTES; METASTASIS; DRP1; PHOSPHORYLATION; TUMORIGENESIS; TRAFFICKING; METABOLISM	The role of mitochondria in cancer continues to be debated and paradoxically implicated in opposing functions in tumor growth and tumor suppression. To understand this dichotomy, we explored the function of mitochondrial isocitrate dehydrogenase (IDH)2, a tricarboxylic acid cycle enzyme mutated in subsets of acute leukemias and gliomas, in cancer. Silencing of IDH2 in prostate cancer cells impaired oxidative bioenergetics, elevated reactive oxygen species (ROS) production, and promoted exaggerated mitochondrial dynamics. This was associated with increased subcellular mitochondrial trafficking, turnover of membrane focal adhesion complexes, and enhanced tumor cell migration and invasion, without changes in cell cycle progression. Mechanistically, loss of IDH2 caused ROS-dependent stabilization of hypoxia-inducible factor-1 alpha in normoxia, which was required for increased mitochondrial trafficking and tumor cell movements. Therefore, IDH2 is a dual regulator of cancer bioenergetics and tumor cell motility. This pathway may reprogram mitochondrial dynamics to differentially adjust energy production or promote tumor cell invasion in response to microenvironment conditions.	[Wang, Yuan; Agarwal, Ekta; Bertolini, Irene; Ghosh, Jagadish C.; Seo, Jae Ho; Altieri, Dario C.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA	The Wistar Institute	Altieri, DC (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	daltieri@wistar.org		BERTOLINI, IRENE/0000-0001-5824-6802; Agarwal, Ekta/0000-0002-5992-3358	U.S. National Institutes of Health, National Cancer Institute [P01 CA140043, R35 CA220446]; Cancer Center Support Grant (CCSG) [P30 CA010815]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Center Support Grant (CCSG); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank James Hayden and Frederick Keeney (The Wistar Institute Imaging Core Facility) for assistance with time-lapse videomicroscopy. This work was supported by U.S. National Institutes of Health, National Cancer Institute Grants P01 CA140043 and R35 CA220446 (to D.C.A.). The support for Shared Resources utilized in this study was provided by Cancer Center Support Grant (CCSG) P30 CA010815. The authors declare no conflicts of interest.	Amaya ML, 2018, CLIN CANCER RES, V24, P4931, DOI 10.1158/1078-0432.CCR-18-0536; Anderson RG, 2018, BBA-REV CANCER, V1870, P96, DOI 10.1016/j.bbcan.2018.05.005; Bhat TA, 2015, DRUG DISCOV TODAY, V20, P635, DOI 10.1016/j.drudis.2015.03.001; Caino MC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13730; Caino MC, 2015, P NATL ACAD SCI USA, V112, P8638, DOI 10.1073/pnas.1500722112; Caino MC, 2013, J CLIN INVEST, V123, P2907, DOI 10.1172/JCI67841; Chen HC, 2017, CELL METAB, V26, P39, DOI 10.1016/j.cmet.2017.05.016; Chiang S, 2016, CANCER RES, V76, P7118, DOI 10.1158/0008-5472.CAN-16-0298; Cox TR, 2015, NATURE, V522, P106, DOI 10.1038/nature14492; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; Cunniff B, 2016, MOL BIOL CELL, V27, P2662, DOI 10.1091/mbc.E16-05-0286; Desai SP, 2013, BIOPHYS J, V104, P2077, DOI 10.1016/j.bpj.2013.03.025; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Gagne LM, 2017, TRENDS CELL BIOL, V27, P738, DOI 10.1016/j.tcb.2017.06.002; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hoekstra AS, 2013, BBA-BIOENERGETICS, V1827, P543, DOI 10.1016/j.bbabio.2012.11.005; Hu X, 2014, CANCER LETT, V346, P114, DOI 10.1016/j.canlet.2013.12.020; Hurd TR, 2012, TRENDS CELL BIOL, V22, P107, DOI 10.1016/j.tcb.2011.11.002; Jo SH, 2001, J BIOL CHEM, V276, P16168, DOI 10.1074/jbc.M010120200; Jo SH, 2001, J BIOL CHEM, V276, P26732; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kim S, 2014, BBA-MOL BASIS DIS, V1842, P135, DOI 10.1016/j.bbadis.2013.11.008; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; Lehuede C, 2016, CANCER RES, V76, P5201, DOI 10.1158/0008-5472.CAN-16-0266; Li JJ, 2018, THERANOSTICS, V8, P4050, DOI 10.7150/thno.21524; Lian CG, 2012, CELL, V150, P1135, DOI 10.1016/j.cell.2012.07.033; Lillig CH, 2004, P NATL ACAD SCI USA, V101, P13227, DOI 10.1073/pnas.0401896101; Ohno N, 2014, P NATL ACAD SCI USA, V111, P9953, DOI 10.1073/pnas.1401155111; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Pienta KJ, 2013, CLIN CANCER RES, V19, P5849, DOI 10.1158/1078-0432.CCR-13-2158; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043; Qian W, 2012, J CELL SCI, V125, P5745, DOI 10.1242/jcs.109769; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Rankin EB, 2014, P NATL ACAD SCI USA, V111, P13373, DOI 10.1073/pnas.1404848111; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; SEMENZA GL, 2016, BBA-MOL CELL RES, V1863, P382, DOI DOI 10.1016/J.BBAMCR.2015.05.036; Senft D, 2016, CURR OPIN CELL BIOL, V39, P43, DOI 10.1016/j.ceb.2016.02.001; Seo JH, 2018, CANCER RES, V78, P4215, DOI 10.1158/0008-5472.CAN-18-0595; Serasinghe MN, 2015, MOL CELL, V57, P521, DOI 10.1016/j.molcel.2015.01.003; Tabassum DP, 2015, NAT REV CANCER, V15, P473, DOI 10.1038/nrc3971; Vyas S, 2016, CELL, V166, P555, DOI 10.1016/j.cell.2016.07.002; Waitkus MS, 2018, CANCER CELL, V34, P186, DOI 10.1016/j.ccell.2018.04.011; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wu DD, 2016, TUMOR BIOL, V37, P5225, DOI 10.1007/s13277-015-4358-2; Xie Q, 2015, NAT NEUROSCI, V18, P501, DOI 10.1038/nn.3960; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Zhao J, 2013, ONCOGENE, V32, P4814, DOI 10.1038/onc.2012.494; Zhou LS, 2016, EMBO REP, V17, P811, DOI 10.15252/embr.201541643; Zou XH, 2017, CANCER RES, V77, P3990, DOI 10.1158/0008-5472.CAN-16-2393	57	17	17	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13398	13411		10.1096/fj.201901366R	http://dx.doi.org/10.1096/fj.201901366R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31530011	Bronze, Green Published			2022-12-26	WOS:000507466100029
J	Yap, JLY; Tai, YK; Frohlich, J; Fong, CHH; Yin, JN; Foo, ZL; Ramanan, S; Beyer, C; Toh, SJ; Casarosa, M; Bharathy, N; Kala, MP; Egli, M; Taneja, R; Lee, CN; Franco-Obregon, A				Yap, Jasmine Lye Yee; Tai, Yee Kit; Frohlich, Juerg; Fong, Charlene Hui Hua; Yin, Jocelyn Naixin; Foo, Zi Ling; Ramanan, Sharanya; Beyer, Christian; Toh, Shi Jie; Casarosa, Marco; Bharathy, Narendra; Kala, Monica Palanichamy; Egli, Marcel; Taneja, Reshma; Lee, Chuen Neng; Franco-Obregon, Alfredo			Ambient and supplemental magnetic fields promote myogenesis via a TRPC1-mitochondrial axis: evidence of a magnetic mitohormetic mechanism	FASEB JOURNAL			English	Article						pulsed electromagnetic fields; reactive oxygen species; PGC-1 alpha; calcineurin; mitochondriogenesis	MECHANOSENSITIVE ION CHANNELS; MYOBLAST DIFFERENTIATION; C2C12 MYOBLASTS; DISTINCT ROLES; MUSCLE; TRPC1; PGC-1-ALPHA; CALCIUM; PROLIFERATION; CALCINEURIN	We show that both supplemental and ambient magnetic fields modulate myogenesis. A lone 10 min exposure of myoblasts to 1.5 mT amplitude supplemental pulsed magnetic fields (PEMFs) accentuated in vitro myogenesis by stimulating transient receptor potential (TRP)-C1-mediated calcium entry and downstream nuclear factor of activated T cells (NFAT)-transcriptional and P300/CBP-associated factor (PCAF)-epigenetic cascades, whereas depriving myoblasts of ambient magnetic fields slowed myogenesis, reduced TRPC1 expression, and silenced NFAT-transcriptional and PCAF-epigenetic cascades. The expression levels of peroxisome proliferator-activated receptor gamma coactivator 1 alpha, the master regulator of mitochondriogenesis, was also enhanced by brief PEMF exposure. Accordingly, mitochondriogenesis and respiratory capacity were both enhanced with PEMF exposure, paralleling TRPC1 expression and pharmacological sensitivity. Clustered regularly interspaced short palindromic repeats-Cas9 knockdown of TRPC1 precluded proliferative and mitochondrial responses to supplemental PEMFs, whereas small interfering RNA gene silencing of TRPM7 did not, coinciding with data that magnetoreception did not coincide with the expression or function of other TRP channels. The aminoglycoside antibiotics antagonized and down-regulated TRPC1 expression and, when applied concomitantly with PEMF exposure, attenuated PEMF-stimulated calcium entry, mitochondrial respiration, proliferation, differentiation, and epigenetic directive in myoblasts, elucidating why the developmental potential of magnetic fields may have previously escaped detection. Mitochondrial-based survival adaptations were also activated upon PEMF stimulation. Magnetism thus deploys an authentic myogenic directive that relies on an interplay between mitochondria and TRPC1 to reach fruition.	[Yap, Jasmine Lye Yee; Tai, Yee Kit; Frohlich, Juerg; Fong, Charlene Hui Hua; Yin, Jocelyn Naixin; Foo, Zi Ling; Ramanan, Sharanya; Toh, Shi Jie; Lee, Chuen Neng; Franco-Obregon, Alfredo] Natl Univ Singapore, Dept Surg, Singapore, Singapore; [Bharathy, Narendra; Kala, Monica Palanichamy; Taneja, Reshma; Franco-Obregon, Alfredo] Natl Univ Singapore, Dept Physiol, Yong Loo Lin Sch Med, Singapore, Singapore; [Yap, Jasmine Lye Yee; Tai, Yee Kit; Fong, Charlene Hui Hua; Yin, Jocelyn Naixin; Foo, Zi Ling; Ramanan, Sharanya; Toh, Shi Jie; Franco-Obregon, Alfredo] Natl Univ Singapore, BioIon Currents Elect Pulsing Syst Lab BICEPS, Singapore, Singapore; [Lee, Chuen Neng; Franco-Obregon, Alfredo] Natl Univ Singapore, Inst Hlth Innovat & Technol, iHealthtech, Singapore, Singapore; [Frohlich, Juerg; Beyer, Christian] ETH, Swiss Fed Inst Technol, Inst Elect Fields, Zurich, Switzerland; [Beyer, Christian] Ctr Suisse Elect & Microtech CSEM SA, Neuchatel, Switzerland; [Casarosa, Marco] Univ Florence, Dept Expt & Clin Biomed Sci Mario Serio, Florence, Italy; [Bharathy, Narendra] Childrens Canc Therapy Dev Inst, Beaverton, OR USA; [Egli, Marcel] Lucerne Univ Appl Sci & Arts, Inst Med Engn, Hergiswil, Switzerland	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Center for Electronics & Microtechnology (CSEM); University of Florence	Franco-Obregon, A (corresponding author), Natl Univ Singapore, Natl Univ Hosp, NUHS Tower Block,Level 8,1E Kent Ridge Rd, Singapore 119228, Singapore.	suraf@nus.edu.sg	Tai, Yee Kit/HCH-5864-2022; ELANGOVAN, NARENDRA BHARATHY/X-9367-2018; Tai, Yee Kit/AHB-6200-2022; Lee, Chuen Neng/B-4516-2011; Taneja, Reshma/F-9658-2014	ELANGOVAN, NARENDRA BHARATHY/0000-0002-4697-5044; Lee, Chuen Neng/0000-0001-9748-4424; Taneja, Reshma/0000-0002-2151-2094; Palanichamy Kala, Monica/0000-0003-3447-7360; Reshma, Taneja/0000-0001-6214-6177; Franco-Obregon, Alfredo/0000-0002-2514-1083; Tai, Yee Kit/0000-0003-0798-3575; Egli, Marcel/0000-0002-4064-2871	European Space Agency Grant ESA-CORA-GBF [4000113883]; Fondation Suisse de Recherche sur les Maladies Musculaires; Lee Foundation, Singapore	European Space Agency Grant ESA-CORA-GBF(European Space Agency); Fondation Suisse de Recherche sur les Maladies Musculaires; Lee Foundation, Singapore	The authors acknowledge Dr. T. Benavides Damm [Swiss Space Center, Swiss Federal Institute of Technology (ETH Zurich)] for assisting with the simulated microgravity experiment shown in Fig. 10D, and Dr. Krzysztof Krawczyk (ETH Zurich) for assistance in conducting the fusion index histogram in Fig. 3H. The authors also acknowledge Zac Goh (iHealthtech, National University of Singapore) for the design of graphical abstract shown in Fig. 1. This study was financially supported by the European Space Agency Grant ESA-CORA-GBF (4000113883), the Fondation Suisse de Recherche sur les Maladies Musculaires, and the Lee Foundation, Singapore. J.F., C.B., C.N.L., and A.F.-O. are inventors on patent WO 2016/178631 A1, System and Method for Applying Pulsed Electromagnetic Fields, and J.F., C.N.L. and A.F.-O. are contributors to QuantumTx Pte. Ltd., which elaborates on the use of similar magnetic fields on human health (targeting muscle). The other authors declare no conflicts of interest.	Adhihetty PJ, 2009, AM J PHYSIOL-CELL PH, V297, pC217, DOI 10.1152/ajpcell.00070.2009; Aquilano K, 2013, ANTIOXID REDOX SIGN, V18, P386, DOI 10.1089/ars.2012.4615; Armand AS, 2008, J BIOL CHEM, V283, P29004, DOI 10.1074/jbc.M801297200; Arsenis NC, 2017, ONCOTARGET, V8, P45008, DOI 10.18632/oncotarget.16726; Baek S, 2014, ACS NANO, V8, P10125, DOI 10.1021/nn502923s; Baldelli S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.458; Calabria E, 2009, P NATL ACAD SCI USA, V106, P13335, DOI 10.1073/pnas.0812911106; Chen MS, 2013, CELL PHYSIOL BIOCHEM, V32, P951, DOI 10.1159/000354498; Cheng CF, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113447; Crocetti S, 2014, CYTOM PART A, V85A, P525, DOI 10.1002/cyto.a.22461; Crocetti S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072944; Damm TB, 2013, CELL CYCLE, V12, P3001, DOI 10.4161/cc.26029; Dick SA, 2015, P NATL ACAD SCI USA, V112, pE5246, DOI 10.1073/pnas.1512869112; Dilworth FJ, 2004, P NATL ACAD SCI USA, V101, P11593, DOI 10.1073/pnas.0404192101; Eijkelkamp N, 2013, ANNU REV NEUROSCI, V36, P519, DOI 10.1146/annurev-neuro-062012-170412; Enoki R, 2017, SCI REP-UK, V7, DOI 10.1038/srep41733; Fauquier L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31102-4; Fogle KJ, 2015, P NATL ACAD SCI USA, V112, P2245, DOI 10.1073/pnas.1416586112; FRANCO A, 1990, J PHYSIOL-LONDON, V427, P361, DOI 10.1113/jphysiol.1990.sp018176; Fraysse B, 2003, FASEB J, V17, P1916, DOI 10.1096/fj.02-1012fje; Frey N, 2008, J CLIN INVEST, V118, P3598, DOI 10.1172/JCI36277; Gao X, 2010, J CELL BIOCHEM, V110, P162, DOI 10.1002/jcb.22522; Gervasio OL, 2008, J CELL SCI, V121, P2246, DOI 10.1242/jcs.032003; Gorlach A, 2015, REDOX BIOL, V6, P260, DOI 10.1016/j.redox.2015.08.010; Goodpaster BH, 2017, CELL METAB, V25, P1027, DOI 10.1016/j.cmet.2017.04.015; Ho TC, 2012, CHANNELS, V6, P246, DOI 10.4161/chan.20719; Hore PJ, 2016, ANNU REV BIOPHYS, V45, P299, DOI 10.1146/annurev-biophys-032116-094545; Hu HZ, 2009, P NATL ACAD SCI USA, V106, P1626, DOI 10.1073/pnas.0812209106; Hudson MB, 2013, INT J BIOCHEM CELL B, V45, P2173, DOI 10.1016/j.biocel.2013.06.029; Hughes SM, 1999, J CELL BIOL, V145, P633, DOI 10.1083/jcb.145.3.633; Jang Y, 2012, ARCH PHARM RES, V35, P1823, DOI 10.1007/s12272-012-1016-8; Kang CH, 2012, ANN NY ACAD SCI, V1271, P110, DOI 10.1111/j.1749-6632.2012.06738.x; Kattnig DR, 2016, NAT CHEM, V8, P384, DOI [10.1038/NCHEM.2447, 10.1038/nchem.2447]; Kook SH, 2008, MOL CELLS, V25, P479; Kuras Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043859; Lambert N, 2013, NAT PHYS, V9, P10, DOI [10.1038/nphys2474, 10.1038/NPHYS2474]; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Martino CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022753; Matsumura CY, 2011, AM J PHYSIOL-CELL PH, V301, pC1344, DOI 10.1152/ajpcell.00056.2011; Morabito C, 2010, FREE RADICAL BIO MED, V48, P579, DOI 10.1016/j.freeradbiomed.2009.12.005; Morales S, 2007, AM J PHYSIOL-CELL PH, V292, pC553, DOI 10.1152/ajpcell.00096.2006; Murray TVA, 2008, J CELL SCI, V121, P3786, DOI 10.1242/jcs.024547; Nicholls David G, 2010, J Vis Exp, DOI 10.3791/2511; Nilius B, 2015, TRP CHANNELS THERAPE, P419, DOI [10.1016/B978-0-12-420024-1.00023-0, DOI 10.1016/B978-0-12-420024-1.00023-0]; Nunn AVW, 2016, BIOCHEM SOC T, V44, P1101, DOI 10.1042/BST20160096; Ong EC, 2013, J BIOL CHEM, V288, P22219, DOI 10.1074/jbc.M113.459826; Parate D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09892-w; Perroud J, 2017, J CELL SCI, V130, P3083, DOI 10.1242/jcs.198978; Pfluger PT, 2015, CELL METAB, V22, P838, DOI 10.1016/j.cmet.2015.08.022; Portelli LA, 2013, BIOELECTROMAGNETICS, V34, P337, DOI 10.1002/bem.21787; Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow; Roberts-Wilson TK, 2010, BBA-MOL CELL RES, V1803, P960, DOI 10.1016/j.bbamcr.2010.03.019; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Sciancalepore M, 2012, FREE RADICAL BIO MED, V53, P1392, DOI 10.1016/j.freeradbiomed.2012.08.002; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sherrard RM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006229; Sin J, 2016, AUTOPHAGY, V12, P369, DOI 10.1080/15548627.2015.1115172; Surma SV, 2014, BIOELECTROMAGNETICS, V35, P537, DOI 10.1002/bem.21876; Tan N, 2014, J PHYSIOL-LONDON, V592, P3303, DOI 10.1113/jphysiol.2014.274332; Targos B, 2005, ACTA BIOCHIM POL, V52, P397, DOI 10.18388/abp.2005_3452; Trewin AJ, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7010007; Usselman RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38543; Vincent F, 2011, CURR TOP MED CHEM, V11, P2216, DOI 10.2174/156802611796904861; Wade B., 2013, AM J HLTH RES, V1, P51; Wagatsuma A, 2013, SCI WORLD J, DOI 10.1155/2013/593267; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Winegar BD, 1996, J GEN PHYSIOL, V107, P433, DOI 10.1085/jgp.107.3.433; Xia L, 2016, J PHYSIOL-LONDON, V594, P3111, DOI 10.1113/JP271705; Xu HX, 2016, BIOCHEM BIOPH RES CO, V479, P97, DOI 10.1016/j.bbrc.2016.09.044; Zanou N, 2012, J BIOL CHEM, V287, P14524, DOI 10.1074/jbc.M112.341784; Zanou N, 2010, AM J PHYSIOL-CELL PH, V298, pC149, DOI 10.1152/ajpcell.00241.2009	71	20	21	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12853	12872		10.1096/fj.201900057R	http://dx.doi.org/10.1096/fj.201900057R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31518158	hybrid, Green Published			2022-12-26	WOS:000507461600097
J	Avila-Mendez, K; Rodrigo, A; Araque, L; Romero, HM				Avila-Mendez, Kelly; Rodrigo, Avila; Araque, Leonardo; Mauricio Romero, Hernan			Simultaneous transcriptome analysis of oil palm clones and Phytophthora palmivora reveals oil palm defense strategies	PLOS ONE			English	Article							GENE-EXPRESSION; BUD ROT; AUXIN; REPRESSION; GROWTH	Phytophthora palmivora is an oomycete that causes oil palm bud rot disease. To understand the molecular mechanisms of this disease, palm clones with contrasting responses (Ortet 34, resistant and Ortet 57, susceptible) were inoculated with P. palmivora, and RNAseq gene expression analysis was performed. The transcriptome was obtained by sequencing using Illumina HiSeq2500 technology during the asymptomatic phase (24, 72 and 120 hours postinfection, hpi). A simultaneous analysis of differentially expressed gene (DEG) profiles in palm and P. palmivora was carried out. Additionally, Gene Ontology (GO) and gene network analysis revealed differences in the transcriptional profile of the two ortets, where a high specificity of the pathogen to colonize the susceptible ortet was found. The transcriptional analysis provided an overview of the genes involved in the recognition and signaling of this pathosystem, where different transcription factors, phytohormones, proteins associated with cell wall hardening and nitrogen metabolism contribute to the resistance of oil palm to P. palmivora. This research provides a description of the molecular response of oil palm to P. palmivora, thus becoming an important source of molecular markers for the study of genotypes resistant to bud rot disease.	[Avila-Mendez, Kelly; Rodrigo, Avila; Araque, Leonardo; Mauricio Romero, Hernan] Cenipalma, OiI Palm Res Ctr, Biol & Breeding Program, Bogota, Colombia; [Mauricio Romero, Hernan] Univ Nacl Colombia, Dept Biol, Bogota, Colombia	CENIPALMA (Colombia); Universidad Nacional de Colombia	Romero, HM (corresponding author), Cenipalma, OiI Palm Res Ctr, Biol & Breeding Program, Bogota, Colombia.; Romero, HM (corresponding author), Univ Nacl Colombia, Dept Biol, Bogota, Colombia.	hmromeroa@unal.edu.co	Avila, Kelly/ABH-4598-2020; Romero, Hernan Mauricio/AFI-6703-2022	Avila, Kelly/0000-0002-7155-2924; Romero, Hernan Mauricio/0000-0002-0760-2296; Avila, Rodrigo/0000-0001-8972-9663	Colciencias [713-2011, 158-2016]; Colombian Oil Promotion Fund Research Grant [IIT-0218]; Oil Palm Promotion Fund (FFP)	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Colombian Oil Promotion Fund Research Grant; Oil Palm Promotion Fund (FFP)	The study received financial support by: Colciencias Doctoral Fellowship, to K.A.; Colciencias Research Grants 713-2011 and 158-2016 to HMR; Colombian Oil Promotion Fund Research Grant IIT-0218 to HMR; The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; To the members of the Biology and Breeding Research Program at Cenipalma for their help with data collection. To the Oil Palm Pests and Diseases group at Cenipalma for providing the P. palmivora isolates. This research was funded by Colciencias and the Oil Palm Promotion Fund (FFP) administered by Fedepalma.	Asai S, 2015, CURR OPIN PLANT BIOL, V28, P1, DOI 10.1016/j.pbi.2015.08.008; Berens ML, 2017, ANNU REV PHYTOPATHOL, V55, P401, DOI 10.1146/annurev-phyto-080516-035544; Bigeard J, 2015, MOL PLANT, V8, P521, DOI 10.1016/j.molp.2014.12.022; Birkenbihl RP, 2017, CURR OPIN PLANT BIOL, V38, P1, DOI 10.1016/j.pbi.2017.04.004; Camejo D, 2016, PLANT PHYSIOL BIOCH, V103, P10, DOI 10.1016/j.plaphy.2016.02.035; Chan PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099774; Chen X-R, 2018, MOL GENET GENOMICS, P1; Coaker G, 2014, SCIENCE, V343, P496, DOI 10.1126/science.1250171; de Vries S, 2017, MOL PLANT PATHOL, V18, P110, DOI 10.1111/mpp.12465; Derevnina L, 2016, NEW PHYTOL, V212, P888, DOI 10.1111/nph.14137; Evangelisti E, 2014, CURR OPIN PLANT BIOL, V20, P118, DOI 10.1016/j.pbi.2014.05.014; Fedepalma, 2018, STAT YB 2018; Franceschetti M, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00066-16, 10.1128/mmbr.00066-16]; Fu J, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00074; Gil-Bedoya J., 2019, THESIS; Kidd BN, 2011, MOL PLANT MICROBE IN, V24, P733, DOI 10.1094/MPMI-08-10-0194; Kong P, 2016, SCI REP-UK, V6, DOI 10.1038/srep33239; Latifah M, 2017, FOREST PATHOL, V47, DOI 10.1111/efp.12374; Li B, 2016, CELL HOST MICROBE, V19, P641, DOI 10.1016/j.chom.2016.04.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llorente F, 2008, MOL PLANT, V1, P496, DOI 10.1093/mp/ssn025; Macho AP, 2014, MOL CELL, V54, P263, DOI 10.1016/j.molcel.2014.03.028; Naseenn M, 2015, J EXP BOT, V66, P4885, DOI 10.1093/jxb/erv297; Sarria GA, 2016, EUR J PLANT PATHOL, V145, P39, DOI 10.1007/s10658-015-0810-9; Sharpee WC, 2016, FUNGAL BIOL REV, V30, P62, DOI 10.1016/j.fbr.2016.04.001; Shigenaga AM, 2016, SEMIN CELL DEV BIOL; Shine MB, 2016, NEW PHYTOL, V212, P627, DOI 10.1111/nph.14078; Sundram S, 2017, CROP PROT, V101, P58, DOI 10.1016/j.cropro.2017.07.010; Torres GA, 2016, PHYTOPATHOLOGY, V106, P320, DOI 10.1094/PHYTO-09-15-0243-RVW; Vijay V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159668; Wang D, 2007, CURR BIOL, V17, P1784, DOI 10.1016/j.cub.2007.09.025; Yang F., 2013, PLOS ONE, V8, P1, DOI DOI 10.1371/annotation/fd65b655-d35b-47d1-8793-07da2273c144	32	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222774	10.1371/journal.pone.0222774	http://dx.doi.org/10.1371/journal.pone.0222774			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553759	Green Published, gold			2022-12-26	WOS:000532319200035
J	Chamberlain, CA; Hatch, M; Garrett, TJ				Chamberlain, Casey A.; Hatch, Marguerite; Garrett, Timothy J.			Metabolomic profiling of oxalate-degrading probiotic Lactobacillus acidophilus and Lactobacillus gasseri	PLOS ONE			English	Article							DIETARY OXALATE; DOUBLE-BLIND; BACTERIA; CASEI; ACID; REDUCTION; MEMBRANE; EFFICACY; PLACEBO; CITRATE	Oxalate, a ubiquitous compound in many plant-based foods, is absorbed through the intestine and precipitates with calcium in the kidneys to form stones. Over 80% of diagnosed kidney stones are found to be calcium oxalate. People who form these stones often experience a high rate of recurrence and treatment options remain limited despite decades of dedicated research. Recently, the intestinal microbiome has become a new focus for novel therapies. Studies have shown that select species of Lactobacillus, the most commonly included genus in modern probiotic supplements, can degrade oxalate in vitro and even decrease urinary oxalate in animal models of Primary Hyperoxaluria. Although the purported health benefits of Lactobacillus probiotics vary significantly between species, there is supporting evidence for their potential use as probiotics for oxalate diseases. Defining the unique metabolic properties of Lactobacillus is essential to define how these bacteria interact with the host intestine and influence overall health. We addressed this need by characterizing and comparing the metabolome and lipidome of the oxalate-degrading Lactobacillus acidophilus and Lactobacillus gasseri using ultra-high-performance liquid chromatography-high resolution mass spectrometry. We report many species-specific differences in the metabolic profiles of these Lactobacillus species and discuss potential probiotic relevance and function resulting from their differential expression. Also described is our validation of the oxalate-degrading ability of Lactobacillus acidophilus and Lactobacillus gasseri, even in the presence of other preferred carbon sources, measuring in vitro C-14-oxalate consumption via liquid scintillation counting.	[Chamberlain, Casey A.; Hatch, Marguerite; Garrett, Timothy J.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Garrett, TJ (corresponding author), Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA.	tgarrett@ufl.edu	Chamberlain, Casey/ABD-2813-2020	Chamberlain, Casey/0000-0002-3633-8594	National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088892] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	TG received 2R01DK088892-05A1 from the National Institutes of Health, www.nih.gov.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abratt VR, 2010, ADV APPL MICROBIOL, V72, P63, DOI 10.1016/S0065-2164(10)72003-7; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Behnsen J, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010074; Benito de Cardenas I L, 1992, Rev Argent Microbiol, V24, P136; BRANEN AL, 1971, APPL MICROBIOL, V21, P993, DOI 10.1128/AEM.21.6.993-998.1971; BRANEN AL, 1970, J DAIRY SCI, V53, P593, DOI 10.3168/jds.S0022-0302(70)86259-2; Brooijmans Rob, 2009, F1000 Biol Rep, V1, P34, DOI 10.3410/B1-34; Chamberlain CA, 2019, ANAL CHEM, V91, P4964, DOI 10.1021/acs.analchem.9b00330; Chamberlain CA, 2019, ANAL BIOANAL CHEM, V411, P4807, DOI 10.1007/s00216-019-01639-y; Chen JY, 2019, BIOTECHNOL BIOFUELS, V12, DOI 10.1186/s13068-019-1384-0; Cho YA, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001714; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Di Felice G, 2008, J CLIN GASTROENTEROL, V42, pS130, DOI 10.1097/MCG.0b013e318169c463; Diaz-Muniz I, 2006, J APPL MICROBIOL, V101, P872, DOI 10.1111/j.1365-2672.2006.02965.x; Diaz-Muniz I, 2006, ANTON LEEUW INT J G, V90, P233, DOI 10.1007/s10482-006-9078-6; Dimidi E, 2017, ADV NUTR, V8, P484, DOI 10.3945/an.116.014407; Engel CAR, 2008, APPL MICROBIOL BIOT, V78, P379, DOI 10.1007/s00253-007-1341-x; Ettinger G, 2014, GUT MICROBES, V5, P719, DOI 10.4161/19490976.2014.983775; Ferrarese R, 2018, EUR REV MED PHARMACO, V22, P7588, DOI 10.26355/eurrev_201811_16301; Fijan S, 2014, INT J ENV RES PUB HE, V11, P4745, DOI 10.3390/ijerph110504745; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fozo EM, 2004, FEMS MICROBIOL LETT, V238, P291, DOI 10.1016/j.femsle.2004.07.047; Frank DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0b013e3282f2b0e8; Gao XW, 2010, AM J GASTROENTEROL, V105, P1636, DOI 10.1038/ajg.2010.11; Guerzoni ME, 2001, MICROBIOL-SGM, V147, P2255, DOI 10.1099/00221287-147-8-2255; Hatch M, 2006, KIDNEY INT, V69, P691, DOI 10.1038/sj.ki.5000162; Hatch M, 2008, SEMIN NEPHROL, V28, P143, DOI 10.1016/j.semnephrol.2008.01.007; Hatch M, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2016.12.70; He LL, 2015, ANAL CHEM, V87, P2459, DOI 10.1021/ac504458r; Heeney DD, 2018, CURR OPIN BIOTECH, V49, P140, DOI 10.1016/j.copbio.2017.08.004; Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66; HOLM S, 1979, SCAND J STAT, V6, P65; Holmes RP, 1998, J UROLOGY, V160, P1617, DOI 10.1016/S0022-5347(01)62363-2; Holmes RP, 2001, KIDNEY INT, V59, P270, DOI 10.1046/j.1523-1755.2001.00488.x; JAKOBY WB, 1956, J BIOL CHEM, V222, P435; Kaur R, 2006, PHYTOCHEMISTRY, V67, P595, DOI 10.1016/j.phytochem.2005.12.011; Khan SR, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.1; Kim J, 2018, J MED FOOD, V21, P454, DOI 10.1089/jmf.2017.3937; King CD, 2000, CURR DRUG METAB, V1, P143, DOI 10.2174/1389200003339171; Koelmel JP, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1744-3; Koelmel JP, 2017, J AM SOC MASS SPECTR, V28, P908, DOI 10.1007/s13361-017-1608-0; La Fata G, 2018, PROBIOTICS ANTIMICRO, V10, P11, DOI 10.1007/s12602-017-9322-6; Liebman M, 2011, ADV NUTR, V2, P254, DOI 10.3945/an.111.000414; Lu HYJ, 2011, J FOOD PROTECT, V74, P893, DOI 10.4315/0362-028X.JFP-10-404; Max B, 2010, BRAZ J MICROBIOL, V41, P862, DOI 10.1590/S1517-83822010000400005; McFarland LV, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00124; Miller AW, 2013, PATHOGENS, V2, P636, DOI 10.3390/pathogens2040636; MINERS JO, 1991, PHARMACOL THERAPEUT, V51, P347, DOI 10.1016/0163-7258(91)90065-T; OREN A, 1991, J GEN MICROBIOL, V137, P1387, DOI 10.1099/00221287-137-6-1387; Ouwehand AC, 2009, WORLD J GASTROENTERO, V15, P3261, DOI 10.3748/wjg.15.3261; Parsons JB, 2013, PROG LIPID RES, V52, P249, DOI 10.1016/j.plipres.2013.02.002; Pirbaglou M, 2016, NUTR RES, V36, P889, DOI 10.1016/j.nutres.2016.06.009; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; Podolak RK, 1996, J FOOD PROTECT, V59, P1037, DOI 10.4315/0362-028X-59.10.1037; PODOLAK RK, 1995, J FOOD SAFETY, V15, P283, DOI 10.1111/j.1745-4565.1995.tb00140.x; Ringel-Kulka T, 2011, J CLIN GASTROENTEROL, V45, P518, DOI 10.1097/MCG.0b013e31820ca4d6; Rossi M, 2016, ENVIRON MICROBIOL, DOI [10.1111/1462-2920.13295, DOI 10.1111/1462-2920.13295]; Sazawal S, 2006, LANCET INFECT DIS, V6, P374, DOI 10.1016/S1473-3099(06)70495-9; Selle K, 2013, FEMS MICROBIOL REV, V37, P915, DOI 10.1111/1574-6976.12021; Sen Gupta M, 2013, HE KUPU, V3, P13; Shimizu M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139795; Sinn DH, 2008, DIGEST DIS SCI, V53, P2714, DOI 10.1007/s10620-007-0196-4; Taranto MP, 2003, J APPL MICROBIOL, V95, P86, DOI 10.1046/j.1365-2672.2003.01962.x; Turroni S, 2007, J APPL MICROBIOL, V103, P1600, DOI 10.1111/j.1365-2672.2007.03388.x; van Baarlen P, 2011, P NATL ACAD SCI USA, V108, P4562, DOI 10.1073/pnas.1000079107; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Venugopalan V, 2010, EMERG INFECT DIS, V16, P1661, DOI 10.3201/eid1611.100574; Walter J, 2008, APPL ENVIRON MICROB, V74, P4985, DOI 10.1128/AEM.00753-08; Wehrens R, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1015-8; Whittamore JM, 2017, UROLITHIASIS, V45, P89, DOI 10.1007/s00240-016-0952-z; Worcester EM, 2008, PRIMARY CARE, V35, P369, DOI 10.1016/j.pop.2008.01.005; Wulff J.E., 2018, ADV BIOSCI BIOTECHNO, V9, P339, DOI [10.4236/abb.2018.98022, DOI 10.4236/ABB.2018.98022]; Ya W, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.023	73	24	24	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222393	10.1371/journal.pone.0222393	http://dx.doi.org/10.1371/journal.pone.0222393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545840	gold, Green Published			2022-12-26	WOS:000532303200016
J	Schmidt-Busby, J; Wiles, J; Exeter, D; Kenealy, T				Schmidt-Busby, Jacqueline; Wiles, Janine; Exeter, Daniel; Kenealy, Timothy			Self-management action and motivation of Pacific adults in New Zealand with end-stage renal disease	PLOS ONE			English	Article							CHRONIC ILLNESS; THEMATIC SYNTHESIS; HOPE; FAMILY; METASYNTHESIS; TIME; CARE	Aims To explore actions and motivations for self-management practices of Pacific adults following diagnosis of end stage renal disease (ESRD). Methods Focused ethnography using in-depth interviews with 16 Pacific people on haemodialysis for diabetic ESRD, in Auckland, New Zealand. Study participants were of Samoan, Cook Islander, Tongan, Niuean, or Tokelauan ethnicity and aged between 30 to 69 years old. Thematic analysis was used to code and identify emergent themes. Results All participants assumed active responsibility for their self-management following their diagnosis of ESRD. They reported positive differences in their current self-management behaviours, compared to pre-ESRD diagnosis. In the face of their terminal diagnosis, participant's motivations to self-manage their health were fuelled by hope; the hope to live long enough to change their family legacy of diabetes and ESRD. To achieve this, there was a dependency upon family members as a resource for self-management support. Yet at the same time, family members also had health concerns (including diabetes), and several participants themselves were carers for sick or elderly family members. Conclusion The growing number of members (within family units) progressing from moderate to late-stage diabetes raises concerns about the sustainability of future family support in Pacific families in New Zealand with histories of diabetes, ESRD, and other chronic diseases. While the burden upon informal carers (family) has been well documented throughout the past few decades, the dynamics of bi-directional carer support between (two or more) sick family members and their families have had less exposure. This has potentially significant implications for Pacific peoples in New Zealand, considering the increases in diabetes prevalence within their families.	[Schmidt-Busby, Jacqueline] Middlemore Hosp, Counties Manukau Hlth, Auckland, New Zealand; [Schmidt-Busby, Jacqueline; Wiles, Janine] Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Dept Social & Community Hlth, Auckland, New Zealand; [Exeter, Daniel] Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Dept Epidemiol & Biostat, Auckland, New Zealand; [Kenealy, Timothy] Univ Auckland, Fac Med & Hlth Sci, Sch Med, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland	Schmidt-Busby, J (corresponding author), Middlemore Hosp, Counties Manukau Hlth, Auckland, New Zealand.; Schmidt-Busby, J (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Sch Populat Hlth, Dept Social & Community Hlth, Auckland, New Zealand.	j.schmidt-busby@auckland.ac.nz			Counties Manukau District Health Board: 2016 CMH Research Fellowship (PhD)	Counties Manukau District Health Board: 2016 CMH Research Fellowship (PhD)	JS-B is funded by Counties Manukau District Health Board: 2016 CMH Research Fellowship (PhD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arstila V., 2014, SUBJECTIVE TIME PHIL; Australia and New Zealand Dialysis and Transplant Registry, 2018, END STAG KIDN DIS AO; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Borneman T, 2014, INT J PALLIAT NURS, V20, P271, DOI 10.12968/ijpn.2014.20.6.271; Braun V., 2022, THEMATIC ANAL PRACTI; BRUHN JG, 1984, SOUTH MED J, V77, P215, DOI 10.1097/00007611-198402000-00020; Davies MJ, 2018, DIABETOLOGIA, V61, P2461, DOI 10.1007/s00125-018-4729-5; Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2; DUFAULT K, 1985, NURS CLIN N AM, V20, P379; Duggleby W, 2012, J ADV NURS, V68, P1211, DOI 10.1111/j.1365-2648.2011.05919.x; Ellingsen S, 2013, SCAND J CARING SCI, V27, P165, DOI 10.1111/j.1471-6712.2012.01019.x; Gamble E, 2015, NUTR DIETETICS; Glasgow RE, 2002, ANN BEHAV MED, V24, P80, DOI 10.1207/S15324796ABM2402_04; GUBA EG, 1981, ECTJ-EDUC COMMUN TEC, V29, P75; Health Navigator New Zealand, 2019, PROGR COURS DIAB SEL; Health Quality and Safety Commission New Zealand, 2018, ATL HEALTHC VAR DIAB; Herth K, 1993, Issues Ment Health Nurs, V14, P139, DOI 10.3109/01612849309031613; HERTH K, 1990, J ADV NURS, V15, P1250, DOI 10.1111/j.1365-2648.1990.tb01740.x; Holder B, 1997, Adv Ren Replace Ther, V4, P13; Jackson G, 2012, METRO AUCKLAND PACIF, DOI [10.1177/1363459311403950, DOI 10.1177/1363459311403950]; Jowsey T, 2016, QUAL LIFE RES, V25, P1093, DOI 10.1007/s11136-015-1169-2; Kiata L, 2004, QUAL HEALTH RES, V14, P313, DOI 10.1177/1049732303261820; Lorig KR, 2003, ANN BEHAV MED, V26, P1, DOI 10.1207/S15324796ABM2601_01; Macpherson C, 2001, EVOLVING IDENTITIES; Ministry of Health, 2014, DIAB QUAL CAR STAND; Ministry of Health, 2016, ANN UPD KEY RES 2015; Ministry of Health and Ministry of Pacific Island Affairs, 2004, TUP OL MOUI PAC HLTH; Moran A, 2011, J ADV NURS, V67, P501, DOI 10.1111/j.1365-2648.2010.05460.x; Newton P, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/638205; OECD, 2015, DOES HLTH SPEND NZ C; Pearson M.L., 2007, PATIENT SELF MANAGEM; Pene G, 2009, SOC POLICY J NZ, P79; Podsiadlowski A, 2011, NEW ZEAL J PSYCHOL, V40, P5; Portsmouth City Council, 2017, PUBL HLTH ANN REP 20; Pulotu-Endemann F.K., 2007, SEITAPU PACIFIC MENT; Reid C, 2016, CLIN J AM SOC NEPHRO, V11, P1206, DOI 10.2215/CJN.10561015; Riegel B, 2002, PATIENT EDUC COUNS, V46, P287, DOI 10.1016/S0738-3991(01)00165-3; Rousseau P, 2000, WESTERN J MED, V173, P117, DOI 10.1136/ewjm.173.2.117; Ryan P, 2009, NURS OUTLOOK, V57, P217, DOI 10.1016/j.outlook.2008.10.004; Saldana J., 2015, CODING MANUAL QUALIT, V3rd; Schmidt-Busby J, 2018, DIABETES RES CLIN PR; Schmidt-Busby J, 2019, HEALTH EXPECT, V22, P1122, DOI 10.1111/hex.12946; Schulman-Green D, 2016, J ADV NURS, V72, P1469, DOI 10.1111/jan.12902; Schulman-Green D, 2012, J NURS SCHOLARSHIP, V44, P136, DOI 10.1111/j.1547-5069.2012.01444.x; Scollan-Koliopoulos M, 2007, RES NURS HEALTH, V30, P508, DOI 10.1002/nur.20208; Scollan-Koliopoulos M, 2010, DIABETES EDUCATOR, V36, P473, DOI 10.1177/0145721710362108; Sheridan NF, 2011, PRIM CARE RESP J, V20, P14; Sheridan NF, 2015, HEALTH EXPECT, V18, P32, DOI 10.1111/hex.12006; SIMMONS D, 1995, J INTERN MED, V237, P315, DOI 10.1111/j.1365-2796.1995.tb01181.x; Social Policy Evaluation and Research Unit, 2016, FAM WHAN STAT REP 20; Southwick M, 2012, PRIMARY CARE PACIFIC; Tamasese T.K., 2010, QUALITATIVE STUDY PA; Taylor SJ., 2014, HEALTH SERV DELIVERY, DOI [10.3310/hsdr02530, DOI 10.3310/HSDR02530]; Tong A, 2015, TRANSPL INT, V28, P771, DOI 10.1111/tri.12575; Vannini P., 2002, J MUNDANE BEHAV, V3, P1; Von Korff M, 1997, ANN INTERN MED, V127, P1097, DOI 10.7326/0003-4819-127-12-199712150-00008; Whitehead L, 2018, J CLIN NURS, V27, P22, DOI 10.1111/jocn.13775; Wright S, 2008, KOTUITUI, V3, P21, DOI 10.1080/1177083X.2008.9522430; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	59	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222642	10.1371/journal.pone.0222642	http://dx.doi.org/10.1371/journal.pone.0222642			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5QI	31545828	Green Published, gold			2022-12-26	WOS:000532303200024
J	Titon, SCM; Titon, B; Barsotti, AMG; Gomes, FR; Assis, VR				Monteiro Titon, Stefanny Christie; Titon Jr, Braz; Giorgi Barsotti, Adriana Maria; Gomes, Fernando Ribeiro; Assis, Vania Regina			Time-related immunomodulation by stressors and corticosterone transdermal application in toads	PLOS ONE			English	Article							IMMUNE FUNCTION; URINARY CORTICOSTERONE; PLASMA-LEVELS; METABOLITE RESPONSES; SUPPRESSES; ENDOCRINE; TESTOSTERONE; VERTEBRATES; MODULATION; MELATONIN	Immune responses have been mostly studied at a specific time in anuran species. However, time-changes related to immunomodulation associated with glucocorticoid (GC) alterations following stressors and GC treatment are complex. The present study describes time-related changes in immune response and corticosterone (CORT) plasma levels following restraint challenge, short, mid and long-term captivity, and CORT exogenous administration by transdermal application (TA) in Rhinella ornata toads. We observed increased neutrophil: lymphocyte ratios after restraint challenge and CORT TA, without changes following short and mid-term captivity. Plasma bacterial killing ability was sustained in all treatments, except long-term captivity, with decreased values after 90 days under such conditions. Phagocytic activity of peritoneal cells increased after mid-term captivity, and the phytohemagglutinin swelling response was impaired in those animals treated with CORT TA for 20 consecutive days. Plasma CORT levels increased or were sustained after restraint challenge (depending on initial values), decreased following mid and long-term captivity (for those animals showing high CORT in the field) and increased after 20 days of CORT TA. By performing assessments of time-changes in immune processes and CORT plasma levels in R. ornata, we demonstrate immuno-enhancing effects following restraint, short and mid-term stressors, while long-term stressors and CORT TA promoted immunosuppression in these toads.	[Monteiro Titon, Stefanny Christie; Titon Jr, Braz; Giorgi Barsotti, Adriana Maria; Gomes, Fernando Ribeiro; Assis, Vania Regina] Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, SP, Brazil	Universidade de Sao Paulo	Titon, SCM (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Fisiol, Sao Paulo, SP, Brazil.	stefannychristie@gmail.com	Titon, Stefanny CM/AAL-2887-2021; Assis, Vania R/F-8310-2013	Titon, Stefanny CM/0000-0002-1351-6546; Assis, Vania R/0000-0003-0326-4397; Gomes, Fernando/0000-0003-2244-6161	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013-00900-1, 2014/16320-7, 2011/10560-8, 2016/05024-3]; Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [142455/2013-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (grant numbers: 2013-00900-1, and 2014/16320-7), PhD scholarships to VRA (2011/10560-8), and AMGB (2016/05024-3). It was also supported by Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) through a PhD scholarship to SCMT (142455/2013-0). F.R. Gomes is a research fellow from the Brazilian CNPq - #302308/2016-4.	Assis V.R., 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE; Assis VR, 2019, GEN COMP ENDOCR, V273, P86, DOI 10.1016/j.ygcen.2018.05.008; Assis VR, 2017, J EXP ZOOL PART A, V327, P200, DOI 10.1002/jez.2093; Barriga C, 2001, J PINEAL RES, V30, P180, DOI 10.1034/j.1600-079X.2001.300307.x; Berger S, 2005, HORM BEHAV, V47, P419, DOI 10.1016/j.yhbeh.2004.11.011; Buehler DM, 2008, PHYSIOL BIOCHEM ZOOL, V81, P673, DOI 10.1086/588591; Campbell T. W., 2012, VET HEMATOLOGY CLIN; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; Davis AK, 2018, METHODS ECOL EVOL, V9, P1556, DOI 10.1111/2041-210X.13020; de Assis VR, 2013, S AM J HERPETOL, V8, P155, DOI 10.2994/SAJH-D-13-00007.1; de Assis VR, 2012, COMP BIOCHEM PHYS A, V163, P265, DOI 10.1016/j.cbpa.2012.08.002; Dhabhar FS, 2014, IMMUNOL RES, V58, P193, DOI 10.1007/s12026-014-8517-0; Dhabhar FS, 2008, NEUROIMMUNE, V7, P207; Dhabhar FS, 1999, P NATL ACAD SCI USA, V96, P1059, DOI 10.1073/pnas.96.3.1059; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; Dhabhar FS, 1996, J IMMUNOL, V156, P2608; DuRant SE, 2015, J EXP BIOL, V218, P2297, DOI 10.1242/jeb.118703; During K, 1999, FEBS LETT, V449, P93, DOI 10.1016/S0014-5793(99)00405-6; Falso PG, 2015, GEN COMP ENDOCR, V212, P73, DOI 10.1016/j.ygcen.2015.01.003; French SS, 2010, HORM BEHAV, V58, P792, DOI 10.1016/j.yhbeh.2010.08.001; Barsotti AMG, 2019, J EXP ZOOL PART A, V331, P168, DOI 10.1002/jez.2250; Barsotti AMG, 2017, COMP BIOCHEM PHYS A, V204, P177, DOI 10.1016/j.cbpa.2016.12.002; Gomes Fernando Ribeiro, 2012, South American Journal of Herpetology, V7, P1; Graham SP, 2012, HORM BEHAV, V62, P146, DOI 10.1016/j.yhbeh.2012.06.001; Hernandez-Arciga U, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190047; Hopkins WA, 2011, GEN COMP ENDOCR, V174, P107, DOI 10.1016/j.ygcen.2011.08.006; Madelaire CB, 2019, GEN COMP ENDOCR, V273, P227, DOI 10.1016/j.ygcen.2018.09.005; Marketon JIW, 2008, CELL IMMUNOL, V252, P16, DOI 10.1016/j.cellimm.2007.09.006; Martin LB, 2005, GEN COMP ENDOCR, V140, P126, DOI 10.1016/j.ygcen.2004.10.010; Martin LB, 2009, GEN COMP ENDOCR, V163, P70, DOI 10.1016/j.ygcen.2009.03.008; Titon SCM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35495-0; Titon SCM, 2017, J EXP ZOOL PART A, V327, P127, DOI 10.1002/jez.2078; Titon SCM, 2016, COMP BIOCHEM PHYS A, V201, P53, DOI 10.1016/j.cbpa.2016.06.023; Narayan E, 2011, AUST J ZOOL, V59, P79, DOI 10.1071/ZO11030; Narayan EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092090; Narayan EJ, 2014, J THERM BIOL, V41, P72, DOI 10.1016/j.jtherbio.2014.02.011; Narayan EJ, 2012, GEN COMP ENDOCR, V179, P345, DOI 10.1016/j.ygcen.2012.09.017; Narayan EJ, 2011, GEN COMP ENDOCR, V173, P371, DOI 10.1016/j.ygcen.2011.06.015; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sarma JV, 2011, CELL TISSUE RES, V343, P227, DOI 10.1007/s00441-010-1034-0; Silberman DM, 2003, J NEUROIMMUNOL, V144, P53, DOI 10.1016/j.jneuroim.2003.08.031; Thomas JR, 2015, GEN COMP ENDOCR, V216, P33, DOI 10.1016/j.ygcen.2015.04.013; Tort L, 2011, DEV COMP IMMUNOL, V35, P1366, DOI 10.1016/j.dci.2011.07.002; Zylberberg M, 2015, J EXP BIOL, V218, P757, DOI 10.1242/jeb.111716	45	23	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222856	10.1371/journal.pone.0222856	http://dx.doi.org/10.1371/journal.pone.0222856			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539413	Green Published, gold			2022-12-26	WOS:000532297900035
J	Handley, G; Kubota, JT; Li, TY; Cloutier, J				Handley, Grace; Kubota, Jennifer T.; Li, Tianyi; Cloutier, Jasmin			Black "Reading the Mind in the Eyes" task: The development of a task assessing mentalizing from black faces	PLOS ONE			English	Article							OWN-RACE BIAS; INDIVIDUAL-DIFFERENCES; NORMAL ADULTS; RECOGNITION; PREJUDICE; TESTOSTERONE; INFORMATION; ACTIVATION; JUDGMENTS; ATTITUDES	Researchers investigating various facets of theory of mind, sometimes referred to as mentalizing, are increasingly exploring how social group membership influences this process. To facilitate this research, we introduce the Black Reading the Mind in The Eyes task, a freely available 36-item Black RME task with an array of norming data about these stimuli. Stimuli have been created and equated to match the original Reading the Mind in the Eyes (RME) task which included only White faces. Norming data were collected in three waves that characterized the physical properties of the stimuli and also participants' subjective ratings of the stimuli. Between each round of ratings, stimuli that did not equate with the original RME task or were not distinctly recognized as Black were removed and new stimuli were incorporated in the next round until we obtained 36 distinctive Black RME targets that matched the 36 mental states used in the original RME stimulus set. Both stimulus sets were similarly difficult and subsequent testing showed that neither Black nor White participants' mentalizing accuracy varied as a function of target race. We provide instructions for obtaining the database and stimulus ratings.	[Handley, Grace; Kubota, Jennifer T.; Cloutier, Jasmin] Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19716 USA; [Kubota, Jennifer T.] Univ Delaware, Dept Polit Sci & Int Relat, Newark, DE USA; [Li, Tianyi] Univ Illinois, Coll Business Adm, Chicago, IL USA	University of Delaware; University of Delaware; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cloutier, J (corresponding author), Univ Delaware, Dept Psychol & Brain Sci, Newark, DE 19716 USA.	jasmin.cloutier@gmail.com		Handley, Grace/0000-0002-5170-0563				Adams RB, 2005, EMOTION, V5, P3, DOI 10.1037/1528-3542.5.1.3; Adams RB, 2010, J COGNITIVE NEUROSCI, V22, P97, DOI 10.1162/jocn.2009.21187; Adolphs R, 2005, NATURE, V433, P68, DOI 10.1038/nature03086; Amodio DM, 2003, J PERS SOC PSYCHOL, V84, P738, DOI 10.1037/0022-3514.84.4.738; BANAJI MR, 1994, ONT SYMP P, V7, P55; Bargh JA, 1996, J PERS SOC PSYCHOL, V71, P230, DOI 10.1037/0022-3514.71.2.230; BARKOWITZ P, 1982, J APPL SOC PSYCHOL, V12, P255, DOI 10.1111/j.1559-1816.1982.tb00863.x; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; BaronCohen S, 1997, VIS COGN, V4, P311, DOI 10.1080/713756761; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Birch SAJ, 2007, PSYCHOL SCI, V18, P382, DOI 10.1111/j.1467-9280.2007.01909.x; Bruce V., 1998, EYE BEHOLDER SCI FAC; Caldara R, 2005, J COGNITIVE NEUROSCI, V17, P1652, DOI 10.1162/089892905774597254; Chapman E, 2006, SOC NEUROSCI-UK, V1, P135, DOI 10.1080/17470910600992239; Cloutier J, 2005, J PERS SOC PSYCHOL, V88, P885, DOI 10.1037/0022-3514.88.6.885; Cloutier J, 2008, SOC NEUROSCI-UK, V3, P69, DOI 10.1080/17470910701563483; Cloutier J, 2007, EUR J SOC PSYCHOL, V37, P1298, DOI 10.1002/ejsp.433; Dasgupta N, 2000, J EXP SOC PSYCHOL, V36, P316, DOI 10.1006/jesp.1999.1418; DeGutis J, 2013, COGNITION, V126, P87, DOI 10.1016/j.cognition.2012.09.004; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.1.5; Domes G, 2007, BIOL PSYCHIAT, V61, P731, DOI 10.1016/j.biopsych.2006.07.015; Dotsch R, 2012, SOC PSYCHOL PERS SCI, V3, P562, DOI 10.1177/1948550611430272; Eberhardt JL, 2004, J PERS SOC PSYCHOL, V87, P876, DOI 10.1037/0022-3514.87.6.876; Fiske S. T, 1998, HDB SOCIAL PSYCHOL, P357, DOI DOI 10.1002/9780470561119; Gaertner SL, 2005, J SOC ISSUES, V61, P615, DOI 10.1111/j.1540-4560.2005.00424.x; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Guastella AJ, 2010, BIOL PSYCHIAT, V67, P692, DOI 10.1016/j.biopsych.2009.09.020; Haslam N, 2014, ANNU REV PSYCHOL, V65, P399, DOI 10.1146/annurev-psych-010213-115045; Haxby J.V., 2011, OXFORD HDB FACE PERC, P93, DOI DOI 10.1093/OXFORDHB/9780199559053.013.0006; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Hugenberg K, 2016, SOC PSYCHOL PERS SCI, V7, P167, DOI 10.1177/1948550615609734; Jack RE, 2015, CURR BIOL, V25, pR621, DOI 10.1016/j.cub.2015.05.052; Kubota JT, 2013, PSYCHOL SCI, V24, P2498, DOI 10.1177/0956797613496435; Lee DH, 2013, PSYCHOL SCI, V24, P957, DOI 10.1177/0956797612464500; Leyens JP, 2000, PERS SOC PSYCHOL REV, V4, P186, DOI 10.1207/S15327957PSPR0402_06; LINDSAY DS, 1991, J APPL PSYCHOL, V76, P587, DOI 10.1037/0021-9010.76.4.587; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Michel C, 2006, PSYCHOL SCI, V17, P608, DOI 10.1111/j.1467-9280.2006.01752.x; Nosek BA, 2007, EUR REV SOC PSYCHOL, V18, P36, DOI 10.1080/10463280701489053; R Core Team, 2021, R LANGUAGE ENV STAT; Rice K, 2014, DEV COGN NEUROS-NETH, V8, P153, DOI 10.1016/j.dcn.2013.09.003; Richler JJ, 2011, PSYCHOL SCI, V22, P464, DOI 10.1177/0956797611401753; Schurgin MW, 2014, J VISION, V14, DOI 10.1167/14.13.14; Schurz M, 2014, NEUROSCI BIOBEHAV R, V42, P9, DOI 10.1016/j.neubiorev.2014.01.009; Contreras-Huerta LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084001; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Stanley DA, 2011, P NATL ACAD SCI USA, V108, P7710, DOI 10.1073/pnas.1014345108; Stone VE, 2003, NEUROPSYCHOLOGIA, V41, P209, DOI 10.1016/S0028-3932(02)00151-3; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; Strachan JWA, 2017, VIS COGN, V25, P802, DOI 10.1080/13506285.2017.1338321; Todorov A, 2013, CURR OPIN NEUROBIOL, V23, P373, DOI 10.1016/j.conb.2012.12.010; van Honka J, 2011, P NATL ACAD SCI USA, V108, P3448, DOI 10.1073/pnas.1011891108; Wang RS, 2012, PSYCHOL SCI, V23, P169, DOI 10.1177/0956797611420575; Warrier V, 2018, MOL PSYCHIATR, V23, P1402, DOI 10.1038/mp.2017.122; Wittenbrink B, 1997, J PERS SOC PSYCHOL, V72, P262, DOI 10.1037/0022-3514.72.2.262; Xu XJ, 2009, J NEUROSCI, V29, P8525, DOI 10.1523/JNEUROSCI.2418-09.2009	59	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0221867	10.1371/journal.pone.0221867	http://dx.doi.org/10.1371/journal.pone.0221867			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5BF	31536498	Green Published, gold, Green Submitted			2022-12-26	WOS:000532262800020
J	Kirst, ME; Baker, D; Li, E; Abu-Hasan, M; Wang, GP				Kirst, Mariana E.; Baker, Dawn; Li, Eric; Abu-Hasan, Mutasim; Wang, Gary P.			Upper versus lower airway microbiome and metagenome in children with cystic fibrosis and their correlation with lung inflammation	PLOS ONE			English	Article							NONTUBERCULOUS MYCOBACTERIAL INFECTION; BRONCHOALVEOLAR LAVAGE; OROPHARYNGEAL CULTURES; ACHROMOBACTER-XYLOSOXIDANS; CEPACIA COLONIZATION; YOUNG-CHILDREN; INFANTS; DISEASE; PATHOGENS; BACTERIA	Objective Airways of children with cystic fibrosis (CF) harbor complex polymicrobial communities which correlates with pulmonary disease progression and use of antibiotics. Throat swabs are widely used in young CF children as a surrogate to detect potentially pathogenic microorganisms in lower airways. However, the relationship between upper and lower airway microbial communities remains poorly understood. This study aims to determine (1) to what extent oropharyngeal microbiome resembles the lung microbiome in CF children and (2) if lung microbiome composition correlates with airway inflammation. Method Throat swabs and bronchoalveolar lavage (BAL) were obtained concurrently from 21 CF children and 26 disease controls. Oropharyngeal and lung microbiota were analyzed using 16S rRNA deep sequencing and correlated with neutrophil counts in BAL and antibiotic exposure. Results Oropharyngeal microbial communities clustered separately from lung communities and had higher microbial diversity (p < 0.001). CF microbiome differed significantly from non-CF controls, with a higher abundance of Proteobacteria in both upper and lower CF airways. Neutrophil count in the BAL correlated negatively with the diversity but not richness of the lung microbiome. In CF children, microbial genes involved in bacterial motility proteins, two-component system, flagella assembly, and secretion system were enriched in both oropharyngeal and lung microbiome, whereas genes associated with synthesis and metabolism of nucleic acids and protein dominated the non-CF controls. Conclusions This study identified a unique microbial profile with altered microbial diversity and metabolic functions in CF airways which is significantly affected by airway inflammation. These results highlight the limitations of using throat swabs as a surrogate to study lower airway microbiome and metagenome in CF children.	[Kirst, Mariana E.; Li, Eric; Wang, Gary P.] Univ Florida, Coll Med, Dept Med, Div Infect Dis & Global Med, Gainesville, FL 32611 USA; [Baker, Dawn; Abu-Hasan, Mutasim] Univ Florida, Coll Med, Dept Pediat, Div Pediat Pulmonol, Gainesville, FL USA; [Wang, Gary P.] North Florida South Georgia Vet Hlth Syst, Infect Dis Sect, Med Serv, Gainesville, FL USA; [Kirst, Mariana E.] Univ Florida, Coll Med, Dept Med, Div Pulm Crit Care & Sleep Med, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Wang, GP (corresponding author), Univ Florida, Coll Med, Dept Med, Div Infect Dis & Global Med, Gainesville, FL 32611 USA.	gary.wang@medicine.ufl.edu		Wang, Gary/0000-0002-3457-442X	Gatorade Trust by the University of Florida, Department of Medicine	Gatorade Trust by the University of Florida, Department of Medicine	This work was supported by the Gatorade Trust through funds distributed by the University of Florida, Department of Medicine to GPW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, LANG ENV STAT COMP; Armstrong DS, 2005, PEDIATR PULM, V40, P500, DOI 10.1002/ppul.20294; Armstrong DS, 1996, PEDIATR PULM, V21, P267, DOI 10.1002/(SICI)1099-0496(199605)21:5<267::AID-PPUL1>3.0.CO;2-K; AVITAL A, 1995, PEDIATR PULM, V20, P40, DOI 10.1002/ppul.1950200108; BALOUGH K, 1995, PEDIATR PULM, V20, P63, DOI 10.1002/ppul.1950200203; Bryant JM, 2016, SCIENCE, V354, P751, DOI 10.1126/science.aaf8156; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; De Baets F, 2007, J CYST FIBROS, V6, P75, DOI 10.1016/j.jcf.2006.05.011; Edgar RC, 2010, BIOINFORMATICS; Esther CR, 2010, J CYST FIBROS, V9, P117, DOI 10.1016/j.jcf.2009.12.001; Esther CR, 2005, PEDIATR PULM, V40, P39, DOI 10.1002/ppul.20222; Flight WG, 2015, J CLIN MICROBIOL, V53, P2022, DOI 10.1128/JCM.00432-15; Frangolias DD, 1999, AM J RESP CRIT CARE, V160, P1572, DOI 10.1164/ajrccm.160.5.9805046; Frayman KB, 2017, THORAX, V72, P1104, DOI 10.1136/thoraxjnl-2016-209279; Giron RM, 2008, ARCH BRONCONEUMOL, V44, P679, DOI 10.1016/S1579-2129(09)60006-9; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; Hansen CR, 2010, J CYST FIBROS, V9, P51, DOI 10.1016/j.jcf.2009.10.005; Hansen CR, 2006, J CYST FIBROS, V5, P245, DOI 10.1016/j.jcf.2006.04.002; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Hoppe JE, 2015, PEDIATR PULM, V50, P638, DOI 10.1002/ppul.23150; Klepac-Ceraj V, 2010, ENVIRON MICROBIOL, V12, P1293, DOI 10.1111/j.1462-2920.2010.02173.x; Kloepfer KM, 2018, PEDIATR PULM, V53, P475, DOI 10.1002/ppul.23953; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Ledson MJ, 2002, THORAX, V57, P142, DOI 10.1136/thorax.57.2.142; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; MacKenzie T, 2014, ANN INTERN MED, V161, P233, DOI 10.7326/M13-0636; Madan JC, 2012, MBIO, V3, DOI 10.1128/mBio.00251-12; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Marsh RL, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0182-1; Nixon GM, 2002, ARCH DIS CHILD, V87, P306, DOI 10.1136/adc.87.4.306; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Paganin P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124348; Paugam A, 2010, MED MYCOL, V48, pS32, DOI 10.3109/13693786.2010.503665; Pittman JE, 2017, ANN AM THORAC SOC, V14, P1548, DOI [10.1513/AnnalsATS.201702-121OC, 10.1513/annalsats.201702-121oc]; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Qvist T, 2016, J CYST FIBROS, V15, P380, DOI 10.1016/j.jcf.2015.09.007; RAMSEY BW, 1991, AM REV RESPIR DIS, V144, P331, DOI 10.1164/ajrccm/144.2.331; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rogers GB, 2013, THORAX, V68, P731, DOI 10.1136/thoraxjnl-2012-203105; Rosenfeld M, 1999, PEDIATR PULM, V28, P321, DOI 10.1002/(SICI)1099-0496(199911)28:5<321::AID-PPUL3>3.0.CO;2-V; Rosenfeld M, 2001, PEDIATR PULM, V32, P356, DOI 10.1002/ppul.1144; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; WHITEFORD ML, 1995, THORAX, V50, P1194, DOI 10.1136/thx.50.11.1194; Zemanick ET, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00832-2017; Zemanick ET, 2015, ANN AM THORAC SOC, V12, P221, DOI 10.1513/AnnalsATS.201407-310OC	47	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222323	10.1371/journal.pone.0222323	http://dx.doi.org/10.1371/journal.pone.0222323			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536536	Green Submitted, Green Published, gold			2022-12-26	WOS:000532262800036
J	Pucken, VB; Schupbach-Regula, G; Gerber, M; Gross, CS; Bodmer, M				Pucken, Valerie-Beau; Schupbach-Regula, Gertraud; Gerber, Manuela; Gross, Corina Salis; Bodmer, Michele			Veterinary peer study groups as a method of continuous education-A new approach to identify and address factors associated with antimicrobial prescribing	PLOS ONE			English	Article							UDDER HEALTH; FARM-ANIMALS; USAGE; STRATEGIES; MASTITIS; PRACTITIONERS; DETERMINANTS; IMPROVEMENT; PREVENTION; RESISTANCE	Within the dairy industry, most antimicrobials are used for dry-cow therapy or mastitis treatment. To reduce antimicrobial usage in dairy cows, increasing awareness and behaviour change is necessary. As veterinarians are known to be influenced by their peers, peer study groups as a continuous education might contribute to this. Therefore, the objective of this study was to analyse written records of veterinary peer study group meetings to identify factors associated with antimicrobial prescribing decisions, and to analyse veterinarians' attitude towards the benefits of this continuous education method. Twenty-three participating Swiss cattle practitioners were divided into three groups. Each group met every two to five months, together with a facilitator and an expert on the topic to be discussed. Written records from every meeting were taken and analysed qualitatively to identify factors influencing veterinarians' decisions on antimicrobial prescribing and mastitis therapy. In addition, focus group discussions were conducted after the last meeting, to assess the veterinarians' learning achievements gained during the peer study group meetings. Extrinsic factors such as external pressure, competition, farmer, individual animal, farm and diagnostics as well as intrinsic factors such as own experience/attitude, knowledge and change of mindset during career could be shown to influence veterinarians' decisions on antimicrobial prescribing. In the focus group discussions, the veterinarians stated that they gained new knowledge, received new stimuli, exchanged with their peers and felt supported in their relationship to their farmers. Since the identified factors are partly interrelated, it is not sufficient to change a single factor to achieve a change in the antimicrobial prescription behaviour of veterinarians. Veterinary peer study groups could contribute to the intention to change, because veterinarians experienced multiple benefits from this method of continuous education. In order to quantify this, the prescription data of the veterinarians are analysed in a next step.	[Pucken, Valerie-Beau; Gerber, Manuela; Bodmer, Michele] Univ Bern, Vetsuisse Fac, Clin Ruminants, Bern, Switzerland; [Schupbach-Regula, Gertraud] Univ Bern, Vetsuisse Fac, Vet Publ Hlth Inst, Liebefeld, Switzerland; [Gross, Corina Salis] Univ Zurich, Swiss Res Inst Publ Hlth & Addict, Zurich, Switzerland	University of Bern; University of Bern; University of Zurich	Pucken, VB (corresponding author), Univ Bern, Vetsuisse Fac, Clin Ruminants, Bern, Switzerland.	valerie.pucken@vetsuisse.unibe.ch		Pucken, Valerie-Beau/0000-0001-8517-9350	Federal Food Safety and Veterinary Office [1.15.10]	Federal Food Safety and Veterinary Office	This research was funded by the Federal Food Safety and Veterinary Office (https://www.blv.admin.ch/blv/en/home.html) of Switzerland (Grant number: 1.15.10, awarded to VBP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the 23 veterinarians, who made this study possible with their great contribution to the peer study group meetings. The experts are gratefully acknowledged for sharing their time and expertise. Furthermore, we want to thank Esther Schelling for supporting this study with her knowledge and experience in qualitative health research.	Al Achkar M, 2016, ADV MED EDUC PRACT, V7, P611, DOI 10.2147/AMEP.S117672; [Anonymous], 2015, FVE SURVEY VET PROFE; [Anonymous], 2018, AUSW DAT MILCH KAL 2; [Anonymous], 2018, TIER TIER 2018; Bager F, 2000, INT J ANTIMICROB AG, V14, P271, DOI 10.1016/S0924-8579(00)00135-7; Bennedsgaard TW, 2010, LIVEST SCI, V131, P183, DOI 10.1016/j.livsci.2010.03.018; Beyer M, 2003, FAM PRACT, V20, P443, DOI 10.1093/fampra/cmg420; CAREY MA, 1994, CRITICAL ISSUES IN QUALITATIVE RESEARCH METHODS, P225; Carmo LP, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00026; Cousin ME, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1352-0; Coyne LA, 2014, VET REC, V175, P593, DOI 10.1136/vr.102686; Curado C, 2015, INT J TRAIN DEV, V19, P98, DOI 10.1111/ijtd.12050; De Briyne N, 2014, VET REC, V175, DOI 10.1136/vr.102462; De Briyne N, 2013, VET REC, V173, P475, DOI 10.1136/vr.101454; European Medicines Agency, 2017, SALES VET ANTIMICROB, DOI [10.2809/283486, DOI 10.2809/283486]; European Medicines Agency, 2018, EMA2759822018; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gegenfurtner A, 2016, INT J TRAIN DEV, V20, P290, DOI 10.1111/ijtd.12089; Gibbons JF, 2013, VET REC, V172, P14, DOI 10.1136/vr.100782; Gonzalez SM, 2010, PREV VET MED, V95, P50, DOI 10.1016/j.prevetmed.2010.03.004; Hall ER, 2013, ANAT SCI EDUC, V6, P56, DOI 10.1002/ase.1308; Higgins HM, 2017, J DAIRY SCI, V100, P2909, DOI 10.3168/jds.2016-11923; Hoelzer K, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1131-3; Hopman NEM, 2018, PREV VET MED, V158, P106, DOI 10.1016/j.prevetmed.2018.07.013; Ivenleyer S, 2008, SCHWEIZ ARCH TIERH, V150, P499, DOI 10.1024/0036-7281.150.10.499; Jarrige N, 2017, PREV VET MED, V144, P158, DOI 10.1016/j.prevetmed.2017.05.018; Kilian K, 2017, GST LAUFBAHNSTUDIE B; Klemm W. R., 1994, Journal of Veterinary Medical Education, V21, P2; Kuipers A, 2016, J DAIRY SCI, V99, P1632, DOI 10.3168/jds.2014-8428; Lam TJGM, 2011, NEW ZEAL VET J, V59, P8, DOI 10.1080/00480169.2011.547163; Landwirtschaft und Ernahrung Taschenstatistik, 2018, LANDW ERN TASCH 2018; Magalhaes-Sant'Ana M, 2017, IRISH VET J, V70, DOI 10.1186/s13620-017-0106-9; McDougall S, 2017, NEW ZEAL VET J, V65, P84, DOI 10.1080/00480169.2016.1246214; Meesters A. J. M., 2007, Proceedings, Cattle Consultancy Days, Best Western Hotel Nyborg Strand, Nyborg, Denmark, 29-30 August 2007, P111; Mills P., 2003, ASSESS EVAL HIGH EDU, V28, P527, DOI [10.1080/02602930301676, DOI 10.1080/02602930301676]; MOLSTAD S, 1989, FAM PRACT, V6, P33, DOI 10.1093/fampra/6.1.33; Moore DA, 2000, J AM VET MED ASSOC, V217, P1001, DOI 10.2460/javma.2000.217.1001; Morley PS, 2005, J VET INTERN MED, V19, P617, DOI 10.1892/0891-6640(2005)19[617:ADUIVM]2.0.CO;2; Nobrega DB, 2018, J DAIRY SCI, V101, P7425, DOI 10.3168/jds.2018-14540; Pelz C, 2004, FORUM QUAL SOZIALFOR, V5; Poizat A, 2017, PREV VET MED, V146, P61, DOI 10.1016/j.prevetmed.2017.07.016; Pope C, 2002, QUAL SAF HEALTH CARE, V11, P148, DOI 10.1136/qhc.11.2.148; Proctor A, 2011, VET REC, V169, P408, DOI 10.1136/vr.d5387; Pucken V.-B., 2016, SCHWEIZ ARCH TIERHEI, V158; Ritter C, 2017, J DAIRY SCI, V100, P3329, DOI 10.3168/jds.2016-11977; Roberson JR, 2012, VET CLIN N AM-FOOD A, V28, P271, DOI 10.1016/j.cvfa.2012.03.011; Saini V, 2012, J DAIRY SCI, V95, P1921, DOI 10.3168/jds.2011-5065; Salis Gross C, 2014, EXPLORATIVE STUDIE A; Scherpenzeel CGM, 2016, J DAIRY SCI, V99, P3753, DOI 10.3168/jds.2015-9963; Silverman D., 2011, QUAL RES, V3rd ed.; Speksnijder DC, 2015, ZOONOSES PUBLIC HLTH, V62, P39, DOI 10.1111/zph.12168; Speksnijder DC, 2018, ANIM FRONT, V8, P4, DOI 10.1093/af/vfy006; Stevens M, 2016, J DAIRY SCI, V99, P2896, DOI 10.3168/jds.2015-10496; swissmilk, 2018, SCHWEIZER MILCHWIRTS; Thomson K, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-15; Topp E, 2017, Can Commun Dis Rep, V43, P224, DOI 10.14745/ccdr.v43i11a03; Tschopp A, 2015, J DAIRY SCI, V98, P840, DOI 10.3168/jds.2014-8053; van Gool WA, 2015, ADVISORY LETT TIGHTE; Vandeweerd JM, 2012, J VET MED EDUC, V39, P142, DOI 10.3138/jvme.0911.098R1; Visschers VHM, 2016, ZOONOSES PUBLIC HLTH, V63, P534, DOI 10.1111/zph.12260; Wagemann C, 2005, SWISS POLIT SCI REV, V11, P1, DOI 10.1002/j.1662-6370.2005.tb00360.x	61	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222497	10.1371/journal.pone.0222497	http://dx.doi.org/10.1371/journal.pone.0222497			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536527	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000532262800046
J	Clayton, GM; White, J; Lee, S; Kappler, JW; Chan, SK				Clayton, Gina M.; White, Janice; Lee, Schuyler; Kappler, John W.; Chan, Sanny K.			Structural characteristics of lipocalin allergens: Crystal structure of the immunogenic dog allergen Can f 6	PLOS ONE			English	Article							CROSS-REACTIVITY; CAT; POPULATION; BINDING	Lipocalins represent the most important protein family of the mammalian respiratory allergens. Four of the seven named dog allergens are lipocalins: Can f 1, Can f 2, Can f 4, and Can f 6. We present the structure of Can f 6 along with data on the biophysical and biological activity of this protein in comparison with other animal lipocalins. The Can f 6 structure displays the classic lipocalin calyx -shaped ligand binding cavity within a central beta-barrel similar to other lipocalins. Despite low sequence identity between the different dog lipocalin proteins, there is a high degree of structural similarity. On the other hand, Can f 6 has a similar primary sequence to cat, horse, mouse lipocalins as well as a structure that may underlie their cross reactivity. Interestingly, the entrance to the ligand binding pocket is capped by a His instead of the usually seen Tyr that may help select its natural ligand binding partner. Our highly pure recombinant Can f 6 is able to bind to human IgE (hIgE) demonstrating biological antigenicity.	[Clayton, Gina M.; White, Janice; Lee, Schuyler; Kappler, John W.; Chan, Sanny K.] Natl Jewish Hlth, Dept Biomed Res, Denver, CO 80206 USA; [Clayton, Gina M.; Kappler, John W.] Univ Colorado, Denver Sch Med, Dept Biomed Res, Dept Immunol & Microbiol, Aurora, CO 80202 USA; [Clayton, Gina M.] Univ Colorado, Denver Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80202 USA; [Kappler, John W.] Univ Colorado, Denver Sch Med, Dept Immunol & Microbiol, Aurora, CO USA; [Chan, Sanny K.] Univ Colorado, Dept Pediat, Denver Sch Med, Aurora, CO 80045 USA; [Chan, Sanny K.] Natl Jewish Hlth, Div Pediat Allergy Immunol, Denver, CO 80206 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health	Chan, SK (corresponding author), Natl Jewish Hlth, Dept Biomed Res, Denver, CO 80206 USA.; Chan, SK (corresponding author), Univ Colorado, Dept Pediat, Denver Sch Med, Aurora, CO 80045 USA.; Chan, SK (corresponding author), Natl Jewish Hlth, Div Pediat Allergy Immunol, Denver, CO 80206 USA.	chans@njhealth.org			National Jewish Health	National Jewish Health	We acknowledge and thank the Advanced Photon Source at Argonne National Laboratory for the facilities and staff of the 24-ID-C beamline for their assistance in data-collection. We are grateful to Dr. Jennifer Maynard for the Mopac54 vector plasmid. Samples and data used for this study were downloaded from the National Jewish Health Research Database (https://www.nationaljewish.org/research-science/support/biobanks/bioinfo), supported by National Jewish Health. We thank Dr. Philippa Marrack for her comments during the preparation of this manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arshad SH, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.2.e33; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Bingham RJ, 2004, J AM CHEM SOC, V126, P1675, DOI 10.1021/ja038461i; Chan SK, 2018, ALLERGY ASTHMA IMMUN, V10, P97, DOI 10.4168/aair.2018.10.2.97; Dahlback B, 2008, FUTURE LIPIDOL, V3, P495, DOI 10.2217/17460875.3.5.495; Delano W., 2002, CCP4 NEWSL PROTEIN C, V700; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hilger C, 2012, CURR ALLERGY ASTHM R, V12, P438, DOI 10.1007/s11882-012-0283-2; Hilger C, 2012, J ALLERGY CLIN IMMUN, V129, P1149, DOI 10.1016/j.jaci.2011.10.017; Huynh Kathy, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps2809s79; Jensen-Jarolim E, 2016, ALLERGY, V71, P286, DOI 10.1111/all.12797; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kack U, 2018, J ALLERGY CLIN IMMUN, V142, P1113, DOI 10.1016/j.jaci.2018.05.012; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Konradsen JR, 2015, J ALLERGY CLIN IMMUN, V135, P616, DOI 10.1016/j.jaci.2014.08.026; Krissinel E, 2015, NUCLEIC ACIDS RES, V43, pW314, DOI 10.1093/nar/gkv314; Lascombe MB, 2000, J BIOL CHEM, V275, P21572, DOI 10.1074/jbc.M002854200; Loebel D, 2000, BIOCH SOC, V379, P369, DOI [10.1016/S0176-6724(86)80137-7, DOI 10.1016/S0176-6724(86)80137-7]; Madhurantakam C, 2010, J MOL BIOL, V401, P68, DOI 10.1016/j.jmb.2010.05.043; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Niemi MH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13841; Niemi MH, 2014, MOL IMMUNOL, V61, P7, DOI 10.1016/j.molimm.2014.04.003; Nilsson OB, 2012, ALLERGY, V67, P751, DOI 10.1111/j.1398-9995.2012.02826.x; Nilsson OB, 2014, METHODS, V66, P86, DOI 10.1016/j.ymeth.2013.09.002; Rouvinen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009037; Saarelainen S, 2008, CLIN EXP ALLERGY, V38, P374, DOI 10.1111/j.1365-2222.2007.02895.x; Scholl I, 2005, J IMMUNOL, V175, P6645, DOI 10.4049/jimmunol.175.10.6645; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Tian W, 2018, NUCLEIC ACIDS RES, V46, pW363, DOI 10.1093/nar/gky473; Ukleja-Sokolowska N, 2016, ALLERGY ASTHMA CL IM, V12, DOI 10.1186/s13223-016-0167-4; Wang YJ, 2017, ONCOTARGET, V8, P90796, DOI 10.18632/oncotarget.21822; Wilkins MR, 1999, METH MOL B, V112, P531; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamamoto K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38134-w; Yin L, 2012, P NATL ACAD SCI USA, V109, P18517, DOI 10.1073/pnas.1215928109; ZANOTTI G, 1994, J BIOL CHEM, V269, P29613; Zhao ZJ, 2010, EXP EYE RES, V90, P344, DOI 10.1016/j.exer.2009.11.013	41	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0213052	10.1371/journal.pone.0213052	http://dx.doi.org/10.1371/journal.pone.0213052			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525203	gold, Green Submitted, Green Published			2022-12-26	WOS:000532225700002
J	Elbasheer, MMA; Alkhidir, AGA; Mohammed, SMA; Abbas, AAH; Mohamed, AO; Bereir, IM; Abdalazeez, HR; Noma, M				Elbasheer, Marwa Maweya Abdelbagi; Alkhidir, Ayah Galal Abdelrahman; Mohammed, Siham Mohammed Awad; Abbas, Areej Abuelgasim Hassan; Mohamed, Aisha Osman; Bereir, Isra Mahgoub; Abdalazeez, Hiba Reyad; Noma, Mounkaila			Spatial distribution of breast cancer in Sudan 2010-2016	PLOS ONE			English	Article								Background Breast cancer is the most prevalent cancer among females worldwide including Sudan. The aim of this study was to determine the spatial distribution of breast cancer in Sudan. Materials and methods A facility based cross-sectional study was implemented in eighteen histopathology laboratories distributed in the three localities of Khartoum State on a sample of 4630 Breast Cancer cases diagnosed during the period 2010-2016. A master database was developed through Epi Info (TM) 7.1.5.2 for computerizing the data collected: the facility name, type (public or private), and its geo-location (latitude and longitude). Personal data on patients were extracted from their respective medical records (name, age, marital status, ethnic group, state, locality, administrative unit, permanent address and phone number, histopathology diagnosis). The data was summarized through SPSS to generate frequency tables for estimating prevalence and the geographical information system (ArcGIS 10.3) was used to generate the epidemiological distribution maps. ArcGIS 10.3 spatial analysis features were used to develop risk maps based on the kriging method. Results Breast cancer prevalence was 3.9 cases per 100,000 female populations. Of the 4423 cases of breast cancer, invasive breast carcinoma of no special type (NST) was the most frequent (79.5%, 3517/4423) histopathological diagnosis. The spatial analysis indicated as high risk areas for breast cancer in Sudan the States of Nile River, Northern, Red Sea, White Nile, Northern and Southern Kordofan.. Conclusions The attempt to develop a predictive map of breast cancer in Sudan revealed three levels of risk areas (risk, intermediate and high risk areas); regardless the risk level, appropriate preventive and curative health interventions with full support from decision makers are urgently needed.	[Elbasheer, Marwa Maweya Abdelbagi; Mohamed, Aisha Osman] Alzaiem Alazhari Univ, Fac Med Lab Sci, Dept Histopathol & Cytol, Khartoum, Sudan; [Alkhidir, Ayah Galal Abdelrahman; Bereir, Isra Mahgoub] Sudanese Med Council, Khartoum, Sudan; [Mohammed, Siham Mohammed Awad] Zanam Specialist Hosp, Khartoum, Sudan; [Abbas, Areej Abuelgasim Hassan] Sudanese Med Specializat Board, Khartoum, Sudan; [Abdalazeez, Hiba Reyad] Sudanese Natl Council Med & Hlth Profess, Khartoum, Sudan; [Noma, Mounkaila] Univ Med Sci & Technol, Khartoum, Sudan		Elbasheer, MMA (corresponding author), Alzaiem Alazhari Univ, Fac Med Lab Sci, Dept Histopathol & Cytol, Khartoum, Sudan.	marwamaweya@hotmail.com		Alkhidir, Ayah/0000-0002-8188-3540; Elbasheer, Marwa/0000-0001-8132-0994				Ageep AK, 2007, SUDAN J MED SCI, V2, P115; Ali AA, 2014, SUDAN MED MONITOR, V9, P109; Awadelkarim Khalid Dafaallah, 2009, THESIS; Badowska-Kozakiewicz AM, 2017, ARCH MED SCI, V13, P1408, DOI 10.5114/aoms.2015.53964; Balekouzou A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3863-6; Bhunia G. S., 2018, Journal of the Saudi Society of Agricultural Sciences, V17, P114, DOI 10.1016/j.jssas.2016.02.001; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Ebrahim EMA, 2017, SUDAN J MED SCI, V12, P133, DOI 10.18502/sjms.v12i3.924; Elamin A, 2015, CANCER MED-US, V4, P447, DOI 10.1002/cam4.378; Elgaili Elgaili M, 2010, INT J WOMENS HLTH, P277; ESRI, KRIG WORKS; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; Gafer N, 2016, CANC CARE COUNTRIES, V1st, P209; Ghoncheh Mahshid, 2016, Asian Pac J Cancer Prev, V17, P43; Grover S, 2017, J GLOB ONCOL, V4, DOI 10.1200/JGO.2016.006585; International Atomic Energy Agency, 2008, SETT RAD PROGR CLIN; Mahdavifar Neda, 2016, Asian Pac J Cancer Prev, V17, P59; MEInour A, 2012, INT J HEALTH SCI-IJH, V6, P63, DOI 10.12816/0005974; MOHAMMED IN, 2012, SUDAN MED J, V48, DOI DOI 10.1029/2012WR011908; Ohene-Yeboah M, 2012, Ghana Med J, V46, P8; Saeed IE, 2014, CANCER MED-US, V3, P1075, DOI 10.1002/cam4.254; Saeed MEM, 2016, ANTICANCER RES, V36, P279; Seneviratne S, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2177-5; Sinn HP, 2013, BREAST CARE, V8, P149, DOI 10.1159/000350774; The Lancet Editorial, 2009, LANCET ONCOL, V10, P1077, DOI [10.1016/S0140-6736(09)61930-9, DOI 10.1016/S0140-6736(09)61930-9]; World Health Organization, 2018, CANC FACT SHEET 2018; Yalaza M, 2016, J BREAST HEALTH, V12, P1, DOI 10.5152/tjbh.2015.2711	28	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0211085	10.1371/journal.pone.0211085	http://dx.doi.org/10.1371/journal.pone.0211085			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525202	Green Submitted, Green Published, gold			2022-12-26	WOS:000532225700001
J	Shin, SB; Jang, HR; Xu, R; Won, JY; Yim, H				Shin, Sol-Bi; Jang, Hay-Ran; Xu, Rong; Won, Jae-Yeon; Yim, Hyungshin			Active PLK1-driven metastasis is amplified by TGF-beta signaling that forms a positive feedback loop in non-small cell lung cancer	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; POLO-LIKE KINASES; PLK1; EXPRESSION; CARCINOMA; MIGRATION; INVASION; TSG-6; PHOSPHORYLATION; SURVIVAL	Early findings that PLK1 is highly expressed in cancer have driven an exploration of its functions in metastasis. However, whether PLK1 induces metastasis in vivo and its underlying mechanisms in NSCLC have not yet been determined. Here, we show that the expression of active PLK1 phosphorylated at T210, abundant in TGF-beta-treated lung cells, potently induced metastasis in a tail-vein injection model. Active PLK1 with intact polo-box and ATP-binding domains accelerated cell motility and invasiveness by triggering EMT reprogramming, whereas a phosphomimetic version of p-S137-PLK1 did not, indicating that the phosphorylation status of PLK1 may determine the cell traits. Active PLK1-driven invasiveness upregulated TGF-beta signaling and TSG6 encoded by TNFAIP6. Loss of TNFAIP6 disturbed the metastatic activity induced by active PLK1 or TGF-beta. Clinical relevance shows that PLK1 and TNFAIP6 are strong predictors of poor survival rates in metastatic NSCLC patients. Therefore, we suggest that active PLK1 promotes metastasis by upregulating TGF-beta signaling, which amplifies its metastatic properties by forming a positive feedback loop and that the PLK1/TGF-beta-driven metastasis is effectively blocked by targeting PLK1 and TSG6, providing PLK1 and TSG6 as negative markers for prognostics and therapeutic targets in metastatic NSCLC.	[Shin, Sol-Bi; Jang, Hay-Ran; Xu, Rong; Won, Jae-Yeon; Yim, Hyungshin] Hanyang Univ, Coll Pharm, Inst Pharmaceut Sci & Technol, Dept Pharm, Ansan, Gyeonggi Do, South Korea	Hanyang University	Yim, H (corresponding author), Hanyang Univ, Coll Pharm, Inst Pharmaceut Sci & Technol, Dept Pharm, Ansan, Gyeonggi Do, South Korea.	hsyim@hanyang.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Science and ICT [NRF- 2014R1A2A1A11049701, NRF-2017R1A2B2012301]	National Research Foundation of Korea (NRF) - Ministry of Science and ICT	We thank Dr. Raymond L. Erikson (Harvard University, MA, USA) for his generous support for experimental materials. We also thank Dr. Jadranka Loncarek (National Cancer Institute, MD, USA) and Dr. Young-Joo Jang (Dankook University, Korea) for help with plasmid pLVX-TRE3G-RFP-PLK1-T210D and pCMV-PLK1-S137D, respectively. We appreciate the helpful discussions about the manuscript by Dr. Chang K. Sung (Texas A&M University, USA) and the technical support by Dr. Gyeoung-Jin Kang (Dongguk University, Korea) for big data analysis. This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (NRF- 2014R1A2A1A11049701, NRF-2017R1A2B2012301) to H. Y.	Acharya PS, 2008, J CELL SCI, V121, P1393, DOI 10.1242/jcs.021683; Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Ali A, 2013, CURR ONCOL, V20, pE300, DOI 10.3747/co.20.1481; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bednarz-Knoll N, 2012, CANCER METAST REV, V31, P673, DOI 10.1007/s10555-012-9370-z; Bommaya G, 2011, INT J BIOCHEM CELL B, V43, P1739, DOI 10.1016/j.biocel.2011.08.009; Cai XP, 2016, AM J TRANSL RES, V8, P4172; Chen QY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108528; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fransvea E, 2008, HEPATOLOGY, V47, P1557, DOI 10.1002/hep.22201; Gordian Edna, 2019, Oncotarget, V10, P810, DOI 10.18632/oncotarget.26574; Grosse-Wilde A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126522; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Han DP, 2012, MED SCI MONITOR, V18, pBR237, DOI 10.12659/MSM.882900; Jang YJ, 2002, J BIOL CHEM, V277, P44115, DOI 10.1074/jbc.M202172200; Jang YJ, 2002, P NATL ACAD SCI USA, V99, P1984, DOI 10.1073/pnas.042689299; Kong D, 2014, J CELL BIOL, V206, P855, DOI 10.1083/jcb.201407087; Kothe M, 2007, CHEM BIOL DRUG DES, V70, P540, DOI 10.1111/j.1747-0285.2007.00594.x; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Larsen JE, 2011, CLIN CHEST MED, V32, P703, DOI 10.1016/j.ccm.2011.08.003; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Maier R, 1996, ARTHRITIS RHEUM, V39, P552, DOI 10.1002/art.1780390403; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mittal M, 2016, P NATL ACAD SCI USA, V113, pE8151, DOI 10.1073/pnas.1614935113; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Rizki A, 2007, CANCER RES, V67, P11106, DOI 10.1158/0008-5472.CAN-07-2348; Sancisi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075489; Steeg PS, 2016, NAT REV CANCER, V16, P201, DOI 10.1038/nrc.2016.25; Su J, 2016, MOL CARCINOGEN, V55, P1962, DOI 10.1002/mc.22443; Takai N, 2005, ONCOGENE, V24, P287, DOI 10.1038/sj.onc.1208272; Tamura T, 2015, MOL CLIN ONCOL, V3, P217, DOI 10.3892/mco.2014.410; Tsvetkov L, 2005, CELL CYCLE, V4, P166, DOI 10.4161/cc.4.1.1348; Wolf G, 1997, ONCOGENE, V14, P543, DOI 10.1038/sj.onc.1200862; Wu JG, 2016, ELIFE, V5, DOI 10.7554/eLife.10734; Yim H, 2014, MUTAT RES-REV MUTAT, V761, P31, DOI 10.1016/j.mrrev.2014.02.005; Yim HS, 2009, MOL CELL BIOL, V29, P2609, DOI 10.1128/MCB.01277-08; Yoo HY, 2004, CELL, V117, P575, DOI 10.1016/S0092-8674(04)00417-9; Zhang Z, 2013, UROL ONCOL-SEMIN ORI, V31, P1222, DOI 10.1016/j.urolonc.2011.11.028; Zheng H, 2014, ONCOGENE, V33, P1755, DOI 10.1038/onc.2013.128	42	38	39	3	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	4					767	785		10.1038/s41388-019-1023-z	http://dx.doi.org/10.1038/s41388-019-1023-z			19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KF4EJ	31548612	Green Published, hybrid			2022-12-26	WOS:000509197200003
J	Iida, T; Minagawa, Y; Ueno, H; Kawai, F; Murata, T; Iino, R				Iida, Tatsuya; Minagawa, Yoshihiro; Ueno, Hiroshi; Kawai, Fumihiro; Murata, Takeshi; Iino, Ryota			Single-molecule analysis reveals rotational substeps and chemo-mechanical coupling scheme of Enterococcus hirae V-1-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPase; biophysics; Enterococcus; molecular motor; single-molecule biophysics; vacuolar ATPase; ion pump; rotary motor; rotational substep; V1-ATPase	ADP-DEPENDENT GLUCOKINASE; YEAST F-1 ATPASE; ESCHERICHIA-COLI; V-ATPASE; ADENOSINE-TRIPHOSPHATASE; THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE; ARGININE FINGER; NA+-ATPASE; F-1-ATPASE	V-1-ATPase (V-1), the catalytic domain of an ion-pumping V-ATPase, is a molecular motor that converts ATP hydrolysis?derived chemical energy into rotation. Here, using a gold nanoparticle probe, we directly observed rotation of V-1 from the pathogen Enterococcus hirae (EhV(1)). We found that 120? steps in each ATP hydrolysis event are divided into 40 and 80? substeps. In the main pause before the 40? substep and at low ATP concentration ([ATP]), the time constant was inversely proportional to [ATP], indicating that ATP binds during the main pause with a rate constant of 1.0 ? 10(7) m(?1) s(?1). At high [ATP], we observed two [ATP]-independent time constants (0.5 and 0.7 ms). One of two time constants was prolonged (144 ms) in a rotation driven by slowly hydrolyzable ATP?S, indicating that ATP is cleaved during the main pause. In another subpause before the 80? substep, we noted an [ATP]-independent time constant (2.5 ms). Furthermore, in an ATP-driven rotation of an arginine-finger mutant in the presence of ADP, ?80 and ?40? backward steps were observed. The time constants of the pauses before ?80? backward and +40? recovery steps were inversely proportional to [ADP] and [ATP], respectively, indicating that ADP- and ATP-binding events trigger these steps. Assuming that backward steps are reverse reactions, we conclude that 40 and 80? substeps are triggered by ATP binding and ADP release, respectively, and that the remaining time constant in the main pause represents phosphate release. We propose a chemo-mechanical coupling scheme of EhV(1), including substeps largely different from those of F-1-ATPases.	[Iida, Tatsuya; Kawai, Fumihiro; Iino, Ryota] Natl Inst Nat Sci, Inst Mol Sci, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi 4448787, Japan; [Iida, Tatsuya; Iino, Ryota] SOKENDAI Grad Univ Adv Studies, Sch Phys Sci, Dept Funct Mol Sci, Hayama, Kanagawa 2400193, Japan; [Minagawa, Yoshihiro; Ueno, Hiroshi] Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan; [Murata, Takeshi] Chiba Univ, Grad Sch Sci, Dept Chem, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan; [Murata, Takeshi] Japan Sci & Technol Agcy JST, PRESTO, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan; [Kawai, Fumihiro] Yamagata Univ, Fac Sci, 1-4-12 Kojirakawa Machi, Yamagata, Yamagata 9908560, Japan	National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Graduate University for Advanced Studies - Japan; University of Tokyo; Chiba University; Japan Science & Technology Agency (JST); Yamagata University	Iino, R (corresponding author), Natl Inst Nat Sci, Inst Mol Sci, 5-1 Higashiyama,Myodaiji Cho, Okazaki, Aichi 4448787, Japan.	iino@ims.ac.jp	Murata, Takeshi/J-6181-2017; Iino, Ryota/B-7746-2011	Murata, Takeshi/0000-0002-5748-4670; Iino, Ryota/0000-0003-0110-5704; Ueno, Hiroshi/0000-0001-5331-4335	Ministry of Education, Culture, Sports, Science, and Technology of Japan [JP18H05424, JP18H02418, JP18H04755, JP17K19213];  [18J23220]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This study was supported by Grant-in-Aid for Scientific Research on Innovative Areas "Molecular Engine" JP18H05424 (to R. I.); Grants-in-Aid for Scientific Research JP18H02418, JP18H04755, and JP17K19213 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to R. I.); and Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Research Fellow 18J23220 (to T. I.). The authors declare that they have no conflicts of interest with the contents of this article.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Ando J, 2018, BIOPHYS J, V115, P2413, DOI 10.1016/j.bpj.2018.11.016; Arai S, 2013, NATURE, V493, P703, DOI 10.1038/nature11778; Arsenieva D, 2010, J BIOL CHEM, V285, P36561, DOI 10.1074/jbc.M110.174383; Bason JV, 2015, P NATL ACAD SCI USA, V112, P6009, DOI 10.1073/pnas.1506465112; Beckett D, 1999, PROTEIN SCI, V8, P921, DOI 10.1110/ps.8.4.921; Bilyard T, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0023; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; BOYER PD, 1973, P NATL ACAD SCI USA, V70, P2837, DOI 10.1073/pnas.70.10.2837; BOYER PD, 1987, BIOCHEMISTRY-US, V26, P8503, DOI 10.1021/bi00400a001; Burton RE, 2003, PROTEIN SCI, V12, P893, DOI 10.1110/ps.0237603; CHOATE GL, 1979, J BIOL CHEM, V254, P286; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Cotter K, 2015, TRENDS BIOCHEM SCI, V40, P611, DOI 10.1016/j.tibs.2015.08.005; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Furuike S, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1215; Gates SN, 2017, SCIENCE, V357, P273, DOI 10.1126/science.aan1052; GRESSER MJ, 1982, J BIOL CHEM, V257, P2030; Gruber G, 2014, BBA-BIOENERGETICS, V1837, P940, DOI 10.1016/j.bbabio.2014.03.004; Guo H, 2019, ELIFE, V8, DOI 10.7554/eLife.43128; Iino R, 2015, CURR OPIN STRUC BIOL, V31, P49, DOI 10.1016/j.sbi.2015.02.013; Iino R, 2013, CURR OPIN STRUC BIOL, V23, P229, DOI 10.1016/j.sbi.2013.01.004; Imamizu H, 2003, P NATL ACAD SCI USA, V100, P5461, DOI 10.1073/pnas.0835746100; Imamura H, 2005, P NATL ACAD SCI USA, V102, P17929, DOI 10.1073/pnas.0507764102; Ito S, 2003, J MOL BIOL, V331, P871, DOI 10.1016/S0022-2836(03)00792-7; Ito S, 2001, STRUCTURE, V9, P205, DOI 10.1016/S0969-2126(01)00577-9; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Kabaleeswaran V, 2009, J BIOL CHEM, V284, P10546, DOI 10.1074/jbc.M900544200; Kagawa R, 2004, EMBO J, V23, P2734, DOI 10.1038/sj.emboj.7600293; KENGEN SWM, 1994, J BIOL CHEM, V269, P17537; Kengen SWM, 1995, J BIOL CHEM, V270, P30453, DOI 10.1074/jbc.270.51.30453; Komoriya Y, 2012, J BIOL CHEM, V287, P15134, DOI 10.1074/jbc.M111.328153; Kon T, 2005, NAT STRUCT MOL BIOL, V12, P513, DOI 10.1038/nsmb930; Li CB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10223; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Marshansky V, 2014, BBA-BIOENERGETICS, V1837, P857, DOI 10.1016/j.bbabio.2014.01.018; Martin JL, 2014, P NATL ACAD SCI USA, V111, P3715, DOI 10.1073/pnas.1317784111; Maruyama S, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau8149; Masaike T, 2008, NAT STRUCT MOL BIOL, V15, P1326, DOI 10.1038/nsmb.1510; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Minagawa Y, 2013, J BIOL CHEM, V288, P32700, DOI 10.1074/jbc.M113.506329; Murata T, 2000, J BIOL CHEM, V275, P13415, DOI 10.1074/jbc.275.18.13415; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Nagamatsu Y, 2013, J MOL BIOL, V425, P2699, DOI 10.1016/j.jmb.2013.04.022; Nakamura A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06362-3; Nakanishi A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02553-6; Nakanishi-Matsui M, 2007, J BIOL CHEM, V282, P20698, DOI 10.1074/jbc.M700551200; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Nishizaka T, 2004, NAT STRUCT MOL BIOL, V11, P142, DOI 10.1038/nsmb721; Noji H, 1999, BIOCHEM BIOPH RES CO, V260, P597, DOI 10.1006/bbrc.1999.0885; Numoto N, 2009, EMBO REP, V10, P1228, DOI 10.1038/embor.2009.202; Rees DM, 2012, P NATL ACAD SCI USA, V109, P11139, DOI 10.1073/pnas.1207587109; Robinson GC, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120164; Schep DG, 2016, P NATL ACAD SCI USA, V113, P3245, DOI 10.1073/pnas.1521990113; Seong IS, 1999, FEBS LETT, V456, P211, DOI 10.1016/S0014-5793(99)00935-7; Shimabukuro K, 2006, BIOPHYS J, V90, P1028, DOI 10.1529/biophysj.105.067298; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; Shirakihara Y, 2015, FEBS J, V282, P2895, DOI 10.1111/febs.13329; Sielaff H, 2016, J BIOL CHEM, V291, P25351, DOI 10.1074/jbc.M116.745240; Sobti M, 2016, ELIFE, V5, DOI 10.7554/eLife.21598; Steel BC, 2015, SCI REP-UK, V5, DOI 10.1038/srep08773; Stewart AG, 2014, CURR OPIN STRUC BIOL, V25, P40, DOI 10.1016/j.sbi.2013.11.013; Suzuki K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13235; Suzuki T, 2014, NAT CHEM BIOL, V10, P930, DOI [10.1038/nchembio.1635, 10.1038/NCHEMBIO.1635]; Tsunoda J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33977-9; Uchihashi T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04587-w; Ueno Hiroshi, 2014, J Biol Chem, V289, P31212, DOI 10.1074/jbc.M114.598177; Ueno H, 2010, BIOPHYS J, V98, P2014, DOI 10.1016/j.bpj.2010.01.011; Watanabe R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4486; Watanabe R, 2010, NAT CHEM BIOL, V6, P814, DOI 10.1038/NCHEMBIO.443; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yokoyama K, 2005, J BIOENERG BIOMEMBR, V37, P405, DOI 10.1007/s10863-005-9480-1; Yokoyama K, 1998, J BIOL CHEM, V273, P20504, DOI 10.1074/jbc.273.32.20504; Yukawa A, 2015, BIOCHEMISTRY-US, V54, P472, DOI 10.1021/bi501138b; Zhao JH, 2015, NATURE, V521, P241, DOI 10.1038/nature14365; Zhou AN, 2015, ELIFE, V4, DOI 10.7554/eLife.10180; Zhou L, 2019, SCIENCE, V365, P773, DOI 10.1126/science.aaw9144	80	11	11	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					17017	17030		10.1074/jbc.RA119.008947	http://dx.doi.org/10.1074/jbc.RA119.008947			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31519751	hybrid, Green Published			2022-12-26	WOS:000501801900044
J	Swayden, M; Alzeeb, G; Masoud, R; Berthois, Y; Audebert, S; Camoin, L; Hannouche, L; Vachon, H; Gayet, O; Bigonnet, M; Roques, J; Silvy, F; Carrier, A; Dusetti, N; Iovanna, JL; Soubeyran, P				Swayden, Mirna; Alzeeb, George; Masoud, Rawand; Berthois, Yolande; Audebert, Stephane; Camoin, Luc; Hannouche, Laurent; Vachon, Hortense; Gayet, Odile; Bigonnet, Martin; Roques, Julie; Silvy, Francoise; Carrier, Alice; Dusetti, Nelson; Iovanna, Juan L.; Soubeyran, Philippe			PML hyposumoylation is responsible for the resistance of pancreatic cancer	FASEB JOURNAL			English	Article						chemoresistance; post-translational modification; ubiquitin family; promyelocytic leukemia protein; sumoylation	PROTEIN CONJUGATION; UBIQUITIN; TRANSCRIPTION; SENSITIVITY; MECHANISMS; SURVIVAL; SYSTEM	The dismal prognosis of pancreatic ductal adenocarcinoma (PDAC) is mainly due to its rapidly acquired resistance to all conventional treatments. Despite drug-specific mechanisms of resistance, none explains how these cells resist the stress induced by any kind of anticancer treatment. Activation of stress-response pathways relies on the post-translational modifications (PTMs) of involved proteins. Among all PTMs, those mediated by the ubiquitin family of proteins play a central role. Our aim was to identify alterations of ubiquitination, neddylation, and sumoylation associated with the multiresistant phenotype and demonstrate their implications in the survival of PDAC cells undergoing treatment. This approach pointed at an alteration of promyelocytic leukemia (PML) protein sumoylation associated with both gemcitabine and oxaliplatin resistance. We could show that this alteration of PML sumoylation is part of a general mechanism of drug resistance, which in addition involves the abnormal activation of NF-kappa B and cAMP response element binding pathways. Importantly, using patient-derived tumors and cell lines, we identified a correlation between the levels of PML expression and sumoylation and the sensitivity of tumors to anticancer treatments.	[Swayden, Mirna; Alzeeb, George; Masoud, Rawand; Berthois, Yolande; Audebert, Stephane; Camoin, Luc; Gayet, Odile; Bigonnet, Martin; Roques, Julie; Silvy, Francoise; Carrier, Alice; Dusetti, Nelson; Iovanna, Juan L.; Soubeyran, Philippe] Aix Marseille Univ, CNRS, Inst Paoli Calmettes, CRCM, Marseille, France; [Hannouche, Laurent; Vachon, Hortense] Aix Marseille Univ, INSERM, Eories & Approches Complexit Genom TAGC, TGML, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Soubeyran, P (corresponding author), CNRS, Inst Paoli Calmettes, INSERM, CRCM,Univ U105,UMR1068,UMR7258, Parc Sci Luminy 163,Ave Luminy, F-13288 Marseille 9, France.	philippe.soubeyran@inserm.fr	Dusetti, Nelson/O-7919-2017; Inserm U1090, TAGC/ABE-9980-2021	Dusetti, Nelson/0000-0002-6161-8483; Alzeeb, George/0000-0003-3492-823X; Soubeyran, Philippe/0000-0002-5876-3217; Audebert, Stephane/0000-0002-9409-2588	INSERM; GIS Infrastructures en Biologie Sante et Agronomie (IBiSA); Aix-Marseille Universite; La Ligue Contre le Cancer; Association pour la Recherche sur le Cancer (ARC); Institute National du Cancer (INCa); Canceropole Provence-Alpes-Cote d'Azur (PACA);  [ANR-10-INBS-0009-10]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); GIS Infrastructures en Biologie Sante et Agronomie (IBiSA); Aix-Marseille Universite; La Ligue Contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Institute National du Cancer (INCa)(Institut National du Cancer (INCA) France); Canceropole Provence-Alpes-Cote d'Azur (PACA); 	The authors thank Dr. Arkaitz Carracedo (Center for Cooperative Research in Bioscience, Spain) for providing PML constructs and to Dr. Guillaume Bossis (IGMM, Montpellier, France) for providing anti-SUMO1 and anti-SUMO2/3 hybridomas. High-throughput sequencing was performed at the Transcriptomique and Genomique Marseille Luminy (TGML) Platform and supported by grants from INSERM, GIS Infrastructures en Biologie Sante et Agronomie (IBiSA), Aix-Marseille Universite, and ANR-10-INBS-0009-10. This work was supported by La Ligue Contre le Cancer, Association pour la Recherche sur le Cancer (ARC), Institute National du Cancer (INCa), Canceropole Provence-Alpes-Cote d'Azur (PACA), and INSERM. Proteomic analyses were done using the mass spectrometry facility of Marseille Proteomics (marseille-proteomique.univ-amu.fr) and were supported by IBiSA, Plateforme Technologique Aix-Marseille, Canceropole PACA, the Institut Paoli-Calmettes, and the Centre de Recherche en Cancerologie de Marseille. The authors declare no conflicts of interest.	Adamska Aleksandra, 2018, Advances in Biological Regulation, V68, P77, DOI 10.1016/j.jbior.2017.11.007; Bedford L, 2011, NAT REV DRUG DISCOV, V10, P29, DOI 10.1038/nrd3321; Best JL, 2002, MOL CELL, V10, P843, DOI 10.1016/S1097-2765(02)00699-8; Bian B, 2017, EMBO MOL MED, V9, P482, DOI 10.15252/emmm.201606975; Bonacci T, 2014, J PROTEOME RES, V13, P2478, DOI 10.1021/pr401258d; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Cappadocia L, 2018, CHEM REV, V118, P889, DOI 10.1021/acs.chemrev.6b00737; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Duconseil P, 2015, AM J PATHOL, V185, P1022, DOI 10.1016/j.ajpath.2014.11.029; GOLDSTEIN G, 1975, P NATL ACAD SCI USA, V72, P11, DOI 10.1073/pnas.72.1.11; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Hattersley N, 2011, MOL BIOL CELL, V22, P78, DOI 10.1091/mbc.E10-06-0504; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Hurwitz SN, 2016, ONCOTARGET, V7, P86999, DOI 10.18632/oncotarget.13569; Krueger KE, 2006, MOL CELL PROTEOMICS, V5, P1799, DOI 10.1074/mcp.R600009-MCP200; Lallemand-Breitenbach V, 2018, CURR OPIN CELL BIOL, V52, P154, DOI 10.1016/j.ceb.2018.03.011; Ma CC, 2014, TUMOR BIOL, V35, P12729, DOI 10.1007/s13277-014-2598-1; Maguire O, 2011, CYTOM PART A, V79A, P461, DOI 10.1002/cyto.a.21068; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Schneider G, 2005, GASTROENTEROLOGY, V128, P1606, DOI 10.1053/j.gastro.2005.04.001; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Silvers CR, 2017, ONCOTARGET, V8, P91199, DOI 10.18632/oncotarget.20043; Tauro BJ, 2013, MOL CELL PROTEOMICS, V12, P587, DOI 10.1074/mcp.M112.021303; Tessier S, 2017, ANTIOXID REDOX SIGN, V26, P432, DOI 10.1089/ars.2016.6898; Vertegaal ACO, 2011, CHEM REV, V111, P7923, DOI 10.1021/cr200187e; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wang ZG, 1998, SCIENCE, V279, P1547; Yau R, 2016, NAT CELL BIOL, V18, P579, DOI 10.1038/ncb3358; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yuan LW, 2001, BBA-MOL CELL RES, V1541, P161, DOI 10.1016/S0167-4889(01)00141-0; Zhang CC, 2018, TECHNOL CANCER RES T, V17, DOI 10.1177/1533033818763450	36	6	6	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12447	12463		10.1096/fj.201901091R	http://dx.doi.org/10.1096/fj.201901091R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31557059	Green Published			2022-12-26	WOS:000507461600066
J	Weiner, ZP; Salzer, JS; LeMasters, E; Ellison, JA; Kondas, AV; Morgan, CN; Doty, JB; Martin, BE; Satheshkumar, PS; Olson, VA; Hutson, CL				Weiner, Zachary P.; Salzer, Johanna S.; LeMasters, Elizabeth; Ellison, James A.; Kondas, Ashley, V; Morgan, Clint N.; Doty, Jeffery B.; Martin, Brock E.; Satheshkumar, Panayampalli Subbian; Olson, Victoria A.; Hutson, Christina L.			Characterization of Monkeypox virus dissemination in the black-tailed prairie dog (Cynomys ludovicianus) through in vivo bioluminescent imaging	PLOS ONE			English	Article							CONGO; WEST; INFECTIONS; FEATURES; AFRICAN	Monkeypox virus (MPXV) is a member of the genus Orthopoxvirus, endemic in Central and West Africa. This viral zoonosis was introduced into the United States in 2003 via African rodents imported for the pet trade and caused 37 human cases, all linked to exposure to MPXV-infected black-tailed prairie dogs (Cynomys ludovicianus). Prairie dogs have since become a useful model of MPXV disease, utilized for testing of potential medical countermeasures. In this study, we used recombinant MPXV containing the firefly luciferase gene (luc) and in vivo imaging technology to characterize MPXV pathogenesis in the black-tailed prairie dog in real time. West African (WA) MPXV could be visualized using in vivo imaging in the nose, lymph nodes, intestines, heart, lung, kidneys, and liver as early as day 6 post infection (p.i.). By day 9 p.i., lesions became visible on the skin and in some cases in the spleen. After day 9 p.i., luminescent signal representing MPXV replication either increased, indicating a progression to what would be a fatal infection, or decreased as infection was resolved. Use of recombinant luc+ MPXV allowed for a greater understanding of how MPXV disseminates throughout the body in prairie dogs during the course of infection. This technology will be used to reduce the number of animals required in future pathogenesis studies as well as aid in determining the effectiveness of potential medical countermeasures.	[Weiner, Zachary P.; Salzer, Johanna S.; LeMasters, Elizabeth; Ellison, James A.; Kondas, Ashley, V; Morgan, Clint N.; Doty, Jeffery B.; Martin, Brock E.; Satheshkumar, Panayampalli Subbian; Olson, Victoria A.; Hutson, Christina L.] Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Atlanta, GA 30333 USA; [Weiner, Zachary P.] Ctr Dis Control & Prevent, Lab Leadership Serv, Poxvirus & Rabies Branch, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Hutson, CL (corresponding author), Ctr Dis Control & Prevent, Poxvirus & Rabies Branch, Atlanta, GA 30333 USA.	zuu6@cdc.gov		Weiner, Zachary/0000-0002-8337-1354; Ellison, James/0000-0003-4492-4857				[Anonymous], 2018, PATIENT MONKEYPOX WA; BLASCO R, 1995, GENE, V158, P157, DOI 10.1016/0378-1119(95)00149-Z; BREMAN JG, 1980, B WORLD HEALTH ORGAN, V58, P165; Chen NH, 2005, VIROLOGY, V340, P46, DOI 10.1016/j.virol.2005.05.030; Cook SH, 2003, J VIROL, V77, P5333, DOI 10.1128/JVI.77.9.5333-5338.2003; Doshi RH, 2018, EMERG INFECT DIS, V24, P1158, DOI 10.3201/eid2406.180248; Doty JB, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100283; Durski KN, 2018, MMWR-MORBID MORTAL W, V67, P306, DOI 10.15585/mmwr.mm6710a5; Earl PL, 2015, VIROLOGY, V475, P150, DOI 10.1016/j.virol.2014.11.015; Falendysz EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005809; Falendysz EA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004130; Falendysz EA, 2014, J WILDLIFE DIS, V50, P524, DOI 10.7589/2013-07-171; Gross E, 2003, ANN EMERG MED, V42, P660, DOI 10.1016/S0196-0644(03)00819-9; Hutson CL, 2007, AM J TROP MED HYG, V76, P757, DOI 10.4269/ajtmh.2007.76.757; Hutson CL, 2019, J AM ASSOC LAB ANIM, V58, P485, DOI [10.30802/AALAS-JAALAS-18-000036, 10.30802/aalas-jaalas-18-000036]; Hutson CL, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/965710; Hutson CL, 2010, VIROLOGY, V402, P72, DOI 10.1016/j.virol.2010.03.012; Hutson CL, 2009, J GEN VIROL, V90, P323, DOI 10.1099/vir.0.005108-0; JEZEK Z, 1987, J INFECT DIS, V156, P293, DOI 10.1093/infdis/156.2.293; JEZEK Z, 1988, B WORLD HEALTH ORGAN, V66, P459; Learned LA, 2005, AM J TROP MED HYG, V73, P428, DOI 10.4269/ajtmh.2005.73.428; Li Y, 2006, J CLIN VIROL, V36, P194, DOI 10.1016/j.jcv.2006.03.012; Likos AM, 2005, J GEN VIROL, V86, P2661, DOI 10.1099/vir.0.81215-0; Luker KE, 2009, METHODS MOL BIOL, V574, P125, DOI 10.1007/978-1-60327-321-3_11; McCollum AM, 2014, CLIN INFECT DIS, V58, P260, DOI 10.1093/cid/cit703; Nakoune E, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx168; Ozkaya H, 2012, NEW MICROBIOL, V35, P53; Reed KD, 2004, NEW ENGL J MED, V350, P342, DOI 10.1056/NEJMoa032299; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; Vaughan A, 2018, EUROSURVEILLANCE, V23, P2, DOI 10.2807/1560-7917.ES.2018.23.38.1800509; Yinka-Ogunleye A, 2018, EMERG INFECT DIS, V24, P1149, DOI 10.3201/eid2406.180017	31	9	9	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222612	10.1371/journal.pone.0222612	http://dx.doi.org/10.1371/journal.pone.0222612			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557167	Green Published, gold			2022-12-26	WOS:000532345500025
J	Kim, MJ; Kim, N; Shin, D; Rhee, SJ; Park, CHK; Kim, H; Cho, SJ; Lee, JW; Kim, EY; Yang, B; Ahn, YM				Kim, Min Ji; Kim, Namwoo; Shin, Daun; Rhee, Sang Jin; Park, C. Hyung Keun; Kim, Hyeyoung; Cho, Sung Joon; Lee, Jae Won; Kim, Eun Young; Yang, Boram; Ahn, Yong Min			The epidemiology of antidepressant use in South Korea: Does short-term antidepressant use affect the relapse and recurrence of depressive episodes?	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITORS; TRICYCLIC ANTIDEPRESSANTS; SOCIOECONOMIC-STATUS; DISORDERS; PATTERNS; CARE; DISCONTINUATION; DETERMINANTS; PREVALENCE; EFFICACY	Background The duration of antidepressant use affects the treatment of depression. Using the National Health Insurance database, which covers almost the entire national population, we verified the factors associated with the inadequate short-term use of initially prescribed antidepressants and their effects on the relapse and recurrence of depressive episodes. Methods There were 752,190 patients included who had been newly prescribed antidepressants in 2012 with the diagnosis of depressive disorder. They were followed-up until December 31, 2015. They were classified as short-term and long-term antidepressant users depending on whether they used a specific initial antidepressant for at least four weeks. Sociodemographic, clinical, and medical utilization factors affecting the duration of antidepressant use were investigated. We also identified whether the duration of antidepressant use affected the risk of relapse and recurrence, which was defined by the restarting of antidepressants. Results Initial antidepressants were taken for less than 28 days by 458,057 (60.84%) patients. Tricyclic antidepressants were used as the initial antidepressant more frequently than selective serotonin reuptake inhibitors (64.5% versus 19.3%). The type of initial antidepressant, polypharmacy, psychiatric and medical comorbidities, type of insurance coverage, and type of medical institution visited were associated with short-term use. Short-term use marginally increased the risk of relapse and recurrence of depressive episodes (Hazard ratio: 1.06, 95% confidence intervals 1.048-1.075). Conclusions Short-term antidepressant use is widespread in Korea, and assessment in various aspects are necessary to set proper treatment plans.	[Kim, Min Ji; Kim, Namwoo; Shin, Daun; Rhee, Sang Jin; Park, C. Hyung Keun; Ahn, Yong Min] Seoul Natl Univ Hosp, Dept Psychiat, Seoul, South Korea; [Park, C. Hyung Keun; Ahn, Yong Min] Seoul Natl Univ, Inst Human Behav Med, Dept Psychiat & Behav Sci, Coll Med, Seoul, South Korea; [Park, C. Hyung Keun] Asan Med Ctr, Dept Psychiat, Seoul, South Korea; [Kim, Hyeyoung] Inha Univ Hosp, Dept Psychiat, Inhang Ro, Incheon, South Korea; [Cho, Sung Joon] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Psychiat, Sch Med, Seoul, South Korea; [Lee, Jae Won] Seoul Metropolitan Eunpyeong Hosp, Dept Psychiat, Seoul, South Korea; [Kim, Eun Young] Seoul Natl Univ, Mental Hlth Ctr, Hlth Care Ctr, Seoul, South Korea; [Kim, Eun Young] Seoul Natl Univ, Dept Med, Coll Med, Seoul, South Korea; [Yang, Boram] Seoul Natl Univ Hosp, Med Res Collaborating Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); University of Ulsan; Asan Medical Center; Inha University; Inha University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Ahn, YM (corresponding author), Seoul Natl Univ Hosp, Dept Psychiat, Seoul, South Korea.; Ahn, YM (corresponding author), Seoul Natl Univ, Inst Human Behav Med, Dept Psychiat & Behav Sci, Coll Med, Seoul, South Korea.	aym@snu.ac.kr	Park, Christopher/L-6074-2017	Park, Christopher/0000-0002-2568-1426; Kim, Namwoo/0000-0002-1684-5417; Kim, Hyeyoung/0000-0002-2313-8892; Yang, Bo Ram/0000-0002-8771-8829				Anderson IM, 2000, J AFFECT DISORDERS, V58, P19, DOI 10.1016/S0165-0327(99)00092-0; ANDERSON IM, 1995, BMJ-BRIT MED J, V310, P1433, DOI 10.1136/bmj.310.6992.1433; Association AP, 2009, PRACTICE GUIDELINE T, V3; Bae KY, 2011, PSYCHIAT INVEST, V8, P234, DOI 10.4306/pi.2011.8.3.234; Briley M, 2004, HUM PSYCHOPHARM CLIN, V19, pS21, DOI 10.1002/hup.621; Bull SA, 2002, ANN PHARMACOTHER, V36, P578, DOI 10.1345/aph.1A254; Bull SA, 2002, JAMA-J AM MED ASSOC, V288, P1403, DOI 10.1001/jama.288.11.1403; Burcusa SL, 2007, CLIN PSYCHOL REV, V27, P959, DOI 10.1016/j.cpr.2007.02.005; Chan D, 2009, PSYCHIAT SERV, V60, P1612, DOI 10.1176/ps.2009.60.12.1612; Demyttenaere K, 1997, J AFFECT DISORDERS, V43, P27, DOI 10.1016/S0165-0327(96)00095-X; Donoghue J, 2000, ACTA PSYCHIAT SCAND, V101, P57, DOI 10.1111/j.1600-0447.2000.tb10949.x; Geddes JR, 2003, LANCET, V361, P653, DOI 10.1016/S0140-6736(03)12599-8; HELZER J E, 1979, American Journal of Psychiatry, V136, P526; Hudson CG, 2005, AM J ORTHOPSYCHIAT, V75, P3, DOI 10.1037/0002-9432.75.1.3; Hwang JE, 2018, INT J CLIN PHARM TH, V56, P224, DOI 10.5414/CP203157; Ikin JF, 2010, J AFFECT DISORDERS, V125, P279, DOI 10.1016/j.jad.2009.12.005; Iosifescu DV, 2005, FOCUS, V160, P2122; Jackson JL, 2000, AM J MED, V108, P65, DOI 10.1016/S0002-9343(99)00299-5; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kim KH, 2011, J AFFECT DISORDERS, V132, P121, DOI 10.1016/j.jad.2011.02.016; Kim L, 2014, EPIDEMIOLOGY HLTH, P36; LIN EHB, 1995, MED CARE, V33, P67, DOI 10.1097/00005650-199501000-00006; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; MacGillivray S, 2003, BMJ-BRIT MED J, V326, P1014, DOI 10.1136/bmj.326.7397.1014; MADDOX JC, 1994, J PSYCHOPHARMACOL, V8, P48, DOI 10.1177/026988119400800108; Melartin TK, 2004, J CLIN PSYCHIAT, V65, P810; Melfi CA, 1998, ARCH GEN PSYCHIAT, V55, P1128, DOI 10.1001/archpsyc.55.12.1128; Melfi CA, 1999, MED CARE, V37, pAS77, DOI 10.1097/00005650-199904001-00010; Mitchell AJ, 2005, AM J PSYCHIAT, V162, P1588, DOI 10.1176/appi.ajp.162.9.1588; Mottram P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003491.pub2; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Olfson M, 2006, AM J PSYCHIAT, V163, P101, DOI 10.1176/appi.ajp.163.1.101; Rosholm JU, 2001, EUR J CLIN PHARMACOL, V56, P923, DOI 10.1007/s002280000234; Sayers J., 2001, B WORLD HEALTH ORGAN, V79, P1085; SIMON GE, 1993, GEN HOSP PSYCHIAT, V15, P399, DOI 10.1016/0163-8343(93)90009-D; Sood N, 2000, AM J MANAG CARE, V6, P1327; Stahl SM, 2003, J CLIN PSYCHIAT, V64, P745; Tai-Seale M, 2000, MED CARE RES REV, V57, P491, DOI 10.1177/107755870005700405; Vos T, 2004, ARCH GEN PSYCHIAT, V61, P1097, DOI 10.1001/archpsyc.61.11.1097; Weilburg JB, 2003, PSYCHIAT SERV, V54, P1233, DOI 10.1176/appi.ps.54.9.1233; Young AS, 2001, ARCH GEN PSYCHIAT, V58, P55, DOI 10.1001/archpsyc.58.1.55; Zimmerman FJ, 2005, HEALTH ECON, V14, P1197, DOI 10.1002/hec.1011; 이경욱, 2006, [The Korean Journal of Psychopharmacology, 대한정신약물학회지], V17, P550	44	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222791	10.1371/journal.pone.0222791	http://dx.doi.org/10.1371/journal.pone.0222791			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5WE	31553786	Green Submitted, Green Published, gold			2022-12-26	WOS:000532319200037
J	Ansari, WA; Atri, N; Ahmad, J; Qureshi, MI; Singh, B; Kumar, R; Rai, V; Pandey, S				Ansari, Waquar Akhter; Atri, Neelam; Ahmad, Javed; Qureshi, Mohammad Irfan; Singh, Bijendra; Kumar, Ram; Rai, Vandna; Pandey, Sudhakar			Drought mediated physiological and molecular changes in muskmelon (Cucumis melo L.)	PLOS ONE			English	Article							COMPARATIVE PROTEOMIC ANALYSIS; CHLOROPHYLL FLUORESCENCE; STRESS; RESPONSES; PROTEINS; RICE; GENOTYPES; IDENTIFICATION; ACCUMULATION; EXPRESSION	Water deficiency up to a certain level and duration leads to a stress condition called drought. It is a multi-dimensional stress causing alteration in the physiological, morphological, biochemical, and molecular traits in plants resulting in improper plant growth and development. Drought is one of the major abiotic stresses responsible for loss of crops including muskmelon (Cucumis melo. L). Muskmelon genotype SC-15, which exhibits high drought resistance as reported in our earlier reports, was exposed to deficient water condition and studied for alteration in physiological, molecular and proteomic profile changes in the leaves. Drought stress results in reduced net photosynthetic rate (Pn), stomatal conductance (Gs) and transpiration (E) rate. With expanded severity of drought, declination recorded in content of total chlorophyll and carotenoid while enhancement observed in phenol content indicating generation of oxidative stress. In contrary, activities of catalase (CAT), superoxide dismutase (SOD), ascorbate peroxidase (APX), and guaiacol (POD) were increased under drought stress. Peptide mass fingerprinting (PMF) showed that drought increased the relative abundance of 38 spots while decreases10 spots of protein. The identified proteins belong to protein synthesis, photosynthesis, nucleotide biosynthesis, stress response, transcription regulation, metabolism, energy and DNA binding. A drought-induced MADS-box transcription factor was identified. The present findings indicate that under drought muskmelon elevates the abundance of defense proteins and suppresses catabolic proteins. The data obtained exhibits possible mechanisms adopted by muskmelon to counter the impacts of drought induced stress.	[Ansari, Waquar Akhter; Singh, Bijendra; Pandey, Sudhakar] Indian Inst Vegetable Res, ICAR, Varanasi, Uttar Pradesh, India; [Ansari, Waquar Akhter; Atri, Neelam] Banaras Hindu Univ, MMV, Dept Bot, Varanasi, Uttar Pradesh, India; [Ahmad, Javed; Qureshi, Mohammad Irfan] Jamia Millia Islamia, Dept Biotechnol, Prote & Bioinformat Lab, New Delhi, India; [Kumar, Ram; Rai, Vandna] LBS Ctr, Natl Res Ctr Plant Biotechnol, ICAR, Pusa Campus, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Vegetable Research; Banaras Hindu University (BHU); Jamia Millia Islamia; Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB)	Pandey, S (corresponding author), Indian Inst Vegetable Res, ICAR, Varanasi, Uttar Pradesh, India.	sudhakariivr@gmail.com	Qureshi, M Irfan/CAF-0824-2022	Qureshi, M Irfan/0000-0001-9625-0036	Maulana Azad Junior and Senior Research Fellowship; National Agricultural Innovation Project (NAIP)	Maulana Azad Junior and Senior Research Fellowship; National Agricultural Innovation Project (NAIP)	This study was supported by the Maulana Azad Junior and Senior Research Fellowship awarded to WA and was also supported by National Agricultural Innovation Project (NAIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali GM, 2006, J PROTEOME RES, V5, P396, DOI 10.1021/pr050291g; Ansari WA, 2018, PHOTOSYNTHETICA, V56, P1019, DOI 10.1007/s11099-018-0821-9; Ansari WA, 2017, BIOL PLANTARUM, V61, P333, DOI 10.1007/s10535-016-0694-3; Ashoub A, 2013, PLANTA, V237, P771, DOI 10.1007/s00425-012-1798-4; Bagheri R, 2015, PLANT PHYSIOL BIOCH, V97, P235, DOI 10.1016/j.plaphy.2015.10.012; Bakshi M, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27700; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Bouche N, 2005, ANNU REV PLANT BIOL, V56, P435, DOI 10.1146/annurev.arplant.56.032604.144224; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown RE, 2007, BBA-MOL CELL BIOL L, V1771, P746, DOI 10.1016/j.bbalip.2007.01.011; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Carpentier SC, 2005, PROTEOMICS, V5, P2497, DOI 10.1002/pmic.200401222; Castillejo M. A., 2008, OPEN PROTEOMICS J, V1, P59, DOI DOI 10.2174/1875039700801010059; Cha-Um S, 2007, J AGRON CROP SCI, V193, P157, DOI 10.1111/j.1439-037X.2007.00251.x; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Chen JH, 2011, PLANT OMICS, V4, P257; Coombs J., 1987, TECHNIQUES BIOPRODUC; Deeba F, 2012, PLANT PHYSIOL BIOCH, V53, P6, DOI 10.1016/j.plaphy.2012.01.002; DHILLON NPS, 2011, PLANT BREED REV, V35, P85; Faghani E, 2015, DATA BRIEF, V2, P26, DOI 10.1016/j.dib.2014.11.001; Fan LQ, 2015, PHYTOCHEMISTRY, V116, P28, DOI 10.1016/j.phytochem.2015.02.023; Feng XH, 2007, CHINA CUCURBITS VEGE, V1, P57; Gupta OP, 2015, MOL BIOL REP, V42, P43, DOI 10.1007/s11033-014-3738-9; Hu RB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-145; Huo Chen-Min, 2004, Acta Genetica Sinica, V31, P1408; Ibrahim E. A., 2012, International Journal of Plant Breeding and Genetics, V6, P238; Jangpromma Nisachon, 2010, American Journal of Biochemistry and Biotechnology, V6, P89, DOI 10.3844/ajbbsp.2010.89.102; Jimenez S, 2013, TREE PHYSIOL, V33, P1061, DOI 10.1093/treephys/tpt074; Kausar A, 2012, PAK J BOT, V44, P47; Ke YQ, 2009, BIOCHEM BIOPH RES CO, V379, P133, DOI 10.1016/j.bbrc.2008.12.067; Kim S. G., P O J, V8, P159; Koh J, 2015, J PROTEOME RES, V14, P3068, DOI 10.1021/pr501323d; Koslowsky S, 2008, PLANT BIOTECHNOL J, V6, P281, DOI 10.1111/j.1467-7652.2007.00314.x; Kusvuran S., 2012, African Journal of Agricultural Research, V7, P775; Langenkamper G, 2001, J EXP BOT, V52, P1545, DOI 10.1093/jexbot/52.360.1545; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Li YJ, 2009, PLANT BREEDING, V128, P404, DOI 10.1111/j.1439-0523.2008.01593.x; Lichtenthaler H.K., 2001, CURR PROTOC FOOD ANA, V1, pF4.3.1, DOI [10.1002/0471142913.faf0403s01, DOI 10.1002/0471142913.FAF0403S01]; Lin HH, 2016, J PLANT BIOCHEM BIOT, V25, P87, DOI 10.1007/s13562-015-0314-x; Malter D, 2011, PROTOPLASMA, V248, P217, DOI 10.1007/s00709-010-0215-8; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Mitra J, 2001, CURR SCI INDIA, V80, P758; Nawaz MA, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4856-x; Nawaz MA, 2018, PLANT GROWTH REGUL, V85, P41, DOI 10.1007/s10725-018-0372-x; Pandey Shashank, 2016, 2016 41st International Conference on Infrared, Millimeter and Terahertz Waves (IRMMW-THz), DOI 10.1109/IRMMW-THz.2016.7758921; Pandey S, 2013, ACTA HORTIC, V979, P335; Pinot F, 2011, FEBS J, V278, P195, DOI 10.1111/j.1742-4658.2010.07948.x; Ranjbarfordoei A, 2006, PHOTOSYNTHETICA, V44, P513, DOI 10.1007/s11099-006-0064-z; Sanjeeta K, 2014, J PROTEOME SCI COMPU, V3, P2, DOI [10.7243/2050-2273-3-2, DOI 10.7243/2050-2273-3-2]; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shu LB, 2010, J INTEGR PLANT BIOL, V52, P981, DOI 10.1111/j.1744-7909.2010.00986.x; SRINIVAS K, 1989, AUSTR J AGR RES, V6, P115; Tai FJ, 2011, PLANT OMICS, V4, P250; Wang HZ, 2010, AGR SCI CHINA, V9, P633, DOI 10.1016/S1671-2927(09)60138-3; Wu AH, 2012, PLANT CELL, V24, P482, DOI 10.1105/tpc.111.090894; YANG P, 2019, AGRONOMY-BASEL, V9, DOI DOI 10.3390/agronomy9050265; Yang Z, 2009, PLANT MOL BIOL, V70, P219, DOI 10.1007/s11103-009-9466-1; Yoshimura K, 2008, PLANT CELL PHYSIOL, V49, P226, DOI 10.1093/pcp/pcm180; Zhao Y, 2011, PHYSIOL PLANTARUM, V141, P40, DOI 10.1111/j.1399-3054.2010.01419.x; Zhao YY, 2010, J ZHEJIANG UNIV-SC B, V11, P443, DOI 10.1631/jzus.B0900357; Zhou G, 2012, PLANT MOL BIOL REP, V30, P349, DOI 10.1007/s11105-011-0343-0; ZIESLIN N, 1993, PLANT PHYSIOL BIOCH, V31, P333	62	9	9	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222647	10.1371/journal.pone.0222647	http://dx.doi.org/10.1371/journal.pone.0222647			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550269	Green Published, gold			2022-12-26	WOS:000532307700022
J	Schenk, HM; van Ockenburg, SL; Nawijn, MC; De Jonge, P; Rosmalen, JGM				Schenk, H. M.; van Ockenburg, S. L.; Nawijn, M. C.; De Jonge, P.; Rosmalen, J. G. M.			Identification of inflammatory markers suitable for non-invasive, repeated measurement studies in biobehavioral research: A feasibility study	PLOS ONE			English	Article							BIOMARKERS; DEPRESSION; CYTOKINES; CORTISOL; STRESS	Introduction Studying the role of the immune system in the interaction between mental and physical health is challenging. To study individuals with an intensive, longitudinal study design that requires repetitive sampling in their daily life, non-invasive sampling techniques are a necessity. Urine can be collected in a non-invasive way, but this may be demanding for participants and little is known about fluctuation of inflammatory markers in urine over time. The aim of this study was to investigate the feasibility of non-invasive sampling, and to explore intra-individual differences in inflammatory markers in urine. Materials & methods Ten healthy individuals collected 24-hour urine for 63 consecutive days. In a pilot analysis, 39 inflammatory markers were examined for detectability in urine, stability over time and under storage conditions, and daily fluctuations. Multiplex analyses were used to quantify levels of eight selected markers: C-reactive protein (CRP), Fractalkine, Interleukin-1 receptor-antagonist (IL-1RA), interferon-alpha (IFN alpha), interferon-gamma (IFN gamma), Interferon gamma-induced protein 10 (IP10), Macrophage inflammatory protein-1 beta (MIP-1 beta), and Vascular Endothelial Growth Factor (VEGF). Cross-correlations were calculated between the overnight and 24-hour samples were calculated, to examine whether 24-hour urine could be replaced by the overnight portion for better feasibility. We examined intra- and interindividual differences in the levels of inflammatory markers in urine and the fluctuations thereof. Results This study showed that levels of selected inflammatory markers can be detected in urine. Cross-correlation analyses showed that correlations between levels of inflammatory markers in the night portion and the 24-hour urine sample varied widely between individuals. In addition, analyses of time series revealed striking inter- and intra-individual variation in levels of inflammatory markers and their fluctuations. Conclusion We show that the assessment of urinary inflammatory markers is feasible in an intensive day-to-day study in healthy individuals. However, 24-hour urine cannot be replaced by an overnight portion to alleviate the protocol burden. Levels of inflammatory markers show substantial variation between and within persons.	[Schenk, H. M.; van Ockenburg, S. L.; De Jonge, P.; Rosmalen, J. G. M.] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Univ Ctr Psychiat, Groningen, Netherlands; [Nawijn, M. C.] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Dept Pathol & Med Biol, Groningen, Netherlands	University of Groningen; University of Groningen	Schenk, HM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Univ Ctr Psychiat, Groningen, Netherlands.	hmschenk@gmail.com	Rosmalen, Judith G.M./F-5375-2011; de Jonge, Peter/L-6395-2013	Rosmalen, Judith G.M./0000-0002-6393-0032; Nawijn, Martijn/0000-0003-3372-6521; de Jonge, Peter/0000-0002-0866-6929; Schenk, H. Maria/0000-0002-2799-0265	De Cock-Hadders Foundation [2016-62]; Espria Academy, a health care group in the Netherlands; Dutch National Research council NWO VICI grant (NWO) [91812607]; Innovation Fund Health Insurances, the Netherlands [2619]	De Cock-Hadders Foundation; Espria Academy, a health care group in the Netherlands; Dutch National Research council NWO VICI grant (NWO); Innovation Fund Health Insurances, the Netherlands(Netherlands Government)	HMS received a grant from the De Cock-Hadders Foundation (2016-62). The Espria Academy, a health care group in the Netherlands consisting of multiple companies targeted mainly at the elderly population (https://www.espria.nl/), provided funding for the salary of HMS. PdJ received a Dutch National Research council NWO VICI grant (NWO grant 91812607). JGMR received a grant from the Innovation Fund Health Insurances, the Netherlands, grant number 2619. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhide AA, 2013, INT UROGYNECOL J, V24, P1065, DOI 10.1007/s00192-012-2027-1; Booij SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131002; Cermakian N, 2013, CHRONOBIOL INT, V30, P870, DOI 10.3109/07420528.2013.782315; Chen QS, 2013, MEDIAT INFLAMM, V2013, DOI [10.1155/2013/928315, 10.1155/2013/434010]; Chiang JJ, 2012, P NATL ACAD SCI USA, V109, P1878, DOI 10.1073/pnas.1120972109; Conner T.S., 2012, HDB RES METHODS STUD, P3; Dahl J, 2014, PSYCHONEUROENDOCRINO, V45, P77, DOI 10.1016/j.psyneuen.2014.03.019; De Melo EN, 2016, J DIABETES COMPLICAT, V30, P295, DOI 10.1016/j.jdiacomp.2015.11.020; Dorn LD, 2016, PSYCHOSOM MED, V78, P646, DOI 10.1097/PSY.0000000000000321; Gabbay V, 2009, J AFFECT DISORDERS, V115, P177, DOI 10.1016/j.jad.2008.07.022; Haberkorn J, 2013, PSYCHONEUROENDOCRINO, V38, P2366, DOI 10.1016/j.psyneuen.2013.03.001; Hamaker E.L., 2012, HDB RES METHODS STUD, P43, DOI DOI 10.5860/CHOICE.50-1159; Hamaker EL, 2005, MULTIVAR BEHAV RES, V40, P207, DOI 10.1207/s15327906mbr4002_3; Honaker J, 2011, J STAT SOFTW, V45, P1; Huan YH, 2018, SCI CHINA LIFE SCI, V61, P1283, DOI 10.1007/s11427-017-9204-5; Khan A, 2012, J PROTEOMICS, V75, P4802, DOI 10.1016/j.jprot.2012.05.018; Khosro Sadeghniiat, 2011, Indian J Occup Environ Med, V15, P38, DOI 10.4103/0019-5278.82996; McAlpine CS, 2016, CIRC RES, V119, P131, DOI 10.1161/CIRCRESAHA.116.308034; Murakami K, 2008, NUTRITION, V24, P16, DOI 10.1016/j.nut.2007.09.001; Nayyar AS, 2012, MALAYS J PATHOL; Patel SR, 2009, SLEEP, V32, P200, DOI 10.1093/sleep/32.2.200; Peng WH, 2008, KIDNEY INT, V74, P1454, DOI 10.1038/ki.2008.459; Prasad S, 2016, EXP BIOL MED, V241, P783, DOI 10.1177/1535370216638770; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Rohleder N, 2014, PSYCHOSOM MED, V76, P181, DOI 10.1097/PSY.0000000000000049; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Schubert C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029415; Segerstrom SC, 2004, PSYCHOL B; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Slavish DC, 2015, BRAIN BEHAV IMMUN, V44, P253, DOI 10.1016/j.bbi.2014.08.008; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Stiegel MA, 2015, BIOMARKERS, V20, P35, DOI 10.3109/1354750X.2014.988646; Sublette ME, 2012, PSYCHOSOM MED, V74, P668, DOI 10.1097/PSY.0b013e318268de9f; van Ockenburg SL, 2016, PSYCHONEUROENDOCRINO, V73, P142, DOI 10.1016/j.psyneuen.2016.07.220; van Ockenburg SL, 2015, PSYCHONEUROENDOCRINO, V62, P189, DOI 10.1016/j.psyneuen.2015.08.002; Wium-Andersen MK, 2013, JAMA PSYCHIAT, V70, P176, DOI 10.1001/2013.jamapsychiatry.102; Wright KP, 2015, BRAIN BEHAV IMMUN, V47, P24, DOI 10.1016/j.bbi.2015.01.004	37	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0221993	10.1371/journal.pone.0221993	http://dx.doi.org/10.1371/journal.pone.0221993			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5RZ	31550260	Green Published, gold			2022-12-26	WOS:000532307700010
J	Wearing, J; Stokes, M; de Bruin, ED				Wearing, Julia; Stokes, Maria; de Bruin, Eling D.			Quadriceps muscle strength is a discriminant predictor of dependence in daily activities in nursing home residents	PLOS ONE			English	Article							HAND-HELD DYNAMOMETRY; TO-STAND PERFORMANCE; QUALITY-OF-LIFE; OLDER-ADULTS; ACTIVATION; DISABILITY; ULTRASONOGRAPHY; RELIABILITY; SARCOPENIA; EXERCISE	Objective This study aimed to explore the relationship between dependence in Activities of Daily Living and muscle strength, muscle morphology and physical function in older nursing home residents, taking possible confounders into consideration. Methods A total of 30 nursing home residents (age, 85.6 +/- 7.1 years) were included in this observational cross-sectional study. Performance of basic Activities of Daily Living (ADL) was assessed with the Resident Assessment Instrument and categorized as either independent or dependent. Isometric grip, quadriceps and elbow-flexor strength were determined by hand-dynamometry, muscle thickness and echo intensity by B-mode ultrasonography, a sit-to-stand task by using a stop watch and physical activity by the German-Physical-Activity Questionnaire. Degree of frailty was evaluated according to Fried's frailty criteria, whereas cognition, depression, incontinence, pain and falls were part of the Resident Assessment Instrument. Results Dependence in Activities of Daily Living was negatively correlated with physical activity (r(s) = -0.44, p =.015), handgrip (r(s) = -0.38, p =.038), elbow-flexor (r(s) = -0.42, p =.032) and quadriceps strength (r(s) = -0.67, p <.001), analysed by Spearman's correlation. Chronic diseases (r(s) = -0.41, p =.027) and incontinence (r(s) = -0.39, p =.037) were positively correlated with ADL while the other variables were not related. Only quadriceps strength remained significant with logistic regression (Wald(1) = 4.7, p =.03), when chronic diseases, quadriceps and handgrip strength were considered (R-2.79). 11 kg was the best fitting value in this sample to predict performance in Activities of Daily Living, evaluated with Receiver-Operating Characteristic analysis, with a sensitivity of 100% and a specificity of 79%. Conclusion and implication Quadriceps strength had a positive independent relationship with performance in ADL in the nursing home residents studied. Although a large prospective study is needed to verify the results, maintaining quadriceps strength above 11 kg may be helpful in retaining independence in this cohort.	[Wearing, Julia] Univ Maastricht, Sch Publ Hlth & Primary Care, Fac Hlth Med & Sci, Maastricht, Netherlands; [Stokes, Maria] Univ Southampton, Sch Hlth Sci, Southampton, Hants, England; [de Bruin, Eling D.] Swiss Fed Inst Technol, Inst Human Movement Sci & Sport IBWS, Dept Hlth Sci & Technol, Zurich, Switzerland; [Wearing, Julia] Adullam Stiftung, Basel, Switzerland; [de Bruin, Eling D.] Karolinska Inst, Div Physiotherapy, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden	Maastricht University; University of Southampton; Swiss Federal Institutes of Technology Domain; ETH Zurich; Karolinska Institutet	de Bruin, ED (corresponding author), Swiss Fed Inst Technol, Inst Human Movement Sci & Sport IBWS, Dept Hlth Sci & Technol, Zurich, Switzerland.; de Bruin, ED (corresponding author), Karolinska Inst, Div Physiotherapy, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.	eling.debruin@hest.ethz.ch	de Bruin, Eling D./A-4751-2011; Stokes, Maria/G-2288-2011	de Bruin, Eling D./0000-0002-6542-7385; Stokes, Maria/0000-0002-4204-0890; Wearing, Julia/0000-0002-1670-4673				Aguirre LE, 2015, NESTLE NUTR WORKS SE, V83, P83, DOI 10.1159/000382065; Agyapong-Badu S, 2014, PHYSIOL MEAS, V35, P2165, DOI 10.1088/0967-3334/35/10/2165; Akima H, 2001, MED SCI SPORT EXER, V33, P220; Alexander NB, 2000, J AM GERIATR SOC, V48, P526, DOI 10.1111/j.1532-5415.2000.tb04999.x; Arnold CM, 2010, J STRENGTH COND RES, V24, P815, DOI 10.1519/JSC.0b013e3181aa36b8; Arrieta H, 2019, J AM GERIATR SOC, V67, P1145, DOI 10.1111/jgs.15824; Arrieta H, 2018, MATURITAS, V109, P45, DOI 10.1016/j.maturitas.2017.12.003; Azegami M, 2007, NURS HEALTH SCI, V9, P168, DOI 10.1111/j.1442-2018.2007.00317.x; Bamman MM, 1998, J APPL PHYSIOL, V84, P157, DOI 10.1152/jappl.1998.84.1.157; bfs, 2017, GES ALT; Bohannon RW, 2011, PERCEPT MOTOR SKILL, V112, P803, DOI 10.2466/15.26.PMS.112.3.803-806; BOHANNON RW, 1986, PHYS THER, V66, P206, DOI 10.1093/ptj/66.2.206; Cadore EL, 2014, AGE, V36, P801, DOI 10.1007/s11357-013-9599-7; Chen WL, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001335; Clark Brian C, 2011, Curr Aging Sci, V4, P192; Clark DJ, 2012, J GERONTOL A-BIOL, V67, P41, DOI 10.1093/gerona/glr041; Colbert LH, 2011, MED SCI SPORT EXER, V43, P867, DOI 10.1249/MSS.0b013e3181fc7162; Crimmins EM, 2015, GERONTOLOGIST, V55, P901, DOI 10.1093/geront/gnv130; de Labra Carmen, 2015, BMC Geriatr, V15, P154, DOI 10.1186/s12877-015-0155-4; de Mazieres CL, 2017, J AM MED DIR ASSOC, V18, P105, DOI 10.1016/j.jamda.2016.11.019; Delaney S, 2010, MUSCLE NERVE, V42, P530, DOI 10.1002/mus.21725; Eriksrud O, 2003, PHYS THER, V83, P544, DOI 10.1093/ptj/83.6.544; FIATARONE MA, 1990, JAMA-J AM MED ASSOC, V263, P3029, DOI 10.1001/jama.263.22.3029; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hairi NN, 2010, J AM GERIATR SOC, V58, P2055, DOI 10.1111/j.1532-5415.2010.03145.x; Harridge SDR, 1999, MUSCLE NERVE, V22, P831, DOI 10.1002/(SICI)1097-4598(199907)22:7<831::AID-MUS4>3.0.CO;2-3; Harris-Love MO, 2016, PEERJ, V4, DOI 10.7717/peerj.1721; Huy C, 2008, Z GERONTOL GERIATR, V41, P208, DOI 10.1007/s00391-007-0474-y; Jerez-Roig J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177353; Kontis V, 2017, LANCET, V389, P1323, DOI 10.1016/S0140-6736(16)32381-9; Krist L, 2013, CLIN INTERV AGING, V8, P443, DOI 10.2147/CIA.S42136; Lane NE, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0444-1; Lord SR, 2002, J GERONTOL A-BIOL, V57, pM539, DOI 10.1093/gerona/57.8.M539; Luleci E, 2008, ARCH GERONTOL GERIAT, V46, P57, DOI 10.1016/j.archger.2007.02.007; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; Makizako H, 2017, PHYS THER, V97, P417, DOI 10.2522/ptj.20150665; Manini TM, 2013, CURR OPIN CLIN NUTR, V16, P21, DOI 10.1097/MCO.0b013e32835b5880; Manini TM, 2012, J GERONTOL A-BIOL, V67, P28, DOI 10.1093/gerona/glr010; Mayans D, 2012, PHYS MED REH CLIN N, V23, P133, DOI 10.1016/j.pmr.2011.11.009; Mechelli F, 2019, METHOD PROTOCOL, V2, DOI 10.3390/mps2030058; Mor V, 2003, BMC HEALTH SERV RES, V3, DOI 10.1186/1472-6963-3-20; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Ota A, 2008, INT J SPORT HLTH SCI, V6, P91, DOI [10.5432/ijshs.6.91, DOI 10.5432/IJSHS.6.91]; Ploutz-Snyder LL, 2002, J GERONTOL A-BIOL, V57, pB144, DOI 10.1093/gerona/57.4.B144; REIMERS K, 1993, J ULTRAS MED, V12, P73; Shechtman O, 2013, CLIN ASSESSMENT RECO; Shen YJ, 2019, J AM MED DIR ASSOC, V20, P5, DOI 10.1016/j.jamda.2018.09.012; SIPILA S, 1993, MUSCLE NERVE, V16, P294, DOI 10.1002/mus.880160309; Stark T, 2011, PM&R, V3, P472, DOI 10.1016/j.pmrj.2010.10.025; Stevens JE, 2003, MUSCLE NERVE, V27, P99, DOI 10.1002/mus.10279; Suzuki M, 2012, DISABIL REHABIL, V34, P202, DOI 10.3109/09638288.2011.593678; Taylor JL, 2009, J APPL PHYSIOL, V107, P354, DOI 10.1152/japplphysiol.91220.2008; Tieland M, 2018, J CACHEXIA SARCOPENI, V9, P3, DOI 10.1002/jcsm.12238; United Nations DoEaSA, 2017, WORLD POP AG; Van der Heijden MMP, 2009, GAIT POSTURE, V30, P110, DOI 10.1016/j.gaitpost.2009.04.002; Volkers KM, 2012, ARCH GERONTOL GERIAT, V54, P399, DOI 10.1016/j.archger.2011.04.018; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Zech A, 2011, ARCH PHYS MED REHAB, V92, P967, DOI 10.1016/j.apmr.2010.12.031	61	13	13	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0223016	10.1371/journal.pone.0223016	http://dx.doi.org/10.1371/journal.pone.0223016			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5RZ	31550272	Green Published, Green Accepted, gold			2022-12-26	WOS:000532307700041
J	Teixeira, KRC; de Medeiros, LA; Mendes, JA; Vaz, ER; Cunha, TM; de Oliveira, EP; Penha-Silva, N; Crispim, CA				Cerqueira Teixeira, Kely Raspante; de Medeiros, Luciana Alves; Mendes, Jordane Amaral; Vaz, Emilia Rezende; Cunha, Thulio Marquez; de Oliveira, Erick P.; Penha-Silva, Nilson; Crispim, Cibele Aparecida			The erythrocyte membrane stability is associated with sleep time and social jetlag in shift workers	PLOS ONE			English	Article							CELL DISTRIBUTION WIDTH; OSMOTIC STABILITY; CIRCADIAN CLOCKS; CHOLESTEROL; CHRONOTYPE; MORTALITY; DISORDER; RHYTHMS; LIPIDS; AGE	The osmotic stability of the erythrocyte membrane (OSEM) has been associated with changes in lipid profile, blood glucose and blood pressure. Changes in these parameters are very frequent in shift workers, possibly because of the lack of synchronization of biological rhythms, which results in the social jetlag. However, the existence of association between OSEM and circadian misalignment has not been investigated in this population. Therefore, this study investigated whether shift work, sleep time and social jetlag (SJL) are associated with biochemical and hematological variables. A population consisting of 79 men working at night (n = 37) or during the day (n = 42), aged between 21 and 65 years and with a mean BMI of 27.56 +/- 4.0 kg/m(2), was investigated cross-sectionally in relation to sleep time, SJL, anthropometric (height, weight and waist circumference) and blood variables, with emphasis on the OSEM. SJL was calculated by the absolute difference between the midpoint of sleep on work and rest days. The Generalized Linear Model (GzLM) was used to investigate the existence of associations between SJL and average sleep time in relation to the analyzed variables. Workers without SJL presented lower baseline lysis values of erythrocytes in isotonic medium in relation to workers with SJL. In addition, workers who slept on average less than 6 hours had higher OSEM, and higher total and LDL-cholesterol in relation to those who slept more than 6 hours, regardless of the shift. It is possible that the association of sleep deprivation and SJL with erythrocyte membrane stability is mediated through changes in the lipid profile.	[Cerqueira Teixeira, Kely Raspante; Mendes, Jordane Amaral; Cunha, Thulio Marquez; de Oliveira, Erick P.; Crispim, Cibele Aparecida] Univ Fed Uberlandia, Fac Med, Uberlandia, MG, Brazil; [de Medeiros, Luciana Alves; Vaz, Emilia Rezende; Penha-Silva, Nilson] Univ Fed Uberlandia, Inst Biotechnol, Uberlandia, MG, Brazil	Universidade Federal de Uberlandia; Universidade Federal de Uberlandia	Teixeira, KRC (corresponding author), Univ Fed Uberlandia, Fac Med, Uberlandia, MG, Brazil.	kelyraspante@gmail.com	de Oliveira, Erick P./D-1138-2011; Crispim, Cibele CAC/R-1269-2016; Penha Silva, Nilson/E-5730-2010	de Oliveira, Erick P./0000-0001-8989-8344; Crispim, Cibele CAC/0000-0002-6638-8197; Penha Silva, Nilson/0000-0002-8205-6213	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), for the doctoral scholarship granted to K. R. C. Teixeira;the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), for the funding of this study; the Programa de Pos-Graduacao em Ciencias da Saude (PPGCS) da Universidade Federal de Uberlandia (UFU), which enabled the realization of this research; the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), for the productivity grant awarded to N. Penha-Silva; and the study volunteers.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Neto MB, 2013, BIORHEOLOGY, V50, P305, DOI 10.3233/BIR-130641; Bertolazi AN, 2008, TRADUC ADAPTAC CULTU; Boivin J, 2007, HUM REPROD, V22, P1506, DOI 10.1093/humrep/dem046; Bujak K, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/824624; Burgueno A, 2010, ATHEROSCLEROSIS, V210, P625, DOI 10.1016/j.atherosclerosis.2009.12.032; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Chua ECP, 2015, SLEEP, V38, P1683, DOI 10.5665/sleep.5142; COOPER RA, 1978, J SUPRAMOL STR CELL, V8, P413, DOI 10.1002/jss.400080404; Danese E, 2015, J THORAC DIS, V7, pE402, DOI 10.3978/j.issn.2072-1439.2015.10.04; de Freitas MV, 2008, TOXICOL IN VITRO, V22, P219, DOI 10.1016/j.tiv.2007.07.010; de Freitas MV, 2010, J MEMBRANE BIOL, V233, P127, DOI 10.1007/s00232-010-9232-y; de Goede P, 2018, J MOL ENDOCRINOL, V60, pR115, DOI 10.1530/JME-17-0196; Dinarelli S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22870-0; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Foster RG, 2005, NAT REV NEUROSCI, V6, P407, DOI 10.1038/nrn1670; Gaikwad SS, 2017, CURR HYPERTENS, DOI [10.1038/nature09702, DOI 10.1038/NATURE09702]; Gamble KL, 2013, CRIT REV BIOCHEM MOL, V48, P317, DOI 10.3109/10409238.2013.786672; Garrote MD, 2017, CURR ATHEROSCLER REP, V19, DOI 10.1007/s11883-017-0653-2; HAUS E, 1983, AM J ANAT, V168, P467, DOI 10.1002/aja.1001680406; Henslee EA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02161-4; HUI SW, 1980, J CELL BIOL, V85, P283, DOI 10.1083/jcb.85.2.283; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Juda M, 2013, J BIOL RHYTHM, V28, P130, DOI 10.1177/0748730412475041; Kantermann T, 2012, PROG BRAIN RES, V199, P399, DOI 10.1016/B978-0-444-59427-3.00022-8; Kendzerska TB, 2014, SLEEP MED REV, V18, P321, DOI 10.1016/j.smrv.2013.08.002; Koter M, 2004, INT J BIOCHEM CELL B, V36, P205, DOI 10.1016/S1357-2725(03)00195-X; Lasselin J, 2015, BRAIN BEHAV IMMUN, V47, P93, DOI 10.1016/j.bbi.2014.10.004; Lemke MK, 2017, IND HEALTH, V55, P149, DOI 10.2486/indhealth.2016-0127; Li N, 2017, ADV METEOROL, V2017, DOI 10.1155/2017/4626585; Lippi G, 2014, CLIN CHEM LAB MED, V52, P1247, DOI 10.1515/cclm-2014-0585; Loprinzi PD, 2015, AM J HEALTH BEHAV, V39, P471, DOI 10.5993/AJHB.39.4.3; Lu LF, 2016, J OCCUP HEALTH, V58, P81, DOI 10.1539/joh.15-0137-OA; MARKS PA, 1958, J CLIN INVEST, V37, P1542, DOI 10.1172/JCI103746; Netto RDM, 2014, PARASITOL RES, V113, P863, DOI 10.1007/s00436-013-3717-4; Mohandas N, 2008, BLOOD, V112, P3939, DOI 10.1182/blood-2008-07-161166; Mota MC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06723-w; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Oishi Katsutaka, 2006, J Circadian Rhythms, V4, P13, DOI 10.1186/1740-3391-4-13; Osuntokl A A, 2007, Nig Q J Hosp Med, V17, P148; Padilha HG, 2010, CHRONOBIOL INT, V27, P1080, DOI 10.3109/07420528.2010.489883; Papantoniou K, 2016, EUR J EPIDEMIOL, V31, P867, DOI 10.1007/s10654-015-0073-y; Paraiso LF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171318; PARK K I, 1987, Yonsei Medical Journal, V28, P282; Parsons MJ, 2015, INT J OBESITY, V39, P842, DOI 10.1038/ijo.2014.201; Penha-Silva N, 2007, MECH AGEING DEV, V128, P444, DOI 10.1016/j.mad.2007.06.007; Pietroiusti A, 2010, OCCUP ENVIRON MED, V67, P54, DOI 10.1136/oem.2009.046797; Pritchett D, 2015, J BIOL RHYTHM, V30, P374, DOI 10.1177/0748730415592729; Puttonen S, 2011, CHRONOBIOL INT, V28, P528, DOI 10.3109/07420528.2011.580869; Reutrakul S, 2013, DIABETES CARE, V36, P2523, DOI 10.2337/dc12-2697; de Freitas MAR, 2018, OBSTET GYNECOL INT, V2018, DOI 10.1155/2018/9628726; Rodrigues R, 2018, DIABETES RES CLIN PR, V144, P153, DOI 10.1016/j.diabres.2018.01.031; Roenneberg T, 2007, COLD SPRING HARB SYM, V72, P293, DOI 10.1101/sqb.2007.72.043; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Salvagno GL, 2015, CRIT REV CL LAB SCI, V52, P86, DOI 10.3109/10408363.2014.992064; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; Schlafer O, 2014, ANAESTHESIST, V63, P844, DOI 10.1007/s00101-014-2374-z; Schulz P, 2009, CNS DRUGS, V23, P3, DOI 10.2165/11318620-000000000-00000; Su C, 2014, J THORAC DIS, V6, P1429, DOI 10.3978/j.issn.2072-1439.2014.09.10; Tai SY, 2014, IND HEALTH, V52, P296, DOI 10.2486/indhealth.2014-0009; Tziakas D, 2012, CLIN HEMORHEOL MICRO, V51, P243, DOI 10.3233/CH-2012-1530; Tziakas DN, 2010, INT J CARDIOL, V142, P2, DOI 10.1016/j.ijcard.2009.10.031; Vetter C, 2015, CURR BIOL, V25, P907, DOI 10.1016/j.cub.2015.01.064; Waterhouse J, 2003, CHRONOBIOL INT, V20, P1075, DOI 10.1081/CBI-120025536; WIDE L, 1989, BRIT J HAEMATOL, V72, P85, DOI 10.1111/j.1365-2141.1989.tb07657.x; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979; Wonnerth A, 2016, EUR J CLIN INVEST, V46, P198, DOI 10.1111/eci.12584; World Health Organization, 2008, WAIST CIRCUMFERENCE	68	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222698	10.1371/journal.pone.0222698	http://dx.doi.org/10.1371/journal.pone.0222698			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545844	Green Published, gold			2022-12-26	WOS:000532303200027
J	McKee, KL; Neale, MC				McKee, Kevin L.; Neale, Michael C.			Direct estimation of the parameters of a delayed, intermittent activation feedback model of postural sway during quiet standing	PLOS ONE			English	Article							ANKLE STIFFNESS; OPEN-LOOP; BALANCE; AGE	Human postural sway during quiet standing has been characterized as a proportional-integral-derivative controller with intermittent activation. In the model, patterns of sway result from both instantaneous, passive, mechanical resistance and delayed, intermittent resistance signaled by the central nervous system. A Kalman-Filter framework was designed to directly estimate from experimental data the parameters of the model's stochastic delay differential equations with discrete dynamic switching conditions. Simulations showed that all parameters could be estimated over a variety of possible data-generating configurations with varying degrees of bias and variance depending on their empirical identification. Applications to experimental data reveal distributions of each parameter that correspond well to previous findings, suggesting that many useful, physiological measures may be extracted from sway data. Individuals varied in degree and type of deviation from theoretical expectations, ranging from harmonic oscillation to non-equilibrium Langevin dynamics.	[McKee, Kevin L.; Neale, Michael C.] Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23284 USA	Virginia Commonwealth University	McKee, KL (corresponding author), Virginia Commonwealth Univ, Virginia Inst Psychiat & Behav Genet, Richmond, VA 23284 USA.	mckeek@vcu.edu		McKee, Kevin/0000-0003-0803-9826	 [NIDA 5 R25 DA026119 10]; NATIONAL INSTITUTE ON DRUG ABUSE [R25DA026119] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	MCN was funded under NIDA 5 R25 DA026119 10 (drugabuse.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aandahl RZ, 2014, GENETICS, V196, P1227, DOI 10.1534/genetics.113.158808; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Asai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006169; Bosek M, 2005, NEUROSCI LETT, V376, P215, DOI 10.1016/j.neulet.2004.11.056; Bosek M, 2004, HUM MOVEMENT SCI, V22, P649, DOI 10.1016/j.humov.2004.02.005; Bottaro A, 2008, HUM MOVEMENT SCI, V27, P473, DOI 10.1016/j.humov.2007.11.005; Casadio M, 2005, GAIT POSTURE, V21, P410, DOI 10.1016/j.gaitpost.2004.05.005; Cenciarini M, 2010, IEEE T BIO-MED ENG, V57, P267, DOI 10.1109/TBME.2009.2031874; COLLINS JJ, 1995, EXP BRAIN RES, V104, P480, DOI 10.1007/BF00231982; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; COLLINS JJ, 1994, PHYS REV LETT, V73, P764, DOI 10.1103/PhysRevLett.73.764; Eddelbuettel D., 2017, PEERJ PREPRINTS, V5, DOI [10.7287/peerj.preprints.3188v1, DOI 10.7287/PEERJ.PREPRINTS.3188V1]; Eddelbuettel D, 2014, COMPUT STAT DATA AN, V71, P1054, DOI 10.1016/j.csda.2013.02.005; Eurich C. W., 1996, Physical Review E (Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics), V54, P6681, DOI 10.1103/PhysRevE.54.6681; Gawthrop PJ, 2007, P I MECH ENG I-J SYS, V221, P1007, DOI 10.1243/09596518JSCE417; Gawthrop P, 2014, BIOL CYBERN, V108, P159, DOI 10.1007/s00422-014-0587-5; Gawthrop P, 2011, BIOL CYBERN, V104, P31, DOI 10.1007/s00422-010-0416-4; Gottschall J, 2009, PHYS LETT A, V373, P811, DOI 10.1016/j.physleta.2008.12.026; HAGEMAN PA, 1995, ARCH PHYS MED REHAB, V76, P961, DOI 10.1016/S0003-9993(95)80075-1; Kalman RE, 1961, J BASIC ENG, V83; Lafond D, 2004, J BIOMECH, V37, P1421, DOI 10.1016/S0021-9290(03)00251-3; Lauk M, 1998, PHYS REV LETT, V80, P413, DOI 10.1103/PhysRevLett.80.413; Li Y, 2012, IEEE T NEUR SYS REH, V20, P738, DOI 10.1109/TNSRE.2012.2199333; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; Loram ID, 2002, J PHYSIOL-LONDON, V545, P1041, DOI 10.1113/jphysiol.2002.025049; Vieira TDM, 2009, J ELECTROMYOGR KINES, V19, pE513, DOI 10.1016/j.jelekin.2008.10.007; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; Michimoto K, 2016, IEEE ENG MED BIO, P37, DOI 10.1109/EMBC.2016.7590634; Milton J, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0212; Milton JG, 2018, PHYS REV E, V98, DOI 10.1103/PhysRevE.98.022223; Mullen KM, 2011, J STAT SOFTW, V40, P1; Nomura T, 2013, MATH BIOSCI, V245, P86, DOI 10.1016/j.mbs.2013.02.002; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Price K. V., 2006, NATURAL COMPUTING; R Core Team, 2018, R LANG ENV STAT COMP; Santos DAD, 2017, PEER J, V5; Tietavainen A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02372-1; Wang HQ, 2018, NEURAL COMPUT, V30, P3072, DOI 10.1162/neco_a_01127; Wei WWS., 2006, TIME SERIES ANAL UNI, V2nd; WOOLLACOTT MH, 1988, EXP BRAIN RES, V72, P593, DOI 10.1007/BF00250604; Yamamoto T, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12329; Zatsiorsky VM, 2000, MOTOR CONTROL, V4, P185, DOI 10.1123/mcj.4.2.185	42	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222664	10.1371/journal.pone.0222664	http://dx.doi.org/10.1371/journal.pone.0222664			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527893	Green Published, Green Submitted, gold			2022-12-26	WOS:000532231400037
J	Nelson, DS; Marano, RL; Joo, Y; Tian, SY; Patel, B; Kaplan, DH; Shlomchik, MJ; Stevenson, K; Bronson, RT; Rollins, BJ				Nelson, David S.; Marano, Ryan L.; Joo, Yechaan; Tian, Sara Y.; Patel, Bhumi; Kaplan, Daniel H.; Shlomchik, Mark J.; Stevenson, Kristen; Bronson, Roderick T.; Rollins, Barrett J.			BRAF V600E and Pten deletion in mice produces a histiocytic disorder with features of Langerhans cell histiocytosis	PLOS ONE			English	Article							ERDHEIM-CHESTER DISEASE; EXPRESSING DENDRITIC CELLS; HIGH PREVALENCE; MUTATIONS; DISTINCT; VEMURAFENIB; MAP2K1; IDENTIFICATION; INACTIVATION; MACROPHAGES	Langerhans cell histiocytosis (LCH) is characterized by the accumulation of Langerin (CD207)-expressing histiocytes. Mutational activation of mitogen-activated protein kinase pathway genes, in particular BRAF, drives most cases. To test whether activated BRAF is sufficient for the development of LCH, we engineered mice to express BRAF V600E under the control of the human Langerin promoter. These mice have shortened survivals, smaller lymphoid organs, absent Leydig cells, and fewer epidermal LCs than controls, but do not accumulate histiocytes. To test whether the absence of histiocyte proliferation could be due to oncogene-induced senescence, we engineered homozygous Pten loss in the same cells that expressed BRAF V600E. Like mice with intact Pten, these mice have shortened survivals, smaller thymi, and absent Leydig cells. However, loss of Pten also leads to the accumulation of CD207(+) histiocytes in spleen, thymus, and some lymph nodes. While many CD207(+) histiocytes in the thymus are CD8(-), reminiscent of LCH cells, the CD207(+) histiocytes in the spleen and lymph nodes are CD8(+). These mice also accumulate large numbers of CD207(-) cells in the lamina propria (LP) of the small intestine. Both the lymphoid and LP phenotypes are likely due to human Langerin promoter-driven BRAF V600E expression in resident CD8(+) dendritic cells in the former and LP dendritic cells in the latter and confirm that Pten loss is required to overcome inhibitory pathways induced by BRAF V600E expression. The complex phenotype of these mice is a consequence of the multiple murine cell types in which the human Langerin promoter is active.	[Nelson, David S.; Marano, Ryan L.; Joo, Yechaan; Tian, Sara Y.; Patel, Bhumi; Rollins, Barrett J.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Kaplan, Daniel H.; Shlomchik, Mark J.] Univ Pittsburgh, Dept Immunol, Sch Med, Pittsburgh, PA USA; [Kaplan, Daniel H.] Univ Pittsburgh, Sch Med, Dept Dermatol, Pittsburgh, PA 15261 USA; [Stevenson, Kristen] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Bronson, Roderick T.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Rollins, Barrett J.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Rollins, Barrett J.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Rollins, BJ (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Rollins, BJ (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.; Rollins, BJ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	barrett_rollins@dfci.harvard.edu		Joo, Yechaan (Eric)/0000-0002-2389-249X	Claudia Adams Barr Program for Innovative Cancer Research; Histiocytosis Association; NATIONAL CANCER INSTITUTE [P30CA006516] Funding Source: NIH RePORTER	Claudia Adams Barr Program for Innovative Cancer Research; Histiocytosis Association; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by funding from the Claudia Adams Barr Program for Innovative Cancer Research and grants from the Histiocytosis Association.; Some slide preparation and staining was performed by the Specialized Histopathology Core Facility of the Dana-Farber/Harvard Cancer Center (P30 CA06516). The authors thank Dr. To-Ha Thai for helpful discussions. The authors also thank the organizers and participants in the Nikolas Symposium on the Histiocytoses for helpful and informative discussions.	AHMED SA, 1985, J IMMUNOL, V134, P204; Allen CE, 2018, NEW ENGL J MED, V379, P856, DOI 10.1056/NEJMra1607548; Allen CE, 2010, J IMMUNOL, V184, P4557, DOI 10.4049/jimmunol.0902336; Antoniou-Tsigkos A., 2019, ADRENAL ANDROGENS; Arceci RJ, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26325; Arceci RJ, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.2907.2907; Badalian-Very G, 2010, BLOOD, V116, P1919, DOI 10.1182/blood-2010-04-279083; BERGH A, 1993, J ENDOCRINOL, V136, P407, DOI 10.1677/joe.0.1360407; Berres ML, 2014, J EXP MED, V211, P669, DOI 10.1084/jem.20130977; Bigley V, 2015, J LEUKOCYTE BIOL, V97, P627, DOI 10.1189/jlb.1HI0714-351R; Brown NA, 2014, BLOOD, V124, P1655, DOI 10.1182/blood-2014-05-577361; Bursch LS, 2007, J EXP MED, V204, P3147, DOI 10.1084/jem.20071966; Chakraborty R, 2014, BLOOD, V124, P3007, DOI 10.1182/blood-2014-05-577825; Chang SY, 2010, IMMUNOL REV, V234, P233, DOI 10.1111/j.0105-2896.2009.00878.x; Chikwava K, 2004, PEDIATR DEVEL PATHOL, V7, P607, DOI 10.1007/s10024-004-3027-z; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Cohen PE, 1996, BIOL REPROD, V55, P310, DOI 10.1095/biolreprod55.2.310; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; De Monte A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00197; DeFalco T, 2015, CELL REP, V12, P1107, DOI 10.1016/j.celrep.2015.07.015; Diamond EL, 2018, JAMA ONCOL, V4, P384, DOI 10.1001/jamaoncol.2017.5029; Diamond EL, 2016, CANCER DISCOV, V6, P154, DOI [10.1158/2159-8290.CD-15-0913, 10.1158/2159-8290.CD-NB2016-001]; Douillard P, 2005, J INVEST DERMATOL, V125, P983, DOI 10.1111/j.0022-202X.2005.23951.x; Emile JF, 2014, BLOOD, V124, P3016, DOI 10.1182/blood-2014-04-570937; Ginhoux F, 2007, J EXP MED, V204, P3133, DOI 10.1084/jem.20071733; Haroche J, 2013, BLOOD, V121, P1495, DOI 10.1182/blood-2012-07-446286; Haroche J, 2012, BLOOD, V120, P2700, DOI 10.1182/blood-2012-05-430140; Heritier S, 2015, BLOOD, V125, P2448, DOI 10.1182/blood-2015-01-625491; Hervier B, 2014, BLOOD, V124, P1119, DOI 10.1182/blood-2013-12-543793; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Kaplan DH, 2007, J EXP MED, V204, P2545, DOI 10.1084/jem.20071401; Kaplan DH, 2005, IMMUNITY, V23, P611, DOI 10.1016/j.immuni.2005.10.008; Kaser A, 2004, J CLIN IMMUNOL, V24, P74, DOI 10.1023/B:JOCI.0000018066.46279.6b; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LENZ A, 1993, J CLIN INVEST, V92, P2587, DOI 10.1172/JCI116873; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mossadegh-Keller N, 2017, J EXP MED, V214, P2829, DOI 10.1084/jem.20170829; Nelson DS, 2015, GENE CHROMOSOME CANC, V54, P361, DOI 10.1002/gcc.22247; Schuster C, 2009, J EXP MED, V206, P169, DOI 10.1084/jem.20081747; Takahara K, 2002, INT IMMUNOL, V14, P433, DOI 10.1093/intimm/14.5.433; Tripp CH, 2004, J INVEST DERMATOL, V122, P670, DOI 10.1111/j.0022-202X.2004.22337.x; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; Vredeveld LCW, 2012, GENE DEV, V26, P1055, DOI 10.1101/gad.187252.112; WEINSTEIN Y, 1981, J IMMUNOL, V126, P998; Weintraub M, 1998, J PEDIAT HEMATOL ONC, V20, P12, DOI 10.1097/00043426-199801000-00002; Welty NE, 2013, J EXP MED, V210, P2011, DOI 10.1084/jem.20130728; Wu JY, 2019, MOL CELL ENDOCRINOL, V479, P159, DOI 10.1016/j.mce.2018.10.008	49	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222400	10.1371/journal.pone.0222400	http://dx.doi.org/10.1371/journal.pone.0222400			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527903	gold, Green Submitted, Green Published			2022-12-26	WOS:000532231400019
J	Djigo, OKM; Bollahi, MA; Ebou, MH; Salem, MSOA; Tahar, R; Bogreau, H; Basco, L; Boukhary, AOMS				Djigo, Oum Kelthoum Mamadou; Bollahi, Mohamed Abdallahi; Ebou, Moina Hasni; Salem, Mohamed Salem Ould Ahmedou; Tahar, Rachida; Bogreau, Herve; Basco, Leonardo; Boukhary, Ali Ould Mohamed Salem			Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania	PLOS ONE			English	Article							DEFICIENCY; HETEROGENEITY; PERFORMANCE; NOUAKCHOTT; PREVALENCE; MUTATIONS; MORBIDITY	Background Primaquine is recommended by the World Health Organization (WHO) for radical treatment of Plasmodium vivax malaria. This drug is known to provoke acute hemolytic anemia in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency. Due to lack of data on G6PD deficiency, the use of primaquine has been limited in Africa. In the present study, G6PD deficiency was investigated in blood donors of various ethnic groups living in Nouakchott, a P. vivaxendemic area in Mauritania. Methodology/Principal findings Venous blood samples from 443 healthy blood donors recruited at the National Transfusion Center in Nouakchott were screened for G6PD activity using the CareStart G6PD deficiency rapid diagnostic test. G6PD allelic variants were investigated using DiaPlexC G6PD genotyping kit that detects African (A-) and Mediterranean (B-) variants. Overall, 50 of 443 (11.3%) individuals (49 [11.8%] men and 1 [3.7%] woman) were phenotypically deficient. Amongst men, Black Africans had the highest prevalence of G6PD deficiency (15 of 100 [15%]) and White Moors the lowest (10 of 168, [5.9%]). The most commonly observed G6PD allelic variants among 44 tested G6PD-deficient men were the African variant K (202A/376G) in 14 (31.8%), the Mediterranean variant B- (563T) in 13 (29.5%), and the Betica-Selma K (376G/968C) allelic variant in 6 (13.6%). The Santamaria K variant (376G/ 542T) and A variant (376G) were observed in only one and two individuals, respectively. None of the expected variants was observed in 8 (18.2%) of the tested phenotypically G6PD-deficient men. Conclusion This is the first published data on G6PD deficiency in Mauritanians. The prevalence of phenotypic G6PD deficiency was relatively high (11.3%). It was mostly associated with either African or Mediterranean variants, in agreement with diverse Arab and Black African origins of the Mauritanian population.	[Djigo, Oum Kelthoum Mamadou; Ebou, Moina Hasni; Salem, Mohamed Salem Ould Ahmedou; Boukhary, Ali Ould Mohamed Salem] Univ Nouakchott Al Aasriya, Fac Sci & Tech, Unite Rech Genomes & Milieux, Nouveau Campus Univ, Nouakchott, Mauritania; [Bollahi, Mohamed Abdallahi] Minist Sante, Ctr Natl Transfus Sanguine, Nouakchott, Mauritania; [Tahar, Rachida] Univ Paris 05, Fac Pharm, IRD, UMR MERIT 216, Paris, France; [Bogreau, Herve] IHU Mediterranee Infect, Inst Rech Biomed Armees, Unite Parasitol & Entomol, Marseille, France; [Bogreau, Herve; Basco, Leonardo; Boukhary, Ali Ould Mohamed Salem] Aix Marseille Univ, AP HM, SSA, IRD,VITROME, Marseille, France; [Bogreau, Herve; Basco, Leonardo] IHU Mediterranee Infect, Marseille, France; [Bogreau, Herve] Inst Hosp Univ IHU Mediterranee Infect, Ctr Natl Reference Paludisme, Marseille, France; [Bollahi, Mohamed Abdallahi] Inst Natl Rech Sante Publ, Nouakchott, Mauritania	University of Nouakchott; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite	Boukhary, AOMS (corresponding author), Univ Nouakchott Al Aasriya, Fac Sci & Tech, Unite Rech Genomes & Milieux, Nouveau Campus Univ, Nouakchott, Mauritania.; Boukhary, AOMS (corresponding author), Aix Marseille Univ, AP HM, SSA, IRD,VITROME, Marseille, France.	alimedsalem@gmail.com	Rachida, Tahar/ABF-1506-2021; b, ali ould mohamed salem/AAM-6842-2021	TAHAR, Rachida/0000-0003-1799-231X	Institut de Recherche pour le Developpement (IRD, France) through JEAI RI3M grant	Institut de Recherche pour le Developpement (IRD, France) through JEAI RI3M grant	This work was published with the support of Institut de Recherche pour le De ' veloppement (IRD, France) through JEAI RI3M grant.	Adu-Gyasi D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125796; [Anonymous], 1989, B WORLD HEALTH ORGAN, V67, P601; [Anonymous], 2017, WHO WORLD MALARIA RE; [Anonymous], 2016, MEDCALC STAT SOFTW V; Ba H, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1118-8; Benmansour I, 2013, BLOOD CELL MOL DIS, V50, P110, DOI 10.1016/j.bcmd.2012.08.005; BEUTLER E, 1966, BLOOD-J HEMATOL, V28, P553, DOI 10.1182/blood.V28.4.553.553; Carter N, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-241; Clark TG, 2009, EUR J HUM GENET, V17, P1080, DOI 10.1038/ejhg.2009.8; De Araujo C, 2006, HAEMATOL-HEMATOL J, V91, P262; Deida J, 2019, EMERG INFECT DIS, V25, P282, DOI 10.3201/eid2502.180732; Dolo A, 2014, Bull Soc Pathol Exot, V107, P165, DOI 10.1007/s13149-014-0372-7; Espino FE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148172; Fernando D, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-351; Gomez-Manzo S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122069; Hamdinou MM, 2017, TROP MED INT HEALTH, V22, P127; Hamed CT, 2012, INT J IMMUNOGENET, V39, P151, DOI 10.1111/j.1744-313X.2011.01064.x; Henriques G, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2390-6; Howes RE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-418; Howes RE, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001339; Jalloh A, 2008, J HUM GENET, V53, P675, DOI 10.1007/s10038-008-0294-y; Kim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028357; Lacerda MVG, 2012, CLIN INFECT DIS, V55, pE67, DOI 10.1093/cid/cis615; Laouini N, 2013, MOL BIOL REP, V40, P851, DOI 10.1007/s11033-012-2124-8; Lekweiry KM, 2011, T ROY SOC TROP MED H, V105, P727, DOI 10.1016/j.trstmh.2011.09.004; Ley B, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0896-8; McNerney R, 2015, DIAGNOSTICS, V5, P200, DOI 10.3390/diagnostics5020200; Minucci A, 2012, BLOOD CELL MOL DIS, V48, P154, DOI 10.1016/j.bcmd.2012.01.001; Monteiro WM, 2017, REV SOC BRAS MED TRO, V50, P282, DOI 10.1590/0037-8682-0003-2017; Brito MAM, 2016, REV SOC BRAS MED TRO, V49, P446, DOI 10.1590/0037-8682-0134-2016; NAFA K, 1994, HUM GENET, V94, P513; Osman N., 2006, HAEMA, V9, P83; Osorio L, 2015, AM J TROP MED HYG, V92, P22, DOI 10.4269/ajtmh.14-0298; Ouattara Abdoul Karim, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P655, DOI 10.12980/APJTB.4.2014APJTB-2014-0100; Roh ME, 2016, AM J TROP MED HYG, V95, P1094, DOI 10.4269/ajtmh.16-0552; Salem MSOA, 2015, ACTA TROP, V152, P1, DOI 10.1016/j.actatropica.2015.08.005; Satyagraha AW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004457; Sirugo G, 2014, AM J TROP MED HYG, V90, P856, DOI 10.4269/ajtmh.13-0622; TAN IK, 1969, CLIN CHEM, V15, P467; United States Food and Drugs Administration, 2018, KRINT TAL SUCC TABL; VANNOORDEN CJF, 1985, BRIT J HAEMATOL, V60, P57, DOI 10.1111/j.1365-2141.1985.tb07385.x; von Fricken ME, 2014, AM J TROP MED HYG, V91, P77, DOI 10.4269/ajtmh.14-0100; Watson J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006440; Wells TNC, 2010, TRENDS PARASITOL, V26, P145, DOI 10.1016/j.pt.2009.12.005; Wurtz N, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-336; Zuniga MA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0823-z	46	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0220977	10.1371/journal.pone.0220977	http://dx.doi.org/10.1371/journal.pone.0220977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525211	gold, Green Published, Green Submitted			2022-12-26	WOS:000532225700009
J	Ko, TY; Sharma, R; Li, SS				Ko, Tengyu; Sharma, Rahul; Li, Shisheng			Genome-wide screening identifies novel genes implicated in cellular sensitivity to BRAF(V600E) expression	ONCOGENE			English	Article							ONCOGENE-INDUCED SENESCENCE; SYRUP-URINE-DISEASE; RECEPTOR SIGNALS; PROTEIN; P53; ACTIVATION; GPR4; BRAF; MECHANISMS; MUTATIONS	The V600E mutation of BRAF (BRAF(V600E)), which constitutively activates the ERK/MAPK signaling pathway, is frequently found in melanoma and other cancers. Like most other oncogenes, BRAF(V600E) causes oncogenic stress to normal cells, leading to growth arrest (senescence) or apoptosis. Through genome-wide screening, we identified genes implicated in sensitivity of human skin melanocytes and fibroblasts to BRAF(V600E) overexpression. Among the identified genes shared by the two cell types are proto-oncogenes ERK2, a component of the ERK/MAPK pathway, and VAV1, a guanine nucleotide exchange factor for Rho family GTPases that also activates the ERK/MAPK pathway. CDKN1A, which has been known to promote senescence of fibroblasts but not melanocytes, is implicated in sensitivity of the fibroblasts but not the melanocytes to BRAF(V600E) overexpression. Disruptions of GPR4, a pH-sensing G-protein coupled receptor, and DBT, a subunit of the branched chain alpha-keto acid dehydrogenase that is required for the second and rate-limiting step of branched amino acid catabolism and implicated in maple syrup urine disease, are the most highly selected in the melanocytes upon BRAF(V600E) overexpression. Disruption of DBT severely attenuates ERK/MAPK signaling, p53 activation, and apoptosis in melanocytes, at least in part due to accumulation of branched chain alpha-keto acids. The expression level of BRAF positively correlates with that of DBT in all cancer types and with that of GPR4 in most cancer types. Overexpression of DBT kills all four melanoma cell lines tested regardless of the presence of BRAF(V600E) mutation. Our findings shed new lights on regulations of oncogenic stress signaling and may be informative for development of novel cancer treatment strategies.	[Ko, Tengyu; Li, Shisheng] Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA; [Sharma, Rahul] Louisiana State Univ, Lab Res Branch, Natl Hansens Dis Program, 3519E Sch Vet Med, Baton Rouge, LA 70803 USA; [Sharma, Rahul] NuProbe Inc, Cambridge, MA 02140 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Li, SS (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Comparat Biomed Sci, Baton Rouge, LA 70803 USA.	shli@lsu.edu			National Science Foundation [MCB-1615550]	National Science Foundation(National Science Foundation (NSF))	We are deeply in debt to Elena Sviderskaya and Philip Goff at Wellcome Trust Functional Genomics Cell Bank for supplying human melanocyte and melanoma cell lines. We also thank Mary Price at the Cell Analysis Core Facility, Louisiana Cancer Research Center for flow cytometry analysis, cell sorting and single cell deposition, and Dr Luan Vu at our department for analysis and graphic preparation of flow cytometry data. This study was supported by the National Science Foundation (MCB-1615550 to SL).	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Bandyopadhyay D, 2000, ANN NY ACAD SCI, V908, P71; Bansal R, 2010, CELL CYCLE, V9, P2782, DOI 10.4161/cc.9.14.12251; Bektas M, 2003, BIOCHEMISTRY-US, V42, P12181, DOI 10.1021/bi035051y; Blackburn PR, 2017, APPL CLIN GENET, V10, P57, DOI 10.2147/TACG.S125962; Brennan DF, 2011, NATURE, V472, P366, DOI 10.1038/nature09860; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Caloca MJ, 2003, EMBO J, V22, P3326, DOI 10.1093/emboj/cdg316; Carpenter K, 2015, NUTR HEALTH SER, P145, DOI 10.1007/978-1-4939-1923-9_12; Castellone RD, 2011, CANCER LETT, V312, P197, DOI 10.1016/j.canlet.2011.08.013; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; CHELLAPPAN S, 1992, P NATL ACAD SCI USA, V89, P4549, DOI 10.1073/pnas.89.10.4549; Childs BG, 2014, EMBO REP, V15, P1139, DOI 10.15252/embr.201439245; Cole JT, 2015, NUTR HEALTH SER, P13, DOI 10.1007/978-1-4939-1923-9_2; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; Dankner M, 2018, ONCOGENE, V37, P3183, DOI 10.1038/s41388-018-0171-x; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Deschenes-Simard X, 2013, GENE DEV, V27, P900, DOI 10.1101/gad.203984.112; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Dong B, 2017, BIOCHEM J, V474, P4065, DOI 10.1042/BCJ20170676; Dong L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020278; Fukuda H, 2016, ACS MED CHEM LETT, V7, P493, DOI 10.1021/acsmedchemlett.6b00014; Galanos P, 2016, NAT CELL BIOL, V18, P777, DOI 10.1038/ncb3378; Georgakilas AG, 2017, TRENDS MOL MED, V23, P310, DOI 10.1016/j.molmed.2017.02.001; Goldman M., 2019, UCSC XENA PLATFORM P; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Gray-Schopfer VC, 2006, BRIT J CANCER, V95, P496, DOI 10.1038/sj.bjc.6603283; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Hernandez B, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020394; Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001; Holecek M, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0271-1; Kakadia S, 2018, ONCOTARGETS THER, V11, P7095, DOI 10.2147/OTT.S182721; Kidger AM, 2016, SEMIN CELL DEV BIOL, V50, P125, DOI 10.1016/j.semcdb.2016.01.009; Kong BY, 2016, MELANOMA MANAG, V3, P33, DOI 10.2217/mmt.15.38; Kotsantis P, 2018, CANCER DISCOV, V8, P537, DOI 10.1158/2159-8290.CD-17-1461; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Labazi M, 2003, ESSAYS BIOCHEM, V39, P89, DOI 10.1042/bse0390089; Lake D, 2016, CELL MOL LIFE SCI, V73, P4397, DOI 10.1007/s00018-016-2297-8; Lee EYHP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003236; Li W, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0843-6; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; McDuff FKE, 2011, CELL SIGNAL, V23, P6, DOI 10.1016/j.cellsig.2010.07.004; Melnikova VO, 2003, ONCOGENE, V22, P5958, DOI 10.1038/sj.onc.1206595; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Palmero I, 1998, NATURE, V395, P125, DOI 10.1038/25870; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Reynolds LF, 2004, J BIOL CHEM, V279, P18239, DOI 10.1074/jbc.M400257200; Sambrook J, 2006, CSH PROTOC, V1, P3871; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Scott MC, 2002, J CELL SCI, V115, P2349; Shamma A, 2009, CANCER CELL, V15, P255, DOI 10.1016/j.ccr.2009.03.001; She QB, 2000, J BIOL CHEM, V275, P20444, DOI 10.1074/jbc.M001020200; Shortt J, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009829; Sin WC, 2004, ONCOGENE, V23, P6299, DOI 10.1038/sj.onc.1207838; SURH CD, 1989, HEPATOLOGY, V9, P63, DOI 10.1002/hep.1840090110; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Tsuruta M, 1998, J HUM GENET, V43, P91, DOI 10.1007/s100380050047; Vredeveld LCW, 2012, GENE DEV, V26, P1055, DOI 10.1101/gad.187252.112; Wellbrock C, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00033; Wilsbacher JL, 2006, CELL COMMUN SIGNAL, V4; Wyder L, 2011, ANGIOGENESIS, V14, P533, DOI 10.1007/s10456-011-9238-9; Xirodimas D, 2001, ONCOGENE, V20, P4972, DOI 10.1038/sj.onc.1204656; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	66	5	6	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	4					723	738		10.1038/s41388-019-1022-0	http://dx.doi.org/10.1038/s41388-019-1022-0			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KF4EJ	31548614				2022-12-26	WOS:000509197200001
J	Sava, GP; Fan, HL; Fisher, RA; Lusvarghi, S; Pancholi, S; Ambudkar, SV; Martin, LA; Coombes, RC; Buluwela, L; Ali, S				Sava, Georgina P.; Fan, Hailing; Fisher, Rosemary A.; Lusvarghi, Sabrina; Pancholi, Sunil; Ambudkar, Suresh, V; Martin, Lesley-Ann; Coombes, R. Charles; Buluwela, Lakjaya; Ali, Simak			ABC-transporter upregulation mediates resistance to the CDK7 inhibitors THZ1 and ICEC0942	ONCOGENE			English	Article							DEPENDENT KINASE INHIBITOR; MESSENGER-RNA EXPRESSION; BREAST-CANCER; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; IN-VITRO; TRANSCRIPTIONAL ADDICTION; LUNG-CANCER; PROTEIN; GLYCOPROTEIN	The CDK7 inhibitors (CDK7i) ICEC0942 and THZ1, are promising new cancer therapeutics. Resistance to targeted drugs frequently compromises cancer treatment. We sought to identify mechanisms by which cancer cells may become resistant to CDK7i. Resistant lines were established through continuous drug selection. ABC-transporter copy number, expression and activity were examined using real-time PCR, immunoblotting and flow cytometry. Drug responses were measured using growth assays. ABCB1 was upregulated in ICEC0942-resistant cells and there was cross-resistance to THZ1. THZ1-resistant cells upregulated ABCG2 but remained sensitive to ICEC0942. Drug resistance in both cell lines was reversible upon inhibition of ABC-transporters. CDK7i response was altered in adriamycin- and mitoxantrone-resistant cell lines demonstrating ABC-transporter upregulation. ABCB1 expression correlated with ICEC0942 and THZ1 response, and ABCG2 expression with THZ2 response, in a panel of cancer cell lines. We have identified ABCB1 upregulation as a common mechanism of resistance to ICEC0942 and THZ1, and confirmed that ABCG2 upregulation is a mechanism of resistance to THZ1. The identification of potential mechanisms of CDK7i resistance and differences in susceptibility of ICEC0942 and THZ1 to ABC-transporters, may help guide their future clinical use.	[Sava, Georgina P.; Fan, Hailing; Fisher, Rosemary A.; Coombes, R. Charles; Buluwela, Lakjaya; Ali, Simak] Imperial Coll London, Dept Surg & Canc, Div Canc, Hammersmith Hosp Campus, London, England; [Lusvarghi, Sabrina; Ambudkar, Suresh, V] NCI, Lab Cell Biol, Ctr Canc Res, Bethesda, MD 20892 USA; [Pancholi, Sunil; Martin, Lesley-Ann] Breast Canc Now Toby Robins Res Ctr, Inst Canc Res, London, England	Imperial College London; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Ali, S (corresponding author), Imperial Coll London, Dept Surg & Canc, Div Canc, Hammersmith Hosp Campus, London, England.	simak.ali@imperial.ac.uk	Ali, Simak/M-6912-2018	Ali, Simak/0000-0002-1320-0816; Pancholi, Sunil/0000-0002-0880-1588; Ambudkar, Suresh/0000-0002-2639-4955; Coombes, Raoul Charles/0000-0002-4811-1100; Fisher, Rosemary/0000-0002-2721-8726; Lusvarghi, Sabrina/0000-0003-1793-0450; Sava, Georgina/0000-0001-5904-3978	Cancer Research UK [C37/A18784]; Breast Cancer Now's Catalyst Programme - Pfizer	Cancer Research UK(Cancer Research UK); Breast Cancer Now's Catalyst Programme - Pfizer	This study was supported by Cancer Research UK grant C37/A18784. HF is funded by Breast Cancer Now's Catalyst Programme, which is supported by funding from Pfizer.	Ali S, 2009, CANCER RES, V69, P6208, DOI 10.1158/0008-5472.CAN-09-0301; Allen JD, 2002, MOL CANCER THER, V1, P417; Amiri-Kordestani L, 2012, DRUG RESIST UPDATE, V15, P50, DOI 10.1016/j.drup.2012.02.002; Bondke A, 2016, US patent, Patent No. [0362410 A1, 0362410]; Bradner JE, 2017, CELL, V168, P629, DOI 10.1016/j.cell.2016.12.013; Bugde P, 2017, EXPERT OPIN THER TAR, V21, P511, DOI 10.1080/14728222.2017.1310841; Chen DS, 2000, MOL CELL, V6, P127, DOI 10.1016/S1097-2765(00)00014-9; Christensen CL, 2014, CANCER CELL, V26, P909, DOI 10.1016/j.ccell.2014.10.019; Christie EL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09312-9; Chymkowitch P, 2011, EMBO J, V30, P468, DOI 10.1038/emboj.2010.337; Clarke R, 2005, SEMIN ONCOL, V32, pS9, DOI 10.1053/j.seminoncol.2005.09.009; CORNWELL MM, 1987, J BIOL CHEM, V262, P2166; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Durbin AD, 2018, NAT GENET, V50, P1240, DOI 10.1038/s41588-018-0191-z; Eliades P, 2018, J INVEST DERMATOL, V138, P1582, DOI 10.1016/j.jid.2017.09.056; Fisher RP, 2005, J CELL SCI, V118, P5171, DOI 10.1242/jcs.02718; Gao Y, 2018, CELL CHEM BIOL, V25, P135, DOI 10.1016/j.chembiol.2017.11.007; Harrod A, 2017, ONCOGENE, V36, P2286, DOI 10.1038/onc.2016.382; Hu SH, 2019, CANCER RES, V79, P3479, DOI 10.1158/0008-5472.CAN-19-0119; Huff LM, 2005, CANCER RES, V65, P11694; Iniguez AB, 2018, CANCER CELL, V33, P202, DOI 10.1016/j.ccell.2017.12.009; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Jeselsohn R, 2018, CANCER CELL, V33, P173, DOI 10.1016/j.ccell.2018.01.004; Jiang YY, 2017, GUT, V66, P1358, DOI 10.1136/gutjnl-2016-311818; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kaliszczak M, 2013, BRIT J CANCER, V109, P2356, DOI 10.1038/bjc.2013.584; Katayama R, 2016, EBIOMEDICINE, V3, P54, DOI 10.1016/j.ebiom.2015.12.009; Kim Yeo-Kyeoung, 2014, Chonnam Med J, V50, P102, DOI 10.4068/cmj.2014.50.3.102; Kim YH, 2009, LUNG CANCER, V65, P105, DOI 10.1016/j.lungcan.2008.10.008; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Larochelle S, 2012, NAT STRUCT MOL BIOL, V19, P1108, DOI 10.1038/nsmb.2399; Lu H, 1997, MOL CELL BIOL, V17, P5923, DOI 10.1128/MCB.17.10.5923; Mansoori B, 2017, ADV PHARM BULL, V7, P339, DOI 10.15171/apb.2017.041; Martin C, 1999, BRIT J PHARMACOL, V128, P403, DOI 10.1038/sj.bjp.0702807; McDermott M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00040; Mistry P, 2001, CANCER RES, V61, P749; NAKAGAWA M, 1992, CANCER RES, V52, P6175; Patch AM, 2015, NATURE, V521, P489, DOI 10.1038/nature14410; Patel H, 2018, MOL CANCER THER, V17, P1156, DOI 10.1158/1535-7163.MCT-16-0847; Pick A, 2010, CHEMMEDCHEM, V5, P1498, DOI 10.1002/cmdc.201000216; Robey RW, 2018, NAT REV CANCER, V18, P452, DOI 10.1038/s41568-018-0005-8; Robinson AN, 2019, DRUG METAB DISPOS, V47, P715, DOI 10.1124/dmd.118.086181; RochetteEgly C, 1997, CELL, V90, P97, DOI 10.1016/S0092-8674(00)80317-7; Roschke AV, 2003, CANCER RES, V63, P8634; Ross DD, 1999, J NATL CANCER I, V91, P429, DOI 10.1093/jnci/91.5.429; Sadik H, 2016, CANCER RES, V76, P4443, DOI 10.1158/0008-5472.CAN-16-0774; Schachter MM, 2013, CELL CYCLE, V12, P3239, DOI 10.4161/cc.26355; Scharenberg CW, 2002, BLOOD, V99, P507, DOI 10.1182/blood.V99.2.507; SHIEKHATTAR R, 1995, NATURE, V374, P283, DOI 10.1038/374283a0; Shiozawa K, 2004, INT J CANCER, V108, P146, DOI 10.1002/ijc.11528; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Skuta C, 2017, NAT METHODS, V14, P758, DOI 10.1038/nmeth.4365; Szafraniec MJ, 2014, DRUG METAB REV, V46, P459, DOI 10.3109/03602532.2014.942037; Turner NC, 2015, NEW ENGL J MED, V373, P209, DOI 10.1056/NEJMoa1505270; UEDA K, 1986, BIOCHEM BIOPH RES CO, V141, P956, DOI 10.1016/S0006-291X(86)80136-X; Uggla B, 2005, LEUKEMIA RES, V29, P141, DOI 10.1016/j.leukres.2004.06.004; Wang YB, 2015, CELL, V163, P174, DOI 10.1016/j.cell.2015.08.063	57	9	10	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2020	39	3					651	663		10.1038/s41388-019-1008-y	http://dx.doi.org/10.1038/s41388-019-1008-y			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	KG1RJ	31530935	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000509718300012
J	Seki, H; Huang, YB; Arakawa, T; Yamada, C; Kinoshita, T; Iwamoto, S; Higuchi, Y; Takegawa, K; Fushinobu, S				Seki, Haruka; Huang, Yibo; Arakawa, Takatoshi; Yamada, Chihaya; Kinoshita, Takashi; Iwamoto, Shogo; Higuchi, Yujiro; Takegawa, Kaoru; Fushinobu, Shinya			Structural basis for the specific cleavage of core-fucosylated N-glycans by endo-?-N-acetylglucosaminidase from the fungus Cordyceps militaris	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoside hydrolase; glycoprotein; X-ray crystallography; monoclonal antibody; N-linked glycosylation; Cordyceps militaris; core-fucosylated N-glycan; endo-?-N-acetylglucosaminidase (ENGase); GH18; substrate-assisted mechanism	CHEMOENZYMATIC SYNTHESIS; CRYSTAL-STRUCTURE; GLYCOSYNTHASE MUTANTS; LINKED GLYCANS; TRANSGLYCOSYLATION ACTIVITY; STREPTOCOCCUS-PYOGENES; SUBSTRATE-SPECIFICITY; ENDOGLYCOSIDASE; IGG; GLYCOPEPTIDES	N-Linked glycans play important roles in various cellular and immunological events. Endo-?-N-acetylglucosaminidase (ENGase) can release or transglycosylate N-glycans and is a promising tool for the chemoenzymatic synthesis of glycoproteins with homogeneously modified glycans. The ability of ENGases to act on core-fucosylated glycans is a key factor determining their therapeutic utility because mammalian N-glycans are frequently ?-1,6-fucosylated. Although the biochemistries and structures of various ENGases have been studied extensively, the structural basis for the recognition of the core fucose and the asparagine-linked GlcNAc is unclear. Herein, we determined the crystal structures of a core fucose-specific ENGase from the caterpillar fungus Cordyceps militaris (Endo-CoM), which belongs to glycoside hydrolase family 18. Structures complexed with fucose-containing ligands were determined at 1.75?2.35 ? resolutions. The fucose moiety linked to GlcNAc is extensively recognized by protein residues in a round-shaped pocket, whereas the asparagine moiety linked to the GlcNAc is exposed to the solvent. The N-glycan?binding cleft of Endo-CoM is Y-shaped, and several lysine and arginine residues are present at its terminal regions. These structural features were consistent with the activity of Endo-CoM on fucose-containing glycans on rituximab (IgG) and its preference for a sialobiantennary substrate. Comparisons with other ENGases provided structural insights into their core fucose tolerance and specificity. In particular, Endo-F3, a known core fucose-specific ENGase, has a similar fucose-binding pocket, but the surrounding residues are not shared with Endo-CoM. Our study provides a foothold for protein engineering to develop enzymatic tools for the preparation of more effective therapeutic antibodies.	[Seki, Haruka; Arakawa, Takatoshi; Yamada, Chihaya; Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Huang, Yibo; Higuchi, Yujiro; Takegawa, Kaoru] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Nishi Ku, Motooka 744, Fukuoka, Fukuoka 8190395, Japan; [Arakawa, Takatoshi; Yamada, Chihaya; Fushinobu, Shinya] Univ Tokyo, Collaborat Res Inst Innovat Microbiol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan; [Kinoshita, Takashi; Iwamoto, Shogo] Fushimi Pharmaceut Co Ltd, Marugame, Kagawa 7638605, Japan	University of Tokyo; Kyushu University; University of Tokyo	Fushinobu, S (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	asfushi@mail.ecc.u-tokyo.ac.jp	Fushinobu, Shinya/E-4987-2011; Arakawa, Takatoshi/K-9739-2013	Fushinobu, Shinya/0000-0003-1346-6435; Arakawa, Takatoshi/0000-0001-6496-5440; Kinoshita, Takashi/0000-0002-3468-002X; Takegawa, Kaoru/0000-0003-3477-7216; Higuchi, Yujiro/0000-0001-7309-291X	Platform Project for Support in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED)	Platform Project for Support in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by the Platform Project for Support in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the Japan Agency for Medical Research and Development (AMED). The authors declare that they have no conflicts of interest with the contents of this article.	Abbott DW, 2009, J BIOL CHEM, V284, P11676, DOI 10.1074/jbc.M809663200; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bieberich E, 2014, GLYCOBIOLOGY NERVOUS, P47, DOI 10.1007/978-1-4939-1154-7_3; Briliute J, 2019, NAT MICROBIOL, V4, P1571, DOI 10.1038/s41564-019-0466-x; Collin M, 2001, EMBO J, V20, P3046, DOI 10.1093/emboj/20.12.3046; Collin M, 2017, METHODS MOL BIOL, V1535, P339, DOI 10.1007/978-1-4939-6673-8_23; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eshima Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132859; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fairbanks AJ, 2017, CHEM SOC REV, V46, P5128, DOI 10.1039/c6cs00897f; Fan SQ, 2012, J BIOL CHEM, V287, P11272, DOI 10.1074/jbc.M112.340497; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geisler C, 2015, METHODS MOL BIOL, V1321, P131, DOI 10.1007/978-1-4939-2760-9_10; Giddens JP, 2016, J BIOL CHEM, V291, P9356, DOI 10.1074/jbc.M116.721597; Goodfellow JJ, 2012, J AM CHEM SOC, V134, P8030, DOI 10.1021/ja301334b; Harbison AM, 2019, GLYCOBIOLOGY, V29, P94, DOI 10.1093/glycob/cwy097; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Holst S, 2015, ADV CANCER RES, V126, P203, DOI 10.1016/bs.acr.2014.11.004; Huang W, 2012, J AM CHEM SOC, V134, P12308, DOI 10.1021/ja3051266; Huang W, 2011, CHEMBIOCHEM, V12, P932, DOI 10.1002/cbic.201000763; Huang YB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17467-y; Itoh T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167310; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh T, 2016, J BIOL CHEM, V291, P23305, DOI 10.1074/jbc.M116.737395; Klontz EH, 2019, ACS CENTRAL SCI, V5, P524, DOI 10.1021/acscentsci.8b00917; Kurogochi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132848; Li L, 2015, CHEM SCI, V6, P5652, DOI 10.1039/c5sc02025e; Li TZ, 2016, J BIOL CHEM, V291, P16508, DOI 10.1074/jbc.M116.738765; Liebschner D, 2016, ACTA CRYSTALLOGR D, V72, P728, DOI 10.1107/S2059798316005349; Lin CW, 2015, P NATL ACAD SCI USA, V112, P10611, DOI 10.1073/pnas.1513456112; Ling ZL, 2009, J MOL BIOL, V389, P1, DOI 10.1016/j.jmb.2009.03.050; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mark BL, 2001, J BIOL CHEM, V276, P10330, DOI 10.1074/jbc.M011067200; Maverakis E, 2015, J AUTOIMMUN, V57, P1, DOI 10.1016/j.jaut.2014.12.002; Mehta A, 2015, ADV CANCER RES, V126, P257, DOI 10.1016/bs.acr.2014.11.005; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Plummer TH, 1996, ANAL BIOCHEM, V235, P98; Pucic M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010090; Rao V, 1999, PROTEIN SCI, V8, P2338; RAO VH, 1995, STRUCTURE, V3, P449, DOI 10.1016/S0969-2126(01)00178-2; Ratnamani MS, 2013, INDIAN J CRIT CARE M, V17, P304, DOI 10.4103/0972-5229.120323; Schiller B, 2012, BIOL CHEM, V393, P661, DOI 10.1515/hsz-2012-0150; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Sjogren J, 2014, FUTURE MICROBIOL, V9, P1039, DOI [10.2217/FMB.14.71, 10.2217/fmb.14.71]; Sjogren J, 2013, BIOCHEM J, V455, P107, DOI 10.1042/BJ20130126; Stals I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040854; Stals I, 2010, FEMS MICROBIOL LETT, V303, P9, DOI 10.1111/j.1574-6968.2009.01849.x; Stanley P, 2015, ESSENTIALS GLYCOBIOL, P99, DOI DOI 10.1101/GLYCOBIOLOGY.3E.009; Takahashi M, 2009, CARBOHYD RES, V344, P1387, DOI 10.1016/j.carres.2009.04.031; Takahashi S, 2016, GLYCOCONJUGATE J, V33, P471, DOI 10.1007/s10719-016-9653-7; TARENTINO AL, 1994, METHOD ENZYMOL, V230, P44; Trastoy B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04300-x; Trastoy B, 2014, P NATL ACAD SCI USA, V111, P6714, DOI 10.1073/pnas.1322908111; TRIMBLE RB, 1991, J BIOL CHEM, V266, P1646; Umekawa M, 2008, J BIOL CHEM, V283, P4469, DOI 10.1074/jbc.M707137200; Umekawa M, 2010, J BIOL CHEM, V285, P511, DOI 10.1074/jbc.M109.059832; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798; VANROEY P, 1994, BIOCHEMISTRY-US, V33, P13989, DOI 10.1021/bi00251a005; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Waddling CA, 2000, BIOCHEMISTRY-US, V39, P7878, DOI 10.1021/bi0001731; Wang LX, 2008, CARBOHYD RES, V343, P1509, DOI 10.1016/j.carres.2008.03.025; Yamamoto K, 2001, J BIOSCI BIOENG, V92, P493, DOI 10.1263/jbb.92.493; Zheng P, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r116	65	8	8	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 8	2019	294	45					17143	17154		10.1074/jbc.RA119.010842	http://dx.doi.org/10.1074/jbc.RA119.010842			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JU6RP	31548313	Green Published, hybrid			2022-12-26	WOS:000501801900053
J	Otieno, MHJ; Ayieko, MA; Niassy, S; Salifu, D; Abdelmutalab, AGA; Fathiya, KM; Subramanian, S; Fiaboe, KKM; Roos, N; Ekesi, S; Tanga, CM				Otieno, Magara H. J.; Ayieko, Monica A.; Niassy, Saliou; Salifu, Daisy; Abdelmutalab, Azrag G. A.; Fathiya, Khamis M.; Subramanian, Sevgan; Fiaboe, Komi K. M.; Roos, Nana; Ekesi, Sunday; Tanga, Chrysantus M.			Integrating temperature-dependent life table data into Insect Life Cycle Model for predicting the potential distribution of Scapsipedus icipe Hugel & Tanga	PLOS ONE			English	Article							CRICKET ACHETA-DOMESTICUS; HOUSE CRICKET; DEVELOPMENT RATES; METABOLIC-RATE; ADULT SIZE; GROWTH; ORTHOPTERA; CLIMATE; PERFORMANCE; DEMOGRAPHY	Scapsipedus icipe Hugel and Tanga (Orthoptera: Gryllidae) is a newly described edible cricket species. Although, there is substantial interest in mass production of S. icipe for human food and animal feed, no information exists on the impact of temperature on their bionomics. Temperature-dependent development, survival, reproductive and life table parameters of S. icipe was generated and integrated into advanced Insect Life Cycle Modeling software to describe relative S. icipe population increase and spatial spread based on nine constant temperature conditions. We examined model predictions and implications for S. icipe potential distribution in Africa under current and future climate. These regions where entomophagy is widely practiced have distinctly different climates. Our results showed that S. icipe eggs were unable to hatch at 10 and 40 degrees C, while emerged nymphs failed to complete development at 15 degrees C. The developmental time of S. icipe was observed to decrease with increased in temperature. The lowest developmental threshold temperatures estimated using linear regressions was 14.3, 12.67 and 19.12 degrees C and the thermal constants for development were 185.2, 1111.1- and 40.7-degree days (DD) for egg, nymph and pre-adult stages, respectively. The highest total fecundity (3416 individuals/female/generation), intrinsic rate of natural increase (0.075 days), net reproductive rate (1330.8 female/female/generation) and shortest doubling time (9.2 days) was recorded at 30 degrees C. The regions predicted to be suitable by the model suggest that S. icipe is tolerant to a wider range of climatic conditions. Our findings provide for the first-time important information on the impact of temperature on the biology, establishment and spread of S. icipe across the Africa continent. The prospect of edible S. icipe production to become a new sector in food and feed industry is discussed.	[Otieno, Magara H. J.; Ayieko, Monica A.] Jaramogi Oginga Odinga Univ Sci & Technol JOOUST, Sch Agr & Food Secur, Bondo, Kenya; [Otieno, Magara H. J.; Niassy, Saliou; Salifu, Daisy; Abdelmutalab, Azrag G. A.; Fathiya, Khamis M.; Subramanian, Sevgan; Ekesi, Sunday; Tanga, Chrysantus M.] Int Ctr Insect Physiol & Ecol Icipe, Nairobi, Kenya; [Fiaboe, Komi K. M.] Int Inst Trop Agr IITA, BP 2008 Messa, Yaounde, Cameroon; [Roos, Nana] Univ Copenhagen, Dept Nutr Exercise & Sports, Rolighedsvej, Frederiksberg C, Denmark	International Centre of Insect Physiology & Ecology (ICIPE); University of Copenhagen	Tanga, CM (corresponding author), Int Ctr Insect Physiol & Ecol Icipe, Nairobi, Kenya.	ctanga@icipe.org	Ekesi, Sunday/P-8944-2019; Azrag, Abdelmutalab G. A./V-2040-2019; , Subramanian/H-8531-2014; Roos, Nanna/D-7671-2015	Azrag, Abdelmutalab G. A./0000-0002-2192-3803; , Subramanian/0000-0003-4447-0744; Roos, Nanna/0000-0002-9733-9523	GREENiNSECT of Danida [BB/J011371/1]; Netherlands Organization for Scientific Research, WOTRO Science for Global Development (NWO-WOTRO) [ILIPA - W 08.250.202]; Federal Ministry for Economic Cooperation and Development (BMZ) [ENTONUTRI - 81194993]; Canadian International Development Research Centre (IDRC) [108866-001]; Australian Centre for International Agricultural Research (ACIAR) [108866-001]; BioInnovate Africa Programme Phase II through SIDA (INSBIZ) through the International Centre of Insect Physiology and Ecology (icipe) [51050076]; UK Aid from the Government of the United Kingdom; Swedish International Development Cooperation Agency (Sida); Swiss Agency for Development and Cooperation (SDC); Federal Ministry for Economic Cooperation and Development (BMZ), Germany; Kenyan Government	GREENiNSECT of Danida; Netherlands Organization for Scientific Research, WOTRO Science for Global Development (NWO-WOTRO); Federal Ministry for Economic Cooperation and Development (BMZ); Canadian International Development Research Centre (IDRC); Australian Centre for International Agricultural Research (ACIAR)(Australian Ctr Intl Agr Res); BioInnovate Africa Programme Phase II through SIDA (INSBIZ) through the International Centre of Insect Physiology and Ecology (icipe); UK Aid from the Government of the United Kingdom; Swedish International Development Cooperation Agency (Sida); Swiss Agency for Development and Cooperation (SDC); Federal Ministry for Economic Cooperation and Development (BMZ), Germany; Kenyan Government	The authors sincerely acknowledge the financial aid by the following organizations and agencies: the GREENiNSECT of Danida (Grant No: BB/J011371/1), the Netherlands Organization for Scientific Research, WOTRO Science for Global Development (NWO-WOTRO) (ILIPA - W 08.250.202), Federal Ministry for Economic Cooperation and Development (BMZ) (ENTONUTRI - 81194993), the Canadian International Development Research Centre (IDRC) and the Australian Centre for International Agricultural Research (ACIAR) (INSFEED - Phase 2: Cultivate Grant No: 108866-001), and BioInnovate Africa Programme Phase II through SIDA (INSBIZ Contribution ID No. 51050076) through the International Centre of Insect Physiology and Ecology (icipe). We also gratefully acknowledge the icipe core funding provided by UK Aid from the Government of the United Kingdom; Swedish International Development Cooperation Agency (Sida); the Swiss Agency for Development and Cooperation (SDC); Federal Ministry for Economic Cooperation and Development (BMZ), Germany, and the Kenyan Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo SA, 2011, J EXP BIOL, V214, P1997, DOI 10.1242/jeb.056531; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allahyari H., 2005, THESIS PONTIFICIA U; Ayieko MA, 2016, J INSECTS FOOD FEED, V2, P203, DOI 10.3920/JIFF2015.0080; Azrag AGA, 2017, J THERM BIOL, V70, P27, DOI 10.1016/j.jtherbio.2017.10.009; BATE J, 1971, PEDOBIOLOGIA, V11, P159; Battisi DS, 2009, J SCI, V323, P240, DOI [10.1126/science.1164363, DOI 10.1126/SCIENCE.1164363]; BERRIGAN D, 1991, OIKOS, V60, P313, DOI 10.2307/3545073; Bonnar JD, 2010, GAMMA FUNCTION; Booth DT, 2007, J INSECT PHYSIOL, V53, P950, DOI 10.1016/j.jinsphys.2007.03.009; Bowling CC, 1955, THESIS; Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22; CAMPBELL A, 1974, J APPL ECOL, V11, P431, DOI 10.2307/2402197; Chemura A, 2018, J INSECTS FOOD FEED, V4, P229, DOI 10.3920/JIFF2017.0074; Chi H, 2003, ENVIRON ENTOMOL, V32, P327, DOI 10.1603/0046-225X-32.2.327; CLIFFORD CW, 1990, J APPL ENTOMOL, V109, P1, DOI 10.1111/j.1439-0418.1990.tb00012.x; CURRY GL, 1978, THEOR POPUL BIOL, V13, P197, DOI 10.1016/0040-5809(78)90042-4; DESTEPHANO DB, 1982, ANN ENTOMOL SOC AM, V75, P111, DOI 10.1093/aesa/75.2.111; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; FAO, 2013, ED INS FUT PROSP FEE; FORREST TG, 1987, OECOLOGIA, V73, P178, DOI 10.1007/BF00377505; Frei A, 2003, J ECON ENTOMOL, V96, P1577, DOI 10.1603/0022-0493-96.5.1577; GHOURI A. S. K., 1958, CANADIAN ENT, V90, P158; GHOURI J, 2012, J INSECT PHYSL, V58, P634, DOI [10.1016/j.jinsphys.2012.01.010, DOI 10.1016/J.JINSPHYS.2012.01.010]; GOODMAN D, 1982, AM NAT, V119, P803, DOI 10.1086/283956; Govindasamy B, 2003, CLIM DYNAM, V21, P391, DOI 10.1007/s00382-003-0340-6; Haghani M, 2007, J PEST SCI, V80, P71, DOI 10.1007/s10340-006-0154-5; Halloran A., 2018, EDIBLE INSECTS SUSTA, DOI [DOI 10.1007/978-3-319-74011-9, DOI 10.1038/NCLIMATE2925]; Hassall C, 2007, GLOBAL CHANGE BIOL, V13, P83; HASSALL J., 2013, FOR RES PAP, V74, P345; HASSALL JD, 2018, J INSECT PHYSL, V107, P89, DOI [10.1016/j.jinsphys.2018.02.010, DOI 10.1016/J.JINSPHYS.2018.02.010]; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HILBERT DW, 1983, ENVIRON ENTOMOL, V12, P1, DOI 10.1093/ee/12.1.1; Homann AM, 2017, J INSECTS FOOD FEED, V3, P95, DOI 10.3920/JIFF2016.0054; HOWE RW, 1967, ANNU REV ENTOMOL, V12, P15, DOI 10.1146/annurev.en.12.010167.000311; Kaspi R, 2002, PHYSIOL ENTOMOL, V27, P29, DOI 10.1046/j.1365-3032.2001.00264.x; KASULE FK, 1991, HEREDITY, V66, P281, DOI 10.1038/hdy.1991.35; Kelemu S, 2015, J INSECTS FOOD FEED, V1, P103, DOI 10.3920/JIFF2014.0016; Khadioli N, 2014, B ENTOMOL RES, V104, P809, DOI 10.1017/S0007485314000601; Khaliq A., 2014, Journal of Entomology and Zoology Studies, V2, P1; KRAUS WF, 1989, J INSECT BEHAV, V2, P623, DOI 10.1007/BF01065783; KRUSE KC, 1990, BEHAV ECOL SOCIOBIOL, V26, P281; Lachenicht MW, 2010, J INSECT PHYSIOL, V56, P822, DOI 10.1016/j.jinsphys.2010.02.010; LOGAN JA, 1976, ENVIRON ENTOMOL, V5, P1133, DOI 10.1093/ee/5.6.1133; Logan JA, 2003, FRONT ECOL ENVIRON, V1, P130, DOI 10.2307/3867985; Ma L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173065; Magara HJO, 2019, J ECON ENTOMOL, V112, P653, DOI 10.1093/jee/toy397; Malaisse F., 1997, FOOD SUPPLY AFRICAN, P384; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; MASAKI S, 1987, EVOL BIOL, V21, P349; Melissa K., 2014, BREEDING RAISING HOU, P1; MERKEL G, 1977, OECOLOGIA, V30, P129, DOI 10.1007/BF00345416; Mirth CK, 2007, BIOESSAYS, V29, P344, DOI 10.1002/bies.20552; Nespolo RF, 2003, J EXP BIOL, V206, P4309, DOI 10.1242/jeb.00687; Nijhout HF, 2014, WIRES DEV BIOL, V3, P113, DOI 10.1002/wdev.124; Nyaga P., 2007, GOOD BIOSECURITY PRA, P157; Obopile M, 2013, FOOD SECUR, V5, P817, DOI 10.1007/s12571-013-0310-8; Orinda Mary Akinyi, 2017, Journal of Entomology and Zoology Studies, V5, P1138; Pascucci S., 2015, AGR FOOD ECON, V3, P3, DOI [10.1186/s40100-014-0025-y, DOI 10.1186/S40100-014-0025-Y]; PATTON RL, 1978, ANN ENTOMOL SOC AM, V71, P40, DOI 10.1093/aesa/71.1.40; PECKARSKY BL, 1993, ECOLOGY, V74, P1836, DOI 10.2307/1939941; R Core Team, 2020, R LANG ENV STAT COMP; Ramirez-Villegas J, 2010, 1 CIAT; Ramos-Elorduy Julieta, 2005, P263; Reiss M.J., 1991, ALLOMETRY GROWTH REP; RENUCCI M, 1983, EXPERIENTIA, V39, P618, DOI 10.1007/BF01971127; ROE RM, 1980, J INSECT PHYSIOL, V26, P639, DOI 10.1016/0022-1910(80)90034-7; Roulon-Doko P., 1998, CHASSE CUEILLETTE CU; Roy M, 2002, ENVIRON ENTOMOL, V31, P177, DOI 10.1603/0046-225X-31.1.177; SHARPE PJH, 1977, J THEOR BIOL, V64, P649, DOI 10.1016/0022-5193(77)90265-X; Silow CA, 1976, STUDIES ETHNO ENTOMO, VII, P223; Soh BSB, 2018, J ECOL EVOL, P1, DOI [10.1002/ee3.4639, DOI 10.1002/EE3.4639]; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sporleder M, 2004, ENVIRON ENTOMOL, V33, P477, DOI 10.1603/0046-225X-33.3.477; Sporleder M., 2013, ILCYM INSECT LIFE CY, P193; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; STINNER RE, 1974, CAN ENTOMOL, V106, P519, DOI 10.4039/Ent106519-5; Sugano Yoshikazu C., 2008, Journal of Orthoptera Research, V17, P243, DOI 10.1665/1082-6467-17.2.243; Takeda J., 1990, African Study Monographs, V11, P1; Tanga C.M, 2018, PLOS ONE, V13; Tanga CM, 2018, ZOOTAXA, V4486, P383, DOI 10.11646/zootaxa.4486.3.9; Terblanche JS, 2007, PHYSIOL ENTOMOL, V32, P175, DOI 10.1111/j.1365-3032.2006.00549.x; van Huis A., 2003, Insect Science and its Application, V23, P163; Van Huis A, 2010, PLOS ONE, V5; van Huis A, 2013, ANNU REV ENTOMOL, V58, P563, DOI 10.1146/annurev-ento-120811-153704; Vargas RI, 2000, ANN ENTOMOL SOC AM, V93, P75, DOI 10.1603/0013-8746(2000)093[0075:CDOTHF]2.0.CO;2; WAGNER TL, 1984, ANN ENTOMOL SOC AM, V77, P208, DOI 10.1093/aesa/77.2.208; WAGNER TL, 1991, J AGR ENTOMOL, V8, P251; Wang R.S., 1982, ACTA ECOLOGICA SINIC, V2, P47; WINERITER SA, 1988, ENTOMOL NEWS, V99, P53; WORNER SP, 1992, ENVIRON ENTOMOL, V21, P689, DOI 10.1093/ee/21.4.689; XUE RD, 1994, ENVIRON ENTOMOL, V23, P1480, DOI 10.1093/ee/23.6.1480; YANG PJ, 1994, ENVIRON ENTOMOL, V23, P971, DOI 10.1093/ee/23.4.971	93	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222941	10.1371/journal.pone.0222941	http://dx.doi.org/10.1371/journal.pone.0222941			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553778	Green Published, gold			2022-12-26	WOS:000532319200047
J	Zhen, XX; Xu, F; Zhang, WZ; Li, N; Li, X				Zhen, Xiaoxi; Xu, Fan; Zhang, Wenzhong; Li, Nan; Li, Xin			Overexpression of rice gene OsATG8b confers tolerance to nitrogen starvation and increases yield and nitrogen use efficiency (NUE) in Arabidopsis	PLOS ONE			English	Article							AUTOPHAGY; SENESCENCE; PROTEIN; ATG8; IDENTIFICATION; REMOBILIZATION; CHLOROPLASTS; ASSIMILATION; DEFICIENCY; EXPRESSION	Nitrogen (N) is an important element required for plant growth and development, which also affects plant yield and quality. Autophagy, a conserved pathway in eukaryotes, degrades and recycles cellular components, thus playing an important role in N remobilization. However, only a few autophagy genes related to N remobilization in rice (Oryza sativa) have been reported. Here, we identified a core autophagy gene in rice, OsATG8b, with increased expression levels under N starvation conditions. It was investigated the function of OsATG8b by generating three independent homozygous 35S-OsATG8b transgenic Arabidopsis thaliana lines. The overexpression of OsATG8b significantly enhanced autophagic flux in the transgenic Arabidopsis plants. It was also showed that over-expressing OsATG8b promoted growth and development of Arabidopsis, in which the rosette leaves were larger than those of the wild type (WT), and the yield increased significantly by 25.25%. In addition, the transgenic lines accumulated more N in seeds than in the rosette leaves. Further examination revealed that overexpression of OsATG8b could effectively alleviate the growth inhibition of transgenic Arabidopsis under nitrogen (N) stress. N partitioning studies revealed that nitrogen-harvest index (NHI) and nitrogen use efficiency (NUE) were significantly increased in the transgenic Arabidopsis, as well as the N-15-tracer experiments revealing that the remobilization of N to seeds in the OsATG8b-overexpressing transgenic Arabidopsis was high and more than WT. Based on our findings, we consider OsATG8b to be a great candidate gene to increase NUE and yield, especially under suboptimal field conditions.	[Zhen, Xiaoxi; Xu, Fan; Zhang, Wenzhong; Li, Xin] Shenyang Agr Univ, Key Lab Northern Japon Rice Genet & Breeding, Rice Res Inst,Key Lab Northeast Rice Biol & Genet, Minist Educ & Liaoning Prov,Minist Agr, Shenyang, Liaoning, Peoples R China; [Li, Nan] Shen Yang Prod Qual Supervis & Inspect Inst, Shenyang, Liaoning, Peoples R China	Ministry of Agriculture & Rural Affairs; Shenyang Agricultural University	Xu, F; Zhang, WZ (corresponding author), Shenyang Agr Univ, Key Lab Northern Japon Rice Genet & Breeding, Rice Res Inst,Key Lab Northeast Rice Biol & Genet, Minist Educ & Liaoning Prov,Minist Agr, Shenyang, Liaoning, Peoples R China.	celiafanfan@syau.edu.cn; zwzhong1@syau.edu.cn			National Natural Science Foundation of China [31401298]; National Key Research and Development Program of China [2018YFD0200200]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This research was funded by the National Natural Science Foundation of China (grant number 31401298) and the National Key Research and Development Program of China (grant number 2018YFD0200200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Avila-Ospina L, 2014, J EXP BOT, V65, P3799, DOI 10.1093/jxb/eru039; Avin-Wittenberg T, 2012, PROTOPLASMA, V249, P285, DOI 10.1007/s00709-011-0296-z; Barros JAS, 2017, PLANT PHYSIOL, V175, P62, DOI 10.1104/pp.16.01576; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chardon F, 2012, J EXP BOT, V63, P3401, DOI 10.1093/jxb/err353; Chen QW, 2019, PLANT CELL PHYSIOL, V60, P343, DOI 10.1093/pcp/pcy214; Chung T, 2009, PLANT PHYSIOL, V149, P220, DOI 10.1104/pp.108.126714; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Contento AL, 2005, PLANT J, V42, P598, DOI 10.1111/j.1365-313X.2005.02396.x; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Ferrario-Mery S, 1998, PLANT PHYSIOL, V117, P293, DOI 10.1104/pp.117.1.293; Guiboileau A, 2012, NEW PHYTOL, V194, P732, DOI 10.1111/j.1469-8137.2012.04084.x; Hafren A, 2017, P NATL ACAD SCI USA, V114, pE2026, DOI 10.1073/pnas.1610687114; Have M, 2018, J EXP BOT, V69, P1369, DOI 10.1093/jxb/erx482; Inoue Y, 2006, PLANT CELL PHYSIOL, V47, P1641, DOI 10.1093/pcp/pcl031; Ishida H, 2008, PLANT PHYSIOL, V148, P142, DOI 10.1104/pp.108.122770; Kellner R, 2017, TRENDS PLANT SCI, V22, P204, DOI 10.1016/j.tplants.2016.11.015; Klionsky DJ, 2014, NAT STRUCT MOL BIOL, V21, P336, DOI 10.1038/nsmb.2787; Kraiser T, 2011, J EXP BOT, V62, P1455, DOI 10.1093/jxb/erq425; Krapp A, 2015, CURR OPIN PLANT BIOL, V25, P115, DOI 10.1016/j.pbi.2015.05.010; Li FQ, 2015, PLANT CELL, V27, P1389, DOI 10.1105/tpc.15.00158; Li WW, 2015, BIOCHEM BIOPH RES CO, V468, P800, DOI 10.1016/j.bbrc.2015.11.035; Li WW, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3113-4; Liu D, 2010, J EXP BOT, V61, P1655, DOI 10.1093/jxb/erq033; Liu YM, 2012, ANNU REV PLANT BIOL, V63, P215, DOI 10.1146/annurev-arplant-042811-105441; MAKINO A, 1991, PLANT PHYSIOL, V96, P355, DOI 10.1104/pp.96.2.355; Marshall RS, 2018, ANNU REV PLANT BIOL, V69, P173, DOI 10.1146/annurev-arplant-042817-040606; Masclaux-Daubresse C, 2017, CURR OPIN PLANT BIOL, V39, P8, DOI 10.1016/j.pbi.2017.05.001; Masclaux-Daubresse C, 2011, J EXP BOT, V62, P2131, DOI 10.1093/jxb/erq405; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; Moriyasu Y, 1996, PLANT PHYSIOL, V111, P1233, DOI 10.1104/pp.111.4.1233; Patrick JW, 2001, J EXP BOT, V52, P551, DOI 10.1093/jexbot/52.356.551; Ren CX, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00301; Roberts IN, 2012, PHYSIOL PLANTARUM, V145, P130, DOI 10.1111/j.1399-3054.2012.01574.x; Rose TL, 2006, BIOL CELL, V98, P53, DOI 10.1042/BC20040516; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Slavikova S, 2008, J EXP BOT, V59, P4029, DOI 10.1093/jxb/ern244; Su W, 2006, MOL BIOL REP, V33, P273, DOI 10.1007/s11033-006-9011-0; Sun X, 2018, PLANT CELL ENVIRON, V41, P469, DOI 10.1111/pce.13110; Svenning S, 2011, AUTOPHAGY, V7, P993, DOI 10.4161/auto.7.9.16389; Thomas H, 2013, NEW PHYTOL, V197, P696, DOI 10.1111/nph.12047; Thompson AR, 2005, PLANT PHYSIOL, V138, P2097, DOI 10.1104/pp.105.060673; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Wada S, 2015, PLANT PHYSIOL, V168, P60, DOI 10.1104/pp.15.00242; Wang P, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00720; Wang Y, 2013, PLANT CELL, V25, P1383, DOI 10.1105/tpc.112.108993; Xia KF, 2011, DNA RES, V18, P363, DOI 10.1093/dnares/dsr024; Xia TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037217; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Xu F, 2011, PLANT PHYSIOL, V157, P2131, DOI 10.1104/pp.111.182899; Yang XC, 2015, INT REV CEL MOL BIO, V320, P1, DOI 10.1016/bs.ircmb.2015.07.005; Yao ZY, 2015, AUTOPHAGY, V11, P2288, DOI 10.1080/15548627.2015.1107692; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395; Yoshimoto K, 2009, PLANT CELL, V21, P2914, DOI 10.1105/tpc.109.068635; Zhu T, 2018, PLANT BIOTECHNOL J, V16, P2063, DOI 10.1111/pbi.12939	57	16	17	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0223011	10.1371/journal.pone.0223011	http://dx.doi.org/10.1371/journal.pone.0223011			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JY8QP	31553788	Green Published, gold			2022-12-26	WOS:000504673300001
J	Dworzanski, J; Drop, B; Kliszczewska, E; Strycharz-Dudziak, M; Polz-Dacewicz, M				Dworzanski, Jakub; Drop, Bartlomiej; Kliszczewska, Ewa; Strycharz-Dudziak, Malgorzata; Polz-Dacewicz, Malgorzata			Prevalence of Epstein-Barr virus, human papillomavirus, cytomegalovirus and herpes simplex virus type 1 in patients with diabetes mellitus type 2 in south-eastern Poland	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; VIROME; CANCER; HEALTH; EBV; HPV	A microbiota is a complex ecosystem of microorganisms consisting of bacteria, viruses, protozoa, and fungi living in different niches of the human body, which plays an essential role in many metabolic functions. Modifications in the microbiota composition can lead to several diseases, including metabolic disorders. The aim of this study was to analyze the prevalence of four viruses which can cause persistent infections-Epstein-Barr virus (EBV), human papillomavirus (HPV), cytomegalovirus (CMV), and herpes simplex virus type 1 (HSV-1) in patients with diabetes mellitus type 2 (DM2). Blood, saliva and oral swabs were collected from all the study participants. The nested-PCR technique was used to detect the viral DNA. DNA of at least one virus was detected in 71.1% of diabetic patients and in 30% of individuals without diabetes. In patients with diabetes EBV DNA was detected the most frequently (25.4%), followed by HPV- 19.1%, HSV- 10.4% and CMV- 5.2%. A higher percentage of EBV+HPV co-infection was found among men (30.8%). EBV DNA was statistically more often detected in patients living in rural areas (53.7%), while HPV (91.5%) and EBV+HPV co-infection (22.2%) prevailed among patients from urban areas. In patients with a DM2 history longer than 10 years viral infection was detected more frequently. The prevalence of EBV, HPV and the EBV+HPV co-infection was significantly higher in diabetic patients than in individuals without diabetes. The frequency of these infections depended on the duration of the disease (DM2).	[Dworzanski, Jakub] Masovian Specialist Hosp, Radom, Poland; [Drop, Bartlomiej] Med Univ Lublin, Dept Informat Technol & Med Stat, Lublin, Poland; [Kliszczewska, Ewa; Polz-Dacewicz, Malgorzata] Med Univ Lublin, Dept Virol, Lublin, Poland; [Strycharz-Dudziak, Malgorzata] Med Univ Lublin, Chair & Dept Conservat Dent Endodont, Lublin, Poland	Medical University of Lublin; Medical University of Lublin; Medical University of Lublin	Strycharz-Dudziak, M (corresponding author), Med Univ Lublin, Chair & Dept Conservat Dent Endodont, Lublin, Poland.	malgorzata.strycharz-dudziak@umlub.pl	Drop, Bartlomiej/AAB-4532-2021; Polz-Dacewicz, Malgorzata Anna/ABI-3021-2020	Drop, Bartlomiej/0000-0001-7044-3657; Polz-Dacewicz, Malgorzata Anna/0000-0002-3222-184X; Strycharz-Dudziak, Malgorzata/0000-0003-0560-7322; Stepien, Ewa/0000-0002-9024-8602	Medical University of Lublin, Lublin, Poland [DS 233]	Medical University of Lublin, Lublin, Poland	This work was supported by the Research Grant from the Medical University of Lublin, Lublin, Poland, grant number DS 233.	Alibek K, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-7; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Boppana SB, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P795; Cadwell K, 2015, IMMUNITY, V42, P805, DOI 10.1016/j.immuni.2015.05.003; Carding SR, 2017, ALIMENT PHARM THER, V46, P800, DOI 10.1111/apt.14280; Casqueiro Juliana, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS27, DOI 10.4103/2230-8210.94253; de Jong RGPJ, 2018, CANCER EPIDEMIOL, V54, P104, DOI 10.1016/j.canep.2018.04.008; Drop B, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122752; Garbuglia A. R., 2014, Cancers, V6, P1705, DOI 10.3390/cancers6031705; Garg SK, 2014, DIABETES OBES METAB, V16, P97, DOI 10.1111/dom.12124; Gillison ML, 2014, INT J CANCER, V134, P497, DOI 10.1002/ijc.28201; Giovannucci E, 2010, DIABETES CARE, V33, P1674, DOI 10.2337/dc10-0666; Glasner ME, 2017, SCIENCE, V355, P577, DOI 10.1126/science.aam7446; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Han MZ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03150; Handley SA, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0287-y; Houghton D, 2018, DIABETOLOGIA, V61, P1700, DOI 10.1007/s00125-018-4632-0; Howley P.M., 2013, FIELDS VIROLOGY, P1802; International Agency for Research on Cancer, 2012, IARC MON EV CARC RIS, V100E; Jalouli J, 2012, ANTICANCER RES, V32, P571; Karjala Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019092; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lontchi-Yimagou E, 2018, J DIABETES, V10, P866, DOI 10.1111/1753-0407.12777; Looker KJ, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0114989, 10.1371/journal.pone.0140765]; Masur K, 2011, BRIT J CANCER, V104, P345, DOI 10.1038/sj.bjc.6606050; Needell JC, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0781-z; Nikolich-Zugich J, 2017, CURR OPIN IMMUNOL, V48, P23, DOI 10.1016/j.coi.2017.07.011; Ogilvie LA, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00918; Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024; Oikonomou E, 2018, HEART FAIL REV, V23, P389, DOI 10.1007/s10741-018-9682-3; Organization WH, 2016, GLOB REP DIAB, DOI [10.2337/db15-0956, DOI 10.2337/DB15-0956]; Parker Michael T., 2016, Yale Journal of Biology and Medicine, V89, P339; Pascale A, 2018, ENDOCRINE, V61, P357, DOI 10.1007/s12020-018-1605-5; Perera RAPM, 2010, ARCH ORAL BIOL, V55, P639, DOI 10.1016/j.archoralbio.2010.06.009; Polz-Dacewicz M, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0093-6; Polz-Gruszka D, 2015, ANTICANCER RES, V35, P1657; Syrjanen K J, 1983, Proc Finn Dent Soc, V79, P1; Tsao SW, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0270; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Youn Jong-Chan, 2018, Clin Hypertens, V24, P5, DOI 10.1186/s40885-018-0090-8; Yu JH, 2019, AGING MENT HEALTH, V23, P706, DOI 10.1080/13607863.2018.1450841; Zhang J, 2015, MED SCI MONITOR, V21, P4102, DOI 10.12659/MSM.896071; Zuwala-Jagiello J, 2017, IN VIVO, V31, P1027, DOI 10.21873/invivo.11165	44	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222607	10.1371/journal.pone.0222607	http://dx.doi.org/10.1371/journal.pone.0222607			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550259	Green Published, gold			2022-12-26	WOS:000532307700018
J	Aso, T; Urayama, S; Fukuyama, H; Murai, T				Aso, Toshihiko; Urayama, Shinnichi; Fukuyama, Hidenao; Murai, Toshiya			Axial variation of deoxyhemoglobin density as a source of the low-frequency time lag structure in blood oxygenation level-dependent signals	PLOS ONE			English	Article							RESTING-STATE FMRI; INDEPENDENT COMPONENT ANALYSIS; DIFFUSE OPTICAL TOMOGRAPHY; FUNCTIONAL MRI; CEREBRAL HEMODYNAMICS; GLOBAL SIGNAL; FLOW VELOCITY; BOLD SIGNAL; OSCILLATIONS; PERFUSION	Perfusion-related information is reportedly embedded in the low-frequency component of a blood oxygen level-dependent (BOLD) functional magnetic resonance imaging (fMRI) signal. The blood-propagation pattern through the cerebral vascular tree is detected as an interregional lag variation of spontaneous low-frequency oscillations (sLFOs). Mapping of this lag, or phase, has been implicitly treated as a projection of the vascular tree structure onto real space. While accumulating evidence supports the biological significance of this signal component, the physiological basis of the "perfusion lag structure," a requirement for an integrative resting-state fMRI-signal model, is lacking. In this study, we conducted analyses furthering the hypothesis that the sLFO is not only largely of systemic origin, but also essentially intrinsic to blood, and hence behaves as a virtual tracer. By summing the small fluctuations of instantaneous phase differences between adjacent vascular regions, a velocity response to respiratory challenges was detected. Regarding the relationship to neurovascular coupling, the removal of the whole lag structure, which can be considered as an optimized global-signal regression, resulted in a reduction of inter-individual variance while preserving the fMRI response. Examination of the T2* and S0, or non-BOLD, components of the fMRI signal revealed that the lag structure is deoxyhemoglobin dependent, while paradoxically presenting a signal-magnitude reduction in the venous side of the cerebral vasculature. These findings provide insight into the origin of BOLD sLFOs, suggesting that they are highly intrinsic to the circulating blood.	[Aso, Toshihiko; Murai, Toshiya] Kyoto Univ, Grad Sch Med, Dept Psychiat, Kyoto, Japan; [Aso, Toshihiko] RIKEN, Ctr Biosyst Dynam Res, Lab Brain Connect Imaging, Kobe, Hyogo, Japan; [Aso, Toshihiko; Urayama, Shinnichi; Fukuyama, Hidenao] Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto, Japan; [Urayama, Shinnichi; Fukuyama, Hidenao] Kyoto Univ, Ctr Promot Interdisciplinary Educ & Res, Res & Educ Unit Leaders Integrated Med Syst, Kyoto, Japan	Kyoto University; RIKEN; Kyoto University; Kyoto University	Aso, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Psychiat, Kyoto, Japan.; Aso, T (corresponding author), RIKEN, Ctr Biosyst Dynam Res, Lab Brain Connect Imaging, Kobe, Hyogo, Japan.; Aso, T (corresponding author), Kyoto Univ, Grad Sch Med, Human Brain Res Ctr, Kyoto, Japan.	aso.toshihiko@gmail.com	Aso, Toshihiko/C-2798-2018	Aso, Toshihiko/0000-0003-4814-089X	Japan Society for the Promotion of Science [JP15H05875, JP16H06395, JP16H06397]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (Non-linear Neuro-oscillology: Towards Integrative Understanding of Human Nature, JP15H05875) to TA and JP16H06395 and JP16H06397 to TM from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1998, NEUROIMAGE, V8, P302, DOI 10.1006/nimg.1998.0367; Amemiya S, 2016, NEUROIMAGE, V133, P331, DOI 10.1016/j.neuroimage.2016.03.033; Amemiya S, 2014, RADIOLOGY, V270, P548, DOI 10.1148/radiol.13130982; An HY, 2002, MAGNET RESON MED, V47, P958, DOI 10.1002/mrm.10148; Anderson JS, 2011, HUM BRAIN MAPP, V32, P919, DOI 10.1002/hbm.21079; Aso T, 2017, P 25 ANN M ISMRM HON; Aso T, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00256; Birn RM, 2008, HUM BRAIN MAPP, V29, P740, DOI 10.1002/hbm.20577; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; Blockley NP, 2011, MAGN RESON MED, V65, P1278, DOI 10.1002/mrm.22719; Boas DA, 2005, APPL OPTICS, V44, P1957, DOI 10.1364/AO.44.001957; Buxton RB, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/9/096601; Byrge L, 2018, NEUROIMAGE, V171, P376, DOI 10.1016/j.neuroimage.2017.12.082; Caballero-Gaudes C, 2017, NEUROIMAGE, V154, P128, DOI 10.1016/j.neuroimage.2016.12.018; Chang C, 2009, NEUROIMAGE, V47, P1448, DOI 10.1016/j.neuroimage.2009.05.012; Chang C, 2009, NEUROIMAGE, V47, P1381, DOI 10.1016/j.neuroimage.2009.04.048; Chang C, 2009, NEUROIMAGE, V44, P857, DOI 10.1016/j.neuroimage.2008.09.029; Chen JJ, 2009, NMR BIOMED, V22, P1054, DOI 10.1002/nbm.1411; Christen T, 2015, J MAGN RESON IMAGING, V41, P424, DOI 10.1002/jmri.24558; Cohen ER, 2002, J CEREBR BLOOD F MET, V22, P1042, DOI 10.1097/00004647-200209000-00002; Collins JA, 2015, BREATHE, V11, P195, DOI 10.1183/20734735.001415; Dresel C, 2005, NEUROIMAGE, V28, P588, DOI 10.1016/j.neuroimage.2005.06.021; Erdogan SB, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00311; FAGRELL B, 1980, MICROVASC RES, V20, P327, DOI 10.1016/0026-2862(80)90033-3; FAGRELL B, 1977, AM J PHYSIOL, V233, pH318, DOI 10.1152/ajpheart.1977.233.2.H318; Fantini S, 2014, NEUROIMAGE, V85, P202, DOI 10.1016/j.neuroimage.2013.03.065; Feinberg DA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015710; Freire L, 2001, NEUROIMAGE, V14, P709, DOI 10.1006/nimg.2001.0869; Friston KJ, 2002, NEUROIMAGE, V16, P484, DOI 10.1006/nimg.2002.1091; Giller CA, 1999, J CEREBR BLOOD F MET, V19, P452, DOI 10.1097/00004647-199904000-00011; Glasser MF, 2018, NEUROIMAGE, V181, P692, DOI 10.1016/j.neuroimage.2018.04.076; GUYTON AC, 1951, AM J PHYSIOL, V165, P158, DOI 10.1152/ajplegacy.1951.165.1.158; Herman P, 2009, J CEREBR BLOOD F MET, V29, P19, DOI 10.1038/jcbfm.2008.100; Hillman EMC, 2014, ANNU REV NEUROSCI, V37, P161, DOI 10.1146/annurev-neuro-071013-014111; Hoge RD, 1999, MAGNET RESON MED, V42, P849, DOI 10.1002/(SICI)1522-2594(199911)42:5<849::AID-MRM4>3.0.CO;2-Z; Hoiland RL, 2016, J PHYSIOL-LONDON, V594, P3463, DOI 10.1113/JP272012; Hudetz AG, 1999, J APPL PHYSIOL, V87, P505, DOI 10.1152/jappl.1999.87.2.505; Intaglietta M, 1996, CARDIOVASC RES, V32, P632; Intaglietta M., 1990, VASC MED REV, V1, P101, DOI [10.1177/1358836X9000100202, DOI 10.1177/1358836X9000100202]; Julien C, 2006, CARDIOVASC RES, V70, P12, DOI 10.1016/j.cardiores.2005.11.008; Katura T, 2006, NEUROIMAGE, V31, P1592, DOI 10.1016/j.neuroimage.2006.02.010; Kennerley AJ, 2005, MAGN RESON MED, V54, P354, DOI 10.1002/mrm.20511; Khalil AA, 2020, J CEREBR BLOOD F MET, V40, P23, DOI 10.1177/0271678X18803951; KILLIP T, 1962, CIRC RES, V11, P987, DOI 10.1161/01.RES.11.6.987; Kim JH, 2016, NEUROIMAGE, V124, P394, DOI 10.1016/j.neuroimage.2015.08.068; Kim SG, 2012, J CEREBR BLOOD F MET, V32, P1188, DOI 10.1038/jcbfm.2012.23; Kleinschmidt A, 1996, J CEREBR BLOOD F MET, V16, P817, DOI 10.1097/00004647-199609000-00006; Krings T, 2001, J NEUROL NEUROSUR PS, V70, P749, DOI 10.1136/jnnp.70.6.749; Krings T, 1999, AM J NEURORADIOL, V20, P1907; Kumar V, 2016, J NEUROSCI, V36, P4170, DOI 10.1523/JNEUROSCI.3914-15.2016; Kundu P, 2012, NEUROIMAGE, V60, P1759, DOI 10.1016/j.neuroimage.2011.12.028; Liu TT, 2017, NEUROIMAGE, V150, P213, DOI 10.1016/j.neuroimage.2017.02.036; Lv YT, 2013, ANN NEUROL, V73, P136, DOI 10.1002/ana.23763; MALATINO LS, 1992, STROKE, V23, P1728, DOI 10.1161/01.STR.23.12.1728; Mayhew JEW, 1996, NEUROIMAGE, V4, P183, DOI 10.1006/nimg.1996.0069; Mazaika P., 2009, NEUROIMAGE, V47, pS58, DOI DOI 10.1016/S1053-8119(09)70238-1; Mckay LC, 2008, NEUROIMAGE, V40, P1824, DOI 10.1016/j.neuroimage.2008.01.058; MORITA Y, 1995, ACTA PHYSIOL SCAND, V154, P121, DOI 10.1111/j.1748-1716.1995.tb09894.x; Murphy K, 2013, NEUROIMAGE, V80, P349, DOI 10.1016/j.neuroimage.2013.04.001; Murphy K, 2011, NEUROIMAGE, V54, P369, DOI 10.1016/j.neuroimage.2010.07.059; Ni L, 2017, SCI REP-UK, V7, DOI 10.1038/srep41586; Nikulin VV, 2014, NEUROIMAGE, V97, P71, DOI 10.1016/j.neuroimage.2014.04.008; Nishida S, 2019, NEUROSURGERY, V85, P680, DOI 10.1093/neuros/nyy434; Obrig H, 2000, NEUROIMAGE, V12, P623, DOI 10.1006/nimg.2000.0657; Ogawa S, 1998, ANNU REV BIOPH BIOM, V27, P447, DOI 10.1146/annurev.biophys.27.1.447; Pattinson KTS, 2009, J NEUROSCI, V29, P8177, DOI 10.1523/JNEUROSCI.1375-09.2009; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; Posse S, 1999, MAGN RESON MED, V42, P87, DOI 10.1002/(SICI)1522-2594(199907)42:1<87::AID-MRM13>3.0.CO;2-O; Poulin MJ, 1996, J APPL PHYSIOL, V81, P1084, DOI 10.1152/jappl.1996.81.3.1084; Power JD, 2017, NEUROIMAGE, V146, P609, DOI 10.1016/j.neuroimage.2016.09.038; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; RADNA RJ, 1981, BRAIN RES, V213, P29, DOI 10.1016/0006-8993(81)91246-4; Rayshubskiy A, 2014, NEUROIMAGE, V87, P323, DOI 10.1016/j.neuroimage.2013.10.044; Rostrup E, 2005, NEUROIMAGE, V24, P1, DOI 10.1016/j.neuroimage.2004.09.043; Salimi-Khorshidi G, 2014, NEUROIMAGE, V90, P449, DOI 10.1016/j.neuroimage.2013.11.046; Sassaroli A, 2012, IEEE J SEL TOP QUANT, V18, P1478, DOI 10.1109/JSTQE.2012.2183581; Satow T, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00387; Satterthwaite TD, 2013, NEUROIMAGE, V64, P240, DOI 10.1016/j.neuroimage.2012.08.052; Siegel AM, 2003, PHYS MED BIOL, V48, P1391, DOI 10.1088/0031-9155/48/10/311; Simonyan K, 2003, BRAIN RES, V974, P43, DOI 10.1016/S0006-8993(03)02548-4; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2013, NEUROIMAGE, V80, P144, DOI 10.1016/j.neuroimage.2013.05.039; Tgavalekos KT, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.10.101410; Thomas DL, 2000, PHYS MED BIOL, V45, pR97, DOI 10.1088/0031-9155/45/8/201; Tian FH, 2011, IEEE T MED IMAGING, V30, P1239, DOI 10.1109/TMI.2011.2111459; Tong YJ, 2019, J CEREBR BLOOD F MET, V39, P1148, DOI 10.1177/0271678X17753329; Tong YJ, 2017, J CEREBR BLOOD F MET, V37, P564, DOI 10.1177/0271678X16631755; Tong YJ, 2014, HUM BRAIN MAPP, V35, P5471, DOI 10.1002/hbm.22564; Tong YJ, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.10.106004; Tuunanen PI, 2006, NEUROIMAGE, V30, P102, DOI 10.1016/j.neuroimage.2005.09.021; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Webb JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084279; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; Winder AT, 2017, NAT NEUROSCI, V20, P1761, DOI 10.1038/s41593-017-0007-y; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025; Wu CWW, 2012, NEUROIMAGE, V59, P3075, DOI 10.1016/j.neuroimage.2011.11.030; YABLONSKIY DA, 1994, MAGNET RESON MED, V32, P749, DOI 10.1002/mrm.1910320610; Yen CCC, 2018, NEUROIMAGE, V164, P121, DOI 10.1016/j.neuroimage.2017.03.005; Zhu DC, 2015, J CEREBR BLOOD F MET, V35, P1910, DOI 10.1038/jcbfm.2015.166	99	10	10	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222787	10.1371/journal.pone.0222787	http://dx.doi.org/10.1371/journal.pone.0222787			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545839	Green Published, gold, Green Submitted			2022-12-26	WOS:000532303200034
J	Lamming, L; McDonach, E; Mohammed, MA; Stoves, J; Lewington, AJ; Roberts, R; Samarasinghe, Y; Shah, N; Fluck, RJ; Jackson, N; Johnson, M; Jones, C; Selby, NM				Lamming, Laura; McDonach, Eileen; Mohammed, Mohammed A.; Stoves, John; Lewington, Andy J.; Roberts, Russell; Samarasinghe, Yohan; Shah, Nikunj; Fluck, Richard J.; Jackson, Natalie; Johnson, Melanie; Jones, Carol; Selby, Nicholas M.			Barriers and enablers to the implementation of a complex quality improvement intervention for acute kidney injury: A qualitative evaluation of stakeholder perceptions of the Tackling AKI study	PLOS ONE			English	Article							PROGRAM	Background Acute kidney injury in hospital patients is common and associated with reduced survival and higher healthcare costs. The Tackling Acute Kidney Injury (TAKI) quality improvement project aimed to reduce mortality rates in patients with acute kidney injury by implementing a multicomponent intervention comprising of an electronic alert, care bundle and education in five UK hospitals across a variety of wards. A parallel developmental evaluation using a case study approach was conducted to provide the implementation teams with insights into factors that might impact intervention implementation and fidelity. The qualitative element of the evaluation will be reported. Methods 29 semi-structured interviews with implementation teams across the five hospitals were carried out to identify perceived barriers and enablers to implementation. Interviews were taped and transcribed verbatim and Framework analysis was conducted. Results Interviews generated four 'barriers and enablers' to implementation themes: i) practical/contextual factors, ii) skills and make-up of the TAKI implementation team, iii) design, development and implementation approach, iv) staff knowledge, attitudes, behaviours and support. Enablers included availability of specialist teams (e.g. educational teams), multi-disciplinary implementation teams with strong leadership, team-based package completion and proactive staff. Barriers were frequently the converse of facilitators. Conclusions Despite diversity of sites, a range of common local factors-contextual, intervention-based and individual-were identified as potential barriers and enablers to fidelity, including intervention structure/design and process of/approach to implementation. Future efforts should focus on early identification and management of barriers and tailored optimisation of known enablers such as leadership and multidisciplinary teams to encourage buy-in. Improved measures of real-time intervention and implementation fidelity would further assist local teams to target their support during such quality improvement initiatives.	[Lamming, Laura; McDonach, Eileen; Mohammed, Mohammed A.] Univ Bradford, Fac Hlth Studies, Bradford, W Yorkshire, England; [Stoves, John; Roberts, Russell] Bradford Teaching Hosp NHS Fdn Trust, Bradford, W Yorkshire, England; [Lewington, Andy J.] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England; [Lewington, Andy J.] NIHR Leeds In Vitro Diagnost Cooperat, Leeds, W Yorkshire, England; [Roberts, Russell] Bradford Inst Hlth Res, Bradford, W Yorkshire, England; [Samarasinghe, Yohan] Frimley Hlth NHS Fdn Trust, Bradford, W Yorkshire, England; [Shah, Nikunj; Jones, Carol] Ashford & St Peters NHS Fdn Trust, Chertsey, Surrey, England; [Fluck, Richard J.; Selby, Nicholas M.] Derby Teaching Hosp NHS Fdn Trust, Dept Renal Med, Derby, England; [Jackson, Natalie; Johnson, Melanie] Yorkshire & Humber AHSN Improvement Acad, Bradford Inst Hlth Res, Bradford, W Yorkshire, England; [Selby, Nicholas M.] Univ Nottingham, Derby Teaching Hosp NHS Fdn Trust, Ctr Kidney Res & Innovat, Sch Med, Derby, England	University of Bradford; University of Leeds; University of Nottingham	Lamming, L (corresponding author), Univ Bradford, Fac Hlth Studies, Bradford, W Yorkshire, England.	L.Lamming@bradford.ac.uk		Lamming, Laura/0000-0003-0984-3621; Selby, Nicholas/0000-0003-0351-8326	Health Foundation [1502-Derby-Selby-SUI]	Health Foundation	Funding for this evaluation and project came from the Scaling Up Improvement call from The Health Foundation (www.health.org.uk.NS received the award (https://www.health.org.uk/programmes/scaling-improvement/projects/tackling-acute-kidney-injury-multi-centre-quality). Grant code: 1502-Derby-Selby-SUI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker R, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005470.pub2; Bosch M, 2007, J EVAL CLIN PRACT, V13, P161, DOI 10.1111/j.1365-2753.2006.00660.x; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Davidoff F, 2015, BMJ QUAL SAF, V24, P228, DOI 10.1136/bmjqs-2014-003627; Davies H., 2007, HEALTHCARE PROFESSIO; De Silva D, 2015, WHATS GETTING WAY BA; Dixon-Woods M, 2012, BMJ QUAL SAF, V21, P876, DOI 10.1136/bmjqs-2011-000760; Evans RE, 2019, J EPIDEMIOL COMMUN H, V73, P481, DOI 10.1136/jech-2018-210840; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Godfrey M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-341; Gollop R, 2004, QUAL SAF HEALTH CARE, V13, P108, DOI 10.1136/qshc.2003.007450; Health Quality Ontario, 2013, QUAL IMPR PRIM QUAL, P1; Kaplan HC, 2012, BMJ QUAL SAF, V21, P13, DOI 10.1136/bmjqs-2011-000010; Lavrakas PJ, 2008, ENCY SURVEY RES METH, DOI DOI 10.1371/journal.pone.0073008; McDonald KM, 2004, AHRQ PUBLICATION; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Michie S, 2015, BEHAV CHANGE WHEEL G; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-10; Ritchie JSL., 1994, QUALITATIVE DATA ANA, DOI DOI 10.4324/9780203413081_CHAPTER_9; Selby NM, 2019, J AM SOC NEPHROL, V30, P505, DOI 10.1681/ASN.2018090886; Selby NM, 2016, NEPHRON, V134, P200, DOI 10.1159/000447675; Spencer L., 2013, QUALITATIVE RES PRAC; Stokes T, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0508-1; Thorndike EL, 1920, J APPL PSYCHOL, V4, P25, DOI 10.1037/h0071663; Tolich M., 2004, QUAL SOCIOL, V27, P101, DOI [DOI 10.1023/B:QUAS.0000015546.20441.4A, 10.1023/B:QUAS.0000015546.20441.4a]; Tong A, 2018, INT J QUAL HEALTH C, V19, P349, DOI DOI 10.1093/intqhc/mzm042; Wallace F., 2005, IMPLEMENTATION RES S; [No title captured], DOI DOI 10.1186/S13012-016-0508-01	28	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222444	10.1371/journal.pone.0222444	http://dx.doi.org/10.1371/journal.pone.0222444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5OJ	31539376	gold, Green Published			2022-12-26	WOS:000532297900012
J	Fu, YQ; Bai, K; Liu, CJ				Fu, Yue-qiang; Bai, Ke; Liu, Cheng-jun			The impact of admission serum lactate on children with moderate to severe traumatic brain injury	PLOS ONE			English	Article							BASE DEFICIT; PROGNOSTIC-SIGNIFICANCE; EARLY HYPERGLYCEMIA; ARTERIAL LACTATE; INITIAL LACTATE; BLOOD LACTATE; BLUNT TRAUMA; MORTALITY; CLEARANCE; UTILITY	Background Lactate is used to evaluate the prognosis of adult patients with trauma. However, the prognostic significance of admission serum lactate in the setting of pediatric traumatic brain injury (TBI) is still unclear. We aim to investigate the impact of admission lactate on the outcome in children with moderate to severe TBI. Methods This retrospective study was conducted in a tertiary pediatric hospital between May 2012 and Jun 2018 included children with an admission Glasgow Coma Scale (GCS) of <= 13. Two hundred and thirteen patients were included in the analysis and 45 patients died in hospital. Results Admission lactate and glucose were significantly higher in non-survivors than those in survivors (P < 0.05). Admission lactate was positively correlated with admission glucose and negatively correlated with GCS in all patients (n = 213), subgroup of isolated TBI (n = 112) and subgroup of GCS. 8 (n = 133), respectively. AUCs of lactate could significantly predict the mortality and were higher than those of glucose in all patients, subgroup of isolated TBI and subgroup of GCS. 8, respectively. Multivariate logistic regression showed that admission lactate (Adjusted OR = 1.189; 95% CI: 1.002-1.410; P = 0.047) was independently associated with mortality, while admission glucose (Adjusted OR = 1.077; 95% CI: 0.978-1.186; P = 0.133) wasn't an independent risk factor of death. Elevated admission lactate (> 2 mmol/L) was associated with death, reduced 14-day ventilation-free days, 14-day ICU-free days and 28-day hospital-free days. Conclusions Admission serum lactate can effectively predict the mortality of children with moderate to severe TBI. Elevated admission lactate is associated with death, reduced ventilator-free, ICU-free, and hospital-free days. Admission serum lactate could be used as a prognostic biomarker of mortality in children with moderate to severe TBI.	[Fu, Yue-qiang; Bai, Ke; Liu, Cheng-jun] Chongqing Med Univ, Childrens Hosp, Dept Crit Care Med, Chongqing, Peoples R China; [Fu, Yue-qiang; Bai, Ke; Liu, Cheng-jun] Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China; [Fu, Yue-qiang; Bai, Ke; Liu, Cheng-jun] Chongqing Key Lab Pediat, Chongqing, Peoples R China	Chongqing Medical University	Fu, YQ (corresponding author), Chongqing Med Univ, Childrens Hosp, Dept Crit Care Med, Chongqing, Peoples R China.; Fu, YQ (corresponding author), Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China.; Fu, YQ (corresponding author), Chongqing Key Lab Pediat, Chongqing, Peoples R China.	fuyueqiang@sina.com						Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Brown JB, 2016, J TRAUMA ACUTE CARE, V81, P445, DOI 10.1097/TA.0000000000001085; Chong SL, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/719476; Dekker SE, 2017, EUR J TRAUMA EMERG S, V43, P841, DOI 10.1007/s00068-016-0733-y; Fu YQ, 2017, BRAIN INJURY, V31, P396, DOI 10.1080/02699052.2016.1264629; Gale SC, 2016, J SURG RES, V205, P446, DOI 10.1016/j.jss.2016.06.103; Glenn TC, 2015, J NEUROTRAUM, V32, P820, DOI 10.1089/neu.2014.3483; Kaplan LJ, 2004, CRIT CARE MED, V32, P1120, DOI 10.1097/01.CCM.0000125517.28517.74; Kong VY, 2018, SAMJ S AFR MED J, V108, P413, DOI [10.7196/SAMJ.2018.v108i5.12837, 10.7196/samj.2018.v108i5.12837]; Lama S, 2014, J BIOL CHEM, V289, P20200, DOI 10.1074/jbc.M114.570978; Lavery RF, 2000, J AM COLL SURGEONS, V190, P656, DOI 10.1016/S1072-7515(00)00271-4; Londono J, 2018, SHOCK, V50, P286, DOI 10.1097/SHK.0000000000001066; Martin MJ, 2006, AM J SURG, V191, P625, DOI 10.1016/j.amjsurg.2006.02.014; Meierhans R, 2012, MINERVA ANESTESIOL, V78, P185; Odom SR, 2013, J TRAUMA ACUTE CARE, V74, P999, DOI 10.1097/TA.0b013e3182858a3e; Okello M, 2014, INT J EMERG MED, V7, DOI 10.1186/s12245-014-0020-9; Ouellet JF, 2012, J TRAUMA ACUTE CARE, V72, P1532, DOI 10.1097/TA.0b013e318256dd5a; Pal JD, 2006, J TRAUMA, V60, P583, DOI 10.1097/01.ta.0000205858.82575.55; Paladino L, 2008, RESUSCITATION, V77, P363, DOI 10.1016/j.resuscitation.2008.01.022; Parsikia A, 2014, SHOCK, V42, P199, DOI 10.1097/SHK.0000000000000208; Quintard H, 2016, J NEUROTRAUM, V33, P681, DOI 10.1089/neu.2015.4057; Ramanathan R, 2015, J PEDIATR SURG, V50, P598, DOI 10.1016/j.jpedsurg.2014.08.013; Raux M, 2017, ANESTHESIOLOGY, V126, P522, DOI 10.1097/ALN.0000000000001490; Regnier MA, 2012, ANESTHESIOLOGY, V117, P1276, DOI 10.1097/ALN.0b013e318273349d; Richards JE, 2018, ANESTH ANALG, V126, P904, DOI 10.1213/ANE.0000000000002626; Richards JE, 2016, J ORTHOP TRAUMA, V30, P312, DOI 10.1097/BOT.0000000000000528; Sammour T, 2009, INJURY, V40, P104, DOI 10.1016/j.injury.2008.07.032; Shah A, 2013, PEDIATR EMERG CARE, V29, P715, DOI 10.1097/PEC.0b013e318294ddb1; Stefani MA, 2017, ANN CLIN TRANSL NEUR, V4, P392, DOI 10.1002/acn3.416; Venkatesan M, 2015, INJURY, V46, P2201, DOI 10.1016/j.injury.2015.06.038	31	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222591	10.1371/journal.pone.0222591	http://dx.doi.org/10.1371/journal.pone.0222591			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536567	Green Published, gold, Green Submitted			2022-12-26	WOS:000532262800057
J	Gorodeski, EZ; Magnelli-Reyes, C; Moennich, LA; Grimaldi, A; Rickard, J				Gorodeski, Eiran Z.; Magnelli-Reyes, Christina; Moennich, Laurie Ann; Grimaldi, Adam; Rickard, John			Cardiac resynchronization therapy-heart failure (CRT-HF) clinic: A novel model of care	PLOS ONE			English	Article							TASK-FORCE; MINI-COG; GUIDELINES; MANAGEMENT; EXERCISE; DEMENTIA; SOCIETY	Background Post-implant care of patients with heart failure (HF) undergoing cardiac resynchronization therapy (CRT) is not addressed in current HF or CRT guidelines and is often fragmented with poor communication between specialties. We sought to develop a new model of postCRT care which could be implemented in busy clinical settings. Methods and results We designed a novel, multidisciplinary approach to standardizing post CRT care. All patients receiving a CRT device at the Cleveland Clinic between March 2017 and August 2018 were invited to be seen in the clinic 6 months post implant. A one-time collaborative visit encompassing cardiac imaging, heart failure, and electrophysiology care was performed. We recorded the operational feasibility of the clinic in terms of patient throughput as well as patient characteristics, interventions, and new diagnoses made. Between September 2017 and February 2019, 150 patients were seen in the clinic. Of these, 125 patients had their index CRT implanted for standard indications and were included in the current analysis. Approximately 45 minutes were dedicated for each patient visit. Interventions in care were made in 95% of patients, with CRT non-responders offered a higher number of interventions as compared to responders (median 3 versus 2 interventions). Types of interventions were device-related (26% of population), medication-related (74%), and referral for alternate medical services (80%). Conclusions Multidisciplinary post-implant care of patients with HF receiving CRT devices, regardless of CRT response status, is feasible and results in frequent medical interventions.	[Gorodeski, Eiran Z.] Cleveland Clin, Dept Cardiovasc Med, Sect Heart Failure & Cardiac Transplantat, Heart & Vasc Inst, Cleveland, OH 44106 USA; [Magnelli-Reyes, Christina; Grimaldi, Adam; Rickard, John] Cleveland Clin, Dept Cardiovasc Med, Sect Cardiac Pacing & Electrophysiol, Heart & Vasc Inst, Cleveland, OH 44106 USA; [Moennich, Laurie Ann] Cleveland Clin, Heart & Vasc Inst, Heart & Vasc Res, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Rickard, J (corresponding author), Cleveland Clin, Dept Cardiovasc Med, Sect Cardiac Pacing & Electrophysiol, Heart & Vasc Inst, Cleveland, OH 44106 USA.	rickardj2@ccf.org		Moennich, Laurie Ann/0000-0002-1070-340X	Abbott	Abbott(Abbott Laboratories)	EZG and JR have received unrestricted research grant funding from Abbott to support the CRT-HF clinic research infrastructure.	Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Altman RK, 2012, EUR HEART J, V33, P2181, DOI 10.1093/eurheartj/ehs107; Arslan S, 2007, TEX HEART I J, V34, P166; Borson S, 2003, J AM GERIATR SOC, V51, P1451, DOI 10.1046/j.1532-5415.2003.51465.x; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Drey M, 2011, GERONTOLOGY, V57, P11, DOI 10.1159/000313433; Kubala Maciej, 2017, JACC Clin Electrophysiol, V3, P1523, DOI 10.1016/j.jacep.2017.06.012; Maass AH, 2018, EUROPACE, V20, pE1, DOI 10.1093/europace/euw445; Maass AH, 2009, J CARDIOVASC ELECTR, V20, P773, DOI 10.1111/j.1540-8167.2008.01422.x; Mentz RJ, 2018, J AM COLL CARDIOL, V72, P41, DOI 10.1016/j.jacc.2018.04.038; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; Mullens W, 2009, J AM COLL CARDIOL, V53, P765, DOI 10.1016/j.jacc.2008.11.024; Parkash R, 2013, CAN J CARDIOL, V29, P1346, DOI 10.1016/j.cjca.2013.09.009; Patwala AY, 2009, J AM COLL CARDIOL, V53, P2332, DOI 10.1016/j.jacc.2009.02.063; Rickard J, 2010, HEART RHYTHM, V7, P885, DOI 10.1016/j.hrthm.2010.04.005; Tang ASL, 2010, NEW ENGL J MED, V363, P2385, DOI 10.1056/NEJMoa1009540; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	19	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222610	10.1371/journal.pone.0222610	http://dx.doi.org/10.1371/journal.pone.0222610			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536565	Green Published, gold, Green Submitted			2022-12-26	WOS:000532262800063
J	Greene-Cramer, B; Boyd, AT; Russell, S; Hulland, E; Tromble, E; Widiati, Y; Sharma, S; Pun, A; Allen, DR; Dokubo, EK; Handzel, E				Greene-Cramer, Blanche; Boyd, Andrew T.; Russell, Steven; Hulland, Erin; Tromble, Erin; Widiati, Yulia; Sharma, Sharad; Pun, Asha; Allen, Denise Roth; Dokubo, Emily Kainne; Handzel, Endang			Systematic identification of facility-based stillbirths and neonatal deaths through the piloted use of an adapted RAPID tool in Liberia and Nepal	PLOS ONE			English	Article							CARE	Maternal, fetal, and neonatal health outcomes are interdependent. Designing public health strategies that link fetal and neonatal outcomes with maternal outcomes is necessary in order to successfully reduce perinatal and neonatal mortality, particularly in low- and middle-income countries. However, to date, there has been no standardized method for documenting, reporting, and reviewing facility-based stillbirths and neonatal deaths that links to maternal health outcomes would enable a more comprehensive understanding of the burden and determinants of poor fetal and neonatal outcomes. We developed and pilot-tested an adapted RAPID tool, Perinatal-Neonatal Rapid Ascertainment Process for Institutional Deaths (PN RAPID), to systematically identify and quantify facility-based stillbirths and neonatal deaths and link them to maternal health factors in two countries: Liberia and Nepal. This study found an absence of stillbirth timing documented in records, a high proportion of neonatal deaths occurring within the first 24 hours, and an absence of documentation of pregnancy-related and maternal factors that might be associated with fetal and neonatal outcomes. The use of an adapted RAPID methodology and tools was limited by these data gaps, highlighting the need for concurrent strengthening of death documentation through training and standardized record templates.	[Greene-Cramer, Blanche; Boyd, Andrew T.; Russell, Steven; Hulland, Erin; Tromble, Erin; Handzel, Endang] Ctr Dis Control & Prevent, Div Global Hlth Protect, Emergency Response & Recovery Branch, Atlanta, GA 30333 USA; [Widiati, Yulia] UNICEF Liberia, Hlth Sect, Monrovia, Liberia; [Sharma, Sharad] Dept Hlth Serv, Management Div, Kathmandu, Nepal; [Pun, Asha] UNICEF Nepal, Hlth Sect, Kathmandu, Nepal; [Allen, Denise Roth; Dokubo, Emily Kainne] Ctr Dis Control & Prevent, Div Global Hlth Protect, Liberia Country Off, Monrovia, Liberia	Centers for Disease Control & Prevention - USA	Greene-Cramer, B (corresponding author), Ctr Dis Control & Prevent, Div Global Hlth Protect, Emergency Response & Recovery Branch, Atlanta, GA 30333 USA.	bgreenec@gmail.com		Hulland, Erin/0000-0003-0525-1856	Center for Disease Control and Prevention (CDC)	Center for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The publication of this article was funded by the Center for Disease Control and Prevention (CDC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberdeen U, I APPL HLTH SCI; Adhikari B, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00121; [Anonymous], NAT AIDS CONTR PROGR; Bhusal Mahesh, 2019, J Prev Med Public Health, V52, P154, DOI 10.3961/jpmph.18.270; Bhutta ZA, 2014, OBSTET GYNECOL SURV, V69, P641, DOI 10.1097/OGX.0000000000000124; Bhutto ZA, 2011, LANCET, V377, P1523, DOI 10.1016/S0140-6736(10)62269-6; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Boyd AT, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1329-1; Delamou A, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000202; eHealth network, 2021, EHEALTH 0202; Goldenberg RL, 2018, BJOG-INT J OBSTET GY, V125, P148, DOI 10.1111/1471-0528.14696; Hartung C., 2010, OPEN DATA KIT TOOLS; Kamath-Rayne BD, 2015, MATERN CHILD HLTH J, V19, P1853, DOI 10.1007/s10995-015-1699-9; Khanal S, 2011, J NEPAL MED ASSOC, V50, P21; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Ministry of Health Nepal; New ERA; and ICF, 2017, NEP DEM HLTH SURV 20; Morof D, 2015 GLOB MAT HLTH C; Oza S, 2015, B WORLD HEALTH ORGAN, V93, P19, DOI 10.2471/BLT.14.139790; Reinebrandt H, BJOG, DOI [10.1111/1471-0528, DOI 10.1111/1471-0528]; UNICEF, NEON MORT; Wall SN, 2010, SEMIN PERINATOL, V34, P395, DOI 10.1053/j.semperi.2010.09.009; WHO, 2016, MAK EV BAB COUNT AUD; World Health Organization, 2016, WHO APPL ICD 10 DEAT; World Health Organization, 2015, PREGN CHILDB POSTP N	26	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222583	10.1371/journal.pone.0222583	http://dx.doi.org/10.1371/journal.pone.0222583			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536573	gold, Green Published, Green Submitted			2022-12-26	WOS:000532262800056
J	Guesdon, IR; Amorim, AM; Meira, RMSA				Guesdon, Isabel Reis; Amorim, Andre Marcio; Strozi Alves Meira, Renata Maria			Functional role and evolutionary contributions of floral gland morphoanatomy in the Paleotropical genus Acridocarpus (Malpighiaceae)	PLOS ONE			English	Article							LEAF GLANDS; SECRETION; NECTARIES; ANATOMY; ULTRASTRUCTURE; PHYLOGENY; FLOWERS; CALYX	The stereotyped floral morphology of Neotropical Malpighiaceae species-zygomorphic and calyx with oil glands-is correlated with oil-bee pollination. In contrast, the floral trends of the Paleotropical lineages are actinomorphy and lack of calyx glands, probably due to the absence of oil-collecting bees. The Paleotropical genus Acridocarpus is an exception because of its zygomorphic, gland-bearing flowers. Glands throughout Acridocarpus inflorescences were morphoanatomically evaluated to verify the occurrence of patterns related to species and geographic distribution. Herbarium (25 species) and fresh samples of A. longifolius were processed according to standard anatomical techniques. To verify the presence of glucose and protein, strip tests were applied to the exudate. Fresh samples were fixed and submitted to histochemical tests. Based on the occurrence, number and placement of glands, three distribution patterns were recognized on the bracteole and ten on the calyx. Bract, bracteole and sepal glands have a typical nectary structure with a palisade-like epidermis and vascularized parenchyma. Glands were classified as short-stalked, sessile or immersed. Histochemical tests performed on bract and sepal glands of A. longifolius were positive for proteins, polysaccharides and phenolic compounds, and negative for oil compounds. Glucose and protein were detected in the exudate. These results allow us to recognize the glands in Acridocarpus inflorescences as nectaries. This comprehensive morphoanatomical study helps to clarify the correlation between patterns of floral morphology and secretion consumers, as well as to better understand floral evolution in Malpighiaceae across their dispersal events.	[Guesdon, Isabel Reis; Strozi Alves Meira, Renata Maria] Univ Fed Vicosa, Dept Biol Vegetal, UFV, Vicosa, MG, Brazil; [Amorim, Andre Marcio] Univ Estadual Santa Cruz, UESC, Dept Ciencias Biol, Ilheus, BA, Brazil; [Amorim, Andre Marcio] CEPEC, Herbario Ctr Pesquisas Cacau, Itabuna, BA, Brazil; [Guesdon, Isabel Reis] Univ Fed Amazonas, UFAM, Inst Ciencias Exatas & Tecnol, Itacoatiara, Amazonas, Brazil	Universidade Federal de Vicosa; Universidade Estadual de Santa Cruz; Universidade Federal de Amazonas	Meira, RMSA (corresponding author), Univ Fed Vicosa, Dept Biol Vegetal, UFV, Vicosa, MG, Brazil.	rmeira@ufv.br	Meira, Renata Maria Strozi Alves/D-7191-2013; Amorim, André M./I-9411-2012	Meira, Renata Maria Strozi Alves/0000-0001-5324-6168; Amorim, Andre/0000-0003-0712-3321	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM/PROGRAMA RH-INTERIORIZACAO); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [310717/2015-9, 307762/2016-5]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [UNIVERSAL APQ00383-16]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM/PROGRAMA RH-INTERIORIZACAO); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. The authors thank the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM/PROGRAMA RH-INTERIORIZACAO) for awarding the doctoral scholarships to IRG; the Programa de Pos-Graduacao em Botanica at the Universidade Federal de Vicosa (UFV) for providing logistical support; the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for awarding research productivity fellowships to AMA (grant 310717/2015-9) and RMSAM (grant 307762/2016-5); and the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) for the financial resources (UNIVERSAL APQ00383-16). We are also grateful to the MNHN Herbarium and Jardin Botanique Meise for kindly loaning samples. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RF, 2019, PHYTOKEYS, P45, DOI 10.3897/phytokeys.117.32207; Anderson Christiane, 2007, Contributions from the University of Michigan Herbarium, V25, P1; ANDERSON W R, 1990, Memoirs of the New York Botanical Garden, V64, P210; Anderson William R., 2007, Contributions from the University of Michigan Herbarium, V25, P113; ANDERSON WR, 1979, BIOTROPICA, V11, P219, DOI 10.2307/2388042; Anderson WR, 1981, MEMOIRS NEW YORK BOT, V32, P137; Anderson WR., 2001, FLORA VENEZUELAN GUA, V6, P82; Araujo JS, 2016, ACTA BOT BRAS, V30, P112, DOI 10.1590/0102-33062015abb0248; Arenes J., 1950, FLORE MADAGASCAR, V108, P1; Arenes J., 1955, NOTULAE SYSTEMATICAE, V15, P4; ARUMUGASAMY K, 1993, ACTA SOC BOT POL, V62, P17; ARUMUGASAMY K, 1989, CURR SCI INDIA, V58, P260; Baker-Meio B, 2012, J ECOL, V100, P242, DOI 10.1111/j.1365-2745.2011.01892.x; Birnbaum P., 2005, ADANSONIA, V27, P235; BUCHMANN SL, 1987, ANNU REV ECOL SYST, V18, P343, DOI 10.1146/annurev.es.18.110187.002015; Carvalho Paula Dib de, 2005, Acta Bot. Bras., V19, P209, DOI 10.1590/S0102-33062005000200002; Castro MA, 2001, AM J BOT, V88, P1935, DOI 10.2307/3558420; Chen S.K., 2008, FLORA CHINA, P132; Clark SG, 1981, STAINING PROCEDURES; Cocucci A.A., 1996, CHILE DARWINIANA, V34, P183, DOI DOI 10.14522/darwiniana.2014.341-4.404; Davis CC, 2002, EVOLUTION, V56, P2395; Davis CC, 2002, P NATL ACAD SCI USA, V99, P6833, DOI 10.1073/pnas.102175899; Davis CC, 2014, P NATL ACAD SCI USA, V111, P5914, DOI 10.1073/pnas.1403157111; Davis CC, 2010, AM J BOT, V97, P2031, DOI 10.3732/ajb.1000146; ELIAS TS, 1980, AM J BOT, V67, P423, DOI 10.2307/2442352; Endress PK, 1996, DIVERSITY EVOLUTIONA; Fahn A, 1990, PLANT ANATOMY; Possobom CCF, 2015, FLORA, V211, P26, DOI 10.1016/j.flora.2015.01.002; FISHER DB, 1968, HISTOCHEMISTRY, V16, P92, DOI 10.1007/BF00306214; Gonzalez-Teuber M, 2009, J CHEM ECOL, V35, P459, DOI 10.1007/s10886-009-9618-4; Guesdon IR, 2017, THESIS; Guesdon IR, 2018, PHYTOTAXA, V345, P13, DOI 10.11646/phytotaxa.345.1.2; Guillemin JA, 1831, FLORAE SENEGAMBIAE T, V29, P123; Heald S.V., 2004, FLOWERING PLANTS NEO, P229, DOI DOI 10.1600/0363644053661878; Hutchinson J, 1958, FLORA W TROPICAL AFR, P350; JOHANSEN D.A., 1940, PLANT MICROTECHNIQUE; LANZA J, 1991, ECOL ENTOMOL, V16, P203, DOI 10.1111/j.1365-2311.1991.tb00210.x; Launert E., 1995, FLORA ETHIOPIA ERITR, P257; Launert E, 1963, FLORA ZAMBESIACA, P109; Launert E, 1968, BRIT MUSEUM NATURAL, P1; LOBREAU-CALLEN D, 1989, Bulletin du Museum National d'Histoire Naturelle Section B Adansonia Botanique Phytochimie, V11, P79; Gonzalez AM, 2018, BOT J LINN SOC, V187, P26, DOI 10.1093/botlinnean/boy004; McKey D., 1979, HERBIVORES THEIR INT, P55; MCMANUS JFA, 1948, STAIN TECHNOL, V23, P99, DOI 10.3109/10520294809106232; Michener C.D., 2000, BEES WORLD, V1st, DOI DOI 10.7171/JBT.12-2303-004; Nery LA, 2017, ACTA BOT BRAS, V31, P459, DOI 10.1590/0102-33062017abb0108; Ness JH, 2009, ECOLOGY, V90, P2823, DOI 10.1890/08-1580.1; Nicolson Susan W., 2007, P215, DOI 10.1007/978-1-4020-5937-7_5; Niedenzu F, 1921, GENERE ACRIDOCARPO A; Niedenzu F., 1928, PFLANZENREICH 4, V141, P1; OBRIEN TP, 1964, PROTOPLASMA, V59, P368, DOI 10.1007/BF01248568; Oliver D, 1868, FLORA TROPICAL AFRIC, P276; Pearse A. G., 1980, HISTOCHEMISTRY THEOR; Possobom CCF, 2010, PLANT BIOLOGY, V12, P863, DOI 10.1111/j.1438-8677.2009.00304.x; Possobom CCF, 2017, PLANT SYST EVOL, V304, P15; RAVEN PH, 1974, ANN MO BOT GARD, V61, P539, DOI 10.2307/2395021; Ren MX, 2013, BOT J LINN SOC, V173, P764, DOI 10.1111/boj.12101; SAZIMA M, 1989, BOT ACTA, V102, P106, DOI 10.1111/j.1438-8677.1989.tb00073.x; Sigrist MR, 2004, ANN BOT-LONDON, V94, P33, DOI 10.1093/aob/mch108; SIMPSON BB, 1981, ANN MO BOT GARD, V68, P301, DOI 10.2307/2398800; Smith FH, 1942, AM J BOT, V29, P464, DOI 10.2307/2437312; Souto LS, 2013, FLORA, V208, P351, DOI 10.1016/j.flora.2013.05.002; SUBRAMANIAN RB, 1990, NORD J BOT, V10, P57, DOI 10.1111/j.1756-1051.1990.tb01753.x; SUDD JH, 1985, ECOL ENTOMOL, V10, P89, DOI 10.1111/j.1365-2311.1985.tb00538.x; Teixeira L. A. G., 2000, Acta Botanica Brasilica, V14, P347, DOI 10.1590/S0102-33062000000300011; Thulin M., 1993, FLORA SOMALIA, P260; VANDOORNHOEKMAN H, 1975, ACTA BOT NEERL, V24, P69, DOI 10.1111/j.1438-8677.1975.tb00995.x; Vinson SB, 1997, BIOTROPICA, V29, P76, DOI 10.1111/j.1744-7429.1997.tb00008.x; VOGEL S, 1990, Memoirs of the New York Botanical Garden, V55, P130; Vogel S., 1974, TROPISCHE SUBTROPISC, V7, P283, DOI DOI 10.1002/FEDR.19770880110; Wilczek R, 1958, FLORE CONGO BELGE RU, P214; Wilczek R., 1955, B JARD BOT ETAT BRUX, V25, P303, DOI DOI 10.2307/3667028; Zhang WH, 2010, P NATL ACAD SCI USA, V107, P6388, DOI 10.1073/pnas.0910155107	73	5	6	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222561	10.1371/journal.pone.0222561	http://dx.doi.org/10.1371/journal.pone.0222561			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527912	gold, Green Published, Green Submitted			2022-12-26	WOS:000532231400028
J	Balogun, EO; Inaoka, DK; Shiba, T; Tsuge, C; May, B; Sato, T; Kido, Y; Nara, T; Aoki, T; Honma, T; Tanaka, A; Inoue, M; Matsuoka, S; Michels, PAM; Watanabe, YI; Moore, AL; Harada, S; Kita, K				Balogun, Emmanuel Oluwadare; Inaoka, Daniel Ken; Shiba, Tomoo; Tsuge, Chiaki; May, Benjamin; Sato, Tomohiro; Kido, Yasutoshi; Nara, Takeshi; Aoki, Takashi; Honma, Teruki; Tanaka, Akiko; Inoue, Masayuki; Matsuoka, Shigeru; Michels, Paul A. M.; Watanabe, Yoh-Ichi; Moore, Anthony L.; Harada, Shigeharu; Kita, Kiyoshi			Discovery of trypanocidal coumarins with dual inhibition of both the glycerol kinase and alternative oxidase of Trypanosoma brucei brucei	FASEB JOURNAL			English	Article						energy metabolism; African trypanosomiasis; rational drug design; inhibitor; screening	INTERFERENCE COMPOUNDS PAINS; PURIFICATION; CLONING; ASSAY; ACID; TARGET; POTENT; GENE	African trypanosomiasis, sleeping sickness in humans or nagana in animals, is a potentially fatal neglected tropical disease and a threat to 65 million human lives and 100 million small and large livestock animals in sub-Saharan Africa. Available treatments for this devastating disease are few and have limited efficacy, prompting the search for new drug candidates. Simultaneous inhibition of the trypanosomal glycerol kinase (TGK) and trypanosomal alternative oxidase (TAO) is considered a validated strategy toward the development of new drugs. Our goal is to develop a TGK-specific inhibitor for coadministration with ascofuranone (AF), the most potent TAO inhibitor. Here, we report on the identification of novel compounds with inhibitory potency against TGK. Importantly, one of these compounds (compound 17) and its derivatives (17a and 17b) killed trypanosomes even in the absence of AF. Inhibition kinetics revealed that derivative 17b is a mixed-type and competitive inhibitor for TGK and TAO, respectively. Structural data revealed the molecular basis of this dual inhibitory action, which, in our opinion, will aid in the successful development of a promising drug to treat trypanosomiasis. Although the EC50 of compound 17b against trypanosome cells was 1.77 mu M, it had no effect on cultured human cells, even at 50 mu M.	[Balogun, Emmanuel Oluwadare; Kido, Yasutoshi] Ahmadu Bello Univ, Dept Biochem, Zaria 2222, Nigeria; [Balogun, Emmanuel Oluwadare; Inaoka, Daniel Ken; Tsuge, Chiaki; Watanabe, Yoh-Ichi; Kita, Kiyoshi] Univ Tokyo, Dept Biomed Chem, Grad Sch Med, Tokyo, Japan; [Inoue, Masayuki; Matsuoka, Shigeru] Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Inaoka, Daniel Ken; Kita, Kiyoshi] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki 8528523, Japan; [Inaoka, Daniel Ken; Kita, Kiyoshi] Nagasaki Univ, Dept Mol Infect Dynam, Shionogi Global Infect Dis Div, Inst Trop Med NEKKEN, Nagasaki, Japan; [Shiba, Tomoo; Harada, Shigeharu] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Appl Biol, Kyoto, Japan; [May, Benjamin; Moore, Anthony L.] Univ Sussex, Biochem & Med, Sch Life Sci, Brighton, E Sussex, England; [Sato, Tomohiro; Honma, Teruki; Tanaka, Akiko] RIKEN, Syst & Struct Biol Ctr, Yokohama, Kanagawa, Japan; [Kido, Yasutoshi] Osaka City Univ, Grad Sch Med, Dept Parasitol, Osaka, Japan; [Nara, Takeshi; Aoki, Takashi] Juntendo Univ, Sch Med, Dept Mol & Cellular Parasitol, Tokyo, Japan; [Michels, Paul A. M.] Univ Edinburgh, Ctr Immun Infect & Evolut, Edinburgh, Midlothian, Scotland; [Michels, Paul A. M.] Univ Edinburgh, Sch Biol Sci, Ctr Translat & Chem Biol, Edinburgh, Midlothian, Scotland	Ahmadu Bello University; University of Tokyo; University of Tokyo; Nagasaki University; Nagasaki University; Kyoto Institute of Technology; University of Sussex; RIKEN; Osaka Metropolitan University; Juntendo University; University of Edinburgh; University of Edinburgh	Balogun, EO (corresponding author), Ahmadu Bello Univ, Dept Biochem, Zaria 2222, Nigeria.; Kita, K (corresponding author), Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki 8528523, Japan.	balogun1@m.u-tokyo.ac.jp; kitak@nagasaki-u.ac.jp	Kido, Yasutoshi/AAW-3688-2021; Balogun, Emmanuel Oluwadare/AAF-3352-2020; Inaoka, Daniel Ken/GMX-4344-2022; Michels, Paul A/A-5637-2009	Kido, Yasutoshi/0000-0003-3615-2631; Inaoka, Daniel Ken/0000-0002-9791-927X; Michels, Paul A/0000-0003-3726-6104; Balogun, Emmanuel/0000-0002-2092-0045	Government of the United Kingdom as part of the Global Challenge Research Fund (GCRF); African Academy of Sciences [FLR\R1\190353]; Royal Society [FLR\R1\190353]; Science and Technology Research Partnership for Sustainable Development [10000284, 14425718]; Program for the Promotion of Basic and Applied Research for Innovations in Bio-Oriented Industries; Japanese Ministry of Education, Science, Culture, Sports, and Technology (MEXT) [26870119, 93002316, 26440027]; Creative Scientific Research grant [18GS0314]; Japanese Society for the Promotion of Science [18073004]; Japanese Ministry of Health and Welfare	Government of the United Kingdom as part of the Global Challenge Research Fund (GCRF); African Academy of Sciences; Royal Society(Royal Society of London); Science and Technology Research Partnership for Sustainable Development; Program for the Promotion of Basic and Applied Research for Innovations in Bio-Oriented Industries; Japanese Ministry of Education, Science, Culture, Sports, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Creative Scientific Research grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan)	The authors thank all the staff members of the synchrotron beamlines BL44XU at SPring-8 and BL1A and BL17A at the Photon Factory (Tsukuba, Japan) for their help with X-ray diffraction experiments. Use of the synchrotron beamline BL44XU at SPring-8 was obtained through the Cooperative Research Program of the Institute for Protein Research (Osaka University, Osaka, Japan). The authors also thank the Open Innovation Center for Drug Discovery at The University of Tokyo for providing the kinase-focused library. This work was partly funded by the Government of the United Kingdom as part of the Global Challenge Research Fund (GCRF) through a partnership between the African Academy of Sciences and the Royal Society (FLR\R1\190353 to E.O.B.). E.O.B. is a Future Leaders-African Independent Research (FLAIR) Research Fellow of The Royal Society. This work was supported, in part, by Grants-in-Aid for Infectious Disease Control from the Science and Technology Research Partnership for Sustainable Development (10000284 to K.K. and 14425718 to D.K.I.); a grant from the Program for the Promotion of Basic and Applied Research for Innovations in Bio-Oriented Industries (to S.H. and K.K.); Grants-in-Aid for Scientific Research (B) (26870119 and 93002316 to D.K.I.) and (C) (26440027 to T.S.) from the Japanese Ministry of Education, Science, Culture, Sports, and Technology (MEXT); a Creative Scientific Research grant (18GS0314 to K.K.); a Grant-in-Aid for Scientific Research on Priority Areas from the Japanese Society for the Promotion of Science (18073004 to K.K.); and a Grant-in-Aid for Research on Emerging and Reemerging Infectious Diseases from the Japanese Ministry of Health and Welfare (to K.K.). The authors declare no conflicts of interest.	Achcar F, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002352; Affourtit C, 2002, FEBS LETT, V510, P121, DOI 10.1016/S0014-5793(01)03261-6; Baell JB, 2018, ACS CHEM BIOL, V13, P36, DOI 10.1021/acschembio.7b00903; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Balogun EO, 2017, BBA-GEN SUBJECTS, V1861, P2830, DOI 10.1016/j.bbagen.2017.07.028; Balogun EO, 2014, MOL MICROBIOL, V94, P1315, DOI 10.1111/mmi.12831; Balogun EO, 2013, J BIOCHEM, V154, P77, DOI 10.1093/jb/mvt037; Balogun EO, 2010, ACTA CRYSTALLOGR F, V66, P304, DOI 10.1107/S1744309110000369; Barrett MP, 1999, CURR OPIN CELL BIOL, V11, P496, DOI 10.1016/S0955-0674(99)80072-6; Beaglehole R., 2003, WORLD HLTH REPORT 20; Bettoun JD, 1997, J CLIN ENDOCR METAB, V82, P1031, DOI 10.1210/jc.82.4.1031; Bisser S, 2007, J INFECT DIS, V195, P322, DOI 10.1086/510534; Brun R, 2001, TROP MED INT HEALTH, V6, P906, DOI 10.1046/j.1365-3156.2001.00775.x; Chaudhuri M, 2006, TRENDS PARASITOL, V22, P484, DOI 10.1016/j.pt.2006.08.007; Clayton CE, 1996, PARASITOL TODAY, V12, P465, DOI 10.1016/S0169-4758(96)10073-9; Coustou V, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000618; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Ebiloma GU, 2019, MED RES REV, V39, P1553, DOI 10.1002/med.21560; Ebiloma GU, 2018, EUR J MED CHEM, V150, P385, DOI 10.1016/j.ejmech.2018.02.075; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; Fairlamb AH, 2003, TRENDS PARASITOL, V19, P488, DOI 10.1016/j.pt.2003.09.002; FAIRLAMB AH, 1977, NATURE, V265, P270, DOI 10.1038/265270a0; Gonzalez FJF, 2017, J MED CHEM, V60, P1509, DOI 10.1021/acs.jmedchem.6b01740; Harris CJ, 2011, COMB CHEM HIGH T SCR, V14, P521; Inaoka DK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167078; Kido Y, 2010, BBA-BIOENERGETICS, V1797, P443, DOI 10.1016/j.bbabio.2009.12.021; Kralova I, 2000, EUR J BIOCHEM, V267, P2323, DOI 10.1046/j.1432-1327.2000.01238.x; Meco-Navas A, 2018, ACS MED CHEM LETT, V9, P923, DOI 10.1021/acsmedchemlett.8b00282; Menzies SK, 2018, PARASITOLOGY, V145, P175, DOI 10.1017/S0031182016002109; Moore AL, 2008, BBA-BIOENERGETICS, V1777, P327, DOI 10.1016/j.bbabio.2008.01.004; Moore AL, 2013, ANNU REV PLANT BIOL, V64, P637, DOI 10.1146/annurev-arplant-042811-105432; Morooka S, 2015, MOL PHARMACOL, V88, P316, DOI 10.1124/mol.114.097345; Murray CJL., 1996, GLOBAL HLTH STAT COM, V1996; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakano H, 2016, BIOORG MED CHEM LETT, V26, P2370, DOI 10.1016/j.bmcl.2016.03.006; Nihei C, 2003, FEBS LETT, V538, P35, DOI 10.1016/S0014-5793(03)00120-0; Njogu PM, 2013, CURR MED CHEM, V20, P1715; Ohashi-Suzuki M, 2011, J VET MED SCI, V73, P615, DOI 10.1292/jvms.10-0481; Pelfrene E, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007381; Raz B, 1997, ACTA TROP, V68, P139, DOI 10.1016/S0001-706X(97)00079-X; RYLEY JF, 1962, BIOCHEM J, V85, P211, DOI 10.1042/bj0850211; Saitoh Y., 2015, Experimental Oncology, V37, P94; Segel IH., 1993, ENZYME KINETICS BEHA; Shiba T, 2019, BBA-BIOENERGETICS, V1860, P375, DOI 10.1016/j.bbabio.2019.03.008; Shiba T, 2013, P NATL ACAD SCI USA, V110, P4580, DOI 10.1073/pnas.1218386110; Simarro PP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001859; Steverding D, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-15; Sun DY, 2006, CHEM BIOL DRUG DES, V67, P385, DOI 10.1111/j.1747-0285.2006.00396.x; Suzuki T, 2004, PARASITOL INT, V53, P235, DOI 10.1016/j.parint.2004.02.001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; World Health Organization, 2016, TRYP HUM AFR SLEEP S; Yabu Y, 2006, PARASITOL INT, V55, P39, DOI 10.1016/j.parint.2005.09.003	53	15	15	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					13002	13013		10.1096/fj.201901342R	http://dx.doi.org/10.1096/fj.201901342R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31525300	Bronze			2022-12-26	WOS:000507461600107
J	Diwakar, BT; Yoast, R; Nettleford, S; Qian, FH; Lee, TJ; Berry, S; Huffnagle, I; Rossi, RM; Trebak, M; Paulson, RF; Prabhu, KS				Diwakar, Bastihalli T.; Yoast, Ryan; Nettleford, Shaneice; Qian, Fenghua; Lee, Tai-Jung; Berry, Svanjita; Huffnagle, Ian; Rossi, Randall M.; Trebak, Mohamed; Paulson, Robert F.; Prabhu, K. Sandeep			Crth2 receptor signaling down-regulates lipopolysaccharide-induced NF-kappa B activation in murine macrophages via changes in intracellular calcium	FASEB JOURNAL			English	Article						cyclopentenone prostaglandins; selenium; protein kinase A; cAMP; resolution of inflammation	NITRIC-OXIDE SYNTHASE; PROSTAGLANDIN D-2 RECEPTOR; RAW 264.7 MACROPHAGES; CYCLIC-AMP; TRANSCRIPTIONAL ACTIVITY; MOLECULAR PHARMACOLOGY; NEUTROPHIL MIGRATION; GENE-EXPRESSION; MICRORNAS; CELLS	Prostaglandin D-2 and its cyclopentenone metabolites [cyclopentenone prostaglandins (CyPGs)], Delta(12) prostaglandin J(2) and 15-deoxy-Delta(12,14)prostaglandin J(2), act through 2 GPCRs, D-type prostanoid 1 and the chemoattractant receptor homologous molecule expressed on type 2 T-helper cells (Crth2). In addition to its role in allergy and asthma, the role of Crth2 in the resolution of inflammation, to mediate the proresolving functions of endogenous CyPGs, is not well understood. We investigated the regulation of LPS or zymosan-induced inflammatory response by signals from the Crth2 receptor in macrophages that lack Crth2 expression [knockout (KO)]. Increased expression of proinflammatory genes, including Tnf-alpha, was observed in Crth2 KO cells. Targeting the endogenous biosynthetic pathway of CyPGs with indomethacin or HQL79, which inhibit cyclooxygenases or hematopoietic prostaglandin D synthase, respectively, or use of Crth2 antagonists recapitulated the proinflammatory phenotype as in Crth2 KO cells. Ligand-dependent activation of Crth2 by 13,14-dihydro-15-keto-prostaglandin D-2 increased Ca2+ influx through store-operated Ca2+ entry (SOCE) accompanied by the up-regulation of stromal interaction molecule 1 and calcium release-activated calcium modulator 1 expression, suggesting that the proresolution effects of CyPG-dependent activation of SOCE could be mediated by Crth2 during inflammation. Interestingly, Crth2 signaling down-regulated the Ca2+-regulated heat stable protein 1 that stabilizes Tnf-alpha mRNA via the increased expression of microRNA 155 to dampen inflammatory responses triggered through the TNF-alpha-NF-kappa B axis. In summary, these studies present a novel regulatory role for Crth2 during inflammatory response in macrophages.	[Diwakar, Bastihalli T.; Nettleford, Shaneice; Qian, Fenghua; Lee, Tai-Jung; Berry, Svanjita; Huffnagle, Ian; Paulson, Robert F.; Prabhu, K. Sandeep] Penn State Univ, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA; [Diwakar, Bastihalli T.; Nettleford, Shaneice; Qian, Fenghua; Lee, Tai-Jung; Berry, Svanjita; Huffnagle, Ian; Paulson, Robert F.; Prabhu, K. Sandeep] Penn State Univ, Ctr Mol Toxicol & Carcinogenesis, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Diwakar, Bastihalli T.; Nettleford, Shaneice; Qian, Fenghua; Lee, Tai-Jung; Berry, Svanjita; Huffnagle, Ian; Paulson, Robert F.; Prabhu, K. Sandeep] Penn State Univ, Penn State Canc Inst, University Pk, PA 16802 USA; [Rossi, Randall M.] Penn State Univ, Transgen Mouse Facil, Huck Inst Life Sci, University Pk, PA 16802 USA; [Diwakar, Bastihalli T.] Univ Toledo, Coll Pharm & Pharmaceut Sci, Dept Pharmacol & Expt Therapeut, 2801 W Bancroft St, Toledo, OH 43606 USA; [Yoast, Ryan; Trebak, Mohamed] Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University System of Ohio; University of Toledo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Prabhu, KS (corresponding author), Penn State Univ, Ctr Mol Immunol & Infect Dis, Ctr Mol Toxicol & Carcinogenesis, Dept Vet & Biomed Sci,Penn State Canc Inst, 115 Henning Bldg, University Pk, PA 16802 USA.	ksprabhu@psu.edu			NIH National Human Genome Research Institute [U01HG004085, U01HG004080, U42RR024244]; Public Health Service (PHS) grants from the NIH National Institute of Diabetes and Digestive and Kidney Diseases [DK077152]; Office of Dietary Supplements; U.S. Department of Agriculture (USDA) Hatch Funds [PENO 4605, 1010021, DK080040, PENO 4581, 1005468]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123364, R01HL097111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080040, R01DK077152] Funding Source: NIH RePORTER	NIH National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Public Health Service (PHS) grants from the NIH National Institute of Diabetes and Digestive and Kidney Diseases; Office of Dietary Supplements(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture (USDA) Hatch Funds(United States Department of Agriculture (USDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Drs. Connie Rogers and Ramesh Ramachandran (Pennsylvania State University, State College, PA, USA) for their help with the MicroBeta microplate counter and fluorescent microscope, respectively. ES cells were from the Trans-U.S. National Institutes of Health (NIH) Knock-Out Mouse Project (KOMP) Repository. NIH National Human Genome Research Institute grants to Velocigene at Regeneron, Inc. (U01HG004085), the Complementary Sex Determination (CSD) Consortium (U01HG004080), and KOMP Repository at University of California-Davis (Davis, CA, USA) and Children's Hospital Oakland Research Institute (CHORI) (U42RR024244) funded the program to generate the gene-targeted ES cells. These studies were funded, in part, by Public Health Service (PHS) grants from the NIH National Institute of Diabetes and Digestive and Kidney Diseases (DK077152) and Office of Dietary Supplements, and U.S. Department of Agriculture (USDA) Hatch Funds (PENO 4605, Accession 1010021 to K.S.P., DK080040; PENO 4581, Accession 1005468 to R.F.P.). The authors declare no conflicts of interest.	Abe H, 1999, GENE, V227, P71, DOI 10.1016/S0378-1119(98)00599-X; Ajuebor MN, 1998, IMMUNOLOGY, V95, P625; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Chen CC, 1999, J BIOL CHEM, V274, P31559, DOI 10.1074/jbc.274.44.31559; Chevalier E, 2005, J IMMUNOL, V175, P2056, DOI 10.4049/jimmunol.175.4.2056; Chinen T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1181; Chio CC, 2004, CELL SIGNAL, V16, P565, DOI 10.1016/j.cellsig.2003.10.003; Choi HK, 2013, BIOCHEM BIOPH RES CO, V436, P473, DOI 10.1016/j.bbrc.2013.05.129; Desai PN, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa8323; Finch ER, 2017, BLOOD, V129, P1802, DOI 10.1182/blood-2016-08-736405; Fujitani Y, 2002, J IMMUNOL, V168, P443, DOI 10.4049/jimmunol.168.1.443; Fullerton JN, 2016, NAT REV DRUG DISCOV, V15, P551, DOI 10.1038/nrd.2016.39; Gandhi UH, 2011, J BIOL CHEM, V286, P27471, DOI 10.1074/jbc.M111.260547; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Haringman JJ, 2005, ANN RHEUM DIS, V64, P834, DOI 10.1136/ard.2004.029751; Hata AN, 2003, J PHARMACOL EXP THER, V306, P463, DOI 10.1124/jpet.103.050955; Hirai H, 2001, J EXP MED, V193, P255, DOI 10.1084/jem.193.2.255; HIROKAWA K, 1994, BRIT J PHARMACOL, V112, P396, DOI 10.1111/j.1476-5381.1994.tb13085.x; Ishii M, 2012, J IMMUNOL, V188, P5655, DOI 10.4049/jimmunol.1102330; Jandl K, 2017, PROSTAG OTH LIPID M, V133, P42, DOI 10.1016/j.prostaglandins.2017.08.006; Jeon YJ, 1996, MOL PHARMACOL, V50, P334; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kojima F, 2008, J IMMUNOL, V180, P8361, DOI 10.4049/jimmunol.180.12.8361; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Lee S, 2014, CELL METAB, V19, P484, DOI 10.1016/j.cmet.2014.01.013; LIU MC, 1990, AM REV RESPIR DIS, V142, P126, DOI 10.1164/ajrccm/142.1.126; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Mandal AK, 2004, J EXP MED, V199, P1317, DOI 10.1084/jem.20031666; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; Nusing RM, 1996, BIOCHEM J, V313, P617, DOI 10.1042/bj3130617; O'Neill LA, 2011, NAT REV IMMUNOL, V11, P163, DOI 10.1038/nri2957; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pettipher R, 2008, BRIT J PHARMACOL, V153, pS191, DOI 10.1038/sj.bjp.0707488; Pfeiffer JR, 2011, MOL CELL BIOL, V31, P277, DOI 10.1128/MCB.00775-10; Prabhu KS, 2002, BIOCHEM J, V366, P203, DOI 10.1042/BJ20020256; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Roulis M, 2014, P NATL ACAD SCI USA, V111, pE4658, DOI 10.1073/pnas.1415762111; Sawyer N, 2002, BRIT J PHARMACOL, V137, P1163, DOI 10.1038/sj.bjp.0704973; Schafer C, 2003, AM J PHYSIOL-GASTR L, V285, pG726, DOI 10.1152/ajpgi.00111.2003; Schuligoi R, 2010, PHARMACOLOGY, V85, P372, DOI 10.1159/000313836; Shay AE, 2017, J BIOL CHEM, V292, P14544, DOI 10.1074/jbc.M117.785014; Shibata T, 2002, J BIOL CHEM, V277, P10459, DOI 10.1074/jbc.M110314200; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Tajima T, 2008, J PHARMACOL EXP THER, V326, P493, DOI 10.1124/jpet.108.137992; Trebak M, 2002, J BIOL CHEM, V277, P21617, DOI 10.1074/jbc.M202549200; Trebak M, 2017, PHYSIOLOGY, V32, P332, DOI 10.1152/physiol.00011.2017; Tsubosaka Y, 2014, J IMMUNOL, V193, P5835, DOI 10.4049/jimmunol.1303478; Vunta H, 2007, J BIOL CHEM, V282, P17964, DOI 10.1074/jbc.M703075200; Wang Z, 2014, J IMMUNOL, V192, P2349, DOI 10.4049/jimmunol.1302982; Westman M, 2004, ARTHRITIS RHEUM-US, V50, P1774, DOI 10.1002/art.20286; Wojno EDT, 2015, MUCOSAL IMMUNOL, V8, P1313, DOI 10.1038/mi.2015.21; Wu XC, 2016, SCI REP-UK, V6, DOI 10.1038/srep19000; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhu JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046551	61	6	6	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2019	33	11					12838	12852		10.1096/fj.201802608R	http://dx.doi.org/10.1096/fj.201802608R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC8ZX	31518163	Green Published			2022-12-26	WOS:000507461600096
J	Gullett, JM; Cuypers, MG; Frank, MW; White, SW; Rock, CO				Gullett, Jessica M.; Cuypers, Maxime G.; Frank, Matthew W.; White, Stephen W.; Rock, Charles O.			A fatty acid-binding protein of Streptococcus pneumoniae facilitates the acquisition of host polyunsaturated fatty acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid-binding protein; X-ray crystallography; glycerophospholipid; bacterial metabolism; Streptococcus; acyl-phosphate; fatty acid kinase; nutrient acquisition	TRANSCRIPTIONAL REGULATION; BIOSYNTHESIS; REFINEMENT; GENES; FABT; APO	Streptococcus pneumoniae is responsible for the majority of pneumonia, motivating ongoing searches for insights into its physiology that could enable new treatments. S. pneumoniae responds to exogenous fatty acids by suppressing its de novo biosynthetic pathway and exclusively utilizing extracellular fatty acids for membrane phospholipid synthesis. The first step in exogenous fatty acid assimilation is phosphorylation by fatty acid kinase (FakA), whereas bound by a fatty acid-binding protein (FakB). Staphylococcus aureus has two binding proteins, whereas S. pneumoniae expresses three. The functions of these binding proteins were not clear. We determined the SpFakB1- and SpFakB2-binding proteins were bioinformatically related to the two binding proteins of Staphylococcus aureus, and biochemical and X-ray crystallographic analysis showed that SpFakB1 selectively bound saturates, whereas SpFakB2 allows the activation of monounsaturates akin to their S. aureus counterparts. The distinct SpFakB3 enables the utilization of polyunsaturates. The SpFakB3 crystal structure in complex with linoleic acid reveals an expanded fatty acid-binding pocket within the hydrophobic interior of SpFakB3 that explains its ability to accommodate multiple cis double bonds. SpFakB3 also utilizes a different hydrogen bond network than other FakBs to anchor the fatty acid carbonyl and stabilize the protein. S. pneumoniae strain JMG1 (?fakB3) was deficient in incorporation of linoleate from human serum verifying the role of FakB3 in this process. Thus, the multiple FakBs of S. pneumoniae permit the utilization of the entire spectrum of mammalian fatty acid structures to construct its membrane.	[Gullett, Jessica M.; Frank, Matthew W.; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Cuypers, Maxime G.; White, Stephen W.] St Jude Childrens Res Hosp, Dept Struct Biol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	Charles.rock@stjude.org	; Rock, Charles/N-2256-2018	Gullett, Jessica/0000-0003-3996-9110; Cuypers, Maxime/0000-0002-8826-2317; Rock, Charles/0000-0001-8648-4189	National Institutes of Health [GM034496]; Cancer Center Support Grant [CA21765]; American Lebanese Syrian Associated Charities	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC))	This work was supported by National Institutes of Health Grant GM034496, Cancer Center Support Grant CA21765, and the American Lebanese Syrian Associated Charities. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boles BR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010146; Brinster S, 2009, NATURE, V458, P83, DOI 10.1038/nature07772; Broussard TC, 2016, J BIOL CHEM, V291, P6292, DOI 10.1074/jbc.M115.706820; Corsico B, 1998, P NATL ACAD SCI USA, V95, P12174, DOI 10.1073/pnas.95.21.12174; Cuypers MG, 2019, J BIOL CHEM, V294, P38, DOI 10.1074/jbc.RA118.006160; D'Elia MA, 2006, J BACTERIOL, V188, P4183, DOI 10.1128/JB.00197-06; Delekta PC, 2018, J BACTERIOL, V200, DOI [10.1123/JB.00728-17, 10.1128/JB.00728-17]; Eckhardt TH, 2013, J BACTERIOL, V195, P1081, DOI 10.1128/JB.02043-12; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ericson ME, 2017, MBIO, V8, DOI 10.1128/mBio.00988-17; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Falomir-Lockhart LJ, 2006, J BIOL CHEM, V281, P13979, DOI 10.1074/jbc.M511943200; Faustoferri RC, 2015, MOL ORAL MICROBIOL, V30, P128, DOI 10.1111/omi.12076; Granok AB, 2000, J BACTERIOL, V182, P1529, DOI 10.1128/JB.182.6.1529-1540.2000; He Y, 2007, BIOCHEMISTRY-US, V46, P12543, DOI 10.1021/bi701092r; Hodsdon ME, 1997, BIOCHEMISTRY-US, V36, P2278, DOI 10.1021/bi962018l; Hodsdon ME, 1997, BIOCHEMISTRY-US, V36, P1450, DOI 10.1021/bi961890r; Jerga A, 2009, J BIOL CHEM, V284, P15364, DOI 10.1074/jbc.C109.002410; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Kim GL, 2017, MOL CELLS, V40, P935, DOI 10.14348/molcells.2017.0201; LEBLANC DJ, 1992, PLASMID, V28, P130, DOI 10.1016/0147-619X(92)90044-B; Lu YJ, 2006, MOL MICROBIOL, V59, P551, DOI 10.1111/j.1365-2958.2005.04951.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nan J, 2009, ACTA CRYSTALLOGR D, V65, P440, DOI 10.1107/S0907444909007756; Pang YY, 2010, J INNATE IMMUN, V2, P546, DOI 10.1159/000319855; Parsons JB, 2014, P NATL ACAD SCI USA, V111, P10532, DOI 10.1073/pnas.1408797111; Parsons JB, 2014, MOL MICROBIOL, V92, P234, DOI 10.1111/mmi.12556; Parsons JB, 2013, PROG LIPID RES, V52, P249, DOI 10.1016/j.plipres.2013.02.002; Parsons JB, 2011, P NATL ACAD SCI USA, V108, P15378, DOI 10.1073/pnas.1109208108; Pieper U, 2014, NUCLEIC ACIDS RES, V42, pD336, DOI 10.1093/nar/gkt1144; Prinsen CFM, 1996, BIOCHEM J, V314, P253, DOI 10.1042/bj3140253; Richieri GV, 2000, BIOCHEMISTRY-US, V39, P7197, DOI 10.1021/bi000314z; SACCHETTINI JC, 1989, P NATL ACAD SCI USA, V86, P7736, DOI 10.1073/pnas.86.20.7736; Schulze-Gahmen U, 2003, PROTEINS, V50, P526, DOI 10.1002/prot.10305; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Subramanian C, 2019, J BIOL CHEM, V294, P9285, DOI 10.1074/jbc.RA119.008439; Tatituri RVV, 2012, J MASS SPECTROM, V47, P115, DOI 10.1002/jms.2033; Tian W, 2018, NUCLEIC ACIDS RES, V46, pW363, DOI 10.1093/nar/gky473; Wurch T, 1998, BIOTECHNOL TECH, V12, P653, DOI 10.1023/A:1008848517221; Yao JW, 2015, J BIOL CHEM, V290, P5940, DOI 10.1074/jbc.R114.636241; Yao JW, 2013, BBA-MOL CELL BIOL L, V1831, P495, DOI 10.1016/j.bbalip.2012.08.018; Zhu L, 2019, MBIO, V10, DOI 10.1128/mBio.00577-19	49	21	21	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					16416	16428		10.1074/jbc.RA119.010659	http://dx.doi.org/10.1074/jbc.RA119.010659			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31530637	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000499478600043
J	Goertz, S; de Menezes, AB; Birtles, RJ; Fenn, J; Lowe, AE; MacColl, ADC; Poulin, B; Young, S; Bradley, JE; Taylor, CH				Goertz, Sarah; de Menezes, Alexandre B.; Birtles, Richard J.; Fenn, Jonathan; Lowe, Ann E.; MacColl, Andrew D. C.; Poulin, Benoit; Young, Stuart; Bradley, Janette E.; Taylor, Christopher H.			Geographical location influences the composition of the gut microbiota in wild house mice (Mus musculus domesticus) at a fine spatial scale	PLOS ONE			English	Article							POPULATION; DIVERSITY; MOTHER; WEIGHT; IMPACT; AGE	The composition of the mammalian gut microbiota can be influenced by a multitude of environmental variables such as diet and infections. Studies investigating the effect of these variables on gut microbiota composition often sample across multiple separate populations and habitat types. In this study we explore how variation in the gut microbiota of the house mouse (Mus musculus domesticus) on the Isle of May, a small island off the east coast of Scotland, is associated with environmental and biological factors. Our study focuses on the effects of environmental variables, specifically trapping location and surrounding vegetation, as well as the host variables sex, age, body weight and endoparasite infection, on the gut microbiota composition across a fine spatial scale in a freely interbreeding population. We found that differences in gut microbiota composition were significantly associated with the trapping location of the host, even across this small spatial scale. Sex of the host showed a weak association with microbiota composition. Whilst sex and location could be identified as playing an important role in the compositional variation of the gut microbiota, 75% of the variation remains unexplained. Whereas other rodent studies have found associations between gut microbiota composition and age of the host or parasite infections, the present study could not clearly establish these associations. We conclude that fine spatial scales are important when considering gut microbiota composition and investigating differences among individuals.	[Goertz, Sarah; Fenn, Jonathan; Lowe, Ann E.; MacColl, Andrew D. C.; Poulin, Benoit; Bradley, Janette E.; Taylor, Christopher H.] Univ Nottingham, Sch Life Sci, Nottingham, England; [de Menezes, Alexandre B.] NUI Galway, Sch Nat Sci, Galway, Ireland; [Birtles, Richard J.] Univ Salford, Sch Environm & Life Sci, Manchester, Lancs, England; [Young, Stuart] Chester Zoo, IUCN SSC Asian Wild Cattle Specialist Grp, Chester, Cheshire, England	University of Nottingham; Ollscoil na Gaillimhe-University of Galway; University of Manchester; University of Salford	Bradley, JE (corresponding author), Univ Nottingham, Sch Life Sci, Nottingham, England.	jan.bradley@nottingham.ac.uk	de Menezes, Alexandre/AAG-1824-2021	de Menezes, Alexandre/0000-0001-5244-3354; Fenn, Jonathan/0000-0002-9255-6975; Birtles, Richard/0000-0002-4216-5044; Bradley, Janette/0000-0003-3973-7977	Natural Environment Research Council (NERC) as part of the Envision Doctoral Training Programme studentship [NE/L002604/1]; Biotechnology and Biological Sciences Research Council [BB/J014508/1]	Natural Environment Research Council (NERC) as part of the Envision Doctoral Training Programme studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by The Natural Environment Research Council (NERC) [grant number NE/L002604/1] as part of the Envision Doctoral Training Programme studentship (URL: https://nerc.ukri.org/) which was awarded to SG. This work was also supported by the Biotechnology and Biological Sciences Research Council [grant number BB/J014508/1], a Doctoral Training Programme studentship (URL: https://bbsrc.ukri.org/) awarded to SY and JF. The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Scottish National Heritage for permission to carry out work on the Isle of May, and David Steel (Scottish National Heritage); Rene ' van der Wal for providing data on vegetation distributions on the island; Andrew Wolfenden for comments on the manuscript. In addition we would like to acknowledge the helpful comments made by two anonymous referees which has significantly improved the manuscript.; This work was supported by The Natural Environment Research Council (NERC) [grant number NE/L002604/1] as part of the Envision Doctoral Training Programme studentship which was awarded to SG. This work was also supported by the Biotechnology and Biological Sciences Research Council [grant number BB/J014508/1], a Doctoral Training Programme studentship awarded to SY and JF.	Abolins S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14811; Amato KR, 2016, OECOLOGIA, V180, P717, DOI 10.1007/s00442-015-3507-z; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andrews S., 2010, FASTQC QUALITY CONTR; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Augusteyn RC, 2014, MOL VIS, V20, P410; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Berry R.J., 1991, P239; BERRY RJ, 1991, J ZOOL, V225, P615, DOI 10.1111/j.1469-7998.1991.tb04329.x; Berry RJ, 1964, SOURCE EVOL, DOI [10.1111/j.1558-5646.1964.tb01623.x, DOI 10.1111/J.1558-5646.1964.TB01623.X]; Biddle A., 2013, DIVERSITY, V5, P627, DOI [10.3390/d5030627, DOI 10.3390/D5030627]; Bolnick DI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5500; Bonder MJ, 2016, NAT GENET, V48, P1407, DOI 10.1038/ng.3663; Bushnell B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185056; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; CARRENO NB, 1990, J MAMMAL, V71, P468, DOI 10.2307/1381964; Clarke G, 2013, MOL PSYCHIATR, V18, P666, DOI 10.1038/mp.2012.77; Dominianni C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124599; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Hayes KS, 2010, SCIENCE, V328, P1391, DOI 10.1126/science.1187703; Hildebrand F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r4; Holm JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125495; Kettel EF, 2016, EUR J WILDLIFE RES, V62, P241, DOI 10.1007/s10344-016-0985-1; Kotzampassi K, 2013, SURG CURR RES, DOI [10.4172/2161-1076.1000152, DOI 10.4172/2161-1076.1000152]; Kreisinger J, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0295; Kreisinger J, 2014, MOL ECOL, V23, P5048, DOI 10.1111/mec.12909; Langille MG, 2014, MICROBIOME, V2, DOI 10.1186/s40168-014-0050-9; Li H, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01169; Linnenbrink M, 2013, MOL ECOL, V22, P1904, DOI 10.1111/mec.12206; Love AM, MODERATED ESTIMATION; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Markle JGM, 2013, SCIENCE, DOI [10.5534/wjmh.190009, DOI 10.5534/WJMH.190009]; Maurice CF, 2015, ISME J, V9, P2423, DOI 10.1038/ismej.2015.53; McKenney EA, 2015, GUT MICROBES, V6, P182, DOI 10.1080/19490976.2015.1047128; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Org E, 2016, GUT MICROBES, V7, P313, DOI 10.1080/19490976.2016.1203502; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Reynolds LA, 2015, J IMMUNOL, DOI [10.4049/jimmunol, DOI 10.4049/JIMMUNOL]; Rogers GB, 2014, SCI REP-UK, V4, DOI 10.1038/srep05437; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; ROWE FP, 1985, J APPL ECOL, V22, P55, DOI 10.2307/2403326; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schulte-Hostedde AI, 2001, CAN J ZOOL, V79, P1021, DOI 10.1139/cjz-79-6-1021; Snijders AM, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.221; Suzuk TA, 2019, MOL ECOL, V28, P3197, DOI 10.1111/mec.15139; Suzuki TA, 2019, MOL ECOL, V28, P2378, DOI 10.1111/mec.14905; TANNOCK GW, 1990, J CLIN MICROBIOL, V28, P1225, DOI 10.1128/JCM.28.6.1225-1228.1990; Taylor CH, 2019, FUNCT ECOL, V33, P1425, DOI 10.1111/1365-2435.13354; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; Thompson CL, 2008, ISME J, V2, P739, DOI 10.1038/ismej.2008.29; TRIGGS GS, 1991, J ZOOL, V225, P449, DOI 10.1111/j.1469-7998.1991.tb03828.x; Vaishampayan PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/gbe/evp057; Vandeputte D, 2017, NATURE, V551, P507, DOI 10.1038/nature24460; Walk ST, 2010, INFLAMM BOWEL DIS, V16, P1841, DOI 10.1002/ibd.21299; Wang J, 2014, P NATL ACAD SCI USA, V111, pE2703, DOI 10.1073/pnas.1402342111; Weldon L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134643; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013	64	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222501	10.1371/journal.pone.0222501	http://dx.doi.org/10.1371/journal.pone.0222501			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557179	Green Published, gold			2022-12-26	WOS:000532345500022
J	Nash, MC; Diaz-Pulido, G; Harvey, AS; Adey, W				Nash, Merinda C.; Diaz-Pulido, Guillermo; Harvey, Adela S.; Adey, Walter			Coralline algal calcification: A morphological and process-based understanding	PLOS ONE			English	Article							OCEAN ACIDIFICATION; INORGANIC CARBON; CELL-WALLS; MG-CALCITE; RED ALGAE; CELLULOSE; GROWTH; BIOMINERALIZATION; POLYSACCHARIDES; RHODOPHYTA	Research purpose and findings Coralline algae are key biological substrates of many carbonate systems globally. Their capacity to build enduring crusts that underpin the formation of tropical reefs, rhodolith beds and other benthic substrate is dependent on the formation of a calcified thallus. However, this important process of skeletal carbonate formation is not well understood. We undertook a study of cellular carbonate features to develop a model for calcification. We describe two types of cell wall calcification; 1) calcified primary cell wall (PCW) in the thin-walled elongate cells such as central medullary cells in articulated corallines and hypothallial cells in crustose coralline algae (CCA), 2) calcified secondary cell wall (SCW) with radial Mg-calcite crystals in thicker-walled rounded cortical cells of articulated corallines and perithallial cells of CCA. The distinctive banding found in many rhodoliths is the regular transition from PCW-only cells to SCW cells. Within the cell walls there can be bands of elevated Mg with Mg content of a few mol% higher than radial Mg-calcite (M-type), ranging up to dolomite composition (D-type). Model for calcification We propose the following three-step model for calcification. 1) A thin (< 0.5 mu m) PCW forms and is filled with a mineralising fluid of organic compounds and seawater. Nanometer-scale Mg-calcite grains precipitate on the organic structures within the PCW. 2) Crystalline cellulose microfibrils (CMF) are extruded perpendicularly from the cellulose synthase complexes (CSC) in the plasmalemma to form the SCW. 3) The CMF soaks in the mineralising fluid as it extrudes and becomes calcified, retaining the perpendicular form, thus building the radial calcite. In Clathromorphum, SCW formation lags PCW creating a zone of weakness resulting in a split in the sub-surface crust. All calcification seems likely to be a bioinduced rather than controlled process. These findings are a substantial step forward in understanding how corallines calcify.	[Nash, Merinda C.; Adey, Walter] Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA; [Nash, Merinda C.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Diaz-Pulido, Guillermo] Griffith Univ, Griffith Sch Environm & Sci, Nathan Campus, Nathan, Qld, Australia; [Diaz-Pulido, Guillermo] Griffith Univ, Australian Rivers Inst, Coast & Estuaries, Nathan Campus, Nathan, Qld, Australia; [Harvey, Adela S.] La Trobe Univ, Dept Ecol Environm & Evolut, Bundoora, Vic, Australia	Smithsonian Institution; Smithsonian National Museum of Natural History; Australian National University; Griffith University; Griffith University; La Trobe University	Nash, MC (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA.; Nash, MC (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia.	Merinda.nash@alumni.anu.edu.au	Diaz-Pulido, Guillermo/B-3648-2013	Diaz-Pulido, Guillermo/0000-0002-0901-3727	Australian Research Council [DP160103071]; Smithsonian Research Fellowship	Australian Research Council(Australian Research Council); Smithsonian Research Fellowship	GDP was supported by an Australian Research Council Discovery Grant (DP160103071). MN was supported by a Smithsonian Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; GDP was supported by an Australian Research Council Discovery Grant (DP160103071). MCN was supported by a Smithsonian Research Fellowship.	Addadi L, 2014, PHYS SCRIPTA, V89, DOI 10.1088/0031-8949/89/9/098003; Adey W, 2017, PHYMATOLITHON MELOBE; ADEY W H, 1974, Phycologia, V13, P329, DOI 10.2216/i0031-8884-13-4-329.1; ADEY W H, 1971, Phycologia, V10, P29, DOI 10.2216/i0031-8884-10-1-29.1; Adey Walter H., 2013, Smithsonian Contributions to the Marine Sciences, P1; ADEY WALTER H., 1965, HYDROBIOLOGIA, V26, P539, DOI 10.1007/BF00045545; ADEY WALTER H., 1964, HYDROBIOLO GIA, V24, P377, DOI 10.1007/BF00170412; ADEY WALTER H., 1966, HYDROBIOLOGIA, V28, P321, DOI 10.1007/BF00130389; ADEY WH, 1973, GEOL SOC AM BULL, V84, P883, DOI 10.1130/0016-7606(1973)84<883:CCAARI>2.0.CO;2; ADEY WH, 1978, SCIENCE, V202, P831, DOI 10.1126/science.202.4370.831; Adey WH, 1998, J PHYCOL, V34, P393, DOI 10.1046/j.1529-8817.1998.340393.x; Adey WH, 2005, J PHYCOL, V1, P41; Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; Amado GM, 2007, CIENC MAR, V33, P399, DOI 10.7773/cm.v33i4.1148; [Anonymous], 2005, ITBM RBM, DOI DOI 10.1016/J.RBMRET.2005.04.006; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Bilan MI, 2001, RUSS J BIOORG CHEM+, V27, P2, DOI 10.1023/A:1009584516443; Bolton JJ, 2016, AQUAT BOT, V132, P1, DOI 10.1016/j.aquabot.2016.02.006; BOROWITZKA M A, 1974, Phycologia, V13, P195, DOI 10.2216/i0031-8884-13-3-195.1; BOROWITZKA MA, 1976, J EXP BOT, V27, P879, DOI 10.1093/jxb/27.5.879; BOROWITZKA MA, 1984, PLANT CELL ENVIRON, V7, P457, DOI 10.1111/j.1365-3040.1984.tb01436.x; BOROWITZKA MA, 1981, MAR BIOL, V62, P17, DOI 10.1007/BF00396947; Buchanan B.B., 2015, BIOCHEM MOL BIOL PLA; Bussell JA, 2007, J MAR BIOL ASSOC UK, V87, P383, DOI 10.1017/S0025315407055385; Campbell N. A., 1999, BIOLOGY-BASEL, V5th; Chan P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15543; Chisholm JRM, 2003, LIMNOL OCEANOGR, V48, P1376; Cohen AL, 2003, REV MINERAL GEOCHEM, V54, P151, DOI 10.2113/0540151; Cole KM., 1990, BIOL RED ALGAE; Cornwall C. E., 2017, GLOBAL CHANGE BIOL, V23, P1; Cornwall CE, 2015, PHOTOSYNTH RES, V124, P181, DOI 10.1007/s11120-015-0114-0; Cornwall CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097235; Cornwall CE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2201; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cox TE, 2017, MAR BIOL, P5; Darrenougue N, 2014, QUATERNARY SCI REV, V93, P34, DOI 10.1016/j.quascirev.2014.03.005; de Araujo AM, 2016, CARBOHYD POLYM, V136, P892, DOI 10.1016/j.carbpol.2015.09.066; de Carvalho WD, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0100; de Nooijer LJ, 2014, EARTH-SCI REV, V135, P48, DOI 10.1016/j.earscirev.2014.03.013; Diaz-Pulido G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4310; Diotallevi F, 2007, BIOPHYS J, V92, P2666, DOI 10.1529/biophysj.106.099473; Donald HK, 2017, GEOCHIM COSMOCHIM AC; Dutra E, 2016, ICES J MAR SCI, V73, P803, DOI 10.1093/icesjms/fsv213; Egilsdottir H, 2013, MAR BIOL, V160, P2103, DOI 10.1007/s00227-012-2090-7; Evert RF., 2006, ESAUS PLANT ANATOMY, DOI [10.1002/0470047380, DOI 10.1002/0470047380]; Fietzke J, 2015, P NATL ACAD SCI USA, V112, P2960, DOI 10.1073/pnas.1419216112; Fisher K, 2014, BIOL BULL-US, V226, P121, DOI 10.1086/BBLv226n2p121; Foster MS, 2001, J PHYCOL, V37, P659, DOI 10.1046/j.1529-8817.2001.00195.x; GOREAU TF, 1963, ANN NY ACAD SCI, V109, P127, DOI 10.1111/j.1749-6632.1963.tb13465.x; Granja PL, 2001, J MATER SCI-MATER M, V12, P785, DOI 10.1023/A:1013960601330; Gregg JM, 2015, SEDIMENTOLOGY, V62, P1749, DOI 10.1111/sed.12202; Gross E, 2016, AQUAT BOT, V132; Halfar J, 2008, GEOLOGY, V36, P463, DOI 10.1130/G24635A.1; Halfar J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028811; Halfar J, 2013, P NATL ACAD SCI USA, V110, P19737, DOI 10.1073/pnas.1313775110; Harvey AS, 2017, MAR FRESHWATER RES, V68, P411, DOI 10.1071/MF15434; Harvey AS, 2009, PHYCOLOGIA, V48, P258, DOI 10.2216/08-84.1; Hernandez-Carmona G., 2013, CONVENTIONAL ALTERNA; Hofmann LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159057; Hofmann LC, 2012, MAR BIOL, V159, P783, DOI 10.1007/s00227-011-1854-9; Hurd CL, 2011, GLOBAL CHANGE BIOL, V17, P3254, DOI 10.1111/j.1365-2486.2011.02473.x; James NP, 1988, J SEDIMENT RES, V58; Johnson MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087678; Kamenos NA, 2008, GEOCHIM COSMOCHIM AC, V72, P771, DOI 10.1016/j.gca.2007.11.019; Kamenos NA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1159; Kato A, 2011, J PHYCOL, V47, P662, DOI 10.1111/j.1529-8817.2011.00996.x; Leadbeater B. S. C., 1986, BIOMINERALIZATION LO, P141; Lee D, 2001, CHEM GEOL, V172, P307, DOI 10.1016/S0009-2541(00)00258-8; Leung JYS, 2017, ENVIRON SCI TECHNOL, V51, P2652, DOI 10.1021/acs.est.6b04709; Lewis B, 2017, MAR ECOL PROG SER, V568, P73, DOI 10.3354/meps12074; Lewis B, 2017, J EXP MAR BIOL ECOL, V490, P64, DOI 10.1016/j.jembe.2017.02.004; LITTLER MM, 1975, J ECOL, V63, P117, DOI 10.2307/2258846; Malagoli BG, 2014, INT J BIOL MACROMOL, V66, P332, DOI 10.1016/j.ijbiomac.2014.02.053; Martone PT, 2010, J PHYCOL, V46, P507, DOI 10.1111/j.1529-8817.2010.00828.x; Martone PT, 2009, CURR BIOL, V19, P169, DOI 10.1016/j.cub.2008.12.031; Martson M, 1998, EUR SURG RES, V30, P426, DOI 10.1159/000008609; Mass T, 2017, P NATL ACAD SCI USA; Mass T, 2013, CURR BIOL, V23, P1126, DOI 10.1016/j.cub.2013.05.007; MATTY PJ, 1981, PHYCOLOGIA, V20, P46, DOI 10.2216/i0031-8884-20-1-46.1; McCulloch M, 2012, NAT CLIM CHANGE, V2, P623, DOI 10.1038/NCLIMATE1473; Mellerowicz EJ, 2008, CURR OPIN PLANT BIOL, V11, P293, DOI 10.1016/j.pbi.2008.03.003; Merk V, 2015, GREEN CHEM, V17, P1423, DOI [10.1039/C4GC01862A, 10.1039/c4gc01862a]; Nakano Y, 2015, FRONT PLANT SCI, P6, DOI [10.3389/fpls.2015.00288/abstract, DOI 10.3389/FPLS.2015.00288/ABSTRACT]; Nash MC, 2013, NAT CLIM CHANGE, V3, P268, DOI 10.1038/NCLIMATE1760; Nash MC, 2011, BIOGEOSCIENCES, V8, P3331, DOI 10.5194/bg-8-3331-2011; Nash M.C., 2016, THESIS AUSTR NATL U, P436; Nash MC, 2018, BIOGEOSCIENCES, V15, P781, DOI 10.5194/bg-15-781-2018; Nash MC, 2017, J PHYCOL, V53, P970, DOI 10.1111/jpy.12559; Nash MC, 2016, BIOGEOSCIENCES, V13, P5937, DOI 10.5194/bg-13-5937-2016; Nash MC, 2015, J PHYCOL, V51, P403, DOI 10.1111/jpy.12299; Nash MC, 2013, J SEDIMENT RES, V83, P1085, DOI 10.2110/jsr.2013.67; Navarro DA, 2011, CARBOHYD POLYM, V84, P944, DOI 10.1016/j.carbpol.2010.12.048; OKAZAKI M, 1982, BOT MAR, V25, P123, DOI 10.1515/botm.1982.25.3.123; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Popper ZA, 2011, ANNU REV PLANT BIOL, V62, P567, DOI 10.1146/annurev-arplant-042110-103809; Rafsanjani A, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0126; Ragazzola F, 2016, SCI REP, P6; Rahman MA, 2014, SCI REP-UK, V4, DOI 10.1038/srep06162; Raz S, 2000, ADV MATER, V12, P38, DOI 10.1002/(SICI)1521-4095(200001)12:1<38::AID-ADMA38>3.0.CO;2-I; REES DA, 1977, ANGEW CHEM INT EDIT, V16, P214, DOI 10.1002/anie.197702141; Ries JB, 2006, GEOCHIM COSMOCHIM AC, V70, P891, DOI 10.1016/j.gca.2005.10.025; Ries JB, 2011, J EXP MAR BIOL ECOL, V403, P54, DOI 10.1016/j.jembe.2011.04.006; Riosmena-Rodriguez R, 2017, COAST RES LIBR, V15, P3, DOI 10.1007/978-3-319-29315-8_1; Shen XP, 2016, GREEN CHEM, V18, P53, DOI 10.1039/c5gc02396c; Sletten HR, 2017, PALAEOGEOGR PALAEOCL, V465, P264, DOI 10.1016/j.palaeo.2016.10.038; Stanley SM, 2002, P NATL ACAD SCI USA, V99, P15323, DOI 10.1073/pnas.232569499; STENECK RS, 1986, ANNU REV ECOL SYST, V17, P273, DOI 10.1146/annurev.es.17.110186.001421; Stoppel WL, 2015, ANN BIOMED ENG, V43, P657, DOI 10.1007/s10439-014-1206-2; Tsekos I, 1999, J PHYCOL, V35, P635, DOI 10.1046/j.1529-8817.1999.3540635.x; Underwood AJ, 1998, MAR FRESHWATER RES, V49, P241, DOI 10.1071/MF97207; van de Locht R, 2014, CRYST GROWTH DES, V14, P1710, DOI 10.1021/cg4018486; Venkatesan J, 2015, STARCH-STARKE, V67, P381, DOI 10.1002/star.201400127; Venkatesan J, 2015, INT J BIOL MACROMOL, V72, P269, DOI 10.1016/j.ijbiomac.2014.07.008; Von Euw S, 2017, SCIENCE, V356, P933, DOI 10.1126/science.aam6371; Wanamaker AD, 2011, PALAEOGEOGR PALAEOCL, V302, P1, DOI 10.1016/j.palaeo.2010.12.024; Wegst UGK, 2015, NAT MATER, V14, P23, DOI [10.1038/NMAT4089, 10.1038/nmat4089]; Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001; Williams B, 2011, BIOGEOSCIENCES, V8, P165, DOI 10.5194/bg-8-165-2011; Zhang FF, 2015, AM MINERAL, V100, P483, DOI 10.2138/am-2015-4999; Zhang FF, 2012, AM MINERAL, V97, P556, DOI 10.2138/am.2012.3979	121	28	29	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0221396	10.1371/journal.pone.0221396	http://dx.doi.org/10.1371/journal.pone.0221396			61	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557180	Green Published, gold			2022-12-26	WOS:000532345500010
J	Messinger, LN; Stuber, EF; Chizinski, CJ; Fontaine, JJ				Messinger, Lindsey N.; Stuber, Erica F.; Chizinski, Christopher J.; Fontaine, Joseph J.			Mortality, perception, and scale: Understanding how predation shapes space use in a wild prey population	PLOS ONE			English	Article							HOME-RANGE SIZE; HABITAT SELECTION; TEMPORAL VARIATION; ANTIPREDATOR RESPONSE; BEHAVIORAL DECISIONS; SAMPLE-SIZE; ROE DEER; RISK; ELK; LANDSCAPE	Attempts to assess behavioral responses of prey to predation risk are often confounded by depredation of prey. Moreover, the scale at which the response of prey is assessed has important implications for discovering how predation risk alters prey behavior. Herein, we assessed space use of wild Ring-necked Pheasants (Phasianus colchicus) in response to spatial and temporal variation in recreational hunting. We radio-marked pheasants and monitored space use at two spatial scales: short-term seasonal home range, and nightly resting locations. Additionally, we considered temporal variation in predation risk by monitoring space use prior to and during the pheasant hunting season. Although we found no change in nightly resting location, pheasants subjected to predation risk expanded their home range and shifted home range location even when invulnerable to predation. Home range formation was plastic, with home ranges expanding and contracting as risk fluctuated before and during the hunting season. Depredation reduced the measured response within the population, obscuring the potential importance of perceived predation risk in shaping prey communities, particularly when not measured at the appropriate scale. By assessing space use of a wild prey population at multiple scales, considering spatial and temporal variation in predation risk, we show that not only does predation risk affect space use, but that the effects at the population level may be challenging to assess when not measured at the appropriate ecological scale because of the direct effects of differential mortality on the same behaviors.	[Messinger, Lindsey N.; Stuber, Erica F.; Fontaine, Joseph J.] Univ Nebraska, Nebraska Cooperat Fish & Wildlife Res Unit, Lincoln, NE 68588 USA; [Chizinski, Christopher J.] Univ Nebraska, Sch Nat Resources, Lincoln, NE USA; [Messinger, Lindsey N.] Minnesota Dept Nat Resources Farmland Wildlife Po, Madelia, MN 56062 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Messinger, LN (corresponding author), Univ Nebraska, Nebraska Cooperat Fish & Wildlife Res Unit, Lincoln, NE 68588 USA.; Messinger, LN (corresponding author), Minnesota Dept Nat Resources Farmland Wildlife Po, Madelia, MN 56062 USA.	lindsey.messinger@state.mn.us	Stuber, Erica/AAT-2803-2020	Stuber, Erica/0000-0002-2687-6874	Federal Aid in Wildlife Restoration Projects [W-98-R]; U.S. Geological Survey; Nebraska Game and Parks Commission; University of Nebraska-Lincoln; U.S. Fish and Wildlife Service; Wildlife Management Institute; Hatch funds through the Agricultural Research Division at the University of Nebraska-Lincoln	Federal Aid in Wildlife Restoration Projects; U.S. Geological Survey(United States Geological Survey); Nebraska Game and Parks Commission; University of Nebraska-Lincoln; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); Wildlife Management Institute; Hatch funds through the Agricultural Research Division at the University of Nebraska-Lincoln	Funding for this project was provided by Federal Aid in Wildlife Restoration Projects W-98-R administered by the Nebraska Game and Parks Commission. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government. The Nebraska Cooperative Fish and Wildlife Research Unit is supported by a cooperative agreement among the U.S. Geological Survey, the Nebraska Game and Parks Commission, the University of Nebraska-Lincoln, the U.S. Fish and Wildlife Service, and the Wildlife Management Institute. CJC was supported by Hatch funds through the Agricultural Research Division at the University of Nebraska-Lincoln.	Abbey-Lee RN, 2016, BEHAV ECOL, V27, P857, DOI 10.1093/beheco/arv228; Altendorf KB, 2001, J MAMMAL, V82, P430, DOI 10.1644/1545-1542(2001)082&lt;0430:AEOPRO&gt;2.0.CO;2; Anderson DP, 2005, LANDSCAPE ECOL, V20, P257, DOI 10.1007/s10980-005-0062-8; ANHOLT BR, 1995, ECOLOGY, V76, P2230, DOI 10.2307/1941696; [Anonymous], 2007, DATA ANAL USING REGR, DOI [10. 1017/CBO9780511790942d, DOI 10.1017/CB09780511790942, 10.1017/CB09780511790942]; Bates D, 2015, J STAT SOFTW, Vxx, pxx; Beschta RL, 2014, ECOLOGY, V95, P2669, DOI 10.1890/13-1624.1; Beschta RL, 2013, ECOLOGY, V94, P1420, DOI 10.1890/11-0063.1; Binckley CA, 2005, BIOL LETTERS, V1, P370, DOI 10.1098/rsbl.2005.0310; Bleicher SS, 2018, BEHAV ECOL SOCIOBIOL, V72, DOI 10.1007/s00265-018-2600-9; Blundell GM, 2001, ECOL MONOGR, V71, P469, DOI 10.1890/0012-9615(2001)071[0469:LHREOS]2.0.CO;2; Borger L, 2006, J ANIM ECOL, V75, P1393, DOI 10.1111/j.1365-2656.2006.01164.x; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Burres E, 1998, CROSS BORDER WATERS: FRAGILE TREASURES FOR THE 21ST CENTURY, P244; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Creel S, 2005, ECOLOGY, V86, P3387, DOI 10.1890/05-0032; Creel S, 2005, ANIM BEHAV, V69, P1181, DOI 10.1016/j.anbehav.2004.07.022; Creel S, 2008, ANIM BEHAV, V76, P1139, DOI 10.1016/j.anbehav.2008.07.006; Cresswell W, 2008, IBIS, V150, P3, DOI 10.1111/j.1474-919X.2007.00793.x; De Solla SR, 1999, J ANIM ECOL, V68, P221, DOI 10.1046/j.1365-2656.1999.00279.x; DENARDO DF, 1994, HORM BEHAV, V28, P273, DOI 10.1006/hbeh.1994.1023; Dorset EE, 2017, EVOL BIOL, V44, P227, DOI 10.1007/s11692-016-9402-7; Droge E, 2017, ECOL EVOL, V7, P189, DOI 10.1002/ece3.2616; Eklov P, 2006, AM NAT, V167, P440, DOI 10.1086/499544; Fieberg J, 2012, J MAMMAL, V93, P890, DOI 10.1644/11-MAMM-S-172.1; Fontaine JJ, 2006, AM NAT, V168, P811, DOI 10.1086/508297; Ford AT, 2015, TRENDS ECOL EVOL, V30, P725, DOI 10.1016/j.tree.2015.09.012; FRETWELL S D, 1969, Acta Biotheoretica, V19, P16, DOI 10.1007/BF01601953; Frid A, 2002, CONSERV ECOL, V6; Frid A, 2008, OIKOS, V117, P191, DOI 10.1111/j.2007.0030-1299.16134.x; Gelman A., 2021, ARM DATA ANAL USING; GILLIAM JF, 1987, ECOLOGY, V68, P1856, DOI 10.2307/1939877; Gilsdorf JM, 2008, J WILDLIFE MANAGE, V72, P1241, DOI 10.2193/2007-348; Giudice JH, 2001, BIRDS N AM, DOI [10.2173/bna.572, DOI 10.2173/BNA.572]; Hebblewhite M, 2002, CAN J ZOOL, V80, P789, DOI 10.1139/Z02-058; Hebblewhite M, 2007, OECOLOGIA, V152, P377, DOI 10.1007/s00442-007-0661-y; Hebblewhite M, 2009, ECOLOGY, V90, P3445, DOI 10.1890/08-2090.1; Heithaus MR, 2006, OIKOS, V114, P257; Holmes RT, 1996, J ANIM ECOL, V65, P183, DOI 10.2307/5721; Hutto R.L., 1985, P455; Johnson CJ, 2001, OECOLOGIA, V127, P590, DOI 10.1007/s004420000573; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; JORDE DG, 1984, CONDOR, V86, P258, DOI 10.2307/1366993; Jorgensen CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099339; Kauffman MJ, 2010, ECOLOGY, V91, P2742, DOI 10.1890/09-1949.1; Kelley JL, 2003, ANIM BEHAV, V65, P655, DOI 10.1006/anbe.2003.2076; Kenward RE., 2000, MANUAL WILDLIFE RADI; Kernohan Brian J., 2001, P125, DOI 10.1016/B978-012497781-5/50006-2; Kittle AM, 2008, OECOLOGIA, V157, P163, DOI 10.1007/s00442-008-1051-9; Klimstra W. D., 1963, Journal of Wildlife Management, V27, P202, DOI 10.2307/3798399; KOTLER BP, 1989, OIKOS, V54, P256, DOI 10.2307/3565279; Labisky R., 1968, NIGHTLIGHTING ITS US; Lack D, 1933, J ANIM ECOL, V2, P239, DOI 10.2307/961; Lafontaine A, 2017, J ANIM ECOL, V86, P624, DOI 10.1111/1365-2656.12645; Lapiedra O, 2018, SCIENCE, V360, P1017, DOI 10.1126/science.aap9289; Laundre John W., 2010, OPEN ECOL J, V3, P1, DOI [10.2174/1874213001003030001, DOI 10.2174/1874213001003030001]; Leedy D, 1945, RING NECKED PHEASANT, P57; Leif A., 2003, SURVIVAL SPATIAL ECO; LENTH RV, 1981, TECHNOMETRICS, V23, P149, DOI 10.2307/1268030; Lima SL, 1996, TRENDS ECOL EVOL, V11, P131, DOI 10.1016/0169-5347(96)81094-9; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Lima SL, 1998, ADV STUD BEHAV, V27, P215; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lone K, 2014, OIKOS, V123, P641, DOI 10.1111/j.1600-0706.2013.00938.x; MACARTHUR RH, 1964, P NATL ACAD SCI USA, V51, P1207, DOI 10.1073/pnas.51.6.1207; Mahr K., 2014, P R SOC B, V282, P1798; Mayor SJ, 2009, ECOSCIENCE, V16, P238, DOI 10.2980/16-2-3238; Morales JM, 2010, PHILOS T R SOC B, V365, P2289, DOI 10.1098/rstb.2010.0082; MORRIS DW, 1992, EVOL ECOL, V6, P412, DOI 10.1007/BF02270701; Morris DW, 2003, OECOLOGIA, V136, P1, DOI 10.1007/s00442-003-1241-4; Nebraska G and PC (NGPC), 2016, HUNTING GUIDE; Nelson EH, 2004, ECOLOGY, V85, P1853, DOI 10.1890/03-3109; Ofstad EG, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2695; Oksanen J., 2017, COMMUNITY ECOLOGY PA; ORIANS GH, 1991, AM NAT, V137, pS29, DOI 10.1086/285138; Proffitt KM, 2009, J WILDLIFE MANAGE, V73, P345, DOI 10.2193/2008-210; Relyea RA, 2000, J WILDLIFE MANAGE, V64, P146, DOI 10.2307/3802984; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; Rochette R, 2000, J EXP MAR BIOL ECOL, V253, P165, DOI 10.1016/S0022-0981(00)00253-7; ROSENZWEIG ML, 1991, AM NAT, V137, pS5, DOI 10.1086/285137; Schmitz OJ, 1998, AM NAT, V151, P327, DOI 10.1086/286122; Seaman DE, 1999, J WILDLIFE MANAGE, V63, P739, DOI 10.2307/3802664; Sih A., 1987, P203; Sih A, 2002, ANIM BEHAV, V63, P437, DOI 10.1006/anbe.2001.1921; Simonsen VL, 2016, J WILDLIFE MANAGE, V80, P877, DOI 10.1002/jwmg.1068; Smith ME, 2001, BEHAV ECOL SOCIOBIOL, V51, P101, DOI 10.1007/s002650100415; Sonnichsen L, 2013, ETHOLOGY, V119, P233, DOI 10.1111/eth.12057; STOKES AW, 1968, J WILDLIFE MANAGE, V32, P867, DOI 10.2307/3799563; Stuber EF, 2014, ANIM BEHAV, V98, P157, DOI 10.1016/j.anbehav.2014.10.010; SWIHART RK, 1985, J WILDLIFE MANAGE, V49, P1019, DOI 10.2307/3801388; Thomson RL, 2016, PREY HABITAT SELECTI, V29, P507; Tolon V, 2009, CAN J ZOOL, V87, P1129, DOI 10.1139/Z09-101; Tufto J, 1996, J ANIM ECOL, V65, P715, DOI 10.2307/5670; Turner AM, 2003, ECOLOGY, V84, P616, DOI 10.1890/0012-9658(2003)084[0616:SATSOP]2.0.CO;2; Valeix M, 2009, ECOLOGY, V90, P23, DOI 10.1890/08-0606.1; VANWINKLE W, 1975, J WILDLIFE MANAGE, V39, P118; WALSBERG GE, 1980, WILSON BULL, V92, P33; WARNER RE, 1982, J WILDLIFE MANAGE, V46, P923, DOI 10.2307/3808225; WHITHAM TG, 1978, ECOLOGY, V59, P1164, DOI 10.2307/1938230; Winnie JA, 2012, ECOLOGY, V93, P2600, DOI 10.1890/11-1990.1; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Wszola LS, 2019, WILDLIFE BIOL, DOI 10.2981/wlb.00526; Wszola LS, 2019, ECOL MODEL, V392, P268, DOI 10.1016/j.ecolmodel.2018.10.017; Zanette LY, 2011, SCIENCE, V334, P1398, DOI 10.1126/science.1210908	105	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222272	10.1371/journal.pone.0222272	http://dx.doi.org/10.1371/journal.pone.0222272			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5WE	31553753	Green Published, gold			2022-12-26	WOS:000532319200021
J	Duy, PN; Thuy, NT; Trang, BK; Giang, NH; Van, NTH; Xuan, NT				Pham Ngoc Duy; Nguyen Thu Thuy; Bui Kieu Trang; Nguyen Hoang Giang; Nguyen Thi Hong Van; Nguyen Thi Xuan			Regulation of NF-kappa B- and STAT1-mediated plasmacytoid dendritic cell functions by A20	PLOS ONE			English	Article							TOXOPLASMA-GONDII INFECTION; CUTTING EDGE; IL-12 PRODUCTION; IFN-GAMMA; ACTIVATION; RESISTANCE; PROFILIN; RECOGNITION; RESPONSES; ANTIGEN	Dendritic cells (DCs) are professional antigen presenting cells involved in the induction of T cell-mediated adaptive immunity. Plasmacytoid DCs (pDCs) originate from lymphoid precursors and produce type I interferons (IFNs) in response to pathogens. A20 is considered as a negative regulator of toll-like receptor (TLR) signaling pathways, in which Toxoplasma gondii- derived profilin (TgPRF) is a TLR11/12 ligand recognised by DCs to stimulate their maturation/activation. Little is known about contributions of A20 to changes in biological properties of pDCs. The present study, therefore, explored whether pDC functions are influenced by A20. To this end, bone marrow cells were isolated and cultured with Flt3L to attain CD8DCs, CD11bDCs and pDCs and followed by challenge with TgPRP in the presence or absence of A20 siRNA. Expression of maturation markers were analysed by flow cytometry, and secretion of inflammatory cytokines by ELISA, cell migration by a transwell migration assay and expression of signalling molecules by western blotting. As a result, treatment with A20 siRNA enhanced activations of I kappa B-alpha and STAT-1, leading to increases in expressions of maturation markers and cytokine productions as well as migration of TgPRP-treated pDCs, while mature CD11bDCs produced at higher levels of TNF-alpha and IL-6 only. In addition, functions of CD8DCs remained unaltered following A20 silencing. The effects of A20 on pDC maturation and activation were completely abolished by IKK inhibitor and partially blunted by fludarabine. In conclusion, the inhibitory effects of A20 on pDC functions are expected to affect the immune response in T. gondii infection.	[Pham Ngoc Duy] Vietnam Natl Univ Agr, Fac Biotechnol, Hanoi, Vietnam; [Nguyen Thu Thuy] Vietnam Mil Med Univ, Inst Biomed & Pharm, Hanoi, Vietnam; [Bui Kieu Trang; Nguyen Hoang Giang; Nguyen Thi Xuan] Vietnam Acad Sci & Technol, Inst Genome Res, Hanoi, Vietnam; [Nguyen Thi Hong Van] VNU Univ Sci, Fac Biol, Dept Genet, Hanoi, Vietnam; [Nguyen Thi Xuan] Grad Univ Sci & Technol, Vietnam Acad Sci & Technol, Hanoi, Vietnam	Vietnam National University of Agriculture (VNUA); Vietnam Academy of Science & Technology (VAST); Vietnam National University Hanoi; Vietnam Academy of Science & Technology (VAST)	Xuan, NT (corresponding author), Vietnam Acad Sci & Technol, Inst Genome Res, Hanoi, Vietnam.; Xuan, NT (corresponding author), Grad Univ Sci & Technol, Vietnam Acad Sci & Technol, Hanoi, Vietnam.	xuannt@igr.ac.vn			Vietnam National Foundation for Science and Technology Development (NAFOSTED) [108.06-2017.16]	Vietnam National Foundation for Science and Technology Development (NAFOSTED)(National Foundation for Science & Technology Development (NAFOSTED))	This research is funded by Vietnam National Foundation for Science and Technology Development (NAFOSTED) under grant number 108.06-2017.16 to NTX. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is funded by Vietnam National Foundation for Science and Technology Development (NAFOSTED) under grant number 108.06-2017.16.	Alberti J, 2003, NAT IMMUNOL, V4, P485, DOI 10.1038/ni915; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Carrington EM, 2015, P NATL ACAD SCI USA, V112, P4044, DOI 10.1073/pnas.1417620112; Chen HY, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0454-6; Cohen SB, 2015, J IMMUNOL, V195, P2754, DOI 10.4049/jimmunol.1501137; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; De Wilde K, 2017, ANN RHEUM DIS, V76, P585, DOI 10.1136/annrheumdis-2016-209454; Doring Y, 2012, ARTERIOSCL THROM VAS, V32, P1613, DOI 10.1161/ATVBAHA.111.236539; Gonzalez RMS, 2014, J INNATE IMMUN, V6, P685, DOI 10.1159/000362367; Johansson P, 2016, INT J CANCER, V138, P121, DOI 10.1002/ijc.29697; Koblansky AA, 2013, IMMUNITY, V38, P119, DOI 10.1016/j.immuni.2012.09.016; Kohli K, 2016, EUR J IMMUNOL, V46, P2659, DOI 10.1002/eji.201646359; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Liu CH, 2006, J IMMUNOL, V177, P31, DOI 10.4049/jimmunol.177.1.31; Longo CR, 2003, CIRCULATION, V108, P1113, DOI 10.1161/01.CIR.0000083718.76889.D0; Matzner N, 2008, J IMMUNOL, V181, P6803, DOI 10.4049/jimmunol.181.10.6803; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Pepper M, 2008, J IMMUNOL, V180, P6229, DOI 10.4049/jimmunol.180.9.6229; Raetz M, 2013, J IMMUNOL, V191, P4818, DOI 10.4049/jimmunol.1301301; Roach JC, 2005, P NATL ACAD SCI USA, V102, P9577, DOI 10.1073/pnas.0502272102; Scanga CA, 2002, J IMMUNOL, V168, P5997, DOI 10.4049/jimmunol.168.12.5997; SchartonKersten TM, 1996, J IMMUNOL, V157, P4045; Schneider AG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060215; Sozzani S, 2017, J AUTOIMMUN, V85, P126, DOI 10.1016/j.jaut.2017.07.012; Tosh KW, 2016, J IMMUNOL, V196, P345, DOI 10.4049/jimmunol.1501558; Wang X, 2013, ACTA NEUROPATHOL, V126, P711, DOI 10.1007/s00401-013-1183-9; Wang Y, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0116359, 10.1371/journal.pone.0124566]; Xuan NT, 2014, EUR J IMMUNOL, DOI [10.1002/eji, DOI 10.1002/EJI]; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Yarovinsky F, 2006, IMMUNITY, V25, P655, DOI 10.1016/j.immuni.2006.07.015; Yin L, 2017, DRUG DES DEV THER, V11, P2841, DOI 10.2147/DDDT.S135993	31	5	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222697	10.1371/journal.pone.0222697	http://dx.doi.org/10.1371/journal.pone.0222697			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545817	Green Published, gold			2022-12-26	WOS:000532303200026
J	Higarza, SG; Arboleya, S; Gueimonde, M; Gomez-Lazaro, E; Arias, JL; Arias, N				Higarza, Sara G.; Arboleya, Silvia; Gueimonde, Miguel; Gomez-Lazaro, Eneritz; Arias, Jorge L.; Arias, Natalia			Neurobehavioral dysfunction in non-alcoholic steatohepatitis is associated with hyperammonemia, gut dysbiosis, and metabolic and functional brain regional deficits	PLOS ONE			English	Article							HIGH-FAT DIET; HIPPOCAMPAL-DEPENDENT MEMORY; LIVER-DISEASE; INTESTINAL MICROBIOTA; INSULIN-RESISTANCE; COGNITIVE IMPAIRMENT; OXIDATIVE-METABOLISM; CYTOCHROME-OXIDASE; PREFRONTAL CORTEX; CHOLESTEROL DIET	Non-alcoholic steatohepatitis (NASH) is one of the most prevalent diseases worldwide. While it has been suggested to cause nervous impairment, its neurophysiological basis remains unknown. Therefore, the aim of this study is to unravel the effects of NASH, through the interrelationship of liver, gut microbiota, and nervous system, on the brain and human behavior. To this end, 40 Sprague-Dawley rats were divided into a control group that received normal chow and a NASH group that received a high-fat, high-cholesterol diet. Our results show that 14 weeks of the high-fat, high-cholesterol diet induced clinical conditions such as NASH, including steatosis and increased levels of ammonia. Rats in the NASH group also demonstrated evidence of gut dysbiosis and decreased levels of short-chain fatty acids in the gut. This may explain the deficits in cognitive ability observed in the NASH group, including their depressive-like behavior and short-term memory impairment characterized in part by deficits in social recognition and prefrontal cortex-dependent spatial working memory. We also reported the impact of this NASH-like condition on metabolic and functional processes. Brain tissue demonstrated lower levels of metabolic brain activity in the prefrontal cortex, thalamus, hippocampus, amygdala, and mammillary bodies, accompanied by a decrease in dopamine levels in the prefrontal cortex and cerebellum and a decrease in noradrenalin in the striatum. In this article, we emphasize the important role of ammonia and gut-derived bacterial toxins in liver-gut-brain neurodegeneration and discuss the metabolic and functional brain regional deficits and behavioral impairments in NASH.	[Higarza, Sara G.; Arias, Jorge L.; Arias, Natalia] Inst Neurosci Principal Asturias INEUROPA, Asturias, Spain; [Higarza, Sara G.; Arias, Jorge L.] Univ Oviedo, Dept Psychol, Lab Neurosci, Oviedo, Spain; [Arboleya, Silvia; Gueimonde, Miguel] CSIC, Inst Dairy Prod Principal Asturias IPLA, Dept Microbiol & Biochem Dairy Prod, Asturias, Spain; [Gomez-Lazaro, Eneritz] Univ Basque Country, Dept Basic Psychol Proc & Their Dev, San Sebastian, Basque Country, Spain; [Arias, Natalia] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Basic & Clin Neurosci, London, England	University of Oviedo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA); University of Basque Country; University of London; King's College London	Higarza, SG; Arias, N (corresponding author), Inst Neurosci Principal Asturias INEUROPA, Asturias, Spain.; Higarza, SG (corresponding author), Univ Oviedo, Dept Psychol, Lab Neurosci, Oviedo, Spain.; Arias, N (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Basic & Clin Neurosci, London, England.	sghigarza@gmail.com; natalia.arias@kcl.ac.uk	Gueimonde, Miguel/A-2106-2008; Lázaro, Eneritz Gómez/ABF-9763-2020; arboleya, silvia/Q-2385-2018	Gueimonde, Miguel/0000-0002-0192-901X; Higarza, Sara G./0000-0003-4121-4358; arboleya, silvia/0000-0002-6155-5822; Gomez-Lazaro, Eneritz/0000-0002-0054-7562	Ministry of Science, Innovation and Universities [PSI2017-83893-R]; Ministry of Economy and Business [PSI2015-63658-R, PSI2015-73111-EXP, PSI2017-90806-REDT]	Ministry of Science, Innovation and Universities; Ministry of Economy and Business	This work was supported by the Ministry of Science, Innovation and Universities (PSI2017-83893-R to JLA) and the Ministry of Economy and Business (PSI2015-63658-R, PSI2015-73111-EXP to JLA, and PSI2017-90806-REDT to JLA) (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 2016, J CEREBR BLOOD F MET, V36, P941, DOI 10.1177/0271678X15606719; Al-Lahham SH, 2010, EUR J CLIN INVEST, V40, P401, DOI 10.1111/j.1365-2362.2010.02278.x; [Anonymous], 2018, NEUROSCIENCE, V370, P148, DOI [10.1016/j.neuroscience.2017.07.013, DOI 10.1016/J.NEUROSCIENCE.2017.07.013]; Arboleya S, 2015, J PEDIATR-US, V166, P538, DOI 10.1016/j.jpeds.2014.09.041; Arboleya S, 2012, FEMS MICROBIOL ECOL, V79, P763, DOI 10.1111/j.1574-6941.2011.01261.x; Arias N, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/390872; Baldini S, 2013, J NEUROSCI, V33, P11715, DOI 10.1523/JNEUROSCI.3541-12.2013; Bercik P, 2011, GASTROENTEROLOGY, V141, P599, DOI 10.1053/j.gastro.2011.04.052; Bharwani A, 2016, PSYCHONEUROENDOCRINO, V63, P217, DOI 10.1016/j.psyneuen.2015.10.001; Boets E, 2017, J PHYSIOL-LONDON, V595, P541, DOI 10.1113/JP272613; Bogdanova O V, 2017, PHYSIOL BEHAV, V118, P227; Boitard C, 2014, BRAIN BEHAV IMMUN, V40, P9, DOI 10.1016/j.bbi.2014.03.005; Bot M, 2016, PSYCHONEUROENDOCRINO, V68, P148, DOI 10.1016/j.psyneuen.2016.02.028; Boulange CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Brenes JC, 2008, PHARMACOL BIOCHEM BE, V89, P85, DOI 10.1016/j.pbb.2007.11.004; Bruce-Keller AJ, 2015, BIOL PSYCHIAT, V77, P607, DOI 10.1016/j.biopsych.2014.07.012; Byrne CD, 2015, J HEPATOL, V62, pS47, DOI 10.1016/j.jhep.2014.12.012; Caricilli AM, 2013, NUTRIENTS, V5, P829, DOI 10.3390/nu5030829; Carr RM, 2016, GASTROENTEROL CLIN N, V45, P639, DOI 10.1016/j.gtc.2016.07.003; Carter-Kent C, 2008, AM J GASTROENTEROL, V103, P1036, DOI 10.1111/j.1572-0241.2007.01709.x; Chambers ES, 2015, GUT, V64, P1744, DOI 10.1136/gutjnl-2014-307913; Christensen CU, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192728; Dandash O, 2017, SCHIZOPHR RES, V180, P48, DOI 10.1016/j.schres.2016.08.020; Darling JN, 2013, OBESITY, V21, P910, DOI 10.1002/oby.20167; De Chiara F, 2018, J HEPATOL, V69, P905, DOI 10.1016/j.jhep.2018.06.023; de la Monte SM, 2009, CURR OPIN INVEST DR, V10, P1049; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; del Campo N, 2011, BIOL PSYCHIAT, V69, pE145, DOI 10.1016/j.biopsych.2011.02.036; Del Rosario A, 2015, BR J NUTR, V33, P395; Deshpande NG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217553; Deuschle M, 1997, PSYCHONEUROENDOCRINO, V22, P493, DOI 10.1016/S0306-4530(97)00046-2; Dinan TG, 2013, NEUROGASTROENT MOTIL, V25, P713, DOI 10.1111/nmo.12198; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Egorin MJ, 1999, CANCER CHEMOTH PHARM, V43, P445, DOI 10.1007/s002800050922; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Felger JC, 2017, NEUROPSYCHOPHARMACOL, V42, P216, DOI 10.1038/npp.2016.143; Felipo V, 2002, PROG NEUROBIOL, V67, P259, DOI 10.1016/S0301-0082(02)00019-9; Francque S, 2010, EUR J GASTROEN HEPAT, V22, P1449, DOI 10.1097/MEG.0b013e32833f14a1; Freeman LR, 2013, FREE RADICAL BIO MED, V56, P226, DOI 10.1016/j.freeradbiomed.2012.08.577; Fukae J, 2005, ARTHRITIS RHEUM-US, V52, P2697, DOI 10.1002/art.21258; Fusco S, 2013, CELL MOL LIFE SCI, V70, P3157, DOI 10.1007/s00018-012-1223-y; Gonda X, 2015, ANN GEN PSYCHIATR, V14, DOI 10.1186/s12991-015-0068-9; GONZALEZLIMA F, 1994, NEUROSCIENCE, V63, P559, DOI 10.1016/0306-4522(94)90550-9; GonzalezPardo H, 1996, BRAIN RES BULL, V41, P31; GONZALORUIZ A, 1992, J COMP NEUROL, V321, P300, DOI 10.1002/cne.903210209; Gordon JA, 2011, CURR OPIN NEUROBIOL, V21, P486, DOI 10.1016/j.conb.2011.02.012; Granholm AC, 2008, J ALZHEIMERS DIS, V14, P133; Griffin AL, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00029; GRIPPON P, 1986, HEPATOLOGY, V6, P682, DOI 10.1002/hep.1840060424; Hargrave SL, 2016, BEHAV NEUROSCI, V130, P123, DOI 10.1037/bne0000110; Harris KM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005587; Heeboll S, 2015, PHARMACOL RES, V95-96, P34, DOI 10.1016/j.phrs.2015.03.005; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hernandez-Rabaza V, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0505-y; Hoshaw BA, 2008, EUR J PHARMACOL, V594, P109, DOI 10.1016/j.ejphar.2008.07.023; Hu X, 2014, BEHAV BRAIN FUNCT, V10, DOI 10.1186/1744-9081-10-30; IKEMOTO S, 1997, AM J PHYSL 1, V273, pE3; Ito HT, 2015, NATURE, V522, P50, DOI 10.1038/nature14396; Jha SK, 2017, BBA-MOL BASIS DIS, V1863, P1132, DOI 10.1016/j.bbadis.2016.06.015; JONES BJ, 1968, J PHARM PHARMACOL, V20, P302, DOI 10.1111/j.2042-7158.1968.tb09743.x; Kang DJ, 2016, HEPATOLOGY, V64, P1232, DOI 10.1002/hep.28696; Kempadoo KA, 2016, P NATL ACAD SCI USA, V113, P14835, DOI 10.1073/pnas.1616515114; Kleinridders A, 2015, P NATL ACAD SCI USA, V112, P3463, DOI 10.1073/pnas.1500877112; Klooker TK, 2009, AM J GASTROENTEROL, V104, P2250, DOI 10.1038/ajg.2009.282; Kolasiewicz W, 2011, CEREBELLUM, V10, P267, DOI 10.1007/s12311-011-0250-9; KOLB B, 1990, PROG BRAIN RES, V85, P501; Kucera O, 2014, WORLD J GASTROENTERO, V20, P8364, DOI 10.3748/wjg.v20.i26.8364; Lammel S, 2014, NEUROPHARMACOLOGY, V76, P351, DOI 10.1016/j.neuropharm.2013.03.019; Ledreux A, 2016, BEHAV BRAIN RES, V312, P294, DOI 10.1016/j.bbr.2016.06.012; Li YL, 2009, BRAIN RES, V1268, P181, DOI 10.1016/j.brainres.2009.02.075; Li Z, 2018, GUT, V67, P1269, DOI 10.1136/gutjnl-2017-314050; Llansola M, 2013, METAB BRAIN DIS, V28, P151, DOI 10.1007/s11011-012-9337-3; Locke TM, 2018, BIOL PSYCHIAT, V84, P401, DOI 10.1016/j.biopsych.2018.01.019; Ma J, 2017, NUTRIENTS, V9, P10; Marques C, 2016, ADIPOCYTE, V5, P11, DOI 10.1080/21623945.2015.1061723; Mastrocola R, 2016, NEUROBIOL DIS, V89, P65, DOI 10.1016/j.nbd.2016.02.005; McNeilly AD, 2015, PSYCHONEUROENDOCRINO, V52, P272, DOI 10.1016/j.psyneuen.2014.12.002; Mebel DM, 2012, EUR J NEUROSCI, V36, P2336, DOI 10.1111/j.1460-9568.2012.08168.x; Mendez M, 2008, PHYSIOL BEHAV, V95, P302, DOI 10.1016/j.physbeh.2008.06.013; Mendez M, 2009, BRAIN RES BULL, V78, P195, DOI 10.1016/j.brainresbull.2008.10.008; Meunier Claire N J, 2017, Front Synaptic Neurosci, V9, P2, DOI 10.3389/fnsyn.2017.00002; Milani C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068739; Mitschelen M, 2011, NEUROSCIENCE, V185, P50, DOI 10.1016/j.neuroscience.2011.04.032; Moloney RD, 2016, CNS NEUROSCI THER, V22, P102, DOI 10.1111/cns.12490; Moris G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32700-y; Morris G, 2017, MOL NEUROBIOL, V54, P4271, DOI 10.1007/s12035-016-9975-2; Morris MC, 2015, ALZHEIMERS DEMENT, V11, P1015, DOI 10.1016/j.jalz.2015.04.011; Nagpal R, 2016, BENEF MICROBES, V7, P181, DOI [10.3920/bm2015.0062, 10.3920/BM2015.0062]; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Neufeld KM, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01620.x; Neuman MG, 2014, CAN J GASTROENTEROL, V28, P607, DOI 10.1155/2014/757929; Nogacka A, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0313-3; Ott T, 2019, TRENDS COGN SCI, V23, P213, DOI 10.1016/j.tics.2018.12.006; Paradies G, 2014, WORLD J GASTROENTERO, V20, P14205, DOI 10.3748/wjg.v20.i39.14205; Paxinos G., 2004, RAT BRAIN STEREOTAXI; Perez-Burgos A, 2013, AM J PHYSIOL-GASTR L, V304, pG211, DOI 10.1152/ajpgi.00128.2012; Perry RJ, 2016, NATURE, V534, P213, DOI 10.1038/nature18309; Picloplichko VI, 2006, P NATL ACAD SCI USA, V103, P11376, DOI 10.1073/pnas.0600768103; Pintana H, 2012, LIFE SCI, V91, P409, DOI 10.1016/j.lfs.2012.08.017; Plaza-Diaz J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060555; PORSOLT RD, 1978, EUR J PHARMACOL, V47, P379, DOI 10.1016/0014-2999(78)90118-8; Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005; Prasad A, 1996, PHYSIOL BEHAV, V60, P1039, DOI 10.1016/0031-9384(96)00135-7; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Radyushkin K, 2005, EUR J NEUROSCI, V21, P219, DOI 10.1111/j.1460-9568.2004.03844.x; Reigstad CS, 2015, FASEB J, V29, P1395, DOI 10.1096/fj.14-259598; Rodrigo R, 2010, GASTROENTEROLOGY, V139, P675, DOI 10.1053/j.gastro.2010.03.040; Rojas JC, 2012, J ALZHEIMERS DIS, V32, P741, DOI 10.3233/JAD-2012-120817; Ronan PJ, 2007, BRAIN RES, V1147, P184, DOI 10.1016/j.brainres.2007.02.015; Ross AP, 2012, PHYSIOL BEHAV, V106, P133, DOI 10.1016/j.physbeh.2012.01.008; Saad MJA, 2016, PHYSIOLOGY, V31, P283, DOI 10.1152/physiol.00041.2015; Saemann MD, 2000, FASEB J, V14, P2380; Santhekadur PK, 2018, J HEPATOL, V68, P230, DOI 10.1016/j.jhep.2017.10.031; Santi A, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0196-5; Schonfeld P, 2016, J LIPID RES, V57, P943, DOI 10.1194/jlr.R067629; Shawcross DL, 2015, EXPERT REV GASTROENT, V9, P539, DOI 10.1586/17474124.2015.1035257; Skowronska M, 2012, NEUROTOX RES, V21, P236, DOI 10.1007/s12640-011-9269-4; Slattery DA, 2007, PSYCHOPHARMACOLOGY, V190, P555, DOI 10.1007/s00213-006-0630-x; Sokolov AA, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00145; Spencer SJ, 2017, NEUROBIOL AGING, V58, P88, DOI 10.1016/j.neurobiolaging.2017.06.014; Stam R, 1997, GUT, V40, P704, DOI 10.1136/gut.40.6.704; Stranahan AM, 2008, HIPPOCAMPUS, V18, P1085, DOI 10.1002/hipo.20470; Strandwitz P, 2018, BRAIN RES, V1693, P128, DOI 10.1016/j.brainres.2018.03.015; Strekalova T, 2015, BRAIN BEHAV IMMUN, V48, P42, DOI 10.1016/j.bbi.2015.02.015; Tangvarasittichai S, 2015, WORLD J DIABETES, V6, P456, DOI 10.4239/wjd.v6.i3.456; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; Thomsen KL, 2011, SCAND J CLIN LAB INV, V71, P150, DOI 10.3109/00365513.2010.547213; Thomsen KL, 2014, AM J PHYSIOL-GASTR L, V307, pG295, DOI 10.1152/ajpgi.00036.2014; Tomic D, 2018, EUR J GASTROEN HEPAT, V30, P1103, DOI 10.1097/MEG.0000000000001235; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Valdes L, 2017, EUR FOOD RES TECHNOL, V243, P157, DOI 10.1007/s00217-016-2732-y; van de Wouw M, 2018, J PHYSIOL-LONDON, V596, P4923, DOI 10.1113/JP276431; Vaugeois JM, 1996, PHARMACOL BIOCHEM BE, V54, P235, DOI 10.1016/0091-3057(95)02131-0; Wang DM, 2015, CELL MOL NEUROBIOL, V35, P1061, DOI 10.1007/s10571-015-0201-y; Wang GW, 2006, BEHAV BRAIN RES, V175, P329, DOI 10.1016/j.bbr.2006.09.002; Wang ZQ, 2016, NEUROSCI LETT, V627, P185, DOI 10.1016/j.neulet.2016.05.014; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Xia M, 2019, BEHAV BRAIN RES, V356, P170, DOI 10.1016/j.bbr.2018.08.024; Xing B, 2016, BRAIN RES, V1641, P217, DOI 10.1016/j.brainres.2016.01.005; Xu ZJ, 2010, DIGEST DIS SCI, V55, P931, DOI 10.1007/s10620-009-0815-3; Yki-Jarvinen H, 2016, DIABETOLOGIA, V59, P1104, DOI 10.1007/s00125-016-3944-1	145	28	28	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0223019	10.1371/journal.pone.0223019	http://dx.doi.org/10.1371/journal.pone.0223019			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539420	Green Published, gold			2022-12-26	WOS:000532297900041
J	Lin, W; Wang, DP; Meng, YL; Chen, SC				Lin, Wei; Wang, Dongping; Meng, Yunlong; Chen, Shih-Chi			Multi-focus microscope with HiLo algorithm for fast 3-D fluorescent imaging	PLOS ONE			English	Article							SECTIONING MICROSCOPY; 2-PHOTON MICROSCOPY; STRUCTURED LIGHT; DEPTH; RESOLUTION; SPECKLE; CELL	In this paper, we present a new multi-focus microscope (MFM) system based on a phase mask and HiLo algorithm, achieving high-speed (20 volumes per second), high-resolution, low-noise 3-D fluorescent imaging. During imaging, the emissions from the specimen at nine different depths are simultaneously modulated and focused to different regions on a single CCD chip, i.e., the CCD chip is subdivided into nine regions to record images from the different selected depths. Next, HiLo algorithm is applied to remove the background noises and to form clean 3-D images. To visualize larger volumes, the nine layers are scanned axially, realizing fast 3-D imaging. In the imaging experiments, a mouse kidney sample of similar to 60 x 60 x 16 mu m(3) is visualized with only 10 raw images, demonstrating substantially enhanced resolution and contrast as well as suppressed background noises. The new method will find important applications in 3-D fluorescent imaging, e.g., recording fast dynamic events at multiple depths in vivo.	[Lin, Wei; Wang, Dongping; Meng, Yunlong; Chen, Shih-Chi] Chinese Univ Hong Kong, Dept Mech & Automat Engn, Shatin, Hong Kong, Peoples R China; [Lin, Wei] Nankai Univ, Inst Modern Opt, Tianjin Key Lab Optoelect Sensor & Sensing Networ, Tianjin, Peoples R China	Chinese University of Hong Kong; Nankai University	Chen, SC (corresponding author), Chinese Univ Hong Kong, Dept Mech & Automat Engn, Shatin, Hong Kong, Peoples R China.	scchen@mae.cuhk.edu.hk	Chen, Shih-Chi/T-2988-2019	Chen, Shih-Chi/0000-0002-4935-8412; Lin, Wei/0000-0001-9711-2022	HKSAR Research Grants Council (RGC) General Research Fund (GRF) [CUHK 14201214]; HKSAR Innovation and Technology Commission [ITS/428/17FP]	HKSAR Research Grants Council (RGC) General Research Fund (GRF); HKSAR Innovation and Technology Commission	This work was supported by HKSAR Research Grants Council (RGC) General Research Fund (GRF) (CUHK 14201214; to SCC); HKSAR Innovation and Technology Commission (ITS/428/17FP; to SCC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson S, 2017, BIOMED OPT EXPRESS, V8, P4135, DOI 10.1364/BOE.8.004135; Abrahamsson S, 2016, BIOMED OPT EXPRESS, V7, P855, DOI 10.1364/BOE.7.000855; Abrahamsson S, 2013, NAT METHODS, V10, P60, DOI [10.1038/NMETH.2277, 10.1038/nmeth.2277]; Blanchard PM, 2000, OPT COMMUN, V183, P29, DOI 10.1016/S0030-4018(00)00874-9; Brooker G, 2011, OPT EXPRESS, V19, P5047, DOI 10.1364/OE.19.005047; CARLSSON K, 1985, OPT LETT, V10, P53, DOI 10.1364/OL.10.000053; Chen HH, 2015, OPT EXPRESS, V23, P7075, DOI 10.1364/OE.23.007075; Chen X, 2011, P 24 IEEE C COMP VIS; Choi H, 2013, BIOMED OPT EXPRESS, V4, P995, DOI 10.1364/BOE.4.000995; Choi H, 2012, OPT EXPRESS, V20, P26219, DOI 10.1364/OE.20.026219; Conchello JA, 2005, NAT METHODS, V2, P920, DOI 10.1038/NMETH815; Descloux A, 2018, NAT PHOTONICS, V12, P165, DOI 10.1038/s41566-018-0109-4; Di Leonardo R, 2007, OPT EXPRESS, V15, P1913, DOI 10.1364/OE.15.001913; Hajj B, 2014, P NATL ACAD SCI USA, V111, P17480, DOI 10.1073/pnas.1412396111; Hu LF, 2004, OPT EXPRESS, V12, P6403, DOI 10.1364/OPEX.12.006403; Humar M, 2015, NAT PHOTONICS, V9, P572, DOI [10.1038/nphoton.2015.129, 10.1038/NPHOTON.2015.129]; Jiang J, 2015, OPT EXPRESS, V23, P24362, DOI 10.1364/OE.23.024362; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Lim D, 2008, OPT LETT, V33, P1819, DOI 10.1364/OL.33.001819; Lin CY, 2016, BIOMED OPT EXPRESS, V7, P3968, DOI 10.1364/BOE.7.003968; Maurer C, 2010, OPT EXPRESS, V18, P3023, DOI 10.1364/OE.18.003023; Mertz J, 2011, NAT METHODS, V8, P811, DOI 10.1038/nmeth.1709; Michaelson J, 2012, BIOMED OPT EXPRESS, V3, P1241, DOI 10.1364/BOE.3.001241; Neil MAA, 1997, OPT LETT, V22, P1905, DOI 10.1364/OL.22.001905; Olivier N, 2009, OPT LETT, V34, P1684, DOI 10.1364/OL.34.001684; Paddock SW, 2014, METHODS MOL BIOL, V1075, P9, DOI 10.1007/978-1-60761-847-8_2; Piestun R, 1996, J OPT SOC AM A, V13, P1837, DOI 10.1364/JOSAA.13.001837; Rosen J, 2008, NAT PHOTONICS, V2, P190, DOI 10.1038/nphoton.2007.300; Rosen J, 2014, OPT EXPRESS, V22, P29048, DOI 10.1364/OE.22.029048; Shao L, 2011, NAT METHODS, V8, P1044, DOI [10.1038/NMETH.1734, 10.1038/nmeth.1734]; Zhang JZ, 2017, OPTICA, V4, P1306, DOI 10.1364/OPTICA.4.001306	31	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222729	10.1371/journal.pone.0222729	http://dx.doi.org/10.1371/journal.pone.0222729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539402	gold, Green Published			2022-12-26	WOS:000532297900026
J	Cohen, R; Gesser-Edelsburg, A; Singhal, A; Benenson, S; Moses, AE				Cohen, Ricky; Gesser-Edelsburg, Anat; Singhal, Arvind; Benenson, Shmuel; Moses, Allon E.			Deconstruction of central line insertion guidelines based on the positive deviance approach-Reducing gaps between guidelines and implementation: A qualitative ethnographic research	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; CARE-ASSOCIATED INFECTIONS; FOR-DISEASE-CONTROL; HAND HYGIENE; PREVENTION; STRATEGIES; EDUCATION; UNITS	Background Despite a proven association between the implementation of prevention guidelines for central line associated blood stream infections (CLABSI) and reduction in CLABSI rates, in practice there is poor adherence. Furthermore, current guidelines fail to address the multiple process on the care continuum. This research is based on the bottom-up "Positive Deviance" (PD) approach, through which multiple creative and safer solutions for central line (CL) insertion were identified that were not previously described in the guidelines. The aim of the study was to deconstruct CLABSI prevention guidelines ("during insertion" process only) through the PD approach, working with physicians to identify additional actions that, in practice, help maintain a sterile environment and contribute to patient safety. Methods and findings Our study included a qualitative ethnographic study involving 76 physicians, working in a division of internal medicine and two intensive care units (ICUs). We triangulated findings from a combination of data-collection methods: semi-structured interviews, focused observations, video documentation, Discovery & Action Dialogue (DAD), and simulations. Deconstruction analysis was performed. A total of 23 creative extensions and variations of CL insertion practices were identified. Conclusions The PD approach enables the identification of vital nuggets of hidden wisdom missing from the formal explicit CLABSI guidelines, and therefore helps bridge the gap between theory and praxis. During the guideline's deconstruction process, through collaborative staff learning, the written procedure is transformed into a living, breathing and cooperative one. It can reduce hospital stays and save lives, and therefore needs careful attention of healthcare scholars and practitioners.	[Cohen, Ricky; Gesser-Edelsburg, Anat] Univ Haifa, Sch Publ Hlth, Haifa, Israel; [Gesser-Edelsburg, Anat] Univ Haifa, Hlth & Risk Commun Res Ctr, Haifa, Israel; [Singhal, Arvind] Univ Texas El Paso, Dept Commun, El Paso, TX 79968 USA; [Singhal, Arvind] Inland Univ Appl Sci, Sch Business & Social Sci, Elverum, Norway; [Benenson, Shmuel; Moses, Allon E.] Hadassah Hebrew Univ Med Ctr, Dept Clin Microbiol & Infect Dis, Jerusalem, Israel; [Gesser-Edelsburg, Anat] Univ Haifa, Haifa, Israel; [Singhal, Arvind] Univ Texas El Paso, El Paso, TX 79968 USA; [Singhal, Arvind] Inland Univ Appl Sci, Elverum, Norway; [Benenson, Shmuel; Moses, Allon E.] Hadassah Hebrew Univ, Med Ctr, Jerusalem, Israel	University of Haifa; University of Haifa; University of Texas System; University of Texas El Paso; Hebrew University of Jerusalem; University of Haifa; University of Texas System; University of Texas El Paso; Hebrew University of Jerusalem; Hadassah University Medical Center	Cohen, R (corresponding author), Univ Haifa, Sch Publ Hlth, Haifa, Israel.	ricky.cohen83@gmail.com		Cohen, Ricky/0000-0003-2868-9666; Gesser-Edelsburg, PhD, Prof. Anat/0000-0003-4467-8799	Israel National Institute for Health Policy Research [2016\134\]; Israel National Institute for Health Policy Research	Israel National Institute for Health Policy Research; Israel National Institute for Health Policy Research	This work was supported by grant number 2016\134\. fromthe Israel National Institute for Health Policy Research to AGE. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Adva Mir Halavi, Prof. Peter Vernon van Heerden, Dr. Sigal Sviri, Dr. Uriel Trahtemberg, Dr. Akiva Nahshon, Dr. Alexsi Vachadze, Dr. Efrat OrenbuchHarroch, Prof. Lior Lowenstein, Dr. Dan Shteinberg, Dr. Asher Salmon, Dr. Khitam Hussein, Dvora Kirshenbom, Gilat Yhye and Aviva Simhon who have participated in this study and the Israel National Institute for Health Policy Research for funding the research.	Baez S, 2017, AM J RESP CRIT CARE, V195; Ben-David D, 2019, INFECT CONT HOSP EP, V40, P1094, DOI 10.1017/ice.2019.190; Berenholtz SM, 2014, INFECT CONT HOSP EP, V35, P56, DOI 10.1086/674384; Carter N, 2014, ONCOL NURS FORUM, V41, P545, DOI 10.1188/14.ONF.545-547; Cartier V, 2016, EUR J ANAESTH, V33, P568, DOI 10.1097/EJA.0000000000000423; Centers for Disease Control and Prevention, 2017, REC US CHLORH IMPR D; Centers for Disease Control and Prevention, 2013, ANT RES THREATS US; Clack L, 2018, BMJ QUAL SAF, V27, P771, DOI 10.1136/bmjqs-2017-007675; Cooke L, 2010, IEEE T PROF COMMUN, V53, P202, DOI 10.1109/TPC.2010.2052859; Creswell J. W., 2013, QUALITATIVE INQUIRY; Dalton L, 2015, AUST J ADV NURS, V33, P29; Erasmus V, 2010, INFECT CONT HOSP EP, V31, P283, DOI 10.1086/650451; European Commission, 2017, EUR COMM LAST VISIT; Furuya EY, 2016, INFECT CONT HOSP EP, V37, P805, DOI 10.1017/ice.2016.67; Gerolemou L, 2014, AM J CRIT CARE, V23, P40, DOI 10.4037/ajcc2014860; Gesser-Edelsburg A, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0418-x; Glanz K, 2015, HLTH BEHAV HLTH ED T; Gurses AP, 2008, QUAL SAF HEALTH CARE, V17, P351, DOI 10.1136/qshc.2006.021709; Herington MJ, 2018, DEVIANT BEHAV, V39, P664, DOI 10.1080/01639625.2017.1286194; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Huis A, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-92; Ista E, 2016, LANCET INFECT DIS, V16, P724, DOI 10.1016/S1473-3099(15)00409-0; James W, 1975, MEANING TRUTH; Johnson Barbara, 1985, CRITICAL DIFFERENCE; Kahneman D., 2011, THINKING FAST SLOW; Kim J, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0672-7; Krein SL, 2015, BMJ QUAL SAF, V24, P385, DOI 10.1136/bmjqs-2014-003870; Latif A, 2015, CURR INFECT DIS REP, V17, DOI 10.1007/s11908-015-0491-8; Liang SY, 2011, ANN EMERG MED, V58, P447, DOI 10.1016/j.annemergmed.2011.07.035; Lindberg C, 2013, AM J INFECT CONTROL, V41, P513, DOI 10.1016/j.ajic.2012.07.015; Ling ML, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0116-5; Marschall J, 2014, INFECT CONT HOSP EP, V35, P753, DOI [10.1086/676533, 10.1017/S0899823X00193870]; O'Grady NP, 2011, CLIN INFECT DIS, V52, pE162, DOI 10.1093/cid/cir257; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pasiechnik D, 2014, ASIA-PAC J CLIN ONCO, V10, P22; Patel PK, 2018, J HOSP MED, V13, P105, DOI 10.12788/jhm.2856; Pittet D., 2017, HAND HYGIENE HDB MED; SINGHAL A, 2009, E Y PERFORMANCE, V2, P78; Singhal A., 2014, INSPIRING CHANGE SAV; Singhal A., 2018, J DEV COMMUNICATION, V29, P34; Singhal A., 2014, HLTH COMMUNICATION S, V5, P176; Singhal A., 2010, INVITING EVERYONE HE; Slettli Victoria Konovalenko, 2017, Electronic Journal of Knowledge Management, V15, P17; Sreeramoju P, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy231; Srigley JA, 2015, J HOSP INFECT, V91, P202, DOI 10.1016/j.jhin.2015.06.019; State Comptroller, 2013, ANN CONTR REPORT63C; State of Israel Ministry of Health, 2016, ACQ INF REP YEAR 201; Suen Lee-Jen Wu, 2014, Hu Li Za Zhi, V61, P105, DOI 10.6224/JN.61.3.105; Tolley E, 2016, QUALITATIVE METHODS, P85; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Valencia C, 2016, ANTIMICROB RESIST IN, V5, DOI 10.1186/s13756-016-0139-y; Weiner LM, 2016, INFECT CONT HOSP EP, V37, P1288, DOI 10.1017/ice.2016.174; WHO, 2009, GUIDE IMPLEMENTATION; Wolfreys J., 1998, DECONSTRUCTION DERRI; World Health Organization (WHO), 2009, WHO GUID HAND HYG HL; Yokoe DS, 2014, AM J INFECT CONTROL, V42, P820, DOI 10.1016/j.ajic.2014.07.002; Zingg W, 2015, LANCET INFECT DIS, V15, P212, DOI 10.1016/S1473-3099(14)70854-0	58	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222608	10.1371/journal.pone.0222608	http://dx.doi.org/10.1371/journal.pone.0222608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5BF	31536568	gold, Green Submitted, Green Published			2022-12-26	WOS:000532262800062
J	Hammond, CL; Roztocil, E; Phipps, RP; Feldon, SE; Woeller, CF				Hammond, Christine L.; Roztocil, Elisa; Phipps, Richard P.; Feldon, Steven E.; Woeller, Collynn F.			Proton pump inhibitors attenuate myofibroblast formation associated with thyroid eye disease through the aryl hydrocarbon receptor	PLOS ONE			English	Article							TGF-BETA; LIVER FIBROSIS; ACTIVATION; OMEPRAZOLE; WNT; AHR; PHARMACEUTICALS; PATHOGENESIS; EXPRESSION; LIGANDS	Thyroid eye disease (TED) can lead to scar formation and tissue remodeling in the orbital space. In severe cases, the scarring process leads to sight-threatening pathophysiology. There is no known effective way to prevent scar formation in TED patients, or to reverse scarring once it occurs. In this study, we show that the proton pump inhibitors (PPIs), esomeprazole and lansoprazole, can prevent transforming growth factor beta (TGF beta)- mediated differentiation of TED orbital fibroblasts to myofibroblasts, a critical step in scar formation. Both PPIs prevent TGF beta- induced increases in alpha-smooth muscle actin (alpha SMA), calponin, and collagen production and reduce TED orbital fibroblast cell proliferation and migration. Esomeprazole and lansoprazole exert these effects through an aryl hydrocarbon receptor (AHR)-dependent pathway that includes reducing beta- catenin/Wnt signaling. We conclude that PPIs are potentially useful therapies for preventing or treating TED by reducing the myofibroblast accumulation that occurs in the disease.	[Hammond, Christine L.; Roztocil, Elisa; Feldon, Steven E.; Woeller, Collynn F.] Univ Rochester, Sch Med & Dent, Flaum Eye Inst, Rochester, NY 14627 USA; [Phipps, Richard P.; Woeller, Collynn F.] Univ Rochester, Dept Environm Med, Sch Med & Dent, Rochester, NY 14627 USA	University of Rochester; University of Rochester	Woeller, CF (corresponding author), Univ Rochester, Sch Med & Dent, Flaum Eye Inst, Rochester, NY 14627 USA.; Woeller, CF (corresponding author), Univ Rochester, Dept Environm Med, Sch Med & Dent, Rochester, NY 14627 USA.	Collynn_Woeller@urmc.rochester.edu		Woeller, Collynn/0000-0001-7197-5057; Feldon, Steven/0000-0003-0603-9312	National Institutes of Health [EY023239]; Research to Prevent Blindness; Rochester/Finger Lakes Eye Tissue Bank	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Rochester/Finger Lakes Eye Tissue Bank	This research was supported by the National Institutes of Health Grants EY023239 to SEF, and an unrestricted grant from Research to Prevent Blindness and a research grant from the Rochester/Finger Lakes Eye & Tissue Bank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonson JMS, 2009, J LEADERSH STUD, V3, P17, DOI 10.1002/jls.20120; Bahn RS, 2015, HORM METAB RES, V47, P773, DOI 10.1055/s-0035-1555762; Bartalena L, 2013, EUR THYROID J, V2, P259, DOI 10.1159/000356042; Basu D, 2014, MOL CANCER THER, V13, P1457, DOI 10.1158/1535-7163.MCT-13-0918; Berardi RR, 2000, AM J MANAG CARE, V6, pS491; Brisebois S, 2018, LARYNGOSCOPE INVEST, V3, P457, DOI 10.1002/lio2.187; Bussman UA, 2008, BIOCHEM PHARMACOL, V76, P1165, DOI 10.1016/j.bcp.2008.08.019; Dik WA, 2016, EXP EYE RES, V142, P83, DOI 10.1016/j.exer.2015.02.007; Douglas RS, 2011, CURR OPIN OPHTHALMOL, V22, P385, DOI 10.1097/ICU.0b013e3283499446; Eltahir HM, 2018, BIOMED PHARMACOTHER, V97, P1356, DOI 10.1016/j.biopha.2017.11.028; Feng ST, 2016, ONCOL REP, V36, P3207, DOI 10.3892/or.2016.5154; Ghebremariam YT, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0614-x; Ginter Anna, 2016, R I Med J (2013), V99, P26; Gomez-Duran A, 2009, BIOCHEM PHARMACOL, V77, P700, DOI 10.1016/j.bcp.2008.08.032; Haarmann-Stemmann T, 2009, BIOCHEM PHARMACOL, V77, P508, DOI 10.1016/j.bcp.2008.09.013; Handa O, 2006, INFLAMM RES, V55, P476, DOI 10.1007/s00011-006-6056-4; Hinz B, 2016, EXP EYE RES, V142, P56, DOI 10.1016/j.exer.2015.07.009; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hu WY, 2007, MOL PHARMACOL, V71, P1475, DOI 10.1124/mol.106.032748; Jeon KI, 2014, AM J PATHOL, V184, P1429, DOI 10.1016/j.ajpath.2014.01.026; Jin UH, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-498; Jin UH, 2012, J PHARMACOL EXP THER, V343, P333, DOI 10.1124/jpet.112.195339; Kedika RR, 2009, DIGEST DIS SCI, V54, P2312, DOI 10.1007/s10620-009-0951-9; Lehmann GM, 2011, AM J PATHOL, V178, P1556, DOI 10.1016/j.ajpath.2010.12.025; Ma Q, 2000, J BIOL CHEM, V275, P8432, DOI 10.1074/jbc.275.12.8432; Marcinkowski P, 2019, THYROID, V29, P111, DOI 10.1089/thy.2018.0349; Morgan JT, 2013, EXP EYE RES, V115, P1, DOI 10.1016/j.exer.2013.06.012; Nelson C, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00016; Nishi T, 2018, J PHARM PHARMACOL, V70, P383, DOI 10.1111/jphp.12870; Novotna A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098711; Piersma B, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00059; Puga A, 2005, BIOCHEM PHARMACOL, V69, P199, DOI 10.1016/j.bcp.2004.06.043; Roman AC, 2018, PHARMACOL THERAPEUT, V185, P50, DOI 10.1016/j.pharmthera.2017.12.003; Schluter A, 2018, CLIN EXP IMMUNOL, V191, P255, DOI 10.1111/cei.13075; Shivanna B, 2011, FREE RADICAL BIO MED, V51, P1910, DOI 10.1016/j.freeradbiomed.2011.08.013; Shivanna B, 2011, J PHARMACOL EXP THER, V339, P106, DOI 10.1124/jpet.111.182980; Smith Terry J, 2018, F1000Res, V7, P134, DOI 10.12688/f1000research.12787.1; Smith TJ, 2017, NEW ENGL J MED, V376, P1748, DOI 10.1056/NEJMoa1614949; Strand DS, 2017, GUT LIVER, V11, P27, DOI 10.5009/gnl15502; Sun ZR, 2014, INT J MOL MED, V33, P1097, DOI 10.3892/ijmm.2014.1672; WANDALL JH, 1992, GUT, V33, P617, DOI 10.1136/gut.33.5.617; Woeller CF, 2016, AM J PATHOL, V186, P3189, DOI 10.1016/j.ajpath.2016.08.017; Wolff S, 2001, MOL PHARMACOL, V59, P716, DOI 10.1124/mol.59.4.716; Yamashita Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097419; Zhou BY, 2012, J BIOL CHEM, V287, P7026, DOI 10.1074/jbc.M111.276311	45	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222779	10.1371/journal.pone.0222779	http://dx.doi.org/10.1371/journal.pone.0222779			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536596	Green Published, Green Submitted, gold			2022-12-26	WOS:000532262800084
J	Ingrasciotta, Y; Sultana, J; Giorgianni, F; Menditto, E; Scuteri, A; Tari, M; Tari, DU; Basile, G; Trifiro', G				Ingrasciotta, Ylenia; Sultana, Janet; Giorgianni, Francesco; Menditto, Enrica; Scuteri, Angelo; Tari, Michele; Tari, Daniele Ugo; Basile, Giorgio; Trifiro', Gianluca			Analgesic drug use in elderly persons: A population-based study in Southern Italy	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CLINICAL-PHARMACOLOGY; OLDER-ADULTS; INAPPROPRIATE; IMPACT; MANAGEMENT; MEDICINES; CRITERIA; RISK; PAIN	Introduction Analgesics such as non-steroidal anti-inflammatory drugs (NSAIDs), weak and strong opioids are commonly used among elderly persons. The aim of this study was to describe the demographic and clinical characteristics of elderly analgesic users and to measure the frequency of analgesic use, including the frequency of potentially inappropriate analgesic use. Methods The Arianna database was used to carry out this study. This database contains prescription data with associated indication of use for 1,076,486 inhabitants registered with their general practitioners (GPs) in the Caserta Local Health Unit (Caserta district, Campania region in Italy). A cohort of persons aged.65 years old with > 1 year of database history having at least one analgesic drug (NSAIDs, strong or weak opioids) between 2010 and 2014 were identified. The date of the first analgesic prescription in the study period was considered the index date (ID). Results From a source population of 1,076,486 persons, 116,486 elderly persons were identified. Of these, 94,820 elderly persons received at least one analgesic drug: 36.6% were incident NSAID users (N = 36,629), while 13.2% were incident weak opioid users (N = 12,485) and 8.1% were incident strong opioid users (N = 7,658). In terms of inappropriate analgesic use, 9.2% (N = 10,763) of all elderly users were prescribed ketorolac/indomethacin inappropriately, since these drugs should not be prescribed to elderly persons. Furthermore, at least half all elderly persons with chronic kidney disease or congestive heart failure were prescribed NSAIDs, while these drugs should be avoided. Conclusion Analgesics are commonly used inappropriately among elderly persons, suggesting that prescribing practice in the catchment area may yet be improved.	[Ingrasciotta, Ylenia; Sultana, Janet; Basile, Giorgio; Trifiro', Gianluca] Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy; [Giorgianni, Francesco] AOU GMartino Hosp, Unit Clin Pharmacol, Messina, Italy; [Menditto, Enrica] Univ Naples Federico II, Ctr Pharmacoecon, CIRFF, Naples, Italy; [Scuteri, Angelo] HSR Pisana IRCCS, Rome, Italy; [Tari, Michele; Tari, Daniele Ugo] Local Hlth Unit Caserta, Caserta, Italy; [Trifiro', Gianluca] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands	University of Messina; University of Naples Federico II; Erasmus University Rotterdam; Erasmus MC	Trifiro', G (corresponding author), Univ Messina, Dept Biomed & Dent Sci & Morphofunct Imaging, Messina, Italy.; Trifiro', G (corresponding author), Erasmus MC, Dept Med Informat, Rotterdam, Netherlands.	trifirog@unime.it	Sultana, Janet/Z-4817-2019; Tari, Daniele Ugo/AAY-8658-2021	Tari, Daniele Ugo/0000-0002-7312-419X; menditto, enrica/0000-0001-8633-5650; orlando, valentina/0000-0002-8209-8878; BASILE, Giorgio/0000-0002-0040-8618; SCUTERI, ANGELO/0000-0003-4784-5441; Sultana, Janet/0000-0001-9622-169X				Abdulla A, 2013, AGE AGEING, V42, pI1, DOI 10.1093/ageing/afs200; Agenzia Italiana del Farmaco (AIFA-Italian Drug Agency), 2008, DOM RISP PRED DALL E; Bacchi S., 2012, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V11, P52; Blondell RD, 2013, AM FAM PHYSICIAN, V87, P766; Bruera Eduardo, 2015, Am Soc Clin Oncol Educ Book, pe593, DOI 10.14694/EdBook_AM.2015.35.e593; Carter JL, 2011, QJM-INT J MED, V104, P839, DOI 10.1093/qjmed/hcr077; Daoust R, 2018, CAN MED ASSOC J, V190, pE500, DOI 10.1503/cmaj.171286; European Medicines Agency (EMA), NIM SUMM; European Medicines Agency (EMA), QUEST ANSW REV ET CO; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Guerriero F, 2015, TRANSL MED UNISA, V13, P59; Ingrasciotta Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122899; Kaye AD, 2010, OCHSNER J, V10, P179; Kocoglu H, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/8419304; Lombardi N, 2019, CLIN DRUG INVEST, V39, P455, DOI 10.1007/s40261-019-00767-8; Marras F, 2016, CLIN CASES MINER BON, V13, P93, DOI 10.11138/ccmbm/2016.13.2.093; McLachlan AJ, 2011, BRIT J CLIN PHARMACO, V71, P351, DOI 10.1111/j.1365-2125.2010.03847.x; Miller M, 2011, J AM GERIATR SOC, V59, P430, DOI 10.1111/j.1532-5415.2011.03318.x; Musazzi UM, 2018, J PAIN RES, V11, P1665, DOI 10.2147/JPR.S163438; O'Mahony D, 2015, AGE AGEING, V44, P213, DOI 10.1093/ageing/afu145; Onder G, 2014, J GERONTOL A-BIOL, V69, P430, DOI 10.1093/gerona/glt118; Ripamonti C, 2006, SUPPORT CARE CANCER, V14, P400, DOI 10.1007/s00520-005-0918-0; Skolnick P, 2018, ANNU REV PHARMACOL, V58, P143, DOI 10.1146/annurev-pharmtox-010617-052534; Societa Italiana di Farmacologia, TRATT DOL CRON IT AP; Solomon DH, 2010, ARCH INTERN MED, V170, P1968, DOI 10.1001/archinternmed.2010.391; Sultana J, 2018, CLIN EPIDEMIOL, V10, P31, DOI 10.2147/CLEP.S145530; Ungprasert P, 2015, EUR J INTERN MED, V26, P285, DOI 10.1016/j.ejim.2015.03.008; Ussai S, 2015, DRUG DES DEV THER, V9, P2073, DOI 10.2147/DDDT.S80686; Viola E, 2016, EXPERT OPIN DRUG SAF, V15, P61, DOI 10.1080/14740338.2016.1221401	30	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222836	10.1371/journal.pone.0222836	http://dx.doi.org/10.1371/journal.pone.0222836			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM5BF	31536588	Green Submitted, Green Published, gold			2022-12-26	WOS:000532262800094
J	Liu, C; Han, XT; Li, ZX; Ha, JS; Peng, GK; Meng, W; He, MG				Liu, Chi; Han, Xiaotong; Li, Zhixi; Ha, Jason; Peng, Guankai; Meng, Wei; He, Mingguang			A self-adaptive deep learning method for automated eye laterality detection based on color fundus photography	PLOS ONE			English	Article							DIABETIC-RETINOPATHY; SYSTEM	Purpose To provide a self-adaptive deep learning (DL) method to automatically detect the eye laterality based on fundus images. Methods A total of 18394 fundus images with real-world eye laterality labels were used for model development and internal validation. A separate dataset of 2000 fundus images with eye laterality labeled manually was used for external validation. A DL model was developed based on a fine-tuned Inception-V3 network with self-adaptive strategy. The area under receiver operator characteristic curve (AUC) with sensitivity and specificity and confusion matrix were applied to assess the model performance. The class activation map (CAM) was used for model visualization. Results In the external validation (N = 2000, 50% labeled as left eye), the AUC of the DL model for overall eye laterality detection was 0.995 (95% CI, 0.993-0.997) with an accuracy of 99.13%. Specifically for left eye detection, the sensitivity was 99.00% (95% CI, 98.11%-99.49%) and the specificity was 99.10% (95% CI, 98.23%-99.56%). Nineteen images were wrongly classified as compared to the human labels: 12 were due to human wrong labelling, while 7 were due to poor image quality. The CAM showed that the region of interest for eye laterality detection was mainly the optic disc and surrounding areas. Conclusion We proposed a self-adaptive DL method with a high performance in detecting eye laterality based on fundus images. Results of our findings were based on real world labels and thus had practical significance in clinical settings.	[Liu, Chi; Han, Xiaotong; Li, Zhixi; He, Mingguang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Peoples R China; [Liu, Chi] Univ Technol, Sch Comp Sci, Sydney, NSW, Australia; [Ha, Jason] Monash Univ, Fac Med Nursing & Hlth Sci, Clayton, Vic, Australia; [Peng, Guankai; Meng, Wei] Guangzhou Healgoo Interact Med Technol Co Ltd, Guangzhou, Peoples R China; [He, Mingguang] Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [He, Mingguang] Univ Melbourne, Dept Surg, Ophthalmol, Melbourne, Vic, Australia	Sun Yat Sen University; University of Technology Sydney; Monash University; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne	He, MG (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou, Peoples R China.; He, MG (corresponding author), Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia.; He, MG (corresponding author), Univ Melbourne, Dept Surg, Ophthalmol, Melbourne, Vic, Australia.	mingguang_he@yahoo.com	He, Mingguang/AAY-5239-2020	He, Mingguang/0000-0002-6912-2810; Han, Xiaotong/0000-0001-6836-3447; Ha, Jason/0000-0003-3013-1469	National Key R&D Program of China [2018YFC0116500]; Fundamental Research Funds of the State Key Laboratory in Ophthalmology, Science and Technology Planning Project of Guangdong Province [2013B20400003]; University of Melbourne at Research Accelerator Program; CERA Foundation	National Key R&D Program of China; Fundamental Research Funds of the State Key Laboratory in Ophthalmology, Science and Technology Planning Project of Guangdong Province; University of Melbourne at Research Accelerator Program; CERA Foundation	This work was supported by the National KeyR&D Program of China (2018YFC0116500). MH receives support from the Fundamental Research Funds of the State Key Laboratory in Ophthalmology, Science and Technology Planning Project of Guangdong Province 2013B20400003. MH receives support from the University of Melbourne at Research Accelerator Program and the CERA Foundation. The Center for Eye Research Australia receives Operational Infrastructure Support from the Victorian State Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben G, 2015, KAGGLE DIABETIC RETI; Bottou Leon, 2012, Neural Networks: Tricks of the Trade. Second Edition: LNCS 7700, P421, DOI 10.1007/978-3-642-35289-8_25; Cuadros J, 2004, ST HEAL T, V107, P207; Ebner M, 2009, MACH VISION APPL, V20, P283, DOI 10.1007/s00138-008-0126-2; Maimo LF, 2018, IEEE ACCESS, V6, P7700, DOI 10.1109/ACCESS.2018.2803446; Grassmann F, 2018, OPHTHALMOLOGY, V125, P1410, DOI 10.1016/j.ophtha.2018.02.037; Jang Y, 2018, J DIGITAL IMAGING; Jin GM, 2018, BRIT J OPHTHALMOL, V102, P625, DOI 10.1136/bjophthalmol-2017-310368; Kumar T, 2010, INT J COMPUTER APPL, V7, P7, DOI DOI 10.5120/1140-1493; Li ZX, 2018, OPHTHALMOLOGY, V125, P1199, DOI 10.1016/j.ophtha.2018.01.023; Liu SD, 2018, OPHTHALMOL GLAUCOMA, V1, P15, DOI 10.1016/j.ogla.2018.04.002; Poplin R, 2018, NAT BIOMED ENG, V2, P158, DOI 10.1038/s41551-018-0195-0; Roy PK, 2016, 2016 INT C DIG IM CO; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Tan NM, 2009, 13 INT C BIOM ENG 20; Ting DSW, 2018, NAT MED, V24, P539, DOI 10.1038/s41591-018-0029-3; Ting DSW, 2017, JAMA-J AM MED ASSOC, V318, P2211, DOI 10.1001/jama.2017.18152; Wong TY, 2016, JAMA-J AM MED ASSOC, V316, P2366, DOI 10.1001/jama.2016.17563; YU XH, 1995, IEEE T NEURAL NETWOR, V6, P669, DOI 10.1109/72.377972; Zhou B, 2016, PROC CVPR IEEE, P2921, DOI 10.1109/CVPR.2016.319; Zuiderveld K.J., 1994, GRAPHICS GEMS, P474, DOI DOI 10.1016/B978-0-12-336156-1.50061-6	22	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222025	10.1371/journal.pone.0222025	http://dx.doi.org/10.1371/journal.pone.0222025			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536537	Green Published, gold			2022-12-26	WOS:000532262800025
J	Sizmur, T; Campbell, L; Dracott, K; Jones, M; O'Driscoll, NJ; Gerwing, T				Sizmur, Tom; Campbell, Lily; Dracott, Karina; Jones, Megan; O'Driscoll, Nelson J.; Gerwing, Travis			Relationships between Potentially Toxic Elements in intertidal sediments and their bioaccumulation by benthic invertebrates	PLOS ONE			English	Article							SUNDERBAN MANGROVE WETLAND; HEAVY-METAL; PULP-MILL; NEREIS-DIVERSICOLOR; DISCONTINUITY ARPD; BIVALVE MOLLUSKS; COMMUNITY; ZINC; ESTUARINE; POLLUTION	The bioaccumulation of Potentially Toxic Elements (PTEs) by benthic invertebrates in estuarine sediments is poorly understood. We sampled and analysed PTEs in sediments and benthic invertebrates from five sites in the Skeena Estuary (British Columbia, Canada), including sites adjacent to an abandoned cannery and a decommissioned papermill. Our aim was to elucidate baseline levels of PTE concentrations at sites that may be recovering from disturbance associated with prior industrial development and identify organisms that could be used to biomonitor the impact of future industrial developments. There was no indication that sediments of the salmon cannery were polluted, but acidic sediments adjacent to the papermill contained elevated concentrations of Cd, Cr, Hg and Pb. Benthic invertebrate community assemblages confirm that sediments have mostly recovered from prior industrial development associated with discharge of papermill sludge. Overall, we did not observe any relationship between PTE concentrations in the sediment and PTE concentrations in invertebrate tissues. However, we did observe a negative relationship between sediment pH and the Biota-Sediment Accumulation Factor (BSAF) of most PTEs for Oregon pill bugs (Gnori-mosphaeroma oregonensis). G. oregonensis, observed at all sites, feeds on the fibers associated with the papermill discharge. Thus, G. oregonensis is a useful biomonitors for quantifying the impact of the decommissioned papermill, and are candidate biomonitors for assessing the impact of similar industrial development projects on intertidal ecosystems.	[Sizmur, Tom; Jones, Megan] Univ Reading, Dept Geog & Environm Sci, Reading, Berks, England; [Campbell, Lily; Gerwing, Travis] Univ Victoria, Dept Biol, Victoria, BC, Canada; [Dracott, Karina] Ocean Wise Conservat Assoc, North Coast Cetacean Res Initiat, Prince Rupert, BC, Canada; [O'Driscoll, Nelson J.] Acadia Univ, Dept Earth & Environm Sci, Wolfville, NS, Canada; [Gerwing, Travis] Univ Northern British Columbia, Ecosyst Sci & Management Program, Prince George, BC, Canada	University of Reading; University of Victoria; Acadia University; University of Northern British Columbia	Sizmur, T (corresponding author), Univ Reading, Dept Geog & Environm Sci, Reading, Berks, England.	t.sizmur@reading.ac.uk	Gerwing, Travis/AAU-6569-2020; Sizmur, Tom/F-4532-2018	Gerwing, Travis/0000-0002-4433-1843; Sizmur, Tom/0000-0001-9835-7195	Royal Geographical Society Environment and Sustainability Research Grant - Mitacs Elevate fellowship	Royal Geographical Society Environment and Sustainability Research Grant - Mitacs Elevate fellowship	This work was funded by a Royal Geographical Society Environment and Sustainability Research Grant awarded to TS and TG, https://www.rgs.org/in-the-field/in-the-fieldgrants/research-grants/environment-and-sustainability-research-grants/.TG was also funded by a Mitacs Elevate fellowship, https://www.mitacs.ca/en/programs/elevate.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akenhead S., 1992, REV OCEANOGRAPHY MAR; Allen L, 2019, APPL BIODIVERSITY IN; Alvarez MB, 2001, FRESEN J ANAL CHEM, V369, P81, DOI 10.1007/s002160000592; Amoozadeh E, 2014, ENVIRON SCI POLLUT R, V21, P2386, DOI 10.1007/s11356-013-1890-8; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 1995, BS775532; Apler A, 2019, CHEMOSPHERE, V215, P470, DOI 10.1016/j.chemosphere.2018.10.010; Bard SM, 1998, WATER ENVIRON RES, V70, P108, DOI 10.2175/106143098X126955; Burke MJW, 1996, ECOLOGY, V77, P776, DOI 10.2307/2265501; Burton ED, 2005, J ENVIRON QUAL, V34, P263, DOI 10.2134/jeq2005.0263; Cacador I, 2012, ECOL INDIC, V19, P184, DOI 10.1016/j.ecolind.2011.09.007; Carr-Harris C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118988; Chakraborty P, 2012, CHEM GEOL, V294, P217, DOI 10.1016/j.chemgeo.2011.11.026; Chapman PM, 2005, INTEGR ENVIRON ASSES, V1, P163, DOI 10.1897/2005-013R.1; Ciutat A, 2003, ENVIRON TOXICOL CHEM, V22, P1574, DOI 10.1002/etc.5620220721; Clarke KR, 2015, PRIMER V7 USER MANUA; Cox KD, 2017, ECOL EVOL, V7, P11213, DOI 10.1002/ece3.3580; DelValls TA, 1998, TRAC-TREND ANAL CHEM, V17, P181, DOI 10.1016/S0165-9936(98)00017-X; EPA US, 1998, 7473SW846 EPA US; EPA US, 2007, 3051ASW846 EPA US; Faggetter BA, 2008, REV ENV SOCIOECONOMI; Fauchald K., 1979, Oceanography and Marine Biology an Annual Review, V17, P193; Gerwing T. G., 2016, PRELIMINARY REPORT I; Gerwing TG, 2018, RESTORATION ECOLOGY, V27, P278; Gerwing TG, 2018, J NAT HIST, V52, P2833, DOI 10.1080/00222933.2018.1553249; Gerwing TG, 2018, MAR ECOL-EVOL PERSP, V39, DOI 10.1111/maec.12505; Gerwing TG, 2018, INT J SEDIMENT RES, V33, P149, DOI 10.1016/j.ijsrc.2017.09.001; Gerwing TG, 2017, INT J SEDIMENT RES, V32, P472, DOI 10.1016/j.ijsrc.2017.09.003; Gerwing TG, 2017, J SEA RES, V129, P22, DOI 10.1016/j.seares.2017.09.001; Gerwing TG, 2017, ESTUAR COAST, V40, P717, DOI 10.1007/s12237-016-0173-2; Gerwing TG, 2016, AUK, V133, P168, DOI 10.1642/AUK-15-176.1; Gerwing TG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147098; Gerwing TG, 2015, NORTHEAST NAT, V22, P1, DOI 10.1656/045.022.m1201; Gesteira JLG, 2000, MAR POLLUT BULL, V40, P1017, DOI 10.1016/S0025-326X(00)00046-1; Guerra-Garcia J, 2004, HELGOLAND MAR RES, V58, P183, DOI 10.1007/s10152-004-0184-4; HC. Hatfield Consultants Ltd, 1994, SKEENA ENV EFFECTS M; Higgins RJ, 1973, 19731 DEP ENV FISH M; HILBORN R, 1977, J FISH RES BOARD CAN, V34, P64, DOI 10.1139/f77-007; Hoffman E, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-5952-0; Hoos LM., 1975, 3 ENV CAN; HOWARD LS, 1983, MAR BIOL, V78, P87, DOI 10.1007/BF00392975; Kienle C, 2013, J SOIL SEDIMENT, V13, P1611, DOI 10.1007/s11368-013-0733-z; Kritzer JP, 2016, BIOSCIENCE, V66, P274, DOI 10.1093/biosci/biw014; LEONARDSSON K, 1993, AMBIO, V22, P359; Light SF, 2007, LIGHT SMITH MANUAL I; Luoma SN, 2017, HEAVY METALS MARINE, P51; Machado AAD, 2016, SCI TOTAL ENVIRON, V541, P268, DOI 10.1016/j.scitotenv.2015.09.045; Majer AP, 2014, MAR POLLUT BULL, V79, P321, DOI 10.1016/j.marpolbul.2013.12.015; McLaren P, 2016, J COASTAL RES, V32, P465, DOI 10.2112/JCOASTRES-D-15-00134.1; Monte MC, 2009, WASTE MANAGE, V29, P293, DOI 10.1016/j.wasman.2008.02.002; Moore JW, 2016, MAR ECOL PROG SER, V559, P201, DOI 10.3354/meps11933; Muller G.M.M.G.M.G.M.G.P., 1969, GEOJOURNAL, V2, P108, DOI DOI 10.1055/S-2007-1023171; NIBR, 2006, VAL WILD SALM EC SKE, P1; Nriagu JO, 1988, CHROMIUM NATURAL HUM; Pagliosa PR, 2005, MAR ECOL-EVOL PERSP, V26, P246, DOI 10.1111/j.1439-0485.2005.00065.x; Pallabi Borah, 2018, Groundwater for Sustainable Development, V6, P189, DOI 10.1016/j.gsd.2018.01.002; Pearson T.H., 1978, Oceanography and Marine Biology an Annual Review, V16, P229; PEARSON T H, 1976, Ambio, V5, P77; PEARSON TH, 1972, PROC R SOC SER B-BIO, V180, P469, DOI 10.1098/rspb.1972.0032; Pourret O, 2018, SCI TOTAL ENVIRON, V610, P419, DOI 10.1016/j.scitotenv.2017.08.043; Rainbow PS, 1995, MAR POLLUT BULL, V31, P183, DOI 10.1016/0025-326X(95)00116-5; Riba I, 2004, ENVIRON TOXICOL CHEM, V23, P1100, DOI 10.1897/023-601; Saha M, 2006, ENVIRON INT, V32, P203, DOI 10.1016/j.envint.2005.08.012; SaizSalinas JI, 1997, MAR ECOL-P S Z N I, V18, P113, DOI 10.1111/j.1439-0485.1997.tb00431.x; Sarkar SK, 2008, CLEAN-SOIL AIR WATER, V36, P187, DOI 10.1002/clen.200700027; Schindler DE, 2003, FRONT ECOL ENVIRON, V1, P31, DOI 10.1890/1540-9295(2003)001[0031:PSATEO]2.0.CO;2; Schone BR, 2016, GLOBAL PLANET CHANGE, V144, P228, DOI 10.1016/j.gloplacha.2016.08.002; Scholz B, 2012, EUR J PHYCOL, V47, P120, DOI 10.1080/09670262.2012.665251; Sibley Paul K., 2000, Journal of Aquatic Ecosystem Stress and Recovery, V7, P229, DOI 10.1023/A:1009987123319; Sizmur T, 2013, ENVIRON TOXICOL CHEM, V32, P1888, DOI 10.1002/etc.2264; Sizmur T, 2013, ENVIRON POLLUT, V176, P18, DOI 10.1016/j.envpol.2013.01.008; Smith MD, 1999, OECOLOGIA, V120, P605, DOI 10.1007/s004420050896; Tuominen TM, 1992, CONSERVATION PROTECT; van Proosdij D, 2009, J COASTAL RES, P772; WALDICHUK M, 1962, J FISH RES BOARD CAN, V19, P1163, DOI 10.1139/f62-077; Wang XP, 2010, ENVIRON POLLUT, V158, P3065, DOI 10.1016/j.envpol.2010.06.034; Weimin Ying, 1992, Science of the Total Environment, V125, P67, DOI 10.1016/0048-9697(92)90383-4; WILKES B, 1991, PULP PAP-CANADA, V92, P20; Yunker MB, 2002, ENVIRON SCI TECHNOL, V36, P1869, DOI 10.1021/es0112893; Zhang C, 2014, ENVIRON INT, V73, P270, DOI 10.1016/j.envint.2014.08.010; Zhang W, 2019, SUSTAINABLE FOOD AND AGRICULTURE: AN INTEGRATED APPROACH, P137, DOI 10.1016/B978-0-12-812134-4.00008-X; Zuykov M, 2013, CHEMOSPHERE, V93, P201, DOI 10.1016/j.chemosphere.2013.05.001	82	12	12	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0216767	10.1371/journal.pone.0216767	http://dx.doi.org/10.1371/journal.pone.0216767			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536494	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000532262800003
J	Vidotti, MS; Lyra, DH; Morosini, JS; Granato, ISC; Quecine, MC; de Azevedo, JL; Fritsche-Neto, R				Vidotti, Miriam Suzane; Lyra, Danilo Hottis; Morosini, Julia Silva; Granato, Italo Stefanine Correia; Quecine, Maria Carolina; de Azevedo, Joao Lucio; Fritsche-Neto, Roberto			Additive and heterozygous (dis)advantage GWAS models reveal candidate genes involved in the genotypic variation of maize hybrids to Azospirillum brasilense	PLOS ONE			English	Article							USE EFFICIENCY; ROOT-GROWTH; NITROGEN; ARABIDOPSIS; STRESS; ASSOCIATION; TOOL; INOCULATION; PROTEINS; WHEAT	Maize genotypes can show different responsiveness to inoculation with Azospirillum brasilense and an intriguing issue is which genes of the plant are involved in the recognition and growth promotion by these Plant Growth-Promoting Bacteria (PGPB). We conducted Genome-Wide Association Studies (GWAS) using additive and heterozygous (dis)advantage models to find candidate genes for root and shoot traits under nitrogen (N) stress and N stress plus A. brasilense. A total of 52,215 Single Nucleotide Polymorphism (SNP) markers were used for GWAS analyses. For the six root traits with significant inoculation effect, the GWAS analyses revealed 25 significant SNPs for the N stress plus A. brasilense treatment, in which only two were overlapped with the 22 found for N stress only. Most were found by the heterozygous (dis)advantage model and were more related to exclusive gene ontology terms. Interestingly, the candidate genes around the significant SNPs found for the maizeA. brasilense association were involved in different functions previously described for PGPB in plants (e.g. signaling pathways of the plant's defense system and phytohormone biosynthesis). Our findings are a benchmark in the understanding of the genetic variation among maize hybrids for the association with A. brasilense and reveal the potential for further enhancement of maize through this association.	[Vidotti, Miriam Suzane; Morosini, Julia Silva; Quecine, Maria Carolina; de Azevedo, Joao Lucio; Fritsche-Neto, Roberto] Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Genet, Piracicaba, SP, Brazil; [Lyra, Danilo Hottis] Rothamsted Res, Harpenden, Herts, England; [Granato, Italo Stefanine Correia] French Natl Inst Agr Res, Montpellier, France	Universidade de Sao Paulo; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; INRAE	Vidotti, MS; Fritsche-Neto, R (corresponding author), Univ Sao Paulo, Luiz de Queiroz Coll Agr, Dept Genet, Piracicaba, SP, Brazil.	miriamvidotti@usp.br; roberto.neto@usp.br	Fritsche-Neto, Roberto/B-2256-2013; Lyra, Danilo Hottis/L-8456-2014; Silva Morosini, Julia/D-5183-2018; Granato, Italo/F-2516-2014	Fritsche-Neto, Roberto/0000-0003-4310-0047; Silva Morosini, Julia/0000-0002-4106-6941; Verdi, Maria/0000-0002-9524-941X; Granato, Italo/0000-0003-2093-6810; Hottis Lyra, Danilo/0000-0002-2214-1555	Sao Paulo Research Foundation (FAPESP) [2015/01188-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; National Council Coordination for the Scientific and Technological Development (CNPq)	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council Coordination for the Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This research was supported by Sao Paulo Research Foundation (FAPESP) process: 2015/01188-9, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) Finance Code 001, and National Council Coordination for the Scientific and Technological Development (CNPq).	Al Abri MA, 2018, J EQUINE VET SCI, V60, P67, DOI 10.1016/j.jevs.2017.05.008; Cura JA, 2017, MICROORGANISMS, V5, DOI 10.3390/microorganisms5030041; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bonnafous F, 2018, THEOR APPL GENET, V131, P319, DOI 10.1007/s00122-017-3003-4; Brien C, AUGMENTS USE ASREML; Browning BL, 2016, AM J HUM GENET, V98, P116, DOI 10.1016/j.ajhg.2015.11.020; Brusamarello-Santos LC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174576; Butler D., 2009, ANAL MIXED MODELS S; Calzavara AK, 2018, PLANT BIOLOGY, V20, P870, DOI 10.1111/plb.12841; Carvalhais LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068555; Carvalho TLG, 2016, PLANT MOL BIOL, V90, P561, DOI 10.1007/s11103-016-0435-1; Cassan F, 2016, SOIL BIOL BIOCHEM, V103, P117, DOI 10.1016/j.soilbio.2016.08.020; Castrillo G, 2017, NATURE, V543, P513, DOI 10.1038/nature21417; Chamam A, 2015, PLANTA, V242, P1439, DOI 10.1007/s00425-015-2382-5; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Cheng P, 2017, THEOR APPL GENET, V130, P999, DOI 10.1007/s00122-017-2866-8; Cohen AC, 2009, BOTANY, V87, P455, DOI 10.1139/B09-023; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cunha F. N., 2016, African Journal of Agricultural Research, V11, P3853; D'Auria JC, 2007, PLANT J, V49, P194, DOI 10.1111/j.1365-313X.2006.02946.x; De Vita P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29020-6; Di Salvo LP, 2018, PLANT SOIL, V424, P405, DOI 10.1007/s11104-017-3548-7; Dicke M, 2016, CURR OPIN PLANT BIOL, V32, P17, DOI 10.1016/j.pbi.2016.05.004; Ding L, 2005, ANN BOT-LONDON, V96, P925, DOI 10.1093/aob/mci244; Ding L, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01143; Ding YZ, 2017, PLANT PHYSIOL, V175, P1455, DOI 10.1104/pp.17.00879; Disi JO, 2018, ENTOMOL SCI, V21, P48, DOI 10.1111/ens.12280; Duca DR, 2018, ANTON LEEUW INT J G, V111, P1645, DOI 10.1007/s10482-018-1051-7; Fesel PH, 2016, CURR OPIN MICROBIOL, V32, P103, DOI 10.1016/j.mib.2016.05.008; Fukami J, 2018, ARCH MICROBIOL, V200, P1191, DOI 10.1007/s00203-018-1535-x; Fukami J, 2017, AMB EXPRESS, V7, DOI 10.1186/s13568-017-0453-7; Fukami J, 2016, AMB EXPRESS, V6, DOI 10.1186/s13568-015-0171-y; Genissel A, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01301; German MA, 2000, BIOL FERT SOILS, V32, P259, DOI 10.1007/s003740000245; Gomes EA, 2018, PHYTOBIOMES J, V2, P129, DOI 10.1094/PBIOMES-03-18-0012-R; Gopal M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01971; Goyette P, 2015, NAT GENET, V47, P172, DOI 10.1038/ng.3176; Groszmann M, 2015, P NATL ACAD SCI USA, V112, pE6397, DOI 10.1073/pnas.1519926112; Hardoim PR, 2019, PLANT SOIL PLANT SOI, DOI [10.1007/s11104-019-03939-9, DOI 10.1007/S11104-019-03939-9]; Hohmann P, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-1900-x; Hu XJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15985-3; Huh SU, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00397; Hungria M, 2010, PLANT SOIL, V331, P413, DOI 10.1007/s11104-009-0262-0; Kamfwa K, 2015, THEOR APPL GENET, V128, P1999, DOI 10.1007/s00122-015-2562-5; Khan MIR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00462; Kishor PBK, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00544; Klay I, 2018, PLANT SCI, V274, P137, DOI 10.1016/j.plantsci.2018.05.023; Ko DK, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006197; Koo AJ, 2018, PHYTOCHEM REV, V17, P51, DOI 10.1007/s11101-017-9510-8; Korte A, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-29; Kox MAR, 2016, PLANT SOIL, V406, P83, DOI 10.1007/s11104-016-2851-z; Lanes ECM, 2014, GENET MOL RES, V13, P7365, DOI 10.4238/2014.September.12.2; Lee YS, 2018, GENES GENOM, V40, P1331, DOI 10.1007/s13258-018-0728-7; Lehnert H, 2017, NEW PHYTOL, V215, P779, DOI 10.1111/nph.14595; Li H, 2017, NONPROFIT POLICY FOR, V8, P3, DOI 10.1515/npf-2016-0010; Li Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191321; Liu LH, 2003, PLANT PHYSIOL, V133, P1220, DOI 10.1104/pp.103.027409; Liu X, 2016, PLOS GENET, V12, DOI DOI 10.1371/JOURNAL.PGEN.1005767; Luo BW, 2015, EUPHYTICA, V206, P117, DOI 10.1007/s10681-015-1481-5; Martins MR, 2018, PLANT SOIL, V422, P239, DOI 10.1007/s11104-017-3193-1; Mendonca LD, 2017, SCI AGR, V74, P481, DOI [10.1590/1678-992x-2016-0313, 10.1590/1678-992X-2016-0313]; Mlodzinska E, 2015, PHYSIOL PLANTARUM, V154, P270, DOI 10.1111/ppl.12305; Monir MM, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00627; Morosini JS, 2017, PLANT SOIL, V421, P453, DOI 10.1007/s11104-017-3479-3; Nguema-Ona E, 2013, TRENDS PLANT SCI, V18, P445, DOI 10.1016/j.tplants.2013.03.006; Nogales A, 2016, BRIEF FUNCT GENOMICS, V15, P288, DOI 10.1093/bfgp/elv030; Oda Y, 2006, J PLANT RES, V119, P167, DOI 10.1007/s10265-006-0260-8; Paschold A, 2010, THEOR APPL GENET, V120, P383, DOI 10.1007/s00122-009-1082-6; Picard C, 2005, FEMS MICROBIOL ECOL, V53, P349, DOI 10.1016/j.femsec.2005.01.007; Picard C, 2006, FEMS MICROBIOL ECOL, V58, P193, DOI 10.1111/j.1574-6941.2006.00151.x; Pieterse CMJ, 2016, TRENDS PLANT SCI, V21, P171, DOI 10.1016/j.tplants.2016.01.018; Planchamp C, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00719; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rai A, 2017, J PLANT NUTR, V40, P2237, DOI 10.1080/01904167.2016.1222419; Ristova D, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf2768; Rodrigues Neto J, 1986, SUMMA PHYTOPATHOL, V12, P32; Rosas JE, 2018, PLANT GENOME-US, V11, DOI 10.3835/plantgenome2017.03.0029; Rosier A, 2016, PLANT MOL BIOL, V90, P537, DOI 10.1007/s11103-016-0433-3; Rozier C., 2016, METABOLOMICS LOS ANG, V6, P1; Rozier C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07929-8; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Sharifi R, 2018, NEW PHYTOL, V220, P684, DOI 10.1111/nph.14955; Spaepen S, 2014, NEW PHYTOL, V201, P850, DOI 10.1111/nph.12590; Sun XH, 2018, PLANT SCI, V274, P32, DOI 10.1016/j.plantsci.2018.05.004; Timm C.M., 2016, FRONT PLANT SCI, V2016, P7, DOI DOI 10.3389/FPLS.2016.00497; Tivendale ND, 2014, TRENDS PLANT SCI, V19, P44, DOI 10.1016/j.tplants.2013.09.012; Trachsel S, 2013, FIELD CROP RES, V140, P18, DOI 10.1016/j.fcr.2012.09.010; Tsairidou S, 2018, ANIM GENET, V49, P103, DOI 10.1111/age.12637; Tsepilov YA, 2015, GENETICS, V200, P707, DOI 10.1534/genetics.115.175760; Unterseer S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-823; Velasquez SM, 2011, SCIENCE, V332, P1401, DOI 10.1126/science.1206657; Vidotti MS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217571; Walker V, 2011, NEW PHYTOL, V189, P494, DOI 10.1111/j.1469-8137.2010.03484.x; Wallace JG, 2018, PHYTOBIOMES J, V2, P208, DOI 10.1094/PBIOMES-02-18-0008-R; Wang CY, 2014, FIELD CROP RES, V165, P138, DOI 10.1016/j.fcr.2014.04.011; Wang H, 2017, SCI REP-UK, V7, DOI 10.1038/srep40239; Wang YK, 2016, BIOCHEM BIOPH RES CO, V470, P233, DOI 10.1016/j.bbrc.2016.01.043; Wintermans PCA, 2016, PLANT MOL BIOL, V90, P623, DOI 10.1007/s11103-016-0442-2; Xu W, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-014-1760-0; Yan JB, 2011, CROP SCI, V51, P433, DOI 10.2135/cropsci2010.04.0233; Yang JL, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007019; Zeffa DM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215332; Zeffa DM, 2018, BRAGANTIA, V77, P493, DOI 10.1590/1678-4499.2017273; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	104	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222788	10.1371/journal.pone.0222788	http://dx.doi.org/10.1371/journal.pone.0222788			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536609	Green Published, gold, Green Submitted			2022-12-26	WOS:000532262800086
J	Beenakker, JWM; Wezel, J; Groen, J; Webb, AG; Bornert, P				Beenakker, Jan-Willem M.; Wezel, Joep; Groen, Jan; Webb, Andrew G.; Boernert, Peter			Silent volumetric multi-contrast 7 Tesla MRI of ocular tumors using Zero Echo Time imaging	PLOS ONE			English	Article							ARRAY; BONE; LENS	Magnetic Resonance Imaging (MRI) has become a valuable imaging modality in ophthalmology, especially for the diagnosis and treatment planning of patients with uveal melanoma, the most common primary intra-ocular tumor. We aim to develop and evaluate the value of silent Zero Echo Time (ZTE) MRI to image patients with ocular tumors at 7Tesla. Therefore, ZTE and different types of magnetization-prepared ZTE (FLAIR, SPIR, T2 and Saturation recovery), have been developed. After an initial validation with 7 healthy subjects, nine patients with an eye tumor have been evaluated. The ZTE scans were compared to their Cartesian equivalent in terms of contrast, motion-sensitivity, diagnostic quality and patient comfort. All volunteers and especially the patients reported a more comfortable experience during the ZTE scans, which had at least a 10 dB lower sound pressure. The image contrast in the native ZTE was poor, but in the different magnetization-prepared ZTE, the eye lens, cornea and retina were clearly discriminated. Overall the T2-prepared scan yielded the best contrast, especially between tumor and healthy tissue, and proved to be robust against eye motion. Although the intrinsic 3D nature of the ZTE-technique provides an accurate analysis of the tumor morphology, the quality of the ZTE-images is lower than their Cartesian equivalent. In conclusion, the quality of magnetization-prepared ZTE images is sufficient to assess the 3D tumor morphology, but insufficient for more detailed evaluations. As such this technique can be an option for patients who cannot comply with the sound-levels of Cartesian scans, but for other patients the conventional Cartesian scans offer a better image quality.	[Beenakker, Jan-Willem M.; Wezel, Joep; Webb, Andrew G.; Boernert, Peter] Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands; [Beenakker, Jan-Willem M.] Leiden Univ, Dept Ophthalmol, Med Ctr, Leiden, Netherlands; [Groen, Jan] Philips Healthcare, Best, Netherlands; [Boernert, Peter] Philips Res Labs, Hamburg, Germany	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Philips; Philips Healthcare; Philips; Philips Research	Beenakker, JWM (corresponding author), Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands.; Beenakker, JWM (corresponding author), Leiden Univ, Dept Ophthalmol, Med Ctr, Leiden, Netherlands.	J.W.M.Beenakker@LUMC.NL	Beenakker, Jan-Willem/AAD-7571-2022; Börnert, Peter/AAA-9380-2022	Beenakker, Jan-Willem/0000-0003-0479-5587; Bornert, Peter/0000-0001-9216-5117	Philips Healthcare	Philips Healthcare	Philips Healthcare provided support in the form of salaries for authors [JG, PB], but did not have any additional role in the study design, data collection or decision to publish. PB assisted with the analysis of the data and preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	BALABAN R S, 1992, Magnetic Resonance Quarterly, V8, P116; Beenakker JWM, 2013, NMR BIOMED, V26, P1864, DOI 10.1002/nbm.3041; Beenakker JWM, 2016, MAGN RESON MATER PHY, V29, P571, DOI 10.1007/s10334-016-0529-4; Beenakker JWM, 2015, INVEST OPHTH VIS SCI, V56, P1033, DOI 10.1167/iovs.14-15161; Berkowitz BA, 2001, MAGN RESON MED, V46, P412, DOI 10.1002/mrm.1206; Bornert P, 2015, USING HIGH PERMITTIV, P55; BRITTAIN JH, 1995, MAGNET RESON MED, V33, P689, DOI 10.1002/mrm.1910330515; Dannels WR, 2009, MAGNETIC RESONANCE I; de Graaf P, 2012, PEDIATR RADIOL, V42, P2, DOI 10.1007/s00247-011-2201-5; Diogo MC, 2016, AM J NEURORADIOL, V37, P2334, DOI 10.3174/ajnr.A4890; Ferreira TA, 2019, CANCERS, V11, DOI 10.3390/cancers11030377; Graessl A, 2014, INVEST RADIOL, V49, P260, DOI 10.1097/RLI.0000000000000049; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; HAFNER S, 1994, MAGN RESON IMAGING, V12, P1047, DOI 10.1016/0730-725X(94)91236-P; Horch RA, 2010, MAGN RESON MED, V64, P1652, DOI 10.1002/mrm.22558; Jones CE, 2004, MAGN RESON IMAGING, V22, P211, DOI 10.1016/j.mri.2003.07.005; Larson PEZ, 2016, MAGN RESON MATER PHY, V29, P359, DOI 10.1007/s10334-015-0509-0; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Richdale K, 2013, INVEST OPHTH VIS SCI, V54, P1095, DOI 10.1167/iovs.12-10619; Richdale K, 2009, J MAGN RESON IMAGING, V30, P924, DOI 10.1002/jmri.21959; Robson MD, 2006, NMR BIOMED, V19, P765, DOI 10.1002/nbm.1100; Schieban K, 2015, MAGN RESON MED, V74, P684, DOI 10.1002/mrm.25464; Weiger M, 2013, MAGN RESON MED, V70, P328, DOI 10.1002/mrm.24816; Wezel J, 2017, MAGN RESON MED, V78, P165, DOI 10.1002/mrm.26355; WONG STS, 1994, MAGNET RESON MED, V32, P778, DOI 10.1002/mrm.1910320614; Wu Y, 1998, CALCIFIED TISSUE INT, V62, P512	26	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222573	10.1371/journal.pone.0222573	http://dx.doi.org/10.1371/journal.pone.0222573			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525248	Green Published, gold, Green Submitted			2022-12-26	WOS:000532225700038
J	Bezeng, BS; van der Bank, HF				Bezeng, Bezeng S.; van der Bank, Herman F.			DNA barcoding of southern African crustaceans reveals a mix of invasive species and potential cryptic diversity	PLOS ONE			English	Article							BALANUS-GLANDULA DARWIN; 1ST RECORD; PHYLOGENY; DECAPODA; IDENTIFICATION; EVOLUTION; ACCURACY; TREE	Globally, crustaceans represent one of the most taxonomically diverse and economically important invertebrate group. Notwithstanding, the diversity within this group is poorly known because most crustaceans are often associated with varied habits, forms, sizes and habitats; making species identification by conventional methods extremely challenging. In addition, progress towards understanding the diversity within this group especially in southern Africa has been severely hampered by the declining number of trained taxonomists, the presence of invasive alien species, over exploitation, etc. However, the advent of molecular techniques such as "DNA barcoding and Metabarcoding" can accelerate species identification and the discovery of new species. To contribute to the growing body of knowledge on crustacean diversity, we collected data from five southern African countries and used a DNA barcoding approach to build the first DNA barcode reference library for southern African crustaceans. We tested the reliability of this DNA barcode reference library to facilitate species identification using two approaches. We recovered high efficacy of specimen identification/discrimination; supported by both barcode gap and tree-base species identification methods. In addition, we identified alien invasive species and specimens with "no ID"in our DNA barcode reference library. The later; highlighting specimens requiring (i) further investigation and/or (ii) the potential presence of cryptic diversity or (iii) misidentifications. This unique data set although with some sampling gaps presents many opportunities for exploring the effect and extent of invasive alien species, the role of the pet trade as a pathway for crustacean species introduction into novel environments, sea food authentication, phylogenetic relationships within the larger crustacean groupings and the discovery of new species.	[Bezeng, Bezeng S.; van der Bank, Herman F.] Univ Johannesburg, African Ctr DNA Barcoding, Auckland Pk, Johannesburg, South Africa; [Bezeng, Bezeng S.] Univ Venda, Sch Math & Nat Sci, P Thohoyandou, Venda, South Africa; [Bezeng, Bezeng S.] Univ Johannesburg, Dept Geog Environm Management & Energy Studies, Auckland Pk, Johannesburg, South Africa	University of Johannesburg; University of Venda; University of Johannesburg	Bezeng, BS (corresponding author), Univ Johannesburg, African Ctr DNA Barcoding, Auckland Pk, Johannesburg, South Africa.; Bezeng, BS (corresponding author), Univ Venda, Sch Math & Nat Sci, P Thohoyandou, Venda, South Africa.; Bezeng, BS (corresponding author), Univ Johannesburg, Dept Geog Environm Management & Energy Studies, Auckland Pk, Johannesburg, South Africa.	bezengsimmy@gmail.com			Government of Canada through Genome Canada [2008-OGI-ICI-03]; Ontario Genomics Institute [2008-OGI-ICI-03]; National Research Foundation, South Africa [423 103944]	Government of Canada through Genome Canada(Genome Canada); Ontario Genomics Institute; National Research Foundation, South Africa(National Research Foundation - South AfricaSouth African Medical Research Council)	HFvdB is thankful to the Government of Canada through Genome Canada and the Ontario Genomics Institute for funding; grant number 2008-OGI-ICI-03. BSB and HFvdB are thankful to the National Research Foundation, South Africa for funding; grant number 423 103944.	Ahyong ST, 2007, MOL PHYLOGENET EVOL, V45, P576, DOI 10.1016/j.ympev.2007.03.022; Ahyong Shane T., 2009, Crustacean Issues, V18, P399; Ahyong ST, 2004, RAFFLES B ZOOL, V52, P673; AHYONG ST, 2006, ZOOTAXA 0117, P1; Bekker EI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161737; Bezeng BS, 2017, GENOME, V60, P629, DOI 10.1139/gen-2016-0198; Bracken Heather D., 2009, Arthropod Systematics & Phylogeny, V67, P99; Branch GM, 2010, 2 OCEANS GUIDE MARIN; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Bruce N, 2006, ARA ENCY NZ; Bucklin A, 2007, J PLANKTON RES, V29, P483, DOI 10.1093/plankt/fbm031; Candek K, 2015, MOL ECOL RESOUR, V15, P268, DOI 10.1111/1755-0998.12304; Cawthorn DM, 2017, FOOD CONTROL, V73, P741, DOI 10.1016/j.foodcont.2016.09.027; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; Costa FO, 2007, CAN J FISH AQUAT SCI, V64, P272, DOI 10.1139/F07-008; De Grave S, 2008, HYDROBIOLOGIA, V595, P287, DOI 10.1007/s10750-007-9024-2; De Grave S, 2009, RAFFLES B ZOOL, P1; Dixon CJ, 2003, CRUSTACEANA, V76, P935, DOI 10.1163/156854003771997846; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; GASTON KJ, 1992, NATURE, V356, P281, DOI 10.1038/356281a0; Griiths CL, 2018, FIELD GUIDE OFFSHORE, P133; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017497; Hebert P. D., 2017, 191619 BIORXIV, DOI [10. 1101/191619, DOI 10.1101/191619]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollatz C, 2017, GENOME, V60, P260, DOI 10.1139/gen-2015-0220; Hopkins GW, 2002, ANIM CONSERV, V5, P245, DOI 10.1017/S1367943002002299; Kerckhof F, 2018, BIOINVASIONS REC, V7, P21, DOI 10.3391/bir.2018.7.1.04; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kuguru B, 2019, BIOINVASIONS REC, V8, P379, DOI 10.3391/bir.2019.8.2.19; Laird MC, 2008, AFR J MAR SCI, V30, P93, DOI 10.2989/AJMS.2008.30.1.9.459; Larsen BB, 2017, Q REV BIOL, V92, P229, DOI 10.1086/693564; Laverty C, 2015, MANAG BIOL INVASION, V6, P341, DOI 10.3391/mbi.2015.6.4.03; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Nunes AL, 2017, AFR J AQUAT SCI, V42, P309, DOI 10.2989/16085914.2017.1405788; Petersen RM, 2017, KOEDOE, V59, DOI 10.4102/koedoe.v59i1.1435; Picker MD, 2011, ALIEN INVASIVE ANIMA; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Poore GCB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043529; Porter ML, 2005, MOL PHYLOGENET EVOL, V37, P355, DOI 10.1016/j.ympev.2005.06.021; Radulovici AE, 2009, MOL ECOL RESOUR, V9, P181, DOI 10.1111/j.1755-0998.2009.02643.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Raupach MJ, 2015, ZOOKEYS, P53, DOI 10.3897/zookeys.539.6530; Raupach MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139421; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Schmidt S, 2015, MOL ECOL RESOUR, V15, P985, DOI 10.1111/1755-0998.12363; SCHOLTZ G, 1995, ZOOL J LINN SOC-LOND, V113, P289, DOI 10.1006/zjls.1995.0011; Schram FR, 2001, HYDROBIOLOGIA, V449, P1, DOI 10.1023/A:1017543712119; Shen H, 2013, MOL PHYLOGENET EVOL, V66, P776, DOI 10.1016/j.ympev.2012.11.002; Simon-Blecher N, 2008, AFR J MAR SCI, V30, P85, DOI 10.2989/AJMS.2008.30.1.8.458; Soltis PS, 2003, STAT SCI, V18, P256; Staats M, 2016, ANAL BIOANAL CHEM, V408, P4615, DOI 10.1007/s00216-016-9595-8; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Toon Alicia, 2009, Crustacean Issues, V18, P15; Tsang LM, 2008, MOL PHYLOGENET EVOL, V48, P359, DOI 10.1016/j.ympev.2008.04.009; Uderbayev T, 2017, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2017018; van der Bank H, 2015, ZOOKEYS, P15, DOI 10.3897/zookeys.481.8188; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Wilson EO, 2003, TRENDS ECOL EVOL, V18, P77, DOI 10.1016/S0169-5347(02)00040-X; Witt JDS, 2006, MOL ECOL, V172, P17; Yan D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055854	64	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0222047	10.1371/journal.pone.0222047	http://dx.doi.org/10.1371/journal.pone.0222047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525221	Green Published, gold, Green Submitted			2022-12-26	WOS:000532225700020
J	Jiang, M; Fang, H; Shao, S; Dang, EL; Zhang, JY; Qiao, P; Yang, AG; Wang, G				Jiang, Man; Fang, Hui; Shao, Shuai; Dang, Erle; Zhang, Jieyu; Qiao, Pei; Yang, Angang; Wang, Gang			Keratinocyte exosomes activate neutrophils and enhance skin inflammation in psoriasis	FASEB JOURNAL			English	Article						neutrophil communication; NET; proteomic	CELL-DERIVED EXOSOMES; EXTRACELLULAR TRAP FORMATION; T-CELLS; VESICLES; DISEASE; COMMUNICATION; MECHANISMS; CYTOKINE; PROTEINS; DELETION	Psoriasis is a chronic inflammatory skin disease that severely affects patients physiologically and psychologically. The pathogenesis involving communication between psoriatic keratinocytes and infiltrated immune cells such as neutrophils remains unclear. Exosomes are emerging mediators of intercellular communication. Herein we aim to investigate the release and function of psoriatic keratinocyte exosomes, which have not been illustrated to any extent. We first isolated exosomes from both healthy and psoriasis-like keratinocytes treated with psoriatic cytokine cocktail. These exosomes were observed to be endocytosed by neutrophils. Unlike non cytokine-treated keratinocyte exosomes, cytokine-treated keratinocyte exosomes significantly induced NETosis (the process by which neutrophils produce and release neutrophil extracellular traps) and the expressions of IL-6, IL-8, and TNF-alpha in neutrophils. Proteomic analysis showed that cytokine-treated keratinocyte exosomes exhibited a specific protein profile with proteins enriched in immune-related pathways. We then confirmed that NF-kappa B and p38 MAPK signaling pathways were activated in neutrophils stimulated by cytokine-treated keratinocyte exosomes and were responsible for the expressions of proinflammatory factors mentioned above. Finally, we verified in vivo that cytokine-treated keratinocyte exosomes participated in the skin lesion development of imiquimod-induced psoriasis-like mouse model. Collectively, we reveal that the release of exosomes works as a way of keratinocyte-neutrophil communication, indicating that keratinocyte exosomes, with their specific cargoes, are therapeutic candidates for psoriasis.	[Jiang, Man; Fang, Hui; Shao, Shuai; Dang, Erle; Zhang, Jieyu; Qiao, Pei; Wang, Gang] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, 127 Changlexi Rd, Xian 710032, Peoples R China; [Jiang, Man; Yang, Angang] Fourth Mil Med Univ, Dept Immunol, State Key Lab Canc Biol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Wang, G (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, 127 Changlexi Rd, Xian 710032, Peoples R China.; Yang, AG (corresponding author), Fourth Mil Med Univ, Dept Immunol, State Key Lab Canc Biol, Xian 710032, Peoples R China.	agyang@fmmu.edu.cn; xjwgang@fmmu.edu.cn	Wang, Gang/H-6710-2019	Dang, Erle/0000-0003-4761-6673; Wang, Gang/0000-0002-5842-8080	National Natural Science Foundation of China [81502726, 81430073]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Chenming Zhou (Department of Electron Microscopy Centre, Hebei Medical University) for assistance with electron microscopy. This work was supported by grants from the National Natural Science Foundation of China (81502726 and 81430073). The authors declare no conflicts of interest.	Boehncke WH, 2015, LANCET, V386, P983, DOI 10.1016/S0140-6736(14)61909-7; Cai XW, 2017, MOL MED REP, V16, P7032, DOI 10.3892/mmr.2017.7492; Cambier L, 2017, EMBO MOL MED, V9, P337, DOI 10.15252/emmm.201606924; Chairoungdua A, 2010, J CELL BIOL, V190, P1079, DOI 10.1083/jcb.201002049; Chan BD, 2019, PROTEOMICS, V19, DOI 10.1002/pmic.201800149; Chaput N, 2011, SEMIN IMMUNOPATHOL, V33, P419, DOI 10.1007/s00281-010-0233-9; Chavez-Munoz C, 2008, J CELL BIOCHEM, V104, P2165, DOI 10.1002/jcb.21774; Chavez-Munoz C, 2009, J CELL PHYSIOL, V221, P221, DOI 10.1002/jcp.21847; Cheng CF, 2008, MOL CELL BIOL, V28, P3344, DOI 10.1128/MCB.01287-07; Cheung KL, 2016, J EXP MED, V213, P2399, DOI 10.1084/jem.20160258; Conrad C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02466-4; Essandoh K, 2015, BBA-MOL BASIS DIS, V1852, P2362, DOI 10.1016/j.bbadis.2015.08.010; Esser J, 2010, J ALLERGY CLIN IMMUN, V126, P1032, DOI 10.1016/j.jaci.2010.06.039; Filipazzi P, 2012, SEMIN CANCER BIOL, V22, P342, DOI 10.1016/j.semcancer.2012.02.005; Garcia-Contreras M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05787-y; Goodman WA, 2009, J IMMUNOL, V183, P3170, DOI 10.4049/jimmunol.0803721; Hu SCS, 2016, SCI REP-UK, V6, DOI 10.1038/srep31119; Jiang M, 2017, J INVEST DERMATOL, V137, P2177, DOI 10.1016/j.jid.2017.06.005; Kennedy-Crispin M, 2012, J INVEST DERMATOL, V132, P105, DOI 10.1038/jid.2011.262; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Kim NH, 2014, J INVEST DERMATOL, V134, P1075, DOI 10.1038/jid.2013.478; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kotzerke K, 2013, EXP DERMATOL, V22, P650, DOI 10.1111/exd.12230; Kulshreshtha A, 2013, J ALLERGY CLIN IMMUN, V131, P1194, DOI 10.1016/j.jaci.2012.12.1565; Lambert S, 2019, J INVEST DERMATOL, V139, P1245, DOI 10.1016/j.jid.2018.11.021; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Lo Cicero A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8506; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Matejuk A, 2018, ARCH IMMUNOL THER EX, V66, P45, DOI 10.1007/s00005-017-0477-3; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Okoye IS, 2014, IMMUNITY, V41, P89, DOI [10.1016/j.immuni.2014.05.019, 10.1016/j.immuni.2014.08.008]; Paredes PT, 2012, ALLERGY, V67, P911, DOI 10.1111/j.1398-9995.2012.02835.x; Pasparakis M, 2002, NATURE, V417, P861, DOI 10.1038/nature00820; Pitt JM, 2016, J CLIN INVEST, V126, P1224, DOI 10.1172/JCI81137; Prieto D, 2017, BLOOD, V130, P777, DOI 10.1182/blood-2017-02-769851; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reich K, 2015, EXP DERMATOL, V24, P529, DOI 10.1111/exd.12710; Robbins PD, 2016, J CLIN INVEST, V126, P1173, DOI 10.1172/JCI81131; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Sanchez-Gomez FJ, 2017, ALLERGY, V72, P385, DOI 10.1111/all.12958; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Schon MP, 2017, EXP DERMATOL, V26, P305, DOI 10.1111/exd.13067; Selmaj I, 2017, J NEUROIMMUNOL, V306, P1, DOI 10.1016/j.jneuroim.2017.02.002; Sen BB, 2014, CUTAN OCUL TOXICOL, V33, P223, DOI 10.3109/15569527.2013.834498; Shao S, 2016, J INVEST DERMATOL, V136, P1418, DOI 10.1016/j.jid.2016.03.002; Sumida H, 2014, J IMMUNOL, V192, P4361, DOI 10.4049/jimmunol.1302959; Terui T, 2000, EXP DERMATOL, V9, P1, DOI 10.1034/j.1600-0625.2000.009001001.x; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thieblemont N, 2016, SEMIN IMMUNOL, V28, P159, DOI 10.1016/j.smim.2016.03.004; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Tofino-Vian M, 2018, BIOCHEM PHARMACOL, V153, P134, DOI 10.1016/j.bcp.2018.02.004; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Whiteside TL, 2016, J CLIN INVEST, V126, P1216, DOI 10.1172/JCI81136; WHO, 2013, EX BOARD 133 SESS AG; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zheng LW, 2018, J PROTEOMICS, V173, P139, DOI 10.1016/j.jprot.2017.12.007	56	35	35	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13241	13253		10.1096/fj.201900642R	http://dx.doi.org/10.1096/fj.201900642R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31539277	Bronze			2022-12-26	WOS:000507466100017
J	Zhang, RF; Hou, TT; Cheng, HP; Wang, XH				Zhang, Rufeng; Hou, Tingting; Cheng, Heping; Wang, Xianhua			NDUFAB1 protects against obesity and insulin resistance by enhancing mitochondrial metabolism	FASEB JOURNAL			English	Article						pyruvate dehydrogenase; mitochondrial respiratory complexes; respiratory supercomplexes; metabolic disorder	ACYL CARRIER PROTEIN; SKELETAL-MUSCLE; COMPLEX-I; ARCHITECTURE; ASSEMBLY/STABILITY; MECHANISMS; GLUCOSE; MICE	Mitochondria are fundamental organelles for cellular and systemic metabolism, and their dysfunction has been implicated in the development of diverse metabolic diseases. Boosted mitochondrial metabolism might be able to protect against metabolic stress and prevent metabolic disorders. Here we show that NADH:ubiquinone oxidoreductase (NDU)-FAB1, also known as mitochondrial acyl carrier protein, acts as a novel enhancer of mitochondrial metabolism and protects against obesity and insulin resistance. Mechanistically, NDUFAB1 coordinately enhances lipoylation and activation of pyruvate dehydrogenase mediated by the mitochondrial fatty acid synthesis pathway and increases the assembly of respiratory complexes and supercomplexes. Skeletal muscle specific ablation of NDUFAB1 causes systemic disruption of glucose homeostasis and defective insulin signaling, leading to growth arrest and early death within 5 postnatal days. In contrast, NDUFAB1 overexpression effectively protects mice against obesity and insulin resistance when the animals are challenged with a high-fat diet. Our findings indicate that NDUFAB1 could be a novel mitochondrial target to prevent obesity and insulin resistance by enhancing mitochondrial metabolism.	[Zhang, Rufeng; Hou, Tingting; Cheng, Heping; Wang, Xianhua] Peking Univ, Inst Mol Med, Peking Tsinghua Ctr Life Sci, State Key Lab Membrane Biol,Beijing Key Lab Cardi, Beijing, Peoples R China	Peking University	Wang, XH (corresponding author), Peking Univ, Inst Mol Med, 5 Yi He Yuan Rd, Beijing 100871, Peoples R China.	xianhua@pku.edu.cn	Heping, Cheng/AAE-2680-2019	Heping, Cheng/0000-0002-9604-6702	National Key Basic Research Program of China [2017YFA0504000, 2016YFA0500403]; National Science Foundation of China [31470811, 31670039, 8182780030, 31821091]	National Key Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Dongwei Ma for histology, Dr. Xiaowei Chen for providing Mlc1f-Cre mice, and Drs. Yan Zhang and Ruiping Xiao (all from the Institute of Molecular Medicine) for valuable comments. This work was supported by the National Key Basic Research Program of China (2017YFA0504000 and 2016YFA0500403) and the National Science Foundation of China (31470811, 31670039, 8182780030, and 31821091). The authors declare no conflicts of interest.	Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2014, BBA-BIOENERGETICS, V1837, P444, DOI 10.1016/j.bbabio.2013.12.009; Antoun G, 2015, DIABETOLOGIA, V58, P2861, DOI 10.1007/s00125-015-3772-8; Barrientos T, 2015, EBIOMEDICINE, V2, P1705, DOI 10.1016/j.ebiom.2015.09.041; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Brody S, 1997, FEBS LETT, V408, P217, DOI 10.1016/S0014-5793(97)00428-6; BRODY S, 1988, EUR J BIOCHEM, V173, P353, DOI 10.1111/j.1432-1033.1988.tb14005.x; DEFRONZO RA, 1985, J CLIN INVEST, V76, P149, DOI 10.1172/JCI111938; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05; Erion DM, 2010, NAT MED, V16, P400, DOI 10.1038/nm0410-400; Feng DJ, 2009, J BIOL CHEM, V284, P11436, DOI 10.1074/jbc.M806991200; Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794; Greggio C, 2017, CELL METAB, V25, P301, DOI 10.1016/j.cmet.2016.11.004; Gu JK, 2016, NATURE, V537, P639, DOI 10.1038/nature19359; Guaras A, 2016, CELL REP, V15, P197, DOI 10.1016/j.celrep.2016.03.009; Guo RY, 2017, CELL, V170, P1247, DOI 10.1016/j.cell.2017.07.050; Hesselink MKC, 2016, NAT REV ENDOCRINOL, V12, P633, DOI 10.1038/nrendo.2016.104; Hiltunen JK, 2010, PROG LIPID RES, V49, P27, DOI 10.1016/j.plipres.2009.08.001; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Kraegen EW, 2008, P NATL ACAD SCI USA, V105, P7627, DOI 10.1073/pnas.0803901105; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Letts JA, 2016, NATURE, V537, P644, DOI 10.1038/nature19774; Lopez-Fabuel I, 2016, P NATL ACAD SCI USA, V113, P13063, DOI 10.1073/pnas.1613701113; LYONS GE, 1990, J CELL BIOL, V111, P1465, DOI 10.1083/jcb.111.4.1465; Maio N, 2015, BBA-MOL CELL RES, V1853, P1493, DOI 10.1016/j.bbamcr.2014.09.009; Maranzana E, 2013, ANTIOXID REDOX SIGN, V19, P1469, DOI 10.1089/ars.2012.4845; Milenkovic D, 2017, CELL METAB, V25, P765, DOI 10.1016/j.cmet.2017.03.009; Muoio DM, 2014, CELL, V159, P1253, DOI 10.1016/j.cell.2014.11.034; Nesteruk M, 2014, FUNCT INTEGR GENOMIC, V14, P245, DOI 10.1007/s10142-013-0342-3; Pagel-Langenickel I, 2010, ENDOCR REV, V31, P25, DOI 10.1210/er.2009-0003; Park S, 2018, DIABETES METAB J, V42, P270, DOI 10.4093/dmj.2018.0101; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Petersen MC, 2018, PHYSIOL REV, V98, P2133, DOI 10.1152/physrev.00063.2017; Porras CA, 2015, FRONT BIOSCI-LANDMRK, V20, P621, DOI 10.2741/4327; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; RUNSWICK MJ, 1991, FEBS LETT, V286, P121, DOI 10.1016/0014-5793(91)80955-3; Schagger H, 2004, J BIOL CHEM, V279, P36349, DOI 10.1074/jbc.M404033200; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531; Sousa JS, 2016, ELIFE, V5, DOI [10.7554/eLife.21290, 10.7554/e.Life.21290]; Szendroedi J, 2012, NAT REV ENDOCRINOL, V8, P92, DOI 10.1038/nrendo.2011.138; Van Vranken JG, 2016, ELIFE, V5, DOI 10.7554/eLife.17828; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; Wegener N, 2011, MOL CELL, V44, P191, DOI 10.1016/j.molcel.2011.07.036; Wu M, 2016, CELL, V167, P1598, DOI 10.1016/j.cell.2016.11.012; Zhang F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057766	47	8	8	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2019	33	12					13310	13322		10.1096/fj.201901117RR	http://dx.doi.org/10.1096/fj.201901117RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	KC9BO	31530015	Green Published, hybrid			2022-12-26	WOS:000507466100022
J	Wang, N; Bian, L; Ma, XQ; Meng, YF; Chen, CS; Rahman, MU; Zhang, TT; Li, Z; Wang, P; Chen, YD				Wang, Na; Bian, Li; Ma, Xueqin; Meng, Yufeng; Chen, Cyndi S.; Rahman, Mujeeb Ur; Zhang, Tingting; Li, Zhe; Wang, Ping; Chen, Yaodong			Assembly properties of the bacterial tubulin homolog FtsZ from the cyanobacterium Synechocystis sp. PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyanobacteria; protein dynamics; electron microscopy (EM); cytoskeleton; cytokinesis; bacterial cell division; FtsZ; toroid; tubulin; Z-ring	CELL-DIVISION PROTEIN; ESCHERICHIA-COLI; CHLOROPLAST DIVISION; GTP HYDROLYSIS; DYNAMICS; POLYMERIZATION; REGULATOR; SEQUENCES; INSIGHTS; TURNOVER	The tubulin homolog FtsZ is the major cytoskeletal protein in the bacterial cell division machinery, conserved in almost all bacteria, archaea, and chloroplasts. Bacterial FtsZ assembles spontaneously into single protofilaments, sheets, and bundles in vitro, and it also accumulates at the site of division early during cell division, where it forms a dynamic protein complex, the contractile ring or Z-ring. The biochemical properties of FtsZ proteins from many bacteria have been studied, but comparable insights into FtsZs from cyanobacteria are limited. Here, using EM and light-scattering assays, we studied the biochemical and assembly properties of SyFtsZ, the FtsZ protein from the cyanobacterial strain Synechocystis sp. PCC 6803. SyFtsZ had a slow GTPase activity of ?0.4 GTP/FtsZ molecule/min and assembled into thick, straight protofilament bundles and curved bundles, designated toroids. The assembly of SyFtsZ in the presence of GTP occurred in two stages. The first stage consisted of the assembly of single-stranded straight protofilaments and opened circles; in the second stage, the protofilaments associated into straight protofilament bundles and toroids. In addition to these assemblies, we also observed highly curved oligomers and minirings after GTP hydrolysis or in the presence of excess GDP. The three types of protofilaments of SyFtsZ observed here provide support for the hypothesis that a constriction force due to curved protofilaments bends the membrane. In summary, our findings indicate that, unlike other bacterial FtsZ, SyFtsZ assembles into thick protofilament bundles. This bundling is similar to that of chloroplast FtsZ, consistent with its origin in cyanobacteria.	[Wang, Na; Bian, Li; Ma, Xueqin; Meng, Yufeng; Rahman, Mujeeb Ur; Zhang, Tingting; Li, Zhe; Chen, Yaodong] Northwest Univ, Coll Life Sci, Minist Educ, Key Lab Resources Biol & Biotechnol Western China, Xian 710069, Shaanxi, Peoples R China; [Chen, Cyndi S.; Wang, Ping] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA	Northwest University Xi'an; Duke University	Wang, P (corresponding author), Duke Univ, Med Ctr, Durham, NC 27710 USA.; Chen, YD (corresponding author), Northwest Univ, Coll Life Sci, Xian 710069, Shaanxi, Peoples R China.	pw45@duke.edu; ydchen@nwu.edu.cn	Chen, Yaodong/X-8923-2019; Rahman, Mujeeb ur/ABD-3655-2020	Chen, Yaodong/0000-0002-3751-0923	First-class University and Academic programs of Northwest University	First-class University and Academic programs of Northwest University	This work was supported by First-class University and Academic programs of Northwest University (to Y. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; Beuria TK, 2009, J BIOL CHEM, V284, P14079, DOI 10.1074/jbc.M808872200; Bisson AW, 2017, SCIENCE, V355, P739, DOI 10.1126/science.aak9973; Chen Y, 2007, J BIOL CHEM, V282, P27736, DOI 10.1074/jbc.M703788200; Chen YD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03983-4; Chen YD, 2017, J BIOL CHEM, V292, P5207, DOI 10.1074/jbc.M116.767715; Chen YD, 2009, BIOCHEMISTRY-US, V48, P6664, DOI 10.1021/bi8022653; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; Chen YD, 2005, BIOPHYS J, V88, P505, DOI 10.1529/biophysj.104.044149; Corrales-Guerrero L, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02260; Erickson HP, 2017, SUBCELL BIOCHEM, V84, P139, DOI 10.1007/978-3-319-53047-5_5; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; Feng Z, 2019, BIOCHEM J, V476, P1433, DOI 10.1042/BCJ20190138; Goley ED, 2010, MOL CELL, V39, P975, DOI 10.1016/j.molcel.2010.08.027; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Haeusser DP, 2016, NAT REV MICROBIOL, V14, P305, DOI 10.1038/nrmicro.2016.26; Holden S, 2018, CURR OPIN MICROBIOL, V43, P84, DOI 10.1016/j.mib.2017.12.005; Honda D, 1999, J MOL EVOL, V48, P723, DOI 10.1007/PL00006517; Huang HY, 2018, J BIOL CHEM, V293, P7786, DOI 10.1074/jbc.RA117.001513; Huecas S, 2017, BIOPHYS J, V113, P1831, DOI 10.1016/j.bpj.2017.08.046; KALLAS T, 1982, J BACTERIOL, V149, P229, DOI 10.1128/JB.149.1.229-236.1982; Krupka Marcin, 2018, F1000Res, V7, P235, DOI 10.12688/f1000research.13504.1; Loose M, 2014, NAT CELL BIOL, V16, P38, DOI 10.1038/ncb2885; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lu CL, 1998, CELL MOTIL CYTOSKEL, V40, P71, DOI 10.1002/(SICI)1097-0169(1998)40:1<71::AID-CM7>3.3.CO;2-Z; Lu CL, 1999, CELL STRUCT FUNCT, V24, P285, DOI 10.1247/csf.24.285; Matsui T, 2014, J BIOL CHEM, V289, P3501, DOI 10.1074/jbc.M113.514901; McAndrew RS, 2001, PLANT PHYSIOL, V127, P1656, DOI 10.1104/pp.010542; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Olson BJSC, 2010, J BIOL CHEM, V285, P20634, DOI 10.1074/jbc.M110.122614; Osawa M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00111; Osteryoung KW, 1998, PLANT CELL, V10, P1991, DOI 10.1105/tpc.10.12.1991; Popp D, 2010, J BIOL CHEM, V285, P11281, DOI 10.1074/jbc.M109.084079; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; Ramirez-Diaz DA, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004845; Redick SD, 2005, J BACTERIOL, V187, P2727, DOI 10.1128/JB.187.8.2727-2736.2005; Robertson BR, 2001, INT J SYST EVOL MICR, V51, P861, DOI 10.1099/00207713-51-3-861; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Romberg L, 2001, J BIOL CHEM, V276, P11743, DOI 10.1074/jbc.M009033200; Romberg L, 2004, BIOCHEMISTRY-US, V43, P282, DOI 10.1021/bi035465r; Salvarelli E, 2015, J BIOL CHEM, V290, P25081, DOI 10.1074/jbc.M115.650077; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; Scheffers DJ, 2002, BIOCHEMISTRY-US, V41, P521, DOI 10.1021/bi011370i; Small E, 2003, MICROBIOL-SGM, V149, P2235, DOI 10.1099/mic.0.26126-0; Srinivasan R, 2008, GENE DEV, V22, P1741, DOI 10.1101/gad.1660908; Tadros M, 2006, FEBS LETT, V580, P4941, DOI 10.1016/j.febslet.2006.07.083; TerBush AD, 2018, PLANT PHYSIOL, V176, P295, DOI 10.1104/pp.17.00558; TerBush AD, 2013, CURR OPIN CELL BIOL, V25, P461, DOI 10.1016/j.ceb.2013.04.006; TerBush AD, 2012, J CELL BIOL, V199, P623, DOI 10.1083/jcb.201205114; White EL, 2000, J BACTERIOL, V182, P4028, DOI 10.1128/JB.182.14.4028-4034.2000; Yang XX, 2017, SCIENCE, V355, P744, DOI 10.1126/science.aak9995; Yoshida Y, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.95, 10.1038/nplants.2016.95]	56	6	6	3	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					16309	16319		10.1074/jbc.RA119.009621	http://dx.doi.org/10.1074/jbc.RA119.009621			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31519752	hybrid, Green Published			2022-12-26	WOS:000499478600035
J	Kruyer, A; Ball, LE; Townsend, DM; Kalivas, PW; Uys, JD				Kruyer, Anna; Ball, Lauren E.; Townsend, Danyelle M.; Kalivas, Peter W.; Uys, Joachim D.			Post-translational S-glutathionylation of cofilin increases actin cycling during cocaine seeking	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS; DENDRITIC SPINES; DOPAMINE RELEASE; IDENTIFICATION; PROTEINS; ADF/COFILIN; CYSTEINE; DYNAMICS; PHOSPHORYLATION; DISSOCIATION	Neuronal defense against oxidative damage is mediated primarily by the glutathione redox system. Traditionally considered a mechanism to protect proteins from irreversible oxidation, mounting evidence supports a role for protein S-glutathionylation in cell signaling in response to changes in intracellular redox status. Here we determined the specific sites on the actin binding protein cofilin that undergo S-glutathionylation. In addition, we show that S-glutathionylation of cofilin reduces its capacity to depolymerize F-actin. We further describe an assay to determine the S-glutathionylation of target proteins in brain tissue from behaving rodents. Using this technique, we show that cofilin in the rat nucleus accumbens undergoes S-glutathionylation during 15-minutes of cued cocaine seeking in the absence of cocaine. Our findings demonstrate that cofilin S-glutathionylation is increased in response to cocaine-associated cues and that increased cofilin S-glutathionylation reduces cofilin-dependent depolymerization of F-actin. Thus, S-glutathionylation of cofilin may serve to regulate actin cycling in response to drug-conditioned cues.	[Kruyer, Anna; Kalivas, Peter W.] Med Univ South Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Ball, Lauren E.; Uys, Joachim D.] Med Univ South Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA; [Townsend, Danyelle M.] Med Univ South Carolina, Dept Drug Discovery & Pharmaceut Sci, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Kruyer, A (corresponding author), Med Univ South Carolina, Dept Neurosci, Charleston, SC 29425 USA.; Uys, JD (corresponding author), Med Univ South Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA.	kruyer@musc.edu; uys@musc.edu		Ball, Lauren/0000-0001-6780-1679; Kruyer, Anna/0000-0001-9267-9492	National Institutes of Health [DA007288, DA044782, OD010731, GM103542, DA012513, AA024426, GM103542-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103542] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by DA007288 (A.K.), DA044782 (A.K.), OD010731 (Orbitrap Elite MS, L.E.B.), GM103542 (Proteomics Core, L.E.B.), GM103542 (Analytical Redox Biochemistry Core, D.M.T.), DA012513 (P.W.K.), and AA024426, GM103542-02 (J.D.U.) from the National Institutes of Health (https://www.nih.gov). Funding agencies played no role in research design, data collection, data analysis, or manuscript preparation.	Aesif SW, 2010, METHOD ENZYMOL, V474, P289, DOI 10.1016/S0076-6879(10)74017-9; BAILLIE TA, 1993, BIOL MASS SPECTROM, V22, P319, DOI 10.1002/bms.1200220602; Baker DA, 2002, AMINO ACIDS, V23, P161, DOI 10.1007/s00726-001-0122-6; Baker PR, 2010, MOL CELL PROTEOMICS, V9, P1795, DOI 10.1074/mcp.M110.000422; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Blanchoin L, 2000, J MOL BIOL, V295, P203, DOI 10.1006/jmbi.1999.3336; Chou CC, 2015, J AM SOC MASS SPECTR, V26, P120, DOI 10.1007/s13361-014-1014-9; Chung HS, 2013, CIRC RES, V112, P382, DOI 10.1161/CIRCRESAHA.112.268680; Cole SPC, 2006, TRENDS PHARMACOL SCI, V27, P438, DOI 10.1016/j.tips.2006.06.008; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dietz DM, 2012, NAT NEUROSCI, V15, P891, DOI 10.1038/nn.3094; Dringen R, 1999, J NEUROCHEM, V72, P2523, DOI 10.1046/j.1471-4159.1999.0722523.x; Ducret E, 2016, BIOL PSYCHIAT, V80, P226, DOI 10.1016/j.biopsych.2015.09.019; Esparza MA, 2012, EUR J NEUROSCI, V36, P3103, DOI 10.1111/j.1460-9568.2012.08239.x; Floresco SB, 2015, ANNU REV PSYCHOL, V66, P25, DOI 10.1146/annurev-psych-010213-115159; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Gipson CD, 2013, NEURON, V77, P867, DOI 10.1016/j.neuron.2013.01.005; Guindalini C, 2005, PHARMACOGENET GENOM, V15, P891, DOI 10.1097/01213011-200512000-00007; Guo J, 2014, NAT PROTOC, V9, P64, DOI 10.1038/nprot.2013.161; Hashimoto T, 2005, AM J MED GENET B, V135B, P5, DOI 10.1002/ajmg.b.30164; Hedges DM, 2018, NEUROPSYCHOPHARMACOL, V43, P1405, DOI 10.1038/npp.2017.291; HEFFNER TG, 1980, PHARMACOL BIOCHEM BE, V13, P453, DOI 10.1016/0091-3057(80)90254-3; HINSHAW DB, 1991, ARCH BIOCHEM BIOPHYS, V288, P311, DOI 10.1016/0003-9861(91)90200-3; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; Hurd TR, 2008, J BIOL CHEM, V283, P24801, DOI 10.1074/jbc.M803432200; Ito R, 2000, J NEUROSCI, V20, P7489; Jones DP, 2008, AM J PHYSIOL-CELL PH, V295, pC849, DOI 10.1152/ajpcell.00283.2008; Kalivas PW, 2011, MOL PSYCHIATR, V16, P974, DOI 10.1038/mp.2011.46; KLEGERIS A, 1995, FREE RADICAL BIO MED, V18, P215, DOI 10.1016/0891-5849(94)00141-6; Knackstedt LA, 2010, BIOL PSYCHIAT, V67, P81, DOI 10.1016/j.biopsych.2009.07.018; Madayag A, 2007, J NEUROSCI, V27, P13968, DOI 10.1523/JNEUROSCI.2808-07.2007; MEISTER A, 1988, TRENDS BIOCHEM SCI, V13, P185, DOI 10.1016/0968-0004(88)90148-X; Miseta A, 2000, MOL BIOL EVOL, V17, P1232, DOI 10.1093/oxfordjournals.molbev.a026406; Ono S, 2003, BIOCHEMISTRY-US, V42, P13363, DOI 10.1021/bi034600x; Prudent R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208979; Ressad F, 1999, J BIOL CHEM, V274, P20970, DOI 10.1074/jbc.274.30.20970; Roberts-Wolfe D, 2018, J NEUROSCI, V38, P7100, DOI 10.1523/JNEUROSCI.0791-18.2018; Scofield MD, 2016, PHARMACOL REV, V68, P816, DOI 10.1124/pr.116.012484; Shi Y, 2009, J NEUROSCI, V29, P8129, DOI 10.1523/JNEUROSCI.4681-08.2009; Smith ACW, 2017, J NEUROSCI, V37, P742, DOI 10.1523/JNEUROSCI.2673-16.2016; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Toda S, 2006, J NEUROSCI, V26, P1579, DOI 10.1523/JNEUROSCI.4132-05.2006; Townsend DM, 2009, CANCER RES, V69, P7626, DOI 10.1158/0008-5472.CAN-09-0493; Uys JDC-W S., 2013, P 61 ASMS C MASS SPE, DOI [10.1038/nbt.1511, DOI 10.1038/NBT.1511]; Uys JD, 2014, BIOMED PHARMACOTHER, V68, P799, DOI 10.1016/j.biopha.2014.06.001; Uys JD, 2011, NEUROPSYCHOPHARMACOL, V36, P2551, DOI 10.1038/npp.2011.143; Womersley JS, 2019, EUR J NEUROSCI, V50, P2538, DOI 10.1111/ejn.14130; Womersley JS, 2016, PROG MOL BIOL TRANSL, V137, P87, DOI 10.1016/bs.pmbts.2015.10.001; Wu SL, 2010, ANAL CHEM, V82, P5296, DOI 10.1021/ac100766r; Xiong Y, 2011, ANTIOXID REDOX SIGN, V15, P233, DOI 10.1089/ars.2010.3540; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	54	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0223037	10.1371/journal.pone.0223037	http://dx.doi.org/10.1371/journal.pone.0223037			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550273	Green Published, gold			2022-12-26	WOS:000532307700042
J	Malande, OO; Nuttall, J; Pillay, V; Bamford, C; Eley, B				Malande, Oliver Ombeva; Nuttall, James; Pillay, Vashini; Bamford, Colleen; Eley, Brian			A ten-year review of ESBL and non-ESBL Escherichia coli bloodstream infections among children at a tertiary referral hospital in South Africa	PLOS ONE			English	Review							SPECTRUM BETA-LACTAMASE; KLEBSIELLA-PNEUMONIAE; ENTEROBACTERIACEAE; RESISTANCE	Introduction There are few studies describing Escherichia coli (E. coli) bloodstream infection (BSI) among children in Africa, yet E.coli is increasing in importance as a cause of antibiotic resistant infection in paediatric settings. Methods In this retrospective, descriptive study aspects of E. coli BSI epidemiology are described over a 10-year period including incidence risk, risk factors for extended-spectrum beta-lactamase (ESBL)-producing E. coli BSI, antibiotic susceptibility of the bacterial isolates and outcome including risk factors for severe disease. Results There were 583 new E. coli BSI episodes among 217,483 admissions, an overall incidence risk of 2.7 events/1,000 hospital admissions. Of 455 of these E. coli BSI episodes that were analysed, 136 (29.9%) were caused by ESBL-producing isolates. Risk factors for ESBL-producing E. coli BSI included hospitalization in the 28-day period preceding E. coli BSI episodes, having an underlying chronic illness other than HIV infection at the time of the E. coli BSI and having a temperature of 38 degrees Celsius or higher at the time of the E. coli BSI. None of the E. coli isolates were resistant to carbapenems or colistin. The mortality rate was 5.9% and admission to the intensive care unit was required in 12.3% of BSI episodes. Predictors of severe disease included age less than 1 month, hospitalization in the 28-day period preceding E. coli BSI and BSI without a definable focus. Conclusions These findings extend our understanding of E. coli BSI in a sub-Saharan African setting, provide useful information that can guide empiric treatment choices for community- and hospital-acquired BSI and help inform prevention strategies.	[Malande, Oliver Ombeva; Nuttall, James; Pillay, Vashini; Eley, Brian] Red Cross War Mem Childrens Hosp, Paediat Infect Dis Unit, Cape Town, South Africa; [Malande, Oliver Ombeva; Nuttall, James; Pillay, Vashini; Eley, Brian] Univ Cape Town, Dept Paediat & Child Hlth, Cape Town, South Africa; [Bamford, Colleen] Groote Schuur Hosp, Natl Hlth Lab Serv, Cape Town, South Africa; [Bamford, Colleen] Univ Cape Town, Div Microbiol, Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town	Malande, OO (corresponding author), Red Cross War Mem Childrens Hosp, Paediat Infect Dis Unit, Cape Town, South Africa.; Malande, OO (corresponding author), Univ Cape Town, Dept Paediat & Child Hlth, Cape Town, South Africa.	ombevaom@gmail.com	Nuttall, James/CAF-4214-2022; Nuttall, James/CAE-8986-2022	Nuttall, James/0000-0002-9389-5880; Nuttall, James/0000-0002-9389-5880; Malande, Ombeva/0000-0002-1840-7402				Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; [Anonymous], 2014, M100S24 CLSI S; Burdet C, 2014, PEDIATR INFECT DIS J, V33, P872, DOI 10.1097/INF.0000000000000309; Buys H, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1919-y; Cardoso T, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-40; Clinical and Laboratory Standard Institute (CLSI), 2008, DEV IN VITRO SUSC TE, V28; Clinical and Laboratory Standards Institute, 2011, M100S21 CLSI; Clinical and Laboratory Standards Institute, 2005, M100S15 CLSI; Clinical and Laboratory Standards Institute, 2010, M100S20 CLSI; Clinical and Laboratory Standards Institute, 2013, M100S23 CLSI; Clinical and Laboratory Standards Institute, 2009, M100S19 CLSI S; CLSI, 2012, M02A1 CLSI; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Dramowski A, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0354-3; Evans SR, 2017, VIRULENCE, V8, P453, DOI 10.1080/21505594.2016.1213473; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Gurieva T, 2018, CLIN INFECT DIS, V66, P489, DOI 10.1093/cid/cix825; Harris PNA, 2018, JAMA-J AM MED ASSOC, V320, P984, DOI 10.1001/jama.2018.12163; Harris PNA, 2015, SEMIN RESP CRIT CARE, V36, P56, DOI 10.1055/s-0034-1398387; Hilty M, 2012, CLIN INFECT DIS, V55, P967, DOI 10.1093/cid/cis581; Kaye KS, 2005, INFECT CONT HOSP EP, V26, P346, DOI 10.1086/502550; Larru B, 2016, PEDIATR INFECT DIS J, V35, P507, DOI 10.1097/INF.0000000000001057; Lochan H, 2013, SAMJ S AFR MED J, V103, P918, DOI [10.7196/samj.6979, 10.7196/SAMJ.6979]; Lochan H, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2862-2; Mattew A, 2006, M2A9 CLSI; McDanel J, 2017, INFECT CONT HOSP EP, V38, P1209, DOI 10.1017/ice.2017.156; McKay R, 2015, SAMJ S AFR MED J, V105, P363, DOI [10.7196/SAMJ.8183, 10.7196/samj.8183]; Murray TS, 2015, CURR OPIN PEDIATR, V27, P124, DOI 10.1097/MOP.0000000000000182; Peirano G, 2011, DIAGN MICR INFEC DIS, V69, P449, DOI 10.1016/j.diagmicrobio.2010.11.011; Performance Standards for Antimicrobial Susceptibility Testing, 2007, M100S17 CLSI; Pitout JDD, 1998, ANTIMICROB AGENTS CH, V42, P1350, DOI 10.1128/AAC.42.6.1350; Rynn L., 2008, Morbidity and Mortality Weekly Report, V57, P1; Tacconelli E, 2017, GLOBAL PRIORITY LIST	33	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222675	10.1371/journal.pone.0222675	http://dx.doi.org/10.1371/journal.pone.0222675			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550295	Green Submitted, gold, Green Published			2022-12-26	WOS:000532307700024
J	Fragoso-Ontiveros, V; Velazquez-Aragon, JA; Nunez-Martinez, PM; Mejia-Aguayo, MD; Vidal-Millan, S; Pedroza-Torres, A; Sanchez-Contreras, Y; Ramirez-Otero, MA; Muniz-Mendoza, R; Dominguez-Ortiz, J; Wegman-Ostrosky, T; Bargallo-Rocha, JE; Gallardo-Rincon, D; Reynoso-Noveron, N; Arriaga-Canon, C; Meneses-Garcia, A; Herrera-Montalvo, LA; Alvarez-Gomez, RM				Fragoso-Ontiveros, Veronica; Antonio Velazquez-Aragon, Jose; Maria Nunez-Martinez, Paulina; de la Luz Mejia-Aguayo, Maria; Vidal-Millan, Silvia; Pedroza-Torres, Abraham; Sanchez-Contreras, Yuliana; Angel Ramirez-Otero, Miguel; Muniz-Mendoza, Rodolfo; Dominguez-Ortiz, Julieta; Wegman-Ostrosky, Talia; Enrique Bargallo-Rocha, Juan; Gallardo-Rincon, Dolores; Reynoso-Noveron, Nancy; Arriaga-Canon, Cristian; Meneses-Garcia, Abelardo; Alonso Herrera-Montalvo, Luis; Maria Alvarez-Gomez, Rosa			Mexican BRCA1 founder mutation: Shortening the gap in genetic assessment for hereditary breast and ovarian cancer patients	PLOS ONE			English	Article							RISK-ASSESSMENT; RECURRENT BRCA1; GENOMIC REARRANGEMENTS; PREVALENCE; WOMEN; CHALLENGES; PREVENTION; CARRIERS	The deletion of exons 9 to 12 of BRCA1 (9-12 del BRCA1) is considered a founder mutation in the Mexican population. We evaluate the usefulness of the target detection of 9-12 del BRCA1 as the first molecular diagnostic strategy in patients with Hereditary Breast and Ovarian Cancer (HBOC). We performed the genetic assessment of 637 patients with suspected HBOC. The region corresponding to the breakpoints for the 9-12 del BRCA1 was amplified by polymerase chain reaction (PCR). An analysis of the clinical data of the carriers and non-carriers was done, searching for characteristics that correlated with the deletion. The 9-12 del BRCA1 was detected in 5% of patients with suspected HBOC (30/637). In patients diagnosed with ovarian cancer, 13 of 30 were 9-12 del BRCA1 carriers, which represents 43%. We found a significant association between the 9-12 del BRCA1 carriers with triple negative breast cancer and high-grade papillary serous ovarian cancer. We concluded that the detection of the 9-12 del BRCA1 is useful as a first molecular diagnostic strategy in the Mexican population. In particular, it shortens the gap in genetic assessment in patients with triple negative breast cancer and ovarian cancer.	[Fragoso-Ontiveros, Veronica; Maria Nunez-Martinez, Paulina; de la Luz Mejia-Aguayo, Maria; Vidal-Millan, Silvia; Sanchez-Contreras, Yuliana; Angel Ramirez-Otero, Miguel; Dominguez-Ortiz, Julieta; Wegman-Ostrosky, Talia; Maria Alvarez-Gomez, Rosa] Natl Canc Inst, Hereditary Canc Clin, Mexico City, DF, Mexico; [Antonio Velazquez-Aragon, Jose] Natl Paediat Inst, Mol Biol Lab, Mexico City, DF, Mexico; [Pedroza-Torres, Abraham; Muniz-Mendoza, Rodolfo; Arriaga-Canon, Cristian; Alonso Herrera-Montalvo, Luis] Natl Canc Inst, Res Direct, Mexico City, DF, Mexico; [Enrique Bargallo-Rocha, Juan] Natl Canc Inst, Breast Canc Dept, Mexico City, DF, Mexico; [Gallardo-Rincon, Dolores] Natl Canc Inst, Med Oncol Dept, Mexico City, DF, Mexico; [Reynoso-Noveron, Nancy] Natl Canc Inst, Epidemiol Dept, Mexico City, DF, Mexico; [Meneses-Garcia, Abelardo] Natl Canc Inst, Gen Direct, Mexico City, DF, Mexico		Alvarez-Gomez, RM (corresponding author), Natl Canc Inst, Hereditary Canc Clin, Mexico City, DF, Mexico.	rosamag2@hotmail.com	Herrera, Luis/GOV-3311-2022; Velázquez-Aragón, Jose/AAH-4559-2021; Wegman-Ostrosky, Talia/AAV-7521-2020	Wegman-Ostrosky, Talia/0000-0002-3207-6697; Ramirez Otero, Miguel Angel/0000-0001-8428-1150; Velazquez-Aragon, Jose/0000-0002-3617-8148; ARRIAGA, CRISTIAN/0000-0002-4866-9067	LXII Legislature of the Congress of the Union of Mexico; LXIII Legislature of the Congress of the Union of Mexico	LXII Legislature of the Congress of the Union of Mexico; LXIII Legislature of the Congress of the Union of Mexico	We thank LXII and LXIII Legislature of the Congress of the Union of Mexico, for their support.	Zayas-Villanueva OA, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5950-4; Ossa CA, 2016, ONCOLOGIST, V21, P832, DOI 10.1634/theoncologist.2015-0416; [Anonymous], 2018, ENCUESTA NACL OCUPAC; Apostolou P, 2017, CLIN GENET, V91, P482, DOI 10.1111/cge.12824; Brody LC, 1998, MEDICINE, V77, P208, DOI 10.1097/00005792-199805000-00006; Chavarri-Guerra Y, 2017, REV INVEST CLIN, V69, P94, DOI 10.24875/ric.17002195; Daly MB, 2017, J NATL COMPR CANC NE, V15, P9, DOI 10.6004/jnccn.2017.0003; Gabai-Kapara E, 2014, P NATL ACAD SCI USA, V111, P14205, DOI 10.1073/pnas.1415979111; Gomes MCB, 2007, BREAST CANCER RES TR, V103, P349, DOI 10.1007/s10549-006-9378-6; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Hartmann Carolin, 2004, Hum Mutat, V24, P534, DOI 10.1002/humu.9291; James PA, 2015, FAM CANCER, V14, P287, DOI 10.1007/s10689-015-9785-0; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Lancaster JM, 2015, GYNECOL ONCOL, V136, P3, DOI 10.1016/j.ygyno.2014.09.009; Landrum MJ, 2018, NUCLEIC ACIDS RES, V46, pD1062, DOI 10.1093/nar/gkx1153; Lazcano-Ponce E, 2016, SALUD PUBLICA MEXICO, V58, P101; Mavaddat N, 2013, JNCI-J NATL CANCER I, V105, P812, DOI 10.1093/jnci/djt095; Moyer VA, 2014, ANN INTERN MED, V160, P271, DOI 10.7326/M13-2747; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Palanca S, 2013, FAM CANCER, V12, P119, DOI 10.1007/s10689-012-9579-6; Palma MD, 2008, CANCER RES, V68, P7006, DOI 10.1158/0008-5472.CAN-08-0599; Paluch-Shimon S, 2016, ANN ONCOL, V27, pv103, DOI 10.1093/annonc/mdw327; PetrijBosch A, 1997, NAT GENET, V17, P341, DOI 10.1038/ng1197-341; Urban RQ, 2018, CANCERS, V10, DOI 10.3390/cancers10100361; Rebbeck TR, 2018, HUM MUTAT, V39, P593, DOI 10.1002/humu.23406; Rebbeck TR, 2015, JAMA-J AM MED ASSOC, V313, P1347, DOI 10.1001/jama.2014.5985; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Strasser-Weippl K, 2015, LANCET ONCOL, V16, P1405, DOI 10.1016/S1470-2045(15)00218-1; Szabo C, 2000, HUM MUTAT, V16, P123, DOI 10.1002/1098-1004(200008)16:2<123::AID-HUMU4>3.0.CO;2-Y; Torres D, 2007, BREAST CANCER RES TR, V103, P225, DOI 10.1007/s10549-006-9370-1; Torres D, 2009, BREAST CANCER RES TR, V117, P679, DOI 10.1007/s10549-009-0383-4; Torres-Mejia G, 2015, CANCER EPIDEM BIOMAR, V24, P498, DOI 10.1158/1055-9965.EPI-13-0980; Villarreal-Garza C, 2015, BREAST CANCER RES TR, V150, P389, DOI 10.1007/s10549-015-3312-8; Villarreal-Garza C, 2015, CANCER-AM CANCER SOC, V121, P372, DOI 10.1002/cncr.29058; Weitzel JN, 2007, CANCER EPIDEM BIOMAR, V16, P1615, DOI 10.1158/1055-9965.EPI-07-0198; Weitzel JN, 2013, J CLIN ONCOL, V31, P210, DOI 10.1200/JCO.2011.41.0027; Weitzel JN, 2005, CANCER EPIDEM BIOMAR, V14, P1666, DOI 10.1158/1055-9965.EPI-05-0072; Wunderle M, 2018, GEBURTSH FRAUENHEILK, V78, P481, DOI 10.1055/a-0603-4350	39	6	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0222709	10.1371/journal.pone.0222709	http://dx.doi.org/10.1371/journal.pone.0222709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545835	gold, Green Published			2022-12-26	WOS:000532303200028
J	Balla, K; Karsai, I; Bonis, P; Kiss, T; Berki, Z; Horvath, A; Mayer, M; Bencze, S; Veisz, O				Balla, Krisztina; Karsai, Ildiko; Bonis, Peter; Kiss, Tibor; Berki, Zita; Horvath, Adam; Mayer, Marianna; Bencze, Szilvia; Veisz, Otto			Heat stress responses in a large set of winter wheat cultivars (Triticum aestivum L.) depend on the timing and duration of stress	PLOS ONE			English	Article							HIGH-TEMPERATURE STRESS; GRAIN-YIELD; PHOTOSYNTHETIC DECLINE; KERNEL DEVELOPMENT; DROUGHT STRESS; WATER-DEFICIT; GROWTH-STAGES; SENESCENCE; TOLERANCE; QUALITY	The adverse effects of heat on plant yield strongly depend on its duration and the phenological stage of the crops when the heat occurs. To clarify the effects of these two aspects of heat stress, systematic research was conducted under controlled conditions on 101 wheat cultivars of various geographic origin. Different durations of heat stress (5, 10 and 15 days) were applied starting from three developmental stages (ZD49: booting stage, ZD59: heading, ZD72: 6th day after heading). Various morphological, yield-related traits and physiological parameters were measured to determine the stress response patterns of the wheat genotypes under combinations of the duration and the timing of heat stress. Phenological timing significantly influenced the thousand-kernel weight and reproductive tiller number. The duration of heat stress was the most significant component in determining both seed number and seed weight, as well as the grain yield consequently, explaining 51.6% of its phenotypic variance. Irrespective of the developmental phase, the yield-related traits gradually deteriorated over time, and even a 5-day heat stress was sufficient to cause significant reductions. ZD59 was significantly more sensitive to heat than either ZD49 or ZD72. The photosynthetic activity of the flag leaf was mostly determined by heat stress duration. No significant associations were noted between physiological parameters and heat stress response as measured by grain yield. Significant differences were observed between the wheat genotypes in heat stress responses, which varied greatly with developmental phase. Based on the grain yield across developmental phases and heat stress treatments, eight major response groups of wheat genotypes could be identified, and among them, three clusters were the most heat-tolerant. These cultivars are currently included in crossing schemes, partially for the identification of the genetic determinants of heat stress response and partially for the development of new wheat varieties with better heat tolerance.	[Balla, Krisztina; Karsai, Ildiko; Kiss, Tibor; Berki, Zita; Horvath, Adam] Hungarian Acad Sci, Ctr Agr Res, Agr Inst, Mol Breeding Dept, Martonvasar, Hungary; [Bonis, Peter] Hungarian Acad Sci, Ctr Agr Res, Agr Inst, Crop Prod Dept, Martonvasar, Hungary; [Mayer, Marianna; Veisz, Otto] Hungarian Acad Sci, Ctr Agr Res, Agr Inst, Cereal Breeding Dept, Martonvasar, Hungary; [Bencze, Szilvia] Res Inst Organ Agr, Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research	Balla, K (corresponding author), Hungarian Acad Sci, Ctr Agr Res, Agr Inst, Mol Breeding Dept, Martonvasar, Hungary.	balla.krisztina@agrar.mta.hu		Horvath, Adam/0000-0002-9256-3040	National Scientific Research Fund (NKFIH) [K-119801];  [GINOP-2.3.2-15-2016-00029]	National Scientific Research Fund (NKFIH)(National Research, Development & Innovation Office (NRDIO) - Hungary); 	This research program was funded by a grant from the National Scientific Research Fund (NKFIH) K-119801 and by the GINOP-2.3.2-15-2016-00029 (Economic Development Operational Programme) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MB, 2013, EUPHYTICA, V192, P189, DOI 10.1007/s10681-012-0824-8; ALKHATIB K, 1984, PHYSIOL PLANTARUM, V61, P363, DOI 10.1111/j.1399-3054.1984.tb06341.x; Balla K, 2006, CEREAL RES COMMUN, V34, P381, DOI 10.1556/CRC.34.2006.1.95; Balla K, 2008, CEREAL RES COMMUN, V36, P1103; Balla K, 2011, CZECH J FOOD SCI, V29, P117, DOI 10.17221/227/2010-CJFS; Barber HM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00051; Bergkamp B, 2018, FIELD CROP RES, V222, P143, DOI 10.1016/j.fcr.2018.03.009; BHULLAR SS, 1985, AUST J PLANT PHYSIOL, V12, P363, DOI 10.1071/PP9850363; Bita CE, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00273; BLUMENTHAL CS, 1991, AUST J AGR RES, V42, P325, DOI 10.1071/AR9910325; Brilli F, 2011, AGR FOREST METEOROL, V151, P1731, DOI 10.1016/j.agrformet.2011.07.007; Camejo D, 2005, J PLANT PHYSIOL, V162, P281, DOI 10.1016/j.jplph.2004.07.014; CHOWDHURY SI, 1978, AUST J AGR RES, V29, P205, DOI 10.1071/AR9780205; Djanaguiraman M, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1263-z; Farooq M, 2011, CRIT REV PLANT SCI, V30, P491, DOI 10.1080/07352689.2011.615687; Feng B, 2014, J AGRON CROP SCI, V200, P143, DOI 10.1111/jac.12045; Ferris R, 1998, ANN BOT-LONDON, V82, P631, DOI 10.1006/anbo.1998.0740; FISCHER RA, 1985, J AGR SCI, V105, P447, DOI 10.1017/S0021859600056495; Fujimura S, 2012, PLANT PROD SCI, V15, P118, DOI 10.1626/pps.15.118; Gregersen PL, 2007, PLANT BIOTECHNOL J, V5, P192, DOI 10.1111/j.1467-7652.2006.00232.x; HARDING SA, 1990, PLANT PHYSIOL, V92, P654, DOI 10.1104/pp.92.3.654; HARDING SA, 1990, PLANT PHYSIOL, V92, P648, DOI 10.1104/pp.92.3.648; Hatfield JL, 2015, WEATHER CLIM EXTREME, V10, P4, DOI 10.1016/j.wace.2015.08.001; Hlavacova M, 2016, PROCEEDINGS OF INTERNATIONAL PHD STUDENTS CONFERENCE, (MENDELNET 2016), P63; Kamrani M, 2018, ARCH AGRON SOIL SCI, V64, P38, DOI 10.1080/03650340.2017.1326104; Kaushal Neeru, 2016, Cogent Food & Agriculture, V2, DOI 10.1080/23311932.2015.1134380; Khan SU, 2013, J CHEM SOC PAKISTAN, V35, P647; Kiss T, 2019, CROP SCI, V59, P591, DOI 10.2135/cropsci2018.09.0531; KOBZA J, 1987, PLANT PHYSIOL, V83, P69, DOI 10.1104/pp.83.1.69; Kumudini S, 2014, AGRON J, V106, P2087, DOI 10.2134/agronj14.0200; Lakatos M, 2012, CHANGES CLIMATIC EXT; Liu B, 2017, AGR FOREST METEOROL, V247, P476, DOI 10.1016/j.agrformet.2017.08.018; Liu B, 2016, GLOBAL CHANGE BIOL, V22, P1890, DOI 10.1111/gcb.13212; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Mahrookashani A, 2017, J AGRON CROP SCI, V203, P453, DOI 10.1111/jac.12218; Cossani CM, 2015, CROP SCI, V55, P2719, DOI 10.2135/cropsci2015.02.0092; McMaster GS, 1997, ADV AGRON, V59, P63, DOI 10.1016/S0065-2113(08)60053-X; Nagy BA, 2011, CLIMATE CHANGE POLIC; ORTIZ-MONASTERIO JI, 1994, FIELD CROP RES, V37, P169, DOI 10.1016/0378-4290(94)90096-5; Porter JR, 1999, EUR J AGRON, V10, P23, DOI 10.1016/S1161-0301(98)00047-1; Prasad PVV, 2008, CROP SCI, V48, P1911, DOI 10.2135/cropsci2008.01.0036; Prasad PVV, 2011, J AGRON CROP SCI, V197, P430, DOI 10.1111/j.1439-037X.2011.00477.x; Prasad PVV, 2014, FUNCT PLANT BIOL, V41, P1261, DOI 10.1071/FP14061; Rahman M. A., 2009, BANGLADESH J, V34, P360; RANDALL PJ, 1990, AUST J AGR RES, V41, P603, DOI 10.1071/AR9900603; Rashid MA, 2018, ENVIRON EXP BOT, V147, P138, DOI 10.1016/j.envexpbot.2017.12.009; Rashid MA, 2018, AGR FOREST METEOROL, V248, P119, DOI 10.1016/j.agrformet.2017.09.018; Reynolds MP, 2000, FIELD CROP RES, V66, P37, DOI 10.1016/S0378-4290(99)00077-5; Rezaei EE, 2015, EUR J AGRON, V64, P98, DOI 10.1016/j.eja.2014.10.003; Ristic Z, 2007, CROP SCI, V47, P2067, DOI 10.2135/cropsci2006.10.0674; SAINI HS, 1983, AUST J PLANT PHYSIOL, V10, P137, DOI 10.1071/PP9830137; SAINI HS, 1981, ANN BOT-LONDON, V48, P623, DOI 10.1093/oxfordjournals.aob.a086170; Salvucci ME, 2004, PHYSIOL PLANTARUM, V120, P179, DOI 10.1111/j.0031-9317.2004.0173.x; SEMENOV MA, 1995, AGR FOREST METEOROL, V73, P265, DOI 10.1016/0168-1923(94)05078-K; Shah NH, 2003, PLANT SOIL, V257, P219, DOI 10.1023/A:1026237816578; Sharma DK, 2015, PHYSIOL PLANTARUM, V153, P284, DOI 10.1111/ppl.12245; Shirdelmoghanloo H, 2016, FUNCT PLANT BIOL, V43, P919, DOI 10.1071/FP15384; Stone PJ, 1995, AUST J PLANT PHYSIOL, V22, P927, DOI 10.1071/PP9950927; STONE PJ, 1995, AUST J AGR RES, V46, P475, DOI 10.1071/AR9950475; STONE PJ, 1994, AUST J PLANT PHYSIOL, V21, P887, DOI 10.1071/PP9940887; Stone PJ, 1995, AUST J PLANT PHYSIOL, V22, P935, DOI 10.1071/PP9950935; Talukder ASMHM, 2014, FIELD CROP RES, V160, P54, DOI 10.1016/j.fcr.2014.01.013; Tewolde H, 2006, J AGRON CROP SCI, V192, P111, DOI 10.1111/j.1439-037X.2006.00189.x; TOTTMAN DR, 1979, ANN APPL BIOL, V93, P221, DOI 10.1111/j.1744-7348.1979.tb06534.x; Vignjevic M, 2015, J AGRON CROP SCI, V201, P32, DOI 10.1111/jac.12085; Wahid A, 2007, ENVIRON EXP BOT, V61, P199, DOI 10.1016/j.envexpbot.2007.05.011; WARDLAW IF, 1994, AUST J PLANT PHYSIOL, V21, P731, DOI 10.1071/PP9940731; Wollenweber B, 2003, J AGRON CROP SCI, V189, P142, DOI 10.1046/j.1439-037X.2003.00025.x; Xu XL, 2004, PHOTOSYNTHETICA, V42, P317, DOI 10.1023/B:PHOT.0000040608.97976.a3; Yang J, 2002, EUPHYTICA, V126, P185, DOI 10.1023/A:1016365728633; Yang JC, 2001, AGRON J, V93, P196, DOI 10.2134/agronj2001.931196x; Yin XY, 2009, FIELD CROP RES, V114, P119, DOI 10.1016/j.fcr.2009.07.013	72	55	57	6	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222639	10.1371/journal.pone.0222639	http://dx.doi.org/10.1371/journal.pone.0222639			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539409	Green Published, Green Submitted, gold			2022-12-26	WOS:000532297900022
J	Ledger, KJ; Keenan, RM; Sayler, KA; Wisely, SM				Ledger, Kimberly J.; Keenan, Ryan M.; Sayler, Katherine A.; Wisely, Samantha M.			Multi-scale patterns of tick occupancy and abundance across an agricultural landscape in southern Africa	PLOS ONE			English	Article							IXODES-SCAPULARIS ACARI; RHIPICEPHALUS-APPENDICULATUS; FOREST FRAGMENTATION; BORNE RICKETTSIOSES; AMBLYOMMA-HEBRAEUM; LYME-DISEASE; WILD ANIMALS; RISK-FACTORS; LAND-COVER; IXODIDAE	Land use influences the prevalence and distribution of ticks due to the intimate relationship of ticks with their environment. This relationship occurs because land use alters two essential tick requirements: vertebrate hosts for blood meals and a suitable microclimate when off-host. Given the risks to human and animal health associated with pathogens transmitted by ticks, there is an ongoing need to understand the impact of environmental drivers on tick distributions. Here, we assessed how landscape features, neighborhood effects, and edges influenced tick occupancy and abundance across an agricultural landscape in southern Africa. We found that Rhipicephalus appendiculatus and Rhipicephalus simus increased in abundance closer to protected savanna, while Haemaphysalis elliptica increased in abundance closer to human habitation. The composition of the landscape surrounding savanna patches also differentially influenced the occupancy of each tick species; H. elliptica was more likely to be found in savanna patches surrounded by subsistence agriculture while R. appendiculatus and R. simus were more likely to be found in savanna surrounded by sugarcane monocultures. At the local scale we found that R. appendiculatus and R. simus avoided savanna edges. The availability of hosts and variation in vegetation structure between commercial agriculture, subsistence agriculture, and savanna likely drove the distribution of ticks at the landscape scale. Understanding how anthropogenic land use influences where ticks occur is useful for land use planning and for assessing public and animal health risks associated with ticks and tick-borne diseases.	[Ledger, Kimberly J.; Sayler, Katherine A.; Wisely, Samantha M.] Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA; [Keenan, Ryan M.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA	State University System of Florida; University of Florida; University of Minnesota System; University of Minnesota Twin Cities	Wisely, SM (corresponding author), Univ Florida, Dept Wildlife Ecol & Conservat, Gainesville, FL 32611 USA.	wisely@ufl.edu	Ledger, Kimberly/O-2151-2017	Wisely, Samantha/0000-0003-1748-4518; Ledger, Kimberly/0000-0002-5552-5598	National Science Foundation Graduate Research Fellowship [DGE-1842473]; NSF ISE grant [1459882]; College of Agriculture and Life Science at the University of Florida	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NSF ISE grant; College of Agriculture and Life Science at the University of Florida	KL was supported by the National Science Foundation Graduate Research Fellowship under grant no. DGE-1842473. This study was funded by NSF ISE grant (no. 1459882) and the College of Agriculture and Life Science at the University of Florida.	Alexander R, 1935, TRANSMISSION LOUPING; Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; ANDERSON JF, 1981, AM J TROP MED HYG, V30, P897, DOI 10.4269/ajtmh.1981.30.897; Angelstam P., 1992, ECOLOGICAL PRINCIPLE, P9, DOI DOI 10.1007/978-1-4615-3524-9_2; [Anonymous], 2015, SUPPLY DEMAND SUGAR; Bailey KM, 2016, J LAND USE SCI, V11, P154, DOI 10.1080/1747423X.2015.1086905; Barandika JF, 2006, MED VET ENTOMOL, V20, P177, DOI 10.1111/j.1365-2915.2006.00619.x; Barton K, 2020, MUMIN MULTIMODEL INF; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bayne EM, 1998, CAN J ZOOL, V76, P62, DOI 10.1139/cjz-76-1-62; Bjornstad ON, 2001, ENVIRON ECOL STAT, V8, P53, DOI 10.1023/A:1009601932481; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bryson NR, 2000, EXP APPL ACAROL, V24, P971, DOI 10.1023/A:1010639113793; Burke DM, 1998, AUK, V115, P96, DOI 10.2307/4089115; Civitello DJ, 2008, J MED ENTOMOL, V45, P867, DOI 10.1603/0022-2585(2008)45[867:EGIRSO]2.0.CO;2; Cliff AD, 1981, SPATIAL PROCESSES ME; Cully JF, 1999, J RANGE MANAGE, V52, P139, DOI 10.2307/4003507; Daniel M, 1994, MICROMETEOROLOGICAL, P138; de la Fuente J, 2008, FRONT BIOSCI-LANDMRK, V13, P6938, DOI 10.2741/3200; Diuk-Wasser MA, 2006, J MED ENTOMOL, V43, P166, DOI 10.1603/0022-2585(2006)043[0166:SPOHIS]2.0.CO;2; Du Toit JT, 1999, BIODIVERS CONSERV, V8, P1643, DOI 10.1023/A:1008959721342; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Estrada-Pena A, 2003, ECOGRAPHY, V26, P661, DOI 10.1034/j.1600-0587.2003.03530.x; Ferrell AM, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040737; Fielden LJ, 1996, EXP APPL ACAROL, V20, P625, DOI 10.1007/BF00053326; Finch C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084758; FIVAZ BH, 1989, TROP ANIM HEALTH PRO, V21, P129, DOI 10.1007/BF02236193; Fortunate M., 2016, STRENGTHENING NATL P; Gallivan GJ, 2011, ONDERSTEPOORT J VET, V78, P27, DOI 10.4102/ojvr.v78i1.41; Gear JHS, 1938, S AFRICAN MED J, V12; Ginsberg HS, 2004, ENVIRON ENTOMOL, V33, P1266, DOI 10.1603/0046-225X-33.5.1266; Gordon IJ, 2009, WILDLIFE BIOL, V15, P1, DOI 10.2981/06-087; Goudie A., 1983, ATLAS SWAZILAND; GUGLIELMONE AA, 1992, B ENTOMOL RES, V82, P203, DOI 10.1017/S0007485300051737; HACKEL JD, 1993, HUM ECOL, V21, P295, DOI 10.1007/BF00891541; Halos L, 2010, APPL ENVIRON MICROB, V76, P4413, DOI 10.1128/AEM.00610-10; Holmes JC, 1996, BIODIVERS CONSERV, V5, P975, DOI 10.1007/BF00054415; Horak IG, 2006, ONDERSTEPOORT J VET, V73, P163; Horak I. G., 2018, IXODID TICKS ACARI I; Horak IG, 2001, ONDERSTEPOORT J VET, V68, P135; Horak IG, 2000, ONDERSTEPOORT J VET, V67, P239; Horak IG, 2011, ONDERSTEPOORT J VET, V78, P8, DOI 10.4102/ojvr.v78i1.32; Horobik V, 2006, ECOHEALTH, V3, P262, DOI 10.1007/s10393-006-0065-1; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Jackson HB, 2015, GLOBAL ECOL BIOGEOGR, V24, P52, DOI 10.1111/geb.12233; Jones BA, 2013, P NATL ACAD SCI USA, V110, P8399, DOI 10.1073/pnas.1208059110; Kastner T, 2012, P NATL ACAD SCI USA, V109, P6868, DOI 10.1073/pnas.1117054109; Keesing F, 2010, NATURE, V468, P647, DOI 10.1038/nature09575; Kery M, 2015, APPL HIERARCHICAL MO, V1; Lawrence J. A., 1980, Zimbabwe Veterinary Journal, V11, P27; LEVINS R, 1994, AM SCI, V82, P52; Linard C, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-15; Lindstrom A, 2003, J MED ENTOMOL, V40, P375, DOI 10.1603/0022-2585-40.4.375; Lounsbury CP, 1904, TRANSMISSON AFRICAN; Lounsbury CP, 1903, TRANSVAAL AGR J, V2, P4; MacKenzie DI, 2004, J AGR BIOL ENVIR ST, V9, P300, DOI 10.1198/108571104X3361; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Madder M, 2005, MED VET ENTOMOL, V19, P245, DOI 10.1111/j.1365-2915.2005.00566.x; Mamba M., 2019, INFLUENCE SUGARCANE; MATSON B. A., 1967, J S AFR VET MED ASS, V38, P93; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; MAUPIN GO, 1991, AM J EPIDEMIOL, V133, P1105, DOI 10.1093/oxfordjournals.aje.a115823; McCleery R, 2018, BIOL CONSERV, V226, P54, DOI 10.1016/j.biocon.2018.07.020; Mijinyawa Y, 2006, LIVESTOCK RES RURAL, V18; Monadjem A., 2003, THREATENED VERTEBRAT; MONTGOMERY E., 1917, Journal of Comparative Pathology and Therapeutics, V30, P28; Mucina L., 2006, VEGETATION S AFRICA; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Neitz E, 1955, J S AFR VET ASSOC, V26, P79; Norval R., 1974, STUDIES BIOL ECOLOGY; NORVAL RAI, 1977, J PARASITOL, V63, P740, DOI 10.2307/3279586; Ottichilo WK, 2000, AFR J ECOL, V38, P202, DOI 10.1046/j.1365-2028.2000.00242.x; Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005; Parola P, 2013, CLIN MICROBIOL REV, V26, P657, DOI 10.1128/CMR.00032-13; Patz JA, 2008, MED CLIN N AM, V92, P1473, DOI 10.1016/j.mcna.2008.07.007; Perez G, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1296-9; PETNEY TN, 1987, ONDERSTEPOORT J VET, V54, P529; Pfaffle M, 2013, INT J PARASITOL, V43, P1059, DOI 10.1016/j.ijpara.2013.06.009; Pietzsch ME, 2005, MED VET ENTOMOL, V19, P306, DOI 10.1111/j.1365-2915.2005.00575.x; POTGIETER FT, 1980, ONDERSTEPOORT J VET, V47, P285; POTGIETER FT, 1987, ONDERSTEPOORT J VET, V54, P5; Pretorius AM, 2002, EMERG INFECT DIS, V8, P874, DOI 10.3201/eid0808.020199; R Core Team, 2021, R LANGUAGE ENV STAT; Raoult D, 2001, NEW ENGL J MED, V344, P1504, DOI 10.1056/NEJM200105173442003; Reynolds C, 2018, LANDSCAPE ECOL, V33, P241, DOI 10.1007/s10980-017-0595-7; Ries L, 2004, ANNU REV ECOL EVOL S, V35, P491, DOI 10.1146/annurev.ecolsys.35.112202.130148; Schwarz A, 2009, INT J HYG ENVIR HEAL, V212, P87, DOI 10.1016/j.ijheh.2007.12.001; Sonenshine D. E., 1994, ECOLOGICAL DYNAMICS; Spickett AM, 2011, ONDERSTEPOORT J VET, V78, P18, DOI 10.4102/ojvr.v78i1.233; STAFFORD KC, 1994, J MED ENTOMOL, V31, P310, DOI 10.1093/jmedent/31.2.310; STAFFORD KC, 1993, J MED ENTOMOL, V30, P762, DOI 10.1093/jmedent/30.4.762; Tack W, 2012, FOREST ECOL MANAG, V265, P30, DOI 10.1016/j.foreco.2011.10.028; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; UILENBERG G, 1989, VET QUART, V11, P33, DOI 10.1080/01652176.1989.9694194; Vanwambeke SO, 2010, VECTOR-BORNE ZOONOT, V10, P497, DOI 10.1089/vbz.2009.0116; Walker A.R., 2003, TICKS DOMESTIC ANIMA; Walker AR, 2001, MED VET ENTOMOL, V15, P40, DOI 10.1046/j.1365-2915.2001.00271.x; Walker J.B., 2005, GENUS RHIPICEPHALUS; WALKER JB, 1987, ONDERSTEPOORT J VET, V54, P353; Williams SC, 2010, ENVIRON ENTOMOL, V39, P1911, DOI 10.1603/EN10131; WILSON ML, 1993, J MED ENTOMOL, V30, P467, DOI 10.1093/jmedent/30.2.467; Wright WJ, 2016, ECOL EVOL, V6, P5404, DOI 10.1002/ece3.2292; Zar J.H., 1996, BIOSTAT ANAL; Zieger U, 1998, ONDERSTEPOORT J VET, V65, P49	104	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0222879	10.1371/journal.pone.0222879	http://dx.doi.org/10.1371/journal.pone.0222879			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539412	Green Published, gold			2022-12-26	WOS:000532297900037
J	Gudka, M; Santos, CD; Dolman, PM; Abad-Gomez, JM; Silva, JP				Gudka, Mishal; Santos, Carlos David; Dolman, Paul M.; Abad-Gomez, Jose Ma; Silva, Joao Paulo			Feeling the heat: Elevated temperature affects male display activity of a lekking grassland bird	PLOS ONE			English	Article							CLIMATE-CHANGE; EJACULATE QUALITY; HATCHING SUCCESS; SEXUAL DISPLAY; TETRAX-TETRAX; BEHAVIOR; FEMALE; LEK; MODELS; THERMOREGULATION	Most species-climate models relate range margins to long-term mean climate but lack mechanistic understanding of the ecological or demographic processes underlying the climate response. We examined the case of a climatically limited edge-of-range population of a medium-sized grassland bird, for which climate responses may involve a behavioural trade-off between temperature stress and reproduction. We hypothesised that temperature will be a limiting factor for the conspicuous, male snort-call display behaviour, and high temperatures would reduce the display activity of male birds. Using remote tracking technology with tri-axial accelerometers we classified and studied the display behaviour of 17 free-ranging male little bustards, Tetrax tetrax, at 5 sites in the Iberian Peninsula. Display behaviour was related to temperature using two classes of Generalized Additive Mixed Models (GAMMs) at different temporal resolutions. GAMMs showed that temperature, time of the day and Julian date explained variation in display behaviour within the day, with birds snort-calling significantly less during higher temperatures. We also showed that variation in daily snort-call activity was related to average daytime temperatures, with our model predicting an average decrease in daytime snort-call display activity of up to 10.4% for the temperature increases projected by 2100 in this region due to global warming. For lekking birds and mammals undertaking energetically-costly displays in a warming climate, reduced display behaviour could impact inter- and intra-sex mating behaviour interactions through sexual selection and mate choice mechanisms, with possible consequences on mating and reproductive success. The study provides a reproducible example for how accelerometer data can be used to answer research questions with important conservation inferences related to the impacts of climate change on a range of taxonomic groups.	[Gudka, Mishal; Dolman, Paul M.] Univ East Anglia, Sch Environm Sci, Norwich, Norfolk, England; [Santos, Carlos David] Univ Fed Para, Nucl Teoria & Pesquisa Comportamento, Belem, Para, Brazil; [Santos, Carlos David] Max Planck Inst Anim Behav, Dept Migrat, Radolfzell am Bodensee, Germany; [Abad-Gomez, Jose Ma] Univ Extremadura, Fac Sci, Dept Anat Cell Biol & Zool, Badajoz, Spain; [Abad-Gomez, Jose Ma] Junta Extremadura, Serv Conservac Nat & Areas Protegidas, Consejeria Medio Ambiente & Rural Polit Agr & Ter, Badajoz, Spain; [Silva, Joao Paulo] Univ Porto, CIBIO InBio, Ctr Invest Biodiversidade & Recursos Genet, Lab Associado, Campus Agr Vairao, Vairao, Portugal; [Silva, Joao Paulo] Univ Lisbon, Ctr Invest Biodiversidade & Recursos Genet, Inst Super Agron, Lab Associado,CIBIO InBio, Lisbon, Portugal; [Gudka, Mishal] Coastal Oceans Res & Dev Indian Ocean CORDIO East, Mombasa, Kenya	University of East Anglia; Universidade Federal do Para; Max Planck Society; Universidad de Extremadura; Universidade do Porto; Universidade de Lisboa	Gudka, M (corresponding author), Univ East Anglia, Sch Environm Sci, Norwich, Norfolk, England.; Gudka, M (corresponding author), Coastal Oceans Res & Dev Indian Ocean CORDIO East, Mombasa, Kenya.	mishal.gudka08@gmail.com	Santos, Carlos/E-5881-2013	Santos, Carlos/0000-0001-5693-9795; Dolman, Paul/0000-0002-9340-2791; Gudka, Mishal/0000-0001-6733-9381; Abad-Gomez/0000-0002-3757-8856	InBIO [UID/BIA/50027/2013, POCI-01-0145-FEDER006821]; FCT/MCTES; Foundation for Science and Technology [DL57/2016]	InBIO; FCT/MCTES(Portuguese Foundation for Science and Technology); Foundation for Science and Technology	Financial support was provided by InBIO (UID/BIA/50027/2013 and POCI-01-0145-FEDER006821) and FCT/MCTES through national funds. JP Silva was funded under contract DL57/2016 (Foundation for Science and Technology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALATALO RV, 1992, BEHAV ECOL, V3, P53, DOI 10.1093/beheco/3.1.53; Alexander LV, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P3; Alonso JC, 2010, BEHAV ECOL SOCIOBIOL, V64, P1589, DOI 10.1007/s00265-010-0972-6; [Anonymous], [No title captured]; APOLLONIO M, 1992, BEHAV ECOL, V3, P25, DOI 10.1093/beheco/3.1.25; APOLLONIO M, 1989, BEHAV ECOL SOCIOBIOL, V25, P89, DOI 10.1007/BF00302925; Araujo MB, 2005, GLOBAL CHANGE BIOL, V11, P1504, DOI 10.1111/j.1365-2486.2005.01000.x; Barron DG, 2010, METHODS ECOL EVOL, V1, P180, DOI 10.1111/j.2041-210X.2010.00013.x; BirdLife I, 2017, SPEC FACTSH TETR TET; Blondel J, 2010, MEDITERRANEAN REGION; Boyles JG, 2011, INTEGR COMP BIOL, V51, P676, DOI 10.1093/icb/icr053; Brown DD, 2013, ANIM BIOTELEM, V1, P20, DOI DOI 10.1186/2050-3385-1-20; Buckley LB, 2016, GLOBAL CHANGE BIOL, V22, P3829, DOI 10.1111/gcb.13313; CACCAMISE DF, 1985, WILSON BULL, V97, P306; Cahill AE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.1890; Charge R, 2013, J ANIM ECOL, V82, P399, DOI 10.1111/1365-2656.12023; Charge R, 2010, J ANIM ECOL, V79, P843, DOI 10.1111/j.1365-2656.2010.01696.x; Chown SL, 2010, CLIM RES, V43, P3, DOI 10.3354/cr00879; Christensen JH, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1217; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Delgado MP, 2011, ARDEOLA, V58, P223, DOI 10.13157/arla.58.2.2011.223; Dillon ME, 2010, NATURE, V467, P704, DOI 10.1038/nature09407; Estrada A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149810; Geisser S., 2017, PREDICTIVE INFERENCE; Granadeiro JP, 2004, J SEA RES, V52, P227, DOI 10.1016/j.seares.2004.01.005; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Hill RA, 2006, AM J PHYS ANTHROPOL, V129, P242, DOI 10.1002/ajpa.20264; HOGLUND J, 1987, BEHAV ECOL SOCIOBIOL, V21, P211, DOI 10.1007/BF00292501; Huey RB, 2012, PHILOS T R SOC B, V367, P1665, DOI 10.1098/rstb.2012.0005; Inigo A., 2010, ACTION PLAN LITTLE B; Isvaran K, 2005, BEHAV ECOL SOCIOBIOL, V57, P283, DOI 10.1007/s00265-004-0844-z; Isvaran K, 2000, BEHAVIOUR, V137, P547, DOI 10.1163/156853900502204; Jiguet F, 2001, BEHAV PROCESS, V55, P107, DOI 10.1016/S0376-6357(01)00173-5; Jiguet F, 2014, BEHAV PROCESS, V103, P246, DOI 10.1016/j.beproc.2014.01.008; Loyau A, 2010, P ROY SOC B-BIOL SCI, V277, P3453, DOI 10.1098/rspb.2010.0473; Marcelino J, 2018, BIRD CONSERV INT, V28, P509, DOI 10.1017/S095927091700051X; Mathewson PD, 2017, GLOBAL CHANGE BIOL, V23, P1048, DOI 10.1111/gcb.13454; MCCOMB KE, 1991, ANIM BEHAV, V41, P79, DOI 10.1016/S0003-3472(05)80504-4; Morales MB, 2008, ACTA OECOL, V34, P345, DOI 10.1016/j.actao.2008.06.009; Morales MB, 2014, BEHAV ECOL SOCIOBIOL, V68, P1493, DOI 10.1007/s00265-014-1758-z; Morales MB, 2003, J ETHOL, V21, P51, DOI 10.1007/s10164-002-0076-5; Munoz-Mas R., 2017, Journal of Ecohydraulics, V2, P3, DOI 10.1080/24705357.2016.1276417; Mustin K, 2007, CLIM RES, V35, P165, DOI 10.3354/cr00723; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; Pagano AM, 2017, ENDANGER SPECIES RES, V32, P19, DOI 10.3354/esr00779; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pennycuick CJ, 2012, J ORNITHOL, V153, P633, DOI 10.1007/s10336-011-0781-3; Ponjoan A, 2008, J WILDLIFE MANAGE, V72, P315, DOI 10.2193/2006-443; Ponjoan A, 2012, BEHAV PROCESS, V91, P35, DOI 10.1016/j.beproc.2012.05.005; Rastogui SC, 2007, ESSENTIALS ANIMAL PH; Resheff Y., 2014, ACCELERATER SOFTWARE; Resheff YS, 2014, MOV ECOL, V2, DOI 10.1186/s40462-014-0027-0; Rezende EL, 2003, J ARID ENVIRON, V55, P63, DOI 10.1016/S0140-1963(02)00259-8; Ribeiro PF, 2014, AGR ECOSYST ENVIRON, V183, P138, DOI 10.1016/j.agee.2013.11.002; Rivas-Martinez S, 2001, CLIMATIC DATA PORTUG; Schulz H., 1985, GRUNDLAGENFORSCHUNG; Silva JLA, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00548.1; Silva JP, 2017, ANIM BEHAV, V129, P197, DOI 10.1016/j.anbehav.2017.05.016; Silva JP, 2014, J ORNITHOL, V155, P53, DOI 10.1007/s10336-013-0986-8; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Studd EK, 2019, ECOL EVOL, V9, P619, DOI 10.1002/ece3.4786; Terrien J, 2011, FRONT BIOSCI-LANDMRK, V16, P1428, DOI 10.2741/3797; Urban MC, 2015, SCIENCE, V348, P571, DOI 10.1126/science.aaa4984; Vandenabeele SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092657; Welbergen JA, 2008, P ROY SOC B-BIOL SCI, V275, P419, DOI 10.1098/rspb.2007.1385; Wilson RP, 2002, MAR ECOL PROG SER, V228, P241, DOI 10.3354/meps228241; Wolff A, 2001, J APPL ECOL, V38, P963, DOI 10.1046/j.1365-2664.2001.00651.x; Woodin SA, 2013, ECOL EVOL, V3, P3334, DOI 10.1002/ece3.680	69	11	11	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0221999	10.1371/journal.pone.0221999	http://dx.doi.org/10.1371/journal.pone.0221999			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4NC	31525206	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000532225700019
J	Mackenzie, DD; Naeth, MA				Mackenzie, Dean D.; Naeth, M. Anne			Native seed, soil and atmosphere respond to boreal forest topsoil (LFH) storage	PLOS ONE			English	Article							JARRAH-FOREST; VIABILITY; RESTORATION; SURVIVAL; DORMANCY; BAUXITE; BANK	During mining topsoil is salvaged and stockpiled until ready for reclamation, stockpiling can have detrimental effects on seed viability and soil quality. Research has assessed effects of salvage and placement depth of forest topsoil on plant community establishment, with little work on effects of storage, particularly in the boreal forest. Our research assessed boreal forest topsoil storage methods to determine effects on soil chemical and physical properties, native seed viability and germination and rhizome viability and emergence. Factors were topsoil stockpiling length, stockpile size, season of construction and soil texture. Four replicates of large and small stockpiles were constructed in the mineable oil sands, in northeastern Alberta. During construction seeds and rhizomes from a variety of native boreal plant species were buried within large (0.05, 1.0, 2.0, 4.0, 6.0 m) and small (0.05, 1.0, 3.0 m) stockpiles. Soil gas probes were installed at similar depths as seed and rhizomes were placed. Seeds and rhizomes were extracted eight months and sixteen months after construction; during that time soil samples were collected for various chemical analyses. Irrespective of stockpile size, the majority of species seeds and rhizomes buried below 1 m lost viability and did not germinate after eight months. Anaerobic soil conditions developed soon after construction and persisted at depths below 1.0 m in large stockpiles, and over time anaerobic conditions developed in smaller stockpiles. Only seeds of Geranium bicknellii and Dracocephalum parviflorum had a high survival rate in stockpiles; both species have hard seed coats and are physically dormant. Various soil nutrients increased in concentrations in their soluble forms after stockpiling. Direct placement of topsoil is a preferred soil handling technique; however, if topsoil has to be stockpiled increasing the surface area of stockpiles will help preserve some seed and rhizome viability.	[Mackenzie, Dean D.] Vertex Resource Grp Ltd, Sherwood Pk, AB, Canada; [Naeth, M. Anne] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada	University of Alberta	Naeth, MA (corresponding author), Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada.	anne.naeth@ualberta.ca		Naeth, M Anne/0000-0002-9147-1638	Natural Sciences and Engineering Research Council	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	The following companies provided an unrestricted research grant to Dr M Anne Naeth to support the research addressed in this publication of her PhD student Dr Dean Mackenzie. This funding was used to cover direct costs of research. No funding was provided for the personal use or salary of the supervisor Dr Naeth: Syncrude Canada Ltd., Suncor Energy Ltd., Shell Canada Limited, Canadian Natural Resources Ltd., Total E&P Canada Ltd., and Fort Hills Energy LP by its General Petro-Canada Oil Sands Inc. (Multi Partner Grant Number G800001067). Dr Dean Mackenzie received a PhD scholarship from the Natural Sciences and Engineering Research Council (DDM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDULKAREEM AW, 1984, PLANT SOIL, V76, P357, DOI 10.1007/BF02205593; Anderson TR, 1988, P 13 ANN AUSTR MIN I, P256; Archibold O.W., 1989, ECOLOGY SOIL SEED BA, P107, DOI [10.1016/B978-0-12-440405- 2.50012-9, DOI 10.1016/B978-0-12-440405-2.50012-9]; Association of Official Seed Analysts, 2006, RUL TEST SEEDS STILL; Baskin C.C., 1998, SEEDS ECOLOGY BIOGEO, P666; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Brophy L., 1980, P N DAK AC SCI ANN M; Carter M.R., 1993, SOIL SAMPLING METHOD, P823; CONN JS, 1990, WEED SCI, V38, P134, DOI 10.1017/S0043174500056277; DICKIE JB, 1988, BIOL CONSERV, V43, P257, DOI 10.1016/0006-3207(88)90119-X; FYLES JW, 1989, CAN J BOT, V67, P274, DOI 10.1139/b89-039; Gama-Arachchige NS, 2012, ANN BOT-LONDON, V110, P637, DOI 10.1093/aob/mcs122; GOULD AB, 1981, MYCOLOGIA, V73, P914, DOI 10.2307/3759802; Hall S. L., 2009, Ecological Restoration, V27, P381, DOI 10.3368/er.27.4.381; HARRIS JA, 1989, SOIL USE MANAGE, V5, P161, DOI 10.1111/j.1475-2743.1989.tb00778.x; Harris JA., 1993, RESTOR ECOL, V1, P88, DOI [10.1111/j.1526-100X.1993.tb00014.x, DOI 10.1111/j.1526-100X.1993.tb00014.x, DOI 10.1111/J.1526-100X.1993.TB00014.X]; Harris JA, 1987, J SCI FOOD AGR, V40, P219; HARRISON B. J., 1966, J NAT INST AGR BOT, V10, P644; Havlin JL, 1999, SOIL FERTILITY FERTI; HUNTER F, 1956, J SOIL SCI, V7, P75, DOI 10.1111/j.1365-2389.1956.tb00864.x; IBRAHIM AE, 1983, J EXP BOT, V34, P620, DOI 10.1093/jxb/34.5.620; Koch JM, 1996, RESTOR ECOL, V4, P368, DOI 10.1111/j.1526-100X.1996.tb00189.x; Kong K, 1980, 91 ALB OIL SANDS ENV, P45; Kundu NK, 1997, ENVIRON CONSERV, V24, P24, DOI 10.1017/S0376892997000064; Lee P, 2004, CAN J BOT, V82, P1468, DOI [10.1139/b04-108, 10.1139/B04-108]; Liest N, 2003, INT SEED TESTING ASS; Maag M, 1999, SOIL SCI SOC AM J, V63, P858, DOI 10.2136/sssaj1999.634858x; Mackenzie DD, 2007, SEEDS: BIOLOGY, DEVELOPMENT AND ECOLOGY, P374, DOI 10.1079/9781845931971.0374; MacKenzie DD, 2012, BEST MANAGEMENT PRAC, P161; Mackenzie DD, 2010, RESTOR ECOL, V18, P418, DOI 10.1111/j.1526-100X.2008.00500.x; MARKS PL, 1974, ECOL MONOGR, V44, P73, DOI 10.2307/1942319; Moss EH., 1993, FLORA ALBERTA MANUAL, P687; OHLROGGE JB, 1982, PLANT PHYSIOL, V70, P791, DOI 10.1104/pp.70.3.791; Rivera D, 2012, ECOL ENG, V44, P94, DOI 10.1016/j.ecoleng.2012.03.005; RIVES CS, 1980, SOIL SCI, V129, P253, DOI 10.1097/00010694-198004000-00009; ROBERTS E. H., 1968, ANN BOT [LONDON], V32, P97; Rokich DP, 2000, RESTOR ECOL, V8, P196, DOI 10.1046/j.1526-100x.2000.80027.x; STARK JM, 1987, SOIL SCI, V144, P72, DOI 10.1097/00010694-198707000-00012; Strong W.L., 1992, ECOREGIONS ALBERTA, P59; TACEY WH, 1980, J APPL ECOL, V17, P195, DOI 10.2307/2402974; TIEDJE JM, 1984, PLANT SOIL, V76, P197, DOI 10.1007/BF02205580; Turchenek LW, 1982, 22 AOSERP ALB OIL SA, P240; VISSER S, 1984, PLANT SOIL, V82, P41, DOI 10.1007/BF02220768; WHITNEY GG, 1986, CAN J BOT, V64, P2916, DOI 10.1139/b86-385; Whittle C. A., 1997, Environmental Reviews, V5, P79, DOI 10.1139/a97-003; WIDDOWSON JP, 1982, NEW ZEAL J SCI, V25, P287	46	8	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2019	14	9							e0220367	10.1371/journal.pone.0220367	http://dx.doi.org/10.1371/journal.pone.0220367			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4NC	31525213	gold, Green Published, Green Submitted			2022-12-26	WOS:000532225700007
J	Miyamoto, S; Nakao, J; Higashino, T; Yoshimoto, S; Hayashi, R; Sakuraba, M				Miyamoto, Shimpei; Nakao, Junichi; Higashino, Takuya; Yoshimoto, Seiichi; Hayashi, Ryuichi; Sakuraba, Minoru			Clavien-Dindo classification for grading complications after total pharyngolaryngectomy and free jejunum transfer	PLOS ONE			English	Article							ANTEROLATERAL THIGH FLAP; SURGICAL COMPLICATIONS; POSTOPERATIVE COMPLICATIONS; PHARYNGOESOPHAGEAL RECONSTRUCTION; NECK RECONSTRUCTION; FUNCTIONAL OUTCOMES; HEAD; SURGERY; RADIATION; REPAIR	Background The frequency of postoperative complications is used as an indicator of surgical quality; however, comparison of outcomes is hampered by a lack of agreement on the definition of complications and their severity. A standard grading system for surgical complications is necessary to improve the quality of clinical research and reporting in head and neck reconstruction. Methods The aim of this study was to compare postoperative morbidity after microvascular head and neck reconstruction between patients with versus without a history of prior radiation therapy (RT) by using the Clavien-Dindo classification. A group of 274 patients was divided into two cohorts based on the history of prior RT: the RT group included 79 patients and the non-RT group included 195 patients. Postoperative (30-day) complications were compared between the groups with a nonstandardized evaluation system and the Clavien-Dindo classification. Results The grades of complications according to the Clavien-Dindo classification were significantly higher in the RT group than in the non-RT group. The frequency of postoperative complications did not differ significantly between the groups according to the nonstandardized evaluation system. Conclusions The Clavien-Dindo classification could serve as a useful, highly objective tool for grading operative morbidity after microvascular head and neck reconstruction when comparing similar defects and methods of reconstruction. Widespread use of the Clavien-Dindo classification system would allow adequate comparisons of surgical outcomes among different surgeons, centers, and therapies.	[Miyamoto, Shimpei] Natl Canc Ctr, Dept Plast & Reconstruct Surg, Tokyo, Japan; [Nakao, Junichi] Nippon Med Coll Hosp, Dept Plast & Reconstruct Surg, Tokyo, Japan; [Higashino, Takuya; Sakuraba, Minoru] Natl Canc Ctr Hosp East, Dept Plast & Reconstruct Surg, Kashiwa, Chiba, Japan; [Yoshimoto, Seiichi] Natl Canc Ctr, Dept Head & Neck Oncol, Tokyo, Japan; [Hayashi, Ryuichi] Natl Canc Ctr Hosp East, Dept Head & Neck Surg, Kashiwa, Chiba, Japan; [Sakuraba, Minoru] Iwate Med Univ, Dept Plast & Reconstruct Surg, Morioka, Iwate, Japan	National Cancer Center - Japan; Nippon Medical School; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Iwate Medical University	Miyamoto, S (corresponding author), Natl Canc Ctr, Dept Plast & Reconstruct Surg, Tokyo, Japan.	shimiyam@ncc.go.jp		, Shimpei/0000-0003-4367-6927				Bosma E, 2012, CAN J SURG, V55, P163, DOI 10.1503/cjs.027810; CLAVIEN PA, 1992, SURGERY, V111, P518; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Haughey BH, 2001, OTOLARYNG HEAD NECK, V125, P10, DOI 10.1067/mhn.2001.116788; Herle P, 2015, ANZ J SURG, V85, P121, DOI 10.1111/ans.12888; Katayama H, 2016, SURG TODAY, V46, P668, DOI 10.1007/s00595-015-1236-x; le Nobel GJ, 2012, LARYNGOSCOPE, V122, P1014, DOI 10.1002/lary.22454; McMahon JD, 2013, BRIT J ORAL MAX SURG, V51, P689, DOI 10.1016/j.bjoms.2013.04.015; Miyamoto S, 2011, LARYNGOSCOPE, V121, P947, DOI 10.1002/lary.21742; Monteiro E, 2014, LARYNGOSCOPE, V124, P2726, DOI 10.1002/lary.24817; Mothes AR, 2015, ARCH GYNECOL OBSTET, V291, P1297, DOI 10.1007/s00404-014-3549-1; Murray DJ, 2007, HEAD NECK-J SCI SPEC, V29, P147, DOI 10.1002/hed.20489; Onoda S, 2014, MICROSURG, V34, P516, DOI 10.1002/micr.22275; Perisanidis C, 2012, BRIT J ORAL MAX SURG, V50, P113, DOI 10.1016/j.bjoms.2011.01.013; Poletajew S, 2014, INT J UROL, V21, P1274, DOI 10.1111/iju.12576; Radosa MP, 2014, GEBURTSH FRAUENHEILK, V74, DOI 10.1055/s-0034-1382925; Spyropoulou GAC, 2011, PLAST RECONSTR SURG, V127, P161, DOI 10.1097/PRS.0b013e3181f95997; Suh JD, 2004, ARCH OTOLARYNGOL, V130, P962, DOI 10.1001/archotol.130.8.962; Tamura S, 2006, TRANSPL INT, V19, P982, DOI 10.1111/j.1432-2277.2006.00375.x; Yu PR, 2006, PLAST RECONSTR SURG, V117, P968, DOI 10.1097/01.prs.0000200622.13312.d3	21	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2019	14	9							e0222570	10.1371/journal.pone.0222570	http://dx.doi.org/10.1371/journal.pone.0222570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4IG	31513680	Green Submitted, gold, Green Published			2022-12-26	WOS:000532212700091
J	Li, D; Wan, ZC; Li, XJ; Duan, M; Yang, L; Ruan, ZC; Wang, Q; Li, WW				Li, Dan; Wan, Zhicheng; Li, Xuejie; Duan, Ming; Yang, Lei; Ruan, Zechao; Wang, Qun; Li, Weiwei			Alternatively spliced down syndrome cell adhesion molecule (Dscam) controls innate immunity in crab	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						invertebrate; bacteria; gene transcription; toll receptor; antimicrobial peptide (AMP); Dock; Dscam; ERK; protein?protein interaction	DROSOPHILA DSCAM; ADAPTER PROTEIN; DIVERSITY; RECEPTOR; SYSTEM	Alternatively-spliced hypervariable immunoglobulin domain-encoding molecules, called Down syndrome cell adhesion molecule (Dscam), have been widely detected as components of the arthropod immune system. Although its ability to specifically bind pathogens and enable phagocytosis of bacteria has been elucidated, the signal transduction mechanisms or effectors that activate post-Dscam?binding pathogens remain poorly characterized. Here, we reveal the alternative splicing exons of Dscam's cytoplasmic tail and its isoforms in the hemocytes of crab (Eriocheir sinensis), showing that the expression of Dscam was acutely induced after an immune challenge, which suggested its functioning for innate immunity. Significantly decreased expression levels of antimicrobial molecular peptides (AMPs) were detected in Dscam-silenced crab hemocytes in vitro, which coincided with their vulnerability to infection by Staphylococcus aureus and higher bacterial concentrations occurring in Dscam-silenced crabs in vivo. Further experimental investigation demonstrated that Dscam-regulated AMP expression via the Src homology (SH)3-binding domain in the first constant exon translated protein of the cytoplasmic tail bound with the SH3 domain of the Dock, an SH3/SH2 adaptor protein required for axon guidance. Dock promoted extracellular signal-regulated kinase (ERK) phosphorylation via indirect binding and then regulated dorsal phosphorylation and translocation from the cytoplasm to the nucleus, subsequently promoting AMP expression for the effective removal of bacteria. To the best of our knowledge, this comprehensive study is the first to highlight the critical role of the alternatively-spliced Dscam cytoplasmic tail in antimicrobial control activity. It also suggests possible cross-talk occurring between Dscam and other pattern recognition receptors.	[Li, Dan; Wan, Zhicheng; Yang, Lei; Ruan, Zechao; Wang, Qun; Li, Weiwei] East China Normal Univ, Sch Life Sci, State Key Lab Estuarine & Coastal Res, Lab Invertebrate Immunol Def & Reprod Biol, Shanghai 200241, Peoples R China; [Li, Xuejie] Dalian Ocean Univ, Coll Fisheries & Life Sci, Dalian 116023, Peoples R China; [Duan, Ming] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan 430072, Hubei, Peoples R China	East China Normal University; Dalian Ocean University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Wang, Q; Li, WW (corresponding author), East China Normal Univ, Sch Life Sci, State Key Lab Estuarine & Coastal Res, Lab Invertebrate Immunol Def & Reprod Biol, Shanghai 200241, Peoples R China.	qwang@bio.ecnu.edu.cn; wwli@bio.ecnu.edu.cn	Wang, Qun/I-7778-2013	Wang, Qun/0000-0001-7929-7692	National Natural Science Foundation of China [31602189, 31672639]; National Key R&D Program of China [2018YFD0901701, 2018YFD0900605]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China	This work was supported by National Natural Science Foundation of China Grants 31602189 (to W. L.) and 31672639 (to Q. W.) and National Key R&D Program of China Grants 2018YFD0901701 and 2018YFD0900605. The authors declare that they have no conflicts of interest with the contents of this article.	Armitage SAO, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-53; Azumi K, 2003, IMMUNOGENETICS, V55, P570, DOI 10.1007/s00251-003-0606-5; Black DL, 2000, CELL, V103, P367, DOI 10.1016/S0092-8674(00)00128-8; Brites D, 2008, MOL BIOL EVOL, V25, P1429, DOI 10.1093/molbev/msn087; Chou PH, 2011, FISH SHELLFISH IMMUN, V30, P1109, DOI 10.1016/j.fsi.2011.02.009; Clemens JC, 1996, J BIOL CHEM, V271, P17002, DOI 10.1074/jbc.271.29.17002; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Dong YM, 2012, CELL HOST MICROBE, V12, P521, DOI 10.1016/j.chom.2012.09.004; Du Pasquier L, 2004, IMMUNOL REV, V198, P233, DOI 10.1111/j.0105-2896.2004.00122.x; Graveley BR, 2005, CELL, V123, P65, DOI 10.1016/j.cell.2005.07.028; Hattori D, 2008, ANNU REV CELL DEV BI, V24, P597, DOI 10.1146/annurev.cellbio.24.110707.175250; Li XJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00801; Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299; Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6; Rao Y, 1998, P NATL ACAD SCI USA, V95, P2077, DOI 10.1073/pnas.95.5.2077; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Smith PH, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-156; Sun JJ, 2016, J BIOL CHEM, V291, P7488, DOI 10.1074/jbc.M115.698134; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Yu HH, 2009, J NEUROSCI, V29, P1904, DOI 10.1523/JNEUROSCI.5743-08.2009; Zhu YT, 2015, AQUACULTURE, V446, P140, DOI 10.1016/j.aquaculture.2015.04.032	24	22	23	4	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					16440	16450		10.1074/jbc.RA119.010247	http://dx.doi.org/10.1074/jbc.RA119.010247			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31537644	hybrid, Green Published			2022-12-26	WOS:000499478600045
J	Rahfeld, P; Wardman, JF; Mehr, K; Huff, D; Morgan-Lang, C; Chen, HM; Hallam, SJ; Withers, SG				Rahfeld, Peter; Wardman, Jacob F.; Mehr, Kevin; Huff, Drew; Morgan-Lang, Connor; Chen, Hong-Ming; Hallam, Steven J.; Withers, Stephen G.			Prospecting for microbial ?-N-acetylgalactosaminidases yields a new class of GH31 O-glycanase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosidase; glycobiology; metagenomics; glycoprotein; blood; glycopeptide cleavage; glycoside hydrolase 31 (GH31); human gut microbiome; mucin; O-glycoprotein; metagenomic analysis; glycoside hydrolase 109 (GH109); O-glycanase; N-acetylgalactosamine (alpha-GalNAc)	GLYCOSIDE HYDROLASE FAMILY; MOLECULAR-CLONING; CATALYTIC NUCLEOPHILE; MUTANT GLYCOSIDASES; ALPHA-GLUCOSIDASE; BACTERIAL; IDENTIFICATION; MECHANISM; METAGENOMICS; PURIFICATION	?-Linked GalNAc (?-GalNAc) is most notably found at the nonreducing terminus of the blood type?determining A-antigen and as the initial point of attachment to the peptide backbone in mucin-type O-glycans. However, despite their ubiquity in saccharolytic microbe-rich environments such as the human gut, relatively few ?-N-acetylgalactosaminidases are known. Here, to discover and characterize novel microbial enzymes that hydrolyze ?-GalNAc, we screened small-insert libraries containing metagenomic DNA from the human gut microbiome. Using a simple fluorogenic glycoside substrate, we identified and characterized a glycoside hydrolase 109 (GH109) that is active on blood type A-antigen, along with a new subfamily of glycoside hydrolase 31 (GH31) that specifically cleaves the initial ?-GalNAc from mucin-type O-glycans. This represents a new activity in this GH family and a potentially useful new enzyme class for analysis or modification of O-glycans on protein or cell surfaces.	[Rahfeld, Peter; Mehr, Kevin; Huff, Drew; Chen, Hong-Ming; Withers, Stephen G.] Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z3, Canada; [Hallam, Steven J.] Univ British Columbia, ECOSCOPE Training Program, Vancouver, BC V6T 1Z3, Canada; [Rahfeld, Peter; Wardman, Jacob F.; Mehr, Kevin; Huff, Drew; Withers, Stephen G.] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Wardman, Jacob F.; Withers, Stephen G.] Univ British Columbia, Life Sci Ctr, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Morgan-Lang, Connor; Hallam, Steven J.] Univ British Columbia, Life Sci Ctr, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Morgan-Lang, Connor; Hallam, Steven J.] Univ British Columbia, Grad Program Bioinformat, Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Hallam, Steven J.] Univ British Columbia, Peter Wall Inst Adv Studies, Vancouver, BC V6T 1Z1, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Rahfeld, P; Withers, SG (corresponding author), Univ British Columbia, Dept Chem, 2036 Main Mall, Vancouver, BC V6T 1Z3, Canada.	prahfeld@chem.ubc.ca; withers@chem.ubc.ca	Morgan-Lang, Connor/P-5309-2014; Withers, Stephen G/I-7229-2019	Morgan-Lang, Connor/0000-0002-6714-0898; Withers, Stephen G/0000-0002-6722-5701; Wardman, Jacob/0000-0002-8235-3576	Deutsche Akademie der Naturforscher Leopoldina; Natural Sciences and Engineering Research Council of Canada (NSERC) Graduate Scholarship-Masters program; Michael Smith Fellowship from the University of British Columbia; NSERC CREATE bioinformatics training program at the University of British Columbia; NSERC; Canada Foundation for Innovation; Canadian Institutes for Health Research (CIHR) [MOP-136940]	Deutsche Akademie der Naturforscher Leopoldina; Natural Sciences and Engineering Research Council of Canada (NSERC) Graduate Scholarship-Masters program(Natural Sciences and Engineering Research Council of Canada (NSERC)); Michael Smith Fellowship from the University of British Columbia; NSERC CREATE bioinformatics training program at the University of British Columbia; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Supported by a Leopoldina-Postdoc-Fellowship from the Deutsche Akademie der Naturforscher Leopoldina.; Supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Graduate Scholarship-Masters program and a Michael Smith Fellowship from the University of British Columbia.; Supported by the NSERC CREATE bioinformatics training program at the University of British Columbia.; Supported by Discovery grants from NSERC as well as grants from the Canada Foundation for Innovation.; Supported by Canadian Institutes for Health Research (CIHR) Grant MOP-136940.	Armstrong Z, 2017, METHOD ENZYMOL, V597, P3, DOI 10.1016/bs.mie.2017.06.001; Armstrong Z, 2018, ISME J, V12, P2757, DOI 10.1038/s41396-018-0215-9; Ashida H, 2000, ARCH BIOCHEM BIOPHYS, V384, P305, DOI 10.1006/abbi.2000.2114; Balabanova LA, 2015, ACTA NATURAE, V7, P117, DOI 10.32607/20758251-2015-7-1-117-120; Bamford NC, 2015, J BIOL CHEM, V290, P27438, DOI 10.1074/jbc.M115.679050; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Briliute J, 2019, NAT MICROBIOL, V4, P1571, DOI 10.1038/s41564-019-0466-x; Brockhausen I, 2009, ESSENTIALS GLYCOBIOL, P115; Calcutt MJ, 2002, FEMS MICROBIOL LETT, V214, P77, DOI 10.1111/j.1574-6968.2002.tb11327.x; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; CHIBA S, 1979, J BIOCHEM-TOKYO, V85, P1135; Clark NE, 2009, J MOL BIOL, V393, P435, DOI 10.1016/j.jmb.2009.08.021; CLAUSEN H, 1989, VOX SANG, V56, P1, DOI 10.1111/j.1423-0410.1989.tb03040.x; Culligan EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082985; Danby PM, 2016, ACS CHEM BIOL, V11, P1784, DOI 10.1021/acschembio.6b00340; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Ernst HA, 2006, J MOL BIOL, V358, P1106, DOI 10.1016/j.jmb.2006.02.056; Frandsen TP, 1998, PLANT MOL BIOL, V37, P1, DOI 10.1023/A:1005925819741; Fujita K, 2005, J BIOL CHEM, V280, P37415, DOI 10.1074/jbc.M506874200; Gabor EM, 2004, ENVIRON MICROBIOL, V6, P948, DOI 10.1111/j.1462-2920.2004.00643.x; GOLDSTEIN J, 1982, SCIENCE, V215, P168, DOI 10.1126/science.6274021; Grondin JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171606; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hobbs JK, 2018, FEBS LETT, V592, P3865, DOI 10.1002/1873-3468.13045; Hsieh HY, 2003, PROTEIN EXPRES PURIF, V32, P309, DOI 10.1016/j.pep.2003.08.007; Hsieh HY, 2000, IUBMB LIFE, V50, P91, DOI 10.1080/713803702; Jahn M, 2003, ANGEW CHEM INT EDIT, V42, P352, DOI 10.1002/anie.200390114; Jones DR, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1027-x; Jongkees SAK, 2014, ACCOUNTS CHEM RES, V47, P226, DOI 10.1021/ar4001313; Kiyohara M, 2012, J BIOL CHEM, V287, P693, DOI 10.1074/jbc.M111.277384; Klock HE, 2008, PROTEINS, V71, P982, DOI 10.1002/prot.21786; Larsbrink J, 2011, BIOCHEM J, V436, P567, DOI 10.1042/BJ20110299; Lee SS, 2003, BIOCHEMISTRY-US, V42, P13081, DOI 10.1021/bi035189g; Lee SS, 2001, BIOCHEM J, V359, P381, DOI 10.1042/0264-6021:3590381; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; LEVY GN, 1980, J BIOL CHEM, V255, P1737; Liu QYP, 2007, NAT BIOTECHNOL, V25, P454, DOI 10.1038/nbt1298; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lovering AL, 2005, J BIOL CHEM, V280, P2105, DOI 10.1074/jbc.M410468200; Mackenzie LF, 1998, J AM CHEM SOC, V120, P5583, DOI 10.1021/ja980833d; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Marcobal A, 2013, GLYCOBIOLOGY, V23, P1038, DOI 10.1093/glycob/cwt040; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Matsen FA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031009; Mewis K, 2013, J BIOTECHNOL, V167, P462, DOI 10.1016/j.jbiotec.2013.07.015; Mitchell AL, 2019, NUCLEIC ACIDS RES, V47, pD351, DOI 10.1093/nar/gky1100; Miyazaki T, 2015, BIOCHEM J, V469, P145, DOI 10.1042/BJ20150261; Nacke H, 2012, BIOTECHNOL LETT, V34, P663, DOI 10.1007/s10529-011-0830-2; Nielsen H, 2017, METHODS MOL BIOL, V1611, P59, DOI 10.1007/978-1-4939-7015-5_6; Noach I, 2017, P NATL ACAD SCI USA, V114, pE679, DOI 10.1073/pnas.1615141114; Pasolli E, 2019, CELL, V176, P649, DOI 10.1016/j.cell.2019.01.001; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Pudlo NA, 2015, MBIO, V6, DOI 10.1128/mBio.01282-15; Rahfeld P, 2019, NAT MICROBIOL, V4, P1475, DOI 10.1038/s41564-019-0469-7; Raussens V, 2003, ANAL BIOCHEM, V319, P114, DOI 10.1016/S0003-2697(03)00285-9; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Rossez Y, 2012, GLYCOBIOLOGY, V22, P1193, DOI 10.1093/glycob/cws072; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skovierova H, 2010, J BIOL CHEM, V285, P41348, DOI 10.1074/jbc.M110.188110; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tailford LE, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00081; Tasse L, 2010, GENOME RES, V20, P1605, DOI 10.1101/gr.108332.110; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; Terrapon N, 2018, NUCLEIC ACIDS RES, V46, pD677, DOI 10.1093/nar/gkx1022; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Vitiazeva V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130197; Vocadlo DJ, 2000, BIOCHEMISTRY-US, V39, P117, DOI 10.1021/bi991958d; Windwarder M, 2014, J PROTEOMICS, V108, P258, DOI 10.1016/j.jprot.2014.05.022; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Yip VLY, 2004, J AM CHEM SOC, V126, P8354, DOI 10.1021/ja047632w; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+; Zechel DL, 2001, CURR OPIN CHEM BIOL, V5, P643, DOI 10.1016/S1367-5931(01)00260-5; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	80	9	9	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 1	2019	294	44					16400	16415		10.1074/jbc.RA119.010628	http://dx.doi.org/10.1074/jbc.RA119.010628			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	JR2RL	31530641	hybrid, Green Published			2022-12-26	WOS:000499478600042
J	Li, J; Teng, Z; Weng, SC; Zhou, B; Turner, ER; Vinyard, BT; Luo, YG				Li, Jie; Teng, Zi; Weng, ShihChi; Zhou, Bin; Turner, Ellen R.; Vinyard, Bryan T.; Luo, Yaguang			Dynamic changes in the physicochemical properties of fresh-cut produce wash water as impacted by commodity type and processing conditions	PLOS ONE			English	Article							CROSS-CONTAMINATION; ORGANIC-COMPOUNDS; CHLORINE DEMAND; VEGETABLES; QUALITY; GUIDELINES; KINETICS; SURVIVAL	Organic materials in fresh-cut produce wash water deplete free chlorine that is required to prevent pathogen survival and cross-contamination. This research evaluated water quality parameters frequently used to describe organic load for their fitness to predict chlorine demand (CLD) and chemical oxygen demand (COD), which are major needs identified by the industry-led produce food safety taskforce. Batches of romaine lettuce, iceberg lettuce, or carrot of different cut sizes and shapes were washed in 40 liters of water. Physicochemical properties of wash water including CLD, COD, total organic carbon (TOC), total suspended solids (TSS), total dissolved solids (TDS), turbidity, total sugar content, and pH, were monitored. Results indicate that pH is primarily commodity dependent, while organic load is additionally impacted by cutting and washing conditions. Significant linear increases in COD, TOC, CLD, TDS, and turbidity resulted from increasing product-to-water ratio, and decreasing cut size. Physicochemical parameters, excluding pH, showed significant positive correlation across different cut sizes within a commodity. High correlations were obtained between CLD and COD and between COD and TOC for pooled products. The convenient measurement of TDS, along with its strong correlation with COD and CLD, suggests the potential of TDS for predicting organic load and chlorine reactivity. Finally, the potential application and limitation of the proposed models in practical produce processing procedures are discussed extensively.	[Li, Jie] Huazhong Agr Univ, Coll Food Sci & Technol, Wuhan, Peoples R China; [Li, Jie; Teng, Zi; Zhou, Bin; Turner, Ellen R.; Luo, Yaguang] ARS, USDA, Beltsville Agr Res Ctr, Environm Microbiol & Food Safety Lab, Beltsville, MD 20705 USA; [Teng, Zi] Univ Maryland, Dept Nutr & Food Sci, College Pk, MD 20742 USA; [Weng, ShihChi] Johns Hopkins Univ, JHU MWH Alliance, 615 N Wolfe St, Baltimore, MD USA; [Vinyard, Bryan T.] ARS, Stat Grp, Northeast Area Off, USDA, Beltsville, MD USA	Huazhong Agricultural University; United States Department of Agriculture (USDA); University System of Maryland; University of Maryland College Park; Johns Hopkins University; United States Department of Agriculture (USDA)	Luo, YG (corresponding author), ARS, USDA, Beltsville Agr Res Ctr, Environm Microbiol & Food Safety Lab, Beltsville, MD 20705 USA.	Yaguang.Luo@ars.usda.gov		Zhou, Bin/0000-0002-0315-8204; Turner, Ellen/0000-0003-1012-670X	USDA-NIFA (Specialty Crops Research Initiative Award) [2016-51181-25403]	USDA-NIFA (Specialty Crops Research Initiative Award)	This research was supported by USDA-NIFA (Specialty Crops Research Initiative Award No. 2016-51181-25403 to YL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletor O, 2002, FOOD CHEM, V78, P63, DOI 10.1016/S0308-8146(01)00376-4; Bornhorst ER, 2018, POSTHARVEST BIOL TEC, V146, P124, DOI 10.1016/j.postharvbio.2018.08.008; Deborde M, 2008, WATER RES, V42, P13, DOI 10.1016/j.watres.2007.07.025; Fadini PS, 2004, J BRAZIL CHEM SOC, V15, P131, DOI 10.1590/S0103-50532004000100020; Fan XT, 2015, POSTHARVEST BIOL TEC, V109, P65, DOI 10.1016/j.postharvbio.2015.06.009; Gazzola D, 2012, J AGR FOOD CHEM, V60, P10666, DOI 10.1021/jf302916n; Gombas D, 2017, J FOOD PROTECT, V80, P312, DOI 10.4315/0362-028X.JFP-16-258; Gomez-Lopez VM, 2013, FOOD CONTROL, V29, P42, DOI 10.1016/j.foodcont.2012.05.052; GORCHEV HG, 1984, WHO CHRON, V38, P104; Guerrero P, 2014, CARBOHYD POLYM, V111, P598, DOI 10.1016/j.carbpol.2014.05.005; Hach, 2015, 10223 HACH; Hach, 2014, 10236 HACH; Cardador MJ, 2012, J AGR FOOD CHEM, V60, P7326, DOI 10.1021/jf302591u; Kramer M, 2005, C APPL STAT AGR, DOI [10.4148/2475-7772.1142, DOI 10.4148/2475-7772.1142]; LECHEVALLIER MW, 1981, APPL ENVIRON MICROB, V42, P159, DOI 10.1128/AEM.42.1.159-167.1981; Leja M, 2013, PLANT FOOD HUM NUTR, V68, P163, DOI 10.1007/s11130-013-0351-3; Llorach R, 2008, FOOD CHEM, V108, P1028, DOI 10.1016/j.foodchem.2007.11.032; Luo YG, 2007, HORTSCIENCE, V42, P1413, DOI 10.21273/HORTSCI.42.6.1413; Luo YG, 2018, FOOD MICROBIOL, V70, P120, DOI 10.1016/j.fm.2017.09.013; Luo YG, 2012, INT J FOOD MICROBIOL, V158, P133, DOI 10.1016/j.ijfoodmicro.2012.07.008; Mattila P, 2007, J FOOD COMPOS ANAL, V20, P152, DOI 10.1016/j.jfca.2006.05.007; Moda EM, 2005, SCI AGR, V62, P127, DOI 10.1590/S0103-90162005000200006; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Storey MV, 2011, WATER RES, V45, P741, DOI 10.1016/j.watres.2010.08.049; Teng Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208945; Toivonen PMA, 2013, POSTHARVEST BIOL TEC, V86, P192, DOI 10.1016/j.postharvbio.2013.06.035; US Environmental Protection Agency, 1971, 1602 US EPA; USDA, 2016, USDA NATL NUTRIENT D; Van Haute S, 2018, POSTHARVEST BIOL TEC, V142, P19, DOI 10.1016/j.postharvbio.2018.02.002; Van Haute S, 2013, APPL ENVIRON MICROB, V79, P2850, DOI 10.1128/AEM.03283-12; Weng SC, 2016, FOOD CONTROL, V60, P543, DOI 10.1016/j.foodcont.2015.08.031; Zhang BC, 2015, FOOD MICROBIOL, V49, P152, DOI 10.1016/j.fm.2015.01.013; Zhou B, 2014, J FOOD PROCESS PRES, V38, P2201, DOI 10.1111/jfpp.12200	34	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 26	2019	14	9							e0222174	10.1371/journal.pone.0222174	http://dx.doi.org/10.1371/journal.pone.0222174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM6FU	31557181	gold, Green Published			2022-12-26	WOS:000532345500014
J	Tenzin, S; Ogunniyi, AD; Khazandi, M; Ferro, S; Bartsch, J; Crabb, S; Abraham, S; Deo, P; Trott, DJ				Tenzin, Sangay; Ogunniyi, Abiodun David; Khazandi, Manouchehr; Ferro, Sergio; Bartsch, Jonathon; Crabb, Simon; Abraham, Sam; Deo, Permal; Trott, Darren J.			Decontamination of aerosolised bacteria from a pig farm environment using a pH neutral electrochemically activated solution (Ecas4 anolyte)	PLOS ONE			English	Article							ACIDIC ELECTROLYZED WATER; RESPIRATORY-DISEASES; RISK-FACTORS; EFFICACY; DISINFECTION; RESISTANCE	An electrochemically activated solution (ECAS), generated by electrolysis of a dilute sodium chloride solution in a four-chamber electrolytic cell (Ecas4), was tested as a sanitising aerosol in eliminating bacteria from the environment of a weaning room vacated 24-48h earlier, at a continuous flow pig farm. An ultrasonic humidifier was used to fill the environment with a fog (droplets with diameters of 1-5 mu m) containing 0.25 ppm of hypochlorous acid. The weaning room was fogged for 3 min at 30 min intervals during five hours of aerosol disinfection. An innovative sample treatment with propidium monoazide dye in conjunction with cyclonic air sampling was optimised and adapted for discerning live/dead bacteria in subsequent molecular quantification steps. Without fogging, total bacterial load ranged from 5.06 +/- 0.04 to 5.75 +/- 0.04 Log(10) CFU/m(3). After the first hour of fogging, a 78% total bacterial reduction was observed, which further increased to > 97% after the second hour, > 99.4% after the third and 99.8% after the fourth hour, finally resulting in a 99.99% reduction from the farm environment over five hours. Unlike the current formaldehyde spray disinfection protocol, which requires a long empty period because of its hazardous properties, this economically viable and environmentally friendly disinfection protocol may significantly lower downtime. Moreover, ECAS fogging can be easily adapted to a variety of applications, including the elimination of pathogens from livestock farm air environment for disease prevention, as well as decontamination after disease outbreaks.	[Tenzin, Sangay; Ogunniyi, Abiodun David; Khazandi, Manouchehr; Trott, Darren J.] Univ Adelaide, Australian Ctr Antimicrobial Resistance Ecol, Sch Anim & Vet Sci, Roseworthy, SA, Australia; [Ferro, Sergio; Crabb, Simon] Ecas4 Australia Pty Ltd, Mile End South, SA, Australia; [Bartsch, Jonathon] Dr Barry Lloyd Pty Ltd, Gawler, SA, Australia; [Abraham, Sam] Murdoch Univ, Sch Vet & Life Sci, Murdoch, WA, Australia; [Deo, Permal] Univ South Australia, Sch Pharm & Med Sci, City East Campus,Playford P1-25, Adelaide, SA, Australia	University of Adelaide; Murdoch University; University of South Australia	Tenzin, S; Trott, DJ (corresponding author), Univ Adelaide, Australian Ctr Antimicrobial Resistance Ecol, Sch Anim & Vet Sci, Roseworthy, SA, Australia.	sangay.tenzin@adelaide.edu.au; darren.trott@adelaide.edu.au	Deo, Permal/S-3304-2019; Khazandi, Manouchehr/ABC-5930-2020; Ferro, Sergio/AAG-8572-2019	Deo, Permal/0000-0002-6477-9127; Ferro, Sergio/0000-0003-0797-795X; Tenzin, Sangay/0000-0002-1662-362X; Ogunniyi, Abiodun/0000-0001-9308-5629; Abraham, Sam/0000-0003-0950-2317	Pork CRC innovation project [2C-121]; Endeavour Postgraduate Scholarship	Pork CRC innovation project; Endeavour Postgraduate Scholarship	This project was funded by the Pork CRC innovation project no. 2C-121. Sangay Tenzin is supported by Endeavour Postgraduate Scholarship.	Ahmed MFE, 2013, ANN AGR ENV MED, V20, P16; [Anonymous], 2018, VET08ED42018 CLSI S; Bilic Vitomir, 2000, Arhiv za Higijenu Rada i Toksikologiju, V51, P199; Chapman JS, 2003, INT BIODETER BIODEGR, V51, P271, DOI 10.1016/S0964-8305(03)00044-1; DONHAM KJ, 1991, AM J VET RES, V52, P1723; Fablet C, 2012, PREV VET MED, V104, P271, DOI 10.1016/j.prevetmed.2011.11.012; Ferro S, 2018, FOOD CONTROL, V91, P321, DOI 10.1016/j.foodcont.2018.04.016; FOTHERINGHAM VJC, 1995, REV SCI TECH OIE, V14, P191, DOI 10.20506/rst.14.1.833; Gardner Ian A., 2002, Animal Health Research Reviews, V3, P43; Hao JX, 2011, J FOOD SAFETY, V31, P28, DOI 10.1111/j.1745-4565.2010.00261.x; Ichihara T, 2004, JPN J THORAC SURG, V57, P1110; Jirawattanapong P, 2010, RES VET SCI, V88, P11, DOI 10.1016/j.rvsc.2009.06.007; Khazandi M, 2017, FOOD MICROBIOL, V68, P51, DOI 10.1016/j.fm.2017.06.008; Koide S, 2009, FOOD CONTROL, V20, P294, DOI 10.1016/j.foodcont.2008.05.019; Lee S, 2018, MICROB BIOTECHNOL, V11, P1008, DOI 10.1111/1751-7915.13039; Loughlin MF, 2002, J ANTIMICROB CHEMOTH, V49, P631, DOI 10.1093/jac/49.4.631; Marenda M, 2014, REAL TIME DETECTION; Meakin NS, 2012, J HOSP INFECT, V80, P122, DOI 10.1016/j.jhin.2011.10.015; Michiels A, 2015, PREV VET MED, V121, P99, DOI 10.1016/j.prevetmed.2015.06.011; Migliarina F, 2014, HEALTHCARE, V2, P516, DOI 10.3390/healthcare2040516; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; NICKLAS W, 1981, ZBL BAKT MIK HYG B, V173, P374; Ohno H, 2000, SURG TODAY, V30, P1055, DOI 10.1007/s005950070035; Ozer NP, 2006, J FOOD ENG, V72, P234, DOI 10.1016/j.jfoodeng.2004.11.038; Paola LD, 2006, WOUNDS, V18, P262; Popescu S., 2014, Scientific Papers: Animal Science and Biotechnologies, V47, P182; Prilutsky V, 1997, VNIII MED ENG; Rahman SME, 2010, FOOD CONTROL, V21, P1383, DOI 10.1016/j.foodcont.2010.03.011; Safe Work Australia, 2019, WORKPL EXP STAND AIR; Sahibzada S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04789-0; Schaller A, 2001, VET MICROBIOL, V79, P47, DOI 10.1016/S0378-1135(00)00345-X; Stark KDC, 1998, NEW ZEAL VET J, V46, P3, DOI 10.1080/00480169.1998.36043; Stark KDC, 2000, VET J, V159, P37, DOI 10.1053/tvjl.1999.0421; Tanaka N, 1999, ARTIF ORGANS, V23, P1055, DOI 10.1046/j.1525-1594.1999.06224.x; Thorn RMS, 2012, EUR J CLIN MICROBIOL, V31, P641, DOI 10.1007/s10096-011-1369-9; Wang HH, 2019, FOOD CONTROL, V95, P50, DOI 10.1016/j.foodcont.2018.07.049; Zinkevich V, 2000, J HOSP INFECT, V46, P153, DOI 10.1053/jhin.2000.0819	37	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 25	2019	14	9							e0222765	10.1371/journal.pone.0222765	http://dx.doi.org/10.1371/journal.pone.0222765			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KF5PI	31553747	Green Published, Green Accepted, gold			2022-12-26	WOS:000509293500001
J	Richomme, C; Courcoul, A; Moyen, JL; Reveillaud, E; Maestrini, O; de Cruz, K; Drapeau, A; Boschiroli, ML				Richomme, Celine; Courcoul, Aurelie; Moyen, Jean-Louis; Reveillaud, Edouard; Maestrini, Oscar; de Cruz, Krystel; Drapeau, Antoine; Boschiroli, Maria Laura			Tuberculosis in the wild boar: Frequentist and Bayesian estimations of diagnostic test parameters when Mycobacterium bovis is present in wild boars but at low prevalence	PLOS ONE			English	Article							SUS-SCROFA; INFECTION; PIGS; SURVEILLANCE; MICROTI; COMPLEX; EPIDEMIOLOGY; ANTIBODIES; RESERVOIR; PATTERNS	The Eurasian wild boar (Sus scrofa) is increasingly considered as a relevant actor in the epidemiology of animal tuberculosis (TB). Therefore, monitoring TB in this species is key when establishing comprehensive control schemes for this disease still present in Europe. No data are available on direct and indirect TB diagnostic methods in wild boars in epidemiological contexts where TB is endemic in cattle and detected in wild boars at low prevalence. We aimed to estimate and compare sensitivity and specificity values for bacterial culture, PCR and three commercial ELISAs, i.e. the TB ELISA-VK (using the bPPD antigen), INgezim TB Porcine and IDEXX M. bovis Ab Test (both using the MPB83 and MPB70 antigens), under field conditions in France. We used frequentist methods, with bacteriology as the gold standard, and a Bayesian formulation of the latent class analysis (LCA), without using a gold standard. Submandibular lymph nodes and sera from 495 wild boars hunter-harvested in three endemic areas (Aquitaine region, Cote d'Or region, and Corsica region) were collected between 2014 and 2016. Only eight individuals were positive for M. bovis by bacteriology (1.61%; CI95% 0.70-3.51%). The LCA method provided high specificities (99.2%; CI95% 98.2-99.8% for INgezim TB Porcine and 99.7%; CI95% 98.8-100% for IDEXX M. bovis Ab Test) and sensitivities (78.5%; CI95% 65.1-88.8% for INgezim TB Porcine and 83.9%; CI95% 58.9-97.2% for IDEXX M. bovis Ab Test) for both ELISAs using the MPB83 and MPB70 antigens. Bacterial culture showed limited sensitivity (42.8%; CI95% 19.0-70.6%), estimated as the probability of a positive result in an animal exposed to M. bovis. PCR and ELISA using the bPPD antigens demonstrated high specificities, and sensitivities intermediates between culture and the ELISAs using the MPB83 and MPB70 antigens. These results suggest that ELISA tests using the MPB83 and MPB70 antigens are useful to detect and monitor TB exposure of wild boar populations in field conditions in France.	[Richomme, Celine] ANSES, Nancy Lab Rabies & Wildlife, Malzeville, France; [Courcoul, Aurelie] Univ Paris Est, Lab Anim Hlth, Epidemiol Unit, ANSES, Maisons Alfort, France; [Moyen, Jean-Louis] Lab Dept Anal & Rech Dordogne, Coulounieix Chamiers, France; [Reveillaud, Edouard] ANSES, Unit Coordinat & Support Surveillance, Maisons Alfort, France; [Maestrini, Oscar] INRA, UR 045, Corte, France; [de Cruz, Krystel; Drapeau, Antoine; Boschiroli, Maria Laura] Univ Paris Est, Lab Anim Hlth, TB Natl Reference Lab, ANSES, Maisons Alfort, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Technopole Agricole et Veterinaire; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Sante Animale de Maisons-Alfort; Ecole Nationale Veterinaire d'Alfort (ENVA); Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Sante Animale de Maisons-Alfort; Ecole Nationale Veterinaire d'Alfort (ENVA)	Boschiroli, ML (corresponding author), Univ Paris Est, Lab Anim Hlth, TB Natl Reference Lab, ANSES, Maisons Alfort, France.	maria-laura.boschiroli@anses.fr	Boschiroli, Maria Laura/AAR-3319-2021	Boschiroli, Maria Laura/0000-0002-6705-1684	French General Directorate for Food (DGAL)	French General Directorate for Food (DGAL)	This project was funded by the French General Directorate for Food (DGAL) through a Bovine Tuberculosis Reseau Francais de Sante Animale (RFSA) research call. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranaz A, 2004, J CLIN MICROBIOL, V42, P2602, DOI 10.1128/JCM.42.6.2602-2608.2004; Aurtenetxe O, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-43; Barasona JA, 2017, TRANSBOUND EMERG DIS, V64, P906, DOI 10.1111/tbed.12458; Lara GHB, 2011, RES VET SCI, V90, P185, DOI 10.1016/j.rvsc.2010.06.009; Boadella Mariana, 2011, BMC Res Notes, V4, P498, DOI 10.1186/1756-0500-4-498; Boadella M, 2011, J VET DIAGN INVEST, V23, P77, DOI 10.1177/104063871102300111; Boniotti MB, 2014, J CLIN MICROBIOL, V52, P2834, DOI 10.1128/JCM.00440-14; Cano-Terriza D, 2018, PREV VET MED, V159, P87, DOI 10.1016/j.prevetmed.2018.08.015; Cardoso-Toset F, 2017, PREV VET MED, V137, P101, DOI 10.1016/j.prevetmed.2016.12.016; Cavalerie L, 2015, ANIM HLTH NUTR, V71, P4; Chiari M, 2016, TRANSBOUND EMERG DIS, V63, pE381, DOI 10.1111/tbed.12313; Corner LAL, 2012, VET MICROBIOL, V156, P162, DOI 10.1016/j.vetmic.2011.10.016; de Lisle GW, 2002, REV SCI TECH OIE, V21, P317, DOI 10.20506/rst.21.2.1339; Dondo A., 2007, Epidemiologie et Sante Animale, P35; Duarte EL, 2008, VET MICROBIOL, V130, P415, DOI 10.1016/j.vetmic.2008.02.012; Garcia-Bocanegra I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034908; Gortazar C, 2017, PREV VET MED, V146, P150, DOI 10.1016/j.prevetmed.2017.08.009; Gortazar C, 2003, VET REC, V152, P779, DOI 10.1136/vr.152.25.779; Hines N, 2006, J VET DIAGN INVEST, V18, P243, DOI 10.1177/104063870601800302; Krajewska M, 2014, J WILDLIFE DIS, V50, P1001, DOI 10.7589/2013-07-187; Madeira S, 2015, TRANSBOUND EMERG DIS; Michelet L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207614; Michelet L, 2015, J CLIN MICROBIOL, V53, P981, DOI 10.1128/JCM.02713-14; Naranjo V, 2008, VET MICROBIOL, V127, P1, DOI 10.1016/j.vetmic.2007.10.002; Nugent G, 2015, NEW ZEAL VET J, V63, P54, DOI 10.1080/00480169.2014.963792; OIE, MAN DIAGN TESTS VACC, P7; Perez de Val B, 2015, TRANSBOUND EMERG DIS; Reveillaud E, 2018, FRONT VET SCI, P5, DOI [10.3389/fvets.2018.00262/full, DOI 10.3389/FVETS.2018.00262/FULL]; Reveillaud E, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00262; Richomme C, 2013, PLOS ONE, P8; Richomme C, 2010, J WILDLIFE DIS, V46, P627, DOI 10.7589/0090-3558-46.2.627; Risco D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110123; Rodriguez S, 2010, VET MICROBIOL, V141, P89, DOI 10.1016/j.vetmic.2009.08.007; Roos EO, 2016, VET IMMUNOL IMMUNOP, V182, P79, DOI 10.1016/j.vetimm.2016.10.006; Roos EO, 2018, BMC VET RES, P14; Santos N, 2015, VET RES, V46, DOI 10.1186/s13567-015-0270-4; Santos N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012663; Santos N, 2009, J WILDLIFE DIS, V45, P1048, DOI 10.7589/0090-3558-45.4.1048; Schiller I, 2011, VET MICROBIOL, V151, P153, DOI 10.1016/j.vetmic.2011.02.039; Sinha P, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1450-1; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; THIERRY D, 1990, J CLIN MICROBIOL, V28, P2668, DOI 10.1128/JCM.28.12.2668-2673.1990; Thomas J, 2019, PREV VET MED, V162, P11, DOI 10.1016/j.prevetmed.2018.11.004; Vicente J, 2013, TRANSBOUND EMERG DIS, V60, P92, DOI 10.1111/tbed.12167; Wiker HG, 2009, SCAND J IMMUNOL, V69, P492, DOI 10.1111/j.1365-3083.2009.02256.x; Zanella G, 2008, VET REC, V163, P43, DOI 10.1136/vr.163.2.43; Zanella G, 2008, J WILDLIFE DIS, V44, P99, DOI 10.7589/0090-3558-44.1.99; Zhang J, 2010, J MED MICROBIOL, V59, P285, DOI 10.1099/jmm.0.016949-0	48	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2019	14	9							e0222661	10.1371/journal.pone.0222661	http://dx.doi.org/10.1371/journal.pone.0222661			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5RZ	31550287	Green Published, gold			2022-12-26	WOS:000532307700023
J	Adetunji, MO; Lamont, SJ; Abasht, B; Schmidt, CJ				Adetunji, Modupeore O.; Lamont, Susan J.; Abasht, Behnam; Schmidt, Carl J.			Variant analysis pipeline for accurate detection of genomic variants from transcriptome sequencing data	PLOS ONE			English	Article							RED JUNGLE FOWL; RNA-SEQ	The wealth of information deliverable from transcriptome sequencing (RNA-seq) is significant, however current applications for variant detection still remain a challenge due to the complexity of the transcriptome. Given the ability of RNA-seq to reveal active regions of the genome, detection of RNA-seq SNPs can prove valuable in understanding the phenotypic diversity between populations. Thus, we present a novel computational workflow named VAP (Variant Analysis Pipeline) that takes advantage of multiple RNA-seq splice aware aligners to call SNPs in non-human models using RNA-seq data only. We applied VAP to RNA-seq from a highly inbred chicken line and achieved high accuracy when compared with the matching whole genome sequencing (WGS) data. Over 65% of WGS coding variants were identified from RNA-seq. Further, our results discovered SNPs resulting from post transcriptional modifications, such as RNA editing, which may reveal potentially functional variation that would have otherwise been missed in genomic data. Even with the limitation in detecting variants in expressed regions only, our method proves to be a reliable alternative for SNP identification using RNA-seq data. The source code and user manuals are available at https://modupeore.github.io/VAP/.	[Adetunji, Modupeore O.; Abasht, Behnam; Schmidt, Carl J.] Univ Delaware, Dept Anim & Food Sci, Newark, DE 19716 USA; [Lamont, Susan J.] Iowa State Univ, Dept Anim Sci, Ames, IA USA	University of Delaware; Iowa State University	Adetunji, MO (corresponding author), Univ Delaware, Dept Anim & Food Sci, Newark, DE 19716 USA.	amodupe@udel.edu	Adetunji, Modupeore/GSN-9929-2022; Adetunji, Modupeore/AAI-2533-2019	Adetunji, Modupeore/0000-0001-8870-1052; Adetunji, Modupeore/0000-0001-8870-1052; Schmidt, Carl/0000-0002-8386-4781	Agriculture and Food Research Initiative Competitive Grants from the United States Department of Agriculture National institute of Food and Agriculture [2011-67003-30228, 2017-67015-26543]	Agriculture and Food Research Initiative Competitive Grants from the United States Department of Agriculture National institute of Food and Agriculture	This project was supported by Agriculture and Food Research Initiative Competitive Grants 2011-67003-30228 and 2017-67015-26543, both awarded to CJS, from the United States Department of Agriculture National institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakhtiarizadeh MR, 2018, BIORXIV, DOI [10.1101/319871, DOI 10.1101/319871]; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Castel SE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0762-6; Chen SF, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1469-3; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fleming DS, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2711-5; Fresard L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126776; Guo Y, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4022-x; Han YX, 2015, BIOINFORM BIOL INSIG, V9, P29, DOI 10.4137/BBI.S28991; Kalari KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079298; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kranis A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-59; Kumar V, 2015, ANIM BIOTECHNOL, V26, P201, DOI 10.1080/10495398.2014.983645; Li H., 2013, ALIGNING SEQUENCE RE, DOI [10.1186/s13756-018-0352-y, DOI 10.1186/S13756-018-0352-Y]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLaren W, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0974-4; Medina I, 2016, DNA RES, V23, P93, DOI 10.1093/dnares/dsv039; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Moiseyeva IG, 2003, GENET SEL EVOL, V35, P403, DOI 10.1051/gse:2003031; Oikkonen Laura, 2017, Wellcome Open Res, V2, P6, DOI 10.12688/wellcomeopenres.10501.2; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Piskol R, 2013, AM J HUM GENET, V93, P641, DOI 10.1016/j.ajhg.2013.08.008; Quinn EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058815; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Tang XJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku1005; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yan YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104652; Zhuo Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12179-9	32	11	11	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2019	14	9							e0216838	10.1371/journal.pone.0216838	http://dx.doi.org/10.1371/journal.pone.0216838			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5QI	31545812	Green Published, Green Submitted, gold			2022-12-26	WOS:000532303200004
J	Weinstein, SY; Thrower, FP; Nichols, KM; Hale, MC				Weinstein, Spencer Y.; Thrower, Frank P.; Nichols, Krista M.; Hale, Matthew C.			A large-scale chromosomal inversion is not associated with life history development in rainbow trout from Southeast Alaska	PLOS ONE			English	Article							MIGRATION-RELATED TRAITS; ONCORHYNCHUS-MYKISS; GENETIC-BASIS; ANADROMOUS STEELHEAD; ADAPTIVE DIVERGENCE; JUVENILE RESIDENT; ATLANTIC SALMON; CANDIDATE GENES; GENOME; EXPRESSION	In studying the causative mechanisms behind migration and life history, the salmonidssalmon, trout, and charr-are an exemplary taxonomic group, as life history development is known to have a strong genetic component. A double inversion located on chromosome 5 in rainbow trout (Oncorhynchus mykiss) is associated with life history development in multiple populations, but the importance of this inversion has not been thoroughly tested in conjunction with other polymorphisms in the genome. To that end, we used a high-density SNP chip to genotype 192 F-1 migratory and resident rainbow trout and focused our analyses to determine whether this inversion is important in life history development in a well-studied population of rainbow trout from Southeast Alaska. We identified 4,994 and 436 SNPs-predominantly outside of the inversion region-associated with life history development in the migrant and resident familial lines, respectively. Although F-1 samples showed genomic patterns consistent with the double inversion on chromosome 5 (reduced observed and expected heterozygosity and an increase in linkage disequilibrium), we found no statistical association between the inversion and life history development. Progeny produced by crossing resident trout and progeny produced by crossing migrant trout both consisted of a mix of migrant and resident individuals, irrespective of the individuals' inversion haplotype on chromosome 5. This suggests that although the inversion is present at a low frequency, it is not strongly associated with migration as it is in populations of Oncorhynchus mykiss from lower latitudes.	[Weinstein, Spencer Y.; Hale, Matthew C.] Texas Christian Univ, Dept Biol, Ft Worth, TX 76129 USA; [Thrower, Frank P.] NOAA, Ted Stevens Marine Res Inst, Alaska Fisheries Ctr, Juneau, AK USA; [Nichols, Krista M.] Northwest Fisheries Sci Ctr, Conservat Biol Div, Seattle, WA 98112 USA; [Weinstein, Spencer Y.] Univ Waterloo, Dept Biol, Waterloo, ON, Canada	Texas Christian University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Waterloo	Hale, MC (corresponding author), Texas Christian Univ, Dept Biol, Ft Worth, TX 76129 USA.; Nichols, KM (corresponding author), Northwest Fisheries Sci Ctr, Conservat Biol Div, Seattle, WA 98112 USA.	krista.nichols@noaa.gov; m.c.hale@tcu.edu			National Science Foundation [NSF-DEB-0845265]; Texas Christian University; NSF	National Science Foundation(National Science Foundation (NSF)); Texas Christian University; NSF(National Science Foundation (NSF))	This work was supported by a National Science Foundation Career Award to Krista Nichols (NSF-DEB-0845265) and Texas Christian University startup funds were used for genotyping. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding was provided by an NSF-career award to Krista Nichols, and Texas Christian University startup funds were used for genotyping. Genotyping was performed by Ben Pejsar and team at Neogen GeneSeek Operations. We would like to thank Garrett McKinney for providing comments on the manuscript, and the staff at the Little Port Walter Marine Station for facilitating the work in the Sashin system.	Arostegui MC, 2019, MOL ECOLOGY; Barth JMI, 2017, MOL ECOL, V26, P4452, DOI 10.1111/mec.14207; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brunelli JP, 2008, GENOME, V51, P739, DOI 10.1139/G08-060; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Colosimo PF, 2004, PLOS BIOL, V2, P635, DOI 10.1371/journal.pbio.0020109; Danzmann RG, 2005, GENOME, V48, P1037, DOI 10.1139/G05-067; Docker MF, 2003, CONSERV GENET, V4, P227, DOI 10.1023/A:1023355114612; Feder JL, 2009, EVOLUTION, V63, P3061, DOI 10.1111/j.1558-5646.2009.00786.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Hale MC, 2016, COMP BIOCHEM PHYS D, V20, P136, DOI 10.1016/j.cbd.2016.07.006; Hale MC, 2014, J HERED, V105, P506, DOI 10.1093/jhered/esu018; Hale MC, 2013, G3-GENES GENOM GENET, V3, P1273, DOI 10.1534/g3.113.006817; Hecht BC, 2015, G3-GENES GENOM GENET, V5, P873, DOI 10.1534/g3.114.016469; Hecht BC, 2014, MAR BIOTECHNOL, V16, P638, DOI 10.1007/s10126-014-9579-7; Hecht BC, 2013, MOL ECOL, V22, P3061, DOI 10.1111/mec.12082; Hecht BC, 2012, G3-GENES GENOM GENET, V2, P1113, DOI 10.1534/g3.112.003137; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Knief U, 2017, NAT ECOL EVOL, V1, P1177, DOI 10.1038/s41559-017-0236-1; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leder EH, 2006, J HERED, V97, P74, DOI 10.1093/jhered/esj004; Leitwein M, 2017, EVOL APPL, V10, P56, DOI 10.1111/eva.12416; Lien S, 2016, NATURE, V533, P200, DOI 10.1038/nature17164; Lindtke D, 2017, MOL ECOL, V26, P6189, DOI 10.1111/mec.14280; Lowry DB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000500; McCormick SD, 2013, FISH PHYSIOL, V32, P199, DOI 10.1016/B978-0-12-396951-4.00005-0; McCusker MR, 2000, MOL ECOL, V9, P2089, DOI 10.1046/j.1365-294X.2000.01121.x; McKinney GJ, 2015, MOL ECOL, V24, P1792, DOI 10.1111/mec.13143; Miller MR, 2012, MOL ECOL, V21, P237, DOI 10.1111/j.1365-294X.2011.05305.x; Morro B, 2019, AQUACULTURE, V507, P282, DOI 10.1016/j.aquaculture.2019.04.039; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0431157100; Nichols KM, 2008, GENETICS, V179, P1559, DOI 10.1534/genetics.107.084251; Nichols KM, 2007, GENETICS, V175, P335, DOI 10.1534/genetics.106.064311; Nichols KM, 2016, EVOL APPL, V9, P1285, DOI 10.1111/eva.12412; O'Malley KG, 2003, J HERED, V94, P273, DOI 10.1093/jhered/esg067; Palti Y, 2015, MOL ECOL RESOUR, V15, P662, DOI 10.1111/1755-0998.12337; Pearse DE, 2018, SEX DEPENDENT DOMINA, DOI DOI 10.1101/504621; Pearse DE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0012; Rockman MV, 2012, EVOLUTION, V66, P1, DOI 10.1111/j.1558-5646.2011.01486.x; Roesti M, 2013, MOL ECOL, V22, P3014, DOI 10.1111/mec.12322; Rosenblum EB, 2011, EVOLUTION, V65, P946, DOI 10.1111/j.1558-5646.2010.01190.x; Schluter D, 2004, AM NAT, V163, P809, DOI 10.1086/383621; Sinclair-Waters M, 2018, MOL ECOL, V27, P339, DOI 10.1111/mec.14442; Stefansson S., 2008, FISH LARVAL PHYSL; Sundin K, 2005, AQUACULTURE, V247, P75, DOI 10.1016/j.aquaculture.2005.02.054; Thrower FP, 2004, AM FISH S S, V44, P485; Thrower FP, 2004, J FISH BIOL, V65, P286, DOI 10.1111/j.0022-1112.2004.00551.x; Waples RS, 2004, EVOLUTION, V58, P386, DOI 10.1111/j.0014-3820.2004.tb01654.x; Wellenreuther M, 2018, TRENDS ECOL EVOL, V33, P427, DOI 10.1016/j.tree.2018.04.002	50	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2019	14	9							e0223018	10.1371/journal.pone.0223018	http://dx.doi.org/10.1371/journal.pone.0223018			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5OJ	31539414	Green Published, gold			2022-12-26	WOS:000532297900040
J	Gentilini, D; Oliveri, A; Fazia, T; Pini, A; Marelli, S; Bernardinelli, L; Di Blasio, AM				Gentilini, Davide; Oliveri, Antonino; Fazia, Teresa; Pini, Alessandro; Marelli, Susan; Bernardinelli, Luisa; Di Blasio, Anna Maria			NGS analysis in Marfan syndrome spectrum: Combination of rare and common genetic variants to improve genotype-phenotype correlation analysis	PLOS ONE			English	Article							FIBRILLIN-1 FBN1; MUTATION-TYPE; MANIFESTATIONS; PATHOGENESIS; ASSOCIATION; PROBANDS; PROTEIN; WOMEN; MEN	The diagnosis of Marfan spectrum includes a large number of clinical criteria. Although the identification of pathogenic variants contributes to the diagnostic process, its value to the prediction of clinical outcomes is still limited. An important novelty of the present study is represented by the statistical approach adopted to investigate genotype-phenotype correlation. The analysis has been improved considering the extended genetic information obtained by Next Generation Sequencing (NGS) and combining the effects of both rare and common genetic variants in an inclusive model. To this aim a cohort of 181 patients were analyzed with a NGS panel including 11 genes associated with Marfan spectrum. The genotype-phenotype correlation was also investigated considering the possibility to predict presence of a pathological mutation in Marfan syndrome (MFS) main genes based only on the analysis of phenotypic traits. Results obtained indicate that information about clinical traits can be summarized in a new variable that resulted significantly associated with the probability to find a pathological mutation in MFS main genes. This is important since the choice of the genetic test is often influenced by the phenotypic characterization of patients. Moreover, both rare and common variants were found to significantly contribute to clinical spectrum and their combination allowed to increase the percentage of phenotype variability that could be explained based on genetic factors. Results highlight the opportunity to take advantage of the overall genetic information obtained by NGS data to have a better clinical classification of patients.	[Gentilini, Davide; Oliveri, Antonino; Fazia, Teresa; Bernardinelli, Luisa] Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy; [Gentilini, Davide] Ist Auxol Italiano IRCCS, Bioinformat & Stat Genom Unit, Milan, Italy; [Gentilini, Davide; Di Blasio, Anna Maria] Ist Auxol Italiano IRCCS, Mol Biol Lab, Milan, Italy; [Pini, Alessandro; Marelli, Susan] ASST FBF Sacco, Cardiol Dept, Rare Dis Ctr, Marfan Clin, Milan, Italy; [Pini, Alessandro] Ctr Cardiogenet Vascolare IRCCS Policlin San Dona, Milan, Italy	University of Pavia; IRCCS Istituto Auxologico Italiano; IRCCS Istituto Auxologico Italiano	Gentilini, D (corresponding author), Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy.; Gentilini, D (corresponding author), Ist Auxol Italiano IRCCS, Bioinformat & Stat Genom Unit, Milan, Italy.; Gentilini, D (corresponding author), Ist Auxol Italiano IRCCS, Mol Biol Lab, Milan, Italy.	davide.gentilini@unipv.it	marelli, susan/AAC-2827-2021; Bernardinelli, Luisa/AAL-5750-2021; Fazia, Teresa/AAV-1412-2021; Marelli, Susan/AAB-5906-2021; Pini, Alessandro/AAG-2020-2020	marelli, susan/0000-0001-5217-7391; Fazia, Teresa/0000-0002-9577-8450; Pini, Alessandro/0000-0002-8325-6057; Oliveri, Antonino/0000-0003-2621-6443; Gentilini, Davide/0000-0002-8391-0725				Althouse AD, 2016, ANN THORAC SURG, V101, P1644, DOI 10.1016/j.athoracsur.2015.11.024; Barness LA., 1996, AM J MED GENET, V3, P4605, DOI [10.1002/(SICI)1096-8628(19961202)66:1%3C87::AID-AJMG20%3E3.0.CO;2-L, DOI 10.1002/(SICI)1096-8628(19961202)66:1%3C87::AID-AJMG20%3E3.0.CO;2-L]; Baudhuin LM, 2015, J HUM GENET, V60, P241, DOI 10.1038/jhg.2015.10; Chandra A, 2014, EYE, V28, P162, DOI 10.1038/eye.2013.274; Child AH, 2017, ANN CARDIOTHORAC SUR, V6, P599, DOI 10.21037/acs.2017.10.02; Detaint D, 2010, EUR HEART J, V31, P2223, DOI 10.1093/eurheartj/ehq258; DIETZ HC, 1995, HUM MOL GENET, V4, P1799, DOI 10.1093/hmg/4.suppl_1.1799; Dietz HC, 1993, MARFAN SYNDROME; Dudbridge F, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003348; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Faivre L, 2007, AM J HUM GENET, V81, P454, DOI 10.1086/520125; Faivre L, 2012, CLIN GENET, V81, P433, DOI 10.1111/j.1399-0004.2011.01703.x; Faivre L, 2009, EUR J HUM GENET, V17, P491, DOI 10.1038/ejhg.2008.207; Franken R, 2016, EUR HEART J, V37, P3285, DOI 10.1093/eurheartj/ehv739; Gao LG, 2010, AGEING RES REV, V9, P363, DOI 10.1016/j.arr.2009.09.001; Groth KA, 2018, AM J CARDIOL, V122, P1231, DOI 10.1016/j.amjcard.2018.06.034; Hennekam RCM, 2005, AM J MED GENET A, V139A, P1, DOI 10.1002/ajmg.a.30979; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Kassambara A., 2017, PRACTICAL GUIDE PRIN, V1; Landis BJ, 2017, HEART, V103, P1750, DOI 10.1136/heartjnl-2017-311513; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loeys B, 2004, HUM MUTAT, V24, P140, DOI 10.1002/humu.20070; Loeys B, 2016, EUR HEART J, V37, P3291, DOI 10.1093/eurheartj/ehw154; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; Loth E, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00188; Maeda J, 2016, HEART VESSELS, V31, P1717, DOI 10.1007/s00380-016-0793-2; Becerra-Munoz V, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-017-0754-6; Martinez-Quintana E, 2017, MOL SYNDROMOL, V8, P148, DOI 10.1159/000467909; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meester JAN, 2017, ANN CARDIOTHORAC SUR, V6, P582, DOI 10.21037/acs.2017.11.03; Pepe G, 2001, CLIN GENET, V59, P444, DOI 10.1034/j.1399-0004.2001.590610.x; Pyeritz RE, 2008, ANN THORAC SURG, V86, P335, DOI 10.1016/j.athoracsur.2006.10.023; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Rocha Cabrera P, 2018, Arch Soc Esp Oftalmol (Engl Ed), V93, P139, DOI 10.1016/j.oftal.2017.07.003; Rommel K, 2005, HUM MUTAT, V26, P529, DOI 10.1002/humu.20239; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Rybczynski M, 2008, AM J MED GENET A, V146A, P3157, DOI 10.1002/ajmg.a.32595; Sato A, 2016, BONE, V86, P53, DOI 10.1016/j.bone.2016.02.018; SAVILLE DJ, 1990, AM STAT, V44, P174, DOI 10.2307/2684163; Schrijver I, 2002, AM J HUM GENET, V71, P223, DOI 10.1086/341581; Seto T, 2017, HUM GENOME VAR, V4, DOI 10.1038/hgv.2017.7; Shah SY, 2018, CLEV CLIN J MED, V85, P779, DOI 10.3949/ccjm.85a.17069; Tiecke F, 2001, EUR J HUM GENET, V9, P13, DOI 10.1038/sj.ejhg.5200582; Verstraeten A, 2016, HUM MUTAT, V37, P524, DOI 10.1002/humu.22977; Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105; Yang X, 2018, J MED GENET, V55, P546, DOI 10.1136/jmedgenet-2018-105313; Zhang L, 2016, CLIN GENET, V89, P639, DOI 10.1111/cge.12713	50	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222506	10.1371/journal.pone.0222506	http://dx.doi.org/10.1371/journal.pone.0222506			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536524	Green Published, Green Submitted, gold			2022-12-26	WOS:000532262800047
J	Gouyon, B; Martin-Mons, S; Iacobelli, S; Razafimahefa, H; Kermorvant-Duchemin, E; Brat, R; Caeymaex, L; Couringa, Y; Alexandre, C; Lafon, C; Ramful, D; Bonsante, F; Binson, G; Flamein, F; Moussy-Durandy, A; Di Maio, M; Mazeiras, G; Girard, O; Desbruyeres, C; Mourdie, J; Escourrou, G; Flechelles, O; Abasse, S; Rosenthal, JM; Pages, AS; Dorsi, M; Karaoui, L; ElGellab, A; Dantec, FL; Yangui, MA; Norbert, K; Kugbe, Y; Lorrain, S; Pignolet, A; Garnier, EM; Lapillonne, A; Mitanchez, D; Jacqz-Aigrain, E; Gouyon, JB				Gouyon, Beatrice; Martin-Mons, Severine; Iacobelli, Silvia; Razafimahefa, Hasinirina; Kermorvant-Duchemin, Elsa; Brat, Roselyne; Caeymaex, Laurence; Couringa, Yvan; Alexandre, Ceneric; Lafon, Catherine; Ramful, Duksha; Bonsante, Francesco; Binson, Guillaume; Flamein, Florence; Moussy-Durandy, Amelie; Di Maio, Massimo; Mazeiras, Gael; Girard, Olivier; Desbruyeres, Cecile; Mourdie, Julien; Escourrou, Guillaume; Flechelles, Olivier; Abasse, Soumeth; Rosenthal, Jean-Marc; Pages, Anne-Sophie; Dorsi, Marine; Karaoui, Leila; ElGellab, Abdellah; Dantec, Florence Le Bail; Yangui, Mohamed-Amine; Norbert, Karine; Kugbe, Yaovi; Lorrain, Simon; Pignolet, Anaelle; Garnier, Elodie Marie; Lapillonne, Alexandre; Mitanchez, Delphine; Jacqz-Aigrain, Evelyne; Gouyon, Jean-Bernard			Characteristics of prescription in 29 Level 3 Neonatal Wards over a 2-year period (2017-2018). An inventory for future research	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; OFF-LABEL USE; MEDICATION ERRORS; DRUG UTILIZATION; INFANTS; SAFETY	Objectives The primary objective of this study is to determine the current level of patient medication exposure in Level 3 Neonatal Wards (L3NW). The secondary objective is to evaluate in the first month of life the rate of medication prescription not cited in the Summary of Product Characteristics (SmPC). A database containing all the medication prescriptions is collected as part of a prescription benchmarking program in the L3NW. Material and methods The research is a two-year observational cohort study (2017-2018) with retrospective analysis of medications prescribed in 29 French L3NW. Seventeen L3NW are present since the beginning of the study and 12 have been progressively included. All neonatal units used the same computerized system of prescription, and all prescription data were completely de-identified within each hospital before being stored in a common data warehouse. Results The study population includes 27,382 newborns. Two hundred and sixty-one different medications (International Nonproprietary Names, INN) were prescribed. Twelve INN (including paracetamol) were prescribed for at least 10% of patients, 55 for less than 10% but at least 1% and 194 to less than 1%. The lowest gestational ages (GA) were exposed to the greatest number of medications (18.0 below 28 weeks of gestation (WG) to 4.1 above 36 WG) (p<0.0001). In addition, 69.2% of the 351 different combinations of an medication INN and a route of administration have no indication for the first month of life according to the French SmPC. Ninety-five percent of premature infants with GA less than 32 weeks received at least one medication not cited in SmPC. Conclusion Neonates remain therapeutic orphans. The consequences of polypharmacy in L3NW should be quickly assessed, especially in the most immature infants.	[Gouyon, Beatrice; Martin-Mons, Severine; Iacobelli, Silvia; Bonsante, Francesco; Lorrain, Simon; Pignolet, Anaelle; Garnier, Elodie Marie; Gouyon, Jean-Bernard] Ctr Hosp Univ La Reunion Site Sud, Ctr Etud Perinatales Ocean Indien EA 7388, St Pierre, Reunion, France; [Razafimahefa, Hasinirina] Ctr Hosp Sud Francilien, Corbeil Essonnes, France; [Kermorvant-Duchemin, Elsa; Lapillonne, Alexandre] Hop Necker Enfants Malad, Paris, France; [Brat, Roselyne] Ctr Hosp Reg Orleans, Orleans, France; [Caeymaex, Laurence] Ctr Hosp Intercommunal Creteil, Creteil, France; [Couringa, Yvan] Ctr Hosp Andree Rosemon, Guyane Francaise, France; [Alexandre, Ceneric] CHU Caen, Caen, France; [Lafon, Catherine] Ctr Hosp Arras, Arras, France; [Ramful, Duksha] Ctr Hosp Univ La Reunion Site Nord, St Denis, Reunion, France; [Binson, Guillaume] CHU Poitiers, Poitiers, France; [Flamein, Florence] CHU Lille, Lille, France; [Moussy-Durandy, Amelie] Ctr Hosp Intercommunal Poissy St Germain Laye, Poissy, France; [Di Maio, Massimo] CHU Nimes, Nimes, France; [Mazeiras, Gael] Ctr Hosp Cote Basque, Bayonne, France; [Girard, Olivier] Ctr Hosp St Denis, St Denis, Reunion, France; [Desbruyeres, Cecile] Ctr Hosp Metropole Savoie, Chambery, France; [Mourdie, Julien] Grp Hosp Havre, Hop Jacques Monod, Montivilliers, France; [Escourrou, Guillaume] Ctr Hosp Intercommunal Andre Gregoire, Montreuil, France; [Flechelles, Olivier] Ctr Hosp Univ Fort de France, Fort De France, Martinique, France; [Abasse, Soumeth] Ctr Hosp Mayotte, Mamoudzou, Mayotte, France; [Rosenthal, Jean-Marc] CHU Pointe a Pitre, Pointe A Pitre, Guadeloupe, France; [Pages, Anne-Sophie] Ctr Hosp Publ Cotentin, Cherbourg En Cotentin, France; [Dorsi, Marine] Ctr Hosp Terr Gaston Bourret, Dumbea, Nouvelle Caledo, France; [Karaoui, Leila] Grand Hop Est Francilien, Meaux, France; [ElGellab, Abdellah] Ctr Hosp Lens, Lens, France; [Dantec, Florence Le Bail] Ctr Hosp St Brieuc, St Brieuc, France; [Yangui, Mohamed-Amine] Hop Rene Dubos, Pontoise, France; [Norbert, Karine] Ctr Hosp Pau, Pau, France; [Kugbe, Yaovi] Ctr Hosp Ouest Guyanais Franck Joly, St Laurent Du Maroni, Guyane Francais, France; [Mitanchez, Delphine] Hop Armand Trousseau, Paris, France; [Jacqz-Aigrain, Evelyne] Hop Robert Debre, Paris, France	CHU Reunion; Centre Hospitalier Sud Francilien; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre Hospitalier Regional d'Orleans; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHI Creteil; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU Reunion; CHU Poitiers; Universite de Poitiers; Universite de Lille - ISITE; CHU Lille; Universite de Montpellier; CHU de Nimes; CHU Martinique; CHU Guadeloupe; Centre Hospitalier Rene Dubos, Pontoise; Centre Hospitalier de Pau; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Gouyon, JB (corresponding author), Ctr Hosp Univ La Reunion Site Sud, Ctr Etud Perinatales Ocean Indien EA 7388, St Pierre, Reunion, France.	jean-bernard.gouyon@chu-reunion.fr	Binson, Guillaume/AAQ-3038-2020; Jacqz-Aigrain, Evelyne/AAW-7089-2021; caeymaex, laurence/ABF-1423-2020; ABASSE, Soumeth/ABD-6071-2020	Jacqz-Aigrain, Evelyne/0000-0002-4285-7067; caeymaex, laurence/0000-0003-3822-5136; ABASSE, Soumeth/0000-0003-2806-0999; Garnier, Elodie/0000-0003-2682-4369; Razafimahefa, Hasinirina/0000-0001-9183-3523	European research program FEDER [2014-34018]	European research program FEDER	This study is part of a European research program FEDER number 2014-34018 (https://ec.europa.eu/regional_policy/en/funding/erdf/) about benchmark of prescription in NICUs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegaert K, 2019, EXPERT REV CLIN PHAR, V12, P343, DOI 10.1080/17512433.2019.1580569; Ancel PY, 2015, JAMA PEDIATR, V169, P230, DOI 10.1001/jamapediatrics.2014.3351; Cantey JB, 2018, J PEDIATR-US, V203, P62, DOI 10.1016/j.jpeds.2018.07.036; Cantey JB, 2016, LANCET INFECT DIS, V16, P1178, DOI 10.1016/S1473-3099(16)30205-5; Clark RH, 2006, PEDIATRICS, V117, P1979, DOI 10.1542/peds.2005-1707; Dai DW, 2016, PEDIATR CRIT CARE ME, V17, pE218, DOI 10.1097/PCC.0000000000000684; de Souza AS, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0551-8; Fabiano V, 2012, EXPERT OPIN DRUG SAF, V11, P95, DOI 10.1517/14740338.2011.584531; Flint RB, 2018, BRIT J CLIN PHARMACO, V84, P1313, DOI 10.1111/bcp.13563; Girardi A, 2017, ITAL J PEDIATR, V43, DOI 10.1186/s13052-017-0354-z; Gouyon B, 2017, J CLIN PHARM THER, V42, P64, DOI 10.1111/jcpt.12474; Horri J, 2014, J CLIN PHARM THER, V39, P637, DOI 10.1111/jcpt.12194; Hsieh EM, 2014, AM J PERINAT, V31, P811, DOI 10.1055/s-0033-1361933; Jain S, 2014, INDIAN PEDIATR, V51, P644, DOI 10.1007/s13312-014-0468-y; Kieran EA, 2014, ACTA PAEDIATR, V103, pE139, DOI 10.1111/apa.12541; Krzyzaniak N, 2016, J CLIN PHARM THER, V41, P612, DOI 10.1111/jcpt.12440; Krzyzaniak N, 2016, THER ADV DRUG SAF, V7, P102, DOI 10.1177/2042098616642231; Ku LC, 2017, PEDIATR CARDIOL, V38, P155, DOI 10.1007/s00246-016-1496-2; Laforgia N, 2014, PEDIATR INT, V56, P57, DOI 10.1111/ped.12190; Laughon MM, 2014, JAMA PEDIATR, V168, P130, DOI 10.1001/jamapediatrics.2013.4208; Lee JL, 2013, INT J CLIN PHARM-NET, V35, P1025, DOI 10.1007/s11096-013-9846-0; Costa HTMD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204427; Neubert A, 2010, EUR J CLIN PHARMACOL, V66, P87, DOI 10.1007/s00228-009-0722-8; Nir-Neuman H, 2018, ADV THER, V35, P1122, DOI 10.1007/s12325-018-0732-y; Nuytten A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170234; Porta A, 2012, J ANTIMICROB CHEMOTH, V67, P1278, DOI 10.1093/jac/dks021; Puopolo KM, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0925; Quantin C, 2014, J GYNECOL OBST BIO R, V43, P680, DOI 10.1016/j.jgyn.2013.09.004; Rosli R, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00027; Sweet DG, 2019, NEONATOLOGY, V115, P432, DOI 10.1159/000499361; Taketomo CKH J. H., 2016, LEXICOMP; Zimmerman KO, 2017, J PEDIATR-US, V180, P99, DOI 10.1016/j.jpeds.2016.07.001	32	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0222667	10.1371/journal.pone.0222667	http://dx.doi.org/10.1371/journal.pone.0222667			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JU6QQ	31536560	Green Published, Green Submitted, gold			2022-12-26	WOS:000501799400001
J	Yang, M; Gong, L; Sui, JX; Li, XZ				Yang, Mei; Gong, Lin; Sui, Jixing; Li, Xinzheng			The complete mitochondrial genome of Calyptogena marissinica (Heterodonta: Veneroida: Vesicomyidae): Insight into the deep-sea adaptive evolution of vesicomyids	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; ENERGY-METABOLISM GENES; AMINO-ACID SITES; TRANSFER-RNA; PHYLOGENETIC-RELATIONSHIPS; BATHYMODIOLUS MUSSELS; MITOGENOMIC ANALYSES; DNA SEQUENCE; BIVALVIA; VENT	The deep-sea chemosynthetic environment is one of the most extreme environments on the Earth, with low oxygen, high hydrostatic pressure and high levels of toxic substances. Species of the family Vesicomyidae are among the dominant chemosymbiotic bivalves found in this harsh habitat. Mitochondria play a vital role in oxygen usage and energy metabolism; thus, they may be under selection during the adaptive evolution of deep-sea vesicomyids. In this study, the mitochondrial genome (mitogenome) of the vesicomyid bivalve Calyptogena marissinica was sequenced with Illumina sequencing. The mitogenome of C. marissinica is 17,374 bp in length and contains 13 protein-coding genes, 2 ribosomal RNA genes (rrnS and rrnL) and 22 transfer RNA genes. All of these genes are encoded on the heavy strand. Some special elements, such as tandem repeat sequences, "G(A)(n)T" motifs and AT-rich sequences, were observed in the control region of the C. marissinica mitogenome, which is involved in the regulation of replication and transcription of the mitogenome and may be helpful in adjusting the mitochondrial energy metabolism of organisms to adapt to the deep-sea chemosynthetic environment. The gene arrangement of protein-coding genes was identical to that of other sequenced vesicomyids. Phylogenetic analyses clustered C. marissinica with previously reported vesicomyid bivalves with high support values. Positive selection analysis revealed evidence of adaptive change in the mitogenome of Vesicomyidae. Ten potentially important adaptive residues were identified, which were located in cox1, cox3, cob, nad2, nad4 and nad5. Overall, this study sheds light on the mitogenomic adaptation of vesicomyid bivalves that inhabit the deep-sea chemosynthetic environment.	[Yang, Mei; Gong, Lin; Sui, Jixing; Li, Xinzheng] Chinese Acad Sci, Inst Oceanol, Dept Marine Organism Taxon & Phylogeny, Qingdao, Peoples R China; [Yang, Mei; Gong, Lin; Sui, Jixing; Li, Xinzheng] Chinese Acad Sci, Ctr Ocean Megasci, Qingdao, Peoples R China; [Yang, Mei; Gong, Lin; Sui, Jixing; Li, Xinzheng] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Yang, Mei; Gong, Lin; Sui, Jixing; Li, Xinzheng] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; Qingdao National Laboratory for Marine Science & Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, XZ (corresponding author), Chinese Acad Sci, Inst Oceanol, Dept Marine Organism Taxon & Phylogeny, Qingdao, Peoples R China.; Li, XZ (corresponding author), Chinese Acad Sci, Ctr Ocean Megasci, Qingdao, Peoples R China.; Li, XZ (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.; Li, XZ (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	lixzh@qdio.ac.cn		Li, Xinzheng/0000-0001-6344-6542	National Key R&D Program of China [2018YFC0309804]; National Natural Science Foundation of China [41506173]; Chinese Academy of Sciences [XDB06010101]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was funded by the National Key R&D Program of China, 2018YFC0309804 to LG, the National Natural Science Foundation of China, 41506173 to MY, and Strategic Priority Research Program of the Chinese Academy of Sciences, XDB06010101 to XL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AQUADRO CF, 1983, GENETICS, V103, P287; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; BENNETT BA, 1994, MAR ECOL PROG SER, V108, P205, DOI 10.3354/meps108205; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boore JL, 1998, CURR OPIN GENET DEV, V8, P668, DOI 10.1016/S0959-437X(98)80035-X; BOSS KJ, 1980, MALACOLOGIA, V20, P161; Brown W.M., 1985, MOL EVOLUTIONARY GEN, P399; Chai HN, 2012, INT J BIOL SCI, V8, P561, DOI 10.7150/ijbs.3540; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen Chong, 2018, Venus (Tokyo), V76, P29, DOI 10.18941/venus.76.1-4_29; Chimnaronk S, 2005, EMBO J, V24, P3369, DOI 10.1038/sj.emboj.7600811; Couch RB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050830; da Fonseca RR, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-119; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Das J, 2006, BIOESSAYS, V28, P890, DOI 10.1002/bies.20463; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Dirmeier R, 2002, J BIOL CHEM, V277, P34773, DOI 10.1074/jbc.M203902200; Dreyer Hermann, 2006, Front Zool, V3, P13, DOI 10.1186/1742-9994-3-13; Fernandez-Silva P, 2003, EXP PHYSIOL, V88, P41, DOI 10.1113/eph8802514; FISHER CR, 1990, REV AQUAT SCI, V2, P399; Flot JF, 2007, GENE, V401, P80, DOI 10.1016/j.gene.2007.07.006; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; Gu ML, 2012, GENE, V496, P37, DOI 10.1016/j.gene.2011.12.016; Haas BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r7; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hui M, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4745-3; Johnson SB, 2017, SYST BIODIVERS, V15, P346, DOI 10.1080/14772000.2016.1252438; Krylova E.M., 2000, Ruthenica, V10, P76; Krylova EM, 2006, J MOLLUS STUD, V72, P359, DOI 10.1093/mollus/eyl022; Krylova EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009957; Kumazawa Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-930; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lan Y, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4720-z; Lavrov DV, 2000, P NATL ACAD SCI USA, V97, P13738, DOI 10.1073/pnas.250402997; Levin LA, 2005, OCEANOGR MAR BIOL, V43, P1, DOI 10.1201/9781420037449.ch1; Liao F, 2010, INT J BIOL SCI, V6, P172; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu HL, 2018, ECOL EVOL, V8, P7261, DOI 10.1002/ece3.4153; Liu HL, 2016, MITOCHONDRIAL DNA A, V27, P4333, DOI 10.3109/19401736.2015.1089488; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo YJ, 2008, MITOCHONDRION, V8, P352, DOI 10.1016/j.mito.2008.07.005; Mahalingam S, 2017, J PHYSIOL-LONDON, V595, P4785, DOI 10.1113/JP274130; Marshall HD, 1997, MOL BIOL EVOL, V14, P173, DOI 10.1093/oxfordjournals.molbev.a025750; Martijn J, 2018, NATURE, V557, P101, DOI 10.1038/s41586-018-0059-5; Martin W, 2008, NAT REV MICROBIOL, V6, P805, DOI 10.1038/nrmicro1991; Milbury CA, 2005, MAR BIOTECHNOL, V7, P697, DOI 10.1007/s10126-005-0004-0; Miller AD, 2005, MAR BIOTECHNOL, V7, P339, DOI 10.1007/s10126-004-4077-8; Mu WD, 2018, ECOL EVOL, V8, P10673, DOI 10.1002/ece3.4427; Mu WD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208051; Tan MH, 2018, MOL PHYLOGENET EVOL, V127, P320, DOI 10.1016/j.ympev.2018.05.015; Nielsen R, 1998, GENETICS, V148, P929; Ning T, 2010, GENET MOL RES, V9, P144, DOI 10.4238/vol9-1gmr705; OHTA T, 1992, ANNU REV ECOL SYST, V23, P263, DOI 10.1146/annurev.es.23.110192.001403; Ohtsuki T, 2002, FEBS LETT, V514, P37, DOI 10.1016/S0014-5793(02)02328-1; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; OKIMOTO R, 1992, GENETICS, V130, P471; Ozawa G, 2017, GENOME BIOL EVOL, V9, P2226, DOI 10.1093/gbe/evx166; Ozawa G, 2017, MAR GENOM, V31, P43, DOI 10.1016/j.margen.2016.09.003; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Perseke M, 2010, MOL PHYLOGENET EVOL, V56, P201, DOI 10.1016/j.ympev.2010.01.035; Plazzi F, 2017, GENOME BIOL EVOL, V9, P956, DOI 10.1093/gbe/evx051; Plazzi F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-409; Ren JF, 2010, J MOL EVOL, V70, P57, DOI 10.1007/s00239-009-9308-4; Sahyoun AH, 2015, NUCLEIC ACIDS RES, V43, P8044, DOI 10.1093/nar/gkv746; Salvato P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-331; Schuster A, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1230-1; Serb JM, 2003, MOL BIOL EVOL, V20, P1854, DOI 10.1093/molbev/msg218; Shen YY, 2010, P NATL ACAD SCI USA, V107, P8666, DOI 10.1073/pnas.0912613107; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; Silva G, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1093; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; STANTON DJ, 1994, GENETICS, V137, P233; Sun J, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0121; Sun S, 2018, GENE, V676, P123, DOI 10.1016/j.gene.2018.07.026; Sun SE, 2018, COMP BIOCHEM PHYS D, V25, P42, DOI 10.1016/j.cbd.2017.11.002; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tomasco IH, 2011, MOL PHYLOGENET EVOL, V61, P64, DOI 10.1016/j.ympev.2011.06.014; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361; von Cosel R, 2001, SARSIA, V86, P333, DOI 10.1080/00364827.2001.10425523; Vrijenhoek RC, 2010, MOL ECOL, V19, P4391, DOI 10.1111/j.1365-294X.2010.04789.x; Wang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep29690; Wang ZF, 2011, MOL BIOL EVOL, V28, P1553, DOI 10.1093/molbev/msq336; Wang ZL, 2016, INT J BIOL SCI, V12, P109, DOI 10.7150/ijbs.12358; Wang ZF, 2017, GENES GENOM, V39, P1367, DOI 10.1007/s13258-017-0600-1; WOLSTENHOLME DR, 1992, INT REV CYTOL, V141, P173, DOI 10.1016/S0074-7696(08)62066-5; Xu Shu-Qing, 2005, Genomics Proteomics & Bioinformatics, V3, P5; Xu XD, 2010, GENOME, V53, P1041, DOI 10.1139/G10-096; Yang YX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099120; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu H, 2012, MOL BIOL REP, V39, P999, DOI 10.1007/s11033-011-0825-z; Yu L, 2011, MITOCHONDRION, V11, P497, DOI 10.1016/j.mito.2011.01.004; Zhang B, 2017, ECOL EVOL, V7, P4951, DOI 10.1002/ece3.3067; Zheng P, 2017, MOL ECOL, V26, P5133, DOI 10.1111/mec.14160; Zhou TC, 2014, MITOCHONDRION, V18, P70, DOI 10.1016/j.mito.2014.07.012; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	102	15	15	6	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2019	14	9							e0217952	10.1371/journal.pone.0217952	http://dx.doi.org/10.1371/journal.pone.0217952			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM5BF	31536521	Green Submitted, gold, Green Published			2022-12-26	WOS:000532262800005
J	Jung, KH; Lee, EJ; Park, JW; Lee, JH; Moon, SH; Cho, YS; Lee, KH				Jung, Kyung-Ho; Lee, Eun Jeong; Park, Jin Won; Lee, Jin Hee; Moon, Seung Hwan; Cho, Young Seok; Lee, Kyung-Han			EGF receptor stimulation shifts breast cancer cell glucose metabolism toward glycolytic flux through PI3 kinase signaling	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; POSITRON-EMISSION-TOMOGRAPHY; IN-VITRO; TUMOR; EXPRESSION; THERAPY; HORMONE; ADENOCARCINOMA; PROLIFERATION; ASSOCIATION	Breast cancers that express epidermal growth factor (EGF) receptors (EGFRs) are associated with poor prognosis. Our group recently showed in breast cancer patients that EGFR expression is strongly correlated with high tumor uptake of the glucose analogue, F-18-fluoro-deoxyglucose (FDG). Here, we explored the cellular mechanism and signaling pathways that can explain the relation between EGFR and breast cancer cell glucose metabolism. FDG uptake, lactate production and hexokinase (HK) activity were measured, and proliferation assays and western blots were performed. EGF stimulated an increase of FDG uptake in EGFR-positive T47D and MDA-MB-468 cells, but not in MCF-7 cells. In T47D cells, the effect was dose-dependent and was accompanied by increased lactate production, indicating a shift toward glycolytic flux. This metabolic response occurred through enhanced HK activity and upregulated glucose transporter 1 (GLUT1) expression. EGFR stimulation also increased T47D cell proliferation. Blocking EGFR activation with BIBX1382 or gefitinib completely abolished both FDG uptake and proliferation effects. EGFR stimulation induced MAP kinase (MAPK) and PI3 kinase (PI3K) activation. Increased cell proliferation by EGFR stimulation was completely abolished by MAPK inhibition with PD98059 or by PI3K inhibition with LY294002. Increased FDG uptake was also completely abrogated by PI3K inhibition but was uninfluenced by MAPK inhibition. These findings suggest that the association between breast tumor EGFR expression and high FDG uptake might be contributed by stimulation of the PI3K pathway downstream of EGFR activation. This was in contrast to EGFRmediated cell proliferation that required MAPK as well as PI3K signaling.	[Jung, Kyung-Ho; Park, Jin Won; Lee, Jin Hee; Moon, Seung Hwan; Cho, Young Seok; Lee, Kyung-Han] Sungkyunkwan Univ, Samsung Med Ctr, Dept Nucl Med, Sch Med, Seoul, South Korea; [Jung, Kyung-Ho; Park, Jin Won; Lee, Jin Hee; Lee, Kyung-Han] Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea; [Lee, Eun Jeong] Seoul Med Ctr, Dept Nucl Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Seoul Medical Center	Lee, KH (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Nucl Med, Sch Med, Seoul, South Korea.; Lee, KH (corresponding author), Sungkyunkwan Univ, Dept Hlth Sci & Technol, SAIHST, Seoul, South Korea.	khnm.lee@samsung.com		Lee, Kyung-Han/0000-0003-3565-5536	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2018R1D1A1B07043260, 2016R1D1A1B03932202]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2018R1D1A1B07043260 and 2016R1D1A1B03932202).	AlFakeeh A, 2018, CURR ONCOL, V25, pS18, DOI 10.3747/co.25.3752; Aloj L, 1999, CANCER RES, V59, P4709; Badve S, 2011, MODERN PATHOL, V24, P157, DOI 10.1038/modpathol.2010.200; Batra S, 2013, ONCOLOGY-NY, V27, P460; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Dehdashti F, 2009, BREAST CANCER RES TR, V113, P509, DOI 10.1007/s10549-008-9953-0; Di Fabio F, 2007, GASTRIC CANCER, V10, P221, DOI 10.1007/s10120-007-0438-3; Elbaz M, 2015, MOL ONCOL, V9, P906, DOI 10.1016/j.molonc.2014.12.010; Enriori PJ, 2006, CLIN ENDOCRINOL, V64, P20, DOI 10.1111/j.1365-2265.2005.02408.x; Fan P, 2007, CANCER RES, V67, P1352, DOI 10.1158/0008-5472.CAN-06-1020; Gonzalez-Conchas GA, 2018, CANCER TREAT REV, V62, P1, DOI 10.1016/j.ctrv.2017.10.008; Grover-McKay M, 1998, Pathol Oncol Res, V4, P115; Gullick William J, 2009, Eur J Cancer, V45 Suppl 1, P205, DOI 10.1016/S0959-8049(09)70035-8; Guo BH, 2015, CANCER LETT, V361, P271, DOI 10.1016/j.canlet.2015.03.011; Hart S, 2005, BIOL CHEM, V386, P845, DOI 10.1515/BC.2005.099; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; ILLG D, 1979, EUR J BIOCHEM, V97, P267, DOI 10.1111/j.1432-1033.1979.tb13111.x; KAPLAN O, 1990, J BIOL CHEM, V265, P13641; Kim S, 2009, CELL SIGNAL, V21, P892, DOI 10.1016/j.cellsig.2009.01.034; Kyriakopoulou K, 2018, CELL SIGNAL, V51, P99, DOI 10.1016/j.cellsig.2018.07.010; Lee J, 2017, EUR J NUCL MED MOL I, V44, P1438, DOI 10.1007/s00259-017-3705-5; Levva S, 2017, CANCER GENOM PROTEOM, V14, P181, DOI 10.21873/cgp.20030; Lindsey S, 2015, INT REV CEL MOL BIO, V314, P1, DOI 10.1016/bs.ircmb.2014.10.001; Masuda Hiroko, 2012, Breast Cancer Res Treat, V136, P331, DOI 10.1007/s10549-012-2289-9; Nakai K, 2016, AM J CANCER RES, V6, P1609; NICHOLSON RI, 1994, BREAST CANCER RES TR, V29, P117, DOI 10.1007/BF00666187; Nose A, 2003, HYPERTENS RES, V26, P67; Ono M, 2006, CLIN CANCER RES, V12, P7242, DOI 10.1158/1078-0432.CCR-06-0646; Oshida M, 1998, CANCER, V82, P2227, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2227::AID-CNCR18>3.0.CO;2-W; Pons F, 2009, Q J NUCL MED MOL IM, V53, P210; PRIGENT SA, 1994, EMBO J, V13, P2831, DOI 10.1002/j.1460-2075.1994.tb06577.x; Reinert T, 2017, THER ADV MED ONCOL, V9, P693, DOI 10.1177/1758834017728928; Sanchez-Munoz A, 2009, CLIN TRANSL ONCOL, V11, P643, DOI 10.1007/s12094-009-0419-6; SARGEANT RJ, 1993, BIOCHEM J, V290, P913, DOI 10.1042/bj2900913; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Smith TAD, 1998, NUCL MED BIOL, V25, P481, DOI 10.1016/S0969-8051(98)00014-6; Solca FF, 2004, J PHARMACOL EXP THER, V311, P502, DOI 10.1124/jpet.104.069138; Su H, 2006, CLIN CANCER RES, V12, P5659, DOI 10.1158/1078-0432.CCR-06-0368; Takahashi R, 2012, CLIN CANCER RES, V18, P220, DOI 10.1158/1078-0432.CCR-11-0868; Toulany M, 2005, RADIOTHER ONCOL, V74, P117, DOI 10.1016/j.radonc.2004.11.008; Toulany M, 2006, CLIN CANCER RES, V12, P4119, DOI 10.1158/1078-0432.CCR-05-2454; van der Hiel B, 2001, J CANCER RES CLIN, V127, P269; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wang H, 2019, CANCER LETT, V455, P48, DOI 10.1016/j.canlet.2019.04.027; Xu JW, 2011, INT J ONCOL, V39, P1501, DOI 10.3892/ijo.2011.1143; Zhou M, 1998, AM J PHYSIOL-ENDOC M, V275, pE187, DOI 10.1152/ajpendo.1998.275.2.E187; Zhu G, 2015, ONCOGENE, V34, P5971, DOI 10.1038/onc.2015.45	47	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2019	14	9							e0221294	10.1371/journal.pone.0221294	http://dx.doi.org/10.1371/journal.pone.0221294			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4SI	31532771	Green Published, Green Submitted, gold			2022-12-26	WOS:000532239600007
J	Jensen, K; Stevens, JM; Glass, EJ				Jensen, Kirsty; Stevens, Joanne M.; Glass, Elizabeth J.			Interleukin 10 knock-down in bovine monocyte-derived macrophages has distinct effects during infection with two divergent strains of Mycobacterium bovis	PLOS ONE			English	Article							TUBERCULOSIS INFECTION; IL-10; CATTLE; EXPRESSION	Mycobacterium bovis is the causative agent of bovine tuberculosis (TB), a cattle disease of global importance. M. bovis infects bovine macrophages (Mo) and subverts the host cell response to generate a suitable niche for survival and replication. We investigated the role of the anti-inflammatory cytokine interleukin (IL) 10 during in vitro infection of bovine monocyte-derived Mo (bMDM) with two divergent UK strains of M. bovis, which differentially modulate expression of IL10. The use of IL10-targeting siRNA revealed that IL10 inhibited the production of IL1B, IL6, tumour necrosis factor (TNF) and interferon gamma (IFNG) during infection of bMDM with the M. bovis strain G18. In contrast, IL10 only regulated a subset of these genes; TNF and IFNG, during infection with the M. bovis reference strain AF2122/97. Furthermore, nitric oxide (NO) production was modulated by IL10 during AF2122/97 infection, but not at the nitric oxide synthase 2 (NOS2) mRNA level, as observed during G18 infection. However, IL10 was found to promote survival of both M. bovis strains during early bMDM infection, but this effect disappeared after 24 h. The role of IL10-induced modulation of TNF, IFNG and NO production in M. bovis survival was investigated using siRNA targeting TNF, IFNG receptor 1 (IFNGR1) and NOS2. Knock-down of these genes individually did not promote survival of either M. bovis strain and therefore modulation of these genes does not account for the effect of IL10 on M. bovis survival. However, TNF knock-down was found to be detrimental to the survival of the M. bovis strain G18 during early infection. The results provide further evidence for the importance of IL10 during M. bovis infection of Mo. Furthermore, they highlight M. bovis strain specific differences in the interaction with the infected bMDM, which may influence the course of infection and progression of bovine TB.	[Jensen, Kirsty; Stevens, Joanne M.; Glass, Elizabeth J.] Univ Edinburgh, Div Infect & Immun, Roslin Inst, Edinburgh, Midlothian, Scotland; [Jensen, Kirsty; Stevens, Joanne M.; Glass, Elizabeth J.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Jensen, K (corresponding author), Univ Edinburgh, Div Infect & Immun, Roslin Inst, Edinburgh, Midlothian, Scotland.	kirsty.jensen@roslin.ed.ac.uk		Jensen, Kirsty/0000-0002-0005-6931	BBSRC Strategic Programme grant (Control of Infectious Diseases) [BB/P013740/1]; BBSRC [BBS/E/D/20002174, BB/L004054/1] Funding Source: UKRI	BBSRC Strategic Programme grant (Control of Infectious Diseases)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	JMS, EJG, and KJ were supported by a BBSRC Strategic Programme grant (Control of Infectious Diseases: [BB/P013740/1]) (https://bbsrc.ukri.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broughan JM, 2016, EPIDEMIOL INFECT, V144, P2899, DOI 10.1017/S095026881600131X; Buza JJ, 2004, INFECT IMMUN, V72, P2425, DOI 10.1128/IAI.72.4.2425-2428.2004; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Denis M, 2005, IMMUNOL CELL BIOL, V83, P643, DOI 10.1111/j.1440-1711.2005.01386.x; Department for Environment, 2019, FOOD RUR AFF DEFRA R; Dorhoi A, 2014, SEMIN IMMUNOL, V26, P203, DOI 10.1016/j.smim.2014.04.003; Duan L, 2016, BIOCHEM BIOPH RES CO, V473, P1229, DOI 10.1016/j.bbrc.2016.04.045; Eberhardt MK, 2014, CURR TOP MICROBIOL, V380, P93, DOI 10.1007/978-3-662-43492-5_5; Engele M, 2002, J IMMUNOL, V168, P1328, DOI 10.4049/jimmunol.168.3.1328; Esquivel-Solis H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063464; Gabrysova L, 2014, CURR TOP MICROBIOL, V380, P157, DOI 10.1007/978-3-662-43492-5_8; Hmama Z, 2015, IMMUNOL REV, V264, P220, DOI 10.1111/imr.12268; Hu XY, 2006, IMMUNITY, V24, P563, DOI 10.1016/j.immuni.2006.02.014; Hussain T, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01915; Jensen K, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00385-17; Jensen K, 2016, VET RES, V47, DOI 10.1186/s13567-016-0328-y; Jensen K, 2014, VET IMMUNOL IMMUNOP, V158, P224, DOI 10.1016/j.vetimm.2014.02.002; Johnson L, 2007, TUBERCULOSIS, V87, P71, DOI 10.1016/j.tube.2006.04.002; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Mori M, 2000, BIOCHEM BIOPH RES CO, V275, P715, DOI 10.1006/bbrc.2000.3169; O'Leary S, 2011, AM J RESP CELL MOL, V45, P172, DOI 10.1165/rcmb.2010-0319OC; Pautz A, 2010, NITRIC OXIDE-BIOL CH, V23, P75, DOI 10.1016/j.niox.2010.04.007; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rojas JM, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/6104054; Rutz S, 2016, ADV EXP MED BIOL, V941, P89, DOI 10.1007/978-94-024-0921-5_5; Smith NH, 2006, NAT REV MICROBIOL, V4, P670, DOI 10.1038/nrmicro1472; Stenger S, 2005, ANN RHEUM DIS, V64, P24, DOI 10.1136/ard.2005.042531; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wang XL, 2018, TUBERCULOSIS, V108, P118, DOI 10.1016/j.tube.2017.11.008; Weiss DJ, 2005, AM J VET RES, V66, P721, DOI 10.2460/ajvr.2005.66.721; Whelan AO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008527; Wright DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074503	33	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222437	10.1371/journal.pone.0222437	http://dx.doi.org/10.1371/journal.pone.0222437			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527895	Green Submitted, Green Published, gold			2022-12-26	WOS:000532231400020
J	Rajan, SK; Lindqvist, M; Brummer, RJ; Schoultz, I; Repsilber, D				Rajan, Sukithar K.; Lindqvist, Marten; Brummer, Robert Jan; Schoultz, Ida; Repsilber, Dirk			Phylogenetic microbiota profiling in fecal samples depends on combination of sequencing depth and choice of NGS analysis method	PLOS ONE			English	Article							DNA EXTRACTION; METAGENOMICS; ECOLOGY	The human gut microbiota is well established as an important factor in health and disease. Fecal sample microbiota are often analyzed as a proxy for gut microbiota, and characterized with respect to their composition profiles. Modern approaches employ whole genome shotgun next-generation sequencing as the basis for these analyses. Sequencing depth as well as choice of next-generation sequencing data analysis method constitute two main interacting methodological factors for such an approach. In this study, we used 200 million sequence read pairs from one fecal sample for comparing different taxonomy classification methods, using default and custom-made reference databases, at different sequencing depths. A mock community data set with known composition was used for validating the classification methods. Results suggest that sequencing beyond 60 million read pairs does not seem to improve classification. The phylogeny prediction pattern, when using the default databases and the consensus database, appeared to be similar for all three methods. Moreover, these methods predicted rather different species. We conclude that the choice of sequencing depth and classification method has important implications for taxonomy composition prediction. A multi-method-consensus approach for robust gut microbiota NGS analysis is recommended.	[Rajan, Sukithar K.; Lindqvist, Marten; Brummer, Robert Jan; Schoultz, Ida; Repsilber, Dirk] Orebro Univ, Sch Med Sci, Orebro, Sweden	Orebro University	Repsilber, D (corresponding author), Orebro Univ, Sch Med Sci, Orebro, Sweden.	dirk.repsilber@oru.se		Repsilber, Dirk/0000-0002-7173-5579	Swedish Knowledge Foundation; Bo Rydin Foundation [F0514]	Swedish Knowledge Foundation(General Electric); Bo Rydin Foundation	RJB received funding for the Research Profile "Nutrition-Gut-Brain Interaction Research Centre" from the Swedish Knowledge Foundation (www.kks.se).IS received funding from the Bo Rydin Foundation (www.borydinfoundation.se, grant no F0514). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allali I, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1101-8; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bazinet AL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-92; Blanco-Miguez A, 2017, DATABASE-OXFORD, DOI 10.1093/database/baw157; Bokulich NA, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00062-16; Brooks JP, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0351-6; Bull Matthew J, 2014, Integr Med (Encinitas), V13, P17; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fumagalli M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079667; Halfvarson J, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.4; Hillmann B, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00069-18; Icaza-Chavez ME, 2013, REV GASTROENTEROL ME, V78, P240, DOI 10.1016/j.rgmx.2013.04.004; Jolley Keith A, 2018, Wellcome Open Res, V3, P124, DOI 10.12688/wellcomeopenres.14826.1; Jovel J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00459; Keegan KP, 2016, METHODS MOL BIOL, V1399, P207, DOI 10.1007/978-1-4939-3369-3_13; Koslicki D, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00020-16; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Larroya-Garcia A, 2019, CRIT REV FOOD SCI, V59, P3102, DOI 10.1080/10408398.2018.1484340; Lewis CM, 2012, TRENDS MICROBIOL, V20, P1, DOI 10.1016/j.tim.2011.10.004; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Lim MY, 2018, SYST APPL MICROBIOL, V41, P151, DOI 10.1016/j.syapm.2017.11.008; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Menzel P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11257; Michel PO, 2012, ANAL BIOCHEM, V430, P138, DOI 10.1016/j.ab.2012.08.028; Natividad JMM, 2013, PHARMACOL RES, V69, P42, DOI 10.1016/j.phrs.2012.10.007; NUDDS TD, 1983, CAN J ZOOL, V61, P1547, DOI 10.1139/z83-208; OLSEN GJ, 1986, ANNU REV MICROBIOL, V40, P337, DOI 10.1146/annurev.mi.40.100186.002005; Oulas A, 2015, BIOINFORM BIOL INSIG, V9, P75, DOI 10.4137/BBI.S12462; Ounit R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1419-2; Rup L, 2012, INDIAN J MICROBIOL, V52, P315, DOI 10.1007/s12088-012-0304-9; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Siegwald L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169563; Smith DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090234; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Treangen TJ, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r2; Uchiyama I, 2015, NUCLEIC ACIDS RES, V43, pD270, DOI 10.1093/nar/gku1152; Vandenberg N, 2002, J FORENSIC SCI, V47, P993; Walsh AM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0437-0; Weinstock GM, 2012, NATURE, V489, P250, DOI 10.1038/nature11553; Wen Y, 2016, AM J TRANSL RES, V8, P1412; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Yeh YC, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00023-18	47	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0222171	10.1371/journal.pone.0222171	http://dx.doi.org/10.1371/journal.pone.0222171			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527871	Green Published, gold, Green Submitted			2022-12-26	WOS:000532231400010
J	Schmitz, K; Wagner, S; Reppke, M; Maier, CL; Windeisen-Holzhauser, E; Benz, JP				Schmitz, Kevin; Wagner, Sebastian; Reppke, Manfred; Maier, Christian Ludwig; Windeisen-Holzhauser, Elisabeth; Benz, J. Philipp			Preserving cultural heritage: Analyzing the antifungal potential of ionic liquids tested in paper restoration	PLOS ONE			English	Article							FUNGI; SALTS	Early industrialization and the development of cheap production processes for paper have led to an exponential accumulation of paper-based documents during the last two centuries. Archives and libraries harbor vast amounts of ancient and modern documents and have to undertake extensive endeavors to protect them from abiotic and biotic deterioration. While services for mechanical preservation such as ex post de-acidification of historic documents are already commercially available, the possibilities for long-term protection of paper-based documents against fungal attack (apart from temperature and humidity control) are very limited. Novel processes for mechanical enhancement of damaged cellulosic documents use Ionic Liquids (IL) as essential process components. With some of these ILs having azolefunctionalities similar to well-known fungicides such as Clotrimazole, the possibility of antifungal activities of these ILs was proposed but has not yet been experimentally confirmed. We evaluated the potency of four ILs with potential application in paper restoration for suppression of fungal growth on five relevant paper-infesting molds. The results revealed a general antifungal activity of all ILs, which increased with the size of the non-polar group. Physiological experiments and ultimate elemental analysis allowed to determine the minimal inhibitory concentration of each IL as well as the residual IL concentration in process-treated paper. These results provide valuable guidelines for IL-applications in paper restoration processes with antifungal activity as an added benefit. With azoles remaining in the paper after the process, simultaneous repair and biotic protection in treated documents could be facilitated.	[Schmitz, Kevin; Wagner, Sebastian; Reppke, Manfred; Windeisen-Holzhauser, Elisabeth; Benz, J. Philipp] Tech Univ Munich, TUM Sch Life Sci Weihenstephan, Wood Res Munich, Freising Weihenstephan, Germany; [Maier, Christian Ludwig] Ludwig Maximilians Univ Munchen, Fac Chem & Pharm, Munich, Germany; [Maier, Christian Ludwig] Nitrochem Aschau GmbH, Aschau, Germany	Technical University of Munich; University of Munich	Schmitz, K (corresponding author), Tech Univ Munich, TUM Sch Life Sci Weihenstephan, Wood Res Munich, Freising Weihenstephan, Germany.	schmitz@hfm.tum.de	Benz, J. Philipp/ABG-5009-2020	Benz, J. Philipp/0000-0001-5361-4514; Schmitz, Kevin/0000-0002-0278-4107	Nitrochemie Aschau GmbH	Nitrochemie Aschau GmbH	This research was partly funded by the Nitrochemie Aschau GmbH (https://www.nitrochemie.com/en/nitrochemie_group/home.php).CLM is an employee of this company, supplied the ionic liquids used in this study and was involved in data interpretation and manuscript proof reading. Other than this, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study design was nevertheless independent of any influence by the company. There was no additional external funding received for this study.	Araque JC, 2015, J PHYS CHEM B, V119, P12727, DOI 10.1021/acs.jpcb.5b05506; Borrego Sofia, 2012, ISRN Microbiol, V2012, P680598, DOI 10.5402/2012/680598; Cedzova M, 2008, RESTAURATOR INT J PR, V27, P35, DOI [10.1515/REST.2006.35, DOI 10.1515/REST.2006.35]; Cedzova M, 2006, RESTAURATOR, V27, P35, DOI 10.1515/REST.2006.35; Area MC, 2011, BIORESOURCES, V6, P5307; da Silva M, 2006, INT BIODETER BIODEGR, V57, P163, DOI 10.1016/j.ibiod.2006.02.003; Ferreira A, 1996, FUNGAL GENETICS REPO, V43; Florian M-LE, 2004, J AM INT CONSERV, V43, P114; Gaumann E, 1964, FAMILIE MEANOSPORACE, V2, P104; GODEFROI EF, 1969, J MED CHEM, V12, P784, DOI 10.1021/jm00305a014; Hayes R, 2015, CHEM REV, V115, P6357, DOI 10.1021/cr500411q; Jiang ZC, 2018, SUSTAIN ENERG FUELS, V2, P936, DOI 10.1039/c8se00045j; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Krupp A, 2016, METHOD PROCESSING MA; LAKSHMIKANT, 1990, WORLD J MICROB BIOT, V6, P64, DOI 10.1007/BF01225357; Maier CL, 2019, THESIS; Mesquita N, 2009, INT BIODETER BIODEGR, V63, P626, DOI 10.1016/j.ibiod.2009.03.010; Nyuksha JP, 1980, RESTAURATOR, V4, P71, DOI [10.1515/rest.1980.4.1.71, DOI 10.1515/REST.1980.4.1.71]; Park N.-H., 2017, PHARM THERAPEUTICS D, V7th ed., P488, DOI DOI 10.1016/B978-0-323-39307-2.00034-5; Plempel M, 1969, Ger Med Mon, V14, P532; Qaisar S, 2014, CARBOHYD POLYM, V104, P199, DOI 10.1016/j.carbpol.2014.01.014; Ramin M, 2017, PROCESS TREATMENT MA; Rastegari AA, 2018, NEW AND FUTURE DEVELOPMENTS IN MICROBIAL BIOTECHNOLOGY AND BIOENGINEERING: PENICILLIUM SYSTEM PROPERTIES AND APPLICATIONS, P153, DOI 10.1016/B978-0-444-63501-3.00008-9; Ricelli A, 1999, RESTAURATOR, V20, P97, DOI 10.1515/rest.1999.20.2.97; Sanmartin P, 2018, MICROB ECOL, V76, P64, DOI 10.1007/s00248-016-0770-4; Schonherr J, 2002, PEST MANAG SCI, V58, P343, DOI 10.1002/ps.462; Sequeira SO, 2014, RESTAURATOR, V35, P181, DOI 10.1515/res-2014-0005; Sequeira SO, 2019, CONSERV PATRIM, P18, DOI 10.14568/cp2018007; Shuter J, 1999, CANCER INVEST, V17, P145; Skora J, 2015, AEROBIOLOGIA, V31, P389, DOI 10.1007/s10453-015-9372-8; SUD IJ, 1979, ANTIMICROB AGENTS CH, V16, P660, DOI 10.1128/AAC.16.5.660; Szczepanowska H., 1992, J AM INT CONSERV, V31, P147, DOI DOI 10.2307/3179489; Vale I, 2014, PROCEEDINGS OF THE PROBLEM@WEB INTERNATIONAL CONFERENCE: TECHNOLOGY, CREATIVITY AND AFFECT IN MATHEMATICAL PROBLEM SOLVING, P229; Vogel HJ, 1956, MICROB GENET B, V13, P42; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wilkes JS, 2002, GREEN CHEM, V4, P73, DOI 10.1039/b110838g; Young D, 2018, BIORESOURCE TECHNOL, V268, P470, DOI 10.1016/j.biortech.2018.07.103; Zyska B, 1997, INT BIODETER BIODEGR, V40, P43, DOI 10.1016/S0964-8305(97)00061-9	38	8	8	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2019	14	9							e0219650	10.1371/journal.pone.0219650	http://dx.doi.org/10.1371/journal.pone.0219650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4PG	31527882	Green Published, gold, Green Submitted			2022-12-26	WOS:000532231400004
J	Fumis, RRL; Ferraz, AB; de Castro, I; de Oliveira, HSB; Moock, M; Vieira, JM				Lins Fumis, Renata Rego; Ferraz, Antonio Bento; de Castro, Isac; Barros de Oliveira, Henrique Souza; Moock, Marcelo; Vieira Junior, Jose Mauro			Mental health and quality of life outcomes in family members of patients with chronic critical illness admitted to the intensive care units of two Brazilian hospitals serving the extremes of the socioeconomic spectrum	PLOS ONE			English	Article							INFORMAL CAREGIVER BURDEN; EPIDEMIOLOGY; SURVIVORS; COSTS	Chronic critical illness (CCI) is a relevant clinical, social and financial health issue. The aim of this study was to compare the mental outcomes (symptoms of anxiety and depression) and quality of life outcomes of the family members of patients with CCI from different socioeconomic backgrounds who were admitted to one of the intensive care units (ICUs) in two Brazilian hospitals, one private and one public. It is a prospective study involving a public hospital that serves a low-income population and a tertiary private hospital that serves a high-income population. Family members of patients with CCI answered the Hospital Anxiety and Depression Scale (HADS) and The World Health Organization Quality of Life-WHOQOL-bref questionnaires. They responded to the European Quality of life Five Dimension three Level (EuroQol-5D-3L) and the Activities of Daily Living (ADL) questionnaires on behalf of the patients at three time points: during the ICU stay, 30 and 90 days after the patient was discharged. We used logistic regression models to evaluate the main predictors of a binary outcome regarding symptoms of anxiety and depression. We enrolled 186 patients with CCI. Many patients from public hospitals who were independent became dependent for their ADLs at 90 days (41.7% versus 14.3%, p = 0.03). At 30 days, family members from public hospital had worse impact on all domains of WHOQOL-bref compared with families from private hospital. At 90-days, the difference persists in the physical domain, worse for families from public hospital (p = 0.006). The symptoms of depression at 30-days (p = 0.008) and at 90-days (p = 0.013) were worse in the public hospital. CCIs affected quality of life and the emotional condition of family members, especially in families with fewer resources when the patients became more dependent. Family members with higher education were more likely to experience depression, while depression was associated with cohabiting with the patient in low-income families.	[Lins Fumis, Renata Rego; Barros de Oliveira, Henrique Souza; Vieira Junior, Jose Mauro] Hosp Sirio Libanes, Intens Care Unit, Sao Paulo, Brazil; [Ferraz, Antonio Bento; Moock, Marcelo] Hosp Geral Grajau, Intens Care Unit, Sao Paulo, Brazil; [de Castro, Isac] Univ Sao Paulo, Dept Med, Div Nephrol & Mol Med, Sch Med, Sao Paulo, Brazil	Hospital Sirio Libanes; Universidade de Sao Paulo	Fumis, RRL (corresponding author), Hosp Sirio Libanes, Intens Care Unit, Sao Paulo, Brazil.	regolins@uol.com.br	Castro, Isac de/J-1984-2015; de Castro, Isac/AAA-8990-2021	Castro, Isac de/0000-0002-1160-3064; Oliveira, Henrique Souza Barros de/0000-0002-9067-8581	'Fundacaode Amparo a Pesquisa do Estado de SaoPaulo-'FAPESP [2015/17687-4]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [800397/2016-9]	'Fundacaode Amparo a Pesquisa do Estado de SaoPaulo-'FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study is supported by 'Fundacaode Amparo a Pesquisa do Estado de SaoPaulo-'FAPESP - Process no 2015/17687-4 to RRLF and supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq, process no 800397/2016-9 to HSBO. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Botega NJ, 1995, REV SAUDE PUBL, V29, P355, DOI 10.1590/S0034-89101995000500004; Cameron JI, 2016, NEW ENGL J MED, V374, P1831, DOI 10.1056/NEJMoa1511160; Carson SS, 2002, CRIT CARE CLIN, V18, P461, DOI 10.1016/S0749-0704(02)00015-5; Dowdy DW, 2005, INTENS CARE MED, V31, P611, DOI 10.1007/s00134-005-2592-6; Erdem O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157119; Fleck MPA, 2000, REV SAUDE PUBL, V34, P178, DOI 10.1590/S0034-89102000000200012; Hickman RL, 2010, AACN ADV CRIT CARE, V21, P80, DOI 10.1097/NCI.0b013e3181c930a3; Im KA, 2004, CHEST, V125, P597, DOI 10.1378/chest.125.2.597; Kahn JM, 2015, CRIT CARE MED, V43, P282, DOI 10.1097/CCM.0000000000000710; Leske J S, 1998, Am J Crit Care, V7, P383; Lewis Maureen, 2015, World Hosp Health Serv, V51, P22; Fumis RRL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115332; Maguire JM, 2013, CURR OPIN CRIT CARE, V19, P480, DOI 10.1097/MCC.0b013e328364d65e; Matt B, 2017, J CRIT CARE, V39, P172, DOI 10.1016/j.jcrc.2017.02.036; Moralez GM, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0276-3; Nelson JE, 2010, AM J RESP CRIT CARE, V182, P446, DOI 10.1164/rccm.201002-0210CI; Rzewuska M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171813; Sakusic A, 2016, LANCET RESP MED, V4, P531, DOI 10.1016/S2213-2600(16)30066-2; Lino VTS, 2008, CAD SAUDE PUBLICA, V24, P103, DOI 10.1590/S0102-311X2008000100010; van Beusekom I, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1185-9; Van den Broucke S, 2014, ARCH PUBLIC HEALTH, V72, DOI 10.1186/2049-3258-72-10; Van Pelt DC, 2007, AM J RESP CRIT CARE, V175, P167, DOI 10.1164/rccm.200604-493OC; Van Pelt DC, 2010, CHEST, V137, P88, DOI 10.1378/chest.09-0795; Wintermann GB, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0174-0	25	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2019	14	9							e0221218	10.1371/journal.pone.0221218	http://dx.doi.org/10.1371/journal.pone.0221218			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LM4KS	31518359	gold, Green Submitted, Green Published			2022-12-26	WOS:000532219300011
J	Ozoh, OB; Aderibigbe, SA; Ayuk, AC; Desalu, OO; Oridota, OE; Olufemi, O; Egbagbe, E; Babashani, M; Shopeyin, A; Ukwaja, K; Dede, SK				Ozoh, Obianuju B.; Aderibigbe, Sunday A.; Ayuk, Adaeze C.; Desalu, Olufemi O.; Oridota, Olufela E.; Olufemi, Olajumoke; Egbagbe, Eruke; Babashani, Musa; Shopeyin, Azeezat; Ukwaja, Kingsley; Dede, Sandra K.			The prevalence of asthma and allergic rhinitis in Nigeria: A nationwide survey among children, adolescents and adults	PLOS ONE			English	Article							RESPIRATORY SYMPTOMS; SCHOOL-CHILDREN; AIR-POLLUTION; GLOBAL BURDEN; AFRICA; RHINOCONJUNCTIVITIS; SEVERITY; INSIGHTS; REALITY; DISEASE	Purpose Asthma is an important cause of morbidity and mortality worldwide and information on the prevalence of asthma in Nigeria is inconsistent. Nationally representative data, important for health planning is unavailable. We aimed to determine the current prevalence of asthma and allergic rhinitis in Nigeria. Materials and methods A cross-sectional population survey conducted between June 2017 and March 2018 across five cities representing five geo-political zones in Nigeria. Validated screening questionnaires were used to identify persons with asthma and allergic rhinitis respectively. Asthma was defined as physician diagnosed asthma, clinical asthma and by presence of wheeze in the last 12 months respectively. Socio-demographic information, tobacco smoking, sources of household cooking fuel were also obtained. Results A total of 20063 participants from 6024 households were screened. The prevalence (95% confidence interval) of physician diagnosed asthma, clinical asthma and wheeze was 2.5% (2.3-2.7%), 6.4% (6.0-6.64%) and 9.0% (8.6-9.4%) respectively. The prevalence of allergic rhinitis was 22.8% (22.2-23.4%). The prevalence of asthma and rhinitis increased with age (prevalence of clinical asthma: 3.1% (2.8-3.4%), 9.8% (9.1-10.5) and 10.7% (9.4%-12.0) among 6-17 years, 18-45 years and >45 years respectively). Prevalence also varied across different cities with the highest prevalence of clinical asthma occurring in Lagos (8.0%) and the lowest in Ilorin (1.1%). The frequency of allergic rhinitis among persons with clinical asthma was 74.7%. Presence of allergic rhinitis, family history of asthma, current smoking and being overweight were independent determinants of current asthma among adults. Conclusion The prevalence of asthma and allergic rhinitis in Nigeria is high with variabilities across regions and age groups. The number of persons with clinical asthma in Nigeria (approximately 13 million) is likely to rank among the highest in Africa. This warrants prioritization by stakeholders and policy makers to actively implement risk reduction measures and increase investment in capacity building for the diagnosis and treatment of asthma and allergic rhinitis.	[Ozoh, Obianuju B.] Univ Lagos, Coll Med, Dept Med, Yaba, Lagos State, Nigeria; [Ozoh, Obianuju B.; Oridota, Olufela E.; Olufemi, Olajumoke; Shopeyin, Azeezat; Dede, Sandra K.] Lagos Univ, Teaching Hosp, Yaba, Lagos State, Nigeria; [Aderibigbe, Sunday A.] Univ Ilorin, Coll Hlth Sci, Dept Publ Hlth, Ilorin, Kwara State, Nigeria; [Ayuk, Adaeze C.] Univ Nigeria, Coll Med, Dept Paediat, Teaching Hosp, Ituku, Enugu State, Nigeria; [Desalu, Olufemi O.] Univ Ilorin, Coll Hlth Sci, Dept Med, Ilorin, Kwara State, Nigeria; [Oridota, Olufela E.] Univ Lagos, Coll Med, Dept Community Med & Child Hlth, Yaba, Lagos State, Nigeria; [Egbagbe, Eruke] Univ Benin, Coll Med, Dept Med, Benin, Edo State, Nigeria; [Babashani, Musa] Aminu Kano Univ, Coll Med, Dept Med, Kano, Kano State, Nigeria; [Ukwaja, Kingsley] Fed Teaching Hosp Abakiliki, Dept Internal Med, Abakaliki, Ebonyi State, Nigeria	University of Lagos; University of Ilorin; University of Nigeria; University of Ilorin; University of Lagos; University of Benin	Ozoh, OB (corresponding author), Univ Lagos, Coll Med, Dept Med, Yaba, Lagos State, Nigeria.; Ozoh, OB (corresponding author), Lagos Univ, Teaching Hosp, Yaba, Lagos State, Nigeria.	ujuozoh@yahoo.com	Desalu, Olufemi Olumuyiwa/AFK-7767-2022; AYUK, ADAEZE C/AAB-7094-2019	AYUK, ADAEZE C/0000-0003-3325-3488; Ozoh, Obianuju/0000-0002-7865-4771	GlaxoSmithKline Pharmaceutical Nigeria [ISS 8210]	GlaxoSmithKline Pharmaceutical Nigeria	This study was funded through an investigator initiated non-interventional grant from GlaxoSmithKline Pharmaceutical Nigeria, ISS 8210, to OBO. The funders had no role in study design, data collection and analysis, decision to publish or preparation of manuscript.	Adam V. Y., 2015, Annals of Biomedical Sciences, V14, P121; Adekoya-Cole T O, 2015, Nig Q J Hosp Med, V25, P112; Adeloye D, 2013, CROAT MED J, V54, P519, DOI 10.3325/cmj.2013.54.519; Ait-Khaled N, 2007, ALLERGY, V62, P247, DOI 10.1111/j.1398-9995.2007.01325.x; Annesi-Maesano I, 2002, ALLERGY, V57, P107, DOI 10.1034/j.1398-9995.2002.1o3170.x; [Anonymous], 2017, WORLD POP PROSP 2017; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Brauer M, 2002, AM J RESP CRIT CARE, V166, P1092, DOI 10.1164/rccm.200108-007OC; Burney P, 2015, INT J TUBERC LUNG D, V19, P10, DOI 10.5588/ijtld.14.0446; Burney P, 1996, EUR RESPIR J, V9, P687; Dave-agboolai O., 2018, INT J HLTH SCI RES, V8, P259; Desalu O O, 2009, Afr J Med Med Sci, V38, P149; Desalu OO, 2009, J INVEST ALLERG CLIN, V19, P474; Desalu OO, 2018, ETHIOP J HEALTH SCI, V28, P725, DOI 10.4314/ejhs.v28i6.7; Ellwood P, 2013, THORAX, V68, P351, DOI 10.1136/thoraxjnl-2012-202285; Falade AG, 2009, J NATL MED ASSOC, V101, P414, DOI 10.1016/S0027-9684(15)30925-1; Falade AG, 2004, MED PRIN PRACT, V13, P20, DOI 10.1159/000074046; GARROW JS, 1985, INT J OBESITY, V9, P147; Guarnieri M, 2014, LANCET, V383, P1581, DOI 10.1016/S0140-6736(14)60617-6; Ibe CC, 2002, NJG J INT MED, V5, P23; Khadadah M, 2009, INT J TUBERC LUNG D, V13, P1015; Khan DA, 2014, ALLERGY ASTHMA PROC, V35, P357, DOI 10.2500/aap.2014.35.3794; Komolafe A. A., 2014, American Journal of Environmental Sciences, V10, P412, DOI 10.3844/ajessp.2014.412.423; Morgan BW, 2018, J ALLER CL IMM-PRACT, V6, P1580, DOI 10.1016/j.jaip.2017.11.032; Musa BM, 2014, AFR J RESPIR MED, V10, P4; Mustapha BA, 2013, INT J TUBERC LUNG D, V17, P982, DOI 10.5588/ijtld.12.0434; Nafti S, 2009, RESP MED, V103, pS2, DOI 10.1016/S0954-6111(09)70022-8; National Population Commission, 2006, NIG POP CENS STAT PO; Obaseki DO, 2014, RESP MED, V108, P1581, DOI 10.1016/j.rmed.2014.09.022; Obel KB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176875; Oliveira P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32837-w; Oluwole O, 2013, AFR HEALTH SCI, V13, P144, DOI 10.4314/ahs.v13i1.20; Omotoso O., 2010, AFRICAN RES REV AFR, V4, P125; Onyedum CC, 2013, ANN MED HEALTH SCI R, V3, P324, DOI 10.4103/2141-9248.117927; Ozoh OB, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040641; Rabe KF, 2004, J ALLERGY CLIN IMMUN, V114, P40, DOI 10.1016/j.jaci.2004.04.042; Reddel KH, 2018, GLOBAL INITIATIVE AS; Sembajwe G, 2010, EUR RESPIR J, V35, P279, DOI 10.1183/09031936.00027509; Soriano JB, 2017, LANCET RESP MED, V5, P691, DOI 10.1016/S2213-2600(17)30293-X; Stewart AW, 2001, INT J EPIDEMIOL, V30, P173, DOI 10.1093/ije/30.1.173; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; TOREN K, 1993, CHEST, V104, P600, DOI 10.1378/chest.104.2.600; Uzochukwu BSC, 2015, NIGER J CLIN PRACT, V18, P437, DOI 10.4103/1119-3077.154196; Vos T, 2016, LANCET, V388, P1545, DOI [10.1016/S0140-6736(16)31012-1, 10.1016/S0140-6736(16)31678-6]; World Health Organization, MAT NEWB CHILD AD HL; World Health Organization, EXP AMB AIR POLL PAR; Zhang Y, 2019, ALLERGY ASTHMA IMMUN, V11, P156, DOI 10.4168/aair.2019.11.2.156	48	25	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2019	14	9							e0222281	10.1371/journal.pone.0222281	http://dx.doi.org/10.1371/journal.pone.0222281			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4KS	31518382	Green Published, gold, Green Submitted			2022-12-26	WOS:000532219300017
J	Yamaguchi, I; Watanabe, T; Ohara, O; Hasegawa, Y				Yamaguchi, Izumi; Watanabe, Takashi; Ohara, Osamu; Hasegawa, Yoshinori			PCR-free whole exome sequencing: Cost-effective and efficient in detecting rare mutations	PLOS ONE			English	Article								In this study, we describe the development of a PCR-free whole exome sequencing method. Using this method, 2 mu g DNA was sufficient for library preparation for whole exome sequencing. Furthermore, the method is simple and makes use of a commercial kit, with additional step of concentrating the captured library by ethanol precipitation. The accuracy of the PCR-free method was found to be equivalent to that of unique molecular identifier-corrected analysis method, which is the commonly used method to detect rare mutations. Thus, the PCR-free whole exome sequencing method is cost-effective as well as efficient in detecting rare mutations.	[Yamaguchi, Izumi; Watanabe, Takashi; Ohara, Osamu; Hasegawa, Yoshinori] Kazusa DNA Res Inst, Dept Appl Genom, Lab Clin Omics Res, Chiba, Japan	Kazusa DNA Research Institute	Hasegawa, Y (corresponding author), Kazusa DNA Res Inst, Dept Appl Genom, Lab Clin Omics Res, Chiba, Japan.	yhasega@kazusa.or.jp	Ohara, Osamu/G-5448-2015	Ohara, Osamu/0000-0002-3328-9571; Hasegawa, Yoshinori/0000-0003-2904-6611				Ahn EH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136216; Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Dolzhenko E, 2017, GENOME RES, V27, P1895, DOI 10.1101/gr.225672.117; Goren A, 2010, NAT METHODS, V7, P47, DOI [10.1038/NMETH.1404, 10.1038/nmeth.1404]; Gundry M, 2012, MUTAT RES-FUND MOL M, V729, P1, DOI [10.1016/j.mrfmmm.2011.10.001, 10.1016/mrfmmm.2011.10.001]; Ikeda F, 2017, HAEMATOLOGICA, V102, pE93, DOI 10.3324/haematol.2016.153932; Karasaki T, 2017, CANCER SCI, V108, P170, DOI 10.1111/cas.13131; Kennedy SR, 2014, NAT PROTOC, V9, P2586, DOI 10.1038/nprot.2014.170; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Kou RQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146638; Petljak M, 2019, CELL, V176, P1282, DOI 10.1016/j.cell.2019.02.012; Sahraeian SME, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09027-x; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Wang R, 2015, BRIT J HAEMATOL, V168, P854, DOI 10.1111/bjh.13229; Warr A, 2015, G3-GENES GENOM GENET, V5, P1543, DOI 10.1534/g3.115.018564	16	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2019	14	9							e0222562	10.1371/journal.pone.0222562	http://dx.doi.org/10.1371/journal.pone.0222562			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LM4KS	31518370	Green Published, Green Submitted, gold			2022-12-26	WOS:000532219300025
